Citrus Sinensis ID: 014609

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370-------380-------390-------400-------410-------420-
Protein Sequence
MVIAEKKQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPANPDDDEEDIFVDNEAFSMHEVPSDGGRTPGSPPLINAFQLIGMSSCLDLSGFFEKEDVSERKIRFTSNHSAKDLLERIEDIVTEMGFRVQKKNGKLKATQEHKPQKSLGSLSVAAEVFEISPSLYVVELRKSYGDPTVYRQLCNKLSSDLGLPPSQELLATEV
Secondary Structure (PSIPRED)
cccccccccccEEEcEEEEEEEEccccEEEEEEEEcccccEEEEEEEEccccccccHHHHHHHHHHHHHHcccccEEEEEEEEEcccEEEEEEEEcccccHHHHHHHcccccHHHHHHHHHHHHHHHHHHHcccccccccccccccccccccEEEEcccccccccccccccEEEcccccccccHHHHcccccccccccccccccEEEEEEEccccccccccHHHHHHHHHHccccccccccHHHHHccccccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHcccccccccccccccccccccccccccHHHHHHHHHHHHHHcccEEEEEccEEEEEEccccccccccEEEEEEEEEEcccEEEEEEEEccccHHHHHHHHHHHHHHcccccccccccccc
Secondary Structure Prediction (SSPRO)
ccccccccccccHHHEEEEEEEEEccccEEEEEEEcccccEEEEEEEEHHHHHHcccHHHHHHHHHHHHHcccccEccEEEEEEcccEEEEEEccccccEHHHHHHHHccccHHHHHHHHHHHHHHHHHHHHccEEcccccHHHEEEcccccEEEccccccccHHHccccccEEcccccHccccHHHHHccccccccHHHHcHcEEEEEEHccccccccccHHHHHHHHHHcccccccEEEHHHHHccHHHcccccccccccccccccccccccccccccccccccccccccccHHHEEEcccccccHHHHHccccccEEEEEEccccHHHHHHHHHHHHHHcccEEEEEccEEEEEEEccccccccEEEEEEEEEEEcccEEEEEEEcccccHHHHHHHHHHHHHHccccccHHcccccc
Coil and Loop (DISEMBL)
mviaekkqegmrlGRYELgrtlgegnfgkvkfaqdldsgLPFAVKILEKNRIIHLKITDQIKREIATLKllkhpnvvrLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVsychnkgvfhrdlKLENILldskgnikisdfglsalpqhfrddgllhttcgspnyvapevlanrgydgatsdiwSCGVILYIFrgdfklpkwlspgaQNLLRkilepnpvkritiagikadewfeqdytpanpdddeedifvdneafsmhevpsdggrtpgspplinAFQLIGMsscldlsgffekedvserkirftsnHSAKDLLERIEDIVTEMGFRvqkkngklkatqehkpqkslgslSVAAEVFEISPSLYVVELRKSYGDPTVYRQLCNKlssdlglppsqellatev
Flexible Loop (DISEMBL)
mviaekkqegmrlgRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATlkllkhpnvvrlHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIFRGDFKLPKWLSPGAQNLlrkilepnpvKRITIAGIKADEWFEQDYTPANPDDDEEDIFVDNEAFSMHEVPSDGGRTPGSPPLINAFQLIGMSSCLDLSGFFEKedvserkirftsnhsakdlLERIEDIVTEMGFRVQKKngklkatqehkpqkslgslsVAAEVFEISPSLYVVELRKSYGDPTVYRQLCNKlssdlglppsqellatev
Low Complexity Region (SEG)
MVIAEKKQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPANPDDDEEDIFVDNEAFSMHEVPSDGGRTPGSPPLINAFQLIGMSSCLDLSGFFEKEDVSERKIRFTSNHSAKDLLERIEDIVTEMGFRVQKKNGKLKATQEHKPQKSLGSLSVAAEVFEISPSLYVVELRKSYGDPTVYRQLCNKLSSDLGLPPSQELLATEV
Disordered region (IsUnstruct)
*************GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY************************************LINAFQLIGMSSCLDLSGFFEKEDVSERKIRFT****AKDLLERIEDIVTEMGFR**********************LSVAAEVFEISPSLYVVELRKSYGDPTVYRQLCNKL*****************
Disordered Region (DISOPRED)
***************YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPA***********************************NAFQLIGMSSCL*************************DLLERIEDIVTEMGFRVQ********************LSVAAEVFEISPSLYVVELRKSYGDPTVYRQLCNKLSSDLGLPPSQELLATEV
Disordered Region (DISEMBL)
********EGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPANPDDDEEDIFVDNEAFSMHEVPSDGGRTPGSPPLINAFQLIGMSSCLDLSGFFEKEDVSERKIRFTSNHSAKDLLERIEDIVTEMGFRVQKKNGKLKATQEHKPQKSLGSLSVAAEVFEISPSLYVVELRKSYGDPTVYRQLCNKLSSDLGLPPSQELLATEV
Disordered Region (DISPRO)
*********GMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYT********************************SPPLINAFQLIGMSSCLDLSGFFEKEDVSERKIRFTSNHSAKDLLERIEDIVTEMGFRVQKKNGKLKATQEHKPQKSLGSLSVAAEVFEISPSLYVVELRKSYGDPTVYRQLCNKLSSDLGLPPS**L*****
Transmembrane Helix (TMHMM)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (HMMTOP)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
Transmembrane Helix (MEMSAT)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiihhhhhhhhhhhhhhhhhhhooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (MEMSAT_SVM)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooohhhhhhhhhhhhhhhhiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (Phobius)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MVIAEKKQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPANPDDDEEDIFVDNEAFSMHEVPSDGGRTPGSPPLINAFQLIGMSSCLDLSGFFEKEDVSERKIRFTSNHSAKDLLERIEDIVTEMGFRVQKKNGKLKATQEHKPQKSLGSLSVAAEVFEISPSLYVVELRKSYGDPTVYRQLCNKLSSDLGLPPSQELLATEV
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	421	2.2.26 [Sep-21-2011]
Q8RWC9	444	CBL-interacting serine/th	yes	no	0.983	0.932	0.665	1e-163
Q94C40	432	CBL-interacting serine/th	no	no	0.969	0.944	0.651	1e-161
Q0D4B2	525	CBL-interacting protein k	yes	no	0.964	0.773	0.642	1e-156
Q9LGV5	461	CBL-interacting protein k	yes	no	0.990	0.904	0.625	1e-156
Q75L42	454	CBL-interacting protein k	no	no	0.961	0.892	0.614	1e-151
Q6ZLP5	450	CBL-interacting protein k	no	no	0.952	0.891	0.506	1e-121
Q93VD3	482	CBL-interacting serine/th	no	no	0.935	0.817	0.497	1e-118
Q2V452	441	CBL-interacting serine/th	no	no	0.938	0.895	0.488	1e-118
Q84VQ3	439	CBL-interacting serine/th	no	no	0.923	0.886	0.490	1e-116
Q6X4A2	449	CBL-interacting protein k	no	no	0.938	0.879	0.490	1e-116

>sp|Q8RWC9|CIPK1_ARATH CBL-interacting serine/threonine-protein kinase 1 OS=Arabidopsis thaliana GN=CIPK1 PE=1 SV=2

 Score =  574 bits (1479), Expect = e-163,   Method: Compositional matrix adjust.
 Identities = 290/436 (66%), Positives = 350/436 (80%), Gaps = 22/436 (5%)

Query: 5   EKKQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKRE 64
           +K ++GMRLG+YELGRTLGEGNFGKVKFA+D  SG  FAVKI++K+RI  L  + QIKRE
Sbjct: 9   KKAEKGMRLGKYELGRTLGEGNFGKVKFAKDTVSGHSFAVKIIDKSRIADLNFSLQIKRE 68

Query: 65  IATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLI 124
           I TLK+LKHP++VRLHEVLASK+KI MV+E VTGGELFD+I S G+L E +GRK+FQQLI
Sbjct: 69  IRTLKMLKHPHIVRLHEVLASKTKINMVMELVTGGELFDRIVSNGKLTETDGRKMFQQLI 128

Query: 125 DGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVA 184
           DG+SYCH+KGVFHRDLKLEN+LLD+KG+IKI+DFGLSALPQHFRDDGLLHTTCGSPNYVA
Sbjct: 129 DGISYCHSKGVFHRDLKLENVLLDAKGHIKITDFGLSALPQHFRDDGLLHTTCGSPNYVA 188

Query: 185 PEVLANRGYDGATSDIWSCGVILYIF--------------------RGDFKLPKWLSPGA 224
           PEVLANRGYDGA SDIWSCGVILY+                     +GD  +P+WLSPGA
Sbjct: 189 PEVLANRGYDGAASDIWSCGVILYVILTGCLPFDDRNLAVLYQKICKGDPPIPRWLSPGA 248

Query: 225 QNLLRKILEPNPVKRITIAGIKADEWFEQDYTPANP-DDDEEDIFVDNEAFSMHEVPSDG 283
           + +++++L+PNPV RIT+ GIKA EWF+ +Y P+ P DDDEE++  D++AFS+ E+ S+ 
Sbjct: 249 RTMIKRMLDPNPVTRITVVGIKASEWFKLEYIPSIPDDDDEEEVDTDDDAFSIQELGSEE 308

Query: 284 GRTPGSPPLINAFQLIGMSSCLDLSGFFEKEDVSERKIRFTSNHSAKDLLERIEDIVTEM 343
           G+   SP +INAFQLIGMSS LDLSGFFE+E+VSER+IRFTSN SAKDLLE+IE  VTEM
Sbjct: 309 GKGSDSPTIINAFQLIGMSSFLDLSGFFEQENVSERRIRFTSNSSAKDLLEKIETAVTEM 368

Query: 344 GFRVQKKNGKLKATQEHKPQKSLGSLSVAAEVFEISPSLYVVELRKSYGDPTVYRQLCNK 403
           GF VQKK+ KL+  QE + QK    LSV AEVFEI PSL VVELRKSYGD  +YRQL  +
Sbjct: 369 GFSVQKKHAKLRVKQEERNQKGQVGLSVTAEVFEIKPSLNVVELRKSYGDSCLYRQLYER 428

Query: 404 LSSDLGL-PPSQELLA 418
           L  D+G   P QE++ 
Sbjct: 429 LLKDVGTSSPEQEIVT 444

CIPK serine-threonine protein kinases interact with CBL proteins. Binding of a CBL protein to the regulatory NAF domain of CIPK protein lead to the activation of the kinase in a calcium-dependent manner.
Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1

>sp|Q94C40|CIPKH_ARATH CBL-interacting serine/threonine-protein kinase 17 OS=Arabidopsis thaliana GN=CIPK17 PE=1 SV=1

 Score =  568 bits (1463), Expect = e-161,   Method: Compositional matrix adjust.
 Identities = 281/431 (65%), Positives = 339/431 (78%), Gaps = 23/431 (5%)

Query: 9   EGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATL 68
           +GMR+G+YELGRTLGEGN  KVKFA D  +G  FA+KI+EK+ I  L ++ QIKREI TL
Sbjct: 4   KGMRVGKYELGRTLGEGNSAKVKFAIDTLTGESFAIKIIEKSCITRLNVSFQIKREIRTL 63

Query: 69  KLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVS 128
           K+LKHPN+VRLHEVLASK+KIYMVLE VTGG+LFD+I SKG+L E +GRK+FQQLIDGVS
Sbjct: 64  KVLKHPNIVRLHEVLASKTKIYMVLECVTGGDLFDRIVSKGKLSETQGRKMFQQLIDGVS 123

Query: 129 YCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVL 188
           YCHNKGVFHRDLKLEN+LLD+KG+IKI+DFGLSAL QH+R+DGLLHTTCGSPNYVAPEVL
Sbjct: 124 YCHNKGVFHRDLKLENVLLDAKGHIKITDFGLSALSQHYREDGLLHTTCGSPNYVAPEVL 183

Query: 189 ANRGYDGATSDIWSCGVILY--------------------IFRGDFKLPKWLSPGAQNLL 228
           AN GYDGA SDIWSCGVILY                    IF+GD  +P+W+S GA+ ++
Sbjct: 184 ANEGYDGAASDIWSCGVILYVILTGCLPFDDANLAVICRKIFKGDPPIPRWISLGAKTMI 243

Query: 229 RKILEPNPVKRITIAGIKADEWFEQDYTPANPDDDEEDIFVDNEAFSMHEVPSDGGRTPG 288
           +++L+PNPV R+TIAGIKA +WF+ DYTP+N DDD++   +  + F M E   +  ++P 
Sbjct: 244 KRMLDPNPVTRVTIAGIKAHDWFKHDYTPSNYDDDDDVYLIQEDVFMMKEYEEE--KSPD 301

Query: 289 SPPLINAFQLIGMSSCLDLSGFFEKEDVSERKIRFTSNHSAKDLLERIEDIVTEMGFRVQ 348
           SP +INAFQLIGMSS LDLSGFFE E +SER+IRFTSN  AKDLLE IE I TEMGF +Q
Sbjct: 302 SPTIINAFQLIGMSSFLDLSGFFETEKLSERQIRFTSNSLAKDLLENIETIFTEMGFCLQ 361

Query: 349 KKNGKLKATQEHKPQKSLGSLSVAAEVFEISPSLYVVELRKSYGDPTVYRQLCNKLSSDL 408
           KK+ KLKA +E   QK    LSV AEVFEISPSL VVELRKS+GD ++Y+QL  +L ++L
Sbjct: 362 KKHAKLKAIKEESTQKRQCGLSVTAEVFEISPSLNVVELRKSHGDSSLYKQLYERLLNEL 421

Query: 409 GLPPS-QELLA 418
           G     QELLA
Sbjct: 422 GSSSQVQELLA 432

CIPK serine-threonine protein kinases interact with CBL proteins. Binding of a CBL protein to the regulatory NAF domain of CIPK protein lead to the activation of the kinase in a calcium-dependent manner.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q0D4B2|CIPKL_ORYSJ CBL-interacting protein kinase 21 OS=Oryza sativa subsp. japonica GN=CIPK21 PE=2 SV=2

 Score =  552 bits (1422), Expect = e-156,   Method: Compositional matrix adjust.
 Identities = 277/431 (64%), Positives = 332/431 (77%), Gaps = 25/431 (5%)

Query: 10  GMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLK 69
            MR+G+YE+GR LGEG+FGKVK A+  D+G  FA+KIL++ RI+ +KI +QIKREIATLK
Sbjct: 81  AMRMGKYEMGRALGEGHFGKVKLARHADTGAAFAIKILDRQRILAMKIDEQIKREIATLK 140

Query: 70  LLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSY 129
           LLKHPNVVRLHEV ASK+KIYMVLEYV GGELFDKIA KG+L E EGRKLFQQL+D VSY
Sbjct: 141 LLKHPNVVRLHEVSASKTKIYMVLEYVNGGELFDKIALKGKLSEKEGRKLFQQLMDAVSY 200

Query: 130 CHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLA 189
           CH KGV+HRDLK EN+L+D+KGNIK+SDFGLSALPQ+ R DGLLHTTCGSPNY+APEVL 
Sbjct: 201 CHEKGVYHRDLKPENVLVDAKGNIKVSDFGLSALPQNQRKDGLLHTTCGSPNYIAPEVLL 260

Query: 190 NRGYDGATSDIWSCGVILY--------------------IFRGDFKLPKWLSPGAQNLLR 229
           NRGYDG+ SDIWSCGVILY                    I +GD ++PKWLSPGAQ++LR
Sbjct: 261 NRGYDGSLSDIWSCGVILYVMLTGNLPFDDQNTVVLYQKILKGDARIPKWLSPGAQDILR 320

Query: 230 KILEPNPVKRITIAGIKADEWFEQDYTPANPDDDEEDIFVDNEAFSMHEVPSDGGRTPGS 289
           KIL+PNP+ R+ I GI+A EWF QDYTPA P DD++D  + +   ++H   +    T  +
Sbjct: 321 KILDPNPITRLDITGIRAHEWFRQDYTPAMPFDDDDDNNISDG--NLHMTENQDIETSPA 378

Query: 290 PPLINAFQLIGMSSCLDLSGFFEKEDVSERKIRFTSNHSAKDLLERIEDIVTEMGFRVQK 349
              INAFQLIGMSSCLDLSGFFEKEDVSERKIRF SN+S   L E+IE  VTE GF+VQK
Sbjct: 379 ISQINAFQLIGMSSCLDLSGFFEKEDVSERKIRFVSNYSPTSLFEKIESTVTEKGFQVQK 438

Query: 350 KNGKLKATQ---EHKPQKSLGSLSVAAEVFEISPSLYVVELRKSYGDPTVYRQLCNKLSS 406
            +GKLK  Q   E    +  G+L ++AEVFEI+ SLYVVEL++S GD ++YRQLC  LS 
Sbjct: 439 NSGKLKVIQVCKEPANPRGHGNLLISAEVFEINESLYVVELKRSSGDCSLYRQLCASLSE 498

Query: 407 DLGLPPSQELL 417
           DLG+   Q+LL
Sbjct: 499 DLGICKRQQLL 509

CIPK serine-threonine protein kinases interact with CBL proteins. Binding of a CBL protein to the regulatory NAF domain of CIPK protein lead to the activation of the kinase in a calcium-dependent manner.

Oryza sativa subsp. japonica (taxid: 39947)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9LGV5|CIPK1_ORYSJ CBL-interacting protein kinase 1 OS=Oryza sativa subsp. japonica GN=CIPK1 PE=2 SV=1

 Score =  551 bits (1420), Expect = e-156,   Method: Compositional matrix adjust.
 Identities = 279/446 (62%), Positives = 342/446 (76%), Gaps = 29/446 (6%)

Query: 1   MVIAEKKQEGMR---LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKI 57
           MV  E + E  R   LGRYE+GRTLGEGNFGKVK+A+ L +G  FA+KIL++N+I+ L+ 
Sbjct: 1   MVNGEAEAECTRASLLGRYEIGRTLGEGNFGKVKYARHLATGAHFAIKILDRNKILSLRF 60

Query: 58  TDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGR 117
            DQI+REI TLKLLKHPNVVRLHEV ASK+KIYMVLEYV GGELFDKIA KG+L E EGR
Sbjct: 61  DDQIRREIGTLKLLKHPNVVRLHEVAASKTKIYMVLEYVNGGELFDKIAVKGKLSEHEGR 120

Query: 118 KLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTC 177
           +LFQQLID VSYCH+KGV+HRDLK EN+L+D +GNIKISDFGLSALPQH  +DGLLHTTC
Sbjct: 121 RLFQQLIDAVSYCHDKGVYHRDLKPENVLVDRRGNIKISDFGLSALPQHLGNDGLLHTTC 180

Query: 178 GSPNYVAPEVLANRGYDGATSDIWSCGVILY--------------------IFRGDFKLP 217
           GSPNY+APEVL NRGYDG+ SDIWSCGVILY                    IF+GD ++P
Sbjct: 181 GSPNYIAPEVLQNRGYDGSLSDIWSCGVILYVMLVGYLPFDDRNLVVLYQKIFKGDTQIP 240

Query: 218 KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPANPDDDEEDIFVDNEAFSMH 277
           KWLSP A++LLR+ILEPNP+KRI IAGIK  EWF++DYTP  P DD++D ++D+    + 
Sbjct: 241 KWLSPSARDLLRRILEPNPMKRINIAGIKEHEWFQKDYTPVVPYDDDDDNYLDS-VLPIK 299

Query: 278 EVPSDGGRTPGSPPLINAFQLIGMSSCLDLSGFFEKEDVSERKIRFTSNHSAKDLLERIE 337
           E   +  +    P  INAFQLIGM+S LDLSGFFE+ED S+RKIRFTS HS KDL ++IE
Sbjct: 300 EQIDEAKQE--KPTHINAFQLIGMASALDLSGFFEEEDASQRKIRFTSTHSPKDLFDKIE 357

Query: 338 DIVTEMGFRVQKKNGKLKATQEHKPQKSL---GSLSVAAEVFEISPSLYVVELRKSYGDP 394
           ++VTEMGF+VQ+ N KLK  +  +  K+L    S  V  EV E+ PSLYVVEL+KS+GDP
Sbjct: 358 NVVTEMGFQVQRGNSKLKVMKNGRGSKNLRNPSSFLVCTEVVELGPSLYVVELKKSHGDP 417

Query: 395 TVYRQLCNKLSSDLGLPPSQELLATE 420
            +YRQLC +LS +LG+  ++++  TE
Sbjct: 418 ILYRQLCERLSDELGVCKTEQIQRTE 443

CIPK serine-threonine protein kinases interact with CBL proteins. Binding of a CBL protein to the regulatory NAF domain of CIPK protein lead to the activation of the kinase in a calcium-dependent manner.

Oryza sativa subsp. japonica (taxid: 39947)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q75L42|CIPKH_ORYSJ CBL-interacting protein kinase 17 OS=Oryza sativa subsp. japonica GN=CIPK17 PE=2 SV=1

 Score =  535 bits (1377), Expect = e-151,   Method: Compositional matrix adjust.
 Identities = 263/428 (61%), Positives = 329/428 (76%), Gaps = 23/428 (5%)

Query: 13  LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK 72
           LG YE+GRTLGEGNFGKVK+A+ L +G  FAVKIL++ R++ L+  DQI+REIATLKLL+
Sbjct: 10  LGGYEMGRTLGEGNFGKVKYARHLATGGHFAVKILDRGRVVSLRAGDQIRREIATLKLLR 69

Query: 73  HPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHN 132
           HP+VVRLHEV ASK+KIYMVLE+V GGELF++IA KG+L E EGR+LFQQLIDGVSYCH+
Sbjct: 70  HPHVVRLHEVAASKTKIYMVLEFVNGGELFERIAVKGKLSEKEGRRLFQQLIDGVSYCHD 129

Query: 133 KGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRG 192
           +GV+HRDLK EN+L+D KGNIKISDFGLSALPQH  +DGLLHTTCGSPNY+APEVL N+G
Sbjct: 130 RGVYHRDLKPENVLVDQKGNIKISDFGLSALPQHLGNDGLLHTTCGSPNYIAPEVLQNKG 189

Query: 193 YDGATSDIWSCGVILY--------------------IFRGDFKLPKWLSPGAQNLLRKIL 232
           YDG+ SDIWSCGVILY                    IF+GD ++PKWLS  AQNLLR+IL
Sbjct: 190 YDGSLSDIWSCGVILYVMLIGYLPFDDRNIVVLYQKIFKGDTQIPKWLSHSAQNLLRRIL 249

Query: 233 EPNPVKRITIAGIKADEWFEQDYTPANP-DDDEEDIFVDNEAFSMHEVPSDGGRTPGSPP 291
           EPNP+KRI +AGIK+ EWF++DY P  P DDD+ED+       +  ++  + G    +  
Sbjct: 250 EPNPMKRIDMAGIKSHEWFQKDYIPVLPYDDDDEDVQFGARLPAKEQINDEPGDK--NSH 307

Query: 292 LINAFQLIGMSSCLDLSGFFEKEDVSERKIRFTSNHSAKDLLERIEDIVTEMGFRVQKKN 351
            INAFQLIGM+S LDLSGFFE E+VS+R+IRFTS H  KD  ++IE   TE+GF+VQ+ +
Sbjct: 308 QINAFQLIGMASSLDLSGFFEDEEVSQRRIRFTSTHPPKDAFDKIESSATELGFQVQRGH 367

Query: 352 GKLKATQEHKPQKSLGSLSVAAEVFEISPSLYVVELRKSYGDPTVYRQLCNKLSSDLGLP 411
            KLK  +  K  K+  S  V+AEVFE+ PS+ VVELRKS GDP +YRQLC ++SSD+G  
Sbjct: 368 SKLKLMRNCKGSKNPESFMVSAEVFELGPSVNVVELRKSNGDPALYRQLCERISSDMGAR 427

Query: 412 PSQELLAT 419
            ++++ AT
Sbjct: 428 NTEQIFAT 435

CIPK serine-threonine protein kinases interact with CBL proteins. Binding of a CBL protein to the regulatory NAF domain of CIPK protein lead to the activation of the kinase in a calcium-dependent manner.

Oryza sativa subsp. japonica (taxid: 39947)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q6ZLP5|CIPKN_ORYSJ CBL-interacting protein kinase 23 OS=Oryza sativa subsp. japonica GN=CIPK23 PE=2 SV=1

 Score =  434 bits (1116), Expect = e-121,   Method: Compositional matrix adjust.
 Identities = 222/438 (50%), Positives = 300/438 (68%), Gaps = 37/438 (8%)

Query: 12  RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL 71
           R+GRYELGRTLGEG F KVKFA++ DSG   A+KIL+K++++  K+  QIKREI+T+KL+
Sbjct: 9   RVGRYELGRTLGEGTFAKVKFARNADSGENVAIKILDKDKVLKHKMIAQIKREISTMKLI 68

Query: 72  KHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCH 131
           +HPNV+R+HEV+ASK+KIY+V+E VTGGELFDKIAS+GRL+E + RK FQQLI+ V YCH
Sbjct: 69  RHPNVIRMHEVMASKTKIYIVMELVTGGELFDKIASRGRLKEDDARKYFQQLINAVDYCH 128

Query: 132 NKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANR 191
           ++GV+HRDLK EN+LLD+ G +K+SDFGLSAL Q  R+DGLLHTTCG+PNYVAPEV+ N+
Sbjct: 129 SRGVYHRDLKPENLLLDASGTLKVSDFGLSALSQQVREDGLLHTTCGTPNYVAPEVINNK 188

Query: 192 GYDGATSDIWSCGVILY--------------------IFRGDFKLPKWLSPGAQNLLRKI 231
           GYDGA +D+WSCGVIL+                    IF+ DF  P W S  A+ L++KI
Sbjct: 189 GYDGAKADLWSCGVILFVLMAGYLPFEDSNLMSLYKKIFKADFSCPSWFSTSAKKLIKKI 248

Query: 232 LEPNPVKRITIAGIKADEWFEQDYTPANPD------DDEEDIFVDNEAFSMHEVPSDGGR 285
           L+PNP  RITIA +  +EWF++ Y P   +      DD   IF  NE+    ++  +  R
Sbjct: 249 LDPNPSTRITIAELINNEWFKKGYQPPRFETADVNLDDINSIF--NESGDQTQLVVE--R 304

Query: 286 TPGSPPLINAFQLIGMSSCLDLSGFFEKEDVS--ERKIRFTSNHSAKDLLERIEDIVTEM 343
               P ++NAF+LI  S  L+L   FEK+     +R+ RF S   A ++L +IE     M
Sbjct: 305 REERPSVMNAFELISTSQGLNLGTLFEKQSQGSVKRETRFASRLPANEILSKIEAAAGPM 364

Query: 344 GFRVQKKNGKLKATQEHKPQKSLGSLSVAAEVFEISPSLYVVELRKSYGDPTVYRQLCNK 403
           GF VQK+N KLK   E+  +K  G L++A EVFE++PSLY+VELRKS GD   + +  + 
Sbjct: 365 GFNVQKRNYKLKLQGENPGRK--GQLAIATEVFEVTPSLYMVELRKSNGDTLEFHKFYHN 422

Query: 404 LSS---DLGLPPSQELLA 418
           +S+   D+   P   ++A
Sbjct: 423 ISNGLKDVMWKPESSIIA 440

CIPK serine-threonine protein kinases interact with CBL proteins. Binding of a CBL protein to the regulatory NAF domain of CIPK protein lead to the activation of the kinase in a calcium-dependent manner.

Oryza sativa subsp. japonica (taxid: 39947)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q93VD3|CIPKN_ARATH CBL-interacting serine/threonine-protein kinase 23 OS=Arabidopsis thaliana GN=CIPK23 PE=1 SV=1

 Score =  425 bits (1092), Expect = e-118,   Method: Compositional matrix adjust.
 Identities = 210/422 (49%), Positives = 289/422 (68%), Gaps = 28/422 (6%)

Query: 13  LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK 72
           +G+YELGRTLGEG F KVKFA+++++G   A+K+++K +++  K+  QIKREI+T+KL+K
Sbjct: 28  VGKYELGRTLGEGTFAKVKFARNVENGDNVAIKVIDKEKVLKNKMIAQIKREISTMKLIK 87

Query: 73  HPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHN 132
           HPNV+R+ EV+ASK+KIY VLE+VTGGELFDKI+S GRL+E E RK FQQLI+ V YCH+
Sbjct: 88  HPNVIRMFEVMASKTKIYFVLEFVTGGELFDKISSNGRLKEDEARKYFQQLINAVDYCHS 147

Query: 133 KGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRG 192
           +GV+HRDLK EN+LLD+ G +K+SDFGLSALPQ  R+DGLLHTTCG+PNYVAPEV+ N+G
Sbjct: 148 RGVYHRDLKPENLLLDANGALKVSDFGLSALPQQVREDGLLHTTCGTPNYVAPEVINNKG 207

Query: 193 YDGATSDIWSCGVILY--------------------IFRGDFKLPKWLSPGAQNLLRKIL 232
           YDGA +D+WSCGVIL+                    IF+ +F  P W S  A+ L+++IL
Sbjct: 208 YDGAKADLWSCGVILFVLMAGYLPFEDSNLTSLYKKIFKAEFTCPPWFSASAKKLIKRIL 267

Query: 233 EPNPVKRITIAGIKADEWFEQDYTP-----ANPDDDEEDIFVDNEAFSMHEVPSDGGRTP 287
           +PNP  RIT A +  +EWF++ Y       A+   D+ D   D+   S + V        
Sbjct: 268 DPNPATRITFAEVIENEWFKKGYKAPKFENADVSLDDVDAIFDDSGESKNLVVERREEGL 327

Query: 288 GSPPLINAFQLIGMSSCLDLSGFFEKE-DVSERKIRFTSNHSAKDLLERIEDIVTEMGFR 346
            +P  +NAF+LI  S  L+L   FEK+  + +RK RFTS  SA +++ +IE     MGF 
Sbjct: 328 KTPVTMNAFELISTSQGLNLGSLFEKQMGLVKRKTRFTSKSSANEIVTKIEAAAAPMGFD 387

Query: 347 VQKKNGKLKATQEHKPQKSLGSLSVAAEVFEISPSLYVVELRKSYGDPTVYRQLCNKLSS 406
           V+  N K+K T E   +K  G L+VA EVF+++PSLY+VE+RKS GD   + +    L++
Sbjct: 388 VKTNNYKMKLTGEKSGRK--GQLAVATEVFQVAPSLYMVEMRKSGGDTLEFHKFYKNLTT 445

Query: 407 DL 408
            L
Sbjct: 446 GL 447

CIPK serine-threonine protein kinases interact with CBL proteins. Binding of a CBL protein to the regulatory NAF domain of CIPK protein leads to activation of the kinase in a calcium-dependent manner. Downstream of CBL1, CBL2, CBL3 and CBL9, regulates by phosphorylation the K(+) conductance and uptake of AKT1 in low K(+) condition, in response to calcium signaling and during the stomatal opening regulation by monitoring the turgor pressure in guard cells. In response to low nitrate concentration, phosphorylates NRT1.1, switching it from a low-affinity nitrate transporter to a high-affinity transporter. Confers tolerance to low potassium conditions. Involved in drought sensitivity and leaf transpiration.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q2V452|CIPK3_ARATH CBL-interacting serine/threonine-protein kinase 3 OS=Arabidopsis thaliana GN=CIPK3 PE=1 SV=2

 Score =  424 bits (1091), Expect = e-118,   Method: Compositional matrix adjust.
 Identities = 210/430 (48%), Positives = 296/430 (68%), Gaps = 35/430 (8%)

Query: 6   KKQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREI 65
           ++Q   R+G+YE+GRT+GEG F KVKFA++ ++G P A+KIL+K +++  K+ +QI+REI
Sbjct: 4   RQQVKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIRREI 63

Query: 66  ATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLID 125
           AT+KL+KHPNVV+L+EV+ASK+KI+++LEYVTGGELFDKI + GR++E E R+ FQQLI 
Sbjct: 64  ATMKLIKHPNVVQLYEVMASKTKIFIILEYVTGGELFDKIVNDGRMKEDEARRYFQQLIH 123

Query: 126 GVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAP 185
            V YCH++GV+HRDLK EN+LLDS GN+KISDFGLSAL Q  RDDGLLHT+CG+PNYVAP
Sbjct: 124 AVDYCHSRGVYHRDLKPENLLLDSYGNLKISDFGLSALSQQVRDDGLLHTSCGTPNYVAP 183

Query: 186 EVLANRGYDGATSDIWSCGVILYIF--------------------RGDFKLPKWLSPGAQ 225
           EVL +RGYDGAT+D+WSCGV+LY+                      G+F  P WLS GA 
Sbjct: 184 EVLNDRGYDGATADMWSCGVVLYVLLAGYLPFDDSNLMNLYKKISSGEFNCPPWLSLGAM 243

Query: 226 NLLRKILEPNPVKRITIAGIKADEWFEQDYTPA-------NPDDDEEDIFVDNEAFSMHE 278
            L+ +IL+PNP+ R+T   +  DEWF++DY P        +  DD + +F D+E   + E
Sbjct: 244 KLITRILDPNPMTRVTPQEVFEDEWFKKDYKPPVFEERDDSNMDDIDAVFKDSEEHLVTE 303

Query: 279 VPSDGGRTPGSPPLINAFQLIGMSSCLDLSGFFEKEDVSERKIRFTSNHSAKDLLERIED 338
                 +    P  INAF++I MS  L+L   F+ E   +R+ R T    A +++E+IE+
Sbjct: 304 ------KREEQPAAINAFEIISMSRGLNLENLFDPEQEFKRETRITLRGGANEIIEKIEE 357

Query: 339 IVTEMGFRVQKKNGKLKATQEHKPQKSLGSLSVAAEVFEISPSLYVVELRKSYGDPTVYR 398
               +GF VQKKN K++       +K  G+L+VA E+F+++PSL++V++ KS GD   + 
Sbjct: 358 AAKPLGFDVQKKNYKMRLENVKAGRK--GNLNVATEIFQVAPSLHMVQVSKSKGDTLEFH 415

Query: 399 QLCNKLSSDL 408
           +   KLS+ L
Sbjct: 416 KFYKKLSNSL 425

Involved in the resistance to some abiotic stresses (e.g. high salt, hyperosmotic stress) in young seedlings, by regulating the expression of several stress-inducible genes (cold-and salt-induced genes but not drought-responsive genes). Required for the ABA response during germination. CIPK serine-threonine protein kinases interact with CBL proteins. Binding of a CBL protein to the regulatory NAF domain of CIPK protein lead to the activation of the kinase in a calcium-dependent manner.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q84VQ3|CIPKQ_ARATH CBL-interacting serine/threonine-protein kinase 26 OS=Arabidopsis thaliana GN=CIPK26 PE=2 SV=2

 Score =  418 bits (1075), Expect = e-116,   Method: Compositional matrix adjust.
 Identities = 208/424 (49%), Positives = 292/424 (68%), Gaps = 35/424 (8%)

Query: 12  RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL 71
           R+G+YE+G+TLG+G F KV+ A + ++G   A+KIL+K +++  K+ +QI+REI T+KL+
Sbjct: 9   RVGKYEVGKTLGQGTFAKVRCAVNTETGERVALKILDKEKVLKHKMAEQIRREICTMKLI 68

Query: 72  KHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCH 131
            HPNVVRL+EVLASK+KIY+VLE+ TGGELFDKI   GRL+E   RK FQQLI+ V YCH
Sbjct: 69  NHPNVVRLYEVLASKTKIYIVLEFGTGGELFDKIVHDGRLKEENARKYFQQLINAVDYCH 128

Query: 132 NKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANR 191
           ++GV+HRDLK EN+LLD++GN+K+SDFGLSAL +  R DGLLHT CG+PNY APEVL ++
Sbjct: 129 SRGVYHRDLKPENLLLDAQGNLKVSDFGLSALSRQVRGDGLLHTACGTPNYAAPEVLNDQ 188

Query: 192 GYDGATSDIWSCGVILY--------------------IFRGDFKLPKWLSPGAQNLLRKI 231
           GYDGAT+D+WSCGVIL+                    I  G++  P WLSPGA+NL+ +I
Sbjct: 189 GYDGATADLWSCGVILFVLLAGYLPFEDSNLMTLYKKIIAGEYHCPPWLSPGAKNLIVRI 248

Query: 232 LEPNPVKRITIAGIKADEWFEQDYTPANPD-------DDEEDIFVDNEAFSMHEVPSDGG 284
           L+PNP+ RITI  +  D WF+++Y PA  +       DD + +F D+E    H V     
Sbjct: 249 LDPNPMTRITIPEVLGDAWFKKNYKPAVFEEKEEANLDDVDAVFKDSEE---HHVTEKKE 305

Query: 285 RTPGSPPLINAFQLIGMSSCLDLSGFFEKEDVSERKIRFTSNHSAKDLLERIEDIVTEMG 344
             P S   +NAF+LI MS  LDL   FE+E+  +R+ RF +  +A DL+++IE+    +G
Sbjct: 306 EQPTS---MNAFELISMSRALDLGNLFEEEEGFKRETRFAAKGAANDLVQKIEEASKPLG 362

Query: 345 FRVQKKNGKLKATQEHKPQKSLGSLSVAAEVFEISPSLYVVELRKSYGDPTVYRQLCNKL 404
           F +QKKN K++       +K  G+L VA E+F++SPSL+++E+RK+ GD   + +   KL
Sbjct: 363 FDIQKKNYKMRLENVTAGRK--GNLRVATEIFQVSPSLHMIEVRKTKGDTLEFHKFYKKL 420

Query: 405 SSDL 408
           S+ L
Sbjct: 421 STSL 424

CIPK serine-threonine protein kinases interact with CBL proteins. Binding of a CBL protein to the regulatory NAF domain of CIPK protein lead to the activation of the kinase in a calcium-dependent manner.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q6X4A2|CIPKV_ORYSJ CBL-interacting protein kinase 31 OS=Oryza sativa subsp. japonica GN=CIPK31 PE=1 SV=1

 Score =  418 bits (1075), Expect = e-116,   Method: Compositional matrix adjust.
 Identities = 205/418 (49%), Positives = 285/418 (68%), Gaps = 23/418 (5%)

Query: 12  RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL 71
           R+G+YELGRT+GEG F KV+FA++ ++  P A+KIL+K ++   ++ +QI+REI T+KL+
Sbjct: 16  RVGKYELGRTIGEGTFAKVRFAKNTENDEPVAIKILDKEKVQKHRLVEQIRREICTMKLV 75

Query: 72  KHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCH 131
           KHPNVVRL EV+ SK++I++VLEYVTGGELF+ IA+ GRL+E E RK FQQLI+ V YCH
Sbjct: 76  KHPNVVRLFEVMGSKARIFIVLEYVTGGELFEIIATNGRLKEEEARKYFQQLINAVDYCH 135

Query: 132 NKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANR 191
           ++GV+HRDLKLEN+LLD+ GN+K+SDFGLSAL +  + DGLLHTTCG+PNYVAPEV+ +R
Sbjct: 136 SRGVYHRDLKLENLLLDASGNLKVSDFGLSALTEQVKADGLLHTTCGTPNYVAPEVIEDR 195

Query: 192 GYDGATSDIWSCGVILYIF--------------------RGDFKLPKWLSPGAQNLLRKI 231
           GYDGA +DIWSCGVILY+                        F  P W S GA+ L+ +I
Sbjct: 196 GYDGAAADIWSCGVILYVLLAGFLPFEDDNIIALYKKISEAQFTCPSWFSTGAKKLITRI 255

Query: 232 LEPNPVKRITIAGIKADEWFEQDYTPANPDDDEEDIFVD-NEAFSMHEVPSDGGRTPGSP 290
           L+PNP  RITI+ I  D WF++ Y P   D+  E  F D + AF   E       T   P
Sbjct: 256 LDPNPTTRITISQILEDPWFKKGYKPPVFDEKYETSFDDVDAAFGDSEDRHVKEETEDQP 315

Query: 291 PLINAFQLIGMSSCLDLSGFFEKEDVSERKIRFTSNHSAKDLLERIEDIVTEMGFRVQKK 350
             +NAF+LI ++  L+L   FE +   +R+ RFTS    K+++ +IE+    +GF +QKK
Sbjct: 316 TSMNAFELISLNQALNLDNLFEAKKEYKRETRFTSQCPPKEIITKIEEAAKPLGFDIQKK 375

Query: 351 NGKLKATQEHKPQKSLGSLSVAAEVFEISPSLYVVELRKSYGDPTVYRQLCNKLSSDL 408
           N K++       +K  G+L+VA EVF+++PSL+VVEL+K+ GD   +++    LS+ L
Sbjct: 376 NYKMRMENLKAGRK--GNLNVATEVFQVAPSLHVVELKKAKGDTLEFQKFYRTLSTQL 431

Involved in cold stress tolerance. CIPK serine-threonine protein kinases interact with CBL proteins. Binding of a CBL protein to the regulatory NAF domain of CIPK protein lead to the activation of the kinase in a calcium-dependent manner.

Oryza sativa subsp. japonica (taxid: 39947)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	421
255556588	436	CBL-interacting serine/threonine-protein	0.976	0.942	0.766	0.0
224110276	474	predicted protein [Populus trichocarpa]	0.973	0.864	0.763	0.0
356548027	446	PREDICTED: CBL-interacting serine/threon	0.976	0.921	0.732	0.0
363807952	448	uncharacterized protein LOC100805710 [Gl	0.976	0.917	0.716	0.0
356530499	447	PREDICTED: CBL-interacting serine/threon	0.995	0.937	0.7	1e-179
357450323	465	CBL-interacting protein kinase [Medicago	0.964	0.873	0.728	1e-177
359477295	392	PREDICTED: CBL-interacting serine/threon	0.847	0.910	0.798	1e-176
297736814	391	unnamed protein product [Vitis vinifera]	0.845	0.910	0.795	1e-175
356558505	437	PREDICTED: CBL-interacting serine/threon	0.952	0.917	0.716	1e-174
449459800	435	PREDICTED: CBL-interacting serine/threon	0.961	0.931	0.684	1e-168

>gi|255556588|ref|XP_002519328.1| CBL-interacting serine/threonine-protein kinase, putative [Ricinus communis] gi|223541643|gb|EEF43192.1| CBL-interacting serine/threonine-protein kinase, putative [Ricinus communis]

 Score =  688 bits (1775), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 334/436 (76%), Positives = 373/436 (85%), Gaps = 25/436 (5%)

Query: 2   VIAEKKQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQI 61
           ++  +   GMRLG YELGRTLGEGNFGKVK A+++DSGLPFAVKILEKNRIIHL I+DQI
Sbjct: 1   MVTHQHHNGMRLGNYELGRTLGEGNFGKVKLAKNIDSGLPFAVKILEKNRIIHLNISDQI 60

Query: 62  KREIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQ 121
           KREIATLKLLKHPNVVRLHEVLASKSKIYMVLEYV GGELFD+IASKG+L EA+GRKLFQ
Sbjct: 61  KREIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVNGGELFDRIASKGKLPEAQGRKLFQ 120

Query: 122 QLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPN 181
           QL+DGVSYCHNKGVFHRDLKLEN+L+D+KGNIKISDFGLSALPQHFRDDGLLHTTCGSPN
Sbjct: 121 QLVDGVSYCHNKGVFHRDLKLENVLVDAKGNIKISDFGLSALPQHFRDDGLLHTTCGSPN 180

Query: 182 YVAPEVLANRGYDGATSDIWSCGVILY--------------------IFRGDFKLPKWLS 221
           YVAPE+L+NRGYDGATSD WSCGVILY                    IF+GD ++PKWLS
Sbjct: 181 YVAPEILSNRGYDGATSDTWSCGVILYVILTGYLPFDDRNLAVLYQKIFKGDAQIPKWLS 240

Query: 222 PGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPANPDDDEEDIFVDNEAFSMHEVPS 281
            GAQN++R+IL+PNPV RIT+A IK+DEWF+QDYTPA     EEDI +DNE FSMHE+P 
Sbjct: 241 SGAQNMIRRILDPNPVTRITMADIKSDEWFKQDYTPA-----EEDIHIDNEGFSMHELPP 295

Query: 282 DGGRTPGSPPLINAFQLIGMSSCLDLSGFFEKEDVSERKIRFTSNHSAKDLLERIEDIVT 341
           +G     SP LINAFQLIGMSSCLDLSGFFEKEDVSERKIRFTSN S KDLL++IE+  T
Sbjct: 296 EGESILRSPTLINAFQLIGMSSCLDLSGFFEKEDVSERKIRFTSNRSMKDLLQKIEETAT 355

Query: 342 EMGFRVQKKNGKLKATQEHKPQKSLGSLSVAAEVFEISPSLYVVELRKSYGDPTVYRQLC 401
           EMGFR+QKKNGKLK  QE K Q+SLGSLSVAAEVFEISPSL+VVEL+KS GDP+VYRQLC
Sbjct: 356 EMGFRIQKKNGKLKVVQERKEQRSLGSLSVAAEVFEISPSLHVVELQKSNGDPSVYRQLC 415

Query: 402 NKLSSDLGLPPSQELL 417
            KLS+DL LP  + LL
Sbjct: 416 KKLSNDLRLPSDEGLL 431

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224110276|ref|XP_002315469.1| predicted protein [Populus trichocarpa] gi|116265922|gb|ABJ91209.1| CBL-interacting protein kinase 1 [Populus trichocarpa] gi|222864509|gb|EEF01640.1| predicted protein [Populus trichocarpa]

 Score =  685 bits (1768), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 329/431 (76%), Positives = 376/431 (87%), Gaps = 21/431 (4%)

Query: 10  GMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLK 69
           GM+LG+YELGRTLGEGNFGKVK A+++++G PFAVKILEKNRII LKITDQIKREIATLK
Sbjct: 14  GMQLGKYELGRTLGEGNFGKVKLAKNIETGQPFAVKILEKNRIIDLKITDQIKREIATLK 73

Query: 70  LLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSY 129
           LLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFD+IASKG+L EAEGRK+FQQLIDGVSY
Sbjct: 74  LLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDRIASKGKLPEAEGRKMFQQLIDGVSY 133

Query: 130 CHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLA 189
           CH+KGVFHRDLKLEN+L+D+KGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPE+L+
Sbjct: 134 CHSKGVFHRDLKLENVLVDAKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEILS 193

Query: 190 NRGYDGATSDIWSCGVILY--------------------IFRGDFKLPKWLSPGAQNLLR 229
           NRGYDGATSDIWSCGVILY                    IF+GD ++PKWLSPGA+N+++
Sbjct: 194 NRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFKGDAQVPKWLSPGAKNMIK 253

Query: 230 KILEPNPVKRITIAGIKADEWFEQDYTPANPDDDEEDIFVDNEAFSMHEVPSDGGRTPGS 289
           +IL+PNPV RIT A IKADEWF+ DYTP +  ++++D+++D+ AFS+ E PS+ G +P S
Sbjct: 254 RILDPNPVTRITTADIKADEWFKLDYTPMDSAEEQDDVYIDDAAFSIQEAPSEDG-SPKS 312

Query: 290 PPLINAFQLIGMSSCLDLSGFFEKEDVSERKIRFTSNHSAKDLLERIEDIVTEMGFRVQK 349
           P LINAFQLIGMSSCLDLSG FEKEDVSERKIRFTSNHS  DLLE+IEDIVTEMGFRVQK
Sbjct: 313 PNLINAFQLIGMSSCLDLSGLFEKEDVSERKIRFTSNHSMSDLLEKIEDIVTEMGFRVQK 372

Query: 350 KNGKLKATQEHKPQKSLGSLSVAAEVFEISPSLYVVELRKSYGDPTVYRQLCNKLSSDLG 409
           +NG+ +  QEH+ +KS GSLSVA EVFEISPSLYVVELRKSYGD + YRQLC KLS+DLG
Sbjct: 373 RNGRFQVIQEHRGKKSSGSLSVATEVFEISPSLYVVELRKSYGDSSAYRQLCTKLSNDLG 432

Query: 410 LPPSQELLATE 420
           +P S  LL TE
Sbjct: 433 VPSSPGLLTTE 443

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356548027|ref|XP_003542405.1| PREDICTED: CBL-interacting serine/threonine-protein kinase 1-like [Glycine max]

 Score =  651 bits (1679), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 318/434 (73%), Positives = 364/434 (83%), Gaps = 23/434 (5%)

Query: 7   KQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIA 66
           ++EGMRLG+YELGRTLGEGNFGKVKFA++ DSG  FAVKI+EKN+I+ L IT+QIKREIA
Sbjct: 12  EREGMRLGKYELGRTLGEGNFGKVKFARNTDSGQAFAVKIIEKNKIVDLNITNQIKREIA 71

Query: 67  TLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDG 126
           TLKLL+HPNVVRL+EVLASK+KIYMVLEYV GGELFD IASKG+L E E RKLFQQLIDG
Sbjct: 72  TLKLLRHPNVVRLYEVLASKTKIYMVLEYVNGGELFDIIASKGKLTEGECRKLFQQLIDG 131

Query: 127 VSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPE 186
           VSYCH KGVFHRDLKLEN+L+D+KGNIK++DFGLSALPQH R+DGLLHTTCGSPNYVAPE
Sbjct: 132 VSYCHTKGVFHRDLKLENVLVDNKGNIKVTDFGLSALPQHLREDGLLHTTCGSPNYVAPE 191

Query: 187 VLANRGYDGATSDIWSCGVILY--------------------IFRGDFKLPKWLSPGAQN 226
           VLAN+GYDGATSD WSCGVILY                    IF+GD ++PKWLSPGAQN
Sbjct: 192 VLANKGYDGATSDTWSCGVILYVSLTGYLPFDDRNLVVLYQKIFKGDAQIPKWLSPGAQN 251

Query: 227 LLRKILEPNPVKRITIAGIKADEWFEQDYTPANPDDDEEDIFVDNEAFSMHEVPSDG-GR 285
           ++R+IL+PNP  RIT+AGIK D WF++ Y PANP+D  ED+ VDNEAFS HE P++   R
Sbjct: 252 MIRRILDPNPETRITMAGIKEDPWFKKGYIPANPED--EDVHVDNEAFSSHEEPNEAEQR 309

Query: 286 TPGSPPLINAFQLIGMSSCLDLSGFFEKEDVSERKIRFTSNHSAKDLLERIEDIVTEMGF 345
             GSP LINAFQLIGMSSCLDLSGFFEKEDVSERKIRF S  S KDL++RIED VTEM F
Sbjct: 310 NSGSPTLINAFQLIGMSSCLDLSGFFEKEDVSERKIRFASILSVKDLIDRIEDTVTEMEF 369

Query: 346 RVQKKNGKLKATQEHKPQKSLGSLSVAAEVFEISPSLYVVELRKSYGDPTVYRQLCNKLS 405
           RV+KKNGKLK  +E+K  K+LG LSV  EVFEISPSLYVVELRKSYGD +VY+QLC KL 
Sbjct: 370 RVEKKNGKLKVMRENKVHKTLGCLSVVVEVFEISPSLYVVELRKSYGDGSVYKQLCKKLL 429

Query: 406 SDLGLPPSQELLAT 419
           +DLG+PP Q L+ +
Sbjct: 430 NDLGVPPKQGLVRS 443

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|363807952|ref|NP_001242199.1| uncharacterized protein LOC100805710 [Glycine max] gi|255644530|gb|ACU22768.1| unknown [Glycine max]

 Score =  640 bits (1652), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 311/434 (71%), Positives = 361/434 (83%), Gaps = 23/434 (5%)

Query: 7   KQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIA 66
           ++EGMRLG+Y+LGRTLGEGNFGKVKFA++ DSG  FAVKI++KN I+ + IT+QI REIA
Sbjct: 14  EREGMRLGKYDLGRTLGEGNFGKVKFARNTDSGQAFAVKIIDKNTIVDINITNQIIREIA 73

Query: 67  TLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDG 126
           TLKLL+HPNVVRL+EVLASK+KIYMVLEYV GGELFD IASKG+  E EGRKLFQQLIDG
Sbjct: 74  TLKLLRHPNVVRLYEVLASKTKIYMVLEYVNGGELFDIIASKGKHIEGEGRKLFQQLIDG 133

Query: 127 VSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPE 186
           VSYCH KGVFHRDLKLEN+L+D+KGNIKI+DFGLSALPQH R+DGLLHTTCGSPNYVAPE
Sbjct: 134 VSYCHTKGVFHRDLKLENVLVDNKGNIKITDFGLSALPQHLREDGLLHTTCGSPNYVAPE 193

Query: 187 VLANRGYDGATSDIWSCGVILY--------------------IFRGDFKLPKWLSPGAQN 226
           VLAN+GYDGATSD WSCGVILY                    IF+GD ++PKWL+PGA+N
Sbjct: 194 VLANKGYDGATSDTWSCGVILYVILPGHLPFDDRNLVVLYQKIFKGDVQIPKWLTPGARN 253

Query: 227 LLRKILEPNPVKRITIAGIKADEWFEQDYTPANPDDDEEDIFVDNEAFSMHEVPSDG-GR 285
           ++R+IL+PNP  RIT+AGIK D WF++ Y P NP+D  ED++VD EAFS+HE P++   R
Sbjct: 254 MIRRILDPNPETRITMAGIKEDPWFKKGYIPVNPED--EDVYVDQEAFSIHEQPNEAEQR 311

Query: 286 TPGSPPLINAFQLIGMSSCLDLSGFFEKEDVSERKIRFTSNHSAKDLLERIEDIVTEMGF 345
             GSP LINAFQLIGMSSCLDLSGFFEKEDVSERKIRF SN S KDL+ERIED  TEM F
Sbjct: 312 NSGSPSLINAFQLIGMSSCLDLSGFFEKEDVSERKIRFASNLSVKDLIERIEDTATEMEF 371

Query: 346 RVQKKNGKLKATQEHKPQKSLGSLSVAAEVFEISPSLYVVELRKSYGDPTVYRQLCNKLS 405
           RV+KKNGKLK  +E+K  K+LG LSV  EVF IS SLYVVELRKSYGD +VY+QLCNKL 
Sbjct: 372 RVEKKNGKLKVIRENKVHKTLGCLSVVVEVFGISSSLYVVELRKSYGDGSVYKQLCNKLL 431

Query: 406 SDLGLPPSQELLAT 419
           +DLG+PP Q L+ +
Sbjct: 432 NDLGIPPKQPLVRS 445

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356530499|ref|XP_003533818.1| PREDICTED: CBL-interacting serine/threonine-protein kinase 1-like [Glycine max]

 Score =  634 bits (1634), Expect = e-179,   Method: Compositional matrix adjust.
 Identities = 308/440 (70%), Positives = 367/440 (83%), Gaps = 21/440 (4%)

Query: 3   IAEKKQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIK 62
           +  K+++G+RLG+YELG+TLGEGNFGKVK A+D  SG  FAVKIL+K++II L   DQIK
Sbjct: 6   LGRKEEQGVRLGKYELGKTLGEGNFGKVKLARDTHSGKLFAVKILDKSKIIDLNNIDQIK 65

Query: 63  REIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQ 122
           REI+TLKLLKHPNVVRL+EVLASK+KIYMVLEYV GGELFDKIASKG+L+EAEGRK+FQQ
Sbjct: 66  REISTLKLLKHPNVVRLYEVLASKTKIYMVLEYVNGGELFDKIASKGKLKEAEGRKIFQQ 125

Query: 123 LIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNY 182
           LID VS+CHNKGVFHRDLKLEN+L+D+KGNIKI+DF LSALPQHFR+DGLLHTTCGSPNY
Sbjct: 126 LIDCVSFCHNKGVFHRDLKLENVLVDAKGNIKITDFNLSALPQHFREDGLLHTTCGSPNY 185

Query: 183 VAPEVLANRGYDGATSDIWSCGVILY--------------------IFRGDFKLPKWLSP 222
           VAPE+LAN+GYDGATSDIWSCGVILY                    IF+G+ ++P+WLSP
Sbjct: 186 VAPEILANKGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFKGEVQIPRWLSP 245

Query: 223 GAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPANPDDDEEDIFVDNEAFSMHEVPSD 282
           G+QN+++++L+ NP  RIT+A IK DEWF++ YTPANP+D+EE +++D+E FS+H+V  +
Sbjct: 246 GSQNIIKRMLDANPKTRITMAMIKEDEWFKEGYTPANPEDEEESVYIDDEDFSIHDVSHE 305

Query: 283 GGR-TPGSPPLINAFQLIGMSSCLDLSGFFEKEDVSERKIRFTSNHSAKDLLERIEDIVT 341
             +  P SP LINAFQLI MSS LDLSG FE+EDVSERKIRFTS HS KDL+ERIEDIVT
Sbjct: 306 ADQGCPRSPTLINAFQLISMSSSLDLSGLFEQEDVSERKIRFTSIHSPKDLVERIEDIVT 365

Query: 342 EMGFRVQKKNGKLKATQEHKPQKSLGSLSVAAEVFEISPSLYVVELRKSYGDPTVYRQLC 401
           EMGFRVQKKNG LK  QE K QK  GS SV AEVFEISPSLYVVEL KS GD ++YRQLC
Sbjct: 366 EMGFRVQKKNGMLKVIQEIKVQKCPGSFSVEAEVFEISPSLYVVELSKSCGDASLYRQLC 425

Query: 402 NKLSSDLGLPPSQELLATEV 421
            KLS+DLG+   Q+L ++EV
Sbjct: 426 KKLSNDLGVHTRQQLGSSEV 445

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|357450323|ref|XP_003595438.1| CBL-interacting protein kinase [Medicago truncatula] gi|355484486|gb|AES65689.1| CBL-interacting protein kinase [Medicago truncatula]

 Score =  626 bits (1614), Expect = e-177,   Method: Compositional matrix adjust.
 Identities = 312/428 (72%), Positives = 359/428 (83%), Gaps = 22/428 (5%)

Query: 11  MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKL 70
           +RLG+YELG+TLGEGNFGKVK A+D D G  FAVKILEKN+I+ L  TDQIKREI+TLKL
Sbjct: 15  VRLGKYELGKTLGEGNFGKVKLARDTDCGQFFAVKILEKNKIVDLNNTDQIKREISTLKL 74

Query: 71  LKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYC 130
           LKHPNVVRL+EVLASK+KIYMVLEYV GGELFDKI+SKG+L EA GRK+FQQLIDGVSYC
Sbjct: 75  LKHPNVVRLYEVLASKTKIYMVLEYVNGGELFDKISSKGKLTEAHGRKMFQQLIDGVSYC 134

Query: 131 HNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLAN 190
           HNKGVFHRDLKLEN+L+D+KGNIKI+DF LSALPQH R DGLLHTTCGSPNYVAPE+LAN
Sbjct: 135 HNKGVFHRDLKLENVLVDAKGNIKITDFNLSALPQHCRADGLLHTTCGSPNYVAPEILAN 194

Query: 191 RGYDGATSDIWSCGVILY--------------------IFRGDFKLPKWLSPGAQNLLRK 230
           RGYDGA SDIWSCGVILY                    IF+ D ++P+WLSPGAQN+++K
Sbjct: 195 RGYDGAKSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFKADVQIPRWLSPGAQNIIKK 254

Query: 231 ILEPNPVKRITIAGIKADEWFEQDYTPAN--PDDDEEDIFVDNEAFSMHEVPSDGGRTPG 288
           IL+PNP  R+T+  IK DEWF++ Y PAN   +++EED+F+D+EAFS+HEV  DG ++P 
Sbjct: 255 ILDPNPKTRVTMDMIKEDEWFKEGYNPANLEDEEEEEDVFIDDEAFSIHEVSLDGDQSPK 314

Query: 289 SPPLINAFQLIGMSSCLDLSGFFEKEDVSERKIRFTSNHSAKDLLERIEDIVTEMGFRVQ 348
           SP LINAFQLIGMSSCLDLSGFFE+EDVSERKIRFTSNHS KDL E+IEDIV EMGF+V 
Sbjct: 315 SPALINAFQLIGMSSCLDLSGFFEQEDVSERKIRFTSNHSPKDLTEKIEDIVIEMGFKVH 374

Query: 349 KKNGKLKATQEHKPQKSLGSLSVAAEVFEISPSLYVVELRKSYGDPTVYRQLCNKLSSDL 408
           KKNGKLK  QE K  KSL SLSVAAEVFE+ PSLYVVELRKSYGD +VYRQLC +LS+DL
Sbjct: 375 KKNGKLKVIQEDKAHKSLDSLSVAAEVFEVGPSLYVVELRKSYGDASVYRQLCKRLSNDL 434

Query: 409 GLPPSQEL 416
           G+    E+
Sbjct: 435 GIAEVAEV 442

Source: Medicago truncatula

Species: Medicago truncatula

Genus: Medicago

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359477295|ref|XP_002275061.2| PREDICTED: CBL-interacting serine/threonine-protein kinase 1-like [Vitis vinifera] gi|229609839|gb|ACQ83535.1| CBL-interacting protein kinase 19 [Vitis vinifera]

 Score =  625 bits (1613), Expect = e-176,   Method: Compositional matrix adjust.
 Identities = 301/377 (79%), Positives = 333/377 (88%), Gaps = 20/377 (5%)

Query: 61  IKREIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLF 120
           IKREIATLKLLKHPNVVRLHEVLASK+KIYMVLEYVTGGELFD+IAS G+L EAEGRKLF
Sbjct: 14  IKREIATLKLLKHPNVVRLHEVLASKTKIYMVLEYVTGGELFDRIASNGKLSEAEGRKLF 73

Query: 121 QQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP 180
           QQLID VSYCHNKGVFHRDLKLEN+L+DSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP
Sbjct: 74  QQLIDAVSYCHNKGVFHRDLKLENVLVDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP 133

Query: 181 NYVAPEVLANRGYDGATSDIWSCGVILY--------------------IFRGDFKLPKWL 220
           NYVAPE+LANRGYDG+TSDIWSCGVILY                    IF+GD ++PKWL
Sbjct: 134 NYVAPEILANRGYDGSTSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFKGDAQMPKWL 193

Query: 221 SPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPANPDDDEEDIFVDNEAFSMHEVP 280
           S GA+N++++IL+P P  RIT+AGIKADEWF+Q YTPA P+++EEDI VD+EAFS++EVP
Sbjct: 194 SSGAKNIIKRILDPKPETRITMAGIKADEWFKQQYTPAYPEEEEEDIHVDDEAFSIYEVP 253

Query: 281 SDGGRTPGSPPLINAFQLIGMSSCLDLSGFFEKEDVSERKIRFTSNHSAKDLLERIEDIV 340
            +  ++PGSP LINAFQLIGMSSCLDLSGFFEKEDVSERKIRFTSNH  KDLLE+IEDIV
Sbjct: 254 MEAKKSPGSPNLINAFQLIGMSSCLDLSGFFEKEDVSERKIRFTSNHCPKDLLEKIEDIV 313

Query: 341 TEMGFRVQKKNGKLKATQEHKPQKSLGSLSVAAEVFEISPSLYVVELRKSYGDPTVYRQL 400
           TEMGFRV+KKNG+LK  QEHK QKS GSLSVAAEVFEISPSLYVVELRKSYGD +VYRQL
Sbjct: 314 TEMGFRVEKKNGRLKVMQEHKCQKSFGSLSVAAEVFEISPSLYVVELRKSYGDSSVYRQL 373

Query: 401 CNKLSSDLGLPPSQELL 417
           C KLSSDLG+P SQELL
Sbjct: 374 CKKLSSDLGVPTSQELL 390

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|297736814|emb|CBI26015.3| unnamed protein product [Vitis vinifera]

 Score =  619 bits (1597), Expect = e-175,   Method: Compositional matrix adjust.
 Identities = 300/377 (79%), Positives = 332/377 (88%), Gaps = 21/377 (5%)

Query: 61  IKREIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLF 120
           IKREIATLKLLKHPNVVRLHEVLASK+KIYMVLEYVTGGELFD+IAS G+L EAEGRKLF
Sbjct: 14  IKREIATLKLLKHPNVVRLHEVLASKTKIYMVLEYVTGGELFDRIASNGKLSEAEGRKLF 73

Query: 121 QQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP 180
           QQLID VSYCHNKGVFHRDLKLEN+L+DSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP
Sbjct: 74  QQLIDAVSYCHNKGVFHRDLKLENVLVDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP 133

Query: 181 NYVAPEVLANRGYDGATSDIWSCGVILY--------------------IFRGDFKLPKWL 220
           NYVAPE+LANRGYDG+TSDIWSCGVILY                    IF+GD ++PKWL
Sbjct: 134 NYVAPEILANRGYDGSTSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFKGDAQMPKWL 193

Query: 221 SPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPANPDDDEEDIFVDNEAFSMHEVP 280
           S GA+N++++IL+P P  RIT+AGIKADEWF+Q YTPA P+++EEDI VD+EAFS++E P
Sbjct: 194 SSGAKNIIKRILDPKPETRITMAGIKADEWFKQQYTPAYPEEEEEDIHVDDEAFSIYE-P 252

Query: 281 SDGGRTPGSPPLINAFQLIGMSSCLDLSGFFEKEDVSERKIRFTSNHSAKDLLERIEDIV 340
            +  ++PGSP LINAFQLIGMSSCLDLSGFFEKEDVSERKIRFTSNH  KDLLE+IEDIV
Sbjct: 253 MEAKKSPGSPNLINAFQLIGMSSCLDLSGFFEKEDVSERKIRFTSNHCPKDLLEKIEDIV 312

Query: 341 TEMGFRVQKKNGKLKATQEHKPQKSLGSLSVAAEVFEISPSLYVVELRKSYGDPTVYRQL 400
           TEMGFRV+KKNG+LK  QEHK QKS GSLSVAAEVFEISPSLYVVELRKSYGD +VYRQL
Sbjct: 313 TEMGFRVEKKNGRLKVMQEHKCQKSFGSLSVAAEVFEISPSLYVVELRKSYGDSSVYRQL 372

Query: 401 CNKLSSDLGLPPSQELL 417
           C KLSSDLG+P SQELL
Sbjct: 373 CKKLSSDLGVPTSQELL 389

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356558505|ref|XP_003547546.1| PREDICTED: CBL-interacting serine/threonine-protein kinase 1-like [Glycine max]

 Score =  617 bits (1592), Expect = e-174,   Method: Compositional matrix adjust.
 Identities = 303/423 (71%), Positives = 355/423 (83%), Gaps = 22/423 (5%)

Query: 9   EGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATL 68
           +GMRLG+YELG+TLGEGNFGKVK A+D  SG  FAVKIL+K++II L  TDQIKREI TL
Sbjct: 12  QGMRLGKYELGKTLGEGNFGKVKLARDTHSGKLFAVKILDKSKIIDLNNTDQIKREIFTL 71

Query: 69  KLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVS 128
           KLLKHPNVVRL+EVLASK+KIYMVLEYV GGELFDKIASKG+L+EA GRK+FQQLID VS
Sbjct: 72  KLLKHPNVVRLYEVLASKTKIYMVLEYVNGGELFDKIASKGKLKEAVGRKIFQQLIDCVS 131

Query: 129 YCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVL 188
           +CHNKGVFHRDLKLEN+L+D+KGNIKI+DF LSALPQHFR DGLLHTTCGSPNYVAPE+L
Sbjct: 132 FCHNKGVFHRDLKLENVLVDAKGNIKITDFNLSALPQHFRADGLLHTTCGSPNYVAPEIL 191

Query: 189 ANRGYDGATSDIWSCGVILY--------------------IFRGDFKLPKWLSPGAQNLL 228
           AN+GYDGATSDIWSCGVILY                    I +G+ ++P+WLSPG+QN++
Sbjct: 192 ANKGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKILKGEVQIPRWLSPGSQNII 251

Query: 229 RKILEPNPVKRITIAGIKADEWFEQDYTPANPDDDEEDIFVDNEAFSMHEVPSDGGR-TP 287
           +++L+ N   RIT+A IK DEWF++ Y+PANP+D+EE +++D E FS+H+V  +  + +P
Sbjct: 252 KRMLDVNLKTRITMAMIKEDEWFKEGYSPANPEDEEESVYID-EDFSIHDVSLEADQGSP 310

Query: 288 GSPPLINAFQLIGMSSCLDLSGFFEKEDVSERKIRFTSNHSAKDLLERIEDIVTEMGFRV 347
            SP LINAFQLI MSS LDLSG FE+EDVSERKIRFTS HS KDL+ER+EDIVTEMGFRV
Sbjct: 311 RSPTLINAFQLISMSSSLDLSGLFEQEDVSERKIRFTSIHSPKDLVERLEDIVTEMGFRV 370

Query: 348 QKKNGKLKATQEHKPQKSLGSLSVAAEVFEISPSLYVVELRKSYGDPTVYRQLCNKLSSD 407
           QKKNG LK  QE K QK LG+LSVAAEVFEISPSLYVVEL KS GD +VYRQLC KLS+D
Sbjct: 371 QKKNGMLKVVQEIKTQKCLGNLSVAAEVFEISPSLYVVELSKSCGDASVYRQLCKKLSND 430

Query: 408 LGL 410
           LG+
Sbjct: 431 LGV 433

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|449459800|ref|XP_004147634.1| PREDICTED: CBL-interacting serine/threonine-protein kinase 1-like [Cucumis sativus] gi|449498776|ref|XP_004160630.1| PREDICTED: CBL-interacting serine/threonine-protein kinase 1-like [Cucumis sativus]

 Score =  597 bits (1539), Expect = e-168,   Method: Compositional matrix adjust.
 Identities = 289/422 (68%), Positives = 347/422 (82%), Gaps = 17/422 (4%)

Query: 11  MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKL 70
           MR+G+YELG+TLGEGNFGKVK A D+ +G  +AVKIL+K +I+HL  +DQIKREI+TLKL
Sbjct: 1   MRVGKYELGKTLGEGNFGKVKLAADVRTGCRYAVKILDKTKILHLNFSDQIKREISTLKL 60

Query: 71  LKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYC 130
           L+HPNVVRL+EVLASK+KIYMV+E  +GGELFD+I SKG++ EAEGR++FQQLIDG+SYC
Sbjct: 61  LRHPNVVRLYEVLASKTKIYMVMECASGGELFDRIESKGKMDEAEGRRIFQQLIDGLSYC 120

Query: 131 HNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLAN 190
           H+KGV+HRDLKLEN+L+D+KGNIKISDFGLSALP++ R+DGLLHTTCGSPNYVAPEVLAN
Sbjct: 121 HDKGVYHRDLKLENVLVDAKGNIKISDFGLSALPKNCREDGLLHTTCGSPNYVAPEVLAN 180

Query: 191 RGYDGATSDIWSCGVILYIFRGDF-------------KLPKWLSPGAQNLLRKILEPNPV 237
           RGY+GA SDIWSCGVILY+    F             K+PKWLS GA+NL+R+ L+PNP 
Sbjct: 181 RGYNGAASDIWSCGVILYVILTAFLPFDETNLALLYKKIPKWLSAGARNLIRRTLDPNPN 240

Query: 238 KRITIAGIKADEWFEQDYTPANP---DDDEEDIFVD-NEAFSMHEVPSDGGRTPGSPPLI 293
            RITIAGIK +EWF+ DY PA+P   DD+EE    D ++A S  + PSD   +P SP +I
Sbjct: 241 TRITIAGIKENEWFKTDYNPASPCYDDDEEEGSLTDQDDAISTLDEPSDAENSPESPSII 300

Query: 294 NAFQLIGMSSCLDLSGFFEKEDVSERKIRFTSNHSAKDLLERIEDIVTEMGFRVQKKNGK 353
           NAF+LIGMSS LDLSGFFE+EDVSERKIRFTSN SAKDLLERIE I T+MGFRVQK++GK
Sbjct: 301 NAFELIGMSSSLDLSGFFEQEDVSERKIRFTSNRSAKDLLERIEVIATDMGFRVQKRSGK 360

Query: 354 LKATQEHKPQKSLGSLSVAAEVFEISPSLYVVELRKSYGDPTVYRQLCNKLSSDLGLPPS 413
           LK  QE + QKSL +LS  AEVFEI P L+VVEL+KS+GD + YRQLC +LSSDLG  P 
Sbjct: 361 LKLIQEIRSQKSLSNLSFVAEVFEIRPLLHVVELKKSFGDSSAYRQLCERLSSDLGTNPE 420

Query: 414 QE 415
            E
Sbjct: 421 LE 422

Source: Cucumis sativus

Species: Cucumis sativus

Genus: Cucumis

Family: Cucurbitaceae

Order: Cucurbitales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	421
TAIR|locus:2090537	444	CIPK1 "CBL-interacting protein	0.486	0.461	0.800	1e-154
TAIR|locus:2007685	432	CIPK17 "CBL-interacting protei	0.477	0.465	0.781	4.1e-147
TAIR|locus:2059279	451	CIPK3 "CBL-interacting protein	0.532	0.496	0.623	3e-110
TAIR|locus:2009812	482	CIPK23 "CBL-interacting protei	0.522	0.456	0.617	1e-109
TAIR|locus:1005716172	439	CIPK26 "calcineurin B-like pro	0.520	0.498	0.588	3.1e-108
TAIR|locus:2155233	446	SOS2 "SALT OVERLY SENSITIVE 2"	0.513	0.484	0.609	1.2e-100
TAIR|locus:2135962	445	CIPK8 "CBL-interacting protein	0.482	0.456	0.645	8.6e-100
TAIR|locus:2181047	421	CIPK15 "CBL-interacting protei	0.529	0.529	0.550	5.5e-92
TAIR|locus:2126749	441	SIP3 "SOS3-interacting protein	0.520	0.496	0.549	7e-92
TAIR|locus:2179260	488	CIPK25 "CBL-interacting protei	0.536	0.463	0.515	3.8e-91

TAIR|locus:2090537 CIPK1 "CBL-interacting protein kinase 1" [Arabidopsis thaliana (taxid:3702)]

 Score = 874 (312.7 bits), Expect = 1.0e-154, Sum P(2) = 1.0e-154
 Identities = 165/206 (80%), Positives = 187/206 (90%)

Query:     5 EKKQE-GMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKR 63
             EKK E GMRLG+YELGRTLGEGNFGKVKFA+D  SG  FAVKI++K+RI  L  + QIKR
Sbjct:     8 EKKAEKGMRLGKYELGRTLGEGNFGKVKFAKDTVSGHSFAVKIIDKSRIADLNFSLQIKR 67

Query:    64 EIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQL 123
             EI TLK+LKHP++VRLHEVLASK+KI MV+E VTGGELFD+I S G+L E +GRK+FQQL
Sbjct:    68 EIRTLKMLKHPHIVRLHEVLASKTKINMVMELVTGGELFDRIVSNGKLTETDGRKMFQQL 127

Query:   124 IDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYV 183
             IDG+SYCH+KGVFHRDLKLEN+LLD+KG+IKI+DFGLSALPQHFRDDGLLHTTCGSPNYV
Sbjct:   128 IDGISYCHSKGVFHRDLKLENVLLDAKGHIKITDFGLSALPQHFRDDGLLHTTCGSPNYV 187

Query:   184 APEVLANRGYDGATSDIWSCGVILYI 209
             APEVLANRGYDGA SDIWSCGVILY+
Sbjct:   188 APEVLANRGYDGAASDIWSCGVILYV 213

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0007165 "signal transduction" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005515 "protein binding" evidence=IPI

GO:0006970 "response to osmotic stress" evidence=IMP

GO:0009651 "response to salt stress" evidence=IMP

GO:0009737 "response to abscisic acid stimulus" evidence=IMP

GO:0010118 "stomatal movement" evidence=RCA

GO:0019722 "calcium-mediated signaling" evidence=RCA

TAIR|locus:2007685 CIPK17 "CBL-interacting protein kinase 17" [Arabidopsis thaliana (taxid:3702)]

 Score = 842 (301.5 bits), Expect = 4.1e-147, Sum P(2) = 4.1e-147
 Identities = 157/201 (78%), Positives = 181/201 (90%)

Query:     9 EGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATL 68
             +GMR+G+YELGRTLGEGN  KVKFA D  +G  FA+KI+EK+ I  L ++ QIKREI TL
Sbjct:     4 KGMRVGKYELGRTLGEGNSAKVKFAIDTLTGESFAIKIIEKSCITRLNVSFQIKREIRTL 63

Query:    69 KLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVS 128
             K+LKHPN+VRLHEVLASK+KIYMVLE VTGG+LFD+I SKG+L E +GRK+FQQLIDGVS
Sbjct:    64 KVLKHPNIVRLHEVLASKTKIYMVLECVTGGDLFDRIVSKGKLSETQGRKMFQQLIDGVS 123

Query:   129 YCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVL 188
             YCHNKGVFHRDLKLEN+LLD+KG+IKI+DFGLSAL QH+R+DGLLHTTCGSPNYVAPEVL
Sbjct:   124 YCHNKGVFHRDLKLENVLLDAKGHIKITDFGLSALSQHYREDGLLHTTCGSPNYVAPEVL 183

Query:   189 ANRGYDGATSDIWSCGVILYI 209
             AN GYDGA SDIWSCGVILY+
Sbjct:   184 ANEGYDGAASDIWSCGVILYV 204

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0007165 "signal transduction" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2059279 CIPK3 "CBL-interacting protein kinase 3" [Arabidopsis thaliana (taxid:3702)]

 Score = 766 (274.7 bits), Expect = 3.0e-110, Sum P(2) = 3.0e-110
 Identities = 141/226 (62%), Positives = 187/226 (82%)

Query:     6 KKQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREI 65
             ++Q   R+G+YE+GRT+GEG F KVKFA++ ++G P A+KIL+K +++  K+ +QI+REI
Sbjct:    14 RQQVKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIRREI 73

Query:    66 ATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLID 125
             AT+KL+KHPNVV+L+EV+ASK+KI+++LEYVTGGELFDKI + GR++E E R+ FQQLI 
Sbjct:    74 ATMKLIKHPNVVQLYEVMASKTKIFIILEYVTGGELFDKIVNDGRMKEDEARRYFQQLIH 133

Query:   126 GVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAP 185
              V YCH++GV+HRDLK EN+LLDS GN+KISDFGLSAL Q  RDDGLLHT+CG+PNYVAP
Sbjct:   134 AVDYCHSRGVYHRDLKPENLLLDSYGNLKISDFGLSALSQQVRDDGLLHTSCGTPNYVAP 193

Query:   186 EVLANRGYDGATSDIWSCGVILYIFRGDFKLPKWLSPGAQNLLRKI 231
             EVL +RGYDGAT+D+WSCGV+LY+    + LP +      NL +KI
Sbjct:   194 EVLNDRGYDGATADMWSCGVVLYVLLAGY-LP-FDDSNLMNLYKKI 237

GO:0004672 "protein kinase activity" evidence=IEA;TAS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0007165 "signal transduction" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009737 "response to abscisic acid stimulus" evidence=IEP

GO:0009738 "abscisic acid mediated signaling pathway" evidence=TAS

GO:0005634 "nucleus" evidence=IDA

GO:0005737 "cytoplasm" evidence=IDA

GO:0009735 "response to cytokinin stimulus" evidence=IEP

TAIR|locus:2009812 CIPK23 "CBL-interacting protein kinase 23" [Arabidopsis thaliana (taxid:3702)]

 Score = 752 (269.8 bits), Expect = 1.0e-109, Sum P(2) = 1.0e-109
 Identities = 137/222 (61%), Positives = 183/222 (82%)

Query:    12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL 71
             R+G+YELGRTLGEG F KVKFA+++++G   A+K+++K +++  K+  QIKREI+T+KL+
Sbjct:    27 RVGKYELGRTLGEGTFAKVKFARNVENGDNVAIKVIDKEKVLKNKMIAQIKREISTMKLI 86

Query:    72 KHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCH 131
             KHPNV+R+ EV+ASK+KIY VLE+VTGGELFDKI+S GRL+E E RK FQQLI+ V YCH
Sbjct:    87 KHPNVIRMFEVMASKTKIYFVLEFVTGGELFDKISSNGRLKEDEARKYFQQLINAVDYCH 146

Query:   132 NKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANR 191
             ++GV+HRDLK EN+LLD+ G +K+SDFGLSALPQ  R+DGLLHTTCG+PNYVAPEV+ N+
Sbjct:   147 SRGVYHRDLKPENLLLDANGALKVSDFGLSALPQQVREDGLLHTTCGTPNYVAPEVINNK 206

Query:   192 GYDGATSDIWSCGVILYIFRGDFKLPKWLSPGAQNLLRKILE 233
             GYDGA +D+WSCGVIL++    + LP +      +L +KI +
Sbjct:   207 GYDGAKADLWSCGVILFVLMAGY-LP-FEDSNLTSLYKKIFK 246

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;IDA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IPI

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0007165 "signal transduction" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005515 "protein binding" evidence=IPI

GO:0005634 "nucleus" evidence=IDA

GO:0005737 "cytoplasm" evidence=IDA

GO:0010107 "potassium ion import" evidence=IMP

GO:0005829 "cytosol" evidence=IDA

GO:0007584 "response to nutrient" evidence=IMP

GO:0009414 "response to water deprivation" evidence=IMP

GO:0010118 "stomatal movement" evidence=RCA;IMP

GO:0009536 "plastid" evidence=IDA

GO:0000911 "cytokinesis by cell plate formation" evidence=RCA

GO:0009723 "response to ethylene stimulus" evidence=RCA

GO:0009738 "abscisic acid mediated signaling pathway" evidence=RCA

GO:0016036 "cellular response to phosphate starvation" evidence=RCA

GO:0019375 "galactolipid biosynthetic process" evidence=RCA

GO:0019722 "calcium-mediated signaling" evidence=RCA

GO:0035556 "intracellular signal transduction" evidence=RCA

GO:0042631 "cellular response to water deprivation" evidence=RCA

TAIR|locus:1005716172 CIPK26 "calcineurin B-like protein (CBL)-interacting protein kinase 26" [Arabidopsis thaliana (taxid:3702)]

 Score = 703 (252.5 bits), Expect = 3.1e-108, Sum P(2) = 3.1e-108
 Identities = 130/221 (58%), Positives = 175/221 (79%)

Query:    12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL 71
             R+G+YE+G+TLG+G F KV+ A + ++G   A+KIL+K +++  K+ +QI+REI T+KL+
Sbjct:     9 RVGKYEVGKTLGQGTFAKVRCAVNTETGERVALKILDKEKVLKHKMAEQIRREICTMKLI 68

Query:    72 KHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCH 131
              HPNVVRL+EVLASK+KIY+VLE+ TGGELFDKI   GRL+E   RK FQQLI+ V YCH
Sbjct:    69 NHPNVVRLYEVLASKTKIYIVLEFGTGGELFDKIVHDGRLKEENARKYFQQLINAVDYCH 128

Query:   132 NKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANR 191
             ++GV+HRDLK EN+LLD++GN+K+SDFGLSAL +  R DGLLHT CG+PNY APEVL ++
Sbjct:   129 SRGVYHRDLKPENLLLDAQGNLKVSDFGLSALSRQVRGDGLLHTACGTPNYAAPEVLNDQ 188

Query:   192 GYDGATSDIWSCGVILYIFRGDFKLPKWLSPGAQNLLRKIL 232
             GYDGAT+D+WSCGVIL++    + LP +       L +KI+
Sbjct:   189 GYDGATADLWSCGVILFVLLAGY-LP-FEDSNLMTLYKKII 227

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007165 "signal transduction" evidence=IEA;ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005829 "cytosol" evidence=IDA

TAIR|locus:2155233 SOS2 "SALT OVERLY SENSITIVE 2" [Arabidopsis thaliana (taxid:3702)]

 Score = 709 (254.6 bits), Expect = 1.2e-100, Sum P(2) = 1.2e-100
 Identities = 134/220 (60%), Positives = 177/220 (80%)

Query:    12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL 71
             R+G+YE+GRT+GEG F KVKFA++ D+G   A+KI+ K+ I+  ++ DQIKREI+ +K++
Sbjct:     7 RVGKYEVGRTIGEGTFAKVKFARNTDTGDNVAIKIMAKSTILKNRMVDQIKREISIMKIV 66

Query:    72 KHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCH 131
             +HPN+VRL+EVLAS SKIY+VLE+VTGGELFD+I  KGRL+E+E RK FQQL+D V++CH
Sbjct:    67 RHPNIVRLYEVLASPSKIYIVLEFVTGGELFDRIVHKGRLEESESRKYFQQLVDAVAHCH 126

Query:   132 NKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANR 191
              KGV+HRDLK EN+LLD+ GN+K+SDFGLSALPQ   +  LL TTCG+PNYVAPEVL+ +
Sbjct:   127 CKGVYHRDLKPENLLLDTNGNLKVSDFGLSALPQEGVE--LLRTTCGTPNYVAPEVLSGQ 184

Query:   192 GYDGATSDIWSCGVILYIFRGDFKLPKWLSPGAQNLLRKI 231
             GYDG+ +DIWSCGVIL++    + LP +       L RKI
Sbjct:   185 GYDGSAADIWSCGVILFVILAGY-LP-FSETDLPGLYRKI 222

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0007165 "signal transduction" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0005515 "protein binding" evidence=IPI

GO:0004672 "protein kinase activity" evidence=IDA

GO:0042802 "identical protein binding" evidence=IPI

GO:0009705 "plant-type vacuole membrane" evidence=IDA

GO:0009651 "response to salt stress" evidence=IMP

TAIR|locus:2135962 CIPK8 "CBL-interacting protein kinase 8" [Arabidopsis thaliana (taxid:3702)]

 Score = 716 (257.1 bits), Expect = 8.6e-100, Sum P(2) = 8.6e-100
 Identities = 133/206 (64%), Positives = 173/206 (83%)

Query:    12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL 71
             ++G+YELGRT+GEG F KVKFAQ+ ++G   A+KI++++ II  K+ DQIKREI+ +KL+
Sbjct:     5 KVGKYELGRTIGEGTFAKVKFAQNTETGESVAMKIVDRSTIIKRKMVDQIKREISIMKLV 64

Query:    72 KHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCH 131
             +HP VVRL+EVLAS++KIY++LEY+TGGELFDKI   GRL E+E RK F QLIDGV YCH
Sbjct:    65 RHPCVVRLYEVLASRTKIYIILEYITGGELFDKIVRNGRLSESEARKYFHQLIDGVDYCH 124

Query:   132 NKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANR 191
             +KGV+HRDLK EN+LLDS+GN+KISDFGLSALP+  +   +L TTCG+PNYVAPEVL+++
Sbjct:   125 SKGVYHRDLKPENLLLDSQGNLKISDFGLSALPE--QGVTILKTTCGTPNYVAPEVLSHK 182

Query:   192 GYDGATSDIWSCGVILYIFRGDFKLP 217
             GY+GA +DIWSCGVILY+    + LP
Sbjct:   183 GYNGAVADIWSCGVILYVLMAGY-LP 207

GO:0004672 "protein kinase activity" evidence=IEA;TAS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;IDA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA;TAS

GO:0007165 "signal transduction" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009749 "response to glucose stimulus" evidence=TAS

GO:0010167 "response to nitrate" evidence=IEP;IMP

GO:0048364 "root development" evidence=IMP

GO:0046777 "protein autophosphorylation" evidence=IDA

TAIR|locus:2181047 CIPK15 "CBL-interacting protein kinase 15" [Arabidopsis thaliana (taxid:3702)]

 Score = 647 (232.8 bits), Expect = 5.5e-92, Sum P(2) = 5.5e-92
 Identities = 125/227 (55%), Positives = 168/227 (74%)

Query:     5 EKKQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKRE 64
             EKK   + L RYE+G+ LG+G F KV  A+ L +G   A+K+++K RI+ + +T+QIKRE
Sbjct:     2 EKKGSVLML-RYEVGKFLGQGTFAKVYHARHLKTGDSVAIKVIDKERILKVGMTEQIKRE 60

Query:    65 IATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLI 124
             I+ ++LL+HPN+V LHEV+A+KSKIY V+E+V GGELF+K+ S G+L+E   RK FQQL+
Sbjct:    61 ISAMRLLRHPNIVELHEVMATKSKIYFVMEHVKGGELFNKV-STGKLREDVARKYFQQLV 119

Query:   125 DGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVA 184
               V +CH++GV HRDLK EN+LLD  GN+KISDFGLSAL    R DGLLHTTCG+P YVA
Sbjct:   120 RAVDFCHSRGVCHRDLKPENLLLDEHGNLKISDFGLSALSDSRRQDGLLHTTCGTPAYVA 179

Query:   185 PEVLANRGYDGATSDIWSCGVILYIFRGDFKLPKWLSPGAQNLLRKI 231
             PEV++  GYDG  +D+WSCGVIL++    + LP +       L +KI
Sbjct:   180 PEVISRNGYDGFKADVWSCGVILFVLLAGY-LP-FRDSNLMELYKKI 224

GO:0004672 "protein kinase activity" evidence=IEA;ISS;TAS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005737 "cytoplasm" evidence=ISM

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0007165 "signal transduction" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009738 "abscisic acid mediated signaling pathway" evidence=TAS

GO:0009788 "negative regulation of abscisic acid mediated signaling pathway" evidence=IMP

TAIR|locus:2126749 SIP3 "SOS3-interacting protein 3" [Arabidopsis thaliana (taxid:3702)]

 Score = 663 (238.4 bits), Expect = 7.0e-92, Sum P(2) = 7.0e-92
 Identities = 122/222 (54%), Positives = 166/222 (74%)

Query:    10 GMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLK 69
             G+  GRYELGR LG G F KV  A+++ +G   A+K++ K +++ + + DQIKREI+ ++
Sbjct:    18 GLLHGRYELGRLLGHGTFAKVYHARNIQTGKSVAMKVVGKEKVVKVGMVDQIKREISVMR 77

Query:    70 LLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSY 129
             ++KHPN+V LHEV+ASKSKIY  +E V GGELF K+A KGRL+E   R  FQQLI  V +
Sbjct:    78 MVKHPNIVELHEVMASKSKIYFAMELVRGGELFAKVA-KGRLREDVARVYFQQLISAVDF 136

Query:   130 CHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLA 189
             CH++GV+HRDLK EN+LLD +GN+K++DFGLSA  +H + DGLLHTTCG+P YVAPEV+ 
Sbjct:   137 CHSRGVYHRDLKPENLLLDEEGNLKVTDFGLSAFTEHLKQDGLLHTTCGTPAYVAPEVIL 196

Query:   190 NRGYDGATSDIWSCGVILYIFRGDFKLPKWLSPGAQNLLRKI 231
              +GYDGA +D+WSCGVIL++    + LP +      N+ RKI
Sbjct:   197 KKGYDGAKADLWSCGVILFVLLAGY-LP-FQDDNLVNMYRKI 236

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0007165 "signal transduction" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005515 "protein binding" evidence=IPI

GO:0007275 "multicellular organismal development" evidence=IMP

GO:0009414 "response to water deprivation" evidence=IEP

GO:0009651 "response to salt stress" evidence=IEP

GO:0010540 "basipetal auxin transport" evidence=IMP

GO:0042538 "hyperosmotic salinity response" evidence=IDA

GO:0010118 "stomatal movement" evidence=RCA

GO:0019722 "calcium-mediated signaling" evidence=RCA

TAIR|locus:2179260 CIPK25 "CBL-interacting protein kinase 25" [Arabidopsis thaliana (taxid:3702)]

 Score = 640 (230.4 bits), Expect = 3.8e-91, Sum P(2) = 3.8e-91
 Identities = 119/231 (51%), Positives = 169/231 (73%)

Query:     5 EKKQEGMRL--GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIK 62
             E++Q+ +R+   +YE+GR LG+G FGKV + +++ +G   A+KI+ K+++    + +QIK
Sbjct:    30 EEEQQQLRVLFAKYEMGRLLGKGTFGKVYYGKEITTGESVAIKIINKDQVKREGMMEQIK 89

Query:    63 REIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQ 122
             REI+ ++L++HPN+V L EV+A+K+KI+ ++EYV GGELF KI  KG+L+E   RK FQQ
Sbjct:    90 REISIMRLVRHPNIVELKEVMATKTKIFFIMEYVKGGELFSKIV-KGKLKEDSARKYFQQ 148

Query:   123 LIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNY 182
             LI  V +CH++GV HRDLK EN+L+D  G++K+SDFGLSALP+    DGLLHT CG+P Y
Sbjct:   149 LISAVDFCHSRGVSHRDLKPENLLVDENGDLKVSDFGLSALPEQILQDGLLHTQCGTPAY 208

Query:   183 VAPEVLANRGYDGATSDIWSCGVILYIFRGDFKLPKWLSPGAQNLLRKILE 233
             VAPEVL  +GYDGA  DIWSCG+ILY+    F LP +       + RKI +
Sbjct:   209 VAPEVLRKKGYDGAKGDIWSCGIILYVLLAGF-LP-FQDENLMKMYRKIFK 257

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0007165 "signal transduction" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0050832 "defense response to fungus" evidence=IEP

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

ID	Name	Annotated EC number	Identity	Query coverage	Hit coverage	RBH(Q2H)	RBH(H2Q)
Q0D4B2	CIPKL_ORYSJ	2, ., 7, ., 1, 1, ., 1	0.6426	0.9643	0.7733	yes	no
Q8RWC9	CIPK1_ARATH	2, ., 7, ., 1, 1, ., 1	0.6651	0.9833	0.9324	yes	no
Q9LGV5	CIPK1_ORYSJ	2, ., 7, ., 1, 1, ., 1	0.6255	0.9904	0.9045	yes	no

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.1	0.991
3rd Layer	2.7.11	0.976

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Fail to connect to STRING server

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	421
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	4e-96
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	1e-82
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	1e-70
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	4e-65
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	1e-63
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	1e-60
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	3e-59
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	5e-55
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	3e-54
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	9e-50
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	5e-48
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	1e-47
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	7e-47
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	2e-45
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	5e-44
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	2e-43
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	2e-43
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	8e-43
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	3e-42
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	8e-42
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	3e-41
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	3e-41
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	3e-40
cd12195	116	cd12195, CIPK_C, C-terminal regulatory domain of C	7e-40
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	9e-40
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	9e-40
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	1e-39
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	2e-39
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	4e-39
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	6e-39
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	7e-39
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	1e-38
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	1e-38
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	7e-38
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	7e-38
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	2e-37
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	4e-37
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	5e-37
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	6e-37
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	1e-36
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	2e-36
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	4e-36
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	4e-36
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	5e-36
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	5e-36
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	7e-36
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	9e-36
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	1e-35
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	2e-35
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	2e-35
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	2e-35
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	6e-35
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	7e-35
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	7e-35
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	2e-34
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	4e-34
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	6e-34
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	1e-33
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	3e-33
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	4e-33
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	4e-33
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	5e-33
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	7e-33
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	8e-33
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	2e-32
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	3e-32
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	3e-32
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	4e-32
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	7e-32
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	1e-31
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	2e-31
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	2e-31
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	2e-31
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	4e-31
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	7e-31
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	8e-31
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	1e-30
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	2e-30
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	6e-30
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	8e-30
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	1e-29
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	1e-29
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	2e-29
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	2e-29
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	2e-29
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	3e-29
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	4e-29
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	5e-29
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	6e-29
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	7e-29
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	8e-29
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	8e-29
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	1e-28
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	2e-28
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	3e-28
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	4e-28
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	5e-28
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	1e-27
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	1e-27
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	2e-27
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	2e-27
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	3e-27
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	5e-27
cd05625	382	cd05625, STKc_LATS1, Catalytic domain of the Prote	1e-26
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	2e-26
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	2e-26
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	3e-26
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	3e-26
cd05626	381	cd05626, STKc_LATS2, Catalytic domain of the Prote	7e-26
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	8e-26
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	1e-25
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	1e-25
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	3e-25
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	4e-25
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	6e-25
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	8e-25
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	8e-25
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	1e-24
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	1e-24
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	1e-24
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	2e-24
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	5e-24
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	5e-24
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	5e-24
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	6e-24
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	8e-24
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	8e-24
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	1e-23
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	1e-23
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	1e-23
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	1e-23
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	1e-23
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	1e-23
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	2e-23
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	3e-23
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	4e-23
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	5e-23
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	7e-23
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	9e-23
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	1e-22
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	1e-22
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	1e-22
pfam03822	58	pfam03822, NAF, NAF domain	1e-22
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	2e-22
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	2e-22
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	2e-22
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	3e-22
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	4e-22
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	6e-22
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	8e-22
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	1e-21
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	1e-21
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	1e-21
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	1e-21
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	2e-21
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	2e-21
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	2e-21
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	2e-21
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	2e-21
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	3e-21
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	3e-21
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	4e-21
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	6e-21
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	6e-21
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	8e-21
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	8e-21
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	2e-20
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	3e-20
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	3e-20
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	4e-20
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	5e-20
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	7e-20
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	8e-20
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	8e-20
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	8e-20
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	8e-20
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	1e-19
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	1e-19
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	1e-19
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	2e-19
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	2e-19
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	2e-19
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	2e-19
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	2e-19
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	2e-19
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	3e-19
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	4e-19
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	5e-19
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	6e-19
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	7e-19
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	8e-19
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	1e-18
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	1e-18
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	1e-18
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	2e-18
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	2e-18
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	2e-18
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	2e-18
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	2e-18
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	3e-18
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	4e-18
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	7e-18
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	7e-18
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	1e-17
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	1e-17
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	1e-17
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	1e-17
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	1e-17
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	2e-17
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	2e-17
cd05576	237	cd05576, STKc_RPK118_like, Catalytic domain of the	2e-17
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	3e-17
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	4e-17
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	5e-17
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	7e-17
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	1e-16
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	1e-16
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	2e-16
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	3e-16
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	3e-16
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	3e-16
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	4e-16
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	4e-16
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	4e-16
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	5e-16
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	5e-16
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	5e-16
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	5e-16
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	7e-16
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	1e-15
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	1e-15
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	2e-15
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	3e-15
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	4e-15
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	4e-15
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	5e-15
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	9e-15
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	2e-14
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	2e-14
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	3e-14
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	4e-14
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	4e-14
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	5e-14
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	5e-14
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	8e-14
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	8e-14
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	9e-14
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	1e-13
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	1e-13
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	1e-13
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	2e-13
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	2e-13
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	2e-13
PHA03211	461	PHA03211, PHA03211, serine/threonine kinase US3; P	3e-13
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	3e-13
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	4e-13
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	4e-13
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	5e-13
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	6e-13
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	6e-13
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	8e-13
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	1e-12
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	2e-12
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	3e-12
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	4e-12
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	6e-12
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	8e-12
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	1e-11
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	1e-11
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	2e-11
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	3e-11
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	3e-11
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	5e-11
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	7e-11
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	7e-11
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	1e-10
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	1e-10
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	2e-10
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	2e-10
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	2e-10
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	3e-10
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	4e-10
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	5e-10
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	7e-10
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	1e-09
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	2e-09
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	4e-09
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	4e-09
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	7e-09
cd05086	268	cd05086, PTKc_Aatyk2, Catalytic domain of the Prot	2e-08
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	5e-08
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	3e-07
cd08226	328	cd08226, PK_STRAD_beta, Pseudokinase domain of STE	3e-07
cd08227	327	cd08227, PK_STRAD_alpha, Pseudokinase domain of ST	8e-07
cd05076	274	cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do	1e-06
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	1e-06
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	3e-06
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	8e-06
PLN03225	566	PLN03225, PLN03225, Serine/threonine-protein kinas	2e-05
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	2e-05
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	2e-05
cd12120	95	cd12120, AMPKA_C_like, C-terminal regulatory domai	4e-05
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	8e-05
PTZ00284	467	PTZ00284, PTZ00284, protein kinase; Provisional	9e-05
cd05037	259	cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom	1e-04
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	2e-04
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	4e-04
PLN03224	507	PLN03224, PLN03224, probable serine/threonine prot	4e-04
cd05120	155	cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot	4e-04
cd05077	262	cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do	0.002
PRK14879	211	PRK14879, PRK14879, serine/threonine protein kinas	0.002
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	0.004
cd12121	96	cd12121, MARK_C_like, C-terminal kinase associated	0.004
cd05078	258	cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat	0.004

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  287 bits (738), Expect = 4e-96
 Identities = 111/260 (42%), Positives = 155/260 (59%), Gaps = 30/260 (11%)

Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
           YE+   LGEG+FGKV  A+D  +G   A+K+++K +I   K  ++I REI  LK LKHPN
Sbjct: 1   YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIK--KDRERILREIKILKKLKHPN 58

Query: 76  VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGV 135
           +VRL++V   + K+Y+V+EY  GG+LFD +  +GRL E E R   +Q++  + Y H+KG+
Sbjct: 59  IVRLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDEARFYLRQILSALEYLHSKGI 118

Query: 136 FHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDG 195
            HRDLK ENILLD  G++K++DFGL+           L T  G+P Y+APEVL  +GY  
Sbjct: 119 VHRDLKPENILLDEDGHVKLADFGLAR---QLDPGEKLTTFVGTPEYMAPEVLLGKGYGK 175

Query: 196 ATSDIWSCGVILYI-------FRGD----------------FKLPKW-LSPGAQNLLRKI 231
           A  DIWS GVILY        F GD                F  P+W +SP A++L+RK+
Sbjct: 176 A-VDIWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWDISPEAKDLIRKL 234

Query: 232 LEPNPVKRITIAGIKADEWF 251
           L  +P KR+T        +F
Sbjct: 235 LVKDPEKRLTAEEALQHPFF 254

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  254 bits (650), Expect = 1e-82
 Identities = 105/263 (39%), Positives = 140/263 (53%), Gaps = 30/263 (11%)

Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
           YEL R LG G+FG V  A+   +G   AVKIL+K      K     +REI  L+ L HPN
Sbjct: 1   YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKK-DQTARREIRILRRLSHPN 59

Query: 76  VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGV 135
           +VRL +    K  +Y+V+EY  GG+LFD ++  G L E E +K+  Q++ G+ Y H+ G+
Sbjct: 60  IVRLIDAFEDKDHLYLVMEYCEGGDLFDYLSRGGPLSEDEAKKIALQILRGLEYLHSNGI 119

Query: 136 FHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDG 195
            HRDLK ENILLD  G +KI+DFGL+   +  +    L T  G+P Y+APEVL      G
Sbjct: 120 IHRDLKPENILLDENGVVKIADFGLAK--KLLKSSSSLTTFVGTPWYMAPEVLLGGNGYG 177

Query: 196 ATSDIWSCGVILYI-------FRGD------------------FKLPKW--LSPGAQNLL 228
              D+WS GVILY        F G+                  F  PKW   S  A++L+
Sbjct: 178 PKVDVWSLGVILYELLTGKPPFSGENILDQLQLIRRILGPPLEFDEPKWSSGSEEAKDLI 237

Query: 229 RKILEPNPVKRITIAGIKADEWF 251
           +K L  +P KR T   I    WF
Sbjct: 238 KKCLNKDPSKRPTAEEILQHPWF 260

Length = 260

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  221 bits (566), Expect = 1e-70
 Identities = 96/227 (42%), Positives = 135/227 (59%), Gaps = 17/227 (7%)

Query: 22  LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHE 81
           LGEG FG V  A+D  +G   A+KI++K     L   +++ REI  LK L HPN+V+L+ 
Sbjct: 1   LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLL--EELLREIEILKKLNHPNIVKLYG 58

Query: 82  VLASKSKIYMVLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDL 140
           V   ++ +Y+V+EY  GG L D +    G+L E E  ++  Q+++G+ Y H+ G+ HRDL
Sbjct: 59  VFEDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDL 118

Query: 141 KLENILLDSK-GNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSD 199
           K ENILLDS  G +K++DFGLS       D  LL T  G+P Y+APEVL  +GY    SD
Sbjct: 119 KPENILLDSDNGKVKLADFGLSK--LLTSDKSLLKTIVGTPAYMAPEVLLGKGYYSEKSD 176

Query: 200 IWSCGVILYIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIK 246
           IWS GVILY             P  ++L+RK+L+ +P KR +   I 
Sbjct: 177 IWSLGVILYEL-----------PELKDLIRKMLQKDPEKRPSAKEIL 212

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score =  208 bits (532), Expect = 4e-65
 Identities = 94/253 (37%), Positives = 145/253 (57%), Gaps = 26/253 (10%)

Query: 22  LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHE 81
           LG+G+FGKV   +  D+G  +A+K+L+K +II  K  +    E   L  + HP +V+LH 
Sbjct: 1   LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHY 60

Query: 82  VLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLK 141
              ++ K+Y+VLEY  GGELF  ++ +GR  E   R    +++  + Y H+ G+ +RDLK
Sbjct: 61  AFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDLK 120

Query: 142 LENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIW 201
            ENILLD+ G+IK++DFGL+   +   +    +T CG+P Y+APEVL  +GY G   D W
Sbjct: 121 PENILLDADGHIKLTDFGLAK--ELSSEGSRTNTFCGTPEYLAPEVLLGKGY-GKAVDWW 177

Query: 202 SCGVILY--------------------IFRGDFKLPKWLSPGAQNLLRKILEPNPVKRIT 241
           S GV+LY                    I +   + P++LSP A++L+  +L+ +P KR+ 
Sbjct: 178 SLGVLLYEMLTGKPPFYAEDRKEIYEKILKDPLRFPEFLSPEARDLISGLLQKDPTKRLG 237

Query: 242 IAG---IKADEWF 251
             G   IKA  +F
Sbjct: 238 SGGAEEIKAHPFF 250

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score =  206 bits (526), Expect = 1e-63
 Identities = 91/262 (34%), Positives = 141/262 (53%), Gaps = 31/262 (11%)

Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
           +E  +TLG G+FG+V   +   SG  +A+KIL K +I+ LK  + +  E   L+ ++HP 
Sbjct: 3   FEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPF 62

Query: 76  VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGV 135
           +V L+      S +Y+V+EYV GGELF  +   GR  E   R    Q++  + Y H+  +
Sbjct: 63  LVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLDI 122

Query: 136 FHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDG 195
            +RDLK EN+LLDS G IKI+DFG +      R  G  +T CG+P Y+APE++ ++GY  
Sbjct: 123 VYRDLKPENLLLDSDGYIKITDFGFAK-----RVKGRTYTLCGTPEYLAPEIILSKGYGK 177

Query: 196 ATSDIWSCGVILY--------------------IFRGDFKLPKWLSPGAQNLLRKILEPN 235
           A  D W+ G+++Y                    I  G  + P + SP A++L+R +L+ +
Sbjct: 178 A-VDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEGKVRFPSFFSPDAKDLIRNLLQVD 236

Query: 236 PVKRI-----TIAGIKADEWFE 252
             KR+      +  IK   WF 
Sbjct: 237 LTKRLGNLKNGVNDIKNHPWFA 258

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  197 bits (502), Expect = 1e-60
 Identities = 83/254 (32%), Positives = 127/254 (50%), Gaps = 27/254 (10%)

Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
            +  G  LG G+FG V  A D D+G   AVK +E +     ++ + ++REI  L  L+HP
Sbjct: 1   EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEEL-EALEREIRILSSLQHP 59

Query: 75  NVVRL--HEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHN 132
           N+VR    E    K+ + + LEYV+GG L   +   G+L E   RK  +Q+++G++Y H+
Sbjct: 60  NIVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHS 119

Query: 133 KGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRG 192
            G+ HRD+K  NIL+DS G +K++DFG +             +  G+P ++APEV+    
Sbjct: 120 NGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVI-RGE 178

Query: 193 YDGATSDIWSCG---------------------VILYIFRGDFK--LPKWLSPGAQNLLR 229
             G  +DIWS G                      +  I        +P+ LS  A++ LR
Sbjct: 179 EYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPEIPEHLSEEAKDFLR 238

Query: 230 KILEPNPVKRITIA 243
           K L  +P KR T  
Sbjct: 239 KCLRRDPKKRPTAD 252

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score =  193 bits (494), Expect = 3e-59
 Identities = 85/279 (30%), Positives = 138/279 (49%), Gaps = 44/279 (15%)

Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATL-KLLKHP 74
           ++ G+ +GEG+F  V  A++ ++   +A+KIL+K ++I  K    +K E   L +L  HP
Sbjct: 3   FKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHP 62

Query: 75  NVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKG 134
            +++L+     +  +Y VLEY   GEL   I   G L E   R    +++  + Y H+KG
Sbjct: 63  GIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKG 122

Query: 135 VFHRDLKLENILLDSKGNIKISDFGLS------ALPQHFRDDGLLHTT------------ 176
           + HRDLK ENILLD   +IKI+DFG +      + P+  + D     +            
Sbjct: 123 IIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASF 182

Query: 177 CGSPNYVAPEVLANRGYDGATSDIWSCGVILY-------IFRG-------------DFKL 216
            G+  YV+PE+L N    G +SD+W+ G I+Y        FRG             ++  
Sbjct: 183 VGTAEYVSPELL-NEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKILKLEYSF 241

Query: 217 PKWLSPGAQNLLRKILEPNPVKRITIAG----IKADEWF 251
           P    P A++L+ K+L  +P  R+ +      +KA  +F
Sbjct: 242 PPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPFF 280

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score =  182 bits (465), Expect = 5e-55
 Identities = 80/262 (30%), Positives = 130/262 (49%), Gaps = 41/262 (15%)

Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKIL------EKNRIIHLKITDQIKREIATL 68
           +YE+ + +G+G+FGKV   +    G  + +K +      EK R       +    E+  L
Sbjct: 1   KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKER-------EDALNEVKIL 53

Query: 69  KLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGR----LQEAEGRKLFQQLI 124
           K L HPN+++ +E    K K+ +V+EY  GG+L  KI  + +      E +    F QL 
Sbjct: 54  KKLNHPNIIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLC 113

Query: 125 DGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVA 184
             + Y H++ + HRD+K +NI L S G +K+ DFG+S +        L  T  G+P Y++
Sbjct: 114 LALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSS--TVDLAKTVVGTPYYLS 171

Query: 185 PEVLANRGYDGATSDIWSCGVILY--------------------IFRGDFK-LPKWLSPG 223
           PE+  N+ Y+   SDIWS G +LY                    I +G +  +P   S  
Sbjct: 172 PELCQNKPYN-YKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQYPPIPSQYSSE 230

Query: 224 AQNLLRKILEPNPVKRITIAGI 245
            +NL+  +L+ +P +R +IA I
Sbjct: 231 LRNLVSSLLQKDPEERPSIAQI 252

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score =  180 bits (460), Expect = 3e-54
 Identities = 85/260 (32%), Positives = 133/260 (51%), Gaps = 33/260 (12%)

Query: 22  LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHE 81
           LG G FG+V+  +       FA+K ++K  I+     + I  E   L+   HP +V+L+ 
Sbjct: 1   LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60

Query: 82  VLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLK 141
               K  IYM++EY  GGEL+  +  +G   E   R     ++    Y HN+G+ +RDLK
Sbjct: 61  TFKDKKYIYMLMEYCLGGELWTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLK 120

Query: 142 LENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIW 201
            EN+LLDS G +K+ DFG +   +  +      T CG+P YVAPE++ N+GYD +  D W
Sbjct: 121 PENLLLDSNGYVKLVDFGFA---KKLKSGQKTWTFCGTPEYVAPEIILNKGYDFS-VDYW 176

Query: 202 SCGVILY----------------------IFRGDFKL--PKWLSPGAQNLLRKILEPNPV 237
           S G++LY                      I +G+ KL  P ++   A++L++++L  NP 
Sbjct: 177 SLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEFPNYIDKAAKDLIKQLLRRNPE 236

Query: 238 KRI-----TIAGIKADEWFE 252
           +R+      I  IK  +WF 
Sbjct: 237 ERLGNLKGGIKDIKKHKWFN 256

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score =  171 bits (434), Expect = 9e-50
 Identities = 81/258 (31%), Positives = 137/258 (53%), Gaps = 26/258 (10%)

Query: 3   IAEKKQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIK 62
             +      +L  +E+G TLG G+FG+V+ A+   +G  +A+K L+K  I+ +K    + 
Sbjct: 7   FTKPDTSSWKLSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVA 66

Query: 63  REIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQ 122
           +E + L  L HP +V +      ++++Y +LE+V GGELF  +   GR      +    +
Sbjct: 67  QEKSILMELSHPFIVNMMCSFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAE 126

Query: 123 LIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNY 182
           L+    Y H+K + +RDLK EN+LLD+KG++K++DFG +      +      T CG+P Y
Sbjct: 127 LVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAK-----KVPDRTFTLCGTPEY 181

Query: 183 VAPEVLANRGYDGATSDIWSCGVILY--------------------IFRGDFKLPKWLSP 222
           +APEV+ ++G+  A  D W+ GV+LY                    I  G  K P W   
Sbjct: 182 LAPEVIQSKGHGKAV-DWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGRLKFPNWFDG 240

Query: 223 GAQNLLRKILEPNPVKRI 240
            A++L++ +L+ +  KR+
Sbjct: 241 RARDLVKGLLQTDHTKRL 258

Length = 329

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  164 bits (417), Expect = 5e-48
 Identities = 78/252 (30%), Positives = 130/252 (51%), Gaps = 31/252 (12%)

Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
           +E+   +G+G FG+V  A+   +G   A+K+++       +  ++I  EI  LK  KHPN
Sbjct: 2   FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLES---KEKKEKIINEIQILKKCKHPN 58

Query: 76  VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGR-LQEAEGRKLFQQLIDGVSYCHNKG 134
           +V+ +     K ++++V+E+ +GG L D + S  + L E++   + ++L+ G+ Y H+ G
Sbjct: 59  IVKYYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNG 118

Query: 135 VFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYD 194
           + HRD+K  NILL S G +K+ DFGLSA      D    +T  G+P ++APEV+  + YD
Sbjct: 119 IIHRDIKAANILLTSDGEVKLIDFGLSA---QLSDTKARNTMVGTPYWMAPEVINGKPYD 175

Query: 195 GATSDIWSCG--------------------VILYIFRGD---FKLPKWLSPGAQNLLRKI 231
              +DIWS G                     +  I        + P+  S   ++ L+K 
Sbjct: 176 YK-ADIWSLGITAIELAEGKPPYSELPPMKALFKIATNGPPGLRNPEKWSDEFKDFLKKC 234

Query: 232 LEPNPVKRITIA 243
           L+ NP KR T  
Sbjct: 235 LQKNPEKRPTAE 246

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score =  163 bits (416), Expect = 1e-47
 Identities = 88/296 (29%), Positives = 129/296 (43%), Gaps = 94/296 (31%)

Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIK----REIATLKLL 71
           YE    LGEG +G V  A+D  +G   A+K     +I      + I     REI+ LK L
Sbjct: 1   YEKLEKLGEGTYGVVYKARDKKTGEIVALK-----KIRLDNEEEGIPSTALREISLLKEL 55

Query: 72  KHPNVVRLHEVLASKSKIYMVLEYVTGGE-----LFDKIASKGRLQEAEGRKLFQQLIDG 126
           KHPN+V+L +V+ ++ K+Y+V EY    +       DK      L     + +  QL+ G
Sbjct: 56  KHPNIVKLLDVIHTERKLYLVFEYC---DMDLKKYLDKRPGP--LSPNLIKSIMYQLLRG 110

Query: 127 VSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPN----- 181
           ++YCH+  + HRDLK +NIL++  G +K++DFGL+                G P      
Sbjct: 111 LAYCHSHRILHRDLKPQNILINRDGVLKLADFGLA-------------RAFGIPLRTYTH 157

Query: 182 ------YVAPEVL-ANRGYDGATSDIWSCGVILY-------IFRGD---------FKL-- 216
                 Y APE+L  ++ Y  A  DIWS G I         +F GD         F++  
Sbjct: 158 EVVTLWYRAPEILLGSKHYSTAV-DIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILG 216

Query: 217 --------------------PKW-----------LSPGAQNLLRKILEPNPVKRIT 241
                               PK+           L P   +LL K+L+ NP KRI+
Sbjct: 217 TPTEESWPGVTKLPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRIS 272

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score =  161 bits (409), Expect = 7e-47
 Identities = 83/259 (32%), Positives = 135/259 (52%), Gaps = 32/259 (12%)

Query: 25  GNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLA 84
           G +G+V  A+   +G  +A+K+++K  +I     DQ+  E   L   + P VV+L+    
Sbjct: 4   GAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQ 63

Query: 85  SKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLEN 144
            K  +Y+V+EY+ GG+L   + + G L E   R    +++  + Y H+ G+ HRDLK +N
Sbjct: 64  GKKNLYLVMEYLPGGDLASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDN 123

Query: 145 ILLDSKGNIKISDFGLSAL----PQHFRDDGLLHT--TCGSPNYVAPEVLANRGYDGATS 198
           IL+DS G++K++DFGLS +     Q   +D         G+P+Y+APEV+  +G+   T 
Sbjct: 124 ILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQGH-SKTV 182

Query: 199 DIWSCGVILY--------------------IFRGDFKLPK--WLSPGAQNLLRKILEPNP 236
           D WS G ILY                    I  G  + P+   +S  A +L+ K+L P+P
Sbjct: 183 DWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKIEWPEDVEVSDEAIDLISKLLVPDP 242

Query: 237 VKRI---TIAGIKADEWFE 252
            KR+   +I  IK   +F+
Sbjct: 243 EKRLGAKSIEEIKNHPFFK 261

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score =  158 bits (401), Expect = 2e-45
 Identities = 82/262 (31%), Positives = 138/262 (52%), Gaps = 31/262 (11%)

Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
            E  +T+G G FG+V   +D  S   +A+K++    +I LK    +  E   LK + HP 
Sbjct: 3   LERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPF 62

Query: 76  VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGV 135
           ++RL      +  +YM++EYV GGELF  + + GR   + G     +++  + Y H+K +
Sbjct: 63  IIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKEI 122

Query: 136 FHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDG 195
            +RDLK ENILLD +G+IK++DFG +   +  RD     T CG+P Y+APEV+ ++G++ 
Sbjct: 123 VYRDLKPENILLDKEGHIKLTDFGFA---KKLRDR--TWTLCGTPEYLAPEVIQSKGHNK 177

Query: 196 ATSDIWSCGVILY--------------------IFRGDFKLPKWLSPGAQNLLRKILEPN 235
           A  D W+ G+++Y                    I  G  + P+ L   A++L++K+L  +
Sbjct: 178 AV-DWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGKLEFPRHLDLYAKDLIKKLLVVD 236

Query: 236 PVKRI-----TIAGIKADEWFE 252
             +R+         +K   WF+
Sbjct: 237 RTRRLGNMKNGADDVKNHRWFK 258

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score =  157 bits (397), Expect = 5e-44
 Identities = 93/292 (31%), Positives = 139/292 (47%), Gaps = 47/292 (16%)

Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP- 74
           Y + R LGEG+FG+V  A+D       A+K+L K      K  ++  REI  L  L HP 
Sbjct: 2   YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPP 58

Query: 75  NVVRLHEVLASKSKIYMVLEYVTGGELFD---KIASKGRLQEAEGRKLFQQLIDGVSYCH 131
           N+V+L++    +  +Y+V+EYV GG L D   KI  KG L E+E   +  Q++  + Y H
Sbjct: 59  NIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH 118

Query: 132 NKGVFHRDLKLENILLDSKGN-IKISDFGLSAL----PQHFRDDGLLHTTCGSPNYVAPE 186
           +KG+ HRD+K ENILLD  G  +K+ DFGL+ L            L  T+ G+P Y+APE
Sbjct: 119 SKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPE 178

Query: 187 VL--ANRGYDGATSDIWSCGVILY---------------------------------IFR 211
           VL   +  Y  ++SDIWS G+ LY                                    
Sbjct: 179 VLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLASP 238

Query: 212 GDFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPANPDDD 263
                P+ +S  A +LL+K+L  +P  R++ +   + +         +   D
Sbjct: 239 LSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHLKLKESDLSD 290

Length = 384

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score =  152 bits (386), Expect = 2e-43
 Identities = 77/248 (31%), Positives = 123/248 (49%), Gaps = 27/248 (10%)

Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
           +EL R +G+G FGKV   Q  D+   FA+K + K + +       +  E   L+ L HP 
Sbjct: 2   FELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPF 61

Query: 76  VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGV 135
           +V L      +  +Y+V++ + GG+L   ++ K +  E + +    +++  + Y H+KG+
Sbjct: 62  LVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGI 121

Query: 136 FHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDG 195
            HRD+K +NILLD +G++ I+DF ++        D L  +T G+P Y+APEVL  +GY  
Sbjct: 122 IHRDIKPDNILLDEQGHVHITDFNIAT---KVTPDTLTTSTSGTPGYMAPEVLCRQGY-S 177

Query: 196 ATSDIWSCGVILYIF-RG----------------------DFKLPKWLSPGAQNLLRKIL 232
              D WS GV  Y   RG                      D   P   S  A + + K+L
Sbjct: 178 VAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQETADVLYPATWSTEAIDAINKLL 237

Query: 233 EPNPVKRI 240
           E +P KR+
Sbjct: 238 ERDPQKRL 245

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score =  152 bits (385), Expect = 2e-43
 Identities = 80/259 (30%), Positives = 124/259 (47%), Gaps = 27/259 (10%)

Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
            Y+LG  +G G FG V    +L++G   A+K +   +I    +   I +EI  LK LKHP
Sbjct: 1   NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKS-IMQEIDLLKNLKHP 59

Query: 75  NVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKG 134
           N+V+    + +   +Y++LEY   G L   I   G   E+       Q++ G++Y H +G
Sbjct: 60  NIVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQG 119

Query: 135 VFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTC-GSPNYVAPEVLANRGY 193
           V HRD+K  NIL    G +K++DFG++       D      +  G+P ++APEV+   G 
Sbjct: 120 VIHRDIKAANILTTKDGVVKLADFGVA---TKLNDVSKDDASVVGTPYWMAPEVIEMSGA 176

Query: 194 DGATSDIWS--CGVI-----------------LY-IFRGDF-KLPKWLSPGAQNLLRKIL 232
             A SDIWS  C VI                 L+ I + D   LP+ +SP  ++ L +  
Sbjct: 177 STA-SDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQDDHPPLPEGISPELKDFLMQCF 235

Query: 233 EPNPVKRITIAGIKADEWF 251
           + +P  R T   +    W 
Sbjct: 236 QKDPNLRPTAKQLLKHPWI 254

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score =  152 bits (386), Expect = 8e-43
 Identities = 84/245 (34%), Positives = 137/245 (55%), Gaps = 27/245 (11%)

Query: 20  RTLGEGNFGKVKFAQDL---DSGLPFAVKILEKNRII-HLKITDQIKREIATLKLLKHPN 75
           + LG+G +GKV   + +   D+G  FA+K+L+K  I+ + K T   K E   L+ +KHP 
Sbjct: 2   KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPF 61

Query: 76  VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGV 135
           +V L     +  K+Y++LEY++GGELF  +  +G   E        ++   + + H +G+
Sbjct: 62  IVDLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQGI 121

Query: 136 FHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDG 195
            +RDLK ENILLD++G++K++DFGL    +   +  + HT CG+  Y+APE+L   G+ G
Sbjct: 122 IYRDLKPENILLDAQGHVKLTDFGLCK--ESIHEGTVTHTFCGTIEYMAPEILMRSGH-G 178

Query: 196 ATSDIWSCGVILY--------------------IFRGDFKLPKWLSPGAQNLLRKILEPN 235
              D WS G ++Y                    I +G   LP +L+P A++LL+K+L+ N
Sbjct: 179 KAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKLNLPPYLTPEARDLLKKLLKRN 238

Query: 236 PVKRI 240
           P  R+
Sbjct: 239 PSSRL 243

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score =  149 bits (378), Expect = 3e-42
 Identities = 85/266 (31%), Positives = 130/266 (48%), Gaps = 33/266 (12%)

Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKI--LEKNRIIHLKITDQIKREIATLKLLK 72
           R++ G  +G G FGKV  A +LD+G   AVK   ++ N     K   +I  E+  L+LLK
Sbjct: 1   RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDND---PKTIKEIADEMKVLELLK 57

Query: 73  HPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHN 132
           HPN+V+ + V   + K+Y+ +EY +GG L + +     L E   R    QL++G++Y H+
Sbjct: 58  HPNLVKYYGVEVHREKVYIFMEYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHS 117

Query: 133 KGVFHRDLKLENILLDSKGNIKISDFGLSAL--PQHFRDDGLLHTTCGSPNYVAPEVLAN 190
            G+ HRD+K  NI LD  G IK+ DFG +             + +  G+P Y+APEV+  
Sbjct: 118 HGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITG 177

Query: 191 RGYDG--ATSDIWSCG-VILYIFRGD-------------FKL----------PKWLSPGA 224
               G    +DIWS G V+L +  G              F +             LSP  
Sbjct: 178 GKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGHKPPIPDSLQLSPEG 237

Query: 225 QNLLRKILEPNPVKRITIAGIKADEW 250
           ++ L + LE +P KR T + +    +
Sbjct: 238 KDFLDRCLESDPKKRPTASELLQHPF 263

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score =  148 bits (377), Expect = 8e-42
 Identities = 83/282 (29%), Positives = 131/282 (46%), Gaps = 58/282 (20%)

Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
           RY++   +GEG  G V  A+D ++G   A+K +   R +   I +Q  REI  L+  +HP
Sbjct: 1   RYKILGRIGEGAHGIVFKAKDRETGETVALKKVA-LRRLEGGIPNQALREIKALQACQHP 59

Query: 75  NVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGR-LQEAEGRKLFQQLIDGVSYCHNK 133
            VV+L +V    S   +V+EY+    L + +  + R L EA+ +   + L+ GV+Y H  
Sbjct: 60  YVVKLLDVFPHGSGFVLVMEYMPSD-LSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHAN 118

Query: 134 GVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHT-TCGSPNYVAPEVL-ANR 191
           G+ HRDLK  N+L+ + G +KI+DFGL+ L     ++  L++    +  Y APE+L   R
Sbjct: 119 GIMHRDLKPANLLISADGVLKIADFGLARL--FSEEEPRLYSHQVATRWYRAPELLYGAR 176

Query: 192 GYDGATSDIWSCGVIL--------------------YIFR-----------GDFKLPKW- 219
            YD    D+W+ G I                      +FR           G   LP + 
Sbjct: 177 KYDPGV-DLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYN 235

Query: 220 ------------------LSPGAQNLLRKILEPNPVKRITIA 243
                              SP A +LL+ +L  +P KR++ A
Sbjct: 236 KITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAA 277

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score =  148 bits (375), Expect = 3e-41
 Identities = 84/242 (34%), Positives = 134/242 (55%), Gaps = 24/242 (9%)

Query: 20  RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVR 78
           + LG+G+FGKV  A+   +   +AVK+L+K+ I+     +    E   L L  KHP + +
Sbjct: 1   KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQ 60

Query: 79  LHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHR 138
           LH    +K +++ V+EYV GG+L   I   GR  E   R    +++ G+ + H +G+ +R
Sbjct: 61  LHSCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYR 120

Query: 139 DLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATS 198
           DLKL+N+LLDS+G+IKI+DFG+    +         T CG+P+Y+APE+L+ + Y G   
Sbjct: 121 DLKLDNVLLDSEGHIKIADFGMCK--EGILGGVTTSTFCGTPDYIAPEILSYQPY-GPAV 177

Query: 199 DIWSCGVILY--------------------IFRGDFKLPKWLSPGAQNLLRKILEPNPVK 238
           D W+ GV+LY                    I   + + P+WLS  A+++L+  L  NP K
Sbjct: 178 DWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDEVRYPRWLSKEAKSILKSFLTKNPEK 237

Query: 239 RI 240
           R+
Sbjct: 238 RL 239

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score =  148 bits (374), Expect = 3e-41
 Identities = 101/324 (31%), Positives = 168/324 (51%), Gaps = 59/324 (18%)

Query: 20  RTLGEGNFGKVKFAQDL---DSGLPFAVKILEKNRIIHLKITDQI--KREIATLKLLKHP 74
           + LG+G+FGKV   + +   D+G  +A+K+L+K     LK+ D++  K E   L  + HP
Sbjct: 2   KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKAT---LKVRDRVRTKMERDILAEVNHP 58

Query: 75  NVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKG 134
            +V+LH    ++ K+Y++L+++ GG+LF +++ +    E + +    +L   + + H+ G
Sbjct: 59  FIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLG 118

Query: 135 VFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYD 194
           + +RDLK ENILLD +G+IK++DFGLS        +   ++ CG+  Y+APEV+  RG+ 
Sbjct: 119 IIYRDLKPENILLDEEGHIKLTDFGLSKESID--HEKKAYSFCGTVEYMAPEVVNRRGHT 176

Query: 195 GATSDIWSCGVILY--------------------IFRGDFKLPKWLSPGAQNLLRKILEP 234
            + +D WS GV+++                    I +    +P++LSP AQ+LLR + + 
Sbjct: 177 QS-ADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKLGMPQFLSPEAQSLLRALFKR 235

Query: 235 NPVKRI-----TIAGIKADEWF-------------EQDYTPA--NPDDDEEDIFVDNEAF 274
           NP  R+      +  IK   +F             +  + PA   PDD     + D E  
Sbjct: 236 NPANRLGAGPDGVEEIKRHPFFSTIDWNKLYRREIKPPFKPAVGRPDD---TFYFDPEFT 292

Query: 275 SMHEVPSDGGRTPGSPPLINAFQL 298
           S    P D   +PG PP  NA QL
Sbjct: 293 S--RTPKD---SPGIPPSANAHQL 311

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score =  144 bits (364), Expect = 3e-40
 Identities = 82/253 (32%), Positives = 126/253 (49%), Gaps = 27/253 (10%)

Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVK--ILEKNRIIHLKITDQIKREIATLKLLK 72
           R+  G  LG G+FG V    +LD G  FAVK   L  +     +   Q+++EIA L  L+
Sbjct: 1   RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQ 60

Query: 73  HPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHN 132
           HPN+V+       +  +Y+ LE V GG L   +   G   E   R   +Q++ G+ Y H+
Sbjct: 61  HPNIVQYLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHD 120

Query: 133 KGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRG 192
           +   HRD+K  NIL+D+ G +K++DFG++   +   +     +  GSP ++APEV+A +G
Sbjct: 121 RNTVHRDIKGANILVDTNGVVKLADFGMA---KQVVEFSFAKSFKGSPYWMAPEVIAQQG 177

Query: 193 YDGATSDIWS--CGVI-----------LYIFRGDFK---------LPKWLSPGAQNLLRK 230
             G  +DIWS  C V+           L      FK         +P  LS  A++ + K
Sbjct: 178 GYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKELPPIPDHLSDEAKDFILK 237

Query: 231 ILEPNPVKRITIA 243
            L+ +P  R T A
Sbjct: 238 CLQRDPSLRPTAA 250

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|213380 cd12195, CIPK_C, C-terminal regulatory domain of Calcineurin B-Like (CBL)-interacting protein kinases

 Score =  138 bits (349), Expect = 7e-40
 Identities = 53/116 (45%), Positives = 76/116 (65%), Gaps = 3/116 (2%)

Query: 294 NAFQLIGMSSCLDLSGFFEKEDVSERKIRFTSNHSAKDLLERIEDIVTEMGFRVQKKN-G 352
           NAF LI +SS LDLSG FE+ED  +R+ RFTS   A++++E++E+   ++GFRV+KK  G
Sbjct: 1   NAFDLISLSSGLDLSGLFEEEDEVKRETRFTSRKPAEEIIEKLEEAAKKLGFRVRKKKEG 60

Query: 353 KLKATQEHKPQKSLGSLSVAAEVFEISPSLYVVELRKSYGDPTVYRQLCNKLSSDL 408
            +K   E +     G L+V+ EVFE++PSL VVE++KS GD   Y +    L   L
Sbjct: 61  GVK--LEGQKGGRKGRLAVSVEVFEVTPSLVVVEVKKSAGDTLEYHKFWKDLLRPL 114

CIPKs are serine/threonine protein kinases (STKs), catalyzing the transfer of the gamma-phosphoryl group from ATP to S/T residues on protein substrates. They comprise a unique family in higher plants of proteins that interact with the calcineurin B-like (CBL) calcium sensors to form a signaling network that decode specific calcium signals triggered by a variety of environmental stimuli including salinity, drought, cold, light, and mechanical perturbation, among others. The specificity of the response relies on differences in expression and localization of both CBLs and CIPKs, as well as on the interaction specificity of CBL-CIPK combinations. There are 25, 30, and 43 CIPK genes identified in the Arabidopsis thaliana, Oryza sativa, and Zea mays genomes, respectively. The founding member of the CIPK family is Arabidopsis thaliana CIPK24, also called SOS2 (Salt Overlay Sensitive 2). CIPKs contain an N-terminal catalytic kinase domain and a C-terminal regulatory domain that contains the FISL (also called NAF for Asn-Ala-Phe) and PPI-binding motifs, which are involved in the interaction with CBLs and PP2C-type protein phosphatases, respectively. Studies using SOS2, SOS3, and ABI2 phosphatase show that the binding of CBL and PP2C-type protein phosphatase to CIPK is mutually exclusive. The binding of CBL to CIPK is inhibitory to kinase activity. Length = 116

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score =  144 bits (364), Expect = 9e-40
 Identities = 86/253 (33%), Positives = 137/253 (54%), Gaps = 24/253 (9%)

Query: 20  RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKL-LKHPNVVR 78
           + LG+G+FGKV  A+   +   FA+K L+K+ ++     +    E   L L  +HP +  
Sbjct: 1   KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTH 60

Query: 79  LHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHR 138
           L     +K  ++ V+EY+ GG+L   I S GR  EA  R    ++I G+ + H KG+ +R
Sbjct: 61  LFCTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYR 120

Query: 139 DLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATS 198
           DLKL+N+LLD  G+IKI+DFG+    ++   +G   T CG+P+Y+APE+L  + Y+ +  
Sbjct: 121 DLKLDNVLLDKDGHIKIADFGMCK--ENMNGEGKASTFCGTPDYIAPEILKGQKYNESV- 177

Query: 199 DIWSCGVILY-------IFRGDFK-------------LPKWLSPGAQNLLRKILEPNPVK 238
           D WS GV+LY        F G+ +              P+W+S  A++ L K+ E +P K
Sbjct: 178 DWWSFGVLLYEMLIGQSPFHGEDEDELFDSILNDRPHFPRWISKEAKDCLSKLFERDPTK 237

Query: 239 RITIAGIKADEWF 251
           R+ + G      F
Sbjct: 238 RLGVDGDIRQHPF 250

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score =  143 bits (362), Expect = 9e-40
 Identities = 85/274 (31%), Positives = 145/274 (52%), Gaps = 42/274 (15%)

Query: 16  YELGRTLGEGNFGKVKFAQDL---DSGLPFAVKILEKNRIIH-LKITDQIKREIATLKLL 71
           +EL R LG G +GKV   + +   D+G  +A+K+L+K  I+   K  +  + E   L+ +
Sbjct: 2   FELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAV 61

Query: 72  KH-PNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYC 130
           +  P +V LH    + +K++++L+YV GGELF  +  +    E+E R    +++  + + 
Sbjct: 62  RRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHL 121

Query: 131 HNKGVFHRDLKLENILLDSKGNIKISDFGLSAL---PQHFRDDGLLHTTCGSPNYVAPEV 187
           H  G+ +RD+KLENILLDS+G++ ++DFGLS      +  R     ++ CG+  Y+APEV
Sbjct: 122 HQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEER----AYSFCGTIEYMAPEV 177

Query: 188 L--ANRGYDGATSDIWSCGVILY------------------------IFRGDFKLPKWLS 221
           +   + G+D A  D WS GV+ +                        I +     PK +S
Sbjct: 178 IRGGSGGHDKAV-DWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSKPPFPKTMS 236

Query: 222 PGAQNLLRKILEPNPVKRITIAG---IKADEWFE 252
             A++ ++K+LE +P KR+   G   IK   +F+
Sbjct: 237 AEARDFIQKLLEKDPKKRLGANGADEIKNHPFFQ 270

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score =  142 bits (360), Expect = 1e-39
 Identities = 79/262 (30%), Positives = 125/262 (47%), Gaps = 36/262 (13%)

Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
           YE+  T+G+G+FG V+  +    G     K ++   +   K   Q+  E+  L+ LKHPN
Sbjct: 2   YEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTE-KEKQQLVSEVNILRELKHPN 60

Query: 76  VVRL--HEVLASKSKIYMVLEYVTGGELFDKI----ASKGRLQEAEGRKLFQQLIDGVSY 129
           +VR     +  S   +Y+V+EY  GG+L   I      +  ++E    ++  QL+  +  
Sbjct: 61  IVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYE 120

Query: 130 CHNKG-----VFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVA 184
           CHN+      V HRDLK  NI LD+  N+K+ DFGL+ +  H  D     T  G+P Y++
Sbjct: 121 CHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGH--DSSFAKTYVGTPYYMS 178

Query: 185 PEVLANRGYDGATSDIWSCGVILY--------------------IFRGDF-KLPKWLSPG 223
           PE L +  YD   SDIWS G ++Y                    I  G F ++P   S  
Sbjct: 179 PEQLNHMSYD-EKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEGKFRRIPYRYSSE 237

Query: 224 AQNLLRKILEPNPVKRITIAGI 245
              +++ +L  +P KR +   +
Sbjct: 238 LNEVIKSMLNVDPDKRPSTEEL 259

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score =  141 bits (358), Expect = 2e-39
 Identities = 80/249 (32%), Positives = 129/249 (51%), Gaps = 26/249 (10%)

Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRI-IHL-KITDQIKREIATLKLLKH 73
           +  G+ LG+G FG+V    D+D+G   AVK +  +       K  + ++ EI  LK L+H
Sbjct: 4   WRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQH 63

Query: 74  PNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNK 133
             +V+ +  L     + + +EY+ GG + D++ + G L E   RK  +Q+++GV Y H+ 
Sbjct: 64  ERIVQYYGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSN 123

Query: 134 GVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDG-LLHTTCGSPNYVAPEVLANRG 192
            + HRD+K  NIL DS GN+K+ DFG S   Q     G  + +  G+P +++PEV++  G
Sbjct: 124 MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEG 183

Query: 193 YDGATSDIWSCGVILY-----------------IFR-----GDFKLPKWLSPGAQNLLRK 230
           Y G  +D+WS G  +                  IF+      + +LP  +SP A+N LR+
Sbjct: 184 Y-GRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPQLPSHVSPDARNFLRR 242

Query: 231 ILEPNPVKR 239
               N  KR
Sbjct: 243 TFVENAKKR 251

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score =  142 bits (360), Expect = 4e-39
 Identities = 80/251 (31%), Positives = 128/251 (50%), Gaps = 24/251 (9%)

Query: 20  RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKL-LKHPNVVR 78
           + LG+G+FGKV  A+   +   +A+K+L+K+ I+     D    E   L L  KHP +  
Sbjct: 1   KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTA 60

Query: 79  LHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHR 138
           LH    +K +++ V+EYV GG+L  +I    +  E   R    ++   + + H  GV +R
Sbjct: 61  LHCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYR 120

Query: 139 DLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATS 198
           DLKL+NILLD++G+ K++DFG+    +   +     T CG+P+Y+APE+L    Y G + 
Sbjct: 121 DLKLDNILLDAEGHCKLADFGMCK--EGILNGVTTTTFCGTPDYIAPEILQELEY-GPSV 177

Query: 199 DIWSCGVILY--------------------IFRGDFKLPKWLSPGAQNLLRKILEPNPVK 238
           D W+ GV++Y                    I   D   P WLS  A ++L+  +  NP K
Sbjct: 178 DWWALGVLMYEMMAGQPPFEADNEDDLFESILHDDVLYPVWLSKEAVSILKAFMTKNPNK 237

Query: 239 RITIAGIKADE 249
           R+     +  E
Sbjct: 238 RLGCVASQGGE 248

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score =  141 bits (357), Expect = 6e-39
 Identities = 93/300 (31%), Positives = 138/300 (46%), Gaps = 77/300 (25%)

Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLK----ITDQIKREIATLKLL 71
           YE    +GEG +G+V  A++  +G   A+K   K R+ + K    IT    REI  L+ L
Sbjct: 1   YEKIAQIGEGTYGQVYKARNKKTGELVALK---KIRMENEKEGFPIT--AIREIKLLQKL 55

Query: 72  KHPNVVRLHEVLASKSK--IYMVLEYV----TGGELFDKIASKG-RLQEAEGRKLFQQLI 124
           +HPN+VRL E++ SK K  IYMV EY+    TG      + S   +  E++ +   +QL+
Sbjct: 56  RHPNIVRLKEIVTSKGKGSIYMVFEYMDHDLTG-----LLDSPEVKFTESQIKCYMKQLL 110

Query: 125 DGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVA 184
           +G+ Y H+ G+ HRD+K  NIL+++ G +K++DFGL A P   R+         +  Y  
Sbjct: 111 EGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGL-ARPYTKRNSADYTNRVITLWYRP 169

Query: 185 PEVL--ANRGYDGATSDIWSCGVILY-------IFRG----------------------- 212
           PE+L  A R Y     D+WS G IL        IF+G                       
Sbjct: 170 PELLLGATR-YGPE-VDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWP 227

Query: 213 ---------DFKLPK------------WLSPGAQNLLRKILEPNPVKRITIAGIKADEWF 251
                    + K  K             + P A +LL K+L  +P KRI+       E+F
Sbjct: 228 GVSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF 287

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score =  142 bits (359), Expect = 7e-39
 Identities = 79/241 (32%), Positives = 124/241 (51%), Gaps = 23/241 (9%)

Query: 20  RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRL 79
           + LG+G FGKV   ++  +G  +A+KIL+K  II          E   L+  +HP +  L
Sbjct: 1   KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTAL 60

Query: 80  HEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRD 139
                +  ++  V+EY  GGELF  ++ +    E   R    +++  + Y H+  V +RD
Sbjct: 61  KYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYRD 120

Query: 140 LKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSD 199
           LKLEN++LD  G+IKI+DFGL    +   D   + T CG+P Y+APEVL +  Y G   D
Sbjct: 121 LKLENLMLDKDGHIKITDFGLCK--EGISDGATMKTFCGTPEYLAPEVLEDNDY-GRAVD 177

Query: 200 IWSCGVILY--------------------IFRGDFKLPKWLSPGAQNLLRKILEPNPVKR 239
            W  GV++Y                    I   + + P+ LSP A++LL  +L+ +P +R
Sbjct: 178 WWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLSPEAKSLLAGLLKKDPKQR 237

Query: 240 I 240
           +
Sbjct: 238 L 238

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score =  141 bits (357), Expect = 1e-38
 Identities = 78/240 (32%), Positives = 129/240 (53%), Gaps = 24/240 (10%)

Query: 22  LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN-VVRLH 80
           LG+G+FGKV  A+   +   +A+KIL+K+ II     +    E   L L   P  + +LH
Sbjct: 8   LGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLH 67

Query: 81  EVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDL 140
               +  ++Y V+EYV GG+L   I   G+ +E        ++  G+ + H+KG+ +RDL
Sbjct: 68  SCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDL 127

Query: 141 KLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDI 200
           KL+N++LD++G+IKI+DFG+    ++        T CG+P+Y+APE++A + Y G + D 
Sbjct: 128 KLDNVMLDAEGHIKIADFGMCK--ENIFGGKTTRTFCGTPDYIAPEIIAYQPY-GKSVDW 184

Query: 201 WSCGVILY--------------------IFRGDFKLPKWLSPGAQNLLRKILEPNPVKRI 240
           W+ GV+LY                    I   +   PK LS  A ++ + +L  +P KR+
Sbjct: 185 WAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKSLSKEAVSICKGLLTKHPAKRL 244

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score =  139 bits (353), Expect = 1e-38
 Identities = 62/198 (31%), Positives = 104/198 (52%), Gaps = 16/198 (8%)

Query: 17  ELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITD----QIKREIATLKLLK 72
           E  + LG+G+ G V   +   +G  +A+K       IH+   +    Q+ RE+ TL+  +
Sbjct: 4   ERVKVLGQGSSGVVYKVRHKPTGKIYALKK------IHVDGDEEFRKQLLRELKTLRSCE 57

Query: 73  HPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHN 132
            P VV+ +     + +I +VLEY+ GG L D +   G++ E     + +Q++ G+ Y H 
Sbjct: 58  SPYVVKCYGAFYKEGEISIVLEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHT 117

Query: 133 K-GVFHRDLKLENILLDSKGNIKISDFGLSA-LPQHFRDDGLLHTTCGSPNYVAPEVLAN 190
           K  + HRD+K  N+L++SKG +KI+DFG+S  L          +T  G+  Y++PE +  
Sbjct: 118 KRHIIHRDIKPSNLLINSKGEVKIADFGISKVLEN---TLDQCNTFVGTVTYMSPERIQG 174

Query: 191 RGYDGATSDIWSCGVILY 208
                  +DIWS G+ L 
Sbjct: 175 E-SYSYAADIWSLGLTLL 191

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score =  139 bits (352), Expect = 7e-38
 Identities = 91/332 (27%), Positives = 161/332 (48%), Gaps = 51/332 (15%)

Query: 16  YELGRTLGEGNFGKVKFAQDL---DSGLPFAVKILEKNRIIH-LKITDQIKREIATLKLL 71
           +EL + LG G +GKV   + +   D+G  +A+K+L+K  ++   K  +  + E   L+ +
Sbjct: 2   FELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHV 61

Query: 72  KH-PNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYC 130
           +  P +V LH    +++K++++L+YV+GGE+F  +  +    E E R    ++I  + + 
Sbjct: 62  RQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHL 121

Query: 131 HNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHF--RDDGLLHTTCGSPNYVAPEVL 188
           H  G+ +RD+KLENILLDS+G++ ++DFGLS   + F   +    ++ CG+  Y+APE++
Sbjct: 122 HKLGIVYRDIKLENILLDSEGHVVLTDFGLS---KEFLSEEKERTYSFCGTIEYMAPEII 178

Query: 189 ANRGYDGATSDIWSCGVILY------------------------IFRGDFKLPKWLSPGA 224
             +G  G   D WS G++++                        I + D   P ++ P A
Sbjct: 179 RGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCDPPFPSFIGPEA 238

Query: 225 QNLLRKILEPNPVKRITIAGIKADEWFEQDY---------------TPANPD-DDEEDIF 268
           Q+LL K+L  +P KR+      A E  E  +                P  P   +E D+ 
Sbjct: 239 QDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKGLDWEALALRKVNPPFRPSIRNELDVG 298

Query: 269 VDNEAFS-MHEVPSDGGRTPGSPPLINAFQLI 299
              E F+ +  V S  G  P    +   +  +
Sbjct: 299 NFAEEFTNLEPVYSPAGTPPSGARVFQGYSFV 330

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score =  139 bits (351), Expect = 7e-38
 Identities = 91/267 (34%), Positives = 134/267 (50%), Gaps = 30/267 (11%)

Query: 20  RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATL-KLLKHPNVVR 78
           + +G+G+FGKV  A+    G  +AVK+L+K  I+  K  + I  E   L K LKHP +V 
Sbjct: 1   KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVG 60

Query: 79  LHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHR 138
           LH    +  K+Y VL+YV GGELF  +  +    E   R    ++   + Y H+  + +R
Sbjct: 61  LHYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYR 120

Query: 139 DLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATS 198
           DLK ENILLDS+G++ ++DFGL    +    +    T CG+P Y+APEVL    YD  T 
Sbjct: 121 DLKPENILLDSQGHVVLTDFGLCK--EGVEPEETTSTFCGTPEYLAPEVLRKEPYD-RTV 177

Query: 199 DIWSCGVILY--------------------IFRGDFKLPKWLSPGAQNLLRKILEPNPVK 238
           D W  G +LY                    I     +LP   +  A +LL  +L  +  +
Sbjct: 178 DWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHKPLQLPGGKTVAACDLLVGLLHKDQRR 237

Query: 239 RITIAGIKADEWFEQD---YTPANPDD 262
           R+   G KAD    ++   ++P N DD
Sbjct: 238 RL---GAKADFLEIKNHVFFSPINWDD 261

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score =  137 bits (347), Expect = 2e-37
 Identities = 81/255 (31%), Positives = 133/255 (52%), Gaps = 27/255 (10%)

Query: 20  RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK-HPNVVR 78
           R LG+G+FGKV  A+  +SG  +AVK+L+K+ I+     +    E   L L + HP + +
Sbjct: 1   RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQ 60

Query: 79  LHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHR 138
           L+    +  +++ V+E+V GG+L   I    R  EA  R    ++   + + H+KG+ +R
Sbjct: 61  LYCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYR 120

Query: 139 DLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATS 198
           DLKL+N+LLD +G+ K++DFG+    +   +     T CG+P+Y+APE+L    Y G + 
Sbjct: 121 DLKLDNVLLDHEGHCKLADFGMCK--EGIFNGKTTSTFCGTPDYIAPEILQEMLY-GPSV 177

Query: 199 DIWSCGVILY--------------------IFRGDFKLPKWLSPGAQNLLRKILEPNPVK 238
           D W+ GV+LY                    I   +   P WLS  A ++L+  +  NP  
Sbjct: 178 DWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTWLSQDAVDILKAFMTKNPTM 237

Query: 239 R---ITIAGIKADEW 250
           R   +T+ G +A   
Sbjct: 238 RLGSLTLGGEEAILR 252

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score =  137 bits (346), Expect = 4e-37
 Identities = 86/250 (34%), Positives = 126/250 (50%), Gaps = 27/250 (10%)

Query: 20  RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATL-KLLKHPNVVR 78
           + +G+G+FGKV  A+    G  +AVK+L+K  I+  K    I  E   L K +KHP +V 
Sbjct: 1   KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVG 60

Query: 79  LHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHR 138
           LH    +  K+Y VL+YV GGELF  +  +    E   R    ++   + Y H+  + +R
Sbjct: 61  LHYSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYR 120

Query: 139 DLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATS 198
           DLK ENILLDS+G++ ++DFGL    +         T CG+P Y+APEVL  + YD  T 
Sbjct: 121 DLKPENILLDSQGHVVLTDFGLCK--EGIEHSKTTSTFCGTPEYLAPEVLRKQPYD-RTV 177

Query: 199 DIWSCGVILY--------------------IFRGDFKLPKWLSPGAQNLLRKILEPNPVK 238
           D W  G +LY                    I     +L   +S  A++LL  +L+ +  K
Sbjct: 178 DWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKPLRLKPNISVSARHLLEGLLQKDRTK 237

Query: 239 RITIAGIKAD 248
           R+   G K D
Sbjct: 238 RL---GAKDD 244

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score =  137 bits (345), Expect = 5e-37
 Identities = 78/241 (32%), Positives = 124/241 (51%), Gaps = 23/241 (9%)

Query: 20  RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRL 79
           + LG+G FGKV   ++  +G  +A+KIL K  II          E   L+  +HP +  L
Sbjct: 1   KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 60

Query: 80  HEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRD 139
                +  ++  V+EY  GGELF  ++ +    E   R    +++  + Y H++ V +RD
Sbjct: 61  KYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRD 120

Query: 140 LKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSD 199
           +KLEN++LD  G+IKI+DFGL    +   D   + T CG+P Y+APEVL +  Y G   D
Sbjct: 121 IKLENLMLDKDGHIKITDFGLCK--EGISDGATMKTFCGTPEYLAPEVLEDNDY-GRAVD 177

Query: 200 IWSCGVILY--------------------IFRGDFKLPKWLSPGAQNLLRKILEPNPVKR 239
            W  GV++Y                    I   + + P+ LSP A++LL  +L+ +P +R
Sbjct: 178 WWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLLKKDPKQR 237

Query: 240 I 240
           +
Sbjct: 238 L 238

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score =  135 bits (341), Expect = 6e-37
 Identities = 77/258 (29%), Positives = 127/258 (49%), Gaps = 41/258 (15%)

Query: 25  GNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKH-PNVVRLHEVL 83
           G FG V  A+   +G  FA+K+L+K+ +I       +K E A + +    P V +L+   
Sbjct: 7   GAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSF 66

Query: 84  ASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLE 143
            SK  +Y+V+EY+ GG+    I + G L E   ++   +++ GV   H +G+ HRD+K E
Sbjct: 67  QSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPE 126

Query: 144 NILLDSKGNIKISDFGLSA---LPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDI 200
           N+L+D  G++K++DFGLS      + F          G+P+Y+APE +   G D   SD 
Sbjct: 127 NLLIDQTGHLKLTDFGLSRNGLENKKF---------VGTPDYLAPETILGVGDDKM-SDW 176

Query: 201 WSCGVILY--------------------IFRGDFKLPK----WLSPGAQNLLRKILEPNP 236
           WS G +++                    I       P+    + SP A +L+ ++L  +P
Sbjct: 177 WSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEVKEFCSPEAVDLINRLLCMDP 236

Query: 237 VKRITIAG---IKADEWF 251
            KR+   G   IK+  +F
Sbjct: 237 AKRLGANGYQEIKSHPFF 254

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score =  136 bits (343), Expect = 1e-36
 Identities = 84/241 (34%), Positives = 124/241 (51%), Gaps = 23/241 (9%)

Query: 20  RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRL 79
           + LG+G FGKV   ++  SG  +A+KIL+K  II          E   LK  +HP +  L
Sbjct: 1   KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSL 60

Query: 80  HEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRD 139
                +K ++  V+EYV GGELF  ++ +    E   R    +++  + Y H+  + +RD
Sbjct: 61  KYSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRD 120

Query: 140 LKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSD 199
           LKLEN++LD  G+IKI+DFGL    +   D   + T CG+P Y+APEVL +  Y G   D
Sbjct: 121 LKLENLMLDKDGHIKITDFGLCK--EGITDAATMKTFCGTPEYLAPEVLEDNDY-GRAVD 177

Query: 200 IWSCGVILY--------------------IFRGDFKLPKWLSPGAQNLLRKILEPNPVKR 239
            W  GV++Y                    I   D K P+ LS  A++LL  +L  +P KR
Sbjct: 178 WWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEDIKFPRTLSADAKSLLSGLLIKDPNKR 237

Query: 240 I 240
           +
Sbjct: 238 L 238

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score =  135 bits (341), Expect = 2e-36
 Identities = 91/313 (29%), Positives = 130/313 (41%), Gaps = 82/313 (26%)

Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKIT-DQIK----REIATLK 69
           RYE G+ LGEG +  V  A+D ++G   A+K   K ++   K   D I     REI  L+
Sbjct: 1   RYEKGKKLGEGTYAVVYKARDKETGRIVAIK---KIKLGERKEAKDGINFTALREIKLLQ 57

Query: 70  LLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKG-RLQEAEGRKLFQQLIDGVS 128
            LKHPN++ L +V   KS I +V E++   +L   I  K   L  A+ +      + G+ 
Sbjct: 58  ELKHPNIIGLLDVFGHKSNINLVFEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLE 116

Query: 129 YCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPN------- 181
           Y H+  + HRDLK  N+L+ S G +K++DFGL+              + GSPN       
Sbjct: 117 YLHSNWILHRDLKPNNLLIASDGVLKLADFGLA-------------RSFGSPNRKMTHQV 163

Query: 182 ----YVAPEVLANRGYDGATSDIWSCGVIL--------------------YIFR------ 211
               Y APE+L    + G   D+WS G I                      IF       
Sbjct: 164 VTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPT 223

Query: 212 -----GDFKLPKWL----SPG-------------AQNLLRKILEPNPVKRITIAGIKADE 249
                G   LP ++     P              A +LL+++L  NP KRIT        
Sbjct: 224 EENWPGVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHP 283

Query: 250 WFEQDYTPANPDD 262
           +F  D  P  P  
Sbjct: 284 YFSNDPAPTPPSQ 296

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  132 bits (335), Expect = 4e-36
 Identities = 68/202 (33%), Positives = 98/202 (48%), Gaps = 13/202 (6%)

Query: 17  ELGRTLGEGNFGKVK----FAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK 72
           ELG+ LGEG FG+V           +    AVK L K      +  +    E + +K L 
Sbjct: 2   ELGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTL-KEGASEEEREE-FLEEASIMKKLS 59

Query: 73  HPNVVRLHEVLASKSKIYMVLEYVTGGELFDKI-ASKGRLQEAEGRKLFQQLIDGVSYCH 131
           HPN+VRL  V      +Y+V EY+ GG+L D +     +L   +  ++  Q+  G+ Y  
Sbjct: 60  HPNIVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKGMEYLE 119

Query: 132 NKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCG--SPNYVAPEVLA 189
           +K   HRDL   N L+     +KISDFGLS     + DD       G     ++APE L 
Sbjct: 120 SKNFVHRDLAARNCLVTENLVVKISDFGLS--RDIYEDDYYRKRGGGKLPIKWMAPESLK 177

Query: 190 NRGYDGATSDIWSCGVILY-IF 210
           +  +    SD+WS GV+L+ IF
Sbjct: 178 DGKFTSK-SDVWSFGVLLWEIF 198

Length = 258

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score =  135 bits (340), Expect = 4e-36
 Identities = 82/255 (32%), Positives = 126/255 (49%), Gaps = 27/255 (10%)

Query: 6   KKQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLP-FAVKILEKNRIIHLKITDQIKRE 64
           K++  M+   +   RTLG G+FG+V  A   +   P  A+K  EK++II  K  D +  E
Sbjct: 22  KRKNKMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSE 81

Query: 65  IATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLI 124
              L  + HP  V L+     +S +Y+VLE+V GGE F  +    R     G     Q++
Sbjct: 82  RKILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIV 141

Query: 125 DGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVA 184
               Y  +  + +RDLK EN+LLD  G IK++DFG + +      D   +T CG+P Y+A
Sbjct: 142 LIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVV-----DTRTYTLCGTPEYIA 196

Query: 185 PEVLANRGYDGATSDIWSCGVILY--------------------IFRGDFKLPKWLSPGA 224
           PE+L N G+ G  +D W+ G+ +Y                    I  G    PK+L    
Sbjct: 197 PEILLNVGH-GKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGIIYFPKFLDNNC 255

Query: 225 QNLLRKILEPNPVKR 239
           ++L++K+L  +  KR
Sbjct: 256 KHLMKKLLSHDLTKR 270

Length = 340

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score =  134 bits (338), Expect = 5e-36
 Identities = 80/242 (33%), Positives = 134/242 (55%), Gaps = 28/242 (11%)

Query: 22  LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIH---LKITDQIKREIATLKLLKHPNVVR 78
           LG+G+FGKV  A+   +   +A+KIL+K+ +I    ++ T   KR +A     K P + +
Sbjct: 8   LGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQD--KPPFLTQ 65

Query: 79  LHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHR 138
           LH    +  ++Y V+EYV GG+L   I   G+ +E +      ++  G+ + H +G+ +R
Sbjct: 66  LHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGIIYR 125

Query: 139 DLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATS 198
           DLKL+N++LDS+G+IKI+DFG+    +H  D     T CG+P+Y+APE++A + Y G + 
Sbjct: 126 DLKLDNVMLDSEGHIKIADFGMCK--EHMVDGVTTRTFCGTPDYIAPEIIAYQPY-GKSV 182

Query: 199 DIWSCGVILY--------------------IFRGDFKLPKWLSPGAQNLLRKILEPNPVK 238
           D W+ GV+LY                    I   +   PK LS  A ++ + ++  +P K
Sbjct: 183 DWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKSLSKEAVSICKGLMTKHPSK 242

Query: 239 RI 240
           R+
Sbjct: 243 RL 244

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score =  134 bits (339), Expect = 5e-36
 Identities = 79/242 (32%), Positives = 120/242 (49%), Gaps = 27/242 (11%)

Query: 22  LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQI---KREIATLKLLKHPNVVR 78
           LG G+FGKV  A+   +G  +A+K L+K  II     + +   KR   T    +HP +V 
Sbjct: 7   LGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVN 66

Query: 79  LHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHR 138
           L     ++  +  V+EY  GG+L   I       E         ++ G+ Y H   + +R
Sbjct: 67  LFACFQTEDHVCFVMEYAAGGDLMMHI-HTDVFSEPRAVFYAACVVLGLQYLHENKIVYR 125

Query: 139 DLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATS 198
           DLKL+N+LLD++G +KI+DFGL      F D     T CG+P ++APEVL    Y  A  
Sbjct: 126 DLKLDNLLLDTEGFVKIADFGLCKEGMGFGDR--TSTFCGTPEFLAPEVLTETSYTRAV- 182

Query: 199 DIWSCGVILY-------IFRGD-------------FKLPKWLSPGAQNLLRKILEPNPVK 238
           D W  GV++Y        F GD              + P++LS  A +++R++L  NP +
Sbjct: 183 DWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSREAISIMRRLLRRNPER 242

Query: 239 RI 240
           R+
Sbjct: 243 RL 244

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score =  132 bits (334), Expect = 7e-36
 Identities = 84/258 (32%), Positives = 128/258 (49%), Gaps = 36/258 (13%)

Query: 19  GRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRII-------HLKITDQIKREIATLKLL 71
           G  +G+G +G+V  A ++ +G   AVK +E    I          +   ++ EI TLK L
Sbjct: 6   GELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDL 65

Query: 72  KHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCH 131
            H N+V+      ++  + + LEYV GG +   + + GR +E   R   +Q+++G++Y H
Sbjct: 66  DHLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLH 125

Query: 132 NKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLAN- 190
           +KG+ HRDLK +N+L+D+ G  KISDFG+S       D+    +  GS  ++APEV+ + 
Sbjct: 126 SKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSY 185

Query: 191 -RGYDGATSDIWSCG-VILYIFRGD------------FKLPKW-------------LSPG 223
            +GY  A  DIWS G V+L +F G             FKL                LSP 
Sbjct: 186 SQGYS-AKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPIPPDVSMNLSPV 244

Query: 224 AQNLLRKILEPNPVKRIT 241
           A + L      NP  R T
Sbjct: 245 ALDFLNACFTINPDNRPT 262

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score =  134 bits (338), Expect = 9e-36
 Identities = 66/190 (34%), Positives = 102/190 (53%), Gaps = 12/190 (6%)

Query: 22  LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHE 81
           +G+G +G+V  A+  D+G   A+K ++K+ +  L     +  E   L   K   +V+L  
Sbjct: 9   VGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLY 68

Query: 82  VLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLK 141
                  +Y+ +EYV GG+    + + G L E   R    ++ + V   H  G  HRDLK
Sbjct: 69  AFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGYIHRDLK 128

Query: 142 LENILLDSKGNIKISDFGLSALPQHFRDDGLL---HTTCGSPNYVAPEVLANRGYDGATS 198
            EN L+D+ G+IK++DFGLS         G++   ++  GSP+Y+APEVL  +GYD  T 
Sbjct: 129 PENFLIDASGHIKLTDFGLSK--------GIVTYANSVVGSPDYMAPEVLRGKGYD-FTV 179

Query: 199 DIWSCGVILY 208
           D WS G +LY
Sbjct: 180 DYWSLGCMLY 189

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score =  133 bits (335), Expect = 1e-35
 Identities = 80/258 (31%), Positives = 142/258 (55%), Gaps = 31/258 (12%)

Query: 20  RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL----KHPN 75
           + LG+G+FGKV  A+    G  FAVK L+K+ ++   I D ++  +   ++L    ++P 
Sbjct: 1   KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVL---IDDDVECTMVEKRVLALAWENPF 57

Query: 76  VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGV 135
           +  L+    +K  ++ V+E++ GG+L   I  KGR           +++ G+ + H+KG+
Sbjct: 58  LTHLYCTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGI 117

Query: 136 FHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDG 195
            +RDLKL+N++LD  G+IKI+DFG+    ++   D    T CG+P+Y+APE+L    Y  
Sbjct: 118 IYRDLKLDNVMLDRDGHIKIADFGMCK--ENVFGDNRASTFCGTPDYIAPEILQGLKYTF 175

Query: 196 ATSDIWSCGVILY-------IFRGDFK-------------LPKWLSPGAQNLLRKILEPN 235
           +  D WS GV+LY        F GD +              P+W++  ++++L K+ E +
Sbjct: 176 SV-DWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDTPHYPRWITKESKDILEKLFERD 234

Query: 236 PVKRITIAG-IKADEWFE 252
           P +R+ + G I+   +F+
Sbjct: 235 PTRRLGVVGNIRGHPFFK 252

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score =  133 bits (335), Expect = 2e-35
 Identities = 95/306 (31%), Positives = 148/306 (48%), Gaps = 39/306 (12%)

Query: 20  RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREI-ATLKLLKHPNVVR 78
           + +G+G+FGKV  A+       +AVK+L+K  I+  K    I  E    LK +KHP +V 
Sbjct: 1   KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVG 60

Query: 79  LHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHR 138
           LH    +  K+Y VL+Y+ GGELF  +  +    E   R    ++   + Y H+  + +R
Sbjct: 61  LHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYR 120

Query: 139 DLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATS 198
           DLK ENILLDS+G+I ++DFGL    ++   +G   T CG+P Y+APEVL  + YD  T 
Sbjct: 121 DLKPENILLDSQGHIVLTDFGLCK--ENIEHNGTTSTFCGTPEYLAPEVLHKQPYD-RTV 177

Query: 199 DIWSCGVILY--------------------IFRGDFKLPKWLSPGAQNLLRKILEPNPVK 238
           D W  G +LY                    I     +L   ++  A++LL  +L+ +  K
Sbjct: 178 DWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPNITNSARHLLEGLLQKDRTK 237

Query: 239 RIT-------------IAGIKADEWFEQDYTPA-NPD-DDEEDIFVDNEAFSMHEVPSDG 283
           R+               + I  D+   +  TP  NP+     D+   +  F+   VP+  
Sbjct: 238 RLGAKDDFMEIKNHIFFSPINWDDLINKKITPPFNPNVSGPNDLRHFDPEFTEEPVPNSI 297

Query: 284 GRTPGS 289
           G++P S
Sbjct: 298 GQSPDS 303

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  131 bits (331), Expect = 2e-35
 Identities = 66/211 (31%), Positives = 99/211 (46%), Gaps = 31/211 (14%)

Query: 17  ELGRTLGEGNFGKVKFAQ----DLDSGLPFAVKILEKNRIIHLKITDQIK---REIATLK 69
            LG+ LGEG FG+V             +  AVK L+++         QI+   RE   ++
Sbjct: 2   TLGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKED-----ASEQQIEEFLREARIMR 56

Query: 70  LLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKL-FQQLID--- 125
            L HPN+V+L  V   +  + +V+EY+ GG+L         L++   ++L    L+    
Sbjct: 57  KLDHPNIVKLLGVCTEEEPLMIVMEYMPGGDL------LDYLRKNRPKELSLSDLLSFAL 110

Query: 126 ----GVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP- 180
               G+ Y  +K   HRDL   N L+     +KISDFGLS     + DD         P 
Sbjct: 111 QIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSR--DLYDDDYYKVKGGKLPI 168

Query: 181 NYVAPEVLANRGYDGATSDIWSCGVILY-IF 210
            ++APE L    +    SD+WS GV+L+ IF
Sbjct: 169 RWMAPESLKEGKFTSK-SDVWSFGVLLWEIF 198

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  130 bits (330), Expect = 2e-35
 Identities = 65/207 (31%), Positives = 98/207 (47%), Gaps = 24/207 (11%)

Query: 17  ELGRTLGEGNFGKVKFAQ----DLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK 72
            LG+ LGEG FG+V   +         +  AVK L+++        ++  RE   ++ L 
Sbjct: 2   TLGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQI--EEFLREARIMRKLD 59

Query: 73  HPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLID------- 125
           HPNVV+L  V   +  +Y+V+EY+ GG+L         L++   +     L+        
Sbjct: 60  HPNVVKLLGVCTEEEPLYIVMEYMEGGDL------LSYLRKNRPKLSLSDLLSFALQIAR 113

Query: 126 GVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP-NYVA 184
           G+ Y  +K   HRDL   N L+     +KISDFGLS     + DD         P  ++A
Sbjct: 114 GMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSR--DLYDDDYYRKRGGKLPIRWMA 171

Query: 185 PEVLANRGYDGATSDIWSCGVILY-IF 210
           PE L    +    SD+WS GV+L+ IF
Sbjct: 172 PESLKEGKFTSK-SDVWSFGVLLWEIF 197

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score =  131 bits (330), Expect = 6e-35
 Identities = 77/249 (30%), Positives = 134/249 (53%), Gaps = 30/249 (12%)

Query: 20  RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL----KHPN 75
           + LG+G+FGKV  A+   +   FA+K L+K+ ++   + D ++  +   ++L    +HP 
Sbjct: 1   KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVL---MDDDVECTMVEKRVLSLAWEHPF 57

Query: 76  VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGV 135
           +  L+    +K  ++ V+EY+ GG+L   I S  +           ++I G+ + H+KG+
Sbjct: 58  LTHLYCTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGI 117

Query: 136 FHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDG 195
            +RDLKL+NILLD+ G+IKI+DFG+    ++   D    T CG+P+Y+APE+L  + Y  
Sbjct: 118 VYRDLKLDNILLDTDGHIKIADFGMCK--ENMLGDAKTCTFCGTPDYIAPEILLGQKY-N 174

Query: 196 ATSDIWSCGVILY--------------------IFRGDFKLPKWLSPGAQNLLRKILEPN 235
            + D WS GV+LY                    I   +   P+WL+  A+++L K+    
Sbjct: 175 TSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDNPCYPRWLTREAKDILVKLFVRE 234

Query: 236 PVKRITIAG 244
           P +R+ + G
Sbjct: 235 PERRLGVKG 243

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score =  130 bits (328), Expect = 7e-35
 Identities = 81/267 (30%), Positives = 149/267 (55%), Gaps = 37/267 (13%)

Query: 16  YELGRTLGEGNFGKVKFAQDL---DSGLPFAVKILEKNRIIH-LKITDQIKREIATLKLL 71
           +EL + LG G +GKV   + +   DSG  +A+K+L+K  I+   K T+  + E   L+ +
Sbjct: 2   FELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHI 61

Query: 72  KH-PNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYC 130
           +  P +V LH    + +K++++L+Y+ GGELF  ++ + R +E E +    +++  + + 
Sbjct: 62  RQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHL 121

Query: 131 HNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGL--LHTTCGSPNYVAPEVL 188
           H  G+ +RD+KLENILLDS G++ ++DFGLS   + F +D +   ++ CG+  Y+AP+++
Sbjct: 122 HKLGIIYRDIKLENILLDSNGHVVLTDFGLS---KEFHEDEVERAYSFCGTIEYMAPDIV 178

Query: 189 A--NRGYDGATSDIWSCGVILY------------------------IFRGDFKLPKWLSP 222
              + G+D A  D WS GV++Y                        I + +   P+ +S 
Sbjct: 179 RGGDGGHDKAV-DWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSA 237

Query: 223 GAQNLLRKILEPNPVKRITIAGIKADE 249
            A+++++++L  +P KR+      ADE
Sbjct: 238 LAKDIIQRLLMKDPKKRLGCGPSDADE 264

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score =  131 bits (330), Expect = 7e-35
 Identities = 79/242 (32%), Positives = 126/242 (52%), Gaps = 24/242 (9%)

Query: 20  RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRL 79
           + LG+G FGKV   ++  +G  +A+KIL+K  I+          E   L+  +HP +  L
Sbjct: 1   KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTAL 60

Query: 80  HEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHN-KGVFHR 138
                +  ++  V+EY  GGELF  ++ +    E   R    +++  + Y H+ K V +R
Sbjct: 61  KYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYR 120

Query: 139 DLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATS 198
           DLKLEN++LD  G+IKI+DFGL    +  +D   + T CG+P Y+APEVL +  Y G   
Sbjct: 121 DLKLENLMLDKDGHIKITDFGLCK--EGIKDGATMKTFCGTPEYLAPEVLEDNDY-GRAV 177

Query: 199 DIWSCGVILY--------------------IFRGDFKLPKWLSPGAQNLLRKILEPNPVK 238
           D W  GV++Y                    I   + + P+ LSP A++LL  +L+ +P +
Sbjct: 178 DWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLSPEAKSLLSGLLKKDPKQ 237

Query: 239 RI 240
           R+
Sbjct: 238 RL 239

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score =  128 bits (323), Expect = 2e-34
 Identities = 61/192 (31%), Positives = 102/192 (53%), Gaps = 11/192 (5%)

Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
           +++   LGEG++G V  A   ++G   A+K++     +      +I +EI+ LK    P 
Sbjct: 5   FDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDLQ-----EIIKEISILKQCDSPY 59

Query: 76  VVRLHEVLASKSKIYMVLEYVTGGELFD--KIASKGRLQEAEGRKLFQQLIDGVSYCHNK 133
           +V+ +      + +++V+EY   G + D  KI +K  L E E   +  Q + G+ Y H+ 
Sbjct: 60  IVKYYGSYFKNTDLWIVMEYCGAGSVSDIMKITNK-TLTEEEIAAILYQTLKGLEYLHSN 118

Query: 134 GVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGY 193
              HRD+K  NILL+ +G  K++DFG+S   Q        +T  G+P ++APEV+   GY
Sbjct: 119 KKIHRDIKAGNILLNEEGQAKLADFGVSG--QLTDTMAKRNTVIGTPFWMAPEVIQEIGY 176

Query: 194 DGATSDIWSCGV 205
           +    DIWS G+
Sbjct: 177 NNKA-DIWSLGI 187

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score =  129 bits (325), Expect = 4e-34
 Identities = 78/243 (32%), Positives = 134/243 (55%), Gaps = 30/243 (12%)

Query: 22  LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL----KHPNVV 77
           LG+G+FGKV  A+   +   +A+KIL+K+ +I     D ++  +   ++L    K P + 
Sbjct: 8   LGKGSFGKVMLAERKGTDELYAIKILKKDVVIQ---DDDVECTMVEKRVLALSGKPPFLT 64

Query: 78  RLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFH 137
           +LH    +  ++Y V+EYV GG+L  +I   GR +E        ++  G+ + H+KG+ +
Sbjct: 65  QLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGIIY 124

Query: 138 RDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGAT 197
           RDLKL+N++LDS+G+IKI+DFG+    ++  D     T CG+P+Y+APE++A + Y G +
Sbjct: 125 RDLKLDNVMLDSEGHIKIADFGMCK--ENMWDGVTTKTFCGTPDYIAPEIIAYQPY-GKS 181

Query: 198 SDIWSCGVILY--------------------IFRGDFKLPKWLSPGAQNLLRKILEPNPV 237
            D W+ GV+LY                    I   +   PK +S  A  + + ++  +P 
Sbjct: 182 VDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAVAICKGLMTKHPG 241

Query: 238 KRI 240
           KR+
Sbjct: 242 KRL 244

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score =  128 bits (323), Expect = 6e-34
 Identities = 82/255 (32%), Positives = 124/255 (48%), Gaps = 26/255 (10%)

Query: 22  LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHE 81
           +G+G+FGKV   +  D+   +A+K + K  I+          E   L  +  P +V L  
Sbjct: 1   IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60

Query: 82  VLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLK 141
              S  K+Y+VL ++ GGELF  +  +GR   +  R    +L+  +   H   V +RDLK
Sbjct: 61  SFQSPEKLYLVLAFINGGELFHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDLK 120

Query: 142 LENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIW 201
            ENILLD +G+I + DFGL  L  + +DD   +T CG+P Y+APE+L   GY  A  D W
Sbjct: 121 PENILLDYQGHIALCDFGLCKL--NMKDDDKTNTFCGTPEYLAPELLLGHGYTKAV-DWW 177

Query: 202 SCGVILY--------------------IFRGDFKLPKWLSPGAQNLLRKILEPNPVKRIT 241
           + GV+LY                    I +   + P      A++LL  +L  +P +R+ 
Sbjct: 178 TLGVLLYEMLTGLPPFYDENVNEMYRKILQEPLRFPDGFDRDAKDLLIGLLSRDPTRRLG 237

Query: 242 IAG---IKADEWFEQ 253
             G   IK   +F Q
Sbjct: 238 YNGAQEIKNHPFFSQ 252

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score =  127 bits (322), Expect = 1e-33
 Identities = 91/315 (28%), Positives = 131/315 (41%), Gaps = 84/315 (26%)

Query: 12  RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVK-ILEKNRIIHLKITDQIKREIATLKL 70
           +L  YE+   LGEG FG+V  A+ + +G   A+K IL  N      IT    REI  LK 
Sbjct: 6   KLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITAL--REIKILKK 63

Query: 71  LKHPNVVRLHEVLASKSK--------IYMVLEYVT---GGELFDKIASKGRLQEAEGRKL 119
           LKHPNVV L ++   +          +YMV  Y+     G L +      +L E++ +  
Sbjct: 64  LKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENP---SVKLTESQIKCY 120

Query: 120 FQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGS 179
             QL++G++Y H   + HRD+K  NIL+D++G +KI+DFGL+   + +          G 
Sbjct: 121 MLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLA---RPYDGPPPNPKGGGG 177

Query: 180 PN------------YVAPE-VLANRGYDGATSDIWSCGVILY-------IFRGD------ 213
                         Y  PE +L  R Y  A  DIW  G +         I +G       
Sbjct: 178 GGTRKYTNLVVTRWYRPPELLLGERRYTTAV-DIWGIGCVFAEMFTRRPILQGKSDIDQL 236

Query: 214 ---FKL---------PKWLS-PGAQN------------------------LLRKILEPNP 236
              FKL         P W S PG +                         LL K+L  +P
Sbjct: 237 HLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDP 296

Query: 237 VKRITIAGIKADEWF 251
            KR+T +      +F
Sbjct: 297 YKRLTASDALEHPYF 311

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score =  125 bits (315), Expect = 3e-33
 Identities = 74/254 (29%), Positives = 131/254 (51%), Gaps = 27/254 (10%)

Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
           +Y   + +GEG+FGK    +  + G  + +K +  +++   K  ++ ++E+A L  +KHP
Sbjct: 1   KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSP-KEREESRKEVAVLSNMKHP 59

Query: 75  NVVRLHEVLASKSKIYMVLEYVTGGELFDKI-ASKGRL-QEAEGRKLFQQLIDGVSYCHN 132
           N+V+  E       +Y+V++Y  GG+L+ KI A +G L  E +    F Q+   + + H+
Sbjct: 60  NIVQYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHD 119

Query: 133 KGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRG 192
           + + HRD+K +NI L   G IK+ DFG++ +     +  L  T  G+P Y++PE+  NR 
Sbjct: 120 RKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVE--LARTCIGTPYYLSPEICENRP 177

Query: 193 YDGATSDIWSCGVILY--------------------IFRGDF-KLPKWLSPGAQNLLRKI 231
           Y+   SDIW+ G +LY                    I RG +  +    S   +NL+ ++
Sbjct: 178 YNN-KSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGSYPPVSSHYSYDLRNLVSQL 236

Query: 232 LEPNPVKRITIAGI 245
            + NP  R ++  I
Sbjct: 237 FKRNPRDRPSVNSI 250

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score =  125 bits (316), Expect = 4e-33
 Identities = 63/197 (31%), Positives = 94/197 (47%), Gaps = 8/197 (4%)

Query: 14  GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVK---ILEKNRIIHLKITDQIKREIATLKL 70
            +YE+   +GEG +G V   ++  +G   A+K     E +  +         RE+  L+ 
Sbjct: 1   NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTAL----REVKVLRQ 56

Query: 71  LKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYC 130
           L+H N+V L E    K ++Y+V EYV    L    AS G L     R    QL+  ++YC
Sbjct: 57  LRHENIVNLKEAFRRKGRLYLVFEYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYC 116

Query: 131 HNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLAN 190
           H+  + HRD+K ENIL+   G +K+ DFG  A     R    L     +  Y APE+L  
Sbjct: 117 HSHNIIHRDIKPENILVSESGVLKLCDFGF-ARALRARPASPLTDYVATRWYRAPELLVG 175

Query: 191 RGYDGATSDIWSCGVIL 207
               G   D+W+ G I+
Sbjct: 176 DTNYGKPVDVWAIGCIM 192

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  124 bits (315), Expect = 4e-33
 Identities = 69/206 (33%), Positives = 97/206 (47%), Gaps = 20/206 (9%)

Query: 20  RTLGEGNFGKVKFA---QDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNV 76
           + LGEG FG+V               AVK L K      +  D   +E   +K L HPNV
Sbjct: 1   KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTL-KEDASEEERKD-FLKEARVMKKLGHPNV 58

Query: 77  VRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLF--QQLID-------GV 127
           VRL  V   +  +Y+VLEY+ GG+L D +     +  +  +     + L+        G+
Sbjct: 59  VRLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGM 118

Query: 128 SYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCG-SPN-YVAP 185
            Y  +K   HRDL   N L+     +KISDFGLS     + DD     T G  P  ++AP
Sbjct: 119 EYLASKKFVHRDLAARNCLVGEDLVVKISDFGLS--RDVYDDDYYRKKTGGKLPIRWMAP 176

Query: 186 EVLANRGYDGATSDIWSCGVILY-IF 210
           E L +  +    SD+WS GV+L+ IF
Sbjct: 177 ESLKDGIFTSK-SDVWSFGVLLWEIF 201

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score =  124 bits (313), Expect = 5e-33
 Identities = 83/260 (31%), Positives = 123/260 (47%), Gaps = 40/260 (15%)

Query: 19  GRTLGEGNFGKVKFAQDLDSGLPFAVKILE------KNRIIHLKITDQIKREIATLKLLK 72
           G  +G G+FG V    +  SG   AVK +E       ++     + D + REIA LK L+
Sbjct: 5   GALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQ 64

Query: 73  HPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHN 132
           H N+V+          + + LEYV GG +   + + G  +E   R   +Q++ G++Y HN
Sbjct: 65  HENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHN 124

Query: 133 KGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTC--------GSPNYVA 184
           +G+ HRD+K  NIL+D+KG IKISDFG+S   +       L T          GS  ++A
Sbjct: 125 RGIIHRDIKGANILVDNKGGIKISDFGISKKLEA----NSLSTKTNGARPSLQGSVFWMA 180

Query: 185 PEVLANRGYDGATSDIWSCGVILY-----------------IFR-GDFKLPKW---LSPG 223
           PEV+    Y     DIWS G ++                  IF+ G+   P+    +S  
Sbjct: 181 PEVVKQTSYTRKA-DIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGENASPEIPSNISSE 239

Query: 224 AQNLLRKILEPNPVKRITIA 243
           A + L K  E +  KR T A
Sbjct: 240 AIDFLEKTFEIDHNKRPTAA 259

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score =  124 bits (314), Expect = 7e-33
 Identities = 82/285 (28%), Positives = 124/285 (43%), Gaps = 71/285 (24%)

Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIK--REIATLKLLKH 73
           Y+    +GEG +G V  A+D  +G   A+K   K ++            REI  LK L H
Sbjct: 1   YQKLGKIGEGTYGVVYKARDKLTGEIVAIK---KIKLRFESEGIPKTALREIKLLKELNH 57

Query: 74  PNVVRLHEVLASKSKIYMVLEYV-TGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHN 132
           PN+++L +V   K  +Y+V E++ T      K   +G L E+  +    QL+ G+++CH+
Sbjct: 58  PNIIKLLDVFRHKGDLYLVFEFMDTDLYKLIKDRQRG-LPESLIKSYLYQLLQGLAFCHS 116

Query: 133 KGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYV------APE 186
            G+ HRDLK EN+L++++G +K++DFGL+     F      +T     +YV      APE
Sbjct: 117 HGILHRDLKPENLLINTEGVLKLADFGLARS---FGSPVRPYT-----HYVVTRWYRAPE 168

Query: 187 VLANRGYDGATSDIWSCGVILY-------IFRGD-------------------------- 213
           +L          DIWS G I         +F G                           
Sbjct: 169 LLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTS 228

Query: 214 ------FKLPKW-----------LSPGAQNLLRKILEPNPVKRIT 241
                 F  PK             SP A +LL ++L  +P KRIT
Sbjct: 229 LARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRIT 273

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score =  126 bits (318), Expect = 8e-33
 Identities = 69/222 (31%), Positives = 110/222 (49%), Gaps = 28/222 (12%)

Query: 14  GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKH 73
             +E+ + +G G FG+V   +D D+G  +A+K+L K+ +I       ++ E   L     
Sbjct: 1   DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADS 60

Query: 74  PNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNK 133
           P +V+L+     +  +Y+V+EY+ GG+L + +  K    E   R    +L+  +   H  
Sbjct: 61  PWIVKLYYSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKL 120

Query: 134 GVFHRDLKLENILLDSKGNIKISDFGLSA---------------LPQHFRDDGLLH---- 174
           G  HRD+K +NIL+D+ G+IK++DFGL                     FRD+ L+     
Sbjct: 121 GFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDH 180

Query: 175 --------TTCGSPNYVAPEVLANRGYDGATSDIWSCGVILY 208
                   +T G+P+Y+APEVL    Y     D WS GVILY
Sbjct: 181 KQRRVRANSTVGTPDYIAPEVLRGTPYGLE-CDWWSLGVILY 221

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score =  124 bits (313), Expect = 2e-32
 Identities = 72/190 (37%), Positives = 107/190 (56%), Gaps = 4/190 (2%)

Query: 20  RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREI-ATLKLLKHPNVVR 78
           + +G+G+FGKV  A+    G  +AVK+L+K  +++ K    I  E    LK +KHP +V 
Sbjct: 1   KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVG 60

Query: 79  LHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHR 138
           LH    +  K+Y VL++V GGELF  +  +    E   R    ++   + Y H+  + +R
Sbjct: 61  LHYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYR 120

Query: 139 DLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATS 198
           DLK ENILLDS+G++ ++DFGL        D     T CG+P Y+APEV+  + YD  T 
Sbjct: 121 DLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTT--TFCGTPEYLAPEVIRKQPYDN-TV 177

Query: 199 DIWSCGVILY 208
           D W  G +LY
Sbjct: 178 DWWCLGAVLY 187

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score =  122 bits (308), Expect = 3e-32
 Identities = 79/268 (29%), Positives = 121/268 (45%), Gaps = 51/268 (19%)

Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITD-----QIKR-----E 64
            +++ + LG+G++G V           + VK L  N+   LK  D     Q +R     E
Sbjct: 1   DFKVLKKLGKGSYGSV-----------YKVKRLSDNQFYALKEVDLGSMSQKEREDAVNE 49

Query: 65  IATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKI----ASKGRLQEAEGRKLF 120
           I  L  + HPN++   E     +K+ +V+EY   G+L   I      +  + E E  ++F
Sbjct: 50  IRILASVNHPNIISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIF 109

Query: 121 QQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP 180
            QL+ G+   H + + HRDLK  NILL +   +KI D G+S + +      +  T  G+P
Sbjct: 110 IQLLRGLQALHEQKILHRDLKSANILLVANDLVKIGDLGISKVLK----KNMAKTQIGTP 165

Query: 181 NYVAPEVLANRGYDGATSDIWSCGVILY--------------------IFRGDF-KLPKW 219
           +Y+APEV   R Y    SDIWS G +LY                    + RG +  +P  
Sbjct: 166 HYMAPEVWKGRPYS-YKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGKYPPIPPI 224

Query: 220 LSPGAQNLLRKILEPNPVKRITIAGIKA 247
            S   QN +R +L+  P  R     I A
Sbjct: 225 YSQDLQNFIRSMLQVKPKLRPNCDKILA 252

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score =  122 bits (307), Expect = 3e-32
 Identities = 74/222 (33%), Positives = 113/222 (50%), Gaps = 15/222 (6%)

Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
           +Y + R +GEG+FG+    Q ++S   +A+K +   +       +  ++E   L  +KHP
Sbjct: 1   QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSS--AVEDSRKEAVLLAKMKHP 58

Query: 75  NVVRLHEVLASKSKIYMVLEYVTGGELFDKIA-SKGRL-QEAEGRKLFQQLIDGVSYCHN 132
           N+V   E   +   +Y+V+EY  GG+L  KI   +G+L  E    + F Q+  GV + H 
Sbjct: 59  NIVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHE 118

Query: 133 KGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRG 192
           K V HRD+K +NI L   G +K+ DFG + L           T  G+P YV PE+  N  
Sbjct: 119 KRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTS--PGAYACTYVGTPYYVPPEIWENMP 176

Query: 193 YDGATSDIWSCGVILY---IFRGDFKLPKWLSPGAQNLLRKI 231
           Y+   SDIWS G ILY     +  F+   W     +NL+ K+
Sbjct: 177 YNN-KSDIWSLGCILYELCTLKHPFQANSW-----KNLILKV 212

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score =  122 bits (309), Expect = 4e-32
 Identities = 72/248 (29%), Positives = 123/248 (49%), Gaps = 39/248 (15%)

Query: 22  LGEGNFGKVKFAQDLDSGLPFAVK--ILEKNRIIHLKITDQIKREIATLKLLKHPNVVRL 79
           +GEG  G+V  A D  +G   A+K   L K         + I  EI  +K  KHPN+V  
Sbjct: 27  IGEGASGEVYKATDRATGKEVAIKKMRLRKQNK------ELIINEILIMKDCKHPNIVDY 80

Query: 80  HEVLASKSKIYMVLEYVTGGELFDKIA-SKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHR 138
           ++      ++++V+EY+ GG L D I  +  R+ E +   + ++++ G+ Y H++ V HR
Sbjct: 81  YDSYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHR 140

Query: 139 DLKLENILLDSKGNIKISDFGLSAL--PQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGA 196
           D+K +NILL   G++K++DFG +A    +  +     ++  G+P ++APEV+  + Y   
Sbjct: 141 DIKSDNILLSKDGSVKLADFGFAAQLTKEKSKR----NSVVGTPYWMAPEVIKRKDYGPK 196

Query: 197 TSDIWSCGVI-------------------LYIFRG----DFKLPKWLSPGAQNLLRKILE 233
             DIWS G++                   L++         K P+  SP  ++ L K L 
Sbjct: 197 V-DIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGIPPLKNPEKWSPEFKDFLNKCLV 255

Query: 234 PNPVKRIT 241
            +P KR +
Sbjct: 256 KDPEKRPS 263

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score =  123 bits (310), Expect = 7e-32
 Identities = 75/287 (26%), Positives = 124/287 (43%), Gaps = 56/287 (19%)

Query: 20  RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRL 79
           + LG+G+ G+V   +   +G  FA+K+L+K  +I      ++  E   L  L HP +  L
Sbjct: 7   KLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTL 66

Query: 80  HEVLASKSKIYMVLEYVTGGELFD--KIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFH 137
           +    +++ + +V++Y  GGELF   +      L E   R    +++  + Y H  G+ +
Sbjct: 67  YASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVY 126

Query: 138 RDLKLENILLDSKGNIKISDFGLS---ALPQHFRDDGLLHTTCGSPN------------- 181
           RDLK ENILL   G+I +SDF LS    +        L   +  S               
Sbjct: 127 RDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPS 186

Query: 182 -----------YVAPEVLANRGYDGATSDIWSCGVILY--------------------IF 210
                      Y+APEV++  G+  A  D W+ G++LY                    I 
Sbjct: 187 FRSNSFVGTEEYIAPEVISGDGHGSAV-DWWTLGILLYEMLYGTTPFKGSNRDETFSNIL 245

Query: 211 RGDFKLPK--WLSPGAQNLLRKILEPNPVKRITIAG----IKADEWF 251
           + +   P    +S  A++L+RK+L  +P KR+        IK   +F
Sbjct: 246 KKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFF 292

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score =  121 bits (306), Expect = 1e-31
 Identities = 80/279 (28%), Positives = 130/279 (46%), Gaps = 48/279 (17%)

Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
           +E  + +  G +G V   +  ++   FA+K + K  +I      Q+  E   L   ++P 
Sbjct: 3   FETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPF 62

Query: 76  VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGV 135
           VV +     +K  + MV+EYV GG+    + + G L     R  F + +  + Y HN G+
Sbjct: 63  VVSMFCSFETKRHLCMVMEYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYGI 122

Query: 136 FHRDLKLENILLDSKGNIKISDFGLSAL-----------------PQHFRDDGLLHTTCG 178
            HRDLK +N+L+ S G+IK++DFGLS +                  + F D  +    CG
Sbjct: 123 VHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQV----CG 178

Query: 179 SPNYVAPEVLANRGYDGATSDIWSCGVILYIF--------------------RGDFKLPK 218
           +P Y+APEV+  +GY G   D W+ G+ILY F                      D + P+
Sbjct: 179 TPEYIAPEVILRQGY-GKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPE 237

Query: 219 W---LSPGAQNLLRKILEPNPVKRITIAG---IKADEWF 251
               L   AQ+L+ ++L  NP++R+   G   +K   +F
Sbjct: 238 GDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFF 276

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score =  120 bits (304), Expect = 2e-31
 Identities = 68/211 (32%), Positives = 109/211 (51%), Gaps = 30/211 (14%)

Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIK-REI-ATLKLLKH 73
           Y++ + LG+G FG V  A++ ++G   A+K + K +    +  + +  RE+ +  KL +H
Sbjct: 1   YKVIKQLGDGTFGSVYLARNKETGELVAIKKM-KKKFYSWE--ECMNLREVKSLRKLNEH 57

Query: 74  PNVVRLHEVLASKSKIYMVLEYVTGGELFDKIAS-KGR-LQEAEGRKLFQQLIDGVSYCH 131
           PN+V+L EV     ++Y V EY+ G  L+  +   KG+   E+  R +  Q++ G+++ H
Sbjct: 58  PNIVKLKEVFRENDELYFVFEYMEG-NLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIH 116

Query: 132 NKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP--NYV------ 183
             G FHRDLK EN+L+     +KI+DFGL+      R           P  +YV      
Sbjct: 117 KHGFFHRDLKPENLLVSGPEVVKIADFGLA------R-----EIRSRPPYTDYVSTRWYR 165

Query: 184 APEVLANRGYDGATSDIWSCGVI---LYIFR 211
           APE+L       +  DIW+ G I   LY  R
Sbjct: 166 APEILLRSTSYSSPVDIWALGCIMAELYTLR 196

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score =  120 bits (303), Expect = 2e-31
 Identities = 79/262 (30%), Positives = 129/262 (49%), Gaps = 41/262 (15%)

Query: 22  LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKR---EIATLKLLKHPNVVR 78
           LG+G FGKV  AQ  ++GL  A KI      I ++  ++++    EI  L   KHPN+V 
Sbjct: 13  LGDGAFGKVYKAQHKETGLFAAAKI------IQIESEEELEDFMVEIDILSECKHPNIVG 66

Query: 79  LHEVLASKSKIYMVLEYVTGGELFDKIASKGR-LQEAEGRKLFQQLIDGVSYCHNKGVFH 137
           L+E    ++K+++++E+  GG L   +    R L E + R + +Q+++ +++ H+  V H
Sbjct: 67  LYEAYFYENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIH 126

Query: 138 RDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLA-----NRG 192
           RDLK  NILL   G++K++DFG+SA  +         T  G+P ++APEV+A     +  
Sbjct: 127 RDLKAGNILLTLDGDVKLADFGVSAKNKS--TLQKRDTFIGTPYWMAPEVVACETFKDNP 184

Query: 193 YDGATSDIWSCG--------------------VILYIFRGD---FKLPKWLSPGAQNLLR 229
           YD   +DIWS G                    V+L I + +      P   S    + L+
Sbjct: 185 YD-YKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSEPPTLDQPSKWSSSFNDFLK 243

Query: 230 KILEPNPVKRITIAGIKADEWF 251
             L  +P  R T A +    + 
Sbjct: 244 SCLVKDPDDRPTAAELLKHPFV 265

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score =  120 bits (302), Expect = 2e-31
 Identities = 81/262 (30%), Positives = 128/262 (48%), Gaps = 47/262 (17%)

Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQ-----IKREIATLK 69
            YEL + +G G +G V  A+D+ +G   A+K++        K+        I++EI+ LK
Sbjct: 4   DYELIQRIGSGTYGDVYKARDIATGELVAIKVI--------KLEPGDDFEIIQQEISMLK 55

Query: 70  LLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKI-ASKGRLQEAEGRKLFQQLIDGVS 128
             +HPN+V        + K+++V+EY  GG L D    ++G L E +   + ++ + G++
Sbjct: 56  ECRHPNIVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLA 115

Query: 129 YCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVL 188
           Y H  G  HRD+K  NILL   G++K++DFG+SA  Q         +  G+P ++APEV 
Sbjct: 116 YLHETGKIHRDIKGANILLTEDGDVKLADFGVSA--QLTATIAKRKSFIGTPYWMAPEVA 173

Query: 189 ANR---GYDGATSDIWSCG--------------------VILYIFRGDFKLP------KW 219
           A     GYDG   DIW+ G                     +  I + +F  P      KW
Sbjct: 174 AVERKGGYDGK-CDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPPKLKDKEKW 232

Query: 220 LSPGAQNLLRKILEPNPVKRIT 241
            SP   + ++K L  +P KR T
Sbjct: 233 -SPVFHDFIKKCLTKDPKKRPT 253

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score =  120 bits (302), Expect = 4e-31
 Identities = 88/282 (31%), Positives = 128/282 (45%), Gaps = 77/282 (27%)

Query: 22  LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQ------IKREIATLKLLKHPN 75
           +GEG +G V  A+D  +G   A+K       I L+  D+      I REI+ LK L HPN
Sbjct: 7   IGEGTYGVVYKARDKLTGEIVALKK------IRLETEDEGVPSTAI-REISLLKELNHPN 59

Query: 76  VVRLHEVLASKSKIYMVLEYVTGG--ELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNK 133
           +VRL +V+ S++K+Y+V E++     +  D     G L     +    QL+ G++YCH+ 
Sbjct: 60  IVRLLDVVHSENKLYLVFEFLDLDLKKYMDSSPLTG-LDPPLIKSYLYQLLQGIAYCHSH 118

Query: 134 GVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGL-----LHTTCGSPNYVAPEVL 188
            V HRDLK +N+L+D +G +K++DFGL+      R  G+      H    +  Y APE+L
Sbjct: 119 RVLHRDLKPQNLLIDREGALKLADFGLA------RAFGVPVRTYTHEVV-TLWYRAPEIL 171

Query: 189 ANRGYDGATSDIWSCGVI-------------------LY-IFR----------------G 212
                     DIWS G I                   L+ IFR                 
Sbjct: 172 LGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLP 231

Query: 213 DFK--LPKW-----------LSPGAQNLLRKILEPNPVKRIT 241
           D+K   PKW           L     +LL K+L  +P KRI+
Sbjct: 232 DYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRIS 273

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score =  120 bits (302), Expect = 7e-31
 Identities = 71/263 (26%), Positives = 134/263 (50%), Gaps = 38/263 (14%)

Query: 20  RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVR 78
           R +G G++ KV   +   +   +A+K+++K  +   +  D ++ E    +    HP +V 
Sbjct: 1   RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVG 60

Query: 79  LHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHR 138
           LH    ++S+++ V+E+V+GG+L   +  + +L E   R    ++   +++ H +G+ +R
Sbjct: 61  LHSCFQTESRLFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYR 120

Query: 139 DLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYD-GAT 197
           DLKL+N+LLD++G+IK++D+G+    +  R      T CG+PNY+APE+L  RG D G +
Sbjct: 121 DLKLDNVLLDAEGHIKLTDYGMCK--EGIRPGDTTSTFCGTPNYIAPEIL--RGEDYGFS 176

Query: 198 SDIWSCGVILY-----------------------------IFRGDFKLPKWLSPGAQNLL 228
            D W+ GV+++                             I     ++P+ LS  A ++L
Sbjct: 177 VDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIRIPRSLSVKASSVL 236

Query: 229 RKILEPNPVKRITIAGIKADEWF 251
           +  L  +P +R+   G      F
Sbjct: 237 KGFLNKDPKERL---GCHPQTGF 256

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score =  118 bits (299), Expect = 8e-31
 Identities = 63/196 (32%), Positives = 106/196 (54%), Gaps = 16/196 (8%)

Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLK-----ITDQIKREIATLK 69
            + L   +G+G+FG+V  A D  +    A+K+      I L+     I D I++EI  L 
Sbjct: 2   LFTLLECIGKGSFGEVYKAIDKRTNQVVAIKV------IDLEEAEDEIED-IQQEIQFLS 54

Query: 70  LLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSY 129
             + P + + +      SK+++++EY  GG   D +   G+L E     + ++++ G+ Y
Sbjct: 55  QCRSPYITKYYGSFLKGSKLWIIMEYCGGGSCLDLLKP-GKLDETYIAFILREVLLGLEY 113

Query: 130 CHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLA 189
            H +G  HRD+K  NILL  +G++K++DFG+S   Q        +T  G+P ++APEV+ 
Sbjct: 114 LHEEGKIHRDIKAANILLSEEGDVKLADFGVSG--QLTSTMSKRNTFVGTPFWMAPEVIK 171

Query: 190 NRGYDGATSDIWSCGV 205
             GYD   +DIWS G+
Sbjct: 172 QSGYDEK-ADIWSLGI 186

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score =  120 bits (303), Expect = 1e-30
 Identities = 68/230 (29%), Positives = 101/230 (43%), Gaps = 42/230 (18%)

Query: 20  RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRL 79
           +T+G G FG+V   + +D+   +A+K L K  ++       +K E   L    +  VV+L
Sbjct: 7   KTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKL 66

Query: 80  HEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRD 139
           +     K  +Y V++Y+ GG++   +   G  +E   R    +L   +   H  G  HRD
Sbjct: 67  YYSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGFIHRD 126

Query: 140 LKLENILLDSKGNIKISDFGLSA------------LPQHFRDDG---------------- 171
           +K +NIL+D  G+IK++DFGL                 H R D                 
Sbjct: 127 IKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLK 186

Query: 172 -------------LLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILY 208
                        L H+  G+PNY+APEVL   GY     D WS GVILY
Sbjct: 187 PLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYT-QLCDWWSVGVILY 235

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score =  117 bits (294), Expect = 2e-30
 Identities = 70/198 (35%), Positives = 113/198 (57%), Gaps = 8/198 (4%)

Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKIL--EKNRIIHLKITDQIKREIATLKLLKH 73
           + LG+ LG G FG+V    D D+G   AVK +  + +     K  + ++ EI  LK L+H
Sbjct: 4   WRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRH 63

Query: 74  PNVVRLHEVL--ASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCH 131
             +V+ +  L    + K+ + +EY+ GG + D++ + G L E   R+  +Q++ GVSY H
Sbjct: 64  DRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLH 123

Query: 132 NKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGL-LHTTCGSPNYVAPEVLAN 190
           +  + HRD+K  NIL DS GN+K+ DFG S   Q     G  + +  G+P +++PEV++ 
Sbjct: 124 SNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVISG 183

Query: 191 RGYDGATSDIWS--CGVI 206
            GY G  +D+WS  C V+
Sbjct: 184 EGY-GRKADVWSVACTVV 200

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score =  116 bits (291), Expect = 6e-30
 Identities = 70/194 (36%), Positives = 111/194 (57%), Gaps = 6/194 (3%)

Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKN--RIIHLKITDQIKREIATLKLLKH 73
           + LG+ LG+G FG+V    D D+G   AVK ++ +       K  + ++ EI  LK L H
Sbjct: 4   WRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLH 63

Query: 74  PNVVRLHEVL--ASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCH 131
             +V+ +  L    +  + + +E++ GG + D++ S G L E   RK  +Q+++GVSY H
Sbjct: 64  ERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLH 123

Query: 132 NKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGL-LHTTCGSPNYVAPEVLAN 190
           +  + HRD+K  NIL DS GN+K+ DFG S   Q     G  + +  G+P +++PEV++ 
Sbjct: 124 SNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVISG 183

Query: 191 RGYDGATSDIWSCG 204
            GY G  +DIWS G
Sbjct: 184 EGY-GRKADIWSVG 196

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score =  115 bits (290), Expect = 8e-30
 Identities = 66/191 (34%), Positives = 111/191 (58%), Gaps = 6/191 (3%)

Query: 19  GRTLGEGNFGKVKFAQDLDSGLPFAVKILE--KNRIIHLKITDQIKREIATLKLLKHPNV 76
           G+ LG+G FG+V    D+D+G   A K ++         K    ++ EI  LK L+H  +
Sbjct: 7   GKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERI 66

Query: 77  VRLHEVLASKSK--IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKG 134
           V+ +  L  +++  + + +EY+ GG + D++ + G L E+  RK  +Q+++G+SY H+  
Sbjct: 67  VQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNM 126

Query: 135 VFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGL-LHTTCGSPNYVAPEVLANRGY 193
           + HRD+K  NIL DS GN+K+ DFG S   Q     G  + +  G+P +++PEV++  GY
Sbjct: 127 IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISGEGY 186

Query: 194 DGATSDIWSCG 204
            G  +D+WS G
Sbjct: 187 -GRKADVWSLG 196

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score =  115 bits (290), Expect = 1e-29
 Identities = 77/254 (30%), Positives = 118/254 (46%), Gaps = 30/254 (11%)

Query: 22  LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHE 81
           LG+G FG+V   Q   +G  +A K L+K R+   K       E   L+ +    +V L  
Sbjct: 1   LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60

Query: 82  VLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLF--QQLIDGVSYCHNKGVFHRD 139
              +K  + +V+  + GG+L   I + G     E R +F   Q+I G+ + H + + +RD
Sbjct: 61  AFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRD 120

Query: 140 LKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSD 199
           LK EN+LLD  GN++ISD GL+      +    +    G+P Y+APEVL    YD  + D
Sbjct: 121 LKPENVLLDDHGNVRISDLGLAV---ELKGGKKIKGRAGTPGYMAPEVLQGEVYD-FSVD 176

Query: 200 IWSCGVILYIF---RGDF---------------------KLPKWLSPGAQNLLRKILEPN 235
            ++ G  LY     R  F                     + P   SP A++L   +L+ +
Sbjct: 177 WFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEYPDKFSPEAKDLCEALLQKD 236

Query: 236 PVKRITIAGIKADE 249
           P KR+   G  ADE
Sbjct: 237 PEKRLGCRGGSADE 250

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score =  116 bits (293), Expect = 1e-29
 Identities = 78/244 (31%), Positives = 124/244 (50%), Gaps = 28/244 (11%)

Query: 22  LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLK-ITDQI-KREIATLKLLKH-PNVVR 78
           +G+G FG+V   +  D+   +A+K+L K  I+  K +   I +R I    LL   P +V 
Sbjct: 1   IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60

Query: 79  LHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHR 138
           L     + S +Y+V +Y++GGELF  +  +GR  E   +    +L+  + + H   + +R
Sbjct: 61  LKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYR 120

Query: 139 DLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLAN-RGYDGAT 197
           DLK ENILLD+ G+I + DFGLS    +  D+   +T CG+  Y+APEVL + +GY    
Sbjct: 121 DLKPENILLDATGHIALCDFGLSK--ANLTDNKTTNTFCGTTEYLAPEVLLDEKGY-TKH 177

Query: 198 SDIWSCGVILY--------------------IFRGDFKLPK-WLSPGAQNLLRKILEPNP 236
            D WS GV+++                    I  G  + PK  LS   +  ++ +L  NP
Sbjct: 178 VDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVRFPKNVLSDEGRQFVKGLLNRNP 237

Query: 237 VKRI 240
             R+
Sbjct: 238 QHRL 241

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score =  114 bits (288), Expect = 2e-29
 Identities = 68/201 (33%), Positives = 107/201 (53%), Gaps = 19/201 (9%)

Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKI--LEKNRIIHLKITDQIKREIATLKLLKH 73
           YEL   +G G    V  A  L +    A+K   LEK +       D++++E+  +    H
Sbjct: 3   YELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTS----VDELRKEVQAMSQCNH 58

Query: 74  PNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASK---GRLQEAEGRKLFQQLIDGVSYC 130
           PNVV+ +       ++++V+ Y++GG L D + S    G L EA    + ++++ G+ Y 
Sbjct: 59  PNVVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYL 118

Query: 131 HNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDG-----LLHTTCGSPNYVAP 185
           H+ G  HRD+K  NILL   G++KI+DFG+SA      D G     +  T  G+P ++AP
Sbjct: 119 HSNGQIHRDIKAGNILLGEDGSVKIADFGVSAS---LADGGDRTRKVRKTFVGTPCWMAP 175

Query: 186 EVLAN-RGYDGATSDIWSCGV 205
           EV+    GYD   +DIWS G+
Sbjct: 176 EVMEQVHGYD-FKADIWSFGI 195

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score =  116 bits (291), Expect = 2e-29
 Identities = 70/251 (27%), Positives = 129/251 (51%), Gaps = 33/251 (13%)

Query: 20  RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATL-KLLKHPNVVR 78
           R +G G++ KV   +   +   +A+K+++K  +   +  D ++ E     +   HP +V 
Sbjct: 1   RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVG 60

Query: 79  LHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHR 138
           LH    ++S+++ V+EYV GG+L   +  + +L E   R    ++   ++Y H +G+ +R
Sbjct: 61  LHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYR 120

Query: 139 DLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATS 198
           DLKL+N+LLDS+G+IK++D+G+    +  R      T CG+PNY+APE+L    Y G + 
Sbjct: 121 DLKLDNVLLDSEGHIKLTDYGMCK--EGLRPGDTTSTFCGTPNYIAPEILRGEDY-GFSV 177

Query: 199 DIWSCGVILY-----------------------------IFRGDFKLPKWLSPGAQNLLR 229
           D W+ GV+++                             I     ++P+ LS  A ++L+
Sbjct: 178 DWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKAASVLK 237

Query: 230 KILEPNPVKRI 240
             L  +P +R+
Sbjct: 238 SFLNKDPKERL 248

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score =  115 bits (289), Expect = 2e-29
 Identities = 71/208 (34%), Positives = 111/208 (53%), Gaps = 23/208 (11%)

Query: 14  GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATL-KLLK 72
           G +EL   +GEG +GKV  A+   +G   A+KI++   II  +  + IK E   L K   
Sbjct: 6   GIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMD---IIEDEEEE-IKEEYNILRKYSN 61

Query: 73  HPNVVRLHEVLASKS------KIYMVLEYVTGG---ELFDKIASKG-RLQEAEGRKLFQQ 122
           HPN+   +     K+      ++++V+E   GG   +L   +  KG RL+E     + ++
Sbjct: 62  HPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRE 121

Query: 123 LIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNY 182
            + G++Y H   V HRD+K +NILL     +K+ DFG+SA  Q     G  +T  G+P +
Sbjct: 122 TLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVSA--QLDSTLGRRNTFIGTPYW 179

Query: 183 VAPEVLA-----NRGYDGATSDIWSCGV 205
           +APEV+A     +  YD A SD+WS G+
Sbjct: 180 MAPEVIACDEQPDASYD-ARSDVWSLGI 206

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score =  115 bits (289), Expect = 3e-29
 Identities = 70/206 (33%), Positives = 108/206 (52%), Gaps = 20/206 (9%)

Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIK--REIATLKLLKH 73
           +++   +GEG +G+V  A+D D+G   A+K   K R+ + K    I   REI  L+ L H
Sbjct: 9   FDIIGQIGEGTYGQVYKARDKDTGELVALK---KVRLDNEKEGFPITAIREIKILRQLNH 65

Query: 74  PNVVRLHEVLASKSK----------IYMVLEYVTGGELFDKIASK-GRLQEAEGRKLFQQ 122
            N+V L E++  K             Y+V EY+   +L   + S      E   +   +Q
Sbjct: 66  RNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQ 124

Query: 123 LIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTT-CGSPN 181
           L++G++YCH K   HRD+K  NILL++KG IK++DFGL+ L  +  ++   +T    +  
Sbjct: 125 LLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLARL--YNSEESRPYTNKVITLW 182

Query: 182 YVAPEVLANRGYDGATSDIWSCGVIL 207
           Y  PE+L      G   D+WSCG IL
Sbjct: 183 YRPPELLLGEERYGPAIDVWSCGCIL 208

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score =  113 bits (285), Expect = 4e-29
 Identities = 73/258 (28%), Positives = 114/258 (44%), Gaps = 29/258 (11%)

Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
           +YE  R +G G FG V   +         +K +   ++         + E   LKLL HP
Sbjct: 1   KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTK-DERLAAQNECQVLKLLSHP 59

Query: 75  NVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGR--LQEAEGRKLFQQLIDGVSYCHN 132
           N++  +E       + +V+EY  GG L + I  +    L E      F Q++  + + H 
Sbjct: 60  NIIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHT 119

Query: 133 KGVFHRDLKLENILLDSKGNI-KISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANR 191
           K + HRDLK +NILLD    + KI DFG+S +          +T  G+P Y++PE+   +
Sbjct: 120 KLILHRDLKTQNILLDKHKMVVKIGDFGISKI---LSSKSKAYTVVGTPCYISPELCEGK 176

Query: 192 GYDGATSDIWSCGVILY--------------------IFRGDFK-LPKWLSPGAQNLLRK 230
            Y+   SDIW+ G +LY                    I  G F  +    SP  + L+  
Sbjct: 177 PYN-QKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTFAPISDRYSPDLRQLILS 235

Query: 231 ILEPNPVKRITIAGIKAD 248
           +L  +P KR  ++ I A 
Sbjct: 236 MLNLDPSKRPQLSQIMAQ 253

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score =  115 bits (290), Expect = 5e-29
 Identities = 91/329 (27%), Positives = 134/329 (40%), Gaps = 87/329 (26%)

Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRII-HLKITDQIKREIATLKLLKH 73
           RYEL + +G G +G V  A D  +G   A+K +  + +   L    +I REI  L+ L+H
Sbjct: 1   RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKI--SNVFDDLIDAKRILREIKLLRHLRH 58

Query: 74  PNVVRLHEVLASKSK-----IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVS 128
            N++ L ++L   S      +Y+V E +   +L   I S   L +   +    Q++ G+ 
Sbjct: 59  ENIIGLLDILRPPSPEDFNDVYIVTELM-ETDLHKVIKSPQPLTDDHIQYFLYQILRGLK 117

Query: 129 YCHNKGVFHRDLKLENILLDSKGNIKISDFGLS--ALPQHFRDDGLLHTTCGSPNYV--- 183
           Y H+  V HRDLK  NIL++S  ++KI DFGL+    P       L         YV   
Sbjct: 118 YLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTE-------YVVTR 170

Query: 184 ---APEV-LANRGYDGATSDIWSCGVILY-------IFRG-------------------- 212
              APE+ L++  Y  A  DIWS G I         +F G                    
Sbjct: 171 WYRAPELLLSSSRYTKAI-DIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEE 229

Query: 213 DFK-------------LPK-----W------LSPGAQNLLRKILEPNPVKRITIAGIKAD 248
           D K             LPK             SP A +LL K+L  +P KRIT     A 
Sbjct: 230 DLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAH 289

Query: 249 EWFEQDYTPA----------NPDDDEEDI 267
            +  Q + P               D++++
Sbjct: 290 PYLAQLHDPEDEPVAKPPFDFDFFDDDEL 318

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score =  113 bits (284), Expect = 6e-29
 Identities = 65/198 (32%), Positives = 112/198 (56%), Gaps = 9/198 (4%)

Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
           RYE+ + +GEG+FGK+  A+         +K ++  ++  +K  +  K+E+  L  +KHP
Sbjct: 1   RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKM-PVKEKEASKKEVILLAKMKHP 59

Query: 75  NVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKL--FQQLIDGVSYCHN 132
           N+V          ++++V+EY  GG+L  +I  +  +  +E + L  F Q+  G+ + H+
Sbjct: 60  NIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHD 119

Query: 133 KGVFHRDLKLENILLDSKGNI-KISDFGLSALPQHFRDDGLLHTTC-GSPNYVAPEVLAN 190
           + + HRD+K +NI L   G + K+ DFG++   +   D   L  TC G+P Y++PE+  N
Sbjct: 120 RKILHRDIKSQNIFLSKNGMVAKLGDFGIA---RQLNDSMELAYTCVGTPYYLSPEICQN 176

Query: 191 RGYDGATSDIWSCGVILY 208
           R Y+  T DIWS G +LY
Sbjct: 177 RPYNNKT-DIWSLGCVLY 193

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score =  114 bits (287), Expect = 7e-29
 Identities = 83/301 (27%), Positives = 124/301 (41%), Gaps = 95/301 (31%)

Query: 24  EGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIK-------REIATLKLLKHPNV 76
           EG +G V  A+D  +G   A+K         LK+  + +       REI  L  L+HPN+
Sbjct: 15  EGTYGVVYRARDKKTGEIVALK--------KLKMEKEKEGFPITSLREINILLKLQHPNI 66

Query: 77  VRLHEVLASKS--KIYMVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNK 133
           V + EV+   +  KIYMV+EYV   +L   + + K    ++E + L  QL+ GV++ H+ 
Sbjct: 67  VTVKEVVVGSNLDKIYMVMEYVEH-DLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDN 125

Query: 134 GVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPN-----------Y 182
            + HRDLK  N+LL+++G +KI DFGL+      R+        GSP            Y
Sbjct: 126 WILHRDLKTSNLLLNNRGILKICDFGLA------RE-------YGSPLKPYTQLVVTLWY 172

Query: 183 VAPEVLANRGYDGATSDIWSCGVIL--------------------YIFR----------- 211
            APE+L          D+WS G I                      IF+           
Sbjct: 173 RAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWP 232

Query: 212 GDFKLPKW---------------------LSPGAQNLLRKILEPNPVKRITIAGIKADEW 250
           G  +LP                       LS    +LL ++L  +P KRI+        +
Sbjct: 233 GFSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPY 292

Query: 251 F 251
           F
Sbjct: 293 F 293

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score =  113 bits (285), Expect = 8e-29
 Identities = 80/284 (28%), Positives = 129/284 (45%), Gaps = 61/284 (21%)

Query: 22  LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHE 81
           +GEG +G V  A++  +G   A+K +  +       +  I REI+ LK L HPN+V+L +
Sbjct: 8   IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAI-REISLLKELNHPNIVKLLD 66

Query: 82  VLASKSKIYMVLEYVTGG-ELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDL 140
           V+ +++K+Y+V E++    + F   +    +     +    QL+ G+++CH+  V HRDL
Sbjct: 67  VIHTENKLYLVFEFLHQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDL 126

Query: 141 KLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPN----YVAPEVLANRGYDGA 196
           K +N+L++++G IK++DFGL+      R  G+   T         Y APE+L    Y   
Sbjct: 127 KPQNLLINTEGAIKLADFGLA------RAFGVPVRTYTHEVVTLWYRAPEILLGCKYYST 180

Query: 197 TSDIWSCGVILY--------------------IFRG----------------DFK--LPK 218
             DIWS G I                      IFR                 D+K   PK
Sbjct: 181 AVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYKPSFPK 240

Query: 219 W-----------LSPGAQNLLRKILEPNPVKRITIAGIKADEWF 251
           W           L    ++LL ++L  +P KRI+     A  +F
Sbjct: 241 WARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF 284

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score =  114 bits (287), Expect = 8e-29
 Identities = 91/316 (28%), Positives = 126/316 (39%), Gaps = 94/316 (29%)

Query: 18  LGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIK--------REIATLK 69
           L R +GEG +G V  A+D  SG   A+K   K R       D  +        REI  L 
Sbjct: 12  LNR-IGEGTYGIVYRARDTTSGEIVALK---KVR------MDNERDGIPISSLREITLLL 61

Query: 70  LLKHPNVVRLHEVLASKS--KIYMVLEYVTG--GELFDKIASKGRLQEAEGRKLFQQLID 125
            L+HPN+V L EV+  K    I++V+EY       L D + +     E++ + L  QL+ 
Sbjct: 62  NLRHPNIVELKEVVVGKHLDSIFLVMEYCEQDLASLLDNMPTP--FSESQVKCLMLQLLR 119

Query: 126 GVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLS---ALPQHFRDDGLLHTTCGSPN- 181
           G+ Y H   + HRDLK+ N+LL  KG +KI+DFGL+    LP              +P  
Sbjct: 120 GLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPM----------TPKV 169

Query: 182 ----YVAPEVL-ANRGYDGATSDIWSCGVILY-------IFRG----------------- 212
               Y APE+L     Y  A  D+W+ G IL        +  G                 
Sbjct: 170 VTLWYRAPELLLGCTTYTTAI-DMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTP 228

Query: 213 ---------------DFKLPK-----------WLSPGAQNLLRKILEPNPVKRITIAGIK 246
                           F LPK           WLS     LL  +L  +P KR T     
Sbjct: 229 NESIWPGFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEAL 288

Query: 247 ADEWFEQDYTPANPDD 262
              +F++   P  P+ 
Sbjct: 289 ESSYFKEKPLPCEPEM 304

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score =  114 bits (288), Expect = 1e-28
 Identities = 68/207 (32%), Positives = 112/207 (54%), Gaps = 15/207 (7%)

Query: 17  ELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNV 76
           E    +G G  G V       +G  +A+K++  N    ++   QI REI  L+ + HPNV
Sbjct: 77  ERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRR--QICREIEILRDVNHPNV 134

Query: 77  VRLHEVLASKSKIYMVLEYVTGGELFD-KIASKGRLQEAEGRKLFQQLIDGVSYCHNKGV 135
           V+ H++     +I ++LE++ GG L    IA +  L +     + +Q++ G++Y H + +
Sbjct: 135 VKCHDMFDHNGEIQVLLEFMDGGSLEGTHIADEQFLAD-----VARQILSGIAYLHRRHI 189

Query: 136 FHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVL---ANRG 192
            HRD+K  N+L++S  N+KI+DFG+S +     D    +++ G+  Y++PE +    N G
Sbjct: 190 VHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDP--CNSSVGTIAYMSPERINTDLNHG 247

Query: 193 -YDGATSDIWSCGV-ILYIFRGDFKLP 217
            YDG   DIWS GV IL  + G F   
Sbjct: 248 AYDGYAGDIWSLGVSILEFYLGRFPFG 274

Length = 353

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score =  113 bits (285), Expect = 2e-28
 Identities = 66/249 (26%), Positives = 128/249 (51%), Gaps = 31/249 (12%)

Query: 20  RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK-HPNVVR 78
           R +G G++ KV   +   +   +A+K+++K  +   +  D ++ E    +    +P +V 
Sbjct: 1   RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVG 60

Query: 79  LHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHR 138
           LH    + S++++V+EYV GG+L   +  + +L E   R    ++   +++ H +G+ +R
Sbjct: 61  LHSCFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYR 120

Query: 139 DLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATS 198
           DLKL+N+LLD+ G+IK++D+G+    +         T CG+PNY+APE+L    Y G + 
Sbjct: 121 DLKLDNVLLDADGHIKLTDYGMCK--EGLGPGDTTSTFCGTPNYIAPEILRGEEY-GFSV 177

Query: 199 DIWSCGVILY---------------------------IFRGDFKLPKWLSPGAQNLLRKI 231
           D W+ GV+++                           I     ++P++LS  A ++L+  
Sbjct: 178 DWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIRIPRFLSVKASHVLKGF 237

Query: 232 LEPNPVKRI 240
           L  +P +R+
Sbjct: 238 LNKDPKERL 246

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score =  111 bits (280), Expect = 3e-28
 Identities = 69/252 (27%), Positives = 118/252 (46%), Gaps = 32/252 (12%)

Query: 19  GRTLGEGNFGKVKFAQDLDSGLPFAVK---ILEKNRIIHLKITDQIKREIATLKLLKHPN 75
           G+ LG G F     A+D+ +G   AVK    +        ++ + +++EI  +  L HP+
Sbjct: 5   GQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPH 64

Query: 76  VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGV 135
           ++R+       S   + +E++ GG +   ++  G  +EA      +QL+ G+SY H   +
Sbjct: 65  IIRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQI 124

Query: 136 FHRDLKLENILLDSKGN-IKISDFGLSA-LPQHFRDDGLLH-TTCGSPNYVAPEVLANRG 192
            HRD+K  N+L+DS G  ++I+DFG +A L       G       G+  ++APEVL    
Sbjct: 125 IHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQ 184

Query: 193 YDGATSDIWSCGVIL--------------------YIFR-----GDFKLPKWLSPGAQNL 227
           Y G + D+WS G ++                     IF+         +P+ LSPG +++
Sbjct: 185 Y-GRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPEHLSPGLRDV 243

Query: 228 LRKILEPNPVKR 239
             + LE  P  R
Sbjct: 244 TLRCLELQPEDR 255

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score =  113 bits (285), Expect = 4e-28
 Identities = 71/229 (31%), Positives = 113/229 (49%), Gaps = 37/229 (16%)

Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
           +E  + +G G FG+V+  Q  D+G  +A+K L K+ ++  +    ++ E   L    +P 
Sbjct: 3   FESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPW 62

Query: 76  VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGV 135
           VV+L+     ++ +Y+++EY+ GG++   +  K    E E R    + I  +   H  G 
Sbjct: 63  VVKLYYSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLGY 122

Query: 136 FHRDLKLENILLDSKGNIKISDFGLS-----------------ALPQHFRDD-------- 170
            HRD+K +N+LLD+KG+IK+SDFGL                  ALP +F D         
Sbjct: 123 IHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSK 182

Query: 171 -----------GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILY 208
                       L ++T G+P+Y+APEV    GY     D WS GVI+Y
Sbjct: 183 RKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGY-NKECDWWSLGVIMY 230

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score =  111 bits (280), Expect = 5e-28
 Identities = 74/221 (33%), Positives = 111/221 (50%), Gaps = 35/221 (15%)

Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQ-----IKREIATLKL 70
           YE    +GEG +G V  A+DL++G   A+K       + + ++++       REIA LK 
Sbjct: 1   YEELAEIGEGAYGTVYKARDLNTGRFVALKK------VRVPLSEEGIPLSTLREIALLKQ 54

Query: 71  LK---HPNVVRLHEVLA-----SKSKIYMVLEYVTG--GELFDKIASKGRLQEAEGRKLF 120
           L+   HPN+VRL +V        + K+ +V E+V         K    G L     + L 
Sbjct: 55  LESFEHPNIVRLLDVCHGPRTDRELKLTLVFEHVDQDLATYLSKCPKPG-LPPETIKDLM 113

Query: 121 QQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP 180
           +QL+ GV + H+  + HRDLK +NIL+ S G +KI+DFGL+ +   +  +  L +   + 
Sbjct: 114 RQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARI---YSFEMALTSVVVTL 170

Query: 181 NYVAPEVLANRGYDGATS-DIWSCGVILY-------IFRGD 213
            Y APEVL    Y  AT  D+WS G I         +FRG 
Sbjct: 171 WYRAPEVLLQSSY--ATPVDMWSVGCIFAELFRRRPLFRGT 209

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score =  110 bits (276), Expect = 1e-27
 Identities = 77/225 (34%), Positives = 110/225 (48%), Gaps = 15/225 (6%)

Query: 20  RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRL 79
             LG GN G V       +G   AVK +     I+  I  QI RE+  L     P +V  
Sbjct: 7   GELGAGNSGVVSKVLHRPTGKIMAVKTIRLE--INEAIQKQILRELDILHKCNSPYIVGF 64

Query: 80  HEVLASKSKIYMVLEYVTGGELFDKI--ASKGRLQEAEGRKLFQQLIDGVSYCHNK-GVF 136
           +    +   I + +EY+ GG L DKI    +GR+ E    K+   ++ G++Y H K  + 
Sbjct: 65  YGAFYNNGDISICMEYMDGGSL-DKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKII 123

Query: 137 HRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGA 196
           HRD+K  NIL++S+G IK+ DFG+S        + L  T  G+ +Y+APE +    Y   
Sbjct: 124 HRDVKPSNILVNSRGQIKLCDFGVSG----QLVNSLAKTFVGTSSYMAPERIQGNDY-SV 178

Query: 197 TSDIWSCGVILY-IFRGDFKLPKWLSP--GAQNLLRKIL-EPNPV 237
            SDIWS G+ L  +  G F  P    P  G   LL+ I+ EP P 
Sbjct: 179 KSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPPR 223

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score =  109 bits (274), Expect = 1e-27
 Identities = 64/248 (25%), Positives = 119/248 (47%), Gaps = 29/248 (11%)

Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
           +E+   +G+G+FG V           +A+K ++ +++   +  + I  E   L  L    
Sbjct: 2   FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAI-DEARVLAKLDSSY 60

Query: 76  VVRLHEVLASKSKIYMVLEYVTGGELFDKIAS--KGRLQEAEGRKLFQQLIDGVSYCHNK 133
           ++R +E    K K+ +V+EY   G+L   +       L E +  + F Q++ G+++ H+K
Sbjct: 61  IIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSK 120

Query: 134 GVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLL-HTTCGSPNYVAPEVLANRG 192
            + HRD+K  N+ LD+  N+KI D G++ L     D+    +T  G+P Y++PE+  ++ 
Sbjct: 121 KILHRDIKSLNLFLDAYDNVKIGDLGVAKL---LSDNTNFANTIVGTPYYLSPELCEDKP 177

Query: 193 YDGATSDIWSCGVILY--------------------IFRGDFK-LPKWLSPGAQNLLRKI 231
           Y+   SD+W+ GV+LY                    I RG F  + +  S     L+ + 
Sbjct: 178 YN-EKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVFPPVSQMYSQQLAQLIDQC 236

Query: 232 LEPNPVKR 239
           L  +  +R
Sbjct: 237 LTKDYRQR 244

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score =  109 bits (275), Expect = 2e-27
 Identities = 68/198 (34%), Positives = 107/198 (54%), Gaps = 26/198 (13%)

Query: 22  LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIK----REIATLKLLKHPNVV 77
           LGEG +  V   ++  +G   A+K       IHL   +       REI+ +K LKH N+V
Sbjct: 8   LGEGTYATVYKGRNRTTGEIVALKE------IHLDAEEGTPSTAIREISLMKELKHENIV 61

Query: 78  RLHEVLASKSKIYMVLEYVTGG--ELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGV 135
           RLH+V+ +++K+ +V EY+     +  D    +G L     +    QL+ G+++CH   V
Sbjct: 62  RLHDVIHTENKLMLVFEYMDKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRV 121

Query: 136 FHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPN----YVAPEVL-AN 190
            HRDLK +N+L++ +G +K++DFGL+      R  G+   T  +      Y AP+VL  +
Sbjct: 122 LHRDLKPQNLLINKRGELKLADFGLA------RAFGIPVNTFSNEVVTLWYRAPDVLLGS 175

Query: 191 RGYDGATS-DIWSCGVIL 207
           R Y  +TS DIWS G I+
Sbjct: 176 RTY--STSIDIWSVGCIM 191

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score =  109 bits (273), Expect = 2e-27
 Identities = 84/259 (32%), Positives = 125/259 (48%), Gaps = 33/259 (12%)

Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKI--TDQIKREIATLKLLK 72
           RY L + LG+G+FG V   +D  +     +K+L++  +  L    T Q  +E   L  L 
Sbjct: 1   RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLD 60

Query: 73  HPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIA----SKGRLQEAEGRKLFQQLIDGVS 128
           HP +V+ H     +    ++ EY  G +L  K+     +   L E +  + F QL+ GV 
Sbjct: 61  HPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVH 120

Query: 129 YCHNKGVFHRDLKLENILLDSKGNI-KISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEV 187
           Y H + + HRDLK +NI L  K N+ KI DFG+S L     D  L  T  G+P Y++PE 
Sbjct: 121 YMHQRRILHRDLKAKNIFL--KNNLLKIGDFGVSRLLMGSCD--LATTFTGTPYYMSPEA 176

Query: 188 LANRGYDGATSDIWSCGVILY--------------------IFRGDF-KLPKWLSPGAQN 226
           L ++GYD + SDIWS G ILY                    I  G    LP+  S    +
Sbjct: 177 LKHQGYD-SKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEGPTPSLPETYSRQLNS 235

Query: 227 LLRKILEPNPVKRITIAGI 245
           +++ +L  +P  R + A I
Sbjct: 236 IMQSMLNKDPSLRPSAAEI 254

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score =  109 bits (273), Expect = 3e-27
 Identities = 62/201 (30%), Positives = 100/201 (49%), Gaps = 9/201 (4%)

Query: 13  LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK 72
           LG +++ + +G+G F  V  A  L  G   A+K ++   ++  K      +EI  LK L 
Sbjct: 1   LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD 60

Query: 73  HPNVVRLHEVLASKSKIYMVLEYVTGGEL---FDKIASKGRL-QEAEGRKLFQQLIDGVS 128
           HPNV++        +++ +VLE    G+L         + RL  E    K F QL   + 
Sbjct: 61  HPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALE 120

Query: 129 YCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGL-LHTTCGSPNYVAPEV 187
           + H+K + HRD+K  N+ + + G +K+ D GL    + F       H+  G+P Y++PE 
Sbjct: 121 HMHSKRIMHRDIKPANVFITATGVVKLGDLGLG---RFFSSKTTAAHSLVGTPYYMSPER 177

Query: 188 LANRGYDGATSDIWSCGVILY 208
           +   GY+   SDIWS G +LY
Sbjct: 178 IHENGYNFK-SDIWSLGCLLY 197

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score =  108 bits (272), Expect = 5e-27
 Identities = 62/200 (31%), Positives = 108/200 (54%), Gaps = 19/200 (9%)

Query: 15  RYELGR--TLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKRE-----IAT 67
           R  L     +GEG+ G V  A D  +G   AVK ++        +  Q +RE     +  
Sbjct: 18  RSYLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMD--------LRKQQRRELLFNEVVI 69

Query: 68  LKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGV 127
           ++  +HPN+V ++       ++++V+E++ GG L D I +  R+ E +   +   ++  +
Sbjct: 70  MRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGALTD-IVTHTRMNEEQIATVCLAVLKAL 128

Query: 128 SYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEV 187
           S+ H +GV HRD+K ++ILL S G +K+SDFG  A  Q  ++     +  G+P ++APEV
Sbjct: 129 SFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCA--QVSKEVPRRKSLVGTPYWMAPEV 186

Query: 188 LANRGYDGATSDIWSCGVIL 207
           ++   Y G   DIWS G+++
Sbjct: 187 ISRLPY-GTEVDIWSLGIMV 205

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

 Score =  110 bits (275), Expect = 1e-26
 Identities = 74/234 (31%), Positives = 103/234 (44%), Gaps = 46/234 (19%)

Query: 20  RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRL 79
           +TLG G FG+V  A+ +D+   +A+K L K  ++       +K E   L    +  VVRL
Sbjct: 7   KTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRL 66

Query: 80  HEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRD 139
           +     K  +Y V++Y+ GG++   +   G   E   R    +L   V   H  G  HRD
Sbjct: 67  YYSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGFIHRD 126

Query: 140 LKLENILLDSKGNIKISDFGL---------SALPQ---HFRDDG---------------- 171
           +K +NIL+D  G+IK++DFGL         S   Q   H R D                 
Sbjct: 127 IKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCG 186

Query: 172 -----------------LLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILY 208
                            L H+  G+PNY+APEVL   GY     D WS GVILY
Sbjct: 187 DRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYT-QLCDWWSVGVILY 239

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score =  107 bits (268), Expect = 2e-26
 Identities = 84/293 (28%), Positives = 130/293 (44%), Gaps = 85/293 (29%)

Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIK-------REIAT 67
           +YE    +GEG +G V  A++ ++    A+K         +++ D  +       REI  
Sbjct: 1   KYEKLEKIGEGTYGTVFKAKNRETHEIVALK--------RVRLDDDDEGVPSSALREICL 52

Query: 68  LKLLKHPNVVRLHEVLASKSKIYMVLEYVTGG--ELFDKIASKGRLQEAEGRKLFQQLID 125
           LK LKH N+VRL++VL S  K+ +V EY      + FD  +  G +     +    QL+ 
Sbjct: 53  LKELKHKNIVRLYDVLHSDKKLTLVFEYCDQDLKKYFD--SCNGDIDPEIVKSFMFQLLK 110

Query: 126 GVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPN---- 181
           G+++CH+  V HRDLK +N+L++  G +K++DFGL+      R  G +   C S      
Sbjct: 111 GLAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLA------RAFG-IPVRCYSAEVVTL 163

Query: 182 -YVAPEVL-ANRGYDGATS-DIWSCGVIL---------------------YIFR------ 211
            Y  P+VL   + Y   TS D+WS G I                       IFR      
Sbjct: 164 WYRPPDVLFGAKLYS--TSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPT 221

Query: 212 -----GDFKLPKW------------------LSPGAQNLLRKILEPNPVKRIT 241
                G  KLP +                  L+   ++LL+ +L  NPV+RI+
Sbjct: 222 EESWPGVSKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRIS 274

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score =  108 bits (271), Expect = 2e-26
 Identities = 70/250 (28%), Positives = 118/250 (47%), Gaps = 36/250 (14%)

Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
           +E  + +G G FG+V+  Q  D+G  +A+KIL K  ++  +    I+ E   L       
Sbjct: 3   FESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAW 62

Query: 76  VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGV 135
           VV++      K  +Y+++E++ GG++   +  K  L E   +    + +  +   H  G 
Sbjct: 63  VVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGF 122

Query: 136 FHRDLKLENILLDSKGNIKISDFGL-SALPQHFRDD------------------------ 170
            HRD+K +N+LLD+KG++K+SDFGL + L +  R +                        
Sbjct: 123 IHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKA 182

Query: 171 --------GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIFRGDFKLPKWLSP 222
                    L ++T G+P+Y+APEV    GY+    D WS GVI+Y     +  P + S 
Sbjct: 183 ETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYN-KLCDWWSLGVIMYEMLIGY--PPFCSE 239

Query: 223 GAQNLLRKIL 232
             Q   RK++
Sbjct: 240 TPQETYRKVM 249

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score =  108 bits (271), Expect = 3e-26
 Identities = 72/250 (28%), Positives = 117/250 (46%), Gaps = 36/250 (14%)

Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
           +E  + +G G FG+V+  Q  D+G  +A+KIL K  ++  +    I+ E   L       
Sbjct: 3   FESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLW 62

Query: 76  VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGV 135
           VV++      K  +Y+++E++ GG++   +  K  L E E +    + +  +   H  G 
Sbjct: 63  VVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGF 122

Query: 136 FHRDLKLENILLDSKGNIKISDFGLS-----------------ALPQHFRDDG------- 171
            HRD+K +N+LLDSKG++K+SDFGL                  +LP  F           
Sbjct: 123 IHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKA 182

Query: 172 ---------LLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIFRGDFKLPKWLSP 222
                    L  +T G+P+Y+APEV    GY+    D WS GVI+Y     +  P + S 
Sbjct: 183 ETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYN-KLCDWWSLGVIMYEMLIGY--PPFCSE 239

Query: 223 GAQNLLRKIL 232
             Q   +K++
Sbjct: 240 TPQETYKKVM 249

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score =  106 bits (267), Expect = 3e-26
 Identities = 78/233 (33%), Positives = 120/233 (51%), Gaps = 22/233 (9%)

Query: 17  ELGRTLGEGNFGKVKFAQDLDSGLPFAVKIL--EKNRIIHLKITDQIKREIATLKLLKHP 74
           EL R LGEG  G V   +  ++G+ FA+K +  + N  +      QI RE+   K  K P
Sbjct: 5   ELSR-LGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQ----KQILRELEINKSCKSP 59

Query: 75  NVVRLHE--VLASKSKIYMVLEYVTGGEL---FDKIASKG-RLQEAEGRKLFQQLIDGVS 128
            +V+ +   +  S S I + +EY  GG L   + K+  +G R+ E    K+ + ++ G+S
Sbjct: 60  YIVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLS 119

Query: 129 YCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVL 188
           Y H++ + HRD+K  NILL  KG +K+ DFG+S        + L  T  G+  Y+APE +
Sbjct: 120 YLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELV----NSLAGTFTGTSFYMAPERI 175

Query: 189 ANRGYDGATSDIWSCGV-ILYIFRGDFKLP--KWLSPGAQNLLRKIL-EPNPV 237
             + Y   TSD+WS G+ +L + +  F  P       G   LL  I+  PNP 
Sbjct: 176 QGKPYS-ITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPE 227

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

 Score =  107 bits (268), Expect = 7e-26
 Identities = 69/234 (29%), Positives = 102/234 (43%), Gaps = 46/234 (19%)

Query: 20  RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRL 79
           +TLG G FG+V  A  +D+   +A+K L K  +++      +K E   L    +  VV+L
Sbjct: 7   KTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKL 66

Query: 80  HEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRD 139
           +     K  +Y V++Y+ GG++   +       E   R    +L   +   H  G  HRD
Sbjct: 67  YYSFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGFIHRD 126

Query: 140 LKLENILLDSKGNIKISDFGL----------------------SALPQHFRDD------- 170
           +K +NIL+D  G+IK++DFGL                      S  P    DD       
Sbjct: 127 IKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCG 186

Query: 171 ----------------GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILY 208
                            L H+  G+PNY+APEVL  +GY     D WS GVIL+
Sbjct: 187 DRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYT-QLCDWWSVGVILF 239

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score =  104 bits (262), Expect = 8e-26
 Identities = 68/197 (34%), Positives = 105/197 (53%), Gaps = 9/197 (4%)

Query: 19  GRTLGEGNFGKVKFAQDLDSGLPFAVKILE---KNRIIHLKITDQIKREIATLKLLKHPN 75
           G  LG+G +G V +    + G   AVK +E    N +   K  ++++ E+  LK LKH N
Sbjct: 5   GEVLGKGAYGTV-YCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVN 63

Query: 76  VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGV 135
           +V+        + I + +E+V GG +   +   G L E    K  +Q++DGV+Y HN  V
Sbjct: 64  IVQYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCV 123

Query: 136 FHRDLKLENILLDSKGNIKISDFG----LSALPQHFRDDGLLHTTCGSPNYVAPEVLANR 191
            HRD+K  N++L   G IK+ DFG    L+ +  H     +L +  G+P ++APEV+   
Sbjct: 124 VHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINES 183

Query: 192 GYDGATSDIWSCGVILY 208
           GY G  SDIWS G  ++
Sbjct: 184 GY-GRKSDIWSIGCTVF 199

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score =  105 bits (263), Expect = 1e-25
 Identities = 80/281 (28%), Positives = 125/281 (44%), Gaps = 74/281 (26%)

Query: 22  LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQ-----IKREIATLKLLKHPNV 76
           +GEG +G V   ++  +G   A+K       I L+  ++       REI+ LK L+HPN+
Sbjct: 8   IGEGTYGVVYKGRNKKTGQIVAMKK------IRLESEEEGVPSTAIREISLLKELQHPNI 61

Query: 77  VRLHEVLASKSKIYMVLEYVTGG--ELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKG 134
           V L +VL  +S++Y++ E+++    +  D +     +     +    Q++ G+ +CH++ 
Sbjct: 62  VCLQDVLMQESRLYLIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRR 121

Query: 135 VFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGL-----LHTTCGSPNYVAPEVLA 189
           V HRDLK +N+L+D+KG IK++DFGL+      R  G+      H    +  Y APEVL 
Sbjct: 122 VLHRDLKPQNLLIDNKGVIKLADFGLA------RAFGIPVRVYTHEVV-TLWYRAPEVLL 174

Query: 190 NRGYDGATSDIWSCGVI--------------------LYIFR----------------GD 213
                    DIWS G I                      IFR                 D
Sbjct: 175 GSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPD 234

Query: 214 FK--LPKW-----------LSPGAQNLLRKILEPNPVKRIT 241
           +K   PKW           L     +LL K+L  +P KRI+
Sbjct: 235 YKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRIS 275

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score =  108 bits (271), Expect = 1e-25
 Identities = 81/266 (30%), Positives = 124/266 (46%), Gaps = 51/266 (19%)

Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKIL--------EKNRIIHLKITDQIKREIA 66
           +Y + R LG G  G V  A+ +  G PFAVK++        +KNR          + E+ 
Sbjct: 33  KYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRA---------QAEVC 83

Query: 67  TLKLLKHPNVVRLHEVLASK--------SKIYMVLEYVTGGELFDKIASKGR----LQEA 114
            L      ++V+ HE  A K          I +VL+Y   G+L  +I S+ +     +E 
Sbjct: 84  CLLNCDFFSIVKCHEDFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREH 143

Query: 115 EGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLH 174
           E   LF Q++  V + H+K + HRD+K  NILL S G +K+ DFG S +      D +  
Sbjct: 144 EAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGR 203

Query: 175 TTCGSPNYVAPEVLANRGYDGATSDIWSCGVILY--------------------IFRGDF 214
           T CG+P YVAPE+   + Y    +D++S GV+LY                       G +
Sbjct: 204 TFCGTPYYVAPEIWRRKPYS-KKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGRY 262

Query: 215 K-LPKWLSPGAQNLLRKILEPNPVKR 239
             LP  +SP  Q ++  +L  +P +R
Sbjct: 263 DPLPPSISPEMQEIVTALLSSDPKRR 288

Length = 496

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score =  103 bits (258), Expect = 3e-25
 Identities = 58/196 (29%), Positives = 100/196 (51%), Gaps = 11/196 (5%)

Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
           + L R LG G FG+V      +  +  A+KIL+ + ++        ++E+  LK L+H +
Sbjct: 8   FTLERKLGSGYFGEVWEGLWKNR-VRVAIKILKSDDLLKQ---QDFQKEVQALKRLRHKH 63

Query: 76  VVRLHEVLASKSKIYMVLEYVTGGELFDKIAS-KGR-LQEAEGRKLFQQLIDGVSYCHNK 133
           ++ L  V +    +Y++ E +  G L   + S +G+ L  A    +  Q+ +G++Y   +
Sbjct: 64  LISLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQ 123

Query: 134 GVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP-NYVAPEVLANRG 192
              HRDL   NIL+      K++DFGL+ L    ++D  L +    P  + APE  A+ G
Sbjct: 124 NSIHRDLAARNILVGEDLVCKVADFGLARL---IKEDVYLSSDKKIPYKWTAPEA-ASHG 179

Query: 193 YDGATSDIWSCGVILY 208
                SD+WS G++LY
Sbjct: 180 TFSTKSDVWSFGILLY 195

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score =  103 bits (259), Expect = 4e-25
 Identities = 66/194 (34%), Positives = 100/194 (51%), Gaps = 11/194 (5%)

Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKIL---EKNRIIHLKITDQIKREIATLKLL 71
           +YE    +GEG++G V   ++ ++G   A+K     E + +I  KI     REI  LK L
Sbjct: 2   KYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIK-KIA---LREIRMLKQL 57

Query: 72  KHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCH 131
           KHPN+V L EV   K K+++V EY     L +   +   + E   +K+  Q +  V++CH
Sbjct: 58  KHPNLVNLIEVFRRKRKLHLVFEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCH 117

Query: 132 NKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPN-YVAPEVLAN 190
                HRD+K ENIL+  +G IK+ DFG + +     DD   +T   +   Y APE+L  
Sbjct: 118 KHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDD---YTDYVATRWYRAPELLVG 174

Query: 191 RGYDGATSDIWSCG 204
               G   D+W+ G
Sbjct: 175 DTQYGPPVDVWAIG 188

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score =  102 bits (256), Expect = 6e-25
 Identities = 81/258 (31%), Positives = 127/258 (49%), Gaps = 42/258 (16%)

Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQ---IKREIATLKLLK 72
           YEL + +G G +G V  A++L +G   AVKI      I L+  D    I++EI  +K  K
Sbjct: 11  YELIQRVGSGTYGDVYKARNLHTGELAAVKI------IKLEPGDDFSLIQQEIFMVKECK 64

Query: 73  HPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHN 132
           H N+V       S+ K+++ +EY  GG L D     G L E +   + ++ + G++Y H+
Sbjct: 65  HCNIVAYFGSYLSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHS 124

Query: 133 KGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLA--- 189
           KG  HRD+K  NILL   G++K++DFG++A  +         +  G+P ++APEV A   
Sbjct: 125 KGKMHRDIKGANILLTDNGDVKLADFGVAA--KITATIAKRKSFIGTPYWMAPEVAAVEK 182

Query: 190 NRGYDGATSDIWSCGV--------------------ILYIFRGDFKLP------KWLSPG 223
           N GY+    DIW+ G+                    +  + + +F+ P      KW S  
Sbjct: 183 NGGYN-QLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPPKLKDKTKW-SST 240

Query: 224 AQNLLRKILEPNPVKRIT 241
             N ++  L  NP KR T
Sbjct: 241 FHNFVKISLTKNPKKRPT 258

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score =  102 bits (255), Expect = 8e-25
 Identities = 70/204 (34%), Positives = 104/204 (50%), Gaps = 22/204 (10%)

Query: 15  RYELGRTLGEGNFGK-VKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKR-----EIATL 68
            Y   R LG+G FG+   + +  D  L   V   E    ++L    + +R     EI  L
Sbjct: 1   HYIPIRVLGKGAFGEATLYRRTEDDSL---VVWKE----VNLTRLSEKERRDALNEIVIL 53

Query: 69  KLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIA-SKGRLQEAE--GRKLFQQLID 125
            LL+HPN++  +      + + + +EY  GG L+DKI   KG+L E E     LFQ ++ 
Sbjct: 54  SLLQHPNIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQ-IVS 112

Query: 126 GVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTC-GSPNYVA 184
            VSY H  G+ HRD+K  NI L   G IK+ DFG+S   +    +  +  T  G+P Y++
Sbjct: 113 AVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGIS---KILGSEYSMAETVVGTPYYMS 169

Query: 185 PEVLANRGYDGATSDIWSCGVILY 208
           PE+     Y+   SDIW+ G +LY
Sbjct: 170 PELCQGVKYN-FKSDIWALGCVLY 192

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score =  102 bits (256), Expect = 8e-25
 Identities = 64/200 (32%), Positives = 98/200 (49%), Gaps = 17/200 (8%)

Query: 20  RTLGEGNFGKVKFA----QDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
           + LGEG+FGKV+         ++G   AVK L  +       +D  +REI  L+ L H N
Sbjct: 10  KQLGEGHFGKVELCRYDPLGDNTGEQVAVKSL-NHSGEEQHRSD-FEREIEILRTLDHEN 67

Query: 76  VVRLHEVL--ASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLF----QQLIDGVSY 129
           +V+   V        + +++EY+  G L D +    R ++    K       Q+  G+ Y
Sbjct: 68  IVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQ---RHRDQINLKRLLLFSSQICKGMDY 124

Query: 130 CHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP-NYVAPEVL 188
             ++   HRDL   NIL++S+  +KISDFGL+ +    +D   +     SP  + APE L
Sbjct: 125 LGSQRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECL 184

Query: 189 ANRGYDGATSDIWSCGVILY 208
               +  A SD+WS GV LY
Sbjct: 185 RTSKFSSA-SDVWSFGVTLY 203

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score =  101 bits (254), Expect = 1e-24
 Identities = 66/203 (32%), Positives = 98/203 (48%), Gaps = 29/203 (14%)

Query: 18  LGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVV 77
           L R LG G FG+V +    +     AVK L+   +      +   +E   +K L+H  +V
Sbjct: 10  LERKLGAGQFGEV-WMGTWNGTTKVAVKTLKPGTMS----PEAFLQEAQIMKKLRHDKLV 64

Query: 78  RLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKL-FQQLID-------GVSY 129
           +L+ V + +  IY+V EY++ G L D       L+  EG+KL   QL+D       G++Y
Sbjct: 65  QLYAVCSEEEPIYIVTEYMSKGSLLD------FLKSGEGKKLRLPQLVDMAAQIAEGMAY 118

Query: 130 CHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNY----VAP 185
             ++   HRDL   NIL+      KI+DFGL+ L     DD   +T      +     AP
Sbjct: 119 LESRNYIHRDLAARNILVGENLVCKIADFGLARL---IEDD--EYTAREGAKFPIKWTAP 173

Query: 186 EVLANRGYDGATSDIWSCGVILY 208
           E  AN G     SD+WS G++L 
Sbjct: 174 EA-ANYGRFTIKSDVWSFGILLT 195

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score =  102 bits (257), Expect = 1e-24
 Identities = 75/245 (30%), Positives = 118/245 (48%), Gaps = 32/245 (13%)

Query: 15  RYELGRTLGEGNFGKVKFAQDLDS--GLPFAVKILEKNRIIHLKITDQIKREIATLKLLK 72
           +YE+   +G G +G+V  A+  +   G  +A+K  + ++  +  I+    REIA L+ LK
Sbjct: 1   KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELK 60

Query: 73  HPNVVRLHEVLASKS--KIYMVLEYVTGGELFDKI-----ASKGRLQEAEGRKLFQQLID 125
           H NVV L EV    +   +Y++ +Y    +L+  I     A +  +  +  + L  Q+++
Sbjct: 61  HENVVSLVEVFLEHADKSVYLLFDY-AEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILN 119

Query: 126 GVSYCHNKGVFHRDLKLENILL----DSKGNIKISDFGL-----SALPQHFRDDGLLHTT 176
           GV Y H+  V HRDLK  NIL+      +G +KI D GL     + L      D ++ T 
Sbjct: 120 GVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVVVTI 179

Query: 177 CGSPNYVAPEV-LANRGYDGATSDIWSCGVILY-------IFRGDFKLPKWLSPGAQNLL 228
                Y APE+ L  R Y  A  DIW+ G I         IF+G     K  +P  ++ L
Sbjct: 180 W----YRAPELLLGARHYTKAI-DIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQL 234

Query: 229 RKILE 233
            +I E
Sbjct: 235 ERIFE 239

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score =  101 bits (254), Expect = 1e-24
 Identities = 89/267 (33%), Positives = 137/267 (51%), Gaps = 53/267 (19%)

Query: 22  LGEGNFGKVKFAQDLDSGLPFAVK-ILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLH 80
           LG+G +G V  A+DL + +  A+K I E++     +    +  EIA    LKH N+V+  
Sbjct: 16  LGKGTYGIVYAARDLSTQVRIAIKEIPERDS----RYVQPLHEEIALHSYLKHRNIVQY- 70

Query: 81  EVLASKS-----KIYMVLEYVTGGELFDKIASK-GRLQEAEGRKLF--QQLIDGVSYCHN 132
             L S S     KI+M  E V GG L   + SK G L++ E   +F  +Q+++G+ Y H+
Sbjct: 71  --LGSDSENGFFKIFM--EQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHD 126

Query: 133 KGVFHRDLKLENILLDS-KGNIKISDFGLSALPQHFRDDGL---LHTTCGSPNYVAPEVL 188
             + HRD+K +N+L+++  G +KISDFG S      R  G+     T  G+  Y+APEV+
Sbjct: 127 NQIVHRDIKGDNVLVNTYSGVVKISDFGTSK-----RLAGINPCTETFTGTLQYMAPEVI 181

Query: 189 --ANRGYDGATSDIWSCGVILY------------------IFR-GDFK----LPKWLSPG 223
               RGY GA +DIWS G  +                   +F+ G FK    +P+ LS  
Sbjct: 182 DKGPRGY-GAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIHPEIPESLSAE 240

Query: 224 AQNLLRKILEPNPVKRITIAGIKADEW 250
           A+N + +  EP+P KR +   +  D +
Sbjct: 241 AKNFILRCFEPDPDKRASAHDLLQDPF 267

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score =  106 bits (265), Expect = 2e-24
 Identities = 69/235 (29%), Positives = 108/235 (45%), Gaps = 34/235 (14%)

Query: 37  DSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRL-HEVLASKSKIYMVLEY 95
            +G   A+K+L  +         + +RE A    L HPN+V L     A    ++ V EY
Sbjct: 1   MTGHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEY 60

Query: 96  VTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKG---N 152
           V G  L + +A+ G L   E  +L  Q++D ++  HN+G+ HRDLK +NI++   G   +
Sbjct: 61  VPGRTLREVLAADGALPAGETGRLMLQVLDALACAHNQGIVHRDLKPQNIMVSQTGVRPH 120

Query: 153 IKISDFGLSALPQHFRDDGLLHTT-----CGSPNYVAPEVLANRGYDGATSDIWSCGVIL 207
            K+ DFG+  L    RD  +   T      G+P Y APE L         SD+++ G+I 
Sbjct: 121 AKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVT-PNSDLYAWGLIF 179

Query: 208 Y-----------------IFRG----DFKLPKWLS--PGAQNLLRKILEPNPVKR 239
                             +++     D  LP W++  P  Q +LRK L  +P +R
Sbjct: 180 LECLTGQRVVQGASVAEILYQQLSPVDVSLPPWIAGHPLGQ-VLRKALNKDPRQR 233

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score =  100 bits (251), Expect = 5e-24
 Identities = 76/256 (29%), Positives = 115/256 (44%), Gaps = 30/256 (11%)

Query: 20  RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRL 79
           R LG+G FG+V   Q   +G  +A K LEK RI   K       E   L+ +    VV L
Sbjct: 6   RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSL 65

Query: 80  HEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLF--QQLIDGVSYCHNKGVFH 137
                +K  + +VL  + GG+L   I + G     E R +F   ++  G+   H + + +
Sbjct: 66  AYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVY 125

Query: 138 RDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGAT 197
           RDLK ENILLD  G+I+ISD GL+       +   +    G+  Y+APEV+ N  Y   +
Sbjct: 126 RDLKPENILLDDYGHIRISDLGLAV---EIPEGETIRGRVGTVGYMAPEVVKNERY-TFS 181

Query: 198 SDIWSCGVILY-------IFRGDFKLPKW-----------------LSPGAQNLLRKILE 233
            D W  G ++Y        FR   +  K                   S  A+++ R++L 
Sbjct: 182 PDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEYSEKFSEAARSICRQLLT 241

Query: 234 PNPVKRITIAGIKADE 249
            +P  R+   G  A+E
Sbjct: 242 KDPGFRLGCRGEGAEE 257

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score =  101 bits (254), Expect = 5e-24
 Identities = 85/324 (26%), Positives = 135/324 (41%), Gaps = 70/324 (21%)

Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEK--NRIIHLKITDQIKREIATLKLLK 72
           RY+    +G G +G+V  A D  +G   A+K L +     IH K T    RE+  LK + 
Sbjct: 16  RYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRT---YRELRLLKHMD 72

Query: 73  HPNVVRLHEV------LASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDG 126
           H NV+ L +V      L     +Y+V   + G +L + +  + +L +   + L  Q++ G
Sbjct: 73  HENVIGLLDVFTPASSLEDFQDVYLVTHLM-GADLNNIVKCQ-KLSDDHIQFLVYQILRG 130

Query: 127 VSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPE 186
           + Y H+ G+ HRDLK  NI ++    +KI DFGL+        D  +     +  Y APE
Sbjct: 131 LKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARHT-----DDEMTGYVATRWYRAPE 185

Query: 187 VLANRGYDGATSDIWSCGVILY-------IFRG--------------------------- 212
           ++ N  +   T DIWS G I+        +F G                           
Sbjct: 186 IMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKISS 245

Query: 213 ----------------DFK-LPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY 255
                           DFK +    +P A +LL K+L  +P KRIT A   A  +  + +
Sbjct: 246 ESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAEYH 305

Query: 256 TPAN-PDDDEEDIFVDNEAFSMHE 278
            P + P     D   ++   ++ E
Sbjct: 306 DPEDEPVAPPYDQSFESRDLTVDE 329

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score =  102 bits (254), Expect = 5e-24
 Identities = 61/212 (28%), Positives = 112/212 (52%), Gaps = 9/212 (4%)

Query: 2   VIAEKKQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQI 61
           ++ + ++  M+   Y++ + +G G FG+V+  +   S   +A+K+L K  +I    +   
Sbjct: 31  IVRKIRKLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFF 90

Query: 62  KREIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQ 121
             E   +     P VV+L         +YMV+EY+ GG+L + + S   + E   +    
Sbjct: 91  WEERDIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVN-LMSNYDVPEKWAKFYTA 149

Query: 122 QLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLH--TTCGS 179
           +++  +   H+ G+ HRD+K +N+LLD  G++K++DFG         + G++   T  G+
Sbjct: 150 EVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTC---MKMDETGMVRCDTAVGT 206

Query: 180 PNYVAPEVLANR---GYDGATSDIWSCGVILY 208
           P+Y++PEVL ++   GY G   D WS GV L+
Sbjct: 207 PDYISPEVLKSQGGDGYYGRECDWWSVGVFLF 238

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 99.7 bits (248), Expect = 6e-24
 Identities = 59/192 (30%), Positives = 106/192 (55%), Gaps = 7/192 (3%)

Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
           +EL + +G G +G V  A+++++G   A+K++   ++   +    +++EI  +K  KH N
Sbjct: 11  FELIQRIGSGTYGDVYKARNVNTGELAAIKVI---KLEPGEDFAVVQQEIIMMKDCKHSN 67

Query: 76  VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGV 135
           +V        + K+++ +E+  GG L D     G L E++   + ++ + G+ Y H+KG 
Sbjct: 68  IVAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGK 127

Query: 136 FHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLA--NRGY 193
            HRD+K  NILL   G++K++DFG+SA  Q         +  G+P ++APEV A   +G 
Sbjct: 128 MHRDIKGANILLTDNGHVKLADFGVSA--QITATIAKRKSFIGTPYWMAPEVAAVERKGG 185

Query: 194 DGATSDIWSCGV 205
                DIW+ G+
Sbjct: 186 YNQLCDIWAVGI 197

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score = 99.1 bits (247), Expect = 8e-24
 Identities = 71/210 (33%), Positives = 97/210 (46%), Gaps = 21/210 (10%)

Query: 20  RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRL 79
             +G+GNFG V +   L      AVK         LK   +  +E   LK   HPN+V+L
Sbjct: 1   EKIGKGNFGDV-YKGVLKGNTEVAVKTCRSTLPPDLKR--KFLQEAEILKQYDHPNIVKL 57

Query: 80  HEVLASKSKIYMVLEYVTGGELFDKI-ASKGRLQEAEGRKLFQQLID---GVSYCHNKGV 135
             V   K  IY+V+E V GG L   +   K RL     +KL Q  +D   G+ Y  +K  
Sbjct: 58  IGVCVQKQPIYIVMELVPGGSLLTFLRKKKNRLTV---KKLLQMSLDAAAGMEYLESKNC 114

Query: 136 FHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPN----YVAPEVLANR 191
            HRDL   N L+     +KISDFG+S       + G+   + G       + APE L N 
Sbjct: 115 IHRDLAARNCLVGENNVLKISDFGMS----REEEGGIYTVSDGLKQIPIKWTAPEAL-NY 169

Query: 192 GYDGATSDIWSCGVILY-IFR-GDFKLPKW 219
           G   + SD+WS G++L+  F  GD   P  
Sbjct: 170 GRYTSESDVWSYGILLWETFSLGDTPYPGM 199

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score =  101 bits (253), Expect = 8e-24
 Identities = 63/203 (31%), Positives = 106/203 (52%), Gaps = 9/203 (4%)

Query: 11  MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKL 70
           M+   YE+ + +G G FG+V+  +   +   +A+K+L K  +I    +     E   +  
Sbjct: 40  MKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAF 99

Query: 71  LKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYC 130
              P VV+L         +YMV+EY+ GG+L + + S   + E   R    +++  +   
Sbjct: 100 ANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVN-LMSNYDVPEKWARFYTAEVVLALDAI 158

Query: 131 HNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLH--TTCGSPNYVAPEVL 188
           H+ G  HRD+K +N+LLD  G++K++DFG          +G++   T  G+P+Y++PEVL
Sbjct: 159 HSMGFIHRDVKPDNMLLDKSGHLKLADFGTC---MKMNKEGMVRCDTAVGTPDYISPEVL 215

Query: 189 ANR---GYDGATSDIWSCGVILY 208
            ++   GY G   D WS GV LY
Sbjct: 216 KSQGGDGYYGRECDWWSVGVFLY 238

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score =  101 bits (253), Expect = 1e-23
 Identities = 66/210 (31%), Positives = 113/210 (53%), Gaps = 23/210 (10%)

Query: 11  MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQI----KREIA 66
           M+   +++ + +G G FG+V+  +   S   +A+K+L K  +I  K +D      +R+I 
Sbjct: 40  MKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMI--KRSDSAFFWEERDI- 96

Query: 67  TLKLLKHPN---VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQL 123
               + H N   +V+LH        +YMV+EY+ GG+L + + S   + E   R    ++
Sbjct: 97  ----MAHANSEWIVQLHYAFQDDKYLYMVMEYMPGGDLVN-LMSNYDIPEKWARFYTAEV 151

Query: 124 IDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLH--TTCGSPN 181
           +  +   H+ G  HRD+K +N+LLD  G++K++DFG          +G++   T  G+P+
Sbjct: 152 VLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCM---KMDANGMVRCDTAVGTPD 208

Query: 182 YVAPEVLANRGYD---GATSDIWSCGVILY 208
           Y++PEVL ++G D   G   D WS GV LY
Sbjct: 209 YISPEVLKSQGGDGYYGRECDWWSVGVFLY 238

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score = 99.9 bits (249), Expect = 1e-23
 Identities = 92/305 (30%), Positives = 136/305 (44%), Gaps = 80/305 (26%)

Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQ-----IKREIATLKL 70
           YE    +GEG +GKV  A+D ++G   A+K   K R   L++ ++       REI+ L++
Sbjct: 3   YEKLEKIGEGTYGKVYKARDKNTGKLVALK---KTR---LEMDEEGIPPTALREISLLQM 56

Query: 71  LKH-PNVVRLHEVLASKSK-----IYMVLEYVTGGELFDKIASKGR-----LQEAEGRKL 119
           L     +VRL +V   + K     +Y+V EY+   +L   + S GR     L     +  
Sbjct: 57  LSESIYIVRLLDVEHVEEKNGKPSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSF 115

Query: 120 FQQLIDGVSYCHNKGVFHRDLKLENILLD-SKGNIKISDFGLS---ALPQHFRDDGLLHT 175
             QL+ GV++CH  GV HRDLK +N+L+D  KG +KI+D GL    ++P         H 
Sbjct: 116 MYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPV----KSYTHE 171

Query: 176 TCGSPNYVAPEVLANRGYDGATSDIWSCGVI--------------------LYIFR---- 211
              +  Y APEVL    +     DIWS G I                    L+IF+    
Sbjct: 172 IV-TLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGT 230

Query: 212 -------GDFKL------PKW-----------LSPGAQNLLRKILEPNPVKRITIAGIKA 247
                  G  KL      P+W           LSP   +LL+K+L  +P KRI+      
Sbjct: 231 PTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT 290

Query: 248 DEWFE 252
             +F+
Sbjct: 291 HPYFD 295

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score =  100 bits (250), Expect = 1e-23
 Identities = 66/209 (31%), Positives = 102/209 (48%), Gaps = 21/209 (10%)

Query: 14  GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVK-ILEKNRIIHLKITDQIKREIATLKLLK 72
            +YE    +G+G FG+V  A+   +    A+K +L +N      IT    REI  L+LLK
Sbjct: 12  SKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITAL--REIKILQLLK 69

Query: 73  HPNVVRLHEVLASKSK--------IYMVLEYVT---GGELFDKIASKGRLQEAEGRKLFQ 121
           H NVV L E+  +K+          Y+V E+      G L +K     +   +E +K+ +
Sbjct: 70  HENVVNLIEICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNK---NVKFTLSEIKKVMK 126

Query: 122 QLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLS-ALPQHFRDDGLLHTT-CGS 179
            L++G+ Y H   + HRD+K  NIL+   G +K++DFGL+ A           +T    +
Sbjct: 127 MLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVVT 186

Query: 180 PNYVAPEVLAN-RGYDGATSDIWSCGVIL 207
             Y  PE+L   R Y G   D+W  G I+
Sbjct: 187 LWYRPPELLLGERDY-GPPIDMWGAGCIM 214

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score = 99.3 bits (248), Expect = 1e-23
 Identities = 68/210 (32%), Positives = 102/210 (48%), Gaps = 37/210 (17%)

Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIK--REIATLKLLK- 72
           Y++   +GEG F +V  AQ   +G  +A+K ++K    H K  +Q+   REI  L+ L  
Sbjct: 1   YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKK----HFKSLEQVNNLREIQALRRLSP 56

Query: 73  HPNVVRLHEVLASKS--KIYMVLEYVTGGELFDKIASKGR---LQEAEGRKLFQQLIDGV 127
           HPN++RL EVL  +   ++ +V E +    L++ I  KGR   L E   +    QL+  +
Sbjct: 57  HPNILRLIEVLFDRKTGRLALVFELMDM-NLYELI--KGRKRPLPEKRVKSYMYQLLKSL 113

Query: 128 SYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYV---- 183
            + H  G+FHRD+K ENIL+     +K++DFG S                  P Y     
Sbjct: 114 DHMHRNGIFHRDIKPENILIK-DDILKLADFG-SC-----------RGIYSKPPYTEYIS 160

Query: 184 -----APEVLANRGYDGATSDIWSCGVILY 208
                APE L   GY G   DIW+ G + +
Sbjct: 161 TRWYRAPECLLTDGYYGPKMDIWAVGCVFF 190

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 99.3 bits (247), Expect = 1e-23
 Identities = 61/191 (31%), Positives = 109/191 (57%), Gaps = 17/191 (8%)

Query: 22  LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKRE-----IATLKLLKHPNV 76
           +GEG+ G V  A++  SG   AVK+++        +  Q +RE     +  ++  +H NV
Sbjct: 29  IGEGSTGIVCIAREKHSGRQVAVKMMD--------LRKQQRRELLFNEVVIMRDYQHQNV 80

Query: 77  VRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVF 136
           V +++      ++++++E++ GG L D I S+ RL E +   + + ++  + Y H++GV 
Sbjct: 81  VEMYKSYLVGEELWVLMEFLQGGALTD-IVSQTRLNEEQIATVCESVLQALCYLHSQGVI 139

Query: 137 HRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGA 196
           HRD+K ++ILL   G +K+SDFG  A  Q  +D     +  G+P ++APEV++   Y G 
Sbjct: 140 HRDIKSDSILLTLDGRVKLSDFGFCA--QISKDVPKRKSLVGTPYWMAPEVISRTPY-GT 196

Query: 197 TSDIWSCGVIL 207
             DIWS G+++
Sbjct: 197 EVDIWSLGIMV 207

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score =  103 bits (257), Expect = 1e-23
 Identities = 47/137 (34%), Positives = 81/137 (59%)

Query: 25  GNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLA 84
           G FGKV   +  ++   +AVK+++K  +I+  +  Q++ E   L L K P +V L+  L 
Sbjct: 15  GAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQ 74

Query: 85  SKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLEN 144
           S + +Y+V+EY+ GG++   +   G   E    K   ++   + Y H  G+ HRDLK +N
Sbjct: 75  SANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDN 134

Query: 145 ILLDSKGNIKISDFGLS 161
           +L+ ++G+IK++DFGLS
Sbjct: 135 MLISNEGHIKLTDFGLS 151

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 99.8 bits (249), Expect = 2e-23
 Identities = 84/322 (26%), Positives = 133/322 (41%), Gaps = 77/322 (23%)

Query: 15  RYE-LGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIK----------- 62
           RY   G  LGEG +GKV+ A D  +G   A+K ++   I +    D+             
Sbjct: 9   RYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTL 68

Query: 63  REIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQ 122
           RE+  +  +KH N++ L +V      I +V++ +   +L   +  K RL E++ + +  Q
Sbjct: 69  RELKIMNEIKHENIMGLVDVYVEGDFINLVMDIMAS-DLKKVVDRKIRLTESQVKCILLQ 127

Query: 123 LIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLS---ALPQHFRDDGLLHTTCGS 179
           +++G++  H     HRDL   NI ++SKG  KI+DFGL+     P +        T    
Sbjct: 128 ILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRR 187

Query: 180 PN---------YVAPEVL--ANRGYDGATSDIWSCGVILY-------IFRGD-------- 213
                      Y APE+L  A + Y  A  D+WS G I         +F G+        
Sbjct: 188 EEMTSKVVTLWYRAPELLMGAEK-YHFAV-DMWSVGCIFAELLTGKPLFPGENEIDQLGR 245

Query: 214 -FKL-------------------------PKWLSPGAQN-------LLRKILEPNPVKRI 240
            F+L                         PK L     N       LL+ +L+ NP++RI
Sbjct: 246 IFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERI 305

Query: 241 TIAGIKADEWFEQDYTPANPDD 262
           +       E+F+ D  P +P  
Sbjct: 306 SAKEALKHEYFKSDPLPCDPSQ 327

Length = 335

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 97.8 bits (243), Expect = 3e-23
 Identities = 67/192 (34%), Positives = 98/192 (51%), Gaps = 12/192 (6%)

Query: 22  LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHE 81
           +G GNFG+V   +      P AVK   +     LK   +  +E   LK   HPN+VRL  
Sbjct: 3   IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLK--AKFLQEARILKQYSHPNIVRLIG 60

Query: 82  VLASKSKIYMVLEYVTGGELFDKIASKG-RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDL 140
           V   K  IY+V+E V GG+    + ++G RL+  E  ++ +    G+ Y  +K   HRDL
Sbjct: 61  VCTQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDL 120

Query: 141 KLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPN----YVAPEVLANRGYDGA 196
              N L+  K  +KISDFG+S       +DG+  +T G       + APE L N G   +
Sbjct: 121 AARNCLVTEKNVLKISDFGMS----REEEDGVYASTGGMKQIPVKWTAPEAL-NYGRYSS 175

Query: 197 TSDIWSCGVILY 208
            SD+WS G++L+
Sbjct: 176 ESDVWSFGILLW 187

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 99.1 bits (247), Expect = 4e-23
 Identities = 56/201 (27%), Positives = 106/201 (52%), Gaps = 11/201 (5%)

Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
           +++   +G G+FG+V+  ++  +G  +A+K+++K+ ++  +     + E   L +   P 
Sbjct: 3   FDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPW 62

Query: 76  VVRLHEVLASKSKIYMVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKG 134
           + +L      K  +Y+V+EY  GG+L   +   + +  E   +    +L+  +   H  G
Sbjct: 63  IPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMG 122

Query: 135 VFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTT--CGSPNYVAPEVL-ANR 191
             HRD+K EN+L+D  G+IK++DFG +A       + ++++    G+P+Y+APEVL    
Sbjct: 123 YVHRDIKPENVLIDRTGHIKLADFGSAA---RLTANKMVNSKLPVGTPDYIAPEVLTTMN 179

Query: 192 GYDGATSDI----WSCGVILY 208
           G    T  +    WS GVI Y
Sbjct: 180 GDGKGTYGVECDWWSLGVIAY 200

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score = 97.1 bits (242), Expect = 5e-23
 Identities = 59/198 (29%), Positives = 95/198 (47%), Gaps = 17/198 (8%)

Query: 17  ELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNV 76
           +LG T+G+G FG V        G   AVK L+               E + +  L+HPN+
Sbjct: 9   KLGATIGKGEFGDVM--LGDYRGQKVAVKCLKD----DSTAAQAFLAEASVMTTLRHPNL 62

Query: 77  VRLHEVLASKSKIYMVLEYVTGGELFDKIASKGR-LQEAEGRKLFQ-QLIDGVSYCHNKG 134
           V+L  V+   + +Y+V EY+  G L D + S+GR +     +  F   + +G+ Y   K 
Sbjct: 63  VQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKN 122

Query: 135 VFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP-NYVAPEVLANRGY 193
             HRDL   N+L+      K+SDFGL+      ++      +   P  + APE L  + +
Sbjct: 123 FVHRDLAARNVLVSEDLVAKVSDFGLA------KEASQGQDSGKLPVKWTAPEALREKKF 176

Query: 194 DGATSDIWSCGVILY-IF 210
               SD+WS G++L+ I+
Sbjct: 177 S-TKSDVWSFGILLWEIY 193

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 96.7 bits (241), Expect = 7e-23
 Identities = 69/206 (33%), Positives = 97/206 (47%), Gaps = 36/206 (17%)

Query: 22  LGEGNFGKVKFAQDLDSG---LPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVR 78
           LG+G+FG V+  +   SG   +P AVK L+ +++    I D   +E A +  L H N++R
Sbjct: 3   LGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKL--SDIMDDFLKEAAIMHSLDHENLIR 60

Query: 79  LHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQ---QLIDGVSYCHNKGV 135
           L+ V+ +   + MV E    G L D++  K  L       L     Q+ +G+ Y  +K  
Sbjct: 61  LYGVVLTHP-LMMVTELAPLGSLLDRL-RKDALGHFLISTLCDYAVQIANGMRYLESKRF 118

Query: 136 FHRDLKLENILLDSKGNIKISDFGLS-ALPQHFRDDGLLHTTCGSPNYV----------- 183
            HRDL   NILL S   +KI DFGL  ALPQ               +YV           
Sbjct: 119 IHRDLAARNILLASDDKVKIGDFGLMRALPQ------------NEDHYVMEEHLKVPFAW 166

Query: 184 -APEVLANRGYDGATSDIWSCGVILY 208
            APE L  R +  A SD+W  GV L+
Sbjct: 167 CAPESLRTRTFSHA-SDVWMFGVTLW 191

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 97.1 bits (242), Expect = 9e-23
 Identities = 66/199 (33%), Positives = 102/199 (51%), Gaps = 15/199 (7%)

Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKIL---EKNRIIHLKITDQIKREIATLKLL 71
           +YE    +GEG++G V   +  ++G   A+K     E ++++  KI     REI  LK L
Sbjct: 2   KYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVK-KIA---MREIRMLKQL 57

Query: 72  KHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCH 131
           +H N+V L EV   K ++Y+V E+V    L D       L E+  RK   Q++ G+ +CH
Sbjct: 58  RHENLVNLIEVFRRKKRLYLVFEFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCH 117

Query: 132 NKGVFHRDLKLENILLDSKGNIKISDFGLS---ALPQHFRDDGLLHTTCGSPNYVAPEVL 188
           +  + HRD+K ENIL+   G +K+ DFG +   A P     D +      +  Y APE+L
Sbjct: 118 SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYV-----ATRWYRAPELL 172

Query: 189 ANRGYDGATSDIWSCGVIL 207
                 G   DIW+ G ++
Sbjct: 173 VGDTKYGRAVDIWAVGCLV 191

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 96.6 bits (240), Expect = 1e-22
 Identities = 61/200 (30%), Positives = 99/200 (49%), Gaps = 7/200 (3%)

Query: 13  LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK 72
           L  + + + +G G F +V  A  L  G+P A+K ++   ++  K      +EI  LK L 
Sbjct: 1   LANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLN 60

Query: 73  HPNVVRLHEVLASKSKIYMVLEYVTGGELFDKI----ASKGRLQEAEGRKLFQQLIDGVS 128
           HPNV++ +      +++ +VLE    G+L   I      K  + E    K F QL   + 
Sbjct: 61  HPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALE 120

Query: 129 YCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVL 188
           + H++ V HRD+K  N+ + + G +K+ D GL             H+  G+P Y++PE +
Sbjct: 121 HMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRF--FSSKTTAAHSLVGTPYYMSPERI 178

Query: 189 ANRGYDGATSDIWSCGVILY 208
              GY+   SDIWS G +LY
Sbjct: 179 HENGYN-FKSDIWSLGCLLY 197

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 97.0 bits (241), Expect = 1e-22
 Identities = 75/233 (32%), Positives = 120/233 (51%), Gaps = 39/233 (16%)

Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK-HP 74
           +E+  T+G+G +GKV    +  +G   AVKIL+    IH  I ++I+ E   LK L  HP
Sbjct: 20  WEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDP---IH-DIDEEIEAEYNILKALSDHP 75

Query: 75  NVVRLHEVLASKS-----KIYMVLEYVTGGELFDKIASKGRLQEAEGRK------LFQQL 123
           NVV+ + +   K      ++++VLE   GG + D +  KG L+  E  +      +  + 
Sbjct: 76  NVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLV--KGFLKRGERMEEPIIAYILHEA 133

Query: 124 IDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYV 183
           + G+ + H     HRD+K  NILL ++G +K+ DFG+SA     R     +T+ G+P ++
Sbjct: 134 LMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLR--RNTSVGTPFWM 191

Query: 184 APEVLA-----NRGYDGATSDIWSCGVI-------------LYIFRGDFKLPK 218
           APEV+A     +  YD A  D+WS G+              L+  R  FK+P+
Sbjct: 192 APEVIACEQQLDSTYD-ARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPR 243

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score = 96.4 bits (240), Expect = 1e-22
 Identities = 62/202 (30%), Positives = 105/202 (51%), Gaps = 21/202 (10%)

Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITD----QIKREIATLKL 70
           R EL   +G G +G V   + + +G   A+KI      I+L   D     I+RE+A L  
Sbjct: 5   RLEL---IGRGAYGAVYRGKHVPTGRVVALKI------INLDTPDDDVSDIQREVALLSQ 55

Query: 71  LKH---PNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGV 127
           L+    PN+ + +       ++++++EY  GG +   +   G + E     + ++++  +
Sbjct: 56  LRQSQPPNITKYYGSYLKGPRLWIIMEYAEGGSV-RTLMKAGPIAEKYISVIIREVLVAL 114

Query: 128 SYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEV 187
            Y H  GV HRD+K  NIL+ + GN+K+ DFG++AL           T  G+P ++APEV
Sbjct: 115 KYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNS--SKRSTFVGTPYWMAPEV 172

Query: 188 LAN-RGYDGATSDIWSCGVILY 208
           +   + YD   +DIWS G+ +Y
Sbjct: 173 ITEGKYYD-TKADIWSLGITIY 193

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|217748 pfam03822, NAF, NAF domain

 Score = 89.9 bits (224), Expect = 1e-22
 Identities = 29/58 (50%), Positives = 43/58 (74%), Gaps = 1/58 (1%)

Query: 293 INAFQLIGMSSCLDLSGFFEKEDVSERK-IRFTSNHSAKDLLERIEDIVTEMGFRVQK 349
           +NAF LI +SS LDLSG FE+E  S++K  RFTS   A +++ ++E+I  E+GF+V+K
Sbjct: 1   LNAFDLISLSSGLDLSGLFEEEKKSKKKETRFTSRKPASEIISKLEEIAKELGFKVKK 58

Length = 58

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 96.3 bits (239), Expect = 2e-22
 Identities = 67/208 (32%), Positives = 113/208 (54%), Gaps = 8/208 (3%)

Query: 22  LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHE 81
           +GEG+ G V  A +  +G   AVK ++  +    +  + +  E+  ++   H NVV ++ 
Sbjct: 30  IGEGSTGIVCIATEKHTGKQVAVKKMDLRK---QQRRELLFNEVVIMRDYHHENVVDMYN 86

Query: 82  VLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLK 141
                 ++++V+E++ GG L D I +  R+ E +   +   ++  +SY HN+GV HRD+K
Sbjct: 87  SYLVGDELWVVMEFLEGGALTD-IVTHTRMNEEQIATVCLSVLRALSYLHNQGVIHRDIK 145

Query: 142 LENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIW 201
            ++ILL S G IK+SDFG  A  Q  ++     +  G+P ++APEV++   Y G   DIW
Sbjct: 146 SDSILLTSDGRIKLSDFGFCA--QVSKEVPKRKSLVGTPYWMAPEVISRLPY-GTEVDIW 202

Query: 202 SCGVILYIFRGDFKLPKWLSPGAQNLLR 229
           S G I+ I   D + P +  P  Q + R
Sbjct: 203 SLG-IMVIEMIDGEPPYFNEPPLQAMRR 229

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 95.9 bits (238), Expect = 2e-22
 Identities = 63/201 (31%), Positives = 112/201 (55%), Gaps = 18/201 (8%)

Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKR---EIATLKLLK 72
           +E+   LG+G FGKV  AQ+ ++G      +L   ++I  K  ++++    EI  L    
Sbjct: 7   WEIIGELGDGAFGKVYKAQNKETG------VLAAAKVIDTKSEEELEDYMVEIDILASCD 60

Query: 73  HPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGR-LQEAEGRKLFQQLIDGVSYCH 131
           HPN+V+L +    ++ +++++E+  GG +   +    R L E + R + +Q ++ ++Y H
Sbjct: 61  HPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLH 120

Query: 132 NKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVL--- 188
              + HRDLK  NIL    G+IK++DFG+SA  ++ R      +  G+P ++APEV+   
Sbjct: 121 ENKIIHRDLKAGNILFTLDGDIKLADFGVSA--KNTRTIQRRDSFIGTPYWMAPEVVMCE 178

Query: 189 --ANRGYDGATSDIWSCGVIL 207
              +R YD   +D+WS G+ L
Sbjct: 179 TSKDRPYD-YKADVWSLGITL 198

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 96.2 bits (239), Expect = 2e-22
 Identities = 68/207 (32%), Positives = 108/207 (52%), Gaps = 22/207 (10%)

Query: 14  GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL-K 72
             +E+  T+G+G +GKV    +   G   AVKIL+        + ++I+ E   L+ L  
Sbjct: 22  DTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS----DVDEEIEAEYNILQSLPN 77

Query: 73  HPNVVRLHEVL-----ASKSKIYMVLEYVTGG---ELFDKIASKG-RLQEAEGRKLFQQL 123
           HPNVV+ + +          ++++VLE   GG   EL   +   G RL EA    +    
Sbjct: 78  HPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGA 137

Query: 124 IDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYV 183
           + G+ + HN  + HRD+K  NILL ++G +K+ DFG+SA     R     +T+ G+P ++
Sbjct: 138 LLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLR--RNTSVGTPFWM 195

Query: 184 APEVLA-----NRGYDGATSDIWSCGV 205
           APEV+A     +  YD A  D+WS G+
Sbjct: 196 APEVIACEQQYDYSYD-ARCDVWSLGI 221

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 95.7 bits (238), Expect = 3e-22
 Identities = 68/253 (26%), Positives = 121/253 (47%), Gaps = 40/253 (15%)

Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKRE-----IATLK 69
           +Y     +G+G  G V  A D+ +G   A+K         + +  Q K+E     I  ++
Sbjct: 20  KYTRFEKIGQGASGTVYTAIDVATGQEVAIK--------QMNLQQQPKKELIINEILVMR 71

Query: 70  LLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSY 129
             KHPN+V   +      ++++V+EY+ GG L D + ++  + E +   + ++ +  + +
Sbjct: 72  ENKHPNIVNYLDSYLVGDELWVVMEYLAGGSLTD-VVTETCMDEGQIAAVCRECLQALEF 130

Query: 130 CHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLA 189
            H+  V HRD+K +NILL   G++K++DFG  A  Q   +     T  G+P ++APEV+ 
Sbjct: 131 LHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCA--QITPEQSKRSTMVGTPYWMAPEVVT 188

Query: 190 NRGYDGATSDIWSCGVI-------------------LYIF----RGDFKLPKWLSPGAQN 226
            + Y G   DIWS G++                   LY+       + + P+ LS   ++
Sbjct: 189 RKAY-GPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRD 247

Query: 227 LLRKILEPNPVKR 239
            L + LE +  KR
Sbjct: 248 FLNRCLEMDVEKR 260

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 95.1 bits (236), Expect = 4e-22
 Identities = 77/256 (30%), Positives = 116/256 (45%), Gaps = 30/256 (11%)

Query: 20  RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRL 79
           R LG+G FG+V   Q   +G  +A K LEK RI   K       E   L+ +    VV L
Sbjct: 6   RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSL 65

Query: 80  HEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLF--QQLIDGVSYCHNKGVFH 137
                +K  + +VL  + GG+L   I   G     EGR +F   ++  G+   H + + +
Sbjct: 66  AYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVY 125

Query: 138 RDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGAT 197
           RDLK ENILLD  G+I+ISD GL+    H  +   +    G+  Y+APEV+ N  Y   +
Sbjct: 126 RDLKPENILLDDHGHIRISDLGLAV---HVPEGQTIKGRVGTVGYMAPEVVKNERYT-FS 181

Query: 198 SDIWSCGVILY------------------------IFRGDFKLPKWLSPGAQNLLRKILE 233
            D W+ G +LY                        +     +  +  SP A++L + +L 
Sbjct: 182 PDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQEEYSEKFSPDARSLCKMLLC 241

Query: 234 PNPVKRITIAGIKADE 249
            +P +R+   G  A E
Sbjct: 242 KDPKERLGCQGGGARE 257

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 94.7 bits (235), Expect = 6e-22
 Identities = 63/200 (31%), Positives = 107/200 (53%), Gaps = 16/200 (8%)

Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
           +E+   LG+G FGKV  A++ ++G   A K++E      L   +    EI  L    HP 
Sbjct: 14  WEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEEL---EDYMVEIEILATCNHPY 70

Query: 76  VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGR-LQEAEGRKLFQQLIDGVSYCHNKG 134
           +V+L        K+++++E+  GG +   +    R L E + + + +Q+++ + Y H+  
Sbjct: 71  IVKLLGAFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMK 130

Query: 135 VFHRDLKLENILLDSKGNIKISDFGLSA--LPQHFRDDGLLHTTCGSPNYVAPEV----- 187
           + HRDLK  N+LL   G+IK++DFG+SA  +    R D  +    G+P ++APEV     
Sbjct: 131 IIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFI----GTPYWMAPEVVMCET 186

Query: 188 LANRGYDGATSDIWSCGVIL 207
           + +  YD   +DIWS G+ L
Sbjct: 187 MKDTPYD-YKADIWSLGITL 205

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 94.3 bits (234), Expect = 8e-22
 Identities = 67/192 (34%), Positives = 97/192 (50%), Gaps = 8/192 (4%)

Query: 20  RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRL 79
           R LG+G FG+V   Q   +G  +A K LEK RI   K       E   L+ +    VV L
Sbjct: 6   RVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNL 65

Query: 80  HEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLF--QQLIDGVSYCHNKGVFH 137
                +K  + +VL  + GG+L   I + G     E R LF   +++ G+   H +   +
Sbjct: 66  AYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVY 125

Query: 138 RDLKLENILLDSKGNIKISDFGLSA-LPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGA 196
           RDLK ENILLD  G+I+ISD GL+  +P+       +    G+  Y+APEVL N+ Y   
Sbjct: 126 RDLKPENILLDDYGHIRISDLGLAVKIPE----GESIRGRVGTVGYMAPEVLNNQRY-TL 180

Query: 197 TSDIWSCGVILY 208
           + D W  G ++Y
Sbjct: 181 SPDYWGLGCLIY 192

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 94.4 bits (234), Expect = 1e-21
 Identities = 71/248 (28%), Positives = 124/248 (50%), Gaps = 33/248 (13%)

Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
           RYE    +G+G  G V  A D+ +G   A+K +   +    ++   I  EI  +K LK+P
Sbjct: 23  RYE---KIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKEL---IINEILVMKELKNP 76

Query: 75  NVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKG 134
           N+V   +      ++++V+EY+ GG L D + ++  + EA+   + ++ +  + + H   
Sbjct: 77  NIVNFLDSFLVGDELFVVMEYLAGGSLTD-VVTETCMDEAQIAAVCRECLQALEFLHANQ 135

Query: 135 VFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYD 194
           V HRD+K +N+LL   G++K++DFG  A  Q   +     T  G+P ++APEV+  + Y 
Sbjct: 136 VIHRDIKSDNVLLGMDGSVKLTDFGFCA--QITPEQSKRSTMVGTPYWMAPEVVTRKAY- 192

Query: 195 GATSDIWSCGVI-------------------LYIFRG----DFKLPKWLSPGAQNLLRKI 231
           G   DIWS G++                   LY+       + + P+ LSP  ++ L + 
Sbjct: 193 GPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSPIFRDFLNRC 252

Query: 232 LEPNPVKR 239
           LE +  KR
Sbjct: 253 LEMDVEKR 260

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 93.5 bits (232), Expect = 1e-21
 Identities = 72/259 (27%), Positives = 124/259 (47%), Gaps = 38/259 (14%)

Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIAT-----LKL 70
           Y   R +G+G++G+V   +    G  + +K L      +L+   + +R+ A      L  
Sbjct: 2   YCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKL------NLRNASRRERKAAEQEAQLLSQ 55

Query: 71  LKHPNVVRLHEVLASKS-KIYMVLEYVTGGELFDKIA-SKGRL-QEAEGRKLFQQLIDGV 127
           LKHPN+V   E    +   +Y+V+ +  GG+L+ K+   KG+L  E +  + F Q+   +
Sbjct: 56  LKHPNIVAYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMAL 115

Query: 128 SYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEV 187
            Y H K + HRDLK +N+ L     IK+ D G++ + ++  D  +  T  G+P Y++PE+
Sbjct: 116 QYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCD--MASTLIGTPYYMSPEL 173

Query: 188 LANRGYDGATSDIWSCGVILY--------------------IFRGDF-KLPKWLSPGAQN 226
            +N+ Y+   SD+W+ G  +Y                    I  G    +PK  SP    
Sbjct: 174 FSNKPYN-YKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKLPPMPKDYSPELGE 232

Query: 227 LLRKILEPNPVKRITIAGI 245
           L+  +L   P KR ++  I
Sbjct: 233 LIATMLSKRPEKRPSVKSI 251

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 93.7 bits (233), Expect = 1e-21
 Identities = 90/301 (29%), Positives = 136/301 (45%), Gaps = 78/301 (25%)

Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQ-----IKREIATLK 69
           +YE    +GEG +G V  A+D  +    A+K       I L+  D+       REI+ LK
Sbjct: 3   QYEKVEKIGEGTYGVVYKARDRVTNETIALKK------IRLEQEDEGVPSTAIREISLLK 56

Query: 70  LLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQ----QLID 125
            ++H N+VRL +V+ S+ ++Y+V EY+   +L  K         A+  +L +    Q++ 
Sbjct: 57  EMQHGNIVRLQDVVHSEKRLYLVFEYL---DLDLKKHMDSSPDFAKNPRLIKTYLYQILR 113

Query: 126 GVSYCHNKGVFHRDLKLENILLDSKGN-IKISDFGLSALPQHFRDDGLLHTTCGSPN--- 181
           G++YCH+  V HRDLK +N+L+D + N +K++DFGL+      R  G+   T        
Sbjct: 114 GIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLA------RAFGIPVRTFTHEVVTL 167

Query: 182 -YVAPEVLANRGYDGATSDIWSCGVI-------------------LY-IFR--------- 211
            Y APE+L    +     DIWS G I                   L+ IFR         
Sbjct: 168 WYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEET 227

Query: 212 -------GDFK--LPKW-----------LSPGAQNLLRKILEPNPVKRITIAGIKADEWF 251
                   D+K   PKW           L P   +LL K+L  +P KRIT       E+F
Sbjct: 228 WPGVTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYF 287

Query: 252 E 252
           +
Sbjct: 288 K 288

Length = 294

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 93.2 bits (231), Expect = 1e-21
 Identities = 61/200 (30%), Positives = 98/200 (49%), Gaps = 7/200 (3%)

Query: 13  LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK 72
           L  +++ + +G G F +V  A  L    P A+K ++   ++  K      +EI  LK L 
Sbjct: 1   LANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLN 60

Query: 73  HPNVVRLHEVLASKSKIYMVLEYVTGGELFDKI----ASKGRLQEAEGRKLFQQLIDGVS 128
           HPNV++  +     +++ +VLE    G+L   I      K  + E    K F QL   V 
Sbjct: 61  HPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVE 120

Query: 129 YCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVL 188
           + H++ V HRD+K  N+ + + G +K+ D GL             H+  G+P Y++PE +
Sbjct: 121 HMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRF--FSSKTTAAHSLVGTPYYMSPERI 178

Query: 189 ANRGYDGATSDIWSCGVILY 208
              GY+   SDIWS G +LY
Sbjct: 179 HENGYN-FKSDIWSLGCLLY 197

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 92.8 bits (230), Expect = 2e-21
 Identities = 66/194 (34%), Positives = 102/194 (52%), Gaps = 18/194 (9%)

Query: 22  LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHE 81
           LG+GNFG+V F   L    P AVK  +++    LKI  +   E   LK   HPN+V+L  
Sbjct: 3   LGKGNFGEV-FKGTLKDKTPVAVKTCKEDLPQELKI--KFLSEARILKQYDHPNIVKLIG 59

Query: 82  VLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLID---GVSYCHNKGVFHR 138
           V   +  IY+V+E V GG+    +  K    E + ++L +  +D   G++Y  +K   HR
Sbjct: 60  VCTQRQPIYIVMELVPGGDFLSFLRKKK--DELKTKQLVKFALDAAAGMAYLESKNCIHR 117

Query: 139 DLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPN----YVAPEVLANRGYD 194
           DL   N L+     +KISDFG+S      ++D  ++++ G       + APE L N G  
Sbjct: 118 DLAARNCLVGENNVLKISDFGMSR-----QEDDGIYSSSGLKQIPIKWTAPEAL-NYGRY 171

Query: 195 GATSDIWSCGVILY 208
            + SD+WS G++L+
Sbjct: 172 SSESDVWSYGILLW 185

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 93.1 bits (231), Expect = 2e-21
 Identities = 76/261 (29%), Positives = 125/261 (47%), Gaps = 32/261 (12%)

Query: 22  LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKH---PNVVR 78
           +G G FG+V   +  D+G  +A+K L+K RI   +       E   L L+     P +V 
Sbjct: 2   IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61

Query: 79  LHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHR 138
           +     +  K+  +L+ + GG+L   ++  G   EAE R    ++I G+ + HN+ V +R
Sbjct: 62  MSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVYR 121

Query: 139 DLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLAN-RGYDGAT 197
           DLK  NILLD  G+++ISD GL+      +     H + G+  Y+APEVL     YD ++
Sbjct: 122 DLKPANILLDEHGHVRISDLGLACDFSKKKP----HASVGTHGYMAPEVLQKGVAYD-SS 176

Query: 198 SDIWSCGVILY-IFRGDF----------------------KLPKWLSPGAQNLLRKILEP 234
           +D +S G +L+ + RG                        +LP   SP  ++LL  +L+ 
Sbjct: 177 ADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEGLLQR 236

Query: 235 NPVKRITIAGIKADEWFEQDY 255
           +  +R+   G  A E  E  +
Sbjct: 237 DVNRRLGCLGRGAQEVKEHPF 257

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 93.1 bits (231), Expect = 2e-21
 Identities = 74/260 (28%), Positives = 123/260 (47%), Gaps = 30/260 (11%)

Query: 22  LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKH---PNVVR 78
           +G G FG+V   +  D+G  +A+K L+K RI   +       E   L L+     P +V 
Sbjct: 2   IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61

Query: 79  LHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHR 138
           +     +  K+  +L+ + GG+L   ++  G   E E R    ++I G+ + HN+ V +R
Sbjct: 62  MTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVYR 121

Query: 139 DLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATS 198
           DLK  NILLD  G+++ISD GL+      +     H + G+  Y+APEVL       +++
Sbjct: 122 DLKPANILLDEHGHVRISDLGLACDFSKKKP----HASVGTHGYMAPEVLQKGTAYDSSA 177

Query: 199 DIWSCGVILY-IFRG----------------------DFKLPKWLSPGAQNLLRKILEPN 235
           D +S G +L+ + RG                      + +LP   SP  ++LL  +L+ +
Sbjct: 178 DWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTVNVELPDSFSPELKSLLEGLLQRD 237

Query: 236 PVKRITIAGIKADEWFEQDY 255
             KR+   G  A E  E  +
Sbjct: 238 VSKRLGCLGRGAQEVKEHVF 257

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score = 93.8 bits (234), Expect = 2e-21
 Identities = 84/244 (34%), Positives = 119/244 (48%), Gaps = 45/244 (18%)

Query: 13  LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIK---------R 63
           L +YE+ + LG+G +G V  A D  +    A+K          KI D  +         R
Sbjct: 6   LRKYEILQKLGKGAYGIVWKAIDRRTKEVVALK----------KIFDAFRNATDAQRTFR 55

Query: 64  EIATLK-LLKHPNVVRLHEVL-ASKSK-IYMVLEYV-TGGELFDKIASKGRLQEAEGRKL 119
           EI  L+ L  HPN+V+L  V+ A   K IY+V EY+ T  +L   I     L++   R +
Sbjct: 56  EIMFLQELGDHPNIVKLLNVIKAENDKDIYLVFEYMET--DLHAVI-RANILEDVHKRYI 112

Query: 120 FQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLS-ALPQHFRDDGLLHTTCG 178
             QL+  + Y H+  V HRDLK  NILL+S   +K++DFGL+ +L +   +      T  
Sbjct: 113 MYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLT-- 170

Query: 179 SPNYVA------PEVL-ANRGYDGATSDIWSCGVILYIFRGDFKLPKWLSPGAQ--NLLR 229
             +YVA      PE+L  +  Y     D+WS G IL    G+  L K L PG    N L 
Sbjct: 171 --DYVATRWYRAPEILLGSTRYTKGV-DMWSVGCIL----GEMLLGKPLFPGTSTLNQLE 223

Query: 230 KILE 233
           KI+E
Sbjct: 224 KIIE 227

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 94.1 bits (234), Expect = 2e-21
 Identities = 74/245 (30%), Positives = 109/245 (44%), Gaps = 29/245 (11%)

Query: 14  GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKH 73
            RY   R LG G+ G V  A D D     AVK +       +K      REI  ++ L H
Sbjct: 5   SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVK---HALREIKIIRRLDH 61

Query: 74  PNVVRLHEVLASKSK--------------IYMVLEYVTGGELFDKIASKGRLQEAEGRKL 119
            N+V+++EVL                   +Y+V EY+        +  +G L E   R  
Sbjct: 62  DNIVKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYMETD--LANVLEQGPLSEEHARLF 119

Query: 120 FQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNI-KISDFGLS-ALPQHFRDDGLLHTTC 177
             QL+ G+ Y H+  V HRDLK  N+ ++++  + KI DFGL+  +  H+   G L    
Sbjct: 120 MYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGL 179

Query: 178 GSPNYVAPE-VLANRGYDGATSDIWSCGVILYIFRGDFKLPKWLSPGAQNL--LRKILEP 234
            +  Y +P  +L+   Y  A  D+W+ G I      +    K L  GA  L  ++ ILE 
Sbjct: 180 VTKWYRSPRLLLSPNNYTKAI-DMWAAGCIF----AEMLTGKPLFAGAHELEQMQLILES 234

Query: 235 NPVKR 239
            PV R
Sbjct: 235 VPVVR 239

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 93.4 bits (232), Expect = 3e-21
 Identities = 65/195 (33%), Positives = 100/195 (51%), Gaps = 11/195 (5%)

Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
           RY   + +G G FG V  A+D  +G   A+K + K     + +  +  RE+  LK L+H 
Sbjct: 11  RYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPV-LAKRTYRELKLLKHLRHE 69

Query: 75  NVVRLHEVLASKSK-IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNK 133
           N++ L ++  S  + IY V E +  G    ++ +   L++   +    Q++ G+ Y H+ 
Sbjct: 70  NIISLSDIFISPLEDIYFVTELL--GTDLHRLLTSRPLEKQFIQYFLYQILRGLKYVHSA 127

Query: 134 GVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEV-LANRG 192
           GV HRDLK  NIL++   ++KI DFGL A  Q  +  G + T      Y APE+ L  + 
Sbjct: 128 GVVHRDLKPSNILINENCDLKICDFGL-ARIQDPQMTGYVSTR----YYRAPEIMLTWQK 182

Query: 193 YDGATSDIWSCGVIL 207
           YD    DIWS G I 
Sbjct: 183 YDVEV-DIWSAGCIF 196

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 93.6 bits (232), Expect = 3e-21
 Identities = 59/200 (29%), Positives = 105/200 (52%), Gaps = 10/200 (5%)

Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
           +E+ + +G G FG+V   +  ++   FA+KIL K  ++    T   + E   L    +  
Sbjct: 3   FEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQW 62

Query: 76  VVRLHEVLASKSKIYMVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKG 134
           +  LH     ++ +Y+V++Y  GG+L   ++  + RL E   R    +++  +   H   
Sbjct: 63  ITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLH 122

Query: 135 VFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTT--CGSPNYVAPEVLA--- 189
             HRD+K +NIL+D  G+I+++DFG S L     +DG + ++   G+P+Y++PE+L    
Sbjct: 123 YVHRDIKPDNILMDMNGHIRLADFG-SCL--KLMEDGTVQSSVAVGTPDYISPEILQAME 179

Query: 190 -NRGYDGATSDIWSCGVILY 208
             +G  G   D WS GV +Y
Sbjct: 180 DGKGKYGPECDWWSLGVCMY 199

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 94.1 bits (234), Expect = 4e-21
 Identities = 66/258 (25%), Positives = 108/258 (41%), Gaps = 48/258 (18%)

Query: 20  RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRL 79
           + +G+G FG+V+  Q  D+G  +A+K L K+ +        +K E   L     P VV L
Sbjct: 7   KVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSL 66

Query: 80  HEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRD 139
           +        +Y+++E++ GG+L   +       E   R    + +  +   H  G  HRD
Sbjct: 67  YYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLGFIHRD 126

Query: 140 LKLENILLDSKGNIKISDFGL--------------------SALPQHFRDDGLL------ 173
           +K +NIL+D  G+IK+SDFGL                    S   +    + +       
Sbjct: 127 IKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINL 186

Query: 174 -------------------HTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIFRGDF 214
                              ++T G+P+Y+APE+   +GY G   D WS G I+  F    
Sbjct: 187 TMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGY-GQECDWWSLGAIM--FECLI 243

Query: 215 KLPKWLSPGAQNLLRKIL 232
             P + S  +    RKI+
Sbjct: 244 GWPPFCSENSHETYRKII 261

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 91.9 bits (228), Expect = 6e-21
 Identities = 68/205 (33%), Positives = 103/205 (50%), Gaps = 20/205 (9%)

Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILE-KNRIIHLKITDQIKREIATLKLLK- 72
           +YE    +G G +G V  A+D  SG   A+K +  +     L ++    RE+A LK L+ 
Sbjct: 1   QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLS--TVREVALLKRLEA 58

Query: 73  --HPNVVRLHEVLAS-----KSKIYMVLEYVTGG--ELFDKIASKGRLQEAEGRKLFQQL 123
             HPN+VRL +V A+     ++K+ +V E+V        DK+   G L     + L +Q 
Sbjct: 59  FDHPNIVRLMDVCATSRTDRETKVTLVFEHVDQDLRTYLDKVPPPG-LPAETIKDLMRQF 117

Query: 124 IDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQ-HFRDDGLLHTTCGSPNY 182
           + G+ + H   + HRDLK ENIL+ S G +K++DFGL+ +         ++ T      Y
Sbjct: 118 LRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIYSCQMALTPVVVTLW----Y 173

Query: 183 VAPEVLANRGYDGATSDIWSCGVIL 207
            APEVL    Y     D+WS G I 
Sbjct: 174 RAPEVLLQSTY-ATPVDMWSVGCIF 197

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score = 91.3 bits (227), Expect = 6e-21
 Identities = 63/195 (32%), Positives = 95/195 (48%), Gaps = 12/195 (6%)

Query: 20  RTLGEGNFGKVKFAQDLDSG---LPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNV 76
           + LG GNFG V     L      +  AVK L++  I   K   +  RE + +  L HP +
Sbjct: 1   KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGK--KEFLREASVMAQLDHPCI 58

Query: 77  VRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVF 136
           VRL  V   +  + +V+E    G L   +  +  +  ++ ++L  Q+  G++Y  +K   
Sbjct: 59  VRLIGVCKGEP-LMLVMELAPLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFV 117

Query: 137 HRDLKLENILLDSKGNIKISDFGLS-ALPQHFRDDGLLHTTCGS-P-NYVAPEVLANRGY 193
           HRDL   N+LL ++   KISDFG+S AL      D    TT G  P  + APE +    +
Sbjct: 118 HRDLAARNVLLVNRHQAKISDFGMSRAL--GAGSDYYRATTAGRWPLKWYAPECINYGKF 175

Query: 194 DGATSDIWSCGVILY 208
               SD+WS GV L+
Sbjct: 176 SSK-SDVWSYGVTLW 189

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 91.3 bits (226), Expect = 8e-21
 Identities = 56/185 (30%), Positives = 102/185 (55%), Gaps = 8/185 (4%)

Query: 22  LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHE 81
           +G+G+FG+V    D  +    A+KI++       +I D I++EI  L     P + R + 
Sbjct: 12  IGKGSFGEVYKGIDNRTKEVVAIKIIDLEEA-EDEIED-IQQEITVLSQCDSPYITRYYG 69

Query: 82  VLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLK 141
                +K+++++EY+ GG   D +   G L+E     + ++++ G+ Y H++   HRD+K
Sbjct: 70  SYLKGTKLWIIMEYLGGGSALD-LLKPGPLEETYIATILREILKGLDYLHSERKIHRDIK 128

Query: 142 LENILLDSKGNIKISDFGLSALPQHFRDDGLLHTT-CGSPNYVAPEVLANRGYDGATSDI 200
             N+LL  +G++K++DFG++       D  +   T  G+P ++APEV+    YD   +DI
Sbjct: 129 AANVLLSEQGDVKLADFGVAG---QLTDTQIKRNTFVGTPFWMAPEVIKQSAYD-FKADI 184

Query: 201 WSCGV 205
           WS G+
Sbjct: 185 WSLGI 189

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 91.4 bits (227), Expect = 8e-21
 Identities = 74/200 (37%), Positives = 107/200 (53%), Gaps = 22/200 (11%)

Query: 22  LGEGNFGKVKFA-----QDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNV 76
           LG+GNFG V+       QD ++G   AVK L+ +   HL+     +REI  LK L+H N+
Sbjct: 12  LGKGNFGSVELCRYDPLQD-NTGEVVAVKKLQHSTAEHLR---DFEREIEILKSLQHDNI 67

Query: 77  VRLHEVLASKSK--IYMVLEYVTGGELFDK-IASKGRLQEAEGRKLFQ---QLIDGVSYC 130
           V+   V  S  +  + +V+EY+  G L D     + RL   + RKL     Q+  G+ Y 
Sbjct: 68  VKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERL---DHRKLLLYASQICKGMEYL 124

Query: 131 HNKGVFHRDLKLENILLDSKGNIKISDFGLSA-LPQHFRDDGLLHTTCGSPNY-VAPEVL 188
            +K   HRDL   NIL++S+  +KI DFGL+  LPQ  ++   +     SP +  APE L
Sbjct: 125 GSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQD-KEYYKVREPGESPIFWYAPESL 183

Query: 189 ANRGYDGATSDIWSCGVILY 208
               +  A SD+WS GV+LY
Sbjct: 184 TESKFSVA-SDVWSFGVVLY 202

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 90.9 bits (225), Expect = 2e-20
 Identities = 57/197 (28%), Positives = 104/197 (52%), Gaps = 17/197 (8%)

Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL--- 71
           +Y     +G+G  G V  A D+ +G   A+K         + +  Q K+E+   ++L   
Sbjct: 20  KYTRFEKIGQGASGTVYTAIDIATGQEVAIK--------QMNLQQQPKKELIINEILVMR 71

Query: 72  --KHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSY 129
             K+PN+V   +      ++++V+EY+ GG L D + ++  + E +   + ++ +  + +
Sbjct: 72  ENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTD-VVTETCMDEGQIAAVCRECLQALDF 130

Query: 130 CHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLA 189
            H+  V HRD+K +NILL   G++K++DFG  A  Q   +     T  G+P ++APEV+ 
Sbjct: 131 LHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCA--QITPEQSKRSTMVGTPYWMAPEVVT 188

Query: 190 NRGYDGATSDIWSCGVI 206
            + Y G   DIWS G++
Sbjct: 189 RKAY-GPKVDIWSLGIM 204

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 91.0 bits (226), Expect = 3e-20
 Identities = 66/205 (32%), Positives = 101/205 (49%), Gaps = 21/205 (10%)

Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
           RY++   +G+G++G V  A D  +G   A+K +  +   H+    +I REI  L+LL+HP
Sbjct: 1   RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKI-NDVFEHVSDATRILREIKLLRLLRHP 59

Query: 75  NVVRLHEVLASKSK-----IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSY 129
           ++V +  ++   S+     IY+V E +   +L   I +   L     +    QL+  + Y
Sbjct: 60  DIVEIKHIMLPPSRREFKDIYVVFE-LMESDLHQVIKANDDLTPEHHQFFLYQLLRALKY 118

Query: 130 CHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYV------ 183
            H   VFHRDLK +NIL ++   +KI DFGL+ +   F D     T     +YV      
Sbjct: 119 IHTANVFHRDLKPKNILANADCKLKICDFGLARV--AFNDTP---TAIFWTDYVATRWYR 173

Query: 184 APEVLANRGYDGATS--DIWSCGVI 206
           APE L    +   T   DIWS G I
Sbjct: 174 APE-LCGSFFSKYTPAIDIWSIGCI 197

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 90.9 bits (225), Expect = 3e-20
 Identities = 78/268 (29%), Positives = 126/268 (47%), Gaps = 30/268 (11%)

Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEK--NRIIHLKITDQIKREIATLKLLK 72
           RY+    +G G +G V  A D       AVK L +    +IH + T    RE+  LK +K
Sbjct: 16  RYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRT---YRELRLLKHMK 72

Query: 73  HPNVVRLHEVLASK------SKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDG 126
           H NV+ L +V          +++Y+V   + G +L + I    +L +   + L  QL+ G
Sbjct: 73  HENVIGLLDVFTPATSIENFNEVYLVTN-LMGADL-NNIVKCQKLSDEHVQFLIYQLLRG 130

Query: 127 VSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPE 186
           + Y H+ G+ HRDLK  N+ ++    ++I DFGL+      + D  +     +  Y APE
Sbjct: 131 LKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLAR-----QADDEMTGYVATRWYRAPE 185

Query: 187 VLANRGYDGATSDIWSCGVILYIFRGDFKLPKWLSPGAQNL--LRKILE----PNPVKRI 240
           ++ N  +   T DIWS G I+     +    K L PG   +  L++I+E    P+P    
Sbjct: 186 IMLNWMHYNQTVDIWSVGCIM----AELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLK 241

Query: 241 TIAGIKADEWFEQDYTPANPDDDEEDIF 268
            I+   A ++ +    P  P  D + IF
Sbjct: 242 KISSEHARKYIQS--LPHMPQQDLKKIF 267

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 89.1 bits (221), Expect = 4e-20
 Identities = 62/207 (29%), Positives = 100/207 (48%), Gaps = 18/207 (8%)

Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPF-AVK-------ILEKNRIIHLKITDQIKREIAT 67
           Y +   LG G FG V   +  ++G    A+K          K++    K    I  E+  
Sbjct: 2   YAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTI 61

Query: 68  LK-LLKHPNVVRLHEVLASKSKIYMVLEYVTG---GELFDKIASKG-RLQEAEGRKLFQQ 122
           +K  L+HPN+VR ++      ++Y+V++ + G   GE F+ +  K  R  E     +F Q
Sbjct: 62  IKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQ 121

Query: 123 LIDGVSYCHN-KGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPN 181
           ++  + Y H  K + HRDL   NI+L     + I+DFGL+   Q    +  L +  G+  
Sbjct: 122 MVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQ---PESKLTSVVGTIL 178

Query: 182 YVAPEVLANRGYDGATSDIWSCGVILY 208
           Y  PE++ N  Y G  +D+W+ G ILY
Sbjct: 179 YSCPEIVKNEPY-GEKADVWAFGCILY 204

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 90.1 bits (224), Expect = 5e-20
 Identities = 60/208 (28%), Positives = 94/208 (45%), Gaps = 26/208 (12%)

Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIH----LKITDQIKREIATLKL 70
           RY+    +G G +G V  A D  SG   A+K     +I H      +  +  RE+  L+ 
Sbjct: 6   RYKPIENIGSGAYGVVCSAIDTRSGKKVAIK-----KIPHAFDVPTLAKRTLRELKILRH 60

Query: 71  LKHPNVVRLHEVLASKSK----IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDG 126
            KH N++ + ++L         +Y+V++ +   +L   I S   L E   R    QL+ G
Sbjct: 61  FKHDNIIAIRDILRPPGADFKDVYVVMD-LMESDLHHIIHSDQPLTEEHIRYFLYQLLRG 119

Query: 127 VSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYV--- 183
           + Y H+  V HRDLK  N+L++    ++I DFG++        +     T     YV   
Sbjct: 120 LKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMT----EYVATR 175

Query: 184 ---APEVL-ANRGYDGATSDIWSCGVIL 207
              APE+L +   Y  A  D+WS G I 
Sbjct: 176 WYRAPELLLSLPEYTTAI-DMWSVGCIF 202

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 89.0 bits (220), Expect = 7e-20
 Identities = 55/199 (27%), Positives = 106/199 (53%), Gaps = 21/199 (10%)

Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL--- 71
           +Y     +G+G  G V  A D+ +G   A++         + +  Q K+E+   ++L   
Sbjct: 21  KYTRFEKIGQGASGTVYTAMDVATGQEVAIR--------QMNLQQQPKKELIINEILVMR 72

Query: 72  --KHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSY 129
             K+PN+V   +      ++++V+EY+ GG L D + ++  + E +   + ++ +  + +
Sbjct: 73  ENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTD-VVTETCMDEGQIAAVCRECLQALEF 131

Query: 130 CHNKGVFHRDLKLENILLDSKGNIKISDFGLSA--LPQHFRDDGLLHTTCGSPNYVAPEV 187
            H+  V HRD+K +NILL   G++K++DFG  A   P+  +   ++    G+P ++APEV
Sbjct: 132 LHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV----GTPYWMAPEV 187

Query: 188 LANRGYDGATSDIWSCGVI 206
           +  + Y G   DIWS G++
Sbjct: 188 VTRKAY-GPKVDIWSLGIM 205

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 90.9 bits (225), Expect = 8e-20
 Identities = 63/217 (29%), Positives = 103/217 (47%), Gaps = 27/217 (12%)

Query: 13  LGRYELGRTLGEGNFGKV---------------KFAQDLDSGLPFAVKILEKNRIIHLKI 57
           L  + +   L  G FGK+               +     + G P   +++ K      + 
Sbjct: 147 LAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRA 206

Query: 58  TDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMV---LEYVTGGELFDK-IASKGRLQE 113
             Q++ EI  L  L H N++++ E+L S++  YM+    ++     ++D+    K R   
Sbjct: 207 AIQLENEILALGRLNHENILKIEEILRSEANTYMITQKYDFDLYSFMYDEAFDWKDRPLL 266

Query: 114 AEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSAL---PQHFRDD 170
            + R + +QL+  V Y H+K + HRD+KLENI L+  G I + DFG +      +   D 
Sbjct: 267 KQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKEREAFDY 326

Query: 171 GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVIL 207
           G + T   +    +PE+LA  GY   T DIWSCG+IL
Sbjct: 327 GWVGTVATN----SPEILAGDGYCEIT-DIWSCGLIL 358

Length = 501

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 88.5 bits (219), Expect = 8e-20
 Identities = 73/220 (33%), Positives = 108/220 (49%), Gaps = 30/220 (13%)

Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFA----VKILEKNRIIHLKITDQIKREIATLKL 70
           +YE    +GEG +GKV  A+DL +G  F     V++      + L       RE+A L+ 
Sbjct: 2   QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTI----REVAVLRH 57

Query: 71  LK---HPNVVRLHEVLA-----SKSKIYMVLEYVTGG--ELFDKIASKGRLQEAEGRKLF 120
           L+   HPNVVRL +V        ++K+ +V E+V        DK+   G   E   + + 
Sbjct: 58  LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETI-KDMM 116

Query: 121 QQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP 180
            QL+ G+ + H+  V HRDLK +NIL+ S G IK++DFGL+ +   +     L +   + 
Sbjct: 117 FQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARI---YSFQMALTSVVVTL 173

Query: 181 NYVAPEVLANRGYDGATSDIWSCGVILY-------IFRGD 213
            Y APEVL    Y     D+WS G I         +FRG 
Sbjct: 174 WYRAPEVLLQSSY-ATPVDLWSVGCIFAEMFRRKPLFRGS 212

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 89.3 bits (222), Expect = 8e-20
 Identities = 92/319 (28%), Positives = 136/319 (42%), Gaps = 65/319 (20%)

Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
           RY+    +GEG +G V  A    +G+  A+K +      H     +  REI  L+  KH 
Sbjct: 6   RYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISP--FEHQTFCQRTLREIKILRRFKHE 63

Query: 75  NVVRLHEVLASKS-----KIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSY 129
           N++ + +++   S      +Y+V E +   +L+  I ++  L     +    Q++ G+ Y
Sbjct: 64  NIIGILDIIRPPSFESFNDVYIVQELMET-DLYKLIKTQ-HLSNDHIQYFLYQILRGLKY 121

Query: 130 CHNKGVFHRDLKLENILLDSKGNIKISDFGL--SALPQHFRDDGLLHTTCGSPNYVAPEV 187
            H+  V HRDLK  N+LL++  ++KI DFGL   A P+H    G L     +  Y APE+
Sbjct: 122 IHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEH-DHTGFLTEYVATRWYRAPEI 180

Query: 188 -LANRGYDGATSDIWSCGVILY-------IFRG--------------------DFK---- 215
            L ++GY  A  DIWS G IL        +F G                    D      
Sbjct: 181 MLNSKGYTKAI-DIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCIIS 239

Query: 216 ---------LP-------KWLSPGAQN----LLRKILEPNPVKRITIAGIKADEWFEQDY 255
                    LP         L P A      LL K+L  NP KRIT+    A  + EQ +
Sbjct: 240 LRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYH 299

Query: 256 TPANPDDDEEDIFVDNEAF 274
            P++    EE    D E F
Sbjct: 300 DPSDEPVAEEPFPFDFELF 318

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 89.5 bits (222), Expect = 8e-20
 Identities = 60/200 (30%), Positives = 103/200 (51%), Gaps = 10/200 (5%)

Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
           +E+ + +G G FG+V   +  ++G  +A+KIL K  ++    T   + E   L       
Sbjct: 3   FEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRW 62

Query: 76  VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKG-RLQEAEGRKLFQQLIDGVSYCHNKG 134
           +  LH     ++ +Y+V++Y  GG+L   ++    RL E   R    +++  +   H  G
Sbjct: 63  ITNLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLG 122

Query: 135 VFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTT--CGSPNYVAPEVLA--- 189
             HRD+K +N+LLD  G+I+++DFG S L      DG + +    G+P+Y++PE+L    
Sbjct: 123 YVHRDIKPDNVLLDKNGHIRLADFG-SCL--RLLADGTVQSNVAVGTPDYISPEILQAME 179

Query: 190 -NRGYDGATSDIWSCGVILY 208
             +G  G   D WS GV +Y
Sbjct: 180 DGKGRYGPECDWWSLGVCMY 199

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 88.1 bits (218), Expect = 1e-19
 Identities = 78/257 (30%), Positives = 116/257 (45%), Gaps = 32/257 (12%)

Query: 20  RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRL 79
           R LG+G FG+V   Q   +G  +A K LEK RI   K       E   L+ +    VV L
Sbjct: 6   RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSL 65

Query: 80  HEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLF--QQLIDGVSYCHNKGVFH 137
                +K  + +VL  + GG+L   I + G     E R +F   +L  G+     + + +
Sbjct: 66  AYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVY 125

Query: 138 RDLKLENILLDSKGNIKISDFGLSA-LPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGA 196
           RDLK ENILLD +G+I+ISD GL+  +P+     G +    G+  Y+APEV+ N  Y   
Sbjct: 126 RDLKPENILLDDRGHIRISDLGLAVQIPEGETVRGRV----GTVGYMAPEVINNEKY-TF 180

Query: 197 TSDIWSCGVILY-------IFRGDFKLPKW-----------------LSPGAQNLLRKIL 232
           + D W  G ++Y        FR   +  K                   S  A+++ R +L
Sbjct: 181 SPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEEYSEKFSEDAKSICRMLL 240

Query: 233 EPNPVKRITIAGIKADE 249
             NP +R+   G  A  
Sbjct: 241 TKNPKERLGCRGNGAAG 257

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 88.2 bits (218), Expect = 1e-19
 Identities = 51/150 (34%), Positives = 86/150 (57%), Gaps = 10/150 (6%)

Query: 63  REIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQ- 121
           RE++ LK LKH N+V LH+++ ++  + +V EY+   +L   + + G L      K+F  
Sbjct: 52  REVSLLKNLKHANIVTLHDIIHTERCLTLVFEYLDS-DLKQYLDNCGNLMSMHNVKIFMF 110

Query: 122 QLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLS---ALPQHFRDDGLLHTTCG 178
           QL+ G+SYCH + + HRDLK +N+L++ KG +K++DFGL+   ++P     + ++     
Sbjct: 111 QLLRGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVV----- 165

Query: 179 SPNYVAPEVLANRGYDGATSDIWSCGVILY 208
           +  Y  P+VL          D+W  G ILY
Sbjct: 166 TLWYRPPDVLLGSTEYSTPIDMWGVGCILY 195

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 88.6 bits (219), Expect = 1e-19
 Identities = 60/190 (31%), Positives = 98/190 (51%), Gaps = 12/190 (6%)

Query: 20  RTLGEGNFGKVKFAQDLDSGLPFAVKILE-KNRIIHLKITDQIKREIATLKLLKHPNVVR 78
           R +G G+FG V FA+D+ +    A+K +    +  + K  D IK E+  L+ L+HPN ++
Sbjct: 21  REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIK-EVRFLQKLRHPNTIQ 79

Query: 79  LHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHR 138
                  +   ++V+EY  G         K  LQE E   +    + G++Y H+  + HR
Sbjct: 80  YRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHR 139

Query: 139 DLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVL--ANRG-YDG 195
           D+K  NILL   G +K+ DFG +++          +   G+P ++APEV+   + G YDG
Sbjct: 140 DVKAGNILLSEPGLVKLGDFGSASIMAP------ANXFVGTPYWMAPEVILAMDEGQYDG 193

Query: 196 ATSDIWSCGV 205
              D+WS G+
Sbjct: 194 KV-DVWSLGI 202

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 87.6 bits (217), Expect = 2e-19
 Identities = 73/203 (35%), Positives = 105/203 (51%), Gaps = 25/203 (12%)

Query: 20  RTLGEGNFGKVKF-----AQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
           R LGEG+FGKV       A D  +G   AVK L++        T   K+EI  LK L H 
Sbjct: 10  RVLGEGHFGKVSLYCYDPAND-GTGEMVAVKTLKRECGQQN--TSGWKKEINILKTLYHE 66

Query: 75  NVVRLHEVLASKSK--IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHN 132
           N+V+     + +    + +++EYV  G L D +  K +L  A+     QQ+ +G++Y H+
Sbjct: 67  NIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYL-PKHKLNLAQLLLFAQQICEGMAYLHS 125

Query: 133 KGVFHRDLKLENILLDSKGNIKISDFGLS-ALPQ-----HFRDDGLLHTTCGSPNY-VAP 185
           +   HRDL   N+LLD+   +KI DFGL+ A+P+       R+DG       SP +  A 
Sbjct: 126 QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDG------DSPVFWYAV 179

Query: 186 EVLANRGYDGATSDIWSCGVILY 208
           E L    +  A SD+WS GV LY
Sbjct: 180 ECLKENKFSYA-SDVWSFGVTLY 201

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 87.9 bits (218), Expect = 2e-19
 Identities = 64/199 (32%), Positives = 105/199 (52%), Gaps = 20/199 (10%)

Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKN-RIIHLKITDQIKREIATLKLLKH 73
            +   R +G G+FG V FA+D+ +    A+K +  + +  + K  D IK E+  L+ L+H
Sbjct: 16  LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIK-EVRFLQQLRH 74

Query: 74  PNVVRLHEVLASKSKIYMVLEYVTG--GELFDKIASKGRLQEAEGRKLFQQLIDGVSYCH 131
           PN +        +   ++V+EY  G   ++ +    K  LQE E   +    + G++Y H
Sbjct: 75  PNTIEYKGCYLREHTAWLVMEYCLGSASDILE--VHKKPLQEVEIAAICHGALQGLAYLH 132

Query: 132 NKGVFHRDLKLENILLDSKGNIKISDFGLSAL--PQHFRDDGLLHTTCGSPNYVAPEV-L 188
           +    HRD+K  NILL   G +K++DFG ++L  P         ++  G+P ++APEV L
Sbjct: 133 SHERIHRDIKAGNILLTEPGTVKLADFGSASLVSPA--------NSFVGTPYWMAPEVIL 184

Query: 189 A-NRG-YDGATSDIWSCGV 205
           A + G YDG   D+WS G+
Sbjct: 185 AMDEGQYDGKV-DVWSLGI 202

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 87.8 bits (217), Expect = 2e-19
 Identities = 63/205 (30%), Positives = 109/205 (53%), Gaps = 19/205 (9%)

Query: 14  GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKH 73
           G +EL   +G G +G+V   + + +G   A+K+++    +     ++IK EI  LK   H
Sbjct: 16  GIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMD----VTEDEEEEIKLEINMLKKYSH 71

Query: 74  -PNVVRLHEVLASKS------KIYMVLEYVTGGELFDKIA-SKGR-LQEAEGRKLFQQLI 124
             N+   +     KS      ++++V+E+   G + D +  +KG  L+E     + ++++
Sbjct: 72  HRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREIL 131

Query: 125 DGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVA 184
            G+++ H   V HRD+K +N+LL     +K+ DFG+SA  Q  R  G  +T  G+P ++A
Sbjct: 132 RGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSA--QLDRTVGRRNTFIGTPYWMA 189

Query: 185 PEVLANRGYDGAT----SDIWSCGV 205
           PEV+A      AT    SDIWS G+
Sbjct: 190 PEVIACDENPDATYDYRSDIWSLGI 214

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 87.4 bits (216), Expect = 2e-19
 Identities = 56/185 (30%), Positives = 101/185 (54%), Gaps = 8/185 (4%)

Query: 22  LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHE 81
           +G+G+FG+V    D  +    A+KI++       +I D I++EI  L     P V + + 
Sbjct: 12  IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA-EDEIED-IQQEITVLSQCDSPYVTKYYG 69

Query: 82  VLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLK 141
                +K+++++EY+ GG   D +   G L E +   + ++++ G+ Y H++   HRD+K
Sbjct: 70  SYLKDTKLWIIMEYLGGGSALD-LLEPGPLDETQIATILREILKGLDYLHSEKKIHRDIK 128

Query: 142 LENILLDSKGNIKISDFGLSALPQHFRDDGLLHTT-CGSPNYVAPEVLANRGYDGATSDI 200
             N+LL   G +K++DFG++       D  +   T  G+P ++APEV+    YD + +DI
Sbjct: 129 AANVLLSEHGEVKLADFGVAG---QLTDTQIKRNTFVGTPFWMAPEVIKQSAYD-SKADI 184

Query: 201 WSCGV 205
           WS G+
Sbjct: 185 WSLGI 189

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 89.7 bits (222), Expect = 2e-19
 Identities = 66/210 (31%), Positives = 99/210 (47%), Gaps = 36/210 (17%)

Query: 62  KREIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRL------QEAE 115
           + E+  L    H  +V+  +   S  K+ +++EY +GG+L  +I  K RL      QE E
Sbjct: 113 RSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQI--KQRLKEHLPFQEYE 170

Query: 116 GRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLL-- 173
              LF Q++  +   H++ + HRDLK  NI L   G IK+ DFG S   + + D   L  
Sbjct: 171 VGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFS---KQYSDSVSLDV 227

Query: 174 -HTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILY--------------------IFRG 212
             + CG+P Y+APE+   + Y    +D+WS GVILY                    +  G
Sbjct: 228 ASSFCGTPYYLAPELWERKRYS-KKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYG 286

Query: 213 DFK-LPKWLSPGAQNLLRKILEPNPVKRIT 241
            +   P  +S G + LL  +L  NP  R T
Sbjct: 287 KYDPFPCPVSSGMKALLDPLLSKNPALRPT 316

Length = 478

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 87.4 bits (216), Expect = 2e-19
 Identities = 55/185 (29%), Positives = 103/185 (55%), Gaps = 8/185 (4%)

Query: 22  LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHE 81
           +G+G+FG+V    D  +    A+KI++       +I D I++EI  L     P V + + 
Sbjct: 12  IGKGSFGEVFKGIDNRTQQVVAIKIIDLEEA-EDEIED-IQQEITVLSQCDSPYVTKYYG 69

Query: 82  VLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLK 141
                +K+++++EY+ GG   D + + G   E +   + ++++ G+ Y H++   HRD+K
Sbjct: 70  SYLKGTKLWIIMEYLGGGSALDLLRA-GPFDEFQIATMLKEILKGLDYLHSEKKIHRDIK 128

Query: 142 LENILLDSKGNIKISDFGLSALPQHFRDDGLLHTT-CGSPNYVAPEVLANRGYDGATSDI 200
             N+LL  +G++K++DFG++       D  +   T  G+P ++APEV+    YD + +DI
Sbjct: 129 AANVLLSEQGDVKLADFGVAG---QLTDTQIKRNTFVGTPFWMAPEVIQQSAYD-SKADI 184

Query: 201 WSCGV 205
           WS G+
Sbjct: 185 WSLGI 189

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 87.8 bits (217), Expect = 3e-19
 Identities = 58/200 (29%), Positives = 102/200 (51%), Gaps = 10/200 (5%)

Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
           +E+ + +G G FG+V   +   +   +A+KIL K  ++    T   + E   L       
Sbjct: 3   FEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQW 62

Query: 76  VVRLHEVLASKSKIYMVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKG 134
           +  LH     ++ +Y+V++Y  GG+L   ++  + RL E   R    +++  +   H   
Sbjct: 63  ITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLH 122

Query: 135 VFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTT--CGSPNYVAPEVLA--- 189
             HRD+K +N+LLD  G+I+++DFG S L  +   DG + ++   G+P+Y++PE+L    
Sbjct: 123 YVHRDIKPDNVLLDMNGHIRLADFG-SCLKMN--QDGTVQSSVAVGTPDYISPEILQAME 179

Query: 190 -NRGYDGATSDIWSCGVILY 208
              G  G   D WS GV +Y
Sbjct: 180 DGMGKYGPECDWWSLGVCMY 199

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 87.4 bits (216), Expect = 4e-19
 Identities = 76/269 (28%), Positives = 124/269 (46%), Gaps = 30/269 (11%)

Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEK--NRIIHLKITDQIKREIATLKLLK 72
           RY+    +G G +G V  A D  +GL  AVK L +    IIH K T    RE+  LK +K
Sbjct: 18  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRT---YRELRLLKHMK 74

Query: 73  HPNVVRLHEVLASKSK------IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDG 126
           H NV+ L +V            +Y+V  ++ G +L + I    +L +   + L  Q++ G
Sbjct: 75  HENVIGLLDVFTPARSLEEFNDVYLV-THLMGADL-NNIVKCQKLTDDHVQFLIYQILRG 132

Query: 127 VSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPE 186
           + Y H+  + HRDLK  N+ ++    +KI DFGL+   +H  D+  +     +  Y APE
Sbjct: 133 LKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA---RHTDDE--MTGYVATRWYRAPE 187

Query: 187 VLANRGYDGATSDIWSCGVILYIFRGDFKLPKWLSPGA------QNLLRKILEPNPVKRI 240
           ++ N  +   T DIWS G I+     +    + L PG       + +LR +  P      
Sbjct: 188 IMLNWMHYNQTVDIWSVGCIM----AELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLK 243

Query: 241 TIAGIKADEWFEQDYTPANPDDDEEDIFV 269
            I+   A  + +       P  +  ++F+
Sbjct: 244 KISSESARNYIQS--LTQMPKMNFANVFI 270

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 86.7 bits (214), Expect = 5e-19
 Identities = 57/189 (30%), Positives = 97/189 (51%), Gaps = 10/189 (5%)

Query: 20  RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRL 79
           R +G G+FG V FA+D+ +    A+K +  +     +    I +E+  L+ +KHPN +  
Sbjct: 31  REIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEY 90

Query: 80  HEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRD 139
                 +   ++V+EY  G         K  LQE E   +    + G++Y H+  + HRD
Sbjct: 91  KGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRD 150

Query: 140 LKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVL--ANRG-YDGA 196
           +K  NILL   G +K++DFG +++          ++  G+P ++APEV+   + G YDG 
Sbjct: 151 IKAGNILLTEPGQVKLADFGSASIASP------ANSFVGTPYWMAPEVILAMDEGQYDGK 204

Query: 197 TSDIWSCGV 205
             D+WS G+
Sbjct: 205 V-DVWSLGI 212

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 85.9 bits (213), Expect = 6e-19
 Identities = 59/214 (27%), Positives = 98/214 (45%), Gaps = 32/214 (14%)

Query: 17  ELGRTLGEGNFGKV-----KFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL 71
            L R LG+G+FG V     K     +     A+K + +N  +  +I  +   E + +K  
Sbjct: 9   TLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERI--EFLNEASVMKEF 66

Query: 72  KHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGR--------KLFQ-- 121
              +VVRL  V+++     +V+E +  G+L   + S+ R +             K  Q  
Sbjct: 67  NCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSR-RPEAENNPGLGPPTLQKFIQMA 125

Query: 122 -QLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSAL---PQHFRDDG--LLHT 175
            ++ DG++Y   K   HRDL   N ++     +KI DFG++       ++R  G  LL  
Sbjct: 126 AEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLL-- 183

Query: 176 TCGSP-NYVAPEVLANRGYDGATSDIWSCGVILY 208
               P  ++APE L + G     SD+WS GV+L+
Sbjct: 184 ----PVRWMAPESLKD-GVFTTKSDVWSFGVVLW 212

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 86.2 bits (213), Expect = 7e-19
 Identities = 60/188 (31%), Positives = 95/188 (50%), Gaps = 12/188 (6%)

Query: 22  LGEGNFGKVKFAQDLDSGLPFAVKILE-KNRIIHLKITDQIKREIATLKLLKHPNVVRLH 80
           +G G+FG V FA +  +    AVK +    +  + K  D IK E+  L+ LKHPN +   
Sbjct: 29  IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIK-EVKFLQQLKHPNTIEYK 87

Query: 81  EVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDL 140
                +   ++V+EY  G         K  LQE E   +    + G++Y H+  + HRD+
Sbjct: 88  GCYLKEHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDI 147

Query: 141 KLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVL--ANRG-YDGAT 197
           K  NILL   G +K++DFG ++           ++  G+P ++APEV+   + G YDG  
Sbjct: 148 KAGNILLTEPGQVKLADFGSASKSSP------ANSFVGTPYWMAPEVILAMDEGQYDGKV 201

Query: 198 SDIWSCGV 205
            D+WS G+
Sbjct: 202 -DVWSLGI 208

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 86.7 bits (215), Expect = 8e-19
 Identities = 81/283 (28%), Positives = 128/283 (45%), Gaps = 52/283 (18%)

Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK-- 72
           RYEL + LG+G +G V  A++ ++     V I +   +   KI    KR +  LKLL+  
Sbjct: 1   RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKIL--AKRALRELKLLRHF 58

Query: 73  --HPNVVRLHE---VLASK-SKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDG 126
             H N+  L++   V     +++Y+  E +   +L   I S   L +A  +    Q++ G
Sbjct: 59  RGHKNITCLYDMDIVFPGNFNELYLYEELMEA-DLHQIIRSGQPLTDAHFQSFIYQILCG 117

Query: 127 VSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSA--LPQHFRDDGLLHTTCGSPNYVA 184
           + Y H+  V HRDLK  N+L+++   +KI DFGL+         + G +     +  Y A
Sbjct: 118 LKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVATRWYRA 177

Query: 185 PEV-LANRGYDGATSDIWSCGVILY-------IFRG-DF-----------------KLPK 218
           PE+ L+ + Y  A  D+WS G IL        +F+G D+                  L +
Sbjct: 178 PEIMLSFQSYTKAI-DVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSR 236

Query: 219 WLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPANPD 261
             SP AQN +R +  PN  K+           FE  +  ANP 
Sbjct: 237 IGSPKAQNYIRSL--PNIPKKP----------FESIFPNANPL 267

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 85.6 bits (212), Expect = 1e-18
 Identities = 66/192 (34%), Positives = 100/192 (52%), Gaps = 18/192 (9%)

Query: 22  LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKIT----DQIKREIATLKLLKHPNVV 77
           LG GN G V       SGL  A K+      IHL+I     +QI RE+  L     P +V
Sbjct: 9   LGAGNGGVVTKVLHRPSGLIMARKL------IHLEIKPAIRNQIIRELKVLHECNSPYIV 62

Query: 78  RLHEVLASKSKIYMVLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNK-GV 135
             +    S  +I + +E++ GG L D++  K GR+ E    K+   ++ G++Y   K  +
Sbjct: 63  GFYGAFYSDGEISICMEHMDGGSL-DQVLKKAGRIPENILGKISIAVLRGLTYLREKHKI 121

Query: 136 FHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDG 195
            HRD+K  NIL++S+G IK+ DFG+S        D + ++  G+ +Y++PE L    Y  
Sbjct: 122 MHRDVKPSNILVNSRGEIKLCDFGVSGQLI----DSMANSFVGTRSYMSPERLQGTHY-T 176

Query: 196 ATSDIWSCGVIL 207
             SDIWS G+ L
Sbjct: 177 VQSDIWSLGLSL 188

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 85.1 bits (210), Expect = 1e-18
 Identities = 63/205 (30%), Positives = 110/205 (53%), Gaps = 19/205 (9%)

Query: 14  GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKH 73
           G +EL   +G G +G+V   + + +G   A+K+++    +     ++IK+EI  LK   H
Sbjct: 6   GIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMD----VTGDEEEEIKQEINMLKKYSH 61

Query: 74  -PNVVRLHEVLASKS------KIYMVLEYVTGGELFDKIA-SKGR-LQEAEGRKLFQQLI 124
             N+   +     K+      ++++V+E+   G + D I  +KG  L+E     + ++++
Sbjct: 62  HRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREIL 121

Query: 125 DGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVA 184
            G+S+ H   V HRD+K +N+LL     +K+ DFG+SA  Q  R  G  +T  G+P ++A
Sbjct: 122 RGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSA--QLDRTVGRRNTFIGTPYWMA 179

Query: 185 PEVLANRGYDGAT----SDIWSCGV 205
           PEV+A      AT    SD+WS G+
Sbjct: 180 PEVIACDENPDATYDFKSDLWSLGI 204

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 85.5 bits (211), Expect = 1e-18
 Identities = 65/215 (30%), Positives = 113/215 (52%), Gaps = 10/215 (4%)

Query: 22  LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHE 81
           +GEG+ G V  A    SG   AVK ++  +    +  + +  E+  ++  +H NVV ++ 
Sbjct: 28  IGEGSTGIVCIATVKSSGKLVAVKKMDLRK---QQRRELLFNEVVIMRDYQHENVVEMYN 84

Query: 82  VLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLK 141
                 ++++V+E++ GG L D I +  R+ E +   +   ++  +S  H +GV HRD+K
Sbjct: 85  SYLVGDELWVVMEFLEGGALTD-IVTHTRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIK 143

Query: 142 LENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIW 201
            ++ILL   G +K+SDFG  A  Q  ++     +  G+P ++APE+++   Y G   DIW
Sbjct: 144 SDSILLTHDGRVKLSDFGFCA--QVSKEVPRRKSLVGTPYWMAPELISRLPY-GPEVDIW 200

Query: 202 SCGVILYIFRGDFKLPKWLSP--GAQNLLRKILEP 234
           S G I+ I   D + P +  P   A  ++R  L P
Sbjct: 201 SLG-IMVIEMVDGEPPYFNEPPLKAMKMIRDNLPP 234

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 84.9 bits (210), Expect = 2e-18
 Identities = 75/267 (28%), Positives = 119/267 (44%), Gaps = 40/267 (14%)

Query: 22  LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHE 81
           LG+G FG+V   Q   +G  +A K L K R+   K  +    E   L  +    +V L  
Sbjct: 1   LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAY 60

Query: 82  VLASKSKIYMVLEYVTGGELFDKIASKGRLQEA--EGRKLF--QQLIDGVSYCHNKGVFH 137
              +K+ + +V+  + GG+L   I +         E R  F   Q+I G+ + H + + +
Sbjct: 61  AFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIY 120

Query: 138 RDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTT--CGSPNYVAPEVLANRGYDG 195
           RDLK EN+LLD+ GN++ISD GL+   +    DG   T    G+P ++APE+L    YD 
Sbjct: 121 RDLKPENVLLDNDGNVRISDLGLAVELK----DGQSKTKGYAGTPGFMAPELLQGEEYDF 176

Query: 196 ATSDIWSCGVILYIF---RGDFK---------------------LPKWLSPGAQNLLRKI 231
           +  D ++ GV LY     RG F+                      P   SP +++    +
Sbjct: 177 SV-DYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDSVTYPDKFSPASKSFCEAL 235

Query: 232 LEPNPVKRI-----TIAGIKADEWFEQ 253
           L  +P KR+        G++    F  
Sbjct: 236 LAKDPEKRLGFRDGNCDGLRTHPLFRD 262

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 85.8 bits (212), Expect = 2e-18
 Identities = 87/314 (27%), Positives = 131/314 (41%), Gaps = 70/314 (22%)

Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
           RY   + +G G +G V  A D  +G   A+K L +     L    +  RE+  LK +KH 
Sbjct: 16  RYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSEL-FAKRAYRELRLLKHMKHE 74

Query: 75  NVVRLHEVLASKSKI------YMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVS 128
           NV+ L +V      +      Y+V+ ++  G    K+    +L E   + L  Q++ G+ 
Sbjct: 75  NVIGLLDVFTPDLSLDRFHDFYLVMPFM--GTDLGKLMKHEKLSEDRIQFLVYQMLKGLK 132

Query: 129 YCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVL 188
           Y H  G+ HRDLK  N+ ++    +KI DFGL+      + D  +     +  Y APEV+
Sbjct: 133 YIHAAGIIHRDLKPGNLAVNEDCELKILDFGLAR-----QTDSEMTGYVVTRWYRAPEVI 187

Query: 189 ANRGYDGATSDIWSCGVILY-------IFRG-------------------DF-------- 214
            N  +   T DIWS G I+        +F+G                   +F        
Sbjct: 188 LNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQSED 247

Query: 215 ------KLPK-----------WLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQ---- 253
                 KLP+             +P A N+L K+L  +   RIT A   A  +FE+    
Sbjct: 248 AKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFHDP 307

Query: 254 -DYTPANPDDDEED 266
            D T A P DD  D
Sbjct: 308 EDETEAPPYDDSFD 321

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 84.1 bits (208), Expect = 2e-18
 Identities = 63/204 (30%), Positives = 96/204 (47%), Gaps = 19/204 (9%)

Query: 16  YELGRT-------LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATL 68
           +E+ RT       LG G +G+V         L  AVK L+++ +      ++  +E A +
Sbjct: 1   WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME----VEEFLKEAAVM 56

Query: 69  KLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQ---QLID 125
           K +KHPN+V+L  V   +   Y++ E++T G L D +    R QE     L     Q+  
Sbjct: 57  KEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNR-QEVNAVVLLYMATQISS 115

Query: 126 GVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP-NYVA 184
            + Y   K   HRDL   N L+     +K++DFGLS L     D    H     P  + A
Sbjct: 116 AMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG--DTYTAHAGAKFPIKWTA 173

Query: 185 PEVLANRGYDGATSDIWSCGVILY 208
           PE LA   +    SD+W+ GV+L+
Sbjct: 174 PESLAYNKFS-IKSDVWAFGVLLW 196

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score = 84.1 bits (209), Expect = 2e-18
 Identities = 52/198 (26%), Positives = 95/198 (47%), Gaps = 38/198 (19%)

Query: 72  KHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCH 131
            +PN ++L+  + +     ++++Y+  G+LFD +  +G+L EAE +K+ +QL++ ++  H
Sbjct: 67  DNPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLH 126

Query: 132 NKGVFHRDLKLENILLD-SKGNIKISDFGLS---ALPQHFRDDGLLHTTCGSPNYVAPEV 187
              + H D+KLEN+L D +K  I + D+GL      P  +  DG L       +Y +PE 
Sbjct: 127 KHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPSCY--DGTL-------DYFSPEK 177

Query: 188 LANRGYDGATSDIWSCGVILY-IFRG-----------------------DFKLPKWLSPG 223
           +    YD  + D W+ GV+ Y +  G                            K +S  
Sbjct: 178 IKGHNYD-VSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQKKLPFIKNVSKN 236

Query: 224 AQNLLRKILEPNPVKRIT 241
           A + ++ +L+ N   R+T
Sbjct: 237 ANDFVQSMLKYNINYRLT 254

Length = 267

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 83.9 bits (207), Expect = 2e-18
 Identities = 62/201 (30%), Positives = 100/201 (49%), Gaps = 18/201 (8%)

Query: 11  MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQ-IKREIATLK 69
           + L +  LG  +GEG FG V   +    G   AVK       I   +T Q    E A + 
Sbjct: 3   LNLQKLTLGEIIGEGEFGAVLQGEYT--GQKVAVKN------IKCDVTAQAFLEETAVMT 54

Query: 70  LLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGR--LQEAEGRKLFQQLIDGV 127
            L H N+VRL  V+     +Y+V+E ++ G L + + ++GR  +   +  +    + +G+
Sbjct: 55  KLHHKNLVRLLGVILHNG-LYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGM 113

Query: 128 SYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEV 187
            Y  +K + HRDL   NIL+   G  K+SDFGL+ +     D+  L        + APE 
Sbjct: 114 EYLESKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKLPV-----KWTAPEA 168

Query: 188 LANRGYDGATSDIWSCGVILY 208
           L ++ +  + SD+WS GV+L+
Sbjct: 169 LKHKKFS-SKSDVWSYGVLLW 188

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score = 83.5 bits (207), Expect = 3e-18
 Identities = 63/207 (30%), Positives = 98/207 (47%), Gaps = 35/207 (16%)

Query: 20  RTLGEGNFGKVKFAQDLDSG---LPFAVKIL-----EKNRIIHLKITDQIKREIATLKLL 71
           + +G G FG+V   +    G   +  A+K L     +K R+  L        E + +   
Sbjct: 10  KVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFL-------TEASIMGQF 62

Query: 72  KHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLID------ 125
            HPN++RL  V+     + ++ EY+  G L DK      L+E +G+    QL+       
Sbjct: 63  DHPNIIRLEGVVTKSRPVMIITEYMENGSL-DKF-----LRENDGKFTVGQLVGMLRGIA 116

Query: 126 -GVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCG--SP-N 181
            G+ Y       HRDL   NIL++S    K+SDFGLS   +   D    +TT G   P  
Sbjct: 117 SGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLS---RRLEDSEATYTTKGGKIPIR 173

Query: 182 YVAPEVLANRGYDGATSDIWSCGVILY 208
           + APE +A R +  A SD+WS G++++
Sbjct: 174 WTAPEAIAYRKFTSA-SDVWSFGIVMW 199

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 83.4 bits (206), Expect = 4e-18
 Identities = 57/193 (29%), Positives = 103/193 (53%), Gaps = 14/193 (7%)

Query: 20  RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRL 79
           + LG G FG VK+ +        A+K++++  +      D+   E   +  L H  +V+L
Sbjct: 10  KELGTGQFGVVKYGK-WRGQYDVAIKMIKEGSMSE----DEFIEEAKVMMKLSHEKLVQL 64

Query: 80  HEVLASKSKIYMVLEYVTGGELFDKIASKG-RLQEAEGRKLFQQLIDGVSYCHNKGVFHR 138
           + V   +  IY+V EY++ G L + +   G R Q ++  ++ + + +G++Y  +K   HR
Sbjct: 65  YGVCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHR 124

Query: 139 DLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP---NYVAPEVLANRGYDG 195
           DL   N L+D +G +K+SDFGLS   ++  DD    ++ GS     +  PEVL    +  
Sbjct: 125 DLAARNCLVDDQGCVKVSDFGLS---RYVLDDEYT-SSVGSKFPVRWSPPEVLLYSKFS- 179

Query: 196 ATSDIWSCGVILY 208
           + SD+W+ GV+++
Sbjct: 180 SKSDVWAFGVLMW 192

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 83.9 bits (207), Expect = 7e-18
 Identities = 70/212 (33%), Positives = 106/212 (50%), Gaps = 20/212 (9%)

Query: 22  LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKIT----DQIKREIATLKLLKHPNVV 77
           LG GN G V       SGL  A K+      IHL+I     +QI RE+  L     P +V
Sbjct: 13  LGAGNGGVVFKVSHKPSGLIMARKL------IHLEIKPAIRNQIIRELQVLHECNSPYIV 66

Query: 78  RLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNK-GVF 136
             +    S  +I + +E++ GG L   +   GR+ E    K+   +I G++Y   K  + 
Sbjct: 67  GFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIM 126

Query: 137 HRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGA 196
           HRD+K  NIL++S+G IK+ DFG+S        D + ++  G+ +Y++PE L    Y   
Sbjct: 127 HRDVKPSNILVNSRGEIKLCDFGVSGQ----LIDSMANSFVGTRSYMSPERLQGTHYS-V 181

Query: 197 TSDIWSCGVILY-IFRGDFKLPKWLSPGAQNL 227
            SDIWS G+ L  +  G + +P    P A+ L
Sbjct: 182 QSDIWSMGLSLVEMAIGRYPIP---PPDAKEL 210

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 83.1 bits (205), Expect = 7e-18
 Identities = 48/150 (32%), Positives = 83/150 (55%), Gaps = 10/150 (6%)

Query: 63  REIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQ- 121
           RE++ LK LKH N+V LH+++ ++  + +V EY+   +L   +   G        KLF  
Sbjct: 53  REVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNSINMHNVKLFLF 111

Query: 122 QLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLS---ALPQHFRDDGLLHTTCG 178
           QL+ G++YCH + V HRDLK +N+L++ +G +K++DFGL+   ++P     + ++     
Sbjct: 112 QLLRGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVV----- 166

Query: 179 SPNYVAPEVLANRGYDGATSDIWSCGVILY 208
           +  Y  P++L          D+W  G I Y
Sbjct: 167 TLWYRPPDILLGSTDYSTQIDMWGVGCIFY 196

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 83.6 bits (206), Expect = 1e-17
 Identities = 64/191 (33%), Positives = 97/191 (50%), Gaps = 16/191 (8%)

Query: 22  LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKIT----DQIKREIATLKLLKHPNVV 77
           LG GN G V   Q   SGL  A K+      IHL+I     +QI RE+  L     P +V
Sbjct: 13  LGAGNGGVVTKVQHKPSGLIMARKL------IHLEIKPAIRNQIIRELQVLHECNSPYIV 66

Query: 78  RLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNK-GVF 136
             +    S  +I + +E++ GG L   +    R+ E    K+   ++ G++Y   K  + 
Sbjct: 67  GFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQIM 126

Query: 137 HRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGA 196
           HRD+K  NIL++S+G IK+ DFG+S        D + ++  G+ +Y++PE L    Y   
Sbjct: 127 HRDVKPSNILVNSRGEIKLCDFGVSGQ----LIDSMANSFVGTRSYMSPERLQGTHYS-V 181

Query: 197 TSDIWSCGVIL 207
            SDIWS G+ L
Sbjct: 182 QSDIWSMGLSL 192

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score = 85.6 bits (211), Expect = 1e-17
 Identities = 68/229 (29%), Positives = 115/229 (50%), Gaps = 37/229 (16%)

Query: 12  RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL 71
           RL  YE+ + +G G FG+V   +   +   F  K +   R +  +   Q+  E+  ++ L
Sbjct: 11  RLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISY-RGLKEREKSQLVIEVNVMREL 69

Query: 72  KHPNVVRLHEVLASKS--KIYMVLEYVTGGELFDKIASK----GRLQEAEGRKLFQQLID 125
           KH N+VR  +   +K+  K+Y+++E+   G+L   I       G+++E     + +QL+ 
Sbjct: 70  KHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLH 129

Query: 126 GVSYCHN-------KGVFHRDLKLENILLDSK----GNI-------------KISDFGLS 161
            ++YCHN       + V HRDLK +NI L +     G I             KI DFGLS
Sbjct: 130 ALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLS 189

Query: 162 ALPQHFRDDGLLHTTCGSPNYVAPEVLAN--RGYDGATSDIWSCGVILY 208
              ++   + + H+  G+P Y +PE+L +  + YD   SD+W+ G I+Y
Sbjct: 190 ---KNIGIESMAHSCVGTPYYWSPELLLHETKSYDD-KSDMWALGCIIY 234

Length = 1021

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 82.4 bits (204), Expect = 1e-17
 Identities = 54/162 (33%), Positives = 83/162 (51%), Gaps = 34/162 (20%)

Query: 63  REIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQ- 121
           RE + LK LKH N+V LH+++ +K  + +V EY+   +L   +   G        +LF  
Sbjct: 52  REASLLKDLKHANIVTLHDIIHTKKTLTLVFEYLDT-DLKQYMDDCGGGLSMHNVRLFLF 110

Query: 122 QLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLS---ALPQH----------FR 168
           QL+ G++YCH + V HRDLK +N+L+  +G +K++DFGL+   ++P            +R
Sbjct: 111 QLLRGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKTYSNEVVTLWYR 170

Query: 169 -DDGLLHTTCGSPNYVAPEVLANRGYDGATS-DIWSCGVILY 208
             D LL    GS  Y             +TS D+W  G I Y
Sbjct: 171 PPDVLL----GSTEY-------------STSLDMWGVGCIFY 195

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 82.4 bits (203), Expect = 1e-17
 Identities = 60/197 (30%), Positives = 96/197 (48%), Gaps = 14/197 (7%)

Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
           YE    LGEG++  V   +   +G   A+K++          T    RE + LK LKH N
Sbjct: 7   YEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFT--AIREASLLKGLKHAN 64

Query: 76  VVRLHEVLASKSKIYMVLEYVTGG--ELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNK 133
           +V LH+++ +K  + +V EYV     +  DK    G L     +    QL+ G+SY H +
Sbjct: 65  IVLLHDIIHTKETLTLVFEYVHTDLCQYMDK--HPGGLHPENVKLFLFQLLRGLSYIHQR 122

Query: 134 GVFHRDLKLENILLDSKGNIKISDFGLS---ALPQHFRDDGLLHTTCGSPNYVAPEVLAN 190
            + HRDLK +N+L+   G +K++DFGL+   ++P H   + ++     +  Y  P+VL  
Sbjct: 123 YILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNEVV-----TLWYRPPDVLLG 177

Query: 191 RGYDGATSDIWSCGVIL 207
                   D+W  G I 
Sbjct: 178 STEYSTCLDMWGVGCIF 194

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 82.2 bits (203), Expect = 1e-17
 Identities = 71/281 (25%), Positives = 118/281 (41%), Gaps = 54/281 (19%)

Query: 22  LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITD----QIKREIATLKLLKHPNVV 77
           LG+GN+G V       +G+  A+K       I L++ +    QI  E+  L     P +V
Sbjct: 9   LGKGNYGSVYKVLHRPTGVTMAMKE------IRLELDESKFNQIIMELDILHKAVSPYIV 62

Query: 78  RLHEVLASKSKIYMVLEYVTGG---ELFDKIASKGRLQEAEGRKLFQQLIDGVSYC---H 131
             +     +  +YM +EY+  G   +L+    +   + E   R++   ++ G+ +    H
Sbjct: 63  DFYGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEH 122

Query: 132 NKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANR 191
           N  + HRD+K  N+L++  G +K+ DFG+S          L  T  G  +Y+APE + + 
Sbjct: 123 N--IIHRDVKPTNVLVNGNGQVKLCDFGVSGN----LVASLAKTNIGCQSYMAPERIKSG 176

Query: 192 GYDGA-----TSDIWSCGV-ILYIFRGDF-----------------------KLPKWLSP 222
           G +        SD+WS G+ IL +  G +                        LP   S 
Sbjct: 177 GPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPPTLPSGYSD 236

Query: 223 GAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPANPDDD 263
            AQ+ + K L   P +R T A +    W  +     N D D
Sbjct: 237 DAQDFVAKCLNKIPNRRPTYAQLLEHPWLVKY---KNADVD 274

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 83.0 bits (205), Expect = 2e-17
 Identities = 55/195 (28%), Positives = 96/195 (49%), Gaps = 17/195 (8%)

Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
           Y + +TL  G+ G+V  A       P  +KI +K   +          E   L+ + HP+
Sbjct: 68  YTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKGTTL---------IEAMLLQNVNHPS 118

Query: 76  VVRLHEVLASKSKIYMVLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNKG 134
           V+R+ + L S +   MVL + +  +L+  +  +   L   +   + +Q+++G+ Y H + 
Sbjct: 119 VIRMKDTLVSGAITCMVLPHYSS-DLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQR 177

Query: 135 VFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD-GLLHTTCGSPNYVAPEVLANRGY 193
           + HRD+K ENI ++    + I D G +  P       GL     G+    APEVLA   Y
Sbjct: 178 IIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFLGL----AGTVETNAPEVLARDKY 233

Query: 194 DGATSDIWSCGVILY 208
           + + +DIWS G++L+
Sbjct: 234 N-SKADIWSAGIVLF 247

Length = 357

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 82.3 bits (203), Expect = 2e-17
 Identities = 46/150 (30%), Positives = 83/150 (55%), Gaps = 10/150 (6%)

Query: 63  REIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLF-Q 121
           RE++ LK LKH N+V LH+++ +   + +V EY+   +L   +   G +      K+F  
Sbjct: 53  REVSLLKDLKHANIVTLHDIVHTDKSLTLVFEYLDK-DLKQYMDDCGNIMSMHNVKIFLY 111

Query: 122 QLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLS---ALPQHFRDDGLLHTTCG 178
           Q++ G++YCH + V HRDLK +N+L++ +G +K++DFGL+   ++P     + ++     
Sbjct: 112 QILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVV----- 166

Query: 179 SPNYVAPEVLANRGYDGATSDIWSCGVILY 208
           +  Y  P+VL          D+W  G I +
Sbjct: 167 TLWYRPPDVLLGSSEYSTQIDMWGVGCIFF 196

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

 Score = 80.7 bits (199), Expect = 2e-17
 Identities = 61/247 (24%), Positives = 111/247 (44%), Gaps = 50/247 (20%)

Query: 29  KVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSK 88
           KV    D  +   F +K L K        + +  RE  T+     PN+V LH+ + S+  
Sbjct: 8   KVLLVMDTRTQQTFILKGLRK--------SSEYSRERLTIIPHCVPNMVCLHKYIVSEDS 59

Query: 89  IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLD 148
           +++VL++  GG+L+  I+    + E   ++   +++  +   H +G+  RDL   NILLD
Sbjct: 60  VFLVLQHAEGGKLWSHISKFLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLD 119

Query: 149 SKGNIKISDFGLSALPQHFRDDGLLHTTCGSPN----YVAPEVLANRGYDGATS------ 198
            +G+I+++ F        + +   +  +C        Y APEV       G  S      
Sbjct: 120 DRGHIQLTYFS------RWSE---VEDSCDGEAVENMYCAPEV-------GGISEETEAC 163

Query: 199 DIWSCGVILY-IFRG---------------DFKLPKWLSPGAQNLLRKILEPNPVKRITI 242
           D WS G IL+ +  G                  +P+W+S  A++LL+++L+ NP +R+  
Sbjct: 164 DWWSLGAILFELLTGKTLVECHPSGINTHTTLNIPEWVSEEARSLLQQLLQFNPTERLGA 223

Query: 243 AGIKADE 249
                ++
Sbjct: 224 GVAGVED 230

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 81.6 bits (201), Expect = 3e-17
 Identities = 63/221 (28%), Positives = 102/221 (46%), Gaps = 26/221 (11%)

Query: 22  LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIK----REIATLKLLKHPNVV 77
           LGEG++  V       +G   A+K+      I +K  + +     RE + LK LKH N+V
Sbjct: 13  LGEGSYATVYKGISRINGQLVALKV------ISMKTEEGVPFTAIREASLLKGLKHANIV 66

Query: 78  RLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFH 137
            LH+++ +K  +  V EY+        I   G L     R    QL+ G++Y H + + H
Sbjct: 67  LLHDIIHTKETLTFVFEYMHTDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILH 126

Query: 138 RDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPN----YVAPEVLANRGY 193
           RDLK +N+L+   G +K++DFGL+      R   +   T  S      Y  P+VL     
Sbjct: 127 RDLKPQNLLISYLGELKLADFGLA------RAKSIPSQTYSSEVVTLWYRPPDVLLGATD 180

Query: 194 DGATSDIWSCGVI-LYIFRGDFKLPKWLSPGAQNLLRKILE 233
             +  DIW  G I + + +G    P    PG  ++  ++ +
Sbjct: 181 YSSALDIWGAGCIFIEMLQGQ---P--AFPGVSDVFEQLEK 216

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score = 80.2 bits (198), Expect = 4e-17
 Identities = 55/205 (26%), Positives = 96/205 (46%), Gaps = 16/205 (7%)

Query: 18  LGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVV 77
             + LG G FG V   +     +  A+K++ +  +      D    E   +  L HPN+V
Sbjct: 8   FLKELGSGQFGVVHLGKWRGK-IDVAIKMIREGAMSE----DDFIEEAKVMMKLSHPNLV 62

Query: 78  RLHEVLASKSKIYMVLEYVTGGELFDKI-ASKGRLQEAEGRKLFQQLIDGVSYCHNKGVF 136
           +L+ V   +  I++V EY+  G L + +   KG+L       +   + + + Y  + G  
Sbjct: 63  QLYGVCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFI 122

Query: 137 HRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP---NYVAPEVLANRGY 193
           HRDL   N L+     +K+SDFGL+   ++  DD    +  G+     +  PEV  +   
Sbjct: 123 HRDLAARNCLVGEDNVVKVSDFGLA---RYVLDDQYTSSQ-GTKFPVKWAPPEVF-DYSR 177

Query: 194 DGATSDIWSCGVILY-IFRGDFKLP 217
             + SD+WS GV+++ +F    K+P
Sbjct: 178 FSSKSDVWSFGVLMWEVFSEG-KMP 201

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 80.4 bits (198), Expect = 5e-17
 Identities = 65/235 (27%), Positives = 114/235 (48%), Gaps = 16/235 (6%)

Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
           ++E+   +GEG +G V   +  ++    A+K   K+   + ++ +   RE+  L+ LK  
Sbjct: 2   KFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKF-KDSEENEEVKETTLRELKMLRTLKQE 60

Query: 75  NVVRLHEVLASKSKIYMVLEYVTGG--ELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHN 132
           N+V L E    + K+Y+V EYV     EL +++ + G   E + R    QLI  + +CH 
Sbjct: 61  NIVELKEAFRRRGKLYLVFEYVEKNMLELLEEMPN-GVPPE-KVRSYIYQLIKAIHWCHK 118

Query: 133 KGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRG 192
             + HRD+K EN+L+     +K+ DFG +       +         +  Y +PE+L    
Sbjct: 119 NDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYV-ATRWYRSPELLLGAP 177

Query: 193 YDGATSDIWSCGVILYIFRGDFKLPKWLSPGAQNL-----LRKILEPNPVKRITI 242
           Y G   D+WS G IL    G+    + L PG   +     ++K+L P P +++ +
Sbjct: 178 Y-GKAVDMWSVGCIL----GELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKL 227

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 79.7 bits (196), Expect = 7e-17
 Identities = 62/213 (29%), Positives = 101/213 (47%), Gaps = 14/213 (6%)

Query: 17  ELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNV 76
           +L + LG G FG+V      ++    AVK L+   +           E   +K L+H  +
Sbjct: 9   KLVKKLGAGQFGEVWMGY-YNNSTKVAVKTLKPGTMS----VQAFLEEANLMKTLQHDKL 63

Query: 77  VRLHEVLASKSKIYMVLEYVTGGELFDKIASK--GRLQEAEGRKLFQQLIDGVSYCHNKG 134
           VRL+ V+  +  IY++ EY+  G L D + S   G++   +      Q+ +G++Y   K 
Sbjct: 64  VRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKN 123

Query: 135 VFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP-NYVAPEVLANRGY 193
             HRDL+  N+L+      KI+DFGL+ + +   ++         P  + APE + N G 
Sbjct: 124 YIHRDLRAANVLVSESLMCKIADFGLARVIED--NEYTAREGAKFPIKWTAPEAI-NFGS 180

Query: 194 DGATSDIWSCGVILYIFRGDFKLPKWLSPGAQN 226
               SD+WS G++LY      K+P    PG  N
Sbjct: 181 FTIKSDVWSFGILLYEIVTYGKIP---YPGMSN 210

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 79.8 bits (197), Expect = 1e-16
 Identities = 71/225 (31%), Positives = 109/225 (48%), Gaps = 38/225 (16%)

Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLP-----FAVKILEKNRIIHLKITDQIKREIATLK 69
           R  LG+ LGEG FG+V  A+ +    P      AVK+L+ +      ++D +  E+  +K
Sbjct: 13  RLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEK-DLSDLVS-EMEMMK 70

Query: 70  LL-KHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAE--------GRKLF 120
           ++ KH N++ L  V   +  +Y+V+EY   G L D + ++    E             L 
Sbjct: 71  MIGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLT 130

Query: 121 Q--------QLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD--- 169
           Q        Q+  G+ +  +K   HRDL   N+L+     +KI+DFGL+      RD   
Sbjct: 131 QKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVTEDHVMKIADFGLA------RDIHH 184

Query: 170 -DGLLHTTCGS-P-NYVAPEVLANRGYDGATSDIWSCGVILY-IF 210
            D    TT G  P  ++APE L +R Y    SD+WS GV+L+ IF
Sbjct: 185 IDYYRKTTNGRLPVKWMAPEALFDRVYT-HQSDVWSFGVLLWEIF 228

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 79.0 bits (195), Expect = 1e-16
 Identities = 55/195 (28%), Positives = 96/195 (49%), Gaps = 13/195 (6%)

Query: 17  ELGRTLGEGNFGKVK---FAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKH 73
            LGR +GEG FG V    +    +  +  AVK  +        + ++  +E   ++   H
Sbjct: 9   TLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNC--TSPSVREKFLQEAYIMRQFDH 66

Query: 74  PNVVRLHEVLASKSKIYMVLEYVTGGELFDKI-ASKGRLQEAEGRKLFQQLIDGVSYCHN 132
           P++V+L  V+ +++ +++V+E    GEL   +  +K  L  A       QL   ++Y  +
Sbjct: 67  PHIVKLIGVI-TENPVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLES 125

Query: 133 KGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGS-P-NYVAPEVLAN 190
           K   HRD+   N+L+ S   +K+ DFGLS   ++  D+     + G  P  ++APE +  
Sbjct: 126 KRFVHRDIAARNVLVSSPDCVKLGDFGLS---RYLEDESYYKASKGKLPIKWMAPESINF 182

Query: 191 RGYDGATSDIWSCGV 205
           R +  A SD+W  GV
Sbjct: 183 RRFTSA-SDVWMFGV 196

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 81.7 bits (202), Expect = 2e-16
 Identities = 60/224 (26%), Positives = 104/224 (46%), Gaps = 30/224 (13%)

Query: 13  LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK 72
           + RY++ R +G+G  G+V  A D       A+K + ++   +  +  +  RE      L 
Sbjct: 1   MQRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLI 60

Query: 73  HPNVVRLHEVLASKSKIYMVLEYVTGGEL-------FDKIASKGRLQEAEGRK----LFQ 121
           HP +V ++ + +    +Y  + Y+ G  L       + K +    L E         +F 
Sbjct: 61  HPGIVPVYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFH 120

Query: 122 QLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD---------GL 172
           ++   + Y H+KGV HRDLK +NILL   G + I D+G +   +   +D          +
Sbjct: 121 KICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNI 180

Query: 173 LHTT-------CGSPNYVAPEVLANRGYDGATS-DIWSCGVILY 208
            +++        G+P+Y+APE L   G   + S DI++ GVILY
Sbjct: 181 CYSSMTIPGKIVGTPDYMAPERL--LGVPASESTDIYALGVILY 222

Length = 932

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 79.2 bits (195), Expect = 3e-16
 Identities = 90/327 (27%), Positives = 138/327 (42%), Gaps = 77/327 (23%)

Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKI-TDQIKREIATLKLLKH 73
           RY   + +G G +G V  A D  +G   A+K L  +R    +I   +  RE+  LK ++H
Sbjct: 16  RYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKL--SRPFQSEIFAKRAYRELTLLKHMQH 73

Query: 74  PNVVRLHEVLASKS------KIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGV 127
            NV+ L +V  S          Y+V+ Y+       KI     L E + + L  Q++ G+
Sbjct: 74  ENVIGLLDVFTSAVSGDEFQDFYLVMPYMQTD--LQKIMGH-PLSEDKVQYLVYQMLCGL 130

Query: 128 SYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEV 187
            Y H+ G+ HRDLK  N+ ++    +KI DFGL+   +H   D  +     +  Y APEV
Sbjct: 131 KYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLA---RH--ADAEMTGYVVTRWYRAPEV 185

Query: 188 LANRGYDGATSDIWSCGVIL-------YIFRG-------------------DF------- 214
           + N  +   T DIWS G I+        +F+G                   +F       
Sbjct: 186 ILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLEDK 245

Query: 215 -------KLPKW-----------LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQ--- 253
                   LPK+            SP A +LL K+LE +  KR+T        +F+    
Sbjct: 246 AAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRD 305

Query: 254 --DYTPANPDDDEEDIFVDNEAFSMHE 278
             + T   P DD     ++NE  S+ E
Sbjct: 306 ADEETEQQPYDDS----LENEKLSVDE 328

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 78.0 bits (192), Expect = 3e-16
 Identities = 57/203 (28%), Positives = 102/203 (50%), Gaps = 20/203 (9%)

Query: 21  TLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLH 80
            LG GN G V  A  L +    AVK++  +  I +++  QI  E+  L     P ++  +
Sbjct: 8   ILGHGNGGTVYKAYHLLTRRILAVKVIPLD--ITVELQKQIMSELEILYKCDSPYIIGFY 65

Query: 81  EVLASKSKIYMVLEYVTGGEL--FDKIASK--GRLQEAEGRKLFQQLIDGVSYCHNKGVF 136
                +++I +  E++ GG L  + KI     GR+  A        ++ G++Y  +  + 
Sbjct: 66  GAFFVENRISICTEFMDGGSLDVYRKIPEHVLGRIAVA--------VVKGLTYLWSLKIL 117

Query: 137 HRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGA 196
           HRD+K  N+L++++G +K+ DFG+S        + +  T  G+  Y+APE ++   Y G 
Sbjct: 118 HRDVKPSNMLVNTRGQVKLCDFGVSTQLV----NSIAKTYVGTNAYMAPERISGEQY-GI 172

Query: 197 TSDIWSCGV-ILYIFRGDFKLPK 218
            SD+WS G+  + +  G F  P+
Sbjct: 173 HSDVWSLGISFMELALGRFPYPQ 195

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 78.0 bits (192), Expect = 3e-16
 Identities = 63/218 (28%), Positives = 101/218 (46%), Gaps = 24/218 (11%)

Query: 15  RYELGRTLGEGNFGKVKFAQDLDSG---LPFAVKIL-----EKNRIIHLKITDQIKREIA 66
             ++ + +G G FG+V   +    G   +P A+K L     EK R   L        E +
Sbjct: 5   CIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFL-------SEAS 57

Query: 67  TLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASK--GRLQEAEGRKLFQQLI 124
            +    HPN++ L  V+     + +V EY+  G L D    K  G+    +   + + + 
Sbjct: 58  IMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSL-DAFLRKHDGQFTVIQLVGMLRGIA 116

Query: 125 DGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP---N 181
            G+ Y  + G  HRDL   NIL++S    K+SDFGLS + +   D    +TT G      
Sbjct: 117 SGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLED--DPEAAYTTRGGKIPIR 174

Query: 182 YVAPEVLANRGYDGATSDIWSCGVILYIFRGDFKLPKW 219
           + APE +A R +  A SD+WS G++++      + P W
Sbjct: 175 WTAPEAIAYRKFTSA-SDVWSYGIVMWEVMSYGERPYW 211

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 78.0 bits (192), Expect = 4e-16
 Identities = 60/198 (30%), Positives = 104/198 (52%), Gaps = 13/198 (6%)

Query: 20  RTLGEGNFGKVKFA----QDLDSGLPFAVKILE-KNRIIHLKITDQIKREIATLKLLKHP 74
           R LGEG+FGKV+      +  ++G   AVK L+ ++   H+     +K+EI  L+ L H 
Sbjct: 10  RDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHI---ADLKKEIEILRNLYHE 66

Query: 75  NVVRLHEVLASK--SKIYMVLEYVTGGELFDKIA-SKGRLQEAEGRKLFQQLIDGVSYCH 131
           N+V+   +      + I +++E++  G L + +  +K ++   +  K   Q+  G+ Y  
Sbjct: 67  NIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLG 126

Query: 132 NKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNY-VAPEVLAN 190
           ++   HRDL   N+L++S+  +KI DFGL+   +  ++   +     SP +  APE L  
Sbjct: 127 SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQ 186

Query: 191 RGYDGATSDIWSCGVILY 208
             +  A SD+WS GV LY
Sbjct: 187 SKFYIA-SDVWSFGVTLY 203

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score = 77.5 bits (191), Expect = 4e-16
 Identities = 61/203 (30%), Positives = 96/203 (47%), Gaps = 27/203 (13%)

Query: 17  ELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNV 76
           +L R LG G FG+V +    ++  P AVK L+      +   D +  E   +K L+HP +
Sbjct: 9   QLLRKLGAGQFGEV-WEGLWNNTTPVAVKTLKPGT---MDPKDFL-AEAQIMKKLRHPKL 63

Query: 77  VRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKL-FQQLID-------GVS 128
           ++L+ V   +  IY+V E +  G L +       LQ   GR L   QLID       G++
Sbjct: 64  IQLYAVCTLEEPIYIVTELMKYGSLLE------YLQGGAGRALKLPQLIDMAAQVASGMA 117

Query: 129 YCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP---NYVAP 185
           Y   +   HRDL   N+L+      K++DFGL+ +    ++D +     G+     + AP
Sbjct: 118 YLEAQNYIHRDLAARNVLVGENNICKVADFGLARV---IKED-IYEAREGAKFPIKWTAP 173

Query: 186 EVLANRGYDGATSDIWSCGVILY 208
           E  A        SD+WS G++L 
Sbjct: 174 EA-ALYNRFSIKSDVWSFGILLT 195

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 77.7 bits (191), Expect = 4e-16
 Identities = 68/212 (32%), Positives = 103/212 (48%), Gaps = 25/212 (11%)

Query: 16  YELGRTLGEGNFGKVKFAQ---DLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK 72
           + LGR LG+G FG V+ AQ   +  S    AVK+L K  I      ++  RE A +K   
Sbjct: 1   FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKML-KADIFSSSDIEEFLREAACMKEFD 59

Query: 73  HPNVVRLHEV-LASKSK----IYMV-LEYVTGGELFDKIASKGRLQE----AEGRKLFQQ 122
           HPNV++L  V L S++K    I MV L ++  G+L   +    R+ E       + L + 
Sbjct: 60  HPNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMS-RIGEEPFTLPLQTLVRF 118

Query: 123 LID---GVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGS 179
           +ID   G+ Y  +K   HRDL   N +L+    + ++DFGLS   +           C S
Sbjct: 119 MIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGLS---KKIYSGDYYRQGCAS 175

Query: 180 P---NYVAPEVLANRGYDGATSDIWSCGVILY 208
                ++A E LA+  Y    SD+W+ GV ++
Sbjct: 176 KLPVKWLALESLADNVYT-THSDVWAFGVTMW 206

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 77.7 bits (191), Expect = 5e-16
 Identities = 55/189 (29%), Positives = 93/189 (49%), Gaps = 6/189 (3%)

Query: 22  LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHE 81
           LG+G FG+V   Q  ++G  +A K L+K R+           E   L+ +  P +V L  
Sbjct: 1   LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAY 60

Query: 82  VLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLF--QQLIDGVSYCHNKGVFHRD 139
              SK+ + +V+  + GG+L   I + G       R +    Q+  G+ + H+  + +RD
Sbjct: 61  AFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRD 120

Query: 140 LKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSD 199
           +K EN+LLD +GN ++SD GL+      +D   +    G+  Y+APE+L    Y     D
Sbjct: 121 MKPENVLLDDQGNCRLSDLGLAV---ELKDGKTITQRAGTNGYMAPEILKEEPYSYPV-D 176

Query: 200 IWSCGVILY 208
            ++ G  +Y
Sbjct: 177 WFAMGCSIY 185

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 77.5 bits (191), Expect = 5e-16
 Identities = 57/195 (29%), Positives = 98/195 (50%), Gaps = 20/195 (10%)

Query: 20  RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHL----KITDQIKREIATLKLLKHPN 75
             LG GN G V   + + +G   A K+      +H+     +  QI RE+  +   + P 
Sbjct: 11  SDLGAGNGGSVSKVKHIPTGTVMAKKV------VHIGAKSSVRKQILRELQIMHECRSPY 64

Query: 76  VVRLHEVLASKSKIYMVLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNK- 133
           +V  +    +++ I M +E++  G L D+I  K G +      K+   +++G++Y +N  
Sbjct: 65  IVSFYGAFLNENNICMCMEFMDCGSL-DRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVH 123

Query: 134 GVFHRDLKLENILLDSKGNIKISDFGLSA-LPQHFRDDGLLHTTCGSPNYVAPEVLANRG 192
            + HRD+K  NIL++S+G IK+ DFG+S  L     D     T  G+  Y++PE +    
Sbjct: 124 RIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSIAD-----TFVGTSTYMSPERIQGGK 178

Query: 193 YDGATSDIWSCGVIL 207
           Y    SD+WS G+ +
Sbjct: 179 YT-VKSDVWSLGISI 192

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 78.5 bits (193), Expect = 5e-16
 Identities = 66/222 (29%), Positives = 101/222 (45%), Gaps = 25/222 (11%)

Query: 13  LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEK--NRIIHLKITDQIKREIATLKL 70
           L RY+  + +G G  G V  A D   G+  AVK L +      H K   +  RE+  LK 
Sbjct: 20  LKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAK---RAYRELVLLKC 76

Query: 71  LKHPNVVRLHEVLASKSK------IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLI 124
           + H N++ L  V   +        +Y+V+E +    L   I  +  L       L  Q++
Sbjct: 77  VNHKNIISLLNVFTPQKSLEEFQDVYLVME-LMDANLCQVIHME--LDHERMSYLLYQML 133

Query: 125 DGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVA 184
            G+ + H+ G+ HRDLK  NI++ S   +KI DFGL+        + ++     +  Y A
Sbjct: 134 CGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAC---TNFMMTPYVVTRYYRA 190

Query: 185 PEVLANRGYDGATSDIWSCGVIL-------YIFRGDFKLPKW 219
           PEV+   GY     DIWS G I+        IF+G   + +W
Sbjct: 191 PEVILGMGYK-ENVDIWSVGCIMGELVKGSVIFQGTDHIDQW 231

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 77.7 bits (191), Expect = 5e-16
 Identities = 65/223 (29%), Positives = 100/223 (44%), Gaps = 38/223 (17%)

Query: 18  LGRTLGEGNFGKV--KFAQDLDSGLP----FAVKILEKNRIIHLKITDQIKREIATLKLL 71
           LG+TLGEG FGKV    A  L  G       AVK+L++N     ++ D +  E   LK +
Sbjct: 4   LGKTLGEGEFGKVVKATAFRL-KGRAGYTTVAVKMLKENAS-SSELRDLLS-EFNLLKQV 60

Query: 72  KHPNVVRLHEVLASKSKIYMVLEYVTGGEL--FDKIASK------GRLQEAEGRKLFQ-- 121
            HP+V++L+   +    + +++EY   G L  F + + K      G         L    
Sbjct: 61  NHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPD 120

Query: 122 --------------QLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHF 167
                         Q+  G+ Y     + HRDL   N+L+     +KISDFGLS     +
Sbjct: 121 ERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEGRKMKISDFGLSR--DVY 178

Query: 168 RDDGLLHTTCGS--PNYVAPEVLANRGYDGATSDIWSCGVILY 208
            +D  +  + G     ++A E L +  Y    SD+WS GV+L+
Sbjct: 179 EEDSYVKRSKGRIPVKWMAIESLFDHIYT-TQSDVWSFGVLLW 220

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score = 77.1 bits (190), Expect = 7e-16
 Identities = 61/208 (29%), Positives = 97/208 (46%), Gaps = 25/208 (12%)

Query: 14  GRYELGRTLGEGNFGKVKFAQDLDSG----LPFAVKILEKNRIIHLKITDQIKREIATLK 69
              E  + LG G FG V     +  G    +P A+K+L +      K   +I  E   + 
Sbjct: 7   TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREET--SPKANKEILDEAYVMA 64

Query: 70  LLKHPNVVRLHEVLASKSKIYMVLEYVTGGELF-------DKIASKGRLQEAEGRKLFQQ 122
            + HP+VVRL  +  S S++ ++ + +  G L        D I S+  L          Q
Sbjct: 65  SVDHPHVVRLLGICLS-SQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCV------Q 117

Query: 123 LIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGS-P- 180
           +  G+SY   K + HRDL   N+L+ +  ++KI+DFGL+ L     D+   H   G  P 
Sbjct: 118 IAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLD--VDEKEYHAEGGKVPI 175

Query: 181 NYVAPEVLANRGYDGATSDIWSCGVILY 208
            ++A E + +R Y    SD+WS GV ++
Sbjct: 176 KWMALESILHRIYT-HKSDVWSYGVTVW 202

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 76.4 bits (188), Expect = 1e-15
 Identities = 71/232 (30%), Positives = 109/232 (46%), Gaps = 27/232 (11%)

Query: 17  ELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNV 76
           +L + LG G FG+V      +     A+K L++  +      +    E   +K L+HP +
Sbjct: 9   KLVKKLGAGQFGEVWMGY-YNGHTKVAIKSLKQGSMS----PEAFLAEANLMKQLQHPRL 63

Query: 77  VRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKL-FQQLID-------GVS 128
           VRL+ V+ ++  IY++ EY+  G L D       L+  EG KL   +LID       G++
Sbjct: 64  VRLYAVV-TQEPIYIITEYMENGSLVD------FLKTPEGIKLTINKLIDMAAQIAEGMA 116

Query: 129 YCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP-NYVAPEV 187
           +   K   HRDL+  NIL+      KI+DFGL+ L +   ++         P  + APE 
Sbjct: 117 FIERKNYIHRDLRAANILVSETLCCKIADFGLARLIED--NEYTAREGAKFPIKWTAPEA 174

Query: 188 LANRGYDGATSDIWSCGVIL--YIFRGDFKLPKWLSPGA-QNLLRKILEPNP 236
           + N G     SD+WS G++L   +  G    P   +P   QNL R    P P
Sbjct: 175 I-NYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGYRMPRP 225

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 76.2 bits (187), Expect = 1e-15
 Identities = 60/190 (31%), Positives = 91/190 (47%), Gaps = 6/190 (3%)

Query: 22  LGEGNFGKVK--FAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRL 79
           LG GNFG VK    +   S    AVKIL KN      + D++ RE   ++ L +P +VR+
Sbjct: 3   LGSGNFGTVKKGMYKMKKSEKTVAVKIL-KNDNNDPALKDELLREANVMQQLDNPYIVRM 61

Query: 80  HEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRD 139
             +  ++S + +V+E    G L   +     + E    +L  Q+  G+ Y       HRD
Sbjct: 62  IGICEAESWM-LVMELAELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVHRD 120

Query: 140 LKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP-NYVAPEVLANRGYDGATS 198
           L   N+LL ++   KISDFGLS       +     T    P  + APE + N     + S
Sbjct: 121 LAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECM-NYYKFSSKS 179

Query: 199 DIWSCGVILY 208
           D+WS GV+++
Sbjct: 180 DVWSFGVLMW 189

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 75.8 bits (186), Expect = 2e-15
 Identities = 58/202 (28%), Positives = 94/202 (46%), Gaps = 18/202 (8%)

Query: 11  MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKL 70
           + +   +L +T+G+G FG V        G   AVK ++ +      +      E + +  
Sbjct: 3   LNMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDATAQAFLA-----EASVMTQ 55

Query: 71  LKHPNVVRLHEVLAS-KSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLID---G 126
           L+H N+V+L  V+   K  +Y+V EY+  G L D + S+GR     G  L +  +D    
Sbjct: 56  LRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGR-SVLGGDCLLKFSLDVCEA 114

Query: 127 VSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPE 186
           + Y       HRDL   N+L+      K+SDFGL+      +D G L        + APE
Sbjct: 115 MEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPV-----KWTAPE 169

Query: 187 VLANRGYDGATSDIWSCGVILY 208
            L  + +    SD+WS G++L+
Sbjct: 170 ALREKKFS-TKSDVWSFGILLW 190

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 75.9 bits (187), Expect = 3e-15
 Identities = 58/204 (28%), Positives = 92/204 (45%), Gaps = 35/204 (17%)

Query: 22  LGEGNFGKVKFAQDLDSGLPFAVKILEK---NRIIHLKITDQIKREIATLKLLKHPNVVR 78
           +G G +G V  A++ ++    A+K +     NRI   +      REI  L+ L H NV+ 
Sbjct: 13  IGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTL----REIKLLRHLDHENVIA 68

Query: 79  LHEVLASKSK-----IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNK 133
           + +++    +     +Y+V E +   +L   I S   L +   +    QL+ G+ Y H+ 
Sbjct: 69  IKDIMPPPHREAFNDVYIVYE-LMDTDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSA 127

Query: 134 GVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPN----------YV 183
            V HRDLK  N+LL++  ++KI DFGL+             TT    +          Y 
Sbjct: 128 NVLHRDLKPSNLLLNANCDLKICDFGLA------------RTTSEKGDFMTEYVVTRWYR 175

Query: 184 APEVLANRGYDGATSDIWSCGVIL 207
           APE+L N        D+WS G I 
Sbjct: 176 APELLLNCSEYTTAIDVWSVGCIF 199

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 74.9 bits (184), Expect = 4e-15
 Identities = 61/210 (29%), Positives = 99/210 (47%), Gaps = 25/210 (11%)

Query: 18  LGRTLGEGNFGKV---KFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
           LG+ LGEG FG V   + +QD  S L  AVK ++ +   + +I + +  E A +K   HP
Sbjct: 3   LGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFL-SEAACMKDFDHP 61

Query: 75  NVVRLHEV---LASKSKI---YMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLID--- 125
           NV++L  V    +S  KI    ++L ++  G+L   +    RL     +   Q L+    
Sbjct: 62  NVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYS-RLGGLPEKLPLQTLLKFMV 120

Query: 126 ----GVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP- 180
               G+ Y  N+   HRDL   N +L     + ++DFGLS   +             +  
Sbjct: 121 DIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLS---KKIYSGDYYRQGRIAKM 177

Query: 181 --NYVAPEVLANRGYDGATSDIWSCGVILY 208
              ++A E LA+R Y  + SD+W+ GV ++
Sbjct: 178 PVKWIAIESLADRVYT-SKSDVWAFGVTMW 206

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 76.0 bits (187), Expect = 4e-15
 Identities = 49/153 (32%), Positives = 76/153 (49%), Gaps = 16/153 (10%)

Query: 63  REIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQ 122
           REI  LK + H  ++ L      KS + MV+      +LF  +   G L   +   + ++
Sbjct: 135 REIDILKTISHRAIINLIHAYRWKSTVCMVMPKYKC-DLFTYVDRSGPLPLEQAITIQRR 193

Query: 123 LIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSA-------LPQHFRDDGLLHT 175
           L++ ++Y H +G+ HRD+K ENI LD   N  + DFG +         PQ +   G L T
Sbjct: 194 LLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYGWSGTLET 253

Query: 176 TCGSPNYVAPEVLANRGYDGATSDIWSCGVILY 208
                   +PE+LA   Y  A +DIWS G++L+
Sbjct: 254 N-------SPELLALDPY-CAKTDIWSAGLVLF 278

Length = 392

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 75.6 bits (186), Expect = 5e-15
 Identities = 69/233 (29%), Positives = 111/233 (47%), Gaps = 30/233 (12%)

Query: 17  ELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNV 76
           E  R +G G FG V    D   G   A+K +  N   +L    ++ RE+  L   KH NV
Sbjct: 3   EPDRPIGYGAFGVVWSVTDPRDGKRVALKKM-PNVFQNLVSCKRVFRELKMLCFFKHDNV 61

Query: 77  VRLHEVLASK-----SKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLF-QQLIDGVSYC 130
           +   ++L         +IY+V E +   +L   I S   L  ++  K+F  Q++ G+ Y 
Sbjct: 62  LSALDILQPPHIDPFEEIYVVTELMQS-DLHKIIVSPQPLS-SDHVKVFLYQILRGLKYL 119

Query: 131 HNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVL-A 189
           H+ G+ HRD+K  N+L++S   +KI DFGL+ + +   +   +     +  Y APE+L  
Sbjct: 120 HSAGILHRDIKPGNLLVNSNCVLKICDFGLARV-EEPDESKHMTQEVVTQYYRAPEILMG 178

Query: 190 NRGYDGATSDIWSCGVILYIFRGDFKLPKWLSPGAQNLLRKIL--EPNPVKRI 240
           +R Y  A  DIWS G I                 A+ L R+IL    +P++++
Sbjct: 179 SRHYTSAV-DIWSVGCIF----------------AELLGRRILFQAQSPIQQL 214

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 73.3 bits (180), Expect = 9e-15
 Identities = 53/202 (26%), Positives = 98/202 (48%), Gaps = 14/202 (6%)

Query: 20  RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRL 79
           + LG G FG V   +   + +  A+K + +  +      +    E   +  L HP +V+L
Sbjct: 10  KELGSGQFGVVHLGK-WRAQIKVAIKAINEGAMSE----EDFIEEAKVMMKLSHPKLVQL 64

Query: 80  HEVLASKSKIYMVLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNKGVFHR 138
           + V   +  +Y+V E++  G L + +  + G+L +     + Q + +G+ Y       HR
Sbjct: 65  YGVCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHR 124

Query: 139 DLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP---NYVAPEVLANRGYDG 195
           DL   N L+ S G +K+SDFG++   ++  DD    ++ G+     +  PEV     Y  
Sbjct: 125 DLAARNCLVSSTGVVKVSDFGMT---RYVLDDEYT-SSSGAKFPVKWSPPEVFNFSKYS- 179

Query: 196 ATSDIWSCGVILYIFRGDFKLP 217
           + SD+WS GV+++    + K+P
Sbjct: 180 SKSDVWSFGVLMWEVFTEGKMP 201

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score = 73.3 bits (180), Expect = 2e-14
 Identities = 58/211 (27%), Positives = 93/211 (44%), Gaps = 30/211 (14%)

Query: 22  LGEGNFGKVKFAQ-----DLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNV 76
           LGEG FGKV   +     +  S    A+K L++N     K+  + ++E   +  L+HPN+
Sbjct: 13  LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEP--KVQQEFRQEAELMSDLQHPNI 70

Query: 77  VRLHEVLASKSKIYMVLEYVTGGELFDKIAS----------------KGRLQEAEGRKLF 120
           V L  V   +    M+ EY+  G+L + +                  K  L  ++   + 
Sbjct: 71  VCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIA 130

Query: 121 QQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSAL---PQHFRDDGLLHTTC 177
            Q+  G+ Y  +    HRDL   N L+     +KISDFGLS       ++R   +   + 
Sbjct: 131 IQIAAGMEYLSSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYR---VQSKSL 187

Query: 178 GSPNYVAPEVLANRGYDGATSDIWSCGVILY 208
               ++ PE +   G     SDIWS GV+L+
Sbjct: 188 LPVRWMPPEAILY-GKFTTESDIWSFGVVLW 217

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 73.1 bits (179), Expect = 2e-14
 Identities = 67/220 (30%), Positives = 106/220 (48%), Gaps = 31/220 (14%)

Query: 15  RYELGRTLGEGNFGKVKFAQ--DLDSGLP-----FAVKILEKNRIIHLKITDQIKREIAT 67
           R  LG+ LGEG FG+V  A+   LD   P      AVK+L K+      ++D I  E+  
Sbjct: 19  RLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKML-KSDATEKDLSDLIS-EMEM 76

Query: 68  LKLL-KHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASK-------------GRLQE 113
           +K++ KH N++ L         +Y+++EY + G L + + ++                ++
Sbjct: 77  MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQ 136

Query: 114 AEGRKLFQ---QLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD 170
              + L     Q+  G+ Y  +K   HRDL   N+L+     +KI+DFGL+    H   D
Sbjct: 137 LSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHI--D 194

Query: 171 GLLHTTCGS--PNYVAPEVLANRGYDGATSDIWSCGVILY 208
               TT G     ++APE L +R Y    SD+WS GV+L+
Sbjct: 195 YYKKTTNGRLPVKWMAPEALFDRIYT-HQSDVWSFGVLLW 233

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 72.0 bits (176), Expect = 3e-14
 Identities = 54/194 (27%), Positives = 94/194 (48%), Gaps = 12/194 (6%)

Query: 17  ELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNV 76
           +L + LG G FG+V  A   +     AVK ++   +           E   +K L+H  +
Sbjct: 9   KLEKKLGAGQFGEVWMAT-YNKHTKVAVKTMKPGSMSVEAFLA----EANVMKTLQHDKL 63

Query: 77  VRLHEVLASKSKIYMVLEYVTGGELFDKIASK--GRLQEAEGRKLFQQLIDGVSYCHNKG 134
           V+LH V+ +K  IY++ E++  G L D + S    +    +      Q+ +G+++   + 
Sbjct: 64  VKLHAVV-TKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN 122

Query: 135 VFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP-NYVAPEVLANRGY 193
             HRDL+  NIL+ +    KI+DFGL+ + +   ++         P  + APE + N G 
Sbjct: 123 YIHRDLRAANILVSASLVCKIADFGLARVIED--NEYTAREGAKFPIKWTAPEAI-NFGS 179

Query: 194 DGATSDIWSCGVIL 207
               SD+WS G++L
Sbjct: 180 FTIKSDVWSFGILL 193

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score = 72.4 bits (177), Expect = 4e-14
 Identities = 68/213 (31%), Positives = 102/213 (47%), Gaps = 25/213 (11%)

Query: 13  LGRYELGRTLGEGNFGKVKFAQDLD--SGLPFAVKILEKNRIIHLKITDQIKREIATLKL 70
           L  YE G  +G G +G V  A+  D      +A+K +E        I+    REIA L+ 
Sbjct: 1   LFEYE-GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGT-----GISMSACREIALLRE 54

Query: 71  LKHPNVVRLHEVLASKS--KIYMVLEYVTGGELFDKI-------ASKGRLQEAEG--RKL 119
           LKHPNV+ L +V  S +  K++++ +Y    +L+  I       A+K  +Q   G  + L
Sbjct: 55  LKHPNVISLQKVFLSHADRKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSL 113

Query: 120 FQQLIDGVSYCHNKGVFHRDLKLENILL----DSKGNIKISDFGLSAL-PQHFRDDGLLH 174
             Q++DG+ Y H   V HRDLK  NIL+      +G +KI+D G + L     +    L 
Sbjct: 114 LYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLD 173

Query: 175 TTCGSPNYVAPEVLANRGYDGATSDIWSCGVIL 207
               +  Y APE+L    +     DIW+ G I 
Sbjct: 174 PVVVTFWYRAPELLLGARHYTKAIDIWAIGCIF 206

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score = 72.4 bits (177), Expect = 4e-14
 Identities = 69/213 (32%), Positives = 102/213 (47%), Gaps = 25/213 (11%)

Query: 13  LGRYELGRTLGEGNFGKVKFAQDLDSG--LPFAVKILEKNRIIHLKITDQIKREIATLKL 70
           L  YE G  +G G +G V  A+  D      +A+K +E        I+    REIA L+ 
Sbjct: 1   LFEYE-GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGT-----GISMSACREIALLRE 54

Query: 71  LKHPNVVRLHEVLASKS--KIYMVLEYVTGGELFDKI----ASKG-----RLQEAEGRKL 119
           LKHPNV+ L +V  S S  K++++ +Y    +L+  I    ASK      +L  +  + L
Sbjct: 55  LKHPNVIALQKVFLSHSDRKVWLLFDYAEH-DLWHIIKFHRASKANKKPMQLPRSMVKSL 113

Query: 120 FQQLIDGVSYCHNKGVFHRDLKLENILL----DSKGNIKISDFGLSAL-PQHFRDDGLLH 174
             Q++DG+ Y H   V HRDLK  NIL+      +G +KI+D G + L     +    L 
Sbjct: 114 LYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLD 173

Query: 175 TTCGSPNYVAPEVLANRGYDGATSDIWSCGVIL 207
               +  Y APE+L    +     DIW+ G I 
Sbjct: 174 PVVVTFWYRAPELLLGARHYTKAIDIWAIGCIF 206

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score = 71.1 bits (174), Expect = 5e-14
 Identities = 53/200 (26%), Positives = 95/200 (47%), Gaps = 14/200 (7%)

Query: 22  LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHE 81
           +G G FG V     L+     A+K + +  +      +    E   +  L HP +V+L+ 
Sbjct: 12  IGSGQFGLVWLGYWLEKR-KVAIKTIREGAMSE----EDFIEEAQVMMKLSHPKLVQLYG 66

Query: 82  VLASKSKIYMVLEYVTGGELFDKI-ASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDL 140
           V   +S I +V E++  G L D + A +G+  +     +   + +G++Y  +  V HRDL
Sbjct: 67  VCTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDL 126

Query: 141 KLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP---NYVAPEVLANRGYDGAT 197
              N L+     +K+SDFG++     F  D    ++ G+     + +PEV +   Y  + 
Sbjct: 127 AARNCLVGENQVVKVSDFGMT----RFVLDDQYTSSTGTKFPVKWSSPEVFSFSKYS-SK 181

Query: 198 SDIWSCGVILYIFRGDFKLP 217
           SD+WS GV+++    + K P
Sbjct: 182 SDVWSFGVLMWEVFSEGKTP 201

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 72.4 bits (178), Expect = 5e-14
 Identities = 63/210 (30%), Positives = 97/210 (46%), Gaps = 32/210 (15%)

Query: 13  LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEK--NRIIHLKITDQIKREIATLKL 70
           L RY+  + +G G  G V  A D  +G   A+K L +    + H K   +  RE+  +KL
Sbjct: 15  LKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAK---RAYRELVLMKL 71

Query: 71  LKHPNVVRLHEV------LASKSKIYMVLEYVTGG--ELFDKIASKGRLQEAEGRKLFQQ 122
           + H N++ L  V      L     +Y+V+E +     ++        R+       L  Q
Sbjct: 72  VNHKNIIGLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQMDLDHERMS-----YLLYQ 126

Query: 123 LIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPN- 181
           ++ G+ + H+ G+ HRDLK  NI++ S   +KI DFGL+      R  G   +   +P  
Sbjct: 127 MLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA------RTAG--TSFMMTPYV 178

Query: 182 ----YVAPEVLANRGYDGATSDIWSCGVIL 207
               Y APEV+   GY     DIWS G I+
Sbjct: 179 VTRYYRAPEVILGMGYK-ENVDIWSVGCIM 207

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 71.4 bits (175), Expect = 8e-14
 Identities = 64/218 (29%), Positives = 96/218 (44%), Gaps = 38/218 (17%)

Query: 15  RYELGRTLGEGNFGKVKFAQDL-----DSGLPFAVKILEKNRIIHLKITDQIKREIATLK 69
               G+TLG G FGKV  A        D+ +  AVK+L+     H    + +  E+  + 
Sbjct: 36  NLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPT--AHSSEREALMSELKIMS 93

Query: 70  LL-KHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQ---QLID 125
            L  H N+V L         I ++ EY   G+L + +  K R        L     Q+  
Sbjct: 94  HLGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRK-RESFLTLEDLLSFSYQVAK 152

Query: 126 GVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYV-- 183
           G+++  +K   HRDL   N+LL     +KI DFGL+      RD  +++ +    NYV  
Sbjct: 153 GMAFLASKNCIHRDLAARNVLLTHGKIVKICDFGLA------RD--IMNDS----NYVVK 200

Query: 184 ----------APEVLANRGYDGATSDIWSCGVILY-IF 210
                     APE + N  Y    SD+WS G++L+ IF
Sbjct: 201 GNARLPVKWMAPESIFNCVYT-FESDVWSYGILLWEIF 237

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 71.2 bits (175), Expect = 8e-14
 Identities = 61/215 (28%), Positives = 94/215 (43%), Gaps = 18/215 (8%)

Query: 22  LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIK--REI-ATLKLLKHPNVVR 78
           +G G FG V       SG   AVK   + R    +  +Q +   ++   ++    P +V+
Sbjct: 12  IGRGAFGTVNKMLHKPSGTIMAVK---RIRSTVDE-KEQKRLLMDLDVVMRSSDCPYIVK 67

Query: 79  LHEVLASKSKIYMVLEYV-TGGELFDKIA---SKGRLQEAEGRKLFQQLIDGVSYCHNK- 133
            +  L  +   ++ +E +    + F K      K  + E    K+    +  ++Y   + 
Sbjct: 68  FYGALFREGDCWICMELMDISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEEL 127

Query: 134 GVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGY 193
            + HRD+K  NILLD  GNIK+ DFG+S       D        G   Y+APE +     
Sbjct: 128 KIIHRDVKPSNILLDRNGNIKLCDFGISG---QLVDSIAKTRDAGCRPYMAPERIDPSAR 184

Query: 194 DG--ATSDIWSCGVILY-IFRGDFKLPKWLSPGAQ 225
           DG    SD+WS G+ LY +  G F  PKW S   Q
Sbjct: 185 DGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQ 219

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 71.5 bits (175), Expect = 9e-14
 Identities = 68/233 (29%), Positives = 107/233 (45%), Gaps = 52/233 (22%)

Query: 15  RYELGRTLGEGNFGKVKFAQDL-------DSGLPFAVKILEKNRIIHLKITDQIKREIAT 67
           R  LG+ LGEG FG+V  A+         D  +  AVK+L+ N      + D I  E+  
Sbjct: 13  RLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNAT-DKDLADLIS-EMEL 70

Query: 68  LKLL-KHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQE------------- 113
           +KL+ KH N++ L  V   +  +Y+++EY          A+KG L+E             
Sbjct: 71  MKLIGKHKNIINLLGVCTQEGPLYVIVEY----------AAKGNLREFLRARRPPGPDYT 120

Query: 114 ------AEGRKLFQQLID-------GVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGL 160
                  E +  F+ L+        G+ Y  ++   HRDL   N+L+     +KI+DFGL
Sbjct: 121 FDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLVTEDNVMKIADFGL 180

Query: 161 SALPQHFRDDGLLHTTCGS--PNYVAPEVLANRGYDGATSDIWSCGVILY-IF 210
           +        D    T+ G     ++APE L +R Y    SD+WS G++++ IF
Sbjct: 181 ARGVHDI--DYYKKTSNGRLPVKWMAPEALFDRVYT-HQSDVWSFGILMWEIF 230

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score = 70.9 bits (174), Expect = 1e-13
 Identities = 64/223 (28%), Positives = 96/223 (43%), Gaps = 43/223 (19%)

Query: 18  LGRTLGEGNFGKVKFAQDLDSGLP------FAVKILEKNRIIHLKITDQIKREIATLKLL 71
           L R LGEG FGKV F  +     P       AVK L++      +     +RE   L   
Sbjct: 9   LKRELGEGAFGKV-FLGECYHLEPENDKELVAVKTLKETASNDAR--KDFEREAELLTNF 65

Query: 72  KHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIAS--------------KGRLQEAEGR 117
           +H N+V+ + V        MV EY+  G+L   + S               G L  ++  
Sbjct: 66  QHENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLL 125

Query: 118 KLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTT- 176
           ++  Q+  G+ Y  ++   HRDL   N L+     +KI DFG+S      RD   ++TT 
Sbjct: 126 QIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLVVKIGDFGMS------RD---VYTTD 176

Query: 177 ----CGSP----NYVAPEVLANRGYDGATSDIWSCGVILY-IF 210
                G       ++ PE +  R +    SD+WS GV+L+ IF
Sbjct: 177 YYRVGGHTMLPIRWMPPESIMYRKFT-TESDVWSFGVVLWEIF 218

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 70.4 bits (172), Expect = 1e-13
 Identities = 66/227 (29%), Positives = 106/227 (46%), Gaps = 27/227 (11%)

Query: 18  LGRTLGEGNFGKV---KFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
           LG+TLGEG FG V   +  QD DS L  AVK ++       ++ D +  E   +K   HP
Sbjct: 3   LGKTLGEGEFGSVMEGQLNQD-DSILKVAVKTMKIAICTRSEMEDFL-SEAVCMKEFDHP 60

Query: 75  NVVRLHEVL--ASKSKIY----MVLEYVTGGEL-----FDKIASKGRLQEAEGR-KLFQQ 122
           NV+RL  V     +S+ Y    ++L ++  G+L     + ++    +    +   K    
Sbjct: 61  NVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTD 120

Query: 123 LIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSAL---PQHFRDDGLLHTTCGS 179
           +  G+ Y  +K   HRDL   N +L+   N+ ++DFGLS       ++R   +       
Sbjct: 121 IASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPV-- 178

Query: 180 PNYVAPEVLANRGYDGATSDIWSCGVILYIFRGDFKLPKWLSPGAQN 226
             ++A E LA+R Y    SD+WS GV ++      + P    PG +N
Sbjct: 179 -KWIAIESLADRVYT-TKSDVWSFGVTMWEIATRGQTP---YPGVEN 220

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 70.6 bits (173), Expect = 1e-13
 Identities = 56/203 (27%), Positives = 89/203 (43%), Gaps = 20/203 (9%)

Query: 21  TLGEGNFGKV-----KFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
           TLG G FG+V     K  ++        VK L+K +  +L+   + +RE+   + L H N
Sbjct: 12  TLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQS--EFRRELDMFRKLSHKN 69

Query: 76  VVRLHEVLASKSKIYMVLEYVTGGEL--FDKIASKGR-------LQEAEGRKLFQQLIDG 126
           VVRL  +       YM+LEY   G+L  F +             L   +   L  Q+  G
Sbjct: 70  VVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALG 129

Query: 127 VSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP-NYVAP 185
           + +  N    HRDL   N L+ S+  +K+S   LS     +  +         P  ++AP
Sbjct: 130 MDHLSNARFVHRDLAARNCLVSSQREVKVSLLSLSKDV--YNSEYYKLRNALIPLRWLAP 187

Query: 186 EVLANRGYDGATSDIWSCGVILY 208
           E +    +    SD+WS GV+++
Sbjct: 188 EAVQEDDFS-TKSDVWSFGVLMW 209

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 69.5 bits (170), Expect = 2e-13
 Identities = 54/204 (26%), Positives = 93/204 (45%), Gaps = 30/204 (14%)

Query: 22  LGEGNFGKVKFAQDLDSG---LPFAVKILEKNRIIHLKITDQIKR----EIATLKLLKHP 74
           +G G FG+V   +    G   +  A+K L+         T++ +R    E + +    HP
Sbjct: 12  IGAGEFGEVCRGRLKLPGKREIFVAIKTLKSG------YTEKQRRDFLSEASIMGQFDHP 65

Query: 75  NVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLI-------DGV 127
           N++ L  V+     + ++ E++  G L         L++ +G+    QL+        G+
Sbjct: 66  NIIHLEGVVTKSRPVMIITEFMENGAL------DSFLRQNDGQFTVIQLVGMLRGIAAGM 119

Query: 128 SYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP---NYVA 184
            Y       HRDL   NIL++S    K+SDFGLS   +    D    ++ G      + A
Sbjct: 120 KYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTA 179

Query: 185 PEVLANRGYDGATSDIWSCGVILY 208
           PE +A R +  A SD+WS G++++
Sbjct: 180 PEAIAYRKFTSA-SDVWSYGIVMW 202

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 69.6 bits (170), Expect = 2e-13
 Identities = 70/228 (30%), Positives = 107/228 (46%), Gaps = 33/228 (14%)

Query: 17  ELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNV 76
           +L + LG G FG+V +    +     AVK L+   +      +    E   +K L+H  +
Sbjct: 9   QLIKKLGNGQFGEV-WMGTWNGNTKVAVKTLKPGTMS----PESFLEEAQIMKKLRHDKL 63

Query: 77  VRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKL-FQQLID-------GVS 128
           V+L+ V+ S+  IY+V EY++ G L D       L++ EGR L    L+D       G++
Sbjct: 64  VQLYAVV-SEEPIYIVTEYMSKGSLLD------FLKDGEGRALKLPNLVDMAAQVAAGMA 116

Query: 129 YCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP---NYVAP 185
           Y       HRDL+  NIL+      KI+DFGL+ L +    D       G+     + AP
Sbjct: 117 YIERMNYIHRDLRSANILVGDGLVCKIADFGLARLIE----DNEYTARQGAKFPIKWTAP 172

Query: 186 EVLANRGYDGATSDIWSCGVILYIFRGDFKLPKWLSPGAQNLLRKILE 233
           E  A  G     SD+WS G++L       ++P    PG  N  R++LE
Sbjct: 173 EA-ALYGRFTIKSDVWSFGILLTELVTKGRVP---YPGMNN--REVLE 214

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 69.6 bits (170), Expect = 2e-13
 Identities = 62/218 (28%), Positives = 97/218 (44%), Gaps = 34/218 (15%)

Query: 20  RTLGEGNFGKVKFAQDLDSG---LPFAVKIL-----EKNRIIHLKITDQIKREIATLKLL 71
           + +G G FG+V        G   +  A+K L     EK R   L        E + +   
Sbjct: 11  KVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLS-------EASIMGQF 63

Query: 72  KHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLID------ 125
            H N++RL  V+       ++ EY+  G L DK      L++ +G     QL+       
Sbjct: 64  SHHNIIRLEGVVTKFKPAMIITEYMENGAL-DKY-----LRDHDGEFSSYQLVGMLRGIA 117

Query: 126 -GVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP---N 181
            G+ Y  +    HRDL   NIL++S    K+SDFGLS + +   +    +TT G      
Sbjct: 118 AGMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEG--TYTTSGGKIPIR 175

Query: 182 YVAPEVLANRGYDGATSDIWSCGVILYIFRGDFKLPKW 219
           + APE +A R +  A SD+WS G++++      + P W
Sbjct: 176 WTAPEAIAYRKFTSA-SDVWSFGIVMWEVMSFGERPYW 212

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional

 Score = 71.1 bits (174), Expect = 3e-13
 Identities = 44/147 (29%), Positives = 78/147 (53%), Gaps = 5/147 (3%)

Query: 64  EIATLKLLKHPNVVRLHEVLASKSKIYMVL-EYVTGGELFDKIASKGR-LQEAEGRKLFQ 121
           E   L+ L HP V+ L +V        +VL +Y +  +L+  + ++ R L  A+   + +
Sbjct: 210 EARLLRRLSHPAVLALLDVRVVGGLTCLVLPKYRS--DLYTYLGARLRPLGLAQVTAVAR 267

Query: 122 QLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPN 181
           QL+  + Y H +G+ HRD+K EN+L++   +I + DFG +   +        +   G+ +
Sbjct: 268 QLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYGIAGTVD 327

Query: 182 YVAPEVLANRGYDGATSDIWSCGVILY 208
             APEVLA   Y   + DIWS G++++
Sbjct: 328 TNAPEVLAGDPYT-PSVDIWSAGLVIF 353

Length = 461

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 69.2 bits (169), Expect = 3e-13
 Identities = 58/194 (29%), Positives = 95/194 (48%), Gaps = 14/194 (7%)

Query: 22  LGEGNFGKVK--FAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRL 79
           LG GNFG VK    +     +  A+K+L+        + D++ RE   +  L +P +VR+
Sbjct: 3   LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNEN--EKSVRDEMMREAEIMHQLDNPYIVRM 60

Query: 80  HEVLASKSKIYMVLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNKGVFHR 138
             V  +++ + +V+E  +GG L   ++ K   +  +   +L  Q+  G+ Y   K   HR
Sbjct: 61  IGVCEAEA-LMLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHR 119

Query: 139 DLKLENILLDSKGNIKISDFGLS-ALPQHFRDDGLLHTTCGSP---NYVAPEVLANRGYD 194
           DL   N+LL ++   KISDFGLS AL     DD              + APE +  R + 
Sbjct: 120 DLAARNVLLVNQHYAKISDFGLSKALGA---DDSYYKARSAGKWPLKWYAPECINFRKFS 176

Query: 195 GATSDIWSCGVILY 208
            + SD+WS G+ ++
Sbjct: 177 -SRSDVWSYGITMW 189

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 69.3 bits (169), Expect = 4e-13
 Identities = 64/221 (28%), Positives = 107/221 (48%), Gaps = 39/221 (17%)

Query: 18  LGRTLGEGNFGKVKFAQDL--DSGLP-----FAVKILEKNRIIHLKITDQIKREIATLKL 70
           LG+ LGEG FG+V  A+ L  D   P      AVK+L K+      ++D +  E+  +K+
Sbjct: 19  LGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKML-KDDATEKDLSDLVS-EMEMMKM 76

Query: 71  L-KHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRL---------QEAEGRKLF 120
           + KH N++ L         +Y+++EY + G L + + ++            +  + +  F
Sbjct: 77  IGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTF 136

Query: 121 QQLID-------GVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD---- 169
           + L+        G+ Y  ++   HRDL   N+L+     +KI+DFGL+      RD    
Sbjct: 137 KDLVSCTYQVARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLA------RDVNNI 190

Query: 170 DGLLHTTCGS--PNYVAPEVLANRGYDGATSDIWSCGVILY 208
           D    TT G     ++APE L +R Y    SD+WS GV+++
Sbjct: 191 DYYKKTTNGRLPVKWMAPEALFDRVYT-HQSDVWSFGVLMW 230

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 68.9 bits (169), Expect = 4e-13
 Identities = 45/175 (25%), Positives = 67/175 (38%), Gaps = 29/175 (16%)

Query: 14  GRYELGRTLGEGNFGKVKFA-----QDLDSGLP-----------FAVKILEKNRIIHLKI 57
                   LGEG FG+V        QD                  AVK+L  +   + + 
Sbjct: 5   QPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNARE 64

Query: 58  TDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGEL---------FDKIASK 108
            D +K E+  L  L  PN+ RL  V      + M++EY+  G+L              + 
Sbjct: 65  -DFLK-EVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLAC 122

Query: 109 GRLQEAEGRKLFQ--QLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLS 161
                +    L+   Q+  G+ Y  +    HRDL   N L+     IKI+DFG+S
Sbjct: 123 NSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNCLVGKNYTIKIADFGMS 177

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 69.3 bits (169), Expect = 5e-13
 Identities = 64/224 (28%), Positives = 108/224 (48%), Gaps = 39/224 (17%)

Query: 15  RYELGRTLGEGNFGKVKFAQDL-------DSGLPFAVKILEKNRIIHLKITDQIKREIAT 67
           R  LG+ LGEG FG+V  A+ +       +  +  AVK+L K+      ++D +  E+  
Sbjct: 13  RLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKML-KDDATDKDLSDLVS-EMEM 70

Query: 68  LKLL-KHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASK---------GRLQEAEGR 117
           +K++ KH N++ L         +Y+++EY + G L + + ++            +  E +
Sbjct: 71  MKMIGKHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQ 130

Query: 118 KLFQQLID-------GVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD- 169
             F+ L+        G+ Y  ++   HRDL   N+L+     +KI+DFGL+      RD 
Sbjct: 131 LTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVTEDNVMKIADFGLA------RDV 184

Query: 170 ---DGLLHTTCGS--PNYVAPEVLANRGYDGATSDIWSCGVILY 208
              D    TT G     ++APE L +R Y    SD+WS GV+L+
Sbjct: 185 HNIDYYKKTTNGRLPVKWMAPEALFDRVYT-HQSDVWSFGVLLW 227

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 68.9 bits (168), Expect = 6e-13
 Identities = 62/215 (28%), Positives = 94/215 (43%), Gaps = 31/215 (14%)

Query: 18  LGRTLGEGNFGKVKFAQ-----DLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK 72
           L R LGEG FGKV  A+          +  AVK L+      L      +RE   L  L+
Sbjct: 9   LKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDP---TLAARKDFQREAELLTNLQ 65

Query: 73  HPNVVRLHEVLASKSKIYMVLEYVTGGELF----------------DKIASKGRLQEAEG 116
           H ++V+ + V      + MV EY+  G+L                     +KG L  ++ 
Sbjct: 66  HEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQM 125

Query: 117 RKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSA---LPQHFRDDGLL 173
             +  Q+  G+ Y  ++   HRDL   N L+ +   +KI DFG+S       ++R  G  
Sbjct: 126 LHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGG-- 183

Query: 174 HTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILY 208
           HT      ++ PE +  R +    SD+WS GVIL+
Sbjct: 184 HTML-PIRWMPPESIMYRKFT-TESDVWSFGVILW 216

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 69.3 bits (169), Expect = 6e-13
 Identities = 39/146 (26%), Positives = 73/146 (50%), Gaps = 5/146 (3%)

Query: 64  EIATLKLLKHPNVVRLHEVLASKSKIYMVL-EYVTGGELFDKIASKGRLQEAEGRKLFQQ 122
           E   L+ + HP++++L           ++L  Y T  +L+  +A+K  +   +   + + 
Sbjct: 133 EAHILRAINHPSIIQLKGTFTYNKFTCLILPRYKT--DLYCYLAAKRNIAICDILAIERS 190

Query: 123 LIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNY 182
           ++  + Y H   + HRD+K ENI ++  G++ + DFG +  P     +   +   G+   
Sbjct: 191 VLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANK-YYGWAGTIAT 249

Query: 183 VAPEVLANRGYDGATSDIWSCGVILY 208
            APE+LA   Y G   DIWS G++L+
Sbjct: 250 NAPELLARDPY-GPAVDIWSAGIVLF 274

Length = 391

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 68.2 bits (167), Expect = 8e-13
 Identities = 64/232 (27%), Positives = 103/232 (44%), Gaps = 35/232 (15%)

Query: 22  LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLK--LLKH--PNVV 77
           +G G  G+V   +   +G   AVK + +         ++ KR +  L   L  H  P +V
Sbjct: 23  IGSGTCGQVYKMRFKKTGHVMAVKQMRRT-----GNKEENKRILMDLDVVLKSHDCPYIV 77

Query: 78  RLHEVLASKSKIYMVLEYVTGGELFDKIA--SKGRLQEAEGRKLFQQLIDGVSYCHNK-G 134
           + +    + S +++ +E +      DK+    +G + E    K+   ++  + Y   K G
Sbjct: 78  KCYGYFITDSDVFICMELM--STCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHG 135

Query: 135 VFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHT-TCGSPNYVAPEVL----A 189
           V HRD+K  NILLD+ GN+K+ DFG+S        D    T + G   Y+APE +     
Sbjct: 136 VIHRDVKPSNILLDASGNVKLCDFGISG----RLVDSKAKTRSAGCAAYMAPERIDPPDP 191

Query: 190 NRGYDGATSDIWSCGVILYIFRGDFKLPKWLSPGAQN-----LLRKILEPNP 236
           N  YD   +D+WS G+ L       +L     P         +L KIL+  P
Sbjct: 192 NPKYD-IRADVWSLGISLV------ELATGQFPYKNCKTEFEVLTKILQEEP 236

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 67.8 bits (165), Expect = 1e-12
 Identities = 61/210 (29%), Positives = 96/210 (45%), Gaps = 24/210 (11%)

Query: 18  LGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIK---REIATLKLLKHP 74
           L R LGEG FGKV F  +  +  P   KIL   + +     +  K   RE   L  L+H 
Sbjct: 9   LKRELGEGAFGKV-FLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHE 67

Query: 75  NVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKG-------------RLQEAEGRKLFQ 121
           ++V+ + V      + MV EY+  G+L   + + G              L +++   + Q
Sbjct: 68  HIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQ 127

Query: 122 QLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSA---LPQHFRDDGLLHTTCG 178
           Q+  G+ Y  ++   HRDL   N L+     +KI DFG+S       ++R  G  HT   
Sbjct: 128 QIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGG--HTML- 184

Query: 179 SPNYVAPEVLANRGYDGATSDIWSCGVILY 208
              ++ PE +  R +    SD+WS GV+L+
Sbjct: 185 PIRWMPPESIMYRKFT-TESDVWSLGVVLW 213

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 67.2 bits (164), Expect = 2e-12
 Identities = 60/213 (28%), Positives = 89/213 (41%), Gaps = 33/213 (15%)

Query: 20  RTLGEGNFGKVKFAQDLD-----SG-LPFAVKILEKNRIIHLKITDQIKREIATLKLLKH 73
             LG G FG+V      D     SG +  AVK L K      K   +  +E   +    H
Sbjct: 1   NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKK--EFLKEAHLMSNFNH 58

Query: 74  PNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEG-----RKLFQQLID--- 125
           PN+V+L  V       Y+++E + GG+L   +    R++         ++L    +D   
Sbjct: 59  PNIVKLLGVCLLNEPQYIIMELMEGGDLLSYL-RDARVERFGPPLLTLKELLDICLDVAK 117

Query: 126 GVSYCHNKGVFHRDLKLENILLDSKGN-----IKISDFGL-----SALPQHFRDDGLLHT 175
           G  Y       HRDL   N L+  KG      +KI DFGL      +       +GLL  
Sbjct: 118 GCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPV 177

Query: 176 TCGSPNYVAPEVLANRGYDGATSDIWSCGVILY 208
                 ++APE L + G     SD+WS GV+++
Sbjct: 178 -----RWMAPESLLD-GKFTTQSDVWSFGVLMW 204

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 67.0 bits (163), Expect = 3e-12
 Identities = 66/222 (29%), Positives = 99/222 (44%), Gaps = 28/222 (12%)

Query: 13  LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEK--NRIIHLKITDQIKREIATLKL 70
           L RY+  + +G G  G V  A D       A+K L +      H K   +  RE+  +K 
Sbjct: 16  LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAK---RAYRELVLMKC 72

Query: 71  LKHPNVVRLHEVLASK------SKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLI 124
           + H N++ L  V   +        +Y+V+E +    L   I  +  L       L  Q++
Sbjct: 73  VNHKNIISLLNVFTPQKSLEEFQDVYLVME-LMDANLCQVIQME--LDHERMSYLLYQML 129

Query: 125 DGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDG---LLHTTCGSPN 181
            G+ + H+ G+ HRDLK  NI++ S   +KI DFGL+      R  G   ++     +  
Sbjct: 130 CGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA------RTAGTSFMMTPYVVTRY 183

Query: 182 YVAPEVLANRGYDGATSDIWSCGVILYIFRGDFKLPKWLSPG 223
           Y APEV+   GY     DIWS G I+    G+    K L PG
Sbjct: 184 YRAPEVILGMGYK-ENVDIWSVGCIM----GEMVRHKILFPG 220

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 66.0 bits (161), Expect = 4e-12
 Identities = 64/231 (27%), Positives = 99/231 (42%), Gaps = 47/231 (20%)

Query: 15  RYELGRTLGEGNFGKV--KFAQDLDSGLPF---AVKILEKNRIIHLKITDQIKREIATLK 69
            Y   R +G+G FG+V    A  L    PF   AVK+L++     ++   Q  RE A + 
Sbjct: 8   EYV--RDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQ--REAALMA 63

Query: 70  LLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIAS---------------------- 107
              HPN+V+L  V A    + ++ EY+  G+L + +                        
Sbjct: 64  EFDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLN 123

Query: 108 KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHF 167
              L   E   + +Q+  G++Y   +   HRDL   N L+     +KI+DFGLS      
Sbjct: 124 PLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLS------ 177

Query: 168 RDDGLLHTTCGSPN------YVAPE-VLANRGYDGATSDIWSCGVILY-IF 210
           R+         S N      ++ PE +  NR Y    SD+W+ GV+L+ IF
Sbjct: 178 RNIYSADYYKASENDAIPIRWMPPESIFYNR-YT-TESDVWAYGVVLWEIF 226

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 65.4 bits (159), Expect = 6e-12
 Identities = 65/214 (30%), Positives = 93/214 (43%), Gaps = 33/214 (15%)

Query: 22  LGEGNFGKVKFAQ------DLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
           LGEG FGKV  A+      + D  L  AVK L++            +RE   L +L+H +
Sbjct: 13  LGEGAFGKVFLAECHNLLPEQDKML-VAVKALKE---ASESARQDFQREAELLTVLQHQH 68

Query: 76  VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGR----LQEAEGRKLFQ---------- 121
           +VR + V      + MV EY+  G+L   + S G     L   E     Q          
Sbjct: 69  IVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIA 128

Query: 122 -QLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSA---LPQHFRDDGLLHTTC 177
            Q+  G+ Y  +    HRDL   N L+     +KI DFG+S       ++R  G    T 
Sbjct: 129 SQIASGMVYLASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGG---RTM 185

Query: 178 GSPNYVAPEVLANRGYDGATSDIWSCGVILY-IF 210
               ++ PE +  R +    SDIWS GV+L+ IF
Sbjct: 186 LPIRWMPPESILYRKFT-TESDIWSFGVVLWEIF 218

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 64.7 bits (157), Expect = 8e-12
 Identities = 68/223 (30%), Positives = 107/223 (47%), Gaps = 33/223 (14%)

Query: 22  LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHE 81
           LG+G FG+V +    +     A+K L+   ++     +   +E   +K L+H  +V L+ 
Sbjct: 14  LGQGCFGEV-WMGTWNGTTKVAIKTLKPGTMM----PEAFLQEAQIMKKLRHDKLVPLYA 68

Query: 82  VLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGR--KLFQ------QLIDGVSYCHNK 133
           V+ S+  IY+V E++  G L D       L+E +G+  KL Q      Q+ DG++Y    
Sbjct: 69  VV-SEEPIYIVTEFMGKGSLLD------FLKEGDGKYLKLPQLVDMAAQIADGMAYIERM 121

Query: 134 GVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP---NYVAPEVLAN 190
              HRDL+  NIL+      KI+DFGL+ L +    D       G+     + APE  A 
Sbjct: 122 NYIHRDLRAANILVGDNLVCKIADFGLARLIE----DNEYTARQGAKFPIKWTAPEA-AL 176

Query: 191 RGYDGATSDIWSCGVILYIFRGDFKLPKWLSPGAQNLLRKILE 233
            G     SD+WS G++L       ++P    PG  N  R++LE
Sbjct: 177 YGRFTIKSDVWSFGILLTELVTKGRVP---YPGMVN--REVLE 214

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 65.5 bits (159), Expect = 1e-11
 Identities = 63/219 (28%), Positives = 96/219 (43%), Gaps = 22/219 (10%)

Query: 13  LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEK--NRIIHLKITDQIKREIATLKL 70
           L RY+  + +G G  G V  A D       A+K L +      H K   +  RE+  +K 
Sbjct: 23  LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAK---RAYRELVLMKC 79

Query: 71  LKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRK---LFQQLIDGV 127
           + H N++ L  V   +  +    +     EL D    +    E +  +   L  Q++ G+
Sbjct: 80  VNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGI 139

Query: 128 SYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDG---LLHTTCGSPNYVA 184
            + H+ G+ HRDLK  NI++ S   +KI DFGL+      R  G   ++     +  Y A
Sbjct: 140 KHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA------RTAGTSFMMTPYVVTRYYRA 193

Query: 185 PEVLANRGYDGATSDIWSCGVILYIFRGDFKLPKWLSPG 223
           PEV+   GY     DIWS G I+    G+      L PG
Sbjct: 194 PEVILGMGYK-ENVDIWSVGCIM----GEMIKGGVLFPG 227

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 64.4 bits (157), Expect = 1e-11
 Identities = 61/231 (26%), Positives = 110/231 (47%), Gaps = 25/231 (10%)

Query: 20  RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREI----ATLKLLKHPN 75
             LG G +G V   + + +G   AVK +       +   +Q KR +     +++ +  P 
Sbjct: 7   EELGRGAYGVVDKMRHVPTGTIMAVKRIRAT----VNSQEQ-KRLLMDLDISMRSVDCPY 61

Query: 76  VVRLHEVLASKSKIYMVLEYVTGG--ELFDKIASKG-RLQEAEGRKLFQQLIDGVSYCHN 132
            V  +  L  +  +++ +E +     + + K+  KG  + E    K+   ++  + Y H+
Sbjct: 62  TVTFYGALFREGDVWICMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHS 121

Query: 133 K-GVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPE----V 187
           K  V HRD+K  N+L++  G +K+ DFG+S    +  D        G   Y+APE     
Sbjct: 122 KLSVIHRDVKPSNVLINRNGQVKLCDFGISG---YLVDSVAKTIDAGCKPYMAPERINPE 178

Query: 188 LANRGYDGATSDIWSCGV-ILYIFRGDFKLPKWLSPGAQNLLRKILE-PNP 236
           L  +GYD   SD+WS G+ ++ +  G F    W +P  Q  L++++E P+P
Sbjct: 179 LNQKGYD-VKSDVWSLGITMIELATGRFPYDSWKTPFQQ--LKQVVEEPSP 226

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 63.9 bits (156), Expect = 2e-11
 Identities = 48/203 (23%), Positives = 86/203 (42%), Gaps = 19/203 (9%)

Query: 17  ELGRTLGEGNFGK--VKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
           EL   +G+       V  A+   +    AVK +  +      +   +++EI T + L+HP
Sbjct: 1   ELLTLIGKCFEDLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLK-LLQQEIITSRQLQHP 59

Query: 75  NVVRLHEVLASKSKIYMVLEYVTGGELFDKIAS--KGRLQEAEGRKLFQQLIDGVSYCHN 132
           N++         S++Y+V   +  G   D + +     L E     + + +++ + Y H+
Sbjct: 60  NILPYVTSFIVDSELYVVSPLMAYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHS 119

Query: 133 KGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP--------NYVA 184
           KG  HR +K  +ILL   G + +S  GL          G                  +++
Sbjct: 120 KGFIHRSVKASHILLSGDGKVVLS--GLRYS-VSMIKHGKRQRVVHDFPKSSVKNLPWLS 176

Query: 185 PEVLAN--RGYDGATSDIWSCGV 205
           PEVL    +GY+   SDI+S G+
Sbjct: 177 PEVLQQNLQGYN-EKSDIYSVGI 198

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 63.4 bits (154), Expect = 3e-11
 Identities = 55/201 (27%), Positives = 89/201 (44%), Gaps = 17/201 (8%)

Query: 22  LGEGNFGKVKFAQDLDSGLPFA-VKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLH 80
           +G G FGKV    +   G+  A V + E              +E+   + L HPNV++  
Sbjct: 3   IGNGWFGKV-LLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCL 61

Query: 81  EVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQ-----LIDGVSYCHNKGV 135
                     +VLE+   G+L + + S   +     +K   Q     +  G+ + H    
Sbjct: 62  GQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADF 121

Query: 136 FHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGS-P-NYVAPEVLANRGY 193
            H DL L N  L +  ++KI D+GL AL Q + +D  +   C + P  ++APE++  RG 
Sbjct: 122 IHSDLALRNCQLTADLSVKIGDYGL-ALEQ-YPEDYYITKDCHAVPLRWLAPELVEIRGQ 179

Query: 194 DGAT------SDIWSCGVILY 208
           D         S+IWS GV ++
Sbjct: 180 DLLPKDQTKKSNIWSLGVTMW 200

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 63.5 bits (154), Expect = 3e-11
 Identities = 58/215 (26%), Positives = 92/215 (42%), Gaps = 38/215 (17%)

Query: 22  LGEGNFGKVKFAQDLDSGLP------FAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
           LGE  FGKV +   L    P       A+K L+        + ++ K E      L+HPN
Sbjct: 13  LGEDRFGKV-YKGHLFGTAPGEQTQAVAIKTLKDK--AEGPLREEFKHEAMMRSRLQHPN 69

Query: 76  VVRLHEVLASKSKIYMVLEYVTGGELF----------------DKIASKGRLQEAEGRKL 119
           +V L  V+  +  + M+  Y +  +L                 D    K  L+ A+   +
Sbjct: 70  IVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHI 129

Query: 120 FQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD------DGLL 173
             Q+  G+ +  +  V H+DL   N+L+  K N+KISD GL      FR+        L+
Sbjct: 130 VTQIAAGMEFLSSHHVVHKDLATRNVLVFDKLNVKISDLGL------FREVYAADYYKLM 183

Query: 174 HTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILY 208
             +     +++PE +   G     SDIWS GV+L+
Sbjct: 184 GNSLLPIRWMSPEAIM-YGKFSIDSDIWSYGVVLW 217

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 63.1 bits (153), Expect = 5e-11
 Identities = 61/210 (29%), Positives = 95/210 (45%), Gaps = 33/210 (15%)

Query: 22  LGEGNFGKVKFAQDLDSGLPF--AVKILEK--NRIIHLKITDQIKREIATLKLLKHPNVV 77
           +GEGNFG+V  A     GL    A+K+L++  +   H     +++      KL  HPN++
Sbjct: 10  IGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELE---VLCKLGHHPNII 66

Query: 78  RLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAE--------------GRKLFQQL 123
            L     ++  +Y+ +EY   G L D +  K R+ E +               ++L Q  
Sbjct: 67  NLLGACENRGYLYIAIEYAPYGNLLDFL-RKSRVLETDPAFAKEHGTASTLTSQQLLQFA 125

Query: 124 ID---GVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGS- 179
            D   G+ Y   K   HRDL   N+L+      KI+DFGLS   + +     +  T G  
Sbjct: 126 SDVATGMQYLSEKQFIHRDLAARNVLVGENLASKIADFGLSRGEEVY-----VKKTMGRL 180

Query: 180 -PNYVAPEVLANRGYDGATSDIWSCGVILY 208
              ++A E L    Y    SD+WS GV+L+
Sbjct: 181 PVRWMAIESLNYSVYT-TKSDVWSFGVLLW 209

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 62.1 bits (151), Expect = 7e-11
 Identities = 66/204 (32%), Positives = 101/204 (49%), Gaps = 26/204 (12%)

Query: 20  RTLGEGNFGKVKFAQDLDSG---LPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNV 76
           R +G+G+FG V     +DS    +  AVK L  NRI  L+  +Q  +E   +K   HPNV
Sbjct: 1   RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSL--NRITDLEEVEQFLKEGIIMKDFSHPNV 58

Query: 77  VRLHEV-LASKSKIYMVLEYVTGGELFDKIASKGR---LQEAEGRKLFQQLIDGVSYCHN 132
           + L  + L S+    +VL Y+  G+L + I S+     +++  G  L  Q+  G+ Y  +
Sbjct: 59  LSLLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGL--QVAKGMEYLAS 116

Query: 133 KGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD-------DGLLHTTCGSP-NYVA 184
           K   HRDL   N +LD    +K++DFGL+      RD           HT    P  ++A
Sbjct: 117 KKFVHRDLAARNCMLDESFTVKVADFGLA------RDIYDKEYYSVHNHTGAKLPVKWMA 170

Query: 185 PEVLANRGYDGATSDIWSCGVILY 208
            E L  + +    SD+WS GV+L+
Sbjct: 171 LESLQTQKFT-TKSDVWSFGVLLW 193

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 62.2 bits (151), Expect = 7e-11
 Identities = 61/230 (26%), Positives = 104/230 (45%), Gaps = 33/230 (14%)

Query: 18  LGRTLGEGNFGKV-KFAQDLDSG--LPFAVKILEKNRIIHLKITDQIKR----EIATLKL 70
           + R LG G FG++ +    L S   LP A+  L          +D+ +R    E  TL  
Sbjct: 9   IERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAG------CSDKQRRGFLAEALTLGQ 62

Query: 71  LKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLID----- 125
             H N+VRL  V+   + + +V EY++ G L         L++ EG+ +  QL+      
Sbjct: 63  FDHSNIVRLEGVITRGNTMMIVTEYMSNGAL------DSFLRKHEGQLVAGQLMGMLPGL 116

Query: 126 --GVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCG-SPN- 181
             G+ Y    G  H+ L    +L++S    KIS F    L +  + + +  T  G SP  
Sbjct: 117 ASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFR--RLQED-KSEAIYTTMSGKSPVL 173

Query: 182 YVAPEVLANRGYDGATSDIWSCGVILYIFRGDFKLPKWLSPGAQNLLRKI 231
           + APE +    +  A SD+WS G++++      + P W     Q++++ +
Sbjct: 174 WAAPEAIQYHHFSSA-SDVWSFGIVMWEVMSYGERPYW-DMSGQDVIKAV 221

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 61.7 bits (150), Expect = 1e-10
 Identities = 59/224 (26%), Positives = 87/224 (38%), Gaps = 47/224 (20%)

Query: 17  ELGRTLGEGNFGKVKFAQ-----DLDSGLPFAVKIL-----EKNRIIHLKITDQIKREIA 66
            L R LG G FG+V              L  AVK L     E++    L        E  
Sbjct: 9   TLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLM-------EAL 61

Query: 67  TLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGR--------- 117
            +    H N+VRL  V   +   +++LE + GG+L      K  L+E   R         
Sbjct: 62  IMSKFNHQNIVRLIGVSFERLPRFILLELMAGGDL------KSFLRENRPRPERPSSLTM 115

Query: 118 ----KLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGN---IKISDFGLSA---LPQHF 167
                  + +  G  Y       HRD+   N LL  KG     KI+DFG++       ++
Sbjct: 116 KDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYY 175

Query: 168 RDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILY-IF 210
           R  G          ++ PE   + G   + +D+WS GV+L+ IF
Sbjct: 176 RKGG---RAMLPIKWMPPEAFLD-GIFTSKTDVWSFGVLLWEIF 215

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 61.6 bits (149), Expect = 1e-10
 Identities = 62/217 (28%), Positives = 103/217 (47%), Gaps = 21/217 (9%)

Query: 22  LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHE 81
           LG+G FG+V +    +     A+K L+   +      +   +E   +K L+H  +V+L+ 
Sbjct: 14  LGQGCFGEV-WMGTWNGTTRVAIKTLKPGTMS----PEAFLQEAQVMKKLRHEKLVQLYA 68

Query: 82  VLASKSKIYMVLEYVTGGELFD--KIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRD 139
           V+ S+  IY+V EY++ G L D  K      L+  +   +  Q+  G++Y       HRD
Sbjct: 69  VV-SEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRD 127

Query: 140 LKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP---NYVAPEVLANRGYDGA 196
           L+  NIL+      K++DFGL+ L +    D       G+     + APE  A  G    
Sbjct: 128 LRAANILVGENLVCKVADFGLARLIE----DNEYTARQGAKFPIKWTAPEA-ALYGRFTI 182

Query: 197 TSDIWSCGVILYIFRGDFKLPKWLSPGAQNLLRKILE 233
            SD+WS G++L       ++P    PG  N  R++L+
Sbjct: 183 KSDVWSFGILLTELTTKGRVP---YPGMVN--REVLD 214

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 60.9 bits (147), Expect = 2e-10
 Identities = 60/210 (28%), Positives = 94/210 (44%), Gaps = 33/210 (15%)

Query: 22  LGEGNFGKVKFAQDLDSGLPF--AVKILEK--NRIIHLKITDQIKREIATLKLLKHPNVV 77
           +GEGNFG+V  A+    GL    A+K +++  ++  H     +++      KL  HPN++
Sbjct: 3   IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELE---VLCKLGHHPNII 59

Query: 78  RLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAE--------------GRKLFQQL 123
            L      +  +Y+ +EY   G L D +  K R+ E +               ++L    
Sbjct: 60  NLLGACEHRGYLYLAIEYAPHGNLLDFL-RKSRVLETDPAFAIANSTASTLSSQQLLHFA 118

Query: 124 ID---GVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGS- 179
            D   G+ Y   K   HRDL   NIL+      KI+DFGLS   + +     +  T G  
Sbjct: 119 ADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVY-----VKKTMGRL 173

Query: 180 -PNYVAPEVLANRGYDGATSDIWSCGVILY 208
              ++A E L    Y    SD+WS GV+L+
Sbjct: 174 PVRWMAIESLNYSVYT-TNSDVWSYGVLLW 202

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 61.3 bits (149), Expect = 2e-10
 Identities = 57/213 (26%), Positives = 92/213 (43%), Gaps = 28/213 (13%)

Query: 15  RYELGRTLGEGNFGKVKFA----QDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKL 70
           R  L   L EG FG++ +     +         VK + K+    +++T  ++ E   L  
Sbjct: 7   RVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTV-KDHASEIQVTLLLQ-ESCLLYG 64

Query: 71  LKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEG------RKLFQ--- 121
           L H N++ +  V     +   VL              + RL EA        ++L     
Sbjct: 65  LSHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAI 124

Query: 122 QLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPN 181
           Q+  G+SY H +GV H+D+   N ++D +  +KI+D  LS      RD   +   C   N
Sbjct: 125 QIACGMSYLHKRGVIHKDIAARNCVIDEELQVKITDNALS------RDLFPMDYHCLGDN 178

Query: 182 ------YVAPEVLANRGYDGATSDIWSCGVILY 208
                 ++A E L N+ Y  A SD+WS GV+L+
Sbjct: 179 ENRPVKWMALESLVNKEYSSA-SDVWSFGVLLW 210

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 61.2 bits (148), Expect = 2e-10
 Identities = 56/196 (28%), Positives = 93/196 (47%), Gaps = 13/196 (6%)

Query: 20  RTLGEGNFGKVKFAQDLDSG----LPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
           + LG G FG V     +  G    +P A+K+L +N     K   +I  E   +  +  P 
Sbjct: 13  KVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLREN--TSPKANKEILDEAYVMAGVGSPY 70

Query: 76  VVRLHEVLASKSKIYMVLEYVTGGELFDKI-ASKGRLQEAEGRKLFQQLIDGVSYCHNKG 134
           V RL  +  + S + +V + +  G L D +  +K R+   +      Q+  G+SY     
Sbjct: 71  VCRLLGICLT-STVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVR 129

Query: 135 VFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP--NYVAPEVLANRG 192
           + HRDL   N+L+ S  ++KI+DFGL+ L     D+   H   G     ++A E + +R 
Sbjct: 130 LVHRDLAARNVLVKSPNHVKITDFGLARLLD--IDETEYHADGGKVPIKWMALESILHRR 187

Query: 193 YDGATSDIWSCGVILY 208
           +    SD+WS GV ++
Sbjct: 188 FT-HQSDVWSYGVTVW 202

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 60.8 bits (147), Expect = 3e-10
 Identities = 48/173 (27%), Positives = 72/173 (41%), Gaps = 28/173 (16%)

Query: 15  RYELGRTLGEGNFGKVKF------AQDLDSGLP--------FAVKILEKNRIIHLKITDQ 60
           +  L   LGEG FG+V        A+ L  G P         AVK+L  +  +     + 
Sbjct: 6   QLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRAD--VTKTARND 63

Query: 61  IKREIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGG---------ELFDKIASKGRL 111
             +EI  +  LK+PN++RL  V  S   + M+ EY+  G         E+         +
Sbjct: 64  FLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNI 123

Query: 112 QEAEGRKLFQ---QLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLS 161
                  L     Q+  G+ Y  +    HRDL   N L+ +   IKI+DFG+S
Sbjct: 124 PSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVGNHYTIKIADFGMS 176

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 60.0 bits (145), Expect = 4e-10
 Identities = 58/209 (27%), Positives = 101/209 (48%), Gaps = 28/209 (13%)

Query: 20  RTLGEGNFGKV--KFAQDLDSGLP---FAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
           R LG+G+FG V    A+D+  G      AVK + ++  +  +I  +   E + +K     
Sbjct: 12  RELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERI--EFLNEASVMKGFTCH 69

Query: 75  NVVRLHEVLASKSKIYMVLEYVTGGELFDKIAS-KGRLQEAEGR---------KLFQQLI 124
           +VVRL  V++      +V+E +  G+L   + S +   +   GR         ++  ++ 
Sbjct: 70  HVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIA 129

Query: 125 DGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSA---LPQHFRD--DGLLHTTCGS 179
           DG++Y + K   HRDL   N ++     +KI DFG++       ++R    GLL      
Sbjct: 130 DGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPV---- 185

Query: 180 PNYVAPEVLANRGYDGATSDIWSCGVILY 208
             ++APE L + G    +SD+WS GV+L+
Sbjct: 186 -RWMAPESLKD-GVFTTSSDMWSFGVVLW 212

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 60.0 bits (145), Expect = 5e-10
 Identities = 61/207 (29%), Positives = 86/207 (41%), Gaps = 27/207 (13%)

Query: 22  LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATL-KLLKHPNVVRLH 80
           +GEGNFG+V  A+    GL     I                 E+  L KL  HPN++ L 
Sbjct: 15  IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 74

Query: 81  EVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLF----------QQLID----- 125
                +  +Y+ +EY   G L D +  K R+ E +               QQL+      
Sbjct: 75  GACEHRGYLYLAIEYAPHGNLLDFL-RKSRVLETDPAFAIANSTASTLSSQQLLHFAADV 133

Query: 126 --GVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGS--PN 181
             G+ Y   K   HRDL   NIL+      KI+DFGLS   + +     +  T G     
Sbjct: 134 ARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVY-----VKKTMGRLPVR 188

Query: 182 YVAPEVLANRGYDGATSDIWSCGVILY 208
           ++A E L    Y    SD+WS GV+L+
Sbjct: 189 WMAIESLNYSVYT-TNSDVWSYGVLLW 214

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 59.5 bits (144), Expect = 7e-10
 Identities = 49/168 (29%), Positives = 76/168 (45%), Gaps = 31/168 (18%)

Query: 22  LGEGNFGKV---------KFAQD-------LDSGLPFAVKILEKNRIIHLKITDQIKREI 65
           LGEG FG+V         KF           +  +  AVK+L ++   + +  D +K EI
Sbjct: 13  LGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNAR-NDFLK-EI 70

Query: 66  ATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEG--------- 116
             +  LK PN++RL  V  +   + M+ EY+  G+L ++  S+   QEA           
Sbjct: 71  KIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDL-NQFLSRHEPQEAAEKADVVTISY 129

Query: 117 ---RKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLS 161
                +  Q+  G+ Y  +    HRDL   N L+     IKI+DFG+S
Sbjct: 130 STLIFMATQIASGMKYLSSLNFVHRDLATRNCLVGKNYTIKIADFGMS 177

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 58.9 bits (142), Expect = 1e-09
 Identities = 52/196 (26%), Positives = 91/196 (46%), Gaps = 13/196 (6%)

Query: 20  RTLGEGNFGKVKFAQDLDSG----LPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
           + LG G FG V     +  G    +P A+K L +      K   +I  E   +  + +P+
Sbjct: 13  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELRE--ATSPKANKEILDEAYVMASVDNPH 70

Query: 76  VVRLHEVLASKSKIYMVLEYVTGGELFDKI-ASKGRLQEAEGRKLFQQLIDGVSYCHNKG 134
           V RL  +  + S + ++ + +  G L D +   K  +          Q+  G++Y   + 
Sbjct: 71  VCRLLGICLT-STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERR 129

Query: 135 VFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP--NYVAPEVLANRG 192
           + HRDL   N+L+ +  ++KI+DFGL+ L     D+   H   G     ++A E + +R 
Sbjct: 130 LVHRDLAARNVLVKTPQHVKITDFGLAKLLG--ADEKEYHAEGGKVPIKWMALESILHRI 187

Query: 193 YDGATSDIWSCGVILY 208
           Y    SD+WS GV ++
Sbjct: 188 YT-HQSDVWSYGVTVW 202

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 58.1 bits (140), Expect = 2e-09
 Identities = 53/211 (25%), Positives = 95/211 (45%), Gaps = 30/211 (14%)

Query: 22  LGEGNFGKVK----FAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVV 77
           LGE  FGK+     +   +D     A+K L+   I + +   + ++E + +  L HPN+V
Sbjct: 13  LGECAFGKIYKGHLYLPGMDHAQLVAIKTLKD--INNPQQWGEFQQEASLMAELHHPNIV 70

Query: 78  RLHEVLASKSKIYMVLEYVTGGELFDKI-----------------ASKGRLQEAEGRKLF 120
            L  V+  +  + M+ EY+  G+L + +                   K  L   +   + 
Sbjct: 71  CLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIA 130

Query: 121 QQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSA---LPQHFRDDGLLHTTC 177
            Q+  G+ Y  +    H+DL   NIL+  + ++KISD GLS       ++R   +   + 
Sbjct: 131 IQIAAGMEYLSSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYR---VQPKSL 187

Query: 178 GSPNYVAPEVLANRGYDGATSDIWSCGVILY 208
               ++ PE +    +  + SDIWS GV+L+
Sbjct: 188 LPIRWMPPEAIMYGKFS-SDSDIWSFGVVLW 217

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 57.4 bits (138), Expect = 4e-09
 Identities = 57/202 (28%), Positives = 94/202 (46%), Gaps = 25/202 (12%)

Query: 20  RTLGEGNFGKVKFAQDLDSG----LPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
           + LG G FG V     +  G    +P A+KIL  N     K   +   E   +  + HP+
Sbjct: 13  KVLGSGAFGTVYKGIWVPEGETVKIPVAIKIL--NETTGPKANVEFMDEALIMASMDHPH 70

Query: 76  VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQ----QLIDGVSYCH 131
           +VRL  V  S + I +V + +  G L D +      ++  G +L      Q+  G+ Y  
Sbjct: 71  LVRLLGVCLSPT-IQLVTQLMPHGCLLDYVHEH---KDNIGSQLLLNWCVQIAKGMMYLE 126

Query: 132 NKGVFHRDLKLENILLDSKGNIKISDFGLSAL-----PQHFRDDGLLHTTCGSPNYVAPE 186
            + + HRDL   N+L+ S  ++KI+DFGL+ L      ++  D G +        ++A E
Sbjct: 127 ERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPI-----KWMALE 181

Query: 187 VLANRGYDGATSDIWSCGVILY 208
            +  R +    SD+WS GV ++
Sbjct: 182 CIHYRKFT-HQSDVWSYGVTIW 202

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 56.9 bits (137), Expect = 4e-09
 Identities = 52/176 (29%), Positives = 76/176 (43%), Gaps = 39/176 (22%)

Query: 22  LGEGNFGKVKFA-----QDLDS-GLPF----------AVKILEKNRIIHLKITDQIKREI 65
           LGEG FG+V        QDL +   PF          AVKIL  +   + +  D +K E+
Sbjct: 13  LGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNAR-NDFLK-EV 70

Query: 66  ATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGR-------- 117
             L  LK PN++RL  V   +  + M+ EY+  G+L ++  S   L + E          
Sbjct: 71  KILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDL-NQFLSSHHLDDKEENGNDAVPPA 129

Query: 118 ------------KLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLS 161
                        +  Q+  G+ Y  +    HRDL   N L+     IKI+DFG+S
Sbjct: 130 HCLPAISYSSLLHVALQIASGMKYLSSLNFVHRDLATRNCLVGENLTIKIADFGMS 185

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 56.1 bits (135), Expect = 7e-09
 Identities = 54/200 (27%), Positives = 89/200 (44%), Gaps = 19/200 (9%)

Query: 19  GRTLGEGNFGKVK---FAQDLDS-GLPFAVKILE--KNRIIHLKITDQIKREIATLKLLK 72
            + LG G FG V    +  + DS  +P A+K ++    R    +ITD +      +  L 
Sbjct: 12  LKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHM----LAMGSLD 67

Query: 73  HPNVVRLHEVLASKSKIYMVLEYVTGGELFDKI-ASKGRLQEAEGRKLFQQLIDGVSYCH 131
           H  +VRL  +    S + +V +    G L D +   +  L          Q+  G+ Y  
Sbjct: 68  HAYIVRLLGICPGAS-LQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLE 126

Query: 132 NKGVFHRDLKLENILLDSKGNIKISDFGLSAL--PQHFRDDGLLHTTCGSP-NYVAPEVL 188
              + HR+L   NILL S   ++I+DFG++ L  P    D    ++   +P  ++A E +
Sbjct: 127 EHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPD---DKKYFYSEHKTPIKWMALESI 183

Query: 189 ANRGYDGATSDIWSCGVILY 208
               Y    SD+WS GV ++
Sbjct: 184 LFGRYT-HQSDVWSYGVTVW 202

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

 Score = 54.5 bits (131), Expect = 2e-08
 Identities = 48/202 (23%), Positives = 93/202 (46%), Gaps = 20/202 (9%)

Query: 22  LGEGNFGKVKFAQ-DLDSGLPFA-VKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRL 79
           +G G FGKV  ++   D+G+    VK L+ N     K  ++  ++    ++L+HPN+++ 
Sbjct: 3   IGNGWFGKVLLSEIYTDTGVARVVVKELKAN--ASSKEQNEFLQQGDPYRILQHPNILQC 60

Query: 80  HEVLASKSKIYMVLEYVTGGELFDKIAS----KGRLQEAEGRKLFQQLIDGVSYCHNKGV 135
                      +V EY   G+L   ++     +   Q    +++  ++  GV++ H    
Sbjct: 61  LGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNF 120

Query: 136 FHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLL--HTTCGSPNYVAPEVLANRGY 193
            H DL L N  L S   +K+ D+G+   P  +++D +      C    ++APE++    +
Sbjct: 121 LHSDLALRNCFLTSDLTVKVGDYGIG--PSRYKEDYIETEDDKCVPLRWLAPELVGEF-H 177

Query: 194 DGAT-------SDIWSCGVILY 208
            G         S++W+ GV L+
Sbjct: 178 GGLITAEQTKPSNVWALGVTLW 199

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 53.5 bits (128), Expect = 5e-08
 Identities = 54/211 (25%), Positives = 100/211 (47%), Gaps = 28/211 (13%)

Query: 18  LGRTLGEGNFGKV--KFAQDLDSGLP---FAVKILEKNRIIHLKITDQIKREIATLKLLK 72
           + R LG+G+FG V    A+ +    P    A+K + +   +  +I  +   E + +K   
Sbjct: 10  MSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERI--EFLNEASVMKEFN 67

Query: 73  HPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIAS-KGRLQEAEG------RKLFQ---Q 122
             +VVRL  V++      +++E +T G+L   + S +  ++          +K+ Q   +
Sbjct: 68  CHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGE 127

Query: 123 LIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLS---ALPQHFRD--DGLLHTTC 177
           + DG++Y +     HRDL   N ++     +KI DFG++       ++R    GLL    
Sbjct: 128 IADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPV-- 185

Query: 178 GSPNYVAPEVLANRGYDGATSDIWSCGVILY 208
               +++PE L + G     SD+WS GV+L+
Sbjct: 186 ---RWMSPESLKD-GVFTTYSDVWSFGVVLW 212

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score = 52.0 bits (124), Expect = 3e-07
 Identities = 55/204 (26%), Positives = 93/204 (45%), Gaps = 22/204 (10%)

Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
           Y+LG  +G G+FG V  A  +D+    A+K +       L+      RE+  +K L H N
Sbjct: 68  YKLGNIIGNGSFGVVYEAICIDTSEKVAIKKV-------LQDPQYKNRELLIMKNLNHIN 120

Query: 76  VVRLHEVLASKS------KIYM--VLEYV--TGGELFDKIASKGRLQEAEGRKLFQ-QLI 124
           ++ L +   ++        I++  V+E++  T  +     A           KL+  QL 
Sbjct: 121 IIFLKDYYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLC 180

Query: 125 DGVSYCHNKGVFHRDLKLENILLDSKGN-IKISDFGLSALPQHFRDDGLLHTTCGSPNYV 183
             ++Y H+K + HRDLK +N+L+D   + +K+ DFG  +          +   C S  Y 
Sbjct: 181 RALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFG--SAKNLLAGQRSVSYIC-SRFYR 237

Query: 184 APEVLANRGYDGATSDIWSCGVIL 207
           APE++          D+WS G I+
Sbjct: 238 APELMLGATNYTTHIDLWSLGCII 261

Length = 440

>gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta

 Score = 51.5 bits (123), Expect = 3e-07
 Identities = 53/203 (26%), Positives = 90/203 (44%), Gaps = 23/203 (11%)

Query: 17  ELGRTLGEGNFGKVKFAQDLDSGLPFAVKI--LEKNRIIHLKITDQIKREIATLKLLKHP 74
           E+GR  G  N   V  A+   +G    V+I  LE     HLK    ++ E+      +HP
Sbjct: 5   EIGR--GFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKA---LQNEVVLSHFFRHP 59

Query: 75  NVVRLHEVLASKSKIYMV---LEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCH 131
           N++    V  + S ++++   + Y +   L      +G + EA    +    + G++Y H
Sbjct: 60  NIMTSWTVFTTGSWLWVISPFMAYGSANSLLKTYFPEG-MSEALIGNILFGALRGLNYLH 118

Query: 132 NKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNY-------VA 184
             G  HR++K  +IL+   G + +S  GLS L    R+          P +       ++
Sbjct: 119 QNGYIHRNIKASHILISGDGLVSLS--GLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLS 176

Query: 185 PEVLAN--RGYDGATSDIWSCGV 205
           PE+L     GY+   SDI+S G+
Sbjct: 177 PELLRQDLYGYN-VKSDIYSVGI 198

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328

>gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha

 Score = 50.3 bits (120), Expect = 8e-07
 Identities = 41/153 (26%), Positives = 69/153 (45%), Gaps = 14/153 (9%)

Query: 64  EIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASK--GRLQEAEGRKLFQ 121
           E+   KL  HPN+V       + +++++V  ++  G   D I +     + E     + Q
Sbjct: 49  ELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMSELAIAYILQ 108

Query: 122 QLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPN 181
            ++  + Y H+ G  HR +K  +IL+   G + +S  GL +          L      P 
Sbjct: 109 GVLKALDYIHHMGYVHRSVKASHILISVDGKVYLS--GLRSNLSMINHGQRLRVVHDFPK 166

Query: 182 Y-------VAPEVLAN--RGYDGATSDIWSCGV 205
           Y       ++PEVL    +GYD A SDI+S G+
Sbjct: 167 YSVKVLPWLSPEVLQQNLQGYD-AKSDIYSVGI 198

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327

>gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 49.5 bits (118), Expect = 1e-06
 Identities = 52/172 (30%), Positives = 77/172 (44%), Gaps = 28/172 (16%)

Query: 55  LKITDQIKREIA-----TLKLLK---HPNVVRLHEVLASKSKIYMVLEYVTGGELFDKI- 105
           LK+ D   R+IA     T  L+    H ++  +H V    S+  MV E+V  G L D   
Sbjct: 49  LKVLDPSHRDIALAFFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPL-DVCL 107

Query: 106 -ASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKG-------NIKISD 157
              KGR+  A    + QQL   +SY  +K + H ++  +NILL   G        IK+SD
Sbjct: 108 RKEKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLAEGTSPFIKLSD 167

Query: 158 FGLS--ALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVIL 207
            G+S  AL +  R + +         ++APE +         +D WS G  L
Sbjct: 168 PGVSFTALSREERVERI--------PWIAPECVPGGNSLSTAADKWSFGTTL 211

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 49.5 bits (118), Expect = 1e-06
 Identities = 71/278 (25%), Positives = 101/278 (36%), Gaps = 98/278 (35%)

Query: 15  RYELGRTLGEGNFGKVKFAQDLD-----SGLPFAVKILE--------KNRIIHLKITDQI 61
           R +LG+ LG G FGKV  A         S    AVK+L+        K  +  LKI   I
Sbjct: 8   RLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHI 67

Query: 62  KREIATLKLL-----------------KHPNVVRLHEVLASKSKIYMV--LEYVTGGELF 102
              +  + LL                 K  N   L   L SK + +     +     E+ 
Sbjct: 68  GHHLNVVNLLGACTKPGGPLMVIVEYCKFGN---LSNYLRSKRECFSPYRNKSTRKREMK 124

Query: 103 DKIASKGRL------------------------QEAEGRKLFQ-------------QLID 125
            K   K RL                        ++ EG +L++             Q+  
Sbjct: 125 QKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELYKEPLTLEDLISYSFQVAR 184

Query: 126 GVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYV-- 183
           G+ +  ++   HRDL   NILL     +KI DFGL+      RD          P+YV  
Sbjct: 185 GMEFLASRKCIHRDLAARNILLSENNVVKICDFGLA------RD------IYKDPDYVRK 232

Query: 184 ----------APEVLANRGYDGATSDIWSCGVILY-IF 210
                     APE + ++ Y    SD+WS GV+L+ IF
Sbjct: 233 GDARLPLKWMAPESIFDKVYT-TQSDVWSFGVLLWEIF 269

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 48.5 bits (115), Expect = 3e-06
 Identities = 32/92 (34%), Positives = 47/92 (51%), Gaps = 11/92 (11%)

Query: 122 QLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLS----ALPQHFRD-DGLLHTT 176
           Q+  G+ +  ++   HRDL   NILL     +KI DFGL+      P + R  D  L   
Sbjct: 187 QVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPL- 245

Query: 177 CGSPNYVAPEVLANRGYDGATSDIWSCGVILY 208
                ++APE + +R Y    SD+WS GV+L+
Sbjct: 246 ----KWMAPETIFDRVYT-IQSDVWSFGVLLW 272

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 46.9 bits (111), Expect = 8e-06
 Identities = 49/209 (23%), Positives = 95/209 (45%), Gaps = 29/209 (13%)

Query: 20  RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIK--REIATLKLLKHPNVV 77
           + +G G FGKV    +++SG   A +++ K   +   + +Q+K   E    + L+H N++
Sbjct: 1   KEIGNGWFGKV-ILGEVNSGYTPA-QVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLL 58

Query: 78  RLHEVLASKSKIYMVLEYVTGGELFDKIAS--KGRLQEAEGRKLFQQLID---GVSYCHN 132
           +        +   +V+E+   G+L   + S  K  L   +   L +   +   G+ + H 
Sbjct: 59  QCLGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHK 118

Query: 133 KGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPN-------YVAP 185
               H DL L N LL +   +KI D+GLS     +++D  +     +P+       ++AP
Sbjct: 119 NNFIHSDLALRNCLLTADLTVKIGDYGLSHN--KYKEDYYV-----TPDQLWVPLRWIAP 171

Query: 186 EVLANRGYD------GATSDIWSCGVILY 208
           E++     +         S++WS GV ++
Sbjct: 172 ELVDEVHGNLLVVDQTKESNVWSLGVTIW 200

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional

 Score = 46.7 bits (111), Expect = 2e-05
 Identities = 33/120 (27%), Positives = 53/120 (44%), Gaps = 26/120 (21%)

Query: 79  LHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGR---KLFQQLIDGVSYCHNKGV 135
           L +++ SK   Y V  Y     L  K+    +  E E +    + +Q++  +   H+ G+
Sbjct: 222 LADLMQSKEFPYNVEPY-----LLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGI 276

Query: 136 FHRDLKLENILLD-SKGNIKISDFGLSA--------LPQHFRDDGLLHTTCGSPNYVAPE 186
            HRD+K +NI+     G+ KI D G +A        +P+ F  D         P Y APE
Sbjct: 277 VHRDVKPQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLD---------PRYAAPE 327

Length = 566

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 46.1 bits (109), Expect = 2e-05
 Identities = 35/106 (33%), Positives = 54/106 (50%), Gaps = 8/106 (7%)

Query: 122 QLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD-DGLLHTTCGSP 180
           Q+  G+ +  ++   HRDL   NILL     +KI DFGL+     ++D D +   +   P
Sbjct: 182 QVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLAR--DIYKDPDYVRKGSARLP 239

Query: 181 -NYVAPEVLANRGYDGATSDIWSCGVILYIFRGDFKLPKWLSPGAQ 225
             ++APE + ++ Y    SD+WS GV+L+     F L     PG Q
Sbjct: 240 LKWMAPESIFDKVYT-TQSDVWSFGVLLWEI---FSLGASPYPGVQ 281

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 46.2 bits (109), Expect = 2e-05
 Identities = 33/127 (25%), Positives = 55/127 (43%), Gaps = 18/127 (14%)

Query: 99  GELFDKIASKGRLQEAEGRKLFQ-----------------QLIDGVSYCHNKGVFHRDLK 141
              +D+ AS     ++E + L                   Q+  G+ +  +K   HRDL 
Sbjct: 205 RSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLA 264

Query: 142 LENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIW 201
             N+LL     +KI DFGL+    H  +     +T     ++APE + +  Y    SD+W
Sbjct: 265 ARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYT-TLSDVW 323

Query: 202 SCGVILY 208
           S G++L+
Sbjct: 324 SYGILLW 330

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|213376 cd12120, AMPKA_C_like, C-terminal regulatory domain of 5'-AMP-activated protein kinase (AMPK) alpha subunit and similar domains

 Score = 41.8 bits (98), Expect = 4e-05
 Identities = 18/92 (19%), Positives = 36/92 (39%), Gaps = 2/92 (2%)

Query: 319 RKIRFTSNHSAKDLLERIEDIVTEMGFR--VQKKNGKLKATQEHKPQKSLGSLSVAAEVF 376
            ++   S     ++ E I  ++   G     +  N  +     +     L S     EV+
Sbjct: 4   WELEIHSRIDPSEIYEGIHKVLEGWGKNLVFRITNFIITGKLVNDHILFLRSTLFEIEVY 63

Query: 377 EISPSLYVVELRKSYGDPTVYRQLCNKLSSDL 408
           E+ P L++V+ +K  G    + +L  K+   L
Sbjct: 64  EVGPGLFMVDFKKKTGSTKTFTKLATKIQIKL 95

This family is composed of AMPKs, microtubule-associated protein/microtubule affinity regulating kinases (MARKs), yeast Kcc4p-like proteins, plant calcineurin B-Like (CBL)-interacting protein kinases (CIPKs), and similar proteins. They are serine/threonine protein kinases (STKs) that catalyze the transfer of the gamma-phosphoryl group from ATP to S/T residues on protein substrates. AMPKs act as sensors for the energy status of the cell and are activated by cellular stresses that lead to ATP depletion such as hypoxia, heat shock, and glucose deprivation, among others. MARKs phosphorylate the tau protein and related microtubule-associated proteins (MAPs) on tubulin binding sites to induce detachment from microtubules, and are involved in the regulation of cell shape and polarity, cell cycle control, transport, and the cytoskeleton. Kcc4p and related proteins are septin-associated proteins that are involved in septin organization and in the yeast morphogenesis checkpoint coordinating the cell cycle with bud formation. CIPKs interact with the calcineurin B-like (CBL) calcium sensors to form a signaling network that decode specific calcium signals triggered by a variety of environmental stimuli including salinity, drought, cold, light, and mechanical perturbation, among others. All members of this family contain an N-terminal catalytic kinase domain and a C-terminal regulatory domain which is also called kinase associated domain 1 (KA1) in some cases. The C-terminal regulatory domain serves as a protein interaction domain in AMPKs and CIPKs. In MARKs and Kcc4p-like proteins, this domain binds phospholipids and may be involved in membrane localization. Length = 95

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 44.2 bits (104), Expect = 8e-05
 Identities = 31/92 (33%), Positives = 49/92 (53%), Gaps = 6/92 (6%)

Query: 122 QLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLH--TTCGS 179
           Q+ +G+ +  +K   HRDL   N+L+     +KI DFGL+      RD   +   +T   
Sbjct: 247 QVANGMEFLASKNCVHRDLAARNVLICEGKLVKICDFGLAR--DIMRDSNYISKGSTFLP 304

Query: 180 PNYVAPEVLANRGYDGATSDIWSCGVILY-IF 210
             ++APE + N  Y    SD+WS G++L+ IF
Sbjct: 305 LKWMAPESIFNNLYT-TLSDVWSFGILLWEIF 335

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional

 Score = 44.2 bits (104), Expect = 9e-05
 Identities = 53/218 (24%), Positives = 89/218 (40%), Gaps = 33/218 (15%)

Query: 14  GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKH 73
            R+++   LGEG FGKV  A D       AVKI+        K T   K EI  ++ ++ 
Sbjct: 129 QRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP----KYTRDAKIEIQFMEKVRQ 184

Query: 74  PNV------VRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGV 127
            +       +++     +++    ++    G  L D I   G        ++  Q    +
Sbjct: 185 ADPADRFPLMKIQRYFQNETGHMCIVMPKYGPCLLDWIMKHGPFSHRHLAQIIFQTGVAL 244

Query: 128 SYCHNK-GVFHRDLKLENILLDSKGN----------------IKISDFGLSALPQHFRDD 170
            Y H +  + H DLK ENIL+++                   ++I D G     +H R  
Sbjct: 245 DYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICDLGGCCDERHSRT- 303

Query: 171 GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILY 208
                   + +Y +PEV+   G+  +T D+WS G I+Y
Sbjct: 304 ----AIVSTRHYRSPEVVLGLGWMYST-DMWSMGCIIY 336

Length = 467

>gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 42.8 bits (101), Expect = 1e-04
 Identities = 43/161 (26%), Positives = 71/161 (44%), Gaps = 28/161 (17%)

Query: 63  REIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLF-- 120
              + +  L H ++V+L+ V      I MV EYV  G L D    + +   +   KL   
Sbjct: 50  ETASLMSQLSHKHLVKLYGVCVRDENI-MVEEYVKFGPL-DVFLHREKNNVSLHWKLDVA 107

Query: 121 QQLIDGVSYCHNKGVFHRDLKLENILL----DSKGN---IKISDFG--LSALPQHFRDDG 171
           +QL   + Y  +K + H ++  +NIL+     ++G    IK+SD G  ++ L +  R + 
Sbjct: 108 KQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSREERVE- 166

Query: 172 LLHTTCGSPNYVAPEVLANRGYDGATSDI----WSCGVILY 208
                   P ++APE + N     A+  I    WS G  L 
Sbjct: 167 ------RIP-WIAPECIRN---GQASLTIAADKWSFGTTLL 197

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 43.0 bits (101), Expect = 2e-04
 Identities = 34/99 (34%), Positives = 46/99 (46%), Gaps = 25/99 (25%)

Query: 122 QLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPN 181
           Q+  G+S+  +K   HRDL   NILL      KI DFGL+   +  R+D          N
Sbjct: 222 QVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLA---RDIRNDS---------N 269

Query: 182 YV------------APEVLANRGYDGATSDIWSCGVILY 208
           YV            APE + N  Y    SD+WS G++L+
Sbjct: 270 YVVKGNARLPVKWMAPESIFNCVYT-FESDVWSYGILLW 307

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 42.1 bits (99), Expect = 4e-04
 Identities = 32/102 (31%), Positives = 45/102 (44%), Gaps = 26/102 (25%)

Query: 122 QLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPN 181
           Q+  G+ +  +K   HRD+   N+LL      KI DFGL+      RD           N
Sbjct: 220 QVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLA------RD------IMNDSN 267

Query: 182 YV------------APEVLANRGYDGATSDIWSCGVILY-IF 210
           YV            APE + +  Y    SD+WS G++L+ IF
Sbjct: 268 YVVKGNARLPVKWMAPESIFDCVYT-VQSDVWSYGILLWEIF 308

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional

 Score = 42.4 bits (99), Expect = 4e-04
 Identities = 17/43 (39%), Positives = 28/43 (65%)

Query: 117 RKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFG 159
           + + +Q++ G+   H  G+ HRD+K EN+L+   G +KI DFG
Sbjct: 312 KGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFG 354

Length = 507

>gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

 Score = 40.1 bits (94), Expect = 4e-04
 Identities = 28/132 (21%), Positives = 52/132 (39%), Gaps = 17/132 (12%)

Query: 37  DSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVV-RLHEVLASKSKIYMVLE 94
                + +KI               +RE+A L+LL +    V ++     S    Y+++E
Sbjct: 19  TKDEDYVLKINPSREKGA-----DREREVAILQLLARKGLPVPKVLASGESDGWSYLLME 73

Query: 95  YVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHN---KGVFHRDLKLENILLDSKG 151
           ++ G  L         + E E   + +QL + ++  H      + H DL   NIL+D   
Sbjct: 74  WIEGETL-------DEVSEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGK 126

Query: 152 NIKISDFGLSAL 163
            + I D+  +  
Sbjct: 127 ILGIIDWEYAGY 138

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155

>gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 39.2 bits (91), Expect = 0.002
 Identities = 46/180 (25%), Positives = 80/180 (44%), Gaps = 28/180 (15%)

Query: 48  EKNRIIHLKITDQIKREIA--------TLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGG 99
           EK   + LK+ D   R+I+         ++ + H ++V L+ V     +  MV E+V  G
Sbjct: 30  EKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENIMVEEFVEFG 89

Query: 100 --ELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILL-----DSKGN 152
             +LF    S   L      K+ +QL   +SY  +K + H ++  +NILL     D +  
Sbjct: 90  PLDLFMHRKSD-VLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECG 148

Query: 153 --IKISDFG--LSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILY 208
             IK+SD G  ++ L +    + +         ++APE + +       +D WS G  L+
Sbjct: 149 PFIKLSDPGIPITVLSRQECVERI--------PWIAPECVEDSKNLSIAADKWSFGTTLW 200

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262

>gnl|CDD|237847 PRK14879, PRK14879, serine/threonine protein kinase; Provisional

 Score = 38.7 bits (91), Expect = 0.002
 Identities = 29/87 (33%), Positives = 43/87 (49%), Gaps = 7/87 (8%)

Query: 75  NVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKG 134
           NV  ++ V      I  V+EY+ G  L D I S G  +    R++ +     V   H+ G
Sbjct: 62  NVPAVYFVDPENFII--VMEYIEGEPLKDLINSNGMEELELSREIGRL----VGKLHSAG 115

Query: 135 VFHRDLKLENILLDSKGNIKISDFGLS 161
           + H DL   N++L S G I + DFGL+
Sbjct: 116 IIHGDLTTSNMIL-SGGKIYLIDFGLA 141

Length = 211

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 38.7 bits (90), Expect = 0.004
 Identities = 31/101 (30%), Positives = 50/101 (49%), Gaps = 14/101 (13%)

Query: 17  ELGRTLGEGNFGKVKFAQDL-----DSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL 71
           + G+TLG G FGKV  A        D+ L  AVK+L+ +   H   TD+ +  ++ LK+L
Sbjct: 41  QFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKAS--AH---TDEREALMSELKIL 95

Query: 72  ----KHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASK 108
               +H N+V L         + ++ EY   G+L + +  K
Sbjct: 96  SHLGQHKNIVNLLGACTHGGPVLVITEYCCYGDLLNFLRKK 136

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|213377 cd12121, MARK_C_like, C-terminal kinase associated domain 1 (KA1), a phospholipid binding domain, of microtubule affinity-regulating kinases, and similar domains

 Score = 36.0 bits (84), Expect = 0.004
 Identities = 20/103 (19%), Positives = 39/103 (37%), Gaps = 20/103 (19%)

Query: 319 RKIRF------TSNHSAKDLLERIEDIVTEMGFR-VQKKNGKLKATQEHKPQKSLGSLSV 371
           R +R       TS  S ++++  I+ ++   G    +     L+            S   
Sbjct: 1   RSLRGPFSVATTSTKSPEEIMNEIKRVLRSNGIDYEEVGGYLLECKHG-------DSSGG 53

Query: 372 AAEVFEI------SPSLYVVELRKSYGDPTVYRQLCNKLSSDL 408
              +FEI         L  +  ++  GD   Y++LC K+ ++L
Sbjct: 54  EFVIFEIEICKLPRLGLNGIRFKRISGDSWQYKRLCKKILNEL 96

Microtubule-associated protein/microtubule affinity regulating kinases (MARKs), also called partition-defective (Par-1) kinases, are serine/threonine protein kinases (STKs) that catalyze the transfer of the gamma-phosphoryl group from ATP to S/T residues on protein substrates. They phosphorylate the tau protein and related microtubule-associated proteins (MAPs) on tubulin binding sites to induce detachment from microtubules, and are involved in the regulation of cell shape and polarity, cell cycle control, transport, and the cytoskeleton. Mammals contain four proteins, MARK1-4, encoded by distinct genes belonging to this subfamily, with additional isoforms arising from alternative splicing. In yeast, MARK/Par-1 homologs are called Kin1/2 kinases. Kin1 is a membrane-associated kinase that is involved in regulating cytokinesis and the cell surface. MARKs contain an N-terminal catalytic kinase domain, a ubiquitin-associated domain (UBA), and a C-terminal kinase associated domain (KA1). The KA1 domain binds anionic phospholipids and may be involved in membrane localization as well as in auto-inhibition of the kinase domain. Length = 96

>gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 38.3 bits (89), Expect = 0.004
 Identities = 54/217 (24%), Positives = 91/217 (41%), Gaps = 42/217 (19%)

Query: 21  TLGEGNFGKVKFAQDLDSG-------LPFAVKILEKNRIIHLKITDQIKREIATLKLLKH 73
           +LG+G F K+      + G           +K+L+K+   H   ++      + +  L H
Sbjct: 2   SLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKS---HRNYSESFFEAASMMSQLSH 58

Query: 74  PNVVRLHEVLASKSKIYMVLEYVTGGEL-------FDKIASKGRLQEAEGRKLFQQLIDG 126
            ++V  + V     +  MV EYV  G L        + I    +L+ A      +QL   
Sbjct: 59  KHLVLNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISWKLEVA------KQLAWA 112

Query: 127 VSYCHNKGVFHRDLKLENILL-----DSKGN---IKISDFGLS--ALPQHFRDDGLLHTT 176
           + +  +KG+ H ++  +N+LL        GN   IK+SD G+S   LP+    + +    
Sbjct: 113 LHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPKEILLERI---- 168

Query: 177 CGSPNYVAPEVLANRGYDGATSDIWSCGVILY-IFRG 212
                +V PE + N       +D WS G  L+ IF G
Sbjct: 169 ----PWVPPECIENPQNLSLAADKWSFGTTLWEIFSG 201

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	421
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
KOG4717	864	consensus Serine/threonine protein kinase [Signal	100.0
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
KOG0694	694	consensus Serine/threonine protein kinase [Signal	100.0
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	100.0
KOG0586	596	consensus Serine/threonine protein kinase [General	100.0
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
KOG0610	459	consensus Putative serine/threonine protein kinase	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
KOG0690	516	consensus Serine/threonine protein kinase [Signal	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
KOG0201	467	consensus Serine/threonine protein kinase [Signal	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
KOG0589	426	consensus Serine/threonine protein kinase [General	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	100.0
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
PTZ00284	467	protein kinase; Provisional	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	100.0
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
KOG1989	738	consensus ARK protein kinase family [Signal transd	100.0
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	100.0
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	100.0
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
KOG0607	463	consensus MAP kinase-interacting kinase and relate	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	100.0
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	100.0
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	100.0
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	100.0
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	100.0
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	100.0
KOG0577	948	consensus Serine/threonine protein kinase [Signal	100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	100.0
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	100.0
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
PLN00009	294	cyclin-dependent kinase A; Provisional	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	100.0
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	100.0
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	100.0
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	100.0
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	100.0
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	100.0
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	100.0
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	100.0
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	100.0
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	100.0
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
PHA03210	501	serine/threonine kinase US3; Provisional	100.0
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	100.0
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	100.0
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	100.0
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	100.0
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	100.0
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	100.0
KOG0596	677	consensus Dual specificity; serine/threonine and t	100.0
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	100.0
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	100.0
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	100.0
PTZ00024	335	cyclin-dependent protein kinase; Provisional	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	100.0
KOG0696	683	consensus Serine/threonine protein kinase [Signal	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	100.0
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	100.0
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
KOG0695	593	consensus Serine/threonine protein kinase [Signal	100.0
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	100.0
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	100.0
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	100.0
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	100.0
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	100.0
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
KOG4721	904	consensus Serine/threonine protein kinase, contain	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	100.0
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	100.0
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	100.0
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	100.0
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	100.0
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	100.0
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	100.0
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	100.0
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	100.0
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	100.0
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	100.0
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	100.0
KOG0584	632	consensus Serine/threonine protein kinase [General	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	100.0
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	100.0
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	100.0
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	100.0
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	100.0
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	100.0
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	100.0
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	100.0
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	100.0
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	100.0
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	100.0
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	100.0
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	100.0
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	100.0
PHA02882	294	putative serine/threonine kinase; Provisional	100.0
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	100.0
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	100.0
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	100.0
KOG1152	772	consensus Signal transduction serine/threonine kin	100.0
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	100.0
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	100.0
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	100.0
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	100.0
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	100.0
KOG1290	590	consensus Serine/threonine protein kinase [Signal	100.0
PLN03224	507	probable serine/threonine protein kinase; Provisio	100.0
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	100.0
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	100.0
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	100.0
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	100.0
KOG0576	829	consensus Mitogen-activated protein kinase kinase	100.0
KOG1027	903	consensus Serine/threonine protein kinase and endo	100.0
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	100.0
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	100.0
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	100.0
KOG2052	513	consensus Activin A type IB receptor, serine/threo	100.0
KOG1167	418	consensus Serine/threonine protein kinase of the C	99.97
KOG3653	534	consensus Transforming growth factor beta/activin	99.97
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	99.97
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.97
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	99.96
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.96
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	99.96
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.96
PLN00181	793	protein SPA1-RELATED; Provisional	99.96
PRK09188	365	serine/threonine protein kinase; Provisional	99.95
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.94
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.92
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.92
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.92
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.92
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	99.92
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.92
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.91
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.91
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.9
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.89
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.88
PRK10345	210	hypothetical protein; Provisional	99.87
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.87
smart00090	237	RIO RIO-like kinase.	99.86
PRK12274	218	serine/threonine protein kinase; Provisional	99.86
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.85
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.84
PRK14879	211	serine/threonine protein kinase; Provisional	99.83
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.83
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.82
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.82
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.81
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.78
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.78
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.74
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.74
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.73
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.67
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.56
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.55
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.54
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.54
KOG1243	690	consensus Protein kinase [General function predict	99.53
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.5
PF03822	63	NAF: NAF domain; InterPro: IPR004041 The NAF domai	99.49
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.49
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.43
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	99.34
KOG1266	458	consensus Protein kinase [Signal transduction mech	99.31
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	99.3
KOG3087	229	consensus Serine/threonine protein kinase [General	99.29
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	99.14
KOG2137	700	consensus Protein kinase [Signal transduction mech	99.12
COG0478	304	RIO-like serine/threonine protein kinase fused to	99.1
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	99.07
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	99.05
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	98.93
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	98.77
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	98.72
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	98.72
PRK09902	216	hypothetical protein; Provisional	98.67
COG4248	637	Uncharacterized protein with protein kinase and he	98.63
PF01636	239	APH: Phosphotransferase enzyme family This family	98.56
COG0661	517	AarF Predicted unusual protein kinase [General fun	98.54
KOG0576	829	consensus Mitogen-activated protein kinase kinase	98.51
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	98.47
PLN02876	822	acyl-CoA dehydrogenase	98.4
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	98.36
PF13095	207	FTA2: Kinetochore Sim4 complex subunit FTA2	98.25
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	98.2
PF02149	47	KA1: Kinase associated domain 1; InterPro: IPR0017	98.18
PF10707	199	YrbL-PhoP_reg: PhoP regulatory network protein Yrb	98.17
COG2112	201	Predicted Ser/Thr protein kinase [Signal transduct	98.11
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	98.1
KOG1235	538	consensus Predicted unusual protein kinase [Genera	98.08
PRK09550	401	mtnK methylthioribose kinase; Reviewed	98.04
cd05157	235	ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes.	97.97
KOG2268	465	consensus Serine/threonine protein kinase [Signal	97.94
TIGR02721	256	ycfN_thiK thiamine kinase. Members of this family	97.91
cd05153	296	HomoserineK_II Homoserine Kinase, type II. Homoser	97.89
PRK10593	297	hypothetical protein; Provisional	97.88
TIGR00938	307	thrB_alt homoserine kinase, Neisseria type. Homose	97.73
KOG2270	520	consensus Serine/threonine protein kinase involved	97.73
KOG1826	2724	consensus Ras GTPase activating protein RasGAP/neu	97.73
PRK05231	319	homoserine kinase; Provisional	97.66
cd05156	302	ChoK_euk Choline Kinase (ChoK) in eukaryotes. The	97.64
COG3173	321	Predicted aminoglycoside phosphotransferase [Gener	97.62
cd05152	276	MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH	97.31
TIGR02906	313	spore_CotS spore coat protein, CotS family. Member	97.18
TIGR01767	370	MTRK 5-methylthioribose kinase. This enzyme is inv	97.18
PLN02756	418	S-methyl-5-thioribose kinase	97.1
PLN02236	344	choline kinase	96.99
PLN02421	330	phosphotransferase, alcohol group as acceptor/kina	96.86
PRK12396	409	5-methylribose kinase; Reviewed	96.76
TIGR02904	309	spore_ysxE spore coat protein YsxE. Members of thi	96.76
PF01633	211	Choline_kinase: Choline/ethanolamine kinase; Inter	96.29
PTZ00384	383	choline kinase; Provisional	96.29
PF03881	288	Fructosamin_kin: Fructosamine kinase; InterPro: IP	96.06
KOG1093	725	consensus Predicted protein kinase (contains TBC a	96.05
PF07387	308	Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099	95.88
PRK11768	325	serine/threonine protein kinase; Provisional	95.84
COG5072	488	ALK1 Serine/threonine kinase of the haspin family	95.82
KOG1236	565	consensus Predicted unusual protein kinase [Genera	95.23
PRK06148	1013	hypothetical protein; Provisional	95.15

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3.8e-60  Score=448.20  Aligned_cols=241  Identities=39%  Similarity=0.724  Sum_probs=213.0

Q ss_pred             eecceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchh----HHHHHHHHHHHHhcCCCCCcceEEEEEEeCC
Q 014609           12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLK----ITDQIKREIATLKLLKHPNVVRLHEVLASKS   87 (421)
Q Consensus        12 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~----~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~   87 (421)
                      .-..|.+.+.||+|+||.|.+|.++.||+.||||++++.......    ....+.+|++||++|+|||||+++++|+.++
T Consensus       170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d  249 (475)
T KOG0615|consen  170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD  249 (475)
T ss_pred             hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence            446789999999999999999999999999999999987655422    2345789999999999999999999999999


Q ss_pred             EEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccC---CCEEEEeccCCCCC
Q 014609           88 KIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSK---GNIKISDFGLSALP  164 (421)
Q Consensus        88 ~~~lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~---~~~kL~DFGla~~~  164 (421)
                      ..||||||+.||+|++++..++.+.+...+.+++||+.|+.|||++||+||||||+|||+..+   ..+||+|||+|++.
T Consensus       250 s~YmVlE~v~GGeLfd~vv~nk~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKItDFGlAK~~  329 (475)
T KOG0615|consen  250 SSYMVLEYVEGGELFDKVVANKYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKITDFGLAKVS  329 (475)
T ss_pred             ceEEEEEEecCccHHHHHHhccccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEecccchhhcc
Confidence            999999999999999999999999999999999999999999999999999999999999776   57999999999975


Q ss_pred             ccccCCCccccccCCCCccChhhhcccCCC--CCcchHHHHHHHHhhhc---------------------CCcCC--CCC
Q 014609          165 QHFRDDGLLHTTCGSPNYVAPEVLANRGYD--GATSDIWSCGVILYIFR---------------------GDFKL--PKW  219 (421)
Q Consensus       165 ~~~~~~~~~~~~~gt~~y~APEvl~~~~~~--~~~~DiwSlGvil~~~~---------------------~~~~~--p~~  219 (421)
                      .   ....+.+.||||.|+|||++.+.++.  +.++||||+||+||++.                     |.+.+  |.|
T Consensus       330 g---~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~y~f~p~~w  406 (475)
T KOG0615|consen  330 G---EGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKGRYAFGPLQW  406 (475)
T ss_pred             c---cceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcCcccccChhh
Confidence            4   46788999999999999999876543  45789999999999433                     22222  223


Q ss_pred             --CCHHHHHHHHHhcCCCCCCCCCHHhhhcCccccccc
Q 014609          220 --LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY  255 (421)
Q Consensus       220 --~s~~~~~li~~~L~~dP~~R~t~~eil~~~w~~~~~  255 (421)
                        +|.++++||.+||..||++|||++|+|+||||+...
T Consensus       407 ~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW~~~~~  444 (475)
T KOG0615|consen  407 DRISEEALDLINWMLVVDPENRPSADEALNHPWFKDAP  444 (475)
T ss_pred             hhhhHHHHHHHHHhhEeCcccCcCHHHHhcChhhhccc
Confidence              789999999999999999999999999999998543

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-58  Score=455.78  Aligned_cols=242  Identities=55%  Similarity=1.021  Sum_probs=224.2

Q ss_pred             CeeecceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccc--hhHHHHHHHHHHHHhcCC-CCCcceEEEEEEeC
Q 014609           10 GMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIH--LKITDQIKREIATLKLLK-HPNVVRLHEVLASK   86 (421)
Q Consensus        10 ~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~--~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~   86 (421)
                      ....++|.+++.||+|+||+|++|.+..+|+.||+|++++.....  ....+.+.+|+.++++++ ||||+++++++...
T Consensus        13 ~~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~   92 (370)
T KOG0583|consen   13 QLSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATP   92 (370)
T ss_pred             ccccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecC
Confidence            367789999999999999999999999999999999888753321  134567889999999999 99999999999999


Q ss_pred             CEEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccC-CCEEEEeccCCCCCc
Q 014609           87 SKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSK-GNIKISDFGLSALPQ  165 (421)
Q Consensus        87 ~~~~lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~-~~~kL~DFGla~~~~  165 (421)
                      ..+|+||||+.||+|++++...+++++..++++|+||++||+|||++||+||||||||||++.+ +++||+|||++....
T Consensus        93 ~~~~ivmEy~~gGdL~~~i~~~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~~~  172 (370)
T KOG0583|consen   93 TKIYIVMEYCSGGDLFDYIVNKGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNEGNLKLSDFGLSAISP  172 (370)
T ss_pred             CeEEEEEEecCCccHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCCCCEEEeccccccccC
Confidence            9999999999999999999999999999999999999999999999999999999999999999 999999999999764


Q ss_pred             cccCCCccccccCCCCccChhhhcccC-CCCCcchHHHHHHHHh--------------------hhcCCcCCCCCC-CHH
Q 014609          166 HFRDDGLLHTTCGSPNYVAPEVLANRG-YDGATSDIWSCGVILY--------------------IFRGDFKLPKWL-SPG  223 (421)
Q Consensus       166 ~~~~~~~~~~~~gt~~y~APEvl~~~~-~~~~~~DiwSlGvil~--------------------~~~~~~~~p~~~-s~~  223 (421)
                        .....+.+.||||.|+|||++.+.. |++.++|||||||+||                    +..+.+.+|.|+ |++
T Consensus       173 --~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki~~~~~~~p~~~~S~~  250 (370)
T KOG0583|consen  173 --GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKIRKGEFKIPSYLLSPE  250 (370)
T ss_pred             --CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHHhcCCccCCCCcCCHH
Confidence              3567889999999999999999988 9999999999999999                    345667889999 999


Q ss_pred             HHHHHHHhcCCCCCCCCCHHhhhcCccccc
Q 014609          224 AQNLLRKILEPNPVKRITIAGIKADEWFEQ  253 (421)
Q Consensus       224 ~~~li~~~L~~dP~~R~t~~eil~~~w~~~  253 (421)
                      +.+|+++||.+||.+|+|+.+|+.||||+.
T Consensus       251 ~~~Li~~mL~~~P~~R~t~~~i~~h~w~~~  280 (370)
T KOG0583|consen  251 ARSLIEKMLVPDPSTRITLLEILEHPWFQK  280 (370)
T ss_pred             HHHHHHHHcCCCcccCCCHHHHhhChhhcc
Confidence            999999999999999999999999999998

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=4.9e-58  Score=453.47  Aligned_cols=244  Identities=37%  Similarity=0.702  Sum_probs=226.9

Q ss_pred             cceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEE
Q 014609           14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVL   93 (421)
Q Consensus        14 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~   93 (421)
                      .+|..++.||+|||+.||.+++..+|+.||+|++++.........+.+.+||+|++.|+|||||+++++|++.+++|||+
T Consensus        18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL   97 (592)
T KOG0575|consen   18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL   97 (592)
T ss_pred             ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence            45999999999999999999999999999999999988888888999999999999999999999999999999999999


Q ss_pred             eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCccccCCCcc
Q 014609           94 EYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLL  173 (421)
Q Consensus        94 E~~~gg~L~~~i~~~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~  173 (421)
                      |+|..++|..++.+.++++|.+|+.+++||+.||.|||+++|+|||||..|++|+++-++||+|||||+....  +....
T Consensus        98 ELC~~~sL~el~Krrk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~--~~Erk  175 (592)
T KOG0575|consen   98 ELCHRGSLMELLKRRKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEY--DGERK  175 (592)
T ss_pred             EecCCccHHHHHHhcCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeecCcCcEEecccceeeeecC--ccccc
Confidence            9999999999999999999999999999999999999999999999999999999999999999999997654  34567


Q ss_pred             ccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhh-c-------------------CCcCCCCCCCHHHHHHHHHhcC
Q 014609          174 HTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIF-R-------------------GDFKLPKWLSPGAQNLLRKILE  233 (421)
Q Consensus       174 ~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~-~-------------------~~~~~p~~~s~~~~~li~~~L~  233 (421)
                      .+.||||.|.||||+...++ +..+||||+||++|.+ .                   .++.+|..+|.++++||.+||+
T Consensus       176 ~TlCGTPNYIAPEVl~k~gH-sfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~~Y~~P~~ls~~A~dLI~~lL~  254 (592)
T KOG0575|consen  176 KTLCGTPNYIAPEVLNKSGH-SFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLNEYSMPSHLSAEAKDLIRKLLR  254 (592)
T ss_pred             ceecCCCcccChhHhccCCC-CCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhcCcccccccCHHHHHHHHHHhc
Confidence            78999999999999998887 6999999999999933 3                   3455688899999999999999


Q ss_pred             CCCCCCCCHHhhhcCccccccccCCCC
Q 014609          234 PNPVKRITIAGIKADEWFEQDYTPANP  260 (421)
Q Consensus       234 ~dP~~R~t~~eil~~~w~~~~~~~~~~  260 (421)
                      +||.+|||+++|+.|+||.+++.|...
T Consensus       255 ~~P~~Rpsl~~vL~h~Ff~~g~~p~~l  281 (592)
T KOG0575|consen  255 PNPSERPSLDEVLDHPFFKSGFTPARL  281 (592)
T ss_pred             CCcccCCCHHHHhcCHhhhCCCcCCCC
Confidence            999999999999999999888776543

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.6e-57  Score=451.43  Aligned_cols=245  Identities=47%  Similarity=0.832  Sum_probs=228.3

Q ss_pred             cCCeeecceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCC
Q 014609            8 QEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKS   87 (421)
Q Consensus         8 ~~~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~   87 (421)
                      ....++|-|+++++||.|+.|.|.+|++..||+.+|||++.+..-........+.+||.||+.+.||||+.+|++++++.
T Consensus         6 ~~~~tiGpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~   85 (786)
T KOG0588|consen    6 SHKNTIGPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQ   85 (786)
T ss_pred             cccccccceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCc
Confidence            34567899999999999999999999999999999999998874444444567999999999999999999999999999


Q ss_pred             EEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCccc
Q 014609           88 KIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHF  167 (421)
Q Consensus        88 ~~~lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~  167 (421)
                      ++|+|.||++||+||+++..++++++.++.++|+||+.|+.|||..+|+||||||||+|||..+++||+|||+|.+-.  
T Consensus        86 ~lylvlEyv~gGELFdylv~kG~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~--  163 (786)
T KOG0588|consen   86 HLYLVLEYVPGGELFDYLVRKGPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDVKNNIKIADFGMASLEV--  163 (786)
T ss_pred             eEEEEEEecCCchhHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhcccCEeeeccceeeccc--
Confidence            999999999999999999999999999999999999999999999999999999999999999999999999999643  


Q ss_pred             cCCCccccccCCCCccChhhhcccCCCCCcchHHHHHHHHh--------------------hhcCCcCCCCCCCHHHHHH
Q 014609          168 RDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILY--------------------IFRGDFKLPKWLSPGAQNL  227 (421)
Q Consensus       168 ~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~--------------------~~~~~~~~p~~~s~~~~~l  227 (421)
                       .+.++.+.||+|.|.|||++.+.+|+|.++||||||||||                    ...|.|.+|..+|+++++|
T Consensus       164 -~gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~G~f~MPs~Is~eaQdL  242 (786)
T KOG0588|consen  164 -PGKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQRGVFEMPSNISSEAQDL  242 (786)
T ss_pred             -CCccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHcCcccCCCcCCHHHHHH
Confidence             4678999999999999999999999999999999999999                    3357788899999999999


Q ss_pred             HHHhcCCCCCCCCCHHhhhcCccccccc
Q 014609          228 LRKILEPNPVKRITIAGIKADEWFEQDY  255 (421)
Q Consensus       228 i~~~L~~dP~~R~t~~eil~~~w~~~~~  255 (421)
                      |++||..||++|+|.++|++|||+....
T Consensus       243 Lr~ml~VDp~~RiT~~eI~kHP~l~g~~  270 (786)
T KOG0588|consen  243 LRRMLDVDPSTRITTEEILKHPFLSGYT  270 (786)
T ss_pred             HHHHhccCccccccHHHHhhCchhhcCC
Confidence            9999999999999999999999998754

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=5.2e-55  Score=410.24  Aligned_cols=241  Identities=38%  Similarity=0.694  Sum_probs=220.5

Q ss_pred             CeeecceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEE
Q 014609           10 GMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKI   89 (421)
Q Consensus        10 ~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~   89 (421)
                      ....++|++++.||+|+||+|++++.+.|++.+|+|++++..+......+....|..||..++||+||+++..|++...+
T Consensus        21 ~~~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kL  100 (357)
T KOG0598|consen   21 MVGPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKL  100 (357)
T ss_pred             cCChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeE
Confidence            35578999999999999999999999999999999999998888777788999999999999999999999999999999


Q ss_pred             EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCccccC
Q 014609           90 YMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD  169 (421)
Q Consensus        90 ~lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~  169 (421)
                      |+|+||+.||+|+..+++.+.+++..++.|+..|+.||.|||+.||+||||||||||||.+|+++|+|||||+..-.  .
T Consensus       101 ylVld~~~GGeLf~hL~~eg~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~--~  178 (357)
T KOG0598|consen  101 YLVLDYLNGGELFYHLQREGRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDEQGHIKLTDFGLCKEDLK--D  178 (357)
T ss_pred             EEEEeccCCccHHHHHHhcCCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecCCCcEEEeccccchhccc--C
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999985332  3


Q ss_pred             CCccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhhc--------------------CC-cCCCCCCCHHHHHHH
Q 014609          170 DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIFR--------------------GD-FKLPKWLSPGAQNLL  228 (421)
Q Consensus       170 ~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~~--------------------~~-~~~p~~~s~~~~~li  228 (421)
                      .....+.|||+.|||||++.+.+|+ ..+|+||||+++|.|.                    +. ...|..++.++++++
T Consensus       179 ~~~t~tfcGT~eYmAPEil~~~gy~-~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k~~~~p~~ls~~ardll  257 (357)
T KOG0598|consen  179 GDATRTFCGTPEYMAPEILLGKGYD-KAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGKLPLPPGYLSEEARDLL  257 (357)
T ss_pred             CCccccccCCccccChHHHhcCCCC-cccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCcCCCCCccCCHHHHHHH
Confidence            4566778999999999999999995 8899999999999443                    33 223445899999999


Q ss_pred             HHhcCCCCCCCC----CHHhhhcCccccc
Q 014609          229 RKILEPNPVKRI----TIAGIKADEWFEQ  253 (421)
Q Consensus       229 ~~~L~~dP~~R~----t~~eil~~~w~~~  253 (421)
                      +++|..||.+|.    .+.+|.+||||..
T Consensus       258 ~~LL~rdp~~RLg~~~d~~~ik~HpfF~~  286 (357)
T KOG0598|consen  258 KKLLKRDPRQRLGGPGDAEEIKRHPFFKG  286 (357)
T ss_pred             HHHhccCHHHhcCCCCChHHhhcCccccc
Confidence            999999999996    6889999999975

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-54  Score=395.56  Aligned_cols=237  Identities=38%  Similarity=0.749  Sum_probs=223.3

Q ss_pred             eeecceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEE
Q 014609           11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIY   90 (421)
Q Consensus        11 ~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~   90 (421)
                      ..+.+|+++++||.|+||.|.+++++.+|..+|+|++++....+..+.+...+|..+|+.+.||+++++++.+.+.+.+|
T Consensus        41 ~~l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~ly  120 (355)
T KOG0616|consen   41 YSLQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLY  120 (355)
T ss_pred             cchhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEE
Confidence            56789999999999999999999999999999999999999888888999999999999999999999999999999999


Q ss_pred             EEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCccccCC
Q 014609           91 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD  170 (421)
Q Consensus        91 lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~  170 (421)
                      +||||++||+|+.++.+.+++++..|+.|+.||+.||+|||+++|++|||||||||||.+|.+||+|||+|+-.     .
T Consensus       121 mvmeyv~GGElFS~Lrk~~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v-----~  195 (355)
T KOG0616|consen  121 MVMEYVPGGELFSYLRKSGRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQNGHIKITDFGFAKRV-----S  195 (355)
T ss_pred             EEEeccCCccHHHHHHhcCCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeeccCCcEEEEeccceEEe-----c
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999843     3


Q ss_pred             CccccccCCCCccChhhhcccCCCCCcchHHHHHHHHh--------------------hhcCCcCCCCCCCHHHHHHHHH
Q 014609          171 GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILY--------------------IFRGDFKLPKWLSPGAQNLLRK  230 (421)
Q Consensus       171 ~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~--------------------~~~~~~~~p~~~s~~~~~li~~  230 (421)
                      +..-+.||||.|+|||++..++|. .++|+|||||++|                    ++.|.+.+|..+++++++||++
T Consensus       196 ~rT~TlCGTPeYLAPEii~sk~yn-kavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~~~v~fP~~fs~~~kdLl~~  274 (355)
T KOG0616|consen  196 GRTWTLCGTPEYLAPEIIQSKGYN-KAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKILEGKVKFPSYFSSDAKDLLKK  274 (355)
T ss_pred             CcEEEecCCccccChHHhhcCCCC-cchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHhCcccCCcccCHHHHHHHHH
Confidence            447789999999999999999994 8899999999999                    4456777899999999999999


Q ss_pred             hcCCCCCCCC-----CHHhhhcCccccc
Q 014609          231 ILEPNPVKRI-----TIAGIKADEWFEQ  253 (421)
Q Consensus       231 ~L~~dP~~R~-----t~~eil~~~w~~~  253 (421)
                      +|+.|-.+|.     ...+|..||||+.
T Consensus       275 LL~vD~t~R~gnlknG~~dIk~H~wF~~  302 (355)
T KOG0616|consen  275 LLQVDLTKRFGNLKNGVEDIKNHPWFKG  302 (355)
T ss_pred             HHhhhhHhhhcCcCCCccccccCccccc
Confidence            9999999994     5789999999985

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=7.8e-53  Score=398.94  Aligned_cols=241  Identities=39%  Similarity=0.666  Sum_probs=217.4

Q ss_pred             CeeecceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEE
Q 014609           10 GMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKI   89 (421)
Q Consensus        10 ~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~   89 (421)
                      ...+++|.+.+.||+|+||+||+|+++.++..||||.+.+..+ ..+..+.+..|+.+|+.++|||||.++++++.++.+
T Consensus         6 ~~~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l-~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i   84 (429)
T KOG0595|consen    6 MRVVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKL-NKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFI   84 (429)
T ss_pred             ccccccceehhhccCcceEEEEEeEeccCCceEEeeeehhhcc-CHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeE
Confidence            4567999999999999999999999999999999999988765 445578899999999999999999999999999999


Q ss_pred             EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccC------CCEEEEeccCCCC
Q 014609           90 YMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSK------GNIKISDFGLSAL  163 (421)
Q Consensus        90 ~lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~------~~~kL~DFGla~~  163 (421)
                      |+|||||.||+|.+++...+.+++..++.+++||+.||++||+++|+||||||+||||+..      -.+||+|||+|+.
T Consensus        85 ~lVMEyC~gGDLs~yi~~~~~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~  164 (429)
T KOG0595|consen   85 YLVMEYCNGGDLSDYIRRRGRLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARF  164 (429)
T ss_pred             EEEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccchhhh
Confidence            9999999999999999999999999999999999999999999999999999999999875      3589999999997


Q ss_pred             CccccCCCccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhh-cCCcCC----------------------CCCC
Q 014609          164 PQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIF-RGDFKL----------------------PKWL  220 (421)
Q Consensus       164 ~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~-~~~~~~----------------------p~~~  220 (421)
                      ..   ......+.||+|.|||||++....|+ .|+|+||+|+|||.+ .|..++                      |.++
T Consensus       165 L~---~~~~a~tlcGSplYMAPEV~~~~~Yd-AKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~~~~~~~~~~~~  240 (429)
T KOG0595|consen  165 LQ---PGSMAETLCGSPLYMAPEVIMSQQYD-AKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKKGNEIVPVLPAEL  240 (429)
T ss_pred             CC---chhHHHHhhCCccccCHHHHHhcccc-chhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhccccccCchhhhc
Confidence            65   45678899999999999999988896 899999999999944 333332                      3457


Q ss_pred             CHHHHHHHHHhcCCCCCCCCCHHhhhcCccccccc
Q 014609          221 SPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY  255 (421)
Q Consensus       221 s~~~~~li~~~L~~dP~~R~t~~eil~~~w~~~~~  255 (421)
                      ++...+|+...|..+|..|.+..+-+.|+++....
T Consensus       241 s~~~~~Ll~~ll~~~~~~~~~~~~~~~~~~l~~~p  275 (429)
T KOG0595|consen  241 SNPLRELLISLLQRNPKDRISFEDFFDHPFLAANP  275 (429)
T ss_pred             cCchhhhhhHHHhcCccccCchHHhhhhhhcccCc
Confidence            78888999999999999999999999999987654

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=4.9e-53  Score=411.87  Aligned_cols=244  Identities=35%  Similarity=0.630  Sum_probs=220.9

Q ss_pred             CeeecceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcC-CCCCcceEEEEEEeCCE
Q 014609           10 GMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEVLASKSK   88 (421)
Q Consensus        10 ~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~   88 (421)
                      .....+|.+++.||+|+|++|++|++..+++.||||++.+..+..+....-+.+|-.+|.+| .||+|++|+-.|.+...
T Consensus        69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~s  148 (604)
T KOG0592|consen   69 KKTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEES  148 (604)
T ss_pred             cCChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccc
Confidence            45568999999999999999999999999999999999998877777777889999999999 79999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCcccc
Q 014609           89 IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFR  168 (421)
Q Consensus        89 ~~lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~~  168 (421)
                      +|+|+||+++|+|.++|..-+.+++..++.|+.||+.||+|||++|||||||||||||||.++++||+|||-|++.....
T Consensus       149 LYFvLe~A~nGdll~~i~K~Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~dmhikITDFGsAK~l~~~~  228 (604)
T KOG0592|consen  149 LYFVLEYAPNGDLLDLIKKYGSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDKDGHIKITDFGSAKILSPSQ  228 (604)
T ss_pred             eEEEEEecCCCcHHHHHHHhCcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcCCCcEEEeeccccccCChhh
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999999764422


Q ss_pred             CC-----------CccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhh--------------------hcCCcCCC
Q 014609          169 DD-----------GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYI--------------------FRGDFKLP  217 (421)
Q Consensus       169 ~~-----------~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~--------------------~~~~~~~p  217 (421)
                      ..           ....+++||-.|++||++.+... ++.+|||+||||||.                    +.-.+.+|
T Consensus       229 ~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~-~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~~l~y~fp  307 (604)
T KOG0592|consen  229 KSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPA-GPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQALDYEFP  307 (604)
T ss_pred             ccccCccCcccccCcccceeeeecccCHHHhcCCCC-CcccchHHHHHHHHHHhcCCCCCccccHHHHHHHHHHhcccCC
Confidence            11           11245889999999999987655 699999999999992                    33346778


Q ss_pred             CCCCHHHHHHHHHhcCCCCCCCCCHHhhhcCcccccc
Q 014609          218 KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD  254 (421)
Q Consensus       218 ~~~s~~~~~li~~~L~~dP~~R~t~~eil~~~w~~~~  254 (421)
                      +.+++.+.+||+++|..||.+|+|+.||.+||||...
T Consensus       308 ~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~HpFF~~V  344 (604)
T KOG0592|consen  308 EGFPEDARDLIKKLLVRDPSDRLTSQQIKAHPFFEGV  344 (604)
T ss_pred             CCCCHHHHHHHHHHHccCccccccHHHHhhCcccccC
Confidence            9999999999999999999999999999999999863

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=8.6e-53  Score=395.38  Aligned_cols=239  Identities=31%  Similarity=0.525  Sum_probs=215.0

Q ss_pred             CeeecceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCC-E
Q 014609           10 GMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKS-K   88 (421)
Q Consensus        10 ~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~-~   88 (421)
                      +..+.+.+.++.||+|+.|+||+++|+.|++.+|+|++..+  .+.....++.+|+++++..+|||||++|+.|.++. .
T Consensus        75 ~i~~~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~--~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~  152 (364)
T KOG0581|consen   75 GISLSDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLN--IDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEE  152 (364)
T ss_pred             ccCHHHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeeccc--CCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCce
Confidence            34556788899999999999999999999999999999543  24455789999999999999999999999999999 4


Q ss_pred             EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCceeccCCCCCEEeccCCCEEEEeccCCCCCccc
Q 014609           89 IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHN-KGVFHRDLKLENILLDSKGNIKISDFGLSALPQHF  167 (421)
Q Consensus        89 ~~lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~ql~~aL~~LH~-~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~  167 (421)
                      ++|+||||.||+|.+.+...++++|....+++.++++||.|||+ ++|+||||||+|||++..|.+||||||.+..... 
T Consensus       153 isI~mEYMDgGSLd~~~k~~g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvn-  231 (364)
T KOG0581|consen  153 ISICMEYMDGGSLDDILKRVGRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVN-  231 (364)
T ss_pred             EEeehhhcCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCCCEEeccccccHHhhh-
Confidence            99999999999999999988999999999999999999999996 8999999999999999999999999999986533 


Q ss_pred             cCCCccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhh-cCCcCCCC-------------------------C-C
Q 014609          168 RDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIF-RGDFKLPK-------------------------W-L  220 (421)
Q Consensus       168 ~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~-~~~~~~p~-------------------------~-~  220 (421)
                         ....+..||..|||||.+.+..| +.++||||||+.++++ .|+||+|+                         . +
T Consensus       232 ---S~a~tfvGT~~YMsPERi~g~~Y-s~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~ppP~lP~~~f  307 (364)
T KOG0581|consen  232 ---SIANTFVGTSAYMSPERISGESY-SVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEPPPRLPEGEF  307 (364)
T ss_pred             ---hhcccccccccccChhhhcCCcC-CcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCCCCCCCcccC
Confidence               36788999999999999999988 5889999999999954 45555443                         2 7


Q ss_pred             CHHHHHHHHHhcCCCCCCCCCHHhhhcCccccccc
Q 014609          221 SPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY  255 (421)
Q Consensus       221 s~~~~~li~~~L~~dP~~R~t~~eil~~~w~~~~~  255 (421)
                      |+++++||..||++||.+|+|+.|+++|||+++..
T Consensus       308 S~ef~~FV~~CL~Kdp~~R~s~~qLl~Hpfi~~~~  342 (364)
T KOG0581|consen  308 SPEFRSFVSCCLRKDPSERPSAKQLLQHPFIKKFE  342 (364)
T ss_pred             CHHHHHHHHHHhcCCcccCCCHHHHhcCHHHhhcc
Confidence            89999999999999999999999999999999754

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=3.2e-53  Score=399.48  Aligned_cols=240  Identities=44%  Similarity=0.769  Sum_probs=223.2

Q ss_pred             cceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEE
Q 014609           14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVL   93 (421)
Q Consensus        14 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~   93 (421)
                      -||++.++||+|.||+|.+|.+...|+.||||.|++..+.+....-.+.+||+||..|+||||+.+|++|++.+.+.|||
T Consensus        53 HRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivM  132 (668)
T KOG0611|consen   53 HRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVM  132 (668)
T ss_pred             hHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEE
Confidence            48999999999999999999999999999999999999988888889999999999999999999999999999999999


Q ss_pred             eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCccccCCCcc
Q 014609           94 EYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLL  173 (421)
Q Consensus        94 E~~~gg~L~~~i~~~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~  173 (421)
                      ||..+|+|+|++...+.+++.+++.+|+||++|+.|||.++++|||||.+|||+|.|+++||+|||++.++.   +...+
T Consensus       133 EYaS~GeLYDYiSer~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~N~NiKIADFGLSNly~---~~kfL  209 (668)
T KOG0611|consen  133 EYASGGELYDYISERGSLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQNNNIKIADFGLSNLYA---DKKFL  209 (668)
T ss_pred             EecCCccHHHHHHHhccccHHHHHHHHHHHHHHHHHHhhccceecccchhheeecCCCCeeeeccchhhhhc---cccHH
Confidence            999999999999999999999999999999999999999999999999999999999999999999998765   35678


Q ss_pred             ccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhh-cCCcCCC------------------CCCCHHHHHHHHHhcCC
Q 014609          174 HTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIF-RGDFKLP------------------KWLSPGAQNLLRKILEP  234 (421)
Q Consensus       174 ~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~-~~~~~~p------------------~~~s~~~~~li~~~L~~  234 (421)
                      +++||+|.|.+||++.+.+|.|+.+|-|||||+||.+ .|..++.                  +.-+.++.-||+.||-.
T Consensus       210 qTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~GaYrEP~~PSdA~gLIRwmLmV  289 (668)
T KOG0611|consen  210 QTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISRGAYREPETPSDASGLIRWMLMV  289 (668)
T ss_pred             HHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhcccccCCCCCchHHHHHHHHHhc
Confidence            9999999999999999999999999999999999943 3333332                  23577889999999999


Q ss_pred             CCCCCCCHHhhhcCcccccccc
Q 014609          235 NPVKRITIAGIKADEWFEQDYT  256 (421)
Q Consensus       235 dP~~R~t~~eil~~~w~~~~~~  256 (421)
                      ||++|.|+++|-.|=|++..+.
T Consensus       290 NP~RRATieDiAsHWWvNwgy~  311 (668)
T KOG0611|consen  290 NPERRATIEDIASHWWVNWGYN  311 (668)
T ss_pred             CcccchhHHHHhhhheeecccc
Confidence            9999999999999999987664

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=9.4e-51  Score=396.07  Aligned_cols=243  Identities=34%  Similarity=0.613  Sum_probs=215.7

Q ss_pred             CeeecceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEE
Q 014609           10 GMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKI   89 (421)
Q Consensus        10 ~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~   89 (421)
                      ...+++|++++.||+|+||.||+|+.+.||+.+|+|++++......+.++.+..|-.+|...++|+||++|..|++...+
T Consensus       137 r~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~L  216 (550)
T KOG0605|consen  137 RLSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYL  216 (550)
T ss_pred             cCCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCee
Confidence            45678999999999999999999999999999999999999888888889999999999999999999999999999999


Q ss_pred             EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCcc---
Q 014609           90 YMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQH---  166 (421)
Q Consensus        90 ~lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~---  166 (421)
                      |+||||++||++..+|.+.+.++++.+++|+.+++.|++.+|..|++||||||+|+|||..|++||+|||||+-...   
T Consensus       217 YLiMEylPGGD~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~~~  296 (550)
T KOG0605|consen  217 YLIMEYLPGGDMMTLLMRKDTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKKHR  296 (550)
T ss_pred             EEEEEecCCccHHHHHHhcCcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecCCCCEeeccccccchhhhhhh
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999863211   


Q ss_pred             -----------------ccCCC-------------------------ccccccCCCCccChhhhcccCCCCCcchHHHHH
Q 014609          167 -----------------FRDDG-------------------------LLHTTCGSPNYVAPEVLANRGYDGATSDIWSCG  204 (421)
Q Consensus       167 -----------------~~~~~-------------------------~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlG  204 (421)
                                       ...+.                         ......|||.|+||||+.+++| +..+|+||||
T Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY-~~~cDwWSLG  375 (550)
T KOG0605|consen  297 IESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGY-GKECDWWSLG  375 (550)
T ss_pred             hhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCC-CccccHHHHH
Confidence                             00000                         1123479999999999999998 5899999999


Q ss_pred             HHHhhhcCCcC-C---------------------CC--CCCHHHHHHHHHhcCCCCCCCCC---HHhhhcCcccccc
Q 014609          205 VILYIFRGDFK-L---------------------PK--WLSPGAQNLLRKILEPNPVKRIT---IAGIKADEWFEQD  254 (421)
Q Consensus       205 vil~~~~~~~~-~---------------------p~--~~s~~~~~li~~~L~~dP~~R~t---~~eil~~~w~~~~  254 (421)
                      ||+|++.-++| +                     |.  .+++++.+||.++|. ||.+|..   ++||.+||||+..
T Consensus       376 ~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~~~~~s~eA~DLI~rll~-d~~~RLG~~G~~EIK~HPfF~~v  451 (550)
T KOG0605|consen  376 CIMYEMLVGYPPFCSETPQETYRKIVNWRETLKFPEEVDLSDEAKDLITRLLC-DPENRLGSKGAEEIKKHPFFKGV  451 (550)
T ss_pred             HHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCCcCcccHHHHHHHHHHhc-CHHHhcCcccHHHHhcCCccccC
Confidence            99996544332 2                     22  278999999999999 9999985   8999999999863

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-50  Score=387.85  Aligned_cols=250  Identities=39%  Similarity=0.684  Sum_probs=211.3

Q ss_pred             ccCCeeecceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccch-----------hHHHHHHHHHHHHhcCCCCC
Q 014609            7 KQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHL-----------KITDQIKREIATLKLLKHPN   75 (421)
Q Consensus         7 ~~~~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~-----------~~~~~~~~Ei~il~~l~hpn   75 (421)
                      -+....+++|++++.||+|.||+|.+|++..+++.||||++++......           .-.+.+.+||.||++|.|||
T Consensus        90 ~~~~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~n  169 (576)
T KOG0585|consen   90 DQDRKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPN  169 (576)
T ss_pred             cccceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcC
Confidence            3445778999999999999999999999999999999999987543211           11468999999999999999


Q ss_pred             cceEEEEEEeC--CEEEEEEeccCCCChHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCC
Q 014609           76 VVRLHEVLASK--SKIYMVLEYVTGGELFDKIASKGR-LQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGN  152 (421)
Q Consensus        76 Iv~l~~~~~~~--~~~~lv~E~~~gg~L~~~i~~~~~-~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~  152 (421)
                      ||+++++..+.  +.+|||+|||..|.+.. .-.+++ +++.+|+.|++.++.||+|||.+||+||||||+|+||+++|.
T Consensus       170 VV~LiEvLDDP~s~~~YlVley~s~G~v~w-~p~d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~~~g~  248 (576)
T KOG0585|consen  170 VVKLIEVLDDPESDKLYLVLEYCSKGEVKW-CPPDKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLSSDGT  248 (576)
T ss_pred             eeEEEEeecCcccCceEEEEEeccCCcccc-CCCCcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEcCCCc
Confidence            99999999765  57999999999998743 444455 999999999999999999999999999999999999999999


Q ss_pred             EEEEeccCCCCCccc---cCCCccccccCCCCccChhhhcc---cCCCCCcchHHHHHHHHh-hhcCCcC----------
Q 014609          153 IKISDFGLSALPQHF---RDDGLLHTTCGSPNYVAPEVLAN---RGYDGATSDIWSCGVILY-IFRGDFK----------  215 (421)
Q Consensus       153 ~kL~DFGla~~~~~~---~~~~~~~~~~gt~~y~APEvl~~---~~~~~~~~DiwSlGvil~-~~~~~~~----------  215 (421)
                      +||+|||.+..+...   ..+..+....|||.|+|||.+.+   ..+.|.+.||||+||+|| .+.|..|          
T Consensus       249 VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~l~  328 (576)
T KOG0585|consen  249 VKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELELF  328 (576)
T ss_pred             EEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHHHH
Confidence            999999999865322   12234455789999999999876   567789999999999999 3344433          


Q ss_pred             ---------CCC--CCCHHHHHHHHHhcCCCCCCCCCHHhhhcCccccccccC
Q 014609          216 ---------LPK--WLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTP  257 (421)
Q Consensus       216 ---------~p~--~~s~~~~~li~~~L~~dP~~R~t~~eil~~~w~~~~~~~  257 (421)
                               +|.  .+.+.+++||.+||++||.+|+++.+|..|||...+...
T Consensus       329 ~KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~g~~  381 (576)
T KOG0585|consen  329 DKIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRDGDS  381 (576)
T ss_pred             HHHhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecceeccCCCC
Confidence                     333  368999999999999999999999999999999887543

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=3.1e-50  Score=367.44  Aligned_cols=237  Identities=29%  Similarity=0.458  Sum_probs=202.5

Q ss_pred             ecceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEE
Q 014609           13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMV   92 (421)
Q Consensus        13 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv   92 (421)
                      +++|+.+.++|+|+||.||+++++.||+.||||.+-.+. .+....+-..|||++|+.|+|||+|.++++|.....+++|
T Consensus         1 MekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Ese-dd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLV   79 (396)
T KOG0593|consen    1 MEKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESE-DDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLV   79 (396)
T ss_pred             CcHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCC-ccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEE
Confidence            478999999999999999999999999999999986433 2334456678999999999999999999999999999999


Q ss_pred             EeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCccccCCCc
Q 014609           93 LEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGL  172 (421)
Q Consensus        93 ~E~~~gg~L~~~i~~~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~  172 (421)
                      +|||+..-|.+.-....+++++.++.|+.|++.|+.|||+++++|||||||||||+.+|.+||||||+|+....  +...
T Consensus        80 FE~~dhTvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~--pgd~  157 (396)
T KOG0593|consen   80 FEYCDHTVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQNGVVKLCDFGFARTLSA--PGDN  157 (396)
T ss_pred             eeecchHHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEecCCcEEeccchhhHhhcC--Ccch
Confidence            99997644443333456799999999999999999999999999999999999999999999999999997653  3455


Q ss_pred             cccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhhcC-Cc-------------------------------------
Q 014609          173 LHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIFRG-DF-------------------------------------  214 (421)
Q Consensus       173 ~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~~~-~~-------------------------------------  214 (421)
                      .+.+..|.+|+|||.+.+...+|.++||||+||++.++.. ..                                     
T Consensus       158 YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~G  237 (396)
T KOG0593|consen  158 YTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFHG  237 (396)
T ss_pred             hhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCceee
Confidence            6778899999999999885555899999999999983321 11                                     


Q ss_pred             -CCC------------CCCCHHHHHHHHHhcCCCCCCCCCHHhhhcCcccc
Q 014609          215 -KLP------------KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFE  252 (421)
Q Consensus       215 -~~p------------~~~s~~~~~li~~~L~~dP~~R~t~~eil~~~w~~  252 (421)
                       .+|            +.++.-+.+++++||+.||++|++.+|++.|++|.
T Consensus       238 v~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H~yFd  288 (396)
T KOG0593|consen  238 VRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHHPYFD  288 (396)
T ss_pred             eecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcChHHH
Confidence             111            12567889999999999999999999999999994

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3.8e-51  Score=370.10  Aligned_cols=236  Identities=31%  Similarity=0.544  Sum_probs=205.0

Q ss_pred             CCeeecceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEE-EEEeC-
Q 014609            9 EGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHE-VLASK-   86 (421)
Q Consensus         9 ~~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~-~~~~~-   86 (421)
                      ....+..|+++++||+|+||.||++.+..+|..||.|.+.-.. .+......+..|+.+|+.|+|||||++++ .+..+ 
T Consensus        14 ~~~~l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~-md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~   92 (375)
T KOG0591|consen   14 PQKTLADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGM-MDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDN   92 (375)
T ss_pred             CcccHHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhh-ccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccc
Confidence            3456778999999999999999999999999999999997433 34455678999999999999999999998 44444 


Q ss_pred             CEEEEEEeccCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh--CC--ceeccCCCCCEEeccCCCEEEEec
Q 014609           87 SKIYMVLEYVTGGELFDKIAS----KGRLQEAEGRKLFQQLIDGVSYCHN--KG--VFHRDLKLENILLDSKGNIKISDF  158 (421)
Q Consensus        87 ~~~~lv~E~~~gg~L~~~i~~----~~~~~~~~~~~~~~ql~~aL~~LH~--~g--i~HrDlkp~NILl~~~~~~kL~DF  158 (421)
                      ..++||||||.+|+|...|..    .+.+++..+++++.||+.||.+||+  ..  |.||||||.||+|+.+|.+||+||
T Consensus        93 evlnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDf  172 (375)
T KOG0591|consen   93 EVLNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDF  172 (375)
T ss_pred             hhhHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccc
Confidence            449999999999999998863    4579999999999999999999999  44  999999999999999999999999


Q ss_pred             cCCCCCccccCCCccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhh--------------------cCCcC-CC
Q 014609          159 GLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIF--------------------RGDFK-LP  217 (421)
Q Consensus       159 Gla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~--------------------~~~~~-~p  217 (421)
                      |+++++.+  .....++..|||.||+||++.+.+|+ .++||||+||++|++                    .|+++ +|
T Consensus       173 GL~r~l~s--~~tfA~S~VGTPyYMSPE~i~~~~Y~-~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI~qgd~~~~p  249 (375)
T KOG0591|consen  173 GLGRFLSS--KTTFAHSLVGTPYYMSPERIHESGYN-FKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKIEQGDYPPLP  249 (375)
T ss_pred             hhHhHhcc--hhHHHHhhcCCCcccCHHHHhcCCCC-cchhHHHHHHHHHHHHhcCCCcccccHHHHHHHHHcCCCCCCc
Confidence            99998765  45567888999999999999999995 999999999999933                    45554 56


Q ss_pred             -CCCCHHHHHHHHHhcCCCCCCCCCHHhhhcCccccc
Q 014609          218 -KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQ  253 (421)
Q Consensus       218 -~~~s~~~~~li~~~L~~dP~~R~t~~eil~~~w~~~  253 (421)
                       ..+|.++..+|..|+.+||..||+.     +|++.+
T Consensus       250 ~~~YS~~l~~li~~ci~vd~~~RP~t-----~~~v~d  281 (375)
T KOG0591|consen  250 DEHYSTDLRELINMCIAVDPEQRPDT-----VPYVQD  281 (375)
T ss_pred             HHHhhhHHHHHHHHHccCCcccCCCc-----chHHHH
Confidence             5689999999999999999999986     555543

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-51  Score=365.69  Aligned_cols=236  Identities=39%  Similarity=0.763  Sum_probs=211.1

Q ss_pred             cceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEE
Q 014609           14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVL   93 (421)
Q Consensus        14 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~   93 (421)
                      +.|++-+.||+|.|+.|+.+.+..+|+.+|+|+++...+... ..+.+.+|++|-+.|+||||+++++.+.+....|+|+
T Consensus        11 d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~-~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvF   89 (355)
T KOG0033|consen   11 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSAR-DFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF   89 (355)
T ss_pred             hhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccc-cHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEE
Confidence            689999999999999999999999999999999987665443 4688999999999999999999999999999999999


Q ss_pred             eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccC---CCEEEEeccCCCCCccccCC
Q 014609           94 EYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSK---GNIKISDFGLSALPQHFRDD  170 (421)
Q Consensus        94 E~~~gg~L~~~i~~~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~---~~~kL~DFGla~~~~~~~~~  170 (421)
                      |++.|++|+.-|..+-.+++..+-.+++||++||+|||.+||+|||+||+|+|+...   .-+||+|||+|....   +.
T Consensus        90 e~m~G~dl~~eIV~R~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~---~g  166 (355)
T KOG0033|consen   90 DLVTGGELFEDIVAREFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVN---DG  166 (355)
T ss_pred             ecccchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceEEEeC---Cc
Confidence            999999998888777778999999999999999999999999999999999999654   359999999998544   45


Q ss_pred             CccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhh--------------------cCCcCCC--CC--CCHHHHH
Q 014609          171 GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIF--------------------RGDFKLP--KW--LSPGAQN  226 (421)
Q Consensus       171 ~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~--------------------~~~~~~p--~~--~s~~~~~  226 (421)
                      .......|||.|||||++...+| +.++|||+||||||++                    .|.+.+|  .|  +++++++
T Consensus       167 ~~~~G~~GtP~fmaPEvvrkdpy-~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~yd~~~~~w~~is~~Ak~  245 (355)
T KOG0033|consen  167 EAWHGFAGTPGYLSPEVLKKDPY-SKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGAYDYPSPEWDTVTPEAKS  245 (355)
T ss_pred             cccccccCCCcccCHHHhhcCCC-CCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhccccCCCCcccCcCCHHHHH
Confidence            56777899999999999998888 6899999999999943                    3333333  34  8999999


Q ss_pred             HHHHhcCCCCCCCCCHHhhhcCcccccc
Q 014609          227 LLRKILEPNPVKRITIAGIKADEWFEQD  254 (421)
Q Consensus       227 li~~~L~~dP~~R~t~~eil~~~w~~~~  254 (421)
                      |+++||..||.+|+|+.|.|+|||+.+.
T Consensus       246 LvrrML~~dP~kRIta~EAL~HpWi~~r  273 (355)
T KOG0033|consen  246 LIRRMLTVNPKKRITADEALKHPWICNR  273 (355)
T ss_pred             HHHHHhccChhhhccHHHHhCCchhcch
Confidence            9999999999999999999999999864

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.5e-50  Score=387.45  Aligned_cols=239  Identities=31%  Similarity=0.556  Sum_probs=207.3

Q ss_pred             eeecceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCC-CCCcceEEEEEEeCC-E
Q 014609           11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK-HPNVVRLHEVLASKS-K   88 (421)
Q Consensus        11 ~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~-~   88 (421)
                      ..++||.++++||.|+||.||+|+...+|+.||||.+++... ..+. -.-.||+..|++|+ |||||++.+++.+.+ .
T Consensus         7 ~~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~-s~ee-~~nLREvksL~kln~hpniikL~Evi~d~~~~   84 (538)
T KOG0661|consen    7 IFMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFY-SWEE-CMNLREVKSLRKLNPHPNIIKLKEVIRDNDRI   84 (538)
T ss_pred             hHHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhc-cHHH-HHHHHHHHHHHhcCCCCcchhhHHHhhccCce
Confidence            356899999999999999999999999999999999976543 2222 22468999999999 999999999998887 9


Q ss_pred             EEEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCccc
Q 014609           89 IYMVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHF  167 (421)
Q Consensus        89 ~~lv~E~~~gg~L~~~i~~-~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~  167 (421)
                      +|+||||| ..+|+..+.. +..|++..++.|+.||++||+|+|.+|+.|||+||||||+..+..+||+|||+|+-..  
T Consensus        85 L~fVfE~M-d~NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~--  161 (538)
T KOG0661|consen   85 LYFVFEFM-DCNLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISGNDVIKIADFGLAREVR--  161 (538)
T ss_pred             EeeeHHhh-hhhHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEecccceeEecccccccccc--
Confidence            99999999 5699999975 4569999999999999999999999999999999999999999999999999998543  


Q ss_pred             cCCCccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhh----------------------cC-------------
Q 014609          168 RDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIF----------------------RG-------------  212 (421)
Q Consensus       168 ~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~----------------------~~-------------  212 (421)
                       .....+.+..|.+|+|||++.+.++++.+.|+||+|||++++                      .|             
T Consensus       162 -SkpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~L  240 (538)
T KOG0661|consen  162 -SKPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYNL  240 (538)
T ss_pred             -cCCCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHHH
Confidence             345667889999999999999998889999999999999822                      11             


Q ss_pred             ----CcCCC-----------CCCCHHHHHHHHHhcCCCCCCCCCHHhhhcCccccccc
Q 014609          213 ----DFKLP-----------KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY  255 (421)
Q Consensus       213 ----~~~~p-----------~~~s~~~~~li~~~L~~dP~~R~t~~eil~~~w~~~~~  255 (421)
                          ++.+|           +..++++.++|.+||..||.+|||+.|+++||||+...
T Consensus       241 a~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~pffq~~~  298 (538)
T KOG0661|consen  241 ASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHPFFQVGR  298 (538)
T ss_pred             HHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCccccccc
Confidence                12222           12689999999999999999999999999999998654

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-49  Score=382.81  Aligned_cols=244  Identities=39%  Similarity=0.709  Sum_probs=222.4

Q ss_pred             CeeecceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEE
Q 014609           10 GMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKI   89 (421)
Q Consensus        10 ~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~   89 (421)
                      |..-|=|.+.++||+|-|+.|.+|++.-||+.||||++++.+..... ..++.+|++.|+.++|||||++|++..+...+
T Consensus        14 gkIAGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~s-t~hlfqEVRCMKLVQHpNiVRLYEViDTQTKl   92 (864)
T KOG4717|consen   14 GKIAGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLS-TGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKL   92 (864)
T ss_pred             cceeeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhh-hhHHHHHHHHHHHhcCcCeeeeeehhcccceE
Confidence            55668899999999999999999999999999999999998775543 56788999999999999999999999999999


Q ss_pred             EEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecc-CCCEEEEeccCCCCCccc
Q 014609           90 YMVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDS-KGNIKISDFGLSALPQHF  167 (421)
Q Consensus        90 ~lv~E~~~gg~L~~~i~~-~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~-~~~~kL~DFGla~~~~~~  167 (421)
                      |+|+|+-.+|+|+|+|.. ..++.++.+++||.||+.|+.|||...++||||||||+.+-+ -|-+||.|||++..+.+ 
T Consensus        93 yLiLELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~P-  171 (864)
T KOG4717|consen   93 YLILELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQP-  171 (864)
T ss_pred             EEEEEecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEeeecCceEeeeccccccCCC-
Confidence            999999999999999865 467999999999999999999999999999999999998865 58999999999986653 


Q ss_pred             cCCCccccccCCCCccChhhhcccCCCCCcchHHHHHHHHh--------------------hhcCCcCCCCCCCHHHHHH
Q 014609          168 RDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILY--------------------IFRGDFKLPKWLSPGAQNL  227 (421)
Q Consensus       168 ~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~--------------------~~~~~~~~p~~~s~~~~~l  227 (421)
                        ...+.+.||+..|.|||++.+..|+.+++||||||||||                    ++.+.+..|..+|.++++|
T Consensus       172 --G~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmImDCKYtvPshvS~eCrdL  249 (864)
T KOG4717|consen  172 --GKKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIMDCKYTVPSHVSKECRDL  249 (864)
T ss_pred             --cchhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhhcccccCchhhhHHHHHH
Confidence              556889999999999999999999999999999999999                    3455667788899999999


Q ss_pred             HHHhcCCCCCCCCCHHhhhcCccccccccC
Q 014609          228 LRKILEPNPVKRITIAGIKADEWFEQDYTP  257 (421)
Q Consensus       228 i~~~L~~dP~~R~t~~eil~~~w~~~~~~~  257 (421)
                      |..||..||.+|.+.++|..++|++....+
T Consensus       250 I~sMLvRdPkkRAslEeI~s~~Wlq~~D~~  279 (864)
T KOG4717|consen  250 IQSMLVRDPKKRASLEEIVSTSWLQAGDRG  279 (864)
T ss_pred             HHHHHhcCchhhccHHHHhccccccCCCCC
Confidence            999999999999999999999999875443

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.2e-49  Score=353.23  Aligned_cols=239  Identities=37%  Similarity=0.709  Sum_probs=220.0

Q ss_pred             CeeecceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEE
Q 014609           10 GMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKI   89 (421)
Q Consensus        10 ~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~   89 (421)
                      .-.+++|++++.||+|-||.||+|+...++--||+|++.++.+.......++.+|++|...|+||||+++|++|.+...+
T Consensus        18 ~~~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~ri   97 (281)
T KOG0580|consen   18 TWTLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRI   97 (281)
T ss_pred             ccchhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheecccee
Confidence            34578999999999999999999999999999999999988877666678999999999999999999999999999999


Q ss_pred             EEEEeccCCCChHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCccc
Q 014609           90 YMVLEYVTGGELFDKIA--SKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHF  167 (421)
Q Consensus        90 ~lv~E~~~gg~L~~~i~--~~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~  167 (421)
                      |+++||+++|+|+..+.  ...++++..+..|+.|++.||.|||..+|+||||||+|+|++.+|.+|++|||.+....  
T Consensus        98 yLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p--  175 (281)
T KOG0580|consen   98 YLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP--  175 (281)
T ss_pred             EEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCCCCCeeccCCCceeecC--
Confidence            99999999999999998  56689999999999999999999999999999999999999999999999999987432  


Q ss_pred             cCCCccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhh--------------------cCCcCCCCCCCHHHHHH
Q 014609          168 RDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIF--------------------RGDFKLPKWLSPGAQNL  227 (421)
Q Consensus       168 ~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~--------------------~~~~~~p~~~s~~~~~l  227 (421)
                        .....+.|||..|.|||+..+.+++ ..+|+|++|++.|.+                    ..++.+|..++.++.++
T Consensus       176 --~~kR~tlcgt~dyl~pEmv~~~~hd-~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k~~~~~p~~is~~a~dl  252 (281)
T KOG0580|consen  176 --SNKRKTLCGTLDYLPPEMVEGRGHD-KFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRKVDLKFPSTISGGAADL  252 (281)
T ss_pred             --CCCceeeecccccCCHhhcCCCCcc-chhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHHccccCCcccChhHHHH
Confidence              4456789999999999999999986 889999999999943                    33456788899999999


Q ss_pred             HHHhcCCCCCCCCCHHhhhcCccccc
Q 014609          228 LRKILEPNPVKRITIAGIKADEWFEQ  253 (421)
Q Consensus       228 i~~~L~~dP~~R~t~~eil~~~w~~~  253 (421)
                      |.+||..+|.+|.+..|++.|||...
T Consensus       253 I~~ll~~~p~~r~~l~~v~~hpwI~a  278 (281)
T KOG0580|consen  253 ISRLLVKNPIERLALTEVMDHPWIVA  278 (281)
T ss_pred             HHHHhccCccccccHHHHhhhHHHHh
Confidence            99999999999999999999999875

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=6.4e-49  Score=380.28  Aligned_cols=244  Identities=34%  Similarity=0.543  Sum_probs=208.5

Q ss_pred             eecceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeC--CEE
Q 014609           12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASK--SKI   89 (421)
Q Consensus        12 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~--~~~   89 (421)
                      ....|+.+++||+|+||.||+|++..+|+.||+|.++.+... .....-..|||.||++|+||||+++.+...+.  ..+
T Consensus       115 ~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~-~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~si  193 (560)
T KOG0600|consen  115 RADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEK-EGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSI  193 (560)
T ss_pred             chHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCC-CcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceE
Confidence            456799999999999999999999999999999999876432 33456788999999999999999999998877  689


Q ss_pred             EEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCcccc
Q 014609           90 YMVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFR  168 (421)
Q Consensus        90 ~lv~E~~~gg~L~~~i~~-~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~~  168 (421)
                      |+|+|||+. +|.-++.. .-.|++.+++.|++||++||+|||++||.|||||..|||||.+|.+||+|||||+++....
T Consensus       194 YlVFeYMdh-DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~~  272 (560)
T KOG0600|consen  194 YLVFEYMDH-DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILIDNNGVLKIADFGLARFYTPSG  272 (560)
T ss_pred             EEEEecccc-hhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEcCCCCEEeccccceeeccCCC
Confidence            999999965 88777765 3479999999999999999999999999999999999999999999999999999876643


Q ss_pred             CCCccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhhcCCc------------------------------CCC-
Q 014609          169 DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIFRGDF------------------------------KLP-  217 (421)
Q Consensus       169 ~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~~~~~------------------------------~~p-  217 (421)
                      . ...+..+-|.+|+|||.+.+..-++.++|+||+||||.++..+-                              .+| 
T Consensus       273 ~-~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~kLP~  351 (560)
T KOG0600|consen  273 S-APYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSKLPH  351 (560)
T ss_pred             C-cccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccccCCc
Confidence            2 34666778999999999998776689999999999998331110                              111 


Q ss_pred             ------------------CCCCHHHHHHHHHhcCCCCCCCCCHHhhhcCccccccccCC
Q 014609          218 ------------------KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPA  258 (421)
Q Consensus       218 ------------------~~~s~~~~~li~~~L~~dP~~R~t~~eil~~~w~~~~~~~~  258 (421)
                                        ..+++.+.+|+..||..||.+|.|+.++++++||.....+.
T Consensus       352 ~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~seyF~t~p~~~  410 (560)
T KOG0600|consen  352 ATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQSEYFTTEPLPC  410 (560)
T ss_pred             ccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcCcccccCCCCC
Confidence                              12689999999999999999999999999999996544433

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-48  Score=372.44  Aligned_cols=241  Identities=34%  Similarity=0.563  Sum_probs=207.2

Q ss_pred             ecceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCC--EEE
Q 014609           13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKS--KIY   90 (421)
Q Consensus        13 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~--~~~   90 (421)
                      ..+|..++.||+|+||.||++.+..+|+..|||.+.......   .+.+.+|+.+|++++|||||++++......  .++
T Consensus        16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~---~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~   92 (313)
T KOG0198|consen   16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPT---SESLEREIRILSRLNHPNIVQYYGSSSSRENDEYN   92 (313)
T ss_pred             cchhhhhccccCccceEEEEEEecCCCcceeeeeeecccchh---HHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeE
Confidence            356899999999999999999999999999999997653221   677999999999999999999999754444  799


Q ss_pred             EEEeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecc-CCCEEEEeccCCCCCccc-
Q 014609           91 MVLEYVTGGELFDKIASKG-RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDS-KGNIKISDFGLSALPQHF-  167 (421)
Q Consensus        91 lv~E~~~gg~L~~~i~~~~-~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~-~~~~kL~DFGla~~~~~~-  167 (421)
                      +.|||++||+|.+.+...+ .++++.+++|.+|+++||+|||++||+||||||+|||++. ++.+||+|||++...... 
T Consensus        93 i~mEy~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~  172 (313)
T KOG0198|consen   93 IFMEYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKG  172 (313)
T ss_pred             eeeeccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCCCCeEEeccCcccccccccc
Confidence            9999999999999999876 7999999999999999999999999999999999999999 799999999999865531 


Q ss_pred             cCCCccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhhcCC-----------------------cCCCCCCCHHH
Q 014609          168 RDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIFRGD-----------------------FKLPKWLSPGA  224 (421)
Q Consensus       168 ~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~~~~-----------------------~~~p~~~s~~~  224 (421)
                      ..........|||.|||||++......+.++||||+||++.++.++                       +.+|.++|+++
T Consensus       173 ~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~~~~P~ip~~ls~~a  252 (313)
T KOG0198|consen  173 TKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGREDSLPEIPDSLSDEA  252 (313)
T ss_pred             ccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhccCCCCCCCcccCHHH
Confidence            1122344678999999999998633334589999999999854332                       35677899999


Q ss_pred             HHHHHHhcCCCCCCCCCHHhhhcCcccccccc
Q 014609          225 QNLLRKILEPNPVKRITIAGIKADEWFEQDYT  256 (421)
Q Consensus       225 ~~li~~~L~~dP~~R~t~~eil~~~w~~~~~~  256 (421)
                      +++|.+|+..||++|||++++++|||..+...
T Consensus       253 ~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~~~~  284 (313)
T KOG0198|consen  253 KDFLRKCFKRDPEKRPTAEELLEHPFLKQNSI  284 (313)
T ss_pred             HHHHHHHhhcCcccCcCHHHHhhChhhhcccc
Confidence            99999999999999999999999999987543

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=1.3e-48  Score=351.35  Aligned_cols=240  Identities=33%  Similarity=0.492  Sum_probs=206.4

Q ss_pred             cceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEE
Q 014609           14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVL   93 (421)
Q Consensus        14 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~   93 (421)
                      .+|...+.||+|.||.||+|+|..||+.||||.++.....+ .......|||+.|+.++||||+.++++|.+.+.+.+|+
T Consensus         2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kd-Gi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVf   80 (318)
T KOG0659|consen    2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKD-GINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVF   80 (318)
T ss_pred             chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeecccccc-CccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEE
Confidence            57999999999999999999999999999999998765432 23467899999999999999999999999999999999


Q ss_pred             eccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCccccCCCc
Q 014609           94 EYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGL  172 (421)
Q Consensus        94 E~~~gg~L~~~i~~-~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~  172 (421)
                      ||++ .+|...|.. ...++..+++.|+.|++.||+|||++.|.||||||+|+|++.+|.+||+|||+|+.+...  +..
T Consensus        81 Efm~-tdLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p--~~~  157 (318)
T KOG0659|consen   81 EFMP-TDLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSDGQLKIADFGLARFFGSP--NRI  157 (318)
T ss_pred             Eecc-ccHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCCCcEEeecccchhccCCC--Ccc
Confidence            9995 489888875 347999999999999999999999999999999999999999999999999999987653  333


Q ss_pred             cccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhhcCCcC-------------------------CC----------
Q 014609          173 LHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIFRGDFK-------------------------LP----------  217 (421)
Q Consensus       173 ~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~~~~~~-------------------------~p----------  217 (421)
                      .....-|.+|+|||.+.+...++..+||||.|||+.++.-+.|                         +|          
T Consensus       158 ~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY~~  237 (318)
T KOG0659|consen  158 QTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDYVK  237 (318)
T ss_pred             cccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccccHHH
Confidence            3344789999999998887666899999999999983321111                         11          


Q ss_pred             -------------CCCCHHHHHHHHHhcCCCCCCCCCHHhhhcCccccccccC
Q 014609          218 -------------KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTP  257 (421)
Q Consensus       218 -------------~~~s~~~~~li~~~L~~dP~~R~t~~eil~~~w~~~~~~~  257 (421)
                                   +..++++.+|+.+||..||.+|+|+.|+++|+||.....|
T Consensus       238 ~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~yf~~~P~p  290 (318)
T KOG0659|consen  238 IQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHPYFKSLPLP  290 (318)
T ss_pred             HhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcchhhhcCCCC
Confidence                         1146888999999999999999999999999999975444

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=3.3e-49  Score=385.51  Aligned_cols=239  Identities=31%  Similarity=0.586  Sum_probs=216.9

Q ss_pred             ecceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEE
Q 014609           13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMV   92 (421)
Q Consensus        13 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv   92 (421)
                      +++|-+.+.||+|+||.||+|+.+.+.+.||+|.+++..-. ......+.+|++|++.++||||+.++++|++..++|+|
T Consensus         1 me~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~-~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vV   79 (808)
T KOG0597|consen    1 MEQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRN-EKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVV   79 (808)
T ss_pred             CcchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCc-hHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEE
Confidence            47899999999999999999999999999999999876533 33467899999999999999999999999999999999


Q ss_pred             EeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCccccCCCc
Q 014609           93 LEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGL  172 (421)
Q Consensus        93 ~E~~~gg~L~~~i~~~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~  172 (421)
                      .||+.| +|+.++..++.++|+.++.++.|+++||.|||+++|.|||+||.|||++.+|.+|+||||+|+....  +...
T Consensus        80 te~a~g-~L~~il~~d~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~--~t~v  156 (808)
T KOG0597|consen   80 TEYAVG-DLFTILEQDGKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEKGGTLKLCDFGLARAMST--NTSV  156 (808)
T ss_pred             ehhhhh-hHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecCCCceeechhhhhhhccc--Ccee
Confidence            999977 9999999999999999999999999999999999999999999999999999999999999986544  4456


Q ss_pred             cccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhh--------------------cCCcCCCCCCCHHHHHHHHHhc
Q 014609          173 LHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIF--------------------RGDFKLPKWLSPGAQNLLRKIL  232 (421)
Q Consensus       173 ~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~--------------------~~~~~~p~~~s~~~~~li~~~L  232 (421)
                      .....|||.|||||.+.+.+|+ ..+|+||+|||+|++                    ....++|...|..+.+++..+|
T Consensus       157 ltsikGtPlYmAPElv~e~pyd-~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I~~d~v~~p~~~S~~f~nfl~gLL  235 (808)
T KOG0597|consen  157 LTSIKGTPLYMAPELVEEQPYD-HTSDLWSLGCILYELYVGQPPFYARSITQLVKSILKDPVKPPSTASSSFVNFLQGLL  235 (808)
T ss_pred             eeeccCcccccCHHHHcCCCcc-chhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHHhcCCCCCcccccHHHHHHHHHHh
Confidence            6777899999999999999886 889999999999943                    2334556778999999999999


Q ss_pred             CCCCCCCCCHHhhhcCcccccccc
Q 014609          233 EPNPVKRITIAGIKADEWFEQDYT  256 (421)
Q Consensus       233 ~~dP~~R~t~~eil~~~w~~~~~~  256 (421)
                      .+||.+|+|..+++.|||.+....
T Consensus       236 ~kdP~~RltW~~Ll~HpF~k~~~~  259 (808)
T KOG0597|consen  236 IKDPAQRLTWTDLLGHPFWKGKIN  259 (808)
T ss_pred             hcChhhcccHHHHhcChHHhhhhh
Confidence            999999999999999999886543

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=5.5e-48  Score=378.16  Aligned_cols=240  Identities=35%  Similarity=0.722  Sum_probs=214.2

Q ss_pred             cCCeeecceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCC
Q 014609            8 QEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKS   87 (421)
Q Consensus         8 ~~~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~   87 (421)
                      .....+++|++.+.||+|+||.||+|++..+++.||+|++.+.........+.+.+|+.++++++||||+++++++.+++
T Consensus        12 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~   91 (329)
T PTZ00263         12 TSSWKLSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDEN   91 (329)
T ss_pred             cCCCCchheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCC
Confidence            34556799999999999999999999999999999999998655444444677899999999999999999999999999


Q ss_pred             EEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCccc
Q 014609           88 KIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHF  167 (421)
Q Consensus        88 ~~~lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~  167 (421)
                      ..|+||||++|++|.+.+...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++..... 
T Consensus        92 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~-  170 (329)
T PTZ00263         92 RVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPD-  170 (329)
T ss_pred             EEEEEEcCCCCChHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECCCCCEEEeeccCceEcCC-
Confidence            9999999999999999999888899999999999999999999999999999999999999999999999999875422 


Q ss_pred             cCCCccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhh--------------------cCCcCCCCCCCHHHHHH
Q 014609          168 RDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIF--------------------RGDFKLPKWLSPGAQNL  227 (421)
Q Consensus       168 ~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~--------------------~~~~~~p~~~s~~~~~l  227 (421)
                          .....+||+.|+|||++.+..+ +.++|||||||++|.+                    .+..++|.+++..+.+|
T Consensus       171 ----~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~l  245 (329)
T PTZ00263        171 ----RTFTLCGTPEYLAPEVIQSKGH-GKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGRLKFPNWFDGRARDL  245 (329)
T ss_pred             ----CcceecCChhhcCHHHHcCCCC-CCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCcCCCCCCCHHHHHH
Confidence                2235689999999999988777 5899999999999943                    23345677899999999


Q ss_pred             HHHhcCCCCCCCCC-----HHhhhcCccccc
Q 014609          228 LRKILEPNPVKRIT-----IAGIKADEWFEQ  253 (421)
Q Consensus       228 i~~~L~~dP~~R~t-----~~eil~~~w~~~  253 (421)
                      |++||+.||.+|++     +++++.||||..
T Consensus       246 i~~~L~~dP~~R~~~~~~~~~~ll~hp~f~~  276 (329)
T PTZ00263        246 VKGLLQTDHTKRLGTLKGGVADVKNHPYFHG  276 (329)
T ss_pred             HHHHhhcCHHHcCCCCCCCHHHHhcCCccCC
Confidence            99999999999997     799999999985

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-48  Score=389.76  Aligned_cols=241  Identities=33%  Similarity=0.634  Sum_probs=217.5

Q ss_pred             CeeecceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCC-CCCcceEEEEEEeCCE
Q 014609           10 GMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK-HPNVVRLHEVLASKSK   88 (421)
Q Consensus        10 ~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~   88 (421)
                      ...+.+|.+++.||+|+||+|++|..+.+++.+|||++++..+.....++....|.+|+...+ ||.++.++..|+++++
T Consensus       364 ~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~  443 (694)
T KOG0694|consen  364 PLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEH  443 (694)
T ss_pred             cccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCe
Confidence            456789999999999999999999999999999999999999888888999999999998885 9999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCcccc
Q 014609           89 IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFR  168 (421)
Q Consensus        89 ~~lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~~  168 (421)
                      +|+||||+.||+++ .+...+.+++..|+.|+..|+.||.|||++||||||||.+|||||.+|++||+|||+++--  ..
T Consensus       444 l~fvmey~~Ggdm~-~~~~~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~--m~  520 (694)
T KOG0694|consen  444 LFFVMEYVAGGDLM-HHIHTDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTEGHVKIADFGLCKEG--MG  520 (694)
T ss_pred             EEEEEEecCCCcEE-EEEecccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEcccCcEEeccccccccc--CC
Confidence            99999999999954 3444578999999999999999999999999999999999999999999999999999832  22


Q ss_pred             CCCccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhh-cCC-------------------cCCCCCCCHHHHHHH
Q 014609          169 DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIF-RGD-------------------FKLPKWLSPGAQNLL  228 (421)
Q Consensus       169 ~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~-~~~-------------------~~~p~~~s~~~~~li  228 (421)
                      ......+.||||.|+|||++.+..| +..+|+|||||+||+| .|.                   +.+|.|+|.++.+++
T Consensus       521 ~g~~TsTfCGTpey~aPEil~e~~Y-t~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~d~~~yP~~ls~ea~~il  599 (694)
T KOG0694|consen  521 QGDRTSTFCGTPEFLAPEVLTEQSY-TRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSKEAIAIM  599 (694)
T ss_pred             CCCccccccCChhhcChhhhccCcc-cchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCCCCCcccHHHHHHH
Confidence            3446789999999999999999999 5999999999999943 343                   455778999999999


Q ss_pred             HHhcCCCCCCCCCH-----HhhhcCcccccc
Q 014609          229 RKILEPNPVKRITI-----AGIKADEWFEQD  254 (421)
Q Consensus       229 ~~~L~~dP~~R~t~-----~eil~~~w~~~~  254 (421)
                      +++|.+||.+|...     ++|+.||||+..
T Consensus       600 ~~ll~k~p~kRLG~~e~d~~~i~~hpFFr~i  630 (694)
T KOG0694|consen  600 RRLLRKNPEKRLGSGERDAEDIKKHPFFRSI  630 (694)
T ss_pred             HHHhccCcccccCCCCCCchhhhhCCccccC
Confidence            99999999999964     789999999863

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-47  Score=378.62  Aligned_cols=237  Identities=41%  Similarity=0.760  Sum_probs=213.5

Q ss_pred             ecceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCC-CCCcceEEEEEEeCCEEEE
Q 014609           13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK-HPNVVRLHEVLASKSKIYM   91 (421)
Q Consensus        13 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~l   91 (421)
                      -..|++++.||+|.||.||.++++.+|+.+|+|++.+.........+.+.+|+.+|+++. ||||+.++++|++...+|+
T Consensus        34 ~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~l  113 (382)
T KOG0032|consen   34 KEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYL  113 (382)
T ss_pred             cccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEE
Confidence            358999999999999999999999999999999999887665545678999999999998 9999999999999999999


Q ss_pred             EEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccC----CCEEEEeccCCCCCccc
Q 014609           92 VLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSK----GNIKISDFGLSALPQHF  167 (421)
Q Consensus        92 v~E~~~gg~L~~~i~~~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~----~~~kL~DFGla~~~~~~  167 (421)
                      |||+|.||+|++.+... .+++..+..+++|++.|++|||+.||+||||||||+|+...    +.+|++|||++..... 
T Consensus       114 vmEL~~GGeLfd~i~~~-~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~~~-  191 (382)
T KOG0032|consen  114 VMELCEGGELFDRIVKK-HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFIKP-  191 (382)
T ss_pred             EEEecCCchHHHHHHHc-cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCCCceEccC-
Confidence            99999999999999876 49999999999999999999999999999999999999644    4799999999986543 


Q ss_pred             cCCCccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhhcCCcC----------------------CCCC--CCHH
Q 014609          168 RDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIFRGDFK----------------------LPKW--LSPG  223 (421)
Q Consensus       168 ~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~~~~~~----------------------~p~~--~s~~  223 (421)
                        .....+.||||.|+|||++...+| +..+||||+||++|++.++.+                      .++|  +|..
T Consensus       192 --~~~~~~~~Gtp~y~APEvl~~~~y-~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~~~f~~~~w~~is~~  268 (382)
T KOG0032|consen  192 --GERLHTIVGTPEYVAPEVLGGRPY-GDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGDFDFTSEPWDDISES  268 (382)
T ss_pred             --CceEeeecCCccccCchhhcCCCC-CcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCCCCCCCCCccccCHH
Confidence              457889999999999999988888 589999999999996654322                      2333  7899


Q ss_pred             HHHHHHHhcCCCCCCCCCHHhhhcCcccccc
Q 014609          224 AQNLLRKILEPNPVKRITIAGIKADEWFEQD  254 (421)
Q Consensus       224 ~~~li~~~L~~dP~~R~t~~eil~~~w~~~~  254 (421)
                      +.++|++||..||..|+|+.++++|||+...
T Consensus       269 akd~i~~ll~~dp~~R~ta~~~L~HpWi~~~  299 (382)
T KOG0032|consen  269 AKDFIRKLLEFDPRKRLTAAQALQHPWIKSI  299 (382)
T ss_pred             HHHHHHHhcccCcccCCCHHHHhcCccccCC
Confidence            9999999999999999999999999998754

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=3.4e-48  Score=383.84  Aligned_cols=245  Identities=43%  Similarity=0.803  Sum_probs=226.6

Q ss_pred             cCCeeecceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCC
Q 014609            8 QEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKS   87 (421)
Q Consensus         8 ~~~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~   87 (421)
                      .....++.|.+.++||+|.|++|.+|++..++..||||++++....... ...+.+|+.+|+.|+|||||+++.+.+...
T Consensus        50 ~~~~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~-~~k~~rev~imk~l~HPnIvkl~~v~~t~~  128 (596)
T KOG0586|consen   50 DDSNSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSK-RQKLGREVDIMKSLNHPNIVKLFSVIETEA  128 (596)
T ss_pred             cccccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHH-HHHHHHHHHHHHhcCCcceeeeeeeeeecc
Confidence            3456789999999999999999999999999999999999987654433 456999999999999999999999999999


Q ss_pred             EEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCccc
Q 014609           88 KIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHF  167 (421)
Q Consensus        88 ~~~lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~  167 (421)
                      .+|+||||+.+|++++++...+++.+..++.+|.|+++|++|||+++|+|||||++||||+.+-++||+|||++..+.  
T Consensus       129 ~lylV~eya~~ge~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~--  206 (596)
T KOG0586|consen  129 TLYLVMEYASGGELFDYLVKHGRMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDENMNIKIADFGFSTFFD--  206 (596)
T ss_pred             eeEEEEEeccCchhHHHHHhcccchhhhhhhhhHHHHHHHHHHhhcceeccccchhhcccccccceeeeccccceeec--
Confidence            999999999999999999999999999999999999999999999999999999999999999999999999999765  


Q ss_pred             cCCCccccccCCCCccChhhhcccCCCCCcchHHHHHHHHh--------------------hhcCCcCCCCCCCHHHHHH
Q 014609          168 RDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILY--------------------IFRGDFKLPKWLSPGAQNL  227 (421)
Q Consensus       168 ~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~--------------------~~~~~~~~p~~~s~~~~~l  227 (421)
                       ....+.+.||+|.|.|||++.+..|+++.+|+||+|++||                    .+.|.+.+|..++.++.++
T Consensus       207 -~~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl~gk~rIp~~ms~dce~l  285 (596)
T KOG0586|consen  207 -YGLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVLRGKYRIPFYMSCDCEDL  285 (596)
T ss_pred             -ccccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchheeeeecccceeechhHHH
Confidence             3567889999999999999999999999999999999999                    2345677788899999999


Q ss_pred             HHHhcCCCCCCCCCHHhhhcCcccccccc
Q 014609          228 LRKILEPNPVKRITIAGIKADEWFEQDYT  256 (421)
Q Consensus       228 i~~~L~~dP~~R~t~~eil~~~w~~~~~~  256 (421)
                      |+++|..+|.+|++.++|++|.|....+.
T Consensus       286 Lrk~lvl~Pskr~~~dqim~~~W~n~~~~  314 (596)
T KOG0586|consen  286 LRKFLVLNPSKRGPCDQIMKDRWRNDLLE  314 (596)
T ss_pred             HHHhhccCccccCCHHHhhhhcccchhhh
Confidence            99999999999999999999999876543

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=100.00  E-value=4.1e-49  Score=355.41  Aligned_cols=239  Identities=37%  Similarity=0.701  Sum_probs=210.6

Q ss_pred             eecceEEeceEeecCcEEEEEEEECCCCceEEEEEeeccccc-----chhHHHHHHHHHHHHhcCC-CCCcceEEEEEEe
Q 014609           12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRII-----HLKITDQIKREIATLKLLK-HPNVVRLHEVLAS   85 (421)
Q Consensus        12 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~-----~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~   85 (421)
                      -..+|.-.+.||.|..++|-.+.+..+|+.+|+|++......     ...+.+.-.+|+.||+++. ||+|+++.++|++
T Consensus        15 fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes   94 (411)
T KOG0599|consen   15 FYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYES   94 (411)
T ss_pred             HHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccC
Confidence            346788889999999999999999999999999999753221     1234566788999999995 9999999999999


Q ss_pred             CCEEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCc
Q 014609           86 KSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQ  165 (421)
Q Consensus        86 ~~~~~lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~  165 (421)
                      +...++|+|.|+.|+|||++.....+++..++++++||.+|++|||.++|+||||||+|||+|++-++||+|||+|+...
T Consensus        95 ~sF~FlVFdl~prGELFDyLts~VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILlddn~~i~isDFGFa~~l~  174 (411)
T KOG0599|consen   95 DAFVFLVFDLMPRGELFDYLTSKVTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDDNMNIKISDFGFACQLE  174 (411)
T ss_pred             cchhhhhhhhcccchHHHHhhhheeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeeccccceEEeccceeeccC
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999999998554


Q ss_pred             cccCCCccccccCCCCccChhhhccc------CCCCCcchHHHHHHHHh--------------------hhcCCcC--CC
Q 014609          166 HFRDDGLLHTTCGSPNYVAPEVLANR------GYDGATSDIWSCGVILY--------------------IFRGDFK--LP  217 (421)
Q Consensus       166 ~~~~~~~~~~~~gt~~y~APEvl~~~------~~~~~~~DiwSlGvil~--------------------~~~~~~~--~p  217 (421)
                         ....+...||||+|+|||.+..+      +| +..+|+||||||+|                    ++.|.+.  .|
T Consensus       175 ---~GekLrelCGTPgYLAPEtikC~m~e~~pGY-s~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeGkyqF~sp  250 (411)
T KOG0599|consen  175 ---PGEKLRELCGTPGYLAPETIKCSMYENHPGY-SKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIMEGKYQFRSP  250 (411)
T ss_pred             ---CchhHHHhcCCCcccChhheeeecccCCCCc-cchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHhcccccCCc
Confidence               34567788999999999998643      34 57799999999999                    3445544  46


Q ss_pred             CC--CCHHHHHHHHHhcCCCCCCCCCHHhhhcCcccccc
Q 014609          218 KW--LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD  254 (421)
Q Consensus       218 ~~--~s~~~~~li~~~L~~dP~~R~t~~eil~~~w~~~~  254 (421)
                      .|  +|...++||++||+.||.+|+|++|+|.||||.+.
T Consensus       251 eWadis~~~KdLIsrlLqVdp~~Ritake~LaHpff~q~  289 (411)
T KOG0599|consen  251 EWADISATVKDLISRLLQVDPTKRITAKEALAHPFFIQI  289 (411)
T ss_pred             chhhccccHHHHHHHHHeeCchhcccHHHHhcChHHHHH
Confidence            66  88999999999999999999999999999999753

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.5e-47  Score=368.43  Aligned_cols=234  Identities=33%  Similarity=0.645  Sum_probs=208.3

Q ss_pred             cceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEE
Q 014609           14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVL   93 (421)
Q Consensus        14 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~   93 (421)
                      ++|++.+.||+|+||.||+|.+..+|+.||+|++...........+.+.+|+.++++++||||+++++++.+.+.+|+||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   80 (291)
T cd05612           1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM   80 (291)
T ss_pred             CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence            47999999999999999999999999999999997654433344567899999999999999999999999999999999


Q ss_pred             eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCccccCCCcc
Q 014609           94 EYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLL  173 (421)
Q Consensus        94 E~~~gg~L~~~i~~~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~  173 (421)
                      ||+++++|.+++...+.+++..++.++.|++.||+|||++||+||||||+|||++.+|.+||+|||++.....     ..
T Consensus        81 e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~-----~~  155 (291)
T cd05612          81 EYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRD-----RT  155 (291)
T ss_pred             eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEEecCcchhccC-----Cc
Confidence            9999999999999888899999999999999999999999999999999999999999999999999875422     22


Q ss_pred             ccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhhc-C-------------------CcCCCCCCCHHHHHHHHHhcC
Q 014609          174 HTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIFR-G-------------------DFKLPKWLSPGAQNLLRKILE  233 (421)
Q Consensus       174 ~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~~-~-------------------~~~~p~~~s~~~~~li~~~L~  233 (421)
                      ...+||+.|+|||++.+..+ +.++|||||||++|.+. |                   ...+|..+++.+.++|++||+
T Consensus       156 ~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~  234 (291)
T cd05612         156 WTLCGTPEYLAPEVIQSKGH-NKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGKLEFPRHLDLYAKDLIKKLLV  234 (291)
T ss_pred             ccccCChhhcCHHHHcCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcCCCccCCHHHHHHHHHHcC
Confidence            34679999999999988777 58899999999999442 2                   334566789999999999999


Q ss_pred             CCCCCCCC-----HHhhhcCccccc
Q 014609          234 PNPVKRIT-----IAGIKADEWFEQ  253 (421)
Q Consensus       234 ~dP~~R~t-----~~eil~~~w~~~  253 (421)
                      .||.+|++     ++++++||||..
T Consensus       235 ~dp~~R~~~~~~~~~~~l~h~~~~~  259 (291)
T cd05612         235 VDRTRRLGNMKNGADDVKNHRWFKS  259 (291)
T ss_pred             CCHHHccCCccCCHHHHhcCccccC
Confidence            99999995     999999999975

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=4.5e-47  Score=370.71  Aligned_cols=231  Identities=35%  Similarity=0.643  Sum_probs=204.2

Q ss_pred             ceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEEeccCCC
Q 014609           20 RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGG   99 (421)
Q Consensus        20 ~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~~gg   99 (421)
                      +.||+|+||.||+|++..+|+.||+|++.+...........+.+|+.++++++||||+++++++...+.+|+||||++|+
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~   80 (323)
T cd05571           1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence            47999999999999999999999999998654444444567889999999999999999999999999999999999999


Q ss_pred             ChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCccccCCCccccccCC
Q 014609          100 ELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGS  179 (421)
Q Consensus       100 ~L~~~i~~~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt  179 (421)
                      +|.+.+...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.....  ........+||
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~--~~~~~~~~~gt  158 (323)
T cd05571          81 ELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGIS--DGATMKTFCGT  158 (323)
T ss_pred             cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEeeCCCCccccc--CCCcccceecC
Confidence            9999998888899999999999999999999999999999999999999999999999999874221  22334567899


Q ss_pred             CCccChhhhcccCCCCCcchHHHHHHHHhhhc-CC-------------------cCCCCCCCHHHHHHHHHhcCCCCCCC
Q 014609          180 PNYVAPEVLANRGYDGATSDIWSCGVILYIFR-GD-------------------FKLPKWLSPGAQNLLRKILEPNPVKR  239 (421)
Q Consensus       180 ~~y~APEvl~~~~~~~~~~DiwSlGvil~~~~-~~-------------------~~~p~~~s~~~~~li~~~L~~dP~~R  239 (421)
                      +.|+|||++.+..+ +.++||||+||++|.+. |.                   ..+|..+++++.++|++||++||++|
T Consensus       159 ~~y~aPE~~~~~~~-~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~L~~dP~~R  237 (323)
T cd05571         159 PEYLAPEVLEDNDY-GRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLSPEAKSLLAGLLKKDPKQR  237 (323)
T ss_pred             ccccChhhhcCCCC-CccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHccCCHHHc
Confidence            99999999988777 58999999999999443 32                   34456689999999999999999999


Q ss_pred             C-----CHHhhhcCccccc
Q 014609          240 I-----TIAGIKADEWFEQ  253 (421)
Q Consensus       240 ~-----t~~eil~~~w~~~  253 (421)
                      |     ++.++++||||..
T Consensus       238 ~~~~~~~~~~ll~h~~f~~  256 (323)
T cd05571         238 LGGGPEDAKEIMEHRFFAS  256 (323)
T ss_pred             CCCCCCCHHHHHcCCCcCC
Confidence            9     8999999999976

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=7.8e-47  Score=371.72  Aligned_cols=241  Identities=34%  Similarity=0.616  Sum_probs=211.8

Q ss_pred             ccCCeeecceEEeceEeecCcEEEEEEEECCCC-ceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEe
Q 014609            7 KQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSG-LPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLAS   85 (421)
Q Consensus         7 ~~~~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~-~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~   85 (421)
                      ......+++|++.+.||+|+||.||+|.+..++ ..||+|.+.+.........+.+.+|+.+++.++||||+++++++.+
T Consensus        23 ~~~~~~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~  102 (340)
T PTZ00426         23 RKNKMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKD  102 (340)
T ss_pred             cCCCCChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEe
Confidence            344567789999999999999999999876554 7899999976554444446778899999999999999999999999


Q ss_pred             CCEEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCc
Q 014609           86 KSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQ  165 (421)
Q Consensus        86 ~~~~~lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~  165 (421)
                      .+..|+||||++||+|.+++...+.+++..+..++.|++.||+|||++||+||||||+|||++.+|.+||+|||++....
T Consensus       103 ~~~~~lv~Ey~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~  182 (340)
T PTZ00426        103 ESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVD  182 (340)
T ss_pred             CCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEecCCCCeecC
Confidence            99999999999999999999988899999999999999999999999999999999999999999999999999997542


Q ss_pred             cccCCCccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhh-cCC-------------------cCCCCCCCHHHH
Q 014609          166 HFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIF-RGD-------------------FKLPKWLSPGAQ  225 (421)
Q Consensus       166 ~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~-~~~-------------------~~~p~~~s~~~~  225 (421)
                      .     .....+||+.|+|||++.+..+ +.++||||+||++|.+ .|.                   ..+|..+++.+.
T Consensus       183 ~-----~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~  256 (340)
T PTZ00426        183 T-----RTYTLCGTPEYIAPEILLNVGH-GKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGIIYFPKFLDNNCK  256 (340)
T ss_pred             C-----CcceecCChhhcCHHHHhCCCC-CccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHH
Confidence            2     2345689999999999987776 5899999999999944 232                   334667899999


Q ss_pred             HHHHHhcCCCCCCCC-----CHHhhhcCccccc
Q 014609          226 NLLRKILEPNPVKRI-----TIAGIKADEWFEQ  253 (421)
Q Consensus       226 ~li~~~L~~dP~~R~-----t~~eil~~~w~~~  253 (421)
                      ++|++||+.||.+|+     +++++++||||..
T Consensus       257 ~li~~~l~~dp~~R~~~~~~~~~~~~~hp~f~~  289 (340)
T PTZ00426        257 HLMKKLLSHDLTKRYGNLKKGAQNVKEHPWFGN  289 (340)
T ss_pred             HHHHHHcccCHHHcCCCCCCCHHHHHcCCCcCC
Confidence            999999999999996     8999999999975

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.2e-47  Score=355.61  Aligned_cols=242  Identities=31%  Similarity=0.482  Sum_probs=207.9

Q ss_pred             cceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEe-----CCE
Q 014609           14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLAS-----KSK   88 (421)
Q Consensus        14 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~-----~~~   88 (421)
                      .+|..++.||+|+||.|..|.++.+|+.||||.+.. .+.+.....+..||+++|+.++|+||+.+++++..     -+.
T Consensus        22 ~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~-~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~D  100 (359)
T KOG0660|consen   22 RYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILN-PFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFND  100 (359)
T ss_pred             ceecccccccCcceeeEEEEEEcCCCCEeehhhhhh-hhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccce
Confidence            356668999999999999999999999999999863 34455567889999999999999999999999865     356


Q ss_pred             EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCcccc
Q 014609           89 IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFR  168 (421)
Q Consensus        89 ~~lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~~  168 (421)
                      +|+|+|++ +.+|...+..+..++++.++.++.|++.||+|+|+.+|+||||||.|+|++.+..+||+|||+|+......
T Consensus       101 vYiV~elM-etDL~~iik~~~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~~~  179 (359)
T KOG0660|consen  101 VYLVFELM-ETDLHQIIKSQQDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNADCDLKICDFGLARYLDKFF  179 (359)
T ss_pred             eEEehhHH-hhHHHHHHHcCccccHHHHHHHHHHHHHhcchhhcccccccccchhheeeccCCCEEeccccceeeccccC
Confidence            99999999 67898888887779999999999999999999999999999999999999999999999999999765443


Q ss_pred             CCCccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhhcCCcCC--------------------------------
Q 014609          169 DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIFRGDFKL--------------------------------  216 (421)
Q Consensus       169 ~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~~~~~~~--------------------------------  216 (421)
                      ..+.++.+..|.+|+|||++....-++..+||||+|||+.++.++.++                                
T Consensus       180 ~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~s~~  259 (359)
T KOG0660|consen  180 EDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKIRSEK  259 (359)
T ss_pred             cccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHhccHH
Confidence            456677889999999999986544346899999999999844322111                                


Q ss_pred             -----------C--------CCCCHHHHHHHHHhcCCCCCCCCCHHhhhcCccccccccC
Q 014609          217 -----------P--------KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTP  257 (421)
Q Consensus       217 -----------p--------~~~s~~~~~li~~~L~~dP~~R~t~~eil~~~w~~~~~~~  257 (421)
                                 |        +..++.+.+|+.+||..||.+|+|++|+++|||+.....+
T Consensus       260 ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~hdp  319 (359)
T KOG0660|consen  260 ARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPYHDP  319 (359)
T ss_pred             HHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhhcCC
Confidence                       0        2367999999999999999999999999999999876544

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.4e-47  Score=374.83  Aligned_cols=237  Identities=27%  Similarity=0.536  Sum_probs=211.9

Q ss_pred             CeeecceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEE
Q 014609           10 GMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKI   89 (421)
Q Consensus        10 ~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~   89 (421)
                      +.....|+...+||+|+.|.||.|....+++.||||.++......   .+-+.+|+.+|+.++|+|||.+++.|.-.+.+
T Consensus       269 ~dP~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~---keLilnEi~Vm~~~~H~NiVnfl~Sylv~deL  345 (550)
T KOG0578|consen  269 GDPRSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPK---KELLLNEILVMRDLHHPNIVNFLDSYLVGDEL  345 (550)
T ss_pred             CChhhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCc---hhhhHHHHHHHHhccchHHHHHHHHhccccee
Confidence            445678999999999999999999999999999999998765433   46789999999999999999999999999999


Q ss_pred             EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCccccC
Q 014609           90 YMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD  169 (421)
Q Consensus        90 ~lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~  169 (421)
                      |+||||++||+|.|.+.. ..++|.++..++++++.||+|||.+||+|||||.+|||++.+|.+||+|||++......  
T Consensus       346 WVVMEym~ggsLTDvVt~-~~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~--  422 (550)
T KOG0578|consen  346 WVVMEYMEGGSLTDVVTK-TRMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEE--  422 (550)
T ss_pred             EEEEeecCCCchhhhhhc-ccccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEeccCCcEEEeeeeeeeccccc--
Confidence            999999999999998765 55999999999999999999999999999999999999999999999999999866542  


Q ss_pred             CCccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhh-cCCc----------------------CCCCCCCHHHHH
Q 014609          170 DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIF-RGDF----------------------KLPKWLSPGAQN  226 (421)
Q Consensus       170 ~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~-~~~~----------------------~~p~~~s~~~~~  226 (421)
                      .....+..|||+|||||++..+.| |+++||||||+++.+| .|..                      ..|..+|+.+++
T Consensus       423 ~~KR~TmVGTPYWMAPEVvtrk~Y-G~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~ng~P~lk~~~klS~~~kd  501 (550)
T KOG0578|consen  423 QSKRSTMVGTPYWMAPEVVTRKPY-GPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPKLKNPEKLSPELKD  501 (550)
T ss_pred             cCccccccCCCCccchhhhhhccc-CccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhhcCCCCcCCccccCHHHHH
Confidence            234567899999999999999988 6999999999999843 2332                      235568999999


Q ss_pred             HHHHhcCCCCCCCCCHHhhhcCccccc
Q 014609          227 LLRKILEPNPVKRITIAGIKADEWFEQ  253 (421)
Q Consensus       227 li~~~L~~dP~~R~t~~eil~~~w~~~  253 (421)
                      |+.+||+.||.+|+++.|+|+||||+.
T Consensus       502 FL~~cL~~dv~~RasA~eLL~HpFl~~  528 (550)
T KOG0578|consen  502 FLDRCLVVDVEQRASAKELLEHPFLKM  528 (550)
T ss_pred             HHHHHhhcchhcCCCHHHHhcChhhhh
Confidence            999999999999999999999999964

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.3e-46  Score=356.68  Aligned_cols=242  Identities=30%  Similarity=0.526  Sum_probs=209.5

Q ss_pred             CeeecceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEE
Q 014609           10 GMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKI   89 (421)
Q Consensus        10 ~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~   89 (421)
                      ....+.|++...||.|..++||+|+...+++.||||+++.+++.+.  .+.+.+|+..|+.++||||++++..|..+..+
T Consensus        22 p~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~--ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~L   99 (516)
T KOG0582|consen   22 PLNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNND--LDALRKEVQTMSLIDHPNIVTYHCSFVVDSEL   99 (516)
T ss_pred             CCCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhh--HHHHHHHHHHhhhcCCCCcceEEEEEEeccee
Confidence            3556799999999999999999999999999999999998876543  68899999999999999999999999999999


Q ss_pred             EEEEeccCCCChHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCccc
Q 014609           90 YMVLEYVTGGELFDKIAS--KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHF  167 (421)
Q Consensus        90 ~lv~E~~~gg~L~~~i~~--~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~  167 (421)
                      |+||.|+.+|++++.+..  ..+++|..+..++++++.||.|||.+|-||||||+.||||+.+|.+||+|||.+......
T Consensus       100 WvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~  179 (516)
T KOG0582|consen  100 WVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILIDSDGTVKLADFGVSASLFDS  179 (516)
T ss_pred             EEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcCCCcEEEcCceeeeeeccc
Confidence            999999999999999976  346999999999999999999999999999999999999999999999999998754332


Q ss_pred             cCC-C-ccccccCCCCccChhhhcc--cCCCCCcchHHHHHHHHhhhc--------------------CCcCCCC-----
Q 014609          168 RDD-G-LLHTTCGSPNYVAPEVLAN--RGYDGATSDIWSCGVILYIFR--------------------GDFKLPK-----  218 (421)
Q Consensus       168 ~~~-~-~~~~~~gt~~y~APEvl~~--~~~~~~~~DiwSlGvil~~~~--------------------~~~~~p~-----  218 (421)
                      +.. . ...+..|||+|||||++..  .+|+ .|+||||||++..++.                    +.++.|.     
T Consensus       180 G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYd-fKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn~pp~~~t~~~~  258 (516)
T KOG0582|consen  180 GDRQVTRFNTFVGTPCWMAPEVLMQQLHGYD-FKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQNDPPTLLTSGLD  258 (516)
T ss_pred             CceeeEeeccccCcccccChHHhhhcccCcc-chhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCCCCcccccCC
Confidence            211 1 1266799999999999543  5675 9999999999988542                    2222111     


Q ss_pred             -----CCCHHHHHHHHHhcCCCCCCCCCHHhhhcCcccccc
Q 014609          219 -----WLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD  254 (421)
Q Consensus       219 -----~~s~~~~~li~~~L~~dP~~R~t~~eil~~~w~~~~  254 (421)
                           .++..++.+|..||++||.+|||++++++|+||++.
T Consensus       259 ~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~FFk~~  299 (516)
T KOG0582|consen  259 KDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKHAFFKKA  299 (516)
T ss_pred             hHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhccHHHhhc
Confidence                 156788999999999999999999999999999864

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=4.7e-47  Score=350.76  Aligned_cols=246  Identities=30%  Similarity=0.425  Sum_probs=207.0

Q ss_pred             eeecceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeC--CE
Q 014609           11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASK--SK   88 (421)
Q Consensus        11 ~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~--~~   88 (421)
                      ..++.|+.+..|++|+||.||+|+|+.|++.||+|.++.+. .....--...|||.+|.+.+|||||.+-++....  +.
T Consensus        73 rsv~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmek-ek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~  151 (419)
T KOG0663|consen   73 RSVEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEK-EKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDK  151 (419)
T ss_pred             ccHHHHHHHhhcccCcceeEEEeccCCcceeEEeeeccccc-ccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccce
Confidence            34678999999999999999999999999999999998654 2222334568999999999999999999988654  57


Q ss_pred             EEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCccc
Q 014609           89 IYMVLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHF  167 (421)
Q Consensus        89 ~~lv~E~~~gg~L~~~i~~~-~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~  167 (421)
                      +|+|||||+. +|...+.+- .++...+++.++.|++.|++|||++.|+||||||+|+|++..|.+||+|||+|+.+.. 
T Consensus       152 iy~VMe~~Eh-DLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygs-  229 (419)
T KOG0663|consen  152 IYIVMEYVEH-DLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSHKGILKIADFGLAREYGS-  229 (419)
T ss_pred             eeeeHHHHHh-hHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeeccCCcEEecccchhhhhcC-
Confidence            9999999965 888888764 4899999999999999999999999999999999999999999999999999997765 


Q ss_pred             cCCCccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhhcCC----------------------------------
Q 014609          168 RDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIFRGD----------------------------------  213 (421)
Q Consensus       168 ~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~~~~----------------------------------  213 (421)
                       .....+...-|.+|+|||.+.+..-++.++|+||+|||+.++...                                  
T Consensus       230 -p~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~l  308 (419)
T KOG0663|consen  230 -PLKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSEL  308 (419)
T ss_pred             -CcccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCcccc
Confidence             233456667899999999999877668999999999999822110                                  


Q ss_pred             -----cCCCC-----------C--CCHHHHHHHHHhcCCCCCCCCCHHhhhcCccccccccCCCC
Q 014609          214 -----FKLPK-----------W--LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPANP  260 (421)
Q Consensus       214 -----~~~p~-----------~--~s~~~~~li~~~L~~dP~~R~t~~eil~~~w~~~~~~~~~~  260 (421)
                           ..+|+           +  ++....+|+..+|..||.+|.|++|.|+|+||.....|..+
T Consensus       309 p~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~F~e~P~p~~P  373 (419)
T KOG0663|consen  309 PAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEYFRETPLPIDP  373 (419)
T ss_pred             chhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcccccccCCCCCCh
Confidence                 01110           1  45889999999999999999999999999999986555433

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=5.6e-46  Score=359.36  Aligned_cols=237  Identities=28%  Similarity=0.440  Sum_probs=199.1

Q ss_pred             ecceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEE
Q 014609           13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMV   92 (421)
Q Consensus        13 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv   92 (421)
                      .++|++.+.||+|+||+||+|++..+++.||+|++.......  ....+.+|+.+++.++||||+++++++.++...|+|
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv   81 (303)
T cd07869           4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEG--TPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLV   81 (303)
T ss_pred             cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccc--cchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEE
Confidence            468999999999999999999999999999999997543221  234678899999999999999999999999999999


Q ss_pred             EeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCccccCCC
Q 014609           93 LEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDG  171 (421)
Q Consensus        93 ~E~~~gg~L~~~i~~-~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~  171 (421)
                      |||+. ++|.+.+.. .+.+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||++.....  ...
T Consensus        82 ~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~--~~~  158 (303)
T cd07869          82 FEYVH-TDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTGELKLADFGLARAKSV--PSH  158 (303)
T ss_pred             EECCC-cCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECCCCcceeccC--CCc
Confidence            99995 577777765 35689999999999999999999999999999999999999999999999999874322  122


Q ss_pred             ccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhh-cCCcCCCC--------------------------------
Q 014609          172 LLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIF-RGDFKLPK--------------------------------  218 (421)
Q Consensus       172 ~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~-~~~~~~p~--------------------------------  218 (421)
                      .....+||+.|+|||++.+....+.++||||+||++|.+ .|..+++.                                
T Consensus       159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (303)
T cd07869         159 TYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPHF  238 (303)
T ss_pred             cCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhcccc
Confidence            334567899999999987655446889999999999944 34333321                                


Q ss_pred             --------------------CCCHHHHHHHHHhcCCCCCCCCCHHhhhcCcccccc
Q 014609          219 --------------------WLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD  254 (421)
Q Consensus       219 --------------------~~s~~~~~li~~~L~~dP~~R~t~~eil~~~w~~~~  254 (421)
                                          ..++.+.+|+.+||++||.+|||+.++++||||++.
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~~f~~~  294 (303)
T cd07869         239 KPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYFSDL  294 (303)
T ss_pred             ccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcCcccccC
Confidence                                124578899999999999999999999999999863

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=4e-46  Score=364.90  Aligned_cols=231  Identities=37%  Similarity=0.637  Sum_probs=203.7

Q ss_pred             ceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEEeccCCC
Q 014609           20 RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGG   99 (421)
Q Consensus        20 ~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~~gg   99 (421)
                      +.||+|+||.||+|++..+|+.||+|++.+...........+.+|+.+++.++||||+++++++..++.+|+||||++++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g   80 (328)
T cd05593           1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG   80 (328)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence            46999999999999999999999999998765444444677889999999999999999999999999999999999999


Q ss_pred             ChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCccccCCCccccccCC
Q 014609          100 ELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGS  179 (421)
Q Consensus       100 ~L~~~i~~~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt  179 (421)
                      +|.+.+.....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.....  ........+||
T Consensus        81 ~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~--~~~~~~~~~gt  158 (328)
T cd05593          81 ELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGIT--DAATMKTFCGT  158 (328)
T ss_pred             CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCCCcEEEecCcCCccCCC--cccccccccCC
Confidence            9999998888899999999999999999999999999999999999999999999999999874321  12234456899


Q ss_pred             CCccChhhhcccCCCCCcchHHHHHHHHhhh-cCC-------------------cCCCCCCCHHHHHHHHHhcCCCCCCC
Q 014609          180 PNYVAPEVLANRGYDGATSDIWSCGVILYIF-RGD-------------------FKLPKWLSPGAQNLLRKILEPNPVKR  239 (421)
Q Consensus       180 ~~y~APEvl~~~~~~~~~~DiwSlGvil~~~-~~~-------------------~~~p~~~s~~~~~li~~~L~~dP~~R  239 (421)
                      +.|+|||++.+..+ +.++|||||||++|.+ .|.                   ..+|..+++++.++|++||++||.+|
T Consensus       159 ~~y~aPE~~~~~~~-~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~L~~dP~~R  237 (328)
T cd05593         159 PEYLAPEVLEDNDY-GRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEDIKFPRTLSADAKSLLSGLLIKDPNKR  237 (328)
T ss_pred             cCccChhhhcCCCC-CccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhccCCccCCCCCCHHHHHHHHHHcCCCHHHc
Confidence            99999999987777 5899999999999943 232                   34456688999999999999999999


Q ss_pred             C-----CHHhhhcCccccc
Q 014609          240 I-----TIAGIKADEWFEQ  253 (421)
Q Consensus       240 ~-----t~~eil~~~w~~~  253 (421)
                      +     ++.++++||||..
T Consensus       238 ~~~~~~~~~~il~h~~~~~  256 (328)
T cd05593         238 LGGGPDDAKEIMRHSFFTG  256 (328)
T ss_pred             CCCCCCCHHHHhcCCCcCC
Confidence            7     8999999999975

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=6.2e-46  Score=356.65  Aligned_cols=235  Identities=28%  Similarity=0.452  Sum_probs=198.8

Q ss_pred             eecceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEE
Q 014609           12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYM   91 (421)
Q Consensus        12 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l   91 (421)
                      .+++|++.+.||.|+||.||+|++..+++.||+|+++.....  .....+.+|+.++++++||||+++++++.+.+..|+
T Consensus         3 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l   80 (288)
T cd07871           3 KLETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEE--GAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTL   80 (288)
T ss_pred             ccccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccC--CcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEE
Confidence            468899999999999999999999999999999999754322  223567899999999999999999999999999999


Q ss_pred             EEeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCccccCC
Q 014609           92 VLEYVTGGELFDKIASKG-RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD  170 (421)
Q Consensus        92 v~E~~~gg~L~~~i~~~~-~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~  170 (421)
                      ||||+++ +|.+.+...+ .+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||++.....  ..
T Consensus        81 v~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~--~~  157 (288)
T cd07871          81 VFEYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLARAKSV--PT  157 (288)
T ss_pred             EEeCCCc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEECcCcceeeccC--CC
Confidence            9999975 8988886544 579999999999999999999999999999999999999999999999999874322  12


Q ss_pred             CccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhhc-CCcCC---------------------------------
Q 014609          171 GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIFR-GDFKL---------------------------------  216 (421)
Q Consensus       171 ~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~~-~~~~~---------------------------------  216 (421)
                      .......+++.|+|||++.+....+.++||||+||++|.+. |..++                                 
T Consensus       158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (288)
T cd07871         158 KTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEF  237 (288)
T ss_pred             ccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhh
Confidence            22344578999999999876444468999999999999443 32221                                 


Q ss_pred             -----C-----------CCCCHHHHHHHHHhcCCCCCCCCCHHhhhcCccc
Q 014609          217 -----P-----------KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWF  251 (421)
Q Consensus       217 -----p-----------~~~s~~~~~li~~~L~~dP~~R~t~~eil~~~w~  251 (421)
                           |           +.+++++.+||++||+.||.+|||++|+++||||
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~hp~f  288 (288)
T cd07871         238 RSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSYF  288 (288)
T ss_pred             hccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcCCCC
Confidence                 1           1256789999999999999999999999999998

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.7e-46  Score=361.73  Aligned_cols=230  Identities=35%  Similarity=0.609  Sum_probs=202.3

Q ss_pred             EeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEEeccCCCCh
Q 014609           22 LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGEL  101 (421)
Q Consensus        22 LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~~gg~L  101 (421)
                      ||+|+||.||+|++..+++.||+|++.+...........+.+|+.++++++||||+++++++.+.+..|+||||++||+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L   80 (312)
T cd05585           1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL   80 (312)
T ss_pred             CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence            69999999999999999999999999865444444457788999999999999999999999999999999999999999


Q ss_pred             HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCccccCCCccccccCCCC
Q 014609          102 FDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPN  181 (421)
Q Consensus       102 ~~~i~~~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~  181 (421)
                      .+.+...+.+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||++.....  ........+||+.
T Consensus        81 ~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~--~~~~~~~~~gt~~  158 (312)
T cd05585          81 FHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMK--DDDKTNTFCGTPE  158 (312)
T ss_pred             HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCCCcEEEEECcccccCcc--CCCccccccCCcc
Confidence            99998888899999999999999999999999999999999999999999999999999875322  2223445689999


Q ss_pred             ccChhhhcccCCCCCcchHHHHHHHHhhh-cCC-------------------cCCCCCCCHHHHHHHHHhcCCCCCCCC-
Q 014609          182 YVAPEVLANRGYDGATSDIWSCGVILYIF-RGD-------------------FKLPKWLSPGAQNLLRKILEPNPVKRI-  240 (421)
Q Consensus       182 y~APEvl~~~~~~~~~~DiwSlGvil~~~-~~~-------------------~~~p~~~s~~~~~li~~~L~~dP~~R~-  240 (421)
                      |+|||++.+..+ +.++||||+||++|.+ .|.                   ..+|..+++.+.++|.+||++||.+|| 
T Consensus       159 y~aPE~~~~~~~-~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~~  237 (312)
T cd05585         159 YLAPELLLGHGY-TKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQEPLRFPDGFDRDAKDLLIGLLSRDPTRRLG  237 (312)
T ss_pred             cCCHHHHcCCCC-CCccceechhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCCCCCcCCHHHHHHHHHHcCCCHHHcCC
Confidence            999999988777 5889999999999943 333                   334566889999999999999999997 


Q ss_pred             --CHHhhhcCcccccc
Q 014609          241 --TIAGIKADEWFEQD  254 (421)
Q Consensus       241 --t~~eil~~~w~~~~  254 (421)
                        ++.+++.||||.+.
T Consensus       238 ~~~~~e~l~hp~~~~~  253 (312)
T cd05585         238 YNGAQEIKNHPFFSQL  253 (312)
T ss_pred             CCCHHHHHcCCCcCCC
Confidence              57999999999863

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.1e-46  Score=368.96  Aligned_cols=239  Identities=32%  Similarity=0.591  Sum_probs=205.8

Q ss_pred             cceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEE
Q 014609           14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVL   93 (421)
Q Consensus        14 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~   93 (421)
                      ++|++++.||+|+||+||+|++..+|+.||||++.+...........+.+|+.+++.++||||+++++++.+++.+|+||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~   80 (364)
T cd05599           1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM   80 (364)
T ss_pred             CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence            47999999999999999999999999999999998654444444567889999999999999999999999999999999


Q ss_pred             eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCccccCC---
Q 014609           94 EYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD---  170 (421)
Q Consensus        94 E~~~gg~L~~~i~~~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~---  170 (421)
                      ||++||+|.+++...+.+++..++.++.|++.||+|||++||+||||||+|||++.+|.+||+|||++.........   
T Consensus        81 E~~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~  160 (364)
T cd05599          81 EYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFY  160 (364)
T ss_pred             CCCCCcHHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEeecccceecccccccccc
Confidence            99999999999988888999999999999999999999999999999999999999999999999998643211000   


Q ss_pred             ---------------------------------CccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhh-cCCcCC
Q 014609          171 ---------------------------------GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIF-RGDFKL  216 (421)
Q Consensus       171 ---------------------------------~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~-~~~~~~  216 (421)
                                                       ......+||+.|+|||++.+..+ +.++|||||||++|.+ .|..++
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlG~il~el~~G~~Pf  239 (364)
T cd05599         161 RILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGY-NKECDWWSLGVIMYEMLVGYPPF  239 (364)
T ss_pred             ccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCC-CCeeeeecchhHHHHhhcCCCCC
Confidence                                             01123579999999999988877 5899999999999954 333322


Q ss_pred             ---------------------CC--CCCHHHHHHHHHhcCCCCCCCCC---HHhhhcCcccccc
Q 014609          217 ---------------------PK--WLSPGAQNLLRKILEPNPVKRIT---IAGIKADEWFEQD  254 (421)
Q Consensus       217 ---------------------p~--~~s~~~~~li~~~L~~dP~~R~t---~~eil~~~w~~~~  254 (421)
                                           |.  .+++.+.++|++||. +|.+|++   +.+++.||||...
T Consensus       240 ~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h~~~~~~  302 (364)
T cd05599         240 CSDNPQETYRKIINWKETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSHPFFKGV  302 (364)
T ss_pred             CCCCHHHHHHHHHcCCCccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcCCCcCCC
Confidence                                 22  258899999999996 9999998   9999999999753

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.7e-46  Score=363.38  Aligned_cols=235  Identities=32%  Similarity=0.537  Sum_probs=208.4

Q ss_pred             cceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEE
Q 014609           14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVL   93 (421)
Q Consensus        14 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~   93 (421)
                      ++|++++.||+|+||.||+|++..+++.||||++.+...........+.+|+.+++.++||||+++++++...+..|+||
T Consensus         1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~   80 (333)
T cd05600           1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM   80 (333)
T ss_pred             CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence            57999999999999999999999999999999998765444444567889999999999999999999999999999999


Q ss_pred             eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCccccCCCcc
Q 014609           94 EYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLL  173 (421)
Q Consensus        94 E~~~gg~L~~~i~~~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~  173 (421)
                      ||++|++|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.....     ..
T Consensus        81 e~~~g~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~-----~~  155 (333)
T cd05600          81 EYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT-----YA  155 (333)
T ss_pred             eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEEEeCcCCccccc-----cc
Confidence            9999999999998888899999999999999999999999999999999999999999999999999975432     34


Q ss_pred             ccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhh-cCCcCC---------------------CC------CCCHHHH
Q 014609          174 HTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIF-RGDFKL---------------------PK------WLSPGAQ  225 (421)
Q Consensus       174 ~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~-~~~~~~---------------------p~------~~s~~~~  225 (421)
                      ...+||+.|+|||++.+..+ +.++|||||||++|.+ .|..++                     |.      .+++++.
T Consensus       156 ~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~~~  234 (333)
T cd05600         156 NSVVGSPDYMAPEVLRGKGY-DFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDDPRFNLSDEAW  234 (333)
T ss_pred             CCcccCccccChhHhcCCCC-CCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhccccccCCCCCccccccCHHHH
Confidence            45689999999999988877 5899999999999954 333332                     21      2478999


Q ss_pred             HHHHHhcCCCCCCCCCHHhhhcCcccccc
Q 014609          226 NLLRKILEPNPVKRITIAGIKADEWFEQD  254 (421)
Q Consensus       226 ~li~~~L~~dP~~R~t~~eil~~~w~~~~  254 (421)
                      ++|.+||..+|.+|+++.++++||||...
T Consensus       235 ~li~~~l~~~~~rr~s~~~ll~h~~~~~~  263 (333)
T cd05600         235 DLITKLINDPSRRFGSLEDIKNHPFFKEV  263 (333)
T ss_pred             HHHHHHhhChhhhcCCHHHHHhCcccCCC
Confidence            99999999999999999999999999863

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=1.3e-45  Score=366.15  Aligned_cols=239  Identities=31%  Similarity=0.536  Sum_probs=203.4

Q ss_pred             cceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEE
Q 014609           14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVL   93 (421)
Q Consensus        14 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~   93 (421)
                      ++|++++.||+|+||+||+|++..+++.||||++++...........+.+|+.+++.++||||+++++.+.+...+|+||
T Consensus         1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~   80 (363)
T cd05628           1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM   80 (363)
T ss_pred             CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence            47999999999999999999999999999999998654444444567889999999999999999999999999999999


Q ss_pred             eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCccccC----
Q 014609           94 EYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD----  169 (421)
Q Consensus        94 E~~~gg~L~~~i~~~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~----  169 (421)
                      ||++||+|.+++...+.+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||++........    
T Consensus        81 E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~~~~  160 (363)
T cd05628          81 EFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFY  160 (363)
T ss_pred             cCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCCEEEeeccCccccccccccccc
Confidence            9999999999999888999999999999999999999999999999999999999999999999999875321100    


Q ss_pred             -----------------------------CCccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhh-cCCcC----
Q 014609          170 -----------------------------DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIF-RGDFK----  215 (421)
Q Consensus       170 -----------------------------~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~-~~~~~----  215 (421)
                                                   .......+||+.|+|||++.+..++ .++|||||||++|++ .|..|    
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~-~~~DvwSlGvil~ell~G~~Pf~~~  239 (363)
T cd05628         161 RNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYN-KLCDWWSLGVIMYEMLIGYPPFCSE  239 (363)
T ss_pred             ccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCC-CchhhhhhHHHHHHHHhCCCCCCCC
Confidence                                         0112346899999999999888774 899999999999943 23222    


Q ss_pred             -----------------CCC--CCCHHHHHHHHHhcCCCCC---CCCCHHhhhcCcccccc
Q 014609          216 -----------------LPK--WLSPGAQNLLRKILEPNPV---KRITIAGIKADEWFEQD  254 (421)
Q Consensus       216 -----------------~p~--~~s~~~~~li~~~L~~dP~---~R~t~~eil~~~w~~~~  254 (421)
                                       +|+  .+++++.++|.+++. +|.   .||++++|++||||+..
T Consensus       240 ~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~-~~~~r~~r~~~~ei~~hp~f~~~  299 (363)
T cd05628         240 TPQETYKKVMNWKETLIFPPEVPISEKAKDLILRFCC-EWEHRIGAPGVEEIKTNPFFEGV  299 (363)
T ss_pred             CHHHHHHHHHcCcCcccCCCcCCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhCCCCCCCC
Confidence                             233  267899999999775 444   46899999999999753

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=1e-45  Score=354.18  Aligned_cols=235  Identities=27%  Similarity=0.439  Sum_probs=200.6

Q ss_pred             cceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEE
Q 014609           14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVL   93 (421)
Q Consensus        14 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~   93 (421)
                      ++|++.+.||+|+||.||+|++..+++.||+|++...... ....+.+.+|+.+++.++||||+++++++..++..|+||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   79 (287)
T cd07848           1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEEN-EEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVF   79 (287)
T ss_pred             CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEeccccc-ccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEE
Confidence            4799999999999999999999999999999999764332 233567889999999999999999999999999999999


Q ss_pred             eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCccccCCCcc
Q 014609           94 EYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLL  173 (421)
Q Consensus        94 E~~~gg~L~~~i~~~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~  173 (421)
                      ||++++.+.........+++..++.++.|++.||+|||+.||+||||||+||+++.++.+||+|||++....... ....
T Consensus        80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~-~~~~  158 (287)
T cd07848          80 EYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGS-NANY  158 (287)
T ss_pred             ecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccCcccccccc-cccc
Confidence            999988776555555679999999999999999999999999999999999999999999999999998643211 1223


Q ss_pred             ccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhh-cCCcCCCC----------------------------------
Q 014609          174 HTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIF-RGDFKLPK----------------------------------  218 (421)
Q Consensus       174 ~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~-~~~~~~p~----------------------------------  218 (421)
                      ....||+.|+|||++.+..+ +.++||||+||++|.+ .|..+++.                                  
T Consensus       159 ~~~~~~~~y~aPE~~~~~~~-~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (287)
T cd07848         159 TEYVATRWYRSPELLLGAPY-GKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHGL  237 (287)
T ss_pred             cccccccccCCcHHHcCCCC-CCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhccc
Confidence            34578999999999988777 5899999999999954 33333221                                  


Q ss_pred             -----------------CCCHHHHHHHHHhcCCCCCCCCCHHhhhcCccc
Q 014609          219 -----------------WLSPGAQNLLRKILEPNPVKRITIAGIKADEWF  251 (421)
Q Consensus       219 -----------------~~s~~~~~li~~~L~~dP~~R~t~~eil~~~w~  251 (421)
                                       .+|+.+.+||++||++||.+|||++++++||||
T Consensus       238 ~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~hp~f  287 (287)
T cd07848         238 RFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHPAF  287 (287)
T ss_pred             ccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence                             156779999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=2.2e-46  Score=355.16  Aligned_cols=247  Identities=31%  Similarity=0.505  Sum_probs=213.9

Q ss_pred             cCCeeecceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCC
Q 014609            8 QEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKS   87 (421)
Q Consensus         8 ~~~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~   87 (421)
                      .....+.+|++++.||.|.-|+||+++...++..+|+|++++..+...+...+++.|-+||+.++||.++.+|..++++.
T Consensus        71 ~~~l~l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~  150 (459)
T KOG0610|consen   71 DGSLGLRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDK  150 (459)
T ss_pred             CCccCHHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccc
Confidence            34556789999999999999999999999999999999999988877777888999999999999999999999999999


Q ss_pred             EEEEEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCc
Q 014609           88 KIYMVLEYVTGGELFDKIASK--GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQ  165 (421)
Q Consensus        88 ~~~lv~E~~~gg~L~~~i~~~--~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~  165 (421)
                      ..|++||||+||+|....+++  +.+++..+++|+..++.||+|||-.|||+||||||||||-++|++.|+||.|+....
T Consensus       151 ~~cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvredGHIMLsDFDLS~~~~  230 (459)
T KOG0610|consen  151 YSCLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVREDGHIMLSDFDLSLRCP  230 (459)
T ss_pred             eeEEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEecCCcEEeeeccccccCC
Confidence            999999999999999888753  569999999999999999999999999999999999999999999999999974210


Q ss_pred             c-----------------------------c---c-C---------------------CCccccccCCCCccChhhhccc
Q 014609          166 H-----------------------------F---R-D---------------------DGLLHTTCGSPNYVAPEVLANR  191 (421)
Q Consensus       166 ~-----------------------------~---~-~---------------------~~~~~~~~gt~~y~APEvl~~~  191 (421)
                      .                             .   . .                     .......+||-.|+|||++.+.
T Consensus       231 ~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~  310 (459)
T KOG0610|consen  231 VSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGE  310 (459)
T ss_pred             CCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecC
Confidence            0                             0   0 0                     0112235789999999999999


Q ss_pred             CCCCCcchHHHHHHHHhhh-cCC-------------------cCCC--CCCCHHHHHHHHHhcCCCCCCCCC----HHhh
Q 014609          192 GYDGATSDIWSCGVILYIF-RGD-------------------FKLP--KWLSPGAQNLLRKILEPNPVKRIT----IAGI  245 (421)
Q Consensus       192 ~~~~~~~DiwSlGvil~~~-~~~-------------------~~~p--~~~s~~~~~li~~~L~~dP~~R~t----~~ei  245 (421)
                      +. +.++|+|+|||+||++ .|.                   ..+|  +.++..+++||+++|.+||.+|..    +.||
T Consensus       311 GH-gsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~l~Fp~~~~vs~~akDLIr~LLvKdP~kRlg~~rGA~eI  389 (459)
T KOG0610|consen  311 GH-GSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQPLKFPEEPEVSSAAKDLIRKLLVKDPSKRLGSKRGAAEI  389 (459)
T ss_pred             CC-CchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcCCCcCCCCCcchhHHHHHHHHHhccChhhhhccccchHHh
Confidence            98 5899999999999954 222                   2233  247899999999999999999998    9999


Q ss_pred             hcCccccccc
Q 014609          246 KADEWFEQDY  255 (421)
Q Consensus       246 l~~~w~~~~~  255 (421)
                      .+||||+...
T Consensus       390 K~HpFF~gVn  399 (459)
T KOG0610|consen  390 KRHPFFEGVN  399 (459)
T ss_pred             hcCccccCCC
Confidence            9999998643

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=8.7e-46  Score=361.71  Aligned_cols=231  Identities=34%  Similarity=0.644  Sum_probs=202.9

Q ss_pred             ceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEEeccCCC
Q 014609           20 RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGG   99 (421)
Q Consensus        20 ~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~~gg   99 (421)
                      +.||+|+||.||+|++..+|+.||+|++.+...........+.+|+.+++.++||||+++++++...+.+|+||||++|+
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (323)
T cd05595           1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence            47999999999999999999999999998654433444567788999999999999999999999999999999999999


Q ss_pred             ChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCccccCCCccccccCC
Q 014609          100 ELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGS  179 (421)
Q Consensus       100 ~L~~~i~~~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt  179 (421)
                      +|.+.+.....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.....  ........+||
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~--~~~~~~~~~gt  158 (323)
T cd05595          81 ELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS--DGATMKTFCGT  158 (323)
T ss_pred             cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCCCCEEecccHHhccccC--CCCccccccCC
Confidence            9999998888899999999999999999999999999999999999999999999999999874221  12233456899


Q ss_pred             CCccChhhhcccCCCCCcchHHHHHHHHhhhc-CC-------------------cCCCCCCCHHHHHHHHHhcCCCCCCC
Q 014609          180 PNYVAPEVLANRGYDGATSDIWSCGVILYIFR-GD-------------------FKLPKWLSPGAQNLLRKILEPNPVKR  239 (421)
Q Consensus       180 ~~y~APEvl~~~~~~~~~~DiwSlGvil~~~~-~~-------------------~~~p~~~s~~~~~li~~~L~~dP~~R  239 (421)
                      +.|+|||++.+..+ +.++|||||||++|.+. |.                   ..+|..+++.+.++|.+||++||.+|
T Consensus       159 ~~y~aPE~~~~~~~-~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~L~~dP~~R  237 (323)
T cd05595         159 PEYLAPEVLEDNDY-GRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLLKKDPKQR  237 (323)
T ss_pred             cCcCCcccccCCCC-CchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHccCCHHHh
Confidence            99999999987777 58999999999999442 32                   33456689999999999999999999


Q ss_pred             C-----CHHhhhcCccccc
Q 014609          240 I-----TIAGIKADEWFEQ  253 (421)
Q Consensus       240 ~-----t~~eil~~~w~~~  253 (421)
                      +     ++.++++||||..
T Consensus       238 ~~~~~~~~~~~l~h~~~~~  256 (323)
T cd05595         238 LGGGPSDAKEVMEHRFFLS  256 (323)
T ss_pred             CCCCCCCHHHHHcCCCcCC
Confidence            8     8999999999986

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=1.5e-45  Score=368.21  Aligned_cols=238  Identities=33%  Similarity=0.550  Sum_probs=204.0

Q ss_pred             ceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEEe
Q 014609           15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLE   94 (421)
Q Consensus        15 ~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E   94 (421)
                      .|++++.||+|+||+||+|++..+++.||||++.+...........+.+|+.+++.++||||+++++++.+.+.+|+|||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E   81 (381)
T cd05626           2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD   81 (381)
T ss_pred             CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence            68999999999999999999999999999999987655555556789999999999999999999999999999999999


Q ss_pred             ccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCccccC-----
Q 014609           95 YVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD-----  169 (421)
Q Consensus        95 ~~~gg~L~~~i~~~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~-----  169 (421)
                      |++||+|.+++.....+++..++.++.||+.||+|||+.||+||||||+|||++.++.+||+|||++..+.....     
T Consensus        82 ~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~~~~~  161 (381)
T cd05626          82 YIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQ  161 (381)
T ss_pred             cCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCCCCEEEeeCcCCccccccccccccc
Confidence            999999999998888899999999999999999999999999999999999999999999999999764311000     


Q ss_pred             ----------------------------------------CCccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhh
Q 014609          170 ----------------------------------------DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYI  209 (421)
Q Consensus       170 ----------------------------------------~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~  209 (421)
                                                              .......+||+.|+|||++.+..+ +.++||||+||++|+
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~-~~~~DiwSlG~il~e  240 (381)
T cd05626         162 KGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGY-TQLCDWWSVGVILFE  240 (381)
T ss_pred             ccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCC-CCccceeehhhHHHH
Confidence                                                    001234579999999999988877 489999999999994


Q ss_pred             h-cCCcC---------------------CCC--CCCHHHHHHHHHhc--CCCCCCCCCHHhhhcCccccc
Q 014609          210 F-RGDFK---------------------LPK--WLSPGAQNLLRKIL--EPNPVKRITIAGIKADEWFEQ  253 (421)
Q Consensus       210 ~-~~~~~---------------------~p~--~~s~~~~~li~~~L--~~dP~~R~t~~eil~~~w~~~  253 (421)
                      + .|..+                     .|.  .+++++.+||.+|+  .++|..|+++.++++||||..
T Consensus       241 lltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~hp~f~~  310 (381)
T cd05626         241 MLVGQPPFLAPTPTETQLKVINWENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIKAHPFFSE  310 (381)
T ss_pred             HHhCCCCCcCCCHHHHHHHHHccccccCCCCCCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCcccCC
Confidence            3 33322                     222  36899999999965  455566999999999999975

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=1.3e-45  Score=360.62  Aligned_cols=231  Identities=35%  Similarity=0.650  Sum_probs=202.6

Q ss_pred             ceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEEeccCCC
Q 014609           20 RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGG   99 (421)
Q Consensus        20 ~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~~gg   99 (421)
                      +.||+|+||+||+|.+..+|+.||+|++.+...........+.+|+.+++.++||||+++++++..++.+|+||||++|+
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (325)
T cd05594           1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (325)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence            47999999999999999999999999998765444444567788999999999999999999999999999999999999


Q ss_pred             ChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCceeccCCCCCEEeccCCCEEEEeccCCCCCccccCCCccccccC
Q 014609          100 ELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHN-KGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCG  178 (421)
Q Consensus       100 ~L~~~i~~~~~~~~~~~~~~~~ql~~aL~~LH~-~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~g  178 (421)
                      +|.+.+.....+++..++.++.||+.||+|||+ .||+||||||+|||++.++.+||+|||++.....  ........+|
T Consensus        81 ~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~--~~~~~~~~~g  158 (325)
T cd05594          81 ELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIK--DGATMKTFCG  158 (325)
T ss_pred             cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCCCEEEecCCCCeecCC--CCcccccccC
Confidence            999999888889999999999999999999997 7999999999999999999999999999864221  2223445689


Q ss_pred             CCCccChhhhcccCCCCCcchHHHHHHHHhhhc-CCc-------------------CCCCCCCHHHHHHHHHhcCCCCCC
Q 014609          179 SPNYVAPEVLANRGYDGATSDIWSCGVILYIFR-GDF-------------------KLPKWLSPGAQNLLRKILEPNPVK  238 (421)
Q Consensus       179 t~~y~APEvl~~~~~~~~~~DiwSlGvil~~~~-~~~-------------------~~p~~~s~~~~~li~~~L~~dP~~  238 (421)
                      |+.|+|||++.+..+ +.++|||||||++|.+. |..                   .+|..+++++.++|++||++||.+
T Consensus       159 t~~y~aPE~~~~~~~-~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~L~~dP~~  237 (325)
T cd05594         159 TPEYLAPEVLEDNDY-GRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLSPEAKSLLSGLLKKDPKQ  237 (325)
T ss_pred             CcccCCHHHHccCCC-CCccccccccceeeeeccCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHhhcCHHH
Confidence            999999999988777 58999999999999432 332                   345668999999999999999999


Q ss_pred             CC-----CHHhhhcCccccc
Q 014609          239 RI-----TIAGIKADEWFEQ  253 (421)
Q Consensus       239 R~-----t~~eil~~~w~~~  253 (421)
                      |+     ++.++++||||..
T Consensus       238 R~~~~~~~~~~il~h~~~~~  257 (325)
T cd05594         238 RLGGGPDDAKEIMQHKFFAG  257 (325)
T ss_pred             hCCCCCCCHHHHhcCCCcCC
Confidence            97     8999999999985

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=1.6e-45  Score=367.94  Aligned_cols=239  Identities=35%  Similarity=0.571  Sum_probs=204.9

Q ss_pred             cceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEE
Q 014609           14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVL   93 (421)
Q Consensus        14 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~   93 (421)
                      .+|++++.||+|+||+||+|++..+++.||+|++.+...........+.+|+.+++.++||||+++++.+.+++.+|+||
T Consensus         1 ~~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~   80 (382)
T cd05625           1 SMFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVM   80 (382)
T ss_pred             CCcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEE
Confidence            36999999999999999999999999999999998655444445678899999999999999999999999999999999


Q ss_pred             eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCcccc-----
Q 014609           94 EYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFR-----  168 (421)
Q Consensus        94 E~~~gg~L~~~i~~~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~~-----  168 (421)
                      ||++||+|.+.+...+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||++..+....     
T Consensus        81 E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~~~~  160 (382)
T cd05625          81 DYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYY  160 (382)
T ss_pred             eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEeECCCCcccccccccccc
Confidence            999999999999887889999999999999999999999999999999999999999999999999975321100     


Q ss_pred             ----------------------------------------CCCccccccCCCCccChhhhcccCCCCCcchHHHHHHHHh
Q 014609          169 ----------------------------------------DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILY  208 (421)
Q Consensus       169 ----------------------------------------~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~  208 (421)
                                                              ........+||+.|+|||++.+.+|+ .++||||+||++|
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~-~~~DiwSlGvil~  239 (382)
T cd05625         161 QSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYT-QLCDWWSVGVILY  239 (382)
T ss_pred             ccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCC-CeeeEEechHHHH
Confidence                                                    00011245799999999999888884 8999999999999


Q ss_pred             hh-cCCcCC---------------------C--CCCCHHHHHHHHHhcCCCCCCCCC---HHhhhcCcccccc
Q 014609          209 IF-RGDFKL---------------------P--KWLSPGAQNLLRKILEPNPVKRIT---IAGIKADEWFEQD  254 (421)
Q Consensus       209 ~~-~~~~~~---------------------p--~~~s~~~~~li~~~L~~dP~~R~t---~~eil~~~w~~~~  254 (421)
                      .+ .|..++                     |  ..+++++.++|.+|+ .+|.+|++   ++++++||||...
T Consensus       240 elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~hp~f~~~  311 (382)
T cd05625         240 EMLVGQPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGADEIKAHPFFKTI  311 (382)
T ss_pred             HHHhCCCCCCCCCHHHHHHHHHccCCCcCCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHhcCCCcCCc
Confidence            44 333322                     2  236899999999986 59999997   9999999999763

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=2e-45  Score=360.10  Aligned_cols=231  Identities=30%  Similarity=0.607  Sum_probs=202.3

Q ss_pred             ceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcC-CCCCcceEEEEEEeCCEEEEEEeccCC
Q 014609           20 RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEVLASKSKIYMVLEYVTG   98 (421)
Q Consensus        20 ~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~lv~E~~~g   98 (421)
                      +.||+|+||+||+|++..+++.||+|++++...........+.+|..+++.+ +||||+++++++.+.+.+|+||||++|
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~   80 (329)
T cd05588           1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG   80 (329)
T ss_pred             CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence            4799999999999999999999999999876544444456788999999988 699999999999999999999999999


Q ss_pred             CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCccccCCCccccccC
Q 014609           99 GELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCG  178 (421)
Q Consensus        99 g~L~~~i~~~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~g  178 (421)
                      ++|.+.+...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.....  ........+|
T Consensus        81 g~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~--~~~~~~~~~g  158 (329)
T cd05588          81 GDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIR--PGDTTSTFCG  158 (329)
T ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEECcCcccccccc--CCCccccccC
Confidence            99999998888999999999999999999999999999999999999999999999999999863211  2233456789


Q ss_pred             CCCccChhhhcccCCCCCcchHHHHHHHHhhh-cCCcC----------------------------CCCCCCHHHHHHHH
Q 014609          179 SPNYVAPEVLANRGYDGATSDIWSCGVILYIF-RGDFK----------------------------LPKWLSPGAQNLLR  229 (421)
Q Consensus       179 t~~y~APEvl~~~~~~~~~~DiwSlGvil~~~-~~~~~----------------------------~p~~~s~~~~~li~  229 (421)
                      |+.|+|||++.+..+ +.++|+||+||++|.+ .|..+                            +|..+++.+.++|+
T Consensus       159 t~~y~aPE~~~~~~~-~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~  237 (329)
T cd05588         159 TPNYIAPEILRGEDY-GFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIRIPRSLSVKASSVLK  237 (329)
T ss_pred             CccccCHHHHcCCCC-CCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence            999999999988777 4899999999999943 33333                            35568899999999


Q ss_pred             HhcCCCCCCCCC------HHhhhcCccccc
Q 014609          230 KILEPNPVKRIT------IAGIKADEWFEQ  253 (421)
Q Consensus       230 ~~L~~dP~~R~t------~~eil~~~w~~~  253 (421)
                      +||++||.+|+|      ++++++||||..
T Consensus       238 ~~L~~dP~~R~~~~~~~~~~~i~~hp~~~~  267 (329)
T cd05588         238 GFLNKDPKERLGCHPQTGFRDIKSHPFFRN  267 (329)
T ss_pred             HHhccCHHHcCCCCCCCCHHHHhcCCCCCC
Confidence            999999999997      789999999964

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=1.3e-45  Score=367.82  Aligned_cols=238  Identities=32%  Similarity=0.552  Sum_probs=203.9

Q ss_pred             cceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEE
Q 014609           14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVL   93 (421)
Q Consensus        14 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~   93 (421)
                      ++|++++.||+|+||.||+|++..+++.||+|++.+...........+.+|+.+|++++||||+++++.+.+++.+|+||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~   80 (376)
T cd05598           1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM   80 (376)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence            47999999999999999999999999999999997654433334567889999999999999999999999999999999


Q ss_pred             eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCccccC----
Q 014609           94 EYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD----  169 (421)
Q Consensus        94 E~~~gg~L~~~i~~~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~----  169 (421)
                      ||++||+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|..+.....    
T Consensus        81 E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~~~~  160 (376)
T cd05598          81 DYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYY  160 (376)
T ss_pred             eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECCCCCEEEEeCCCCcccccccccccc
Confidence            9999999999998888899999999999999999999999999999999999999999999999999853211000    


Q ss_pred             -------------------------------------CCccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhh-c
Q 014609          170 -------------------------------------DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIF-R  211 (421)
Q Consensus       170 -------------------------------------~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~-~  211 (421)
                                                           .......+||+.|+|||++.+..+ +.++|||||||++|.+ .
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlGvilyell~  239 (376)
T cd05598         161 QKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGY-TQLCDWWSVGVILYEMLV  239 (376)
T ss_pred             ccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCC-Ccceeeeeccceeeehhh
Confidence                                                 001123579999999999988877 5899999999999943 3


Q ss_pred             CCcCC---------------------CC--CCCHHHHHHHHHhcCCCCCCCC---CHHhhhcCccccc
Q 014609          212 GDFKL---------------------PK--WLSPGAQNLLRKILEPNPVKRI---TIAGIKADEWFEQ  253 (421)
Q Consensus       212 ~~~~~---------------------p~--~~s~~~~~li~~~L~~dP~~R~---t~~eil~~~w~~~  253 (421)
                      |..++                     |.  .+++.+.++|.+|+ .+|.+|+   |+.++++||||..
T Consensus       240 G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h~~~~~  306 (376)
T cd05598         240 GQPPFLADTPAETQLKVINWETTLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKAHPFFKG  306 (376)
T ss_pred             CCCCCCCCCHHHHHHHHhccCccccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCCCCcCC
Confidence            33332                     22  36889999999976 5999999   9999999999985

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=1.8e-45  Score=359.00  Aligned_cols=231  Identities=35%  Similarity=0.650  Sum_probs=201.5

Q ss_pred             ceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcC-CCCCcceEEEEEEeCCEEEEEEeccCC
Q 014609           20 RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEVLASKSKIYMVLEYVTG   98 (421)
Q Consensus        20 ~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~lv~E~~~g   98 (421)
                      +.||+|+||+||+|++..+++.||+|++.+.........+.+.+|..++..+ +||||+++++++.+.+.+|+||||++|
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~   80 (320)
T cd05590           1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG   80 (320)
T ss_pred             CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence            4799999999999999999999999999865443334456777888888876 699999999999999999999999999


Q ss_pred             CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCccccCCCccccccC
Q 014609           99 GELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCG  178 (421)
Q Consensus        99 g~L~~~i~~~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~g  178 (421)
                      ++|.+.+.....+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||++.....  ........+|
T Consensus        81 g~L~~~i~~~~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~--~~~~~~~~~g  158 (320)
T cd05590          81 GDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIF--NGKTTSTFCG  158 (320)
T ss_pred             chHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCc--CCCccccccc
Confidence            99999998888899999999999999999999999999999999999999999999999999874321  2223445689


Q ss_pred             CCCccChhhhcccCCCCCcchHHHHHHHHhhh-cCC-------------------cCCCCCCCHHHHHHHHHhcCCCCCC
Q 014609          179 SPNYVAPEVLANRGYDGATSDIWSCGVILYIF-RGD-------------------FKLPKWLSPGAQNLLRKILEPNPVK  238 (421)
Q Consensus       179 t~~y~APEvl~~~~~~~~~~DiwSlGvil~~~-~~~-------------------~~~p~~~s~~~~~li~~~L~~dP~~  238 (421)
                      |+.|+|||++.+..+ +.++||||+||++|.+ .|.                   ..+|.++++++.++|++||+.||.+
T Consensus       159 t~~y~aPE~~~~~~~-~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~L~~dP~~  237 (320)
T cd05590         159 TPDYIAPEILQEMLY-GPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTWLSQDAVDILKAFMTKNPTM  237 (320)
T ss_pred             CccccCHHHHcCCCC-CCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHcccCHHH
Confidence            999999999987777 5889999999999943 232                   3456678999999999999999999


Q ss_pred             CCCH------HhhhcCccccc
Q 014609          239 RITI------AGIKADEWFEQ  253 (421)
Q Consensus       239 R~t~------~eil~~~w~~~  253 (421)
                      |+++      +++++||||..
T Consensus       238 R~~~~~~~~~~~~~~h~~f~~  258 (320)
T cd05590         238 RLGSLTLGGEEAILRHPFFKE  258 (320)
T ss_pred             CCCCCCCCCHHHHHcCCCcCC
Confidence            9998      99999999975

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=2.7e-45  Score=351.67  Aligned_cols=235  Identities=31%  Similarity=0.462  Sum_probs=203.2

Q ss_pred             ceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEEe
Q 014609           15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLE   94 (421)
Q Consensus        15 ~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E   94 (421)
                      .|++.+.||+|+||+||+|.+..+|+.||+|.+.+...........+.+|+.+++.++|+||+++++++.+.+..|+|||
T Consensus         1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e   80 (285)
T cd05631           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence            38899999999999999999999999999999986554433334567899999999999999999999999999999999


Q ss_pred             ccCCCChHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCccccCCCc
Q 014609           95 YVTGGELFDKIAS--KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGL  172 (421)
Q Consensus        95 ~~~gg~L~~~i~~--~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~  172 (421)
                      |+++|+|.+.+..  ...+++..+..++.|++.||+|||+.||+||||||+|||++.++.+||+|||++.....   ...
T Consensus        81 ~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~---~~~  157 (285)
T cd05631          81 IMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPE---GET  157 (285)
T ss_pred             ecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCC---CCe
Confidence            9999999887754  34689999999999999999999999999999999999999999999999999875322   122


Q ss_pred             cccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhh-cCCcCC-----------------------CCCCCHHHHHHH
Q 014609          173 LHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIF-RGDFKL-----------------------PKWLSPGAQNLL  228 (421)
Q Consensus       173 ~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~-~~~~~~-----------------------p~~~s~~~~~li  228 (421)
                      .....||+.|+|||++.+..+ +.++||||+||++|.+ .|..++                       +..+++.+.+||
T Consensus       158 ~~~~~g~~~y~aPE~~~~~~~-~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li  236 (285)
T cd05631         158 VRGRVGTVGYMAPEVINNEKY-TFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEEYSEKFSEDAKSIC  236 (285)
T ss_pred             ecCCCCCCCccCHhhhcCCCC-CcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhcccccCCccCCHHHHHHH
Confidence            345579999999999988777 4889999999999944 343332                       334788999999


Q ss_pred             HHhcCCCCCCCCC-----HHhhhcCccccc
Q 014609          229 RKILEPNPVKRIT-----IAGIKADEWFEQ  253 (421)
Q Consensus       229 ~~~L~~dP~~R~t-----~~eil~~~w~~~  253 (421)
                      ++||+.||.+||+     ++++++||||..
T Consensus       237 ~~~l~~~P~~R~~~~~~~~~~~~~h~~~~~  266 (285)
T cd05631         237 RMLLTKNPKERLGCRGNGAAGVKQHPIFKN  266 (285)
T ss_pred             HHHhhcCHHHhcCCCCCCHHHHhcCHhhcC
Confidence            9999999999997     899999999975

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=3.8e-45  Score=357.21  Aligned_cols=236  Identities=34%  Similarity=0.621  Sum_probs=205.6

Q ss_pred             ceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCC-CcceEEEEEEeCCEEEEEE
Q 014609           15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP-NVVRLHEVLASKSKIYMVL   93 (421)
Q Consensus        15 ~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hp-nIv~l~~~~~~~~~~~lv~   93 (421)
                      +|++++.||+|+||.||+|++..+++.||||++.+.........+.+..|..++..++|+ +|+++++++.+.+.+|+||
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (324)
T cd05587           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM   80 (324)
T ss_pred             CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence            589999999999999999999999999999999875443334456788899999999765 5888999999999999999


Q ss_pred             eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCccccCCCcc
Q 014609           94 EYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLL  173 (421)
Q Consensus        94 E~~~gg~L~~~i~~~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~  173 (421)
                      ||++||+|.+.+.....+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++.....  .....
T Consensus        81 E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~--~~~~~  158 (324)
T cd05587          81 EYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIF--GGKTT  158 (324)
T ss_pred             cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCCCCEEEeecCcceecCC--CCCce
Confidence            9999999999998888899999999999999999999999999999999999999999999999999864221  12234


Q ss_pred             ccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhhc-CCcC-------------------CCCCCCHHHHHHHHHhcC
Q 014609          174 HTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIFR-GDFK-------------------LPKWLSPGAQNLLRKILE  233 (421)
Q Consensus       174 ~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~~-~~~~-------------------~p~~~s~~~~~li~~~L~  233 (421)
                      ...+||+.|+|||++.+..+ +.++||||+||++|.+. |..+                   +|..+++++.+++++||+
T Consensus       159 ~~~~gt~~y~aPE~~~~~~~-~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~  237 (324)
T cd05587         159 RTFCGTPDYIAPEIIAYQPY-GKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKSLSKEAVSICKGLLT  237 (324)
T ss_pred             eeecCCccccChhhhcCCCC-CcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhh
Confidence            45689999999999988777 58899999999999443 3333                   356689999999999999


Q ss_pred             CCCCCCCCH-----HhhhcCccccc
Q 014609          234 PNPVKRITI-----AGIKADEWFEQ  253 (421)
Q Consensus       234 ~dP~~R~t~-----~eil~~~w~~~  253 (421)
                      +||.+|++.     .++++||||..
T Consensus       238 ~~P~~R~~~~~~~~~~~~~hp~~~~  262 (324)
T cd05587         238 KHPAKRLGCGPTGERDIREHAFFRR  262 (324)
T ss_pred             cCHHHcCCCCCCCHHHHhcCCCcCC
Confidence            999999986     89999999975

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.9e-47  Score=349.86  Aligned_cols=241  Identities=34%  Similarity=0.643  Sum_probs=222.5

Q ss_pred             CeeecceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEE
Q 014609           10 GMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKI   89 (421)
Q Consensus        10 ~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~   89 (421)
                      ..++++|+.++.||+|.||+|-+++.+.+|+.+|||+++++.+........-..|-++|+..+||.+..+...|+..+++
T Consensus       164 kvTm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drl  243 (516)
T KOG0690|consen  164 KVTMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRL  243 (516)
T ss_pred             eeccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceE
Confidence            46789999999999999999999999999999999999998877777677888999999999999999999999999999


Q ss_pred             EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCccccC
Q 014609           90 YMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD  169 (421)
Q Consensus        90 ~lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~  169 (421)
                      |+||||+.||+|+-.+.+...++++.++.|-..|++||.|||+++|++||||.+|+|+|.+|++||+|||+++--  ...
T Consensus       244 CFVMeyanGGeLf~HLsrer~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~--I~~  321 (516)
T KOG0690|consen  244 CFVMEYANGGELFFHLSRERVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLDKDGHIKITDFGLCKEE--IKY  321 (516)
T ss_pred             EEEEEEccCceEeeehhhhhcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheeccCCceEeeecccchhc--ccc
Confidence            999999999999999999899999999999999999999999999999999999999999999999999999832  223


Q ss_pred             CCccccccCCCCccChhhhcccCCCCCcchHHHHHHHHh--------------------hhcCCcCCCCCCCHHHHHHHH
Q 014609          170 DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILY--------------------IFRGDFKLPKWLSPGAQNLLR  229 (421)
Q Consensus       170 ~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~--------------------~~~~~~~~p~~~s~~~~~li~  229 (421)
                      .....+.||||.|+|||++....| +..+|+|.+||++|                    ++.++..+|..++++++.|+.
T Consensus       322 g~t~kTFCGTPEYLAPEVleDnDY-graVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~ed~kFPr~ls~eAktLLs  400 (516)
T KOG0690|consen  322 GDTTKTFCGTPEYLAPEVLEDNDY-GRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILMEDLKFPRTLSPEAKTLLS  400 (516)
T ss_pred             cceeccccCChhhcCchhhccccc-cceeehhhhhHHHHHHHhccCcccccchhHHHHHHHhhhccCCccCCHHHHHHHH
Confidence            456789999999999999999988 69999999999999                    344556788999999999999


Q ss_pred             HhcCCCCCCCCC-----HHhhhcCccccc
Q 014609          230 KILEPNPVKRIT-----IAGIKADEWFEQ  253 (421)
Q Consensus       230 ~~L~~dP~~R~t-----~~eil~~~w~~~  253 (421)
                      .+|.+||.+|..     +.+|.+|+||..
T Consensus       401 GLL~kdP~kRLGgGpdDakEi~~h~FF~~  429 (516)
T KOG0690|consen  401 GLLKKDPKKRLGGGPDDAKEIMRHRFFAS  429 (516)
T ss_pred             HHhhcChHhhcCCCchhHHHHHhhhhhcc
Confidence            999999999985     789999999975

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=8.7e-45  Score=355.67  Aligned_cols=239  Identities=33%  Similarity=0.627  Sum_probs=204.3

Q ss_pred             ceEEeceEeecCcEEEEEEEEC---CCCceEEEEEeeccccc-chhHHHHHHHHHHHHhcCC-CCCcceEEEEEEeCCEE
Q 014609           15 RYELGRTLGEGNFGKVKFAQDL---DSGLPFAVKILEKNRII-HLKITDQIKREIATLKLLK-HPNVVRLHEVLASKSKI   89 (421)
Q Consensus        15 ~y~i~~~LG~G~~g~V~~a~~~---~~~~~vAvK~i~~~~~~-~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~~   89 (421)
                      +|++++.||+|+||+||+|++.   .+++.||+|++.+.... .....+.+.+|+.+++.++ ||||+++++++..++.+
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (332)
T cd05614           1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL   80 (332)
T ss_pred             CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence            5899999999999999999864   47899999999764332 2233467889999999995 89999999999999999


Q ss_pred             EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCccccC
Q 014609           90 YMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD  169 (421)
Q Consensus        90 ~lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~  169 (421)
                      |+||||++||+|.+++.....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++....... 
T Consensus        81 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~~~-  159 (332)
T cd05614          81 HLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEE-  159 (332)
T ss_pred             EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECCCCCEEEeeCcCCccccccC-
Confidence            9999999999999999888889999999999999999999999999999999999999999999999999997543221 


Q ss_pred             CCccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhh-cCCcC-----------------------CCCCCCHHHH
Q 014609          170 DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIF-RGDFK-----------------------LPKWLSPGAQ  225 (421)
Q Consensus       170 ~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~-~~~~~-----------------------~p~~~s~~~~  225 (421)
                      .......+||+.|+|||++.+....+.++|||||||++|.+ .|..+                       +|..+++.+.
T Consensus       160 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (332)
T cd05614         160 KERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCDPPFPSFIGPEAQ  239 (332)
T ss_pred             CCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHH
Confidence            22234568999999999988765446889999999999954 33322                       3445789999


Q ss_pred             HHHHHhcCCCCCCCC-----CHHhhhcCcccccc
Q 014609          226 NLLRKILEPNPVKRI-----TIAGIKADEWFEQD  254 (421)
Q Consensus       226 ~li~~~L~~dP~~R~-----t~~eil~~~w~~~~  254 (421)
                      ++|.+||+.||++||     +++++++||||+..
T Consensus       240 ~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~  273 (332)
T cd05614         240 DLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKGL  273 (332)
T ss_pred             HHHHHHcCCCHHHcCCCCCCCHHHHHcCCCcCCC
Confidence            999999999999999     78899999999863

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=100.00  E-value=6.2e-46  Score=348.57  Aligned_cols=239  Identities=33%  Similarity=0.506  Sum_probs=203.2

Q ss_pred             ecceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCC-cceEEEEEEeCC----
Q 014609           13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN-VVRLHEVLASKS----   87 (421)
Q Consensus        13 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpn-Iv~l~~~~~~~~----   87 (421)
                      +..|+.+++||+|+||+||+|+++.+|+.||+|.++.+... +..-....+|+.+|+.|+|+| |+.+++++.+.+    
T Consensus        10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~-EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~   88 (323)
T KOG0594|consen   10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEE-EGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRG   88 (323)
T ss_pred             HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccc-cCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccc
Confidence            56688889999999999999999999999999999865432 223456789999999999999 999999998877    


Q ss_pred             --EEEEEEeccCCCChHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCC
Q 014609           88 --KIYMVLEYVTGGELFDKIASKG----RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLS  161 (421)
Q Consensus        88 --~~~lv~E~~~gg~L~~~i~~~~----~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla  161 (421)
                        .+++|+||+ ..+|..++....    .++...++.+++||+.||+|||++||+||||||+||||+.+|.+||+|||+|
T Consensus        89 ~~~l~lvfe~~-d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~~G~lKlaDFGlA  167 (323)
T KOG0594|consen   89 IGKLYLVFEFL-DRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISSSGVLKLADFGLA  167 (323)
T ss_pred             cceEEEEEEee-cccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECCCCcEeeeccchH
Confidence              899999999 568988887644    5888999999999999999999999999999999999999999999999999


Q ss_pred             CCCccccCCCccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhhcCC----------------------------
Q 014609          162 ALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIFRGD----------------------------  213 (421)
Q Consensus       162 ~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~~~~----------------------------  213 (421)
                      +.+..  +........+|.+|+|||++.+...++...||||+|||+.++..+                            
T Consensus       168 ra~~i--p~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~W  245 (323)
T KOG0594|consen  168 RAFSI--PMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDW  245 (323)
T ss_pred             HHhcC--CcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCC
Confidence            85543  233355668899999999999886667999999999999832111                            


Q ss_pred             ----------cCCCCC------------CCHHHHHHHHHhcCCCCCCCCCHHhhhcCccccccc
Q 014609          214 ----------FKLPKW------------LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY  255 (421)
Q Consensus       214 ----------~~~p~~------------~s~~~~~li~~~L~~dP~~R~t~~eil~~~w~~~~~  255 (421)
                                .++|.|            .+++..+++.+||+.+|.+|.|+..++.||||....
T Consensus       246 p~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~~  309 (323)
T KOG0594|consen  246 PGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSELP  309 (323)
T ss_pred             CCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhcccc
Confidence                      122222            236889999999999999999999999999998754

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.4e-45  Score=366.01  Aligned_cols=238  Identities=31%  Similarity=0.542  Sum_probs=202.6

Q ss_pred             cceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEE
Q 014609           14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVL   93 (421)
Q Consensus        14 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~   93 (421)
                      ++|++++.||+|+||+||+|++..+|+.||||++.+...........+.+|+.+++.++||||+++++++.+.+.+|+||
T Consensus         1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~   80 (377)
T cd05629           1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM   80 (377)
T ss_pred             CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence            47999999999999999999999999999999997654434444577899999999999999999999999999999999


Q ss_pred             eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCccccCC---
Q 014609           94 EYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD---  170 (421)
Q Consensus        94 E~~~gg~L~~~i~~~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~---  170 (421)
                      ||++||+|.+++...+.+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||+++.+......   
T Consensus        81 E~~~gg~L~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~  160 (377)
T cd05629          81 EFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYY  160 (377)
T ss_pred             eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEEeecccccccccccccccc
Confidence            99999999999988888999999999999999999999999999999999999999999999999998632110000   


Q ss_pred             ------------------------------------------CccccccCCCCccChhhhcccCCCCCcchHHHHHHHHh
Q 014609          171 ------------------------------------------GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILY  208 (421)
Q Consensus       171 ------------------------------------------~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~  208 (421)
                                                                ......+||+.|+|||++.+..+ +.++|||||||++|
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlGvil~  239 (377)
T cd05629         161 QKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGY-GQECDWWSLGAIMF  239 (377)
T ss_pred             cccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCC-CCceeeEecchhhh
Confidence                                                      00113579999999999988777 58999999999999


Q ss_pred             hhc-CCcC---------------------CCC--CCCHHHHHHHHHhcCCCCCCC---CCHHhhhcCccccc
Q 014609          209 IFR-GDFK---------------------LPK--WLSPGAQNLLRKILEPNPVKR---ITIAGIKADEWFEQ  253 (421)
Q Consensus       209 ~~~-~~~~---------------------~p~--~~s~~~~~li~~~L~~dP~~R---~t~~eil~~~w~~~  253 (421)
                      ++. |..+                     +|.  .+++++.+||++||. +|.+|   +++.+++.||||..
T Consensus       240 elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~hp~~~~  310 (377)
T cd05629         240 ECLIGWPPFCSENSHETYRKIINWRETLYFPDDIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIKSHPFFRG  310 (377)
T ss_pred             hhhcCCCCCCCCCHHHHHHHHHccCCccCCCCCCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhcCCCcCC
Confidence            543 3322                     232  267899999999997 66665   59999999999974

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=5.1e-45  Score=365.20  Aligned_cols=234  Identities=22%  Similarity=0.357  Sum_probs=200.7

Q ss_pred             CeeecceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEE
Q 014609           10 GMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKI   89 (421)
Q Consensus        10 ~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~   89 (421)
                      +...++|++++.||+|+||.||+|.+..+++.||+|...         ...+.+|+.++++++||||+++++++..+...
T Consensus        88 ~~~~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~---------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~  158 (391)
T PHA03212         88 GIEKAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ---------RGGTATEAHILRAINHPSIIQLKGTFTYNKFT  158 (391)
T ss_pred             ccccCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh---------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCee
Confidence            445578999999999999999999999999999999653         23467899999999999999999999999999


Q ss_pred             EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCccccC
Q 014609           90 YMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD  169 (421)
Q Consensus        90 ~lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~  169 (421)
                      ++|+|++ +++|.+++.....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++...... .
T Consensus       159 ~lv~e~~-~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~-~  236 (391)
T PHA03212        159 CLILPRY-KTDLYCYLAAKRNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDI-N  236 (391)
T ss_pred             EEEEecC-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcCCCCEEEEeCCcccccccc-c
Confidence            9999999 4689999888788999999999999999999999999999999999999999999999999999753221 1


Q ss_pred             CCccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhhc-CCcCC------------------------------C-
Q 014609          170 DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIFR-GDFKL------------------------------P-  217 (421)
Q Consensus       170 ~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~~-~~~~~------------------------------p-  217 (421)
                      .......+||+.|+|||++.+..| +.++||||+||++|.+. |..++                              | 
T Consensus       237 ~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~  315 (391)
T PHA03212        237 ANKYYGWAGTIATNAPELLARDPY-GPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPI  315 (391)
T ss_pred             ccccccccCccCCCChhhhcCCCC-CcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCc
Confidence            223345689999999999988777 58999999999999553 32111                              0 


Q ss_pred             -------------------------C-----CCCHHHHHHHHHhcCCCCCCCCCHHhhhcCccccccc
Q 014609          218 -------------------------K-----WLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY  255 (421)
Q Consensus       218 -------------------------~-----~~s~~~~~li~~~L~~dP~~R~t~~eil~~~w~~~~~  255 (421)
                                               .     .++.++.+||.+||+.||.+|||+.|+++||||+...
T Consensus       316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~f~~~~  383 (391)
T PHA03212        316 DAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFAAFQDIP  383 (391)
T ss_pred             chhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcChhhccCC
Confidence                                     0     1345788999999999999999999999999998643

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=3e-45  Score=357.48  Aligned_cols=231  Identities=35%  Similarity=0.637  Sum_probs=202.1

Q ss_pred             ceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcC-CCCCcceEEEEEEeCCEEEEEEeccCC
Q 014609           20 RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEVLASKSKIYMVLEYVTG   98 (421)
Q Consensus        20 ~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~lv~E~~~g   98 (421)
                      +.||+|+||.||+|++..+++.||+|++.+.........+.+..|..++..+ +||||+++++++.+++.+|+||||++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~   80 (321)
T cd05591           1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG   80 (321)
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence            4699999999999999999999999999875443444456677899998866 799999999999999999999999999


Q ss_pred             CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCccccCCCccccccC
Q 014609           99 GELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCG  178 (421)
Q Consensus        99 g~L~~~i~~~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~g  178 (421)
                      ++|.+.+.....+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++.....  ........+|
T Consensus        81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~--~~~~~~~~~g  158 (321)
T cd05591          81 GDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGIL--NGVTTTTFCG  158 (321)
T ss_pred             CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeecccceeccc--CCcccccccc
Confidence            99999998888899999999999999999999999999999999999999999999999999874322  2233445689


Q ss_pred             CCCccChhhhcccCCCCCcchHHHHHHHHhhh-cCCc-------------------CCCCCCCHHHHHHHHHhcCCCCCC
Q 014609          179 SPNYVAPEVLANRGYDGATSDIWSCGVILYIF-RGDF-------------------KLPKWLSPGAQNLLRKILEPNPVK  238 (421)
Q Consensus       179 t~~y~APEvl~~~~~~~~~~DiwSlGvil~~~-~~~~-------------------~~p~~~s~~~~~li~~~L~~dP~~  238 (421)
                      |+.|+|||++.+..+ +.++||||+||++|.+ .|..                   .+|.++++++.++|++||++||.+
T Consensus       159 t~~y~aPE~~~~~~~-~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~ll~~~L~~dp~~  237 (321)
T cd05591         159 TPDYIAPEILQELEY-GPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDDVLYPVWLSKEAVSILKAFMTKNPNK  237 (321)
T ss_pred             CccccCHHHHcCCCC-CCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhccCHHH
Confidence            999999999988777 5889999999999944 3333                   346678999999999999999999


Q ss_pred             CC-------CHHhhhcCccccc
Q 014609          239 RI-------TIAGIKADEWFEQ  253 (421)
Q Consensus       239 R~-------t~~eil~~~w~~~  253 (421)
                      |+       ++.++++||||..
T Consensus       238 R~~~~~~~~~~~~~~~hp~~~~  259 (321)
T cd05591         238 RLGCVASQGGEDAIKQHPFFKE  259 (321)
T ss_pred             cCCCCCCCCCHHHHhcCCccCC
Confidence            99       8999999999965

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=1e-44  Score=355.29  Aligned_cols=236  Identities=31%  Similarity=0.505  Sum_probs=197.9

Q ss_pred             ceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeC-----CEE
Q 014609           15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASK-----SKI   89 (421)
Q Consensus        15 ~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~-----~~~   89 (421)
                      +|++.+.||+|+||.||+|++..+|+.||||.+..... .......+.+|+.++++++||||+++++++...     ..+
T Consensus         1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~   79 (338)
T cd07859           1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFE-HVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDI   79 (338)
T ss_pred             CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhc-cchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceE
Confidence            69999999999999999999999999999999864321 222345688999999999999999999988543     358


Q ss_pred             EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCccccC
Q 014609           90 YMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD  169 (421)
Q Consensus        90 ~lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~  169 (421)
                      |+||||+ +++|.+.+.....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++........
T Consensus        80 ~lv~e~~-~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~  158 (338)
T cd07859          80 YVVFELM-ESDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTP  158 (338)
T ss_pred             EEEEecC-CCCHHHHHHhcccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEccCccccccccccC
Confidence            9999999 568999998878899999999999999999999999999999999999999999999999999975432111


Q ss_pred             -CCccccccCCCCccChhhhcc--cCCCCCcchHHHHHHHHhhh-cCCcCCC----------------------------
Q 014609          170 -DGLLHTTCGSPNYVAPEVLAN--RGYDGATSDIWSCGVILYIF-RGDFKLP----------------------------  217 (421)
Q Consensus       170 -~~~~~~~~gt~~y~APEvl~~--~~~~~~~~DiwSlGvil~~~-~~~~~~p----------------------------  217 (421)
                       ........||+.|+|||++.+  ..+ +.++|||||||++|.+ .|..+++                            
T Consensus       159 ~~~~~~~~~~t~~y~aPE~~~~~~~~~-~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~  237 (338)
T cd07859         159 TAIFWTDYVATRWYRAPELCGSFFSKY-TPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVRN  237 (338)
T ss_pred             ccccccCCCCCCCcCCHHHHhcccccc-CchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhh
Confidence             112245679999999999865  445 5889999999999954 3443331                            


Q ss_pred             ----------------------CCCCHHHHHHHHHhcCCCCCCCCCHHhhhcCccccc
Q 014609          218 ----------------------KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQ  253 (421)
Q Consensus       218 ----------------------~~~s~~~~~li~~~L~~dP~~R~t~~eil~~~w~~~  253 (421)
                                            +.+++.+.++|.+||+.||++|||++++++||||+.
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f~~  295 (338)
T cd07859         238 EKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFKG  295 (338)
T ss_pred             hhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCchhhh
Confidence                                  124677889999999999999999999999999975

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=5.4e-45  Score=355.00  Aligned_cols=232  Identities=33%  Similarity=0.642  Sum_probs=200.0

Q ss_pred             ceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcC-CCCCcceEEEEEEeCCEEEEEEeccCC
Q 014609           20 RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEVLASKSKIYMVLEYVTG   98 (421)
Q Consensus        20 ~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~lv~E~~~g   98 (421)
                      +.||+|+||.||+|++..+|+.||+|++++..............|..++..+ +||||+++++++.+++.+|+||||++|
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~   80 (316)
T cd05620           1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence            4799999999999999999999999999865432223345677788888754 899999999999999999999999999


Q ss_pred             CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCccccCCCccccccC
Q 014609           99 GELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCG  178 (421)
Q Consensus        99 g~L~~~i~~~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~g  178 (421)
                      ++|.+.+.....+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||++.....  ........+|
T Consensus        81 g~L~~~i~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~--~~~~~~~~~g  158 (316)
T cd05620          81 GDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVF--GDNRASTFCG  158 (316)
T ss_pred             CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEeCccCCCeeccc--CCCceeccCC
Confidence            99999998888899999999999999999999999999999999999999999999999999863221  2233456789


Q ss_pred             CCCccChhhhcccCCCCCcchHHHHHHHHhhh-cCCc-------------------CCCCCCCHHHHHHHHHhcCCCCCC
Q 014609          179 SPNYVAPEVLANRGYDGATSDIWSCGVILYIF-RGDF-------------------KLPKWLSPGAQNLLRKILEPNPVK  238 (421)
Q Consensus       179 t~~y~APEvl~~~~~~~~~~DiwSlGvil~~~-~~~~-------------------~~p~~~s~~~~~li~~~L~~dP~~  238 (421)
                      |+.|+|||++.+..+ +.++||||+||++|.+ .|..                   .+|.+++.++.++|++||+.||.+
T Consensus       159 t~~y~aPE~~~~~~~-~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~  237 (316)
T cd05620         159 TPDYIAPEILQGLKY-TFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDTPHYPRWITKESKDILEKLFERDPTR  237 (316)
T ss_pred             CcCccCHHHHcCCCC-CcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHccCCHHH
Confidence            999999999988777 5889999999999944 2332                   346678999999999999999999


Q ss_pred             CCCH-HhhhcCcccccc
Q 014609          239 RITI-AGIKADEWFEQD  254 (421)
Q Consensus       239 R~t~-~eil~~~w~~~~  254 (421)
                      |+++ +++++||||...
T Consensus       238 R~~~~~~~~~h~~f~~~  254 (316)
T cd05620         238 RLGVVGNIRGHPFFKTI  254 (316)
T ss_pred             cCCChHHHHcCCCcCCC
Confidence            9998 589999999763

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=6.3e-45  Score=355.66  Aligned_cols=234  Identities=32%  Similarity=0.586  Sum_probs=201.5

Q ss_pred             eEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHH---hcCCCCCcceEEEEEEeCCEEEEE
Q 014609           16 YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATL---KLLKHPNVVRLHEVLASKSKIYMV   92 (421)
Q Consensus        16 y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il---~~l~hpnIv~l~~~~~~~~~~~lv   92 (421)
                      |++.+.||+|+||.||+|.+..+|+.||||++++.........+.+.+|+.++   +.++||||+++++++.+.+..|+|
T Consensus         1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv   80 (324)
T cd05589           1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV   80 (324)
T ss_pred             CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence            78999999999999999999999999999999865443333456677777665   566799999999999999999999


Q ss_pred             EeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCccccCCCc
Q 014609           93 LEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGL  172 (421)
Q Consensus        93 ~E~~~gg~L~~~i~~~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~  172 (421)
                      |||++|++|...+.. ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.....  ....
T Consensus        81 ~E~~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~--~~~~  157 (324)
T cd05589          81 MEYAAGGDLMMHIHT-DVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMG--FGDR  157 (324)
T ss_pred             EcCCCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCcEEeCcccCCccCCC--CCCc
Confidence            999999999887764 5799999999999999999999999999999999999999999999999999874322  1223


Q ss_pred             cccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhh-cCCc-------------------CCCCCCCHHHHHHHHHhc
Q 014609          173 LHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIF-RGDF-------------------KLPKWLSPGAQNLLRKIL  232 (421)
Q Consensus       173 ~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~-~~~~-------------------~~p~~~s~~~~~li~~~L  232 (421)
                      ....+||+.|+|||++.+..+ +.++|||||||++|.+ .|..                   .+|..+++.+.++|++||
T Consensus       158 ~~~~~g~~~y~aPE~~~~~~~-~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~L  236 (324)
T cd05589         158 TSTFCGTPEFLAPEVLTETSY-TRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSREAISIMRRLL  236 (324)
T ss_pred             ccccccCccccCHhHhcCCCC-CcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHh
Confidence            446789999999999988777 5889999999999943 3333                   345568999999999999


Q ss_pred             CCCCCCCC-----CHHhhhcCccccc
Q 014609          233 EPNPVKRI-----TIAGIKADEWFEQ  253 (421)
Q Consensus       233 ~~dP~~R~-----t~~eil~~~w~~~  253 (421)
                      +.||.+||     ++.++++||||..
T Consensus       237 ~~dP~~R~~~~~~~~~~l~~~~~f~~  262 (324)
T cd05589         237 RRNPERRLGSGEKDAEDVKKQPFFRD  262 (324)
T ss_pred             hcCHhHcCCCCCCCHHHHhhCCCcCC
Confidence            99999999     6999999999975

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=8.3e-45  Score=355.73  Aligned_cols=231  Identities=31%  Similarity=0.616  Sum_probs=201.4

Q ss_pred             ceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcC-CCCCcceEEEEEEeCCEEEEEEeccCC
Q 014609           20 RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEVLASKSKIYMVLEYVTG   98 (421)
Q Consensus        20 ~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~lv~E~~~g   98 (421)
                      +.||+|+||+||+|++..+++.||+|++.+...........+.+|+.++.++ +||||+++++++...+.+|+||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~   80 (329)
T cd05618           1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG   80 (329)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence            4799999999999999999999999999876544444456788899998876 799999999999999999999999999


Q ss_pred             CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCccccCCCccccccC
Q 014609           99 GELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCG  178 (421)
Q Consensus        99 g~L~~~i~~~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~g  178 (421)
                      ++|.+.+...+.+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||++.....  ........+|
T Consensus        81 ~~L~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~--~~~~~~~~~g  158 (329)
T cd05618          81 GDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR--PGDTTSTFCG  158 (329)
T ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCCEEEeeCCccccccC--CCCccccccC
Confidence            99999998888899999999999999999999999999999999999999999999999999874321  1223345689


Q ss_pred             CCCccChhhhcccCCCCCcchHHHHHHHHhhh-cCCcC----------------------------CCCCCCHHHHHHHH
Q 014609          179 SPNYVAPEVLANRGYDGATSDIWSCGVILYIF-RGDFK----------------------------LPKWLSPGAQNLLR  229 (421)
Q Consensus       179 t~~y~APEvl~~~~~~~~~~DiwSlGvil~~~-~~~~~----------------------------~p~~~s~~~~~li~  229 (421)
                      |+.|+|||++.+..+ +.++|||||||++|.+ .|..+                            +|..++..+.++|+
T Consensus       159 t~~y~aPE~~~~~~~-~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~~~~~~~~~ll~  237 (329)
T cd05618         159 TPNYIAPEILRGEDY-GFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKAASVLK  237 (329)
T ss_pred             CccccCHHHHcCCCC-CCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCCCCCCCCCHHHHHHHH
Confidence            999999999988777 5899999999999944 33332                            35557889999999


Q ss_pred             HhcCCCCCCCCC------HHhhhcCccccc
Q 014609          230 KILEPNPVKRIT------IAGIKADEWFEQ  253 (421)
Q Consensus       230 ~~L~~dP~~R~t------~~eil~~~w~~~  253 (421)
                      +||+.||.+|+|      +.++++||||..
T Consensus       238 ~~L~~dP~~R~~~~~~~~~~~i~~hp~f~~  267 (329)
T cd05618         238 SFLNKDPKERLGCHPQTGFADIQGHPFFRN  267 (329)
T ss_pred             HHhcCCHHHcCCCCCCCCHHHHhcCCCCCC
Confidence            999999999998      579999999975

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.3e-45  Score=359.99  Aligned_cols=238  Identities=33%  Similarity=0.597  Sum_probs=207.6

Q ss_pred             cceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEE
Q 014609           14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVL   93 (421)
Q Consensus        14 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~   93 (421)
                      ++|++++.||+|+||+||+|++..+|+.||||++.+...........+.+|+.+++.++||||+++++++.+++..|+||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (350)
T cd05573           1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM   80 (350)
T ss_pred             CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence            47999999999999999999999999999999998765444344677899999999999999999999999999999999


Q ss_pred             eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCcccc-----
Q 014609           94 EYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFR-----  168 (421)
Q Consensus        94 E~~~gg~L~~~i~~~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~~-----  168 (421)
                      ||++|++|.+++...+.+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||++.......     
T Consensus        81 e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~  160 (350)
T cd05573          81 EYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYY  160 (350)
T ss_pred             cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEeecCCCCccCcccCccccc
Confidence            999999999999888889999999999999999999999999999999999999999999999999997543321     


Q ss_pred             ----------------------CCCccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhhc-CCcC----------
Q 014609          169 ----------------------DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIFR-GDFK----------  215 (421)
Q Consensus       169 ----------------------~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~~-~~~~----------  215 (421)
                                            .........||+.|+|||++.+..+ +.++|||||||++|.+. |..+          
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~  239 (350)
T cd05573         161 LNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPY-GLECDWWSLGVILYEMLYGFPPFYSDTLQETY  239 (350)
T ss_pred             ccccccccccccccccccccccccccccccccCccccCHHHHcCCCC-CCceeeEecchhhhhhccCCCCCCCCCHHHHH
Confidence                                  0012345579999999999988877 58999999999999542 3322          


Q ss_pred             -----------CCCC--CCHHHHHHHHHhcCCCCCCCCC-HHhhhcCccccc
Q 014609          216 -----------LPKW--LSPGAQNLLRKILEPNPVKRIT-IAGIKADEWFEQ  253 (421)
Q Consensus       216 -----------~p~~--~s~~~~~li~~~L~~dP~~R~t-~~eil~~~w~~~  253 (421)
                                 +|..  +++.+.++|.+||. ||.+|++ +.++++||||..
T Consensus       240 ~~i~~~~~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~hp~~~~  290 (350)
T cd05573         240 NKIINWKESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSHPFFKG  290 (350)
T ss_pred             HHHhccCCcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcCCCcCC
Confidence                       2322  48999999999997 9999999 999999999975

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=2.6e-44  Score=352.43  Aligned_cols=236  Identities=30%  Similarity=0.481  Sum_probs=206.4

Q ss_pred             eecceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEE
Q 014609           12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYM   91 (421)
Q Consensus        12 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l   91 (421)
                      ..++|++.+.||+|+||.||+|++..+|..+|+|++....  .....+.+.+|+++++.++||||+++++++..++..|+
T Consensus         3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l   80 (331)
T cd06649           3 KDDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISI   80 (331)
T ss_pred             CcccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeeccc--CHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence            3578999999999999999999999999999999997542  22345679999999999999999999999999999999


Q ss_pred             EEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC-CceeccCCCCCEEeccCCCEEEEeccCCCCCccccCC
Q 014609           92 VLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNK-GVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD  170 (421)
Q Consensus        92 v~E~~~gg~L~~~i~~~~~~~~~~~~~~~~ql~~aL~~LH~~-gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~  170 (421)
                      ||||++|++|.+++.....+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||++.....    
T Consensus        81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~----  156 (331)
T cd06649          81 CMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID----  156 (331)
T ss_pred             EeecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCCcEEEccCcccccccc----
Confidence            999999999999998888899999999999999999999986 699999999999999999999999999874422    


Q ss_pred             CccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhh-cCCcCCCC-------------------------------
Q 014609          171 GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIF-RGDFKLPK-------------------------------  218 (421)
Q Consensus       171 ~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~-~~~~~~p~-------------------------------  218 (421)
                      .......||+.|+|||++.+..+ +.++||||+||++|.+ .|..+++.                               
T Consensus       157 ~~~~~~~g~~~y~aPE~~~~~~~-~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (331)
T cd06649         157 SMANSFVGTRSYMSPERLQGTHY-SVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPRPRP  235 (331)
T ss_pred             cccccCCCCcCcCCHhHhcCCCC-CchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCccccCccccc
Confidence            22345579999999999988777 5899999999999944 34433310                               


Q ss_pred             ------------------------------------CCCHHHHHHHHHhcCCCCCCCCCHHhhhcCcccccc
Q 014609          219 ------------------------------------WLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD  254 (421)
Q Consensus       219 ------------------------------------~~s~~~~~li~~~L~~dP~~R~t~~eil~~~w~~~~  254 (421)
                                                          .+++++.+||.+||+.||++|||+.++++||||+..
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~~~~~  307 (331)
T cd06649         236 PGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTFIKRS  307 (331)
T ss_pred             ccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcChHHhhc
Confidence                                                256789999999999999999999999999999853

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=1.2e-44  Score=353.58  Aligned_cols=236  Identities=35%  Similarity=0.625  Sum_probs=204.9

Q ss_pred             ceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcC-CCCCcceEEEEEEeCCEEEEEE
Q 014609           15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEVLASKSKIYMVL   93 (421)
Q Consensus        15 ~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~lv~   93 (421)
                      +|++.+.||+|+||+||+|++..+++.||+|++.+..............|..++..+ .||+|+++++++.+.+.+|+||
T Consensus         1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05616           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM   80 (323)
T ss_pred             CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence            589999999999999999999999999999999875443333445677788888877 5899999999999999999999


Q ss_pred             eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCccccCCCcc
Q 014609           94 EYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLL  173 (421)
Q Consensus        94 E~~~gg~L~~~i~~~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~  173 (421)
                      ||++||+|.+.+...+.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++.....  .....
T Consensus        81 E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~--~~~~~  158 (323)
T cd05616          81 EYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMW--DGVTT  158 (323)
T ss_pred             cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCCCcEEEccCCCceecCC--CCCcc
Confidence            9999999999998888899999999999999999999999999999999999999999999999999874321  12234


Q ss_pred             ccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhhc-CC-------------------cCCCCCCCHHHHHHHHHhcC
Q 014609          174 HTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIFR-GD-------------------FKLPKWLSPGAQNLLRKILE  233 (421)
Q Consensus       174 ~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~~-~~-------------------~~~p~~~s~~~~~li~~~L~  233 (421)
                      ...+||+.|+|||++.+..+ +.++||||+||++|.+. |.                   ..+|..+++++.+++.+||+
T Consensus       159 ~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~l~  237 (323)
T cd05616         159 KTFCGTPDYIAPEIIAYQPY-GKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAVAICKGLMT  237 (323)
T ss_pred             ccCCCChhhcCHHHhcCCCC-CCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCcCCHHHHHHHHHHcc
Confidence            45689999999999988877 58999999999999442 33                   23456689999999999999


Q ss_pred             CCCCCCCCH-----HhhhcCccccc
Q 014609          234 PNPVKRITI-----AGIKADEWFEQ  253 (421)
Q Consensus       234 ~dP~~R~t~-----~eil~~~w~~~  253 (421)
                      .||.+|++.     .++++||||..
T Consensus       238 ~~p~~R~~~~~~~~~~i~~h~~~~~  262 (323)
T cd05616         238 KHPGKRLGCGPEGERDIKEHAFFRY  262 (323)
T ss_pred             cCHHhcCCCCCCCHHHHhcCCCcCC
Confidence            999999984     89999999975

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-46  Score=358.83  Aligned_cols=235  Identities=28%  Similarity=0.483  Sum_probs=211.8

Q ss_pred             cceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEE
Q 014609           14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVL   93 (421)
Q Consensus        14 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~   93 (421)
                      ..|+.++.||+|+||.||+|.+..+++.||+|+++.+....  ..+.+++|+.+|..+++|||.++|+.+..+..+|++|
T Consensus        13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~d--eIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiM   90 (467)
T KOG0201|consen   13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAED--EIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIM   90 (467)
T ss_pred             cccccchhccccccceeeeeeeccccceEEEEEechhhcch--hhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHH
Confidence            36888899999999999999999999999999998776443  3788999999999999999999999999999999999


Q ss_pred             eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCccccCCCcc
Q 014609           94 EYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLL  173 (421)
Q Consensus        94 E~~~gg~L~~~i~~~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~  173 (421)
                      |||.||++.+.+.....+++..+..++++++.||.|||+++.+|||||+.|||+..+|++||+|||++.......  ...
T Consensus        91 ey~~gGsv~~lL~~~~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~--~rr  168 (467)
T KOG0201|consen   91 EYCGGGSVLDLLKSGNILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSESGDVKLADFGVAGQLTNTV--KRR  168 (467)
T ss_pred             HHhcCcchhhhhccCCCCccceeeeehHHHHHHhhhhhhcceecccccccceeEeccCcEEEEecceeeeeechh--hcc
Confidence            999999999999988878999999999999999999999999999999999999999999999999998655432  233


Q ss_pred             ccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhhcC-CcCC----------------C----CCCCHHHHHHHHHhc
Q 014609          174 HTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIFRG-DFKL----------------P----KWLSPGAQNLLRKIL  232 (421)
Q Consensus       174 ~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~~~-~~~~----------------p----~~~s~~~~~li~~~L  232 (421)
                      .++.|||.||||||+.+.+|+ .++||||||++.|++.. ..|.                |    ..+|+.+++||..||
T Consensus       169 ~tfvGTPfwMAPEVI~~~~Y~-~KADIWSLGITaiEla~GePP~s~~hPmrvlflIpk~~PP~L~~~~S~~~kEFV~~CL  247 (467)
T KOG0201|consen  169 KTFVGTPFWMAPEVIKQSGYD-TKADIWSLGITAIELAKGEPPHSKLHPMRVLFLIPKSAPPRLDGDFSPPFKEFVEACL  247 (467)
T ss_pred             ccccccccccchhhhcccccc-chhhhhhhhHHHHHHhcCCCCCcccCcceEEEeccCCCCCccccccCHHHHHHHHHHh
Confidence            789999999999999988896 89999999999996643 3322                1    237899999999999


Q ss_pred             CCCCCCCCCHHhhhcCccccc
Q 014609          233 EPNPVKRITIAGIKADEWFEQ  253 (421)
Q Consensus       233 ~~dP~~R~t~~eil~~~w~~~  253 (421)
                      ++||+.||++.++++|+|++.
T Consensus       248 ~k~P~~RpsA~~LLKh~FIk~  268 (467)
T KOG0201|consen  248 DKNPEFRPSAKELLKHKFIKR  268 (467)
T ss_pred             hcCcccCcCHHHHhhhHHHHh
Confidence            999999999999999999987

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=1.2e-44  Score=360.23  Aligned_cols=242  Identities=29%  Similarity=0.518  Sum_probs=206.1

Q ss_pred             CeeecceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEE
Q 014609           10 GMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKI   89 (421)
Q Consensus        10 ~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~   89 (421)
                      ....++|++.+.||+|+||.||+|++..+++.||+|++.+...........+.+|+.+++.++||||+++++++.+++.+
T Consensus        39 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~  118 (370)
T cd05596          39 RMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYL  118 (370)
T ss_pred             CCCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence            35568999999999999999999999999999999999765443333456688999999999999999999999999999


Q ss_pred             EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCccccC
Q 014609           90 YMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD  169 (421)
Q Consensus        90 ~lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~  169 (421)
                      |+||||++||+|.+++.. ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++....... 
T Consensus       119 ~lv~Ey~~gg~L~~~l~~-~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~~-  196 (370)
T cd05596         119 YMVMEYMPGGDLVNLMSN-YDIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANG-  196 (370)
T ss_pred             EEEEcCCCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcCCCCEEEEeccceeeccCCC-
Confidence            999999999999998865 568999999999999999999999999999999999999999999999999987543211 


Q ss_pred             CCccccccCCCCccChhhhcccC---CCCCcchHHHHHHHHhhhc-CCcC---------------------CCC--CCCH
Q 014609          170 DGLLHTTCGSPNYVAPEVLANRG---YDGATSDIWSCGVILYIFR-GDFK---------------------LPK--WLSP  222 (421)
Q Consensus       170 ~~~~~~~~gt~~y~APEvl~~~~---~~~~~~DiwSlGvil~~~~-~~~~---------------------~p~--~~s~  222 (421)
                      .......+||+.|+|||++.+..   +.+.++|||||||++|++. |..|                     +|.  .+|.
T Consensus       197 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~  276 (370)
T cd05596         197 MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLTFPDDIEISK  276 (370)
T ss_pred             cccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCcCCCCCcCCCCH
Confidence            11234568999999999986543   2368899999999999543 3222                     233  3689


Q ss_pred             HHHHHHHHhcCCCCCC--CCCHHhhhcCccccc
Q 014609          223 GAQNLLRKILEPNPVK--RITIAGIKADEWFEQ  253 (421)
Q Consensus       223 ~~~~li~~~L~~dP~~--R~t~~eil~~~w~~~  253 (421)
                      ++.++|++||+.+|.+  |+|++++++||||..
T Consensus       277 ~~~~li~~~L~~~p~r~~R~s~~ell~h~~~~~  309 (370)
T cd05596         277 QAKDLICAFLTDREVRLGRNGVDEIKSHPFFKN  309 (370)
T ss_pred             HHHHHHHHHccChhhccCCCCHHHHhcCcccCC
Confidence            9999999999999988  999999999999986

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=1.2e-44  Score=353.70  Aligned_cols=232  Identities=37%  Similarity=0.686  Sum_probs=201.1

Q ss_pred             eceEeecCcEEEEEEEEC---CCCceEEEEEeeccccc-chhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEEe
Q 014609           19 GRTLGEGNFGKVKFAQDL---DSGLPFAVKILEKNRII-HLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLE   94 (421)
Q Consensus        19 ~~~LG~G~~g~V~~a~~~---~~~~~vAvK~i~~~~~~-~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E   94 (421)
                      ++.||+|+||.||+|++.   .+++.||+|++.+.... .......+.+|+.+|+.++||||+++++++..++.+|+|||
T Consensus         1 ~~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e   80 (323)
T cd05584           1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILE   80 (323)
T ss_pred             CceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEe
Confidence            368999999999999864   47899999999765432 22234567899999999999999999999999999999999


Q ss_pred             ccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCccccCCCccc
Q 014609           95 YVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLH  174 (421)
Q Consensus        95 ~~~gg~L~~~i~~~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~  174 (421)
                      |++|++|.+.+...+.+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||++.....  ......
T Consensus        81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~--~~~~~~  158 (323)
T cd05584          81 YLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIH--EGTVTH  158 (323)
T ss_pred             CCCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEeeCcCCeeccc--CCCccc
Confidence            999999999998888899999999999999999999999999999999999999999999999999864321  223344


Q ss_pred             cccCCCCccChhhhcccCCCCCcchHHHHHHHHhhhc-C-------------------CcCCCCCCCHHHHHHHHHhcCC
Q 014609          175 TTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIFR-G-------------------DFKLPKWLSPGAQNLLRKILEP  234 (421)
Q Consensus       175 ~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~~-~-------------------~~~~p~~~s~~~~~li~~~L~~  234 (421)
                      ..+||+.|+|||++.+..+ +.++|||||||++|.+. |                   ...+|+.+++.+.++|++||++
T Consensus       159 ~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~  237 (323)
T cd05584         159 TFCGTIEYMAPEILMRSGH-GKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKLNLPPYLTPEARDLLKKLLKR  237 (323)
T ss_pred             ccCCCccccChhhccCCCC-CCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHccc
Confidence            5689999999999987776 58899999999999442 3                   3345677899999999999999


Q ss_pred             CCCCCC-----CHHhhhcCccccc
Q 014609          235 NPVKRI-----TIAGIKADEWFEQ  253 (421)
Q Consensus       235 dP~~R~-----t~~eil~~~w~~~  253 (421)
                      ||.+||     ++.++++||||..
T Consensus       238 ~p~~R~~~~~~~~~~l~~h~~~~~  261 (323)
T cd05584         238 NPSSRLGAGPGDAAEVQSHPFFRH  261 (323)
T ss_pred             CHhHcCCCCCCCHHHHhcCCCcCC
Confidence            999999     8999999999975

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=1.5e-44  Score=352.20  Aligned_cols=231  Identities=38%  Similarity=0.704  Sum_probs=202.3

Q ss_pred             ceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcC-CCCCcceEEEEEEeCCEEEEEEeccCC
Q 014609           20 RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEVLASKSKIYMVLEYVTG   98 (421)
Q Consensus        20 ~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~lv~E~~~g   98 (421)
                      +.||+|+||+||+|.+..+++.||+|++.+...........+.+|..+++.+ +||||+++++++.+.+.+|+||||++|
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~   80 (318)
T cd05570           1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG   80 (318)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            4799999999999999999999999999876544444456778899999888 699999999999999999999999999


Q ss_pred             CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCccccCCCccccccC
Q 014609           99 GELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCG  178 (421)
Q Consensus        99 g~L~~~i~~~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~g  178 (421)
                      ++|.+.+...+.+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||++.....  ........+|
T Consensus        81 ~~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~--~~~~~~~~~g  158 (318)
T cd05570          81 GDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGIL--GGVTTSTFCG  158 (318)
T ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCCCcEEecccCCCeecCc--CCCcccceec
Confidence            99999998888899999999999999999999999999999999999999999999999999864211  2233445689


Q ss_pred             CCCccChhhhcccCCCCCcchHHHHHHHHhhh-cCCcC-------------------CCCCCCHHHHHHHHHhcCCCCCC
Q 014609          179 SPNYVAPEVLANRGYDGATSDIWSCGVILYIF-RGDFK-------------------LPKWLSPGAQNLLRKILEPNPVK  238 (421)
Q Consensus       179 t~~y~APEvl~~~~~~~~~~DiwSlGvil~~~-~~~~~-------------------~p~~~s~~~~~li~~~L~~dP~~  238 (421)
                      |+.|+|||++.+..+ +.++|+||+||++|.+ .|..+                   +|..+++.+.++|++||+.||.+
T Consensus       159 ~~~y~aPE~~~~~~~-~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~dP~~  237 (318)
T cd05570         159 TPDYIAPEILSYQPY-GPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDEVRYPRWLSKEAKSILKSFLTKNPEK  237 (318)
T ss_pred             CccccCHHHhcCCCC-CcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCcCCHHHHHHHHHHccCCHHH
Confidence            999999999988777 4889999999999944 33333                   35568899999999999999999


Q ss_pred             CCCH-----HhhhcCccccc
Q 014609          239 RITI-----AGIKADEWFEQ  253 (421)
Q Consensus       239 R~t~-----~eil~~~w~~~  253 (421)
                      |||+     .+++.||||..
T Consensus       238 R~s~~~~~~~~ll~~~~~~~  257 (318)
T cd05570         238 RLGCLPTGEQDIKGHPFFRE  257 (318)
T ss_pred             cCCCCCCCHHHHhcCCCcCC
Confidence            9999     99999999976

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=1.3e-44  Score=358.47  Aligned_cols=238  Identities=31%  Similarity=0.569  Sum_probs=204.1

Q ss_pred             cceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEE
Q 014609           14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVL   93 (421)
Q Consensus        14 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~   93 (421)
                      ++|++++.||+|+||+||+|++..+++.||+|++++...........+.+|+.++..++||||+++++.+.+++.+|+||
T Consensus         1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~   80 (360)
T cd05627           1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM   80 (360)
T ss_pred             CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            46999999999999999999999999999999998654444444677889999999999999999999999999999999


Q ss_pred             eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCccccC----
Q 014609           94 EYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD----  169 (421)
Q Consensus        94 E~~~gg~L~~~i~~~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~----  169 (421)
                      ||++||+|.+++...+.+++..++.++.|++.||+|||++||+||||||+|||++.+|.+||+|||++........    
T Consensus        81 E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~~~~  160 (360)
T cd05627          81 EFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFY  160 (360)
T ss_pred             eCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEeeccCCcccccccccccc
Confidence            9999999999998888899999999999999999999999999999999999999999999999999864321100    


Q ss_pred             -----------------------------CCccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhhc-CCcC----
Q 014609          170 -----------------------------DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIFR-GDFK----  215 (421)
Q Consensus       170 -----------------------------~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~~-~~~~----  215 (421)
                                                   .......+||+.|+|||++.+..+. .++|||||||++|.+. |..+    
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~-~~~DiwSlGvilyel~tG~~Pf~~~  239 (360)
T cd05627         161 RNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYN-KLCDWWSLGVIMYEMLIGYPPFCSE  239 (360)
T ss_pred             cccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCC-CcceeccccceeeecccCCCCCCCC
Confidence                                         0112245899999999999888874 8899999999999443 3222    


Q ss_pred             -----------------CCC--CCCHHHHHHHHHhcCCCCCCCC---CHHhhhcCccccc
Q 014609          216 -----------------LPK--WLSPGAQNLLRKILEPNPVKRI---TIAGIKADEWFEQ  253 (421)
Q Consensus       216 -----------------~p~--~~s~~~~~li~~~L~~dP~~R~---t~~eil~~~w~~~  253 (421)
                                       +|+  .+++.+.++|.+++ .||.+|+   ++.++++||||..
T Consensus       240 ~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~hp~f~~  298 (360)
T cd05627         240 TPQETYRKVMNWKETLVFPPEVPISEKAKDLILRFC-TDSENRIGSNGVEEIKSHPFFEG  298 (360)
T ss_pred             CHHHHHHHHHcCCCceecCCCCCCCHHHHHHHHHhc-cChhhcCCCCCHHHHhcCCCCCC
Confidence                             232  26889999999987 4999998   4799999999986

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=1.9e-44  Score=351.22  Aligned_cols=231  Identities=37%  Similarity=0.697  Sum_probs=198.4

Q ss_pred             ceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhc-CCCCCcceEEEEEEeCCEEEEEEeccCC
Q 014609           20 RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKL-LKHPNVVRLHEVLASKSKIYMVLEYVTG   98 (421)
Q Consensus        20 ~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~-l~hpnIv~l~~~~~~~~~~~lv~E~~~g   98 (421)
                      +.||+|+||+||+|++..+++.||+|++++.........+.+..|..++.. .+||||+++++++.....+|+||||++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g   80 (316)
T cd05592           1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            479999999999999999999999999986543333334556667777765 4899999999999999999999999999


Q ss_pred             CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCccccCCCccccccC
Q 014609           99 GELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCG  178 (421)
Q Consensus        99 g~L~~~i~~~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~g  178 (421)
                      |+|.+.+.....+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++.....  ........+|
T Consensus        81 g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~--~~~~~~~~~g  158 (316)
T cd05592          81 GDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMN--GEGKASTFCG  158 (316)
T ss_pred             CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCC--CCCccccccC
Confidence            99999998888899999999999999999999999999999999999999999999999999874322  1233456689


Q ss_pred             CCCccChhhhcccCCCCCcchHHHHHHHHhhh-cCCcC-------------------CCCCCCHHHHHHHHHhcCCCCCC
Q 014609          179 SPNYVAPEVLANRGYDGATSDIWSCGVILYIF-RGDFK-------------------LPKWLSPGAQNLLRKILEPNPVK  238 (421)
Q Consensus       179 t~~y~APEvl~~~~~~~~~~DiwSlGvil~~~-~~~~~-------------------~p~~~s~~~~~li~~~L~~dP~~  238 (421)
                      |+.|+|||++.+..+ +.++||||+||++|.+ .|..+                   +|.+++.++.++|.+||+.||.+
T Consensus       159 t~~y~aPE~~~~~~~-~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ll~~~l~~~P~~  237 (316)
T cd05592         159 TPDYIAPEILKGQKY-NESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILNDRPHFPRWISKEAKDCLSKLFERDPTK  237 (316)
T ss_pred             CccccCHHHHcCCCC-CCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHccCCHHH
Confidence            999999999988777 5889999999999944 33332                   45668999999999999999999


Q ss_pred             CCCHH-hhhcCccccc
Q 014609          239 RITIA-GIKADEWFEQ  253 (421)
Q Consensus       239 R~t~~-eil~~~w~~~  253 (421)
                      ||++. ++++||||..
T Consensus       238 R~~~~~~l~~h~~~~~  253 (316)
T cd05592         238 RLGVDGDIRQHPFFRG  253 (316)
T ss_pred             cCCChHHHHcCcccCC
Confidence            99864 8999999975

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=2.8e-44  Score=350.07  Aligned_cols=232  Identities=34%  Similarity=0.623  Sum_probs=199.5

Q ss_pred             ceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhc-CCCCCcceEEEEEEeCCEEEEEEeccCC
Q 014609           20 RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKL-LKHPNVVRLHEVLASKSKIYMVLEYVTG   98 (421)
Q Consensus        20 ~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~-l~hpnIv~l~~~~~~~~~~~lv~E~~~g   98 (421)
                      +.||+|+||+||+|++..+++.||||++++..............|..++.. ++||||+++++++.+.+.+|+||||++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~   80 (316)
T cd05619           1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence            479999999999999999999999999986543222334566778888876 4899999999999999999999999999


Q ss_pred             CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCccccCCCccccccC
Q 014609           99 GELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCG  178 (421)
Q Consensus        99 g~L~~~i~~~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~g  178 (421)
                      |+|.+.+.....+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||++.....  ........+|
T Consensus        81 g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~--~~~~~~~~~g  158 (316)
T cd05619          81 GDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDGHIKIADFGMCKENML--GDAKTCTFCG  158 (316)
T ss_pred             CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEccCCcceECCC--CCCceeeecC
Confidence            99999998878899999999999999999999999999999999999999999999999999863211  1223445689


Q ss_pred             CCCccChhhhcccCCCCCcchHHHHHHHHhhhc-CCc-------------------CCCCCCCHHHHHHHHHhcCCCCCC
Q 014609          179 SPNYVAPEVLANRGYDGATSDIWSCGVILYIFR-GDF-------------------KLPKWLSPGAQNLLRKILEPNPVK  238 (421)
Q Consensus       179 t~~y~APEvl~~~~~~~~~~DiwSlGvil~~~~-~~~-------------------~~p~~~s~~~~~li~~~L~~dP~~  238 (421)
                      |+.|+|||++.+..+ +.++||||+||++|.+. |..                   .+|.+++.++.++|.+||+.||.+
T Consensus       159 t~~y~aPE~~~~~~~-~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~~P~~  237 (316)
T cd05619         159 TPDYIAPEILLGQKY-NTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDNPCYPRWLTREAKDILVKLFVREPER  237 (316)
T ss_pred             CccccCHHHHcCCCC-CchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHHHHHHHhccCHhh
Confidence            999999999988777 58999999999999443 332                   345678999999999999999999


Q ss_pred             CCCHH-hhhcCcccccc
Q 014609          239 RITIA-GIKADEWFEQD  254 (421)
Q Consensus       239 R~t~~-eil~~~w~~~~  254 (421)
                      ||++. ++++||||...
T Consensus       238 R~~~~~~l~~h~~~~~~  254 (316)
T cd05619         238 RLGVKGDIRQHPFFREI  254 (316)
T ss_pred             cCCChHHHHcCcccCCC
Confidence            99996 89999999763

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=1.9e-44  Score=352.17  Aligned_cols=231  Identities=37%  Similarity=0.609  Sum_probs=197.6

Q ss_pred             ceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHH-HHhcCCCCCcceEEEEEEeCCEEEEEEeccCC
Q 014609           20 RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIA-TLKLLKHPNVVRLHEVLASKSKIYMVLEYVTG   98 (421)
Q Consensus        20 ~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~-il~~l~hpnIv~l~~~~~~~~~~~lv~E~~~g   98 (421)
                      +.||+|+||+||+|++..+|+.||+|++.+...........+.+|.. +++.++||||+++++++...+..|+||||++|
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (323)
T cd05575           1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence            47999999999999999999999999998654333333344555555 56889999999999999999999999999999


Q ss_pred             CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCccccCCCccccccC
Q 014609           99 GELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCG  178 (421)
Q Consensus        99 g~L~~~i~~~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~g  178 (421)
                      ++|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.....  ........+|
T Consensus        81 g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~--~~~~~~~~~g  158 (323)
T cd05575          81 GELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIE--HSKTTSTFCG  158 (323)
T ss_pred             CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeccCCCccccc--CCCccccccC
Confidence            99999998888899999999999999999999999999999999999999999999999999874321  2233445689


Q ss_pred             CCCccChhhhcccCCCCCcchHHHHHHHHhhhc-CCc-------------------CCCCCCCHHHHHHHHHhcCCCCCC
Q 014609          179 SPNYVAPEVLANRGYDGATSDIWSCGVILYIFR-GDF-------------------KLPKWLSPGAQNLLRKILEPNPVK  238 (421)
Q Consensus       179 t~~y~APEvl~~~~~~~~~~DiwSlGvil~~~~-~~~-------------------~~p~~~s~~~~~li~~~L~~dP~~  238 (421)
                      |+.|+|||++.+..+ +.++|||||||++|.+. |..                   ..++.+++.+.++|++||+.||.+
T Consensus       159 t~~y~aPE~~~~~~~-~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~~p~~  237 (323)
T cd05575         159 TPEYLAPEVLRKQPY-DRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKPLRLKPNISVSARHLLEGLLQKDRTK  237 (323)
T ss_pred             ChhhcChhhhcCCCC-CccccccccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhcCHHh
Confidence            999999999988777 48899999999999443 333                   234457899999999999999999


Q ss_pred             CCCH----HhhhcCccccc
Q 014609          239 RITI----AGIKADEWFEQ  253 (421)
Q Consensus       239 R~t~----~eil~~~w~~~  253 (421)
                      ||++    .++++||||..
T Consensus       238 R~~~~~~~~~il~~~~~~~  256 (323)
T cd05575         238 RLGAKDDFLEIKNHVFFSS  256 (323)
T ss_pred             CCCCCCCHHHHHcCCCcCC
Confidence            9997    69999999975

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=4.2e-44  Score=349.80  Aligned_cols=236  Identities=33%  Similarity=0.619  Sum_probs=204.0

Q ss_pred             ceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCC-CCCcceEEEEEEeCCEEEEEE
Q 014609           15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK-HPNVVRLHEVLASKSKIYMVL   93 (421)
Q Consensus        15 ~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~lv~   93 (421)
                      +|++.+.||+|+||+||+|++..+|+.||+|++.+.........+.+..|..+++.+. ||+|+++++++.+.+.+|+||
T Consensus         1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05615           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM   80 (323)
T ss_pred             CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence            4788999999999999999999999999999998654433334566788999998886 577889999999999999999


Q ss_pred             eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCccccCCCcc
Q 014609           94 EYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLL  173 (421)
Q Consensus        94 E~~~gg~L~~~i~~~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~  173 (421)
                      ||++||+|.+++...+.+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||++.....  .....
T Consensus        81 Ey~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~--~~~~~  158 (323)
T cd05615          81 EYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMV--DGVTT  158 (323)
T ss_pred             cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeccccccccCC--CCccc
Confidence            9999999999998888899999999999999999999999999999999999999999999999999874322  12233


Q ss_pred             ccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhhc-CCc-------------------CCCCCCCHHHHHHHHHhcC
Q 014609          174 HTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIFR-GDF-------------------KLPKWLSPGAQNLLRKILE  233 (421)
Q Consensus       174 ~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~~-~~~-------------------~~p~~~s~~~~~li~~~L~  233 (421)
                      ...+||+.|+|||++.+..+ +.++||||+||++|.+. |..                   .+|..+++.+.+++.+||+
T Consensus       159 ~~~~gt~~y~aPE~~~~~~~-~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~l~  237 (323)
T cd05615         159 RTFCGTPDYIAPEIIAYQPY-GKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKSLSKEAVSICKGLMT  237 (323)
T ss_pred             cCccCCccccCHHHHcCCCC-CCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHHHHHHHcc
Confidence            45679999999999988777 58899999999999443 333                   3456689999999999999


Q ss_pred             CCCCCCCC-----HHhhhcCccccc
Q 014609          234 PNPVKRIT-----IAGIKADEWFEQ  253 (421)
Q Consensus       234 ~dP~~R~t-----~~eil~~~w~~~  253 (421)
                      ++|.+|++     ..++++||||..
T Consensus       238 ~~p~~R~~~~~~~~~~i~~h~~f~~  262 (323)
T cd05615         238 KHPSKRLGCGPEGERDIREHAFFRR  262 (323)
T ss_pred             cCHhhCCCCCCCCHHHHhcCcccCC
Confidence            99999997     478999999985

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=2.4e-44  Score=358.01  Aligned_cols=242  Identities=30%  Similarity=0.540  Sum_probs=204.5

Q ss_pred             eeecceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEE
Q 014609           11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIY   90 (421)
Q Consensus        11 ~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~   90 (421)
                      ...++|++.+.||+|+||.||+|++..+++.||+|++.+...........+.+|+.+++.++||||+++++++.+++.+|
T Consensus        40 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~  119 (370)
T cd05621          40 MKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLY  119 (370)
T ss_pred             CCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEE
Confidence            44579999999999999999999999999999999997654433334566889999999999999999999999999999


Q ss_pred             EEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCccccCC
Q 014609           91 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD  170 (421)
Q Consensus        91 lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~  170 (421)
                      +||||++||+|.+++.. ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++...... ..
T Consensus       120 lv~Ey~~gg~L~~~l~~-~~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~~-~~  197 (370)
T cd05621         120 MVMEYMPGGDLVNLMSN-YDVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDET-GM  197 (370)
T ss_pred             EEEcCCCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEEecccceecccC-Cc
Confidence            99999999999998865 46899999999999999999999999999999999999999999999999999754321 11


Q ss_pred             CccccccCCCCccChhhhcccC---CCCCcchHHHHHHHHhhh-cCCcC---------------------CCC--CCCHH
Q 014609          171 GLLHTTCGSPNYVAPEVLANRG---YDGATSDIWSCGVILYIF-RGDFK---------------------LPK--WLSPG  223 (421)
Q Consensus       171 ~~~~~~~gt~~y~APEvl~~~~---~~~~~~DiwSlGvil~~~-~~~~~---------------------~p~--~~s~~  223 (421)
                      ....+.+||+.|+|||++.+.+   +.+.++||||+||++|.+ .|..|                     +|.  .++..
T Consensus       198 ~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~  277 (370)
T cd05621         198 VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLNFPEDVEISKH  277 (370)
T ss_pred             eecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcccCCCCcccCCHH
Confidence            1234668999999999987643   236889999999999944 23322                     233  35889


Q ss_pred             HHHHHHHhcCCCCCC--CCCHHhhhcCcccccc
Q 014609          224 AQNLLRKILEPNPVK--RITIAGIKADEWFEQD  254 (421)
Q Consensus       224 ~~~li~~~L~~dP~~--R~t~~eil~~~w~~~~  254 (421)
                      +.+++.+||..+|.+  |+|+.++++||||+..
T Consensus       278 ~~~li~~~L~~~~~r~~R~~~~e~l~hp~~~~~  310 (370)
T cd05621         278 AKNLICAFLTDREVRLGRNGVEEIKQHPFFKND  310 (370)
T ss_pred             HHHHHHHHccCchhccCCCCHHHHhcCcccCCC
Confidence            999999999865544  8999999999999863

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=1.7e-44  Score=353.31  Aligned_cols=238  Identities=27%  Similarity=0.525  Sum_probs=204.0

Q ss_pred             cceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEE
Q 014609           14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVL   93 (421)
Q Consensus        14 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~   93 (421)
                      ++|++.+.||+|+||+||+|++..+|+.||+|++++...........+.+|+.+++.++||||+++++++.+.+.+|+||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (330)
T cd05601           1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM   80 (330)
T ss_pred             CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence            47999999999999999999999999999999998765433444567889999999999999999999999999999999


Q ss_pred             eccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCccccCCCc
Q 014609           94 EYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGL  172 (421)
Q Consensus        94 E~~~gg~L~~~i~~~-~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~  172 (421)
                      ||++|++|.+++... ..+++..++.++.|++.||+|||++||+||||||+|||++.+|.+||+|||++....... ...
T Consensus        81 e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~-~~~  159 (330)
T cd05601          81 EYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANK-MVN  159 (330)
T ss_pred             CCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECCCCCEEeccCCCCeECCCCC-cee
Confidence            999999999999875 679999999999999999999999999999999999999999999999999997543211 112


Q ss_pred             cccccCCCCccChhhhcc-----cCCCCCcchHHHHHHHHhhh-cCCcCC---------------------C--CCCCHH
Q 014609          173 LHTTCGSPNYVAPEVLAN-----RGYDGATSDIWSCGVILYIF-RGDFKL---------------------P--KWLSPG  223 (421)
Q Consensus       173 ~~~~~gt~~y~APEvl~~-----~~~~~~~~DiwSlGvil~~~-~~~~~~---------------------p--~~~s~~  223 (421)
                      ....+||+.|+|||++..     ....+.++|||||||++|.+ .|..++                     |  +.+++.
T Consensus       160 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  239 (330)
T cd05601         160 SKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLKFPEDPKVSSD  239 (330)
T ss_pred             eecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcCCCccCCCCCCCCCHH
Confidence            234579999999999863     22235889999999999944 333222                     2  246889


Q ss_pred             HHHHHHHhcCCCCCCCCCHHhhhcCccccc
Q 014609          224 AQNLLRKILEPNPVKRITIAGIKADEWFEQ  253 (421)
Q Consensus       224 ~~~li~~~L~~dP~~R~t~~eil~~~w~~~  253 (421)
                      +.+||.+||. +|.+|||+.+++.||||..
T Consensus       240 ~~~li~~ll~-~p~~R~t~~~l~~h~~~~~  268 (330)
T cd05601         240 FLDLIQSLLC-GQKERLGYEGLCCHPFFSK  268 (330)
T ss_pred             HHHHHHHHcc-ChhhCCCHHHHhCCCCcCC
Confidence            9999999998 9999999999999999986

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=3.7e-44  Score=349.20  Aligned_cols=232  Identities=34%  Similarity=0.649  Sum_probs=200.5

Q ss_pred             eceEeecCcEEEEEEEEC---CCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEEec
Q 014609           19 GRTLGEGNFGKVKFAQDL---DSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLEY   95 (421)
Q Consensus        19 ~~~LG~G~~g~V~~a~~~---~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E~   95 (421)
                      ++.||+|+||.||++++.   .+|+.||+|++.+..... .....+.+|++++++++||||+++++++.+++.+|+||||
T Consensus         1 l~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~   79 (318)
T cd05582           1 LKVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKV-RDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDF   79 (318)
T ss_pred             CceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhh-hhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcC
Confidence            368999999999999863   578999999998654322 2245678899999999999999999999999999999999


Q ss_pred             cCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCccccCCCcccc
Q 014609           96 VTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHT  175 (421)
Q Consensus        96 ~~gg~L~~~i~~~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~  175 (421)
                      ++|++|.+++.....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.....  .......
T Consensus        80 ~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~--~~~~~~~  157 (318)
T cd05582          80 LRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESID--HEKKAYS  157 (318)
T ss_pred             CCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCCCcEEEeeccCCcccCC--CCCceec
Confidence            99999999998878899999999999999999999999999999999999999999999999999875432  2223445


Q ss_pred             ccCCCCccChhhhcccCCCCCcchHHHHHHHHhhhc-C-------------------CcCCCCCCCHHHHHHHHHhcCCC
Q 014609          176 TCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIFR-G-------------------DFKLPKWLSPGAQNLLRKILEPN  235 (421)
Q Consensus       176 ~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~~-~-------------------~~~~p~~~s~~~~~li~~~L~~d  235 (421)
                      .+||+.|+|||++.+..+ +.++|||||||++|.+. |                   ...+|..+++.+.++|++||++|
T Consensus       158 ~~g~~~y~aPE~~~~~~~-~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~l~~~  236 (318)
T cd05582         158 FCGTVEYMAPEVVNRRGH-TQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKLGMPQFLSPEAQSLLRALFKRN  236 (318)
T ss_pred             ccCChhhcCHHHHcCCCC-CCccceeccceEeeeeccCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhcC
Confidence            689999999999988777 58899999999999432 2                   23446678999999999999999


Q ss_pred             CCCCCC-----HHhhhcCcccccc
Q 014609          236 PVKRIT-----IAGIKADEWFEQD  254 (421)
Q Consensus       236 P~~R~t-----~~eil~~~w~~~~  254 (421)
                      |.+||+     +.+++.||||...
T Consensus       237 P~~R~~a~~~~~~~~~~~~~~~~~  260 (318)
T cd05582         237 PANRLGAGPDGVEEIKRHPFFSTI  260 (318)
T ss_pred             HhHcCCCCCCCHHHHhCCCCcCCC
Confidence            999999     7789999999753

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=2.2e-45  Score=358.68  Aligned_cols=239  Identities=30%  Similarity=0.535  Sum_probs=216.5

Q ss_pred             eecceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCE-EE
Q 014609           12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSK-IY   90 (421)
Q Consensus        12 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~-~~   90 (421)
                      .+++|..++.+|+|+||.+++++++..++.+++|.+......... .+...+|+.++++++|||||.+.+.|+.++. .+
T Consensus         2 ~m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~-r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~   80 (426)
T KOG0589|consen    2 EMDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPE-RRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLC   80 (426)
T ss_pred             ccchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchh-hHHHHHHHHHHHhccCCCeeeeccchhcCCceEE
Confidence            468899999999999999999999999999999999877654433 4578999999999999999999999999988 99


Q ss_pred             EEEeccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCcccc
Q 014609           91 MVLEYVTGGELFDKIASKG--RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFR  168 (421)
Q Consensus        91 lv~E~~~gg~L~~~i~~~~--~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~~  168 (421)
                      |||+||+||+|.+.|...+  -++++.+..||.|++.|+.|||+++|.|||||+.||+++.++.+||+|||+|+....  
T Consensus        81 Ivm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~--  158 (426)
T KOG0589|consen   81 IVMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNP--  158 (426)
T ss_pred             EEEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhccccCceeecchhhhhhcCC--
Confidence            9999999999999997644  589999999999999999999999999999999999999999999999999997665  


Q ss_pred             CCCccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhh--------------------cCC-cCCCCCCCHHHHHH
Q 014609          169 DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIF--------------------RGD-FKLPKWLSPGAQNL  227 (421)
Q Consensus       169 ~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~--------------------~~~-~~~p~~~s~~~~~l  227 (421)
                      ......+..|||.|+.||++.+.+| +.++|||||||++|++                    .+. .+.|...+.+++.+
T Consensus       159 ~~~~a~tvvGTp~YmcPEil~d~pY-n~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~~~Plp~~ys~el~~l  237 (426)
T KOG0589|consen  159 EDSLASTVVGTPYYMCPEILSDIPY-NEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRGLYSPLPSMYSSELRSL  237 (426)
T ss_pred             chhhhheecCCCcccCHHHhCCCCC-CccCcchhhcchHHHHHhcccccCccchHHHHHHHhhccCCCCCccccHHHHHH
Confidence            3346788899999999999999999 5999999999999933                    333 56788899999999


Q ss_pred             HHHhcCCCCCCCCCHHhhhcCcccccc
Q 014609          228 LRKILEPNPVKRITIAGIKADEWFEQD  254 (421)
Q Consensus       228 i~~~L~~dP~~R~t~~eil~~~w~~~~  254 (421)
                      |+.||..+|..||++.+++.+|.+...
T Consensus       238 v~~~l~~~P~~RPsa~~LL~~P~l~~~  264 (426)
T KOG0589|consen  238 VKSMLRKNPEHRPSALELLRRPHLLRY  264 (426)
T ss_pred             HHHHhhcCCccCCCHHHHhhChhhhhH
Confidence            999999999999999999999988754

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=3.9e-44  Score=350.61  Aligned_cols=232  Identities=30%  Similarity=0.604  Sum_probs=202.2

Q ss_pred             ceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcC-CCCCcceEEEEEEeCCEEEEEEeccCC
Q 014609           20 RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEVLASKSKIYMVLEYVTG   98 (421)
Q Consensus        20 ~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~lv~E~~~g   98 (421)
                      +.||+|+||+||+|++..+++.||+|++.+.........+.+.+|+.++.++ +||||+++++++...+.+|+||||++|
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (327)
T cd05617           1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG   80 (327)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence            4799999999999999999999999999876544444566788999999888 599999999999999999999999999


Q ss_pred             CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCccccCCCccccccC
Q 014609           99 GELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCG  178 (421)
Q Consensus        99 g~L~~~i~~~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~g  178 (421)
                      ++|.+.+...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.....  ........+|
T Consensus        81 ~~L~~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~--~~~~~~~~~g  158 (327)
T cd05617          81 GDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLG--PGDTTSTFCG  158 (327)
T ss_pred             CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCCCCEEEeccccceeccC--CCCceecccC
Confidence            99999998888899999999999999999999999999999999999999999999999999874211  1223456789


Q ss_pred             CCCccChhhhcccCCCCCcchHHHHHHHHhhh-cCCcC--------------------------CCCCCCHHHHHHHHHh
Q 014609          179 SPNYVAPEVLANRGYDGATSDIWSCGVILYIF-RGDFK--------------------------LPKWLSPGAQNLLRKI  231 (421)
Q Consensus       179 t~~y~APEvl~~~~~~~~~~DiwSlGvil~~~-~~~~~--------------------------~p~~~s~~~~~li~~~  231 (421)
                      |+.|+|||++.+..+ +.++|||||||++|.+ .|..+                          +|..++..+.++|++|
T Consensus       159 t~~y~aPE~~~~~~~-~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~  237 (327)
T cd05617         159 TPNYIAPEILRGEEY-GFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIRIPRFLSVKASHVLKGF  237 (327)
T ss_pred             CcccCCHHHHCCCCC-CchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHHH
Confidence            999999999988777 5899999999999943 34333                          3445788999999999


Q ss_pred             cCCCCCCCCC------HHhhhcCcccccc
Q 014609          232 LEPNPVKRIT------IAGIKADEWFEQD  254 (421)
Q Consensus       232 L~~dP~~R~t------~~eil~~~w~~~~  254 (421)
                      |++||.+|++      ++++++||||...
T Consensus       238 L~~dP~~R~~~~~~~~~~~i~~h~~f~~~  266 (327)
T cd05617         238 LNKDPKERLGCQPQTGFSDIKSHTFFRSI  266 (327)
T ss_pred             hccCHHHcCCCCCCCCHHHHHcCCCCCCC
Confidence            9999999998      5799999999863

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=3.7e-44  Score=342.94  Aligned_cols=229  Identities=29%  Similarity=0.475  Sum_probs=197.0

Q ss_pred             EeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEEeccCCCCh
Q 014609           22 LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGEL  101 (421)
Q Consensus        22 LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~~gg~L  101 (421)
                      ||+|+||+||++.+..+|+.||+|.+.+.........+.+..|+.+++.++||||+++++++..+...|+||||++||+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L   80 (280)
T cd05608           1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL   80 (280)
T ss_pred             CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence            69999999999999999999999999765444333346778899999999999999999999999999999999999999


Q ss_pred             HHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCccccCCCcccccc
Q 014609          102 FDKIAS----KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTC  177 (421)
Q Consensus       102 ~~~i~~----~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~  177 (421)
                      .+.+..    ...+++..+..++.|++.||+|||++||+||||||+||+++.++.++|+|||++.....  .........
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~--~~~~~~~~~  158 (280)
T cd05608          81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKD--GQSKTKGYA  158 (280)
T ss_pred             HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCccceecCC--CCccccccC
Confidence            877742    35689999999999999999999999999999999999999999999999999875432  122234557


Q ss_pred             CCCCccChhhhcccCCCCCcchHHHHHHHHhhh-cCCcC-----------------------CCCCCCHHHHHHHHHhcC
Q 014609          178 GSPNYVAPEVLANRGYDGATSDIWSCGVILYIF-RGDFK-----------------------LPKWLSPGAQNLLRKILE  233 (421)
Q Consensus       178 gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~-~~~~~-----------------------~p~~~s~~~~~li~~~L~  233 (421)
                      ||+.|+|||++.+..+ +.++|+||+||++|.+ .|..+                       +|..+++.+.+++.+||+
T Consensus       159 g~~~y~aPE~~~~~~~-~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~  237 (280)
T cd05608         159 GTPGFMAPELLQGEEY-DFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDSVTYPDKFSPASKSFCEALLA  237 (280)
T ss_pred             CCcCccCHHHhcCCCC-CccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhcccCCCCcccCCHHHHHHHHHHhc
Confidence            9999999999988877 4889999999999954 33332                       234478899999999999


Q ss_pred             CCCCCCC-----CHHhhhcCccccc
Q 014609          234 PNPVKRI-----TIAGIKADEWFEQ  253 (421)
Q Consensus       234 ~dP~~R~-----t~~eil~~~w~~~  253 (421)
                      .||.+||     |++++++||||+.
T Consensus       238 ~~P~~R~~~~~~~~~~~l~h~~~~~  262 (280)
T cd05608         238 KDPEKRLGFRDGNCDGLRTHPLFRD  262 (280)
T ss_pred             CCHHHhcCCCCCCHHHHhcChhhhc
Confidence            9999999     8899999999975

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=3.6e-44  Score=354.45  Aligned_cols=237  Identities=29%  Similarity=0.489  Sum_probs=201.1

Q ss_pred             eeecceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEE
Q 014609           11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIY   90 (421)
Q Consensus        11 ~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~   90 (421)
                      ..+++|++++.||+|+||.||+|.+..+++.||||++....  .......+.+|+++++.++||||+++++++...+.+|
T Consensus        71 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  148 (353)
T PLN00034         71 KSLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNH--EDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQ  148 (353)
T ss_pred             CCHHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCC--cHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEE
Confidence            45678999999999999999999999999999999986543  2233567899999999999999999999999999999


Q ss_pred             EEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCccccCC
Q 014609           91 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD  170 (421)
Q Consensus        91 lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~  170 (421)
                      +||||+++++|.+.    ...++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++......  .
T Consensus       149 lv~e~~~~~~L~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~--~  222 (353)
T PLN00034        149 VLLEFMDGGSLEGT----HIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQT--M  222 (353)
T ss_pred             EEEecCCCCccccc----ccCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEcccccceecccc--c
Confidence            99999999998643    34567888899999999999999999999999999999999999999999999754321  1


Q ss_pred             CccccccCCCCccChhhhcc----cCCCCCcchHHHHHHHHhhh-cCCcCC-----------------------CCCCCH
Q 014609          171 GLLHTTCGSPNYVAPEVLAN----RGYDGATSDIWSCGVILYIF-RGDFKL-----------------------PKWLSP  222 (421)
Q Consensus       171 ~~~~~~~gt~~y~APEvl~~----~~~~~~~~DiwSlGvil~~~-~~~~~~-----------------------p~~~s~  222 (421)
                      .......||+.|+|||++..    ..+.+.++|||||||++|.+ .|..++                       +..++.
T Consensus       223 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (353)
T PLN00034        223 DPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQPPEAPATASR  302 (353)
T ss_pred             ccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhccCCCCCCCccCH
Confidence            22345579999999998743    34556789999999999954 343333                       334678


Q ss_pred             HHHHHHHHhcCCCCCCCCCHHhhhcCccccccc
Q 014609          223 GAQNLLRKILEPNPVKRITIAGIKADEWFEQDY  255 (421)
Q Consensus       223 ~~~~li~~~L~~dP~~R~t~~eil~~~w~~~~~  255 (421)
                      ++.+||.+||+.||++|||+.|+++||||.+..
T Consensus       303 ~l~~li~~~l~~~P~~Rpt~~ell~hp~~~~~~  335 (353)
T PLN00034        303 EFRHFISCCLQREPAKRWSAMQLLQHPFILRAQ  335 (353)
T ss_pred             HHHHHHHHHccCChhhCcCHHHHhcCcccccCC
Confidence            999999999999999999999999999999754

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=1e-43  Score=348.65  Aligned_cols=235  Identities=30%  Similarity=0.477  Sum_probs=204.3

Q ss_pred             ecceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEE
Q 014609           13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMV   92 (421)
Q Consensus        13 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv   92 (421)
                      -++|++.+.||+|+||.||+|.+..++..+|+|++....  .......+.+|+++++.++||||+++++++..++.+|+|
T Consensus         4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv   81 (333)
T cd06650           4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISIC   81 (333)
T ss_pred             hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeeccc--CHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEE
Confidence            478999999999999999999999999999999987542  223356789999999999999999999999999999999


Q ss_pred             EeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC-CceeccCCCCCEEeccCCCEEEEeccCCCCCccccCCC
Q 014609           93 LEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNK-GVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDG  171 (421)
Q Consensus        93 ~E~~~gg~L~~~i~~~~~~~~~~~~~~~~ql~~aL~~LH~~-gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~  171 (421)
                      |||++|++|.+++...+.+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||++.....    .
T Consensus        82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~----~  157 (333)
T cd06650          82 MEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID----S  157 (333)
T ss_pred             EecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhh----h
Confidence            99999999999998888899999999999999999999985 799999999999999999999999999874422    2


Q ss_pred             ccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhh-cCCcCCCC--------------------------------
Q 014609          172 LLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIF-RGDFKLPK--------------------------------  218 (421)
Q Consensus       172 ~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~-~~~~~~p~--------------------------------  218 (421)
                      .....+||+.|+|||++.+..+ +.++|+||+||++|.+ .|..+++.                                
T Consensus       158 ~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (333)
T cd06650         158 MANSFVGTRSYMSPERLQGTHY-SVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPRPPGR  236 (333)
T ss_pred             ccccCCCCccccCHHHhcCCCC-CcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcccCCccc
Confidence            2334579999999999987766 5889999999999944 34333210                                


Q ss_pred             ---------------------------------CCCHHHHHHHHHhcCCCCCCCCCHHhhhcCcccccc
Q 014609          219 ---------------------------------WLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD  254 (421)
Q Consensus       219 ---------------------------------~~s~~~~~li~~~L~~dP~~R~t~~eil~~~w~~~~  254 (421)
                                                       .++.++.+||.+||+.||++|||+.+++.||||+..
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~~~~~~  305 (333)
T cd06650         237 PLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS  305 (333)
T ss_pred             hhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhCHHHhcC
Confidence                                             245778999999999999999999999999999864

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=1.1e-43  Score=344.39  Aligned_cols=239  Identities=26%  Similarity=0.423  Sum_probs=200.7

Q ss_pred             eecceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEE
Q 014609           12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYM   91 (421)
Q Consensus        12 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l   91 (421)
                      .+++|++.+.||+|+||.||+|.+..+++.||+|.++......  ....+.+|+.++++++||||+++++++..++..|+
T Consensus         4 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l   81 (309)
T cd07872           4 KMETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEG--APCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTL   81 (309)
T ss_pred             CCCceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCC--cchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEE
Confidence            4678999999999999999999999999999999987543221  23467789999999999999999999999999999


Q ss_pred             EEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCccccCC
Q 014609           92 VLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD  170 (421)
Q Consensus        92 v~E~~~gg~L~~~i~~~-~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~  170 (421)
                      ||||+++ +|.+.+... ..+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||++.....  ..
T Consensus        82 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~--~~  158 (309)
T cd07872          82 VFEYLDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSV--PT  158 (309)
T ss_pred             EEeCCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECccccceecCC--Cc
Confidence            9999975 888877654 4589999999999999999999999999999999999999999999999999874322  11


Q ss_pred             CccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhh-cCCcCCC--------------------------------
Q 014609          171 GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIF-RGDFKLP--------------------------------  217 (421)
Q Consensus       171 ~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~-~~~~~~p--------------------------------  217 (421)
                      .......+|+.|+|||++.+....+.++||||+||++|.+ .|..+++                                
T Consensus       159 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (309)
T cd07872         159 KTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEF  238 (309)
T ss_pred             cccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhh
Confidence            2233456899999999987654446899999999999944 3333221                                


Q ss_pred             -----------------CCCCHHHHHHHHHhcCCCCCCCCCHHhhhcCccccccc
Q 014609          218 -----------------KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY  255 (421)
Q Consensus       218 -----------------~~~s~~~~~li~~~L~~dP~~R~t~~eil~~~w~~~~~  255 (421)
                                       +.+++++.++|.+||+.||.+|||+.|+++||||+...
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~  293 (309)
T cd07872         239 KNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRSLG  293 (309)
T ss_pred             hhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChhhhhcc
Confidence                             12577889999999999999999999999999998643

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=4.5e-44  Score=350.30  Aligned_cols=229  Identities=31%  Similarity=0.507  Sum_probs=197.4

Q ss_pred             ecceEEeceEeecCcEEEEEEEECCCCce-EEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCC-EEE
Q 014609           13 LGRYELGRTLGEGNFGKVKFAQDLDSGLP-FAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKS-KIY   90 (421)
Q Consensus        13 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~-vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~-~~~   90 (421)
                      .....+.+.||+|+||+||+|..  .|+. ||+|++......... .+.+.+|+.+|.+++|||||++++++.++. .++
T Consensus        40 ~~~l~~~~~iG~G~~g~V~~~~~--~g~~~vavK~~~~~~~~~~~-~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~  116 (362)
T KOG0192|consen   40 PDELPIEEVLGSGSFGTVYKGKW--RGTDVVAVKIISDPDFDDES-RKAFRREASLLSRLRHPNIVQFYGACTSPPGSLC  116 (362)
T ss_pred             hHHhhhhhhcccCCceeEEEEEe--CCceeEEEEEecchhcChHH-HHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceE
Confidence            45567777899999999999986  4555 999999876554443 678999999999999999999999999887 799


Q ss_pred             EEEeccCCCChHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCC-ceeccCCCCCEEeccCC-CEEEEeccCCCCCcc
Q 014609           91 MVLEYVTGGELFDKIAS--KGRLQEAEGRKLFQQLIDGVSYCHNKG-VFHRDLKLENILLDSKG-NIKISDFGLSALPQH  166 (421)
Q Consensus        91 lv~E~~~gg~L~~~i~~--~~~~~~~~~~~~~~ql~~aL~~LH~~g-i~HrDlkp~NILl~~~~-~~kL~DFGla~~~~~  166 (421)
                      +||||+++|+|.+++..  ...++...+..++.||+.|+.|||+++ |+||||||+|||++.++ ++||+|||+++....
T Consensus       117 iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~  196 (362)
T KOG0192|consen  117 IVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVI  196 (362)
T ss_pred             EEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCCCCEEEECCCccceeecc
Confidence            99999999999999987  678999999999999999999999999 99999999999999998 999999999985433


Q ss_pred             ccCCCccccccCCCCccChhhhc--ccCCCCCcchHHHHHHHHhhhc-CC---------------------cCCCCCCCH
Q 014609          167 FRDDGLLHTTCGSPNYVAPEVLA--NRGYDGATSDIWSCGVILYIFR-GD---------------------FKLPKWLSP  222 (421)
Q Consensus       167 ~~~~~~~~~~~gt~~y~APEvl~--~~~~~~~~~DiwSlGvil~~~~-~~---------------------~~~p~~~s~  222 (421)
                      ..  .......||+.|||||++.  ...|+ .++||||+|++||++. +.                     ..+|..+++
T Consensus       197 ~~--~~~~~~~GT~~wMAPEv~~~~~~~~~-~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~~~Rp~~p~~~~~  273 (362)
T KOG0192|consen  197 SK--TSMTSVAGTYRWMAPEVLRGEKSPYT-EKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVVGGLRPPIPKECPP  273 (362)
T ss_pred             cc--ccccCCCCCccccChhhhcCCCCcCC-ccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCCccCCH
Confidence            11  2333468999999999999  55774 9999999999999442 22                     234556899


Q ss_pred             HHHHHHHHhcCCCCCCCCCHHhhhc
Q 014609          223 GAQNLLRKILEPNPVKRITIAGIKA  247 (421)
Q Consensus       223 ~~~~li~~~L~~dP~~R~t~~eil~  247 (421)
                      .+..+|.+||+.||..||++.+|+.
T Consensus       274 ~l~~l~~~CW~~dp~~RP~f~ei~~  298 (362)
T KOG0192|consen  274 HLSSLMERCWLVDPSRRPSFLEIVS  298 (362)
T ss_pred             HHHHHHHHhCCCCCCcCCCHHHHHH
Confidence            9999999999999999999999865

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.6e-44  Score=351.07  Aligned_cols=230  Identities=32%  Similarity=0.547  Sum_probs=195.7

Q ss_pred             EeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcC---CCCCcceEEEEEEeCCEEEEEEeccCC
Q 014609           22 LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL---KHPNVVRLHEVLASKSKIYMVLEYVTG   98 (421)
Q Consensus        22 LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l---~hpnIv~l~~~~~~~~~~~lv~E~~~g   98 (421)
                      ||+|+||+||+|++..+|+.||+|++.+..............|..++..+   +||||+++++++.+.+.+|+||||++|
T Consensus         1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~   80 (330)
T cd05586           1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG   80 (330)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence            79999999999999999999999999765443333344556677777665   699999999999999999999999999


Q ss_pred             CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCccccCCCccccccC
Q 014609           99 GELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCG  178 (421)
Q Consensus        99 g~L~~~i~~~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~g  178 (421)
                      ++|.+.+...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.....  ........+|
T Consensus        81 g~L~~~l~~~~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~--~~~~~~~~~g  158 (330)
T cd05586          81 GELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLT--DNKTTNTFCG  158 (330)
T ss_pred             ChHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCC--CCCCccCccC
Confidence            99999998888899999999999999999999999999999999999999999999999999874322  2233456789


Q ss_pred             CCCccChhhhcccCCCCCcchHHHHHHHHhhhc-CCcC-------------------CCC-CCCHHHHHHHHHhcCCCCC
Q 014609          179 SPNYVAPEVLANRGYDGATSDIWSCGVILYIFR-GDFK-------------------LPK-WLSPGAQNLLRKILEPNPV  237 (421)
Q Consensus       179 t~~y~APEvl~~~~~~~~~~DiwSlGvil~~~~-~~~~-------------------~p~-~~s~~~~~li~~~L~~dP~  237 (421)
                      |+.|+|||++.+....+.++|||||||++|.+. |..+                   +|. .+++.+.++|++||++||.
T Consensus       159 t~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li~~~L~~~P~  238 (330)
T cd05586         159 TTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVRFPKNVLSDEGRQFVKGLLNRNPQ  238 (330)
T ss_pred             CccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCCCHH
Confidence            999999999876543468899999999999443 3322                   232 3689999999999999999


Q ss_pred             CCC----CHHhhhcCccccc
Q 014609          238 KRI----TIAGIKADEWFEQ  253 (421)
Q Consensus       238 ~R~----t~~eil~~~w~~~  253 (421)
                      +||    ++.++++||||..
T Consensus       239 ~R~~~~~~~~~ll~h~~~~~  258 (330)
T cd05586         239 HRLGAHRDAVELKEHPFFAD  258 (330)
T ss_pred             HCCCCCCCHHHHhcCccccC
Confidence            998    7999999999975

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=5.6e-44  Score=349.10  Aligned_cols=231  Identities=35%  Similarity=0.581  Sum_probs=197.2

Q ss_pred             ceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHH-HHhcCCCCCcceEEEEEEeCCEEEEEEeccCC
Q 014609           20 RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIA-TLKLLKHPNVVRLHEVLASKSKIYMVLEYVTG   98 (421)
Q Consensus        20 ~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~-il~~l~hpnIv~l~~~~~~~~~~~lv~E~~~g   98 (421)
                      +.||+|+||+||+|++..+|+.||+|++.+...........+.+|.. +++.++||||+++++++..++..|+||||++|
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05604           1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG   80 (325)
T ss_pred             CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence            46999999999999999999999999997654333333445556655 56789999999999999999999999999999


Q ss_pred             CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCccccCCCccccccC
Q 014609           99 GELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCG  178 (421)
Q Consensus        99 g~L~~~i~~~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~g  178 (421)
                      ++|.+.+.....+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||++.....  ........+|
T Consensus        81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~--~~~~~~~~~g  158 (325)
T cd05604          81 GELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIA--QSDTTTTFCG  158 (325)
T ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEeecCCcccCCC--CCCCcccccC
Confidence            99999998888999999999999999999999999999999999999999999999999999874321  1223446689


Q ss_pred             CCCccChhhhcccCCCCCcchHHHHHHHHhhh-cCCcC-------------------CCCCCCHHHHHHHHHhcCCCCCC
Q 014609          179 SPNYVAPEVLANRGYDGATSDIWSCGVILYIF-RGDFK-------------------LPKWLSPGAQNLLRKILEPNPVK  238 (421)
Q Consensus       179 t~~y~APEvl~~~~~~~~~~DiwSlGvil~~~-~~~~~-------------------~p~~~s~~~~~li~~~L~~dP~~  238 (421)
                      |+.|+|||++.+..+ +.++|||||||++|.+ .|..+                   .++..+..+.++|++||+.+|.+
T Consensus       159 t~~y~aPE~~~~~~~-~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~ll~~~p~~  237 (325)
T cd05604         159 TPEYLAPEVIRKQPY-DNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPLVLRPGASLTAWSILEELLEKDRQR  237 (325)
T ss_pred             ChhhCCHHHHcCCCC-CCcCccccccceehhhhcCCCCCCCCCHHHHHHHHHcCCccCCCCCCHHHHHHHHHHhccCHHh
Confidence            999999999988877 4889999999999954 33333                   23457888999999999999999


Q ss_pred             CCCH----HhhhcCccccc
Q 014609          239 RITI----AGIKADEWFEQ  253 (421)
Q Consensus       239 R~t~----~eil~~~w~~~  253 (421)
                      ||++    .++++||||..
T Consensus       238 R~~~~~~~~~i~~h~~f~~  256 (325)
T cd05604         238 RLGAKEDFLEIQEHPFFES  256 (325)
T ss_pred             cCCCCCCHHHHhcCCCcCC
Confidence            9986    58999999975

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=9.4e-44  Score=346.83  Aligned_cols=231  Identities=37%  Similarity=0.607  Sum_probs=197.0

Q ss_pred             ceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHH-HHhcCCCCCcceEEEEEEeCCEEEEEEeccCC
Q 014609           20 RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIA-TLKLLKHPNVVRLHEVLASKSKIYMVLEYVTG   98 (421)
Q Consensus        20 ~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~-il~~l~hpnIv~l~~~~~~~~~~~lv~E~~~g   98 (421)
                      +.||+|+||+||+|++..+|+.||+|++.+...........+.+|.. +++.++||||+++++++.+.+..|+||||++|
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (321)
T cd05603           1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG   80 (321)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            47999999999999999999999999998654433333445555554 67889999999999999999999999999999


Q ss_pred             CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCccccCCCccccccC
Q 014609           99 GELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCG  178 (421)
Q Consensus        99 g~L~~~i~~~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~g  178 (421)
                      ++|.+.+.....+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||++.....  ........+|
T Consensus        81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~--~~~~~~~~~g  158 (321)
T cd05603          81 GELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVE--PEETTSTFCG  158 (321)
T ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEccCCCCccCCC--CCCccccccC
Confidence            99999998888899999999999999999999999999999999999999999999999999874321  2233455689


Q ss_pred             CCCccChhhhcccCCCCCcchHHHHHHHHhhhc-CCc-------------------CCCCCCCHHHHHHHHHhcCCCCCC
Q 014609          179 SPNYVAPEVLANRGYDGATSDIWSCGVILYIFR-GDF-------------------KLPKWLSPGAQNLLRKILEPNPVK  238 (421)
Q Consensus       179 t~~y~APEvl~~~~~~~~~~DiwSlGvil~~~~-~~~-------------------~~p~~~s~~~~~li~~~L~~dP~~  238 (421)
                      |+.|+|||++.+..++ .++|||||||++|.+. |..                   .+|+..+..+.++|.+||++||.+
T Consensus       159 t~~y~aPE~~~~~~~~-~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~~p~~  237 (321)
T cd05603         159 TPEYLAPEVLRKEPYD-RTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHKPLQLPGGKTVAACDLLVGLLHKDQRR  237 (321)
T ss_pred             CcccCCHHHhcCCCCC-CcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHccCCHhh
Confidence            9999999999887774 8899999999999443 322                   345567888999999999999999


Q ss_pred             CCCH----HhhhcCccccc
Q 014609          239 RITI----AGIKADEWFEQ  253 (421)
Q Consensus       239 R~t~----~eil~~~w~~~  253 (421)
                      |+++    .++++|+||..
T Consensus       238 R~~~~~~~~~~~~~~~~~~  256 (321)
T cd05603         238 RLGAKADFLEIKNHVFFSP  256 (321)
T ss_pred             cCCCCCCHHHHhCCCCcCC
Confidence            9975    59999999974

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=2.2e-43  Score=349.66  Aligned_cols=239  Identities=30%  Similarity=0.464  Sum_probs=198.9

Q ss_pred             eeecceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCC---
Q 014609           11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKS---   87 (421)
Q Consensus        11 ~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~---   87 (421)
                      ..+++|++.+.||+|+||.||+|.+..+|+.||+|++..... .......+.+|+.+++.++||||+++++++....   
T Consensus        18 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~   96 (359)
T cd07876          18 TVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQ-NQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLE   96 (359)
T ss_pred             hhhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEeccccc-chhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcc
Confidence            356899999999999999999999999999999999975432 2333567889999999999999999999986543   


Q ss_pred             ---EEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCC
Q 014609           88 ---KIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALP  164 (421)
Q Consensus        88 ---~~~lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~  164 (421)
                         ..|+||||+.+ +|.+.+.  ..+++..+..++.|++.||+|||++||+||||||+|||++.+|.+||+|||++...
T Consensus        97 ~~~~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~  173 (359)
T cd07876          97 EFQDVYLVMELMDA-NLCQVIH--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA  173 (359)
T ss_pred             ccceeEEEEeCCCc-CHHHHHh--ccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEecCCCcccc
Confidence               57999999965 5666664  35889999999999999999999999999999999999999999999999999743


Q ss_pred             ccccCCCccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhh-cCCcCCC--------------------------
Q 014609          165 QHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIF-RGDFKLP--------------------------  217 (421)
Q Consensus       165 ~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~-~~~~~~p--------------------------  217 (421)
                      ..   ........||+.|+|||++.+..+ +.++|||||||++|.+ .|..++.                          
T Consensus       174 ~~---~~~~~~~~~t~~y~aPE~~~~~~~-~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  249 (359)
T cd07876         174 CT---NFMMTPYVVTRYYRAPEVILGMGY-KENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRL  249 (359)
T ss_pred             cc---CccCCCCcccCCCCCchhccCCCC-CcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHH
Confidence            22   223345678999999999988777 4889999999999954 3333221                          


Q ss_pred             ------------------------C-----------CCCHHHHHHHHHhcCCCCCCCCCHHhhhcCccccccccC
Q 014609          218 ------------------------K-----------WLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTP  257 (421)
Q Consensus       218 ------------------------~-----------~~s~~~~~li~~~L~~dP~~R~t~~eil~~~w~~~~~~~  257 (421)
                                              .           ..++.+++||.+||+.||++|||+.|+++||||...+.+
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~~~  324 (359)
T cd07876         250 QPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPYITVWYDP  324 (359)
T ss_pred             HHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCchhhhhcCc
Confidence                                    0           124678999999999999999999999999999865443

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=1.5e-43  Score=359.85  Aligned_cols=231  Identities=26%  Similarity=0.369  Sum_probs=190.7

Q ss_pred             ecceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeC------
Q 014609           13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASK------   86 (421)
Q Consensus        13 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~------   86 (421)
                      .++|++++.||+|+||.||+|.+..+++.||||.+....       ....+|+.+|+.++||||+++++++...      
T Consensus        65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~-------~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~  137 (440)
T PTZ00036         65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP-------QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNE  137 (440)
T ss_pred             CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc-------chHHHHHHHHHhcCCCCCcceeeeEeecccccCC
Confidence            357999999999999999999999999999999885432       2345799999999999999999987432      


Q ss_pred             --CEEEEEEeccCCCChHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCC-CEEEEecc
Q 014609           87 --SKIYMVLEYVTGGELFDKIA----SKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKG-NIKISDFG  159 (421)
Q Consensus        87 --~~~~lv~E~~~gg~L~~~i~----~~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~-~~kL~DFG  159 (421)
                        ..+++||||+++ +|.+.+.    ....+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||
T Consensus       138 ~~~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~~~~vkL~DFG  216 (440)
T PTZ00036        138 KNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFG  216 (440)
T ss_pred             CceEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCCCCceeeeccc
Confidence              247799999975 6766654    346799999999999999999999999999999999999999765 69999999


Q ss_pred             CCCCCccccCCCccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhhc-CCcCC----------------------
Q 014609          160 LSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIFR-GDFKL----------------------  216 (421)
Q Consensus       160 la~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~~-~~~~~----------------------  216 (421)
                      +|.....   .......+||+.|+|||++.+....+.++|||||||++|.+. |..++                      
T Consensus       217 la~~~~~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~  293 (440)
T PTZ00036        217 SAKNLLA---GQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTED  293 (440)
T ss_pred             cchhccC---CCCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH
Confidence            9985432   222335678999999999876543468999999999999543 32222                      


Q ss_pred             --------------------------CCCCCHHHHHHHHHhcCCCCCCCCCHHhhhcCcccccc
Q 014609          217 --------------------------PKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD  254 (421)
Q Consensus       217 --------------------------p~~~s~~~~~li~~~L~~dP~~R~t~~eil~~~w~~~~  254 (421)
                                                |...++++.+||.+||++||.+|||+.|+++||||...
T Consensus       294 ~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~~  357 (440)
T PTZ00036        294 QLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDL  357 (440)
T ss_pred             HHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHhh
Confidence                                      22356789999999999999999999999999999764

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.7e-43  Score=339.20  Aligned_cols=235  Identities=30%  Similarity=0.439  Sum_probs=202.5

Q ss_pred             ceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEEe
Q 014609           15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLE   94 (421)
Q Consensus        15 ~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E   94 (421)
                      .|++.+.||+|+||+||++.+..+++.||+|++.............+.+|+.+++.++||||+++++.+..++..|+|||
T Consensus         1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (285)
T cd05605           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence            48999999999999999999999999999999976544333334567889999999999999999999999999999999


Q ss_pred             ccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCccccCCCc
Q 014609           95 YVTGGELFDKIASK--GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGL  172 (421)
Q Consensus        95 ~~~gg~L~~~i~~~--~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~  172 (421)
                      |++|++|.+.+...  ..+++..+..++.|++.||.|||+.||+||||||+||++++++.++|+|||++.....   ...
T Consensus        81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~---~~~  157 (285)
T cd05605          81 LMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPE---GET  157 (285)
T ss_pred             ccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCCCCEEEeeCCCceecCC---CCc
Confidence            99999998887643  4689999999999999999999999999999999999999999999999999875432   122


Q ss_pred             cccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhhc-CCcC-----------------------CCCCCCHHHHHHH
Q 014609          173 LHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIFR-GDFK-----------------------LPKWLSPGAQNLL  228 (421)
Q Consensus       173 ~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~~-~~~~-----------------------~p~~~s~~~~~li  228 (421)
                      ....+|++.|+|||++.+..+ +.++||||+||++|.+. |..+                       +|..+++.+.++|
T Consensus       158 ~~~~~~~~~y~aPE~~~~~~~-~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  236 (285)
T cd05605         158 IRGRVGTVGYMAPEVVKNERY-TFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEYSEKFSEAARSIC  236 (285)
T ss_pred             cccccCCCCccCcHHhcCCCC-CccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhhcccccCcccCHHHHHHH
Confidence            234579999999999987766 58899999999999432 3332                       2334788999999


Q ss_pred             HHhcCCCCCCCC-----CHHhhhcCccccc
Q 014609          229 RKILEPNPVKRI-----TIAGIKADEWFEQ  253 (421)
Q Consensus       229 ~~~L~~dP~~R~-----t~~eil~~~w~~~  253 (421)
                      .+||+.||.+||     +++++++||||.+
T Consensus       237 ~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~  266 (285)
T cd05605         237 RQLLTKDPGFRLGCRGEGAEEVKAHPFFRT  266 (285)
T ss_pred             HHHccCCHHHhcCCCCCCHHHHhcCcCccC
Confidence            999999999999     8999999999985

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=1.4e-43  Score=352.61  Aligned_cols=243  Identities=31%  Similarity=0.533  Sum_probs=204.2

Q ss_pred             CeeecceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEE
Q 014609           10 GMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKI   89 (421)
Q Consensus        10 ~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~   89 (421)
                      .+..++|++.+.||+|+||.||+|++..+++.||+|++.+...........+.+|+.+++.++||||+++++++.+.+.+
T Consensus        39 ~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~  118 (371)
T cd05622          39 RMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYL  118 (371)
T ss_pred             CcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEE
Confidence            45568999999999999999999999999999999999765443334456688999999999999999999999999999


Q ss_pred             EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCccccC
Q 014609           90 YMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD  169 (421)
Q Consensus        90 ~lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~  169 (421)
                      |+||||++||+|.+++.. ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++...... .
T Consensus       119 ~lv~Ey~~gg~L~~~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~~~-~  196 (371)
T cd05622         119 YMVMEYMPGGDLVNLMSN-YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKE-G  196 (371)
T ss_pred             EEEEcCCCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECCCCCEEEEeCCceeEcCcC-C
Confidence            999999999999998865 46899999999999999999999999999999999999999999999999998754321 1


Q ss_pred             CCccccccCCCCccChhhhcccC---CCCCcchHHHHHHHHhhhc-CCcC---------------------CC--CCCCH
Q 014609          170 DGLLHTTCGSPNYVAPEVLANRG---YDGATSDIWSCGVILYIFR-GDFK---------------------LP--KWLSP  222 (421)
Q Consensus       170 ~~~~~~~~gt~~y~APEvl~~~~---~~~~~~DiwSlGvil~~~~-~~~~---------------------~p--~~~s~  222 (421)
                      .......+||+.|+|||++....   +.+.++|||||||++|.+. |..|                     +|  ..++.
T Consensus       197 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~  276 (371)
T cd05622         197 MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISK  276 (371)
T ss_pred             cccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCcccCCCcCCCCH
Confidence            11234568999999999987543   2368899999999999442 3222                     22  24789


Q ss_pred             HHHHHHHHhcCCCCCC--CCCHHhhhcCcccccc
Q 014609          223 GAQNLLRKILEPNPVK--RITIAGIKADEWFEQD  254 (421)
Q Consensus       223 ~~~~li~~~L~~dP~~--R~t~~eil~~~w~~~~  254 (421)
                      .+.++|.+||..++.+  |++++++++|+||.+.
T Consensus       277 ~~~~li~~~L~~~~~r~~r~~~~ei~~h~~~~~~  310 (371)
T cd05622         277 EAKNLICAFLTDREVRLGRNGVEEIKRHLFFKND  310 (371)
T ss_pred             HHHHHHHHHcCChhhhcCCCCHHHHhcCcccCCC
Confidence            9999999999854443  7899999999999763

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.9e-43  Score=345.09  Aligned_cols=239  Identities=28%  Similarity=0.526  Sum_probs=200.2

Q ss_pred             cceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEE
Q 014609           14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVL   93 (421)
Q Consensus        14 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~   93 (421)
                      ++|++++.||+|+||.||+|++..+++.||+|++.+...........+.+|+.+++.++||||+++++++.+++.+|+||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (331)
T cd05597           1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM   80 (331)
T ss_pred             CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence            47999999999999999999999999999999998644433444567889999999999999999999999999999999


Q ss_pred             eccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCccccCCCc
Q 014609           94 EYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGL  172 (421)
Q Consensus        94 E~~~gg~L~~~i~~-~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~  172 (421)
                      ||++|++|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++...... ....
T Consensus        81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~-~~~~  159 (331)
T cd05597          81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLAD-GTVQ  159 (331)
T ss_pred             ecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECCCCCEEEEECCceeecCCC-CCcc
Confidence            99999999999976 457999999999999999999999999999999999999999999999999998643221 1112


Q ss_pred             cccccCCCCccChhhhcc----cCCCCCcchHHHHHHHHhhh-cCCcCC---------------------C---CCCCHH
Q 014609          173 LHTTCGSPNYVAPEVLAN----RGYDGATSDIWSCGVILYIF-RGDFKL---------------------P---KWLSPG  223 (421)
Q Consensus       173 ~~~~~gt~~y~APEvl~~----~~~~~~~~DiwSlGvil~~~-~~~~~~---------------------p---~~~s~~  223 (421)
                      ....+||+.|+|||++..    ....+.++||||+||++|.+ .|..++                     |   ..+++.
T Consensus       160 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  239 (331)
T cd05597         160 SNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQFPPDVTDVSEE  239 (331)
T ss_pred             ccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcCCCcccCCCccCCCCHH
Confidence            233579999999999863    23336789999999999944 333322                     2   236889


Q ss_pred             HHHHHHHhcCCCCCC--CCCHHhhhcCccccc
Q 014609          224 AQNLLRKILEPNPVK--RITIAGIKADEWFEQ  253 (421)
Q Consensus       224 ~~~li~~~L~~dP~~--R~t~~eil~~~w~~~  253 (421)
                      ++++|++||..++.+  |+++.++++||||..
T Consensus       240 ~~~li~~ll~~~~~r~~r~~~~~~l~hp~~~~  271 (331)
T cd05597         240 AKDLIRRLICSPETRLGRNGLQDFKDHPFFEG  271 (331)
T ss_pred             HHHHHHHHccCcccccCCCCHHHHhcCCCCCC
Confidence            999999999764443  889999999999975

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=100.00  E-value=5.3e-45  Score=332.66  Aligned_cols=232  Identities=35%  Similarity=0.647  Sum_probs=202.7

Q ss_pred             eeecceEE-eceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcC-CCCCcceEEEEEEe---
Q 014609           11 MRLGRYEL-GRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEVLAS---   85 (421)
Q Consensus        11 ~~~~~y~i-~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~---   85 (421)
                      ...++|++ -+.||-|-.|+|-.+.++.||+.+|+|++..        ....++|++++-+. .|||||.++++|++   
T Consensus        58 ~itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~D--------s~KARrEVeLHw~~s~h~~iV~IidVyeNs~~  129 (400)
T KOG0604|consen   58 SITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLD--------SPKARREVELHWMASGHPHIVSIIDVYENSYQ  129 (400)
T ss_pred             cchhhheehhhhhccccCCceEEEEeccchhhhHHHHHhc--------CHHHHhHhhhhhhhcCCCceEEeehhhhhhcc
Confidence            35578887 4679999999999999999999999999853        35678999988766 49999999999864   


Q ss_pred             -CCEEEEEEeccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccC---CCEEEEecc
Q 014609           86 -KSKIYMVLEYVTGGELFDKIASKG--RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSK---GNIKISDFG  159 (421)
Q Consensus        86 -~~~~~lv~E~~~gg~L~~~i~~~~--~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~---~~~kL~DFG  159 (421)
                       ...+.+|||.++||+||..|+.++  .++|.+|..+++||..|+.|||+.+|+||||||||+|...+   ..+||+|||
T Consensus       130 ~rkcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLtDfG  209 (400)
T KOG0604|consen  130 GRKCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLTDFG  209 (400)
T ss_pred             CceeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEecccc
Confidence             467899999999999999998765  49999999999999999999999999999999999999754   469999999


Q ss_pred             CCCCCccccCCCccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhhcCCc------------------------C
Q 014609          160 LSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIFRGDF------------------------K  215 (421)
Q Consensus       160 la~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~~~~~------------------------~  215 (421)
                      +|+....   ...+.+.|-||.|+|||++....|+ ...|+||+|||+|++.+++                        .
T Consensus       210 FAK~t~~---~~~L~TPc~TPyYvaPevlg~eKyd-kscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~gqy~  285 (400)
T KOG0604|consen  210 FAKETQE---PGDLMTPCFTPYYVAPEVLGPEKYD-KSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTGQYE  285 (400)
T ss_pred             cccccCC---CccccCCcccccccCHHHhCchhcC-CCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhccCcc
Confidence            9986442   4567899999999999999988886 8899999999999665443                        2


Q ss_pred             C--CCC--CCHHHHHHHHHhcCCCCCCCCCHHhhhcCcccccc
Q 014609          216 L--PKW--LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD  254 (421)
Q Consensus       216 ~--p~~--~s~~~~~li~~~L~~dP~~R~t~~eil~~~w~~~~  254 (421)
                      +  |+|  +|..++++|+++|..+|.+|.|+.++++|||+.+.
T Consensus       286 FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi~~~  328 (400)
T KOG0604|consen  286 FPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWINQY  328 (400)
T ss_pred             CCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcCchhccc
Confidence            2  344  78999999999999999999999999999999864

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=1.5e-43  Score=346.18  Aligned_cols=231  Identities=36%  Similarity=0.604  Sum_probs=196.2

Q ss_pred             ceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHH-HHHhcCCCCCcceEEEEEEeCCEEEEEEeccCC
Q 014609           20 RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREI-ATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTG   98 (421)
Q Consensus        20 ~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei-~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~~g   98 (421)
                      +.||+|+||+||+|++..+++.||+|++.+...........+.+|. .+++.++||||+++++++...+..|+||||++|
T Consensus         1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05602           1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING   80 (325)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence            4799999999999999999999999999865433222233444444 456889999999999999999999999999999


Q ss_pred             CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCccccCCCccccccC
Q 014609           99 GELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCG  178 (421)
Q Consensus        99 g~L~~~i~~~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~g  178 (421)
                      ++|.+.+.....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.....  ........+|
T Consensus        81 ~~L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~--~~~~~~~~~g  158 (325)
T cd05602          81 GELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIE--HNGTTSTFCG  158 (325)
T ss_pred             CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEEccCCCCccccc--CCCCcccccC
Confidence            99999998888899999999999999999999999999999999999999999999999999874321  2233456789


Q ss_pred             CCCccChhhhcccCCCCCcchHHHHHHHHhhhc-CCcC-------------------CCCCCCHHHHHHHHHhcCCCCCC
Q 014609          179 SPNYVAPEVLANRGYDGATSDIWSCGVILYIFR-GDFK-------------------LPKWLSPGAQNLLRKILEPNPVK  238 (421)
Q Consensus       179 t~~y~APEvl~~~~~~~~~~DiwSlGvil~~~~-~~~~-------------------~p~~~s~~~~~li~~~L~~dP~~  238 (421)
                      |+.|+|||++.+..+ +.++||||+||++|.+. |..+                   +++.+++.+.++|.+||++||.+
T Consensus       159 t~~y~aPE~~~~~~~-~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~~p~~  237 (325)
T cd05602         159 TPEYLAPEVLHKQPY-DRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPNITNSARHLLEGLLQKDRTK  237 (325)
T ss_pred             CccccCHHHHcCCCC-CCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHhCCcCCCCCCCHHHHHHHHHHcccCHHH
Confidence            999999999988777 48899999999999543 3322                   34457899999999999999999


Q ss_pred             CCCHH----hhhcCccccc
Q 014609          239 RITIA----GIKADEWFEQ  253 (421)
Q Consensus       239 R~t~~----eil~~~w~~~  253 (421)
                      |+++.    ++++|+||..
T Consensus       238 R~~~~~~~~~i~~~~~~~~  256 (325)
T cd05602         238 RLGAKDDFMEIKNHIFFSP  256 (325)
T ss_pred             CCCCCCCHHHHhcCcccCC
Confidence            99876    8999999964

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=3.6e-43  Score=336.51  Aligned_cols=231  Identities=32%  Similarity=0.461  Sum_probs=191.3

Q ss_pred             ceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcC---CCCCcceEEEEEEe-----C
Q 014609           15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL---KHPNVVRLHEVLAS-----K   86 (421)
Q Consensus        15 ~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l---~hpnIv~l~~~~~~-----~   86 (421)
                      +|++.+.||+|+||+||+|++..+|+.||+|.++...... .....+.+|+.+++.+   +||||+++++++..     .
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~   79 (288)
T cd07863           1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNED-GLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRE   79 (288)
T ss_pred             CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCC-CCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCC
Confidence            6999999999999999999999999999999987543221 1223566777777765   69999999998864     3


Q ss_pred             CEEEEEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCC
Q 014609           87 SKIYMVLEYVTGGELFDKIASK--GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALP  164 (421)
Q Consensus        87 ~~~~lv~E~~~gg~L~~~i~~~--~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~  164 (421)
                      ...+++|||+++ +|.+++...  ..+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||++...
T Consensus        80 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~kl~dfg~~~~~  158 (288)
T cd07863          80 TKVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIY  158 (288)
T ss_pred             ceEEEEEccccc-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccCccccc
Confidence            468999999974 888887653  35899999999999999999999999999999999999999999999999999865


Q ss_pred             ccccCCCccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhhcCCcCC----------------------------
Q 014609          165 QHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIFRGDFKL----------------------------  216 (421)
Q Consensus       165 ~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~~~~~~~----------------------------  216 (421)
                      ..   ........||+.|+|||++.+..+ +.++||||+||++|.+.+..++                            
T Consensus       159 ~~---~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (288)
T cd07863         159 SC---QMALTPVVVTLWYRAPEVLLQSTY-ATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRD  234 (288)
T ss_pred             cC---cccCCCccccccccCchHhhCCCC-CCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCccc
Confidence            32   222334578999999999987776 5899999999999965432211                            


Q ss_pred             -------------------CCCCCHHHHHHHHHhcCCCCCCCCCHHhhhcCccc
Q 014609          217 -------------------PKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWF  251 (421)
Q Consensus       217 -------------------p~~~s~~~~~li~~~L~~dP~~R~t~~eil~~~w~  251 (421)
                                         .+.++..+.++|.+||++||.+|||+.+++.||||
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~hp~f  288 (288)
T cd07863         235 VTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF  288 (288)
T ss_pred             ccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence                               01256778999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=1.9e-43  Score=351.73  Aligned_cols=237  Identities=28%  Similarity=0.430  Sum_probs=200.6

Q ss_pred             ceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCC-----EE
Q 014609           15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKS-----KI   89 (421)
Q Consensus        15 ~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~-----~~   89 (421)
                      +|++++.||+|+||.||+|.+..+|+.||||.+.... ........+.+|+.+++.++||||+++++++...+     ..
T Consensus         1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~   79 (372)
T cd07853           1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVF-QNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEI   79 (372)
T ss_pred             CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccc-cchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceE
Confidence            4789999999999999999999999999999986432 22233567889999999999999999999998876     89


Q ss_pred             EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCccccC
Q 014609           90 YMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD  169 (421)
Q Consensus        90 ~lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~  169 (421)
                      |+||||+. ++|.+.+.....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++...... .
T Consensus        80 ~lv~e~~~-~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~-~  157 (372)
T cd07853          80 YVVTELMQ-SDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPD-E  157 (372)
T ss_pred             EEEeeccc-cCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCCCCEEeccccceeecccC-c
Confidence            99999995 688888887788999999999999999999999999999999999999999999999999999754321 1


Q ss_pred             CCccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhhc-CCcCC--------------------------------
Q 014609          170 DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIFR-GDFKL--------------------------------  216 (421)
Q Consensus       170 ~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~~-~~~~~--------------------------------  216 (421)
                      ........+|+.|+|||++.+....+.++||||+||++|.+. |..++                                
T Consensus       158 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~  237 (372)
T cd07853         158 SKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEGAR  237 (372)
T ss_pred             cccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhHHHH
Confidence            122334568999999999887554468899999999999543 33222                                


Q ss_pred             -------------------CCCCCHHHHHHHHHhcCCCCCCCCCHHhhhcCcccccc
Q 014609          217 -------------------PKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD  254 (421)
Q Consensus       217 -------------------p~~~s~~~~~li~~~L~~dP~~R~t~~eil~~~w~~~~  254 (421)
                                         +...++++.+||.+||+.||.+|||+.++++||||...
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~  294 (372)
T cd07853         238 AHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYLDEG  294 (372)
T ss_pred             HHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCHhhCCC
Confidence                               12357789999999999999999999999999999874

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=4.4e-43  Score=336.45  Aligned_cols=232  Identities=33%  Similarity=0.473  Sum_probs=191.0

Q ss_pred             cceEEeceEeecCcEEEEEEEECC-CCceEEEEEeecccccchhHHHHHHHHHHHHhcC---CCCCcceEEEEEE-----
Q 014609           14 GRYELGRTLGEGNFGKVKFAQDLD-SGLPFAVKILEKNRIIHLKITDQIKREIATLKLL---KHPNVVRLHEVLA-----   84 (421)
Q Consensus        14 ~~y~i~~~LG~G~~g~V~~a~~~~-~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l---~hpnIv~l~~~~~-----   84 (421)
                      .+|++.+.||+|+||+||+|++.. +++.||+|.++...... .....+.+|+.+++.+   +||||+++++++.     
T Consensus         1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~   79 (290)
T cd07862           1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEE-GMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD   79 (290)
T ss_pred             CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCC-CchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCC
Confidence            479999999999999999999864 57889999987543222 2234566788777766   6999999999985     


Q ss_pred             eCCEEEEEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCC
Q 014609           85 SKSKIYMVLEYVTGGELFDKIASK--GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSA  162 (421)
Q Consensus        85 ~~~~~~lv~E~~~gg~L~~~i~~~--~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~  162 (421)
                      ....+++||||+. ++|.+++...  ..+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||++.
T Consensus        80 ~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~  158 (290)
T cd07862          80 RETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLAR  158 (290)
T ss_pred             CCCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcCCCCEEEccccceE
Confidence            3456899999996 5898888653  458999999999999999999999999999999999999999999999999997


Q ss_pred             CCccccCCCccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhhcCC-cCCC------------------------
Q 014609          163 LPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIFRGD-FKLP------------------------  217 (421)
Q Consensus       163 ~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~~~~-~~~p------------------------  217 (421)
                      ....   ........||+.|+|||++.+..+ +.++||||+||++|.+.+. .++.                        
T Consensus       159 ~~~~---~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~  234 (290)
T cd07862         159 IYSF---QMALTSVVVTLWYRAPEVLLQSSY-ATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWP  234 (290)
T ss_pred             eccC---CcccccccccccccChHHHhCCCC-CCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhch
Confidence            5432   223445679999999999987777 5889999999999954332 1110                        


Q ss_pred             ----------------------CCCCHHHHHHHHHhcCCCCCCCCCHHhhhcCccc
Q 014609          218 ----------------------KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWF  251 (421)
Q Consensus       218 ----------------------~~~s~~~~~li~~~L~~dP~~R~t~~eil~~~w~  251 (421)
                                            +.+++.+.+++.+||+.||++|||+.++++||||
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~hp~f  290 (290)
T cd07862         235 RDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF  290 (290)
T ss_pred             hhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcCCCC
Confidence                                  2356778999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=3.3e-43  Score=330.89  Aligned_cols=233  Identities=36%  Similarity=0.648  Sum_probs=201.3

Q ss_pred             eEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEEec
Q 014609           16 YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLEY   95 (421)
Q Consensus        16 y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E~   95 (421)
                      |++++.||+|+||+||+|++..+++.||+|++......... .....+|+.++++++||||+++++++......++||||
T Consensus         1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~-~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~   79 (260)
T PF00069_consen    1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEE-REENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEY   79 (260)
T ss_dssp             EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHH-HHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEE
T ss_pred             CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccc-cchhhhhhhccccccccccccccccccccccccccccc
Confidence            89999999999999999999999999999999876543322 23445699999999999999999999999999999999


Q ss_pred             cCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCccccCCCcccc
Q 014609           96 VTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHT  175 (421)
Q Consensus        96 ~~gg~L~~~i~~~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~  175 (421)
                      +.+++|.+++...+.+++..+..++.|++.||++||++||+||||||+||+++.++.++|+|||.+....  ........
T Consensus        80 ~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~--~~~~~~~~  157 (260)
T PF00069_consen   80 CPGGSLQDYLQKNKPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDENGEVKLIDFGSSVKLS--ENNENFNP  157 (260)
T ss_dssp             ETTEBHHHHHHHHSSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTTSEEEESSGTTTEEST--STTSEBSS
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc--cccccccc
Confidence            9999999999977889999999999999999999999999999999999999999999999999987431  12344556


Q ss_pred             ccCCCCccChhhhcccCCCCCcchHHHHHHHHhhh-cCCcCCCCC--------------------------CCHHHHHHH
Q 014609          176 TCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIF-RGDFKLPKW--------------------------LSPGAQNLL  228 (421)
Q Consensus       176 ~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~-~~~~~~p~~--------------------------~s~~~~~li  228 (421)
                      ..+++.|+|||++......+.++|+||||+++|.+ .+..++...                          .++.+.++|
T Consensus       158 ~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li  237 (260)
T PF00069_consen  158 FVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSSQQSREKSEELRDLI  237 (260)
T ss_dssp             SSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHTTSHTTSHHHHHHHH
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccccccchhHHHHHHHH
Confidence            78899999999987333446899999999999944 444433321                          137899999


Q ss_pred             HHhcCCCCCCCCCHHhhhcCccc
Q 014609          229 RKILEPNPVKRITIAGIKADEWF  251 (421)
Q Consensus       229 ~~~L~~dP~~R~t~~eil~~~w~  251 (421)
                      .+||+.||++|||+.++++||||
T Consensus       238 ~~~l~~~p~~R~~~~~l~~~~~~  260 (260)
T PF00069_consen  238 KKMLSKDPEQRPSAEELLKHPWF  260 (260)
T ss_dssp             HHHSSSSGGGSTTHHHHHTSGGG
T ss_pred             HHHccCChhHCcCHHHHhcCCCC
Confidence            99999999999999999999997

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=7.7e-43  Score=336.99  Aligned_cols=238  Identities=26%  Similarity=0.442  Sum_probs=200.5

Q ss_pred             eeecceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEE
Q 014609           11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIY   90 (421)
Q Consensus        11 ~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~   90 (421)
                      .++++|++.+.||+|+||.||+|.+..+++.||+|.+.......  ....+.+|+.+++.++||||+++++++..++..|
T Consensus         3 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~   80 (301)
T cd07873           3 GKLETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEG--APCTAIREVSLLKDLKHANIVTLHDIIHTEKSLT   80 (301)
T ss_pred             ccccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccC--chhHHHHHHHHHHhcCCCCcceEEEEEecCCeEE
Confidence            36789999999999999999999999999999999987543222  2346778999999999999999999999999999


Q ss_pred             EEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCccccC
Q 014609           91 MVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD  169 (421)
Q Consensus        91 lv~E~~~gg~L~~~i~~-~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~  169 (421)
                      +||||++ ++|.+.+.. ...+++..++.++.|++.||+|||++||+||||||+||+++.++.+||+|||++.....  .
T Consensus        81 lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~--~  157 (301)
T cd07873          81 LVFEYLD-KDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSI--P  157 (301)
T ss_pred             EEEeccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECCCCcEEECcCcchhccCC--C
Confidence            9999996 588887765 35689999999999999999999999999999999999999999999999999875322  1


Q ss_pred             CCccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhhc-CCcCC--------------------------------
Q 014609          170 DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIFR-GDFKL--------------------------------  216 (421)
Q Consensus       170 ~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~~-~~~~~--------------------------------  216 (421)
                      ........+++.|+|||++.+....+.++|||||||++|.+. |..++                                
T Consensus       158 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (301)
T cd07873         158 TKTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEE  237 (301)
T ss_pred             CCcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhcccc
Confidence            122334467899999999876554568899999999999543 32221                                


Q ss_pred             ------C-----------CCCCHHHHHHHHHhcCCCCCCCCCHHhhhcCccccc
Q 014609          217 ------P-----------KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQ  253 (421)
Q Consensus       217 ------p-----------~~~s~~~~~li~~~L~~dP~~R~t~~eil~~~w~~~  253 (421)
                            |           +.+++.+.+||.+||+.||.+|||++++++||||+.
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f~~  291 (301)
T cd07873         238 FKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHC  291 (301)
T ss_pred             ccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCccccc
Confidence                  1           125778899999999999999999999999999975

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=3.1e-43  Score=346.26  Aligned_cols=235  Identities=31%  Similarity=0.453  Sum_probs=196.7

Q ss_pred             ecceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeC------
Q 014609           13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASK------   86 (421)
Q Consensus        13 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~------   86 (421)
                      .++|++++.||+|+||+||+|.+..+++.||+|++..... .......+.+|+.+++.++||||+++++++...      
T Consensus        14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   92 (343)
T cd07878          14 PERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQ-SLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENF   92 (343)
T ss_pred             hhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhh-hhHHHHHHHHHHHHHHhcCCCchhhhhhhhccccccccc
Confidence            4789999999999999999999999999999999875432 122345678899999999999999999987543      


Q ss_pred             CEEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCcc
Q 014609           87 SKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQH  166 (421)
Q Consensus        87 ~~~~lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~  166 (421)
                      ...|++++++ |++|.+.+. ...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.....
T Consensus        93 ~~~~~~~~~~-~~~l~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~  170 (343)
T cd07878          93 NEVYLVTNLM-GADLNNIVK-CQKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQADD  170 (343)
T ss_pred             CcEEEEeecC-CCCHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECCCCCEEEcCCccceecCC
Confidence            4579999998 788987765 46799999999999999999999999999999999999999999999999999975322


Q ss_pred             ccCCCccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhh-cCCcCCCC---------------------------
Q 014609          167 FRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIF-RGDFKLPK---------------------------  218 (421)
Q Consensus       167 ~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~-~~~~~~p~---------------------------  218 (421)
                           ......||+.|+|||++.+....+.++|||||||++|.+ .|..+++.                           
T Consensus       171 -----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (343)
T cd07878         171 -----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKISS  245 (343)
T ss_pred             -----CcCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhcch
Confidence                 234567999999999987744446899999999999954 34333321                           


Q ss_pred             -----------------------CCCHHHHHHHHHhcCCCCCCCCCHHhhhcCccccccc
Q 014609          219 -----------------------WLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY  255 (421)
Q Consensus       219 -----------------------~~s~~~~~li~~~L~~dP~~R~t~~eil~~~w~~~~~  255 (421)
                                             ..++.+.+||.+||+.||.+|||+.++++||||....
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp~~~~~~  305 (343)
T cd07878         246 EHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQYH  305 (343)
T ss_pred             hhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhccC
Confidence                                   1345678999999999999999999999999998643

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=9.6e-43  Score=344.43  Aligned_cols=238  Identities=29%  Similarity=0.441  Sum_probs=197.6

Q ss_pred             eeecceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeC----
Q 014609           11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASK----   86 (421)
Q Consensus        11 ~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~----   86 (421)
                      ..+++|++++.||+|+||.||+|.+..+++.||+|.+..... .......+.+|+.+++.++||||+++++++...    
T Consensus        14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~   92 (355)
T cd07874          14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQ-NQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLE   92 (355)
T ss_pred             hhhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCccc-ChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccc
Confidence            356899999999999999999999999999999999875432 223356788999999999999999999998644    


Q ss_pred             --CEEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCC
Q 014609           87 --SKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALP  164 (421)
Q Consensus        87 --~~~~lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~  164 (421)
                        ...|+||||+++ +|.+.+.  ..+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||++...
T Consensus        93 ~~~~~~lv~e~~~~-~l~~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~~~~~~kl~Dfg~~~~~  169 (355)
T cd07874          93 EFQDVYLVMELMDA-NLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA  169 (355)
T ss_pred             ccceeEEEhhhhcc-cHHHHHh--hcCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEECCCCCEEEeeCcccccC
Confidence              357999999965 6766665  35889999999999999999999999999999999999999999999999999753


Q ss_pred             ccccCCCccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhhc-CCcCCC--------------------------
Q 014609          165 QHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIFR-GDFKLP--------------------------  217 (421)
Q Consensus       165 ~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~~-~~~~~p--------------------------  217 (421)
                      ..   ........||+.|+|||++.+..+ +.++|||||||++|.+. |..+++                          
T Consensus       170 ~~---~~~~~~~~~t~~y~aPE~~~~~~~-~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (355)
T cd07874         170 GT---SFMMTPYVVTRYYRAPEVILGMGY-KENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKL  245 (355)
T ss_pred             CC---ccccCCccccCCccCHHHHcCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhh
Confidence            22   223345679999999999988877 48899999999999442 222211                          


Q ss_pred             -----------------------------------CCCCHHHHHHHHHhcCCCCCCCCCHHhhhcCcccccccc
Q 014609          218 -----------------------------------KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYT  256 (421)
Q Consensus       218 -----------------------------------~~~s~~~~~li~~~L~~dP~~R~t~~eil~~~w~~~~~~  256 (421)
                                                         ...+..+.+||.+||+.||.+|||+.|+++||||...+.
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp~~~~~~~  319 (355)
T cd07874         246 QPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPYINVWYD  319 (355)
T ss_pred             cHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcCcchhcccC
Confidence                                               012456789999999999999999999999999986543

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=9.4e-43  Score=358.59  Aligned_cols=240  Identities=32%  Similarity=0.509  Sum_probs=206.0

Q ss_pred             eecceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCC----
Q 014609           12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKS----   87 (421)
Q Consensus        12 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~----   87 (421)
                      .-++|++.+.||+|+||+||+|++..+|+.||||+++..... ......+.+|+.++..++|+||+++++.+....    
T Consensus        30 ~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~-~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~  108 (496)
T PTZ00283         30 QAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMS-EADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNP  108 (496)
T ss_pred             cCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCC-HHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCc
Confidence            347999999999999999999999999999999999765432 333567889999999999999999998775432    


Q ss_pred             ----EEEEEEeccCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEecc
Q 014609           88 ----KIYMVLEYVTGGELFDKIAS----KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFG  159 (421)
Q Consensus        88 ----~~~lv~E~~~gg~L~~~i~~----~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFG  159 (421)
                          .+++||||+++|+|.+.+..    ...+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||
T Consensus       109 ~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~~~~vkL~DFG  188 (496)
T PTZ00283        109 ENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFG  188 (496)
T ss_pred             ccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeCCCCEEEEecc
Confidence                37899999999999998864    3468999999999999999999999999999999999999999999999999


Q ss_pred             CCCCCccccCCCccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhhc-CCc--------------------CCCC
Q 014609          160 LSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIFR-GDF--------------------KLPK  218 (421)
Q Consensus       160 la~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~~-~~~--------------------~~p~  218 (421)
                      ++...............+||+.|+|||++.+..| +.++|||||||++|.+. |..                    ++|+
T Consensus       189 ls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~-s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~  267 (496)
T PTZ00283        189 FSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPY-SKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGRYDPLPP  267 (496)
T ss_pred             cCeeccccccccccccccCCcceeCHHHhCCCCC-CcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCCCCC
Confidence            9986543323334456789999999999988777 58999999999999542 322                    2456


Q ss_pred             CCCHHHHHHHHHhcCCCCCCCCCHHhhhcCccccc
Q 014609          219 WLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQ  253 (421)
Q Consensus       219 ~~s~~~~~li~~~L~~dP~~R~t~~eil~~~w~~~  253 (421)
                      .+++++.+++.+||+.||.+||++.++++|||++.
T Consensus       268 ~~~~~l~~li~~~L~~dP~~RPs~~ell~~p~~~~  302 (496)
T PTZ00283        268 SISPEMQEIVTALLSSDPKRRPSSSKLLNMPICKL  302 (496)
T ss_pred             CCCHHHHHHHHHHcccChhhCcCHHHHHhCHHHHH
Confidence            68899999999999999999999999999999875

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=1.7e-42  Score=343.82  Aligned_cols=236  Identities=29%  Similarity=0.439  Sum_probs=197.0

Q ss_pred             eecceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeC-----
Q 014609           12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASK-----   86 (421)
Q Consensus        12 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~-----   86 (421)
                      .+++|++++.||+|+||.||+|.+..+++.||||++..... .......+.+|+.+++.++||||+++++++...     
T Consensus        22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~  100 (364)
T cd07875          22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQ-NQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEE  100 (364)
T ss_pred             hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCcccc-CchhHHHHHHHHHHHHhcCCCCccccceeecccccccc
Confidence            46899999999999999999999999999999999875432 223356788999999999999999999987543     


Q ss_pred             -CEEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCc
Q 014609           87 -SKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQ  165 (421)
Q Consensus        87 -~~~~lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~  165 (421)
                       ...|+||||+.+ +|.+.+.  ..+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||++....
T Consensus       101 ~~~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~  177 (364)
T cd07875         101 FQDVYIVMELMDA-NLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG  177 (364)
T ss_pred             cCeEEEEEeCCCC-CHHHHHH--hcCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECCCCcEEEEeCCCccccC
Confidence             458999999965 6777765  348899999999999999999999999999999999999999999999999997542


Q ss_pred             cccCCCccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhh-cCCcCCCC--------------------------
Q 014609          166 HFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIF-RGDFKLPK--------------------------  218 (421)
Q Consensus       166 ~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~-~~~~~~p~--------------------------  218 (421)
                      .   ........||+.|+|||++.+..+ +.++|||||||++|.+ .|..+++.                          
T Consensus       178 ~---~~~~~~~~~t~~y~aPE~~~~~~~-~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  253 (364)
T cd07875         178 T---SFMMTPYVVTRYYRAPEVILGMGY-KENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQ  253 (364)
T ss_pred             C---CCcccCCcccCCcCCHHHHhCCCC-CchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhh
Confidence            2   223345678999999999988777 4889999999999954 33333210                          


Q ss_pred             -----------------------------------CCCHHHHHHHHHhcCCCCCCCCCHHhhhcCccccccc
Q 014609          219 -----------------------------------WLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY  255 (421)
Q Consensus       219 -----------------------------------~~s~~~~~li~~~L~~dP~~R~t~~eil~~~w~~~~~  255 (421)
                                                         ..+..+++||.+||+.||.+|||+.++++||||...+
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp~~~~~~  325 (364)
T cd07875         254 PTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWY  325 (364)
T ss_pred             HHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCccccccc
Confidence                                               0235688999999999999999999999999997544

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=1.9e-42  Score=355.52  Aligned_cols=237  Identities=28%  Similarity=0.419  Sum_probs=203.3

Q ss_pred             ecceEEeceEeecCcEEEEEEEECCC-CceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEE
Q 014609           13 LGRYELGRTLGEGNFGKVKFAQDLDS-GLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYM   91 (421)
Q Consensus        13 ~~~y~i~~~LG~G~~g~V~~a~~~~~-~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l   91 (421)
                      ...|.+.+.||+|+||.||+|.+..+ ++.||+|.+...   .......+.+|+.+|+.++||||+++++++..++..|+
T Consensus        66 ~~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~---~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~l  142 (478)
T PTZ00267         66 EHMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLN---DERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLL  142 (478)
T ss_pred             ceeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccC---CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEE
Confidence            34599999999999999999998877 788999977543   22334567889999999999999999999999999999


Q ss_pred             EEeccCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCccc
Q 014609           92 VLEYVTGGELFDKIAS----KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHF  167 (421)
Q Consensus        92 v~E~~~gg~L~~~i~~----~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~  167 (421)
                      ||||++||+|.+.+..    ..++++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||++......
T Consensus       143 v~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~  222 (478)
T PTZ00267        143 IMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDS  222 (478)
T ss_pred             EEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECCCCcEEEEeCcCceecCCc
Confidence            9999999999887753    456899999999999999999999999999999999999999999999999999865432


Q ss_pred             cCCCccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhh-cCCcC--------------------CCCCCCHHHHH
Q 014609          168 RDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIF-RGDFK--------------------LPKWLSPGAQN  226 (421)
Q Consensus       168 ~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~-~~~~~--------------------~p~~~s~~~~~  226 (421)
                      .........+||+.|+|||++.+..+ +.++||||+||++|.+ .|..+                    .|..+++++.+
T Consensus       223 ~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~  301 (478)
T PTZ00267        223 VSLDVASSFCGTPYYLAPELWERKRY-SKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYDPFPCPVSSGMKA  301 (478)
T ss_pred             cccccccccCCCccccCHhHhCCCCC-CcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCccCCHHHHH
Confidence            22223456689999999999988777 5899999999999944 23222                    34457899999


Q ss_pred             HHHHhcCCCCCCCCCHHhhhcCccccc
Q 014609          227 LLRKILEPNPVKRITIAGIKADEWFEQ  253 (421)
Q Consensus       227 li~~~L~~dP~~R~t~~eil~~~w~~~  253 (421)
                      +|.+||++||++||++.+++.|+|++.
T Consensus       302 li~~~L~~dP~~Rps~~~~l~~~~~~~  328 (478)
T PTZ00267        302 LLDPLLSKNPALRPTTQQLLHTEFLKY  328 (478)
T ss_pred             HHHHHhccChhhCcCHHHHHhCHHHHH
Confidence            999999999999999999999999874

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=1.1e-42  Score=341.01  Aligned_cols=239  Identities=27%  Similarity=0.496  Sum_probs=200.0

Q ss_pred             cceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEE
Q 014609           14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVL   93 (421)
Q Consensus        14 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~   93 (421)
                      ++|++.+.||+|+||.||++++..+++.+|+|++.+...........+.+|+.++..++||||+++++++.+.+.+|+||
T Consensus         1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (332)
T cd05623           1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM   80 (332)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence            47999999999999999999999999999999997644333334556888999999999999999999999999999999


Q ss_pred             eccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCccccCCCc
Q 014609           94 EYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGL  172 (421)
Q Consensus        94 E~~~gg~L~~~i~~-~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~  172 (421)
                      ||++||+|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++...... ....
T Consensus        81 ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~-~~~~  159 (332)
T cd05623          81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMED-GTVQ  159 (332)
T ss_pred             eccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEeecchheecccC-Ccce
Confidence            99999999999976 467899999999999999999999999999999999999999999999999998643221 1112


Q ss_pred             cccccCCCCccChhhhcc----cCCCCCcchHHHHHHHHhhh-cCCcC---------------------CCC---CCCHH
Q 014609          173 LHTTCGSPNYVAPEVLAN----RGYDGATSDIWSCGVILYIF-RGDFK---------------------LPK---WLSPG  223 (421)
Q Consensus       173 ~~~~~gt~~y~APEvl~~----~~~~~~~~DiwSlGvil~~~-~~~~~---------------------~p~---~~s~~  223 (421)
                      ....+||+.|+|||++..    ....+.++|||||||++|.+ .|..+                     +|.   .++++
T Consensus       160 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~s~~  239 (332)
T cd05623         160 SSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPAQVTDVSED  239 (332)
T ss_pred             ecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCccccCCCccccCCHH
Confidence            234689999999999863    22336889999999999944 33332                     222   36899


Q ss_pred             HHHHHHHhcCCCCCC--CCCHHhhhcCccccc
Q 014609          224 AQNLLRKILEPNPVK--RITIAGIKADEWFEQ  253 (421)
Q Consensus       224 ~~~li~~~L~~dP~~--R~t~~eil~~~w~~~  253 (421)
                      +.+||++||..+|.+  |++++++++||||..
T Consensus       240 ~~~li~~ll~~~~~r~~r~~~~~~~~h~~f~~  271 (332)
T cd05623         240 AKDLIRRLICSREHRLGQNGIEDFKQHPFFTG  271 (332)
T ss_pred             HHHHHHHHccChhhhcCCCCHHHHhCCCCcCC
Confidence            999999999765544  789999999999975

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=100.00  E-value=2.2e-42  Score=332.04  Aligned_cols=234  Identities=38%  Similarity=0.730  Sum_probs=208.4

Q ss_pred             cceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEE
Q 014609           14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVL   93 (421)
Q Consensus        14 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~   93 (421)
                      ++|++.+.||+|+||.||+|.+..+++.||+|++...........+.+.+|++++++++||||+++++++.+...+|+||
T Consensus         1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   80 (290)
T cd05580           1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM   80 (290)
T ss_pred             CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence            47999999999999999999999999999999998665444445678999999999999999999999999999999999


Q ss_pred             eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCccccCCCcc
Q 014609           94 EYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLL  173 (421)
Q Consensus        94 E~~~gg~L~~~i~~~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~  173 (421)
                      ||+++++|.+++.....+++..+..++.|++.||+|||+.||+||||+|.||+++.++.+||+|||++......     .
T Consensus        81 e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~-----~  155 (290)
T cd05580          81 EYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR-----T  155 (290)
T ss_pred             ecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEeeCCCccccCCC-----C
Confidence            99999999999988888999999999999999999999999999999999999999999999999998754321     3


Q ss_pred             ccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhhc--------------------CCcCCCCCCCHHHHHHHHHhcC
Q 014609          174 HTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIFR--------------------GDFKLPKWLSPGAQNLLRKILE  233 (421)
Q Consensus       174 ~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~~--------------------~~~~~p~~~s~~~~~li~~~L~  233 (421)
                      ...+|++.|+|||.+.+..+ +.++|+||||+++|.+.                    +..++|..+++.+.++|.+||.
T Consensus       156 ~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~  234 (290)
T cd05580         156 YTLCGTPEYLAPEIILSKGY-GKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEGKVRFPSFFSPDAKDLIRNLLQ  234 (290)
T ss_pred             CCCCCCccccChhhhcCCCC-CccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCccCCccCCHHHHHHHHHHcc
Confidence            45578999999999877665 58899999999999332                    2334566678999999999999


Q ss_pred             CCCCCCC-----CHHhhhcCccccc
Q 014609          234 PNPVKRI-----TIAGIKADEWFEQ  253 (421)
Q Consensus       234 ~dP~~R~-----t~~eil~~~w~~~  253 (421)
                      .||.+|+     +++++++||||..
T Consensus       235 ~~p~~R~~~~~~~~~~l~~~~~~~~  259 (290)
T cd05580         235 VDLTKRLGNLKNGVNDIKNHPWFAG  259 (290)
T ss_pred             CCHHHccCcccCCHHHHHcCccccc
Confidence            9999999     8999999999975

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=1.7e-42  Score=332.32  Aligned_cols=235  Identities=31%  Similarity=0.462  Sum_probs=202.5

Q ss_pred             ceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEEe
Q 014609           15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLE   94 (421)
Q Consensus        15 ~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E   94 (421)
                      .|++.+.||+|+||.||+|.+..+++.||+|.+.+...........+.+|+.++++++|+||+++++.+.+.+..|+|||
T Consensus         1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e   80 (285)
T cd05630           1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEE
Confidence            47888999999999999999999999999999976554444334567889999999999999999999999999999999


Q ss_pred             ccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCccccCCCc
Q 014609           95 YVTGGELFDKIASK--GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGL  172 (421)
Q Consensus        95 ~~~gg~L~~~i~~~--~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~  172 (421)
                      |++|++|.+.+...  ..+++..+..++.|++.||.|||+.||+||||||+||+++.++.++|+|||++.....   ...
T Consensus        81 ~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~---~~~  157 (285)
T cd05630          81 LMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPE---GQT  157 (285)
T ss_pred             ecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeccceeecCC---Ccc
Confidence            99999999888543  3589999999999999999999999999999999999999999999999999874322   122


Q ss_pred             cccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhh-cCCcCCC-----------------------CCCCHHHHHHH
Q 014609          173 LHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIF-RGDFKLP-----------------------KWLSPGAQNLL  228 (421)
Q Consensus       173 ~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~-~~~~~~p-----------------------~~~s~~~~~li  228 (421)
                      .....|++.|+|||++.+..+ +.++||||+||++|.+ .|..++.                       ..+++++.+|+
T Consensus       158 ~~~~~g~~~y~aPE~~~~~~~-~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  236 (285)
T cd05630         158 IKGRVGTVGYMAPEVVKNERY-TFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQEEYSEKFSPDARSLC  236 (285)
T ss_pred             ccCCCCCccccChHHHcCCCC-CCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhhhhhhcCccCCHHHHHHH
Confidence            234579999999999987776 5889999999999944 3444332                       23678899999


Q ss_pred             HHhcCCCCCCCCC-----HHhhhcCccccc
Q 014609          229 RKILEPNPVKRIT-----IAGIKADEWFEQ  253 (421)
Q Consensus       229 ~~~L~~dP~~R~t-----~~eil~~~w~~~  253 (421)
                      ++||+.||.+|||     ++++++||||..
T Consensus       237 ~~~l~~~p~~R~s~~~~~~~~~~~h~~~~~  266 (285)
T cd05630         237 KMLLCKDPKERLGCQGGGAREVKEHPLFKQ  266 (285)
T ss_pred             HHHhhcCHHHccCCCCCchHHHHcChhhhc
Confidence            9999999999999     899999999975

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=1.3e-42  Score=337.79  Aligned_cols=227  Identities=32%  Similarity=0.485  Sum_probs=183.6

Q ss_pred             eceEeecCcEEEEEEEEC--CCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEe--CCEEEEEEe
Q 014609           19 GRTLGEGNFGKVKFAQDL--DSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLAS--KSKIYMVLE   94 (421)
Q Consensus        19 ~~~LG~G~~g~V~~a~~~--~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~--~~~~~lv~E   94 (421)
                      +++||+|+||.||+|++.  .+++.||+|.+.....     ...+.+|+.++++++||||+++++++..  ...+|++||
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e   80 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI-----SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFD   80 (317)
T ss_pred             ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCC-----cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEe
Confidence            578999999999999965  4778999999865422     3457889999999999999999999854  467899999


Q ss_pred             ccCCCChHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEe----ccCCCEEEEeccCC
Q 014609           95 YVTGGELFDKIASK---------GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILL----DSKGNIKISDFGLS  161 (421)
Q Consensus        95 ~~~gg~L~~~i~~~---------~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl----~~~~~~kL~DFGla  161 (421)
                      |+. ++|.+.+...         ..+++..++.++.||+.||+|||++||+||||||+|||+    +.++.+||+|||++
T Consensus        81 ~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a  159 (317)
T cd07868          81 YAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFA  159 (317)
T ss_pred             ccC-CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence            995 5888876532         258999999999999999999999999999999999999    45678999999999


Q ss_pred             CCCcccc-CCCccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhhc-CCcCCC----------------------
Q 014609          162 ALPQHFR-DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIFR-GDFKLP----------------------  217 (421)
Q Consensus       162 ~~~~~~~-~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~~-~~~~~p----------------------  217 (421)
                      ....... .........||+.|+|||++.+....+.++||||+||++|.+. |..++.                      
T Consensus       160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~  239 (317)
T cd07868         160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFN  239 (317)
T ss_pred             eccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHHHHH
Confidence            8653321 1122345678999999999877554468899999999999543 322210                      


Q ss_pred             -----------------C---------------------------CCCHHHHHHHHHhcCCCCCCCCCHHhhhcCccc
Q 014609          218 -----------------K---------------------------WLSPGAQNLLRKILEPNPVKRITIAGIKADEWF  251 (421)
Q Consensus       218 -----------------~---------------------------~~s~~~~~li~~~L~~dP~~R~t~~eil~~~w~  251 (421)
                                       .                           ..++.+.+||++||+.||.+|||++|+++||||
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~hp~f  317 (317)
T cd07868         240 VMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYF  317 (317)
T ss_pred             hcCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence                             0                           013467899999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=1.5e-42  Score=331.30  Aligned_cols=228  Identities=26%  Similarity=0.425  Sum_probs=194.4

Q ss_pred             EeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEEeccCCCCh
Q 014609           22 LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGEL  101 (421)
Q Consensus        22 LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~~gg~L  101 (421)
                      ||+|+||.||++++..+|+.||+|.+.............+..|++++++++||||+++++++.++...|+||||++|++|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L   80 (277)
T cd05607           1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL   80 (277)
T ss_pred             CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence            69999999999999999999999999765443333344567799999999999999999999999999999999999999


Q ss_pred             HHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCccccCCCccccccCC
Q 014609          102 FDKIASK--GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGS  179 (421)
Q Consensus       102 ~~~i~~~--~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt  179 (421)
                      .+.+...  ..+++..+..++.|++.||+|||+.||+||||||+||+++.++.++|+|||++.....   ........|+
T Consensus        81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~---~~~~~~~~~~  157 (277)
T cd05607          81 KYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKD---GKTITQRAGT  157 (277)
T ss_pred             HHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCCCCEEEeeceeeeecCC---CceeeccCCC
Confidence            8887543  3588999999999999999999999999999999999999999999999999875432   1223345789


Q ss_pred             CCccChhhhcccCCCCCcchHHHHHHHHhhh-cCCcCCC------------------------CCCCHHHHHHHHHhcCC
Q 014609          180 PNYVAPEVLANRGYDGATSDIWSCGVILYIF-RGDFKLP------------------------KWLSPGAQNLLRKILEP  234 (421)
Q Consensus       180 ~~y~APEvl~~~~~~~~~~DiwSlGvil~~~-~~~~~~p------------------------~~~s~~~~~li~~~L~~  234 (421)
                      +.|+|||++.+..+ +.++|+||+||++|.+ .|..++.                        ..+++++.++|++||++
T Consensus       158 ~~y~aPE~~~~~~~-~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~  236 (277)
T cd05607         158 NGYMAPEILKEEPY-SYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVKFEHQNFTEESKDICRLFLAK  236 (277)
T ss_pred             CCccCHHHHccCCC-CCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhccccccccccCCHHHHHHHHHHhcc
Confidence            99999999988776 5899999999999954 3444432                        23678899999999999


Q ss_pred             CCCCCCCH----HhhhcCccccc
Q 014609          235 NPVKRITI----AGIKADEWFEQ  253 (421)
Q Consensus       235 dP~~R~t~----~eil~~~w~~~  253 (421)
                      ||.+||++    ++++.||||+.
T Consensus       237 ~P~~R~~~~~~~~~~~~h~~f~~  259 (277)
T cd05607         237 KPEDRLGSREKNDDPRKHEFFKT  259 (277)
T ss_pred             CHhhCCCCccchhhhhcChhhcC
Confidence            99999999    67889999975

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=1.3e-42  Score=340.47  Aligned_cols=239  Identities=26%  Similarity=0.476  Sum_probs=200.5

Q ss_pred             cceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEE
Q 014609           14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVL   93 (421)
Q Consensus        14 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~   93 (421)
                      ++|++.+.||+|+||.||++++..+++.||+|++.+...........+.+|+.+++.++||||+++++++.+++..|+||
T Consensus         1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~   80 (331)
T cd05624           1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM   80 (331)
T ss_pred             CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            47999999999999999999999999999999997644333334566888999999999999999999999999999999


Q ss_pred             eccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCccccCCCc
Q 014609           94 EYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGL  172 (421)
Q Consensus        94 E~~~gg~L~~~i~~-~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~  172 (421)
                      ||++||+|.+++.. ...+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||++....... ...
T Consensus        81 Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~-~~~  159 (331)
T cd05624          81 DYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDG-TVQ  159 (331)
T ss_pred             eCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcCCCCEEEEeccceeeccCCC-cee
Confidence            99999999999976 4679999999999999999999999999999999999999999999999999987543211 112


Q ss_pred             cccccCCCCccChhhhccc----CCCCCcchHHHHHHHHhhh-cCCcC---------------------CCC---CCCHH
Q 014609          173 LHTTCGSPNYVAPEVLANR----GYDGATSDIWSCGVILYIF-RGDFK---------------------LPK---WLSPG  223 (421)
Q Consensus       173 ~~~~~gt~~y~APEvl~~~----~~~~~~~DiwSlGvil~~~-~~~~~---------------------~p~---~~s~~  223 (421)
                      ....+||+.|+|||++.+.    ...+.++||||+||++|.+ .|..+                     +|.   .++..
T Consensus       160 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~~~~  239 (331)
T cd05624         160 SSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSHITDVSEE  239 (331)
T ss_pred             eccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHcCCCcccCCCccccCCHH
Confidence            2345799999999998652    2235889999999999943 33322                     222   25789


Q ss_pred             HHHHHHHhcCCCCCC--CCCHHhhhcCccccc
Q 014609          224 AQNLLRKILEPNPVK--RITIAGIKADEWFEQ  253 (421)
Q Consensus       224 ~~~li~~~L~~dP~~--R~t~~eil~~~w~~~  253 (421)
                      +.++|.+||..++.+  |++++++++||||..
T Consensus       240 ~~~li~~ll~~~~~~~~~~~~~~~~~h~~f~~  271 (331)
T cd05624         240 AKDLIQRLICSRERRLGQNGIEDFKKHAFFEG  271 (331)
T ss_pred             HHHHHHHHccCchhhcCCCCHHHHhcCCCcCC
Confidence            999999999876654  578999999999975

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=100.00  E-value=5.2e-43  Score=350.13  Aligned_cols=230  Identities=32%  Similarity=0.454  Sum_probs=198.1

Q ss_pred             cceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCC-C-----CCcceEEEEEEeCC
Q 014609           14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK-H-----PNVVRLHEVLASKS   87 (421)
Q Consensus        14 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~-h-----pnIv~l~~~~~~~~   87 (421)
                      .+|++++.||+|+||.|-+|.|..|++.||||+++...    ....+...|+.+|..|+ |     -|+|+++++|...+
T Consensus       186 ~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k----~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~  261 (586)
T KOG0667|consen  186 YRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKK----RFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRN  261 (586)
T ss_pred             EEEEEEEEecccccceeEEEEecCCCcEEEEEeeccCh----HHHHHHHHHHHHHHHHhccCCCCCeeEEEeeecccccc
Confidence            48999999999999999999999999999999998653    34678888999999997 4     48999999999999


Q ss_pred             EEEEEEeccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCC--CEEEEeccCCCC
Q 014609           88 KIYMVLEYVTGGELFDKIASKG--RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKG--NIKISDFGLSAL  163 (421)
Q Consensus        88 ~~~lv~E~~~gg~L~~~i~~~~--~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~--~~kL~DFGla~~  163 (421)
                      ++|||+|.+ +.+|++++..+.  +++...++.+++||+.||.+||+.||||+|||||||||.+-+  .+||+|||.|+.
T Consensus       262 HlciVfELL-~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~  340 (586)
T KOG0667|consen  262 HLCIVFELL-STNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKRSRIKVIDFGSSCF  340 (586)
T ss_pred             ceeeeehhh-hhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCcCceeEEecccccc
Confidence            999999999 679999998654  689999999999999999999999999999999999997654  799999999985


Q ss_pred             CccccCCCccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhhcCCcC----------------------------
Q 014609          164 PQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIFRGDFK----------------------------  215 (421)
Q Consensus       164 ~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~~~~~~----------------------------  215 (421)
                      ..     ....+++.+..|+|||++.+.+|+ .++||||||||+.++..+.+                            
T Consensus       341 ~~-----q~vytYiQSRfYRAPEVILGlpY~-~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~  414 (586)
T KOG0667|consen  341 ES-----QRVYTYIQSRFYRAPEVILGLPYD-TAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLDT  414 (586)
T ss_pred             cC-----CcceeeeeccccccchhhccCCCC-CccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence            32     234488999999999999999995 88999999999982211110                            


Q ss_pred             --------------------------------------------CCCC-----------CCHHHHHHHHHhcCCCCCCCC
Q 014609          216 --------------------------------------------LPKW-----------LSPGAQNLLRKILEPNPVKRI  240 (421)
Q Consensus       216 --------------------------------------------~p~~-----------~s~~~~~li~~~L~~dP~~R~  240 (421)
                                                                  .|+.           -...+.++|++||+.||.+|+
T Consensus       415 ~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~  494 (586)
T KOG0667|consen  415 AKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERI  494 (586)
T ss_pred             ccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhcC
Confidence                                                        1100           124568999999999999999


Q ss_pred             CHHhhhcCcccccc
Q 014609          241 TIAGIKADEWFEQD  254 (421)
Q Consensus       241 t~~eil~~~w~~~~  254 (421)
                      |+.|+++|||+...
T Consensus       495 tp~qal~Hpfl~~~  508 (586)
T KOG0667|consen  495 TPAQALNHPFLTGT  508 (586)
T ss_pred             CHHHHhcCcccccc
Confidence            99999999999853

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=100.00  E-value=1.3e-43  Score=332.75  Aligned_cols=233  Identities=33%  Similarity=0.515  Sum_probs=194.3

Q ss_pred             cceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCC-----E
Q 014609           14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKS-----K   88 (421)
Q Consensus        14 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~-----~   88 (421)
                      =.|+-.+.+|+|+||.||.|....+++.||||.+-.+.-       --.+|+.+|++++|||||++..+|....     .
T Consensus        24 i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r-------~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~   96 (364)
T KOG0658|consen   24 ISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR-------YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVY   96 (364)
T ss_pred             EEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC-------cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhH
Confidence            368999999999999999999999999999998754321       2246999999999999999999886432     3


Q ss_pred             EEEEEeccCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccC-CCEEEEeccCCCC
Q 014609           89 IYMVLEYVTGGELFDKIAS----KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSK-GNIKISDFGLSAL  163 (421)
Q Consensus        89 ~~lv~E~~~gg~L~~~i~~----~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~-~~~kL~DFGla~~  163 (421)
                      ..+||||++ .+|.+.+..    +.+++...++-|..||.+||+|||+.||+||||||+|||+|.+ |.+||||||.|+.
T Consensus        97 lnlVleymP-~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~  175 (364)
T KOG0658|consen   97 LNLVLEYMP-ETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPDTGVLKICDFGSAKV  175 (364)
T ss_pred             HHHHHHhch-HHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCCCCeEEeccCCccee
Confidence            568999995 589888873    5789999999999999999999999999999999999999977 8999999999997


Q ss_pred             CccccCCCccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhhc-CC-----------------------------
Q 014609          164 PQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIFR-GD-----------------------------  213 (421)
Q Consensus       164 ~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~~-~~-----------------------------  213 (421)
                      ...   .....++.-|..|+|||.+.+...++.++||||+||++.++. |.                             
T Consensus       176 L~~---~epniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~  252 (364)
T KOG0658|consen  176 LVK---GEPNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKS  252 (364)
T ss_pred             ecc---CCCceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhh
Confidence            654   233356677999999999888665579999999999998321 11                             


Q ss_pred             -------cCCC------------CCCCHHHHHHHHHhcCCCCCCCCCHHhhhcCccccccccC
Q 014609          214 -------FKLP------------KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTP  257 (421)
Q Consensus       214 -------~~~p------------~~~s~~~~~li~~~L~~dP~~R~t~~eil~~~w~~~~~~~  257 (421)
                             +.+|            ...++++.+|+.++|..+|.+|.++.|++.||||..-..+
T Consensus       253 mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr~~  315 (364)
T KOG0658|consen  253 MNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELRDP  315 (364)
T ss_pred             cCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhhCc
Confidence                   1111            2268999999999999999999999999999999864433

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.3e-42  Score=325.08  Aligned_cols=237  Identities=32%  Similarity=0.561  Sum_probs=203.6

Q ss_pred             cceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccc--hhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEE
Q 014609           14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIH--LKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYM   91 (421)
Q Consensus        14 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~--~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l   91 (421)
                      +.|++.+.||+|++|.||.|.+..+++.||+|.+.......  ......+.+|+.++++++||||+++++++......|+
T Consensus         2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   81 (263)
T cd06625           2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI   81 (263)
T ss_pred             CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence            46999999999999999999999999999999987543221  1234678899999999999999999999999999999


Q ss_pred             EEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCccccCC-
Q 014609           92 VLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD-  170 (421)
Q Consensus        92 v~E~~~gg~L~~~i~~~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~-  170 (421)
                      |+||++|++|.+.+...+.+++..++.++.|++.||.|||+.||+||||+|+||+++.++.++|+|||++......... 
T Consensus        82 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~~~~  161 (263)
T cd06625          82 FMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSG  161 (263)
T ss_pred             EEEECCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecccccccc
Confidence            9999999999999988888999999999999999999999999999999999999999999999999998754321111 


Q ss_pred             CccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhh-cCCc---------------------CCCCCCCHHHHHHH
Q 014609          171 GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIF-RGDF---------------------KLPKWLSPGAQNLL  228 (421)
Q Consensus       171 ~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~-~~~~---------------------~~p~~~s~~~~~li  228 (421)
                      .......|++.|+|||++.+..+ +.++||||+|+++|.+ .|..                     .+|..++..+.++|
T Consensus       162 ~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  240 (263)
T cd06625         162 TGMKSVTGTPYWMSPEVISGEGY-GRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPQLPSHVSPDARNFL  240 (263)
T ss_pred             ccccCCCcCccccCcceeccCCC-CchhhhHHHHHHHHHHHhCCCCccccchHHHHHHHhccCCCCCCCccCCHHHHHHH
Confidence            11134568899999999987765 5899999999999943 3322                     23445789999999


Q ss_pred             HHhcCCCCCCCCCHHhhhcCccc
Q 014609          229 RKILEPNPVKRITIAGIKADEWF  251 (421)
Q Consensus       229 ~~~L~~dP~~R~t~~eil~~~w~  251 (421)
                      ++||..+|.+|||+.++++||||
T Consensus       241 ~~~l~~~p~~Rpt~~~ll~~~~~  263 (263)
T cd06625         241 RRTFVENAKKRPSAEELLRHFFV  263 (263)
T ss_pred             HHHhhcCcccCCCHHHHhhCCCC
Confidence            99999999999999999999997

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=3.2e-42  Score=353.01  Aligned_cols=233  Identities=24%  Similarity=0.374  Sum_probs=191.9

Q ss_pred             ecceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCC------CCcceEEEEEEeC
Q 014609           13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKH------PNVVRLHEVLASK   86 (421)
Q Consensus        13 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~h------pnIv~l~~~~~~~   86 (421)
                      .++|++++.||+|+||+||+|.+..+++.||||+++...    ........|+.+++.++|      ++++++++++...
T Consensus       128 ~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~  203 (467)
T PTZ00284        128 TQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP----KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNE  203 (467)
T ss_pred             CCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch----hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcC
Confidence            368999999999999999999999999999999996432    123456667777777654      4588999988765


Q ss_pred             -CEEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCceeccCCCCCEEeccCC-------------
Q 014609           87 -SKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHN-KGVFHRDLKLENILLDSKG-------------  151 (421)
Q Consensus        87 -~~~~lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~ql~~aL~~LH~-~gi~HrDlkp~NILl~~~~-------------  151 (421)
                       .++|+|||++ |++|.+++...+.+++..++.++.||+.||+|||+ .||+||||||+|||++.++             
T Consensus       204 ~~~~~iv~~~~-g~~l~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~~~~  282 (467)
T PTZ00284        204 TGHMCIVMPKY-GPCLLDWIMKHGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALPP  282 (467)
T ss_pred             CceEEEEEecc-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCcccccccccccCC
Confidence             5789999998 78999999888889999999999999999999998 5999999999999998766             


Q ss_pred             ---CEEEEeccCCCCCccccCCCccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhh-cCCcCCCCC--------
Q 014609          152 ---NIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIF-RGDFKLPKW--------  219 (421)
Q Consensus       152 ---~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~-~~~~~~p~~--------  219 (421)
                         .+||+|||++....     ......+||+.|+|||++.+..| +.++|||||||++|++ .|..++...        
T Consensus       283 ~~~~vkl~DfG~~~~~~-----~~~~~~~gt~~Y~APE~~~~~~~-~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~  356 (467)
T PTZ00284        283 DPCRVRICDLGGCCDER-----HSRTAIVSTRHYRSPEVVLGLGW-MYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHL  356 (467)
T ss_pred             CCceEEECCCCccccCc-----cccccccCCccccCcHHhhcCCC-CcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Confidence               49999999876322     22345689999999999988887 5899999999999954 343333110        


Q ss_pred             -----------------------------------------------------CCHHHHHHHHHhcCCCCCCCCCHHhhh
Q 014609          220 -----------------------------------------------------LSPGAQNLLRKILEPNPVKRITIAGIK  246 (421)
Q Consensus       220 -----------------------------------------------------~s~~~~~li~~~L~~dP~~R~t~~eil  246 (421)
                                                                           .++.+.+||.+||+.||.+|||+.|++
T Consensus       357 i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~L  436 (467)
T PTZ00284        357 MEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQMT  436 (467)
T ss_pred             HHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHHh
Confidence                                                                 023456999999999999999999999


Q ss_pred             cCcccccccc
Q 014609          247 ADEWFEQDYT  256 (421)
Q Consensus       247 ~~~w~~~~~~  256 (421)
                      +||||.+.+.
T Consensus       437 ~Hp~~~~~~~  446 (467)
T PTZ00284        437 THPYVLKYYP  446 (467)
T ss_pred             cCccccccCC
Confidence            9999987543

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=5.9e-42  Score=332.25  Aligned_cols=234  Identities=29%  Similarity=0.478  Sum_probs=203.3

Q ss_pred             cceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEE
Q 014609           14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVL   93 (421)
Q Consensus        14 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~   93 (421)
                      ++|++.+.||+|+||.||+|.+..++..+|+|.+....  ......++.+|++++++++||||+++++++..++.+|+||
T Consensus         1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   78 (308)
T cd06615           1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEI--KPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICM   78 (308)
T ss_pred             CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEecccc--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEe
Confidence            46999999999999999999999999999999986532  2233567889999999999999999999999999999999


Q ss_pred             eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCceeccCCCCCEEeccCCCEEEEeccCCCCCccccCCCc
Q 014609           94 EYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHN-KGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGL  172 (421)
Q Consensus        94 E~~~gg~L~~~i~~~~~~~~~~~~~~~~ql~~aL~~LH~-~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~  172 (421)
                      ||++|++|.+++...+.+++..+..++.|++.||+|||+ .+++||||||+|||++.++.+||+|||++.....    ..
T Consensus        79 ey~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~----~~  154 (308)
T cd06615          79 EHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID----SM  154 (308)
T ss_pred             eccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCCcEEEccCCCcccccc----cc
Confidence            999999999999888889999999999999999999998 5999999999999999999999999999874322    22


Q ss_pred             cccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhh-cCCcCCC----------------------------------
Q 014609          173 LHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIF-RGDFKLP----------------------------------  217 (421)
Q Consensus       173 ~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~-~~~~~~p----------------------------------  217 (421)
                      ....+|++.|+|||++.+..+ +.++|+||+||++|.+ .|..+++                                  
T Consensus       155 ~~~~~~~~~~~aPE~~~~~~~-~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (308)
T cd06615         155 ANSFVGTRSYMSPERLQGTHY-TVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPDS  233 (308)
T ss_pred             cccCCCCcCccChhHhcCCCC-CccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCCCCCc
Confidence            345688999999999877666 5889999999999943 3443321                                  


Q ss_pred             -----------------------CCCCHHHHHHHHHhcCCCCCCCCCHHhhhcCcccccc
Q 014609          218 -----------------------KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD  254 (421)
Q Consensus       218 -----------------------~~~s~~~~~li~~~L~~dP~~R~t~~eil~~~w~~~~  254 (421)
                                             ..+++++.+++.+||..||++|||+.++++||||.+.
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~  293 (308)
T cd06615         234 PRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKRA  293 (308)
T ss_pred             cchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhhc
Confidence                                   0146789999999999999999999999999999763

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=3.7e-42  Score=328.78  Aligned_cols=233  Identities=30%  Similarity=0.480  Sum_probs=195.9

Q ss_pred             ceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEEe
Q 014609           15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLE   94 (421)
Q Consensus        15 ~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E   94 (421)
                      +|++.+.||+|++|.||+|.+..+++.||+|.+..... .......+.+|+.++++++||||+++++++.+++..|+|||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e   79 (285)
T cd07861           1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESE-EEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFE   79 (285)
T ss_pred             CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccc-cCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEe
Confidence            58999999999999999999999999999999865432 22234678899999999999999999999999999999999


Q ss_pred             ccCCCChHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCccccCCC
Q 014609           95 YVTGGELFDKIASK---GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDG  171 (421)
Q Consensus        95 ~~~gg~L~~~i~~~---~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~  171 (421)
                      |++ ++|.+++...   ..+++..++.++.|++.||+|||++||+||||||+||+++.++.++|+|||++.....  ...
T Consensus        80 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~--~~~  156 (285)
T cd07861          80 FLS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGI--PVR  156 (285)
T ss_pred             cCC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCCCcEEECcccceeecCC--Ccc
Confidence            997 5888877542   4689999999999999999999999999999999999999999999999999874432  112


Q ss_pred             ccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhhc-CCcCCC---------------------------------
Q 014609          172 LLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIFR-GDFKLP---------------------------------  217 (421)
Q Consensus       172 ~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~~-~~~~~p---------------------------------  217 (421)
                      ......+++.|+|||++.+....+.++|+|||||++|.+. |..++.                                 
T Consensus       157 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (285)
T cd07861         157 VYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDYK  236 (285)
T ss_pred             cccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHHHH
Confidence            2233467899999999876554468899999999999543 322221                                 


Q ss_pred             ---------------CCCCHHHHHHHHHhcCCCCCCCCCHHhhhcCccc
Q 014609          218 ---------------KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWF  251 (421)
Q Consensus       218 ---------------~~~s~~~~~li~~~L~~dP~~R~t~~eil~~~w~  251 (421)
                                     ..+++++.++|++||+.||.+|||+.+++.||||
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~~~~  285 (285)
T cd07861         237 NTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF  285 (285)
T ss_pred             hhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcCCCC
Confidence                           1257888899999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=1.4e-42  Score=340.69  Aligned_cols=232  Identities=27%  Similarity=0.384  Sum_probs=190.1

Q ss_pred             ecceEEeceEeecCcEEEEEEEEC-----CCCceEEEEEeecccccchhHHHHHHHHHHHHhcC-CCCCcceEEEEEEeC
Q 014609           13 LGRYELGRTLGEGNFGKVKFAQDL-----DSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEVLASK   86 (421)
Q Consensus        13 ~~~y~i~~~LG~G~~g~V~~a~~~-----~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~   86 (421)
                      .++|++++.||+|+||.||+|.+.     .+++.||+|++....  .......+.+|+.+++.+ +||||+++++++...
T Consensus         6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~   83 (338)
T cd05102           6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGA--TASEHKALMSELKILIHIGNHLNVVNLLGACTKP   83 (338)
T ss_pred             hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheecccccc--chHHHHHHHHHHHHHHHhccCcceeeEEeEecCC
Confidence            368999999999999999999752     456789999986432  222346789999999999 899999999988764


Q ss_pred             -CEEEEEEeccCCCChHHHHHhc---------------------------------------------------------
Q 014609           87 -SKIYMVLEYVTGGELFDKIASK---------------------------------------------------------  108 (421)
Q Consensus        87 -~~~~lv~E~~~gg~L~~~i~~~---------------------------------------------------------  108 (421)
                       ..+|+||||+++|+|.+++...                                                         
T Consensus        84 ~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  163 (338)
T cd05102          84 NGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQET  163 (338)
T ss_pred             CCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhc
Confidence             4689999999999999988642                                                         


Q ss_pred             -----CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCccccCCCccccccCCCCcc
Q 014609          109 -----GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYV  183 (421)
Q Consensus       109 -----~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~  183 (421)
                           .++++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++................+++.|+
T Consensus       164 ~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~  243 (338)
T cd05102         164 DDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWM  243 (338)
T ss_pred             cccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCcccc
Confidence                 247788899999999999999999999999999999999999999999999997543211111122334567899


Q ss_pred             ChhhhcccCCCCCcchHHHHHHHHhhhc--CCcCC---------------------CCCCCHHHHHHHHHhcCCCCCCCC
Q 014609          184 APEVLANRGYDGATSDIWSCGVILYIFR--GDFKL---------------------PKWLSPGAQNLLRKILEPNPVKRI  240 (421)
Q Consensus       184 APEvl~~~~~~~~~~DiwSlGvil~~~~--~~~~~---------------------p~~~s~~~~~li~~~L~~dP~~R~  240 (421)
                      |||++.+..+ +.++|||||||++|.+.  |..++                     |..+++.+.+++.+||++||.+||
T Consensus       244 aPE~~~~~~~-~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RP  322 (338)
T cd05102         244 APESIFDKVY-TTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTRMRAPENATPEIYRIMLACWQGDPKERP  322 (338)
T ss_pred             CcHHhhcCCC-CcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHccCChhhCc
Confidence            9999987777 58999999999999653  54443                     234678899999999999999999


Q ss_pred             CHHhhhc
Q 014609          241 TIAGIKA  247 (421)
Q Consensus       241 t~~eil~  247 (421)
                      |+.++++
T Consensus       323 s~~el~~  329 (338)
T cd05102         323 TFSALVE  329 (338)
T ss_pred             CHHHHHH
Confidence            9999875

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=2e-42  Score=346.87  Aligned_cols=232  Identities=26%  Similarity=0.383  Sum_probs=196.9

Q ss_pred             ecceEEeceEeecCcEEEEEEEEC--CCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEE
Q 014609           13 LGRYELGRTLGEGNFGKVKFAQDL--DSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIY   90 (421)
Q Consensus        13 ~~~y~i~~~LG~G~~g~V~~a~~~--~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~   90 (421)
                      -.+|++++.||+|+||.||+|...  .++..||+|.+...        ....+|+.+|++++||||+++++++......|
T Consensus        91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~--------~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~  162 (392)
T PHA03207         91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG--------KTPGREIDILKTISHRAIINLIHAYRWKSTVC  162 (392)
T ss_pred             cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc--------ccHHHHHHHHHhcCCCCccceeeeEeeCCEEE
Confidence            357999999999999999999754  46788999987643        23568999999999999999999999999999


Q ss_pred             EEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCccccCC
Q 014609           91 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD  170 (421)
Q Consensus        91 lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~  170 (421)
                      ++||++. ++|.+++.....+++..++.++.||+.||+|||++||+||||||+|||++.++.++|+|||++.........
T Consensus       163 lv~e~~~-~~l~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~~~  241 (392)
T PHA03207        163 MVMPKYK-CDLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDT  241 (392)
T ss_pred             EEehhcC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEccCccccccCccccc
Confidence            9999995 689898877788999999999999999999999999999999999999999999999999999754432222


Q ss_pred             CccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhh-cCCcCCC--------------------------------
Q 014609          171 GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIF-RGDFKLP--------------------------------  217 (421)
Q Consensus       171 ~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~-~~~~~~p--------------------------------  217 (421)
                      .......||+.|+|||++....| +.++||||+||++|.+ .|..++.                                
T Consensus       242 ~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~  320 (392)
T PHA03207        242 PQCYGWSGTLETNSPELLALDPY-CAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGSTN  320 (392)
T ss_pred             ccccccccccCccCHhHhcCCCC-CchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccchh
Confidence            22335679999999999988777 4889999999999954 3332221                                


Q ss_pred             -------------------C-----CCCHHHHHHHHHhcCCCCCCCCCHHhhhcCcccccc
Q 014609          218 -------------------K-----WLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD  254 (421)
Q Consensus       218 -------------------~-----~~s~~~~~li~~~L~~dP~~R~t~~eil~~~w~~~~  254 (421)
                                         .     .++.++.++|++||..||.+|||+.+++.||||.+.
T Consensus       321 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~f~~~  381 (392)
T PHA03207        321 LCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPLFTKE  381 (392)
T ss_pred             HHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCchhhcc
Confidence                               0     135678889999999999999999999999999864

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-44  Score=354.92  Aligned_cols=235  Identities=29%  Similarity=0.473  Sum_probs=205.4

Q ss_pred             cceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEE
Q 014609           14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVL   93 (421)
Q Consensus        14 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~   93 (421)
                      +.|+|+..||.|+||+||+|.++.++-..|-|+|...   .....+++.-||.||..++||+|+++++.|..++.+||..
T Consensus        32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetk---seEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwili  108 (1187)
T KOG0579|consen   32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETK---SEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILI  108 (1187)
T ss_pred             HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhccc---chhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEE
Confidence            5789999999999999999999999999999999644   3445788999999999999999999999999999999999


Q ss_pred             eccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCccccCCCc
Q 014609           94 EYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGL  172 (421)
Q Consensus        94 E~~~gg~L~~~i~~-~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~  172 (421)
                      |||.||-....+.. ..++++++++.+++|++.||.|||+++|||||||..|||++-+|.++|+|||.+.....  ....
T Consensus       109 EFC~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~--t~qk  186 (1187)
T KOG0579|consen  109 EFCGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKS--TRQK  186 (1187)
T ss_pred             eecCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEecCcEeeecccccccchh--HHhh
Confidence            99999998777654 56799999999999999999999999999999999999999999999999999874322  2234


Q ss_pred             cccccCCCCccChhhhc-----ccCCCCCcchHHHHHHHHhhhcCC-----------------------cCCCCCCCHHH
Q 014609          173 LHTTCGSPNYVAPEVLA-----NRGYDGATSDIWSCGVILYIFRGD-----------------------FKLPKWLSPGA  224 (421)
Q Consensus       173 ~~~~~gt~~y~APEvl~-----~~~~~~~~~DiwSlGvil~~~~~~-----------------------~~~p~~~s~~~  224 (421)
                      ..++.|||+|||||++.     +.+|+ .++||||||++|..+...                       +-.|..++..+
T Consensus       187 RDsFIGTPYWMAPEVvmCET~KD~PYD-ykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaKSePPTLlqPS~Ws~~F  265 (1187)
T KOG0579|consen  187 RDSFIGTPYWMAPEVVMCETFKDQPYD-YKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLLQPSHWSRSF  265 (1187)
T ss_pred             hccccCCcccccchheeeccccCCCch-hhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhhcCCCcccCcchhhhHH
Confidence            46789999999999965     46775 899999999999854321                       11255678999


Q ss_pred             HHHHHHhcCCCCCCCCCHHhhhcCcccccc
Q 014609          225 QNLLRKILEPNPVKRITIAGIKADEWFEQD  254 (421)
Q Consensus       225 ~~li~~~L~~dP~~R~t~~eil~~~w~~~~  254 (421)
                      .+++++||.+||..||+++++++|||+.+.
T Consensus       266 ~DfLk~cL~Knp~~Rp~aaqll~Hpfv~~~  295 (1187)
T KOG0579|consen  266 SDFLKRCLVKNPRNRPPAAQLLKHPFVQNA  295 (1187)
T ss_pred             HHHHHHHHhcCCccCCCHHHHhhCcccccC
Confidence            999999999999999999999999999853

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=100.00  E-value=1.4e-42  Score=331.73  Aligned_cols=233  Identities=30%  Similarity=0.484  Sum_probs=197.7

Q ss_pred             ceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEEe
Q 014609           15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLE   94 (421)
Q Consensus        15 ~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E   94 (421)
                      +|++.+.||+|+||.||+|++..+|+.||+|.++.... .......+.+|+.++++++||||+++++++.+....|+++|
T Consensus         1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~-~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   79 (284)
T cd07839           1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD-DEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFE   79 (284)
T ss_pred             CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccc-cccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEe
Confidence            69999999999999999999999999999999975432 22234567889999999999999999999999999999999


Q ss_pred             ccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCccccCCCcc
Q 014609           95 YVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLL  173 (421)
Q Consensus        95 ~~~gg~L~~~i~~-~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~  173 (421)
                      |+. ++|.+.+.. .+.+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++.....  .....
T Consensus        80 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~--~~~~~  156 (284)
T cd07839          80 YCD-QDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLARAFGI--PVRCY  156 (284)
T ss_pred             cCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCCCcEEECccchhhccCC--CCCCc
Confidence            996 578777754 56799999999999999999999999999999999999999999999999999875432  11223


Q ss_pred             ccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhhc-CCcCC------------------------------------
Q 014609          174 HTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIFR-GDFKL------------------------------------  216 (421)
Q Consensus       174 ~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~~-~~~~~------------------------------------  216 (421)
                      ....+++.|+|||++.+....+.++||||+||++|.+. |..++                                    
T Consensus       157 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (284)
T cd07839         157 SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYKP  236 (284)
T ss_pred             CCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhcccccc
Confidence            34567899999999877554468899999999999654 43331                                    


Q ss_pred             -------------CCCCCHHHHHHHHHhcCCCCCCCCCHHhhhcCccc
Q 014609          217 -------------PKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWF  251 (421)
Q Consensus       217 -------------p~~~s~~~~~li~~~L~~dP~~R~t~~eil~~~w~  251 (421)
                                   .+.+++++.++|.+||+.||.+|||+++++.||||
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h~~f  284 (284)
T cd07839         237 YPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPYF  284 (284)
T ss_pred             cCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcCCCC
Confidence                         01257888999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=1.1e-41  Score=325.41  Aligned_cols=235  Identities=29%  Similarity=0.459  Sum_probs=199.5

Q ss_pred             cceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEE
Q 014609           14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVL   93 (421)
Q Consensus        14 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~   93 (421)
                      ++|++.+.||+|+||.||+|.+..+|+.||+|.+...... ....+.+.+|+.+++.++||||+++++++......|+||
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~   79 (286)
T cd07847           1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDD-PVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVF   79 (286)
T ss_pred             CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccC-ccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEE
Confidence            4799999999999999999999999999999998654321 122356789999999999999999999999999999999


Q ss_pred             eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCccccCCCcc
Q 014609           94 EYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLL  173 (421)
Q Consensus        94 E~~~gg~L~~~i~~~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~  173 (421)
                      ||++++.|...+.....+++..++.++.|++.||+|||+.|++||||||+||+++.++.++|+|||++.......  ...
T Consensus        80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~--~~~  157 (286)
T cd07847          80 EYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPG--DDY  157 (286)
T ss_pred             eccCccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcCCCcEEECccccceecCCCc--ccc
Confidence            999998888777766779999999999999999999999999999999999999999999999999998653321  122


Q ss_pred             ccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhh-cCCcCCC-----------------------------------
Q 014609          174 HTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIF-RGDFKLP-----------------------------------  217 (421)
Q Consensus       174 ~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~-~~~~~~p-----------------------------------  217 (421)
                      ....++..|+|||++.+....+.++|+||+|+++|.+ .|..+++                                   
T Consensus       158 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (286)
T cd07847         158 TDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKGL  237 (286)
T ss_pred             cCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcccccccccc
Confidence            3446788999999987644446889999999999954 3433321                                   


Q ss_pred             ---------------CCCCHHHHHHHHHhcCCCCCCCCCHHhhhcCccc
Q 014609          218 ---------------KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWF  251 (421)
Q Consensus       218 ---------------~~~s~~~~~li~~~L~~dP~~R~t~~eil~~~w~  251 (421)
                                     +.++..+.++|.+||+++|++|||+.+++.||||
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~~~f  286 (286)
T cd07847         238 SIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPYF  286 (286)
T ss_pred             cCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcCCCC
Confidence                           1246778899999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=2.1e-42  Score=342.52  Aligned_cols=226  Identities=27%  Similarity=0.423  Sum_probs=192.0

Q ss_pred             cceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEE
Q 014609           14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVL   93 (421)
Q Consensus        14 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~   93 (421)
                      .+|++++.||+|+||.||+|.+..+++.||+|+..+.         ....|+.++++++||||+++++++......|+||
T Consensus        66 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~---------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  136 (357)
T PHA03209         66 LGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG---------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVL  136 (357)
T ss_pred             cCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc---------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEE
Confidence            5799999999999999999999999999999985432         2356899999999999999999999999999999


Q ss_pred             eccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCccccCCCc
Q 014609           94 EYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGL  172 (421)
Q Consensus        94 E~~~gg~L~~~i~~-~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~  172 (421)
                      ||+. ++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....   ...
T Consensus       137 e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~---~~~  212 (357)
T PHA03209        137 PHYS-SDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVV---APA  212 (357)
T ss_pred             EccC-CcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEecCcccccccc---Ccc
Confidence            9995 588887764 45799999999999999999999999999999999999999999999999999874322   222


Q ss_pred             cccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhhcC-CcC---------------------------------CC-
Q 014609          173 LHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIFRG-DFK---------------------------------LP-  217 (421)
Q Consensus       173 ~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~~~-~~~---------------------------------~p-  217 (421)
                      .....||+.|+|||++.+..+ +.++||||+||++|.+.. ..+                                 +| 
T Consensus       213 ~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~  291 (357)
T PHA03209        213 FLGLAGTVETNAPEVLARDKY-NSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFPR  291 (357)
T ss_pred             cccccccccccCCeecCCCCC-CchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhhcCC
Confidence            345679999999999988777 589999999999995431 000                                 11 


Q ss_pred             -----------------------------CCCCHHHHHHHHHhcCCCCCCCCCHHhhhcCccccc
Q 014609          218 -----------------------------KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQ  253 (421)
Q Consensus       218 -----------------------------~~~s~~~~~li~~~L~~dP~~R~t~~eil~~~w~~~  253 (421)
                                                   ..++.++.+||.+||+.||.+|||+.|+++||||++
T Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~hp~f~~  356 (357)
T PHA03209        292 DPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNYPMFAQ  356 (357)
T ss_pred             CCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcCchhcc
Confidence                                         013456677999999999999999999999999975

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=4.1e-42  Score=349.44  Aligned_cols=230  Identities=25%  Similarity=0.352  Sum_probs=194.6

Q ss_pred             ecceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEE
Q 014609           13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMV   92 (421)
Q Consensus        13 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv   92 (421)
                      ..+|.+.+.||+|+||.||+|.+..+++.||||...         ...+.+|+.+|++++||||+++++++...+..|+|
T Consensus       168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~---------~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv  238 (461)
T PHA03211        168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW---------YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLV  238 (461)
T ss_pred             cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc---------ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEE
Confidence            357999999999999999999999999999999632         13456899999999999999999999999999999


Q ss_pred             EeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCccccCCC
Q 014609           93 LEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDG  171 (421)
Q Consensus        93 ~E~~~gg~L~~~i~~~-~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~  171 (421)
                      ||++. ++|.+++... ..+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||++..........
T Consensus       239 ~e~~~-~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~  317 (461)
T PHA03211        239 LPKYR-SDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTP  317 (461)
T ss_pred             EEccC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECCCCCEEEcccCCceecccccccc
Confidence            99994 6888887653 469999999999999999999999999999999999999999999999999997653322222


Q ss_pred             ccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhhcC-Cc------------------------------CCCC--
Q 014609          172 LLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIFRG-DF------------------------------KLPK--  218 (421)
Q Consensus       172 ~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~~~-~~------------------------------~~p~--  218 (421)
                      .....+||+.|+|||++.+..+ +.++|||||||++|++.. ..                              .+|.  
T Consensus       318 ~~~~~~GT~~Y~APE~~~~~~~-~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~  396 (461)
T PHA03211        318 FHYGIAGTVDTNAPEVLAGDPY-TPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHA  396 (461)
T ss_pred             cccccCCCcCCcCHHHHcCCCC-CchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCCc
Confidence            2334579999999999988877 489999999999995421 00                              0110  


Q ss_pred             -----------------------------CCCHHHHHHHHHhcCCCCCCCCCHHhhhcCccccc
Q 014609          219 -----------------------------WLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQ  253 (421)
Q Consensus       219 -----------------------------~~s~~~~~li~~~L~~dP~~R~t~~eil~~~w~~~  253 (421)
                                                   .+++.+.+||.+||+.||.+|||+.|+|+||||+.
T Consensus       397 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~hp~f~~  460 (461)
T PHA03211        397 GSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRLPLFQS  460 (461)
T ss_pred             chHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhCcccCC
Confidence                                         13457889999999999999999999999999974

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=100.00  E-value=8.1e-42  Score=328.94  Aligned_cols=242  Identities=33%  Similarity=0.475  Sum_probs=204.1

Q ss_pred             ceEEeceEeecCcEEEEEEEECCCCceEEEEEeeccccc--chhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEE
Q 014609           15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRII--HLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMV   92 (421)
Q Consensus        15 ~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~--~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv   92 (421)
                      +|++.+.||+|+||.||+|.+..+|+.||+|.+......  .......+.+|+.++++++||||+++++++.+.+..|+|
T Consensus         1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (298)
T cd07841           1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV   80 (298)
T ss_pred             CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence            589999999999999999999999999999999765433  122345677899999999999999999999999999999


Q ss_pred             EeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCccccCCC
Q 014609           93 LEYVTGGELFDKIASKG-RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDG  171 (421)
Q Consensus        93 ~E~~~gg~L~~~i~~~~-~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~  171 (421)
                      |||+ +++|.+++.... .+++..+..++.||++||+|||++||+||||+|+||+++.++.++|+|||++......  ..
T Consensus        81 ~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~--~~  157 (298)
T cd07841          81 FEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSP--NR  157 (298)
T ss_pred             Eccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCCCCEEEccceeeeeccCC--Cc
Confidence            9999 899999998765 7999999999999999999999999999999999999999999999999999755331  12


Q ss_pred             ccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhhcCCcCC-C---------------------------------
Q 014609          172 LLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIFRGDFKL-P---------------------------------  217 (421)
Q Consensus       172 ~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~~~~~~~-p---------------------------------  217 (421)
                      ......+++.|+|||.+.+....+.++|+||+||++|.+..+.++ +                                 
T Consensus       158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (298)
T cd07841         158 KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPDYV  237 (298)
T ss_pred             cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhcccccccc
Confidence            223345688999999986544446889999999999955433221 0                                 


Q ss_pred             --------------CCCCHHHHHHHHHhcCCCCCCCCCHHhhhcCccccccccCCC
Q 014609          218 --------------KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPAN  259 (421)
Q Consensus       218 --------------~~~s~~~~~li~~~L~~dP~~R~t~~eil~~~w~~~~~~~~~  259 (421)
                                    ...+..+.++|.+||.+||.+|||+.+++.|+||.+...+..
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~~~~~~~~~~  293 (298)
T cd07841         238 EFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSNDPAPTP  293 (298)
T ss_pred             cccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhCccccCCCCCCC
Confidence                          123678889999999999999999999999999998766544

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=1.2e-41  Score=326.42  Aligned_cols=236  Identities=30%  Similarity=0.449  Sum_probs=202.9

Q ss_pred             ceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEEe
Q 014609           15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLE   94 (421)
Q Consensus        15 ~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E   94 (421)
                      .|+..+.||+|+||+||+|.+..+++.||+|.+.............+.+|+.++++++|+||+.+++.+..++..|++||
T Consensus         1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e   80 (285)
T cd05632           1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEE
Confidence            47888999999999999999999999999999976554433334567889999999999999999999999999999999


Q ss_pred             ccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCccccCCCc
Q 014609           95 YVTGGELFDKIASK--GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGL  172 (421)
Q Consensus        95 ~~~gg~L~~~i~~~--~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~  172 (421)
                      |+++++|.+.+...  .++++..+..++.|++.||.|||+.||+||||||+||+++.++.++|+|||++.....   ...
T Consensus        81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~---~~~  157 (285)
T cd05632          81 IMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPE---GES  157 (285)
T ss_pred             eccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCCCCEEEecCCcceecCC---CCc
Confidence            99999998887643  4699999999999999999999999999999999999999999999999999864322   122


Q ss_pred             cccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhh-cCCcCC-----------------------CCCCCHHHHHHH
Q 014609          173 LHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIF-RGDFKL-----------------------PKWLSPGAQNLL  228 (421)
Q Consensus       173 ~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~-~~~~~~-----------------------p~~~s~~~~~li  228 (421)
                      .....|++.|+|||++.+..+ +.++|+||+||++|.+ .|..++                       +..+++.+.+++
T Consensus       158 ~~~~~g~~~~~aPE~~~~~~~-~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  236 (285)
T cd05632         158 IRGRVGTVGYMAPEVLNNQRY-TLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYSAKFSEEAKSIC  236 (285)
T ss_pred             ccCCCCCcCccChHHhcCCCC-CcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhccccccCccCCHHHHHHH
Confidence            234578999999999987776 5889999999999944 343332                       234778899999


Q ss_pred             HHhcCCCCCCCCC-----HHhhhcCcccccc
Q 014609          229 RKILEPNPVKRIT-----IAGIKADEWFEQD  254 (421)
Q Consensus       229 ~~~L~~dP~~R~t-----~~eil~~~w~~~~  254 (421)
                      .+||++||.+|||     +.+++.|+||...
T Consensus       237 ~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~  267 (285)
T cd05632         237 KMLLTKDPKQRLGCQEEGAGEVKRHPFFRNM  267 (285)
T ss_pred             HHHccCCHhHcCCCcccChHHHHcChhhhcC
Confidence            9999999999999     8899999999864

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=1.2e-41  Score=325.14  Aligned_cols=230  Identities=24%  Similarity=0.429  Sum_probs=198.5

Q ss_pred             cceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEE
Q 014609           14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVL   93 (421)
Q Consensus        14 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~   93 (421)
                      ++|++.+.||+|+||.||+|++..+++.||+|++....  .......+.+|+.++++++||||+++++++...+..++||
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   78 (279)
T cd06619           1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDI--TVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICT   78 (279)
T ss_pred             CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCC--ChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEE
Confidence            36889999999999999999999999999999987542  2233467889999999999999999999999999999999


Q ss_pred             eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCccccCCCcc
Q 014609           94 EYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLL  173 (421)
Q Consensus        94 E~~~gg~L~~~i~~~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~  173 (421)
                      ||+++++|...    ..+++..+..++.|++.||+|||+.||+|+||||+|||++.++.++|+|||++.....    ...
T Consensus        79 e~~~~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~----~~~  150 (279)
T cd06619          79 EFMDGGSLDVY----RKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVN----SIA  150 (279)
T ss_pred             ecCCCCChHHh----hcCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECCCCCEEEeeCCcceeccc----ccc
Confidence            99999998644    3578999999999999999999999999999999999999999999999999874322    233


Q ss_pred             ccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhhc-CCcCCC----------------------------CCCCHHH
Q 014609          174 HTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIFR-GDFKLP----------------------------KWLSPGA  224 (421)
Q Consensus       174 ~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~~-~~~~~p----------------------------~~~s~~~  224 (421)
                      ...+||+.|+|||++.+..+ +.++|+||+||++|.+. |..++.                            ...++++
T Consensus       151 ~~~~~~~~y~aPE~~~~~~~-~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (279)
T cd06619         151 KTYVGTNAYMAPERISGEQY-GIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLPVGQFSEKF  229 (279)
T ss_pred             cCCCCChhhcCceeecCCCC-CCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCCCCCCCCcCCHHH
Confidence            45689999999999987776 58999999999999543 433321                            1256789


Q ss_pred             HHHHHHhcCCCCCCCCCHHhhhcCcccccc
Q 014609          225 QNLLRKILEPNPVKRITIAGIKADEWFEQD  254 (421)
Q Consensus       225 ~~li~~~L~~dP~~R~t~~eil~~~w~~~~  254 (421)
                      .++|.+||+++|.+||++++++.||||...
T Consensus       230 ~~li~~~l~~~P~~Rp~~~eil~~~~~~~~  259 (279)
T cd06619         230 VHFITQCMRKQPKERPAPENLMDHPFIVQY  259 (279)
T ss_pred             HHHHHHHhhCChhhCCCHHHHhcCcccccc
Confidence            999999999999999999999999999754

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=2.5e-41  Score=318.01  Aligned_cols=233  Identities=28%  Similarity=0.538  Sum_probs=199.4

Q ss_pred             ceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEe-CCEEEEEE
Q 014609           15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLAS-KSKIYMVL   93 (421)
Q Consensus        15 ~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~-~~~~~lv~   93 (421)
                      +|++++.||+|++|.||+|.+..+++.||+|.+...... ....+.+.+|+.++++++|||++++++.+.. +..+|++|
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~   79 (257)
T cd08223           1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNAS-RRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVM   79 (257)
T ss_pred             CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcC-HHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEe
Confidence            599999999999999999999999999999999754332 2235678899999999999999999998864 45689999


Q ss_pred             eccCCCChHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCccccCCC
Q 014609           94 EYVTGGELFDKIAS--KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDG  171 (421)
Q Consensus        94 E~~~gg~L~~~i~~--~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~  171 (421)
                      ||+++++|.+.+..  ...+++.+++.++.|++.||+|||+.|++||||||+||+++.++.++|+|||++.....  ...
T Consensus        80 e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~--~~~  157 (257)
T cd08223          80 GFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLEN--QCD  157 (257)
T ss_pred             cccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEecCCcEEEecccceEEecc--cCC
Confidence            99999999998875  34589999999999999999999999999999999999999999999999999875533  222


Q ss_pred             ccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhhc-CCc--------------------CCCCCCCHHHHHHHHH
Q 014609          172 LLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIFR-GDF--------------------KLPKWLSPGAQNLLRK  230 (421)
Q Consensus       172 ~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~~-~~~--------------------~~p~~~s~~~~~li~~  230 (421)
                      ......+++.|+|||++.+..+ +.++|+||+||++|.+. +..                    +.|..+++.+.+++.+
T Consensus       158 ~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  236 (257)
T cd08223         158 MASTLIGTPYYMSPELFSNKPY-NYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKLPPMPKDYSPELGELIAT  236 (257)
T ss_pred             ccccccCCcCccChhHhcCCCC-CchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCccccCHHHHHHHHH
Confidence            3445678999999999887776 48899999999999442 221                    2234477899999999


Q ss_pred             hcCCCCCCCCCHHhhhcCccc
Q 014609          231 ILEPNPVKRITIAGIKADEWF  251 (421)
Q Consensus       231 ~L~~dP~~R~t~~eil~~~w~  251 (421)
                      ||++||.+|||+.++++||||
T Consensus       237 ~l~~~p~~Rp~~~~~l~~~~~  257 (257)
T cd08223         237 MLSKRPEKRPSVKSILRQPYI  257 (257)
T ss_pred             HhccCcccCCCHHHHhcCCCC
Confidence            999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=100.00  E-value=6e-42  Score=327.50  Aligned_cols=235  Identities=29%  Similarity=0.455  Sum_probs=201.0

Q ss_pred             cceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEE
Q 014609           14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVL   93 (421)
Q Consensus        14 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~   93 (421)
                      ++|++.+.||+|+||.||+|.+..+++.||+|.+.+..... ...+.+.+|+++++.++||||+++++++..+...|+|+
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   79 (286)
T cd07846           1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDK-MVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVF   79 (286)
T ss_pred             CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcc-hhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEE
Confidence            47999999999999999999998899999999986543322 33567889999999999999999999999999999999


Q ss_pred             eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCccccCCCcc
Q 014609           94 EYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLL  173 (421)
Q Consensus        94 E~~~gg~L~~~i~~~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~  173 (421)
                      ||++++.|.+.......+++..+..++.|++.||+|||+.|++||||+|+||+++.++.++|+|||++......  ....
T Consensus        80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~--~~~~  157 (286)
T cd07846          80 EFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAP--GEVY  157 (286)
T ss_pred             ecCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCcEEEEeeeeeeeccCC--cccc
Confidence            99999988887776667999999999999999999999999999999999999999999999999998754331  2223


Q ss_pred             ccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhhc-CCcCC------------------------------------
Q 014609          174 HTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIFR-GDFKL------------------------------------  216 (421)
Q Consensus       174 ~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~~-~~~~~------------------------------------  216 (421)
                      ....++..|+|||++.+....+.++||||+|+++|.+. |..++                                    
T Consensus       158 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (286)
T cd07846         158 TDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGM  237 (286)
T ss_pred             CcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHhhcc
Confidence            34568899999999876554568899999999999553 32222                                    


Q ss_pred             --------------CCCCCHHHHHHHHHhcCCCCCCCCCHHhhhcCccc
Q 014609          217 --------------PKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWF  251 (421)
Q Consensus       217 --------------p~~~s~~~~~li~~~L~~dP~~R~t~~eil~~~w~  251 (421)
                                    ++.++..+.+++.+||+.+|.+||++.+++.||||
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~  286 (286)
T cd07846         238 RLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEFF  286 (286)
T ss_pred             ccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcCCCC
Confidence                          12356789999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=100.00  E-value=7.9e-43  Score=338.17  Aligned_cols=235  Identities=34%  Similarity=0.673  Sum_probs=205.3

Q ss_pred             eEE--eceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEE
Q 014609           16 YEL--GRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVL   93 (421)
Q Consensus        16 y~i--~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~   93 (421)
                      |++  .+.||+|-||+||-|+++.+|+.||||+|++.++.... .+++++|+.||+.+.||+||.+--.|++.+++++||
T Consensus       564 YQif~devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kq-esqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVM  642 (888)
T KOG4236|consen  564 YQIFADEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQ-ESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVM  642 (888)
T ss_pred             HHhhhHhhccCCcceeeecceecccCceeeeeeeecccCCCch-HHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEe
Confidence            554  57899999999999999999999999999988776543 588999999999999999999999999999999999


Q ss_pred             eccCCCChHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCC---CEEEEeccCCCCCcccc
Q 014609           94 EYVTGGELFDKIA--SKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKG---NIKISDFGLSALPQHFR  168 (421)
Q Consensus        94 E~~~gg~L~~~i~--~~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~---~~kL~DFGla~~~~~~~  168 (421)
                      |-+. |+..+.|.  ..+++++...++++.||+.||+|||.++|+|.||||||||+....   .+||||||+|++...  
T Consensus       643 EKl~-GDMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgE--  719 (888)
T KOG4236|consen  643 EKLH-GDMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGE--  719 (888)
T ss_pred             hhhc-chHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccceeecch--
Confidence            9995 46666664  367899999999999999999999999999999999999997654   699999999997653  


Q ss_pred             CCCccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhh-hcCCcC-----------------CC--CC--CCHHHHH
Q 014609          169 DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYI-FRGDFK-----------------LP--KW--LSPGAQN  226 (421)
Q Consensus       169 ~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~-~~~~~~-----------------~p--~~--~s~~~~~  226 (421)
                       .....+..|||.|+|||++.+++|+ ..-|+||.|||+|. +.|.||                 +|  +|  +++++.+
T Consensus       720 -ksFRrsVVGTPAYLaPEVLrnkGyN-rSLDMWSVGVIiYVsLSGTFPFNEdEdIndQIQNAaFMyPp~PW~eis~~Aid  797 (888)
T KOG4236|consen  720 -KSFRRSVVGTPAYLAPEVLRNKGYN-RSLDMWSVGVIIYVSLSGTFPFNEDEDINDQIQNAAFMYPPNPWSEISPEAID  797 (888)
T ss_pred             -hhhhhhhcCCccccCHHHHhhcccc-ccccceeeeEEEEEEecccccCCCccchhHHhhccccccCCCchhhcCHHHHH
Confidence             3455677999999999999999996 78999999999992 333333                 23  34  8999999


Q ss_pred             HHHHhcCCCCCCCCCHHhhhcCcccccccc
Q 014609          227 LLRKILEPNPVKRITIAGIKADEWFEQDYT  256 (421)
Q Consensus       227 li~~~L~~dP~~R~t~~eil~~~w~~~~~~  256 (421)
                      ||..+|+..-.+|+|.++.+.|||++....
T Consensus       798 lIn~LLqVkm~kRysvdk~lsh~Wlq~yq~  827 (888)
T KOG4236|consen  798 LINNLLQVKMRKRYSVDKSLSHPWLQDYQT  827 (888)
T ss_pred             HHHHHHHHHHHHhcchHhhccchhhhcchH
Confidence            999999999999999999999999987543

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=2.5e-41  Score=326.02  Aligned_cols=240  Identities=26%  Similarity=0.468  Sum_probs=206.3

Q ss_pred             cCCeeecceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCC
Q 014609            8 QEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKS   87 (421)
Q Consensus         8 ~~~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~   87 (421)
                      ..+....+|++.+.||+|+||.||+|++..+++.||+|.+......   ..+.+.+|+.+++.++||||+++++.+....
T Consensus        14 ~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~---~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~   90 (296)
T cd06654          14 SVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP---KKELIINEILVMRENKNPNIVNYLDSYLVGD   90 (296)
T ss_pred             ccCCcccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcc---hHHHHHHHHHHHHhCCCCCEeeEEEEEEeCC
Confidence            3456668999999999999999999999999999999998765432   2467889999999999999999999999999


Q ss_pred             EEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCccc
Q 014609           88 KIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHF  167 (421)
Q Consensus        88 ~~~lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~  167 (421)
                      ..|+||||++|++|.+++.. ..+++..+..++.|++.||+|||+.||+||||||+||+++.++.++|+|||++..... 
T Consensus        91 ~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~-  168 (296)
T cd06654          91 ELWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP-  168 (296)
T ss_pred             EEEEeecccCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEECccccchhccc-
Confidence            99999999999999998865 5689999999999999999999999999999999999999999999999999875432 


Q ss_pred             cCCCccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhhc-CCcC----------------------CCCCCCHHH
Q 014609          168 RDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIFR-GDFK----------------------LPKWLSPGA  224 (421)
Q Consensus       168 ~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~~-~~~~----------------------~p~~~s~~~  224 (421)
                       .........|++.|+|||.+.+..+ +.++|+||+||++|.+. |..+                      .|..+++.+
T Consensus       169 -~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  246 (296)
T cd06654         169 -EQSKRSTMVGTPYWMAPEVVTRKAY-GPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIF  246 (296)
T ss_pred             -cccccCcccCCccccCHHHHcCCCC-CccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhcCCCCCCCCccccCHHH
Confidence             1222334578999999999887666 58999999999999432 3322                      133467889


Q ss_pred             HHHHHHhcCCCCCCCCCHHhhhcCcccccc
Q 014609          225 QNLLRKILEPNPVKRITIAGIKADEWFEQD  254 (421)
Q Consensus       225 ~~li~~~L~~dP~~R~t~~eil~~~w~~~~  254 (421)
                      .++|.+||.++|.+|||+.+++.||||...
T Consensus       247 ~~li~~~l~~~p~~Rpt~~eil~~~~~~~~  276 (296)
T cd06654         247 RDFLNRCLDMDVEKRGSAKELLQHQFLKIA  276 (296)
T ss_pred             HHHHHHHCcCCcccCcCHHHHhhChhhhcc
Confidence            999999999999999999999999999853

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=1.1e-41  Score=322.73  Aligned_cols=234  Identities=29%  Similarity=0.472  Sum_probs=200.1

Q ss_pred             eeecceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEE
Q 014609           11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIY   90 (421)
Q Consensus        11 ~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~   90 (421)
                      ...++|++.+.||+|+||.||+|.+..+++.||+|+++....   .....+.+|+.+++.++||||+++++++...+..|
T Consensus         6 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~---~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~   82 (267)
T cd06645           6 NPQEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPG---EDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLW   82 (267)
T ss_pred             CcHHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCch---hHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEE
Confidence            344689999999999999999999999999999999875432   22456889999999999999999999999999999


Q ss_pred             EEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCccccCC
Q 014609           91 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD  170 (421)
Q Consensus        91 lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~  170 (421)
                      +||||+++++|.+++...+.+++..++.++.|++.||+|||+.|++|+||||+||+++.++.++|+|||++.....  ..
T Consensus        83 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~--~~  160 (267)
T cd06645          83 ICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQITA--TI  160 (267)
T ss_pred             EEEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECcceeeeEccC--cc
Confidence            9999999999999998888999999999999999999999999999999999999999999999999999864432  11


Q ss_pred             CccccccCCCCccChhhhc---ccCCCCCcchHHHHHHHHhhhcC-CcCC-------------------C-----CCCCH
Q 014609          171 GLLHTTCGSPNYVAPEVLA---NRGYDGATSDIWSCGVILYIFRG-DFKL-------------------P-----KWLSP  222 (421)
Q Consensus       171 ~~~~~~~gt~~y~APEvl~---~~~~~~~~~DiwSlGvil~~~~~-~~~~-------------------p-----~~~s~  222 (421)
                      .......|++.|+|||++.   ...+ +.++|+||+||++|.+.. ..++                   +     ..++.
T Consensus       161 ~~~~~~~~~~~y~aPE~~~~~~~~~~-~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (267)
T cd06645         161 AKRKSFIGTPYWMAPEVAAVERKGGY-NQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLKDKMKWSN  239 (267)
T ss_pred             cccccccCcccccChhhhccccCCCC-CchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhccCCCCCcccccCCCCH
Confidence            2233457899999999974   3334 578999999999995533 2221                   1     12467


Q ss_pred             HHHHHHHHhcCCCCCCCCCHHhhhcCcc
Q 014609          223 GAQNLLRKILEPNPVKRITIAGIKADEW  250 (421)
Q Consensus       223 ~~~~li~~~L~~dP~~R~t~~eil~~~w  250 (421)
                      .+.++|.+||..+|++|||++++++|||
T Consensus       240 ~~~~li~~~l~~~P~~R~~~~~ll~~~~  267 (267)
T cd06645         240 SFHHFVKMALTKNPKKRPTAEKLLQHPF  267 (267)
T ss_pred             HHHHHHHHHccCCchhCcCHHHHhcCCC
Confidence            8999999999999999999999999999

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=3e-41  Score=319.46  Aligned_cols=236  Identities=34%  Similarity=0.542  Sum_probs=202.6

Q ss_pred             ceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccc------hhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCE
Q 014609           15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIH------LKITDQIKREIATLKLLKHPNVVRLHEVLASKSK   88 (421)
Q Consensus        15 ~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~------~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~   88 (421)
                      +|.+++.||+|+||.||+|.+..+++.+|+|.+.......      ....+.+.+|+.++++++||||+++++++.....
T Consensus         1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   80 (267)
T cd06628           1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH   80 (267)
T ss_pred             CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence            5889999999999999999998899999999887543321      1234678899999999999999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCcccc
Q 014609           89 IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFR  168 (421)
Q Consensus        89 ~~lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~~  168 (421)
                      .+++|||+++++|.+++...+.+++..+..++.|++.||+|||+.|++||||+|+||+++.++.++|+|||++.......
T Consensus        81 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~~~~~~l~dfg~~~~~~~~~  160 (267)
T cd06628          81 LNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANS  160 (267)
T ss_pred             cEEEEEecCCCCHHHHHHhccCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcCCCCEEecccCCCccccccc
Confidence            99999999999999999888889999999999999999999999999999999999999999999999999987554211


Q ss_pred             C----CCccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhhc-CCcC--------------------CCCCCCHH
Q 014609          169 D----DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIFR-GDFK--------------------LPKWLSPG  223 (421)
Q Consensus       169 ~----~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~~-~~~~--------------------~p~~~s~~  223 (421)
                      .    ........|++.|+|||.+.+..+ +.++|+||+||++|.+. |..+                    .|..++..
T Consensus       161 ~~~~~~~~~~~~~~~~~y~~pe~~~~~~~-~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (267)
T cd06628         161 LSTKTNGARPSLQGSVFWMAPEVVKQTSY-TRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGENASPEIPSNISSE  239 (267)
T ss_pred             ccCCccccccccCCCcCccChhHhccCCC-CchhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHHhccCCCcCCcccCHH
Confidence            1    111234568899999999987776 48899999999999543 3322                    23447889


Q ss_pred             HHHHHHHhcCCCCCCCCCHHhhhcCccc
Q 014609          224 AQNLLRKILEPNPVKRITIAGIKADEWF  251 (421)
Q Consensus       224 ~~~li~~~L~~dP~~R~t~~eil~~~w~  251 (421)
                      +.++|++||++||.+||++.++++||||
T Consensus       240 ~~~li~~~l~~~p~~Rp~~~~il~~~~~  267 (267)
T cd06628         240 AIDFLEKTFEIDHNKRPTAAELLKHPFL  267 (267)
T ss_pred             HHHHHHHHccCCchhCcCHHHHhhCCCC
Confidence            9999999999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=1.9e-41  Score=327.69  Aligned_cols=231  Identities=25%  Similarity=0.371  Sum_probs=190.3

Q ss_pred             ecceEEeceEeecCcEEEEEEEECC----------------CCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCc
Q 014609           13 LGRYELGRTLGEGNFGKVKFAQDLD----------------SGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNV   76 (421)
Q Consensus        13 ~~~y~i~~~LG~G~~g~V~~a~~~~----------------~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnI   76 (421)
                      -++|++.+.||+|+||.||+|.+..                ++..||+|++....  .......+.+|+.++++++||||
T Consensus         4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~ni   81 (304)
T cd05096           4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDA--NKNARNDFLKEVKILSRLKDPNI   81 (304)
T ss_pred             hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCC--CHHHHHHHHHHHHHHhhcCCCCe
Confidence            4689999999999999999997532                34579999987542  22335678999999999999999


Q ss_pred             ceEEEEEEeCCEEEEEEeccCCCChHHHHHhcC-------------------CCCHHHHHHHHHHHHHHHHHHHhCCcee
Q 014609           77 VRLHEVLASKSKIYMVLEYVTGGELFDKIASKG-------------------RLQEAEGRKLFQQLIDGVSYCHNKGVFH  137 (421)
Q Consensus        77 v~l~~~~~~~~~~~lv~E~~~gg~L~~~i~~~~-------------------~~~~~~~~~~~~ql~~aL~~LH~~gi~H  137 (421)
                      +++++++.+.+..|+||||+++++|.+++....                   .+++..+..++.||+.||+|||+.||+|
T Consensus        82 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~ivH  161 (304)
T cd05096          82 IRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVH  161 (304)
T ss_pred             eEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCccc
Confidence            999999999999999999999999999886431                   3677888999999999999999999999


Q ss_pred             ccCCCCCEEeccCCCEEEEeccCCCCCccccCCCccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhhc---CCc
Q 014609          138 RDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIFR---GDF  214 (421)
Q Consensus       138 rDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~~---~~~  214 (421)
                      |||||+|||++.++.+||+|||++................+++.|+|||++....+ +.++|||||||++|.+.   +..
T Consensus       162 ~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~~l~el~~~~~~~  240 (304)
T cd05096         162 RDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKF-TTASDVWAFGVTLWEILMLCKEQ  240 (304)
T ss_pred             cCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCC-CchhhhHHHHHHHHHHHHccCCC
Confidence            99999999999999999999999875432111112233456788999999887766 58999999999999643   222


Q ss_pred             CC---------------------------CCCCCHHHHHHHHHhcCCCCCCCCCHHhhh
Q 014609          215 KL---------------------------PKWLSPGAQNLLRKILEPNPVKRITIAGIK  246 (421)
Q Consensus       215 ~~---------------------------p~~~s~~~~~li~~~L~~dP~~R~t~~eil  246 (421)
                      ++                           |+.++..+.+++.+||+.||.+|||+.+|.
T Consensus       241 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~  299 (304)
T cd05096         241 PYGELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIH  299 (304)
T ss_pred             CCCcCCHHHHHHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHH
Confidence            21                           234678899999999999999999999984

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=3.2e-41  Score=325.44  Aligned_cols=239  Identities=27%  Similarity=0.479  Sum_probs=205.3

Q ss_pred             CeeecceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEE
Q 014609           10 GMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKI   89 (421)
Q Consensus        10 ~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~   89 (421)
                      +...++|++++.||+|+||.||+|.+..+++.||+|.+.....   ...+.+.+|+.+++.++||||+++++++...+..
T Consensus        15 ~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~   91 (297)
T cd06656          15 GDPKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQ---PKKELIINEILVMRENKNPNIVNYLDSYLVGDEL   91 (297)
T ss_pred             CChhhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCcc---chHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEE
Confidence            4455899999999999999999999999999999999875432   2246788999999999999999999999999999


Q ss_pred             EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCccccC
Q 014609           90 YMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD  169 (421)
Q Consensus        90 ~lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~  169 (421)
                      |+||||++|++|.+++.. ..+++..+..++.|++.||.|||+.|++||||||+|||++.++.++|+|||++.....  .
T Consensus        92 ~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~--~  168 (297)
T cd06656          92 WVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP--E  168 (297)
T ss_pred             EEeecccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEECcCccceEccC--C
Confidence            999999999999998865 5689999999999999999999999999999999999999999999999999875432  1


Q ss_pred             CCccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhh-cCCcC----------------------CCCCCCHHHHH
Q 014609          170 DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIF-RGDFK----------------------LPKWLSPGAQN  226 (421)
Q Consensus       170 ~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~-~~~~~----------------------~p~~~s~~~~~  226 (421)
                      ........+++.|+|||.+.+..+ +.++|+||+||++|.+ .|..+                      .|..+++.+.+
T Consensus       169 ~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (297)
T cd06656         169 QSKRSTMVGTPYWMAPEVVTRKAY-GPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPERLSAVFRD  247 (297)
T ss_pred             ccCcCcccCCccccCHHHHcCCCC-CcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeeccCCCCCCCCccccCHHHHH
Confidence            222334578999999999987766 5889999999999943 22222                      12346788999


Q ss_pred             HHHHhcCCCCCCCCCHHhhhcCccccccc
Q 014609          227 LLRKILEPNPVKRITIAGIKADEWFEQDY  255 (421)
Q Consensus       227 li~~~L~~dP~~R~t~~eil~~~w~~~~~  255 (421)
                      ++.+||..+|.+||++.+++.||||....
T Consensus       248 li~~~l~~~p~~Rps~~~il~~~~~~~~~  276 (297)
T cd06656         248 FLNRCLEMDVDRRGSAKELLQHPFLKLAK  276 (297)
T ss_pred             HHHHHccCChhhCcCHHHHhcCchhcccc
Confidence            99999999999999999999999998644

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=2.5e-41  Score=322.97  Aligned_cols=235  Identities=32%  Similarity=0.508  Sum_probs=200.9

Q ss_pred             ceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEEe
Q 014609           15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLE   94 (421)
Q Consensus        15 ~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E   94 (421)
                      +|++.+.||+|+||.||+|.+..+|+.||+|++...... ......+.+|+.++++++||||+++++++......|+|+|
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~-~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e   79 (286)
T cd07832           1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLE-GGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVME   79 (286)
T ss_pred             CceEEeecccCCCcEEEEEEECCCCceEEEEEEEccccc-chhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEec
Confidence            699999999999999999999999999999999765432 2335678999999999999999999999999999999999


Q ss_pred             ccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCccccCCCcc
Q 014609           95 YVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLL  173 (421)
Q Consensus        95 ~~~gg~L~~~i~~-~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~  173 (421)
                      |+ +++|.+.+.. ...+++..++.++.|++.||+|||+.|++|+||||+||+++.++.++|+|||++....... ....
T Consensus        80 ~~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~-~~~~  157 (286)
T cd07832          80 YM-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEE-PRLY  157 (286)
T ss_pred             cc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCC-CCcc
Confidence            99 9999998864 4568999999999999999999999999999999999999999999999999988654321 1223


Q ss_pred             ccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhhcCCcC-CC-----------------------------------
Q 014609          174 HTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIFRGDFK-LP-----------------------------------  217 (421)
Q Consensus       174 ~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~~~~~~-~p-----------------------------------  217 (421)
                      ....|+..|+|||++.+....+.++||||+||++|.+..+.+ ++                                   
T Consensus       158 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (286)
T cd07832         158 SHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYNKI  237 (286)
T ss_pred             ccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcchhhcc
Confidence            445789999999998765555689999999999996543221 10                                   


Q ss_pred             --------------CCCCHHHHHHHHHhcCCCCCCCCCHHhhhcCcccc
Q 014609          218 --------------KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFE  252 (421)
Q Consensus       218 --------------~~~s~~~~~li~~~L~~dP~~R~t~~eil~~~w~~  252 (421)
                                    +..+..+.++|.+||+++|.+|||+++++.||||.
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h~~~~  286 (286)
T cd07832         238 TFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYFT  286 (286)
T ss_pred             cCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhCcCcC
Confidence                          12467888999999999999999999999999984

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=4.7e-42  Score=353.15  Aligned_cols=233  Identities=33%  Similarity=0.569  Sum_probs=195.1

Q ss_pred             ceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCC-CCCcceEEEE-EEe---C---
Q 014609           15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK-HPNVVRLHEV-LAS---K---   86 (421)
Q Consensus        15 ~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~-~~~---~---   86 (421)
                      +++|.+.|.+|||+.||+|.+...|..||+|.+-..   +....+.+.+||++|++|+ |+|||.+++. ...   +   
T Consensus        38 ~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~---de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~  114 (738)
T KOG1989|consen   38 RVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN---DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGV  114 (738)
T ss_pred             EEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC---CHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCce
Confidence            567899999999999999999888899999987543   5556788999999999997 9999999993 221   1   


Q ss_pred             CEEEEEEeccCCCChHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCC--ceeccCCCCCEEeccCCCEEEEeccCCC
Q 014609           87 SKIYMVLEYVTGGELFDKIAS--KGRLQEAEGRKLFQQLIDGVSYCHNKG--VFHRDLKLENILLDSKGNIKISDFGLSA  162 (421)
Q Consensus        87 ~~~~lv~E~~~gg~L~~~i~~--~~~~~~~~~~~~~~ql~~aL~~LH~~g--i~HrDlkp~NILl~~~~~~kL~DFGla~  162 (421)
                      -.+++.||||.||.|-|+++.  ..+|++.++++||.|+++||++||...  |||||||-|||||+.+|+.||||||.|+
T Consensus       115 ~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g~~KLCDFGSat  194 (738)
T KOG1989|consen  115 WEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADGNYKLCDFGSAT  194 (738)
T ss_pred             eEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCCCEEeCcccccc
Confidence            257899999999999999984  456999999999999999999999997  9999999999999999999999999998


Q ss_pred             CCccccC--CCc-----cccccCCCCccChhhhc--ccCCCCCcchHHHHHHHHh----------------hhcCCcCCC
Q 014609          163 LPQHFRD--DGL-----LHTTCGSPNYVAPEVLA--NRGYDGATSDIWSCGVILY----------------IFRGDFKLP  217 (421)
Q Consensus       163 ~~~~~~~--~~~-----~~~~~gt~~y~APEvl~--~~~~~~~~~DiwSlGvil~----------------~~~~~~~~p  217 (421)
                      -......  .+.     --....|+-|+|||++.  +....+.|+|||+|||+||                |+.|.+.+|
T Consensus       195 t~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~laIlng~Y~~P  274 (738)
T KOG1989|consen  195 TKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKLAILNGNYSFP  274 (738)
T ss_pred             cccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcceeEEeccccCC
Confidence            4322110  000     01235799999999863  3445579999999999999                566777777


Q ss_pred             C--CCCHHHHHHHHHhcCCCCCCCCCHHhhhcCcc
Q 014609          218 K--WLSPGAQNLLRKILEPNPVKRITIAGIKADEW  250 (421)
Q Consensus       218 ~--~~s~~~~~li~~~L~~dP~~R~t~~eil~~~w  250 (421)
                      +  .++..+.+||+.||++||.+||++.|++.+-+
T Consensus       275 ~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~  309 (738)
T KOG1989|consen  275 PFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIF  309 (738)
T ss_pred             CCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHH
Confidence            6  58999999999999999999999999887644

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=100.00  E-value=3.1e-41  Score=323.77  Aligned_cols=235  Identities=30%  Similarity=0.490  Sum_probs=195.5

Q ss_pred             eecceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEE
Q 014609           12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYM   91 (421)
Q Consensus        12 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l   91 (421)
                      .+++|++.+.||+|++|.||+|.+..+++.||+|.+.......  ....+.+|+.+++.++||||+++++++.+.+..|+
T Consensus         3 ~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~--~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l   80 (291)
T cd07844           3 KLETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEG--APFTAIREASLLKDLKHANIVTLHDIIHTKKTLTL   80 (291)
T ss_pred             CccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccC--CchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEE
Confidence            4689999999999999999999998899999999987543221  12456789999999999999999999999999999


Q ss_pred             EEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCccccCC
Q 014609           92 VLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD  170 (421)
Q Consensus        92 v~E~~~gg~L~~~i~~~-~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~  170 (421)
                      ||||+.+ +|.+++... ..+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||++......  .
T Consensus        81 v~e~~~~-~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~--~  157 (291)
T cd07844          81 VFEYLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLARAKSVP--S  157 (291)
T ss_pred             EEecCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcCCCCEEECccccccccCCC--C
Confidence            9999975 898888653 46899999999999999999999999999999999999999999999999998743221  1


Q ss_pred             CccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhhc-CCcCCC--------------------------------
Q 014609          171 GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIFR-GDFKLP--------------------------------  217 (421)
Q Consensus       171 ~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~~-~~~~~p--------------------------------  217 (421)
                      .......+++.|+|||++.+....+.++||||+||++|.+. |..+++                                
T Consensus       158 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (291)
T cd07844         158 KTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPE  237 (291)
T ss_pred             ccccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhccc
Confidence            11223356889999999876443468899999999999543 332221                                


Q ss_pred             ------------------CCCC--HHHHHHHHHhcCCCCCCCCCHHhhhcCccc
Q 014609          218 ------------------KWLS--PGAQNLLRKILEPNPVKRITIAGIKADEWF  251 (421)
Q Consensus       218 ------------------~~~s--~~~~~li~~~L~~dP~~R~t~~eil~~~w~  251 (421)
                                        +.++  ..+.+++.+||+++|.+|||+.+++.||||
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~~~f  291 (291)
T cd07844         238 FKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPYF  291 (291)
T ss_pred             cccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence                              0123  777899999999999999999999999998

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=5.1e-41  Score=318.95  Aligned_cols=237  Identities=32%  Similarity=0.519  Sum_probs=200.1

Q ss_pred             ceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccc-------hhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCC
Q 014609           15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIH-------LKITDQIKREIATLKLLKHPNVVRLHEVLASKS   87 (421)
Q Consensus        15 ~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~-------~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~   87 (421)
                      +|.+.+.||.|+||.||+|.+..+|+.||+|.+.......       ....+.+.+|+.+++.++||||+++++++...+
T Consensus         2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   81 (272)
T cd06629           2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE   81 (272)
T ss_pred             ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence            6899999999999999999998899999999886432111       112456889999999999999999999999999


Q ss_pred             EEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCccc
Q 014609           88 KIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHF  167 (421)
Q Consensus        88 ~~~lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~  167 (421)
                      ..++||||++|++|.+.+...+.+++..++.++.|++.||.|||+.|++||||+|+||+++.++.++|+|||++......
T Consensus        82 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~  161 (272)
T cd06629          82 YLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGICKISDFGISKKSDDI  161 (272)
T ss_pred             ceEEEEecCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcCCCeEEEeecccccccccc
Confidence            99999999999999999988788999999999999999999999999999999999999999999999999998754332


Q ss_pred             cCCCccccccCCCCccChhhhcccC-CCCCcchHHHHHHHHhhh-cCCcCC---------------------CC----CC
Q 014609          168 RDDGLLHTTCGSPNYVAPEVLANRG-YDGATSDIWSCGVILYIF-RGDFKL---------------------PK----WL  220 (421)
Q Consensus       168 ~~~~~~~~~~gt~~y~APEvl~~~~-~~~~~~DiwSlGvil~~~-~~~~~~---------------------p~----~~  220 (421)
                      ..........|+..|+|||++.... ..+.++|+||||+++|.+ .|..++                     |.    .+
T Consensus       162 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (272)
T cd06629         162 YDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPIPPDVSMNL  241 (272)
T ss_pred             ccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhccccCCcCCccccccC
Confidence            2222234457889999999987654 235889999999999943 222221                     11    24


Q ss_pred             CHHHHHHHHHhcCCCCCCCCCHHhhhcCccc
Q 014609          221 SPGAQNLLRKILEPNPVKRITIAGIKADEWF  251 (421)
Q Consensus       221 s~~~~~li~~~L~~dP~~R~t~~eil~~~w~  251 (421)
                      +..+.++|.+||.++|.+|||++++++|||+
T Consensus       242 ~~~~~~li~~~l~~~p~~Rps~~~il~~~~~  272 (272)
T cd06629         242 SPVALDFLNACFTINPDNRPTARELLQHPFI  272 (272)
T ss_pred             CHHHHHHHHHHhcCChhhCCCHHHHhhCCCC
Confidence            7889999999999999999999999999996

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=100.00  E-value=4.9e-41  Score=317.30  Aligned_cols=236  Identities=30%  Similarity=0.495  Sum_probs=202.2

Q ss_pred             cceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEE
Q 014609           14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVL   93 (421)
Q Consensus        14 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~   93 (421)
                      ++|++++.||.|+||+||+|.+..++..+|+|++.......  ....+.+|+.+++.++||||+++++.+..+...|+||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~   78 (267)
T cd06610           1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQT--SVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVM   78 (267)
T ss_pred             CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcch--HHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEE
Confidence            47999999999999999999998899999999987544322  4578999999999999999999999999999999999


Q ss_pred             eccCCCChHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCccccCC
Q 014609           94 EYVTGGELFDKIASK---GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD  170 (421)
Q Consensus        94 E~~~gg~L~~~i~~~---~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~  170 (421)
                      |+++|++|.+.+...   ..+++..++.++.|++.||+|||++|++||||+|+||++++++.++|+|||++.........
T Consensus        79 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~~  158 (267)
T cd06610          79 PYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDR  158 (267)
T ss_pred             eccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCccc
Confidence            999999999998763   45899999999999999999999999999999999999999999999999998765432221


Q ss_pred             --CccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhh-cCCcCCC-------------------------CCCCH
Q 014609          171 --GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIF-RGDFKLP-------------------------KWLSP  222 (421)
Q Consensus       171 --~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~-~~~~~~p-------------------------~~~s~  222 (421)
                        .......|++.|+|||++......+.++|+|||||++|.+ .|..++.                         ..+++
T Consensus       159 ~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (267)
T cd06610         159 TRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDPPSLETGADYKKYSK  238 (267)
T ss_pred             cccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhcCCCCCcCCccccccccH
Confidence              1234457899999999987763346889999999999944 3333321                         13568


Q ss_pred             HHHHHHHHhcCCCCCCCCCHHhhhcCccc
Q 014609          223 GAQNLLRKILEPNPVKRITIAGIKADEWF  251 (421)
Q Consensus       223 ~~~~li~~~L~~dP~~R~t~~eil~~~w~  251 (421)
                      .+.+++.+||..||++|||+.+++.||||
T Consensus       239 ~~~~li~~~l~~~p~~Rp~~~~ll~~p~~  267 (267)
T cd06610         239 SFRKMISLCLQKDPSKRPTAEELLKHKFF  267 (267)
T ss_pred             HHHHHHHHHcCCChhhCcCHHHHhhCCCC
Confidence            89999999999999999999999999997

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=4.4e-41  Score=318.54  Aligned_cols=233  Identities=32%  Similarity=0.477  Sum_probs=198.5

Q ss_pred             eecceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEE
Q 014609           12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYM   91 (421)
Q Consensus        12 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l   91 (421)
                      ..++|++++.||+|+||.||+|.+..+++.||+|++.....   .....+.+|+.++++++||||+++++++..+...|+
T Consensus         7 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~---~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~i   83 (267)
T cd06646           7 PQHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPG---DDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWI   83 (267)
T ss_pred             chhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCcc---chHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEE
Confidence            34689999999999999999999999999999999865422   224568899999999999999999999999999999


Q ss_pred             EEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCccccCCC
Q 014609           92 VLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDG  171 (421)
Q Consensus        92 v~E~~~gg~L~~~i~~~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~  171 (421)
                      ||||+++++|.+.+....++++..+..++.|++.||+|||+.||+||||||+||+++.++.++|+|||++.....  ...
T Consensus        84 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~--~~~  161 (267)
T cd06646          84 CMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGVAAKITA--TIA  161 (267)
T ss_pred             EEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEECcCccceeecc--ccc
Confidence            999999999999998778899999999999999999999999999999999999999999999999999875432  111


Q ss_pred             ccccccCCCCccChhhhcc---cCCCCCcchHHHHHHHHhhhc-CCcCC-------------------C-----CCCCHH
Q 014609          172 LLHTTCGSPNYVAPEVLAN---RGYDGATSDIWSCGVILYIFR-GDFKL-------------------P-----KWLSPG  223 (421)
Q Consensus       172 ~~~~~~gt~~y~APEvl~~---~~~~~~~~DiwSlGvil~~~~-~~~~~-------------------p-----~~~s~~  223 (421)
                      ......|++.|+|||.+..   ..+ +.++|+||+||++|.+. |..++                   |     ..++..
T Consensus       162 ~~~~~~~~~~y~~PE~~~~~~~~~~-~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (267)
T cd06646         162 KRKSFIGTPYWMAPEVAAVEKNGGY-NQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPPKLKDKTKWSST  240 (267)
T ss_pred             ccCccccCccccCHhHcccccCCCC-cchhhHHHHHHHHHHHHhCCCCccccchhhhheeeecCCCCCCCCccccccCHH
Confidence            2234578899999998742   334 47899999999999542 22111                   1     125788


Q ss_pred             HHHHHHHhcCCCCCCCCCHHhhhcCcc
Q 014609          224 AQNLLRKILEPNPVKRITIAGIKADEW  250 (421)
Q Consensus       224 ~~~li~~~L~~dP~~R~t~~eil~~~w  250 (421)
                      +.++|++||..+|++|||++++++|+|
T Consensus       241 ~~~li~~~l~~~P~~Rp~~~~il~~l~  267 (267)
T cd06646         241 FHNFVKISLTKNPKKRPTAERLLTHLF  267 (267)
T ss_pred             HHHHHHHHhhCChhhCcCHHHHhcCCC
Confidence            999999999999999999999999998

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-42  Score=319.60  Aligned_cols=237  Identities=31%  Similarity=0.608  Sum_probs=203.4

Q ss_pred             ceEE-eceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCC-CCCcceEEEEEEeCCEEEEE
Q 014609           15 RYEL-GRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK-HPNVVRLHEVLASKSKIYMV   92 (421)
Q Consensus        15 ~y~i-~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~lv   92 (421)
                      -|++ .+.||+|+|+.|-.++...+|..+|||++++..   .....++.+|++++...+ |+||++++++|+++++.|+|
T Consensus        78 ~YkLt~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~---gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLV  154 (463)
T KOG0607|consen   78 MYKLTSELLGEGAYASVQTCVSIQTGKEYAVKIIDKQP---GHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLV  154 (463)
T ss_pred             HHHhHHHHhcCccceeeeeeeeeccchhhhhhhhhcCC---chHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEE
Confidence            3555 578999999999999999999999999998863   223578999999999996 99999999999999999999


Q ss_pred             EeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCC---EEEEeccCCCCCcccc-
Q 014609           93 LEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGN---IKISDFGLSALPQHFR-  168 (421)
Q Consensus        93 ~E~~~gg~L~~~i~~~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~---~kL~DFGla~~~~~~~-  168 (421)
                      ||-+.||.|...|..+..+++.+|.++.+.|+.||+|||.+||.|||+||+|||....+.   +|||||.+..-..... 
T Consensus       155 fEKm~GGplLshI~~~~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~  234 (463)
T KOG0607|consen  155 FEKMRGGPLLSHIQKRKHFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNND  234 (463)
T ss_pred             EecccCchHHHHHHHhhhccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeeccccccccccCCC
Confidence            999999999999999999999999999999999999999999999999999999976654   7999999986432211 


Q ss_pred             ----CCCccccccCCCCccChhhhc----ccCCCCCcchHHHHHHHHhhhc-----------------------------
Q 014609          169 ----DDGLLHTTCGSPNYVAPEVLA----NRGYDGATSDIWSCGVILYIFR-----------------------------  211 (421)
Q Consensus       169 ----~~~~~~~~~gt~~y~APEvl~----~~~~~~~~~DiwSlGvil~~~~-----------------------------  211 (421)
                          ....+.+.||+..|||||+..    ...++..+.|.||||||||++.                             
T Consensus       235 ~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~L  314 (463)
T KOG0607|consen  235 CSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKL  314 (463)
T ss_pred             CCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHHH
Confidence                123455779999999999863    2333358899999999999554                             


Q ss_pred             ------CCcCCCC--C--CCHHHHHHHHHhcCCCCCCCCCHHhhhcCcccccc
Q 014609          212 ------GDFKLPK--W--LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD  254 (421)
Q Consensus       212 ------~~~~~p~--~--~s~~~~~li~~~L~~dP~~R~t~~eil~~~w~~~~  254 (421)
                            |.+.+|.  |  +|.++.++|+.+|..|+.+|.++.++++|||++..
T Consensus       315 FesIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnhPw~~~~  367 (463)
T KOG0607|consen  315 FESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNHPWVQRC  367 (463)
T ss_pred             HHHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCCcccccc
Confidence                  3445553  2  89999999999999999999999999999999864

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=2.3e-41  Score=330.80  Aligned_cols=234  Identities=22%  Similarity=0.392  Sum_probs=193.4

Q ss_pred             EeceEeec--CcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEEec
Q 014609           18 LGRTLGEG--NFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLEY   95 (421)
Q Consensus        18 i~~~LG~G--~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E~   95 (421)
                      ++++||+|  +|++||++.+..+|+.||+|.++..... ....+.+.+|+.+++.++||||+++++++..++..|+||||
T Consensus         2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~   80 (327)
T cd08227           2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACT-NEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSF   80 (327)
T ss_pred             hhhhccccccceEEEEEEeecccCcEEEEEEechhhcc-HHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEec
Confidence            57889999  7899999999999999999999765432 23456788999999999999999999999999999999999


Q ss_pred             cCCCChHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCccccC----
Q 014609           96 VTGGELFDKIAS--KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD----  169 (421)
Q Consensus        96 ~~gg~L~~~i~~--~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~----  169 (421)
                      +++++|.+++..  ...+++..++.++.|++.||+|||++||+||||||+|||++.++.++++||+.+........    
T Consensus        81 ~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~~~  160 (327)
T cd08227          81 MAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLRV  160 (327)
T ss_pred             cCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecCCcEEEcccchhhccccccccccc
Confidence            999999999864  34589999999999999999999999999999999999999999999999986543211111    


Q ss_pred             -CCccccccCCCCccChhhhccc--CCCCCcchHHHHHHHHhhh-cCCcCCC----------------------------
Q 014609          170 -DGLLHTTCGSPNYVAPEVLANR--GYDGATSDIWSCGVILYIF-RGDFKLP----------------------------  217 (421)
Q Consensus       170 -~~~~~~~~gt~~y~APEvl~~~--~~~~~~~DiwSlGvil~~~-~~~~~~p----------------------------  217 (421)
                       ........++..|+|||++.+.  .| +.++||||+||++|.+ .|..++.                            
T Consensus       161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~-~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (327)
T cd08227         161 VHDFPKYSVKVLPWLSPEVLQQNLQGY-DAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTIPAE  239 (327)
T ss_pred             cccccccccceecccChHHhhcccCCC-CchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccccchhhh
Confidence             0111233567889999998753  45 5889999999999944 2332221                            


Q ss_pred             -------------------------------------CCCCHHHHHHHHHhcCCCCCCCCCHHhhhcCccccc
Q 014609          218 -------------------------------------KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQ  253 (421)
Q Consensus       218 -------------------------------------~~~s~~~~~li~~~L~~dP~~R~t~~eil~~~w~~~  253 (421)
                                                           ..+++.+.++|.+||+.||++|||++++++||||++
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~f~~  312 (327)
T cd08227         240 ELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQ  312 (327)
T ss_pred             hcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcChhhhh
Confidence                                                 013568889999999999999999999999999975

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=3.4e-41  Score=319.92  Aligned_cols=231  Identities=29%  Similarity=0.476  Sum_probs=196.1

Q ss_pred             cceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcC-CCCCcceEEEEEEeC------
Q 014609           14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEVLASK------   86 (421)
Q Consensus        14 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~------   86 (421)
                      |+|++.+.||+|+||.||+|.+..+++.||+|.+....    .....+.+|+.+++++ +||||+++++++...      
T Consensus         6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~----~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~   81 (272)
T cd06637           6 GIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG----DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD   81 (272)
T ss_pred             hhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC----ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCC
Confidence            67999999999999999999999999999999987542    1245788999999998 699999999998653      


Q ss_pred             CEEEEEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCC
Q 014609           87 SKIYMVLEYVTGGELFDKIASK--GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALP  164 (421)
Q Consensus        87 ~~~~lv~E~~~gg~L~~~i~~~--~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~  164 (421)
                      ..+|++|||+++++|.+.+...  ..+++..+..++.|++.||+|||+++|+||||||+||+++.++.++|+|||++...
T Consensus        82 ~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~~~~~~l~Dfg~~~~~  161 (272)
T cd06637          82 DQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQL  161 (272)
T ss_pred             cEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECCCCCEEEccCCCceec
Confidence            4689999999999999988763  46899999999999999999999999999999999999999999999999998754


Q ss_pred             ccccCCCccccccCCCCccChhhhcc-----cCCCCCcchHHHHHHHHhhhc-CCcCC---------------------C
Q 014609          165 QHFRDDGLLHTTCGSPNYVAPEVLAN-----RGYDGATSDIWSCGVILYIFR-GDFKL---------------------P  217 (421)
Q Consensus       165 ~~~~~~~~~~~~~gt~~y~APEvl~~-----~~~~~~~~DiwSlGvil~~~~-~~~~~---------------------p  217 (421)
                      ..  .........|++.|+|||++..     ..+ +.++|+||+||++|.+. |..++                     +
T Consensus       162 ~~--~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~-~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~  238 (272)
T cd06637         162 DR--TVGRRNTFIGTPYWMAPEVIACDENPDATY-DFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRLKS  238 (272)
T ss_pred             cc--ccccCCcccccccccCHhHhccccCcCCCC-CchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhcCCCCCCCC
Confidence            32  1223345679999999999863     234 47899999999999543 43332                     1


Q ss_pred             CCCCHHHHHHHHHhcCCCCCCCCCHHhhhcCccc
Q 014609          218 KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWF  251 (421)
Q Consensus       218 ~~~s~~~~~li~~~L~~dP~~R~t~~eil~~~w~  251 (421)
                      ..++..+.+|+.+||..||.+|||+.+++.||||
T Consensus       239 ~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~~  272 (272)
T cd06637         239 KKWSKKFQSFIESCLVKNHSQRPTTEQLMKHPFI  272 (272)
T ss_pred             CCcCHHHHHHHHHHcCCChhhCCCHHHHhhCCCC
Confidence            2357899999999999999999999999999997

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.1e-41  Score=323.13  Aligned_cols=236  Identities=32%  Similarity=0.481  Sum_probs=201.4

Q ss_pred             ecceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEE
Q 014609           13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMV   92 (421)
Q Consensus        13 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv   92 (421)
                      -++|++++.||.|+||.||+|.+..+++.+|+|.+...   .....+.+.+|+.++++++||||+++++++..+...|+|
T Consensus         4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   80 (280)
T cd06611           4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIE---SEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWIL   80 (280)
T ss_pred             hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeC---CHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEE
Confidence            35799999999999999999999889999999998643   233456788999999999999999999999999999999


Q ss_pred             EeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCccccCCC
Q 014609           93 LEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDG  171 (421)
Q Consensus        93 ~E~~~gg~L~~~i~~-~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~  171 (421)
                      |||+++++|.+++.. ...+++..++.++.|++.||.|||++||+||||||+||+++.++.++|+|||++......  ..
T Consensus        81 ~e~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~--~~  158 (280)
T cd06611          81 IEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKST--LQ  158 (280)
T ss_pred             eeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECCCCCEEEccCccchhhccc--cc
Confidence            999999999998876 356999999999999999999999999999999999999999999999999998754321  12


Q ss_pred             ccccccCCCCccChhhhcc-----cCCCCCcchHHHHHHHHhhhc-CCcC----------------------CCCCCCHH
Q 014609          172 LLHTTCGSPNYVAPEVLAN-----RGYDGATSDIWSCGVILYIFR-GDFK----------------------LPKWLSPG  223 (421)
Q Consensus       172 ~~~~~~gt~~y~APEvl~~-----~~~~~~~~DiwSlGvil~~~~-~~~~----------------------~p~~~s~~  223 (421)
                      ......+++.|+|||++..     ..+ +.++|+||+||++|.+. |..+                      .|..++.+
T Consensus       159 ~~~~~~~~~~y~~PE~~~~~~~~~~~~-~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (280)
T cd06611         159 KRDTFIGTPYWMAPEVVACETFKDNPY-DYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSEPPTLDQPSKWSSS  237 (280)
T ss_pred             ccceeecchhhcCHHHHhhcccCCCCC-CccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHhcCCCCCcCCcccCCHH
Confidence            2334578999999999753     223 46899999999999443 2221                      23446789


Q ss_pred             HHHHHHHhcCCCCCCCCCHHhhhcCcccccc
Q 014609          224 AQNLLRKILEPNPVKRITIAGIKADEWFEQD  254 (421)
Q Consensus       224 ~~~li~~~L~~dP~~R~t~~eil~~~w~~~~  254 (421)
                      +.++|.+||+.+|.+||++.++++||||.+.
T Consensus       238 ~~~li~~~l~~~p~~Rps~~~il~~~~~~~~  268 (280)
T cd06611         238 FNDFLKSCLVKDPDDRPTAAELLKHPFVSDQ  268 (280)
T ss_pred             HHHHHHHHhccChhhCcCHHHHhcChhhccc
Confidence            9999999999999999999999999999864

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=4.6e-41  Score=324.24  Aligned_cols=238  Identities=29%  Similarity=0.499  Sum_probs=204.8

Q ss_pred             CeeecceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEE
Q 014609           10 GMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKI   89 (421)
Q Consensus        10 ~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~   89 (421)
                      +....+|++.+.||.|+||.||+|.+..+|+.||+|.+.....   ...+.+.+|+.+++.++||||+++++++.....+
T Consensus        15 ~~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~   91 (296)
T cd06655          15 GDPKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQ---PKKELIINEILVMKELKNPNIVNFLDSFLVGDEL   91 (296)
T ss_pred             CCCcceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccC---chHHHHHHHHHHHHhcCCCceeeeeeeEecCceE
Confidence            4455679999999999999999999999999999999875432   2356788999999999999999999999999999


Q ss_pred             EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCccccC
Q 014609           90 YMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD  169 (421)
Q Consensus        90 ~lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~  169 (421)
                      |+|+||+++++|.+.+.. ..+++..+..++.|++.||+|||++|++||||||+||+++.++.+||+|||++......  
T Consensus        92 ~lv~e~~~~~~L~~~~~~-~~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~--  168 (296)
T cd06655          92 FVVMEYLAGGSLTDVVTE-TCMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPE--  168 (296)
T ss_pred             EEEEEecCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccchhcccc--
Confidence            999999999999988865 56899999999999999999999999999999999999999999999999998754331  


Q ss_pred             CCccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhh-cCCcC----------------------CCCCCCHHHHH
Q 014609          170 DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIF-RGDFK----------------------LPKWLSPGAQN  226 (421)
Q Consensus       170 ~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~-~~~~~----------------------~p~~~s~~~~~  226 (421)
                      .......++++.|+|||.+.+..+ +.++|+|||||++|.+ .|..+                      .|..+++.+.+
T Consensus       169 ~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (296)
T cd06655         169 QSKRSTMVGTPYWMAPEVVTRKAY-GPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSPIFRD  247 (296)
T ss_pred             cccCCCcCCCccccCcchhcCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCcccCCcccCCHHHHH
Confidence            122334578999999999887766 5889999999999943 23222                      23346788999


Q ss_pred             HHHHhcCCCCCCCCCHHhhhcCcccccc
Q 014609          227 LLRKILEPNPVKRITIAGIKADEWFEQD  254 (421)
Q Consensus       227 li~~~L~~dP~~R~t~~eil~~~w~~~~  254 (421)
                      +|++||..||.+|||+.+++.||||+..
T Consensus       248 li~~~l~~dp~~Rpt~~~il~~~~~~~~  275 (296)
T cd06655         248 FLNRCLEMDVEKRGSAKELLQHPFLKLA  275 (296)
T ss_pred             HHHHHhhcChhhCCCHHHHhhChHhhhc
Confidence            9999999999999999999999999853

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=100.00  E-value=5.7e-41  Score=325.14  Aligned_cols=242  Identities=32%  Similarity=0.473  Sum_probs=199.2

Q ss_pred             eecceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeC--CEE
Q 014609           12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASK--SKI   89 (421)
Q Consensus        12 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~--~~~   89 (421)
                      .+++|++.+.||+|+||.||+|.+..+|+.||+|.+....... .....+.+|+.++++++||||+++++++...  +.+
T Consensus         5 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   83 (309)
T cd07845           5 SVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERD-GIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSI   83 (309)
T ss_pred             cccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCC-CCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeE
Confidence            5689999999999999999999999999999999987543221 2233567899999999999999999998765  578


Q ss_pred             EEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCcccc
Q 014609           90 YMVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFR  168 (421)
Q Consensus        90 ~lv~E~~~gg~L~~~i~~-~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~~  168 (421)
                      |+||||+.+ +|.+.+.. ...+++..+..++.|++.||+|||+.|++||||||+||+++.++.+||+|||++.......
T Consensus        84 ~lv~e~~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~~  162 (309)
T cd07845          84 FLVMEYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPA  162 (309)
T ss_pred             EEEEecCCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccceeeecCCcc
Confidence            999999964 78777765 3678999999999999999999999999999999999999999999999999998554311


Q ss_pred             CCCccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhhc-CCcCCC------------------------------
Q 014609          169 DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIFR-GDFKLP------------------------------  217 (421)
Q Consensus       169 ~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~~-~~~~~p------------------------------  217 (421)
                        .......+++.|+|||++.+....+.++|+||+||++|.+. |..+++                              
T Consensus       163 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (309)
T cd07845         163 --KPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLP  240 (309)
T ss_pred             --CCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhccc
Confidence              12223345788999999876444468899999999999543 322211                              


Q ss_pred             -------------------CCCCHHHHHHHHHhcCCCCCCCCCHHhhhcCccccccccC
Q 014609          218 -------------------KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTP  257 (421)
Q Consensus       218 -------------------~~~s~~~~~li~~~L~~dP~~R~t~~eil~~~w~~~~~~~  257 (421)
                                         .+.++.+.++|.+||++||.+|||+.+++.||||+....+
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f~~~~~~  299 (309)
T cd07845         241 LVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKEKPLP  299 (309)
T ss_pred             ccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcChhhccCCCC
Confidence                               1257888999999999999999999999999999875544

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=4.3e-41  Score=326.69  Aligned_cols=227  Identities=32%  Similarity=0.474  Sum_probs=182.1

Q ss_pred             eceEeecCcEEEEEEEECC--CCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEE--eCCEEEEEEe
Q 014609           19 GRTLGEGNFGKVKFAQDLD--SGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLA--SKSKIYMVLE   94 (421)
Q Consensus        19 ~~~LG~G~~g~V~~a~~~~--~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~--~~~~~~lv~E   94 (421)
                      +.+||+|+||+||+|++..  ++..||+|.+.....     ...+.+|+.+++.++||||+++++++.  .+...|+|||
T Consensus         6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e   80 (317)
T cd07867           6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGI-----SMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFD   80 (317)
T ss_pred             ceEeccCCCeeEEEEEecCCCccceEEEEEecCCCC-----cHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEe
Confidence            4689999999999998653  678999999865422     346788999999999999999999885  4567899999


Q ss_pred             ccCCCChHHHHHh---------cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEe----ccCCCEEEEeccCC
Q 014609           95 YVTGGELFDKIAS---------KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILL----DSKGNIKISDFGLS  161 (421)
Q Consensus        95 ~~~gg~L~~~i~~---------~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl----~~~~~~kL~DFGla  161 (421)
                      |+. ++|.+.+..         ...+++..++.++.||+.||+|||+.||+||||||+|||+    +.++.+||+|||++
T Consensus        81 ~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a  159 (317)
T cd07867          81 YAE-HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFA  159 (317)
T ss_pred             eeC-CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeeccce
Confidence            995 578777642         1248899999999999999999999999999999999999    45678999999999


Q ss_pred             CCCccccC-CCccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhh-cCCcCCC----------------------
Q 014609          162 ALPQHFRD-DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIF-RGDFKLP----------------------  217 (421)
Q Consensus       162 ~~~~~~~~-~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~-~~~~~~p----------------------  217 (421)
                      ........ ........||+.|+|||++.+....+.++||||+||++|.+ .|..++.                      
T Consensus       160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~  239 (317)
T cd07867         160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFS  239 (317)
T ss_pred             eccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHHHH
Confidence            86533211 11234457899999999987755446889999999999944 3332210                      


Q ss_pred             --------------------------------------------CCCCHHHHHHHHHhcCCCCCCCCCHHhhhcCccc
Q 014609          218 --------------------------------------------KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWF  251 (421)
Q Consensus       218 --------------------------------------------~~~s~~~~~li~~~L~~dP~~R~t~~eil~~~w~  251 (421)
                                                                  ...+..+.+||.+||+.||.+|||++|+++||||
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~hp~f  317 (317)
T cd07867         240 VMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQDPYF  317 (317)
T ss_pred             hcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence                                                        0013457789999999999999999999999997

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=100.00  E-value=2.1e-41  Score=319.08  Aligned_cols=233  Identities=33%  Similarity=0.582  Sum_probs=206.2

Q ss_pred             ceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEEe
Q 014609           15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLE   94 (421)
Q Consensus        15 ~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E   94 (421)
                      +|++.+.||.|+||.||+|.+..+++.||+|++.+.........+.+.+|++++++++||||+++++++.+....|+|+|
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   80 (258)
T cd05578           1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD   80 (258)
T ss_pred             CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence            59999999999999999999999999999999987655444456789999999999999999999999999999999999


Q ss_pred             ccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCccccCCCccc
Q 014609           95 YVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLH  174 (421)
Q Consensus        95 ~~~gg~L~~~i~~~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~  174 (421)
                      |+.|++|.+.+....++++..+..++.|+++||.|||++|++|+||+|+||+++.++.++|+|||++.....   .....
T Consensus        81 ~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~---~~~~~  157 (258)
T cd05578          81 LLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTP---DTLTT  157 (258)
T ss_pred             CCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCCCCEEEeecccccccCC---Ccccc
Confidence            999999999998877899999999999999999999999999999999999999999999999999875433   22334


Q ss_pred             cccCCCCccChhhhcccCCCCCcchHHHHHHHHhhhc-CCc----------------------CCCCCCCHHHHHHHHHh
Q 014609          175 TTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIFR-GDF----------------------KLPKWLSPGAQNLLRKI  231 (421)
Q Consensus       175 ~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~~-~~~----------------------~~p~~~s~~~~~li~~~  231 (421)
                      ...|+..|+|||++....+ +.++|+||+|+++|.+. |..                      ..|..++..+.++|.+|
T Consensus       158 ~~~~~~~y~~PE~~~~~~~-~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~  236 (258)
T cd05578         158 STSGTPGYMAPEVLCRQGY-SVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQETADVLYPATWSTEAIDAINKL  236 (258)
T ss_pred             ccCCChhhcCHHHHcccCC-CCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHhccccccCcccCcHHHHHHHHHH
Confidence            5578899999999887775 58899999999999442 322                      23445789999999999


Q ss_pred             cCCCCCCCCCH--HhhhcCccc
Q 014609          232 LEPNPVKRITI--AGIKADEWF  251 (421)
Q Consensus       232 L~~dP~~R~t~--~eil~~~w~  251 (421)
                      |+.||.+||++  .++++||||
T Consensus       237 l~~~p~~R~~~~~~~l~~~~~~  258 (258)
T cd05578         237 LERDPQKRLGDNLKDLKNHPYF  258 (258)
T ss_pred             ccCChhHcCCccHHHHhcCCCC
Confidence            99999999999  999999997

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=100.00  E-value=4.7e-41  Score=318.10  Aligned_cols=237  Identities=28%  Similarity=0.508  Sum_probs=201.7

Q ss_pred             ceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccc---hhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEE
Q 014609           15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIH---LKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYM   91 (421)
Q Consensus        15 ~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~---~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l   91 (421)
                      +|+.++.||+|+||.||+|.+..+++.||+|++.......   ....+.+.+|+.++++++||||+++++++.+.+.+++
T Consensus         1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   80 (268)
T cd06630           1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL   80 (268)
T ss_pred             CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence            5889999999999999999999999999999987543211   2235788999999999999999999999999999999


Q ss_pred             EEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCC-CEEEEeccCCCCCccccC-
Q 014609           92 VLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKG-NIKISDFGLSALPQHFRD-  169 (421)
Q Consensus        92 v~E~~~gg~L~~~i~~~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~-~~kL~DFGla~~~~~~~~-  169 (421)
                      |+||++|++|.+.+...+++++..+..++.|++.||.|||++|++||||+|+||+++.++ .++|+|||++........ 
T Consensus        81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~~~~  160 (268)
T cd06630          81 FVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTG  160 (268)
T ss_pred             EEeccCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccccccccccccccc
Confidence            999999999999998878899999999999999999999999999999999999998876 599999999875533211 


Q ss_pred             -CCccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhh-cCCcC------------------------CCCCCCHH
Q 014609          170 -DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIF-RGDFK------------------------LPKWLSPG  223 (421)
Q Consensus       170 -~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~-~~~~~------------------------~p~~~s~~  223 (421)
                       ........|+..|+|||++.+..+ +.++|+||+|+++|.+ .|..+                        .|..++++
T Consensus       161 ~~~~~~~~~~~~~~~~PE~~~~~~~-~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (268)
T cd06630         161 AGEFQGQLLGTIAFMAPEVLRGEQY-GRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPEHLSPG  239 (268)
T ss_pred             CCccccccccccceeCHhHhccCCC-CcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhccCCCCCCchhhCHH
Confidence             111223468899999999877766 5889999999999943 23322                        23346788


Q ss_pred             HHHHHHHhcCCCCCCCCCHHhhhcCcccc
Q 014609          224 AQNLLRKILEPNPVKRITIAGIKADEWFE  252 (421)
Q Consensus       224 ~~~li~~~L~~dP~~R~t~~eil~~~w~~  252 (421)
                      +.+++.+||..+|++|||+.++++||||.
T Consensus       240 ~~~~i~~~l~~~p~~R~~~~~ll~~~~~~  268 (268)
T cd06630         240 LRDVTLRCLELQPEDRPPSRELLKHPVFR  268 (268)
T ss_pred             HHHHHHHHcCCCcccCcCHHHHhcCcccC
Confidence            99999999999999999999999999984

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=100.00  E-value=5.4e-41  Score=320.98  Aligned_cols=229  Identities=31%  Similarity=0.481  Sum_probs=190.3

Q ss_pred             eEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHh---cCCCCCcceEEEEEEeCCEEEEEEeccC
Q 014609           21 TLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLK---LLKHPNVVRLHEVLASKSKIYMVLEYVT   97 (421)
Q Consensus        21 ~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~---~l~hpnIv~l~~~~~~~~~~~lv~E~~~   97 (421)
                      .||+|+||.||+|.+..+++.+|+|.+.+.............+|..+++   ..+||||+.+++++..++..|+||||++
T Consensus         1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   80 (279)
T cd05633           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN   80 (279)
T ss_pred             CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence            4899999999999999999999999997654432222233444544444   4479999999999999999999999999


Q ss_pred             CCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCccccCCCcccccc
Q 014609           98 GGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTC  177 (421)
Q Consensus        98 gg~L~~~i~~~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~  177 (421)
                      |++|.+++...+.+++..+..++.|++.||+|||++||+||||||+|||++.++.++|+|||++.....    .......
T Consensus        81 ~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~----~~~~~~~  156 (279)
T cd05633          81 GGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSK----KKPHASV  156 (279)
T ss_pred             CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCCCCEEEccCCcceeccc----cCccCcC
Confidence            999999998888899999999999999999999999999999999999999999999999999864322    1223457


Q ss_pred             CCCCccChhhhcccCCCCCcchHHHHHHHHhhh-cCCcC----------------------CCCCCCHHHHHHHHHhcCC
Q 014609          178 GSPNYVAPEVLANRGYDGATSDIWSCGVILYIF-RGDFK----------------------LPKWLSPGAQNLLRKILEP  234 (421)
Q Consensus       178 gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~-~~~~~----------------------~p~~~s~~~~~li~~~L~~  234 (421)
                      ||+.|+|||++......+.++|+||+||++|.+ .|..+                      +|+.+++++.++|++||+.
T Consensus       157 ~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~  236 (279)
T cd05633         157 GTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTVNVELPDSFSPELKSLLEGLLQR  236 (279)
T ss_pred             CCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHHhhcCCcCCccccCHHHHHHHHHHhcC
Confidence            999999999986433335889999999999944 33332                      2345788999999999999


Q ss_pred             CCCCCC-----CHHhhhcCccccc
Q 014609          235 NPVKRI-----TIAGIKADEWFEQ  253 (421)
Q Consensus       235 dP~~R~-----t~~eil~~~w~~~  253 (421)
                      ||.+|+     |+.++++||||+.
T Consensus       237 ~p~~R~~~~~~~~~~~~~h~~~~~  260 (279)
T cd05633         237 DVSKRLGCLGRGAQEVKEHVFFKG  260 (279)
T ss_pred             CHHHhcCCCCCCHHHHHhCccccC
Confidence            999999     6999999999986

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=1.3e-40  Score=312.66  Aligned_cols=233  Identities=25%  Similarity=0.458  Sum_probs=202.1

Q ss_pred             ceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEEe
Q 014609           15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLE   94 (421)
Q Consensus        15 ~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E   94 (421)
                      +|++.+.||+|++|.||+|.+..+++.|++|.+...... ......+.+|+.+++.++||||+++++++...+..|+|||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   79 (256)
T cd08529           1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMN-RREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVME   79 (256)
T ss_pred             CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCC-HHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEE
Confidence            488999999999999999999999999999998764433 3345778999999999999999999999999999999999


Q ss_pred             ccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCccccCCCc
Q 014609           95 YVTGGELFDKIASK--GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGL  172 (421)
Q Consensus        95 ~~~gg~L~~~i~~~--~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~  172 (421)
                      |++|++|.+++...  ..+++..+..++.|++.||.|||+.|++||||||+||+++.++.++|+|||++.....  ....
T Consensus        80 ~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~--~~~~  157 (256)
T cd08529          80 YAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSD--NTNF  157 (256)
T ss_pred             eCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCCCCEEEcccccceeccC--ccch
Confidence            99999999998764  5789999999999999999999999999999999999999999999999999875433  1222


Q ss_pred             cccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhhc-CCcCC--------------------CCCCCHHHHHHHHHh
Q 014609          173 LHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIFR-GDFKL--------------------PKWLSPGAQNLLRKI  231 (421)
Q Consensus       173 ~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~~-~~~~~--------------------p~~~s~~~~~li~~~  231 (421)
                      ....+|++.|+|||++.+..+ +.++|+|||||++|.+. |..++                    +..++..+.+++.+|
T Consensus       158 ~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~  236 (256)
T cd08529         158 ANTIVGTPYYLSPELCEDKPY-NEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVFPPVSQMYSQQLAQLIDQC  236 (256)
T ss_pred             hhccccCccccCHHHhcCCCC-CCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCccccCHHHHHHHHHH
Confidence            344578999999999988776 48899999999999543 33222                    224678899999999


Q ss_pred             cCCCCCCCCCHHhhhcCccc
Q 014609          232 LEPNPVKRITIAGIKADEWF  251 (421)
Q Consensus       232 L~~dP~~R~t~~eil~~~w~  251 (421)
                      |+.+|++||++.++++|||+
T Consensus       237 l~~~p~~Rp~~~~ll~~~~~  256 (256)
T cd08529         237 LTKDYRQRPDTFQLLRNPSL  256 (256)
T ss_pred             ccCCcccCcCHHHHhhCCCC
Confidence            99999999999999999995

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=100.00  E-value=1.1e-40  Score=320.07  Aligned_cols=234  Identities=28%  Similarity=0.428  Sum_probs=193.5

Q ss_pred             ecceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEE
Q 014609           13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMV   92 (421)
Q Consensus        13 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv   92 (421)
                      .++|++.+.||+|+||.||+|.+..+|+.||+|.+......  .....+.+|+.+++.++|+||+++++++..+...|+|
T Consensus         4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv   81 (291)
T cd07870           4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEE--GVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFV   81 (291)
T ss_pred             cceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcC--CCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEE
Confidence            36899999999999999999999999999999998754322  2234677899999999999999999999999999999


Q ss_pred             EeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCccccCCC
Q 014609           93 LEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDG  171 (421)
Q Consensus        93 ~E~~~gg~L~~~i~~-~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~  171 (421)
                      |||+. ++|.+.+.. ...+++..++.++.|++.||+|||++||+||||||+||+++.++.++|+|||++......  ..
T Consensus        82 ~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~--~~  158 (291)
T cd07870          82 FEYMH-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLGELKLADFGLARAKSIP--SQ  158 (291)
T ss_pred             Eeccc-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcCCCcEEEeccccccccCCC--CC
Confidence            99995 677666654 456888999999999999999999999999999999999999999999999998754321  11


Q ss_pred             ccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhh-cCCcCCC-------------------------------C-
Q 014609          172 LLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIF-RGDFKLP-------------------------------K-  218 (421)
Q Consensus       172 ~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~-~~~~~~p-------------------------------~-  218 (421)
                      ......+++.|+|||++.+....+.++|+||+||++|.+ .|..++.                               . 
T Consensus       159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (291)
T cd07870         159 TYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPNY  238 (291)
T ss_pred             CCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhcccc
Confidence            223446789999999987644335789999999999954 3332220                               0 


Q ss_pred             --------------------CCCHHHHHHHHHhcCCCCCCCCCHHhhhcCccc
Q 014609          219 --------------------WLSPGAQNLLRKILEPNPVKRITIAGIKADEWF  251 (421)
Q Consensus       219 --------------------~~s~~~~~li~~~L~~dP~~R~t~~eil~~~w~  251 (421)
                                          ..++.+.+++.+||..||.+|||+.+++.||||
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h~~~  291 (291)
T cd07870         239 KPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPYF  291 (291)
T ss_pred             cchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcCCCC
Confidence                                024678899999999999999999999999997

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1e-40  Score=324.21  Aligned_cols=239  Identities=31%  Similarity=0.530  Sum_probs=204.3

Q ss_pred             cceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEE
Q 014609           14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVL   93 (421)
Q Consensus        14 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~   93 (421)
                      .+|++.+.||+|+||.||+|.+..+++.||+|.+.............+.+|+++++.++||||+++++.+.+....|+||
T Consensus         1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   80 (316)
T cd05574           1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM   80 (316)
T ss_pred             CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence            37999999999999999999999999999999998765544344677899999999999999999999999999999999


Q ss_pred             eccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCccccC--
Q 014609           94 EYVTGGELFDKIASK--GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD--  169 (421)
Q Consensus        94 E~~~gg~L~~~i~~~--~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~--  169 (421)
                      ||+.|++|.+++...  ..+++..++.++.|++.||+|||+.|++||||||+||+++.++.++|+|||++........  
T Consensus        81 e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~  160 (316)
T cd05574          81 DYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPV  160 (316)
T ss_pred             EecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcCCCCEEEeecchhhccccccccc
Confidence            999999999988753  5689999999999999999999999999999999999999999999999999874322110  


Q ss_pred             -------------------------CCccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhh-cCCcCC-------
Q 014609          170 -------------------------DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIF-RGDFKL-------  216 (421)
Q Consensus       170 -------------------------~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~-~~~~~~-------  216 (421)
                                               ........||..|+|||++.+..+ +.++||||||+++|.+ .|..++       
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~Di~slG~ll~~l~~g~~pf~~~~~~~  239 (316)
T cd05574         161 SKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGH-GSAVDWWTLGILLYEMLYGTTPFKGSNRDE  239 (316)
T ss_pred             ccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCC-CchHHHHHHHHHHHHHhhCCCCCCCCchHH
Confidence                                     001123468899999999987766 5889999999999943 333322       


Q ss_pred             ------------CCC--CCHHHHHHHHHhcCCCCCCCCC----HHhhhcCccccc
Q 014609          217 ------------PKW--LSPGAQNLLRKILEPNPVKRIT----IAGIKADEWFEQ  253 (421)
Q Consensus       217 ------------p~~--~s~~~~~li~~~L~~dP~~R~t----~~eil~~~w~~~  253 (421)
                                  |..  +++.+.++|.+||..||++|||    +++++.||||+.
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~~~~~~  294 (316)
T cd05574         240 TFSNILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFFRG  294 (316)
T ss_pred             HHHHHhcCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcCchhhc
Confidence                        222  5889999999999999999999    999999999986

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=6.4e-41  Score=358.03  Aligned_cols=245  Identities=28%  Similarity=0.463  Sum_probs=203.3

Q ss_pred             cCCeeecceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEe--
Q 014609            8 QEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLAS--   85 (421)
Q Consensus         8 ~~~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~--   85 (421)
                      .....+++|++++.||+|+||+||+|.+..+++.||+|++...... ......+.+|+.+|+.|+||||++++++|..  
T Consensus         7 ~ge~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~-e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~   85 (1021)
T PTZ00266          7 DGESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLK-EREKSQLVIEVNVMRELKHKNIVRYIDRFLNKA   85 (1021)
T ss_pred             CCccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccC-HHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecC
Confidence            3456779999999999999999999999999999999999765432 2335678999999999999999999998854  


Q ss_pred             CCEEEEEEeccCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC-------CceeccCCCCCEEeccC----
Q 014609           86 KSKIYMVLEYVTGGELFDKIAS----KGRLQEAEGRKLFQQLIDGVSYCHNK-------GVFHRDLKLENILLDSK----  150 (421)
Q Consensus        86 ~~~~~lv~E~~~gg~L~~~i~~----~~~~~~~~~~~~~~ql~~aL~~LH~~-------gi~HrDlkp~NILl~~~----  150 (421)
                      ...+|+||||+++++|.++|..    ...+++..++.|+.||+.||+|||+.       +|+||||||+||||+.+    
T Consensus        86 ~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~l  165 (1021)
T PTZ00266         86 NQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHI  165 (1021)
T ss_pred             CCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccc
Confidence            4579999999999999998864    35799999999999999999999985       49999999999999642    


Q ss_pred             -------------CCEEEEeccCCCCCccccCCCccccccCCCCccChhhhccc-CCCCCcchHHHHHHHHhhh-cCCcC
Q 014609          151 -------------GNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANR-GYDGATSDIWSCGVILYIF-RGDFK  215 (421)
Q Consensus       151 -------------~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~-~~~~~~~DiwSlGvil~~~-~~~~~  215 (421)
                                   +.+||+|||++.....   .......+||+.|+|||++.+. ...+.++|||||||+||.+ .|..|
T Consensus       166 g~i~~~~~n~ng~~iVKLsDFGlAr~l~~---~s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~P  242 (1021)
T PTZ00266        166 GKITAQANNLNGRPIAKIGDFGLSKNIGI---ESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTP  242 (1021)
T ss_pred             ccccccccccCCCCceEEccCCccccccc---cccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCC
Confidence                         3489999999975432   2233456799999999998643 2235889999999999944 34433


Q ss_pred             CC--------------------CCCCHHHHHHHHHhcCCCCCCCCCHHhhhcCcccccccc
Q 014609          216 LP--------------------KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYT  256 (421)
Q Consensus       216 ~p--------------------~~~s~~~~~li~~~L~~dP~~R~t~~eil~~~w~~~~~~  256 (421)
                      +.                    ...++++.+||.+||..+|.+||++.|++.|+|+.....
T Consensus       243 F~~~~~~~qli~~lk~~p~lpi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ik~i~~  303 (1021)
T PTZ00266        243 FHKANNFSQLISELKRGPDLPIKGKSKELNILIKNLLNLSAKERPSALQCLGYQIIKNVGP  303 (1021)
T ss_pred             CCcCCcHHHHHHHHhcCCCCCcCCCCHHHHHHHHHHhcCChhHCcCHHHHhccHHHhhcCC
Confidence            31                    225789999999999999999999999999999986543

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=100.00  E-value=4.9e-41  Score=321.29  Aligned_cols=236  Identities=30%  Similarity=0.498  Sum_probs=201.3

Q ss_pred             cceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEE
Q 014609           14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVL   93 (421)
Q Consensus        14 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~   93 (421)
                      ++|++.+.||+|+||.||+|.+..+++.||+|.++.... .....+.+.+|++++++++||||+++++++...+..|++|
T Consensus         1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~   79 (288)
T cd07833           1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESED-DEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVF   79 (288)
T ss_pred             CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcc-cccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEE
Confidence            579999999999999999999999999999999865432 2233578899999999999999999999999999999999


Q ss_pred             eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCccccCCCcc
Q 014609           94 EYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLL  173 (421)
Q Consensus        94 E~~~gg~L~~~i~~~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~  173 (421)
                      ||++++.+.........+++..+..++.|++.||+|||+.|++||||+|+||+++.++.+||+|||++........ ...
T Consensus        80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~-~~~  158 (288)
T cd07833          80 EYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPA-SPL  158 (288)
T ss_pred             ecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEEeeecccccCCCcc-ccc
Confidence            9999877766666667799999999999999999999999999999999999999999999999999886543221 133


Q ss_pred             ccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhhc-CCcCC------------------------------------
Q 014609          174 HTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIFR-GDFKL------------------------------------  216 (421)
Q Consensus       174 ~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~~-~~~~~------------------------------------  216 (421)
                      ....+++.|+|||++.+....+.++|+||+|+++|.+. |..++                                    
T Consensus       159 ~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (288)
T cd07833         159 TDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAGV  238 (288)
T ss_pred             cCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCcccccc
Confidence            44678899999999887734468999999999999543 32211                                    


Q ss_pred             ---------------CCCCCHHHHHHHHHhcCCCCCCCCCHHhhhcCccc
Q 014609          217 ---------------PKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWF  251 (421)
Q Consensus       217 ---------------p~~~s~~~~~li~~~L~~dP~~R~t~~eil~~~w~  251 (421)
                                     |..+++.+.++|++||..+|++|||+++++.||||
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~f  288 (288)
T cd07833         239 AFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF  288 (288)
T ss_pred             ccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcCCCC
Confidence                           22347889999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=1e-40  Score=320.60  Aligned_cols=234  Identities=28%  Similarity=0.457  Sum_probs=199.1

Q ss_pred             cceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEE
Q 014609           14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVL   93 (421)
Q Consensus        14 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~   93 (421)
                      +.|++++.||+|+||.||+|++..+++.+|+|.+...   .......+.+|+.+++.++||||+++++++..++.+|+||
T Consensus        12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   88 (292)
T cd06644          12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETK---SEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMI   88 (292)
T ss_pred             hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccC---CHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEE
Confidence            6799999999999999999999999999999998654   2334677889999999999999999999999999999999


Q ss_pred             eccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCccccCCCc
Q 014609           94 EYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGL  172 (421)
Q Consensus        94 E~~~gg~L~~~i~~-~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~  172 (421)
                      ||++|++|...+.. ...+++..+..++.|++.||+|||++|++||||||+||+++.++.++|+|||++.....  ....
T Consensus        89 e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~--~~~~  166 (292)
T cd06644          89 EFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVK--TLQR  166 (292)
T ss_pred             ecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcCCCCEEEccCccceeccc--cccc
Confidence            99999999887754 45789999999999999999999999999999999999999999999999999864322  1122


Q ss_pred             cccccCCCCccChhhhcc-----cCCCCCcchHHHHHHHHhhhc-CCcCC----------------------CCCCCHHH
Q 014609          173 LHTTCGSPNYVAPEVLAN-----RGYDGATSDIWSCGVILYIFR-GDFKL----------------------PKWLSPGA  224 (421)
Q Consensus       173 ~~~~~gt~~y~APEvl~~-----~~~~~~~~DiwSlGvil~~~~-~~~~~----------------------p~~~s~~~  224 (421)
                      .....+++.|+|||++..     ..+ +.++|+|||||++|.+. |..++                      |..++.++
T Consensus       167 ~~~~~~~~~y~aPE~~~~~~~~~~~~-~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (292)
T cd06644         167 RDSFIGTPYWMAPEVVMCETMKDTPY-DYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLSQPSKWSMEF  245 (292)
T ss_pred             cceecCCccccCceeeccccccCCCC-CchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHhcCCCccCCCCcccCHHH
Confidence            234568899999998753     333 47899999999999543 32221                      23356789


Q ss_pred             HHHHHHhcCCCCCCCCCHHhhhcCccccc
Q 014609          225 QNLLRKILEPNPVKRITIAGIKADEWFEQ  253 (421)
Q Consensus       225 ~~li~~~L~~dP~~R~t~~eil~~~w~~~  253 (421)
                      .++|++||+.||++||++.++++||||..
T Consensus       246 ~~li~~~l~~~p~~Rp~~~~il~~~~~~~  274 (292)
T cd06644         246 RDFLKTALDKHPETRPSAAQLLEHPFVSS  274 (292)
T ss_pred             HHHHHHHhcCCcccCcCHHHHhcCccccc
Confidence            99999999999999999999999999975

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=100.00  E-value=3.1e-41  Score=318.80  Aligned_cols=233  Identities=30%  Similarity=0.482  Sum_probs=202.9

Q ss_pred             cceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEE
Q 014609           14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVL   93 (421)
Q Consensus        14 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~   93 (421)
                      ++|++.+.||.|+||.||+|.+..+++.+|+|.+......  .....+.+|++++++++||||+++++.+...+.+|+++
T Consensus         1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   78 (265)
T cd06605           1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINE--AIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICM   78 (265)
T ss_pred             CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccCh--HHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEE
Confidence            4688999999999999999999999999999998765322  33567889999999999999999999999999999999


Q ss_pred             eccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHh-CCceeccCCCCCEEeccCCCEEEEeccCCCCCccccCCC
Q 014609           94 EYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHN-KGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDG  171 (421)
Q Consensus        94 E~~~gg~L~~~i~~~-~~~~~~~~~~~~~ql~~aL~~LH~-~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~  171 (421)
                      ||+++++|.+++... ..+++..+..++.|++.|++|||+ .|++||||||+||+++.++.++|+|||.+......    
T Consensus        79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~----  154 (265)
T cd06605          79 EYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNS----  154 (265)
T ss_pred             EecCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCCCCEEEeecccchhhHHH----
Confidence            999999999999865 789999999999999999999999 99999999999999999999999999998754321    


Q ss_pred             ccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhh-cCCcCCCCC--------------------------CCHHH
Q 014609          172 LLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIF-RGDFKLPKW--------------------------LSPGA  224 (421)
Q Consensus       172 ~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~-~~~~~~p~~--------------------------~s~~~  224 (421)
                      ......+++.|+|||.+.+..+ +.++|+||+|+++|.+ .|..+++..                          +++.+
T Consensus       155 ~~~~~~~~~~y~~PE~~~~~~~-~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (265)
T cd06605         155 LAKTFVGTSSYMAPERIQGNDY-SVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPPRLPSGKFSPDF  233 (265)
T ss_pred             HhhcccCChhccCHHHHcCCCC-CchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcCCCCCCChhhcCHHH
Confidence            1122678899999999988766 5889999999999944 344443221                          57789


Q ss_pred             HHHHHHhcCCCCCCCCCHHhhhcCccccc
Q 014609          225 QNLLRKILEPNPVKRITIAGIKADEWFEQ  253 (421)
Q Consensus       225 ~~li~~~L~~dP~~R~t~~eil~~~w~~~  253 (421)
                      .++|.+||..||.+|||+.+++.||||++
T Consensus       234 ~~li~~~l~~~p~~Rpt~~~ll~~~~~~~  262 (265)
T cd06605         234 QDFVNLCLIKDPRERPSYKELLEHPFIKK  262 (265)
T ss_pred             HHHHHHHcCCCchhCcCHHHHhhCchhhc
Confidence            99999999999999999999999999975

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=1.1e-40  Score=315.57  Aligned_cols=235  Identities=31%  Similarity=0.517  Sum_probs=200.2

Q ss_pred             ceEEeceEeecCcEEEEEEEECCCCceEEEEEeeccccc---chhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEE
Q 014609           15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRII---HLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYM   91 (421)
Q Consensus        15 ~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~---~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l   91 (421)
                      +|++++.||+|+||.||+|.+ .+|+.+|+|.+......   .......+.+|+.++++++|+||+++++++.+.+..|+
T Consensus         1 ~~~~~~~ig~g~~~~v~~~~~-~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l   79 (265)
T cd06631           1 EWTKGEVLGKGAYGTVYCGLT-NQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISI   79 (265)
T ss_pred             CccccceEeccCCeEEEEEEE-cCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEE
Confidence            589999999999999999986 58899999998754321   12234678999999999999999999999999999999


Q ss_pred             EEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCcccc---
Q 014609           92 VLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFR---  168 (421)
Q Consensus        92 v~E~~~gg~L~~~i~~~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~~---  168 (421)
                      ++||++|++|.+++....++++..++.++.|++.||+|||+.||+|+||+|+||+++.++.++|+|||++.......   
T Consensus        80 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~  159 (265)
T cd06631          80 FMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHG  159 (265)
T ss_pred             EEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCCCeEEeccchhhHhhhhccccc
Confidence            99999999999999887889999999999999999999999999999999999999999999999999987432111   


Q ss_pred             -CCCccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhh-cCCc----------------------CCCCCCCHHH
Q 014609          169 -DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIF-RGDF----------------------KLPKWLSPGA  224 (421)
Q Consensus       169 -~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~-~~~~----------------------~~p~~~s~~~  224 (421)
                       .........|++.|+|||++.+..+ +.++|+|||||++|.+ .|..                      +.|..++..+
T Consensus       160 ~~~~~~~~~~~~~~~~~pe~~~~~~~-~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (265)
T cd06631         160 THSNMLKSMHGTPYWMAPEVINESGY-GRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLMPRLPDSFSAAA  238 (265)
T ss_pred             cccccccccCCCccccChhhhcCCCC-cchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhccCCCCCCCCCCCHHH
Confidence             1122334578999999999987776 5889999999999943 2222                      2334478899


Q ss_pred             HHHHHHhcCCCCCCCCCHHhhhcCccc
Q 014609          225 QNLLRKILEPNPVKRITIAGIKADEWF  251 (421)
Q Consensus       225 ~~li~~~L~~dP~~R~t~~eil~~~w~  251 (421)
                      .++|++||+++|.+||++.+++.||||
T Consensus       239 ~~~i~~~l~~~p~~Rp~~~~~l~~~~~  265 (265)
T cd06631         239 IDFVTSCLTRDQHERPSALQLLRHDFL  265 (265)
T ss_pred             HHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence            999999999999999999999999997

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=100.00  E-value=5.1e-41  Score=320.94  Aligned_cols=233  Identities=30%  Similarity=0.487  Sum_probs=196.5

Q ss_pred             ceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEEe
Q 014609           15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLE   94 (421)
Q Consensus        15 ~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E   94 (421)
                      .|++.+.||.|++|.||+|++..+|+.||||.+..... .......+.+|++++++++||||+++++++.+.+..|+|||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e   79 (284)
T cd07860           1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE-TEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE   79 (284)
T ss_pred             CceeeeeecCCCceEEEEEEECCCCCEEEEEEcccccc-ccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEee
Confidence            48999999999999999999999999999999865432 22223578899999999999999999999999999999999


Q ss_pred             ccCCCChHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCccccCCCc
Q 014609           95 YVTGGELFDKIAS--KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGL  172 (421)
Q Consensus        95 ~~~gg~L~~~i~~--~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~  172 (421)
                      |+. ++|.+++..  ...+++..+..++.|++.||+|||+.|++||||+|+||+++.++.+||+|||++......  ...
T Consensus        80 ~~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~--~~~  156 (284)
T cd07860          80 FLH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP--VRT  156 (284)
T ss_pred             ccc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEeeccchhhcccC--ccc
Confidence            995 588888764  356899999999999999999999999999999999999999999999999998754321  122


Q ss_pred             cccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhh-cCCcCCC----------------------------------
Q 014609          173 LHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIF-RGDFKLP----------------------------------  217 (421)
Q Consensus       173 ~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~-~~~~~~p----------------------------------  217 (421)
                      .....+++.|+|||++.+....+.++|+|||||++|.+ .|..+++                                  
T Consensus       157 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (284)
T cd07860         157 YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYKP  236 (284)
T ss_pred             cccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHHHHh
Confidence            23445788999999887665556889999999999954 3433221                                  


Q ss_pred             --------------CCCCHHHHHHHHHhcCCCCCCCCCHHhhhcCccc
Q 014609          218 --------------KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWF  251 (421)
Q Consensus       218 --------------~~~s~~~~~li~~~L~~dP~~R~t~~eil~~~w~  251 (421)
                                    +.+++.+.++|.+||+.||.+|||+.+++.||||
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~f  284 (284)
T cd07860         237 SFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF  284 (284)
T ss_pred             hcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcCCCC
Confidence                          1256788899999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=1.2e-40  Score=318.40  Aligned_cols=234  Identities=29%  Similarity=0.483  Sum_probs=199.2

Q ss_pred             ceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEEe
Q 014609           15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLE   94 (421)
Q Consensus        15 ~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E   94 (421)
                      -|++.+.||+|+||.||+|.+..++..+|+|.+....   ....+.+.+|+.+++.++||||+++++++..+...|+|+|
T Consensus         6 ~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e   82 (282)
T cd06643           6 FWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKS---EEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIE   82 (282)
T ss_pred             HHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCC---HHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEE
Confidence            3788999999999999999999999999999986542   2335678899999999999999999999999999999999


Q ss_pred             ccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCccccCCCcc
Q 014609           95 YVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLL  173 (421)
Q Consensus        95 ~~~gg~L~~~i~~-~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~  173 (421)
                      |+++++|.+.+.. ..++++..+..++.|++.||.|||+.|++||||||+||+++.++.+||+|||++.....  .....
T Consensus        83 ~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~--~~~~~  160 (282)
T cd06643          83 FCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTR--TIQRR  160 (282)
T ss_pred             ecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccCCCEEEccccccccccc--ccccc
Confidence            9999999887764 46799999999999999999999999999999999999999999999999999874322  12223


Q ss_pred             ccccCCCCccChhhhcc-----cCCCCCcchHHHHHHHHhhhc-CCcC----------------------CCCCCCHHHH
Q 014609          174 HTTCGSPNYVAPEVLAN-----RGYDGATSDIWSCGVILYIFR-GDFK----------------------LPKWLSPGAQ  225 (421)
Q Consensus       174 ~~~~gt~~y~APEvl~~-----~~~~~~~~DiwSlGvil~~~~-~~~~----------------------~p~~~s~~~~  225 (421)
                      ....+++.|+|||++..     ..+ +.++|+||+||++|.+. |..+                      .|..++..+.
T Consensus       161 ~~~~~~~~y~aPE~~~~~~~~~~~~-~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (282)
T cd06643         161 DSFIGTPYWMAPEVVMCETSKDRPY-DYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSEFK  239 (282)
T ss_pred             ccccccccccCHhhccccCCCCCCC-CccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhcCCCCCCCccccCHHHH
Confidence            44578999999999742     233 46899999999999543 2222                      1234678999


Q ss_pred             HHHHHhcCCCCCCCCCHHhhhcCcccccc
Q 014609          226 NLLRKILEPNPVKRITIAGIKADEWFEQD  254 (421)
Q Consensus       226 ~li~~~L~~dP~~R~t~~eil~~~w~~~~  254 (421)
                      ++|.+||++||.+||+++++++||||...
T Consensus       240 ~li~~~l~~~p~~Rp~~~~il~~~~~~~~  268 (282)
T cd06643         240 DFLKKCLEKNVDARWTTTQLLQHPFVTVN  268 (282)
T ss_pred             HHHHHHccCChhhCcCHHHHhcCCCEecc
Confidence            99999999999999999999999999864

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=1.2e-40  Score=313.27  Aligned_cols=233  Identities=29%  Similarity=0.585  Sum_probs=200.7

Q ss_pred             ceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEEe
Q 014609           15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLE   94 (421)
Q Consensus        15 ~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E   94 (421)
                      +|++.+.||+|+||.||++.+..+|+.||+|.+...... ......+.+|+.++++++||||+++++++...+..|+|+|
T Consensus         1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   79 (256)
T cd08218           1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMS-PKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMD   79 (256)
T ss_pred             CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCC-hHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEe
Confidence            699999999999999999999999999999998754332 2234678999999999999999999999999999999999


Q ss_pred             ccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCccccCCCc
Q 014609           95 YVTGGELFDKIASK--GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGL  172 (421)
Q Consensus        95 ~~~gg~L~~~i~~~--~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~  172 (421)
                      |+++++|.+.+...  ..+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++......  ...
T Consensus        80 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~--~~~  157 (256)
T cd08218          80 YCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNST--VEL  157 (256)
T ss_pred             cCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEEeeccceeecCcc--hhh
Confidence            99999999988753  35789999999999999999999999999999999999999999999999999754331  112


Q ss_pred             cccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhh-cCCc--------------------CCCCCCCHHHHHHHHHh
Q 014609          173 LHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIF-RGDF--------------------KLPKWLSPGAQNLLRKI  231 (421)
Q Consensus       173 ~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~-~~~~--------------------~~p~~~s~~~~~li~~~  231 (421)
                      .....|++.|+|||++.+..+ +.++|+|||||++|.+ .|..                    +.|..++.++.++|.+|
T Consensus       158 ~~~~~~~~~~~~pe~~~~~~~-~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~  236 (256)
T cd08218         158 ARTCIGTPYYLSPEICENRPY-NNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGSYPPVSSHYSYDLRNLVSQL  236 (256)
T ss_pred             hhhccCCccccCHHHhCCCCC-CCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHhcCCCCCCcccCCHHHHHHHHHH
Confidence            233468899999999877766 4789999999999944 2222                    23445788999999999


Q ss_pred             cCCCCCCCCCHHhhhcCccc
Q 014609          232 LEPNPVKRITIAGIKADEWF  251 (421)
Q Consensus       232 L~~dP~~R~t~~eil~~~w~  251 (421)
                      |+.+|++||++.++++||||
T Consensus       237 l~~~p~~Rp~~~~vl~~~~~  256 (256)
T cd08218         237 FKRNPRDRPSVNSILEKNFI  256 (256)
T ss_pred             hhCChhhCcCHHHHhhCcCC
Confidence            99999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=1.6e-40  Score=321.55  Aligned_cols=239  Identities=33%  Similarity=0.588  Sum_probs=203.1

Q ss_pred             cceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEE
Q 014609           14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVL   93 (421)
Q Consensus        14 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~   93 (421)
                      ++|++.+.||+|+||.||+|.+..+++.||+|.+.............+.+|+.+++.++||||+++++.+..++..|+||
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (305)
T cd05609           1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM   80 (305)
T ss_pred             CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence            36999999999999999999999999999999997664433444567889999999999999999999999999999999


Q ss_pred             eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCcccc-----
Q 014609           94 EYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFR-----  168 (421)
Q Consensus        94 E~~~gg~L~~~i~~~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~~-----  168 (421)
                      ||++|++|.+++...+.+++..+..++.|++.||+|||++|++||||||+||+++.++.++|+|||++.......     
T Consensus        81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~~~~  160 (305)
T cd05609          81 EYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLY  160 (305)
T ss_pred             ecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECCCCCEEEeeCCCccccCcCcccccc
Confidence            999999999999888889999999999999999999999999999999999999999999999999986311000     


Q ss_pred             --------CCCccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhh-cCCcCC-------------------C---
Q 014609          169 --------DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIF-RGDFKL-------------------P---  217 (421)
Q Consensus       169 --------~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~-~~~~~~-------------------p---  217 (421)
                              .........+++.|+|||.+....+ +.++|+|||||++|.+ .|..++                   |   
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  239 (305)
T cd05609         161 EGHIEKDTREFLDKQVCGTPEYIAPEVILRQGY-GKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPEGD  239 (305)
T ss_pred             ccccccchhhccccCCccCccccCchhccCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCCcc
Confidence                    0001123467889999999877666 5899999999999944 332222                   1   


Q ss_pred             CCCCHHHHHHHHHhcCCCCCCCCC---HHhhhcCccccc
Q 014609          218 KWLSPGAQNLLRKILEPNPVKRIT---IAGIKADEWFEQ  253 (421)
Q Consensus       218 ~~~s~~~~~li~~~L~~dP~~R~t---~~eil~~~w~~~  253 (421)
                      ..+++.+.++|.+||++||++||+   +.++++||||..
T Consensus       240 ~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~~~~  278 (305)
T cd05609         240 EALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFLG  278 (305)
T ss_pred             ccCCHHHHHHHHHHhccChhhccCccCHHHHHhCccccC
Confidence            136788999999999999999998   799999999975

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.4e-42  Score=359.97  Aligned_cols=243  Identities=28%  Similarity=0.507  Sum_probs=211.5

Q ss_pred             CeeecceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEE
Q 014609           10 GMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKI   89 (421)
Q Consensus        10 ~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~   89 (421)
                      .+.-++|++++.||+|+||.|.+++++.|++.||+|++++-..........|..|-.+|.--+.+.|+.++..|.++.++
T Consensus        71 rl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~L  150 (1317)
T KOG0612|consen   71 RLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERYL  150 (1317)
T ss_pred             hCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccce
Confidence            35557999999999999999999999999999999999875444444467799999999999999999999999999999


Q ss_pred             EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCccccC
Q 014609           90 YMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD  169 (421)
Q Consensus        90 ~lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~  169 (421)
                      |+||||++||+|...+..-.+++++.|++|+..|+.||+-||+.|+|||||||+|||||..|++||+|||.+-..... +
T Consensus       151 YlVMdY~pGGDlltLlSk~~~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~~GHikLADFGsClkm~~d-G  229 (1317)
T KOG0612|consen  151 YLVMDYMPGGDLLTLLSKFDRLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDKSGHIKLADFGSCLKMDAD-G  229 (1317)
T ss_pred             EEEEecccCchHHHHHhhcCCChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEecccCcEeeccchhHHhcCCC-C
Confidence            999999999999999988778999999999999999999999999999999999999999999999999988754321 2


Q ss_pred             CCccccccCCCCccChhhhcc----cCCCCCcchHHHHHHHHhhh-cC---------------------CcCCC--CCCC
Q 014609          170 DGLLHTTCGSPNYVAPEVLAN----RGYDGATSDIWSCGVILYIF-RG---------------------DFKLP--KWLS  221 (421)
Q Consensus       170 ~~~~~~~~gt~~y~APEvl~~----~~~~~~~~DiwSlGvil~~~-~~---------------------~~~~p--~~~s  221 (421)
                      .-.....+|||.|.+||++..    .+.+|..+|+||+||++|+| .|                     .+.+|  ..+|
T Consensus       230 ~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~hk~~l~FP~~~~VS  309 (1317)
T KOG0612|consen  230 TVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNHKESLSFPDETDVS  309 (1317)
T ss_pred             cEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhchhhhcCCCcccccC
Confidence            234567799999999999863    24558999999999999943 22                     34566  4589


Q ss_pred             HHHHHHHHHhcCCCCCCCCC---HHhhhcCcccccc
Q 014609          222 PGAQNLLRKILEPNPVKRIT---IAGIKADEWFEQD  254 (421)
Q Consensus       222 ~~~~~li~~~L~~dP~~R~t---~~eil~~~w~~~~  254 (421)
                      .++++||.+++. +|+.|..   +++|..||||...
T Consensus       310 eeakdLI~~ll~-~~e~RLgrngiedik~HpFF~g~  344 (1317)
T KOG0612|consen  310 EEAKDLIEALLC-DREVRLGRNGIEDIKNHPFFEGI  344 (1317)
T ss_pred             HHHHHHHHHHhc-ChhhhcccccHHHHHhCccccCC
Confidence            999999999885 5778887   9999999999864

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.7e-42  Score=329.85  Aligned_cols=240  Identities=31%  Similarity=0.475  Sum_probs=212.2

Q ss_pred             eeecceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEE
Q 014609           11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIY   90 (421)
Q Consensus        11 ~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~   90 (421)
                      ++.+.|+.-+.||+|+||.||-++-..||+.+|+|.+.+.++..........+|-.||.+++.+.||.+-..|++++.+|
T Consensus       182 vt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LC  261 (591)
T KOG0986|consen  182 VTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALC  261 (591)
T ss_pred             ccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceE
Confidence            44567888999999999999999999999999999998887765555566889999999999999999999999999999


Q ss_pred             EEEeccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCcccc
Q 014609           91 MVLEYVTGGELFDKIASKG--RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFR  168 (421)
Q Consensus        91 lv~E~~~gg~L~~~i~~~~--~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~~  168 (421)
                      +||..|.||+|.-.|.+.+  .+++..++.|+.+|+-||++||+++|++||+||+|||||+.|+++|+|+|||.-...  
T Consensus       262 lVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~--  339 (591)
T KOG0986|consen  262 LVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLDDHGHVRISDLGLAVEIPE--  339 (591)
T ss_pred             EEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeeccCCCeEeeccceEEecCC--
Confidence            9999999999977776544  899999999999999999999999999999999999999999999999999985432  


Q ss_pred             CCCccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhh-cCC-----------------------cCCCCCCCHHH
Q 014609          169 DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIF-RGD-----------------------FKLPKWLSPGA  224 (421)
Q Consensus       169 ~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~-~~~-----------------------~~~p~~~s~~~  224 (421)
                       ........||.+|||||++.+..|+ ..+|+|||||+||.+ .|.                       ..+|..+|+++
T Consensus       340 -g~~~~~rvGT~GYMAPEvl~ne~Y~-~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~~~~~ey~~kFS~ea  417 (591)
T KOG0986|consen  340 -GKPIRGRVGTVGYMAPEVLQNEVYD-FSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTLEDPEEYSDKFSEEA  417 (591)
T ss_pred             -CCccccccCcccccCHHHHcCCccc-CCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHhcchhhcccccCHHH
Confidence             3344455899999999999998885 889999999999943 232                       34567799999


Q ss_pred             HHHHHHhcCCCCCCCCC-----HHhhhcCcccccc
Q 014609          225 QNLLRKILEPNPVKRIT-----IAGIKADEWFEQD  254 (421)
Q Consensus       225 ~~li~~~L~~dP~~R~t-----~~eil~~~w~~~~  254 (421)
                      +++.+.+|++||.+|..     ++++.+||+|+.-
T Consensus       418 kslc~~LL~Kdp~~RLGcrg~ga~evk~HpfFk~l  452 (591)
T KOG0986|consen  418 KSLCEGLLTKDPEKRLGCRGEGAQEVKEHPFFKDL  452 (591)
T ss_pred             HHHHHHHHccCHHHhccCCCcCcchhhhCcccccC
Confidence            99999999999999974     6799999999863

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=100.00  E-value=7.4e-41  Score=321.64  Aligned_cols=236  Identities=32%  Similarity=0.447  Sum_probs=198.1

Q ss_pred             eecceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeC--CEE
Q 014609           12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASK--SKI   89 (421)
Q Consensus        12 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~--~~~   89 (421)
                      .+++|++.+.||.|+||.||+|.+..+++.+|+|.++..... ......+.+|+.++++++||||+++++++...  +..
T Consensus         3 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~   81 (293)
T cd07843           3 SVDEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEK-EGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKI   81 (293)
T ss_pred             chhhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeecccc-ccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcE
Confidence            356899999999999999999999999999999999754332 22345677899999999999999999999887  899


Q ss_pred             EEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCcccc
Q 014609           90 YMVLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFR  168 (421)
Q Consensus        90 ~lv~E~~~gg~L~~~i~~~-~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~~  168 (421)
                      |+||||+.+ +|.+.+... ..+++..++.++.|++.||+|||+.|++||||||+||+++.++.++|+|||++...... 
T Consensus        82 ~lv~e~~~~-~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~-  159 (293)
T cd07843          82 YMVMEYVEH-DLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSP-  159 (293)
T ss_pred             EEEehhcCc-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCcEEEeecCceeeccCC-
Confidence            999999974 898888764 35899999999999999999999999999999999999999999999999998854331 


Q ss_pred             CCCccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhhc-CCcCC-------------------------------
Q 014609          169 DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIFR-GDFKL-------------------------------  216 (421)
Q Consensus       169 ~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~~-~~~~~-------------------------------  216 (421)
                       ........+++.|+|||++.+....+.++|+||+|+++|.+. |..++                               
T Consensus       160 -~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (293)
T cd07843         160 -LKPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELP  238 (293)
T ss_pred             -ccccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhccc
Confidence             122334567889999999876554468899999999999543 32211                               


Q ss_pred             -------------------CCC-CCHHHHHHHHHhcCCCCCCCCCHHhhhcCccc
Q 014609          217 -------------------PKW-LSPGAQNLLRKILEPNPVKRITIAGIKADEWF  251 (421)
Q Consensus       217 -------------------p~~-~s~~~~~li~~~L~~dP~~R~t~~eil~~~w~  251 (421)
                                         |.. +++.+.++|++||+.+|++|||+.|++.||||
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~~~f  293 (293)
T cd07843         239 GAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF  293 (293)
T ss_pred             hhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcCCCC
Confidence                               111 47889999999999999999999999999998

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=8.4e-41  Score=317.96  Aligned_cols=235  Identities=26%  Similarity=0.490  Sum_probs=203.9

Q ss_pred             cceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEE
Q 014609           14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVL   93 (421)
Q Consensus        14 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~   93 (421)
                      ++|++.+.||.|+||.||+|.+..+++.||+|++.....  ......+.+|+.+++.++||||+++++++.++...|+|+
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   78 (274)
T cd06609           1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEA--EDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIM   78 (274)
T ss_pred             ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeecccc--chHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEE
Confidence            479999999999999999999999999999999875432  233567889999999999999999999999999999999


Q ss_pred             eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCccccCCCcc
Q 014609           94 EYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLL  173 (421)
Q Consensus        94 E~~~gg~L~~~i~~~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~  173 (421)
                      ||+++++|.+++... ++++..+..++.|++.|+.|||+.+++||||+|+||+++.++.++|+|||++......  ....
T Consensus        79 e~~~~~~L~~~~~~~-~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~--~~~~  155 (274)
T cd06609          79 EYCGGGSCLDLLKPG-KLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTST--MSKR  155 (274)
T ss_pred             EeeCCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEcccccceeeccc--cccc
Confidence            999999999998864 8999999999999999999999999999999999999999999999999999755432  1223


Q ss_pred             ccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhh-cCCcCC--------------------CCC-CCHHHHHHHHHh
Q 014609          174 HTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIF-RGDFKL--------------------PKW-LSPGAQNLLRKI  231 (421)
Q Consensus       174 ~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~-~~~~~~--------------------p~~-~s~~~~~li~~~  231 (421)
                      ....+++.|+|||++.+..+ +.++|+||+||++|.+ .|..++                    +.. +++.+.+++.+|
T Consensus       156 ~~~~~~~~y~~PE~~~~~~~-~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  234 (274)
T cd06609         156 NTFVGTPFWMAPEVIKQSGY-DEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKNNPPSLEGNKFSKPFKDFVSLC  234 (274)
T ss_pred             ccccCCccccChhhhccCCC-CchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhhhcCCCCCcccccCHHHHHHHHHH
Confidence            34578899999999987776 5899999999999954 333332                    122 678899999999


Q ss_pred             cCCCCCCCCCHHhhhcCcccccc
Q 014609          232 LEPNPVKRITIAGIKADEWFEQD  254 (421)
Q Consensus       232 L~~dP~~R~t~~eil~~~w~~~~  254 (421)
                      |..+|++|||++++++||||.+.
T Consensus       235 l~~~p~~Rpt~~~il~~~~~~~~  257 (274)
T cd06609         235 LNKDPKERPSAKELLKHKFIKKA  257 (274)
T ss_pred             hhCChhhCcCHHHHhhChhhcCC
Confidence            99999999999999999999863

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-40  Score=327.31  Aligned_cols=239  Identities=31%  Similarity=0.505  Sum_probs=197.1

Q ss_pred             cceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeC-----CE
Q 014609           14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASK-----SK   88 (421)
Q Consensus        14 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~-----~~   88 (421)
                      ++|++.+.||+|+||.||+|.+..+|+.||+|.+....  .......+.+|+.++++++||||+++++++...     ..
T Consensus         5 ~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~   82 (336)
T cd07849           5 PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFE--HQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFND   82 (336)
T ss_pred             cceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccc--cchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccce
Confidence            68999999999999999999999999999999986422  223356788899999999999999999987654     35


Q ss_pred             EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCcccc
Q 014609           89 IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFR  168 (421)
Q Consensus        89 ~~lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~~  168 (421)
                      .|+++||+. ++|.+.+.. ..+++..++.++.|++.||+|||++||+||||||+||+++.++.+||+|||++.......
T Consensus        83 ~~lv~e~~~-~~l~~~~~~-~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~  160 (336)
T cd07849          83 VYIVQELME-TDLYKLIKT-QHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEH  160 (336)
T ss_pred             EEEEehhcc-cCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEECcccceeeccccc
Confidence            899999995 588777754 679999999999999999999999999999999999999999999999999987543221


Q ss_pred             C-CCccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhh-cCCcCCC-----------------------------
Q 014609          169 D-DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIF-RGDFKLP-----------------------------  217 (421)
Q Consensus       169 ~-~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~-~~~~~~p-----------------------------  217 (421)
                      . .......+||+.|+|||++.+....+.++||||+||++|.+ .|..+++                             
T Consensus       161 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (336)
T cd07849         161 DHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCIISL  240 (336)
T ss_pred             cccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhch
Confidence            1 12233457899999999876544346889999999999944 3333221                             


Q ss_pred             ---------------------CCCCHHHHHHHHHhcCCCCCCCCCHHhhhcCcccccccc
Q 014609          218 ---------------------KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYT  256 (421)
Q Consensus       218 ---------------------~~~s~~~~~li~~~L~~dP~~R~t~~eil~~~w~~~~~~  256 (421)
                                           +..++.+.++|.+||+++|.+|||+.++++||||.....
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~~  300 (336)
T cd07849         241 RARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYHD  300 (336)
T ss_pred             hhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccCC
Confidence                                 124677889999999999999999999999999997654

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-40  Score=323.35  Aligned_cols=236  Identities=31%  Similarity=0.462  Sum_probs=194.8

Q ss_pred             ceEEeceEeecCcEEEEEEEECC--CCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeC--CEEE
Q 014609           15 RYELGRTLGEGNFGKVKFAQDLD--SGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASK--SKIY   90 (421)
Q Consensus        15 ~y~i~~~LG~G~~g~V~~a~~~~--~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~--~~~~   90 (421)
                      +|++.+.||+|+||.||+|.+..  +++.||+|.+...........+.+.+|+.+++.++||||+++++++...  ..+|
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   80 (316)
T cd07842           1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY   80 (316)
T ss_pred             CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence            58999999999999999999988  8999999999864322333356788999999999999999999999988  8899


Q ss_pred             EEEeccCCCChHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecc----CCCEEEEeccCC
Q 014609           91 MVLEYVTGGELFDKIASK-----GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDS----KGNIKISDFGLS  161 (421)
Q Consensus        91 lv~E~~~gg~L~~~i~~~-----~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~----~~~~kL~DFGla  161 (421)
                      +||||+++ +|.+.+...     ..+++..++.++.|++.||+|||+.||+||||||+||+++.    ++.+||+|||++
T Consensus        81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~~  159 (316)
T cd07842          81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLA  159 (316)
T ss_pred             EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccceEEECCCccc
Confidence            99999964 676666421     36899999999999999999999999999999999999999    899999999999


Q ss_pred             CCCccccC-CCccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhhc-CCcCCC----------------------
Q 014609          162 ALPQHFRD-DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIFR-GDFKLP----------------------  217 (421)
Q Consensus       162 ~~~~~~~~-~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~~-~~~~~p----------------------  217 (421)
                      ........ .......++++.|+|||++.+....+.++|||||||++|.+. +..++.                      
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (316)
T cd07842         160 RLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIFE  239 (316)
T ss_pred             cccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHHHH
Confidence            86533221 112234578899999998876544468899999999999543 222210                      


Q ss_pred             -------------------------------C------------CCCHHHHHHHHHhcCCCCCCCCCHHhhhcCccc
Q 014609          218 -------------------------------K------------WLSPGAQNLLRKILEPNPVKRITIAGIKADEWF  251 (421)
Q Consensus       218 -------------------------------~------------~~s~~~~~li~~~L~~dP~~R~t~~eil~~~w~  251 (421)
                                                     +            ..+..+.+++.+||++||++|||+.+++.||||
T Consensus       240 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~~~f  316 (316)
T cd07842         240 VLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEHPYF  316 (316)
T ss_pred             HhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcCCCC
Confidence                                           0            345678899999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=3.8e-41  Score=335.48  Aligned_cols=232  Identities=26%  Similarity=0.403  Sum_probs=191.8

Q ss_pred             ecceEEeceEeecCcEEEEEEEECCC-----CceEEEEEeecccccchhHHHHHHHHHHHHhcC-CCCCcceEEEEEEeC
Q 014609           13 LGRYELGRTLGEGNFGKVKFAQDLDS-----GLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEVLASK   86 (421)
Q Consensus        13 ~~~y~i~~~LG~G~~g~V~~a~~~~~-----~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~   86 (421)
                      .++|++++.||+|+||.||+|++..+     +..||+|.+.....  ....+.+.+|+.+++.+ +||||+++++.+...
T Consensus        37 ~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~  114 (374)
T cd05106          37 RDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAH--TDEREALMSELKILSHLGQHKNIVNLLGACTHG  114 (374)
T ss_pred             HHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCC--HHHHHHHHHHHHHHHhhccCCceeeEeeEecCC
Confidence            45799999999999999999986443     45799999975432  23356788999999999 899999999999999


Q ss_pred             CEEEEEEeccCCCChHHHHHhc----------------------------------------------------------
Q 014609           87 SKIYMVLEYVTGGELFDKIASK----------------------------------------------------------  108 (421)
Q Consensus        87 ~~~~lv~E~~~gg~L~~~i~~~----------------------------------------------------------  108 (421)
                      +..|+||||+++|+|.+++...                                                          
T Consensus       115 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  194 (374)
T cd05106         115 GPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQS  194 (374)
T ss_pred             CCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccc
Confidence            9999999999999999988532                                                          


Q ss_pred             ------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCccccCCCccccc
Q 014609          109 ------------GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTT  176 (421)
Q Consensus       109 ------------~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~  176 (421)
                                  .++++..+++++.|++.||+|||++||+||||||+|||++.++.+||+|||++...............
T Consensus       195 ~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~~  274 (374)
T cd05106         195 SDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNA  274 (374)
T ss_pred             ccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccCC
Confidence                        24788899999999999999999999999999999999999999999999998754321111111222


Q ss_pred             cCCCCccChhhhcccCCCCCcchHHHHHHHHhhhc--CCcCC---------------------CCCCCHHHHHHHHHhcC
Q 014609          177 CGSPNYVAPEVLANRGYDGATSDIWSCGVILYIFR--GDFKL---------------------PKWLSPGAQNLLRKILE  233 (421)
Q Consensus       177 ~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~~--~~~~~---------------------p~~~s~~~~~li~~~L~  233 (421)
                      .+++.|+|||++.+..+ +.++||||+||++|.+.  |..++                     |...++++.+++.+||+
T Consensus       275 ~~~~~y~aPE~~~~~~~-~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~  353 (374)
T cd05106         275 RLPVKWMAPESIFDCVY-TVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGYQMSRPDFAPPEIYSIMKMCWN  353 (374)
T ss_pred             CCccceeCHHHhcCCCC-CccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHcccCccCCCCCCHHHHHHHHHHcC
Confidence            34567999999987776 58999999999999653  55443                     33468999999999999


Q ss_pred             CCCCCCCCHHhhhc
Q 014609          234 PNPVKRITIAGIKA  247 (421)
Q Consensus       234 ~dP~~R~t~~eil~  247 (421)
                      .||.+|||+.++.+
T Consensus       354 ~dp~~RPs~~~l~~  367 (374)
T cd05106         354 LEPTERPTFSQISQ  367 (374)
T ss_pred             CChhhCcCHHHHHH
Confidence            99999999999865

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=100.00  E-value=1.7e-40  Score=319.14  Aligned_cols=235  Identities=34%  Similarity=0.480  Sum_probs=193.9

Q ss_pred             cceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCC-CCCcceEEEEEEeCCE----
Q 014609           14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK-HPNVVRLHEVLASKSK----   88 (421)
Q Consensus        14 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~----   88 (421)
                      ++|++.+.||+|+||.||+|.+..+|+.||+|.++.... .......+.+|+.++++++ ||||+++++++.....    
T Consensus         1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~-~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~   79 (295)
T cd07837           1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMD-EEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKP   79 (295)
T ss_pred             CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhcc-ccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCc
Confidence            479999999999999999999999999999999865432 2223457888999999995 6999999999987665    


Q ss_pred             -EEEEEeccCCCChHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecc-CCCEEEEeccCC
Q 014609           89 -IYMVLEYVTGGELFDKIASK-----GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDS-KGNIKISDFGLS  161 (421)
Q Consensus        89 -~~lv~E~~~gg~L~~~i~~~-----~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~-~~~~kL~DFGla  161 (421)
                       .|+||||+++ +|.+++...     ..+++..++.++.||+.||.|||++||+||||||+||+++. ++.+||+|||++
T Consensus        80 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~~~~~~kl~dfg~~  158 (295)
T cd07837          80 SLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLG  158 (295)
T ss_pred             eEEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEecCCCeEEEeecccc
Confidence             8999999975 788887642     35799999999999999999999999999999999999998 889999999998


Q ss_pred             CCCccccCCCccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhhc-CCcCCC-----------------------
Q 014609          162 ALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIFR-GDFKLP-----------------------  217 (421)
Q Consensus       162 ~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~~-~~~~~p-----------------------  217 (421)
                      ......  ........+++.|+|||++.+....+.++|+||+|+++|.+. |..+++                       
T Consensus       159 ~~~~~~--~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (295)
T cd07837         159 RAFSIP--VKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVW  236 (295)
T ss_pred             eecCCC--ccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhhC
Confidence            754321  112223457889999999866444468999999999999543 332221                       


Q ss_pred             ------------------------CCCCHHHHHHHHHhcCCCCCCCCCHHhhhcCcccc
Q 014609          218 ------------------------KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFE  252 (421)
Q Consensus       218 ------------------------~~~s~~~~~li~~~L~~dP~~R~t~~eil~~~w~~  252 (421)
                                              +.+++.+.++|.+||.+||.+||++.+++.||||+
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~~~~~  295 (295)
T cd07837         237 PGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPYFD  295 (295)
T ss_pred             cchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcCCCcC
Confidence                                    23678899999999999999999999999999985

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=4.9e-41  Score=334.88  Aligned_cols=233  Identities=28%  Similarity=0.417  Sum_probs=192.1

Q ss_pred             ecceEEeceEeecCcEEEEEEEE-----CCCCceEEEEEeecccccchhHHHHHHHHHHHHhcC-CCCCcceEEEEEEeC
Q 014609           13 LGRYELGRTLGEGNFGKVKFAQD-----LDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEVLASK   86 (421)
Q Consensus        13 ~~~y~i~~~LG~G~~g~V~~a~~-----~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~   86 (421)
                      .++|++++.||+|+||+||+|.+     ..++..||||+++....  ....+.+.+|+.+++.+ +||||+++++++...
T Consensus        34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~--~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~  111 (375)
T cd05104          34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAH--LTEREALMSELKVLSYLGNHINIVNLLGACTVG  111 (375)
T ss_pred             hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcC--cHHHHHHHHHHHHHHHhcCCcceeeeeeeeccC
Confidence            35899999999999999999964     35677999999864432  22356788999999999 899999999999999


Q ss_pred             CEEEEEEeccCCCChHHHHHhcC---------------------------------------------------------
Q 014609           87 SKIYMVLEYVTGGELFDKIASKG---------------------------------------------------------  109 (421)
Q Consensus        87 ~~~~lv~E~~~gg~L~~~i~~~~---------------------------------------------------------  109 (421)
                      +..|+||||++||+|.+++....                                                         
T Consensus       112 ~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~  191 (375)
T cd05104         112 GPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRS  191 (375)
T ss_pred             CcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccccccc
Confidence            99999999999999999886421                                                         


Q ss_pred             ------------------CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCccccCCC
Q 014609          110 ------------------RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDG  171 (421)
Q Consensus       110 ------------------~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~  171 (421)
                                        .+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++..........
T Consensus       192 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~  271 (375)
T cd05104         192 GSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYV  271 (375)
T ss_pred             ceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECCCcEEEecCccceeccCccccc
Confidence                              46788899999999999999999999999999999999999999999999997543321111


Q ss_pred             ccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhhc--CCcCC---------------------CCCCCHHHHHHH
Q 014609          172 LLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIFR--GDFKL---------------------PKWLSPGAQNLL  228 (421)
Q Consensus       172 ~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~~--~~~~~---------------------p~~~s~~~~~li  228 (421)
                      ......++..|+|||++.+..+ +.++|||||||++|.+.  |..++                     |...+.++.+++
T Consensus       272 ~~~~~~~~~~y~aPE~~~~~~~-~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li  350 (375)
T cd05104         272 VKGNARLPVKWMAPESIFNCVY-TFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYRMLSPECAPSEMYDIM  350 (375)
T ss_pred             ccCCCCCCcceeChhHhcCCCC-CCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHhCccCCCCCCCCHHHHHHH
Confidence            1222335567999999988777 58999999999999643  33332                     234578899999


Q ss_pred             HHhcCCCCCCCCCHHhhhcC
Q 014609          229 RKILEPNPVKRITIAGIKAD  248 (421)
Q Consensus       229 ~~~L~~dP~~R~t~~eil~~  248 (421)
                      .+||++||++|||+.++++.
T Consensus       351 ~~cl~~dP~~RPs~~eil~~  370 (375)
T cd05104         351 KSCWDADPLKRPTFKQIVQL  370 (375)
T ss_pred             HHHccCChhHCcCHHHHHHH
Confidence            99999999999999999764

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=100.00  E-value=1.7e-40  Score=320.89  Aligned_cols=241  Identities=28%  Similarity=0.440  Sum_probs=195.5

Q ss_pred             CCeeecceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCC-
Q 014609            9 EGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKS-   87 (421)
Q Consensus         9 ~~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~-   87 (421)
                      .+..+++|++.+.||+|+||.||+|.+..+++.||||.+...... ......+.+|+.++++++||||+++++++.... 
T Consensus         7 ~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~   85 (310)
T cd07865           7 FCDEVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEK-EGFPITALREIKILQLLKHENVVNLIEICRTKAT   85 (310)
T ss_pred             ccchhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCc-CCchhHHHHHHHHHHhCCCCCccceEEEEecccc
Confidence            355678999999999999999999999999999999998654322 222345678999999999999999999986653 


Q ss_pred             -------EEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEecc
Q 014609           88 -------KIYMVLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFG  159 (421)
Q Consensus        88 -------~~~lv~E~~~gg~L~~~i~~~-~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFG  159 (421)
                             ..|+||||+. ++|.+.+... ..+++..++.++.|++.||+|||++|++|+||||+||+++.++.+||+|||
T Consensus        86 ~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg  164 (310)
T cd07865          86 PYNRYKGSFYLVFEFCE-HDLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFG  164 (310)
T ss_pred             cccCCCceEEEEEcCCC-cCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCCcEEECcCC
Confidence                   4699999995 5787777654 368999999999999999999999999999999999999999999999999


Q ss_pred             CCCCCccccCC--CccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhhcCCcC-C--------------------
Q 014609          160 LSALPQHFRDD--GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIFRGDFK-L--------------------  216 (421)
Q Consensus       160 la~~~~~~~~~--~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~~~~~~-~--------------------  216 (421)
                      ++.........  .......++..|+|||++.+....+.++|+||+|+++|.+..+.+ +                    
T Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~  244 (310)
T cd07865         165 LARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSIT  244 (310)
T ss_pred             CcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence            99755332111  122344678899999998765434688999999999996532211 1                    


Q ss_pred             ------------------CC-------------CCCHHHHHHHHHhcCCCCCCCCCHHhhhcCccc
Q 014609          217 ------------------PK-------------WLSPGAQNLLRKILEPNPVKRITIAGIKADEWF  251 (421)
Q Consensus       217 ------------------p~-------------~~s~~~~~li~~~L~~dP~~R~t~~eil~~~w~  251 (421)
                                        |.             ..++.+.++|.+||..||.+|||++++++||||
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h~~f  310 (310)
T cd07865         245 PEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNHDFF  310 (310)
T ss_pred             hhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcCCCC
Confidence                              00             124667899999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-42  Score=339.67  Aligned_cols=235  Identities=27%  Similarity=0.436  Sum_probs=202.6

Q ss_pred             ceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEEe
Q 014609           15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLE   94 (421)
Q Consensus        15 ~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E   94 (421)
                      .|.-++.||+|+||.||.|+|..+.+.||||.+.-..-.......++.+|+..|+.++|||+|.+.++|.-+...|+|||
T Consensus        27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVME  106 (948)
T KOG0577|consen   27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVME  106 (948)
T ss_pred             HHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHH
Confidence            46778999999999999999999999999999976554444556789999999999999999999999999999999999


Q ss_pred             ccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCccccCCCcc
Q 014609           95 YVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLL  173 (421)
Q Consensus        95 ~~~gg~L~~~i~~-~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~  173 (421)
                      ||- |+-.|.+.- .+++.+.++..+..+.+.||+|||+.+.||||||..|||+++.|.|||+|||.|.+..      +.
T Consensus       107 YCl-GSAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~------PA  179 (948)
T KOG0577|consen  107 YCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLSEPGLVKLADFGSASIMA------PA  179 (948)
T ss_pred             HHh-ccHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEecCCCeeeeccccchhhcC------ch
Confidence            995 577777753 5789999999999999999999999999999999999999999999999999998643      45


Q ss_pred             ccccCCCCccChhhhc---ccCCCCCcchHHHHHHHHhhhcCCcCC----------------------CCCCCHHHHHHH
Q 014609          174 HTTCGSPNYVAPEVLA---NRGYDGATSDIWSCGVILYIFRGDFKL----------------------PKWLSPGAQNLL  228 (421)
Q Consensus       174 ~~~~gt~~y~APEvl~---~~~~~~~~~DiwSlGvil~~~~~~~~~----------------------p~~~s~~~~~li  228 (421)
                      .++.|||.||||||+.   ...|+ -++||||||++...+....|.                      .+.+|..++.|+
T Consensus       180 nsFvGTPywMAPEVILAMDEGqYd-gkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQNesPtLqs~eWS~~F~~Fv  258 (948)
T KOG0577|consen  180 NSFVGTPYWMAPEVILAMDEGQYD-GKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWSDYFRNFV  258 (948)
T ss_pred             hcccCCccccchhHheeccccccC-CccceeeccchhhhhhhcCCCccCchHHHHHHHHHhcCCCCCCCchhHHHHHHHH
Confidence            6789999999999974   34565 689999999888754332211                      123688999999


Q ss_pred             HHhcCCCCCCCCCHHhhhcCccccccccC
Q 014609          229 RKILEPNPVKRITIAGIKADEWFEQDYTP  257 (421)
Q Consensus       229 ~~~L~~dP~~R~t~~eil~~~w~~~~~~~  257 (421)
                      ..||++-|.+|||.++++.|+|.....++
T Consensus       259 d~CLqKipqeRptse~ll~H~fv~R~Rp~  287 (948)
T KOG0577|consen  259 DSCLQKIPQERPTSEELLKHRFVLRERPP  287 (948)
T ss_pred             HHHHhhCcccCCcHHHHhhcchhccCCCc
Confidence            99999999999999999999999865443

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=2.3e-40  Score=313.81  Aligned_cols=236  Identities=30%  Similarity=0.525  Sum_probs=198.1

Q ss_pred             ceEEeceEeecCcEEEEEEEECCCCceEEEEEeeccccc--chhHHHHHHHHHHHHhcCCCCCcceEEEEEEe--CCEEE
Q 014609           15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRII--HLKITDQIKREIATLKLLKHPNVVRLHEVLAS--KSKIY   90 (421)
Q Consensus        15 ~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~--~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~--~~~~~   90 (421)
                      .|++.+.||+|+||.||+|.+..++..||+|.+......  .......+.+|+.+++.++||||+++++++..  ....+
T Consensus         3 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   82 (266)
T cd06651           3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLT   82 (266)
T ss_pred             CccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEEE
Confidence            589999999999999999999999999999998754321  22335678999999999999999999999875  36789


Q ss_pred             EEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCcccc-C
Q 014609           91 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFR-D  169 (421)
Q Consensus        91 lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~~-~  169 (421)
                      +++||+++++|.+.+.....+++...+.++.|++.||+|||+++|+||||+|+||+++.++.+||+|||++....... .
T Consensus        83 l~~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~~~~~  162 (266)
T cd06651          83 IFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMS  162 (266)
T ss_pred             EEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCCCcccccccccc
Confidence            999999999999999887789999999999999999999999999999999999999999999999999987443211 1


Q ss_pred             CCccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhh-cCCcC---------------------CCCCCCHHHHHH
Q 014609          170 DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIF-RGDFK---------------------LPKWLSPGAQNL  227 (421)
Q Consensus       170 ~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~-~~~~~---------------------~p~~~s~~~~~l  227 (421)
                      ........++..|+|||.+.+..+ +.++|+||+||++|.+ .|..+                     +|..+++.+.++
T Consensus       163 ~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  241 (266)
T cd06651         163 GTGIRSVTGTPYWMSPEVISGEGY-GRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPTNPQLPSHISEHARDF  241 (266)
T ss_pred             CCccccCCccccccCHHHhCCCCC-CchhhhHHHHHHHHHHHHCCCCccccchHHHHHHHhcCCCCCCCchhcCHHHHHH
Confidence            112233568899999999987766 5889999999999944 33322                     234467888899


Q ss_pred             HHHhcCCCCCCCCCHHhhhcCcccc
Q 014609          228 LRKILEPNPVKRITIAGIKADEWFE  252 (421)
Q Consensus       228 i~~~L~~dP~~R~t~~eil~~~w~~  252 (421)
                      + +||..+|++||++.++++||||+
T Consensus       242 i-~~~~~~p~~Rp~~~eil~hp~~~  265 (266)
T cd06651         242 L-GCIFVEARHRPSAEELLRHPFAQ  265 (266)
T ss_pred             H-HHhcCChhhCcCHHHHhcCcccc
Confidence            9 57778999999999999999986

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=8e-41  Score=319.44  Aligned_cols=235  Identities=26%  Similarity=0.377  Sum_probs=197.6

Q ss_pred             eeecceEEeceEeecCcEEEEEEEECCCC-----ceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEe
Q 014609           11 MRLGRYELGRTLGEGNFGKVKFAQDLDSG-----LPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLAS   85 (421)
Q Consensus        11 ~~~~~y~i~~~LG~G~~g~V~~a~~~~~~-----~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~   85 (421)
                      ..+++|++.+.||+|+||.||+|.+...+     ..||+|.+....  .......+.+|+.+++.++||||+++++++..
T Consensus         2 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~--~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~   79 (283)
T cd05048           2 IPLSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENA--EPKVQQEFRQEAELMSDLQHPNIVCLLGVCTK   79 (283)
T ss_pred             CChHHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCC--CHHHHHHHHHHHHHHHhcCCcccceEEEEEcC
Confidence            45678999999999999999999876554     689999986443  22335678999999999999999999999999


Q ss_pred             CCEEEEEEeccCCCChHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecc
Q 014609           86 KSKIYMVLEYVTGGELFDKIASK----------------GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDS  149 (421)
Q Consensus        86 ~~~~~lv~E~~~gg~L~~~i~~~----------------~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~  149 (421)
                      ....|++|||+++++|.+++...                ..+++..+..++.|++.||+|||++|++||||||+||+++.
T Consensus        80 ~~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~~~  159 (283)
T cd05048          80 EQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGE  159 (283)
T ss_pred             CCceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEEcC
Confidence            99999999999999999998754                45788999999999999999999999999999999999999


Q ss_pred             CCCEEEEeccCCCCCccccCCCccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhhc--CCcC------------
Q 014609          150 KGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIFR--GDFK------------  215 (421)
Q Consensus       150 ~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~~--~~~~------------  215 (421)
                      ++.++|+|||++................+++.|+|||.+.+..+ +.++|||||||++|.+.  |..+            
T Consensus       160 ~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~~~  238 (283)
T cd05048         160 GLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKF-TTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEM  238 (283)
T ss_pred             CCcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcC-chhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Confidence            99999999999874432211122334467889999999887776 58999999999999764  3322            


Q ss_pred             --------CCCCCCHHHHHHHHHhcCCCCCCCCCHHhhhcC
Q 014609          216 --------LPKWLSPGAQNLLRKILEPNPVKRITIAGIKAD  248 (421)
Q Consensus       216 --------~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~~  248 (421)
                              .|..+++++.+++.+||+.||.+||++.+|+++
T Consensus       239 i~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~  279 (283)
T cd05048         239 IRSRQLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTR  279 (283)
T ss_pred             HHcCCcCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence                    234578999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.3e-40  Score=312.07  Aligned_cols=231  Identities=31%  Similarity=0.514  Sum_probs=200.0

Q ss_pred             cceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEE
Q 014609           14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVL   93 (421)
Q Consensus        14 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~   93 (421)
                      ++|++.+.||.|+||.||+|.+..+++.+|+|++.....   .....+.+|+.++++++||||+++++++.....+|++|
T Consensus         3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~---~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~   79 (262)
T cd06613           3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPG---DDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVM   79 (262)
T ss_pred             cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCch---hhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEE
Confidence            579999999999999999999998999999999975432   23578999999999999999999999999999999999


Q ss_pred             eccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCccccCCCc
Q 014609           94 EYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGL  172 (421)
Q Consensus        94 E~~~gg~L~~~i~~~-~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~  172 (421)
                      ||+++++|.+++... ..+++..+..++.|++.||+|||++|++||||+|+||+++.++.+||+|||++......  ...
T Consensus        80 e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~--~~~  157 (262)
T cd06613          80 EYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTAT--IAK  157 (262)
T ss_pred             eCCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECCCCCEEECccccchhhhhh--hhc
Confidence            999999999988765 78999999999999999999999999999999999999999999999999998754331  112


Q ss_pred             cccccCCCCccChhhhccc---CCCCCcchHHHHHHHHhhhc-CCcCCC------------------------CCCCHHH
Q 014609          173 LHTTCGSPNYVAPEVLANR---GYDGATSDIWSCGVILYIFR-GDFKLP------------------------KWLSPGA  224 (421)
Q Consensus       173 ~~~~~gt~~y~APEvl~~~---~~~~~~~DiwSlGvil~~~~-~~~~~p------------------------~~~s~~~  224 (421)
                      .....++..|+|||++...   .+ +.++|+||||+++|.+. |..++.                        ..++.++
T Consensus       158 ~~~~~~~~~y~~Pe~~~~~~~~~~-~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (262)
T cd06613         158 RKSFIGTPYWMAPEVAAVERKGGY-DGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPPKLKDKEKWSPVF  236 (262)
T ss_pred             cccccCCccccCchhhcccccCCc-CchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCccccchhhhhHHH
Confidence            3345788999999998765   56 47899999999999543 333221                        1235778


Q ss_pred             HHHHHHhcCCCCCCCCCHHhhhcCcc
Q 014609          225 QNLLRKILEPNPVKRITIAGIKADEW  250 (421)
Q Consensus       225 ~~li~~~L~~dP~~R~t~~eil~~~w  250 (421)
                      .+++++||.++|.+|||+.+++.|+|
T Consensus       237 ~~li~~~l~~~p~~Rpt~~~il~~~~  262 (262)
T cd06613         237 HDFIKKCLTKDPKKRPTATKLLQHPF  262 (262)
T ss_pred             HHHHHHHcCCChhhCCCHHHHhcCCC
Confidence            99999999999999999999999998

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=100.00  E-value=2.1e-40  Score=316.45  Aligned_cols=232  Identities=30%  Similarity=0.515  Sum_probs=195.6

Q ss_pred             ceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEEe
Q 014609           15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLE   94 (421)
Q Consensus        15 ~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E   94 (421)
                      +|++.+.||.|++|.||+|.+..+|+.||+|.+......  .....+.+|+.++++++||||+++++++.+.+..|+|||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   78 (284)
T cd07836           1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEE--GTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFE   78 (284)
T ss_pred             CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccc--cchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEe
Confidence            589999999999999999999999999999998754322  224567789999999999999999999999999999999


Q ss_pred             ccCCCChHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCccccCCC
Q 014609           95 YVTGGELFDKIASK---GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDG  171 (421)
Q Consensus        95 ~~~gg~L~~~i~~~---~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~  171 (421)
                      |+++ +|.+.+...   ..+++..+..++.|++.||+|||+.|++||||||+||++++++.++|+|||++......  ..
T Consensus        79 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~--~~  155 (284)
T cd07836          79 YMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIP--VN  155 (284)
T ss_pred             cCCc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCC--cc
Confidence            9975 888877653   35899999999999999999999999999999999999999999999999998754321  11


Q ss_pred             ccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhhc-CCcCCC---------------------------------
Q 014609          172 LLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIFR-GDFKLP---------------------------------  217 (421)
Q Consensus       172 ~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~~-~~~~~p---------------------------------  217 (421)
                      ......+++.|+|||++.+....+.++|+|||||++|.+. |..++.                                 
T Consensus       156 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (284)
T cd07836         156 TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYK  235 (284)
T ss_pred             ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchhc
Confidence            2233467889999999876554468899999999999543 332211                                 


Q ss_pred             ---------------CCCCHHHHHHHHHhcCCCCCCCCCHHhhhcCccc
Q 014609          218 ---------------KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWF  251 (421)
Q Consensus       218 ---------------~~~s~~~~~li~~~L~~dP~~R~t~~eil~~~w~  251 (421)
                                     +.+++.+.++|.+||+.||.+||++.++++||||
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~f  284 (284)
T cd07836         236 PTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPWF  284 (284)
T ss_pred             ccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence                           1346788899999999999999999999999998

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=3.7e-40  Score=312.02  Aligned_cols=237  Identities=32%  Similarity=0.525  Sum_probs=199.0

Q ss_pred             cceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccc--cchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeC--CEE
Q 014609           14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRI--IHLKITDQIKREIATLKLLKHPNVVRLHEVLASK--SKI   89 (421)
Q Consensus        14 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~--~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~--~~~   89 (421)
                      .+|++.+.||+|+||.||.|.+..+|+.||||.+.....  ......+.+.+|+.++++++||||+++++++.+.  ..+
T Consensus         2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (265)
T cd06652           2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL   81 (265)
T ss_pred             CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence            469999999999999999999999999999999864321  1223356789999999999999999999998763  578


Q ss_pred             EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCcccc-
Q 014609           90 YMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFR-  168 (421)
Q Consensus        90 ~lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~~-  168 (421)
                      |++|||++|++|.+++.....+++..+..++.|++.||+|||++|++||||||+||+++.++.++|+|||++....... 
T Consensus        82 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~~~~  161 (265)
T cd06652          82 SIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICL  161 (265)
T ss_pred             EEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecCCCCEEECcCccccccccccc
Confidence            8999999999999999887788999999999999999999999999999999999999999999999999987543211 


Q ss_pred             CCCccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhhc-CCcC---------------------CCCCCCHHHHH
Q 014609          169 DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIFR-GDFK---------------------LPKWLSPGAQN  226 (421)
Q Consensus       169 ~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~~-~~~~---------------------~p~~~s~~~~~  226 (421)
                      .........|+..|+|||++.+..+ +.++|+|||||++|.+. |..+                     .|..++..+.+
T Consensus       162 ~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (265)
T cd06652         162 SGTGMKSVTGTPYWMSPEVISGEGY-GRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPVLPPHVSDHCRD  240 (265)
T ss_pred             cccccccCCCCccccChhhhcCCCC-CcchhHHHHHHHHHHHhhCCCCCCccchHHHHHHHhcCCCCCCCchhhCHHHHH
Confidence            1112334568999999999887766 58899999999999543 3322                     23346778899


Q ss_pred             HHHHhcCCCCCCCCCHHhhhcCcccc
Q 014609          227 LLRKILEPNPVKRITIAGIKADEWFE  252 (421)
Q Consensus       227 li~~~L~~dP~~R~t~~eil~~~w~~  252 (421)
                      +|++|+. +|.+||+++++++|||+.
T Consensus       241 ~i~~~l~-~p~~Rp~~~~il~~~~~~  265 (265)
T cd06652         241 FLKRIFV-EAKLRPSADELLRHTFVH  265 (265)
T ss_pred             HHHHHhc-ChhhCCCHHHHhcCcccC
Confidence            9999995 999999999999999974

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=4.3e-40  Score=309.58  Aligned_cols=233  Identities=29%  Similarity=0.481  Sum_probs=201.9

Q ss_pred             ceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEEe
Q 014609           15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLE   94 (421)
Q Consensus        15 ~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E   94 (421)
                      +|++++.||.|+||.||.+++..+++.+++|.+...... ......+.+|+.++++++|+||+++++++.+.+..+++||
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~-~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e   79 (256)
T cd08221           1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLS-EKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEME   79 (256)
T ss_pred             CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccc-hhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEE
Confidence            699999999999999999999999999999998765432 2335678899999999999999999999999999999999


Q ss_pred             ccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCccccCCCc
Q 014609           95 YVTGGELFDKIASK--GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGL  172 (421)
Q Consensus        95 ~~~gg~L~~~i~~~--~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~  172 (421)
                      |+++++|.+.+...  ..+++..+..++.|++.||.|||+.|++||||+|+||+++.++.+||+|||++.......  ..
T Consensus        80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~--~~  157 (256)
T cd08221          80 YANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEY--SM  157 (256)
T ss_pred             ecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCCCCEEECcCcceEEccccc--cc
Confidence            99999999998764  468999999999999999999999999999999999999999999999999987553321  13


Q ss_pred             cccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhhc-CCcC--------------------CCCCCCHHHHHHHHHh
Q 014609          173 LHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIFR-GDFK--------------------LPKWLSPGAQNLLRKI  231 (421)
Q Consensus       173 ~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~~-~~~~--------------------~p~~~s~~~~~li~~~  231 (421)
                      .....|++.|+|||++.+..+ +.++|+||+|+++|.+. |..+                    .+..++..+.++|.+|
T Consensus       158 ~~~~~~~~~y~ape~~~~~~~-~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~  236 (256)
T cd08221         158 AETVVGTPYYMSPELCQGVKY-NFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYTPVVSVYSSELISLVHSL  236 (256)
T ss_pred             ccccCCCccccCHhhcCCCCC-CCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCccccCHHHHHHHHHH
Confidence            345578999999999887766 47899999999999542 2211                    2234688999999999


Q ss_pred             cCCCCCCCCCHHhhhcCccc
Q 014609          232 LEPNPVKRITIAGIKADEWF  251 (421)
Q Consensus       232 L~~dP~~R~t~~eil~~~w~  251 (421)
                      |.++|.+||++.++++|+|+
T Consensus       237 l~~~p~~R~s~~~ll~~~~l  256 (256)
T cd08221         237 LQQDPEKRPTADEVLDQPLL  256 (256)
T ss_pred             cccCcccCCCHHHHhhCcCC
Confidence            99999999999999999996

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=2.5e-40  Score=313.15  Aligned_cols=233  Identities=29%  Similarity=0.491  Sum_probs=198.8

Q ss_pred             ecceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEE
Q 014609           13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMV   92 (421)
Q Consensus        13 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv   92 (421)
                      +++|++.+.||+|+||.||+|++..+++.||||.+.............+.+|+.+++.++||||+++++++...+..|++
T Consensus         1 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v   80 (267)
T cd08228           1 LANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIV   80 (267)
T ss_pred             CcceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEE
Confidence            47899999999999999999999999999999998764444445556789999999999999999999999999999999


Q ss_pred             EeccCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCcccc
Q 014609           93 LEYVTGGELFDKIAS----KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFR  168 (421)
Q Consensus        93 ~E~~~gg~L~~~i~~----~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~~  168 (421)
                      +||+++++|.+.+..    ...+++..+..++.|++.||+|||++|++||||||+||+++.++.++|+|||++...... 
T Consensus        81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~-  159 (267)
T cd08228          81 LELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSK-  159 (267)
T ss_pred             EEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcCCCCEEECccccceeccch-
Confidence            999999999888753    345899999999999999999999999999999999999999999999999998865331 


Q ss_pred             CCCccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhhc-CCcCC-------------------C----CCCCHHH
Q 014609          169 DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIFR-GDFKL-------------------P----KWLSPGA  224 (421)
Q Consensus       169 ~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~~-~~~~~-------------------p----~~~s~~~  224 (421)
                       ........|++.|+|||.+.+..+ +.++|+||+|+++|.+. |..++                   |    ...+..+
T Consensus       160 -~~~~~~~~~~~~~~aPE~~~~~~~-~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (267)
T cd08228         160 -TTAAHSLVGTPYYMSPERIHENGY-NFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPPLPTEHYSEKL  237 (267)
T ss_pred             -hHHHhcCCCCccccChhhhccCCC-CchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhcCCCCCCChhhcCHHH
Confidence             122334578899999999987776 48899999999999543 33221                   1    2356789


Q ss_pred             HHHHHHhcCCCCCCCCCHHhhhcC
Q 014609          225 QNLLRKILEPNPVKRITIAGIKAD  248 (421)
Q Consensus       225 ~~li~~~L~~dP~~R~t~~eil~~  248 (421)
                      .++|.+||..+|++||++.++++.
T Consensus       238 ~~li~~cl~~~p~~Rp~~~~vl~~  261 (267)
T cd08228         238 RELVSMCIYPDPDQRPDIGYVHQI  261 (267)
T ss_pred             HHHHHHHCCCCcccCcCHHHHHHH
Confidence            999999999999999999999863

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=100.00  E-value=1.9e-40  Score=327.78  Aligned_cols=237  Identities=31%  Similarity=0.490  Sum_probs=197.6

Q ss_pred             eecceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeC-----
Q 014609           12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASK-----   86 (421)
Q Consensus        12 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~-----   86 (421)
                      ..++|++.+.||+|+||.||+|.+..+|+.||+|.+.+... .......+.+|+.++++++||||+++++++...     
T Consensus        14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   92 (353)
T cd07850          14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQ-NVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEE   92 (353)
T ss_pred             hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCcccc-ChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccc
Confidence            35789999999999999999999999999999999865322 223346778899999999999999999998644     


Q ss_pred             -CEEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCc
Q 014609           87 -SKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQ  165 (421)
Q Consensus        87 -~~~~lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~  165 (421)
                       ...|+||||+. ++|.+.+...  +++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||++....
T Consensus        93 ~~~~~lv~e~~~-~~l~~~~~~~--l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~  169 (353)
T cd07850          93 FQDVYLVMELMD-ANLCQVIQMD--LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG  169 (353)
T ss_pred             cCcEEEEEeccC-CCHHHHHhhc--CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCccceeCC
Confidence             35799999995 5888877653  8999999999999999999999999999999999999999999999999997543


Q ss_pred             cccCCCccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhh-cCCcCCC---------------------------
Q 014609          166 HFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIF-RGDFKLP---------------------------  217 (421)
Q Consensus       166 ~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~-~~~~~~p---------------------------  217 (421)
                      .   ........+++.|+|||++.+..+ +.++|||||||++|.+ .|..+++                           
T Consensus       170 ~---~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (353)
T cd07850         170 T---SFMMTPYVVTRYYRAPEVILGMGY-KENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQ  245 (353)
T ss_pred             C---CCCCCCCcccccccCHHHHhCCCC-CCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhh
Confidence            2   222344578999999999988877 5889999999999944 3332221                           


Q ss_pred             -----------------------------------CCCCHHHHHHHHHhcCCCCCCCCCHHhhhcCcccccccc
Q 014609          218 -----------------------------------KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYT  256 (421)
Q Consensus       218 -----------------------------------~~~s~~~~~li~~~L~~dP~~R~t~~eil~~~w~~~~~~  256 (421)
                                                         ...++.++++|.+||+.||++|||+.+++.||||+..+.
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~~~~~~~~  319 (353)
T cd07850         246 PTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHPYINVWYD  319 (353)
T ss_pred             hhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcChhHhhccC
Confidence                                               012456789999999999999999999999999986554

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=100.00  E-value=1.9e-40  Score=313.24  Aligned_cols=228  Identities=36%  Similarity=0.675  Sum_probs=199.8

Q ss_pred             EeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEEeccCCCCh
Q 014609           22 LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGEL  101 (421)
Q Consensus        22 LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~~gg~L  101 (421)
                      ||.|+||.||+|.+..+++.||+|++.+.........+.+.+|+.+++.++||||+++++.+.++...|+++||+++++|
T Consensus         1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (262)
T cd05572           1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL   80 (262)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence            69999999999999999999999999876554444567899999999999999999999999999999999999999999


Q ss_pred             HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCccccCCCccccccCCCC
Q 014609          102 FDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPN  181 (421)
Q Consensus       102 ~~~i~~~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~  181 (421)
                      .+.+.....+++..+..++.|++.||+|||++|++|+||+|+||+++.++.++|+|||++......   .......|++.
T Consensus        81 ~~~l~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~---~~~~~~~~~~~  157 (262)
T cd05572          81 WTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSG---QKTWTFCGTPE  157 (262)
T ss_pred             HHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCcc---cccccccCCcC
Confidence            999988778999999999999999999999999999999999999999999999999998855332   12334578999


Q ss_pred             ccChhhhcccCCCCCcchHHHHHHHHhhh-cCCc-----------------------CCCCCCCHHHHHHHHHhcCCCCC
Q 014609          182 YVAPEVLANRGYDGATSDIWSCGVILYIF-RGDF-----------------------KLPKWLSPGAQNLLRKILEPNPV  237 (421)
Q Consensus       182 y~APEvl~~~~~~~~~~DiwSlGvil~~~-~~~~-----------------------~~p~~~s~~~~~li~~~L~~dP~  237 (421)
                      |+|||.+.+..+ +.++|+||+|+++|.+ .|..                       ..|...++++.++|.+||.++|+
T Consensus       158 ~~~PE~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~  236 (262)
T cd05572         158 YVAPEIILNKGY-DFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEFPNYIDKAAKDLIKQLLRRNPE  236 (262)
T ss_pred             ccChhHhcCCCC-CChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccCCCCCCCcccCHHHHHHHHHHccCChh
Confidence            999999877766 4889999999999933 2222                       23444678999999999999999


Q ss_pred             CCCC-----HHhhhcCccccc
Q 014609          238 KRIT-----IAGIKADEWFEQ  253 (421)
Q Consensus       238 ~R~t-----~~eil~~~w~~~  253 (421)
                      +||+     +.|+++||||..
T Consensus       237 ~R~~~~~~~~~~l~~~~~~~~  257 (262)
T cd05572         237 ERLGNLKGGIKDIKKHKWFNG  257 (262)
T ss_pred             hCcCCcccCHHHHhcChhhhC
Confidence            9999     999999999985

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=100.00  E-value=2.4e-43  Score=321.86  Aligned_cols=233  Identities=28%  Similarity=0.462  Sum_probs=205.6

Q ss_pred             ceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEEe
Q 014609           15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLE   94 (421)
Q Consensus        15 ~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E   94 (421)
                      -|.++++||+|+||.||+|.++++|+.+|||.++.+     .....+.+|+.||++++.|++|++|+.|.....+|+|||
T Consensus        34 VFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~-----sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVME  108 (502)
T KOG0574|consen   34 VFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD-----TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVME  108 (502)
T ss_pred             HHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc-----chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehh
Confidence            478899999999999999999999999999988654     236789999999999999999999999999999999999


Q ss_pred             ccCCCChHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCccccCCCcc
Q 014609           95 YVTGGELFDKIA-SKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLL  173 (421)
Q Consensus        95 ~~~gg~L~~~i~-~~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~  173 (421)
                      ||..|+..|.+. +++++++.++..+++..+.||+|||...-+|||||..|||++.+|..||+|||.|.....  .....
T Consensus       109 YCGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTD--TMAKR  186 (502)
T KOG0574|consen  109 YCGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTD--TMAKR  186 (502)
T ss_pred             hcCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEcccchhhhhhccccchhhh--hHHhh
Confidence            999999999886 467899999999999999999999999999999999999999999999999999975432  12234


Q ss_pred             ccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhhcCCc-----------------------CCCCCCCHHHHHHHHH
Q 014609          174 HTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIFRGDF-----------------------KLPKWLSPGAQNLLRK  230 (421)
Q Consensus       174 ~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~~~~~-----------------------~~p~~~s~~~~~li~~  230 (421)
                      .+..|||.|||||++..-+|+ .++||||||+...++..+.                       .-|..+|.++.+++++
T Consensus       187 NTVIGTPFWMAPEVI~EIGY~-~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMIPT~PPPTF~KPE~WS~~F~DFi~~  265 (502)
T KOG0574|consen  187 NTVIGTPFWMAPEVIEEIGYD-TKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMIPTKPPPTFKKPEEWSSEFNDFIRS  265 (502)
T ss_pred             CccccCcccccHHHHHHhccc-hhhhHhhhcchhhhhhcCCCCcccccccceeEeccCCCCCCCCChHhhhhHHHHHHHH
Confidence            577899999999999999997 8899999999988543221                       1133478999999999


Q ss_pred             hcCCCCCCCCCHHhhhcCccccccc
Q 014609          231 ILEPNPVKRITIAGIKADEWFEQDY  255 (421)
Q Consensus       231 ~L~~dP~~R~t~~eil~~~w~~~~~  255 (421)
                      ||.++|++|.|+.++++|||.++..
T Consensus       266 CLiK~PE~R~TA~~L~~H~FiknA~  290 (502)
T KOG0574|consen  266 CLIKKPEERKTALRLCEHTFIKNAP  290 (502)
T ss_pred             HhcCCHHHHHHHHHHhhhhhhcCCC
Confidence            9999999999999999999998643

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=2.1e-40  Score=311.23  Aligned_cols=230  Identities=28%  Similarity=0.493  Sum_probs=200.3

Q ss_pred             cceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEE
Q 014609           14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVL   93 (421)
Q Consensus        14 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~   93 (421)
                      ++|++.+.||+|+||.||+|.+..+++.+|+|.+.....     .+.+.+|+.++++++||||+++++++......|+++
T Consensus         3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-----~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~   77 (256)
T cd06612           3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED-----LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVM   77 (256)
T ss_pred             ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH-----HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEE
Confidence            579999999999999999999988899999999865421     578999999999999999999999999999999999


Q ss_pred             eccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCccccCCCc
Q 014609           94 EYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGL  172 (421)
Q Consensus        94 E~~~gg~L~~~i~~-~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~  172 (421)
                      ||+++++|.+.+.. ...+++..++.++.|++.|+.|||+.|++||||+|+||+++.++.++|+|||++......  ...
T Consensus        78 e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~--~~~  155 (256)
T cd06612          78 EYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDT--MAK  155 (256)
T ss_pred             ecCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECCCCcEEEcccccchhcccC--ccc
Confidence            99999999999875 457899999999999999999999999999999999999999999999999998865432  112


Q ss_pred             cccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhh-cCCcCC----------------------CCCCCHHHHHHHH
Q 014609          173 LHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIF-RGDFKL----------------------PKWLSPGAQNLLR  229 (421)
Q Consensus       173 ~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~-~~~~~~----------------------p~~~s~~~~~li~  229 (421)
                      .....++..|+|||++.+..+ +.++||||+|+++|.+ .|..++                      +..++..+.++|.
T Consensus       156 ~~~~~~~~~y~~PE~~~~~~~-~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~  234 (256)
T cd06612         156 RNTVIGTPFWMAPEVIQEIGY-NNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNKPPPTLSDPEKWSPEFNDFVK  234 (256)
T ss_pred             cccccCCccccCHHHHhcCCC-CchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhccCCCCCCCchhhcCHHHHHHHH
Confidence            334558899999999988776 5889999999999954 333322                      1235678999999


Q ss_pred             HhcCCCCCCCCCHHhhhcCccc
Q 014609          230 KILEPNPVKRITIAGIKADEWF  251 (421)
Q Consensus       230 ~~L~~dP~~R~t~~eil~~~w~  251 (421)
                      +||+.||++|||+.+++.||||
T Consensus       235 ~~l~~~P~~Rps~~~il~~~~~  256 (256)
T cd06612         235 KCLVKDPEERPSAIQLLQHPFI  256 (256)
T ss_pred             HHHhcChhhCcCHHHHhcCCCC
Confidence            9999999999999999999997

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=100.00  E-value=3.6e-40  Score=317.01  Aligned_cols=238  Identities=31%  Similarity=0.487  Sum_probs=196.8

Q ss_pred             ecceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEE
Q 014609           13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMV   92 (421)
Q Consensus        13 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv   92 (421)
                      +++|++.+.||+|++|.||+|.+..+|+.||+|.+..... .....+.+.+|++++++++||||+++++++......|+|
T Consensus         1 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   79 (294)
T PLN00009          1 MDQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQE-DEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLV   79 (294)
T ss_pred             CCceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccc-cccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEE
Confidence            4789999999999999999999999999999999865432 222346788999999999999999999999999999999


Q ss_pred             EeccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecc-CCCEEEEeccCCCCCccccC
Q 014609           93 LEYVTGGELFDKIASKG--RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDS-KGNIKISDFGLSALPQHFRD  169 (421)
Q Consensus        93 ~E~~~gg~L~~~i~~~~--~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~-~~~~kL~DFGla~~~~~~~~  169 (421)
                      |||++ ++|.+.+....  .+++..++.++.||+.||+|||++|++||||+|+||+++. ++.+||+|||++......  
T Consensus        80 ~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~--  156 (294)
T PLN00009         80 FEYLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIP--  156 (294)
T ss_pred             Eeccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEECCCCEEEEcccccccccCCC--
Confidence            99995 57888776543  3578889999999999999999999999999999999985 457999999999754321  


Q ss_pred             CCccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhh-cCCcCCC-------------------------------
Q 014609          170 DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIF-RGDFKLP-------------------------------  217 (421)
Q Consensus       170 ~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~-~~~~~~p-------------------------------  217 (421)
                      ........+++.|+|||++.+....+.++||||+||++|.+ .|..+++                               
T Consensus       157 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (294)
T PLN00009        157 VRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPD  236 (294)
T ss_pred             ccccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccchh
Confidence            11223346788999999987654446889999999999954 3333221                               


Q ss_pred             -----------------CCCCHHHHHHHHHhcCCCCCCCCCHHhhhcCcccccc
Q 014609          218 -----------------KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD  254 (421)
Q Consensus       218 -----------------~~~s~~~~~li~~~L~~dP~~R~t~~eil~~~w~~~~  254 (421)
                                       +.+++.+.+++.+||+.+|.+||++.+++.||||...
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~~~~~~~  290 (294)
T PLN00009        237 YKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFKDL  290 (294)
T ss_pred             hhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcCchHhHH
Confidence                             2357888999999999999999999999999999853

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=1.7e-40  Score=317.91  Aligned_cols=236  Identities=27%  Similarity=0.441  Sum_probs=200.5

Q ss_pred             cceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEE
Q 014609           14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVL   93 (421)
Q Consensus        14 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~   93 (421)
                      ++|++++.||+|+||.||+|.+..+|+.||+|.+....  .......+.+|+.++++++||||+++++.+...+..|+||
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   78 (286)
T cd06622           1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLEL--DESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCM   78 (286)
T ss_pred             ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeeccc--CHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEE
Confidence            47899999999999999999999999999999986532  2233467889999999999999999999999999999999


Q ss_pred             eccCCCChHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHh-CCceeccCCCCCEEeccCCCEEEEeccCCCCCccccC
Q 014609           94 EYVTGGELFDKIASK---GRLQEAEGRKLFQQLIDGVSYCHN-KGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD  169 (421)
Q Consensus        94 E~~~gg~L~~~i~~~---~~~~~~~~~~~~~ql~~aL~~LH~-~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~  169 (421)
                      ||++|++|..++...   ..+++..+..++.|++.||.|||+ .||+||||||+||+++.++.+||+|||++.....   
T Consensus        79 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~---  155 (286)
T cd06622          79 EYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVA---  155 (286)
T ss_pred             eecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCCCEEEeecCCcccccC---
Confidence            999999998887653   378999999999999999999997 5999999999999999999999999999874422   


Q ss_pred             CCccccccCCCCccChhhhcccCC-----CCCcchHHHHHHHHhhh-cCCcCC-----------------------CCCC
Q 014609          170 DGLLHTTCGSPNYVAPEVLANRGY-----DGATSDIWSCGVILYIF-RGDFKL-----------------------PKWL  220 (421)
Q Consensus       170 ~~~~~~~~gt~~y~APEvl~~~~~-----~~~~~DiwSlGvil~~~-~~~~~~-----------------------p~~~  220 (421)
                       .......+++.|+|||++.+...     .+.++|+||+||++|.+ .|..++                       |+.+
T Consensus       156 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (286)
T cd06622         156 -SLAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPPTLPSGY  234 (286)
T ss_pred             -CccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHHhhcCCCCCCccc
Confidence             23345578899999999854332     25789999999999944 333332                       3346


Q ss_pred             CHHHHHHHHHhcCCCCCCCCCHHhhhcCccccccc
Q 014609          221 SPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY  255 (421)
Q Consensus       221 s~~~~~li~~~L~~dP~~R~t~~eil~~~w~~~~~  255 (421)
                      ++++.++|.+||+.+|++||++.+++.||||....
T Consensus       235 ~~~~~~li~~~l~~~p~~Rp~~~~l~~~~~~~~~~  269 (286)
T cd06622         235 SDDAQDFVAKCLNKIPNRRPTYAQLLEHPWLVKYK  269 (286)
T ss_pred             CHHHHHHHHHHcccCcccCCCHHHHhcChhhhhcc
Confidence            78899999999999999999999999999998654

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=5.1e-40  Score=308.64  Aligned_cols=232  Identities=30%  Similarity=0.514  Sum_probs=200.2

Q ss_pred             ceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEEe
Q 014609           15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLE   94 (421)
Q Consensus        15 ~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E   94 (421)
                      +|++.+.||+|+||.||+|.+..+++.+|+|.+....... .....+.+|+.++++++||||+++++.+..++..++|||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e   79 (256)
T cd08220           1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTK-DERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVME   79 (256)
T ss_pred             CceEEEEecccCceEEEEEEEcCCCcEEEEEEEecccccc-HHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEe
Confidence            6999999999999999999999999999999997654332 335789999999999999999999999999999999999


Q ss_pred             ccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCC-CEEEEeccCCCCCccccCCC
Q 014609           95 YVTGGELFDKIASK--GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKG-NIKISDFGLSALPQHFRDDG  171 (421)
Q Consensus        95 ~~~gg~L~~~i~~~--~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~-~~kL~DFGla~~~~~~~~~~  171 (421)
                      |++|++|.+++...  ..+++..+..++.|++.||+|||++|++||||+|+||+++.++ .+||+|||++.....   ..
T Consensus        80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~---~~  156 (256)
T cd08220          80 YAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSS---KS  156 (256)
T ss_pred             cCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCC---Cc
Confidence            99999999999763  3589999999999999999999999999999999999998655 579999999985432   22


Q ss_pred             ccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhhcC-C--------------------cCCCCCCCHHHHHHHHH
Q 014609          172 LLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIFRG-D--------------------FKLPKWLSPGAQNLLRK  230 (421)
Q Consensus       172 ~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~~~-~--------------------~~~p~~~s~~~~~li~~  230 (421)
                      ......|++.|+|||.+.+..+ +.++|+||+|+++|.+.. .                    .++|..+++++.+++.+
T Consensus       157 ~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~  235 (256)
T cd08220         157 KAYTVVGTPCYISPELCEGKPY-NQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTFAPISDRYSPDLRQLILS  235 (256)
T ss_pred             cccccccCCcccCchhccCCCC-CcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHHhcCCCCCCCCcCHHHHHHHHH
Confidence            2334578999999999887665 588999999999995432 1                    12344578999999999


Q ss_pred             hcCCCCCCCCCHHhhhcCccc
Q 014609          231 ILEPNPVKRITIAGIKADEWF  251 (421)
Q Consensus       231 ~L~~dP~~R~t~~eil~~~w~  251 (421)
                      ||+++|++|||+.++++||||
T Consensus       236 ~l~~~p~~Rpt~~~ll~~p~~  256 (256)
T cd08220         236 MLNLDPSKRPQLSQIMAQPIC  256 (256)
T ss_pred             HccCChhhCCCHHHHhhCCCC
Confidence            999999999999999999996

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=100.00  E-value=1.2e-40  Score=316.91  Aligned_cols=237  Identities=34%  Similarity=0.643  Sum_probs=206.2

Q ss_pred             cceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCC-CCCcceEEEEEEeCCEEEEE
Q 014609           14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK-HPNVVRLHEVLASKSKIYMV   92 (421)
Q Consensus        14 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~lv   92 (421)
                      ++|++.+.||+|+||.||+|.+..+|+.||+|++.+...........+.+|..++++++ ||||+++++++...+..|+|
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv   80 (280)
T cd05581           1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV   80 (280)
T ss_pred             CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence            47999999999999999999999999999999998755544444577889999999998 99999999999999999999


Q ss_pred             EeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCccccCC--
Q 014609           93 LEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD--  170 (421)
Q Consensus        93 ~E~~~gg~L~~~i~~~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~--  170 (421)
                      |||+++++|.+.+...+.+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++.........  
T Consensus        81 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~~~~  160 (280)
T cd05581          81 LEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPES  160 (280)
T ss_pred             EcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEecCCccccccCCcccccc
Confidence            999999999999988888999999999999999999999999999999999999999999999999998855332110  


Q ss_pred             ----------------CccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhh-cCC-------------------c
Q 014609          171 ----------------GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIF-RGD-------------------F  214 (421)
Q Consensus       171 ----------------~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~-~~~-------------------~  214 (421)
                                      .......++..|+|||++....+ +.++|+||+|+++|.+ .|.                   .
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~-~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~  239 (280)
T cd05581         161 NKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPA-GKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKILKLEY  239 (280)
T ss_pred             CCCCCccccccccccccccccccCCccccCHHHhCCCCC-ChhhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhcCC
Confidence                            12233467889999999877665 5889999999999943 222                   2


Q ss_pred             CCCCCCCHHHHHHHHHhcCCCCCCCCCH----HhhhcCccc
Q 014609          215 KLPKWLSPGAQNLLRKILEPNPVKRITI----AGIKADEWF  251 (421)
Q Consensus       215 ~~p~~~s~~~~~li~~~L~~dP~~R~t~----~eil~~~w~  251 (421)
                      .+|..+++.+.++|.+||+.+|.+|||+    .++++||||
T Consensus       240 ~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~~~~  280 (280)
T cd05581         240 SFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPFF  280 (280)
T ss_pred             CCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcCCCC
Confidence            3455678999999999999999999999    999999997

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=100.00  E-value=2.1e-40  Score=316.12  Aligned_cols=228  Identities=31%  Similarity=0.497  Sum_probs=196.1

Q ss_pred             EeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEEeccCCCCh
Q 014609           22 LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGEL  101 (421)
Q Consensus        22 LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~~gg~L  101 (421)
                      ||+|+||+||+|.+..+|+.||+|++.+...........+.+|+.++++++||||+++++++...+..|+||||++|++|
T Consensus         1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (277)
T cd05577           1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL   80 (277)
T ss_pred             CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence            68999999999999999999999999765443333345677899999999999999999999999999999999999999


Q ss_pred             HHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCccccCCCccccccCC
Q 014609          102 FDKIASKG--RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGS  179 (421)
Q Consensus       102 ~~~i~~~~--~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt  179 (421)
                      .+++....  .+++..+..++.|++.||.|||+.|++||||+|+||+++.++.++|+|||++.....   ........++
T Consensus        81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~---~~~~~~~~~~  157 (277)
T cd05577          81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKG---GKKIKGRAGT  157 (277)
T ss_pred             HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEccCcchhhhcc---CCccccccCC
Confidence            99987655  799999999999999999999999999999999999999999999999999875432   2223345678


Q ss_pred             CCccChhhhcccCCCCCcchHHHHHHHHhhh-cCCcCC-----------------------CCCCCHHHHHHHHHhcCCC
Q 014609          180 PNYVAPEVLANRGYDGATSDIWSCGVILYIF-RGDFKL-----------------------PKWLSPGAQNLLRKILEPN  235 (421)
Q Consensus       180 ~~y~APEvl~~~~~~~~~~DiwSlGvil~~~-~~~~~~-----------------------p~~~s~~~~~li~~~L~~d  235 (421)
                      ..|+|||++.+..+ +.++|+||+||++|.+ .|..++                       |..+++.+.++|++||+.|
T Consensus       158 ~~y~~PE~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~  236 (277)
T cd05577         158 PGYMAPEVLQGEVY-DFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEYPDKFSPEAKDLCEALLQKD  236 (277)
T ss_pred             CCcCCHHHhcCCCC-CchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhccccccccCCccCCHHHHHHHHHHccCC
Confidence            89999999887765 5889999999999944 333332                       3346889999999999999


Q ss_pred             CCCCC-----CHHhhhcCccccc
Q 014609          236 PVKRI-----TIAGIKADEWFEQ  253 (421)
Q Consensus       236 P~~R~-----t~~eil~~~w~~~  253 (421)
                      |.+||     ++.+++.||||..
T Consensus       237 p~~R~~~~~~~~~~ll~h~~~~~  259 (277)
T cd05577         237 PEKRLGCRGGSADEVREHPLFKD  259 (277)
T ss_pred             hhHccCCCcccHHHHHhChhhhc
Confidence            99999     8888999999974

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.2e-40  Score=312.80  Aligned_cols=234  Identities=29%  Similarity=0.460  Sum_probs=196.5

Q ss_pred             eecceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcC-CCCCcceEEEEEEeCC---
Q 014609           12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEVLASKS---   87 (421)
Q Consensus        12 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~---   87 (421)
                      ..++|++.+.||+|++|.||+|.+..+++.+++|++.....    ..+.+.+|+.+++++ +||||+++++++....   
T Consensus         4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~----~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~   79 (275)
T cd06608           4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED----EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPG   79 (275)
T ss_pred             chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch----hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCC
Confidence            34899999999999999999999998999999999875432    246789999999999 6999999999997644   


Q ss_pred             ---EEEEEEeccCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccC
Q 014609           88 ---KIYMVLEYVTGGELFDKIAS----KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGL  160 (421)
Q Consensus        88 ---~~~lv~E~~~gg~L~~~i~~----~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGl  160 (421)
                         .+|+||||+++++|.+.+..    +..+++..++.++.|++.||.|||+.|++||||+|+||+++.++.++|+|||+
T Consensus        80 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~~~~~~l~d~~~  159 (275)
T cd06608          80 NDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGV  159 (275)
T ss_pred             cceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEccCCeEEECCCcc
Confidence               48999999999999988764    35789999999999999999999999999999999999999999999999999


Q ss_pred             CCCCccccCCCccccccCCCCccChhhhcccC----CCCCcchHHHHHHHHhhhc-CCcCCC------------------
Q 014609          161 SALPQHFRDDGLLHTTCGSPNYVAPEVLANRG----YDGATSDIWSCGVILYIFR-GDFKLP------------------  217 (421)
Q Consensus       161 a~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~----~~~~~~DiwSlGvil~~~~-~~~~~p------------------  217 (421)
                      +......  ........|++.|+|||++....    ..+.++|||||||++|.+. |..++.                  
T Consensus       160 ~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~  237 (275)
T cd06608         160 SAQLDST--LGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPRNPPPT  237 (275)
T ss_pred             ceecccc--hhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHhhccCCCC
Confidence            8754321  12233456899999999975422    2257899999999999544 333321                  


Q ss_pred             ----CCCCHHHHHHHHHhcCCCCCCCCCHHhhhcCccc
Q 014609          218 ----KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWF  251 (421)
Q Consensus       218 ----~~~s~~~~~li~~~L~~dP~~R~t~~eil~~~w~  251 (421)
                          ..++..+.++|.+||..||++|||+.+++.|||+
T Consensus       238 ~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~~~~  275 (275)
T cd06608         238 LKSPENWSKKFNDFISECLIKNYEQRPFMEELLEHPFI  275 (275)
T ss_pred             CCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcCCCC
Confidence                1256789999999999999999999999999996

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=100.00  E-value=6.9e-40  Score=309.20  Aligned_cols=236  Identities=35%  Similarity=0.587  Sum_probs=202.8

Q ss_pred             ceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEEe
Q 014609           15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLE   94 (421)
Q Consensus        15 ~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E   94 (421)
                      +|++.+.||+|+||.||+|.+..+++.||+|.+...... ......+.+|+.++++++||||+++++++.+.+.+++|+|
T Consensus         1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e   79 (264)
T cd06626           1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDND-PKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFME   79 (264)
T ss_pred             CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccc-hHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEe
Confidence            699999999999999999999889999999999765433 3356789999999999999999999999999999999999


Q ss_pred             ccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCccccCCC-c-
Q 014609           95 YVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDG-L-  172 (421)
Q Consensus        95 ~~~gg~L~~~i~~~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~-~-  172 (421)
                      |+++++|.+++.....+++..++.++.|++.||+|||+.||+|+||+|+||+++.++.+||+|||++.......... . 
T Consensus        80 ~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~~~~  159 (264)
T cd06626          80 YCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEE  159 (264)
T ss_pred             cCCCCcHHHHHhhcCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEcccccccccCCCCCccccc
Confidence            99999999999887779999999999999999999999999999999999999999999999999988653321111 1 


Q ss_pred             cccccCCCCccChhhhcccC--CCCCcchHHHHHHHHhhh-cCCcC---------------------CCCC--CCHHHHH
Q 014609          173 LHTTCGSPNYVAPEVLANRG--YDGATSDIWSCGVILYIF-RGDFK---------------------LPKW--LSPGAQN  226 (421)
Q Consensus       173 ~~~~~gt~~y~APEvl~~~~--~~~~~~DiwSlGvil~~~-~~~~~---------------------~p~~--~s~~~~~  226 (421)
                      .....+++.|+|||++.+..  ..+.++||||+|+++|.+ .|..+                     +|.+  +++.+.+
T Consensus       160 ~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (264)
T cd06626         160 VQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGHKPPIPDSLQLSPEGKD  239 (264)
T ss_pred             ccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhcCCCCCCCcccccCHHHHH
Confidence            22457889999999987654  135889999999999943 33332                     2333  3788999


Q ss_pred             HHHHhcCCCCCCCCCHHhhhcCccc
Q 014609          227 LLRKILEPNPVKRITIAGIKADEWF  251 (421)
Q Consensus       227 li~~~L~~dP~~R~t~~eil~~~w~  251 (421)
                      +|.+||+.+|.+|||+.+++.|||+
T Consensus       240 li~~~l~~~p~~R~~~~~i~~~~~~  264 (264)
T cd06626         240 FLDRCLESDPKKRPTASELLQHPFV  264 (264)
T ss_pred             HHHHHccCCcccCCCHHHHhcCCCC
Confidence            9999999999999999999999996

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=5.5e-40  Score=308.55  Aligned_cols=234  Identities=34%  Similarity=0.545  Sum_probs=202.2

Q ss_pred             ceEEeceEeecCcEEEEEEEECCCCceEEEEEeeccccc--chhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEE
Q 014609           15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRII--HLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMV   92 (421)
Q Consensus        15 ~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~--~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv   92 (421)
                      +|+..+.||+|+||+||+|.+..+++.|++|.+......  .......+.+|+.+++.++||||+++++++.....+|++
T Consensus         1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (258)
T cd06632           1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF   80 (258)
T ss_pred             CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence            588899999999999999999889999999998754321  223456789999999999999999999999999999999


Q ss_pred             EeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCccccCCCc
Q 014609           93 LEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGL  172 (421)
Q Consensus        93 ~E~~~gg~L~~~i~~~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~  172 (421)
                      +||+++++|.+++.....+++..+..++.|++.||+|||+.||+|+||+|+||+++.++.+||+|||++......   ..
T Consensus        81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~---~~  157 (258)
T cd06632          81 LELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEF---SF  157 (258)
T ss_pred             EEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccceecccc---cc
Confidence            999999999999988778999999999999999999999999999999999999999999999999998754332   12


Q ss_pred             cccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhhc-CCcC---------------------CCCCCCHHHHHHHHH
Q 014609          173 LHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIFR-GDFK---------------------LPKWLSPGAQNLLRK  230 (421)
Q Consensus       173 ~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~~-~~~~---------------------~p~~~s~~~~~li~~  230 (421)
                      .....|++.|+|||.+......+.++|+||+||++|.+. |..+                     .|..+++.+.+++++
T Consensus       158 ~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  237 (258)
T cd06632         158 AKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKELPPIPDHLSDEAKDFILK  237 (258)
T ss_pred             ccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHhcccCCCcCCCcCHHHHHHHHH
Confidence            345678999999999876652358899999999999443 3222                     234567899999999


Q ss_pred             hcCCCCCCCCCHHhhhcCccc
Q 014609          231 ILEPNPVKRITIAGIKADEWF  251 (421)
Q Consensus       231 ~L~~dP~~R~t~~eil~~~w~  251 (421)
                      ||+.+|++||++.+++.|||+
T Consensus       238 ~l~~~p~~Rp~~~~~l~~~~~  258 (258)
T cd06632         238 CLQRDPSLRPTAAELLEHPFV  258 (258)
T ss_pred             HhhcCcccCcCHHHHhcCCCC
Confidence            999999999999999999996

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=100.00  E-value=3.4e-40  Score=315.19  Aligned_cols=230  Identities=30%  Similarity=0.467  Sum_probs=191.4

Q ss_pred             eEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHH---HHHhcCCCCCcceEEEEEEeCCEEEEEEeccC
Q 014609           21 TLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREI---ATLKLLKHPNVVRLHEVLASKSKIYMVLEYVT   97 (421)
Q Consensus        21 ~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei---~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~~   97 (421)
                      .||+|+||.||+|.+..+++.||+|.+.+..............|.   ..++...||||+++++++...+..|+||||++
T Consensus         1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (278)
T cd05606           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN   80 (278)
T ss_pred             CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence            489999999999999999999999999865433222122233343   34555679999999999999999999999999


Q ss_pred             CCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCccccCCCcccccc
Q 014609           98 GGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTC  177 (421)
Q Consensus        98 gg~L~~~i~~~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~  177 (421)
                      |++|.+++...+.+++..++.++.|++.||+|||+.+|+||||||+||+++.++.++|+|||++.....    ......+
T Consensus        81 g~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~----~~~~~~~  156 (278)
T cd05606          81 GGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSK----KKPHASV  156 (278)
T ss_pred             CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCCCCEEEccCcCccccCc----cCCcCcC
Confidence            999999998888899999999999999999999999999999999999999999999999999874432    1223457


Q ss_pred             CCCCccChhhhcccCCCCCcchHHHHHHHHhhh-cCCcCC----------------------CCCCCHHHHHHHHHhcCC
Q 014609          178 GSPNYVAPEVLANRGYDGATSDIWSCGVILYIF-RGDFKL----------------------PKWLSPGAQNLLRKILEP  234 (421)
Q Consensus       178 gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~-~~~~~~----------------------p~~~s~~~~~li~~~L~~  234 (421)
                      |++.|+|||++.+....+.++||||+||++|.+ .|..++                      |..+++.+.+++.+||..
T Consensus       157 ~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~  236 (278)
T cd05606         157 GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEGLLQR  236 (278)
T ss_pred             CCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHhhccCCCCCCcCCHHHHHHHHHHhhc
Confidence            999999999987543335889999999999944 333332                      333678999999999999


Q ss_pred             CCCCCC-----CHHhhhcCcccccc
Q 014609          235 NPVKRI-----TIAGIKADEWFEQD  254 (421)
Q Consensus       235 dP~~R~-----t~~eil~~~w~~~~  254 (421)
                      +|.+|+     ++.++++||||...
T Consensus       237 ~p~~R~~~~~~~~~~ll~~~~~~~~  261 (278)
T cd05606         237 DVNRRLGCLGRGAQEVKEHPFFRSL  261 (278)
T ss_pred             CHHhccCCCCCCHHHHHhCccccCC
Confidence            999999     99999999999863

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.8e-41  Score=335.03  Aligned_cols=229  Identities=31%  Similarity=0.547  Sum_probs=202.2

Q ss_pred             eEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEEeccCCCC
Q 014609           21 TLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGE  100 (421)
Q Consensus        21 ~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~~gg~  100 (421)
                      .||+|.||+||-|+|..|...+|||.+....   ......+..||.+++.|+|.|||++++.+..++.+-|.||-++||+
T Consensus       582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekd---sr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGS  658 (1226)
T KOG4279|consen  582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKD---SREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGS  658 (1226)
T ss_pred             EeecCceeEEEeeccccceeEEEeeeccccc---chhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCc
Confidence            5999999999999999999999999997543   2346779999999999999999999999999999999999999999


Q ss_pred             hHHHHHhc-CCC--CHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEec-cCCCEEEEeccCCCCCccccCCCccccc
Q 014609          101 LFDKIASK-GRL--QEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLD-SKGNIKISDFGLSALPQHFRDDGLLHTT  176 (421)
Q Consensus       101 L~~~i~~~-~~~--~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~-~~~~~kL~DFGla~~~~~~~~~~~~~~~  176 (421)
                      |.+.+... +++  .+...-.|.+||++||.|||++.|+|||||-+|+|++ -.|.+||+|||-++-..  +-+....++
T Consensus       659 LSsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLA--ginP~TETF  736 (1226)
T KOG4279|consen  659 LSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLA--GINPCTETF  736 (1226)
T ss_pred             HHHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEeeccceEEecccccchhhc--cCCcccccc
Confidence            99999763 667  8889999999999999999999999999999999997 46899999999887432  245677888


Q ss_pred             cCCCCccChhhhcc--cCCCCCcchHHHHHHHHhhh-----------------------cCCcCCCCCCCHHHHHHHHHh
Q 014609          177 CGSPNYVAPEVLAN--RGYDGATSDIWSCGVILYIF-----------------------RGDFKLPKWLSPGAQNLLRKI  231 (421)
Q Consensus       177 ~gt~~y~APEvl~~--~~~~~~~~DiwSlGvil~~~-----------------------~~~~~~p~~~s~~~~~li~~~  231 (421)
                      .||.-|||||++..  .+| |.++|||||||++.++                       ...+++|..+|.+++.+|.+|
T Consensus       737 TGTLQYMAPEvIDqG~RGY-G~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkVGmyKvHP~iPeelsaeak~Filrc  815 (1226)
T KOG4279|consen  737 TGTLQYMAPEVIDQGPRGY-GKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKVGMYKVHPPIPEELSAEAKNFILRC  815 (1226)
T ss_pred             ccchhhhChHhhccCCcCC-CchhhhhhccceeEeeccCCCCeeecCChhHhhhhhcceecCCCCcHHHHHHHHHHHHHH
Confidence            99999999999864  455 7999999999999844                       234566777899999999999


Q ss_pred             cCCCCCCCCCHHhhhcCccccccc
Q 014609          232 LEPNPVKRITIAGIKADEWFEQDY  255 (421)
Q Consensus       232 L~~dP~~R~t~~eil~~~w~~~~~  255 (421)
                      +.+||..||++.+++.+||++...
T Consensus       816 Fepd~~~R~sA~~LL~DpFlq~~~  839 (1226)
T KOG4279|consen  816 FEPDPCDRPSAKDLLQDPFLQHNN  839 (1226)
T ss_pred             cCCCcccCccHHHhccCcccccCC
Confidence            999999999999999999998763

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=2.6e-40  Score=316.62  Aligned_cols=237  Identities=26%  Similarity=0.425  Sum_probs=204.7

Q ss_pred             eecceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEE
Q 014609           12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYM   91 (421)
Q Consensus        12 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l   91 (421)
                      ...+|++++.||+|+||+||+|.+..+|+.||+|++....  .......+.+|+++++.++||||+++++++...+.+|+
T Consensus         3 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l   80 (284)
T cd06620           3 RNEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGA--KSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICM   80 (284)
T ss_pred             cHHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecC--cchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEE
Confidence            3568999999999999999999999999999999987543  22335788999999999999999999999999999999


Q ss_pred             EEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCceeccCCCCCEEeccCCCEEEEeccCCCCCccccCC
Q 014609           92 VLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHN-KGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD  170 (421)
Q Consensus        92 v~E~~~gg~L~~~i~~~~~~~~~~~~~~~~ql~~aL~~LH~-~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~  170 (421)
                      ||||+++++|.+++...+.+++..++.++.|++.||.|||+ .+++||||||+||+++.++.++|+|||++.....    
T Consensus        81 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~----  156 (284)
T cd06620          81 CMEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELIN----  156 (284)
T ss_pred             EEecCCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCCcEEEccCCcccchhh----
Confidence            99999999999998887889999999999999999999997 5999999999999999999999999999864322    


Q ss_pred             CccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhhc-CCcCCC-------------------------------C
Q 014609          171 GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIFR-GDFKLP-------------------------------K  218 (421)
Q Consensus       171 ~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~~-~~~~~p-------------------------------~  218 (421)
                      ......+|+..|+|||++.+..+ +.++|+||+||++|.+. |..++.                               .
T Consensus       157 ~~~~~~~~~~~~~aPE~~~~~~~-~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (284)
T cd06620         157 SIADTFVGTSTYMSPERIQGGKY-TVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPRLPS  235 (284)
T ss_pred             hccCccccCcccCCHHHHccCCC-CccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhccCCCCCc
Confidence            12234578999999999877666 58899999999999543 443331                               1


Q ss_pred             -CCCHHHHHHHHHhcCCCCCCCCCHHhhhcCccccccc
Q 014609          219 -WLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY  255 (421)
Q Consensus       219 -~~s~~~~~li~~~L~~dP~~R~t~~eil~~~w~~~~~  255 (421)
                       .++..+.+|+.+||++||++|||+.++++|+||.+..
T Consensus       236 ~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~~~  273 (284)
T cd06620         236 SDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQAL  273 (284)
T ss_pred             hhcCHHHHHHHHHHhcCCcccCcCHHHHhcCccccccc
Confidence             1567899999999999999999999999999998754

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=4.4e-40  Score=312.12  Aligned_cols=231  Identities=23%  Similarity=0.327  Sum_probs=193.0

Q ss_pred             ecceEEeceEeecCcEEEEEEEEC---CCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEE
Q 014609           13 LGRYELGRTLGEGNFGKVKFAQDL---DSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKI   89 (421)
Q Consensus        13 ~~~y~i~~~LG~G~~g~V~~a~~~---~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~   89 (421)
                      ..+|++.+.||+|+||.||+|.+.   ..+..||+|.++...  .......+.+|+.+++.++||||+++++++...+..
T Consensus         4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~   81 (266)
T cd05064           4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGC--SDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTM   81 (266)
T ss_pred             hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCC--CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCc
Confidence            467999999999999999999764   456799999987542  223346788999999999999999999999999999


Q ss_pred             EEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCcccc
Q 014609           90 YMVLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFR  168 (421)
Q Consensus        90 ~lv~E~~~gg~L~~~i~~~-~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~~  168 (421)
                      |+||||+++++|.+++... ..+++..++.++.|++.||+|||++|++||||||+|||++.++.++++|||.+.......
T Consensus        82 ~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~~~  161 (266)
T cd05064          82 MIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEA  161 (266)
T ss_pred             EEEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcCCCcEEECCCcccccccccc
Confidence            9999999999999988763 578999999999999999999999999999999999999999999999999876432110


Q ss_pred             CCCccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhh-hc-CCcC--------------------CCCCCCHHHHH
Q 014609          169 DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYI-FR-GDFK--------------------LPKWLSPGAQN  226 (421)
Q Consensus       169 ~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~-~~-~~~~--------------------~p~~~s~~~~~  226 (421)
                       ........+++.|+|||++.+..+ +.++||||+||++|. +. |..+                    .|..++..+.+
T Consensus       162 -~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (266)
T cd05064         162 -IYTTMSGKSPVLWAAPEAIQYHHF-SSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDGFRLPAPRNCPNLLHQ  239 (266)
T ss_pred             -hhcccCCCCceeecCHHHHhhCCc-cchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCCCCCCCCCHHHHH
Confidence             111112345678999999988777 589999999999996 32 4333                    23446889999


Q ss_pred             HHHHhcCCCCCCCCCHHhhhc
Q 014609          227 LLRKILEPNPVKRITIAGIKA  247 (421)
Q Consensus       227 li~~~L~~dP~~R~t~~eil~  247 (421)
                      ++.+||+++|.+||++.+|++
T Consensus       240 li~~c~~~~p~~RP~~~~i~~  260 (266)
T cd05064         240 LMLDCWQKERGERPRFSQIHS  260 (266)
T ss_pred             HHHHHcCCCchhCCCHHHHHH
Confidence            999999999999999999865

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=100.00  E-value=5.6e-40  Score=309.58  Aligned_cols=235  Identities=29%  Similarity=0.515  Sum_probs=204.9

Q ss_pred             cceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEE
Q 014609           14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVL   93 (421)
Q Consensus        14 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~   93 (421)
                      .+|++.+.||+|++|.||+|.+..+++.||+|++......  .....+.+|+.++.+++||||+++++++......|+||
T Consensus         1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   78 (264)
T cd06623           1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDE--EFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVL   78 (264)
T ss_pred             CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcch--HHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEE
Confidence            3689999999999999999999999999999998765322  33578999999999999999999999999999999999


Q ss_pred             eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCceeccCCCCCEEeccCCCEEEEeccCCCCCccccCCCc
Q 014609           94 EYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHN-KGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGL  172 (421)
Q Consensus        94 E~~~gg~L~~~i~~~~~~~~~~~~~~~~ql~~aL~~LH~-~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~  172 (421)
                      ||+++++|.+++.....+++..+..++.|++.|++|||+ .|++||||+|+||+++.++.++|+|||++......  ...
T Consensus        79 e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~--~~~  156 (264)
T cd06623          79 EYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENT--LDQ  156 (264)
T ss_pred             EecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCCCCEEEccCccceecccC--CCc
Confidence            999999999999887889999999999999999999999 99999999999999999999999999998865432  122


Q ss_pred             cccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhh-cCCcCC-----------------------CCC-CCHHHHHH
Q 014609          173 LHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIF-RGDFKL-----------------------PKW-LSPGAQNL  227 (421)
Q Consensus       173 ~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~-~~~~~~-----------------------p~~-~s~~~~~l  227 (421)
                      .....++..|+|||.+....+ +.++|+||||+++|.+ .|..++                       +.. ++..+.++
T Consensus       157 ~~~~~~~~~y~~pE~~~~~~~-~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  235 (264)
T cd06623         157 CNTFVGTVTYMSPERIQGESY-SYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPPSLPAEEFSPEFRDF  235 (264)
T ss_pred             ccceeecccccCHhhhCCCCC-CchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhcCCCCCCCcccCCHHHHHH
Confidence            234568899999999877755 5889999999999944 333332                       222 67889999


Q ss_pred             HHHhcCCCCCCCCCHHhhhcCccccc
Q 014609          228 LRKILEPNPVKRITIAGIKADEWFEQ  253 (421)
Q Consensus       228 i~~~L~~dP~~R~t~~eil~~~w~~~  253 (421)
                      |.+||.++|++|||+.++++|||++.
T Consensus       236 i~~~l~~~p~~R~~~~~ll~~~~~~~  261 (264)
T cd06623         236 ISACLQKDPKKRPSAAELLQHPFIKK  261 (264)
T ss_pred             HHHHccCChhhCCCHHHHHhCHHHHh
Confidence            99999999999999999999999975

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=100.00  E-value=6.2e-40  Score=308.91  Aligned_cols=233  Identities=31%  Similarity=0.543  Sum_probs=199.7

Q ss_pred             ceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEe--CCEEEEE
Q 014609           15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLAS--KSKIYMV   92 (421)
Q Consensus        15 ~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~--~~~~~lv   92 (421)
                      +|++.+.||.|+||.||+|.+..+++.||+|.+...... ....+.+.+|+.+++.++||||+++++++..  ....|++
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~   79 (265)
T cd08217           1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMT-EKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIV   79 (265)
T ss_pred             CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCC-HHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEE
Confidence            589999999999999999999999999999998765432 3335678899999999999999999998753  4578999


Q ss_pred             EeccCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH-----hCCceeccCCCCCEEeccCCCEEEEeccCCCC
Q 014609           93 LEYVTGGELFDKIAS----KGRLQEAEGRKLFQQLIDGVSYCH-----NKGVFHRDLKLENILLDSKGNIKISDFGLSAL  163 (421)
Q Consensus        93 ~E~~~gg~L~~~i~~----~~~~~~~~~~~~~~ql~~aL~~LH-----~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~  163 (421)
                      |||+++++|.+.+..    ..++++..++.++.||+.||+|||     +.+++||||+|+||+++.++.+||+|||++..
T Consensus        80 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~  159 (265)
T cd08217          80 MEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKI  159 (265)
T ss_pred             ehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEeccccccc
Confidence            999999999998865    357899999999999999999999     89999999999999999999999999999986


Q ss_pred             CccccCCCccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhhc-CCcC--------------------CCCCCCH
Q 014609          164 PQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIFR-GDFK--------------------LPKWLSP  222 (421)
Q Consensus       164 ~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~~-~~~~--------------------~p~~~s~  222 (421)
                      ....  ........+++.|+|||++....+ +.++|+||||+++|.+. |..+                    +|..++.
T Consensus       160 ~~~~--~~~~~~~~~~~~~~~pE~~~~~~~-~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (265)
T cd08217         160 LGHD--SSFAKTYVGTPYYMSPEQLNHMSY-DEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEGKFRRIPYRYSS  236 (265)
T ss_pred             ccCC--cccccccccCCCccChhhhcCCCC-CchhHHHHHHHHHHHHHHCCCcccCcCHHHHHHHHhcCCCCCCccccCH
Confidence            5432  222344578999999999887666 58899999999999443 3322                    3445779


Q ss_pred             HHHHHHHHhcCCCCCCCCCHHhhhcCccc
Q 014609          223 GAQNLLRKILEPNPVKRITIAGIKADEWF  251 (421)
Q Consensus       223 ~~~~li~~~L~~dP~~R~t~~eil~~~w~  251 (421)
                      .+.+++.+||+.+|++|||+.+|++|||+
T Consensus       237 ~~~~l~~~~l~~~p~~Rp~~~~il~~~~~  265 (265)
T cd08217         237 ELNEVIKSMLNVDPDKRPSTEELLQLPLI  265 (265)
T ss_pred             HHHHHHHHHccCCcccCCCHHHHhhCCCC
Confidence            99999999999999999999999999996

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=100.00  E-value=4.3e-40  Score=313.81  Aligned_cols=229  Identities=32%  Similarity=0.492  Sum_probs=191.0

Q ss_pred             eEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCC-CCCcceEEEEEEeC--CEEEEE
Q 014609           16 YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK-HPNVVRLHEVLASK--SKIYMV   92 (421)
Q Consensus        16 y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~--~~~~lv   92 (421)
                      |++.+.||+|+||.||+|.+..+++.||+|.++..... .. .....+|+.+++++. ||||+++++++.+.  +..++|
T Consensus         1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~-~~-~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv   78 (282)
T cd07831           1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKS-LE-QVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALV   78 (282)
T ss_pred             CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCC-ch-hhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEE
Confidence            78899999999999999999999999999998754221 11 223457888998885 99999999999987  899999


Q ss_pred             EeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCccccCCC
Q 014609           93 LEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDG  171 (421)
Q Consensus        93 ~E~~~gg~L~~~i~~-~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~  171 (421)
                      |||++ ++|.+.+.. ...+++..++.++.|++.||+|||+.|++||||+|+||+++. +.+||+|||++.....   ..
T Consensus        79 ~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~---~~  153 (282)
T cd07831          79 FELMD-MNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD-DILKLADFGSCRGIYS---KP  153 (282)
T ss_pred             EecCC-ccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcC-CCeEEEeccccccccc---CC
Confidence            99996 488887765 356899999999999999999999999999999999999999 9999999999975432   12


Q ss_pred             ccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhhc-CCcCCC---------------------------------
Q 014609          172 LLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIFR-GDFKLP---------------------------------  217 (421)
Q Consensus       172 ~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~~-~~~~~p---------------------------------  217 (421)
                      ......+++.|+|||++....+.+.++||||+||++|.+. +..+++                                 
T Consensus       154 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (282)
T cd07831         154 PYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMN  233 (282)
T ss_pred             CcCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhccccccc
Confidence            2234568899999998766555578999999999999553 322221                                 


Q ss_pred             ---------------CCCCHHHHHHHHHhcCCCCCCCCCHHhhhcCccc
Q 014609          218 ---------------KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWF  251 (421)
Q Consensus       218 ---------------~~~s~~~~~li~~~L~~dP~~R~t~~eil~~~w~  251 (421)
                                     +.++..+.++|.+||+++|++|||+.+++.||||
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~~~~  282 (282)
T cd07831         234 YNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPYF  282 (282)
T ss_pred             ccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhCCCC
Confidence                           1356889999999999999999999999999997

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=100.00  E-value=8.3e-40  Score=314.03  Aligned_cols=238  Identities=29%  Similarity=0.464  Sum_probs=197.0

Q ss_pred             CCeeecceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcC-CCCCcceEEEEEEeC-
Q 014609            9 EGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEVLASK-   86 (421)
Q Consensus         9 ~~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~-   86 (421)
                      .+...++|++.+.||+|+||.||+|.+..+++.+|+|++....    .....+.+|+.+++++ +|||++++++++... 
T Consensus        17 ~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~----~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~   92 (291)
T cd06639          17 LGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS----DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKAD   92 (291)
T ss_pred             CCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc----cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEecc
Confidence            3445688999999999999999999999999999999986432    1245678899999999 799999999998654 


Q ss_pred             ----CEEEEEEeccCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEec
Q 014609           87 ----SKIYMVLEYVTGGELFDKIAS----KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDF  158 (421)
Q Consensus        87 ----~~~~lv~E~~~gg~L~~~i~~----~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DF  158 (421)
                          ...|+||||++|++|.+.+..    ...+++..++.++.|++.||+|||+.|++||||||+||+++.++.+||+||
T Consensus        93 ~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~~~~~kl~df  172 (291)
T cd06639          93 KLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDF  172 (291)
T ss_pred             ccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEeec
Confidence                368999999999999988753    457899999999999999999999999999999999999999999999999


Q ss_pred             cCCCCCccccCCCccccccCCCCccChhhhcccCC----CCCcchHHHHHHHHhhhc-CCcCC-----------------
Q 014609          159 GLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGY----DGATSDIWSCGVILYIFR-GDFKL-----------------  216 (421)
Q Consensus       159 Gla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~----~~~~~DiwSlGvil~~~~-~~~~~-----------------  216 (421)
                      |++.......  .......|++.|+|||++.....    .+.++||||+||++|.+. |..++                 
T Consensus       173 g~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~~  250 (291)
T cd06639         173 GVSAQLTSTR--LRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPRNPP  250 (291)
T ss_pred             ccchhccccc--ccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHHhcCCC
Confidence            9987543211  11234568899999999764321    257899999999999543 33322                 


Q ss_pred             -----CCCCCHHHHHHHHHhcCCCCCCCCCHHhhhcCcccc
Q 014609          217 -----PKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFE  252 (421)
Q Consensus       217 -----p~~~s~~~~~li~~~L~~dP~~R~t~~eil~~~w~~  252 (421)
                           |..++..+.++|.+||+.+|++||++.++++||||+
T Consensus       251 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~  291 (291)
T cd06639         251 PTLLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEHPFIK  291 (291)
T ss_pred             CCCCcccccCHHHHHHHHHHhhcChhhCcCHHHHhcCcccC
Confidence                 122456789999999999999999999999999984

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=100.00  E-value=3.3e-40  Score=315.17  Aligned_cols=233  Identities=27%  Similarity=0.445  Sum_probs=195.3

Q ss_pred             eecceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcC-CCCCcceEEEEEE------
Q 014609           12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEVLA------   84 (421)
Q Consensus        12 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~------   84 (421)
                      ..+.|++.+.||.|+||.||+|.+..+++.+|+|++....    .....+..|+.+++++ +||||+++++++.      
T Consensus        14 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~----~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~   89 (282)
T cd06636          14 PAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE----DEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPG   89 (282)
T ss_pred             hhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh----HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccC
Confidence            4489999999999999999999999999999999986542    2245688899999998 6999999999985      


Q ss_pred             eCCEEEEEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCC
Q 014609           85 SKSKIYMVLEYVTGGELFDKIASK--GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSA  162 (421)
Q Consensus        85 ~~~~~~lv~E~~~gg~L~~~i~~~--~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~  162 (421)
                      ....+|++|||+++++|.+.+...  ..+++..+..++.||+.||+|||++||+||||+|+||+++.++.++|+|||++.
T Consensus        90 ~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~~~~~~l~dfg~~~  169 (282)
T cd06636          90 HDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSA  169 (282)
T ss_pred             CCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCcchh
Confidence            346789999999999999988653  458889999999999999999999999999999999999999999999999987


Q ss_pred             CCccccCCCccccccCCCCccChhhhcc-----cCCCCCcchHHHHHHHHhhhc-CCcCCC-------------------
Q 014609          163 LPQHFRDDGLLHTTCGSPNYVAPEVLAN-----RGYDGATSDIWSCGVILYIFR-GDFKLP-------------------  217 (421)
Q Consensus       163 ~~~~~~~~~~~~~~~gt~~y~APEvl~~-----~~~~~~~~DiwSlGvil~~~~-~~~~~p-------------------  217 (421)
                      ....  .........|++.|+|||++..     ..+ +.++|+|||||++|.+. |..++.                   
T Consensus       170 ~~~~--~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~-~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~  246 (282)
T cd06636         170 QLDR--TVGRRNTFIGTPYWMAPEVIACDENPDATY-DYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPPPKL  246 (282)
T ss_pred             hhhc--cccCCCcccccccccCHhhcCcccCcCcCC-CcccchhHHHHHHHHHHhCCCCccccCHHhhhhhHhhCCCCCC
Confidence            4432  1122344678999999999752     334 47899999999999543 332221                   


Q ss_pred             --CCCCHHHHHHHHHhcCCCCCCCCCHHhhhcCccc
Q 014609          218 --KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWF  251 (421)
Q Consensus       218 --~~~s~~~~~li~~~L~~dP~~R~t~~eil~~~w~  251 (421)
                        ..++..+.++|.+||+.||.+|||+.++++||||
T Consensus       247 ~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~~~~  282 (282)
T cd06636         247 KSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKHPFI  282 (282)
T ss_pred             cccccCHHHHHHHHHHhCCChhhCcCHHHHhcCCCC
Confidence              1257899999999999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.8e-40  Score=313.10  Aligned_cols=236  Identities=26%  Similarity=0.506  Sum_probs=201.1

Q ss_pred             ceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCC---CCCcceEEEEEEeCCEEEE
Q 014609           15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK---HPNVVRLHEVLASKSKIYM   91 (421)
Q Consensus        15 ~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~---hpnIv~l~~~~~~~~~~~l   91 (421)
                      .|++.+.||+|+||.||+|.+..+++.||+|.++....  ......+.+|+.++++++   |||++++++++..+...|+
T Consensus         2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~l   79 (277)
T cd06917           2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTP--DDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWI   79 (277)
T ss_pred             hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCC--chhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEE
Confidence            58889999999999999999999999999999875432  223567889999999997   9999999999999999999


Q ss_pred             EEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCccccCCC
Q 014609           92 VLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDG  171 (421)
Q Consensus        92 v~E~~~gg~L~~~i~~~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~  171 (421)
                      ||||++|++|.+++.. ..+++..+..++.|++.||.|||+.||+||||+|+||+++.++.++|+|||++......  ..
T Consensus        80 v~e~~~~~~L~~~~~~-~~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~--~~  156 (277)
T cd06917          80 IMEYAEGGSVRTLMKA-GPIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQN--SS  156 (277)
T ss_pred             EEecCCCCcHHHHHHc-cCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcCCCCEEEccCCceeecCCC--cc
Confidence            9999999999998865 57899999999999999999999999999999999999999999999999998755432  22


Q ss_pred             ccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhh-cCCcCC--------------------CC-CCCHHHHHHHH
Q 014609          172 LLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIF-RGDFKL--------------------PK-WLSPGAQNLLR  229 (421)
Q Consensus       172 ~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~-~~~~~~--------------------p~-~~s~~~~~li~  229 (421)
                      ......|++.|+|||.+.+....+.++|+||+||++|.+ .|..++                    +. .++.++.+++.
T Consensus       157 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~  236 (277)
T cd06917         157 KRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKSKPPRLEDNGYSKLLREFVA  236 (277)
T ss_pred             ccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhccccCCCCCCCcccCCHHHHHHHH
Confidence            233457899999999987544446899999999999944 333322                    11 15778999999


Q ss_pred             HhcCCCCCCCCCHHhhhcCccccccc
Q 014609          230 KILEPNPVKRITIAGIKADEWFEQDY  255 (421)
Q Consensus       230 ~~L~~dP~~R~t~~eil~~~w~~~~~  255 (421)
                      +||+.||++||++.+++.|+||++..
T Consensus       237 ~~l~~~p~~R~~~~~il~~~~~~~~~  262 (277)
T cd06917         237 ACLDEEPKERLSAEELLKSKWIKAHS  262 (277)
T ss_pred             HHcCCCcccCcCHHHHhhChHhhccc
Confidence            99999999999999999999997644

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=3e-40  Score=324.38  Aligned_cols=237  Identities=28%  Similarity=0.430  Sum_probs=199.3

Q ss_pred             cceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeC-----CE
Q 014609           14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASK-----SK   88 (421)
Q Consensus        14 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~-----~~   88 (421)
                      .+|++.+.||+|+||.||+|++..+++.||||.+...... ......+.+|+.+++.++||||+++++++...     ..
T Consensus         5 ~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~   83 (337)
T cd07858           5 TKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDN-RIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND   83 (337)
T ss_pred             cceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccc-cchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence            5899999999999999999999999999999998754322 22245677899999999999999999987654     35


Q ss_pred             EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCcccc
Q 014609           89 IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFR  168 (421)
Q Consensus        89 ~~lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~~  168 (421)
                      .|+|+||+. ++|.+.+...+.+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++...... 
T Consensus        84 ~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~-  161 (337)
T cd07858          84 VYIVYELMD-TDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEK-  161 (337)
T ss_pred             EEEEEeCCC-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcCccccccCCC-
Confidence            899999995 689999888788999999999999999999999999999999999999999999999999999854331 


Q ss_pred             CCCccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhhcCC-cCC-------------------------------
Q 014609          169 DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIFRGD-FKL-------------------------------  216 (421)
Q Consensus       169 ~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~~~~-~~~-------------------------------  216 (421)
                       ........++..|+|||++......+.++|+||+||++|.+.+. .++                               
T Consensus       162 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (337)
T cd07858         162 -GDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNEK  240 (337)
T ss_pred             -cccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcCchh
Confidence             12334557889999999987543346899999999999955332 222                               


Q ss_pred             -------------------CCCCCHHHHHHHHHhcCCCCCCCCCHHhhhcCcccccc
Q 014609          217 -------------------PKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD  254 (421)
Q Consensus       217 -------------------p~~~s~~~~~li~~~L~~dP~~R~t~~eil~~~w~~~~  254 (421)
                                         .+.+++.+.++|++||+++|++|||+.++++||||...
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~  297 (337)
T cd07858         241 ARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASL  297 (337)
T ss_pred             hhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhh
Confidence                               12367888999999999999999999999999999753

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=1e-39  Score=309.55  Aligned_cols=228  Identities=32%  Similarity=0.496  Sum_probs=192.4

Q ss_pred             eceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEEeccCC
Q 014609           19 GRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTG   98 (421)
Q Consensus        19 ~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~~g   98 (421)
                      -..||+|+||.||+|.+..++..||+|.+....   ....+.+.+|+.++++++||||+++++++...+..|+|+||+++
T Consensus        13 ~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~   89 (268)
T cd06624          13 RVVLGKGTYGIVYAARDLSTQVRIAIKEIPERD---SRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFMEQVPG   89 (268)
T ss_pred             eEEEecCCceEEEEeEecCCCcEEEEEEecCCC---HHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEEecCCC
Confidence            358999999999999999999999999886543   22356789999999999999999999999999999999999999


Q ss_pred             CChHHHHHhc-CCC--CHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecc-CCCEEEEeccCCCCCccccCCCccc
Q 014609           99 GELFDKIASK-GRL--QEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDS-KGNIKISDFGLSALPQHFRDDGLLH  174 (421)
Q Consensus        99 g~L~~~i~~~-~~~--~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~-~~~~kL~DFGla~~~~~~~~~~~~~  174 (421)
                      ++|.+.+... ..+  ++..+..++.|++.||+|||++||+||||||+||+++. ++.++|+|||++.....  ......
T Consensus        90 ~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~--~~~~~~  167 (268)
T cd06624          90 GSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAG--INPCTE  167 (268)
T ss_pred             CCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCeEEEecchhheeccc--CCCccc
Confidence            9999998764 445  88889999999999999999999999999999999986 67999999999875432  122233


Q ss_pred             cccCCCCccChhhhcccC-CCCCcchHHHHHHHHhhhc-CCcC----------------------CCCCCCHHHHHHHHH
Q 014609          175 TTCGSPNYVAPEVLANRG-YDGATSDIWSCGVILYIFR-GDFK----------------------LPKWLSPGAQNLLRK  230 (421)
Q Consensus       175 ~~~gt~~y~APEvl~~~~-~~~~~~DiwSlGvil~~~~-~~~~----------------------~p~~~s~~~~~li~~  230 (421)
                      ...|++.|+|||++.... ..+.++|+||+|+++|.+. |..+                      +|..+++.+.+++.+
T Consensus       168 ~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  247 (268)
T cd06624         168 TFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIHPEIPESLSAEAKNFILR  247 (268)
T ss_pred             cCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhhhhhccCCCCCcccCHHHHHHHHH
Confidence            446899999999986543 2358899999999999543 2222                      344567889999999


Q ss_pred             hcCCCCCCCCCHHhhhcCccc
Q 014609          231 ILEPNPVKRITIAGIKADEWF  251 (421)
Q Consensus       231 ~L~~dP~~R~t~~eil~~~w~  251 (421)
                      ||+++|.+|||+.+++.||||
T Consensus       248 ~l~~~p~~Rpt~~~ll~~~~~  268 (268)
T cd06624         248 CFEPDPDKRASAHDLLQDPFL  268 (268)
T ss_pred             HcCCCchhCCCHHHHHhCCCC
Confidence            999999999999999999997

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=100.00  E-value=6.1e-40  Score=317.79  Aligned_cols=240  Identities=26%  Similarity=0.413  Sum_probs=201.2

Q ss_pred             cCCeeecceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCC
Q 014609            8 QEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKS   87 (421)
Q Consensus         8 ~~~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~   87 (421)
                      .......+|++.+.||+|+||.||+|.+..+|+.||+|.+.............+.+|+.+++.++||||+++++++...+
T Consensus         9 ~~~~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~   88 (307)
T cd06607           9 SKDDPEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREH   88 (307)
T ss_pred             cCCCcchhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCC
Confidence            34445577999999999999999999998899999999987554434444567899999999999999999999999999


Q ss_pred             EEEEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCcc
Q 014609           88 KIYMVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQH  166 (421)
Q Consensus        88 ~~~lv~E~~~gg~L~~~i~~-~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~  166 (421)
                      ..|+|+||+. |+|.+.+.. ...+++..+..++.|++.||.|||+.||+||||+|+||+++.++.++|+|||++.....
T Consensus        89 ~~~lv~e~~~-g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~  167 (307)
T cd06607          89 TAWLVMEYCL-GSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSASLVSP  167 (307)
T ss_pred             eEEEEHHhhC-CCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECCCCCEEEeecCcceecCC
Confidence            9999999996 567666653 45789999999999999999999999999999999999999999999999999875322


Q ss_pred             ccCCCccccccCCCCccChhhhcc---cCCCCCcchHHHHHHHHhhhc-CCcCC---------------------CCCCC
Q 014609          167 FRDDGLLHTTCGSPNYVAPEVLAN---RGYDGATSDIWSCGVILYIFR-GDFKL---------------------PKWLS  221 (421)
Q Consensus       167 ~~~~~~~~~~~gt~~y~APEvl~~---~~~~~~~~DiwSlGvil~~~~-~~~~~---------------------p~~~s  221 (421)
                            .....+++.|+|||++.+   ..+ +.++||||+|+++|.+. |..++                     +..++
T Consensus       168 ------~~~~~~~~~y~aPE~~~~~~~~~~-~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (307)
T cd06607         168 ------ANSFVGTPYWMAPEVILAMDEGQY-DGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLSSNDWS  240 (307)
T ss_pred             ------CCCccCCccccCceeeeccCCCCC-CcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCCCCchhhC
Confidence                  234568899999998742   334 57899999999999553 32221                     11256


Q ss_pred             HHHHHHHHHhcCCCCCCCCCHHhhhcCccccccc
Q 014609          222 PGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY  255 (421)
Q Consensus       222 ~~~~~li~~~L~~dP~~R~t~~eil~~~w~~~~~  255 (421)
                      ..+.++|.+||..||++||++.+++.||||....
T Consensus       241 ~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~  274 (307)
T cd06607         241 DYFRNFVDSCLQKIPQDRPSSEELLKHRFVLRER  274 (307)
T ss_pred             HHHHHHHHHHhcCChhhCcCHHHHhcChhhcccC
Confidence            7899999999999999999999999999998643

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=1.2e-39  Score=306.68  Aligned_cols=229  Identities=33%  Similarity=0.564  Sum_probs=196.9

Q ss_pred             ceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEEe
Q 014609           15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLE   94 (421)
Q Consensus        15 ~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E   94 (421)
                      +|++.+.||.|+||.||++.+..+++.+|+|.++....  ....+.+.+|+.+++.++||||+++++.+.+.+.+|++||
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   78 (255)
T cd08219           1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKS--SSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVME   78 (255)
T ss_pred             CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcc--hHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEe
Confidence            58999999999999999999999999999999875432  2335778899999999999999999999999999999999


Q ss_pred             ccCCCChHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCccccCCCc
Q 014609           95 YVTGGELFDKIAS--KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGL  172 (421)
Q Consensus        95 ~~~gg~L~~~i~~--~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~  172 (421)
                      |+++++|.+++..  ...+++..+..++.|++.||.|||++||+|+||||+||+++.++.++|+|||++......  ...
T Consensus        79 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~--~~~  156 (255)
T cd08219          79 YCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSP--GAY  156 (255)
T ss_pred             eCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCCCcEEEcccCcceeeccc--ccc
Confidence            9999999998864  345899999999999999999999999999999999999999999999999998754321  222


Q ss_pred             cccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhhc-CCcC--------------------CCCCCCHHHHHHHHHh
Q 014609          173 LHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIFR-GDFK--------------------LPKWLSPGAQNLLRKI  231 (421)
Q Consensus       173 ~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~~-~~~~--------------------~p~~~s~~~~~li~~~  231 (421)
                      .....|++.|+|||++.+..+ +.++|+||+|+++|.+. |..+                    .|..++..+.++|.+|
T Consensus       157 ~~~~~~~~~~~aPE~~~~~~~-~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~  235 (255)
T cd08219         157 ACTYVGTPYYVPPEIWENMPY-NNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYKPLPSHYSYELRSLIKQM  235 (255)
T ss_pred             cccccCCccccCHHHHccCCc-CchhhhhhhchhheehhhccCCCCCCCHHHHHHHHhcCCCCCCCcccCHHHHHHHHHH
Confidence            334578999999999887766 58899999999999443 2222                    3445788899999999


Q ss_pred             cCCCCCCCCCHHhhhcC
Q 014609          232 LEPNPVKRITIAGIKAD  248 (421)
Q Consensus       232 L~~dP~~R~t~~eil~~  248 (421)
                      |+.||++|||+.+++.-
T Consensus       236 l~~~P~~Rp~~~~il~~  252 (255)
T cd08219         236 FKRNPRSRPSATTILSR  252 (255)
T ss_pred             HhCCcccCCCHHHHhhc
Confidence            99999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=100.00  E-value=4.2e-40  Score=314.45  Aligned_cols=232  Identities=32%  Similarity=0.470  Sum_probs=195.8

Q ss_pred             eEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEEec
Q 014609           16 YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLEY   95 (421)
Q Consensus        16 y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E~   95 (421)
                      |++.+.||.|++|.||+|.+..+|+.||+|++...... ......+.+|+.+++.++||||+++++++.+.+..|++|||
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~   79 (283)
T cd07835           1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETED-EGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEF   79 (283)
T ss_pred             CchheEecCCCCeEEEEEEEcCCCCEEEEEEeeccccc-ccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEec
Confidence            67889999999999999999999999999998765322 22345688899999999999999999999999999999999


Q ss_pred             cCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCccccCCCcc
Q 014609           96 VTGGELFDKIASKG--RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLL  173 (421)
Q Consensus        96 ~~gg~L~~~i~~~~--~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~  173 (421)
                      ++ ++|.+++....  .+++..+..++.|++.||+|||+++++||||+|+||+++.++.++|+|||++......  ....
T Consensus        80 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~--~~~~  156 (283)
T cd07835          80 LD-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVP--VRTY  156 (283)
T ss_pred             cC-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCcEEEeecccccccCCC--cccc
Confidence            95 68999887655  6899999999999999999999999999999999999999999999999998754321  1122


Q ss_pred             ccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhhc-CCcCC------------------------------------
Q 014609          174 HTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIFR-GDFKL------------------------------------  216 (421)
Q Consensus       174 ~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~~-~~~~~------------------------------------  216 (421)
                      ....+++.|+|||++.+....+.++|+||+|+++|.+. |..++                                    
T Consensus       157 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (283)
T cd07835         157 THEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYKPT  236 (283)
T ss_pred             CccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhhhhh
Confidence            23356889999998876544468899999999999543 33222                                    


Q ss_pred             ------------CCCCCHHHHHHHHHhcCCCCCCCCCHHhhhcCccc
Q 014609          217 ------------PKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWF  251 (421)
Q Consensus       217 ------------p~~~s~~~~~li~~~L~~dP~~R~t~~eil~~~w~  251 (421)
                                  .+.+++.+.++|.+||++||.+|||+.+++.||||
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~  283 (283)
T cd07835         237 FPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF  283 (283)
T ss_pred             cccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcCCCC
Confidence                        12356789999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=6.8e-40  Score=348.76  Aligned_cols=235  Identities=26%  Similarity=0.417  Sum_probs=195.7

Q ss_pred             ecceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEE
Q 014609           13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMV   92 (421)
Q Consensus        13 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv   92 (421)
                      +++|++++.||+|+||.||+|.+..+|+.||+|++...........+++.+|++++++++||||+++++++.+++..|+|
T Consensus         1 igrYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLV   80 (932)
T PRK13184          1 MQRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYT   80 (932)
T ss_pred             CCCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEE
Confidence            58999999999999999999999999999999999765443444457799999999999999999999999999999999


Q ss_pred             EeccCCCChHHHHHhc-----------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCC
Q 014609           93 LEYVTGGELFDKIASK-----------GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLS  161 (421)
Q Consensus        93 ~E~~~gg~L~~~i~~~-----------~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla  161 (421)
                      |||++|++|.+.+...           ...+...+..++.||+.||+|||++||+||||||+|||++.+|.++|+|||++
T Consensus        81 MEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~dg~vKLiDFGLA  160 (932)
T PRK13184         81 MPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAA  160 (932)
T ss_pred             EEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcCCCCEEEEecCcc
Confidence            9999999999988641           23556778899999999999999999999999999999999999999999999


Q ss_pred             CCCccccC----------------CCccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhh-cCCcCCC-------
Q 014609          162 ALPQHFRD----------------DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIF-RGDFKLP-------  217 (421)
Q Consensus       162 ~~~~~~~~----------------~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~-~~~~~~p-------  217 (421)
                      ........                .......+||+.|+|||++.+..+ +.++||||+||++|.+ .|..|+.       
T Consensus       161 k~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~-S~kSDIWSLGVILyELLTG~~PF~~~~~~ki  239 (932)
T PRK13184        161 IFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPA-SESTDIYALGVILYQMLTLSFPYRRKKGRKI  239 (932)
T ss_pred             eecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCC-CcHhHHHHHHHHHHHHHHCCCCCCCcchhhh
Confidence            75521100                011123479999999999988777 5899999999999954 4444331       


Q ss_pred             ---------------CCCCHHHHHHHHHhcCCCCCCCCCHHhhhcC
Q 014609          218 ---------------KWLSPGAQNLLRKILEPNPVKRITIAGIKAD  248 (421)
Q Consensus       218 ---------------~~~s~~~~~li~~~L~~dP~~R~t~~eil~~  248 (421)
                                     ..+++.+.+++.+||.+||++|++..+.+.+
T Consensus       240 ~~~~~i~~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~  285 (932)
T PRK13184        240 SYRDVILSPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQ  285 (932)
T ss_pred             hhhhhccChhhccccccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence                           1367889999999999999999886655443

>PHA03210 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.5e-40  Score=342.89  Aligned_cols=241  Identities=29%  Similarity=0.409  Sum_probs=187.3

Q ss_pred             eeecceEEeceEeecCcEEEEEEEECC-CCceEEEEEe--------------ecccccchhHHHHHHHHHHHHhcCCCCC
Q 014609           11 MRLGRYELGRTLGEGNFGKVKFAQDLD-SGLPFAVKIL--------------EKNRIIHLKITDQIKREIATLKLLKHPN   75 (421)
Q Consensus        11 ~~~~~y~i~~~LG~G~~g~V~~a~~~~-~~~~vAvK~i--------------~~~~~~~~~~~~~~~~Ei~il~~l~hpn   75 (421)
                      ..+++|++++.||+|+||+||++.... ++...+.|.+              .+...........+.+|+.+|++++|||
T Consensus       145 ~~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~Hpn  224 (501)
T PHA03210        145 EFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHEN  224 (501)
T ss_pred             hhhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCC
Confidence            345789999999999999999987643 2333333311              1111112223456889999999999999


Q ss_pred             cceEEEEEEeCCEEEEEEeccCCCChHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccC
Q 014609           76 VVRLHEVLASKSKIYMVLEYVTGGELFDKIASK-----GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSK  150 (421)
Q Consensus        76 Iv~l~~~~~~~~~~~lv~E~~~gg~L~~~i~~~-----~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~  150 (421)
                      |+++++++...+..|+|++++ +++|++++...     .......++.++.||+.||+|||++||+||||||+|||++.+
T Consensus       225 Iv~l~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl~~~  303 (501)
T PHA03210        225 ILKIEEILRSEANTYMITQKY-DFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCD  303 (501)
T ss_pred             cCcEeEEEEECCeeEEEEecc-ccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCC
Confidence            999999999999999999999 45777776532     234467788999999999999999999999999999999999


Q ss_pred             CCEEEEeccCCCCCccccCCCccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhhc-CCcC--------------
Q 014609          151 GNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIFR-GDFK--------------  215 (421)
Q Consensus       151 ~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~~-~~~~--------------  215 (421)
                      +.+||+|||++...... ........+||+.|+|||++.+..| +.++|||||||++|++. +.+.              
T Consensus       304 ~~vkL~DFGla~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~  381 (501)
T PHA03210        304 GKIVLGDFGTAMPFEKE-REAFDYGWVGTVATNSPEILAGDGY-CEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLL  381 (501)
T ss_pred             CCEEEEeCCCceecCcc-cccccccccCCcCCCCchhhcCCCC-CcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHH
Confidence            99999999999755331 1122334689999999999988877 58899999999999553 2211              


Q ss_pred             ------------CCC----------------------------CCCHHHHHHHHHhcCCCCCCCCCHHhhhcCcccccc
Q 014609          216 ------------LPK----------------------------WLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD  254 (421)
Q Consensus       216 ------------~p~----------------------------~~s~~~~~li~~~L~~dP~~R~t~~eil~~~w~~~~  254 (421)
                                  +|.                            .++.++.++|.+||+.||.+|||+.|++.||||...
T Consensus       382 ~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~hp~f~~~  460 (501)
T PHA03210        382 KIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLALPLFSAE  460 (501)
T ss_pred             HHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhChhhhcC
Confidence                        010                            134566778999999999999999999999999753

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=100.00  E-value=2.5e-40  Score=324.44  Aligned_cols=242  Identities=28%  Similarity=0.435  Sum_probs=201.4

Q ss_pred             cceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEe----CCEE
Q 014609           14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLAS----KSKI   89 (421)
Q Consensus        14 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~----~~~~   89 (421)
                      ++|++.+.||+|+||.||+|.+..+|+.||+|.+..... .......+.+|+.++++++||||+++++++..    ....
T Consensus         5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   83 (334)
T cd07855           5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFD-VPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV   83 (334)
T ss_pred             hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccc-cccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence            689999999999999999999999999999999875432 22335678889999999999999999998753    3578


Q ss_pred             EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCccccC
Q 014609           90 YMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD  169 (421)
Q Consensus        90 ~lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~  169 (421)
                      |+||||+. ++|.+.+.....+++..++.++.|++.||+|||++||+||||||+||+++.++.+||+|||++........
T Consensus        84 ~lv~e~~~-~~l~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~  162 (334)
T cd07855          84 YVVMDLME-SDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPT  162 (334)
T ss_pred             EEEEehhh-hhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEecccccceeecccCc
Confidence            99999995 68999988777899999999999999999999999999999999999999999999999999875432111


Q ss_pred             --CCccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhhc-CCcCCC-----------------------------
Q 014609          170 --DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIFR-GDFKLP-----------------------------  217 (421)
Q Consensus       170 --~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~~-~~~~~p-----------------------------  217 (421)
                        ........|+..|+|||++.+....+.++||||+||++|.+. |..+++                             
T Consensus       163 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~  242 (334)
T cd07855         163 EHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRIGSD  242 (334)
T ss_pred             CCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhhhhchh
Confidence              122234578999999999866443468899999999999543 322221                             


Q ss_pred             ---------------------CCCCHHHHHHHHHhcCCCCCCCCCHHhhhcCccccccccC
Q 014609          218 ---------------------KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTP  257 (421)
Q Consensus       218 ---------------------~~~s~~~~~li~~~L~~dP~~R~t~~eil~~~w~~~~~~~  257 (421)
                                           +..++.+.++|++||+.+|.+|||+.+++.||||.+...+
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~~~~~~~  303 (334)
T cd07855         243 RVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLAQYHDP  303 (334)
T ss_pred             hHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChhhhhccCC
Confidence                                 2257889999999999999999999999999999865443

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=9.1e-40  Score=313.33  Aligned_cols=220  Identities=18%  Similarity=0.223  Sum_probs=188.7

Q ss_pred             ceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEe----CCEEEEEEec
Q 014609           20 RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLAS----KSKIYMVLEY   95 (421)
Q Consensus        20 ~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~----~~~~~lv~E~   95 (421)
                      ..||+|++|.||+|..  +|+.||||.+...........+.+.+|+.+|++++||||+++++++.+    ...+++||||
T Consensus        26 ~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey  103 (283)
T PHA02988         26 VLIKENDQNSIYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEY  103 (283)
T ss_pred             eEEeeCCceEEEEEEE--CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEe
Confidence            6799999999999986  789999999976544444445778899999999999999999999876    4578999999


Q ss_pred             cCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC-CceeccCCCCCEEeccCCCEEEEeccCCCCCccccCCCccc
Q 014609           96 VTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNK-GVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLH  174 (421)
Q Consensus        96 ~~gg~L~~~i~~~~~~~~~~~~~~~~ql~~aL~~LH~~-gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~  174 (421)
                      ++||+|.+++.....+++..+..++.|++.||.|||+. +++||||||+|||++.++.+||+|||++.....     ...
T Consensus       104 ~~~g~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~-----~~~  178 (283)
T PHA02988        104 CTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYKLKIICHGLEKILSS-----PPF  178 (283)
T ss_pred             CCCCcHHHHHhhCCCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCCcEEEcccchHhhhcc-----ccc
Confidence            99999999998888899999999999999999999985 999999999999999999999999999875432     122


Q ss_pred             cccCCCCccChhhhcc--cCCCCCcchHHHHHHHHhhh-cCC---------------------cCCCCCCCHHHHHHHHH
Q 014609          175 TTCGSPNYVAPEVLAN--RGYDGATSDIWSCGVILYIF-RGD---------------------FKLPKWLSPGAQNLLRK  230 (421)
Q Consensus       175 ~~~gt~~y~APEvl~~--~~~~~~~~DiwSlGvil~~~-~~~---------------------~~~p~~~s~~~~~li~~  230 (421)
                      ...|++.|+|||++.+  ..+ +.++|||||||++|.+ .|.                     ++.|..+++.+.+++.+
T Consensus       179 ~~~~~~~y~aPE~~~~~~~~~-~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~l~~li~~  257 (283)
T PHA02988        179 KNVNFMVYFSYKMLNDIFSEY-TIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNSLKLPLDCPLEIKCIVEA  257 (283)
T ss_pred             cccCcccccCHHHhhhccccc-cchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCCCcCcHHHHHHHHH
Confidence            4568999999999876  455 5899999999999943 222                     23344578999999999


Q ss_pred             hcCCCCCCCCCHHhhhc
Q 014609          231 ILEPNPVKRITIAGIKA  247 (421)
Q Consensus       231 ~L~~dP~~R~t~~eil~  247 (421)
                      ||+.||++|||+.++++
T Consensus       258 cl~~dp~~Rps~~ell~  274 (283)
T PHA02988        258 CTSHDSIKRPNIKEILY  274 (283)
T ss_pred             HhcCCcccCcCHHHHHH
Confidence            99999999999999875

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=100.00  E-value=1.1e-39  Score=311.50  Aligned_cols=235  Identities=24%  Similarity=0.415  Sum_probs=192.8

Q ss_pred             cceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHH-HhcCCCCCcceEEEEEEeCCEEEEE
Q 014609           14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIAT-LKLLKHPNVVRLHEVLASKSKIYMV   92 (421)
Q Consensus        14 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~i-l~~l~hpnIv~l~~~~~~~~~~~lv   92 (421)
                      ++|++.+.||+|+||.||+|.+..+|+.||+|.++......  ....+..|+.+ ++.++||||+++++++..++..|++
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv   78 (283)
T cd06617           1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQ--EQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWIC   78 (283)
T ss_pred             CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcH--HHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEE
Confidence            47999999999999999999999999999999987643221  12345556665 6677899999999999999999999


Q ss_pred             EeccCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC-CceeccCCCCCEEeccCCCEEEEeccCCCCCccc
Q 014609           93 LEYVTGGELFDKIAS----KGRLQEAEGRKLFQQLIDGVSYCHNK-GVFHRDLKLENILLDSKGNIKISDFGLSALPQHF  167 (421)
Q Consensus        93 ~E~~~gg~L~~~i~~----~~~~~~~~~~~~~~ql~~aL~~LH~~-gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~  167 (421)
                      |||++ ++|.+.+..    ...+++..++.++.|++.||+|||++ +++||||||+||+++.++.+||+|||++..... 
T Consensus        79 ~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~-  156 (283)
T cd06617          79 MEVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVD-  156 (283)
T ss_pred             hhhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeeccccccccc-
Confidence            99996 577666643    34689999999999999999999997 999999999999999999999999999875432 


Q ss_pred             cCCCccccccCCCCccChhhhcc----cCCCCCcchHHHHHHHHhhh-cCCcCCC----------------------CCC
Q 014609          168 RDDGLLHTTCGSPNYVAPEVLAN----RGYDGATSDIWSCGVILYIF-RGDFKLP----------------------KWL  220 (421)
Q Consensus       168 ~~~~~~~~~~gt~~y~APEvl~~----~~~~~~~~DiwSlGvil~~~-~~~~~~p----------------------~~~  220 (421)
                        ........|+..|+|||++.+    ..+ +.++|+||+||++|.+ .|..++.                      ..+
T Consensus       157 --~~~~~~~~~~~~y~aPE~~~~~~~~~~~-~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (283)
T cd06617         157 --SVAKTIDAGCKPYMAPERINPELNQKGY-DVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEPSPQLPAEKF  233 (283)
T ss_pred             --ccccccccCCccccChhhcCCccccccc-CccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHhcCCCCCCcccc
Confidence              112223568899999998864    233 5789999999999954 3333321                      136


Q ss_pred             CHHHHHHHHHhcCCCCCCCCCHHhhhcCccccccc
Q 014609          221 SPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY  255 (421)
Q Consensus       221 s~~~~~li~~~L~~dP~~R~t~~eil~~~w~~~~~  255 (421)
                      |.++.++|.+||..+|.+||++.+++.||||.+..
T Consensus       234 ~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~  268 (283)
T cd06617         234 SPEFQDFVNKCLKKNYKERPNYPELLQHPFFELHL  268 (283)
T ss_pred             CHHHHHHHHHHccCChhhCcCHHHHhcCchhhhcc
Confidence            78899999999999999999999999999998743

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=7.1e-40  Score=312.41  Aligned_cols=236  Identities=24%  Similarity=0.452  Sum_probs=202.3

Q ss_pred             cceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEE
Q 014609           14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVL   93 (421)
Q Consensus        14 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~   93 (421)
                      +.|+..+.||.|+||.||+|.+..+++.||+|++.....  ......+.+|+.++++++||||+++++++.++...|+||
T Consensus         4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   81 (277)
T cd06640           4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEA--EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIM   81 (277)
T ss_pred             HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEecccc--HHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence            468899999999999999999999999999999875432  233578899999999999999999999999999999999


Q ss_pred             eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCccccCCCcc
Q 014609           94 EYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLL  173 (421)
Q Consensus        94 E~~~gg~L~~~i~~~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~  173 (421)
                      ||++|++|.+++.. +++++..+..++.|++.||+|||+.+++|+||+|+||+++.++.++|+|||++......  ....
T Consensus        82 e~~~~~~L~~~i~~-~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~--~~~~  158 (277)
T cd06640          82 EYLGGGSALDLLRA-GPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDT--QIKR  158 (277)
T ss_pred             ecCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcCCCCEEEcccccceeccCC--cccc
Confidence            99999999998865 57899999999999999999999999999999999999999999999999998754321  1122


Q ss_pred             ccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhhc-CCcCCC--------------------CCCCHHHHHHHHHhc
Q 014609          174 HTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIFR-GDFKLP--------------------KWLSPGAQNLLRKIL  232 (421)
Q Consensus       174 ~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~~-~~~~~p--------------------~~~s~~~~~li~~~L  232 (421)
                      ....++..|+|||++.+..+ +.++|+||+||++|.+. |..++.                    ..++..+.+++.+||
T Consensus       159 ~~~~~~~~y~apE~~~~~~~-~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l  237 (277)
T cd06640         159 NTFVGTPFWMAPEVIQQSAY-DSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNNPPTLTGEFSKPFKEFIDACL  237 (277)
T ss_pred             ccccCcccccCHhHhccCCC-ccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhhhcCCCCCCchhhhHHHHHHHHHHc
Confidence            33468889999999887766 58899999999999543 433321                    125678899999999


Q ss_pred             CCCCCCCCCHHhhhcCccccccc
Q 014609          233 EPNPVKRITIAGIKADEWFEQDY  255 (421)
Q Consensus       233 ~~dP~~R~t~~eil~~~w~~~~~  255 (421)
                      +.+|.+||++.+++.|+||.+..
T Consensus       238 ~~~p~~Rp~~~~il~~~~~~~~~  260 (277)
T cd06640         238 NKDPSFRPTAKELLKHKFIVKNA  260 (277)
T ss_pred             ccCcccCcCHHHHHhChHhhhcc
Confidence            99999999999999999997643

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=100.00  E-value=2.3e-39  Score=303.31  Aligned_cols=235  Identities=35%  Similarity=0.575  Sum_probs=204.5

Q ss_pred             ceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeC--CEEEEE
Q 014609           15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASK--SKIYMV   92 (421)
Q Consensus        15 ~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~--~~~~lv   92 (421)
                      +|++.+.||+|++|.||+|.+..+++.|++|++...... ....+.+.+|+.++++++||||+++++.+...  ..++++
T Consensus         1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv   79 (260)
T cd06606           1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDS-EEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIF   79 (260)
T ss_pred             CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccc-hHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEE
Confidence            588999999999999999999989999999998765432 23467899999999999999999999999988  899999


Q ss_pred             EeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCccccCCCc
Q 014609           93 LEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGL  172 (421)
Q Consensus        93 ~E~~~gg~L~~~i~~~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~  172 (421)
                      +||+++++|.+++.....+++..+..++.|++.||+|||+.|++|+||+|+||+++.++.++|+|||.+...........
T Consensus        80 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~  159 (260)
T cd06606          80 LEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEG  159 (260)
T ss_pred             EEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEcccccEEeccccccccc
Confidence            99999999999998877899999999999999999999999999999999999999999999999999886544221112


Q ss_pred             cccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhhc-CCcC----------------------CCCCCCHHHHHHHH
Q 014609          173 LHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIFR-GDFK----------------------LPKWLSPGAQNLLR  229 (421)
Q Consensus       173 ~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~~-~~~~----------------------~p~~~s~~~~~li~  229 (421)
                      .....++..|+|||.+....+ +.++|+||+|+++|.+. |..+                      .|..++..+.++|.
T Consensus       160 ~~~~~~~~~y~~pE~~~~~~~-~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~  238 (260)
T cd06606         160 TGSVRGTPYWMAPEVIRGEEY-GRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPEIPEHLSEEAKDFLR  238 (260)
T ss_pred             ccCCCCCccccCHhhhcCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHhccccCCCcCCCcccCHHHHHHHH
Confidence            345678999999999877665 58899999999999443 2322                      24456889999999


Q ss_pred             HhcCCCCCCCCCHHhhhcCccc
Q 014609          230 KILEPNPVKRITIAGIKADEWF  251 (421)
Q Consensus       230 ~~L~~dP~~R~t~~eil~~~w~  251 (421)
                      +||+.||++||++.+++.||||
T Consensus       239 ~~l~~~p~~Rp~~~~ll~~~~~  260 (260)
T cd06606         239 KCLRRDPKKRPTADELLQHPFL  260 (260)
T ss_pred             HhCcCChhhCCCHHHHhhCCCC
Confidence            9999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=2.4e-39  Score=305.95  Aligned_cols=232  Identities=30%  Similarity=0.511  Sum_probs=198.4

Q ss_pred             ecceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEE
Q 014609           13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMV   92 (421)
Q Consensus        13 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv   92 (421)
                      +++|++.+.||+|+||.||+|.+..+|+.||+|.++............+.+|+.++++++|+||+++++++...+..++|
T Consensus         1 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv   80 (267)
T cd08224           1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIV   80 (267)
T ss_pred             CCceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEE
Confidence            36899999999999999999999889999999998754444444467899999999999999999999999999999999


Q ss_pred             EeccCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCcccc
Q 014609           93 LEYVTGGELFDKIAS----KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFR  168 (421)
Q Consensus        93 ~E~~~gg~L~~~i~~----~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~~  168 (421)
                      |||+++++|.+++..    ...+++..+..++.|++.||+|||+.||+||||+|+||+++.++.++|+|||++.....  
T Consensus        81 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~--  158 (267)
T cd08224          81 LELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSS--  158 (267)
T ss_pred             EecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECCCCcEEEeccceeeeccC--
Confidence            999999999988853    34589999999999999999999999999999999999999999999999999875432  


Q ss_pred             CCCccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhhc-CCcC----------------------CCC-CCCHHH
Q 014609          169 DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIFR-GDFK----------------------LPK-WLSPGA  224 (421)
Q Consensus       169 ~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~~-~~~~----------------------~p~-~~s~~~  224 (421)
                      .........+++.|+|||.+.+..+ +.++|+||+||++|.+. |..+                      .|. .++..+
T Consensus       159 ~~~~~~~~~~~~~y~apE~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (267)
T cd08224         159 KTTAAHSLVGTPYYMSPERIHENGY-NFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDYPPLPADHYSEEL  237 (267)
T ss_pred             CCcccceecCCccccCHHHhccCCC-CchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhhcCCCCCCChhhcCHHH
Confidence            1222344578999999999987777 48899999999999542 2222                      222 466789


Q ss_pred             HHHHHHhcCCCCCCCCCHHhhhc
Q 014609          225 QNLLRKILEPNPVKRITIAGIKA  247 (421)
Q Consensus       225 ~~li~~~L~~dP~~R~t~~eil~  247 (421)
                      .++|.+||.++|++|||+.+|++
T Consensus       238 ~~~i~~cl~~~p~~Rp~~~~il~  260 (267)
T cd08224         238 RDLVSRCINPDPEKRPDISYVLQ  260 (267)
T ss_pred             HHHHHHHcCCCcccCCCHHHHHH
Confidence            99999999999999999998864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=100.00  E-value=1.3e-39  Score=311.63  Aligned_cols=234  Identities=31%  Similarity=0.493  Sum_probs=194.5

Q ss_pred             eeecceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcC-CCCCcceEEEEEE-----
Q 014609           11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEVLA-----   84 (421)
Q Consensus        11 ~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~-----   84 (421)
                      ...++|++.+.||+|+||.||+|.+..+++.+|+|++....    .....+.+|+.+++++ +||||+++++++.     
T Consensus        15 ~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~----~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~   90 (286)
T cd06638          15 DPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH----DIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVK   90 (286)
T ss_pred             CcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc----chHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccC
Confidence            34579999999999999999999999999999999876432    1235688899999999 6999999999873     


Q ss_pred             eCCEEEEEEeccCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccC
Q 014609           85 SKSKIYMVLEYVTGGELFDKIAS----KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGL  160 (421)
Q Consensus        85 ~~~~~~lv~E~~~gg~L~~~i~~----~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGl  160 (421)
                      .....|+||||++|++|.+.+..    ...+++..+..++.|++.||.|||+++++||||||+||+++.++.+||+|||+
T Consensus        91 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~kl~dfg~  170 (286)
T cd06638          91 NGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGV  170 (286)
T ss_pred             CCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEECCCCCEEEccCCc
Confidence            44679999999999999887652    35688999999999999999999999999999999999999999999999999


Q ss_pred             CCCCccccCCCccccccCCCCccChhhhcc-----cCCCCCcchHHHHHHHHhhhc-CCcC-------------------
Q 014609          161 SALPQHFRDDGLLHTTCGSPNYVAPEVLAN-----RGYDGATSDIWSCGVILYIFR-GDFK-------------------  215 (421)
Q Consensus       161 a~~~~~~~~~~~~~~~~gt~~y~APEvl~~-----~~~~~~~~DiwSlGvil~~~~-~~~~-------------------  215 (421)
                      +.....  .........|++.|+|||++..     ..+ +.++||||+||++|.+. |..+                   
T Consensus       171 ~~~~~~--~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~-~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~~~  247 (286)
T cd06638         171 SAQLTS--TRLRRNTSVGTPFWMAPEVIACEQQLDSTY-DARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPRNPPP  247 (286)
T ss_pred             eeeccc--CCCccccccCCCcccChhhhchhhhccccc-cchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhhccccCCC
Confidence            875432  1122334568999999998753     234 57899999999999553 2222                   


Q ss_pred             ---CCCCCCHHHHHHHHHhcCCCCCCCCCHHhhhcCccc
Q 014609          216 ---LPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWF  251 (421)
Q Consensus       216 ---~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~~~w~  251 (421)
                         .|..++..+.++|.+||+.||++|||+.++++|+||
T Consensus       248 ~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~~~  286 (286)
T cd06638         248 TLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI  286 (286)
T ss_pred             cccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcccC
Confidence               122356789999999999999999999999999997

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=3.6e-40  Score=317.41  Aligned_cols=237  Identities=28%  Similarity=0.476  Sum_probs=201.5

Q ss_pred             cceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEE
Q 014609           14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVL   93 (421)
Q Consensus        14 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~   93 (421)
                      +.|.....||+|+||.||++.+..++..||||.+....   ....+.+.+|+.+++.++||||+++++.+...+..|+||
T Consensus        22 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~   98 (292)
T cd06658          22 EYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRK---QQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVM   98 (292)
T ss_pred             HHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecch---HHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEE
Confidence            45666788999999999999998999999999986532   233567889999999999999999999999999999999


Q ss_pred             eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCccccCCCcc
Q 014609           94 EYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLL  173 (421)
Q Consensus        94 E~~~gg~L~~~i~~~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~  173 (421)
                      ||+++++|.+++.. +.+++..+..++.||+.||+|||++||+||||||+||+++.++.++|+|||++.....  .....
T Consensus        99 e~~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~--~~~~~  175 (292)
T cd06658          99 EFLEGGALTDIVTH-TRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSK--EVPKR  175 (292)
T ss_pred             eCCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEccCcchhhccc--ccccC
Confidence            99999999888754 5689999999999999999999999999999999999999999999999999874322  12223


Q ss_pred             ccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhh-cCCcCCC----------------------CCCCHHHHHHHHH
Q 014609          174 HTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIF-RGDFKLP----------------------KWLSPGAQNLLRK  230 (421)
Q Consensus       174 ~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~-~~~~~~p----------------------~~~s~~~~~li~~  230 (421)
                      ....|++.|+|||.+.+..+ +.++|+||+|+++|.+ .|..++.                      ...+..+.+++.+
T Consensus       176 ~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  254 (292)
T cd06658         176 KSLVGTPYWMAPEVISRLPY-GTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLPPRVKDSHKVSSVLRGFLDL  254 (292)
T ss_pred             ceeecCccccCHHHHccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCccccccccCHHHHHHHHH
Confidence            44678999999999887776 5889999999999944 3332221                      1257789999999


Q ss_pred             hcCCCCCCCCCHHhhhcCccccccccC
Q 014609          231 ILEPNPVKRITIAGIKADEWFEQDYTP  257 (421)
Q Consensus       231 ~L~~dP~~R~t~~eil~~~w~~~~~~~  257 (421)
                      ||..||.+|||+.++++||||.....+
T Consensus       255 ~l~~~P~~Rpt~~~il~~~~~~~~~~~  281 (292)
T cd06658         255 MLVREPSQRATAQELLQHPFLKLAGPP  281 (292)
T ss_pred             HccCChhHCcCHHHHhhChhhhccCCc
Confidence            999999999999999999999965544

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=100.00  E-value=1.2e-39  Score=313.90  Aligned_cols=239  Identities=28%  Similarity=0.476  Sum_probs=204.0

Q ss_pred             CeeecceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEE
Q 014609           10 GMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKI   89 (421)
Q Consensus        10 ~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~   89 (421)
                      +...++|++.+.||+|+||.||++.+..+++.||+|.+....   ....+.+.+|+.+++.++||||+++++++......
T Consensus        15 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~   91 (293)
T cd06647          15 GDPKKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQ---QPKKELIINEILVMRENKHPNIVNYLDSYLVGDEL   91 (293)
T ss_pred             cCchhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEecccc---chHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcE
Confidence            455689999999999999999999998899999999986432   22346788999999999999999999999999999


Q ss_pred             EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCccccC
Q 014609           90 YMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD  169 (421)
Q Consensus        90 ~lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~  169 (421)
                      |+|+||+++++|.+++.. ..+++..+..++.|++.||+|||++|++||||||+||+++.++.++|+|||++......  
T Consensus        92 ~lv~e~~~~~~L~~~~~~-~~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~--  168 (293)
T cd06647          92 WVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE--  168 (293)
T ss_pred             EEEEecCCCCcHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcCCCCEEEccCcceeccccc--
Confidence            999999999999998865 46889999999999999999999999999999999999999999999999998754331  


Q ss_pred             CCccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhh-cCCcCC----------------------CCCCCHHHHH
Q 014609          170 DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIF-RGDFKL----------------------PKWLSPGAQN  226 (421)
Q Consensus       170 ~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~-~~~~~~----------------------p~~~s~~~~~  226 (421)
                      ........|++.|+|||.+....+ +.++|+||+||++|.+ .|..++                      +..++..+.+
T Consensus       169 ~~~~~~~~~~~~y~~PE~~~~~~~-~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  247 (293)
T cd06647         169 QSKRSTMVGTPYWMAPEVVTRKAY-GPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRD  247 (293)
T ss_pred             ccccccccCChhhcCchhhccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhcCCCCCCCCccccCHHHHH
Confidence            222334568899999999877766 5889999999999944 333222                      1124678999


Q ss_pred             HHHHhcCCCCCCCCCHHhhhcCccccccc
Q 014609          227 LLRKILEPNPVKRITIAGIKADEWFEQDY  255 (421)
Q Consensus       227 li~~~L~~dP~~R~t~~eil~~~w~~~~~  255 (421)
                      +|.+||..+|.+||++.+++.|+||+...
T Consensus       248 li~~~l~~~p~~Rp~~~~il~h~~~~~~~  276 (293)
T cd06647         248 FLNRCLEMDVEKRGSAKELLQHPFLKIAK  276 (293)
T ss_pred             HHHHHccCChhhCcCHHHHhcCHHHhcCc
Confidence            99999999999999999999999998654

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=100.00  E-value=6.4e-40  Score=316.45  Aligned_cols=238  Identities=28%  Similarity=0.508  Sum_probs=202.1

Q ss_pred             ecceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEE
Q 014609           13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMV   92 (421)
Q Consensus        13 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv   92 (421)
                      ..-|+....||+|+||.||+|.+..+++.||+|.+.....   ...+.+.+|+.+++.++||||+++++++..++..|++
T Consensus        20 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~---~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv   96 (297)
T cd06659          20 RSLLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQ---QRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVL   96 (297)
T ss_pred             hhhHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEeccc---chHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEE
Confidence            3446667789999999999999988999999999865432   2246788999999999999999999999999999999


Q ss_pred             EeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCccccCCCc
Q 014609           93 LEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGL  172 (421)
Q Consensus        93 ~E~~~gg~L~~~i~~~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~  172 (421)
                      +||+++++|.+.+.. ..+++..++.++.|++.||+|||++|++||||||+||+++.++.+||+|||++.....  ....
T Consensus        97 ~e~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~--~~~~  173 (297)
T cd06659          97 MEFLQGGALTDIVSQ-TRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISK--DVPK  173 (297)
T ss_pred             EecCCCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccCCcEEEeechhHhhccc--cccc
Confidence            999999999887654 6789999999999999999999999999999999999999999999999999874432  1122


Q ss_pred             cccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhhc-CCcCC----------------------CCCCCHHHHHHHH
Q 014609          173 LHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIFR-GDFKL----------------------PKWLSPGAQNLLR  229 (421)
Q Consensus       173 ~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~~-~~~~~----------------------p~~~s~~~~~li~  229 (421)
                      ....+|++.|+|||++.+..+ +.++|+||+||++|.+. |..++                      +..+++.+.++|.
T Consensus       174 ~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~  252 (297)
T cd06659         174 RKSLVGTPYWMAPEVISRTPY-GTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNAHKISPVLRDFLE  252 (297)
T ss_pred             ccceecCccccCHHHHccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCccccCCCCHHHHHHHH
Confidence            334678999999999987776 58899999999999543 43322                      1236788999999


Q ss_pred             HhcCCCCCCCCCHHhhhcCccccccccC
Q 014609          230 KILEPNPVKRITIAGIKADEWFEQDYTP  257 (421)
Q Consensus       230 ~~L~~dP~~R~t~~eil~~~w~~~~~~~  257 (421)
                      +||+.+|.+||++.++++||||.+...+
T Consensus       253 ~~l~~~P~~Rps~~~ll~~~~~~~~~~~  280 (297)
T cd06659         253 RMLTREPQERATAQELLDHPFLLQTGLP  280 (297)
T ss_pred             HHhcCCcccCcCHHHHhhChhhccCCCc
Confidence            9999999999999999999999876544

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=100.00  E-value=6e-40  Score=309.00  Aligned_cols=231  Identities=35%  Similarity=0.623  Sum_probs=198.7

Q ss_pred             EeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEEeccCCCCh
Q 014609           22 LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGEL  101 (421)
Q Consensus        22 LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~~gg~L  101 (421)
                      ||.|+||.||+|++..+|+.+|+|++.............+.+|+.++++++||||+++++.+......|+++||++|++|
T Consensus         1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (265)
T cd05579           1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL   80 (265)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence            68999999999999989999999999765544444567899999999999999999999999999999999999999999


Q ss_pred             HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCccccC------CCcccc
Q 014609          102 FDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD------DGLLHT  175 (421)
Q Consensus       102 ~~~i~~~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~------~~~~~~  175 (421)
                      .+++...+.+++..+..++.|++.||+|||++|++||||+|+||+++.++.++|+|||++........      ......
T Consensus        81 ~~~l~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~  160 (265)
T cd05579          81 ASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKR  160 (265)
T ss_pred             HHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccccccccC
Confidence            99998877899999999999999999999999999999999999999999999999999875432111      112234


Q ss_pred             ccCCCCccChhhhcccCCCCCcchHHHHHHHHhhhc-CCc-------------------CCCCCC--CHHHHHHHHHhcC
Q 014609          176 TCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIFR-GDF-------------------KLPKWL--SPGAQNLLRKILE  233 (421)
Q Consensus       176 ~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~~-~~~-------------------~~p~~~--s~~~~~li~~~L~  233 (421)
                      ..+++.|+|||.+....+ +.++|+||||+++|.+. |..                   ++|...  ++.+.+++++||+
T Consensus       161 ~~~~~~~~~Pe~~~~~~~-~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~  239 (265)
T cd05579         161 IVGTPDYIAPEVILGQGH-SKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKIEWPEDVEVSDEAIDLISKLLV  239 (265)
T ss_pred             cccCccccCHHHhcCCCC-CcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCcCCCccccCCHHHHHHHHHHhc
Confidence            568889999999877665 58899999999999543 322                   223333  8899999999999


Q ss_pred             CCCCCCCCH---HhhhcCccccc
Q 014609          234 PNPVKRITI---AGIKADEWFEQ  253 (421)
Q Consensus       234 ~dP~~R~t~---~eil~~~w~~~  253 (421)
                      .+|.+|||+   .++++||||.+
T Consensus       240 ~~p~~Rpt~~~~~~~l~~~~~~~  262 (265)
T cd05579         240 PDPEKRLGAKSIEEIKNHPFFKG  262 (265)
T ss_pred             CCHhhcCCCccHHHHhcCccccC
Confidence            999999999   99999999974

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=2.2e-40  Score=315.71  Aligned_cols=235  Identities=25%  Similarity=0.447  Sum_probs=200.6

Q ss_pred             cceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEE
Q 014609           14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVL   93 (421)
Q Consensus        14 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~   93 (421)
                      +.|+..+.||+|+||.||+|.+..+++.||+|.++....  ....+.+.+|+.++++++||||+++++++..++..|+||
T Consensus         4 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   81 (277)
T cd06642           4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEA--EDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIM   81 (277)
T ss_pred             HHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccc--hHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEE
Confidence            457788999999999999999999999999999875432  223567899999999999999999999999999999999


Q ss_pred             eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCccccCCCcc
Q 014609           94 EYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLL  173 (421)
Q Consensus        94 E~~~gg~L~~~i~~~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~  173 (421)
                      ||+++++|.+.+.. ..+++..++.++.|++.|+.|||++|++|+||+|+||+++.++.++|+|||++......  ....
T Consensus        82 e~~~~~~L~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~--~~~~  158 (277)
T cd06642          82 EYLGGGSALDLLKP-GPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDT--QIKR  158 (277)
T ss_pred             EccCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeCCCCEEEccccccccccCc--chhh
Confidence            99999999988764 57899999999999999999999999999999999999999999999999998754321  1122


Q ss_pred             ccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhhc-CCcCC--------------------CCCCCHHHHHHHHHhc
Q 014609          174 HTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIFR-GDFKL--------------------PKWLSPGAQNLLRKIL  232 (421)
Q Consensus       174 ~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~~-~~~~~--------------------p~~~s~~~~~li~~~L  232 (421)
                      ....|+..|+|||++.+..+ +.++|+||+||++|.+. |..++                    +..++..+.++|.+||
T Consensus       159 ~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l  237 (277)
T cd06642         159 NTFVGTPFWMAPEVIKQSAY-DFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSPPTLEGQYSKPFKEFVEACL  237 (277)
T ss_pred             hcccCcccccCHHHhCcCCC-chhhhHHHHHHHHHHHHhCCCCCcccchhhHHhhhhcCCCCCCCcccCHHHHHHHHHHc
Confidence            33468889999999987776 48899999999999543 33332                    1125678999999999


Q ss_pred             CCCCCCCCCHHhhhcCcccccc
Q 014609          233 EPNPVKRITIAGIKADEWFEQD  254 (421)
Q Consensus       233 ~~dP~~R~t~~eil~~~w~~~~  254 (421)
                      +.+|++||++.++++||||.+.
T Consensus       238 ~~~p~~Rp~~~~il~~~~~~~~  259 (277)
T cd06642         238 NKDPRFRPTAKELLKHKFITRY  259 (277)
T ss_pred             cCCcccCcCHHHHHHhHHHHHH
Confidence            9999999999999999999753

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=5.2e-41  Score=286.41  Aligned_cols=236  Identities=31%  Similarity=0.509  Sum_probs=198.6

Q ss_pred             cceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEE
Q 014609           14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVL   93 (421)
Q Consensus        14 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~   93 (421)
                      .+|.-.++||+|.||+||+|++..+++.||+|.++.... +...-....+||.+|+.++|.|||+++++..+++.+.+|+
T Consensus         2 ~~ydkmekigegtygtvfkarn~~t~eivalkrvrlddd-degvpssalreicllkelkhknivrl~dvlhsdkkltlvf   80 (292)
T KOG0662|consen    2 QKYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDD-DEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVF   80 (292)
T ss_pred             cchHHHHhhcCCcceeeEecccCCccceEEEEEEeccCC-CCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeH
Confidence            357778899999999999999999999999999986543 2233467899999999999999999999999999999999


Q ss_pred             eccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCccccCCCc
Q 014609           94 EYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGL  172 (421)
Q Consensus        94 E~~~gg~L~~~i~~-~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~  172 (421)
                      ||| ..+|..+... ++.++.+.++.++.|++.||.|||++++.|||+||.|+|++.+|.+||+|||+++.+.-  .-..
T Consensus        81 e~c-dqdlkkyfdslng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~ngelkladfglarafgi--pvrc  157 (292)
T KOG0662|consen   81 EFC-DQDLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRNGELKLADFGLARAFGI--PVRC  157 (292)
T ss_pred             HHh-hHHHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEeccCCcEEecccchhhhcCC--ceEe
Confidence            999 4577777664 56799999999999999999999999999999999999999999999999999986543  2223


Q ss_pred             cccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhhc-----------------------CCc---------------
Q 014609          173 LHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIFR-----------------------GDF---------------  214 (421)
Q Consensus       173 ~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~~-----------------------~~~---------------  214 (421)
                      .....-|.+|++|.++.+...++...|+||.|||+.++.                       |..               
T Consensus       158 ysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpdyk  237 (292)
T KOG0662|consen  158 YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDYK  237 (292)
T ss_pred             eeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCCCc
Confidence            334456899999999988776678999999999998321                       111               


Q ss_pred             CCC------------CCCCHHHHHHHHHhcCCCCCCCCCHHhhhcCccccc
Q 014609          215 KLP------------KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQ  253 (421)
Q Consensus       215 ~~p------------~~~s~~~~~li~~~L~~dP~~R~t~~eil~~~w~~~  253 (421)
                      ++|            +.++..-++|+.++|..+|.+|+++++.++||||..
T Consensus       238 ~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqhpyf~d  288 (292)
T KOG0662|consen  238 PYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQHPYFSD  288 (292)
T ss_pred             ccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcCccccc
Confidence            011            113456789999999999999999999999999975

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=100.00  E-value=2.5e-41  Score=309.94  Aligned_cols=246  Identities=33%  Similarity=0.499  Sum_probs=200.9

Q ss_pred             ecceEEeceEeecCcEEEEEEEECCCC----ceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEe-CC
Q 014609           13 LGRYELGRTLGEGNFGKVKFAQDLDSG----LPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLAS-KS   87 (421)
Q Consensus        13 ~~~y~i~~~LG~G~~g~V~~a~~~~~~----~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~-~~   87 (421)
                      +..|++.+.||+|.||.||+|....++    +.+|||.++.+.. .........||+.+++.++||||+.+..++.+ +.
T Consensus        23 l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd-~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~  101 (438)
T KOG0666|consen   23 LFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKD-GTGISMSACREIALLRELKHPNVISLVKVFLSHDK  101 (438)
T ss_pred             HHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCC-CCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCc
Confidence            457999999999999999999655443    3789999875532 22345678999999999999999999999877 88


Q ss_pred             EEEEEEeccCCCChHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccC----CCEEEEec
Q 014609           88 KIYMVLEYVTGGELFDKIAS-----KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSK----GNIKISDF  158 (421)
Q Consensus        88 ~~~lv~E~~~gg~L~~~i~~-----~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~----~~~kL~DF  158 (421)
                      .+|+++||++. +|+..|.-     ...++...++.++.||++|+.|||++-|.||||||.|||+..+    |.+||+||
T Consensus       102 ~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VKIaDl  180 (438)
T KOG0666|consen  102 KVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVKIADL  180 (438)
T ss_pred             eEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeEeecc
Confidence            99999999965 88888753     2468999999999999999999999999999999999999887    89999999


Q ss_pred             cCCCCCccccCC-CccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhhcC-------------------------
Q 014609          159 GLSALPQHFRDD-GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIFRG-------------------------  212 (421)
Q Consensus       159 Gla~~~~~~~~~-~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~~~-------------------------  212 (421)
                      |+++++...-.. .......-|.+|+|||.+.+...++.++|+||.|||+.++.+                         
T Consensus       181 GlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~r  260 (438)
T KOG0666|consen  181 GLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLDR  260 (438)
T ss_pred             cHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHHH
Confidence            999987542211 123445678899999999987777799999999999983321                         


Q ss_pred             ------Cc---------CCCCC--------------------------CCHHHHHHHHHhcCCCCCCCCCHHhhhcCccc
Q 014609          213 ------DF---------KLPKW--------------------------LSPGAQNLLRKILEPNPVKRITIAGIKADEWF  251 (421)
Q Consensus       213 ------~~---------~~p~~--------------------------~s~~~~~li~~~L~~dP~~R~t~~eil~~~w~  251 (421)
                            ..         .+|.+                          -++.+.+|+.+||+.||.+|+|++++++|+||
T Consensus       261 If~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh~yF  340 (438)
T KOG0666|consen  261 IFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEHPYF  340 (438)
T ss_pred             HHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhccccc
Confidence                  11         11221                          24668999999999999999999999999999


Q ss_pred             cccccCCCC
Q 014609          252 EQDYTPANP  260 (421)
Q Consensus       252 ~~~~~~~~~  260 (421)
                      ..+..|..+
T Consensus       341 ~~d~lpp~p  349 (438)
T KOG0666|consen  341 TEDPLPPLP  349 (438)
T ss_pred             ccCCCCCCc
Confidence            988666443

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=8.2e-40  Score=309.63  Aligned_cols=232  Identities=29%  Similarity=0.500  Sum_probs=198.3

Q ss_pred             ecceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEE
Q 014609           13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMV   92 (421)
Q Consensus        13 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv   92 (421)
                      +++|++.+.||+|+||.||+|.+..+++.+|||.+.............+.+|+.+++.++||||+++++++..++..+++
T Consensus         1 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v   80 (267)
T cd08229           1 LANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIV   80 (267)
T ss_pred             CchhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEE
Confidence            46899999999999999999999999999999988765444444456888999999999999999999999999999999


Q ss_pred             EeccCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCcccc
Q 014609           93 LEYVTGGELFDKIAS----KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFR  168 (421)
Q Consensus        93 ~E~~~gg~L~~~i~~----~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~~  168 (421)
                      |||++|++|.+++..    ...+++..++.++.|++.||+|||++|++|+||||+||+++.++.++|+|||++...... 
T Consensus        81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~-  159 (267)
T cd08229          81 LELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSK-  159 (267)
T ss_pred             EEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEECcchhhhccccC-
Confidence            999999999988763    346899999999999999999999999999999999999999999999999998755331 


Q ss_pred             CCCccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhhc-CCcCC-----------------------CCCCCHHH
Q 014609          169 DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIFR-GDFKL-----------------------PKWLSPGA  224 (421)
Q Consensus       169 ~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~~-~~~~~-----------------------p~~~s~~~  224 (421)
                       .......+|++.|+|||.+.+..+ +.++|+||+|+++|.+. |..++                       +..+++.+
T Consensus       160 -~~~~~~~~~~~~~~ape~~~~~~~-~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (267)
T cd08229         160 -TTAAHSLVGTPYYMSPERIHENGY-NFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEEL  237 (267)
T ss_pred             -CcccccccCCcCccCHHHhcCCCc-cchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhhcCCCCCCCcccccHHH
Confidence             222345678999999999987776 48899999999999543 32221                       12367899


Q ss_pred             HHHHHHhcCCCCCCCCCHHhhhc
Q 014609          225 QNLLRKILEPNPVKRITIAGIKA  247 (421)
Q Consensus       225 ~~li~~~L~~dP~~R~t~~eil~  247 (421)
                      .+++.+||+.||.+|||+.+|++
T Consensus       238 ~~li~~~l~~~p~~Rpt~~~i~~  260 (267)
T cd08229         238 RQLVNMCINPDPEKRPDITYVYD  260 (267)
T ss_pred             HHHHHHhcCCCcccCCCHHHHHH
Confidence            99999999999999999997754

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=100.00  E-value=1.1e-39  Score=320.98  Aligned_cols=236  Identities=30%  Similarity=0.454  Sum_probs=194.2

Q ss_pred             cceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeC-------
Q 014609           14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASK-------   86 (421)
Q Consensus        14 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~-------   86 (421)
                      ++|++.+.||.|+||.||+|.+..+|+.||+|.+.....   ...+.+.+|+.++++++||||+++++++...       
T Consensus         5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~---~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~   81 (342)
T cd07854           5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDP---QSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTED   81 (342)
T ss_pred             cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCC---chHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccc
Confidence            799999999999999999999999999999999875543   2356788999999999999999999876544       


Q ss_pred             -------CEEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecc-CCCEEEEec
Q 014609           87 -------SKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDS-KGNIKISDF  158 (421)
Q Consensus        87 -------~~~~lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~-~~~~kL~DF  158 (421)
                             ...|+||||++ ++|.+.+.. ..+++..++.++.|+++||.|||++||+||||||+||+++. ++.+||+||
T Consensus        82 ~~~~~~~~~~~lv~e~~~-~~L~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~~~~~~kl~df  159 (342)
T cd07854          82 VGSLTELNSVYIVQEYME-TDLANVLEQ-GPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGDF  159 (342)
T ss_pred             cccccccceEEEEeeccc-ccHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCceEEECCc
Confidence                   35899999996 588887754 57999999999999999999999999999999999999974 557899999


Q ss_pred             cCCCCCccccC-CCccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhh-cCCcCCC-------------------
Q 014609          159 GLSALPQHFRD-DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIF-RGDFKLP-------------------  217 (421)
Q Consensus       159 Gla~~~~~~~~-~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~-~~~~~~p-------------------  217 (421)
                      |++........ ........++..|+|||++.+....+.++||||+||++|.+ .|..++.                   
T Consensus       160 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~  239 (342)
T cd07854         160 GLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVVR  239 (342)
T ss_pred             ccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCC
Confidence            99875432111 11223346788999999876544446889999999999954 3333221                   


Q ss_pred             ------------------------------CCCCHHHHHHHHHhcCCCCCCCCCHHhhhcCcccccc
Q 014609          218 ------------------------------KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD  254 (421)
Q Consensus       218 ------------------------------~~~s~~~~~li~~~L~~dP~~R~t~~eil~~~w~~~~  254 (421)
                                                    +.++.++.++|.+||++||.+|||+.+++.||||+..
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~~~  306 (342)
T cd07854         240 EEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMSCY  306 (342)
T ss_pred             hHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCCCccccc
Confidence                                          1356788899999999999999999999999999864

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=100.00  E-value=1.2e-39  Score=306.34  Aligned_cols=233  Identities=29%  Similarity=0.553  Sum_probs=199.0

Q ss_pred             ceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEEe
Q 014609           15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLE   94 (421)
Q Consensus        15 ~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E   94 (421)
                      +|++.+.||+|+||.||+|.+..+|..+|+|.+....... ...+.+.+|+.+++.++||||+++++.+......|+|+|
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e   79 (257)
T cd08225           1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPV-KEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVME   79 (257)
T ss_pred             CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccc-hhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEe
Confidence            6899999999999999999999999999999987643322 234678899999999999999999999999999999999


Q ss_pred             ccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCC-EEEEeccCCCCCccccCCC
Q 014609           95 YVTGGELFDKIASKG--RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGN-IKISDFGLSALPQHFRDDG  171 (421)
Q Consensus        95 ~~~gg~L~~~i~~~~--~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~-~kL~DFGla~~~~~~~~~~  171 (421)
                      |+++++|.+++....  .+++..+..++.|++.||.|||+.+++|+||||+||+++.++. +||+|||.+.....  ...
T Consensus        80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~--~~~  157 (257)
T cd08225          80 YCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLND--SME  157 (257)
T ss_pred             cCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCCCCeEEecccccchhccC--Ccc
Confidence            999999999887643  4799999999999999999999999999999999999998864 69999999876533  122


Q ss_pred             ccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhhc-CCcCC--------------------CCCCCHHHHHHHHH
Q 014609          172 LLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIFR-GDFKL--------------------PKWLSPGAQNLLRK  230 (421)
Q Consensus       172 ~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~~-~~~~~--------------------p~~~s~~~~~li~~  230 (421)
                      ......|++.|+|||++.+..+ +.++|+||+|+++|.+. |..++                    ++.++..+.++|.+
T Consensus       158 ~~~~~~~~~~~~ape~~~~~~~-~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~  236 (257)
T cd08225         158 LAYTCVGTPYYLSPEICQNRPY-NNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYFAPISPNFSRDLRSLISQ  236 (257)
T ss_pred             cccccCCCccccCHHHHcCCCC-CchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhcccCCCCCCCCCHHHHHHHHH
Confidence            2234468999999999877766 48899999999999543 32222                    23367889999999


Q ss_pred             hcCCCCCCCCCHHhhhcCccc
Q 014609          231 ILEPNPVKRITIAGIKADEWF  251 (421)
Q Consensus       231 ~L~~dP~~R~t~~eil~~~w~  251 (421)
                      ||..+|++|||+.+++.||||
T Consensus       237 ~l~~~p~~Rpt~~~ll~~~~~  257 (257)
T cd08225         237 LFKVSPRDRPSITSILKRPFL  257 (257)
T ss_pred             HhccChhhCcCHHHHhhCCCC
Confidence            999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=100.00  E-value=1.7e-39  Score=309.76  Aligned_cols=235  Identities=25%  Similarity=0.462  Sum_probs=200.6

Q ss_pred             ceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEEe
Q 014609           15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLE   94 (421)
Q Consensus        15 ~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E   94 (421)
                      -|++.+.||+|+||.||+|.+..+++.||+|++.....  ......+.+|+.++++++||||+++++++..+...|+|||
T Consensus         5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   82 (277)
T cd06641           5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA--EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME   82 (277)
T ss_pred             hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccc--hHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEE
Confidence            37788999999999999999988999999999865432  2235678999999999999999999999999999999999


Q ss_pred             ccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCccccCCCccc
Q 014609           95 YVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLH  174 (421)
Q Consensus        95 ~~~gg~L~~~i~~~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~  174 (421)
                      |+++++|.+++.. ..+++..+..++.|++.|+.|||+.|++|+||+|+||+++.++.++|+|||++......  .....
T Consensus        83 ~~~~~~l~~~i~~-~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~--~~~~~  159 (277)
T cd06641          83 YLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDT--QIKRN  159 (277)
T ss_pred             eCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCCCCEEEeecccceecccc--hhhhc
Confidence            9999999988865 56899999999999999999999999999999999999999999999999998754321  11223


Q ss_pred             cccCCCCccChhhhcccCCCCCcchHHHHHHHHhhh-cCCcC--------------------CCCCCCHHHHHHHHHhcC
Q 014609          175 TTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIF-RGDFK--------------------LPKWLSPGAQNLLRKILE  233 (421)
Q Consensus       175 ~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~-~~~~~--------------------~p~~~s~~~~~li~~~L~  233 (421)
                      ...++..|+|||.+....+ +.++|+||+||++|.+ .|..+                    ++..++.++.+++.+||+
T Consensus       160 ~~~~~~~y~~PE~~~~~~~-~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~  238 (277)
T cd06641         160 TFVGTPFWMAPEVIKQSAY-DSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVEACLN  238 (277)
T ss_pred             cccCCccccChhhhccCCC-CchhhHHHHHHHHHHHHcCCCCCCccchHHHHHHHhcCCCCCCCcccCHHHHHHHHHHcc
Confidence            3568889999999877666 4789999999999944 33322                    223467889999999999


Q ss_pred             CCCCCCCCHHhhhcCccccccc
Q 014609          234 PNPVKRITIAGIKADEWFEQDY  255 (421)
Q Consensus       234 ~dP~~R~t~~eil~~~w~~~~~  255 (421)
                      .+|.+||++.++++||||.+..
T Consensus       239 ~~p~~Rp~~~~~l~~~~~~~~~  260 (277)
T cd06641         239 KEPSFRPTAKELLKHKFIVRFA  260 (277)
T ss_pred             CChhhCcCHHHHHhCHHHhhhh
Confidence            9999999999999999998743

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=8.1e-40  Score=328.23  Aligned_cols=233  Identities=26%  Similarity=0.384  Sum_probs=191.9

Q ss_pred             eecceEEeceEeecCcEEEEEEEECCC-----CceEEEEEeecccccchhHHHHHHHHHHHHhcCC-CCCcceEEEEEEe
Q 014609           12 RLGRYELGRTLGEGNFGKVKFAQDLDS-----GLPFAVKILEKNRIIHLKITDQIKREIATLKLLK-HPNVVRLHEVLAS   85 (421)
Q Consensus        12 ~~~~y~i~~~LG~G~~g~V~~a~~~~~-----~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~   85 (421)
                      ..++|++++.||+|+||.||+|.+...     +..||||++....  .....+.+.+|+.+++++. ||||+++++++..
T Consensus        35 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~  112 (400)
T cd05105          35 PRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTA--RSSEKQALMSELKIMTHLGPHLNIVNLLGACTK  112 (400)
T ss_pred             cccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCC--ChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEcc
Confidence            346889999999999999999987433     4579999996543  2233567899999999996 9999999999999


Q ss_pred             CCEEEEEEeccCCCChHHHHHhc---------------------------------------------------------
Q 014609           86 KSKIYMVLEYVTGGELFDKIASK---------------------------------------------------------  108 (421)
Q Consensus        86 ~~~~~lv~E~~~gg~L~~~i~~~---------------------------------------------------------  108 (421)
                      ....|+||||+++|+|.+++...                                                         
T Consensus       113 ~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  192 (400)
T cd05105         113 SGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPML  192 (400)
T ss_pred             CCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhh
Confidence            99999999999999999887542                                                         


Q ss_pred             ---------------------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecc
Q 014609          109 ---------------------------------------GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDS  149 (421)
Q Consensus       109 ---------------------------------------~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~  149 (421)
                                                             ..+++..+..++.|++.||+|||+.||+||||||+|||++.
T Consensus       193 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~Nill~~  272 (400)
T cd05105         193 EIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLLAQ  272 (400)
T ss_pred             hhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHhEEEeC
Confidence                                                   23677888999999999999999999999999999999999


Q ss_pred             CCCEEEEeccCCCCCccccCCCccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhhc--CCcCC-----------
Q 014609          150 KGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIFR--GDFKL-----------  216 (421)
Q Consensus       150 ~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~~--~~~~~-----------  216 (421)
                      ++.+||+|||++................+++.|+|||++.+..+ +.++|||||||++|.+.  |..++           
T Consensus       273 ~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~~~~  351 (400)
T cd05105         273 GKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLY-TTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFYN  351 (400)
T ss_pred             CCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCC-CchhhHHHHHHHHHHHHHCCCCCCcccchhHHHHH
Confidence            99999999999875433211122233456788999999987776 58999999999999642  44443           


Q ss_pred             ----------CCCCCHHHHHHHHHhcCCCCCCCCCHHhhhc
Q 014609          217 ----------PKWLSPGAQNLLRKILEPNPVKRITIAGIKA  247 (421)
Q Consensus       217 ----------p~~~s~~~~~li~~~L~~dP~~R~t~~eil~  247 (421)
                                |..++..+.+++.+||+.||++|||+.++.+
T Consensus       352 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~  392 (400)
T cd05105         352 KIKSGYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSD  392 (400)
T ss_pred             HHhcCCCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHH
Confidence                      2336788999999999999999999988765

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=1.4e-39  Score=311.27  Aligned_cols=235  Identities=24%  Similarity=0.368  Sum_probs=194.9

Q ss_pred             eeecceEEeceEeecCcEEEEEEEEC----CCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeC
Q 014609           11 MRLGRYELGRTLGEGNFGKVKFAQDL----DSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASK   86 (421)
Q Consensus        11 ~~~~~y~i~~~LG~G~~g~V~~a~~~----~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~   86 (421)
                      ..+.+|++.+.||+|+||+||+|.+.    .++..||+|.+....  .......+.+|+.++++++||||+++++++...
T Consensus         2 ~~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~   79 (283)
T cd05090           2 LPLSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDIN--NPQQWGEFQQEASLMAELHHPNIVCLLGVVTQE   79 (283)
T ss_pred             CChhhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCC--CHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecC
Confidence            35678999999999999999999853    456789999986432  223346788999999999999999999999999


Q ss_pred             CEEEEEEeccCCCChHHHHHhc-----------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecc
Q 014609           87 SKIYMVLEYVTGGELFDKIASK-----------------GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDS  149 (421)
Q Consensus        87 ~~~~lv~E~~~gg~L~~~i~~~-----------------~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~  149 (421)
                      ...|+||||+++++|.+++...                 ..+++..+..++.|++.||+|||++||+||||||+|||++.
T Consensus        80 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili~~  159 (283)
T cd05090          80 QPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGE  159 (283)
T ss_pred             CceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEEcC
Confidence            9999999999999999988532                 23788889999999999999999999999999999999999


Q ss_pred             CCCEEEEeccCCCCCccccCCCccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhhc--CCcC------------
Q 014609          150 KGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIFR--GDFK------------  215 (421)
Q Consensus       150 ~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~~--~~~~------------  215 (421)
                      ++.+||+|||++................++..|+|||++.+..+ +.++|+|||||++|.+.  |..+            
T Consensus       160 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~~~~  238 (283)
T cd05090         160 QLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKF-SSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEM  238 (283)
T ss_pred             CCcEEeccccccccccCCcceecccCCCccceecChHHhccCCC-CchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Confidence            99999999999975432211122233456778999999877666 58999999999999654  3322            


Q ss_pred             --------CCCCCCHHHHHHHHHhcCCCCCCCCCHHhhhcC
Q 014609          216 --------LPKWLSPGAQNLLRKILEPNPVKRITIAGIKAD  248 (421)
Q Consensus       216 --------~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~~  248 (421)
                              .|..+++.+.+++.+||++||.+||++.+|+++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~  279 (283)
T cd05090         239 VRKRQLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTR  279 (283)
T ss_pred             HHcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence                    234478899999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-40  Score=297.00  Aligned_cols=232  Identities=28%  Similarity=0.442  Sum_probs=192.3

Q ss_pred             cceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEE-----eCCE
Q 014609           14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLA-----SKSK   88 (421)
Q Consensus        14 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~-----~~~~   88 (421)
                      .||++.+.||+|||+.||++++..+++.+|+|.+....   .+..+...+|++..++++|||+++++++..     ....
T Consensus        21 ~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~---~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~   97 (302)
T KOG2345|consen   21 KRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHS---QEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHE   97 (302)
T ss_pred             ceEEEeeeecCCCceeeeeecccCcccchhhheeeccc---hHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCcee
Confidence            69999999999999999999999999999999986543   345788999999999999999999988753     2345


Q ss_pred             EEEEEeccCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC--ceeccCCCCCEEeccCCCEEEEeccCCC
Q 014609           89 IYMVLEYVTGGELFDKIAS----KGRLQEAEGRKLFQQLIDGVSYCHNKG--VFHRDLKLENILLDSKGNIKISDFGLSA  162 (421)
Q Consensus        89 ~~lv~E~~~gg~L~~~i~~----~~~~~~~~~~~~~~ql~~aL~~LH~~g--i~HrDlkp~NILl~~~~~~kL~DFGla~  162 (421)
                      .|++++|...|+|.+.+..    ...+++.++..||.++++||++||+..  ++||||||.|||+.+.+.++|.|||.++
T Consensus        98 ~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~~vl~D~GS~~  177 (302)
T KOG2345|consen   98 AYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGLPVLMDLGSAT  177 (302)
T ss_pred             EEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCceEEEeccCcc
Confidence            9999999999999999875    236999999999999999999999998  9999999999999999999999999988


Q ss_pred             CCccccCCC----c---cccccCCCCccChhhhcccCC--CCCcchHHHHHHHHhh-h---------------------c
Q 014609          163 LPQHFRDDG----L---LHTTCGSPNYVAPEVLANRGY--DGATSDIWSCGVILYI-F---------------------R  211 (421)
Q Consensus       163 ~~~~~~~~~----~---~~~~~gt~~y~APEvl~~~~~--~~~~~DiwSlGvil~~-~---------------------~  211 (421)
                      ...-.-..+    .   ......|..|+|||.+.-+.+  .+.++|||||||+||. +                     .
T Consensus       178 ~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSlaLAv~n  257 (302)
T KOG2345|consen  178 QAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSLALAVQN  257 (302)
T ss_pred             ccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCeEEEeeec
Confidence            542211110    0   111245889999998764432  3689999999999992 2                     2


Q ss_pred             CCcCCCC--CCCHHHHHHHHHhcCCCCCCCCCHHhhhcC
Q 014609          212 GDFKLPK--WLSPGAQNLLRKILEPNPVKRITIAGIKAD  248 (421)
Q Consensus       212 ~~~~~p~--~~s~~~~~li~~~L~~dP~~R~t~~eil~~  248 (421)
                      +.+.+|.  .+|..+.++|+.||++||.+||++.+++.+
T Consensus       258 ~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~  296 (302)
T KOG2345|consen  258 AQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSK  296 (302)
T ss_pred             cccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence            3334443  389999999999999999999999998764

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.5e-40  Score=324.60  Aligned_cols=236  Identities=26%  Similarity=0.403  Sum_probs=193.5

Q ss_pred             cceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCC-CCCcceEEEEEEeCCEEEEE
Q 014609           14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK-HPNVVRLHEVLASKSKIYMV   92 (421)
Q Consensus        14 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~lv   92 (421)
                      ..|++++.||+||.++||++... ..+.+|+|.+..... +......+.+|+..|.+|+ |.+||++++|-..++.+|+|
T Consensus       361 ~~Yeilk~iG~GGSSkV~kV~~s-~~~iyalkkv~~~~~-D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmv  438 (677)
T KOG0596|consen  361 REYEILKQIGSGGSSKVFKVLNS-DKQIYALKKVVLLEA-DNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMV  438 (677)
T ss_pred             chhhHHHhhcCCCcceeeeeecC-CCcchhhhHHHHhhc-CHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEE
Confidence            47999999999999999999864 445566665543222 3445788999999999996 99999999999999999999


Q ss_pred             EeccCCCChHHHHHhcCCC-CHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCccccCCC
Q 014609           93 LEYVTGGELFDKIASKGRL-QEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDG  171 (421)
Q Consensus        93 ~E~~~gg~L~~~i~~~~~~-~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~  171 (421)
                      |||- ..+|...+...... +.-..+.|..|++.|+.++|.+||||.||||.|+|+ -.|.+||+|||.|......-..-
T Consensus       439 mE~G-d~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLl-VkG~LKLIDFGIA~aI~~DTTsI  516 (677)
T KOG0596|consen  439 MECG-DIDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLL-VKGRLKLIDFGIANAIQPDTTSI  516 (677)
T ss_pred             eecc-cccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEE-EeeeEEeeeechhcccCccccce
Confidence            9987 56898888775543 335888999999999999999999999999999998 67899999999998765544444


Q ss_pred             ccccccCCCCccChhhhcccCCC----------CCcchHHHHHHHHhhh-cCCc----------------------CCCC
Q 014609          172 LLHTTCGSPNYVAPEVLANRGYD----------GATSDIWSCGVILYIF-RGDF----------------------KLPK  218 (421)
Q Consensus       172 ~~~~~~gt~~y~APEvl~~~~~~----------~~~~DiwSlGvil~~~-~~~~----------------------~~p~  218 (421)
                      ...+.+||+.||+||.+....+.          +.++||||||||||.| .|..                      ++|.
T Consensus       517 ~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~~aKl~aI~~P~~~Iefp~  596 (677)
T KOG0596|consen  517 VKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQIAKLHAITDPNHEIEFPD  596 (677)
T ss_pred             eeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHHHHHHHhhcCCCccccccC
Confidence            56678999999999998654432          6789999999999943 2222                      3343


Q ss_pred             CCCHH-HHHHHHHhcCCCCCCCCCHHhhhcCccccc
Q 014609          219 WLSPG-AQNLLRKILEPNPVKRITIAGIKADEWFEQ  253 (421)
Q Consensus       219 ~~s~~-~~~li~~~L~~dP~~R~t~~eil~~~w~~~  253 (421)
                      .-+.. +.++++.||..||.+|||+.++|+|||++-
T Consensus       597 ~~~~~~li~~mK~CL~rdPkkR~si~eLLqhpFl~~  632 (677)
T KOG0596|consen  597 IPENDELIDVMKCCLARDPKKRWSIPELLQHPFLQI  632 (677)
T ss_pred             CCCchHHHHHHHHHHhcCcccCCCcHHHhcCccccc
Confidence            33333 999999999999999999999999999874

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4e-39  Score=301.77  Aligned_cols=233  Identities=32%  Similarity=0.552  Sum_probs=204.5

Q ss_pred             ceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEEe
Q 014609           15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLE   94 (421)
Q Consensus        15 ~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E   94 (421)
                      +|++.+.||+|++|.||+|.+..+++.||+|.+...... ....+.+.+|++++++++|||++++++++.+....|++||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e   79 (254)
T cd06627           1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIK-EEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILE   79 (254)
T ss_pred             CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccC-HHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEe
Confidence            589999999999999999999989999999999765432 2345789999999999999999999999999999999999


Q ss_pred             ccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCccccCCCccc
Q 014609           95 YVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLH  174 (421)
Q Consensus        95 ~~~gg~L~~~i~~~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~  174 (421)
                      |+++++|.+.+.....+++..+..++.|++.||.|||+.||+||||+|+||+++.++.++|+|||++......  .....
T Consensus        80 ~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~--~~~~~  157 (254)
T cd06627          80 YAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDV--SKDDA  157 (254)
T ss_pred             cCCCCcHHHHHHhccCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECCCCCEEEeccccceecCCC--ccccc
Confidence            9999999999988888999999999999999999999999999999999999999999999999999865432  12234


Q ss_pred             cccCCCCccChhhhcccCCCCCcchHHHHHHHHhhhc-CCcC--------------------CCCCCCHHHHHHHHHhcC
Q 014609          175 TTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIFR-GDFK--------------------LPKWLSPGAQNLLRKILE  233 (421)
Q Consensus       175 ~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~~-~~~~--------------------~p~~~s~~~~~li~~~L~  233 (421)
                      ...++..|+|||.+.+..+ +.++|+||+|+++|.+. |..+                    +|..++..+.+++.+||.
T Consensus       158 ~~~~~~~y~~pe~~~~~~~-~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~  236 (254)
T cd06627         158 SVVGTPYWMAPEVIEMSGA-STASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQDDHPPLPEGISPELKDFLMQCFQ  236 (254)
T ss_pred             ccccchhhcCHhhhcCCCC-CcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhccCCCCCCCCCCHHHHHHHHHHHh
Confidence            4578999999999877665 58899999999999443 3322                    234578899999999999


Q ss_pred             CCCCCCCCHHhhhcCccc
Q 014609          234 PNPVKRITIAGIKADEWF  251 (421)
Q Consensus       234 ~dP~~R~t~~eil~~~w~  251 (421)
                      ++|++|||+.+++.||||
T Consensus       237 ~~p~~R~~~~~~l~~~~~  254 (254)
T cd06627         237 KDPNLRPTAKQLLKHPWI  254 (254)
T ss_pred             CChhhCcCHHHHhcCCCC
Confidence            999999999999999997

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=8.2e-40  Score=311.79  Aligned_cols=233  Identities=27%  Similarity=0.382  Sum_probs=194.6

Q ss_pred             eecceEEeceEeecCcEEEEEEEEC-----CCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeC
Q 014609           12 RLGRYELGRTLGEGNFGKVKFAQDL-----DSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASK   86 (421)
Q Consensus        12 ~~~~y~i~~~LG~G~~g~V~~a~~~-----~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~   86 (421)
                      ..++|.+.+.||+|+||.||+|.+.     .+++.||+|.+.....  ......+.+|++++++++||||+++++++...
T Consensus         3 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~   80 (280)
T cd05049           3 QRDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETAS--NDARKDFEREAELLTNFQHENIVKFYGVCTEG   80 (280)
T ss_pred             ChHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCC--HHHHHHHHHHHHHHHhcCCCCchheeeEEecC
Confidence            3568999999999999999999874     3468899999865422  22357899999999999999999999999999


Q ss_pred             CEEEEEEeccCCCChHHHHHhc--------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCC
Q 014609           87 SKIYMVLEYVTGGELFDKIASK--------------GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGN  152 (421)
Q Consensus        87 ~~~~lv~E~~~gg~L~~~i~~~--------------~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~  152 (421)
                      ...|+||||++|++|.+++...              ..+++..+..++.|++.||+|||++|++||||||+||+++.++.
T Consensus        81 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~  160 (280)
T cd05049          81 DPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLV  160 (280)
T ss_pred             CCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEcCCCe
Confidence            9999999999999999998754              24788899999999999999999999999999999999999999


Q ss_pred             EEEEeccCCCCCccccCCCccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhhc--CCcCC--------------
Q 014609          153 IKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIFR--GDFKL--------------  216 (421)
Q Consensus       153 ~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~~--~~~~~--------------  216 (421)
                      +||+|||++................+++.|+|||++.+..+ +.++|||||||++|.+.  |..++              
T Consensus       161 ~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~~~~~  239 (280)
T cd05049         161 VKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKF-TTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECITQ  239 (280)
T ss_pred             EEECCcccceecccCcceecCCCCcccceecChhhhccCCc-chhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHc
Confidence            99999999874322111112223345788999999988777 58899999999999654  44332              


Q ss_pred             ------CCCCCHHHHHHHHHhcCCCCCCCCCHHhhhc
Q 014609          217 ------PKWLSPGAQNLLRKILEPNPVKRITIAGIKA  247 (421)
Q Consensus       217 ------p~~~s~~~~~li~~~L~~dP~~R~t~~eil~  247 (421)
                            |..++..+.+++.+||++||++|||+.++++
T Consensus       240 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~  276 (280)
T cd05049         240 GRLLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHE  276 (280)
T ss_pred             CCcCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence                  3346789999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.4e-39  Score=307.07  Aligned_cols=227  Identities=33%  Similarity=0.583  Sum_probs=191.2

Q ss_pred             ceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHH-hcCCCCCcceEEEEEEeCCEEEEEEeccCC
Q 014609           20 RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATL-KLLKHPNVVRLHEVLASKSKIYMVLEYVTG   98 (421)
Q Consensus        20 ~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il-~~l~hpnIv~l~~~~~~~~~~~lv~E~~~g   98 (421)
                      +.||+|+||.||+|.+..+|+.||+|.+++...........+..|..++ ...+||||+++++++...+.+|+|+||++|
T Consensus         2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   81 (260)
T cd05611           2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG   81 (260)
T ss_pred             ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence            5799999999999999999999999998765433222233445555544 455899999999999999999999999999


Q ss_pred             CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCccccCCCccccccC
Q 014609           99 GELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCG  178 (421)
Q Consensus        99 g~L~~~i~~~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~g  178 (421)
                      ++|.+++.....+++..+..++.|++.||.|||+.|++||||+|+||+++.++.++|+|||++.....      .....|
T Consensus        82 ~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~------~~~~~~  155 (260)
T cd05611          82 GDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE------NKKFVG  155 (260)
T ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEeecccceeccc------cccCCC
Confidence            99999998878899999999999999999999999999999999999999999999999999874322      234568


Q ss_pred             CCCccChhhhcccCCCCCcchHHHHHHHHhhhc-CCcCC-----------------------CCCCCHHHHHHHHHhcCC
Q 014609          179 SPNYVAPEVLANRGYDGATSDIWSCGVILYIFR-GDFKL-----------------------PKWLSPGAQNLLRKILEP  234 (421)
Q Consensus       179 t~~y~APEvl~~~~~~~~~~DiwSlGvil~~~~-~~~~~-----------------------p~~~s~~~~~li~~~L~~  234 (421)
                      ++.|+|||.+.+..+ +.++||||+|+++|.+. |..++                       +..+++.+.++|.+||+.
T Consensus       156 ~~~y~~pe~~~~~~~-~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~  234 (260)
T cd05611         156 TPDYLAPETILGVGD-DKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEVKEFCSPEAVDLINRLLCM  234 (260)
T ss_pred             CcCccChhhhcCCCC-cchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccCCCCcccccCCHHHHHHHHHHccC
Confidence            899999999887765 58999999999999443 33322                       123689999999999999


Q ss_pred             CCCCCCC---HHhhhcCccccc
Q 014609          235 NPVKRIT---IAGIKADEWFEQ  253 (421)
Q Consensus       235 dP~~R~t---~~eil~~~w~~~  253 (421)
                      ||++||+   ++|++.||||.+
T Consensus       235 ~p~~R~~~~~~~~~l~~~~~~~  256 (260)
T cd05611         235 DPAKRLGANGYQEIKSHPFFKS  256 (260)
T ss_pred             CHHHccCCCcHHHHHcChHhhc
Confidence            9999995   579999999975

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-40  Score=324.79  Aligned_cols=224  Identities=29%  Similarity=0.462  Sum_probs=189.1

Q ss_pred             ceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEEe
Q 014609           15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLE   94 (421)
Q Consensus        15 ~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E   94 (421)
                      .+++++.||+|-||.||+|... ....||+|.+......    .+.+.+|+++|++|+|+|||++++++..+..+|||||
T Consensus       207 ~l~l~~~LG~G~FG~V~~g~~~-~~~~vavk~ik~~~m~----~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE  281 (468)
T KOG0197|consen  207 ELKLIRELGSGQFGEVWLGKWN-GSTKVAVKTIKEGSMS----PEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTE  281 (468)
T ss_pred             HHHHHHHhcCCccceEEEEEEc-CCCcccceEEeccccC----hhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEE
Confidence            4566889999999999999973 3448999998754322    3678899999999999999999999999889999999


Q ss_pred             ccCCCChHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCccccCCC-
Q 014609           95 YVTGGELFDKIAS--KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDG-  171 (421)
Q Consensus        95 ~~~gg~L~~~i~~--~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~-  171 (421)
                      |++.|+|.+++..  ...+...+...++.||++|++||+++++|||||-..||||+++..+||+|||+|+....  +.- 
T Consensus       282 ~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d--~~Y~  359 (468)
T KOG0197|consen  282 YMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVDEDLVVKISDFGLARLIGD--DEYT  359 (468)
T ss_pred             ecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeeccCceEEEcccccccccCC--Ccee
Confidence            9999999999986  45789999999999999999999999999999999999999999999999999994322  111 


Q ss_pred             ccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhhcC----------------------CcCCCCCCCHHHHHHHH
Q 014609          172 LLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIFRG----------------------DFKLPKWLSPGAQNLLR  229 (421)
Q Consensus       172 ~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~~~----------------------~~~~p~~~s~~~~~li~  229 (421)
                      ......-...|.|||.+....+ +.++|||||||+||++..                      +.+.|+.+|+.+-++|.
T Consensus       360 ~~~~~kfPIkWtAPEa~~~~~F-S~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le~GyRlp~P~~CP~~vY~lM~  438 (468)
T KOG0197|consen  360 ASEGGKFPIKWTAPEALNYGKF-SSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLERGYRLPRPEGCPDEVYELMK  438 (468)
T ss_pred             ecCCCCCCceecCHHHHhhCCc-ccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHhccCcCCCCCCCCHHHHHHHH
Confidence            1111122346999999998888 589999999999995422                      34557779999999999


Q ss_pred             HhcCCCCCCCCCHHhhh
Q 014609          230 KILEPNPVKRITIAGIK  246 (421)
Q Consensus       230 ~~L~~dP~~R~t~~eil  246 (421)
                      .||+.+|++|||++.+.
T Consensus       439 ~CW~~~P~~RPtF~~L~  455 (468)
T KOG0197|consen  439 SCWHEDPEDRPTFETLR  455 (468)
T ss_pred             HHhhCCcccCCCHHHHH
Confidence            99999999999998543

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=2.5e-39  Score=310.58  Aligned_cols=238  Identities=25%  Similarity=0.325  Sum_probs=193.8

Q ss_pred             ecceEEeceEeecCcEEEEEEEECC-----CCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCC
Q 014609           13 LGRYELGRTLGEGNFGKVKFAQDLD-----SGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKS   87 (421)
Q Consensus        13 ~~~y~i~~~LG~G~~g~V~~a~~~~-----~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~   87 (421)
                      -++|++.+.||+|+||.||+|.+..     .+..||+|.+....  .......+.+|+.++++++||||+++++++...+
T Consensus         5 ~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~   82 (288)
T cd05061           5 REKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESA--SLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQ   82 (288)
T ss_pred             HHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcC--CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC
Confidence            4689999999999999999997542     35589999886443  2223456788999999999999999999999999


Q ss_pred             EEEEEEeccCCCChHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEe
Q 014609           88 KIYMVLEYVTGGELFDKIASK----------GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISD  157 (421)
Q Consensus        88 ~~~lv~E~~~gg~L~~~i~~~----------~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~D  157 (421)
                      ..|+||||+++|+|.+++...          ...+...+..++.|++.||+|||++||+||||||+|||++.++.++|+|
T Consensus        83 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~~~~~~~L~D  162 (288)
T cd05061          83 PTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGD  162 (288)
T ss_pred             CcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEcCCCcEEECc
Confidence            999999999999999998642          2346678889999999999999999999999999999999999999999


Q ss_pred             ccCCCCCccccCCCccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhhc--CCcC--------------------
Q 014609          158 FGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIFR--GDFK--------------------  215 (421)
Q Consensus       158 FGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~~--~~~~--------------------  215 (421)
                      ||++................++..|+|||.+.+..+ +.++|+||+||++|.+.  +..+                    
T Consensus       163 fg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~-~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~  241 (288)
T cd05061         163 FGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVF-TTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGYLD  241 (288)
T ss_pred             CCccccccccccccccCCCcccccccCHHHhccCCC-ChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC
Confidence            999875422111111122345678999999887766 58999999999999553  2322                    


Q ss_pred             CCCCCCHHHHHHHHHhcCCCCCCCCCHHhhhc------Cccccc
Q 014609          216 LPKWLSPGAQNLLRKILEPNPVKRITIAGIKA------DEWFEQ  253 (421)
Q Consensus       216 ~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~------~~w~~~  253 (421)
                      .|...++.+.+++.+||+.||++|||+.++++      ||||..
T Consensus       242 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~~~  285 (288)
T cd05061         242 QPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFPE  285 (288)
T ss_pred             CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcCCCCCC
Confidence            23446789999999999999999999999987      888763

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=1.9e-39  Score=304.70  Aligned_cols=225  Identities=29%  Similarity=0.441  Sum_probs=186.4

Q ss_pred             ceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEEeccCCC
Q 014609           20 RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGG   99 (421)
Q Consensus        20 ~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~~gg   99 (421)
                      +.||+|+||.||+|.+..+++.||+|.+....  .......+.+|++++++++||||+++++++......|+||||++++
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~   78 (252)
T cd05084           1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETL--PPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGG   78 (252)
T ss_pred             CccCcccCccEEEEEEecCCceEEEEecCccC--CHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCC
Confidence            46999999999999999999999999876432  2334567999999999999999999999999999999999999999


Q ss_pred             ChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCccccCCCccccccC
Q 014609          100 ELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCG  178 (421)
Q Consensus       100 ~L~~~i~~~-~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~g  178 (421)
                      +|.+++... ..+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||++................+
T Consensus        79 ~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~  158 (252)
T cd05084          79 DFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQI  158 (252)
T ss_pred             cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCCCcEEECccccCcccccccccccCCCCCC
Confidence            999998754 3589999999999999999999999999999999999999999999999999874322100000011122


Q ss_pred             CCCccChhhhcccCCCCCcchHHHHHHHHhhhc--CCcC--------------------CCCCCCHHHHHHHHHhcCCCC
Q 014609          179 SPNYVAPEVLANRGYDGATSDIWSCGVILYIFR--GDFK--------------------LPKWLSPGAQNLLRKILEPNP  236 (421)
Q Consensus       179 t~~y~APEvl~~~~~~~~~~DiwSlGvil~~~~--~~~~--------------------~p~~~s~~~~~li~~~L~~dP  236 (421)
                      +..|+|||.+.+..+ +.++|+|||||++|.+.  +..+                    .|..++..+.+++.+||+++|
T Consensus       159 ~~~y~aPE~~~~~~~-~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p  237 (252)
T cd05084         159 PVKWTAPEALNYGRY-SSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGVRLPCPELCPDAVYRLMERCWEYDP  237 (252)
T ss_pred             ceeecCchhhcCCCC-ChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCCCCcccCCHHHHHHHHHHcCCCh
Confidence            456999999877766 58899999999999543  3322                    233467899999999999999


Q ss_pred             CCCCCHHhhhc
Q 014609          237 VKRITIAGIKA  247 (421)
Q Consensus       237 ~~R~t~~eil~  247 (421)
                      ++|||+.++++
T Consensus       238 ~~Rps~~~~~~  248 (252)
T cd05084         238 GQRPSFSTVHQ  248 (252)
T ss_pred             hhCcCHHHHHH
Confidence            99999999864

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=4.5e-39  Score=308.60  Aligned_cols=234  Identities=31%  Similarity=0.499  Sum_probs=196.9

Q ss_pred             cceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEe--CCEEEE
Q 014609           14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLAS--KSKIYM   91 (421)
Q Consensus        14 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~--~~~~~l   91 (421)
                      ++|+..+.||.|++|.||+|.+..+++.+|+|.+.....  ......+.+|++++++++||||+++++++..  .+.+|+
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~l   78 (287)
T cd06621           1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPN--PDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGI   78 (287)
T ss_pred             CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCc--hHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEE
Confidence            479999999999999999999999999999999875432  2335778999999999999999999998854  347899


Q ss_pred             EEeccCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCccc
Q 014609           92 VLEYVTGGELFDKIAS----KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHF  167 (421)
Q Consensus        92 v~E~~~gg~L~~~i~~----~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~  167 (421)
                      ||||++|++|.+.+..    ...+++..+..++.||+.||+|||+.|++|+||+|+||+++.++.++|+|||++..... 
T Consensus        79 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~-  157 (287)
T cd06621          79 AMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVN-  157 (287)
T ss_pred             EEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecCCeEEEeeccccccccc-
Confidence            9999999999887643    34589999999999999999999999999999999999999999999999999874322 


Q ss_pred             cCCCccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhh-cCCcCCCC----------------------------
Q 014609          168 RDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIF-RGDFKLPK----------------------------  218 (421)
Q Consensus       168 ~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~-~~~~~~p~----------------------------  218 (421)
                         .......++..|+|||.+.+..+ +.++|+|||||++|.+ .|..++..                            
T Consensus       158 ---~~~~~~~~~~~y~~pE~~~~~~~-~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (287)
T cd06621         158 ---SLAGTFTGTSFYMAPERIQGKPY-SITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDEPG  233 (287)
T ss_pred             ---cccccccCCccccCHHHhcCCCC-CchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCCchhhccCCC
Confidence               12224567889999999887777 4889999999999944 34333211                            


Q ss_pred             ---CCCHHHHHHHHHhcCCCCCCCCCHHhhhcCcccccc
Q 014609          219 ---WLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD  254 (421)
Q Consensus       219 ---~~s~~~~~li~~~L~~dP~~R~t~~eil~~~w~~~~  254 (421)
                         .+++.+.++|.+||.++|++|||+.|++.||||.+.
T Consensus       234 ~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~~~~~  272 (287)
T cd06621         234 NGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKAQ  272 (287)
T ss_pred             CCCchHHHHHHHHHHHcCCCcccCCCHHHHHhCcccccc
Confidence               124578899999999999999999999999999653

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=100.00  E-value=3.1e-39  Score=318.04  Aligned_cols=236  Identities=31%  Similarity=0.424  Sum_probs=197.6

Q ss_pred             eecceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCC----
Q 014609           12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKS----   87 (421)
Q Consensus        12 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~----   87 (421)
                      .-++|++++.||+|+||.||+|.+..+|+.||||.+.+... .......+.+|+.++++++||||+++++++....    
T Consensus        13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   91 (343)
T cd07880          13 VPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQ-SELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDR   91 (343)
T ss_pred             cccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEeccccc-chHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccc
Confidence            34689999999999999999999999999999999865322 2223467889999999999999999999987653    


Q ss_pred             --EEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCc
Q 014609           88 --KIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQ  165 (421)
Q Consensus        88 --~~~lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~  165 (421)
                        .+|+||||+ |++|.+.+.. ..+++..++.++.|++.||+|||+.||+||||||+||+++.++.++|+|||++....
T Consensus        92 ~~~~~lv~e~~-~~~l~~~~~~-~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~~~~~kl~dfg~~~~~~  169 (343)
T cd07880          92 FHDFYLVMPFM-GTDLGKLMKH-EKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQTD  169 (343)
T ss_pred             cceEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccccccc
Confidence              468999999 7788877764 679999999999999999999999999999999999999999999999999987532


Q ss_pred             cccCCCccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhh-cCCcCC----------------------------
Q 014609          166 HFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIF-RGDFKL----------------------------  216 (421)
Q Consensus       166 ~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~-~~~~~~----------------------------  216 (421)
                      .     ......+++.|+|||++.+....+.++|+||+||++|.+ .|..++                            
T Consensus       170 ~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (343)
T cd07880         170 S-----EMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQ  244 (343)
T ss_pred             c-----CccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhc
Confidence            2     223456789999999987644346889999999999944 333222                            


Q ss_pred             ----------------------CCCCCHHHHHHHHHhcCCCCCCCCCHHhhhcCccccccc
Q 014609          217 ----------------------PKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY  255 (421)
Q Consensus       217 ----------------------p~~~s~~~~~li~~~L~~dP~~R~t~~eil~~~w~~~~~  255 (421)
                                            .+.+++.+.++|.+||+.||.+|||+.+++.||||+...
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~~  305 (343)
T cd07880         245 SEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFH  305 (343)
T ss_pred             chhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhhc
Confidence                                  123577889999999999999999999999999998653

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=1.7e-39  Score=309.65  Aligned_cols=233  Identities=22%  Similarity=0.302  Sum_probs=190.8

Q ss_pred             ecceEEeceEeecCcEEEEEEEEC-----CCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCC
Q 014609           13 LGRYELGRTLGEGNFGKVKFAQDL-----DSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKS   87 (421)
Q Consensus        13 ~~~y~i~~~LG~G~~g~V~~a~~~-----~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~   87 (421)
                      -++|++.+.||+|+||.||+|.+.     .++..||+|.+....  .......+.+|+.+++.++||||+++++++....
T Consensus         5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~--~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~   82 (277)
T cd05062           5 REKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAA--SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQ   82 (277)
T ss_pred             HHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC
Confidence            368999999999999999999864     245789999886432  2223456889999999999999999999999999


Q ss_pred             EEEEEEeccCCCChHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEe
Q 014609           88 KIYMVLEYVTGGELFDKIASKG----------RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISD  157 (421)
Q Consensus        88 ~~~lv~E~~~gg~L~~~i~~~~----------~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~D  157 (421)
                      ..++||||+++++|.+++....          .++...+..++.|++.||+|||+.|++||||||+||+++.++.++|+|
T Consensus        83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~~~~~~~l~d  162 (277)
T cd05062          83 PTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGD  162 (277)
T ss_pred             CeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEcCCCCEEECC
Confidence            9999999999999999886522          356778899999999999999999999999999999999999999999


Q ss_pred             ccCCCCCccccCCCccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhhc--CCcC--------------------
Q 014609          158 FGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIFR--GDFK--------------------  215 (421)
Q Consensus       158 FGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~~--~~~~--------------------  215 (421)
                      ||++................+++.|+|||++.+..+ +.++|||||||++|.+.  +..+                    
T Consensus       163 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~  241 (277)
T cd05062         163 FGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVF-TTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVMEGGLLD  241 (277)
T ss_pred             CCCccccCCcceeecCCCCccCHhhcChhHhhcCCc-CchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCcCC
Confidence            999874322111111122345778999999887666 58899999999999553  2322                    


Q ss_pred             CCCCCCHHHHHHHHHhcCCCCCCCCCHHhhhcC
Q 014609          216 LPKWLSPGAQNLLRKILEPNPVKRITIAGIKAD  248 (421)
Q Consensus       216 ~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~~  248 (421)
                      .|...++.+.+++.+||+.||++|||+.+++++
T Consensus       242 ~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~  274 (277)
T cd05062         242 KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS  274 (277)
T ss_pred             CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            234467889999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=100.00  E-value=2e-39  Score=308.18  Aligned_cols=227  Identities=27%  Similarity=0.486  Sum_probs=191.1

Q ss_pred             eecceEEeceE--eecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcC-CCCCcceEEEEEEeCCE
Q 014609           12 RLGRYELGRTL--GEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEVLASKSK   88 (421)
Q Consensus        12 ~~~~y~i~~~L--G~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~   88 (421)
                      ..++|++.+.+  |+|+||.||++.+..++..+|+|++.......        .|+.....+ +||||+++++.+...+.
T Consensus        12 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~--------~e~~~~~~~~~h~~iv~~~~~~~~~~~   83 (267)
T PHA03390         12 FLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA--------IEPMVHQLMKDNPNFIKLYYSVTTLKG   83 (267)
T ss_pred             HHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch--------hhHHHHHHhhcCCCEEEEEEEEecCCe
Confidence            34678887776  99999999999999999999999987543211        122222222 69999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCC-CEEEEeccCCCCCccc
Q 014609           89 IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKG-NIKISDFGLSALPQHF  167 (421)
Q Consensus        89 ~~lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~-~~kL~DFGla~~~~~~  167 (421)
                      .|+||||++|++|.+++.....+++..+..++.|++.||.|||+.|++||||||+||+++.++ .++|+|||++..... 
T Consensus        84 ~~iv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~-  162 (267)
T PHA03390         84 HVLIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGT-  162 (267)
T ss_pred             eEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCCCeEEEecCccceecCC-
Confidence            999999999999999998877899999999999999999999999999999999999999998 999999999874322 


Q ss_pred             cCCCccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhh-cCCcCC-----------------------CCCCCHH
Q 014609          168 RDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIF-RGDFKL-----------------------PKWLSPG  223 (421)
Q Consensus       168 ~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~-~~~~~~-----------------------p~~~s~~  223 (421)
                           .....|++.|+|||++.+..+ +.++|+||+|+++|.+ .|..|+                       ++.+++.
T Consensus       163 -----~~~~~~~~~y~aPE~~~~~~~-~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (267)
T PHA03390        163 -----PSCYDGTLDYFSPEKIKGHNY-DVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQKKLPFIKNVSKN  236 (267)
T ss_pred             -----CccCCCCCcccChhhhcCCCC-CchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhhcccCCcccccCHH
Confidence                 223468999999999988777 4889999999999944 333322                       2237899


Q ss_pred             HHHHHHHhcCCCCCCCCC-HHhhhcCccccc
Q 014609          224 AQNLLRKILEPNPVKRIT-IAGIKADEWFEQ  253 (421)
Q Consensus       224 ~~~li~~~L~~dP~~R~t-~~eil~~~w~~~  253 (421)
                      +.++|.+||+++|.+|++ ++++++||||.+
T Consensus       237 ~~~li~~~l~~~p~~R~~~~~~~l~h~~~~~  267 (267)
T PHA03390        237 ANDFVQSMLKYNINYRLTNYNEIIKHPFLKI  267 (267)
T ss_pred             HHHHHHHHhccChhhCCchHHHHhcCCcccC
Confidence            999999999999999996 699999999963

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=100.00  E-value=4.7e-39  Score=301.41  Aligned_cols=233  Identities=33%  Similarity=0.586  Sum_probs=203.2

Q ss_pred             ceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEEe
Q 014609           15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLE   94 (421)
Q Consensus        15 ~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E   94 (421)
                      +|++.+.||.|+||.||+|.+..+++.||+|.+...... ......+.+|+++++.++|||++++++.+......++|+|
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e   79 (258)
T cd08215           1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMS-EKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVME   79 (258)
T ss_pred             CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCC-hHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEE
Confidence            689999999999999999999989999999999764432 2345678999999999999999999999999999999999


Q ss_pred             ccCCCChHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCccccCC
Q 014609           95 YVTGGELFDKIASK----GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD  170 (421)
Q Consensus        95 ~~~gg~L~~~i~~~----~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~  170 (421)
                      |+++++|.+.+...    ..+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++......  .
T Consensus        80 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~--~  157 (258)
T cd08215          80 YADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSST--V  157 (258)
T ss_pred             ecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcCCCcEEECCccceeecccC--c
Confidence            99999999988763    67999999999999999999999999999999999999999999999999999865432  1


Q ss_pred             CccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhh-cCCcC--------------------CCCCCCHHHHHHHH
Q 014609          171 GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIF-RGDFK--------------------LPKWLSPGAQNLLR  229 (421)
Q Consensus       171 ~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~-~~~~~--------------------~p~~~s~~~~~li~  229 (421)
                      ......+|++.|+|||.+....+ +.++|+||+|+++|.+ .|..+                    +|..++..+.+++.
T Consensus       158 ~~~~~~~~~~~y~~pe~~~~~~~-~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~  236 (258)
T cd08215         158 DLAKTVVGTPYYLSPELCQNKPY-NYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQYPPIPSQYSSELRNLVS  236 (258)
T ss_pred             ceecceeeeecccChhHhccCCC-CccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHhcCCCCCCCCCCCHHHHHHHH
Confidence            23445678999999999877766 5889999999999843 23222                    23457789999999


Q ss_pred             HhcCCCCCCCCCHHhhhcCccc
Q 014609          230 KILEPNPVKRITIAGIKADEWF  251 (421)
Q Consensus       230 ~~L~~dP~~R~t~~eil~~~w~  251 (421)
                      +||..+|++|||+.++++||||
T Consensus       237 ~~l~~~p~~Rp~~~~ll~~~~~  258 (258)
T cd08215         237 SLLQKDPEERPSIAQILQSPFI  258 (258)
T ss_pred             HHcCCChhhCcCHHHHhcCCCC
Confidence            9999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=100.00  E-value=2e-39  Score=318.02  Aligned_cols=243  Identities=30%  Similarity=0.406  Sum_probs=199.9

Q ss_pred             ecceEE-eceEeecCcEEEEEEEECCCCceEEEEEeecccccchh-----------HHHHHHHHHHHHhcCCCCCcceEE
Q 014609           13 LGRYEL-GRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLK-----------ITDQIKREIATLKLLKHPNVVRLH   80 (421)
Q Consensus        13 ~~~y~i-~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~-----------~~~~~~~Ei~il~~l~hpnIv~l~   80 (421)
                      -++|.. .+.||.|+||+||+|.+..+++.||||++.........           ....+.+|+.+++.++||||++++
T Consensus         7 ~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~   86 (335)
T PTZ00024          7 SERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLV   86 (335)
T ss_pred             ccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeee
Confidence            467875 57799999999999999999999999998754322100           012477899999999999999999


Q ss_pred             EEEEeCCEEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccC
Q 014609           81 EVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGL  160 (421)
Q Consensus        81 ~~~~~~~~~~lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGl  160 (421)
                      +++...+..|+||||+. ++|.+.+.....+++..+..++.|++.||+|||+.||+||||+|+||+++.++.++|+|||+
T Consensus        87 ~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~~~~~~kl~dfg~  165 (335)
T PTZ00024         87 DVYVEGDFINLVMDIMA-SDLKKVVDRKIRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADFGL  165 (335)
T ss_pred             EEEecCCcEEEEEeccc-cCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEECCCCCEEECCccc
Confidence            99999999999999996 58999998878899999999999999999999999999999999999999999999999999


Q ss_pred             CCCCcccc------------CCCccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhhc-CCcCCC----------
Q 014609          161 SALPQHFR------------DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIFR-GDFKLP----------  217 (421)
Q Consensus       161 a~~~~~~~------------~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~~-~~~~~p----------  217 (421)
                      +.......            .........+++.|+|||++.+....+.++|+|||||++|.+. |..+++          
T Consensus       166 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~  245 (335)
T PTZ00024        166 ARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQLGR  245 (335)
T ss_pred             eeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence            87543110            1112233457889999999876554468999999999999543 322211          


Q ss_pred             -------------------------------------CCCCHHHHHHHHHhcCCCCCCCCCHHhhhcCcccccccc
Q 014609          218 -------------------------------------KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYT  256 (421)
Q Consensus       218 -------------------------------------~~~s~~~~~li~~~L~~dP~~R~t~~eil~~~w~~~~~~  256 (421)
                                                           +..+..+.++|.+||+++|++|||+++++.||||+....
T Consensus       246 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~~~~~~~~  321 (335)
T PTZ00024        246 IFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHEYFKSDPL  321 (335)
T ss_pred             HHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCcccCCCCC
Confidence                                                 124678899999999999999999999999999986543

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=2e-39  Score=315.48  Aligned_cols=232  Identities=22%  Similarity=0.309  Sum_probs=192.7

Q ss_pred             ecceEEeceEeecCcEEEEEEEECCCCce----EEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCE
Q 014609           13 LGRYELGRTLGEGNFGKVKFAQDLDSGLP----FAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSK   88 (421)
Q Consensus        13 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~----vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~   88 (421)
                      -.+|++.+.||+|+||+||+|.+..+++.    ||+|++....  .......+.+|+.+++.++||||+++++++... .
T Consensus         6 ~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~   82 (316)
T cd05108           6 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT--SPKANKEILDEAYVMASVDNPHVCRLLGICLTS-T   82 (316)
T ss_pred             hhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-C
Confidence            45799999999999999999998666654    8999986432  233356788999999999999999999998765 5


Q ss_pred             EEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCccc
Q 014609           89 IYMVLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHF  167 (421)
Q Consensus        89 ~~lv~E~~~gg~L~~~i~~~-~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~  167 (421)
                      .++++||+++|+|.+.+... ..+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||++......
T Consensus        83 ~~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~  162 (316)
T cd05108          83 VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAD  162 (316)
T ss_pred             ceeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEecCCCcEEEccccccccccCC
Confidence            77999999999999998764 46889999999999999999999999999999999999999999999999999865432


Q ss_pred             cCCCccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhhc--CCcC--------------------CCCCCCHHHH
Q 014609          168 RDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIFR--GDFK--------------------LPKWLSPGAQ  225 (421)
Q Consensus       168 ~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~~--~~~~--------------------~p~~~s~~~~  225 (421)
                      ..........++..|+|||++.+..+ +.++|||||||++|.+.  |..+                    .|+.++.++.
T Consensus       163 ~~~~~~~~~~~~~~y~apE~~~~~~~-~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (316)
T cd05108         163 EKEYHAEGGKVPIKWMALESILHRIY-THQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVY  241 (316)
T ss_pred             CcceeccCCccceeecChHHhccCCC-CchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhCCCCCCCCCCCCHHHH
Confidence            21111222344678999999987777 58999999999999642  3332                    2445778899


Q ss_pred             HHHHHhcCCCCCCCCCHHhhhcC
Q 014609          226 NLLRKILEPNPVKRITIAGIKAD  248 (421)
Q Consensus       226 ~li~~~L~~dP~~R~t~~eil~~  248 (421)
                      +++.+||..+|.+||++.+++.+
T Consensus       242 ~li~~cl~~~p~~Rps~~~l~~~  264 (316)
T cd05108         242 MIMVKCWMIDADSRPKFRELIIE  264 (316)
T ss_pred             HHHHHHccCChhhCcCHHHHHHH
Confidence            99999999999999999999986

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=1.6e-39  Score=314.44  Aligned_cols=233  Identities=27%  Similarity=0.397  Sum_probs=192.2

Q ss_pred             eeecceEEeceEeecCcEEEEEEEECCCCce--EEEEEeecccccchhHHHHHHHHHHHHhcC-CCCCcceEEEEEEeCC
Q 014609           11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLP--FAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEVLASKS   87 (421)
Q Consensus        11 ~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~--vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~   87 (421)
                      ..+++|++.+.||+|+||.||+|.+..++..  +|+|.+...  ........+.+|+.++.++ +||||+++++++...+
T Consensus         4 ~~~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~--~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~   81 (303)
T cd05088           4 LEWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY--ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRG   81 (303)
T ss_pred             cchhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEeccc--CCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCC
Confidence            4678999999999999999999998877765  466665432  2233456788999999999 8999999999999999


Q ss_pred             EEEEEEeccCCCChHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCC
Q 014609           88 KIYMVLEYVTGGELFDKIASKG----------------RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKG  151 (421)
Q Consensus        88 ~~~lv~E~~~gg~L~~~i~~~~----------------~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~  151 (421)
                      .+|+||||+++++|.+++...+                .+++..++.++.|++.||+|||++||+||||||+|||++.++
T Consensus        82 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili~~~~  161 (303)
T cd05088          82 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENY  161 (303)
T ss_pred             CceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEecCCC
Confidence            9999999999999999986532                478999999999999999999999999999999999999999


Q ss_pred             CEEEEeccCCCCCccccCCCccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhhc--CCcCC-------------
Q 014609          152 NIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIFR--GDFKL-------------  216 (421)
Q Consensus       152 ~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~~--~~~~~-------------  216 (421)
                      .+||+|||++.......   ......++..|+|||++.+..+ +.++|||||||++|.+.  |..++             
T Consensus       162 ~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~  237 (303)
T cd05088         162 VAKIADFGLSRGQEVYV---KKTMGRLPVRWMAIESLNYSVY-TTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLP  237 (303)
T ss_pred             cEEeCccccCcccchhh---hcccCCCcccccCHHHHhccCC-cccccchhhhhHHHHHHhcCCCCcccCChHHHHHHHh
Confidence            99999999986322110   1111223567999999877665 58999999999999664  44433             


Q ss_pred             -------CCCCCHHHHHHHHHhcCCCCCCCCCHHhhhcCc
Q 014609          217 -------PKWLSPGAQNLLRKILEPNPVKRITIAGIKADE  249 (421)
Q Consensus       217 -------p~~~s~~~~~li~~~L~~dP~~R~t~~eil~~~  249 (421)
                             |..+++.+.+++.+||+.+|++||++++++.+.
T Consensus       238 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l  277 (303)
T cd05088         238 QGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSL  277 (303)
T ss_pred             cCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence                   223678999999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=100.00  E-value=5e-39  Score=308.21  Aligned_cols=235  Identities=28%  Similarity=0.495  Sum_probs=199.9

Q ss_pred             ceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEEe
Q 014609           15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLE   94 (421)
Q Consensus        15 ~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E   94 (421)
                      .|...+.||+|++|.||+|.+..+++.+|+|.++...   ....+.+.+|+.+++.++||||+++++++...+..|+++|
T Consensus        20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~---~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e   96 (285)
T cd06648          20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRK---QQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVME   96 (285)
T ss_pred             hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccc---hhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEe
Confidence            4555679999999999999998999999999886432   2234668899999999999999999999999999999999


Q ss_pred             ccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCccccCCCccc
Q 014609           95 YVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLH  174 (421)
Q Consensus        95 ~~~gg~L~~~i~~~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~  174 (421)
                      |++|++|.+.+.. .++++..+..++.|++.||+|||++|++||||+|+||+++.++.++|+|||++......  .....
T Consensus        97 ~~~~~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~--~~~~~  173 (285)
T cd06648          97 FLEGGALTDIVTH-TRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKE--VPRRK  173 (285)
T ss_pred             ccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCCCcEEEcccccchhhccC--Ccccc
Confidence            9999999998877 67899999999999999999999999999999999999999999999999988743321  11223


Q ss_pred             cccCCCCccChhhhcccCCCCCcchHHHHHHHHhhhc-CCcCC----------------------CCCCCHHHHHHHHHh
Q 014609          175 TTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIFR-GDFKL----------------------PKWLSPGAQNLLRKI  231 (421)
Q Consensus       175 ~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~~-~~~~~----------------------p~~~s~~~~~li~~~  231 (421)
                      ...|++.|+|||++.+..+ +.++|+||+||++|.+. |..++                      +..++..+.+++.+|
T Consensus       174 ~~~~~~~y~aPE~~~~~~~-~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~  252 (285)
T cd06648         174 SLVGTPYWMAPEVISRLPY-GTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNLPPKLKNLHKVSPRLRSFLDRM  252 (285)
T ss_pred             cccCCccccCHHHhcCCCC-CCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhcCCCCCcccccCCHHHHHHHHHH
Confidence            4568999999999887776 58899999999999543 32221                      112678899999999


Q ss_pred             cCCCCCCCCCHHhhhcCcccccccc
Q 014609          232 LEPNPVKRITIAGIKADEWFEQDYT  256 (421)
Q Consensus       232 L~~dP~~R~t~~eil~~~w~~~~~~  256 (421)
                      |+.+|.+|||+.++++||||.+...
T Consensus       253 l~~~p~~Rpt~~~il~~~~~~~~~~  277 (285)
T cd06648         253 LVRDPAQRATAAELLNHPFLAKAGP  277 (285)
T ss_pred             cccChhhCcCHHHHccCcccccCCC
Confidence            9999999999999999999987543

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.5e-41  Score=317.47  Aligned_cols=241  Identities=35%  Similarity=0.624  Sum_probs=215.1

Q ss_pred             CeeecceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcC-CCCCcceEEEEEEeCCE
Q 014609           10 GMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEVLASKSK   88 (421)
Q Consensus        10 ~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~   88 (421)
                      .++..+|..+..||+|+||+|-+|..+.+.+.+|||++++..+......+--..|-++|... +-|.+++++.+|++-++
T Consensus       345 ~i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDR  424 (683)
T KOG0696|consen  345 RIKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDR  424 (683)
T ss_pred             ceeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhh
Confidence            46678999999999999999999999999999999999988776665566666788888777 46899999999999999


Q ss_pred             EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCcccc
Q 014609           89 IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFR  168 (421)
Q Consensus        89 ~~lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~~  168 (421)
                      +|+||||+.||+|...|+.-+.+.++.|..|+..|+-||-+||++||++||||.+|||||.+|++||+|||+++-  ..-
T Consensus       425 LyFVMEyvnGGDLMyhiQQ~GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKE--ni~  502 (683)
T KOG0696|consen  425 LYFVMEYVNGGDLMYHIQQVGKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKE--NIF  502 (683)
T ss_pred             eeeEEEEecCchhhhHHHHhcccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEeccCCceEeeecccccc--ccc
Confidence            999999999999999999999999999999999999999999999999999999999999999999999999973  222


Q ss_pred             CCCccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhh-cCC-------------------cCCCCCCCHHHHHHH
Q 014609          169 DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIF-RGD-------------------FKLPKWLSPGAQNLL  228 (421)
Q Consensus       169 ~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~-~~~-------------------~~~p~~~s~~~~~li  228 (421)
                      ......+.||||.|+|||++.-.+| |..+|+||+||+||++ .|.                   ..+|..+|.++.+++
T Consensus       503 ~~~TTkTFCGTPdYiAPEIi~YqPY-gksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~ehnvsyPKslSkEAv~ic  581 (683)
T KOG0696|consen  503 DGVTTKTFCGTPDYIAPEIIAYQPY-GKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEHNVSYPKSLSKEAVAIC  581 (683)
T ss_pred             CCcceeeecCCCcccccceEEeccc-ccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHccCcCcccccHHHHHHH
Confidence            4456778999999999999999988 6999999999999944 333                   345778999999999


Q ss_pred             HHhcCCCCCCCCCH-----HhhhcCccccc
Q 014609          229 RKILEPNPVKRITI-----AGIKADEWFEQ  253 (421)
Q Consensus       229 ~~~L~~dP~~R~t~-----~eil~~~w~~~  253 (421)
                      +..|.+.|.+|...     .+|..||||+.
T Consensus       582 kg~ltK~P~kRLGcg~~ge~di~~H~FFR~  611 (683)
T KOG0696|consen  582 KGLLTKHPGKRLGCGPEGERDIREHPFFRR  611 (683)
T ss_pred             HHHhhcCCccccCCCCccccchhhCcchhh
Confidence            99999999999863     67999999985

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=8.9e-40  Score=321.20  Aligned_cols=232  Identities=28%  Similarity=0.397  Sum_probs=190.1

Q ss_pred             cceEEeceEeecCcEEEEEEEEC-----CCCceEEEEEeecccccchhHHHHHHHHHHHHhcC-CCCCcceEEEEEEeC-
Q 014609           14 GRYELGRTLGEGNFGKVKFAQDL-----DSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEVLASK-   86 (421)
Q Consensus        14 ~~y~i~~~LG~G~~g~V~~a~~~-----~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~-   86 (421)
                      ++|++.+.||+|+||.||+|.+.     .+++.||+|+++...  .....+.+.+|+.+++++ +||||+++++++... 
T Consensus         7 ~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~   84 (337)
T cd05054           7 DRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGA--TASEYKALMTELKILIHIGHHLNVVNLLGACTKPG   84 (337)
T ss_pred             HHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCC--CHHHHHHHHHHHHHHHhhccCcchhheeeeEecCC
Confidence            58999999999999999999753     346889999986432  222346788899999999 799999999988654 


Q ss_pred             CEEEEEEeccCCCChHHHHHhc----------------------------------------------------------
Q 014609           87 SKIYMVLEYVTGGELFDKIASK----------------------------------------------------------  108 (421)
Q Consensus        87 ~~~~lv~E~~~gg~L~~~i~~~----------------------------------------------------------  108 (421)
                      ..++++|||+++++|.+.+...                                                          
T Consensus        85 ~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  164 (337)
T cd05054          85 GPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDE  164 (337)
T ss_pred             CCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhH
Confidence            5789999999999999888542                                                          


Q ss_pred             ---CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCccccCCCccccccCCCCccCh
Q 014609          109 ---GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAP  185 (421)
Q Consensus       109 ---~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~AP  185 (421)
                         .++++..+..++.|++.||+|||++||+||||||+|||++.++.++|+|||++................++..|+||
T Consensus       165 ~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~aP  244 (337)
T cd05054         165 LYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAP  244 (337)
T ss_pred             HhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccccCc
Confidence               25788999999999999999999999999999999999999999999999999854321111112233456789999


Q ss_pred             hhhcccCCCCCcchHHHHHHHHhhhc--CCcCCC---------------------CCCCHHHHHHHHHhcCCCCCCCCCH
Q 014609          186 EVLANRGYDGATSDIWSCGVILYIFR--GDFKLP---------------------KWLSPGAQNLLRKILEPNPVKRITI  242 (421)
Q Consensus       186 Evl~~~~~~~~~~DiwSlGvil~~~~--~~~~~p---------------------~~~s~~~~~li~~~L~~dP~~R~t~  242 (421)
                      |++.+..+ +.++||||+||++|.+.  |..+++                     ...++++.+++.+||+.+|++||++
T Consensus       245 E~~~~~~~-~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~  323 (337)
T cd05054         245 ESIFDKVY-TTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRMRAPEYATPEIYSIMLDCWHNNPEDRPTF  323 (337)
T ss_pred             HHhcCCCC-CccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccCCCCCCccCCHHHHHHHHHHccCChhhCcCH
Confidence            99988877 48899999999999753  554432                     2246788999999999999999999


Q ss_pred             HhhhcC
Q 014609          243 AGIKAD  248 (421)
Q Consensus       243 ~eil~~  248 (421)
                      .++++|
T Consensus       324 ~ell~~  329 (337)
T cd05054         324 SELVEI  329 (337)
T ss_pred             HHHHHH
Confidence            999875

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=100.00  E-value=1.8e-39  Score=313.97  Aligned_cols=238  Identities=31%  Similarity=0.479  Sum_probs=192.4

Q ss_pred             eecceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeC-----
Q 014609           12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASK-----   86 (421)
Q Consensus        12 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~-----   86 (421)
                      .+++|++.+.||.|+||.||+|.+..+++.+|+|.+....... .....+.+|++++++++||||+++++++...     
T Consensus         6 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   84 (311)
T cd07866           6 KLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKD-GFPITALREIKILKKLKHPNVVPLIDMAVERPDKSK   84 (311)
T ss_pred             ccccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCC-CcchhHHHHHHHHHhcCCCCccchhhheeccccccc
Confidence            4789999999999999999999999999999999987543222 1234577899999999999999999987543     


Q ss_pred             ---CEEEEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCC
Q 014609           87 ---SKIYMVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSA  162 (421)
Q Consensus        87 ---~~~~lv~E~~~gg~L~~~i~~-~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~  162 (421)
                         ..+|+||||+.+ +|...+.. ...+++..++.++.|+++||+|||++||+||||||+||+++.++.++|+|||++.
T Consensus        85 ~~~~~~~lv~~~~~~-~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~  163 (311)
T cd07866          85 RKRGSVYMVTPYMDH-DLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLAR  163 (311)
T ss_pred             ccCceEEEEEecCCc-CHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECcCccch
Confidence               357999999964 67666654 4579999999999999999999999999999999999999999999999999997


Q ss_pred             CCccccCC---------CccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhhcCCc-CCC---------------
Q 014609          163 LPQHFRDD---------GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIFRGDF-KLP---------------  217 (421)
Q Consensus       163 ~~~~~~~~---------~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~~~~~-~~p---------------  217 (421)
                      ........         .......+++.|+|||++.+....+.++||||+||++|.+..+. ++.               
T Consensus       164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~  243 (311)
T cd07866         164 PYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKLC  243 (311)
T ss_pred             hccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh
Confidence            54322111         11123356888999998876544468899999999999554322 110               


Q ss_pred             ----------------------------------CCCCHHHHHHHHHhcCCCCCCCCCHHhhhcCccc
Q 014609          218 ----------------------------------KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWF  251 (421)
Q Consensus       218 ----------------------------------~~~s~~~~~li~~~L~~dP~~R~t~~eil~~~w~  251 (421)
                                                        ..+++.+.++|.+||+.||.+|||+.+++.||||
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~~~f  311 (311)
T cd07866         244 GTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEHPYF  311 (311)
T ss_pred             CCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcCCCC
Confidence                                              1134678899999999999999999999999998

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.1e-39  Score=318.94  Aligned_cols=240  Identities=34%  Similarity=0.469  Sum_probs=202.5

Q ss_pred             ceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCC-----EE
Q 014609           15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKS-----KI   89 (421)
Q Consensus        15 ~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~-----~~   89 (421)
                      +|++.+.||.|+||.||+|++..+++.||+|.+..... .......+.+|+.+++.++||||+++++++....     .+
T Consensus         1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~   79 (330)
T cd07834           1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFD-DLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDV   79 (330)
T ss_pred             CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccc-cchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccce
Confidence            69999999999999999999998999999999875421 2233567899999999999999999999988775     79


Q ss_pred             EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCccccC
Q 014609           90 YMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD  169 (421)
Q Consensus        90 ~lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~  169 (421)
                      |++|||++ ++|.+.+....++++..++.++.||+.||+|||+.||+||||||+|||++.++.++|+|||++........
T Consensus        80 ~lv~e~~~-~~l~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~~~  158 (330)
T cd07834          80 YIVTELME-TDLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDED  158 (330)
T ss_pred             EEEecchh-hhHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccCceEeeccccc
Confidence            99999996 58999988877899999999999999999999999999999999999999999999999999986543211


Q ss_pred             -CCccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhhc-CCcCCC------------------------------
Q 014609          170 -DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIFR-GDFKLP------------------------------  217 (421)
Q Consensus       170 -~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~~-~~~~~p------------------------------  217 (421)
                       ........+++.|+|||++.+....+.++|+||+|+++|.+. |..+++                              
T Consensus       159 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  238 (330)
T cd07834         159 EKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITSEK  238 (330)
T ss_pred             ccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhccccc
Confidence             012344568999999999887734468999999999999543 332221                              


Q ss_pred             --------------------CCCCHHHHHHHHHhcCCCCCCCCCHHhhhcCcccccccc
Q 014609          218 --------------------KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYT  256 (421)
Q Consensus       218 --------------------~~~s~~~~~li~~~L~~dP~~R~t~~eil~~~w~~~~~~  256 (421)
                                          +.+++.+.++|.+||+++|.+|||+.+++.||||+....
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~  297 (330)
T cd07834         239 ARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHD  297 (330)
T ss_pred             hhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhcc
Confidence                                125678899999999999999999999999999987543

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3e-40  Score=325.94  Aligned_cols=238  Identities=32%  Similarity=0.536  Sum_probs=206.8

Q ss_pred             cceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEE
Q 014609           14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVL   93 (421)
Q Consensus        14 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~   93 (421)
                      .-|..++.||-|+||+|.++....|...||+|.+++...........++.|-.||..-+.+.||+||..|.+++.+|+||
T Consensus       629 SmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVM  708 (1034)
T KOG0608|consen  629 SMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVM  708 (1034)
T ss_pred             cceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEE
Confidence            45888999999999999999999999999999999888777777888999999999999999999999999999999999


Q ss_pred             eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCcc-------
Q 014609           94 EYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQH-------  166 (421)
Q Consensus        94 E~~~gg~L~~~i~~~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~-------  166 (421)
                      +|++||++..++.+-+-|.|+.|++|+..|..|+++.|..|+|||||||+|||||.+|++||+||||++-+.=       
T Consensus       709 dYIPGGDmMSLLIrmgIFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHdskYY  788 (1034)
T KOG0608|consen  709 DYIPGGDMMSLLIRMGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYY  788 (1034)
T ss_pred             eccCCccHHHHHHHhccCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEccCCceeeeeccccccceeccccccc
Confidence            9999999999999989999999999999999999999999999999999999999999999999999974210       


Q ss_pred             -cc----C----------------------------CCccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhh-cC
Q 014609          167 -FR----D----------------------------DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIF-RG  212 (421)
Q Consensus       167 -~~----~----------------------------~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~-~~  212 (421)
                       .+    .                            .-..+...||+.|+|||++...+|+ ..+|+||.|||||.+ .|
T Consensus       789 q~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~-q~cdwws~gvil~em~~g  867 (1034)
T KOG0608|consen  789 QEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYT-QLCDWWSVGVILYEMLVG  867 (1034)
T ss_pred             cCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCcc-ccchhhHhhHHHHHHhhC
Confidence             00    0                            0112345799999999999999995 889999999999944 44


Q ss_pred             CcCC-----------------------CCCCCHHHHHHHHHhcCCCCCCCCC---HHhhhcCccccc
Q 014609          213 DFKL-----------------------PKWLSPGAQNLLRKILEPNPVKRIT---IAGIKADEWFEQ  253 (421)
Q Consensus       213 ~~~~-----------------------p~~~s~~~~~li~~~L~~dP~~R~t---~~eil~~~w~~~  253 (421)
                      ..++                       -..+|+++.++|.++. .+++.|..   ++++..||||+.
T Consensus       868 ~~pf~~~tp~~tq~kv~nw~~~l~~~~~~~ls~e~~~li~kLc-~sad~RLGkng~d~vKaHpfFkg  933 (1034)
T KOG0608|consen  868 QPPFLADTPGETQYKVINWRNFLHIPYQGNLSKEALDLIQKLC-CSADSRLGKNGADQVKAHPFFKG  933 (1034)
T ss_pred             CCCccCCCCCcceeeeeehhhccccccccccCHHHHHHHHHHh-cChhhhhcccchhhhhcCccccc
Confidence            4333                       1237999999999865 55777774   778999999985

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=3.3e-39  Score=305.67  Aligned_cols=233  Identities=23%  Similarity=0.358  Sum_probs=194.6

Q ss_pred             ecceEEeceEeecCcEEEEEEEECCC---CceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEE
Q 014609           13 LGRYELGRTLGEGNFGKVKFAQDLDS---GLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKI   89 (421)
Q Consensus        13 ~~~y~i~~~LG~G~~g~V~~a~~~~~---~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~   89 (421)
                      .++|++.+.||+|+||+||+|.+..+   ...||+|.++...  .......+.+|+.++++++||||+++++++......
T Consensus         3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   80 (266)
T cd05033           3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGS--SDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPV   80 (266)
T ss_pred             hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCC--ChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCce
Confidence            36799999999999999999988644   4589999986543  223356788999999999999999999999999999


Q ss_pred             EEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCcccc
Q 014609           90 YMVLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFR  168 (421)
Q Consensus        90 ~lv~E~~~gg~L~~~i~~~-~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~~  168 (421)
                      |++|||+++++|.+++... +.+++..+..++.|++.||+|||++||+||||||+||+++.++.++|+|||++.......
T Consensus        81 ~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~  160 (266)
T cd05033          81 MIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSE  160 (266)
T ss_pred             EEEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCCEEECccchhhcccccc
Confidence            9999999999999998753 468999999999999999999999999999999999999999999999999998654211


Q ss_pred             CCCccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhhc--CCcC--------------------CCCCCCHHHHH
Q 014609          169 DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIFR--GDFK--------------------LPKWLSPGAQN  226 (421)
Q Consensus       169 ~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~~--~~~~--------------------~p~~~s~~~~~  226 (421)
                      .........+++.|+|||.+.+..+ +.++||||||+++|.+.  |..+                    .|...++.+.+
T Consensus       161 ~~~~~~~~~~~~~y~~Pe~~~~~~~-~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  239 (266)
T cd05033         161 ATYTTKGGKIPIRWTAPEAIAYRKF-TSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDGYRLPPPMDCPSALYQ  239 (266)
T ss_pred             cceeccCCCCCccccChhhhccCCC-ccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHH
Confidence            1111122345678999999887776 58899999999999642  4332                    23446889999


Q ss_pred             HHHHhcCCCCCCCCCHHhhhcC
Q 014609          227 LLRKILEPNPVKRITIAGIKAD  248 (421)
Q Consensus       227 li~~~L~~dP~~R~t~~eil~~  248 (421)
                      ++.+||+.+|++||++.+++++
T Consensus       240 li~~cl~~~p~~Rp~~~ei~~~  261 (266)
T cd05033         240 LMLDCWQKDRNERPTFSQIVST  261 (266)
T ss_pred             HHHHHcCCCcccCcCHHHHHHH
Confidence            9999999999999999998764

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=3.3e-39  Score=303.22  Aligned_cols=226  Identities=30%  Similarity=0.411  Sum_probs=194.8

Q ss_pred             ceEeecCcEEEEEEEECCC---CceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEEecc
Q 014609           20 RTLGEGNFGKVKFAQDLDS---GLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLEYV   96 (421)
Q Consensus        20 ~~LG~G~~g~V~~a~~~~~---~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~   96 (421)
                      +.||+|+||.||+|.+...   +..||+|++.......  ....+.+|+.+++.++||||+++++++.....++++|||+
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~   78 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEE--ERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYM   78 (262)
T ss_pred             CccccCCceEEEEEEEecCCCCCceEEeEeeccccchh--HHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEec
Confidence            4799999999999998765   8999999997654322  3578999999999999999999999999999999999999


Q ss_pred             CCCChHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCccc
Q 014609           97 TGGELFDKIASK---------GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHF  167 (421)
Q Consensus        97 ~gg~L~~~i~~~---------~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~  167 (421)
                      ++++|.+++...         ..+++..+..++.|++.||+|||++|++||||||+||+++.++.++|+|||.+......
T Consensus        79 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~  158 (262)
T cd00192          79 EGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDD  158 (262)
T ss_pred             cCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECCCCcEEEcccccccccccc
Confidence            999999999875         77999999999999999999999999999999999999999999999999999865432


Q ss_pred             cCCCccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhhc--CCcC--------------------CCCCCCHHHH
Q 014609          168 RDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIFR--GDFK--------------------LPKWLSPGAQ  225 (421)
Q Consensus       168 ~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~~--~~~~--------------------~p~~~s~~~~  225 (421)
                      ..........+++.|+|||.+....+ +.++||||||+++|.+.  |..+                    .|..+++.+.
T Consensus       159 ~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (262)
T cd00192         159 DYYRKKTGGKLPIRWMAPESLKDGIF-TSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKGYRLPKPEYCPDELY  237 (262)
T ss_pred             cccccccCCCcCccccCHHHhccCCc-chhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCccCChHHH
Confidence            21122344567889999999887766 58899999999999653  2332                    3456789999


Q ss_pred             HHHHHhcCCCCCCCCCHHhhhcC
Q 014609          226 NLLRKILEPNPVKRITIAGIKAD  248 (421)
Q Consensus       226 ~li~~~L~~dP~~R~t~~eil~~  248 (421)
                      +++.+||..+|.+|||+.+++++
T Consensus       238 ~li~~~l~~~p~~Rps~~~l~~~  260 (262)
T cd00192         238 ELMLSCWQLDPEDRPTFSELVER  260 (262)
T ss_pred             HHHHHHccCCcccCcCHHHHHHh
Confidence            99999999999999999999864

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.9e-39  Score=319.56  Aligned_cols=237  Identities=31%  Similarity=0.456  Sum_probs=199.7

Q ss_pred             eecceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCE---
Q 014609           12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSK---   88 (421)
Q Consensus        12 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~---   88 (421)
                      .-++|++.+.||+|++|.||+|++..+++.||+|++..... .......+.+|+.+++.++||||+++++++.....   
T Consensus        13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   91 (343)
T cd07851          13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQ-SAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLED   91 (343)
T ss_pred             ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccc-hhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccc
Confidence            34789999999999999999999999999999999865422 22334667889999999999999999998866554   


Q ss_pred             ---EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCc
Q 014609           89 ---IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQ  165 (421)
Q Consensus        89 ---~~lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~  165 (421)
                         .|+|+||+ |++|.+.+.. .++++..++.++.|++.||+|||+.||+||||||+||+++.++.++|+|||++....
T Consensus        92 ~~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~~~~~kL~dfg~~~~~~  169 (343)
T cd07851          92 FQDVYLVTHLM-GADLNNIVKC-QKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARHTD  169 (343)
T ss_pred             cccEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEcccccccccc
Confidence               89999999 6799888875 579999999999999999999999999999999999999999999999999997543


Q ss_pred             cccCCCccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhh-cCCcCCC---------------------------
Q 014609          166 HFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIF-RGDFKLP---------------------------  217 (421)
Q Consensus       166 ~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~-~~~~~~p---------------------------  217 (421)
                      .     ......+++.|+|||++.+....+.++||||+||++|.+ .|..+++                           
T Consensus       170 ~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  244 (343)
T cd07851         170 D-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKIS  244 (343)
T ss_pred             c-----cccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhcc
Confidence            2     234457889999999986644446899999999999944 3433331                           


Q ss_pred             -----------------------CCCCHHHHHHHHHhcCCCCCCCCCHHhhhcCcccccccc
Q 014609          218 -----------------------KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYT  256 (421)
Q Consensus       218 -----------------------~~~s~~~~~li~~~L~~dP~~R~t~~eil~~~w~~~~~~  256 (421)
                                             ..+++.+.++|.+||++||.+|||+.+++.||||.+...
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h~~~~~~~~  306 (343)
T cd07851         245 SESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAEYHD  306 (343)
T ss_pred             chhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcCCCccccCC
Confidence                                   124788999999999999999999999999999997543

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=4.1e-39  Score=306.49  Aligned_cols=233  Identities=24%  Similarity=0.324  Sum_probs=194.2

Q ss_pred             eecceEEeceEeecCcEEEEEEEECCC-----CceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeC
Q 014609           12 RLGRYELGRTLGEGNFGKVKFAQDLDS-----GLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASK   86 (421)
Q Consensus        12 ~~~~y~i~~~LG~G~~g~V~~a~~~~~-----~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~   86 (421)
                      ..++|++.+.||+|+||.||+|.+...     +..||+|.+....  .......+.+|+.+++.++||||+++++++...
T Consensus         4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~--~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~   81 (277)
T cd05032           4 PREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENA--SMRERIEFLNEASVMKEFNCHHVVRLLGVVSTG   81 (277)
T ss_pred             chHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCcc--CHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCC
Confidence            346899999999999999999987643     4889999986442  222345788999999999999999999999999


Q ss_pred             CEEEEEEeccCCCChHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEE
Q 014609           87 SKIYMVLEYVTGGELFDKIASKG----------RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKIS  156 (421)
Q Consensus        87 ~~~~lv~E~~~gg~L~~~i~~~~----------~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~  156 (421)
                      ...|+||||+++++|.+++....          .+++..+..++.|++.||.|||+.||+||||||+||+++.++.+||+
T Consensus        82 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~~~~~~kl~  161 (277)
T cd05032          82 QPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIG  161 (277)
T ss_pred             CCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEcCCCCEEEC
Confidence            99999999999999999986422          36788999999999999999999999999999999999999999999


Q ss_pred             eccCCCCCccccCCCccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhhc--CCcC-------------------
Q 014609          157 DFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIFR--GDFK-------------------  215 (421)
Q Consensus       157 DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~~--~~~~-------------------  215 (421)
                      |||++................++..|+|||.+....+ +.++|||||||++|.+.  |..+                   
T Consensus       162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~  240 (277)
T cd05032         162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVF-TTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVIDGGHL  240 (277)
T ss_pred             CcccchhhccCcccccCCCCCccccccCHHHHhcCCC-CcccchHHHHHHHHHhhccCCCCCccCCHHHHHHHHhcCCCC
Confidence            9999875433211122334456789999999877666 58899999999999653  3332                   


Q ss_pred             -CCCCCCHHHHHHHHHhcCCCCCCCCCHHhhhc
Q 014609          216 -LPKWLSPGAQNLLRKILEPNPVKRITIAGIKA  247 (421)
Q Consensus       216 -~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~  247 (421)
                       .|..++..+.+++.+||+.+|++|||+.++++
T Consensus       241 ~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~  273 (277)
T cd05032         241 DLPENCPDKLLELMRMCWQYNPKMRPTFLEIVS  273 (277)
T ss_pred             CCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence             34557899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-40  Score=307.96  Aligned_cols=243  Identities=30%  Similarity=0.618  Sum_probs=217.6

Q ss_pred             cCCeeecceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcC-CCCCcceEEEEEEeC
Q 014609            8 QEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEVLASK   86 (421)
Q Consensus         8 ~~~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~   86 (421)
                      ..+.-+.+|.+++.||+|+|++|.+++...|.+.+|+|+++++-....+..+-++.|-.+...- +||.+|.++.+|+++
T Consensus       244 ~~~l~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqte  323 (593)
T KOG0695|consen  244 SQGLGLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTE  323 (593)
T ss_pred             ccccccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhccc
Confidence            3455678999999999999999999999999999999999988777666678888888888766 699999999999999


Q ss_pred             CEEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCcc
Q 014609           87 SKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQH  166 (421)
Q Consensus        87 ~~~~lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~  166 (421)
                      .++++|.||++||+|.-.++++..++++.|+.|...|+.||.|||++||++||||.+|+|+|..|++||+|+|+++-  .
T Consensus       324 srlffvieyv~ggdlmfhmqrqrklpeeharfys~ei~lal~flh~rgiiyrdlkldnvlldaeghikltdygmcke--~  401 (593)
T KOG0695|consen  324 SRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKE--G  401 (593)
T ss_pred             ceEEEEEEEecCcceeeehhhhhcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEccCCceeecccchhhc--C
Confidence            99999999999999988888889999999999999999999999999999999999999999999999999999973  3


Q ss_pred             ccCCCccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhh-cC---------------------------CcCCCC
Q 014609          167 FRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIF-RG---------------------------DFKLPK  218 (421)
Q Consensus       167 ~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~-~~---------------------------~~~~p~  218 (421)
                      ..+.....+.||||.|.|||++.+..| |..+|+|+|||++|++ .|                           ...+|.
T Consensus       402 l~~gd~tstfcgtpnyiapeilrgeey-gfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqiripr  480 (593)
T KOG0695|consen  402 LGPGDTTSTFCGTPNYIAPEILRGEEY-GFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQIRIPR  480 (593)
T ss_pred             CCCCcccccccCCCcccchhhhccccc-CceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhcccccc
Confidence            345567789999999999999999988 7999999999999943 22                           234566


Q ss_pred             CCCHHHHHHHHHhcCCCCCCCCC------HHhhhcCccccc
Q 014609          219 WLSPGAQNLLRKILEPNPVKRIT------IAGIKADEWFEQ  253 (421)
Q Consensus       219 ~~s~~~~~li~~~L~~dP~~R~t------~~eil~~~w~~~  253 (421)
                      .+|-.+..+++..|++||.+|..      +.++..|+||..
T Consensus       481 slsvkas~vlkgflnkdp~erlgc~~~~g~~dik~h~ffr~  521 (593)
T KOG0695|consen  481 SLSVKASHVLKGFLNKDPKERLGCRPQTGFSDIKSHAFFRS  521 (593)
T ss_pred             eeehhhHHHHHHhhcCCcHHhcCCCcccchhhhhcchhhhh
Confidence            78888999999999999999974      789999999984

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2e-41  Score=327.48  Aligned_cols=240  Identities=32%  Similarity=0.610  Sum_probs=219.1

Q ss_pred             CeeecceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEE
Q 014609           10 GMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKI   89 (421)
Q Consensus        10 ~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~   89 (421)
                      ...+.+.+++.+||-|+||.|=++.-......+|+|++++..+.+....+.+..|-+||..++.|.||++|..|.+...+
T Consensus       416 ~v~l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyv  495 (732)
T KOG0614|consen  416 QVKLSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYV  495 (732)
T ss_pred             ccchhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhh
Confidence            45677889999999999999999986555556999999998888888889999999999999999999999999999999


Q ss_pred             EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCccccC
Q 014609           90 YMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD  169 (421)
Q Consensus        90 ~lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~  169 (421)
                      |+.||-|-||+|+..+..++.|++..+++|+..+++|++|||++||++|||||||+++|.+|-+||.|||+|+....   
T Consensus       496 YmLmEaClGGElWTiLrdRg~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~---  572 (732)
T KOG0614|consen  496 YMLMEACLGGELWTILRDRGSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGS---  572 (732)
T ss_pred             hhhHHhhcCchhhhhhhhcCCcccchhhhhHHHHHHHHHHHHhcCceeccCChhheeeccCCceEEeehhhHHHhcc---
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999996543   


Q ss_pred             CCccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhh-cCCcC---------------------CCCCCCHHHHHH
Q 014609          170 DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIF-RGDFK---------------------LPKWLSPGAQNL  227 (421)
Q Consensus       170 ~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~-~~~~~---------------------~p~~~s~~~~~l  227 (421)
                      .+..-++||||.|+|||++.+++.+ .++|.||||+++|++ .|..|                     +|..++..+.+|
T Consensus       573 g~KTwTFcGTpEYVAPEIILnKGHD-~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~i~~Pr~I~k~a~~L  651 (732)
T KOG0614|consen  573 GRKTWTFCGTPEYVAPEIILNKGHD-RAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDKIEFPRRITKTATDL  651 (732)
T ss_pred             CCceeeecCCcccccchhhhccCcc-hhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhhhhcccccchhHHHH
Confidence            5567789999999999999999986 889999999999954 34433                     466789999999


Q ss_pred             HHHhcCCCCCCCCC-----HHhhhcCccccc
Q 014609          228 LRKILEPNPVKRIT-----IAGIKADEWFEQ  253 (421)
Q Consensus       228 i~~~L~~dP~~R~t-----~~eil~~~w~~~  253 (421)
                      |+++...+|.+|..     +.+|.+|.||..
T Consensus       652 ik~LCr~~P~ERLG~~~~gI~DIkkH~Wf~g  682 (732)
T KOG0614|consen  652 IKKLCRDNPTERLGYQKGGINDIKKHRWFEG  682 (732)
T ss_pred             HHHHHhcCcHhhhccccCChHHHHhhhhhhc
Confidence            99999999999986     899999999975

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=4.8e-39  Score=308.56  Aligned_cols=231  Identities=28%  Similarity=0.397  Sum_probs=192.4

Q ss_pred             ecceEEeceEeecCcEEEEEEEE-----CCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCC
Q 014609           13 LGRYELGRTLGEGNFGKVKFAQD-----LDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKS   87 (421)
Q Consensus        13 ~~~y~i~~~LG~G~~g~V~~a~~-----~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~   87 (421)
                      -.+|.+.+.||+|+||+||++.+     ..++..+|+|.+....   ......+.+|+.++++++||||+++++++...+
T Consensus         4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   80 (288)
T cd05093           4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDAS---DNARKDFHREAELLTNLQHEHIVKFYGVCVEGD   80 (288)
T ss_pred             hHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcC---HHHHHHHHHHHHHHHhCCCCCcceEEEEEecCC
Confidence            35799999999999999999985     2356679999886432   233567999999999999999999999999999


Q ss_pred             EEEEEEeccCCCChHHHHHhcC-------------CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEE
Q 014609           88 KIYMVLEYVTGGELFDKIASKG-------------RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIK  154 (421)
Q Consensus        88 ~~~lv~E~~~gg~L~~~i~~~~-------------~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~k  154 (421)
                      ..|+||||+++++|.+++...+             .+++..+..++.|++.||+|||++|++||||||+|||++.++.+|
T Consensus        81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~~~~~~k  160 (288)
T cd05093          81 PLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVK  160 (288)
T ss_pred             ccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCcEE
Confidence            9999999999999999987543             489999999999999999999999999999999999999999999


Q ss_pred             EEeccCCCCCccccCCCccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhhc--CCcCC----------------
Q 014609          155 ISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIFR--GDFKL----------------  216 (421)
Q Consensus       155 L~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~~--~~~~~----------------  216 (421)
                      |+|||++................+++.|+|||++.+..+ +.++|+|||||++|.+.  |..++                
T Consensus       161 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~i~~~~  239 (288)
T cd05093         161 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKF-TTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGR  239 (288)
T ss_pred             eccCCccccccCCceeecCCCCCccccccCHHHhccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC
Confidence            999999875432111112223345778999999887766 58999999999999654  33332                


Q ss_pred             ----CCCCCHHHHHHHHHhcCCCCCCCCCHHhhhc
Q 014609          217 ----PKWLSPGAQNLLRKILEPNPVKRITIAGIKA  247 (421)
Q Consensus       217 ----p~~~s~~~~~li~~~L~~dP~~R~t~~eil~  247 (421)
                          +..+++.+.+++.+||++||.+|||+.+++.
T Consensus       240 ~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~  274 (288)
T cd05093         240 VLQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHS  274 (288)
T ss_pred             cCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence                2346789999999999999999999999854

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=100.00  E-value=4.9e-39  Score=308.53  Aligned_cols=239  Identities=32%  Similarity=0.602  Sum_probs=201.3

Q ss_pred             ceEEeceEeecCcEEEEEEEEC---CCCceEEEEEeeccccc-chhHHHHHHHHHHHHhcC-CCCCcceEEEEEEeCCEE
Q 014609           15 RYELGRTLGEGNFGKVKFAQDL---DSGLPFAVKILEKNRII-HLKITDQIKREIATLKLL-KHPNVVRLHEVLASKSKI   89 (421)
Q Consensus        15 ~y~i~~~LG~G~~g~V~~a~~~---~~~~~vAvK~i~~~~~~-~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~   89 (421)
                      .|++.+.||.|+||.||+|.+.   .+|+.||+|++...... .....+.+.+|+.+++++ +||||+++++++..+...
T Consensus         1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (290)
T cd05613           1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL   80 (290)
T ss_pred             CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence            4899999999999999999875   47899999999754322 222346788999999999 599999999999999999


Q ss_pred             EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCccccC
Q 014609           90 YMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD  169 (421)
Q Consensus        90 ~lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~  169 (421)
                      |+||||+++++|.+++....++++..+..++.|++.||.|||+.|++||||+|+|||++.++.+||+|||++...... .
T Consensus        81 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~-~  159 (290)
T cd05613          81 HLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHED-E  159 (290)
T ss_pred             EEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEECCCCCEEEeeCccceecccc-c
Confidence            999999999999999988888999999999999999999999999999999999999999999999999998754321 1


Q ss_pred             CCccccccCCCCccChhhhccc-CCCCCcchHHHHHHHHhhh-cCCcC-----------------------CCCCCCHHH
Q 014609          170 DGLLHTTCGSPNYVAPEVLANR-GYDGATSDIWSCGVILYIF-RGDFK-----------------------LPKWLSPGA  224 (421)
Q Consensus       170 ~~~~~~~~gt~~y~APEvl~~~-~~~~~~~DiwSlGvil~~~-~~~~~-----------------------~p~~~s~~~  224 (421)
                      .......+|+..|+|||.+... ...+.++||||+|+++|.+ .|..+                       +|..+++.+
T Consensus       160 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (290)
T cd05613         160 VERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSALA  239 (290)
T ss_pred             ccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhccCCCCCccCCHHH
Confidence            1223356789999999998653 2235789999999999943 33322                       334467889


Q ss_pred             HHHHHHhcCCCCCCCC-----CHHhhhcCcccccc
Q 014609          225 QNLLRKILEPNPVKRI-----TIAGIKADEWFEQD  254 (421)
Q Consensus       225 ~~li~~~L~~dP~~R~-----t~~eil~~~w~~~~  254 (421)
                      .+++.+||+.||++|+     ++.+++.||||++.
T Consensus       240 ~~ll~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~  274 (290)
T cd05613         240 KDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQKI  274 (290)
T ss_pred             HHHHHHHhcCCHHHhcCCCCCCHHHHHcCcccccC
Confidence            9999999999999997     89999999999864

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=2.4e-39  Score=310.90  Aligned_cols=235  Identities=29%  Similarity=0.452  Sum_probs=194.1

Q ss_pred             eeecceEEeceEeecCcEEEEEEEECCC-----CceEEEEEeecccccchhHHHHHHHHHHHHhcC-CCCCcceEEEEEE
Q 014609           11 MRLGRYELGRTLGEGNFGKVKFAQDLDS-----GLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEVLA   84 (421)
Q Consensus        11 ~~~~~y~i~~~LG~G~~g~V~~a~~~~~-----~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~   84 (421)
                      ...++|++.+.||+|+||.||+|.+...     ...+|+|.+....  .......+.+|+.+++++ +||||+++++++.
T Consensus         9 ~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~   86 (293)
T cd05053           9 LPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINLLGVCT   86 (293)
T ss_pred             cCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCC--CHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEc
Confidence            3447899999999999999999987643     3789999987542  223346788999999999 7999999999999


Q ss_pred             eCCEEEEEEeccCCCChHHHHHh----------------cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEec
Q 014609           85 SKSKIYMVLEYVTGGELFDKIAS----------------KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLD  148 (421)
Q Consensus        85 ~~~~~~lv~E~~~gg~L~~~i~~----------------~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~  148 (421)
                      .++..|++|||+++++|.+++..                ...+++..+..++.|++.||+|||+.||+||||||+||+++
T Consensus        87 ~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~Nil~~  166 (293)
T cd05053          87 QEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVT  166 (293)
T ss_pred             CCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccceeeEEEc
Confidence            99999999999999999999854                24588999999999999999999999999999999999999


Q ss_pred             cCCCEEEEeccCCCCCccccCCCccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhhc--CCcCC----------
Q 014609          149 SKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIFR--GDFKL----------  216 (421)
Q Consensus       149 ~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~~--~~~~~----------  216 (421)
                      .++.+||+|||++................++..|+|||++.+..+ +.++||||+||++|.+.  |..++          
T Consensus       167 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~  245 (293)
T cd05053         167 EDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVY-THQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFK  245 (293)
T ss_pred             CCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCc-CcccceeehhhHHHHHhcCCCCCCCCCCHHHHHH
Confidence            999999999999986433211111222334568999999877766 58899999999999643  43332          


Q ss_pred             ----------CCCCCHHHHHHHHHhcCCCCCCCCCHHhhhcC
Q 014609          217 ----------PKWLSPGAQNLLRKILEPNPVKRITIAGIKAD  248 (421)
Q Consensus       217 ----------p~~~s~~~~~li~~~L~~dP~~R~t~~eil~~  248 (421)
                                |...+..+.+++.+||.+||.+|||+.+++++
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~  287 (293)
T cd05053         246 LLKEGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVED  287 (293)
T ss_pred             HHHcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence                      33467899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=2.9e-39  Score=310.63  Aligned_cols=233  Identities=23%  Similarity=0.306  Sum_probs=194.2

Q ss_pred             eecceEEeceEeecCcEEEEEEEECCCC----------------ceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCC
Q 014609           12 RLGRYELGRTLGEGNFGKVKFAQDLDSG----------------LPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN   75 (421)
Q Consensus        12 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~----------------~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpn   75 (421)
                      ..++|++++.||+|+||.||+|.+..++                ..||+|.+.....  ....+.+.+|++++++++|||
T Consensus         3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~--~~~~~~~~~e~~~l~~l~~~~   80 (296)
T cd05051           3 PRQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDAS--DNAREDFLKEVKILSRLSDPN   80 (296)
T ss_pred             chhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccC--HHHHHHHHHHHHHHHhcCCCC
Confidence            3578999999999999999999876543                5689999875432  234578899999999999999


Q ss_pred             cceEEEEEEeCCEEEEEEeccCCCChHHHHHhcC-----------CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCC
Q 014609           76 VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKG-----------RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLEN  144 (421)
Q Consensus        76 Iv~l~~~~~~~~~~~lv~E~~~gg~L~~~i~~~~-----------~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~N  144 (421)
                      |+++++++..+...+++|||+++++|.+++....           .+++..++.++.|++.||+|||++||+||||||+|
T Consensus        81 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlkp~N  160 (296)
T cd05051          81 IARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRN  160 (296)
T ss_pred             EeEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccchhc
Confidence            9999999999999999999999999999987655           68999999999999999999999999999999999


Q ss_pred             EEeccCCCEEEEeccCCCCCccccCCCccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhhc---CCcC------
Q 014609          145 ILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIFR---GDFK------  215 (421)
Q Consensus       145 ILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~~---~~~~------  215 (421)
                      |+++.++.++|+|||++................+++.|+|||++.+..+ +.++|||||||++|.+.   +..+      
T Consensus       161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~~l~el~~~~~~~p~~~~~~  239 (296)
T cd05051         161 CLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKF-TTKSDVWAFGVTLWEILTLCREQPYEHLTD  239 (296)
T ss_pred             eeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCC-CccchhhhhHHHHHHHHhcCCCCCCCCcCh
Confidence            9999999999999999875432211122234456788999999877666 58999999999999543   2111      


Q ss_pred             ---------------------CCCCCCHHHHHHHHHhcCCCCCCCCCHHhhhc
Q 014609          216 ---------------------LPKWLSPGAQNLLRKILEPNPVKRITIAGIKA  247 (421)
Q Consensus       216 ---------------------~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~  247 (421)
                                           .|..++.++.+++.+||+.||.+|||+.++++
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~  292 (296)
T cd05051         240 QQVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHL  292 (296)
T ss_pred             HHHHHHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHH
Confidence                                 12335689999999999999999999999854

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=100.00  E-value=1.9e-39  Score=318.47  Aligned_cols=241  Identities=32%  Similarity=0.465  Sum_probs=200.0

Q ss_pred             eeecceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcC-CCCCcceEEEEEEeC--C
Q 014609           11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEVLASK--S   87 (421)
Q Consensus        11 ~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~--~   87 (421)
                      ...++|++.+.||+|+||.||+|.+..+|+.+|+|.+..... .......+.+|+.+++++ +||||+++++++...  .
T Consensus         4 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~-~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~   82 (337)
T cd07852           4 HILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFR-NATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDK   82 (337)
T ss_pred             hhhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccC-cchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCc
Confidence            345789999999999999999999988999999998864322 222345677899999999 999999999998653  4


Q ss_pred             EEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCccc
Q 014609           88 KIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHF  167 (421)
Q Consensus        88 ~~~lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~  167 (421)
                      ..|+||||+. ++|.+.+... .+++..++.++.|++.||+|||+.||+||||||+||+++.++.+||+|||++......
T Consensus        83 ~~~lv~e~~~-~~L~~~~~~~-~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~~  160 (337)
T cd07852          83 DIYLVFEYME-TDLHAVIRAN-ILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSEL  160 (337)
T ss_pred             eEEEEecccc-cCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccchhccccc
Confidence            6899999996 5998888765 7899999999999999999999999999999999999999999999999999855332


Q ss_pred             cCC---CccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhh-cCCcCCC--------------------------
Q 014609          168 RDD---GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIF-RGDFKLP--------------------------  217 (421)
Q Consensus       168 ~~~---~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~-~~~~~~p--------------------------  217 (421)
                      ...   .......||+.|+|||++.+....+.++|+||||+++|.+ .|..+++                          
T Consensus       161 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (337)
T cd07852         161 EENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIESI  240 (337)
T ss_pred             cccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHH
Confidence            211   2334457899999999886655556889999999999944 3433321                          


Q ss_pred             ------------------------CCCCHHHHHHHHHhcCCCCCCCCCHHhhhcCcccccc
Q 014609          218 ------------------------KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD  254 (421)
Q Consensus       218 ------------------------~~~s~~~~~li~~~L~~dP~~R~t~~eil~~~w~~~~  254 (421)
                                              +.++..+.++|.+||+.||++|||+.++++|||+++-
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~~  301 (337)
T cd07852         241 KSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQF  301 (337)
T ss_pred             HhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhChhhhhh
Confidence                                    1257788999999999999999999999999999874

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=100.00  E-value=2.9e-39  Score=311.52  Aligned_cols=238  Identities=31%  Similarity=0.526  Sum_probs=195.7

Q ss_pred             eeecceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCC---
Q 014609           11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKS---   87 (421)
Q Consensus        11 ~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~---   87 (421)
                      ..+++|++.+.||+|+||.||+|.+..+|+.||+|.++..... ......+.+|+.++++++||||+++++++.+..   
T Consensus         4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~-~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~   82 (302)
T cd07864           4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEK-EGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDAL   82 (302)
T ss_pred             hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccc-cCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhh
Confidence            4568999999999999999999999999999999999754322 222356788999999999999999999987654   


Q ss_pred             -------EEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEecc
Q 014609           88 -------KIYMVLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFG  159 (421)
Q Consensus        88 -------~~~lv~E~~~gg~L~~~i~~~-~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFG  159 (421)
                             .+|+|+||+++ ++.+.+... ..+++..++.++.|++.||+|||+.||+||||||+||+++.++.+||+|||
T Consensus        83 ~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~kl~dfg  161 (302)
T cd07864          83 DFKKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFG  161 (302)
T ss_pred             hccccCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCcEEeCccc
Confidence                   79999999976 677766653 468999999999999999999999999999999999999999999999999


Q ss_pred             CCCCCccccCCCccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhhc-CCcCC----------------------
Q 014609          160 LSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIFR-GDFKL----------------------  216 (421)
Q Consensus       160 la~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~~-~~~~~----------------------  216 (421)
                      ++........ .......+++.|+|||++.+....+.++||||+||++|.+. |..++                      
T Consensus       162 ~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (302)
T cd07864         162 LARLYNSEES-RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCPA  240 (302)
T ss_pred             ccccccCCcc-cccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChh
Confidence            9985533211 11222356788999998865444468899999999999543 22111                      


Q ss_pred             ---------------------------CCCCCHHHHHHHHHhcCCCCCCCCCHHhhhcCccc
Q 014609          217 ---------------------------PKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWF  251 (421)
Q Consensus       217 ---------------------------p~~~s~~~~~li~~~L~~dP~~R~t~~eil~~~w~  251 (421)
                                                 ...+++.+.+++.+||+.||.+|||+.+++.||||
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~  302 (302)
T cd07864         241 VWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNSPWL  302 (302)
T ss_pred             hcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcCCCC
Confidence                                       11257889999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=100.00  E-value=9.1e-39  Score=314.96  Aligned_cols=236  Identities=31%  Similarity=0.461  Sum_probs=196.3

Q ss_pred             ecceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeC------
Q 014609           13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASK------   86 (421)
Q Consensus        13 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~------   86 (421)
                      -++|++.+.||+|+||.||+|.+..+|+.||+|++.+... .....+.+.+|+.++++++||||+++++++...      
T Consensus        16 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~~   94 (345)
T cd07877          16 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ-SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF   94 (345)
T ss_pred             cCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcch-hhHHHHHHHHHHHHHHHcCCCcccceeeeeeeccccccc
Confidence            3789999999999999999999999999999999875422 222346788899999999999999999988643      


Q ss_pred             CEEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCcc
Q 014609           87 SKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQH  166 (421)
Q Consensus        87 ~~~~lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~  166 (421)
                      ...|++++++ |++|.+.+.. ..+++..++.++.|++.||+|||++||+||||||+||+++.++.+||+|||++.....
T Consensus        95 ~~~~lv~~~~-~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~dfg~~~~~~~  172 (345)
T cd07877          95 NDVYLVTHLM-GADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD  172 (345)
T ss_pred             ccEEEEehhc-ccCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcCCCCEEEecccccccccc
Confidence            3478888887 7899877764 4699999999999999999999999999999999999999999999999999874321


Q ss_pred             ccCCCccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhhc-CCcCCCC---------------------------
Q 014609          167 FRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIFR-GDFKLPK---------------------------  218 (421)
Q Consensus       167 ~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~~-~~~~~p~---------------------------  218 (421)
                           ......+++.|+|||++.+....+.++||||+||++|.+. |..+++.                           
T Consensus       173 -----~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (345)
T cd07877         173 -----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS  247 (345)
T ss_pred             -----cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhhccc
Confidence                 2334578999999999876433468899999999999543 4333321                           


Q ss_pred             -----------------------CCCHHHHHHHHHhcCCCCCCCCCHHhhhcCcccccccc
Q 014609          219 -----------------------WLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYT  256 (421)
Q Consensus       219 -----------------------~~s~~~~~li~~~L~~dP~~R~t~~eil~~~w~~~~~~  256 (421)
                                             ..++.+.++|.+||++||.+|||+.+++.||||.+...
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~f~~~~~  308 (345)
T cd07877         248 ESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD  308 (345)
T ss_pred             HhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcChhhhhcCC
Confidence                                   13667889999999999999999999999999997443

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=100.00  E-value=1.1e-38  Score=310.01  Aligned_cols=234  Identities=26%  Similarity=0.415  Sum_probs=197.3

Q ss_pred             cceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEE
Q 014609           14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVL   93 (421)
Q Consensus        14 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~   93 (421)
                      +.|...+.||+|+||+||+|.+..+|+.||+|.+.............+.+|+.+++.++|||++++++++.+....|+||
T Consensus        21 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  100 (313)
T cd06633          21 EIFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVM  100 (313)
T ss_pred             HHhhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEE
Confidence            45777889999999999999999999999999997654444444567889999999999999999999999999999999


Q ss_pred             eccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCccccCCCc
Q 014609           94 EYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGL  172 (421)
Q Consensus        94 E~~~gg~L~~~i~~-~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~  172 (421)
                      ||+. ++|.+.+.. ..++++..+..++.|++.||.|||++|++||||+|+||+++.++.+||+|||++....      .
T Consensus       101 e~~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~------~  173 (313)
T cd06633         101 EYCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASKSS------P  173 (313)
T ss_pred             ecCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECCCCCEEEeecCCCcccC------C
Confidence            9996 577777754 4568999999999999999999999999999999999999999999999999986322      2


Q ss_pred             cccccCCCCccChhhhcc--cCCCCCcchHHHHHHHHhhhc-CCcCCC---------------------CCCCHHHHHHH
Q 014609          173 LHTTCGSPNYVAPEVLAN--RGYDGATSDIWSCGVILYIFR-GDFKLP---------------------KWLSPGAQNLL  228 (421)
Q Consensus       173 ~~~~~gt~~y~APEvl~~--~~~~~~~~DiwSlGvil~~~~-~~~~~p---------------------~~~s~~~~~li  228 (421)
                      .....|+..|+|||++..  ....+.++|+|||||++|.+. |..++.                     ..++..+.+++
T Consensus       174 ~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li  253 (313)
T cd06633         174 ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLQSNEWTDSFRGFV  253 (313)
T ss_pred             CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccCHHHHHHH
Confidence            234578999999999742  222357899999999999553 333221                     12567899999


Q ss_pred             HHhcCCCCCCCCCHHhhhcCcccccc
Q 014609          229 RKILEPNPVKRITIAGIKADEWFEQD  254 (421)
Q Consensus       229 ~~~L~~dP~~R~t~~eil~~~w~~~~  254 (421)
                      .+||+++|.+||++.+++.||||...
T Consensus       254 ~~~l~~~P~~Rp~~~~~l~~~~~~~~  279 (313)
T cd06633         254 DYCLQKIPQERPASAELLRHDFVRRD  279 (313)
T ss_pred             HHHccCChhhCcCHHHHhcCcccCCC
Confidence            99999999999999999999999863

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=100.00  E-value=1.2e-38  Score=297.27  Aligned_cols=229  Identities=33%  Similarity=0.567  Sum_probs=199.7

Q ss_pred             ceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEEe
Q 014609           15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLE   94 (421)
Q Consensus        15 ~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E   94 (421)
                      .|++.+.||+|++|.||+|.+..+++.+++|++.....   .....+.+|+.+++.++||||+++++++......++++|
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e   77 (253)
T cd05122           1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK---EKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVME   77 (253)
T ss_pred             CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch---hHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEe
Confidence            48899999999999999999988999999999976532   235789999999999999999999999999999999999


Q ss_pred             ccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCccccCCCcc
Q 014609           95 YVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLL  173 (421)
Q Consensus        95 ~~~gg~L~~~i~~~-~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~  173 (421)
                      |++|++|.+.+... ..+++..+..++.|++.||+|||+.|++||||+|+||+++.++.++|+|||.+........   .
T Consensus        78 ~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~---~  154 (253)
T cd05122          78 FCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA---R  154 (253)
T ss_pred             cCCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccCCeEEEeecccccccccccc---c
Confidence            99999999998775 5799999999999999999999999999999999999999999999999999875443211   3


Q ss_pred             ccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhh-cCCcCCC----------------------CCCCHHHHHHHHH
Q 014609          174 HTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIF-RGDFKLP----------------------KWLSPGAQNLLRK  230 (421)
Q Consensus       174 ~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~-~~~~~~p----------------------~~~s~~~~~li~~  230 (421)
                      ....++..|+|||.+....+ +.++|+||+|+++|.+ .|..++.                      ..++..+.++|.+
T Consensus       155 ~~~~~~~~~~~PE~~~~~~~-~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~  233 (253)
T cd05122         155 NTMVGTPYWMAPEVINGKPY-DYKADIWSLGITAIELAEGKPPYSELPPMKALFKIATNGPPGLRNPEKWSDEFKDFLKK  233 (253)
T ss_pred             cceecCCcccCHHHHcCCCC-CccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcCCCCcCcccccCHHHHHHHHH
Confidence            45678999999999877665 5889999999999944 3333221                      1137889999999


Q ss_pred             hcCCCCCCCCCHHhhhcCcc
Q 014609          231 ILEPNPVKRITIAGIKADEW  250 (421)
Q Consensus       231 ~L~~dP~~R~t~~eil~~~w  250 (421)
                      ||+.||.+|||+.+++.|||
T Consensus       234 ~l~~~p~~R~t~~~~l~~~~  253 (253)
T cd05122         234 CLQKNPEKRPTAEQLLKHPF  253 (253)
T ss_pred             HccCChhhCCCHHHHhcCCC
Confidence            99999999999999999999

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=100.00  E-value=2.2e-39  Score=310.43  Aligned_cols=235  Identities=25%  Similarity=0.353  Sum_probs=193.5

Q ss_pred             ecceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCC-CCCcceEEEEEEeCCEEEE
Q 014609           13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK-HPNVVRLHEVLASKSKIYM   91 (421)
Q Consensus        13 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~l   91 (421)
                      ..+|+..+.||+|+||.||++.+..+++.||+|.+......  .....+.+|+.++.++. ||||+++++++..+...++
T Consensus         3 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~   80 (288)
T cd06616           3 AEDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDE--KEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWI   80 (288)
T ss_pred             HHHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccCh--HHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEE
Confidence            35677889999999999999999999999999998754322  33567889999999996 9999999999999999999


Q ss_pred             EEeccCCCChHHH---HH--hcCCCCHHHHHHHHHHHHHHHHHHHhC-CceeccCCCCCEEeccCCCEEEEeccCCCCCc
Q 014609           92 VLEYVTGGELFDK---IA--SKGRLQEAEGRKLFQQLIDGVSYCHNK-GVFHRDLKLENILLDSKGNIKISDFGLSALPQ  165 (421)
Q Consensus        92 v~E~~~gg~L~~~---i~--~~~~~~~~~~~~~~~ql~~aL~~LH~~-gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~  165 (421)
                      +|||+.+ ++.+.   +.  ....+++..+..++.|++.||+|||+. |++||||||+||+++.++.+||+|||++....
T Consensus        81 ~~e~~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~  159 (288)
T cd06616          81 CMELMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLV  159 (288)
T ss_pred             EEecccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCCcEEEeecchhHHhc
Confidence            9999854 55443   22  235799999999999999999999985 99999999999999999999999999986432


Q ss_pred             cccCCCccccccCCCCccChhhhccc--CCCCCcchHHHHHHHHhhh-cCCcCCC-------------------------
Q 014609          166 HFRDDGLLHTTCGSPNYVAPEVLANR--GYDGATSDIWSCGVILYIF-RGDFKLP-------------------------  217 (421)
Q Consensus       166 ~~~~~~~~~~~~gt~~y~APEvl~~~--~~~~~~~DiwSlGvil~~~-~~~~~~p-------------------------  217 (421)
                      .   ........|++.|+|||++.+.  ...+.++||||+||++|.+ .|..+++                         
T Consensus       160 ~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (288)
T cd06616         160 D---SIAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKGDPPILSNSEE  236 (288)
T ss_pred             c---CCccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchHHHHHhhhcCCCCCcCCCcCC
Confidence            2   1222344689999999998765  2335889999999999944 3443321                         


Q ss_pred             CCCCHHHHHHHHHhcCCCCCCCCCHHhhhcCccccc
Q 014609          218 KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQ  253 (421)
Q Consensus       218 ~~~s~~~~~li~~~L~~dP~~R~t~~eil~~~w~~~  253 (421)
                      ..+++.+.+||.+||++||++|||+++++.||||..
T Consensus       237 ~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~~~~~~  272 (288)
T cd06616         237 REFSPSFVNFINLCLIKDESKRPKYKELLEHPFIKD  272 (288)
T ss_pred             CccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhc
Confidence            125678999999999999999999999999999986

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=7.6e-39  Score=302.85  Aligned_cols=230  Identities=27%  Similarity=0.396  Sum_probs=194.1

Q ss_pred             eecceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEE
Q 014609           12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYM   91 (421)
Q Consensus        12 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l   91 (421)
                      ...+|++.+.||+|+||.||+|.+..+++.||+|++....    .....+.+|++++++++||||+++++++...+.+++
T Consensus         4 ~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   79 (263)
T cd05052           4 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT----MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYI   79 (263)
T ss_pred             chHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCc----hHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEE
Confidence            3467999999999999999999999999999999986432    124678899999999999999999999999999999


Q ss_pred             EEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCccccC
Q 014609           92 VLEYVTGGELFDKIASK--GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD  169 (421)
Q Consensus        92 v~E~~~gg~L~~~i~~~--~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~  169 (421)
                      +|||+++++|.+.+...  ..+++..++.++.|++.||+|||++|++||||||+||+++.++.+||+|||++........
T Consensus        80 v~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~  159 (263)
T cd05052          80 ITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY  159 (263)
T ss_pred             EEEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCcEEeCCCcccccccccee
Confidence            99999999999998753  3589999999999999999999999999999999999999999999999999875432111


Q ss_pred             CCccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhhc--CCcCC--------------------CCCCCHHHHHH
Q 014609          170 DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIFR--GDFKL--------------------PKWLSPGAQNL  227 (421)
Q Consensus       170 ~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~~--~~~~~--------------------p~~~s~~~~~l  227 (421)
                       .......+++.|+|||.+.+..+ +.++|||||||++|.+.  |..++                    |..+++.+.++
T Consensus       160 -~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  237 (263)
T cd05052         160 -TAHAGAKFPIKWTAPESLAYNKF-SIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKGYRMERPEGCPPKVYEL  237 (263)
T ss_pred             -eccCCCCCccccCCHHHhccCCC-CchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHHH
Confidence             11112234567999999887776 58899999999999664  43333                    33467899999


Q ss_pred             HHHhcCCCCCCCCCHHhhhc
Q 014609          228 LRKILEPNPVKRITIAGIKA  247 (421)
Q Consensus       228 i~~~L~~dP~~R~t~~eil~  247 (421)
                      +.+||+.||++|||+.++++
T Consensus       238 i~~cl~~~p~~Rp~~~~l~~  257 (263)
T cd05052         238 MRACWQWNPSDRPSFAEIHQ  257 (263)
T ss_pred             HHHHccCCcccCCCHHHHHH
Confidence            99999999999999999865

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=100.00  E-value=2e-40  Score=324.01  Aligned_cols=220  Identities=27%  Similarity=0.427  Sum_probs=194.9

Q ss_pred             cceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEE
Q 014609           14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVL   93 (421)
Q Consensus        14 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~   93 (421)
                      +...-++-||.|+.|.||+|+  -.++.||||.++          +.-..+|+-|++|+||||+.+.++|.....+||||
T Consensus       124 e~IsELeWlGSGaQGAVF~Gr--l~netVAVKKV~----------elkETdIKHLRkLkH~NII~FkGVCtqsPcyCIiM  191 (904)
T KOG4721|consen  124 EEISELEWLGSGAQGAVFLGR--LHNETVAVKKVR----------ELKETDIKHLRKLKHPNIITFKGVCTQSPCYCIIM  191 (904)
T ss_pred             HHhhhhhhhccCcccceeeee--ccCceehhHHHh----------hhhhhhHHHHHhccCcceeeEeeeecCCceeEEee
Confidence            334457789999999999998  468899999774          22345789999999999999999999999999999


Q ss_pred             eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCccccCCCcc
Q 014609           94 EYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLL  173 (421)
Q Consensus        94 E~~~gg~L~~~i~~~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~  173 (421)
                      |||..|.|...+.....++......|..+|+.|+.|||.+.|||||||.-||||..+..+||+|||-+....   +....
T Consensus       192 EfCa~GqL~~VLka~~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~---~~STk  268 (904)
T KOG4721|consen  192 EFCAQGQLYEVLKAGRPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISYDDVVKISDFGTSKELS---DKSTK  268 (904)
T ss_pred             eccccccHHHHHhccCccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeeccceEEeccccchHhhh---hhhhh
Confidence            999999999999999999999999999999999999999999999999999999999999999999987433   23445


Q ss_pred             ccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhhc-CC---------------------cCCCCCCCHHHHHHHHHh
Q 014609          174 HTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIFR-GD---------------------FKLPKWLSPGAQNLLRKI  231 (421)
Q Consensus       174 ~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~~-~~---------------------~~~p~~~s~~~~~li~~~  231 (421)
                      -.++||..|||||++...+. +.|+|||||||+||++. +.                     ++.|..++..++-||+.|
T Consensus       269 MSFaGTVaWMAPEvIrnePc-sEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIwGVGsNsL~LpvPstcP~GfklL~Kqc  347 (904)
T KOG4721|consen  269 MSFAGTVAWMAPEVIRNEPC-SEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIWGVGSNSLHLPVPSTCPDGFKLLLKQC  347 (904)
T ss_pred             hhhhhhHhhhCHHHhhcCCc-ccccceehhHHHHHHHHhcCCCccccchheeEEeccCCcccccCcccCchHHHHHHHHH
Confidence            67899999999999988776 69999999999999442 22                     456778999999999999


Q ss_pred             cCCCCCCCCCHHhhhcCc
Q 014609          232 LEPNPVKRITIAGIKADE  249 (421)
Q Consensus       232 L~~dP~~R~t~~eil~~~  249 (421)
                      |+..|.+||++.+|+.|-
T Consensus       348 w~sKpRNRPSFrqil~Hl  365 (904)
T KOG4721|consen  348 WNSKPRNRPSFRQILLHL  365 (904)
T ss_pred             HhcCCCCCccHHHHHHHH
Confidence            999999999999999984

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=4e-39  Score=305.49  Aligned_cols=231  Identities=26%  Similarity=0.359  Sum_probs=189.3

Q ss_pred             eEEeceEeecCcEEEEEEEECC---CCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCE----
Q 014609           16 YELGRTLGEGNFGKVKFAQDLD---SGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSK----   88 (421)
Q Consensus        16 y~i~~~LG~G~~g~V~~a~~~~---~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~----   88 (421)
                      |++++.||+|+||.||.|....   ++..||+|.+..... .....+.+.+|+.+++.++||||+++++++.....    
T Consensus         1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~   79 (273)
T cd05035           1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIH-TYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKI   79 (273)
T ss_pred             CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcC-CHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccC
Confidence            6789999999999999998754   457899999875432 23335678999999999999999999998866544    


Q ss_pred             --EEEEEeccCCCChHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccC
Q 014609           89 --IYMVLEYVTGGELFDKIASK------GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGL  160 (421)
Q Consensus        89 --~~lv~E~~~gg~L~~~i~~~------~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGl  160 (421)
                        .++++||+++++|...+...      ..+++..+..++.|++.||+|||++|++||||||+||++++++.+||+|||+
T Consensus        80 ~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~  159 (273)
T cd05035          80 PKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGL  159 (273)
T ss_pred             cccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEECCCCeEEECCccc
Confidence              79999999999998887432      3589999999999999999999999999999999999999999999999999


Q ss_pred             CCCCccccCCCccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhhc--CCcC--------------------CCC
Q 014609          161 SALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIFR--GDFK--------------------LPK  218 (421)
Q Consensus       161 a~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~~--~~~~--------------------~p~  218 (421)
                      +................++..|+|||++....+ +.++||||+||++|.+.  |..+                    .|.
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~-~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~  238 (273)
T cd05035         160 SKKIYSGDYYRQGRIAKMPVKWIAIESLADRVY-TSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHGNRLKQPE  238 (273)
T ss_pred             eeeccccccccccccccCCccccCHhhcccCCC-CcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCc
Confidence            875432211111222345678999999877666 58999999999999653  3332                    344


Q ss_pred             CCCHHHHHHHHHhcCCCCCCCCCHHhhhcC
Q 014609          219 WLSPGAQNLLRKILEPNPVKRITIAGIKAD  248 (421)
Q Consensus       219 ~~s~~~~~li~~~L~~dP~~R~t~~eil~~  248 (421)
                      .++..+.+++.+||+.||++|||+.+++++
T Consensus       239 ~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~  268 (273)
T cd05035         239 DCLDELYDLMYSCWRADPKDRPTFTKLREV  268 (273)
T ss_pred             CCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            578899999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=4.8e-39  Score=306.71  Aligned_cols=233  Identities=24%  Similarity=0.314  Sum_probs=192.8

Q ss_pred             ecceEEeceEeecCcEEEEEEEECC-----CCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCC
Q 014609           13 LGRYELGRTLGEGNFGKVKFAQDLD-----SGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKS   87 (421)
Q Consensus        13 ~~~y~i~~~LG~G~~g~V~~a~~~~-----~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~   87 (421)
                      .++|++.+.||+|+||.||+|.+..     ++..||+|.+....  .......+.+|+.+++.++||||+++++++.+..
T Consensus         5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~   82 (277)
T cd05036           5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESC--SEQDESDFLMEALIMSKFNHQNIVRLIGVSFERL   82 (277)
T ss_pred             HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCC--CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCC
Confidence            3679999999999999999999877     78899999876432  2222456889999999999999999999999999


Q ss_pred             EEEEEEeccCCCChHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCC---CEEEEe
Q 014609           88 KIYMVLEYVTGGELFDKIASKG-------RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKG---NIKISD  157 (421)
Q Consensus        88 ~~~lv~E~~~gg~L~~~i~~~~-------~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~---~~kL~D  157 (421)
                      ..|+||||++|++|.+++....       .+++..+..++.||+.||+|||+++++||||||+||+++.++   .+||+|
T Consensus        83 ~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~kl~d  162 (277)
T cd05036          83 PRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIAD  162 (277)
T ss_pred             CcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcceEecc
Confidence            9999999999999999987643       488999999999999999999999999999999999998765   599999


Q ss_pred             ccCCCCCccccCCCccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhhc--CCcCC-------------------
Q 014609          158 FGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIFR--GDFKL-------------------  216 (421)
Q Consensus       158 FGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~~--~~~~~-------------------  216 (421)
                      ||++.................++.|+|||++.+..+ +.++|||||||++|.+.  |..++                   
T Consensus       163 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~  241 (277)
T cd05036         163 FGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIF-TSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVTGGGRLD  241 (277)
T ss_pred             CccccccCCccceecCCCCCccHhhCCHHHHhcCCc-CchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCcCC
Confidence            999975422111111112233567999999987776 58999999999999643  44332                   


Q ss_pred             -CCCCCHHHHHHHHHhcCCCCCCCCCHHhhhcC
Q 014609          217 -PKWLSPGAQNLLRKILEPNPVKRITIAGIKAD  248 (421)
Q Consensus       217 -p~~~s~~~~~li~~~L~~dP~~R~t~~eil~~  248 (421)
                       |..++..+.+++.+||+++|++|||+.++++|
T Consensus       242 ~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~  274 (277)
T cd05036         242 PPKGCPGPVYRIMTDCWQHTPEDRPNFATILER  274 (277)
T ss_pred             CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence             34467899999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=100.00  E-value=5.6e-39  Score=306.45  Aligned_cols=233  Identities=33%  Similarity=0.536  Sum_probs=195.8

Q ss_pred             eEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeC--CEEEEEE
Q 014609           16 YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASK--SKIYMVL   93 (421)
Q Consensus        16 y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~--~~~~lv~   93 (421)
                      |++.+.||+|+||.||+|.+..+|+.+|+|.+.... ........+.+|+.+++.++|||++++++++...  +..|+|+
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~   79 (287)
T cd07840           1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMEN-EKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVF   79 (287)
T ss_pred             CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEeccc-ccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEe
Confidence            788999999999999999999999999999998654 2233346788999999999999999999999988  8999999


Q ss_pred             eccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCccccCCCc
Q 014609           94 EYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGL  172 (421)
Q Consensus        94 E~~~gg~L~~~i~~~-~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~  172 (421)
                      ||+++ +|.+.+... ..+++..++.++.|++.||+|||+.|++|+||+|+||++++++.+||+|||++........ ..
T Consensus        80 e~~~~-~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~-~~  157 (287)
T cd07840          80 EYMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNS-AD  157 (287)
T ss_pred             ccccc-cHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCCCCEEEccccceeeccCCCc-cc
Confidence            99975 888888764 5799999999999999999999999999999999999999999999999999986543211 12


Q ss_pred             cccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhhc-CCcCCC----------------------------------
Q 014609          173 LHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIFR-GDFKLP----------------------------------  217 (421)
Q Consensus       173 ~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~~-~~~~~p----------------------------------  217 (421)
                      .....++..|+|||.+.+....+.++||||+|+++|.+. |..++.                                  
T Consensus       158 ~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (287)
T cd07840         158 YTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWFEN  237 (287)
T ss_pred             ccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccchhhhh
Confidence            233467889999998765444468999999999999543 222210                                  


Q ss_pred             ---------------CC-CCHHHHHHHHHhcCCCCCCCCCHHhhhcCccc
Q 014609          218 ---------------KW-LSPGAQNLLRKILEPNPVKRITIAGIKADEWF  251 (421)
Q Consensus       218 ---------------~~-~s~~~~~li~~~L~~dP~~R~t~~eil~~~w~  251 (421)
                                     .. +++.+.+++++||..+|.+||++.+++.||||
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~~~~  287 (287)
T cd07840         238 LKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF  287 (287)
T ss_pred             ccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhCcCC
Confidence                           01 27888999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=2.8e-39  Score=308.95  Aligned_cols=234  Identities=25%  Similarity=0.362  Sum_probs=194.0

Q ss_pred             eecceEEeceEeecCcEEEEEEEECC-----CCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeC
Q 014609           12 RLGRYELGRTLGEGNFGKVKFAQDLD-----SGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASK   86 (421)
Q Consensus        12 ~~~~y~i~~~LG~G~~g~V~~a~~~~-----~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~   86 (421)
                      .+.+|++.+.||+|+||+||+|.+..     .++.||+|.++...  .....+.+.+|+.+++.++||||+++++++...
T Consensus         3 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~   80 (283)
T cd05091           3 NLSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKA--EGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKE   80 (283)
T ss_pred             CHHHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCC--CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCC
Confidence            45679999999999999999998754     35789999987442  223356788999999999999999999999999


Q ss_pred             CEEEEEEeccCCCChHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccC
Q 014609           87 SKIYMVLEYVTGGELFDKIASK----------------GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSK  150 (421)
Q Consensus        87 ~~~~lv~E~~~gg~L~~~i~~~----------------~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~  150 (421)
                      ...++++||+++++|.+++...                ..+++..+..++.|++.||+|||++||+||||||+||+++.+
T Consensus        81 ~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~~~~  160 (283)
T cd05091          81 QPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDK  160 (283)
T ss_pred             CceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEecCC
Confidence            9999999999999999988531                347888899999999999999999999999999999999999


Q ss_pred             CCEEEEeccCCCCCccccCCCccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhhc--CCcC-------------
Q 014609          151 GNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIFR--GDFK-------------  215 (421)
Q Consensus       151 ~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~~--~~~~-------------  215 (421)
                      +.+||+|||++................+++.|+|||++....+ +.++||||+||++|.+.  |..+             
T Consensus       161 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~i  239 (283)
T cd05091         161 LNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKF-SIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEMI  239 (283)
T ss_pred             CceEecccccccccccchheeeccCccCCccccCHHHHhcCCC-CcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence            9999999999875432211122233456789999999877766 58899999999999643  3222             


Q ss_pred             -------CCCCCCHHHHHHHHHhcCCCCCCCCCHHhhhcC
Q 014609          216 -------LPKWLSPGAQNLLRKILEPNPVKRITIAGIKAD  248 (421)
Q Consensus       216 -------~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~~  248 (421)
                             .|..++..+.+++.+||+.+|.+||++.+|+..
T Consensus       240 ~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~  279 (283)
T cd05091         240 RNRQVLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSR  279 (283)
T ss_pred             HcCCcCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHH
Confidence                   244578889999999999999999999999764

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.9e-38  Score=300.28  Aligned_cols=236  Identities=31%  Similarity=0.519  Sum_probs=199.1

Q ss_pred             cceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccc--cchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeC--CEE
Q 014609           14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRI--IHLKITDQIKREIATLKLLKHPNVVRLHEVLASK--SKI   89 (421)
Q Consensus        14 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~--~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~--~~~   89 (421)
                      .+|++.+.||+|+||.||+|.+..+++.||+|.+.....  ........+.+|+.++++++||||+++++++.+.  ..+
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (264)
T cd06653           2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL   81 (264)
T ss_pred             CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence            469999999999999999999999999999998864321  1223356889999999999999999999998764  568


Q ss_pred             EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCccccC
Q 014609           90 YMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD  169 (421)
Q Consensus        90 ~lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~  169 (421)
                      ++++||+++++|.+.+...+.+++..++.++.|++.||.|||++|++||||||+||+++.++.++|+|||++........
T Consensus        82 ~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~  161 (264)
T cd06653          82 SIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICM  161 (264)
T ss_pred             EEEEEeCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECccccccccccccc
Confidence            99999999999999998877899999999999999999999999999999999999999999999999999975432111


Q ss_pred             -CCccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhhc-CCc---------------------CCCCCCCHHHHH
Q 014609          170 -DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIFR-GDF---------------------KLPKWLSPGAQN  226 (421)
Q Consensus       170 -~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~~-~~~---------------------~~p~~~s~~~~~  226 (421)
                       ........|+..|+|||.+.+..+ +.++|+|||||++|.+. |..                     .+|..+++.+.+
T Consensus       162 ~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~  240 (264)
T cd06653         162 SGTGIKSVTGTPYWMSPEVISGEGY-GRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQPTKPMLPDGVSDACRD  240 (264)
T ss_pred             cCccccccCCcccccCHhhhcCCCC-CccccHHHHHHHHHHHHhCCCCCCccCHHHHHHHHHcCCCCCCCCcccCHHHHH
Confidence             112234568999999999887766 58899999999999543 222                     234557899999


Q ss_pred             HHHHhcCCCCCCCCCHHhhhcCccc
Q 014609          227 LLRKILEPNPVKRITIAGIKADEWF  251 (421)
Q Consensus       227 li~~~L~~dP~~R~t~~eil~~~w~  251 (421)
                      +|.+||+ +|..||++.+++.|||.
T Consensus       241 ~i~~~l~-~~~~r~~~~~~~~~~~~  264 (264)
T cd06653         241 FLKQIFV-EEKRRPTAEFLLRHPFV  264 (264)
T ss_pred             HHHHHhc-CcccCccHHHHhcCCCC
Confidence            9999999 57999999999999984

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.4e-41  Score=356.41  Aligned_cols=238  Identities=34%  Similarity=0.546  Sum_probs=208.7

Q ss_pred             ceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEEe
Q 014609           15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLE   94 (421)
Q Consensus        15 ~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E   94 (421)
                      ||+-+.+||.|.||.||.|.+..+|+..|+|-+.-.... ......+.+|..++..++|||+|++|++=.+....||.||
T Consensus      1236 rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~-~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFME 1314 (1509)
T KOG4645|consen 1236 RWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSD-HKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFME 1314 (1509)
T ss_pred             eeccccccCCcceeeeEEeecCCccchhhhhhhhcCccc-cccCcchHHHHHHHHhccCccccccCceeecHHHHHHHHH
Confidence            688899999999999999999999999999988765544 3446789999999999999999999999999999999999


Q ss_pred             ccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCcccc--CCCc
Q 014609           95 YVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFR--DDGL  172 (421)
Q Consensus        95 ~~~gg~L~~~i~~~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~~--~~~~  172 (421)
                      ||+||+|.+.++..+-.++...+.|..|++.|++|||++||+||||||+||+|+.+|.+|++|||.|.......  -.+.
T Consensus      1315 yC~~GsLa~ll~~gri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~~~~e 1394 (1509)
T KOG4645|consen 1315 YCEGGSLASLLEHGRIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQTMPGE 1394 (1509)
T ss_pred             HhccCcHHHHHHhcchhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecCCcEEeecccceeEecCchhcCCHH
Confidence            99999999999987778889999999999999999999999999999999999999999999999997543321  1244


Q ss_pred             cccccCCCCccChhhhcccC--CCCCcchHHHHHHHHhhhc-C---------------------CcCCCCCCCHHHHHHH
Q 014609          173 LHTTCGSPNYVAPEVLANRG--YDGATSDIWSCGVILYIFR-G---------------------DFKLPKWLSPGAQNLL  228 (421)
Q Consensus       173 ~~~~~gt~~y~APEvl~~~~--~~~~~~DiwSlGvil~~~~-~---------------------~~~~p~~~s~~~~~li  228 (421)
                      +....|||.|||||++.+..  -.+-++|||||||++.+|. |                     .+++|..+|++.+++|
T Consensus      1395 l~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~gh~Pq~P~~ls~~g~dFl 1474 (1509)
T KOG4645|consen 1395 LQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAAGHKPQIPERLSSEGRDFL 1474 (1509)
T ss_pred             HHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhccCCCCCchhhhHhHHHHH
Confidence            56778999999999997643  2256799999999998332 2                     3456778999999999


Q ss_pred             HHhcCCCCCCCCCHHhhhcCccccc
Q 014609          229 RKILEPNPVKRITIAGIKADEWFEQ  253 (421)
Q Consensus       229 ~~~L~~dP~~R~t~~eil~~~w~~~  253 (421)
                      .+||+.||.+|.++.|+++|.|-+.
T Consensus      1475 e~Cl~~dP~~Rw~~~qlle~~f~~~ 1499 (1509)
T KOG4645|consen 1475 EHCLEQDPKMRWTASQLLEHAFGKS 1499 (1509)
T ss_pred             HHHHhcCchhhhHHHHHHHhhcccc
Confidence            9999999999999999999998664

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.6e-39  Score=300.05  Aligned_cols=227  Identities=41%  Similarity=0.765  Sum_probs=199.8

Q ss_pred             EeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEEeccCCCCh
Q 014609           22 LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGEL  101 (421)
Q Consensus        22 LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~~gg~L  101 (421)
                      ||.|+||.||.+.+..+++.+|+|++.+...........+.+|+.++++++||||+++++.+..+...|++|||+++++|
T Consensus         1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L   80 (250)
T cd05123           1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL   80 (250)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence            69999999999999889999999999876655444567899999999999999999999999999999999999999999


Q ss_pred             HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCccccCCCccccccCCCC
Q 014609          102 FDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPN  181 (421)
Q Consensus       102 ~~~i~~~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~  181 (421)
                      .+++.....+++..+..++.|++.||.|||+.+++|+||+|+||+++.++.++|+|||++......  ........++..
T Consensus        81 ~~~l~~~~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~--~~~~~~~~~~~~  158 (250)
T cd05123          81 FSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSE--GSRTNTFCGTPE  158 (250)
T ss_pred             HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCCCcEEEeecCcceecccC--CCcccCCcCCcc
Confidence            999988778999999999999999999999999999999999999999999999999998754331  123345578899


Q ss_pred             ccChhhhcccCCCCCcchHHHHHHHHhhh-cC-------------------CcCCCCCCCHHHHHHHHHhcCCCCCCCCC
Q 014609          182 YVAPEVLANRGYDGATSDIWSCGVILYIF-RG-------------------DFKLPKWLSPGAQNLLRKILEPNPVKRIT  241 (421)
Q Consensus       182 y~APEvl~~~~~~~~~~DiwSlGvil~~~-~~-------------------~~~~p~~~s~~~~~li~~~L~~dP~~R~t  241 (421)
                      |+|||.+.+..+ +.++|+||||+++|.+ .|                   ..++|..++..+.+++++||..||++||+
T Consensus       159 ~~~Pe~~~~~~~-~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~~~l~~~p~~R~~  237 (250)
T cd05123         159 YLAPEVLLGKGY-GKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILKDPLRFPEFLSPEARDLISGLLQKDPTKRLG  237 (250)
T ss_pred             ccChHHhCCCCC-CchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHhcCCHhhCCC
Confidence            999999877665 5789999999999833 22                   23455667899999999999999999999


Q ss_pred             H---HhhhcCccc
Q 014609          242 I---AGIKADEWF  251 (421)
Q Consensus       242 ~---~eil~~~w~  251 (421)
                      +   .++++||||
T Consensus       238 ~~~~~~l~~~~~f  250 (250)
T cd05123         238 SGGAEEIKAHPFF  250 (250)
T ss_pred             cccHHHHHhCCCC
Confidence            9   999999998

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=7e-39  Score=310.34  Aligned_cols=235  Identities=28%  Similarity=0.434  Sum_probs=192.9

Q ss_pred             eeecceEEeceEeecCcEEEEEEEECC-------CCceEEEEEeecccccchhHHHHHHHHHHHHhcC-CCCCcceEEEE
Q 014609           11 MRLGRYELGRTLGEGNFGKVKFAQDLD-------SGLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEV   82 (421)
Q Consensus        11 ~~~~~y~i~~~LG~G~~g~V~~a~~~~-------~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~   82 (421)
                      ...++|.+++.||+|+||.||+|++..       ++..+|+|.+....  .......+.+|+.+++.+ +||||++++++
T Consensus        15 ~~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~   92 (307)
T cd05098          15 VPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDA--TEKDLSDLISEMEMMKMIGKHKNIINLLGA   92 (307)
T ss_pred             eehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCC--ChHHHHHHHHHHHHHHHhcCCCCEeeEEEE
Confidence            445899999999999999999998643       33579999987542  222346788899999999 79999999999


Q ss_pred             EEeCCEEEEEEeccCCCChHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEE
Q 014609           83 LASKSKIYMVLEYVTGGELFDKIASKG----------------RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENIL  146 (421)
Q Consensus        83 ~~~~~~~~lv~E~~~gg~L~~~i~~~~----------------~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NIL  146 (421)
                      +...+..|+||||+++++|.+++....                .++...+..++.|++.||+|||++|++||||||+||+
T Consensus        93 ~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nil  172 (307)
T cd05098          93 CTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVL  172 (307)
T ss_pred             EecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccHHheE
Confidence            999999999999999999999997532                4788899999999999999999999999999999999


Q ss_pred             eccCCCEEEEeccCCCCCccccCCCccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhhc--CCc----------
Q 014609          147 LDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIFR--GDF----------  214 (421)
Q Consensus       147 l~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~~--~~~----------  214 (421)
                      ++.++.+||+|||++................+++.|+|||++.+..+ +.++|+|||||++|.+.  |..          
T Consensus       173 l~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwslG~~l~el~~~g~~p~~~~~~~~~  251 (307)
T cd05098         173 VTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIY-THQSDVWSFGVLLWEIFTLGGSPYPGVPVEEL  251 (307)
T ss_pred             EcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCC-CcHHHHHHHHHHHHHHHcCCCCCCCcCCHHHH
Confidence            99999999999999875432111111122234568999999887766 58899999999999653  332          


Q ss_pred             ----------CCCCCCCHHHHHHHHHhcCCCCCCCCCHHhhhcC
Q 014609          215 ----------KLPKWLSPGAQNLLRKILEPNPVKRITIAGIKAD  248 (421)
Q Consensus       215 ----------~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~~  248 (421)
                                +.|..++.++.+++.+||..+|.+|||+.+++++
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~  295 (307)
T cd05098         252 FKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED  295 (307)
T ss_pred             HHHHHcCCCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence                      2234468899999999999999999999998765

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.3e-40  Score=328.72  Aligned_cols=226  Identities=37%  Similarity=0.626  Sum_probs=199.3

Q ss_pred             eecceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcC-CCCCcceEEEEEEeCCEEE
Q 014609           12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEVLASKSKIY   90 (421)
Q Consensus        12 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~   90 (421)
                      ....|++...+|.|+|+.|..+.+..+++..++|++.+..       .+..+|+.++.+. +||||+++++++.+....|
T Consensus       320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~-------~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~  392 (612)
T KOG0603|consen  320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA-------DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIY  392 (612)
T ss_pred             cchhhccccccCCCCccceeeeeccccccchhheeccccc-------cccccccchhhhhcCCCcceeecceecCCceee
Confidence            3568999999999999999999999999999999998762       3445678777666 6999999999999999999


Q ss_pred             EEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEe-ccCCCEEEEeccCCCCCccccC
Q 014609           91 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILL-DSKGNIKISDFGLSALPQHFRD  169 (421)
Q Consensus        91 lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl-~~~~~~kL~DFGla~~~~~~~~  169 (421)
                      +|||++.|+.|.+.+.....+. ..+..|+.||+.|+.|||++||+||||||+|||+ +..|+++|+|||.+.....   
T Consensus       393 ~v~e~l~g~ell~ri~~~~~~~-~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~---  468 (612)
T KOG0603|consen  393 LVMELLDGGELLRRIRSKPEFC-SEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELER---  468 (612)
T ss_pred             eeehhccccHHHHHHHhcchhH-HHHHHHHHHHHHHHHHHHhcCeeecCCChhheeecCCCCcEEEEEechhhhCch---
Confidence            9999999999999998766555 7888999999999999999999999999999999 5889999999999985433   


Q ss_pred             CCccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhhcCCc----------------CCC---CCCCHHHHHHHHH
Q 014609          170 DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIFRGDF----------------KLP---KWLSPGAQNLLRK  230 (421)
Q Consensus       170 ~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~~~~~----------------~~p---~~~s~~~~~li~~  230 (421)
                        ...+.|-|..|.|||++...+|+ +++||||||++||.|..+.                ..|   .++|+.+++||++
T Consensus       469 --~~~tp~~t~~y~APEvl~~~~yt-~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei~~~i~~~~~s~~vS~~AKdLl~~  545 (612)
T KOG0603|consen  469 --SCDTPALTLQYVAPEVLAIQEYT-EACDWWSLGVLLYEMLTGRTLFAAHPAGIEIHTRIQMPKFSECVSDEAKDLLQQ  545 (612)
T ss_pred             --hhcccchhhcccChhhhccCCCC-cchhhHHHHHHHHHHHhCCCccccCCchHHHHHhhcCCccccccCHHHHHHHHH
Confidence              15567889999999999999995 9999999999999553321                223   6799999999999


Q ss_pred             hcCCCCCCCCCHHhhhcCccc
Q 014609          231 ILEPNPVKRITIAGIKADEWF  251 (421)
Q Consensus       231 ~L~~dP~~R~t~~eil~~~w~  251 (421)
                      ||+.||.+|+++.++..|||+
T Consensus       546 LL~~dP~~Rl~~~~i~~h~w~  566 (612)
T KOG0603|consen  546 LLQVDPALRLGADEIGAHPWF  566 (612)
T ss_pred             hccCChhhCcChhhhccCcch
Confidence            999999999999999999999

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=5.9e-39  Score=308.99  Aligned_cols=232  Identities=24%  Similarity=0.334  Sum_probs=189.7

Q ss_pred             ecceEEeceEeecCcEEEEEEEECCC--------------CceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcce
Q 014609           13 LGRYELGRTLGEGNFGKVKFAQDLDS--------------GLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVR   78 (421)
Q Consensus        13 ~~~y~i~~~LG~G~~g~V~~a~~~~~--------------~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~   78 (421)
                      .++|++.+.||+|+||.||+|++..+              ...||+|.++...  .....+.+.+|++++++++||||++
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~ei~~l~~l~h~~i~~   81 (295)
T cd05097           4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADV--TKTARNDFLKEIKIMSRLKNPNIIR   81 (295)
T ss_pred             hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCC--CHHHHHHHHHHHHHHHhCCCCCcCe
Confidence            36899999999999999999987543              2359999987542  2333567999999999999999999


Q ss_pred             EEEEEEeCCEEEEEEeccCCCChHHHHHhcC------------CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEE
Q 014609           79 LHEVLASKSKIYMVLEYVTGGELFDKIASKG------------RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENIL  146 (421)
Q Consensus        79 l~~~~~~~~~~~lv~E~~~gg~L~~~i~~~~------------~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NIL  146 (421)
                      +++++......|+||||+++++|.+.+....            .+++..+..++.|++.||+|||++|++||||||+||+
T Consensus        82 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil  161 (295)
T cd05097          82 LLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCL  161 (295)
T ss_pred             EEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccChhhEE
Confidence            9999999999999999999999999885431            3678889999999999999999999999999999999


Q ss_pred             eccCCCEEEEeccCCCCCccccCCCccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhhcC---CcCC-------
Q 014609          147 LDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIFRG---DFKL-------  216 (421)
Q Consensus       147 l~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~~~---~~~~-------  216 (421)
                      ++.++.+||+|||++................+++.|+|||++....+ +.++|+|||||++|.+..   ..++       
T Consensus       162 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~  240 (295)
T cd05097         162 VGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKF-TTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQ  240 (295)
T ss_pred             EcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCc-CchhhHHHHHHHHHHHHHcCCCCCCcccChHH
Confidence            99999999999999875432111111222345678999999887766 589999999999995532   1111       


Q ss_pred             --------------------CCCCCHHHHHHHHHhcCCCCCCCCCHHhhhc
Q 014609          217 --------------------PKWLSPGAQNLLRKILEPNPVKRITIAGIKA  247 (421)
Q Consensus       217 --------------------p~~~s~~~~~li~~~L~~dP~~R~t~~eil~  247 (421)
                                          ++.+++.+.+++.+||+.||.+|||+++|++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~  291 (295)
T cd05097         241 VIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHH  291 (295)
T ss_pred             HHHHHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence                                2336788999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=9.7e-39  Score=308.93  Aligned_cols=235  Identities=27%  Similarity=0.401  Sum_probs=194.6

Q ss_pred             CeeecceEEeceEeecCcEEEEEEEE-----CCCCceEEEEEeecccccchhHHHHHHHHHHHHhcC-CCCCcceEEEEE
Q 014609           10 GMRLGRYELGRTLGEGNFGKVKFAQD-----LDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEVL   83 (421)
Q Consensus        10 ~~~~~~y~i~~~LG~G~~g~V~~a~~-----~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~   83 (421)
                      ....++|++.+.||+|+||.||+|.+     ..++..||+|.++...  .....+.+.+|+.+++++ +||||+++++++
T Consensus        31 ~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~  108 (302)
T cd05055          31 EFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTA--HSSEREALMSELKIMSHLGNHENIVNLLGAC  108 (302)
T ss_pred             cccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccC--ChHHHHHHHHHHHHHHhccCCCCcceEEEEE
Confidence            34456899999999999999999975     2356689999986543  223356789999999999 799999999999


Q ss_pred             EeCCEEEEEEeccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCC
Q 014609           84 ASKSKIYMVLEYVTGGELFDKIASKG--RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLS  161 (421)
Q Consensus        84 ~~~~~~~lv~E~~~gg~L~~~i~~~~--~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla  161 (421)
                      ...+..|++|||+++++|.+++....  .+++.++..++.|++.||+|||++||+|+||||+|||++.++.++|+|||++
T Consensus       109 ~~~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~dfg~~  188 (302)
T cd05055         109 TIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICDFGLA  188 (302)
T ss_pred             ecCCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEcCCCeEEECCCccc
Confidence            99999999999999999999987533  3899999999999999999999999999999999999999999999999998


Q ss_pred             CCCccccCCCccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhhc--CCcCC---------------------CC
Q 014609          162 ALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIFR--GDFKL---------------------PK  218 (421)
Q Consensus       162 ~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~~--~~~~~---------------------p~  218 (421)
                      ................+++.|+|||++.+..+ +.++||||+||++|.+.  |..++                     |.
T Consensus       189 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  267 (302)
T cd05055         189 RDIMNDSNYVVKGNARLPVKWMAPESIFNCVY-TFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGYRMAQPE  267 (302)
T ss_pred             ccccCCCceeecCCCCcccccCCHhhhccCCC-CcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHHcCCcCCCCC
Confidence            75433211111122345778999999887776 58899999999999653  44332                     23


Q ss_pred             CCCHHHHHHHHHhcCCCCCCCCCHHhhhc
Q 014609          219 WLSPGAQNLLRKILEPNPVKRITIAGIKA  247 (421)
Q Consensus       219 ~~s~~~~~li~~~L~~dP~~R~t~~eil~  247 (421)
                      ..++.+.+++.+||+++|++|||+.+++.
T Consensus       268 ~~~~~~~~li~~cl~~~p~~Rpt~~ell~  296 (302)
T cd05055         268 HAPAEIYDIMKTCWDADPLKRPTFKQIVQ  296 (302)
T ss_pred             CCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence            46789999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=3.4e-39  Score=317.78  Aligned_cols=233  Identities=27%  Similarity=0.373  Sum_probs=190.1

Q ss_pred             ecceEEeceEeecCcEEEEEEEE-----CCCCceEEEEEeecccccchhHHHHHHHHHHHHhcC-CCCCcceEEEEEEeC
Q 014609           13 LGRYELGRTLGEGNFGKVKFAQD-----LDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEVLASK   86 (421)
Q Consensus        13 ~~~y~i~~~LG~G~~g~V~~a~~-----~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~   86 (421)
                      .++|++++.||+|+||.||+|.+     ..+++.||||+++....  ......+.+|+.++.++ +||||+++++++...
T Consensus         6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~   83 (343)
T cd05103           6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT--HSEHRALMSELKILIHIGHHLNVVNLLGACTKP   83 (343)
T ss_pred             hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCC--hHHHHHHHHHHHHHHhccCCccHhhhcceeecC
Confidence            46899999999999999999984     35688999999975432  22346788999999999 689999999987654


Q ss_pred             -CEEEEEEeccCCCChHHHHHhc---------------------------------------------------------
Q 014609           87 -SKIYMVLEYVTGGELFDKIASK---------------------------------------------------------  108 (421)
Q Consensus        87 -~~~~lv~E~~~gg~L~~~i~~~---------------------------------------------------------  108 (421)
                       ...+++|||+++|+|.+++...                                                         
T Consensus        84 ~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  163 (343)
T cd05103          84 GGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEE  163 (343)
T ss_pred             CCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchh
Confidence             5689999999999999988642                                                         


Q ss_pred             ----------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCccccCCCccccccC
Q 014609          109 ----------GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCG  178 (421)
Q Consensus       109 ----------~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~g  178 (421)
                                ..++...+..++.|++.||+|||++||+||||||+|||++.++.+||+|||++................+
T Consensus       164 ~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~  243 (343)
T cd05103         164 EEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARL  243 (343)
T ss_pred             hhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCCC
Confidence                      1367788889999999999999999999999999999999999999999999875422111111222345


Q ss_pred             CCCccChhhhcccCCCCCcchHHHHHHHHhhhc--CCcCC---------------------CCCCCHHHHHHHHHhcCCC
Q 014609          179 SPNYVAPEVLANRGYDGATSDIWSCGVILYIFR--GDFKL---------------------PKWLSPGAQNLLRKILEPN  235 (421)
Q Consensus       179 t~~y~APEvl~~~~~~~~~~DiwSlGvil~~~~--~~~~~---------------------p~~~s~~~~~li~~~L~~d  235 (421)
                      ++.|+|||++.+..+ +.++||||||+++|.+.  |..++                     |.+.++.+.+++.+||++|
T Consensus       244 ~~~y~aPE~~~~~~~-~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~~  322 (343)
T cd05103         244 PLKWMAPETIFDRVY-TIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGE  322 (343)
T ss_pred             CcceECcHHhcCCCC-CchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhccCCCCCCCCCCHHHHHHHHHHccCC
Confidence            678999999887776 58899999999999653  43332                     3446788999999999999


Q ss_pred             CCCCCCHHhhhcC
Q 014609          236 PVKRITIAGIKAD  248 (421)
Q Consensus       236 P~~R~t~~eil~~  248 (421)
                      |.+|||+.++++|
T Consensus       323 p~~Rps~~eil~~  335 (343)
T cd05103         323 PSQRPTFSELVEH  335 (343)
T ss_pred             hhhCcCHHHHHHH
Confidence            9999999999876

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=6e-39  Score=321.89  Aligned_cols=237  Identities=27%  Similarity=0.351  Sum_probs=194.4

Q ss_pred             CCeeecceEEeceEeecCcEEEEEEEEC-----CCCceEEEEEeecccccchhHHHHHHHHHHHHhcCC-CCCcceEEEE
Q 014609            9 EGMRLGRYELGRTLGEGNFGKVKFAQDL-----DSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK-HPNVVRLHEV   82 (421)
Q Consensus         9 ~~~~~~~y~i~~~LG~G~~g~V~~a~~~-----~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~   82 (421)
                      -.+..++|.+++.||+|+||.||+|++.     .+++.||+|++.....  ....+.+.+|+.+|.++. ||||++++++
T Consensus        32 ~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~--~~~~~~~~~E~~~l~~l~~H~niv~~~~~  109 (401)
T cd05107          32 WEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTAR--SSEKQALMSELKIMSHLGPHLNIVNLLGA  109 (401)
T ss_pred             ceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCC--hhHHHHHHHHHHHHHhcCCCCCeEEEEEE
Confidence            3455678999999999999999999853     3567899999975432  223457889999999997 9999999999


Q ss_pred             EEeCCEEEEEEeccCCCChHHHHHhcC-----------------------------------------------------
Q 014609           83 LASKSKIYMVLEYVTGGELFDKIASKG-----------------------------------------------------  109 (421)
Q Consensus        83 ~~~~~~~~lv~E~~~gg~L~~~i~~~~-----------------------------------------------------  109 (421)
                      +...+..|+||||+++|+|.+++...+                                                     
T Consensus       110 ~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  189 (401)
T cd05107         110 CTKGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADY  189 (401)
T ss_pred             EccCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCc
Confidence            999999999999999999999886431                                                     


Q ss_pred             ---------------------------------------------CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCC
Q 014609          110 ---------------------------------------------RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLEN  144 (421)
Q Consensus       110 ---------------------------------------------~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~N  144 (421)
                                                                   .+++..++.++.|++.||+|||+.||+||||||+|
T Consensus       190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp~N  269 (401)
T cd05107         190 VPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARN  269 (401)
T ss_pred             cchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccCCcce
Confidence                                                         25667788899999999999999999999999999


Q ss_pred             EEeccCCCEEEEeccCCCCCccccCCCccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhhc--CCcCC------
Q 014609          145 ILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIFR--GDFKL------  216 (421)
Q Consensus       145 ILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~~--~~~~~------  216 (421)
                      ||++.++.+||+|||++................+++.|+|||++.+..+ +.++|||||||++|.+.  +..++      
T Consensus       270 iLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwslGvil~e~l~~g~~P~~~~~~~  348 (401)
T cd05107         270 VLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLY-TTLSDVWSFGILLWEIFTLGGTPYPELPMN  348 (401)
T ss_pred             EEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCC-CcHhHHHHHHHHHHHHHHcCCCCCCCCCch
Confidence            9999999999999999975432111111223457789999999987766 58899999999999543  33332      


Q ss_pred             ---------------CCCCCHHHHHHHHHhcCCCCCCCCCHHhhhcC
Q 014609          217 ---------------PKWLSPGAQNLLRKILEPNPVKRITIAGIKAD  248 (421)
Q Consensus       217 ---------------p~~~s~~~~~li~~~L~~dP~~R~t~~eil~~  248 (421)
                                     |..++..+.+++.+||.++|.+||++.+|++.
T Consensus       349 ~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~  395 (401)
T cd05107         349 EQFYNAIKRGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHL  395 (401)
T ss_pred             HHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence                           33467899999999999999999999999764

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=1e-38  Score=306.81  Aligned_cols=232  Identities=28%  Similarity=0.405  Sum_probs=193.2

Q ss_pred             eecceEEeceEeecCcEEEEEEEEC-----CCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeC
Q 014609           12 RLGRYELGRTLGEGNFGKVKFAQDL-----DSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASK   86 (421)
Q Consensus        12 ~~~~y~i~~~LG~G~~g~V~~a~~~-----~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~   86 (421)
                      +.++|.+.+.||+|+||.||+|.+.     .++..+++|.+....   ......+.+|+.++++++||||+++++++...
T Consensus         3 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   79 (291)
T cd05094           3 KRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPT---LAARKDFQREAELLTNLQHEHIVKFYGVCGDG   79 (291)
T ss_pred             chHHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCcc---HHHHHHHHHHHHHHhcCCCCCcceEEEEEccC
Confidence            4678999999999999999999853     345679999876432   22346788999999999999999999999999


Q ss_pred             CEEEEEEeccCCCChHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccC
Q 014609           87 SKIYMVLEYVTGGELFDKIASKG----------------RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSK  150 (421)
Q Consensus        87 ~~~~lv~E~~~gg~L~~~i~~~~----------------~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~  150 (421)
                      ...++||||+++++|.+++....                .+++..++.++.||+.||+|||++||+||||||+|||++.+
T Consensus        80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~~~~  159 (291)
T cd05094          80 DPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGAN  159 (291)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccC
Confidence            99999999999999999987532                37899999999999999999999999999999999999999


Q ss_pred             CCEEEEeccCCCCCccccCCCccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhhc--CCcCC------------
Q 014609          151 GNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIFR--GDFKL------------  216 (421)
Q Consensus       151 ~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~~--~~~~~------------  216 (421)
                      +.++|+|||++................+++.|+|||++.+..+ +.++||||+||++|.+.  |..++            
T Consensus       160 ~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~  238 (291)
T cd05094         160 LLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKF-TTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECI  238 (291)
T ss_pred             CcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence            9999999999875432111112233456788999999887766 58899999999999653  44442            


Q ss_pred             --------CCCCCHHHHHHHHHhcCCCCCCCCCHHhhhc
Q 014609          217 --------PKWLSPGAQNLLRKILEPNPVKRITIAGIKA  247 (421)
Q Consensus       217 --------p~~~s~~~~~li~~~L~~dP~~R~t~~eil~  247 (421)
                              +..++..+.+++.+||+++|++|||+.++++
T Consensus       239 ~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~  277 (291)
T cd05094         239 TQGRVLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYK  277 (291)
T ss_pred             hCCCCCCCCccCCHHHHHHHHHHcccChhhCcCHHHHHH
Confidence                    2236788999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=1.1e-38  Score=307.39  Aligned_cols=231  Identities=24%  Similarity=0.356  Sum_probs=189.4

Q ss_pred             cceEEeceEeecCcEEEEEEEECC----------------CCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcc
Q 014609           14 GRYELGRTLGEGNFGKVKFAQDLD----------------SGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVV   77 (421)
Q Consensus        14 ~~y~i~~~LG~G~~g~V~~a~~~~----------------~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv   77 (421)
                      ++|++.+.||+|+||.||++.+..                ++..+|+|++....  .......+.+|+.+++.++||||+
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~--~~~~~~~~~~E~~~l~~l~~~~i~   82 (296)
T cd05095           5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDA--NKNARNDFLKEIKIMSRLKDPNII   82 (296)
T ss_pred             hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCCcc
Confidence            579999999999999999986432                34579999986542  223356789999999999999999


Q ss_pred             eEEEEEEeCCEEEEEEeccCCCChHHHHHhcC-----------CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEE
Q 014609           78 RLHEVLASKSKIYMVLEYVTGGELFDKIASKG-----------RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENIL  146 (421)
Q Consensus        78 ~l~~~~~~~~~~~lv~E~~~gg~L~~~i~~~~-----------~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NIL  146 (421)
                      ++++++...+..|++|||+++++|.+++....           .+++..+..++.|++.||+|||+.|++||||||+|||
T Consensus        83 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp~Nil  162 (296)
T cd05095          83 RLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCL  162 (296)
T ss_pred             eEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCChheEE
Confidence            99999999999999999999999999887532           3667789999999999999999999999999999999


Q ss_pred             eccCCCEEEEeccCCCCCccccCCCccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhhc---CCc---------
Q 014609          147 LDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIFR---GDF---------  214 (421)
Q Consensus       147 l~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~~---~~~---------  214 (421)
                      ++.++.++|+|||++................+++.|+|||+..+..+ +.++|+|||||++|.+.   +..         
T Consensus       163 i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~-~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~~  241 (296)
T cd05095         163 VGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKF-TTASDVWAFGVTLWEILTLCKEQPYSQLSDEQ  241 (296)
T ss_pred             EcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCc-cchhhhhHHHHHHHHHHHhCCCCCccccChHH
Confidence            99999999999999875432111111222344678999998877666 58999999999999653   222         


Q ss_pred             ------------------CCCCCCCHHHHHHHHHhcCCCCCCCCCHHhhhc
Q 014609          215 ------------------KLPKWLSPGAQNLLRKILEPNPVKRITIAGIKA  247 (421)
Q Consensus       215 ------------------~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~  247 (421)
                                        +.|..+++.+.+++.+||+.||.+||++.++.+
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~  292 (296)
T cd05095         242 VIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHA  292 (296)
T ss_pred             HHHHHHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence                              223446788999999999999999999999864

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=6.5e-39  Score=306.91  Aligned_cols=231  Identities=28%  Similarity=0.425  Sum_probs=191.7

Q ss_pred             ceEEeceEeecCcEEEEEEEE----CCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeC--CE
Q 014609           15 RYELGRTLGEGNFGKVKFAQD----LDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASK--SK   88 (421)
Q Consensus        15 ~y~i~~~LG~G~~g~V~~a~~----~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~--~~   88 (421)
                      -|++++.||+|+||.||+|..    ..++..||+|.++...  .......+.+|+.+++.++||||+++++++...  ..
T Consensus         5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   82 (284)
T cd05079           5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES--GGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNG   82 (284)
T ss_pred             hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccc--cHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCc
Confidence            368899999999999999974    4578899999986442  223356799999999999999999999998775  57


Q ss_pred             EEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCccc
Q 014609           89 IYMVLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHF  167 (421)
Q Consensus        89 ~~lv~E~~~gg~L~~~i~~~-~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~  167 (421)
                      .|+||||++|++|.+++... ..+++..+..++.|++.||+|||++|++||||||+||+++.++.++|+|||++......
T Consensus        83 ~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~  162 (284)
T cd05079          83 IKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETD  162 (284)
T ss_pred             eEEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEcCCCCEEECCCccccccccC
Confidence            89999999999999998654 35899999999999999999999999999999999999999999999999999854332


Q ss_pred             cCC-CccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhhcCC---------------------------------
Q 014609          168 RDD-GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIFRGD---------------------------------  213 (421)
Q Consensus       168 ~~~-~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~~~~---------------------------------  213 (421)
                      ... .......++..|+|||++.+..+ +.++||||+||++|.+...                                 
T Consensus       163 ~~~~~~~~~~~~~~~y~apE~~~~~~~-~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (284)
T cd05079         163 KEYYTVKDDLDSPVFWYAPECLIQSKF-YIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVLEE  241 (284)
T ss_pred             ccceeecCCCCCCccccCHHHhccCCC-CccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHHHHc
Confidence            111 11224456778999999887766 5889999999999965321                                 


Q ss_pred             ---cCCCCCCCHHHHHHHHHhcCCCCCCCCCHHhhhcC
Q 014609          214 ---FKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKAD  248 (421)
Q Consensus       214 ---~~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~~  248 (421)
                         .+.+..++..+.+++.+||++||.+|||+.+++++
T Consensus       242 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~  279 (284)
T cd05079         242 GKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEG  279 (284)
T ss_pred             CccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence               12234478899999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=100.00  E-value=4.5e-39  Score=314.79  Aligned_cols=235  Identities=21%  Similarity=0.347  Sum_probs=189.8

Q ss_pred             ceEeec--CcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEEeccC
Q 014609           20 RTLGEG--NFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVT   97 (421)
Q Consensus        20 ~~LG~G--~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~~   97 (421)
                      ..||+|  +||+||+|++..+|+.||+|++...... ....+.+.+|+.+++.++||||+++++++...+..|+|+||+.
T Consensus         4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~   82 (328)
T cd08226           4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCT-EEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMA   82 (328)
T ss_pred             HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCC-HHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEeccc
Confidence            456666  9999999999999999999998755332 2335789999999999999999999999999999999999999


Q ss_pred             CCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCccccCCC----
Q 014609           98 GGELFDKIASK--GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDG----  171 (421)
Q Consensus        98 gg~L~~~i~~~--~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~----  171 (421)
                      +++|.+++...  ..+++..++.++.|++.||+|||++||+||||||+|||++.++.++++||+.+..........    
T Consensus        83 ~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~~~  162 (328)
T cd08226          83 YGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVVY  162 (328)
T ss_pred             CCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccccccc
Confidence            99999988763  358999999999999999999999999999999999999999999999998654221111100    


Q ss_pred             -ccccccCCCCccChhhhcccC-CCCCcchHHHHHHHHhhhc-CCcCCC-------------------------------
Q 014609          172 -LLHTTCGSPNYVAPEVLANRG-YDGATSDIWSCGVILYIFR-GDFKLP-------------------------------  217 (421)
Q Consensus       172 -~~~~~~gt~~y~APEvl~~~~-~~~~~~DiwSlGvil~~~~-~~~~~p-------------------------------  217 (421)
                       ......++..|+|||++.+.. ..+.++||||+||++|.+. |..++.                               
T Consensus       163 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (328)
T cd08226         163 DFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCEESR  242 (328)
T ss_pred             cccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccchhhhh
Confidence             011223566799999987642 1258899999999999543 333221                               


Q ss_pred             -----------------------------------CCCCHHHHHHHHHhcCCCCCCCCCHHhhhcCccccccc
Q 014609          218 -----------------------------------KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY  255 (421)
Q Consensus       218 -----------------------------------~~~s~~~~~li~~~L~~dP~~R~t~~eil~~~w~~~~~  255 (421)
                                                         ..+++.+.+||++||+.||++|||+.++++||||....
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~~~  315 (328)
T cd08226         243 MKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQVK  315 (328)
T ss_pred             hccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHHHHH
Confidence                                               11356789999999999999999999999999998654

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=100.00  E-value=1.8e-38  Score=310.70  Aligned_cols=237  Identities=32%  Similarity=0.484  Sum_probs=197.6

Q ss_pred             ecceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEe-CCEEEE
Q 014609           13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLAS-KSKIYM   91 (421)
Q Consensus        13 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~-~~~~~l   91 (421)
                      -++|++.+.||.|+||.||+|.+..+++.||+|.+.+... .......+.+|+.+++.++||||+++++++.. ....|+
T Consensus         9 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~l   87 (328)
T cd07856           9 TNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFS-TPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYF   87 (328)
T ss_pred             ccceEEEEeecccCCeEEEEEEECCCCCEEEEEEeccccc-ccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEEE
Confidence            3689999999999999999999999999999999865432 22335678899999999999999999999865 567899


Q ss_pred             EEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCccccCCC
Q 014609           92 VLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDG  171 (421)
Q Consensus        92 v~E~~~gg~L~~~i~~~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~  171 (421)
                      ++||+ +++|.+.+.. .++++..+..++.|+++||+|||+.||+||||+|.||+++.++.++|+|||++.....     
T Consensus        88 v~e~~-~~~L~~~~~~-~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~-----  160 (328)
T cd07856          88 VTELL-GTDLHRLLTS-RPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLARIQDP-----  160 (328)
T ss_pred             Eeehh-ccCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECCCCCEEeCccccccccCC-----
Confidence            99998 6688777754 5688999999999999999999999999999999999999999999999999874321     


Q ss_pred             ccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhhc-CCcCCC---------------------------------
Q 014609          172 LLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIFR-GDFKLP---------------------------------  217 (421)
Q Consensus       172 ~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~~-~~~~~p---------------------------------  217 (421)
                      ......+++.|+|||++.+....+.++|+||+||++|.+. |..+++                                 
T Consensus       161 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (328)
T cd07856         161 QMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTLR  240 (328)
T ss_pred             CcCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccchhhHH
Confidence            2234567889999998766333368999999999999543 332221                                 


Q ss_pred             -----------------CCCCHHHHHHHHHhcCCCCCCCCCHHhhhcCccccccccC
Q 014609          218 -----------------KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTP  257 (421)
Q Consensus       218 -----------------~~~s~~~~~li~~~L~~dP~~R~t~~eil~~~w~~~~~~~  257 (421)
                                       +.+++.+.++|++||+.+|.+|||+++++.||||.....+
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~~~~~~~~~  297 (328)
T cd07856         241 FVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAPYHDP  297 (328)
T ss_pred             HHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCCccccccCC
Confidence                             1356889999999999999999999999999999865444

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=100.00  E-value=1.4e-38  Score=311.82  Aligned_cols=238  Identities=27%  Similarity=0.406  Sum_probs=194.4

Q ss_pred             ceEEeceEeecCcEEEEEEEECCC--CceEEEEEeecccccchhHHHHHHHHHHHHhcC-CCCCcceEEEEEEeC----C
Q 014609           15 RYELGRTLGEGNFGKVKFAQDLDS--GLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEVLASK----S   87 (421)
Q Consensus        15 ~y~i~~~LG~G~~g~V~~a~~~~~--~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~----~   87 (421)
                      +|++.+.||+|+||.||+|++..+  +..||+|.+.... ........+.+|+.+++++ +||||+++++.....    .
T Consensus         1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~   79 (332)
T cd07857           1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVF-SKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFN   79 (332)
T ss_pred             CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEecccc-ccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCC
Confidence            589999999999999999999887  9999999986432 1222345678899999999 599999999875432    4


Q ss_pred             EEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCccc
Q 014609           88 KIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHF  167 (421)
Q Consensus        88 ~~~lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~  167 (421)
                      .+|+++||+. ++|.+.+.....+++..++.++.||+.||+|||+.||+||||||+||+++.++.+||+|||++......
T Consensus        80 ~~~~~~e~~~-~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~  158 (332)
T cd07857          80 ELYLYEELME-ADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSEN  158 (332)
T ss_pred             cEEEEEeccc-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcCCCCEEeCcCCCceecccc
Confidence            6889999985 689999988788999999999999999999999999999999999999999999999999999754321


Q ss_pred             cC--CCccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhhcCCc-CCC---------------------------
Q 014609          168 RD--DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIFRGDF-KLP---------------------------  217 (421)
Q Consensus       168 ~~--~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~~~~~-~~p---------------------------  217 (421)
                      ..  ........||+.|+|||++.+....+.++||||+||++|.+.+.. ++.                           
T Consensus       159 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (332)
T cd07857         159 PGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSRIG  238 (332)
T ss_pred             cccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHHhhh
Confidence            11  112234578999999998765433358899999999999543322 110                           


Q ss_pred             -----------------------CCCCHHHHHHHHHhcCCCCCCCCCHHhhhcCcccccc
Q 014609          218 -----------------------KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD  254 (421)
Q Consensus       218 -----------------------~~~s~~~~~li~~~L~~dP~~R~t~~eil~~~w~~~~  254 (421)
                                             +..+..+.+++.+||+.||.+|||+.+++.|||+.+.
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~~~~~~  298 (332)
T cd07857         239 SPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYLAIW  298 (332)
T ss_pred             hhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhhhh
Confidence                                   1146789999999999999999999999999999754

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=100.00  E-value=1.3e-38  Score=308.92  Aligned_cols=238  Identities=26%  Similarity=0.401  Sum_probs=198.9

Q ss_pred             CeeecceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEE
Q 014609           10 GMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKI   89 (421)
Q Consensus        10 ~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~   89 (421)
                      ...-..|+..+.||+|+||.||+|++..+++.+|+|.+............++.+|+++++.++|||++++++++......
T Consensus        11 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   90 (308)
T cd06634          11 DDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTA   90 (308)
T ss_pred             CCcHHHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCee
Confidence            34445688899999999999999999999999999998754333333456788999999999999999999999999999


Q ss_pred             EEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCcccc
Q 014609           90 YMVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFR  168 (421)
Q Consensus        90 ~lv~E~~~gg~L~~~i~~-~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~~  168 (421)
                      |+||||+. ++|.+.+.. ..++++..+..++.|++.||.|||++|++||||+|+||+++.++.++|+|||++.....  
T Consensus        91 ~lv~e~~~-~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~--  167 (308)
T cd06634          91 WLVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP--  167 (308)
T ss_pred             EEEEEccC-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECCCCcEEECCcccceeecC--
Confidence            99999996 577776643 45689999999999999999999999999999999999999999999999999874322  


Q ss_pred             CCCccccccCCCCccChhhhcc--cCCCCCcchHHHHHHHHhhhc-CCcCC---------------------CCCCCHHH
Q 014609          169 DDGLLHTTCGSPNYVAPEVLAN--RGYDGATSDIWSCGVILYIFR-GDFKL---------------------PKWLSPGA  224 (421)
Q Consensus       169 ~~~~~~~~~gt~~y~APEvl~~--~~~~~~~~DiwSlGvil~~~~-~~~~~---------------------p~~~s~~~  224 (421)
                          .....+++.|+|||++.+  ....+.++|||||||++|.+. |..++                     +..++..+
T Consensus       168 ----~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (308)
T cd06634         168 ----ANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYF  243 (308)
T ss_pred             ----cccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHhhcCCCCcCcccccHHH
Confidence                234568899999999753  222357899999999999543 33221                     12367789


Q ss_pred             HHHHHHhcCCCCCCCCCHHhhhcCcccccc
Q 014609          225 QNLLRKILEPNPVKRITIAGIKADEWFEQD  254 (421)
Q Consensus       225 ~~li~~~L~~dP~~R~t~~eil~~~w~~~~  254 (421)
                      .++|++||.++|.+||++.+++.|||+...
T Consensus       244 ~~li~~cl~~~P~~Rp~~~~ll~~~~~~~~  273 (308)
T cd06634         244 RNFVDSCLQKIPQDRPTSEVLLKHRFVLRE  273 (308)
T ss_pred             HHHHHHHhhCCcccCCCHHHHhhCcccccc
Confidence            999999999999999999999999999874

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=1.6e-38  Score=303.18  Aligned_cols=232  Identities=24%  Similarity=0.336  Sum_probs=191.2

Q ss_pred             eecceEEeceEeecCcEEEEEEEECCCCc----eEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCC
Q 014609           12 RLGRYELGRTLGEGNFGKVKFAQDLDSGL----PFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKS   87 (421)
Q Consensus        12 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~----~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~   87 (421)
                      ...+|++.+.||+|+||+||+|.+..+++    .||+|++....  .......+.+|+.+++.++||||+++++++... 
T Consensus         5 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-   81 (279)
T cd05109           5 KETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENT--SPKANKEILDEAYVMAGVGSPYVCRLLGICLTS-   81 (279)
T ss_pred             chhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCC--CHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC-
Confidence            34689999999999999999999877766    48999986432  223356788999999999999999999998764 


Q ss_pred             EEEEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCcc
Q 014609           88 KIYMVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQH  166 (421)
Q Consensus        88 ~~~lv~E~~~gg~L~~~i~~-~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~  166 (421)
                      ..++++||+++|+|.+.+.. .+.+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||++.....
T Consensus        82 ~~~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~  161 (279)
T cd05109          82 TVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDI  161 (279)
T ss_pred             CcEEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCCcEEECCCCceeeccc
Confidence            47899999999999999876 45689999999999999999999999999999999999999999999999999985533


Q ss_pred             ccCCCccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhh-c-CCcC--------------------CCCCCCHHH
Q 014609          167 FRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIF-R-GDFK--------------------LPKWLSPGA  224 (421)
Q Consensus       167 ~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~-~-~~~~--------------------~p~~~s~~~  224 (421)
                      ...........+++.|+|||++.+..+ +.++|||||||++|++ . |..+                    .|..++.++
T Consensus       162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~-~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (279)
T cd05109         162 DETEYHADGGKVPIKWMALESILHRRF-THQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEKGERLPQPPICTIDV  240 (279)
T ss_pred             ccceeecCCCccchhhCCHHHhccCCC-CchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCcCCCCccCCHHH
Confidence            211111122234678999999987777 4889999999999964 3 3332                    233467889


Q ss_pred             HHHHHHhcCCCCCCCCCHHhhhc
Q 014609          225 QNLLRKILEPNPVKRITIAGIKA  247 (421)
Q Consensus       225 ~~li~~~L~~dP~~R~t~~eil~  247 (421)
                      .+++.+||+.||++||++.+++.
T Consensus       241 ~~li~~~l~~dp~~Rp~~~~l~~  263 (279)
T cd05109         241 YMIMVKCWMIDSECRPRFRELVD  263 (279)
T ss_pred             HHHHHHHcCCChhhCcCHHHHHH
Confidence            99999999999999999999984

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=100.00  E-value=4.6e-39  Score=300.22  Aligned_cols=213  Identities=29%  Similarity=0.468  Sum_probs=183.6

Q ss_pred             cCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEEeccCCCChHHH
Q 014609           25 GNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDK  104 (421)
Q Consensus        25 G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~~gg~L~~~  104 (421)
                      |.+|+||+|++..+++.||+|.+++..        ...+|...+....||||+++++++.+....|+||||++|++|.+.
T Consensus         4 g~~~~v~~~~~~~~~~~~~~K~i~~~~--------~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~   75 (237)
T cd05576           4 GVIDKVLLVMDTRTQQTFILKGLRKSS--------EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSH   75 (237)
T ss_pred             cccceEEEEEEccCCcEEEEEeecchh--------hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHH
Confidence            899999999999999999999997542        223445555566799999999999999999999999999999999


Q ss_pred             HHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCccccCCCccccccCCCCccC
Q 014609          105 IASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVA  184 (421)
Q Consensus       105 i~~~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~A  184 (421)
                      +....++++..+..++.|+++||+|||++||+||||||+||+++.++.++|+|||.+.....     ......+++.|+|
T Consensus        76 l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~-----~~~~~~~~~~y~a  150 (237)
T cd05576          76 ISKFLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVED-----SCDGEAVENMYCA  150 (237)
T ss_pred             HHHhcCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEecccchhcccc-----ccccCCcCccccC
Confidence            98877899999999999999999999999999999999999999999999999998764322     1233456788999


Q ss_pred             hhhhcccCCCCCcchHHHHHHHHhhhcCC----------------cCCCCCCCHHHHHHHHHhcCCCCCCCCCH-----H
Q 014609          185 PEVLANRGYDGATSDIWSCGVILYIFRGD----------------FKLPKWLSPGAQNLLRKILEPNPVKRITI-----A  243 (421)
Q Consensus       185 PEvl~~~~~~~~~~DiwSlGvil~~~~~~----------------~~~p~~~s~~~~~li~~~L~~dP~~R~t~-----~  243 (421)
                      ||.+....+ +.++|+||+|+++|.+..+                ..+|.++++.+.++|.+||+.||++|+++     +
T Consensus       151 PE~~~~~~~-~~~~DvwslG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~  229 (237)
T cd05576         151 PEVGGISEE-TEACDWWSLGAILFELLTGKTLVECHPSGINTHTTLNIPEWVSEEARSLLQQLLQFNPTERLGAGVAGVE  229 (237)
T ss_pred             CcccCCCCC-CchhhHHHHHHHHHHHHHCcchhhcCchhcccccccCCcccCCHHHHHHHHHHccCCHHHhcCCCccchH
Confidence            999877666 5889999999999954321                23567789999999999999999999986     9


Q ss_pred             hhhcCccc
Q 014609          244 GIKADEWF  251 (421)
Q Consensus       244 eil~~~w~  251 (421)
                      ++++||||
T Consensus       230 ~~~~h~~~  237 (237)
T cd05576         230 DIKSHPFF  237 (237)
T ss_pred             HHHcCCCC
Confidence            99999997

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=1.6e-38  Score=307.24  Aligned_cols=237  Identities=26%  Similarity=0.427  Sum_probs=194.9

Q ss_pred             CCeeecceEEeceEeecCcEEEEEEEEC-------CCCceEEEEEeecccccchhHHHHHHHHHHHHhcC-CCCCcceEE
Q 014609            9 EGMRLGRYELGRTLGEGNFGKVKFAQDL-------DSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLH   80 (421)
Q Consensus         9 ~~~~~~~y~i~~~LG~G~~g~V~~a~~~-------~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~   80 (421)
                      -....++|++.+.||+|+||.||+|++.       ..+..||+|.+....  .......+.+|+.+++.+ +||||++++
T Consensus        10 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~i~~~~   87 (304)
T cd05101          10 WEFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINLL   87 (304)
T ss_pred             ccccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeeccccc--chHHHHHHHHHHHHHHhhccCCCchhee
Confidence            3455679999999999999999999753       234579999886432  223356789999999999 899999999


Q ss_pred             EEEEeCCEEEEEEeccCCCChHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCC
Q 014609           81 EVLASKSKIYMVLEYVTGGELFDKIASK----------------GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLEN  144 (421)
Q Consensus        81 ~~~~~~~~~~lv~E~~~gg~L~~~i~~~----------------~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~N  144 (421)
                      +++......|++|||+++++|.+++...                ..++...+..++.|++.||.|||++||+||||||+|
T Consensus        88 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp~N  167 (304)
T cd05101          88 GACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARN  167 (304)
T ss_pred             EEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeecccccce
Confidence            9999999999999999999999998753                246778899999999999999999999999999999


Q ss_pred             EEeccCCCEEEEeccCCCCCccccCCCccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhhc--CCcCC------
Q 014609          145 ILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIFR--GDFKL------  216 (421)
Q Consensus       145 ILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~~--~~~~~------  216 (421)
                      |+++.++.+||+|||++................+++.|+|||++.+..+ +.++||||||+++|.+.  |..++      
T Consensus       168 ili~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~el~~~g~~p~~~~~~~  246 (304)
T cd05101         168 VLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVY-THQSDVWSFGVLMWEIFTLGGSPYPGIPVE  246 (304)
T ss_pred             EEEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCC-CchhhHHHHHHHHHHHHcCCCCCcccCCHH
Confidence            9999999999999999975433222222233456678999999987777 48899999999999653  33322      


Q ss_pred             --------------CCCCCHHHHHHHHHhcCCCCCCCCCHHhhhcC
Q 014609          217 --------------PKWLSPGAQNLLRKILEPNPVKRITIAGIKAD  248 (421)
Q Consensus       217 --------------p~~~s~~~~~li~~~L~~dP~~R~t~~eil~~  248 (421)
                                    |..++..+.+++.+||.++|.+|||+.++++.
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~  292 (304)
T cd05101         247 ELFKLLKEGHRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVED  292 (304)
T ss_pred             HHHHHHHcCCcCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHH
Confidence                          23467899999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=1.3e-38  Score=305.29  Aligned_cols=233  Identities=27%  Similarity=0.373  Sum_probs=192.6

Q ss_pred             eecceEEeceEeecCcEEEEEEEEC-----CCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeC
Q 014609           12 RLGRYELGRTLGEGNFGKVKFAQDL-----DSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASK   86 (421)
Q Consensus        12 ~~~~y~i~~~LG~G~~g~V~~a~~~-----~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~   86 (421)
                      ..++|++.+.||+|+||.||+|.+.     .++..||+|++....  .......+.+|+.++++++||||+++++++...
T Consensus         3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~   80 (288)
T cd05050           3 PRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALMAEFDHPNIVKLLGVCAVG   80 (288)
T ss_pred             ChHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCc--CHHHHHHHHHHHHHHHhcCCCchheEEEEEcCC
Confidence            3468999999999999999999874     367899999987543  223346788999999999999999999999999


Q ss_pred             CEEEEEEeccCCCChHHHHHhc----------------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCC
Q 014609           87 SKIYMVLEYVTGGELFDKIASK----------------------GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLEN  144 (421)
Q Consensus        87 ~~~~lv~E~~~gg~L~~~i~~~----------------------~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~N  144 (421)
                      ...|++|||+++++|.+++...                      ..+++..+..++.|++.||+|||++|++||||||+|
T Consensus        81 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~p~n  160 (288)
T cd05050          81 KPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRN  160 (288)
T ss_pred             CccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccccHhh
Confidence            9999999999999999998642                      236788899999999999999999999999999999


Q ss_pred             EEeccCCCEEEEeccCCCCCccccCCCccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhhc--CCcC-------
Q 014609          145 ILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIFR--GDFK-------  215 (421)
Q Consensus       145 ILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~~--~~~~-------  215 (421)
                      |+++.++.++|+|||++.................++.|+|||++.+..+ +.++|||||||++|.+.  +..+       
T Consensus       161 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~il~el~~~~~~p~~~~~~~  239 (288)
T cd05050         161 CLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRY-TTESDVWAYGVVLWEIFSYGMQPYYGMAHE  239 (288)
T ss_pred             eEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCC-CchhHHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence            9999999999999999874322111111222334667999999887777 58999999999999664  3222       


Q ss_pred             -------------CCCCCCHHHHHHHHHhcCCCCCCCCCHHhhhc
Q 014609          216 -------------LPKWLSPGAQNLLRKILEPNPVKRITIAGIKA  247 (421)
Q Consensus       216 -------------~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~  247 (421)
                                   .|..++..+.++|.+||+.+|.+|||+.|+++
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~  284 (288)
T cd05050         240 EVIYYVRDGNVLSCPDNCPLELYNLMRLCWSKLPSDRPSFASINR  284 (288)
T ss_pred             HHHHHHhcCCCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence                         24457889999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.3e-38  Score=299.96  Aligned_cols=228  Identities=24%  Similarity=0.428  Sum_probs=189.9

Q ss_pred             cceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEE
Q 014609           14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVL   93 (421)
Q Consensus        14 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~   93 (421)
                      .+|++.+.||+|+||.||+|.+. ++..+|+|++......    .+.+.+|+.+++.++||||+++++++...+..|+||
T Consensus         4 ~~~~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~~~----~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   78 (256)
T cd05059           4 SELTFLKELGSGQFGVVHLGKWR-GKIDVAIKMIREGAMS----EDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVT   78 (256)
T ss_pred             HHcchhhhhccCCCceEEEeEec-CCccEEEEEeccCCCC----HHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEE
Confidence            46899999999999999999875 5678999998654321    356788999999999999999999999999999999


Q ss_pred             eccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCccccCCCc
Q 014609           94 EYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGL  172 (421)
Q Consensus        94 E~~~gg~L~~~i~~-~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~  172 (421)
                      ||++|++|.+++.. ...+++..+..++.|++.||+|||++|++||||||+||+++.++.+||+|||++........ ..
T Consensus        79 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~-~~  157 (256)
T cd05059          79 EYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQY-TS  157 (256)
T ss_pred             ecCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECCCCcEEECCcccceecccccc-cc
Confidence            99999999999875 34689999999999999999999999999999999999999999999999999874322110 01


Q ss_pred             cccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhhc--CCcCC--------------------CCCCCHHHHHHHHH
Q 014609          173 LHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIFR--GDFKL--------------------PKWLSPGAQNLLRK  230 (421)
Q Consensus       173 ~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~~--~~~~~--------------------p~~~s~~~~~li~~  230 (421)
                      .....++..|+|||.+.+..+ +.++|+||||+++|.+.  |..++                    |...++.+.+++.+
T Consensus       158 ~~~~~~~~~y~~Pe~~~~~~~-~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  236 (256)
T cd05059         158 SQGTKFPVKWAPPEVFDYSRF-SSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGYRLYRPKLAPTEVYTIMYS  236 (256)
T ss_pred             cCCCCCCccccCHHHhccCCC-CchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHH
Confidence            111123457999999887777 58899999999999654  33332                    33468999999999


Q ss_pred             hcCCCCCCCCCHHhhhcC
Q 014609          231 ILEPNPVKRITIAGIKAD  248 (421)
Q Consensus       231 ~L~~dP~~R~t~~eil~~  248 (421)
                      ||..+|++|||+.++++.
T Consensus       237 cl~~~p~~Rpt~~~~l~~  254 (256)
T cd05059         237 CWHEKPEDRPAFKKLLSQ  254 (256)
T ss_pred             HhcCChhhCcCHHHHHHH
Confidence            999999999999998763

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=100.00  E-value=1.4e-38  Score=304.72  Aligned_cols=236  Identities=30%  Similarity=0.521  Sum_probs=203.9

Q ss_pred             eeecceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEE
Q 014609           11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIY   90 (421)
Q Consensus        11 ~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~   90 (421)
                      .....|++.+.||+|++|.||+|.+..+++.||+|++.....    ..+.+.+|+.+++.++||||+++++++......|
T Consensus        16 ~~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   91 (286)
T cd06614          16 DPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ----NKELIINEILIMKDCKHPNIVDYYDSYLVGDELW   91 (286)
T ss_pred             CccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch----hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEE
Confidence            344679999999999999999999988999999999975432    3567889999999999999999999999999999


Q ss_pred             EEEeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCccccC
Q 014609           91 MVLEYVTGGELFDKIASKG-RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD  169 (421)
Q Consensus        91 lv~E~~~gg~L~~~i~~~~-~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~  169 (421)
                      +++||++|++|.+++.... .+++..+..++.|++.||+|||+.|++|+||+|+||+++.++.++|+|||++......  
T Consensus        92 lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~--  169 (286)
T cd06614          92 VVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKE--  169 (286)
T ss_pred             EEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcCCCCEEECccchhhhhccc--
Confidence            9999999999999998766 8999999999999999999999999999999999999999999999999998754321  


Q ss_pred             CCccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhhc-CCcCC----------------------CCCCCHHHHH
Q 014609          170 DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIFR-GDFKL----------------------PKWLSPGAQN  226 (421)
Q Consensus       170 ~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~~-~~~~~----------------------p~~~s~~~~~  226 (421)
                      ........+++.|+|||++.+..+ +.++|+||+||++|.+. |..++                      +..++..+.+
T Consensus       170 ~~~~~~~~~~~~y~~PE~~~~~~~-~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  248 (286)
T cd06614         170 KSKRNSVVGTPYWMAPEVIKRKDY-GPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGIPPLKNPEKWSPEFKD  248 (286)
T ss_pred             hhhhccccCCcccCCHhHhcCCCC-CCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCcchhhCCHHHHH
Confidence            112234467889999999887766 58899999999999543 22211                      1126788999


Q ss_pred             HHHHhcCCCCCCCCCHHhhhcCccccc
Q 014609          227 LLRKILEPNPVKRITIAGIKADEWFEQ  253 (421)
Q Consensus       227 li~~~L~~dP~~R~t~~eil~~~w~~~  253 (421)
                      +|.+||+++|.+|||+.+++.|+||.+
T Consensus       249 li~~~l~~~p~~Rpt~~~il~~~~~~~  275 (286)
T cd06614         249 FLNKCLVKDPEKRPSAEELLQHPFLKK  275 (286)
T ss_pred             HHHHHhccChhhCcCHHHHhhChHhhc
Confidence            999999999999999999999999987

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=2.2e-38  Score=302.91  Aligned_cols=230  Identities=28%  Similarity=0.447  Sum_probs=188.3

Q ss_pred             cceEEeceEeecCcEEEEEEE----ECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEe--CC
Q 014609           14 GRYELGRTLGEGNFGKVKFAQ----DLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLAS--KS   87 (421)
Q Consensus        14 ~~y~i~~~LG~G~~g~V~~a~----~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~--~~   87 (421)
                      .+|++.+.||+|+||.||+|.    +..+++.||+|.+....   ......+.+|+++++.++||||+++++++..  ..
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~   80 (284)
T cd05081           4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHST---AEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRR   80 (284)
T ss_pred             ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCC---HHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCC
Confidence            479999999999999999997    44678999999986442   2335678999999999999999999998753  35


Q ss_pred             EEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCcc
Q 014609           88 KIYMVLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQH  166 (421)
Q Consensus        88 ~~~lv~E~~~gg~L~~~i~~~-~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~  166 (421)
                      .+|+||||+++++|.+++... ..+++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||++.....
T Consensus        81 ~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~  160 (284)
T cd05081          81 NLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQ  160 (284)
T ss_pred             ceEEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEECCCCeEEECCCcccccccC
Confidence            689999999999999998754 4689999999999999999999999999999999999999999999999999985432


Q ss_pred             ccCCC-ccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhhcCC--------------------------------
Q 014609          167 FRDDG-LLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIFRGD--------------------------------  213 (421)
Q Consensus       167 ~~~~~-~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~~~~--------------------------------  213 (421)
                      ..... ......++..|+|||++.+..+ +.++||||+||++|.+...                                
T Consensus       161 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (284)
T cd05081         161 DKEYYKVREPGESPIFWYAPESLTESKF-SVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIELL  239 (284)
T ss_pred             CCcceeecCCCCCceEeeCHHHhccCCc-ChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHHHH
Confidence            11110 1111223446999999887766 5889999999999955431                                


Q ss_pred             -----cCCCCCCCHHHHHHHHHhcCCCCCCCCCHHhhhc
Q 014609          214 -----FKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKA  247 (421)
Q Consensus       214 -----~~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~  247 (421)
                           ++.+..++..+.+++.+||.++|++|||+.++++
T Consensus       240 ~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~  278 (284)
T cd05081         240 KNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELAL  278 (284)
T ss_pred             hcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence                 1123346789999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=1.2e-38  Score=302.43  Aligned_cols=231  Identities=27%  Similarity=0.366  Sum_probs=187.3

Q ss_pred             eEEeceEeecCcEEEEEEEECCCCc--eEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeC------C
Q 014609           16 YELGRTLGEGNFGKVKFAQDLDSGL--PFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASK------S   87 (421)
Q Consensus        16 y~i~~~LG~G~~g~V~~a~~~~~~~--~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~------~   87 (421)
                      |.+++.||+|+||.||+|.+..+++  .+|+|.++.... .....+.+.+|+.+++.++||||+++++++...      .
T Consensus         1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   79 (272)
T cd05075           1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAIC-TRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYP   79 (272)
T ss_pred             CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcC-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCC
Confidence            4578999999999999999877765  699998865432 333457889999999999999999999987432      3


Q ss_pred             EEEEEEeccCCCChHHHHHh------cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCC
Q 014609           88 KIYMVLEYVTGGELFDKIAS------KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLS  161 (421)
Q Consensus        88 ~~~lv~E~~~gg~L~~~i~~------~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla  161 (421)
                      ..+++|||+++++|.+.+..      ...+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||++
T Consensus        80 ~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~  159 (272)
T cd05075          80 SPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLS  159 (272)
T ss_pred             CcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEcCCCCEEECCCCcc
Confidence            57899999999999887742      234789999999999999999999999999999999999999999999999999


Q ss_pred             CCCccccCCCccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhhc--CCcCC--------------------CCC
Q 014609          162 ALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIFR--GDFKL--------------------PKW  219 (421)
Q Consensus       162 ~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~~--~~~~~--------------------p~~  219 (421)
                      ................+++.|+|||++.+..+ +.++||||+||++|.+.  |..++                    ++.
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~-~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  238 (272)
T cd05075         160 KKIYNGDYYRQGRIAKMPVKWIAIESLADRVY-TTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGNRLKQPPD  238 (272)
T ss_pred             cccCcccceecCCcccCCcccCCHHHccCCCc-ChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCCCCCC
Confidence            86532111111123356778999999887766 58999999999999653  33332                    334


Q ss_pred             CCHHHHHHHHHhcCCCCCCCCCHHhhhcC
Q 014609          220 LSPGAQNLLRKILEPNPVKRITIAGIKAD  248 (421)
Q Consensus       220 ~s~~~~~li~~~L~~dP~~R~t~~eil~~  248 (421)
                      ++..+.++|.+||++||++|||+.+++++
T Consensus       239 ~~~~~~~li~~~l~~~p~~Rps~~~l~~~  267 (272)
T cd05075         239 CLDGLYSLMSSCWLLNPKDRPSFETLRCE  267 (272)
T ss_pred             CCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence            67889999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=1e-38  Score=304.13  Aligned_cols=232  Identities=34%  Similarity=0.527  Sum_probs=196.6

Q ss_pred             eEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEEec
Q 014609           16 YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLEY   95 (421)
Q Consensus        16 y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E~   95 (421)
                      |++.+.||+|++|.||+|.+..+++.||+|++.... ......+.+.+|+.++++++||||+++++++.+....|+|+||
T Consensus         1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~   79 (282)
T cd07829           1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDN-EEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEY   79 (282)
T ss_pred             CeeehcccccCcceEEEeeecCCCcEEEEEEecccc-ccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecC
Confidence            678899999999999999999999999999997654 2223346778899999999999999999999999999999999


Q ss_pred             cCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCccccCCCccc
Q 014609           96 VTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLH  174 (421)
Q Consensus        96 ~~gg~L~~~i~~~-~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~  174 (421)
                      ++ ++|.+.+... ..+++..+..++.|++.||+|||++||+||||+|+||+++.++.++|+|||++......  .....
T Consensus        80 ~~-~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~--~~~~~  156 (282)
T cd07829          80 CD-MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDGVLKLADFGLARAFGIP--LRTYT  156 (282)
T ss_pred             cC-cCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcCCCCEEEecCCcccccCCC--ccccC
Confidence            97 5899999875 57999999999999999999999999999999999999999999999999998754331  11223


Q ss_pred             cccCCCCccChhhhcccCCCCCcchHHHHHHHHhhhcCC-cCCC------------------------------------
Q 014609          175 TTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIFRGD-FKLP------------------------------------  217 (421)
Q Consensus       175 ~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~~~~-~~~p------------------------------------  217 (421)
                      ...++..|+|||.+.+....+.++|+||+||++|.+... .++.                                    
T Consensus       157 ~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (282)
T cd07829         157 HEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKPTF  236 (282)
T ss_pred             ccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccccccccc
Confidence            345678899999987663446889999999999954332 2111                                    


Q ss_pred             ------------CCCCHHHHHHHHHhcCCCCCCCCCHHhhhcCccc
Q 014609          218 ------------KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWF  251 (421)
Q Consensus       218 ------------~~~s~~~~~li~~~L~~dP~~R~t~~eil~~~w~  251 (421)
                                  +.++..+.++|++||..||++||++.+++.||||
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~p~~  282 (282)
T cd07829         237 PKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF  282 (282)
T ss_pred             cccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhCcCC
Confidence                        1136789999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=2.2e-38  Score=307.91  Aligned_cols=234  Identities=27%  Similarity=0.424  Sum_probs=191.2

Q ss_pred             eecceEEeceEeecCcEEEEEEEECC-------CCceEEEEEeecccccchhHHHHHHHHHHHHhcC-CCCCcceEEEEE
Q 014609           12 RLGRYELGRTLGEGNFGKVKFAQDLD-------SGLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEVL   83 (421)
Q Consensus        12 ~~~~y~i~~~LG~G~~g~V~~a~~~~-------~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~   83 (421)
                      ..++|.+++.||+|+||.||+|.+..       .+..+|+|.+....  .......+.+|+.+++++ +||||+++++++
T Consensus        10 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~   87 (314)
T cd05099          10 PRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNA--TDKDLADLISEMELMKLIGKHKNIINLLGVC   87 (314)
T ss_pred             cHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCC--ChHHHHHHHHHHHHHHhccCCCCeeeEEEEE
Confidence            34789999999999999999998632       35579999986432  223356788999999999 699999999999


Q ss_pred             EeCCEEEEEEeccCCCChHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEe
Q 014609           84 ASKSKIYMVLEYVTGGELFDKIASK----------------GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILL  147 (421)
Q Consensus        84 ~~~~~~~lv~E~~~gg~L~~~i~~~----------------~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl  147 (421)
                      ...+.+|++|||+++++|.+++...                ..++...+..++.|++.||+|||++||+||||||+|||+
T Consensus        88 ~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill  167 (314)
T cd05099          88 TQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLV  167 (314)
T ss_pred             ccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeeccccceeEEE
Confidence            9999999999999999999998653                247888999999999999999999999999999999999


Q ss_pred             ccCCCEEEEeccCCCCCccccCCCccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhhc--CCcC----------
Q 014609          148 DSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIFR--GDFK----------  215 (421)
Q Consensus       148 ~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~~--~~~~----------  215 (421)
                      +.++.+||+|||++................+++.|+|||++.+..+ +.++|||||||++|.+.  |..+          
T Consensus       168 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~  246 (314)
T cd05099         168 TEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVY-THQSDVWSFGILMWEIFTLGGSPYPGIPVEELF  246 (314)
T ss_pred             cCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCc-CccchhhHHHHHHHHHHhCCCCCCCCCCHHHHH
Confidence            9999999999999975432111111222234568999999887766 58899999999999543  3332          


Q ss_pred             ----------CCCCCCHHHHHHHHHhcCCCCCCCCCHHhhhcC
Q 014609          216 ----------LPKWLSPGAQNLLRKILEPNPVKRITIAGIKAD  248 (421)
Q Consensus       216 ----------~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~~  248 (421)
                                .|..++.++.+++.+||..+|.+|||+.++++.
T Consensus       247 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~  289 (314)
T cd05099         247 KLLREGHRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEA  289 (314)
T ss_pred             HHHHcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence                      233467889999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=1.9e-38  Score=305.91  Aligned_cols=229  Identities=27%  Similarity=0.408  Sum_probs=189.5

Q ss_pred             cceEEeceEeecCcEEEEEEEECCCCc--eEEEEEeecccccchhHHHHHHHHHHHHhcC-CCCCcceEEEEEEeCCEEE
Q 014609           14 GRYELGRTLGEGNFGKVKFAQDLDSGL--PFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEVLASKSKIY   90 (421)
Q Consensus        14 ~~y~i~~~LG~G~~g~V~~a~~~~~~~--~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~   90 (421)
                      ++|++.+.||+|+||.||+|.+..++.  .+++|.+...  ......+.+.+|+.++.++ +||||+++++++...+..|
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~--~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~   79 (297)
T cd05089           2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEF--ASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLY   79 (297)
T ss_pred             ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEcccc--CCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcce
Confidence            689999999999999999999877665  4688877532  1223356789999999999 7999999999999999999


Q ss_pred             EEEeccCCCChHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEE
Q 014609           91 MVLEYVTGGELFDKIASKG----------------RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIK  154 (421)
Q Consensus        91 lv~E~~~gg~L~~~i~~~~----------------~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~k  154 (421)
                      ++|||+++++|.+++....                .+++..++.++.|++.||+|||++||+||||||+|||++.++.+|
T Consensus        80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~k  159 (297)
T cd05089          80 IAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLASK  159 (297)
T ss_pred             EEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEECCCCeEE
Confidence            9999999999999986532                478899999999999999999999999999999999999999999


Q ss_pred             EEeccCCCCCccccCCCccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhhc--CCcCC----------------
Q 014609          155 ISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIFR--GDFKL----------------  216 (421)
Q Consensus       155 L~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~~--~~~~~----------------  216 (421)
                      |+|||++.......   .......+..|+|||++.+..+ +.++|||||||++|.+.  |..++                
T Consensus       160 l~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~~~~~~  235 (297)
T cd05089         160 IADFGLSRGEEVYV---KKTMGRLPVRWMAIESLNYSVY-TTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQGY  235 (297)
T ss_pred             ECCcCCCcccccee---ccCCCCcCccccCchhhccCCC-CchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCC
Confidence            99999986322110   0111123457999999887776 58999999999999763  54432                


Q ss_pred             ----CCCCCHHHHHHHHHhcCCCCCCCCCHHhhhcC
Q 014609          217 ----PKWLSPGAQNLLRKILEPNPVKRITIAGIKAD  248 (421)
Q Consensus       217 ----p~~~s~~~~~li~~~L~~dP~~R~t~~eil~~  248 (421)
                          |..+++.+.+++.+||+.+|.+|||++++++.
T Consensus       236 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~  271 (297)
T cd05089         236 RMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQ  271 (297)
T ss_pred             CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence                23478899999999999999999999998765

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=100.00  E-value=3.9e-38  Score=306.71  Aligned_cols=235  Identities=26%  Similarity=0.427  Sum_probs=198.4

Q ss_pred             cceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEE
Q 014609           14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVL   93 (421)
Q Consensus        14 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~   93 (421)
                      ..|+..+.||+|+||.||+|++..+++.||+|.+.............+.+|++++++++|||++++++++..+...|+||
T Consensus        25 ~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  104 (317)
T cd06635          25 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVM  104 (317)
T ss_pred             hhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEE
Confidence            45889999999999999999999999999999997654444445567899999999999999999999999999999999


Q ss_pred             eccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCccccCCCc
Q 014609           94 EYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGL  172 (421)
Q Consensus        94 E~~~gg~L~~~i~~-~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~  172 (421)
                      ||+.| +|.+.+.. ..++++..+..++.|++.||.|||++||+||||+|+||+++.++.++|+|||++.....      
T Consensus       105 e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~------  177 (317)
T cd06635         105 EYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIASP------  177 (317)
T ss_pred             eCCCC-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECCCCCEEEecCCCccccCC------
Confidence            99975 77776654 55789999999999999999999999999999999999999999999999999874322      


Q ss_pred             cccccCCCCccChhhhcc--cCCCCCcchHHHHHHHHhhhc-CCcCC---------------------CCCCCHHHHHHH
Q 014609          173 LHTTCGSPNYVAPEVLAN--RGYDGATSDIWSCGVILYIFR-GDFKL---------------------PKWLSPGAQNLL  228 (421)
Q Consensus       173 ~~~~~gt~~y~APEvl~~--~~~~~~~~DiwSlGvil~~~~-~~~~~---------------------p~~~s~~~~~li  228 (421)
                      .....|++.|+|||++..  ....+.++|+||+||++|.+. |..++                     +..+++.+.+++
T Consensus       178 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li  257 (317)
T cd06635         178 ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWSDYFRNFV  257 (317)
T ss_pred             cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhccCCCCCCccccHHHHHHH
Confidence            234578999999999742  222357899999999999543 33221                     123577899999


Q ss_pred             HHhcCCCCCCCCCHHhhhcCccccccc
Q 014609          229 RKILEPNPVKRITIAGIKADEWFEQDY  255 (421)
Q Consensus       229 ~~~L~~dP~~R~t~~eil~~~w~~~~~  255 (421)
                      .+||+.+|.+||++.++++|+|+....
T Consensus       258 ~~~l~~~p~~Rpt~~~il~~~~~~~~~  284 (317)
T cd06635         258 DSCLQKIPQDRPTSEELLKHMFVLRER  284 (317)
T ss_pred             HHHccCCcccCcCHHHHHhChhhhccC
Confidence            999999999999999999999997644

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=100.00  E-value=1e-39  Score=342.73  Aligned_cols=237  Identities=33%  Similarity=0.554  Sum_probs=195.6

Q ss_pred             ecceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEe-------
Q 014609           13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLAS-------   85 (421)
Q Consensus        13 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~-------   85 (421)
                      +.+|+.++.||+||||.||+++++-+|+.||||.|+...  .......+.+|+..|.+|+|||||++|..+.+       
T Consensus       478 ~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~--s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~  555 (1351)
T KOG1035|consen  478 LNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKA--SDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTV  555 (1351)
T ss_pred             hhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCch--HHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccc
Confidence            467788999999999999999999999999999998764  33446789999999999999999999875411       


Q ss_pred             --------------------------------------------------------------------------------
Q 014609           86 --------------------------------------------------------------------------------   85 (421)
Q Consensus        86 --------------------------------------------------------------------------------   85 (421)
                                                                                                      
T Consensus       556 ~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~  635 (1351)
T KOG1035|consen  556 LEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSD  635 (1351)
T ss_pred             ccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccc
Confidence                                                                                            


Q ss_pred             ------------------------C--------CEEEEEEeccCCCChHHHHHhcCCC-CHHHHHHHHHHHHHHHHHHHh
Q 014609           86 ------------------------K--------SKIYMVLEYVTGGELFDKIASKGRL-QEAEGRKLFQQLIDGVSYCHN  132 (421)
Q Consensus        86 ------------------------~--------~~~~lv~E~~~gg~L~~~i~~~~~~-~~~~~~~~~~ql~~aL~~LH~  132 (421)
                                              +        ..+||-||||+...|.+.+..+... ....++++|+||++||.|+|+
T Consensus       636 ~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH~  715 (1351)
T KOG1035|consen  636 SEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIHD  715 (1351)
T ss_pred             cCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHHh
Confidence                                    0        2379999999987777777765544 578899999999999999999


Q ss_pred             CCceeccCCCCCEEeccCCCEEEEeccCCCCCc----c------------ccCCCccccccCCCCccChhhhcccC---C
Q 014609          133 KGVFHRDLKLENILLDSKGNIKISDFGLSALPQ----H------------FRDDGLLHTTCGSPNYVAPEVLANRG---Y  193 (421)
Q Consensus       133 ~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~----~------------~~~~~~~~~~~gt~~y~APEvl~~~~---~  193 (421)
                      +|||||||||.||++|+++.+||+|||+|+...    .            ..+.+..+...||--|+|||++.+..   |
T Consensus       716 ~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Y  795 (1351)
T KOG1035|consen  716 QGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKY  795 (1351)
T ss_pred             CceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccccc
Confidence            999999999999999999999999999998611    0            01122345678999999999998765   6


Q ss_pred             CCCcchHHHHHHHHhhhc------------------CCcCCCCCC----CHHHHHHHHHhcCCCCCCCCCHHhhhcCccc
Q 014609          194 DGATSDIWSCGVILYIFR------------------GDFKLPKWL----SPGAQNLLRKILEPNPVKRITIAGIKADEWF  251 (421)
Q Consensus       194 ~~~~~DiwSlGvil~~~~------------------~~~~~p~~~----s~~~~~li~~~L~~dP~~R~t~~eil~~~w~  251 (421)
                       ..|+|+||||+|||+|.                  |.+|.|..+    -+....+|++||+.||++|||+.|+|++.||
T Consensus       796 -n~KiDmYSLGIVlFEM~yPF~TsMERa~iL~~LR~g~iP~~~~f~~~~~~~e~slI~~Ll~hdP~kRPtA~eLL~s~ll  874 (1351)
T KOG1035|consen  796 -NSKIDMYSLGIVLFEMLYPFGTSMERASILTNLRKGSIPEPADFFDPEHPEEASLIRWLLSHDPSKRPTATELLNSELL  874 (1351)
T ss_pred             -cchhhhHHHHHHHHHHhccCCchHHHHHHHHhcccCCCCCCcccccccchHHHHHHHHHhcCCCccCCCHHHHhhccCC
Confidence             49999999999999553                  333444221    2456789999999999999999999999999


Q ss_pred             c
Q 014609          252 E  252 (421)
Q Consensus       252 ~  252 (421)
                      .
T Consensus       875 p  875 (1351)
T KOG1035|consen  875 P  875 (1351)
T ss_pred             C
Confidence            7

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=2.3e-38  Score=298.83  Aligned_cols=229  Identities=25%  Similarity=0.417  Sum_probs=191.8

Q ss_pred             eecceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEE
Q 014609           12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYM   91 (421)
Q Consensus        12 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l   91 (421)
                      ..++|+++++||+|+||.||+|.+ .++..||+|.+.....    ..+.+.+|+.++++++||||+++++++...+..|+
T Consensus         4 ~~~~~~~~~~lg~g~~g~v~~~~~-~~~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   78 (261)
T cd05072           4 PRESIKLVKKLGAGQFGEVWMGYY-NNSTKVAVKTLKPGTM----SVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYI   78 (261)
T ss_pred             chHHeEEeeecCCcCCceEEEEEe-cCCceEEEEEccCCch----hHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEE
Confidence            357899999999999999999986 4567899998764322    24678999999999999999999999999999999


Q ss_pred             EEeccCCCChHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCccccC
Q 014609           92 VLEYVTGGELFDKIAS--KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD  169 (421)
Q Consensus        92 v~E~~~gg~L~~~i~~--~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~  169 (421)
                      +|||+++++|.+++..  ...++......++.|++.||+|||+.+++||||||+||+++.++.++|+|||++....... 
T Consensus        79 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~-  157 (261)
T cd05072          79 ITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNE-  157 (261)
T ss_pred             EEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEecCCCcEEECCCccceecCCCc-
Confidence            9999999999999865  3468889999999999999999999999999999999999999999999999998543211 


Q ss_pred             CCccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhhc--CCcCCC--------------------CCCCHHHHHH
Q 014609          170 DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIFR--GDFKLP--------------------KWLSPGAQNL  227 (421)
Q Consensus       170 ~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~~--~~~~~p--------------------~~~s~~~~~l  227 (421)
                      ........++..|+|||++....+ +.++|||||||++|.+.  |..+++                    ..++.++.++
T Consensus       158 ~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  236 (261)
T cd05072         158 YTAREGAKFPIKWTAPEAINFGSF-TIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYRMPRMENCPDELYDI  236 (261)
T ss_pred             eeccCCCccceecCCHHHhccCCC-ChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHH
Confidence            111122345668999999877666 58899999999999654  554442                    2257899999


Q ss_pred             HHHhcCCCCCCCCCHHhhhc
Q 014609          228 LRKILEPNPVKRITIAGIKA  247 (421)
Q Consensus       228 i~~~L~~dP~~R~t~~eil~  247 (421)
                      +.+||.++|++||+++++.+
T Consensus       237 i~~~l~~~p~~Rp~~~~i~~  256 (261)
T cd05072         237 MKTCWKEKAEERPTFDYLQS  256 (261)
T ss_pred             HHHHccCCcccCcCHHHHHH
Confidence            99999999999999999864

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=100.00  E-value=3.9e-38  Score=300.85  Aligned_cols=230  Identities=34%  Similarity=0.478  Sum_probs=190.9

Q ss_pred             eEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcC---CCCCcceEEEEEEeCCE----
Q 014609           16 YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL---KHPNVVRLHEVLASKSK----   88 (421)
Q Consensus        16 y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l---~hpnIv~l~~~~~~~~~----   88 (421)
                      |++.+.||+|+||.||+|++..+++.||+|.+..... .......+.+|+.+++++   +||||+++++++.....    
T Consensus         1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~   79 (287)
T cd07838           1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLS-EEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDREL   79 (287)
T ss_pred             CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccc-cchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCc
Confidence            7899999999999999999988999999999975433 222234566788877766   59999999999988776    


Q ss_pred             -EEEEEeccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCc
Q 014609           89 -IYMVLEYVTGGELFDKIASKG--RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQ  165 (421)
Q Consensus        89 -~~lv~E~~~gg~L~~~i~~~~--~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~  165 (421)
                       .|++|||+.+ +|.+++....  .+++..++.++.|++.||+|||+.|++|+||+|+||+++.++.+||+|||++....
T Consensus        80 ~~~l~~e~~~~-~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~~~~~~l~dfg~~~~~~  158 (287)
T cd07838          80 KLTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYS  158 (287)
T ss_pred             eeEEEehhccc-CHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEccCCCEEEeccCcceecc
Confidence             9999999964 8888887643  58999999999999999999999999999999999999999999999999987653


Q ss_pred             cccCCCccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhhcCCcC-CC---------------------------
Q 014609          166 HFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIFRGDFK-LP---------------------------  217 (421)
Q Consensus       166 ~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~~~~~~-~p---------------------------  217 (421)
                      ..   .......+++.|+|||++.+..+ +.++|+||+||++|.+.+..+ +.                           
T Consensus       159 ~~---~~~~~~~~~~~~~~PE~~~~~~~-~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (287)
T cd07838         159 FE---MALTSVVVTLWYRAPEVLLQSSY-ATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNV  234 (287)
T ss_pred             CC---cccccccccccccChHHhccCCC-CCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCCc
Confidence            31   22233457889999999987776 588999999999996543221 10                           


Q ss_pred             -------------------CCCCHHHHHHHHHhcCCCCCCCCCHHhhhcCccc
Q 014609          218 -------------------KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWF  251 (421)
Q Consensus       218 -------------------~~~s~~~~~li~~~L~~dP~~R~t~~eil~~~w~  251 (421)
                                         +.+++.+.++|.+||++||.+||++.+++.||||
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~~~~  287 (287)
T cd07838         235 SLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPYF  287 (287)
T ss_pred             ccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcCcCC
Confidence                               0135677899999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-38  Score=303.62  Aligned_cols=232  Identities=33%  Similarity=0.509  Sum_probs=196.0

Q ss_pred             eEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEEec
Q 014609           16 YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLEY   95 (421)
Q Consensus        16 y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E~   95 (421)
                      |++.+.||.|++|.||+|.+..+|+.+|+|.+...... ......+.+|+.++++++||||+++++++..++..|+|+||
T Consensus         1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   79 (283)
T cd05118           1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFES-EGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEF   79 (283)
T ss_pred             CccceeeecCCCceEEEEEcCCCCcEEEEEEecccccc-chhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEec
Confidence            67889999999999999999999999999998754432 23356788999999999999999999999999999999999


Q ss_pred             cCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCccccCCCccc
Q 014609           96 VTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLH  174 (421)
Q Consensus        96 ~~gg~L~~~i~~-~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~  174 (421)
                      +++ +|.+.+.. ...+++..+..++.|++.||.|||+.||+|+||||+||+++.++.++|+|||.+.......  ....
T Consensus        80 ~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~--~~~~  156 (283)
T cd05118          80 MDT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPV--RPYT  156 (283)
T ss_pred             cCC-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc--cccc
Confidence            965 88887765 4579999999999999999999999999999999999999999999999999987553321  1223


Q ss_pred             cccCCCCccChhhhcccCCCCCcchHHHHHHHHhhh-cCCcCCC------------------------------------
Q 014609          175 TTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIF-RGDFKLP------------------------------------  217 (421)
Q Consensus       175 ~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~-~~~~~~p------------------------------------  217 (421)
                      ...++..|+|||.+.+....+.++|+||+|+++|.+ .|..+++                                    
T Consensus       157 ~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (283)
T cd05118         157 HYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKFS  236 (283)
T ss_pred             CccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhhhhh
Confidence            345788999999987763346899999999999944 3332221                                    


Q ss_pred             -------------CCCCHHHHHHHHHhcCCCCCCCCCHHhhhcCccc
Q 014609          218 -------------KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWF  251 (421)
Q Consensus       218 -------------~~~s~~~~~li~~~L~~dP~~R~t~~eil~~~w~  251 (421)
                                   +.++.++.++|.+||++||.+||++.+++.||||
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~~~~  283 (283)
T cd05118         237 FPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF  283 (283)
T ss_pred             hccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhCCCC
Confidence                         1256789999999999999999999999999997

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=3.1e-38  Score=297.28  Aligned_cols=228  Identities=25%  Similarity=0.425  Sum_probs=189.8

Q ss_pred             ecceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEE
Q 014609           13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMV   92 (421)
Q Consensus        13 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv   92 (421)
                      ..+|++.+.||+|+||.||+|... .+..+|+|.+......    ...+.+|+.++++++||||+++++++......|+|
T Consensus         3 ~~~~~~~~~lg~G~~~~vy~~~~~-~~~~~a~K~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv   77 (256)
T cd05114           3 PSELTFMKELGSGQFGVVHLGKWR-AQIKVAIKAINEGAMS----EEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIV   77 (256)
T ss_pred             HHHcEEeeEecCCcCceEEEEEec-cCceEEEEecccCCcc----HHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEE
Confidence            367999999999999999999874 4568999988644321    35788999999999999999999999999999999


Q ss_pred             EeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCccccCCC
Q 014609           93 LEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDG  171 (421)
Q Consensus        93 ~E~~~gg~L~~~i~~-~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~  171 (421)
                      |||+++++|.+.+.. ...+++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||++....... ..
T Consensus        78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~-~~  156 (256)
T cd05114          78 TEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDE-YT  156 (256)
T ss_pred             EEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcCCCeEEECCCCCccccCCCc-ee
Confidence            999999999998875 3468999999999999999999999999999999999999999999999999987532211 11


Q ss_pred             ccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhhc--CCcCC--------------------CCCCCHHHHHHHH
Q 014609          172 LLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIFR--GDFKL--------------------PKWLSPGAQNLLR  229 (421)
Q Consensus       172 ~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~~--~~~~~--------------------p~~~s~~~~~li~  229 (421)
                      ......++..|+|||++....+ +.++|+||+|+++|.+.  |..++                    |...+..+.+++.
T Consensus       157 ~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li~  235 (256)
T cd05114         157 SSSGAKFPVKWSPPEVFNFSKY-SSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFRLYRPKLASMTVYEVMY  235 (256)
T ss_pred             ccCCCCCchhhCChhhcccCcc-chhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHH
Confidence            1112234567999999887776 48899999999999654  33332                    3335778999999


Q ss_pred             HhcCCCCCCCCCHHhhhc
Q 014609          230 KILEPNPVKRITIAGIKA  247 (421)
Q Consensus       230 ~~L~~dP~~R~t~~eil~  247 (421)
                      +||..+|.+||++.++++
T Consensus       236 ~c~~~~p~~Rps~~~l~~  253 (256)
T cd05114         236 SCWHEKPEGRPTFAELLR  253 (256)
T ss_pred             HHccCCcccCcCHHHHHH
Confidence            999999999999999875

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=100.00  E-value=2.1e-38  Score=305.17  Aligned_cols=235  Identities=28%  Similarity=0.485  Sum_probs=198.6

Q ss_pred             eEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEEec
Q 014609           16 YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLEY   95 (421)
Q Consensus        16 y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E~   95 (421)
                      |+....||+|+||.||+|.+..+|+.||+|.+....   ......+.+|+.+++.++||||+++++++...+..|+||||
T Consensus        22 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   98 (292)
T cd06657          22 LDNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRK---QQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEF   98 (292)
T ss_pred             hhhHHHcCCCCCeEEEEEEEcCCCeEEEEEEecccc---hhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEec
Confidence            334578999999999999999999999999885432   22356789999999999999999999999999999999999


Q ss_pred             cCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCccccCCCcccc
Q 014609           96 VTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHT  175 (421)
Q Consensus        96 ~~gg~L~~~i~~~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~  175 (421)
                      +++++|.+.+.. ..+++..++.++.|++.||+|||+.|++||||+|+||+++.++.++|+|||++......  ......
T Consensus        99 ~~~~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~--~~~~~~  175 (292)
T cd06657          99 LEGGALTDIVTH-TRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKE--VPRRKS  175 (292)
T ss_pred             CCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEcccccceecccc--cccccc
Confidence            999999887654 56899999999999999999999999999999999999999999999999988644321  112234


Q ss_pred             ccCCCCccChhhhcccCCCCCcchHHHHHHHHhhhc-CCcCC----------------C------CCCCHHHHHHHHHhc
Q 014609          176 TCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIFR-GDFKL----------------P------KWLSPGAQNLLRKIL  232 (421)
Q Consensus       176 ~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~~-~~~~~----------------p------~~~s~~~~~li~~~L  232 (421)
                      ..|++.|+|||.+.+..+ +.++|+||+|+++|.+. |..++                |      ..+++.+.+++.+||
T Consensus       176 ~~~~~~y~~pE~~~~~~~-~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l  254 (292)
T cd06657         176 LVGTPYWMAPELISRLPY-GPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPKLKNLHKVSPSLKGFLDRLL  254 (292)
T ss_pred             cccCccccCHHHhcCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCcccCCcccCCHHHHHHHHHHH
Confidence            568999999999877666 58899999999999543 33321                1      125788999999999


Q ss_pred             CCCCCCCCCHHhhhcCccccccccC
Q 014609          233 EPNPVKRITIAGIKADEWFEQDYTP  257 (421)
Q Consensus       233 ~~dP~~R~t~~eil~~~w~~~~~~~  257 (421)
                      +.+|.+||++.+++.||||.+...+
T Consensus       255 ~~~P~~R~~~~~ll~~~~~~~~~~~  279 (292)
T cd06657         255 VRDPAQRATAAELLKHPFLAKAGPP  279 (292)
T ss_pred             hCCcccCcCHHHHhcChHHhccCCC
Confidence            9999999999999999999986643

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=2.4e-38  Score=302.43  Aligned_cols=231  Identities=28%  Similarity=0.404  Sum_probs=191.9

Q ss_pred             ecceEEeceEeecCcEEEEEEEEC-----CCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCC
Q 014609           13 LGRYELGRTLGEGNFGKVKFAQDL-----DSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKS   87 (421)
Q Consensus        13 ~~~y~i~~~LG~G~~g~V~~a~~~-----~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~   87 (421)
                      ..+|++.++||+|+||.||+|...     .++..+|+|.+...   .......+.+|+++++.++||||+++++++....
T Consensus         4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   80 (280)
T cd05092           4 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA---SESARQDFQREAELLTVLQHQHIVRFYGVCTEGR   80 (280)
T ss_pred             hHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcC---CHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCC
Confidence            457889999999999999999742     35778999987643   2334578999999999999999999999999999


Q ss_pred             EEEEEEeccCCCChHHHHHhcC---------------CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCC
Q 014609           88 KIYMVLEYVTGGELFDKIASKG---------------RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGN  152 (421)
Q Consensus        88 ~~~lv~E~~~gg~L~~~i~~~~---------------~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~  152 (421)
                      ..|++|||+++++|.+++....               .+++..++.++.|++.||+|||++|++||||||+|||+++++.
T Consensus        81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~~~~~~  160 (280)
T cd05092          81 PLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQGLV  160 (280)
T ss_pred             ceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEEcCCCC
Confidence            9999999999999999987542               4788999999999999999999999999999999999999999


Q ss_pred             EEEEeccCCCCCccccCCCccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhhc--CCcCC--------------
Q 014609          153 IKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIFR--GDFKL--------------  216 (421)
Q Consensus       153 ~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~~--~~~~~--------------  216 (421)
                      +||+|||++................+++.|+|||.+.+..+ +.++|||||||++|.+.  |..++              
T Consensus       161 ~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~  239 (280)
T cd05092         161 VKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKF-TTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECITQ  239 (280)
T ss_pred             EEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCc-CchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHHHHc
Confidence            99999999874322111111223345678999999887777 58899999999999653  44332              


Q ss_pred             ------CCCCCHHHHHHHHHhcCCCCCCCCCHHhhhc
Q 014609          217 ------PKWLSPGAQNLLRKILEPNPVKRITIAGIKA  247 (421)
Q Consensus       217 ------p~~~s~~~~~li~~~L~~dP~~R~t~~eil~  247 (421)
                            |..+++.+.++|.+||+.||.+||++.++..
T Consensus       240 ~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~  276 (280)
T cd05092         240 GRELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHS  276 (280)
T ss_pred             CccCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence                  2347899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=2.2e-38  Score=304.20  Aligned_cols=230  Identities=30%  Similarity=0.386  Sum_probs=190.0

Q ss_pred             ceEEeceEeecCcEEEEEEEECC-----CCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEE
Q 014609           15 RYELGRTLGEGNFGKVKFAQDLD-----SGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKI   89 (421)
Q Consensus        15 ~y~i~~~LG~G~~g~V~~a~~~~-----~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~   89 (421)
                      +|++.+.||+|+||.||+|.+..     ....+|+|.+.....  ......+.+|+.+++.++||||+++++.+...+..
T Consensus         1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   78 (290)
T cd05045           1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENAS--SSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPL   78 (290)
T ss_pred             CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCC--HHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCc
Confidence            58899999999999999998753     335799998865432  22356789999999999999999999999999999


Q ss_pred             EEEEeccCCCChHHHHHhc------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCE
Q 014609           90 YMVLEYVTGGELFDKIASK------------------------GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENI  145 (421)
Q Consensus        90 ~lv~E~~~gg~L~~~i~~~------------------------~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NI  145 (421)
                      |+++||+.+++|.+++...                        ..+++..+..++.|++.||+|||+.||+||||||+||
T Consensus        79 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp~ni  158 (290)
T cd05045          79 LLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNV  158 (290)
T ss_pred             EEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhhhheE
Confidence            9999999999999987642                        2478889999999999999999999999999999999


Q ss_pred             EeccCCCEEEEeccCCCCCccccCCCccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhhc--CCcCC-------
Q 014609          146 LLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIFR--GDFKL-------  216 (421)
Q Consensus       146 Ll~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~~--~~~~~-------  216 (421)
                      |+++++.+||+|||++...............+++..|+|||++.+..+ +.++||||||+++|.+.  |..++       
T Consensus       159 ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~-~~~~Di~slG~~l~el~t~g~~p~~~~~~~~  237 (290)
T cd05045         159 LVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIY-TTQSDVWSFGVLLWEIVTLGGNPYPGIAPER  237 (290)
T ss_pred             EEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCc-chHhHHHHHHHHHHHHHhcCCCCCCCCCHHH
Confidence            999999999999999875432211111223456678999999877766 58899999999999654  43322       


Q ss_pred             -------------CCCCCHHHHHHHHHhcCCCCCCCCCHHhhhc
Q 014609          217 -------------PKWLSPGAQNLLRKILEPNPVKRITIAGIKA  247 (421)
Q Consensus       217 -------------p~~~s~~~~~li~~~L~~dP~~R~t~~eil~  247 (421)
                                   |..++.++.+++.+||+++|.+||++.++++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~  281 (290)
T cd05045         238 LFNLLKTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISK  281 (290)
T ss_pred             HHHHHhCCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence                         3346789999999999999999999999865

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=2.2e-38  Score=311.77  Aligned_cols=233  Identities=31%  Similarity=0.445  Sum_probs=192.7

Q ss_pred             ecceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeC------
Q 014609           13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASK------   86 (421)
Q Consensus        13 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~------   86 (421)
                      -++|.+.+.||+|+||.||+|.+..+|+.||+|.+.+... .......+.+|+.+++.++||||+++++++...      
T Consensus        14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~   92 (342)
T cd07879          14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQ-SEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEF   92 (342)
T ss_pred             ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccc-cccchhHHHHHHHHHHhcCCCCccchhheecccccCCCC
Confidence            3689999999999999999999999999999999875432 222345688999999999999999999998754      


Q ss_pred             CEEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCcc
Q 014609           87 SKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQH  166 (421)
Q Consensus        87 ~~~~lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~  166 (421)
                      ..+|+|+||+. .+|.+.+  ...+++..+..++.|++.||+|||+.||+||||||+||+++.++.+||+|||++.....
T Consensus        93 ~~~~lv~e~~~-~~l~~~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~~~~~kL~dfg~~~~~~~  169 (342)
T cd07879          93 QDFYLVMPYMQ-TDLQKIM--GHPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLARHADA  169 (342)
T ss_pred             ceEEEEecccc-cCHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCCCCcCCCC
Confidence            35799999995 4676554  24689999999999999999999999999999999999999999999999999874321


Q ss_pred             ccCCCccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhh-cCCcCCC----------------------------
Q 014609          167 FRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIF-RGDFKLP----------------------------  217 (421)
Q Consensus       167 ~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~-~~~~~~p----------------------------  217 (421)
                           ......+++.|+|||++.+....+.++|+||+||++|.+ .|..++.                            
T Consensus       170 -----~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (342)
T cd07879         170 -----EMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLED  244 (342)
T ss_pred             -----CCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhcc
Confidence                 223456789999999987644346889999999999954 3332221                            


Q ss_pred             ----------------------CCCCHHHHHHHHHhcCCCCCCCCCHHhhhcCcccccc
Q 014609          218 ----------------------KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD  254 (421)
Q Consensus       218 ----------------------~~~s~~~~~li~~~L~~dP~~R~t~~eil~~~w~~~~  254 (421)
                                            +..++.+.++|.+||+.||.+||++.+++.||||...
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~  303 (342)
T cd07879         245 KAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSF  303 (342)
T ss_pred             cchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhc
Confidence                                  1246778999999999999999999999999999864

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=1.3e-38  Score=300.48  Aligned_cols=227  Identities=25%  Similarity=0.411  Sum_probs=193.4

Q ss_pred             cceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEE
Q 014609           14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVL   93 (421)
Q Consensus        14 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~   93 (421)
                      .+|++++.||.|+||.||+|.+.. ++.+|+|++.....   .....+.+|+.+++.++||||+++++++......|+||
T Consensus         6 ~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   81 (261)
T cd05148           6 EEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDDL---LKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIIT   81 (261)
T ss_pred             HHHHHhhhhccCCCccEEEeEecC-CCcEEEEeccccch---hhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEE
Confidence            579999999999999999999877 89999999875432   22467889999999999999999999999999999999


Q ss_pred             eccCCCChHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCccccCCC
Q 014609           94 EYVTGGELFDKIAS--KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDG  171 (421)
Q Consensus        94 E~~~gg~L~~~i~~--~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~  171 (421)
                      ||+++++|.+++..  ...+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||++......  ..
T Consensus        82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~--~~  159 (261)
T cd05148          82 ELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDLVCKVADFGLARLIKED--VY  159 (261)
T ss_pred             eecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcCCceEEEccccchhhcCCc--cc
Confidence            99999999999875  346899999999999999999999999999999999999999999999999998754321  11


Q ss_pred             ccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhhc--CCcCC--------------------CCCCCHHHHHHHH
Q 014609          172 LLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIFR--GDFKL--------------------PKWLSPGAQNLLR  229 (421)
Q Consensus       172 ~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~~--~~~~~--------------------p~~~s~~~~~li~  229 (421)
                      ......++..|+|||++....+ +.++||||||+++|.+.  |..++                    |..+++.+.+++.
T Consensus       160 ~~~~~~~~~~~~~PE~~~~~~~-~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~  238 (261)
T cd05148         160 LSSDKKIPYKWTAPEAASHGTF-STKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAGYRMPCPAKCPQEIYKIML  238 (261)
T ss_pred             cccCCCCceEecCHHHHccCCC-CchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHhCCcCCCCCCCCHHHHHHHH
Confidence            1223345678999999887766 58899999999999654  34332                    3346789999999


Q ss_pred             HhcCCCCCCCCCHHhhhc
Q 014609          230 KILEPNPVKRITIAGIKA  247 (421)
Q Consensus       230 ~~L~~dP~~R~t~~eil~  247 (421)
                      +||+.||.+|||+.++++
T Consensus       239 ~~l~~~p~~Rpt~~~l~~  256 (261)
T cd05148         239 ECWAAEPEDRPSFKALRE  256 (261)
T ss_pred             HHcCCCchhCcCHHHHHH
Confidence            999999999999999865

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=3.4e-38  Score=297.48  Aligned_cols=229  Identities=25%  Similarity=0.422  Sum_probs=190.1

Q ss_pred             ecceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEE
Q 014609           13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMV   92 (421)
Q Consensus        13 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv   92 (421)
                      .++|++++.||+|+||+||+|.+. .+..+|+|.+.....    ..+.+.+|+.++++++||||+++++++......|++
T Consensus         3 ~~~~~~~~~lg~G~~~~vy~~~~~-~~~~~aik~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   77 (256)
T cd05113           3 PKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSM----SEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIV   77 (256)
T ss_pred             hHHeEEeeEecCcccceEEEEEec-CCCcEEEEEcCCCcc----cHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEE
Confidence            468999999999999999999864 355699998864432    135688999999999999999999999999999999


Q ss_pred             EeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCccccCCC
Q 014609           93 LEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDG  171 (421)
Q Consensus        93 ~E~~~gg~L~~~i~~~-~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~  171 (421)
                      |||+++++|.+++... ..+++..++.++.|++.||+|||+.|++|+||||+||+++.++.+||+|||++........ .
T Consensus        78 ~e~~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~-~  156 (256)
T cd05113          78 TEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEY-T  156 (256)
T ss_pred             EEcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCCEEECCCccceecCCCce-e
Confidence            9999999999998753 4689999999999999999999999999999999999999999999999999874322110 0


Q ss_pred             ccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhhc--CCcCC--------------------CCCCCHHHHHHHH
Q 014609          172 LLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIFR--GDFKL--------------------PKWLSPGAQNLLR  229 (421)
Q Consensus       172 ~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~~--~~~~~--------------------p~~~s~~~~~li~  229 (421)
                      ......++..|+|||++.+..+ +.++|||||||++|.+.  |..++                    |...+..+.+++.
T Consensus       157 ~~~~~~~~~~y~~pe~~~~~~~-~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  235 (256)
T cd05113         157 SSVGSKFPVRWSPPEVLLYSKF-SSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLRLYRPHLASEKVYAIMY  235 (256)
T ss_pred             ecCCCccChhhCCHHHHhcCcc-cchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHhcCCCCCCCCCCCHHHHHHHH
Confidence            1111234567999999987766 48899999999999654  44332                    2235788999999


Q ss_pred             HhcCCCCCCCCCHHhhhcC
Q 014609          230 KILEPNPVKRITIAGIKAD  248 (421)
Q Consensus       230 ~~L~~dP~~R~t~~eil~~  248 (421)
                      +||++||.+|||+.+++.+
T Consensus       236 ~cl~~~p~~Rp~~~~ll~~  254 (256)
T cd05113         236 SCWHEKAEERPTFQQLLSS  254 (256)
T ss_pred             HHcCCCcccCCCHHHHHHh
Confidence            9999999999999999864

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=3.4e-38  Score=299.19  Aligned_cols=232  Identities=23%  Similarity=0.381  Sum_probs=192.8

Q ss_pred             ecceEEeceEeecCcEEEEEEEECCCCc---eEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEE
Q 014609           13 LGRYELGRTLGEGNFGKVKFAQDLDSGL---PFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKI   89 (421)
Q Consensus        13 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~---~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~   89 (421)
                      ++.|++.+.||+|+||.||+|.+..+++   .||||.+....  .......+.+|+.+++.++||||+++++++......
T Consensus         3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~   80 (269)
T cd05065           3 VSCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGY--TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPV   80 (269)
T ss_pred             hHHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCC--CHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCce
Confidence            5679999999999999999999877665   69999986532  233457899999999999999999999999999999


Q ss_pred             EEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCcccc
Q 014609           90 YMVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFR  168 (421)
Q Consensus        90 ~lv~E~~~gg~L~~~i~~-~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~~  168 (421)
                      ++||||+++++|.+++.. .+.+++..++.++.|++.||+|||++|++||||||+||+++.++.+||+|||++.......
T Consensus        81 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~  160 (269)
T cd05065          81 MIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDT  160 (269)
T ss_pred             EEEEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEcCCCcEEECCCccccccccCc
Confidence            999999999999998875 3568999999999999999999999999999999999999999999999999987543321


Q ss_pred             CCCcccccc---CCCCccChhhhcccCCCCCcchHHHHHHHHhhh-c-CCcCC--------------------CCCCCHH
Q 014609          169 DDGLLHTTC---GSPNYVAPEVLANRGYDGATSDIWSCGVILYIF-R-GDFKL--------------------PKWLSPG  223 (421)
Q Consensus       169 ~~~~~~~~~---gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~-~-~~~~~--------------------p~~~s~~  223 (421)
                      .........   .+..|+|||++....+ +.++||||+||++|.+ . |..++                    |..++..
T Consensus       161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~-~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~  239 (269)
T cd05065         161 SDPTYTSSLGGKIPIRWTAPEAIAYRKF-TSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQDYRLPPPMDCPTA  239 (269)
T ss_pred             cccccccccCCCcceeecCHhHhccCcc-cchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCcCCCcccCCHH
Confidence            111111111   2357999999987777 4889999999999963 2 44332                    3346788


Q ss_pred             HHHHHHHhcCCCCCCCCCHHhhhc
Q 014609          224 AQNLLRKILEPNPVKRITIAGIKA  247 (421)
Q Consensus       224 ~~~li~~~L~~dP~~R~t~~eil~  247 (421)
                      +.+++.+||.++|++||++.+++.
T Consensus       240 ~~~li~~~l~~~p~~Rp~~~~i~~  263 (269)
T cd05065         240 LHQLMLDCWQKDRNARPKFGQIVS  263 (269)
T ss_pred             HHHHHHHHcCCChhhCcCHHHHHH
Confidence            999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=1.7e-38  Score=303.14  Aligned_cols=230  Identities=31%  Similarity=0.516  Sum_probs=193.2

Q ss_pred             eEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCC-CCCcceEEEEEEeCCEEEEEEe
Q 014609           16 YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK-HPNVVRLHEVLASKSKIYMVLE   94 (421)
Q Consensus        16 y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~lv~E   94 (421)
                      |++.+.||+|++|+||+|.+..+++.||||.+...... . ......+|+..+++++ ||||+++++++..++..|+|||
T Consensus         1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~-~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e   78 (283)
T cd07830           1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYS-W-EECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFE   78 (283)
T ss_pred             CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccc-h-hHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEe
Confidence            78899999999999999999889999999998654321 1 1234567999999999 9999999999999999999999


Q ss_pred             ccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCccccCCCc
Q 014609           95 YVTGGELFDKIASKG--RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGL  172 (421)
Q Consensus        95 ~~~gg~L~~~i~~~~--~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~  172 (421)
                      |+ +++|.+.+....  .+++..+..++.|++.+|.|||++|++|+||+|+||+++.++.++|+|||++.....   ...
T Consensus        79 ~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~---~~~  154 (283)
T cd07830          79 YM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRS---RPP  154 (283)
T ss_pred             cC-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCCEEEeecccceeccC---CCC
Confidence            99 789999887654  789999999999999999999999999999999999999999999999999875432   122


Q ss_pred             cccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhhc-CCcCCC----------------------------------
Q 014609          173 LHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIFR-GDFKLP----------------------------------  217 (421)
Q Consensus       173 ~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~~-~~~~~p----------------------------------  217 (421)
                      .....++..|+|||++.+....+.++|+||||+++|.+. |..+++                                  
T Consensus       155 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (283)
T cd07830         155 YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLG  234 (283)
T ss_pred             cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhcccc
Confidence            234568899999998865444468899999999999543 322221                                  


Q ss_pred             ---------------CCCCHHHHHHHHHhcCCCCCCCCCHHhhhcCccc
Q 014609          218 ---------------KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWF  251 (421)
Q Consensus       218 ---------------~~~s~~~~~li~~~L~~dP~~R~t~~eil~~~w~  251 (421)
                                     +..++.+.++|++||+.+|++|||+.|++.||||
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~~~~  283 (283)
T cd07830         235 FRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF  283 (283)
T ss_pred             ccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhCCCC
Confidence                           1135778999999999999999999999999997

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=8.3e-39  Score=301.88  Aligned_cols=220  Identities=23%  Similarity=0.284  Sum_probs=183.2

Q ss_pred             ceEeecCcEEEEEEEECCCCc-------eEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEE
Q 014609           20 RTLGEGNFGKVKFAQDLDSGL-------PFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMV   92 (421)
Q Consensus        20 ~~LG~G~~g~V~~a~~~~~~~-------~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv   92 (421)
                      +.||+|+||.||+|.+..++.       .+|+|.+....   ....+.+.+|+.+++.++||||+++++++..+...++|
T Consensus         1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv   77 (258)
T cd05078           1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSH---RNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMV   77 (258)
T ss_pred             CCCCcccchhheeeeecccccccccccchhhHHhhcchh---HHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEE
Confidence            469999999999998865544       48888875432   23356788999999999999999999999999999999


Q ss_pred             EeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCC--------EEEEeccCCCC
Q 014609           93 LEYVTGGELFDKIASKG-RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGN--------IKISDFGLSAL  163 (421)
Q Consensus        93 ~E~~~gg~L~~~i~~~~-~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~--------~kL~DFGla~~  163 (421)
                      |||+++|+|.+++...+ .+++..+..++.|++.||+|||+.||+||||||+||+++.++.        ++++|||++..
T Consensus        78 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~  157 (258)
T cd05078          78 QEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISIT  157 (258)
T ss_pred             EecCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEecccccccc
Confidence            99999999999987644 5899999999999999999999999999999999999987765        69999999864


Q ss_pred             CccccCCCccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhhcCCc--------------------CCCCCCCHH
Q 014609          164 PQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIFRGDF--------------------KLPKWLSPG  223 (421)
Q Consensus       164 ~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~~~~~--------------------~~p~~~s~~  223 (421)
                      ...      .....+++.|+|||++.+....+.++||||+||++|.+..+.                    .+|...+.+
T Consensus       158 ~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (258)
T cd05078         158 VLP------KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQFYEDRHQLPAPKWTE  231 (258)
T ss_pred             cCC------chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHHHHHccccCCCCCcHH
Confidence            321      234568899999999876544468899999999999553321                    223345678


Q ss_pred             HHHHHHHhcCCCCCCCCCHHhhhcC
Q 014609          224 AQNLLRKILEPNPVKRITIAGIKAD  248 (421)
Q Consensus       224 ~~~li~~~L~~dP~~R~t~~eil~~  248 (421)
                      +.+++.+||+.||++|||++++++.
T Consensus       232 ~~~li~~~l~~~p~~Rps~~~il~~  256 (258)
T cd05078         232 LANLINQCMDYEPDFRPSFRAIIRD  256 (258)
T ss_pred             HHHHHHHHhccChhhCCCHHHHHHh
Confidence            9999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=100.00  E-value=3.7e-38  Score=302.09  Aligned_cols=239  Identities=33%  Similarity=0.600  Sum_probs=199.4

Q ss_pred             ceEEeceEeecCcEEEEEEEEC---CCCceEEEEEeeccccc-chhHHHHHHHHHHHHhcC-CCCCcceEEEEEEeCCEE
Q 014609           15 RYELGRTLGEGNFGKVKFAQDL---DSGLPFAVKILEKNRII-HLKITDQIKREIATLKLL-KHPNVVRLHEVLASKSKI   89 (421)
Q Consensus        15 ~y~i~~~LG~G~~g~V~~a~~~---~~~~~vAvK~i~~~~~~-~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~   89 (421)
                      +|++.+.||+|+||.||+|.+.   .+++.||||++.+.... .......+.+|+.++.++ +||||+++++.+..+...
T Consensus         1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~   80 (288)
T cd05583           1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL   80 (288)
T ss_pred             CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence            4899999999999999999864   46789999998754332 122346788999999999 599999999999999999


Q ss_pred             EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCccccC
Q 014609           90 YMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD  169 (421)
Q Consensus        90 ~lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~  169 (421)
                      |+||||+++++|.+.+.....+++..++.++.|++.||+|||+.|++||||||.||+++.++.++|+|||++...... .
T Consensus        81 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~-~  159 (288)
T cd05583          81 HLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAE-E  159 (288)
T ss_pred             EEEEecCCCCcHHHHHhhcCCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEEECccccccccc-c
Confidence            999999999999999987778999999999999999999999999999999999999999999999999998754332 1


Q ss_pred             CCccccccCCCCccChhhhcccC-CCCCcchHHHHHHHHhhhc-CCcCC-----------------------CCCCCHHH
Q 014609          170 DGLLHTTCGSPNYVAPEVLANRG-YDGATSDIWSCGVILYIFR-GDFKL-----------------------PKWLSPGA  224 (421)
Q Consensus       170 ~~~~~~~~gt~~y~APEvl~~~~-~~~~~~DiwSlGvil~~~~-~~~~~-----------------------p~~~s~~~  224 (421)
                      .......+|++.|+|||.+.+.. ..+.++|+||+|+++|.+. |..++                       |..+++.+
T Consensus       160 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  239 (288)
T cd05583         160 EERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSKPPFPKTMSAEA  239 (288)
T ss_pred             ccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHccCCCCCcccCHHH
Confidence            11223456899999999986543 2357899999999999543 33332                       33468899


Q ss_pred             HHHHHHhcCCCCCCCCC---HHhhhcCcccccc
Q 014609          225 QNLLRKILEPNPVKRIT---IAGIKADEWFEQD  254 (421)
Q Consensus       225 ~~li~~~L~~dP~~R~t---~~eil~~~w~~~~  254 (421)
                      .++|.+||+.||++|||   +.++++||||+..
T Consensus       240 ~~li~~~l~~~p~~R~t~~~~~~~l~~~~~~~~  272 (288)
T cd05583         240 RDFIQKLLEKDPKKRLGANGADEIKNHPFFQGI  272 (288)
T ss_pred             HHHHHHHhcCCHhhccCcchHHHHhcCcccccC
Confidence            99999999999999998   5678999999763

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=4e-38  Score=298.07  Aligned_cols=228  Identities=25%  Similarity=0.390  Sum_probs=188.5

Q ss_pred             eecceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEE
Q 014609           12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYM   91 (421)
Q Consensus        12 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l   91 (421)
                      ..++|++.+.||+|+||.||+|.+..+ ..||+|++.....    ..+.+.+|+.++++++||||+++++++.. ...|+
T Consensus         4 ~~~~~~~~~~lg~g~~~~v~~~~~~~~-~~valK~~~~~~~----~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~l   77 (262)
T cd05071           4 PRESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTM----SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYI   77 (262)
T ss_pred             ChHHeeEeeecCCCCCCcEEEEEecCC-ceEEEEecccCcc----CHHHHHHHHHHHHhCCCCCcceEEEEECC-CCcEE
Confidence            347899999999999999999988655 4599999875332    13578999999999999999999998754 56899


Q ss_pred             EEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCccccC
Q 014609           92 VLEYVTGGELFDKIASK--GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD  169 (421)
Q Consensus        92 v~E~~~gg~L~~~i~~~--~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~  169 (421)
                      ||||+++++|.+++...  ..+++..+..++.|++.||+|||+.|++||||||+||+++.++.++|+|||.+....... 
T Consensus        78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~-  156 (262)
T cd05071          78 VTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE-  156 (262)
T ss_pred             EEEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcCCCcEEeccCCceeeccccc-
Confidence            99999999999998753  357899999999999999999999999999999999999999999999999997543211 


Q ss_pred             CCccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhhc--CCcCC--------------------CCCCCHHHHHH
Q 014609          170 DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIFR--GDFKL--------------------PKWLSPGAQNL  227 (421)
Q Consensus       170 ~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~~--~~~~~--------------------p~~~s~~~~~l  227 (421)
                      ........++..|+|||++.+..+ +.++|+||+||++|.+.  |..++                    +..++..+.++
T Consensus       157 ~~~~~~~~~~~~y~~PE~~~~~~~-~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  235 (262)
T cd05071         157 YTARQGAKFPIKWTAPEAALYGRF-TIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDL  235 (262)
T ss_pred             cccccCCcccceecCHhHhccCCC-CchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhcCCCCCCccccCHHHHHH
Confidence            111223345678999999877776 58999999999999654  33332                    23367889999


Q ss_pred             HHHhcCCCCCCCCCHHhhhc
Q 014609          228 LRKILEPNPVKRITIAGIKA  247 (421)
Q Consensus       228 i~~~L~~dP~~R~t~~eil~  247 (421)
                      +.+||++||++||++.++++
T Consensus       236 i~~~l~~~p~~Rp~~~~~~~  255 (262)
T cd05071         236 MCQCWRKEPEERPTFEYLQA  255 (262)
T ss_pred             HHHHccCCcccCCCHHHHHH
Confidence            99999999999999998764

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=4.6e-38  Score=300.52  Aligned_cols=232  Identities=22%  Similarity=0.307  Sum_probs=189.2

Q ss_pred             eecceEEeceEeecCcEEEEEEEECCCCce----EEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCC
Q 014609           12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLP----FAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKS   87 (421)
Q Consensus        12 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~----vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~   87 (421)
                      ..++|++++.||+|+||+||+|.+..+++.    +++|.+....  .......+..|+.++++++||||+++++++.. .
T Consensus         5 ~~~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~   81 (279)
T cd05111           5 KETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRS--GRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-A   81 (279)
T ss_pred             CHhhceeccccCccCCcceEEEEEcCCCCceeeEEEEeeccccc--chHHHHHHHHHHHHHhcCCCCCcceEEEEECC-C
Confidence            347899999999999999999998777764    6777764321  12234678888999999999999999998754 4


Q ss_pred             EEEEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCcc
Q 014609           88 KIYMVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQH  166 (421)
Q Consensus        88 ~~~lv~E~~~gg~L~~~i~~-~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~  166 (421)
                      ..++++||+++|+|.+++.. .+.+++..+..++.|++.||+|||++|++||||||+|||++.++.+||+|||++.....
T Consensus        82 ~~~~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~  161 (279)
T cd05111          82 SLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVADLLYP  161 (279)
T ss_pred             ccEEEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEEcCCccceeccC
Confidence            57889999999999999975 45689999999999999999999999999999999999999999999999999975432


Q ss_pred             ccCCCccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhhc--CCcCC--------------------CCCCCHHH
Q 014609          167 FRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIFR--GDFKL--------------------PKWLSPGA  224 (421)
Q Consensus       167 ~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~~--~~~~~--------------------p~~~s~~~  224 (421)
                      ...........++..|+|||++.+..+ +.++|||||||++|.+.  |..++                    |...+..+
T Consensus       162 ~~~~~~~~~~~~~~~y~~pE~~~~~~~-~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (279)
T cd05111         162 DDKKYFYSEHKTPIKWMALESILFGRY-THQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLEKGERLAQPQICTIDV  240 (279)
T ss_pred             CCcccccCCCCCcccccCHHHhccCCc-CchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCcCCCCCCCCHHH
Confidence            211122233456778999999887766 58999999999999653  44333                    22356788


Q ss_pred             HHHHHHhcCCCCCCCCCHHhhhc
Q 014609          225 QNLLRKILEPNPVKRITIAGIKA  247 (421)
Q Consensus       225 ~~li~~~L~~dP~~R~t~~eil~  247 (421)
                      .+++.+|+..||.+|||+.++++
T Consensus       241 ~~li~~c~~~~p~~Rps~~el~~  263 (279)
T cd05111         241 YMVMVKCWMIDENVRPTFKELAN  263 (279)
T ss_pred             HHHHHHHcCCCcccCcCHHHHHH
Confidence            89999999999999999999866

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=4.5e-38  Score=297.07  Aligned_cols=228  Identities=24%  Similarity=0.354  Sum_probs=190.0

Q ss_pred             ecceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEE
Q 014609           13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMV   92 (421)
Q Consensus        13 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv   92 (421)
                      .++|++.+.||+|++|.||+|.+. +++.||+|.++....    ....+.+|+.++++++||||+++++++...+..|++
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   79 (261)
T cd05068           5 RTSIQLLRKLGAGQFGEVWEGLWN-NTTPVAVKTLKPGTM----DPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIV   79 (261)
T ss_pred             hhheeeEEEecccCCccEEEEEec-CCeEEEEEeeCCCcc----cHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeee
Confidence            367999999999999999999874 557899999865432    145688999999999999999999999999999999


Q ss_pred             EeccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCccccCC
Q 014609           93 LEYVTGGELFDKIASKG--RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD  170 (421)
Q Consensus        93 ~E~~~gg~L~~~i~~~~--~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~  170 (421)
                      |||+++++|.+++....  .+++..+..++.|++.||.|||+.||+||||||+||+++.++.++|+|||++........ 
T Consensus        80 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~-  158 (261)
T cd05068          80 TELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIY-  158 (261)
T ss_pred             eecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcCCCCEEECCcceEEEccCCcc-
Confidence            99999999999987643  689999999999999999999999999999999999999999999999999875432110 


Q ss_pred             CccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhhc--CCcC--------------------CCCCCCHHHHHHH
Q 014609          171 GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIFR--GDFK--------------------LPKWLSPGAQNLL  228 (421)
Q Consensus       171 ~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~~--~~~~--------------------~p~~~s~~~~~li  228 (421)
                      ........+..|+|||++.+..+ +.++|+||||+++|.+.  |..+                    .+...+..+.+++
T Consensus       159 ~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  237 (261)
T cd05068         159 EAREGAKFPIKWTAPEAALYNRF-SIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQGYRMPCPPGCPKELYDIM  237 (261)
T ss_pred             cccCCCcCceeccCccccccCCC-CchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHHHHHH
Confidence            00111122357999999877766 58899999999999553  3332                    2334678999999


Q ss_pred             HHhcCCCCCCCCCHHhhhc
Q 014609          229 RKILEPNPVKRITIAGIKA  247 (421)
Q Consensus       229 ~~~L~~dP~~R~t~~eil~  247 (421)
                      .+||+.+|.+||++.++.+
T Consensus       238 ~~~l~~~P~~Rp~~~~l~~  256 (261)
T cd05068         238 LDCWKEDPDDRPTFETLQW  256 (261)
T ss_pred             HHHhhcCcccCCCHHHHHH
Confidence            9999999999999999864

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=100.00  E-value=6e-38  Score=333.54  Aligned_cols=150  Identities=31%  Similarity=0.592  Sum_probs=141.1

Q ss_pred             ecceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEE
Q 014609           13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMV   92 (421)
Q Consensus        13 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv   92 (421)
                      +++|++++.||+|+||+||+|.+..+++.||||++.............+.+|+.+++.++||||+++++++.....+|+|
T Consensus         3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lV   82 (669)
T cd05610           3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLV   82 (669)
T ss_pred             cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEE
Confidence            68999999999999999999999999999999999876555555567899999999999999999999999999999999


Q ss_pred             EeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCC
Q 014609           93 LEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSA  162 (421)
Q Consensus        93 ~E~~~gg~L~~~i~~~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~  162 (421)
                      |||+.|++|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.
T Consensus        83 mEy~~g~~L~~li~~~~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~~~g~vkL~DFGls~  152 (669)
T cd05610          83 MEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISNEGHIKLTDFGLSK  152 (669)
T ss_pred             EeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence            9999999999999887889999999999999999999999999999999999999999999999999975

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=5.1e-38  Score=300.36  Aligned_cols=230  Identities=30%  Similarity=0.405  Sum_probs=187.9

Q ss_pred             cce-EEeceEeecCcEEEEEEE----ECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeC--
Q 014609           14 GRY-ELGRTLGEGNFGKVKFAQ----DLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASK--   86 (421)
Q Consensus        14 ~~y-~i~~~LG~G~~g~V~~a~----~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~--   86 (421)
                      +|| ++.+.||+|+||+||++.    ...+++.||+|.++....  ......+.+|+.++++++||||+++++++...  
T Consensus         3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~   80 (283)
T cd05080           3 KRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECG--QQNTSGWKKEINILKTLYHENIVKYKGCCSEQGG   80 (283)
T ss_pred             hhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccC--hHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCC
Confidence            566 999999999999998864    335788999999875421  22346788999999999999999999987653  


Q ss_pred             CEEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCcc
Q 014609           87 SKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQH  166 (421)
Q Consensus        87 ~~~~lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~  166 (421)
                      ...|++|||+++++|.+++.. ..+++..++.++.|++.||+|||++||+||||||+|||++.++.++|+|||++.....
T Consensus        81 ~~~~lv~e~~~~~~l~~~~~~-~~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~  159 (283)
T cd05080          81 KGLQLIMEYVPLGSLRDYLPK-HKLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPE  159 (283)
T ss_pred             ceEEEEecCCCCCCHHHHHHH-cCCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEcCCCcEEEeecccccccCC
Confidence            468999999999999998876 4699999999999999999999999999999999999999999999999999885433


Q ss_pred             ccCC-CccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhhcC-CcC-----------------------------
Q 014609          167 FRDD-GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIFRG-DFK-----------------------------  215 (421)
Q Consensus       167 ~~~~-~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~~~-~~~-----------------------------  215 (421)
                      .... .......++..|+|||++.+..+ +.++||||||+++|.+.. ..+                             
T Consensus       160 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~-~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (283)
T cd05080         160 GHEYYRVREDGDSPVFWYAVECLKENKF-SYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLE  238 (283)
T ss_pred             cchhhccCCCCCCCceeeCHhHhcccCC-CcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhhhhh
Confidence            1111 11122345667999999877666 589999999999995532 211                             


Q ss_pred             ------CCCCCCHHHHHHHHHhcCCCCCCCCCHHhhhc
Q 014609          216 ------LPKWLSPGAQNLLRKILEPNPVKRITIAGIKA  247 (421)
Q Consensus       216 ------~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~  247 (421)
                            .|..++..+.+++.+||+++|++|||+.++++
T Consensus       239 ~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~  276 (283)
T cd05080         239 RGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIP  276 (283)
T ss_pred             cCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence                  12335789999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=100.00  E-value=5.2e-38  Score=294.75  Aligned_cols=231  Identities=31%  Similarity=0.514  Sum_probs=200.1

Q ss_pred             ceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEEe
Q 014609           15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLE   94 (421)
Q Consensus        15 ~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E   94 (421)
                      +|++.+.||+|+||.||++.+..+++.+|+|.+....... .....+.+|+.+++.++||||+++++++.+....|+|+|
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e   79 (256)
T cd08530           1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQ-KEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVME   79 (256)
T ss_pred             CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccH-HHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEeh
Confidence            5899999999999999999999999999999987654332 335677889999999999999999999999999999999


Q ss_pred             ccCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCccccCC
Q 014609           95 YVTGGELFDKIAS----KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD  170 (421)
Q Consensus        95 ~~~gg~L~~~i~~----~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~  170 (421)
                      |+++++|.+++..    ...+++..+..++.|++.||+|||+.|++||||+|+||+++.++.+||+|||++......   
T Consensus        80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~---  156 (256)
T cd08530          80 YAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVANDLVKIGDLGISKVLKKN---  156 (256)
T ss_pred             hcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEecCCcEEEeeccchhhhccC---
Confidence            9999999988865    356899999999999999999999999999999999999999999999999999765432   


Q ss_pred             CccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhhc-CCcC--------------------CCCCCCHHHHHHHH
Q 014609          171 GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIFR-GDFK--------------------LPKWLSPGAQNLLR  229 (421)
Q Consensus       171 ~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~~-~~~~--------------------~p~~~s~~~~~li~  229 (421)
                       ......+++.|+|||.+.+..+ +.++|+||+|+++|.+. |..+                    .+..++.++.+++.
T Consensus       157 -~~~~~~~~~~~~~Pe~~~~~~~-~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  234 (256)
T cd08530         157 -MAKTQIGTPHYMAPEVWKGRPY-SYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGKYPPIPPIYSQDLQNFIR  234 (256)
T ss_pred             -CcccccCCccccCHHHHCCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCchhhCHHHHHHHH
Confidence             3334568899999999987776 47899999999999543 3322                    22336788999999


Q ss_pred             HhcCCCCCCCCCHHhhhcCccc
Q 014609          230 KILEPNPVKRITIAGIKADEWF  251 (421)
Q Consensus       230 ~~L~~dP~~R~t~~eil~~~w~  251 (421)
                      +||+.+|++|||+.++++||.+
T Consensus       235 ~~l~~~p~~Rp~~~~~l~~p~~  256 (256)
T cd08530         235 SMLQVKPKLRPNCDKILASPAV  256 (256)
T ss_pred             HHcCCCcccCCCHHHHhcCCCC
Confidence            9999999999999999999974

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=5.2e-38  Score=295.63  Aligned_cols=224  Identities=29%  Similarity=0.504  Sum_probs=192.2

Q ss_pred             eecceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEE
Q 014609           12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYM   91 (421)
Q Consensus        12 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l   91 (421)
                      ..++|++.+.||.|+||.||+|.+  .|+.||+|.+.....    ...++.+|+.+++.++||||+++++++.+.+..|+
T Consensus         4 ~~~~~~~~~~ig~g~~g~v~~~~~--~~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   77 (256)
T cd05039           4 NSKELKLGATIGKGEFGDVMLGDY--RGQKVAVKCLKDDST----AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYI   77 (256)
T ss_pred             ChhhccceeeeecCCCceEEEEEe--cCcEEEEEEeccchh----HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEE
Confidence            356899999999999999999986  488999999875432    35678999999999999999999999999999999


Q ss_pred             EEeccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCccccC
Q 014609           92 VLEYVTGGELFDKIASKG--RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD  169 (421)
Q Consensus        92 v~E~~~gg~L~~~i~~~~--~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~  169 (421)
                      ||||+++++|.+++....  .+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++......  
T Consensus        78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~--  155 (256)
T cd05039          78 VTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQG--  155 (256)
T ss_pred             EEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeCCCCEEEcccccccccccc--
Confidence            999999999999997655  6899999999999999999999999999999999999999999999999999754221  


Q ss_pred             CCccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhhc--CCcC--------------------CCCCCCHHHHHH
Q 014609          170 DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIFR--GDFK--------------------LPKWLSPGAQNL  227 (421)
Q Consensus       170 ~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~~--~~~~--------------------~p~~~s~~~~~l  227 (421)
                         .....++..|+|||++....+ +.++|+||||+++|.+.  |..+                    .|..+++.+.++
T Consensus       156 ---~~~~~~~~~~~ape~~~~~~~-~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  231 (256)
T cd05039         156 ---QDSGKLPVKWTAPEALREKKF-STKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKGYRMEAPEGCPPEVYKV  231 (256)
T ss_pred             ---cccCCCcccccCchhhcCCcC-CcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCccCCCHHHHHH
Confidence               112334567999999877666 58899999999999553  4333                    233468899999


Q ss_pred             HHHhcCCCCCCCCCHHhhhc
Q 014609          228 LRKILEPNPVKRITIAGIKA  247 (421)
Q Consensus       228 i~~~L~~dP~~R~t~~eil~  247 (421)
                      |.+||..+|++|||+.++++
T Consensus       232 i~~~l~~~p~~Rp~~~~l~~  251 (256)
T cd05039         232 MKDCWELDPAKRPTFKQLRE  251 (256)
T ss_pred             HHHHhccChhhCcCHHHHHH
Confidence            99999999999999999875

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=5.5e-38  Score=295.94  Aligned_cols=225  Identities=27%  Similarity=0.369  Sum_probs=186.4

Q ss_pred             ceEeecCcEEEEEEEE--CCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEEeccC
Q 014609           20 RTLGEGNFGKVKFAQD--LDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVT   97 (421)
Q Consensus        20 ~~LG~G~~g~V~~a~~--~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~~   97 (421)
                      +.||+|+||.||+|.+  ..++..+|+|+++... ......+.+.+|+.+++.++||||+++++++.. ...++||||++
T Consensus         1 ~~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~e~~~   78 (257)
T cd05116           1 GELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDN-NDPALKDELLREANVMQQLDNPYIVRMIGICEA-ESWMLVMELAE   78 (257)
T ss_pred             CcCCCcCCcceEEeEEecCCCceEEEEEEccCCC-CcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCcEEEEecCC
Confidence            3689999999999964  4578899999986443 233446789999999999999999999998864 46789999999


Q ss_pred             CCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCccccCC-Cccccc
Q 014609           98 GGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD-GLLHTT  176 (421)
Q Consensus        98 gg~L~~~i~~~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~-~~~~~~  176 (421)
                      +++|.+++.....+++..+..++.|++.||+|||++||+||||||.||+++.++.+||+|||++......... ......
T Consensus        79 ~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~  158 (257)
T cd05116          79 LGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHG  158 (257)
T ss_pred             CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeecCCC
Confidence            9999999988788999999999999999999999999999999999999999999999999999754332111 011222


Q ss_pred             cCCCCccChhhhcccCCCCCcchHHHHHHHHhhhc--CCcC--------------------CCCCCCHHHHHHHHHhcCC
Q 014609          177 CGSPNYVAPEVLANRGYDGATSDIWSCGVILYIFR--GDFK--------------------LPKWLSPGAQNLLRKILEP  234 (421)
Q Consensus       177 ~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~~--~~~~--------------------~p~~~s~~~~~li~~~L~~  234 (421)
                      .+++.|+|||.+....+ +.++|+|||||++|.+.  |..+                    .|..+++++.++|.+||++
T Consensus       159 ~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~~~~~  237 (257)
T cd05116         159 KWPVKWYAPECMNYYKF-SSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGERMECPQRCPPEMYDLMKLCWTY  237 (257)
T ss_pred             CCCccccCHhHhccCCc-CchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHhcc
Confidence            34678999999876665 58899999999999653  4433                    3445789999999999999


Q ss_pred             CCCCCCCHHhhhc
Q 014609          235 NPVKRITIAGIKA  247 (421)
Q Consensus       235 dP~~R~t~~eil~  247 (421)
                      ||++||++++|..
T Consensus       238 ~p~~Rp~~~~i~~  250 (257)
T cd05116         238 GVDERPGFAVVEL  250 (257)
T ss_pred             CchhCcCHHHHHH
Confidence            9999999998854

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=100.00  E-value=1.9e-38  Score=299.23  Aligned_cols=233  Identities=33%  Similarity=0.543  Sum_probs=194.5

Q ss_pred             ceEEeceEeecCcEEEEEEEECCCCceEEEEEeeccccc--chhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEE
Q 014609           15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRII--HLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMV   92 (421)
Q Consensus        15 ~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~--~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv   92 (421)
                      ||.+.+.||+|+||.||++++..++..+++|+++.....  ......++.+|+.+++.++||||+++++++.+....++|
T Consensus         1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   80 (260)
T cd08222           1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII   80 (260)
T ss_pred             CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence            699999999999999999999888888888877643221  112245677899999999999999999999999999999


Q ss_pred             EeccCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCcccc
Q 014609           93 LEYVTGGELFDKIAS----KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFR  168 (421)
Q Consensus        93 ~E~~~gg~L~~~i~~----~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~~  168 (421)
                      +||+++++|.+.+..    ...+++..++.++.|++.||.|||+.|++|+||+|+||+++. +.++|+|||++.....  
T Consensus        81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~--  157 (260)
T cd08222          81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMG--  157 (260)
T ss_pred             EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEeec-CCEeecccCceeecCC--
Confidence            999999999888753    356899999999999999999999999999999999999975 6799999999875432  


Q ss_pred             CCCccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhhc-CCcC--------------------CCCCCCHHHHHH
Q 014609          169 DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIFR-GDFK--------------------LPKWLSPGAQNL  227 (421)
Q Consensus       169 ~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~~-~~~~--------------------~p~~~s~~~~~l  227 (421)
                      .........|++.|+|||.+.+..++ .++|+||+|+++|.+. +..+                    .|..++.++.++
T Consensus       158 ~~~~~~~~~~~~~~~~pe~~~~~~~~-~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  236 (260)
T cd08222         158 SCDLATTFTGTPYYMSPEALKHQGYD-SKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEGPTPSLPETYSRQLNSI  236 (260)
T ss_pred             CcccccCCCCCcCccCHHHHccCCCC-chhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHcCCCCCCcchhcHHHHHH
Confidence            22233345688999999998777664 7899999999999432 2221                    233467899999


Q ss_pred             HHHhcCCCCCCCCCHHhhhcCccc
Q 014609          228 LRKILEPNPVKRITIAGIKADEWF  251 (421)
Q Consensus       228 i~~~L~~dP~~R~t~~eil~~~w~  251 (421)
                      |.+||..+|++||++.++++||||
T Consensus       237 i~~~l~~~p~~Rp~~~~il~~~~~  260 (260)
T cd08222         237 MQSMLNKDPSLRPSAAEILRNPFI  260 (260)
T ss_pred             HHHHhcCChhhCcCHHHHhhCCCC
Confidence            999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=5.8e-38  Score=297.46  Aligned_cols=232  Identities=24%  Similarity=0.404  Sum_probs=192.0

Q ss_pred             ecceEEeceEeecCcEEEEEEEECCCCc---eEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEE
Q 014609           13 LGRYELGRTLGEGNFGKVKFAQDLDSGL---PFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKI   89 (421)
Q Consensus        13 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~---~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~   89 (421)
                      .++|++.+.||+|+||.||+|.+..++.   .+|+|.++...  .......+.+|+.++++++||||+++++++.+.+..
T Consensus         3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   80 (267)
T cd05066           3 ASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGY--TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPV   80 (267)
T ss_pred             HHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCC--CHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCcc
Confidence            4689999999999999999998865443   79999886532  223356889999999999999999999999999999


Q ss_pred             EEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCcccc
Q 014609           90 YMVLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFR  168 (421)
Q Consensus        90 ~lv~E~~~gg~L~~~i~~~-~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~~  168 (421)
                      |+||||++|++|.+++... ..+++..+..++.|++.||+|||++|++||||||+|||++.++.++|+|||++.......
T Consensus        81 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~~  160 (267)
T cd05066          81 MIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP  160 (267)
T ss_pred             EEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEECCCCeEEeCCCCccccccccc
Confidence            9999999999999998764 468999999999999999999999999999999999999999999999999998654321


Q ss_pred             CCC-ccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhh-hc-CCcCC--------------------CCCCCHHHH
Q 014609          169 DDG-LLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYI-FR-GDFKL--------------------PKWLSPGAQ  225 (421)
Q Consensus       169 ~~~-~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~-~~-~~~~~--------------------p~~~s~~~~  225 (421)
                      ... ......++..|+|||.+.+..+ +.++|+|||||++|. +. |..++                    +..+++.+.
T Consensus       161 ~~~~~~~~~~~~~~y~~pe~~~~~~~-~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (267)
T cd05066         161 EAAYTTRGGKIPIRWTAPEAIAYRKF-TSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEGYRLPAPMDCPAALH  239 (267)
T ss_pred             ceeeecCCCccceeecCHhHhccCcc-CchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHhCCCcCCCCCCCCHHHH
Confidence            111 0111223567999999987766 589999999999996 32 44332                    223578999


Q ss_pred             HHHHHhcCCCCCCCCCHHhhhc
Q 014609          226 NLLRKILEPNPVKRITIAGIKA  247 (421)
Q Consensus       226 ~li~~~L~~dP~~R~t~~eil~  247 (421)
                      +++.+||+++|.+||++.++++
T Consensus       240 ~li~~~l~~~p~~Rp~~~~i~~  261 (267)
T cd05066         240 QLMLDCWQKDRNERPKFEQIVS  261 (267)
T ss_pred             HHHHHHcccCchhCCCHHHHHH
Confidence            9999999999999999999864

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=100.00  E-value=5.1e-38  Score=298.81  Aligned_cols=232  Identities=26%  Similarity=0.389  Sum_probs=193.5

Q ss_pred             ecceEEeceEeecCcEEEEEEEECC-----CCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCC
Q 014609           13 LGRYELGRTLGEGNFGKVKFAQDLD-----SGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKS   87 (421)
Q Consensus        13 ~~~y~i~~~LG~G~~g~V~~a~~~~-----~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~   87 (421)
                      .++|++++.||+|+||.||+|+...     +.+.||+|.+....  .......+.+|+.++++++||||+++++++....
T Consensus         4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   81 (275)
T cd05046           4 RSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTK--DENLQSEFRRELDMFRKLSHKNVVRLLGLCREAE   81 (275)
T ss_pred             hHhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCcc--chHHHHHHHHHHHHHHhcCCcceeeeEEEECCCC
Confidence            3689999999999999999998653     45689999886432  2223567999999999999999999999999999


Q ss_pred             EEEEEEeccCCCChHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEec
Q 014609           88 KIYMVLEYVTGGELFDKIASKG---------RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDF  158 (421)
Q Consensus        88 ~~~lv~E~~~gg~L~~~i~~~~---------~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DF  158 (421)
                      ..|+||||+++++|.+++....         .+++..+..++.|++.||+|||++||+||||||+||+++.++.++|+||
T Consensus        82 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~~~  161 (275)
T cd05046          82 PHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQREVKVSLL  161 (275)
T ss_pred             cceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEeCCCcEEEccc
Confidence            9999999999999999997655         6899999999999999999999999999999999999999999999999


Q ss_pred             cCCCCCccccCCCccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhhc--CCcCC--------------------
Q 014609          159 GLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIFR--GDFKL--------------------  216 (421)
Q Consensus       159 Gla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~~--~~~~~--------------------  216 (421)
                      |++...... .........+++.|+|||.+.+..+ +.++||||||+++|.+.  |..++                    
T Consensus       162 ~~~~~~~~~-~~~~~~~~~~~~~y~~PE~~~~~~~-~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~~~~~~~~~  239 (275)
T cd05046         162 SLSKDVYNS-EYYKLRNALIPLRWLAPEAVQEDDF-STKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGKLELP  239 (275)
T ss_pred             ccccccCcc-cccccCCceeEEeecChhhhccCCC-CchhhHHHHHHHHHHHHhCCCCCccccchHHHHHHHHcCCcCCC
Confidence            998643221 1111223355778999999877666 58899999999999543  33222                    


Q ss_pred             -CCCCCHHHHHHHHHhcCCCCCCCCCHHhhhcC
Q 014609          217 -PKWLSPGAQNLLRKILEPNPVKRITIAGIKAD  248 (421)
Q Consensus       217 -p~~~s~~~~~li~~~L~~dP~~R~t~~eil~~  248 (421)
                       +..++..+.+++.+||+.+|.+|||+.+++..
T Consensus       240 ~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~  272 (275)
T cd05046         240 VPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSA  272 (275)
T ss_pred             CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHH
Confidence             33467899999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=1.5e-38  Score=300.84  Aligned_cols=228  Identities=33%  Similarity=0.508  Sum_probs=184.5

Q ss_pred             EEeceEeecCcEEEEEEEEC----CCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEE
Q 014609           17 ELGRTLGEGNFGKVKFAQDL----DSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMV   92 (421)
Q Consensus        17 ~i~~~LG~G~~g~V~~a~~~----~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv   92 (421)
                      .+.+.||.|+||.||+|...    ..+..|+||.+...  ......+.+.+|++.+++++||||+++++++...+..++|
T Consensus         2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~--~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv   79 (259)
T PF07714_consen    2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPS--SSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLV   79 (259)
T ss_dssp             EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTT--SSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEE
T ss_pred             EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccc--cccccceeeeeccccccccccccccccccccccccccccc
Confidence            56789999999999999887    45778999999542  2333468899999999999999999999999988889999


Q ss_pred             EeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCccccCC
Q 014609           93 LEYVTGGELFDKIASK--GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD  170 (421)
Q Consensus        93 ~E~~~gg~L~~~i~~~--~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~  170 (421)
                      +||+++|+|.+++...  ..+++.....++.|++.||+|||+++++|+||+|.||+++.++.+||+|||++.........
T Consensus        80 ~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~  159 (259)
T PF07714_consen   80 MEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKY  159 (259)
T ss_dssp             EE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSE
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence            9999999999999886  67999999999999999999999999999999999999999999999999998754221111


Q ss_pred             CccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhhcC--CcC--------------------CCCCCCHHHHHHH
Q 014609          171 GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIFRG--DFK--------------------LPKWLSPGAQNLL  228 (421)
Q Consensus       171 ~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~~~--~~~--------------------~p~~~s~~~~~li  228 (421)
                      .......+...|+|||.+....+ +.++||||||+++|++..  ..+                    .|..++..+.++|
T Consensus       160 ~~~~~~~~~~~~~aPE~~~~~~~-~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  238 (259)
T PF07714_consen  160 KNDSSQQLPLRYLAPEVLKDGEY-TKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKLKQGQRLPIPDNCPKDIYSLI  238 (259)
T ss_dssp             EESTTSESGGGGS-HHHHHHSEE-SHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHHHTTEETTSBTTSBHHHHHHH
T ss_pred             ccccccccccccccccccccccc-cccccccccccccccccccccccccccccccccccccccccceeccchhHHHHHHH
Confidence            12233346678999999987766 589999999999995432  232                    2445789999999


Q ss_pred             HHhcCCCCCCCCCHHhhhc
Q 014609          229 RKILEPNPVKRITIAGIKA  247 (421)
Q Consensus       229 ~~~L~~dP~~R~t~~eil~  247 (421)
                      .+||..||.+|||+.++++
T Consensus       239 ~~C~~~~p~~RPs~~~i~~  257 (259)
T PF07714_consen  239 QQCWSHDPEKRPSFQEILQ  257 (259)
T ss_dssp             HHHT-SSGGGS--HHHHHH
T ss_pred             HHHcCCChhhCcCHHHHHh
Confidence            9999999999999999874

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.1e-37  Score=293.81  Aligned_cols=224  Identities=27%  Similarity=0.388  Sum_probs=185.9

Q ss_pred             ceEeecCcEEEEEEEECCCC---ceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEEecc
Q 014609           20 RTLGEGNFGKVKFAQDLDSG---LPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLEYV   96 (421)
Q Consensus        20 ~~LG~G~~g~V~~a~~~~~~---~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~   96 (421)
                      +.||+|+||.||+|....++   ..+|+|.+......  ...+.+.+|+.+++.++||||+++++++.. ...++||||+
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~   77 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIA--AGKKEFLREASVMAQLDHPCIVRLIGVCKG-EPLMLVMELA   77 (257)
T ss_pred             CccCccCceeEEEeEeeccCCCcceEEEEecccccch--HHHHHHHHHHHHHHhcCCCCeeeEEEEEcC-CceEEEEEeC
Confidence            47999999999999876544   78999998765432  335678999999999999999999998764 4689999999


Q ss_pred             CCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCccccCCC-cccc
Q 014609           97 TGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDG-LLHT  175 (421)
Q Consensus        97 ~gg~L~~~i~~~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~-~~~~  175 (421)
                      ++++|.+++.....+++..+..++.|++.||+|||++|++||||||+|||++.++.+||+|||++.......... ....
T Consensus        78 ~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~~~~  157 (257)
T cd05060          78 PLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTA  157 (257)
T ss_pred             CCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCCCcEEeccccccceeecCCcccccccC
Confidence            999999999887789999999999999999999999999999999999999999999999999988553311110 0111


Q ss_pred             ccCCCCccChhhhcccCCCCCcchHHHHHHHHhhhc--CCcC--------------------CCCCCCHHHHHHHHHhcC
Q 014609          176 TCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIFR--GDFK--------------------LPKWLSPGAQNLLRKILE  233 (421)
Q Consensus       176 ~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~~--~~~~--------------------~p~~~s~~~~~li~~~L~  233 (421)
                      ..++..|+|||.+.+..+ +.++|||||||++|.+.  |..+                    .|..+++.+.++|.+||.
T Consensus       158 ~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~  236 (257)
T cd05060         158 GRWPLKWYAPECINYGKF-SSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGERLPRPEECPQEIYSIMLSCWK  236 (257)
T ss_pred             ccccccccCHHHhcCCCC-CccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHhc
Confidence            123457999999877766 58999999999999654  4433                    244578899999999999


Q ss_pred             CCCCCCCCHHhhhc
Q 014609          234 PNPVKRITIAGIKA  247 (421)
Q Consensus       234 ~dP~~R~t~~eil~  247 (421)
                      ++|.+||++.++++
T Consensus       237 ~~p~~Rp~~~~l~~  250 (257)
T cd05060         237 YRPEDRPTFSELES  250 (257)
T ss_pred             CChhhCcCHHHHHH
Confidence            99999999999864

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=7.7e-38  Score=296.32  Aligned_cols=220  Identities=22%  Similarity=0.278  Sum_probs=180.3

Q ss_pred             ceEeecCcEEEEEEEECC------------CCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCC
Q 014609           20 RTLGEGNFGKVKFAQDLD------------SGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKS   87 (421)
Q Consensus        20 ~~LG~G~~g~V~~a~~~~------------~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~   87 (421)
                      +.||+|+||.||+|....            ....||+|.+....   ......+.+|+.+++.++||||+++++++..+.
T Consensus         1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~---~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~   77 (262)
T cd05077           1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSH---RDISLAFFETASMMRQVSHKHIVLLYGVCVRDV   77 (262)
T ss_pred             CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhh---hhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCC
Confidence            468999999999997432            23358889876432   233457888999999999999999999999999


Q ss_pred             EEEEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCC-------EEEEecc
Q 014609           88 KIYMVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGN-------IKISDFG  159 (421)
Q Consensus        88 ~~~lv~E~~~gg~L~~~i~~-~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~-------~kL~DFG  159 (421)
                      ..++||||+++++|..++.. ...+++..+..++.|++.||+|||++||+||||||+|||++.++.       ++++|||
T Consensus        78 ~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g  157 (262)
T cd05077          78 ENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPG  157 (262)
T ss_pred             CCEEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeEeCCCC
Confidence            99999999999999888765 356899999999999999999999999999999999999987664       8999999


Q ss_pred             CCCCCccccCCCccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhhc--CCcCCCC------------------C
Q 014609          160 LSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIFR--GDFKLPK------------------W  219 (421)
Q Consensus       160 la~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~~--~~~~~p~------------------~  219 (421)
                      ++.....      .....++..|+|||++......+.++||||+||++|.+.  +..++..                  .
T Consensus       158 ~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~  231 (262)
T cd05077         158 IPITVLS------RQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKERFYEGQCMLVTP  231 (262)
T ss_pred             CCccccC------cccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHHHHHhcCccCCCC
Confidence            9864322      223457889999999874444468899999999999653  4443321                  1


Q ss_pred             CCHHHHHHHHHhcCCCCCCCCCHHhhhcC
Q 014609          220 LSPGAQNLLRKILEPNPVKRITIAGIKAD  248 (421)
Q Consensus       220 ~s~~~~~li~~~L~~dP~~R~t~~eil~~  248 (421)
                      .++++.++|.+||+.||.+||++.+|+++
T Consensus       232 ~~~~~~~li~~cl~~dp~~Rp~~~~il~~  260 (262)
T cd05077         232 SCKELADLMTHCMNYDPNQRPFFRAIMRD  260 (262)
T ss_pred             ChHHHHHHHHHHcCCChhhCcCHHHHHHh
Confidence            35778999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=1e-37  Score=293.77  Aligned_cols=224  Identities=26%  Similarity=0.466  Sum_probs=188.6

Q ss_pred             eeecceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEE-EeCCEE
Q 014609           11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVL-ASKSKI   89 (421)
Q Consensus        11 ~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~-~~~~~~   89 (421)
                      +.+.+|++.+.||+|+||.||+|..  .|..||+|.+....     ..+.+.+|+.++++++|||++++++++ ..+...
T Consensus         3 ~~~~~~~~~~~lg~g~~~~v~~~~~--~~~~~~~k~~~~~~-----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   75 (256)
T cd05082           3 LNMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGL   75 (256)
T ss_pred             ccHHhCeeeeeecccCCCeEEEEEE--cCCcEEEEEeCCCc-----hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCce
Confidence            3467899999999999999999975  47889999886432     245788999999999999999999975 455679


Q ss_pred             EEEEeccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCccc
Q 014609           90 YMVLEYVTGGELFDKIASKG--RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHF  167 (421)
Q Consensus        90 ~lv~E~~~gg~L~~~i~~~~--~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~  167 (421)
                      |++|||+++++|.+++....  .+++..+..++.|++.||+|||++|++||||||+||+++.++.+||+|||++..... 
T Consensus        76 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~-  154 (256)
T cd05082          76 YIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS-  154 (256)
T ss_pred             EEEEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcCCCcEEecCCccceeccc-
Confidence            99999999999999987643  478999999999999999999999999999999999999999999999999874322 


Q ss_pred             cCCCccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhhc--CCcCC--------------------CCCCCHHHH
Q 014609          168 RDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIFR--GDFKL--------------------PKWLSPGAQ  225 (421)
Q Consensus       168 ~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~~--~~~~~--------------------p~~~s~~~~  225 (421)
                          ......++..|+|||++....+ +.++|||||||++|.+.  |..++                    ++.+++.+.
T Consensus       155 ----~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (256)
T cd05082         155 ----TQDTGKLPVKWTAPEALREKKF-STKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPVVY  229 (256)
T ss_pred             ----cCCCCccceeecCHHHHccCCC-CchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCHHHH
Confidence                1223345668999999887766 58899999999999653  44443                    233678899


Q ss_pred             HHHHHhcCCCCCCCCCHHhhhc
Q 014609          226 NLLRKILEPNPVKRITIAGIKA  247 (421)
Q Consensus       226 ~li~~~L~~dP~~R~t~~eil~  247 (421)
                      +++.+||+.+|++|||+.++++
T Consensus       230 ~li~~~l~~~p~~Rpt~~~l~~  251 (256)
T cd05082         230 DVMKQCWHLDAATRPSFLQLRE  251 (256)
T ss_pred             HHHHHHhcCChhhCcCHHHHHH
Confidence            9999999999999999999875

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.1e-37  Score=292.44  Aligned_cols=224  Identities=29%  Similarity=0.389  Sum_probs=187.3

Q ss_pred             ceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEEeccCCC
Q 014609           20 RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGG   99 (421)
Q Consensus        20 ~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~~gg   99 (421)
                      +.||+|+||.||+|.+.. ++.||+|.+......  .....+.+|++++++++||||+++++++......|+||||++|+
T Consensus         1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~   77 (251)
T cd05041           1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPP--DLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGG   77 (251)
T ss_pred             CccccCCCceEEEEEEeC-CCcEEEEeccccCCH--HHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCC
Confidence            479999999999999877 999999998754332  34567899999999999999999999999999999999999999


Q ss_pred             ChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCccccCCCccccccC
Q 014609          100 ELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCG  178 (421)
Q Consensus       100 ~L~~~i~~-~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~g  178 (421)
                      +|.+++.. ...+++..+..++.|++.||+|||++|++||||||+||+++.++.++|+|||++................+
T Consensus        78 ~l~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~  157 (251)
T cd05041          78 SLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQI  157 (251)
T ss_pred             cHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccCcc
Confidence            99999865 35689999999999999999999999999999999999999999999999999875432111111112234


Q ss_pred             CCCccChhhhcccCCCCCcchHHHHHHHHhhhc--CCcC--------------------CCCCCCHHHHHHHHHhcCCCC
Q 014609          179 SPNYVAPEVLANRGYDGATSDIWSCGVILYIFR--GDFK--------------------LPKWLSPGAQNLLRKILEPNP  236 (421)
Q Consensus       179 t~~y~APEvl~~~~~~~~~~DiwSlGvil~~~~--~~~~--------------------~p~~~s~~~~~li~~~L~~dP  236 (421)
                      +..|+|||++.+..+ +.++|+|||||++|.+.  +..+                    .|...+..+.+++.+||..+|
T Consensus       158 ~~~y~~PE~~~~~~~-~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p  236 (251)
T cd05041         158 PIKWTAPEALNYGRY-TSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESGYRMPAPQLCPEEIYRLMLQCWAYDP  236 (251)
T ss_pred             eeccCChHhhccCCC-CcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHhcCCCCCCCccCCHHHHHHHHHHhccCh
Confidence            567999999877766 58999999999999654  3332                    233467899999999999999


Q ss_pred             CCCCCHHhhhc
Q 014609          237 VKRITIAGIKA  247 (421)
Q Consensus       237 ~~R~t~~eil~  247 (421)
                      .+|||+.++++
T Consensus       237 ~~Rp~~~ell~  247 (251)
T cd05041         237 ENRPSFSEIYN  247 (251)
T ss_pred             hhCcCHHHHHH
Confidence            99999999875

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=1.2e-37  Score=294.08  Aligned_cols=223  Identities=27%  Similarity=0.391  Sum_probs=182.7

Q ss_pred             eEeecCcEEEEEEEEC--CCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEEeccCC
Q 014609           21 TLGEGNFGKVKFAQDL--DSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTG   98 (421)
Q Consensus        21 ~LG~G~~g~V~~a~~~--~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~~g   98 (421)
                      .||+|+||.||+|.+.  ..+..||+|++....  .....+.+.+|+.++++++||||+++++++.. ...++||||+++
T Consensus         2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~--~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~-~~~~lv~e~~~~   78 (257)
T cd05115           2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNEN--EKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA-EALMLVMEMASG   78 (257)
T ss_pred             ccCCCCcccEEEEEEecCCCceeEEEEEccccc--ChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC-CCeEEEEEeCCC
Confidence            4899999999999765  456679999986542  23335679999999999999999999998864 578999999999


Q ss_pred             CChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCccccCCC-ccccc
Q 014609           99 GELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDG-LLHTT  176 (421)
Q Consensus        99 g~L~~~i~~-~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~-~~~~~  176 (421)
                      ++|.+++.. ...+++..+..++.|++.||+|||++|++||||||+|||++.++.+||+|||++.......... .....
T Consensus        79 ~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~  158 (257)
T cd05115          79 GPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAG  158 (257)
T ss_pred             CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcCCCcEEeccCCccccccCCccceeccCCC
Confidence            999998874 4578999999999999999999999999999999999999999999999999987543211111 11112


Q ss_pred             cCCCCccChhhhcccCCCCCcchHHHHHHHHhhhc--CCcC--------------------CCCCCCHHHHHHHHHhcCC
Q 014609          177 CGSPNYVAPEVLANRGYDGATSDIWSCGVILYIFR--GDFK--------------------LPKWLSPGAQNLLRKILEP  234 (421)
Q Consensus       177 ~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~~--~~~~--------------------~p~~~s~~~~~li~~~L~~  234 (421)
                      .+++.|+|||++....+ +.++|||||||++|.+.  |..+                    .|...++++.++|.+||..
T Consensus       159 ~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c~~~  237 (257)
T cd05115         159 KWPLKWYAPECINFRKF-SSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQGKRLDCPAECPPEMYALMKDCWIY  237 (257)
T ss_pred             CCCcccCCHHHHccCCC-CchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHcCC
Confidence            33578999999877666 58899999999999643  4433                    2345689999999999999


Q ss_pred             CCCCCCCHHhhhc
Q 014609          235 NPVKRITIAGIKA  247 (421)
Q Consensus       235 dP~~R~t~~eil~  247 (421)
                      +|++||++.++.+
T Consensus       238 ~~~~Rp~~~~i~~  250 (257)
T cd05115         238 KWEDRPNFAKVEE  250 (257)
T ss_pred             ChhhCcCHHHHHH
Confidence            9999999999864

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.5e-37  Score=293.17  Aligned_cols=229  Identities=27%  Similarity=0.398  Sum_probs=191.5

Q ss_pred             eecceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEE
Q 014609           12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYM   91 (421)
Q Consensus        12 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l   91 (421)
                      ..++|++.+.||+|+||.||+|.+. +++.||||.+.....    ....+.+|+.++++++||||+++++++......|+
T Consensus         4 ~~~~~~i~~~ig~g~~~~v~~~~~~-~~~~~~vK~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   78 (261)
T cd05034           4 PRESLKLERKLGAGQFGEVWMGTWN-GTTKVAVKTLKPGTM----SPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYI   78 (261)
T ss_pred             chhheeeeeeeccCcceEEEEEEEc-CCceEEEEEecCCcc----CHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEE
Confidence            3468999999999999999999974 567899999875432    14578899999999999999999999999899999


Q ss_pred             EEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCccccC
Q 014609           92 VLEYVTGGELFDKIASK--GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD  169 (421)
Q Consensus        92 v~E~~~gg~L~~~i~~~--~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~  169 (421)
                      ||||+++++|.+.+...  ..+++..+..++.|++.|+.|||++|++||||||+||+++.++.+||+|||++....... 
T Consensus        79 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~-  157 (261)
T cd05034          79 VTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDE-  157 (261)
T ss_pred             EEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcCCCCEEECccccceeccchh-
Confidence            99999999999998764  368999999999999999999999999999999999999999999999999987543211 


Q ss_pred             CCccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhhc--CCcCC--------------------CCCCCHHHHHH
Q 014609          170 DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIFR--GDFKL--------------------PKWLSPGAQNL  227 (421)
Q Consensus       170 ~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~~--~~~~~--------------------p~~~s~~~~~l  227 (421)
                      ........++..|+|||.+.+..+ +.++|+||+|+++|.+.  |..++                    |...+..+.++
T Consensus       158 ~~~~~~~~~~~~y~~PE~~~~~~~-~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (261)
T cd05034         158 YTAREGAKFPIKWTAPEAANYGRF-TIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGYRMPRPPNCPEELYDL  236 (261)
T ss_pred             hhhhhccCCCccccCHHHhccCCc-CchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHH
Confidence            111112234568999999887666 58899999999999553  44332                    33467899999


Q ss_pred             HHHhcCCCCCCCCCHHhhhc
Q 014609          228 LRKILEPNPVKRITIAGIKA  247 (421)
Q Consensus       228 i~~~L~~dP~~R~t~~eil~  247 (421)
                      +.+||..+|.+||++.++.+
T Consensus       237 i~~~l~~~p~~Rp~~~~l~~  256 (261)
T cd05034         237 MLQCWDKDPEERPTFEYLQS  256 (261)
T ss_pred             HHHHcccCcccCCCHHHHHH
Confidence            99999999999999998763

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=2e-37  Score=295.75  Aligned_cols=232  Identities=26%  Similarity=0.353  Sum_probs=191.8

Q ss_pred             eecceEEeceEeecCcEEEEEEEECCCCc----eEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCC
Q 014609           12 RLGRYELGRTLGEGNFGKVKFAQDLDSGL----PFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKS   87 (421)
Q Consensus        12 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~----~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~   87 (421)
                      ..++|++++.||+|+||+||+|.+..+|+    .+|+|.+.....  ......+.+|+.++++++||||+++++++.. .
T Consensus         5 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~   81 (279)
T cd05057           5 KETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETS--PKANKEILDEAYVMASVDHPHVVRLLGICLS-S   81 (279)
T ss_pred             CHHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCC--HHHHHHHHHHHHHHHhCCCCCcceEEEEEec-C
Confidence            34789999999999999999999876665    589998865432  2335678899999999999999999999987 7


Q ss_pred             EEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCcc
Q 014609           88 KIYMVLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQH  166 (421)
Q Consensus        88 ~~~lv~E~~~gg~L~~~i~~~-~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~  166 (421)
                      ..++||||+++++|.+.+... ..+++..+..++.|++.||+|||++|++||||||+||+++.++.+||+|||++.....
T Consensus        82 ~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~  161 (279)
T cd05057          82 QVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDV  161 (279)
T ss_pred             ceEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEcCCCeEEECCCcccccccC
Confidence            899999999999999998763 4689999999999999999999999999999999999999999999999999986543


Q ss_pred             ccCCCccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhhc--CCcC--------------------CCCCCCHHH
Q 014609          167 FRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIFR--GDFK--------------------LPKWLSPGA  224 (421)
Q Consensus       167 ~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~~--~~~~--------------------~p~~~s~~~  224 (421)
                      ...........++..|+|||.+....+ +.++|+|||||++|.+.  |..+                    .|...+..+
T Consensus       162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~-~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (279)
T cd05057         162 DEKEYHAEGGKVPIKWMALESILHRIY-THKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKGERLPQPPICTIDV  240 (279)
T ss_pred             cccceecCCCcccccccCHHHhhcCCc-CchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCCCCCCCCCCCCHHH
Confidence            211111112234568999999877666 48899999999999543  4333                    233467889


Q ss_pred             HHHHHHhcCCCCCCCCCHHhhhc
Q 014609          225 QNLLRKILEPNPVKRITIAGIKA  247 (421)
Q Consensus       225 ~~li~~~L~~dP~~R~t~~eil~  247 (421)
                      .+++.+||..||..||++.++++
T Consensus       241 ~~~~~~~l~~~p~~Rp~~~~l~~  263 (279)
T cd05057         241 YMVLVKCWMIDAESRPTFKELIN  263 (279)
T ss_pred             HHHHHHHcCCChhhCCCHHHHHH
Confidence            99999999999999999998754

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=100.00  E-value=1.4e-37  Score=299.49  Aligned_cols=239  Identities=23%  Similarity=0.357  Sum_probs=194.9

Q ss_pred             CeeecceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCC-CCCcceEEEEEEeCCE
Q 014609           10 GMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK-HPNVVRLHEVLASKSK   88 (421)
Q Consensus        10 ~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~   88 (421)
                      ...+++|++.+.||+|+||.||+|.+..+++.||||.+.+....  .....+.+|+.++.++. ||||+++++++.+...
T Consensus        11 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~--~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~   88 (296)
T cd06618          11 PADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNK--EENKRILMDLDVVLKSHDCPYIVKCYGYFITDSD   88 (296)
T ss_pred             cCCcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCCh--HHHHHHHHHHHHHHhccCCCchHhhheeeecCCe
Confidence            45678999999999999999999999888999999999754322  22345666777676664 9999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHh-CCceeccCCCCCEEeccCCCEEEEeccCCCCCcc
Q 014609           89 IYMVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHN-KGVFHRDLKLENILLDSKGNIKISDFGLSALPQH  166 (421)
Q Consensus        89 ~~lv~E~~~gg~L~~~i~~-~~~~~~~~~~~~~~ql~~aL~~LH~-~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~  166 (421)
                      .|++|||+. +.|.+.+.. ...+++..+..++.|++.|++|||+ .||+||||+|+||+++.++.+||+|||++.....
T Consensus        89 ~~~v~e~~~-~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~  167 (296)
T cd06618          89 VFICMELMS-TCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVD  167 (296)
T ss_pred             EEEEeeccC-cCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCCCEEECccccchhccC
Confidence            999999985 467666654 4578999999999999999999997 5999999999999999999999999999875432


Q ss_pred             ccCCCccccccCCCCccChhhhcccC---CCCCcchHHHHHHHHhhhc-CCcCCC-----------------------CC
Q 014609          167 FRDDGLLHTTCGSPNYVAPEVLANRG---YDGATSDIWSCGVILYIFR-GDFKLP-----------------------KW  219 (421)
Q Consensus       167 ~~~~~~~~~~~gt~~y~APEvl~~~~---~~~~~~DiwSlGvil~~~~-~~~~~p-----------------------~~  219 (421)
                         ........+++.|+|||.+.+..   ..+.++||||||+++|.+. |..++.                       ..
T Consensus       168 ---~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (296)
T cd06618         168 ---SKAKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEPPSLPPNEG  244 (296)
T ss_pred             ---CCcccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcCCCCCCCCCCC
Confidence               11122345788999999986543   1257899999999999443 333321                       12


Q ss_pred             CCHHHHHHHHHhcCCCCCCCCCHHhhhcCcccccc
Q 014609          220 LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD  254 (421)
Q Consensus       220 ~s~~~~~li~~~L~~dP~~R~t~~eil~~~w~~~~  254 (421)
                      ++.++.+++.+||+.||.+||++.+++.||||...
T Consensus       245 ~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~  279 (296)
T cd06618         245 FSPDFCSFVDLCLTKDHRKRPKYRELLQHPFIRRY  279 (296)
T ss_pred             CCHHHHHHHHHHccCChhhCCCHHHHhcChhhhcc
Confidence            57789999999999999999999999999999853

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=100.00  E-value=1e-37  Score=305.89  Aligned_cols=234  Identities=27%  Similarity=0.429  Sum_probs=191.0

Q ss_pred             ecceEEeceEeecCcEEEEEEEECCC-------CceEEEEEeecccccchhHHHHHHHHHHHHhcC-CCCCcceEEEEEE
Q 014609           13 LGRYELGRTLGEGNFGKVKFAQDLDS-------GLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEVLA   84 (421)
Q Consensus        13 ~~~y~i~~~LG~G~~g~V~~a~~~~~-------~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~   84 (421)
                      -.+|++++.||+|+||.||+|.+...       +..||+|.+....  .......+.+|+.+++++ +||||+++++++.
T Consensus        11 ~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~   88 (334)
T cd05100          11 RTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDA--TDKDLSDLVSEMEMMKMIGKHKNIINLLGACT   88 (334)
T ss_pred             HhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEccccc--CHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEc
Confidence            35799999999999999999986432       3479999886432  223356789999999999 7999999999999


Q ss_pred             eCCEEEEEEeccCCCChHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEec
Q 014609           85 SKSKIYMVLEYVTGGELFDKIASKG----------------RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLD  148 (421)
Q Consensus        85 ~~~~~~lv~E~~~gg~L~~~i~~~~----------------~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~  148 (421)
                      ..+..|+++||+++++|.+++....                .++...+..++.|++.||+|||++|++||||||+|||++
T Consensus        89 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nill~  168 (334)
T cd05100          89 QDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVT  168 (334)
T ss_pred             cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEc
Confidence            9999999999999999999987532                367788899999999999999999999999999999999


Q ss_pred             cCCCEEEEeccCCCCCccccCCCccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhhc--CCcCC----------
Q 014609          149 SKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIFR--GDFKL----------  216 (421)
Q Consensus       149 ~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~~--~~~~~----------  216 (421)
                      .++.+||+|||++................++..|+|||++.+..+ +.++|||||||++|.+.  |..++          
T Consensus       169 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~  247 (334)
T cd05100         169 EDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVY-THQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFK  247 (334)
T ss_pred             CCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCc-CchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Confidence            999999999999875432111111222334567999999987777 48899999999999653  33322          


Q ss_pred             ----------CCCCCHHHHHHHHHhcCCCCCCCCCHHhhhcCc
Q 014609          217 ----------PKWLSPGAQNLLRKILEPNPVKRITIAGIKADE  249 (421)
Q Consensus       217 ----------p~~~s~~~~~li~~~L~~dP~~R~t~~eil~~~  249 (421)
                                |...+..+.+++.+||+.+|.+|||+.+++++-
T Consensus       248 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l  290 (334)
T cd05100         248 LLKEGHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDL  290 (334)
T ss_pred             HHHcCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHH
Confidence                      233578899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=7e-38  Score=298.65  Aligned_cols=219  Identities=26%  Similarity=0.316  Sum_probs=178.9

Q ss_pred             eEeecCcEEEEEEEECC------------------------CCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCc
Q 014609           21 TLGEGNFGKVKFAQDLD------------------------SGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNV   76 (421)
Q Consensus        21 ~LG~G~~g~V~~a~~~~------------------------~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnI   76 (421)
                      .||+|+||.||+|....                        ....||+|++....   ......+.+|+.+++.++||||
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~---~~~~~~~~~~~~~~~~l~h~ni   78 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSH---RDIALAFFETASLMSQVSHIHL   78 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHH---HHHHHHHHHHHHHHhcCCCCCe
Confidence            69999999999997432                        12458899886432   2334678889999999999999


Q ss_pred             ceEEEEEEeCCEEEEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCC----
Q 014609           77 VRLHEVLASKSKIYMVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKG----  151 (421)
Q Consensus        77 v~l~~~~~~~~~~~lv~E~~~gg~L~~~i~~-~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~----  151 (421)
                      +++++++......|+||||+++++|...+.. .+.+++..+..++.|++.||+|||++||+||||||+|||++..+    
T Consensus        79 v~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~~~~~  158 (274)
T cd05076          79 AFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLAEG  158 (274)
T ss_pred             eeEEEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEeccCcccC
Confidence            9999999999999999999999999888865 46789999999999999999999999999999999999998654    


Q ss_pred             ---CEEEEeccCCCCCccccCCCccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhh--cCCcCC----------
Q 014609          152 ---NIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIF--RGDFKL----------  216 (421)
Q Consensus       152 ---~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~--~~~~~~----------  216 (421)
                         .+|++|||++.....      .....+++.|+|||.+.+....+.++|||||||++|.+  .|..++          
T Consensus       159 ~~~~~kl~d~g~~~~~~~------~~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~  232 (274)
T cd05076         159 TSPFIKLSDPGVSFTALS------REERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKER  232 (274)
T ss_pred             ccceeeecCCcccccccc------ccccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHHHH
Confidence               389999998763221      12235788899999887644346899999999999964  344332          


Q ss_pred             --------CCCCCHHHHHHHHHhcCCCCCCCCCHHhhhcC
Q 014609          217 --------PKWLSPGAQNLLRKILEPNPVKRITIAGIKAD  248 (421)
Q Consensus       217 --------p~~~s~~~~~li~~~L~~dP~~R~t~~eil~~  248 (421)
                              |...++.+.++|.+||+.+|++|||+.+++++
T Consensus       233 ~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~  272 (274)
T cd05076         233 FYEKKHRLPEPSCKELATLISQCLTYEPTQRPSFRTILRD  272 (274)
T ss_pred             HHHhccCCCCCCChHHHHHHHHHcccChhhCcCHHHHHHh
Confidence                    23345789999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=9.8e-38  Score=294.58  Aligned_cols=227  Identities=26%  Similarity=0.382  Sum_probs=187.8

Q ss_pred             eecceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEE
Q 014609           12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYM   91 (421)
Q Consensus        12 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l   91 (421)
                      ..++|++.+.||+|+||.||+|.+. .+..+|+|.+......    .+.+.+|+.++++++||||+++++++. ....|+
T Consensus         4 ~~~~~~~~~~ig~g~~~~v~~~~~~-~~~~~~~k~~~~~~~~----~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~l   77 (260)
T cd05070           4 PRESLQLIKKLGNGQFGEVWMGTWN-GNTKVAVKTLKPGTMS----PESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYI   77 (260)
T ss_pred             chHHhhhhheeccccCceEEEEEec-CCceeEEEEecCCCCC----HHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEE
Confidence            3468999999999999999999864 5677999998754321    356899999999999999999999885 456899


Q ss_pred             EEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCccccC
Q 014609           92 VLEYVTGGELFDKIASK--GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD  169 (421)
Q Consensus        92 v~E~~~gg~L~~~i~~~--~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~  169 (421)
                      +|||+++++|.+++...  ..+++..++.++.|++.||+|||++||+||||||+||++++++.++|+|||++....... 
T Consensus        78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~-  156 (260)
T cd05070          78 VTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNE-  156 (260)
T ss_pred             EEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeCCceEEeCCceeeeeccCcc-
Confidence            99999999999998753  358999999999999999999999999999999999999999999999999997543211 


Q ss_pred             CCccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhhc--CCcCC--------------------CCCCCHHHHHH
Q 014609          170 DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIFR--GDFKL--------------------PKWLSPGAQNL  227 (421)
Q Consensus       170 ~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~~--~~~~~--------------------p~~~s~~~~~l  227 (421)
                      ........++..|+|||++.+..+ +.++|+||||+++|.+.  |..++                    |...+..+.++
T Consensus       157 ~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  235 (260)
T cd05070         157 YTARQGAKFPIKWTAPEAALYGRF-TIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYRMPCPQDCPISLHEL  235 (260)
T ss_pred             cccccCCCCCccccChHHHhcCCC-cchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHHHHH
Confidence            111112234567999999877666 58899999999999654  33332                    33467899999


Q ss_pred             HHHhcCCCCCCCCCHHhhh
Q 014609          228 LRKILEPNPVKRITIAGIK  246 (421)
Q Consensus       228 i~~~L~~dP~~R~t~~eil  246 (421)
                      +.+||.++|++|||+.++.
T Consensus       236 i~~~l~~~p~~Rpt~~~l~  254 (260)
T cd05070         236 MLQCWKKDPEERPTFEYLQ  254 (260)
T ss_pred             HHHHcccCcccCcCHHHHH
Confidence            9999999999999999876

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=100.00  E-value=9.9e-38  Score=302.84  Aligned_cols=234  Identities=22%  Similarity=0.369  Sum_probs=187.2

Q ss_pred             EeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEEeccC
Q 014609           18 LGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVT   97 (421)
Q Consensus        18 i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~~   97 (421)
                      +++.+|.  +|.||.+++..+++.||||++..... .......+.+|+.+++.++||||+++++++......|++|||++
T Consensus         6 i~~~~~~--~~~v~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~   82 (314)
T cd08216           6 IGKCFED--LMIVHLAKHKPTNTLVAVKKINLDSC-SKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMA   82 (314)
T ss_pred             hhHhhcC--CceEEEEEecCCCCEEEEEEEecccc-chhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccC
Confidence            3444444  45566666667999999999976532 23346789999999999999999999999999999999999999


Q ss_pred             CCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCccccC-----C
Q 014609           98 GGELFDKIASK--GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD-----D  170 (421)
Q Consensus        98 gg~L~~~i~~~--~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~-----~  170 (421)
                      +++|.+++...  ..+++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||.+........     .
T Consensus        83 ~~~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~  162 (314)
T cd08216          83 YGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVH  162 (314)
T ss_pred             CCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecCCceEEecCccceeeccccccccccc
Confidence            99999988753  4689999999999999999999999999999999999999999999999998864321111     1


Q ss_pred             CccccccCCCCccChhhhccc--CCCCCcchHHHHHHHHhhhc-CCcCCCC-----------------------------
Q 014609          171 GLLHTTCGSPNYVAPEVLANR--GYDGATSDIWSCGVILYIFR-GDFKLPK-----------------------------  218 (421)
Q Consensus       171 ~~~~~~~gt~~y~APEvl~~~--~~~~~~~DiwSlGvil~~~~-~~~~~p~-----------------------------  218 (421)
                      .......++..|+|||++...  .+ +.++|+||+||++|.+. |..++..                             
T Consensus       163 ~~~~~~~~~~~y~aPE~~~~~~~~~-~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (314)
T cd08216         163 DFPKSSVKNLPWLSPEVLQQNLQGY-NEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYED  241 (314)
T ss_pred             cccccccccccccCHHHhcCCCCCC-CcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhhhcC
Confidence            122334577889999998653  35 57899999999999543 3332210                             


Q ss_pred             ------------------------CCCHHHHHHHHHhcCCCCCCCCCHHhhhcCccccccc
Q 014609          219 ------------------------WLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY  255 (421)
Q Consensus       219 ------------------------~~s~~~~~li~~~L~~dP~~R~t~~eil~~~w~~~~~  255 (421)
                                              .++..+.+++.+||+.||++|||+.++++||||+...
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~~~~~~  302 (314)
T cd08216         242 SMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFFKQCK  302 (314)
T ss_pred             CcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCchHhhhc
Confidence                                    1235678999999999999999999999999998643

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=1.7e-37  Score=292.16  Aligned_cols=224  Identities=30%  Similarity=0.467  Sum_probs=188.2

Q ss_pred             ceEeecCcEEEEEEEECC-CCc--eEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEEecc
Q 014609           20 RTLGEGNFGKVKFAQDLD-SGL--PFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLEYV   96 (421)
Q Consensus        20 ~~LG~G~~g~V~~a~~~~-~~~--~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~   96 (421)
                      +.||+|++|.||+|.+.. +++  .||+|.+......  ...+.+.+|+.++++++||||+++++++.. ...++||||+
T Consensus         1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~   77 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS--DIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELA   77 (257)
T ss_pred             CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccH--HHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEec
Confidence            468999999999998765 333  6999999765443  446789999999999999999999999988 8999999999


Q ss_pred             CCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCccccCC-Ccc
Q 014609           97 TGGELFDKIASKG--RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD-GLL  173 (421)
Q Consensus        97 ~gg~L~~~i~~~~--~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~-~~~  173 (421)
                      ++++|.+.+....  .+++..++.++.|++.||+|||++|++||||||+||+++.++.+||+|||++......... ...
T Consensus        78 ~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~  157 (257)
T cd05040          78 PLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVME  157 (257)
T ss_pred             CCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecCCEEEeccccccccccccccceecc
Confidence            9999999997654  6899999999999999999999999999999999999999999999999999865332111 111


Q ss_pred             ccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhhc--CCcCC---------------------CCCCCHHHHHHHHH
Q 014609          174 HTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIFR--GDFKL---------------------PKWLSPGAQNLLRK  230 (421)
Q Consensus       174 ~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~~--~~~~~---------------------p~~~s~~~~~li~~  230 (421)
                      ....++..|+|||.+....+ +.++||||+||++|.+.  |..++                     |...+..+.+++.+
T Consensus       158 ~~~~~~~~y~~pE~~~~~~~-~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  236 (257)
T cd05040         158 EHLKVPFAWCAPESLRTRTF-SHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGERLERPEACPQDIYNVMLQ  236 (257)
T ss_pred             cCCCCCceecCHHHhcccCc-CchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCcCCCCccCCHHHHHHHHH
Confidence            23456788999999887776 58899999999999663  44432                     23467899999999


Q ss_pred             hcCCCCCCCCCHHhhhc
Q 014609          231 ILEPNPVKRITIAGIKA  247 (421)
Q Consensus       231 ~L~~dP~~R~t~~eil~  247 (421)
                      ||+.+|.+|||+.++++
T Consensus       237 ~l~~~p~~Rps~~~~~~  253 (257)
T cd05040         237 CWAHNPADRPTFAALRE  253 (257)
T ss_pred             HCCCCcccCCCHHHHHH
Confidence            99999999999999875

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=100.00  E-value=1.6e-37  Score=294.86  Aligned_cols=225  Identities=20%  Similarity=0.256  Sum_probs=180.1

Q ss_pred             ceEeecCcEEEEEEEEC--CCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEEeccC
Q 014609           20 RTLGEGNFGKVKFAQDL--DSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVT   97 (421)
Q Consensus        20 ~~LG~G~~g~V~~a~~~--~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~~   97 (421)
                      +.||+|+||.||+|...  .++..+|+|.++....  ......+.+|+.++++++||||+++++++.+....|+||||++
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~   78 (269)
T cd05087           1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSAS--VQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCP   78 (269)
T ss_pred             CcccccCCceEEEEEEcCCCCceEEEEEecCCCCC--hHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCC
Confidence            46899999999999754  3567899998865432  2223578889999999999999999999999999999999999


Q ss_pred             CCChHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCccccCCCc
Q 014609           98 GGELFDKIASKG-----RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGL  172 (421)
Q Consensus        98 gg~L~~~i~~~~-----~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~  172 (421)
                      +|+|.+++....     ..++..++.++.|++.|++|||++|++||||||+||+++.++.+||+|||++...........
T Consensus        79 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~  158 (269)
T cd05087          79 LGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVT  158 (269)
T ss_pred             CCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEECCccccccccCcceeec
Confidence            999999986422     456778889999999999999999999999999999999999999999999874322111111


Q ss_pred             cccccCCCCccChhhhcccC------CCCCcchHHHHHHHHhhhc--CCcCCCC-------------------------C
Q 014609          173 LHTTCGSPNYVAPEVLANRG------YDGATSDIWSCGVILYIFR--GDFKLPK-------------------------W  219 (421)
Q Consensus       173 ~~~~~gt~~y~APEvl~~~~------~~~~~~DiwSlGvil~~~~--~~~~~p~-------------------------~  219 (421)
                      .....+++.|+|||++.+..      ..+.++|+||+|+++|.+.  |..+++.                         .
T Consensus       159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (269)
T cd05087         159 PDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLKLPKPRLKLP  238 (269)
T ss_pred             CCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhcccCCCCCCccCCC
Confidence            22346788899999986432      1257899999999999653  6555431                         1


Q ss_pred             CCHHHHHHHHHhcCCCCCCCCCHHhhhc
Q 014609          220 LSPGAQNLLRKILEPNPVKRITIAGIKA  247 (421)
Q Consensus       220 ~s~~~~~li~~~L~~dP~~R~t~~eil~  247 (421)
                      .++.+.+++.+|+ .+|++|||++++..
T Consensus       239 ~~~~~~~l~~~c~-~~P~~Rpt~~~l~~  265 (269)
T cd05087         239 LSDRWYEVMQFCW-LQPEQRPSAEEVHL  265 (269)
T ss_pred             CChHHHHHHHHHh-cCcccCCCHHHHHH
Confidence            4577889999998 68999999999874

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=2.2e-37  Score=292.31  Aligned_cols=228  Identities=26%  Similarity=0.393  Sum_probs=187.5

Q ss_pred             eecceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEE
Q 014609           12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYM   91 (421)
Q Consensus        12 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l   91 (421)
                      ..++|++.+.||+|+||.||+|.+..+ ..+|+|.+.....    ..+.+.+|+.++++++|||++++++++. .+..|+
T Consensus         4 ~~~~~~~~~~ig~g~~~~v~~~~~~~~-~~~~lK~~~~~~~----~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~   77 (260)
T cd05069           4 PRESLRLDVKLGQGCFGEVWMGTWNGT-TKVAIKTLKPGTM----MPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYI   77 (260)
T ss_pred             ChHHeeeeeeecCcCCCeEEEEEEcCC-ceEEEEEcccCCc----cHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEE
Confidence            347899999999999999999987554 4699998865432    2356889999999999999999999885 456899


Q ss_pred             EEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCccccC
Q 014609           92 VLEYVTGGELFDKIASK--GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD  169 (421)
Q Consensus        92 v~E~~~gg~L~~~i~~~--~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~  169 (421)
                      +|||+++++|.+++...  ..+++..+..++.|++.||+|||+.|++||||||+||++++++.++|+|||++....... 
T Consensus        78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~-  156 (260)
T cd05069          78 VTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNE-  156 (260)
T ss_pred             EEEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCeEEECCCccceEccCCc-
Confidence            99999999999998753  347899999999999999999999999999999999999999999999999997543211 


Q ss_pred             CCccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhhc--CCcCC--------------------CCCCCHHHHHH
Q 014609          170 DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIFR--GDFKL--------------------PKWLSPGAQNL  227 (421)
Q Consensus       170 ~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~~--~~~~~--------------------p~~~s~~~~~l  227 (421)
                      ........++..|+|||.+.+..+ +.++|+||+|+++|.+.  |..++                    |..++..+.++
T Consensus       157 ~~~~~~~~~~~~y~~Pe~~~~~~~-~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  235 (260)
T cd05069         157 YTARQGAKFPIKWTAPEAALYGRF-TIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGYRMPCPQGCPESLHEL  235 (260)
T ss_pred             ccccCCCccchhhCCHHHhccCCc-ChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCcccCHHHHHH
Confidence            111122345678999999877666 58899999999999664  44332                    23367889999


Q ss_pred             HHHhcCCCCCCCCCHHhhhc
Q 014609          228 LRKILEPNPVKRITIAGIKA  247 (421)
Q Consensus       228 i~~~L~~dP~~R~t~~eil~  247 (421)
                      +++||.+||.+||+++++++
T Consensus       236 i~~~l~~~p~~Rp~~~~i~~  255 (260)
T cd05069         236 MKLCWKKDPDERPTFEYIQS  255 (260)
T ss_pred             HHHHccCCcccCcCHHHHHH
Confidence            99999999999999998864

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-38  Score=314.54  Aligned_cols=231  Identities=24%  Similarity=0.409  Sum_probs=199.5

Q ss_pred             eeecceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEE
Q 014609           11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIY   90 (421)
Q Consensus        11 ~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~   90 (421)
                      +..+...++..||+|.||+||+|++-.   .||||+++...... +..+.|++|+.++++-+|.||+=+.|++..+.. .
T Consensus       389 Ip~~ev~l~~rIGsGsFGtV~Rg~whG---dVAVK~Lnv~~pt~-~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~-A  463 (678)
T KOG0193|consen  389 IPPEEVLLGERIGSGSFGTVYRGRWHG---DVAVKLLNVDDPTP-EQLQAFKNEVAVLKKTRHENILLFMGACMNPPL-A  463 (678)
T ss_pred             cCHHHhhccceeccccccceeeccccc---ceEEEEEecCCCCH-HHHHHHHHHHHHHhhcchhhheeeehhhcCCce-e
Confidence            344677889999999999999999754   59999998765544 468899999999999999999999999998877 9


Q ss_pred             EEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCccccC
Q 014609           91 MVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD  169 (421)
Q Consensus        91 lv~E~~~gg~L~~~i~~-~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~  169 (421)
                      ||+.+|+|.+|+.+++- ...|.....+.|++|++.|+.|||.++|+|||||..||+|.+++.|||+|||+++.......
T Consensus       464 IiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~~w~g  543 (678)
T KOG0193|consen  464 IITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLHEDLKVKIGDFGLATVKTRWSG  543 (678)
T ss_pred             eeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEccCCcEEEecccceeeeeeecc
Confidence            99999999999998874 35688899999999999999999999999999999999999999999999999998766655


Q ss_pred             CCccccccCCCCccChhhhcc---cCCCCCcchHHHHHHHHhhh-cCCcCCCC------------------------CCC
Q 014609          170 DGLLHTTCGSPNYVAPEVLAN---RGYDGATSDIWSCGVILYIF-RGDFKLPK------------------------WLS  221 (421)
Q Consensus       170 ~~~~~~~~gt~~y~APEvl~~---~~~~~~~~DiwSlGvil~~~-~~~~~~p~------------------------~~s  221 (421)
                      ........|...|||||++..   .+| +..+||||+||++|++ .|.+++..                        ..+
T Consensus       544 ~~q~~qp~gsilwmAPEvIRmqd~nPf-S~qSDVYaFGiV~YELltg~lPysi~~~dqIifmVGrG~l~pd~s~~~s~~p  622 (678)
T KOG0193|consen  544 EQQLEQPHGSLLWMAPEVIRMQDDNPF-SFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVGRGYLMPDLSKIRSNCP  622 (678)
T ss_pred             ccccCCCccchhhhcHHHHhhcccCCC-CcccchhhhhHHHHHHHhCcCCcCCCChhheEEEecccccCccchhhhccCH
Confidence            666677788999999999864   344 6889999999999954 45554421                        145


Q ss_pred             HHHHHHHHHhcCCCCCCCCCHHhhhc
Q 014609          222 PGAQNLLRKILEPNPVKRITIAGIKA  247 (421)
Q Consensus       222 ~~~~~li~~~L~~dP~~R~t~~eil~  247 (421)
                      .++++|+..||..++++||++.+|+.
T Consensus       623 k~mk~Ll~~C~~~~~~eRP~F~~il~  648 (678)
T KOG0193|consen  623 KAMKRLLSDCWKFDREERPLFPQLLS  648 (678)
T ss_pred             HHHHHHHHHHHhcCcccCccHHHHHH
Confidence            68999999999999999999999886

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=2.1e-37  Score=294.29  Aligned_cols=222  Identities=28%  Similarity=0.413  Sum_probs=182.7

Q ss_pred             ceEeecCcEEEEEEEECCCCc--eEEEEEeecccccchhHHHHHHHHHHHHhcC-CCCCcceEEEEEEeCCEEEEEEecc
Q 014609           20 RTLGEGNFGKVKFAQDLDSGL--PFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEVLASKSKIYMVLEYV   96 (421)
Q Consensus        20 ~~LG~G~~g~V~~a~~~~~~~--~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~lv~E~~   96 (421)
                      +.||+|+||.||+|.+..++.  .+|+|.+....  .....+.+.+|+.++.++ +||||+++++++...+..|+||||+
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~   78 (270)
T cd05047           1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA--SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYA   78 (270)
T ss_pred             CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccC--CHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeC
Confidence            468999999999999887776  46888775322  223356788999999999 7999999999999999999999999


Q ss_pred             CCCChHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccC
Q 014609           97 TGGELFDKIASKG----------------RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGL  160 (421)
Q Consensus        97 ~gg~L~~~i~~~~----------------~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGl  160 (421)
                      ++++|.+++....                .+++..+..++.|++.||+|||++|++||||||+|||++.++.+||+|||+
T Consensus        79 ~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~~~~~kl~dfgl  158 (270)
T cd05047          79 PHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGL  158 (270)
T ss_pred             CCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcCCCeEEECCCCC
Confidence            9999999986532                478899999999999999999999999999999999999999999999999


Q ss_pred             CCCCccccCCCccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhhc--CCcCC--------------------CC
Q 014609          161 SALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIFR--GDFKL--------------------PK  218 (421)
Q Consensus       161 a~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~~--~~~~~--------------------p~  218 (421)
                      +......   ........++.|+|||++....+ +.++|+|||||++|.+.  |..++                    |.
T Consensus       159 ~~~~~~~---~~~~~~~~~~~y~apE~~~~~~~-~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  234 (270)
T cd05047         159 SRGQEVY---VKKTMGRLPVRWMAIESLNYSVY-TTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKPL  234 (270)
T ss_pred             ccccchh---hhccCCCCccccCChHHHccCCC-CchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHHHhCCCCCCCCC
Confidence            8632211   01111234567999999877766 58899999999999664  44432                    22


Q ss_pred             CCCHHHHHHHHHhcCCCCCCCCCHHhhhc
Q 014609          219 WLSPGAQNLLRKILEPNPVKRITIAGIKA  247 (421)
Q Consensus       219 ~~s~~~~~li~~~L~~dP~~R~t~~eil~  247 (421)
                      .++.++.+++.+||..||.+|||+.+++.
T Consensus       235 ~~~~~~~~li~~~l~~~p~~Rps~~~il~  263 (270)
T cd05047         235 NCDDEVYDLMRQCWREKPYERPSFAQILV  263 (270)
T ss_pred             cCCHHHHHHHHHHcccChhhCCCHHHHHH
Confidence            35788999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=2.2e-37  Score=295.34  Aligned_cols=232  Identities=23%  Similarity=0.311  Sum_probs=191.4

Q ss_pred             ecceEEeceEeecCcEEEEEEEECC----CCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEe-CC
Q 014609           13 LGRYELGRTLGEGNFGKVKFAQDLD----SGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLAS-KS   87 (421)
Q Consensus        13 ~~~y~i~~~LG~G~~g~V~~a~~~~----~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~-~~   87 (421)
                      -++|++.+.||+|+||.||+|.+..    ++..||+|.+....  .......+.+|+.++++++||||+++++++.. +.
T Consensus         5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~--~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~   82 (280)
T cd05043           5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHA--SEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGE   82 (280)
T ss_pred             hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCC--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCC
Confidence            4689999999999999999999865    36889999886432  33446778999999999999999999998765 56


Q ss_pred             EEEEEEeccCCCChHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEecc
Q 014609           88 KIYMVLEYVTGGELFDKIASK--------GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFG  159 (421)
Q Consensus        88 ~~~lv~E~~~gg~L~~~i~~~--------~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFG  159 (421)
                      ..++++||+++++|.+++...        ..+++..+..++.|++.||+|||+++++||||||+||+++.++.+||+|||
T Consensus        83 ~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~~~~~kl~d~g  162 (280)
T cd05043          83 PPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQVKITDNA  162 (280)
T ss_pred             CCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcCCCcEEECCCC
Confidence            789999999999999988653        358899999999999999999999999999999999999999999999999


Q ss_pred             CCCCCccccCCCccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhhc--CCcCC--------------------C
Q 014609          160 LSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIFR--GDFKL--------------------P  217 (421)
Q Consensus       160 la~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~~--~~~~~--------------------p  217 (421)
                      +++...............++..|+|||++.+..+ +.++|||||||++|.+.  |..++                    +
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~-~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~  241 (280)
T cd05043         163 LSRDLFPMDYHCLGDNENRPVKWMALESLVNKEY-SSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLKDGYRLAQP  241 (280)
T ss_pred             CcccccCCceEEeCCCCCcchhccCHHHHhcCCC-CchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHHHHHHcCCCCCCC
Confidence            9975432111111122345678999999987776 58899999999999654  43332                    2


Q ss_pred             CCCCHHHHHHHHHhcCCCCCCCCCHHhhhc
Q 014609          218 KWLSPGAQNLLRKILEPNPVKRITIAGIKA  247 (421)
Q Consensus       218 ~~~s~~~~~li~~~L~~dP~~R~t~~eil~  247 (421)
                      ..+++.+.+++.+||..||++|||+.++++
T Consensus       242 ~~~~~~~~~li~~~l~~~p~~Rps~~~~~~  271 (280)
T cd05043         242 INCPDELFAVMACCWALDPEERPSFSQLVQ  271 (280)
T ss_pred             CcCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence            345789999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=100.00  E-value=2.3e-37  Score=290.49  Aligned_cols=228  Identities=29%  Similarity=0.435  Sum_probs=191.9

Q ss_pred             eEEeceEeecCcEEEEEEEECCCC----ceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEE
Q 014609           16 YELGRTLGEGNFGKVKFAQDLDSG----LPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYM   91 (421)
Q Consensus        16 y~i~~~LG~G~~g~V~~a~~~~~~----~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l   91 (421)
                      +++.+.||.|+||.||+|.+..++    ..||+|.+.....  ......+.+|+.+++.++||||+++++++.+.+..|+
T Consensus         1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   78 (258)
T smart00219        1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDAD--EQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMI   78 (258)
T ss_pred             CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCC--hHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEE
Confidence            467899999999999999998766    8999999865432  2245789999999999999999999999999999999


Q ss_pred             EEeccCCCChHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCccccC
Q 014609           92 VLEYVTGGELFDKIASKGR--LQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD  169 (421)
Q Consensus        92 v~E~~~gg~L~~~i~~~~~--~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~  169 (421)
                      +|||+++++|.+.+.....  +++..+..++.|++.||+|||+.|++||||||+||+++.++.++|+|||++........
T Consensus        79 i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~  158 (258)
T smart00219       79 VMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDY  158 (258)
T ss_pred             EEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEccCCeEEEcccCCceecccccc
Confidence            9999999999999876444  99999999999999999999999999999999999999999999999999975543211


Q ss_pred             CCccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhhc--CCcC--------------------CCCCCCHHHHHH
Q 014609          170 DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIFR--GDFK--------------------LPKWLSPGAQNL  227 (421)
Q Consensus       170 ~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~~--~~~~--------------------~p~~~s~~~~~l  227 (421)
                      .. .....+++.|+|||.+.+..+ +.++|+||+|+++|.+.  |..+                    .+...+..+.++
T Consensus       159 ~~-~~~~~~~~~y~~Pe~~~~~~~-~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (258)
T smart00219      159 YK-KKGGKLPIRWMAPESLKDGKF-TSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLKKGYRLPKPENCPPEIYKL  236 (258)
T ss_pred             cc-cccCCCcccccChHHhccCCC-CcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCcCCHHHHHH
Confidence            11 112236789999999866655 58999999999999553  3332                    234478999999


Q ss_pred             HHHhcCCCCCCCCCHHhhhc
Q 014609          228 LRKILEPNPVKRITIAGIKA  247 (421)
Q Consensus       228 i~~~L~~dP~~R~t~~eil~  247 (421)
                      +.+||..||.+|||+.++++
T Consensus       237 i~~~l~~~p~~Rpt~~~ll~  256 (258)
T smart00219      237 MLQCWAEDPEDRPTFSELVE  256 (258)
T ss_pred             HHHHCcCChhhCcCHHHHHh
Confidence            99999999999999999875

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=2.1e-37  Score=292.37  Aligned_cols=227  Identities=26%  Similarity=0.420  Sum_probs=188.4

Q ss_pred             ecceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEE
Q 014609           13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMV   92 (421)
Q Consensus        13 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv   92 (421)
                      -++|++++.||+|+||.||+|.+ .+++.||+|.+......    ...+.+|+.++++++||||+++++++. .+..|++
T Consensus         5 ~~~~~~~~~ig~G~~g~v~~~~~-~~~~~~a~K~~~~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v   78 (260)
T cd05067           5 RETLKLVKKLGAGQFGEVWMGYY-NGHTKVAIKSLKQGSMS----PEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYII   78 (260)
T ss_pred             hHHceeeeeeccCccceEEeeec-CCCceEEEEEecCCCCc----HHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEE
Confidence            36799999999999999999985 46788999998754321    357889999999999999999999874 4578999


Q ss_pred             EeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCccccCC
Q 014609           93 LEYVTGGELFDKIASK--GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD  170 (421)
Q Consensus        93 ~E~~~gg~L~~~i~~~--~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~  170 (421)
                      |||+++++|.+.+...  ..+++..+..++.|++.||+|||+.|++||||||+||+++.++.++|+|||++....... .
T Consensus        79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~-~  157 (260)
T cd05067          79 TEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNE-Y  157 (260)
T ss_pred             EEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcCCCCEEEccCcceeecCCCC-c
Confidence            9999999999988653  468999999999999999999999999999999999999999999999999987543211 1


Q ss_pred             CccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhhc--CCcCC--------------------CCCCCHHHHHHH
Q 014609          171 GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIFR--GDFKL--------------------PKWLSPGAQNLL  228 (421)
Q Consensus       171 ~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~~--~~~~~--------------------p~~~s~~~~~li  228 (421)
                      .......++..|+|||++....+ +.++||||+|+++|.+.  |..++                    |...+.++.+++
T Consensus       158 ~~~~~~~~~~~y~~pe~~~~~~~-~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  236 (260)
T cd05067         158 TAREGAKFPIKWTAPEAINYGTF-TIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGYRMPRPDNCPEELYELM  236 (260)
T ss_pred             ccccCCcccccccCHHHhccCCc-CcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCCCCCCCCCHHHHHHH
Confidence            11122345678999999877666 58899999999999543  44433                    233568899999


Q ss_pred             HHhcCCCCCCCCCHHhhhc
Q 014609          229 RKILEPNPVKRITIAGIKA  247 (421)
Q Consensus       229 ~~~L~~dP~~R~t~~eil~  247 (421)
                      .+||..+|++|||+++++.
T Consensus       237 ~~~l~~~p~~Rp~~~~l~~  255 (260)
T cd05067         237 RLCWKEKPEERPTFEYLRS  255 (260)
T ss_pred             HHHccCChhhCCCHHHHHH
Confidence            9999999999999999864

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=3.3e-37  Score=292.14  Aligned_cols=232  Identities=23%  Similarity=0.364  Sum_probs=192.0

Q ss_pred             ecceEEeceEeecCcEEEEEEEECCCCc---eEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEE
Q 014609           13 LGRYELGRTLGEGNFGKVKFAQDLDSGL---PFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKI   89 (421)
Q Consensus        13 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~---~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~   89 (421)
                      ..+|+..+.||+|+||.||+|.+..++.   .+|+|.+....  .....+.+.+|+++++.++||||+++++++...+..
T Consensus         4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   81 (268)
T cd05063           4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGY--TEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPA   81 (268)
T ss_pred             hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccC--CHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCc
Confidence            3578999999999999999999876554   79999886542  223356788999999999999999999999999999


Q ss_pred             EEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCcccc
Q 014609           90 YMVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFR  168 (421)
Q Consensus        90 ~lv~E~~~gg~L~~~i~~-~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~~  168 (421)
                      |+||||+++++|.+++.. .+.+++..+..++.|++.|++|||+.|++||||||+||+++.++.+||+|||++.......
T Consensus        82 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~  161 (268)
T cd05063          82 MIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDP  161 (268)
T ss_pred             EEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEcCCCcEEECCCccceeccccc
Confidence            999999999999998875 3578999999999999999999999999999999999999999999999999987543321


Q ss_pred             CCCcc-ccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhh-c-CCcCC--------------------CCCCCHHHH
Q 014609          169 DDGLL-HTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIF-R-GDFKL--------------------PKWLSPGAQ  225 (421)
Q Consensus       169 ~~~~~-~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~-~-~~~~~--------------------p~~~s~~~~  225 (421)
                      ..... .....++.|+|||++....+ +.++|||||||++|.+ . |..++                    +...+..+.
T Consensus       162 ~~~~~~~~~~~~~~y~~PE~~~~~~~-~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  240 (268)
T cd05063         162 EGTYTTSGGKIPIRWTAPEAIAYRKF-TSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGFRLPAPMDCPSAVY  240 (268)
T ss_pred             ccceeccCCCcCceecCHHHhhcCCc-ChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhcCCCCCCCCCCCHHHH
Confidence            11111 11123457999999887766 5889999999999963 3 55443                    223578899


Q ss_pred             HHHHHhcCCCCCCCCCHHhhhc
Q 014609          226 NLLRKILEPNPVKRITIAGIKA  247 (421)
Q Consensus       226 ~li~~~L~~dP~~R~t~~eil~  247 (421)
                      +++.+||+.+|++||++.++++
T Consensus       241 ~li~~c~~~~p~~Rp~~~~i~~  262 (268)
T cd05063         241 QLMLQCWQQDRARRPRFVDIVN  262 (268)
T ss_pred             HHHHHHcCCCcccCcCHHHHHH
Confidence            9999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=100.00  E-value=4.4e-37  Score=289.11  Aligned_cols=229  Identities=24%  Similarity=0.403  Sum_probs=191.0

Q ss_pred             ecceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEE
Q 014609           13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMV   92 (421)
Q Consensus        13 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv   92 (421)
                      ..+|++.+.||+|+||.||+|.+. ++..+|+|.+......    ...+.+|++++++++||||+++++++......|+|
T Consensus         3 ~~~~~~~~~ig~g~~g~v~~~~~~-~~~~~~~k~~~~~~~~----~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v   77 (256)
T cd05112           3 PSELTLVQEIGSGQFGLVWLGYWL-EKRKVAIKTIREGAMS----EEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLV   77 (256)
T ss_pred             hhHeEEEeeecCcccceEEEEEEe-CCCeEEEEECCCCCCC----HHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEE
Confidence            357999999999999999999874 4778999998654322    35688999999999999999999999999999999


Q ss_pred             EeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCccccCCC
Q 014609           93 LEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDG  171 (421)
Q Consensus        93 ~E~~~gg~L~~~i~~~-~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~  171 (421)
                      |||+++++|.+++... +.++++.++.++.|++.|++|||++|++||||||+||+++.++.++|+|||++....... ..
T Consensus        78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~-~~  156 (256)
T cd05112          78 FEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQ-YT  156 (256)
T ss_pred             EEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcCCCeEEECCCcceeecccCc-cc
Confidence            9999999999988753 468999999999999999999999999999999999999999999999999987432211 01


Q ss_pred             ccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhhc--CCcCC--------------------CCCCCHHHHHHHH
Q 014609          172 LLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIFR--GDFKL--------------------PKWLSPGAQNLLR  229 (421)
Q Consensus       172 ~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~~--~~~~~--------------------p~~~s~~~~~li~  229 (421)
                      ......++..|+|||.+.+..+ +.++|+||||+++|.+.  |..++                    |...+..+.+++.
T Consensus       157 ~~~~~~~~~~~~aPe~~~~~~~-~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  235 (256)
T cd05112         157 SSTGTKFPVKWSSPEVFSFSKY-SSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGFRLYKPRLASQSVYELMQ  235 (256)
T ss_pred             ccCCCccchhhcCHhHhccCCc-ChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHhCCCCCCCCCCCCHHHHHHHH
Confidence            1112234568999999887666 58899999999999654  33332                    3336788999999


Q ss_pred             HhcCCCCCCCCCHHhhhcC
Q 014609          230 KILEPNPVKRITIAGIKAD  248 (421)
Q Consensus       230 ~~L~~dP~~R~t~~eil~~  248 (421)
                      +||+.+|++|||+.++++.
T Consensus       236 ~~l~~~p~~Rp~~~~~l~~  254 (256)
T cd05112         236 HCWKERPEDRPSFSLLLHQ  254 (256)
T ss_pred             HHcccChhhCCCHHHHHHh
Confidence            9999999999999998763

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.4e-38  Score=315.97  Aligned_cols=234  Identities=26%  Similarity=0.518  Sum_probs=201.6

Q ss_pred             cce-EEeceEeecCcEEEEEEEECCCCceEEEEEeeccccc-chhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCE--E
Q 014609           14 GRY-ELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRII-HLKITDQIKREIATLKLLKHPNVVRLHEVLASKSK--I   89 (421)
Q Consensus        14 ~~y-~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~-~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~--~   89 (421)
                      ||| +....||+|+|-+||+|.|..+|..||.-.++..... .....+++..|+.+|+.|+||||+++|+++.+...  +
T Consensus        39 gRy~k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~i  118 (632)
T KOG0584|consen   39 GRYLKFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTI  118 (632)
T ss_pred             CceeehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCcee
Confidence            556 3467899999999999999999999998665543332 34446899999999999999999999999987765  8


Q ss_pred             EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC--CceeccCCCCCEEeccC-CCEEEEeccCCCCCcc
Q 014609           90 YMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNK--GVFHRDLKLENILLDSK-GNIKISDFGLSALPQH  166 (421)
Q Consensus        90 ~lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~ql~~aL~~LH~~--gi~HrDlkp~NILl~~~-~~~kL~DFGla~~~~~  166 (421)
                      -+|+|++.+|+|..++.+.+.++...++.|++||+.||.|||++  .|+|||||-+||+|+.+ |.+||+|+|||++...
T Consensus       119 n~iTEL~TSGtLr~Y~kk~~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~  198 (632)
T KOG0584|consen  119 NFITELFTSGTLREYRKKHRRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRK  198 (632)
T ss_pred             eeeeecccCCcHHHHHHHhccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchhHHHHhhc
Confidence            89999999999999999999999999999999999999999998  59999999999999866 8999999999997543


Q ss_pred             ccCCCccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhh-hcCCcCCCCC----------------------CCHH
Q 014609          167 FRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYI-FRGDFKLPKW----------------------LSPG  223 (421)
Q Consensus       167 ~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~-~~~~~~~p~~----------------------~s~~  223 (421)
                          .......|||.|||||++. ..|+ ..+||||||+.+.+ .++.+|+...                      -.++
T Consensus       199 ----s~aksvIGTPEFMAPEmYE-E~Yn-E~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP~sl~kV~dPe  272 (632)
T KOG0584|consen  199 ----SHAKSVIGTPEFMAPEMYE-ENYN-ELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKPAALSKVKDPE  272 (632)
T ss_pred             ----cccceeccCccccChHHHh-hhcc-hhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCHHHhhccCCHH
Confidence                3344578999999999876 6786 99999999988874 4566665422                      2588


Q ss_pred             HHHHHHHhcCCCCCCCCCHHhhhcCcccccc
Q 014609          224 AQNLLRKILEPNPVKRITIAGIKADEWFEQD  254 (421)
Q Consensus       224 ~~~li~~~L~~dP~~R~t~~eil~~~w~~~~  254 (421)
                      ++++|.+||.. .+.|+|+.|+|.||||..+
T Consensus       273 vr~fIekCl~~-~~~R~sa~eLL~d~Ff~~d  302 (632)
T KOG0584|consen  273 VREFIEKCLAT-KSERLSAKELLKDPFFDED  302 (632)
T ss_pred             HHHHHHHHhcC-chhccCHHHHhhChhhccc
Confidence            99999999999 9999999999999999875

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=5.8e-37  Score=287.26  Aligned_cols=223  Identities=27%  Similarity=0.422  Sum_probs=184.9

Q ss_pred             ceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEEeccCCC
Q 014609           20 RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGG   99 (421)
Q Consensus        20 ~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~~gg   99 (421)
                      +.||+|+||.||+|.. .++..+|+|.+....  .......+.+|+.+++.++||||+++++++...+..++||||++++
T Consensus         1 ~~ig~g~~g~vy~~~~-~~~~~~a~K~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~   77 (250)
T cd05085           1 ELLGKGNFGEVFKGTL-KDKTPVAVKTCKEDL--PQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGG   77 (250)
T ss_pred             CccCCCCCceEEEEEe-cCCcEEEEEecCCcC--CHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCC
Confidence            4689999999999985 468899999986543  2223456889999999999999999999999999999999999999


Q ss_pred             ChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCccccCCCccccccC
Q 014609          100 ELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCG  178 (421)
Q Consensus       100 ~L~~~i~~~-~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~g  178 (421)
                      +|.+++... ..+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++...... .........+
T Consensus        78 ~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~-~~~~~~~~~~  156 (250)
T cd05085          78 DFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDG-IYSSSGLKQI  156 (250)
T ss_pred             cHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCCCeEEECCCccceecccc-ccccCCCCCC
Confidence            999988753 46799999999999999999999999999999999999999999999999998643211 0111112244


Q ss_pred             CCCccChhhhcccCCCCCcchHHHHHHHHhhhc--CCcCC--------------------CCCCCHHHHHHHHHhcCCCC
Q 014609          179 SPNYVAPEVLANRGYDGATSDIWSCGVILYIFR--GDFKL--------------------PKWLSPGAQNLLRKILEPNP  236 (421)
Q Consensus       179 t~~y~APEvl~~~~~~~~~~DiwSlGvil~~~~--~~~~~--------------------p~~~s~~~~~li~~~L~~dP  236 (421)
                      ++.|+|||++....+ +.++||||+|+++|.+.  |..++                    |..++..+.+++.+||..+|
T Consensus       157 ~~~y~aPE~~~~~~~-~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p  235 (250)
T cd05085         157 PIKWTAPEALNYGRY-SSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGYRMSCPQKCPDDVYKVMQRCWDYKP  235 (250)
T ss_pred             cccccCHHHhccCCC-CchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcccCc
Confidence            567999999877666 58899999999999543  43332                    34477999999999999999


Q ss_pred             CCCCCHHhhhc
Q 014609          237 VKRITIAGIKA  247 (421)
Q Consensus       237 ~~R~t~~eil~  247 (421)
                      ++||++.++.+
T Consensus       236 ~~Rp~~~~l~~  246 (250)
T cd05085         236 ENRPKFSELQK  246 (250)
T ss_pred             ccCCCHHHHHH
Confidence            99999999865

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=100.00  E-value=2.7e-37  Score=298.76  Aligned_cols=233  Identities=24%  Similarity=0.338  Sum_probs=190.9

Q ss_pred             eecceEEeceEeecCcEEEEEEEECCCCc----eEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCC
Q 014609           12 RLGRYELGRTLGEGNFGKVKFAQDLDSGL----PFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKS   87 (421)
Q Consensus        12 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~----~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~   87 (421)
                      ..++|+..+.||+|+||.||+|.+..+|+    .||+|.+.....  ......+.+|+.+++.++||||+++++++... 
T Consensus         5 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-   81 (303)
T cd05110           5 KETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTG--PKANVEFMDEALIMASMDHPHLVRLLGVCLSP-   81 (303)
T ss_pred             chhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCC--HHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-
Confidence            34689999999999999999999877776    468888764322  22234688999999999999999999998765 


Q ss_pred             EEEEEEeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCcc
Q 014609           88 KIYMVLEYVTGGELFDKIASKG-RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQH  166 (421)
Q Consensus        88 ~~~lv~E~~~gg~L~~~i~~~~-~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~  166 (421)
                      ..++++||+++|+|.+.+.... .+++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||++.....
T Consensus        82 ~~~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~  161 (303)
T cd05110          82 TIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEG  161 (303)
T ss_pred             CceeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeecCCCceEEccccccccccC
Confidence            4679999999999999987643 689999999999999999999999999999999999999999999999999985533


Q ss_pred             ccCCCccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhhc--CCcCC--------------------CCCCCHHH
Q 014609          167 FRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIFR--GDFKL--------------------PKWLSPGA  224 (421)
Q Consensus       167 ~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~~--~~~~~--------------------p~~~s~~~  224 (421)
                      ...........++..|+|||++.+..+ +.++|||||||++|.+.  |..++                    ++..+..+
T Consensus       162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~-~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (303)
T cd05110         162 DEKEYNADGGKMPIKWMALECIHYRKF-THQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEKGERLPQPPICTIDV  240 (303)
T ss_pred             cccccccCCCccccccCCHHHhccCCC-ChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHH
Confidence            211112223445778999999887766 58899999999999653  33332                    23357788


Q ss_pred             HHHHHHhcCCCCCCCCCHHhhhcC
Q 014609          225 QNLLRKILEPNPVKRITIAGIKAD  248 (421)
Q Consensus       225 ~~li~~~L~~dP~~R~t~~eil~~  248 (421)
                      .+++.+||..+|++||++.++++.
T Consensus       241 ~~li~~c~~~~p~~Rp~~~~l~~~  264 (303)
T cd05110         241 YMVMVKCWMIDADSRPKFKELAAE  264 (303)
T ss_pred             HHHHHHHcCCChhhCcCHHHHHHH
Confidence            999999999999999999998775

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=2.5e-37  Score=290.83  Aligned_cols=217  Identities=23%  Similarity=0.258  Sum_probs=180.6

Q ss_pred             ceEeecCcEEEEEEEECCCC----------ceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEE
Q 014609           20 RTLGEGNFGKVKFAQDLDSG----------LPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKI   89 (421)
Q Consensus        20 ~~LG~G~~g~V~~a~~~~~~----------~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~   89 (421)
                      +.||+|+||.||+|.+..++          ..+++|++.....    ....+.+|+.++++++||||+++++++.. ...
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~   75 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHR----DSLAFFETASLMSQLSHKHLVKLYGVCVR-DEN   75 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchh----hHHHHHHHHHHHHcCCCcchhheeeEEec-CCc
Confidence            47999999999999987766          3588887754321    14678899999999999999999999988 778


Q ss_pred             EEEEeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCC-------CEEEEeccCC
Q 014609           90 YMVLEYVTGGELFDKIASKG-RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKG-------NIKISDFGLS  161 (421)
Q Consensus        90 ~lv~E~~~gg~L~~~i~~~~-~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~-------~~kL~DFGla  161 (421)
                      ++||||+++++|.+++.... .++...+..++.||+.||+|||++||+||||||+|||++.++       .+||+|||++
T Consensus        76 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a  155 (259)
T cd05037          76 IMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIP  155 (259)
T ss_pred             EEEEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEEeCCCCcc
Confidence            99999999999999998755 789999999999999999999999999999999999999888       7999999998


Q ss_pred             CCCccccCCCccccccCCCCccChhhhccc-CCCCCcchHHHHHHHHhhhcC--CcCC------------------CCCC
Q 014609          162 ALPQHFRDDGLLHTTCGSPNYVAPEVLANR-GYDGATSDIWSCGVILYIFRG--DFKL------------------PKWL  220 (421)
Q Consensus       162 ~~~~~~~~~~~~~~~~gt~~y~APEvl~~~-~~~~~~~DiwSlGvil~~~~~--~~~~------------------p~~~  220 (421)
                      .....      .....++..|+|||++... ...+.++||||+||++|.+..  ..++                  |...
T Consensus       156 ~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~  229 (259)
T cd05037         156 ITVLS------REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQDQHRLPMPD  229 (259)
T ss_pred             ccccc------ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHHhcCCCCCCCC
Confidence            74322      2234567889999998765 233688999999999996532  3322                  1112


Q ss_pred             CHHHHHHHHHhcCCCCCCCCCHHhhhc
Q 014609          221 SPGAQNLLRKILEPNPVKRITIAGIKA  247 (421)
Q Consensus       221 s~~~~~li~~~L~~dP~~R~t~~eil~  247 (421)
                      ...+.++|.+||..+|.+|||+.++++
T Consensus       230 ~~~~~~li~~~l~~~p~~Rpt~~~il~  256 (259)
T cd05037         230 CAELANLINQCWTYDPTKRPSFRAILR  256 (259)
T ss_pred             chHHHHHHHHHhccChhhCCCHHHHHH
Confidence            368889999999999999999999875

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=3.7e-37  Score=292.09  Aligned_cols=225  Identities=23%  Similarity=0.285  Sum_probs=176.3

Q ss_pred             ceEeecCcEEEEEEEEC--CCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEEeccC
Q 014609           20 RTLGEGNFGKVKFAQDL--DSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVT   97 (421)
Q Consensus        20 ~~LG~G~~g~V~~a~~~--~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~~   97 (421)
                      +.||+|+||+||+|...  .....+|+|.+....  .......+.+|+.+++.++||||+++++.+......|+||||++
T Consensus         1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~   78 (269)
T cd05042           1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASA--TPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCP   78 (269)
T ss_pred             CcCCccCCceEEEEEEecCCCCeEEEEeecCccC--ChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCC
Confidence            46999999999999643  245678888775432  22234568899999999999999999999999999999999999


Q ss_pred             CCChHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCccccCCCc
Q 014609           98 GGELFDKIASKG-----RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGL  172 (421)
Q Consensus        98 gg~L~~~i~~~~-----~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~  172 (421)
                      +|+|.+++....     ..++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++...........
T Consensus        79 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~  158 (269)
T cd05042          79 LGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYIT  158 (269)
T ss_pred             CCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecCCCcEEEeccccccccccchheec
Confidence            999999987643     246788899999999999999999999999999999999999999999999864322111111


Q ss_pred             cccccCCCCccChhhhccc------CCCCCcchHHHHHHHHhhhc--CCcCCC-------------------------CC
Q 014609          173 LHTTCGSPNYVAPEVLANR------GYDGATSDIWSCGVILYIFR--GDFKLP-------------------------KW  219 (421)
Q Consensus       173 ~~~~~gt~~y~APEvl~~~------~~~~~~~DiwSlGvil~~~~--~~~~~p-------------------------~~  219 (421)
                      .....+++.|+|||++...      ...+.++||||+||++|.+.  +..+++                         ..
T Consensus       159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (269)
T cd05042         159 KDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKLPKPQLDLK  238 (269)
T ss_pred             cCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhccCccCCCCccccc
Confidence            1233456789999997532      22357899999999999543  332221                         13


Q ss_pred             CCHHHHHHHHHhcCCCCCCCCCHHhhhc
Q 014609          220 LSPGAQNLLRKILEPNPVKRITIAGIKA  247 (421)
Q Consensus       220 ~s~~~~~li~~~L~~dP~~R~t~~eil~  247 (421)
                      +++...+++..|+ .||++|||++++++
T Consensus       239 ~~~~~~~~~~~~~-~dp~~Rpt~~~v~~  265 (269)
T cd05042         239 YSDRWYEVMQFCW-LDPETRPTAEEVHE  265 (269)
T ss_pred             CCHHHHHHHHHHh-cCcccccCHHHHHH
Confidence            5677888999998 59999999999875

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=100.00  E-value=2.3e-37  Score=293.18  Aligned_cols=225  Identities=26%  Similarity=0.380  Sum_probs=184.7

Q ss_pred             ceEeecCcEEEEEEEECCCC------ceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEE
Q 014609           20 RTLGEGNFGKVKFAQDLDSG------LPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVL   93 (421)
Q Consensus        20 ~~LG~G~~g~V~~a~~~~~~------~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~   93 (421)
                      +.||+|+||.||+|.+....      +.+|+|.+.....  ......+.+|+.+++.++||||+++++++......|+||
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   78 (269)
T cd05044           1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGAT--DQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIM   78 (269)
T ss_pred             CccccccceeEEeeeecccccCcccceeehhhhhhcccc--hhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEE
Confidence            46899999999999876543      7899998864321  123567889999999999999999999999999999999


Q ss_pred             eccCCCChHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCC-----CEEEEeccCC
Q 014609           94 EYVTGGELFDKIASK-------GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKG-----NIKISDFGLS  161 (421)
Q Consensus        94 E~~~gg~L~~~i~~~-------~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~-----~~kL~DFGla  161 (421)
                      ||+++++|.+++...       ..+++..+..++.|++.||+|||+.+++|+||||+||+++.++     .++|+|||++
T Consensus        79 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~  158 (269)
T cd05044          79 ELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLA  158 (269)
T ss_pred             eccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEECCcccc
Confidence            999999999998642       3478899999999999999999999999999999999999887     8999999998


Q ss_pred             CCCccccCCCccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhhc--CCcCC--------------------CCC
Q 014609          162 ALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIFR--GDFKL--------------------PKW  219 (421)
Q Consensus       162 ~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~~--~~~~~--------------------p~~  219 (421)
                      ................++..|+|||++.+..+ +.++|||||||++|.+.  |..++                    +..
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  237 (269)
T cd05044         159 RDIYKSDYYRKEGEGLLPVRWMAPESLLDGKF-TTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAGGRLQKPEN  237 (269)
T ss_pred             cccccccccccCcccCCCccccCHHHHccCCc-ccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHHhcCCccCCccc
Confidence            74322111111223345778999999987766 58999999999999653  44332                    334


Q ss_pred             CCHHHHHHHHHhcCCCCCCCCCHHhhhc
Q 014609          220 LSPGAQNLLRKILEPNPVKRITIAGIKA  247 (421)
Q Consensus       220 ~s~~~~~li~~~L~~dP~~R~t~~eil~  247 (421)
                      +|..+.++|.+||.++|.+||++.++++
T Consensus       238 ~~~~~~~li~~~l~~~p~~Rp~~~~i~~  265 (269)
T cd05044         238 CPDKIYQLMTNCWAQDPSERPTFDRIQE  265 (269)
T ss_pred             chHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence            6788999999999999999999999864

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-38  Score=299.48  Aligned_cols=230  Identities=31%  Similarity=0.493  Sum_probs=191.6

Q ss_pred             ecceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCC--C----CcceEEEEEEeC
Q 014609           13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKH--P----NVVRLHEVLASK   86 (421)
Q Consensus        13 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~h--p----nIv~l~~~~~~~   86 (421)
                      -+||++..++|+|.||+|-.+.|..++..||||+++.-.    ...+...-|+++|.++.+  |    -++.+.++|...
T Consensus        88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~----kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyr  163 (415)
T KOG0671|consen   88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVD----KYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYR  163 (415)
T ss_pred             ccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHH----HHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhcc
Confidence            479999999999999999999999999999999996432    234567779999999942  3    378888999999


Q ss_pred             CEEEEEEeccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecc---------------
Q 014609           87 SKIYMVLEYVTGGELFDKIASKG--RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDS---------------  149 (421)
Q Consensus        87 ~~~~lv~E~~~gg~L~~~i~~~~--~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~---------------  149 (421)
                      ++.|||+|.+ |.+++|++..++  +++...++.+..||+++++|||+.+++|-||||||||+.+               
T Consensus       164 ghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~~~~k~~~~~  242 (415)
T KOG0671|consen  164 GHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKTYNPKKKVCF  242 (415)
T ss_pred             CceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEEeccCCccce
Confidence            9999999999 889999998755  6899999999999999999999999999999999999943               


Q ss_pred             -----CCCEEEEeccCCCCCccccCCCccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhhc-------------
Q 014609          150 -----KGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIFR-------------  211 (421)
Q Consensus       150 -----~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~~-------------  211 (421)
                           +-.++|+|||.|+.-..     --.+...|..|+|||++.+-++ +.++||||+||||+++.             
T Consensus       243 ~r~~ks~~I~vIDFGsAtf~~e-----~hs~iVsTRHYRAPEViLgLGw-S~pCDvWSiGCIL~ElytG~~LFqtHen~E  316 (415)
T KOG0671|consen  243 IRPLKSTAIKVIDFGSATFDHE-----HHSTIVSTRHYRAPEVILGLGW-SQPCDVWSIGCILVELYTGETLFQTHENLE  316 (415)
T ss_pred             eccCCCcceEEEecCCcceecc-----CcceeeeccccCCchheeccCc-CCccCceeeeeEEEEeeccceecccCCcHH
Confidence                 22589999999985332     2256678999999999999999 59999999999998221             


Q ss_pred             ---------C-------------------CcCCCCCC-------------------------CHHHHHHHHHhcCCCCCC
Q 014609          212 ---------G-------------------DFKLPKWL-------------------------SPGAQNLLRKILEPNPVK  238 (421)
Q Consensus       212 ---------~-------------------~~~~p~~~-------------------------s~~~~~li~~~L~~dP~~  238 (421)
                               |                   ...+|...                         -..+.+||++||..||.+
T Consensus       317 HLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~  396 (415)
T KOG0671|consen  317 HLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPAR  396 (415)
T ss_pred             HHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCccc
Confidence                     1                   11112110                         134679999999999999


Q ss_pred             CCCHHhhhcCccccc
Q 014609          239 RITIAGIKADEWFEQ  253 (421)
Q Consensus       239 R~t~~eil~~~w~~~  253 (421)
                      |+|+.|++.||||..
T Consensus       397 RiTl~EAL~HpFF~~  411 (415)
T KOG0671|consen  397 RITLREALSHPFFAR  411 (415)
T ss_pred             cccHHHHhcCHHhhc
Confidence            999999999999985

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=100.00  E-value=6.8e-37  Score=288.79  Aligned_cols=226  Identities=26%  Similarity=0.357  Sum_probs=181.3

Q ss_pred             ceEeecCcEEEEEEEECC---CCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEE-eCCEEEEEEec
Q 014609           20 RTLGEGNFGKVKFAQDLD---SGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLA-SKSKIYMVLEY   95 (421)
Q Consensus        20 ~~LG~G~~g~V~~a~~~~---~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~-~~~~~~lv~E~   95 (421)
                      +.||+|+||.||+|.+..   .+..||+|.+....  .....+.+.+|+.+++.++||||+++++++. .++..|++|||
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~   78 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRIT--DLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPY   78 (262)
T ss_pred             CcccccCCceEEEEEEecCCCceEEEEEEecCccC--CHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEec
Confidence            468999999999998653   34679999875322  2333567889999999999999999999765 45668999999


Q ss_pred             cCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCccccC--CCc
Q 014609           96 VTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD--DGL  172 (421)
Q Consensus        96 ~~gg~L~~~i~~~-~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~--~~~  172 (421)
                      +++++|.+++... ...++..+..++.|++.||+|||+.+++||||||+|||++.++.+||+|||++........  ...
T Consensus        79 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~  158 (262)
T cd05058          79 MKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHN  158 (262)
T ss_pred             CCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCccccccccCCcceeecc
Confidence            9999999998763 3467788889999999999999999999999999999999999999999999874322110  011


Q ss_pred             cccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhhcC-C-cCC--------------------CCCCCHHHHHHHHH
Q 014609          173 LHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIFRG-D-FKL--------------------PKWLSPGAQNLLRK  230 (421)
Q Consensus       173 ~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~~~-~-~~~--------------------p~~~s~~~~~li~~  230 (421)
                      .....+++.|+|||.+....+ +.++|||||||++|.+.. . .++                    |..+++.+.+++.+
T Consensus       159 ~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  237 (262)
T cd05058         159 HTGAKLPVKWMALESLQTQKF-TTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQGRRLLQPEYCPDPLYEVMLS  237 (262)
T ss_pred             cccCcCCccccChhHhccCcc-chHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCCCCCCcCCHHHHHHHHH
Confidence            123345678999999887766 589999999999996532 2 221                    33467899999999


Q ss_pred             hcCCCCCCCCCHHhhhcC
Q 014609          231 ILEPNPVKRITIAGIKAD  248 (421)
Q Consensus       231 ~L~~dP~~R~t~~eil~~  248 (421)
                      ||.++|++||++.+++..
T Consensus       238 cl~~~p~~Rp~~~~il~~  255 (262)
T cd05058         238 CWHPKPEMRPTFSELVSR  255 (262)
T ss_pred             HcCCChhhCCCHHHHHHH
Confidence            999999999999998753

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=7e-37  Score=291.76  Aligned_cols=231  Identities=28%  Similarity=0.422  Sum_probs=190.2

Q ss_pred             cceEEeceEeecCcEEEEEEEEC----CCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEe--CC
Q 014609           14 GRYELGRTLGEGNFGKVKFAQDL----DSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLAS--KS   87 (421)
Q Consensus        14 ~~y~i~~~LG~G~~g~V~~a~~~----~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~--~~   87 (421)
                      .+|++.+.||+|+||.||+|...    .+++.+|+|++......  .....+.+|+++++.++||||+++++++..  ..
T Consensus         4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~--~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~   81 (284)
T cd05038           4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEE--QHRSDFEREIEILRTLDHENIVKYKGVCEKPGGR   81 (284)
T ss_pred             hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccch--HHHHHHHHHHHHHHhCCCCChheEEeeeecCCCC
Confidence            57889999999999999999864    35889999999755332  345789999999999999999999999887  56


Q ss_pred             EEEEEEeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCcc
Q 014609           88 KIYMVLEYVTGGELFDKIASKG-RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQH  166 (421)
Q Consensus        88 ~~~lv~E~~~gg~L~~~i~~~~-~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~  166 (421)
                      ..|++|||+++++|.+++.... .+++..+..++.|++.||+|||++|++||||||+||+++.++.++|+|||++.....
T Consensus        82 ~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~  161 (284)
T cd05038          82 SLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVLPE  161 (284)
T ss_pred             ceEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEccccccccccc
Confidence            7999999999999999987644 589999999999999999999999999999999999999999999999999986542


Q ss_pred             ccCC-CccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhhcC-CcC-----------------------------
Q 014609          167 FRDD-GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIFRG-DFK-----------------------------  215 (421)
Q Consensus       167 ~~~~-~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~~~-~~~-----------------------------  215 (421)
                      .... .......++..|+|||.+....+ +.++||||||+++|.+.. ..+                             
T Consensus       162 ~~~~~~~~~~~~~~~~~~~Pe~~~~~~~-~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (284)
T cd05038         162 DKDYYYVKEPGESPIFWYAPECLRTSKF-SSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLK  240 (284)
T ss_pred             CCcceeccCCCCCcccccCcHHHccCCC-CcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHHHH
Confidence            1111 11112344567999999877766 588999999999995432 211                             


Q ss_pred             ------CCCCCCHHHHHHHHHhcCCCCCCCCCHHhhhc
Q 014609          216 ------LPKWLSPGAQNLLRKILEPNPVKRITIAGIKA  247 (421)
Q Consensus       216 ------~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~  247 (421)
                            .|..++..+.+++.+||+++|.+|||+.++++
T Consensus       241 ~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~  278 (284)
T cd05038         241 EGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLIL  278 (284)
T ss_pred             cCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence                  12335678999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=100.00  E-value=5.9e-37  Score=288.29  Aligned_cols=222  Identities=28%  Similarity=0.486  Sum_probs=186.9

Q ss_pred             eecceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEE
Q 014609           12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYM   91 (421)
Q Consensus        12 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l   91 (421)
                      .+++|++.+.||+|+||.||++.  .+++.||+|.+....     ..+.+.+|+.++++++||||+++++++..+ ..|+
T Consensus         4 ~~~~~~~~~~lg~g~~g~v~~~~--~~~~~~~iK~~~~~~-----~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~   75 (254)
T cd05083           4 NLQKLTLGEIIGEGEFGAVLQGE--YTGQKVAVKNIKCDV-----TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYI   75 (254)
T ss_pred             cHHHceeeeeeccCCCCceEecc--cCCCceEEEeecCcc-----hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEE
Confidence            45789999999999999999986  478899999986432     246788999999999999999999998765 4799


Q ss_pred             EEeccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCccccC
Q 014609           92 VLEYVTGGELFDKIASKG--RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD  169 (421)
Q Consensus        92 v~E~~~gg~L~~~i~~~~--~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~  169 (421)
                      +|||+++++|.+++....  .+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++.....   
T Consensus        76 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~---  152 (254)
T cd05083          76 VMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSM---  152 (254)
T ss_pred             EEECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCcEEECCCccceeccc---
Confidence            999999999999987543  478999999999999999999999999999999999999999999999999874321   


Q ss_pred             CCccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhhc--CCcCC--------------------CCCCCHHHHHH
Q 014609          170 DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIFR--GDFKL--------------------PKWLSPGAQNL  227 (421)
Q Consensus       170 ~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~~--~~~~~--------------------p~~~s~~~~~l  227 (421)
                        .......+..|+|||.+.+..+ +.++|+||+||++|.+.  |..++                    +..+++.+.++
T Consensus       153 --~~~~~~~~~~y~~pe~~~~~~~-~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  229 (254)
T cd05083         153 --GVDNSKLPVKWTAPEALKHKKF-SSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGYRMEPPEGCPADVYVL  229 (254)
T ss_pred             --cCCCCCCCceecCHHHhccCCc-CchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhCCCCCCCCCcCCHHHHHH
Confidence              1112234567999999877666 58899999999999653  44443                    23367889999


Q ss_pred             HHHhcCCCCCCCCCHHhhhc
Q 014609          228 LRKILEPNPVKRITIAGIKA  247 (421)
Q Consensus       228 i~~~L~~dP~~R~t~~eil~  247 (421)
                      +.+||+.+|.+||++.+++.
T Consensus       230 i~~~l~~~p~~Rp~~~~l~~  249 (254)
T cd05083         230 MTSCWETEPKKRPSFHKLRE  249 (254)
T ss_pred             HHHHcCCChhhCcCHHHHHH
Confidence            99999999999999999865

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=100.00  E-value=9.3e-37  Score=289.54  Aligned_cols=231  Identities=26%  Similarity=0.392  Sum_probs=189.1

Q ss_pred             ecceEEeceEeecCcEEEEEEEECCC---CceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEE
Q 014609           13 LGRYELGRTLGEGNFGKVKFAQDLDS---GLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKI   89 (421)
Q Consensus        13 ~~~y~i~~~LG~G~~g~V~~a~~~~~---~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~   89 (421)
                      -.+|.+.+.||+|+||.||+|.+...   ...||+|......  .....+.+.+|+.+++.++||||+++++++.. ...
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~--~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~   81 (270)
T cd05056           5 REDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCT--SPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPV   81 (270)
T ss_pred             hhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcC--CHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCc
Confidence            35799999999999999999987543   4578999876432  23345688999999999999999999999875 457


Q ss_pred             EEEEeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCcccc
Q 014609           90 YMVLEYVTGGELFDKIASKG-RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFR  168 (421)
Q Consensus        90 ~lv~E~~~gg~L~~~i~~~~-~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~~  168 (421)
                      |+||||+++++|.+++.... .+++..+..++.|++.||+|||+.|++||||||+||+++.++.++|+|||++.......
T Consensus        82 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~  161 (270)
T cd05056          82 WIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDES  161 (270)
T ss_pred             EEEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEecCCCeEEccCceeeeccccc
Confidence            89999999999999997643 58999999999999999999999999999999999999999999999999987543211


Q ss_pred             CCCccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhhc--CCcC--------------------CCCCCCHHHHH
Q 014609          169 DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIFR--GDFK--------------------LPKWLSPGAQN  226 (421)
Q Consensus       169 ~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~~--~~~~--------------------~p~~~s~~~~~  226 (421)
                       ........+++.|+|||.+....+ +.++||||||+++|.+.  |..+                    .|+.+++.+.+
T Consensus       162 -~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (270)
T cd05056         162 -YYKASKGKLPIKWMAPESINFRRF-TSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYS  239 (270)
T ss_pred             -ceecCCCCccccccChhhhccCCC-CchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCcCCCCCCCCHHHHH
Confidence             001112234568999999877766 58899999999999632  4433                    34457899999


Q ss_pred             HHHHhcCCCCCCCCCHHhhhcC
Q 014609          227 LLRKILEPNPVKRITIAGIKAD  248 (421)
Q Consensus       227 li~~~L~~dP~~R~t~~eil~~  248 (421)
                      +|.+|+..+|++|||+.+++..
T Consensus       240 li~~~l~~~P~~Rpt~~~~~~~  261 (270)
T cd05056         240 LMTKCWAYDPSKRPRFTELKAQ  261 (270)
T ss_pred             HHHHHcCCChhhCcCHHHHHHH
Confidence            9999999999999999998753

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=100.00  E-value=1.7e-36  Score=286.26  Aligned_cols=229  Identities=25%  Similarity=0.406  Sum_probs=188.3

Q ss_pred             eeecceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEE
Q 014609           11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIY   90 (421)
Q Consensus        11 ~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~   90 (421)
                      ...++|++.+.||+|+||.||+|.+. .+..+|+|.+....    ...+.+.+|+.++++++|+||+++++++.. ...|
T Consensus         3 ~~~~~~~~~~~lg~g~~~~vy~~~~~-~~~~~~iK~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~   76 (260)
T cd05073           3 IPRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGS----MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIY   76 (260)
T ss_pred             ccccceeEEeEecCccceEEEEEEec-CCccEEEEecCCCh----hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeE
Confidence            34679999999999999999999854 55679999886432    124678899999999999999999999887 7789


Q ss_pred             EEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCcccc
Q 014609           91 MVLEYVTGGELFDKIASK--GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFR  168 (421)
Q Consensus        91 lv~E~~~gg~L~~~i~~~--~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~~  168 (421)
                      ++|||+++++|.+++...  ..++...+..++.|++.||.|||+.|++||||||+||+++.++.+||+|||++.......
T Consensus        77 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~  156 (260)
T cd05073          77 IITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNE  156 (260)
T ss_pred             EEEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCCcceeeccCCC
Confidence            999999999999998753  357888999999999999999999999999999999999999999999999987543211


Q ss_pred             CCCccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhhc--CCcCCC--------------------CCCCHHHHH
Q 014609          169 DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIFR--GDFKLP--------------------KWLSPGAQN  226 (421)
Q Consensus       169 ~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~~--~~~~~p--------------------~~~s~~~~~  226 (421)
                       ........++..|+|||++....+ +.++|+|||||++|.+.  |..+++                    ...+.++.+
T Consensus       157 -~~~~~~~~~~~~y~~PE~~~~~~~-~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (260)
T cd05073         157 -YTAREGAKFPIKWTAPEAINFGSF-TIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENCPEELYN  234 (260)
T ss_pred             -cccccCCcccccccCHhHhccCCc-CccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCCCCCcccCCHHHHH
Confidence             111112234567999999877665 58899999999999543  444332                    236688999


Q ss_pred             HHHHhcCCCCCCCCCHHhhhc
Q 014609          227 LLRKILEPNPVKRITIAGIKA  247 (421)
Q Consensus       227 li~~~L~~dP~~R~t~~eil~  247 (421)
                      ++.+||+++|++||++.++++
T Consensus       235 ~i~~~l~~~p~~Rp~~~~l~~  255 (260)
T cd05073         235 IMMRCWKNRPEERPTFEYIQS  255 (260)
T ss_pred             HHHHHcccCcccCcCHHHHHH
Confidence            999999999999999988753

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=100.00  E-value=7.4e-37  Score=290.30  Aligned_cols=231  Identities=26%  Similarity=0.362  Sum_probs=186.3

Q ss_pred             eEEeceEeecCcEEEEEEEEC---CCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCC-----
Q 014609           16 YELGRTLGEGNFGKVKFAQDL---DSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKS-----   87 (421)
Q Consensus        16 y~i~~~LG~G~~g~V~~a~~~---~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~-----   87 (421)
                      |++.+.||+|+||.||+|.+.   .+++.||||++..... .....+.+.+|+.+++.++||||+++++++....     
T Consensus         1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~   79 (273)
T cd05074           1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIF-SSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRL   79 (273)
T ss_pred             CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccC-ChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCcc
Confidence            678899999999999999864   3678999999865432 2334577889999999999999999999886532     


Q ss_pred             -EEEEEEeccCCCChHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccC
Q 014609           88 -KIYMVLEYVTGGELFDKIASK------GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGL  160 (421)
Q Consensus        88 -~~~lv~E~~~gg~L~~~i~~~------~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGl  160 (421)
                       ..++++||+.+++|.+.+...      ..++...++.++.|++.||+|||++||+||||||+||+++.++.+||+|||+
T Consensus        80 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~~~~~kl~dfg~  159 (273)
T cd05074          80 PIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGL  159 (273)
T ss_pred             cceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEcCCCCEEECcccc
Confidence             347899999999998876432      2478899999999999999999999999999999999999999999999999


Q ss_pred             CCCCccccCCCccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhhc--CCcC--------------------CCC
Q 014609          161 SALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIFR--GDFK--------------------LPK  218 (421)
Q Consensus       161 a~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~~--~~~~--------------------~p~  218 (421)
                      +................+++.|++||.+....+ +.++|||||||++|.+.  |..+                    .++
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~-~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~  238 (273)
T cd05074         160 SKKIYSGDYYRQGCASKLPVKWLALESLADNVY-TTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKGNRLKQPP  238 (273)
T ss_pred             cccccCCcceecCCCccCchhhcCHhHHhcCcc-chhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCcCCCCC
Confidence            885432111111223345678999999887766 47899999999999653  2222                    234


Q ss_pred             CCCHHHHHHHHHhcCCCCCCCCCHHhhhcC
Q 014609          219 WLSPGAQNLLRKILEPNPVKRITIAGIKAD  248 (421)
Q Consensus       219 ~~s~~~~~li~~~L~~dP~~R~t~~eil~~  248 (421)
                      ..++.+.+++.+||+++|++|||+.+++..
T Consensus       239 ~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~  268 (273)
T cd05074         239 DCLEDVYELMCQCWSPEPKCRPSFQHLRDQ  268 (273)
T ss_pred             CCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            567899999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.5e-37  Score=302.52  Aligned_cols=227  Identities=31%  Similarity=0.427  Sum_probs=182.5

Q ss_pred             cceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCC-EEEEE
Q 014609           14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKS-KIYMV   92 (421)
Q Consensus        14 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~-~~~lv   92 (421)
                      +.|.-.+.||+|+||.||+|.- .+|..||||.+.......   ..+|.+|+.++.+++|||+|+++|||.+.+ ..++|
T Consensus        75 ~~Fs~~~~ig~Ggfg~VYkG~l-~~~~~vAVK~~~~~~~~~---~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~~~~~LV  150 (361)
T KOG1187|consen   75 NNFSESNLIGEGGFGTVYKGVL-SDGTVVAVKRLSSNSGQG---EREFLNEVEILSRLRHPNLVKLLGYCLEGGEHRLLV  150 (361)
T ss_pred             hCCchhcceecCCCeEEEEEEE-CCCCEEEEEEecCCCCcc---hhHHHHHHHHHhcCCCcCcccEEEEEecCCceEEEE
Confidence            4667778999999999999985 455899999776543221   345999999999999999999999999998 59999


Q ss_pred             EeccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC---ceeccCCCCCEEeccCCCEEEEeccCCCCCccc
Q 014609           93 LEYVTGGELFDKIASKG--RLQEAEGRKLFQQLIDGVSYCHNKG---VFHRDLKLENILLDSKGNIKISDFGLSALPQHF  167 (421)
Q Consensus        93 ~E~~~gg~L~~~i~~~~--~~~~~~~~~~~~ql~~aL~~LH~~g---i~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~  167 (421)
                      +||+++|+|.+.+....  +++|....+|+.+++.||+|||+..   |+||||||+|||||++.++||+|||+|......
T Consensus       151 YEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsDFGLa~~~~~~  230 (361)
T KOG1187|consen  151 YEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSDFGLAKLGPEG  230 (361)
T ss_pred             EEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccCccCcccCCcc
Confidence            99999999999998755  8999999999999999999999863   999999999999999999999999999643321


Q ss_pred             cCCCccccc-cCCCCccChhhhcccCCCCCcchHHHHHHHHhhh-cCCcCCC----------------------------
Q 014609          168 RDDGLLHTT-CGSPNYVAPEVLANRGYDGATSDIWSCGVILYIF-RGDFKLP----------------------------  217 (421)
Q Consensus       168 ~~~~~~~~~-~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~-~~~~~~p----------------------------  217 (421)
                        .....+. .||.+|+|||.+..... +.++|||||||+|.++ .|..+..                            
T Consensus       231 --~~~~~~~~~gt~gY~~PEy~~~g~l-t~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~~~~~eiiD  307 (361)
T KOG1187|consen  231 --DTSVSTTVMGTFGYLAPEYASTGKL-TEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEEGKLREIVD  307 (361)
T ss_pred             --ccceeeecCCCCccCChhhhccCCc-CcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHCcchhheeC
Confidence              2222222 89999999999876444 6899999999999743 2221110                            


Q ss_pred             -----CCCC--HH---HHHHHHHhcCCCCCCCCCHHhhhc
Q 014609          218 -----KWLS--PG---AQNLLRKILEPNPVKRITIAGIKA  247 (421)
Q Consensus       218 -----~~~s--~~---~~~li~~~L~~dP~~R~t~~eil~  247 (421)
                           ...+  ..   +..+..+|++.+|..||++.|+.+
T Consensus       308 ~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~  347 (361)
T KOG1187|consen  308 PRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVK  347 (361)
T ss_pred             CCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHH
Confidence                 0112  12   345678899999999999999743

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.3e-37  Score=305.07  Aligned_cols=229  Identities=29%  Similarity=0.449  Sum_probs=191.0

Q ss_pred             ceEEeceEeecCcEEEEEEEECCCC----ceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEE
Q 014609           15 RYELGRTLGEGNFGKVKFAQDLDSG----LPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIY   90 (421)
Q Consensus        15 ~y~i~~~LG~G~~g~V~~a~~~~~~----~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~   90 (421)
                      +-.+.++||+|+||.||+|.-...+    ..||+|....+..........+.+|.++|+.++|||||++||+......+|
T Consensus       158 ~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl~  237 (474)
T KOG0194|consen  158 DIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPLM  237 (474)
T ss_pred             CccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCccE
Confidence            4456789999999999999765432    238999987644345556788999999999999999999999999999999


Q ss_pred             EEEeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCccccC
Q 014609           91 MVLEYVTGGELFDKIASKG-RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD  169 (421)
Q Consensus        91 lv~E~~~gg~L~~~i~~~~-~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~  169 (421)
                      +|||+|+||+|.+++...+ .++..+...++.+.+.||+|||+++++||||-..|+|++.++.+||+|||++..-..   
T Consensus       238 ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~~~~~vKISDFGLs~~~~~---  314 (474)
T KOG0194|consen  238 LVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYSKKGVVKISDFGLSRAGSQ---  314 (474)
T ss_pred             EEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheecCCCeEEeCccccccCCcc---
Confidence            9999999999999999876 499999999999999999999999999999999999999999999999999874321   


Q ss_pred             CCcccccc-CCCCccChhhhcccCCCCCcchHHHHHHHHhhhcC--C---------------------cCCCCCCCHHHH
Q 014609          170 DGLLHTTC-GSPNYVAPEVLANRGYDGATSDIWSCGVILYIFRG--D---------------------FKLPKWLSPGAQ  225 (421)
Q Consensus       170 ~~~~~~~~-gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~~~--~---------------------~~~p~~~s~~~~  225 (421)
                      .......+ -...|+|||.+....| +.++||||+||++|+...  .                     .+.|...+..+.
T Consensus       315 ~~~~~~~~klPirWLAPEtl~~~~~-s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~~~~~r~~~~~~~p~~~~  393 (474)
T KOG0194|consen  315 YVMKKFLKKLPIRWLAPETLNTGIF-SFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIVKNGYRMPIPSKTPKELA  393 (474)
T ss_pred             eeeccccccCcceecChhhhccCcc-ccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHHhcCccCCCCCCCHHHHH
Confidence            11111123 3458999999988877 599999999999994322  1                     233445678889


Q ss_pred             HHHHHhcCCCCCCCCCHHhhhc
Q 014609          226 NLLRKILEPNPVKRITIAGIKA  247 (421)
Q Consensus       226 ~li~~~L~~dP~~R~t~~eil~  247 (421)
                      .++.+|+..+|+.|||+.++.+
T Consensus       394 ~~~~~c~~~~p~~R~tm~~i~~  415 (474)
T KOG0194|consen  394 KVMKQCWKKDPEDRPTMSTIKK  415 (474)
T ss_pred             HHHHHhccCChhhccCHHHHHH
Confidence            9999999999999999998865

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-37  Score=280.93  Aligned_cols=236  Identities=25%  Similarity=0.401  Sum_probs=192.8

Q ss_pred             ecceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCC-CCCcceEEEEEEeCCEEEE
Q 014609           13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK-HPNVVRLHEVLASKSKIYM   91 (421)
Q Consensus        13 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~l   91 (421)
                      +++.+.+..||.|+-|.||+++.+.+|...|||.+.+..  +.+...++.+.+.++.+.. +|+||+.+++|..+...++
T Consensus        91 indl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~--Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~I  168 (391)
T KOG0983|consen   91 INDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTG--NKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFI  168 (391)
T ss_pred             hHHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccC--CHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHH
Confidence            345677888999999999999999999999999998654  3444677888888877665 8999999999999999999


Q ss_pred             EEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhC-CceeccCCCCCEEeccCCCEEEEeccCCCCCccccC
Q 014609           92 VLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNK-GVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD  169 (421)
Q Consensus        92 v~E~~~gg~L~~~i~~-~~~~~~~~~~~~~~ql~~aL~~LH~~-gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~  169 (421)
                      .||.+. ..+..++.+ .++++|..+-++...++.||.||.++ ||+|||+||+|||+|+.|++||||||.+...-.   
T Consensus       169 cMelMs-~C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~GniKlCDFGIsGrlvd---  244 (391)
T KOG0983|consen  169 CMELMS-TCAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVD---  244 (391)
T ss_pred             HHHHHH-HHHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCCCEEeecccccceeec---
Confidence            999983 233333332 46799999999999999999999875 999999999999999999999999999874322   


Q ss_pred             CCccccccCCCCccChhhhcc---cCCCCCcchHHHHHHHHhhh-cCCcCCC-----------------C------CCCH
Q 014609          170 DGLLHTTCGSPNYVAPEVLAN---RGYDGATSDIWSCGVILYIF-RGDFKLP-----------------K------WLSP  222 (421)
Q Consensus       170 ~~~~~~~~gt~~y~APEvl~~---~~~~~~~~DiwSlGvil~~~-~~~~~~p-----------------~------~~s~  222 (421)
                      ...-....|.+.|||||.+.-   ..|+ -++||||||+.|+++ +|.+|++                 +      .+|+
T Consensus       245 SkAhtrsAGC~~YMaPERidp~~~~kYD-iRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln~ePP~L~~~~gFSp  323 (391)
T KOG0983|consen  245 SKAHTRSAGCAAYMAPERIDPPDKPKYD-IRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLNEEPPLLPGHMGFSP  323 (391)
T ss_pred             ccccccccCCccccCccccCCCCCCccc-hhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHhcCCCCCCcccCcCH
Confidence            122234478999999998753   3454 789999999999954 3333332                 1      2799


Q ss_pred             HHHHHHHHhcCCCCCCCCCHHhhhcCccccccc
Q 014609          223 GAQNLLRKILEPNPVKRITIAGIKADEWFEQDY  255 (421)
Q Consensus       223 ~~~~li~~~L~~dP~~R~t~~eil~~~w~~~~~  255 (421)
                      .+++++..||.+|+.+||...++++|||+....
T Consensus       324 ~F~~fv~~CL~kd~r~RP~Y~~Ll~h~Fi~~ye  356 (391)
T KOG0983|consen  324 DFQSFVKDCLTKDHRKRPKYNKLLEHPFIKRYE  356 (391)
T ss_pred             HHHHHHHHHhhcCcccCcchHHHhcCcceeecc
Confidence            999999999999999999999999999998643

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3.1e-39  Score=288.64  Aligned_cols=245  Identities=29%  Similarity=0.466  Sum_probs=199.5

Q ss_pred             eeecceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEe-----
Q 014609           11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLAS-----   85 (421)
Q Consensus        11 ~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~-----   85 (421)
                      ...+.|+-..+||+|.||.||+|+...+|+.||+|++-.+. .....-....+|+.+|..|+|+|++.++++|.+     
T Consensus        14 ~~~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmen-eKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~   92 (376)
T KOG0669|consen   14 DEVSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMEN-EKEGFPITALREIKILQLLKHENVVNLIEICRTKATPT   92 (376)
T ss_pred             ecchHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhc-cccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCc
Confidence            44578888999999999999999999999999998764321 122334567899999999999999999988743     


Q ss_pred             ---CCEEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCC
Q 014609           86 ---KSKIYMVLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLS  161 (421)
Q Consensus        86 ---~~~~~lv~E~~~gg~L~~~i~~~-~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla  161 (421)
                         ...+|+|+.+|+. +|+-.+... .+++..+++++++++++||.|+|+..|+|||+||+|+||+.+|.+||+|||++
T Consensus        93 ~r~r~t~ylVf~~ceh-DLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~dgilklADFGla  171 (376)
T KOG0669|consen   93 NRDRATFYLVFDFCEH-DLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITKDGILKLADFGLA  171 (376)
T ss_pred             ccccceeeeeHHHhhh-hHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcCCceEEeeccccc
Confidence               2459999999964 888877654 67999999999999999999999999999999999999999999999999999


Q ss_pred             CCCccccCC--CccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhhcCC----------------------c---
Q 014609          162 ALPQHFRDD--GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIFRGD----------------------F---  214 (421)
Q Consensus       162 ~~~~~~~~~--~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~~~~----------------------~---  214 (421)
                      +.+....+.  .......-|.+|++||.+.+..-++++.|||+.|||+..+..+                      .   
T Consensus       172 r~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tke  251 (376)
T KOG0669|consen  172 RAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKE  251 (376)
T ss_pred             cceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCcc
Confidence            765443221  1223445699999999988866668999999999999833211                      1   


Q ss_pred             -----------------CCCCC-------------CCHHHHHHHHHhcCCCCCCCCCHHhhhcCccccccccC
Q 014609          215 -----------------KLPKW-------------LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTP  257 (421)
Q Consensus       215 -----------------~~p~~-------------~s~~~~~li~~~L~~dP~~R~t~~eil~~~w~~~~~~~  257 (421)
                                       |+|..             -.+++.+|+.++|..||.+|++++++++|.||.++..|
T Consensus       252 vWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F~kdp~p  324 (376)
T KOG0669|consen  252 VWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDFFWKDPMP  324 (376)
T ss_pred             cCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhhhhcCCcc
Confidence                             11110             24688999999999999999999999999999987665

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=100.00  E-value=3.4e-36  Score=285.30  Aligned_cols=230  Identities=29%  Similarity=0.489  Sum_probs=191.2

Q ss_pred             ceEEeceEeecCcEEEEEEEECC-CCceEEEEEeecccc-------cchhHHHHHHHHHHHHhc-CCCCCcceEEEEEEe
Q 014609           15 RYELGRTLGEGNFGKVKFAQDLD-SGLPFAVKILEKNRI-------IHLKITDQIKREIATLKL-LKHPNVVRLHEVLAS   85 (421)
Q Consensus        15 ~y~i~~~LG~G~~g~V~~a~~~~-~~~~vAvK~i~~~~~-------~~~~~~~~~~~Ei~il~~-l~hpnIv~l~~~~~~   85 (421)
                      .|++.+.||+|+||.||+|.+.. +++.+|+|.+.....       ........+.+|+.++++ ++||||+++++++..
T Consensus         1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~   80 (269)
T cd08528           1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE   80 (269)
T ss_pred             CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence            48899999999999999999887 788999998864321       122234567788888865 799999999999999


Q ss_pred             CCEEEEEEeccCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh-CCceeccCCCCCEEeccCCCEEEEeccC
Q 014609           86 KSKIYMVLEYVTGGELFDKIAS----KGRLQEAEGRKLFQQLIDGVSYCHN-KGVFHRDLKLENILLDSKGNIKISDFGL  160 (421)
Q Consensus        86 ~~~~~lv~E~~~gg~L~~~i~~----~~~~~~~~~~~~~~ql~~aL~~LH~-~gi~HrDlkp~NILl~~~~~~kL~DFGl  160 (421)
                      ++..|++|||++|++|.+.+..    ...+++..++.++.|++.||.|||+ .|++||||+|+||+++.++.++|+|||+
T Consensus        81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~~~~l~dfg~  160 (269)
T cd08528          81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGL  160 (269)
T ss_pred             CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCCcEEEecccc
Confidence            9999999999999999888743    3468999999999999999999996 6899999999999999999999999999


Q ss_pred             CCCCccccCCCccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhhc-CCcCC--------------------C-C
Q 014609          161 SALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIFR-GDFKL--------------------P-K  218 (421)
Q Consensus       161 a~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~~-~~~~~--------------------p-~  218 (421)
                      +......   .......|+..|+|||.+.+..+ +.++|+||||+++|.+. |..++                    + .
T Consensus       161 ~~~~~~~---~~~~~~~~~~~~~~Pe~~~~~~~-~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  236 (269)
T cd08528         161 AKQKQPE---SKLTSVVGTILYSCPEIVKNEPY-GEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEPLPEG  236 (269)
T ss_pred             eeecccc---cccccccCcccCcChhhhcCCCC-chHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHhhccCCcCCcc
Confidence            9754331   13445678999999999987666 68999999999999543 32221                    1 1


Q ss_pred             CCCHHHHHHHHHhcCCCCCCCCCHHhhhcC
Q 014609          219 WLSPGAQNLLRKILEPNPVKRITIAGIKAD  248 (421)
Q Consensus       219 ~~s~~~~~li~~~L~~dP~~R~t~~eil~~  248 (421)
                      .+++.+.++|.+||+.||++||++.++..+
T Consensus       237 ~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~  266 (269)
T cd08528         237 MYSEDVTDVITSCLTPDAEARPDIIQVSAM  266 (269)
T ss_pred             cCCHHHHHHHHHHCCCCCccCCCHHHHHHH
Confidence            468899999999999999999999998653

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-37  Score=311.73  Aligned_cols=221  Identities=31%  Similarity=0.512  Sum_probs=186.5

Q ss_pred             cceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCC------
Q 014609           14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKS------   87 (421)
Q Consensus        14 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~------   87 (421)
                      +-|..-+.||+||||.||+++++.+|+.||||.+++....  ...+...+|+++|++|+|||||+++++=++..      
T Consensus        13 y~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~--r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~   90 (732)
T KOG4250|consen   13 YLWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSL--RPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTR   90 (732)
T ss_pred             cceeehhhhcCCccceeeeecccccccchhHHhhhhhccc--chHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccc
Confidence            5678889999999999999999999999999999865432  33688899999999999999999999876544      


Q ss_pred             EEEEEEeccCCCChHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecc--CC--CEEEEeccC
Q 014609           88 KIYMVLEYVTGGELFDKIAS---KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDS--KG--NIKISDFGL  160 (421)
Q Consensus        88 ~~~lv~E~~~gg~L~~~i~~---~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~--~~--~~kL~DFGl  160 (421)
                      ...+|||||+||+|+..+..   ..++++.+.+.++..+..|+.|||++||+||||||+||++-.  +|  .-||+|||.
T Consensus        91 ~~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~  170 (732)
T KOG4250|consen   91 LPVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGA  170 (732)
T ss_pred             cceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeeecccc
Confidence            56899999999999999874   457999999999999999999999999999999999999853  34  369999999


Q ss_pred             CCCCccccCCCccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhh-hcCCcCCCCC-CCHHHHHHHHHhcCCCCCC
Q 014609          161 SALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYI-FRGDFKLPKW-LSPGAQNLLRKILEPNPVK  238 (421)
Q Consensus       161 a~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~-~~~~~~~p~~-~s~~~~~li~~~L~~dP~~  238 (421)
                      |+-.+   ++....+..||+.|.+||++....+.+..+|.||+||++|. .+|.+||-+. -+....+++...+..+|+-
T Consensus       171 Arel~---d~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~~  247 (732)
T KOG4250|consen  171 ARELD---DNSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKPSG  247 (732)
T ss_pred             cccCC---CCCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCCCc
Confidence            98543   45578889999999999999864555789999999999995 4677887554 4445677777777777654


Q ss_pred             C
Q 014609          239 R  239 (421)
Q Consensus       239 R  239 (421)
                      =
T Consensus       248 v  248 (732)
T KOG4250|consen  248 V  248 (732)
T ss_pred             e
Confidence            3

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=100.00  E-value=4.3e-36  Score=285.05  Aligned_cols=225  Identities=22%  Similarity=0.302  Sum_probs=176.1

Q ss_pred             ceEeecCcEEEEEEEECC--CCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEEeccC
Q 014609           20 RTLGEGNFGKVKFAQDLD--SGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVT   97 (421)
Q Consensus        20 ~~LG~G~~g~V~~a~~~~--~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~~   97 (421)
                      +.||+|+||+||+|....  ....+++|.+.....  ....+.+.+|+.+++.++||||+++++.+......|+||||++
T Consensus         1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~   78 (268)
T cd05086           1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANAS--SKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCE   78 (268)
T ss_pred             CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCC--hHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCC
Confidence            469999999999997533  234566776654322  2235688999999999999999999999999999999999999


Q ss_pred             CCChHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCccccCCCcc
Q 014609           98 GGELFDKIASK----GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLL  173 (421)
Q Consensus        98 gg~L~~~i~~~----~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~  173 (421)
                      +++|.+++...    ...++..++.++.|++.||+|||+.+++||||||+|||++.++.++|+|||++............
T Consensus        79 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~  158 (268)
T cd05086          79 LGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETE  158 (268)
T ss_pred             CCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcCCccEEecccccccccCcchhhhcc
Confidence            99999998753    24567778899999999999999999999999999999999999999999998632211111122


Q ss_pred             ccccCCCCccChhhhcccC------CCCCcchHHHHHHHHhhhc--CCcCC-------------------------CCCC
Q 014609          174 HTTCGSPNYVAPEVLANRG------YDGATSDIWSCGVILYIFR--GDFKL-------------------------PKWL  220 (421)
Q Consensus       174 ~~~~gt~~y~APEvl~~~~------~~~~~~DiwSlGvil~~~~--~~~~~-------------------------p~~~  220 (421)
                      ...++++.|+|||++....      ..+.++|||||||++|.+.  +..++                         +..+
T Consensus       159 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (268)
T cd05086         159 DDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVKLFKPQLELPY  238 (268)
T ss_pred             cCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhcccccCCCccCCCC
Confidence            3457889999999875321      1246899999999999653  22221                         1225


Q ss_pred             CHHHHHHHHHhcCCCCCCCCCHHhhhc
Q 014609          221 SPGAQNLLRKILEPNPVKRITIAGIKA  247 (421)
Q Consensus       221 s~~~~~li~~~L~~dP~~R~t~~eil~  247 (421)
                      ++.+.+++.+|+ .+|++||++.++++
T Consensus       239 ~~~~~~l~~~c~-~~P~~Rp~~~~i~~  264 (268)
T cd05086         239 SERWYEVLQFCW-LSPEKRATAEEVHR  264 (268)
T ss_pred             cHHHHHHHHHHh-hCcccCCCHHHHHH
Confidence            677889999999 67999999999864

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>PHA02882 putative serine/threonine kinase; Provisional

Probab=100.00  E-value=8.6e-36  Score=287.23  Aligned_cols=232  Identities=13%  Similarity=0.129  Sum_probs=178.0

Q ss_pred             cceEEeceEeecCcEEEEEEEECCC---CceEEEEEeecccccchhH--------HHHHHHHHHHHhcCCCCCcceEEEE
Q 014609           14 GRYELGRTLGEGNFGKVKFAQDLDS---GLPFAVKILEKNRIIHLKI--------TDQIKREIATLKLLKHPNVVRLHEV   82 (421)
Q Consensus        14 ~~y~i~~~LG~G~~g~V~~a~~~~~---~~~vAvK~i~~~~~~~~~~--------~~~~~~Ei~il~~l~hpnIv~l~~~   82 (421)
                      ++|++.+.||+|+||+||+|.+..+   +..+|+|+...........        ......+...+..+.|+||++++++
T Consensus        12 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~   91 (294)
T PHA02882         12 KEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYGC   91 (294)
T ss_pred             CceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEEe
Confidence            5899999999999999999998777   6778888654322110000        0112234445667789999999997


Q ss_pred             EEeCC----EEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEec
Q 014609           83 LASKS----KIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDF  158 (421)
Q Consensus        83 ~~~~~----~~~lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DF  158 (421)
                      +....    ..++++|++ ..++.+.+......++..++.++.|++.||+|||+.+|+||||||+|||++.++.++|+||
T Consensus        92 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~~~~~~~l~DF  170 (294)
T PHA02882         92 GSFKRCRMYYRFILLEKL-VENTKEIFKRIKCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNRGYIIDY  170 (294)
T ss_pred             eeEecCCceEEEEEEehh-ccCHHHHHHhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCcEEEEEc
Confidence            76543    457888887 3466666666556788999999999999999999999999999999999999999999999


Q ss_pred             cCCCCCccccC-----CCccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhh-cCCcCCC---------------
Q 014609          159 GLSALPQHFRD-----DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIF-RGDFKLP---------------  217 (421)
Q Consensus       159 Gla~~~~~~~~-----~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~-~~~~~~p---------------  217 (421)
                      |+|+.+.....     ........||+.|+|||++.+..+ +.++||||+||++|.+ .|..|+.               
T Consensus       171 Gla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~-~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~~~~~~  249 (294)
T PHA02882        171 GIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACV-TRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIHAAKCD  249 (294)
T ss_pred             CCceeeccCCcccccccccccccCCCccccCHHHhCCCCC-CcHHHHHHHHHHHHHHHhCCCCCCccccchHHHHHhHHH
Confidence            99975432111     112233479999999999988777 5899999999999954 3433331               


Q ss_pred             ------------CCCCHHHHHHHHHhcCCCCCCCCCHHhhhc
Q 014609          218 ------------KWLSPGAQNLLRKILEPNPVKRITIAGIKA  247 (421)
Q Consensus       218 ------------~~~s~~~~~li~~~L~~dP~~R~t~~eil~  247 (421)
                                  +..++.+.+++..|+..+|++||+++++++
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~  291 (294)
T PHA02882        250 FIKRLHEGKIKIKNANKFIYDFIECVTKLSYEEKPDYDALIK  291 (294)
T ss_pred             HHHHhhhhhhccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHH
Confidence                        224677889999999999999999999864

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=100.00  E-value=1.8e-36  Score=315.33  Aligned_cols=238  Identities=21%  Similarity=0.279  Sum_probs=170.6

Q ss_pred             CeeecceEEeceEeecCcEEEEEEEECCC----CceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEE---
Q 014609           10 GMRLGRYELGRTLGEGNFGKVKFAQDLDS----GLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEV---   82 (421)
Q Consensus        10 ~~~~~~y~i~~~LG~G~~g~V~~a~~~~~----~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~---   82 (421)
                      ....++|++.+.||+|+||.||+|.+..+    +..||+|.+.....     .+....+  .++...+.++..+...   
T Consensus       128 ~~~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~-----~e~~~~e--~l~~~~~~~~~~~~~~~~~  200 (566)
T PLN03225        128 SFKKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA-----VEIWMNE--RVRRACPNSCADFVYGFLE  200 (566)
T ss_pred             CCccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch-----hHHHHHH--HHHhhchhhHHHHHHhhhc
Confidence            44668999999999999999999999888    99999998754321     1111111  1122222222222211   


Q ss_pred             ---EEeCCEEEEEEeccCCCChHHHHHhcCC--------------------CCHHHHHHHHHHHHHHHHHHHhCCceecc
Q 014609           83 ---LASKSKIYMVLEYVTGGELFDKIASKGR--------------------LQEAEGRKLFQQLIDGVSYCHNKGVFHRD  139 (421)
Q Consensus        83 ---~~~~~~~~lv~E~~~gg~L~~~i~~~~~--------------------~~~~~~~~~~~ql~~aL~~LH~~gi~HrD  139 (421)
                         ......+++|+||+.+++|.+++.....                    .....+..++.||+.||+|||++||+|||
T Consensus       201 ~~~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHRD  280 (566)
T PLN03225        201 PVSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRD  280 (566)
T ss_pred             ccccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeCc
Confidence               2456789999999999999998865321                    12345678999999999999999999999


Q ss_pred             CCCCCEEecc-CCCEEEEeccCCCCCccccCCCccccccCCCCccChhhhcccCCC---------------------CCc
Q 014609          140 LKLENILLDS-KGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYD---------------------GAT  197 (421)
Q Consensus       140 lkp~NILl~~-~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~---------------------~~~  197 (421)
                      |||+|||++. ++.+||+|||+|+..... ........++|+.|+|||++....+.                     +.+
T Consensus       281 LKP~NILl~~~~~~~KL~DFGlA~~l~~~-~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k  359 (566)
T PLN03225        281 VKPQNIIFSEGSGSFKIIDLGAAADLRVG-INYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDR  359 (566)
T ss_pred             CCHHHEEEeCCCCcEEEEeCCCccccccc-cccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCC
Confidence            9999999986 579999999999754321 12234567899999999976432221                     235


Q ss_pred             chHHHHHHHHhhhcC-CcCC-------------------------CCCCC--------------HHHHHHHHHhcCCCCC
Q 014609          198 SDIWSCGVILYIFRG-DFKL-------------------------PKWLS--------------PGAQNLLRKILEPNPV  237 (421)
Q Consensus       198 ~DiwSlGvil~~~~~-~~~~-------------------------p~~~s--------------~~~~~li~~~L~~dP~  237 (421)
                      +||||+||+||++.. .++.                         ++..+              ....+||.+||++||.
T Consensus       360 ~DVwSlGviL~el~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~  439 (566)
T PLN03225        360 FDIYSAGLIFLQMAFPNLRSDSNLIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKGR  439 (566)
T ss_pred             cccHHHHHHHHHHHhCcCCCchHHHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCCcc
Confidence            699999999995532 1110                         00111              2234899999999999


Q ss_pred             CCCCHHhhhcCccccccc
Q 014609          238 KRITIAGIKADEWFEQDY  255 (421)
Q Consensus       238 ~R~t~~eil~~~w~~~~~  255 (421)
                      +|||+.++++||||....
T Consensus       440 kR~ta~e~L~Hpff~~~~  457 (566)
T PLN03225        440 QRISAKAALAHPYFDREG  457 (566)
T ss_pred             cCCCHHHHhCCcCcCCCC
Confidence            999999999999998643

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-37  Score=297.25  Aligned_cols=243  Identities=30%  Similarity=0.433  Sum_probs=204.9

Q ss_pred             eecceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchh----HHHHHHHHHHHHhcCCCCCcceEEEEEE-eC
Q 014609           12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLK----ITDQIKREIATLKLLKHPNVVRLHEVLA-SK   86 (421)
Q Consensus        12 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~----~~~~~~~Ei~il~~l~hpnIv~l~~~~~-~~   86 (421)
                      .-+||-+++.||+|+|+.||+|.|...+++||+|+-..++.+..+    ......+|..|.+.|+||.||++|+++. +.
T Consensus       461 Ln~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDt  540 (775)
T KOG1151|consen  461 LNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDT  540 (775)
T ss_pred             hHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeecc
Confidence            346899999999999999999999999999999998766554332    3456789999999999999999999996 45


Q ss_pred             CEEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC--CceeccCCCCCEEeccC---CCEEEEeccCC
Q 014609           87 SKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNK--GVFHRDLKLENILLDSK---GNIKISDFGLS  161 (421)
Q Consensus        87 ~~~~lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~ql~~aL~~LH~~--gi~HrDlkp~NILl~~~---~~~kL~DFGla  161 (421)
                      +.+|-|+|||+|.+|.-++...+-+++.+|+.|+.||+.||.||.+.  .|+|-||||.||||-..   |.+||.|||++
T Consensus       541 dsFCTVLEYceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITDFGLS  620 (775)
T KOG1151|consen  541 DSFCTVLEYCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITDFGLS  620 (775)
T ss_pred             ccceeeeeecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeeecchh
Confidence            67899999999999988999889999999999999999999999987  69999999999999543   67999999999


Q ss_pred             CCCccccCC-----CccccccCCCCccChhhhcc---cCCCCCcchHHHHHHHHhh-hc---------------------
Q 014609          162 ALPQHFRDD-----GLLHTTCGSPNYVAPEVLAN---RGYDGATSDIWSCGVILYI-FR---------------------  211 (421)
Q Consensus       162 ~~~~~~~~~-----~~~~~~~gt~~y~APEvl~~---~~~~~~~~DiwSlGvil~~-~~---------------------  211 (421)
                      ++......+     .......||-+|++||.+.-   .+..+.++||||+|||+|- +.                     
T Consensus       621 KIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILqeNTIl  700 (775)
T KOG1151|consen  621 KIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQENTIL  700 (775)
T ss_pred             hhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHhhhchh
Confidence            987553322     23445679999999998642   3445788999999999992 11                     


Q ss_pred             --CCcCCC--CCCCHHHHHHHHHhcCCCCCCCCCHHhhhcCcccccc
Q 014609          212 --GDFKLP--KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD  254 (421)
Q Consensus       212 --~~~~~p--~~~s~~~~~li~~~L~~dP~~R~t~~eil~~~w~~~~  254 (421)
                        ....+|  +.++++++++|++||...-+.|+...++-.||+|.-.
T Consensus       701 kAtEVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~dpyllPh  747 (775)
T KOG1151|consen  701 KATEVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLACDPYLLPH  747 (775)
T ss_pred             cceeccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHccCccccch
Confidence              122333  5589999999999999999999999999999999753

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=100.00  E-value=1.9e-37  Score=273.77  Aligned_cols=231  Identities=26%  Similarity=0.488  Sum_probs=192.3

Q ss_pred             eecceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCC-CCCcceEEEEEEeC--CE
Q 014609           12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK-HPNVVRLHEVLASK--SK   88 (421)
Q Consensus        12 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~--~~   88 (421)
                      ..++|++.+++|+|.|+.||.|++..+++.++||+++.-+      ...+.+|+.||+.|+ ||||++++++..++  ..
T Consensus        36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVk------kkKIkREikIL~nL~gg~NIi~L~DiV~Dp~Skt  109 (338)
T KOG0668|consen   36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVK------KKKIKREIKILQNLRGGPNIIKLLDIVKDPESKT  109 (338)
T ss_pred             ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHH------HHHHHHHHHHHHhccCCCCeeehhhhhcCccccC
Confidence            3568999999999999999999999999999999996432      467999999999998 99999999998765  45


Q ss_pred             EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccC-CCEEEEeccCCCCCccc
Q 014609           89 IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSK-GNIKISDFGLSALPQHF  167 (421)
Q Consensus        89 ~~lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~-~~~kL~DFGla~~~~~~  167 (421)
                      ..+|+||+.+.+.....   ..++.-.++.|+.||+.||.|||++||.|||+||.|+++|.. ..++|+|+|+|.++...
T Consensus       110 paLiFE~v~n~Dfk~ly---~tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~  186 (338)
T KOG0668|consen  110 PSLIFEYVNNTDFKQLY---PTLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG  186 (338)
T ss_pred             chhHhhhhccccHHHHh---hhhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeechhhceeeeeecchHhhcCCC
Confidence            78999999887654443   348889999999999999999999999999999999999965 57999999999987652


Q ss_pred             cCCCccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhh-------------------------------------
Q 014609          168 RDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIF-------------------------------------  210 (421)
Q Consensus       168 ~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~-------------------------------------  210 (421)
                         ........+..|--||.+..-......-|+|||||+|..+                                     
T Consensus       187 ---~eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~  263 (338)
T KOG0668|consen  187 ---KEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQ  263 (338)
T ss_pred             ---ceeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHc
Confidence               2234456778889999988755556889999999998710                                     


Q ss_pred             ----------cCCcCCCCC-----------CCHHHHHHHHHhcCCCCCCCCCHHhhhcCcccccc
Q 014609          211 ----------RGDFKLPKW-----------LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD  254 (421)
Q Consensus       211 ----------~~~~~~p~~-----------~s~~~~~li~~~L~~dP~~R~t~~eil~~~w~~~~  254 (421)
                                .|...--+|           .++++.+|+.++|..|-.+|+|+.|++.||||...
T Consensus       264 i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~HpyF~~~  328 (338)
T KOG0668|consen  264 IDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAHPYFAPV  328 (338)
T ss_pred             cCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcCchHHHH
Confidence                      011111111           57999999999999999999999999999999753

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=100.00  E-value=7e-37  Score=299.99  Aligned_cols=194  Identities=34%  Similarity=0.628  Sum_probs=176.9

Q ss_pred             eeecceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHH-----HHHHHHHHHHhcCC---CCCcceEEEE
Q 014609           11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKIT-----DQIKREIATLKLLK---HPNVVRLHEV   82 (421)
Q Consensus        11 ~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~-----~~~~~Ei~il~~l~---hpnIv~l~~~   82 (421)
                      ..+..|..++.+|.|+||+|++|.++.+...|+||.|.++++.-....     -.+-.||+||..|+   |+||++++++
T Consensus       558 ~k~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdf  637 (772)
T KOG1152|consen  558 KKFSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDF  637 (772)
T ss_pred             cccccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhhe
Confidence            456789999999999999999999999999999999988775432222     23667999999998   9999999999


Q ss_pred             EEeCCEEEEEEecc-CCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCC
Q 014609           83 LASKSKIYMVLEYV-TGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLS  161 (421)
Q Consensus        83 ~~~~~~~~lv~E~~-~gg~L~~~i~~~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla  161 (421)
                      |++++.+|++||-- +|-+||++|+.+..++|.++..+|+|++.|+++||+.||+|||||-||+.++.+|-+||+|||.|
T Consensus       638 FEddd~yyl~te~hg~gIDLFd~IE~kp~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd~~g~~klidfgsa  717 (772)
T KOG1152|consen  638 FEDDDYYYLETEVHGEGIDLFDFIEFKPRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVDSNGFVKLIDFGSA  717 (772)
T ss_pred             eecCCeeEEEecCCCCCcchhhhhhccCccchHHHHHHHHHHHhccccccccCceecccccccEEEecCCeEEEeeccch
Confidence            99999999999975 56799999999999999999999999999999999999999999999999999999999999999


Q ss_pred             CCCccccCCCccccccCCCCccChhhhcccCCCCCcchHHHHHHHHh
Q 014609          162 ALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILY  208 (421)
Q Consensus       162 ~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~  208 (421)
                      ...    ..+......||..|.|||++.+.+|-|.+-|||++|++||
T Consensus       718 a~~----ksgpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgilly  760 (772)
T KOG1152|consen  718 AYT----KSGPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLY  760 (772)
T ss_pred             hhh----cCCCcceeeeeccccchhhhCCCccCCCcchhhhhhheee
Confidence            854    4577889999999999999999999999999999999999

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=100.00  E-value=3.1e-36  Score=309.11  Aligned_cols=231  Identities=28%  Similarity=0.408  Sum_probs=191.8

Q ss_pred             ecceEEeceEeecCcEEEEEEEEC-----CCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCC
Q 014609           13 LGRYELGRTLGEGNFGKVKFAQDL-----DSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKS   87 (421)
Q Consensus        13 ~~~y~i~~~LG~G~~g~V~~a~~~-----~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~   87 (421)
                      ..+-++.+.||+|+||+||+|+-.     .....||||.++...  +.....+|+||++++..++|||||+++|+|..++
T Consensus       485 r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a--~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~  562 (774)
T KOG1026|consen  485 RSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKA--ENQARQDFRREAELLAELQHPNIVRLLGVCREGD  562 (774)
T ss_pred             hhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccc--cHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCC
Confidence            356678899999999999999753     245689999997543  3335688999999999999999999999999999


Q ss_pred             EEEEEEeccCCCChHHHHHhcC--------------CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCE
Q 014609           88 KIYMVLEYVTGGELFDKIASKG--------------RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNI  153 (421)
Q Consensus        88 ~~~lv~E~~~gg~L~~~i~~~~--------------~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~  153 (421)
                      .+|+|+||+..|+|-+++....              +++..+...++.||+.|++||-++.++||||-..|+||.++-.|
T Consensus       563 P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCLVge~l~V  642 (774)
T KOG1026|consen  563 PLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCLVGENLVV  642 (774)
T ss_pred             eeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhceeccceEE
Confidence            9999999999999999885321              27888999999999999999999999999999999999999999


Q ss_pred             EEEeccCCCCCccccCCCccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhhc---------------------C
Q 014609          154 KISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIFR---------------------G  212 (421)
Q Consensus       154 kL~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~~---------------------~  212 (421)
                      ||+|||+++-.-..+.-.......-..+|||||.+....| +.++||||+||+||++.                     |
T Consensus       643 KIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kF-TteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~i~~g  721 (774)
T KOG1026|consen  643 KISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKF-TTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIECIRAG  721 (774)
T ss_pred             EecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcc-cchhhhhhhhhhhhhhhccccCcccccchHHHHHHHHcC
Confidence            9999999983211111111111122458999999998888 58999999999999331                     1


Q ss_pred             -CcCCCCCCCHHHHHHHHHhcCCCCCCCCCHHhhh
Q 014609          213 -DFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIK  246 (421)
Q Consensus       213 -~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil  246 (421)
                       -.+.|..+|.++.+||..||+.+|.+||++.||-
T Consensus       722 ~lL~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~  756 (774)
T KOG1026|consen  722 QLLSCPENCPTEVYSLMLECWNENPKRRPSFKEIH  756 (774)
T ss_pred             CcccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHH
Confidence             2466888999999999999999999999999974

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.5e-35  Score=301.35  Aligned_cols=234  Identities=27%  Similarity=0.471  Sum_probs=201.0

Q ss_pred             ecceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcC-CCCCcceEEEEEEe-----C
Q 014609           13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEVLAS-----K   86 (421)
Q Consensus        13 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~-----~   86 (421)
                      -+.|++.++||.|.+|+||+++++.+++..|+||.....    +..+.+.-|.++|+.+ .|||++.+++++.-     +
T Consensus        18 ~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~----d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~   93 (953)
T KOG0587|consen   18 ADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTE----DEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNG   93 (953)
T ss_pred             CCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCc----cccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCC
Confidence            367999999999999999999999999999999987543    2346788899999988 59999999999853     4


Q ss_pred             CEEEEEEeccCCCChHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCC
Q 014609           87 SKIYMVLEYVTGGELFDKIAS--KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALP  164 (421)
Q Consensus        87 ~~~~lv~E~~~gg~L~~~i~~--~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~  164 (421)
                      +.+|+|||||.||+..|++..  ..++.|+.+..+++.++.|+.|||.+.++|||||-.|||++.+|.+||+|||++...
T Consensus        94 DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~e~~VKLvDFGvSaQl  173 (953)
T KOG0587|consen   94 DQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTENAEVKLVDFGVSAQL  173 (953)
T ss_pred             CeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEeccCcEEEeeeeeeeee
Confidence            689999999999999999875  457899999999999999999999999999999999999999999999999999865


Q ss_pred             ccccCCCccccccCCCCccChhhhccc-----CCCCCcchHHHHHHHHhhhcCCc-C-----------------C-----
Q 014609          165 QHFRDDGLLHTTCGSPNYVAPEVLANR-----GYDGATSDIWSCGVILYIFRGDF-K-----------------L-----  216 (421)
Q Consensus       165 ~~~~~~~~~~~~~gt~~y~APEvl~~~-----~~~~~~~DiwSlGvil~~~~~~~-~-----------------~-----  216 (421)
                      ..  ..+...+..|||.|||||++...     .|+ ..+|+||||++..++..+- +                 .     
T Consensus       174 ds--T~grRnT~iGtP~WMAPEViac~e~~d~tyd-~R~D~WsLGITaIEladG~PPl~DmHPmraLF~IpRNPPPkLkr  250 (953)
T KOG0587|consen  174 DS--TVGRRNTFIGTPYWMAPEVIACDESPDATYD-YRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPPPKLKR  250 (953)
T ss_pred             ec--ccccccCcCCCcccccceeeecccCCCCCcc-cccchhhccceeehhcCCCCCccCcchhhhhccCCCCCCccccc
Confidence            44  33455678999999999998643     353 7799999999988553221 1                 1     


Q ss_pred             CCCCCHHHHHHHHHhcCCCCCCCCCHHhhhcCccccc
Q 014609          217 PKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQ  253 (421)
Q Consensus       217 p~~~s~~~~~li~~~L~~dP~~R~t~~eil~~~w~~~  253 (421)
                      |..++.++.++|..||.+|-.+||+..++++|||...
T Consensus       251 p~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~hpFi~e  287 (953)
T KOG0587|consen  251 PKKWSKKFNDFISTCLVKDYEQRPSTEELLKHPFITE  287 (953)
T ss_pred             hhhHHHHHHHHHHHHHhhccccCcchhhhccCCcccc
Confidence            1236788999999999999999999999999999974

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.5e-35  Score=312.20  Aligned_cols=230  Identities=27%  Similarity=0.404  Sum_probs=193.9

Q ss_pred             cceEEeceEeecCcEEEEEEEECC-CCc----eEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCE
Q 014609           14 GRYELGRTLGEGNFGKVKFAQDLD-SGL----PFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSK   88 (421)
Q Consensus        14 ~~y~i~~~LG~G~~g~V~~a~~~~-~~~----~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~   88 (421)
                      ..-++.+.||+|+||.||.|.-.. .|.    .||||.+.+.  .+......|.+|..+|+.++||||+++++++-+...
T Consensus       692 ~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~--~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~  769 (1025)
T KOG1095|consen  692 KNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRL--SSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGP  769 (1025)
T ss_pred             hheEeeeeeccccccceEEEEEecCCCCccceEEEEEecccc--CCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCC
Confidence            356788999999999999997654 232    4888887643  345567899999999999999999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCC
Q 014609           89 IYMVLEYVTGGELFDKIASK-------GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLS  161 (421)
Q Consensus        89 ~~lv~E~~~gg~L~~~i~~~-------~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla  161 (421)
                      .+|++|||+||+|..+|...       ..++..+...++.|++.|..||++++.|||||-..|+||+....+||+|||+|
T Consensus       770 ~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~~r~VKIaDFGlA  849 (1025)
T KOG1095|consen  770 PLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLDERRVVKIADFGLA  849 (1025)
T ss_pred             cEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeecccCcEEEcccchh
Confidence            99999999999999999865       35889999999999999999999999999999999999999999999999999


Q ss_pred             C-CCccccCCCccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhh----------------------cCCcCCCC
Q 014609          162 A-LPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIF----------------------RGDFKLPK  218 (421)
Q Consensus       162 ~-~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~----------------------~~~~~~p~  218 (421)
                      + ++.... -+.-....-...|||||.+.+..+ +.++|||||||+||++                      .|+.+.|+
T Consensus       850 rDiy~~~y-yr~~~~a~lPvkWm~PEsl~d~iF-tskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~ggRL~~P~  927 (1025)
T KOG1095|consen  850 RDIYDKDY-YRKHGEAMLPVKWMPPESLKDGIF-TSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLEGGRLDPPS  927 (1025)
T ss_pred             Hhhhhchh-eeccCccccceecCCHHHHhhccc-ccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHhCCccCCCC
Confidence            8 322110 000000112347999999998777 5899999999999932                      35677888


Q ss_pred             CCCHHHHHHHHHhcCCCCCCCCCHHhhhc
Q 014609          219 WLSPGAQNLLRKILEPNPVKRITIAGIKA  247 (421)
Q Consensus       219 ~~s~~~~~li~~~L~~dP~~R~t~~eil~  247 (421)
                      .++..+.++|..||+.+|++||++..|++
T Consensus       928 ~CP~~ly~lM~~CW~~~pe~RP~F~~i~~  956 (1025)
T KOG1095|consen  928 YCPEKLYQLMLQCWKHDPEDRPSFRTIVE  956 (1025)
T ss_pred             CCChHHHHHHHHHccCChhhCccHHHHHh
Confidence            99999999999999999999999999887

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-36  Score=274.25  Aligned_cols=232  Identities=28%  Similarity=0.431  Sum_probs=191.1

Q ss_pred             EEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHH-hcCCCCCcceEEEEEEeCCEEEEEEec
Q 014609           17 ELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATL-KLLKHPNVVRLHEVLASKSKIYMVLEY   95 (421)
Q Consensus        17 ~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il-~~l~hpnIv~l~~~~~~~~~~~lv~E~   95 (421)
                      +-+..||.|+||+|++-.++.+|+..|||.|+....  .....++..|.... +.-+.||||++|+.+..++..||.||+
T Consensus        67 qdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~--~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMEL  144 (361)
T KOG1006|consen   67 QDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNI--EKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMEL  144 (361)
T ss_pred             HHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccc--hHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHH
Confidence            446789999999999999999999999999987654  23356788888865 445799999999999999999999999


Q ss_pred             cCCCChHHHH-----HhcCCCCHHHHHHHHHHHHHHHHHHHhC-CceeccCCCCCEEeccCCCEEEEeccCCCCCccccC
Q 014609           96 VTGGELFDKI-----ASKGRLQEAEGRKLFQQLIDGVSYCHNK-GVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD  169 (421)
Q Consensus        96 ~~gg~L~~~i-----~~~~~~~~~~~~~~~~ql~~aL~~LH~~-gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~  169 (421)
                      +. .+|..+.     ..+..++|...-.+..-.+.||.||... .|+|||+||+|||++..|.+||||||.+.....   
T Consensus       145 Md-~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~---  220 (361)
T KOG1006|consen  145 MD-ISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRHGDVKLCDFGICGQLVD---  220 (361)
T ss_pred             Hh-hhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecCCCEeeecccchHhHHH---
Confidence            94 4553222     2346799999999999999999999865 899999999999999999999999999874321   


Q ss_pred             CCccccccCCCCccChhhhcc--cCCCCCcchHHHHHHHHhh-hcCCcCCCCC--------------------------C
Q 014609          170 DGLLHTTCGSPNYVAPEVLAN--RGYDGATSDIWSCGVILYI-FRGDFKLPKW--------------------------L  220 (421)
Q Consensus       170 ~~~~~~~~gt~~y~APEvl~~--~~~~~~~~DiwSlGvil~~-~~~~~~~p~~--------------------------~  220 (421)
                      .-....-.|...|||||.+..  .+|+ -++|+||||++||+ -+|.+|++.|                          +
T Consensus       221 SiAkT~daGCrpYmAPERi~p~~~gyD-iRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv~gdpp~l~~~~~~~~~  299 (361)
T KOG1006|consen  221 SIAKTVDAGCRPYMAPERIDPSDKGYD-IRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVVIGDPPILLFDKECVHY  299 (361)
T ss_pred             HHHhhhccCCccccChhccCCccCCcc-hhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHHcCCCCeecCccccccc
Confidence            112233468899999999853  4565 88999999999994 4677777665                          5


Q ss_pred             CHHHHHHHHHhcCCCCCCCCCHHhhhcCccccccc
Q 014609          221 SPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY  255 (421)
Q Consensus       221 s~~~~~li~~~L~~dP~~R~t~~eil~~~w~~~~~  255 (421)
                      +..+..+|..||.+|-+.||...+++++||+.-..
T Consensus       300 s~~~~~fintCl~Kd~~~Rpky~~Lk~~~fyr~y~  334 (361)
T KOG1006|consen  300 SFSMVRFINTCLIKDRSDRPKYDDLKKFPFYRMYA  334 (361)
T ss_pred             CHHHHHHHHHHhhcccccCcchhhhhcCchhhhhh
Confidence            78899999999999999999999999999998543

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=100.00  E-value=2.9e-34  Score=265.62  Aligned_cols=220  Identities=45%  Similarity=0.805  Sum_probs=190.3

Q ss_pred             CcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEEeccCCCChHHHH
Q 014609           26 NFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKI  105 (421)
Q Consensus        26 ~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~~gg~L~~~i  105 (421)
                      +||.||+|.+..+|+.+|+|++........  .+.+.+|+..+++++|+||+++++++......++++||+++++|.+++
T Consensus         1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~   78 (244)
T smart00220        1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKK--RERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLL   78 (244)
T ss_pred             CceEEEEEEECCCCcEEEEEEecccccccH--HHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHH
Confidence            689999999988999999999976543221  578999999999999999999999999999999999999999999999


Q ss_pred             HhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCccccCCCccccccCCCCccCh
Q 014609          106 ASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAP  185 (421)
Q Consensus       106 ~~~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~AP  185 (421)
                      .....++...+..++.|++.++.|||+.+++|+||+|.||+++.++.++|+|||.+......   .......++..|+||
T Consensus        79 ~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~---~~~~~~~~~~~~~~p  155 (244)
T smart00220       79 KKRGRLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPG---GLLTTFVGTPEYMAP  155 (244)
T ss_pred             HhccCCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCCCcEEEccccceeeeccc---cccccccCCcCCCCH
Confidence            87666899999999999999999999999999999999999999999999999999854331   134456788999999


Q ss_pred             hhhcccCCCCCcchHHHHHHHHhhhc-CCcCCCC---------------------C--CCHHHHHHHHHhcCCCCCCCCC
Q 014609          186 EVLANRGYDGATSDIWSCGVILYIFR-GDFKLPK---------------------W--LSPGAQNLLRKILEPNPVKRIT  241 (421)
Q Consensus       186 Evl~~~~~~~~~~DiwSlGvil~~~~-~~~~~p~---------------------~--~s~~~~~li~~~L~~dP~~R~t  241 (421)
                      |.+....+ +.++|+||+|+++|.+. +..++..                     +  ++..+.+++.+||..+|++||+
T Consensus       156 E~~~~~~~-~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~  234 (244)
T smart00220      156 EVLLGKGY-GKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWKISPEAKDLIRKLLVKDPEKRLT  234 (244)
T ss_pred             HHHccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCccccccCCHHHHHHHHHHccCCchhccC
Confidence            99887666 47999999999998443 3222211                     1  7788999999999999999999


Q ss_pred             HHhhhcCccc
Q 014609          242 IAGIKADEWF  251 (421)
Q Consensus       242 ~~eil~~~w~  251 (421)
                      +.++++||||
T Consensus       235 ~~~~~~~~~~  244 (244)
T smart00220      235 AEEALQHPFF  244 (244)
T ss_pred             HHHHhhCCCC
Confidence            9999999997

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-35  Score=273.72  Aligned_cols=235  Identities=29%  Similarity=0.443  Sum_probs=196.7

Q ss_pred             eeecceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeC----
Q 014609           11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASK----   86 (421)
Q Consensus        11 ~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~----   86 (421)
                      ..-.||.-++.+|.|+- .|-.|-|..+++.||+|.+... ..+.....+..+|..++..++|+||++++.+|.-.    
T Consensus        14 tv~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~p-f~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~   91 (369)
T KOG0665|consen   14 TVPKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRP-FQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLE   91 (369)
T ss_pred             eeeeeeeeecccCCCCc-eEEecchhhccCceehhhhcCc-cccCccchhhhhhhhhhhhhcccceeeeeeccCccccHH
Confidence            33468999999999999 7888999999999999998766 33344467899999999999999999999998543    


Q ss_pred             --CEEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCC
Q 014609           87 --SKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALP  164 (421)
Q Consensus        87 --~~~~lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~  164 (421)
                        ...|+||||+ ..+|...+.  -.++-+....++.|++.|++|||+.||+||||||+||++..++.+||.|||+|...
T Consensus        92 ~~~e~y~v~e~m-~~nl~~vi~--~elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~~~~lKi~dfg~ar~e  168 (369)
T KOG0665|consen   92 EFQEVYLVMELM-DANLCQVIL--MELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNSDCTLKILDFGLARTE  168 (369)
T ss_pred             HHHhHHHHHHhh-hhHHHHHHH--HhcchHHHHHHHHHHHHHHHHHHhcceeecccCcccceecchhheeeccchhhccc
Confidence              3589999999 558877776  45788999999999999999999999999999999999999999999999999843


Q ss_pred             ccccCCCccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhhc----------------------CC---------
Q 014609          165 QHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIFR----------------------GD---------  213 (421)
Q Consensus       165 ~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~~----------------------~~---------  213 (421)
                      ..   .-.+..+..|..|+|||++.+.+| .+.+||||+|||+.++.                      |.         
T Consensus       169 ~~---~~~mtpyVvtRyyrapevil~~~~-ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL  244 (369)
T KOG0665|consen  169 DT---DFMMTPYVVTRYYRAPEVILGMGY-KENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQL  244 (369)
T ss_pred             Cc---ccccCchhheeeccCchheeccCC-cccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHh
Confidence            22   235677889999999999999887 58999999999997221                      00         


Q ss_pred             ----------------cC----CCC-----------CCCHHHHHHHHHhcCCCCCCCCCHHhhhcCcccccc
Q 014609          214 ----------------FK----LPK-----------WLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD  254 (421)
Q Consensus       214 ----------------~~----~p~-----------~~s~~~~~li~~~L~~dP~~R~t~~eil~~~w~~~~  254 (421)
                                      +.    +|.           .-+..+++++.+||..||++|.+++++|+|||++-.
T Consensus       245 ~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HPY~~vw  316 (369)
T KOG0665|consen  245 QPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHPYIKVW  316 (369)
T ss_pred             hHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCCeeeee
Confidence                            01    111           124668999999999999999999999999999843

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=9.2e-35  Score=280.58  Aligned_cols=130  Identities=31%  Similarity=0.491  Sum_probs=115.3

Q ss_pred             cceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCC-----C---CCcceEEEEEEe
Q 014609           14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK-----H---PNVVRLHEVLAS   85 (421)
Q Consensus        14 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~-----h---pnIv~l~~~~~~   85 (421)
                      +||.+.++||-|-|++||+|.|+.+.+.||+|+.+...    ...+....||++|++++     |   .+||++++.|..
T Consensus        78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAq----hYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~Fkh  153 (590)
T KOG1290|consen   78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQ----HYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKH  153 (590)
T ss_pred             ceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhh----HHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeecccee
Confidence            69999999999999999999999999999999987542    34577888999999885     3   379999999965


Q ss_pred             ----CCEEEEEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC-CceeccCCCCCEEec
Q 014609           86 ----KSKIYMVLEYVTGGELFDKIASK--GRLQEAEGRKLFQQLIDGVSYCHNK-GVFHRDLKLENILLD  148 (421)
Q Consensus        86 ----~~~~~lv~E~~~gg~L~~~i~~~--~~~~~~~~~~~~~ql~~aL~~LH~~-gi~HrDlkp~NILl~  148 (421)
                          ..++|||+|++ |.+|..+|...  ++++...++.|++||+.||.|||.. ||||.||||+|||+.
T Consensus       154 sGpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl~  222 (590)
T KOG1290|consen  154 SGPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLLC  222 (590)
T ss_pred             cCCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceeeee
Confidence                45899999999 88999998764  4799999999999999999999976 999999999999994

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=100.00  E-value=5e-34  Score=290.77  Aligned_cols=243  Identities=20%  Similarity=0.255  Sum_probs=178.0

Q ss_pred             eeecceEEeceEeecCcEEEEEEEEC----------------CCCceEEEEEeecccccch-----------hHHHHHHH
Q 014609           11 MRLGRYELGRTLGEGNFGKVKFAQDL----------------DSGLPFAVKILEKNRIIHL-----------KITDQIKR   63 (421)
Q Consensus        11 ~~~~~y~i~~~LG~G~~g~V~~a~~~----------------~~~~~vAvK~i~~~~~~~~-----------~~~~~~~~   63 (421)
                      ...++|++.++||+|+||.||+|.+.                ..++.||||.+........           ...+....
T Consensus       142 ~~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~v  221 (507)
T PLN03224        142 WSSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMV  221 (507)
T ss_pred             ccccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHH
Confidence            34579999999999999999999752                2456899999864321100           01122345


Q ss_pred             HHHHHhcCCCCCc-----ceEEEEEEe--------CCEEEEEEeccCCCChHHHHHhcC---------------------
Q 014609           64 EIATLKLLKHPNV-----VRLHEVLAS--------KSKIYMVLEYVTGGELFDKIASKG---------------------  109 (421)
Q Consensus        64 Ei~il~~l~hpnI-----v~l~~~~~~--------~~~~~lv~E~~~gg~L~~~i~~~~---------------------  109 (421)
                      |+.++.+++|.++     +++++++..        .+..|+||||+++++|.+++....                     
T Consensus       222 E~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~  301 (507)
T PLN03224        222 EAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNM  301 (507)
T ss_pred             HHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhc
Confidence            6777777766544     667776643        356899999999999998886321                     


Q ss_pred             ---CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCccccCCCccccccCCCCccChh
Q 014609          110 ---RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPE  186 (421)
Q Consensus       110 ---~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE  186 (421)
                         .+++..++.++.|++.||.|||+.+|+||||||+|||++.++.+||+|||++....... ........+|+.|+|||
T Consensus       302 ~~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~-~~~~~~g~~tp~Y~aPE  380 (507)
T PLN03224        302 PQDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGI-NFNPLYGMLDPRYSPPE  380 (507)
T ss_pred             ccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCCCcEEEEeCcCccccccCC-ccCccccCCCcceeChh
Confidence               23567788999999999999999999999999999999999999999999987433211 11111233489999999


Q ss_pred             hhcccC--------------------CC-CCcchHHHHHHHHhhhcC-Cc------------------------------
Q 014609          187 VLANRG--------------------YD-GATSDIWSCGVILYIFRG-DF------------------------------  214 (421)
Q Consensus       187 vl~~~~--------------------~~-~~~~DiwSlGvil~~~~~-~~------------------------------  214 (421)
                      ++....                    |. ..+.|+||+||++|.+.. ..                              
T Consensus       381 ~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~~~  460 (507)
T PLN03224        381 ELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKGQK  460 (507)
T ss_pred             hhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhcccC
Confidence            875422                    11 124799999999995422 11                              


Q ss_pred             -CCC--CCCCHHHHHHHHHhcCCCC---CCCCCHHhhhcCcccccc
Q 014609          215 -KLP--KWLSPGAQNLLRKILEPNP---VKRITIAGIKADEWFEQD  254 (421)
Q Consensus       215 -~~p--~~~s~~~~~li~~~L~~dP---~~R~t~~eil~~~w~~~~  254 (421)
                       .++  ...++...+|+.+||..+|   .+|+|+.|+|+||||...
T Consensus       461 ~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~f~~~  506 (507)
T PLN03224        461 YDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHRFFLPE  506 (507)
T ss_pred             CCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCCCcCCC
Confidence             111  2267889999999999866   689999999999999753

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.5e-36  Score=272.75  Aligned_cols=236  Identities=28%  Similarity=0.431  Sum_probs=195.1

Q ss_pred             eEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCC-----EEE
Q 014609           16 YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKS-----KIY   90 (421)
Q Consensus        16 y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~-----~~~   90 (421)
                      .+--+.||-|+||.||.+.|..+|+.||+|.+.. ...+......+.+|+++|..++|.|++..+++.....     .+|
T Consensus        55 i~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pn-vfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiY  133 (449)
T KOG0664|consen   55 IQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPN-VFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELY  133 (449)
T ss_pred             CCCCCcccccceeEEEeccCCCCccchhHhhcch-HHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHH
Confidence            4456899999999999999999999999998853 2233334578999999999999999999999886654     478


Q ss_pred             EEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCccccCC
Q 014609           91 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD  170 (421)
Q Consensus        91 lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~  170 (421)
                      +++|++ ..+|...|.....++.+.++-+..||+.||+|||+.||.||||||.|+|++.|..+||||||+++.-+... .
T Consensus       134 V~TELm-QSDLHKIIVSPQ~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~-~  211 (449)
T KOG0664|consen  134 VLTELM-QSDLHKIIVSPQALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNSNCILKICDFGLARTWDQRD-R  211 (449)
T ss_pred             HHHHHH-HhhhhheeccCCCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEeccCceEEecccccccccchhh-h
Confidence            888988 45888888887889999999999999999999999999999999999999999999999999999755432 2


Q ss_pred             CccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhhc---------------------------------------
Q 014609          171 GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIFR---------------------------------------  211 (421)
Q Consensus       171 ~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~~---------------------------------------  211 (421)
                      ..+....-|..|+|||++.+...++.++||||.|||+.++.                                       
T Consensus       212 ~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEGAk~  291 (449)
T KOG0664|consen  212 LNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEGAKN  291 (449)
T ss_pred             hhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhhhHH
Confidence            33444567889999999988766678999999999987322                                       


Q ss_pred             ----CCcCCCC-----------CCCHHHHHHHHHhcCCCCCCCCCHHhhhcCcccccc
Q 014609          212 ----GDFKLPK-----------WLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD  254 (421)
Q Consensus       212 ----~~~~~p~-----------~~s~~~~~li~~~L~~dP~~R~t~~eil~~~w~~~~  254 (421)
                          +....|.           .-..+...++.++|.+||++|++.++.+.|+++...
T Consensus       292 H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~~e~  349 (449)
T KOG0664|consen  292 HVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYLEEG  349 (449)
T ss_pred             HhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccccccccc
Confidence                2222221           123567889999999999999999999999998653

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=100.00  E-value=2.2e-35  Score=286.26  Aligned_cols=230  Identities=29%  Similarity=0.450  Sum_probs=193.7

Q ss_pred             cceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCC------CCcceEEEEEEeCC
Q 014609           14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKH------PNVVRLHEVLASKS   87 (421)
Q Consensus        14 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~h------pnIv~l~~~~~~~~   87 (421)
                      ++|.+....|+|-|++|-.|.|..-|+.||||||..+...    -..=.+|++||++|+.      -|.++++..|...+
T Consensus       432 ~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M----~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hkn  507 (752)
T KOG0670|consen  432 SRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVM----HKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHKN  507 (752)
T ss_pred             ceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHH----hhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhcc
Confidence            5899999999999999999999999999999999876543    3455789999999973      48999999999999


Q ss_pred             EEEEEEeccCCCChHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCC-CEEEEeccCCCC
Q 014609           88 KIYMVLEYVTGGELFDKIAS---KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKG-NIKISDFGLSAL  163 (421)
Q Consensus        88 ~~~lv~E~~~gg~L~~~i~~---~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~-~~kL~DFGla~~  163 (421)
                      ++|+|+|-+ ..+|.+.+..   +.++....++.|++||..||..|-.+||+|.||||+|||+++.. .+||||||.|..
T Consensus       508 HLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVNE~k~iLKLCDfGSA~~  586 (752)
T KOG0670|consen  508 HLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVNESKNILKLCDFGSASF  586 (752)
T ss_pred             eeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEeccCcceeeeccCccccc
Confidence            999999998 5688888875   34688999999999999999999999999999999999999875 589999999975


Q ss_pred             CccccCCCccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhh----------------------cCCcC------
Q 014609          164 PQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIF----------------------RGDFK------  215 (421)
Q Consensus       164 ~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~----------------------~~~~~------  215 (421)
                      ..    ......+.-+..|.|||++.+.+|+ .+.|+||.||.||++                      .|.+|      
T Consensus       587 ~~----eneitPYLVSRFYRaPEIiLG~~yd-~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~KmlRK  661 (752)
T KOG0670|consen  587 AS----ENEITPYLVSRFYRAPEIILGLPYD-YPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPNKMLRK  661 (752)
T ss_pred             cc----cccccHHHHHHhccCcceeecCccc-CCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcHHHhhh
Confidence            42    2344556667789999999999996 889999999999922                      11111      


Q ss_pred             -------------------------------------------------CCCC---CCHHHHHHHHHhcCCCCCCCCCHH
Q 014609          216 -------------------------------------------------LPKW---LSPGAQNLLRKILEPNPVKRITIA  243 (421)
Q Consensus       216 -------------------------------------------------~p~~---~s~~~~~li~~~L~~dP~~R~t~~  243 (421)
                                                                       +|..   +-..+.+|+.+||..||++|.|..
T Consensus       662 gqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KRit~n  741 (752)
T KOG0670|consen  662 GQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKRITVN  741 (752)
T ss_pred             cchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhhcCCHH
Confidence                                                             0000   115578999999999999999999


Q ss_pred             hhhcCccccc
Q 014609          244 GIKADEWFEQ  253 (421)
Q Consensus       244 eil~~~w~~~  253 (421)
                      |+|.||||+.
T Consensus       742 qAL~HpFi~~  751 (752)
T KOG0670|consen  742 QALKHPFITE  751 (752)
T ss_pred             HHhcCCcccC
Confidence            9999999974

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=100.00  E-value=2e-34  Score=283.03  Aligned_cols=228  Identities=26%  Similarity=0.399  Sum_probs=189.6

Q ss_pred             ceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEEe
Q 014609           15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLE   94 (421)
Q Consensus        15 ~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E   94 (421)
                      +..+.++||+|-||.|.+++- ..+..||+|+++.....+  ....|.+|+++|.+|+||||+.++++|..++.+++|+|
T Consensus       539 ~L~~~ekiGeGqFGEVhLCev-eg~lkVAVK~Lr~~a~~~--~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~E  615 (807)
T KOG1094|consen  539 RLRFKEKIGEGQFGEVHLCEV-EGPLKVAVKILRPDATKN--ARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITE  615 (807)
T ss_pred             heehhhhhcCcccceeEEEEe-cCceEEEEeecCcccchh--HHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHH
Confidence            457889999999999999984 557999999998665443  36889999999999999999999999999999999999


Q ss_pred             ccCCCChHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCccccCCCc
Q 014609           95 YVTGGELFDKIASKGR--LQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGL  172 (421)
Q Consensus        95 ~~~gg~L~~~i~~~~~--~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~  172 (421)
                      |++.|+|..++..+..  .......+++.||++|++||.+.+++||||-|.|+|++.++++||+|||+++-.-....-..
T Consensus       616 YmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~yy~v  695 (807)
T KOG1094|consen  616 YMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDYYRV  695 (807)
T ss_pred             HHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceeecCcccEEecCcccccccccCCceee
Confidence            9999999999987532  34455667999999999999999999999999999999999999999999983321111111


Q ss_pred             cccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhhc------------------------------CCcCCCCCCCH
Q 014609          173 LHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIFR------------------------------GDFKLPKWLSP  222 (421)
Q Consensus       173 ~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~~------------------------------~~~~~p~~~s~  222 (421)
                      -....-...|||||.+...++ +.++|+|++|+++|++.                              .-+..|+-++.
T Consensus       696 qgr~vlpiRwmawEsillgkF-ttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~~~~~l~~P~~cp~  774 (807)
T KOG1094|consen  696 QGRAVLPIRWMAWESILLGKF-TTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQGRQVVLSRPPACPQ  774 (807)
T ss_pred             ecceeeeeeehhHHHHHhccc-cchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCCcceeccCCCcCcH
Confidence            112234568999999888888 48999999999999321                              01345777999


Q ss_pred             HHHHHHHHhcCCCCCCCCCHHhhh
Q 014609          223 GAQNLLRKILEPNPVKRITIAGIK  246 (421)
Q Consensus       223 ~~~~li~~~L~~dP~~R~t~~eil  246 (421)
                      ++.++|.+|+..+..+||+++++-
T Consensus       775 ~lyelml~Cw~~es~~RPsFe~lh  798 (807)
T KOG1094|consen  775 GLYELMLRCWRRESEQRPSFEQLH  798 (807)
T ss_pred             HHHHHHHHHhchhhhcCCCHHHHH
Confidence            999999999999999999999974

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=100.00  E-value=9.7e-34  Score=279.77  Aligned_cols=227  Identities=27%  Similarity=0.433  Sum_probs=188.9

Q ss_pred             cceEEeceEeecCcEEEEEEEECC--CCc--eEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEE
Q 014609           14 GRYELGRTLGEGNFGKVKFAQDLD--SGL--PFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKI   89 (421)
Q Consensus        14 ~~y~i~~~LG~G~~g~V~~a~~~~--~~~--~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~   89 (421)
                      +..++.+.||.|-||.||.|....  .|+  .||||..+.+..  ....+.|..|..+|+.++||||++++|++.+. ..
T Consensus       389 e~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t--~d~tekflqEa~iMrnfdHphIikLIGv~~e~-P~  465 (974)
T KOG4257|consen  389 ELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCT--PDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQ-PM  465 (974)
T ss_pred             hhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCC--hhhHHHHHHHHHHHHhCCCcchhheeeeeecc-ce
Confidence            345567889999999999997543  333  688888865432  23378999999999999999999999999764 68


Q ss_pred             EEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCcccc
Q 014609           90 YMVLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFR  168 (421)
Q Consensus        90 ~lv~E~~~gg~L~~~i~~~-~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~~  168 (421)
                      |||||+++-|+|..+++.+ ..++......|+.||..||+|||+...+||||-..|||+.....+||+|||+++..+.  
T Consensus       466 WivmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed--  543 (974)
T KOG4257|consen  466 WIVMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVSSPQCVKLADFGLSRYLED--  543 (974)
T ss_pred             eEEEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeecCcceeeecccchhhhccc--
Confidence            9999999999999999864 4688899999999999999999999999999999999999999999999999986543  


Q ss_pred             CCCccccccC--CCCccChhhhcccCCCCCcchHHHHHHHHhhh----------------------cCCcCCCCCCCHHH
Q 014609          169 DDGLLHTTCG--SPNYVAPEVLANRGYDGATSDIWSCGVILYIF----------------------RGDFKLPKWLSPGA  224 (421)
Q Consensus       169 ~~~~~~~~~g--t~~y~APEvl~~~~~~~~~~DiwSlGvil~~~----------------------~~~~~~p~~~s~~~  224 (421)
                       +...+...|  ..-|||||-+.-..+ +.++|||-|||.+|+.                      ..+.|.|+.+|+.+
T Consensus       544 -~~yYkaS~~kLPIKWmaPESINfRrF-TtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~iEnGeRlP~P~nCPp~L  621 (974)
T KOG4257|consen  544 -DAYYKASRGKLPIKWMAPESINFRRF-TTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHIENGERLPCPPNCPPAL  621 (974)
T ss_pred             -cchhhccccccceeecCccccchhcc-cchhhHHHHHHHHHHHHHhcCCccccccccceEEEecCCCCCCCCCCCChHH
Confidence             222111122  336999999887777 4889999999999932                      23468899999999


Q ss_pred             HHHHHHhcCCCCCCCCCHHhhhc
Q 014609          225 QNLLRKILEPNPVKRITIAGIKA  247 (421)
Q Consensus       225 ~~li~~~L~~dP~~R~t~~eil~  247 (421)
                      ..|+.+||..+|.+||++.+|..
T Consensus       622 YslmskcWayeP~kRPrftei~~  644 (974)
T KOG4257|consen  622 YSLMSKCWAYEPSKRPRFTEIKA  644 (974)
T ss_pred             HHHHHHHhccCcccCCcHHHHHH
Confidence            99999999999999999877643

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=5.5e-35  Score=290.86  Aligned_cols=238  Identities=32%  Similarity=0.496  Sum_probs=205.5

Q ss_pred             eeecceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEE
Q 014609           11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIY   90 (421)
Q Consensus        11 ~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~   90 (421)
                      ..-.+|+++..+|.|+||.||+|+|+.+++..|+|+++...-.+   ..-+++|+-+++..+||||+.+++.+......|
T Consensus        12 nP~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd---~~~iqqei~~~~dc~h~nivay~gsylr~dklw   88 (829)
T KOG0576|consen   12 NPQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDD---FSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLW   88 (829)
T ss_pred             CCccchhheeeecCCcccchhhhcccccCchhhheeeeccCCcc---ccccccceeeeecCCCcChHHHHhhhhhhcCcE
Confidence            44578999999999999999999999999999999998765333   466889999999999999999999999999999


Q ss_pred             EEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCccccCC
Q 014609           91 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD  170 (421)
Q Consensus        91 lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~  170 (421)
                      ++||||.||+|.+...-.+++++.++....+..+.+++|||+.|-+|||||-.|||+++.|.+||+|||.+..+...  -
T Consensus        89 icMEycgggslQdiy~~TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd~gDvklaDfgvsaqitat--i  166 (829)
T KOG0576|consen   89 ICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTDEGDVKLADFGVSAQITAT--I  166 (829)
T ss_pred             EEEEecCCCcccceeeecccchhHHHHHHHhhhhccchhhhcCCcccccccccceeecccCceeecccCchhhhhhh--h
Confidence            99999999999998888899999999999999999999999999999999999999999999999999998754331  2


Q ss_pred             CccccccCCCCccChhhhc---ccCCCCCcchHHHHHHHHhhh--------------------cCCcCCC-----CCCCH
Q 014609          171 GLLHTTCGSPNYVAPEVLA---NRGYDGATSDIWSCGVILYIF--------------------RGDFKLP-----KWLSP  222 (421)
Q Consensus       171 ~~~~~~~gt~~y~APEvl~---~~~~~~~~~DiwSlGvil~~~--------------------~~~~~~p-----~~~s~  222 (421)
                      .....+.|||.|||||+-.   ..+| ...+|||++|+...++                    ...+..|     ...++
T Consensus       167 ~KrksfiGtpywmapEvaaverkggy-nqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~~qpp~lkDk~kws~  245 (829)
T KOG0576|consen  167 AKRKSFIGTPYWMAPEVAAVERKGGY-NQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSGFQPPTLKDKTKWSE  245 (829)
T ss_pred             hhhhcccCCccccchhHHHHHhcccc-cccccccccccchhhhhhcCCcccccchHHHHHHhhccCCCCCcccCCccchH
Confidence            2345678999999999853   3456 5899999999765511                    2223333     23688


Q ss_pred             HHHHHHHHhcCCCCCCCCCHHhhhcCcccccc
Q 014609          223 GAQNLLRKILEPNPVKRITIAGIKADEWFEQD  254 (421)
Q Consensus       223 ~~~~li~~~L~~dP~~R~t~~eil~~~w~~~~  254 (421)
                      .+-+|++.+|.++|.+|||++.++.|||....
T Consensus       246 ~fh~fvK~altknpKkRptaeklL~h~fvs~~  277 (829)
T KOG0576|consen  246 FFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT  277 (829)
T ss_pred             HHHHHHHHHhcCCCccCCChhhheeceeeccc
Confidence            89999999999999999999999999998653

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=100.00  E-value=6.3e-34  Score=289.91  Aligned_cols=225  Identities=30%  Similarity=0.422  Sum_probs=179.5

Q ss_pred             eceEeecCcEE-EEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCC-CCCcceEEEEEEeCCEEEEEEecc
Q 014609           19 GRTLGEGNFGK-VKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK-HPNVVRLHEVLASKSKIYMVLEYV   96 (421)
Q Consensus        19 ~~~LG~G~~g~-V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~lv~E~~   96 (421)
                      -+.+|.|+.|+ ||+|.  -.|+.||||.+-.+      ....+.+|+..|+..+ |||||++|+.-.+....||+.|.|
T Consensus       514 ~eilG~Gs~Gt~Vf~G~--ye~R~VAVKrll~e------~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC  585 (903)
T KOG1027|consen  514 KEILGYGSNGTVVFRGV--YEGREVAVKRLLEE------FFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELC  585 (903)
T ss_pred             HHHcccCCCCcEEEEEe--eCCceehHHHHhhH------hHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHh
Confidence            46689999986 89997  47889999976432      2457889999999985 999999999999999999999999


Q ss_pred             CCCChHHHHHhcCC----CCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecc---CC--CEEEEeccCCCCCccc
Q 014609           97 TGGELFDKIASKGR----LQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDS---KG--NIKISDFGLSALPQHF  167 (421)
Q Consensus        97 ~gg~L~~~i~~~~~----~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~---~~--~~kL~DFGla~~~~~~  167 (421)
                       ..+|.|+++....    ......+....|+++||+|||+.+|+||||||.||||+.   ++  .++|+|||+++.....
T Consensus       586 -~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~  664 (903)
T KOG1027|consen  586 -ACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGG  664 (903)
T ss_pred             -hhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEecccccccccCCC
Confidence             5699999987411    122456788999999999999999999999999999976   34  6899999999865432


Q ss_pred             cC-CCccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhh-------------------cCCcCCC---CCCCHHH
Q 014609          168 RD-DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIF-------------------RGDFKLP---KWLSPGA  224 (421)
Q Consensus       168 ~~-~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~-------------------~~~~~~p---~~~s~~~  224 (421)
                      .. -....+..||-+|+|||++..... ..++||+|+||++|+.                   .+.+.+-   +.-..++
T Consensus       665 ~sS~~r~s~~sGt~GW~APE~L~~~~~-~~avDiFslGCvfyYvltgG~HpFGd~~~R~~NIl~~~~~L~~L~~~~d~eA  743 (903)
T KOG1027|consen  665 KSSFSRLSGGSGTSGWQAPEQLREDRK-TQAVDIFSLGCVFYYVLTGGSHPFGDSLERQANILTGNYTLVHLEPLPDCEA  743 (903)
T ss_pred             cchhhcccCCCCcccccCHHHHhcccc-CcccchhhcCceEEEEecCCccCCCchHHhhhhhhcCccceeeeccCchHHH
Confidence            21 123456679999999999987765 4789999999999932                   2222111   1111289


Q ss_pred             HHHHHHhcCCCCCCCCCHHhhhcCccccc
Q 014609          225 QNLLRKILEPNPVKRITIAGIKADEWFEQ  253 (421)
Q Consensus       225 ~~li~~~L~~dP~~R~t~~eil~~~w~~~  253 (421)
                      .+||.+|++++|..||++.+++.||+|=.
T Consensus       744 ~dLI~~ml~~dP~~RPsa~~VL~HPlFW~  772 (903)
T KOG1027|consen  744 KDLISRMLNPDPQLRPSATDVLNHPLFWD  772 (903)
T ss_pred             HHHHHHhcCCCcccCCCHHHHhCCCccCC
Confidence            99999999999999999999999999853

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=1.1e-32  Score=306.23  Aligned_cols=217  Identities=24%  Similarity=0.362  Sum_probs=177.6

Q ss_pred             cceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEE
Q 014609           14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVL   93 (421)
Q Consensus        14 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~   93 (421)
                      +.|...+.||+|+||.||+|++..++..||+|.+.....       ...+|++++++++||||+++++++.+....|+||
T Consensus       690 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-------~~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~  762 (968)
T PLN00113        690 SSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS-------IPSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIH  762 (968)
T ss_pred             hhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc-------ccHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEE
Confidence            356667889999999999999989999999998864321       1234688999999999999999999999999999


Q ss_pred             eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---hCCceeccCCCCCEEeccCCCEEEEeccCCCCCccccCC
Q 014609           94 EYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCH---NKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD  170 (421)
Q Consensus        94 E~~~gg~L~~~i~~~~~~~~~~~~~~~~ql~~aL~~LH---~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~  170 (421)
                      ||+++|+|.+++..   +++..+..++.|++.|++|||   +.+|+||||||+||+++.++..++. ||.......    
T Consensus       763 Ey~~~g~L~~~l~~---l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~----  834 (968)
T PLN00113        763 EYIEGKNLSEVLRN---LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCT----  834 (968)
T ss_pred             eCCCCCcHHHHHhc---CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccccc----
Confidence            99999999999863   889999999999999999999   6699999999999999999888876 665543211    


Q ss_pred             CccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhhc-CCcCCCC-----------------------C----C--
Q 014609          171 GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIFR-GDFKLPK-----------------------W----L--  220 (421)
Q Consensus       171 ~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~~-~~~~~p~-----------------------~----~--  220 (421)
                        .....||+.|+|||++.+..| +.++||||+||++|++. |..++..                       +    +  
T Consensus       835 --~~~~~~t~~y~aPE~~~~~~~-~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  911 (968)
T PLN00113        835 --DTKCFISSAYVAPETRETKDI-TEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRG  911 (968)
T ss_pred             --CCCccccccccCcccccCCCC-CcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCccccC
Confidence              123368899999999988777 58999999999999653 3332210                       0    0  


Q ss_pred             --------CHHHHHHHHHhcCCCCCCCCCHHhhhcC
Q 014609          221 --------SPGAQNLLRKILEPNPVKRITIAGIKAD  248 (421)
Q Consensus       221 --------s~~~~~li~~~L~~dP~~R~t~~eil~~  248 (421)
                              ..++.+++.+||+.||++|||+.|+++.
T Consensus       912 ~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~  947 (968)
T PLN00113        912 DVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKT  947 (968)
T ss_pred             CCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHH
Confidence                    1245678999999999999999999764

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=100.00  E-value=1.1e-31  Score=241.89  Aligned_cols=213  Identities=45%  Similarity=0.784  Sum_probs=186.4

Q ss_pred             EeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEEeccCCCCh
Q 014609           22 LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGEL  101 (421)
Q Consensus        22 LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~~gg~L  101 (421)
                      ||+|++|.||++.+..+++.+++|++.......  ..+.+.+|+..++.++|++|+++++++......++++||++|++|
T Consensus         1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~--~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l   78 (215)
T cd00180           1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS--LLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSL   78 (215)
T ss_pred             CCcCCceEEEEEEecCCCcEEEEEEeccccchh--HHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcH
Confidence            689999999999998889999999987654321  246799999999999999999999999999999999999999999


Q ss_pred             HHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecc-CCCEEEEeccCCCCCccccCCCccccccCC
Q 014609          102 FDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDS-KGNIKISDFGLSALPQHFRDDGLLHTTCGS  179 (421)
Q Consensus       102 ~~~i~~~-~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~-~~~~kL~DFGla~~~~~~~~~~~~~~~~gt  179 (421)
                      .+++... ..++...+..++.|++.++++||+.|++|+||+|.||+++. ++.++|+|||.+........  ......+.
T Consensus        79 ~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~  156 (215)
T cd00180          79 KDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS--LLKTIVGT  156 (215)
T ss_pred             HHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc--hhhcccCC
Confidence            9998765 47899999999999999999999999999999999999999 89999999999975433111  23345678


Q ss_pred             CCccChhhhcccCCCCCcchHHHHHHHHhhhcCCcCCCCCCCHHHHHHHHHhcCCCCCCCCCHHhhhcCc
Q 014609          180 PNYVAPEVLANRGYDGATSDIWSCGVILYIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADE  249 (421)
Q Consensus       180 ~~y~APEvl~~~~~~~~~~DiwSlGvil~~~~~~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~~~  249 (421)
                      ..|++||.+......+.++|+|++|+++|.+           ..+.+++.+|++.||++||++.++++++
T Consensus       157 ~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l-----------~~~~~~l~~~l~~~p~~R~~~~~l~~~~  215 (215)
T cd00180         157 PAYMAPEVLLGKGYYSEKSDIWSLGVILYEL-----------PELKDLIRKMLQKDPEKRPSAKEILEHL  215 (215)
T ss_pred             CCccChhHhcccCCCCchhhhHHHHHHHHHH-----------HHHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence            8999999987652336889999999999987           8899999999999999999999999875

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.6e-33  Score=278.77  Aligned_cols=235  Identities=30%  Similarity=0.432  Sum_probs=196.0

Q ss_pred             cceEEeceEeecCcEEEEEEEECC-CCc--eEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEE
Q 014609           14 GRYELGRTLGEGNFGKVKFAQDLD-SGL--PFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIY   90 (421)
Q Consensus        14 ~~y~i~~~LG~G~~g~V~~a~~~~-~~~--~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~   90 (421)
                      ++..+.++||+|+||.|+.|.++. +|+  .||||.++......  ...+|.+|+.+|.+|+|||++++|++..+ ..+.
T Consensus       110 e~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~--~mddflrEas~M~~L~H~hliRLyGvVl~-qp~m  186 (1039)
T KOG0199|consen  110 EQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNA--IMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAM  186 (1039)
T ss_pred             HHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccch--hHHHHHHHHHHHHhccCcceeEEeeeecc-chhh
Confidence            567788999999999999998864 343  69999997654432  46899999999999999999999999987 6788


Q ss_pred             EEEeccCCCChHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCcccc
Q 014609           91 MVLEYVTGGELFDKIAS--KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFR  168 (421)
Q Consensus        91 lv~E~~~gg~L~~~i~~--~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~~  168 (421)
                      +|+|++++|+|.+.+..  ...|-......|+.||+.|+.||.+++.|||||-..|+||.....+||+||||++-.....
T Consensus       187 MV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllasprtVKI~DFGLmRaLg~ne  266 (1039)
T KOG0199|consen  187 MVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLASPRTVKICDFGLMRALGENE  266 (1039)
T ss_pred             HHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheecccceeeeecccceeccCCCC
Confidence            99999999999999976  3457888889999999999999999999999999999999999999999999998655432


Q ss_pred             CCCccc-cccCCCCccChhhhcccCCCCCcchHHHHHHHHhhhcC----------------------CcCCCCCCCHHHH
Q 014609          169 DDGLLH-TTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIFRG----------------------DFKLPKWLSPGAQ  225 (421)
Q Consensus       169 ~~~~~~-~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~~~----------------------~~~~p~~~s~~~~  225 (421)
                      +.-.+. ...-...|+|||.+....+ +.++|+|++||++|++..                      .++-|+.+|.++.
T Consensus       267 d~Yvm~p~rkvPfAWCaPEsLrh~kF-ShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD~~erLpRPk~csedIY  345 (1039)
T KOG0199|consen  267 DMYVMAPQRKVPFAWCAPESLRHRKF-SHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNIDAGERLPRPKYCSEDIY  345 (1039)
T ss_pred             cceEecCCCcCcccccCHhHhccccc-cccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhccccccCCCCCCChHHHH
Confidence            221111 1122347999999998888 589999999999995421                      2455778999999


Q ss_pred             HHHHHhcCCCCCCCCCHHhhhcCcccc
Q 014609          226 NLLRKILEPNPVKRITIAGIKADEWFE  252 (421)
Q Consensus       226 ~li~~~L~~dP~~R~t~~eil~~~w~~  252 (421)
                      ++++.||..+|.+|||+..|.++-.+.
T Consensus       346 ~imk~cWah~paDRptFsair~~~~l~  372 (1039)
T KOG0199|consen  346 QIMKNCWAHNPADRPTFSAIREDLVLA  372 (1039)
T ss_pred             HHHHHhccCCccccccHHHHHHhHHHH
Confidence            999999999999999999987655544

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.9e-33  Score=273.41  Aligned_cols=223  Identities=28%  Similarity=0.449  Sum_probs=190.7

Q ss_pred             ceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEEe
Q 014609           15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLE   94 (421)
Q Consensus        15 ~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E   94 (421)
                      +....++||-|-||.||.|.++.-.-.||||.++.+..    ..+.|..|..+|+.++|||+|+++++|..+..+|||+|
T Consensus       268 dItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtM----eveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTE  343 (1157)
T KOG4278|consen  268 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITE  343 (1157)
T ss_pred             heeeeeccCCCcccceeeeeeeccceeeehhhhhhcch----hHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEe
Confidence            34567889999999999999999999999999865432    36889999999999999999999999999999999999


Q ss_pred             ccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCccccCCCc
Q 014609           95 YVTGGELFDKIASKG--RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGL  172 (421)
Q Consensus        95 ~~~gg~L~~~i~~~~--~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~  172 (421)
                      ||..|+|.|++.+..  .++......++.||.+|++||..+++|||||-..|.|+.++..+|++||||+++....    .
T Consensus       344 fM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVgEnhiVKvADFGLsRlMtgD----T  419 (1157)
T KOG4278|consen  344 FMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHIVKVADFGLSRLMTGD----T  419 (1157)
T ss_pred             cccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhccccccceEEeeccchhhhhcCC----c
Confidence            999999999998643  4777788889999999999999999999999999999999999999999999976431    1


Q ss_pred             cccccC---CCCccChhhhcccCCCCCcchHHHHHHHHhhhc--C--------------------CcCCCCCCCHHHHHH
Q 014609          173 LHTTCG---SPNYVAPEVLANRGYDGATSDIWSCGVILYIFR--G--------------------DFKLPKWLSPGAQNL  227 (421)
Q Consensus       173 ~~~~~g---t~~y~APEvl~~~~~~~~~~DiwSlGvil~~~~--~--------------------~~~~p~~~s~~~~~l  227 (421)
                      .....|   ..-|.|||-+.-..+ +.++|||+|||+||++.  |                    +..-|..+++.+.+|
T Consensus       420 YTAHAGAKFPIKWTAPEsLAyNtF-SiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~LLEkgyRM~~PeGCPpkVYeL  498 (1157)
T KOG4278|consen  420 YTAHAGAKFPIKWTAPESLAYNTF-SIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLLEKGYRMDGPEGCPPKVYEL  498 (1157)
T ss_pred             eecccCccCcccccCccccccccc-ccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHhccccccCCCCCCHHHHHH
Confidence            111222   336999999987777 58999999999999431  1                    223467799999999


Q ss_pred             HHHhcCCCCCCCCCHHhhh
Q 014609          228 LRKILEPNPVKRITIAGIK  246 (421)
Q Consensus       228 i~~~L~~dP~~R~t~~eil  246 (421)
                      |+.||+.+|..||++.+|-
T Consensus       499 MraCW~WsPsDRPsFaeiH  517 (1157)
T KOG4278|consen  499 MRACWNWSPSDRPSFAEIH  517 (1157)
T ss_pred             HHHHhcCCcccCccHHHHH
Confidence            9999999999999999873

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=100.00  E-value=4.9e-33  Score=281.06  Aligned_cols=231  Identities=24%  Similarity=0.409  Sum_probs=197.0

Q ss_pred             cceEEeceEeecCcEEEEEEEECCCC---ceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEE
Q 014609           14 GRYELGRTLGEGNFGKVKFAQDLDSG---LPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIY   90 (421)
Q Consensus        14 ~~y~i~~~LG~G~~g~V~~a~~~~~~---~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~   90 (421)
                      ..-.|.+.||.|.||.|++|+-+..|   ..||||.++...  ......+|..|..||-+++||||+++.++........
T Consensus       629 s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~Gy--tekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvM  706 (996)
T KOG0196|consen  629 SCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGY--TEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVM  706 (996)
T ss_pred             hheEEEEEEecccccceecccccCCCCcceeEEEeeeccCc--cHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeE
Confidence            34578899999999999999987655   479999997543  3445678999999999999999999999999999999


Q ss_pred             EEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCccccC
Q 014609           91 MVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD  169 (421)
Q Consensus        91 lv~E~~~gg~L~~~i~~-~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~  169 (421)
                      ||+|||++|+|..++.. +++|+..+...+++.|+.|++||-+.|++||||-..|||++.+-..|++|||+++..+... 
T Consensus       707 IiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVNsnLvCKVsDFGLSRvledd~-  785 (996)
T KOG0196|consen  707 IITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP-  785 (996)
T ss_pred             EEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeeccceEEEeccccceeecccCC-
Confidence            99999999999998864 5789999999999999999999999999999999999999999999999999999765432 


Q ss_pred             CCccccccC--CCCccChhhhcccCCCCCcchHHHHHHHHhhh----------------------cCCcCCCCCCCHHHH
Q 014609          170 DGLLHTTCG--SPNYVAPEVLANRGYDGATSDIWSCGVILYIF----------------------RGDFKLPKWLSPGAQ  225 (421)
Q Consensus       170 ~~~~~~~~g--t~~y~APEvl~~~~~~~~~~DiwSlGvil~~~----------------------~~~~~~p~~~s~~~~  225 (421)
                      .....+.-|  ...|.|||.+.-.++. .++||||+|+++|+.                      .-++|.|-.+|..+-
T Consensus       786 ~~~ytt~GGKIPiRWTAPEAIa~RKFT-sASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe~gyRLPpPmDCP~aL~  864 (996)
T KOG0196|consen  786 EAAYTTLGGKIPIRWTAPEAIAYRKFT-SASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEQGYRLPPPMDCPAALY  864 (996)
T ss_pred             CccccccCCccceeecChhHhhhcccC-chhhccccceEEEEecccCCCcccccchHHHHHHHHhccCCCCCCCCcHHHH
Confidence            111222222  2479999999988885 789999999999921                      224566677999999


Q ss_pred             HHHHHhcCCCCCCCCCHHhhhcC
Q 014609          226 NLLRKILEPNPVKRITIAGIKAD  248 (421)
Q Consensus       226 ~li~~~L~~dP~~R~t~~eil~~  248 (421)
                      .|+..||++|-.+||.+.||..+
T Consensus       865 qLMldCWqkdR~~RP~F~qiV~~  887 (996)
T KOG0196|consen  865 QLMLDCWQKDRNRRPKFAQIVST  887 (996)
T ss_pred             HHHHHHHHHHhhcCCCHHHHHHH
Confidence            99999999999999999998764

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3e-32  Score=260.90  Aligned_cols=225  Identities=27%  Similarity=0.456  Sum_probs=178.2

Q ss_pred             cceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHh--cCCCCCcceEEEEEEeC----C
Q 014609           14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLK--LLKHPNVVRLHEVLASK----S   87 (421)
Q Consensus        14 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~--~l~hpnIv~l~~~~~~~----~   87 (421)
                      .+.++.+.||+|-||.||+|.+  .|+.||||++....      .....+|.+|.+  .|+|+||+.+++.=..+    .
T Consensus       211 rqI~L~e~IGkGRyGEVwrG~w--rGe~VAVKiF~srd------E~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~T  282 (513)
T KOG2052|consen  211 RQIVLQEIIGKGRFGEVWRGRW--RGEDVAVKIFSSRD------ERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWT  282 (513)
T ss_pred             heeEEEEEecCccccceeeccc--cCCceEEEEecccc------hhhhhhHHHHHHHHHhccchhhhhhhccccCCCceE
Confidence            4678999999999999999986  68899999996432      356777777775  56999999998764322    4


Q ss_pred             EEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC--------CceeccCCCCCEEeccCCCEEEEecc
Q 014609           88 KIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNK--------GVFHRDLKLENILLDSKGNIKISDFG  159 (421)
Q Consensus        88 ~~~lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~ql~~aL~~LH~~--------gi~HrDlkp~NILl~~~~~~kL~DFG  159 (421)
                      .+|+|++|-+.|+|+|++.+ ..++.+...+++..+++||+|||-.        .|+|||||..|||+..+|..-|+|+|
T Consensus       283 QLwLvTdYHe~GSL~DyL~r-~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLG  361 (513)
T KOG2052|consen  283 QLWLVTDYHEHGSLYDYLNR-NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLG  361 (513)
T ss_pred             EEEEeeecccCCcHHHHHhh-ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeece
Confidence            69999999999999999998 7799999999999999999999952        49999999999999999999999999


Q ss_pred             CCCCCccccC--CCccccccCCCCccChhhhccc----CCCC-CcchHHHHHHHHhhhcC--------------------
Q 014609          160 LSALPQHFRD--DGLLHTTCGSPNYVAPEVLANR----GYDG-ATSDIWSCGVILYIFRG--------------------  212 (421)
Q Consensus       160 la~~~~~~~~--~~~~~~~~gt~~y~APEvl~~~----~~~~-~~~DiwSlGvil~~~~~--------------------  212 (421)
                      ||-......+  +-.....+||..|||||++...    .+.+ ..+||||||.++|+...                    
T Consensus       362 LAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp  441 (513)
T KOG2052|consen  362 LAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVP  441 (513)
T ss_pred             eeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCC
Confidence            9976544321  2245677999999999998642    2222 24899999999993210                    


Q ss_pred             -----------------CcCCC-CCCCH----HHHHHHHHhcCCCCCCCCCHHhhhc
Q 014609          213 -----------------DFKLP-KWLSP----GAQNLLRKILEPNPVKRITIAGIKA  247 (421)
Q Consensus       213 -----------------~~~~p-~~~s~----~~~~li~~~L~~dP~~R~t~~eil~  247 (421)
                                       ++.+| .|-+.    .+..+|+.||..||.-|.|+-.|.+
T Consensus       442 ~DPs~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKK  498 (513)
T KOG2052|consen  442 SDPSFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKK  498 (513)
T ss_pred             CCCCHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHH
Confidence                             11122 23332    3457899999999999999877654

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=99.97  E-value=2.3e-32  Score=260.70  Aligned_cols=233  Identities=29%  Similarity=0.450  Sum_probs=191.1

Q ss_pred             ecceEEeceEeecCcEEEEEEEECC---CCceEEEEEeecccccchhHHHHHHHHHHHHhcCC-CCCcceEEEEEEeCCE
Q 014609           13 LGRYELGRTLGEGNFGKVKFAQDLD---SGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK-HPNVVRLHEVLASKSK   88 (421)
Q Consensus        13 ~~~y~i~~~LG~G~~g~V~~a~~~~---~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~   88 (421)
                      ...|.++++||+|+|++||+|.+..   ..+.||+|.+.....     ..++..|+++|..+. +.||+++.+++..++.
T Consensus        35 ~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~-----p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~  109 (418)
T KOG1167|consen   35 SNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSS-----PSRILNELEMLYRLGGSDNIIKLNGCFRNNDQ  109 (418)
T ss_pred             hhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccC-----chHHHHHHHHHHHhccchhhhcchhhhccCCe
Confidence            3578999999999999999998877   788999998865432     467999999999995 8999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccC-CCEEEEeccCCCCCccc
Q 014609           89 IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSK-GNIKISDFGLSALPQHF  167 (421)
Q Consensus        89 ~~lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~-~~~kL~DFGla~~~~~~  167 (421)
                      ..+|+||++..+..++...   ++...++.|++.++.||+++|.+||+||||||.|+|.+.. +.-.|+|||+|...+..
T Consensus       110 v~ivlp~~~H~~f~~l~~~---l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d~~  186 (418)
T KOG1167|consen  110 VAIVLPYFEHDRFRDLYRS---LSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYDGY  186 (418)
T ss_pred             eEEEecccCccCHHHHHhc---CCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccccccCCceEEechhHHHHHhh
Confidence            9999999999888777654   6789999999999999999999999999999999999854 78899999998721100


Q ss_pred             c-------------------------------CCC-----------ccccccCCCCccChhhhcccCCCCCcchHHHHHH
Q 014609          168 R-------------------------------DDG-----------LLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGV  205 (421)
Q Consensus       168 ~-------------------------------~~~-----------~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGv  205 (421)
                      .                               ..+           ..-...|||+|+|||++...+-.++++||||.||
T Consensus       187 ~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~GV  266 (418)
T KOG1167|consen  187 QQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSAGV  266 (418)
T ss_pred             hhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeeccc
Confidence            0                               000           0012359999999999988777788999999999


Q ss_pred             HHh-----------------------------------hhcCC------cCC----------------------------
Q 014609          206 ILY-----------------------------------IFRGD------FKL----------------------------  216 (421)
Q Consensus       206 il~-----------------------------------~~~~~------~~~----------------------------  216 (421)
                      |+.                                   .+.|.      -..                            
T Consensus       267 I~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~n~~~  346 (418)
T KOG1167|consen  267 ILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQPNTER  346 (418)
T ss_pred             eeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccccccceee
Confidence            986                                   01111      000                            


Q ss_pred             ---CCCCCHHHHHHHHHhcCCCCCCCCCHHhhhcCccccc
Q 014609          217 ---PKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQ  253 (421)
Q Consensus       217 ---p~~~s~~~~~li~~~L~~dP~~R~t~~eil~~~w~~~  253 (421)
                         ...++..+.+|+.+||+.||.+|+|++++|.||||..
T Consensus       347 ~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkHpFF~~  386 (418)
T KOG1167|consen  347 EIGSDVFPALLLDLLDKCLELNPQKRITAEDALKHPFFDE  386 (418)
T ss_pred             ccccccccHHHHHHHHHHccCChhhcccHHHHhcCcCCcc
Confidence               0114568999999999999999999999999999983

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=99.97  E-value=1e-31  Score=259.02  Aligned_cols=224  Identities=24%  Similarity=0.365  Sum_probs=182.0

Q ss_pred             ecceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHh--cCCCCCcceEEEEEEeCC---
Q 014609           13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLK--LLKHPNVVRLHEVLASKS---   87 (421)
Q Consensus        13 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~--~l~hpnIv~l~~~~~~~~---   87 (421)
                      +...++++.||+|.||+||+|.  -+++.||||+++...      ...+..|-+|.+  .++|+||+++++.-+..+   
T Consensus       209 l~pl~l~eli~~Grfg~V~Kaq--L~~~~VAVKifp~~~------kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~  280 (534)
T KOG3653|consen  209 LDPLQLLELIGRGRFGCVWKAQ--LDNRLVAVKIFPEQE------KQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADR  280 (534)
T ss_pred             CCchhhHHHhhcCccceeehhh--ccCceeEEEecCHHH------HHHHHhHHHHHhccCccchhHHHhhchhccCCccc
Confidence            4567888999999999999998  467999999997542      456777777766  458999999999876555   


Q ss_pred             -EEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---------CceeccCCCCCEEeccCCCEEEEe
Q 014609           88 -KIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNK---------GVFHRDLKLENILLDSKGNIKISD  157 (421)
Q Consensus        88 -~~~lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~ql~~aL~~LH~~---------gi~HrDlkp~NILl~~~~~~kL~D  157 (421)
                       .+++|++|.+.|+|.+++.. ..+++....+++..+++||+|||+.         .|+|||||..||||..++..-|+|
T Consensus       281 ~eywLVt~fh~kGsL~dyL~~-ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaD  359 (534)
T KOG3653|consen  281 MEYWLVTEFHPKGSLCDYLKA-NTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIAD  359 (534)
T ss_pred             cceeEEeeeccCCcHHHHHHh-ccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeec
Confidence             89999999999999999986 5689999999999999999999962         599999999999999999999999


Q ss_pred             ccCCCCCccccCCCccccccCCCCccChhhhcccCCC-----CCcchHHHHHHHHhhhcCC-----------cCC-----
Q 014609          158 FGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYD-----GATSDIWSCGVILYIFRGD-----------FKL-----  216 (421)
Q Consensus       158 FGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~-----~~~~DiwSlGvil~~~~~~-----------~~~-----  216 (421)
                      ||+|-.+......+......||.+|||||++.+.---     -...||||+|.+||++..+           +.+     
T Consensus       360 FGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~e  439 (534)
T KOG3653|consen  360 FGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAE  439 (534)
T ss_pred             cceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHH
Confidence            9999988766666667778999999999998653211     1248999999999954221           111     


Q ss_pred             -----------------------CC-C----CCHHHHHHHHHhcCCCCCCCCCHHhh
Q 014609          217 -----------------------PK-W----LSPGAQNLLRKILEPNPVKRITIAGI  245 (421)
Q Consensus       217 -----------------------p~-~----~s~~~~~li~~~L~~dP~~R~t~~ei  245 (421)
                                             |. |    --..+.+.+..||+.||+.|.|+.=+
T Consensus       440 vG~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv  496 (534)
T KOG3653|consen  440 VGNHPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCV  496 (534)
T ss_pred             hcCCCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHH
Confidence                                   10 0    12446788999999999999997644

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=99.97  E-value=2.8e-31  Score=231.46  Aligned_cols=199  Identities=26%  Similarity=0.462  Sum_probs=164.6

Q ss_pred             eEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcC-CCCCcceEEEEEEeCCEEEEEEe
Q 014609           16 YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEVLASKSKIYMVLE   94 (421)
Q Consensus        16 y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~lv~E   94 (421)
                      ..-+..||+|+||.|-+-++..+|+..|+|.+...-  +.....++.+|+.+..+. .+|.+|.+|+.+..+...|+.||
T Consensus        48 L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tv--n~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME  125 (282)
T KOG0984|consen   48 LVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATV--NSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICME  125 (282)
T ss_pred             hhhhhhhcCCccchhhheeeccCCeEEEEeeehhhc--ChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHH
Confidence            344678999999999999999999999999986432  233356788888876555 69999999999999999999999


Q ss_pred             ccCCCChHHH----HHhcCCCCHHHHHHHHHHHHHHHHHHHhC-CceeccCCCCCEEeccCCCEEEEeccCCCCCccccC
Q 014609           95 YVTGGELFDK----IASKGRLQEAEGRKLFQQLIDGVSYCHNK-GVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD  169 (421)
Q Consensus        95 ~~~gg~L~~~----i~~~~~~~~~~~~~~~~ql~~aL~~LH~~-gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~  169 (421)
                      .+. .+|..+    +...+.++|..+-+++..++.||.|||++ .|+|||+||.|||++.+|.+|+||||.+.....   
T Consensus       126 ~M~-tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~d---  201 (282)
T KOG0984|consen  126 LMD-TSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDGQVKICDFGISGYLVD---  201 (282)
T ss_pred             Hhh-hhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCCcEEEcccccceeehh---
Confidence            994 466432    34567799999999999999999999998 899999999999999999999999999875432   


Q ss_pred             CCcccc-ccCCCCccChhhhc----ccCCCCCcchHHHHHHHHhhh-cCCcCCCCCCCH
Q 014609          170 DGLLHT-TCGSPNYVAPEVLA----NRGYDGATSDIWSCGVILYIF-RGDFKLPKWLSP  222 (421)
Q Consensus       170 ~~~~~~-~~gt~~y~APEvl~----~~~~~~~~~DiwSlGvil~~~-~~~~~~p~~~s~  222 (421)
                       +...+ -.|...|+|||.+.    .++| +-++||||||+.++++ .+.+|++.|.++
T Consensus       202 -SiAkt~daGCkpYmaPEri~~e~n~~gY-~vksDvWSLGItmiElA~lr~PY~~w~tp  258 (282)
T KOG0984|consen  202 -SIAKTMDAGCKPYMAPERINPELNQKGY-SVKSDVWSLGITMIEMAILRFPYESWGTP  258 (282)
T ss_pred             -hhHHHHhcCCCccCChhhcCcccCcccc-eeehhhhhhhhhhhhhhhccccccccCCH
Confidence             23333 56888999999874    3466 4899999999999965 578999999775

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.97  E-value=1.4e-30  Score=235.52  Aligned_cols=231  Identities=28%  Similarity=0.467  Sum_probs=187.7

Q ss_pred             ecceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCC-CCCcceEEEE-EEeCCEEE
Q 014609           13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK-HPNVVRLHEV-LASKSKIY   90 (421)
Q Consensus        13 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~-~~~~~~~~   90 (421)
                      .+.|.|.+.||+|-||++.+++++.+++.+++|.+++...    ...+|.+|..---.|. |.||+.-|++ |++.+.+.
T Consensus        23 ~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~t----t~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~Yv   98 (378)
T KOG1345|consen   23 EDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQT----TQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYV   98 (378)
T ss_pred             hhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchh----hHHHHHHHhccceeeccchhhhHHHHHHhhcCceEE
Confidence            4689999999999999999999999999999999986542    2567888887666664 8999998876 57778889


Q ss_pred             EEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccC--CCEEEEeccCCCCCcccc
Q 014609           91 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSK--GNIKISDFGLSALPQHFR  168 (421)
Q Consensus        91 lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~--~~~kL~DFGla~~~~~~~  168 (421)
                      +++||++.|+|...+.. .++-|....+++.|+++|+.|+|+.+++|||||.+||||-..  -++||||||+.+..    
T Consensus        99 F~qE~aP~gdL~snv~~-~GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~----  173 (378)
T KOG1345|consen   99 FVQEFAPRGDLRSNVEA-AGIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKV----  173 (378)
T ss_pred             EeeccCccchhhhhcCc-ccccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCCccEEEeeeccccccc----
Confidence            99999999999988776 568899999999999999999999999999999999999533  37999999998742    


Q ss_pred             CCCccccccCCCCccChhhhcccC---C-CCCcchHHHHHHHHh-hhcCCcCCC--------------------------
Q 014609          169 DDGLLHTTCGSPNYVAPEVLANRG---Y-DGATSDIWSCGVILY-IFRGDFKLP--------------------------  217 (421)
Q Consensus       169 ~~~~~~~~~gt~~y~APEvl~~~~---~-~~~~~DiwSlGvil~-~~~~~~~~p--------------------------  217 (421)
                       ........-+..|.|||++....   + ..+..|+|.||+++| .++|.+|+-                          
T Consensus       174 -g~tV~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk~~~~P~~  252 (378)
T KOG1345|consen  174 -GTTVKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRKNPALPKK  252 (378)
T ss_pred             -CceehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcccCccCchh
Confidence             23344455677899999864321   1 135689999999998 556665542                          


Q ss_pred             -CCCCHHHHHHHHHhcCCCCCCC---CCHHhhhcCccccc
Q 014609          218 -KWLSPGAQNLLRKILEPNPVKR---ITIAGIKADEWFEQ  253 (421)
Q Consensus       218 -~~~s~~~~~li~~~L~~dP~~R---~t~~eil~~~w~~~  253 (421)
                       ..+|+.+..+.++-|.++|++|   -++..-....|...
T Consensus       253 F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk~~w~E~  292 (378)
T KOG1345|consen  253 FNPFSEKALRLFKKSLTPRFKDRCKIWTAKKMRKCLWKEK  292 (378)
T ss_pred             hcccCHHHHHHHHHhcCCcccccchhHHHHHHHHHHHHHh
Confidence             1268999999999999999999   55666666777664

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=99.96  E-value=5.1e-30  Score=260.20  Aligned_cols=227  Identities=24%  Similarity=0.348  Sum_probs=191.5

Q ss_pred             eEEeceEeecCcEEEEEEEECCCCc----eEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEE
Q 014609           16 YELGRTLGEGNFGKVKFAQDLDSGL----PFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYM   91 (421)
Q Consensus        16 y~i~~~LG~G~~g~V~~a~~~~~~~----~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l   91 (421)
                      .+..+.||+|+||+||+|.+...|+    +||+|++.....  .+....+.+|+-+|.+|+|||++++++++.... +-|
T Consensus       698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~--~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~ql  774 (1177)
T KOG1025|consen  698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTS--PKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQL  774 (1177)
T ss_pred             hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCC--chhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHH
Confidence            3456789999999999998865554    788998875443  333678999999999999999999999998876 889


Q ss_pred             EEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCccccCC
Q 014609           92 VLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD  170 (421)
Q Consensus        92 v~E~~~gg~L~~~i~~-~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~  170 (421)
                      |++|+++|.|.|++.. +..+-......|..||++|+.|||+++++||||-..|+||..-..+|+.|||++.+.......
T Consensus       775 vtq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~e  854 (1177)
T KOG1025|consen  775 VTQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEKE  854 (1177)
T ss_pred             HHHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeecCCCeEEEEecchhhccCccccc
Confidence            9999999999999875 456888899999999999999999999999999999999999999999999999987664443


Q ss_pred             CccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhhc----------------------CCcCCCCCCCHHHHHHH
Q 014609          171 GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIFR----------------------GDFKLPKWLSPGAQNLL  228 (421)
Q Consensus       171 ~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~~----------------------~~~~~p~~~s~~~~~li  228 (421)
                      -......-.+.|||-|.+....|. .++||||+||++|++.                      .+++.|+.++-++--++
T Consensus       855 y~~~~gK~pikwmale~i~~~~~t-hqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle~geRLsqPpiCtiDVy~~m  933 (1177)
T KOG1025|consen  855 YSAPGGKVPIKWMALESIRIRKYT-HQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLEKGERLSQPPICTIDVYMVM  933 (1177)
T ss_pred             ccccccccCcHHHHHHHhhccCCC-chhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHhccccCCCCCCccHHHHHHH
Confidence            333333345679999998888884 8999999999999432                      23566888999999999


Q ss_pred             HHhcCCCCCCCCCHHhhh
Q 014609          229 RKILEPNPVKRITIAGIK  246 (421)
Q Consensus       229 ~~~L~~dP~~R~t~~eil  246 (421)
                      .+||..|++.||+++++-
T Consensus       934 vkCwmid~~~rp~fkel~  951 (1177)
T KOG1025|consen  934 VKCWMIDADSRPTFKELA  951 (1177)
T ss_pred             HHHhccCcccCccHHHHH
Confidence            999999999999988753

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.96  E-value=5.6e-31  Score=273.85  Aligned_cols=241  Identities=33%  Similarity=0.563  Sum_probs=199.8

Q ss_pred             cce-EEeceEeecCcEEEEEEEECCCCceEEEEEeecc---cccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEE
Q 014609           14 GRY-ELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKN---RIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKI   89 (421)
Q Consensus        14 ~~y-~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~---~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~   89 (421)
                      ..| ...+.+|.|++|.|+.+......+.++.|.....   ..........+..|..+-..+.|||++..+..+.+....
T Consensus       317 ~~y~~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~  396 (601)
T KOG0590|consen  317 EKYGKPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGI  396 (601)
T ss_pred             cccCCccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccc
Confidence            456 4678999999999999988777777777765421   111122223377788888999999998887777776666


Q ss_pred             EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCccccC
Q 014609           90 YMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD  169 (421)
Q Consensus        90 ~lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~  169 (421)
                      +-+||||++ +|+..+...+.++..++..+++||+.||+|+|+.||.|||+||+|+++..+|.+||+|||.+..+.....
T Consensus       397 ~~~mE~~~~-Dlf~~~~~~~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e  475 (601)
T KOG0590|consen  397 LQSMEYCPY-DLFSLVMSNGKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTENGILKIIDFGAASVFRYPWE  475 (601)
T ss_pred             hhhhhcccH-HHHHHHhcccccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEecCCceEEeecCcceeeccCcc
Confidence            667999999 9999999877899999999999999999999999999999999999999999999999999998766544


Q ss_pred             C--CccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhh-cCCcCCC----------------------------C
Q 014609          170 D--GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIF-RGDFKLP----------------------------K  218 (421)
Q Consensus       170 ~--~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~-~~~~~~p----------------------------~  218 (421)
                      .  ......+|+.+|+|||++.+..|+....||||+|+++..+ .+++++-                            .
T Consensus       476 ~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~~~~~~~~~~~~~  555 (601)
T KOG0590|consen  476 KNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQRNIFEGPNRLLS  555 (601)
T ss_pred             hhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhccccccccccChHHHHH
Confidence            4  5667789999999999999999999999999999999832 2332220                            1


Q ss_pred             CCCHHHHHHHHHhcCCCCCCCCCHHhhhcCccccccc
Q 014609          219 WLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY  255 (421)
Q Consensus       219 ~~s~~~~~li~~~L~~dP~~R~t~~eil~~~w~~~~~  255 (421)
                      .++...+.+|.+||++||.+|+|+++|++++||+...
T Consensus       556 ~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d~W~~~i~  592 (601)
T KOG0590|consen  556 LLPRETRIIIYRMLQLDPTKRITIEQILNDEWIRSIE  592 (601)
T ss_pred             hchhhHHHHHHHHccCChhheecHHHHhhChHhhhcc
Confidence            1678889999999999999999999999999998654

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=99.96  E-value=4.7e-29  Score=262.09  Aligned_cols=228  Identities=29%  Similarity=0.474  Sum_probs=187.0

Q ss_pred             eEEeceEeecCcEEEEEEEEC----C---CCceEEEEEeecccccchhHHHHHHHHHHHHhcC-CCCCcceEEEEEEeCC
Q 014609           16 YELGRTLGEGNFGKVKFAQDL----D---SGLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEVLASKS   87 (421)
Q Consensus        16 y~i~~~LG~G~~g~V~~a~~~----~---~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~   87 (421)
                      ..+.+.||+|+||+|++|.-.    .   ....||||.++.....  ...+.+..|+++|+.+ +||||+.+++.+..++
T Consensus       298 l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~--~~~~~~~~El~~m~~~g~H~niv~llG~~t~~~  375 (609)
T KOG0200|consen  298 LKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASS--SEKKDLMSELNVLKELGKHPNIVNLLGACTQDG  375 (609)
T ss_pred             ccccceeecccccceEeEEEeecccccccceEEEEEEecccccCc--HHHHHHHHHHHHHHHhcCCcchhhheeeeccCC
Confidence            356779999999999999632    1   2568999998755433  4568899999999999 5999999999999999


Q ss_pred             EEEEEEeccCCCChHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCC
Q 014609           88 KIYMVLEYVTGGELFDKIASKG----------------RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKG  151 (421)
Q Consensus        88 ~~~lv~E~~~gg~L~~~i~~~~----------------~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~  151 (421)
                      ..++|+||+..|+|.+++...+                .++..+...++.||+.|++||++.+++||||-..|||+..+.
T Consensus       376 ~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAaRNVLi~~~~  455 (609)
T KOG0200|consen  376 PLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLAARNVLITKNK  455 (609)
T ss_pred             ceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhhhhhEEecCCC
Confidence            9999999999999999998655                388899999999999999999999999999999999999999


Q ss_pred             CEEEEeccCCCCCccccCCCccccccCCC--CccChhhhcccCCCCCcchHHHHHHHHhhh--cCCc-------------
Q 014609          152 NIKISDFGLSALPQHFRDDGLLHTTCGSP--NYVAPEVLANRGYDGATSDIWSCGVILYIF--RGDF-------------  214 (421)
Q Consensus       152 ~~kL~DFGla~~~~~~~~~~~~~~~~gt~--~y~APEvl~~~~~~~~~~DiwSlGvil~~~--~~~~-------------  214 (421)
                      .+||+|||+|+.......- ......|+.  .|||||.+....| +.++||||+|++||++  .|..             
T Consensus       456 ~~kIaDFGlar~~~~~~~y-~~~~~~~~LP~kWmApEsl~~~~f-t~kSDVWSfGI~L~EifsLG~~PYp~~~~~~~l~~  533 (609)
T KOG0200|consen  456 VIKIADFGLARDHYNKDYY-RTKSSAGTLPVKWMAPESLFDRVF-TSKSDVWSFGILLWEIFTLGGTPYPGIPPTEELLE  533 (609)
T ss_pred             EEEEccccceeccCCCCce-EecCCCCccceeecCHHHhccCcc-cccchhhHHHHHHHHHhhCCCCCCCCCCcHHHHHH
Confidence            9999999999843321111 111122223  4999999998777 5899999999999943  2332             


Q ss_pred             --------CCCCCCCHHHHHHHHHhcCCCCCCCCCHHhhhc
Q 014609          215 --------KLPKWLSPGAQNLLRKILEPNPVKRITIAGIKA  247 (421)
Q Consensus       215 --------~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~  247 (421)
                              ..|..+++++.++++.||+.+|.+||++.++.+
T Consensus       534 ~l~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~  574 (609)
T KOG0200|consen  534 FLKEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVE  574 (609)
T ss_pred             HHhcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHH
Confidence                    345567899999999999999999999998764

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.96  E-value=3.4e-28  Score=222.99  Aligned_cols=197  Identities=47%  Similarity=0.804  Sum_probs=169.1

Q ss_pred             eEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEEec
Q 014609           16 YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLEY   95 (421)
Q Consensus        16 y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E~   95 (421)
                      |.+.+.||.|++|.||+|.+..+++.+|+|.+......  ...+.+.+|++.+++++|+|++++++++......++++||
T Consensus         1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~   78 (225)
T smart00221        1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE--KQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEY   78 (225)
T ss_pred             CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch--HHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEec
Confidence            67889999999999999999888999999999765432  2467899999999999999999999999999999999999


Q ss_pred             cCCCChHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCccccCCCccc
Q 014609           96 VTGGELFDKIASKGR-LQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLH  174 (421)
Q Consensus        96 ~~gg~L~~~i~~~~~-~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~  174 (421)
                      +++++|.+.+..... +++.....++.|++.++.+||+++++|+||+|.||+++.++.++|+|||.+....... .....
T Consensus        79 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~-~~~~~  157 (225)
T smart00221       79 CEGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDL-AALLK  157 (225)
T ss_pred             cCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcc-ccccc
Confidence            999999999987666 8999999999999999999999999999999999999999999999999988654321 11334


Q ss_pred             cccCCCCccChhhh-cccCCCCCcchHHHHHHHHhhh-cCCcCC
Q 014609          175 TTCGSPNYVAPEVL-ANRGYDGATSDIWSCGVILYIF-RGDFKL  216 (421)
Q Consensus       175 ~~~gt~~y~APEvl-~~~~~~~~~~DiwSlGvil~~~-~~~~~~  216 (421)
                      ...++..|++||.+ ....+ +.++|+||||+++|.+ .|..++
T Consensus       158 ~~~~~~~~~~pe~~~~~~~~-~~~~Dv~~lG~~~~~l~~g~~pf  200 (225)
T smart00221      158 TVKGTPFYLAPEVLLGGKGY-GEAVDIWSLGVILYELLWGPEPF  200 (225)
T ss_pred             ceeccCCcCCHhHhcCCCCC-CchhhHHHHHHHHHHHHHCCCCc
Confidence            56788899999998 45555 4689999999999955 444444

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.96  E-value=4.3e-29  Score=271.38  Aligned_cols=183  Identities=18%  Similarity=0.232  Sum_probs=137.8

Q ss_pred             cCCC-CCcceEEEEE-------EeCCEEEEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccC
Q 014609           70 LLKH-PNVVRLHEVL-------ASKSKIYMVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDL  140 (421)
Q Consensus        70 ~l~h-pnIv~l~~~~-------~~~~~~~lv~E~~~gg~L~~~i~~-~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDl  140 (421)
                      .++| +||.+++++|       .....++.++||+ +++|.+++.. ...+++.+++.+++||+.||+|||++||+||||
T Consensus        28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrDl  106 (793)
T PLN00181         28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQGIVVHNV  106 (793)
T ss_pred             hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCCeeeccC
Confidence            4455 5777787777       2334677888988 6699999965 456999999999999999999999999999999


Q ss_pred             CCCCEEeccCC-------------------CEEEEeccCCCCCccccC--------------CCccccccCCCCccChhh
Q 014609          141 KLENILLDSKG-------------------NIKISDFGLSALPQHFRD--------------DGLLHTTCGSPNYVAPEV  187 (421)
Q Consensus       141 kp~NILl~~~~-------------------~~kL~DFGla~~~~~~~~--------------~~~~~~~~gt~~y~APEv  187 (421)
                      ||+||||+..|                   .+|++|||+++.......              .......+||+.|+|||+
T Consensus       107 KP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~  186 (793)
T PLN00181        107 RPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEE  186 (793)
T ss_pred             CchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChhh
Confidence            99999996544                   455556665542110000              000112468999999999


Q ss_pred             hcccCCCCCcchHHHHHHHHhhhcCCcCC----------------CCC---CCHHHHHHHHHhcCCCCCCCCCHHhhhcC
Q 014609          188 LANRGYDGATSDIWSCGVILYIFRGDFKL----------------PKW---LSPGAQNLLRKILEPNPVKRITIAGIKAD  248 (421)
Q Consensus       188 l~~~~~~~~~~DiwSlGvil~~~~~~~~~----------------p~~---~s~~~~~li~~~L~~dP~~R~t~~eil~~  248 (421)
                      +.+..| +.++|||||||+||++....+.                |+.   -.+...+++.+||+++|.+||++.|+++|
T Consensus       187 ~~~~~~-~~~sDVwSlGviL~ELl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~~P~~Rps~~eil~h  265 (793)
T PLN00181        187 DNGSSS-NCASDVYRLGVLLFELFCPVSSREEKSRTMSSLRHRVLPPQILLNWPKEASFCLWLLHPEPSCRPSMSELLQS  265 (793)
T ss_pred             hccCCC-CchhhhhhHHHHHHHHhhCCCchhhHHHHHHHHHHhhcChhhhhcCHHHHHHHHHhCCCChhhCcChHHHhhc
Confidence            988888 5899999999999976543221                111   23556789999999999999999999999


Q ss_pred             cccccc
Q 014609          249 EWFEQD  254 (421)
Q Consensus       249 ~w~~~~  254 (421)
                      |||...
T Consensus       266 ~~~~~~  271 (793)
T PLN00181        266 EFINEP  271 (793)
T ss_pred             hhhhhh
Confidence            999763

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.95  E-value=6.5e-28  Score=236.40  Aligned_cols=170  Identities=21%  Similarity=0.172  Sum_probs=134.1

Q ss_pred             CeeecceEEeceEeecCcEEEEEEEECC-CCceEEEEEeecccc--cchhHHHHHHHHHHHHhcCCCCCcce-EEEEEEe
Q 014609           10 GMRLGRYELGRTLGEGNFGKVKFAQDLD-SGLPFAVKILEKNRI--IHLKITDQIKREIATLKLLKHPNVVR-LHEVLAS   85 (421)
Q Consensus        10 ~~~~~~y~i~~~LG~G~~g~V~~a~~~~-~~~~vAvK~i~~~~~--~~~~~~~~~~~Ei~il~~l~hpnIv~-l~~~~~~   85 (421)
                      ....++|++.+.||+|+||+||+|.+.. +++.||||++.....  ........+.+|+++|++++|+||+. +++.   
T Consensus        14 ~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~---   90 (365)
T PRK09188         14 PALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT---   90 (365)
T ss_pred             ccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc---
Confidence            3456889999999999999999998876 788889998753311  12223567999999999999999985 5442   


Q ss_pred             CCEEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccC-CCCCEEeccCCCEEEEeccCCCCC
Q 014609           86 KSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDL-KLENILLDSKGNIKISDFGLSALP  164 (421)
Q Consensus        86 ~~~~~lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDl-kp~NILl~~~~~~kL~DFGla~~~  164 (421)
                       +..|+||||++|++|.. +..   ..   ...++.|+++||+|||++||+|||| ||+|||++.++.+||+|||+|+..
T Consensus        91 -~~~~LVmE~~~G~~L~~-~~~---~~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~~~~ikLiDFGlA~~~  162 (365)
T PRK09188         91 -GKDGLVRGWTEGVPLHL-ARP---HG---DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMGPDGEAAVIDFQLASVF  162 (365)
T ss_pred             -CCcEEEEEccCCCCHHH-hCc---cc---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcCCCCEEEEECccceec
Confidence             46899999999999963 211   11   1568899999999999999999999 999999999999999999999876


Q ss_pred             ccccCCCc------cccccCCCCccChhhhcc
Q 014609          165 QHFRDDGL------LHTTCGSPNYVAPEVLAN  190 (421)
Q Consensus       165 ~~~~~~~~------~~~~~gt~~y~APEvl~~  190 (421)
                      ........      ..+.++++.|+|||.+.-
T Consensus       163 ~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~  194 (365)
T PRK09188        163 RRRGALYRIAAYEDLRHLLKHKRTYAPDALTP  194 (365)
T ss_pred             ccCcchhhhhhhhhhhhhhccCccCCcccCCh
Confidence            54322212      246678999999998753

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.94  E-value=7.6e-25  Score=209.26  Aligned_cols=236  Identities=38%  Similarity=0.637  Sum_probs=194.7

Q ss_pred             eEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCC-CcceEEEEEEeCCEEEEEEe
Q 014609           16 YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP-NVVRLHEVLASKSKIYMVLE   94 (421)
Q Consensus        16 y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hp-nIv~l~~~~~~~~~~~lv~E   94 (421)
                      |.+.+.||.|+||.||.+.+.   ..+++|.+.............+.+|+.+++.+.|+ +|+++++++......+++++
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~   78 (384)
T COG0515           2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVME   78 (384)
T ss_pred             ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEe
Confidence            789999999999999999986   78999999876544433467899999999999988 79999999988888999999


Q ss_pred             ccCCCChHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCC-CEEEEeccCCCCCccccCC
Q 014609           95 YVTGGELFDKIASKG---RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKG-NIKISDFGLSALPQHFRDD  170 (421)
Q Consensus        95 ~~~gg~L~~~i~~~~---~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~-~~kL~DFGla~~~~~~~~~  170 (421)
                      ++.++++.+.+....   .+++.....++.|++.++.|+|+.|++|||+||+||+++..+ .++++|||.+.........
T Consensus        79 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~~  158 (384)
T COG0515          79 YVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGST  158 (384)
T ss_pred             cCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecCCCCeEEEeccCcceecCCCCcc
Confidence            999999997777654   799999999999999999999999999999999999999998 7999999999754332211


Q ss_pred             ----CccccccCCCCccChhhhccc--CCCCCcchHHHHHHHHhhh-cCCcCC------------------------CCC
Q 014609          171 ----GLLHTTCGSPNYVAPEVLANR--GYDGATSDIWSCGVILYIF-RGDFKL------------------------PKW  219 (421)
Q Consensus       171 ----~~~~~~~gt~~y~APEvl~~~--~~~~~~~DiwSlGvil~~~-~~~~~~------------------------p~~  219 (421)
                          ......+||+.|+|||.+...  .+.+...|+||+|++++.+ .+..++                        ...
T Consensus       159 ~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (384)
T COG0515         159 SSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLASP  238 (384)
T ss_pred             ccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCcccccc
Confidence                135677899999999998874  3456889999999888832 222111                        111


Q ss_pred             CC--------HHHHHHHHHhcCCCCCCCCCHHhhhcCcccccc
Q 014609          220 LS--------PGAQNLLRKILEPNPVKRITIAGIKADEWFEQD  254 (421)
Q Consensus       220 ~s--------~~~~~li~~~L~~dP~~R~t~~eil~~~w~~~~  254 (421)
                      ..        ..+.+++.+++..+|..|.+..+...++|....
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~~~~~~~  281 (384)
T COG0515         239 LSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHL  281 (384)
T ss_pred             cCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhchHhhCc
Confidence            11        368899999999999999999998888766543

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.92  E-value=2.9e-25  Score=197.17  Aligned_cols=139  Identities=24%  Similarity=0.263  Sum_probs=116.2

Q ss_pred             CChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCccccCCCcccccc
Q 014609           99 GELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTC  177 (421)
Q Consensus        99 g~L~~~i~~-~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~  177 (421)
                      |+|.+.+.. ..++++..++.++.|++.||+|||+++      ||+|||++.++.+|+  ||++.....       ....
T Consensus         1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~~~~~~--fG~~~~~~~-------~~~~   65 (176)
T smart00750        1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWDGLLKL--DGSVAFKTP-------EQSR   65 (176)
T ss_pred             CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCccceee--ccceEeecc-------ccCC
Confidence            689999876 456999999999999999999999999      999999999999999  999875432       1226


Q ss_pred             CCCCccChhhhcccCCCCCcchHHHHHHHHhhhc-CCcCCCC---------------------------CCCH--HHHHH
Q 014609          178 GSPNYVAPEVLANRGYDGATSDIWSCGVILYIFR-GDFKLPK---------------------------WLSP--GAQNL  227 (421)
Q Consensus       178 gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~~-~~~~~p~---------------------------~~s~--~~~~l  227 (421)
                      ||+.|+|||++.+..| +.++||||+||++|.+. |..++..                           .++.  .+.++
T Consensus        66 g~~~y~aPE~~~~~~~-~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  144 (176)
T smart00750       66 VDPYFMAPEVIQGQSY-TEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRDRSNLESVSAARSFADF  144 (176)
T ss_pred             CcccccChHHhcCCCC-cchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCccccccHHHHHhhhhHHHH
Confidence            8999999999988887 48999999999999553 4333210                           1122  58999


Q ss_pred             HHHhcCCCCCCCCCHHhhhcCccccc
Q 014609          228 LRKILEPNPVKRITIAGIKADEWFEQ  253 (421)
Q Consensus       228 i~~~L~~dP~~R~t~~eil~~~w~~~  253 (421)
                      |.+||..||.+||++.++++|+|+..
T Consensus       145 i~~cl~~~p~~Rp~~~~ll~~~~~~~  170 (176)
T smart00750      145 MRVCASRLPQRREAANHYLAHCRALF  170 (176)
T ss_pred             HHHHHhcccccccCHHHHHHHHHHHH
Confidence            99999999999999999999999864

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.92  E-value=3e-25  Score=203.37  Aligned_cols=172  Identities=15%  Similarity=0.228  Sum_probs=135.6

Q ss_pred             cceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHH------HHHHHHHHhcCCCCCcceEEEEEEeC-
Q 014609           14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQ------IKREIATLKLLKHPNVVRLHEVLASK-   86 (421)
Q Consensus        14 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~------~~~Ei~il~~l~hpnIv~l~~~~~~~-   86 (421)
                      ++|++.+.||.|+||.||++.+  ++..+|||+++............      +.+|+..+.++.||+|..+.+++... 
T Consensus        31 ~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~~  108 (232)
T PRK10359         31 YNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLAE  108 (232)
T ss_pred             CceEEEEEecCCCceEEEEEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeecc
Confidence            7999999999999999999754  47789999997654444433333      68999999999999999999986643 


Q ss_pred             -------CEEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEecc
Q 014609           87 -------SKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFG  159 (421)
Q Consensus        87 -------~~~~lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFG  159 (421)
                             +..+++|||++|.+|.+...    +++    ....+++.++..||+.|++|||+||+||+++.+| ++|+|||
T Consensus       109 ~~~~~~~~~~~lvmEyi~G~tL~~~~~----~~~----~~~~~i~~~l~~lH~~gi~H~Dikp~Nili~~~g-i~liDfg  179 (232)
T PRK10359        109 RKTLRYAHTYIMLIEYIEGVELNDMPE----ISE----DVKAKIKASIESLHQHGMVSGDPHKGNFIVSKNG-LRIIDLS  179 (232)
T ss_pred             cccccccCCeEEEEEEECCccHHHhhh----ccH----HHHHHHHHHHHHHHHcCCccCCCChHHEEEeCCC-EEEEECC
Confidence                   35899999999999977632    333    2456999999999999999999999999999988 9999999


Q ss_pred             CCCCCccccCCCccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhhc
Q 014609          160 LSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIFR  211 (421)
Q Consensus       160 la~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~~  211 (421)
                      .+.......              ....++....|+ .++|+||||+.+.++.
T Consensus       180 ~~~~~~e~~--------------a~d~~vler~y~-~~~di~~lg~~~~~~~  216 (232)
T PRK10359        180 GKRCTAQRK--------------AKDRIDLERHYG-IKNEIKDLGYYLLIYK  216 (232)
T ss_pred             Ccccccchh--------------hHHHHHHHhHhc-ccccccceeEeehHHH
Confidence            887432110              001144556676 8899999999887644

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.92  E-value=3.2e-25  Score=199.85  Aligned_cols=141  Identities=21%  Similarity=0.281  Sum_probs=112.9

Q ss_pred             eceEeecCcEEEEEEEECCCCceEEEEEeecccccchh-----------------------HHHHHHHHHHHHhcCCCCC
Q 014609           19 GRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLK-----------------------ITDQIKREIATLKLLKHPN   75 (421)
Q Consensus        19 ~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~-----------------------~~~~~~~Ei~il~~l~hpn   75 (421)
                      ...||+|+||.||+|.+. +|+.||||+++........                       ......+|++++.++.+++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~   80 (190)
T cd05147           2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAG   80 (190)
T ss_pred             CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCC
Confidence            468999999999999986 8999999999764321111                       0123456999999998887


Q ss_pred             cceEEEEEEeCCEEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHH-HhCCceeccCCCCCEEeccCCCEE
Q 014609           76 VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYC-HNKGVFHRDLKLENILLDSKGNIK  154 (421)
Q Consensus        76 Iv~l~~~~~~~~~~~lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~ql~~aL~~L-H~~gi~HrDlkp~NILl~~~~~~k  154 (421)
                      +.....+...  ..++||||++|+++........++++..+..++.|++.+|+|+ |+.||+||||||+|||++ ++.++
T Consensus        81 v~~p~~~~~~--~~~iVmE~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~-~~~v~  157 (190)
T cd05147          81 IPCPEPILLK--SHVLVMEFIGDDGWAAPRLKDAPLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYH-DGKLY  157 (190)
T ss_pred             CCCCcEEEec--CCEEEEEEeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEE-CCcEE
Confidence            7544433222  2389999999887766555557899999999999999999999 699999999999999998 57899


Q ss_pred             EEeccCCCC
Q 014609          155 ISDFGLSAL  163 (421)
Q Consensus       155 L~DFGla~~  163 (421)
                      |+|||+|..
T Consensus       158 LiDFG~a~~  166 (190)
T cd05147         158 IIDVSQSVE  166 (190)
T ss_pred             EEEcccccc
Confidence            999999974

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.92  E-value=1.9e-26  Score=230.50  Aligned_cols=224  Identities=32%  Similarity=0.611  Sum_probs=193.1

Q ss_pred             eEeecCcEEEEEEEE---CCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCC-CCCcceEEEEEEeCCEEEEEEecc
Q 014609           21 TLGEGNFGKVKFAQD---LDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK-HPNVVRLHEVLASKSKIYMVLEYV   96 (421)
Q Consensus        21 ~LG~G~~g~V~~a~~---~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~lv~E~~   96 (421)
                      .+|+|+||+|++++.   ...|..+|+|+..+......... ....|..++..++ ||.+++++..++.++..|+++++.
T Consensus         1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~-~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~   79 (612)
T KOG0603|consen    1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRT-HTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFL   79 (612)
T ss_pred             CCCcCCCcchHHHHHhccccccchhhhhccccccccccccc-ccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhc
Confidence            479999999998753   24688999999987655433322 5667888888887 999999999999999999999999


Q ss_pred             CCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCccccCCCccccc
Q 014609           97 TGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTT  176 (421)
Q Consensus        97 ~gg~L~~~i~~~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~  176 (421)
                      .||+|+..+.....+++...+.+...++-|++++|+.||+|||+|++||+++.+|++++.|||+++..-.      ....
T Consensus        80 rgg~lft~l~~~~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~------~~~~  153 (612)
T KOG0603|consen   80 RGGDLFTRLSKEVMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVK------EKIA  153 (612)
T ss_pred             ccchhhhccccCCchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeecccCccccCCchhhhHhHh------hhhc
Confidence            9999999998888899999999999999999999999999999999999999999999999999985422      1222


Q ss_pred             cCCCCccChhhhcccCCCCCcchHHHHHHHHhh----------------hcCCcCCCCCCCHHHHHHHHHhcCCCCCCCC
Q 014609          177 CGSPNYVAPEVLANRGYDGATSDIWSCGVILYI----------------FRGDFKLPKWLSPGAQNLLRKILEPNPVKRI  240 (421)
Q Consensus       177 ~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~----------------~~~~~~~p~~~s~~~~~li~~~L~~dP~~R~  240 (421)
                      |||..|||||++.  ++ ...+|+||+|++.|.                +...+..|..+++.+++++..++..+|.+|.
T Consensus       154 cgt~eymApEI~~--gh-~~a~D~ws~gvl~felltg~~pf~~~~~~~Il~~~~~~p~~l~~~a~~~~~~l~~r~p~nrL  230 (612)
T KOG0603|consen  154 CGTYEYRAPEIIN--GH-LSAADWWSFGVLAFELLTGTLPFGGDTMKRILKAELEMPRELSAEARSLFRQLFKRNPENRL  230 (612)
T ss_pred             ccchhhhhhHhhh--cc-CCcccchhhhhhHHHHhhCCCCCchHHHHHHhhhccCCchhhhHHHHHHHHHHHhhCHHHHh
Confidence            9999999999987  44 478999999999993                3346677888999999999999999999998


Q ss_pred             C-----HHhhhcCcccccc
Q 014609          241 T-----IAGIKADEWFEQD  254 (421)
Q Consensus       241 t-----~~eil~~~w~~~~  254 (421)
                      .     ..+|++|++|+..
T Consensus       231 g~~~~~~~eik~h~f~~~i  249 (612)
T KOG0603|consen  231 GAGPDGVDEIKQHEFFQSI  249 (612)
T ss_pred             ccCcchhHHHhccchheee
Confidence            6     4799999999864

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=99.92  E-value=9e-25  Score=206.55  Aligned_cols=231  Identities=20%  Similarity=0.232  Sum_probs=184.3

Q ss_pred             cceEEeceEeecCcEEEEEEEECC-----CCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEe-CC
Q 014609           14 GRYELGRTLGEGNFGKVKFAQDLD-----SGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLAS-KS   87 (421)
Q Consensus        14 ~~y~i~~~LG~G~~g~V~~a~~~~-----~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~-~~   87 (421)
                      .|+++.-.+-+|.||.||.|++++     +.+.|-+|.++...  +.-....+..|...+..+.|||+..+.+++.+ ..
T Consensus       284 ~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~A--S~iQv~~~L~es~lly~~sH~nll~V~~V~ie~~~  361 (563)
T KOG1024|consen  284 CRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHA--SQIQVNLLLQESMLLYGASHPNLLSVLGVSIEDYA  361 (563)
T ss_pred             hheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcc--cHHHHHHHHHHHHHHhcCcCCCccceeEEEeeccC
Confidence            578888899999999999997653     34556777665432  23346778899999999999999999998754 46


Q ss_pred             EEEEEEeccCCCChHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEecc
Q 014609           88 KIYMVLEYVTGGELFDKIASK--------GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFG  159 (421)
Q Consensus        88 ~~~lv~E~~~gg~L~~~i~~~--------~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFG  159 (421)
                      ..++++.+..-|+|..++...        ..++-.+...++.|++.|++|||++||+|.||-..|.+||+.-.+||+|=.
T Consensus       362 ~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvIdd~LqVkltDsa  441 (563)
T KOG1024|consen  362 TPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVIDDQLQVKLTDSA  441 (563)
T ss_pred             cceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhcceehhheeEEeccch
Confidence            788889999889998887621        236667778889999999999999999999999999999999999999999


Q ss_pred             CCCCCccccCCCccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhhc--CC--------------------cCCC
Q 014609          160 LSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIFR--GD--------------------FKLP  217 (421)
Q Consensus       160 la~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~~--~~--------------------~~~p  217 (421)
                      +++-.-+......-........||+||.+....| +.++|+|||||+||++.  |+                    ...|
T Consensus       442 LSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~y-ssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~ylkdGyRlaQP  520 (563)
T KOG1024|consen  442 LSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHY-SSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYLKDGYRLAQP  520 (563)
T ss_pred             hccccCcccccccCCCCCCcccccCHHHHhhhhh-cchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHHhccceecCC
Confidence            9985433222222233344568999999999988 58899999999999542  22                    2346


Q ss_pred             CCCCHHHHHHHHHhcCCCCCCCCCHHhhhc
Q 014609          218 KWLSPGAQNLLRKILEPNPVKRITIAGIKA  247 (421)
Q Consensus       218 ~~~s~~~~~li~~~L~~dP~~R~t~~eil~  247 (421)
                      -.+|+++..++.-||..+|++||+++|+..
T Consensus       521 ~NCPDeLf~vMacCWallpeeRPsf~Qlv~  550 (563)
T KOG1024|consen  521 FNCPDELFTVMACCWALLPEERPSFSQLVI  550 (563)
T ss_pred             CCCcHHHHHHHHHHHhcCcccCCCHHHHHH
Confidence            679999999999999999999999999753

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.92  E-value=4.2e-24  Score=192.84  Aligned_cols=143  Identities=22%  Similarity=0.268  Sum_probs=115.2

Q ss_pred             EeceEeecCcEEEEEEEECCCCceEEEEEeecccccch-----------------------hHHHHHHHHHHHHhcCCCC
Q 014609           18 LGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHL-----------------------KITDQIKREIATLKLLKHP   74 (421)
Q Consensus        18 i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~-----------------------~~~~~~~~Ei~il~~l~hp   74 (421)
                      +.+.||+|+||+||+|.+. +|+.||||+++.......                       .....+.+|...+.++.|+
T Consensus         1 ~~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~   79 (190)
T cd05145           1 INGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEA   79 (190)
T ss_pred             CCceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhC
Confidence            3578999999999999986 899999999986521100                       0022356899999999999


Q ss_pred             CcceEEEEEEeCCEEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCceeccCCCCCEEeccCCCE
Q 014609           75 NVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHN-KGVFHRDLKLENILLDSKGNI  153 (421)
Q Consensus        75 nIv~l~~~~~~~~~~~lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~ql~~aL~~LH~-~gi~HrDlkp~NILl~~~~~~  153 (421)
                      +|.....+....  .|+||||++|+++........+++...+..++.|++.++.++|+ .||+||||||+|||++ ++.+
T Consensus        80 ~i~~p~~~~~~~--~~lVmE~~~g~~~~~~~l~~~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~-~~~~  156 (190)
T cd05145          80 GVPVPEPILLKK--NVLVMEFIGDDGSPAPRLKDVPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILYH-DGKP  156 (190)
T ss_pred             CCCCceEEEecC--CEEEEEEecCCCchhhhhhhccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEEE-CCCE
Confidence            886555444333  48999999988665443345678899999999999999999999 9999999999999998 8999


Q ss_pred             EEEeccCCCCC
Q 014609          154 KISDFGLSALP  164 (421)
Q Consensus       154 kL~DFGla~~~  164 (421)
                      +|+|||++...
T Consensus       157 ~liDFG~a~~~  167 (190)
T cd05145         157 YIIDVSQAVEL  167 (190)
T ss_pred             EEEEcccceec
Confidence            99999999854

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.91  E-value=3.6e-24  Score=191.08  Aligned_cols=207  Identities=22%  Similarity=0.349  Sum_probs=167.3

Q ss_pred             ccccCCeeecceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCC-CCcceEEEEE
Q 014609            5 EKKQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKH-PNVVRLHEVL   83 (421)
Q Consensus         5 ~~~~~~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~h-pnIv~l~~~~   83 (421)
                      ...++-...|+|.++++||+|+||.+|+|....+|+.||||+-.... .    -.++..|..+.+.|++ .+|..+..+.
T Consensus         6 ~s~~~~iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a-~----hpqL~yEskvY~iL~~g~GiP~i~~y~   80 (341)
T KOG1163|consen    6 GSLEELIVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKA-K----HPQLLYESKVYRILQGGVGIPHIRHYG   80 (341)
T ss_pred             cchhhheeccceEEEEeecCCchhheeeeeeccCCceEEEEeecccC-C----CcchhHHHHHHHHhccCCCCchhhhhc
Confidence            34455677799999999999999999999999999999999865332 1    2467889999999985 7888888888


Q ss_pred             EeCCEEEEEEeccCCCChHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccC---CCEEEEecc
Q 014609           84 ASKSKIYMVLEYVTGGELFDKIA-SKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSK---GNIKISDFG  159 (421)
Q Consensus        84 ~~~~~~~lv~E~~~gg~L~~~i~-~~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~---~~~kL~DFG  159 (421)
                      .+...-.+||++. |.+|.+.+. ....++..+..-++-|++.-++|+|.++.+||||||+|.|..-+   ..+.|+|||
T Consensus        81 ~e~~ynvlVMdLL-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFG  159 (341)
T KOG1163|consen   81 TEKDYNVLVMDLL-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFG  159 (341)
T ss_pred             cccccceeeeecc-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEecc
Confidence            8888999999999 889988876 35679999999999999999999999999999999999999644   469999999


Q ss_pred             CCCCCccccCC-----CccccccCCCCccChhhhcccCCCCCcchHHHHHHHH-hhhcCCcCCCC
Q 014609          160 LSALPQHFRDD-----GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVIL-YIFRGDFKLPK  218 (421)
Q Consensus       160 la~~~~~~~~~-----~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil-~~~~~~~~~p~  218 (421)
                      +|+.+......     +.-....||..|.+--...+... +...|+=|+|.+| |...|..|+..
T Consensus       160 LaKky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eq-SRRDDmeSvgYvLmYfnrG~LPWQg  223 (341)
T KOG1163|consen  160 LAKKYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQ-SRRDDMESVGYVLMYFNRGSLPWQG  223 (341)
T ss_pred             chhhhccccccccCccccCCccceeeeehhhhhhhhhhh-hhhhhhhhhcceeeeeecCCCcccc
Confidence            99866432211     12234578999998776665544 5778999999665 45667766643

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.91  E-value=6e-23  Score=200.51  Aligned_cols=197  Identities=26%  Similarity=0.359  Sum_probs=159.5

Q ss_pred             ceEEeceEeecCcEEEEEEEECCCC-ceEEEEEeecccccchhHHHHHHHHHHHHhcCCC----CCcceEEEEE-EeCCE
Q 014609           15 RYELGRTLGEGNFGKVKFAQDLDSG-LPFAVKILEKNRIIHLKITDQIKREIATLKLLKH----PNVVRLHEVL-ASKSK   88 (421)
Q Consensus        15 ~y~i~~~LG~G~~g~V~~a~~~~~~-~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~h----pnIv~l~~~~-~~~~~   88 (421)
                      +|++.+.||+|+||.||++.+..++ ..+|+|+.........   ..+..|+.++..+..    +++..+++.. ..+..
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~---~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~   95 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKP---SVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDF   95 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCC---ccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCce
Confidence            8999999999999999999987764 6899998765432211   267889999998873    6999999999 58888


Q ss_pred             EEEEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccC-----CCEEEEeccCC
Q 014609           89 IYMVLEYVTGGELFDKIASK--GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSK-----GNIKISDFGLS  161 (421)
Q Consensus        89 ~~lv~E~~~gg~L~~~i~~~--~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~-----~~~kL~DFGla  161 (421)
                      .|+||+.+ |.+|.+.....  +.++..++.+++.|++.+|+++|+.|++||||||+|+++...     ..+.|.|||++
T Consensus        96 ~~iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGla  174 (322)
T KOG1164|consen   96 NFIVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLA  174 (322)
T ss_pred             eEEEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEecCCC
Confidence            99999999 88999977543  579999999999999999999999999999999999999865     35999999999


Q ss_pred             CCCccccCCC-------c-cccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhhc-CCcCC
Q 014609          162 ALPQHFRDDG-------L-LHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIFR-GDFKL  216 (421)
Q Consensus       162 ~~~~~~~~~~-------~-~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~~-~~~~~  216 (421)
                      +.+......+       . .....||..|.++.+..+... +.+.|+||++.++..+. |..|+
T Consensus       175 r~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~-~r~DDles~~Y~l~el~~g~LPW  237 (322)
T KOG1164|consen  175 RRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQ-GRRDDLESLFYMLLELLKGSLPW  237 (322)
T ss_pred             ccccccCCCCcccccCCCCccCCCCccccccHHHhCCCcc-CCchhhhhHHHHHHHHhcCCCCC
Confidence            8432211111       1 123459999999999888776 69999999998887655 44444

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.90  E-value=4.2e-23  Score=191.85  Aligned_cols=197  Identities=24%  Similarity=0.407  Sum_probs=165.5

Q ss_pred             cceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCC-CCCcceEEEEEEeCCEEEEE
Q 014609           14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK-HPNVVRLHEVLASKSKIYMV   92 (421)
Q Consensus        14 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~lv   92 (421)
                      -.|+++++||+|+||..+.|.+.-++++||||.-+...     ...++..|.+..+.|. .++|...|.+..+..+-.+|
T Consensus        28 ~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS-----~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLV  102 (449)
T KOG1165|consen   28 PHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKS-----EAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILV  102 (449)
T ss_pred             ccceeccccccCcceeeecccccccCceEEEEeccccC-----CcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhh
Confidence            48999999999999999999999999999999765432     2578889999999886 69999999999998888999


Q ss_pred             EeccCCCChHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCC-----CEEEEeccCCCCCcc
Q 014609           93 LEYVTGGELFDKIA-SKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKG-----NIKISDFGLSALPQH  166 (421)
Q Consensus        93 ~E~~~gg~L~~~i~-~~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~-----~~kL~DFGla~~~~~  166 (421)
                      +|++ |-+|.|++. +.+.|+..++..++.|++.-++|+|++.+|.|||||+|+||..-+     .+.++|||+|+.+..
T Consensus       103 idLL-GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrD  181 (449)
T KOG1165|consen  103 IDLL-GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRD  181 (449)
T ss_pred             hhhh-CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEeccchhhhcC
Confidence            9999 889888876 456799999999999999999999999999999999999997544     589999999997643


Q ss_pred             ccCC-----CccccccCCCCccChhhhcccCCCCCcchHHHHH-HHHhhhcCCcCCC
Q 014609          167 FRDD-----GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCG-VILYIFRGDFKLP  217 (421)
Q Consensus       167 ~~~~-----~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlG-vil~~~~~~~~~p  217 (421)
                      ....     +......||..||+--...++.. +...|+=||| +.+|.+.|.+|+-
T Consensus       182 p~TkqHIPYrE~KSLsGTARYMSINTHlGrEQ-SRRDDLEaLGHvFmYFLRGsLPWQ  237 (449)
T KOG1165|consen  182 PKTKQHIPYREHKSLSGTARYMSINTHLGREQ-SRRDDLEALGHVFMYFLRGSLPWQ  237 (449)
T ss_pred             ccccccCccccccccccceeeeEeeccccchh-hhhhhHHHhhhhhhhhccCCCccc
Confidence            2111     12345579999999888777766 5889999999 5556778877763

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.89  E-value=1.2e-24  Score=226.52  Aligned_cols=240  Identities=34%  Similarity=0.576  Sum_probs=206.8

Q ss_pred             ecceEEeceEeecCcEEEEEEEECC-CCceEEEEEeecccccchhHHHHHHHHHHHHhcCC-CCCcceEEEEEEeCCEEE
Q 014609           13 LGRYELGRTLGEGNFGKVKFAQDLD-SGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK-HPNVVRLHEVLASKSKIY   90 (421)
Q Consensus        13 ~~~y~i~~~LG~G~~g~V~~a~~~~-~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~   90 (421)
                      ...|.+.+.||+|+|+.|-++.... +...+|+|.+.... ......+++..|..+.+.+. |+|++.+++...+....+
T Consensus        19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~-~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~   97 (601)
T KOG0590|consen   19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPP-KSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYL   97 (601)
T ss_pred             cccccccccccccccchhhhhhhcCCCcceeeccCCCCCC-CccchhhhcCccccccccccccccccccCCccCCCcccc
Confidence            5679999999999999999887643 45567778776543 22334567778999999997 999999999999999999


Q ss_pred             EEEeccCCCChHHHH-HhcC-CCCHHHHHHHHHHHHHHHHHHH-hCCceeccCCCCCEEeccCC-CEEEEeccCCCCCcc
Q 014609           91 MVLEYVTGGELFDKI-ASKG-RLQEAEGRKLFQQLIDGVSYCH-NKGVFHRDLKLENILLDSKG-NIKISDFGLSALPQH  166 (421)
Q Consensus        91 lv~E~~~gg~L~~~i-~~~~-~~~~~~~~~~~~ql~~aL~~LH-~~gi~HrDlkp~NILl~~~~-~~kL~DFGla~~~~~  166 (421)
                      ++++|..|+++++.+ ..+. ..+...+.+++.|+..++.|+| +.++.|||+||+|.+++..+ +++++|||+|+.+..
T Consensus        98 ~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~  177 (601)
T KOG0590|consen   98 LSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDESGSALKIADFGLATAYRN  177 (601)
T ss_pred             cccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhccCCCcccCCCchhhccccc
Confidence            999999999999999 6665 7899999999999999999999 99999999999999999999 999999999998877


Q ss_pred             -ccCCCccccccC-CCCccChhhhcccCCCCCcchHHHHHHHHhhh-cCCc------------------------CCCCC
Q 014609          167 -FRDDGLLHTTCG-SPNYVAPEVLANRGYDGATSDIWSCGVILYIF-RGDF------------------------KLPKW  219 (421)
Q Consensus       167 -~~~~~~~~~~~g-t~~y~APEvl~~~~~~~~~~DiwSlGvil~~~-~~~~------------------------~~p~~  219 (421)
                       .+........|| ++.|+|||...+..|.++..|+||+|+++..+ .|..                        .....
T Consensus       178 ~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  257 (601)
T KOG0590|consen  178 KNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSNKGRFTQLPWNS  257 (601)
T ss_pred             cCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceeecccccccccCcccc
Confidence             555667788899 99999999998888889999999999999822 1111                        11223


Q ss_pred             CCHHHHHHHHHhcCCCCCCCCCHHhhhcCccccc
Q 014609          220 LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQ  253 (421)
Q Consensus       220 ~s~~~~~li~~~L~~dP~~R~t~~eil~~~w~~~  253 (421)
                      ++....+++.+++..+|..|.+.+++..++|+..
T Consensus       258 ~~~~~~~~l~k~l~~~~~~r~s~~~~~~d~~~~~  291 (601)
T KOG0590|consen  258 ISDQAHDLLHKILKENPSNRLSIEELKLDNWLSS  291 (601)
T ss_pred             CChhhhhcccccccCCchhccccccccccccccc
Confidence            7888999999999999999999999999999987

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.88  E-value=4.7e-23  Score=215.55  Aligned_cols=199  Identities=33%  Similarity=0.626  Sum_probs=151.3

Q ss_pred             cceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEE
Q 014609           14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVL   93 (421)
Q Consensus        14 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~   93 (421)
                      .+|..+++|..|+||.||+++|+.+.+.+|+| ++++.+.       +++   ++.....|.+|                
T Consensus        83 ~df~~IklisngAygavylvrh~~trqrfa~k-iNkq~li-------lRn---ilt~a~npfvv----------------  135 (1205)
T KOG0606|consen   83 SDFNTIKLISNGAYGAVYLVRHKETRQRFAMK-INKQNLI-------LRN---ILTFAGNPFVV----------------  135 (1205)
T ss_pred             cccceeEeeccCCCCceeeeeccccccchhhc-ccccchh-------hhc---cccccCCccee----------------
Confidence            47999999999999999999999999999995 4443321       111   44444555555                


Q ss_pred             eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCccc------
Q 014609           94 EYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHF------  167 (421)
Q Consensus        94 E~~~gg~L~~~i~~~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~------  167 (421)
                           |+-...+..-+.++.+.        +.+++|||+-||+|||+||+|+||+.-|++|+.|||++..--..      
T Consensus       136 -----gDc~tllk~~g~lPvdm--------vla~Eylh~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl~  202 (1205)
T KOG0606|consen  136 -----GDCATLLKNIGPLPVDM--------VLAVEYLHSYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNLK  202 (1205)
T ss_pred             -----chhhhhcccCCCCcchh--------hHHhHhhccCCeecCCCCCCcceeeecccccccchhhhhhhhhhccchhh
Confidence                 34445555545555443        78999999999999999999999999999999999998641100      


Q ss_pred             -------cCCCccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhh-cCCc-------------------CCCC--
Q 014609          168 -------RDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIF-RGDF-------------------KLPK--  218 (421)
Q Consensus       168 -------~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~-~~~~-------------------~~p~--  218 (421)
                             ...-.....||||.|.||||+...+| |.++|+|++|+|+|.+ -|..                   .+|+  
T Consensus       203 eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgy-gkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i~wpE~d  281 (1205)
T KOG0606|consen  203 EGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGY-GKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPEED  281 (1205)
T ss_pred             hcchHHHHHHhhhccccCCccccChhhhhhhcc-CCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhccccccC
Confidence                   00112234599999999999999999 7999999999999943 1221                   2222  


Q ss_pred             -CCCHHHHHHHHHhcCCCCCCCC---CHHhhhcCccccc
Q 014609          219 -WLSPGAQNLLRKILEPNPVKRI---TIAGIKADEWFEQ  253 (421)
Q Consensus       219 -~~s~~~~~li~~~L~~dP~~R~---t~~eil~~~w~~~  253 (421)
                       -++++++++|.++|+.+|..|.   .+-++.+|+||+.
T Consensus       282 ea~p~Ea~dli~~LL~qnp~~Rlgt~ga~evk~h~ff~~  320 (1205)
T KOG0606|consen  282 EALPPEAQDLIEQLLRQNPLCRLGTGGALEVKQHGFFQL  320 (1205)
T ss_pred             cCCCHHHHHHHHHHHHhChHhhcccchhhhhhhccceee
Confidence             2789999999999999999996   4678999999975

>PRK10345 hypothetical protein; Provisional

Probab=99.87  E-value=1.2e-21  Score=178.69  Aligned_cols=135  Identities=18%  Similarity=0.213  Sum_probs=108.5

Q ss_pred             eceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcC-----CCCCcceEEEEEEeCC---EEE
Q 014609           19 GRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL-----KHPNVVRLHEVLASKS---KIY   90 (421)
Q Consensus        19 ~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-----~hpnIv~l~~~~~~~~---~~~   90 (421)
                      .+.||+|+||.||.  ++.++.. +||++.....   ...+.+.+|+.+++.+     +||||++++++++++.   ..+
T Consensus         7 ~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~~---~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~   80 (210)
T PRK10345          7 QSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRGD---GGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVY   80 (210)
T ss_pred             cceecCCCceEEEE--CCCCcCe-EEEEEecccc---chHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEE
Confidence            47899999999995  7777666 6999876432   2346799999999999     5799999999999874   434


Q ss_pred             -EEEec--cCCCChHHHHHhcCCCCHHHHHHHHHHHHHHH-HHHHhCCceeccCCCCCEEeccC----CCEEEEeccCCC
Q 014609           91 -MVLEY--VTGGELFDKIASKGRLQEAEGRKLFQQLIDGV-SYCHNKGVFHRDLKLENILLDSK----GNIKISDFGLSA  162 (421)
Q Consensus        91 -lv~E~--~~gg~L~~~i~~~~~~~~~~~~~~~~ql~~aL-~~LH~~gi~HrDlkp~NILl~~~----~~~kL~DFGla~  162 (421)
                       +|+||  +.+++|.+++.. ..+++.  ..++.|++.++ +|||+++|+||||||+|||++.+    +.++|+||+.+.
T Consensus        81 ~~I~e~~G~~~~tL~~~l~~-~~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G~~  157 (210)
T PRK10345         81 DVIADFDGKPSITLTEFAEQ-CRYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCDNIGES  157 (210)
T ss_pred             EEEecCCCCcchhHHHHHHc-ccccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEECCCCc
Confidence             78999  557999999976 456666  35678888777 99999999999999999999743    379999955443

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.87  E-value=3.5e-21  Score=181.68  Aligned_cols=218  Identities=25%  Similarity=0.360  Sum_probs=140.7

Q ss_pred             ceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCC----------CCcceEEEEEE
Q 014609           15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKH----------PNVVRLHEVLA   84 (421)
Q Consensus        15 ~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~h----------pnIv~l~~~~~   84 (421)
                      ....++.||.|+++.||.+.|..||+.+|+|+............+++++|.-....+.+          -.++..++...
T Consensus        13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~   92 (288)
T PF14531_consen   13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR   92 (288)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred             EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence            45678899999999999999999999999999876554344456777777755555332          12333333221


Q ss_pred             ---------e---CCE-----EEEEEeccCCCChHHHHH---hcCCC---CHHHH-HHHHHHHHHHHHHHHhCCceeccC
Q 014609           85 ---------S---KSK-----IYMVLEYVTGGELFDKIA---SKGRL---QEAEG-RKLFQQLIDGVSYCHNKGVFHRDL  140 (421)
Q Consensus        85 ---------~---~~~-----~~lv~E~~~gg~L~~~i~---~~~~~---~~~~~-~~~~~ql~~aL~~LH~~gi~HrDl  140 (421)
                               .   .+.     .+++|+-+ .++|.+.+.   .....   ....+ ..+..|++..+++||+.|++|+||
T Consensus        93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHgdi  171 (288)
T PF14531_consen   93 IPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHGDI  171 (288)
T ss_dssp             ETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEEST-
T ss_pred             EcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEeccc
Confidence                     1   112     36778877 457776643   22222   11223 344589999999999999999999


Q ss_pred             CCCCEEeccCCCEEEEeccCCCCCccccCCCccccccCCCCccChhhhccc--------CCCCCcchHHHHHHHHhhhcC
Q 014609          141 KLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANR--------GYDGATSDIWSCGVILYIFRG  212 (421)
Q Consensus       141 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~--------~~~~~~~DiwSlGvil~~~~~  212 (421)
                      +|+|++++.+|.++|+||+.......     .......+..|.+||.....        .+ +.+.|.|+||+++|.+.+
T Consensus       172 ~~~nfll~~~G~v~Lg~F~~~~r~g~-----~~~~~~~~~~~~PPe~~~~~~~~~~~~~~~-t~~~DaW~LG~~ly~lWC  245 (288)
T PF14531_consen  172 KPENFLLDQDGGVFLGDFSSLVRAGT-----RYRCSEFPVAFTPPELESCAGQFGQNNAPY-TFATDAWQLGITLYSLWC  245 (288)
T ss_dssp             SGGGEEE-TTS-EEE--GGGEEETTE-----EEEGGGS-TTTS-HHHHHHHTSCHHSEEEE--HHHHHHHHHHHHHHHHH
T ss_pred             ceeeEEEcCCCCEEEcChHHHeecCc-----eeeccCCCcccCChhhhhhhcccCccccee-eeccCHHHHHHHHHHHHH
Confidence            99999999999999999987653221     11113456789999986543        23 477899999999994432


Q ss_pred             -CcCC---------------CCCCCHHHHHHHHHhcCCCCCCC
Q 014609          213 -DFKL---------------PKWLSPGAQNLLRKILEPNPVKR  239 (421)
Q Consensus       213 -~~~~---------------p~~~s~~~~~li~~~L~~dP~~R  239 (421)
                       ..|+               -..+|..++.||+.+|++||.+|
T Consensus       246 ~~lPf~~~~~~~~~~~~f~~C~~~Pe~v~~LI~~lL~~~~~~R  288 (288)
T PF14531_consen  246 GRLPFGLSSPEADPEWDFSRCRDMPEPVQFLIRGLLQRNPEDR  288 (288)
T ss_dssp             SS-STCCCGGGSTSGGGGTTSS---HHHHHHHHHHT-SSGGGS
T ss_pred             ccCCCCCCCccccccccchhcCCcCHHHHHHHHHHccCCcccC
Confidence             2222               12478899999999999999987

>smart00090 RIO RIO-like kinase

Probab=99.86  E-value=1.1e-21  Score=182.88  Aligned_cols=144  Identities=22%  Similarity=0.251  Sum_probs=116.1

Q ss_pred             ceEEeceEeecCcEEEEEEE-ECCCCceEEEEEeecccccch---------------------hHHHHHHHHHHHHhcCC
Q 014609           15 RYELGRTLGEGNFGKVKFAQ-DLDSGLPFAVKILEKNRIIHL---------------------KITDQIKREIATLKLLK   72 (421)
Q Consensus        15 ~y~i~~~LG~G~~g~V~~a~-~~~~~~~vAvK~i~~~~~~~~---------------------~~~~~~~~Ei~il~~l~   72 (421)
                      .|++.+.||+|+||.||+|. +..+|+.||+|+++.......                     .....+.+|+.+++++.
T Consensus        29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~  108 (237)
T smart00090       29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY  108 (237)
T ss_pred             hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence            48899999999999999998 667999999999975432100                     01134678999999997


Q ss_pred             CCC--cceEEEEEEeCCEEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC-ceeccCCCCCEEecc
Q 014609           73 HPN--VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKG-VFHRDLKLENILLDS  149 (421)
Q Consensus        73 hpn--Iv~l~~~~~~~~~~~lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~ql~~aL~~LH~~g-i~HrDlkp~NILl~~  149 (421)
                      +.+  +.++++.    ...|+||||++|.+|.........+....+..++.|++.++.+||+.| |+||||||+||+++ 
T Consensus       109 ~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~NIli~-  183 (237)
T smart00090      109 EAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKDVEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEYNILVH-  183 (237)
T ss_pred             hcCCCCCeeeEe----cCceEEEEEecCCcccccccccCCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhhEEEE-
Confidence            633  4444443    235899999999888766544556777778899999999999999999 99999999999999 


Q ss_pred             CCCEEEEeccCCCC
Q 014609          150 KGNIKISDFGLSAL  163 (421)
Q Consensus       150 ~~~~kL~DFGla~~  163 (421)
                      ++.++|+|||.+..
T Consensus       184 ~~~i~LiDFg~a~~  197 (237)
T smart00090      184 DGKVVIIDVSQSVE  197 (237)
T ss_pred             CCCEEEEEChhhhc
Confidence            88999999999874

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.86  E-value=4e-21  Score=172.82  Aligned_cols=180  Identities=19%  Similarity=0.206  Sum_probs=132.7

Q ss_pred             EEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchh-HHHHHHHHHHHHhcCC-CCCcceEEEEEEeCCEEEEEEe
Q 014609           17 ELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLK-ITDQIKREIATLKLLK-HPNVVRLHEVLASKSKIYMVLE   94 (421)
Q Consensus        17 ~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~-~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~lv~E   94 (421)
                      .+...|++|+||+|+++..  .+..++.+.+......... ....+.+|+++|++|. |++|++++++    +..|++||
T Consensus         5 ~~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvme   78 (218)
T PRK12274          5 AVNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRS   78 (218)
T ss_pred             ccceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEe
Confidence            4568899999999998864  6778887777654332111 1235889999999996 5889999886    45799999


Q ss_pred             ccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccC-CCCCEEeccCCCEEEEeccCCCCCccccCC---
Q 014609           95 YVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDL-KLENILLDSKGNIKISDFGLSALPQHFRDD---  170 (421)
Q Consensus        95 ~~~gg~L~~~i~~~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDl-kp~NILl~~~~~~kL~DFGla~~~~~~~~~---  170 (421)
                      |+.|.+|...+..      . ...++.|++.+|+++|++||+|||| ||+|||++.+|.++|+|||+|.........   
T Consensus        79 yI~G~~L~~~~~~------~-~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~~r~  151 (218)
T PRK12274         79 YLAGAAMYQRPPR------G-DLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARWMRL  151 (218)
T ss_pred             eecCccHHhhhhh------h-hHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcchHHHH
Confidence            9999998654321      1 2357899999999999999999999 799999999999999999999854432110   


Q ss_pred             -C-------ccccccCCCCccChhhhcccCCCC-CcchHHHHHHHHhh
Q 014609          171 -G-------LLHTTCGSPNYVAPEVLANRGYDG-ATSDIWSCGVILYI  209 (421)
Q Consensus       171 -~-------~~~~~~gt~~y~APEvl~~~~~~~-~~~DiwSlGvil~~  209 (421)
                       .       .......++.|++|+.-.-..-.+ ...++++.|+-+|-
T Consensus       152 L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~  199 (218)
T PRK12274        152 LAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYR  199 (218)
T ss_pred             HHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHH
Confidence             0       011234688999998643221112 45788899999983

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.85  E-value=5.8e-21  Score=181.36  Aligned_cols=170  Identities=28%  Similarity=0.484  Sum_probs=128.2

Q ss_pred             CCCCcceEEEEEEe---------------------------CCEEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHH
Q 014609           72 KHPNVVRLHEVLAS---------------------------KSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLI  124 (421)
Q Consensus        72 ~hpnIv~l~~~~~~---------------------------~~~~~lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~ql~  124 (421)
                      +|||||++...|-+                           +..+|+||..+ ..+|..++-.+ ..+....+-++.|++
T Consensus       274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY-~~tLr~yl~~~-~~s~r~~~~~laQlL  351 (598)
T KOG4158|consen  274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRY-RQTLREYLWTR-HRSYRTGRVILAQLL  351 (598)
T ss_pred             CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcc-hhhHHHHHhcC-CCchHHHHHHHHHHH
Confidence            59999999887632                           34689999988 45888888753 456777888999999


Q ss_pred             HHHHHHHhCCceeccCCCCCEEec--cCC--CEEEEeccCCCCCccccC----CCccccccCCCCccChhhhcccCC---
Q 014609          125 DGVSYCHNKGVFHRDLKLENILLD--SKG--NIKISDFGLSALPQHFRD----DGLLHTTCGSPNYVAPEVLANRGY---  193 (421)
Q Consensus       125 ~aL~~LH~~gi~HrDlkp~NILl~--~~~--~~kL~DFGla~~~~~~~~----~~~~~~~~gt~~y~APEvl~~~~~---  193 (421)
                      +|+.|||.+||.|||+|.+|||+.  +++  .+.|+|||.+---+..+-    .+-.-..-|.-.-||||+....+-   
T Consensus       352 Eav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~a  431 (598)
T KOG4158|consen  352 EAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGPNA  431 (598)
T ss_pred             HHHHHHHHccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCCCCce
Confidence            999999999999999999999994  333  489999998752211000    000112346778899999754321   


Q ss_pred             --CCCcchHHHHHHHHhhhcCC----------------------cCCCCCCCHHHHHHHHHhcCCCCCCCCCHH
Q 014609          194 --DGATSDIWSCGVILYIFRGD----------------------FKLPKWLSPGAQNLLRKILEPNPVKRITIA  243 (421)
Q Consensus       194 --~~~~~DiwSlGvil~~~~~~----------------------~~~p~~~s~~~~~li~~~L~~dP~~R~t~~  243 (421)
                        +-.++|.|++|.+.|+..|.                      .++|..+++.+++++..+|++||++|++..
T Consensus       432 vvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~Yqe~qLPalp~~vpp~~rqlV~~lL~r~pskRvsp~  505 (598)
T KOG4158|consen  432 VVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRTYQESQLPALPSRVPPVARQLVFDLLKRDPSKRVSPN  505 (598)
T ss_pred             eeccchhhhhhhhhhHHHHhccCCcccccchheechhhhhhhhCCCCcccCChHHHHHHHHHhcCCccccCCcc
Confidence              12579999999999955443                      235667999999999999999999999854

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.84  E-value=4.9e-22  Score=208.21  Aligned_cols=230  Identities=28%  Similarity=0.387  Sum_probs=175.7

Q ss_pred             ceEEeceEeecCcEEEEEEEECCCCceEEEEEeeccc-ccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEE
Q 014609           15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNR-IIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVL   93 (421)
Q Consensus        15 ~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~   93 (421)
                      .|...+-||.+-|=+|.+|++. .|. |+||++-+.. ........+..+|++ ...++|||.+++.-+.+.+...|+|-
T Consensus        24 e~~~~~~LGstRFlKv~r~k~~-eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvR  100 (1431)
T KOG1240|consen   24 ECHYVENLGSTRFLKVARAKDR-EGL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVR  100 (1431)
T ss_pred             ceeeecccCchhhhhhhhccCC-Cce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHH
Confidence            6888999999999999999874 455 9999987654 222222334444555 66678999999999888888899999


Q ss_pred             eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCC--ccccCCC
Q 014609           94 EYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALP--QHFRDDG  171 (421)
Q Consensus        94 E~~~gg~L~~~i~~~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~--~~~~~~~  171 (421)
                      +|+. .+|+|++..++-+...+.+.|+.||+.||.-||..||+|||||.|||||+.=+-+.|+||..-+..  ..+++..
T Consensus       101 qyvk-hnLyDRlSTRPFL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDNPad  179 (1431)
T KOG1240|consen  101 QYVK-HNLYDRLSTRPFLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDNPAD  179 (1431)
T ss_pred             HHHh-hhhhhhhccchHHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEeeechhhhhcccccCCccCCCCCccc
Confidence            9995 599999999888899999999999999999999999999999999999999999999999765421  1111111


Q ss_pred             c---cccccCCCCccChhhhcccC---------C-CCCcchHHHHHHHHhhhcCC-cCCC--------------------
Q 014609          172 L---LHTTCGSPNYVAPEVLANRG---------Y-DGATSDIWSCGVILYIFRGD-FKLP--------------------  217 (421)
Q Consensus       172 ~---~~~~~gt~~y~APEvl~~~~---------~-~~~~~DiwSlGvil~~~~~~-~~~p--------------------  217 (421)
                      .   ..+...-..|.|||.+....         . -.++-||||+||++.++..+ .|+.                    
T Consensus       180 f~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQL~aYr~~~~~~~e~~L  259 (1431)
T KOG1240|consen  180 FTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQLLAYRSGNADDPEQLL  259 (1431)
T ss_pred             ceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHHHHhHhccCccCHHHHH
Confidence            1   11222334799999876422         1 24678999999999965433 1111                    


Q ss_pred             -CCCCHHHHHHHHHhcCCCCCCCCCHHhhhcC
Q 014609          218 -KWLSPGAQNLLRKILEPNPVKRITIAGIKAD  248 (421)
Q Consensus       218 -~~~s~~~~~li~~~L~~dP~~R~t~~eil~~  248 (421)
                       .--+...+.+|..|++.||++|.++++.|+.
T Consensus       260 e~Ied~~~Rnlil~Mi~rdPs~RlSAedyL~~  291 (1431)
T KOG1240|consen  260 EKIEDVSLRNLILSMIQRDPSKRLSAEDYLQK  291 (1431)
T ss_pred             HhCcCccHHHHHHHHHccCchhccCHHHHHHh
Confidence             0124678999999999999999999998876

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.83  E-value=6.1e-20  Score=168.00  Aligned_cols=138  Identities=24%  Similarity=0.354  Sum_probs=116.4

Q ss_pred             eceEeecCcEEEEEEEECCCCceEEEEEeecccccchh-----HHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEE
Q 014609           19 GRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLK-----ITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVL   93 (421)
Q Consensus        19 ~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~-----~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~   93 (421)
                      ++.||+|++|.||+|.+  .|..+++|+..........     ....+.+|+.++..+.|++|.....++...+..+++|
T Consensus         1 ~~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~   78 (211)
T PRK14879          1 MKLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVM   78 (211)
T ss_pred             CcccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEE
Confidence            36799999999999986  7788999986543322111     1246788999999999999988777777788899999


Q ss_pred             eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCC
Q 014609           94 EYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSAL  163 (421)
Q Consensus        94 E~~~gg~L~~~i~~~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~  163 (421)
                      ||++|++|.+.+.....    ....++.+++.+|.++|+.|++|||++|.|||++ ++.++|+|||.+..
T Consensus        79 e~~~G~~L~~~~~~~~~----~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~  143 (211)
T PRK14879         79 EYIEGEPLKDLINSNGM----EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS-GGKIYLIDFGLAEF  143 (211)
T ss_pred             EEeCCcCHHHHHHhccH----HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence            99999999998865332    7888999999999999999999999999999999 88999999999874

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.83  E-value=1.6e-20  Score=200.09  Aligned_cols=188  Identities=22%  Similarity=0.295  Sum_probs=156.8

Q ss_pred             ecceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCC---CCCcceEEEEEEeCCEE
Q 014609           13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK---HPNVVRLHEVLASKSKI   89 (421)
Q Consensus        13 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~---hpnIv~l~~~~~~~~~~   89 (421)
                      ...|.|-+.||+|+||+||.|.+.. |+.||||+=.....+..-...+      ++.+|+   -+.|..+...+.-.+.-
T Consensus       697 ~~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~WEfYI~~q------~~~RLk~~~~~~~~~~~~a~~~~~~S  769 (974)
T KOG1166|consen  697 GEKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNPWEFYICLQ------VMERLKPQMLPSIMHISSAHVFQNAS  769 (974)
T ss_pred             ceeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCCceeeeehHH------HHHhhchhhhcchHHHHHHHccCCcc
Confidence            3589999999999999999999866 9999999977665544322333      334444   35566666666777788


Q ss_pred             EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecc-------CCCEEEEeccCCC
Q 014609           90 YMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDS-------KGNIKISDFGLSA  162 (421)
Q Consensus        90 ~lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~-------~~~~kL~DFGla~  162 (421)
                      ++|+||.+.|+|.++++..+.+++.....+..|++..|++||..+|||+||||+|.||..       +..++|+|||.+-
T Consensus       770 ~lv~ey~~~Gtlld~~N~~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~si  849 (974)
T KOG1166|consen  770 VLVSEYSPYGTLLDLINTNKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKGLYLIDFGRSI  849 (974)
T ss_pred             eeeeeccccccHHHhhccCCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccceEEEecccce
Confidence            999999999999999999899999999999999999999999999999999999999943       2359999999987


Q ss_pred             CCccccCCCccccccCCCCccChhhhcccCCCCCcchHHHHHHHHh
Q 014609          163 LPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILY  208 (421)
Q Consensus       163 ~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~  208 (421)
                      -.....+.......++|-.+-.+|+..+++|. ..+|.|.+..+++
T Consensus       850 Dm~lfp~~~~F~~~~~td~f~C~EM~~grpWt-Yq~DyfGlAa~~h  894 (974)
T KOG1166|consen  850 DMKLFPDGTKFKAVWHTDLFDCIEMREGRPWT-YQIDYFGLAATVH  894 (974)
T ss_pred             eeeEcCCCcEEeeeeccccchhHHHhcCCCCc-hhhhhHHHHHHHH
Confidence            55544455566777899999999999999994 9999999999988

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.82  E-value=1.3e-19  Score=164.26  Aligned_cols=133  Identities=21%  Similarity=0.277  Sum_probs=108.8

Q ss_pred             eEeecCcEEEEEEEECCCCceEEEEEeecccccch-----hHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEEec
Q 014609           21 TLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHL-----KITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLEY   95 (421)
Q Consensus        21 ~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~-----~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E~   95 (421)
                      .||+|+||.||+|.  .+|..+++|..........     ....++.+|+++++.++|+++....-++......++||||
T Consensus         1 ~ig~G~~~~vy~~~--~~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~   78 (199)
T TIGR03724         1 LIAKGAEAIIYLGD--FLGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEY   78 (199)
T ss_pred             CCCCCceEEEEEee--cCCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEE
Confidence            48999999999998  4678899998654322211     1236678999999999988766555555566778999999


Q ss_pred             cCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCC
Q 014609           96 VTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSAL  163 (421)
Q Consensus        96 ~~gg~L~~~i~~~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~  163 (421)
                      ++|++|.+.+.....       .++.|++.+|.+||+.|++|||++|.||+++ ++.++++|||++..
T Consensus        79 ~~g~~l~~~~~~~~~-------~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~  138 (199)
T TIGR03724        79 IEGKPLKDVIEEGND-------ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKY  138 (199)
T ss_pred             ECCccHHHHHhhcHH-------HHHHHHHHHHHHHHHCCeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence            999999887764321       7899999999999999999999999999999 89999999999875

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.82  E-value=1.6e-20  Score=170.49  Aligned_cols=226  Identities=19%  Similarity=0.358  Sum_probs=180.2

Q ss_pred             CCeeecceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCE
Q 014609            9 EGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSK   88 (421)
Q Consensus         9 ~~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~   88 (421)
                      .|+.++...+.-+|.+.-.|..|+|++.  |..++.|++...... .....+|..|.-.|+-+.||||+.+++.|.++.+
T Consensus       185 ~gid~~~lnl~tkl~e~hsgelwrgrwq--gndivakil~vr~~t-~risrdfneefp~lrifshpnilpvlgacnsppn  261 (448)
T KOG0195|consen  185 TGIDVSSLNLITKLAESHSGELWRGRWQ--GNDIVAKILNVREVT-ARISRDFNEEFPALRIFSHPNILPVLGACNSPPN  261 (448)
T ss_pred             cCcchhhhhhhhhhccCCCccccccccc--Ccchhhhhhhhhhcc-hhhcchhhhhCcceeeecCCchhhhhhhccCCCC
Confidence            4555666778888999999999999974  456778888654432 3345789999999999999999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCC--ceeccCCCCCEEeccCCCEEEE--eccCCC
Q 014609           89 IYMVLEYVTGGELFDKIASKGR--LQEAEGRKLFQQLIDGVSYCHNKG--VFHRDLKLENILLDSKGNIKIS--DFGLSA  162 (421)
Q Consensus        89 ~~lv~E~~~gg~L~~~i~~~~~--~~~~~~~~~~~ql~~aL~~LH~~g--i~HrDlkp~NILl~~~~~~kL~--DFGla~  162 (421)
                      +.++..|++-|+|+..+.....  .+..++.+++..++.|++|||+..  |----|....+++|++-+.+|+  |--++.
T Consensus       262 lv~isq~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltarismad~kfsf  341 (448)
T KOG0195|consen  262 LVIISQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARISMADTKFSF  341 (448)
T ss_pred             ceEeeeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhheecccceeee
Confidence            9999999999999999987543  678899999999999999999973  4444689999999998766554  433222


Q ss_pred             CCccccCCCccccccCCCCccChhhhcccCCC--CCcchHHHHHHHHhhhcC----------------------CcCCCC
Q 014609          163 LPQHFRDDGLLHTTCGSPNYVAPEVLANRGYD--GATSDIWSCGVILYIFRG----------------------DFKLPK  218 (421)
Q Consensus       163 ~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~--~~~~DiwSlGvil~~~~~----------------------~~~~p~  218 (421)
                      .         .....-.|.|++||.+..++-+  -.++|+|||.+++|++..                      +..+|+
T Consensus       342 q---------e~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkialeglrv~ipp  412 (448)
T KOG0195|consen  342 Q---------EVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIALEGLRVHIPP  412 (448)
T ss_pred             e---------ccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhhccccccCCC
Confidence            0         1122357899999999876644  246899999999995532                      235678


Q ss_pred             CCCHHHHHHHHHhcCCCCCCCCCHHhhh
Q 014609          219 WLSPGAQNLLRKILEPNPVKRITIAGIK  246 (421)
Q Consensus       219 ~~s~~~~~li~~~L~~dP~~R~t~~eil  246 (421)
                      .+++.+..|++-|++.||.+||.+++|.
T Consensus       413 gis~hm~klm~icmnedpgkrpkfdmiv  440 (448)
T KOG0195|consen  413 GISRHMNKLMNICMNEDPGKRPKFDMIV  440 (448)
T ss_pred             CccHHHHHHHHHHhcCCCCcCCCcceeh
Confidence            8999999999999999999999988764

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.81  E-value=1.4e-19  Score=164.29  Aligned_cols=138  Identities=25%  Similarity=0.353  Sum_probs=109.6

Q ss_pred             eEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccch-------------------hHHHHHHHHHHHHhcCCCCC-
Q 014609           16 YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHL-------------------KITDQIKREIATLKLLKHPN-   75 (421)
Q Consensus        16 y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~-------------------~~~~~~~~Ei~il~~l~hpn-   75 (421)
                      |.+.+.||+|+||.||+|.+ .+|+.||||+++.......                   .......+|+.++..+.|++ 
T Consensus        17 ~~~~~~i~~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i   95 (198)
T cd05144          17 ESLGNQIGVGKESDVYLALD-PDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGF   95 (198)
T ss_pred             hhcCCccccCcceEEEEEEc-CCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCC
Confidence            88899999999999999986 4899999999875321000                   01123678999999998874 


Q ss_pred             -cceEEEEEEeCCEEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEE
Q 014609           76 -VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIK  154 (421)
Q Consensus        76 -Iv~l~~~~~~~~~~~lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~k  154 (421)
                       +...++    ....++||||++|++|.+....      .....++.+++.++.++|+.||+||||||+||+++.++.++
T Consensus        96 ~v~~~~~----~~~~~lv~e~~~g~~L~~~~~~------~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill~~~~~~~  165 (198)
T cd05144          96 PVPKPID----WNRHAVVMEYIDGVELYRVRVL------EDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILVDDDEKIY  165 (198)
T ss_pred             CCCceee----cCCceEEEEEeCCcchhhcccc------ccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEEcCCCcEE
Confidence             444443    2456899999999988654321      44677889999999999999999999999999999999999


Q ss_pred             EEeccCCCCC
Q 014609          155 ISDFGLSALP  164 (421)
Q Consensus       155 L~DFGla~~~  164 (421)
                      |+|||++...
T Consensus       166 liDfg~~~~~  175 (198)
T cd05144         166 IIDWPQMVST  175 (198)
T ss_pred             EEECCccccC
Confidence            9999999643

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.78  E-value=1.1e-18  Score=181.86  Aligned_cols=139  Identities=21%  Similarity=0.267  Sum_probs=112.7

Q ss_pred             ceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccc-----hhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEE
Q 014609           15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIH-----LKITDQIKREIATLKLLKHPNVVRLHEVLASKSKI   89 (421)
Q Consensus        15 ~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~-----~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~   89 (421)
                      .|...+.||+|+||+||+|.+..  ..+++|+........     ....+.+.+|+++++.++|++++....+.......
T Consensus       334 ~~~~~~~iG~G~~g~Vy~~~~~~--~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~  411 (535)
T PRK09605        334 RKIPDHLIGKGAEADIKKGEYLG--RDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEK  411 (535)
T ss_pred             ccCccceeccCCcEEEEEEeecC--ccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCC
Confidence            44567899999999999998643  345555432221111     11235688999999999999999888887777788


Q ss_pred             EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCC
Q 014609           90 YMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALP  164 (421)
Q Consensus        90 ~lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~  164 (421)
                      ++||||++|++|.+.+.        ....++.|++.+|.|||+.|++||||||+|||+ .++.++|+|||++...
T Consensus       412 ~lv~E~~~g~~L~~~l~--------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl-~~~~~~liDFGla~~~  477 (535)
T PRK09605        412 TIVMEYIGGKDLKDVLE--------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIV-RDDRLYLIDFGLGKYS  477 (535)
T ss_pred             EEEEEecCCCcHHHHHH--------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEE-ECCcEEEEeCcccccC
Confidence            99999999999988875        357789999999999999999999999999999 6789999999999853

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.78  E-value=6.8e-19  Score=157.96  Aligned_cols=138  Identities=27%  Similarity=0.396  Sum_probs=101.0

Q ss_pred             EeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHH---------------------HHHHHHHHHhcCCCCC-
Q 014609           18 LGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITD---------------------QIKREIATLKLLKHPN-   75 (421)
Q Consensus        18 i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~---------------------~~~~Ei~il~~l~hpn-   75 (421)
                      +++.||+|+||+||+|.+. +|+.||||++............                     ....|...+..+.+.+ 
T Consensus         1 ~~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~   79 (187)
T cd05119           1 VGGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGV   79 (187)
T ss_pred             CCcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCC
Confidence            3578999999999999976 8999999998754321111111                     1145667777765443 


Q ss_pred             -cceEEEEEEeCCEEEEEEeccCCCChHH-HHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCceeccCCCCCEEeccCCC
Q 014609           76 -VVRLHEVLASKSKIYMVLEYVTGGELFD-KIASKGRLQEAEGRKLFQQLIDGVSYCHN-KGVFHRDLKLENILLDSKGN  152 (421)
Q Consensus        76 -Iv~l~~~~~~~~~~~lv~E~~~gg~L~~-~i~~~~~~~~~~~~~~~~ql~~aL~~LH~-~gi~HrDlkp~NILl~~~~~  152 (421)
                       +.+.+++    ...++||||++|+.+.. .+.. ... ...++.++.|++.++.++|+ .||+||||||+||+++ ++.
T Consensus        80 ~~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~-~~~-~~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~-~~~  152 (187)
T cd05119          80 PVPKPIDL----NRHVLVMEFIGGDGIPAPRLKD-VRL-LEDPEELYDQILELMRKLYREAGLVHGDLSEYNILVD-DGK  152 (187)
T ss_pred             CCCceEec----CCCEEEEEEeCCCCccChhhhh-hhh-cccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEEE-CCc
Confidence             4555543    23589999999854322 1111 111 16788999999999999999 9999999999999999 899


Q ss_pred             EEEEeccCCCC
Q 014609          153 IKISDFGLSAL  163 (421)
Q Consensus       153 ~kL~DFGla~~  163 (421)
                      ++|+|||.+..
T Consensus       153 ~~liDfg~a~~  163 (187)
T cd05119         153 VYIIDVPQAVE  163 (187)
T ss_pred             EEEEECccccc
Confidence            99999999873

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.74  E-value=2.5e-17  Score=153.83  Aligned_cols=138  Identities=22%  Similarity=0.360  Sum_probs=106.6

Q ss_pred             eceEe-ecCcEEEEEEEECCCCceEEEEEeecccc----c------chhHHHHHHHHHHHHhcCCCCCc--ceEEEEEEe
Q 014609           19 GRTLG-EGNFGKVKFAQDLDSGLPFAVKILEKNRI----I------HLKITDQIKREIATLKLLKHPNV--VRLHEVLAS   85 (421)
Q Consensus        19 ~~~LG-~G~~g~V~~a~~~~~~~~vAvK~i~~~~~----~------~~~~~~~~~~Ei~il~~l~hpnI--v~l~~~~~~   85 (421)
                      ...|| .|+.|+||.+..  .+..++||.+.....    .      .......+.+|++++.+|+|++|  +..+++...
T Consensus        36 ~~~lg~~~g~gtv~~v~~--~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~  113 (239)
T PRK01723         36 ARVVGSAKGRGTTWFVQT--PGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVV  113 (239)
T ss_pred             CceeecCCCCccEEEEEe--CCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeee
Confidence            35677 788888988875  478899998864321    0      11123568899999999998875  667766443


Q ss_pred             CC----EEEEEEeccCC-CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccC
Q 014609           86 KS----KIYMVLEYVTG-GELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGL  160 (421)
Q Consensus        86 ~~----~~~lv~E~~~g-g~L~~~i~~~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGl  160 (421)
                      ..    ..++|||+++| .+|.+.+.. .++++..    +.|++.+|.+||++||+||||||+|||++.++.++|+|||.
T Consensus       114 ~~~~~~~~~lV~e~l~G~~~L~~~l~~-~~l~~~~----~~~i~~~l~~lH~~GI~HrDlkp~NILv~~~~~v~LIDfg~  188 (239)
T PRK01723        114 RHGLFYRADILIERIEGARDLVALLQE-APLSEEQ----WQAIGQLIARFHDAGVYHADLNAHNILLDPDGKFWLIDFDR  188 (239)
T ss_pred             ecCcceeeeEEEEecCCCCCHHHHHhc-CCCCHHH----HHHHHHHHHHHHHCCCCCCCCCchhEEEcCCCCEEEEECCC
Confidence            32    23599999997 688887764 4555543    57899999999999999999999999999999999999999


Q ss_pred             CCC
Q 014609          161 SAL  163 (421)
Q Consensus       161 a~~  163 (421)
                      +..
T Consensus       189 ~~~  191 (239)
T PRK01723        189 GEL  191 (239)
T ss_pred             ccc
Confidence            874

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.74  E-value=4.2e-19  Score=174.92  Aligned_cols=231  Identities=23%  Similarity=0.310  Sum_probs=157.9

Q ss_pred             cceEEeceEeecCcEEEEEEEECCC---CceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEE-------EE
Q 014609           14 GRYELGRTLGEGNFGKVKFAQDLDS---GLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHE-------VL   83 (421)
Q Consensus        14 ~~y~i~~~LG~G~~g~V~~a~~~~~---~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~-------~~   83 (421)
                      +.+.+.+..+..+++.+....-..+   .+.++-+..+...   ........+++-.+....|-+..-+.+       .+
T Consensus       244 ~s~~~~k~~~~~~~~~~~~~q~~~~~s~~E~~~s~~~~~d~---~~~~~~~~r~~~~l~~~~~~~~s~~~d~~~s~~~~~  320 (516)
T KOG1033|consen  244 GSSSISKSSERVSSGIVFEKQGKNNSSLREWLKSKRADVDS---LCACKYTFRQLGVLVDSSHSNRSILEDLRPSLFESS  320 (516)
T ss_pred             ccccccccccccccCCchhhhhcccchhhhhccchhhhccc---hhhhhhhhhhhhheeccccCCcccccCCCCchhhhc
Confidence            3455556666666666655432222   2233333222221   111233444555555544433333333       11


Q ss_pred             E-----eCCEEEEEEeccCCCChHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEE
Q 014609           84 A-----SKSKIYMVLEYVTGGELFDKIASKG---RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKI  155 (421)
Q Consensus        84 ~-----~~~~~~lv~E~~~gg~L~~~i~~~~---~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL  155 (421)
                      .     ....+||.|++|.-.+|.+++....   ..+......++.|++.|++|   +|.+|||+||.||....++.+||
T Consensus       321 ~~~~v~~~~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d~q~kI  397 (516)
T KOG1033|consen  321 KRNKVGKKVYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDDDQLKI  397 (516)
T ss_pred             cccccccccchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccccchhhhh
Confidence            1     1235899999999999999997543   36777889999999999999   99999999999999999999999


Q ss_pred             EeccCCCCCcccc----CCCccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhhcCC----------------cC
Q 014609          156 SDFGLSALPQHFR----DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIFRGD----------------FK  215 (421)
Q Consensus       156 ~DFGla~~~~~~~----~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~~~~----------------~~  215 (421)
                      .|||+.+......    .........||+.||+||.+.+..| +.++||||||+||+++...                ..
T Consensus       398 gDFgl~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y-~~kvdIyaLGlil~EL~~~f~T~~er~~t~~d~r~g~  476 (516)
T KOG1033|consen  398 GDFGLVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQY-SEKVDIYALGLILAELLIQFSTQFERIATLTDIRDGI  476 (516)
T ss_pred             hhhhheeecccCCcccchhhhhhhcccccccCCHHHHhhhhh-hhhcchhhHHHHHHHHHHHhccHHHHHHhhhhhhcCC
Confidence            9999988544322    1113345679999999999999988 5999999999999954321                12


Q ss_pred             CCCC---CCHHHHHHHHHhcCCCCCCCCCHHhhhcCccc
Q 014609          216 LPKW---LSPGAQNLLRKILEPNPVKRITIAGIKADEWF  251 (421)
Q Consensus       216 ~p~~---~s~~~~~li~~~L~~dP~~R~t~~eil~~~w~  251 (421)
                      +|+.   --+....|+.++|.+.|..||++.+.--|+|.
T Consensus       477 ip~~~~~d~p~e~~ll~~lls~~p~~RP~~~~~~~~~~~  515 (516)
T KOG1033|consen  477 IPPEFLQDYPEEYTLLQQLLSPSPEERPSAIEVALHEFL  515 (516)
T ss_pred             CChHHhhcCcHHHHHHHHhcCCCcccCchHHHHhhhhhc
Confidence            3321   23556689999999999999988777777765

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.73  E-value=1.4e-17  Score=142.57  Aligned_cols=132  Identities=23%  Similarity=0.280  Sum_probs=113.1

Q ss_pred             EeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCC--CCcceEEEEEEeCCEEEEEEec
Q 014609           18 LGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKH--PNVVRLHEVLASKSKIYMVLEY   95 (421)
Q Consensus        18 i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~h--pnIv~l~~~~~~~~~~~lv~E~   95 (421)
                      +++.||+|.++.||++.+.  +..+++|.......     ...+.+|+.+++.++|  +++++++.+....+..|++|||
T Consensus         2 ~~~~i~~g~~~~v~~~~~~--~~~~~iK~~~~~~~-----~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~   74 (155)
T cd05120           2 SIKLLKGGLTNRVYLLGTK--DEDYVLKINPSREK-----GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEW   74 (155)
T ss_pred             cceecccccccceEEEEec--CCeEEEEecCCCCc-----hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEe
Confidence            4678999999999999964  37899999865432     3578899999999986  5899999998888899999999


Q ss_pred             cCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CceeccCCCCCEEeccCCCEEEEeccCCCC
Q 014609           96 VTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNK---GVFHRDLKLENILLDSKGNIKISDFGLSAL  163 (421)
Q Consensus        96 ~~gg~L~~~i~~~~~~~~~~~~~~~~ql~~aL~~LH~~---gi~HrDlkp~NILl~~~~~~kL~DFGla~~  163 (421)
                      ++|+.+...       +......++.+++.+++++|..   +++|+|++|+||+++..+.++++|||.+..
T Consensus        75 ~~g~~~~~~-------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~  138 (155)
T cd05120          75 IEGETLDEV-------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY  138 (155)
T ss_pred             cCCeecccC-------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence            998877543       5567778899999999999985   799999999999999989999999999874

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.67  E-value=1.8e-16  Score=158.90  Aligned_cols=180  Identities=27%  Similarity=0.406  Sum_probs=140.8

Q ss_pred             HhcCCCCCcceEEEEEEeCCEEEEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCc-eeccCCCCCE
Q 014609           68 LKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGV-FHRDLKLENI  145 (421)
Q Consensus        68 l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~gg~L~~~i~~-~~~~~~~~~~~~~~ql~~aL~~LH~~gi-~HrDlkp~NI  145 (421)
                      |+.+.|.|+.++++.+.+....++|.+||..|+|.|.+.. ...++.--...+.+.++.|++|||+..| +|+.+++.|.
T Consensus         1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~nC   80 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSSNC   80 (484)
T ss_pred             CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeeccccc
Confidence            4678999999999999999999999999999999999987 4467777777888999999999999866 9999999999


Q ss_pred             EeccCCCEEEEeccCCCCCccccCCCccccccCCCCccChhhhcccCC------CCCcchHHHHHHHHhhhc--------
Q 014609          146 LLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGY------DGATSDIWSCGVILYIFR--------  211 (421)
Q Consensus       146 Ll~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~------~~~~~DiwSlGvil~~~~--------  211 (421)
                      ++|....+||+|||+..+..............-..-|.|||.+.....      .+.++|+||+|+++|++.        
T Consensus        81 lvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~~~  160 (484)
T KOG1023|consen   81 LVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGPFDL  160 (484)
T ss_pred             eeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCcccc
Confidence            999999999999999886532111111111223346999999876422      245699999999999321        


Q ss_pred             -----------------CCcCCCC------CCCHHHHHHHHHhcCCCCCCCCCHHhhhc
Q 014609          212 -----------------GDFKLPK------WLSPGAQNLLRKILEPNPVKRITIAGIKA  247 (421)
Q Consensus       212 -----------------~~~~~p~------~~s~~~~~li~~~L~~dP~~R~t~~eil~  247 (421)
                                       +..++-+      .+.+.+..+++.||..+|..||++++|..
T Consensus       161 ~~~~~~~~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~  219 (484)
T KOG1023|consen  161 RNLVEDPDEIILRVKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIRS  219 (484)
T ss_pred             ccccCChHHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHHh
Confidence                             1111111      24457899999999999999999998754

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.56  E-value=2.4e-14  Score=145.01  Aligned_cols=141  Identities=25%  Similarity=0.307  Sum_probs=97.3

Q ss_pred             ceEeecCcEEEEEEEECCCCceEEEEEeecccccch---------------------------h----HH------HHHH
Q 014609           20 RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHL---------------------------K----IT------DQIK   62 (421)
Q Consensus        20 ~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~---------------------------~----~~------~~~~   62 (421)
                      +.||.|++|.||+|+. .+|+.||||+.+.......                           .    ..      -++.
T Consensus       123 ~plasaSigQVh~A~l-~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~  201 (437)
T TIGR01982       123 KPLAAASIAQVHRARL-VDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR  201 (437)
T ss_pred             cceeeeehhheEEEEe-cCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence            6799999999999985 5899999999865321000                           0    00      0244


Q ss_pred             HHHHHHhcCC-----CCCcceEEEEEEeCCEEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHH-HHHHHHhCCc
Q 014609           63 REIATLKLLK-----HPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLID-GVSYCHNKGV  135 (421)
Q Consensus        63 ~Ei~il~~l~-----hpnIv~l~~~~~~~~~~~lv~E~~~gg~L~~~i~~~-~~~~~~~~~~~~~ql~~-aL~~LH~~gi  135 (421)
                      +|...+.+++     +++|.-..-+....+..++||||++|++|.+..... ...   ....++.+++. .+..+|..|+
T Consensus       202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~~---~~~~ia~~~~~~~l~ql~~~g~  278 (437)
T TIGR01982       202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAGL---DRKALAENLARSFLNQVLRDGF  278 (437)
T ss_pred             HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcCC---CHHHHHHHHHHHHHHHHHhCCc
Confidence            5666555552     344322222223344578999999999998876432 122   23445566665 4678999999


Q ss_pred             eeccCCCCCEEeccCCCEEEEeccCCCCC
Q 014609          136 FHRDLKLENILLDSKGNIKISDFGLSALP  164 (421)
Q Consensus       136 ~HrDlkp~NILl~~~~~~kL~DFGla~~~  164 (421)
                      +|+|+||.||+++.+|.++|+|||++...
T Consensus       279 ~H~D~hPgNilv~~~g~i~liDfG~~~~l  307 (437)
T TIGR01982       279 FHADLHPGNIFVLKDGKIIALDFGIVGRL  307 (437)
T ss_pred             eeCCCCcccEEECCCCcEEEEeCCCeeEC
Confidence            99999999999999999999999998743

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.55  E-value=6.7e-14  Score=125.72  Aligned_cols=141  Identities=16%  Similarity=0.215  Sum_probs=104.5

Q ss_pred             eceEeecCcEEEEEEEECC------CCceEEEEEeeccccc-------------------chhHHHH----HHHHHHHHh
Q 014609           19 GRTLGEGNFGKVKFAQDLD------SGLPFAVKILEKNRII-------------------HLKITDQ----IKREIATLK   69 (421)
Q Consensus        19 ~~~LG~G~~g~V~~a~~~~------~~~~vAvK~i~~~~~~-------------------~~~~~~~----~~~Ei~il~   69 (421)
                      ...||.|--+.||.|....      .+..+|||+.+.....                   ..+....    ..+|.+.|+
T Consensus         2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~   81 (197)
T cd05146           2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK   81 (197)
T ss_pred             CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence            4679999999999998643      3579999998642210                   0111222    348999999


Q ss_pred             cCCC--CCcceEEEEEEeCCEEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHH-HhCCceeccCCCCCEE
Q 014609           70 LLKH--PNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYC-HNKGVFHRDLKLENIL  146 (421)
Q Consensus        70 ~l~h--pnIv~l~~~~~~~~~~~lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~ql~~aL~~L-H~~gi~HrDlkp~NIL  146 (421)
                      ++..  -++.+++++    ...++||||+.+..+......+..+++..+..++.|++.++..| |+.||+||||+|.|||
T Consensus        82 rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd~~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs~~NIL  157 (197)
T cd05146          82 RMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKDAKLNDEEMKNAYYQVLSMMKQLYKECNLVHADLSEYNML  157 (197)
T ss_pred             HHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhccccCHHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEE
Confidence            9863  466677765    45689999997654433222334566677788899999999999 8999999999999999


Q ss_pred             eccCCCEEEEeccCCCCC
Q 014609          147 LDSKGNIKISDFGLSALP  164 (421)
Q Consensus       147 l~~~~~~kL~DFGla~~~  164 (421)
                      ++ ++.+.|+|||.+...
T Consensus       158 ~~-~~~v~iIDF~qav~~  174 (197)
T cd05146         158 WH-DGKVWFIDVSQSVEP  174 (197)
T ss_pred             EE-CCcEEEEECCCceeC
Confidence            96 578999999988743

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.54  E-value=3.6e-15  Score=153.04  Aligned_cols=145  Identities=24%  Similarity=0.376  Sum_probs=100.9

Q ss_pred             eecceEEeceEeecCcEEEEEEEECCCCceEEEEEeeccccc--------------------------c-h----hHHHH
Q 014609           12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRII--------------------------H-L----KITDQ   60 (421)
Q Consensus        12 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~--------------------------~-~----~~~~~   60 (421)
                      .+..|+. +.||+|++|+||.|+...+|+.||||+.+.....                          + .    +..+.
T Consensus       118 ~F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~  196 (537)
T PRK04750        118 WFDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKT  196 (537)
T ss_pred             HHHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHH
Confidence            3456777 8999999999999998878999999999754210                          0 0    11122


Q ss_pred             ------HHHHHHHHhcCC----CCCcceEEEEEEe-CCEEEEEEeccCCCChHHH--HHhcC----CCCHHHHHHHHHHH
Q 014609           61 ------IKREIATLKLLK----HPNVVRLHEVLAS-KSKIYMVLEYVTGGELFDK--IASKG----RLQEAEGRKLFQQL  123 (421)
Q Consensus        61 ------~~~Ei~il~~l~----hpnIv~l~~~~~~-~~~~~lv~E~~~gg~L~~~--i~~~~----~~~~~~~~~~~~ql  123 (421)
                            +.+|...+.+++    +.+.+.+-.++.+ .+..++||||+.|+.+.+.  +...+    .+.+..+..++.|+
T Consensus       197 l~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qi  276 (537)
T PRK04750        197 LHDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQV  276 (537)
T ss_pred             HHHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHH
Confidence                  344444444442    3444444444432 4567899999999999764  33322    24555566666666


Q ss_pred             HHHHHHHHhCCceeccCCCCCEEeccCC----CEEEEeccCCCCC
Q 014609          124 IDGVSYCHNKGVFHRDLKLENILLDSKG----NIKISDFGLSALP  164 (421)
Q Consensus       124 ~~aL~~LH~~gi~HrDlkp~NILl~~~~----~~kL~DFGla~~~  164 (421)
                      .       ..|++|+|+||.||+++.+|    .++++|||++...
T Consensus       277 f-------~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l  314 (537)
T PRK04750        277 F-------RDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSL  314 (537)
T ss_pred             H-------hCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEEC
Confidence            4       58999999999999999988    9999999998754

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.54  E-value=1.3e-15  Score=160.21  Aligned_cols=245  Identities=25%  Similarity=0.383  Sum_probs=193.2

Q ss_pred             CeeecceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEE
Q 014609           10 GMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKI   89 (421)
Q Consensus        10 ~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~   89 (421)
                      ......+.+.+.+-+|+++.++.+.-..+|...++|+..+.........+...++-.++-...+|.++...-.+......
T Consensus       800 rsS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~  879 (1205)
T KOG0606|consen  800 RSSPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPL  879 (1205)
T ss_pred             cCCCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCc
Confidence            34667889999999999999999998888888888877654433333344555555555555667777666556667789


Q ss_pred             EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCccc--
Q 014609           90 YMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHF--  167 (421)
Q Consensus        90 ~lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~--  167 (421)
                      +++++|+.|++|...++..+..+++-++.+...+..+++|||+..+.|||++|.|+|...+|..+++|||........  
T Consensus       880 ~L~~~~~~~~~~~Skl~~~~~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~~p  959 (1205)
T KOG0606|consen  880 PLVGHYLNGGDLPSKLHNSGCLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLIPP  959 (1205)
T ss_pred             chhhHHhccCCchhhhhcCCCcccccccchhHHHHhhhhccccchhhcccccccchhhcccCCcccCccccccccccccC
Confidence            999999999999999999888999999999999999999999999999999999999999999999999843211000  


Q ss_pred             --------------------c-------CCCccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhhc---------
Q 014609          168 --------------------R-------DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIFR---------  211 (421)
Q Consensus       168 --------------------~-------~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~~---------  211 (421)
                                          .       +........||+.|.|||.+.+... +..+|+|+.|++++...         
T Consensus       960 ~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~h-gs~ad~~~~g~~l~e~l~g~pp~na~ 1038 (1205)
T KOG0606|consen  960 TTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRH-GSAADWWSSGVCLFEVLTGIPPFNAE 1038 (1205)
T ss_pred             cCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccC-CCcchhhhhhhhhhhhhcCCCCCCCc
Confidence                                0       0011233468999999999988776 68899999999999432         


Q ss_pred             -----------CCcCCC---CCCCHHHHHHHHHhcCCCCCCCCCHH---hhhcCccccccc
Q 014609          212 -----------GDFKLP---KWLSPGAQNLLRKILEPNPVKRITIA---GIKADEWFEQDY  255 (421)
Q Consensus       212 -----------~~~~~p---~~~s~~~~~li~~~L~~dP~~R~t~~---eil~~~w~~~~~  255 (421)
                                 +..++|   ...++.+++++.++|..+|.+|..+.   +...|++|+...
T Consensus      1039 tpq~~f~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~~~~e~k~~~~~~~~~ 1099 (1205)
T KOG0606|consen 1039 TPQQIFENILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAKGAAEVKGHPFFQDVD 1099 (1205)
T ss_pred             chhhhhhccccCCCCCCCCccccChhhhhhhhhhhccCchhccCcccccccccCCccCCCC
Confidence                       222332   23789999999999999999999988   999999998644

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=99.53  E-value=1.7e-13  Score=139.21  Aligned_cols=226  Identities=17%  Similarity=0.262  Sum_probs=161.2

Q ss_pred             eEEeceEeecCcEEEE-EEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEEe
Q 014609           16 YELGRTLGEGNFGKVK-FAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLE   94 (421)
Q Consensus        16 y~i~~~LG~G~~g~V~-~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E   94 (421)
                      |++ ...+-++.+ +| .|..+.++.+|.|...+....   ...+.+.+.++-|+.++||||+++++.++..+..|+|+|
T Consensus        15 Y~l-e~~~~~~~a-~~~~~t~k~~~~~vsVF~~~~~~~---~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTE   89 (690)
T KOG1243|consen   15 YDL-EETAFSSEA-LWPDGTRKADGGPVSVFVYKRSNG---EVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTE   89 (690)
T ss_pred             ccc-ccccCCCcc-cccccceeccCCceEEEEEeCCCc---hhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEee
Confidence            555 333334444 34 355567899999999876543   335678889999999999999999999999999999999


Q ss_pred             ccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCceeccCCCCCEEeccCCCEEEEeccCCCCCccccCCCcc
Q 014609           95 YVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHN-KGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLL  173 (421)
Q Consensus        95 ~~~gg~L~~~i~~~~~~~~~~~~~~~~ql~~aL~~LH~-~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~  173 (421)
                      .+.  .|..++.+.   ........+.||+.||.|||+ .+++|++|.-..|+++..|.+||++|.++........  ..
T Consensus        90 rV~--Pl~~~lk~l---~~~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~--~~  162 (690)
T KOG1243|consen   90 RVR--PLETVLKEL---GKEEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA--PA  162 (690)
T ss_pred             ccc--cHHHHHHHh---HHHHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc--cc
Confidence            984  455566653   366667778999999999985 5899999999999999999999999998864332211  12


Q ss_pred             ccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhhcCC-------cCCCCCCCHHHHHHHHHhcCCCCCCCCCHH---
Q 014609          174 HTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIFRGD-------FKLPKWLSPGAQNLLRKILEPNPVKRITIA---  243 (421)
Q Consensus       174 ~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~~~~-------~~~p~~~s~~~~~li~~~L~~dP~~R~t~~---  243 (421)
                      +...---.|..|+.+....   -..|.|.|||+++.+.+.       ...+..++.....+..+-+.-.+..||...   
T Consensus       163 ~~~~~~~s~~~P~~~~~s~---~s~D~~~Lg~li~el~ng~~~~~~~~~~~~~ipk~~~~~~~k~~~~~~~~r~n~~~~~  239 (690)
T KOG1243|consen  163 KSLYLIESFDDPEEIDPSE---WSIDSWGLGCLIEELFNGSLLTKTDLSNTGKIPKALIELYCKKLGATELKRPNKLRFI  239 (690)
T ss_pred             ccchhhhcccChhhcCccc---cchhhhhHHHHHHHHhCcccCcchhhhccCccchhHHHHHHHHhccccccccchhhHH
Confidence            2222333577777654333   347999999999966554       223344665666666566666666666632   


Q ss_pred             --hhhcCcccccccc
Q 014609          244 --GIKADEWFEQDYT  256 (421)
Q Consensus       244 --eil~~~w~~~~~~  256 (421)
                        -.+-|.||++.+.
T Consensus       240 ~~~~~~~gff~n~fv  254 (690)
T KOG1243|consen  240 LECRLLGGFFRNDFV  254 (690)
T ss_pred             HHHHhccccccchHH
Confidence              2344888887653

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.50  E-value=7.7e-14  Score=122.83  Aligned_cols=128  Identities=18%  Similarity=0.238  Sum_probs=97.4

Q ss_pred             eceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCc-ceEEEEEEeCCEEEEEEeccC
Q 014609           19 GRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNV-VRLHEVLASKSKIYMVLEYVT   97 (421)
Q Consensus        19 ~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnI-v~l~~~~~~~~~~~lv~E~~~   97 (421)
                      ++.|+.|.++.||.+..  .+..|++|+......    ....+.+|+.+++.+.+.++ .+++.+..  ...++||||++
T Consensus         3 ~~~l~~G~~~~vy~~~~--~~~~~~lK~~~~~~~----~~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~~~lv~e~i~   74 (170)
T cd05151           3 ISPLKGGMTNKNYRVEV--ANKKYVVRIPGNGTE----LLINRENEAENSKLAAEAGIGPKLYYFDP--ETGVLITEFIE   74 (170)
T ss_pred             eeecCCcccCceEEEEE--CCeEEEEEeCCCCcc----cccCHHHHHHHHHHHHHhCCCCceEEEeC--CCCeEEEEecC
Confidence            46789999999999985  478899998754321    12346789999999876554 44554433  33579999999


Q ss_pred             CCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCc-----eeccCCCCCEEeccCCCEEEEeccCCCC
Q 014609           98 GGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGV-----FHRDLKLENILLDSKGNIKISDFGLSAL  163 (421)
Q Consensus        98 gg~L~~~i~~~~~~~~~~~~~~~~ql~~aL~~LH~~gi-----~HrDlkp~NILl~~~~~~kL~DFGla~~  163 (421)
                      |.++.+.        ......++.+++.+|+.||+.++     +|+|++|.||+++ ++.++++|||.+..
T Consensus        75 G~~l~~~--------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~  136 (170)
T cd05151          75 GSELLTE--------DFSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM  136 (170)
T ss_pred             CCccccc--------cccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence            9887543        11123467899999999999985     9999999999998 67899999999873

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>PF03822 NAF: NAF domain; InterPro: IPR004041 The NAF domain is a 24 amino acid domain that is found in a plant-specific subgroup of serine-threonine protein kinases (CIPKs), that interact with calcineurin B-like calcium sensor proteins (CBLs)

Probab=99.49  E-value=3.6e-14  Score=101.50  Aligned_cols=60  Identities=47%  Similarity=0.866  Sum_probs=48.3

Q ss_pred             CCccchhhhhccccccccCCCcccccc--ccceeeEEecCCHHHHHHHHHHHHHhcCcEEEE
Q 014609          290 PPLINAFQLIGMSSCLDLSGFFEKEDV--SERKIRFTSNHSAKDLLERIEDIVTEMGFRVQK  349 (421)
Q Consensus       290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~f~s~~~~~~i~~~l~~~~~~~~~~~~~  349 (421)
                      |..+|||++|++|+|+|||++|+....  .++.+||+|..++++|+++||++++.+|++|++
T Consensus         2 p~~lNAFdiIS~S~G~DLSgLFe~~~~~~~~~~~RF~S~~~~~~Ii~klEe~a~~~~~~V~K   63 (63)
T PF03822_consen    2 PKSLNAFDIISLSSGFDLSGLFEEKDKSSVKRETRFTSKEPASEIIEKLEEIAKKLGFRVKK   63 (63)
T ss_dssp             -EE--HHHHHCTSTTTSCGGGGGCG-S-SS---EEEEESS-HHHHHHHHHHHHHHTTEEEEE
T ss_pred             CccccHHHHHHhccCCChHHhcCccccccccccceEecCCCHHHHHHHHHHHHHhcCceeeC
Confidence            567999999999999999999986543  468899999999999999999999999999975

Whereas the N-terminal part of CIPKs comprises a conserved catalytic domain typical of Ser-Thr kinases, the much less conserved C-terminal domain appears to be unique to this subgroup of kinases. The only exception is the NAF domain that forms an 'island of conservation' in this otherwise variable region. The NAF domain has been named after the prominent conserved amino acids Asn-Ala-Phe. It represents a minimum protein interaction module that is both necessary and sufficient to mediate the interaction with the CBL calcium sensor proteins []. The secondary structure of the NAF domain is currently not known, but secondary structure computation of the C-terminal region of Arabidopsis thaliana CBL-interacting protein kinase 1 revealed a long helical structure [].; GO: 0007165 signal transduction; PDB: 2ZFD_B 2EHB_D.

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.49  E-value=3.3e-14  Score=142.94  Aligned_cols=235  Identities=22%  Similarity=0.213  Sum_probs=181.0

Q ss_pred             ceEEeceEee--cCcEEEEEEEE--CCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCC-CCCcceEEEEEEeCCEE
Q 014609           15 RYELGRTLGE--GNFGKVKFAQD--LDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK-HPNVVRLHEVLASKSKI   89 (421)
Q Consensus        15 ~y~i~~~LG~--G~~g~V~~a~~--~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~~   89 (421)
                      .+.+.+.+|.  |.+|.||.+..  ..++..+|+|.-+.... ......+=.+|+...+.++ |+|.++.+..++..+..
T Consensus       115 ~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s-~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~l  193 (524)
T KOG0601|consen  115 RFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFS-PPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGIL  193 (524)
T ss_pred             hcccccccccCCCCCceeecccCCcccCCcccccccccCCCC-CccccccccchhhcccccCccccccccCcccccCCcc
Confidence            5677889999  99999999988  78999999997322111 0111223345666667774 99999999999999999


Q ss_pred             EEEEeccCCCChHHHHHhcCC-CCHHHHHHHHHHHHH----HHHHHHhCCceeccCCCCCEEeccC-CCEEEEeccCCCC
Q 014609           90 YMVLEYVTGGELFDKIASKGR-LQEAEGRKLFQQLID----GVSYCHNKGVFHRDLKLENILLDSK-GNIKISDFGLSAL  163 (421)
Q Consensus        90 ~lv~E~~~gg~L~~~i~~~~~-~~~~~~~~~~~ql~~----aL~~LH~~gi~HrDlkp~NILl~~~-~~~kL~DFGla~~  163 (421)
                      |+-+|++ |.+|..+...... +++..++..+.+..+    ||.++|+.+++|-|+||+||....+ ...+++|||+...
T Consensus       194 fiqtE~~-~~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~~~s~~~~df~~v~~  272 (524)
T KOG0601|consen  194 FIQTELC-GESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTSDWTSCKLTDFGLVSK  272 (524)
T ss_pred             eeeeccc-cchhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheecccccceeecCCcceeEE
Confidence            9999999 5788888876554 899999999999999    9999999999999999999999999 7899999999875


Q ss_pred             CccccCCC---ccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhhcC------------CcCCCC---------C
Q 014609          164 PQHFRDDG---LLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIFRG------------DFKLPK---------W  219 (421)
Q Consensus       164 ~~~~~~~~---~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~~~------------~~~~p~---------~  219 (421)
                      .....-..   ......|...|++||...+. + +...|++|+|.+...-..            -.++..         .
T Consensus       273 i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l-~-~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ip~e~~~~  350 (524)
T KOG0601|consen  273 ISDGNFSSVFKVSKRPEGDCIYAAKELLNGL-A-TFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGYIPLEFCEG  350 (524)
T ss_pred             ccCCccccceeeeecCCCCceEeChhhhccc-c-chHhhhcchhhhhHhhHhhcccccCCCCCCccccccccCchhhhcC
Confidence            54322111   12223577789999987654 3 578999999987762110            111111         1


Q ss_pred             CCHHHHHHHHHhcCCCCCCCCCHHhhhcCccccc
Q 014609          220 LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQ  253 (421)
Q Consensus       220 ~s~~~~~li~~~L~~dP~~R~t~~eil~~~w~~~  253 (421)
                      .+..+...+..|++.+|-.|++...+++|++...
T Consensus       351 ~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s  384 (524)
T KOG0601|consen  351 GSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHS  384 (524)
T ss_pred             cchhhhhHHHHhcCcchhhhhHHHHHhccccccc
Confidence            3566777999999999999999999999999874

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.43  E-value=1.2e-13  Score=138.90  Aligned_cols=237  Identities=21%  Similarity=0.193  Sum_probs=180.0

Q ss_pred             eeecceEEeceEeecCcEEEEEEEEC-CCCceEEEEEeecccccchhHHHHHHHHHHHHhcC-CCCCcceEEEEEEeCCE
Q 014609           11 MRLGRYELGRTLGEGNFGKVKFAQDL-DSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEVLASKSK   88 (421)
Q Consensus        11 ~~~~~y~i~~~LG~G~~g~V~~a~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~   88 (421)
                      ..+++|.++..||.|.|+.|+..... .++..|++|.+.+........ ..-..|+-+...+ .|.+++.++..+.....
T Consensus       262 ~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~d-i~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~  340 (524)
T KOG0601|consen  262 CKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASD-IFSLGEVILEAILGSHLPSVGKNSSWSQLRQ  340 (524)
T ss_pred             eecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhh-hcchhhhhHhhHhhcccccCCCCCCcccccc
Confidence            45688999999999999999988655 688899999886654433322 2234566666666 59999999999988888


Q ss_pred             EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccC-CCEEEEeccCCCCCccc
Q 014609           89 IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSK-GNIKISDFGLSALPQHF  167 (421)
Q Consensus        89 ~~lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~-~~~kL~DFGla~~~~~~  167 (421)
                      .|+-.|||.++++...+.....+++...+++..|++.++.++|+..++|+|+||+||++..+ +.-++.|||..+-....
T Consensus       341 ~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~~~  420 (524)
T KOG0601|consen  341 GYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDGFFSKLGDFGCWTRLAFS  420 (524)
T ss_pred             ccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccchhhhhcccccccccccee
Confidence            89999999999887776555668889999999999999999999999999999999999886 78899999998731110


Q ss_pred             cCCCccccccCCCCcc-ChhhhcccCCCCCcchHHHHHHHHhh-----------------hcCCcCCCCCCCHHHHHHHH
Q 014609          168 RDDGLLHTTCGSPNYV-APEVLANRGYDGATSDIWSCGVILYI-----------------FRGDFKLPKWLSPGAQNLLR  229 (421)
Q Consensus       168 ~~~~~~~~~~gt~~y~-APEvl~~~~~~~~~~DiwSlGvil~~-----------------~~~~~~~p~~~s~~~~~li~  229 (421)
                           .....++-.+. .+|++........++|++|||.-++.                 ..|..+..+..+..++.+.+
T Consensus       421 -----~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~~~~i~~~~~p~~~~~~~~~q~~~k  495 (524)
T KOG0601|consen  421 -----SGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQSLTIRSGDTPNLPGLKLQLQVLLK  495 (524)
T ss_pred             -----cccccccccccccchhhccccccccccccccccccccccccCcccCcccccceeeecccccCCCchHHhhhhhhh
Confidence                 01111222333 35555444444689999999977763                 33444444555688899999


Q ss_pred             HhcCCCCCCCCCHHhhhcCccccc
Q 014609          230 KILEPNPVKRITIAGIKADEWFEQ  253 (421)
Q Consensus       230 ~~L~~dP~~R~t~~eil~~~w~~~  253 (421)
                      .+..+++..|+.+.++..|.-|..
T Consensus       496 v~~~~~~~~~~l~~~l~~~~~~~~  519 (524)
T KOG0601|consen  496 VMINPDRKRRPSAVELSLHSEFYR  519 (524)
T ss_pred             hhcCCccccchhhhhhcccchhhh
Confidence            999999999999999888776654

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.34  E-value=1.6e-11  Score=107.21  Aligned_cols=134  Identities=25%  Similarity=0.322  Sum_probs=102.6

Q ss_pred             ceEeecCcEEEEEEEECCCCceEEEEEeecccccchhH-----HHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEEe
Q 014609           20 RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKI-----TDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLE   94 (421)
Q Consensus        20 ~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~-----~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E   94 (421)
                      ..+++|+-+.+|.+..  -|..+++|.=.+....+...     .++..+|..++.+++--+|...+=+..+.....|+||
T Consensus         2 ~~i~~GAEa~i~~~~~--~g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me   79 (204)
T COG3642           2 DLIKQGAEAIIYLTDF--LGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVME   79 (204)
T ss_pred             chhhCCcceeEEeeec--cCcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEE
Confidence            4678999999999864  45557777644444433332     2456789999999887676666666667777889999


Q ss_pred             ccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCC
Q 014609           95 YVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSAL  163 (421)
Q Consensus        95 ~~~gg~L~~~i~~~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~  163 (421)
                      |++|..|.+.+...       ...+++.+=..+.-||..||+|+||.++||++...+ +.++||||+..
T Consensus        80 ~I~G~~lkd~l~~~-------~~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~~~-i~~IDfGLg~~  140 (204)
T COG3642          80 YIEGELLKDALEEA-------RPDLLREVGRLVGKLHKAGIVHGDLTTSNIILSGGR-IYFIDFGLGEF  140 (204)
T ss_pred             EeCChhHHHHHHhc-------chHHHHHHHHHHHHHHhcCeecCCCccceEEEeCCc-EEEEECCcccc
Confidence            99998888888764       244566677777889999999999999999996554 99999999984

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.31  E-value=2.6e-12  Score=120.37  Aligned_cols=186  Identities=20%  Similarity=0.305  Sum_probs=133.3

Q ss_pred             HHhcCCCCCcceEEEEEEeC-----CEEEEEEeccCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC--Cc
Q 014609           67 TLKLLKHPNVVRLHEVLASK-----SKIYMVLEYVTGGELFDKIAS----KGRLQEAEGRKLFQQLIDGVSYCHNK--GV  135 (421)
Q Consensus        67 il~~l~hpnIv~l~~~~~~~-----~~~~lv~E~~~gg~L~~~i~~----~~~~~~~~~~~~~~ql~~aL~~LH~~--gi  135 (421)
                      -+-.+-|.||++++.++.+.     .+..++.||+..|++..++.+    ...+....+++|+-||++||.|||+.  -|
T Consensus       120 nllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~Ppi  199 (458)
T KOG1266|consen  120 NLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPPI  199 (458)
T ss_pred             HHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCcc
Confidence            34556799999999998544     458899999999999988864    34688899999999999999999998  59


Q ss_pred             eeccCCCCCEEeccCCCEEEEeccCCCCCccccC--CCccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhhc-C
Q 014609          136 FHRDLKLENILLDSKGNIKISDFGLSALPQHFRD--DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIFR-G  212 (421)
Q Consensus       136 ~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~--~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~~-~  212 (421)
                      +|+++.-..|++..+|-+|+.--.....-.....  ........+-++|.|||.=..... ..++|||++|.....+. +
T Consensus       200 ihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~-~~a~dIy~fgmcAlemail  278 (458)
T KOG1266|consen  200 IHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNT-TGASDIYKFGMCALEMAIL  278 (458)
T ss_pred             ccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCccccc-ccchhhhhhhHHHHHHHHh
Confidence            9999999999999999998853222221111100  011122346789999996443333 35799999996655321 1


Q ss_pred             CcCCC---------CC-------C-CHHHHHHHHHhcCCCCCCCCCHHhhhcCccccc
Q 014609          213 DFKLP---------KW-------L-SPGAQNLLRKILEPNPVKRITIAGIKADEWFEQ  253 (421)
Q Consensus       213 ~~~~p---------~~-------~-s~~~~~li~~~L~~dP~~R~t~~eil~~~w~~~  253 (421)
                      ....-         ..       + .+--++++.+||+..|..||++.+++.||.+-+
T Consensus       279 Eiq~tnseS~~~~ee~ia~~i~~len~lqr~~i~kcl~~eP~~rp~ar~llfHpllfe  336 (458)
T KOG1266|consen  279 EIQSTNSESKVEVEENIANVIIGLENGLQRGSITKCLEGEPNGRPDARLLLFHPLLFE  336 (458)
T ss_pred             eeccCCCcceeehhhhhhhheeeccCccccCcCcccccCCCCCCcchhhhhcCceeee
Confidence            11100         00       1 123357899999999999999999999998654

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=99.30  E-value=1.6e-11  Score=112.59  Aligned_cols=140  Identities=23%  Similarity=0.341  Sum_probs=106.9

Q ss_pred             ceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCC--CCcceEEEEEEeCC---EEEEEEe
Q 014609           20 RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKH--PNVVRLHEVLASKS---KIYMVLE   94 (421)
Q Consensus        20 ~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~h--pnIv~l~~~~~~~~---~~~lv~E   94 (421)
                      +.||.|..+.||++... +|+.+++|+.......  .....+.+|.++++.+++  .++.+++.+.....   ..|+|||
T Consensus         4 ~~l~~G~~n~~~~v~~~-~g~~~ilK~~~~~~~~--~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e   80 (223)
T cd05154           4 RQLSGGQSNLTYLLTAG-GGRRLVLRRPPPGALL--PSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVME   80 (223)
T ss_pred             eecCCCccceEEEEEec-CCcceEEEeCCCcccC--cccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEE
Confidence            67899999999999863 4689999997654321  124578899999999976  44677887776543   6789999


Q ss_pred             ccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh------------------------------------------
Q 014609           95 YVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHN------------------------------------------  132 (421)
Q Consensus        95 ~~~gg~L~~~i~~~~~~~~~~~~~~~~ql~~aL~~LH~------------------------------------------  132 (421)
                      |++|.++.+.+.. ..+++.....++.+++.+|..||+                                          
T Consensus        81 ~i~G~~l~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (223)
T cd05154          81 RVDGRVLRDRLLR-PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMER  159 (223)
T ss_pred             EeCCEecCCCCCC-CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHH
Confidence            9999888665432 346677777777788777777773                                          


Q ss_pred             --------------CCceeccCCCCCEEecc--CCCEEEEeccCCCC
Q 014609          133 --------------KGVFHRDLKLENILLDS--KGNIKISDFGLSAL  163 (421)
Q Consensus       133 --------------~gi~HrDlkp~NILl~~--~~~~kL~DFGla~~  163 (421)
                                    ..++|+|++|.||+++.  ++.+.|+||+.+..
T Consensus       160 ~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~  206 (223)
T cd05154         160 LLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL  206 (223)
T ss_pred             HHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence                          24699999999999998  56689999998873

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.29  E-value=7e-11  Score=102.85  Aligned_cols=145  Identities=21%  Similarity=0.242  Sum_probs=110.6

Q ss_pred             EeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhH-----HHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEE
Q 014609           18 LGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKI-----TDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMV   92 (421)
Q Consensus        18 i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~-----~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv   92 (421)
                      .+..|-+|+-+.|+.+.  ..|+...||.=......+...     ..+..+|+++|.++.--+|.-..-++.+...-.++
T Consensus        11 ~l~likQGAEArv~~~~--~~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~   88 (229)
T KOG3087|consen   11 SLELIKQGAEARVPRGS--FSGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIY   88 (229)
T ss_pred             cceeeeccceeeEeeec--cCCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEE
Confidence            56789999999999997  478888888654434333322     35678899999998866766655566666777899


Q ss_pred             EeccCC-CChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCC---CEEEEeccCCCCC
Q 014609           93 LEYVTG-GELFDKIASKG--RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKG---NIKISDFGLSALP  164 (421)
Q Consensus        93 ~E~~~g-g~L~~~i~~~~--~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~---~~kL~DFGla~~~  164 (421)
                      |||++| .++.+++....  ...+.....+++++=+.+.-||.++|+|+||..+||+|..+|   .+.++|||++...
T Consensus        89 ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~s  166 (229)
T KOG3087|consen   89 MEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILIDFGLSSVS  166 (229)
T ss_pred             EEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEEEeecchhcc
Confidence            999987 36667665432  233334478899999999999999999999999999997766   3589999998753

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=99.14  E-value=3.8e-10  Score=101.03  Aligned_cols=127  Identities=29%  Similarity=0.383  Sum_probs=84.5

Q ss_pred             EEEEEEECCCCceEEEEEeecccc-----------------------cchhHHHHHHHHHHHHhcCCCC--CcceEEEEE
Q 014609           29 KVKFAQDLDSGLPFAVKILEKNRI-----------------------IHLKITDQIKREIATLKLLKHP--NVVRLHEVL   83 (421)
Q Consensus        29 ~V~~a~~~~~~~~vAvK~i~~~~~-----------------------~~~~~~~~~~~Ei~il~~l~hp--nIv~l~~~~   83 (421)
                      .||.|.. ..|..+|||+.+....                       ..........+|.+.|.++..-  ++.+++++.
T Consensus         1 ~Vy~~~~-~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~   79 (188)
T PF01163_consen    1 DVYHAID-PDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN   79 (188)
T ss_dssp             EEEEEEE-CTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE
T ss_pred             CEEEEEC-CCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe
Confidence            4899986 5788999999864211                       0011124578899999999865  466676553


Q ss_pred             EeCCEEEEEEeccC--CCChHHHHHhcCCCCHHHHHHHHHHHHHHHHH-HHhCCceeccCCCCCEEeccCCCEEEEeccC
Q 014609           84 ASKSKIYMVLEYVT--GGELFDKIASKGRLQEAEGRKLFQQLIDGVSY-CHNKGVFHRDLKLENILLDSKGNIKISDFGL  160 (421)
Q Consensus        84 ~~~~~~~lv~E~~~--gg~L~~~i~~~~~~~~~~~~~~~~ql~~aL~~-LH~~gi~HrDlkp~NILl~~~~~~kL~DFGl  160 (421)
                          ..++||||++  |..+......  .++.+....++.+++..+.. +|+.||+|+||.+.|||++++ .+.++|||.
T Consensus        80 ----~~~ivME~I~~~G~~~~~l~~~--~~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~~~-~~~iIDf~q  152 (188)
T PF01163_consen   80 ----RNVIVMEYIGEDGVPLPRLKDV--DLSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVDDG-KVYIIDFGQ  152 (188)
T ss_dssp             ----TTEEEEE--EETTEEGGCHHHC--GGGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEETT-CEEE--GTT
T ss_pred             ----CCEEEEEecCCCccchhhHHhc--cccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEeecc-eEEEEecCc
Confidence                2369999998  6555443322  22255677788888886665 579999999999999999877 999999998


Q ss_pred             CCC
Q 014609          161 SAL  163 (421)
Q Consensus       161 a~~  163 (421)
                      +..
T Consensus       153 av~  155 (188)
T PF01163_consen  153 AVD  155 (188)
T ss_dssp             EEE
T ss_pred             cee
Confidence            863

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.12  E-value=5.2e-11  Score=121.72  Aligned_cols=133  Identities=24%  Similarity=0.405  Sum_probs=103.7

Q ss_pred             HHHHHHHHHHhC-CceeccCCCCCEEeccCCCEEEEeccCCCCCccc-------cCCCccccccCCCCccChhhhcccCC
Q 014609          122 QLIDGVSYCHNK-GVFHRDLKLENILLDSKGNIKISDFGLSALPQHF-------RDDGLLHTTCGSPNYVAPEVLANRGY  193 (421)
Q Consensus       122 ql~~aL~~LH~~-gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~-------~~~~~~~~~~gt~~y~APEvl~~~~~  193 (421)
                      +++.|+.|+|.. +++|++|.|++|.++.+|.+||+.|+++......       .+............|.|||++.... 
T Consensus       107 ~v~dgl~flh~sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~~~-  185 (700)
T KOG2137|consen  107 NVADGLAFLHRSAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLGTT-  185 (700)
T ss_pred             cccchhhhhccCcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcccc-
Confidence            445999999987 8999999999999999999999999987643220       0111111123456899999988744 


Q ss_pred             CCCcchHHHHHHHHhhhc-CC------------------------cCCCCCCCHHHHHHHHHhcCCCCCCCCCHHhhhcC
Q 014609          194 DGATSDIWSCGVILYIFR-GD------------------------FKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKAD  248 (421)
Q Consensus       194 ~~~~~DiwSlGvil~~~~-~~------------------------~~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~~  248 (421)
                      .+.++|++|+||++|... ++                        +..+..+++++++-+.++|..++.-||++.++...
T Consensus       186 ~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~~~~~~~~~~s~~~p~el~~~l~k~l~~~~~~rp~~~~l~~~  265 (700)
T KOG2137|consen  186 NTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRNLLNAGAFGYSNNLPSELRESLKKLLNGDSAVRPTLDLLLSI  265 (700)
T ss_pred             ccccccceeeeeEEEEEecCCcchhhccCCcchhhhhhcccccccccccccCcHHHHHHHHHHhcCCcccCcchhhhhcc
Confidence            468899999999999322 21                        22345689999999999999999999999999999


Q ss_pred             ccccccc
Q 014609          249 EWFEQDY  255 (421)
Q Consensus       249 ~w~~~~~  255 (421)
                      |||....
T Consensus       266 ~ff~D~~  272 (700)
T KOG2137|consen  266 PFFSDPG  272 (700)
T ss_pred             cccCCch
Confidence            9998754

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=99.10  E-value=5.1e-10  Score=103.45  Aligned_cols=136  Identities=26%  Similarity=0.381  Sum_probs=104.9

Q ss_pred             EEeceEeecCcEEEEEEEECCCCceEEEEEeecccc---------------cch----hHHHHHHHHHHHHhcCCCC--C
Q 014609           17 ELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRI---------------IHL----KITDQIKREIATLKLLKHP--N   75 (421)
Q Consensus        17 ~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~---------------~~~----~~~~~~~~Ei~il~~l~hp--n   75 (421)
                      .++..||-|--|.||.|.+ ..|..+|||.-+....               .+.    -.....++|.++|.+|...  .
T Consensus        94 ~iG~~IGvGKEsdVY~~~~-~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~  172 (304)
T COG0478          94 AIGTKIGVGKESDVYVAID-PKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK  172 (304)
T ss_pred             hhccccccCccceEEEEEC-CCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence            5678999999999999997 4799999997643211               000    0124578999999999754  6


Q ss_pred             cceEEEEEEeCCEEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEE
Q 014609           76 VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKI  155 (421)
Q Consensus        76 Iv~l~~~~~~~~~~~lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL  155 (421)
                      |.+.+++    +...+||||++|-.|...     +++.+.+..++..|+.-+.-+-..||+|+|+++-||+++++|.+.+
T Consensus       173 VP~P~~~----nRHaVvMe~ieG~eL~~~-----r~~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV~~dg~~~v  243 (304)
T COG0478         173 VPKPIAW----NRHAVVMEYIEGVELYRL-----RLDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILVTEDGDIVV  243 (304)
T ss_pred             CCCcccc----ccceeeeehcccceeecc-----cCcccCHHHHHHHHHHHHHHHHHcCccccCCchheEEEecCCCEEE
Confidence            7777764    667899999999877542     2245566667777777777767899999999999999999999999


Q ss_pred             EeccCCC
Q 014609          156 SDFGLSA  162 (421)
Q Consensus       156 ~DFGla~  162 (421)
                      +||-.+.
T Consensus       244 IDwPQ~v  250 (304)
T COG0478         244 IDWPQAV  250 (304)
T ss_pred             EeCcccc
Confidence            9998765

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=99.07  E-value=3.1e-09  Score=100.62  Aligned_cols=132  Identities=16%  Similarity=0.103  Sum_probs=93.8

Q ss_pred             EEEEEEECCCCceEEEEEeecccccc---h-----hHHHHHHHHHHHHhcCCCCCc--ceEEEEEEe-----CCEEEEEE
Q 014609           29 KVKFAQDLDSGLPFAVKILEKNRIIH---L-----KITDQIKREIATLKLLKHPNV--VRLHEVLAS-----KSKIYMVL   93 (421)
Q Consensus        29 ~V~~a~~~~~~~~vAvK~i~~~~~~~---~-----~~~~~~~~Ei~il~~l~hpnI--v~l~~~~~~-----~~~~~lv~   93 (421)
                      .|..+.  -.|+.|.||.........   .     .-...+.+|...+.+|..-+|  +.++.+.+.     ...-++||
T Consensus        37 rvvr~~--~~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVt  114 (268)
T PRK15123         37 RTLRFE--LAGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIIT  114 (268)
T ss_pred             eEEEEE--ECCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEE
Confidence            344543  356788888663322100   0     001247889999888854333  334444433     23578999


Q ss_pred             eccCCC-ChHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecc-------CCCEEEEeccCCC
Q 014609           94 EYVTGG-ELFDKIAS--KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDS-------KGNIKISDFGLSA  162 (421)
Q Consensus        94 E~~~gg-~L~~~i~~--~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~-------~~~~kL~DFGla~  162 (421)
                      |++++. +|.+++..  ..+.++.....++.+++..+.-||+.||+|+|++|.|||++.       ++.+.|+||+.+.
T Consensus       115 e~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~  193 (268)
T PRK15123        115 EDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQ  193 (268)
T ss_pred             eeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceEEEEECCccc
Confidence            999886 78888753  345667788899999999999999999999999999999975       4579999999886

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=99.05  E-value=3.5e-09  Score=105.12  Aligned_cols=198  Identities=21%  Similarity=0.234  Sum_probs=149.5

Q ss_pred             cEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEe----CCEEEEEEeccCC-CCh
Q 014609           27 FGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLAS----KSKIYMVLEYVTG-GEL  101 (421)
Q Consensus        27 ~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~----~~~~~lv~E~~~g-g~L  101 (421)
                      -.+.|++....+|..|++|.++..+....   ...-.-+++++++.|+|||++.+++.+    +..+++|++|.++ ++|
T Consensus       289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~---nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL  365 (655)
T KOG3741|consen  289 SITTYKATSNVDGNAYVLKRLHGDRDQST---NKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTL  365 (655)
T ss_pred             cceeEeeeeccCCceeeeeeeccccccCc---ccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchH
Confidence            46789999889999999999955443332   122334778999999999999999863    4579999999986 467


Q ss_pred             HHHHHh---------------cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCcc
Q 014609          102 FDKIAS---------------KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQH  166 (421)
Q Consensus       102 ~~~i~~---------------~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~  166 (421)
                      .++.-.               ....++...|.|+.||..||.++|+.|+.-+-|.|.+||++.+-+++|+..|...+...
T Consensus       366 ~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~  445 (655)
T KOG3741|consen  366 YDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVTGKMRIRISGCGIMDVLQE  445 (655)
T ss_pred             HHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEeeCcceEEEecccceeeecC
Confidence            776421               22478899999999999999999999999999999999999888999988887765433


Q ss_pred             ccCCCccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhhcCCcCC---------------CCCCCHHHHHHHHHh
Q 014609          167 FRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIFRGDFKL---------------PKWLSPGAQNLLRKI  231 (421)
Q Consensus       167 ~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~~~~~~~---------------p~~~s~~~~~li~~~  231 (421)
                      ..              .+|  +.+.    .+-|.=.||.+++.+..+..-               -...|.+++++|.-+
T Consensus       446 d~--------------~~~--le~~----Qq~D~~~lG~ll~aLAt~~~ns~~~d~~~~s~~~~I~~~yS~D~rn~v~yl  505 (655)
T KOG3741|consen  446 DP--------------TEP--LESQ----QQNDLRDLGLLLLALATGTENSNRTDSTQSSHLTRITTTYSTDLRNVVEYL  505 (655)
T ss_pred             CC--------------Ccc--hhHH----hhhhHHHHHHHHHHHhhcccccccccchHHHHHHHhhhhhhHHHHHHHHHH
Confidence            11              111  2221    346888999999966544221               123688899999998


Q ss_pred             cCCCCCCCCCHHhhhcC
Q 014609          232 LEPNPVKRITIAGIKAD  248 (421)
Q Consensus       232 L~~dP~~R~t~~eil~~  248 (421)
                      ..-++++ -++.+++.+
T Consensus       506 ~s~~~~~-ksI~~llp~  521 (655)
T KOG3741|consen  506 ESLNFRE-KSIQDLLPM  521 (655)
T ss_pred             HhcCccc-ccHHHHHHH
Confidence            8888886 677777654

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.93  E-value=2.8e-08  Score=90.77  Aligned_cols=105  Identities=23%  Similarity=0.378  Sum_probs=85.1

Q ss_pred             HHHHHHHHHHhcCCCCC--cceEEEEEEeC----CEEEEEEeccCCC-ChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH
Q 014609           59 DQIKREIATLKLLKHPN--VVRLHEVLASK----SKIYMVLEYVTGG-ELFDKIASKGRLQEAEGRKLFQQLIDGVSYCH  131 (421)
Q Consensus        59 ~~~~~Ei~il~~l~hpn--Iv~l~~~~~~~----~~~~lv~E~~~gg-~L~~~i~~~~~~~~~~~~~~~~ql~~aL~~LH  131 (421)
                      ....+|...+.+|..-+  +.+.+.+.+..    ...++|+|+++|. +|.+.+......+......++.+++..++-||
T Consensus        56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~~~~~~~~~ll~~l~~~i~~lH  135 (206)
T PF06293_consen   56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQLDPSQRRELLRALARLIAKLH  135 (206)
T ss_pred             hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcccchhhHHHHHHHHHHHHHHHH
Confidence            46788888888875333  34555555442    2458999999885 78888876555778888999999999999999


Q ss_pred             hCCceeccCCCCCEEeccCC---CEEEEeccCCCC
Q 014609          132 NKGVFHRDLKLENILLDSKG---NIKISDFGLSAL  163 (421)
Q Consensus       132 ~~gi~HrDlkp~NILl~~~~---~~kL~DFGla~~  163 (421)
                      +.||+|+|++|.|||++.++   .+.|+||+-+..
T Consensus       136 ~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~  170 (206)
T PF06293_consen  136 DAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF  170 (206)
T ss_pred             HCcCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence            99999999999999999887   899999998774

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=98.77  E-value=9.3e-08  Score=87.75  Aligned_cols=140  Identities=21%  Similarity=0.209  Sum_probs=99.4

Q ss_pred             eceEeecCcEEEEEEEECCCCceEEEEEeecccccchhH---------------------HHHHHHHHHHHhcCC--CCC
Q 014609           19 GRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKI---------------------TDQIKREIATLKLLK--HPN   75 (421)
Q Consensus        19 ~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~---------------------~~~~~~Ei~il~~l~--hpn   75 (421)
                      ...|+.|--+.||+|.. .++..+|+|+.......-...                     ..-..+|..-|+++.  +-.
T Consensus        53 ~g~istGKEA~Vy~a~~-~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVr  131 (268)
T COG1718          53 VGCISTGKEANVYLAET-GDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVR  131 (268)
T ss_pred             EeeecCCcceEEEeecc-CCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCC
Confidence            34677788889999974 678999999986543211110                     112567888888885  444


Q ss_pred             cceEEEEEEeCCEEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCceeccCCCCCEEeccCCCEE
Q 014609           76 VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHN-KGVFHRDLKLENILLDSKGNIK  154 (421)
Q Consensus        76 Iv~l~~~~~~~~~~~lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~ql~~aL~~LH~-~gi~HrDlkp~NILl~~~~~~k  154 (421)
                      +.+.+.+..    -.+||||+.....-.-...+.++..+++..++.++++.+.-|-. .|++|+||+.-|||+. ++.+.
T Consensus       132 vP~Pi~~~~----nVLvMEfIg~~g~pAP~LkDv~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~~-~~~p~  206 (268)
T COG1718         132 VPEPIAFRN----NVLVMEFIGDDGLPAPRLKDVPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILVH-DGEPY  206 (268)
T ss_pred             CCCceeecC----CeEEEEeccCCCCCCCCcccCCcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheEEE-CCeEE
Confidence            555665543    35899999543111111122345555899999999999998876 8999999999999998 88999


Q ss_pred             EEeccCCCCC
Q 014609          155 ISDFGLSALP  164 (421)
Q Consensus       155 L~DFGla~~~  164 (421)
                      ++|||.|...
T Consensus       207 iID~~QaV~~  216 (268)
T COG1718         207 IIDVSQAVTI  216 (268)
T ss_pred             EEECcccccc
Confidence            9999998744

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=98.72  E-value=2e-07  Score=86.32  Aligned_cols=134  Identities=15%  Similarity=0.227  Sum_probs=86.2

Q ss_pred             ceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCC--cceEEEEEEeCCEEEEEEeccC
Q 014609           20 RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN--VVRLHEVLASKSKIYMVLEYVT   97 (421)
Q Consensus        20 ~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpn--Iv~l~~~~~~~~~~~lv~E~~~   97 (421)
                      ..||+|..+.||+.    .|..+++|......     ....+.+|.++++.+..-+  +.+.+++.+..+..++|||+++
T Consensus         7 ~~i~~G~t~~~y~~----~~~~~VlR~~~~~~-----~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~   77 (226)
T TIGR02172         7 TQTGEGGNGESYTH----KTGKWMLKLYNPGF-----DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIV   77 (226)
T ss_pred             eeecCCCCcceeEe----cCCCEEEEeCCCCC-----CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecC
Confidence            57899999999973    25567889875422     1356789999999986433  5778888888888899999999


Q ss_pred             CCC-hH--------------HH-------HHhc--CCCCHHH-HHHHHHHH----------HH-HHHHHHh----CCcee
Q 014609           98 GGE-LF--------------DK-------IASK--GRLQEAE-GRKLFQQL----------ID-GVSYCHN----KGVFH  137 (421)
Q Consensus        98 gg~-L~--------------~~-------i~~~--~~~~~~~-~~~~~~ql----------~~-aL~~LH~----~gi~H  137 (421)
                      |.. +.              ..       ++.-  ....... ...+..++          .. ..++|.+    ..++|
T Consensus        78 G~~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~H  157 (226)
T TIGR02172        78 GKRSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLH  157 (226)
T ss_pred             CccchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEe
Confidence            863 11              11       1110  0111111 11111111          11 1222221    24789


Q ss_pred             ccCCCCCEEeccCCCEEEEeccCCCC
Q 014609          138 RDLKLENILLDSKGNIKISDFGLSAL  163 (421)
Q Consensus       138 rDlkp~NILl~~~~~~kL~DFGla~~  163 (421)
                      +|+.|.||++++++ +.++||+.+..
T Consensus       158 gD~~~~Nii~~~~~-~~iIDwe~a~~  182 (226)
T TIGR02172       158 GDFQIGNLITSGKG-TYWIDLGDFGY  182 (226)
T ss_pred             cCCCCCcEEEcCCC-cEEEechhcCc
Confidence            99999999999888 99999998863

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=98.72  E-value=1e-07  Score=86.48  Aligned_cols=138  Identities=17%  Similarity=0.255  Sum_probs=91.0

Q ss_pred             cceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHH------HHHHHHHHHHhcCCC---CCcceEEEEEE
Q 014609           14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKIT------DQIKREIATLKLLKH---PNVVRLHEVLA   84 (421)
Q Consensus        14 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~------~~~~~Ei~il~~l~h---pnIv~l~~~~~   84 (421)
                      ++|.+.+.+-......|.+..  -+|+.+++|..+......+...      +...+.+..+.+++.   .....++-+.+
T Consensus        31 ~~~~~~kv~k~~~r~~ValIe--i~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~e  108 (229)
T PF06176_consen   31 NNYKIIKVFKNTKRNYVALIE--IDGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAAE  108 (229)
T ss_pred             CCceEEEeecCCCccEEEEEE--ECCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeeee
Confidence            578888888888877777665  4678899998764332111111      123344444444432   22333232222


Q ss_pred             -----eCCEEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEecc
Q 014609           85 -----SKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFG  159 (421)
Q Consensus        85 -----~~~~~~lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFG  159 (421)
                           -....+++|||++|.+|.+...    +++    .+...+++++.-+|+.|+.|+|.+|.|++++.+ .+++.||+
T Consensus       109 kk~~~~~~~~~ll~EYIeG~~l~d~~~----i~e----~~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~~~-~i~iID~~  179 (229)
T PF06176_consen  109 KKIFRYTSSYVLLMEYIEGVELNDIED----IDE----DLAEKIVEAIKQLHKHGFYHGDPHPGNFLVSNN-GIRIIDTQ  179 (229)
T ss_pred             eeeccceeEEEEEEEEecCeecccchh----cCH----HHHHHHHHHHHHHHHcCCccCCCCcCcEEEECC-cEEEEECc
Confidence                 2234668999999988866432    333    244567788999999999999999999999855 59999998


Q ss_pred             CCC
Q 014609          160 LSA  162 (421)
Q Consensus       160 la~  162 (421)
                      ...
T Consensus       180 ~k~  182 (229)
T PF06176_consen  180 GKR  182 (229)
T ss_pred             ccc
Confidence            765

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>PRK09902 hypothetical protein; Provisional

Probab=98.67  E-value=3.3e-07  Score=82.92  Aligned_cols=138  Identities=17%  Similarity=0.151  Sum_probs=98.0

Q ss_pred             eecCcEEEEEEEECCCCceEEEEEeecccc---cchhHHHHHHHHHHHHhcCCCCC--cceEEEEEE--eC--CEEEEEE
Q 014609           23 GEGNFGKVKFAQDLDSGLPFAVKILEKNRI---IHLKITDQIKREIATLKLLKHPN--VVRLHEVLA--SK--SKIYMVL   93 (421)
Q Consensus        23 G~G~~g~V~~a~~~~~~~~vAvK~i~~~~~---~~~~~~~~~~~Ei~il~~l~hpn--Iv~l~~~~~--~~--~~~~lv~   93 (421)
                      |+||.+.|+....  .|+.+=+|.-.....   ....-...+.+|+..+.+|..-+  +.+......  ..  -.-+||+
T Consensus        27 ~rgG~SgV~r~~~--~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVT  104 (216)
T PRK09902         27 RRNGMSGVQCVER--NGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVT  104 (216)
T ss_pred             CCCCcceEEEEEe--CCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEE
Confidence            4588888988763  344677776431110   00112467999999999886322  444442211  11  2468999


Q ss_pred             eccCC-CChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCC--EEEEeccCCC
Q 014609           94 EYVTG-GELFDKIASK--GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGN--IKISDFGLSA  162 (421)
Q Consensus        94 E~~~g-g~L~~~i~~~--~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~--~kL~DFGla~  162 (421)
                      |-+.| .+|.+++...  .+.++.....++.+++.+++-||+.|+.|+|+.+.||+++.+|.  ++++||.-+.
T Consensus       105 e~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r  178 (216)
T PRK09902        105 EDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSR  178 (216)
T ss_pred             EeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCCCeeEEEEEhhccc
Confidence            97754 5787777652  35677778899999999999999999999999999999987777  9999998765

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=98.63  E-value=7.6e-07  Score=86.87  Aligned_cols=213  Identities=18%  Similarity=0.224  Sum_probs=138.7

Q ss_pred             EEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcC-CCCCcce--------EEEEEEeCC
Q 014609           17 ELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVR--------LHEVLASKS   87 (421)
Q Consensus        17 ~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~--------l~~~~~~~~   87 (421)
                      ..++.||+|+-+.+|-.-.  -+.. +-|+..+......      .+-+..|... .||-+-.        +++-- ...
T Consensus        14 ~~gr~LgqGgea~ly~l~e--~~d~-VAKIYh~Pppa~~------aqk~a~la~~p~~p~~~~rvaWPqa~L~G~~-~~~   83 (637)
T COG4248          14 PPGRPLGQGGEADLYTLGE--VRDQ-VAKIYHAPPPAAQ------AQKVAELAATPDAPLLNYRVAWPQATLHGGR-RGK   83 (637)
T ss_pred             CCCccccCCccceeeecch--hhch-hheeecCCCchHH------HHHHHHhccCCCCcchhhhhcccHHHhhCCC-ccc
Confidence            3568899999999996542  2223 4488876543221      1122333333 4554322        11111 122


Q ss_pred             EEEEEEeccCCCChHHHH-Hh------cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccC
Q 014609           88 KIYMVLEYVTGGELFDKI-AS------KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGL  160 (421)
Q Consensus        88 ~~~lv~E~~~gg~L~~~i-~~------~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGl  160 (421)
                      .+.+.|..++|..--..+ ..      ..-..++-+.+..+.|+.+.+.||+.|..-+|++++|+|+.+++.+.|.|-..
T Consensus        84 ~iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~~~V~LVdsDs  163 (637)
T COG4248          84 VIGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDDSKVVLVDSDS  163 (637)
T ss_pred             eeEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecCceEEEEcccc
Confidence            377889988876432222 11      12367788899999999999999999999999999999999999999998543


Q ss_pred             CCCCccccCCCccccccCCCCccChhhhc-----ccCCCCCcchHHHHHHHHhhh-cC-C--------------------
Q 014609          161 SALPQHFRDDGLLHTTCGSPNYVAPEVLA-----NRGYDGATSDIWSCGVILYIF-RG-D--------------------  213 (421)
Q Consensus       161 a~~~~~~~~~~~~~~~~gt~~y~APEvl~-----~~~~~~~~~DiwSlGvil~~~-~~-~--------------------  213 (421)
                      -.+-   .+........|.+.|.+||.-.     +-.. ....|.|.||+++|.+ .| .                    
T Consensus       164 fqi~---~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r-~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~I  239 (637)
T COG4248         164 FQIN---ANGTLHLCPVGVSEFTPPELQTLPSFVGFER-TANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDI  239 (637)
T ss_pred             eeec---cCCceEecccCccccCCHHHhccccccccCC-CccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhh
Confidence            3321   1333444567899999999743     2222 3568999999999922 11 1                    


Q ss_pred             ----c-----------CCC---C--CCCHHHHHHHHHhcCC--CCCCCCCHH
Q 014609          214 ----F-----------KLP---K--WLSPGAQNLLRKILEP--NPVKRITIA  243 (421)
Q Consensus       214 ----~-----------~~p---~--~~s~~~~~li~~~L~~--dP~~R~t~~  243 (421)
                          |           +.|   +  .++++++.|..+|+..  ++.-|||++
T Consensus       240 a~g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~  291 (637)
T COG4248         240 AHGRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAK  291 (637)
T ss_pred             hcceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHH
Confidence                0           111   1  1689999999999975  466899965

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=98.56  E-value=7e-07  Score=82.14  Aligned_cols=137  Identities=26%  Similarity=0.324  Sum_probs=82.6

Q ss_pred             eceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCC--CcceEEEEE---EeCCEEEEEE
Q 014609           19 GRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP--NVVRLHEVL---ASKSKIYMVL   93 (421)
Q Consensus        19 ~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hp--nIv~l~~~~---~~~~~~~lv~   93 (421)
                      ++.|+.|..+.||++....  ..+++|.....     .....+.+|..+++.+...  .+.+++...   ......+++|
T Consensus         2 i~~l~~G~~n~~~~v~~~~--~~~vlK~~~~~-----~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~   74 (239)
T PF01636_consen    2 IRPLSGGFSNRVYRVTTDD--GRYVLKFYRPP-----DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLM   74 (239)
T ss_dssp             EEEEEESSSSEEEEEEETT--SEEEEEEESSH-----HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEE
T ss_pred             CccCCCCCeeeEEEEEECC--cEEEEEEeCCC-----CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEE
Confidence            4689999999999998644  58999987543     2356788999999888533  355666644   2334689999


Q ss_pred             eccCCCChHH----------------HH---Hhc----CCCCHHH------HHHH---------------HHHHHH-HHH
Q 014609           94 EYVTGGELFD----------------KI---ASK----GRLQEAE------GRKL---------------FQQLID-GVS  128 (421)
Q Consensus        94 E~~~gg~L~~----------------~i---~~~----~~~~~~~------~~~~---------------~~ql~~-aL~  128 (421)
                      ++++|..+..                .+   +..    .++....      ....               ...+.. .++
T Consensus        75 ~~i~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  154 (239)
T PF01636_consen   75 EYIPGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQ  154 (239)
T ss_dssp             EEESSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHH
T ss_pred             EEeccccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHH
Confidence            9999987766                11   111    1111100      0000               011222 233


Q ss_pred             HHHh-------CCceeccCCCCCEEec-cCCCEEEEeccCCC
Q 014609          129 YCHN-------KGVFHRDLKLENILLD-SKGNIKISDFGLSA  162 (421)
Q Consensus       129 ~LH~-------~gi~HrDlkp~NILl~-~~~~~kL~DFGla~  162 (421)
                      .+++       ..++|+|+.|.|||++ .++.+-|+||+.+.
T Consensus       155 ~~~~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~  196 (239)
T PF01636_consen  155 ELEALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAG  196 (239)
T ss_dssp             HHHHHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred             HHHhhhccCCCcEEEEeccccccceeeeccceeEEEecccce
Confidence            3332       3699999999999999 56667899999775

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=98.54  E-value=2.6e-07  Score=94.77  Aligned_cols=136  Identities=24%  Similarity=0.332  Sum_probs=92.4

Q ss_pred             ceEeecCcEEEEEEEECCCCceEEEEEeecccccc---------------------------hhHH----------HHHH
Q 014609           20 RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIH---------------------------LKIT----------DQIK   62 (421)
Q Consensus        20 ~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~---------------------------~~~~----------~~~~   62 (421)
                      ..|+.++-|.||.|+- .+|+.||||+.+..-...                           ....          -++.
T Consensus       131 ~PiAsASIaQVH~A~L-~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~  209 (517)
T COG0661         131 EPIASASIAQVHRAVL-KSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYR  209 (517)
T ss_pred             CchhhhhHhhheeEEe-cCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHH
Confidence            6789999999999985 569999999986521100                           0000          1245


Q ss_pred             HHHHHHhcCC-----CCCcceEEEEEEeCCEEEEEEeccCCCChHHHH--HhcCCCCHH-----HHHHHHHHHHHHHHHH
Q 014609           63 REIATLKLLK-----HPNVVRLHEVLASKSKIYMVLEYVTGGELFDKI--ASKGRLQEA-----EGRKLFQQLIDGVSYC  130 (421)
Q Consensus        63 ~Ei~il~~l~-----hpnIv~l~~~~~~~~~~~lv~E~~~gg~L~~~i--~~~~~~~~~-----~~~~~~~ql~~aL~~L  130 (421)
                      +|...+.+++     .|++.-..=+++-.+.-.++|||++|-.+.+..  .. .+.+..     .+..++.|+       
T Consensus       210 ~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~-~g~d~k~ia~~~~~~f~~q~-------  281 (517)
T COG0661         210 REAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS-AGIDRKELAELLVRAFLRQL-------  281 (517)
T ss_pred             HHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHh-cCCCHHHHHHHHHHHHHHHH-------
Confidence            5666555553     344433333344456678999999999887764  33 444422     223333333       


Q ss_pred             HhCCceeccCCCCCEEeccCCCEEEEeccCCCCC
Q 014609          131 HNKGVFHRDLKLENILLDSKGNIKISDFGLSALP  164 (421)
Q Consensus       131 H~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~  164 (421)
                      =..|+.|.|.+|.||+++.+|.+.+.|||+....
T Consensus       282 ~~dgffHaDpHpGNi~v~~~g~i~~lDfGi~g~l  315 (517)
T COG0661         282 LRDGFFHADPHPGNILVRSDGRIVLLDFGIVGRL  315 (517)
T ss_pred             HhcCccccCCCccceEEecCCcEEEEcCcceecC
Confidence            3489999999999999999999999999998744

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=98.51  E-value=9.3e-09  Score=104.50  Aligned_cols=223  Identities=19%  Similarity=0.174  Sum_probs=157.0

Q ss_pred             cceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCC-cceEEEEEEeCCEEEEE
Q 014609           14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN-VVRLHEVLASKSKIYMV   92 (421)
Q Consensus        14 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpn-Iv~l~~~~~~~~~~~lv   92 (421)
                      .-|...+-+++|+++++++.+...+...+ .+.+...        ....-++++|.+++||| .+..++-++.+...+++
T Consensus       242 kws~~fh~fvK~altknpKkRptaeklL~-h~fvs~~--------l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~  312 (829)
T KOG0576|consen  242 KWSEFFHNFVKGALTKNPKKRPTAEKLLQ-HPFVSQT--------LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIP  312 (829)
T ss_pred             cchHHHHHHHHHHhcCCCccCCChhhhee-ceeeccc--------hhhHHHHHHHHHccCCCCcccccccCCcccccchh
Confidence            34667888999999999999977665555 6665432        34566889999999999 77777778888899999


Q ss_pred             EeccCCC-ChHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCccccCC
Q 014609           93 LEYVTGG-ELFDKIA-SKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD  170 (421)
Q Consensus        93 ~E~~~gg-~L~~~i~-~~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~  170 (421)
                      ++++.++ +-.+.+. ..-.+..-+.....+.-..+++++|+.--+|||    ||+..+ +..+..||+....+....  
T Consensus       313 ~~i~s~~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~--  385 (829)
T KOG0576|consen  313 MRICSTGRSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSSYKVHRD----NILGSE-EEVKLLDFAVPPQLTRTM--  385 (829)
T ss_pred             hhhhcCCccccccCChhhHhhhhhhhhhhhhhhcccccccccccccCcc----cccccc-cccccccccCCcccCccc--
Confidence            9999877 2222111 111233334445556667889999998878998    887754 778999999887544321  


Q ss_pred             CccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhhcCC----------------cC-CC------CCCCHHHHHH
Q 014609          171 GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIFRGD----------------FK-LP------KWLSPGAQNL  227 (421)
Q Consensus       171 ~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~~~~----------------~~-~p------~~~s~~~~~l  227 (421)
                       ...+..+|+.++|||+.....++ ...|.|++|+--..+...                -+ .|      .|-+..-.++
T Consensus       386 -~~~t~~~~~~~~~pev~~~~~~~-~~p~~~~~~~~~~~~ap~~pPr~~P~~~~~~~g~~p~s~~L~~~~aw~~~~~~~~  463 (829)
T KOG0576|consen  386 -KPRTAIGTPEPLAPEVIQENTID-GCPDSGSLAVSAIQMAPGLPPRSSPPAVLPMIGNGPNSPMLTDKSAWSPVFHRDF  463 (829)
T ss_pred             -ccccCCCCCCCCCchhhcccccc-cCCCccCCCcchhhcCCCCCCCCCCccccCCCCCCCCccccchhhhcCcccccCC
Confidence             34567899999999998888886 678999999632211111                11 01      1111112247


Q ss_pred             HHHhcCCCCCCCCCHHhhhcCcccccc
Q 014609          228 LRKILEPNPVKRITIAGIKADEWFEQD  254 (421)
Q Consensus       228 i~~~L~~dP~~R~t~~eil~~~w~~~~  254 (421)
                      ...|+..-|..|++....+.|.+|+..
T Consensus       464 ~~~~~~g~P~~pkv~mgacfsKvfngC  490 (829)
T KOG0576|consen  464 PAPCLNGLPPTPKVHMGACFSKVFNGC  490 (829)
T ss_pred             cccccCCCCCCCcchhhHHHHHHhccC
Confidence            788999999999999999998888754

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=98.47  E-value=1.6e-06  Score=81.01  Aligned_cols=135  Identities=18%  Similarity=0.154  Sum_probs=84.9

Q ss_pred             eEeecCc-EEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCC-CCCcceEEEEEEeCCEEEEEEeccCC
Q 014609           21 TLGEGNF-GKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK-HPNVVRLHEVLASKSKIYMVLEYVTG   98 (421)
Q Consensus        21 ~LG~G~~-g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~lv~E~~~g   98 (421)
                      .|-.|.. +.||+...  .+..+.+|+.....      ...+.+|+.+++.+. +--+.+++++....+..++|||+++|
T Consensus         5 ~~~~g~~~~~v~~~~~--~~~~~~vk~~~~~~------~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G   76 (244)
T cd05150           5 RVTEGQSGATVYRLDG--KNPGLYLKIAPSGP------TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPG   76 (244)
T ss_pred             ecCCCCCcCeEEEEcC--CCCcEEEEecCCCc------ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCC
Confidence            3445555 78998864  34788889875432      245778999988884 44466788887777778999999999


Q ss_pred             CChHHHH-------------------HhcC----CCCHH------HHHHHHH----------------HHHHHHHHHH--
Q 014609           99 GELFDKI-------------------ASKG----RLQEA------EGRKLFQ----------------QLIDGVSYCH--  131 (421)
Q Consensus        99 g~L~~~i-------------------~~~~----~~~~~------~~~~~~~----------------ql~~aL~~LH--  131 (421)
                      .+|....                   +.-.    ++...      .....+.                ++...++.|-  
T Consensus        77 ~~l~~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  156 (244)
T cd05150          77 VPAAALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEAT  156 (244)
T ss_pred             ccHhHhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhh
Confidence            7765321                   1100    11100      0000000                0111122221  


Q ss_pred             -----hCCceeccCCCCCEEeccCCCEEEEeccCCCC
Q 014609          132 -----NKGVFHRDLKLENILLDSKGNIKISDFGLSAL  163 (421)
Q Consensus       132 -----~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~  163 (421)
                           ...++|+|+.|.|||++.++.+.|+||+.+..
T Consensus       157 ~~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~~  193 (244)
T cd05150         157 RPAEEDLVVTHGDACLPNIIVDPGKFSGFIDLGRLGV  193 (244)
T ss_pred             CCCcCceEEECCCCCCccEEEeCCcEEEEEEcccccc
Confidence                 23589999999999999877788999998864

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>PLN02876 acyl-CoA dehydrogenase

Probab=98.40  E-value=3.9e-06  Score=92.10  Aligned_cols=144  Identities=18%  Similarity=0.384  Sum_probs=92.0

Q ss_pred             eceEeecCcEEEEEEEECCCC--ceEEEEEeecccccchhHHHHHHHHHHHHhcCC-CCCc--ceEEEEEEeC---CEEE
Q 014609           19 GRTLGEGNFGKVKFAQDLDSG--LPFAVKILEKNRIIHLKITDQIKREIATLKLLK-HPNV--VRLHEVLASK---SKIY   90 (421)
Q Consensus        19 ~~~LG~G~~g~V~~a~~~~~~--~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnI--v~l~~~~~~~---~~~~   90 (421)
                      ++.++.|.+..+|+......+  ..+++|+.+......  ....+.+|..+|+.+. |+++  .+++.++.+.   +..|
T Consensus        43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~--~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~f  120 (822)
T PLN02876         43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQ--SAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAF  120 (822)
T ss_pred             EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCc--cHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCce
Confidence            577899999999998764332  467888765432211  1357889999999996 6665  7778877664   4689


Q ss_pred             EEEeccCCCChHH--------------------H---HHhcC----CC---------CHHHHHHHHHH------------
Q 014609           91 MVLEYVTGGELFD--------------------K---IASKG----RL---------QEAEGRKLFQQ------------  122 (421)
Q Consensus        91 lv~E~~~gg~L~~--------------------~---i~~~~----~~---------~~~~~~~~~~q------------  122 (421)
                      +||||++|..+.+                    .   |+.-.    .+         ...++.+|..|            
T Consensus       121 lVME~v~G~~~~~~~~~~~~~~~r~~l~~~l~~~La~LH~vd~~~~gl~~~g~~~~~~~~~l~~w~~~~~~~~~~~~~~~  200 (822)
T PLN02876        121 YIMEYLEGRIFVDPKLPGVAPERRRAIYRATAKVLAALHSADVDAIGLGKYGRRDNYCKRQVERWAKQYLASTGEGKPPR  200 (822)
T ss_pred             EEEEecCCcccCCccCCCCCHHHHHHHHHHHHHHHHHHhCCCchhcChhhcCCCCchHHHHHHHHHHHHHHhhcccCCCC
Confidence            9999998864321                    1   11100    00         01122222222            


Q ss_pred             ---HHHHHHHHHh-----------CCceeccCCCCCEEeccC-CC-EEEEeccCCCCC
Q 014609          123 ---LIDGVSYCHN-----------KGVFHRDLKLENILLDSK-GN-IKISDFGLSALP  164 (421)
Q Consensus       123 ---l~~aL~~LH~-----------~gi~HrDlkp~NILl~~~-~~-~kL~DFGla~~~  164 (421)
                         +...+++|..           ..++|+|++|.|+|++.+ +. .-|.||+++++-
T Consensus       201 ~~~~~~l~~wL~~~~P~~~~~~~~~~LvHGD~~~~Nvl~~~~~~~v~aVLDWE~a~~G  258 (822)
T PLN02876        201 NPKMLELIDWLRENIPAEDSTGAGTGIVHGDFRIDNLVFHPTEDRVIGILDWELSTLG  258 (822)
T ss_pred             ChhHHHHHHHHHhcCCCccccCCCcceEecCcccccEEEcCCCCeEEEEEeeeccccC
Confidence               2233566632           249999999999999853 34 579999998753

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=98.36  E-value=4.1e-06  Score=90.84  Aligned_cols=192  Identities=20%  Similarity=0.227  Sum_probs=138.6

Q ss_pred             HHHHHHHHHhcCCCCCcceEEEEEEeCCEEE----EEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 014609           60 QIKREIATLKLLKHPNVVRLHEVLASKSKIY----MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGV  135 (421)
Q Consensus        60 ~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~----lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~ql~~aL~~LH~~gi  135 (421)
                      ....|...+.+..|+|++.++.+........    +..+++++-++...+..-+..+....+.+..+++.||+|+|+...
T Consensus       228 ~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~~i~~~~~r~~~~~~~~GL~~~h~~~l  307 (1351)
T KOG1035|consen  228 TTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVGSIPLETLRILHQKLLEGLAYLHSLSL  307 (1351)
T ss_pred             HHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhccccCHHHHHHHHHHHhhhHHHHHHhcc
Confidence            3455777788889999999999876554333    445788899999999988899999999999999999999999966


Q ss_pred             eeccCCCC---CEEeccCCCEEEE--eccCCCCCccccCCCccccccCCCCccChhhhcccCCC-CCcchHHHHHHHHhh
Q 014609          136 FHRDLKLE---NILLDSKGNIKIS--DFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYD-GATSDIWSCGVILYI  209 (421)
Q Consensus       136 ~HrDlkp~---NILl~~~~~~kL~--DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~-~~~~DiwSlGvil~~  209 (421)
                      .|.-+...   +-..+..+....+  ||+.+.....   ........-++.+.|||....+.+. +...|+|.+|..+.-
T Consensus       308 ~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d---~~~~~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll~~~  384 (1351)
T KOG1035|consen  308 EHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPD---NEKSFSDLLAEIRNADEDLKENTAKKSRLTDLWCLGLLLLQ  384 (1351)
T ss_pred             ceeEEecccccccccCccceeecchhhhcccccCCC---cccchhhcCccccccccccccccchhhhhhHHHHHHHHHhh
Confidence            66555444   4444555666666  8887764332   2223333456678888887665543 123699999988873


Q ss_pred             hcCCcCCCC----------CCC-HHHHHHHHHhcCCCCCCCCCHHhhhcCcccccc
Q 014609          210 FRGDFKLPK----------WLS-PGAQNLLRKILEPNPVKRITIAGIKADEWFEQD  254 (421)
Q Consensus       210 ~~~~~~~p~----------~~s-~~~~~li~~~L~~dP~~R~t~~eil~~~w~~~~  254 (421)
                      +...-..+.          ..+ ....++..+|+.-++++|+++.+++.|++..-.
T Consensus       385 ~~~~~~i~~~~~~~~~~l~~~~~~~~~d~~~~~~~~~~~~Rl~~~~ll~~~f~~~~  440 (1351)
T KOG1035|consen  385 LSQGEDISEKSAVPVSLLDVLSTSELLDALPKCLDEDSEERLSALELLTHPFLRFP  440 (1351)
T ss_pred             hhhcCcccccccchhhhhccccchhhhhhhhhhcchhhhhccchhhhhhchhcccc
Confidence            332222211          122 267889999999999999999999999998743

>PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2

Probab=98.25  E-value=1.3e-05  Score=71.98  Aligned_cols=128  Identities=24%  Similarity=0.301  Sum_probs=92.6

Q ss_pred             cceEEeceEeecCc-EEEEEEEECCCCceEEEEEeec---cc-------ccc--------hhHHHHHHHHHHHHhcCC--
Q 014609           14 GRYELGRTLGEGNF-GKVKFAQDLDSGLPFAVKILEK---NR-------IIH--------LKITDQIKREIATLKLLK--   72 (421)
Q Consensus        14 ~~y~i~~~LG~G~~-g~V~~a~~~~~~~~vAvK~i~~---~~-------~~~--------~~~~~~~~~Ei~il~~l~--   72 (421)
                      ..++.++.||.|+- |.||+++  -.|+.+|+|++..   ..       ...        ....+.|..|.+...+|+  
T Consensus        37 ~~I~flefLg~g~~~~~V~kv~--I~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~  114 (207)
T PF13095_consen   37 DDIEFLEFLGHGSHDGYVFKVE--IDGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEA  114 (207)
T ss_pred             CcEeeeeecCCCCceeEEEEEE--ECCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhc
Confidence            67899999999999 9999998  4788999999321   00       000        022356888999888775  


Q ss_pred             -CCCc--ceEEEEEEeC------------------CEEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH
Q 014609           73 -HPNV--VRLHEVLASK------------------SKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCH  131 (421)
Q Consensus        73 -hpnI--v~l~~~~~~~------------------~~~~lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~ql~~aL~~LH  131 (421)
                       +.++  ++.+++..-.                  ....||.||++...         .++.    .=+.+|.+-+..+|
T Consensus       115 ~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~---------~~~~----~~~~~~~~dl~~~~  181 (207)
T PF13095_consen  115 GREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP---------PLQI----RDIPQMLRDLKILH  181 (207)
T ss_pred             cccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc---------ccch----hHHHHHHHHHHHHH
Confidence             4455  8999987321                  12567888886643         1222    33457777788899


Q ss_pred             hCCceeccCCCCCEEeccCCCEEEEeccCC
Q 014609          132 NKGVFHRDLKLENILLDSKGNIKISDFGLS  161 (421)
Q Consensus       132 ~~gi~HrDlkp~NILl~~~~~~kL~DFGla  161 (421)
                      ..||+-+|+++.|..     .-||+|||.+
T Consensus       182 k~gI~~~Dv~~~ny~-----~G~lvDfs~~  206 (207)
T PF13095_consen  182 KLGIVPRDVKPRNYR-----GGKLVDFSSS  206 (207)
T ss_pred             HCCeeeccCcccccc-----CCEEEecccC
Confidence            999999999999986     4589999864

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=98.20  E-value=8e-06  Score=76.01  Aligned_cols=72  Identities=13%  Similarity=0.064  Sum_probs=46.1

Q ss_pred             ceEeecCcE-EEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCC---CcceEEEEEEeC---CEEEEE
Q 014609           20 RTLGEGNFG-KVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP---NVVRLHEVLASK---SKIYMV   92 (421)
Q Consensus        20 ~~LG~G~~g-~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hp---nIv~l~~~~~~~---~~~~lv   92 (421)
                      +.|+.|+.. .||...     ..+++|+.+...     ....+.+|..+++.+...   .+.++++.....   ...|++
T Consensus         3 ~~~~~gG~~n~vy~~~-----~~~VlR~~~~~~-----~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l   72 (235)
T cd05155           3 EPVDSGGTDNATFRLG-----DDMSVRLPSAAG-----YAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSV   72 (235)
T ss_pred             eeccCCCcccceEEcC-----CceEEEcCCccc-----hHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEE
Confidence            567777776 488652     357778754321     245789999999888532   344555544332   245889


Q ss_pred             EeccCCCCh
Q 014609           93 LEYVTGGEL  101 (421)
Q Consensus        93 ~E~~~gg~L  101 (421)
                      |++++|.++
T Consensus        73 ~~~i~G~~l   81 (235)
T cd05155          73 YRWLEGETA   81 (235)
T ss_pred             EEeecCCCC
Confidence            999998765

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>PF02149 KA1: Kinase associated domain 1; InterPro: IPR001772 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.18  E-value=5.8e-06  Score=56.10  Aligned_cols=43  Identities=28%  Similarity=0.554  Sum_probs=38.4

Q ss_pred             CceEEEEEEEEec-CceEEEEEEccCCChhhHHHHHHHHHhhcC
Q 014609          367 GSLSVAAEVFEIS-PSLYVVELRKSYGDPTVYRQLCNKLSSDLG  409 (421)
Q Consensus       367 ~~l~~~~~i~~~~-~~~~~v~~~k~~Gd~le~~~~~~~l~~~l~  409 (421)
                      ..+.|.+||+++. .+++.|+|+|.+||.+.|+++|.+|...|+
T Consensus         3 ~~v~fEieV~kl~~~~l~Gv~~kRi~Gd~~~yk~lc~~il~~l~   46 (47)
T PF02149_consen    3 EVVKFEIEVCKLPRLGLYGVDFKRISGDSWQYKDLCSKILNELR   46 (47)
T ss_dssp             C-EEEEEEEEEECCCTCEEEEEEEEES-HHHHHHHHHHHHHHTT
T ss_pred             cceEEEEEEEEecCCCeeEEEEEEeeCCHHHHHHHHHHHHHHcc
Confidence            5789999999998 899999999999999999999999988875

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. Members of the KIN2/PAR-1/MARK kinase subfamily are conserved from yeast to human and share the same domain organisation: an N-terminal kinase domain (IPR000719 from INTERPRO) and a C-terminal kinase associated domain 1 (KA1). Some members of the KIN1/PAR-1/MARK family also contain an UBA domain (IPR000449 from INTERPRO). Members of this kinase subfamily are involved in various biological processes such as cell polarity, cell cycle control, intracellular signalling, microtubule stability and protein stability []. The function of the KA1 domain is not yet known. Some proteins known to contain a KA1 domain are listed below: Mammalian MAP/microtubule affinity-regulating kinases (MARK 1,2,3). They regulate polarity in neuronal cell models and appear to function redundantly in phosphorylating MT-associated proteins and in regulating MT stability []. Mammalian maternal embryonic leucine zipper kinase (MELK). It phosphorylates ZNF622 and may contribute to its redirection to the nucleus. It may be involved in the inhibition of spliceosome assembly during mitosis. Caenorhabditis elegans and drosophila PAR-1 protein. It is required for establishing polarity in embryos where it is asymmetrically distributed []. Fungal Kin1 and Kin2 protein kinases involved in regulation of exocytosis. They localise to the cytoplasmic face of the plasma membrane []. Plant KIN10 and KIN11 proteins, catalytic subunits of the putative trimeric SNF1-related protein kinase (SnRK) complex. This entry represents the KA1 domain.; GO: 0004674 protein serine/threonine kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3OSE_A 1V5S_A 1UL7_A.

>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP

Probab=98.17  E-value=5.3e-05  Score=68.47  Aligned_cols=135  Identities=20%  Similarity=0.264  Sum_probs=96.9

Q ss_pred             ceEeecCcEEEEEEEECCCCceEEEEEeecccc-------------cchhHHHHHHHHHHHHhcCC------CCCcceEE
Q 014609           20 RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRI-------------IHLKITDQIKREIATLKLLK------HPNVVRLH   80 (421)
Q Consensus        20 ~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~-------------~~~~~~~~~~~Ei~il~~l~------hpnIv~l~   80 (421)
                      ..||+|+.=.||.  | ......+||++.....             .......+..+|+.-...+.      +.+|.+++
T Consensus         7 ~~i~~G~~R~cy~--H-P~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~   83 (199)
T PF10707_consen    7 DLIAQGGERDCYQ--H-PDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFY   83 (199)
T ss_pred             cccccCCCceEEE--C-CCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEe
Confidence            5789999999984  3 3455678999876550             01112456677777666665      78999999


Q ss_pred             EEEEeCCEEEEEEeccCC------CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCC---
Q 014609           81 EVLASKSKIYMVLEYVTG------GELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKG---  151 (421)
Q Consensus        81 ~~~~~~~~~~lv~E~~~g------g~L~~~i~~~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~---  151 (421)
                      |+.+++....+|+|.+..      .+|.+++.. +.+++    .+...+-+-.+||-+.+|+.+|++|.||++..++   
T Consensus        84 G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~-~~~~~----~~~~~L~~f~~~l~~~~Iv~~dl~~~NIv~~~~~~~~  158 (199)
T PF10707_consen   84 GFVETNLGLGLVVELIRDADGNISPTLEDYLKE-GGLTE----ELRQALDEFKRYLLDHHIVIRDLNPHNIVVQRRDSGE  158 (199)
T ss_pred             EEEecCCceEEEEEEEECCCCCcCccHHHHHHc-CCccH----HHHHHHHHHHHHHHHcCCeecCCCcccEEEEecCCCc
Confidence            999999999999998753      357777754 45665    3334455566788999999999999999996543   


Q ss_pred             -CEEEEe-ccCCC
Q 014609          152 -NIKISD-FGLSA  162 (421)
Q Consensus       152 -~~kL~D-FGla~  162 (421)
                       .+.|+| ||...
T Consensus       159 ~~lvlIDG~G~~~  171 (199)
T PF10707_consen  159 FRLVLIDGLGEKE  171 (199)
T ss_pred             eEEEEEeCCCCcc
Confidence             477777 45433

PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].

>COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms]

Probab=98.11  E-value=2.6e-05  Score=68.16  Aligned_cols=129  Identities=18%  Similarity=0.248  Sum_probs=91.8

Q ss_pred             EEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcc-eEEEEEEeCCEEEEEEec
Q 014609           17 ELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVV-RLHEVLASKSKIYMVLEY   95 (421)
Q Consensus        17 ~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv-~l~~~~~~~~~~~lv~E~   95 (421)
                      ++.+.||+|.+|.||++.+  .|..+|+|+-+.+.     ....+..|.++|..++-.++- ++|.+-+    .++.|||
T Consensus        25 ~v~~~L~KG~~s~Vyl~~~--~~~~~a~Kvrr~ds-----~r~~l~kEakiLeil~g~~~~p~vy~yg~----~~i~me~   93 (201)
T COG2112          25 RVEKELAKGTTSVVYLGEW--RGGEVALKVRRRDS-----PRRNLEKEAKILEILAGEGVTPEVYFYGE----DFIRMEY   93 (201)
T ss_pred             hhhhhhhcccccEEEEeec--cCceEEEEEecCCc-----chhhHHHHHHHHHHhhhcCCCceEEEech----hhhhhhh
Confidence            3467899999999999985  56689999865432     257799999999999877664 4555433    3455999


Q ss_pred             cCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCC-CCCEEeccCCCEEEEeccCCCC
Q 014609           96 VTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLK-LENILLDSKGNIKISDFGLSAL  163 (421)
Q Consensus        96 ~~gg~L~~~i~~~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlk-p~NILl~~~~~~kL~DFGla~~  163 (421)
                      +.|.+|.+.-...   +    ++-...++++---|-..||-|+.|. |...+|-.++.+.|+||.-|++
T Consensus        94 i~G~~L~~~~~~~---~----rk~l~~vlE~a~~LD~~GI~H~El~~~~k~vlv~~~~~~iIDFd~At~  155 (201)
T COG2112          94 IDGRPLGKLEIGG---D----RKHLLRVLEKAYKLDRLGIEHGELSRPWKNVLVNDRDVYIIDFDSATF  155 (201)
T ss_pred             hcCcchhhhhhcc---c----HHHHHHHHHHHHHHHHhccchhhhcCCceeEEecCCcEEEEEccchhh
Confidence            9998886654321   2    2223345555444667799999885 5555565666999999999884

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=98.10  E-value=4.4e-05  Score=68.54  Aligned_cols=99  Identities=19%  Similarity=0.239  Sum_probs=79.6

Q ss_pred             HHHHHHHhcCCC-CCcceEEEEEEeCCEEEEEEeccCCCChHHH---HHhcCCCCHHHHHHHHHHHHHHHHHHHh---CC
Q 014609           62 KREIATLKLLKH-PNVVRLHEVLASKSKIYMVLEYVTGGELFDK---IASKGRLQEAEGRKLFQQLIDGVSYCHN---KG  134 (421)
Q Consensus        62 ~~Ei~il~~l~h-pnIv~l~~~~~~~~~~~lv~E~~~gg~L~~~---i~~~~~~~~~~~~~~~~ql~~aL~~LH~---~g  134 (421)
                      ..|.-+++.+.+ +++++++|+|-    .++|.||...+++...   +..-...++..+.+++.|+++.+.++++   ..
T Consensus         7 ~~E~lll~~l~~~~~~pk~lG~CG----~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~   82 (188)
T PF12260_consen    7 NNEPLLLQLLQGSEPFPKLLGSCG----RFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGF   82 (188)
T ss_pred             ccHHHHHHHcCCCCCCCCeeeECC----CEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence            458888999976 69999999983    2568899987766421   1122346899999999999999999987   35


Q ss_pred             ceeccCCCCCEEeccCCCEEEEeccCCCCC
Q 014609          135 VFHRDLKLENILLDSKGNIKISDFGLSALP  164 (421)
Q Consensus       135 i~HrDlkp~NILl~~~~~~kL~DFGla~~~  164 (421)
                      +.-.|++|+|+-++++|++|++|...+...
T Consensus        83 ~~lcDv~~~nfgv~~~~~lk~iDld~v~~~  112 (188)
T PF12260_consen   83 FYLCDVSPDNFGVNDDGRLKLIDLDDVFVE  112 (188)
T ss_pred             EEEeecchHHeEEeCCCcEEEEechhcchh
Confidence            888899999999999999999999987643

Proteins in this uncharacterised family are described as transmembrane proteins.

>KOG1235 consensus Predicted unusual protein kinase [General function prediction only]

Probab=98.08  E-value=2.4e-05  Score=80.28  Aligned_cols=138  Identities=22%  Similarity=0.271  Sum_probs=86.5

Q ss_pred             ceEeecCcEEEEEEEECCCCceEEEEEeecccccc----------------------------hhHHH------HHHHHH
Q 014609           20 RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIH----------------------------LKITD------QIKREI   65 (421)
Q Consensus        20 ~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~----------------------------~~~~~------~~~~Ei   65 (421)
                      +.||..+.|.|++|+- .+|+.||||+-+..--..                            .+..+      ++.+|.
T Consensus       167 ~piaaASlaQVhrA~L-~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA  245 (538)
T KOG1235|consen  167 EPIAAASLAQVHRARL-KNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEA  245 (538)
T ss_pred             chhhhcchhheEEEEe-cCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHH
Confidence            6899999999999986 459999999865421000                            00011      234444


Q ss_pred             HHHhc----CCCCC------cceEEEEEEeCCEEEEEEeccCCCChHHH--HHhcCCCCHHHHHHHHHHHHHHH-HHHHh
Q 014609           66 ATLKL----LKHPN------VVRLHEVLASKSKIYMVLEYVTGGELFDK--IASKGRLQEAEGRKLFQQLIDGV-SYCHN  132 (421)
Q Consensus        66 ~il~~----l~hpn------Iv~l~~~~~~~~~~~lv~E~~~gg~L~~~--i~~~~~~~~~~~~~~~~ql~~aL-~~LH~  132 (421)
                      +-..+    +.|-+      |.++|-  ...+...++|||++|..+.|.  |.+ ..++...+..   -+.++. +-+=.
T Consensus       246 ~Nae~~~~~f~~~~~~~~V~VP~Vy~--~~st~RVLtME~~~G~~i~Dl~~i~~-~gi~~~~i~~---~l~~~~~~qIf~  319 (538)
T KOG1235|consen  246 KNAERFRENFKDFSLLTYVLVPKVYW--DLSTKRVLTMEYVDGIKINDLDAIDK-RGISPHDILN---KLVEAYLEQIFK  319 (538)
T ss_pred             HhHHHHHHHHHhcccccceeCCeehh--hcCcceEEEEEecCCccCCCHHHHHH-cCCCHHHHHH---HHHHHHHHHHHh
Confidence            43333    33444      333332  223457899999999877554  444 3455553332   222221 12235


Q ss_pred             CCceeccCCCCCEEecc----CCCEEEEeccCCCCC
Q 014609          133 KGVFHRDLKLENILLDS----KGNIKISDFGLSALP  164 (421)
Q Consensus       133 ~gi~HrDlkp~NILl~~----~~~~kL~DFGla~~~  164 (421)
                      .|.+|.|=+|.||++..    ++.+.+-|||+....
T Consensus       320 ~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~i  355 (538)
T KOG1235|consen  320 TGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVI  355 (538)
T ss_pred             cCCccCCCCCCcEEEecCCCCCccEEEEcccccccc
Confidence            68999999999999984    568999999998743

>PRK09550 mtnK methylthioribose kinase; Reviewed

Probab=98.04  E-value=0.00011  Score=73.36  Aligned_cols=80  Identities=20%  Similarity=0.185  Sum_probs=55.3

Q ss_pred             eceEeecCcEEEEEEEECCCCceEEEEEeecccc---cc-hhHHHHHHHHHHHHhcCC---CCCcceEEEEEEeCCEEEE
Q 014609           19 GRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRI---IH-LKITDQIKREIATLKLLK---HPNVVRLHEVLASKSKIYM   91 (421)
Q Consensus        19 ~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~---~~-~~~~~~~~~Ei~il~~l~---hpnIv~l~~~~~~~~~~~l   91 (421)
                      .+.||.|.+..||.+.+...++.++||.-.....   .. .-..++...|.+.|+.+.   ..++++++.+  +....++
T Consensus        31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~l  108 (401)
T PRK09550         31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVT  108 (401)
T ss_pred             eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEE
Confidence            4689999999999999854446899998531100   00 112467788888888763   3467777777  4455789


Q ss_pred             EEeccCCCC
Q 014609           92 VLEYVTGGE  100 (421)
Q Consensus        92 v~E~~~gg~  100 (421)
                      ||||+++..
T Consensus       109 VME~L~~~~  117 (401)
T PRK09550        109 VMEDLSDHK  117 (401)
T ss_pred             EEecCCCcc
Confidence            999998643

>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes

Probab=97.97  E-value=0.0001  Score=68.39  Aligned_cols=137  Identities=19%  Similarity=0.222  Sum_probs=81.6

Q ss_pred             eceEeecCcEEEEEEEECC-CCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCC-cceEEEEEEeCCEEEEEEecc
Q 014609           19 GRTLGEGNFGKVKFAQDLD-SGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN-VVRLHEVLASKSKIYMVLEYV   96 (421)
Q Consensus        19 ~~~LG~G~~g~V~~a~~~~-~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpn-Iv~l~~~~~~~~~~~lv~E~~   96 (421)
                      ++.|..|-...+|+..... .++.|++|+......    ..-...+|+.+++.+...+ ..+++....  +  .++|||+
T Consensus         3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~----~~~d~~~E~~~~~~l~~~gl~P~v~~~~~--~--~~l~e~i   74 (235)
T cd05157           3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTE----LIIDRERELRIHKLLSKHGLAPKLYATFQ--N--GLIYEFI   74 (235)
T ss_pred             EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCcc----ceecHHHHHHHHHHHHhCCCCCeEEEEeC--C--cEEEEee
Confidence            4567788888999987432 367899997654321    1123457899998885433 444544332  2  3799999


Q ss_pred             CCCChHHH----------H-------HhcC-CC----------C-HHHHHHHHHHH----------------------HH
Q 014609           97 TGGELFDK----------I-------ASKG-RL----------Q-EAEGRKLFQQL----------------------ID  125 (421)
Q Consensus        97 ~gg~L~~~----------i-------~~~~-~~----------~-~~~~~~~~~ql----------------------~~  125 (421)
                      +|.++...          +       +... ..          . ...+..+...+                      ..
T Consensus        75 ~G~~l~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  154 (235)
T cd05157          75 PGRTLEPEDLRNPKIYRLIARELAKLHSIKPPEAISSPGTPKPILWPTIRKWINLVPTEFKKPEKFQKKTKAISFEQLRD  154 (235)
T ss_pred             CCCcCCHHHccChHHHHHHHHHHHHHhcccccccccccCCCCCcHHHHHHHHHHHhHHhhccccchhhhhccccHHHHHH
Confidence            98765211          1       1100 11          0 11222222111                      11


Q ss_pred             HHHHH----H----hCCceeccCCCCCEEecc-CCCEEEEeccCCCC
Q 014609          126 GVSYC----H----NKGVFHRDLKLENILLDS-KGNIKISDFGLSAL  163 (421)
Q Consensus       126 aL~~L----H----~~gi~HrDlkp~NILl~~-~~~~kL~DFGla~~  163 (421)
                      .+..|    -    ..+++|+|+.|.|||++. ++.+.|+||..|..
T Consensus       155 ~~~~l~~~l~~~~~~~~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~~  201 (235)
T cd05157         155 EISWLKELLSALNSPIVFCHNDLLSGNIIYNEEKNSVKFIDYEYAGY  201 (235)
T ss_pred             HHHHHHHHhcccCCCEEEEcCCCCcCcEEEeCCCCCEEEEEcccCCc
Confidence            11111    1    236999999999999998 57899999998874

ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo

>KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only]

Probab=97.94  E-value=8.6e-06  Score=77.54  Aligned_cols=136  Identities=21%  Similarity=0.289  Sum_probs=99.8

Q ss_pred             eEEeceEeecCcEEEEEEEECCCCceEEEEEeeccccc-----------------chhH--HHHHHHHHHHHhcCC-C-C
Q 014609           16 YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRII-----------------HLKI--TDQIKREIATLKLLK-H-P   74 (421)
Q Consensus        16 y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~-----------------~~~~--~~~~~~Ei~il~~l~-h-p   74 (421)
                      |.+++.||-|.-+.+|.+-+ ..|++.++|+-+..+..                 .+-.  .-...+|...|+.|. | -
T Consensus        94 ~svGnqIGVGKESDIY~v~d-~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gf  172 (465)
T KOG2268|consen   94 ESVGNQIGVGKESDIYVVAD-EEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGF  172 (465)
T ss_pred             hhhccccccccccceEEEec-CCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCC
Confidence            56789999999999999986 67889999975432210                 0000  123567888888885 3 3


Q ss_pred             CcceEEEEEEeCCEEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEE
Q 014609           75 NVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIK  154 (421)
Q Consensus        75 nIv~l~~~~~~~~~~~lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~k  154 (421)
                      -+.+.+++    ++.++|||++.|-.|...-.      ...+..+...++.-+--|-.+|+||+|.+-=||++++++.++
T Consensus       173 pVPkpiD~----~RH~Vvmelv~g~Pl~~v~~------v~d~~~ly~~lm~~Iv~la~~GlIHgDFNEFNimv~dd~~i~  242 (465)
T KOG2268|consen  173 PVPKPIDH----NRHCVVMELVDGYPLRQVRH------VEDPPTLYDDLMGLIVRLANHGLIHGDFNEFNIMVKDDDKIV  242 (465)
T ss_pred             CCCCcccc----cceeeHHHhhcccceeeeee------cCChHHHHHHHHHHHHHHHHcCceecccchheeEEecCCCEE
Confidence            35556654    56789999999877754321      223445666777777788899999999999999999999999


Q ss_pred             EEeccCCC
Q 014609          155 ISDFGLSA  162 (421)
Q Consensus       155 L~DFGla~  162 (421)
                      ++||-.+.
T Consensus       243 vIDFPQmv  250 (465)
T KOG2268|consen  243 VIDFPQMV  250 (465)
T ss_pred             EeechHhh
Confidence            99997554

>TIGR02721 ycfN_thiK thiamine kinase

Probab=97.91  E-value=4.4e-05  Score=71.94  Aligned_cols=133  Identities=17%  Similarity=0.179  Sum_probs=79.1

Q ss_pred             eEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCc-ceEEEEEEeCCEEEEEEeccCCC
Q 014609           21 TLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNV-VRLHEVLASKSKIYMVLEYVTGG   99 (421)
Q Consensus        21 ~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnI-v~l~~~~~~~~~~~lv~E~~~gg   99 (421)
                      .+..|-...+|+..  .+++.+++|+......   ...-...+|..+++.+...++ .+++....    -++||||++|.
T Consensus         3 ~~~~G~tn~~y~~~--~~~~~~vlR~~~~~~~---~~~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~   73 (256)
T TIGR02721         3 TLSGGLTNRSWRIE--HPGISFVWRPQSPVCK---ALGVDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGE   73 (256)
T ss_pred             cCCCcCcCCeEEEE--eCCccEEEeeCCcccc---cccCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCc
Confidence            45568888999886  4567888997543211   110135778999998864433 34444332    36899999986


Q ss_pred             ChHH--------------H---HHhcC----CCCH-HHHHHHHHHHH---------HHHHHHHh--------CCceeccC
Q 014609          100 ELFD--------------K---IASKG----RLQE-AEGRKLFQQLI---------DGVSYCHN--------KGVFHRDL  140 (421)
Q Consensus       100 ~L~~--------------~---i~~~~----~~~~-~~~~~~~~ql~---------~aL~~LH~--------~gi~HrDl  140 (421)
                      .+..              .   ++...    +++. ..+..+..++.         ..+..+-.        ..++|+|+
T Consensus        74 ~~~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl  153 (256)
T TIGR02721        74 VITLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDV  153 (256)
T ss_pred             ccccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCC
Confidence            6531              1   11111    1111 22223332221         11222211        25899999


Q ss_pred             CCCCEEeccCCCEEEEeccCCCC
Q 014609          141 KLENILLDSKGNIKISDFGLSAL  163 (421)
Q Consensus       141 kp~NILl~~~~~~kL~DFGla~~  163 (421)
                      .|.||+++.++ +.|+||..|..
T Consensus       154 ~~~Nil~~~~~-~~lIDwE~a~~  175 (256)
T TIGR02721       154 HAYNLVVTPQG-LKLIDWEYASD  175 (256)
T ss_pred             CcCcEEEeCCC-CEEEeccccCc
Confidence            99999999877 78999999874

Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.

>cd05153 HomoserineK_II Homoserine Kinase, type II

Probab=97.89  E-value=8.9e-05  Score=71.35  Aligned_cols=136  Identities=20%  Similarity=0.222  Sum_probs=83.7

Q ss_pred             eceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCC--cceEEE------EEEeCCEEE
Q 014609           19 GRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN--VVRLHE------VLASKSKIY   90 (421)
Q Consensus        19 ~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpn--Iv~l~~------~~~~~~~~~   90 (421)
                      .+.|..|....+|+...  .+..+++|+....   .   .+.+..|+.++..+.+.+  +.+++.      +....+..+
T Consensus        19 i~~i~~G~~n~~y~v~~--~~~~~vLr~~~~~---~---~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~   90 (296)
T cd05153          19 FEGISAGIENTNYFVTT--DSGRYVLTLFEKV---S---AEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPA   90 (296)
T ss_pred             eecccCccccceEEEEe--CCCcEEEEEcCCC---C---hHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceE
Confidence            56777888889998863  3457899987531   1   356777888888875322  444443      223345678


Q ss_pred             EEEeccCCCChHH--------------HHHhc-CCCCH--------HHHH------------HHHHHHHHHHHHHHh---
Q 014609           91 MVLEYVTGGELFD--------------KIASK-GRLQE--------AEGR------------KLFQQLIDGVSYCHN---  132 (421)
Q Consensus        91 lv~E~~~gg~L~~--------------~i~~~-~~~~~--------~~~~------------~~~~ql~~aL~~LH~---  132 (421)
                      ++++|++|..+..              .++.. ..+..        ....            .....+..++.++.+   
T Consensus        91 ~l~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~  170 (296)
T cd05153          91 ALVEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDP  170 (296)
T ss_pred             EEEEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhh
Confidence            9999999876421              01110 00000        0000            011112334444443   


Q ss_pred             ----CCceeccCCCCCEEeccCCCEEEEeccCCC
Q 014609          133 ----KGVFHRDLKLENILLDSKGNIKISDFGLSA  162 (421)
Q Consensus       133 ----~gi~HrDlkp~NILl~~~~~~kL~DFGla~  162 (421)
                          .+++|+|+.|.|||++.++.+.|.||+.+.
T Consensus       171 ~~~~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~  204 (296)
T cd05153         171 SDLPRGVIHADLFRDNVLFDGDELSGVIDFYFAC  204 (296)
T ss_pred             hcCCCcCCccCcCcccEEEeCCceEEEeehhhhc
Confidence                479999999999999987777899999876

Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine.

>PRK10593 hypothetical protein; Provisional

Probab=97.88  E-value=0.00026  Score=68.35  Aligned_cols=77  Identities=13%  Similarity=0.109  Sum_probs=55.7

Q ss_pred             EeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCC---CCcceEEEEEEe---CCEEEE
Q 014609           18 LGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKH---PNVVRLHEVLAS---KSKIYM   91 (421)
Q Consensus        18 i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~h---pnIv~l~~~~~~---~~~~~l   91 (421)
                      -.+.||.|..+.||.... .++ .+.+|..+...     ....+..|...|+.|.-   -.+.++++++..   .+..++
T Consensus        18 ~~~~i~~G~~~~vy~~~~-~~~-~~~~k~~~~~~-----~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~L   90 (297)
T PRK10593         18 RVECISEQPYAALWALYD-SQG-NPMPLMARSFS-----TPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVL   90 (297)
T ss_pred             eeeecCCccceeEEEEEc-CCC-CEEEEEecccc-----cchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEE
Confidence            356899999999999863 233 56778743211     13578899999998853   367888887754   366899


Q ss_pred             EEeccCCCCh
Q 014609           92 VLEYVTGGEL  101 (421)
Q Consensus        92 v~E~~~gg~L  101 (421)
                      |||+++|.++
T Consensus        91 VmE~i~G~~~  100 (297)
T PRK10593         91 LLERLRGVSV  100 (297)
T ss_pred             EEeccCCEec
Confidence            9999998654

>TIGR00938 thrB_alt homoserine kinase, Neisseria type

Probab=97.73  E-value=0.0003  Score=68.23  Aligned_cols=139  Identities=17%  Similarity=0.216  Sum_probs=82.7

Q ss_pred             EEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCC--cceEEEE------EEeCCE
Q 014609           17 ELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN--VVRLHEV------LASKSK   88 (421)
Q Consensus        17 ~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpn--Iv~l~~~------~~~~~~   88 (421)
                      .-.+.++.|....+|++.. .+| .+++|+.....  .   .+.+..|.++++.|...+  +.+++..      ....+.
T Consensus        25 ~~i~~~~~G~~n~~y~v~t-~~~-~~vLK~~~~~~--~---~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~   97 (307)
T TIGR00938        25 LSLKGIAEGVENSNYLLTT-DVG-RYILTLYEKRV--K---AEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGK   97 (307)
T ss_pred             eeccccCCccccceEEEEe-CCC-cEEEEEecCCC--C---HHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCe
Confidence            3456778888889998863 344 67889875421  1   244566777777774322  3444432      122456


Q ss_pred             EEEEEeccCCCChH-----------HH---HHh-cCCC--------CHHHHH---------------HHHHHHHHHHHHH
Q 014609           89 IYMVLEYVTGGELF-----------DK---IAS-KGRL--------QEAEGR---------------KLFQQLIDGVSYC  130 (421)
Q Consensus        89 ~~lv~E~~~gg~L~-----------~~---i~~-~~~~--------~~~~~~---------------~~~~ql~~aL~~L  130 (421)
                      .+++++|++|.++.           ..   ++. ...+        ......               .....+...++++
T Consensus        98 ~~~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l  177 (307)
T TIGR00938        98 PACLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYL  177 (307)
T ss_pred             EEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHH
Confidence            89999999985431           11   111 0111        001000               0011223345555


Q ss_pred             Hh-------CCceeccCCCCCEEeccCCCEEEEeccCCC
Q 014609          131 HN-------KGVFHRDLKLENILLDSKGNIKISDFGLSA  162 (421)
Q Consensus       131 H~-------~gi~HrDlkp~NILl~~~~~~kL~DFGla~  162 (421)
                      ..       .+++|+|+++.|++++.++...|.||+.+.
T Consensus       178 ~~~~~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~  216 (307)
T TIGR00938       178 DKFWPRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC  216 (307)
T ss_pred             HhhhhhcCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence            32       589999999999999988877899999886

Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase.

>KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning]

Probab=97.73  E-value=0.00028  Score=68.49  Aligned_cols=142  Identities=21%  Similarity=0.315  Sum_probs=100.5

Q ss_pred             EeceEeecCcEEEEEEEECCCCceEEEEEeeccccc----------------------chhHH-HHHHHHHHHHhcCCCC
Q 014609           18 LGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRII----------------------HLKIT-DQIKREIATLKLLKHP   74 (421)
Q Consensus        18 i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~----------------------~~~~~-~~~~~Ei~il~~l~hp   74 (421)
                      +-.+|..|--+.||.|.. .+|..+|||+.+.+-+.                      ...+. -...+|++-|++|+..
T Consensus       148 inGCiSTGKEANVYHat~-~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~a  226 (520)
T KOG2270|consen  148 INGCISTGKEANVYHATE-EDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNA  226 (520)
T ss_pred             cccccccCccceeEeeec-CCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhc
Confidence            456788899999999974 67888999998642210                      11111 2356799999999866


Q ss_pred             CcceEEEEEEeCCEEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHH-HhCCceeccCCCCCEEeccCCCE
Q 014609           75 NVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYC-HNKGVFHRDLKLENILLDSKGNI  153 (421)
Q Consensus        75 nIv~l~~~~~~~~~~~lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~ql~~aL~~L-H~~gi~HrDlkp~NILl~~~~~~  153 (421)
                      +|.-.--+..  ....+||+++.+..-..-...+..++...+..+.+|++.-+.-| |.++++|.||.--|+|+ .+|.+
T Consensus       227 GIP~PePIlL--k~hVLVM~FlGrdgw~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN~Ly-hdG~l  303 (520)
T KOG2270|consen  227 GIPCPEPILL--KNHVLVMEFLGRDGWAAPKLKDASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFNLLY-HDGKL  303 (520)
T ss_pred             CCCCCCceee--ecceEeeeeccCCCCcCcccccccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhhhheE-ECCEE
Confidence            6442211111  23468999995322211122345688889999999999998887 45699999999999999 67899


Q ss_pred             EEEeccCCCC
Q 014609          154 KISDFGLSAL  163 (421)
Q Consensus       154 kL~DFGla~~  163 (421)
                      .++|.+.+.-
T Consensus       304 yiIDVSQSVE  313 (520)
T KOG2270|consen  304 YIIDVSQSVE  313 (520)
T ss_pred             EEEEcccccc
Confidence            9999998763

>KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms]

Probab=97.73  E-value=4e-06  Score=92.82  Aligned_cols=235  Identities=16%  Similarity=0.110  Sum_probs=150.5

Q ss_pred             ecceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccc--hhHHHHHHHHHHHHhcCCCCCcceEEEEEEe--CCE
Q 014609           13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIH--LKITDQIKREIATLKLLKHPNVVRLHEVLAS--KSK   88 (421)
Q Consensus        13 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~--~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~--~~~   88 (421)
                      +..|++.-.+|-|.+++-..-+.+..  -+.+|+.+.-...+  ....+....|...++...|+++...+.-...  ...
T Consensus      1228 ~e~~EV~l~i~~~~~~R~k~Lr~kid--~Fk~~I~ke~d~e~LsePlkemll~e~de~~~~~h~~~~~~p~rI~ps~s~e 1305 (2724)
T KOG1826|consen 1228 MEHSEVNLGISNHFHFRNKWLRSKID--WFKFSIYKEYDFENLSEPLKEMLLSERDELREAKHYLTEVDPLRIPPSESTE 1305 (2724)
T ss_pred             hhhhheeeecccceeeccchHhhhhc--eeEEEeehhhhHHHHhhHHHHhhhhhhhhhhhhhceeeecccccCCCCCChH
Confidence            45566666666666654322221111  23555554322211  1112334456666677789998877665533  345


Q ss_pred             EEEEEeccCCCChHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC-----CceeccCCCCCEEeccCCCEEEEecc
Q 014609           89 IYMVLEYVTGGELFDKIASK----GRLQEAEGRKLFQQLIDGVSYCHNK-----GVFHRDLKLENILLDSKGNIKISDFG  159 (421)
Q Consensus        89 ~~lv~E~~~gg~L~~~i~~~----~~~~~~~~~~~~~ql~~aL~~LH~~-----gi~HrDlkp~NILl~~~~~~kL~DFG  159 (421)
                      .|..++|+.+|.+++.|.+.    .++...-+....++.+.+..-+|+.     -.+|+++|+-|.+|..+-++|++++|
T Consensus      1306 e~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~tnlg~T~v~~~Lkf~lpmIVtny~v~~gk~g 1385 (2724)
T KOG1826|consen 1306 EYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLTNLGNTNVSKSLKFTLPMIVTNYNVKLGKGG 1385 (2724)
T ss_pred             HHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcccCCccchhhhhhhhccceecCCcccccccc
Confidence            78999999999999998643    3345555555556668888888865     27899999999999999999999999


Q ss_pred             CCCCCccccCCCccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhh---------------cCC------cCCCC
Q 014609          160 LSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIF---------------RGD------FKLPK  218 (421)
Q Consensus       160 la~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~---------------~~~------~~~p~  218 (421)
                      +.++..+  .........++|.|++|++...-.+. .++|+|..|+-+|..               .|.      +..+.
T Consensus      1386 LdKIknp--~~sf~Gl~l~sp~~v~qli~N~ik~t-~rsdilr~s~~ly~rs~~n~~fi~flq~~Lkgiidn~tf~sIe~ 1462 (2724)
T KOG1826|consen 1386 LDKIKNP--VLSFFGLELCSPIYVLQLIKNEIKFT-KRSDILRRSLSLYLRSDGNAYFIFFLQPALKGIIDNHTFFSIEK 1462 (2724)
T ss_pred             cccccCc--hHhhhhhhhCCHHHHHHHHHHHHhhh-hHHHHHHHHHHHHHHhcccHHHHHHHHHHHcCcccccccccccc
Confidence            9985433  22334456788899999998877774 669999999999822               221      22233


Q ss_pred             CCCHHHHHHHHHhcCCCCCCCCCHHhhhcCcccc
Q 014609          219 WLSPGAQNLLRKILEPNPVKRITIAGIKADEWFE  252 (421)
Q Consensus       219 ~~s~~~~~li~~~L~~dP~~R~t~~eil~~~w~~  252 (421)
                      ..|.++-.....+|-..-..||.-..++.-+.+.
T Consensus      1463 l~pgdaNve~~~~Ll~K~~~rp~q~isls~d~~a 1496 (2724)
T KOG1826|consen 1463 LKPGDANVEALHRLLWKYMERPGQYISLSRDHFA 1496 (2724)
T ss_pred             cCCCcccHHHHHHHHHHhhhcchhhhhccccccc
Confidence            3344444444444444455677766666666553

>PRK05231 homoserine kinase; Provisional

Probab=97.66  E-value=0.0011  Score=64.54  Aligned_cols=136  Identities=15%  Similarity=0.224  Sum_probs=75.7

Q ss_pred             eceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCC--cceEEE------EEEeCCEEE
Q 014609           19 GRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN--VVRLHE------VLASKSKIY   90 (421)
Q Consensus        19 ~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpn--Iv~l~~------~~~~~~~~~   90 (421)
                      .+.|+.|....+|.... .+| .+++|+...  . .   .+.+..|+.+++.|...+  +.+.+.      +....+..+
T Consensus        27 ~~~l~~G~~n~~y~v~t-~~g-~~vLK~~~~--~-~---~~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~   98 (319)
T PRK05231         27 LKGIAEGIENSNFFLTT-TQG-EYVLTLFER--L-T---AEDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPA   98 (319)
T ss_pred             cchhccccccceEEEEe-CCC-cEEEEEecc--C-C---hHHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEE
Confidence            45577788789998874 334 689998751  1 1   234445666665553211  333332      123356789


Q ss_pred             EEEeccCCCChH-----------HHH---Hh-cCCC--------CH----HHHHH-----------HHHH-HHHHHHHHH
Q 014609           91 MVLEYVTGGELF-----------DKI---AS-KGRL--------QE----AEGRK-----------LFQQ-LIDGVSYCH  131 (421)
Q Consensus        91 lv~E~~~gg~L~-----------~~i---~~-~~~~--------~~----~~~~~-----------~~~q-l~~aL~~LH  131 (421)
                      ++++|++|..+.           ..+   +. ...+        ..    ..+..           .+.+ +...++.+.
T Consensus        99 ~l~~~l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~  178 (319)
T PRK05231         99 AIVTFLEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQAALLEAELAAQLAFLA  178 (319)
T ss_pred             EEEEecCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHHHHHHHHHHHHHHhhh
Confidence            999999987431           111   11 0001        00    00011           1111 111222332


Q ss_pred             -------hCCceeccCCCCCEEeccCCCEEEEeccCCC
Q 014609          132 -------NKGVFHRDLKLENILLDSKGNIKISDFGLSA  162 (421)
Q Consensus       132 -------~~gi~HrDlkp~NILl~~~~~~kL~DFGla~  162 (421)
                             ..++||+|++|.|||++.+...-|+||+.+.
T Consensus       179 ~~~~~~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~  216 (319)
T PRK05231        179 SAAWPALPRGVIHADLFRDNVLFEGDRLSGFIDFYFAC  216 (319)
T ss_pred             ccccccCCcccCCCCCCCCcEEEECCceEEEEeccccc
Confidence                   2389999999999999866556899999886

>cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes

Probab=97.64  E-value=0.00039  Score=67.13  Aligned_cols=74  Identities=14%  Similarity=0.176  Sum_probs=48.2

Q ss_pred             ceEeecCcEEEEEEEECC------CCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCc-ceEEEEEEeCCEEEEE
Q 014609           20 RTLGEGNFGKVKFAQDLD------SGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNV-VRLHEVLASKSKIYMV   92 (421)
Q Consensus        20 ~~LG~G~~g~V~~a~~~~------~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnI-v~l~~~~~~~~~~~lv   92 (421)
                      +.|..|-...+|+.....      +++.+++|+.....    .......+|..+++.+...++ .+++.++..    .+|
T Consensus         4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~----~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~----~~v   75 (302)
T cd05156           4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV----ELLIDRERELVVFARLSERNLGPKLYGIFPN----GRI   75 (302)
T ss_pred             EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCC----cceechHHHHHHHHHHHhCCCCCceEEEeCC----Cch
Confidence            456667777899887432      26789999965432    112456788888888864333 455555532    358


Q ss_pred             EeccCCCCh
Q 014609           93 LEYVTGGEL  101 (421)
Q Consensus        93 ~E~~~gg~L  101 (421)
                      +||++|..+
T Consensus        76 ~e~i~G~~l   84 (302)
T cd05156          76 EEFIPSRTL   84 (302)
T ss_pred             hheeCCCcC
Confidence            999988765

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer

>COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only]

Probab=97.62  E-value=0.00054  Score=66.26  Aligned_cols=144  Identities=16%  Similarity=0.199  Sum_probs=84.8

Q ss_pred             EEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCC--CCcceEEEEEEeCC--EEEEE
Q 014609           17 ELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKH--PNVVRLHEVLASKS--KIYMV   92 (421)
Q Consensus        17 ~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~h--pnIv~l~~~~~~~~--~~~lv   92 (421)
                      .+++.+..|..-.+|...+.  ++.+++. .+. ............+|..+++.+.-  .-+...++++.++.  ..|.|
T Consensus        28 ~~v~~~~~G~sn~t~~~~~~--~~~~vlR-~P~-~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v  103 (321)
T COG3173          28 LIVEEISGGWSNDTFRLGDT--GQKYVLR-KPP-RGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYV  103 (321)
T ss_pred             ceeeeccCCcccceEEEecC--CceEEEe-cCC-ccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEE
Confidence            34444544444456666543  8888988 332 12223345778889999988753  33445566665555  77999


Q ss_pred             EeccCCCChHHH------------------HHh-------c----C---CCCHHHHHHHHHHH--------------HHH
Q 014609           93 LEYVTGGELFDK------------------IAS-------K----G---RLQEAEGRKLFQQL--------------IDG  126 (421)
Q Consensus        93 ~E~~~gg~L~~~------------------i~~-------~----~---~~~~~~~~~~~~ql--------------~~a  126 (421)
                      |+|++|..+.+.                  +..       .    +   .....+..++..+.              ..-
T Consensus       104 ~~~veGe~~~~~~~~~~~~~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~  183 (321)
T COG3173         104 MEWVEGEVVWSALPPESLGRQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRL  183 (321)
T ss_pred             EEEecceeccCcCCcccchHHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHH
Confidence            999998432211                  110       0    0   00111111111111              122


Q ss_pred             HHHHHh--------CCceeccCCCCCEEeccCCCEEEEeccCCCCC
Q 014609          127 VSYCHN--------KGVFHRDLKLENILLDSKGNIKISDFGLSALP  164 (421)
Q Consensus       127 L~~LH~--------~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~  164 (421)
                      ..||+.        ..++|+|+++.||+++.++-+-|.||+++.+-
T Consensus       184 ~~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lG  229 (321)
T COG3173         184 IKWLEANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATLG  229 (321)
T ss_pred             HHHHHhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEeccccccC
Confidence            334432        25899999999999999998999999999853

>cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2')

Probab=97.31  E-value=0.002  Score=61.47  Aligned_cols=30  Identities=23%  Similarity=0.381  Sum_probs=25.8

Q ss_pred             CceeccCCCCCEEeccCCC-EEEEeccCCCC
Q 014609          134 GVFHRDLKLENILLDSKGN-IKISDFGLSAL  163 (421)
Q Consensus       134 gi~HrDlkp~NILl~~~~~-~kL~DFGla~~  163 (421)
                      .++|+|++|.|||++.++. .-|.||+.+.+
T Consensus       186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i  216 (276)
T cd05152         186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKV  216 (276)
T ss_pred             eeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence            4899999999999987565 46999999874

MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported

>TIGR02906 spore_CotS spore coat protein, CotS family

Probab=97.18  E-value=0.0049  Score=59.58  Aligned_cols=29  Identities=31%  Similarity=0.618  Sum_probs=25.9

Q ss_pred             CCceeccCCCCCEEeccCCCEEEEeccCCC
Q 014609          133 KGVFHRDLKLENILLDSKGNIKISDFGLSA  162 (421)
Q Consensus       133 ~gi~HrDlkp~NILl~~~~~~kL~DFGla~  162 (421)
                      .+++|+|+++.||+++. +.+.|.||+.+.
T Consensus       187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~  215 (313)
T TIGR02906       187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCT  215 (313)
T ss_pred             CceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence            47999999999999987 678999999765

Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers.

>TIGR01767 MTRK 5-methylthioribose kinase

Probab=97.18  E-value=0.0038  Score=61.36  Aligned_cols=77  Identities=21%  Similarity=0.181  Sum_probs=49.5

Q ss_pred             eEeecCcEEEEEEEECCCCceEEEEEeecc-cc--cc-hhHHHHHHHHHHHHhcCC--CC-CcceEEEEEEeCCEEEEEE
Q 014609           21 TLGEGNFGKVKFAQDLDSGLPFAVKILEKN-RI--IH-LKITDQIKREIATLKLLK--HP-NVVRLHEVLASKSKIYMVL   93 (421)
Q Consensus        21 ~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~-~~--~~-~~~~~~~~~Ei~il~~l~--hp-nIv~l~~~~~~~~~~~lv~   93 (421)
                      .||.|...-||++.+...++.|+||.-..- +.  .+ .-..++..-|...|+...  .| .+.++|.+  ++....+||
T Consensus         2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~--D~e~~~~vM   79 (370)
T TIGR01767         2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF--DTEMAVTVM   79 (370)
T ss_pred             cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE--ccccceehH
Confidence            579999999999997544478999964311 10  00 112456677888887764  34 45555544  444566999


Q ss_pred             eccCCC
Q 014609           94 EYVTGG   99 (421)
Q Consensus        94 E~~~gg   99 (421)
                      |+++..
T Consensus        80 EdL~~~   85 (370)
T TIGR01767        80 EDLSHH   85 (370)
T ss_pred             hhCccc
Confidence            999653

This enzyme is involved in the methionine salvage pathway in certain bacteria.

>PLN02756 S-methyl-5-thioribose kinase

Probab=97.10  E-value=0.0063  Score=60.89  Aligned_cols=77  Identities=16%  Similarity=0.109  Sum_probs=52.0

Q ss_pred             EeceEeecCcEEEEEEEECCCCceEEEEEeecccc-cch---hHHHHHHHHHHHHhcCC---CCCcceEEEEEEeCCEEE
Q 014609           18 LGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRI-IHL---KITDQIKREIATLKLLK---HPNVVRLHEVLASKSKIY   90 (421)
Q Consensus        18 i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~-~~~---~~~~~~~~Ei~il~~l~---hpnIv~l~~~~~~~~~~~   90 (421)
                      -.+.||.|....||+..+  .+..++||.-..... ...   ...++...|.+.|+.+.   ..++.+++.++.  +..+
T Consensus        36 ~~~eiggGn~N~VyrV~~--~~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~v  111 (418)
T PLN02756         36 KIKEVGDGNLNFVYIVVS--SSGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMAL  111 (418)
T ss_pred             eEEEcCCCceeeEEEEEc--CCccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCE
Confidence            367889999999999886  345799997542111 111   12445566677776664   347888888877  3467


Q ss_pred             EEEeccCC
Q 014609           91 MVLEYVTG   98 (421)
Q Consensus        91 lv~E~~~g   98 (421)
                      ++|||+++
T Consensus       112 lvME~L~~  119 (418)
T PLN02756        112 IGMRYLEP  119 (418)
T ss_pred             EEEeecCC
Confidence            88999977

>PLN02236 choline kinase

Probab=96.99  E-value=0.0055  Score=60.46  Aligned_cols=137  Identities=20%  Similarity=0.192  Sum_probs=81.2

Q ss_pred             eceEeecCcEEEEEEEECC----CCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCc-ceEEEEEEeCCEEEEEE
Q 014609           19 GRTLGEGNFGKVKFAQDLD----SGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNV-VRLHEVLASKSKIYMVL   93 (421)
Q Consensus        19 ~~~LG~G~~g~V~~a~~~~----~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnI-v~l~~~~~~~~~~~lv~   93 (421)
                      +..|-.|-.-.+|++....    +++.|++|+.....   ....+ ..+|..+++.+..-++ .++++.+...    .|.
T Consensus        41 i~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t---~~~id-R~~E~~~~~~l~~~gl~P~~~~~~~~g----~v~  112 (344)
T PLN02236         41 VIPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGV---ELFFD-RDDEIRTFECMSRHGQGPRLLGRFPNG----RVE  112 (344)
T ss_pred             EEEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCC---Ceeec-hHHHHHHHHHHHHcCCCCceEEEECCc----eEE
Confidence            3455558888999986432    34789999875432   11122 3778999988864443 3556655332    578


Q ss_pred             eccCCCChHHH-----------------HHhcC------CCCHHHHHHHHHHHH-----------------HHHHHH---
Q 014609           94 EYVTGGELFDK-----------------IASKG------RLQEAEGRKLFQQLI-----------------DGVSYC---  130 (421)
Q Consensus        94 E~~~gg~L~~~-----------------i~~~~------~~~~~~~~~~~~ql~-----------------~aL~~L---  130 (421)
                      +|++|.+|...                 ++...      ......+..+..++.                 ..+..|   
T Consensus       113 efi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~  192 (344)
T PLN02236        113 EFIHARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKE  192 (344)
T ss_pred             EeeCCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHH
Confidence            99987665311                 11101      111223333332221                 111122   


Q ss_pred             -H----hCCceeccCCCCCEEecc-CCCEEEEeccCCCC
Q 014609          131 -H----NKGVFHRDLKLENILLDS-KGNIKISDFGLSAL  163 (421)
Q Consensus       131 -H----~~gi~HrDlkp~NILl~~-~~~~kL~DFGla~~  163 (421)
                       .    ...++|+|+++.|||+++ ++.+.++||..|..
T Consensus       193 ~~~~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~  231 (344)
T PLN02236        193 LSGDDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYASY  231 (344)
T ss_pred             hcccCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence             1    236899999999999986 46899999998863

>PLN02421 phosphotransferase, alcohol group as acceptor/kinase

Probab=96.86  E-value=0.0065  Score=59.57  Aligned_cols=136  Identities=15%  Similarity=0.224  Sum_probs=79.3

Q ss_pred             ceEeecCcEEEEEEEECCC---CceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCc-ceEEEEEEeCCEEEEEEec
Q 014609           20 RTLGEGNFGKVKFAQDLDS---GLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNV-VRLHEVLASKSKIYMVLEY   95 (421)
Q Consensus        20 ~~LG~G~~g~V~~a~~~~~---~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnI-v~l~~~~~~~~~~~lv~E~   95 (421)
                      +.|..|-...+|+......   +..|++|+......   . .-.-.+|..+++.+..-++ .++++++. .+   +|.+|
T Consensus        20 ~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~---~-~IdR~~E~~il~~l~~~gl~P~~l~~~~-~G---~i~~f   91 (330)
T PLN02421         20 ERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTD---Y-VIDRERELQAIKYLSAAGFGAKLLGVFG-NG---MIQSF   91 (330)
T ss_pred             EEeCCcccceEEEEEecCCCCCCceEEEEEecCCcC---e-EechHHHHHHHHHHHhcCCCCceeEEeC-Cc---Eeehh
Confidence            4454477788998864332   34789998754321   1 1234678888888875554 45565553 22   58899


Q ss_pred             cCCCChHH----------H-------HHhcC-C----C-CHHHHHHHHHHHH----------------------HHHHH-
Q 014609           96 VTGGELFD----------K-------IASKG-R----L-QEAEGRKLFQQLI----------------------DGVSY-  129 (421)
Q Consensus        96 ~~gg~L~~----------~-------i~~~~-~----~-~~~~~~~~~~ql~----------------------~aL~~-  129 (421)
                      ++|..|..          .       ++... +    . ....+..++.++-                      .-+.. 
T Consensus        92 i~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l  171 (330)
T PLN02421         92 INARTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIVEL  171 (330)
T ss_pred             hcCCCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHHHH
Confidence            98765421          1       11111 0    1 1223333333321                      11211 


Q ss_pred             ---HHhC----CceeccCCCCCEEecc-CCCEEEEeccCCCC
Q 014609          130 ---CHNK----GVFHRDLKLENILLDS-KGNIKISDFGLSAL  163 (421)
Q Consensus       130 ---LH~~----gi~HrDlkp~NILl~~-~~~~kL~DFGla~~  163 (421)
                         +.+.    -.+|.|+.|.|||+++ ++.++++||..|..
T Consensus       172 ~~~~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~  213 (330)
T PLN02421        172 KEITDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSY  213 (330)
T ss_pred             HHHhccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence               2122    2799999999999975 47899999999873

>PRK12396 5-methylribose kinase; Reviewed

Probab=96.76  E-value=0.0091  Score=59.47  Aligned_cols=77  Identities=21%  Similarity=0.225  Sum_probs=51.8

Q ss_pred             eceEeecCcEEEEEEEECCCCceEEEEEeec----ccccchhHHHHHHHHHHHHhcCC--CC-CcceEEEEEEeCCEEEE
Q 014609           19 GRTLGEGNFGKVKFAQDLDSGLPFAVKILEK----NRIIHLKITDQIKREIATLKLLK--HP-NVVRLHEVLASKSKIYM   91 (421)
Q Consensus        19 ~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~----~~~~~~~~~~~~~~Ei~il~~l~--hp-nIv~l~~~~~~~~~~~l   91 (421)
                      .+.||.|.-.-||++.+...++.|+||.-..    ...+. -..++..-|.++|+.+.  .| ++.++|.+  ++....+
T Consensus        34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swp-L~~~R~~~E~~aL~~~~~~~P~~VP~vy~~--D~e~~~~  110 (409)
T PRK12396         34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFK-LSTNRIRIESDVLQLEEELAPGLVPKVYLF--DSVMNCC  110 (409)
T ss_pred             eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCC-CChHHHHHHHHHHHHHHhhCCCcCCeEEEE--CcHHhhH
Confidence            5789999999999999744467899996421    11111 12567788888888774  34 45556654  4445678


Q ss_pred             EEeccCC
Q 014609           92 VLEYVTG   98 (421)
Q Consensus        92 v~E~~~g   98 (421)
                      |||+++.
T Consensus       111 vMEdL~~  117 (409)
T PRK12396        111 VMEDLSD  117 (409)
T ss_pred             HHHhCcc
Confidence            8998864

>TIGR02904 spore_ysxE spore coat protein YsxE

Probab=96.76  E-value=0.014  Score=56.58  Aligned_cols=30  Identities=20%  Similarity=0.292  Sum_probs=27.9

Q ss_pred             CceeccCCCCCEEeccCCCEEEEeccCCCC
Q 014609          134 GVFHRDLKLENILLDSKGNIKISDFGLSAL  163 (421)
Q Consensus       134 gi~HrDlkp~NILl~~~~~~kL~DFGla~~  163 (421)
                      ++||+|+.+.|+|++.++.+.++||..+..
T Consensus       197 ~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~  226 (309)
T TIGR02904       197 VLVHGKLSLSHFLYDETRGGYFINFEKASF  226 (309)
T ss_pred             eeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence            799999999999999999999999998873

Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat.

>PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2

Probab=96.29  E-value=0.01  Score=54.09  Aligned_cols=30  Identities=33%  Similarity=0.594  Sum_probs=21.7

Q ss_pred             CceeccCCCCCEEe-ccCCCEEEEeccCCCC
Q 014609          134 GVFHRDLKLENILL-DSKGNIKISDFGLSAL  163 (421)
Q Consensus       134 gi~HrDlkp~NILl-~~~~~~kL~DFGla~~  163 (421)
                      .++|+|+.|.|||+ +.++.++|+||..|..
T Consensus       144 v~cHnDl~~~Nil~~~~~~~~~lIDfEya~~  174 (211)
T PF01633_consen  144 VFCHNDLNPGNILINNKDGEVKLIDFEYAGY  174 (211)
T ss_dssp             EEE-S--SGGGEEETSSSSCEEE--GTT-EE
T ss_pred             eEeeccCccccEEeccCCCeEEEecHHHHhh
Confidence            58999999999999 8889999999999873

7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B ....

>PTZ00384 choline kinase; Provisional

Probab=96.29  E-value=0.032  Score=55.82  Aligned_cols=75  Identities=16%  Similarity=0.156  Sum_probs=45.3

Q ss_pred             eceEeecCcEEEEEEEECCC-Cce-----EEEEEeecccccchhHHHHHHHHHHHHhcCCCCC-cceEEEEEEeCCEEEE
Q 014609           19 GRTLGEGNFGKVKFAQDLDS-GLP-----FAVKILEKNRIIHLKITDQIKREIATLKLLKHPN-VVRLHEVLASKSKIYM   91 (421)
Q Consensus        19 ~~~LG~G~~g~V~~a~~~~~-~~~-----vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpn-Iv~l~~~~~~~~~~~l   91 (421)
                      ++.|..|-...+|++..... +..     |.+++...    .....-.-.+|+.+++.+..-+ -.++++.+..    ++
T Consensus        55 i~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g~----~~~l~IdR~~E~~i~~~Ls~~glgP~l~~~f~~----g~  126 (383)
T PTZ00384         55 IKKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSST----YNSLVIDNDLQYNIAKLLGDNNFGPKIIGRFGD----FT  126 (383)
T ss_pred             EEEeCCcccceEEEEEecCCCCCccccceEEEEeccC----CCceEeccHHHHHHHHHHHhCCCCCeEEEecCC----EE
Confidence            34565588899999864332 222     44443211    1111223467899999997544 4556666543    58


Q ss_pred             EEeccCCCCh
Q 014609           92 VLEYVTGGEL  101 (421)
Q Consensus        92 v~E~~~gg~L  101 (421)
                      +.||++|.+|
T Consensus       127 l~efIeGr~l  136 (383)
T PTZ00384        127 IQEWVEGNTM  136 (383)
T ss_pred             EEEEeccccC
Confidence            9999998765

>PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein []

Probab=96.06  E-value=0.023  Score=54.51  Aligned_cols=74  Identities=18%  Similarity=0.230  Sum_probs=48.7

Q ss_pred             EeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCC---CCCcceEEEEEEeCCEEEEEEe
Q 014609           18 LGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK---HPNVVRLHEVLASKSKIYMVLE   94 (421)
Q Consensus        18 i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~---hpnIv~l~~~~~~~~~~~lv~E   94 (421)
                      -.+.++.|....+|...  .+++.+.||+-....      ...+..|.+-|+.|.   .-.+.+.+.+....+..|++||
T Consensus        21 ~~~~v~GG~i~~a~~~~--~~~~~~FvK~~~~~~------~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle   92 (288)
T PF03881_consen   21 SIEPVSGGDINEAYRLD--TDGGSYFVKVNSESG------RDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLE   92 (288)
T ss_dssp             EEEEE--SSSSEEEEEE--TTS-EEEEEEEEGGG------CCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE
T ss_pred             eeEecCCCChhheEEEE--CCCccEEEEecChhh------HHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEE
Confidence            35678889999999887  778899999876221      346788888888884   3457788888887777899999


Q ss_pred             ccCCC
Q 014609           95 YVTGG   99 (421)
Q Consensus        95 ~~~gg   99 (421)
                      |++.+
T Consensus        93 ~l~~~   97 (288)
T PF03881_consen   93 FLEMG   97 (288)
T ss_dssp             -----
T ss_pred             eecCC
Confidence            99866

Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A.

>KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only]

Probab=96.05  E-value=0.02  Score=58.15  Aligned_cols=143  Identities=27%  Similarity=0.352  Sum_probs=91.1

Q ss_pred             HHHHHHHHHHHhcCCCCCcceEEEEEEeC-CEEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCce
Q 014609           58 TDQIKREIATLKLLKHPNVVRLHEVLASK-SKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVF  136 (421)
Q Consensus        58 ~~~~~~Ei~il~~l~hpnIv~l~~~~~~~-~~~~lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~ql~~aL~~LH~~gi~  136 (421)
                      ..++.-....++.+.|+|...++++.... .+..+|||++ +.+|.|.+..+. +-.....              .+|+.
T Consensus        26 s~~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~-~~Sled~~~~~~-l~~~s~~--------------~~~~~   89 (725)
T KOG1093|consen   26 SIQILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHY-TMSLEDILKTGN-LKDESLL--------------AHGVL   89 (725)
T ss_pred             HHHHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhh-ccchHHHHHhcc-cchhhhc--------------ccccc
Confidence            34566678889999999999999988654 4578899999 679988877643 2211111              12222


Q ss_pred             eccCCCCCEEeccCCCEEEEeccCCCCCccccCCCccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhh-cCC--
Q 014609          137 HRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIF-RGD--  213 (421)
Q Consensus       137 HrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~-~~~--  213 (421)
                      |     -|+       ++.+| -+++.                  |  |      ...++++||||+|.++..+ .|.  
T Consensus        90 ~-----~~~-------~~~td-~~~t~------------------~--~------~~~~pKsdVwsl~~i~~el~L~~~l  130 (725)
T KOG1093|consen   90 H-----LNI-------IYITD-HFLTK------------------Y--P------SPIGPKSDVWSLGFIILELYLGISL  130 (725)
T ss_pred             e-----ehh-------hhccc-ccccc------------------C--C------CCCCcchhhhhHHHHHHHHHHhhHH
Confidence            1     122       22333 11110                  0  1      1123589999999998721 111  


Q ss_pred             ----------------cCCCC-------------CCCHHHHHHHHHhcCCCCCCCCCHHhhhcCccccccc
Q 014609          214 ----------------FKLPK-------------WLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY  255 (421)
Q Consensus       214 ----------------~~~p~-------------~~s~~~~~li~~~L~~dP~~R~t~~eil~~~w~~~~~  255 (421)
                                      +..+.             ..+.....+..+|+-..|..||...+..+++-|...+
T Consensus       131 ~~~~~~s~~l~~i~k~~~~d~~~~~~a~e~~~~~~~d~~~~~~~~~c~~~~~~ir~l~~~~~k~~i~~ev~  201 (725)
T KOG1093|consen  131 EAELTESEYLEILLKYYTDDQELLSTAMEHLIQLLADKKRLPLLKKCLWLEPIIRPLPMELSKRCSFTEVY  201 (725)
T ss_pred             HHHHHHHHHHHHHHHhccCchhHHHHHHHHHHHHhhhHhHHHHhccCCccccccccchhHHhcCccHHHHH
Confidence                            11111             1456677889999999999999999999999987654

>PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length

Probab=95.88  E-value=0.027  Score=51.40  Aligned_cols=102  Identities=17%  Similarity=0.154  Sum_probs=64.8

Q ss_pred             eEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEEeccCCCChHHHHHhcCCCCHHHHHHHH
Q 014609           41 PFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLF  120 (421)
Q Consensus        41 ~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~  120 (421)
                      +..+|.++...+.-.  ...+..+.+++.++.  +|+++..=  ..-.+.+++|+|-....         .   . ..++
T Consensus        87 ~L~lKKi~slp~~~~--~~~y~nky~v~Armh--GilrL~ND--n~~~yGvIlE~Cy~~~i---------~---~-~N~i  147 (308)
T PF07387_consen   87 PLFLKKIRSLPCCIN--DALYFNKYRVFARMH--GILRLKND--NNYKYGVILERCYKIKI---------N---F-SNFI  147 (308)
T ss_pred             hhhhhhccCCCcccc--hhhhhhhhhHHHHhh--heeEeecC--CCceeEEEEeeccCccc---------c---h-hHHH
Confidence            345565554333211  244677888888774  67777632  33457799999843211         0   0 0111


Q ss_pred             HHHHHHHHHHHhC--CceeccCCCCCEEeccCCCEEEEeccCC
Q 014609          121 QQLIDGVSYCHNK--GVFHRDLKLENILLDSKGNIKISDFGLS  161 (421)
Q Consensus       121 ~ql~~aL~~LH~~--gi~HrDlkp~NILl~~~~~~kL~DFGla  161 (421)
                      .-=+.+|.-.|+.  +.+|||-.|+||+-|..|.+||.|-+..
T Consensus       148 ~agi~~L~~fH~~~~~~lHGD~np~NiM~D~~G~lKlVDP~~L  190 (308)
T PF07387_consen  148 TAGIKDLMDFHSENQHCLHGDCNPDNIMCDKFGYLKLVDPVCL  190 (308)
T ss_pred             HHhHHHHHHhhccCCCeecCCCChhheeecCCCCEEecChhhh
Confidence            1114567777843  7999999999999999999999998743

The function of this family is unknown.

>PRK11768 serine/threonine protein kinase; Provisional

Probab=95.84  E-value=0.21  Score=48.88  Aligned_cols=71  Identities=18%  Similarity=0.106  Sum_probs=43.1

Q ss_pred             cCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCC--cceEE---E--EEEeCCEEEEEEeccC
Q 014609           25 GNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN--VVRLH---E--VLASKSKIYMVLEYVT   97 (421)
Q Consensus        25 G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpn--Iv~l~---~--~~~~~~~~~lv~E~~~   97 (421)
                      +.-..||.... .+|..+++|+.+....    ....+..|+..+..|....  ++...   +  +...++..+.++++++
T Consensus        36 s~eN~vy~v~~-~~~~~~vlKv~r~~~~----~~~~i~~E~~~l~~L~~~gipv~~p~~~~G~~~~~~~g~~~~l~~~~~  110 (325)
T PRK11768         36 SYENRVYQFGD-EDGRRVVAKFYRPERW----SDAQILEEHAFALELAEAEIPVVAPLAFNGQTLHEHQGFRFALFPRRG  110 (325)
T ss_pred             cccceEEEEec-CCCCEEEEEEcCcccC----CHHHHHHHHHHHHHHHHCCCCCCCCccCCCCEEEEECCEEEEEEeeeC
Confidence            44456888863 5677899998754321    1356777888877664211  22211   1  1233567889999998


Q ss_pred             CCC
Q 014609           98 GGE  100 (421)
Q Consensus        98 gg~  100 (421)
                      |..
T Consensus       111 G~~  113 (325)
T PRK11768        111 GRA  113 (325)
T ss_pred             CCC
Confidence            764

>COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning]

Probab=95.82  E-value=0.029  Score=54.85  Aligned_cols=71  Identities=31%  Similarity=0.434  Sum_probs=55.9

Q ss_pred             CEEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC-CceeccCCCCCEEeccCCCEEEEeccCCCC
Q 014609           87 SKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNK-GVFHRDLKLENILLDSKGNIKISDFGLSAL  163 (421)
Q Consensus        87 ~~~~lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~ql~~aL~~LH~~-gi~HrDlkp~NILl~~~~~~kL~DFGla~~  163 (421)
                      ...|++|++- |+.+. .+   ..-..+++..++.+.+..++-+... ..-|||+...||||+ +|++.|+||-++++
T Consensus       299 ~y~yl~~kdh-gt~is-~i---k~~~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLId-~GnvtLIDfklsRl  370 (488)
T COG5072         299 LYLYLHFKDH-GTPIS-II---KADRSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILID-EGNVTLIDFKLSRL  370 (488)
T ss_pred             eEEEEEEecC-Cceee-ee---ecccHHHHHHHHHHHHHHHhhhhhcCCcccccccccceeee-cCceEEEEeeeeec
Confidence            3567788875 55542 22   2245678888999988888877766 789999999999999 99999999999984

>KOG1236 consensus Predicted unusual protein kinase [General function prediction only]

Probab=95.23  E-value=0.068  Score=53.09  Aligned_cols=61  Identities=18%  Similarity=0.177  Sum_probs=44.0

Q ss_pred             EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHH-HHhCCceeccCCCCCEEeccC
Q 014609           89 IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSY-CHNKGVFHRDLKLENILLDSK  150 (421)
Q Consensus        89 ~~lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~ql~~aL~~-LH~~gi~HrDlkp~NILl~~~  150 (421)
                      ..++-+|..|.++...+.. ...++...++++.-.+.|+-- +--.+.+|.|++|.||++-.+
T Consensus       320 ~vl~E~~~~Gl~v~~~v~~-~~~pe~l~kkva~lg~~AllkMl~vDNFvHaDlHPGNVlirf~  381 (565)
T KOG1236|consen  320 LVLVETYERGLSVLRFVKW-KSQPEALVKKVAKLGVNALLKMLIVDNFVHADLHPGNVLIRFN  381 (565)
T ss_pred             ceeeeeccccccHHhhhhc-ccChHHHHHHHHHHHHHHHHHHHHhhcceecccCCCcEEEEec
Confidence            4566678888888777765 345566667777666666554 345689999999999999544

>PRK06148 hypothetical protein; Provisional

Probab=95.15  E-value=0.27  Score=55.58  Aligned_cols=31  Identities=35%  Similarity=0.494  Sum_probs=26.6

Q ss_pred             CCceeccCCCCCEEeccCC--CEE-EEeccCCCC
Q 014609          133 KGVFHRDLKLENILLDSKG--NIK-ISDFGLSAL  163 (421)
Q Consensus       133 ~gi~HrDlkp~NILl~~~~--~~k-L~DFGla~~  163 (421)
                      .++||+|+++.|||++.++  .+. |+|||-+..
T Consensus       203 ~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~  236 (1013)
T PRK06148        203 AQVIHNDANDYNILVDADDGERISGLIDFGDAVH  236 (1013)
T ss_pred             cceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence            4799999999999999875  565 999998863

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	421
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		8e-66
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		9e-65
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		5e-64
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		7e-63
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		8e-63
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		1e-62
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		6e-62
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		8e-59
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		7e-58
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		3e-57
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-56
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		3e-56
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		4e-56
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-55
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		2e-55
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		2e-55
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		1e-53
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		7e-53
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		3e-52
3ujg_A	361	Crystal Structure Of Snrk2.6 In Complex With Hab1 L		2e-51
3uc4_A	362	The Crystal Structure Of Snf1-Related Kinase 2.6 Le		4e-51
3zut_A	362	The Structure Of Ost1 (D160a) Kinase Length = 362		2e-50
3zuu_A	362	The Structure Of Ost1 (D160a, S175d) Kinase In Comp		2e-50
3udb_A	317	Crystal Structure Of Snrk2.6 Length = 317		2e-49
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		6e-46
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		2e-42
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		3e-42
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		3e-42
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		3e-42
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		3e-42
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		3e-42
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		3e-42
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		3e-42
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		3e-42
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		4e-42
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		4e-42
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		4e-42
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		4e-42
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		4e-42
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		4e-42
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		4e-42
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		5e-42
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		7e-42
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		1e-41
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		2e-41
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		4e-41
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		9e-41
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		1e-40
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		1e-40
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		1e-40
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		1e-40
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		1e-40
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		3e-40
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		4e-40
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		5e-40
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		1e-39
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		2e-39
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		2e-39
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		2e-39
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		2e-39
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		4e-39
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		6e-39
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		6e-39
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		7e-39
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		2e-38
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		2e-38
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		2e-38
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		2e-38
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		2e-38
3kk9_A	282	Camkii Substrate Complex B Length = 282		2e-38
3kk8_A	284	Camkii Substrate Complex A Length = 284		3e-38
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		3e-38
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		3e-38
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		3e-38
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		3e-38
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		3e-38
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		3e-38
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		4e-38
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		4e-38
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		4e-38
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		4e-38
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		5e-38
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		5e-38
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		6e-38
3soa_A	444	Full-Length Human Camkii Length = 444		8e-38
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		9e-38
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		1e-37
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		1e-37
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		1e-37
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		1e-37
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		1e-37
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		1e-37
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		1e-37
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		1e-37
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		1e-37
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		1e-37
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		2e-37
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		2e-37
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		2e-37
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		2e-37
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		3e-37
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		3e-37
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		3e-37
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		4e-37
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		5e-37
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		5e-37
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		6e-37
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		6e-37
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		6e-37
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		7e-37
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		8e-37
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		8e-37
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		8e-37
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		9e-37
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		9e-37
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		9e-37
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		9e-37
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		9e-37
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		9e-37
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		1e-36
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		1e-36
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		1e-36
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		1e-36
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		1e-36
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		1e-36
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		1e-36
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		1e-36
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		2e-36
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		2e-36
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		2e-36
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		2e-36
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		2e-36
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		2e-36
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		2e-36
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		2e-36
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		2e-36
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		3e-36
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		3e-36
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		3e-36
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		3e-36
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		3e-36
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		3e-36
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		3e-36
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		3e-36
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		3e-36
4ae6_A	343	Structure And Function Of The Human Sperm-specific		3e-36
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		3e-36
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		3e-36
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		4e-36
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		4e-36
4ae9_A	343	Structure And Function Of The Human Sperm-specific		4e-36
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		4e-36
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		4e-36
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		5e-36
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		5e-36
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		6e-36
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		6e-36
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		6e-36
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		6e-36
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		7e-36
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		7e-36
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		1e-35
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		1e-35
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		1e-35
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		2e-35
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		3e-35
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		3e-35
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		3e-35
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		5e-35
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		5e-35
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		2e-34
2wtk_C	305	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		2e-34
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		3e-34
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		4e-34
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		4e-34
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		4e-34
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		5e-34
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		5e-34
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		5e-34
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		6e-34
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		6e-34
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		6e-34
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		6e-34
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		6e-34
3g51_A	325	Structural Diversity Of The Active Conformation Of		6e-34
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		6e-34
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		7e-34
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		8e-34
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		1e-33
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		1e-33
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		1e-33
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		2e-33
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		2e-33
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		2e-33
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		2e-33
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		2e-33
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		3e-33
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		4e-33
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		4e-33
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		4e-33
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		6e-33
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		6e-33
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		7e-33
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		7e-33
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		7e-33
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		1e-32
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		1e-32
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		1e-32
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		1e-32
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		2e-32
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		2e-32
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		2e-32
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		3e-32
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		4e-32
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		4e-32
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		4e-32
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		4e-32
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		5e-32
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		5e-32
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		5e-32
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		5e-32
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		6e-32
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		7e-32
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		9e-32
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		9e-32
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		1e-31
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		1e-31
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		2e-31
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		2e-31
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		4e-31
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		4e-31
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		4e-31
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		7e-31
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		8e-31
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		1e-30
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		1e-30
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		2e-30
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		3e-30
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		4e-30
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		4e-30
2iwi_A	312	Crystal Structure Of The Human Pim2 In Complex With		4e-30
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		5e-30
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		6e-30
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		6e-30
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		6e-30
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		6e-30
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		6e-30
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		6e-30
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		7e-30
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		7e-30
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		7e-30
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		7e-30
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		7e-30
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		7e-30
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		7e-30
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		7e-30
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		8e-30
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		8e-30
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		9e-30
3tac_A	361	Crystal Structure Of The Liprin-AlphaCASK COMPLEX L		1e-29
3c0g_A	351	Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len		1e-29
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		2e-29
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		2e-29
2qr7_A	342	2.0a X-Ray Structure Of C-Terminal Kinase Domain Of		3e-29
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		4e-29
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		4e-29
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		7e-29
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		1e-28
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		3e-28
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		4e-28
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		5e-28
1yxs_A	293	Crystal Structure Of Kinase Pim1 With P123m Mutatio		1e-27
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		3e-27
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		3e-27
3r00_A	299	The Discovery Of Novel Benzofuran-2-Carboxylic Acid		3e-27
1yhs_A	273	Crystal Structure Of Pim-1 Bound To Staurosporine L		3e-27
3uix_A	298	Crystal Structure Of Pim1 Kinase In Complex With Sm		3e-27
1xqz_A	300	Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut		3e-27
3jxw_A	294	Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-		3e-27
1ywv_A	293	Crystal Structures Of Proto-Oncogene Kinase Pim1: A		4e-27
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		4e-27
2xj0_A	301	Protein Kinase Pim-1 In Complex With Fragment-4 Fro		4e-27
2xix_A	301	Protein Kinase Pim-1 In Complex With Fragment-1 Fro		4e-27
1xws_A	313	Crystal Structure Of The Human Pim1 Kinase Domain L		4e-27
4alv_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		4e-27
3f2a_A	300	Crystal Structure Of Human Pim-1 In Complex With Da		4e-27
3a99_A	320	Structure Of Pim-1 Kinase Crystallized In The Prese		4e-27
3c4e_A	273	Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7		4e-27
2xiy_A	301	Protein Kinase Pim-1 In Complex With Fragment-2 Fro		4e-27
4dtk_A	276	Novel And Selective Pan-Pim Kinase Inhibitor Length		4e-27
3dcv_A	328	Crystal Structure Of Human Pim1 Kinase Complexed Wi		5e-27
4a7c_A	308	Crystal Structure Of Pim1 Kinase With Etp46546 Leng		5e-27
2obj_A	333	Crystal Structure Of Human Pim-1 Kinase In Complex		6e-27
3dls_A	335	Crystal Structure Of Human Pas Kinase Bound To Adp		7e-27
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		8e-27
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		1e-26
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		3e-26
3cxw_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		3e-26
3jpv_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		3e-26
2bil_B	313	The Human Protein Kinase Pim1 In Complex With Its C		4e-26
2j2i_B	312	Crystal Structure Of The Humab Pim1 In Complex With		4e-26
3cy3_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		4e-26
3ma3_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		4e-26
4as0_A	273	Cyclometalated Phthalimides As Protein Kinase Inhib		4e-26
2bik_B	313	Human Pim1 Phosphorylated On Ser261 Length = 313		5e-26
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		1e-25
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		2e-25
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		2e-25
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		3e-25
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		2e-23
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		2e-23
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		2e-23
3hko_A	345	Crystal Structure Of A Cdpk Kinase Domain From Cryp		3e-23
4alu_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		5e-23
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		5e-23
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		2e-22
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		6e-22
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		7e-22
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		8e-22
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		9e-22
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		9e-22
1kwp_A	400	Crystal Structure Of Mapkap2 Length = 400		2e-21
3r2y_A	319	Mk2 Kinase Bound To Compound 1 Length = 319		2e-21
3r2b_A	318	Mk2 Kinase Bound To Compound 5b Length = 318		2e-21
2p3g_X	327	Crystal Structure Of A Pyrrolopyridine Inhibitor Bo		2e-21
2pzy_A	324	Structure Of Mk2 Complexed With Compound 76 Length		2e-21
3fpm_A	325	Crystal Structure Of A Squarate Inhibitor Bound To		2e-21
2oza_A	356	Structure Of P38alpha Complex Length = 356		2e-21
2jbo_A	326	Protein Kinase Mk2 In Complex With An Inhibitor (Cr		2e-21
3gok_A	334	Binding Site Mapping Of Protein Ligands Length = 33		2e-21
2onl_C	406	Crystal Structure Of The P38a-Mapkap Kinase 2 Heter		2e-21
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		2e-21
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		3e-21
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		3e-21
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		3e-21
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		3e-21
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		3e-21
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		4e-21
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		4e-21
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		4e-21
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		4e-21
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		6e-21
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		7e-21
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		7e-21
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		7e-21
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		8e-21
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		8e-21
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		8e-21
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		8e-21
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		9e-21
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		9e-21
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		1e-20
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		1e-20
3ka0_A	320	Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4		1e-20
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		1e-20
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		1e-20
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		1e-20
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		1e-20
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		1e-20
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		1e-20
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		2e-20
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		2e-20
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		2e-20
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		2e-20
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		2e-20
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		2e-20
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		2e-20
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		2e-20
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		2e-20
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		2e-20
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		2e-20
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		2e-20
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		2e-20
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		2e-20
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		2e-20
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		2e-20
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		2e-20
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		2e-20
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		2e-20
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		2e-20
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		2e-20
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		3e-20
2ac5_A	316	Structure Of Human Mnk2 Kinase Domain Mutant D228g		3e-20
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		4e-20
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		5e-20
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		6e-20
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		6e-20
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		6e-20
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		7e-20
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		7e-20
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		7e-20
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		8e-20
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		1e-19
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		1e-19
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		1e-19
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		1e-19
1nxk_A	400	Crystal Structure Of Staurosporine Bound To Map Kap		1e-19
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		1e-19
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		1e-19
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		2e-19
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		2e-19
3fhr_A	336	High Resolution Crystal Structure Of Mitogen-Activa		2e-19
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		2e-19
3r1n_A	317	Mk3 Kinase Bound To Compound 5b Length = 317		2e-19
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		2e-19
2ac3_A	316	Structure Of Human Mnk2 Kinase Domain Length = 316		2e-19
3ll6_A	337	Crystal Structure Of The Human Cyclin G Associated		2e-19
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		2e-19
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		2e-19
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		2e-19
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		3e-19
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		3e-19
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		3e-19
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		3e-19
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		3e-19
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		4e-19
1tki_A	321	Autoinhibited Serine Kinase Domain Of The Giant Mus		4e-19
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		5e-19
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		5e-19
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		5e-19
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		6e-19
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		6e-19
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		6e-19
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		7e-19
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		7e-19
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		7e-19
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		7e-19
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		7e-19
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		8e-19
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		8e-19
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		9e-19
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		9e-19
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		9e-19
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		9e-19
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		1e-18
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		1e-18
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		1e-18
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		1e-18
4fie_A	423	Full-Length Human Pak4 Length = 423		1e-18
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		1e-18
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		1e-18
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		1e-18
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		1e-18
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		1e-18
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		1e-18
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		1e-18
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		1e-18
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		1e-18
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		1e-18
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		1e-18
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		1e-18
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		1e-18
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		1e-18
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		1e-18
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		1e-18
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		1e-18
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		1e-18
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		1e-18
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		1e-18
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		1e-18
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		1e-18
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		1e-18
3hec_A	348	P38 In Complex With Imatinib Length = 348		1e-18
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		1e-18
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		1e-18
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		1e-18
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		1e-18
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		1e-18
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		1e-18
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		1e-18
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		1e-18
3a7f_A	303	Human Mst3 Kinase Length = 303		2e-18
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		2e-18
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		2e-18
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		2e-18
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		2e-18
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		2e-18
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		2e-18
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		2e-18
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		2e-18
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		2e-18
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		2e-18
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		3e-18
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		3e-18
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		3e-18
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		3e-18
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		3e-18
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		3e-18
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		3e-18
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		3e-18
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		3e-18
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		3e-18
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		4e-18
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		4e-18
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		4e-18
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		4e-18
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		4e-18
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		4e-18
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		5e-18
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		5e-18
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		5e-18
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		6e-18
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		6e-18
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		6e-18
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		6e-18
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		6e-18
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		7e-18
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		7e-18
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		7e-18
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		7e-18
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		7e-18
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		8e-18
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		8e-18
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		8e-18
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		8e-18
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		8e-18
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		8e-18
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		9e-18
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		9e-18
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		9e-18
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		9e-18
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		9e-18
2oza_B	366	Structure Of P38alpha Complex Length = 366		9e-18
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		9e-18
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		1e-17
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		1e-17
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		1e-17
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		1e-17
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		2e-17
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		2e-17
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		2e-17
2vd5_A	412	Structure Of Human Myotonic Dystrophy Protein Kinas		2e-17
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		2e-17
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		3e-17
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		3e-17
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		3e-17
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		4e-17
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		4e-17
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		5e-17
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		6e-17
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		6e-17
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		7e-17
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		7e-17
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		8e-17
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		9e-17
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		1e-16
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		1e-16
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		1e-16
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		1e-16
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		1e-16
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		1e-16
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		2e-16
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		2e-16
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		2e-16
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		2e-16
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		2e-16
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		2e-16
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		2e-16
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		2e-16
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		2e-16
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		2e-16
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		2e-16
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		2e-16
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		3e-16
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		3e-16
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		4e-16
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		4e-16
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		4e-16
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		4e-16
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		4e-16
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		5e-16
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		5e-16
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		5e-16
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		8e-16
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		8e-16
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		9e-16
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		9e-16
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		9e-16
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		9e-16
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		1e-15
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		1e-15
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		1e-15
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		1e-15
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		1e-15
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		1e-15
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		1e-15
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		1e-15
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		1e-15
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		1e-15
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		1e-15
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		1e-15
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		1e-15
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		1e-15
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		1e-15
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		1e-15
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		1e-15
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		1e-15
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		1e-15
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		1e-15
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		1e-15
2ehb_D	143	The Structure Of The C-Terminal Domain Of The Prote		1e-15
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		2e-15
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		2e-15
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		2e-15
3a4o_X	286	Lyn Kinase Domain Length = 286		2e-15
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		2e-15
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		2e-15
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		2e-15
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		2e-15
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		2e-15
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		2e-15
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		2e-15
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		2e-15
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		2e-15
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		3e-15
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		3e-15
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		3e-15
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		3e-15
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		3e-15
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		3e-15
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		3e-15
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		3e-15
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		3e-15
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		3e-15
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		4e-15
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		4e-15
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		4e-15
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		4e-15
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		4e-15
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		4e-15
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		4e-15
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		4e-15
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		4e-15
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		5e-15
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		5e-15
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		5e-15
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		5e-15
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		5e-15
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		5e-15
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		5e-15
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		5e-15
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		5e-15
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		5e-15
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		5e-15
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		5e-15
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		5e-15
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		5e-15
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		5e-15
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		5e-15
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		6e-15
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		6e-15
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		6e-15
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		7e-15
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		8e-15
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		8e-15
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		9e-15
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		9e-15
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		1e-14
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		1e-14
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		1e-14
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		1e-14
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		1e-14
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		1e-14
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		1e-14
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		1e-14
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		2e-14
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		2e-14
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		2e-14
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		2e-14
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		2e-14
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		2e-14
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		2e-14
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		2e-14
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		3e-14
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		3e-14
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		3e-14
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		4e-14
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		4e-14
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		4e-14
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		4e-14
4exu_A	371	Mapk13, Inactive Form Length = 371		4e-14
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		4e-14
4g3g_A	350	Crystal Structure Of Murine Nf-kappab Inducing Kina		5e-14
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		5e-14
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		5e-14
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		5e-14
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		5e-14
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		6e-14
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		6e-14
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		6e-14
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		6e-14
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		6e-14
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		7e-14
3rp9_A	458	Crystal Structure Of The Apo Mapk From Toxoplasma G		7e-14
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		7e-14
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		7e-14
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		7e-14
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		8e-14
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		8e-14
4g3f_A	336	Crystal Structure Of Murine Nf-kappab Inducing Kina		9e-14
4g3c_A	352	Crystal Structure Of Apo Murine Nf-kappab Inducing		9e-14
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		9e-14
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		9e-14
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		1e-13
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		1e-13
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		1e-13
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		1e-13
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		1e-13
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-13
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		1e-13
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		1e-13
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		1e-13
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-13
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		1e-13
3b2t_A	311	Structure Of Phosphotransferase Length = 311		1e-13
2pl0_A	289	Lck Bound To Imatinib Length = 289		1e-13
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		1e-13
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-13
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		1e-13
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		1e-13
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		1e-13
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		1e-13
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		1e-13
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		1e-13
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		2e-13
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		2e-13
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		2e-13
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		2e-13
3rgf_A	405	Crystal Structure Of Human Cdk8CYCC Length = 405		2e-13
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		2e-13
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		2e-13
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		2e-13
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		2e-13
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		2e-13
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		2e-13
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		2e-13
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		2e-13
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		2e-13
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		2e-13
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		2e-13
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		2e-13
4h58_A	275	Braf In Complex With Compound 3 Length = 275		2e-13
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		2e-13
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		2e-13
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		2e-13
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		2e-13
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		2e-13
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		2e-13
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-13
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		2e-13
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		2e-13
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		2e-13
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		2e-13
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		2e-13
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		2e-13
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		3e-13
3nie_A	429	Crystal Structure Of Pf11_0147 Length = 429		3e-13
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		3e-13
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		3e-13
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		3e-13
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		3e-13
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		3e-13
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		4e-13
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		4e-13
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		4e-13
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		4e-13
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		4e-13
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		4e-13
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		4e-13
3o17_A	370	Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3		4e-13
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		4e-13
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		4e-13
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		4e-13
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		4e-13
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		5e-13
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		5e-13
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		5e-13
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		5e-13
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		5e-13
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		5e-13
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		6e-13
2y4i_B	319	Ksr2-Mek1 Heterodimer Length = 319		6e-13
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		6e-13
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		6e-13
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		6e-13
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		7e-13
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		7e-13
3kga_A	299	Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe		7e-13
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		7e-13
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		8e-13
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		9e-13
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		9e-13
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		9e-13
2g01_A	370	Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit		9e-13
2p0c_A	313	Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro		9e-13
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		1e-12
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		1e-12
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		1e-12
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		1e-12
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		1e-12
3pze_A	358	Jnk1 In Complex With Inhibitor Length = 358		1e-12
3elj_A	369	Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine		1e-12
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		1e-12
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		2e-12
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		2e-12
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		2e-12
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		2e-12
4eut_A	396	Structure Of Bx-795 Complexed With Unphosphorylated		2e-12
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		2e-12
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		3e-12
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		3e-12
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		3e-12
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		3e-12
3p1a_A	311	Structure Of Human Membrane-Associated Tyrosine- An		3e-12
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		4e-12
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		4e-12
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		4e-12
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		4e-12
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		4e-12
4euu_A	319	Structure Of Bx-795 Complexed With Human Tbk1 Kinas		5e-12
3e3p_A	360	Glycogen Synthase Kinase From Leishmania Major Leng		5e-12
3kvw_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		5e-12
4azf_A	417	Human Dyrk2 In Complex With Leucettine L41 Length =		5e-12
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		5e-12
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		5e-12
3n9x_A	432	Crystal Structure Of Map Kinase From Plasmodium Ber		5e-12
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		6e-12
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		7e-12
1na7_A	329	Crystal Structure Of The Catalytic Subunit Of Human		7e-12
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		7e-12
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		8e-12
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		8e-12
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		8e-12
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		8e-12
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		8e-12
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		8e-12
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		8e-12
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		9e-12
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		9e-12
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		9e-12
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		9e-12
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		9e-12
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		9e-12
1z57_A	339	Crystal Structure Of Human Clk1 In Complex With 10z		1e-11
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		1e-11
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		1e-11
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		1e-11
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		1e-11
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		1e-11
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		1e-11
3qup_A	323	Inhibitor Bound Structure Of The Kinase Domain Of T		1e-11
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		1e-11
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		1e-11
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		1e-11
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		2e-11
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		2e-11
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		2e-11
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		2e-11
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		2e-11
3g0f_A	336	Kit Kinase Domain Mutant D816h In Complex With Suni		2e-11
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		2e-11
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		2e-11
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		2e-11
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		2e-11
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		2e-11
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-11
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-11
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		2e-11
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-11
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		2e-11
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		2e-11
4fl3_A	635	Structural And Biophysical Characterization Of The		3e-11
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		3e-11
4gt4_A	308	Structure Of Unliganded, Inactive Ror2 Kinase Domai		3e-11
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		3e-11
2vag_A	339	Crystal Structure Of Di-Phosphorylated Human Clk1 I		3e-11
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		3e-11
4fl2_A	636	Structural And Biophysical Characterization Of The		3e-11
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		3e-11
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		3e-11
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		3e-11
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		3e-11
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		3e-11
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		3e-11
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		3e-11
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		3e-11
3k2l_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		3e-11
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		3e-11
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		3e-11
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		3e-11
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		4e-11
3zzw_A	289	Crystal Structure Of The Kinase Domain Of Ror2 Leng		4e-11
3eb0_A	383	Crystal Structure Of Cgd4_240 From Cryptosporidium		6e-11
3enm_A	316	The Structure Of The Map2k Mek6 Reveals An Autoinhi		7e-11
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		8e-11
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		8e-11
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		8e-11
3hmn_A	342	Crystal Structure Of Human Mps1 Catalytic Domain In		9e-11
2pzi_A	681	Crystal Structure Of Protein Kinase Pkng From Mycob		1e-10
3cek_A	313	Crystal Structure Of Human Dual Specificity Protein		1e-10
2zmc_A	390	Crystal Structure Of Human Mitotic Checkpoint Kinas		1e-10
3dbq_A	343	Crystal Structure Of Ttk Kinase Domain Length = 343		1e-10
2zmd_A	390	Crystal Structure Of Human Mps1 Catalytic Domain T6		1e-10
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		1e-10
3vqu_A	320	Crystal Structure Of Human Mps1 Catalytic Domain In		1e-10
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		1e-10
2x9e_A	317	Human Mps1 In Complex With Nms-P715 Length = 317		1e-10
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		2e-10
2buj_A	317	Crystal Structure Of The Human Serine-Threonine Kin		2e-10
3h9f_A	313	Crystal Structure Of Human Dual Specificity Protein		2e-10
1pkg_A	329	Structure Of A C-kit Kinase Product Complex Length		2e-10
1t45_A	331	Structural Basis For The Autoinhibition And Sti-571		2e-10
3g0e_A	336	Kit Kinase Domain In Complex With Sunitinib Length		2e-10
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		2e-10
1t46_A	313	Structural Basis For The Autoinhibition And Sti-571		2e-10
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		3e-10
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		4e-10
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		4e-10
1q8y_A	373	The Structure Of The Yeast Sr Protein Kinase, Sky1p		5e-10
1how_A	373	The X-Ray Crystal Structure Of Sky1p, An Sr Protein		6e-10
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		6e-10
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		6e-10
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		6e-10
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		6e-10
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		7e-10
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		7e-10
1fvr_A	327	Tie2 Kinase Domain Length = 327		7e-10
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		9e-10
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		1e-09
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		1e-09
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		1e-09
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		1e-09
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		1e-09
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		1e-09
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		1e-09
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		2e-09
3uib_A	362	Map Kinase Lmampk10 From Leishmania Major In Comple		2e-09
3pg1_A	362	Map Kinase Lmampk10 From Leishmania Major (1.95 Ang		2e-09
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		2e-09
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		2e-09
1p14_A	306	Crystal Structure Of A Catalytic-Loop Mutant Of The		2e-09
3sdj_A	448	Structure Of Rnase-Inactive Point Mutant Of Oligome		2e-09
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		2e-09
3fbv_A	448	Crystal Structure Of The Oligomer Formed By The Kin		3e-09
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		5e-09
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		5e-09
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		6e-09
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		8e-09
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		9e-09
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		9e-09
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		9e-09
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		9e-09
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		9e-09
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		1e-08
2rio_A	434	Structure Of The Dual Enzyme Ire1 Reveals The Basis		1e-08
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		1e-08
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		1e-08
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		1e-08
3lj0_A	434	Ire1 Complexed With Adp And Quercetin Length = 434		2e-08
2vx3_A	382	Crystal Structure Of The Human Dual Specificity Tyr		2e-08
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		2e-08
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		2e-08
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		2e-08
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		2e-08
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		2e-08
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		2e-08
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		2e-08
3anq_A	368	Human Dyrk1aINHIBITOR COMPLEX Length = 368		2e-08
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		2e-08
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		2e-08
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		2e-08
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		2e-08
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		2e-08
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		2e-08
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		2e-08
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		2e-08
4aze_A	382	Human Dyrk1a In Complex With Leucettine L41 Length		3e-08
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		3e-08
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		3e-08
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		3e-08
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		3e-08
3llt_A	360	Crystal Structure Of Pf14_0431, Kinase Domain Lengt		3e-08
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		4e-08
2wtk_B	373	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		4e-08
3gni_B	389	Structure Of Strad And Mo25 Length = 389		4e-08
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		4e-08
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		4e-08
3qd2_B	332	Crsytal Structure Of Mouse Perk Kinase Domain Lengt		4e-08
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		5e-08
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		5e-08
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		6e-08
2in6_A	287	Wee1 Kinase Complex With Inhibitor Pd311839 Length		7e-08
3d94_A	301	Crystal Structure Of The Insulin-Like Growth Factor		7e-08
3bi6_A	287	Wee1 Kinase Complex With Inhibitor Pd352396 Length		8e-08
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		8e-08
3p23_A	432	Crystal Structure Of The Human Kinase And Rnase Dom		8e-08
1x8b_A	289	Structure Of Human Wee1a Kinase: Kinase Domain Comp		8e-08
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		8e-08
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		9e-08
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		9e-08

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score =  247 bits (631), Expect = 8e-66,   Method: Compositional matrix adjust.
 Identities = 134/298 (44%), Positives = 183/298 (61%), Gaps = 31/298 (10%)
Query: 3   IAEK-KQEG-MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQ 60
           +AEK K +G +++G Y LG TLG G FGKVK  +   +G   AVKIL + +I  L +  +
Sbjct: 3   MAEKQKHDGRVKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGK 62
Query: 61  IKREIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLF 120
           I+REI  LKL +HP++++L++V+++ S I+MV+EYV+GGELFD I   GRL E E R+LF
Sbjct: 63  IRREIQNLKLFRHPHIIKLYQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLF 122
Query: 121 QQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP 180
           QQ++ GV YCH   V HRDLK EN+LLD+  N KI+DFGLS +     D   L  +CGSP
Sbjct: 123 QQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNM---MSDGEFLRXSCGSP 179
Query: 181 NYVAPEVLANRGYDGATSDIWSCGVILY--------------------IFRGDFKLPKWL 220
           NY APEV++ R Y G   DIWS GVILY                    I  G F  P++L
Sbjct: 180 NYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIFYTPQYL 239
Query: 221 SPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYT----PANPDDDEEDIFVDNEAF 274
           +P   +LL+ +L+ +P+KR TI  I+  EWF+QD      P +P        +D+EA 
Sbjct: 240 NPSVISLLKHMLQVDPMKRATIKDIREHEWFKQDLPKYLFPEDP--SYSSTMIDDEAL 295

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score =  244 bits (622), Expect = 9e-65,   Method: Compositional matrix adjust.
 Identities = 124/269 (46%), Positives = 172/269 (63%), Gaps = 24/269 (8%)
Query: 7   KQEG-MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREI 65
           K +G +++G Y LG TLG G FGKVK  +   +G   AVKIL + +I  L +  +IKREI
Sbjct: 3   KHDGRVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREI 62
Query: 66  ATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLID 125
             LKL +HP++++L++V+++ +  +MV+EYV+GGELFD I   GR++E E R+LFQQ++ 
Sbjct: 63  QNLKLFRHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILS 122
Query: 126 GVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAP 185
            V YCH   V HRDLK EN+LLD+  N KI+DFGLS +     D   L T+CGSPNY AP
Sbjct: 123 AVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNM---MSDGEFLRTSCGSPNYAAP 179
Query: 186 EVLANRGYDGATSDIWSCGVILY----------------IFR----GDFKLPKWLSPGAQ 225
           EV++ R Y G   DIWSCGVILY                +F+    G F +P++L+    
Sbjct: 180 EVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFYIPEYLNRSVA 239
Query: 226 NLLRKILEPNPVKRITIAGIKADEWFEQD 254
            LL  +L+ +P+KR TI  I+  EWF+QD
Sbjct: 240 TLLMHMLQVDPLKRATIKDIREHEWFKQD 268

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score =  241 bits (615), Expect = 5e-64,   Method: Compositional matrix adjust.
 Identities = 123/269 (45%), Positives = 171/269 (63%), Gaps = 24/269 (8%)
Query: 7   KQEG-MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREI 65
           K +G +++G Y LG TLG G FGKVK  +   +G   AVKIL + +I  L +  +IKREI
Sbjct: 3   KHDGRVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREI 62
Query: 66  ATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLID 125
             LKL +HP++++L++V+++ +  +MV+EYV+GGELFD I   GR++E E R+LFQQ++ 
Sbjct: 63  QNLKLFRHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILS 122
Query: 126 GVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAP 185
            V YCH   V HRDLK EN+LLD+  N KI+DFGLS +     D   L  +CGSPNY AP
Sbjct: 123 AVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNM---MSDGEFLRDSCGSPNYAAP 179
Query: 186 EVLANRGYDGATSDIWSCGVILY----------------IFR----GDFKLPKWLSPGAQ 225
           EV++ R Y G   DIWSCGVILY                +F+    G F +P++L+    
Sbjct: 180 EVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFYIPEYLNRSVA 239
Query: 226 NLLRKILEPNPVKRITIAGIKADEWFEQD 254
            LL  +L+ +P+KR TI  I+  EWF+QD
Sbjct: 240 TLLMHMLQVDPLKRATIKDIREHEWFKQD 268

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score =  238 bits (606), Expect = 7e-63,   Method: Compositional matrix adjust.
 Identities = 117/266 (43%), Positives = 168/266 (63%), Gaps = 24/266 (9%)
Query: 9   EGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATL 68
           +G  +G Y++ +TLGEG+FGKVK A    +G   A+KI+ K  +    +  +I+REI+ L
Sbjct: 9   DGAHIGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYL 68
Query: 69  KLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVS 128
           +LL+HP++++L++V+ SK +I MV+EY  G ELFD I  + ++ E E R+ FQQ+I  V 
Sbjct: 69  RLLRHPHIIKLYDVIKSKDEIIMVIEY-AGNELFDYIVQRDKMSEQEARRFFQQIISAVE 127
Query: 129 YCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVL 188
           YCH   + HRDLK EN+LLD   N+KI+DFGLS +     D   L T+CGSPNY APEV+
Sbjct: 128 YCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNI---MTDGNFLKTSCGSPNYAAPEVI 184
Query: 189 ANRGYDGATSDIWSCGVILYIF--------------------RGDFKLPKWLSPGAQNLL 228
           + + Y G   D+WSCGVILY+                      G + LPK+LSPGA  L+
Sbjct: 185 SGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYTLPKFLSPGAAGLI 244
Query: 229 RKILEPNPVKRITIAGIKADEWFEQD 254
           +++L  NP+ RI+I  I  D+WF+ D
Sbjct: 245 KRMLIVNPLNRISIHEIMQDDWFKVD 270

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score =  237 bits (605), Expect = 8e-63,   Method: Compositional matrix adjust.
 Identities = 117/266 (43%), Positives = 168/266 (63%), Gaps = 24/266 (9%)
Query: 9   EGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATL 68
           +G  +G Y++ +TLGEG+FGKVK A    +G   A+KI+ K  +    +  +I+REI+ L
Sbjct: 8   DGAHIGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYL 67
Query: 69  KLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVS 128
           +LL+HP++++L++V+ SK +I MV+EY  G ELFD I  + ++ E E R+ FQQ+I  V 
Sbjct: 68  RLLRHPHIIKLYDVIKSKDEIIMVIEY-AGNELFDYIVQRDKMSEQEARRFFQQIISAVE 126
Query: 129 YCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVL 188
           YCH   + HRDLK EN+LLD   N+KI+DFGLS +     D   L T+CGSPNY APEV+
Sbjct: 127 YCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNI---MTDGNFLKTSCGSPNYAAPEVI 183
Query: 189 ANRGYDGATSDIWSCGVILYIF--------------------RGDFKLPKWLSPGAQNLL 228
           + + Y G   D+WSCGVILY+                      G + LPK+LSPGA  L+
Sbjct: 184 SGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYTLPKFLSPGAAGLI 243
Query: 229 RKILEPNPVKRITIAGIKADEWFEQD 254
           +++L  NP+ RI+I  I  D+WF+ D
Sbjct: 244 KRMLIVNPLNRISIHEIMQDDWFKVD 269

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score =  237 bits (604), Expect = 1e-62,   Method: Compositional matrix adjust.
 Identities = 117/266 (43%), Positives = 168/266 (63%), Gaps = 24/266 (9%)
Query: 9   EGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATL 68
           +G  +G Y++ +TLGEG+FGKVK A    +G   A+KI+ K  +    +  +I+REI+ L
Sbjct: 3   DGAHIGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYL 62
Query: 69  KLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVS 128
           +LL+HP++++L++V+ SK +I MV+EY  G ELFD I  + ++ E E R+ FQQ+I  V 
Sbjct: 63  RLLRHPHIIKLYDVIKSKDEIIMVIEY-AGNELFDYIVQRDKMSEQEARRFFQQIISAVE 121
Query: 129 YCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVL 188
           YCH   + HRDLK EN+LLD   N+KI+DFGLS +     D   L T+CGSPNY APEV+
Sbjct: 122 YCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNI---MTDGNFLKTSCGSPNYAAPEVI 178
Query: 189 ANRGYDGATSDIWSCGVILYIF--------------------RGDFKLPKWLSPGAQNLL 228
           + + Y G   D+WSCGVILY+                      G + LPK+LSPGA  L+
Sbjct: 179 SGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYTLPKFLSPGAAGLI 238
Query: 229 RKILEPNPVKRITIAGIKADEWFEQD 254
           +++L  NP+ RI+I  I  D+WF+ D
Sbjct: 239 KRMLIVNPLNRISIHEIMQDDWFKVD 264

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score =  234 bits (598), Expect = 6e-62,   Method: Compositional matrix adjust.
 Identities = 116/262 (44%), Positives = 166/262 (63%), Gaps = 24/262 (9%)
Query: 13  LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK 72
           +G Y++ +TLGEG+FGKVK A    +G   A+KI+ K  +    +  +I+REI+ L+LL+
Sbjct: 3   IGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLR 62
Query: 73  HPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHN 132
           HP++++L++V+ SK +I MV+EY  G ELFD I  + ++ E E R+ FQQ+I  V YCH 
Sbjct: 63  HPHIIKLYDVIKSKDEIIMVIEY-AGNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHR 121
Query: 133 KGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRG 192
             + HRDLK EN+LLD   N+KI+DFGLS +     D   L T+CGSPNY APEV++ + 
Sbjct: 122 HKIVHRDLKPENLLLDEHLNVKIADFGLSNI---MTDGNFLKTSCGSPNYAAPEVISGKL 178
Query: 193 YDGATSDIWSCGVILYIF--------------------RGDFKLPKWLSPGAQNLLRKIL 232
           Y G   D+WSCGVILY+                      G + LPK+LSPGA  L++++L
Sbjct: 179 YAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYTLPKFLSPGAAGLIKRML 238
Query: 233 EPNPVKRITIAGIKADEWFEQD 254
             NP+ RI+I  I  D+WF+ D
Sbjct: 239 IVNPLNRISIHEIMQDDWFKVD 260

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score =  224 bits (570), Expect = 8e-59,   Method: Compositional matrix adjust.
 Identities = 111/259 (42%), Positives = 163/259 (62%), Gaps = 24/259 (9%)
Query: 13  LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK 72
           +G Y +  TLGEG+FGKVK A    +    A+K + +  +    +  +++REI+ LKLL+
Sbjct: 8   IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLR 67
Query: 73  HPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHN 132
           HP++++L++V+ + + I MV+EY  GGELFD I  K R+ E EGR+ FQQ+I  + YCH 
Sbjct: 68  HPHIIKLYDVITTPTDIVMVIEY-AGGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHR 126
Query: 133 KGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRG 192
             + HRDLK EN+LLD   N+KI+DFGLS +     D   L T+CGSPNY APEV+  + 
Sbjct: 127 HKIVHRDLKPENLLLDDNLNVKIADFGLSNI---MTDGNFLKTSCGSPNYAAPEVINGKL 183
Query: 193 YDGATSDIWSCGVILYI-------FRGDF-------------KLPKWLSPGAQNLLRKIL 232
           Y G   D+WSCG++LY+       F  +F              +P +LSPGAQ+L+R+++
Sbjct: 184 YAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNSCVYVMPDFLSPGAQSLIRRMI 243
Query: 233 EPNPVKRITIAGIKADEWF 251
             +P++RITI  I+ D WF
Sbjct: 244 VADPMQRITIQEIRRDPWF 262

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score =  221 bits (562), Expect = 7e-58,   Method: Compositional matrix adjust.
 Identities = 111/280 (39%), Positives = 168/280 (60%), Gaps = 29/280 (10%)
Query: 13  LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK 72
           +G Y L +T+G+GNF KVK A+ + +G   A+KI++K ++    +  ++ RE+  +K+L 
Sbjct: 11  IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSL-QKLFREVRIMKILN 69
Query: 73  HPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHN 132
           HPN+V+L EV+ ++  +Y+++EY +GGE+FD + + GR++E E R  F+Q++  V YCH 
Sbjct: 70  HPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQ 129
Query: 133 KGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRG 192
           K + HRDLK EN+LLD+  NIKI+DFG S     F   G L T CGSP Y APE+   + 
Sbjct: 130 KRIVHRDLKAENLLLDADMNIKIADFGFS---NEFTVGGKLDTFCGSPPYAAPELFQGKK 186
Query: 193 YDGATSDIWSCGVILY--------------------IFRGDFKLPKWLSPGAQNLLRKIL 232
           YDG   D+WS GVILY                    + RG +++P ++S   +NLL++ L
Sbjct: 187 YDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMSTDCENLLKRFL 246
Query: 233 EPNPVKRITIAGIKADEWFEQDYTPANPDDDEEDIFVDNE 272
             NP+KR T+  I  D W       A  ++DE   FV+ E
Sbjct: 247 VLNPIKRGTLEQIMKDRWIN-----AGHEEDELKPFVEPE 281

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score =  219 bits (557), Expect = 3e-57,   Method: Compositional matrix adjust.
 Identities = 112/290 (38%), Positives = 170/290 (58%), Gaps = 29/290 (10%)
Query: 3   IAEKKQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIK 62
           IA    E   +G Y L +T+G+GNF KVK A+ + +G   A+KI++K ++    +  ++ 
Sbjct: 4   IASCADEQPHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSL-QKLF 62
Query: 63  REIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQ 122
           RE+  +K+L HPN+V+L EV+ ++  +Y+++EY +GGE+FD + + GR++E E R  F+Q
Sbjct: 63  REVRIMKILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQ 122
Query: 123 LIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNY 182
           ++  V YCH K + HRDLK EN+LLD+  NIKI+DFG S     F   G L   CG+P Y
Sbjct: 123 IVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFS---NEFTVGGKLDAFCGAPPY 179
Query: 183 VAPEVLANRGYDGATSDIWSCGVILY--------------------IFRGDFKLPKWLSP 222
            APE+   + YDG   D+WS GVILY                    + RG +++P ++S 
Sbjct: 180 AAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMST 239
Query: 223 GAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPANPDDDEEDIFVDNE 272
             +NLL++ L  NP+KR T+  I  D W       A  ++DE   FV+ E
Sbjct: 240 DCENLLKRFLVLNPIKRGTLEQIMKDRWIN-----AGHEEDELKPFVEPE 284

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score =  216 bits (549), Expect = 2e-56,   Method: Compositional matrix adjust.
 Identities = 113/287 (39%), Positives = 166/287 (57%), Gaps = 29/287 (10%)
Query: 4   AEKKQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKR 63
           A    E   +G Y L +T+G+GNF KVK A+ + +G   AVKI++K ++    +  ++ R
Sbjct: 4   ATSADEQPHIGNYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSL-QKLFR 62
Query: 64  EIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQL 123
           E+  +K+L HPN+V+L EV+ ++  +Y+V+EY +GGE+FD + + GR++E E R  F+Q+
Sbjct: 63  EVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQI 122
Query: 124 IDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYV 183
           +  V YCH K + HRDLK EN+LLD+  NIKI+DFG S     F     L T CGSP Y 
Sbjct: 123 VSAVQYCHQKFIVHRDLKAENLLLDADMNIKIADFGFS---NEFTFGNKLDTFCGSPPYA 179
Query: 184 APEVLANRGYDGATSDIWSCGVILY--------------------IFRGDFKLPKWLSPG 223
           APE+   + YDG   D+WS GVILY                    + RG +++P ++S  
Sbjct: 180 APELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMSTD 239
Query: 224 AQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPANPDDDEEDIFVD 270
            +NLL+K L  NP KR T+  I  D W          +DDE   +V+
Sbjct: 240 CENLLKKFLILNPSKRGTLEQIMKDRWMN-----VGHEDDELKPYVE 281

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score =  215 bits (548), Expect = 3e-56,   Method: Compositional matrix adjust.
 Identities = 109/268 (40%), Positives = 159/268 (59%), Gaps = 24/268 (8%)
Query: 4   AEKKQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKR 63
           A    E   +G Y L +T+G+GNF KVK A+ + +G   AVKI++K ++    +  ++ R
Sbjct: 4   ATSADEQPHIGNYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSL-QKLFR 62
Query: 64  EIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQL 123
           E+  +K+L HPN+V+L EV+ ++  +Y+V+EY +GGE+FD + + GR++E E R  F+Q+
Sbjct: 63  EVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQI 122
Query: 124 IDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYV 183
           +  V YCH K + HRDLK EN+LLD+  NIKI+DFG S     F     L T CGSP Y 
Sbjct: 123 VSAVQYCHQKFIVHRDLKAENLLLDADMNIKIADFGFS---NEFTFGNKLDTFCGSPPYA 179
Query: 184 APEVLANRGYDGATSDIWSCGVILY--------------------IFRGDFKLPKWLSPG 223
           APE+   + YDG   D+WS GVILY                    + RG +++P ++S  
Sbjct: 180 APELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMSTD 239
Query: 224 AQNLLRKILEPNPVKRITIAGIKADEWF 251
            +NLL+K L  NP KR T+  I  D W 
Sbjct: 240 CENLLKKFLILNPSKRGTLEQIMKDRWM 267

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score =  215 bits (547), Expect = 4e-56,   Method: Compositional matrix adjust.
 Identities = 112/287 (39%), Positives = 166/287 (57%), Gaps = 29/287 (10%)
Query: 4   AEKKQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKR 63
           A    E   +G Y L +T+G+GNF KVK A+ + +G   AV+I++K ++    +  ++ R
Sbjct: 4   ATSADEQPHIGNYRLLKTIGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSL-QKLFR 62
Query: 64  EIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQL 123
           E+  +K+L HPN+V+L EV+ ++  +Y+V+EY +GGE+FD + + GR++E E R  F+Q+
Sbjct: 63  EVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQI 122
Query: 124 IDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYV 183
           +  V YCH K + HRDLK EN+LLD+  NIKI+DFG S     F     L T CGSP Y 
Sbjct: 123 VSAVQYCHQKFIVHRDLKAENLLLDADMNIKIADFGFS---NEFTFGNKLDTFCGSPPYA 179
Query: 184 APEVLANRGYDGATSDIWSCGVILY--------------------IFRGDFKLPKWLSPG 223
           APE+   + YDG   D+WS GVILY                    + RG +++P ++S  
Sbjct: 180 APELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMSTD 239
Query: 224 AQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPANPDDDEEDIFVD 270
            +NLL+K L  NP KR T+  I  D W          +DDE   +V+
Sbjct: 240 CENLLKKFLILNPSKRGTLEQIMKDRWMN-----VGHEDDELKPYVE 281

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score =  213 bits (541), Expect = 2e-55,   Method: Compositional matrix adjust.
 Identities = 111/287 (38%), Positives = 166/287 (57%), Gaps = 29/287 (10%)
Query: 4   AEKKQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKR 63
           A    E   +G Y L +T+G+GNF KVK A+ + +G   AVKI++K ++    +  ++ R
Sbjct: 4   ATSADEQPHIGNYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSL-QKLFR 62
Query: 64  EIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQL 123
           E+  +K+L HPN+V+L EV+ ++  +Y+V+EY +GGE+FD + + GR++E E R  F+Q+
Sbjct: 63  EVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQI 122
Query: 124 IDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYV 183
           +  V YCH K + HRDLK EN+LLD+  NIKI+DFG S     F     L   CG+P Y 
Sbjct: 123 VSAVQYCHQKFIVHRDLKAENLLLDADMNIKIADFGFS---NEFTFGNKLDAFCGAPPYA 179
Query: 184 APEVLANRGYDGATSDIWSCGVILY--------------------IFRGDFKLPKWLSPG 223
           APE+   + YDG   D+WS GVILY                    + RG +++P ++S  
Sbjct: 180 APELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMSTD 239
Query: 224 AQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPANPDDDEEDIFVD 270
            +NLL+K L  NP KR T+  I  D W    +     +DDE   +V+
Sbjct: 240 CENLLKKFLILNPSKRGTLEQIMKDRWMNVGH-----EDDELKPYVE 281

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score =  213 bits (541), Expect = 2e-55,   Method: Compositional matrix adjust.
 Identities = 110/280 (39%), Positives = 164/280 (58%), Gaps = 29/280 (10%)
Query: 11  MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKL 70
           + +G Y L +T+G+GNF KVK A+ + +G   AVKI++K ++    +  ++ RE+  +K+
Sbjct: 4   LHIGNYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSL-QKLFREVRIMKV 62
Query: 71  LKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYC 130
           L HPN+V+L EV+ ++  +Y+V+EY +GGE+FD + + G ++E E R  F+Q++  V YC
Sbjct: 63  LNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGWMKEKEARAKFRQIVSAVQYC 122
Query: 131 HNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLAN 190
           H K + HRDLK EN+LLD+  NIKI+DFG S     F     L T CGSP Y APE+   
Sbjct: 123 HQKFIVHRDLKAENLLLDADMNIKIADFGFS---NEFTFGNKLDTFCGSPPYAAPELFQG 179
Query: 191 RGYDGATSDIWSCGVILY--------------------IFRGDFKLPKWLSPGAQNLLRK 230
           + YDG   D+WS GVILY                    + RG +++P ++S   +NLL+K
Sbjct: 180 KKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMSTDCENLLKK 239
Query: 231 ILEPNPVKRITIAGIKADEWFEQDYTPANPDDDEEDIFVD 270
            L  NP KR T+  I  D W          +DDE   +V+
Sbjct: 240 FLILNPSKRGTLEQIMKDRWMN-----VGHEDDELKPYVE 274

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score =  213 bits (541), Expect = 2e-55,   Method: Compositional matrix adjust.
 Identities = 111/287 (38%), Positives = 165/287 (57%), Gaps = 29/287 (10%)
Query: 4   AEKKQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKR 63
           A    E   +G Y L +T+G+GNF KVK A+ + +G   AV+I++K ++    +  ++ R
Sbjct: 4   ATSADEQPHIGNYRLLKTIGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSL-QKLFR 62
Query: 64  EIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQL 123
           E+  +K+L HPN+V+L EV+ ++  +Y+V+EY +GGE+FD + + GR++E E R  F+Q+
Sbjct: 63  EVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQI 122
Query: 124 IDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYV 183
           +  V YCH K + HRDLK EN+LLD+  NIKI+DFG S     F     L   CGSP Y 
Sbjct: 123 VSAVQYCHQKFIVHRDLKAENLLLDADMNIKIADFGFS---NEFTFGNKLDEFCGSPPYA 179
Query: 184 APEVLANRGYDGATSDIWSCGVILY--------------------IFRGDFKLPKWLSPG 223
           APE+   + YDG   D+WS GVILY                    + RG +++P ++S  
Sbjct: 180 APELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMSTD 239
Query: 224 AQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPANPDDDEEDIFVD 270
            +NLL+K L  NP KR T+  I  D W          +DDE   +V+
Sbjct: 240 CENLLKKFLILNPSKRGTLEQIMKDRWMN-----VGHEDDELKPYVE 281

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score =  207 bits (526), Expect = 1e-53,   Method: Compositional matrix adjust.
 Identities = 107/267 (40%), Positives = 154/267 (57%), Gaps = 24/267 (8%)
Query: 4   AEKKQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKR 63
           A    E   +G Y L +T+G+GNF KVK A+ + +G   AVKI++K ++    +  ++ R
Sbjct: 4   ATSADEQPHIGNYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSL-QKLFR 62
Query: 64  EIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQL 123
           E+   K+L HPN+V+L EV+ ++  +Y+V EY +GGE+FD + + GR +E E R  F+Q+
Sbjct: 63  EVRIXKVLNHPNIVKLFEVIETEKTLYLVXEYASGGEVFDYLVAHGRXKEKEARAKFRQI 122
Query: 124 IDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYV 183
           +  V YCH K + HRDLK EN+LLD+  NIKI+DFG S     F     L   CG+P Y 
Sbjct: 123 VSAVQYCHQKFIVHRDLKAENLLLDADXNIKIADFGFS---NEFTFGNKLDAFCGAPPYA 179
Query: 184 APEVLANRGYDGATSDIWSCGVILY--------------------IFRGDFKLPKWLSPG 223
           APE+   + YDG   D+WS GVILY                    + RG +++P + S  
Sbjct: 180 APELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYXSTD 239
Query: 224 AQNLLRKILEPNPVKRITIAGIKADEW 250
            +NLL+K L  NP KR T+  I  D W
Sbjct: 240 CENLLKKFLILNPSKRGTLEQIXKDRW 266

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score =  204 bits (519), Expect = 7e-53,   Method: Compositional matrix adjust.
 Identities = 112/287 (39%), Positives = 166/287 (57%), Gaps = 32/287 (11%)
Query: 3   IAEKKQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIK 62
           I     E   +G Y L +T+G+GNF KVK A+ + +G   AVKI++K ++    +  ++ 
Sbjct: 4   ITSATDEQPHIGNYRLQKTIGKGNFAKVKLARHVLTGREVAVKIIDKTQLNPTSL-QKLF 62
Query: 63  REIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQ 122
           RE+  +K+L HPN+V+L EV+ ++  +Y+V+EY +GGE+FD + + GR++E E R  F+Q
Sbjct: 63  REVRIMKILNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQ 122
Query: 123 LIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNY 182
           ++  V YCH K + HRDLK EN+LLD   NIKI+DFG S     F     L T CGSP Y
Sbjct: 123 IVSAVQYCHQKYIVHRDLKAENLLLDGDMNIKIADFGFS---NEFTVGNKLDTFCGSPPY 179
Query: 183 VAPEVLANRGYDGATSDIWSCGVILY--------------------IFRGDFKLPKWLSP 222
            APE+   + YDG   D+WS GVILY                    + RG +++P ++S 
Sbjct: 180 AAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMST 239
Query: 223 GAQNLLRKILEPNPVKRITIAGIKADEWFE--------QDYTPANPD 261
             +NLL+K+L  NP+KR ++  I  D W          + YT  +PD
Sbjct: 240 DCENLLKKLLVLNPIKRGSLEQIMKDRWMNVGHEEEELKPYTEPDPD 286

>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361

Iteration: 1
 Score =  199 bits (506), Expect = 2e-51,   Method: Compositional matrix adjust.
 Identities = 110/269 (40%), Positives = 151/269 (56%), Gaps = 43/269 (15%)
Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
           RYEL + +G GNFG  +  +D  S    AVK +E+      KI + +KREI   + L+HP
Sbjct: 19  RYELVKDIGSGNFGVARLMRDKQSNELVAVKYIERGE----KIDENVKREIINHRSLRHP 74
Query: 75  NVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKG 134
           N+VR  EV+ + + + +V+EY +GGELF++I + GR  E E R  FQQLI GVSYCH   
Sbjct: 75  NIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQ 134
Query: 135 VFHRDLKLENILLDSK--GNIKISDFGLSALPQHFRDDGLLH----TTCGSPNYVAPEVL 188
           V HRDLKLEN LLD      +KI DFG S          +LH    +T G+P Y+APEVL
Sbjct: 135 VCHRDLKLENTLLDGSPAPRLKICDFGYSK-------SSVLHSQPKSTVGTPAYIAPEVL 187
Query: 189 ANRGYDGATSDIWSCGVILYI----------------FRG--------DFKLPKW--LSP 222
             + YDG  +D+WSCGV LY+                FR          + +P +  +SP
Sbjct: 188 LKKEYDGKVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQYAIPDYVHISP 247
Query: 223 GAQNLLRKILEPNPVKRITIAGIKADEWF 251
             ++L+ +I   +P KRI+I  I+  EWF
Sbjct: 248 ECRHLISRIFVADPAKRISIPEIRNHEWF 276

>pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362

Iteration: 1
 Score =  198 bits (504), Expect = 4e-51,   Method: Compositional matrix adjust.
 Identities = 110/269 (40%), Positives = 150/269 (55%), Gaps = 43/269 (15%)
Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
           RYEL + +G GNFG  +  +D  S    AVK +E+      KI   +KREI   + L+HP
Sbjct: 20  RYELVKDIGSGNFGVARLMRDKQSNELVAVKYIERGE----KIAANVKREIINHRSLRHP 75
Query: 75  NVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKG 134
           N+VR  EV+ + + + +V+EY +GGELF++I + GR  E E R  FQQLI GVSYCH   
Sbjct: 76  NIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQ 135
Query: 135 VFHRDLKLENILLDSK--GNIKISDFGLSALPQHFRDDGLLH----TTCGSPNYVAPEVL 188
           V HRDLKLEN LLD      +KI DFG S          +LH    +T G+P Y+APEVL
Sbjct: 136 VCHRDLKLENTLLDGSPAPRLKICDFGYSK-------SSVLHSQPKSTVGTPAYIAPEVL 188
Query: 189 ANRGYDGATSDIWSCGVILYI----------------FRG--------DFKLPKW--LSP 222
             + YDG  +D+WSCGV LY+                FR          + +P +  +SP
Sbjct: 189 LKKEYDGKVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQYAIPDYVHISP 248
Query: 223 GAQNLLRKILEPNPVKRITIAGIKADEWF 251
             ++L+ +I   +P KRI+I  I+  EWF
Sbjct: 249 ECRHLISRIFVADPAKRISIPEIRNHEWF 277

>pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362

Iteration: 1
 Score =  196 bits (498), Expect = 2e-50,   Method: Compositional matrix adjust.
 Identities = 109/269 (40%), Positives = 150/269 (55%), Gaps = 43/269 (15%)
Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
           RYEL + +G GNFG  +  +D  S    AVK +E+      KI + +KREI   + L+HP
Sbjct: 20  RYELVKDIGSGNFGVARLMRDKQSNELVAVKYIERGE----KIDENVKREIINHRSLRHP 75
Query: 75  NVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKG 134
           N+VR  EV+ + + + +V+EY +GGELF++I + GR  E E R  FQQLI GVSYCH   
Sbjct: 76  NIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQ 135
Query: 135 VFHRDLKLENILLDSK--GNIKISDFGLSALPQHFRDDGLLH----TTCGSPNYVAPEVL 188
           V HRDLKLEN LLD      +KI  FG S          +LH    +T G+P Y+APEVL
Sbjct: 136 VCHRDLKLENTLLDGSPAPRLKICAFGYSK-------SSVLHSQPKSTVGTPAYIAPEVL 188
Query: 189 ANRGYDGATSDIWSCGVILYI----------------FRG--------DFKLPKW--LSP 222
             + YDG  +D+WSCGV LY+                FR          + +P +  +SP
Sbjct: 189 LKKEYDGKVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQYAIPDYVHISP 248
Query: 223 GAQNLLRKILEPNPVKRITIAGIKADEWF 251
             ++L+ +I   +P KRI+I  I+  EWF
Sbjct: 249 ECRHLISRIFVADPAKRISIPEIRNHEWF 277

>pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362

Iteration: 1
 Score =  196 bits (498), Expect = 2e-50,   Method: Compositional matrix adjust.
 Identities = 109/269 (40%), Positives = 150/269 (55%), Gaps = 43/269 (15%)
Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
           RYEL + +G GNFG  +  +D  S    AVK +E+      KI + +KREI   + L+HP
Sbjct: 20  RYELVKDIGSGNFGVARLMRDKQSNELVAVKYIERGE----KIDENVKREIINHRSLRHP 75
Query: 75  NVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKG 134
           N+VR  EV+ + + + +V+EY +GGELF++I + GR  E E R  FQQLI GVSYCH   
Sbjct: 76  NIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQ 135
Query: 135 VFHRDLKLENILLDSK--GNIKISDFGLSALPQHFRDDGLLHT----TCGSPNYVAPEVL 188
           V HRDLKLEN LLD      +KI  FG S          +LH+    T G+P Y+APEVL
Sbjct: 136 VCHRDLKLENTLLDGSPAPRLKICAFGYSK-------SSVLHSQPKDTVGTPAYIAPEVL 188
Query: 189 ANRGYDGATSDIWSCGVILYI----------------FRG--------DFKLPKW--LSP 222
             + YDG  +D+WSCGV LY+                FR          + +P +  +SP
Sbjct: 189 LKKEYDGKVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQYAIPDYVHISP 248
Query: 223 GAQNLLRKILEPNPVKRITIAGIKADEWF 251
             ++L+ +I   +P KRI+I  I+  EWF
Sbjct: 249 ECRHLISRIFVADPAKRISIPEIRNHEWF 277

>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317

Iteration: 1
 Score =  192 bits (489), Expect = 2e-49,   Method: Compositional matrix adjust.
 Identities = 107/269 (39%), Positives = 150/269 (55%), Gaps = 43/269 (15%)
Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
           RYEL + +G GNFG  +  +D  +    AVK +E+      KI + +KREI   + L+HP
Sbjct: 20  RYELVKDIGAGNFGVARLMRDKQANELVAVKYIERGE----KIDENVKREIINHRSLRHP 75
Query: 75  NVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKG 134
           N+VR  EV+ + + + +V+EY +GGELF++I + GR  E E R  FQQLI GVSY H   
Sbjct: 76  NIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYAHAMQ 135
Query: 135 VFHRDLKLENILLDSK--GNIKISDFGLSALPQHFRDDGLLH----TTCGSPNYVAPEVL 188
           V HRDLKLEN LLD      +KI+DFG S          +LH    +  G+P Y+APEVL
Sbjct: 136 VAHRDLKLENTLLDGSPAPRLKIADFGYSKA-------SVLHSQPKSAVGTPAYIAPEVL 188
Query: 189 ANRGYDGATSDIWSCGVILYI----------------FRG--------DFKLPKW--LSP 222
             + YDG  +D+WSCGV LY+                FR          + +P +  +SP
Sbjct: 189 LKKEYDGKVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQYAIPDYVHISP 248
Query: 223 GAQNLLRKILEPNPVKRITIAGIKADEWF 251
             ++L+ +I   +P KRI+I  I+  EWF
Sbjct: 249 ECRHLISRIFVADPAKRISIPEIRNHEWF 277

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score =  181 bits (459), Expect = 6e-46,   Method: Compositional matrix adjust.
 Identities = 99/269 (36%), Positives = 144/269 (53%), Gaps = 43/269 (15%)
Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
           RY+  + +G GNFG  +  +D  +    AVK +E+       I + ++REI   + L+HP
Sbjct: 21  RYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERG----AAIDENVQREIINHRSLRHP 76
Query: 75  NVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKG 134
           N+VR  EV+ + + + +++EY +GGEL+++I + GR  E E R  FQQL+ GVSYCH+  
Sbjct: 77  NIVRFKEVILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQ 136
Query: 135 VFHRDLKLENILLDSK--GNIKISDFGLSALPQHFRDDGLLH----TTCGSPNYVAPEVL 188
           + HRDLKLEN LLD      +KI DFG S          +LH    +T G+P Y+APEVL
Sbjct: 137 ICHRDLKLENTLLDGSPAPRLKICDFGYSK-------SSVLHSQPKSTVGTPAYIAPEVL 189
Query: 189 ANRGYDGATSDIWSCGVILY------------------------IFRGDFKLPK--WLSP 222
             + YDG  +D+WSCGV LY                        I    + +P    +SP
Sbjct: 190 LRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDDIRISP 249
Query: 223 GAQNLLRKILEPNPVKRITIAGIKADEWF 251
              +L+ +I   +P  RI+I  IK   WF
Sbjct: 250 ECCHLISRIFVADPATRISIPEIKTHSWF 278

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score =  169 bits (429), Expect = 2e-42,   Method: Compositional matrix adjust.
 Identities = 102/269 (37%), Positives = 146/269 (54%), Gaps = 33/269 (12%)
Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
           RY+  R LG+G+FG+V   +D  +G   AVK++ K ++      + + RE+  LK L HP
Sbjct: 27  RYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHP 86
Query: 75  NVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKG 134
           N+++L+E    K   Y+V E  TGGELFD+I S+ R  E +  ++ +Q++ G++Y H   
Sbjct: 87  NIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNK 146
Query: 135 VFHRDLKLENILLDSK---GNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANR 191
           + HRDLK EN+LL+SK    NI+I DFGLS    HF     +    G+  Y+APEVL   
Sbjct: 147 IVHRDLKPENLLLESKSKDANIRIIDFGLST---HFEASKKMKDKIGTAYYIAPEVL--H 201
Query: 192 GYDGATSDIWSCGVILYI-------FRG---------------DFKLPKW--LSPGAQNL 227
           G      D+WS GVILYI       F G                F+LP+W  +S  A++L
Sbjct: 202 GTYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESAKDL 261
Query: 228 LRKILEPNPVKRITIAGIKADEWFEQDYT 256
           +RK+L   P  RI+       EW  Q YT
Sbjct: 262 IRKMLTYVPSMRISARDALDHEWI-QTYT 289

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score =  169 bits (428), Expect = 3e-42,   Method: Compositional matrix adjust.
 Identities = 102/269 (37%), Positives = 146/269 (54%), Gaps = 33/269 (12%)
Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
           RY+  R LG+G+FG+V   +D  +G   AVK++ K ++      + + RE+  LK L HP
Sbjct: 50  RYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHP 109
Query: 75  NVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKG 134
           N+++L+E    K   Y+V E  TGGELFD+I S+ R  E +  ++ +Q++ G++Y H   
Sbjct: 110 NIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNK 169
Query: 135 VFHRDLKLENILLDSK---GNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANR 191
           + HRDLK EN+LL+SK    NI+I DFGLS    HF     +    G+  Y+APEVL   
Sbjct: 170 IVHRDLKPENLLLESKSKDANIRIIDFGLST---HFEASKKMKDKIGTAYYIAPEVL--H 224
Query: 192 GYDGATSDIWSCGVILYI-------FRG---------------DFKLPKW--LSPGAQNL 227
           G      D+WS GVILYI       F G                F+LP+W  +S  A++L
Sbjct: 225 GTYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESAKDL 284
Query: 228 LRKILEPNPVKRITIAGIKADEWFEQDYT 256
           +RK+L   P  RI+       EW  Q YT
Sbjct: 285 IRKMLTYVPSMRISARDALDHEWI-QTYT 312

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score =  169 bits (427), Expect = 3e-42,   Method: Compositional matrix adjust.
 Identities = 98/261 (37%), Positives = 146/261 (55%), Gaps = 25/261 (9%)
Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
           ++L +TLGEG +G+V+ A +  +    AVKI++  R +     + IK+EI   K+L H N
Sbjct: 9   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKMLNHEN 66
Query: 76  VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGV 135
           VV+ +      +  Y+ LEY +GGELFD+I     + E + ++ F QL+ GV Y H  G+
Sbjct: 67  VVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGI 126
Query: 136 FHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDG 195
            HRD+K EN+LLD + N+KISDFGL+ + ++   + LL+  CG+  YVAPE+L  R +  
Sbjct: 127 THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHA 186
Query: 196 ATSDIWSCGVILYIF----------------RGDFKLPK-WLSPGAQ------NLLRKIL 232
              D+WSCG++L                     D+K  K +L+P  +       LL KIL
Sbjct: 187 EPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKIL 246
Query: 233 EPNPVKRITIAGIKADEWFEQ 253
             NP  RITI  IK D W+ +
Sbjct: 247 VENPSARITIPDIKKDRWYNK 267

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score =  169 bits (427), Expect = 3e-42,   Method: Compositional matrix adjust.
 Identities = 98/261 (37%), Positives = 146/261 (55%), Gaps = 25/261 (9%)
Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
           ++L +TLGEG +G+V+ A +  +    AVKI++  R +     + IK+EI   K+L H N
Sbjct: 8   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKMLNHEN 65
Query: 76  VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGV 135
           VV+ +      +  Y+ LEY +GGELFD+I     + E + ++ F QL+ GV Y H  G+
Sbjct: 66  VVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGI 125
Query: 136 FHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDG 195
            HRD+K EN+LLD + N+KISDFGL+ + ++   + LL+  CG+  YVAPE+L  R +  
Sbjct: 126 THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHA 185
Query: 196 ATSDIWSCGVILYIF----------------RGDFKLPK-WLSPGAQ------NLLRKIL 232
              D+WSCG++L                     D+K  K +L+P  +       LL KIL
Sbjct: 186 EPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKIL 245
Query: 233 EPNPVKRITIAGIKADEWFEQ 253
             NP  RITI  IK D W+ +
Sbjct: 246 VENPSARITIPDIKKDRWYNK 266

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score =  169 bits (427), Expect = 3e-42,   Method: Compositional matrix adjust.
 Identities = 102/269 (37%), Positives = 146/269 (54%), Gaps = 33/269 (12%)
Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
           RY+  R LG+G+FG+V   +D  +G   AVK++ K ++      + + RE+  LK L HP
Sbjct: 51  RYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHP 110
Query: 75  NVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKG 134
           N+++L+E    K   Y+V E  TGGELFD+I S+ R  E +  ++ +Q++ G++Y H   
Sbjct: 111 NIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNK 170
Query: 135 VFHRDLKLENILLDSK---GNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANR 191
           + HRDLK EN+LL+SK    NI+I DFGLS    HF     +    G+  Y+APEVL   
Sbjct: 171 IVHRDLKPENLLLESKSKDANIRIIDFGLST---HFEASKKMKDKIGTAYYIAPEVL--H 225
Query: 192 GYDGATSDIWSCGVILYI-------FRG---------------DFKLPKW--LSPGAQNL 227
           G      D+WS GVILYI       F G                F+LP+W  +S  A++L
Sbjct: 226 GTYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESAKDL 285
Query: 228 LRKILEPNPVKRITIAGIKADEWFEQDYT 256
           +RK+L   P  RI+       EW  Q YT
Sbjct: 286 IRKMLTYVPSMRISARDALDHEWI-QTYT 313

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score =  169 bits (427), Expect = 3e-42,   Method: Compositional matrix adjust.
 Identities = 98/261 (37%), Positives = 146/261 (55%), Gaps = 25/261 (9%)
Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
           ++L +TLGEG +G+V+ A +  +    AVKI++  R +     + IK+EI   K+L H N
Sbjct: 9   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKMLNHEN 66
Query: 76  VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGV 135
           VV+ +      +  Y+ LEY +GGELFD+I     + E + ++ F QL+ GV Y H  G+
Sbjct: 67  VVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGI 126
Query: 136 FHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDG 195
            HRD+K EN+LLD + N+KISDFGL+ + ++   + LL+  CG+  YVAPE+L  R +  
Sbjct: 127 THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHA 186
Query: 196 ATSDIWSCGVILYIF----------------RGDFKLPK-WLSPGAQ------NLLRKIL 232
              D+WSCG++L                     D+K  K +L+P  +       LL KIL
Sbjct: 187 EPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKIL 246
Query: 233 EPNPVKRITIAGIKADEWFEQ 253
             NP  RITI  IK D W+ +
Sbjct: 247 VENPSARITIPDIKKDRWYNK 267

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score =  169 bits (427), Expect = 3e-42,   Method: Compositional matrix adjust.
 Identities = 98/261 (37%), Positives = 146/261 (55%), Gaps = 25/261 (9%)
Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
           ++L +TLGEG +G+V+ A +  +    AVKI++  R +     + IK+EI   K+L H N
Sbjct: 9   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKMLNHEN 66
Query: 76  VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGV 135
           VV+ +      +  Y+ LEY +GGELFD+I     + E + ++ F QL+ GV Y H  G+
Sbjct: 67  VVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGI 126
Query: 136 FHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDG 195
            HRD+K EN+LLD + N+KISDFGL+ + ++   + LL+  CG+  YVAPE+L  R +  
Sbjct: 127 THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHA 186
Query: 196 ATSDIWSCGVILYIF----------------RGDFKLPK-WLSPGAQ------NLLRKIL 232
              D+WSCG++L                     D+K  K +L+P  +       LL KIL
Sbjct: 187 EPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKIL 246
Query: 233 EPNPVKRITIAGIKADEWFEQ 253
             NP  RITI  IK D W+ +
Sbjct: 247 VENPSARITIPDIKKDRWYNK 267

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score =  169 bits (427), Expect = 3e-42,   Method: Compositional matrix adjust.
 Identities = 98/261 (37%), Positives = 146/261 (55%), Gaps = 25/261 (9%)
Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
           ++L +TLGEG +G+V+ A +  +    AVKI++  R +     + IK+EI   K+L H N
Sbjct: 9   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKMLNHEN 66
Query: 76  VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGV 135
           VV+ +      +  Y+ LEY +GGELFD+I     + E + ++ F QL+ GV Y H  G+
Sbjct: 67  VVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGI 126
Query: 136 FHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDG 195
            HRD+K EN+LLD + N+KISDFGL+ + ++   + LL+  CG+  YVAPE+L  R +  
Sbjct: 127 THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHA 186
Query: 196 ATSDIWSCGVILYIF----------------RGDFKLPK-WLSPGAQ------NLLRKIL 232
              D+WSCG++L                     D+K  K +L+P  +       LL KIL
Sbjct: 187 EPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKIL 246
Query: 233 EPNPVKRITIAGIKADEWFEQ 253
             NP  RITI  IK D W+ +
Sbjct: 247 VENPSARITIPDIKKDRWYNK 267

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score =  169 bits (427), Expect = 3e-42,   Method: Compositional matrix adjust.
 Identities = 98/261 (37%), Positives = 146/261 (55%), Gaps = 25/261 (9%)
Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
           ++L +TLGEG +G+V+ A +  +    AVKI++  R +     + IK+EI   K+L H N
Sbjct: 9   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKMLNHEN 66
Query: 76  VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGV 135
           VV+ +      +  Y+ LEY +GGELFD+I     + E + ++ F QL+ GV Y H  G+
Sbjct: 67  VVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGI 126
Query: 136 FHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDG 195
            HRD+K EN+LLD + N+KISDFGL+ + ++   + LL+  CG+  YVAPE+L  R +  
Sbjct: 127 THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHA 186
Query: 196 ATSDIWSCGVILYIF----------------RGDFKLPK-WLSPGAQ------NLLRKIL 232
              D+WSCG++L                     D+K  K +L+P  +       LL KIL
Sbjct: 187 EPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKIL 246
Query: 233 EPNPVKRITIAGIKADEWFEQ 253
             NP  RITI  IK D W+ +
Sbjct: 247 VENPSARITIPDIKKDRWYNK 267

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score =  169 bits (427), Expect = 4e-42,   Method: Compositional matrix adjust.
 Identities = 98/261 (37%), Positives = 146/261 (55%), Gaps = 25/261 (9%)
Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
           ++L +TLGEG +G+V+ A +  +    AVKI++  R +     + IK+EI   K+L H N
Sbjct: 8   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKMLNHEN 65
Query: 76  VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGV 135
           VV+ +      +  Y+ LEY +GGELFD+I     + E + ++ F QL+ GV Y H  G+
Sbjct: 66  VVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGI 125
Query: 136 FHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDG 195
            HRD+K EN+LLD + N+KISDFGL+ + ++   + LL+  CG+  YVAPE+L  R +  
Sbjct: 126 THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHA 185
Query: 196 ATSDIWSCGVILYIF----------------RGDFKLPK-WLSPGAQ------NLLRKIL 232
              D+WSCG++L                     D+K  K +L+P  +       LL KIL
Sbjct: 186 EPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKIL 245
Query: 233 EPNPVKRITIAGIKADEWFEQ 253
             NP  RITI  IK D W+ +
Sbjct: 246 VENPSARITIPDIKKDRWYNK 266

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score =  169 bits (427), Expect = 4e-42,   Method: Compositional matrix adjust.
 Identities = 98/261 (37%), Positives = 146/261 (55%), Gaps = 25/261 (9%)
Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
           ++L +TLGEG +G+V+ A +  +    AVKI++  R +     + IK+EI   K+L H N
Sbjct: 8   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKMLNHEN 65
Query: 76  VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGV 135
           VV+ +      +  Y+ LEY +GGELFD+I     + E + ++ F QL+ GV Y H  G+
Sbjct: 66  VVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGI 125
Query: 136 FHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDG 195
            HRD+K EN+LLD + N+KISDFGL+ + ++   + LL+  CG+  YVAPE+L  R +  
Sbjct: 126 THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHA 185
Query: 196 ATSDIWSCGVILYIF----------------RGDFKLPK-WLSPGAQ------NLLRKIL 232
              D+WSCG++L                     D+K  K +L+P  +       LL KIL
Sbjct: 186 EPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKIL 245
Query: 233 EPNPVKRITIAGIKADEWFEQ 253
             NP  RITI  IK D W+ +
Sbjct: 246 VENPSARITIPDIKKDRWYNK 266

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score =  169 bits (427), Expect = 4e-42,   Method: Compositional matrix adjust.
 Identities = 98/261 (37%), Positives = 146/261 (55%), Gaps = 25/261 (9%)
Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
           ++L +TLGEG +G+V+ A +  +    AVKI++  R +     + IK+EI   K+L H N
Sbjct: 8   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKMLNHEN 65
Query: 76  VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGV 135
           VV+ +      +  Y+ LEY +GGELFD+I     + E + ++ F QL+ GV Y H  G+
Sbjct: 66  VVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGI 125
Query: 136 FHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDG 195
            HRD+K EN+LLD + N+KISDFGL+ + ++   + LL+  CG+  YVAPE+L  R +  
Sbjct: 126 THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHA 185
Query: 196 ATSDIWSCGVILYIF----------------RGDFKLPK-WLSPGAQ------NLLRKIL 232
              D+WSCG++L                     D+K  K +L+P  +       LL KIL
Sbjct: 186 EPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKIL 245
Query: 233 EPNPVKRITIAGIKADEWFEQ 253
             NP  RITI  IK D W+ +
Sbjct: 246 VENPSARITIPDIKKDRWYNK 266

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score =  168 bits (426), Expect = 4e-42,   Method: Compositional matrix adjust.
 Identities = 98/261 (37%), Positives = 146/261 (55%), Gaps = 25/261 (9%)
Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
           ++L +TLGEG +G+V+ A +  +    AVKI++  R +     + IK+EI   K+L H N
Sbjct: 8   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKMLNHEN 65
Query: 76  VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGV 135
           VV+ +      +  Y+ LEY +GGELFD+I     + E + ++ F QL+ GV Y H  G+
Sbjct: 66  VVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGI 125
Query: 136 FHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDG 195
            HRD+K EN+LLD + N+KISDFGL+ + ++   + LL+  CG+  YVAPE+L  R +  
Sbjct: 126 THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHA 185
Query: 196 ATSDIWSCGVILYIF----------------RGDFKLPK-WLSPGAQ------NLLRKIL 232
              D+WSCG++L                     D+K  K +L+P  +       LL KIL
Sbjct: 186 EPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKIL 245
Query: 233 EPNPVKRITIAGIKADEWFEQ 253
             NP  RITI  IK D W+ +
Sbjct: 246 VENPSARITIPDIKKDRWYNK 266

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score =  168 bits (426), Expect = 4e-42,   Method: Compositional matrix adjust.
 Identities = 98/261 (37%), Positives = 146/261 (55%), Gaps = 25/261 (9%)
Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
           ++L +TLGEG +G+V+ A +  +    AVKI++  R +     + IK+EI   K+L H N
Sbjct: 9   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKMLNHEN 66
Query: 76  VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGV 135
           VV+ +      +  Y+ LEY +GGELFD+I     + E + ++ F QL+ GV Y H  G+
Sbjct: 67  VVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGI 126
Query: 136 FHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDG 195
            HRD+K EN+LLD + N+KISDFGL+ + ++   + LL+  CG+  YVAPE+L  R +  
Sbjct: 127 THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHA 186
Query: 196 ATSDIWSCGVILYIF----------------RGDFKLPK-WLSPGAQ------NLLRKIL 232
              D+WSCG++L                     D+K  K +L+P  +       LL KIL
Sbjct: 187 EPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKIL 246
Query: 233 EPNPVKRITIAGIKADEWFEQ 253
             NP  RITI  IK D W+ +
Sbjct: 247 VENPSARITIPDIKKDRWYNK 267

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score =  168 bits (426), Expect = 4e-42,   Method: Compositional matrix adjust.
 Identities = 98/261 (37%), Positives = 146/261 (55%), Gaps = 25/261 (9%)
Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
           ++L +TLGEG +G+V+ A +  +    AVKI++  R +     + IK+EI   K+L H N
Sbjct: 7   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKMLNHEN 64
Query: 76  VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGV 135
           VV+ +      +  Y+ LEY +GGELFD+I     + E + ++ F QL+ GV Y H  G+
Sbjct: 65  VVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGI 124
Query: 136 FHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDG 195
            HRD+K EN+LLD + N+KISDFGL+ + ++   + LL+  CG+  YVAPE+L  R +  
Sbjct: 125 THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHA 184
Query: 196 ATSDIWSCGVILYIF----------------RGDFKLPK-WLSPGAQ------NLLRKIL 232
              D+WSCG++L                     D+K  K +L+P  +       LL KIL
Sbjct: 185 EPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKIL 244
Query: 233 EPNPVKRITIAGIKADEWFEQ 253
             NP  RITI  IK D W+ +
Sbjct: 245 VENPSARITIPDIKKDRWYNK 265

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score =  168 bits (426), Expect = 4e-42,   Method: Compositional matrix adjust.
 Identities = 98/261 (37%), Positives = 146/261 (55%), Gaps = 25/261 (9%)
Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
           ++L +TLGEG +G+V+ A +  +    AVKI++  R +     + IK+EI   K+L H N
Sbjct: 8   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKMLNHEN 65
Query: 76  VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGV 135
           VV+ +      +  Y+ LEY +GGELFD+I     + E + ++ F QL+ GV Y H  G+
Sbjct: 66  VVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGI 125
Query: 136 FHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDG 195
            HRD+K EN+LLD + N+KISDFGL+ + ++   + LL+  CG+  YVAPE+L  R +  
Sbjct: 126 THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHA 185
Query: 196 ATSDIWSCGVILYIF----------------RGDFKLPK-WLSPGAQ------NLLRKIL 232
              D+WSCG++L                     D+K  K +L+P  +       LL KIL
Sbjct: 186 EPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKIL 245
Query: 233 EPNPVKRITIAGIKADEWFEQ 253
             NP  RITI  IK D W+ +
Sbjct: 246 VENPSARITIPDIKKDRWYNK 266

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score =  168 bits (425), Expect = 5e-42,   Method: Compositional matrix adjust.
 Identities = 98/261 (37%), Positives = 146/261 (55%), Gaps = 25/261 (9%)
Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
           ++L +TLGEG +G+V+ A +  +    AVKI++  R +     + IK+EI   K+L H N
Sbjct: 8   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEIXINKMLNHEN 65
Query: 76  VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGV 135
           VV+ +      +  Y+ LEY +GGELFD+I     + E + ++ F QL+ GV Y H  G+
Sbjct: 66  VVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGI 125
Query: 136 FHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDG 195
            HRD+K EN+LLD + N+KISDFGL+ + ++   + LL+  CG+  YVAPE+L  R +  
Sbjct: 126 THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHA 185
Query: 196 ATSDIWSCGVILYIF----------------RGDFKLPK-WLSPGAQ------NLLRKIL 232
              D+WSCG++L                     D+K  K +L+P  +       LL KIL
Sbjct: 186 EPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKIL 245
Query: 233 EPNPVKRITIAGIKADEWFEQ 253
             NP  RITI  IK D W+ +
Sbjct: 246 VENPSARITIPDIKKDRWYNK 266

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score =  168 bits (425), Expect = 7e-42,   Method: Compositional matrix adjust.
 Identities = 102/269 (37%), Positives = 146/269 (54%), Gaps = 33/269 (12%)
Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
           RY+  R LG+G+FG+V   +D  +G   AVK++ K ++      + + RE+  LK L HP
Sbjct: 33  RYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHP 92
Query: 75  NVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKG 134
           N+++L+E    K   Y+V E  TGGELFD+I S+ R  E +  ++ +Q++ G++Y H   
Sbjct: 93  NIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNK 152
Query: 135 VFHRDLKLENILLDSK---GNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANR 191
           + HRDLK EN+LL+SK    NI+I DFGLS    HF     +    G+  Y+APEVL   
Sbjct: 153 IVHRDLKPENLLLESKSKDANIRIIDFGLST---HFEASKKMKDKIGTAYYIAPEVL--H 207
Query: 192 GYDGATSDIWSCGVILYI-------FRG---------------DFKLPKW--LSPGAQNL 227
           G      D+WS GVILYI       F G                F+LP+W  +S  A++L
Sbjct: 208 GTYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESAKDL 267
Query: 228 LRKILEPNPVKRITIAGIKADEWFEQDYT 256
           +RK+L   P  RI+       EW  Q YT
Sbjct: 268 IRKMLTYVPSMRISARDALDHEWI-QTYT 295

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score =  167 bits (422), Expect = 1e-41,   Method: Compositional matrix adjust.
 Identities = 97/261 (37%), Positives = 145/261 (55%), Gaps = 25/261 (9%)
Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
           ++L +TLGEG +G+V+ A +  +    AVKI++  R +     + IK+EI    +L H N
Sbjct: 9   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINAMLNHEN 66
Query: 76  VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGV 135
           VV+ +      +  Y+ LEY +GGELFD+I     + E + ++ F QL+ GV Y H  G+
Sbjct: 67  VVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGI 126
Query: 136 FHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDG 195
            HRD+K EN+LLD + N+KISDFGL+ + ++   + LL+  CG+  YVAPE+L  R +  
Sbjct: 127 THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHA 186
Query: 196 ATSDIWSCGVILYIF----------------RGDFKLPK-WLSPGAQ------NLLRKIL 232
              D+WSCG++L                     D+K  K +L+P  +       LL KIL
Sbjct: 187 EPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKIL 246
Query: 233 EPNPVKRITIAGIKADEWFEQ 253
             NP  RITI  IK D W+ +
Sbjct: 247 VENPSARITIPDIKKDRWYNK 267

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score =  166 bits (421), Expect = 2e-41,   Method: Compositional matrix adjust.
 Identities = 98/261 (37%), Positives = 145/261 (55%), Gaps = 25/261 (9%)
Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
           ++L +TLGEG  G+V+ A +  +    AVKI++  R +     + IK+EI   K+L H N
Sbjct: 8   WDLVQTLGEGAAGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKMLNHEN 65
Query: 76  VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGV 135
           VV+ +      +  Y+ LEY +GGELFD+I     + E + ++ F QL+ GV Y H  G+
Sbjct: 66  VVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGI 125
Query: 136 FHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDG 195
            HRD+K EN+LLD + N+KISDFGL+ + ++   + LL+  CG+  YVAPE+L  R +  
Sbjct: 126 THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHA 185
Query: 196 ATSDIWSCGVILYIF----------------RGDFKLPK-WLSPGAQ------NLLRKIL 232
              D+WSCG++L                     D+K  K +L+P  +       LL KIL
Sbjct: 186 EPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKIL 245
Query: 233 EPNPVKRITIAGIKADEWFEQ 253
             NP  RITI  IK D W+ +
Sbjct: 246 VENPSARITIPDIKKDRWYNK 266

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score =  165 bits (418), Expect = 4e-41,   Method: Compositional matrix adjust.
 Identities = 102/269 (37%), Positives = 143/269 (53%), Gaps = 33/269 (12%)
Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
           RY+  R LG+G+FG+V   +D  +G   AVK++ K ++      + + RE+  LK L HP
Sbjct: 27  RYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHP 86
Query: 75  NVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKG 134
           N+ +L+E    K   Y+V E  TGGELFD+I S+ R  E +  ++ +Q++ G++Y H   
Sbjct: 87  NIXKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYXHKNK 146
Query: 135 VFHRDLKLENILLDSK---GNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANR 191
           + HRDLK EN+LL+SK    NI+I DFGLS    HF          G+  Y+APEVL   
Sbjct: 147 IVHRDLKPENLLLESKSKDANIRIIDFGLST---HFEASKKXKDKIGTAYYIAPEVL--H 201
Query: 192 GYDGATSDIWSCGVILYI-------FRG---------------DFKLPKW--LSPGAQNL 227
           G      D+WS GVILYI       F G                F+LP+W  +S  A++L
Sbjct: 202 GTYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESAKDL 261
Query: 228 LRKILEPNPVKRITIAGIKADEWFEQDYT 256
           +RK L   P  RI+       EW  Q YT
Sbjct: 262 IRKXLTYVPSXRISARDALDHEWI-QTYT 289

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score =  164 bits (415), Expect = 9e-41,   Method: Compositional matrix adjust.
 Identities = 97/261 (37%), Positives = 145/261 (55%), Gaps = 25/261 (9%)
Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
           ++L +TLGEG +G+V+ A +  +    AVKI++  R +     + IK+EI   K+L H N
Sbjct: 8   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKMLNHEN 65
Query: 76  VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGV 135
           VV+ +      +  Y+ LEY +GGELFD+I     + E + ++ F QL+ GV Y H  G+
Sbjct: 66  VVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGI 125
Query: 136 FHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDG 195
            HRD+K EN+LLD + N+KISDFGL+ + ++   + LL+   G+  YVAPE+L  R +  
Sbjct: 126 THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFHA 185
Query: 196 ATSDIWSCGVILYIF----------------RGDFKLPK-WLSPGAQ------NLLRKIL 232
              D+WSCG++L                     D+K  K +L+P  +       LL KIL
Sbjct: 186 EPVDVWSCGIVLTAMLAGELPWDQPSDSXQEYSDWKEKKTYLNPWKKIDSAPLALLHKIL 245
Query: 233 EPNPVKRITIAGIKADEWFEQ 253
             NP  RITI  IK D W+ +
Sbjct: 246 VENPSARITIPDIKKDRWYNK 266

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score =  164 bits (415), Expect = 1e-40,   Method: Compositional matrix adjust.
 Identities = 97/261 (37%), Positives = 145/261 (55%), Gaps = 25/261 (9%)
Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
           ++L +TLGEG +G+V+ A +  +    AVKI++  R +     + IK+EI   K+L H N
Sbjct: 8   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKMLNHEN 65
Query: 76  VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGV 135
           VV+ +      +  Y+ LEY +GGELFD+I     + E + ++ F QL+ GV Y H  G+
Sbjct: 66  VVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGI 125
Query: 136 FHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDG 195
            HRD+K EN+LLD + N+KISDFGL+ + ++   + LL+   G+  YVAPE+L  R +  
Sbjct: 126 THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFHA 185
Query: 196 ATSDIWSCGVILYIF----------------RGDFKLPK-WLSPGAQ------NLLRKIL 232
              D+WSCG++L                     D+K  K +L+P  +       LL KIL
Sbjct: 186 EPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKIL 245
Query: 233 EPNPVKRITIAGIKADEWFEQ 253
             NP  RITI  IK D W+ +
Sbjct: 246 VENPSARITIPDIKKDRWYNK 266

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score =  164 bits (414), Expect = 1e-40,   Method: Compositional matrix adjust.
 Identities = 97/261 (37%), Positives = 145/261 (55%), Gaps = 25/261 (9%)
Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
           ++L +TLGEG +G+V+ A +  +    AVKI++  R +     + IK+EI   K+L H N
Sbjct: 8   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKMLNHEN 65
Query: 76  VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGV 135
           VV+ +      +  Y+ LEY +GGELFD+I     + E + ++ F QL+ GV Y H  G+
Sbjct: 66  VVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGI 125
Query: 136 FHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDG 195
            HRD+K EN+LLD + N+KISDFGL+ + ++   + LL+   G+  YVAPE+L  R +  
Sbjct: 126 THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFHA 185
Query: 196 ATSDIWSCGVILYIF----------------RGDFKLPK-WLSPGAQ------NLLRKIL 232
              D+WSCG++L                     D+K  K +L+P  +       LL KIL
Sbjct: 186 EPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKIL 245
Query: 233 EPNPVKRITIAGIKADEWFEQ 253
             NP  RITI  IK D W+ +
Sbjct: 246 VENPSARITIPDIKKDRWYNK 266

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score =  164 bits (414), Expect = 1e-40,   Method: Compositional matrix adjust.
 Identities = 97/261 (37%), Positives = 145/261 (55%), Gaps = 25/261 (9%)
Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
           ++L +TLGEG +G+V+ A +  +    AVKI++  R +     + IK+EI   K+L H N
Sbjct: 9   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEIXINKMLNHEN 66
Query: 76  VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGV 135
           VV+ +      +  Y+ LEY +GGELFD+I     + E + ++ F QL+ GV Y H  G+
Sbjct: 67  VVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGI 126
Query: 136 FHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDG 195
            HRD+K EN+LLD + N+KISDFGL+ + ++   + LL+   G+  YVAPE+L  R +  
Sbjct: 127 THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFHA 186
Query: 196 ATSDIWSCGVILYIF----------------RGDFKLPK-WLSPGAQ------NLLRKIL 232
              D+WSCG++L                     D+K  K +L+P  +       LL KIL
Sbjct: 187 EPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKIL 246
Query: 233 EPNPVKRITIAGIKADEWFEQ 253
             NP  RITI  IK D W+ +
Sbjct: 247 VENPSARITIPDIKKDRWYNK 267

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score =  164 bits (414), Expect = 1e-40,   Method: Compositional matrix adjust.
 Identities = 105/279 (37%), Positives = 148/279 (53%), Gaps = 34/279 (12%)
Query: 9   EGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATL 68
           +G    RY +   LG+G+FG+V   +D  +   +AVK++ K    + K T  I RE+  L
Sbjct: 17  QGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKN-KDTSTILREVELL 75
Query: 69  KLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVS 128
           K L HPN+++L E+L   S  Y+V E  TGGELFD+I  + R  E +  ++ +Q+  G++
Sbjct: 76  KKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGIT 135
Query: 129 YCHNKGVFHRDLKLENILLDSK---GNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAP 185
           Y H   + HRDLK ENILL+SK    +IKI DFGLS     F+ +  +    G+  Y+AP
Sbjct: 136 YMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTC---FQQNTKMKDRIGTAYYIAP 192
Query: 186 EVLANRGYDGATSDIWSCGVILYI-------FRGD---------------FKLPKW--LS 221
           EVL  RG      D+WS GVILYI       F G                F LP+W  +S
Sbjct: 193 EVL--RGTYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTIS 250
Query: 222 PGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPANP 260
             A++L+RK+L  +P  RIT        W  Q Y+   P
Sbjct: 251 DDAKDLIRKMLTFHPSLRITATQCLEHPWI-QKYSSETP 288

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score =  164 bits (414), Expect = 1e-40,   Method: Compositional matrix adjust.
 Identities = 97/261 (37%), Positives = 145/261 (55%), Gaps = 25/261 (9%)
Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
           ++L +TLGEG +G+V+ A +  +    AVKI++  R +     + IK+EI   K+L H N
Sbjct: 8   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEIXINKMLNHEN 65
Query: 76  VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGV 135
           VV+ +      +  Y+ LEY +GGELFD+I     + E + ++ F QL+ GV Y H  G+
Sbjct: 66  VVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGI 125
Query: 136 FHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDG 195
            HRD+K EN+LLD + N+KISDFGL+ + ++   + LL+   G+  YVAPE+L  R +  
Sbjct: 126 THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFHA 185
Query: 196 ATSDIWSCGVILYIF----------------RGDFKLPK-WLSPGAQ------NLLRKIL 232
              D+WSCG++L                     D+K  K +L+P  +       LL KIL
Sbjct: 186 EPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKIL 245
Query: 233 EPNPVKRITIAGIKADEWFEQ 253
             NP  RITI  IK D W+ +
Sbjct: 246 VENPSARITIPDIKKDRWYNK 266

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score =  162 bits (410), Expect = 3e-40,   Method: Compositional matrix adjust.
 Identities = 97/279 (34%), Positives = 149/279 (53%), Gaps = 31/279 (11%)
Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
           Y+L   LG+G F  V+    + +G  +A KI+   ++   +   +++RE    +LLKHPN
Sbjct: 6   YQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKL-SARDHQKLEREARICRLLKHPN 64
Query: 76  VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGV 135
           +VRLH+ ++ +   Y+V + VTGGELF+ I ++    EA+     QQ+++ V++CH  G+
Sbjct: 65  IVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQQILESVNHCHLNGI 124
Query: 136 FHRDLKLENILLDSKGN---IKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRG 192
            HRDLK EN+LL SK     +K++DFGL+   Q   D        G+P Y++PEVL    
Sbjct: 125 VHRDLKPENLLLASKSKGAAVKLADFGLAIEVQ--GDQQAWFGFAGTPGYLSPEVLRKDP 182
Query: 193 YDGATSDIWSCGVILYIF----------------------RGDFKLPKW--LSPGAQNLL 228
           Y G   D+W+CGVILYI                         DF  P+W  ++P A++L+
Sbjct: 183 Y-GKPVDMWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPEAKDLI 241
Query: 229 RKILEPNPVKRITIAGIKADEWFEQDYTPANPDDDEEDI 267
            K+L  NP KRIT +      W  Q  T A+    +E +
Sbjct: 242 NKMLTINPAKRITASEALKHPWICQRSTVASMMHRQETV 280

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score =  162 bits (409), Expect = 4e-40,   Method: Compositional matrix adjust.
 Identities = 97/279 (34%), Positives = 149/279 (53%), Gaps = 31/279 (11%)
Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
           Y+L   LG+G F  V+    + +G  +A KI+   ++   +   +++RE    +LLKHPN
Sbjct: 6   YQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKL-SARDHQKLEREARICRLLKHPN 64
Query: 76  VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGV 135
           +VRLH+ ++ +   Y+V + VTGGELF+ I ++    EA+     QQ+++ V++CH  G+
Sbjct: 65  IVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQQILESVNHCHLNGI 124
Query: 136 FHRDLKLENILLDSKGN---IKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRG 192
            HRDLK EN+LL SK     +K++DFGL+   Q   D        G+P Y++PEVL    
Sbjct: 125 VHRDLKPENLLLASKSKGAAVKLADFGLAIEVQ--GDQQAWFGFAGTPGYLSPEVLRKDP 182
Query: 193 YDGATSDIWSCGVILYIF----------------------RGDFKLPKW--LSPGAQNLL 228
           Y G   D+W+CGVILYI                         DF  P+W  ++P A++L+
Sbjct: 183 Y-GKPVDMWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPEAKDLI 241
Query: 229 RKILEPNPVKRITIAGIKADEWFEQDYTPANPDDDEEDI 267
            K+L  NP KRIT +      W  Q  T A+    +E +
Sbjct: 242 NKMLTINPAKRITASEALKHPWICQRSTVASMMHRQETV 280

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score =  161 bits (408), Expect = 5e-40,   Method: Compositional matrix adjust.
 Identities = 97/266 (36%), Positives = 138/266 (51%), Gaps = 33/266 (12%)
Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
           +E   TLG G F +V  A++  +G  FAVK + K  +   +    I+ EIA L+ +KH N
Sbjct: 24  FEFKETLGTGAFSEVVLAEEKATGKLFAVKCIPKKALKGKE--SSIENEIAVLRKIKHEN 81
Query: 76  VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGV 135
           +V L ++  S + +Y+V++ V+GGELFD+I  KG   E +   L +Q++D V Y H  G+
Sbjct: 82  IVALEDIYESPNHLYLVMQLVSGGELFDRIVEKGFYTEKDASTLIRQVLDAVYYLHRMGI 141
Query: 136 FHRDLKLENILL---DSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRG 192
            HRDLK EN+L    D +  I ISDFGLS +        ++ T CG+P YVAPEVLA + 
Sbjct: 142 VHRDLKPENLLYYSQDEESKIMISDFGLSKMEGK---GDVMSTACGTPGYVAPEVLAQKP 198
Query: 193 YDGATSDIWSCGVILYIF----------------------RGDFKLPKW--LSPGAQNLL 228
           Y  A  D WS GVI YI                         +F  P W  +S  A++ +
Sbjct: 199 YSKAV-DCWSIGVIAYILLCGYPPFYDENDSKLFEQILKAEYEFDSPYWDDISDSAKDFI 257
Query: 229 RKILEPNPVKRITIAGIKADEWFEQD 254
           R ++E +P KR T        W   D
Sbjct: 258 RNLMEKDPNKRYTCEQAARHPWIAGD 283

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score =  160 bits (406), Expect = 1e-39,   Method: Compositional matrix adjust.
 Identities = 98/279 (35%), Positives = 146/279 (52%), Gaps = 31/279 (11%)
Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
           Y+L   +G+G F  V+    L +G  +A KI+   ++   +   +++RE    +LLKH N
Sbjct: 6   YQLYEDIGKGAFSVVRRCVKLCTGHEYAAKIINTKKL-SARDHQKLEREARICRLLKHSN 64
Query: 76  VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGV 135
           +VRLH+ ++ +   Y+V + VTGGELF+ I ++    EA+     QQ+++ V +CH  GV
Sbjct: 65  IVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMGV 124
Query: 136 FHRDLKLENILLDSK---GNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRG 192
            HRDLK EN+LL SK     +K++DFGL+   Q   D        G+P Y++PEVL    
Sbjct: 125 VHRDLKPENLLLASKCKGAAVKLADFGLAIEVQ--GDQQAWFGFAGTPGYLSPEVLRKEA 182
Query: 193 YDGATSDIWSCGVILYIF----------------------RGDFKLPKW--LSPGAQNLL 228
           Y G   DIW+CGVILYI                         DF  P+W  ++P A+NL+
Sbjct: 183 Y-GKPVDIWACGVILYILLVGYPPFWDEDQHKLYQQIKAGAYDFPSPEWDTVTPEAKNLI 241
Query: 229 RKILEPNPVKRITIAGIKADEWFEQDYTPANPDDDEEDI 267
            ++L  NP KRIT        W  Q  T A+    +E +
Sbjct: 242 NQMLTINPAKRITAHEALKHPWVCQRSTVASMMHRQETV 280

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score =  160 bits (404), Expect = 2e-39,   Method: Compositional matrix adjust.
 Identities = 102/272 (37%), Positives = 146/272 (53%), Gaps = 33/272 (12%)
Query: 9   EGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATL 68
           +G    RY +   LG+G+FG+V   +D  +   +AVK++ K    + K T  I RE+  L
Sbjct: 17  QGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKN-KDTSTILREVELL 75
Query: 69  KLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVS 128
           K L HPN+++L E+L   S  Y+V E  TGGELFD+I  + R  E +  ++ +Q+  G++
Sbjct: 76  KKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGIT 135
Query: 129 YCHNKGVFHRDLKLENILLDSK---GNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAP 185
           Y H   + HRDLK ENILL+SK    +IKI DFGLS     F+ +  +    G+  Y+AP
Sbjct: 136 YMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTC---FQQNTKMKDRIGTAYYIAP 192
Query: 186 EVLANRGYDGATSDIWSCGVILYI-------FRGD---------------FKLPKW--LS 221
           EVL  RG      D+WS GVILYI       F G                F LP+W  +S
Sbjct: 193 EVL--RGTYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTIS 250
Query: 222 PGAQNLLRKILEPNPVKRITIAGIKADEWFEQ 253
             A++L+RK+L  +P  RIT        W ++
Sbjct: 251 DDAKDLIRKMLTFHPSLRITATQCLEHPWIQK 282

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score =  160 bits (404), Expect = 2e-39,   Method: Compositional matrix adjust.
 Identities = 102/272 (37%), Positives = 146/272 (53%), Gaps = 33/272 (12%)
Query: 9   EGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATL 68
           +G    RY +   LG+G+FG+V   +D  +   +AVK++ K    + K T  I RE+  L
Sbjct: 17  QGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKN-KDTSTILREVELL 75
Query: 69  KLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVS 128
           K L HPN+++L E+L   S  Y+V E  TGGELFD+I  + R  E +  ++ +Q+  G++
Sbjct: 76  KKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGIT 135
Query: 129 YCHNKGVFHRDLKLENILLDSK---GNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAP 185
           Y H   + HRDLK ENILL+SK    +IKI DFGLS     F+ +  +    G+  Y+AP
Sbjct: 136 YMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTC---FQQNTKMKDRIGTAYYIAP 192
Query: 186 EVLANRGYDGATSDIWSCGVILYI-------FRGD---------------FKLPKW--LS 221
           EVL  RG      D+WS GVILYI       F G                F LP+W  +S
Sbjct: 193 EVL--RGTYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTIS 250
Query: 222 PGAQNLLRKILEPNPVKRITIAGIKADEWFEQ 253
             A++L+RK+L  +P  RIT        W ++
Sbjct: 251 DDAKDLIRKMLTFHPSLRITATQCLEHPWIQK 282

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score =  159 bits (403), Expect = 2e-39,   Method: Compositional matrix adjust.
 Identities = 81/269 (30%), Positives = 142/269 (52%), Gaps = 25/269 (9%)
Query: 2   VIAEKKQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQI 61
            +AE  +    +  +++GR LG+G FG V  A++  +    A+K+L K+++    +  Q+
Sbjct: 3   ALAEMPKRKFTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQL 62
Query: 62  KREIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQ 121
           +REI     L+HPN++R++     + +IY++LE+   GEL+ ++   GR  E       +
Sbjct: 63  RREIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFME 122
Query: 122 QLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPN 181
           +L D + YCH + V HRD+K EN+L+  KG +KI+DFG S      R   +    CG+ +
Sbjct: 123 ELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRRXM----CGTLD 178
Query: 182 YVAPEVLANRGYDGATSDIWSCGVILY--------------------IFRGDFKLPKWLS 221
           Y+ PE++  + +D    D+W  GV+ Y                    I   D K P +LS
Sbjct: 179 YLPPEMIEGKTHDEKV-DLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKFPPFLS 237
Query: 222 PGAQNLLRKILEPNPVKRITIAGIKADEW 250
            G+++L+ K+L  +P +R+ + G+    W
Sbjct: 238 DGSKDLISKLLRYHPPQRLPLKGVMEHPW 266

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score =  159 bits (401), Expect = 4e-39,   Method: Compositional matrix adjust.
 Identities = 87/281 (30%), Positives = 148/281 (52%), Gaps = 26/281 (9%)
Query: 5   EKKQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKRE 64
           E K+    L  +E+GR LG+G FG V  A++  S    A+K+L K ++    +  Q++RE
Sbjct: 4   ESKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRRE 63
Query: 65  IATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLI 124
           +     L+HPN++RL+      +++Y++LEY   GE++ ++    +  E        +L 
Sbjct: 64  VEIQSHLRHPNILRLYGYFHDATRVYLILEYAPRGEVYKELQKLSKFDEQRTATYITELA 123
Query: 125 DGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVA 184
           + +SYCH+K V HRD+K EN+LL S G +KI+DFG S      R      T CG+ +Y+ 
Sbjct: 124 NALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT----TLCGTLDYLP 179
Query: 185 PEVLANRGYDGATSDIWSCGVILYIF--------------------RGDFKLPKWLSPGA 224
           PE++  R +D    D+WS GV+ Y F                    R +F  P +++ GA
Sbjct: 180 PEMIEGRMHDEKV-DLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGA 238
Query: 225 QNLLRKILEPNPVKRITIAGIKADEWFEQDYT-PANPDDDE 264
           ++L+ ++L+ NP +R  +  +    W   + + P+N  + E
Sbjct: 239 RDLISRLLKHNPSQRPMLREVLEHPWITANSSKPSNCQNKE 279

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score =  158 bits (399), Expect = 6e-39,   Method: Compositional matrix adjust.
 Identities = 82/259 (31%), Positives = 141/259 (54%), Gaps = 25/259 (9%)
Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
           +++GR LG+G FG V  A++  S    A+K+L K ++    +  Q++RE+     L+HPN
Sbjct: 14  FDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRHPN 73
Query: 76  VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGV 135
           ++RL+      +++Y++LEY   G ++ ++    R  E        +L + +SYCH+K V
Sbjct: 74  ILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSRFDEQRTATYITELANALSYCHSKRV 133
Query: 136 FHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDG 195
            HRD+K EN+LL S G +KI+DFG S      R D    T CG+ +Y+ PE++  R +D 
Sbjct: 134 IHRDIKPENLLLGSNGELKIADFGWSVHAPSSRRD----TLCGTLDYLPPEMIEGRMHDE 189
Query: 196 ATSDIWSCGVILYIF--------------------RGDFKLPKWLSPGAQNLLRKILEPN 235
              D+WS GV+ Y F                    R +F  P +++ GA++L+ ++L+ N
Sbjct: 190 KV-DLWSLGVLCYEFLVGMPPFEAHTYQETYRRISRVEFTFPDFVTEGARDLISRLLKHN 248
Query: 236 PVKRITIAGIKADEWFEQD 254
             +R+T+A +    W + +
Sbjct: 249 ASQRLTLAEVLEHPWIKAN 267

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score =  158 bits (399), Expect = 6e-39,   Method: Compositional matrix adjust.
 Identities = 88/282 (31%), Positives = 149/282 (52%), Gaps = 28/282 (9%)
Query: 5   EKKQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKRE 64
           E K+    L  +E+GR LG+G FG V  A++  S    A+K+L K ++    +  Q++RE
Sbjct: 25  ESKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRRE 84
Query: 65  IATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLI 124
           +     L+HPN++RL+      +++Y++LEY   G ++ ++    +  E        +L 
Sbjct: 85  VEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELA 144
Query: 125 DGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSA-LPQHFRDDGLLHTTCGSPNYV 183
           + +SYCH+K V HRD+K EN+LL S G +KI+DFG S   P   RDD      CG+ +Y+
Sbjct: 145 NALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRDD-----LCGTLDYL 199
Query: 184 APEVLANRGYDGATSDIWSCGVILYIF--------------------RGDFKLPKWLSPG 223
            PE++  R +D    D+WS GV+ Y F                    R +F  P +++ G
Sbjct: 200 PPEMIEGRMHDEKV-DLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEG 258
Query: 224 AQNLLRKILEPNPVKRITIAGIKADEWFEQDYT-PANPDDDE 264
           A++L+ ++L+ NP +R  +  +    W   + + P+N  + E
Sbjct: 259 ARDLISRLLKHNPSQRPMLREVLEHPWITANSSKPSNCQNKE 300

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score =  158 bits (399), Expect = 7e-39,   Method: Compositional matrix adjust.
 Identities = 95/279 (34%), Positives = 147/279 (52%), Gaps = 31/279 (11%)
Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
           Y+L   LG+G F  V+    + +G  +A KI+   ++   +   +++RE    +LLKHPN
Sbjct: 24  YQLFEELGKGAFSVVRRCVKVLAGQEYAAKIINTKKL-SARDHQKLEREARICRLLKHPN 82
Query: 76  VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGV 135
           +VRLH+ ++ +   Y++ + VTGGELF+ I ++    EA+     QQ+++ V +CH  GV
Sbjct: 83  IVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMGV 142
Query: 136 FHRDLKLENILLDSK---GNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRG 192
            HRDLK EN+LL SK     +K++DFGL+   +   +        G+P Y++PEVL    
Sbjct: 143 VHRDLKPENLLLASKLKGAAVKLADFGLAIEVE--GEQQAWFGFAGTPGYLSPEVLRKDP 200
Query: 193 YDGATSDIWSCGVILYIF----------------------RGDFKLPKW--LSPGAQNLL 228
           Y G   D+W+CGVILYI                         DF  P+W  ++P A++L+
Sbjct: 201 Y-GKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPEAKDLI 259
Query: 229 RKILEPNPVKRITIAGIKADEWFEQDYTPANPDDDEEDI 267
            K+L  NP KRIT A      W     T A+    +E +
Sbjct: 260 NKMLTINPSKRITAAEALKHPWISHRSTVASCMHRQETV 298

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score =  156 bits (395), Expect = 2e-38,   Method: Compositional matrix adjust.
 Identities = 86/279 (30%), Positives = 147/279 (52%), Gaps = 26/279 (9%)
Query: 7   KQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIA 66
           K+    L  +E+GR LG+G FG V  A++  S    A+K+L K ++    +  Q++RE+ 
Sbjct: 2   KKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVE 61
Query: 67  TLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDG 126
               L+HPN++RL+      +++Y++LEY   G ++ ++    +  E        +L + 
Sbjct: 62  IQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANA 121
Query: 127 VSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPE 186
           +SYCH+K V HRD+K EN+LL S G +KI+DFG S      R D    T CG+ +Y+ PE
Sbjct: 122 LSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRD----TLCGTLDYLPPE 177
Query: 187 VLANRGYDGATSDIWSCGVILYIF--------------------RGDFKLPKWLSPGAQN 226
           ++  R +D    D+WS GV+ Y F                    R +F  P +++ GA++
Sbjct: 178 MIEGRMHDEKV-DLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARD 236
Query: 227 LLRKILEPNPVKRITIAGIKADEWFEQDYT-PANPDDDE 264
           L+ ++L+ NP +R  +  +    W   + + P+N  + E
Sbjct: 237 LISRLLKHNPSQRPMLREVLEHPWITANSSKPSNCQNKE 275

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score =  156 bits (395), Expect = 2e-38,   Method: Compositional matrix adjust.
 Identities = 93/265 (35%), Positives = 145/265 (54%), Gaps = 35/265 (13%)
Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
           Y L  T+G G++G+VK A    + +  A K + K     ++  D+ K+EI  +K L HPN
Sbjct: 28  YTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPK---YFVEDVDRFKQEIEIMKSLDHPN 84
Query: 76  VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGV 135
           ++RL+E     + IY+V+E  TGGELF+++  K   +E++  ++ + ++  V+YCH   V
Sbjct: 85  IIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNV 144
Query: 136 FHRDLKLENILL--DSKGN-IKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRG 192
            HRDLK EN L   DS  + +K+ DFGL+A    F+   ++ T  G+P YV+P+VL   G
Sbjct: 145 AHRDLKPENFLFLTDSPDSPLKLIDFGLAA---RFKPGKMMRTKVGTPYYVSPQVL--EG 199
Query: 193 YDGATSDIWSCGVILYIF--------------------RGDFKLPK--WL--SPGAQNLL 228
             G   D WS GV++Y+                      G F  P+  WL  SP A++L+
Sbjct: 200 LYGPECDEWSAGVMMYVLLCGYPPFSAPTDXEVMLKIREGTFTFPEKDWLNVSPQAESLI 259
Query: 229 RKILEPNPVKRITIAGIKADEWFEQ 253
           R++L  +P +RIT       EWFE+
Sbjct: 260 RRLLTKSPKQRITSLQALEHEWFEK 284

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score =  156 bits (395), Expect = 2e-38,   Method: Compositional matrix adjust.
 Identities = 89/253 (35%), Positives = 138/253 (54%), Gaps = 32/253 (12%)
Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
           Y++   LG+G F  V+      +GL FA KI+   ++   +   +++RE    + L+HPN
Sbjct: 31  YDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKL-SARDFQKLEREARICRKLQHPN 89
Query: 76  VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGV 135
           +VRLH+ +  +S  Y+V + VTGGELF+ I ++    EA+     QQ+++ ++YCH+ G+
Sbjct: 90  IVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGI 149
Query: 136 FHRDLKLENILLDSKGN---IKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRG 192
            HR+LK EN+LL SK     +K++DFGL+       D    H   G+P Y++PEVL    
Sbjct: 150 VHRNLKPENLLLASKAKGAAVKLADFGLAI---EVNDSEAWHGFAGTPGYLSPEVLKKDP 206
Query: 193 YDGATSDIWSCGVILYIF----------------------RGDFKLPKW--LSPGAQNLL 228
           Y     DIW+CGVILYI                         D+  P+W  ++P A++L+
Sbjct: 207 YSKPV-DIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLI 265
Query: 229 RKILEPNPVKRIT 241
             +L  NP KRIT
Sbjct: 266 DSMLTVNPKKRIT 278

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score =  156 bits (394), Expect = 2e-38,   Method: Compositional matrix adjust.
 Identities = 80/269 (29%), Positives = 141/269 (52%), Gaps = 25/269 (9%)
Query: 2   VIAEKKQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQI 61
            +AE  +    +  +++ R LG+G FG V  A++  +    A+K+L K+++    +  Q+
Sbjct: 2   ALAEMPKRKFTIDDFDIVRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQL 61
Query: 62  KREIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQ 121
           +REI     L+HPN++R++     + +IY++LE+   GEL+ ++   GR  E       +
Sbjct: 62  RREIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFME 121
Query: 122 QLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPN 181
           +L D + YCH + V HRD+K EN+L+  KG +KI+DFG S      R   +    CG+ +
Sbjct: 122 ELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRRXM----CGTLD 177
Query: 182 YVAPEVLANRGYDGATSDIWSCGVILY--------------------IFRGDFKLPKWLS 221
           Y+ PE++  + +D    D+W  GV+ Y                    I   D K P +LS
Sbjct: 178 YLPPEMIEGKTHDEKV-DLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKFPPFLS 236
Query: 222 PGAQNLLRKILEPNPVKRITIAGIKADEW 250
            G+++L+ K+L  +P +R+ + G+    W
Sbjct: 237 DGSKDLISKLLRYHPPQRLPLKGVMEHPW 265

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score =  156 bits (394), Expect = 2e-38,   Method: Compositional matrix adjust.
 Identities = 89/253 (35%), Positives = 138/253 (54%), Gaps = 32/253 (12%)
Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
           Y++   LG+G F  V+      +GL FA KI+   ++   +   +++RE    + L+HPN
Sbjct: 8   YDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKL-SARDFQKLEREARICRKLQHPN 66
Query: 76  VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGV 135
           +VRLH+ +  +S  Y+V + VTGGELF+ I ++    EA+     QQ+++ ++YCH+ G+
Sbjct: 67  IVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGI 126
Query: 136 FHRDLKLENILLDSKGN---IKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRG 192
            HR+LK EN+LL SK     +K++DFGL+       D    H   G+P Y++PEVL    
Sbjct: 127 VHRNLKPENLLLASKAKGAAVKLADFGLAI---EVNDSEAWHGFAGTPGYLSPEVLKKDP 183
Query: 193 YDGATSDIWSCGVILYIF----------------------RGDFKLPKW--LSPGAQNLL 228
           Y     DIW+CGVILYI                         D+  P+W  ++P A++L+
Sbjct: 184 YSKPV-DIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLI 242
Query: 229 RKILEPNPVKRIT 241
             +L  NP KRIT
Sbjct: 243 DSMLTVNPKKRIT 255

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score =  156 bits (394), Expect = 2e-38,   Method: Compositional matrix adjust.
 Identities = 89/253 (35%), Positives = 138/253 (54%), Gaps = 32/253 (12%)
Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
           Y++   LG+G F  V+      +GL FA KI+   ++   +   +++RE    + L+HPN
Sbjct: 7   YDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKL-SARDFQKLEREARICRKLQHPN 65
Query: 76  VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGV 135
           +VRLH+ +  +S  Y+V + VTGGELF+ I ++    EA+     QQ+++ ++YCH+ G+
Sbjct: 66  IVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGI 125
Query: 136 FHRDLKLENILLDSKGN---IKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRG 192
            HR+LK EN+LL SK     +K++DFGL+       D    H   G+P Y++PEVL    
Sbjct: 126 VHRNLKPENLLLASKAKGAAVKLADFGLAI---EVNDSEAWHGFAGTPGYLSPEVLKKDP 182
Query: 193 YDGATSDIWSCGVILYIF----------------------RGDFKLPKW--LSPGAQNLL 228
           Y     DIW+CGVILYI                         D+  P+W  ++P A++L+
Sbjct: 183 YSKPV-DIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLI 241
Query: 229 RKILEPNPVKRIT 241
             +L  NP KRIT
Sbjct: 242 DSMLTVNPKKRIT 254

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score =  156 bits (394), Expect = 3e-38,   Method: Compositional matrix adjust.
 Identities = 89/253 (35%), Positives = 138/253 (54%), Gaps = 32/253 (12%)
Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
           Y++   LG+G F  V+      +GL FA KI+   ++   +   +++RE    + L+HPN
Sbjct: 8   YDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKL-SARDFQKLEREARICRKLQHPN 66
Query: 76  VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGV 135
           +VRLH+ +  +S  Y+V + VTGGELF+ I ++    EA+     QQ+++ ++YCH+ G+
Sbjct: 67  IVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGI 126
Query: 136 FHRDLKLENILLDSKGN---IKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRG 192
            HR+LK EN+LL SK     +K++DFGL+       D    H   G+P Y++PEVL    
Sbjct: 127 VHRNLKPENLLLASKAKGAAVKLADFGLAI---EVNDSEAWHGFAGTPGYLSPEVLKKDP 183
Query: 193 YDGATSDIWSCGVILYIF----------------------RGDFKLPKW--LSPGAQNLL 228
           Y     DIW+CGVILYI                         D+  P+W  ++P A++L+
Sbjct: 184 YSKPV-DIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLI 242
Query: 229 RKILEPNPVKRIT 241
             +L  NP KRIT
Sbjct: 243 DSMLTVNPKKRIT 255

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score =  156 bits (394), Expect = 3e-38,   Method: Compositional matrix adjust.
 Identities = 93/265 (35%), Positives = 145/265 (54%), Gaps = 35/265 (13%)
Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
           Y L  T+G G++G+VK A    + +  A K + K     ++  D+ K+EI  +K L HPN
Sbjct: 11  YTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPK---YFVEDVDRFKQEIEIMKSLDHPN 67
Query: 76  VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGV 135
           ++RL+E     + IY+V+E  TGGELF+++  K   +E++  ++ + ++  V+YCH   V
Sbjct: 68  IIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNV 127
Query: 136 FHRDLKLENILL--DSKGN-IKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRG 192
            HRDLK EN L   DS  + +K+ DFGL+A    F+   ++ T  G+P YV+P+VL   G
Sbjct: 128 AHRDLKPENFLFLTDSPDSPLKLIDFGLAA---RFKPGKMMRTKVGTPYYVSPQVL--EG 182
Query: 193 YDGATSDIWSCGVILYIF--------------------RGDFKLPK--WL--SPGAQNLL 228
             G   D WS GV++Y+                      G F  P+  WL  SP A++L+
Sbjct: 183 LYGPECDEWSAGVMMYVLLCGYPPFSAPTDXEVMLKIREGTFTFPEKDWLNVSPQAESLI 242
Query: 229 RKILEPNPVKRITIAGIKADEWFEQ 253
           R++L  +P +RIT       EWFE+
Sbjct: 243 RRLLTKSPKQRITSLQALEHEWFEK 267

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score =  155 bits (393), Expect = 3e-38,   Method: Compositional matrix adjust.
 Identities = 86/281 (30%), Positives = 147/281 (52%), Gaps = 26/281 (9%)
Query: 5   EKKQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKRE 64
           E K+    L  +E+GR LG+G FG V  A++  S    A+K+L K ++    +  Q++RE
Sbjct: 16  ESKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRRE 75
Query: 65  IATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLI 124
           +     L+HPN++RL+      +++Y++LEY   G ++ ++    +  E        +L 
Sbjct: 76  VEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELA 135
Query: 125 DGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVA 184
           + +SYCH+K V HRD+K EN+LL S G +KI+DFG S      R      T CG+ +Y+ 
Sbjct: 136 NALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT----TLCGTLDYLP 191
Query: 185 PEVLANRGYDGATSDIWSCGVILYIF--------------------RGDFKLPKWLSPGA 224
           PE++  R +D    D+WS GV+ Y F                    R +F  P +++ GA
Sbjct: 192 PEMIEGRMHDEKV-DLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGA 250
Query: 225 QNLLRKILEPNPVKRITIAGIKADEWFEQDYT-PANPDDDE 264
           ++L+ ++L+ NP +R  +  +    W   + + P+N  + E
Sbjct: 251 RDLISRLLKHNPSQRPMLREVLEHPWITANSSKPSNCQNKE 291

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score =  155 bits (393), Expect = 3e-38,   Method: Compositional matrix adjust.
 Identities = 86/281 (30%), Positives = 147/281 (52%), Gaps = 26/281 (9%)
Query: 5   EKKQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKRE 64
           E K+    L  +E+GR LG+G FG V  A++  S    A+K+L K ++    +  Q++RE
Sbjct: 4   ESKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRRE 63
Query: 65  IATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLI 124
           +     L+HPN++RL+      +++Y++LEY   G ++ ++    +  E        +L 
Sbjct: 64  VEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELA 123
Query: 125 DGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVA 184
           + +SYCH+K V HRD+K EN+LL S G +KI+DFG S      R      T CG+ +Y+ 
Sbjct: 124 NALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT----TLCGTLDYLP 179
Query: 185 PEVLANRGYDGATSDIWSCGVILYIF--------------------RGDFKLPKWLSPGA 224
           PE++  R +D    D+WS GV+ Y F                    R +F  P +++ GA
Sbjct: 180 PEMIEGRMHDEKV-DLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGA 238
Query: 225 QNLLRKILEPNPVKRITIAGIKADEWFEQDYT-PANPDDDE 264
           ++L+ ++L+ NP +R  +  +    W   + + P+N  + E
Sbjct: 239 RDLISRLLKHNPSQRPMLREVLEHPWITANSSKPSNCQNKE 279

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score =  155 bits (393), Expect = 3e-38,   Method: Compositional matrix adjust.
 Identities = 86/281 (30%), Positives = 147/281 (52%), Gaps = 26/281 (9%)
Query: 5   EKKQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKRE 64
           E K+    L  +E+GR LG+G FG V  A++  S    A+K+L K ++    +  Q++RE
Sbjct: 2   ESKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRRE 61
Query: 65  IATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLI 124
           +     L+HPN++RL+      +++Y++LEY   G ++ ++    +  E        +L 
Sbjct: 62  VEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELA 121
Query: 125 DGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVA 184
           + +SYCH+K V HRD+K EN+LL S G +KI+DFG S      R      T CG+ +Y+ 
Sbjct: 122 NALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT----TLCGTLDYLP 177
Query: 185 PEVLANRGYDGATSDIWSCGVILYIF--------------------RGDFKLPKWLSPGA 224
           PE++  R +D    D+WS GV+ Y F                    R +F  P +++ GA
Sbjct: 178 PEMIEGRMHDEKV-DLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGA 236
Query: 225 QNLLRKILEPNPVKRITIAGIKADEWFEQDYT-PANPDDDE 264
           ++L+ ++L+ NP +R  +  +    W   + + P+N  + E
Sbjct: 237 RDLISRLLKHNPSQRPMLREVLEHPWITANSSKPSNCQNKE 277

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score =  155 bits (393), Expect = 3e-38,   Method: Compositional matrix adjust.
 Identities = 81/259 (31%), Positives = 140/259 (54%), Gaps = 25/259 (9%)
Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
           +++GR LG+G FG V  A++  S    A+K+L K ++    +  Q++RE+     L+HPN
Sbjct: 14  FDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRHPN 73
Query: 76  VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGV 135
           ++RL+      +++Y++LEY   G ++ ++    R  E        +L + +SYCH+K V
Sbjct: 74  ILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSRFDEQRTATYITELANALSYCHSKRV 133
Query: 136 FHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDG 195
            HRD+K EN+LL S G +KI+DFG S      R      T CG+ +Y+ PE++  R +D 
Sbjct: 134 IHRDIKPENLLLGSNGELKIADFGWSVHAPSSRRT----TLCGTLDYLPPEMIEGRMHDE 189
Query: 196 ATSDIWSCGVILYIF--------------------RGDFKLPKWLSPGAQNLLRKILEPN 235
              D+WS GV+ Y F                    R +F  P +++ GA++L+ ++L+ N
Sbjct: 190 KV-DLWSLGVLCYEFLVGMPPFEAHTYQETYRRISRVEFTFPDFVTEGARDLISRLLKHN 248
Query: 236 PVKRITIAGIKADEWFEQD 254
             +R+T+A +    W + +
Sbjct: 249 ASQRLTLAEVLEHPWIKAN 267

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score =  155 bits (393), Expect = 3e-38,   Method: Compositional matrix adjust.
 Identities = 86/281 (30%), Positives = 147/281 (52%), Gaps = 26/281 (9%)
Query: 5   EKKQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKRE 64
           E K+    L  +E+GR LG+G FG V  A++  S    A+K+L K ++    +  Q++RE
Sbjct: 25  ESKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRRE 84
Query: 65  IATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLI 124
           +     L+HPN++RL+      +++Y++LEY   G ++ ++    +  E        +L 
Sbjct: 85  VEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELA 144
Query: 125 DGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVA 184
           + +SYCH+K V HRD+K EN+LL S G +KI+DFG S      R      T CG+ +Y+ 
Sbjct: 145 NALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT----TLCGTLDYLP 200
Query: 185 PEVLANRGYDGATSDIWSCGVILYIF--------------------RGDFKLPKWLSPGA 224
           PE++  R +D    D+WS GV+ Y F                    R +F  P +++ GA
Sbjct: 201 PEMIEGRMHDEKV-DLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGA 259
Query: 225 QNLLRKILEPNPVKRITIAGIKADEWFEQDYT-PANPDDDE 264
           ++L+ ++L+ NP +R  +  +    W   + + P+N  + E
Sbjct: 260 RDLISRLLKHNPSQRPMLREVLEHPWITANSSKPSNCQNKE 300

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score =  155 bits (392), Expect = 4e-38,   Method: Compositional matrix adjust.
 Identities = 100/277 (36%), Positives = 142/277 (51%), Gaps = 36/277 (12%)
Query: 6   KKQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREI 65
           K+ E +R   Y+    LG G F +V  A+D  +    A+K + K  +   +    ++ EI
Sbjct: 11  KQAEDIR-DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKE--GSMENEI 67
Query: 66  ATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLID 125
           A L  +KHPN+V L ++  S   +Y++++ V+GGELFD+I  KG   E +  +L  Q++D
Sbjct: 68  AVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLD 127
Query: 126 GVSYCHNKGVFHRDLKLENIL---LDSKGNIKISDFGLSALPQHFRDDG-LLHTTCGSPN 181
            V Y H+ G+ HRDLK EN+L   LD    I ISDFGLS +     D G +L T CG+P 
Sbjct: 128 AVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM----EDPGSVLSTACGTPG 183
Query: 182 YVAPEVLANRGYDGATSDIWSCGVILYIF----------------------RGDFKLPKW 219
           YVAPEVLA + Y  A  D WS GVI YI                         +F  P W
Sbjct: 184 YVAPEVLAQKPYSKAV-DCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYW 242
Query: 220 --LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD 254
             +S  A++ +R ++E +P KR T        W   D
Sbjct: 243 DDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIAGD 279

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score =  155 bits (392), Expect = 4e-38,   Method: Compositional matrix adjust.
 Identities = 93/254 (36%), Positives = 137/254 (53%), Gaps = 32/254 (12%)
Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
           RY+  + LG G +G+V   +D  +G   A+KI++K+ +     +  +  E+A LK L HP
Sbjct: 5   RYQRVKKLGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQLDHP 64
Query: 75  NVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKG 134
           N+++L+E    K   Y+V+E   GGELFD+I  + +  E +   + +Q++ G +Y H   
Sbjct: 65  NIMKLYEFFEDKRNYYLVMEVYRGGELFDEIILRQKFSEVDAAVIMKQVLSGTTYLHKHN 124
Query: 135 VFHRDLKLENILLDSKGN---IKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANR 191
           + HRDLK EN+LL+SK     IKI DFGLSA   HF   G +    G+  Y+APEVL  +
Sbjct: 125 IVHRDLKPENLLLESKSRDALIKIVDFGLSA---HFEVGGKMKERLGTAYYIAPEVLRKK 181
Query: 192 GYDGATSDIWSCGVILYIF--------------------RGDFKL--PKW--LSPGAQNL 227
            YD    D+WSCGVILYI                     +G F    P W  +S  A+ L
Sbjct: 182 -YD-EKCDVWSCGVILYILLCGYPPFGGQTDQEILKRVEKGKFSFDPPDWTQVSDEAKQL 239
Query: 228 LRKILEPNPVKRIT 241
           ++ +L   P KRI+
Sbjct: 240 VKLMLTYEPSKRIS 253

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score =  155 bits (392), Expect = 4e-38,   Method: Compositional matrix adjust.
 Identities = 97/267 (36%), Positives = 137/267 (51%), Gaps = 35/267 (13%)
Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
           Y+    LG G F +V  A+D  +    A+K + K  +   +    ++ EIA L  +KHPN
Sbjct: 20  YDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKE--GSMENEIAVLHKIKHPN 77
Query: 76  VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGV 135
           +V L ++  S   +Y++++ V+GGELFD+I  KG   E +  +L  Q++D V Y H+ G+
Sbjct: 78  IVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGI 137
Query: 136 FHRDLKLENIL---LDSKGNIKISDFGLSALPQHFRDDG-LLHTTCGSPNYVAPEVLANR 191
            HRDLK EN+L   LD    I ISDFGLS +     D G +L T CG+P YVAPEVLA +
Sbjct: 138 VHRDLKPENLLYYSLDEDSKIMISDFGLSKM----EDPGSVLSTACGTPGYVAPEVLAQK 193
Query: 192 GYDGATSDIWSCGVILYIF----------------------RGDFKLPKW--LSPGAQNL 227
            Y  A  D WS GVI YI                         +F  P W  +S  A++ 
Sbjct: 194 PYSKAV-DCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAKDF 252
Query: 228 LRKILEPNPVKRITIAGIKADEWFEQD 254
           +R ++E +P KR T        W   D
Sbjct: 253 IRHLMEKDPEKRFTCEQALQHPWIAGD 279

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score =  155 bits (392), Expect = 4e-38,   Method: Compositional matrix adjust.
 Identities = 97/267 (36%), Positives = 137/267 (51%), Gaps = 35/267 (13%)
Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
           Y+    LG G F +V  A+D  +    A+K + K  +   +    ++ EIA L  +KHPN
Sbjct: 20  YDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKE--GSMENEIAVLHKIKHPN 77
Query: 76  VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGV 135
           +V L ++  S   +Y++++ V+GGELFD+I  KG   E +  +L  Q++D V Y H+ G+
Sbjct: 78  IVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGI 137
Query: 136 FHRDLKLENIL---LDSKGNIKISDFGLSALPQHFRDDG-LLHTTCGSPNYVAPEVLANR 191
            HRDLK EN+L   LD    I ISDFGLS +     D G +L T CG+P YVAPEVLA +
Sbjct: 138 VHRDLKPENLLYYSLDEDSKIMISDFGLSKM----EDPGSVLSTACGTPGYVAPEVLAQK 193
Query: 192 GYDGATSDIWSCGVILYIF----------------------RGDFKLPKW--LSPGAQNL 227
            Y  A  D WS GVI YI                         +F  P W  +S  A++ 
Sbjct: 194 PYSKAV-DCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAKDF 252
Query: 228 LRKILEPNPVKRITIAGIKADEWFEQD 254
           +R ++E +P KR T        W   D
Sbjct: 253 IRHLMEKDPEKRFTCEQALQHPWIAGD 279

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score =  155 bits (391), Expect = 5e-38,   Method: Compositional matrix adjust.
 Identities = 86/281 (30%), Positives = 147/281 (52%), Gaps = 26/281 (9%)
Query: 5   EKKQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKRE 64
           E K+    L  +E+GR LG+G FG V  A++  S    A+K+L K ++    +  Q++RE
Sbjct: 1   ESKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRRE 60
Query: 65  IATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLI 124
           +     L+HPN++RL+      +++Y++LEY   G ++ ++    +  E        +L 
Sbjct: 61  VEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELA 120
Query: 125 DGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVA 184
           + +SYCH+K V HRD+K EN+LL S G +KI+DFG S      R   L    CG+ +Y+ 
Sbjct: 121 NALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRXXL----CGTLDYLP 176
Query: 185 PEVLANRGYDGATSDIWSCGVILYIF--------------------RGDFKLPKWLSPGA 224
           PE++  R +D    D+WS GV+ Y F                    R +F  P +++ GA
Sbjct: 177 PEMIEGRMHDEKV-DLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGA 235
Query: 225 QNLLRKILEPNPVKRITIAGIKADEWFEQDYT-PANPDDDE 264
           ++L+ ++L+ NP +R  +  +    W   + + P+N  + E
Sbjct: 236 RDLISRLLKHNPSQRPMLREVLEHPWITANSSKPSNCQNKE 276

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score =  155 bits (391), Expect = 5e-38,   Method: Compositional matrix adjust.
 Identities = 97/267 (36%), Positives = 137/267 (51%), Gaps = 35/267 (13%)
Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
           Y+    LG G F +V  A+D  +    A+K + K  +   +    ++ EIA L  +KHPN
Sbjct: 20  YDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKE--GSMENEIAVLHKIKHPN 77
Query: 76  VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGV 135
           +V L ++  S   +Y++++ V+GGELFD+I  KG   E +  +L  Q++D V Y H+ G+
Sbjct: 78  IVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGI 137
Query: 136 FHRDLKLENIL---LDSKGNIKISDFGLSALPQHFRDDG-LLHTTCGSPNYVAPEVLANR 191
            HRDLK EN+L   LD    I ISDFGLS +     D G +L T CG+P YVAPEVLA +
Sbjct: 138 VHRDLKPENLLYYSLDEDSKIMISDFGLSKM----EDPGSVLSTACGTPGYVAPEVLAQK 193
Query: 192 GYDGATSDIWSCGVILYIF----------------------RGDFKLPKW--LSPGAQNL 227
            Y  A  D WS GVI YI                         +F  P W  +S  A++ 
Sbjct: 194 PYSKAV-DCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAKDF 252
Query: 228 LRKILEPNPVKRITIAGIKADEWFEQD 254
           +R ++E +P KR T        W   D
Sbjct: 253 IRHLMEKDPEKRFTCEQALQHPWIAGD 279

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score =  155 bits (391), Expect = 6e-38,   Method: Compositional matrix adjust.
 Identities = 86/281 (30%), Positives = 146/281 (51%), Gaps = 26/281 (9%)
Query: 5   EKKQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKRE 64
           E K+    L  +E+GR LG+G FG V  A++  S    A+K+L K ++    +  Q++RE
Sbjct: 4   ESKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRRE 63
Query: 65  IATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLI 124
           +     L+HPN++RL+      +++Y++LEY   G ++ ++    +  E        +L 
Sbjct: 64  VEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELA 123
Query: 125 DGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVA 184
           + +SYCH+K V HRD+K EN+LL S G +KI+DFG S      R      T CG+ +Y+ 
Sbjct: 124 NALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT----TLCGTLDYLP 179
Query: 185 PEVLANRGYDGATSDIWSCGVILYIF--------------------RGDFKLPKWLSPGA 224
           PE +  R +D    D+WS GV+ Y F                    R +F  P +++ GA
Sbjct: 180 PEXIEGRXHDEKV-DLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGA 238
Query: 225 QNLLRKILEPNPVKRITIAGIKADEWFEQDYT-PANPDDDE 264
           ++L+ ++L+ NP +R  +  +    W   + + P+N  + E
Sbjct: 239 RDLISRLLKHNPSQRPXLREVLEHPWITANSSKPSNCQNKE 279

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score =  154 bits (389), Expect = 8e-38,   Method: Compositional matrix adjust.
 Identities = 93/279 (33%), Positives = 146/279 (52%), Gaps = 31/279 (11%)
Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
           Y+L   LG+G F  V+    + +G  +A  I+   ++   +   +++RE    +LLKHPN
Sbjct: 13  YQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKL-SARDHQKLEREARICRLLKHPN 71
Query: 76  VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGV 135
           +VRLH+ ++ +   Y++ + VTGGELF+ I ++    EA+     QQ+++ V +CH  GV
Sbjct: 72  IVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMGV 131
Query: 136 FHRDLKLENILLDSK---GNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRG 192
            HR+LK EN+LL SK     +K++DFGL+   +   +        G+P Y++PEVL    
Sbjct: 132 VHRNLKPENLLLASKLKGAAVKLADFGLAIEVE--GEQQAWFGFAGTPGYLSPEVLRKDP 189
Query: 193 YDGATSDIWSCGVILYIF----------------------RGDFKLPKW--LSPGAQNLL 228
           Y G   D+W+CGVILYI                         DF  P+W  ++P A++L+
Sbjct: 190 Y-GKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPEAKDLI 248
Query: 229 RKILEPNPVKRITIAGIKADEWFEQDYTPANPDDDEEDI 267
            K+L  NP KRIT A      W     T A+    +E +
Sbjct: 249 NKMLTINPSKRITAAEALKHPWISHRSTVASCMHRQETV 287

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score =  154 bits (389), Expect = 9e-38,   Method: Compositional matrix adjust.
 Identities = 93/254 (36%), Positives = 137/254 (53%), Gaps = 32/254 (12%)
Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
           RY+  + LG G +G+V   +D  +G   A+KI++K+ +     +  +  E+A LK L HP
Sbjct: 22  RYQRVKKLGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQLDHP 81
Query: 75  NVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKG 134
           N+++L+E    K   Y+V+E   GGELFD+I  + +  E +   + +Q++ G +Y H   
Sbjct: 82  NIMKLYEFFEDKRNYYLVMEVYRGGELFDEIILRQKFSEVDAAVIMKQVLSGTTYLHKHN 141
Query: 135 VFHRDLKLENILLDSKGN---IKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANR 191
           + HRDLK EN+LL+SK     IKI DFGLSA   HF   G +    G+  Y+APEVL  +
Sbjct: 142 IVHRDLKPENLLLESKSRDALIKIVDFGLSA---HFEVGGKMKERLGTAYYIAPEVLRKK 198
Query: 192 GYDGATSDIWSCGVILYIF--------------------RGDFKL--PKW--LSPGAQNL 227
            YD    D+WSCGVILYI                     +G F    P W  +S  A+ L
Sbjct: 199 -YD-EKCDVWSCGVILYILLCGYPPFGGQTDQEILKRVEKGKFSFDPPDWTQVSDEAKQL 256
Query: 228 LRKILEPNPVKRIT 241
           ++ +L   P KRI+
Sbjct: 257 VKLMLTYEPSKRIS 270

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score =  154 bits (388), Expect = 1e-37,   Method: Compositional matrix adjust.
 Identities = 85/281 (30%), Positives = 147/281 (52%), Gaps = 26/281 (9%)
Query: 5   EKKQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKRE 64
           E K+    L  +E+GR LG+G FG V  A++  S    A+K+L K ++    +  Q++RE
Sbjct: 1   ESKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRRE 60
Query: 65  IATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLI 124
           +     L+HPN++RL+      +++Y++LEY   G ++ ++    +  E        +L 
Sbjct: 61  VEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELA 120
Query: 125 DGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVA 184
           + +SYCH+K V HRD+K EN+LL S G +KI++FG S      R      T CG+ +Y+ 
Sbjct: 121 NALSYCHSKRVIHRDIKPENLLLGSAGELKIANFGWSVHAPSSRRT----TLCGTLDYLP 176
Query: 185 PEVLANRGYDGATSDIWSCGVILYIF--------------------RGDFKLPKWLSPGA 224
           PE++  R +D    D+WS GV+ Y F                    R +F  P +++ GA
Sbjct: 177 PEMIEGRMHDEKV-DLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGA 235
Query: 225 QNLLRKILEPNPVKRITIAGIKADEWFEQDYT-PANPDDDE 264
           ++L+ ++L+ NP +R  +  +    W   + + P+N  + E
Sbjct: 236 RDLISRLLKHNPSQRPMLREVLEHPWITANSSKPSNCQNKE 276

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score =  154 bits (388), Expect = 1e-37,   Method: Compositional matrix adjust.
 Identities = 86/280 (30%), Positives = 147/280 (52%), Gaps = 28/280 (10%)
Query: 7   KQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIA 66
           K+    L  +E+GR LG+G FG V  A++  S    A+K+L K ++    +  Q++RE+ 
Sbjct: 2   KKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVE 61
Query: 67  TLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDG 126
               L+HPN++RL+      +++Y++LEY   G ++ ++    +  E        +L + 
Sbjct: 62  IQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANA 121
Query: 127 VSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSA-LPQHFRDDGLLHTTCGSPNYVAP 185
           +SYCH+K V HRD+K EN+LL S G +KI+DFG S   P   R D      CG+ +Y+ P
Sbjct: 122 LSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTD-----LCGTLDYLPP 176
Query: 186 EVLANRGYDGATSDIWSCGVILYIF--------------------RGDFKLPKWLSPGAQ 225
           E++  R +D    D+WS GV+ Y F                    R +F  P +++ GA+
Sbjct: 177 EMIEGRMHDEKV-DLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGAR 235
Query: 226 NLLRKILEPNPVKRITIAGIKADEWFEQDYT-PANPDDDE 264
           +L+ ++L+ NP +R  +  +    W   + + P+N  + E
Sbjct: 236 DLISRLLKHNPSQRPMLREVLEHPWITANSSKPSNCQNKE 275

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score =  154 bits (388), Expect = 1e-37,   Method: Compositional matrix adjust.
 Identities = 86/280 (30%), Positives = 147/280 (52%), Gaps = 28/280 (10%)
Query: 7   KQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIA 66
           K+    L  +E+GR LG+G FG V  A++  S    A+K+L K ++    +  Q++RE+ 
Sbjct: 6   KKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVE 65
Query: 67  TLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDG 126
               L+HPN++RL+      +++Y++LEY   G ++ ++    +  E        +L + 
Sbjct: 66  IQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANA 125
Query: 127 VSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSA-LPQHFRDDGLLHTTCGSPNYVAP 185
           +SYCH+K V HRD+K EN+LL S G +KI+DFG S   P   R D      CG+ +Y+ P
Sbjct: 126 LSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTD-----LCGTLDYLPP 180
Query: 186 EVLANRGYDGATSDIWSCGVILYIF--------------------RGDFKLPKWLSPGAQ 225
           E++  R +D    D+WS GV+ Y F                    R +F  P +++ GA+
Sbjct: 181 EMIEGRMHDEKV-DLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGAR 239
Query: 226 NLLRKILEPNPVKRITIAGIKADEWFEQDYT-PANPDDDE 264
           +L+ ++L+ NP +R  +  +    W   + + P+N  + E
Sbjct: 240 DLISRLLKHNPSQRPMLREVLEHPWITANSSKPSNCQNKE 279

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score =  154 bits (388), Expect = 1e-37,   Method: Compositional matrix adjust.
 Identities = 90/265 (33%), Positives = 135/265 (50%), Gaps = 23/265 (8%)
Query: 13  LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK 72
           + RY  GR LG+G F K     D+D+   FA K++ K+ ++     +++  EIA  K L 
Sbjct: 41  MKRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLD 100
Query: 73  HPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHN 132
           +P+VV  H        +Y+VLE      L +    +  + E E R   +Q I GV Y HN
Sbjct: 101 NPHVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTIQGVQYLHN 160
Query: 133 KGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRG 192
             V HRDLKL N+ L+   ++KI DFGL+   +   D     T CG+PNY+APEVL  +G
Sbjct: 161 NRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEF--DGERKKTLCGTPNYIAPEVLCKKG 218
Query: 193 YDGATSDIWSCGVILY--------------------IFRGDFKLPKWLSPGAQNLLRKIL 232
           +     DIWS G ILY                    I + ++ +P+ ++P A  L+R++L
Sbjct: 219 HSFEV-DIWSLGCILYTLLVGKPPFETSCLKETYIRIKKNEYSVPRHINPVASALIRRML 277
Query: 233 EPNPVKRITIAGIKADEWFEQDYTP 257
             +P  R ++A +  DE+F   Y P
Sbjct: 278 HADPTLRPSVAELLTDEFFTSGYAP 302

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score =  153 bits (387), Expect = 1e-37,   Method: Compositional matrix adjust.
 Identities = 82/256 (32%), Positives = 138/256 (53%), Gaps = 27/256 (10%)
Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
           +E+GR LG+G FG V  A++  S    A+K+L K ++    +  Q++RE+     L+HPN
Sbjct: 13  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 72
Query: 76  VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGV 135
           ++RL+      +++Y++LEY   G ++ ++    +  E        +L + +SYCH+K V
Sbjct: 73  ILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRV 132
Query: 136 FHRDLKLENILLDSKGNIKISDFGLSA-LPQHFRDDGLLHTTCGSPNYVAPEVLANRGYD 194
            HRD+K EN+LL S G +KI+DFG S   P   RDD      CG+ +Y+ PE++  R +D
Sbjct: 133 IHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRDD-----LCGTLDYLPPEMIEGRMHD 187
Query: 195 GATSDIWSCGVILYIF--------------------RGDFKLPKWLSPGAQNLLRKILEP 234
               D+WS GV+ Y F                    R +F  P +++ GA++L+ ++L+ 
Sbjct: 188 EKV-DLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKH 246
Query: 235 NPVKRITIAGIKADEW 250
           NP +R  +  +    W
Sbjct: 247 NPSQRPMLREVLEHPW 262

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score =  153 bits (387), Expect = 1e-37,   Method: Compositional matrix adjust.
 Identities = 86/280 (30%), Positives = 147/280 (52%), Gaps = 28/280 (10%)
Query: 7   KQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIA 66
           K+    L  +E+GR LG+G FG V  A++  S    A+K+L K ++    +  Q++RE+ 
Sbjct: 1   KKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVE 60
Query: 67  TLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDG 126
               L+HPN++RL+      +++Y++LEY   G ++ ++    +  E        +L + 
Sbjct: 61  IQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANA 120
Query: 127 VSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSA-LPQHFRDDGLLHTTCGSPNYVAP 185
           +SYCH+K V HRD+K EN+LL S G +KI+DFG S   P   R D      CG+ +Y+ P
Sbjct: 121 LSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTD-----LCGTLDYLPP 175
Query: 186 EVLANRGYDGATSDIWSCGVILYIF--------------------RGDFKLPKWLSPGAQ 225
           E++  R +D    D+WS GV+ Y F                    R +F  P +++ GA+
Sbjct: 176 EMIEGRMHDEKV-DLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGAR 234
Query: 226 NLLRKILEPNPVKRITIAGIKADEWFEQDYT-PANPDDDE 264
           +L+ ++L+ NP +R  +  +    W   + + P+N  + E
Sbjct: 235 DLISRLLKHNPSQRPMLREVLEHPWITANSSKPSNCQNKE 274

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score =  153 bits (387), Expect = 1e-37,   Method: Compositional matrix adjust.
 Identities = 84/271 (30%), Positives = 144/271 (53%), Gaps = 28/271 (10%)
Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
           +E+GR LG+G FG V  A++  S    A+K+L K ++    +  Q++RE+     L+HPN
Sbjct: 10  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 69
Query: 76  VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGV 135
           ++RL+      +++Y++LEY   G ++ ++    +  E        +L + +SYCH+K V
Sbjct: 70  ILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRV 129
Query: 136 FHRDLKLENILLDSKGNIKISDFGLSA-LPQHFRDDGLLHTTCGSPNYVAPEVLANRGYD 194
            HRD+K EN+LL S G +KI+DFG S   P   R D      CG+ +Y+ PE++  R +D
Sbjct: 130 IHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTD-----LCGTLDYLPPEMIEGRMHD 184
Query: 195 GATSDIWSCGVILYIF--------------------RGDFKLPKWLSPGAQNLLRKILEP 234
               D+WS GV+ Y F                    R +F  P +++ GA++L+ ++L+ 
Sbjct: 185 EKV-DLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKH 243
Query: 235 NPVKRITIAGIKADEWFEQDYT-PANPDDDE 264
           NP +R  +  +    W   + + P+N  + E
Sbjct: 244 NPSQRPMLREVLEHPWITANSSKPSNCQNKE 274

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score =  153 bits (387), Expect = 1e-37,   Method: Compositional matrix adjust.
 Identities = 83/270 (30%), Positives = 143/270 (52%), Gaps = 26/270 (9%)
Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
           +E+GR LG+G FG V  A++  S    A+K+L K ++    +  Q++RE+     L+HPN
Sbjct: 13  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 72
Query: 76  VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGV 135
           ++RL+      +++Y++LEY   G ++ ++    +  E        +L + +SYCH+K V
Sbjct: 73  ILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRV 132
Query: 136 FHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDG 195
            HRD+K EN+LL S G +KI+DFG S      R   L    CG+ +Y+ PE++  R +D 
Sbjct: 133 IHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRAAL----CGTLDYLPPEMIEGRMHDE 188
Query: 196 ATSDIWSCGVILYIF--------------------RGDFKLPKWLSPGAQNLLRKILEPN 235
              D+WS GV+ Y F                    R +F  P +++ GA++L+ ++L+ N
Sbjct: 189 KV-DLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHN 247
Query: 236 PVKRITIAGIKADEWFEQDYT-PANPDDDE 264
           P +R  +  +    W   + + P+N  + E
Sbjct: 248 PSQRPMLREVLEHPWITANSSKPSNCQNKE 277

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score =  153 bits (387), Expect = 1e-37,   Method: Compositional matrix adjust.
 Identities = 83/266 (31%), Positives = 140/266 (52%), Gaps = 25/266 (9%)
Query: 5   EKKQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKRE 64
           E K+    L  +E+GR LG+G FG V  A++  S    A+K+L K ++    +  Q++RE
Sbjct: 2   ESKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRRE 61
Query: 65  IATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLI 124
           +     L+HPN++RL+      +++Y++LEY   G ++ ++    +  E        +L 
Sbjct: 62  VEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELA 121
Query: 125 DGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVA 184
           + +SYCH+K V HRD+K EN+LL S G +KI+DFG S      R      T CG+ +Y+ 
Sbjct: 122 NALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT----TLCGTLDYLP 177
Query: 185 PEVLANRGYDGATSDIWSCGVILYIF--------------------RGDFKLPKWLSPGA 224
           PE++  R +D    D+WS GV+ Y F                    R +F  P +++ GA
Sbjct: 178 PEMIEGRMHDEKV-DLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGA 236
Query: 225 QNLLRKILEPNPVKRITIAGIKADEW 250
           ++L+ ++L+ NP +R  +  +    W
Sbjct: 237 RDLISRLLKHNPSQRPMLREVLEHPW 262

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score =  153 bits (387), Expect = 1e-37,   Method: Compositional matrix adjust.
 Identities = 86/281 (30%), Positives = 147/281 (52%), Gaps = 26/281 (9%)
Query: 5   EKKQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKRE 64
           E K+    L  +E+GR LG+G FG V  A++  S    A+K+L K ++    +  Q++RE
Sbjct: 4   ESKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRRE 63
Query: 65  IATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLI 124
           +     L+HPN++RL+      +++Y++LEY   GE++ ++    +  E        +L 
Sbjct: 64  VEIQSHLRHPNILRLYGYFHDATRVYLILEYAPRGEVYKELQKLSKFDEQRTATYITELA 123
Query: 125 DGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVA 184
           + +SYCH+K V HRD+K EN+LL S G +KI+DFG S      R   L     G+ +Y+ 
Sbjct: 124 NALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRXXLX----GTLDYLP 179
Query: 185 PEVLANRGYDGATSDIWSCGVILYIF--------------------RGDFKLPKWLSPGA 224
           PE++  R +D    D+WS GV+ Y F                    R +F  P +++ GA
Sbjct: 180 PEMIEGRMHDEKV-DLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGA 238
Query: 225 QNLLRKILEPNPVKRITIAGIKADEWFEQDYT-PANPDDDE 264
           ++L+ ++L+ NP +R  +  +    W   + + P+N  + E
Sbjct: 239 RDLISRLLKHNPSQRPMLREVLEHPWITANSSKPSNCQNKE 279

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score =  153 bits (387), Expect = 2e-37,   Method: Compositional matrix adjust.
 Identities = 83/270 (30%), Positives = 143/270 (52%), Gaps = 26/270 (9%)
Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
           +E+GR LG+G FG V  A++  S    A+K+L K ++    +  Q++RE+     L+HPN
Sbjct: 10  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 69
Query: 76  VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGV 135
           ++RL+      +++Y++LEY   G ++ ++    +  E        +L + +SYCH+K V
Sbjct: 70  ILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRV 129
Query: 136 FHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDG 195
            HRD+K EN+LL S G +KI+DFG S      R      T CG+ +Y+ PE++  R +D 
Sbjct: 130 IHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT----TLCGTLDYLPPEMIEGRMHDE 185
Query: 196 ATSDIWSCGVILYIF--------------------RGDFKLPKWLSPGAQNLLRKILEPN 235
              D+WS GV+ Y F                    R +F  P +++ GA++L+ ++L+ N
Sbjct: 186 KV-DLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHN 244
Query: 236 PVKRITIAGIKADEWFEQDYT-PANPDDDE 264
           P +R  +  +    W   + + P+N  + E
Sbjct: 245 PSQRPMLREVLEHPWITANSSKPSNCQNKE 274

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score =  153 bits (386), Expect = 2e-37,   Method: Compositional matrix adjust.
 Identities = 86/269 (31%), Positives = 140/269 (52%), Gaps = 31/269 (11%)
Query: 8   QEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIAT 67
           Q    L ++E  +TLG G+FG+V   + +++G  +A+KIL+K +++ LK  +    E   
Sbjct: 36  QNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRI 95
Query: 68  LKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGV 127
           L+ +  P +V+L       S +YMV+EYV GGE+F  +   GR  E   R    Q++   
Sbjct: 96  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTF 155
Query: 128 SYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEV 187
            Y H+  + +RDLK EN+L+D +G I+++DFG +      R  G   T CG+P Y+APE+
Sbjct: 156 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWTLCGTPEYLAPEI 210
Query: 188 LANRGYDGATSDIWSCGVILY--------------------IFRGDFKLPKWLSPGAQNL 227
           + ++GY+ A  D W+ GV++Y                    I  G  + P   S   ++L
Sbjct: 211 ILSKGYNKAV-DWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDL 269
Query: 228 LRKILEPNPVKRI-----TIAGIKADEWF 251
           LR +L+ +  KR       +  IK  +WF
Sbjct: 270 LRNLLQVDLTKRFGNLKNGVNDIKNHKWF 298

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score =  153 bits (386), Expect = 2e-37,   Method: Compositional matrix adjust.
 Identities = 86/269 (31%), Positives = 140/269 (52%), Gaps = 31/269 (11%)
Query: 8   QEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIAT 67
           Q    L ++E  +TLG G+FG+V   + +++G  +A+KIL+K +++ LK  +    E   
Sbjct: 21  QNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRI 80
Query: 68  LKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGV 127
           L+ +  P +V+L       S +YMV+EYV GGE+F  +   GR  E   R    Q++   
Sbjct: 81  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTF 140
Query: 128 SYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEV 187
            Y H+  + +RDLK EN+L+D +G I+++DFG +      R  G   T CG+P Y+APE+
Sbjct: 141 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWTLCGTPEYLAPEI 195
Query: 188 LANRGYDGATSDIWSCGVILY--------------------IFRGDFKLPKWLSPGAQNL 227
           + ++GY+ A  D W+ GV++Y                    I  G  + P   S   ++L
Sbjct: 196 ILSKGYNKAV-DWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDL 254
Query: 228 LRKILEPNPVKRI-----TIAGIKADEWF 251
           LR +L+ +  KR       +  IK  +WF
Sbjct: 255 LRNLLQVDLTKRFGNLKDGVNDIKNHKWF 283

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score =  153 bits (386), Expect = 2e-37,   Method: Compositional matrix adjust.
 Identities = 83/270 (30%), Positives = 143/270 (52%), Gaps = 26/270 (9%)
Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
           +E+GR LG+G FG V  A++  S    A+K+L K ++    +  Q++RE+     L+HPN
Sbjct: 10  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 69
Query: 76  VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGV 135
           ++RL+      +++Y++LEY   G ++ ++    +  E        +L + +SYCH+K V
Sbjct: 70  ILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRV 129
Query: 136 FHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDG 195
            HRD+K EN+LL S G +KI+DFG S      R   L    CG+ +Y+ PE++  R +D 
Sbjct: 130 IHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTEL----CGTLDYLPPEMIEGRMHDE 185
Query: 196 ATSDIWSCGVILYIF--------------------RGDFKLPKWLSPGAQNLLRKILEPN 235
              D+WS GV+ Y F                    R +F  P +++ GA++L+ ++L+ N
Sbjct: 186 KV-DLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHN 244
Query: 236 PVKRITIAGIKADEWFEQDYT-PANPDDDE 264
           P +R  +  +    W   + + P+N  + E
Sbjct: 245 PSQRPMLREVLEHPWITANSSKPSNCQNKE 274

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score =  152 bits (385), Expect = 3e-37,   Method: Compositional matrix adjust.
 Identities = 83/266 (31%), Positives = 140/266 (52%), Gaps = 25/266 (9%)
Query: 5   EKKQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKRE 64
           E K+    L  +E+GR LG+G FG V  A++  S    A+K+L K ++    +  Q++RE
Sbjct: 2   ESKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRRE 61
Query: 65  IATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLI 124
           +     L+HPN++RL+      +++Y++LEY   G ++ ++    +  E        +L 
Sbjct: 62  VEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELA 121
Query: 125 DGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVA 184
           + +SYCH+K V HRD+K EN+LL S G +KI+DFG S      R   L    CG+ +Y+ 
Sbjct: 122 NALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRXXL----CGTLDYLP 177
Query: 185 PEVLANRGYDGATSDIWSCGVILYIF--------------------RGDFKLPKWLSPGA 224
           PE++  R +D    D+WS GV+ Y F                    R +F  P +++ GA
Sbjct: 178 PEMIEGRMHDEKV-DLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGA 236
Query: 225 QNLLRKILEPNPVKRITIAGIKADEW 250
           ++L+ ++L+ NP +R  +  +    W
Sbjct: 237 RDLISRLLKHNPSQRPMLREVLEHPW 262

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score =  152 bits (384), Expect = 3e-37,   Method: Compositional matrix adjust.
 Identities = 80/255 (31%), Positives = 137/255 (53%), Gaps = 25/255 (9%)
Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
           +E+GR LG+G FG V  A++ +S    A+K+L K ++    +  Q++RE+     L+HPN
Sbjct: 10  FEIGRPLGKGKFGNVYLAREKNSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 69
Query: 76  VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGV 135
           ++RL+      +++Y++LEY   G ++ ++    +  E        +L + +SYCH+K V
Sbjct: 70  ILRLYGYFHDSTRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKKV 129
Query: 136 FHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDG 195
            HRD+K EN+LL S G +KI+DFG S      R   L    CG+ +Y+ PE++  R +D 
Sbjct: 130 IHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRAAL----CGTLDYLPPEMIEGRMHDE 185
Query: 196 ATSDIWSCGVILYIF--------------------RGDFKLPKWLSPGAQNLLRKILEPN 235
              D+WS GV+ Y F                    R +F  P +++ GA++L+ ++L+ N
Sbjct: 186 KV-DLWSLGVLCYEFLVGKPPFEANTYQDTYKRISRVEFTFPDFVTEGARDLISRLLKHN 244
Query: 236 PVKRITIAGIKADEW 250
           P +R  +  +    W
Sbjct: 245 PSQRPMLREVLEHPW 259

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score =  152 bits (384), Expect = 3e-37,   Method: Compositional matrix adjust.
 Identities = 84/276 (30%), Positives = 145/276 (52%), Gaps = 26/276 (9%)
Query: 5   EKKQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKRE 64
           E K+    L  +E+GR LG+G FG V  A++  S    A+K+L K ++    +  Q++RE
Sbjct: 2   ESKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRRE 61
Query: 65  IATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLI 124
           +     L+HPN++RL+      +++Y++LEY   G ++ ++    +  E        +L 
Sbjct: 62  VEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELA 121
Query: 125 DGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVA 184
           + +SYCH+K V HRD+K EN+LL S G +KI++FG S      R      T CG+ +Y+ 
Sbjct: 122 NALSYCHSKRVIHRDIKPENLLLGSAGELKIANFGWSVHAPSSRRT----TLCGTLDYLP 177
Query: 185 PEVLANRGYDGATSDIWSCGVILYIF--------------------RGDFKLPKWLSPGA 224
           PE++  R +D    D+WS GV+ Y F                    R +F  P +++ GA
Sbjct: 178 PEMIEGRMHDEKV-DLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGA 236
Query: 225 QNLLRKILEPNPVKRITIAGIKADEWFEQDYT-PAN 259
           ++L+ ++L+ NP +R  +  +    W   + + P+N
Sbjct: 237 RDLISRLLKHNPSQRPMLREVLEHPWITANSSKPSN 272

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score =  152 bits (383), Expect = 4e-37,   Method: Compositional matrix adjust.
 Identities = 86/269 (31%), Positives = 140/269 (52%), Gaps = 31/269 (11%)
Query: 8   QEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIAT 67
           Q   +L +++  +TLG G+FG+V   +  +SG  +A+KIL+K +++ LK  +    E   
Sbjct: 56  QNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRI 115
Query: 68  LKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGV 127
           L+ +  P +V+L       S +YMV+EYV GGE+F  +   GR  E   R    Q++   
Sbjct: 116 LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTF 175
Query: 128 SYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEV 187
            Y H+  + +RDLK EN+L+D +G I+++DFG +      R  G   T CG+P Y+APE+
Sbjct: 176 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGATWTLCGTPEYLAPEI 230
Query: 188 LANRGYDGATSDIWSCGVILY--------------------IFRGDFKLPKWLSPGAQNL 227
           + ++GY+ A  D W+ GV++Y                    I  G  + P   S   ++L
Sbjct: 231 ILSKGYNKAV-DWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDL 289
Query: 228 LRKILEPNPVKRI-----TIAGIKADEWF 251
           LR +L+ +  KR       +  IK  +WF
Sbjct: 290 LRNLLQVDLTKRFGNLKNGVNDIKNHKWF 318

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score =  152 bits (383), Expect = 5e-37,   Method: Compositional matrix adjust.
 Identities = 89/265 (33%), Positives = 134/265 (50%), Gaps = 23/265 (8%)
Query: 13  LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK 72
           + RY  GR LG+G F K     D+D+   FA K++ K+ ++     +++  EIA  K L 
Sbjct: 41  MKRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLD 100
Query: 73  HPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHN 132
           +P+VV  H        +Y+VLE      L +    +  + E E R   +Q I GV Y HN
Sbjct: 101 NPHVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTIQGVQYLHN 160
Query: 133 KGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRG 192
             V HRDLKL N+ L+   ++KI DFGL+   +   D       CG+PNY+APEVL  +G
Sbjct: 161 NRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEF--DGERKKXLCGTPNYIAPEVLCKKG 218
Query: 193 YDGATSDIWSCGVILY--------------------IFRGDFKLPKWLSPGAQNLLRKIL 232
           +     DIWS G ILY                    I + ++ +P+ ++P A  L+R++L
Sbjct: 219 HSFEV-DIWSLGCILYTLLVGKPPFETSCLKETYIRIKKNEYSVPRHINPVASALIRRML 277
Query: 233 EPNPVKRITIAGIKADEWFEQDYTP 257
             +P  R ++A +  DE+F   Y P
Sbjct: 278 HADPTLRPSVAELLTDEFFTSGYAP 302

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score =  151 bits (382), Expect = 5e-37,   Method: Compositional matrix adjust.
 Identities = 80/255 (31%), Positives = 136/255 (53%), Gaps = 25/255 (9%)
Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
           +E+GR LG+G FG V  A++  S    A+K+L K ++    +  Q++RE+     L+HPN
Sbjct: 9   FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 68
Query: 76  VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGV 135
           ++RL+      +++Y++LEY   G ++ ++    +  E        +L + +SYCH+K V
Sbjct: 69  ILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRV 128
Query: 136 FHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDG 195
            HRD+K EN+LL S G +KI+DFG S      R      T CG+ +Y+ PE++  R +D 
Sbjct: 129 IHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT----TLCGTLDYLPPEMIEGRMHDE 184
Query: 196 ATSDIWSCGVILYIF--------------------RGDFKLPKWLSPGAQNLLRKILEPN 235
              D+WS GV+ Y F                    R +F  P +++ GA++L+ ++L+ N
Sbjct: 185 KV-DLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHN 243
Query: 236 PVKRITIAGIKADEW 250
           P +R  +  +    W
Sbjct: 244 PSQRPMLREVLEHPW 258

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score =  151 bits (382), Expect = 6e-37,   Method: Compositional matrix adjust.
 Identities = 85/269 (31%), Positives = 139/269 (51%), Gaps = 31/269 (11%)
Query: 8   QEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIAT 67
           Q    L ++E  +TLG G+FG+V   + +++G  +A+KIL+K +++ LK  +    E   
Sbjct: 35  QNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRI 94
Query: 68  LKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGV 127
           L+ +  P +V+L       S +YMV+EYV GGE+F  +   GR  E   R    Q++   
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTF 154
Query: 128 SYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEV 187
            Y H+  + +RDLK EN+L+D +G I+++DFG +      R  G     CG+P Y+APE+
Sbjct: 155 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYLAPEI 209
Query: 188 LANRGYDGATSDIWSCGVILY--------------------IFRGDFKLPKWLSPGAQNL 227
           + ++GY+ A  D W+ GV++Y                    I  G  + P   S   ++L
Sbjct: 210 ILSKGYNKAV-DWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDL 268
Query: 228 LRKILEPNPVKRI-----TIAGIKADEWF 251
           LR +L+ +  KR       +  IK  +WF
Sbjct: 269 LRNLLQVDLTKRFGNLKDGVNDIKNHKWF 297

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score =  151 bits (382), Expect = 6e-37,   Method: Compositional matrix adjust.
 Identities = 80/255 (31%), Positives = 136/255 (53%), Gaps = 25/255 (9%)
Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
           +E+GR LG+G FG V  A++  S    A+K+L K ++    +  Q++RE+     L+HPN
Sbjct: 14  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 73
Query: 76  VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGV 135
           ++RL+      +++Y++LEY   G ++ ++    +  E        +L + +SYCH+K V
Sbjct: 74  ILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRV 133
Query: 136 FHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDG 195
            HRD+K EN+LL S G +KI+DFG S      R      T CG+ +Y+ PE++  R +D 
Sbjct: 134 IHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT----TLCGTLDYLPPEMIEGRMHDE 189
Query: 196 ATSDIWSCGVILYIF--------------------RGDFKLPKWLSPGAQNLLRKILEPN 235
              D+WS GV+ Y F                    R +F  P +++ GA++L+ ++L+ N
Sbjct: 190 KV-DLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHN 248
Query: 236 PVKRITIAGIKADEW 250
           P +R  +  +    W
Sbjct: 249 PSQRPMLREVLEHPW 263

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score =  151 bits (382), Expect = 6e-37,   Method: Compositional matrix adjust.
 Identities = 80/255 (31%), Positives = 136/255 (53%), Gaps = 25/255 (9%)
Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
           +E+GR LG+G FG V  A++  S    A+K+L K ++    +  Q++RE+     L+HPN
Sbjct: 10  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 69
Query: 76  VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGV 135
           ++RL+      +++Y++LEY   G ++ ++    +  E        +L + +SYCH+K V
Sbjct: 70  ILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRV 129
Query: 136 FHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDG 195
            HRD+K EN+LL S G +KI+DFG S      R   L    CG+ +Y+ PE++  R +D 
Sbjct: 130 IHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRAAL----CGTLDYLPPEMIEGRMHDE 185
Query: 196 ATSDIWSCGVILYIF--------------------RGDFKLPKWLSPGAQNLLRKILEPN 235
              D+WS GV+ Y F                    R +F  P +++ GA++L+ ++L+ N
Sbjct: 186 KV-DLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHN 244
Query: 236 PVKRITIAGIKADEW 250
           P +R  +  +    W
Sbjct: 245 PSQRPMLREVLEHPW 259

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score =  151 bits (382), Expect = 7e-37,   Method: Compositional matrix adjust.
 Identities = 89/265 (33%), Positives = 134/265 (50%), Gaps = 23/265 (8%)
Query: 13  LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK 72
           + RY  GR LG+G F K     D+D+   FA K++ K+ ++     +++  EIA  K L 
Sbjct: 41  MKRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLD 100
Query: 73  HPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHN 132
           +P+VV  H        +Y+VLE      L +    +  + E E R   +Q I GV Y HN
Sbjct: 101 NPHVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTIQGVQYLHN 160
Query: 133 KGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRG 192
             V HRDLKL N+ L+   ++KI DFGL+   +   D       CG+PNY+APEVL  +G
Sbjct: 161 NRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEF--DGERKKDLCGTPNYIAPEVLCKKG 218
Query: 193 YDGATSDIWSCGVILY--------------------IFRGDFKLPKWLSPGAQNLLRKIL 232
           +     DIWS G ILY                    I + ++ +P+ ++P A  L+R++L
Sbjct: 219 HSFEV-DIWSLGCILYTLLVGKPPFETSCLKETYIRIKKNEYSVPRHINPVASALIRRML 277
Query: 233 EPNPVKRITIAGIKADEWFEQDYTP 257
             +P  R ++A +  DE+F   Y P
Sbjct: 278 HADPTLRPSVAELLTDEFFTSGYAP 302

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score =  151 bits (381), Expect = 8e-37,   Method: Compositional matrix adjust.
 Identities = 79/277 (28%), Positives = 147/277 (53%), Gaps = 30/277 (10%)
Query: 10  GMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLK 69
           G ++  +++G  LG+G+F  V  A+ + +GL  A+K+++K  +    +  +++ E+    
Sbjct: 7   GEKIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHC 66
Query: 70  LLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGR-LQEAEGRKLFQQLIDGVS 128
            LKHP+++ L+      + +Y+VLE    GE+   + ++ +   E E R    Q+I G+ 
Sbjct: 67  QLKHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGML 126
Query: 129 YCHNKGVFHRDLKLENILLDSKGNIKISDFGLSA---LPQHFRDDGLLHTTCGSPNYVAP 185
           Y H+ G+ HRDL L N+LL    NIKI+DFGL+    +P         +T CG+PNY++P
Sbjct: 127 YLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKH-----YTLCGTPNYISP 181
Query: 186 EVLANRGYDGATSDIWSCGVILY--------------------IFRGDFKLPKWLSPGAQ 225
           E+ A R   G  SD+WS G + Y                    +   D+++P +LS  A+
Sbjct: 182 EI-ATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADYEMPSFLSIEAK 240
Query: 226 NLLRKILEPNPVKRITIAGIKADEWFEQDYTPANPDD 262
           +L+ ++L  NP  R++++ +    +  ++ +  + D+
Sbjct: 241 DLIHQLLRRNPADRLSLSSVLDHPFMSRNSSTKSKDE 277

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score =  151 bits (381), Expect = 8e-37,   Method: Compositional matrix adjust.
 Identities = 85/269 (31%), Positives = 139/269 (51%), Gaps = 31/269 (11%)
Query: 8   QEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIAT 67
           Q    L ++E  +T+G G+FG+V   + +++G  +A+KIL+K +++ LK  +    E   
Sbjct: 35  QNTAHLDQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRI 94
Query: 68  LKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGV 127
           L+ +  P +V+L       S +YMV+EYV GGE+F  +   GR  E   R    Q++   
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTF 154
Query: 128 SYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEV 187
            Y H+  + +RDLK EN+L+D +G IK++DFG +      R  G     CG+P Y+APE+
Sbjct: 155 EYLHSLDLIYRDLKPENLLIDQQGYIKVADFGFAK-----RVKGRTWXLCGTPEYLAPEI 209
Query: 188 LANRGYDGATSDIWSCGVILY--------------------IFRGDFKLPKWLSPGAQNL 227
           + ++GY+ A  D W+ GV++Y                    I  G  + P   S   ++L
Sbjct: 210 ILSKGYNKAV-DWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDL 268
Query: 228 LRKILEPNPVKRI-----TIAGIKADEWF 251
           LR +L+ +  KR       +  IK  +WF
Sbjct: 269 LRNLLQVDLTKRFGNLKNGVNDIKNHKWF 297

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score =  151 bits (381), Expect = 8e-37,   Method: Compositional matrix adjust.
 Identities = 85/269 (31%), Positives = 139/269 (51%), Gaps = 31/269 (11%)
Query: 8   QEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIAT 67
           Q    L ++E  +TLG G+FG+V   + +++G  +A+KIL+K +++ LK  +    E   
Sbjct: 36  QNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRI 95
Query: 68  LKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGV 127
           L+ +  P +V+L       S +YMV+EYV GGE+F  +   GR  E   R    Q++   
Sbjct: 96  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTF 155
Query: 128 SYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEV 187
            Y H+  + +RDLK EN+L+D +G I+++DFG +      R  G     CG+P Y+APE+
Sbjct: 156 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYLAPEI 210
Query: 188 LANRGYDGATSDIWSCGVILY--------------------IFRGDFKLPKWLSPGAQNL 227
           + ++GY+ A  D W+ GV++Y                    I  G  + P   S   ++L
Sbjct: 211 ILSKGYNKAV-DWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDL 269
Query: 228 LRKILEPNPVKRI-----TIAGIKADEWF 251
           LR +L+ +  KR       +  IK  +WF
Sbjct: 270 LRNLLQVDLTKRFGNLKNGVNDIKNHKWF 298

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score =  150 bits (380), Expect = 9e-37,   Method: Compositional matrix adjust.
 Identities = 80/255 (31%), Positives = 136/255 (53%), Gaps = 25/255 (9%)
Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
           +E+GR LG+G FG V  A++  S    A+K+L K ++    +  Q++RE+     L+HPN
Sbjct: 10  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 69
Query: 76  VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGV 135
           ++RL+      +++Y++LEY   G ++ ++    +  E        +L + +SYCH+K V
Sbjct: 70  ILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRV 129
Query: 136 FHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDG 195
            HRD+K EN+LL S G +KI+DFG S      R   L    CG+ +Y+ PE++  R +D 
Sbjct: 130 IHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTXL----CGTLDYLPPEMIEGRMHDE 185
Query: 196 ATSDIWSCGVILYIF--------------------RGDFKLPKWLSPGAQNLLRKILEPN 235
              D+WS GV+ Y F                    R +F  P +++ GA++L+ ++L+ N
Sbjct: 186 KV-DLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHN 244
Query: 236 PVKRITIAGIKADEW 250
           P +R  +  +    W
Sbjct: 245 PSQRPMLREVLEHPW 259

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score =  150 bits (380), Expect = 9e-37,   Method: Compositional matrix adjust.
 Identities = 89/265 (33%), Positives = 134/265 (50%), Gaps = 23/265 (8%)
Query: 13  LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK 72
           + RY  GR LG+G F K     D+D+   FA K++ K+ ++     +++  EIA  K L 
Sbjct: 25  MKRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLD 84
Query: 73  HPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHN 132
           +P+VV  H        +Y+VLE      L +    +  + E E R   +Q I GV Y HN
Sbjct: 85  NPHVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTIQGVQYLHN 144
Query: 133 KGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRG 192
             V HRDLKL N+ L+   ++KI DFGL+   +   D       CG+PNY+APEVL  +G
Sbjct: 145 NRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEF--DGERKKDLCGTPNYIAPEVLCKKG 202
Query: 193 YDGATSDIWSCGVILY--------------------IFRGDFKLPKWLSPGAQNLLRKIL 232
           +     DIWS G ILY                    I + ++ +P+ ++P A  L+R++L
Sbjct: 203 HSFEV-DIWSLGCILYTLLVGKPPFETSCLKETYIRIKKNEYSVPRHINPVASALIRRML 261
Query: 233 EPNPVKRITIAGIKADEWFEQDYTP 257
             +P  R ++A +  DE+F   Y P
Sbjct: 262 HADPTLRPSVAELLTDEFFTSGYAP 286

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score =  150 bits (380), Expect = 9e-37,   Method: Compositional matrix adjust.
 Identities = 85/269 (31%), Positives = 139/269 (51%), Gaps = 31/269 (11%)
Query: 8   QEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIAT 67
           Q    L ++E  +TLG G+FG+V   + +++G  +A+KIL+K +++ LK  +    E   
Sbjct: 35  QNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLNEKRI 94
Query: 68  LKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGV 127
           L+ +  P +V+L       S +YMV+EY  GGE+F  +   GR  E   R    Q++   
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTF 154
Query: 128 SYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEV 187
            Y H+  + +RDLK EN+++D +G IK++DFGL+      R  G     CG+P Y+APE+
Sbjct: 155 EYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGLAK-----RVKGRTWXLCGTPEYLAPEI 209
Query: 188 LANRGYDGATSDIWSCGVILY--------------------IFRGDFKLPKWLSPGAQNL 227
           + ++GY+ A  D W+ GV++Y                    I  G  + P   S   ++L
Sbjct: 210 ILSKGYNKAV-DWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDL 268
Query: 228 LRKILEPNPVKRI-----TIAGIKADEWF 251
           LR +L+ +  KR       +  IK  +WF
Sbjct: 269 LRNLLQVDLTKRFGNLKNGVNDIKNHKWF 297

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score =  150 bits (380), Expect = 9e-37,   Method: Compositional matrix adjust.
 Identities = 85/269 (31%), Positives = 139/269 (51%), Gaps = 31/269 (11%)
Query: 8   QEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIAT 67
           Q    L ++E  +TLG G+FG+V   + +++G  +A+KIL+K +++ LK  +    E   
Sbjct: 35  QNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRI 94
Query: 68  LKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGV 127
           L+ +  P +V+L       S +YMV+EYV GGE+F  +   GR  E   R    Q++   
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTF 154
Query: 128 SYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEV 187
            Y H+  + +RDLK EN+L+D +G I+++DFG +      R  G     CG+P Y+APE+
Sbjct: 155 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYLAPEI 209
Query: 188 LANRGYDGATSDIWSCGVILY--------------------IFRGDFKLPKWLSPGAQNL 227
           + ++GY+ A  D W+ GV++Y                    I  G  + P   S   ++L
Sbjct: 210 ILSKGYNKAV-DWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDL 268
Query: 228 LRKILEPNPVKRI-----TIAGIKADEWF 251
           LR +L+ +  KR       +  IK  +WF
Sbjct: 269 LRNLLQVDLTKRFGNLKNGVNDIKNHKWF 297

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score =  150 bits (380), Expect = 9e-37,   Method: Compositional matrix adjust.
 Identities = 85/269 (31%), Positives = 139/269 (51%), Gaps = 31/269 (11%)
Query: 8   QEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIAT 67
           Q    L ++E  +TLG G+FG+V   + +++G  +A+KIL+K +++ LK  +    E   
Sbjct: 35  QNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRI 94
Query: 68  LKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGV 127
           L+ +  P +V+L       S +YMV+EYV GGE+F  +   GR  E   R    Q++   
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTF 154
Query: 128 SYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEV 187
            Y H+  + +RDLK EN+L+D +G I+++DFG +      R  G     CG+P Y+APE+
Sbjct: 155 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYLAPEI 209
Query: 188 LANRGYDGATSDIWSCGVILY--------------------IFRGDFKLPKWLSPGAQNL 227
           + ++GY+ A  D W+ GV++Y                    I  G  + P   S   ++L
Sbjct: 210 ILSKGYNKAV-DWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDL 268
Query: 228 LRKILEPNPVKRI-----TIAGIKADEWF 251
           LR +L+ +  KR       +  IK  +WF
Sbjct: 269 LRNLLQVDLTKRFGNLKDGVNDIKNHKWF 297

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score =  150 bits (380), Expect = 9e-37,   Method: Compositional matrix adjust.
 Identities = 85/269 (31%), Positives = 139/269 (51%), Gaps = 31/269 (11%)
Query: 8   QEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIAT 67
           Q    L ++E  +TLG G+FG+V   + +++G  +A+KIL+K +++ LK  +    E   
Sbjct: 35  QNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRI 94
Query: 68  LKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGV 127
           L+ +  P +V+L       S +YMV+EYV GGE+F  +   GR  E   R    Q++   
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTF 154
Query: 128 SYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEV 187
            Y H+  + +RDLK EN+L+D +G I+++DFG +      R  G     CG+P Y+APE+
Sbjct: 155 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYLAPEI 209
Query: 188 LANRGYDGATSDIWSCGVILY--------------------IFRGDFKLPKWLSPGAQNL 227
           + ++GY+ A  D W+ GV++Y                    I  G  + P   S   ++L
Sbjct: 210 ILSKGYNKAV-DWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDL 268
Query: 228 LRKILEPNPVKRI-----TIAGIKADEWF 251
           LR +L+ +  KR       +  IK  +WF
Sbjct: 269 LRNLLQVDLTKRFGNLKNGVNDIKNHKWF 297

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score =  150 bits (380), Expect = 1e-36,   Method: Compositional matrix adjust.
 Identities = 86/269 (31%), Positives = 138/269 (51%), Gaps = 31/269 (11%)
Query: 8   QEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIAT 67
           Q    L ++E  +TLG G+FG+V   +  ++G  FA+KIL+K +++ LK  +    E   
Sbjct: 35  QNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRI 94
Query: 68  LKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGV 127
           L+ +  P +V+L       S +YMV+EYV GGE+F  +   GR  E   R    Q++   
Sbjct: 95  LQAVNFPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTF 154
Query: 128 SYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEV 187
            Y H+  + +RDLK EN+L+D +G I+++DFG +      R  G     CG+P Y+APE+
Sbjct: 155 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYLAPEI 209
Query: 188 LANRGYDGATSDIWSCGVILY--------------------IFRGDFKLPKWLSPGAQNL 227
           + ++GY+ A  D W+ GV++Y                    I  G  + P   S   ++L
Sbjct: 210 ILSKGYNKAV-DWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDL 268
Query: 228 LRKILEPNPVKRI-----TIAGIKADEWF 251
           LR +L+ +  KR       +  IK  +WF
Sbjct: 269 LRNLLQVDLTKRFGNLKDGVNDIKNHKWF 297

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score =  150 bits (380), Expect = 1e-36,   Method: Compositional matrix adjust.
 Identities = 85/269 (31%), Positives = 139/269 (51%), Gaps = 31/269 (11%)
Query: 8   QEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIAT 67
           Q    L ++E  +TLG G+FG+V   + +++G  +A+KIL+K +++ LK  +    E   
Sbjct: 35  QNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRI 94
Query: 68  LKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGV 127
           L+ +  P +V+L       S +YMV+EYV GGE+F  +   GR  E   R    Q++   
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIVLTF 154
Query: 128 SYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEV 187
            Y H+  + +RDLK EN+L+D +G I+++DFG +      R  G     CG+P Y+APE+
Sbjct: 155 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYLAPEI 209
Query: 188 LANRGYDGATSDIWSCGVILY--------------------IFRGDFKLPKWLSPGAQNL 227
           + ++GY+ A  D W+ GV++Y                    I  G  + P   S   ++L
Sbjct: 210 ILSKGYNKAV-DWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDL 268
Query: 228 LRKILEPNPVKRI-----TIAGIKADEWF 251
           LR +L+ +  KR       +  IK  +WF
Sbjct: 269 LRNLLQVDLTKRFGNLKNGVNDIKNHKWF 297

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score =  150 bits (380), Expect = 1e-36,   Method: Compositional matrix adjust.
 Identities = 80/255 (31%), Positives = 136/255 (53%), Gaps = 25/255 (9%)
Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
           +E+GR LG+G FG V  A++  S    A+K+L K ++    +  Q++RE+     L+HPN
Sbjct: 10  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 69
Query: 76  VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGV 135
           ++RL+      +++Y++LEY   G ++ ++    +  E        +L + +SYCH+K V
Sbjct: 70  ILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRV 129
Query: 136 FHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDG 195
            HRD+K EN+LL S G +KI+DFG S      R   L    CG+ +Y+ PE++  R +D 
Sbjct: 130 IHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRXXL----CGTLDYLPPEMIEGRMHDE 185
Query: 196 ATSDIWSCGVILYIF--------------------RGDFKLPKWLSPGAQNLLRKILEPN 235
              D+WS GV+ Y F                    R +F  P +++ GA++L+ ++L+ N
Sbjct: 186 KV-DLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHN 244
Query: 236 PVKRITIAGIKADEW 250
           P +R  +  +    W
Sbjct: 245 PSQRPMLREVLEHPW 259

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score =  150 bits (380), Expect = 1e-36,   Method: Compositional matrix adjust.
 Identities = 86/269 (31%), Positives = 138/269 (51%), Gaps = 31/269 (11%)
Query: 8   QEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIAT 67
           Q    L ++E  +TLG G+FG+V   +  ++G  FA+KIL+K +++ LK  +    E   
Sbjct: 35  QNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRI 94
Query: 68  LKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGV 127
           L+ +  P +V+L       S +YMV+EYV GGE+F  +   GR  E   R    Q++   
Sbjct: 95  LQAVNFPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTF 154
Query: 128 SYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEV 187
            Y H+  + +RDLK EN+L+D +G I+++DFG +      R  G     CG+P Y+APE+
Sbjct: 155 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYLAPEI 209
Query: 188 LANRGYDGATSDIWSCGVILY--------------------IFRGDFKLPKWLSPGAQNL 227
           + ++GY+ A  D W+ GV++Y                    I  G  + P   S   ++L
Sbjct: 210 ILSKGYNKAV-DWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDL 268
Query: 228 LRKILEPNPVKRI-----TIAGIKADEWF 251
           LR +L+ +  KR       +  IK  +WF
Sbjct: 269 LRNLLQVDLTKRFGNLKNGVNDIKNHKWF 297

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score =  150 bits (380), Expect = 1e-36,   Method: Compositional matrix adjust.
 Identities = 84/279 (30%), Positives = 145/279 (51%), Gaps = 26/279 (9%)
Query: 7   KQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIA 66
           K+    L  +E+GR LG+G FG V  A++  S    A+K+L K ++    +  Q++RE+ 
Sbjct: 2   KKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVE 61
Query: 67  TLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDG 126
               L+HPN++RL+      +++Y++LEY   G ++ ++    +  E        +L + 
Sbjct: 62  IQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANA 121
Query: 127 VSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPE 186
           +SYCH+K V HRD+K EN+LL S G +KI+DFG S      R      T  G+ +Y+ PE
Sbjct: 122 LSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSCHAPSSRRT----TLSGTLDYLPPE 177
Query: 187 VLANRGYDGATSDIWSCGVILYIF--------------------RGDFKLPKWLSPGAQN 226
           ++  R +D    D+WS GV+ Y F                    R +F  P +++ GA++
Sbjct: 178 MIEGRMHDEKV-DLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARD 236
Query: 227 LLRKILEPNPVKRITIAGIKADEWFEQDYT-PANPDDDE 264
           L+ ++L+ NP +R  +  +    W   + + P+N  + E
Sbjct: 237 LISRLLKHNPSQRPMLREVLEHPWITANSSKPSNSQNKE 275

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score =  150 bits (379), Expect = 1e-36,   Method: Compositional matrix adjust.
 Identities = 86/269 (31%), Positives = 138/269 (51%), Gaps = 31/269 (11%)
Query: 8   QEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIAT 67
           Q    L ++E  +TLG G+FG+V   +  ++G  FA+KIL+K +++ LK  +    E   
Sbjct: 35  QNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRI 94
Query: 68  LKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGV 127
           L+ +  P +V+L       S +YMV+EYV GGE+F  +   GR  E   R    Q++   
Sbjct: 95  LQAVNFPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTF 154
Query: 128 SYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEV 187
            Y H+  + +RDLK EN+L+D +G I+++DFG +      R  G     CG+P Y+APE+
Sbjct: 155 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYLAPEI 209
Query: 188 LANRGYDGATSDIWSCGVILY--------------------IFRGDFKLPKWLSPGAQNL 227
           + ++GY+ A  D W+ GV++Y                    I  G  + P   S   ++L
Sbjct: 210 ILSKGYNKAV-DWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDL 268
Query: 228 LRKILEPNPVKRI-----TIAGIKADEWF 251
           LR +L+ +  KR       +  IK  +WF
Sbjct: 269 LRNLLQVDLTKRFGNLKDGVNDIKNHKWF 297

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score =  150 bits (379), Expect = 1e-36,   Method: Compositional matrix adjust.
 Identities = 85/269 (31%), Positives = 139/269 (51%), Gaps = 31/269 (11%)
Query: 8   QEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIAT 67
           Q    L ++E  +TLG G+FG+V   + +++G  +A+KIL+K +++ LK  +    E   
Sbjct: 35  QNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRI 94
Query: 68  LKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGV 127
           L+ +  P +V+L       S +YMV+EYV GGE+F  +   GR  E   R    Q++   
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIVLTF 154
Query: 128 SYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEV 187
            Y H+  + +RDLK EN+L+D +G I+++DFG +      R  G     CG+P Y+APE+
Sbjct: 155 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYLAPEI 209
Query: 188 LANRGYDGATSDIWSCGVILY--------------------IFRGDFKLPKWLSPGAQNL 227
           + ++GY+ A  D W+ GV++Y                    I  G  + P   S   ++L
Sbjct: 210 ILSKGYNKAV-DWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDL 268
Query: 228 LRKILEPNPVKRI-----TIAGIKADEWF 251
           LR +L+ +  KR       +  IK  +WF
Sbjct: 269 LRNLLQVDLTKRFGNLKNGVNDIKNHKWF 297

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score =  150 bits (379), Expect = 1e-36,   Method: Compositional matrix adjust.
 Identities = 85/269 (31%), Positives = 139/269 (51%), Gaps = 31/269 (11%)
Query: 8   QEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIAT 67
           Q    L ++E  +TLG G+FG+V   + +++G  +A+KIL+K +++ LK  +    E   
Sbjct: 36  QNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRI 95
Query: 68  LKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGV 127
           L+ +  P +V+L       S +YMV+EYV GGE+F  +   GR  E   R    Q++   
Sbjct: 96  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIVLTF 155
Query: 128 SYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEV 187
            Y H+  + +RDLK EN+L+D +G I+++DFG +      R  G     CG+P Y+APE+
Sbjct: 156 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYLAPEI 210
Query: 188 LANRGYDGATSDIWSCGVILY--------------------IFRGDFKLPKWLSPGAQNL 227
           + ++GY+ A  D W+ GV++Y                    I  G  + P   S   ++L
Sbjct: 211 ILSKGYNKAV-DWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDL 269
Query: 228 LRKILEPNPVKRI-----TIAGIKADEWF 251
           LR +L+ +  KR       +  IK  +WF
Sbjct: 270 LRNLLQVDLTKRFGNLKNGVNDIKNHKWF 298

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score =  150 bits (378), Expect = 2e-36,   Method: Compositional matrix adjust.
 Identities = 89/259 (34%), Positives = 134/259 (51%), Gaps = 35/259 (13%)
Query: 21  TLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLH 80
            LG G F +V   +   +G  FA+K ++K+          ++ EIA LK +KH N+V L 
Sbjct: 16  VLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFR---DSSLENEIAVLKKIKHENIVTLE 72
Query: 81  EVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDL 140
           ++  S +  Y+V++ V+GGELFD+I  +G   E +   + QQ++  V Y H  G+ HRDL
Sbjct: 73  DIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENGIVHRDL 132
Query: 141 KLENILL---DSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGAT 197
           K EN+L    +    I I+DFGLS + Q    +G++ T CG+P YVAPEVLA + Y  A 
Sbjct: 133 KPENLLYLTPEENSKIMITDFGLSKMEQ----NGIMSTACGTPGYVAPEVLAQKPYSKAV 188
Query: 198 SDIWSCGVILYIFRG----------------------DFKLPKW--LSPGAQNLLRKILE 233
            D WS GVI YI                         +F+ P W  +S  A++ +  +LE
Sbjct: 189 -DCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFESPFWDDISESAKDFICHLLE 247
Query: 234 PNPVKRITIAGIKADEWFE 252
            +P +R T     +  W +
Sbjct: 248 KDPNERYTCEKALSHPWID 266

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score =  150 bits (378), Expect = 2e-36,   Method: Compositional matrix adjust.
 Identities = 87/259 (33%), Positives = 136/259 (52%), Gaps = 25/259 (9%)
Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
           +E+GR LG+G FG V  A++  S    A+K+L K++I    +  Q++REI     L HPN
Sbjct: 25  FEIGRPLGKGKFGNVYLAREKKSHFIVALKVLFKSQIEKEGVEHQLRREIEIQAHLHHPN 84
Query: 76  VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGV 135
           ++RL+     + +IY++LEY   GEL+ ++       E     + ++L D + YCH K V
Sbjct: 85  ILRLYNYFYDRRRIYLILEYAPRGELYKELQKSCTFDEQRTATIMEELADALMYCHGKKV 144
Query: 136 FHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDG 195
            HRD+K EN+LL  KG +KI+DFG S      R      T CG+ +Y+ PE++  R ++ 
Sbjct: 145 IHRDIKPENLLLGLKGELKIADFGWSVHAPSLRRK----TMCGTLDYLPPEMIEGRMHNE 200
Query: 196 ATSDIWSCGVILY--------------------IFRGDFKLPKWLSPGAQNLLRKILEPN 235
              D+W  GV+ Y                    I + D K P  +  GAQ+L+ K+L  N
Sbjct: 201 KV-DLWCIGVLCYELLVGNPPFESASHNETYRRIVKVDLKFPASVPTGAQDLISKLLRHN 259
Query: 236 PVKRITIAGIKADEWFEQD 254
           P +R+ +A + A  W   +
Sbjct: 260 PSERLPLAQVSAHPWVRAN 278

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score =  149 bits (377), Expect = 2e-36,   Method: Compositional matrix adjust.
 Identities = 85/269 (31%), Positives = 139/269 (51%), Gaps = 31/269 (11%)
Query: 8   QEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIAT 67
           Q   +L +++  +TLG G+FG+V   +  +SG  +A+KIL+K +++ LK  +    E   
Sbjct: 36  QNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRI 95
Query: 68  LKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGV 127
           L+ +  P +V+L       S +YMV+EYV GGE+F  +   GR  E   R    Q++   
Sbjct: 96  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTF 155
Query: 128 SYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEV 187
            Y H+  + +RDLK EN+L+D +G I+++DFG +      R  G     CG+P Y+APE+
Sbjct: 156 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYLAPEI 210
Query: 188 LANRGYDGATSDIWSCGVILY--------------------IFRGDFKLPKWLSPGAQNL 227
           + ++GY+ A  D W+ GV++Y                    I  G  + P   S   ++L
Sbjct: 211 ILSKGYNKAV-DWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDL 269
Query: 228 LRKILEPNPVKRI-----TIAGIKADEWF 251
           LR +L+ +  KR       +  IK  +WF
Sbjct: 270 LRNLLQVDLTKRFGNLKNGVNDIKNHKWF 298

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score =  149 bits (377), Expect = 2e-36,   Method: Compositional matrix adjust.
 Identities = 84/269 (31%), Positives = 138/269 (51%), Gaps = 31/269 (11%)
Query: 8   QEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIAT 67
           Q    L ++E  +TLG G+FG+V   + +++G  +A+KIL+K +++ LK  +    E   
Sbjct: 35  QNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRI 94
Query: 68  LKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGV 127
           L+ +  P +V+L       S +YMV+EY  GGE+F  +   GR  E   R    Q++   
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTF 154
Query: 128 SYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEV 187
            Y H+  + +RDLK EN+++D +G IK++DFG +      R  G     CG+P Y+APE+
Sbjct: 155 EYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGFAK-----RVKGRTWXLCGTPEYLAPEI 209
Query: 188 LANRGYDGATSDIWSCGVILY--------------------IFRGDFKLPKWLSPGAQNL 227
           + ++GY+ A  D W+ GV++Y                    I  G  + P   S   ++L
Sbjct: 210 ILSKGYNKAV-DWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDL 268
Query: 228 LRKILEPNPVKRI-----TIAGIKADEWF 251
           LR +L+ +  KR       +  IK  +WF
Sbjct: 269 LRNLLQVDLTKRFGNLKNGVNDIKNHKWF 297

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score =  149 bits (377), Expect = 2e-36,   Method: Compositional matrix adjust.
 Identities = 84/269 (31%), Positives = 139/269 (51%), Gaps = 31/269 (11%)
Query: 8   QEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIAT 67
           Q    L ++E  +TLG G+FG+V   + +++G  +A+KIL+K +++ LK  +    E   
Sbjct: 35  QNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLNEKRI 94
Query: 68  LKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGV 127
           L+ +  P +V+L       S +YMV+EY  GGE+F  +   GR  E   R    Q++   
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTF 154
Query: 128 SYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEV 187
            Y H+  + +RDLK EN+++D +G I+++DFGL+      R  G     CG+P Y+APE+
Sbjct: 155 EYLHSLDLIYRDLKPENLMIDQQGYIQVTDFGLAK-----RVKGRTWXLCGTPEYLAPEI 209
Query: 188 LANRGYDGATSDIWSCGVILY--------------------IFRGDFKLPKWLSPGAQNL 227
           + ++GY+ A  D W+ GV++Y                    I  G  + P   S   ++L
Sbjct: 210 ILSKGYNKAV-DWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDL 268
Query: 228 LRKILEPNPVKRI-----TIAGIKADEWF 251
           LR +L+ +  KR       +  IK  +WF
Sbjct: 269 LRNLLQVDLTKRFGNLKNGVNDIKNHKWF 297

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score =  149 bits (377), Expect = 2e-36,   Method: Compositional matrix adjust.
 Identities = 84/269 (31%), Positives = 138/269 (51%), Gaps = 31/269 (11%)
Query: 8   QEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIAT 67
           Q    L ++E  +TLG G+FG+V   + +++G  +A+KIL+K +++ LK  +    E   
Sbjct: 35  QNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRI 94
Query: 68  LKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGV 127
           L+ +  P +V+L       S +YMV+EY  GGE+F  +   GR  E   R    Q++   
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFXEPHARFYAAQIVLTF 154
Query: 128 SYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEV 187
            Y H+  + +RDLK EN+++D +G IK++DFG +      R  G     CG+P Y+APE+
Sbjct: 155 EYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGFAK-----RVKGRTWXLCGTPEYLAPEI 209
Query: 188 LANRGYDGATSDIWSCGVILY--------------------IFRGDFKLPKWLSPGAQNL 227
           + ++GY+ A  D W+ GV++Y                    I  G  + P   S   ++L
Sbjct: 210 ILSKGYNKAV-DWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDL 268
Query: 228 LRKILEPNPVKRI-----TIAGIKADEWF 251
           LR +L+ +  KR       +  IK  +WF
Sbjct: 269 LRNLLQVDLTKRFGNLKNGVNDIKNHKWF 297

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score =  149 bits (377), Expect = 2e-36,   Method: Compositional matrix adjust.
 Identities = 85/269 (31%), Positives = 139/269 (51%), Gaps = 31/269 (11%)
Query: 8   QEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIAT 67
           Q   +L +++  +TLG G+FG+V   +  +SG  +A+KIL+K +++ LK  +    E   
Sbjct: 35  QNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRI 94
Query: 68  LKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGV 127
           L+ +  P +V+L       S +YMV+EYV GGE+F  +   GR  E   R    Q++   
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTF 154
Query: 128 SYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEV 187
            Y H+  + +RDLK EN+L+D +G I+++DFG +      R  G     CG+P Y+APE+
Sbjct: 155 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYLAPEI 209
Query: 188 LANRGYDGATSDIWSCGVILY--------------------IFRGDFKLPKWLSPGAQNL 227
           + ++GY+ A  D W+ GV++Y                    I  G  + P   S   ++L
Sbjct: 210 ILSKGYNKAV-DWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDL 268
Query: 228 LRKILEPNPVKRI-----TIAGIKADEWF 251
           LR +L+ +  KR       +  IK  +WF
Sbjct: 269 LRNLLQVDLTKRFGNLPNGVNDIKNHKWF 297

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score =  149 bits (377), Expect = 2e-36,   Method: Compositional matrix adjust.
 Identities = 85/269 (31%), Positives = 139/269 (51%), Gaps = 31/269 (11%)
Query: 8   QEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIAT 67
           Q   +L +++  +TLG G+FG+V   +  +SG  +A+KIL+K +++ LK  +    E   
Sbjct: 22  QNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRI 81
Query: 68  LKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGV 127
           L+ +  P +V+L       S +YMV+EYV GGE+F  +   GR  E   R    Q++   
Sbjct: 82  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTF 141
Query: 128 SYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEV 187
            Y H+  + +RDLK EN+L+D +G I+++DFG +      R  G     CG+P Y+APE+
Sbjct: 142 EYLHSLDLIYRDLKPENLLIDEQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYLAPEI 196
Query: 188 LANRGYDGATSDIWSCGVILY--------------------IFRGDFKLPKWLSPGAQNL 227
           + ++GY+ A  D W+ GV++Y                    I  G  + P   S   ++L
Sbjct: 197 ILSKGYNKAV-DWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDL 255
Query: 228 LRKILEPNPVKRI-----TIAGIKADEWF 251
           LR +L+ +  KR       +  IK  +WF
Sbjct: 256 LRNLLQVDLTKRFGNLKNGVNDIKNHKWF 284

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score =  149 bits (377), Expect = 2e-36,   Method: Compositional matrix adjust.
 Identities = 85/269 (31%), Positives = 139/269 (51%), Gaps = 31/269 (11%)
Query: 8   QEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIAT 67
           Q   +L +++  +TLG G+FG+V   +  +SG  +A+KIL+K +++ LK  +    E   
Sbjct: 35  QNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRI 94
Query: 68  LKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGV 127
           L+ +  P +V+L       S +YMV+EYV GGE+F  +   GR  E   R    Q++   
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTF 154
Query: 128 SYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEV 187
            Y H+  + +RDLK EN+L+D +G I+++DFG +      R  G     CG+P Y+APE+
Sbjct: 155 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYLAPEI 209
Query: 188 LANRGYDGATSDIWSCGVILY--------------------IFRGDFKLPKWLSPGAQNL 227
           + ++GY+ A  D W+ GV++Y                    I  G  + P   S   ++L
Sbjct: 210 ILSKGYNKAV-DWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDL 268
Query: 228 LRKILEPNPVKRI-----TIAGIKADEWF 251
           LR +L+ +  KR       +  IK  +WF
Sbjct: 269 LRNLLQVDLTKRFGNLKNGVNDIKNHKWF 297

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score =  149 bits (376), Expect = 3e-36,   Method: Compositional matrix adjust.
 Identities = 79/255 (30%), Positives = 135/255 (52%), Gaps = 25/255 (9%)
Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
           +E+GR LG+G FG V  A++       A+K+L K ++    +  Q++RE+     L+HPN
Sbjct: 7   FEIGRPLGKGKFGNVYLAREKQRKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 66
Query: 76  VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGV 135
           ++RL+      +++Y++LEY   G ++ ++    +  E        +L + +SYCH+K V
Sbjct: 67  ILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRV 126
Query: 136 FHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDG 195
            HRD+K EN+LL S G +KI+DFG S      R      T CG+ +Y+ PE++  R +D 
Sbjct: 127 IHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT----TLCGTLDYLPPEMIEGRMHDE 182
Query: 196 ATSDIWSCGVILYIF--------------------RGDFKLPKWLSPGAQNLLRKILEPN 235
              D+WS GV+ Y F                    R +F  P +++ GA++L+ ++L+ N
Sbjct: 183 KV-DLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHN 241
Query: 236 PVKRITIAGIKADEW 250
           P +R  +  +    W
Sbjct: 242 PSQRPMLREVLEHPW 256

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score =  149 bits (376), Expect = 3e-36,   Method: Compositional matrix adjust.
 Identities = 85/269 (31%), Positives = 139/269 (51%), Gaps = 31/269 (11%)
Query: 8   QEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIAT 67
           Q   +L +++  +TLG G+FG+V   +  +SG  +A+KIL+K +++ LK  +    E   
Sbjct: 35  QNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRI 94
Query: 68  LKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGV 127
           L+ +  P +V+L       S +YMV+EYV GGE+F  +   GR  E   R    Q++   
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTF 154
Query: 128 SYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEV 187
            Y H+  + +RDLK EN+L+D +G I+++DFG +      R  G     CG+P Y+APE+
Sbjct: 155 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYLAPEI 209
Query: 188 LANRGYDGATSDIWSCGVILY--------------------IFRGDFKLPKWLSPGAQNL 227
           + ++GY+ A  D W+ GV++Y                    I  G  + P   S   ++L
Sbjct: 210 ILSKGYNKAV-DWWALGVLIYQMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDL 268
Query: 228 LRKILEPNPVKRI-----TIAGIKADEWF 251
           LR +L+ +  KR       +  IK  +WF
Sbjct: 269 LRNLLQVDLTKRFGNLKNGVNDIKNHKWF 297

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score =  149 bits (376), Expect = 3e-36,   Method: Compositional matrix adjust.
 Identities = 85/269 (31%), Positives = 139/269 (51%), Gaps = 31/269 (11%)
Query: 8   QEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIAT 67
           Q   +L +++  +TLG G+FG+V   +  +SG  +A+KIL+K +++ LK  +    E   
Sbjct: 35  QNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRI 94
Query: 68  LKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGV 127
           L+ +  P +V+L       S +YMV+EYV GGE+F  +   GR  E   R    Q++   
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTF 154
Query: 128 SYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEV 187
            Y H+  + +RDLK EN+L+D +G I+++DFG +      R  G     CG+P Y+APE+
Sbjct: 155 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYLAPEI 209
Query: 188 LANRGYDGATSDIWSCGVILY--------------------IFRGDFKLPKWLSPGAQNL 227
           + ++GY+ A  D W+ GV++Y                    I  G  + P   S   ++L
Sbjct: 210 ILSKGYNKAV-DWWALGVLIYEMAAGYPPFFADEPIQIYEKIVSGKVRFPSHFSSDLKDL 268
Query: 228 LRKILEPNPVKRI-----TIAGIKADEWF 251
           LR +L+ +  KR       +  IK  +WF
Sbjct: 269 LRNLLQVDLTKRFGNLKNGVNDIKNHKWF 297

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score =  149 bits (376), Expect = 3e-36,   Method: Compositional matrix adjust.
 Identities = 85/269 (31%), Positives = 139/269 (51%), Gaps = 31/269 (11%)
Query: 8   QEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIAT 67
           Q   +L +++  +TLG G+FG+V   +  +SG  +A+KIL+K +++ LK  +    E   
Sbjct: 35  QNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRI 94
Query: 68  LKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGV 127
           L+ +  P +V+L       S +YMV+EYV GGE+F  +   GR  E   R    Q++   
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTF 154
Query: 128 SYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEV 187
            Y H+  + +RDLK EN+L+D +G I+++DFG +      R  G     CG+P Y+APE+
Sbjct: 155 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYLAPEI 209
Query: 188 LANRGYDGATSDIWSCGVILY--------------------IFRGDFKLPKWLSPGAQNL 227
           + ++GY+ A  D W+ GV++Y                    I  G  + P   S   ++L
Sbjct: 210 ILSKGYNKAV-DWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDL 268
Query: 228 LRKILEPNPVKRI-----TIAGIKADEWF 251
           LR +L+ +  KR       +  IK  +WF
Sbjct: 269 LRNLLQVDLTKRFGNLKNGVNDIKNHKWF 297

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score =  149 bits (376), Expect = 3e-36,   Method: Compositional matrix adjust.
 Identities = 85/269 (31%), Positives = 139/269 (51%), Gaps = 31/269 (11%)
Query: 8   QEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIAT 67
           Q   +L +++  +TLG G+FG+V   +  +SG  +A+KIL+K +++ LK  +    E   
Sbjct: 56  QNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRI 115
Query: 68  LKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGV 127
           L+ +  P +V+L       S +YMV+EYV GGE+F  +   GR  E   R    Q++   
Sbjct: 116 LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVLTF 175
Query: 128 SYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEV 187
            Y H+  + +RDLK EN+L+D +G I+++DFG +      R  G     CG+P Y+APE+
Sbjct: 176 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYLAPEI 230
Query: 188 LANRGYDGATSDIWSCGVILY--------------------IFRGDFKLPKWLSPGAQNL 227
           + ++GY+ A  D W+ GV++Y                    I  G  + P   S   ++L
Sbjct: 231 ILSKGYNKAV-DWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDL 289
Query: 228 LRKILEPNPVKRI-----TIAGIKADEWF 251
           LR +L+ +  KR       +  IK  +WF
Sbjct: 290 LRNLLQVDLTKRFGNLKNGVNDIKNHKWF 318

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score =  149 bits (376), Expect = 3e-36,   Method: Compositional matrix adjust.
 Identities = 85/269 (31%), Positives = 139/269 (51%), Gaps = 31/269 (11%)
Query: 8   QEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIAT 67
           Q   +L +++  +TLG G+FG+V   +  +SG  +A+KIL+K +++ LK  +    E   
Sbjct: 35  QNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRI 94
Query: 68  LKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGV 127
           L+ +  P +V+L       S +YMV+EYV GGE+F  +   GR  E   R    Q++   
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVLTF 154
Query: 128 SYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEV 187
            Y H+  + +RDLK EN+L+D +G I+++DFG +      R  G     CG+P Y+APE+
Sbjct: 155 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYLAPEI 209
Query: 188 LANRGYDGATSDIWSCGVILY--------------------IFRGDFKLPKWLSPGAQNL 227
           + ++GY+ A  D W+ GV++Y                    I  G  + P   S   ++L
Sbjct: 210 ILSKGYNKAV-DWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDL 268
Query: 228 LRKILEPNPVKRI-----TIAGIKADEWF 251
           LR +L+ +  KR       +  IK  +WF
Sbjct: 269 LRNLLQVDLTKRFGNLKNGVNDIKNHKWF 297

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score =  149 bits (376), Expect = 3e-36,   Method: Compositional matrix adjust.
 Identities = 85/269 (31%), Positives = 139/269 (51%), Gaps = 31/269 (11%)
Query: 8   QEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIAT 67
           Q   +L +++  +TLG G+FG+V   +  +SG  +A+KIL+K +++ LK  +    E   
Sbjct: 30  QNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRI 89
Query: 68  LKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGV 127
           L+ +  P +V+L       S +YMV+EYV GGE+F  +   GR  E   R    Q++   
Sbjct: 90  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVLTF 149
Query: 128 SYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEV 187
            Y H+  + +RDLK EN+L+D +G I+++DFG +      R  G     CG+P Y+APE+
Sbjct: 150 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYLAPEI 204
Query: 188 LANRGYDGATSDIWSCGVILY--------------------IFRGDFKLPKWLSPGAQNL 227
           + ++GY+ A  D W+ GV++Y                    I  G  + P   S   ++L
Sbjct: 205 ILSKGYNKAV-DWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDL 263
Query: 228 LRKILEPNPVKRI-----TIAGIKADEWF 251
           LR +L+ +  KR       +  IK  +WF
Sbjct: 264 LRNLLQVDLTKRFGNLKNGVNDIKNHKWF 292

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score =  149 bits (376), Expect = 3e-36,   Method: Compositional matrix adjust.
 Identities = 92/254 (36%), Positives = 138/254 (54%), Gaps = 37/254 (14%)
Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
           +E+   LG G    V   +   +  P+A+K+L+K   +  KI   ++ EI  L  L HPN
Sbjct: 55  FEVESELGRGATSIVYRCKQKGTQKPYALKVLKKT--VDKKI---VRTEIGVLLRLSHPN 109
Query: 76  VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGV 135
           +++L E+  + ++I +VLE VTGGELFD+I  KG   E +     +Q+++ V+Y H  G+
Sbjct: 110 IIKLKEIFETPTEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGI 169
Query: 136 FHRDLKLENILLDS---KGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRG 192
            HRDLK EN+L  +      +KI+DFGLS + +H     L+ T CG+P Y APE+L    
Sbjct: 170 VHRDLKPENLLYATPAPDAPLKIADFGLSKIVEH---QVLMKTVCGTPGYCAPEILRGCA 226
Query: 193 YDGATSDIWSCGVILYIF----------RGD-------------FKLPKW--LSPGAQNL 227
           Y G   D+WS G+I YI           RGD             F  P W  +S  A++L
Sbjct: 227 Y-GPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPWWDEVSLNAKDL 285
Query: 228 LRKILEPNPVKRIT 241
           +RK++  +P KR+T
Sbjct: 286 VRKLIVLDPKKRLT 299

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score =  149 bits (376), Expect = 3e-36,   Method: Compositional matrix adjust.
 Identities = 85/269 (31%), Positives = 139/269 (51%), Gaps = 31/269 (11%)
Query: 8   QEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIAT 67
           Q   +L +++  +TLG G+FG+V   +  +SG  +A+KIL+K +++ LK  +    E   
Sbjct: 35  QNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRI 94
Query: 68  LKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGV 127
           L+ +  P +V+L       S +YMV+EYV GGE+F  +   GR  E   R    Q++   
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVLTF 154
Query: 128 SYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEV 187
            Y H+  + +RDLK EN+L+D +G I+++DFG +      R  G     CG+P Y+APE+
Sbjct: 155 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYLAPEI 209
Query: 188 LANRGYDGATSDIWSCGVILY--------------------IFRGDFKLPKWLSPGAQNL 227
           + ++GY+ A  D W+ GV++Y                    I  G  + P   S   ++L
Sbjct: 210 ILSKGYNKAV-DWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDL 268
Query: 228 LRKILEPNPVKRI-----TIAGIKADEWF 251
           LR +L+ +  KR       +  IK  +WF
Sbjct: 269 LRNLLQVDLTKRFGNLKNGVNDIKNHKWF 297

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score =  149 bits (376), Expect = 3e-36,   Method: Compositional matrix adjust.
 Identities = 85/269 (31%), Positives = 138/269 (51%), Gaps = 31/269 (11%)
Query: 8   QEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIAT 67
           Q    L ++E  +TLG G+FG+V   +  ++G  +A+KIL+K +++ LK  +    E   
Sbjct: 28  QNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRI 87
Query: 68  LKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGV 127
           L+ +  P +V+L       S +YMV+EYV GGE+F  +   GR  E   R    Q++   
Sbjct: 88  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTF 147
Query: 128 SYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEV 187
            Y H+  + +RDLK EN+L+D +G I+++DFG +      R  G     CG+P Y+APE+
Sbjct: 148 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYLAPEI 202
Query: 188 LANRGYDGATSDIWSCGVILY--------------------IFRGDFKLPKWLSPGAQNL 227
           + ++GY+ A  D W+ GV++Y                    I  G  + P   S   ++L
Sbjct: 203 ILSKGYNKAV-DWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDL 261
Query: 228 LRKILEPNPVKRI-----TIAGIKADEWF 251
           LR +L+ +  KR       +  IK  +WF
Sbjct: 262 LRNLLQVDLTKRFGNLKNGVNDIKNHKWF 290

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score =  149 bits (376), Expect = 3e-36,   Method: Compositional matrix adjust.
 Identities = 85/269 (31%), Positives = 139/269 (51%), Gaps = 31/269 (11%)
Query: 8   QEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIAT 67
           Q   +L +++  +TLG G+FG+V   +  +SG  +A+KIL+K +++ LK  +    E   
Sbjct: 35  QNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRI 94
Query: 68  LKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGV 127
           L+ +  P +V+L       S +YMV+EYV GGE+F  +   GR  E   R    Q++   
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVLTF 154
Query: 128 SYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEV 187
            Y H+  + +RDLK EN+L+D +G I+++DFG +      R  G     CG+P Y+APE+
Sbjct: 155 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYLAPEI 209
Query: 188 LANRGYDGATSDIWSCGVILY--------------------IFRGDFKLPKWLSPGAQNL 227
           + ++GY+ A  D W+ GV++Y                    I  G  + P   S   ++L
Sbjct: 210 ILSKGYNKAV-DWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDL 268
Query: 228 LRKILEPNPVKRI-----TIAGIKADEWF 251
           LR +L+ +  KR       +  IK  +WF
Sbjct: 269 LRNLLQVDLTKRFGNLKNGVNDIKNHKWF 297

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score =  149 bits (375), Expect = 3e-36,   Method: Compositional matrix adjust.
 Identities = 85/269 (31%), Positives = 139/269 (51%), Gaps = 31/269 (11%)
Query: 8   QEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIAT 67
           Q   +L +++  +TLG G+FG+V   +  +SG  +A+KIL+K +++ LK  +    E   
Sbjct: 35  QNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRI 94
Query: 68  LKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGV 127
           L+ +  P +V+L       S +YMV+EYV GGE+F  +   GR  E   R    Q++   
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFAEPHARFYAAQIVLTF 154
Query: 128 SYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEV 187
            Y H+  + +RDLK EN+L+D +G I+++DFG +      R  G     CG+P Y+APE+
Sbjct: 155 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYLAPEI 209
Query: 188 LANRGYDGATSDIWSCGVILY--------------------IFRGDFKLPKWLSPGAQNL 227
           + ++GY+ A  D W+ GV++Y                    I  G  + P   S   ++L
Sbjct: 210 ILSKGYNKAV-DWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDL 268
Query: 228 LRKILEPNPVKRI-----TIAGIKADEWF 251
           LR +L+ +  KR       +  IK  +WF
Sbjct: 269 LRNLLQVDLTKRFGNLKNGVNDIKNHKWF 297

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score =  149 bits (375), Expect = 4e-36,   Method: Compositional matrix adjust.
 Identities = 85/269 (31%), Positives = 138/269 (51%), Gaps = 31/269 (11%)
Query: 8   QEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIAT 67
           Q    L ++E  +TLG G+FG+V   +  ++G  +A+KIL+K +++ LK  +    E   
Sbjct: 36  QNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRI 95
Query: 68  LKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGV 127
           L+ +  P +V+L       S +YMV+EYV GGE+F  +   GR  E   R    Q++   
Sbjct: 96  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTF 155
Query: 128 SYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEV 187
            Y H+  + +RDLK EN+L+D +G I+++DFG +      R  G     CG+P Y+APE+
Sbjct: 156 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYLAPEI 210
Query: 188 LANRGYDGATSDIWSCGVILY--------------------IFRGDFKLPKWLSPGAQNL 227
           + ++GY+ A  D W+ GV++Y                    I  G  + P   S   ++L
Sbjct: 211 ILSKGYNKAV-DWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDL 269
Query: 228 LRKILEPNPVKRI-----TIAGIKADEWF 251
           LR +L+ +  KR       +  IK  +WF
Sbjct: 270 LRNLLQVDLTKRFGNLKNGVNDIKNHKWF 298

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score =  149 bits (375), Expect = 4e-36,   Method: Compositional matrix adjust.
 Identities = 85/269 (31%), Positives = 138/269 (51%), Gaps = 31/269 (11%)
Query: 8   QEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIAT 67
           Q    L ++E  +TLG G+FG+V   +  ++G  +A+KIL+K +++ LK  +    E   
Sbjct: 36  QNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRI 95
Query: 68  LKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGV 127
           L+ +  P +V+L       S +YMV+EYV GGE+F  +   GR  E   R    Q++   
Sbjct: 96  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTF 155
Query: 128 SYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEV 187
            Y H+  + +RDLK EN+L+D +G I+++DFG +      R  G     CG+P Y+APE+
Sbjct: 156 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYLAPEI 210
Query: 188 LANRGYDGATSDIWSCGVILY--------------------IFRGDFKLPKWLSPGAQNL 227
           + ++GY+ A  D W+ GV++Y                    I  G  + P   S   ++L
Sbjct: 211 ILSKGYNKAV-DWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDL 269
Query: 228 LRKILEPNPVKRI-----TIAGIKADEWF 251
           LR +L+ +  KR       +  IK  +WF
Sbjct: 270 LRNLLQVDLTKRFGNLKNGVNDIKNHKWF 298

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score =  149 bits (375), Expect = 4e-36,   Method: Compositional matrix adjust.
 Identities = 85/269 (31%), Positives = 138/269 (51%), Gaps = 31/269 (11%)
Query: 8   QEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIAT 67
           Q    L ++E  +TLG G+FG+V   +  ++G  +A+KIL+K +++ LK  +    E   
Sbjct: 28  QNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRI 87
Query: 68  LKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGV 127
           L+ +  P +V+L       S +YMV+EYV GGE+F  +   GR  E   R    Q++   
Sbjct: 88  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIVLTF 147
Query: 128 SYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEV 187
            Y H+  + +RDLK EN+L+D +G I+++DFG +      R  G     CG+P Y+APE+
Sbjct: 148 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYLAPEI 202
Query: 188 LANRGYDGATSDIWSCGVILY--------------------IFRGDFKLPKWLSPGAQNL 227
           + ++GY+ A  D W+ GV++Y                    I  G  + P   S   ++L
Sbjct: 203 ILSKGYNKAV-DWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDL 261
Query: 228 LRKILEPNPVKRI-----TIAGIKADEWF 251
           LR +L+ +  KR       +  IK  +WF
Sbjct: 262 LRNLLQVDLTKRFGNLKNGVNDIKNHKWF 290

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score =  149 bits (375), Expect = 4e-36,   Method: Compositional matrix adjust.
 Identities = 85/269 (31%), Positives = 138/269 (51%), Gaps = 31/269 (11%)
Query: 8   QEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIAT 67
           Q    L ++E  +TLG G+FG+V   +  ++G  +A+KIL+K +++ LK  +    E   
Sbjct: 56  QNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRI 115
Query: 68  LKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGV 127
           L+ +  P +V+L       S +YMV+EYV GGE+F  +   GR  E   R    Q++   
Sbjct: 116 LQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTF 175
Query: 128 SYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEV 187
            Y H+  + +RDLK EN+L+D +G I+++DFG +      R  G     CG+P Y+APE+
Sbjct: 176 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYLAPEI 230
Query: 188 LANRGYDGATSDIWSCGVILY--------------------IFRGDFKLPKWLSPGAQNL 227
           + ++GY+ A  D W+ GV++Y                    I  G  + P   S   ++L
Sbjct: 231 ILSKGYNKAV-DWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDL 289
Query: 228 LRKILEPNPVKRI-----TIAGIKADEWF 251
           LR +L+ +  KR       +  IK  +WF
Sbjct: 290 LRNLLQVDLTKRFGNLKNGVNDIKNHKWF 318

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score =  149 bits (375), Expect = 4e-36,   Method: Compositional matrix adjust.
 Identities = 84/269 (31%), Positives = 139/269 (51%), Gaps = 31/269 (11%)
Query: 8   QEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIAT 67
           Q   +L +++  +TLG G+FG+V   +  +SG  +A+KIL+K +++ LK  +    E   
Sbjct: 35  QNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRI 94
Query: 68  LKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGV 127
           L+ +  P +V+L       S +YMV+EYV GGE+F  +   GR  E   R    Q++   
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTF 154
Query: 128 SYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEV 187
            Y H+  + +RDLK EN+++D +G I+++DFG +      R  G     CG+P Y+APE+
Sbjct: 155 EYLHSLDLIYRDLKPENLIIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYLAPEI 209
Query: 188 LANRGYDGATSDIWSCGVILY--------------------IFRGDFKLPKWLSPGAQNL 227
           + ++GY+ A  D W+ GV++Y                    I  G  + P   S   ++L
Sbjct: 210 IISKGYNKAV-DWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDL 268
Query: 228 LRKILEPNPVKRI-----TIAGIKADEWF 251
           LR +L+ +  KR       +  IK  +WF
Sbjct: 269 LRNLLQVDLTKRFGNLKNGVNDIKNHKWF 297

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score =  148 bits (374), Expect = 5e-36,   Method: Compositional matrix adjust.
 Identities = 83/269 (30%), Positives = 138/269 (51%), Gaps = 31/269 (11%)
Query: 8   QEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIAT 67
           Q    L ++E  +TLG G+FG+V   + +++G  +A+KIL+K +++ LK  +    E   
Sbjct: 35  QNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRI 94
Query: 68  LKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGV 127
           L+ +  P +V+L       S +YMV+EY  GGE+F  +   GR  E   R    Q++   
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTF 154
Query: 128 SYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEV 187
            Y H+  + +RDLK EN+++D +G I+++DFG +      R  G     CG+P Y+APE+
Sbjct: 155 EYLHSLDLIYRDLKPENLMIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYLAPEI 209
Query: 188 LANRGYDGATSDIWSCGVILY--------------------IFRGDFKLPKWLSPGAQNL 227
           + ++GY+ A  D W+ GV++Y                    I  G  + P   S   ++L
Sbjct: 210 ILSKGYNKAV-DWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDL 268
Query: 228 LRKILEPNPVKRI-----TIAGIKADEWF 251
           LR +L+ +  KR       +  IK  +WF
Sbjct: 269 LRNLLQVDLTKRFGNLKNGVNDIKNHKWF 297

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score =  148 bits (374), Expect = 5e-36,   Method: Compositional matrix adjust.
 Identities = 83/269 (30%), Positives = 139/269 (51%), Gaps = 31/269 (11%)
Query: 8   QEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIAT 67
           Q    L ++E  +T+G G+FG+V   + +++G  +A+KIL+K +++ LK  +    E   
Sbjct: 35  QNTAHLDQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRI 94
Query: 68  LKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGV 127
           L+ +  P +V+L       S +YMV+EY+ GG++F  +   GR  E   R    Q++   
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYMPGGDMFSHLRRIGRFSEPHARFYAAQIVLTF 154
Query: 128 SYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEV 187
            Y H+  + +RDLK EN+L+D +G IK++DFG +      R  G     CG+P Y+APE+
Sbjct: 155 EYLHSLDLIYRDLKPENLLIDQQGYIKVADFGFAK-----RVKGRTWXLCGTPEYLAPEI 209
Query: 188 LANRGYDGATSDIWSCGVILY--------------------IFRGDFKLPKWLSPGAQNL 227
           + ++GY+ A  D W+ GV++Y                    I  G  + P   S   ++L
Sbjct: 210 ILSKGYNKAV-DWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDL 268
Query: 228 LRKILEPNPVKRI-----TIAGIKADEWF 251
           LR +L+ +  KR       +  IK  +WF
Sbjct: 269 LRNLLQVDLTKRFGNLKNGVNDIKNHKWF 297

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score =  148 bits (374), Expect = 6e-36,   Method: Compositional matrix adjust.
 Identities = 83/269 (30%), Positives = 139/269 (51%), Gaps = 31/269 (11%)
Query: 8   QEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIAT 67
           Q    L ++E  +T+G G+FG+V   + +++G  +A+KIL+K +++ LK  +    E   
Sbjct: 35  QNTAHLDQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRI 94
Query: 68  LKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGV 127
           L+ +  P +V+L       S +YMV+EY+ GG++F  +   GR  E   R    Q++   
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYMPGGDMFSHLRRIGRFSEPHARFYAAQIVLTF 154
Query: 128 SYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEV 187
            Y H+  + +RDLK EN+L+D +G IK++DFG +      R  G     CG+P Y+APE+
Sbjct: 155 EYLHSLDLIYRDLKPENLLIDQQGYIKVADFGFAK-----RVKGRTWXLCGTPEYLAPEI 209
Query: 188 LANRGYDGATSDIWSCGVILY--------------------IFRGDFKLPKWLSPGAQNL 227
           + ++GY+ A  D W+ GV++Y                    I  G  + P   S   ++L
Sbjct: 210 ILSKGYNKAV-DWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDL 268
Query: 228 LRKILEPNPVKRI-----TIAGIKADEWF 251
           LR +L+ +  KR       +  IK  +WF
Sbjct: 269 LRNLLQVDLTKRFGNLKNGVNDIKNHKWF 297

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score =  148 bits (373), Expect = 6e-36,   Method: Compositional matrix adjust.
 Identities = 83/269 (30%), Positives = 137/269 (50%), Gaps = 31/269 (11%)
Query: 8   QEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIAT 67
           Q    L ++E  +TLG G+FG+V   + +++G  +A+KIL+K +++ LK  +    E   
Sbjct: 36  QNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRI 95
Query: 68  LKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGV 127
           L+ +  P + +L       S +YMV+EY  GGE+F  +   GR  E   R    Q++   
Sbjct: 96  LQAVNFPFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTF 155
Query: 128 SYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEV 187
            Y H+  + +RDLK EN+++D +G IK++DFG +      R  G     CG+P Y+APE+
Sbjct: 156 EYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGFAK-----RVKGRTWXLCGTPEYLAPEI 210
Query: 188 LANRGYDGATSDIWSCGVILY--------------------IFRGDFKLPKWLSPGAQNL 227
           + ++GY+ A  D W+ GV++Y                    I  G  + P   S   ++L
Sbjct: 211 ILSKGYNKAV-DWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDL 269
Query: 228 LRKILEPNPVKRI-----TIAGIKADEWF 251
           LR +L+ +  KR       +  IK  +WF
Sbjct: 270 LRNLLQVDLTKRFGNLKNGVNDIKNHKWF 298

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score =  148 bits (373), Expect = 6e-36,   Method: Compositional matrix adjust.
 Identities = 83/269 (30%), Positives = 137/269 (50%), Gaps = 31/269 (11%)
Query: 8   QEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIAT 67
           Q    L ++E  +TLG G+FG+V   + +++G  +A+KIL+K +++ LK  +    E   
Sbjct: 36  QNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRI 95
Query: 68  LKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGV 127
           L+ +  P + +L       S +YMV+EY  GGE+F  +   GR  E   R    Q++   
Sbjct: 96  LQAVNFPFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTF 155
Query: 128 SYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEV 187
            Y H+  + +RDLK EN+++D +G IK++DFG +      R  G     CG+P Y+APE+
Sbjct: 156 EYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGFAK-----RVKGRTWXLCGTPEYLAPEI 210
Query: 188 LANRGYDGATSDIWSCGVILY--------------------IFRGDFKLPKWLSPGAQNL 227
           + ++GY+ A  D W+ GV++Y                    I  G  + P   S   ++L
Sbjct: 211 ILSKGYNKAV-DWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDL 269
Query: 228 LRKILEPNPVKRI-----TIAGIKADEWF 251
           LR +L+ +  KR       +  IK  +WF
Sbjct: 270 LRNLLQVDLTKRFGNLKNGVNDIKNHKWF 298

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score =  148 bits (373), Expect = 6e-36,   Method: Compositional matrix adjust.
 Identities = 83/269 (30%), Positives = 137/269 (50%), Gaps = 31/269 (11%)
Query: 8   QEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIAT 67
           Q    L ++E  +TLG G+FG+V   + +++G  +A+KIL+K +++ LK  +    E   
Sbjct: 36  QNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRI 95
Query: 68  LKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGV 127
           L+ +  P + +L       S +YMV+EY  GGE+F  +   GR  E   R    Q++   
Sbjct: 96  LQAVNFPFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFXEPHARFYAAQIVLTF 155
Query: 128 SYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEV 187
            Y H+  + +RDLK EN+++D +G IK++DFG +      R  G     CG+P Y+APE+
Sbjct: 156 EYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGFAK-----RVKGRTWXLCGTPEYLAPEI 210
Query: 188 LANRGYDGATSDIWSCGVILY--------------------IFRGDFKLPKWLSPGAQNL 227
           + ++GY+ A  D W+ GV++Y                    I  G  + P   S   ++L
Sbjct: 211 ILSKGYNKAV-DWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDL 269
Query: 228 LRKILEPNPVKRI-----TIAGIKADEWF 251
           LR +L+ +  KR       +  IK  +WF
Sbjct: 270 LRNLLQVDLTKRFGNLKNGVNDIKNHKWF 298

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score =  148 bits (373), Expect = 7e-36,   Method: Compositional matrix adjust.
 Identities = 86/269 (31%), Positives = 136/269 (50%), Gaps = 31/269 (11%)
Query: 8   QEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIAT 67
           Q    L ++E  RTLG G+FG+V   +  ++G  +A+KIL+K +++ LK  +    E   
Sbjct: 36  QNTAHLDQFERIRTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRI 95
Query: 68  LKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGV 127
            + +  P +V+L       S +YMVLEY  GGE+F  +   GR  E   R    Q++   
Sbjct: 96  QQAVNFPFLVKLEFSFKDNSNLYMVLEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTF 155
Query: 128 SYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEV 187
            Y H+  + +RDLK EN+L+D +G IK++DFG +      R  G     CG+P Y+APE+
Sbjct: 156 EYLHSLDLIYRDLKPENLLIDQQGYIKVADFGFAK-----RVKGRTWXLCGTPEYLAPEI 210
Query: 188 LANRGYDGATSDIWSCGVILY--------------------IFRGDFKLPKWLSPGAQNL 227
           + ++GY+ A  D W+ GV++Y                    I  G  + P   S   ++L
Sbjct: 211 ILSKGYNKAV-DWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDL 269
Query: 228 LRKILEPNPVKRI-----TIAGIKADEWF 251
           LR +L+ +  KR       +  IK  +WF
Sbjct: 270 LRNLLQVDLTKRFGNLKNGVNDIKNHKWF 298

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score =  147 bits (372), Expect = 7e-36,   Method: Compositional matrix adjust.
 Identities = 84/269 (31%), Positives = 137/269 (50%), Gaps = 31/269 (11%)
Query: 8   QEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIAT 67
           Q    L ++E  +TLG G+FG+V   +  ++G  +A+KIL+K +++ LK  +    E   
Sbjct: 36  QNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRI 95
Query: 68  LKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGV 127
           L+ +  P +V+L       S +YMV+EY  GGE+F  +   GR  E   R    Q++   
Sbjct: 96  LQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTF 155
Query: 128 SYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEV 187
            Y H+  + +RDLK EN+++D +G IK++DFG +      R  G     CG+P Y+APE+
Sbjct: 156 EYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGFAK-----RVKGRTWXLCGTPEYLAPEI 210
Query: 188 LANRGYDGATSDIWSCGVILY--------------------IFRGDFKLPKWLSPGAQNL 227
           + ++GY+ A  D W+ GV++Y                    I  G  + P   S   ++L
Sbjct: 211 ILSKGYNKAV-DWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDL 269
Query: 228 LRKILEPNPVKRI-----TIAGIKADEWF 251
           LR +L+ +  KR       +  IK  +WF
Sbjct: 270 LRNLLQVDLTKRFGNLKNGVNDIKNHKWF 298

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score =  147 bits (371), Expect = 1e-35,   Method: Compositional matrix adjust.
 Identities = 84/269 (31%), Positives = 138/269 (51%), Gaps = 31/269 (11%)
Query: 8   QEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIAT 67
           Q   +L +++  +TLG G+FG+V   +  +SG  +A+KIL+K +++ LK  +    E   
Sbjct: 35  QNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRI 94
Query: 68  LKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGV 127
           L+ +  P +V+L       S +YMV+EYV GGE+F  +   GR  E   R    Q++   
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTF 154
Query: 128 SYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEV 187
            Y H+  + +RDLK EN+L+D +G I+++DFG +      R  G     CG+P Y+AP +
Sbjct: 155 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYLAPAI 209
Query: 188 LANRGYDGATSDIWSCGVILY--------------------IFRGDFKLPKWLSPGAQNL 227
           + ++GY+ A  D W+ GV++Y                    I  G  + P   S   ++L
Sbjct: 210 ILSKGYNKAV-DWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDL 268
Query: 228 LRKILEPNPVKRI-----TIAGIKADEWF 251
           LR +L+ +  KR       +  IK  +WF
Sbjct: 269 LRNLLQVDLTKRFGNLKNGVNDIKNHKWF 297

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score =  147 bits (371), Expect = 1e-35,   Method: Compositional matrix adjust.
 Identities = 93/279 (33%), Positives = 142/279 (50%), Gaps = 31/279 (11%)
Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
           Y+L   LG+G F  V+          +A KI+   ++   +   +++RE    +LLKHPN
Sbjct: 33  YQLFEELGKGAFSVVRRCVKKTPTQEYAAKIINTKKL-SARDHQKLEREARICRLLKHPN 91
Query: 76  VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGV 135
           +VRLH+ ++ +   Y+V + VTGGELF+ I ++    EA+      Q+++ V++ H   +
Sbjct: 92  IVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIHQILESVNHIHQHDI 151
Query: 136 FHRDLKLENILLDSK---GNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRG 192
            HRDLK EN+LL SK     +K++DFGL+   Q   +        G+P Y++PEVL    
Sbjct: 152 VHRDLKPENLLLASKCKGAAVKLADFGLAIEVQ--GEQQAWFGFAGTPGYLSPEVLRKDP 209
Query: 193 YDGATSDIWSCGVILYIF----------------------RGDFKLPKW--LSPGAQNLL 228
           Y G   DIW+CGVILYI                         DF  P+W  ++P A+NL+
Sbjct: 210 Y-GKPVDIWACGVILYILLVGYPPFWDEDQHKLYQQIKAGAYDFPSPEWDTVTPEAKNLI 268
Query: 229 RKILEPNPVKRITIAGIKADEWFEQDYTPANPDDDEEDI 267
            ++L  NP KRIT        W  Q  T A+    +E +
Sbjct: 269 NQMLTINPAKRITADQALKHPWVCQRSTVASMMHRQETV 307

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score =  147 bits (370), Expect = 1e-35,   Method: Compositional matrix adjust.
 Identities = 84/269 (31%), Positives = 137/269 (50%), Gaps = 31/269 (11%)
Query: 8   QEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIAT 67
           Q    L ++E  +TLG G+FG+V   +  ++G  +A+KIL+K +++ LK  +    E   
Sbjct: 36  QNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRI 95
Query: 68  LKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGV 127
           L+ +  P +V+L       S +YMV+EYV GGE+F  +   GR  E   R    Q++   
Sbjct: 96  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTF 155
Query: 128 SYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEV 187
            Y H+  + +RDLK EN+L+D +G I+++DFG +      R  G     CG+P Y+APE+
Sbjct: 156 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYLAPEI 210
Query: 188 LANRGYDGATSDIWSCGVILY--------------------IFRGDFKLPKWLSPGAQNL 227
           + ++GY+ A  D W+ GV++Y                    I  G  + P   S   ++L
Sbjct: 211 ILSKGYNKAV-DWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDL 269
Query: 228 LRKILEPNPVKRI-----TIAGIKADEWF 251
           LR +L+ +  KR       +  I   +WF
Sbjct: 270 LRNLLQVDLTKRFGNLKNGVNDIXNHKWF 298

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score =  147 bits (370), Expect = 2e-35,   Method: Compositional matrix adjust.
 Identities = 84/269 (31%), Positives = 138/269 (51%), Gaps = 31/269 (11%)
Query: 8   QEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIAT 67
           Q   +L +++  +TLG G+FG+V   +  +SG  +A+KIL+K +++ LK  +    E   
Sbjct: 35  QNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRI 94
Query: 68  LKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGV 127
           L+ +  P +V+L       S +YMV+EYV GGE+F  +   GR  E   R    Q++   
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTF 154
Query: 128 SYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEV 187
            Y H+  + +RDLK EN+L+D +G I+++DFG +      R  G     CG+P Y+APE+
Sbjct: 155 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYLAPEI 209
Query: 188 LANRGYDGATSDIWSCGVILY--------------------IFRGDFKLPKWLSPGAQNL 227
           + ++GY+ A  D W+ GV++Y                    I  G  + P   S   ++L
Sbjct: 210 ILSKGYNKAV-DWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDL 268
Query: 228 LRKILEPNPVKRI-----TIAGIKADEWF 251
           LR +L+ +  K        +  IK  +WF
Sbjct: 269 LRNLLQVDLTKAFGNLKNGVNDIKNHKWF 297

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score =  145 bits (367), Expect = 3e-35,   Method: Compositional matrix adjust.
 Identities = 84/269 (31%), Positives = 138/269 (51%), Gaps = 31/269 (11%)
Query: 8   QEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIAT 67
           Q   +L +++  +TLG G+FG+V   +  +SG  +A+KIL+K +++ LK  +    E   
Sbjct: 35  QNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRI 94
Query: 68  LKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGV 127
           L+ +  P +V+L       S +YMV+EYV GGE+F  +   GR  E   R    Q++   
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTF 154
Query: 128 SYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEV 187
            Y H+  + +RDLK EN+L+D +G I+++DFG +      R  G     CG+P  +APE+
Sbjct: 155 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEALAPEI 209
Query: 188 LANRGYDGATSDIWSCGVILY--------------------IFRGDFKLPKWLSPGAQNL 227
           + ++GY+ A  D W+ GV++Y                    I  G  + P   S   ++L
Sbjct: 210 ILSKGYNKAV-DWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDL 268
Query: 228 LRKILEPNPVKRI-----TIAGIKADEWF 251
           LR +L+ +  KR       +  IK  +WF
Sbjct: 269 LRNLLQVDLTKRFGNLKNGVNDIKNHKWF 297

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score =  145 bits (367), Expect = 3e-35,   Method: Compositional matrix adjust.
 Identities = 84/269 (31%), Positives = 138/269 (51%), Gaps = 31/269 (11%)
Query: 8   QEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIAT 67
           Q   +L +++  +TLG G+FG+V   +  +SG  +A+KIL+K +++ LK  +    E   
Sbjct: 35  QNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRI 94
Query: 68  LKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGV 127
           L+ +  P +V+L       S +YMV+EYV GGE+F  +   GR  E   R    Q++   
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTF 154
Query: 128 SYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEV 187
            Y H+  + +RDLK EN+L+D +G I+++DFG +      R  G      G+P Y+APE+
Sbjct: 155 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLAGTPEYLAPEI 209
Query: 188 LANRGYDGATSDIWSCGVILY--------------------IFRGDFKLPKWLSPGAQNL 227
           + ++GY+ A  D W+ GV++Y                    I  G  + P   S   ++L
Sbjct: 210 ILSKGYNKAV-DWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDL 268
Query: 228 LRKILEPNPVKRI-----TIAGIKADEWF 251
           LR +L+ +  KR       +  IK  +WF
Sbjct: 269 LRNLLQVDLTKRFGNLKNGVNDIKNHKWF 297

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score =  145 bits (367), Expect = 3e-35,   Method: Compositional matrix adjust.
 Identities = 92/268 (34%), Positives = 141/268 (52%), Gaps = 44/268 (16%)
Query: 20  RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK-HPNVVR 78
           + LGEG+F   +      S   FAVKI+ K      ++    ++EI  LKL + HPN+V+
Sbjct: 17  KPLGEGSFSICRKCVHKKSNQAFAVKIISK------RMEANTQKEITALKLCEGHPNIVK 70
Query: 79  LHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHR 138
           LHEV   +   ++V+E + GGELF++I  K    E E   + ++L+  VS+ H+ GV HR
Sbjct: 71  LHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVGVVHR 130
Query: 139 DLKLENILLDSKGN---IKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDG 195
           DLK EN+L   + +   IKI DFG + L     D+  L T C + +Y APE+L   GYD 
Sbjct: 131 DLKPENLLFTDENDNLEIKIIDFGFARLKP--PDNQPLKTPCFTLHYAAPELLNQNGYD- 187
Query: 196 ATSDIWSCGVILY---------------------------IFRGDFKLP----KWLSPGA 224
            + D+WS GVILY                           I +GDF       K +S  A
Sbjct: 188 ESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEAWKNVSQEA 247
Query: 225 QNLLRKILEPNPVKRITIAGIKADEWFE 252
           ++L++ +L  +P KR+ ++G++ +EW +
Sbjct: 248 KDLIQGLLTVDPNKRLKMSGLRYNEWLQ 275

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score =  145 bits (365), Expect = 5e-35,   Method: Compositional matrix adjust.
 Identities = 84/269 (31%), Positives = 138/269 (51%), Gaps = 31/269 (11%)
Query: 8   QEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIAT 67
           Q   +L +++  +TLG G+FG+V   +  +SG  +A+KIL+K +++ LK  +    E   
Sbjct: 35  QNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRI 94
Query: 68  LKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGV 127
           L+ +  P +V+L       S +YMV+EYV GGE+F  +   GR  E   R    Q++   
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTF 154
Query: 128 SYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEV 187
            Y H+  + +RDLK EN+L+D +G I+++DFG +      R  G      G+P Y+APE+
Sbjct: 155 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLXGTPEYLAPEI 209
Query: 188 LANRGYDGATSDIWSCGVILY--------------------IFRGDFKLPKWLSPGAQNL 227
           + ++GY+ A  D W+ GV++Y                    I  G  + P   S   ++L
Sbjct: 210 ILSKGYNKAV-DWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDL 268
Query: 228 LRKILEPNPVKRI-----TIAGIKADEWF 251
           LR +L+ +  KR       +  IK  +WF
Sbjct: 269 LRNLLQVDLTKRFGNLKNGVNDIKNHKWF 297

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score =  145 bits (365), Expect = 5e-35,   Method: Compositional matrix adjust.
 Identities = 92/280 (32%), Positives = 147/280 (52%), Gaps = 35/280 (12%)
Query: 1   MVIAEKKQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQ 60
           M I  KK  G     Y+  + LG G +G+V   +D  + +  A+KI+ K  +       +
Sbjct: 26  MFITSKK--GHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSV-STSSNSK 82
Query: 61  IKREIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLF 120
           +  E+A LKLL HPN+++L++    K   Y+V+E   GGELFD+I  + +  E +   + 
Sbjct: 83  LLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVII 142
Query: 121 QQLIDGVSYCHNKGVFHRDLKLENILLDSKGN---IKISDFGLSALPQHFRDDGLLHTTC 177
           +Q++ GV+Y H   + HRDLK EN+LL+SK     IKI DFGLSA+   F +   +    
Sbjct: 143 KQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAV---FENQKKMKERL 199
Query: 178 GSPNYVAPEVLANRGYDGATSDIWSCGVILYIF----------------------RGDFK 215
           G+  Y+APEVL  + YD    D+WS GVIL+I                       +  F 
Sbjct: 200 GTAYYIAPEVLRKK-YD-EKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFD 257
Query: 216 LPKW--LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQ 253
            P+W  +S GA++L++++L+ +  +RI+        W ++
Sbjct: 258 SPEWKNVSEGAKDLIKQMLQFDSQRRISAQQALEHPWIKE 297

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score =  142 bits (359), Expect = 2e-34,   Method: Compositional matrix adjust.
 Identities = 92/267 (34%), Positives = 142/267 (53%), Gaps = 37/267 (13%)
Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLK---ITDQIKREIATLKLLK 72
           Y++G  LG G F  VK  ++  +GL +A K ++K +    +     ++I+RE++ L+ + 
Sbjct: 14  YDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVL 73
Query: 73  HPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHN 132
           HPN++ LH+V  +++ + ++LE V+GGELFD +A K  L E E     +Q++DGV+Y H 
Sbjct: 74  HPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHT 133
Query: 133 KGVFHRDLKLENILLDSKG----NIKISDFGLSALPQHFRDDGL-LHTTCGSPNYVAPEV 187
           K + H DLK ENI+L  K     +IK+ DFGL+    H  +DG+      G+P +VAPE+
Sbjct: 134 KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA----HEIEDGVEFKNIFGTPEFVAPEI 189
Query: 188 LANRGYDGATSDIWSCGVILYI-------FRGDFK-----------------LPKWLSPG 223
           + N    G  +D+WS GVI YI       F GD K                      S  
Sbjct: 190 V-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFFSQTSEL 248
Query: 224 AQNLLRKILEPNPVKRITIAGIKADEW 250
           A++ +RK+L     KR+TI       W
Sbjct: 249 AKDFIRKLLVKETRKRLTIQEALRHPW 275

>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305

Iteration: 1
 Score =  142 bits (359), Expect = 2e-34,   Method: Compositional matrix adjust.
 Identities = 97/273 (35%), Positives = 147/273 (53%), Gaps = 29/273 (10%)
Query: 13  LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITD-QIKREIATLKLL 71
           +G+Y +G  LGEG++GKVK   D ++    AVKIL+K ++  +   +  +K+EI  L+ L
Sbjct: 4   IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRL 63
Query: 72  KHPNVVRLHEVLAS--KSKIYMVLEYVTGG--ELFDKIASKGRLQEAEGRKLFQQLIDGV 127
           +H NV++L +VL +  K K+YMV+EY   G  E+ D +  K R    +    F QLIDG+
Sbjct: 64  RHKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEK-RFPVCQAHGYFCQLIDGL 122
Query: 128 SYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEV 187
            Y H++G+ H+D+K  N+LL + G +KIS  G++     F  D    T+ GSP +  PE+
Sbjct: 123 EYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEI 182
Query: 188 LAN--RGYDGATSDIWSCGVILY--------------------IFRGDFKLPKWLSPGAQ 225
            AN    + G   DIWS GV LY                    I +G + +P    P   
Sbjct: 183 -ANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGSYAIPGDCGPPLS 241
Query: 226 NLLRKILEPNPVKRITIAGIKADEWFEQDYTPA 258
           +LL+ +LE  P KR +I  I+   WF + + PA
Sbjct: 242 DLLKGMLEYEPAKRFSIRQIRQHSWFRKKHPPA 274

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score =  142 bits (359), Expect = 3e-34,   Method: Compositional matrix adjust.
 Identities = 83/250 (33%), Positives = 145/250 (58%), Gaps = 31/250 (12%)
Query: 16  YELGRTLGEGNFGKVKFAQDL---DSGLPFAVKILEKNRIIHLKITDQI--KREIATLKL 70
           +EL + LG+G+FGKV   + +   DSG  +A+K+L+K     LK+ D++  K E   L  
Sbjct: 30  FELLKVLGQGSFGKVFLVRKVTRPDSGHLYAMKVLKKAT---LKVRDRVRTKMERDILAD 86
Query: 71  LKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYC 130
           + HP VV+LH    ++ K+Y++L+++ GG+LF +++ +    E + +    +L  G+ + 
Sbjct: 87  VNHPFVVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALGLDHL 146
Query: 131 HNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLAN 190
           H+ G+ +RDLK ENILLD +G+IK++DFGLS   +    +   ++ CG+  Y+APEV+  
Sbjct: 147 HSLGIIYRDLKPENILLDEEGHIKLTDFGLSK--EAIDHEKKAYSFCGTVEYMAPEVVNR 204
Query: 191 RGYDGATSDIWSCGVILY--------------------IFRGDFKLPKWLSPGAQNLLRK 230
           +G+   ++D WS GV+++                    I +    +P++LS  AQ+LLR 
Sbjct: 205 QGH-SHSADWWSYGVLMFEMLTGSLPFQGKDRKETMTLILKAKLGMPQFLSTEAQSLLRA 263
Query: 231 ILEPNPVKRI 240
           + + NP  R+
Sbjct: 264 LFKRNPANRL 273

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score =  142 bits (358), Expect = 4e-34,   Method: Compositional matrix adjust.
 Identities = 98/267 (36%), Positives = 140/267 (52%), Gaps = 37/267 (13%)
Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLK---ITDQIKREIATLKLLK 72
           Y+ G  LG G F  VK  ++  +GL +A K ++K R    +     + I+RE++ LK ++
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 73  HPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHN 132
           HPNV+ LHEV  +K+ + ++LE V GGELFD +A K  L E E  +  +Q+++GV Y H+
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHS 132
Query: 133 KGVFHRDLKLENI-LLDS---KGNIKISDFGLSALPQHFRDDG-LLHTTCGSPNYVAPEV 187
             + H DLK ENI LLD    K  IKI DFGL+    H  D G       G+P +VAPE+
Sbjct: 133 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA----HKIDFGNEFKNIFGTPEFVAPEI 188
Query: 188 LANRGYDGATSDIWSCGVILYI-------FRGDFKLPKW-----------------LSPG 223
           + N    G  +D+WS GVI YI       F GD K                      S  
Sbjct: 189 V-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSAL 247
Query: 224 AQNLLRKILEPNPVKRITIAGIKADEW 250
           A++ +R++L  +P KR+TI       W
Sbjct: 248 AKDFIRRLLVKDPKKRMTIQDSLQHPW 274

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score =  142 bits (357), Expect = 4e-34,   Method: Compositional matrix adjust.
 Identities = 98/267 (36%), Positives = 140/267 (52%), Gaps = 37/267 (13%)
Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLK---ITDQIKREIATLKLLK 72
           Y+ G  LG G F  VK  ++  +GL +A K ++K R    +     + I+RE++ LK ++
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 73  HPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHN 132
           HPNV+ LHEV  +K+ + ++LE V GGELFD +A K  L E E  +  +Q+++GV Y H+
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHS 132
Query: 133 KGVFHRDLKLENI-LLDS---KGNIKISDFGLSALPQHFRDDG-LLHTTCGSPNYVAPEV 187
             + H DLK ENI LLD    K  IKI DFGL+    H  D G       G+P +VAPE+
Sbjct: 133 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA----HKIDFGNEFKNIFGTPEFVAPEI 188
Query: 188 LANRGYDGATSDIWSCGVILYI-------FRGDFKLPKW-----------------LSPG 223
           + N    G  +D+WS GVI YI       F GD K                      S  
Sbjct: 189 V-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSAL 247
Query: 224 AQNLLRKILEPNPVKRITIAGIKADEW 250
           A++ +R++L  +P KR+TI       W
Sbjct: 248 AKDFIRRLLVKDPKKRMTIQDSLQHPW 274

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score =  142 bits (357), Expect = 4e-34,   Method: Compositional matrix adjust.
 Identities = 98/267 (36%), Positives = 140/267 (52%), Gaps = 37/267 (13%)
Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLK---ITDQIKREIATLKLLK 72
           Y+ G  LG G F  VK  ++  +GL +A K ++K R    +     + I+RE++ LK ++
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 73  HPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHN 132
           HPNV+ LHEV  +K+ + ++LE V GGELFD +A K  L E E  +  +Q+++GV Y H+
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHS 132
Query: 133 KGVFHRDLKLENI-LLDS---KGNIKISDFGLSALPQHFRDDG-LLHTTCGSPNYVAPEV 187
             + H DLK ENI LLD    K  IKI DFGL+    H  D G       G+P +VAPE+
Sbjct: 133 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA----HKIDFGNEFKNIFGTPEFVAPEI 188
Query: 188 LANRGYDGATSDIWSCGVILYI-------FRGDFKLPKW-----------------LSPG 223
           + N    G  +D+WS GVI YI       F GD K                      S  
Sbjct: 189 V-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSAL 247
Query: 224 AQNLLRKILEPNPVKRITIAGIKADEW 250
           A++ +R++L  +P KR+TI       W
Sbjct: 248 AKDFIRRLLVKDPKKRMTIQDSLQHPW 274

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score =  142 bits (357), Expect = 5e-34,   Method: Compositional matrix adjust.
 Identities = 98/267 (36%), Positives = 140/267 (52%), Gaps = 37/267 (13%)
Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLK---ITDQIKREIATLKLLK 72
           Y+ G  LG G F  VK  ++  +GL +A K ++K R    +     + I+RE++ LK ++
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 73  HPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHN 132
           HPNV+ LHEV  +K+ + ++LE V GGELFD +A K  L E E  +  +Q+++GV Y H+
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHS 132
Query: 133 KGVFHRDLKLENI-LLDS---KGNIKISDFGLSALPQHFRDDG-LLHTTCGSPNYVAPEV 187
             + H DLK ENI LLD    K  IKI DFGL+    H  D G       G+P +VAPE+
Sbjct: 133 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA----HKIDFGNEFKNIFGTPEFVAPEI 188
Query: 188 LANRGYDGATSDIWSCGVILYI-------FRGDFKLPKW-----------------LSPG 223
           + N    G  +D+WS GVI YI       F GD K                      S  
Sbjct: 189 V-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSAL 247
Query: 224 AQNLLRKILEPNPVKRITIAGIKADEW 250
           A++ +R++L  +P KR+TI       W
Sbjct: 248 AKDFIRRLLVKDPKKRMTIQDSLQHPW 274

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score =  142 bits (357), Expect = 5e-34,   Method: Compositional matrix adjust.
 Identities = 98/267 (36%), Positives = 140/267 (52%), Gaps = 37/267 (13%)
Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLK---ITDQIKREIATLKLLK 72
           Y+ G  LG G F  VK  ++  +GL +A K ++K R    +     + I+RE++ LK ++
Sbjct: 12  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 71
Query: 73  HPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHN 132
           HPNV+ LHEV  +K+ + ++LE V GGELFD +A K  L E E  +  +Q+++GV Y H+
Sbjct: 72  HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHS 131
Query: 133 KGVFHRDLKLENI-LLDS---KGNIKISDFGLSALPQHFRDDG-LLHTTCGSPNYVAPEV 187
             + H DLK ENI LLD    K  IKI DFGL+    H  D G       G+P +VAPE+
Sbjct: 132 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA----HKIDFGNEFKNIFGTPEFVAPEI 187
Query: 188 LANRGYDGATSDIWSCGVILYI-------FRGDFKLPKW-----------------LSPG 223
           + N    G  +D+WS GVI YI       F GD K                      S  
Sbjct: 188 V-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSAL 246
Query: 224 AQNLLRKILEPNPVKRITIAGIKADEW 250
           A++ +R++L  +P KR+TI       W
Sbjct: 247 AKDFIRRLLVKDPKKRMTIQDSLQHPW 273

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score =  142 bits (357), Expect = 5e-34,   Method: Compositional matrix adjust.
 Identities = 98/267 (36%), Positives = 140/267 (52%), Gaps = 37/267 (13%)
Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLK---ITDQIKREIATLKLLK 72
           Y+ G  LG G F  VK  ++  +GL +A K ++K R    +     + I+RE++ LK ++
Sbjct: 12  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 71
Query: 73  HPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHN 132
           HPNV+ LHEV  +K+ + ++LE V GGELFD +A K  L E E  +  +Q+++GV Y H+
Sbjct: 72  HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHS 131
Query: 133 KGVFHRDLKLENI-LLDS---KGNIKISDFGLSALPQHFRDDG-LLHTTCGSPNYVAPEV 187
             + H DLK ENI LLD    K  IKI DFGL+    H  D G       G+P +VAPE+
Sbjct: 132 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA----HKIDFGNEFKNIFGTPEFVAPEI 187
Query: 188 LANRGYDGATSDIWSCGVILYI-------FRGDFKLPKW-----------------LSPG 223
           + N    G  +D+WS GVI YI       F GD K                      S  
Sbjct: 188 V-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSAL 246
Query: 224 AQNLLRKILEPNPVKRITIAGIKADEW 250
           A++ +R++L  +P KR+TI       W
Sbjct: 247 AKDFIRRLLVKDPKKRMTIQDSLQHPW 273

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score =  141 bits (356), Expect = 6e-34,   Method: Compositional matrix adjust.
 Identities = 98/267 (36%), Positives = 140/267 (52%), Gaps = 37/267 (13%)
Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLK---ITDQIKREIATLKLLK 72
           Y+ G  LG G F  VK  ++  +GL +A K ++K R    +     + I+RE++ LK ++
Sbjct: 13  YDTGEELGSGKFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 73  HPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHN 132
           HPNV+ LHEV  +K+ + ++LE V GGELFD +A K  L E E  +  +Q+++GV Y H+
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHS 132
Query: 133 KGVFHRDLKLENI-LLDS---KGNIKISDFGLSALPQHFRDDG-LLHTTCGSPNYVAPEV 187
             + H DLK ENI LLD    K  IKI DFGL+    H  D G       G+P +VAPE+
Sbjct: 133 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA----HKIDFGNEFKNIFGTPEFVAPEI 188
Query: 188 LANRGYDGATSDIWSCGVILYI-------FRGDFKLPKW-----------------LSPG 223
           + N    G  +D+WS GVI YI       F GD K                      S  
Sbjct: 189 V-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSAL 247
Query: 224 AQNLLRKILEPNPVKRITIAGIKADEW 250
           A++ +R++L  +P KR+TI       W
Sbjct: 248 AKDFIRRLLVKDPKKRMTIQDSLQHPW 274

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score =  141 bits (356), Expect = 6e-34,   Method: Compositional matrix adjust.
 Identities = 98/267 (36%), Positives = 140/267 (52%), Gaps = 37/267 (13%)
Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLK---ITDQIKREIATLKLLK 72
           Y+ G  LG G F  VK  ++  +GL +A K ++K R    +     + I+RE++ LK ++
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 73  HPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHN 132
           HPNV+ LHEV  +K+ + ++LE V GGELFD +A K  L E E  +  +Q+++GV Y H+
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHS 132
Query: 133 KGVFHRDLKLENI-LLDS---KGNIKISDFGLSALPQHFRDDG-LLHTTCGSPNYVAPEV 187
             + H DLK ENI LLD    K  IKI DFGL+    H  D G       G+P +VAPE+
Sbjct: 133 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA----HKIDFGNEFKNIFGTPEFVAPEI 188
Query: 188 LANRGYDGATSDIWSCGVILYI-------FRGDFKLPKW-----------------LSPG 223
           + N    G  +D+WS GVI YI       F GD K                      S  
Sbjct: 189 V-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSAL 247
Query: 224 AQNLLRKILEPNPVKRITIAGIKADEW 250
           A++ +R++L  +P KR+TI       W
Sbjct: 248 AKDFIRRLLVKDPKKRMTIQDSLQHPW 274

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score =  141 bits (356), Expect = 6e-34,   Method: Compositional matrix adjust.
 Identities = 98/267 (36%), Positives = 140/267 (52%), Gaps = 37/267 (13%)
Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLK---ITDQIKREIATLKLLK 72
           Y+ G  LG G F  VK  ++  +GL +A K ++K R    +     + I+RE++ LK ++
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 73  HPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHN 132
           HPNV+ LHEV  +K+ + ++LE V GGELFD +A K  L E E  +  +Q+++GV Y H+
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHS 132
Query: 133 KGVFHRDLKLENI-LLDS---KGNIKISDFGLSALPQHFRDDG-LLHTTCGSPNYVAPEV 187
             + H DLK ENI LLD    K  IKI DFGL+    H  D G       G+P +VAPE+
Sbjct: 133 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA----HKIDFGNEFKNIFGTPEFVAPEI 188
Query: 188 LANRGYDGATSDIWSCGVILYI-------FRGDFKLPKW-----------------LSPG 223
           + N    G  +D+WS GVI YI       F GD K                      S  
Sbjct: 189 V-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSAL 247
Query: 224 AQNLLRKILEPNPVKRITIAGIKADEW 250
           A++ +R++L  +P KR+TI       W
Sbjct: 248 AKDFIRRLLVKDPKKRMTIQDSLQHPW 274

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score =  141 bits (356), Expect = 6e-34,   Method: Compositional matrix adjust.
 Identities = 98/269 (36%), Positives = 141/269 (52%), Gaps = 37/269 (13%)
Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLK---ITDQIKREIATLKLLK 72
           Y+ G  LG G F  VK  ++  +GL +A K ++K R    +     + I+RE++ LK ++
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 73  HPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHN 132
           HPNV+ LHEV  +K+ + ++LE V GGELFD +A K  L E E  +  +Q+++GV Y H+
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHS 132
Query: 133 KGVFHRDLKLENI-LLDS---KGNIKISDFGLSALPQHFRDDG-LLHTTCGSPNYVAPEV 187
             + H DLK ENI LLD    K  IKI DFGL+    H  D G       G+P +VAPE+
Sbjct: 133 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA----HKIDFGNEFKNIFGTPAFVAPEI 188
Query: 188 LANRGYDGATSDIWSCGVILYI-------FRGDFKLPKW-----------------LSPG 223
           + N    G  +D+WS GVI YI       F GD K                      S  
Sbjct: 189 V-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSAL 247
Query: 224 AQNLLRKILEPNPVKRITIAGIKADEWFE 252
           A++ +R++L  +P KR+TI       W +
Sbjct: 248 AKDFIRRLLVKDPKKRMTIQDSLQHPWIK 276

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score =  141 bits (356), Expect = 6e-34,   Method: Compositional matrix adjust.
 Identities = 98/267 (36%), Positives = 140/267 (52%), Gaps = 37/267 (13%)
Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLK---ITDQIKREIATLKLLK 72
           Y+ G  LG G F  VK  ++  +GL +A K ++K R    +     + I+RE++ LK ++
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 73  HPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHN 132
           HPNV+ LHEV  +K+ + ++LE V GGELFD +A K  L E E  +  +Q+++GV Y H+
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHS 132
Query: 133 KGVFHRDLKLENI-LLDS---KGNIKISDFGLSALPQHFRDDG-LLHTTCGSPNYVAPEV 187
             + H DLK ENI LLD    K  IKI DFGL+    H  D G       G+P +VAPE+
Sbjct: 133 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA----HKIDFGNEFKNIFGTPEFVAPEI 188
Query: 188 LANRGYDGATSDIWSCGVILYI-------FRGDFKLPKW-----------------LSPG 223
           + N    G  +D+WS GVI YI       F GD K                      S  
Sbjct: 189 V-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSAL 247
Query: 224 AQNLLRKILEPNPVKRITIAGIKADEW 250
           A++ +R++L  +P KR+TI       W
Sbjct: 248 AKDFIRRLLVKDPKKRMTIQDSLQHPW 274

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score =  141 bits (356), Expect = 6e-34,   Method: Compositional matrix adjust.
 Identities = 81/251 (32%), Positives = 145/251 (57%), Gaps = 31/251 (12%)
Query: 15  RYELGRTLGEGNFGKVKFAQDL---DSGLPFAVKILEKNRIIHLKITDQI--KREIATLK 69
           ++EL + LG+G+FGKV   + +   D+   +A+K+L+K     LK+ D++  K E   L 
Sbjct: 25  QFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKAT---LKVRDRVRTKMERDILV 81
Query: 70  LLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSY 129
            + HP +V+LH    ++ K+Y++L+++ GG+LF +++ +    E + +    +L   + +
Sbjct: 82  EVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDH 141
Query: 130 CHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLA 189
            H+ G+ +RDLK ENILLD +G+IK++DFGLS   +    +   ++ CG+  Y+APEV+ 
Sbjct: 142 LHSLGIIYRDLKPENILLDEEGHIKLTDFGLSK--ESIDHEKKAYSFCGTVEYMAPEVVN 199
Query: 190 NRGYDGATSDIWSCGVILY--------------------IFRGDFKLPKWLSPGAQNLLR 229
            RG+   ++D WS GV+++                    I +    +P++LSP AQ+LLR
Sbjct: 200 RRGHT-QSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMPQFLSPEAQSLLR 258
Query: 230 KILEPNPVKRI 240
            + + NP  R+
Sbjct: 259 MLFKRNPANRL 269

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score =  141 bits (356), Expect = 6e-34,   Method: Compositional matrix adjust.
 Identities = 98/267 (36%), Positives = 140/267 (52%), Gaps = 37/267 (13%)
Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLK---ITDQIKREIATLKLLK 72
           Y+ G  LG G F  VK  ++  +GL +A K ++K R    +     + I+RE++ LK ++
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 73  HPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHN 132
           HPNV+ LHEV  +K+ + ++LE V GGELFD +A K  L E E  +  +Q+++GV Y H+
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHS 132
Query: 133 KGVFHRDLKLENI-LLDS---KGNIKISDFGLSALPQHFRDDG-LLHTTCGSPNYVAPEV 187
             + H DLK ENI LLD    K  IKI DFGL+    H  D G       G+P +VAPE+
Sbjct: 133 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA----HKIDFGNEFKNIFGTPEFVAPEI 188
Query: 188 LANRGYDGATSDIWSCGVILYI-------FRGDFKLPKW-----------------LSPG 223
           + N    G  +D+WS GVI YI       F GD K                      S  
Sbjct: 189 V-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSAL 247
Query: 224 AQNLLRKILEPNPVKRITIAGIKADEW 250
           A++ +R++L  +P KR+TI       W
Sbjct: 248 AKDFIRRLLVKDPKKRMTIQDSLQHPW 274

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score =  141 bits (355), Expect = 7e-34,   Method: Compositional matrix adjust.
 Identities = 81/251 (32%), Positives = 145/251 (57%), Gaps = 31/251 (12%)
Query: 15  RYELGRTLGEGNFGKVKFAQDL---DSGLPFAVKILEKNRIIHLKITDQI--KREIATLK 69
           ++EL + LG+G+FGKV   + +   D+   +A+K+L+K     LK+ D++  K E   L 
Sbjct: 26  QFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKAT---LKVRDRVRTKMERDILV 82
Query: 70  LLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSY 129
            + HP +V+LH    ++ K+Y++L+++ GG+LF +++ +    E + +    +L   + +
Sbjct: 83  EVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDH 142
Query: 130 CHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLA 189
            H+ G+ +RDLK ENILLD +G+IK++DFGLS   +    +   ++ CG+  Y+APEV+ 
Sbjct: 143 LHSLGIIYRDLKPENILLDEEGHIKLTDFGLSK--ESIDHEKKAYSFCGTVEYMAPEVVN 200
Query: 190 NRGYDGATSDIWSCGVILY--------------------IFRGDFKLPKWLSPGAQNLLR 229
            RG+   ++D WS GV+++                    I +    +P++LSP AQ+LLR
Sbjct: 201 RRGHT-QSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMPQFLSPEAQSLLR 259
Query: 230 KILEPNPVKRI 240
            + + NP  R+
Sbjct: 260 MLFKRNPANRL 270

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score =  141 bits (355), Expect = 8e-34,   Method: Compositional matrix adjust.
 Identities = 81/251 (32%), Positives = 145/251 (57%), Gaps = 31/251 (12%)
Query: 15  RYELGRTLGEGNFGKVKFAQDL---DSGLPFAVKILEKNRIIHLKITDQI--KREIATLK 69
           ++EL + LG+G+FGKV   + +   D+   +A+K+L+K     LK+ D++  K E   L 
Sbjct: 25  QFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKAT---LKVRDRVRTKMERDILV 81
Query: 70  LLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSY 129
            + HP +V+LH    ++ K+Y++L+++ GG+LF +++ +    E + +    +L   + +
Sbjct: 82  EVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDH 141
Query: 130 CHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLA 189
            H+ G+ +RDLK ENILLD +G+IK++DFGLS   +    +   ++ CG+  Y+APEV+ 
Sbjct: 142 LHSLGIIYRDLKPENILLDEEGHIKLTDFGLSK--ESIDHEKKAYSFCGTVEYMAPEVVN 199
Query: 190 NRGYDGATSDIWSCGVILY--------------------IFRGDFKLPKWLSPGAQNLLR 229
            RG+   ++D WS GV+++                    I +    +P++LSP AQ+LLR
Sbjct: 200 RRGHT-QSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMPQFLSPEAQSLLR 258
Query: 230 KILEPNPVKRI 240
            + + NP  R+
Sbjct: 259 MLFKRNPANRL 269

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score =  140 bits (354), Expect = 1e-33,   Method: Compositional matrix adjust.
 Identities = 86/256 (33%), Positives = 140/256 (54%), Gaps = 27/256 (10%)
Query: 9   EGMRLGRYELGRTLGEGNFGKV---KFAQDLDSGLPFAVKILEKNRII-HLKITDQIKRE 64
           E +R   +EL R LG+G +GKV   +     ++G  FA+K+L+K  I+ + K T   K E
Sbjct: 12  EKIRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAE 71
Query: 65  IATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLI 124
              L+ +KHP +V L     +  K+Y++LEY++GGELF ++  +G   E        ++ 
Sbjct: 72  RNILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEIS 131
Query: 125 DGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVA 184
             + + H KG+ +RDLK ENI+L+ +G++K++DFGL     H  D  + HT CG+  Y+A
Sbjct: 132 MALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIH--DGTVTHTFCGTIEYMA 189
Query: 185 PEVLANRGYDGATSDIWSCGVILY--------------------IFRGDFKLPKWLSPGA 224
           PE+L   G++ A  D WS G ++Y                    I +    LP +L+  A
Sbjct: 190 PEILMRSGHNRAV-DWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLPPYLTQEA 248
Query: 225 QNLLRKILEPNPVKRI 240
           ++LL+K+L+ N   R+
Sbjct: 249 RDLLKKLLKRNAASRL 264

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score =  140 bits (354), Expect = 1e-33,   Method: Compositional matrix adjust.
 Identities = 98/267 (36%), Positives = 140/267 (52%), Gaps = 37/267 (13%)
Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLK---ITDQIKREIATLKLLK 72
           Y+ G  LG G F  VK  ++  +GL +A K ++K R    +     + I+RE++ LK ++
Sbjct: 13  YDTGEELGSGVFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 73  HPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHN 132
           HPNV+ LHEV  +K+ + ++LE V GGELFD +A K  L E E  +  +Q+++GV Y H+
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHS 132
Query: 133 KGVFHRDLKLENI-LLDS---KGNIKISDFGLSALPQHFRDDG-LLHTTCGSPNYVAPEV 187
             + H DLK ENI LLD    K  IKI DFGL+    H  D G       G+P +VAPE+
Sbjct: 133 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA----HKIDFGNEFKNIFGTPEFVAPEI 188
Query: 188 LANRGYDGATSDIWSCGVILYI-------FRGDFKLPKW-----------------LSPG 223
           + N    G  +D+WS GVI YI       F GD K                      S  
Sbjct: 189 V-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSAL 247
Query: 224 AQNLLRKILEPNPVKRITIAGIKADEW 250
           A++ +R++L  +P KR+TI       W
Sbjct: 248 AKDFIRRLLVKDPKKRMTIQDSLQHPW 274

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score =  140 bits (353), Expect = 1e-33,   Method: Compositional matrix adjust.
 Identities = 87/266 (32%), Positives = 138/266 (51%), Gaps = 35/266 (13%)
Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLK---ITDQIKREIATLKLLK 72
           YE+G  LG G F  V+  +   +G  +A K ++K R+   +     ++I+RE+  L+ ++
Sbjct: 7   YEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIR 66
Query: 73  HPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHN 132
           HPN++ LH++  +K+ + ++LE V+GGELFD +A K  L E E  +  +Q++DGV Y H+
Sbjct: 67  HPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHS 126
Query: 133 KGVFHRDLKLENILLDSKG----NIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVL 188
           K + H DLK ENI+L  K      IK+ DFG++                G+P +VAPE++
Sbjct: 127 KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIA---HKIEAGNEFKNIFGTPEFVAPEIV 183
Query: 189 ANRGYDGATSDIWSCGVILYI-------FRGDFKLPKWLSPGAQN--------------- 226
            N    G  +D+WS GVI YI       F G+ K     +  A N               
Sbjct: 184 -NYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFSNTSELA 242
Query: 227 --LLRKILEPNPVKRITIAGIKADEW 250
              +R++L  +P +R+TIA      W
Sbjct: 243 KDFIRRLLVKDPKRRMTIAQSLEHSW 268

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score =  140 bits (353), Expect = 2e-33,   Method: Compositional matrix adjust.
 Identities = 91/294 (30%), Positives = 144/294 (48%), Gaps = 42/294 (14%)
Query: 6   KKQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITD------ 59
           +K+EG     Y   R LG G +G+V   ++ +     A+K+++K++    + +D      
Sbjct: 28  RKKEGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIE 87
Query: 60  ----QIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAE 115
               +I  EI+ LK L HPN+++L +V   K   Y+V E+  GGELF++I ++ +  E +
Sbjct: 88  KFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECD 147
Query: 116 GRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKG---NIKISDFGLSALPQHFRDDGL 172
              + +Q++ G+ Y H   + HRD+K ENILL++K    NIKI DFGLS+    F  D  
Sbjct: 148 AANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSF---FSKDYK 204
Query: 173 LHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYI----------------------- 209
           L    G+  Y+APEVL  +       D+WSCGVI+YI                       
Sbjct: 205 LRDRLGTAYYIAPEVLKKKY--NEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKG 262
Query: 210 -FRGDFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPANPDD 262
            +  DF   K +S  A+ L++ +L  +  KR T        W ++     N  D
Sbjct: 263 KYYFDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKYANNINKSD 316

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score =  139 bits (351), Expect = 2e-33,   Method: Compositional matrix adjust.
 Identities = 93/267 (34%), Positives = 143/267 (53%), Gaps = 37/267 (13%)
Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEK--NRIIHLKIT-DQIKREIATLKLLK 72
           Y++G  LG G F  VK  ++  +GL +A K ++K  +R     ++ ++I+RE++ L+ + 
Sbjct: 14  YDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVL 73
Query: 73  HPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHN 132
           H NV+ LH+V  +++ + ++LE V+GGELFD +A K  L E E     +Q++DGV+Y H 
Sbjct: 74  HHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHT 133
Query: 133 KGVFHRDLKLENILLDSKG----NIKISDFGLSALPQHFRDDGL-LHTTCGSPNYVAPEV 187
           K + H DLK ENI+L  K     +IK+ DFGL+    H  +DG+      G+P +VAPE+
Sbjct: 134 KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA----HEIEDGVEFKNIFGTPEFVAPEI 189
Query: 188 LANRGYDGATSDIWSCGVILYI-------FRGDFK-----------------LPKWLSPG 223
           + N    G  +D+WS GVI YI       F GD K                      S  
Sbjct: 190 V-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFFSQTSEL 248
Query: 224 AQNLLRKILEPNPVKRITIAGIKADEW 250
           A++ +RK+L     KR+TI       W
Sbjct: 249 AKDFIRKLLVKETRKRLTIQEALRHPW 275

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score =  139 bits (351), Expect = 2e-33,   Method: Compositional matrix adjust.
 Identities = 93/267 (34%), Positives = 143/267 (53%), Gaps = 37/267 (13%)
Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEK--NRIIHLKIT-DQIKREIATLKLLK 72
           Y++G  LG G F  VK  ++  +GL +A K ++K  +R     ++ ++I+RE++ L+ + 
Sbjct: 14  YDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVL 73
Query: 73  HPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHN 132
           H NV+ LH+V  +++ + ++LE V+GGELFD +A K  L E E     +Q++DGV+Y H 
Sbjct: 74  HHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHT 133
Query: 133 KGVFHRDLKLENILLDSKG----NIKISDFGLSALPQHFRDDGL-LHTTCGSPNYVAPEV 187
           K + H DLK ENI+L  K     +IK+ DFGL+    H  +DG+      G+P +VAPE+
Sbjct: 134 KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA----HEIEDGVEFKNIFGTPEFVAPEI 189
Query: 188 LANRGYDGATSDIWSCGVILYI-------FRGDFK-----------------LPKWLSPG 223
           + N    G  +D+WS GVI YI       F GD K                      S  
Sbjct: 190 V-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFFSHTSEL 248
Query: 224 AQNLLRKILEPNPVKRITIAGIKADEW 250
           A++ +RK+L     KR+TI       W
Sbjct: 249 AKDFIRKLLVKETRKRLTIQEALRHPW 275

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score =  139 bits (351), Expect = 2e-33,   Method: Compositional matrix adjust.
 Identities = 93/267 (34%), Positives = 143/267 (53%), Gaps = 37/267 (13%)
Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEK--NRIIHLKIT-DQIKREIATLKLLK 72
           Y++G  LG G F  VK  ++  +GL +A K ++K  +R     ++ ++I+RE++ L+ + 
Sbjct: 14  YDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVL 73
Query: 73  HPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHN 132
           H NV+ LH+V  +++ + ++LE V+GGELFD +A K  L E E     +Q++DGV+Y H 
Sbjct: 74  HHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHT 133
Query: 133 KGVFHRDLKLENILLDSKG----NIKISDFGLSALPQHFRDDGL-LHTTCGSPNYVAPEV 187
           K + H DLK ENI+L  K     +IK+ DFGL+    H  +DG+      G+P +VAPE+
Sbjct: 134 KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA----HEIEDGVEFKNIFGTPEFVAPEI 189
Query: 188 LANRGYDGATSDIWSCGVILYI-------FRGDFK-----------------LPKWLSPG 223
           + N    G  +D+WS GVI YI       F GD K                      S  
Sbjct: 190 V-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFFSHTSEL 248
Query: 224 AQNLLRKILEPNPVKRITIAGIKADEW 250
           A++ +RK+L     KR+TI       W
Sbjct: 249 AKDFIRKLLVKETRKRLTIQEALRHPW 275

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score =  139 bits (351), Expect = 2e-33,   Method: Compositional matrix adjust.
 Identities = 93/267 (34%), Positives = 143/267 (53%), Gaps = 37/267 (13%)
Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEK--NRIIHLKIT-DQIKREIATLKLLK 72
           Y++G  LG G F  VK  ++  +GL +A K ++K  +R     ++ ++I+RE++ L+ + 
Sbjct: 14  YDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVL 73
Query: 73  HPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHN 132
           H NV+ LH+V  +++ + ++LE V+GGELFD +A K  L E E     +Q++DGV+Y H 
Sbjct: 74  HHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHT 133
Query: 133 KGVFHRDLKLENILLDSKG----NIKISDFGLSALPQHFRDDGL-LHTTCGSPNYVAPEV 187
           K + H DLK ENI+L  K     +IK+ DFGL+    H  +DG+      G+P +VAPE+
Sbjct: 134 KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA----HEIEDGVEFKNIFGTPEFVAPEI 189
Query: 188 LANRGYDGATSDIWSCGVILYI-------FRGDFK-----------------LPKWLSPG 223
           + N    G  +D+WS GVI YI       F GD K                      S  
Sbjct: 190 V-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFFSQTSEL 248
Query: 224 AQNLLRKILEPNPVKRITIAGIKADEW 250
           A++ +RK+L     KR+TI       W
Sbjct: 249 AKDFIRKLLVKETRKRLTIQEALRHPW 275

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score =  139 bits (350), Expect = 3e-33,   Method: Compositional matrix adjust.
 Identities = 93/267 (34%), Positives = 143/267 (53%), Gaps = 37/267 (13%)
Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEK--NRIIHLKIT-DQIKREIATLKLLK 72
           Y++G  LG G F  VK  ++  +GL +A K ++K  +R     ++ ++I+RE++ L+ + 
Sbjct: 14  YDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVL 73
Query: 73  HPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHN 132
           H NV+ LH+V  +++ + ++LE V+GGELFD +A K  L E E     +Q++DGV+Y H 
Sbjct: 74  HHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHT 133
Query: 133 KGVFHRDLKLENILLDSKG----NIKISDFGLSALPQHFRDDGL-LHTTCGSPNYVAPEV 187
           K + H DLK ENI+L  K     +IK+ DFGL+    H  +DG+      G+P +VAPE+
Sbjct: 134 KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA----HEIEDGVEFKNIFGTPEFVAPEI 189
Query: 188 LANRGYDGATSDIWSCGVILYI-------FRGDFK-----------------LPKWLSPG 223
           + N    G  +D+WS GVI YI       F GD K                      S  
Sbjct: 190 V-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFFSHTSEL 248
Query: 224 AQNLLRKILEPNPVKRITIAGIKADEW 250
           A++ +RK+L     KR+TI       W
Sbjct: 249 AKDFIRKLLVKETRKRLTIQEALRHPW 275

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score =  139 bits (349), Expect = 4e-33,   Method: Compositional matrix adjust.
 Identities = 86/266 (32%), Positives = 137/266 (51%), Gaps = 35/266 (13%)
Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLK---ITDQIKREIATLKLLK 72
           YE+G  LG G F  V+  +   +G  +A K ++K R+   +     ++I+RE+  L+ ++
Sbjct: 28  YEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLXSSRRGVSREEIEREVNILREIR 87
Query: 73  HPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHN 132
           HPN++ LH++  +K+ + ++LE V+GGELFD +A K  L E E  +  +Q++DGV Y H+
Sbjct: 88  HPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHS 147
Query: 133 KGVFHRDLKLENILLDSKG----NIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVL 188
           K + H DLK ENI+L  K      IK+ DFG++                G+P +VAPE++
Sbjct: 148 KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIA---HKIEAGNEFKNIFGTPEFVAPEIV 204
Query: 189 ANRGYDGATSDIWSCGVILYI-------FRGDFKLPKWLSPGAQN--------------- 226
            N    G  +D+WS GVI YI       F G+ K     +  A N               
Sbjct: 205 -NYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFSNTSELA 263
Query: 227 --LLRKILEPNPVKRITIAGIKADEW 250
              +R++L  +P +R+ IA      W
Sbjct: 264 KDFIRRLLVKDPKRRMXIAQSLEHSW 289

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score =  139 bits (349), Expect = 4e-33,   Method: Compositional matrix adjust.
 Identities = 85/256 (33%), Positives = 139/256 (54%), Gaps = 27/256 (10%)
Query: 9   EGMRLGRYELGRTLGEGNFGKV---KFAQDLDSGLPFAVKILEKNRII-HLKITDQIKRE 64
           E +R   +EL R LG+G +GKV   +     ++G  FA+K+L+K  I+ + K T   K E
Sbjct: 12  EKIRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAE 71
Query: 65  IATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLI 124
              L+ +KHP +V L     +  K+Y++LEY++GGELF ++  +G   E        ++ 
Sbjct: 72  RNILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEIS 131
Query: 125 DGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVA 184
             + + H KG+ +RDLK ENI+L+ +G++K++DFGL     H  D  + H  CG+  Y+A
Sbjct: 132 MALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIH--DGTVTHXFCGTIEYMA 189
Query: 185 PEVLANRGYDGATSDIWSCGVILY--------------------IFRGDFKLPKWLSPGA 224
           PE+L   G++ A  D WS G ++Y                    I +    LP +L+  A
Sbjct: 190 PEILMRSGHNRAV-DWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLPPYLTQEA 248
Query: 225 QNLLRKILEPNPVKRI 240
           ++LL+K+L+ N   R+
Sbjct: 249 RDLLKKLLKRNAASRL 264

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score =  138 bits (348), Expect = 4e-33,   Method: Compositional matrix adjust.
 Identities = 97/267 (36%), Positives = 139/267 (52%), Gaps = 37/267 (13%)
Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLK---ITDQIKREIATLKLLK 72
           Y+ G  LG G F  VK  ++  +GL +A K ++K R    +     + I+RE++ LK ++
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 73  HPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHN 132
           HPNV+ LHEV  +K+ + ++ E V GGELFD +A K  L E E  +  +Q+++GV Y H+
Sbjct: 73  HPNVITLHEVYENKTDVILIGELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHS 132
Query: 133 KGVFHRDLKLENI-LLDS---KGNIKISDFGLSALPQHFRDDG-LLHTTCGSPNYVAPEV 187
             + H DLK ENI LLD    K  IKI DFGL+    H  D G       G+P +VAPE+
Sbjct: 133 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA----HKIDFGNEFKNIFGTPEFVAPEI 188
Query: 188 LANRGYDGATSDIWSCGVILYI-------FRGDFKLPKW-----------------LSPG 223
           + N    G  +D+WS GVI YI       F GD K                      S  
Sbjct: 189 V-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSAL 247
Query: 224 AQNLLRKILEPNPVKRITIAGIKADEW 250
           A++ +R++L  +P KR+TI       W
Sbjct: 248 AKDFIRRLLVKDPKKRMTIQDSLQHPW 274

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score =  138 bits (348), Expect = 6e-33,   Method: Compositional matrix adjust.
 Identities = 86/266 (32%), Positives = 137/266 (51%), Gaps = 35/266 (13%)
Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLK---ITDQIKREIATLKLLK 72
           YE+G  LG G F  V+  +   +G  +A K ++K R+   +     ++I+RE+  L+ ++
Sbjct: 14  YEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIR 73
Query: 73  HPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHN 132
           HPN++ LH++  +K+ + ++LE V+GGELFD +A K  L E E  +  +Q++DGV Y H+
Sbjct: 74  HPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHS 133
Query: 133 KGVFHRDLKLENILLDSKG----NIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVL 188
           K + H DLK ENI+L  K      IK+ DFG++                G+P +VAPE++
Sbjct: 134 KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIA---HKIEAGNEFKNIFGTPEFVAPEIV 190
Query: 189 ANRGYDGATSDIWSCGVILYI-------FRGDFKLPKWLSPGAQN--------------- 226
            N    G  +D+WS GVI YI       F G+ K     +  A N               
Sbjct: 191 -NYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFSNTSELA 249
Query: 227 --LLRKILEPNPVKRITIAGIKADEW 250
              +R++L  +P +R+ IA      W
Sbjct: 250 KDFIRRLLVKDPKRRMXIAQSLEHSW 275

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score =  138 bits (347), Expect = 6e-33,   Method: Compositional matrix adjust.
 Identities = 83/257 (32%), Positives = 130/257 (50%), Gaps = 23/257 (8%)
Query: 22  LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHE 81
           LG+G F K     D D+   FA KI+ K+ ++     +++  EI+  + L H +VV  H 
Sbjct: 29  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 88
Query: 82  VLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLK 141
                  +++VLE      L +    +  L E E R   +Q++ G  Y H   V HRDLK
Sbjct: 89  FFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLK 148
Query: 142 LENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIW 201
           L N+ L+    +KI DFGL+   ++  D     T CG+PNY+APEVL+ +G+     D+W
Sbjct: 149 LGNLFLNEDLEVKIGDFGLATKVEY--DGERKKTLCGTPNYIAPEVLSKKGHSFEV-DVW 205
Query: 202 SCGVILY--------------------IFRGDFKLPKWLSPGAQNLLRKILEPNPVKRIT 241
           S G I+Y                    I + ++ +PK ++P A +L++K+L+ +P  R T
Sbjct: 206 SIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQKMLQTDPTARPT 265
Query: 242 IAGIKADEWFEQDYTPA 258
           I  +  DE+F   Y PA
Sbjct: 266 INELLNDEFFTSGYIPA 282

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score =  138 bits (347), Expect = 7e-33,   Method: Compositional matrix adjust.
 Identities = 83/257 (32%), Positives = 130/257 (50%), Gaps = 23/257 (8%)
Query: 22  LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHE 81
           LG+G F K     D D+   FA KI+ K+ ++     +++  EI+  + L H +VV  H 
Sbjct: 25  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 84
Query: 82  VLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLK 141
                  +++VLE      L +    +  L E E R   +Q++ G  Y H   V HRDLK
Sbjct: 85  FFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLK 144
Query: 142 LENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIW 201
           L N+ L+    +KI DFGL+   ++  D     T CG+PNY+APEVL+ +G+     D+W
Sbjct: 145 LGNLFLNEDLEVKIGDFGLATKVEY--DGERKKTLCGTPNYIAPEVLSKKGHSFEV-DVW 201
Query: 202 SCGVILY--------------------IFRGDFKLPKWLSPGAQNLLRKILEPNPVKRIT 241
           S G I+Y                    I + ++ +PK ++P A +L++K+L+ +P  R T
Sbjct: 202 SIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQKMLQTDPTARPT 261
Query: 242 IAGIKADEWFEQDYTPA 258
           I  +  DE+F   Y PA
Sbjct: 262 INELLNDEFFTSGYIPA 278

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score =  138 bits (347), Expect = 7e-33,   Method: Compositional matrix adjust.
 Identities = 83/257 (32%), Positives = 130/257 (50%), Gaps = 23/257 (8%)
Query: 22  LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHE 81
           LG+G F K     D D+   FA KI+ K+ ++     +++  EI+  + L H +VV  H 
Sbjct: 25  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 84
Query: 82  VLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLK 141
                  +++VLE      L +    +  L E E R   +Q++ G  Y H   V HRDLK
Sbjct: 85  FFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLK 144
Query: 142 LENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIW 201
           L N+ L+    +KI DFGL+   ++  D     T CG+PNY+APEVL+ +G+     D+W
Sbjct: 145 LGNLFLNEDLEVKIGDFGLATKVEY--DGERKKTLCGTPNYIAPEVLSKKGHSFEV-DVW 201
Query: 202 SCGVILY--------------------IFRGDFKLPKWLSPGAQNLLRKILEPNPVKRIT 241
           S G I+Y                    I + ++ +PK ++P A +L++K+L+ +P  R T
Sbjct: 202 SIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQKMLQTDPTARPT 261
Query: 242 IAGIKADEWFEQDYTPA 258
           I  +  DE+F   Y PA
Sbjct: 262 INELLNDEFFTSGYIPA 278

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score =  138 bits (347), Expect = 7e-33,   Method: Compositional matrix adjust.
 Identities = 81/252 (32%), Positives = 130/252 (51%), Gaps = 26/252 (10%)
Query: 12  RLG--RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLK 69
           RLG   +E  R LG+G+FGKV  A+  ++G  +AVK+L+K+ I+     +    E   L 
Sbjct: 19  RLGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILS 78
Query: 70  LLK-HPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVS 128
           L + HP + +L     +  +++ V+E+V GG+L   I    R  EA  R    ++I  + 
Sbjct: 79  LARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALM 138
Query: 129 YCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVL 188
           + H+KG+ +RDLKL+N+LLD +G+ K++DFG+    +   +     T CG+P+Y+APE+L
Sbjct: 139 FLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCK--EGICNGVTTATFCGTPDYIAPEIL 196
Query: 189 ANRGYDGATSDIWSCGVILY--------------------IFRGDFKLPKWLSPGAQNLL 228
               Y G   D W+ GV+LY                    I   +   P WL   A  +L
Sbjct: 197 QEMLY-GPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTWLHEDATGIL 255
Query: 229 RKILEPNPVKRI 240
           +  +  NP  R+
Sbjct: 256 KSFMTKNPTMRL 267

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score =  137 bits (345), Expect = 1e-32,   Method: Compositional matrix adjust.
 Identities = 80/251 (31%), Positives = 134/251 (53%), Gaps = 24/251 (9%)
Query: 11  MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKL 70
           ++L  +     LG+G+FGKV  A    +   +A+KIL+K+ +I     +    E   L L
Sbjct: 16  VKLTDFNFLMVLGKGSFGKVMLADRKGTEELYAIKILKKDVVIQDDDVECTMVEKRVLAL 75
Query: 71  L-KHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSY 129
           L K P + +LH    +  ++Y V+EYV GG+L   I   G+ +E +      ++  G+ +
Sbjct: 76  LDKPPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISIGLFF 135
Query: 130 CHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLA 189
            H +G+ +RDLKL+N++LDS+G+IKI+DFG+    +H  D       CG+P+Y+APE++A
Sbjct: 136 LHKRGIIYRDLKLDNVMLDSEGHIKIADFGMCK--EHMMDGVTTREFCGTPDYIAPEIIA 193
Query: 190 NRGYDGATSDIWSCGVILY--------------------IFRGDFKLPKWLSPGAQNLLR 229
            + Y G + D W+ GV+LY                    I   +   PK LS  A ++ +
Sbjct: 194 YQPY-GKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKSLSKEAVSICK 252
Query: 230 KILEPNPVKRI 240
            ++  +P KR+
Sbjct: 253 GLMTKHPAKRL 263

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score =  137 bits (345), Expect = 1e-32,   Method: Compositional matrix adjust.
 Identities = 78/245 (31%), Positives = 126/245 (51%), Gaps = 23/245 (9%)
Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
           ++  + LG+G FGKV   ++  +G  +A+KIL K  II          E   L+  +HP 
Sbjct: 7   FDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPF 66
Query: 76  VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGV 135
           +  L     +  ++  V+EY  GGELF  ++ +    E   R    +++  + Y H++ V
Sbjct: 67  LTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDV 126
Query: 136 FHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDG 195
            +RD+KLEN++LD  G+IKI+DFGL    +   D   + T CG+P Y+APEVL +  Y G
Sbjct: 127 VYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKTFCGTPEYLAPEVLEDNDY-G 183
Query: 196 ATSDIWSCGVILY--------------------IFRGDFKLPKWLSPGAQNLLRKILEPN 235
              D W  GV++Y                    I   + + P+ LSP A++LL  +L+ +
Sbjct: 184 RAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLLKKD 243
Query: 236 PVKRI 240
           P +R+
Sbjct: 244 PKQRL 248

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score =  137 bits (345), Expect = 1e-32,   Method: Compositional matrix adjust.
 Identities = 78/241 (32%), Positives = 124/241 (51%), Gaps = 23/241 (9%)
Query: 20  RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRL 79
           + LG+G FGKV   ++  +G  +A+KIL K  II          E   L+  +HP +  L
Sbjct: 14  KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 73
Query: 80  HEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRD 139
                +  ++  V+EY  GGELF  ++ +    E   R    +++  + Y H++ V +RD
Sbjct: 74  KYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRD 133
Query: 140 LKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSD 199
           +KLEN++LD  G+IKI+DFGL    +   D   + T CG+P Y+APEVL +  Y G   D
Sbjct: 134 IKLENLMLDKDGHIKITDFGLCK--EGISDGATMKTFCGTPEYLAPEVLEDNDY-GRAVD 190
Query: 200 IWSCGVILY--------------------IFRGDFKLPKWLSPGAQNLLRKILEPNPVKR 239
            W  GV++Y                    I   + + P+ LSP A++LL  +L+ +P +R
Sbjct: 191 WWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLLKKDPKQR 250
Query: 240 I 240
           +
Sbjct: 251 L 251

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score =  137 bits (344), Expect = 1e-32,   Method: Compositional matrix adjust.
 Identities = 78/241 (32%), Positives = 124/241 (51%), Gaps = 23/241 (9%)
Query: 20  RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRL 79
           + LG+G FGKV   ++  +G  +A+KIL K  II          E   L+  +HP +  L
Sbjct: 11  KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 70
Query: 80  HEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRD 139
                +  ++  V+EY  GGELF  ++ +    E   R    +++  + Y H++ V +RD
Sbjct: 71  KYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRD 130
Query: 140 LKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSD 199
           +KLEN++LD  G+IKI+DFGL    +   D   + T CG+P Y+APEVL +  Y G   D
Sbjct: 131 IKLENLMLDKDGHIKITDFGLCK--EGISDGATMKTFCGTPEYLAPEVLEDNDY-GRAVD 187
Query: 200 IWSCGVILY--------------------IFRGDFKLPKWLSPGAQNLLRKILEPNPVKR 239
            W  GV++Y                    I   + + P+ LSP A++LL  +L+ +P +R
Sbjct: 188 WWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLLKKDPKQR 247
Query: 240 I 240
           +
Sbjct: 248 L 248

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score =  136 bits (343), Expect = 2e-32,   Method: Compositional matrix adjust.
 Identities = 82/257 (31%), Positives = 129/257 (50%), Gaps = 23/257 (8%)
Query: 22  LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHE 81
           LG+G F K     D D+   FA KI+ K+ ++     +++  EI+  + L H +VV  H 
Sbjct: 23  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 82
Query: 82  VLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLK 141
                  +++VLE      L +    +  L E E R   +Q++ G  Y H   V HRDLK
Sbjct: 83  FFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLK 142
Query: 142 LENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIW 201
           L N+ L+    +KI DFGL+   ++  D       CG+PNY+APEVL+ +G+     D+W
Sbjct: 143 LGNLFLNEDLEVKIGDFGLATKVEY--DGERKKVLCGTPNYIAPEVLSKKGHSFEV-DVW 199
Query: 202 SCGVILY--------------------IFRGDFKLPKWLSPGAQNLLRKILEPNPVKRIT 241
           S G I+Y                    I + ++ +PK ++P A +L++K+L+ +P  R T
Sbjct: 200 SIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQKMLQTDPTARPT 259
Query: 242 IAGIKADEWFEQDYTPA 258
           I  +  DE+F   Y PA
Sbjct: 260 INELLNDEFFTSGYIPA 276

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score =  136 bits (342), Expect = 2e-32,   Method: Compositional matrix adjust.
 Identities = 82/257 (31%), Positives = 129/257 (50%), Gaps = 23/257 (8%)
Query: 22  LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHE 81
           LG+G F K     D D+   FA KI+ K+ ++     +++  EI+  + L H +VV  H 
Sbjct: 49  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 108
Query: 82  VLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLK 141
                  +++VLE      L +    +  L E E R   +Q++ G  Y H   V HRDLK
Sbjct: 109 FFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLK 168
Query: 142 LENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIW 201
           L N+ L+    +KI DFGL+   ++  D       CG+PNY+APEVL+ +G+     D+W
Sbjct: 169 LGNLFLNEDLEVKIGDFGLATKVEY--DGERKKVLCGTPNYIAPEVLSKKGHSFEV-DVW 225
Query: 202 SCGVILY--------------------IFRGDFKLPKWLSPGAQNLLRKILEPNPVKRIT 241
           S G I+Y                    I + ++ +PK ++P A +L++K+L+ +P  R T
Sbjct: 226 SIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQKMLQTDPTARPT 285
Query: 242 IAGIKADEWFEQDYTPA 258
           I  +  DE+F   Y PA
Sbjct: 286 INELLNDEFFTSGYIPA 302

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score =  136 bits (342), Expect = 2e-32,   Method: Compositional matrix adjust.
 Identities = 82/257 (31%), Positives = 129/257 (50%), Gaps = 23/257 (8%)
Query: 22  LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHE 81
           LG+G F K     D D+   FA KI+ K+ ++     +++  EI+  + L H +VV  H 
Sbjct: 47  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 106
Query: 82  VLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLK 141
                  +++VLE      L +    +  L E E R   +Q++ G  Y H   V HRDLK
Sbjct: 107 FFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLK 166
Query: 142 LENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIW 201
           L N+ L+    +KI DFGL+   ++  D       CG+PNY+APEVL+ +G+     D+W
Sbjct: 167 LGNLFLNEDLEVKIGDFGLATKVEY--DGERKKVLCGTPNYIAPEVLSKKGHSFEV-DVW 223
Query: 202 SCGVILY--------------------IFRGDFKLPKWLSPGAQNLLRKILEPNPVKRIT 241
           S G I+Y                    I + ++ +PK ++P A +L++K+L+ +P  R T
Sbjct: 224 SIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQKMLQTDPTARPT 283
Query: 242 IAGIKADEWFEQDYTPA 258
           I  +  DE+F   Y PA
Sbjct: 284 INELLNDEFFTSGYIPA 300

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score =  135 bits (341), Expect = 3e-32,   Method: Compositional matrix adjust.
 Identities = 73/266 (27%), Positives = 139/266 (52%), Gaps = 31/266 (11%)
Query: 13  LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK 72
           L  +++ RTLG G+FG+V   +   +G  +A+K+L+K  ++ LK  +    E   L ++ 
Sbjct: 5   LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVT 64
Query: 73  HPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHN 132
           HP ++R+        +I+M+++Y+ GGELF  +    R      +    ++   + Y H+
Sbjct: 65  HPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHS 124
Query: 133 KGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRG 192
           K + +RDLK ENILLD  G+IKI+DFG +   ++  D  + +  CG+P+Y+APEV++ + 
Sbjct: 125 KDIIYRDLKPENILLDKNGHIKITDFGFA---KYVPD--VTYXLCGTPDYIAPEVVSTKP 179
Query: 193 YDGATSDIWSCGVILY--------------------IFRGDFKLPKWLSPGAQNLLRKIL 232
           Y+ +  D WS G+++Y                    I   + + P + +   ++LL +++
Sbjct: 180 YNKSI-DWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNEDVKDLLSRLI 238
Query: 233 EPNPVKRI-----TIAGIKADEWFEQ 253
             +  +R+         +K   WF++
Sbjct: 239 TRDLSQRLGNLQNGTEDVKNHPWFKE 264

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score =  135 bits (340), Expect = 4e-32,   Method: Compositional matrix adjust.
 Identities = 102/315 (32%), Positives = 151/315 (47%), Gaps = 55/315 (17%)
Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNR--IIHLKITD---QIKREIATLKL 70
           Y + +TLG G  G+VK A +  +    A+KI+ K +  I   +  D    ++ EI  LK 
Sbjct: 12  YIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKK 71
Query: 71  LKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYC 130
           L HP ++++     ++   Y+VLE + GGELFDK+    RL+EA  +  F Q++  V Y 
Sbjct: 72  LNHPCIIKIKNFFDAED-YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYL 130
Query: 131 HNKGVFHRDLKLENILLDSKGN---IKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEV 187
           H  G+ HRDLK EN+LL S+     IKI+DFG S +     +  L+ T CG+P Y+APEV
Sbjct: 131 HENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI---LGETSLMRTLCGTPTYLAPEV 187
Query: 188 LANRGYDGATS--DIWSCGVILYI----------FRGDFKLPKWLSPGAQN--------- 226
           L + G  G     D WS GVIL+I           R    L   ++ G  N         
Sbjct: 188 LVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEV 247
Query: 227 ------LLRKILEPNPVKRITIAGIKADEWFEQDYTPANPDDDEEDIFVD-----NEAFS 275
                 L++K+L  +P  R T        W +        D+D +  F D     NE+ +
Sbjct: 248 SEKALDLVKKLLVVDPKARFTTEEALRHPWLQ--------DEDMKRKFQDLLSEENESTA 299
Query: 276 MHEV---PSDGGRTP 287
           + +V   PS   + P
Sbjct: 300 LPQVLAQPSTSRKRP 314

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score =  135 bits (340), Expect = 4e-32,   Method: Compositional matrix adjust.
 Identities = 81/204 (39%), Positives = 116/204 (56%), Gaps = 14/204 (6%)
Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNR--IIHLKITD---QIKREIATLKL 70
           Y + +TLG G  G+VK A +  +    A+KI+ K +  I   +  D    ++ EI  LK 
Sbjct: 12  YIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKK 71
Query: 71  LKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYC 130
           L HP ++++     ++   Y+VLE + GGELFDK+    RL+EA  +  F Q++  V Y 
Sbjct: 72  LNHPCIIKIKNFFDAED-YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYL 130
Query: 131 HNKGVFHRDLKLENILLDSKGN---IKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEV 187
           H  G+ HRDLK EN+LL S+     IKI+DFG S +     +  L+ T CG+P Y+APEV
Sbjct: 131 HENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI---LGETSLMRTLCGTPTYLAPEV 187
Query: 188 LANRGYDGATS--DIWSCGVILYI 209
           L + G  G     D WS GVIL+I
Sbjct: 188 LVSVGTAGYNRAVDCWSLGVILFI 211

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score =  135 bits (340), Expect = 4e-32,   Method: Compositional matrix adjust.
 Identities = 102/315 (32%), Positives = 151/315 (47%), Gaps = 55/315 (17%)
Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNR--IIHLKITD---QIKREIATLKL 70
           Y + +TLG G  G+VK A +  +    A+KI+ K +  I   +  D    ++ EI  LK 
Sbjct: 11  YIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKK 70
Query: 71  LKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYC 130
           L HP ++++     ++   Y+VLE + GGELFDK+    RL+EA  +  F Q++  V Y 
Sbjct: 71  LNHPCIIKIKNFFDAED-YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYL 129
Query: 131 HNKGVFHRDLKLENILLDSKGN---IKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEV 187
           H  G+ HRDLK EN+LL S+     IKI+DFG S +     +  L+ T CG+P Y+APEV
Sbjct: 130 HENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI---LGETSLMRTLCGTPTYLAPEV 186
Query: 188 LANRGYDGATS--DIWSCGVILYI----------FRGDFKLPKWLSPGAQN--------- 226
           L + G  G     D WS GVIL+I           R    L   ++ G  N         
Sbjct: 187 LVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEV 246
Query: 227 ------LLRKILEPNPVKRITIAGIKADEWFEQDYTPANPDDDEEDIFVD-----NEAFS 275
                 L++K+L  +P  R T        W +        D+D +  F D     NE+ +
Sbjct: 247 SEKALDLVKKLLVVDPKARFTTEEALRHPWLQ--------DEDMKRKFQDLLSEENESTA 298
Query: 276 MHEV---PSDGGRTP 287
           + +V   PS   + P
Sbjct: 299 LPQVLAQPSTSRKRP 313

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score =  135 bits (340), Expect = 4e-32,   Method: Compositional matrix adjust.
 Identities = 77/248 (31%), Positives = 126/248 (50%), Gaps = 23/248 (9%)
Query: 13  LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK 72
           +  ++  + LG+G FGKV   ++  +G  +A+KIL K  II          E   L+  +
Sbjct: 9   MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTR 68
Query: 73  HPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHN 132
           HP +  L     +  ++  V+EY  GGELF  ++ +    E   R    +++  + Y H+
Sbjct: 69  HPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHS 128
Query: 133 KGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRG 192
           + V +RD+KLEN++LD  G+IKI+DFGL    +   D   +   CG+P Y+APEVL +  
Sbjct: 129 RDVVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKXFCGTPEYLAPEVLEDND 186
Query: 193 YDGATSDIWSCGVILY--------------------IFRGDFKLPKWLSPGAQNLLRKIL 232
           Y G   D W  GV++Y                    I   + + P+ LSP A++LL  +L
Sbjct: 187 Y-GRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLL 245
Query: 233 EPNPVKRI 240
           + +P +R+
Sbjct: 246 KKDPKQRL 253

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score =  135 bits (340), Expect = 5e-32,   Method: Compositional matrix adjust.
 Identities = 102/315 (32%), Positives = 151/315 (47%), Gaps = 55/315 (17%)
Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNR--IIHLKITD---QIKREIATLKL 70
           Y + +TLG G  G+VK A +  +    A+KI+ K +  I   +  D    ++ EI  LK 
Sbjct: 12  YIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKK 71
Query: 71  LKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYC 130
           L HP ++++     ++   Y+VLE + GGELFDK+    RL+EA  +  F Q++  V Y 
Sbjct: 72  LNHPCIIKIKNFFDAED-YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYL 130
Query: 131 HNKGVFHRDLKLENILLDSKGN---IKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEV 187
           H  G+ HRDLK EN+LL S+     IKI+DFG S +     +  L+ T CG+P Y+APEV
Sbjct: 131 HENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI---LGETSLMRTLCGTPTYLAPEV 187
Query: 188 LANRGYDGATS--DIWSCGVILYI----------FRGDFKLPKWLSPGAQN--------- 226
           L + G  G     D WS GVIL+I           R    L   ++ G  N         
Sbjct: 188 LVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEV 247
Query: 227 ------LLRKILEPNPVKRITIAGIKADEWFEQDYTPANPDDDEEDIFVD-----NEAFS 275
                 L++K+L  +P  R T        W +        D+D +  F D     NE+ +
Sbjct: 248 SEKALDLVKKLLVVDPKARFTTEEALRHPWLQ--------DEDMKRKFQDLLSEENESTA 299
Query: 276 MHEV---PSDGGRTP 287
           + +V   PS   + P
Sbjct: 300 LPQVLAQPSTSRKRP 314

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score =  135 bits (339), Expect = 5e-32,   Method: Compositional matrix adjust.
 Identities = 102/315 (32%), Positives = 151/315 (47%), Gaps = 55/315 (17%)
Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNR--IIHLKITD---QIKREIATLKL 70
           Y + +TLG G  G+VK A +  +    A+KI+ K +  I   +  D    ++ EI  LK 
Sbjct: 18  YIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKK 77
Query: 71  LKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYC 130
           L HP ++++     ++   Y+VLE + GGELFDK+    RL+EA  +  F Q++  V Y 
Sbjct: 78  LNHPCIIKIKNFFDAED-YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYL 136
Query: 131 HNKGVFHRDLKLENILLDSKGN---IKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEV 187
           H  G+ HRDLK EN+LL S+     IKI+DFG S +     +  L+ T CG+P Y+APEV
Sbjct: 137 HENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI---LGETSLMRTLCGTPTYLAPEV 193
Query: 188 LANRGYDGATS--DIWSCGVILYI----------FRGDFKLPKWLSPGAQN--------- 226
           L + G  G     D WS GVIL+I           R    L   ++ G  N         
Sbjct: 194 LVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEV 253
Query: 227 ------LLRKILEPNPVKRITIAGIKADEWFEQDYTPANPDDDEEDIFVD-----NEAFS 275
                 L++K+L  +P  R T        W +        D+D +  F D     NE+ +
Sbjct: 254 SEKALDLVKKLLVVDPKARFTTEEALRHPWLQ--------DEDMKRKFQDLLSEENESTA 305
Query: 276 MHEV---PSDGGRTP 287
           + +V   PS   + P
Sbjct: 306 LPQVLAQPSTSRKRP 320

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score =  135 bits (339), Expect = 5e-32,   Method: Compositional matrix adjust.
 Identities = 77/241 (31%), Positives = 123/241 (51%), Gaps = 23/241 (9%)
Query: 20  RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRL 79
           + LG+G FGKV   ++  +G  +A+KIL K  II          E   L+  +HP +  L
Sbjct: 11  KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 70
Query: 80  HEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRD 139
                +  ++  V+EY  GGELF  ++ +    E   R    +++  + Y H++ V +RD
Sbjct: 71  KYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRD 130
Query: 140 LKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSD 199
           +KLEN++LD  G+IKI+DFGL    +   D   +   CG+P Y+APEVL +  Y G   D
Sbjct: 131 IKLENLMLDKDGHIKITDFGLCK--EGISDGATMKXFCGTPEYLAPEVLEDNDY-GRAVD 187
Query: 200 IWSCGVILY--------------------IFRGDFKLPKWLSPGAQNLLRKILEPNPVKR 239
            W  GV++Y                    I   + + P+ LSP A++LL  +L+ +P +R
Sbjct: 188 WWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLLKKDPKQR 247
Query: 240 I 240
           +
Sbjct: 248 L 248

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score =  135 bits (339), Expect = 5e-32,   Method: Compositional matrix adjust.
 Identities = 84/271 (30%), Positives = 143/271 (52%), Gaps = 37/271 (13%)
Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLK--ITDQIKREIATLKLLKH 73
           YEL   +G+G F  V+   + ++G  FAVKI++  +        T+ +KRE +   +LKH
Sbjct: 26  YELCEVIGKGAFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKH 85
Query: 74  PNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGR----LQEAEGRKLFQQLIDGVSY 129
           P++V L E  +S   +YMV E++ G +L  +I  +        EA      +Q+++ + Y
Sbjct: 86  PHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRY 145
Query: 130 CHNKGVFHRDLKLENILLDSKGN---IKISDFGLSALPQHFRDDGLLH-TTCGSPNYVAP 185
           CH+  + HRD+K EN+LL SK N   +K+ DFG++       + GL+     G+P+++AP
Sbjct: 146 CHDNNIIHRDVKPENVLLASKENSAPVKLGDFGVAI---QLGESGLVAGGRVGTPHFMAP 202
Query: 186 EVLANRGYDGATSDIWSCGVILYIF-------------------RGDFKLP--KW--LSP 222
           EV+    Y G   D+W CGVIL+I                    +G +K+   +W  +S 
Sbjct: 203 EVVKREPY-GKPVDVWGCGVILFILLSGCLPFYGTKERLFEGIIKGKYKMNPRQWSHISE 261
Query: 223 GAQNLLRKILEPNPVKRITIAGIKADEWFEQ 253
            A++L+R++L  +P +RIT+       W ++
Sbjct: 262 SAKDLVRRMLMLDPAERITVYEALNHPWLKE 292

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score =  135 bits (339), Expect = 6e-32,   Method: Compositional matrix adjust.
 Identities = 77/248 (31%), Positives = 126/248 (50%), Gaps = 23/248 (9%)
Query: 13  LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK 72
           +  ++  + LG+G FGKV   ++  +G  +A+KIL K  II          E   L+  +
Sbjct: 4   MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTR 63
Query: 73  HPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHN 132
           HP +  L     +  ++  V+EY  GGELF  ++ +    E   R    +++  + Y H+
Sbjct: 64  HPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHS 123
Query: 133 KGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRG 192
           + V +RD+KLEN++LD  G+IKI+DFGL    +   D   +   CG+P Y+APEVL +  
Sbjct: 124 RDVVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKXFCGTPEYLAPEVLEDND 181
Query: 193 YDGATSDIWSCGVILY--------------------IFRGDFKLPKWLSPGAQNLLRKIL 232
           Y G   D W  GV++Y                    I   + + P+ LSP A++LL  +L
Sbjct: 182 Y-GRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLL 240
Query: 233 EPNPVKRI 240
           + +P +R+
Sbjct: 241 KKDPKQRL 248

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score =  134 bits (338), Expect = 7e-32,   Method: Compositional matrix adjust.
 Identities = 77/245 (31%), Positives = 125/245 (51%), Gaps = 23/245 (9%)
Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
           ++  + LG+G FGKV   ++  +G  +A+KIL K  II          E   L+  +HP 
Sbjct: 7   FDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPF 66
Query: 76  VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGV 135
           +  L     +  ++  V+EY  GGELF  ++ +    E   R    +++  + Y H++ V
Sbjct: 67  LTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDV 126
Query: 136 FHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDG 195
            +RD+KLEN++LD  G+IKI+DFGL    +   D   +   CG+P Y+APEVL +  Y G
Sbjct: 127 VYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKXFCGTPEYLAPEVLEDNDY-G 183
Query: 196 ATSDIWSCGVILY--------------------IFRGDFKLPKWLSPGAQNLLRKILEPN 235
              D W  GV++Y                    I   + + P+ LSP A++LL  +L+ +
Sbjct: 184 RAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLLKKD 243
Query: 236 PVKRI 240
           P +R+
Sbjct: 244 PKQRL 248

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score =  134 bits (337), Expect = 9e-32,   Method: Compositional matrix adjust.
 Identities = 80/256 (31%), Positives = 131/256 (51%), Gaps = 24/256 (9%)
Query: 6   KKQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREI 65
           K +  + +  +E  + LG+G FGKV   ++  +G  +A+KIL+K  I+          E 
Sbjct: 140 KPKHRVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTEN 199
Query: 66  ATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLID 125
             L+  +HP +  L     +  ++  V+EY  GGELF  ++ +    E   R    +++ 
Sbjct: 200 RVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVS 259
Query: 126 GVSYCHN-KGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVA 184
            + Y H+ K V +RDLKLEN++LD  G+IKI+DFGL    +  +D   + T CG+P Y+A
Sbjct: 260 ALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCK--EGIKDGATMKTFCGTPEYLA 317
Query: 185 PEVLANRGYDGATSDIWSCGVILY--------------------IFRGDFKLPKWLSPGA 224
           PEVL +  Y G   D W  GV++Y                    I   + + P+ L P A
Sbjct: 318 PEVLEDNDY-GRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPEA 376
Query: 225 QNLLRKILEPNPVKRI 240
           ++LL  +L+ +P +R+
Sbjct: 377 KSLLSGLLKKDPKQRL 392

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score =  134 bits (337), Expect = 9e-32,   Method: Compositional matrix adjust.
 Identities = 88/264 (33%), Positives = 135/264 (51%), Gaps = 37/264 (14%)
Query: 20  RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRL 79
           R LG G FG V   ++  SGL   +K + K+R       +QI+ EI  LK L HPN++++
Sbjct: 28  RKLGSGAFGDVHLVEERSSGLERVIKTINKDR--SQVPMEQIEAEIEVLKSLDHPNIIKI 85
Query: 80  HEVLASKSKIYMVLEYVTGGELFDKIAS---KGR-LQEAEGRKLFQQLIDGVSYCHNKGV 135
            EV      +Y+V+E   GGEL ++I S   +G+ L E    +L +Q+++ ++Y H++ V
Sbjct: 86  FEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHV 145
Query: 136 FHRDLKLENILLDS---KGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRG 192
            H+DLK ENIL         IKI DFGL+ L   F+ D       G+  Y+APEV     
Sbjct: 146 VHKDLKPENILFQDTSPHSPIKIIDFGLAEL---FKSDEHSTNAAGTALYMAPEVFKRDV 202
Query: 193 YDGATSDIWSCGVILYIF-----------------RGDFKLPKW------LSPGAQNLLR 229
                 DIWS GV++Y                   +  +K P +      L+P A +LL+
Sbjct: 203 --TFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYAVECRPLTPQAVDLLK 260
Query: 230 KILEPNPVKRITIAGIKADEWFEQ 253
           ++L  +P +R + A +   EWF+Q
Sbjct: 261 QMLTKDPERRPSAAQVLHHEWFKQ 284

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score =  134 bits (337), Expect = 1e-31,   Method: Compositional matrix adjust.
 Identities = 80/256 (31%), Positives = 131/256 (51%), Gaps = 24/256 (9%)
Query: 6   KKQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREI 65
           K +  + +  +E  + LG+G FGKV   ++  +G  +A+KIL+K  I+          E 
Sbjct: 143 KPKHRVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTEN 202
Query: 66  ATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLID 125
             L+  +HP +  L     +  ++  V+EY  GGELF  ++ +    E   R    +++ 
Sbjct: 203 RVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVS 262
Query: 126 GVSYCHN-KGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVA 184
            + Y H+ K V +RDLKLEN++LD  G+IKI+DFGL    +  +D   + T CG+P Y+A
Sbjct: 263 ALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCK--EGIKDGATMKTFCGTPEYLA 320
Query: 185 PEVLANRGYDGATSDIWSCGVILY--------------------IFRGDFKLPKWLSPGA 224
           PEVL +  Y G   D W  GV++Y                    I   + + P+ L P A
Sbjct: 321 PEVLEDNDY-GRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPEA 379
Query: 225 QNLLRKILEPNPVKRI 240
           ++LL  +L+ +P +R+
Sbjct: 380 KSLLSGLLKKDPKQRL 395

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score =  134 bits (336), Expect = 1e-31,   Method: Compositional matrix adjust.
 Identities = 81/261 (31%), Positives = 141/261 (54%), Gaps = 30/261 (11%)
Query: 8   QEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIAT 67
           Q  +++  +EL + LG+G+FGKV  A+   +   FA+K L+K+ ++   + D ++  +  
Sbjct: 12  QIKLKIEDFELHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVL---MDDDVECTMVE 68
Query: 68  LKLL----KHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQL 123
            ++L    +HP +  +     +K  ++ V+EY+ GG+L   I S  +   +       ++
Sbjct: 69  KRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEI 128
Query: 124 IDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYV 183
           I G+ + H+KG+ +RDLKL+NILLD  G+IKI+DFG+    ++   D   +  CG+P+Y+
Sbjct: 129 ILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCK--ENMLGDAKTNEFCGTPDYI 186
Query: 184 APEVLANRGYDGATSDIWSCGVILY---IFRGDFK-----------------LPKWLSPG 223
           APE+L  + Y+ +  D WS GV+LY   I +  F                   P+WL   
Sbjct: 187 APEILLGQKYNHSV-DWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKE 245
Query: 224 AQNLLRKILEPNPVKRITIAG 244
           A++LL K+    P KR+ + G
Sbjct: 246 AKDLLVKLFVREPEKRLGVRG 266

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score =  133 bits (335), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 80/204 (39%), Positives = 116/204 (56%), Gaps = 14/204 (6%)
Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNR--IIHLKITD---QIKREIATLKL 70
           Y + +TLG G  G+VK A +  +    A++I+ K +  I   +  D    ++ EI  LK 
Sbjct: 151 YIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKK 210
Query: 71  LKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYC 130
           L HP ++++     ++   Y+VLE + GGELFDK+    RL+EA  +  F Q++  V Y 
Sbjct: 211 LNHPCIIKIKNFFDAED-YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYL 269
Query: 131 HNKGVFHRDLKLENILLDSKGN---IKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEV 187
           H  G+ HRDLK EN+LL S+     IKI+DFG S +     +  L+ T CG+P Y+APEV
Sbjct: 270 HENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI---LGETSLMRTLCGTPTYLAPEV 326
Query: 188 LANRGYDGATS--DIWSCGVILYI 209
           L + G  G     D WS GVIL+I
Sbjct: 327 LVSVGTAGYNRAVDCWSLGVILFI 350

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score =  133 bits (334), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 80/204 (39%), Positives = 116/204 (56%), Gaps = 14/204 (6%)
Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNR--IIHLKITD---QIKREIATLKL 70
           Y + +TLG G  G+VK A +  +    A++I+ K +  I   +  D    ++ EI  LK 
Sbjct: 137 YIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKK 196
Query: 71  LKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYC 130
           L HP ++++     ++   Y+VLE + GGELFDK+    RL+EA  +  F Q++  V Y 
Sbjct: 197 LNHPCIIKIKNFFDAED-YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYL 255
Query: 131 HNKGVFHRDLKLENILLDSKGN---IKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEV 187
           H  G+ HRDLK EN+LL S+     IKI+DFG S +     +  L+ T CG+P Y+APEV
Sbjct: 256 HENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI---LGETSLMRTLCGTPTYLAPEV 312
Query: 188 LANRGYDGATS--DIWSCGVILYI 209
           L + G  G     D WS GVIL+I
Sbjct: 313 LVSVGTAGYNRAVDCWSLGVILFI 336

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score =  132 bits (332), Expect = 4e-31,   Method: Compositional matrix adjust.
 Identities = 78/249 (31%), Positives = 127/249 (51%), Gaps = 24/249 (9%)
Query: 13  LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK 72
           +  +E  + LG+G FGKV   ++  +G  +A+KIL+K  I+          E   L+  +
Sbjct: 7   MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSR 66
Query: 73  HPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHN 132
           HP +  L     +  ++  V+EY  GGELF  ++ +    E   R    +++  + Y H+
Sbjct: 67  HPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHS 126
Query: 133 -KGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANR 191
            K V +RDLKLEN++LD  G+IKI+DFGL    +  +D   +   CG+P Y+APEVL + 
Sbjct: 127 EKNVVYRDLKLENLMLDKDGHIKITDFGLCK--EGIKDGATMKXFCGTPEYLAPEVLEDN 184
Query: 192 GYDGATSDIWSCGVILY--------------------IFRGDFKLPKWLSPGAQNLLRKI 231
            Y G   D W  GV++Y                    I   + + P+ L P A++LL  +
Sbjct: 185 DY-GRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPEAKSLLSGL 243
Query: 232 LEPNPVKRI 240
           L+ +P +R+
Sbjct: 244 LKKDPKQRL 252

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score =  132 bits (332), Expect = 4e-31,   Method: Compositional matrix adjust.
 Identities = 78/249 (31%), Positives = 127/249 (51%), Gaps = 24/249 (9%)
Query: 13  LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK 72
           +  +E  + LG+G FGKV   ++  +G  +A+KIL+K  I+          E   L+  +
Sbjct: 9   MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSR 68
Query: 73  HPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHN 132
           HP +  L     +  ++  V+EY  GGELF  ++ +    E   R    +++  + Y H+
Sbjct: 69  HPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHS 128
Query: 133 -KGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANR 191
            K V +RDLKLEN++LD  G+IKI+DFGL    +  +D   +   CG+P Y+APEVL + 
Sbjct: 129 EKNVVYRDLKLENLMLDKDGHIKITDFGLCK--EGIKDGATMKXFCGTPEYLAPEVLEDN 186
Query: 192 GYDGATSDIWSCGVILY--------------------IFRGDFKLPKWLSPGAQNLLRKI 231
            Y G   D W  GV++Y                    I   + + P+ L P A++LL  +
Sbjct: 187 DY-GRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPEAKSLLSGL 245
Query: 232 LEPNPVKRI 240
           L+ +P +R+
Sbjct: 246 LKKDPKQRL 254

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score =  132 bits (332), Expect = 4e-31,   Method: Compositional matrix adjust.
 Identities = 78/249 (31%), Positives = 127/249 (51%), Gaps = 24/249 (9%)
Query: 13  LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK 72
           +  +E  + LG+G FGKV   ++  +G  +A+KIL+K  I+          E   L+  +
Sbjct: 8   MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSR 67
Query: 73  HPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHN 132
           HP +  L     +  ++  V+EY  GGELF  ++ +    E   R    +++  + Y H+
Sbjct: 68  HPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHS 127
Query: 133 -KGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANR 191
            K V +RDLKLEN++LD  G+IKI+DFGL    +  +D   +   CG+P Y+APEVL + 
Sbjct: 128 EKNVVYRDLKLENLMLDKDGHIKITDFGLCK--EGIKDGATMKXFCGTPEYLAPEVLEDN 185
Query: 192 GYDGATSDIWSCGVILY--------------------IFRGDFKLPKWLSPGAQNLLRKI 231
            Y G   D W  GV++Y                    I   + + P+ L P A++LL  +
Sbjct: 186 DY-GRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPEAKSLLSGL 244
Query: 232 LEPNPVKRI 240
           L+ +P +R+
Sbjct: 245 LKKDPKQRL 253

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score =  131 bits (330), Expect = 7e-31,   Method: Compositional matrix adjust.
 Identities = 89/290 (30%), Positives = 143/290 (49%), Gaps = 54/290 (18%)
Query: 11  MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLK-------------- 56
           ++L +Y L   +G+G++G VK A + +    +A+K+L K ++I                 
Sbjct: 10  VQLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPA 69
Query: 57  ---------ITDQIKREIATLKLLKHPNVVRLHEVL--ASKSKIYMVLEYVTGGELFDKI 105
                      +Q+ +EIA LK L HPNVV+L EVL   ++  +YMV E V  G + + +
Sbjct: 70  PGGCIQPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVME-V 128
Query: 106 ASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQ 165
            +   L E + R  FQ LI G+ Y H + + HRD+K  N+L+   G+IKI+DFG+S    
Sbjct: 129 PTLKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADFGVS---N 185
Query: 166 HFR-DDGLLHTTCGSPNYVAPEVLAN--RGYDGATSDIWSCGVILYIF------------ 210
            F+  D LL  T G+P ++APE L+   + + G   D+W+ GV LY F            
Sbjct: 186 EFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERI 245
Query: 211 --------RGDFKLPKW--LSPGAQNLLRKILEPNPVKRITIAGIKADEW 250
                       + P    ++   ++L+ ++L+ NP  RI +  IK   W
Sbjct: 246 MCLHSKIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPW 295

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score =  131 bits (329), Expect = 8e-31,   Method: Compositional matrix adjust.
 Identities = 94/310 (30%), Positives = 148/310 (47%), Gaps = 39/310 (12%)
Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREI-ATLKLLKHP 74
           +   + +G+G+FGKV  A+     + +AVK+L+K  I+  K    I  E    LK +KHP
Sbjct: 40  FHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHP 99
Query: 75  NVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKG 134
            +V LH    +  K+Y VL+Y+ GGELF  +  +    E   R    ++   + Y H+  
Sbjct: 100 FLVGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLN 159
Query: 135 VFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYD 194
           + +RDLK ENILLDS+G+I ++DFGL    ++   +    T CG+P Y+APEVL  + YD
Sbjct: 160 IVYRDLKPENILLDSQGHIVLTDFGLCK--ENIEHNSTTSTFCGTPEYLAPEVLHKQPYD 217
Query: 195 GATSDIWSCGVILY--------------------IFRGDFKLPKWLSPGAQNLLRKILEP 234
             T D W  G +LY                    I     +L   ++  A++LL  +L+ 
Sbjct: 218 -RTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPNITNSARHLLEGLLQK 276
Query: 235 NPVKR-------------ITIAGIKADEWFEQDYTPA-NPD-DDEEDIFVDNEAFSMHEV 279
           +  KR             +  + I  D+   +  TP  NP+     D+   +  F+   V
Sbjct: 277 DRTKRLGAKDDFMEIKSHVFFSLINWDDLINKKITPPFNPNVSGPNDLRHFDPEFTEEPV 336
Query: 280 PSDGGRTPGS 289
           P+  G+ P S
Sbjct: 337 PNAIGKAPDS 346

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score =  130 bits (328), Expect = 1e-30,   Method: Compositional matrix adjust.
 Identities = 79/251 (31%), Positives = 132/251 (52%), Gaps = 24/251 (9%)
Query: 11  MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKL 70
           M+L  +     LG+G+FGKV  ++   +   +AVKIL+K+ +I     +    E   L L
Sbjct: 17  MKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLAL 76
Query: 71  L-KHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSY 129
             K P + +LH    +  ++Y V+EYV GG+L   I   GR +E        ++  G+ +
Sbjct: 77  PGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFF 136
Query: 130 CHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLA 189
             +KG+ +RDLKL+N++LDS+G+IKI+DFG+    ++  D       CG+P+Y+APE++A
Sbjct: 137 LQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCK--ENIWDGVTTKXFCGTPDYIAPEIIA 194
Query: 190 NRGYDGATSDIWSCGVILY--------------------IFRGDFKLPKWLSPGAQNLLR 229
            + Y G + D W+ GV+LY                    I   +   PK +S  A  + +
Sbjct: 195 YQPY-GKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAVAICK 253
Query: 230 KILEPNPVKRI 240
            ++  +P KR+
Sbjct: 254 GLMTKHPGKRL 264

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score =  130 bits (328), Expect = 1e-30,   Method: Compositional matrix adjust.
 Identities = 80/261 (30%), Positives = 140/261 (53%), Gaps = 30/261 (11%)
Query: 8   QEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIAT 67
           Q  +++  + L + LG+G+FGKV  A+   +   FA+K L+K+ ++   + D ++  +  
Sbjct: 11  QIKLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVL---MDDDVECTMVE 67
Query: 68  LKLL----KHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQL 123
            ++L    +HP +  +     +K  ++ V+EY+ GG+L   I S  +   +       ++
Sbjct: 68  KRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEI 127
Query: 124 IDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYV 183
           I G+ + H+KG+ +RDLKL+NILLD  G+IKI+DFG+    ++   D   +  CG+P+Y+
Sbjct: 128 ILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCK--ENMLGDAKTNXFCGTPDYI 185
Query: 184 APEVLANRGYDGATSDIWSCGVILY---IFRGDFK-----------------LPKWLSPG 223
           APE+L  + Y+ +  D WS GV+LY   I +  F                   P+WL   
Sbjct: 186 APEILLGQKYNHSV-DWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKE 244
Query: 224 AQNLLRKILEPNPVKRITIAG 244
           A++LL K+    P KR+ + G
Sbjct: 245 AKDLLVKLFVREPEKRLGVRG 265

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score =  130 bits (327), Expect = 2e-30,   Method: Compositional matrix adjust.
 Identities = 79/251 (31%), Positives = 132/251 (52%), Gaps = 24/251 (9%)
Query: 11  MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKL 70
           M+L  +     LG+G+FGKV  ++   +   +AVKIL+K+ +I     +    E   L L
Sbjct: 338 MKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLAL 397
Query: 71  L-KHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSY 129
             K P + +LH    +  ++Y V+EYV GG+L   I   GR +E        ++  G+ +
Sbjct: 398 PGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFF 457
Query: 130 CHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLA 189
             +KG+ +RDLKL+N++LDS+G+IKI+DFG+    ++  D       CG+P+Y+APE++A
Sbjct: 458 LQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCK--ENIWDGVTTKXFCGTPDYIAPEIIA 515
Query: 190 NRGYDGATSDIWSCGVILY--------------------IFRGDFKLPKWLSPGAQNLLR 229
            + Y G + D W+ GV+LY                    I   +   PK +S  A  + +
Sbjct: 516 YQPY-GKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAVAICK 574
Query: 230 KILEPNPVKRI 240
            ++  +P KR+
Sbjct: 575 GLMTKHPGKRL 585

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score =  129 bits (325), Expect = 3e-30,   Method: Compositional matrix adjust.
 Identities = 91/267 (34%), Positives = 132/267 (49%), Gaps = 40/267 (14%)
Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
           YE+   +G G++   K      + + FAVKI++K++       D  +     L+  +HPN
Sbjct: 24  YEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSK------RDPTEEIEILLRYGQHPN 77
Query: 76  VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGV 135
           ++ L +V      +Y+V E + GGEL DKI  +    E E   +   +   V Y H +GV
Sbjct: 78  IITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGV 137
Query: 136 FHRDLKLENIL-LDSKGN---IKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANR 191
            HRDLK  NIL +D  GN   I+I DFG +   Q   ++GLL T C + N+VAPEVL  +
Sbjct: 138 VHRDLKPSNILYVDESGNPESIRICDFGFAK--QLRAENGLLMTPCYTANFVAPEVLERQ 195
Query: 192 GYDGATSDIWSCGVILY-----------------------IFRGDFKLP--KW--LSPGA 224
           GYD A  DIWS GV+LY                       I  G F L    W  +S  A
Sbjct: 196 GYDAA-CDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGGYWNSVSDTA 254
Query: 225 QNLLRKILEPNPVKRITIAGIKADEWF 251
           ++L+ K+L  +P +R+T A +    W 
Sbjct: 255 KDLVSKMLHVDPHQRLTAALVLRHPWI 281

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score =  129 bits (323), Expect = 4e-30,   Method: Compositional matrix adjust.
 Identities = 75/245 (30%), Positives = 120/245 (48%), Gaps = 21/245 (8%)
Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
           ++ G+ LGEG+F  V  A++L +   +A+KILEK  II       + RE   +  L HP 
Sbjct: 31  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 90
Query: 76  VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGV 135
            V+L+       K+Y  L Y   GEL   I   G   E   R    +++  + Y H KG+
Sbjct: 91  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGI 150
Query: 136 FHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDG 195
            HRDLK ENILL+   +I+I+DFG + +          ++  G+  YV+PE+L  +    
Sbjct: 151 IHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKS-AC 209
Query: 196 ATSDIWSCGVILY--------------------IFRGDFKLPKWLSPGAQNLLRKILEPN 235
            +SD+W+ G I+Y                    I + ++  P+   P A++L+ K+L  +
Sbjct: 210 KSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEKLLVLD 269
Query: 236 PVKRI 240
             KR+
Sbjct: 270 ATKRL 274

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score =  129 bits (323), Expect = 4e-30,   Method: Compositional matrix adjust.
 Identities = 75/245 (30%), Positives = 120/245 (48%), Gaps = 21/245 (8%)
Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
           ++ G+ LGEG+F  V  A++L +   +A+KILEK  II       + RE   +  L HP 
Sbjct: 35  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 94
Query: 76  VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGV 135
            V+L+       K+Y  L Y   GEL   I   G   E   R    +++  + Y H KG+
Sbjct: 95  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGI 154
Query: 136 FHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDG 195
            HRDLK ENILL+   +I+I+DFG + +          ++  G+  YV+PE+L  +    
Sbjct: 155 IHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKS-AC 213
Query: 196 ATSDIWSCGVILY--------------------IFRGDFKLPKWLSPGAQNLLRKILEPN 235
            +SD+W+ G I+Y                    I + ++  P+   P A++L+ K+L  +
Sbjct: 214 KSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEKLLVLD 273
Query: 236 PVKRI 240
             KR+
Sbjct: 274 ATKRL 278

>pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312

Iteration: 1
 Score =  129 bits (323), Expect = 4e-30,   Method: Compositional matrix adjust.
 Identities = 91/295 (30%), Positives = 137/295 (46%), Gaps = 45/295 (15%)
Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLK-ITDQIKREIATLKLLK-- 72
           Y LG  LG+G FG V     L   L  A+K++ +NR++    ++D +   +    L K  
Sbjct: 33  YRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVG 92
Query: 73  ----HPNVVRLHEVLASKSKIYMVLEY-VTGGELFDKIASKGRLQEAEGRKLFQQLIDGV 127
               HP V+RL +   ++    +VLE  +   +LFD I  KG L E   R  F Q++  +
Sbjct: 93  AGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAI 152
Query: 128 SYCHNKGVFHRDLKLENILLD-SKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPE 186
            +CH++GV HRD+K ENIL+D  +G  K+ DFG  AL     D+       G+  Y  PE
Sbjct: 153 QHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSGAL---LHDEPYTDFD-GTRVYSPPE 208
Query: 187 VLANRGYDGATSDIWSCGVILY--------------IFRGDFKLPKWLSPGAQNLLRKIL 232
            ++   Y    + +WS G++LY              I   +   P  +SP    L+R+ L
Sbjct: 209 WISRHQYHALPATVWSLGILLYDMVCGDIPFERDQEILEAELHFPAHVSPDCCALIRRCL 268
Query: 233 EPNPVKRITIAGIKADEWFEQDYTPANPDDDEEDIFVDNEAFSMHEVPSDGGRTP 287
            P P  R ++  I  D W +   TPA      ED+ ++         PS GG  P
Sbjct: 269 APKPSSRPSLEEILLDPWMQ---TPA------EDVPLN---------PSKGGPAP 305

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score =  128 bits (322), Expect = 5e-30,   Method: Compositional matrix adjust.
 Identities = 75/245 (30%), Positives = 119/245 (48%), Gaps = 21/245 (8%)
Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
           ++ G+ LGEG+F  V  A++L +   +A+KILEK  II       + RE   +  L HP 
Sbjct: 32  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 91
Query: 76  VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGV 135
            V+L+       K+Y  L Y   GEL   I   G   E   R    +++  + Y H KG+
Sbjct: 92  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGI 151
Query: 136 FHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDG 195
            HRDLK ENILL+   +I+I+DFG + +          +   G+  YV+PE+L  +    
Sbjct: 152 IHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANAFVGTAQYVSPELLTEKS-AC 210
Query: 196 ATSDIWSCGVILY--------------------IFRGDFKLPKWLSPGAQNLLRKILEPN 235
            +SD+W+ G I+Y                    I + ++  P+   P A++L+ K+L  +
Sbjct: 211 KSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEKLLVLD 270
Query: 236 PVKRI 240
             KR+
Sbjct: 271 ATKRL 275

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score =  128 bits (322), Expect = 6e-30,   Method: Compositional matrix adjust.
 Identities = 75/245 (30%), Positives = 119/245 (48%), Gaps = 21/245 (8%)
Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
           ++ G+ LGEG+F  V  A++L +   +A+KILEK  II       + RE   +  L HP 
Sbjct: 11  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 70
Query: 76  VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGV 135
            V+L+       K+Y  L Y   GEL   I   G   E   R    +++  + Y H KG+
Sbjct: 71  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGI 130
Query: 136 FHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDG 195
            HRDLK ENILL+   +I+I+DFG + +          +   G+  YV+PE+L  +    
Sbjct: 131 IHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKS-AC 189
Query: 196 ATSDIWSCGVILY--------------------IFRGDFKLPKWLSPGAQNLLRKILEPN 235
            +SD+W+ G I+Y                    I + ++  P+   P A++L+ K+L  +
Sbjct: 190 KSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEKLLVLD 249
Query: 236 PVKRI 240
             KR+
Sbjct: 250 ATKRL 254

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score =  128 bits (322), Expect = 6e-30,   Method: Compositional matrix adjust.
 Identities = 75/245 (30%), Positives = 119/245 (48%), Gaps = 21/245 (8%)
Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
           ++ G+ LGEG+F  V  A++L +   +A+KILEK  II       + RE   +  L HP 
Sbjct: 32  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 91
Query: 76  VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGV 135
            V+L+       K+Y  L Y   GEL   I   G   E   R    +++  + Y H KG+
Sbjct: 92  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGI 151
Query: 136 FHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDG 195
            HRDLK ENILL+   +I+I+DFG + +          +   G+  YV+PE+L  +    
Sbjct: 152 IHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKS-AC 210
Query: 196 ATSDIWSCGVILY--------------------IFRGDFKLPKWLSPGAQNLLRKILEPN 235
            +SD+W+ G I+Y                    I + ++  P+   P A++L+ K+L  +
Sbjct: 211 KSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEKLLVLD 270
Query: 236 PVKRI 240
             KR+
Sbjct: 271 ATKRL 275

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score =  128 bits (321), Expect = 6e-30,   Method: Compositional matrix adjust.
 Identities = 75/245 (30%), Positives = 119/245 (48%), Gaps = 21/245 (8%)
Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
           ++ G+ LGEG+F  V  A++L +   +A+KILEK  II       + RE   +  L HP 
Sbjct: 16  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 75
Query: 76  VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGV 135
            V+L+       K+Y  L Y   GEL   I   G   E   R    +++  + Y H KG+
Sbjct: 76  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGI 135
Query: 136 FHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDG 195
            HRDLK ENILL+   +I+I+DFG + +          +   G+  YV+PE+L  +    
Sbjct: 136 IHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKS-AC 194
Query: 196 ATSDIWSCGVILY--------------------IFRGDFKLPKWLSPGAQNLLRKILEPN 235
            +SD+W+ G I+Y                    I + ++  P+   P A++L+ K+L  +
Sbjct: 195 KSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEKLLVLD 254
Query: 236 PVKRI 240
             KR+
Sbjct: 255 ATKRL 259

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score =  128 bits (321), Expect = 6e-30,   Method: Compositional matrix adjust.
 Identities = 75/245 (30%), Positives = 119/245 (48%), Gaps = 21/245 (8%)
Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
           ++ G+ LGEG+F  V  A++L +   +A+KILEK  II       + RE   +  L HP 
Sbjct: 12  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 71
Query: 76  VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGV 135
            V+L+       K+Y  L Y   GEL   I   G   E   R    +++  + Y H KG+
Sbjct: 72  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGI 131
Query: 136 FHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDG 195
            HRDLK ENILL+   +I+I+DFG + +          +   G+  YV+PE+L  +    
Sbjct: 132 IHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKS-AC 190
Query: 196 ATSDIWSCGVILY--------------------IFRGDFKLPKWLSPGAQNLLRKILEPN 235
            +SD+W+ G I+Y                    I + ++  P+   P A++L+ K+L  +
Sbjct: 191 KSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEKLLVLD 250
Query: 236 PVKRI 240
             KR+
Sbjct: 251 ATKRL 255

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score =  128 bits (321), Expect = 6e-30,   Method: Compositional matrix adjust.
 Identities = 75/245 (30%), Positives = 119/245 (48%), Gaps = 21/245 (8%)
Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
           ++ G+ LGEG+F  V  A++L +   +A+KILEK  II       + RE   +  L HP 
Sbjct: 34  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 93
Query: 76  VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGV 135
            V+L+       K+Y  L Y   GEL   I   G   E   R    +++  + Y H KG+
Sbjct: 94  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGI 153
Query: 136 FHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDG 195
            HRDLK ENILL+   +I+I+DFG + +          +   G+  YV+PE+L  +    
Sbjct: 154 IHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKS-AC 212
Query: 196 ATSDIWSCGVILY--------------------IFRGDFKLPKWLSPGAQNLLRKILEPN 235
            +SD+W+ G I+Y                    I + ++  P+   P A++L+ K+L  +
Sbjct: 213 KSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEKLLVLD 272
Query: 236 PVKRI 240
             KR+
Sbjct: 273 ATKRL 277

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score =  128 bits (321), Expect = 6e-30,   Method: Compositional matrix adjust.
 Identities = 75/245 (30%), Positives = 119/245 (48%), Gaps = 21/245 (8%)
Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
           ++ G+ LGEG+F  V  A++L +   +A+KILEK  II       + RE   +  L HP 
Sbjct: 39  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 98
Query: 76  VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGV 135
            V+L+       K+Y  L Y   GEL   I   G   E   R    +++  + Y H KG+
Sbjct: 99  FVKLYFCFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGI 158
Query: 136 FHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDG 195
            HRDLK ENILL+   +I+I+DFG + +          +   G+  YV+PE+L  +    
Sbjct: 159 IHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKS-AC 217
Query: 196 ATSDIWSCGVILY--------------------IFRGDFKLPKWLSPGAQNLLRKILEPN 235
            +SD+W+ G I+Y                    I + ++  P+   P A++L+ K+L  +
Sbjct: 218 KSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEKLLVLD 277
Query: 236 PVKRI 240
             KR+
Sbjct: 278 ATKRL 282

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score =  128 bits (321), Expect = 7e-30,   Method: Compositional matrix adjust.
 Identities = 75/245 (30%), Positives = 119/245 (48%), Gaps = 21/245 (8%)
Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
           ++ G+ LGEG+F  V  A++L +   +A+KILEK  II       + RE   +  L HP 
Sbjct: 34  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 93
Query: 76  VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGV 135
            V+L+       K+Y  L Y   GEL   I   G   E   R    +++  + Y H KG+
Sbjct: 94  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGI 153
Query: 136 FHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDG 195
            HRDLK ENILL+   +I+I+DFG + +          +   G+  YV+PE+L  +    
Sbjct: 154 IHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKS-AX 212
Query: 196 ATSDIWSCGVILY--------------------IFRGDFKLPKWLSPGAQNLLRKILEPN 235
            +SD+W+ G I+Y                    I + ++  P+   P A++L+ K+L  +
Sbjct: 213 KSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLEYDFPEKFFPKARDLVEKLLVLD 272
Query: 236 PVKRI 240
             KR+
Sbjct: 273 ATKRL 277

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score =  128 bits (321), Expect = 7e-30,   Method: Compositional matrix adjust.
 Identities = 75/245 (30%), Positives = 119/245 (48%), Gaps = 21/245 (8%)
Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
           ++ G+ LGEG+F  V  A++L +   +A+KILEK  II       + RE   +  L HP 
Sbjct: 32  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 91
Query: 76  VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGV 135
            V+L+       K+Y  L Y   GEL   I   G   E   R    +++  + Y H KG+
Sbjct: 92  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGI 151
Query: 136 FHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDG 195
            HRDLK ENILL+   +I+I+DFG + +          +   G+  YV+PE+L  +    
Sbjct: 152 IHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKS-AC 210
Query: 196 ATSDIWSCGVILY--------------------IFRGDFKLPKWLSPGAQNLLRKILEPN 235
            +SD+W+ G I+Y                    I + ++  P+   P A++L+ K+L  +
Sbjct: 211 KSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEKLLVLD 270
Query: 236 PVKRI 240
             KR+
Sbjct: 271 ATKRL 275

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score =  128 bits (321), Expect = 7e-30,   Method: Compositional matrix adjust.
 Identities = 75/245 (30%), Positives = 119/245 (48%), Gaps = 21/245 (8%)
Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
           ++ G+ LGEG+F  V  A++L +   +A+KILEK  II       + RE   +  L HP 
Sbjct: 9   FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 68
Query: 76  VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGV 135
            V+L+       K+Y  L Y   GEL   I   G   E   R    +++  + Y H KG+
Sbjct: 69  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGI 128
Query: 136 FHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDG 195
            HRDLK ENILL+   +I+I+DFG + +          +   G+  YV+PE+L  +    
Sbjct: 129 IHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKS-AC 187
Query: 196 ATSDIWSCGVILY--------------------IFRGDFKLPKWLSPGAQNLLRKILEPN 235
            +SD+W+ G I+Y                    I + ++  P+   P A++L+ K+L  +
Sbjct: 188 KSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEKLLVLD 247
Query: 236 PVKRI 240
             KR+
Sbjct: 248 ATKRL 252

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score =  128 bits (321), Expect = 7e-30,   Method: Compositional matrix adjust.
 Identities = 75/245 (30%), Positives = 119/245 (48%), Gaps = 21/245 (8%)
Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
           ++ G+ LGEG+F  V  A++L +   +A+KILEK  II       + RE   +  L HP 
Sbjct: 34  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 93
Query: 76  VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGV 135
            V+L+       K+Y  L Y   GEL   I   G   E   R    +++  + Y H KG+
Sbjct: 94  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGI 153
Query: 136 FHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDG 195
            HRDLK ENILL+   +I+I+DFG + +          +   G+  YV+PE+L  +    
Sbjct: 154 IHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKS-AC 212
Query: 196 ATSDIWSCGVILY--------------------IFRGDFKLPKWLSPGAQNLLRKILEPN 235
            +SD+W+ G I+Y                    I + ++  P+   P A++L+ K+L  +
Sbjct: 213 KSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEKLLVLD 272
Query: 236 PVKRI 240
             KR+
Sbjct: 273 ATKRL 277

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score =  128 bits (321), Expect = 7e-30,   Method: Compositional matrix adjust.
 Identities = 75/245 (30%), Positives = 119/245 (48%), Gaps = 21/245 (8%)
Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
           ++ G+ LGEG+F  V  A++L +   +A+KILEK  II       + RE   +  L HP 
Sbjct: 10  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 69
Query: 76  VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGV 135
            V+L+       K+Y  L Y   GEL   I   G   E   R    +++  + Y H KG+
Sbjct: 70  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGI 129
Query: 136 FHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDG 195
            HRDLK ENILL+   +I+I+DFG + +          +   G+  YV+PE+L  +    
Sbjct: 130 IHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKS-AC 188
Query: 196 ATSDIWSCGVILY--------------------IFRGDFKLPKWLSPGAQNLLRKILEPN 235
            +SD+W+ G I+Y                    I + ++  P+   P A++L+ K+L  +
Sbjct: 189 KSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEKLLVLD 248
Query: 236 PVKRI 240
             KR+
Sbjct: 249 ATKRL 253

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score =  128 bits (321), Expect = 7e-30,   Method: Compositional matrix adjust.
 Identities = 75/245 (30%), Positives = 119/245 (48%), Gaps = 21/245 (8%)
Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
           ++ G+ LGEG+F  V  A++L +   +A+KILEK  II       + RE   +  L HP 
Sbjct: 31  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 90
Query: 76  VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGV 135
            V+L+       K+Y  L Y   GEL   I   G   E   R    +++  + Y H KG+
Sbjct: 91  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGI 150
Query: 136 FHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDG 195
            HRDLK ENILL+   +I+I+DFG + +          +   G+  YV+PE+L  +    
Sbjct: 151 IHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKS-AC 209
Query: 196 ATSDIWSCGVILY--------------------IFRGDFKLPKWLSPGAQNLLRKILEPN 235
            +SD+W+ G I+Y                    I + ++  P+   P A++L+ K+L  +
Sbjct: 210 KSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEKLLVLD 269
Query: 236 PVKRI 240
             KR+
Sbjct: 270 ATKRL 274

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score =  128 bits (321), Expect = 7e-30,   Method: Compositional matrix adjust.
 Identities = 75/245 (30%), Positives = 119/245 (48%), Gaps = 21/245 (8%)
Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
           ++ G+ LGEG+F  V  A++L +   +A+KILEK  II       + RE   +  L HP 
Sbjct: 34  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 93
Query: 76  VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGV 135
            V+L+       K+Y  L Y   GEL   I   G   E   R    +++  + Y H KG+
Sbjct: 94  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGI 153
Query: 136 FHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDG 195
            HRDLK ENILL+   +I+I+DFG + +          +   G+  YV+PE+L  +    
Sbjct: 154 IHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKS-AC 212
Query: 196 ATSDIWSCGVILY--------------------IFRGDFKLPKWLSPGAQNLLRKILEPN 235
            +SD+W+ G I+Y                    I + ++  P+   P A++L+ K+L  +
Sbjct: 213 KSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLEYDFPEKFFPKARDLVEKLLVLD 272
Query: 236 PVKRI 240
             KR+
Sbjct: 273 ATKRL 277

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score =  128 bits (321), Expect = 7e-30,   Method: Compositional matrix adjust.
 Identities = 75/245 (30%), Positives = 119/245 (48%), Gaps = 21/245 (8%)
Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
           ++ G+ LGEG+F  V  A++L +   +A+KILEK  II       + RE   +  L HP 
Sbjct: 35  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 94
Query: 76  VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGV 135
            V+L+       K+Y  L Y   GEL   I   G   E   R    +++  + Y H KG+
Sbjct: 95  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGI 154
Query: 136 FHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDG 195
            HRDLK ENILL+   +I+I+DFG + +          +   G+  YV+PE+L  +    
Sbjct: 155 IHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKS-AC 213
Query: 196 ATSDIWSCGVILY--------------------IFRGDFKLPKWLSPGAQNLLRKILEPN 235
            +SD+W+ G I+Y                    I + ++  P+   P A++L+ K+L  +
Sbjct: 214 KSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEKLLVLD 273
Query: 236 PVKRI 240
             KR+
Sbjct: 274 ATKRL 278

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score =  128 bits (321), Expect = 8e-30,   Method: Compositional matrix adjust.
 Identities = 75/245 (30%), Positives = 119/245 (48%), Gaps = 21/245 (8%)
Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
           ++ G+ LGEG+F  V  A++L +   +A+KILEK  II       + RE   +  L HP 
Sbjct: 34  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 93
Query: 76  VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGV 135
            V+L+       K+Y  L Y   GEL   I   G   E   R    +++  + Y H KG+
Sbjct: 94  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGI 153
Query: 136 FHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDG 195
            HRDLK ENILL+   +I+I+DFG + +          +   G+  YV+PE+L  +    
Sbjct: 154 IHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKS-AC 212
Query: 196 ATSDIWSCGVILY--------------------IFRGDFKLPKWLSPGAQNLLRKILEPN 235
            +SD+W+ G I+Y                    I + ++  P+   P A++L+ K+L  +
Sbjct: 213 KSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEKLLVLD 272
Query: 236 PVKRI 240
             KR+
Sbjct: 273 ATKRL 277

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score =  127 bits (320), Expect = 8e-30,   Method: Compositional matrix adjust.
 Identities = 82/274 (29%), Positives = 149/274 (54%), Gaps = 37/274 (13%)
Query: 9   EGMRLGRYELGRTLGEGNFGKVKFAQDL---DSGLPFAVKILEKNRIIH-LKITDQIKRE 64
           E + +  +EL + LG G +GKV   + +   D+G  +A+K+L+K  I+   K T+  + E
Sbjct: 49  EKVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTE 108
Query: 65  IATLKLLKH-PNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQL 123
              L+ ++  P +V LH    +++K++++L+Y+ GGELF  ++ + R  E E +    ++
Sbjct: 109 RQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEI 168
Query: 124 IDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGL--LHTTCGSPN 181
           +  + + H  G+ +RD+KLENILLDS G++ ++DFGLS   + F  D     +  CG+  
Sbjct: 169 VLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLS---KEFVADETERAYDFCGTIE 225
Query: 182 YVAPEVL--ANRGYDGATSDIWSCGVILY------------------------IFRGDFK 215
           Y+AP+++   + G+D A  D WS GV++Y                        I + +  
Sbjct: 226 YMAPDIVRGGDSGHDKAV-DWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPP 284
Query: 216 LPKWLSPGAQNLLRKILEPNPVKRITIAGIKADE 249
            P+ +S  A++L++++L  +P KR+      ADE
Sbjct: 285 YPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADE 318

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score =  127 bits (320), Expect = 9e-30,   Method: Compositional matrix adjust.
 Identities = 75/245 (30%), Positives = 118/245 (48%), Gaps = 21/245 (8%)
Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
           ++ G+ LGEG+F  V  A++L +   +A+KILEK  II       + RE   +  L HP 
Sbjct: 37  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 96
Query: 76  VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGV 135
            V+L+       K+Y  L Y   GEL   I   G   E   R    +++  + Y H KG+
Sbjct: 97  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGI 156
Query: 136 FHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDG 195
            HRDLK ENILL+   +I+I+DFG + +          +   G+  YV+PE+L  +    
Sbjct: 157 IHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKS-AC 215
Query: 196 ATSDIWSCGVILY--------------------IFRGDFKLPKWLSPGAQNLLRKILEPN 235
            +SD+W+ G I+Y                    I + ++  P    P A++L+ K+L  +
Sbjct: 216 KSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPAAFFPKARDLVEKLLVLD 275
Query: 236 PVKRI 240
             KR+
Sbjct: 276 ATKRL 280

>pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361

Iteration: 1
 Score =  127 bits (319), Expect = 1e-29,   Method: Compositional matrix adjust.
 Identities = 81/271 (29%), Positives = 140/271 (51%), Gaps = 37/271 (13%)
Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLK--ITDQIKREIATLKLLKH 73
           YEL   +G+G F  V+   + ++G  FAVKI++  +        T+ +KRE +   +LKH
Sbjct: 28  YELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKH 87
Query: 74  PNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGR----LQEAEGRKLFQQLIDGVSY 129
           P++V L E  +S   +YMV E++ G +L  +I  +        EA      +Q+++ + Y
Sbjct: 88  PHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRY 147
Query: 130 CHNKGVFHRDLKLENILLDSKGN---IKISDFGLSALPQHFRDDGLLH-TTCGSPNYVAP 185
           CH+  + HRD+K   +LL SK N   +K+  FG++       + GL+     G+P+++AP
Sbjct: 148 CHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAI---QLGESGLVAGGRVGTPHFMAP 204
Query: 186 EVLANRGYDGATSDIWSCGVILYIF-------------------RGDFKLP--KW--LSP 222
           EV+    Y G   D+W CGVIL+I                    +G +K+   +W  +S 
Sbjct: 205 EVVKREPY-GKPVDVWGCGVILFILLSGCLPFYGTKERLFEGIIKGKYKMNPRQWSHISE 263
Query: 223 GAQNLLRKILEPNPVKRITIAGIKADEWFEQ 253
            A++L+R++L  +P +RIT+       W ++
Sbjct: 264 SAKDLVRRMLMLDPAERITVYEALNHPWLKE 294

>pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351

Iteration: 1
 Score =  127 bits (318), Expect = 1e-29,   Method: Compositional matrix adjust.
 Identities = 81/271 (29%), Positives = 140/271 (51%), Gaps = 37/271 (13%)
Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLK--ITDQIKREIATLKLLKH 73
           YEL   +G+G F  V+   + ++G  FAVKI++  +        T+ +KRE +   +LKH
Sbjct: 26  YELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKH 85
Query: 74  PNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGR----LQEAEGRKLFQQLIDGVSY 129
           P++V L E  +S   +YMV E++ G +L  +I  +        EA      +Q+++ + Y
Sbjct: 86  PHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRY 145
Query: 130 CHNKGVFHRDLKLENILLDSKGN---IKISDFGLSALPQHFRDDGLLH-TTCGSPNYVAP 185
           CH+  + HRD+K   +LL SK N   +K+  FG++       + GL+     G+P+++AP
Sbjct: 146 CHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAI---QLGESGLVAGGRVGTPHFMAP 202
Query: 186 EVLANRGYDGATSDIWSCGVILYIF-------------------RGDFKLP--KW--LSP 222
           EV+    Y G   D+W CGVIL+I                    +G +K+   +W  +S 
Sbjct: 203 EVVKREPY-GKPVDVWGCGVILFILLSGCLPFYGTKERLFEGIIKGKYKMNPRQWSHISE 261
Query: 223 GAQNLLRKILEPNPVKRITIAGIKADEWFEQ 253
            A++L+R++L  +P +RIT+       W ++
Sbjct: 262 SAKDLVRRMLMLDPAERITVYEALNHPWLKE 292

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score =  127 bits (318), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 74/245 (30%), Positives = 118/245 (48%), Gaps = 21/245 (8%)
Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
           ++ G+ LGEG+F     A++L +   +A+KILEK  II       + RE   +  L HP 
Sbjct: 32  FKFGKILGEGSFSTTVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 91
Query: 76  VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGV 135
            V+L+       K+Y  L Y   GEL   I   G   E   R    +++  + Y H KG+
Sbjct: 92  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGI 151
Query: 136 FHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDG 195
            HRDLK ENILL+   +I+I+DFG + +          +   G+  YV+PE+L  +    
Sbjct: 152 IHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKS-AC 210
Query: 196 ATSDIWSCGVILY--------------------IFRGDFKLPKWLSPGAQNLLRKILEPN 235
            +SD+W+ G I+Y                    I + ++  P+   P A++L+ K+L  +
Sbjct: 211 KSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEKLLVLD 270
Query: 236 PVKRI 240
             KR+
Sbjct: 271 ATKRL 275

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score =  126 bits (317), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 74/245 (30%), Positives = 119/245 (48%), Gaps = 21/245 (8%)
Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
           ++ G+ LGEG+F  V  A++L +   +A+KILEK  II       + RE   +  L HP 
Sbjct: 34  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 93
Query: 76  VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGV 135
            V+L+       K+Y  L Y   G L   I   G   E   R    +++  + Y H KG+
Sbjct: 94  FVKLYFTFQDDEKLYFGLSYAKNGCLLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGI 153
Query: 136 FHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDG 195
            HRDLK ENILL+   +I+I+DFG + +          ++  G+  YV+PE+L  +    
Sbjct: 154 IHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKS-AS 212
Query: 196 ATSDIWSCGVILY--------------------IFRGDFKLPKWLSPGAQNLLRKILEPN 235
            +SD+W+ G I+Y                    I + ++  P+   P A++L+ K+L  +
Sbjct: 213 KSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEKLLVLD 272
Query: 236 PVKRI 240
             KR+
Sbjct: 273 ATKRL 277

>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342

Iteration: 1
 Score =  126 bits (316), Expect = 3e-29,   Method: Compositional matrix adjust.
 Identities = 91/267 (34%), Positives = 129/267 (48%), Gaps = 40/267 (14%)
Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
           YE+   +G G++   K      +   FAVKI++K++       D  +     L+  +HPN
Sbjct: 24  YEVKEDIGVGSYSVCKRCIHKATNXEFAVKIIDKSK------RDPTEEIEILLRYGQHPN 77
Query: 76  VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGV 135
           ++ L +V      +Y+V E   GGEL DKI  +    E E   +   +   V Y H +GV
Sbjct: 78  IITLKDVYDDGKYVYVVTELXKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGV 137
Query: 136 FHRDLKLENIL-LDSKGN---IKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANR 191
            HRDLK  NIL +D  GN   I+I DFG +   Q   ++GLL T C + N+VAPEVL  +
Sbjct: 138 VHRDLKPSNILYVDESGNPESIRICDFGFAK--QLRAENGLLXTPCYTANFVAPEVLERQ 195
Query: 192 GYDGATSDIWSCGVILY-----------------------IFRGDFKLP--KW--LSPGA 224
           GYD A  DIWS GV+LY                       I  G F L    W  +S  A
Sbjct: 196 GYDAA-CDIWSLGVLLYTXLTGYTPFANGPDDTPEEILARIGSGKFSLSGGYWNSVSDTA 254
Query: 225 QNLLRKILEPNPVKRITIAGIKADEWF 251
           ++L+ K L  +P +R+T A +    W 
Sbjct: 255 KDLVSKXLHVDPHQRLTAALVLRHPWI 281

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score =  125 bits (314), Expect = 4e-29,   Method: Compositional matrix adjust.
 Identities = 86/269 (31%), Positives = 133/269 (49%), Gaps = 40/269 (14%)
Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
           Y +  T+G G++ + K      + + +AVK+++K++       D  +     L+  +HPN
Sbjct: 29  YVVKETIGVGSYSECKRCVHKATNMEYAVKVIDKSK------RDPSEEIEILLRYGQHPN 82
Query: 76  VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGV 135
           ++ L +V      +Y+V E + GGEL DKI  +    E E   +   +   V Y H++GV
Sbjct: 83  IITLKDVYDDGKHVYLVTELMRGGELLDKILRQKFFSEREASFVLHTIGKTVEYLHSQGV 142
Query: 136 FHRDLKLENIL-LDSKGN---IKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANR 191
            HRDLK  NIL +D  GN   ++I DFG +   Q   ++GLL T C + N+VAPEVL  +
Sbjct: 143 VHRDLKPSNILYVDESGNPECLRICDFGFAK--QLRAENGLLMTPCYTANFVAPEVLKRQ 200
Query: 192 GYDGATSDIWSCGVILY-----------------------IFRGDFKLP--KW--LSPGA 224
           GYD    DIWS G++LY                       I  G F L    W  +S  A
Sbjct: 201 GYDEG-CDIWSLGILLYTMLAGYTPFANGPSDTPEEILTRIGSGKFTLSGGNWNTVSETA 259
Query: 225 QNLLRKILEPNPVKRITIAGIKADEWFEQ 253
           ++L+ K+L  +P +R+T   +    W  Q
Sbjct: 260 KDLVSKMLHVDPHQRLTAKQVLQHPWVTQ 288

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score =  125 bits (314), Expect = 4e-29,   Method: Compositional matrix adjust.
 Identities = 86/269 (31%), Positives = 133/269 (49%), Gaps = 40/269 (14%)
Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
           Y +  T+G G++ + K      + + +AVK+++K++       D  +     L+  +HPN
Sbjct: 29  YVVKETIGVGSYSECKRCVHKATNMEYAVKVIDKSK------RDPSEEIEILLRYGQHPN 82
Query: 76  VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGV 135
           ++ L +V      +Y+V E + GGEL DKI  +    E E   +   +   V Y H++GV
Sbjct: 83  IITLKDVYDDGKHVYLVTELMRGGELLDKILRQKFFSEREASFVLHTIGKTVEYLHSQGV 142
Query: 136 FHRDLKLENIL-LDSKGN---IKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANR 191
            HRDLK  NIL +D  GN   ++I DFG +   Q   ++GLL T C + N+VAPEVL  +
Sbjct: 143 VHRDLKPSNILYVDESGNPECLRICDFGFAK--QLRAENGLLMTPCYTANFVAPEVLKRQ 200
Query: 192 GYDGATSDIWSCGVILY-----------------------IFRGDFKLP--KW--LSPGA 224
           GYD    DIWS G++LY                       I  G F L    W  +S  A
Sbjct: 201 GYDEG-CDIWSLGILLYTMLAGYTPFANGPSDTPEEILTRIGSGKFTLSGGNWNTVSETA 259
Query: 225 QNLLRKILEPNPVKRITIAGIKADEWFEQ 253
           ++L+ K+L  +P +R+T   +    W  Q
Sbjct: 260 KDLVSKMLHVDPHQRLTAKQVLQHPWVTQ 288

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score =  124 bits (312), Expect = 7e-29,   Method: Compositional matrix adjust.
 Identities = 72/265 (27%), Positives = 135/265 (50%), Gaps = 33/265 (12%)
Query: 6   KKQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREI 65
           K    + L  ++L R +G G++ KV   +   +   +A+++++K  +   +  D ++ E 
Sbjct: 44  KASSSLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEK 103
Query: 66  ATL-KLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLI 124
               +   HP +V LH    ++S+++ V+EYV GG+L   +  + +L E   R    ++ 
Sbjct: 104 HVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEIS 163
Query: 125 DGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVA 184
             ++Y H +G+ +RDLKL+N+LLDS+G+IK++D+G+    +  R      T CG+PNY+A
Sbjct: 164 LALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCK--EGLRPGDTTSTFCGTPNYIA 221
Query: 185 PEVLANRGYDGATSDIWSCGVILY-----------------------------IFRGDFK 215
           PE+L    Y G + D W+ GV+++                             I     +
Sbjct: 222 PEILRGEDY-GFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIR 280
Query: 216 LPKWLSPGAQNLLRKILEPNPVKRI 240
           +P+ LS  A ++L+  L  +P +R+
Sbjct: 281 IPRSLSVKAASVLKSFLNKDPKERL 305

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score =  124 bits (310), Expect = 1e-28,   Method: Compositional matrix adjust.
 Identities = 84/275 (30%), Positives = 135/275 (49%), Gaps = 40/275 (14%)
Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILE--KNRIIHLK---ITDQIKREIATLK 69
           +Y+    +G G    V+      +G  FAVKI+E    R+   +   + +  +RE   L+
Sbjct: 95  KYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILR 154
Query: 70  LLK-HPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVS 128
            +  HP+++ L +   S S +++V + +  GELFD +  K  L E E R + + L++ VS
Sbjct: 155 QVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVS 214
Query: 129 YCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVL 188
           + H   + HRDLK ENILLD    I++SDFG S    H      L   CG+P Y+APE+L
Sbjct: 215 FLHANNIVHRDLKPENILLDDNMQIRLSDFGFSC---HLEPGEKLRELCGTPGYLAPEIL 271
Query: 189 ------ANRGYDGATSDIWSCGVILY--------------------IFRGDFKL--PKW- 219
                  + GY G   D+W+CGVIL+                    I  G ++   P+W 
Sbjct: 272 KCSMDETHPGY-GKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQFSSPEWD 330
Query: 220 -LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQ 253
             S   ++L+ ++L+ +P  R+T        +FE+
Sbjct: 331 DRSSTVKDLISRLLQVDPEARLTAEQALQHPFFER 365

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score =  122 bits (307), Expect = 3e-28,   Method: Compositional matrix adjust.
 Identities = 71/265 (26%), Positives = 134/265 (50%), Gaps = 33/265 (12%)
Query: 6   KKQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREI 65
           K    + L  ++L R +G G++ KV   +   +   +A+K+++K  +   +  D ++ E 
Sbjct: 12  KASSSLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEK 71
Query: 66  ATL-KLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLI 124
               +   HP +V LH    ++S+++ V+EYV GG+L   +  + +L E   R    ++ 
Sbjct: 72  HVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEIS 131
Query: 125 DGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVA 184
             ++Y H +G+ +RDLKL+N+LLDS+G+IK++D+G+    +  R        CG+PNY+A
Sbjct: 132 LALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCK--EGLRPGDTTSXFCGTPNYIA 189
Query: 185 PEVLANRGYDGATSDIWSCGVILY-----------------------------IFRGDFK 215
           PE+L    Y G + D W+ GV+++                             I     +
Sbjct: 190 PEILRGEDY-GFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIR 248
Query: 216 LPKWLSPGAQNLLRKILEPNPVKRI 240
           +P+ +S  A ++L+  L  +P +R+
Sbjct: 249 IPRSMSVKAASVLKSFLNKDPKERL 273

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score =  122 bits (306), Expect = 4e-28,   Method: Compositional matrix adjust.
 Identities = 71/258 (27%), Positives = 132/258 (51%), Gaps = 33/258 (12%)
Query: 13  LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATL-KLL 71
           L  ++L R +G G++ KV   +   +   +A+K+++K  +   +  D ++ E     +  
Sbjct: 4   LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQAS 63
Query: 72  KHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCH 131
            HP +V LH    ++S+++ V+EYV GG+L   +  + +L E   R    ++   ++Y H
Sbjct: 64  NHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLH 123
Query: 132 NKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANR 191
            +G+ +RDLKL+N+LLDS+G+IK++D+G+    +  R        CG+PNY+APE+L   
Sbjct: 124 ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCK--EGLRPGDTTSXFCGTPNYIAPEILRGE 181
Query: 192 GYDGATSDIWSCGVILY-----------------------------IFRGDFKLPKWLSP 222
            Y G + D W+ GV+++                             I     ++P+ LS 
Sbjct: 182 DY-GFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSV 240
Query: 223 GAQNLLRKILEPNPVKRI 240
            A ++L+  L  +P +R+
Sbjct: 241 KAASVLKSFLNKDPKERL 258

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score =  122 bits (305), Expect = 5e-28,   Method: Compositional matrix adjust.
 Identities = 71/258 (27%), Positives = 132/258 (51%), Gaps = 33/258 (12%)
Query: 13  LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATL-KLL 71
           L  ++L R +G G++ KV   +   +   +A+K+++K  +   +  D ++ E     +  
Sbjct: 8   LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQAS 67
Query: 72  KHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCH 131
            HP +V LH    ++S+++ V+EYV GG+L   +  + +L E   R    ++   ++Y H
Sbjct: 68  NHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLH 127
Query: 132 NKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANR 191
            +G+ +RDLKL+N+LLDS+G+IK++D+G+    +  R        CG+PNY+APE+L   
Sbjct: 128 ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCK--EGLRPGDTTSXFCGTPNYIAPEILRGE 185
Query: 192 GYDGATSDIWSCGVILY-----------------------------IFRGDFKLPKWLSP 222
            Y G + D W+ GV+++                             I     ++P+ LS 
Sbjct: 186 DY-GFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSV 244
Query: 223 GAQNLLRKILEPNPVKRI 240
            A ++L+  L  +P +R+
Sbjct: 245 KAASVLKSFLNKDPKERL 262

>pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293

Iteration: 1
 Score =  120 bits (301), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 84/264 (31%), Positives = 127/264 (48%), Gaps = 25/264 (9%)
Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRII---HLKITDQIKREIATLKLL 71
           +Y++G  LG G FG V     +   LP A+K +EK+RI     L    ++  E+  LK +
Sbjct: 9   QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 68
Query: 72  K--HPNVVRLHEVLASKSKIYMVLEYVTG-GELFDKIASKGRLQEAEGRKLFQQLIDGVS 128
                 V+RL +         ++LE +    +LFD I  +G LQE   R  F Q+++ V 
Sbjct: 69  SSGFSGVIRLLDWFERPDSFVLILERMEPVQDLFDFITERGALQEELARSFFWQVLEAVR 128
Query: 129 YCHNKGVFHRDLKLENILLD-SKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEV 187
           +CHN GV HRD+K ENIL+D ++G +K+ DFG  AL +    D +     G+  Y  PE 
Sbjct: 129 HCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK----DTVYTDFDGTRVYSPPEW 184
Query: 188 LANRGYDGATSDIWSCGVILY--------------IFRGDFKLPKWLSPGAQNLLRKILE 233
           +    Y G ++ +WS G++LY              I RG     + +S   Q+L+R  L 
Sbjct: 185 IRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQHLIRWCLA 244
Query: 234 PNPVKRITIAGIKADEWFEQDYTP 257
             P  R T   I+   W +    P
Sbjct: 245 LRPSDRPTFEEIQNHPWMQDVLLP 268

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score =  119 bits (298), Expect = 3e-27,   Method: Compositional matrix adjust.
 Identities = 64/198 (32%), Positives = 113/198 (57%), Gaps = 6/198 (3%)
Query: 13  LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK 72
           + +Y   + +GEG+FGK    +  + G  + +K +  +R+   K  ++ +RE+A L  +K
Sbjct: 23  MEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSS-KEREESRREVAVLANMK 81
Query: 73  HPNVVRLHEVLASKSKIYMVLEYVTGGELFDKI-ASKGRL-QEAEGRKLFQQLIDGVSYC 130
           HPN+V+  E       +Y+V++Y  GG+LF +I A KG L QE +    F Q+   + + 
Sbjct: 82  HPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHV 141
Query: 131 HNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLAN 190
           H++ + HRD+K +NI L   G +++ DFG++ +     +  L     G+P Y++PE+  N
Sbjct: 142 HDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVE--LARACIGTPYYLSPEICEN 199
Query: 191 RGYDGATSDIWSCGVILY 208
           + Y+   SDIW+ G +LY
Sbjct: 200 KPYNN-KSDIWALGCVLY 216

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score =  119 bits (298), Expect = 3e-27,   Method: Compositional matrix adjust.
 Identities = 81/274 (29%), Positives = 132/274 (48%), Gaps = 38/274 (13%)
Query: 13  LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK 72
           L  Y++   LG G FG V    +  +G  FA K +      H    + +++EI T+ +L+
Sbjct: 50  LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFV---MTPHESDKETVRKEIQTMSVLR 106
Query: 73  HPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCH 131
           HP +V LH+     +++ M+ E+++GGELF+K+A +  ++ E E  +  +Q+  G+ + H
Sbjct: 107 HPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMH 166
Query: 132 NKGVFHRDLKLENILLDSK--GNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLA 189
                H DLK ENI+  +K    +K+ DFGL+A   H      +  T G+  + APEV  
Sbjct: 167 ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTA---HLDPKQSVKVTTGTAEFAAPEVAE 223
Query: 190 NRGYDGATSDIWSCGVILYI-------FRG--------DFKLPKW---------LSPGAQ 225
            +   G  +D+WS GV+ YI       F G        + K   W         +S   +
Sbjct: 224 GKPV-GYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGK 282
Query: 226 NLLRKILEPNPVKRITIAGIKADEWFEQDYTPAN 259
           + +RK+L  +P  R+TI       W     TP N
Sbjct: 283 DFIRKLLLADPNTRMTIHQALEHPWL----TPGN 312

>pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299

Iteration: 1
 Score =  119 bits (298), Expect = 3e-27,   Method: Compositional matrix adjust.
 Identities = 84/264 (31%), Positives = 126/264 (47%), Gaps = 25/264 (9%)
Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRII---HLKITDQIKREIATLKLL 71
           +Y++G  LG G FG V     +   LP A+K +EK+RI     L    ++  E+  LK +
Sbjct: 10  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 69
Query: 72  KH--PNVVRLHEVLASKSKIYMVLEYVTG-GELFDKIASKGRLQEAEGRKLFQQLIDGVS 128
                 V+RL +         ++LE      +LFD I  +G LQE   R  F Q+++ V 
Sbjct: 70  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVR 129
Query: 129 YCHNKGVFHRDLKLENILLD-SKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEV 187
           +CHN GV HRD+K ENIL+D ++G +K+ DFG  AL +    D +     G+  Y  PE 
Sbjct: 130 HCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK----DTVYTDFDGTRVYSPPEW 185
Query: 188 LANRGYDGATSDIWSCGVILY--------------IFRGDFKLPKWLSPGAQNLLRKILE 233
           +    Y G ++ +WS G++LY              I RG     + +S   Q+L+R  L 
Sbjct: 186 IRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQHLIRWCLA 245
Query: 234 PNPVKRITIAGIKADEWFEQDYTP 257
             P  R T   I+   W +    P
Sbjct: 246 LRPSDRPTFEEIQNHPWMQDVLLP 269

>pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273

Iteration: 1
 Score =  119 bits (298), Expect = 3e-27,   Method: Compositional matrix adjust.
 Identities = 84/264 (31%), Positives = 126/264 (47%), Gaps = 25/264 (9%)
Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRII---HLKITDQIKREIATLKLL 71
           +Y++G  LG G FG V     +   LP A+K +EK+RI     L    ++  E+  LK +
Sbjct: 5   QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 64
Query: 72  K--HPNVVRLHEVLASKSKIYMVLEYVTG-GELFDKIASKGRLQEAEGRKLFQQLIDGVS 128
                 V+RL +         ++LE      +LFD I  +G LQE   R  F Q+++ V 
Sbjct: 65  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVR 124
Query: 129 YCHNKGVFHRDLKLENILLD-SKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEV 187
           +CHN GV HRD+K ENIL+D ++G +K+ DFG  AL +    D +     G+  Y  PE 
Sbjct: 125 HCHNXGVLHRDIKDENILIDLNRGELKLIDFGSGALLK----DTVYTDFDGTRVYSPPEW 180
Query: 188 LANRGYDGATSDIWSCGVILY--------------IFRGDFKLPKWLSPGAQNLLRKILE 233
           +    Y G ++ +WS G++LY              I RG     + +S   Q+L+R  L 
Sbjct: 181 IRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSXECQHLIRWCLA 240
Query: 234 PNPVKRITIAGIKADEWFEQDYTP 257
             P  R T   I+   W +    P
Sbjct: 241 LRPSDRPTFEEIQNHPWMQDVLLP 264

>pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298

Iteration: 1
 Score =  119 bits (298), Expect = 3e-27,   Method: Compositional matrix adjust.
 Identities = 84/264 (31%), Positives = 126/264 (47%), Gaps = 25/264 (9%)
Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRII---HLKITDQIKREIATLKLL 71
           +Y++G  LG G FG V     +   LP A+K +EK+RI     L    ++  E+  LK +
Sbjct: 10  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 69
Query: 72  KH--PNVVRLHEVLASKSKIYMVLEYVTG-GELFDKIASKGRLQEAEGRKLFQQLIDGVS 128
                 V+RL +         ++LE      +LFD I  +G LQE   R  F Q+++ V 
Sbjct: 70  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVR 129
Query: 129 YCHNKGVFHRDLKLENILLD-SKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEV 187
           +CHN GV HRD+K ENIL+D ++G +K+ DFG  AL +    D +     G+  Y  PE 
Sbjct: 130 HCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK----DTVYTDFDGTRVYSPPEW 185
Query: 188 LANRGYDGATSDIWSCGVILY--------------IFRGDFKLPKWLSPGAQNLLRKILE 233
           +    Y G ++ +WS G++LY              I RG     + +S   Q+L+R  L 
Sbjct: 186 IRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQHLIRWCLA 245
Query: 234 PNPVKRITIAGIKADEWFEQDYTP 257
             P  R T   I+   W +    P
Sbjct: 246 LRPSDRPTFEEIQNHPWMQDVLLP 269

>pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300

Iteration: 1
 Score =  119 bits (298), Expect = 3e-27,   Method: Compositional matrix adjust.
 Identities = 84/264 (31%), Positives = 126/264 (47%), Gaps = 25/264 (9%)
Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRII---HLKITDQIKREIATLKLL 71
           +Y++G  LG G FG V     +   LP A+K +EK+RI     L    ++  E+  LK +
Sbjct: 24  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 83
Query: 72  KH--PNVVRLHEVLASKSKIYMVLEYVTG-GELFDKIASKGRLQEAEGRKLFQQLIDGVS 128
                 V+RL +         ++LE      +LFD I  +G LQE   R  F Q+++ V 
Sbjct: 84  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVR 143
Query: 129 YCHNKGVFHRDLKLENILLD-SKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEV 187
           +CHN GV HRD+K ENIL+D ++G +K+ DFG  AL +    D +     G+  Y  PE 
Sbjct: 144 HCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK----DTVYTDFDGTRVYSPPEW 199
Query: 188 LANRGYDGATSDIWSCGVILY--------------IFRGDFKLPKWLSPGAQNLLRKILE 233
           +    Y G ++ +WS G++LY              I RG     + +S   Q+L+R  L 
Sbjct: 200 IRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQHLIRWCLA 259
Query: 234 PNPVKRITIAGIKADEWFEQDYTP 257
             P  R T   I+   W +    P
Sbjct: 260 LRPSDRPTFEEIQNHPWMQDVLLP 283

>pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294

Iteration: 1
 Score =  119 bits (298), Expect = 3e-27,   Method: Compositional matrix adjust.
 Identities = 84/264 (31%), Positives = 126/264 (47%), Gaps = 25/264 (9%)
Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRII---HLKITDQIKREIATLKLL 71
           +Y++G  LG G FG V     +   LP A+K +EK+RI     L    ++  E+  LK +
Sbjct: 10  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 69
Query: 72  K--HPNVVRLHEVLASKSKIYMVLEYVTG-GELFDKIASKGRLQEAEGRKLFQQLIDGVS 128
                 V+RL +         ++LE      +LFD I  +G LQE   R  F Q+++ V 
Sbjct: 70  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVR 129
Query: 129 YCHNKGVFHRDLKLENILLD-SKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEV 187
           +CHN GV HRD+K ENIL+D ++G +K+ DFG  AL +    D +     G+  Y  PE 
Sbjct: 130 HCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK----DTVYTDFDGTRVYSPPEW 185
Query: 188 LANRGYDGATSDIWSCGVILY--------------IFRGDFKLPKWLSPGAQNLLRKILE 233
           +    Y G ++ +WS G++LY              I RG     + +S   Q+L+R  L 
Sbjct: 186 IRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQHLIRWCLA 245
Query: 234 PNPVKRITIAGIKADEWFEQDYTP 257
             P  R T   I+   W +    P
Sbjct: 246 LRPSDRPTFEEIQNHPWMQDVLLP 269

>pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293

Iteration: 1
 Score =  119 bits (298), Expect = 4e-27,   Method: Compositional matrix adjust.
 Identities = 84/264 (31%), Positives = 126/264 (47%), Gaps = 25/264 (9%)
Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRII---HLKITDQIKREIATLKLL 71
           +Y++G  LG G FG V     +   LP A+K +EK+RI     L    ++  E+  LK +
Sbjct: 9   QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 68
Query: 72  K--HPNVVRLHEVLASKSKIYMVLEYVTG-GELFDKIASKGRLQEAEGRKLFQQLIDGVS 128
                 V+RL +         ++LE      +LFD I  +G LQE   R  F Q+++ V 
Sbjct: 69  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVR 128
Query: 129 YCHNKGVFHRDLKLENILLD-SKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEV 187
           +CHN GV HRD+K ENIL+D ++G +K+ DFG  AL +    D +     G+  Y  PE 
Sbjct: 129 HCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK----DTVYTDFDGTRVYSPPEW 184
Query: 188 LANRGYDGATSDIWSCGVILY--------------IFRGDFKLPKWLSPGAQNLLRKILE 233
           +    Y G ++ +WS G++LY              I RG     + +S   Q+L+R  L 
Sbjct: 185 IRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQHLIRWCLA 244
Query: 234 PNPVKRITIAGIKADEWFEQDYTP 257
             P  R T   I+   W +    P
Sbjct: 245 LRPSDRPTFEEIQNHPWMQDVLLP 268

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score =  119 bits (297), Expect = 4e-27,   Method: Compositional matrix adjust.
 Identities = 81/274 (29%), Positives = 132/274 (48%), Gaps = 38/274 (13%)
Query: 13  LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK 72
           L  Y++   LG G FG V    +  +G  FA K +      H    + +++EI T+ +L+
Sbjct: 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFV---MTPHESDKETVRKEIQTMSVLR 212
Query: 73  HPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCH 131
           HP +V LH+     +++ M+ E+++GGELF+K+A +  ++ E E  +  +Q+  G+ + H
Sbjct: 213 HPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMH 272
Query: 132 NKGVFHRDLKLENILLDSK--GNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLA 189
                H DLK ENI+  +K    +K+ DFGL+A   H      +  T G+  + APEV  
Sbjct: 273 ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTA---HLDPKQSVKVTTGTAEFAAPEVAE 329
Query: 190 NRGYDGATSDIWSCGVILYI-------FRG--------DFKLPKW---------LSPGAQ 225
            +   G  +D+WS GV+ YI       F G        + K   W         +S   +
Sbjct: 330 GKPV-GYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGK 388
Query: 226 NLLRKILEPNPVKRITIAGIKADEWFEQDYTPAN 259
           + +RK+L  +P  R+TI       W     TP N
Sbjct: 389 DFIRKLLLADPNTRMTIHQALEHPWL----TPGN 418

>pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score =  119 bits (297), Expect = 4e-27,   Method: Compositional matrix adjust.
 Identities = 84/264 (31%), Positives = 126/264 (47%), Gaps = 25/264 (9%)
Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRII---HLKITDQIKREIATLKLL 71
           +Y++G  LG G FG V     +   LP A+K +EK+RI     L    ++  E+  LK +
Sbjct: 25  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 84
Query: 72  KH--PNVVRLHEVLASKSKIYMVLEYVTG-GELFDKIASKGRLQEAEGRKLFQQLIDGVS 128
                 V+RL +         ++LE      +LFD I  +G LQE   R  F Q+++ V 
Sbjct: 85  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVR 144
Query: 129 YCHNKGVFHRDLKLENILLD-SKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEV 187
           +CHN GV HRD+K ENIL+D ++G +K+ DFG  AL +    D +     G+  Y  PE 
Sbjct: 145 HCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK----DTVYTDFDGTRVYSPPEW 200
Query: 188 LANRGYDGATSDIWSCGVILY--------------IFRGDFKLPKWLSPGAQNLLRKILE 233
           +    Y G ++ +WS G++LY              I RG     + +S   Q+L+R  L 
Sbjct: 201 IRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQHLIRWCLA 260
Query: 234 PNPVKRITIAGIKADEWFEQDYTP 257
             P  R T   I+   W +    P
Sbjct: 261 LRPSDRPTFEEIQNHPWMQDVLLP 284

>pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score =  119 bits (297), Expect = 4e-27,   Method: Compositional matrix adjust.
 Identities = 84/264 (31%), Positives = 126/264 (47%), Gaps = 25/264 (9%)
Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRII---HLKITDQIKREIATLKLL 71
           +Y++G  LG G FG V     +   LP A+K +EK+RI     L    ++  E+  LK +
Sbjct: 25  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 84
Query: 72  KH--PNVVRLHEVLASKSKIYMVLEYVTG-GELFDKIASKGRLQEAEGRKLFQQLIDGVS 128
                 V+RL +         ++LE      +LFD I  +G LQE   R  F Q+++ V 
Sbjct: 85  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVR 144
Query: 129 YCHNKGVFHRDLKLENILLD-SKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEV 187
           +CHN GV HRD+K ENIL+D ++G +K+ DFG  AL +    D +     G+  Y  PE 
Sbjct: 145 HCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK----DTVYTDFDGTRVYSPPEW 200
Query: 188 LANRGYDGATSDIWSCGVILY--------------IFRGDFKLPKWLSPGAQNLLRKILE 233
           +    Y G ++ +WS G++LY              I RG     + +S   Q+L+R  L 
Sbjct: 201 IRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSXECQHLIRWCLA 260
Query: 234 PNPVKRITIAGIKADEWFEQDYTP 257
             P  R T   I+   W +    P
Sbjct: 261 LRPXDRPTFEEIQNHPWMQDVLLP 284

>pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313

Iteration: 1
 Score =  119 bits (297), Expect = 4e-27,   Method: Compositional matrix adjust.
 Identities = 84/264 (31%), Positives = 126/264 (47%), Gaps = 25/264 (9%)
Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRII---HLKITDQIKREIATLKLL 71
           +Y++G  LG G FG V     +   LP A+K +EK+RI     L    ++  E+  LK +
Sbjct: 37  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 96
Query: 72  KH--PNVVRLHEVLASKSKIYMVLEYVTG-GELFDKIASKGRLQEAEGRKLFQQLIDGVS 128
                 V+RL +         ++LE      +LFD I  +G LQE   R  F Q+++ V 
Sbjct: 97  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVR 156
Query: 129 YCHNKGVFHRDLKLENILLD-SKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEV 187
           +CHN GV HRD+K ENIL+D ++G +K+ DFG  AL +    D +     G+  Y  PE 
Sbjct: 157 HCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK----DTVYTDFDGTRVYSPPEW 212
Query: 188 LANRGYDGATSDIWSCGVILY--------------IFRGDFKLPKWLSPGAQNLLRKILE 233
           +    Y G ++ +WS G++LY              I RG     + +S   Q+L+R  L 
Sbjct: 213 IRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQHLIRWCLA 272
Query: 234 PNPVKRITIAGIKADEWFEQDYTP 257
             P  R T   I+   W +    P
Sbjct: 273 LRPSDRPTFEEIQNHPWMQDVLLP 296

>pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score =  119 bits (297), Expect = 4e-27,   Method: Compositional matrix adjust.
 Identities = 84/264 (31%), Positives = 126/264 (47%), Gaps = 25/264 (9%)
Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRII---HLKITDQIKREIATLKLL 71
           +Y++G  LG G FG V     +   LP A+K +EK+RI     L    ++  E+  LK +
Sbjct: 52  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 111
Query: 72  KH--PNVVRLHEVLASKSKIYMVLEYVTG-GELFDKIASKGRLQEAEGRKLFQQLIDGVS 128
                 V+RL +         ++LE      +LFD I  +G LQE   R  F Q+++ V 
Sbjct: 112 SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVR 171
Query: 129 YCHNKGVFHRDLKLENILLD-SKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEV 187
           +CHN GV HRD+K ENIL+D ++G +K+ DFG  AL +    D +     G+  Y  PE 
Sbjct: 172 HCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK----DTVYTDFDGTRVYSPPEW 227
Query: 188 LANRGYDGATSDIWSCGVILY--------------IFRGDFKLPKWLSPGAQNLLRKILE 233
           +    Y G ++ +WS G++LY              I RG     + +S   Q+L+R  L 
Sbjct: 228 IRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQHLIRWCLA 287
Query: 234 PNPVKRITIAGIKADEWFEQDYTP 257
             P  R T   I+   W +    P
Sbjct: 288 LRPSDRPTFEEIQNHPWMQDVLLP 311

>pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300

Iteration: 1
 Score =  119 bits (297), Expect = 4e-27,   Method: Compositional matrix adjust.
 Identities = 84/264 (31%), Positives = 126/264 (47%), Gaps = 25/264 (9%)
Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRII---HLKITDQIKREIATLKLL 71
           +Y++G  LG G FG V     +   LP A+K +EK+RI     L    ++  E+  LK +
Sbjct: 24  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 83
Query: 72  KH--PNVVRLHEVLASKSKIYMVLEYVTG-GELFDKIASKGRLQEAEGRKLFQQLIDGVS 128
                 V+RL +         ++LE      +LFD I  +G LQE   R  F Q+++ V 
Sbjct: 84  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVR 143
Query: 129 YCHNKGVFHRDLKLENILLD-SKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEV 187
           +CHN GV HRD+K ENIL+D ++G +K+ DFG  AL +    D +     G+  Y  PE 
Sbjct: 144 HCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK----DTVYTDFDGTRVYSPPEW 199
Query: 188 LANRGYDGATSDIWSCGVILY--------------IFRGDFKLPKWLSPGAQNLLRKILE 233
           +    Y G ++ +WS G++LY              I RG     + +S   Q+L+R  L 
Sbjct: 200 IRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSXECQHLIRWCLA 259
Query: 234 PNPVKRITIAGIKADEWFEQDYTP 257
             P  R T   I+   W +    P
Sbjct: 260 LRPSDRPTFEEIQNHPWMQDVLLP 283

>pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320

Iteration: 1
 Score =  119 bits (297), Expect = 4e-27,   Method: Compositional matrix adjust.
 Identities = 84/264 (31%), Positives = 126/264 (47%), Gaps = 25/264 (9%)
Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRII---HLKITDQIKREIATLKLL 71
           +Y++G  LG G FG V     +   LP A+K +EK+RI     L    ++  E+  LK +
Sbjct: 44  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 103
Query: 72  KH--PNVVRLHEVLASKSKIYMVLEYVTG-GELFDKIASKGRLQEAEGRKLFQQLIDGVS 128
                 V+RL +         ++LE      +LFD I  +G LQE   R  F Q+++ V 
Sbjct: 104 SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVR 163
Query: 129 YCHNKGVFHRDLKLENILLD-SKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEV 187
           +CHN GV HRD+K ENIL+D ++G +K+ DFG  AL +    D +     G+  Y  PE 
Sbjct: 164 HCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK----DTVYTDFDGTRVYSPPEW 219
Query: 188 LANRGYDGATSDIWSCGVILY--------------IFRGDFKLPKWLSPGAQNLLRKILE 233
           +    Y G ++ +WS G++LY              I RG     + +S   Q+L+R  L 
Sbjct: 220 IRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQHLIRWCLA 279
Query: 234 PNPVKRITIAGIKADEWFEQDYTP 257
             P  R T   I+   W +    P
Sbjct: 280 LRPSDRPTFEEIQNHPWMQDVLLP 303

>pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273

Iteration: 1
 Score =  119 bits (297), Expect = 4e-27,   Method: Compositional matrix adjust.
 Identities = 84/264 (31%), Positives = 126/264 (47%), Gaps = 25/264 (9%)
Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRII---HLKITDQIKREIATLKLL 71
           +Y++G  LG G FG V     +   LP A+K +EK+RI     L    ++  E+  LK +
Sbjct: 5   QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 64
Query: 72  K--HPNVVRLHEVLASKSKIYMVLEYVTG-GELFDKIASKGRLQEAEGRKLFQQLIDGVS 128
                 V+RL +         ++LE      +LFD I  +G LQE   R  F Q+++ V 
Sbjct: 65  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVR 124
Query: 129 YCHNKGVFHRDLKLENILLD-SKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEV 187
           +CHN GV HRD+K ENIL+D ++G +K+ DFG  AL +    D +     G+  Y  PE 
Sbjct: 125 HCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK----DTVYTDFDGTRVYSPPEW 180
Query: 188 LANRGYDGATSDIWSCGVILY--------------IFRGDFKLPKWLSPGAQNLLRKILE 233
           +    Y G ++ +WS G++LY              I RG     + +S   Q+L+R  L 
Sbjct: 181 IRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQHLIRWCLA 240
Query: 234 PNPVKRITIAGIKADEWFEQDYTP 257
             P  R T   I+   W +    P
Sbjct: 241 LRPSDRPTFEEIQNHPWMQDVLLP 264

>pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score =  119 bits (297), Expect = 4e-27,   Method: Compositional matrix adjust.
 Identities = 84/264 (31%), Positives = 126/264 (47%), Gaps = 25/264 (9%)
Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRII---HLKITDQIKREIATLKLL 71
           +Y++G  LG G FG V     +   LP A+K +EK+RI     L    ++  E+  LK +
Sbjct: 25  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 84
Query: 72  KH--PNVVRLHEVLASKSKIYMVLEYVTG-GELFDKIASKGRLQEAEGRKLFQQLIDGVS 128
                 V+RL +         ++LE      +LFD I  +G LQE   R  F Q+++ V 
Sbjct: 85  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVR 144
Query: 129 YCHNKGVFHRDLKLENILLD-SKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEV 187
           +CHN GV HRD+K ENIL+D ++G +K+ DFG  AL +    D +     G+  Y  PE 
Sbjct: 145 HCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK----DTVYTDFDGTRVYSPPEW 200
Query: 188 LANRGYDGATSDIWSCGVILY--------------IFRGDFKLPKWLSPGAQNLLRKILE 233
           +    Y G ++ +WS G++LY              I RG     + +S   Q+L+R  L 
Sbjct: 201 IRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSXECQHLIRWCLA 260
Query: 234 PNPVKRITIAGIKADEWFEQDYTP 257
             P  R T   I+   W +    P
Sbjct: 261 LRPSDRPTFEEIQNHPWMQDVLLP 284

>pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276

Iteration: 1
 Score =  119 bits (297), Expect = 4e-27,   Method: Compositional matrix adjust.
 Identities = 84/264 (31%), Positives = 126/264 (47%), Gaps = 25/264 (9%)
Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRII---HLKITDQIKREIATLKLL 71
           +Y++G  LG G FG V     +   LP A+K +EK+RI     L    ++  E+  LK +
Sbjct: 8   QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 67
Query: 72  K--HPNVVRLHEVLASKSKIYMVLEYVTG-GELFDKIASKGRLQEAEGRKLFQQLIDGVS 128
                 V+RL +         ++LE      +LFD I  +G LQE   R  F Q+++ V 
Sbjct: 68  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVR 127
Query: 129 YCHNKGVFHRDLKLENILLD-SKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEV 187
           +CHN GV HRD+K ENIL+D ++G +K+ DFG  AL +    D +     G+  Y  PE 
Sbjct: 128 HCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK----DTVYTDFDGTRVYSPPEW 183
Query: 188 LANRGYDGATSDIWSCGVILY--------------IFRGDFKLPKWLSPGAQNLLRKILE 233
           +    Y G ++ +WS G++LY              I RG     + +S   Q+L+R  L 
Sbjct: 184 IRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQHLIRWCLA 243
Query: 234 PNPVKRITIAGIKADEWFEQDYTP 257
             P  R T   I+   W +    P
Sbjct: 244 LRPSDRPTFEEIQNHPWMQDVLLP 267

>pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328

Iteration: 1
 Score =  119 bits (297), Expect = 5e-27,   Method: Compositional matrix adjust.
 Identities = 84/264 (31%), Positives = 126/264 (47%), Gaps = 25/264 (9%)
Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRII---HLKITDQIKREIATLKLL 71
           +Y++G  LG G FG V     +   LP A+K +EK+RI     L    ++  E+  LK +
Sbjct: 52  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 111
Query: 72  KH--PNVVRLHEVLASKSKIYMVLEYVTG-GELFDKIASKGRLQEAEGRKLFQQLIDGVS 128
                 V+RL +         ++LE      +LFD I  +G LQE   R  F Q+++ V 
Sbjct: 112 SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVR 171
Query: 129 YCHNKGVFHRDLKLENILLD-SKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEV 187
           +CHN GV HRD+K ENIL+D ++G +K+ DFG  AL +    D +     G+  Y  PE 
Sbjct: 172 HCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK----DTVYTDFDGTRVYSPPEW 227
Query: 188 LANRGYDGATSDIWSCGVILY--------------IFRGDFKLPKWLSPGAQNLLRKILE 233
           +    Y G ++ +WS G++LY              I RG     + +S   Q+L+R  L 
Sbjct: 228 IRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSXECQHLIRWCLA 287
Query: 234 PNPVKRITIAGIKADEWFEQDYTP 257
             P  R T   I+   W +    P
Sbjct: 288 LRPSDRPTFEEIQNHPWMQDVLLP 311

>pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308

Iteration: 1
 Score =  118 bits (296), Expect = 5e-27,   Method: Compositional matrix adjust.
 Identities = 84/264 (31%), Positives = 126/264 (47%), Gaps = 25/264 (9%)
Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRII---HLKITDQIKREIATLKLL 71
           +Y++G  LG G FG V     +   LP A+K +EK+RI     L    ++  E+  LK +
Sbjct: 32  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 91
Query: 72  K--HPNVVRLHEVLASKSKIYMVLEYVTG-GELFDKIASKGRLQEAEGRKLFQQLIDGVS 128
                 V+RL +         ++LE      +LFD I  +G LQE   R  F Q+++ V 
Sbjct: 92  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVR 151
Query: 129 YCHNKGVFHRDLKLENILLD-SKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEV 187
           +CHN GV HRD+K ENIL+D ++G +K+ DFG  AL +    D +     G+  Y  PE 
Sbjct: 152 HCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK----DTVYTDFDGTRVYSPPEW 207
Query: 188 LANRGYDGATSDIWSCGVILY--------------IFRGDFKLPKWLSPGAQNLLRKILE 233
           +    Y G ++ +WS G++LY              I RG     + +S   Q+L+R  L 
Sbjct: 208 IRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSXECQHLIRWCLA 267
Query: 234 PNPVKRITIAGIKADEWFEQDYTP 257
             P  R T   I+   W +    P
Sbjct: 268 LRPSDRPTFEEIQNHPWMQDVLLP 291

>pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333

Iteration: 1
 Score =  118 bits (296), Expect = 6e-27,   Method: Compositional matrix adjust.
 Identities = 84/264 (31%), Positives = 126/264 (47%), Gaps = 25/264 (9%)
Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRII---HLKITDQIKREIATLKLL 71
           +Y++G  LG G FG V     +   LP A+K +EK+RI     L    ++  E+  LK +
Sbjct: 57  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 116
Query: 72  KH--PNVVRLHEVLASKSKIYMVLEYVTG-GELFDKIASKGRLQEAEGRKLFQQLIDGVS 128
                 V+RL +         ++LE      +LFD I  +G LQE   R  F Q+++ V 
Sbjct: 117 SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVR 176
Query: 129 YCHNKGVFHRDLKLENILLD-SKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEV 187
           +CHN GV HRD+K ENIL+D ++G +K+ DFG  AL +    D +     G+  Y  PE 
Sbjct: 177 HCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK----DTVYTDFDGTRVYSPPEW 232
Query: 188 LANRGYDGATSDIWSCGVILY--------------IFRGDFKLPKWLSPGAQNLLRKILE 233
           +    Y G ++ +WS G++LY              I RG     + +S   Q+L+R  L 
Sbjct: 233 IRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSXECQHLIRWCLA 292
Query: 234 PNPVKRITIAGIKADEWFEQDYTP 257
             P  R T   I+   W +    P
Sbjct: 293 LRPSDRPTFEEIQNHPWMQDVLLP 316

>pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335

Iteration: 1
 Score =  118 bits (295), Expect = 7e-27,   Method: Compositional matrix adjust.
 Identities = 85/284 (29%), Positives = 133/284 (46%), Gaps = 27/284 (9%)
Query: 9   EGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIH-LKITD----QIKR 63
           EG    +Y     LG G FG V  A D +      VK ++K +++    I D    ++  
Sbjct: 19  EGEYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTL 78
Query: 64  EIATLKLLKHPNVVRLHEVLASKSKIYMVLE-YVTGGELFDKIASKGRLQEAEGRKLFQQ 122
           EIA L  ++H N++++ ++  ++    +V+E + +G +LF  I    RL E     +F+Q
Sbjct: 79  EIAILSRVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQ 138
Query: 123 LIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNY 182
           L+  V Y   K + HRD+K ENI++     IK+ DFG +A   +     L +T CG+  Y
Sbjct: 139 LVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAA---YLERGKLFYTFCGTIEY 195
Query: 183 VAPEVLANRGYDGATSDIWSCGVILYIF--------------RGDFKLPKWLSPGAQNLL 228
            APEVL    Y G   ++WS GV LY                      P  +S    +L+
Sbjct: 196 CAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEETVEAAIHPPYLVSKELMSLV 255
Query: 229 RKILEPNPVKRITIAGIKADEWFEQDYTPAN-PDDDEEDIFVDN 271
             +L+P P +R T+  +  D W  Q   P N  D   E++F  N
Sbjct: 256 SGLLQPVPERRTTLEKLVTDPWVTQ---PVNLADYTWEEVFRVN 296

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score =  117 bits (294), Expect = 8e-27,   Method: Compositional matrix adjust.
 Identities = 74/201 (36%), Positives = 117/201 (58%), Gaps = 14/201 (6%)
Query: 16  YELGRT--LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKH 73
           Y + +T  LG G FG+V   ++  +GL  A KI+ K R   +K  +++K EI+ +  L H
Sbjct: 89  YTVSKTEILGGGRFGQVHKCEETATGLKLAAKII-KTR--GMKDKEEVKNEISVMNQLDH 145
Query: 74  PNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKG-RLQEAEGRKLFQQLIDGVSYCHN 132
            N+++L++   SK+ I +V+EYV GGELFD+I  +   L E +     +Q+ +G+ + H 
Sbjct: 146 ANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQ 205
Query: 133 KGVFHRDLKLENILL---DSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLA 189
             + H DLK ENIL    D+K  IKI DFGL+   + ++    L    G+P ++APEV+ 
Sbjct: 206 MYILHLDLKPENILCVNRDAK-QIKIIDFGLA---RRYKPREKLKVNFGTPEFLAPEVV- 260
Query: 190 NRGYDGATSDIWSCGVILYIF 210
           N  +    +D+WS GVI Y+ 
Sbjct: 261 NYDFVSFPTDMWSVGVIAYML 281

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score =  117 bits (293), Expect = 1e-26,   Method: Compositional matrix adjust.
 Identities = 77/276 (27%), Positives = 140/276 (50%), Gaps = 34/276 (12%)
Query: 8   QEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIAT 67
           ++G     Y++   LG G FG V    +  +G  F  K +     +  K T  +K EI+ 
Sbjct: 45  KQGSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLD-KYT--VKNEISI 101
Query: 68  LKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKG-RLQEAEGRKLFQQLIDG 126
           +  L HP ++ LH+    K ++ ++LE+++GGELFD+IA++  ++ EAE     +Q  +G
Sbjct: 102 MNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEG 161
Query: 127 VSYCHNKGVFHRDLKLENILLDSK--GNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVA 184
           + + H   + H D+K ENI+ ++K   ++KI DFGL+        D ++  T  +  + A
Sbjct: 162 LKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLAT---KLNPDEIVKVTTATAEFAA 218
Query: 185 PEVLANRGYDGATSDIWSCGVILYI-------FRG--------DFKLPKW---------L 220
           PE++ +R   G  +D+W+ GV+ Y+       F G        + K   W         +
Sbjct: 219 PEIV-DREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSV 277
Query: 221 SPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYT 256
           SP A++ ++ +L+  P KR+T+       W + D++
Sbjct: 278 SPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDHS 313

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score =  116 bits (290), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 74/262 (28%), Positives = 130/262 (49%), Gaps = 32/262 (12%)
Query: 7   KQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIA 66
           + E +    +E+ R +G+G+FGKV   Q  D+   +A+K + K + +       + +E+ 
Sbjct: 8   ENEDVNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQ 67
Query: 67  TLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDG 126
            ++ L+HP +V L      +  ++MV++ + GG+L   +      +E   +    +L+  
Sbjct: 68  IMQGLEHPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMA 127
Query: 127 VSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSA-LPQHFRDDGLLHTTCGSPNYVAP 185
           + Y  N+ + HRD+K +NILLD  G++ I+DF ++A LP+    +  + T  G+  Y+AP
Sbjct: 128 LDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPR----ETQITTMAGTKPYMAP 183
Query: 186 EVLANR---GYDGATSDIWSCGVILY-IFRGD----------------------FKLPKW 219
           E+ ++R   GY  A  D WS GV  Y + RG                          P  
Sbjct: 184 EMFSSRKGAGYSFAV-DWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVTYPSA 242
Query: 220 LSPGAQNLLRKILEPNPVKRIT 241
            S    +LL+K+LEPNP +R +
Sbjct: 243 WSQEMVSLLKKLLEPNPDQRFS 264

>pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314

Iteration: 1
 Score =  116 bits (290), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 83/264 (31%), Positives = 125/264 (47%), Gaps = 25/264 (9%)
Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRII---HLKITDQIKREIATLKLL 71
           +Y++G  LG G FG V     +   LP A+K +EK+RI     L    ++  E+  LK +
Sbjct: 38  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 97
Query: 72  KH--PNVVRLHEVLASKSKIYMVLEYVTG-GELFDKIASKGRLQEAEGRKLFQQLIDGVS 128
                 V+RL +         ++LE      +LFD I  +G LQE   R  F Q+++ V 
Sbjct: 98  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVR 157
Query: 129 YCHNKGVFHRDLKLENILLD-SKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEV 187
           +CHN GV HRD+K ENIL+D ++G +K+ DFG  AL +    D +     G+  Y  PE 
Sbjct: 158 HCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK----DTVYTDFDGTRVYSPPEW 213
Query: 188 LANRGYDGATSDIWSCGVILY--------------IFRGDFKLPKWLSPGAQNLLRKILE 233
           +    Y G ++ +WS G++LY              I  G     + +S   Q+L+R  L 
Sbjct: 214 IRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGGQVFFRQRVSSECQHLIRWCLA 273
Query: 234 PNPVKRITIAGIKADEWFEQDYTP 257
             P  R T   I+   W +    P
Sbjct: 274 LRPSDRPTFEEIQNHPWMQDVLLP 297

>pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313

Iteration: 1
 Score =  115 bits (289), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 83/264 (31%), Positives = 125/264 (47%), Gaps = 25/264 (9%)
Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRII---HLKITDQIKREIATLKLL 71
           +Y++G  LG G FG V     +   LP A+K +EK+RI     L    ++  E+  LK +
Sbjct: 38  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 97
Query: 72  KH--PNVVRLHEVLASKSKIYMVLEYVTG-GELFDKIASKGRLQEAEGRKLFQQLIDGVS 128
                 V+RL +         ++LE      +LFD I  +G LQE   R  F Q+++ V 
Sbjct: 98  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVR 157
Query: 129 YCHNKGVFHRDLKLENILLD-SKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEV 187
           +CHN GV HRD+K ENIL+D ++G +K+ DFG  AL +    D +     G+  Y  PE 
Sbjct: 158 HCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK----DTVYTDFDGTRVYSPPEW 213
Query: 188 LANRGYDGATSDIWSCGVILY--------------IFRGDFKLPKWLSPGAQNLLRKILE 233
           +    Y G ++ +WS G++LY              I  G     + +S   Q+L+R  L 
Sbjct: 214 IRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGGQVFFRQRVSSECQHLIRWCLA 273
Query: 234 PNPVKRITIAGIKADEWFEQDYTP 257
             P  R T   I+   W +    P
Sbjct: 274 LRPSDRPTFEEIQNHPWMQDVLLP 297

>pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313

Iteration: 1
 Score =  115 bits (289), Expect = 4e-26,   Method: Compositional matrix adjust.
 Identities = 83/264 (31%), Positives = 125/264 (47%), Gaps = 25/264 (9%)
Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRII---HLKITDQIKREIATLKLL 71
           +Y++G  LG G FG V     +   LP A+K +EK+RI     L    ++  E+  LK +
Sbjct: 37  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 96
Query: 72  KH--PNVVRLHEVLASKSKIYMVLEYVTG-GELFDKIASKGRLQEAEGRKLFQQLIDGVS 128
                 V+RL +         ++LE      +LFD I  +G LQE   R  F Q+++ V 
Sbjct: 97  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVR 156
Query: 129 YCHNKGVFHRDLKLENILLD-SKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEV 187
           +CHN GV HRD+K ENIL+D ++G +K+ DFG  AL +    D +     G+  Y  PE 
Sbjct: 157 HCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK----DTVYTDFDGTRVYSPPEW 212
Query: 188 LANRGYDGATSDIWSCGVILY--------------IFRGDFKLPKWLSPGAQNLLRKILE 233
           +    Y G ++ +WS G++LY              I  G     + +S   Q+L+R  L 
Sbjct: 213 IRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGGQVFFRQRVSSECQHLIRWCLA 272
Query: 234 PNPVKRITIAGIKADEWFEQDYTP 257
             P  R T   I+   W +    P
Sbjct: 273 LRPSDRPTFEEIQNHPWMQDVLLP 296

>pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312

Iteration: 1
 Score =  115 bits (289), Expect = 4e-26,   Method: Compositional matrix adjust.
 Identities = 83/264 (31%), Positives = 125/264 (47%), Gaps = 25/264 (9%)
Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRII---HLKITDQIKREIATLKLL 71
           +Y++G  LG G FG V     +   LP A+K +EK+RI     L    ++  E+  LK +
Sbjct: 37  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 96
Query: 72  KH--PNVVRLHEVLASKSKIYMVLEYVTG-GELFDKIASKGRLQEAEGRKLFQQLIDGVS 128
                 V+RL +         ++LE      +LFD I  +G LQE   R  F Q+++ V 
Sbjct: 97  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVR 156
Query: 129 YCHNKGVFHRDLKLENILLD-SKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEV 187
           +CHN GV HRD+K ENIL+D ++G +K+ DFG  AL +    D +     G+  Y  PE 
Sbjct: 157 HCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK----DTVYTDFDGTRVYSPPEW 212
Query: 188 LANRGYDGATSDIWSCGVILY--------------IFRGDFKLPKWLSPGAQNLLRKILE 233
           +    Y G ++ +WS G++LY              I  G     + +S   Q+L+R  L 
Sbjct: 213 IRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGGQVFFRQRVSSECQHLIRWCLA 272
Query: 234 PNPVKRITIAGIKADEWFEQDYTP 257
             P  R T   I+   W +    P
Sbjct: 273 LRPSDRPTFEEIQNHPWMQDVLLP 296

>pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314

Iteration: 1
 Score =  115 bits (288), Expect = 4e-26,   Method: Compositional matrix adjust.
 Identities = 83/264 (31%), Positives = 125/264 (47%), Gaps = 25/264 (9%)
Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRII---HLKITDQIKREIATLKLL 71
           +Y++G  LG G FG V     +   LP A+K +EK+RI     L    ++  E+  LK +
Sbjct: 38  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 97
Query: 72  KH--PNVVRLHEVLASKSKIYMVLEYVTG-GELFDKIASKGRLQEAEGRKLFQQLIDGVS 128
                 V+RL +         ++LE      +LFD I  +G LQE   R  F Q+++ V 
Sbjct: 98  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVR 157
Query: 129 YCHNKGVFHRDLKLENILLD-SKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEV 187
           +CHN GV HRD+K ENIL+D ++G +K+ DFG  AL +    D +     G+  Y  PE 
Sbjct: 158 HCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK----DTVYTDFDGTRVYSPPEW 213
Query: 188 LANRGYDGATSDIWSCGVILY--------------IFRGDFKLPKWLSPGAQNLLRKILE 233
           +    Y G ++ +WS G++LY              I  G     + +S   Q+L+R  L 
Sbjct: 214 IRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGGQVFFRQRVSXECQHLIRWCLA 273
Query: 234 PNPVKRITIAGIKADEWFEQDYTP 257
             P  R T   I+   W +    P
Sbjct: 274 LRPSDRPTFEEIQNHPWMQDVLLP 297

>pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313

Iteration: 1
 Score =  115 bits (288), Expect = 4e-26,   Method: Compositional matrix adjust.
 Identities = 83/264 (31%), Positives = 125/264 (47%), Gaps = 25/264 (9%)
Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRII---HLKITDQIKREIATLKLL 71
           +Y++G  LG G FG V     +   LP A+K +EK+RI     L    ++  E+  LK +
Sbjct: 38  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 97
Query: 72  KH--PNVVRLHEVLASKSKIYMVLEYVTG-GELFDKIASKGRLQEAEGRKLFQQLIDGVS 128
                 V+RL +         ++LE      +LFD I  +G LQE   R  F Q+++ V 
Sbjct: 98  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVR 157
Query: 129 YCHNKGVFHRDLKLENILLD-SKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEV 187
           +CHN GV HRD+K ENIL+D ++G +K+ DFG  AL +    D +     G+  Y  PE 
Sbjct: 158 HCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK----DTVYTDFDGTRVYSPPEW 213
Query: 188 LANRGYDGATSDIWSCGVILY--------------IFRGDFKLPKWLSPGAQNLLRKILE 233
           +    Y G ++ +WS G++LY              I  G     + +S   Q+L+R  L 
Sbjct: 214 IRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGGQVFFRQRVSXECQHLIRWCLA 273
Query: 234 PNPVKRITIAGIKADEWFEQDYTP 257
             P  R T   I+   W +    P
Sbjct: 274 LRPSDRPTFEEIQNHPWMQDVLLP 297

>pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273

Iteration: 1
 Score =  115 bits (288), Expect = 4e-26,   Method: Compositional matrix adjust.
 Identities = 83/264 (31%), Positives = 125/264 (47%), Gaps = 25/264 (9%)
Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRII---HLKITDQIKREIATLKLL 71
           +Y++G  LG G FG V     +   LP A+K +EK+RI     L    ++  E+  LK +
Sbjct: 5   QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 64
Query: 72  K--HPNVVRLHEVLASKSKIYMVLEYVTG-GELFDKIASKGRLQEAEGRKLFQQLIDGVS 128
                 V+RL +         ++LE      +LFD I  +G LQE   R  F Q+++ V 
Sbjct: 65  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVR 124
Query: 129 YCHNKGVFHRDLKLENILLD-SKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEV 187
           +CHN GV HRD+K ENIL+D ++G +K+ DFG  AL +    D +     G+  Y  PE 
Sbjct: 125 HCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK----DTVYTDFDGTRVYSPPEW 180
Query: 188 LANRGYDGATSDIWSCGVILY--------------IFRGDFKLPKWLSPGAQNLLRKILE 233
           +    Y G ++ +WS G++LY              I  G     + +S   Q+L+R  L 
Sbjct: 181 IRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGGQVFFRQRVSSECQHLIRWCLA 240
Query: 234 PNPVKRITIAGIKADEWFEQDYTP 257
             P  R T   I+   W +    P
Sbjct: 241 LRPSDRPTFEEIQNHPWMQDVLLP 264

>pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313

Iteration: 1
 Score =  115 bits (288), Expect = 5e-26,   Method: Compositional matrix adjust.
 Identities = 83/264 (31%), Positives = 125/264 (47%), Gaps = 25/264 (9%)
Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRII---HLKITDQIKREIATLKLL 71
           +Y++G  LG G FG V     +   LP A+K +EK+RI     L    ++  E+  LK +
Sbjct: 37  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 96
Query: 72  KH--PNVVRLHEVLASKSKIYMVLEYVTG-GELFDKIASKGRLQEAEGRKLFQQLIDGVS 128
                 V+RL +         ++LE      +LFD I  +G LQE   R  F Q+++ V 
Sbjct: 97  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVR 156
Query: 129 YCHNKGVFHRDLKLENILLD-SKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEV 187
           +CHN GV HRD+K ENIL+D ++G +K+ DFG  AL +    D +     G+  Y  PE 
Sbjct: 157 HCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK----DTVYTDFDGTRVYSPPEW 212
Query: 188 LANRGYDGATSDIWSCGVILY--------------IFRGDFKLPKWLSPGAQNLLRKILE 233
           +    Y G ++ +WS G++LY              I  G     + +S   Q+L+R  L 
Sbjct: 213 IRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGGQVFFRQRVSXECQHLIRWCLA 272
Query: 234 PNPVKRITIAGIKADEWFEQDYTP 257
             P  R T   I+   W +    P
Sbjct: 273 LRPSDRPTFEEIQNHPWMQDVLLP 296

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score =  114 bits (284), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 76/249 (30%), Positives = 123/249 (49%), Gaps = 40/249 (16%)
Query: 35  DLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLE 94
           D+  G  F+ + +++ R   LK  D ++      K+  HPN+++L +   + +  ++V +
Sbjct: 51  DVTGGGSFSAEEVQELREATLKEVDILR------KVSGHPNIIQLKDTYETNTFFFLVFD 104
Query: 95  YVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIK 154
            +  GELFD +  K  L E E RK+ + L++ +   H   + HRDLK ENILLD   NIK
Sbjct: 105 LMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIK 164
Query: 155 ISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLA------NRGYDGATSDIWSCGVILY 208
           ++DFG S           L + CG+P+Y+APE++       + GY G   D+WS GVI+Y
Sbjct: 165 LTDFGFSC---QLDPGEKLRSVCGTPSYLAPEIIECSMNDNHPGY-GKEVDMWSTGVIMY 220
Query: 209 --------------------IFRGDFKL--PKW--LSPGAQNLLRKILEPNPVKRITIAG 244
                               I  G+++   P+W   S   ++L+ + L   P KR T   
Sbjct: 221 TLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEE 280
Query: 245 IKADEWFEQ 253
             A  +F+Q
Sbjct: 281 ALAHPFFQQ 289

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score =  113 bits (283), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 87/267 (32%), Positives = 129/267 (48%), Gaps = 39/267 (14%)
Query: 19  GRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKH-PNVV 77
            + LG G F  V+      +G  +A K L+K R        +I  EIA L+L K  P V+
Sbjct: 34  SKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQ-DCRAEILHEIAVLELAKSCPRVI 92
Query: 78  RLHEVLASKSKIYMVLEYVTGGELFDKIASK--GRLQEAEGRKLFQQLIDGVSYCHNKGV 135
            LHEV  + S+I ++LEY  GGE+F     +    + E +  +L +Q+++GV Y H   +
Sbjct: 93  NLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNI 152
Query: 136 FHRDLKLENILLDS---KGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRG 192
            H DLK +NILL S    G+IKI DFG+S    H  +   L    G+P Y+APE+L    
Sbjct: 153 VHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACE---LREIMGTPEYLAPEIL---N 206
Query: 193 YDGAT--SDIWSCGVILYI-------FRGDFKLPKWL-----------------SPGAQN 226
           YD  T  +D+W+ G+I Y+       F G+     +L                 S  A +
Sbjct: 207 YDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSEETFSSVSQLATD 266
Query: 227 LLRKILEPNPVKRITIAGIKADEWFEQ 253
            ++ +L  NP KR T     +  W +Q
Sbjct: 267 FIQSLLVKNPEKRPTAEICLSHSWLQQ 293

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score =  113 bits (282), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 76/249 (30%), Positives = 122/249 (48%), Gaps = 40/249 (16%)
Query: 35  DLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLE 94
           D+  G  F+ + +++ R   LK  D ++      K+  HPN+++L +   + +  ++V +
Sbjct: 51  DVTGGGSFSAEEVQELREATLKEVDILR------KVSGHPNIIQLKDTYETNTFFFLVFD 104
Query: 95  YVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIK 154
            +  GELFD +  K  L E E RK+ + L++ +   H   + HRDLK ENILLD   NIK
Sbjct: 105 LMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIK 164
Query: 155 ISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLA------NRGYDGATSDIWSCGVILY 208
           ++DFG S           L   CG+P+Y+APE++       + GY G   D+WS GVI+Y
Sbjct: 165 LTDFGFSC---QLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGY-GKEVDMWSTGVIMY 220
Query: 209 --------------------IFRGDFKL--PKW--LSPGAQNLLRKILEPNPVKRITIAG 244
                               I  G+++   P+W   S   ++L+ + L   P KR T   
Sbjct: 221 TLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEE 280
Query: 245 IKADEWFEQ 253
             A  +F+Q
Sbjct: 281 ALAHPFFQQ 289

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score =  112 bits (281), Expect = 3e-25,   Method: Compositional matrix adjust.
 Identities = 76/249 (30%), Positives = 122/249 (48%), Gaps = 40/249 (16%)
Query: 35  DLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLE 94
           D+  G  F+ + +++ R   LK  D ++      K+  HPN+++L +   + +  ++V +
Sbjct: 38  DVTGGGSFSAEEVQELREATLKEVDILR------KVSGHPNIIQLKDTYETNTFFFLVFD 91
Query: 95  YVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIK 154
            +  GELFD +  K  L E E RK+ + L++ +   H   + HRDLK ENILLD   NIK
Sbjct: 92  LMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIK 151
Query: 155 ISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLA------NRGYDGATSDIWSCGVILY 208
           ++DFG S           L   CG+P+Y+APE++       + GY G   D+WS GVI+Y
Sbjct: 152 LTDFGFSC---QLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGY-GKEVDMWSTGVIMY 207
Query: 209 --------------------IFRGDFKL--PKW--LSPGAQNLLRKILEPNPVKRITIAG 244
                               I  G+++   P+W   S   ++L+ + L   P KR T   
Sbjct: 208 TLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEE 267
Query: 245 IKADEWFEQ 253
             A  +F+Q
Sbjct: 268 ALAHPFFQQ 276

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score =  106 bits (265), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 63/203 (31%), Positives = 106/203 (52%), Gaps = 9/203 (4%)
Query: 11  MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKL 70
           M+   YE+ + +G G FG+V+  +   +   +A+K+L K  +I    +     E   +  
Sbjct: 66  MKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAF 125
Query: 71  LKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYC 130
              P VV+L         +YMV+EY+ GG+L + + S   + E   R    +++  +   
Sbjct: 126 ANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVN-LMSNYDVPEKWARFYTAEVVLALDAI 184
Query: 131 HNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLH--TTCGSPNYVAPEVL 188
           H+ G  HRD+K +N+LLD  G++K++DFG          +G++   T  G+P+Y++PEVL
Sbjct: 185 HSMGFIHRDVKPDNMLLDKSGHLKLADFGTC---MKMNKEGMVRCDTAVGTPDYISPEVL 241
Query: 189 ANR---GYDGATSDIWSCGVILY 208
            ++   GY G   D WS GV LY
Sbjct: 242 KSQGGDGYYGRECDWWSVGVFLY 264

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score =  106 bits (265), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 63/203 (31%), Positives = 106/203 (52%), Gaps = 9/203 (4%)
Query: 11  MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKL 70
           M+   YE+ + +G G FG+V+  +   +   +A+K+L K  +I    +     E   +  
Sbjct: 71  MKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAF 130
Query: 71  LKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYC 130
              P VV+L         +YMV+EY+ GG+L + + S   + E   R    +++  +   
Sbjct: 131 ANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVN-LMSNYDVPEKWARFYTAEVVLALDAI 189
Query: 131 HNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLH--TTCGSPNYVAPEVL 188
           H+ G  HRD+K +N+LLD  G++K++DFG          +G++   T  G+P+Y++PEVL
Sbjct: 190 HSMGFIHRDVKPDNMLLDKSGHLKLADFGTC---MKMNKEGMVRCDTAVGTPDYISPEVL 246
Query: 189 ANR---GYDGATSDIWSCGVILY 208
            ++   GY G   D WS GV LY
Sbjct: 247 KSQGGDGYYGRECDWWSVGVFLY 269

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score =  106 bits (265), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 63/203 (31%), Positives = 106/203 (52%), Gaps = 9/203 (4%)
Query: 11  MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKL 70
           M+   YE+ + +G G FG+V+  +   +   +A+K+L K  +I    +     E   +  
Sbjct: 71  MKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAF 130
Query: 71  LKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYC 130
              P VV+L         +YMV+EY+ GG+L + + S   + E   R    +++  +   
Sbjct: 131 ANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVN-LMSNYDVPEKWARFYTAEVVLALDAI 189
Query: 131 HNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLH--TTCGSPNYVAPEVL 188
           H+ G  HRD+K +N+LLD  G++K++DFG          +G++   T  G+P+Y++PEVL
Sbjct: 190 HSMGFIHRDVKPDNMLLDKSGHLKLADFGTC---MKMNKEGMVRCDTAVGTPDYISPEVL 246
Query: 189 ANR---GYDGATSDIWSCGVILY 208
            ++   GY G   D WS GV LY
Sbjct: 247 KSQGGDGYYGRECDWWSVGVFLY 269

>pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345

Iteration: 1
 Score =  106 bits (264), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 90/311 (28%), Positives = 137/311 (44%), Gaps = 73/311 (23%)
Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRI--IHLKITDQIKREIATLKLLK 72
           +Y L   +G+G++G V+ A +  +    A+KI+ KN+I  I+ K  ++IK E+  +K L 
Sbjct: 27  KYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLH 86
Query: 73  HPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIA-----SKGRL---------------- 111
           HPN+ RL+EV   +  I +V+E   GG L DK+      S G+                 
Sbjct: 87  HPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECN 146
Query: 112 -------------------QEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGN 152
                              +E     + +Q+   + Y HN+G+ HRD+K EN L  +  +
Sbjct: 147 EEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFSTNKS 206
Query: 153 --IKISDFGLSALPQHFRDDGL--LHTTCGSPNYVAPEVL--ANRGYDGATSDIWSCGVI 206
             IK+ DFGLS       +     + T  G+P +VAPEVL   N  Y G   D WS GV+
Sbjct: 207 FEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESY-GPKCDAWSAGVL 265
Query: 207 LYI-------FRG---------------DFKLPKW--LSPGAQNLLRKILEPNPVKRITI 242
           L++       F G                F+ P +  LSP A++LL  +L  N  +R   
Sbjct: 266 LHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFDA 325
Query: 243 AGIKADEWFEQ 253
                  W  Q
Sbjct: 326 MRALQHPWISQ 336

>pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score =  105 bits (262), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 83/265 (31%), Positives = 125/265 (47%), Gaps = 25/265 (9%)
Query: 14  GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRII---HLKITDQIKREIATLKL 70
            +Y++G  LG G  G V     +   LP A+K +EK+RI     L    ++  E+  LK 
Sbjct: 51  SQYQVGPLLGSGGSGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 110
Query: 71  LKH--PNVVRLHEVLASKSKIYMVLEYVTG-GELFDKIASKGRLQEAEGRKLFQQLIDGV 127
           +      V+RL +         ++LE      +LFD I  +G LQE   R  F Q+++ V
Sbjct: 111 VSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAV 170
Query: 128 SYCHNKGVFHRDLKLENILLD-SKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPE 186
            +CHN GV HRD+K ENIL+D ++G +K+ DFG  AL +    D +     G+  Y  PE
Sbjct: 171 RHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK----DTVYTDFDGTRVYSPPE 226
Query: 187 VLANRGYDGATSDIWSCGVILY--------------IFRGDFKLPKWLSPGAQNLLRKIL 232
            +    Y G ++ +WS G++LY              I RG     + +S   Q+L+R  L
Sbjct: 227 WIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQHLIRWCL 286
Query: 233 EPNPVKRITIAGIKADEWFEQDYTP 257
              P  R T   I+   W +    P
Sbjct: 287 ALRPSDRPTFEEIQNHPWMQDVLLP 311

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score =  105 bits (262), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 62/203 (30%), Positives = 108/203 (53%), Gaps = 9/203 (4%)
Query: 11  MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKL 70
           M+   Y++ + +G G FG+V+  +   S   +A+K+L K  +I    +     E   +  
Sbjct: 72  MKAEDYDVVKVIGRGAFGEVQLVRHKASQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAF 131
Query: 71  LKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYC 130
              P VV+L         +YMV+EY+ GG+L + + S   + E   +    +++  +   
Sbjct: 132 ANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVN-LMSNYDVPEKWAKFYTAEVVLALDAI 190
Query: 131 HNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLH--TTCGSPNYVAPEVL 188
           H+ G+ HRD+K +N+LLD  G++K++DFG         + G++H  T  G+P+Y++PEVL
Sbjct: 191 HSMGLIHRDVKPDNMLLDKHGHLKLADFGTC---MKMDETGMVHCDTAVGTPDYISPEVL 247
Query: 189 ANR---GYDGATSDIWSCGVILY 208
            ++   GY G   D WS GV L+
Sbjct: 248 KSQGGDGYYGRECDWWSVGVFLF 270

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score =  103 bits (257), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 70/208 (33%), Positives = 110/208 (52%), Gaps = 23/208 (11%)
Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKR----EIATLKLL 71
           YE+  T+G G++G+ +  +    G     KIL    + +  +T+  K+    E+  L+ L
Sbjct: 8   YEVLYTIGTGSYGRCQKIRRKSDG-----KILVWKELDYGSMTEAEKQMLVSEVNLLREL 62
Query: 72  KHPNVVRLHEVLASKSK--IYMVLEYVTGGELFDKIA--SKGR--LQEAEGRKLFQQLID 125
           KHPN+VR ++ +  ++   +Y+V+EY  GG+L   I   +K R  L E    ++  QL  
Sbjct: 63  KHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTL 122
Query: 126 GVSYCHNKG-----VFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP 180
            +  CH +      V HRDLK  N+ LD K N+K+ DFGL+ +  H  D     T  G+P
Sbjct: 123 ALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNH--DTSFAKTFVGTP 180
Query: 181 NYVAPEVLANRGYDGATSDIWSCGVILY 208
            Y++PE +    Y+   SDIWS G +LY
Sbjct: 181 YYMSPEQMNRMSYN-EKSDIWSLGCLLY 207

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score =  101 bits (252), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 69/208 (33%), Positives = 109/208 (52%), Gaps = 23/208 (11%)
Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKR----EIATLKLL 71
           YE+  T+G G++G+ +  +    G     KIL    + +  +T+  K+    E+  L+ L
Sbjct: 8   YEVLYTIGTGSYGRCQKIRRKSDG-----KILVWKELDYGSMTEAEKQMLVSEVNLLREL 62
Query: 72  KHPNVVRLHEVLASKSK--IYMVLEYVTGGELFDKIA--SKGR--LQEAEGRKLFQQLID 125
           KHPN+VR ++ +  ++   +Y+V+EY  GG+L   I   +K R  L E    ++  QL  
Sbjct: 63  KHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTL 122
Query: 126 GVSYCHNKG-----VFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP 180
            +  CH +      V HRDLK  N+ LD K N+K+ DFGL+ +  H  D        G+P
Sbjct: 123 ALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNH--DTSFAKAFVGTP 180
Query: 181 NYVAPEVLANRGYDGATSDIWSCGVILY 208
            Y++PE +    Y+   SDIWS G +LY
Sbjct: 181 YYMSPEQMNRMSYN-EKSDIWSLGCLLY 207

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score =  101 bits (252), Expect = 7e-22,   Method: Compositional matrix adjust.
 Identities = 69/208 (33%), Positives = 110/208 (52%), Gaps = 23/208 (11%)
Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKR----EIATLKLL 71
           YE+  T+G G++G+ +  +    G     KIL    + +  +T+  K+    E+  L+ L
Sbjct: 8   YEVLYTIGTGSYGRCQKIRRKSDG-----KILVWKELDYGSMTEAEKQMLVSEVNLLREL 62
Query: 72  KHPNVVRLHEVLASKSK--IYMVLEYVTGGELFDKIA--SKGR--LQEAEGRKLFQQLID 125
           KHPN+VR ++ +  ++   +Y+V+EY  GG+L   I   +K R  L E    ++  QL  
Sbjct: 63  KHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTL 122
Query: 126 GVSYCHNKG-----VFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP 180
            +  CH +      V HRDLK  N+ LD K N+K+ DFGL+ +  H  D+       G+P
Sbjct: 123 ALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNH--DEDFAKEFVGTP 180
Query: 181 NYVAPEVLANRGYDGATSDIWSCGVILY 208
            Y++PE +    Y+   SDIWS G +LY
Sbjct: 181 YYMSPEQMNRMSYN-EKSDIWSLGCLLY 207

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score =  101 bits (252), Expect = 8e-22,   Method: Compositional matrix adjust.
 Identities = 68/193 (35%), Positives = 108/193 (55%), Gaps = 18/193 (9%)
Query: 22  LGEGNFGKVKFAQDLDSGLPFAVKI--LEKNRIIHLKITDQIKREIATLKLLKHPNVVRL 79
           +GEG +G V  AQ+ + G  FA+K   LEK       I     REI+ LK LKH N+V+L
Sbjct: 10  IGEGTYGVVYKAQN-NYGETFALKKIRLEKE---DEGIPSTTIREISILKELKHSNIVKL 65
Query: 80  HEVLASKSKIYMVLEYVTGG--ELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFH 137
           ++V+ +K ++ +V E++     +L D    +G L+    +    QL++G++YCH++ V H
Sbjct: 66  YDVIHTKKRLVLVFEHLDQDLKKLLD--VCEGGLESVTAKSFLLQLLNGIAYCHDRRVLH 123
Query: 138 RDLKLENILLDSKGNIKISDFGLS---ALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYD 194
           RDLK +N+L++ +G +KI+DFGL+    +P       ++     +  Y AP+VL      
Sbjct: 124 RDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIV-----TLWYRAPDVLMGSKKY 178
Query: 195 GATSDIWSCGVIL 207
             T DIWS G I 
Sbjct: 179 STTIDIWSVGCIF 191

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score =  101 bits (251), Expect = 9e-22,   Method: Compositional matrix adjust.
 Identities = 68/193 (35%), Positives = 108/193 (55%), Gaps = 18/193 (9%)
Query: 22  LGEGNFGKVKFAQDLDSGLPFAVKI--LEKNRIIHLKITDQIKREIATLKLLKHPNVVRL 79
           +GEG +G V  AQ+ + G  FA+K   LEK       I     REI+ LK LKH N+V+L
Sbjct: 10  IGEGTYGVVYKAQN-NYGETFALKKIRLEKE---DEGIPSTTIREISILKELKHSNIVKL 65
Query: 80  HEVLASKSKIYMVLEYVTGG--ELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFH 137
           ++V+ +K ++ +V E++     +L D    +G L+    +    QL++G++YCH++ V H
Sbjct: 66  YDVIHTKKRLVLVFEHLDQDLKKLLD--VCEGGLESVTAKSFLLQLLNGIAYCHDRRVLH 123
Query: 138 RDLKLENILLDSKGNIKISDFGLS---ALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYD 194
           RDLK +N+L++ +G +KI+DFGL+    +P       ++     +  Y AP+VL      
Sbjct: 124 RDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEVV-----TLWYRAPDVLMGSKKY 178
Query: 195 GATSDIWSCGVIL 207
             T DIWS G I 
Sbjct: 179 STTIDIWSVGCIF 191

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score =  101 bits (251), Expect = 9e-22,   Method: Compositional matrix adjust.
 Identities = 68/193 (35%), Positives = 108/193 (55%), Gaps = 18/193 (9%)
Query: 22  LGEGNFGKVKFAQDLDSGLPFAVKI--LEKNRIIHLKITDQIKREIATLKLLKHPNVVRL 79
           +GEG +G V  AQ+ + G  FA+K   LEK       I     REI+ LK LKH N+V+L
Sbjct: 10  IGEGTYGVVYKAQN-NYGETFALKKIRLEKE---DEGIPSTTIREISILKELKHSNIVKL 65
Query: 80  HEVLASKSKIYMVLEYVTGG--ELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFH 137
           ++V+ +K ++ +V E++     +L D    +G L+    +    QL++G++YCH++ V H
Sbjct: 66  YDVIHTKKRLVLVFEHLDQDLKKLLD--VCEGGLESVTAKSFLLQLLNGIAYCHDRRVLH 123
Query: 138 RDLKLENILLDSKGNIKISDFGLS---ALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYD 194
           RDLK +N+L++ +G +KI+DFGL+    +P       ++     +  Y AP+VL      
Sbjct: 124 RDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEVV-----TLWYRAPDVLMGSKKY 178
Query: 195 GATSDIWSCGVIL 207
             T DIWS G I 
Sbjct: 179 STTIDIWSVGCIF 191

>pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400

Iteration: 1
 Score =  100 bits (248), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 79/281 (28%), Positives = 130/281 (46%), Gaps = 51/281 (18%)
Query: 19  GRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIAT-LKLLKHPNVV 77
            + LG G  GKV    +  +   FA+K+L+           + +RE+    +  + P++V
Sbjct: 67  SQVLGLGINGKVLQIFNKRTQEKFALKMLQD--------CPKARREVELHWRASQCPHIV 118
Query: 78  RLHEVL----ASKSKIYMVLEYVTGGELFDKIASKG--RLQEAEGRKLFQQLIDGVSYCH 131
           R+ +V     A +  + +V+E + GGELF +I  +G     E E  ++ + + + + Y H
Sbjct: 119 RIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH 178
Query: 132 NKGVFHRDLKLENILLDSK---GNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVL 188
           +  + HRD+K EN+L  SK     +K++DFG +   +       L T C +P YVAPEVL
Sbjct: 179 SINIAHRDVKPENLLYTSKRPNAILKLTDFGFA---KETTSHNSLTTPCYTPYYVAPEVL 235
Query: 189 ANRGYDGATSDIWSCGVILYIF--------------------------RGDFKLPKW--L 220
               YD  + D+WS GVI+YI                           + +F  P+W  +
Sbjct: 236 GPEKYD-KSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEV 294
Query: 221 SPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY-TPANP 260
           S   + L+R +L+  P +R+TI       W  Q    P  P
Sbjct: 295 SEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTP 335

>pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319

Iteration: 1
 Score =  100 bits (248), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 79/281 (28%), Positives = 130/281 (46%), Gaps = 51/281 (18%)
Query: 19  GRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIAT-LKLLKHPNVV 77
            + LG G  GKV    +  +   FA+K+L+           + +RE+    +  + P++V
Sbjct: 22  SQVLGLGINGKVLQIFNKRTQEKFALKMLQD--------CPKARREVELHWRASQCPHIV 73
Query: 78  RLHEVL----ASKSKIYMVLEYVTGGELFDKIASKG--RLQEAEGRKLFQQLIDGVSYCH 131
           R+ +V     A +  + +V+E + GGELF +I  +G     E E  ++ + + + + Y H
Sbjct: 74  RIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH 133
Query: 132 NKGVFHRDLKLENILLDSK---GNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVL 188
           +  + HRD+K EN+L  SK     +K++DFG +   +       L T C +P YVAPEVL
Sbjct: 134 SINIAHRDVKPENLLYTSKRPNAILKLTDFGFA---KETTSHNSLTTPCYTPYYVAPEVL 190
Query: 189 ANRGYDGATSDIWSCGVILYIF--------------------------RGDFKLPKW--L 220
               YD  + D+WS GVI+YI                           + +F  P+W  +
Sbjct: 191 GPEKYD-KSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEV 249
Query: 221 SPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY-TPANP 260
           S   + L+R +L+  P +R+TI       W  Q    P  P
Sbjct: 250 SEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTP 290

>pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318

Iteration: 1
 Score =  100 bits (248), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 79/281 (28%), Positives = 130/281 (46%), Gaps = 51/281 (18%)
Query: 19  GRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIAT-LKLLKHPNVV 77
            + LG G  GKV    +  +   FA+K+L+           + +RE+    +  + P++V
Sbjct: 21  SQVLGLGINGKVLQIFNKRTQEKFALKMLQD--------CPKARREVELHWRASQCPHIV 72
Query: 78  RLHEVL----ASKSKIYMVLEYVTGGELFDKIASKG--RLQEAEGRKLFQQLIDGVSYCH 131
           R+ +V     A +  + +V+E + GGELF +I  +G     E E  ++ + + + + Y H
Sbjct: 73  RIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH 132
Query: 132 NKGVFHRDLKLENILLDSK---GNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVL 188
           +  + HRD+K EN+L  SK     +K++DFG +   +       L T C +P YVAPEVL
Sbjct: 133 SINIAHRDVKPENLLYTSKRPNAILKLTDFGFA---KETTSHNSLTTPCYTPYYVAPEVL 189
Query: 189 ANRGYDGATSDIWSCGVILYIF--------------------------RGDFKLPKW--L 220
               YD  + D+WS GVI+YI                           + +F  P+W  +
Sbjct: 190 GPEKYD-KSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEV 248
Query: 221 SPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY-TPANP 260
           S   + L+R +L+  P +R+TI       W  Q    P  P
Sbjct: 249 SEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTP 289

>pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327

Iteration: 1
 Score =  100 bits (248), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 79/281 (28%), Positives = 130/281 (46%), Gaps = 51/281 (18%)
Query: 19  GRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIAT-LKLLKHPNVV 77
            + LG G  GKV    +  +   FA+K+L+           + +RE+    +  + P++V
Sbjct: 23  SQVLGLGINGKVLQIFNKRTQEKFALKMLQD--------CPKARREVELHWRASQCPHIV 74
Query: 78  RLHEVL----ASKSKIYMVLEYVTGGELFDKIASKG--RLQEAEGRKLFQQLIDGVSYCH 131
           R+ +V     A +  + +V+E + GGELF +I  +G     E E  ++ + + + + Y H
Sbjct: 75  RIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH 134
Query: 132 NKGVFHRDLKLENILLDSK---GNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVL 188
           +  + HRD+K EN+L  SK     +K++DFG +   +       L T C +P YVAPEVL
Sbjct: 135 SINIAHRDVKPENLLYTSKRPNAILKLTDFGFA---KETTSHNSLTTPCYTPYYVAPEVL 191
Query: 189 ANRGYDGATSDIWSCGVILYIF--------------------------RGDFKLPKW--L 220
               YD  + D+WS GVI+YI                           + +F  P+W  +
Sbjct: 192 GPEKYD-KSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEV 250
Query: 221 SPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY-TPANP 260
           S   + L+R +L+  P +R+TI       W  Q    P  P
Sbjct: 251 SEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTP 291

>pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324

Iteration: 1
 Score =  100 bits (248), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 79/281 (28%), Positives = 130/281 (46%), Gaps = 51/281 (18%)
Query: 19  GRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIAT-LKLLKHPNVV 77
            + LG G  GKV    +  +   FA+K+L+           + +RE+    +  + P++V
Sbjct: 27  SQVLGLGINGKVLQIFNKRTQEKFALKMLQD--------CPKARREVELHWRASQCPHIV 78
Query: 78  RLHEVL----ASKSKIYMVLEYVTGGELFDKIASKG--RLQEAEGRKLFQQLIDGVSYCH 131
           R+ +V     A +  + +V+E + GGELF +I  +G     E E  ++ + + + + Y H
Sbjct: 79  RIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH 138
Query: 132 NKGVFHRDLKLENILLDSK---GNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVL 188
           +  + HRD+K EN+L  SK     +K++DFG +   +       L T C +P YVAPEVL
Sbjct: 139 SINIAHRDVKPENLLYTSKRPNAILKLTDFGFA---KETTSHNSLTTPCYTPYYVAPEVL 195
Query: 189 ANRGYDGATSDIWSCGVILYIF--------------------------RGDFKLPKW--L 220
               YD  + D+WS GVI+YI                           + +F  P+W  +
Sbjct: 196 GPEKYD-KSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEV 254
Query: 221 SPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY-TPANP 260
           S   + L+R +L+  P +R+TI       W  Q    P  P
Sbjct: 255 SEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTP 295

>pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325

Iteration: 1
 Score =  100 bits (248), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 79/281 (28%), Positives = 130/281 (46%), Gaps = 51/281 (18%)
Query: 19  GRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIAT-LKLLKHPNVV 77
            + LG G  GKV    +  +   FA+K+L+           + +RE+    +  + P++V
Sbjct: 28  SQVLGLGINGKVLQIFNKRTQEKFALKMLQD--------CPKARREVELHWRASQCPHIV 79
Query: 78  RLHEVL----ASKSKIYMVLEYVTGGELFDKIASKG--RLQEAEGRKLFQQLIDGVSYCH 131
           R+ +V     A +  + +V+E + GGELF +I  +G     E E  ++ + + + + Y H
Sbjct: 80  RIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH 139
Query: 132 NKGVFHRDLKLENILLDSK---GNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVL 188
           +  + HRD+K EN+L  SK     +K++DFG +   +       L T C +P YVAPEVL
Sbjct: 140 SINIAHRDVKPENLLYTSKRPNAILKLTDFGFA---KETTSHNSLTTPCYTPYYVAPEVL 196
Query: 189 ANRGYDGATSDIWSCGVILYIF--------------------------RGDFKLPKW--L 220
               YD  + D+WS GVI+YI                           + +F  P+W  +
Sbjct: 197 GPEKYD-KSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEV 255
Query: 221 SPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY-TPANP 260
           S   + L+R +L+  P +R+TI       W  Q    P  P
Sbjct: 256 SEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTP 296

>pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356

Iteration: 1
 Score =  100 bits (248), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 79/281 (28%), Positives = 130/281 (46%), Gaps = 51/281 (18%)
Query: 19  GRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIAT-LKLLKHPNVV 77
            + LG G  GKV    +  +   FA+K+L+           + +RE+    +  + P++V
Sbjct: 23  SQVLGLGINGKVLQIFNKRTQEKFALKMLQD--------CPKARREVELHWRASQCPHIV 74
Query: 78  RLHEVL----ASKSKIYMVLEYVTGGELFDKIASKG--RLQEAEGRKLFQQLIDGVSYCH 131
           R+ +V     A +  + +V+E + GGELF +I  +G     E E  ++ + + + + Y H
Sbjct: 75  RIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH 134
Query: 132 NKGVFHRDLKLENILLDSK---GNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVL 188
           +  + HRD+K EN+L  SK     +K++DFG +   +       L T C +P YVAPEVL
Sbjct: 135 SINIAHRDVKPENLLYTSKRPNAILKLTDFGFA---KETTSHNSLTTPCYTPYYVAPEVL 191
Query: 189 ANRGYDGATSDIWSCGVILYIF--------------------------RGDFKLPKW--L 220
               YD  + D+WS GVI+YI                           + +F  P+W  +
Sbjct: 192 GPEKYD-KSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEV 250
Query: 221 SPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY-TPANP 260
           S   + L+R +L+  P +R+TI       W  Q    P  P
Sbjct: 251 SEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTP 291

>pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326

Iteration: 1
 Score =  100 bits (248), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 79/281 (28%), Positives = 130/281 (46%), Gaps = 51/281 (18%)
Query: 19  GRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIAT-LKLLKHPNVV 77
            + LG G  GKV    +  +   FA+K+L+           + +RE+    +  + P++V
Sbjct: 29  SQVLGLGINGKVLQIFNKRTQEKFALKMLQD--------CPKARREVELHWRASQCPHIV 80
Query: 78  RLHEVL----ASKSKIYMVLEYVTGGELFDKIASKG--RLQEAEGRKLFQQLIDGVSYCH 131
           R+ +V     A +  + +V+E + GGELF +I  +G     E E  ++ + + + + Y H
Sbjct: 81  RIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH 140
Query: 132 NKGVFHRDLKLENILLDSK---GNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVL 188
           +  + HRD+K EN+L  SK     +K++DFG +   +       L T C +P YVAPEVL
Sbjct: 141 SINIAHRDVKPENLLYTSKRPNAILKLTDFGFA---KETTSHNSLTTPCYTPYYVAPEVL 197
Query: 189 ANRGYDGATSDIWSCGVILYIF--------------------------RGDFKLPKW--L 220
               YD  + D+WS GVI+YI                           + +F  P+W  +
Sbjct: 198 GPEKYD-KSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEV 256
Query: 221 SPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY-TPANP 260
           S   + L+R +L+  P +R+TI       W  Q    P  P
Sbjct: 257 SEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTP 297

>pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334

Iteration: 1
 Score =  100 bits (248), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 79/281 (28%), Positives = 130/281 (46%), Gaps = 51/281 (18%)
Query: 19  GRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIAT-LKLLKHPNVV 77
            + LG G  GKV    +  +   FA+K+L+           + +RE+    +  + P++V
Sbjct: 37  SQVLGLGINGKVLQIFNKRTQEKFALKMLQD--------CPKARREVELHWRASQCPHIV 88
Query: 78  RLHEVL----ASKSKIYMVLEYVTGGELFDKIASKG--RLQEAEGRKLFQQLIDGVSYCH 131
           R+ +V     A +  + +V+E + GGELF +I  +G     E E  ++ + + + + Y H
Sbjct: 89  RIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH 148
Query: 132 NKGVFHRDLKLENILLDSK---GNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVL 188
           +  + HRD+K EN+L  SK     +K++DFG +   +       L T C +P YVAPEVL
Sbjct: 149 SINIAHRDVKPENLLYTSKRPNAILKLTDFGFA---KETTSHNSLTTPCYTPYYVAPEVL 205
Query: 189 ANRGYDGATSDIWSCGVILYIF--------------------------RGDFKLPKW--L 220
               YD  + D+WS GVI+YI                           + +F  P+W  +
Sbjct: 206 GPEKYD-KSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEV 264
Query: 221 SPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY-TPANP 260
           S   + L+R +L+  P +R+TI       W  Q    P  P
Sbjct: 265 SEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTP 305

>pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406

Iteration: 1
 Score =  100 bits (248), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 79/281 (28%), Positives = 130/281 (46%), Gaps = 51/281 (18%)
Query: 19  GRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIAT-LKLLKHPNVV 77
            + LG G  GKV    +  +   FA+K+L+           + +RE+    +  + P++V
Sbjct: 73  SQVLGLGINGKVLQIFNKRTQEKFALKMLQD--------CPKARREVELHWRASQCPHIV 124
Query: 78  RLHEVL----ASKSKIYMVLEYVTGGELFDKIASKG--RLQEAEGRKLFQQLIDGVSYCH 131
           R+ +V     A +  + +V+E + GGELF +I  +G     E E  ++ + + + + Y H
Sbjct: 125 RIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH 184
Query: 132 NKGVFHRDLKLENILLDSK---GNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVL 188
           +  + HRD+K EN+L  SK     +K++DFG +   +       L T C +P YVAPEVL
Sbjct: 185 SINIAHRDVKPENLLYTSKRPNAILKLTDFGFA---KETTSHNSLTTPCYTPYYVAPEVL 241
Query: 189 ANRGYDGATSDIWSCGVILYIF--------------------------RGDFKLPKW--L 220
               YD  + D+WS GVI+YI                           + +F  P+W  +
Sbjct: 242 GPEKYD-KSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEV 300
Query: 221 SPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY-TPANP 260
           S   + L+R +L+  P +R+TI       W  Q    P  P
Sbjct: 301 SEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTP 341

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score =  100 bits (248), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 61/200 (30%), Positives = 99/200 (49%), Gaps = 7/200 (3%)
Query: 13  LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK 72
           L  + + + +G G F +V  A  L  G+P A+K ++   ++  K      +EI  LK L 
Sbjct: 31  LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLN 90
Query: 73  HPNVVRLHEVLASKSKIYMVLEYVTGGELFDKI----ASKGRLQEAEGRKLFQQLIDGVS 128
           HPNV++ +      +++ +VLE    G+L   I      K  + E    K F QL   + 
Sbjct: 91  HPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALE 150
Query: 129 YCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVL 188
           + H++ V HRD+K  N+ + + G +K+ D GL             H+  G+P Y++PE +
Sbjct: 151 HMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRF--FSSKTTAAHSLVGTPYYMSPERI 208
Query: 189 ANRGYDGATSDIWSCGVILY 208
              GY+   SDIWS G +LY
Sbjct: 209 HENGYN-FKSDIWSLGCLLY 227

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 99.8 bits (247), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 65/194 (33%), Positives = 105/194 (54%), Gaps = 15/194 (7%)
Query: 22  LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHE 81
           +G G+FG V  A+   S +  AVKIL +    H +  ++  RE+A +K L+HPN+V    
Sbjct: 45  IGAGSFGTVHRAEWHGSDV--AVKILMEQDF-HAERVNEFLREVAIMKRLRHPNIVLFMG 101
Query: 82  VLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLID---GVSYCHNKG--VF 136
            +     + +V EY++ G L+  +   G  ++ + R+      D   G++Y HN+   + 
Sbjct: 102 AVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIV 161
Query: 137 HRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHT--TCGSPNYVAPEVLANRGYD 194
           HRDLK  N+L+D K  +K+ DFGLS L    +    L +    G+P ++APEVL +    
Sbjct: 162 HRDLKSPNLLVDKKYTVKVCDFGLSRL----KASXFLXSKXAAGTPEWMAPEVLRDEP-S 216
Query: 195 GATSDIWSCGVILY 208
              SD++S GVIL+
Sbjct: 217 NEKSDVYSFGVILW 230

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score = 99.8 bits (247), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 72/206 (34%), Positives = 106/206 (51%), Gaps = 24/206 (11%)
Query: 22  LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK-HPNVVRLH 80
           LGEG + KV+ A  L +G  +AVKI+EK +  H +   ++ RE+ TL   + + N++ L 
Sbjct: 21  LGEGAYAKVQGAVSLQNGKEYAVKIIEK-QAGHSR--SRVFREVETLYQCQGNKNILELI 77
Query: 81  EVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDL 140
           E     ++ Y+V E + GG +   I  +    E E  ++ + +   + + H KG+ HRDL
Sbjct: 78  EFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDL 137
Query: 141 KLENILLDSK---GNIKISDFGL--------SALPQHFRDDGLLHTTCGSPNYVAPEVLA 189
           K ENIL +S      +KI DF L        S  P    +   L T CGS  Y+APEV+ 
Sbjct: 138 KPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPE---LTTPCGSAEYMAPEVV- 193
Query: 190 NRGYDGAT-----SDIWSCGVILYIF 210
               D AT      D+WS GV+LYI 
Sbjct: 194 EVFTDQATFYDKRCDLWSLGVVLYIM 219

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score = 99.4 bits (246), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 64/211 (30%), Positives = 109/211 (51%), Gaps = 12/211 (5%)
Query: 7   KQEGMRLGR--YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKRE 64
           K + MRL R  +E+ + +G G FG+V   +  ++   FA+KIL K  ++    T   + E
Sbjct: 65  KVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREE 124
Query: 65  IATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQL 123
              L       +  LH      + +Y+V++Y  GG+L   ++  + RL E   R    ++
Sbjct: 125 RDVLVNGDSKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEM 184
Query: 124 IDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTT--CGSPN 181
           +  +   H     HRD+K +NIL+D  G+I+++DFG S L     +DG + ++   G+P+
Sbjct: 185 VIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFG-SCL--KLMEDGTVQSSVAVGTPD 241
Query: 182 YVAPEVL----ANRGYDGATSDIWSCGVILY 208
           Y++PE+L      +G  G   D WS GV +Y
Sbjct: 242 YISPEILQAMEGGKGRYGPECDWWSLGVCMY 272

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 99.4 bits (246), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 62/198 (31%), Positives = 111/198 (56%), Gaps = 12/198 (6%)
Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
           +E+   LG+G FGKV  AQ+ ++ +  A K+++      L   +    EI  L    HPN
Sbjct: 39  WEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEEL---EDYMVEIDILASCDHPN 95
Query: 76  VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGR-LQEAEGRKLFQQLIDGVSYCHNKG 134
           +V+L +    ++ +++++E+  GG +   +    R L E++ + + +Q +D ++Y H+  
Sbjct: 96  IVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNK 155
Query: 135 VFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLA----- 189
           + HRDLK  NIL    G+IK++DFG+SA  ++ R      +  G+P ++APEV+      
Sbjct: 156 IIHRDLKAGNILFTLDGDIKLADFGVSA--KNTRTIQRRDSFIGTPYWMAPEVVMCETSK 213
Query: 190 NRGYDGATSDIWSCGVIL 207
           +R YD   +D+WS G+ L
Sbjct: 214 DRPYD-YKADVWSLGITL 230

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 99.4 bits (246), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 62/198 (31%), Positives = 111/198 (56%), Gaps = 12/198 (6%)
Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
           +E+   LG+G FGKV  AQ+ ++ +  A K+++      L   +    EI  L    HPN
Sbjct: 39  WEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEEL---EDYMVEIDILASCDHPN 95
Query: 76  VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGR-LQEAEGRKLFQQLIDGVSYCHNKG 134
           +V+L +    ++ +++++E+  GG +   +    R L E++ + + +Q +D ++Y H+  
Sbjct: 96  IVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNK 155
Query: 135 VFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLA----- 189
           + HRDLK  NIL    G+IK++DFG+SA  ++ R      +  G+P ++APEV+      
Sbjct: 156 IIHRDLKAGNILFTLDGDIKLADFGVSA--KNTRXIQRRDSFIGTPYWMAPEVVMCETSK 213
Query: 190 NRGYDGATSDIWSCGVIL 207
           +R YD   +D+WS G+ L
Sbjct: 214 DRPYD-YKADVWSLGITL 230

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 99.4 bits (246), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 58/186 (31%), Positives = 107/186 (57%), Gaps = 7/186 (3%)
Query: 22  LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHE 81
           +GEG+ G V  A++  SG   AVK+++  +    +  + +  E+  ++  +H NVV +++
Sbjct: 53  IGEGSTGIVCLAREKHSGRQVAVKMMDLRK---QQRRELLFNEVVIMRDYQHFNVVEMYK 109
Query: 82  VLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLK 141
                 ++++++E++ GG L D I S+ RL E +   + + ++  ++Y H +GV HRD+K
Sbjct: 110 SYLVGEELWVLMEFLQGGALTD-IVSQVRLNEEQIATVCEAVLQALAYLHAQGVIHRDIK 168
Query: 142 LENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIW 201
            ++ILL   G +K+SDFG  A  Q  +D        G+P ++APEV++   Y     DIW
Sbjct: 169 SDSILLTLDGRVKLSDFGFCA--QISKDVPKRKXLVGTPYWMAPEVISRSLY-ATEVDIW 225
Query: 202 SCGVIL 207
           S G+++
Sbjct: 226 SLGIMV 231

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 99.0 bits (245), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 78/262 (29%), Positives = 130/262 (49%), Gaps = 31/262 (11%)
Query: 22  LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHE 81
           +GEG +G V  A++  +G   A+K +  +      +     REI+ LK L HPN+V+L +
Sbjct: 14  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETE-GVPSTAIREISLLKELNHPNIVKLLD 72
Query: 82  VLASKSKIYMVLEYVTGG--ELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRD 139
           V+ +++K+Y+V E+++    +  D  A  G         LFQ L+ G+++CH+  V HRD
Sbjct: 73  VIHTENKLYLVFEFLSMDLKKFMDASALTGIPLPLIKSYLFQ-LLQGLAFCHSHRVLHRD 131
Query: 140 LKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTT----CGSPNYVAPEVLANRGYDG 195
           LK EN+L++++G IK++DFGL+      R  G+   T      +  Y APE+L    Y  
Sbjct: 132 LKPENLLINTEGAIKLADFGLA------RAFGVPVRTYXHEVVTLWYRAPEILLGCKYYS 185
Query: 196 ATSDIWSCGVIL-------YIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRITIAGI--- 245
              DIWS G I         +F GD ++ +        + R +  P+ V    +  +   
Sbjct: 186 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLF-----RIFRTLGTPDEVVWPGVTSMPDY 240
Query: 246 --KADEWFEQDYTPANPDDDEE 265
                +W  QD++   P  DE+
Sbjct: 241 KPSFPKWARQDFSKVVPPLDED 262

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 99.0 bits (245), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 78/262 (29%), Positives = 130/262 (49%), Gaps = 31/262 (11%)
Query: 22  LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHE 81
           +GEG +G V  A++  +G   A+K +  +      +     REI+ LK L HPN+V+L +
Sbjct: 12  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETE-GVPSTAIREISLLKELNHPNIVKLLD 70
Query: 82  VLASKSKIYMVLEYVTGG--ELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRD 139
           V+ +++K+Y+V E+++    +  D  A  G         LFQ L+ G+++CH+  V HRD
Sbjct: 71  VIHTENKLYLVFEFLSMDLKKFMDASALTGIPLPLIKSYLFQ-LLQGLAFCHSHRVLHRD 129
Query: 140 LKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTT----CGSPNYVAPEVLANRGYDG 195
           LK EN+L++++G IK++DFGL+      R  G+   T      +  Y APE+L    Y  
Sbjct: 130 LKPENLLINTEGAIKLADFGLA------RAFGVPVRTYXHEVVTLWYRAPEILLGCKYYS 183
Query: 196 ATSDIWSCGVIL-------YIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRITIAGI--- 245
              DIWS G I         +F GD ++ +        + R +  P+ V    +  +   
Sbjct: 184 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLF-----RIFRTLGTPDEVVWPGVTSMPDY 238
Query: 246 --KADEWFEQDYTPANPDDDEE 265
                +W  QD++   P  DE+
Sbjct: 239 KPSFPKWARQDFSKVVPPLDED 260

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 99.0 bits (245), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 67/208 (32%), Positives = 112/208 (53%), Gaps = 8/208 (3%)
Query: 22  LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHE 81
           +GEG+ G V  A +  +G   AVK ++  +    +  + +  E+  ++   H NVV ++ 
Sbjct: 53  IGEGSTGIVCIATEKHTGKQVAVKKMDLRK---QQRRELLFNEVVIMRDYHHDNVVDMYS 109
Query: 82  VLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLK 141
                 ++++V+E++ GG L D I +  R+ E +   +   ++  +SY HN+GV HRD+K
Sbjct: 110 SYLVGDELWVVMEFLEGGALTD-IVTHTRMNEEQIATVCLSVLRALSYLHNQGVIHRDIK 168
Query: 142 LENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIW 201
            ++ILL S G IK+SDFG  A  Q  ++        G+P ++APEV++   Y G   DIW
Sbjct: 169 SDSILLTSDGRIKLSDFGFCA--QVSKEVPKRKXLVGTPYWMAPEVISRLPY-GTEVDIW 225
Query: 202 SCGVILYIFRGDFKLPKWLSPGAQNLLR 229
           S G I+ I   D + P +  P  Q + R
Sbjct: 226 SLG-IMVIEMIDGEPPYFNEPPLQAMRR 252

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 98.6 bits (244), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 62/198 (31%), Positives = 110/198 (55%), Gaps = 12/198 (6%)
Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
           +E+   LG+G FGKV  AQ+ ++ +  A K+++      L   +    EI  L    HPN
Sbjct: 39  WEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEEL---EDYMVEIDILASCDHPN 95
Query: 76  VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGR-LQEAEGRKLFQQLIDGVSYCHNKG 134
           +V+L +    ++ +++++E+  GG +   +    R L E++ + + +Q +D ++Y H+  
Sbjct: 96  IVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNK 155
Query: 135 VFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLA----- 189
           + HRDLK  NIL    G+IK++DFG+SA  ++ R         G+P ++APEV+      
Sbjct: 156 IIHRDLKAGNILFTLDGDIKLADFGVSA--KNTRXIQRRDXFIGTPYWMAPEVVMCETSK 213
Query: 190 NRGYDGATSDIWSCGVIL 207
           +R YD   +D+WS G+ L
Sbjct: 214 DRPYD-YKADVWSLGITL 230

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 98.2 bits (243), Expect = 7e-21,   Method: Compositional matrix adjust.
 Identities = 77/262 (29%), Positives = 130/262 (49%), Gaps = 31/262 (11%)
Query: 22  LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHE 81
           +GEG +G V  A++  +G   A+K +  +      +     REI+ LK L HPN+V+L +
Sbjct: 13  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETE-GVPSTAIREISLLKELNHPNIVKLLD 71
Query: 82  VLASKSKIYMVLEYVTGG--ELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRD 139
           V+ +++K+Y+V E+++    +  D  A  G         LFQ L+ G+++CH+  V HRD
Sbjct: 72  VIHTENKLYLVFEFLSMDLKDFMDASALTGIPLPLIKSYLFQ-LLQGLAFCHSHRVLHRD 130
Query: 140 LKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTT----CGSPNYVAPEVLANRGYDG 195
           LK +N+L++++G IK++DFGL+      R  G+   T      +  Y APE+L    Y  
Sbjct: 131 LKPQNLLINTEGAIKLADFGLA------RAFGVPVRTYXHEVVTLWYRAPEILLGCKYYS 184
Query: 196 ATSDIWSCGVIL-------YIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRITIAGI--- 245
              DIWS G I         +F GD ++ +        + R +  P+ V    +  +   
Sbjct: 185 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLF-----RIFRTLGTPDEVVWPGVTSMPDY 239
Query: 246 --KADEWFEQDYTPANPDDDEE 265
                +W  QD++   P  DE+
Sbjct: 240 KPSFPKWARQDFSKVVPPLDED 261

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 98.2 bits (243), Expect = 7e-21,   Method: Compositional matrix adjust.
 Identities = 77/262 (29%), Positives = 130/262 (49%), Gaps = 31/262 (11%)
Query: 22  LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHE 81
           +GEG +G V  A++  +G   A+K +  +      +     REI+ LK L HPN+V+L +
Sbjct: 14  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETE-GVPSTAIREISLLKELNHPNIVKLLD 72
Query: 82  VLASKSKIYMVLEYVTGG--ELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRD 139
           V+ +++K+Y+V E+++    +  D  A  G         LFQ L+ G+++CH+  V HRD
Sbjct: 73  VIHTENKLYLVFEFLSMDLKDFMDASALTGIPLPLIKSYLFQ-LLQGLAFCHSHRVLHRD 131
Query: 140 LKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTT----CGSPNYVAPEVLANRGYDG 195
           LK +N+L++++G IK++DFGL+      R  G+   T      +  Y APE+L    Y  
Sbjct: 132 LKPQNLLINTEGAIKLADFGLA------RAFGVPVRTYXHEVVTLWYRAPEILLGCKYYS 185
Query: 196 ATSDIWSCGVIL-------YIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRITIAGI--- 245
              DIWS G I         +F GD ++ +        + R +  P+ V    +  +   
Sbjct: 186 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLF-----RIFRTLGTPDEVVWPGVTSMPDY 240
Query: 246 --KADEWFEQDYTPANPDDDEE 265
                +W  QD++   P  DE+
Sbjct: 241 KPSFPKWARQDFSKVVPPLDED 262

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 98.2 bits (243), Expect = 7e-21,   Method: Compositional matrix adjust.
 Identities = 73/265 (27%), Positives = 126/265 (47%), Gaps = 30/265 (11%)
Query: 11  MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKL 70
           + +  + + R +G G FG+V   +  D+G  +A+K L+K RI   +       E   L L
Sbjct: 186 LTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSL 245
Query: 71  LKH---PNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGV 127
           +     P +V +     +  K+  +L+ + GG+L   ++  G   EA+ R    ++I G+
Sbjct: 246 VSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGL 305
Query: 128 SYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEV 187
            + HN+ V +RDLK  NILLD  G+++ISD GL+      +     H + G+  Y+APEV
Sbjct: 306 EHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP----HASVGTHGYMAPEV 361
Query: 188 LANRGYDGATSDIWSCGVILY-IFRGD----------------------FKLPKWLSPGA 224
           L       +++D +S G +L+ + RG                        +LP   SP  
Sbjct: 362 LQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPEL 421
Query: 225 QNLLRKILEPNPVKRITIAGIKADE 249
           ++LL  +L+ +  +R+   G  A E
Sbjct: 422 RSLLEGLLQRDVNRRLGCLGRGAQE 446

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 98.2 bits (243), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 64/194 (32%), Positives = 105/194 (54%), Gaps = 15/194 (7%)
Query: 22  LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHE 81
           +G G+FG V  A+   S +  AVKIL +    H +  ++  RE+A +K L+HPN+V    
Sbjct: 45  IGAGSFGTVHRAEWHGSDV--AVKILMEQDF-HAERVNEFLREVAIMKRLRHPNIVLFMG 101
Query: 82  VLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLID---GVSYCHNKG--VF 136
            +     + +V EY++ G L+  +   G  ++ + R+      D   G++Y HN+   + 
Sbjct: 102 AVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIV 161
Query: 137 HRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLH--TTCGSPNYVAPEVLANRGYD 194
           HR+LK  N+L+D K  +K+ DFGLS L    +    L   +  G+P ++APEVL +    
Sbjct: 162 HRNLKSPNLLVDKKYTVKVCDFGLSRL----KASTFLSSKSAAGTPEWMAPEVLRDEP-S 216
Query: 195 GATSDIWSCGVILY 208
              SD++S GVIL+
Sbjct: 217 NEKSDVYSFGVILW 230

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 98.2 bits (243), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 73/265 (27%), Positives = 126/265 (47%), Gaps = 30/265 (11%)
Query: 11  MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKL 70
           + +  + + R +G G FG+V   +  D+G  +A+K L+K RI   +       E   L L
Sbjct: 186 LTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSL 245
Query: 71  LKH---PNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGV 127
           +     P +V +     +  K+  +L+ + GG+L   ++  G   EA+ R    ++I G+
Sbjct: 246 VSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGL 305
Query: 128 SYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEV 187
            + HN+ V +RDLK  NILLD  G+++ISD GL+      +     H + G+  Y+APEV
Sbjct: 306 EHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP----HASVGTHGYMAPEV 361
Query: 188 LANRGYDGATSDIWSCGVILY-IFRGD----------------------FKLPKWLSPGA 224
           L       +++D +S G +L+ + RG                        +LP   SP  
Sbjct: 362 LQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPEL 421
Query: 225 QNLLRKILEPNPVKRITIAGIKADE 249
           ++LL  +L+ +  +R+   G  A E
Sbjct: 422 RSLLEGLLQRDVNRRLGCLGRGAQE 446

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 98.2 bits (243), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 73/265 (27%), Positives = 126/265 (47%), Gaps = 30/265 (11%)
Query: 11  MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKL 70
           + +  + + R +G G FG+V   +  D+G  +A+K L+K RI   +       E   L L
Sbjct: 186 LTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSL 245
Query: 71  LKH---PNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGV 127
           +     P +V +     +  K+  +L+ + GG+L   ++  G   EA+ R    ++I G+
Sbjct: 246 VSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGL 305
Query: 128 SYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEV 187
            + HN+ V +RDLK  NILLD  G+++ISD GL+      +     H + G+  Y+APEV
Sbjct: 306 EHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP----HASVGTHGYMAPEV 361
Query: 188 LANRGYDGATSDIWSCGVILY-IFRGD----------------------FKLPKWLSPGA 224
           L       +++D +S G +L+ + RG                        +LP   SP  
Sbjct: 362 LQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPEL 421
Query: 225 QNLLRKILEPNPVKRITIAGIKADE 249
           ++LL  +L+ +  +R+   G  A E
Sbjct: 422 RSLLEGLLQRDVNRRLGCLGRGAQE 446

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 98.2 bits (243), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 73/265 (27%), Positives = 126/265 (47%), Gaps = 30/265 (11%)
Query: 11  MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKL 70
           + +  + + R +G G FG+V   +  D+G  +A+K L+K RI   +       E   L L
Sbjct: 185 LTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSL 244
Query: 71  LKH---PNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGV 127
           +     P +V +     +  K+  +L+ + GG+L   ++  G   EA+ R    ++I G+
Sbjct: 245 VSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGL 304
Query: 128 SYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEV 187
            + HN+ V +RDLK  NILLD  G+++ISD GL+      +     H + G+  Y+APEV
Sbjct: 305 EHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP----HASVGTHGYMAPEV 360
Query: 188 LANRGYDGATSDIWSCGVILY-IFRGD----------------------FKLPKWLSPGA 224
           L       +++D +S G +L+ + RG                        +LP   SP  
Sbjct: 361 LQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPEL 420
Query: 225 QNLLRKILEPNPVKRITIAGIKADE 249
           ++LL  +L+ +  +R+   G  A E
Sbjct: 421 RSLLEGLLQRDVNRRLGCLGRGAQE 445

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 97.8 bits (242), Expect = 9e-21,   Method: Compositional matrix adjust.
 Identities = 78/262 (29%), Positives = 129/262 (49%), Gaps = 31/262 (11%)
Query: 22  LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHE 81
           +GEG +G V  A++  +G   A+K +  +      +     REI+ LK L HPN+V+L +
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETE-GVPSTAIREISLLKELNHPNIVKLLD 69
Query: 82  VLASKSKIYMVLEYVTGG--ELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRD 139
           V+ +++K+Y+V E++     +  D  A  G         LFQ L+ G+++CH+  V HRD
Sbjct: 70  VIHTENKLYLVFEFLHQDLKDFMDASALTGIPLPLIKSYLFQ-LLQGLAFCHSHRVLHRD 128
Query: 140 LKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTT----CGSPNYVAPEVLANRGYDG 195
           LK EN+L++++G IK++DFGL+      R  G+   T      +  Y APE+L    Y  
Sbjct: 129 LKPENLLINTEGAIKLADFGLA------RAFGVPVRTYXHEVVTLWYRAPEILLGCKYYS 182
Query: 196 ATSDIWSCGVIL-------YIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRITIAGI--- 245
              DIWS G I         +F GD ++ +        + R +  P+ V    +  +   
Sbjct: 183 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLF-----RIFRTLGTPDEVVWPGVTSMPDY 237
Query: 246 --KADEWFEQDYTPANPDDDEE 265
                +W  QD++   P  DE+
Sbjct: 238 KPSFPKWARQDFSKVVPPLDED 259

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 97.8 bits (242), Expect = 9e-21,   Method: Compositional matrix adjust.
 Identities = 78/262 (29%), Positives = 129/262 (49%), Gaps = 31/262 (11%)
Query: 22  LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHE 81
           +GEG +G V  A++  +G   A+K +  +      +     REI+ LK L HPN+V+L +
Sbjct: 13  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETE-GVPSTAIREISLLKELNHPNIVKLLD 71
Query: 82  VLASKSKIYMVLEYVTGG--ELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRD 139
           V+ +++K+Y+V E++     +  D  A  G         LFQ L+ G+++CH+  V HRD
Sbjct: 72  VIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ-LLQGLAFCHSHRVLHRD 130
Query: 140 LKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTT----CGSPNYVAPEVLANRGYDG 195
           LK EN+L++++G IK++DFGL+      R  G+   T      +  Y APE+L    Y  
Sbjct: 131 LKPENLLINTEGAIKLADFGLA------RAFGVPVRTYXHEVVTLWYRAPEILLGCKYYS 184
Query: 196 ATSDIWSCGVIL-------YIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRITIAGI--- 245
              DIWS G I         +F GD ++ +        + R +  P+ V    +  +   
Sbjct: 185 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLF-----RIFRTLGTPDEVVWPGVTSMPDY 239
Query: 246 --KADEWFEQDYTPANPDDDEE 265
                +W  QD++   P  DE+
Sbjct: 240 KPSFPKWARQDFSKVVPPLDED 261

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 97.8 bits (242), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 78/262 (29%), Positives = 129/262 (49%), Gaps = 31/262 (11%)
Query: 22  LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHE 81
           +GEG +G V  A++  +G   A+K +  +      +     REI+ LK L HPN+V+L +
Sbjct: 12  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETE-GVPSTAIREISLLKELNHPNIVKLLD 70
Query: 82  VLASKSKIYMVLEYVTGG--ELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRD 139
           V+ +++K+Y+V E++     +  D  A  G         LFQ L+ G+++CH+  V HRD
Sbjct: 71  VIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ-LLQGLAFCHSHRVLHRD 129
Query: 140 LKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTT----CGSPNYVAPEVLANRGYDG 195
           LK EN+L++++G IK++DFGL+      R  G+   T      +  Y APE+L    Y  
Sbjct: 130 LKPENLLINTEGAIKLADFGLA------RAFGVPVRTYXHEVVTLWYRAPEILLGCKYYS 183
Query: 196 ATSDIWSCGVIL-------YIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRITIAGI--- 245
              DIWS G I         +F GD ++ +        + R +  P+ V    +  +   
Sbjct: 184 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLF-----RIFRTLGTPDEVVWPGVTSMPDY 238
Query: 246 --KADEWFEQDYTPANPDDDEE 265
                +W  QD++   P  DE+
Sbjct: 239 KPSFPKWARQDFSKVVPPLDED 260

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 97.8 bits (242), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 65/204 (31%), Positives = 107/204 (52%), Gaps = 19/204 (9%)
Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKI--LEKNRIIHLKITDQIKREIATLKLLKH 73
           YEL   +G G    V+ A         A+K   LEK +       D++ +EI  +    H
Sbjct: 17  YELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTS----MDELLKEIQAMSQCHH 72
Query: 74  PNVVRLHEVLASKSKIYMVLEYVTGGELFD---KIASKGR-----LQEAEGRKLFQQLID 125
           PN+V  +     K ++++V++ ++GG + D    I +KG      L E+    + +++++
Sbjct: 73  PNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLE 132
Query: 126 GVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD---DGLLHTTCGSPNY 182
           G+ Y H  G  HRD+K  NILL   G+++I+DFG+SA      D   + +  T  G+P +
Sbjct: 133 GLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCW 192
Query: 183 VAPEVLAN-RGYDGATSDIWSCGV 205
           +APEV+   RGYD   +DIWS G+
Sbjct: 193 MAPEVMEQVRGYD-FKADIWSFGI 215

>pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320

Iteration: 1
 Score = 97.8 bits (242), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 78/281 (27%), Positives = 129/281 (45%), Gaps = 51/281 (18%)
Query: 19  GRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIAT-LKLLKHPNVV 77
            + LG G  GKV    +  +   FA+K+L+           + +RE+    +  + P++V
Sbjct: 21  SQVLGLGINGKVLQIFNKRTQEKFALKMLQD--------CPKARREVELHWRASQCPHIV 72
Query: 78  RLHEVL----ASKSKIYMVLEYVTGGELFDKIASKG--RLQEAEGRKLFQQLIDGVSYCH 131
           R+ +V     A +  + +V+E + GGELF +I  +G     E E  ++ + + + + Y H
Sbjct: 73  RIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH 132
Query: 132 NKGVFHRDLKLENILLDSK---GNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVL 188
           +  + HRD+K EN+L  SK     +K++DFG +   +       L   C +P YVAPEVL
Sbjct: 133 SINIAHRDVKPENLLYTSKRPNAILKLTDFGFA---KETTSHNSLTEPCYTPYYVAPEVL 189
Query: 189 ANRGYDGATSDIWSCGVILYIF--------------------------RGDFKLPKW--L 220
               YD  + D+WS GVI+YI                           + +F  P+W  +
Sbjct: 190 GPEKYD-KSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEV 248
Query: 221 SPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY-TPANP 260
           S   + L+R +L+  P +R+TI       W  Q    P  P
Sbjct: 249 SEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTP 289

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 97.8 bits (242), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 78/262 (29%), Positives = 129/262 (49%), Gaps = 31/262 (11%)
Query: 22  LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHE 81
           +GEG +G V  A++  +G   A+K +  +      +     REI+ LK L HPN+V+L +
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETE-GVPSTAIREISLLKELNHPNIVKLLD 69
Query: 82  VLASKSKIYMVLEYVTGG--ELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRD 139
           V+ +++K+Y+V E++     +  D  A  G         LFQ L+ G+S+CH+  V HRD
Sbjct: 70  VIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ-LLQGLSFCHSHRVLHRD 128
Query: 140 LKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTT----CGSPNYVAPEVLANRGYDG 195
           LK +N+L++++G IK++DFGL+      R  G+   T      +  Y APE+L    Y  
Sbjct: 129 LKPQNLLINTEGAIKLADFGLA------RAFGVPVRTYTHEVVTLWYRAPEILLGCKYYS 182
Query: 196 ATSDIWSCGVIL-------YIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRITIAGI--- 245
              DIWS G I         +F GD ++ +        + R +  P+ V    +  +   
Sbjct: 183 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLF-----RIFRTLGTPDEVVWPGVTSMPDY 237
Query: 246 --KADEWFEQDYTPANPDDDEE 265
                +W  QD++   P  DE+
Sbjct: 238 KPSFPKWARQDFSKVVPPLDED 259

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 97.8 bits (242), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 77/262 (29%), Positives = 129/262 (49%), Gaps = 31/262 (11%)
Query: 22  LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHE 81
           +GEG +G V  A++  +G   A+K +  +      +     REI+ LK L HPN+V+L +
Sbjct: 18  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETE-GVPSTAIREISLLKELNHPNIVKLLD 76
Query: 82  VLASKSKIYMVLEYVTGG--ELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRD 139
           V+ +++K+Y+V E++     +  D  A  G         LFQ L+ G+++CH+  V HRD
Sbjct: 77  VIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ-LLQGLAFCHSHRVLHRD 135
Query: 140 LKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTT----CGSPNYVAPEVLANRGYDG 195
           LK +N+L++++G IK++DFGL+      R  G+   T      +  Y APE+L    Y  
Sbjct: 136 LKPQNLLINTEGAIKLADFGLA------RAFGVPVRTYTHEVVTLWYRAPEILLGXKYYS 189
Query: 196 ATSDIWSCGVIL-------YIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRITIAGI--- 245
              DIWS G I         +F GD ++ +        + R +  P+ V    +  +   
Sbjct: 190 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLF-----RIFRTLGTPDEVVWPGVTSMPDY 244
Query: 246 --KADEWFEQDYTPANPDDDEE 265
                +W  QD++   P  DE+
Sbjct: 245 KPSFPKWARQDFSKVVPPLDED 266

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 65/204 (31%), Positives = 107/204 (52%), Gaps = 19/204 (9%)
Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKI--LEKNRIIHLKITDQIKREIATLKLLKH 73
           YEL   +G G    V+ A         A+K   LEK +       D++ +EI  +    H
Sbjct: 12  YELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTS----MDELLKEIQAMSQCHH 67
Query: 74  PNVVRLHEVLASKSKIYMVLEYVTGGELFD---KIASKGR-----LQEAEGRKLFQQLID 125
           PN+V  +     K ++++V++ ++GG + D    I +KG      L E+    + +++++
Sbjct: 68  PNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLE 127
Query: 126 GVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD---DGLLHTTCGSPNY 182
           G+ Y H  G  HRD+K  NILL   G+++I+DFG+SA      D   + +  T  G+P +
Sbjct: 128 GLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCW 187
Query: 183 VAPEVLAN-RGYDGATSDIWSCGV 205
           +APEV+   RGYD   +DIWS G+
Sbjct: 188 MAPEVMEQVRGYD-FKADIWSFGI 210

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 78/262 (29%), Positives = 129/262 (49%), Gaps = 31/262 (11%)
Query: 22  LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHE 81
           +GEG +G V  A++  +G   A+K +  +      +     REI+ LK L HPN+V+L +
Sbjct: 14  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETE-GVPSTAIREISLLKELNHPNIVKLLD 72
Query: 82  VLASKSKIYMVLEYVTGG--ELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRD 139
           V+ +++K+Y+V E+V     +  D  A  G         LFQ L+ G+++CH+  V HRD
Sbjct: 73  VIHTENKLYLVFEHVDQDLKKFMDASALTGIPLPLIKSYLFQ-LLQGLAFCHSHRVLHRD 131
Query: 140 LKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTT----CGSPNYVAPEVLANRGYDG 195
           LK +N+L++++G IK++DFGL+      R  G+   T      +  Y APE+L    Y  
Sbjct: 132 LKPQNLLINTEGAIKLADFGLA------RAFGVPVRTYXHEVVTLWYRAPEILLGCKYYS 185
Query: 196 ATSDIWSCGVIL-------YIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRITIAGI--- 245
              DIWS G I         +F GD ++ +        + R +  P+ V    +  +   
Sbjct: 186 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLF-----RIFRTLGTPDEVVWPGVTSMPDY 240
Query: 246 --KADEWFEQDYTPANPDDDEE 265
                +W  QD++   P  DE+
Sbjct: 241 KPSFPKWARQDFSKVVPPLDED 262

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 77/262 (29%), Positives = 129/262 (49%), Gaps = 31/262 (11%)
Query: 22  LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHE 81
           +GEG +G V  A++  +G   A+K +  +      +     REI+ LK L HPN+V+L +
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETE-GVPSTAIREISLLKELNHPNIVKLLD 69
Query: 82  VLASKSKIYMVLEYVTGG--ELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRD 139
           V+ +++K+Y+V E++     +  D  A  G         LFQ L+ G+++CH+  V HRD
Sbjct: 70  VIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ-LLQGLAFCHSHRVLHRD 128
Query: 140 LKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTT----CGSPNYVAPEVLANRGYDG 195
           LK +N+L++++G IK++DFGL+      R  G+   T      +  Y APE+L    Y  
Sbjct: 129 LKPQNLLINTEGAIKLADFGLA------RAFGVPVRTYTHEVVTLWYRAPEILLGXKYYS 182
Query: 196 ATSDIWSCGVIL-------YIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRITIAGI--- 245
              DIWS G I         +F GD ++ +        + R +  P+ V    +  +   
Sbjct: 183 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLF-----RIFRTLGTPDEVVWPGVTSMPDY 237
Query: 246 --KADEWFEQDYTPANPDDDEE 265
                +W  QD++   P  DE+
Sbjct: 238 KPSFPKWARQDFSKVVPPLDED 259

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 70/209 (33%), Positives = 107/209 (51%), Gaps = 14/209 (6%)
Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVK-ILEKNRIIHLKITDQIK-REIATLKLLK 72
           +YE    +GEG++G V   ++ D+G   A+K  LE +     K+  +I  REI  LK L+
Sbjct: 26  KYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDD---KMVKKIAMREIKLLKQLR 82
Query: 73  HPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHN 132
           H N+V L EV   K + Y+V E+V    L D       L     +K   Q+I+G+ +CH+
Sbjct: 83  HENLVNLLEVCKKKKRWYLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHS 142
Query: 133 KGVFHRDLKLENILLDSKGNIKISDFGLS---ALPQHFRDDGLLHTTCGSPNYVAPEVLA 189
             + HRD+K ENIL+   G +K+ DFG +   A P    DD +      +  Y APE+L 
Sbjct: 143 HNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEV-----ATRWYRAPELLV 197
Query: 190 NRGYDGATSDIWSCGVILY-IFRGDFKLP 217
                G   D+W+ G ++  +F G+   P
Sbjct: 198 GDVKYGKAVDVWAIGCLVTEMFMGEPLFP 226

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 97.1 bits (240), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 77/262 (29%), Positives = 129/262 (49%), Gaps = 31/262 (11%)
Query: 22  LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHE 81
           +GEG +G V  A++  +G   A+K +  +      +     REI+ LK L HPN+V+L +
Sbjct: 18  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETE-GVPSTAIREISLLKELNHPNIVKLLD 76
Query: 82  VLASKSKIYMVLEYVTGG--ELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRD 139
           V+ +++K+Y+V E++     +  D  A  G         LFQ L+ G+++CH+  V HRD
Sbjct: 77  VIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ-LLQGLAFCHSHRVLHRD 135
Query: 140 LKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTT----CGSPNYVAPEVLANRGYDG 195
           LK +N+L++++G IK++DFGL+      R  G+   T      +  Y APE+L    Y  
Sbjct: 136 LKPQNLLINTEGAIKLADFGLA------RAFGVPVRTYTHEVVTLWYRAPEILLGCKYYS 189
Query: 196 ATSDIWSCGVIL-------YIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRITIAGI--- 245
              DIWS G I         +F GD ++ +        + R +  P+ V    +  +   
Sbjct: 190 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLF-----RIFRTLGTPDEVVWPGVTSMPDY 244
Query: 246 --KADEWFEQDYTPANPDDDEE 265
                +W  QD++   P  DE+
Sbjct: 245 KPSFPKWARQDFSKVVPPLDED 266

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 97.1 bits (240), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 77/262 (29%), Positives = 129/262 (49%), Gaps = 31/262 (11%)
Query: 22  LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHE 81
           +GEG +G V  A++  +G   A+K +  +      +     REI+ LK L HPN+V+L +
Sbjct: 14  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETE-GVPSTAIREISLLKELNHPNIVKLLD 72
Query: 82  VLASKSKIYMVLEYVTGG--ELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRD 139
           V+ +++K+Y+V E++     +  D  A  G         LFQ L+ G+++CH+  V HRD
Sbjct: 73  VIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ-LLQGLAFCHSHRVLHRD 131
Query: 140 LKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTT----CGSPNYVAPEVLANRGYDG 195
           LK +N+L++++G IK++DFGL+      R  G+   T      +  Y APE+L    Y  
Sbjct: 132 LKPQNLLINTEGAIKLADFGLA------RAFGVPVRTYXHEVVTLWYRAPEILLGCKYYS 185
Query: 196 ATSDIWSCGVIL-------YIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRITIAGI--- 245
              DIWS G I         +F GD ++ +        + R +  P+ V    +  +   
Sbjct: 186 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLF-----RIFRTLGTPDEVVWPGVTSMPDY 240
Query: 246 --KADEWFEQDYTPANPDDDEE 265
                +W  QD++   P  DE+
Sbjct: 241 KPSFPKWARQDFSKVVPPLDED 262

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 97.1 bits (240), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 77/262 (29%), Positives = 129/262 (49%), Gaps = 31/262 (11%)
Query: 22  LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHE 81
           +GEG +G V  A++  +G   A+K +  +      +     REI+ LK L HPN+V+L +
Sbjct: 13  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETE-GVPSTAIREISLLKELNHPNIVKLLD 71
Query: 82  VLASKSKIYMVLEYVTGG--ELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRD 139
           V+ +++K+Y+V E++     +  D  A  G         LFQ L+ G+++CH+  V HRD
Sbjct: 72  VIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ-LLQGLAFCHSHRVLHRD 130
Query: 140 LKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTT----CGSPNYVAPEVLANRGYDG 195
           LK +N+L++++G IK++DFGL+      R  G+   T      +  Y APE+L    Y  
Sbjct: 131 LKPQNLLINTEGAIKLADFGLA------RAFGVPVRTYXHEVVTLWYRAPEILLGCKYYS 184
Query: 196 ATSDIWSCGVIL-------YIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRITIAGI--- 245
              DIWS G I         +F GD ++ +        + R +  P+ V    +  +   
Sbjct: 185 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLF-----RIFRTLGTPDEVVWPGVTSMPDY 239
Query: 246 --KADEWFEQDYTPANPDDDEE 265
                +W  QD++   P  DE+
Sbjct: 240 KPSFPKWARQDFSKVVPPLDED 261

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 97.1 bits (240), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 77/262 (29%), Positives = 129/262 (49%), Gaps = 31/262 (11%)
Query: 22  LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHE 81
           +GEG +G V  A++  +G   A+K +  +      +     REI+ LK L HPN+V+L +
Sbjct: 15  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETE-GVPSTAIREISLLKELNHPNIVKLLD 73
Query: 82  VLASKSKIYMVLEYVTGG--ELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRD 139
           V+ +++K+Y+V E++     +  D  A  G         LFQ L+ G+++CH+  V HRD
Sbjct: 74  VIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ-LLQGLAFCHSHRVLHRD 132
Query: 140 LKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTT----CGSPNYVAPEVLANRGYDG 195
           LK +N+L++++G IK++DFGL+      R  G+   T      +  Y APE+L    Y  
Sbjct: 133 LKPQNLLINTEGAIKLADFGLA------RAFGVPVRTYXHEVVTLWYRAPEILLGCKYYS 186
Query: 196 ATSDIWSCGVIL-------YIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRITIAGI--- 245
              DIWS G I         +F GD ++ +        + R +  P+ V    +  +   
Sbjct: 187 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLF-----RIFRTLGTPDEVVWPGVTSMPDY 241
Query: 246 --KADEWFEQDYTPANPDDDEE 265
                +W  QD++   P  DE+
Sbjct: 242 KPSFPKWARQDFSKVVPPLDED 263

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 97.1 bits (240), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 77/262 (29%), Positives = 129/262 (49%), Gaps = 31/262 (11%)
Query: 22  LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHE 81
           +GEG +G V  A++  +G   A+K +  +      +     REI+ LK L HPN+V+L +
Sbjct: 13  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETE-GVPSTAIREISLLKELNHPNIVKLLD 71
Query: 82  VLASKSKIYMVLEYVTGG--ELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRD 139
           V+ +++K+Y+V E++     +  D  A  G         LFQ L+ G+++CH+  V HRD
Sbjct: 72  VIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ-LLQGLAFCHSHRVLHRD 130
Query: 140 LKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTT----CGSPNYVAPEVLANRGYDG 195
           LK +N+L++++G IK++DFGL+      R  G+   T      +  Y APE+L    Y  
Sbjct: 131 LKPQNLLINTEGAIKLADFGLA------RAFGVPVRTYXHEVVTLWYRAPEILLGCKYYS 184
Query: 196 ATSDIWSCGVIL-------YIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRITIAGI--- 245
              DIWS G I         +F GD ++ +        + R +  P+ V    +  +   
Sbjct: 185 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLF-----RIFRTLGTPDEVVWPGVTSMPDY 239
Query: 246 --KADEWFEQDYTPANPDDDEE 265
                +W  QD++   P  DE+
Sbjct: 240 KPSFPKWARQDFSKVVPPLDED 261

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 97.1 bits (240), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 77/262 (29%), Positives = 129/262 (49%), Gaps = 31/262 (11%)
Query: 22  LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHE 81
           +GEG +G V  A++  +G   A+K +  +      +     REI+ LK L HPN+V+L +
Sbjct: 12  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETE-GVPSTAIREISLLKELNHPNIVKLLD 70
Query: 82  VLASKSKIYMVLEYVTGG--ELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRD 139
           V+ +++K+Y+V E++     +  D  A  G         LFQ L+ G+++CH+  V HRD
Sbjct: 71  VIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ-LLQGLAFCHSHRVLHRD 129
Query: 140 LKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTT----CGSPNYVAPEVLANRGYDG 195
           LK +N+L++++G IK++DFGL+      R  G+   T      +  Y APE+L    Y  
Sbjct: 130 LKPQNLLINTEGAIKLADFGLA------RAFGVPVRTYXHEVVTLWYRAPEILLGCKYYS 183
Query: 196 ATSDIWSCGVIL-------YIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRITIAGI--- 245
              DIWS G I         +F GD ++ +        + R +  P+ V    +  +   
Sbjct: 184 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLF-----RIFRTLGTPDEVVWPGVTSMPDY 238
Query: 246 --KADEWFEQDYTPANPDDDEE 265
                +W  QD++   P  DE+
Sbjct: 239 KPSFPKWARQDFSKVVPPLDED 260

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 96.7 bits (239), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 78/262 (29%), Positives = 128/262 (48%), Gaps = 31/262 (11%)
Query: 22  LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHE 81
           +GEG +G V  A++  +G   A+K +  +      +     REI+ LK L HPN+V+L +
Sbjct: 10  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETE-GVPSTAIREISLLKELNHPNIVKLLD 68
Query: 82  VLASKSKIYMVLEYVTGG--ELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRD 139
           V+ +++K+Y+V E+V        D  A  G         LFQ L+ G+++CH+  V HRD
Sbjct: 69  VIHTENKLYLVFEHVHQDLKTFMDASALTGIPLPLIKSYLFQ-LLQGLAFCHSHRVLHRD 127
Query: 140 LKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTT----CGSPNYVAPEVLANRGYDG 195
           LK +N+L++++G IK++DFGL+      R  G+   T      +  Y APE+L    Y  
Sbjct: 128 LKPQNLLINTEGAIKLADFGLA------RAFGVPVRTYTHEVVTLWYRAPEILLGCKYYS 181
Query: 196 ATSDIWSCGVIL-------YIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRITIAGI--- 245
              DIWS G I         +F GD ++ +        + R +  P+ V    +  +   
Sbjct: 182 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLF-----RIFRTLGTPDEVVWPGVTSMPDY 236
Query: 246 --KADEWFEQDYTPANPDDDEE 265
                +W  QD++   P  DE+
Sbjct: 237 KPSFPKWARQDFSKVVPPLDED 258

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 96.7 bits (239), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 77/262 (29%), Positives = 129/262 (49%), Gaps = 31/262 (11%)
Query: 22  LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHE 81
           +GEG +G V  A++  +G   A+K +  +      +     REI+ LK L HPN+V+L +
Sbjct: 14  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETE-GVPSTAIREISLLKELNHPNIVKLLD 72
Query: 82  VLASKSKIYMVLEYVTGG--ELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRD 139
           V+ +++K+Y+V E++     +  D  A  G         LFQ L+ G+++CH+  V HRD
Sbjct: 73  VIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ-LLQGLAFCHSHRVLHRD 131
Query: 140 LKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTT----CGSPNYVAPEVLANRGYDG 195
           LK +N+L++++G IK++DFGL+      R  G+   T      +  Y APE+L    Y  
Sbjct: 132 LKPQNLLINTEGAIKLADFGLA------RAFGVPVRTYXHEVVTLWYRAPEILLGCKYYS 185
Query: 196 ATSDIWSCGVIL-------YIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRITIAGI--- 245
              DIWS G I         +F GD ++ +        + R +  P+ V    +  +   
Sbjct: 186 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLF-----RIFRTLGTPDEVVWPGVTSMPDY 240
Query: 246 --KADEWFEQDYTPANPDDDEE 265
                +W  QD++   P  DE+
Sbjct: 241 KPSFPKWARQDFSKVVPPLDED 262

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 96.7 bits (239), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 77/262 (29%), Positives = 129/262 (49%), Gaps = 31/262 (11%)
Query: 22  LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHE 81
           +GEG +G V  A++  +G   A+K +  +      +     REI+ LK L HPN+V+L +
Sbjct: 10  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETE-GVPSTAIREISLLKELNHPNIVKLLD 68
Query: 82  VLASKSKIYMVLEYVTGG--ELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRD 139
           V+ +++K+Y+V E++     +  D  A  G         LFQ L+ G+++CH+  V HRD
Sbjct: 69  VIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ-LLQGLAFCHSHRVLHRD 127
Query: 140 LKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTT----CGSPNYVAPEVLANRGYDG 195
           LK +N+L++++G IK++DFGL+      R  G+   T      +  Y APE+L    Y  
Sbjct: 128 LKPQNLLINTEGAIKLADFGLA------RAFGVPVRTYXHEVVTLWYRAPEILLGCKYYS 181
Query: 196 ATSDIWSCGVIL-------YIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRITIAGI--- 245
              DIWS G I         +F GD ++ +        + R +  P+ V    +  +   
Sbjct: 182 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLF-----RIFRTLGTPDEVVWPGVTSMPDY 236
Query: 246 --KADEWFEQDYTPANPDDDEE 265
                +W  QD++   P  DE+
Sbjct: 237 KPSFPKWARQDFSKVVPPLDED 258

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 96.7 bits (239), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 77/262 (29%), Positives = 129/262 (49%), Gaps = 31/262 (11%)
Query: 22  LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHE 81
           +GEG +G V  A++  +G   A+K +  +      +     REI+ LK L HPN+V+L +
Sbjct: 12  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETE-GVPSTAIREISLLKELNHPNIVKLLD 70
Query: 82  VLASKSKIYMVLEYVTGG--ELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRD 139
           V+ +++K+Y+V E++     +  D  A  G         LFQ L+ G+++CH+  V HRD
Sbjct: 71  VIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ-LLQGLAFCHSHRVLHRD 129
Query: 140 LKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTT----CGSPNYVAPEVLANRGYDG 195
           LK +N+L++++G IK++DFGL+      R  G+   T      +  Y APE+L    Y  
Sbjct: 130 LKPQNLLINTEGAIKLADFGLA------RAFGVPVRTYTHEVVTLWYRAPEILLGCKYYS 183
Query: 196 ATSDIWSCGVIL-------YIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRITIAGI--- 245
              DIWS G I         +F GD ++ +        + R +  P+ V    +  +   
Sbjct: 184 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLF-----RIFRTLGTPDEVVWPGVTSMPDY 238
Query: 246 --KADEWFEQDYTPANPDDDEE 265
                +W  QD++   P  DE+
Sbjct: 239 KPSFPKWARQDFSKVVPPLDED 260

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 96.7 bits (239), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 77/262 (29%), Positives = 129/262 (49%), Gaps = 31/262 (11%)
Query: 22  LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHE 81
           +GEG +G V  A++  +G   A+K +  +      +     REI+ LK L HPN+V+L +
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETE-GVPSTAIREISLLKELNHPNIVKLLD 69
Query: 82  VLASKSKIYMVLEYVTGG--ELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRD 139
           V+ +++K+Y+V E++     +  D  A  G         LFQ L+ G+++CH+  V HRD
Sbjct: 70  VIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ-LLQGLAFCHSHRVLHRD 128
Query: 140 LKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTT----CGSPNYVAPEVLANRGYDG 195
           LK +N+L++++G IK++DFGL+      R  G+   T      +  Y APE+L    Y  
Sbjct: 129 LKPQNLLINTEGAIKLADFGLA------RAFGVPVRTYXHEVVTLWYRAPEILLGCKYYS 182
Query: 196 ATSDIWSCGVIL-------YIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRITIAGI--- 245
              DIWS G I         +F GD ++ +        + R +  P+ V    +  +   
Sbjct: 183 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLF-----RIFRTLGTPDEVVWPGVTSMPDY 237
Query: 246 --KADEWFEQDYTPANPDDDEE 265
                +W  QD++   P  DE+
Sbjct: 238 KPSFPKWARQDFSKVVPPLDED 259

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 96.7 bits (239), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 77/262 (29%), Positives = 129/262 (49%), Gaps = 31/262 (11%)
Query: 22  LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHE 81
           +GEG +G V  A++  +G   A+K +  +      +     REI+ LK L HPN+V+L +
Sbjct: 10  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETE-GVPSTAIREISLLKELNHPNIVKLLD 68
Query: 82  VLASKSKIYMVLEYVTGG--ELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRD 139
           V+ +++K+Y+V E++     +  D  A  G         LFQ L+ G+++CH+  V HRD
Sbjct: 69  VIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ-LLQGLAFCHSHRVLHRD 127
Query: 140 LKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTT----CGSPNYVAPEVLANRGYDG 195
           LK +N+L++++G IK++DFGL+      R  G+   T      +  Y APE+L    Y  
Sbjct: 128 LKPQNLLINTEGAIKLADFGLA------RAFGVPVRTYTHEVVTLWYRAPEILLGCKYYS 181
Query: 196 ATSDIWSCGVIL-------YIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRITIAGI--- 245
              DIWS G I         +F GD ++ +        + R +  P+ V    +  +   
Sbjct: 182 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLF-----RIFRTLGTPDEVVWPGVTSMPDY 236
Query: 246 --KADEWFEQDYTPANPDDDEE 265
                +W  QD++   P  DE+
Sbjct: 237 KPSFPKWARQDFSKVVPPLDED 258

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 96.7 bits (239), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 77/262 (29%), Positives = 129/262 (49%), Gaps = 31/262 (11%)
Query: 22  LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHE 81
           +GEG +G V  A++  +G   A+K +  +      +     REI+ LK L HPN+V+L +
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETE-GVPSTAIREISLLKELNHPNIVKLLD 69
Query: 82  VLASKSKIYMVLEYVTGG--ELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRD 139
           V+ +++K+Y+V E++     +  D  A  G         LFQ L+ G+++CH+  V HRD
Sbjct: 70  VIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ-LLQGLAFCHSHRVLHRD 128
Query: 140 LKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTT----CGSPNYVAPEVLANRGYDG 195
           LK +N+L++++G IK++DFGL+      R  G+   T      +  Y APE+L    Y  
Sbjct: 129 LKPQNLLINTEGAIKLADFGLA------RAFGVPVRTYXHEVVTLWYRAPEILLGCKYYS 182
Query: 196 ATSDIWSCGVIL-------YIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRITIAGI--- 245
              DIWS G I         +F GD ++ +        + R +  P+ V    +  +   
Sbjct: 183 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLF-----RIFRTLGTPDEVVWPGVTSMPDY 237
Query: 246 --KADEWFEQDYTPANPDDDEE 265
                +W  QD++   P  DE+
Sbjct: 238 KPSFPKWARQDFSKVVPPLDED 259

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 96.7 bits (239), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 77/262 (29%), Positives = 129/262 (49%), Gaps = 31/262 (11%)
Query: 22  LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHE 81
           +GEG +G V  A++  +G   A+K +  +      +     REI+ LK L HPN+V+L +
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETE-GVPSTAIREISLLKELNHPNIVKLLD 69
Query: 82  VLASKSKIYMVLEYVTGG--ELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRD 139
           V+ +++K+Y+V E++     +  D  A  G         LFQ L+ G+++CH+  V HRD
Sbjct: 70  VIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ-LLQGLAFCHSHRVLHRD 128
Query: 140 LKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTT----CGSPNYVAPEVLANRGYDG 195
           LK +N+L++++G IK++DFGL+      R  G+   T      +  Y APE+L    Y  
Sbjct: 129 LKPQNLLINTEGAIKLADFGLA------RAFGVPVRTYXHEVVTLWYRAPEILLGCKYYS 182
Query: 196 ATSDIWSCGVIL-------YIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRITIAGI--- 245
              DIWS G I         +F GD ++ +        + R +  P+ V    +  +   
Sbjct: 183 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLF-----RIFRTLGTPDEVVWPGVTSMPDY 237
Query: 246 --KADEWFEQDYTPANPDDDEE 265
                +W  QD++   P  DE+
Sbjct: 238 KPSFPKWARQDFSKVVPPLDED 259

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 96.7 bits (239), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 77/262 (29%), Positives = 129/262 (49%), Gaps = 31/262 (11%)
Query: 22  LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHE 81
           +GEG +G V  A++  +G   A+K +  +      +     REI+ LK L HPN+V+L +
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETE-GVPSTAIREISLLKELNHPNIVKLLD 69
Query: 82  VLASKSKIYMVLEYVTGG--ELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRD 139
           V+ +++K+Y+V E++     +  D  A  G         LFQ L+ G+++CH+  V HRD
Sbjct: 70  VIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ-LLQGLAFCHSHRVLHRD 128
Query: 140 LKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTT----CGSPNYVAPEVLANRGYDG 195
           LK +N+L++++G IK++DFGL+      R  G+   T      +  Y APE+L    Y  
Sbjct: 129 LKPQNLLINTEGAIKLADFGLA------RAFGVPVRTYTHEVVTLWYRAPEILLGCKYYS 182
Query: 196 ATSDIWSCGVIL-------YIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRITIAGI--- 245
              DIWS G I         +F GD ++ +        + R +  P+ V    +  +   
Sbjct: 183 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLF-----RIFRTLGTPDEVVWPGVTSMPDY 237
Query: 246 --KADEWFEQDYTPANPDDDEE 265
                +W  QD++   P  DE+
Sbjct: 238 KPSFPKWARQDFSKVVPPLDED 259

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 96.7 bits (239), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 77/262 (29%), Positives = 129/262 (49%), Gaps = 31/262 (11%)
Query: 22  LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHE 81
           +GEG +G V  A++  +G   A+K +  +      +     REI+ LK L HPN+V+L +
Sbjct: 10  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETE-GVPSTAIREISLLKELNHPNIVKLLD 68
Query: 82  VLASKSKIYMVLEYVTGG--ELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRD 139
           V+ +++K+Y+V E++     +  D  A  G         LFQ L+ G+++CH+  V HRD
Sbjct: 69  VIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ-LLQGLAFCHSHRVLHRD 127
Query: 140 LKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTT----CGSPNYVAPEVLANRGYDG 195
           LK +N+L++++G IK++DFGL+      R  G+   T      +  Y APE+L    Y  
Sbjct: 128 LKPQNLLINTEGAIKLADFGLA------RAFGVPVRTYXHEVVTLWYRAPEILLGCKYYS 181
Query: 196 ATSDIWSCGVIL-------YIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRITIAGI--- 245
              DIWS G I         +F GD ++ +        + R +  P+ V    +  +   
Sbjct: 182 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLF-----RIFRTLGTPDEVVWPGVTSMPDY 236
Query: 246 --KADEWFEQDYTPANPDDDEE 265
                +W  QD++   P  DE+
Sbjct: 237 KPSFPKWARQDFSKVVPPLDED 258

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 96.7 bits (239), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 77/262 (29%), Positives = 129/262 (49%), Gaps = 31/262 (11%)
Query: 22  LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHE 81
           +GEG +G V  A++  +G   A+K +  +      +     REI+ LK L HPN+V+L +
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETE-GVPSTAIREISLLKELNHPNIVKLLD 69
Query: 82  VLASKSKIYMVLEYVTGG--ELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRD 139
           V+ +++K+Y+V E++     +  D  A  G         LFQ L+ G+++CH+  V HRD
Sbjct: 70  VIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ-LLQGLAFCHSHRVLHRD 128
Query: 140 LKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTT----CGSPNYVAPEVLANRGYDG 195
           LK +N+L++++G IK++DFGL+      R  G+   T      +  Y APE+L    Y  
Sbjct: 129 LKPQNLLINTEGAIKLADFGLA------RAFGVPVRTYTHEVVTLWYRAPEILLGCKYYS 182
Query: 196 ATSDIWSCGVIL-------YIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRITIAGI--- 245
              DIWS G I         +F GD ++ +        + R +  P+ V    +  +   
Sbjct: 183 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLF-----RIFRTLGTPDEVVWPGVTSMPDY 237
Query: 246 --KADEWFEQDYTPANPDDDEE 265
                +W  QD++   P  DE+
Sbjct: 238 KPSFPKWARQDFSKVVPPLDED 259

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 96.7 bits (239), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 77/262 (29%), Positives = 129/262 (49%), Gaps = 31/262 (11%)
Query: 22  LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHE 81
           +GEG +G V  A++  +G   A+K +  +      +     REI+ LK L HPN+V+L +
Sbjct: 10  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETE-GVPSTAIREISLLKELNHPNIVKLLD 68
Query: 82  VLASKSKIYMVLEYVTGG--ELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRD 139
           V+ +++K+Y+V E++     +  D  A  G         LFQ L+ G+++CH+  V HRD
Sbjct: 69  VIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ-LLQGLAFCHSHRVLHRD 127
Query: 140 LKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTT----CGSPNYVAPEVLANRGYDG 195
           LK +N+L++++G IK++DFGL+      R  G+   T      +  Y APE+L    Y  
Sbjct: 128 LKPQNLLINTEGAIKLADFGLA------RAFGVPVRTYTHEVVTLWYRAPEILLGCKYYS 181
Query: 196 ATSDIWSCGVIL-------YIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRITIAGI--- 245
              DIWS G I         +F GD ++ +        + R +  P+ V    +  +   
Sbjct: 182 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLF-----RIFRTLGTPDEVVWPGVTSMPDY 236
Query: 246 --KADEWFEQDYTPANPDDDEE 265
                +W  QD++   P  DE+
Sbjct: 237 KPSFPKWARQDFSKVVPPLDED 258

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 96.7 bits (239), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 77/262 (29%), Positives = 129/262 (49%), Gaps = 31/262 (11%)
Query: 22  LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHE 81
           +GEG +G V  A++  +G   A+K +  +      +     REI+ LK L HPN+V+L +
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETE-GVPSTAIREISLLKELNHPNIVKLLD 69
Query: 82  VLASKSKIYMVLEYVTGG--ELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRD 139
           V+ +++K+Y+V E++     +  D  A  G         LFQ L+ G+++CH+  V HRD
Sbjct: 70  VIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ-LLQGLAFCHSHRVLHRD 128
Query: 140 LKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTT----CGSPNYVAPEVLANRGYDG 195
           LK +N+L++++G IK++DFGL+      R  G+   T      +  Y APE+L    Y  
Sbjct: 129 LKPQNLLINTEGAIKLADFGLA------RAFGVPVRTYXHEVVTLWYRAPEILLGCKYYS 182
Query: 196 ATSDIWSCGVIL-------YIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRITIAGI--- 245
              DIWS G I         +F GD ++ +        + R +  P+ V    +  +   
Sbjct: 183 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLF-----RIFRTLGTPDEVVWPGVTSMPDY 237
Query: 246 --KADEWFEQDYTPANPDDDEE 265
                +W  QD++   P  DE+
Sbjct: 238 KPSFPKWARQDFSKVVPPLDED 259

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 96.7 bits (239), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 77/262 (29%), Positives = 129/262 (49%), Gaps = 31/262 (11%)
Query: 22  LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHE 81
           +GEG +G V  A++  +G   A+K +  +      +     REI+ LK L HPN+V+L +
Sbjct: 12  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETE-GVPSTAIREISLLKELNHPNIVKLLD 70
Query: 82  VLASKSKIYMVLEYVTGG--ELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRD 139
           V+ +++K+Y+V E++     +  D  A  G         LFQ L+ G+++CH+  V HRD
Sbjct: 71  VIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ-LLQGLAFCHSHRVLHRD 129
Query: 140 LKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTT----CGSPNYVAPEVLANRGYDG 195
           LK +N+L++++G IK++DFGL+      R  G+   T      +  Y APE+L    Y  
Sbjct: 130 LKPQNLLINTEGAIKLADFGLA------RAFGVPVRTYXHEVVTLWYRAPEILLGCKYYS 183
Query: 196 ATSDIWSCGVIL-------YIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRITIAGI--- 245
              DIWS G I         +F GD ++ +        + R +  P+ V    +  +   
Sbjct: 184 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLF-----RIFRTLGTPDEVVWPGVTSMPDY 238
Query: 246 --KADEWFEQDYTPANPDDDEE 265
                +W  QD++   P  DE+
Sbjct: 239 KPSFPKWARQDFSKVVPPLDED 260

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 96.7 bits (239), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 77/262 (29%), Positives = 129/262 (49%), Gaps = 31/262 (11%)
Query: 22  LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHE 81
           +GEG +G V  A++  +G   A+K +  +      +     REI+ LK L HPN+V+L +
Sbjct: 15  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETE-GVPSTAIREISLLKELNHPNIVKLLD 73
Query: 82  VLASKSKIYMVLEYVTGG--ELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRD 139
           V+ +++K+Y+V E++     +  D  A  G         LFQ L+ G+++CH+  V HRD
Sbjct: 74  VIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ-LLQGLAFCHSHRVLHRD 132
Query: 140 LKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTT----CGSPNYVAPEVLANRGYDG 195
           LK +N+L++++G IK++DFGL+      R  G+   T      +  Y APE+L    Y  
Sbjct: 133 LKPQNLLINTEGAIKLADFGLA------RAFGVPVRTYTHEVVTLWYRAPEILLGCKYYS 186
Query: 196 ATSDIWSCGVIL-------YIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRITIAGI--- 245
              DIWS G I         +F GD ++ +        + R +  P+ V    +  +   
Sbjct: 187 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLF-----RIFRTLGTPDEVVWPGVTSMPDY 241
Query: 246 --KADEWFEQDYTPANPDDDEE 265
                +W  QD++   P  DE+
Sbjct: 242 KPSFPKWARQDFSKVVPPLDED 263

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 96.3 bits (238), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 77/262 (29%), Positives = 128/262 (48%), Gaps = 31/262 (11%)
Query: 22  LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHE 81
           +GEG +G V  A++  +G   A+K +  +      +     REI+ LK L HPN+V+L +
Sbjct: 14  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETE-GVPSTAIREISLLKELNHPNIVKLLD 72
Query: 82  VLASKSKIYMVLEYVTGG--ELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRD 139
           V+ +++K+Y+V E++        D  A  G         LFQ L+ G+++CH+  V HRD
Sbjct: 73  VIHTENKLYLVFEFLHQDLKTFMDASALTGIPLPLIKSYLFQ-LLQGLAFCHSHRVLHRD 131
Query: 140 LKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTT----CGSPNYVAPEVLANRGYDG 195
           LK +N+L++++G IK++DFGL+      R  G+   T      +  Y APE+L    Y  
Sbjct: 132 LKPQNLLINTEGAIKLADFGLA------RAFGVPVRTYXHEVVTLWYRAPEILLGCKYYS 185
Query: 196 ATSDIWSCGVIL-------YIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRITIAGI--- 245
              DIWS G I         +F GD ++ +        + R +  P+ V    +  +   
Sbjct: 186 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLF-----RIFRTLGTPDEVVWPGVTSMPDY 240
Query: 246 --KADEWFEQDYTPANPDDDEE 265
                +W  QD++   P  DE+
Sbjct: 241 KPSFPKWARQDFSKVVPPLDED 262

>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316

Iteration: 1
 Score = 96.3 bits (238), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 69/203 (33%), Positives = 100/203 (49%), Gaps = 16/203 (7%)
Query: 21  TLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK-HPNVVRL 79
            LGEG   +V+   +L +   +AVKI+EK       I  ++ RE+  L   + H NV+ L
Sbjct: 20  VLGEGAHARVQTCINLITSQEYAVKIIEKQP---GHIRSRVFREVEMLYQCQGHRNVLEL 76
Query: 80  HEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRD 139
            E    + + Y+V E + GG +   I  +    E E   + Q +   + + HNKG+ HRD
Sbjct: 77  IEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRD 136
Query: 140 LKLENILLDSKGN---IKISDFGLSALPQHFRDDGL-----LHTTCGSPNYVAPEVLANR 191
           LK ENIL +       +KI DFGL +  +   D        L T CGS  Y+APEV+   
Sbjct: 137 LKPENILCEHPNQVSPVKICDFGLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAF 196
Query: 192 GYDGAT----SDIWSCGVILYIF 210
             + +      D+WS GVILYI 
Sbjct: 197 SEEASIYDKRCDLWSLGVILYIL 219

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 95.9 bits (237), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 56/197 (28%), Positives = 104/197 (52%), Gaps = 17/197 (8%)
Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL--- 71
           +Y     +G+G  G V  A D+ +G   A++         + +  Q K+E+   ++L   
Sbjct: 21  KYTRFEKIGQGASGTVYTAMDVATGQEVAIR--------QMNLQQQPKKELIINEILVMR 72
Query: 72  --KHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSY 129
             K+PN+V   +      ++++V+EY+ GG L D + ++  + E +   + ++ +  + +
Sbjct: 73  ENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTD-VVTETCMDEGQIAAVCRECLQALEF 131
Query: 130 CHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLA 189
            H+  V HRD+K +NILL   G++K++DFG  A  Q   +     T  G+P ++APEV+ 
Sbjct: 132 LHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCA--QITPEQSKRSTMVGTPYWMAPEVVT 189
Query: 190 NRGYDGATSDIWSCGVI 206
            + Y G   DIWS G++
Sbjct: 190 RKAY-GPKVDIWSLGIM 205

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 95.5 bits (236), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 57/199 (28%), Positives = 96/199 (48%), Gaps = 6/199 (3%)
Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
           RYELG  LG G   +V  A+DL      AVK+L  +         + +RE      L HP
Sbjct: 13  RYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHP 72
Query: 75  NVVRLHEVLASKSKI----YMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYC 130
            +V +++   +++      Y+V+EYV G  L D + ++G +      ++       +++ 
Sbjct: 73  AIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFS 132
Query: 131 HNKGVFHRDLKLENILLDSKGNIKISDFGLS-ALPQHFRDDGLLHTTCGSPNYVAPEVLA 189
           H  G+ HRD+K  NIL+ +   +K+ DFG++ A+              G+  Y++PE   
Sbjct: 133 HQNGIIHRDVKPANILISATNAVKVVDFGIARAIADSGNSVXQTAAVIGTAQYLSPEQAR 192
Query: 190 NRGYDGATSDIWSCGVILY 208
               D A SD++S G +LY
Sbjct: 193 GDSVD-ARSDVYSLGCVLY 210

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 95.1 bits (235), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 79/265 (29%), Positives = 131/265 (49%), Gaps = 43/265 (16%)
Query: 21  TLGEGNFGKVKFAQDLDSGLPFAVK-ILEKNRIIHLKITDQIKREIATLKLLKHPNVVRL 79
            LG+G +G V   +DL + +  A+K I E++     + +  +  EIA  K LKH N+V+ 
Sbjct: 29  VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDS----RYSQPLHEEIALHKHLKHKNIVQY 84
Query: 80  HEVLASKSKIYMVLEYVTGGELFDKIASK-GRLQEAEGRKLF--QQLIDGVSYCHNKGVF 136
               +    I + +E V GG L   + SK G L++ E    F  +Q+++G+ Y H+  + 
Sbjct: 85  LGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIV 144
Query: 137 HRDLKLENILLDS-KGNIKISDFGLSALPQHFRDDGL---LHTTCGSPNYVAPEVL--AN 190
           HRD+K +N+L+++  G +KISDFG S      R  G+     T  G+  Y+APE++    
Sbjct: 145 HRDIKGDNVLINTYSGVLKISDFGTSK-----RLAGINPCTETFTGTLQYMAPEIIDKGP 199
Query: 191 RGYDGATSDIWSCGVILY-----------------------IFRGDFKLPKWLSPGAQNL 227
           RGY G  +DIWS G  +                        +F+   ++P+ +S  A+  
Sbjct: 200 RGY-GKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEIPESMSAEAKAF 258
Query: 228 LRKILEPNPVKRITIAGIKADEWFE 252
           + K  EP+P KR     +  DE+ +
Sbjct: 259 ILKCFEPDPDKRACANDLLVDEFLK 283

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 95.1 bits (235), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 79/264 (29%), Positives = 129/264 (48%), Gaps = 35/264 (13%)
Query: 22  LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLK--ITDQIKREIATLKLLKHPNVVRL 79
           +GEG +G V  A++  +G    V  L K R+      +     REI+ LK L HPN+V+L
Sbjct: 11  IGEGTYGVVYKARNKLTG---EVVALXKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 67
Query: 80  HEVLASKSKIYMVLEYVTGG--ELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFH 137
            +V+ +++K+Y+V E++     +  D  A  G         LFQ L+ G+++CH+  V H
Sbjct: 68  LDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ-LLQGLAFCHSHRVLH 126
Query: 138 RDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTT----CGSPNYVAPEVLANRGY 193
           RDLK +N+L++++G IK++DFGL+      R  G+   T      +  Y APE+L    Y
Sbjct: 127 RDLKPQNLLINTEGAIKLADFGLA------RAFGVPVRTYTHEVVTLWYRAPEILLGCKY 180
Query: 194 DGATSDIWSCGVIL-------YIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRITIAGI- 245
                DIWS G I         +F GD ++ +        + R +  P+ V    +  + 
Sbjct: 181 YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLF-----RIFRTLGTPDEVVWPGVTSMP 235
Query: 246 ----KADEWFEQDYTPANPDDDEE 265
                  +W  QD++   P  DE+
Sbjct: 236 DYKPSFPKWARQDFSKVVPPLDED 259

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 95.1 bits (235), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 79/264 (29%), Positives = 129/264 (48%), Gaps = 35/264 (13%)
Query: 22  LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLK--ITDQIKREIATLKLLKHPNVVRL 79
           +GEG +G V  A++  +G    V  L K R+      +     REI+ LK L HPN+V+L
Sbjct: 10  IGEGTYGVVYKARNKLTG---EVVALXKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 66
Query: 80  HEVLASKSKIYMVLEYVTGG--ELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFH 137
            +V+ +++K+Y+V E++     +  D  A  G         LFQ L+ G+++CH+  V H
Sbjct: 67  LDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ-LLQGLAFCHSHRVLH 125
Query: 138 RDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTT----CGSPNYVAPEVLANRGY 193
           RDLK +N+L++++G IK++DFGL+      R  G+   T      +  Y APE+L    Y
Sbjct: 126 RDLKPQNLLINTEGAIKLADFGLA------RAFGVPVRTYTHEVVTLWYRAPEILLGCKY 179
Query: 194 DGATSDIWSCGVIL-------YIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRITIAGI- 245
                DIWS G I         +F GD ++ +        + R +  P+ V    +  + 
Sbjct: 180 YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLF-----RIFRTLGTPDEVVWPGVTSMP 234
Query: 246 ----KADEWFEQDYTPANPDDDEE 265
                  +W  QD++   P  DE+
Sbjct: 235 DYKPSFPKWARQDFSKVVPPLDED 258

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 95.1 bits (235), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 56/199 (28%), Positives = 96/199 (48%), Gaps = 6/199 (3%)
Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
           RYELG  LG G   +V  A+DL      AVK+L  +         + +RE      L HP
Sbjct: 13  RYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHP 72
Query: 75  NVVRLHEVLASKSKI----YMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYC 130
            +V +++   +++      Y+V+EYV G  L D + ++G +      ++       +++ 
Sbjct: 73  AIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFS 132
Query: 131 HNKGVFHRDLKLENILLDSKGNIKISDFGLS-ALPQHFRDDGLLHTTCGSPNYVAPEVLA 189
           H  G+ HRD+K  NI++ +   +K+ DFG++ A+              G+  Y++PE   
Sbjct: 133 HQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQAR 192
Query: 190 NRGYDGATSDIWSCGVILY 208
               D A SD++S G +LY
Sbjct: 193 GDSVD-ARSDVYSLGCVLY 210

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score = 95.1 bits (235), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 68/212 (32%), Positives = 100/212 (47%), Gaps = 37/212 (17%)
Query: 13  LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLK----------ITDQIK 62
           + +YE    +GEG +G V           F  K  E + I+ LK          +     
Sbjct: 1   MQKYEKLEKIGEGTYGTV-----------FKAKNRETHEIVALKRVRLDDDDEGVPSSAL 49
Query: 63  REIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGG--ELFDKIASKGRLQEAEGRKLF 120
           REI  LK LKH N+VRLH+VL S  K+ +V E+      + FD  +  G L     +   
Sbjct: 50  REICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFD--SCNGDLDPEIVKSFL 107
Query: 121 QQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP 180
            QL+ G+ +CH++ V HRDLK +N+L++  G +K++DFGL+      R  G +   C S 
Sbjct: 108 FQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLADFGLA------RAFG-IPVRCYSA 160
Query: 181 N-----YVAPEVLANRGYDGATSDIWSCGVIL 207
                 Y  P+VL        + D+WS G I 
Sbjct: 161 EVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIF 192

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 95.1 bits (235), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 56/199 (28%), Positives = 96/199 (48%), Gaps = 6/199 (3%)
Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
           RYELG  LG G   +V  A+DL      AVK+L  +         + +RE      L HP
Sbjct: 13  RYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHP 72
Query: 75  NVVRLHEVLASKSKI----YMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYC 130
            +V +++   +++      Y+V+EYV G  L D + ++G +      ++       +++ 
Sbjct: 73  AIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFS 132
Query: 131 HNKGVFHRDLKLENILLDSKGNIKISDFGLS-ALPQHFRDDGLLHTTCGSPNYVAPEVLA 189
           H  G+ HRD+K  NI++ +   +K+ DFG++ A+              G+  Y++PE   
Sbjct: 133 HQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQAR 192
Query: 190 NRGYDGATSDIWSCGVILY 208
               D A SD++S G +LY
Sbjct: 193 GDSVD-ARSDVYSLGCVLY 210

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 94.7 bits (234), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 79/265 (29%), Positives = 131/265 (49%), Gaps = 43/265 (16%)
Query: 21  TLGEGNFGKVKFAQDLDSGLPFAVK-ILEKNRIIHLKITDQIKREIATLKLLKHPNVVRL 79
            LG+G +G V   +DL + +  A+K I E++     + +  +  EIA  K LKH N+V+ 
Sbjct: 15  VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDS----RYSQPLHEEIALHKHLKHKNIVQY 70
Query: 80  HEVLASKSKIYMVLEYVTGGELFDKIASK-GRLQEAEGRKLF--QQLIDGVSYCHNKGVF 136
               +    I + +E V GG L   + SK G L++ E    F  +Q+++G+ Y H+  + 
Sbjct: 71  LGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIV 130
Query: 137 HRDLKLENILLDS-KGNIKISDFGLSALPQHFRDDGL---LHTTCGSPNYVAPEVL--AN 190
           HRD+K +N+L+++  G +KISDFG S      R  G+     T  G+  Y+APE++    
Sbjct: 131 HRDIKGDNVLINTYSGVLKISDFGTSK-----RLAGINPCTETFTGTLQYMAPEIIDKGP 185
Query: 191 RGYDGATSDIWSCGVILY-----------------------IFRGDFKLPKWLSPGAQNL 227
           RGY G  +DIWS G  +                        +F+   ++P+ +S  A+  
Sbjct: 186 RGY-GKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEIPESMSAEAKAF 244
Query: 228 LRKILEPNPVKRITIAGIKADEWFE 252
           + K  EP+P KR     +  DE+ +
Sbjct: 245 ILKCFEPDPDKRACANDLLVDEFLK 269

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 55/199 (27%), Positives = 106/199 (53%), Gaps = 21/199 (10%)
Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL--- 71
           +Y     +G+G  G V  A D+ +G   A++         + +  Q K+E+   ++L   
Sbjct: 22  KYTRFEKIGQGASGTVYTAMDVATGQEVAIR--------QMNLQQQPKKELIINEILVMR 73
Query: 72  --KHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSY 129
             K+PN+V   +      ++++V+EY+ GG L D + ++  + E +   + ++ +  + +
Sbjct: 74  ENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTD-VVTETCMDEGQIAAVCRECLQALEF 132
Query: 130 CHNKGVFHRDLKLENILLDSKGNIKISDFGLSA--LPQHFRDDGLLHTTCGSPNYVAPEV 187
            H+  V HRD+K +NILL   G++K++DFG  A   P+  +   ++    G+P ++APEV
Sbjct: 133 LHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSXMV----GTPYWMAPEV 188
Query: 188 LANRGYDGATSDIWSCGVI 206
           +  + Y G   DIWS G++
Sbjct: 189 VTRKAY-GPKVDIWSLGIM 206

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 66/201 (32%), Positives = 104/201 (51%), Gaps = 18/201 (8%)
Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEK--NRIIHLKITDQIKREIATLKLLK 72
           RY+    +G G +G V  + D+ SGL  AVK L +    IIH K T    RE+  LK +K
Sbjct: 52  RYQTLSPVGSGAYGSVCSSYDVKSGLKIAVKKLSRPFQSIIHAKRT---YRELRLLKHMK 108
Query: 73  HPNVVRLHEVLASKSK------IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDG 126
           H NV+ L +V    +       +Y+V  ++ G +L + I    +L +   + L  Q++ G
Sbjct: 109 HENVIGLLDVFTPATSLEEFNDVYLV-THLMGADL-NNIVKCQKLTDDHVQFLIYQILRG 166
Query: 127 VSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPE 186
           + Y H+  + HRDLK  N+ ++    +KI DFGL+   +H  D+  +     +  Y APE
Sbjct: 167 LKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA---RHTDDE--MTGYVATRWYRAPE 221
Query: 187 VLANRGYDGATSDIWSCGVIL 207
           ++ N  +   T DIWS G I+
Sbjct: 222 IMLNWMHYNMTVDIWSVGCIM 242

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 55/197 (27%), Positives = 104/197 (52%), Gaps = 17/197 (8%)
Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL--- 71
           +Y     +G+G  G V  A D+ +G   A++         + +  Q K+E+   ++L   
Sbjct: 22  KYTRFEKIGQGASGTVYTAMDVATGQEVAIR--------QMNLQQQPKKELIINEILVMR 73
Query: 72  --KHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSY 129
             K+PN+V   +      ++++V+EY+ GG L D + ++  + E +   + ++ +  + +
Sbjct: 74  ENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTD-VVTETCMDEGQIAAVCRECLQALEF 132
Query: 130 CHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLA 189
            H+  V HR++K +NILL   G++K++DFG  A  Q   +     T  G+P ++APEV+ 
Sbjct: 133 LHSNQVIHRNIKSDNILLGMDGSVKLTDFGFCA--QITPEQSKRSTMVGTPYWMAPEVVT 190
Query: 190 NRGYDGATSDIWSCGVI 206
            + Y G   DIWS G++
Sbjct: 191 RKAY-GPKVDIWSLGIM 206

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 55/199 (27%), Positives = 106/199 (53%), Gaps = 21/199 (10%)
Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL--- 71
           +Y     +G+G  G V  A D+ +G   A++         + +  Q K+E+   ++L   
Sbjct: 21  KYTRFEKIGQGASGTVYTAMDVATGQEVAIR--------QMNLQQQPKKELIINEILVMR 72
Query: 72  --KHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSY 129
             K+PN+V   +      ++++V+EY+ GG L D + ++  + E +   + ++ +  + +
Sbjct: 73  ENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTD-VVTETCMDEGQIAAVCRECLQALEF 131
Query: 130 CHNKGVFHRDLKLENILLDSKGNIKISDFGLSA--LPQHFRDDGLLHTTCGSPNYVAPEV 187
            H+  V HRD+K +NILL   G++K++DFG  A   P+  +   ++    G+P ++APEV
Sbjct: 132 LHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSXMV----GTPYWMAPEV 187
Query: 188 LANRGYDGATSDIWSCGVI 206
           +  + Y G   DIWS G++
Sbjct: 188 VTRKAY-GPKVDIWSLGIM 205

>pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 79/281 (28%), Positives = 125/281 (44%), Gaps = 51/281 (18%)
Query: 19  GRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIAT-LKLLKHPNVV 77
            + LG G  GKV    +  +   FA+K L+           + +RE+    +  + P++V
Sbjct: 67  SQVLGLGINGKVLQIFNKRTQEKFALKXLQD--------CPKARREVELHWRASQCPHIV 118
Query: 78  RLHEVL----ASKSKIYMVLEYVTGGELFDKIASKG--RLQEAEGRKLFQQLIDGVSYCH 131
           R+ +V     A +  + +V E + GGELF +I  +G     E E  ++ + + + + Y H
Sbjct: 119 RIVDVYENLYAGRKCLLIVXECLDGGELFSRIQDRGDQAFTEREASEIXKSIGEAIQYLH 178
Query: 132 NKGVFHRDLKLENILLDSK---GNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVL 188
           +  + HRD+K EN+L  SK     +K++DFG +   +       L T C +P YVAPEVL
Sbjct: 179 SINIAHRDVKPENLLYTSKRPNAILKLTDFGFA---KETTSHNSLTTPCYTPYYVAPEVL 235
Query: 189 ANRGYDGATSDIWSCGVILYIF--------------------------RGDFKLPKW--L 220
               YD  + D WS GVI YI                           + +F  P+W  +
Sbjct: 236 GPEKYD-KSCDXWSLGVIXYILLCGYPPFYSNHGLAISPGXKTRIRXGQYEFPNPEWSEV 294
Query: 221 SPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY-TPANP 260
           S   + L+R +L+  P +R TI       W  Q    P  P
Sbjct: 295 SEEVKXLIRNLLKTEPTQRXTITEFXNHPWIXQSTKVPQTP 335

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 55/199 (27%), Positives = 106/199 (53%), Gaps = 21/199 (10%)
Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL--- 71
           +Y     +G+G  G V  A D+ +G   A++         + +  Q K+E+   ++L   
Sbjct: 21  KYTRFEKIGQGASGTVYTAMDVATGQEVAIR--------QMNLQQQPKKELIINEILVMR 72
Query: 72  --KHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSY 129
             K+PN+V   +      ++++V+EY+ GG L D + ++  + E +   + ++ +  + +
Sbjct: 73  ENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTD-VVTETCMDEGQIAAVCRECLQALEF 131
Query: 130 CHNKGVFHRDLKLENILLDSKGNIKISDFGLSA--LPQHFRDDGLLHTTCGSPNYVAPEV 187
            H+  V HRD+K +NILL   G++K++DFG  A   P+  +   ++    G+P ++APEV
Sbjct: 132 LHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSEMV----GTPYWMAPEV 187
Query: 188 LANRGYDGATSDIWSCGVI 206
           +  + Y G   DIWS G++
Sbjct: 188 VTRKAY-GPKVDIWSLGIM 205

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 56/199 (28%), Positives = 96/199 (48%), Gaps = 6/199 (3%)
Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
           RYELG  LG G   +V  A+DL      AVK+L  +         + +RE      L HP
Sbjct: 13  RYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHP 72
Query: 75  NVVRLHEVLASKSKI----YMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYC 130
            +V +++   +++      Y+V+EYV G  L D + ++G +      ++       +++ 
Sbjct: 73  AIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFS 132
Query: 131 HNKGVFHRDLKLENILLDSKGNIKISDFGLS-ALPQHFRDDGLLHTTCGSPNYVAPEVLA 189
           H  G+ HRD+K  NI++ +   +K+ DFG++ A+              G+  Y++PE   
Sbjct: 133 HQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQAR 192
Query: 190 NRGYDGATSDIWSCGVILY 208
               D A SD++S G +LY
Sbjct: 193 GDSVD-ARSDVYSLGCVLY 210

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 61/201 (30%), Positives = 97/201 (48%), Gaps = 16/201 (7%)
Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKIL-----EKNRIIHLKITDQIKREIATLK 69
           RY++   LG G    V  A+D    +  A+K +     EK   +      + +RE+    
Sbjct: 12  RYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLK-----RFEREVHNSS 66
Query: 70  LLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSY 129
            L H N+V + +V       Y+V+EY+ G  L + I S G L          Q++DG+ +
Sbjct: 67  QLSHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKH 126
Query: 130 CHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHT--TCGSPNYVAPEV 187
            H+  + HRD+K +NIL+DS   +KI DFG++   +   +  L  T    G+  Y +PE 
Sbjct: 127 AHDMRIVHRDIKPQNILIDSNKTLKIFDFGIA---KALSETSLTQTNHVLGTVQYFSPEQ 183
Query: 188 LANRGYDGATSDIWSCGVILY 208
                 D  T DI+S G++LY
Sbjct: 184 AKGEATDECT-DIYSIGIVLY 203

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 64/201 (31%), Positives = 100/201 (49%), Gaps = 15/201 (7%)
Query: 13  LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKIL---EKNRIIHLKITDQIKREIATLK 69
           + +YE    +GEG++G V   ++ D+G   A+K     E + +I  KI     REI  LK
Sbjct: 2   MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIK-KIA---LREIRMLK 57
Query: 70  LLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSY 129
            LKHPN+V L EV   K ++++V EY     L +    +  + E   + +  Q +  V++
Sbjct: 58  QLKHPNLVNLLEVFRRKRRLHLVFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNF 117
Query: 130 CHNKGVFHRDLKLENILLDSKGNIKISDFGLSAL---PQHFRDDGLLHTTCGSPNYVAPE 186
           CH     HRD+K ENIL+     IK+ DFG + L   P  + DD +      +  Y +PE
Sbjct: 118 CHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEV-----ATRWYRSPE 172
Query: 187 VLANRGYDGATSDIWSCGVIL 207
           +L      G   D+W+ G + 
Sbjct: 173 LLVGDTQYGPPVDVWAIGCVF 193

>pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 65/225 (28%), Positives = 105/225 (46%), Gaps = 43/225 (19%)
Query: 74  PNVVRLHEVLAS----KSKIYMVLEYVTGGELFDKIASKG--RLQEAEGRKLFQQLIDGV 127
           P++V + +V  +    K  + +++E + GGELF +I  +G     E E  ++ + +   +
Sbjct: 82  PHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAI 141
Query: 128 SYCHNKGVFHRDLKLENILLDSK---GNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVA 184
            + H+  + HRD+K EN+L  SK     +K++DFG +           L T C +P YVA
Sbjct: 142 QFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKE----TTQNALQTPCYTPYYVA 197
Query: 185 PEVLANRGYDGATSDIWSCGVILYIF--------------------------RGDFKLPK 218
           PEVL    YD  + D+WS GVI+YI                           +  F  P+
Sbjct: 198 PEVLGPEKYD-KSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNPE 256
Query: 219 W--LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY-TPANP 260
           W  +S  A+ L+R +L+ +P +R+TI       W  Q    P  P
Sbjct: 257 WSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQSMVVPQTP 301

>pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 65/225 (28%), Positives = 105/225 (46%), Gaps = 43/225 (19%)
Query: 74  PNVVRLHEVLAS----KSKIYMVLEYVTGGELFDKIASKG--RLQEAEGRKLFQQLIDGV 127
           P++V + +V  +    K  + +++E + GGELF +I  +G     E E  ++ + +   +
Sbjct: 63  PHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAI 122
Query: 128 SYCHNKGVFHRDLKLENILLDSK---GNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVA 184
            + H+  + HRD+K EN+L  SK     +K++DFG +           L T C +P YVA
Sbjct: 123 QFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQ----NALQTPCYTPYYVA 178
Query: 185 PEVLANRGYDGATSDIWSCGVILYIF--------------------------RGDFKLPK 218
           PEVL    YD  + D+WS GVI+YI                           +  F  P+
Sbjct: 179 PEVLGPEKYD-KSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNPE 237
Query: 219 W--LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY-TPANP 260
           W  +S  A+ L+R +L+ +P +R+TI       W  Q    P  P
Sbjct: 238 WSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQSMVVPQTP 282

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 56/199 (28%), Positives = 96/199 (48%), Gaps = 6/199 (3%)
Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
           RYELG  LG G   +V  A+DL      AVK+L  +         + +RE      L HP
Sbjct: 30  RYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHP 89
Query: 75  NVVRLHEVLASKSKI----YMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYC 130
            +V +++   +++      Y+V+EYV G  L D + ++G +      ++       +++ 
Sbjct: 90  AIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFS 149
Query: 131 HNKGVFHRDLKLENILLDSKGNIKISDFGLS-ALPQHFRDDGLLHTTCGSPNYVAPEVLA 189
           H  G+ HRD+K  NI++ +   +K+ DFG++ A+              G+  Y++PE   
Sbjct: 150 HQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQAR 209
Query: 190 NRGYDGATSDIWSCGVILY 208
               D A SD++S G +LY
Sbjct: 210 GDSVD-ARSDVYSLGCVLY 227

>pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 68/203 (33%), Positives = 99/203 (48%), Gaps = 16/203 (7%)
Query: 21  TLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK-HPNVVRL 79
            LGEG   +V+   +L +   +AVKI+EK       I  ++ RE+  L   + H NV+ L
Sbjct: 20  VLGEGAHARVQTCINLITSQEYAVKIIEKQP---GHIRSRVFREVEMLYQCQGHRNVLEL 76
Query: 80  HEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRD 139
            E    + + Y+V E + GG +   I  +    E E   + Q +   + + HNKG+ HRD
Sbjct: 77  IEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRD 136
Query: 140 LKLENILLDSKGN---IKISDFGLSALPQHFRDDGL-----LHTTCGSPNYVAPEVLANR 191
           LK ENIL +       +KI DF L +  +   D        L T CGS  Y+APEV+   
Sbjct: 137 LKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAF 196
Query: 192 GYDGAT----SDIWSCGVILYIF 210
             + +      D+WS GVILYI 
Sbjct: 197 SEEASIYDKRCDLWSLGVILYIL 219

>pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 83/278 (29%), Positives = 124/278 (44%), Gaps = 54/278 (19%)
Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKIL-----EKNRIIHLKITDQIKREIATLK 69
           R  + R L EG F  V  AQD+ SG  +A+K L     EKNR I       I+      K
Sbjct: 29  RLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAI-------IQEVCFMKK 81
Query: 70  LLKHPNVVRL--------HEVLASKSKIYMVLEYVTGG--ELFDKIASKGRLQEAEGRKL 119
           L  HPN+V+          E    +++  ++ E   G   E   K+ S+G L      K+
Sbjct: 82  LSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKI 141
Query: 120 FQQLIDGVSYCHNKG--VFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD-------D 170
           F Q    V + H +   + HRDLK+EN+LL ++G IK+ DFG +    H+ D        
Sbjct: 142 FYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRR 201
Query: 171 GLLH---TTCGSPNYVAPEV--LANRGYDGATSDIWSCGVILY----------------I 209
            L+    T   +P Y  PE+  L +    G   DIW+ G ILY                I
Sbjct: 202 ALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLRI 261
Query: 210 FRGDFKLPKWLSPGA--QNLLRKILEPNPVKRITIAGI 245
             G + +P   +      +L+R +L+ NP +R++IA +
Sbjct: 262 VNGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEV 299

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 61/207 (29%), Positives = 108/207 (52%), Gaps = 12/207 (5%)
Query: 11  MRLGR--YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATL 68
           M+L R  +E+ + +G G FG+V   +  ++   +A+KIL K  ++    T   + E   L
Sbjct: 69  MQLHREDFEIIKVIGRGAFGEVAVVKMKNTERIYAMKILNKWEMLKRAETACFREERDVL 128
Query: 69  KLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGV 127
                  +  LH     ++ +Y+V++Y  GG+L   ++  + +L E   R    +++  +
Sbjct: 129 VNGDCQWITALHYAFQDENHLYLVMDYYVGGDLLTLLSKFEDKLPEDMARFYIGEMVLAI 188
Query: 128 SYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTT--CGSPNYVAP 185
              H     HRD+K +N+LLD  G+I+++DFG S L  +  DDG + ++   G+P+Y++P
Sbjct: 189 DSIHQLHYVHRDIKPDNVLLDVNGHIRLADFG-SCLKMN--DDGTVQSSVAVGTPDYISP 245
Query: 186 EVLA----NRGYDGATSDIWSCGVILY 208
           E+L       G  G   D WS GV +Y
Sbjct: 246 EILQAMEDGMGKYGPECDWWSLGVCMY 272

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 61/207 (29%), Positives = 108/207 (52%), Gaps = 12/207 (5%)
Query: 11  MRLGR--YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATL 68
           M+L R  +E+ + +G G FG+V   +  ++   +A+KIL K  ++    T   + E   L
Sbjct: 85  MQLHREDFEIIKVIGRGAFGEVAVVKMKNTERIYAMKILNKWEMLKRAETACFREERDVL 144
Query: 69  KLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGV 127
                  +  LH     ++ +Y+V++Y  GG+L   ++  + +L E   R    +++  +
Sbjct: 145 VNGDCQWITALHYAFQDENHLYLVMDYYVGGDLLTLLSKFEDKLPEDMARFYIGEMVLAI 204
Query: 128 SYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTT--CGSPNYVAP 185
              H     HRD+K +N+LLD  G+I+++DFG S L  +  DDG + ++   G+P+Y++P
Sbjct: 205 DSIHQLHYVHRDIKPDNVLLDVNGHIRLADFG-SCLKMN--DDGTVQSSVAVGTPDYISP 261
Query: 186 EVLA----NRGYDGATSDIWSCGVILY 208
           E+L       G  G   D WS GV +Y
Sbjct: 262 EILQAMEDGMGKYGPECDWWSLGVCMY 288

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 56/199 (28%), Positives = 95/199 (47%), Gaps = 6/199 (3%)
Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
           RYELG  LG G   +V  A+DL      AVK+L  +         + +RE      L HP
Sbjct: 13  RYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHP 72
Query: 75  NVVRLHEVLASKSKI----YMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYC 130
            +V ++    +++      Y+V+EYV G  L D + ++G +      ++       +++ 
Sbjct: 73  AIVAVYATGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFS 132
Query: 131 HNKGVFHRDLKLENILLDSKGNIKISDFGLS-ALPQHFRDDGLLHTTCGSPNYVAPEVLA 189
           H  G+ HRD+K  NI++ +   +K+ DFG++ A+              G+  Y++PE   
Sbjct: 133 HQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQAR 192
Query: 190 NRGYDGATSDIWSCGVILY 208
               D A SD++S G +LY
Sbjct: 193 GDSVD-ARSDVYSLGCVLY 210

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 93.2 bits (230), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 60/198 (30%), Positives = 112/198 (56%), Gaps = 12/198 (6%)
Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
           +E+   LG+G FGKV  A++ ++G   A K++E       ++ D I  EI  L    HP 
Sbjct: 21  WEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKS--EEELEDYIV-EIEILATCDHPY 77
Query: 76  VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGR-LQEAEGRKLFQQLIDGVSYCHNKG 134
           +V+L        K+++++E+  GG +   +    R L E + + + +Q+++ +++ H+K 
Sbjct: 78  IVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKR 137
Query: 135 VFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEV-----LA 189
           + HRDLK  N+L+  +G+I+++DFG+SA  ++ +      +  G+P ++APEV     + 
Sbjct: 138 IIHRDLKAGNVLMTLEGDIRLADFGVSA--KNLKTLQKRDSFIGTPYWMAPEVVMCETMK 195
Query: 190 NRGYDGATSDIWSCGVIL 207
           +  YD   +DIWS G+ L
Sbjct: 196 DTPYD-YKADIWSLGITL 212

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score = 93.2 bits (230), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 67/212 (31%), Positives = 100/212 (47%), Gaps = 37/212 (17%)
Query: 13  LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLK----------ITDQIK 62
           + +YE    +GEG +G V           F  K  E + I+ LK          +     
Sbjct: 1   MQKYEKLEKIGEGTYGTV-----------FKAKNRETHEIVALKRVRLDDDDEGVPSSAL 49
Query: 63  REIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGG--ELFDKIASKGRLQEAEGRKLF 120
           REI  LK LKH N+VRLH+VL S  K+ +V E+      + FD  +  G L     +   
Sbjct: 50  REICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFD--SCNGDLDPEIVKSFL 107
Query: 121 QQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP 180
            QL+ G+ +CH++ V HRDLK +N+L++  G +K+++FGL+      R  G +   C S 
Sbjct: 108 FQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLA------RAFG-IPVRCYSA 160
Query: 181 N-----YVAPEVLANRGYDGATSDIWSCGVIL 207
                 Y  P+VL        + D+WS G I 
Sbjct: 161 EVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIF 192

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 70/215 (32%), Positives = 105/215 (48%), Gaps = 32/215 (14%)
Query: 21  TLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLH 80
            LG+G FG+V  A++      +A+K   K R    K++  I  E+  L  L H  VVR +
Sbjct: 13  VLGQGAFGQVVKARNALDSRYYAIK---KIRHTEEKLS-TILSEVMLLASLNHQYVVRYY 68
Query: 81  -------------EVLASKSKIYMVLEYVTGGELFDKIASKG-RLQEAEGRKLFQQLIDG 126
                          +  KS +++ +EY   G L+D I S+    Q  E  +LF+Q+++ 
Sbjct: 69  AAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEA 128
Query: 127 VSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGL-------------L 173
           +SY H++G+ HRDLK  NI +D   N+KI DFGL A   H   D L             L
Sbjct: 129 LSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGL-AKNVHRSLDILKLDSQNLPGSSDNL 187
Query: 174 HTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILY 208
            +  G+  YVA EVL   G+     D++S G+I +
Sbjct: 188 TSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFF 222

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 60/198 (30%), Positives = 112/198 (56%), Gaps = 12/198 (6%)
Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
           +E+   LG+G FGKV  A++ ++G   A K++E       ++ D I  EI  L    HP 
Sbjct: 13  WEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKS--EEELEDYIV-EIEILATCDHPY 69
Query: 76  VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGR-LQEAEGRKLFQQLIDGVSYCHNKG 134
           +V+L        K+++++E+  GG +   +    R L E + + + +Q+++ +++ H+K 
Sbjct: 70  IVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKR 129
Query: 135 VFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEV-----LA 189
           + HRDLK  N+L+  +G+I+++DFG+SA  ++ +      +  G+P ++APEV     + 
Sbjct: 130 IIHRDLKAGNVLMTLEGDIRLADFGVSA--KNLKTLQKRDSFIGTPYWMAPEVVMCETMK 187
Query: 190 NRGYDGATSDIWSCGVIL 207
           +  YD   +DIWS G+ L
Sbjct: 188 DTPYD-YKADIWSLGITL 204

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 54/185 (29%), Positives = 97/185 (52%), Gaps = 8/185 (4%)
Query: 22  LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHE 81
           +G+G+FG+V    D  +    A+KI++           Q  +EI  L     P V + + 
Sbjct: 35  IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQ--QEITVLSQCDSPYVTKYYG 92
Query: 82  VLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLK 141
                +K+++++EY+ GG   D +   G L E +   + ++++ G+ Y H++   HRD+K
Sbjct: 93  SYLKDTKLWIIMEYLGGGSALD-LLEPGPLDETQIATILREILKGLDYLHSEKKIHRDIK 151
Query: 142 LENILLDSKGNIKISDFGLSALPQHFRDDGLLHTT-CGSPNYVAPEVLANRGYDGATSDI 200
             N+LL   G +K++DFG++       D  +   T  G+P ++APEV+    YD + +DI
Sbjct: 152 AANVLLSEHGEVKLADFGVAG---QLTDTQIKRNTFVGTPFWMAPEVIKQSAYD-SKADI 207
Query: 201 WSCGV 205
           WS G+
Sbjct: 208 WSLGI 212

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 92.8 bits (229), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 54/185 (29%), Positives = 97/185 (52%), Gaps = 8/185 (4%)
Query: 22  LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHE 81
           +G+G+FG+V    D  +    A+KI++           Q  +EI  L     P V + + 
Sbjct: 15  IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQ--QEITVLSQCDSPYVTKYYG 72
Query: 82  VLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLK 141
                +K+++++EY+ GG   D +   G L E +   + ++++ G+ Y H++   HRD+K
Sbjct: 73  SYLKDTKLWIIMEYLGGGSALD-LLEPGPLDETQIATILREILKGLDYLHSEKKIHRDIK 131
Query: 142 LENILLDSKGNIKISDFGLSALPQHFRDDGLLHTT-CGSPNYVAPEVLANRGYDGATSDI 200
             N+LL   G +K++DFG++       D  +   T  G+P ++APEV+    YD + +DI
Sbjct: 132 AANVLLSEHGEVKLADFGVAG---QLTDTQIKRNTFVGTPFWMAPEVIKQSAYD-SKADI 187
Query: 201 WSCGV 205
           WS G+
Sbjct: 188 WSLGI 192

>pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321

Iteration: 1
 Score = 92.4 bits (228), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 63/223 (28%), Positives = 114/223 (51%), Gaps = 17/223 (7%)
Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQI--KREIATLKLLK 72
           +Y +   LG G FG V    +  S   +  K ++      +K TDQ+  K+EI+ L + +
Sbjct: 6   KYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVK------VKGTDQVLVKKEISILNIAR 59
Query: 73  HPNVVRLHEVLASKSKIYMVLEYVTGGELFDKI-ASKGRLQEAEGRKLFQQLIDGVSYCH 131
           H N++ LHE   S  ++ M+ E+++G ++F++I  S   L E E      Q+ + + + H
Sbjct: 60  HRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLH 119
Query: 132 NKGVFHRDLKLENILLDSK--GNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLA 189
           +  + H D++ ENI+  ++    IKI +FG +   +   +  LL T   +P Y APEV  
Sbjct: 120 SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFT---APEYYAPEVHQ 176
Query: 190 NRGYDGATSDIWSCGVILYIFRGDFKLPKWLSPGAQNLLRKIL 232
           +     AT D+WS G ++Y+      +  +L+   Q ++  I+
Sbjct: 177 HDVVSTAT-DMWSLGTLVYVLLSG--INPFLAETNQQIIENIM 216

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 92.4 bits (228), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 72/215 (33%), Positives = 106/215 (49%), Gaps = 22/215 (10%)
Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK-- 72
           +YE    +GEG +GKV  A+DL +G  F      + +     +     RE+A L+ L+  
Sbjct: 12  QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETF 71
Query: 73  -HPNVVRLHEVLA-----SKSKIYMVLEYVTG--GELFDKIASKGRLQEAEGRKLFQQLI 124
            HPNVVRL +V        ++K+ +V E+V        DK+   G   E     +FQ L+
Sbjct: 72  EHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQ-LL 130
Query: 125 DGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVA 184
            G+ + H+  V HRDLK +NIL+ S G IK++DFGL+ +   +     L +   +  Y A
Sbjct: 131 RGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARI---YSFQMALTSVVVTLWYRA 187
Query: 185 PEVLANRGYDGATSDIWSCGVILY-------IFRG 212
           PEVL    Y     D+WS G I         +FRG
Sbjct: 188 PEVLLQSSY-ATPVDLWSVGCIFAEMFRRKPLFRG 221

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 92.0 bits (227), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 56/154 (36%), Positives = 88/154 (57%), Gaps = 15/154 (9%)
Query: 63  REIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGG--ELFDK--IASKGRLQEAEGRK 118
           REI+ +K LKH N+VRL++V+ +++K+ +V E++     +  D   + +  R  E    K
Sbjct: 52  REISLMKELKHENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVK 111
Query: 119 LFQ-QLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTC 177
            FQ QL+ G+++CH   + HRDLK +N+L++ +G +K+ DFGL+      R  G+   T 
Sbjct: 112 YFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLA------RAFGIPVNTF 165
Query: 178 GSP----NYVAPEVLANRGYDGATSDIWSCGVIL 207
            S      Y AP+VL        + DIWSCG IL
Sbjct: 166 SSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCIL 199

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 92.0 bits (227), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 72/215 (33%), Positives = 106/215 (49%), Gaps = 22/215 (10%)
Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK-- 72
           +YE    +GEG +GKV  A+DL +G  F      + +     +     RE+A L+ L+  
Sbjct: 12  QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETF 71
Query: 73  -HPNVVRLHEVLA-----SKSKIYMVLEYVTG--GELFDKIASKGRLQEAEGRKLFQQLI 124
            HPNVVRL +V        ++K+ +V E+V        DK+   G   E     +FQ L+
Sbjct: 72  EHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQ-LL 130
Query: 125 DGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVA 184
            G+ + H+  V HRDLK +NIL+ S G IK++DFGL+ +   +     L +   +  Y A
Sbjct: 131 RGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARI---YSFQMALTSVVVTLWYRA 187
Query: 185 PEVLANRGYDGATSDIWSCGVILY-------IFRG 212
           PEVL    Y     D+WS G I         +FRG
Sbjct: 188 PEVLLQSSY-ATPVDLWSVGCIFAEMFRRKPLFRG 221

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 92.0 bits (227), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 72/215 (33%), Positives = 106/215 (49%), Gaps = 22/215 (10%)
Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK-- 72
           +YE    +GEG +GKV  A+DL +G  F      + +     +     RE+A L+ L+  
Sbjct: 12  QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETF 71
Query: 73  -HPNVVRLHEVLA-----SKSKIYMVLEYVTG--GELFDKIASKGRLQEAEGRKLFQQLI 124
            HPNVVRL +V        ++K+ +V E+V        DK+   G   E     +FQ L+
Sbjct: 72  EHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQ-LL 130
Query: 125 DGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVA 184
            G+ + H+  V HRDLK +NIL+ S G IK++DFGL+ +   +     L +   +  Y A
Sbjct: 131 RGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARI---YSFQMALTSVVVTLWYRA 187
Query: 185 PEVLANRGYDGATSDIWSCGVILY-------IFRG 212
           PEVL    Y     D+WS G I         +FRG
Sbjct: 188 PEVLLQSSY-ATPVDLWSVGCIFAEMFRRKPLFRG 221

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 91.7 bits (226), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 68/201 (33%), Positives = 104/201 (51%), Gaps = 18/201 (8%)
Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEK--NRIIHLKITDQIKREIATLKLLK 72
           RY+    +G G +G V  A D  +GL  AVK L K    IIH K T    RE+  LK +K
Sbjct: 35  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSKPFQSIIHAKRT---YRELRLLKHMK 91
Query: 73  HPNVVRLHEV------LASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDG 126
           H NV+ L +V      L   + +Y+V  ++ G +L + I    +L +   + L  Q++ G
Sbjct: 92  HENVIGLLDVFTPARSLEEFNDVYLV-THLMGADL-NNIVKCQKLTDDHVQFLIYQILRG 149
Query: 127 VSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPE 186
           + Y H+  + HRDLK  N+ ++    +KI DFGL+   +H  D+  +     +  Y APE
Sbjct: 150 LKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA---RHTDDE--MTGYVATRWYRAPE 204
Query: 187 VLANRGYDGATSDIWSCGVIL 207
           ++ N  +   T DIWS G I+
Sbjct: 205 IMLNWMHYNQTVDIWSVGCIM 225

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 91.7 bits (226), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 67/201 (33%), Positives = 104/201 (51%), Gaps = 18/201 (8%)
Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEK--NRIIHLKITDQIKREIATLKLLK 72
           RY+    +G G +G V  A D  +GL  AVK L +    IIH K T    RE+  LK +K
Sbjct: 23  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRT---YRELRLLKHMK 79
Query: 73  HPNVVRLHEV------LASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDG 126
           H NV+ L +V      L   + +Y+V  ++ G +L + I    +L +   + L  Q++ G
Sbjct: 80  HENVIGLLDVFTPARSLEEFNDVYLV-THLMGADL-NNIVKXQKLTDDHVQFLIYQILRG 137
Query: 127 VSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPE 186
           + Y H+  + HRDLK  N+ ++    +KI DFGL+   +H  D+  +     +  Y APE
Sbjct: 138 LKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA---RHTDDE--MTGYVATRWYRAPE 192
Query: 187 VLANRGYDGATSDIWSCGVIL 207
           ++ N  +   T DIWS G I+
Sbjct: 193 IMLNWMHYNQTVDIWSVGCIM 213

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 91.7 bits (226), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 67/201 (33%), Positives = 103/201 (51%), Gaps = 18/201 (8%)
Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEK--NRIIHLKITDQIKREIATLKLLK 72
           RY+    +G G +G V  A D  +GL  AVK L +    IIH K T    RE+  LK +K
Sbjct: 23  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRT---YRELRLLKHMK 79
Query: 73  HPNVVRLHEV------LASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDG 126
           H NV+ L +V      L   + +Y+V  ++ G +L + I    +L +   + L  Q++ G
Sbjct: 80  HENVIGLLDVFTPARSLEEFNDVYLV-THLMGADL-NNIVKSQKLTDDHVQFLIYQILRG 137
Query: 127 VSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPE 186
           + Y H+  + HRDLK  N+ ++    +KI DFGL    +H  D+  +     +  Y APE
Sbjct: 138 LKYIHSADIIHRDLKPSNLAVNEDSELKILDFGLC---RHTDDE--MTGYVATRWYRAPE 192
Query: 187 VLANRGYDGATSDIWSCGVIL 207
           ++ N  +   T DIWS G I+
Sbjct: 193 IMLNWMHYNQTVDIWSVGCIM 213

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 91.7 bits (226), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 67/201 (33%), Positives = 104/201 (51%), Gaps = 18/201 (8%)
Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEK--NRIIHLKITDQIKREIATLKLLK 72
           RY+    +G G +G V  A D  +GL  AVK L +    IIH K T    RE+  LK +K
Sbjct: 23  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRT---YRELRLLKHMK 79
Query: 73  HPNVVRLHEV------LASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDG 126
           H NV+ L +V      L   + +Y+V  ++ G +L + I    +L +   + L  Q++ G
Sbjct: 80  HENVIGLLDVFTPARSLEEFNDVYLV-THLMGADL-NNIVKXQKLTDDHVQFLIYQILRG 137
Query: 127 VSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPE 186
           + Y H+  + HRDLK  N+ ++    +KI DFGL+   +H  D+  +     +  Y APE
Sbjct: 138 LKYIHSADIIHRDLKPSNLAVNEDXELKILDFGLA---RHTDDE--MTGYVATRWYRAPE 192
Query: 187 VLANRGYDGATSDIWSCGVIL 207
           ++ N  +   T DIWS G I+
Sbjct: 193 IMLNWMHYNQTVDIWSVGCIM 213

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 91.7 bits (226), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 79/263 (30%), Positives = 124/263 (47%), Gaps = 30/263 (11%)
Query: 20  RTLGEGNFGKVKFAQDLDSGLPFAVKILEK--NRIIHLKITDQIKREIATLKLLKHPNVV 77
           R +G G +G V  A D       AVK L +    +IH + T    RE+  LK LKH NV+
Sbjct: 34  RPVGSGAYGSVCSAYDARLRQKVAVKKLSRPFQSLIHARRT---YRELRLLKHLKHENVI 90
Query: 78  RLHEVLASK------SKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCH 131
            L +V          S++Y+V   + G +L + + S+  L +   + L  QL+ G+ Y H
Sbjct: 91  GLLDVFTPATSIEDFSEVYLVTT-LMGADLNNIVKSQA-LSDEHVQFLVYQLLRGLKYIH 148
Query: 132 NKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANR 191
           + G+ HRDLK  N+ ++    ++I DFGL+      + D  +     +  Y APE++ N 
Sbjct: 149 SAGIIHRDLKPSNVAVNEDSELRILDFGLAR-----QADEEMTGYVATRWYRAPEIMLNW 203
Query: 192 GYDGATSDIWSCGVILYIFRGDFKLPKWLSPGAQNL--LRKILE----PNPVKRITIAGI 245
            +   T DIWS G I+     +    K L PG+  +  L++I+E    P+P     I+  
Sbjct: 204 MHYNQTVDIWSVGCIM----AELLQGKALFPGSDYIDQLKRIMEVVGTPSPEVLAKISSE 259
Query: 246 KADEWFEQDYTPANPDDDEEDIF 268
            A  + +    P  P  D   IF
Sbjct: 260 HARTYIQS--LPPMPQKDLSSIF 280

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 91.7 bits (226), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 67/201 (33%), Positives = 104/201 (51%), Gaps = 18/201 (8%)
Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEK--NRIIHLKITDQIKREIATLKLLK 72
           RY+    +G G +G V  A D  +GL  AVK L +    IIH K T    RE+  LK +K
Sbjct: 25  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRT---YRELRLLKHMK 81
Query: 73  HPNVVRLHEV------LASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDG 126
           H NV+ L +V      L   + +Y+V  ++ G +L + I    +L +   + L  Q++ G
Sbjct: 82  HENVIGLLDVFTPARSLEEFNDVYLV-THLMGADL-NNIVKCQKLTDDHVQFLIYQILRG 139
Query: 127 VSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPE 186
           + Y H+  + HRDLK  N+ ++    +KI DFGL+   +H  D+  +     +  Y APE
Sbjct: 140 LKYIHSADIIHRDLKPSNLAVNEDSELKILDFGLA---RHTDDE--MTGYVATRWYRAPE 194
Query: 187 VLANRGYDGATSDIWSCGVIL 207
           ++ N  +   T DIWS G I+
Sbjct: 195 IMLNWMHYNQTVDIWSVGCIM 215

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 91.7 bits (226), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 67/201 (33%), Positives = 104/201 (51%), Gaps = 18/201 (8%)
Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEK--NRIIHLKITDQIKREIATLKLLK 72
           RY+    +G G +G V  A D  +GL  AVK L +    IIH K T    RE+  LK +K
Sbjct: 29  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRT---YRELRLLKHMK 85
Query: 73  HPNVVRLHEV------LASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDG 126
           H NV+ L +V      L   + +Y+V  ++ G +L + I    +L +   + L  Q++ G
Sbjct: 86  HENVIGLLDVFTPARSLEEFNDVYLV-THLMGADL-NNIVKCQKLTDDHVQFLIYQILRG 143
Query: 127 VSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPE 186
           + Y H+  + HRDLK  N+ ++    +KI DFGL+   +H  D+  +     +  Y APE
Sbjct: 144 LKYIHSADIIHRDLKPSNLAVNEDSELKILDFGLA---RHTDDE--MTGYVATRWYRAPE 198
Query: 187 VLANRGYDGATSDIWSCGVIL 207
           ++ N  +   T DIWS G I+
Sbjct: 199 IMLNWMHYNQTVDIWSVGCIM 219

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 91.7 bits (226), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 67/201 (33%), Positives = 104/201 (51%), Gaps = 18/201 (8%)
Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEK--NRIIHLKITDQIKREIATLKLLK 72
           RY+    +G G +G V  A D  +GL  AVK L +    IIH K T    RE+  LK +K
Sbjct: 30  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRT---YRELRLLKHMK 86
Query: 73  HPNVVRLHEV------LASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDG 126
           H NV+ L +V      L   + +Y+V  ++ G +L + I    +L +   + L  Q++ G
Sbjct: 87  HENVIGLLDVFTPARSLEEFNDVYLV-THLMGADL-NNIVKCQKLTDDHVQFLIYQILRG 144
Query: 127 VSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPE 186
           + Y H+  + HRDLK  N+ ++    +KI DFGL+   +H  D+  +     +  Y APE
Sbjct: 145 LKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA---RHTADE--MTGYVATRWYRAPE 199
Query: 187 VLANRGYDGATSDIWSCGVIL 207
           ++ N  +   T DIWS G I+
Sbjct: 200 IMLNWMHYNQTVDIWSVGCIM 220

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 91.3 bits (225), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 67/201 (33%), Positives = 104/201 (51%), Gaps = 18/201 (8%)
Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEK--NRIIHLKITDQIKREIATLKLLK 72
           RY+    +G G +G V  A D  +GL  AVK L +    IIH K T    RE+  LK +K
Sbjct: 30  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRT---YRELRLLKHMK 86
Query: 73  HPNVVRLHEV------LASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDG 126
           H NV+ L +V      L   + +Y+V  ++ G +L + I    +L +   + L  Q++ G
Sbjct: 87  HENVIGLLDVFTPARSLEEFNDVYLV-THLMGADL-NNIVKCQKLTDDHVQFLIYQILRG 144
Query: 127 VSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPE 186
           + Y H+  + HRDLK  N+ ++    +KI DFGL+   +H  D+  +     +  Y APE
Sbjct: 145 LKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA---RHTADE--MTGYVATRWYRAPE 199
Query: 187 VLANRGYDGATSDIWSCGVIL 207
           ++ N  +   T DIWS G I+
Sbjct: 200 IMLNWMHYNQTVDIWSVGCIM 220

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 91.3 bits (225), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 66/196 (33%), Positives = 95/196 (48%), Gaps = 12/196 (6%)
Query: 18  LGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVV 77
           LG  +G GNFG+V   +        AVK   +     LK   +  +E   LK   HPN+V
Sbjct: 118 LGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKA--KFLQEARILKQYSHPNIV 175
Query: 78  RLHEVLASKSKIYMVLEYVTGGELFDKIASKG-RLQEAEGRKLFQQLIDGVSYCHNKGVF 136
           RL  V   K  IY+V+E V GG+    + ++G RL+     ++      G+ Y  +K   
Sbjct: 176 RLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCI 235
Query: 137 HRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCG----SPNYVAPEVLANRG 192
           HRDL   N L+  K  +KISDFG+S        DG+   + G       + APE L N G
Sbjct: 236 HRDLAARNCLVTEKNVLKISDFGMS----REEADGVYAASGGLRQVPVKWTAPEAL-NYG 290
Query: 193 YDGATSDIWSCGVILY 208
              + SD+WS G++L+
Sbjct: 291 RYSSESDVWSFGILLW 306

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 91.3 bits (225), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 67/201 (33%), Positives = 104/201 (51%), Gaps = 18/201 (8%)
Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEK--NRIIHLKITDQIKREIATLKLLK 72
           RY+    +G G +G V  A D  +GL  AVK L +    IIH K T    RE+  LK +K
Sbjct: 28  RYQNLSPIGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRT---YRELRLLKHMK 84
Query: 73  HPNVVRLHEV------LASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDG 126
           H NV+ L +V      L   + +Y+V  ++ G +L + I    +L +   + L  Q++ G
Sbjct: 85  HENVIGLLDVFTPARSLEEFNDVYLV-THLMGADL-NNIVKCQKLTDDHVQFLIYQILRG 142
Query: 127 VSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPE 186
           + Y H+  + HRDLK  N+ ++    +KI DFGL+   +H  D+  +     +  Y APE
Sbjct: 143 LKYIHSADIIHRDLKPSNLAVNEDXELKILDFGLA---RHTDDE--MTGYVATRWYRAPE 197
Query: 187 VLANRGYDGATSDIWSCGVIL 207
           ++ N  +   T DIWS G I+
Sbjct: 198 IMLNWMHYNQTVDIWSVGCIM 218

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 91.3 bits (225), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 66/196 (33%), Positives = 95/196 (48%), Gaps = 12/196 (6%)
Query: 18  LGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVV 77
           LG  +G GNFG+V   +        AVK   +     LK   +  +E   LK   HPN+V
Sbjct: 118 LGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKA--KFLQEARILKQYSHPNIV 175
Query: 78  RLHEVLASKSKIYMVLEYVTGGELFDKIASKG-RLQEAEGRKLFQQLIDGVSYCHNKGVF 136
           RL  V   K  IY+V+E V GG+    + ++G RL+     ++      G+ Y  +K   
Sbjct: 176 RLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCI 235
Query: 137 HRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCG----SPNYVAPEVLANRG 192
           HRDL   N L+  K  +KISDFG+S        DG+   + G       + APE L N G
Sbjct: 236 HRDLAARNCLVTEKNVLKISDFGMS----REEADGVXAASGGLRQVPVKWTAPEAL-NYG 290
Query: 193 YDGATSDIWSCGVILY 208
              + SD+WS G++L+
Sbjct: 291 RYSSESDVWSFGILLW 306

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 91.3 bits (225), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 67/201 (33%), Positives = 104/201 (51%), Gaps = 18/201 (8%)
Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEK--NRIIHLKITDQIKREIATLKLLK 72
           RY+    +G G +G V  A D  +GL  AVK L +    IIH K T    RE+  LK +K
Sbjct: 30  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRT---YRELRLLKHMK 86
Query: 73  HPNVVRLHEV------LASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDG 126
           H NV+ L +V      L   + +Y+V  ++ G +L + I    +L +   + L  Q++ G
Sbjct: 87  HENVIGLLDVFTPARSLEEFNDVYLV-THLMGADL-NNIVKCQKLTDDHVQFLIYQILRG 144
Query: 127 VSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPE 186
           + Y H+  + HRDLK  N+ ++    +KI DFGL+   +H  D+  +     +  Y APE
Sbjct: 145 LKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA---RHTADE--MTGYVATRWYRAPE 199
Query: 187 VLANRGYDGATSDIWSCGVIL 207
           ++ N  +   T DIWS G I+
Sbjct: 200 IMLNWMHYNQTVDIWSVGCIM 220

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 67/201 (33%), Positives = 104/201 (51%), Gaps = 18/201 (8%)
Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEK--NRIIHLKITDQIKREIATLKLLK 72
           RY+    +G G +G V  A D  +GL  AVK L +    IIH K T    RE+  LK +K
Sbjct: 23  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRT---YRELRLLKHMK 79
Query: 73  HPNVVRLHEV------LASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDG 126
           H NV+ L +V      L   + +Y+V  ++ G +L + I    +L +   + L  Q++ G
Sbjct: 80  HENVIGLLDVFTPARSLEEFNDVYLV-THLMGADL-NNIVKCQKLTDDHVQFLIYQILRG 137
Query: 127 VSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPE 186
           + Y H+  + HRDLK  N+ ++    +KI DFGL+   +H  D+  +     +  Y APE
Sbjct: 138 LKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA---RHTDDE--MTGXVATRWYRAPE 192
Query: 187 VLANRGYDGATSDIWSCGVIL 207
           ++ N  +   T DIWS G I+
Sbjct: 193 IMLNWMHYNQTVDIWSVGCIM 213

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 67/201 (33%), Positives = 104/201 (51%), Gaps = 18/201 (8%)
Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEK--NRIIHLKITDQIKREIATLKLLK 72
           RY+    +G G +G V  A D  +GL  AVK L +    IIH K T    RE+  LK +K
Sbjct: 23  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRT---YRELRLLKHMK 79
Query: 73  HPNVVRLHEV------LASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDG 126
           H NV+ L +V      L   + +Y+V  ++ G +L + I    +L +   + L  Q++ G
Sbjct: 80  HENVIGLLDVFTPARSLEEFNDVYLV-THLMGADL-NNIVKCQKLTDDHVQFLIYQILRG 137
Query: 127 VSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPE 186
           + Y H+  + HRDLK  N+ ++    +KI DFGL+   +H  D+  +     +  Y APE
Sbjct: 138 LKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA---RHTDDE--MTGYVATRWYRAPE 192
Query: 187 VLANRGYDGATSDIWSCGVIL 207
           ++ N  +   T DIWS G I+
Sbjct: 193 IMLNAMHYNQTVDIWSVGCIM 213

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 67/201 (33%), Positives = 104/201 (51%), Gaps = 18/201 (8%)
Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEK--NRIIHLKITDQIKREIATLKLLK 72
           RY+    +G G +G V  A D  +GL  AVK L +    IIH K T    RE+  LK +K
Sbjct: 23  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRT---YRELRLLKHMK 79
Query: 73  HPNVVRLHEV------LASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDG 126
           H NV+ L +V      L   + +Y+V  ++ G +L + I    +L +   + L  Q++ G
Sbjct: 80  HENVIGLLDVFTPARSLEEFNDVYLV-THLMGADL-NNIVKCQKLTDDHVQFLIYQILRG 137
Query: 127 VSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPE 186
           + Y H+  + HRDLK  N+ ++    +KI DFGL+   +H  D+  +     +  Y APE
Sbjct: 138 LKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA---RHTDDE--MTGYVATRWYRAPE 192
Query: 187 VLANRGYDGATSDIWSCGVIL 207
           ++ N  +   T DIWS G I+
Sbjct: 193 IMLNWMHYNQTVDIWSVGCIM 213

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 67/201 (33%), Positives = 104/201 (51%), Gaps = 18/201 (8%)
Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEK--NRIIHLKITDQIKREIATLKLLK 72
           RY+    +G G +G V  A D  +GL  AVK L +    IIH K T    RE+  LK +K
Sbjct: 46  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRT---YRELRLLKHMK 102
Query: 73  HPNVVRLHEV------LASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDG 126
           H NV+ L +V      L   + +Y+V  ++ G +L + I    +L +   + L  Q++ G
Sbjct: 103 HENVIGLLDVFTPARSLEEFNDVYLV-THLMGADL-NNIVKCQKLTDDHVQFLIYQILRG 160
Query: 127 VSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPE 186
           + Y H+  + HRDLK  N+ ++    +KI DFGL+   +H  D+  +     +  Y APE
Sbjct: 161 LKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA---RHTDDE--MXGYVATRWYRAPE 215
Query: 187 VLANRGYDGATSDIWSCGVIL 207
           ++ N  +   T DIWS G I+
Sbjct: 216 IMLNWMHYNQTVDIWSVGCIM 236

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 71/261 (27%), Positives = 125/261 (47%), Gaps = 30/261 (11%)
Query: 22  LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHE 81
           +GEG+ G V  A    SG   AVK ++  +    ++   +  E+  ++  +H NVV ++ 
Sbjct: 159 IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRREL---LFNEVVIMRDYQHENVVEMYN 215
Query: 82  VLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLK 141
                 ++++V+E++ GG L D I +  R+ E +   +   ++  +S  H +GV HRD+K
Sbjct: 216 SYLVGDELWVVMEFLEGGALTD-IVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIK 274
Query: 142 LENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIW 201
            ++ILL   G +K+SDFG  A  Q  ++        G+P ++APE+++   Y G   DIW
Sbjct: 275 SDSILLTHDGRVKLSDFGFCA--QVSKEVPRRKXLVGTPYWMAPELISRLPY-GPEVDIW 331
Query: 202 SCGVIL---------YIFRGDFK--------LPKWL------SPGAQNLLRKILEPNPVK 238
           S G+++         Y      K        LP  L      SP  +  L ++L  +P +
Sbjct: 332 SLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLDRLLVRDPAQ 391
Query: 239 RITIAGIKADEWFEQDYTPAN 259
           R T A +    +  +   PA+
Sbjct: 392 RATAAELLKHPFLAKAGPPAS 412

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 67/201 (33%), Positives = 104/201 (51%), Gaps = 18/201 (8%)
Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEK--NRIIHLKITDQIKREIATLKLLK 72
           RY+    +G G +G V  A D  +GL  AVK L +    IIH K T    RE+  LK +K
Sbjct: 23  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRT---YRELRLLKHMK 79
Query: 73  HPNVVRLHEV------LASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDG 126
           H NV+ L +V      L   + +Y+V  ++ G +L + I    +L +   + L  Q++ G
Sbjct: 80  HENVIGLLDVFTPARSLEEFNDVYLV-THLMGADL-NNIVKCQKLTDDHVQFLIYQILRG 137
Query: 127 VSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPE 186
           + Y H+  + HRDLK  N+ ++    +KI DFGL+   +H  D+  +     +  Y APE
Sbjct: 138 LKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA---RHTDDE--MTGYVATRWYRAPE 192
Query: 187 VLANRGYDGATSDIWSCGVIL 207
           ++ N  +   T DIWS G I+
Sbjct: 193 IMLNWMHYNQTVDIWSVGCIM 213

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 67/201 (33%), Positives = 104/201 (51%), Gaps = 18/201 (8%)
Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEK--NRIIHLKITDQIKREIATLKLLK 72
           RY+    +G G +G V  A D  +GL  AVK L +    IIH K T    RE+  LK +K
Sbjct: 23  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRT---YRELRLLKHMK 79
Query: 73  HPNVVRLHEV------LASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDG 126
           H NV+ L +V      L   + +Y+V  ++ G +L + I    +L +   + L  Q++ G
Sbjct: 80  HENVIGLLDVFTPARSLEEFNDVYLV-THLMGADL-NNIVKCQKLTDDHVQFLIYQILRG 137
Query: 127 VSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPE 186
           + Y H+  + HRDLK  N+ ++    +KI DFGL+   +H  D+  +     +  Y APE
Sbjct: 138 LKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA---RHTDDE--MTGYVATRWYRAPE 192
Query: 187 VLANRGYDGATSDIWSCGVIL 207
           ++ N  +   T DIWS G I+
Sbjct: 193 IMLNWMHYNQTVDIWSVGCIM 213

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 67/201 (33%), Positives = 104/201 (51%), Gaps = 18/201 (8%)
Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEK--NRIIHLKITDQIKREIATLKLLK 72
           RY+    +G G +G V  A D  +GL  AVK L +    IIH K T    RE+  LK +K
Sbjct: 28  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRT---YRELRLLKHMK 84
Query: 73  HPNVVRLHEV------LASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDG 126
           H NV+ L +V      L   + +Y+V  ++ G +L + I    +L +   + L  Q++ G
Sbjct: 85  HENVIGLLDVFTPARSLEEFNDVYLV-THLMGADL-NNIVKCQKLTDDHVQFLIYQILRG 142
Query: 127 VSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPE 186
           + Y H+  + HRDLK  N+ ++    +KI DFGL+   +H  D+  +     +  Y APE
Sbjct: 143 LKYIHSADIIHRDLKPSNLAVNEDXELKILDFGLA---RHTDDE--MTGYVATRWYRAPE 197
Query: 187 VLANRGYDGATSDIWSCGVIL 207
           ++ N  +   T DIWS G I+
Sbjct: 198 IMLNWMHYNQTVDIWSVGCIM 218

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 67/201 (33%), Positives = 104/201 (51%), Gaps = 18/201 (8%)
Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEK--NRIIHLKITDQIKREIATLKLLK 72
           RY+    +G G +G V  A D  +GL  AVK L +    IIH K T    RE+  LK +K
Sbjct: 23  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRT---YRELRLLKHMK 79
Query: 73  HPNVVRLHEV------LASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDG 126
           H NV+ L +V      L   + +Y+V  ++ G +L + I    +L +   + L  Q++ G
Sbjct: 80  HENVIGLLDVFTPARSLEEFNDVYLV-THLMGADL-NNIVKCQKLTDDHVQFLIYQILRG 137
Query: 127 VSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPE 186
           + Y H+  + HRDLK  N+ ++    +KI DFGL+   +H  D+  +     +  Y APE
Sbjct: 138 LKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA---RHTDDE--MTGYVATRWYRAPE 192
Query: 187 VLANRGYDGATSDIWSCGVIL 207
           ++ N  +   T DIWS G I+
Sbjct: 193 IMLNWMHYNQTVDIWSVGCIM 213

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 67/201 (33%), Positives = 104/201 (51%), Gaps = 18/201 (8%)
Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEK--NRIIHLKITDQIKREIATLKLLK 72
           RY+    +G G +G V  A D  +GL  AVK L +    IIH K T    RE+  LK +K
Sbjct: 25  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRT---YRELRLLKHMK 81
Query: 73  HPNVVRLHEV------LASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDG 126
           H NV+ L +V      L   + +Y+V  ++ G +L + I    +L +   + L  Q++ G
Sbjct: 82  HENVIGLLDVFTPARSLEEFNDVYLV-THLMGADL-NNIVKCQKLTDDHVQFLIYQILRG 139
Query: 127 VSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPE 186
           + Y H+  + HRDLK  N+ ++    +KI DFGL+   +H  D+  +     +  Y APE
Sbjct: 140 LKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA---RHTDDE--MTGYVATRWYRAPE 194
Query: 187 VLANRGYDGATSDIWSCGVIL 207
           ++ N  +   T DIWS G I+
Sbjct: 195 IMLNWMHYNQTVDIWSVGCIM 215

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 67/201 (33%), Positives = 104/201 (51%), Gaps = 18/201 (8%)
Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEK--NRIIHLKITDQIKREIATLKLLK 72
           RY+    +G G +G V  A D  +GL  AVK L +    IIH K T    RE+  LK +K
Sbjct: 28  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRT---YRELRLLKHMK 84
Query: 73  HPNVVRLHEV------LASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDG 126
           H NV+ L +V      L   + +Y+V  ++ G +L + I    +L +   + L  Q++ G
Sbjct: 85  HENVIGLLDVFTPARSLEEFNDVYLV-THLMGADL-NNIVKCQKLTDDHVQFLIYQILRG 142
Query: 127 VSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPE 186
           + Y H+  + HRDLK  N+ ++    +KI DFGL+   +H  D+  +     +  Y APE
Sbjct: 143 LKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA---RHTDDE--MTGYVATRWYRAPE 197
Query: 187 VLANRGYDGATSDIWSCGVIL 207
           ++ N  +   T DIWS G I+
Sbjct: 198 IMLNWMHYNQTVDIWSVGCIM 218

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 67/201 (33%), Positives = 104/201 (51%), Gaps = 18/201 (8%)
Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEK--NRIIHLKITDQIKREIATLKLLK 72
           RY+    +G G +G V  A D  +GL  AVK L +    IIH K T    RE+  LK +K
Sbjct: 35  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRT---YRELRLLKHMK 91
Query: 73  HPNVVRLHEV------LASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDG 126
           H NV+ L +V      L   + +Y+V  ++ G +L + I    +L +   + L  Q++ G
Sbjct: 92  HENVIGLLDVFTPARSLEEFNDVYLV-THLMGADL-NNIVKCQKLTDDHVQFLIYQILRG 149
Query: 127 VSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPE 186
           + Y H+  + HRDLK  N+ ++    +KI DFGL+   +H  D+  +     +  Y APE
Sbjct: 150 LKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA---RHTDDE--MTGYVATRWYRAPE 204
Query: 187 VLANRGYDGATSDIWSCGVIL 207
           ++ N  +   T DIWS G I+
Sbjct: 205 IMLNWMHYNQTVDIWSVGCIM 225

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 71/261 (27%), Positives = 125/261 (47%), Gaps = 30/261 (11%)
Query: 22  LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHE 81
           +GEG+ G V  A    SG   AVK ++  +    +  + +  E+  ++  +H NVV ++ 
Sbjct: 82  IGEGSTGIVCIATVRSSGKLVAVKKMDLRK---QQRRELLFNEVVIMRDYQHENVVEMYN 138
Query: 82  VLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLK 141
                 ++++V+E++ GG L D I +  R+ E +   +   ++  +S  H +GV HRD+K
Sbjct: 139 SYLVGDELWVVMEFLEGGALTD-IVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIK 197
Query: 142 LENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIW 201
            ++ILL   G +K+SDFG  A  Q  ++        G+P ++APE+++   Y G   DIW
Sbjct: 198 SDSILLTHDGRVKLSDFGFCA--QVSKEVPRRKXLVGTPYWMAPELISRLPY-GPEVDIW 254
Query: 202 SCGVIL---------YIFRGDFK--------LPKWL------SPGAQNLLRKILEPNPVK 238
           S G+++         Y      K        LP  L      SP  +  L ++L  +P +
Sbjct: 255 SLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLDRLLVRDPAQ 314
Query: 239 RITIAGIKADEWFEQDYTPAN 259
           R T A +    +  +   PA+
Sbjct: 315 RATAAELLKHPFLAKAGPPAS 335

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 67/201 (33%), Positives = 104/201 (51%), Gaps = 18/201 (8%)
Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEK--NRIIHLKITDQIKREIATLKLLK 72
           RY+    +G G +G V  A D  +GL  AVK L +    IIH K T    RE+  LK +K
Sbjct: 25  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRT---YRELRLLKHMK 81
Query: 73  HPNVVRLHEV------LASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDG 126
           H NV+ L +V      L   + +Y+V  ++ G +L + I    +L +   + L  Q++ G
Sbjct: 82  HENVIGLLDVFTPARSLEEFNDVYLV-THLMGADL-NNIVKCQKLTDDHVQFLIYQILRG 139
Query: 127 VSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPE 186
           + Y H+  + HRDLK  N+ ++    +KI DFGL+   +H  D+  +     +  Y APE
Sbjct: 140 LKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA---RHTDDE--MTGYVATRWYRAPE 194
Query: 187 VLANRGYDGATSDIWSCGVIL 207
           ++ N  +   T DIWS G I+
Sbjct: 195 IMLNWMHYNQTVDIWSVGCIM 215

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 67/201 (33%), Positives = 104/201 (51%), Gaps = 18/201 (8%)
Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEK--NRIIHLKITDQIKREIATLKLLK 72
           RY+    +G G +G V  A D  +GL  AVK L +    IIH K T    RE+  LK +K
Sbjct: 22  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRT---YRELRLLKHMK 78
Query: 73  HPNVVRLHEV------LASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDG 126
           H NV+ L +V      L   + +Y+V  ++ G +L + I    +L +   + L  Q++ G
Sbjct: 79  HENVIGLLDVFTPARSLEEFNDVYLV-THLMGADL-NNIVKCQKLTDDHVQFLIYQILRG 136
Query: 127 VSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPE 186
           + Y H+  + HRDLK  N+ ++    +KI DFGL+   +H  D+  +     +  Y APE
Sbjct: 137 LKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA---RHTDDE--MTGYVATRWYRAPE 191
Query: 187 VLANRGYDGATSDIWSCGVIL 207
           ++ N  +   T DIWS G I+
Sbjct: 192 IMLNWMHYNQTVDIWSVGCIM 212

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 67/201 (33%), Positives = 104/201 (51%), Gaps = 18/201 (8%)
Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEK--NRIIHLKITDQIKREIATLKLLK 72
           RY+    +G G +G V  A D  +GL  AVK L +    IIH K T    RE+  LK +K
Sbjct: 35  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRT---YRELRLLKHMK 91
Query: 73  HPNVVRLHEV------LASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDG 126
           H NV+ L +V      L   + +Y+V  ++ G +L + I    +L +   + L  Q++ G
Sbjct: 92  HENVIGLLDVFTPARSLEEFNDVYLV-THLMGADL-NNIVKCQKLTDDHVQFLIYQILRG 149
Query: 127 VSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPE 186
           + Y H+  + HRDLK  N+ ++    +KI DFGL+   +H  D+  +     +  Y APE
Sbjct: 150 LKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA---RHTDDE--MTGYVATRWYRAPE 204
Query: 187 VLANRGYDGATSDIWSCGVIL 207
           ++ N  +   T DIWS G I+
Sbjct: 205 IMLNWMHYNQTVDIWSVGCIM 225

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 67/201 (33%), Positives = 104/201 (51%), Gaps = 18/201 (8%)
Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEK--NRIIHLKITDQIKREIATLKLLK 72
           RY+    +G G +G V  A D  +GL  AVK L +    IIH K T    RE+  LK +K
Sbjct: 23  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRT---YRELRLLKHMK 79
Query: 73  HPNVVRLHEV------LASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDG 126
           H NV+ L +V      L   + +Y+V  ++ G +L + I    +L +   + L  Q++ G
Sbjct: 80  HENVIGLLDVFTPARSLEEFNDVYLV-THLMGADL-NNIVKCQKLTDDHVQFLIYQILRG 137
Query: 127 VSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPE 186
           + Y H+  + HRDLK  N+ ++    +KI DFGL+   +H  D+  +     +  Y APE
Sbjct: 138 LKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA---RHTDDE--MTGYVATRWYRAPE 192
Query: 187 VLANRGYDGATSDIWSCGVIL 207
           ++ N  +   T DIWS G I+
Sbjct: 193 IMLNWMHYNQTVDIWSVGCIM 213

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 71/261 (27%), Positives = 125/261 (47%), Gaps = 30/261 (11%)
Query: 22  LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHE 81
           +GEG+ G V  A    SG   AVK ++  +    +  + +  E+  ++  +H NVV ++ 
Sbjct: 37  IGEGSTGIVCIATVRSSGKLVAVKKMDLRK---QQRRELLFNEVVIMRDYQHENVVEMYN 93
Query: 82  VLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLK 141
                 ++++V+E++ GG L D I +  R+ E +   +   ++  +S  H +GV HRD+K
Sbjct: 94  SYLVGDELWVVMEFLEGGALTD-IVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIK 152
Query: 142 LENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIW 201
            ++ILL   G +K+SDFG  A  Q  ++        G+P ++APE+++   Y G   DIW
Sbjct: 153 SDSILLTHDGRVKLSDFGFCA--QVSKEVPRRKXLVGTPYWMAPELISRLPY-GPEVDIW 209
Query: 202 SCGVIL---------YIFRGDFK--------LPKWL------SPGAQNLLRKILEPNPVK 238
           S G+++         Y      K        LP  L      SP  +  L ++L  +P +
Sbjct: 210 SLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLDRLLVRDPAQ 269
Query: 239 RITIAGIKADEWFEQDYTPAN 259
           R T A +    +  +   PA+
Sbjct: 270 RATAAELLKHPFLAKAGPPAS 290

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 67/201 (33%), Positives = 104/201 (51%), Gaps = 18/201 (8%)
Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEK--NRIIHLKITDQIKREIATLKLLK 72
           RY+    +G G +G V  A D  +GL  AVK L +    IIH K T    RE+  LK +K
Sbjct: 29  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRT---YRELRLLKHMK 85
Query: 73  HPNVVRLHEV------LASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDG 126
           H NV+ L +V      L   + +Y+V  ++ G +L + I    +L +   + L  Q++ G
Sbjct: 86  HENVIGLLDVFTPARSLEEFNDVYLV-THLMGADL-NNIVKCQKLTDDHVQFLIYQILRG 143
Query: 127 VSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPE 186
           + Y H+  + HRDLK  N+ ++    +KI DFGL+   +H  D+  +     +  Y APE
Sbjct: 144 LKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA---RHTDDE--MTGYVATRWYRAPE 198
Query: 187 VLANRGYDGATSDIWSCGVIL 207
           ++ N  +   T DIWS G I+
Sbjct: 199 IMLNWMHYNQTVDIWSVGCIM 219

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 67/201 (33%), Positives = 104/201 (51%), Gaps = 18/201 (8%)
Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEK--NRIIHLKITDQIKREIATLKLLK 72
           RY+    +G G +G V  A D  +GL  AVK L +    IIH K T    RE+  LK +K
Sbjct: 25  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRT---YRELRLLKHMK 81
Query: 73  HPNVVRLHEV------LASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDG 126
           H NV+ L +V      L   + +Y+V  ++ G +L + I    +L +   + L  Q++ G
Sbjct: 82  HENVIGLLDVFTPARSLEEFNDVYLV-THLMGADL-NNIVKCQKLTDDHVQFLIYQILRG 139
Query: 127 VSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPE 186
           + Y H+  + HRDLK  N+ ++    +KI DFGL+   +H  D+  +     +  Y APE
Sbjct: 140 LKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA---RHTDDE--MTGYVATRWYRAPE 194
Query: 187 VLANRGYDGATSDIWSCGVIL 207
           ++ N  +   T DIWS G I+
Sbjct: 195 IMLNWMHYNQTVDIWSVGCIM 215

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 67/201 (33%), Positives = 104/201 (51%), Gaps = 18/201 (8%)
Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEK--NRIIHLKITDQIKREIATLKLLK 72
           RY+    +G G +G V  A D  +GL  AVK L +    IIH K T    RE+  LK +K
Sbjct: 30  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRT---YRELRLLKHMK 86
Query: 73  HPNVVRLHEV------LASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDG 126
           H NV+ L +V      L   + +Y+V  ++ G +L + I    +L +   + L  Q++ G
Sbjct: 87  HENVIGLLDVFTPARSLEEFNDVYLV-THLMGADL-NNIVKCQKLTDDHVQFLIYQILRG 144
Query: 127 VSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPE 186
           + Y H+  + HRDLK  N+ ++    +KI DFGL+   +H  D+  +     +  Y APE
Sbjct: 145 LKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA---RHTDDE--MTGYVATRWYRAPE 199
Query: 187 VLANRGYDGATSDIWSCGVIL 207
           ++ N  +   T DIWS G I+
Sbjct: 200 IMLNWMHYNQTVDIWSVGCIM 220

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 67/201 (33%), Positives = 104/201 (51%), Gaps = 18/201 (8%)
Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEK--NRIIHLKITDQIKREIATLKLLK 72
           RY+    +G G +G V  A D  +GL  AVK L +    IIH K T    RE+  LK +K
Sbjct: 34  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRT---YRELRLLKHMK 90
Query: 73  HPNVVRLHEV------LASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDG 126
           H NV+ L +V      L   + +Y+V  ++ G +L + I    +L +   + L  Q++ G
Sbjct: 91  HENVIGLLDVFTPARSLEEFNDVYLV-THLMGADL-NNIVKCQKLTDDHVQFLIYQILRG 148
Query: 127 VSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPE 186
           + Y H+  + HRDLK  N+ ++    +KI DFGL+   +H  D+  +     +  Y APE
Sbjct: 149 LKYIHSADIIHRDLKPSNLAVNEDXELKILDFGLA---RHTDDE--MTGYVATRWYRAPE 203
Query: 187 VLANRGYDGATSDIWSCGVIL 207
           ++ N  +   T DIWS G I+
Sbjct: 204 IMLNWMHYNQTVDIWSVGCIM 224

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 67/201 (33%), Positives = 104/201 (51%), Gaps = 18/201 (8%)
Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEK--NRIIHLKITDQIKREIATLKLLK 72
           RY+    +G G +G V  A D  +GL  AVK L +    IIH K T    RE+  LK +K
Sbjct: 46  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRT---YRELRLLKHMK 102
Query: 73  HPNVVRLHEV------LASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDG 126
           H NV+ L +V      L   + +Y+V  ++ G +L + I    +L +   + L  Q++ G
Sbjct: 103 HENVIGLLDVFTPARSLEEFNDVYLV-THLMGADL-NNIVKCQKLTDDHVQFLIYQILRG 160
Query: 127 VSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPE 186
           + Y H+  + HRDLK  N+ ++    +KI DFGL+   +H  D+  +     +  Y APE
Sbjct: 161 LKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA---RHTDDE--MTGYVATRWYRAPE 215
Query: 187 VLANRGYDGATSDIWSCGVIL 207
           ++ N  +   T DIWS G I+
Sbjct: 216 IMLNWMHYNQTVDIWSVGCIM 236

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 67/201 (33%), Positives = 104/201 (51%), Gaps = 18/201 (8%)
Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEK--NRIIHLKITDQIKREIATLKLLK 72
           RY+    +G G +G V  A D  +GL  AVK L +    IIH K T    RE+  LK +K
Sbjct: 28  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRT---YRELRLLKHMK 84
Query: 73  HPNVVRLHEV------LASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDG 126
           H NV+ L +V      L   + +Y+V  ++ G +L + I    +L +   + L  Q++ G
Sbjct: 85  HENVIGLLDVFTPARSLEEFNDVYLV-THLMGADL-NNIVKCQKLTDDHVQFLIYQILRG 142
Query: 127 VSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPE 186
           + Y H+  + HRDLK  N+ ++    +KI DFGL+   +H  D+  +     +  Y APE
Sbjct: 143 LKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA---RHTDDE--MTGYVATRWYRAPE 197
Query: 187 VLANRGYDGATSDIWSCGVIL 207
           ++ N  +   T DIWS G I+
Sbjct: 198 IMLNWMHYNQTVDIWSVGCIM 218

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 71/261 (27%), Positives = 125/261 (47%), Gaps = 30/261 (11%)
Query: 22  LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHE 81
           +GEG+ G V  A    SG   AVK ++  +    +  + +  E+  ++  +H NVV ++ 
Sbjct: 39  IGEGSTGIVCIATVRSSGKLVAVKKMDLRK---QQRRELLFNEVVIMRDYQHENVVEMYN 95
Query: 82  VLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLK 141
                 ++++V+E++ GG L D I +  R+ E +   +   ++  +S  H +GV HRD+K
Sbjct: 96  SYLVGDELWVVMEFLEGGALTD-IVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIK 154
Query: 142 LENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIW 201
            ++ILL   G +K+SDFG  A  Q  ++        G+P ++APE+++   Y G   DIW
Sbjct: 155 SDSILLTHDGRVKLSDFGFCA--QVSKEVPRRKXLVGTPYWMAPELISRLPY-GPEVDIW 211
Query: 202 SCGVIL---------YIFRGDFK--------LPKWL------SPGAQNLLRKILEPNPVK 238
           S G+++         Y      K        LP  L      SP  +  L ++L  +P +
Sbjct: 212 SLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLDRLLVRDPAQ 271
Query: 239 RITIAGIKADEWFEQDYTPAN 259
           R T A +    +  +   PA+
Sbjct: 272 RATAAELLKHPFLAKAGPPAS 292

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 67/201 (33%), Positives = 104/201 (51%), Gaps = 18/201 (8%)
Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEK--NRIIHLKITDQIKREIATLKLLK 72
           RY+    +G G +G V  A D  +GL  AVK L +    IIH K T    RE+  LK +K
Sbjct: 23  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRT---YRELRLLKHMK 79
Query: 73  HPNVVRLHEV------LASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDG 126
           H NV+ L +V      L   + +Y+V  ++ G +L + I    +L +   + L  Q++ G
Sbjct: 80  HENVIGLLDVFTPARSLEEFNDVYLV-THLMGADL-NNIVKCQKLTDDHVQFLIYQILRG 137
Query: 127 VSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPE 186
           + Y H+  + HRDLK  N+ ++    +KI DFGL+   +H  D+  +     +  Y APE
Sbjct: 138 LKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA---RHTDDE--MTGYVATRWYRAPE 192
Query: 187 VLANRGYDGATSDIWSCGVIL 207
           ++ N  +   T DIWS G I+
Sbjct: 193 IMLNWMHYNQTVDIWSVGCIM 213

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 67/201 (33%), Positives = 104/201 (51%), Gaps = 18/201 (8%)
Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEK--NRIIHLKITDQIKREIATLKLLK 72
           RY+    +G G +G V  A D  +GL  AVK L +    IIH K T    RE+  LK +K
Sbjct: 23  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRT---YRELRLLKHMK 79
Query: 73  HPNVVRLHEV------LASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDG 126
           H NV+ L +V      L   + +Y+V  ++ G +L + I    +L +   + L  Q++ G
Sbjct: 80  HENVIGLLDVFTPARSLEEFNDVYLV-THLMGADL-NNIVKCQKLTDDHVQFLIYQILRG 137
Query: 127 VSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPE 186
           + Y H+  + HRDLK  N+ ++    +KI DFGL+   +H  D+  +     +  Y APE
Sbjct: 138 LKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA---RHTDDE--MTGYVATRWYRAPE 192
Query: 187 VLANRGYDGATSDIWSCGVIL 207
           ++ N  +   T DIWS G I+
Sbjct: 193 IMLNWMHYNQTVDIWSVGCIM 213

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 67/201 (33%), Positives = 104/201 (51%), Gaps = 18/201 (8%)
Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEK--NRIIHLKITDQIKREIATLKLLK 72
           RY+    +G G +G V  A D  +GL  AVK L +    IIH K T    RE+  LK +K
Sbjct: 43  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRT---YRELRLLKHMK 99
Query: 73  HPNVVRLHEV------LASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDG 126
           H NV+ L +V      L   + +Y+V  ++ G +L + I    +L +   + L  Q++ G
Sbjct: 100 HENVIGLLDVFTPARSLEEFNDVYLV-THLMGADL-NNIVKCQKLTDDHVQFLIYQILRG 157
Query: 127 VSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPE 186
           + Y H+  + HRDLK  N+ ++    +KI DFGL+   +H  D+  +     +  Y APE
Sbjct: 158 LKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA---RHTDDE--MTGYVATRWYRAPE 212
Query: 187 VLANRGYDGATSDIWSCGVIL 207
           ++ N  +   T DIWS G I+
Sbjct: 213 IMLNWMHYNQTVDIWSVGCIM 233

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 67/201 (33%), Positives = 104/201 (51%), Gaps = 18/201 (8%)
Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEK--NRIIHLKITDQIKREIATLKLLK 72
           RY+    +G G +G V  A D  +GL  AVK L +    IIH K T    RE+  LK +K
Sbjct: 19  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRT---YRELRLLKHMK 75
Query: 73  HPNVVRLHEV------LASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDG 126
           H NV+ L +V      L   + +Y+V  ++ G +L + I    +L +   + L  Q++ G
Sbjct: 76  HENVIGLLDVFTPARSLEEFNDVYLV-THLMGADL-NNIVKCQKLTDDHVQFLIYQILRG 133
Query: 127 VSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPE 186
           + Y H+  + HRDLK  N+ ++    +KI DFGL+   +H  D+  +     +  Y APE
Sbjct: 134 LKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA---RHTDDE--MTGYVATRWYRAPE 188
Query: 187 VLANRGYDGATSDIWSCGVIL 207
           ++ N  +   T DIWS G I+
Sbjct: 189 IMLNWMHYNQTVDIWSVGCIM 209

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 67/201 (33%), Positives = 104/201 (51%), Gaps = 18/201 (8%)
Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEK--NRIIHLKITDQIKREIATLKLLK 72
           RY+    +G G +G V  A D  +GL  AVK L +    IIH K T    RE+  LK +K
Sbjct: 34  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRT---YRELRLLKHMK 90
Query: 73  HPNVVRLHEV------LASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDG 126
           H NV+ L +V      L   + +Y+V  ++ G +L + I    +L +   + L  Q++ G
Sbjct: 91  HENVIGLLDVFTPARSLEEFNDVYLV-THLMGADL-NNIVKCQKLTDDHVQFLIYQILRG 148
Query: 127 VSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPE 186
           + Y H+  + HRDLK  N+ ++    +KI DFGL+   +H  D+  +     +  Y APE
Sbjct: 149 LKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA---RHTDDE--MTGYVATRWYRAPE 203
Query: 187 VLANRGYDGATSDIWSCGVIL 207
           ++ N  +   T DIWS G I+
Sbjct: 204 IMLNWMHYNQTVDIWSVGCIM 224

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 71/261 (27%), Positives = 125/261 (47%), Gaps = 30/261 (11%)
Query: 22  LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHE 81
           +GEG+ G V  A    SG   AVK ++  +    +  + +  E+  ++  +H NVV ++ 
Sbjct: 32  IGEGSTGIVCIATVRSSGKLVAVKKMDLRK---QQRRELLFNEVVIMRDYQHENVVEMYN 88
Query: 82  VLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLK 141
                 ++++V+E++ GG L D I +  R+ E +   +   ++  +S  H +GV HRD+K
Sbjct: 89  SYLVGDELWVVMEFLEGGALTD-IVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIK 147
Query: 142 LENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIW 201
            ++ILL   G +K+SDFG  A  Q  ++        G+P ++APE+++   Y G   DIW
Sbjct: 148 SDSILLTHDGRVKLSDFGFCA--QVSKEVPRRKXLVGTPYWMAPELISRLPY-GPEVDIW 204
Query: 202 SCGVIL---------YIFRGDFK--------LPKWL------SPGAQNLLRKILEPNPVK 238
           S G+++         Y      K        LP  L      SP  +  L ++L  +P +
Sbjct: 205 SLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLDRLLVRDPAQ 264
Query: 239 RITIAGIKADEWFEQDYTPAN 259
           R T A +    +  +   PA+
Sbjct: 265 RATAAELLKHPFLAKAGPPAS 285

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 67/201 (33%), Positives = 104/201 (51%), Gaps = 18/201 (8%)
Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEK--NRIIHLKITDQIKREIATLKLLK 72
           RY+    +G G +G V  A D  +GL  AVK L +    IIH K T    RE+  LK +K
Sbjct: 20  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRT---YRELRLLKHMK 76
Query: 73  HPNVVRLHEV------LASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDG 126
           H NV+ L +V      L   + +Y+V  ++ G +L + I    +L +   + L  Q++ G
Sbjct: 77  HENVIGLLDVFTPARSLEEFNDVYLV-THLMGADL-NNIVKCQKLTDDHVQFLIYQILRG 134
Query: 127 VSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPE 186
           + Y H+  + HRDLK  N+ ++    +KI DFGL+   +H  D+  +     +  Y APE
Sbjct: 135 LKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA---RHTDDE--MTGYVATRWYRAPE 189
Query: 187 VLANRGYDGATSDIWSCGVIL 207
           ++ N  +   T DIWS G I+
Sbjct: 190 IMLNWMHYNQTVDIWSVGCIM 210

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 67/201 (33%), Positives = 104/201 (51%), Gaps = 18/201 (8%)
Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEK--NRIIHLKITDQIKREIATLKLLK 72
           RY+    +G G +G V  A D  +GL  AVK L +    IIH K T    RE+  LK +K
Sbjct: 42  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRT---YRELRLLKHMK 98
Query: 73  HPNVVRLHEV------LASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDG 126
           H NV+ L +V      L   + +Y+V  ++ G +L + I    +L +   + L  Q++ G
Sbjct: 99  HENVIGLLDVFTPARSLEEFNDVYLV-THLMGADL-NNIVKCQKLTDDHVQFLIYQILRG 156
Query: 127 VSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPE 186
           + Y H+  + HRDLK  N+ ++    +KI DFGL+   +H  D+  +     +  Y APE
Sbjct: 157 LKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA---RHTDDE--MTGYVATRWYRAPE 211
Query: 187 VLANRGYDGATSDIWSCGVIL 207
           ++ N  +   T DIWS G I+
Sbjct: 212 IMLNWMHYNQTVDIWSVGCIM 232

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 67/201 (33%), Positives = 104/201 (51%), Gaps = 18/201 (8%)
Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEK--NRIIHLKITDQIKREIATLKLLK 72
           RY+    +G G +G V  A D  +GL  AVK L +    IIH K T    RE+  LK +K
Sbjct: 20  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRT---YRELRLLKHMK 76
Query: 73  HPNVVRLHEV------LASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDG 126
           H NV+ L +V      L   + +Y+V  ++ G +L + I    +L +   + L  Q++ G
Sbjct: 77  HENVIGLLDVFTPARSLEEFNDVYLV-THLMGADL-NNIVKCQKLTDDHVQFLIYQILRG 134
Query: 127 VSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPE 186
           + Y H+  + HRDLK  N+ ++    +KI DFGL+   +H  D+  +     +  Y APE
Sbjct: 135 LKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA---RHTDDE--MTGYVATRWYRAPE 189
Query: 187 VLANRGYDGATSDIWSCGVIL 207
           ++ N  +   T DIWS G I+
Sbjct: 190 IMLNWMHYNQTVDIWSVGCIM 210

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 71/261 (27%), Positives = 125/261 (47%), Gaps = 30/261 (11%)
Query: 22  LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHE 81
           +GEG+ G V  A    SG   AVK ++  +    +  + +  E+  ++  +H NVV ++ 
Sbjct: 28  IGEGSTGIVCIATVRSSGKLVAVKKMDLRK---QQRRELLFNEVVIMRDYQHENVVEMYN 84
Query: 82  VLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLK 141
                 ++++V+E++ GG L D I +  R+ E +   +   ++  +S  H +GV HRD+K
Sbjct: 85  SYLVGDELWVVMEFLEGGALTD-IVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIK 143
Query: 142 LENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIW 201
            ++ILL   G +K+SDFG  A  Q  ++        G+P ++APE+++   Y G   DIW
Sbjct: 144 SDSILLTHDGRVKLSDFGFCA--QVSKEVPRRKXLVGTPYWMAPELISRLPY-GPEVDIW 200
Query: 202 SCGVIL---------YIFRGDFK--------LPKWL------SPGAQNLLRKILEPNPVK 238
           S G+++         Y      K        LP  L      SP  +  L ++L  +P +
Sbjct: 201 SLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLDRLLVRDPAQ 260
Query: 239 RITIAGIKADEWFEQDYTPAN 259
           R T A +    +  +   PA+
Sbjct: 261 RATAAELLKHPFLAKAGPPAS 281

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 67/201 (33%), Positives = 104/201 (51%), Gaps = 18/201 (8%)
Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEK--NRIIHLKITDQIKREIATLKLLK 72
           RY+    +G G +G V  A D  +GL  AVK L +    IIH K T    RE+  LK +K
Sbjct: 29  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRT---YRELRLLKHMK 85
Query: 73  HPNVVRLHEV------LASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDG 126
           H NV+ L +V      L   + +Y+V  ++ G +L + I    +L +   + L  Q++ G
Sbjct: 86  HENVIGLLDVFTPARSLEEFNDVYLV-THLMGADL-NNIVKCQKLTDDHVQFLIYQILRG 143
Query: 127 VSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPE 186
           + Y H+  + HRDLK  N+ ++    +KI DFGL+   +H  D+  +     +  Y APE
Sbjct: 144 LKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA---RHTDDE--MTGYVATRWYRAPE 198
Query: 187 VLANRGYDGATSDIWSCGVIL 207
           ++ N  +   T DIWS G I+
Sbjct: 199 IMLNWMHYNQTVDIWSVGCIM 219

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 67/201 (33%), Positives = 104/201 (51%), Gaps = 18/201 (8%)
Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEK--NRIIHLKITDQIKREIATLKLLK 72
           RY+    +G G +G V  A D  +GL  AVK L +    IIH K T    RE+  LK +K
Sbjct: 21  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRT---YRELRLLKHMK 77
Query: 73  HPNVVRLHEV------LASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDG 126
           H NV+ L +V      L   + +Y+V  ++ G +L + I    +L +   + L  Q++ G
Sbjct: 78  HENVIGLLDVFTPARSLEEFNDVYLV-THLMGADL-NNIVKCQKLTDDHVQFLIYQILRG 135
Query: 127 VSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPE 186
           + Y H+  + HRDLK  N+ ++    +KI DFGL+   +H  D+  +     +  Y APE
Sbjct: 136 LKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA---RHTDDE--MTGYVATRWYRAPE 190
Query: 187 VLANRGYDGATSDIWSCGVIL 207
           ++ N  +   T DIWS G I+
Sbjct: 191 IMLNWMHYNQTVDIWSVGCIM 211

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 53/185 (28%), Positives = 96/185 (51%), Gaps = 8/185 (4%)
Query: 22  LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHE 81
           +G+G+FG+V    D  +    A+KI++           Q  +EI  L     P V + + 
Sbjct: 30  IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQ--QEITVLSQCDSPYVTKYYG 87
Query: 82  VLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLK 141
                +K+++++EY+ GG   D +   G L E +   + ++++ G+ Y H++   HRD+K
Sbjct: 88  SYLKDTKLWIIMEYLGGGSALD-LLEPGPLDETQIATILREILKGLDYLHSEKKIHRDIK 146
Query: 142 LENILLDSKGNIKISDFGLSALPQHFRDDGLLHTT-CGSPNYVAPEVLANRGYDGATSDI 200
             N+LL   G +K++DFG++       D  +      G+P ++APEV+    YD + +DI
Sbjct: 147 AANVLLSEHGEVKLADFGVAG---QLTDTQIKRNXFVGTPFWMAPEVIKQSAYD-SKADI 202
Query: 201 WSCGV 205
           WS G+
Sbjct: 203 WSLGI 207

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 53/185 (28%), Positives = 96/185 (51%), Gaps = 8/185 (4%)
Query: 22  LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHE 81
           +G+G+FG+V    D  +    A+KI++           Q  +EI  L     P V + + 
Sbjct: 15  IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQ--QEITVLSQCDSPYVTKYYG 72
Query: 82  VLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLK 141
                +K+++++EY+ GG   D +   G L E +   + ++++ G+ Y H++   HRD+K
Sbjct: 73  SYLKDTKLWIIMEYLGGGSALD-LLEPGPLDETQIATILREILKGLDYLHSEKKIHRDIK 131
Query: 142 LENILLDSKGNIKISDFGLSALPQHFRDDGLLHTT-CGSPNYVAPEVLANRGYDGATSDI 200
             N+LL   G +K++DFG++       D  +      G+P ++APEV+    YD + +DI
Sbjct: 132 AANVLLSEHGEVKLADFGVAG---QLTDTQIKRNXFVGTPFWMAPEVIKQSAYD-SKADI 187
Query: 201 WSCGV 205
           WS G+
Sbjct: 188 WSLGI 192

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 56/191 (29%), Positives = 102/191 (53%), Gaps = 9/191 (4%)
Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
           +++   LGEG++G V  A   ++G   A+K +     +      +I +EI+ ++    P+
Sbjct: 31  FDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQ-----EIIKEISIMQQCDSPH 85
Query: 76  VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGR-LQEAEGRKLFQQLIDGVSYCHNKG 134
           VV+ +      + +++V+EY   G + D I  + + L E E   + Q  + G+ Y H   
Sbjct: 86  VVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMR 145
Query: 135 VFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYD 194
             HRD+K  NILL+++G+ K++DFG++   Q        +   G+P ++APEV+   GY+
Sbjct: 146 KIHRDIKAGNILLNTEGHAKLADFGVAG--QLTDXMAKRNXVIGTPFWMAPEVIQEIGYN 203
Query: 195 GATSDIWSCGV 205
              +DIWS G+
Sbjct: 204 -CVADIWSLGI 213

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 53/185 (28%), Positives = 96/185 (51%), Gaps = 8/185 (4%)
Query: 22  LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHE 81
           +G+G+FG+V    D  +    A+KI++           Q  +EI  L     P + R   
Sbjct: 27  IGKGSFGEVYKGIDNHTKEVVAIKIIDLEEAEDEIEDIQ--QEITVLSQCDSPYITRYFG 84
Query: 82  VLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLK 141
                +K+++++EY+ GG   D +   G L+E     + ++++ G+ Y H++   HRD+K
Sbjct: 85  SYLKSTKLWIIMEYLGGGSALD-LLKPGPLEETYIATILREILKGLDYLHSERKIHRDIK 143
Query: 142 LENILLDSKGNIKISDFGLSALPQHFRDDGLLHTT-CGSPNYVAPEVLANRGYDGATSDI 200
             N+LL  +G++K++DFG++       D  +      G+P ++APEV+    YD   +DI
Sbjct: 144 AANVLLSEQGDVKLADFGVAG---QLTDTQIKRNXFVGTPFWMAPEVIKQSAYD-FKADI 199
Query: 201 WSCGV 205
           WS G+
Sbjct: 200 WSLGI 204

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 79/263 (30%), Positives = 122/263 (46%), Gaps = 30/263 (11%)
Query: 20  RTLGEGNFGKVKFAQDLDSGLPFAVKILEK--NRIIHLKITDQIKREIATLKLLKHPNVV 77
           R +G G +G V  A D       AVK L +    +IH + T    RE+  LK LKH NV+
Sbjct: 34  RPVGSGAYGSVCSAYDARLRQKVAVKKLSRPFQSLIHARRT---YRELRLLKHLKHENVI 90
Query: 78  RLHEVLASK------SKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCH 131
            L +V          S++Y+V   + G +L + I     L +   + L  QL+ G+ Y H
Sbjct: 91  GLLDVFTPATSIEDFSEVYLVTT-LMGADL-NNIVKCQALSDEHVQFLVYQLLRGLKYIH 148
Query: 132 NKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANR 191
           + G+ HRDLK  N+ ++    ++I DFGL+      + D  +     +  Y APE++ N 
Sbjct: 149 SAGIIHRDLKPSNVAVNEDSELRILDFGLAR-----QADEEMTGYVATRWYRAPEIMLNW 203
Query: 192 GYDGATSDIWSCGVILYIFRGDFKLPKWLSPGAQNL--LRKILE----PNPVKRITIAGI 245
            +   T DIWS G I+     +    K L PG+  +  L++I+E    P+P     I+  
Sbjct: 204 MHYNQTVDIWSVGCIM----AELLQGKALFPGSDYIDQLKRIMEVVGTPSPEVLAKISSE 259
Query: 246 KADEWFEQDYTPANPDDDEEDIF 268
            A  + +    P  P  D   IF
Sbjct: 260 HARTYIQS--LPPMPQKDLSSIF 280

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 69/215 (32%), Positives = 104/215 (48%), Gaps = 32/215 (14%)
Query: 21  TLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLH 80
            LG+G FG+V  A++      +A+K   K R    K++  I  E+  L  L H  VVR +
Sbjct: 13  VLGQGAFGQVVKARNALDSRYYAIK---KIRHTEEKLS-TILSEVMLLASLNHQYVVRYY 68
Query: 81  -------------EVLASKSKIYMVLEYVTGGELFDKIASKG-RLQEAEGRKLFQQLIDG 126
                          +  KS +++ +EY     L+D I S+    Q  E  +LF+Q+++ 
Sbjct: 69  AAWLERRNFVKPMTAVKKKSTLFIQMEYCENRTLYDLIHSENLNQQRDEYWRLFRQILEA 128
Query: 127 VSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGL-------------L 173
           +SY H++G+ HRDLK  NI +D   N+KI DFGL A   H   D L             L
Sbjct: 129 LSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGL-AKNVHRSLDILKLDSQNLPGSSDNL 187
Query: 174 HTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILY 208
            +  G+  YVA EVL   G+     D++S G+I +
Sbjct: 188 TSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFF 222

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 89.7 bits (221), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 67/198 (33%), Positives = 102/198 (51%), Gaps = 14/198 (7%)
Query: 20  RTLGEGNFGKVKFA-----QDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
           + LG+GNFG V+       QD ++G   AVK L+ +   HL+     +REI  LK L+H 
Sbjct: 23  QQLGKGNFGSVEMCRYDPLQD-NTGEVVAVKKLQHSTEEHLR---DFEREIEILKSLQHD 78
Query: 75  NVVRLHEVL--ASKSKIYMVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCH 131
           N+V+   V   A +  + +++EY+  G L D +   K R+   +  +   Q+  G+ Y  
Sbjct: 79  NIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG 138
Query: 132 NKGVFHRDLKLENILLDSKGNIKISDFGLS-ALPQHFRDDGLLHTTCGSPNYVAPEVLAN 190
            K   HRDL   NIL++++  +KI DFGL+  LPQ      +         + APE L  
Sbjct: 139 TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTE 198
Query: 191 RGYDGATSDIWSCGVILY 208
             +  A SD+WS GV+LY
Sbjct: 199 SKFSVA-SDVWSFGVVLY 215

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 89.7 bits (221), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 67/198 (33%), Positives = 102/198 (51%), Gaps = 14/198 (7%)
Query: 20  RTLGEGNFGKVKFA-----QDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
           + LG+GNFG V+       QD ++G   AVK L+ +   HL+     +REI  LK L+H 
Sbjct: 14  QQLGKGNFGSVEMCRYDPLQD-NTGEVVAVKKLQHSTEEHLR---DFEREIEILKSLQHD 69
Query: 75  NVVRLHEVL--ASKSKIYMVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCH 131
           N+V+   V   A +  + +++EY+  G L D +   K R+   +  +   Q+  G+ Y  
Sbjct: 70  NIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG 129
Query: 132 NKGVFHRDLKLENILLDSKGNIKISDFGLS-ALPQHFRDDGLLHTTCGSPNYVAPEVLAN 190
            K   HRDL   NIL++++  +KI DFGL+  LPQ      +         + APE L  
Sbjct: 130 TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTE 189
Query: 191 RGYDGATSDIWSCGVILY 208
             +  A SD+WS GV+LY
Sbjct: 190 SKFSVA-SDVWSFGVVLY 206

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 89.7 bits (221), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 67/198 (33%), Positives = 102/198 (51%), Gaps = 14/198 (7%)
Query: 20  RTLGEGNFGKVKFA-----QDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
           + LG+GNFG V+       QD ++G   AVK L+ +   HL+     +REI  LK L+H 
Sbjct: 20  QQLGKGNFGSVEMCRYDPLQD-NTGEVVAVKKLQHSTEEHLR---DFEREIEILKSLQHD 75
Query: 75  NVVRLHEVL--ASKSKIYMVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCH 131
           N+V+   V   A +  + +++EY+  G L D +   K R+   +  +   Q+  G+ Y  
Sbjct: 76  NIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG 135
Query: 132 NKGVFHRDLKLENILLDSKGNIKISDFGLS-ALPQHFRDDGLLHTTCGSPNYVAPEVLAN 190
            K   HRDL   NIL++++  +KI DFGL+  LPQ      +         + APE L  
Sbjct: 136 TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTE 195
Query: 191 RGYDGATSDIWSCGVILY 208
             +  A SD+WS GV+LY
Sbjct: 196 SKFSVA-SDVWSFGVVLY 212

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 89.7 bits (221), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 67/198 (33%), Positives = 102/198 (51%), Gaps = 14/198 (7%)
Query: 20  RTLGEGNFGKVKFA-----QDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
           + LG+GNFG V+       QD ++G   AVK L+ +   HL+     +REI  LK L+H 
Sbjct: 16  QQLGKGNFGSVEMCRYDPLQD-NTGEVVAVKKLQHSTEEHLR---DFEREIEILKSLQHD 71
Query: 75  NVVRLHEVL--ASKSKIYMVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCH 131
           N+V+   V   A +  + +++EY+  G L D +   K R+   +  +   Q+  G+ Y  
Sbjct: 72  NIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG 131
Query: 132 NKGVFHRDLKLENILLDSKGNIKISDFGLS-ALPQHFRDDGLLHTTCGSPNYVAPEVLAN 190
            K   HRDL   NIL++++  +KI DFGL+  LPQ      +         + APE L  
Sbjct: 132 TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTE 191
Query: 191 RGYDGATSDIWSCGVILY 208
             +  A SD+WS GV+LY
Sbjct: 192 SKFSVA-SDVWSFGVVLY 208

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 89.7 bits (221), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 67/198 (33%), Positives = 102/198 (51%), Gaps = 14/198 (7%)
Query: 20  RTLGEGNFGKVKFA-----QDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
           + LG+GNFG V+       QD ++G   AVK L+ +   HL+     +REI  LK L+H 
Sbjct: 47  QQLGKGNFGSVEMCRYDPLQD-NTGEVVAVKKLQHSTEEHLR---DFEREIEILKSLQHD 102
Query: 75  NVVRLHEVL--ASKSKIYMVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCH 131
           N+V+   V   A +  + +++EY+  G L D +   K R+   +  +   Q+  G+ Y  
Sbjct: 103 NIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG 162
Query: 132 NKGVFHRDLKLENILLDSKGNIKISDFGLS-ALPQHFRDDGLLHTTCGSPNYVAPEVLAN 190
            K   HRDL   NIL++++  +KI DFGL+  LPQ      +         + APE L  
Sbjct: 163 TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTE 222
Query: 191 RGYDGATSDIWSCGVILY 208
             +  A SD+WS GV+LY
Sbjct: 223 SKFSVA-SDVWSFGVVLY 239

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 89.7 bits (221), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 67/198 (33%), Positives = 102/198 (51%), Gaps = 14/198 (7%)
Query: 20  RTLGEGNFGKVKFA-----QDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
           + LG+GNFG V+       QD ++G   AVK L+ +   HL+     +REI  LK L+H 
Sbjct: 21  QQLGKGNFGSVEMCRYDPLQD-NTGEVVAVKKLQHSTEEHLR---DFEREIEILKSLQHD 76
Query: 75  NVVRLHEVL--ASKSKIYMVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCH 131
           N+V+   V   A +  + +++EY+  G L D +   K R+   +  +   Q+  G+ Y  
Sbjct: 77  NIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG 136
Query: 132 NKGVFHRDLKLENILLDSKGNIKISDFGLS-ALPQHFRDDGLLHTTCGSPNYVAPEVLAN 190
            K   HRDL   NIL++++  +KI DFGL+  LPQ      +         + APE L  
Sbjct: 137 TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTE 196
Query: 191 RGYDGATSDIWSCGVILY 208
             +  A SD+WS GV+LY
Sbjct: 197 SKFSVA-SDVWSFGVVLY 213

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 89.7 bits (221), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 67/198 (33%), Positives = 102/198 (51%), Gaps = 14/198 (7%)
Query: 20  RTLGEGNFGKVKFA-----QDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
           + LG+GNFG V+       QD ++G   AVK L+ +   HL+     +REI  LK L+H 
Sbjct: 15  QQLGKGNFGSVEMCRYDPLQD-NTGEVVAVKKLQHSTEEHLR---DFEREIEILKSLQHD 70
Query: 75  NVVRLHEVL--ASKSKIYMVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCH 131
           N+V+   V   A +  + +++EY+  G L D +   K R+   +  +   Q+  G+ Y  
Sbjct: 71  NIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG 130
Query: 132 NKGVFHRDLKLENILLDSKGNIKISDFGLS-ALPQHFRDDGLLHTTCGSPNYVAPEVLAN 190
            K   HRDL   NIL++++  +KI DFGL+  LPQ      +         + APE L  
Sbjct: 131 TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTE 190
Query: 191 RGYDGATSDIWSCGVILY 208
             +  A SD+WS GV+LY
Sbjct: 191 SKFSVA-SDVWSFGVVLY 207

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 89.7 bits (221), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 67/198 (33%), Positives = 102/198 (51%), Gaps = 14/198 (7%)
Query: 20  RTLGEGNFGKVKFA-----QDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
           + LG+GNFG V+       QD ++G   AVK L+ +   HL+     +REI  LK L+H 
Sbjct: 19  QQLGKGNFGSVEMCRYDPLQD-NTGEVVAVKKLQHSTEEHLR---DFEREIEILKSLQHD 74
Query: 75  NVVRLHEVL--ASKSKIYMVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCH 131
           N+V+   V   A +  + +++EY+  G L D +   K R+   +  +   Q+  G+ Y  
Sbjct: 75  NIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG 134
Query: 132 NKGVFHRDLKLENILLDSKGNIKISDFGLS-ALPQHFRDDGLLHTTCGSPNYVAPEVLAN 190
            K   HRDL   NIL++++  +KI DFGL+  LPQ      +         + APE L  
Sbjct: 135 TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTE 194
Query: 191 RGYDGATSDIWSCGVILY 208
             +  A SD+WS GV+LY
Sbjct: 195 SKFSVA-SDVWSFGVVLY 211

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 89.7 bits (221), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 67/198 (33%), Positives = 102/198 (51%), Gaps = 14/198 (7%)
Query: 20  RTLGEGNFGKVKFA-----QDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
           + LG+GNFG V+       QD ++G   AVK L+ +   HL+     +REI  LK L+H 
Sbjct: 22  QQLGKGNFGSVEMCRYDPLQD-NTGEVVAVKKLQHSTEEHLR---DFEREIEILKSLQHD 77
Query: 75  NVVRLHEVL--ASKSKIYMVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCH 131
           N+V+   V   A +  + +++EY+  G L D +   K R+   +  +   Q+  G+ Y  
Sbjct: 78  NIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG 137
Query: 132 NKGVFHRDLKLENILLDSKGNIKISDFGLS-ALPQHFRDDGLLHTTCGSPNYVAPEVLAN 190
            K   HRDL   NIL++++  +KI DFGL+  LPQ      +         + APE L  
Sbjct: 138 TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTE 197
Query: 191 RGYDGATSDIWSCGVILY 208
             +  A SD+WS GV+LY
Sbjct: 198 SKFSVA-SDVWSFGVVLY 214

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 89.7 bits (221), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 66/201 (32%), Positives = 104/201 (51%), Gaps = 18/201 (8%)
Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEK--NRIIHLKITDQIKREIATLKLLK 72
           RY+    +G G +G V  A D  +GL  AVK L +    IIH K T    RE+  LK +K
Sbjct: 23  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRT---YRELRLLKHMK 79
Query: 73  HPNVVRLHEV------LASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDG 126
           H NV+ L +V      L   + +Y+V  ++ G +L + I    +L +   + L  Q++ G
Sbjct: 80  HENVIGLLDVFTPARSLEEFNDVYLV-THLMGADL-NNIVKCQKLTDDHVQFLIYQILRG 137
Query: 127 VSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPE 186
           + Y H+  + HRDLK  N+ ++    +KI D+GL+   +H  D+  +     +  Y APE
Sbjct: 138 LKYIHSADIIHRDLKPSNLAVNEDCELKILDYGLA---RHTDDE--MTGYVATRWYRAPE 192
Query: 187 VLANRGYDGATSDIWSCGVIL 207
           ++ N  +   T DIWS G I+
Sbjct: 193 IMLNWMHYNQTVDIWSVGCIM 213

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 89.7 bits (221), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 67/198 (33%), Positives = 102/198 (51%), Gaps = 14/198 (7%)
Query: 20  RTLGEGNFGKVKFA-----QDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
           + LG+GNFG V+       QD ++G   AVK L+ +   HL+     +REI  LK L+H 
Sbjct: 16  QQLGKGNFGSVEMCRYDPLQD-NTGEVVAVKKLQHSTEEHLR---DFEREIEILKSLQHD 71
Query: 75  NVVRLHEVL--ASKSKIYMVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCH 131
           N+V+   V   A +  + +++EY+  G L D +   K R+   +  +   Q+  G+ Y  
Sbjct: 72  NIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG 131
Query: 132 NKGVFHRDLKLENILLDSKGNIKISDFGLS-ALPQHFRDDGLLHTTCGSPNYVAPEVLAN 190
            K   HRDL   NIL++++  +KI DFGL+  LPQ      +         + APE L  
Sbjct: 132 TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTE 191
Query: 191 RGYDGATSDIWSCGVILY 208
             +  A SD+WS GV+LY
Sbjct: 192 SKFSVA-SDVWSFGVVLY 208

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 89.7 bits (221), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 53/185 (28%), Positives = 98/185 (52%), Gaps = 8/185 (4%)
Query: 22  LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHE 81
           +G+G+FG+V    D  +    A+KI++           Q  +EI  L       V + + 
Sbjct: 31  IGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQ--QEITVLSQCDSSYVTKYYG 88
Query: 82  VLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLK 141
                SK+++++EY+ GG   D + + G   E +   + ++++ G+ Y H++   HRD+K
Sbjct: 89  SYLKGSKLWIIMEYLGGGSALDLLRA-GPFDEFQIATMLKEILKGLDYLHSEKKIHRDIK 147
Query: 142 LENILLDSKGNIKISDFGLSALPQHFRDDGLLHTT-CGSPNYVAPEVLANRGYDGATSDI 200
             N+LL  +G++K++DFG++       D  +   T  G+P ++APEV+    YD + +DI
Sbjct: 148 AANVLLSEQGDVKLADFGVAG---QLTDTQIKRNTFVGTPFWMAPEVIQQSAYD-SKADI 203
Query: 201 WSCGV 205
           WS G+
Sbjct: 204 WSLGI 208

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 89.7 bits (221), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 67/198 (33%), Positives = 102/198 (51%), Gaps = 14/198 (7%)
Query: 20  RTLGEGNFGKVKFA-----QDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
           + LG+GNFG V+       QD ++G   AVK L+ +   HL+     +REI  LK L+H 
Sbjct: 19  QQLGKGNFGSVEMCRYDPLQD-NTGEVVAVKKLQHSTEEHLR---DFEREIEILKSLQHD 74
Query: 75  NVVRLHEVL--ASKSKIYMVLEYVTGGELFDKI-ASKGRLQEAEGRKLFQQLIDGVSYCH 131
           N+V+   V   A +  + +++EY+  G L D + A   R+   +  +   Q+  G+ Y  
Sbjct: 75  NIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQAHAERIDHIKLLQYTSQICKGMEYLG 134
Query: 132 NKGVFHRDLKLENILLDSKGNIKISDFGLS-ALPQHFRDDGLLHTTCGSPNYVAPEVLAN 190
            K   HRDL   NIL++++  +KI DFGL+  LPQ      +         + APE L  
Sbjct: 135 TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTE 194
Query: 191 RGYDGATSDIWSCGVILY 208
             +  A SD+WS GV+LY
Sbjct: 195 SKFSVA-SDVWSFGVVLY 211

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 79/263 (30%), Positives = 122/263 (46%), Gaps = 30/263 (11%)
Query: 20  RTLGEGNFGKVKFAQDLDSGLPFAVKILEK--NRIIHLKITDQIKREIATLKLLKHPNVV 77
           R +G G +G V  A D       AVK L +    +IH + T    RE+  LK LKH NV+
Sbjct: 26  RPVGSGAYGSVCSAYDARLRQKVAVKKLSRPFQSLIHARRT---YRELRLLKHLKHENVI 82
Query: 78  RLHEVLASK------SKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCH 131
            L +V          S++Y+V   + G +L + I     L +   + L  QL+ G+ Y H
Sbjct: 83  GLLDVFTPATSIEDFSEVYLVTT-LMGADL-NNIVKCQALSDEHVQFLVYQLLRGLKYIH 140
Query: 132 NKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANR 191
           + G+ HRDLK  N+ ++    ++I DFGL+      + D  +     +  Y APE++ N 
Sbjct: 141 SAGIIHRDLKPSNVAVNEDCELRILDFGLAR-----QADEEMTGYVATRWYRAPEIMLNW 195
Query: 192 GYDGATSDIWSCGVILYIFRGDFKLPKWLSPGAQNL--LRKILE----PNPVKRITIAGI 245
            +   T DIWS G I+     +    K L PG+  +  L++I+E    P+P     I+  
Sbjct: 196 MHYNQTVDIWSVGCIM----AELLQGKALFPGSDYIDQLKRIMEVVGTPSPEVLAKISSE 251
Query: 246 KADEWFEQDYTPANPDDDEEDIF 268
            A  + +    P  P  D   IF
Sbjct: 252 HARTYIQS--LPPMPQKDLSSIF 272

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 67/198 (33%), Positives = 102/198 (51%), Gaps = 14/198 (7%)
Query: 20  RTLGEGNFGKVKFA-----QDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
           + LG+GNFG V+       QD ++G   AVK L+ +   HL+     +REI  LK L+H 
Sbjct: 34  QQLGKGNFGSVEMCRYDPLQD-NTGEVVAVKKLQHSTEEHLR---DFEREIEILKSLQHD 89
Query: 75  NVVRLHEVL--ASKSKIYMVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCH 131
           N+V+   V   A +  + +++EY+  G L D +   K R+   +  +   Q+  G+ Y  
Sbjct: 90  NIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG 149
Query: 132 NKGVFHRDLKLENILLDSKGNIKISDFGLS-ALPQHFRDDGLLHTTCGSPNYVAPEVLAN 190
            K   HRDL   NIL++++  +KI DFGL+  LPQ      +         + APE L  
Sbjct: 150 TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTE 209
Query: 191 RGYDGATSDIWSCGVILY 208
             +  A SD+WS GV+LY
Sbjct: 210 SKFSVA-SDVWSFGVVLY 226

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 89.4 bits (220), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 67/198 (33%), Positives = 102/198 (51%), Gaps = 14/198 (7%)
Query: 20  RTLGEGNFGKVKFA-----QDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
           + LG+GNFG V+       QD ++G   AVK L+ +   HL+     +REI  LK L+H 
Sbjct: 34  QQLGKGNFGSVEMCRYDPLQD-NTGEVVAVKKLQHSTEEHLR---DFEREIEILKSLQHD 89
Query: 75  NVVRLHEVL--ASKSKIYMVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCH 131
           N+V+   V   A +  + +++EY+  G L D +   K R+   +  +   Q+  G+ Y  
Sbjct: 90  NIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG 149
Query: 132 NKGVFHRDLKLENILLDSKGNIKISDFGLS-ALPQHFRDDGLLHTTCGSPNYVAPEVLAN 190
            K   HRDL   NIL++++  +KI DFGL+  LPQ      +         + APE L  
Sbjct: 150 TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTE 209
Query: 191 RGYDGATSDIWSCGVILY 208
             +  A SD+WS GV+LY
Sbjct: 210 SKFSVA-SDVWSFGVVLY 226

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 89.4 bits (220), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 65/210 (30%), Positives = 106/210 (50%), Gaps = 34/210 (16%)
Query: 13  LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLK----------ITDQIK 62
           + +Y+    +GEG +G V  A+D             + RI+ LK          I     
Sbjct: 20  MEKYQKLEKVGEGTYGVVYKAKD------------SQGRIVALKRIRLDAEDEGIPSTAI 67
Query: 63  REIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGG--ELFDKIASKGRLQEAEGRKLF 120
           REI+ LK L HPN+V L +V+ S+  + +V E++     ++ D+  +K  LQ+++ +   
Sbjct: 68  REISLLKELHHPNIVSLIDVIHSERCLTLVFEFMEKDLKKVLDE--NKTGLQDSQIKIYL 125
Query: 121 QQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLS---ALPQHFRDDGLLHTTC 177
            QL+ GV++CH   + HRDLK +N+L++S G +K++DFGL+    +P         H   
Sbjct: 126 YQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVR----SYTHEVV 181
Query: 178 GSPNYVAPEVLANRGYDGATSDIWSCGVIL 207
            +  Y AP+VL        + DIWS G I 
Sbjct: 182 -TLWYRAPDVLMGSKKYSTSVDIWSIGCIF 210

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 89.4 bits (220), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 65/198 (32%), Positives = 100/198 (50%), Gaps = 9/198 (4%)
Query: 22  LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHE 81
           LG GN G V       SGL  A K++     I   I +QI RE+  L     P +V  + 
Sbjct: 76  LGAGNGGVVFKVSHKPSGLVMARKLIHLE--IKPAIRNQIIRELQVLHECNSPYIVGFYG 133
Query: 82  VLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNK-GVFHRDL 140
              S  +I + +E++ GG L   +   GR+ E    K+   +I G++Y   K  + HRD+
Sbjct: 134 AFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDV 193
Query: 141 KLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDI 200
           K  NIL++S+G IK+ DFG+S        D + ++  G+ +Y++PE L    Y    SDI
Sbjct: 194 KPSNILVNSRGEIKLCDFGVSGQ----LIDSMANSFVGTRSYMSPERLQGTHYS-VQSDI 248
Query: 201 WSCGVILY-IFRGDFKLP 217
           WS G+ L  +  G + +P
Sbjct: 249 WSMGLSLVEMAVGRYPIP 266

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 89.0 bits (219), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 65/210 (30%), Positives = 106/210 (50%), Gaps = 34/210 (16%)
Query: 13  LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLK----------ITDQIK 62
           + +Y+    +GEG +G V  A+D             + RI+ LK          I     
Sbjct: 20  MEKYQKLEKVGEGTYGVVYKAKD------------SQGRIVALKRIRLDAEDEGIPSTAI 67
Query: 63  REIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGG--ELFDKIASKGRLQEAEGRKLF 120
           REI+ LK L HPN+V L +V+ S+  + +V E++     ++ D+  +K  LQ+++ +   
Sbjct: 68  REISLLKELHHPNIVSLIDVIHSERCLTLVFEFMEKDLKKVLDE--NKTGLQDSQIKIYL 125
Query: 121 QQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLS---ALPQHFRDDGLLHTTC 177
            QL+ GV++CH   + HRDLK +N+L++S G +K++DFGL+    +P         H   
Sbjct: 126 YQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVR----SYTHEVV 181
Query: 178 GSPNYVAPEVLANRGYDGATSDIWSCGVIL 207
            +  Y AP+VL        + DIWS G I 
Sbjct: 182 -TLWYRAPDVLMGSKKYSTSVDIWSIGCIF 210

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 89.0 bits (219), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 57/189 (30%), Positives = 96/189 (50%), Gaps = 10/189 (5%)
Query: 20  RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRL 79
           R +G G+FG V FA+D+ +    A+K +  +     +    I +E+  L+ L+HPN ++ 
Sbjct: 60  REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQY 119
Query: 80  HEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRD 139
                 +   ++V+EY  G         K  LQE E   +    + G++Y H+  + HRD
Sbjct: 120 RGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRD 179
Query: 140 LKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVL--ANRG-YDGA 196
           +K  NILL   G +K+ DFG +++          +   G+P ++APEV+   + G YDG 
Sbjct: 180 VKAGNILLSEPGLVKLGDFGSASIM------APANXFVGTPYWMAPEVILAMDEGQYDGK 233
Query: 197 TSDIWSCGV 205
             D+WS G+
Sbjct: 234 V-DVWSLGI 241

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 89.0 bits (219), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 66/201 (32%), Positives = 103/201 (51%), Gaps = 18/201 (8%)
Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEK--NRIIHLKITDQIKREIATLKLLK 72
           RY+    +G G +G V  A D  +G   AVK L +    IIH K T    RE+  LK +K
Sbjct: 19  RYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRT---YRELRLLKHMK 75
Query: 73  HPNVVRLHEV------LASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDG 126
           H NV+ L +V      L   + +Y+V  ++ G +L + I    +L +   + L  Q++ G
Sbjct: 76  HENVIGLLDVFTPARSLEEFNDVYLV-THLMGADL-NNIVKCAKLTDDHVQFLIYQILRG 133
Query: 127 VSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPE 186
           + Y H+  + HRDLK  N+ ++    +KI DFGL+   +H  D+  +     +  Y APE
Sbjct: 134 LKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA---RHTDDE--MTGYVATRWYRAPE 188
Query: 187 VLANRGYDGATSDIWSCGVIL 207
           ++ N  +   T DIWS G I+
Sbjct: 189 IMLNWMHYNQTVDIWSVGCIM 209

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 89.0 bits (219), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 57/189 (30%), Positives = 96/189 (50%), Gaps = 10/189 (5%)
Query: 20  RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRL 79
           R +G G+FG V FA+D+ +    A+K +  +     +    I +E+  L+ L+HPN ++ 
Sbjct: 21  REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQY 80
Query: 80  HEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRD 139
                 +   ++V+EY  G         K  LQE E   +    + G++Y H+  + HRD
Sbjct: 81  RGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRD 140
Query: 140 LKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVL--ANRG-YDGA 196
           +K  NILL   G +K+ DFG +++          +   G+P ++APEV+   + G YDG 
Sbjct: 141 VKAGNILLSEPGLVKLGDFGSASIM------APANXFVGTPYWMAPEVILAMDEGQYDGK 194
Query: 197 TSDIWSCGV 205
             D+WS G+
Sbjct: 195 V-DVWSLGI 202

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 89.0 bits (219), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 66/204 (32%), Positives = 102/204 (50%), Gaps = 9/204 (4%)
Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
           +E    LG GN G V   Q   SGL  A K++     I   I +QI RE+  L     P 
Sbjct: 18  FERISELGAGNGGVVTKVQHRPSGLIMARKLIHLE--IKPAIRNQIIRELQVLHECNSPY 75
Query: 76  VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKG- 134
           +V  +    S  +I + +E++ GG L   +    R+ E    K+   ++ G++Y   K  
Sbjct: 76  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQ 135
Query: 135 VFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYD 194
           + HRD+K  NIL++S+G IK+ DFG+S        D + ++  G+ +Y+APE L    Y 
Sbjct: 136 IMHRDVKPSNILVNSRGEIKLCDFGVSGQ----LIDSMANSFVGTRSYMAPERLQGTHYS 191
Query: 195 GATSDIWSCGVILY-IFRGDFKLP 217
              SDIWS G+ L  +  G + +P
Sbjct: 192 -VQSDIWSMGLSLVELAVGRYPIP 214

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 88.6 bits (218), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 79/288 (27%), Positives = 124/288 (43%), Gaps = 43/288 (14%)
Query: 11  MRLGRYELGRT-------LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKR 63
           M L ++E+ RT       LG G FG+V         L  AVK L+++ +      ++  +
Sbjct: 1   MSLDKWEMERTDITMKHKLGGGQFGEVYEGVWKKYSLTVAVKTLKEDTME----VEEFLK 56
Query: 64  EIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLF--- 120
           E A +K +KHPN+V+L  V   +   Y++ E++T G L D +    R QE     L    
Sbjct: 57  EAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNR-QEVSAVVLLYMA 115
Query: 121 QQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP 180
            Q+   + Y   K   HRDL   N L+     +K++DFGLS L     D    H     P
Sbjct: 116 TQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG--DTXTAHAGAKFP 173
Query: 181 -NYVAPEVLANRGYDGATSDIWSCGVILY--------------------IFRGDFKL--P 217
             + APE LA   +    SD+W+ GV+L+                    +   D+++  P
Sbjct: 174 IKWTAPESLAYNKF-SIKSDVWAFGVLLWEIATYGMSPYPGIDPSQVYELLEKDYRMERP 232
Query: 218 KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPANPDDDEE 265
           +        L+R   + NP  R + A I     FE  +  ++  D+ E
Sbjct: 233 EGCPEKVYELMRACWQWNPSDRPSFAEIHQA--FETMFQESSISDEVE 278

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 88.6 bits (218), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 66/201 (32%), Positives = 103/201 (51%), Gaps = 18/201 (8%)
Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEK--NRIIHLKITDQIKREIATLKLLK 72
           RY+    +G G +G V  A D  +G   AVK L +    IIH K T    RE+  LK +K
Sbjct: 43  RYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRT---YRELRLLKHMK 99
Query: 73  HPNVVRLHEV------LASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDG 126
           H NV+ L +V      L   + +Y+V  ++ G +L + I    +L +   + L  Q++ G
Sbjct: 100 HENVIGLLDVFTPARSLEEFNDVYLV-THLMGADL-NNIVKCQKLTDDHVQFLIYQILRG 157
Query: 127 VSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPE 186
           + Y H+  + HRDLK  N+ ++    +KI DFGL+   +H  D+  +     +  Y APE
Sbjct: 158 LKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA---RHTDDE--MXGXVATRWYRAPE 212
Query: 187 VLANRGYDGATSDIWSCGVIL 207
           ++ N  +   T DIWS G I+
Sbjct: 213 IMLNWMHYNQTVDIWSVGCIM 233

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 88.6 bits (218), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 66/198 (33%), Positives = 102/198 (51%), Gaps = 14/198 (7%)
Query: 20  RTLGEGNFGKVKFA-----QDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
           R LG+GNFG V+       QD ++G   AVK L+ +   HL+     +REI  LK L+H 
Sbjct: 19  RQLGKGNFGSVEMCRYDPLQD-NTGEVVAVKKLQHSTEEHLR---DFEREIEILKSLQHD 74
Query: 75  NVVRLHEVL--ASKSKIYMVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCH 131
           N+V+   V   A +  + +++E++  G L + +   K R+   +  +   Q+  G+ Y  
Sbjct: 75  NIVKYKGVCYSAGRRNLKLIMEFLPYGSLREYLQKHKERIDHIKLLQYTSQICKGMEYLG 134
Query: 132 NKGVFHRDLKLENILLDSKGNIKISDFGLS-ALPQHFRDDGLLHTTCGSPNYVAPEVLAN 190
            K   HRDL   NIL++++  +KI DFGL+  LPQ      +         + APE L  
Sbjct: 135 TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTE 194
Query: 191 RGYDGATSDIWSCGVILY 208
             +  A SD+WS GV+LY
Sbjct: 195 SKFSVA-SDVWSFGVVLY 211

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 88.6 bits (218), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 70/209 (33%), Positives = 98/209 (46%), Gaps = 17/209 (8%)
Query: 11  MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIK--REIATL 68
           M   RYE    +G G +G V  A+D  SG   A+K +             I   RE+A L
Sbjct: 6   MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALL 65
Query: 69  KLLK---HPNVVRLHEVLASKS-----KIYMVLEYVTGG--ELFDKIASKGRLQEAEGRK 118
           + L+   HPNVVRL +V A+       K+ +V E+V        DK    G L     + 
Sbjct: 66  RRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPG-LPAETIKD 124
Query: 119 LFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCG 178
           L +Q + G+ + H   + HRDLK ENIL+ S G +K++DFGL+ +   +     L     
Sbjct: 125 LMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARI---YSYQMALTPVVV 181
Query: 179 SPNYVAPEVLANRGYDGATSDIWSCGVIL 207
           +  Y APEVL    Y     D+WS G I 
Sbjct: 182 TLWYRAPEVLLQSTY-ATPVDMWSVGCIF 209

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 88.6 bits (218), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 65/198 (32%), Positives = 100/198 (50%), Gaps = 9/198 (4%)
Query: 22  LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHE 81
           LG GN G V       SGL  A K++     I   I +QI RE+  L     P +V  + 
Sbjct: 14  LGAGNGGVVFKVSHKPSGLVMARKLIHLE--IKPAIRNQIIRELQVLHECNSPYIVGFYG 71
Query: 82  VLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNK-GVFHRDL 140
              S  +I + +E++ GG L   +   GR+ E    K+   +I G++Y   K  + HRD+
Sbjct: 72  AFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDV 131
Query: 141 KLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDI 200
           K  NIL++S+G IK+ DFG+S        D + ++  G+ +Y++PE L    Y    SDI
Sbjct: 132 KPSNILVNSRGEIKLCDFGVSGQ----LIDSMANSFVGTRSYMSPERLQGTHYS-VQSDI 186
Query: 201 WSCGVILY-IFRGDFKLP 217
           WS G+ L  +  G + +P
Sbjct: 187 WSMGLSLVEMAVGRYPIP 204

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 88.6 bits (218), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 63/187 (33%), Positives = 95/187 (50%), Gaps = 8/187 (4%)
Query: 22  LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHE 81
           LG GN G V       SGL  A K++     I   I +QI RE+  L     P +V  + 
Sbjct: 14  LGAGNGGVVFKVSHKPSGLVMARKLIHLE--IKPAIRNQIIRELQVLHECNSPYIVGFYG 71
Query: 82  VLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNK-GVFHRDL 140
              S  +I + +E++ GG L   +   GR+ E    K+   +I G++Y   K  + HRD+
Sbjct: 72  AFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDV 131
Query: 141 KLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDI 200
           K  NIL++S+G IK+ DFG+S        D + ++  G+ +Y++PE L    Y    SDI
Sbjct: 132 KPSNILVNSRGEIKLCDFGVSGQ----LIDSMANSFVGTRSYMSPERLQGTHYS-VQSDI 186
Query: 201 WSCGVIL 207
           WS G+ L
Sbjct: 187 WSMGLSL 193

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 88.6 bits (218), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 65/198 (32%), Positives = 100/198 (50%), Gaps = 9/198 (4%)
Query: 22  LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHE 81
           LG GN G V       SGL  A K++     I   I +QI RE+  L     P +V  + 
Sbjct: 14  LGAGNGGVVFKVSHKPSGLVMARKLIHLE--IKPAIRNQIIRELQVLHECNSPYIVGFYG 71
Query: 82  VLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNK-GVFHRDL 140
              S  +I + +E++ GG L   +   GR+ E    K+   +I G++Y   K  + HRD+
Sbjct: 72  AFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDV 131
Query: 141 KLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDI 200
           K  NIL++S+G IK+ DFG+S        D + ++  G+ +Y++PE L    Y    SDI
Sbjct: 132 KPSNILVNSRGEIKLCDFGVSGQ----LIDSMANSFVGTRSYMSPERLQGTHYS-VQSDI 186
Query: 201 WSCGVILY-IFRGDFKLP 217
           WS G+ L  +  G + +P
Sbjct: 187 WSMGLSLVEMAVGRYPIP 204

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 88.6 bits (218), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 64/191 (33%), Positives = 97/191 (50%), Gaps = 16/191 (8%)
Query: 22  LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKIT----DQIKREIATLKLLKHPNVV 77
           LG GN G V       SGL  A       ++IHL+I     +QI RE+  L     P +V
Sbjct: 41  LGAGNGGVVFKVSHKPSGLVMA------RKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 94
Query: 78  RLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNK-GVF 136
             +    S  +I + +E++ GG L   +   GR+ E    K+   +I G++Y   K  + 
Sbjct: 95  GFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIM 154
Query: 137 HRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGA 196
           HRD+K  NIL++S+G IK+ DFG+S        D + ++  G+ +Y++PE L    Y   
Sbjct: 155 HRDVKPSNILVNSRGEIKLCDFGVSGQ----LIDSMANSFVGTRSYMSPERLQGTHYS-V 209
Query: 197 TSDIWSCGVIL 207
            SDIWS G+ L
Sbjct: 210 QSDIWSMGLSL 220

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 88.6 bits (218), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 72/208 (34%), Positives = 101/208 (48%), Gaps = 18/208 (8%)
Query: 11  MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILE-KNRIIHLKITDQIKREIATLK 69
           M   RYE    +G G +G V  A+D  SG   A+K +   N    L I+    RE+A L+
Sbjct: 1   MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPIS--TVREVALLR 58
Query: 70  LLK---HPNVVRLHEVLASKS-----KIYMVLEYVTGG--ELFDKIASKGRLQEAEGRKL 119
            L+   HPNVVRL +V A+       K+ +V E+V        DK    G L     + L
Sbjct: 59  RLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPG-LPAETIKDL 117
Query: 120 FQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGS 179
            +Q + G+ + H   + HRDLK ENIL+ S G +K++DFGL+ +   +     L     +
Sbjct: 118 MRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARI---YSYQMALFPVVVT 174
Query: 180 PNYVAPEVLANRGYDGATSDIWSCGVIL 207
             Y APEVL    Y     D+WS G I 
Sbjct: 175 LWYRAPEVLLQSTY-ATPVDMWSVGCIF 201

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 88.2 bits (217), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 72/208 (34%), Positives = 101/208 (48%), Gaps = 18/208 (8%)
Query: 11  MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILE-KNRIIHLKITDQIKREIATLK 69
           M   RYE    +G G +G V  A+D  SG   A+K +   N    L I+    RE+A L+
Sbjct: 1   MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPIS--TVREVALLR 58
Query: 70  LLK---HPNVVRLHEVLASKS-----KIYMVLEYVTGG--ELFDKIASKGRLQEAEGRKL 119
            L+   HPNVVRL +V A+       K+ +V E+V        DK    G L     + L
Sbjct: 59  RLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPG-LPAETIKDL 117
Query: 120 FQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGS 179
            +Q + G+ + H   + HRDLK ENIL+ S G +K++DFGL+ +   +     L     +
Sbjct: 118 MRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARI---YSYQMALDPVVVT 174
Query: 180 PNYVAPEVLANRGYDGATSDIWSCGVIL 207
             Y APEVL    Y     D+WS G I 
Sbjct: 175 LWYRAPEVLLQSTY-ATPVDMWSVGCIF 201

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 88.2 bits (217), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 66/201 (32%), Positives = 103/201 (51%), Gaps = 18/201 (8%)
Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEK--NRIIHLKITDQIKREIATLKLLK 72
           RY+    +G G +G V  A D  +G   AVK L +    IIH K T    RE+  LK +K
Sbjct: 23  RYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRT---YRELRLLKHMK 79
Query: 73  HPNVVRLHEV------LASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDG 126
           H NV+ L +V      L   + +Y+V  ++ G +L + I    +L +   + L  Q++ G
Sbjct: 80  HENVIGLLDVFTPARSLEEFNDVYLV-THLMGADL-NNIVKCQKLTDDHVQFLIYQILRG 137
Query: 127 VSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPE 186
           + Y H+  + HRDLK  N+ ++    +KI DFGL+   +H  D+  +     +  Y APE
Sbjct: 138 LKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA---RHTDDE--MTGYVATRWYRAPE 192
Query: 187 VLANRGYDGATSDIWSCGVIL 207
           ++ N  +   T DIWS G I+
Sbjct: 193 IMLNWMHYNQTVDIWSVGCIM 213

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 88.2 bits (217), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 63/187 (33%), Positives = 95/187 (50%), Gaps = 8/187 (4%)
Query: 22  LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHE 81
           LG GN G V       SGL  A K++     I   I +QI RE+  L     P +V  + 
Sbjct: 14  LGAGNGGVVFKVSHKPSGLVMARKLIHLE--IKPAIRNQIIRELQVLHECNSPYIVGFYG 71
Query: 82  VLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNK-GVFHRDL 140
              S  +I + +E++ GG L   +   GR+ E    K+   +I G++Y   K  + HRD+
Sbjct: 72  AFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDV 131
Query: 141 KLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDI 200
           K  NIL++S+G IK+ DFG+S        D + ++  G+ +Y++PE L    Y    SDI
Sbjct: 132 KPSNILVNSRGEIKLCDFGVSGQ----LIDSMANSFVGTRSYMSPERLQGTHYS-VQSDI 186
Query: 201 WSCGVIL 207
           WS G+ L
Sbjct: 187 WSMGLSL 193

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 88.2 bits (217), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 63/187 (33%), Positives = 95/187 (50%), Gaps = 8/187 (4%)
Query: 22  LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHE 81
           LG GN G V       SGL  A K++     I   I +QI RE+  L     P +V  + 
Sbjct: 14  LGAGNGGVVFKVSHKPSGLVMARKLIHLE--IKPAIRNQIIRELQVLHECNSPYIVGFYG 71
Query: 82  VLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNK-GVFHRDL 140
              S  +I + +E++ GG L   +   GR+ E    K+   +I G++Y   K  + HRD+
Sbjct: 72  AFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDV 131
Query: 141 KLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDI 200
           K  NIL++S+G IK+ DFG+S        D + ++  G+ +Y++PE L    Y    SDI
Sbjct: 132 KPSNILVNSRGEIKLCDFGVSGQ----LIDSMANSFVGTRSYMSPERLQGTHYS-VQSDI 186
Query: 201 WSCGVIL 207
           WS G+ L
Sbjct: 187 WSMGLSL 193

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 88.2 bits (217), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 72/208 (34%), Positives = 101/208 (48%), Gaps = 18/208 (8%)
Query: 11  MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILE-KNRIIHLKITDQIKREIATLK 69
           M   RYE    +G G +G V  A+D  SG   A+K +   N    L I+    RE+A L+
Sbjct: 1   MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPIS--TVREVALLR 58
Query: 70  LLK---HPNVVRLHEVLASKS-----KIYMVLEYVTGG--ELFDKIASKGRLQEAEGRKL 119
            L+   HPNVVRL +V A+       K+ +V E+V        DK    G L     + L
Sbjct: 59  RLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPG-LPAETIKDL 117
Query: 120 FQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGS 179
            +Q + G+ + H   + HRDLK ENIL+ S G +K++DFGL+ +   +     L     +
Sbjct: 118 MRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARI---YSYQMALAPVVVT 174
Query: 180 PNYVAPEVLANRGYDGATSDIWSCGVIL 207
             Y APEVL    Y     D+WS G I 
Sbjct: 175 LWYRAPEVLLQSTY-ATPVDMWSVGCIF 201

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 88.2 bits (217), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 68/203 (33%), Positives = 104/203 (51%), Gaps = 22/203 (10%)
Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEK--NRIIHLKITDQIKREIATLKLLK 72
           RY+    +G G +G V  A D  +G   AVK L +    IIH K T    RE+  LK +K
Sbjct: 23  RYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRT---YRELRLLKHMK 79
Query: 73  HPNVVRLHEV------LASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDG 126
           H NV+ L +V      L   + +Y+V  ++ G +L + I    +L +   + L  Q++ G
Sbjct: 80  HENVIGLLDVFTPARSLEEFNDVYLV-THLMGADL-NNIVKCQKLTDDHVQFLIYQILRG 137
Query: 127 VSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD--GLLHTTCGSPNYVA 184
           + Y H+  + HRDLK  N+ ++    +KI DFGL+   +H  D+  G + T      Y A
Sbjct: 138 LKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA---RHTDDEMAGFVATRW----YRA 190
Query: 185 PEVLANRGYDGATSDIWSCGVIL 207
           PE++ N  +   T DIWS G I+
Sbjct: 191 PEIMLNWMHYNQTVDIWSVGCIM 213

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 88.2 bits (217), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 66/201 (32%), Positives = 103/201 (51%), Gaps = 18/201 (8%)
Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEK--NRIIHLKITDQIKREIATLKLLK 72
           RY+    +G G +G V  A D  +G   AVK L +    IIH K T    RE+  LK +K
Sbjct: 42  RYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRT---YRELRLLKHMK 98
Query: 73  HPNVVRLHEV------LASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDG 126
           H NV+ L +V      L   + +Y+V  ++ G +L + I    +L +   + L  Q++ G
Sbjct: 99  HENVIGLLDVFTPARSLEEFNDVYLV-THLMGADL-NNIVKCQKLTDDHVQFLIYQILRG 156
Query: 127 VSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPE 186
           + Y H+  + HRDLK  N+ ++    +KI DFGL+   +H  D+  +     +  Y APE
Sbjct: 157 LKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA---RHTDDE--MTGYVATRWYRAPE 211
Query: 187 VLANRGYDGATSDIWSCGVIL 207
           ++ N  +   T DIWS G I+
Sbjct: 212 IMLNWMHYNQTVDIWSVGCIM 232

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 88.2 bits (217), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 66/198 (33%), Positives = 104/198 (52%), Gaps = 14/198 (7%)
Query: 20  RTLGEGNFGKVKFA-----QDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
           + LG+GNFG V+       QD ++G   AVK L+ +   HL+     +REI  LK L+H 
Sbjct: 16  QQLGKGNFGSVEMCRYDPLQD-NTGEVVAVKKLQHSTEEHLR---DFEREIEILKSLQHD 71
Query: 75  NVVRLHEVL--ASKSKIYMVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCH 131
           N+V+   V   A +  + +++EY+  G L D +   K R+   +  +   Q+  G+ Y  
Sbjct: 72  NIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG 131
Query: 132 NKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP-NYVAPEVLAN 190
            K   HRDL   NIL++++  +KI DFGL+ +    ++   +     SP  + APE L  
Sbjct: 132 TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTE 191
Query: 191 RGYDGATSDIWSCGVILY 208
             +  A SD+WS GV+LY
Sbjct: 192 SKFSVA-SDVWSFGVVLY 208

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 88.2 bits (217), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 66/201 (32%), Positives = 103/201 (51%), Gaps = 18/201 (8%)
Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEK--NRIIHLKITDQIKREIATLKLLK 72
           RY+    +G G +G V  A D  +G   AVK L +    IIH K T    RE+  LK +K
Sbjct: 43  RYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRT---YRELRLLKHMK 99
Query: 73  HPNVVRLHEV------LASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDG 126
           H NV+ L +V      L   + +Y+V  ++ G +L + I    +L +   + L  Q++ G
Sbjct: 100 HENVIGLLDVFTPARSLEEFNDVYLV-THLMGADL-NNIVKCQKLTDDHVQFLIYQILRG 157
Query: 127 VSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPE 186
           + Y H+  + HRDLK  N+ ++    +KI DFGL+   +H  D+  +     +  Y APE
Sbjct: 158 LKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA---RHTDDE--MTGYVATRWYRAPE 212
Query: 187 VLANRGYDGATSDIWSCGVIL 207
           ++ N  +   T DIWS G I+
Sbjct: 213 IMLNWMHYNQTVDIWSVGCIM 233

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 88.2 bits (217), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 66/201 (32%), Positives = 103/201 (51%), Gaps = 18/201 (8%)
Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEK--NRIIHLKITDQIKREIATLKLLK 72
           RY+    +G G +G V  A D  +G   AVK L +    IIH K T    RE+  LK +K
Sbjct: 33  RYQNLAPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRT---YRELRLLKHMK 89
Query: 73  HPNVVRLHEV------LASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDG 126
           H NV+ L +V      L   + +Y+V  ++ G +L + I    +L +   + L  Q++ G
Sbjct: 90  HENVIGLLDVFTPARSLEEFNDVYLV-THLMGADL-NNIVKCQKLTDDHVQFLIYQILRG 147
Query: 127 VSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPE 186
           + Y H+  + HRDLK  N+ ++    +KI DFGL+   +H  D+  +     +  Y APE
Sbjct: 148 LKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA---RHTDDE--MTGYVATRWYRAPE 202
Query: 187 VLANRGYDGATSDIWSCGVIL 207
           ++ N  +   T DIWS G I+
Sbjct: 203 IMLNWMHYNQTVDIWSVGCIM 223

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 88.2 bits (217), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 66/201 (32%), Positives = 103/201 (51%), Gaps = 18/201 (8%)
Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEK--NRIIHLKITDQIKREIATLKLLK 72
           RY+    +G G +G V  A D  +G   AVK L +    IIH K T    RE+  LK +K
Sbjct: 23  RYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRT---YRELRLLKHMK 79
Query: 73  HPNVVRLHEV------LASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDG 126
           H NV+ L +V      L   + +Y+V  ++ G +L + I    +L +   + L  Q++ G
Sbjct: 80  HENVIGLLDVFTPARSLEEFNDVYLV-THLMGADL-NNIVKCQKLTDDHVQFLIYQILRG 137
Query: 127 VSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPE 186
           + Y H+  + HRDLK  N+ ++    +KI DFGL+   +H  D+  +     +  Y APE
Sbjct: 138 LKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA---RHTDDE--MAGFVATRWYRAPE 192
Query: 187 VLANRGYDGATSDIWSCGVIL 207
           ++ N  +   T DIWS G I+
Sbjct: 193 IMLNWMHYNQTVDIWSVGCIM 213

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 88.2 bits (217), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 64/191 (33%), Positives = 97/191 (50%), Gaps = 16/191 (8%)
Query: 22  LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKIT----DQIKREIATLKLLKHPNVV 77
           LG GN G V       SGL  A       ++IHL+I     +QI RE+  L     P +V
Sbjct: 33  LGAGNGGVVFKVSHKPSGLVMA------RKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 86
Query: 78  RLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNK-GVF 136
             +    S  +I + +E++ GG L   +   GR+ E    K+   +I G++Y   K  + 
Sbjct: 87  GFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIM 146
Query: 137 HRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGA 196
           HRD+K  NIL++S+G IK+ DFG+S        D + ++  G+ +Y++PE L    Y   
Sbjct: 147 HRDVKPSNILVNSRGEIKLCDFGVSGQ----LIDSMANSFVGTRSYMSPERLQGTHYS-V 201
Query: 197 TSDIWSCGVIL 207
            SDIWS G+ L
Sbjct: 202 QSDIWSMGLSL 212

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 88.2 bits (217), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 66/201 (32%), Positives = 103/201 (51%), Gaps = 18/201 (8%)
Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEK--NRIIHLKITDQIKREIATLKLLK 72
           RY+    +G G +G V  A D  +G   AVK L +    IIH K T    RE+  LK +K
Sbjct: 19  RYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRT---YRELRLLKHMK 75
Query: 73  HPNVVRLHEV------LASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDG 126
           H NV+ L +V      L   + +Y+V  ++ G +L + I    +L +   + L  Q++ G
Sbjct: 76  HENVIGLLDVFTPARSLEEFNDVYLV-THLMGADL-NNIVKCQKLTDDHVQFLIYQILRG 133
Query: 127 VSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPE 186
           + Y H+  + HRDLK  N+ ++    +KI DFGL+   +H  D+  +     +  Y APE
Sbjct: 134 LKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA---RHTDDE--MTGYVATRWYRAPE 188
Query: 187 VLANRGYDGATSDIWSCGVIL 207
           ++ N  +   T DIWS G I+
Sbjct: 189 IMLNWMHYNQTVDIWSVGCIM 209

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 87.8 bits (216), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 66/201 (32%), Positives = 103/201 (51%), Gaps = 18/201 (8%)
Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEK--NRIIHLKITDQIKREIATLKLLK 72
           RY+    +G G +G V  A D  +G   AVK L +    IIH K T    RE+  LK +K
Sbjct: 29  RYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRT---YRELRLLKHMK 85
Query: 73  HPNVVRLHEV------LASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDG 126
           H NV+ L +V      L   + +Y+V  ++ G +L + I    +L +   + L  Q++ G
Sbjct: 86  HENVIGLLDVFTPARSLEEFNDVYLV-THLMGADL-NNIVKCQKLTDDHVQFLIYQILRG 143
Query: 127 VSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPE 186
           + Y H+  + HRDLK  N+ ++    +KI DFGL+   +H  D+  +     +  Y APE
Sbjct: 144 LKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA---RHTDDE--MTGYVATRWYRAPE 198
Query: 187 VLANRGYDGATSDIWSCGVIL 207
           ++ N  +   T DIWS G I+
Sbjct: 199 IMLNWMHYNQTVDIWSVGCIM 219

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score = 87.8 bits (216), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 66/201 (32%), Positives = 103/201 (51%), Gaps = 18/201 (8%)
Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEK--NRIIHLKITDQIKREIATLKLLK 72
           RY+    +G G +G V  A D  +GL  AVK L +    IIH K T    RE+  LK +K
Sbjct: 23  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRT---YRELRLLKHMK 79
Query: 73  HPNVVRLHEV------LASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDG 126
           H NV+ L +V      L   + +Y+V  ++ G +L + I    +L +   + L  Q++ G
Sbjct: 80  HENVIGLLDVFTPARSLEEFNDVYLV-THLMGADL-NNIVKCQKLTDDHVQFLIYQILRG 137
Query: 127 VSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPE 186
           + Y H+  + HRDLK  N+ ++    +KI  FGL+   +H  D+  +     +  Y APE
Sbjct: 138 LKYIHSADIIHRDLKPSNLAVNEDCELKILGFGLA---RHTDDE--MTGYVATRWYRAPE 192
Query: 187 VLANRGYDGATSDIWSCGVIL 207
           ++ N  +   T DIWS G I+
Sbjct: 193 IMLNWMHYNQTVDIWSVGCIM 213

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 49/150 (32%), Positives = 85/150 (56%), Gaps = 10/150 (6%)
Query: 63  REIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQ- 121
           RE++ LK LKH N+V LH+++ ++  + +V EY+   +L   +   G +      KLF  
Sbjct: 49  REVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYL-DKDLKQYLDDCGNIINMHNVKLFLF 107
Query: 122 QLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLS---ALPQHFRDDGLLHTTCG 178
           QL+ G++YCH + V HRDLK +N+L++ +G +K++DFGL+   ++P    D+ ++     
Sbjct: 108 QLLRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVV----- 162
Query: 179 SPNYVAPEVLANRGYDGATSDIWSCGVILY 208
           +  Y  P++L          D+W  G I Y
Sbjct: 163 TLWYRPPDILLGSTDYSTQIDMWGVGCIFY 192

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 63/205 (30%), Positives = 110/205 (53%), Gaps = 19/205 (9%)
Query: 14  GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKH 73
           G +EL   +G G +G+V   + + +G   A+K+++    +     ++IK+EI  LK   H
Sbjct: 24  GIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMD----VTGDEEEEIKQEINMLKKYSH 79
Query: 74  P-NVVRLHEVLASKS------KIYMVLEYVTGGELFDKIA-SKGR-LQEAEGRKLFQQLI 124
             N+   +     K+      ++++V+E+   G + D I  +KG  L+E     + ++++
Sbjct: 80  HRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREIL 139
Query: 125 DGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVA 184
            G+S+ H   V HRD+K +N+LL     +K+ DFG+SA  Q  R  G  +T  G+P ++A
Sbjct: 140 RGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSA--QLDRTVGRRNTFIGTPYWMA 197
Query: 185 PEVLANRGYDGAT----SDIWSCGV 205
           PEV+A      AT    SD+WS G+
Sbjct: 198 PEVIACDENPDATYDFKSDLWSLGI 222

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 66/201 (32%), Positives = 103/201 (51%), Gaps = 18/201 (8%)
Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEK--NRIIHLKITDQIKREIATLKLLK 72
           RY+    +G G +G V  A D  +G   AVK L +    IIH K T    RE+  LK +K
Sbjct: 19  RYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRT---YRELRLLKHMK 75
Query: 73  HPNVVRLHEV------LASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDG 126
           H NV+ L +V      L   + +Y+V  ++ G +L + I    +L +   + L  Q++ G
Sbjct: 76  HENVIGLLDVFTPARSLEEFNDVYLV-THLMGADL-NNIVKCQKLTDDHVQFLIYQILRG 133
Query: 127 VSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPE 186
           + Y H+  + HRDLK  N+ ++    +KI DFGL+   +H  D+  +     +  Y APE
Sbjct: 134 LKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA---RHTDDE--MAGFVATRWYRAPE 188
Query: 187 VLANRGYDGATSDIWSCGVIL 207
           ++ N  +   T DIWS G I+
Sbjct: 189 IMLNWMHYNQTVDIWSVGCIM 209

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 66/201 (32%), Positives = 103/201 (51%), Gaps = 18/201 (8%)
Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEK--NRIIHLKITDQIKREIATLKLLK 72
           RY+    +G G +G V  A D  +GL  AVK L +    IIH K T    RE+  LK +K
Sbjct: 23  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRT---YRELRLLKHMK 79
Query: 73  HPNVVRLHEV------LASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDG 126
           H NV+ L +V      L   + +Y+V  ++ G +L + I    +L +   + L  Q++ G
Sbjct: 80  HENVIGLLDVFTPARSLEEFNDVYLV-THLMGADL-NNIVKCQKLTDDHVQFLIYQILRG 137
Query: 127 VSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPE 186
           + Y H+  + HRDLK  N+ ++    +KI D GL+   +H  D+  +     +  Y APE
Sbjct: 138 LKYIHSADIIHRDLKPSNLAVNEDCELKILDAGLA---RHTDDE--MTGYVATRWYRAPE 192
Query: 187 VLANRGYDGATSDIWSCGVIL 207
           ++ N  +   T DIWS G I+
Sbjct: 193 IMLNWMHYNQTVDIWSVGCIM 213

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 66/201 (32%), Positives = 103/201 (51%), Gaps = 18/201 (8%)
Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEK--NRIIHLKITDQIKREIATLKLLK 72
           RY+    +G G +G V  A D  +GL  AVK L +    IIH K T    RE+  LK +K
Sbjct: 23  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRT---YRELRLLKHMK 79
Query: 73  HPNVVRLHEV------LASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDG 126
           H NV+ L +V      L   + +Y+V  ++ G +L + I    +L +   + L  Q++ G
Sbjct: 80  HENVIGLLDVFTPARSLEEFNDVYLV-THLMGADL-NNIVKCQKLTDDHVQFLIYQILRG 137
Query: 127 VSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPE 186
           + Y H+  + HRDLK  N+ ++    +KI D GL+   +H  D+  +     +  Y APE
Sbjct: 138 LKYIHSADIIHRDLKPSNLAVNEDCELKILDRGLA---RHTDDE--MTGYVATRWYRAPE 192
Query: 187 VLANRGYDGATSDIWSCGVIL 207
           ++ N  +   T DIWS G I+
Sbjct: 193 IMLNWMHYNQTVDIWSVGCIM 213

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 78/288 (27%), Positives = 124/288 (43%), Gaps = 43/288 (14%)
Query: 11  MRLGRYELGRT-------LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKR 63
           M L ++E+ RT       LG G +G+V         L  AVK L+++ +      ++  +
Sbjct: 1   MSLDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME----VEEFLK 56
Query: 64  EIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLF--- 120
           E A +K +KHPN+V+L  V   +   Y++ E++T G L D +    R QE     L    
Sbjct: 57  EAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNR-QEVSAVVLLYMA 115
Query: 121 QQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP 180
            Q+   + Y   K   HRDL   N L+     +K++DFGLS L     D    H     P
Sbjct: 116 TQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG--DTFTAHAGAKFP 173
Query: 181 -NYVAPEVLANRGYDGATSDIWSCGVILY--------------------IFRGDFKL--P 217
             + APE LA   +    SD+W+ GV+L+                    +   D+++  P
Sbjct: 174 IKWTAPESLAYNKF-SIKSDVWAFGVLLWEIATYGMSPYPGIDPSQVYELLEKDYRMERP 232
Query: 218 KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPANPDDDEE 265
           +        L+R   + NP  R + A I     FE  +  ++  D+ E
Sbjct: 233 EGCPEKVYELMRACWQWNPSDRPSFAEIHQA--FETMFQESSISDEVE 278

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 66/201 (32%), Positives = 103/201 (51%), Gaps = 18/201 (8%)
Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEK--NRIIHLKITDQIKREIATLKLLK 72
           RY+    +G G +G V  A D  +GL  AVK L +    IIH K T    RE+  LK +K
Sbjct: 23  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRT---YRELRLLKHMK 79
Query: 73  HPNVVRLHEV------LASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDG 126
           H NV+ L +V      L   + +Y+V  ++ G +L + I    +L +   + L  Q++ G
Sbjct: 80  HENVIGLLDVFTPARSLEEFNDVYLV-THLMGADL-NNIVKCQKLTDDHVQFLIYQILRG 137
Query: 127 VSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPE 186
           + Y H+  + HRDLK  N+ ++    +KI D GL+   +H  D+  +     +  Y APE
Sbjct: 138 LKYIHSADIIHRDLKPSNLAVNEDCELKILDGGLA---RHTDDE--MTGYVATRWYRAPE 192
Query: 187 VLANRGYDGATSDIWSCGVIL 207
           ++ N  +   T DIWS G I+
Sbjct: 193 IMLNWMHYNQTVDIWSVGCIM 213

>pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 62/221 (28%), Positives = 109/221 (49%), Gaps = 13/221 (5%)
Query: 2   VIAEKKQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQI 61
           ++   K+  ++   +E+ + +G G F +V   +   +G  +A+KI+ K  ++        
Sbjct: 49  IVVRLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCF 108
Query: 62  KREIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAE-GRKLF 120
           + E   L       + +LH     ++ +Y+V+EY  GG+L   ++  G    AE  R   
Sbjct: 109 REERDVLVNGDRRWITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYL 168
Query: 121 QQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHT--TCG 178
            +++  +   H  G  HRD+K +NILLD  G+I+++DFG S L    R DG + +    G
Sbjct: 169 AEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFG-SCL--KLRADGTVRSLVAVG 225
Query: 179 SPNYVAPEVL------ANRGYDGATSDIWSCGVILY-IFRG 212
           +P+Y++PE+L         G  G   D W+ GV  Y +F G
Sbjct: 226 TPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYG 266

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 65/198 (32%), Positives = 104/198 (52%), Gaps = 14/198 (7%)
Query: 20  RTLGEGNFGKVKFA-----QDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
           + LG+GNFG V+       QD ++G   AVK L+ +   HL+     +REI  LK L+H 
Sbjct: 17  QQLGKGNFGSVEMCRYDPLQD-NTGEVVAVKKLQHSTEEHLR---DFEREIEILKSLQHD 72
Query: 75  NVVRLHEVL--ASKSKIYMVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCH 131
           N+V+   V   A +  + +++EY+  G L D +   K R+   +  +   Q+  G+ Y  
Sbjct: 73  NIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG 132
Query: 132 NKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP-NYVAPEVLAN 190
            K   HR+L   NIL++++  +KI DFGL+ +    ++   +     SP  + APE L  
Sbjct: 133 TKRYIHRNLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTE 192
Query: 191 RGYDGATSDIWSCGVILY 208
             +  A SD+WS GV+LY
Sbjct: 193 SKFSVA-SDVWSFGVVLY 209

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 63/187 (33%), Positives = 94/187 (50%), Gaps = 8/187 (4%)
Query: 22  LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHE 81
           LG GN G V       SGL  A K++     I   I +QI RE+  L     P +V  + 
Sbjct: 17  LGAGNGGVVFKVSHKPSGLVMARKLIHLE--IKPAIRNQIIRELQVLHECNSPYIVGFYG 74
Query: 82  VLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNK-GVFHRDL 140
              S  +I + +E++ GG L   +   GR+ E    K+   +I G++Y   K  + HRD+
Sbjct: 75  AFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDV 134
Query: 141 KLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDI 200
           K  NIL++S+G IK+ DFG+S        D + +   G+ +Y++PE L    Y    SDI
Sbjct: 135 KPSNILVNSRGEIKLCDFGVSGQ----LIDEMANEFVGTRSYMSPERLQGTHYS-VQSDI 189
Query: 201 WSCGVIL 207
           WS G+ L
Sbjct: 190 WSMGLSL 196

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 68/215 (31%), Positives = 102/215 (47%), Gaps = 32/215 (14%)
Query: 21  TLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLH 80
            LG+G FG+V  A++      +A+K   K R    K++  I  E+  L  L H  VVR +
Sbjct: 13  VLGQGAFGQVVKARNALDSRYYAIK---KIRHTEEKLS-TILSEVXLLASLNHQYVVRYY 68
Query: 81  -------------EVLASKSKIYMVLEYVTGGELFDKIASKG-RLQEAEGRKLFQQLIDG 126
                          +  KS +++  EY     L+D I S+    Q  E  +LF+Q+++ 
Sbjct: 69  AAWLERRNFVKPXTAVKKKSTLFIQXEYCENRTLYDLIHSENLNQQRDEYWRLFRQILEA 128
Query: 127 VSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGL-------------L 173
           +SY H++G+ HR+LK  NI +D   N+KI DFGL A   H   D L             L
Sbjct: 129 LSYIHSQGIIHRNLKPXNIFIDESRNVKIGDFGL-AKNVHRSLDILKLDSQNLPGSSDNL 187
Query: 174 HTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILY 208
            +  G+  YVA EVL   G+     D +S G+I +
Sbjct: 188 TSAIGTAXYVATEVLDGTGHYNEKIDXYSLGIIFF 222

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 73/266 (27%), Positives = 116/266 (43%), Gaps = 41/266 (15%)
Query: 13  LGRYELGRT-------LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREI 65
           L ++E+ RT       LG G +G+V         L  AVK L+++ +      ++  +E 
Sbjct: 3   LDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME----VEEFLKEA 58
Query: 66  ATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLF---QQ 122
           A +K +KHPN+V+L  V   +   Y+++E++T G L D +    R QE     L     Q
Sbjct: 59  AVMKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNR-QEVSAVVLLYMATQ 117
Query: 123 LIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP-N 181
           +   + Y   K   HRDL   N L+     +K++DFGLS L     D    H     P  
Sbjct: 118 ISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG--DTXTAHAGAKFPIK 175
Query: 182 YVAPEVLANRGYDGATSDIWSCGVILY--------------------IFRGDFKL--PKW 219
           + APE LA   +    SD+W+ GV+L+                    +   D+++  P+ 
Sbjct: 176 WTAPESLAYNKF-SIKSDVWAFGVLLWEIATYGMSPYPGIDPSQVYELLEKDYRMERPEG 234
Query: 220 LSPGAQNLLRKILEPNPVKRITIAGI 245
                  L+R   + NP  R + A I
Sbjct: 235 CPEKVYELMRACWQWNPSDRPSFAEI 260

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 58/206 (28%), Positives = 100/206 (48%), Gaps = 25/206 (12%)
Query: 19  GRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKR----EIATLKLLKHP 74
           G  LG+G FG+       ++G    +K L       ++  ++ +R    E+  ++ L+HP
Sbjct: 15  GEVLGKGCFGQAIKVTHRETGEVMVMKEL-------IRFDEETQRTFLKEVKVMRCLEHP 67
Query: 75  NVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLF-QQLIDGVSYCHNK 133
           NV++   VL    ++  + EY+ GG L   I S         R  F + +  G++Y H+ 
Sbjct: 68  NVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSM 127
Query: 134 GVFHRDLKLENILLDSKGNIKISDFGLSAL-------PQHFR-----DDGLLHTTCGSPN 181
            + HRDL   N L+    N+ ++DFGL+ L       P+  R     D    +T  G+P 
Sbjct: 128 NIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPY 187
Query: 182 YVAPEVLANRGYDGATSDIWSCGVIL 207
           ++APE++  R YD    D++S G++L
Sbjct: 188 WMAPEMINGRSYDEKV-DVFSFGIVL 212

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 84/304 (27%), Positives = 130/304 (42%), Gaps = 65/304 (21%)
Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
           RY     +GEG +G V  A D  + +  A+K +      H     +  REI  L   +H 
Sbjct: 44  RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE--HQTYCQRTLREIKILLRFRHE 101
Query: 75  NVVRLHEVLASKS-----KIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSY 129
           N++ +++++ + +      +Y+V  ++ G +L+ K+     L          Q++ G+ Y
Sbjct: 102 NIIGINDIIRAPTIEQMKDVYLV-THLMGADLY-KLLKTQHLSNDHICYFLYQILRGLKY 159
Query: 130 CHNKGVFHRDLKLENILLDSKGNIKISDFGLS--ALPQHFRDDGLLHTTCGSPNYVAPEV 187
            H+  V HRDLK  N+LL++  ++KI DFGL+  A P H    G L     +  Y APE+
Sbjct: 160 IHSANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDH-DHTGFLTEYVATRWYRAPEI 218
Query: 188 LAN-RGYDGATSDIWSCGVILY-------IFRGDFKLPK--------------------- 218
           + N +GY  +  DIWS G IL        IF G   L +                     
Sbjct: 219 MLNSKGYTKSI-DIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIIN 277
Query: 219 -----------------W--LSPGAQ----NLLRKILEPNPVKRITIAGIKADEWFEQDY 255
                            W  L P A     +LL K+L  NP KRI +    A  + EQ Y
Sbjct: 278 LKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYY 337
Query: 256 TPAN 259
            P++
Sbjct: 338 DPSD 341

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 85.5 bits (210), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 67/210 (31%), Positives = 96/210 (45%), Gaps = 28/210 (13%)
Query: 12  RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLK--ITDQIKREIATLK 69
           R  RYE    LGEG F  V  A+D ++    A+K ++       K  I     REI  L+
Sbjct: 8   RAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQ 67
Query: 70  LLKHPNVVRLHEVLASKSKIYMVLEYV-TGGELFDKIASKGRLQEAEGRKLFQQLIDGVS 128
            L HPN++ L +    KS I +V +++ T  E+  K  S   L  +  +      + G+ 
Sbjct: 68  ELSHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSL-VLTPSHIKAYMLMTLQGLE 126
Query: 129 YCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPN------- 181
           Y H   + HRDLK  N+LLD  G +K++DFGL+              + GSPN       
Sbjct: 127 YLHQHWILHRDLKPNNLLLDENGVLKLADFGLA-------------KSFGSPNRAYXHQV 173
Query: 182 ----YVAPEVLANRGYDGATSDIWSCGVIL 207
               Y APE+L      G   D+W+ G IL
Sbjct: 174 VTRWYRAPELLFGARMYGVGVDMWAVGCIL 203

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 85.1 bits (209), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 76/284 (26%), Positives = 123/284 (43%), Gaps = 43/284 (15%)
Query: 15  RYELGRT-------LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIAT 67
           ++E+ RT       LG G +G+V         L  AVK L+++ +      ++  +E A 
Sbjct: 8   KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME----VEEFLKEAAV 63
Query: 68  LKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLF---QQLI 124
           +K +KHPN+V+L  V   +   Y+++E++T G L D +    R QE     L     Q+ 
Sbjct: 64  MKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNR-QEVNAVVLLYMATQIS 122
Query: 125 DGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP-NYV 183
             + Y   K   HRDL   N L+     +K++DFGLS L     D    H     P  + 
Sbjct: 123 SAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG--DTXTAHAGAKFPIKWT 180
Query: 184 APEVLANRGYDGATSDIWSCGVILY--------------------IFRGDFKL--PKWLS 221
           APE LA   +    SD+W+ GV+L+                    +   D+++  P+   
Sbjct: 181 APESLAYNKF-SIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCP 239
Query: 222 PGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPANPDDDEE 265
                L+R   + NP  R + A I     FE  +  ++  D+ E
Sbjct: 240 EKVYELMRACWQWNPSDRPSFAEIHQA--FETMFQESSISDEVE 281

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score = 85.1 bits (209), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 65/201 (32%), Positives = 102/201 (50%), Gaps = 18/201 (8%)
Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEK--NRIIHLKITDQIKREIATLKLLK 72
           RY+    +G G +G V  A D  +G   AVK L +    IIH K T    RE+  LK +K
Sbjct: 23  RYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRT---YRELRLLKHMK 79
Query: 73  HPNVVRLHEV------LASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDG 126
           H NV+ L +V      L   + +Y+V  ++ G +L + I    +L +   + L  Q++ G
Sbjct: 80  HENVIGLLDVFTPARSLEEFNDVYLV-THLMGADL-NNIVKCQKLTDDHVQFLIYQILRG 137
Query: 127 VSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPE 186
           + Y H+  + HRDLK  N+ ++    +KI DF L+   +H  D+  +     +  Y APE
Sbjct: 138 LKYIHSADIIHRDLKPSNLAVNEDCELKILDFYLA---RHTDDE--MTGYVATRWYRAPE 192
Query: 187 VLANRGYDGATSDIWSCGVIL 207
           ++ N  +   T DIWS G I+
Sbjct: 193 IMLNWMHYNQTVDIWSVGCIM 213

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 85.1 bits (209), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 76/284 (26%), Positives = 123/284 (43%), Gaps = 43/284 (15%)
Query: 15  RYELGRT-------LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIAT 67
           ++E+ RT       LG G +G+V         L  AVK L+++ +      ++  +E A 
Sbjct: 7   KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME----VEEFLKEAAV 62
Query: 68  LKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLF---QQLI 124
           +K +KHPN+V+L  V   +   Y+++E++T G L D +    R QE     L     Q+ 
Sbjct: 63  MKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNR-QEVSAVVLLYMATQIS 121
Query: 125 DGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP-NYV 183
             + Y   K   HRDL   N L+     +K++DFGLS L     D    H     P  + 
Sbjct: 122 SAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG--DTYTAHAGAKFPIKWT 179
Query: 184 APEVLANRGYDGATSDIWSCGVILY--------------------IFRGDFKL--PKWLS 221
           APE LA   +    SD+W+ GV+L+                    +   D+++  P+   
Sbjct: 180 APESLAYNKF-SIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCP 238
Query: 222 PGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPANPDDDEE 265
                L+R   + NP  R + A I     FE  +  ++  D+ E
Sbjct: 239 EKVYELMRACWQWNPSDRPSFAEIHQA--FETMFQESSISDEVE 280

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 85.1 bits (209), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 72/264 (27%), Positives = 115/264 (43%), Gaps = 41/264 (15%)
Query: 15  RYELGRT-------LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIAT 67
           ++E+ RT       LG G +G+V         L  AVK L+++ +      ++  +E A 
Sbjct: 12  KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME----VEEFLKEAAV 67
Query: 68  LKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLF---QQLI 124
           +K +KHPN+V+L  V   +   Y+++E++T G L D +    R QE     L     Q+ 
Sbjct: 68  MKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNR-QEVNAVVLLYMATQIS 126
Query: 125 DGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP-NYV 183
             + Y   K   HRDL   N L+     +K++DFGLS L     D    H     P  + 
Sbjct: 127 SAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG--DTYTAHAGAKFPIKWT 184
Query: 184 APEVLANRGYDGATSDIWSCGVILY--------------------IFRGDFKL--PKWLS 221
           APE LA   +    SD+W+ GV+L+                    +   D+++  P+   
Sbjct: 185 APESLAYNKF-SIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCP 243
Query: 222 PGAQNLLRKILEPNPVKRITIAGI 245
                L+R   + NP  R + A I
Sbjct: 244 EKVYELMRACWQWNPSDRPSFAEI 267

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 84.7 bits (208), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 76/284 (26%), Positives = 123/284 (43%), Gaps = 43/284 (15%)
Query: 15  RYELGRT-------LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIAT 67
           ++E+ RT       LG G +G+V         L  AVK L+++ +      ++  +E A 
Sbjct: 7   KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME----VEEFLKEAAV 62
Query: 68  LKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLF---QQLI 124
           +K +KHPN+V+L  V   +   Y+++E++T G L D +    R QE     L     Q+ 
Sbjct: 63  MKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNR-QEVSAVVLLYMATQIS 121
Query: 125 DGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP-NYV 183
             + Y   K   HRDL   N L+     +K++DFGLS L     D    H     P  + 
Sbjct: 122 SAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG--DTYTAHAGAKFPIKWT 179
Query: 184 APEVLANRGYDGATSDIWSCGVILY--------------------IFRGDFKL--PKWLS 221
           APE LA   +    SD+W+ GV+L+                    +   D+++  P+   
Sbjct: 180 APESLAYNKF-SIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCP 238
Query: 222 PGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPANPDDDEE 265
                L+R   + NP  R + A I     FE  +  ++  D+ E
Sbjct: 239 EKVYELMRACWQWNPSDRPSFAEIHQA--FETMFQESSISDEVE 280

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 84.7 bits (208), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 68/253 (26%), Positives = 128/253 (50%), Gaps = 22/253 (8%)
Query: 11  MRLGRYE--LGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATL 68
           M L R E  L + LG G FG VK  +        AVK++++  +      D+  +E  T+
Sbjct: 3   MELKREEITLLKELGSGQFGVVKLGK-WKGQYDVAVKMIKEGSMSE----DEFFQEAQTM 57
Query: 69  KLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGR-LQEAEGRKLFQQLIDGV 127
             L HP +V+ + V + +  IY+V EY++ G L + + S G+ L+ ++  ++   + +G+
Sbjct: 58  MKLSHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGM 117
Query: 128 SYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP---NYVA 184
           ++  +    HRDL   N L+D    +K+SDFG++   ++  DD  + ++ G+     + A
Sbjct: 118 AFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMT---RYVLDDQYV-SSVGTKFPVKWSA 173
Query: 185 PEVLANRGYDGATSDIWSCGVILYIFRGDFKLPKWLSPGAQNLLR-----KILEPNPVKR 239
           PEV     Y  + SD+W+ G++++      K+P  L   ++ +L+     ++  P+ +  
Sbjct: 174 PEVFHYFKY-SSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHRLYRPH-LAS 231
Query: 240 ITIAGIKADEWFE 252
            TI  I    W E
Sbjct: 232 DTIYQIMYSCWHE 244

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 85/310 (27%), Positives = 131/310 (42%), Gaps = 65/310 (20%)
Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
           RY   + +GEG +G V  A D       A+K +      H     +  REI  L   +H 
Sbjct: 44  RYTQLQYIGEGAYGMVSSAYDHVRKTRVAIKKISPFE--HQTYCQRTLREIQILLRFRHE 101
Query: 75  NVVRLHEVLASKS-----KIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSY 129
           NV+ + ++L + +      +Y+V + +   +L+ K+    +L          Q++ G+ Y
Sbjct: 102 NVIGIRDILRASTLEAMRDVYIVQD-LMETDLY-KLLKSQQLSNDHICYFLYQILRGLKY 159
Query: 130 CHNKGVFHRDLKLENILLDSKGNIKISDFGLSAL--PQHFRDDGLLHTTCGSPNYVAPEV 187
            H+  V HRDLK  N+L+++  ++KI DFGL+ +  P+H    G L     +  Y APE+
Sbjct: 160 IHSANVLHRDLKPSNLLINTTCDLKICDFGLARIADPEH-DHTGFLTEXVATRWYRAPEI 218
Query: 188 LAN-RGYDGATSDIWSCGVILY-------IFRGDFKLPK--------------------- 218
           + N +GY  +  DIWS G IL        IF G   L +                     
Sbjct: 219 MLNSKGYTKSI-DIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIIN 277
Query: 219 -----------------W--LSP----GAQNLLRKILEPNPVKRITIAGIKADEWFEQDY 255
                            W  L P     A +LL ++L  NP KRIT+    A  + EQ Y
Sbjct: 278 MKARNYLQSLPSKTKVAWAKLFPKSDSKALDLLDRMLTFNPNKRITVEEALAHPYLEQYY 337
Query: 256 TPANPDDDEE 265
            P +    EE
Sbjct: 338 DPTDEPVAEE 347

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 72/264 (27%), Positives = 114/264 (43%), Gaps = 41/264 (15%)
Query: 15  RYELGRT-------LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIAT 67
           ++E+ RT       LG G +G+V         L  AVK L+++ +      ++  +E A 
Sbjct: 12  KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME----VEEFLKEAAV 67
Query: 68  LKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLF---QQLI 124
           +K +KHPN+V+L  V   +   Y++ E++T G L D +    R QE     L     Q+ 
Sbjct: 68  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNR-QEVNAVVLLYMATQIS 126
Query: 125 DGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP-NYV 183
             + Y   K   HRDL   N L+     +K++DFGLS L     D    H     P  + 
Sbjct: 127 SAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG--DTXTAHAGAKFPIKWT 184
Query: 184 APEVLANRGYDGATSDIWSCGVILY--------------------IFRGDFKL--PKWLS 221
           APE LA   +    SD+W+ GV+L+                    +   D+++  P+   
Sbjct: 185 APESLAYNKF-SIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCP 243
Query: 222 PGAQNLLRKILEPNPVKRITIAGI 245
                L+R   + NP  R + A I
Sbjct: 244 EKVYELMRACWQWNPSDRPSFAEI 267

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 69/216 (31%), Positives = 107/216 (49%), Gaps = 10/216 (4%)
Query: 22  LGEGNFGKVKFAQ-DLDSG--LPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVR 78
           LG+G+FG V+  + D  SG  +  AVK L+ + +   +  D   RE+  +  L H N++R
Sbjct: 26  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 85
Query: 79  LHEVLASKSKIYMVLEYVTGGELFDKI-ASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFH 137
           L+ V+ +   + MV E    G L D++   +G        +   Q+ +G+ Y  +K   H
Sbjct: 86  LYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIH 144
Query: 138 RDLKLENILLDSKGNIKISDFGL-SALPQHFRDDGLLHTTCGSP-NYVAPEVLANRGYDG 195
           RDL   N+LL ++  +KI DFGL  ALPQ+  D  ++      P  + APE L  R +  
Sbjct: 145 RDLAARNLLLATRDLVKIGDFGLMRALPQN-DDHXVMQEHRKVPFAWCAPESLKTRTFSH 203
Query: 196 ATSDIWSCGVILYIFRGDFKLPKWLSPGAQNLLRKI 231
           A SD W  GV L+      + P W+      +L KI
Sbjct: 204 A-SDTWMFGVTLWEMFTYGQEP-WIGLNGSQILHKI 237

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 76/284 (26%), Positives = 122/284 (42%), Gaps = 43/284 (15%)
Query: 15  RYELGRT-------LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIAT 67
           ++E+ RT       LG G +G+V         L  AVK L+++ +      ++  +E A 
Sbjct: 7   KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME----VEEFLKEAAV 62
Query: 68  LKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLF---QQLI 124
           +K +KHPN+V+L  V   +   Y++ E++T G L D +    R QE     L     Q+ 
Sbjct: 63  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNR-QEVSAVVLLYMATQIS 121
Query: 125 DGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP-NYV 183
             + Y   K   HRDL   N L+     +K++DFGLS L     D    H     P  + 
Sbjct: 122 SAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG--DTYTAHAGAKFPIKWT 179
Query: 184 APEVLANRGYDGATSDIWSCGVILY--------------------IFRGDFKL--PKWLS 221
           APE LA   +    SD+W+ GV+L+                    +   D+++  P+   
Sbjct: 180 APESLAYNKF-SIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCP 238
Query: 222 PGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPANPDDDEE 265
                L+R   + NP  R + A I     FE  +  ++  D+ E
Sbjct: 239 EKVYELMRACWQWNPSDRPSFAEIHQA--FETMFQESSISDEVE 280

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 72/264 (27%), Positives = 114/264 (43%), Gaps = 41/264 (15%)
Query: 15  RYELGRT-------LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIAT 67
           ++E+ RT       LG G +G+V         L  AVK L+++ +      ++  +E A 
Sbjct: 12  KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME----VEEFLKEAAV 67
Query: 68  LKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLF---QQLI 124
           +K +KHPN+V+L  V   +   Y++ E++T G L D +    R QE     L     Q+ 
Sbjct: 68  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNR-QEVNAVVLLYMATQIS 126
Query: 125 DGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP-NYV 183
             + Y   K   HRDL   N L+     +K++DFGLS L     D    H     P  + 
Sbjct: 127 SAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG--DTYTAHAGAKFPIKWT 184
Query: 184 APEVLANRGYDGATSDIWSCGVILY--------------------IFRGDFKL--PKWLS 221
           APE LA   +    SD+W+ GV+L+                    +   D+++  P+   
Sbjct: 185 APESLAYNKF-SIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCP 243
Query: 222 PGAQNLLRKILEPNPVKRITIAGI 245
                L+R   + NP  R + A I
Sbjct: 244 EKVYELMRACWQWNPSDRPSFAEI 267

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 76/284 (26%), Positives = 122/284 (42%), Gaps = 43/284 (15%)
Query: 15  RYELGRT-------LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIAT 67
           ++E+ RT       LG G +G+V         L  AVK L+++ +      ++  +E A 
Sbjct: 9   KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME----VEEFLKEAAV 64
Query: 68  LKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLF---QQLI 124
           +K +KHPN+V+L  V   +   Y++ E++T G L D +    R QE     L     Q+ 
Sbjct: 65  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNR-QEVNAVVLLYMATQIS 123
Query: 125 DGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP-NYV 183
             + Y   K   HRDL   N L+     +K++DFGLS L     D    H     P  + 
Sbjct: 124 SAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT--GDTYTAHAGAKFPIKWT 181
Query: 184 APEVLANRGYDGATSDIWSCGVILY--------------------IFRGDFKL--PKWLS 221
           APE LA   +    SD+W+ GV+L+                    +   D+++  P+   
Sbjct: 182 APESLAYNKF-SIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCP 240
Query: 222 PGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPANPDDDEE 265
                L+R   + NP  R + A I     FE  +  ++  D+ E
Sbjct: 241 EKVYELMRACWQWNPSDRPSFAEIHQA--FETMFQESSISDEVE 282

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 72/264 (27%), Positives = 114/264 (43%), Gaps = 41/264 (15%)
Query: 15  RYELGRT-------LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIAT 67
           ++E+ RT       LG G +G+V         L  AVK L+++ +      ++  +E A 
Sbjct: 12  KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME----VEEFLKEAAV 67
Query: 68  LKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLF---QQLI 124
           +K +KHPN+V+L  V   +   Y++ E++T G L D +    R QE     L     Q+ 
Sbjct: 68  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNR-QEVSAVVLLYMATQIS 126
Query: 125 DGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP-NYV 183
             + Y   K   HRDL   N L+     +K++DFGLS L     D    H     P  + 
Sbjct: 127 SAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG--DTYTAHAGAKFPIKWT 184
Query: 184 APEVLANRGYDGATSDIWSCGVILY--------------------IFRGDFKL--PKWLS 221
           APE LA   +    SD+W+ GV+L+                    +   D+++  P+   
Sbjct: 185 APESLAYNKF-SIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCP 243
Query: 222 PGAQNLLRKILEPNPVKRITIAGI 245
                L+R   + NP  R + A I
Sbjct: 244 EKVYELMRACWQWNPSDRPSFAEI 267

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 72/264 (27%), Positives = 114/264 (43%), Gaps = 41/264 (15%)
Query: 15  RYELGRT-------LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIAT 67
           ++E+ RT       LG G +G+V         L  AVK L+++ +      ++  +E A 
Sbjct: 12  KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME----VEEFLKEAAV 67
Query: 68  LKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLF---QQLI 124
           +K +KHPN+V+L  V   +   Y++ E++T G L D +    R QE     L     Q+ 
Sbjct: 68  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNR-QEVNAVVLLYMATQIS 126
Query: 125 DGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP-NYV 183
             + Y   K   HRDL   N L+     +K++DFGLS L     D    H     P  + 
Sbjct: 127 SAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG--DTYTAHAGAKFPIKWT 184
Query: 184 APEVLANRGYDGATSDIWSCGVILY--------------------IFRGDFKL--PKWLS 221
           APE LA   +    SD+W+ GV+L+                    +   D+++  P+   
Sbjct: 185 APESLAYNKF-SIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCP 243
Query: 222 PGAQNLLRKILEPNPVKRITIAGI 245
                L+R   + NP  R + A I
Sbjct: 244 EKVYELMRACWQWNPSDRPSFAEI 267

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 72/264 (27%), Positives = 114/264 (43%), Gaps = 41/264 (15%)
Query: 15  RYELGRT-------LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIAT 67
           ++E+ RT       LG G +G+V         L  AVK L+++ +      ++  +E A 
Sbjct: 9   KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME----VEEFLKEAAV 64
Query: 68  LKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLF---QQLI 124
           +K +KHPN+V+L  V   +   Y++ E++T G L D +    R QE     L     Q+ 
Sbjct: 65  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNR-QEVNAVVLLYMATQIS 123
Query: 125 DGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP-NYV 183
             + Y   K   HRDL   N L+     +K++DFGLS L     D    H     P  + 
Sbjct: 124 SAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG--DTYTAHAGAKFPIKWT 181
Query: 184 APEVLANRGYDGATSDIWSCGVILY--------------------IFRGDFKL--PKWLS 221
           APE LA   +    SD+W+ GV+L+                    +   D+++  P+   
Sbjct: 182 APESLAYNKF-SIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCP 240
Query: 222 PGAQNLLRKILEPNPVKRITIAGI 245
                L+R   + NP  R + A I
Sbjct: 241 EKVYELMRACWQWNPSDRPSFAEI 264

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 76/284 (26%), Positives = 122/284 (42%), Gaps = 43/284 (15%)
Query: 15  RYELGRT-------LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIAT 67
           ++E+ RT       LG G +G+V         L  AVK L+++ +      ++  +E A 
Sbjct: 7   KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME----VEEFLKEAAV 62
Query: 68  LKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLF---QQLI 124
           +K +KHPN+V+L  V   +   Y++ E++T G L D +    R QE     L     Q+ 
Sbjct: 63  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNR-QEVSAVVLLYMATQIS 121
Query: 125 DGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP-NYV 183
             + Y   K   HRDL   N L+     +K++DFGLS L     D    H     P  + 
Sbjct: 122 SAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG--DTYTAHAGAKFPIKWT 179
Query: 184 APEVLANRGYDGATSDIWSCGVILY--------------------IFRGDFKL--PKWLS 221
           APE LA   +    SD+W+ GV+L+                    +   D+++  P+   
Sbjct: 180 APESLAYNKF-SIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCP 238
Query: 222 PGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPANPDDDEE 265
                L+R   + NP  R + A I     FE  +  ++  D+ E
Sbjct: 239 EKVYELMRACWQWNPSDRPSFAEIHQA--FETMFQESSISDEVE 280

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 76/284 (26%), Positives = 122/284 (42%), Gaps = 43/284 (15%)
Query: 15  RYELGRT-------LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIAT 67
           ++E+ RT       LG G +G+V         L  AVK L+++ +      ++  +E A 
Sbjct: 20  KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME----VEEFLKEAAV 75
Query: 68  LKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLF---QQLI 124
           +K +KHPN+V+L  V   +   Y++ E++T G L D +    R QE     L     Q+ 
Sbjct: 76  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNR-QEVNAVVLLYMATQIS 134
Query: 125 DGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP-NYV 183
             + Y   K   HRDL   N L+     +K++DFGLS L     D    H     P  + 
Sbjct: 135 SAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG--DTYTAHAGAKFPIKWT 192
Query: 184 APEVLANRGYDGATSDIWSCGVILY--------------------IFRGDFKL--PKWLS 221
           APE LA   +    SD+W+ GV+L+                    +   D+++  P+   
Sbjct: 193 APESLAYNKF-SIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCP 251
Query: 222 PGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPANPDDDEE 265
                L+R   + NP  R + A I     FE  +  ++  D+ E
Sbjct: 252 EKVYELMRACWQWNPSDRPSFAEIHQA--FETMFQESSISDEVE 293

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 72/264 (27%), Positives = 114/264 (43%), Gaps = 41/264 (15%)
Query: 15  RYELGRT-------LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIAT 67
           ++E+ RT       LG G +G+V         L  AVK L+++ +      ++  +E A 
Sbjct: 11  KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME----VEEFLKEAAV 66
Query: 68  LKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLF---QQLI 124
           +K +KHPN+V+L  V   +   Y++ E++T G L D +    R QE     L     Q+ 
Sbjct: 67  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNR-QEVNAVVLLYMATQIS 125
Query: 125 DGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP-NYV 183
             + Y   K   HRDL   N L+     +K++DFGLS L     D    H     P  + 
Sbjct: 126 SAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG--DTYTAHAGAKFPIKWT 183
Query: 184 APEVLANRGYDGATSDIWSCGVILY--------------------IFRGDFKL--PKWLS 221
           APE LA   +    SD+W+ GV+L+                    +   D+++  P+   
Sbjct: 184 APESLAYNKF-SIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCP 242
Query: 222 PGAQNLLRKILEPNPVKRITIAGI 245
                L+R   + NP  R + A I
Sbjct: 243 EKVYELMRACWQWNPSDRPSFAEI 266

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 72/264 (27%), Positives = 114/264 (43%), Gaps = 41/264 (15%)
Query: 15  RYELGRT-------LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIAT 67
           ++E+ RT       LG G +G+V         L  AVK L+++ +      ++  +E A 
Sbjct: 7   KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME----VEEFLKEAAV 62
Query: 68  LKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLF---QQLI 124
           +K +KHPN+V+L  V   +   Y++ E++T G L D +    R QE     L     Q+ 
Sbjct: 63  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNR-QEVNAVVLLYMATQIS 121
Query: 125 DGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP-NYV 183
             + Y   K   HRDL   N L+     +K++DFGLS L     D    H     P  + 
Sbjct: 122 SAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG--DTYTAHAGAKFPIKWT 179
Query: 184 APEVLANRGYDGATSDIWSCGVILY--------------------IFRGDFKL--PKWLS 221
           APE LA   +    SD+W+ GV+L+                    +   D+++  P+   
Sbjct: 180 APESLAYNKF-SIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCP 238
Query: 222 PGAQNLLRKILEPNPVKRITIAGI 245
                L+R   + NP  R + A I
Sbjct: 239 EKVYELMRACWQWNPSDRPSFAEI 262

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 63/205 (30%), Positives = 97/205 (47%), Gaps = 19/205 (9%)
Query: 15  RYELGRT-------LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIAT 67
           ++E+ RT       LG G +G+V         L  AVK L+++ +      ++  +E A 
Sbjct: 7   KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME----VEEFLKEAAV 62
Query: 68  LKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLF---QQLI 124
           +K +KHPN+V+L  V   +   Y++ E++T G L D +    R QE     L     Q+ 
Sbjct: 63  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNR-QEVNAVVLLYMATQIS 121
Query: 125 DGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP-NYV 183
             + Y   K   HRDL   N L+     +K++DFGLS L     D    H     P  + 
Sbjct: 122 SAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG--DTYTAHAGAKFPIKWT 179
Query: 184 APEVLANRGYDGATSDIWSCGVILY 208
           APE LA   +    SD+W+ GV+L+
Sbjct: 180 APESLAYNKF-SIKSDVWAFGVLLW 203

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 69/216 (31%), Positives = 107/216 (49%), Gaps = 10/216 (4%)
Query: 22  LGEGNFGKVKFAQ-DLDSG--LPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVR 78
           LG+G+FG V+  + D  SG  +  AVK L+ + +   +  D   RE+  +  L H N++R
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 79  LHEVLASKSKIYMVLEYVTGGELFDKI-ASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFH 137
           L+ V+ +   + MV E    G L D++   +G        +   Q+ +G+ Y  +K   H
Sbjct: 76  LYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIH 134
Query: 138 RDLKLENILLDSKGNIKISDFGL-SALPQHFRDDGLLHTTCGSP-NYVAPEVLANRGYDG 195
           RDL   N+LL ++  +KI DFGL  ALPQ+  D  ++      P  + APE L  R +  
Sbjct: 135 RDLAARNLLLATRDLVKIGDFGLMRALPQN-DDHXVMQEHRKVPFAWCAPESLKTRTFSH 193
Query: 196 ATSDIWSCGVILYIFRGDFKLPKWLSPGAQNLLRKI 231
           A SD W  GV L+      + P W+      +L KI
Sbjct: 194 A-SDTWMFGVTLWEMFTYGQEP-WIGLNGSQILHKI 227

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 69/216 (31%), Positives = 107/216 (49%), Gaps = 10/216 (4%)
Query: 22  LGEGNFGKVKFAQ-DLDSG--LPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVR 78
           LG+G+FG V+  + D  SG  +  AVK L+ + +   +  D   RE+  +  L H N++R
Sbjct: 20  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 79
Query: 79  LHEVLASKSKIYMVLEYVTGGELFDKI-ASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFH 137
           L+ V+ +   + MV E    G L D++   +G        +   Q+ +G+ Y  +K   H
Sbjct: 80  LYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIH 138
Query: 138 RDLKLENILLDSKGNIKISDFGL-SALPQHFRDDGLLHTTCGSP-NYVAPEVLANRGYDG 195
           RDL   N+LL ++  +KI DFGL  ALPQ+  D  ++      P  + APE L  R +  
Sbjct: 139 RDLAARNLLLATRDLVKIGDFGLMRALPQN-DDHYVMQEHRKVPFAWCAPESLKTRTFSH 197
Query: 196 ATSDIWSCGVILYIFRGDFKLPKWLSPGAQNLLRKI 231
           A SD W  GV L+      + P W+      +L KI
Sbjct: 198 A-SDTWMFGVTLWEMFTYGQEP-WIGLNGSQILHKI 231

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 62/206 (30%), Positives = 97/206 (47%), Gaps = 17/206 (8%)
Query: 13  LGRYELGRT-------LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREI 65
           + ++E+ RT       LG G +G+V         L  AVK L+++ +      ++  +E 
Sbjct: 24  MDKWEMERTDITMKHKLGGGQYGEVYVGVWKKYSLTVAVKTLKEDTME----VEEFLKEA 79
Query: 66  ATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQ--QL 123
           A +K +KHPN+V+L  V   +   Y+V EY+  G L D +    R +      L+   Q+
Sbjct: 80  AVMKEIKHPNLVQLLGVCTLEPPFYIVTEYMPYGNLLDYLRECNREEVTAVVLLYMATQI 139
Query: 124 IDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP-NY 182
              + Y   K   HRDL   N L+     +K++DFGLS L     D    H     P  +
Sbjct: 140 SSAMEYLEKKNFIHRDLAARNCLVGENHVVKVADFGLSRLMT--GDTYTAHAGAKFPIKW 197
Query: 183 VAPEVLANRGYDGATSDIWSCGVILY 208
            APE LA   +    SD+W+ GV+L+
Sbjct: 198 TAPESLAYNTFS-IKSDVWAFGVLLW 222

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 69/216 (31%), Positives = 107/216 (49%), Gaps = 10/216 (4%)
Query: 22  LGEGNFGKVKFAQ-DLDSG--LPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVR 78
           LG+G+FG V+  + D  SG  +  AVK L+ + +   +  D   RE+  +  L H N++R
Sbjct: 26  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 85
Query: 79  LHEVLASKSKIYMVLEYVTGGELFDKI-ASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFH 137
           L+ V+ +   + MV E    G L D++   +G        +   Q+ +G+ Y  +K   H
Sbjct: 86  LYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIH 144
Query: 138 RDLKLENILLDSKGNIKISDFGL-SALPQHFRDDGLLHTTCGSP-NYVAPEVLANRGYDG 195
           RDL   N+LL ++  +KI DFGL  ALPQ+  D  ++      P  + APE L  R +  
Sbjct: 145 RDLAARNLLLATRDLVKIGDFGLMRALPQN-DDHYVMQEHRKVPFAWCAPESLKTRTFSH 203
Query: 196 ATSDIWSCGVILYIFRGDFKLPKWLSPGAQNLLRKI 231
           A SD W  GV L+      + P W+      +L KI
Sbjct: 204 A-SDTWMFGVTLWEMFTYGQEP-WIGLNGSQILHKI 237

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 69/216 (31%), Positives = 107/216 (49%), Gaps = 10/216 (4%)
Query: 22  LGEGNFGKVKFAQ-DLDSG--LPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVR 78
           LG+G+FG V+  + D  SG  +  AVK L+ + +   +  D   RE+  +  L H N++R
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 79  LHEVLASKSKIYMVLEYVTGGELFDKI-ASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFH 137
           L+ V+ +   + MV E    G L D++   +G        +   Q+ +G+ Y  +K   H
Sbjct: 76  LYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIH 134
Query: 138 RDLKLENILLDSKGNIKISDFGL-SALPQHFRDDGLLHTTCGSP-NYVAPEVLANRGYDG 195
           RDL   N+LL ++  +KI DFGL  ALPQ+  D  ++      P  + APE L  R +  
Sbjct: 135 RDLAARNLLLATRDLVKIGDFGLMRALPQN-DDHYVMQEHRKVPFAWCAPESLKTRTFSH 193
Query: 196 ATSDIWSCGVILYIFRGDFKLPKWLSPGAQNLLRKI 231
           A SD W  GV L+      + P W+      +L KI
Sbjct: 194 A-SDTWMFGVTLWEMFTYGQEP-WIGLNGSQILHKI 227

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 69/216 (31%), Positives = 107/216 (49%), Gaps = 10/216 (4%)
Query: 22  LGEGNFGKVKFAQ-DLDSG--LPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVR 78
           LG+G+FG V+  + D  SG  +  AVK L+ + +   +  D   RE+  +  L H N++R
Sbjct: 20  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 79
Query: 79  LHEVLASKSKIYMVLEYVTGGELFDKI-ASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFH 137
           L+ V+ +   + MV E    G L D++   +G        +   Q+ +G+ Y  +K   H
Sbjct: 80  LYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIH 138
Query: 138 RDLKLENILLDSKGNIKISDFGL-SALPQHFRDDGLLHTTCGSP-NYVAPEVLANRGYDG 195
           RDL   N+LL ++  +KI DFGL  ALPQ+  D  ++      P  + APE L  R +  
Sbjct: 139 RDLAARNLLLATRDLVKIGDFGLMRALPQN-DDHYVMQEHRKVPFAWCAPESLKTRTFSH 197
Query: 196 ATSDIWSCGVILYIFRGDFKLPKWLSPGAQNLLRKI 231
           A SD W  GV L+      + P W+      +L KI
Sbjct: 198 A-SDTWMFGVTLWEMFTYGQEP-WIGLNGSQILHKI 231

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 69/216 (31%), Positives = 107/216 (49%), Gaps = 10/216 (4%)
Query: 22  LGEGNFGKVKFAQ-DLDSG--LPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVR 78
           LG+G+FG V+  + D  SG  +  AVK L+ + +   +  D   RE+  +  L H N++R
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 79  LHEVLASKSKIYMVLEYVTGGELFDKI-ASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFH 137
           L+ V+ +   + MV E    G L D++   +G        +   Q+ +G+ Y  +K   H
Sbjct: 76  LYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIH 134
Query: 138 RDLKLENILLDSKGNIKISDFGL-SALPQHFRDDGLLHTTCGSP-NYVAPEVLANRGYDG 195
           RDL   N+LL ++  +KI DFGL  ALPQ+  D  ++      P  + APE L  R +  
Sbjct: 135 RDLAARNLLLATRDLVKIGDFGLMRALPQN-DDHYVMQEHRKVPFAWCAPESLKTRTFSH 193
Query: 196 ATSDIWSCGVILYIFRGDFKLPKWLSPGAQNLLRKI 231
           A SD W  GV L+      + P W+      +L KI
Sbjct: 194 A-SDTWMFGVTLWEMFTYGQEP-WIGLNGSQILHKI 227

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 80/280 (28%), Positives = 123/280 (43%), Gaps = 42/280 (15%)
Query: 13  LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEK--NRIIHLKITDQIKREIATLKL 70
           L RY+  + +G G  G V  A D   G+  AVK L +      H K   +  RE+  LK 
Sbjct: 23  LKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAK---RAYRELVLLKC 79
Query: 71  LKHPNVVRLHEVLASKSK------IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLI 124
           + H N++ L  V   +        +Y+V+E +    L   I  +  L       L  Q++
Sbjct: 80  VNHKNIISLLNVFTPQKTLEEFQDVYLVME-LMDANLCQVIHME--LDHERMSYLLYQML 136
Query: 125 DGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVA 184
            G+ + H+ G+ HRDLK  NI++ S   +KI DFGL+   +    + ++     +  Y A
Sbjct: 137 CGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA---RTACTNFMMTPYVVTRYYRA 193
Query: 185 PEVLANRGYDGATSDIWSCGVIL-------YIFRGDFKLPKWL-------SPGA------ 224
           PEV+   GY  A  DIWS G I+        IF+G   + +W        +P A      
Sbjct: 194 PEVILGMGY-AANVDIWSVGCIMGELVKGCVIFQGTDHIDQWNKVIEQLGTPSAEFMAAL 252
Query: 225 QNLLRKILEPNPVKRITIAGIKADEWFEQDYTPANPDDDE 264
           Q  +R  +E  P       GIK +E F     P+  + D+
Sbjct: 253 QPTVRNYVENRP----KYPGIKFEELFPDWIFPSESERDK 288

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 105/209 (50%), Gaps = 19/209 (9%)
Query: 13  LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVK-ILEKNRIIHLKITDQIKREIATLKLL 71
           + +YE    +G+G FG+V  A+   +G   A+K +L +N      IT    REI  L+LL
Sbjct: 17  VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPIT--ALREIKILQLL 74
Query: 72  KHPNVVRLHEVLASKSK--------IYMVLEYVTG--GELFDKIASKGRLQEAEGRKLFQ 121
           KH NVV L E+  +K+         IY+V ++       L   +  K  L E   +++ Q
Sbjct: 75  KHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEI--KRVMQ 132
Query: 122 QLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLS---ALPQHFRDDGLLHTTCG 178
            L++G+ Y H   + HRD+K  N+L+   G +K++DFGL+   +L ++ + +   +    
Sbjct: 133 MLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVV- 191
Query: 179 SPNYVAPEVLANRGYDGATSDIWSCGVIL 207
           +  Y  PE+L      G   D+W  G I+
Sbjct: 192 TLWYRPPELLLGERDYGPPIDLWGAGCIM 220

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 78/256 (30%), Positives = 119/256 (46%), Gaps = 30/256 (11%)
Query: 20  RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRL 79
           R LG+G FG+V   Q   +G  +A K LEK RI   K       E   L+ +    VV L
Sbjct: 190 RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSL 249
Query: 80  HEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLF--QQLIDGVSYCHNKGVFH 137
                +K  + +VL  + GG+L   I   G+    E R +F   ++  G+   H + + +
Sbjct: 250 AYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVY 309
Query: 138 RDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGAT 197
           RDLK ENILLD  G+I+ISD GL+    H  +   +    G+  Y+APEV+ N  Y   +
Sbjct: 310 RDLKPENILLDDHGHIRISDLGLAV---HVPEGQTIKGRVGTVGYMAPEVVKNERYT-FS 365
Query: 198 SDIWSCGVILY--------------------IFRGDFKLP----KWLSPGAQNLLRKILE 233
            D W+ G +LY                    + R   ++P    +  SP A++L  ++L 
Sbjct: 366 PDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYSERFSPQARSLCSQLLC 425
Query: 234 PNPVKRITIAGIKADE 249
            +P +R+   G  A E
Sbjct: 426 KDPAERLGCRGGSARE 441

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 78/256 (30%), Positives = 119/256 (46%), Gaps = 30/256 (11%)
Query: 20  RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRL 79
           R LG+G FG+V   Q   +G  +A K LEK RI   K       E   L+ +    VV L
Sbjct: 190 RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSL 249
Query: 80  HEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLF--QQLIDGVSYCHNKGVFH 137
                +K  + +VL  + GG+L   I   G+    E R +F   ++  G+   H + + +
Sbjct: 250 AYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVY 309
Query: 138 RDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGAT 197
           RDLK ENILLD  G+I+ISD GL+    H  +   +    G+  Y+APEV+ N  Y   +
Sbjct: 310 RDLKPENILLDDHGHIRISDLGLAV---HVPEGQTIKGRVGTVGYMAPEVVKNERYT-FS 365
Query: 198 SDIWSCGVILY--------------------IFRGDFKLP----KWLSPGAQNLLRKILE 233
            D W+ G +LY                    + R   ++P    +  SP A++L  ++L 
Sbjct: 366 PDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYSERFSPQARSLCSQLLC 425
Query: 234 PNPVKRITIAGIKADE 249
            +P +R+   G  A E
Sbjct: 426 KDPAERLGCRGGSARE 441

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 82.4 bits (202), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 105/209 (50%), Gaps = 19/209 (9%)
Query: 13  LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVK-ILEKNRIIHLKITDQIKREIATLKLL 71
           + +YE    +G+G FG+V  A+   +G   A+K +L +N      IT    REI  L+LL
Sbjct: 16  VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITAL--REIKILQLL 73
Query: 72  KHPNVVRLHEVLASKSK--------IYMVLEYVTG--GELFDKIASKGRLQEAEGRKLFQ 121
           KH NVV L E+  +K+         IY+V ++       L   +  K  L E   +++ Q
Sbjct: 74  KHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEI--KRVMQ 131
Query: 122 QLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLS---ALPQHFRDDGLLHTTCG 178
            L++G+ Y H   + HRD+K  N+L+   G +K++DFGL+   +L ++ + +   +    
Sbjct: 132 MLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVV- 190
Query: 179 SPNYVAPEVLANRGYDGATSDIWSCGVIL 207
           +  Y  PE+L      G   D+W  G I+
Sbjct: 191 TLWYRPPELLLGERDYGPPIDLWGAGCIM 219

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 105/209 (50%), Gaps = 19/209 (9%)
Query: 13  LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVK-ILEKNRIIHLKITDQIKREIATLKLL 71
           + +YE    +G+G FG+V  A+   +G   A+K +L +N      IT    REI  L+LL
Sbjct: 17  VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITAL--REIKILQLL 74
Query: 72  KHPNVVRLHEVLASKSK--------IYMVLEYVTG--GELFDKIASKGRLQEAEGRKLFQ 121
           KH NVV L E+  +K+         IY+V ++       L   +  K  L E   +++ Q
Sbjct: 75  KHENVVNLIEICRTKASPYNRCKASIYLVFDFCEHDLAGLLSNVLVKFTLSEI--KRVMQ 132
Query: 122 QLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLS---ALPQHFRDDGLLHTTCG 178
            L++G+ Y H   + HRD+K  N+L+   G +K++DFGL+   +L ++ + +   +    
Sbjct: 133 MLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVV- 191
Query: 179 SPNYVAPEVLANRGYDGATSDIWSCGVIL 207
           +  Y  PE+L      G   D+W  G I+
Sbjct: 192 TLWYRPPELLLGERDYGPPIDLWGAGCIM 220

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 105/209 (50%), Gaps = 19/209 (9%)
Query: 13  LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVK-ILEKNRIIHLKITDQIKREIATLKLL 71
           + +YE    +G+G FG+V  A+   +G   A+K +L +N      IT    REI  L+LL
Sbjct: 17  VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITAL--REIKILQLL 74
Query: 72  KHPNVVRLHEVLASKSK--------IYMVLEYVTG--GELFDKIASKGRLQEAEGRKLFQ 121
           KH NVV L E+  +K+         IY+V ++       L   +  K  L E   +++ Q
Sbjct: 75  KHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEI--KRVMQ 132
Query: 122 QLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLS---ALPQHFRDDGLLHTTCG 178
            L++G+ Y H   + HRD+K  N+L+   G +K++DFGL+   +L ++ + +   +    
Sbjct: 133 MLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVV- 191
Query: 179 SPNYVAPEVLANRGYDGATSDIWSCGVIL 207
           +  Y  PE+L      G   D+W  G I+
Sbjct: 192 TLWYRPPELLLGERDYGPPIDLWGAGCIM 220

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 81.6 bits (200), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 65/222 (29%), Positives = 105/222 (47%), Gaps = 32/222 (14%)
Query: 15  RYELGRTLGEGNFGKVKFAQDLDSG---LPFAVKILEKNRIIHLKITDQIKR----EIAT 67
           R  + + +G G+ G+V + +    G   +P A+K L+         T++ +R    E + 
Sbjct: 50  RIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAG------YTERQRRDFLSEASI 103
Query: 68  LKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLID-- 125
           +    HPN++RL  V+       +V EY+  G L D       L+  +G+    QL+   
Sbjct: 104 MGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSL-DTF-----LRTHDGQFTIMQLVGML 157
Query: 126 -----GVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP 180
                G+ Y  + G  HRDL   N+L+DS    K+SDFGLS + +   D    +TT G  
Sbjct: 158 RGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLED--DPDAAYTTTGGK 215
Query: 181 ---NYVAPEVLANRGYDGATSDIWSCGVILYIFRGDFKLPKW 219
               + APE +A R +  A SD+WS GV+++      + P W
Sbjct: 216 IPIRWTAPEAIAFRTFSSA-SDVWSFGVVMWEVLAYGERPYW 256

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 81.3 bits (199), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 63/212 (29%), Positives = 102/212 (48%), Gaps = 22/212 (10%)
Query: 20  RTLGEGNFGKVKFAQDLDSG---LPFAVKILEKNRIIHLKITDQIKR----EIATLKLLK 72
           R +G G FG+V   +    G   LP A+K L+      +  T++ +R    E + +    
Sbjct: 28  RVIGAGEFGEVCSGRLKLPGKRELPVAIKTLK------VGYTEKQRRDFLGEASIMGQFD 81
Query: 73  HPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASK--GRLQEAEGRKLFQQLIDGVSYC 130
           HPN++ L  V+     + +V EY+  G L D    K  G+    +   + + +  G+ Y 
Sbjct: 82  HPNIIHLEGVVTKSKPVMIVTEYMENGSL-DTFLKKNDGQFTVIQLVGMLRGISAGMKYL 140
Query: 131 HNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP---NYVAPEV 187
            + G  HRDL   NIL++S    K+SDFGLS + +   D    +TT G      + APE 
Sbjct: 141 SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLED--DPEAAYTTRGGKIPIRWTAPEA 198
Query: 188 LANRGYDGATSDIWSCGVILYIFRGDFKLPKW 219
           +A R +  A SD+WS G++++      + P W
Sbjct: 199 IAFRKFTSA-SDVWSYGIVMWEVVSYGERPYW 229

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 81.3 bits (199), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 83/304 (27%), Positives = 129/304 (42%), Gaps = 65/304 (21%)
Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
           RY     +GEG +G V  A D  + +  A+K +      H     +  REI  L   +H 
Sbjct: 24  RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE--HQTYCQRTLREIKILLRFRHE 81
Query: 75  NVVRLHEVLASKS-----KIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSY 129
           N++ +++++ + +      +Y+V + +   +L+ K+     L          Q++ G+ Y
Sbjct: 82  NIIGINDIIRAPTIEQMKDVYIVQD-LMETDLY-KLLKTQHLSNDHICYFLYQILRGLKY 139
Query: 130 CHNKGVFHRDLKLENILLDSKGNIKISDFGLS--ALPQHFRDDGLLHTTCGSPNYVAPEV 187
            H+  V HRDLK  N+LL++  ++KI DFGL+  A P H    G L     +  Y APE+
Sbjct: 140 IHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDH-DHTGFLTEYVATRWYRAPEI 198
Query: 188 LAN-RGYDGATSDIWSCGVILY-------IFRGDFKLPK--------------------- 218
           + N +GY  +  DIWS G IL        IF G   L +                     
Sbjct: 199 MLNSKGYTKSI-DIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIIN 257
Query: 219 -----------------W--LSPGAQ----NLLRKILEPNPVKRITIAGIKADEWFEQDY 255
                            W  L P A     +LL K+L  NP KRI +    A  + EQ Y
Sbjct: 258 LKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYY 317
Query: 256 TPAN 259
            P++
Sbjct: 318 DPSD 321

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 81.3 bits (199), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 82/303 (27%), Positives = 128/303 (42%), Gaps = 63/303 (20%)
Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
           RY     +GEG +G V  A D  + +  A+K +      H     +  REI  L   +H 
Sbjct: 28  RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFE--HQTYCQRTLREIKILLRFRHE 85
Query: 75  NVVRLHEVLASKS----KIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYC 130
           N++ +++++ + +    K   +++ +   +L+ K+     L          Q++ G+ Y 
Sbjct: 86  NIIGINDIIRAPTIEQMKDVYIVQDLMETDLY-KLLKTQHLSNDHICYFLYQILRGLKYI 144
Query: 131 HNKGVFHRDLKLENILLDSKGNIKISDFGLS--ALPQHFRDDGLLHTTCGSPNYVAPEVL 188
           H+  V HRDLK  N+LL++  ++KI DFGL+  A P H    G L     +  Y APE++
Sbjct: 145 HSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDH-DHTGFLXEXVATRWYRAPEIM 203
Query: 189 AN-RGYDGATSDIWSCGVILY-------IFRGDFKLPK---------------------- 218
            N +GY  +  DIWS G IL        IF G   L +                      
Sbjct: 204 LNSKGYTKSI-DIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINL 262
Query: 219 ----------------W--LSPGAQ----NLLRKILEPNPVKRITIAGIKADEWFEQDYT 256
                           W  L P A     +LL K+L  NP KRI +    A  + EQ Y 
Sbjct: 263 KARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYD 322
Query: 257 PAN 259
           P++
Sbjct: 323 PSD 325

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 81.3 bits (199), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 82/303 (27%), Positives = 128/303 (42%), Gaps = 63/303 (20%)
Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
           RY     +GEG +G V  A D  + +  A+K +      H     +  REI  L   +H 
Sbjct: 29  RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFE--HQTYCQRTLREIKILLRFRHE 86
Query: 75  NVVRLHEVLASKS----KIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYC 130
           N++ +++++ + +    K   +++ +   +L+ K+     L          Q++ G+ Y 
Sbjct: 87  NIIGINDIIRAPTIEQMKDVYIVQDLMETDLY-KLLKTQHLSNDHICYFLYQILRGLKYI 145
Query: 131 HNKGVFHRDLKLENILLDSKGNIKISDFGLS--ALPQHFRDDGLLHTTCGSPNYVAPEVL 188
           H+  V HRDLK  N+LL++  ++KI DFGL+  A P H    G L     +  Y APE++
Sbjct: 146 HSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDH-DHTGFLXEXVATRWYRAPEIM 204
Query: 189 AN-RGYDGATSDIWSCGVILY-------IFRGDFKLPK---------------------- 218
            N +GY  +  DIWS G IL        IF G   L +                      
Sbjct: 205 LNSKGYTKSI-DIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINL 263
Query: 219 ----------------W--LSPGAQ----NLLRKILEPNPVKRITIAGIKADEWFEQDYT 256
                           W  L P A     +LL K+L  NP KRI +    A  + EQ Y 
Sbjct: 264 KARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYD 323
Query: 257 PAN 259
           P++
Sbjct: 324 PSD 326

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 81.3 bits (199), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 83/304 (27%), Positives = 129/304 (42%), Gaps = 65/304 (21%)
Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
           RY     +GEG +G V  A D  + +  A+K +      H     +  REI  L   +H 
Sbjct: 26  RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE--HQTYCQRTLREIKILLRFRHE 83
Query: 75  NVVRLHEVLASKS-----KIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSY 129
           N++ +++++ + +      +Y+V + +   +L+ K+     L          Q++ G+ Y
Sbjct: 84  NIIGINDIIRAPTIEQMKDVYIVQD-LMETDLY-KLLKTQHLSNDHICYFLYQILRGLKY 141
Query: 130 CHNKGVFHRDLKLENILLDSKGNIKISDFGLS--ALPQHFRDDGLLHTTCGSPNYVAPEV 187
            H+  V HRDLK  N+LL++  ++KI DFGL+  A P H    G L     +  Y APE+
Sbjct: 142 IHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDH-DHTGFLTEYVATRWYRAPEI 200
Query: 188 LAN-RGYDGATSDIWSCGVILY-------IFRGDFKLPK--------------------- 218
           + N +GY  +  DIWS G IL        IF G   L +                     
Sbjct: 201 MLNSKGYTKSI-DIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIIN 259
Query: 219 -----------------W--LSPGAQ----NLLRKILEPNPVKRITIAGIKADEWFEQDY 255
                            W  L P A     +LL K+L  NP KRI +    A  + EQ Y
Sbjct: 260 LKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYY 319
Query: 256 TPAN 259
            P++
Sbjct: 320 DPSD 323

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 71/264 (26%), Positives = 114/264 (43%), Gaps = 41/264 (15%)
Query: 15  RYELGRT-------LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIAT 67
           ++E+ RT       LG G +G+V         L  AVK L+++ +      ++  +E A 
Sbjct: 214 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME----VEEFLKEAAV 269
Query: 68  LKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLF---QQLI 124
           +K +KHPN+V+L  V   +   Y++ E++T G L D +    R QE     L     Q+ 
Sbjct: 270 MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNR-QEVSAVVLLYMATQIS 328
Query: 125 DGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP-NYV 183
             + Y   K   HR+L   N L+     +K++DFGLS L     D    H     P  + 
Sbjct: 329 SAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMT--GDTYTAHAGAKFPIKWT 386
Query: 184 APEVLANRGYDGATSDIWSCGVILY--------------------IFRGDFKL--PKWLS 221
           APE LA   +    SD+W+ GV+L+                    +   D+++  P+   
Sbjct: 387 APESLAYNKFS-IKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCP 445
Query: 222 PGAQNLLRKILEPNPVKRITIAGI 245
                L+R   + NP  R + A I
Sbjct: 446 EKVYELMRACWQWNPSDRPSFAEI 469

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 83/304 (27%), Positives = 129/304 (42%), Gaps = 65/304 (21%)
Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
           RY     +GEG +G V  A D  + +  A+K +      H     +  REI  L   +H 
Sbjct: 24  RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE--HQTYCQRTLREIKILLRFRHE 81
Query: 75  NVVRLHEVLASKS-----KIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSY 129
           N++ +++++ + +      +Y+V + +   +L+ K+     L          Q++ G+ Y
Sbjct: 82  NIIGINDIIRAPTIEQMKDVYIVQD-LMETDLY-KLLKTQHLSNDHICYFLYQILRGLKY 139
Query: 130 CHNKGVFHRDLKLENILLDSKGNIKISDFGLS--ALPQHFRDDGLLHTTCGSPNYVAPEV 187
            H+  V HRDLK  N+LL++  ++KI DFGL+  A P H    G L     +  Y APE+
Sbjct: 140 IHSANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDH-DHTGFLTEYVATRWYRAPEI 198
Query: 188 LAN-RGYDGATSDIWSCGVILY-------IFRGDFKLPK--------------------- 218
           + N +GY  +  DIWS G IL        IF G   L +                     
Sbjct: 199 MLNSKGYTKSI-DIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIIN 257
Query: 219 -----------------W--LSPGAQ----NLLRKILEPNPVKRITIAGIKADEWFEQDY 255
                            W  L P A     +LL K+L  NP KRI +    A  + EQ Y
Sbjct: 258 LKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYY 317
Query: 256 TPAN 259
            P++
Sbjct: 318 DPSD 321

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 83/304 (27%), Positives = 129/304 (42%), Gaps = 65/304 (21%)
Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
           RY     +GEG +G V  A D  + +  A+K +      H     +  REI  L   +H 
Sbjct: 44  RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE--HQTYCQRTLREIKILLRFRHE 101
Query: 75  NVVRLHEVLASKS-----KIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSY 129
           N++ +++++ + +      +Y+V + +   +L+ K+     L          Q++ G+ Y
Sbjct: 102 NIIGINDIIRAPTIEQMKDVYIVQD-LMETDLY-KLLKTQHLSNDHICYFLYQILRGLKY 159
Query: 130 CHNKGVFHRDLKLENILLDSKGNIKISDFGLS--ALPQHFRDDGLLHTTCGSPNYVAPEV 187
            H+  V HRDLK  N+LL++  ++KI DFGL+  A P H    G L     +  Y APE+
Sbjct: 160 IHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDH-DHTGFLTEYVATRWYRAPEI 218
Query: 188 LAN-RGYDGATSDIWSCGVILY-------IFRGDFKLPK--------------------- 218
           + N +GY  +  DIWS G IL        IF G   L +                     
Sbjct: 219 MLNSKGYTKSI-DIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIIN 277
Query: 219 -----------------W--LSPGAQ----NLLRKILEPNPVKRITIAGIKADEWFEQDY 255
                            W  L P A     +LL K+L  NP KRI +    A  + EQ Y
Sbjct: 278 LKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYY 337
Query: 256 TPAN 259
            P++
Sbjct: 338 DPSD 341

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 83/304 (27%), Positives = 129/304 (42%), Gaps = 65/304 (21%)
Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
           RY     +GEG +G V  A D  + +  A+K +      H     +  REI  L   +H 
Sbjct: 24  RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE--HQTYCQRTLREIKILLRFRHE 81
Query: 75  NVVRLHEVLASKS-----KIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSY 129
           N++ +++++ + +      +Y+V + +   +L+ K+     L          Q++ G+ Y
Sbjct: 82  NIIGINDIIRAPTIEQMKDVYIVQD-LMETDLY-KLLKTQHLSNDHICYFLYQILRGLKY 139
Query: 130 CHNKGVFHRDLKLENILLDSKGNIKISDFGLS--ALPQHFRDDGLLHTTCGSPNYVAPEV 187
            H+  V HRDLK  N+LL++  ++KI DFGL+  A P H    G L     +  Y APE+
Sbjct: 140 IHSANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDH-DHTGFLTEYVATRWYRAPEI 198
Query: 188 LAN-RGYDGATSDIWSCGVILY-------IFRGDFKLPK--------------------- 218
           + N +GY  +  DIWS G IL        IF G   L +                     
Sbjct: 199 MLNSKGYTKSI-DIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNXIIN 257
Query: 219 -----------------W--LSPGAQ----NLLRKILEPNPVKRITIAGIKADEWFEQDY 255
                            W  L P A     +LL K+L  NP KRI +    A  + EQ Y
Sbjct: 258 LKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYY 317
Query: 256 TPAN 259
            P++
Sbjct: 318 DPSD 321

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 83/304 (27%), Positives = 129/304 (42%), Gaps = 65/304 (21%)
Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
           RY     +GEG +G V  A D  + +  A+K +      H     +  REI  L   +H 
Sbjct: 32  RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE--HQTYCQRTLREIKILLRFRHE 89
Query: 75  NVVRLHEVLASKS-----KIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSY 129
           N++ +++++ + +      +Y+V + +   +L+ K+     L          Q++ G+ Y
Sbjct: 90  NIIGINDIIRAPTIEQMKDVYIVQD-LMETDLY-KLLKTQHLSNDHICYFLYQILRGLKY 147
Query: 130 CHNKGVFHRDLKLENILLDSKGNIKISDFGLS--ALPQHFRDDGLLHTTCGSPNYVAPEV 187
            H+  V HRDLK  N+LL++  ++KI DFGL+  A P H    G L     +  Y APE+
Sbjct: 148 IHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDH-DHTGFLTEYVATRWYRAPEI 206
Query: 188 LAN-RGYDGATSDIWSCGVILY-------IFRGDFKLPK--------------------- 218
           + N +GY  +  DIWS G IL        IF G   L +                     
Sbjct: 207 MLNSKGYTKSI-DIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIIN 265
Query: 219 -----------------W--LSPGAQ----NLLRKILEPNPVKRITIAGIKADEWFEQDY 255
                            W  L P A     +LL K+L  NP KRI +    A  + EQ Y
Sbjct: 266 LKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYY 325
Query: 256 TPAN 259
            P++
Sbjct: 326 DPSD 329

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 83/304 (27%), Positives = 129/304 (42%), Gaps = 65/304 (21%)
Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
           RY     +GEG +G V  A D  + +  A+K +      H     +  REI  L   +H 
Sbjct: 24  RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE--HQTYCQRTLREIKILLRFRHE 81
Query: 75  NVVRLHEVLASKS-----KIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSY 129
           N++ +++++ + +      +Y+V + +   +L+ K+     L          Q++ G+ Y
Sbjct: 82  NIIGINDIIRAPTIEQMKDVYIVQD-LMETDLY-KLLKTQHLSNDHICYFLYQILRGLKY 139
Query: 130 CHNKGVFHRDLKLENILLDSKGNIKISDFGLS--ALPQHFRDDGLLHTTCGSPNYVAPEV 187
            H+  V HRDLK  N+LL++  ++KI DFGL+  A P H    G L     +  Y APE+
Sbjct: 140 IHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDH-DHTGFLTEYVATRWYRAPEI 198
Query: 188 LAN-RGYDGATSDIWSCGVILY-------IFRGDFKLPK--------------------- 218
           + N +GY  +  DIWS G IL        IF G   L +                     
Sbjct: 199 MLNSKGYTKSI-DIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIIN 257
Query: 219 -----------------W--LSPGAQ----NLLRKILEPNPVKRITIAGIKADEWFEQDY 255
                            W  L P A     +LL K+L  NP KRI +    A  + EQ Y
Sbjct: 258 LKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYY 317
Query: 256 TPAN 259
            P++
Sbjct: 318 DPSD 321

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 83/304 (27%), Positives = 129/304 (42%), Gaps = 65/304 (21%)
Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
           RY     +GEG +G V  A D  + +  A+K +      H     +  REI  L   +H 
Sbjct: 28  RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFE--HQTYCQRTLREIKILLRFRHE 85
Query: 75  NVVRLHEVLASKS-----KIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSY 129
           N++ +++++ + +      +Y+V + +   +L+ K+     L          Q++ G+ Y
Sbjct: 86  NIIGINDIIRAPTIEQMKDVYIVQD-LMETDLY-KLLKTQHLSNDHICYFLYQILRGLKY 143
Query: 130 CHNKGVFHRDLKLENILLDSKGNIKISDFGLS--ALPQHFRDDGLLHTTCGSPNYVAPEV 187
            H+  V HRDLK  N+LL++  ++KI DFGL+  A P H    G L     +  Y APE+
Sbjct: 144 IHSANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDH-DHTGFLTEYVATRWYRAPEI 202
Query: 188 LAN-RGYDGATSDIWSCGVILY-------IFRGDFKLPK--------------------- 218
           + N +GY  +  DIWS G IL        IF G   L +                     
Sbjct: 203 MLNSKGYTKSI-DIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIIN 261
Query: 219 -----------------W--LSPGAQ----NLLRKILEPNPVKRITIAGIKADEWFEQDY 255
                            W  L P A     +LL K+L  NP KRI +    A  + EQ Y
Sbjct: 262 LKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYY 321
Query: 256 TPAN 259
            P++
Sbjct: 322 DPSD 325

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 83/304 (27%), Positives = 129/304 (42%), Gaps = 65/304 (21%)
Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
           RY     +GEG +G V  A D  + +  A+K +      H     +  REI  L   +H 
Sbjct: 29  RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFE--HQTYCQRTLREIKILLRFRHE 86
Query: 75  NVVRLHEVLASKS-----KIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSY 129
           N++ +++++ + +      +Y+V + +   +L+ K+     L          Q++ G+ Y
Sbjct: 87  NIIGINDIIRAPTIEQMKDVYIVQD-LMETDLY-KLLKTQHLSNDHICYFLYQILRGLKY 144
Query: 130 CHNKGVFHRDLKLENILLDSKGNIKISDFGLS--ALPQHFRDDGLLHTTCGSPNYVAPEV 187
            H+  V HRDLK  N+LL++  ++KI DFGL+  A P H    G L     +  Y APE+
Sbjct: 145 IHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDH-DHTGFLTEYVATRWYRAPEI 203
Query: 188 LAN-RGYDGATSDIWSCGVILY-------IFRGDFKLPK--------------------- 218
           + N +GY  +  DIWS G IL        IF G   L +                     
Sbjct: 204 MLNSKGYTKSI-DIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIIN 262
Query: 219 -----------------W--LSPGAQ----NLLRKILEPNPVKRITIAGIKADEWFEQDY 255
                            W  L P A     +LL K+L  NP KRI +    A  + EQ Y
Sbjct: 263 LKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYY 322
Query: 256 TPAN 259
            P++
Sbjct: 323 DPSD 326

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 83/304 (27%), Positives = 129/304 (42%), Gaps = 65/304 (21%)
Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
           RY     +GEG +G V  A D  + +  A+K +      H     +  REI  L   +H 
Sbjct: 30  RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFE--HQTYCQRTLREIKILLRFRHE 87
Query: 75  NVVRLHEVLASKS-----KIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSY 129
           N++ +++++ + +      +Y+V + +   +L+ K+     L          Q++ G+ Y
Sbjct: 88  NIIGINDIIRAPTIEQMKDVYIVQD-LMETDLY-KLLKTQHLSNDHICYFLYQILRGLKY 145
Query: 130 CHNKGVFHRDLKLENILLDSKGNIKISDFGLS--ALPQHFRDDGLLHTTCGSPNYVAPEV 187
            H+  V HRDLK  N+LL++  ++KI DFGL+  A P H    G L     +  Y APE+
Sbjct: 146 IHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDH-DHTGFLTEYVATRWYRAPEI 204
Query: 188 LAN-RGYDGATSDIWSCGVILY-------IFRGDFKLPK--------------------- 218
           + N +GY  +  DIWS G IL        IF G   L +                     
Sbjct: 205 MLNSKGYTKSI-DIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIIN 263
Query: 219 -----------------W--LSPGAQ----NLLRKILEPNPVKRITIAGIKADEWFEQDY 255
                            W  L P A     +LL K+L  NP KRI +    A  + EQ Y
Sbjct: 264 LKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYY 323
Query: 256 TPAN 259
            P++
Sbjct: 324 DPSD 327

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 83/304 (27%), Positives = 129/304 (42%), Gaps = 65/304 (21%)
Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
           RY     +GEG +G V  A D  + +  A+K +      H     +  REI  L   +H 
Sbjct: 21  RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFE--HQTYCQRTLREIKILLRFRHE 78
Query: 75  NVVRLHEVLASKS-----KIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSY 129
           N++ +++++ + +      +Y+V + +   +L+ K+     L          Q++ G+ Y
Sbjct: 79  NIIGINDIIRAPTIEQMKDVYIVQD-LMETDLY-KLLKTQHLSNDHICYFLYQILRGLKY 136
Query: 130 CHNKGVFHRDLKLENILLDSKGNIKISDFGLS--ALPQHFRDDGLLHTTCGSPNYVAPEV 187
            H+  V HRDLK  N+LL++  ++KI DFGL+  A P H    G L     +  Y APE+
Sbjct: 137 IHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDH-DHTGFLTEYVATRWYRAPEI 195
Query: 188 LAN-RGYDGATSDIWSCGVILY-------IFRGDFKLPK--------------------- 218
           + N +GY  +  DIWS G IL        IF G   L +                     
Sbjct: 196 MLNSKGYTKSI-DIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIIN 254
Query: 219 -----------------W--LSPGAQ----NLLRKILEPNPVKRITIAGIKADEWFEQDY 255
                            W  L P A     +LL K+L  NP KRI +    A  + EQ Y
Sbjct: 255 LKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYY 314
Query: 256 TPAN 259
            P++
Sbjct: 315 DPSD 318

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 83/304 (27%), Positives = 129/304 (42%), Gaps = 65/304 (21%)
Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
           RY     +GEG +G V  A D  + +  A+K +      H     +  REI  L   +H 
Sbjct: 28  RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFE--HQTYCQRTLREIKILLRFRHE 85
Query: 75  NVVRLHEVLASKS-----KIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSY 129
           N++ +++++ + +      +Y+V + +   +L+ K+     L          Q++ G+ Y
Sbjct: 86  NIIGINDIIRAPTIEQMKDVYIVQD-LMETDLY-KLLKTQHLSNDHICYFLYQILRGLKY 143
Query: 130 CHNKGVFHRDLKLENILLDSKGNIKISDFGLS--ALPQHFRDDGLLHTTCGSPNYVAPEV 187
            H+  V HRDLK  N+LL++  ++KI DFGL+  A P H    G L     +  Y APE+
Sbjct: 144 IHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDH-DHTGFLTEYVATRWYRAPEI 202
Query: 188 LAN-RGYDGATSDIWSCGVILY-------IFRGDFKLPK--------------------- 218
           + N +GY  +  DIWS G IL        IF G   L +                     
Sbjct: 203 MLNSKGYTKSI-DIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIIN 261
Query: 219 -----------------W--LSPGAQ----NLLRKILEPNPVKRITIAGIKADEWFEQDY 255
                            W  L P A     +LL K+L  NP KRI +    A  + EQ Y
Sbjct: 262 LKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYY 321
Query: 256 TPAN 259
            P++
Sbjct: 322 DPSD 325

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 68/202 (33%), Positives = 103/202 (50%), Gaps = 23/202 (11%)
Query: 20  RTLGEGNFGKVKF----AQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
           R LGEG+FGKV        +  +G   AVK L+ +     +     K+EI  L+ L H +
Sbjct: 37  RDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHR--SGWKQEIDILRTLYHEH 94
Query: 76  VVRLHEVL--ASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNK 133
           +++       A  + + +V+EYV  G L D +  +  +  A+     QQ+ +G++Y H +
Sbjct: 95  IIKYKGCCEDAGAASLQLVMEYVPLGSLRDYL-PRHSIGLAQLLLFAQQICEGMAYLHAQ 153
Query: 134 GVFHRDLKLENILLDSKGNIKISDFGLS-ALPQ-----HFRDDGLLHTTCGSPN-YVAPE 186
              HRDL   N+LLD+   +KI DFGL+ A+P+       R+DG       SP  + APE
Sbjct: 154 HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEXYRVREDG------DSPVFWYAPE 207
Query: 187 VLANRGYDGATSDIWSCGVILY 208
            L    +  A SD+WS GV LY
Sbjct: 208 CLKEYKFYYA-SDVWSFGVTLY 228

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 83/304 (27%), Positives = 129/304 (42%), Gaps = 65/304 (21%)
Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
           RY     +GEG +G V  A D  + +  A+K +      H     +  REI  L   +H 
Sbjct: 24  RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE--HQTYCQRTLREIKILLRFRHE 81
Query: 75  NVVRLHEVLASKS-----KIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSY 129
           N++ +++++ + +      +Y+V + +   +L+ K+     L          Q++ G+ Y
Sbjct: 82  NIIGINDIIRAPTIEQMKDVYIVQD-LMETDLY-KLLKTQHLSNDHICYFLYQILRGLKY 139
Query: 130 CHNKGVFHRDLKLENILLDSKGNIKISDFGLS--ALPQHFRDDGLLHTTCGSPNYVAPEV 187
            H+  V HRDLK  N+LL++  ++KI DFGL+  A P H    G L     +  Y APE+
Sbjct: 140 IHSANVLHRDLKPSNLLLNTTXDLKIXDFGLARVADPDH-DHTGFLTEYVATRWYRAPEI 198
Query: 188 LAN-RGYDGATSDIWSCGVILY-------IFRGDFKLPK--------------------- 218
           + N +GY  +  DIWS G IL        IF G   L +                     
Sbjct: 199 MLNSKGYTKSI-DIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNXIIN 257
Query: 219 -----------------W--LSPGAQ----NLLRKILEPNPVKRITIAGIKADEWFEQDY 255
                            W  L P A     +LL K+L  NP KRI +    A  + EQ Y
Sbjct: 258 LKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYY 317
Query: 256 TPAN 259
            P++
Sbjct: 318 DPSD 321

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 83/304 (27%), Positives = 129/304 (42%), Gaps = 65/304 (21%)
Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
           RY     +GEG +G V  A D  + +  A+K +      H     +  REI  L   +H 
Sbjct: 22  RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFE--HQTYCQRTLREIKILLRFRHE 79
Query: 75  NVVRLHEVLASKS-----KIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSY 129
           N++ +++++ + +      +Y+V + +   +L+ K+     L          Q++ G+ Y
Sbjct: 80  NIIGINDIIRAPTIEQMKDVYIVQD-LMETDLY-KLLKTQHLSNDHICYFLYQILRGLKY 137
Query: 130 CHNKGVFHRDLKLENILLDSKGNIKISDFGLS--ALPQHFRDDGLLHTTCGSPNYVAPEV 187
            H+  V HRDLK  N+LL++  ++KI DFGL+  A P H    G L     +  Y APE+
Sbjct: 138 IHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDH-DHTGFLTEYVATRWYRAPEI 196
Query: 188 LAN-RGYDGATSDIWSCGVILY-------IFRGDFKLPK--------------------- 218
           + N +GY  +  DIWS G IL        IF G   L +                     
Sbjct: 197 MLNSKGYTKSI-DIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIIN 255
Query: 219 -----------------W--LSPGAQ----NLLRKILEPNPVKRITIAGIKADEWFEQDY 255
                            W  L P A     +LL K+L  NP KRI +    A  + EQ Y
Sbjct: 256 LKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYY 315
Query: 256 TPAN 259
            P++
Sbjct: 316 DPSD 319

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 97/205 (47%), Gaps = 19/205 (9%)
Query: 15  RYELGRT-------LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIAT 67
           ++E+ RT       LG G +G+V         L  AVK L+++ +      ++  +E A 
Sbjct: 253 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME----VEEFLKEAAV 308
Query: 68  LKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLF---QQLI 124
           +K +KHPN+V+L  V   +   Y++ E++T G L D +    R QE     L     Q+ 
Sbjct: 309 MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNR-QEVNAVVLLYMATQIS 367
Query: 125 DGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP-NYV 183
             + Y   K   HR+L   N L+     +K++DFGLS L     D    H     P  + 
Sbjct: 368 SAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMT--GDTYTAHAGAKFPIKWT 425
Query: 184 APEVLANRGYDGATSDIWSCGVILY 208
           APE LA   +    SD+W+ GV+L+
Sbjct: 426 APESLAYNKFS-IKSDVWAFGVLLW 449

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 83/304 (27%), Positives = 129/304 (42%), Gaps = 65/304 (21%)
Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
           RY     +GEG +G V  A D  + +  A+K +      H     +  REI  L   +H 
Sbjct: 22  RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFE--HQTYCQRTLREIKILLRFRHE 79
Query: 75  NVVRLHEVLASKS-----KIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSY 129
           N++ +++++ + +      +Y+V + +   +L+ K+     L          Q++ G+ Y
Sbjct: 80  NIIGINDIIRAPTIEQMKDVYIVQD-LMETDLY-KLLKTQHLSNDHICYFLYQILRGLKY 137
Query: 130 CHNKGVFHRDLKLENILLDSKGNIKISDFGLS--ALPQHFRDDGLLHTTCGSPNYVAPEV 187
            H+  V HRDLK  N+LL++  ++KI DFGL+  A P H    G L     +  Y APE+
Sbjct: 138 IHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDH-DHTGFLTEYVATRWYRAPEI 196
Query: 188 LAN-RGYDGATSDIWSCGVILY-------IFRGDFKLPK--------------------- 218
           + N +GY  +  DIWS G IL        IF G   L +                     
Sbjct: 197 MLNSKGYTKSI-DIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPEQEDLNCIIN 255
Query: 219 -----------------W--LSPGAQ----NLLRKILEPNPVKRITIAGIKADEWFEQDY 255
                            W  L P A     +LL K+L  NP KRI +    A  + EQ Y
Sbjct: 256 LKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYY 315
Query: 256 TPAN 259
            P++
Sbjct: 316 DPSD 319

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 61/201 (30%), Positives = 100/201 (49%), Gaps = 14/201 (6%)
Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
           RY     +GEG +G V  A D  + +  A+K +      H     +  REI  L   +H 
Sbjct: 26  RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE--HQTYCQRTLREIKILLAFRHE 83
Query: 75  NVVRLHEVLASKS-----KIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSY 129
           N++ +++++ + +      +Y+V + +   +L+ K+     L          Q++ G+ Y
Sbjct: 84  NIIGINDIIRAPTIEQMKDVYIVQD-LMETDLY-KLLKTQHLSNDHICYFLYQILRGLKY 141
Query: 130 CHNKGVFHRDLKLENILLDSKGNIKISDFGLS--ALPQHFRDDGLLHTTCGSPNYVAPEV 187
            H+  V HRDLK  N+LL++  ++KI DFGL+  A P H    G L     +  Y APE+
Sbjct: 142 IHSANVLHRDLKPSNLLLNTTSDLKICDFGLARVADPDH-DHTGFLTEYVATRWYRAPEI 200
Query: 188 LAN-RGYDGATSDIWSCGVIL 207
           + N +GY  +  DIWS G IL
Sbjct: 201 MLNSKGYTKSI-DIWSVGCIL 220

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 83/304 (27%), Positives = 129/304 (42%), Gaps = 65/304 (21%)
Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
           RY     +GEG +G V  A D  + +  A+K +      H     +  REI  L   +H 
Sbjct: 28  RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFE--HQTYXQRTLREIKILLRFRHE 85
Query: 75  NVVRLHEVLASKS-----KIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSY 129
           N++ +++++ + +      +Y+V + +   +L+ K+     L          Q++ G+ Y
Sbjct: 86  NIIGINDIIRAPTIEQMKDVYIVQD-LMETDLY-KLLKTQHLSNDHICYFLYQILRGLKY 143
Query: 130 CHNKGVFHRDLKLENILLDSKGNIKISDFGLS--ALPQHFRDDGLLHTTCGSPNYVAPEV 187
            H+  V HRDLK  N+LL++  ++KI DFGL+  A P H    G L     +  Y APE+
Sbjct: 144 IHSANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDH-DHTGFLTEYVATRWYRAPEI 202
Query: 188 LAN-RGYDGATSDIWSCGVILY-------IFRGDFKLPK--------------------- 218
           + N +GY  +  DIWS G IL        IF G   L +                     
Sbjct: 203 MLNSKGYTKSI-DIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIIN 261
Query: 219 -----------------W--LSPGAQ----NLLRKILEPNPVKRITIAGIKADEWFEQDY 255
                            W  L P A     +LL K+L  NP KRI +    A  + EQ Y
Sbjct: 262 LKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYY 321
Query: 256 TPAN 259
            P++
Sbjct: 322 DPSD 325

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 64/220 (29%), Positives = 103/220 (46%), Gaps = 28/220 (12%)
Query: 15  RYELGRTLGEGNFGKVKFAQDLDSG---LPFAVKILEKNRIIHLKITDQIKR----EIAT 67
           R  + + +G G+ G+V + +    G   +P A+K L+         T++ +R    E + 
Sbjct: 50  RIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAG------YTERQRRDFLSEASI 103
Query: 68  LKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLID-- 125
           +    HPN++RL  V+       +V EY+  G L D       L+  +G+    QL+   
Sbjct: 104 MGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSL-DTF-----LRTHDGQFTIMQLVGML 157
Query: 126 -----GVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP 180
                G+ Y  + G  HRDL   N+L+DS    K+SDFGLS + +   D     T    P
Sbjct: 158 RGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAXTTTGGKIP 217
Query: 181 -NYVAPEVLANRGYDGATSDIWSCGVILYIFRGDFKLPKW 219
             + APE +A R +  A SD+WS GV+++      + P W
Sbjct: 218 IRWTAPEAIAFRTFSSA-SDVWSFGVVMWEVLAYGERPYW 256

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 71/270 (26%), Positives = 115/270 (42%), Gaps = 53/270 (19%)
Query: 15  RYELGRT-------LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIAT 67
           ++E+ RT       LG G +G+V         L  AVK L+++ +      ++  +E A 
Sbjct: 8   KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME----VEEFLKEAAV 63
Query: 68  LKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLF---QQLI 124
           +K +KHPN+V+L  V   +   Y++ E++T G L D +    R QE     L     Q+ 
Sbjct: 64  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNR-QEVNAVVLLYMATQIS 122
Query: 125 DGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP---- 180
             + Y   K   HRDL   N L+     +K++DFGLS L        +   T  +P    
Sbjct: 123 SAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRL--------MTGDTYTAPAGAK 174
Query: 181 ---NYVAPEVLANRGYDGATSDIWSCGVILY--------------------IFRGDFKL- 216
               + APE LA   +    SD+W+ GV+L+                    +   D+++ 
Sbjct: 175 FPIKWTAPESLAYNKF-SIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRME 233
Query: 217 -PKWLSPGAQNLLRKILEPNPVKRITIAGI 245
            P+        L+R   + NP  R + A I
Sbjct: 234 RPEGCPEKVYELMRACWQWNPSDRPSFAEI 263

>pdb|2EHB|D Chain D, The Structure Of The C-Terminal Domain Of The Protein Kinase Atsos2 Bound To The Calcium Sensor Atsos3 Length = 143

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 44/137 (32%), Positives = 79/137 (57%), Gaps = 12/137 (8%)
Query: 290 PPLINAFQLIGMSSCLDLSGFFEK-EDVSERKIRFTSNHSAKDLLERIEDIVTEMGFRVQ 348
           P ++NAF++I +S  L+LS  F++ +D  +R+ RF S     +++  IE +   MGF+  
Sbjct: 4   PLMMNAFEMITLSQGLNLSALFDRRQDFVKRQTRFVSRREPSEIIANIEAVANSMGFKSH 63
Query: 349 KKNGKLKATQEHKPQKSLGSLSVAAEVFEISPSLYVVELRKSYGDP----TVYRQLCNKL 404
            +N   K   E       G L+V  E++E++PSL++V++RK+ G+       Y++LC+KL
Sbjct: 64  TRN--FKTRLEGLSSIKAGQLAVVIEIYEVAPSLFMVDVRKAAGETLEYHKFYKKLCSKL 121
Query: 405 SSDL-----GLPPSQEL 416
            + +     G+P S+ L
Sbjct: 122 ENIIWRATEGIPKSEIL 138

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 71/270 (26%), Positives = 115/270 (42%), Gaps = 53/270 (19%)
Query: 15  RYELGRT-------LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIAT 67
           ++E+ RT       LG G +G+V         L  AVK L+++ +      ++  +E A 
Sbjct: 9   KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME----VEEFLKEAAV 64
Query: 68  LKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLF---QQLI 124
           +K +KHPN+V+L  V   +   Y++ E++T G L D +    R QE     L     Q+ 
Sbjct: 65  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNR-QEVNAVVLLYMATQIS 123
Query: 125 DGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP---- 180
             + Y   K   HRDL   N L+     +K++DFGLS L        +   T  +P    
Sbjct: 124 SAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRL--------MTGDTYTAPAGAK 175
Query: 181 ---NYVAPEVLANRGYDGATSDIWSCGVILY--------------------IFRGDFKL- 216
               + APE LA   +    SD+W+ GV+L+                    +   D+++ 
Sbjct: 176 FPIKWTAPESLAYNKF-SIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRME 234
Query: 217 -PKWLSPGAQNLLRKILEPNPVKRITIAGI 245
            P+        L+R   + NP  R + A I
Sbjct: 235 RPEGCPEKVYELMRACWQWNPSDRPSFAEI 264

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 61/201 (30%), Positives = 100/201 (49%), Gaps = 14/201 (6%)
Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
           RY     +GEG +G V  A D  + +  A+K +      H     +  REI  L   +H 
Sbjct: 26  RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE--HQTYCQRTLREIKILLAFRHE 83
Query: 75  NVVRLHEVLASKS-----KIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSY 129
           N++ +++++ + +      +Y+V + +   +L+ K+     L          Q++ G+ Y
Sbjct: 84  NIIGINDIIRAPTIEQMKDVYIVQD-LMETDLY-KLLKTQHLSNDHICYFLYQILRGLKY 141
Query: 130 CHNKGVFHRDLKLENILLDSKGNIKISDFGLS--ALPQHFRDDGLLHTTCGSPNYVAPEV 187
            H+  V HRDLK  N+LL++  ++KI DFGL+  A P H    G L     +  Y APE+
Sbjct: 142 IHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDH-DHTGFLTEYVATRWYRAPEI 200
Query: 188 LAN-RGYDGATSDIWSCGVIL 207
           + N +GY  +  DIWS G IL
Sbjct: 201 MLNSKGYTKSI-DIWSVGCIL 220

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 63/229 (27%), Positives = 107/229 (46%), Gaps = 26/229 (11%)
Query: 22  LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKR--EIATLKLLKHPNVVRL 79
           LG G+FG+V   +D  +G   AVK          K+  ++ R  E+     L  P +V L
Sbjct: 101 LGRGSFGEVHRMEDKQTGFQCAVK----------KVRLEVFRAEELMACAGLTSPRIVPL 150
Query: 80  HEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRD 139
           +  +     + + +E + GG L   +  +G L E        Q ++G+ Y H++ + H D
Sbjct: 151 YGAVREGPWVNIFMELLEGGSLGQLVKEQGCLPEDRALYYLGQALEGLEYLHSRRILHGD 210
Query: 140 LKLENILLDSKG-NIKISDFGLSALPQHFRDDGLLHTTC------GSPNYVAPEVLANRG 192
           +K +N+LL S G +  + DFG +      + DGL  +        G+  ++APEV+  R 
Sbjct: 211 VKADNVLLSSDGSHAALCDFGHAVC---LQPDGLGKSLLTGDYIPGTETHMAPEVVLGRS 267
Query: 193 YDGATSDIW-SCGVILYIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRI 240
            D A  D+W SC ++L++  G     ++        L+   EP PV+ I
Sbjct: 268 CD-AKVDVWSSCCMMLHMLNGCHPWTQFFR--GPLCLKIASEPPPVREI 313

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 65/218 (29%), Positives = 102/218 (46%), Gaps = 24/218 (11%)
Query: 17  ELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNV 76
           +L + LG G FG+V      ++    AVK L+   +           E   +K L+H  +
Sbjct: 16  KLVKRLGAGQFGEVWMGY-YNNSTKVAVKTLKPGTMS----VQAFLEEANLMKTLQHDKL 70
Query: 77  VRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLID-------GVSY 129
           VRL+ V+  +  IY++ EY+  G L D + S     +  G+ L  +LID       G++Y
Sbjct: 71  VRLYAVVTREEPIYIITEYMAKGSLLDFLKS-----DEGGKVLLPKLIDFSAQIAEGMAY 125
Query: 130 CHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP-NYVAPEVL 188
              K   HRDL+  N+L+      KI+DFGL+ + +   ++         P  + APE +
Sbjct: 126 IERKNYIHRDLRAANVLVSESLMCKIADFGLARVIED--NEYTAREGAKFPIKWTAPEAI 183
Query: 189 ANRGYDGATSDIWSCGVILYIFRGDFKLPKWLSPGAQN 226
            N G     SD+WS G++LY      K+P    PG  N
Sbjct: 184 -NFGCFTIKSDVWSFGILLYEIVTYGKIP---YPGRTN 217

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 82/304 (26%), Positives = 129/304 (42%), Gaps = 65/304 (21%)
Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
           RY     +GEG +G V  A D  + +  A++ +      H     +  REI  L   +H 
Sbjct: 28  RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIRKISPFE--HQTYCQRTLREIKILLRFRHE 85
Query: 75  NVVRLHEVLASKS-----KIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSY 129
           N++ +++++ + +      +Y+V + +   +L+ K+     L          Q++ G+ Y
Sbjct: 86  NIIGINDIIRAPTIEQMKDVYIVQD-LMETDLY-KLLKTQHLSNDHICYFLYQILRGLKY 143
Query: 130 CHNKGVFHRDLKLENILLDSKGNIKISDFGLS--ALPQHFRDDGLLHTTCGSPNYVAPEV 187
            H+  V HRDLK  N+LL++  ++KI DFGL+  A P H    G L     +  Y APE+
Sbjct: 144 IHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDH-DHTGFLTEYVATRWYRAPEI 202
Query: 188 LAN-RGYDGATSDIWSCGVILY-------IFRGDFKLPK--------------------- 218
           + N +GY  +  DIWS G IL        IF G   L +                     
Sbjct: 203 MLNSKGYTKSI-DIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIIN 261
Query: 219 -----------------W--LSPGAQ----NLLRKILEPNPVKRITIAGIKADEWFEQDY 255
                            W  L P A     +LL K+L  NP KRI +    A  + EQ Y
Sbjct: 262 LKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYY 321
Query: 256 TPAN 259
            P++
Sbjct: 322 DPSD 325

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 83/304 (27%), Positives = 129/304 (42%), Gaps = 65/304 (21%)
Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
           RY     +GEG +G V  A D  + +  A+K +      H     +  REI  L   +H 
Sbjct: 28  RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFE--HQTYCQRTLREIKILLRFRHE 85
Query: 75  NVVRLHEVLASKS-----KIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSY 129
           N++ +++++ + +      +Y+V + +   +L+ K+     L          Q++ G+ Y
Sbjct: 86  NIIGINDIIRAPTIEQMKDVYIVQD-LMETDLY-KLLKCQHLSNDHICYFLYQILRGLKY 143
Query: 130 CHNKGVFHRDLKLENILLDSKGNIKISDFGLS--ALPQHFRDDGLLHTTCGSPNYVAPEV 187
            H+  V HRDLK  N+LL++  ++KI DFGL+  A P H    G L     +  Y APE+
Sbjct: 144 IHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDH-DHTGFLTEYVATRWYRAPEI 202
Query: 188 LAN-RGYDGATSDIWSCGVILY-------IFRGDFKLPK--------------------- 218
           + N +GY  +  DIWS G IL        IF G   L +                     
Sbjct: 203 MLNSKGYTKSI-DIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIIN 261
Query: 219 -----------------W--LSPGAQ----NLLRKILEPNPVKRITIAGIKADEWFEQDY 255
                            W  L P A     +LL K+L  NP KRI +    A  + EQ Y
Sbjct: 262 LKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYY 321
Query: 256 TPAN 259
            P++
Sbjct: 322 DPSD 325

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 56/198 (28%), Positives = 98/198 (49%), Gaps = 9/198 (4%)
Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLP-FAVKILEKNRIIHLKITDQIKREIATLKLLKH 73
           R ELGR +GEG FG V     +    P  AV I          + ++  +E  T++   H
Sbjct: 39  RIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDH 98
Query: 74  PNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQ-QLIDGVSYCHN 132
           P++V+L  V+ +++ +++++E  T GEL   +  +    +     L+  QL   ++Y  +
Sbjct: 99  PHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLES 157
Query: 133 KGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGS--PNYVAPEVLAN 190
           K   HRD+   N+L+ S   +K+ DFGLS   ++  D      + G     ++APE +  
Sbjct: 158 KRFVHRDIAARNVLVSSNDCVKLGDFGLS---RYMEDSTYYKASKGKLPIKWMAPESINF 214
Query: 191 RGYDGATSDIWSCGVILY 208
           R +  A SD+W  GV ++
Sbjct: 215 RRFTSA-SDVWMFGVCMW 231

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 58/192 (30%), Positives = 90/192 (46%), Gaps = 6/192 (3%)
Query: 19  GRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVR 78
           G  +GEG FG V +   +++      K+     I   ++  Q  +EI  +   +H N+V 
Sbjct: 36  GNKMGEGGFGVV-YKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVE 94
Query: 79  LHEVLASKSKIYMVLEYVTGGELFDKIAS---KGRLQEAEGRKLFQQLIDGVSYCHNKGV 135
           L    +    + +V  Y+  G L D+++       L      K+ Q   +G+++ H    
Sbjct: 95  LLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHH 154
Query: 136 FHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDG 195
            HRD+K  NILLD     KISDFGL+   + F    +     G+  Y+APE L  RG   
Sbjct: 155 IHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMXXRIVGTTAYMAPEAL--RGEIT 212
Query: 196 ATSDIWSCGVIL 207
             SDI+S GV+L
Sbjct: 213 PKSDIYSFGVVL 224

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 58/192 (30%), Positives = 90/192 (46%), Gaps = 6/192 (3%)
Query: 19  GRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVR 78
           G  +GEG FG V +   +++      K+     I   ++  Q  +EI  +   +H N+V 
Sbjct: 36  GNKMGEGGFGVV-YKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVE 94
Query: 79  LHEVLASKSKIYMVLEYVTGGELFDKIAS---KGRLQEAEGRKLFQQLIDGVSYCHNKGV 135
           L    +    + +V  Y+  G L D+++       L      K+ Q   +G+++ H    
Sbjct: 95  LLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHH 154
Query: 136 FHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDG 195
            HRD+K  NILLD     KISDFGL+   + F    +     G+  Y+APE L  RG   
Sbjct: 155 IHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMXSRIVGTTAYMAPEAL--RGEIT 212
Query: 196 ATSDIWSCGVIL 207
             SDI+S GV+L
Sbjct: 213 PKSDIYSFGVVL 224

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 56/198 (28%), Positives = 98/198 (49%), Gaps = 9/198 (4%)
Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLP-FAVKILEKNRIIHLKITDQIKREIATLKLLKH 73
           R ELGR +GEG FG V     +    P  AV I          + ++  +E  T++   H
Sbjct: 13  RIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDH 72
Query: 74  PNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQ-QLIDGVSYCHN 132
           P++V+L  V+ +++ +++++E  T GEL   +  +    +     L+  QL   ++Y  +
Sbjct: 73  PHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLES 131
Query: 133 KGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGS--PNYVAPEVLAN 190
           K   HRD+   N+L+ S   +K+ DFGLS   ++  D      + G     ++APE +  
Sbjct: 132 KRFVHRDIAARNVLVSSNDCVKLGDFGLS---RYMEDSTYYKASKGKLPIKWMAPESINF 188
Query: 191 RGYDGATSDIWSCGVILY 208
           R +  A SD+W  GV ++
Sbjct: 189 RRFTSA-SDVWMFGVCMW 205

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 56/198 (28%), Positives = 98/198 (49%), Gaps = 9/198 (4%)
Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLP-FAVKILEKNRIIHLKITDQIKREIATLKLLKH 73
           R ELGR +GEG FG V     +    P  AV I          + ++  +E  T++   H
Sbjct: 8   RIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDH 67
Query: 74  PNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQ-QLIDGVSYCHN 132
           P++V+L  V+ +++ +++++E  T GEL   +  +    +     L+  QL   ++Y  +
Sbjct: 68  PHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLES 126
Query: 133 KGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGS--PNYVAPEVLAN 190
           K   HRD+   N+L+ S   +K+ DFGLS   ++  D      + G     ++APE +  
Sbjct: 127 KRFVHRDIAARNVLVSSNDCVKLGDFGLS---RYMEDSTYYKASKGKLPIKWMAPESINF 183
Query: 191 RGYDGATSDIWSCGVILY 208
           R +  A SD+W  GV ++
Sbjct: 184 RRFTSA-SDVWMFGVCMW 200

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 56/198 (28%), Positives = 98/198 (49%), Gaps = 9/198 (4%)
Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLP-FAVKILEKNRIIHLKITDQIKREIATLKLLKH 73
           R ELGR +GEG FG V     +    P  AV I          + ++  +E  T++   H
Sbjct: 11  RIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDH 70
Query: 74  PNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQ-QLIDGVSYCHN 132
           P++V+L  V+ +++ +++++E  T GEL   +  +    +     L+  QL   ++Y  +
Sbjct: 71  PHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLES 129
Query: 133 KGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGS--PNYVAPEVLAN 190
           K   HRD+   N+L+ S   +K+ DFGLS   ++  D      + G     ++APE +  
Sbjct: 130 KRFVHRDIAARNVLVSSNDCVKLGDFGLS---RYMEDSTYYKASKGKLPIKWMAPESINF 186
Query: 191 RGYDGATSDIWSCGVILY 208
           R +  A SD+W  GV ++
Sbjct: 187 RRFTSA-SDVWMFGVCMW 203

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 67/220 (30%), Positives = 105/220 (47%), Gaps = 31/220 (14%)
Query: 15  RYELGRTLGEGNFGKVKFAQ--DLDSGLP-----FAVKILEKNRIIHLKITDQIKREIAT 67
           R  LG+ LGEG FG+V  A+   LD   P      AVK+L K+      ++D I  E+  
Sbjct: 29  RLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKML-KSDATEKDLSDLIS-EMEM 86
Query: 68  LKLL-KHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKG----------------R 110
           +K++ KH N++ L         +Y+++EY + G L + + ++                 +
Sbjct: 87  MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEFSFNPSHNPEEQ 146
Query: 111 LQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD 170
           L   +      Q+  G+ Y  +K   HRDL   N+L+     +KI+DFGL+    H   D
Sbjct: 147 LSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHI--D 204
Query: 171 GLLHTTCG--SPNYVAPEVLANRGYDGATSDIWSCGVILY 208
               TT G     ++APE L +R Y    SD+WS GV+L+
Sbjct: 205 XXKKTTNGRLPVKWMAPEALFDRIY-THQSDVWSFGVLLW 243

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 56/198 (28%), Positives = 98/198 (49%), Gaps = 9/198 (4%)
Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLP-FAVKILEKNRIIHLKITDQIKREIATLKLLKH 73
           R ELGR +GEG FG V     +    P  AV I          + ++  +E  T++   H
Sbjct: 14  RIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDH 73
Query: 74  PNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQ-QLIDGVSYCHN 132
           P++V+L  V+ +++ +++++E  T GEL   +  +    +     L+  QL   ++Y  +
Sbjct: 74  PHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLES 132
Query: 133 KGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGS--PNYVAPEVLAN 190
           K   HRD+   N+L+ S   +K+ DFGLS   ++  D      + G     ++APE +  
Sbjct: 133 KRFVHRDIAARNVLVSSNDCVKLGDFGLS---RYMEDSTYYKASKGKLPIKWMAPESINF 189
Query: 191 RGYDGATSDIWSCGVILY 208
           R +  A SD+W  GV ++
Sbjct: 190 RRFTSA-SDVWMFGVCMW 206

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 58/192 (30%), Positives = 90/192 (46%), Gaps = 6/192 (3%)
Query: 19  GRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVR 78
           G  +GEG FG V +   +++      K+     I   ++  Q  +EI  +   +H N+V 
Sbjct: 30  GNKMGEGGFGVV-YKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVE 88
Query: 79  LHEVLASKSKIYMVLEYVTGGELFDKIAS---KGRLQEAEGRKLFQQLIDGVSYCHNKGV 135
           L    +    + +V  Y+  G L D+++       L      K+ Q   +G+++ H    
Sbjct: 89  LLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHH 148
Query: 136 FHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDG 195
            HRD+K  NILLD     KISDFGL+   + F    +     G+  Y+APE L  RG   
Sbjct: 149 IHRDIKSANILLDEAFTAKISDFGLARASEKFAQXVMXXRIVGTTAYMAPEAL--RGEIT 206
Query: 196 ATSDIWSCGVIL 207
             SDI+S GV+L
Sbjct: 207 PKSDIYSFGVVL 218

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 56/198 (28%), Positives = 98/198 (49%), Gaps = 9/198 (4%)
Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLP-FAVKILEKNRIIHLKITDQIKREIATLKLLKH 73
           R ELGR +GEG FG V     +    P  AV I          + ++  +E  T++   H
Sbjct: 16  RIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDH 75
Query: 74  PNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQ-QLIDGVSYCHN 132
           P++V+L  V+ +++ +++++E  T GEL   +  +    +     L+  QL   ++Y  +
Sbjct: 76  PHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLES 134
Query: 133 KGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGS--PNYVAPEVLAN 190
           K   HRD+   N+L+ S   +K+ DFGLS   ++  D      + G     ++APE +  
Sbjct: 135 KRFVHRDIAARNVLVSSNDCVKLGDFGLS---RYMEDSTYYKASKGKLPIKWMAPESINF 191
Query: 191 RGYDGATSDIWSCGVILY 208
           R +  A SD+W  GV ++
Sbjct: 192 RRFTSA-SDVWMFGVCMW 208

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 70/221 (31%), Positives = 99/221 (44%), Gaps = 22/221 (9%)
Query: 14  GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKH 73
           G +E+   LG G FG V      D+G   A+K   +   +  K  ++   EI  +K L H
Sbjct: 15  GPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQE--LSPKNRERWCLEIQIMKKLNH 72
Query: 74  PNVVRLHEV------LASKSKIYMVLEYVTGGEL---FDKIASKGRLQEAEGRKLFQQLI 124
           PNVV   EV      LA      + +EY  GG+L    ++  +   L+E   R L   + 
Sbjct: 73  PNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDIS 132
Query: 125 DGVSYCHNKGVFHRDLKLENILLD---SKGNIKISDFGLSALPQHFRDDGLLHTT-CGSP 180
             + Y H   + HRDLK ENI+L     +   KI D G +       D G L T   G+ 
Sbjct: 133 SALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAK----ELDQGELCTEFVGTL 188
Query: 181 NYVAPEVLANRGYDGATSDIWSCGVILYIFRGDFK--LPKW 219
            Y+APE+L  + Y   T D WS G + +     F+  LP W
Sbjct: 189 QYLAPELLEQKKYT-VTVDYWSFGTLAFECITGFRPFLPNW 228

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 56/198 (28%), Positives = 98/198 (49%), Gaps = 9/198 (4%)
Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLP-FAVKILEKNRIIHLKITDQIKREIATLKLLKH 73
           R ELGR +GEG FG V     +    P  AV I          + ++  +E  T++   H
Sbjct: 11  RIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDH 70
Query: 74  PNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQ-QLIDGVSYCHN 132
           P++V+L  V+ +++ +++++E  T GEL   +  +    +     L+  QL   ++Y  +
Sbjct: 71  PHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLES 129
Query: 133 KGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGS--PNYVAPEVLAN 190
           K   HRD+   N+L+ S   +K+ DFGLS   ++  D      + G     ++APE +  
Sbjct: 130 KRFVHRDIAARNVLVSSNDCVKLGDFGLS---RYMEDSTYYKASKGKLPIKWMAPESINF 186
Query: 191 RGYDGATSDIWSCGVILY 208
           R +  A SD+W  GV ++
Sbjct: 187 RRFTSA-SDVWMFGVCMW 203

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 70/221 (31%), Positives = 99/221 (44%), Gaps = 22/221 (9%)
Query: 14  GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKH 73
           G +E+   LG G FG V      D+G   A+K   +   +  K  ++   EI  +K L H
Sbjct: 14  GPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQE--LSPKNRERWCLEIQIMKKLNH 71
Query: 74  PNVVRLHEV------LASKSKIYMVLEYVTGGEL---FDKIASKGRLQEAEGRKLFQQLI 124
           PNVV   EV      LA      + +EY  GG+L    ++  +   L+E   R L   + 
Sbjct: 72  PNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDIS 131
Query: 125 DGVSYCHNKGVFHRDLKLENILLD---SKGNIKISDFGLSALPQHFRDDGLLHTT-CGSP 180
             + Y H   + HRDLK ENI+L     +   KI D G +       D G L T   G+ 
Sbjct: 132 SALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAK----ELDQGELCTEFVGTL 187
Query: 181 NYVAPEVLANRGYDGATSDIWSCGVILYIFRGDFK--LPKW 219
            Y+APE+L  + Y   T D WS G + +     F+  LP W
Sbjct: 188 QYLAPELLEQKKYT-VTVDYWSFGTLAFECITGFRPFLPNW 227

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 66/222 (29%), Positives = 102/222 (45%), Gaps = 25/222 (11%)
Query: 13  LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEK--NRIIHLKITDQIKREIATLKL 70
           L RY+  + +G G  G V  A D   G+  AVK L +      H K   +  RE+  LK 
Sbjct: 21  LKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAK---RAYRELVLLKC 77
Query: 71  LKHPNVVRLHEVLASKSK------IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLI 124
           + H N++ L  V   +        +Y+V+E +    L   I  +  L       L  Q++
Sbjct: 78  VNHKNIISLLNVFTPQKTLEEFQDVYLVME-LMDANLCQVIHME--LDHERMSYLLYQML 134
Query: 125 DGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVA 184
            G+ + H+ G+ HRDLK  NI++ S   +KI DFGL+   +    + ++     +  Y A
Sbjct: 135 CGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA---RTASTNFMMTPYVVTRYYRA 191
Query: 185 PEVLANRGYDGATSDIWSCGVIL-------YIFRGDFKLPKW 219
           PEV+   GY     DIWS G I+        IF+G   + +W
Sbjct: 192 PEVILGMGYK-ENVDIWSVGCIMGELVKGSVIFQGTDHIDQW 232

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 65/229 (28%), Positives = 108/229 (47%), Gaps = 26/229 (11%)
Query: 22  LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKR--EIATLKLLKHPNVVRL 79
           LG G+FG+V   +D  +G   AVK          K+  ++ R  E+     L  P +V L
Sbjct: 82  LGRGSFGEVHRMEDKQTGFQCAVK----------KVRLEVFRAEELMACAGLTSPRIVPL 131
Query: 80  HEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRD 139
           +  +     + + +E + GG L   +  +G L E        Q ++G+ Y H++ + H D
Sbjct: 132 YGAVREGPWVNIFMELLEGGSLGQLVKEQGCLPEDRALYYLGQALEGLEYLHSRRILHGD 191
Query: 140 LKLENILLDSKG-NIKISDFGLSALPQHFRDDGL---LHT---TCGSPNYVAPEVLANRG 192
           +K +N+LL S G +  + DFG +      + DGL   L T     G+  ++APEV+  R 
Sbjct: 192 VKADNVLLSSDGSHAALCDFGHAVC---LQPDGLGKDLLTGDYIPGTETHMAPEVVLGRS 248
Query: 193 YDGATSDIW-SCGVILYIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRI 240
            D A  D+W SC ++L++  G     ++        L+   EP PV+ I
Sbjct: 249 CD-AKVDVWSSCCMMLHMLNGCHPWTQFFR--GPLCLKIASEPPPVREI 294

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 55/201 (27%), Positives = 102/201 (50%), Gaps = 14/201 (6%)
Query: 14  GRYELGRTLGEGNFGKV---KFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKL 70
           G+  +G+ +G G+FG V   K+  D+      AVK+L        ++    K E+  L+ 
Sbjct: 12  GQITVGQRIGSGSFGTVYKGKWHGDV------AVKMLNVTAPTPQQL-QAFKNEVGVLRK 64
Query: 71  LKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKI-ASKGRLQEAEGRKLFQQLIDGVSY 129
            +H N++ L    ++K ++ +V ++  G  L+  + AS+ + +  +   + +Q   G+ Y
Sbjct: 65  TRHVNIL-LFMGYSTKPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDY 123
Query: 130 CHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLA 189
            H K + HRDLK  NI L     +KI DFGL+ +   +          GS  ++APEV+ 
Sbjct: 124 LHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIR 183
Query: 190 NRGYDGAT--SDIWSCGVILY 208
            +  +  +  SD+++ G++LY
Sbjct: 184 MQDSNPYSFQSDVYAFGIVLY 204

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 56/198 (28%), Positives = 98/198 (49%), Gaps = 9/198 (4%)
Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLP-FAVKILEKNRIIHLKITDQIKREIATLKLLKH 73
           R ELGR +GEG FG V     +    P  AV I          + ++  +E  T++   H
Sbjct: 11  RIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDH 70
Query: 74  PNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQ-QLIDGVSYCHN 132
           P++V+L  V+ +++ +++++E  T GEL   +  +    +     L+  QL   ++Y  +
Sbjct: 71  PHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLES 129
Query: 133 KGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGS--PNYVAPEVLAN 190
           K   HRD+   N+L+ S   +K+ DFGLS   ++  D      + G     ++APE +  
Sbjct: 130 KRFVHRDIAARNVLVSSNDCVKLGDFGLS---RYMEDSTXXKASKGKLPIKWMAPESINF 186
Query: 191 RGYDGATSDIWSCGVILY 208
           R +  A SD+W  GV ++
Sbjct: 187 RRFTSA-SDVWMFGVCMW 203

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 67/219 (30%), Positives = 102/219 (46%), Gaps = 35/219 (15%)
Query: 20  RTLGEGNFGKV-KFAQDLDSG---LPFAVKIL-----EKNRIIHLKITDQIKREIATLKL 70
           + +G G FG+V K      SG   +P A+K L     EK R+  L        E   +  
Sbjct: 50  KVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLG-------EAGIMGQ 102
Query: 71  LKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLID----- 125
             H N++RL  V++    + ++ EY+  G L DK      L+E +G     QL+      
Sbjct: 103 FSHHNIIRLEGVISKYKPMMIITEYMENGAL-DKF-----LREKDGEFSVLQLVGMLRGI 156
Query: 126 --GVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP--- 180
             G+ Y  N    HRDL   NIL++S    K+SDFGLS + +   D    +TT G     
Sbjct: 157 AAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLED--DPEATYTTSGGKIPI 214
Query: 181 NYVAPEVLANRGYDGATSDIWSCGVILYIFRGDFKLPKW 219
            + APE ++ R +  A SD+WS G++++      + P W
Sbjct: 215 RWTAPEAISYRKFTSA-SDVWSFGIVMWEVMTYGERPYW 252

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 67/220 (30%), Positives = 105/220 (47%), Gaps = 31/220 (14%)
Query: 15  RYELGRTLGEGNFGKVKFAQ--DLDSGLP-----FAVKILEKNRIIHLKITDQIKREIAT 67
           R  LG+ LGEG FG+V  A+   LD   P      AVK+L K+      ++D I  E+  
Sbjct: 21  RLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKML-KSDATEKDLSDLIS-EMEM 78
Query: 68  LKLL-KHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKG----------------R 110
           +K++ KH N++ L         +Y+++EY + G L + + ++                 +
Sbjct: 79  MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQ 138
Query: 111 LQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD 170
           L   +      Q+  G+ Y  +K   HRDL   N+L+     +KI+DFGL+    H   D
Sbjct: 139 LSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHI--D 196
Query: 171 GLLHTTCG--SPNYVAPEVLANRGYDGATSDIWSCGVILY 208
               TT G     ++APE L +R Y    SD+WS GV+L+
Sbjct: 197 YYKKTTNGRLPVKWMAPEALFDRIYT-HQSDVWSFGVLLW 235

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 67/220 (30%), Positives = 105/220 (47%), Gaps = 31/220 (14%)
Query: 15  RYELGRTLGEGNFGKVKFAQ--DLDSGLP-----FAVKILEKNRIIHLKITDQIKREIAT 67
           R  LG+ LGEG FG+V  A+   LD   P      AVK+L K+      ++D I  E+  
Sbjct: 18  RLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKML-KSDATEKDLSDLIS-EMEM 75
Query: 68  LKLL-KHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKG----------------R 110
           +K++ KH N++ L         +Y+++EY + G L + + ++                 +
Sbjct: 76  MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQ 135
Query: 111 LQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD 170
           L   +      Q+  G+ Y  +K   HRDL   N+L+     +KI+DFGL+    H   D
Sbjct: 136 LSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHI--D 193
Query: 171 GLLHTTCG--SPNYVAPEVLANRGYDGATSDIWSCGVILY 208
               TT G     ++APE L +R Y    SD+WS GV+L+
Sbjct: 194 YYKKTTNGRLPVKWMAPEALFDRIYT-HQSDVWSFGVLLW 232

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 67/220 (30%), Positives = 105/220 (47%), Gaps = 31/220 (14%)
Query: 15  RYELGRTLGEGNFGKVKFAQ--DLDSGLP-----FAVKILEKNRIIHLKITDQIKREIAT 67
           R  LG+ LGEG FG+V  A+   LD   P      AVK+L K+      ++D I  E+  
Sbjct: 29  RLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKML-KSDATEKDLSDLIS-EMEM 86
Query: 68  LKLL-KHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKG----------------R 110
           +K++ KH N++ L         +Y+++EY + G L + + ++                 +
Sbjct: 87  MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQAREPPGLEYSYNPSHNPEEQ 146
Query: 111 LQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD 170
           L   +      Q+  G+ Y  +K   HRDL   N+L+     +KI+DFGL+    H   D
Sbjct: 147 LSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHI--D 204
Query: 171 GLLHTTCG--SPNYVAPEVLANRGYDGATSDIWSCGVILY 208
               TT G     ++APE L +R Y    SD+WS GV+L+
Sbjct: 205 YYKKTTNGRLPVKWMAPEALFDRIYT-HQSDVWSFGVLLW 243

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 67/220 (30%), Positives = 105/220 (47%), Gaps = 31/220 (14%)
Query: 15  RYELGRTLGEGNFGKVKFAQ--DLDSGLP-----FAVKILEKNRIIHLKITDQIKREIAT 67
           R  LG+ LGEG FG+V  A+   LD   P      AVK+L K+      ++D I  E+  
Sbjct: 22  RLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKML-KSDATEKDLSDLIS-EMEM 79
Query: 68  LKLL-KHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKG----------------R 110
           +K++ KH N++ L         +Y+++EY + G L + + ++                 +
Sbjct: 80  MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQ 139
Query: 111 LQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD 170
           L   +      Q+  G+ Y  +K   HRDL   N+L+     +KI+DFGL+    H   D
Sbjct: 140 LSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHI--D 197
Query: 171 GLLHTTCG--SPNYVAPEVLANRGYDGATSDIWSCGVILY 208
               TT G     ++APE L +R Y    SD+WS GV+L+
Sbjct: 198 YYKKTTNGRLPVKWMAPEALFDRIYT-HQSDVWSFGVLLW 236

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 67/220 (30%), Positives = 105/220 (47%), Gaps = 31/220 (14%)
Query: 15  RYELGRTLGEGNFGKVKFAQ--DLDSGLP-----FAVKILEKNRIIHLKITDQIKREIAT 67
           R  LG+ LGEG FG+V  A+   LD   P      AVK+L K+      ++D I  E+  
Sbjct: 29  RLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKML-KSDATEKDLSDLIS-EMEM 86
Query: 68  LKLL-KHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKG----------------R 110
           +K++ KH N++ L         +Y+++EY + G L + + ++                 +
Sbjct: 87  MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQ 146
Query: 111 LQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD 170
           L   +      Q+  G+ Y  +K   HRDL   N+L+     +KI+DFGL+    H   D
Sbjct: 147 LSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHI--D 204
Query: 171 GLLHTTCG--SPNYVAPEVLANRGYDGATSDIWSCGVILY 208
               TT G     ++APE L +R Y    SD+WS GV+L+
Sbjct: 205 YYKKTTNGRLPVKWMAPEALFDRIYT-HQSDVWSFGVLLW 243

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 69/202 (34%), Positives = 103/202 (50%), Gaps = 23/202 (11%)
Query: 20  RTLGEGNFGKVKF----AQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
           R LGEG+FGKV        +  +G   AVK L++     L+   Q  REI  L+ L H +
Sbjct: 14  RDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEGCGPQLRSGWQ--REIEILRTLYHEH 71
Query: 76  VVRLHEVLASKSK--IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNK 133
           +V+       + +  + +V+EYV  G L D +  +  +  A+     QQ+ +G++Y H +
Sbjct: 72  IVKYKGCCEDQGEKSVQLVMEYVPLGSLRDYL-PRHCVGLAQLLLFAQQICEGMAYLHAQ 130
Query: 134 GVFHRDLKLENILLDSKGNIKISDFGLS-ALPQ-----HFRDDGLLHTTCGSP-NYVAPE 186
              HR L   N+LLD+   +KI DFGL+ A+P+       R+DG       SP  + APE
Sbjct: 131 HYIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDG------DSPVFWYAPE 184
Query: 187 VLANRGYDGATSDIWSCGVILY 208
            L    +  A SD+WS GV LY
Sbjct: 185 CLKECKFYYA-SDVWSFGVTLY 205

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 69/202 (34%), Positives = 103/202 (50%), Gaps = 23/202 (11%)
Query: 20  RTLGEGNFGKVKF----AQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
           R LGEG+FGKV        +  +G   AVK L++     L+   Q  REI  L+ L H +
Sbjct: 15  RDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEGCGPQLRSGWQ--REIEILRTLYHEH 72
Query: 76  VVRLHEVLASKSK--IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNK 133
           +V+       + +  + +V+EYV  G L D +  +  +  A+     QQ+ +G++Y H +
Sbjct: 73  IVKYKGCCEDQGEKSVQLVMEYVPLGSLRDYLP-RHCVGLAQLLLFAQQICEGMAYLHAQ 131
Query: 134 GVFHRDLKLENILLDSKGNIKISDFGLS-ALPQ-----HFRDDGLLHTTCGSP-NYVAPE 186
              HR L   N+LLD+   +KI DFGL+ A+P+       R+DG       SP  + APE
Sbjct: 132 HYIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDG------DSPVFWYAPE 185
Query: 187 VLANRGYDGATSDIWSCGVILY 208
            L    +  A SD+WS GV LY
Sbjct: 186 CLKECKFYYA-SDVWSFGVTLY 206

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 101/211 (47%), Gaps = 16/211 (7%)
Query: 18  LGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKR----EIATLKLLKH 73
           + + +G G FG+V   +     LP   +I    + + +  T++ +R    E + +    H
Sbjct: 20  IDKVVGAGEFGEVCSGR---LKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 76
Query: 74  PNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASK--GRLQEAEGRKLFQQLIDGVSYCH 131
           PN++RL  V+     + +V EY+  G L D    K   +    +   + + +  G+ Y  
Sbjct: 77  PNIIRLEGVVTKSKPVMIVTEYMENGSL-DSFLRKHDAQFTVIQLVGMLRGIASGMKYLS 135
Query: 132 NKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP---NYVAPEVL 188
           + G  HRDL   NIL++S    K+SDFGLS + +   D    +TT G      + +PE +
Sbjct: 136 DMGYVHRDLAARNILINSNLVCKVSDFGLSRVLED--DPEAAYTTRGGKIPIRWTSPEAI 193
Query: 189 ANRGYDGATSDIWSCGVILYIFRGDFKLPKW 219
           A R +  A SD+WS G++L+      + P W
Sbjct: 194 AYRKFTSA-SDVWSYGIVLWEVMSYGERPYW 223

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 101/211 (47%), Gaps = 16/211 (7%)
Query: 18  LGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKR----EIATLKLLKH 73
           + + +G G FG+V   +     LP   +I    + + +  T++ +R    E + +    H
Sbjct: 37  IDKVVGAGEFGEVCSGR---LKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 93
Query: 74  PNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASK--GRLQEAEGRKLFQQLIDGVSYCH 131
           PN++RL  V+     + +V EY+  G L D    K   +    +   + + +  G+ Y  
Sbjct: 94  PNIIRLEGVVTKSKPVMIVTEYMENGSL-DSFLRKHDAQFTVIQLVGMLRGIASGMKYLS 152
Query: 132 NKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP---NYVAPEVL 188
           + G  HRDL   NIL++S    K+SDFGLS + +   D    +TT G      + +PE +
Sbjct: 153 DMGYVHRDLAARNILINSNLVCKVSDFGLSRVLED--DPEAAYTTRGGKIPIRWTSPEAI 210
Query: 189 ANRGYDGATSDIWSCGVILYIFRGDFKLPKW 219
           A R +  A SD+WS G++L+      + P W
Sbjct: 211 AYRKFTSA-SDVWSYGIVLWEVMSYGERPYW 240

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 55/202 (27%), Positives = 102/202 (50%), Gaps = 14/202 (6%)
Query: 20  RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRL 79
           + LG G FG VK+ +        A+K++++  +      D+   E   +  L H  +V+L
Sbjct: 30  KELGTGQFGVVKYGK-WRGQYDVAIKMIKEGSMSE----DEFIEEAKVMMNLSHEKLVQL 84
Query: 80  HEVLASKSKIYMVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHR 138
           + V   +  I+++ EY+  G L + +   + R Q  +  ++ + + + + Y  +K   HR
Sbjct: 85  YGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHR 144
Query: 139 DLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP---NYVAPEVLANRGYDG 195
           DL   N L++ +G +K+SDFGLS   ++  DD    ++ GS     +  PEVL    +  
Sbjct: 145 DLAARNCLVNDQGVVKVSDFGLS---RYVLDDEYT-SSVGSKFPVRWSPPEVLMYSKF-S 199
Query: 196 ATSDIWSCGVILYIFRGDFKLP 217
           + SDIW+ GV+++      K+P
Sbjct: 200 SKSDIWAFGVLMWEIYSLGKMP 221

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 55/202 (27%), Positives = 102/202 (50%), Gaps = 14/202 (6%)
Query: 20  RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRL 79
           + LG G FG VK+ +        A+K++++  +      D+   E   +  L H  +V+L
Sbjct: 14  KELGTGQFGVVKYGK-WRGQYDVAIKMIKEGSMSE----DEFIEEAKVMMNLSHEKLVQL 68
Query: 80  HEVLASKSKIYMVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHR 138
           + V   +  I+++ EY+  G L + +   + R Q  +  ++ + + + + Y  +K   HR
Sbjct: 69  YGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHR 128
Query: 139 DLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP---NYVAPEVLANRGYDG 195
           DL   N L++ +G +K+SDFGLS   ++  DD    ++ GS     +  PEVL    +  
Sbjct: 129 DLAARNCLVNDQGVVKVSDFGLS---RYVLDDEYT-SSVGSKFPVRWSPPEVLMYSKF-S 183
Query: 196 ATSDIWSCGVILYIFRGDFKLP 217
           + SDIW+ GV+++      K+P
Sbjct: 184 SKSDIWAFGVLMWEIYSLGKMP 205

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 67/220 (30%), Positives = 105/220 (47%), Gaps = 31/220 (14%)
Query: 15  RYELGRTLGEGNFGKVKFAQ--DLDSGLP-----FAVKILEKNRIIHLKITDQIKREIAT 67
           R  LG+ LGEG FG+V  A+   LD   P      AVK+L K+      ++D I  E+  
Sbjct: 14  RLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKML-KSDATEKDLSDLIS-EMEM 71
Query: 68  LKLL-KHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKG----------------R 110
           +K++ KH N++ L         +Y+++EY + G L + + ++                 +
Sbjct: 72  MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQ 131
Query: 111 LQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD 170
           L   +      Q+  G+ Y  +K   HRDL   N+L+     +KI+DFGL+    H   D
Sbjct: 132 LSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHI--D 189
Query: 171 GLLHTTCG--SPNYVAPEVLANRGYDGATSDIWSCGVILY 208
               TT G     ++APE L +R Y    SD+WS GV+L+
Sbjct: 190 YYKKTTNGRLPVKWMAPEALFDRIY-THQSDVWSFGVLLW 228

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 101/211 (47%), Gaps = 16/211 (7%)
Query: 18  LGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKR----EIATLKLLKH 73
           + + +G G FG+V   +     LP   +I    + + +  T++ +R    E + +    H
Sbjct: 49  IDKVVGAGEFGEVCSGR---LKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 105
Query: 74  PNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASK--GRLQEAEGRKLFQQLIDGVSYCH 131
           PN++RL  V+     + +V EY+  G L D    K   +    +   + + +  G+ Y  
Sbjct: 106 PNIIRLEGVVTKSKPVMIVTEYMENGSL-DSFLRKHDAQFTVIQLVGMLRGIASGMKYLS 164
Query: 132 NKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP---NYVAPEVL 188
           + G  HRDL   NIL++S    K+SDFGLS + +   D    +TT G      + +PE +
Sbjct: 165 DMGYVHRDLAARNILINSNLVCKVSDFGLSRVLED--DPEAAYTTRGGKIPIRWTSPEAI 222
Query: 189 ANRGYDGATSDIWSCGVILYIFRGDFKLPKW 219
           A R +  A SD+WS G++L+      + P W
Sbjct: 223 AYRKFTSA-SDVWSYGIVLWEVMSYGERPYW 252

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 67/220 (30%), Positives = 105/220 (47%), Gaps = 31/220 (14%)
Query: 15  RYELGRTLGEGNFGKVKFAQ--DLDSGLP-----FAVKILEKNRIIHLKITDQIKREIAT 67
           R  LG+ LGEG FG+V  A+   LD   P      AVK+L K+      ++D I  E+  
Sbjct: 29  RLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKML-KSDATEKDLSDLIS-EMEM 86
Query: 68  LKLL-KHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKG----------------R 110
           +K++ KH N++ L         +Y+++EY + G L + + ++                 +
Sbjct: 87  MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQ 146
Query: 111 LQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD 170
           L   +      Q+  G+ Y  +K   HRDL   N+L+     +KI+DFGL+    H   D
Sbjct: 147 LSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHI--D 204
Query: 171 GLLHTTCG--SPNYVAPEVLANRGYDGATSDIWSCGVILY 208
               TT G     ++APE L +R Y    SD+WS GV+L+
Sbjct: 205 YYKKTTNGRLPVKWMAPEALFDRIYT-HQSDVWSFGVLLW 243

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 101/211 (47%), Gaps = 16/211 (7%)
Query: 18  LGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKR----EIATLKLLKH 73
           + + +G G FG+V   +     LP   +I    + + +  T++ +R    E + +    H
Sbjct: 49  IDKVVGAGEFGEVCSGR---LKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 105
Query: 74  PNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASK--GRLQEAEGRKLFQQLIDGVSYCH 131
           PN++RL  V+     + +V EY+  G L D    K   +    +   + + +  G+ Y  
Sbjct: 106 PNIIRLEGVVTKSKPVMIVTEYMENGSL-DSFLRKHDAQFTVIQLVGMLRGIASGMKYLS 164
Query: 132 NKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP---NYVAPEVL 188
           + G  HRDL   NIL++S    K+SDFGLS + +   D    +TT G      + +PE +
Sbjct: 165 DMGYVHRDLAARNILINSNLVCKVSDFGLSRVLED--DPEAAYTTRGGKIPIRWTSPEAI 222
Query: 189 ANRGYDGATSDIWSCGVILYIFRGDFKLPKW 219
           A R +  A SD+WS G++L+      + P W
Sbjct: 223 AYRKFTSA-SDVWSYGIVLWEVMSYGERPYW 252

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 101/211 (47%), Gaps = 16/211 (7%)
Query: 18  LGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKR----EIATLKLLKH 73
           + + +G G FG+V   +     LP   +I    + + +  T++ +R    E + +    H
Sbjct: 49  IDKVVGAGEFGEVCSGR---LKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 105
Query: 74  PNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASK--GRLQEAEGRKLFQQLIDGVSYCH 131
           PN++RL  V+     + +V EY+  G L D    K   +    +   + + +  G+ Y  
Sbjct: 106 PNIIRLEGVVTKSKPVMIVTEYMENGSL-DSFLRKHDAQFTVIQLVGMLRGIASGMKYLS 164
Query: 132 NKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP---NYVAPEVL 188
           + G  HRDL   NIL++S    K+SDFGLS + +   D    +TT G      + +PE +
Sbjct: 165 DMGYVHRDLAARNILINSNLVCKVSDFGLSRVLED--DPEAAYTTRGGKIPIRWTSPEAI 222
Query: 189 ANRGYDGATSDIWSCGVILYIFRGDFKLPKW 219
           A R +  A SD+WS G++L+      + P W
Sbjct: 223 AYRKFTSA-SDVWSYGIVLWEVMSYGERPYW 252

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 101/211 (47%), Gaps = 16/211 (7%)
Query: 18  LGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKR----EIATLKLLKH 73
           + + +G G FG+V   +     LP   +I    + + +  T++ +R    E + +    H
Sbjct: 49  IDKVVGAGEFGEVCSGR---LKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 105
Query: 74  PNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASK--GRLQEAEGRKLFQQLIDGVSYCH 131
           PN++RL  V+     + +V EY+  G L D    K   +    +   + + +  G+ Y  
Sbjct: 106 PNIIRLEGVVTKSKPVMIVTEYMENGSL-DSFLRKHDAQFTVIQLVGMLRGIASGMKYLS 164
Query: 132 NKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP---NYVAPEVL 188
           + G  HRDL   NIL++S    K+SDFGLS + +   D    +TT G      + +PE +
Sbjct: 165 DMGFVHRDLAARNILINSNLVCKVSDFGLSRVLED--DPEAAYTTRGGKIPIRWTSPEAI 222
Query: 189 ANRGYDGATSDIWSCGVILYIFRGDFKLPKW 219
           A R +  A SD+WS G++L+      + P W
Sbjct: 223 AYRKFTSA-SDVWSYGIVLWEVMSYGERPYW 252

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 55/202 (27%), Positives = 102/202 (50%), Gaps = 14/202 (6%)
Query: 20  RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRL 79
           + LG G FG VK+ +        A+K++++  +      D+   E   +  L H  +V+L
Sbjct: 10  KELGTGQFGVVKYGK-WRGQYDVAIKMIKEGSMSE----DEFIEEAKVMMNLSHEKLVQL 64
Query: 80  HEVLASKSKIYMVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHR 138
           + V   +  I+++ EY+  G L + +   + R Q  +  ++ + + + + Y  +K   HR
Sbjct: 65  YGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHR 124
Query: 139 DLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP---NYVAPEVLANRGYDG 195
           DL   N L++ +G +K+SDFGLS   ++  DD    ++ GS     +  PEVL    +  
Sbjct: 125 DLAARNCLVNDQGVVKVSDFGLS---RYVLDDEYT-SSVGSKFPVRWSPPEVLMYSKF-S 179
Query: 196 ATSDIWSCGVILYIFRGDFKLP 217
           + SDIW+ GV+++      K+P
Sbjct: 180 SKSDIWAFGVLMWEIYSLGKMP 201

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 101/211 (47%), Gaps = 16/211 (7%)
Query: 18  LGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKR----EIATLKLLKH 73
           + + +G G FG+V   +     LP   +I    + + +  T++ +R    E + +    H
Sbjct: 47  IDKVVGAGEFGEVCSGR---LKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 103
Query: 74  PNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASK--GRLQEAEGRKLFQQLIDGVSYCH 131
           PN++RL  V+     + +V EY+  G L D    K   +    +   + + +  G+ Y  
Sbjct: 104 PNIIRLEGVVTKSKPVMIVTEYMENGSL-DSFLRKHDAQFTVIQLVGMLRGIASGMKYLS 162
Query: 132 NKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP---NYVAPEVL 188
           + G  HRDL   NIL++S    K+SDFGLS + +   D    +TT G      + +PE +
Sbjct: 163 DMGYVHRDLAARNILINSNLVCKVSDFGLSRVLED--DPEAAYTTRGGKIPIRWTSPEAI 220
Query: 189 ANRGYDGATSDIWSCGVILYIFRGDFKLPKW 219
           A R +  A SD+WS G++L+      + P W
Sbjct: 221 AYRKFTSA-SDVWSYGIVLWEVMSYGERPYW 250

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 101/211 (47%), Gaps = 16/211 (7%)
Query: 18  LGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKR----EIATLKLLKH 73
           + + +G G FG+V   +     LP   +I    + + +  T++ +R    E + +    H
Sbjct: 49  IDKVVGAGEFGEVCSGR---LKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 105
Query: 74  PNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASK--GRLQEAEGRKLFQQLIDGVSYCH 131
           PN++RL  V+     + +V EY+  G L D    K   +    +   + + +  G+ Y  
Sbjct: 106 PNIIRLEGVVTKSKPVMIVTEYMENGSL-DSFLRKHDAQFTVIQLVGMLRGIASGMKYLS 164
Query: 132 NKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP---NYVAPEVL 188
           + G  HRDL   NIL++S    K+SDFGLS + +   D    +TT G      + +PE +
Sbjct: 165 DMGYVHRDLAARNILINSNLVCKVSDFGLSRVLED--DPEAAYTTRGGKIPIRWTSPEAI 222
Query: 189 ANRGYDGATSDIWSCGVILYIFRGDFKLPKW 219
           A R +  A SD+WS G++L+      + P W
Sbjct: 223 AYRKFTSA-SDVWSYGIVLWEVMSYGERPYW 252

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 58/198 (29%), Positives = 97/198 (48%), Gaps = 9/198 (4%)
Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLP-FAVKILEKNRIIHLKITDQIKREIATLKLLKH 73
           R ELGR +GEG FG V     +    P  AV I          + ++  +E  T++   H
Sbjct: 391 RIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDH 450
Query: 74  PNVVRLHEVLASKSKIYMVLEYVTGGELFDKI-ASKGRLQEAEGRKLFQQLIDGVSYCHN 132
           P++V+L  V+ +++ +++++E  T GEL   +   K  L  A       QL   ++Y  +
Sbjct: 451 PHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLES 509
Query: 133 KGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGS--PNYVAPEVLAN 190
           K   HRD+   N+L+ S   +K+ DFGLS   ++  D      + G     ++APE +  
Sbjct: 510 KRFVHRDIAARNVLVSSNDCVKLGDFGLS---RYMEDSTYYKASKGKLPIKWMAPESINF 566
Query: 191 RGYDGATSDIWSCGVILY 208
           R +  A SD+W  GV ++
Sbjct: 567 RRFTSA-SDVWMFGVCMW 583

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 61/195 (31%), Positives = 101/195 (51%), Gaps = 12/195 (6%)
Query: 22  LGEGNFGKVKFAQ----DLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVV 77
           LG+GNFG V+  +      ++G   AVK L+ +     +     +REI  LK L    +V
Sbjct: 15  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQR---DFQREIQILKALHSDFIV 71
Query: 78  RLHEVL--ASKSKIYMVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKG 134
           +   V     + ++ +V+EY+  G L D +   + RL  +       Q+  G+ Y  ++ 
Sbjct: 72  KYRGVSYGPGRPELRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRR 131
Query: 135 VFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP-NYVAPEVLANRGY 193
             HRDL   NIL++S+ ++KI+DFGL+ L    +D  ++     SP  + APE L++  +
Sbjct: 132 CVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDXXVVREPGQSPIFWYAPESLSDNIF 191
Query: 194 DGATSDIWSCGVILY 208
               SD+WS GV+LY
Sbjct: 192 -SRQSDVWSFGVVLY 205

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 67/220 (30%), Positives = 105/220 (47%), Gaps = 31/220 (14%)
Query: 15  RYELGRTLGEGNFGKVKFAQ--DLDSGLP-----FAVKILEKNRIIHLKITDQIKREIAT 67
           R  LG+ LGEG FG+V  A+   LD   P      AVK+L K+      ++D I  E+  
Sbjct: 70  RLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKML-KSDATEKDLSDLIS-EMEM 127
Query: 68  LKLL-KHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKG----------------R 110
           +K++ KH N++ L         +Y+++EY + G L + + ++                 +
Sbjct: 128 MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQ 187
Query: 111 LQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD 170
           L   +      Q+  G+ Y  +K   HRDL   N+L+     +KI+DFGL+    H   D
Sbjct: 188 LSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHI--D 245
Query: 171 GLLHTTCG--SPNYVAPEVLANRGYDGATSDIWSCGVILY 208
               TT G     ++APE L +R Y    SD+WS GV+L+
Sbjct: 246 YYKKTTNGRLPVKWMAPEALFDRIYT-HQSDVWSFGVLLW 284

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 62/223 (27%), Positives = 107/223 (47%), Gaps = 17/223 (7%)
Query: 20  RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKR----EIATLKLLKHPN 75
           R +G G FG+V   +     LP    +    + + +  T++ +R    E + +    HPN
Sbjct: 49  RVIGAGEFGEVCSGR---LKLPGKRDVAVAIKTLKVGYTEKQRRDFLCEASIMGQFDHPN 105
Query: 76  VVRLHEVLASKSKIYMVLEYVTGGELFDKIASK--GRLQEAEGRKLFQQLIDGVSYCHNK 133
           VV L  V+     + +V+E++  G L D    K  G+    +   + + +  G+ Y  + 
Sbjct: 106 VVHLEGVVTRGKPVMIVIEFMENGAL-DAFLRKHDGQFTVIQLVGMLRGIAAGMRYLADM 164
Query: 134 GVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP---NYVAPEVLAN 190
           G  HRDL   NIL++S    K+SDFGLS + +   D   ++TT G      + APE +  
Sbjct: 165 GYVHRDLAARNILVNSNLVCKVSDFGLSRVIED--DPEAVYTTTGGKIPVRWTAPEAIQY 222
Query: 191 RGYDGATSDIWSCGVILYIFRGDFKLPKWLSPGAQNLLRKILE 233
           R +  A SD+WS G++++      + P W     Q++++ I E
Sbjct: 223 RKFTSA-SDVWSYGIVMWEVMSYGERPYW-DMSNQDVIKAIEE 263

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 55/202 (27%), Positives = 102/202 (50%), Gaps = 14/202 (6%)
Query: 20  RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRL 79
           + LG G FG VK+ +        A+K++++  +      D+   E   +  L H  +V+L
Sbjct: 21  KELGTGQFGVVKYGK-WRGQYDVAIKMIKEGSMSE----DEFIEEAKVMMNLSHEKLVQL 75
Query: 80  HEVLASKSKIYMVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHR 138
           + V   +  I+++ EY+  G L + +   + R Q  +  ++ + + + + Y  +K   HR
Sbjct: 76  YGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHR 135
Query: 139 DLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP---NYVAPEVLANRGYDG 195
           DL   N L++ +G +K+SDFGLS   ++  DD    ++ GS     +  PEVL    +  
Sbjct: 136 DLAARNCLVNDQGVVKVSDFGLS---RYVLDDEYT-SSVGSKFPVRWSPPEVLMYSKF-S 190
Query: 196 ATSDIWSCGVILYIFRGDFKLP 217
           + SDIW+ GV+++      K+P
Sbjct: 191 SKSDIWAFGVLMWEIYSLGKMP 212

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 55/202 (27%), Positives = 102/202 (50%), Gaps = 14/202 (6%)
Query: 20  RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRL 79
           + LG G FG VK+ +        A+K++++  +      D+   E   +  L H  +V+L
Sbjct: 15  KELGTGQFGVVKYGK-WRGQYDVAIKMIKEGSMSE----DEFIEEAKVMMNLSHEKLVQL 69
Query: 80  HEVLASKSKIYMVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHR 138
           + V   +  I+++ EY+  G L + +   + R Q  +  ++ + + + + Y  +K   HR
Sbjct: 70  YGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHR 129
Query: 139 DLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP---NYVAPEVLANRGYDG 195
           DL   N L++ +G +K+SDFGLS   ++  DD    ++ GS     +  PEVL    +  
Sbjct: 130 DLAARNCLVNDQGVVKVSDFGLS---RYVLDDEYT-SSVGSKFPVRWSPPEVLMYSKF-S 184
Query: 196 ATSDIWSCGVILYIFRGDFKLP 217
           + SDIW+ GV+++      K+P
Sbjct: 185 SKSDIWAFGVLMWEIYSLGKMP 206

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 72/246 (29%), Positives = 112/246 (45%), Gaps = 47/246 (19%)
Query: 13  LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIK---------R 63
           L +YEL + LG+G +G V  + D  +G   AVK          KI D  +         R
Sbjct: 8   LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVK----------KIFDAFQNSTDAQRTFR 57
Query: 64  EIATLKLLK-HPNVVRLHEVLASKSK--IYMVLEYVTGGELFDKIASKGRLQEAEGRKLF 120
           EI  L  L  H N+V L  VL + +   +Y+V +Y+        +     L+    + + 
Sbjct: 58  EIMILTELSGHENIVNLLNVLRADNDRDVYLVFDYMETD--LHAVIRANILEPVHKQYVV 115
Query: 121 QQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLS-----------ALP----- 164
            QLI  + Y H+ G+ HRD+K  NILL+++ ++K++DFGLS            +P     
Sbjct: 116 YQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINE 175
Query: 165 --QHFRDDG-LLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIFRGDFKLPKWLS 221
             ++F DD  +L     +  Y APE+L          D+WS G IL    G+    K + 
Sbjct: 176 NTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCIL----GEILCGKPIF 231
Query: 222 PGAQNL 227
           PG+  +
Sbjct: 232 PGSSTM 237

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score = 78.2 bits (191), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 59/192 (30%), Positives = 91/192 (47%), Gaps = 14/192 (7%)
Query: 22  LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRL-- 79
           +G G +G V  A D  +G   A+K L +     L    +  RE+  LK ++H NV+ L  
Sbjct: 33  VGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSEL-FAKRAYRELRLLKHMRHENVIGLLD 91
Query: 80  ----HEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGV 135
                E L   +  Y+V+ ++  G    K+    +L E   + L  Q++ G+ Y H  G+
Sbjct: 92  VFTPDETLDDFTDFYLVMPFM--GTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAAGI 149
Query: 136 FHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDG 195
            HRDLK  N+ ++    +KI DFGL+      + D  +     +  Y APEV+ N     
Sbjct: 150 IHRDLKPGNLAVNEDCELKILDFGLAR-----QADSEMXGXVVTRWYRAPEVILNWMRYT 204
Query: 196 ATSDIWSCGVIL 207
            T DIWS G I+
Sbjct: 205 QTVDIWSVGCIM 216

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 78.2 bits (191), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 57/198 (28%), Positives = 97/198 (48%), Gaps = 9/198 (4%)
Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLP-FAVKILEKNRIIHLKITDQIKREIATLKLLKH 73
           R ELGR +GEG FG V     +    P  AV I          + ++  +E  T++   H
Sbjct: 11  RIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDH 70
Query: 74  PNVVRLHEVLASKSKIYMVLEYVTGGELFDKI-ASKGRLQEAEGRKLFQQLIDGVSYCHN 132
           P++V+L  V+ +++ +++++E  T GEL   +   K  L  A       QL   ++Y  +
Sbjct: 71  PHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLES 129
Query: 133 KGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGS--PNYVAPEVLAN 190
           K   HRD+   N+L+ +   +K+ DFGLS   ++  D      + G     ++APE +  
Sbjct: 130 KRFVHRDIAARNVLVSATDCVKLGDFGLS---RYMEDSTYYKASKGKLPIKWMAPESINF 186
Query: 191 RGYDGATSDIWSCGVILY 208
           R +  A SD+W  GV ++
Sbjct: 187 RRFTSA-SDVWMFGVCMW 203

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 78.2 bits (191), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 66/202 (32%), Positives = 104/202 (51%), Gaps = 23/202 (11%)
Query: 20  RTLGEGNFGKVKF----AQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
           R LGEG+FGKV        +  +G   AVK L+ +     +     K+EI  L+ L H +
Sbjct: 20  RDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKAD--CGPQHRSGWKQEIDILRTLYHEH 77
Query: 76  VVRLHEVLASKSK--IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNK 133
           +++       + +  + +V+EYV  G L D +  +  +  A+     QQ+ +G++Y H++
Sbjct: 78  IIKYKGCCEDQGEKSLQLVMEYVPLGSLRDYLP-RHSIGLAQLLLFAQQICEGMAYLHSQ 136
Query: 134 GVFHRDLKLENILLDSKGNIKISDFGLS-ALPQ-----HFRDDGLLHTTCGSP-NYVAPE 186
              HR+L   N+LLD+   +KI DFGL+ A+P+       R+DG       SP  + APE
Sbjct: 137 HYIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDG------DSPVFWYAPE 190
Query: 187 VLANRGYDGATSDIWSCGVILY 208
            L    +  A SD+WS GV LY
Sbjct: 191 CLKEYKFYYA-SDVWSFGVTLY 211

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 78.2 bits (191), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 55/202 (27%), Positives = 102/202 (50%), Gaps = 14/202 (6%)
Query: 20  RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRL 79
           + LG G FG VK+ +        A+K++++  +      D+   E   +  L H  +V+L
Sbjct: 30  KELGTGQFGVVKYGK-WRGQYDVAIKMIKEGSMSE----DEFIEEAKVMMNLSHEKLVQL 84
Query: 80  HEVLASKSKIYMVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHR 138
           + V   +  I+++ EY+  G L + +   + R Q  +  ++ + + + + Y  +K   HR
Sbjct: 85  YGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHR 144
Query: 139 DLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP---NYVAPEVLANRGYDG 195
           DL   N L++ +G +K+SDFGLS   ++  DD    ++ GS     +  PEVL    +  
Sbjct: 145 DLAARNCLVNDQGVVKVSDFGLS---RYVLDDEET-SSVGSKFPVRWSPPEVLMYSKF-S 199
Query: 196 ATSDIWSCGVILYIFRGDFKLP 217
           + SDIW+ GV+++      K+P
Sbjct: 200 SKSDIWAFGVLMWEIYSLGKMP 221

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 78.2 bits (191), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 61/227 (26%), Positives = 111/227 (48%), Gaps = 30/227 (13%)
Query: 7   KQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVK-----ILEKNRIIHLKITDQI 61
           K++   +  Y + RTL +G F K+   +  D+   +A+K     +LEK R       D+I
Sbjct: 24  KEKDKYINDYRIIRTLNQGKFNKIILCEK-DNKF-YALKKYEKSLLEKKRDFTKSNNDKI 81
Query: 62  ---------KREIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGEL--FDK---IAS 107
                    K E+  +  +K+   +    ++ +  ++Y++ EY+    +  FD+   +  
Sbjct: 82  SIKSKYDDFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLD 141
Query: 108 KGR---LQEAEGRKLFQQLIDGVSYCHN-KGVFHRDLKLENILLDSKGNIKISDFGLSAL 163
           K     +     + + + +++  SY HN K + HRD+K  NIL+D  G +K+SDFG S  
Sbjct: 142 KNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNGRVKLSDFGES-- 199
Query: 164 PQHFRDDGLLHTTCGSPNYVAPEVLANR-GYDGATSDIWSCGVILYI 209
              +  D  +  + G+  ++ PE  +N   Y+GA  DIWS G+ LY+
Sbjct: 200 --EYMVDKKIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYV 244

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 101/211 (47%), Gaps = 16/211 (7%)
Query: 18  LGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKR----EIATLKLLKH 73
           + + +G G FG+V   +     LP   +I    + + +  T++ +R    E + +    H
Sbjct: 49  IDKVVGAGEFGEVCSGR---LKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 105
Query: 74  PNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASK--GRLQEAEGRKLFQQLIDGVSYCH 131
           PN++RL  V+     + +V EY+  G L D    K   +    +   + + +  G+ Y  
Sbjct: 106 PNIIRLEGVVTKSKPVMIVTEYMENGSL-DSFLRKHDAQFTVIQLVGMLRGIASGMKYLS 164
Query: 132 NKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP---NYVAPEVL 188
           + G  HRDL   NIL++S    K+SDFGL+ + +   D    +TT G      + +PE +
Sbjct: 165 DMGYVHRDLAARNILINSNLVCKVSDFGLARVLED--DPEAAYTTRGGKIPIRWTSPEAI 222
Query: 189 ANRGYDGATSDIWSCGVILYIFRGDFKLPKW 219
           A R +  A SD+WS G++L+      + P W
Sbjct: 223 AYRKFTSA-SDVWSYGIVLWEVMSYGERPYW 252

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 55/202 (27%), Positives = 101/202 (50%), Gaps = 14/202 (6%)
Query: 20  RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRL 79
           + LG G FG VK+ +        A+K++++  +      D+   E   +  L H  +V+L
Sbjct: 15  KELGTGQFGVVKYGK-WRGQYDVAIKMIKEGSMSE----DEFIEEAKVMMNLSHEKLVQL 69
Query: 80  HEVLASKSKIYMVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHR 138
           + V   +  I+++ EY+  G L + +   + R Q  +  ++ + + + + Y  +K   HR
Sbjct: 70  YGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHR 129
Query: 139 DLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP---NYVAPEVLANRGYDG 195
           DL   N L++ +G +K+SDFGLS   ++  DD    +  GS     +  PEVL    +  
Sbjct: 130 DLAARNCLVNDQGVVKVSDFGLS---RYVLDDEYTSSR-GSKFPVRWSPPEVLMYSKF-S 184
Query: 196 ATSDIWSCGVILYIFRGDFKLP 217
           + SDIW+ GV+++      K+P
Sbjct: 185 SKSDIWAFGVLMWEIYSLGKMP 206

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 57/198 (28%), Positives = 97/198 (48%), Gaps = 9/198 (4%)
Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLP-FAVKILEKNRIIHLKITDQIKREIATLKLLKH 73
           R ELGR +GEG FG V     +    P  AV I          + ++  +E  T++   H
Sbjct: 391 RIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDH 450
Query: 74  PNVVRLHEVLASKSKIYMVLEYVTGGELFDKI-ASKGRLQEAEGRKLFQQLIDGVSYCHN 132
           P++V+L  V+ +++ +++++E  T GEL   +   K  L  A       QL   ++Y  +
Sbjct: 451 PHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLES 509
Query: 133 KGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGS--PNYVAPEVLAN 190
           K   HRD+   N+L+ +   +K+ DFGLS   ++  D      + G     ++APE +  
Sbjct: 510 KRFVHRDIAARNVLVSATDCVKLGDFGLS---RYMEDSTYYKASKGKLPIKWMAPESINF 566
Query: 191 RGYDGATSDIWSCGVILY 208
           R +  A SD+W  GV ++
Sbjct: 567 RRFTSA-SDVWMFGVCMW 583

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 55/201 (27%), Positives = 101/201 (50%), Gaps = 14/201 (6%)
Query: 14  GRYELGRTLGEGNFGKV---KFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKL 70
           G+  +G+ +G G+FG V   K+  D+      AVK+L        ++    K E+  L+ 
Sbjct: 24  GQITVGQRIGSGSFGTVYKGKWHGDV------AVKMLNVTAPTPQQL-QAFKNEVGVLRK 76
Query: 71  LKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKI-ASKGRLQEAEGRKLFQQLIDGVSY 129
            +H N++ L    ++K ++ +V ++  G  L+  + AS+ + +  +   + +Q   G+ Y
Sbjct: 77  TRHVNIL-LFMGYSTKPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDY 135
Query: 130 CHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLA 189
            H K + HRDLK  NI L     +KI DFGL+     +          GS  ++APEV+ 
Sbjct: 136 LHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIR 195
Query: 190 NRGYDGAT--SDIWSCGVILY 208
            +  +  +  SD+++ G++LY
Sbjct: 196 MQDSNPYSFQSDVYAFGIVLY 216

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 70/251 (27%), Positives = 112/251 (44%), Gaps = 35/251 (13%)
Query: 20  RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRL 79
           R LG G FG+V   Q   +G  +A K L K R+   K       E   L  +    +V L
Sbjct: 191 RVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSL 250
Query: 80  HEVLASKSKIYMVLEYVTGGELFDKIASKGR----LQEAEGRKLFQQLIDGVSYCHNKGV 135
                +K+ + +V+  + GG++   I +        QE        Q++ G+ + H + +
Sbjct: 251 AYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNI 310
Query: 136 FHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTT--CGSPNYVAPEVLANRGY 193
            +RDLK EN+LLD  GN++ISD GL+   +     G   T    G+P ++APE+L    Y
Sbjct: 311 IYRDLKPENVLLDDDGNVRISDLGLAVELKA----GQTKTKGYAGTPGFMAPELLLGEEY 366
Query: 194 DGATSDIWSCGVILY---IFRGDFK---------------------LPKWLSPGAQNLLR 229
           D +  D ++ GV LY     RG F+                      P   SP +++   
Sbjct: 367 DFSV-DYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPDKFSPASKDFCE 425
Query: 230 KILEPNPVKRI 240
            +L+ +P KR+
Sbjct: 426 ALLQKDPEKRL 436

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 70/251 (27%), Positives = 112/251 (44%), Gaps = 35/251 (13%)
Query: 20  RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRL 79
           R LG G FG+V   Q   +G  +A K L K R+   K       E   L  +    +V L
Sbjct: 191 RVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSL 250
Query: 80  HEVLASKSKIYMVLEYVTGGELFDKIASKGR----LQEAEGRKLFQQLIDGVSYCHNKGV 135
                +K+ + +V+  + GG++   I +        QE        Q++ G+ + H + +
Sbjct: 251 AYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNI 310
Query: 136 FHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTT--CGSPNYVAPEVLANRGY 193
            +RDLK EN+LLD  GN++ISD GL+   +     G   T    G+P ++APE+L    Y
Sbjct: 311 IYRDLKPENVLLDDDGNVRISDLGLAVELKA----GQTKTKGYAGTPGFMAPELLLGEEY 366
Query: 194 DGATSDIWSCGVILY---IFRGDFK---------------------LPKWLSPGAQNLLR 229
           D +  D ++ GV LY     RG F+                      P   SP +++   
Sbjct: 367 DFSV-DYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPDKFSPASKDFCE 425
Query: 230 KILEPNPVKRI 240
            +L+ +P KR+
Sbjct: 426 ALLQKDPEKRL 436

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 70/251 (27%), Positives = 112/251 (44%), Gaps = 35/251 (13%)
Query: 20  RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRL 79
           R LG G FG+V   Q   +G  +A K L K R+   K       E   L  +    +V L
Sbjct: 191 RVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSL 250
Query: 80  HEVLASKSKIYMVLEYVTGGELFDKIASKGR----LQEAEGRKLFQQLIDGVSYCHNKGV 135
                +K+ + +V+  + GG++   I +        QE        Q++ G+ + H + +
Sbjct: 251 AYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNI 310
Query: 136 FHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTT--CGSPNYVAPEVLANRGY 193
            +RDLK EN+LLD  GN++ISD GL+   +     G   T    G+P ++APE+L    Y
Sbjct: 311 IYRDLKPENVLLDDDGNVRISDLGLAVELKA----GQTKTKGYAGTPGFMAPELLLGEEY 366
Query: 194 DGATSDIWSCGVILY---IFRGDFK---------------------LPKWLSPGAQNLLR 229
           D +  D ++ GV LY     RG F+                      P   SP +++   
Sbjct: 367 DFSV-DYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPDKFSPASKDFCE 425
Query: 230 KILEPNPVKRI 240
            +L+ +P KR+
Sbjct: 426 ALLQKDPEKRL 436

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 70/251 (27%), Positives = 112/251 (44%), Gaps = 35/251 (13%)
Query: 20  RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRL 79
           R LG G FG+V   Q   +G  +A K L K R+   K       E   L  +    +V L
Sbjct: 191 RVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSL 250
Query: 80  HEVLASKSKIYMVLEYVTGGELFDKIASKGR----LQEAEGRKLFQQLIDGVSYCHNKGV 135
                +K+ + +V+  + GG++   I +        QE        Q++ G+ + H + +
Sbjct: 251 AYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNI 310
Query: 136 FHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTT--CGSPNYVAPEVLANRGY 193
            +RDLK EN+LLD  GN++ISD GL+   +     G   T    G+P ++APE+L    Y
Sbjct: 311 IYRDLKPENVLLDDDGNVRISDLGLAVELKA----GQTKTKGYAGTPGFMAPELLLGEEY 366
Query: 194 DGATSDIWSCGVILY---IFRGDFK---------------------LPKWLSPGAQNLLR 229
           D +  D ++ GV LY     RG F+                      P   SP +++   
Sbjct: 367 DFSV-DYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPDKFSPASKDFCE 425
Query: 230 KILEPNPVKRI 240
            +L+ +P KR+
Sbjct: 426 ALLQKDPEKRL 436

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 66/202 (32%), Positives = 103/202 (50%), Gaps = 23/202 (11%)
Query: 20  RTLGEGNFGKVKF----AQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
           R LGEG+FGKV        +  +G   AVK L+ +     +     K+EI  L+ L H +
Sbjct: 20  RDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKAD--CGPQHRSGWKQEIDILRTLYHEH 77
Query: 76  VVRLHEVLASKSK--IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNK 133
           +++       + +  + +V+EYV  G L D +  +  +  A+     QQ+ +G++Y H +
Sbjct: 78  IIKYKGCCEDQGEKSLQLVMEYVPLGSLRDYLP-RHSIGLAQLLLFAQQICEGMAYLHAQ 136
Query: 134 GVFHRDLKLENILLDSKGNIKISDFGLS-ALPQ-----HFRDDGLLHTTCGSPN-YVAPE 186
              HR+L   N+LLD+   +KI DFGL+ A+P+       R+DG       SP  + APE
Sbjct: 137 HYIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDG------DSPVFWYAPE 190
Query: 187 VLANRGYDGATSDIWSCGVILY 208
            L    +  A SD+WS GV LY
Sbjct: 191 CLKEYKFYYA-SDVWSFGVTLY 211

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 63/218 (28%), Positives = 102/218 (46%), Gaps = 24/218 (11%)
Query: 17  ELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNV 76
           +L + LG G FG+V      ++    AVK L+   +           E   +K L+H  +
Sbjct: 15  KLVKKLGAGQFGEVWMGY-YNNSTKVAVKTLKPGTMS----VQAFLEEANLMKTLQHDKL 69
Query: 77  VRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLID-------GVSY 129
           VRL+ V+  +  IY++ E++  G L D + S     +  G+ L  +LID       G++Y
Sbjct: 70  VRLYAVVTKEEPIYIITEFMAKGSLLDFLKS-----DEGGKVLLPKLIDFSAQIAEGMAY 124
Query: 130 CHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP-NYVAPEVL 188
              K   HRDL+  N+L+      KI+DFGL+ + +   ++         P  + APE +
Sbjct: 125 IERKNYIHRDLRAANVLVSESLMCKIADFGLARVIED--NEYTAREGAKFPIKWTAPEAI 182
Query: 189 ANRGYDGATSDIWSCGVILYIFRGDFKLPKWLSPGAQN 226
            N G     S++WS G++LY      K+P    PG  N
Sbjct: 183 -NFGCFTIKSNVWSFGILLYEIVTYGKIP---YPGRTN 216

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 61/195 (31%), Positives = 100/195 (51%), Gaps = 12/195 (6%)
Query: 22  LGEGNFGKVKFAQ----DLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVV 77
           LG+GNFG V+  +      ++G   AVK L+ +     +     +REI  LK L    +V
Sbjct: 18  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQR---DFQREIQILKALHSDFIV 74
Query: 78  RLHEVL--ASKSKIYMVLEYVTGGELFDKIA-SKGRLQEAEGRKLFQQLIDGVSYCHNKG 134
           +   V     +  + +V+EY+  G L D +   + RL  +       Q+  G+ Y  ++ 
Sbjct: 75  KYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRR 134
Query: 135 VFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP-NYVAPEVLANRGY 193
             HRDL   NIL++S+ ++KI+DFGL+ L    +D  ++     SP  + APE L++  +
Sbjct: 135 CVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIF 194
Query: 194 DGATSDIWSCGVILY 208
               SD+WS GV+LY
Sbjct: 195 -SRQSDVWSFGVVLY 208

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 61/195 (31%), Positives = 100/195 (51%), Gaps = 12/195 (6%)
Query: 22  LGEGNFGKVKFAQ----DLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVV 77
           LG+GNFG V+  +      ++G   AVK L+ +     +     +REI  LK L    +V
Sbjct: 19  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQR---DFQREIQILKALHSDFIV 75
Query: 78  RLHEVL--ASKSKIYMVLEYVTGGELFDKIA-SKGRLQEAEGRKLFQQLIDGVSYCHNKG 134
           +   V     +  + +V+EY+  G L D +   + RL  +       Q+  G+ Y  ++ 
Sbjct: 76  KYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRR 135
Query: 135 VFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP-NYVAPEVLANRGY 193
             HRDL   NIL++S+ ++KI+DFGL+ L    +D  ++     SP  + APE L++  +
Sbjct: 136 CVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIF 195
Query: 194 DGATSDIWSCGVILY 208
               SD+WS GV+LY
Sbjct: 196 S-RQSDVWSFGVVLY 209

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 100/211 (47%), Gaps = 16/211 (7%)
Query: 18  LGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKR----EIATLKLLKH 73
           + + +G G FG+V   +     LP   +I    + + +  T++ +R    E + +    H
Sbjct: 49  IDKVVGAGEFGEVCSGR---LKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 105
Query: 74  PNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASK--GRLQEAEGRKLFQQLIDGVSYCH 131
           PN++RL  V+     + +V EY+  G L D    K   +    +   + + +  G+ Y  
Sbjct: 106 PNIIRLEGVVTKSKPVMIVTEYMENGSL-DSFLRKHDAQFTVIQLVGMLRGIASGMKYLS 164
Query: 132 NKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP---NYVAPEVL 188
           + G  HRDL   NIL++S    K+SDFGL  + +   D    +TT G      + +PE +
Sbjct: 165 DMGYVHRDLAARNILINSNLVCKVSDFGLGRVLED--DPEAAYTTRGGKIPIRWTSPEAI 222
Query: 189 ANRGYDGATSDIWSCGVILYIFRGDFKLPKW 219
           A R +  A SD+WS G++L+      + P W
Sbjct: 223 AYRKFTSA-SDVWSYGIVLWEVMSYGERPYW 252

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 61/195 (31%), Positives = 100/195 (51%), Gaps = 12/195 (6%)
Query: 22  LGEGNFGKVKFAQ----DLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVV 77
           LG+GNFG V+  +      ++G   AVK L+ +     +     +REI  LK L    +V
Sbjct: 31  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQR---DFQREIQILKALHSDFIV 87
Query: 78  RLHEVL--ASKSKIYMVLEYVTGGELFDKIA-SKGRLQEAEGRKLFQQLIDGVSYCHNKG 134
           +   V     +  + +V+EY+  G L D +   + RL  +       Q+  G+ Y  ++ 
Sbjct: 88  KYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRR 147
Query: 135 VFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP-NYVAPEVLANRGY 193
             HRDL   NIL++S+ ++KI+DFGL+ L    +D  ++     SP  + APE L++  +
Sbjct: 148 CVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIF 207
Query: 194 DGATSDIWSCGVILY 208
               SD+WS GV+LY
Sbjct: 208 S-RQSDVWSFGVVLY 221

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 62/219 (28%), Positives = 107/219 (48%), Gaps = 32/219 (14%)
Query: 7   KQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIA 66
           K+ GM     EL   +G G FG+V  A+    G  + +K ++ N        ++ +RE+ 
Sbjct: 7   KRFGMDFKEIEL---IGSGGFGQVFKAKHRIDGKTYVIKRVKYN-------NEKAEREVK 56
Query: 67  TLKLLKHPNVVRLHEVL-------------ASKSK---IYMVLEYVTGGELFDKIASKG- 109
            L  L H N+V  +                +S+SK   +++ +E+   G L   I  +  
Sbjct: 57  ALAKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRG 116
Query: 110 -RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFR 168
            +L +    +LF+Q+  GV Y H+K + +RDLK  NI L     +KI DFGL       +
Sbjct: 117 EKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVT---SLK 173
Query: 169 DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVIL 207
           +DG    + G+  Y++PE ++++ Y G   D+++ G+IL
Sbjct: 174 NDGKRXRSKGTLRYMSPEQISSQDY-GKEVDLYALGLIL 211

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 99/205 (48%), Gaps = 21/205 (10%)
Query: 13  LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLK--ITDQIKREIATLKL 70
           + RY     LGEG +G+V  A D  +    A+K   + R+ H +  +     RE++ LK 
Sbjct: 33  IDRYRRITKLGEGTYGEVYKAIDTVTNETVAIK---RIRLEHEEEGVPGTAIREVSLLKE 89
Query: 71  LKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYC 130
           L+H N++ L  V+    +++++ EY    +L   +     +     +    QLI+GV++C
Sbjct: 90  LQHRNIIELKSVIHHNHRLHLIFEYAEN-DLKKYMDKNPDVSMRVIKSFLYQLINGVNFC 148
Query: 131 HNKGVFHRDLKLENILLDSKGN-----IKISDFGLS---ALP-QHFRDDGLLHTTCGSPN 181
           H++   HRDLK +N+LL          +KI DFGL+    +P + F  + +      +  
Sbjct: 149 HSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEII------TLW 202
Query: 182 YVAPEVLANRGYDGATSDIWSCGVI 206
           Y  PE+L    +   + DIWS   I
Sbjct: 203 YRPPEILLGSRHYSTSVDIWSIACI 227

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 61/201 (30%), Positives = 102/201 (50%), Gaps = 19/201 (9%)
Query: 20  RTLGEGNFGKVKFA----QDLDSGLPFAVKILEK----NRIIHLKITDQIKREIATLKLL 71
           R LGEG+FGKV+      +  ++G   AVK L+     N I  LK      +EI  L+ L
Sbjct: 27  RDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLK------KEIEILRNL 80
Query: 72  KHPNVVRLHEVLASK--SKIYMVLEYVTGGELFDKI-ASKGRLQEAEGRKLFQQLIDGVS 128
            H N+V+   +      + I +++E++  G L + +  +K ++   +  K   Q+  G+ 
Sbjct: 81  YHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMD 140
Query: 129 YCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNY-VAPEV 187
           Y  ++   HRDL   N+L++S+  +KI DFGL+   +  ++   +     SP +  APE 
Sbjct: 141 YLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWYAPEC 200
Query: 188 LANRGYDGATSDIWSCGVILY 208
           L    +  A SD+WS GV L+
Sbjct: 201 LMQSKFYIA-SDVWSFGVTLH 220

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 100/211 (47%), Gaps = 16/211 (7%)
Query: 18  LGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKR----EIATLKLLKH 73
           + + +G G FG+V   +     LP   +I    + + +  T++ +R    E + +    H
Sbjct: 49  IDKVVGAGEFGEVCSGR---LKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 105
Query: 74  PNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASK--GRLQEAEGRKLFQQLIDGVSYCH 131
           PN++RL  V+     + +V E +  G L D    K   +    +   + + +  G+ Y  
Sbjct: 106 PNIIRLEGVVTKSKPVMIVTEXMENGSL-DSFLRKHDAQFTVIQLVGMLRGIASGMKYLS 164
Query: 132 NKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP---NYVAPEVL 188
           + G  HRDL   NIL++S    K+SDFGLS + +   D    +TT G      + +PE +
Sbjct: 165 DMGAVHRDLAARNILINSNLVCKVSDFGLSRVLED--DPEAAYTTRGGKIPIRWTSPEAI 222
Query: 189 ANRGYDGATSDIWSCGVILYIFRGDFKLPKW 219
           A R +  A SD+WS G++L+      + P W
Sbjct: 223 AYRKFTSA-SDVWSYGIVLWEVMSYGERPYW 252

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 63/205 (30%), Positives = 99/205 (48%), Gaps = 23/205 (11%)
Query: 16  YELGRT------LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKI-TDQIKREIATL 68
           +EL +T      +G G +G V  A D  SG   A+K L  +R    +I   +  RE+  L
Sbjct: 20  WELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKL--SRPFQSEIFAKRAYRELLLL 77
Query: 69  KLLKHPNVVRLHEVLASKSKI------YMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQ 122
           K ++H NV+ L +V    S +      Y+V+ ++       KI    +  E + + L  Q
Sbjct: 78  KHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQTD--LQKIMGL-KFSEEKIQYLVYQ 134
Query: 123 LIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNY 182
           ++ G+ Y H+ GV HRDLK  N+ ++    +KI DFGL+        D  +     +  Y
Sbjct: 135 MLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLAR-----HADAEMTGYVVTRWY 189
Query: 183 VAPEVLANRGYDGATSDIWSCGVIL 207
            APEV+ +  +   T DIWS G I+
Sbjct: 190 RAPEVILSWMHYNQTVDIWSVGCIM 214

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 60/223 (26%), Positives = 105/223 (47%), Gaps = 17/223 (7%)
Query: 20  RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKR----EIATLKLLKHPN 75
           + +G G FG+V   +     +P   +I    + +    TD+ +R    E + +    HPN
Sbjct: 35  KVIGVGEFGEVCSGR---LKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPN 91
Query: 76  VVRLHEVLASKSKIYMVLEYVTGGELFDKIASK--GRLQEAEGRKLFQQLIDGVSYCHNK 133
           ++ L  V+     + ++ EY+  G L D    K  GR    +   + + +  G+ Y  + 
Sbjct: 92  IIHLEGVVTKCKPVMIITEYMENGSL-DAFLRKNDGRFTVIQLVGMLRGIGSGMKYLSDM 150
Query: 134 GVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP---NYVAPEVLAN 190
              HRDL   NIL++S    K+SDFG+S + +   D    +TT G      + APE +A 
Sbjct: 151 SAVHRDLAARNILVNSNLVCKVSDFGMSRVLED--DPEAAYTTRGGKIPIRWTAPEAIAY 208
Query: 191 RGYDGATSDIWSCGVILYIFRGDFKLPKWLSPGAQNLLRKILE 233
           R +  A SD+WS G++++      + P W     Q++++ I E
Sbjct: 209 RKFTSA-SDVWSYGIVMWEVMSYGERPYW-DMSNQDVIKAIEE 249

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 61/201 (30%), Positives = 102/201 (50%), Gaps = 19/201 (9%)
Query: 20  RTLGEGNFGKVKFA----QDLDSGLPFAVKILEK----NRIIHLKITDQIKREIATLKLL 71
           R LGEG+FGKV+      +  ++G   AVK L+     N I  LK      +EI  L+ L
Sbjct: 15  RDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLK------KEIEILRNL 68
Query: 72  KHPNVVRLHEVLASK--SKIYMVLEYVTGGELFDKI-ASKGRLQEAEGRKLFQQLIDGVS 128
            H N+V+   +      + I +++E++  G L + +  +K ++   +  K   Q+  G+ 
Sbjct: 69  YHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMD 128
Query: 129 YCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNY-VAPEV 187
           Y  ++   HRDL   N+L++S+  +KI DFGL+   +  ++   +     SP +  APE 
Sbjct: 129 YLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWYAPEC 188
Query: 188 LANRGYDGATSDIWSCGVILY 208
           L    +  A SD+WS GV L+
Sbjct: 189 LMQSKFYIA-SDVWSFGVTLH 208

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 100/211 (47%), Gaps = 16/211 (7%)
Query: 18  LGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKR----EIATLKLLKH 73
           + + +G G FG+V   +     LP   +I    + + +  T++ +R    E + +    H
Sbjct: 20  IDKVVGAGEFGEVCSGR---LKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 76
Query: 74  PNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASK--GRLQEAEGRKLFQQLIDGVSYCH 131
           PN++RL  V+     + +V E +  G L D    K   +    +   + + +  G+ Y  
Sbjct: 77  PNIIRLEGVVTKSKPVMIVTEXMENGSL-DSFLRKHDAQFTVIQLVGMLRGIASGMKYLS 135
Query: 132 NKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP---NYVAPEVL 188
           + G  HRDL   NIL++S    K+SDFGLS + +   D    +TT G      + +PE +
Sbjct: 136 DMGYVHRDLAARNILINSNLVCKVSDFGLSRVLED--DPEAAYTTRGGKIPIRWTSPEAI 193
Query: 189 ANRGYDGATSDIWSCGVILYIFRGDFKLPKW 219
           A R +  A SD+WS G++L+      + P W
Sbjct: 194 AYRKFTSA-SDVWSYGIVLWEVMSYGERPYW 223

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 54/201 (26%), Positives = 100/201 (49%), Gaps = 14/201 (6%)
Query: 14  GRYELGRTLGEGNFGKV---KFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKL 70
           G+  +G+ +G G+FG V   K+  D+      AVK+L        ++    K E+  L+ 
Sbjct: 24  GQITVGQRIGSGSFGTVYKGKWHGDV------AVKMLNVTAPTPQQL-QAFKNEVGVLRK 76
Query: 71  LKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKI-ASKGRLQEAEGRKLFQQLIDGVSY 129
            +H N++ L    ++  ++ +V ++  G  L+  + AS+ + +  +   + +Q   G+ Y
Sbjct: 77  TRHVNIL-LFMGYSTAPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDY 135
Query: 130 CHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLA 189
            H K + HRDLK  NI L     +KI DFGL+     +          GS  ++APEV+ 
Sbjct: 136 LHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIR 195
Query: 190 NRGYDGAT--SDIWSCGVILY 208
            +  +  +  SD+++ G++LY
Sbjct: 196 MQDSNPYSFQSDVYAFGIVLY 216

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 60/193 (31%), Positives = 93/193 (48%), Gaps = 17/193 (8%)
Query: 22  LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKI-TDQIKREIATLKLLKHPNVVRLH 80
           +G G +G V  A D  SG   A+K L  +R    +I   +  RE+  LK ++H NV+ L 
Sbjct: 50  VGSGAYGSVCSAIDKRSGEKVAIKKL--SRPFQSEIFAKRAYRELLLLKHMQHENVIGLL 107
Query: 81  EVLASKSKI------YMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKG 134
           +V    S +      Y+V+ ++       KI       E + + L  Q++ G+ Y H+ G
Sbjct: 108 DVFTPASSLRNFYDFYLVMPFMQTD--LQKIMGM-EFSEEKIQYLVYQMLKGLKYIHSAG 164
Query: 135 VFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYD 194
           V HRDLK  N+ ++    +KI DFGL+        D  +     +  Y APEV+ +  + 
Sbjct: 165 VVHRDLKPGNLAVNEDCELKILDFGLAR-----HADAEMTGYVVTRWYRAPEVILSWMHY 219
Query: 195 GATSDIWSCGVIL 207
             T DIWS G I+
Sbjct: 220 NQTVDIWSVGCIM 232

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 62/221 (28%), Positives = 100/221 (45%), Gaps = 24/221 (10%)
Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
           YE+  T+G G +G V  A+   +G   A+K +  N    +    +  RE+  LK  KH N
Sbjct: 56  YEIIETIGNGAYGVVSSARRRLTGQQVAIKKI-PNAFDVVTNAKRTLRELKILKHFKHDN 114
Query: 76  VVRLHEVLASK------SKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSY 129
           ++ + ++L           +Y+VL+ +   +L   I S   L     R    QL+ G+ Y
Sbjct: 115 IIAIKDILRPTVPYGEFKSVYVVLDLMES-DLHQIIHSSQPLTLEHVRYFLYQLLRGLKY 173
Query: 130 CHNKGVFHRDLKLENILLDSKGNIKISDFGLS-------ALPQHFRDDGLLHTTCGSPNY 182
            H+  V HRDLK  N+L++    +KI DFG++       A  Q+F     +     +  Y
Sbjct: 174 MHSAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYF-----MTEYVATRWY 228
Query: 183 VAPEVLANRGYDGATSDIWSCGVILYIFRGDFKLPKWLSPG 223
            APE++ +        D+WS G I     G+    + L PG
Sbjct: 229 RAPELMLSLHEYTQAIDLWSVGCIF----GEMLARRQLFPG 265

>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350

Iteration: 1
 Score = 75.9 bits (185), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 58/199 (29%), Positives = 95/199 (47%), Gaps = 20/199 (10%)
Query: 22  LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHE 81
           LG G+FG+V   +D  +G   AVK   K R+   ++      E+     L  P +V L+ 
Sbjct: 80  LGRGSFGEVHRMKDKQTGFQCAVK---KVRLEVFRV-----EELVACAGLSSPRIVPLYG 131
Query: 82  VLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLK 141
            +     + + +E + GG L   I   G L E        Q ++G+ Y H + + H D+K
Sbjct: 132 AVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVK 191
Query: 142 LENILLDSKGN-IKISDFGLSALPQHFRDDGLLHTTC------GSPNYVAPEVLANRGYD 194
            +N+LL S G+   + DFG +      + DGL  +        G+  ++APEV+  +  D
Sbjct: 192 ADNVLLSSDGSRAALCDFGHALC---LQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCD 248
Query: 195 GATSDIW-SCGVILYIFRG 212
            A  DIW SC ++L++  G
Sbjct: 249 -AKVDIWSSCCMMLHMLNG 266

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 100/211 (47%), Gaps = 16/211 (7%)
Query: 18  LGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKR----EIATLKLLKH 73
           + + +G G FG+V   +     LP   +I    + + +  T++ +R    E + +    H
Sbjct: 49  IDKVVGAGEFGEVCSGR---LKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 105
Query: 74  PNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASK--GRLQEAEGRKLFQQLIDGVSYCH 131
           PN++RL  V+     + +V E +  G L D    K   +    +   + + +  G+ Y  
Sbjct: 106 PNIIRLEGVVTKSKPVMIVTEXMENGSL-DSFLRKHDAQFTVIQLVGMLRGIASGMKYLS 164
Query: 132 NKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP---NYVAPEVL 188
           + G  HRDL   NIL++S    K+SDFGLS + +   D    +TT G      + +PE +
Sbjct: 165 DMGYVHRDLAARNILINSNLVCKVSDFGLSRVLED--DPEAAYTTRGGKIPIRWTSPEAI 222
Query: 189 ANRGYDGATSDIWSCGVILYIFRGDFKLPKW 219
           A R +  A SD+WS G++L+      + P W
Sbjct: 223 AYRKFTSA-SDVWSYGIVLWEVMSYGERPYW 252

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 57/202 (28%), Positives = 93/202 (46%), Gaps = 16/202 (7%)
Query: 10  GMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLK 69
            + +   +L +T+G+G FG V        G   AVK ++ +      +      E + + 
Sbjct: 17  ALNMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDATAQAFLA-----EASVMT 69
Query: 70  LLKHPNVVRLHEVLAS-KSKIYMVLEYVTGGELFDKIASKGR--LQEAEGRKLFQQLIDG 126
            L+H N+V+L  V+   K  +Y+V EY+  G L D + S+GR  L      K    + + 
Sbjct: 70  QLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEA 129
Query: 127 VSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPE 186
           + Y       HRDL   N+L+      K+SDFGL+      +D G L        + APE
Sbjct: 130 MEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPV-----KWTAPE 184
Query: 187 VLANRGYDGATSDIWSCGVILY 208
            L  + +    SD+WS G++L+
Sbjct: 185 ALREKKFS-TKSDVWSFGILLW 205

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 57/202 (28%), Positives = 93/202 (46%), Gaps = 16/202 (7%)
Query: 10  GMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLK 69
            + +   +L +T+G+G FG V        G   AVK ++ +      +      E + + 
Sbjct: 189 ALNMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDATAQAFLA-----EASVMT 241
Query: 70  LLKHPNVVRLHEVLAS-KSKIYMVLEYVTGGELFDKIASKGR--LQEAEGRKLFQQLIDG 126
            L+H N+V+L  V+   K  +Y+V EY+  G L D + S+GR  L      K    + + 
Sbjct: 242 QLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEA 301
Query: 127 VSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPE 186
           + Y       HRDL   N+L+      K+SDFGL+      +D G L        + APE
Sbjct: 302 MEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPV-----KWTAPE 356
Query: 187 VLANRGYDGATSDIWSCGVILY 208
            L  + +    SD+WS G++L+
Sbjct: 357 ALREKKFS-TKSDVWSFGILLW 377

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 62/221 (28%), Positives = 100/221 (45%), Gaps = 24/221 (10%)
Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
           YE+  T+G G +G V  A+   +G   A+K +  N    +    +  RE+  LK  KH N
Sbjct: 57  YEIIETIGNGAYGVVSSARRRLTGQQVAIKKI-PNAFDVVTNAKRTLRELKILKHFKHDN 115
Query: 76  VVRLHEVLASK------SKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSY 129
           ++ + ++L           +Y+VL+ +   +L   I S   L     R    QL+ G+ Y
Sbjct: 116 IIAIKDILRPTVPYGEFKSVYVVLDLMES-DLHQIIHSSQPLTLEHVRYFLYQLLRGLKY 174
Query: 130 CHNKGVFHRDLKLENILLDSKGNIKISDFGLS-------ALPQHFRDDGLLHTTCGSPNY 182
            H+  V HRDLK  N+L++    +KI DFG++       A  Q+F     +     +  Y
Sbjct: 175 MHSAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYF-----MTEYVATRWY 229
Query: 183 VAPEVLANRGYDGATSDIWSCGVILYIFRGDFKLPKWLSPG 223
            APE++ +        D+WS G I     G+    + L PG
Sbjct: 230 RAPELMLSLHEYTQAIDLWSVGCIF----GEMLARRQLFPG 266

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 57/202 (28%), Positives = 93/202 (46%), Gaps = 16/202 (7%)
Query: 10  GMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLK 69
            + +   +L +T+G+G FG V        G   AVK ++ +      +      E + + 
Sbjct: 2   ALNMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDATAQAFLA-----EASVMT 54
Query: 70  LLKHPNVVRLHEVLAS-KSKIYMVLEYVTGGELFDKIASKGR--LQEAEGRKLFQQLIDG 126
            L+H N+V+L  V+   K  +Y+V EY+  G L D + S+GR  L      K    + + 
Sbjct: 55  QLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEA 114
Query: 127 VSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPE 186
           + Y       HRDL   N+L+      K+SDFGL+      +D G L        + APE
Sbjct: 115 MEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPV-----KWTAPE 169
Query: 187 VLANRGYDGATSDIWSCGVILY 208
            L  + +    SD+WS G++L+
Sbjct: 170 ALREKKFS-TKSDVWSFGILLW 190

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 60/223 (26%), Positives = 105/223 (47%), Gaps = 17/223 (7%)
Query: 20  RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKR----EIATLKLLKHPN 75
           + +G G FG+V   +     +P   +I    + +    TD+ +R    E + +    HPN
Sbjct: 20  KVIGVGEFGEVCSGR---LKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPN 76
Query: 76  VVRLHEVLASKSKIYMVLEYVTGGELFDKIASK--GRLQEAEGRKLFQQLIDGVSYCHNK 133
           ++ L  V+     + ++ EY+  G L D    K  GR    +   + + +  G+ Y  + 
Sbjct: 77  IIHLEGVVTKCKPVMIITEYMENGSL-DAFLRKNDGRFTVIQLVGMLRGIGSGMKYLSDM 135
Query: 134 GVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP---NYVAPEVLAN 190
              HRDL   NIL++S    K+SDFG+S + +   D    +TT G      + APE +A 
Sbjct: 136 SYVHRDLAARNILVNSNLVCKVSDFGMSRVLED--DPEAAYTTRGGKIPIRWTAPEAIAY 193
Query: 191 RGYDGATSDIWSCGVILYIFRGDFKLPKWLSPGAQNLLRKILE 233
           R +  A SD+WS G++++      + P W     Q++++ I E
Sbjct: 194 RKFTSA-SDVWSYGIVMWEVMSYGERPYW-DMSNQDVIKAIEE 234

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 91/207 (43%), Gaps = 21/207 (10%)
Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEK--NRIIHLKITDQIKREIATLKLLKH 73
           ++L   LGEG +G V  A    +G   A+K +E     +  L+      REI  LK  KH
Sbjct: 13  FQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTL----REIKILKHFKH 68
Query: 74  PNVVRLHEVLASKS-----KIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVS 128
            N++ +  +    S     ++Y++ E +       ++ S   L +   +    Q +  V 
Sbjct: 69  ENIITIFNIQRPDSFENFNEVYIIQELMQTD--LHRVISTQMLSDDHIQYFIYQTLRAVK 126
Query: 129 YCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHT--TCGSPNYV--- 183
             H   V HRDLK  N+L++S  ++K+ DFGL+ +      D    T    G   YV   
Sbjct: 127 VLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMTEYVATR 186
Query: 184 ---APEVLANRGYDGATSDIWSCGVIL 207
              APEV+          D+WSCG IL
Sbjct: 187 WYRAPEVMLTSAKYSRAMDVWSCGCIL 213

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 60/223 (26%), Positives = 105/223 (47%), Gaps = 17/223 (7%)
Query: 20  RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKR----EIATLKLLKHPN 75
           + +G G FG+V   +     +P   +I    + +    TD+ +R    E + +    HPN
Sbjct: 14  KVIGVGEFGEVCSGR---LKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPN 70
Query: 76  VVRLHEVLASKSKIYMVLEYVTGGELFDKIASK--GRLQEAEGRKLFQQLIDGVSYCHNK 133
           ++ L  V+     + ++ EY+  G L D    K  GR    +   + + +  G+ Y  + 
Sbjct: 71  IIHLEGVVTKCKPVMIITEYMENGSL-DAFLRKNDGRFTVIQLVGMLRGIGSGMKYLSDM 129
Query: 134 GVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP---NYVAPEVLAN 190
              HRDL   NIL++S    K+SDFG+S + +   D    +TT G      + APE +A 
Sbjct: 130 SYVHRDLAARNILVNSNLVCKVSDFGMSRVLED--DPEAAYTTRGGKIPIRWTAPEAIAY 187
Query: 191 RGYDGATSDIWSCGVILYIFRGDFKLPKWLSPGAQNLLRKILE 233
           R +  A SD+WS G++++      + P W     Q++++ I E
Sbjct: 188 RKFTSA-SDVWSYGIVMWEVMSYGERPYW-DMSNQDVIKAIEE 228

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 61/217 (28%), Positives = 104/217 (47%), Gaps = 31/217 (14%)
Query: 18  LGRTLGEGNFGKVKFAQDL-------DSGLPFAVKILEKNRIIHLKITDQIKREIATLKL 70
           LG+ LGEG FG+V  A+ +          +  AVK+L K+      ++D +  E+  +K+
Sbjct: 39  LGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKML-KDDATEKDLSDLVS-EMEMMKM 96
Query: 71  L-KHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASK-----------GRLQEAEGR- 117
           + KH N++ L         +Y+++EY + G L + + ++            R+ E +   
Sbjct: 97  IGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEXSYDINRVPEEQMTF 156
Query: 118 ----KLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLL 173
                   QL  G+ Y  ++   HRDL   N+L+     +KI+DFGL+    +   D   
Sbjct: 157 KDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNI--DXXK 214
Query: 174 HTTCG--SPNYVAPEVLANRGYDGATSDIWSCGVILY 208
            TT G     ++APE L +R Y    SD+WS GV+++
Sbjct: 215 KTTNGRLPVKWMAPEALFDRVY-THQSDVWSFGVLMW 250

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 61/203 (30%), Positives = 94/203 (46%), Gaps = 18/203 (8%)
Query: 13  LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEK--NRIIHLKITDQIKREIATLKL 70
           L RY+  + +G G  G V  A D       A+K L +      H K   +  RE+  +K+
Sbjct: 23  LKRYQNLKPIGSGAQGIVVAAYDAILERNVAIKKLSRPFQNQTHAK---RAYRELVLMKV 79
Query: 71  LKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRK---LFQQLIDGV 127
           + H N++ L  V   +  +    +     EL D   S+    E +  +   L  Q++ G+
Sbjct: 80  VNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQMLVGI 139
Query: 128 SYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDG---LLHTTCGSPNYVA 184
            + H+ G+ HRDLK  NI++ S   +KI DFGL+      R  G   ++     +  Y A
Sbjct: 140 KHLHSAGIIHRDLKPSNIVVKSDATLKILDFGLA------RTAGTSFMMTPYVVTRYYRA 193
Query: 185 PEVLANRGYDGATSDIWSCGVIL 207
           PEV+   GY     DIWS GVI+
Sbjct: 194 PEVILGMGYK-ENVDIWSVGVIM 215

>pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 71/226 (31%), Positives = 105/226 (46%), Gaps = 38/226 (16%)
Query: 15  RYELGRTLGEGNFGKVKFAQD-LDSGLPFAVKILEKNRIIH-LKITDQIKREIATLKLLK 72
           RYE+   +G G++G V  A D L+  +    KIL   R+   L    +I REIA L  L 
Sbjct: 54  RYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKIL---RVFEDLIDCKRILREIAILNRLN 110
Query: 73  HPNVVRLHEVLASKS-----KIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGV 127
           H +VV++ +++  K      ++Y+VLE +   +      +   L E   + L   L+ GV
Sbjct: 111 HDHVVKVLDIVIPKDVEKFDELYVVLE-IADSDFKKLFRTPVYLTELHIKTLLYNLLVGV 169
Query: 128 SYCHNKGVFHRDLKLENILLDSKGNIKISDFGL-----------SALPQHFRDDGL-LHT 175
            Y H+ G+ HRDLK  N L++   ++K+ DFGL           S LP   R+D + L T
Sbjct: 170 KYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVT 229
Query: 176 TCGSPN-------------YVAPE-VLANRGYDGATSDIWSCGVIL 207
              + N             Y APE +L    Y  A  D+WS G I 
Sbjct: 230 FPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAI-DVWSIGCIF 274

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 63/221 (28%), Positives = 105/221 (47%), Gaps = 39/221 (17%)
Query: 18  LGRTLGEGNFGKVKFAQDL-------DSGLPFAVKILEKNRIIHLKITDQIKREIATLKL 70
           LG+ LGEG FG+V  A+ +          +  AVK+L K+      ++D +  E+  +K+
Sbjct: 39  LGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKML-KDDATEKDLSDLVS-EMEMMKM 96
Query: 71  L-KHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASK-----------GRLQEAEGR- 117
           + KH N++ L         +Y+++EY + G L + + ++            R+ E +   
Sbjct: 97  IGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTF 156
Query: 118 ----KLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD---- 169
                   QL  G+ Y  ++   HRDL   N+L+     +KI+DFGL+      RD    
Sbjct: 157 KDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLA------RDINNI 210
Query: 170 DGLLHTTCG--SPNYVAPEVLANRGYDGATSDIWSCGVILY 208
           D    TT G     ++APE L +R Y    SD+WS GV+++
Sbjct: 211 DXXKKTTNGRLPVKWMAPEALFDRVY-THQSDVWSFGVLMW 250

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 57/202 (28%), Positives = 92/202 (45%), Gaps = 16/202 (7%)
Query: 10  GMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLK 69
            + +   +L +T+G+G FG V        G   AVK ++ +      +      E + + 
Sbjct: 8   ALNMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDATAQAFLA-----EASVMT 60
Query: 70  LLKHPNVVRLHEVLAS-KSKIYMVLEYVTGGELFDKIASKGR--LQEAEGRKLFQQLIDG 126
            L+H N+V+L  V+   K  +Y+V EY+  G L D + S+GR  L      K    + + 
Sbjct: 61  QLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEA 120
Query: 127 VSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPE 186
           + Y       HRDL   N+L+      K+SDFGL+      +D G L        + APE
Sbjct: 121 MEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPV-----KWTAPE 175
Query: 187 VLANRGYDGATSDIWSCGVILY 208
            L    +    SD+WS G++L+
Sbjct: 176 ALREAAFS-TKSDVWSFGILLW 196

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 61/217 (28%), Positives = 105/217 (48%), Gaps = 31/217 (14%)
Query: 18  LGRTLGEGNFGKVKFAQDL-------DSGLPFAVKILEKNRIIHLKITDQIKREIATLKL 70
           LG+ LGEG FG+V  A+ +          +  AVK+L K+      ++D +  E+  +K+
Sbjct: 39  LGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKML-KDDATEKDLSDLVS-EMEMMKM 96
Query: 71  L-KHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASK-----------GRLQEAEGR- 117
           + KH N++ L         +Y+++EY + G L + + ++            R+ E +   
Sbjct: 97  IGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTF 156
Query: 118 ----KLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLL 173
                   QL  G+ Y  ++   HRDL   N+L+     +KI+DFGL+    +   D   
Sbjct: 157 KDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNI--DYYK 214
Query: 174 HTTCG--SPNYVAPEVLANRGYDGATSDIWSCGVILY 208
           +TT G     ++APE L +R Y    SD+WS GV+++
Sbjct: 215 NTTNGRLPVKWMAPEALFDRVY-THQSDVWSFGVLMW 250

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score = 75.1 bits (183), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 90/207 (43%), Gaps = 21/207 (10%)
Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEK--NRIIHLKITDQIKREIATLKLLKH 73
           ++L   LGEG +G V  A    +G   A+K +E     +  L+      REI  LK  KH
Sbjct: 13  FQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTL----REIKILKHFKH 68
Query: 74  PNVVRLHEVLASKS-----KIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVS 128
            N++ +  +    S     ++Y++ E +       ++ S   L +   +    Q +  V 
Sbjct: 69  ENIITIFNIQRPDSFENFNEVYIIQELMQTD--LHRVISTQMLSDDHIQYFIYQTLRAVK 126
Query: 129 YCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGL--------LHTTCGSP 180
             H   V HRDLK  N+L++S  ++K+ DFGL+ +      D          +     + 
Sbjct: 127 VLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMTEXVATR 186
Query: 181 NYVAPEVLANRGYDGATSDIWSCGVIL 207
            Y APEV+          D+WSCG IL
Sbjct: 187 WYRAPEVMLTSAKYSRAMDVWSCGCIL 213

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 74.7 bits (182), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 61/203 (30%), Positives = 94/203 (46%), Gaps = 18/203 (8%)
Query: 13  LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEK--NRIIHLKITDQIKREIATLKL 70
           L RY+  + +G G  G V  A D       A+K L +      H K   +  RE+  +K+
Sbjct: 23  LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAK---RAYRELVLMKV 79
Query: 71  LKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRK---LFQQLIDGV 127
           + H N++ L  V   +  +    +     EL D   S+    E +  +   L  Q++ G+
Sbjct: 80  VNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQMLVGI 139
Query: 128 SYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDG---LLHTTCGSPNYVA 184
            + H+ G+ HRDLK  NI++ S   +KI DFGL+      R  G   ++     +  Y A
Sbjct: 140 KHLHSAGIIHRDLKPSNIVVKSDATLKILDFGLA------RTAGTSFMMTPYVVTRYYRA 193
Query: 185 PEVLANRGYDGATSDIWSCGVIL 207
           PEV+   GY     DIWS GVI+
Sbjct: 194 PEVILGMGYK-ENVDIWSVGVIM 215

>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336

Iteration: 1
 Score = 74.7 bits (182), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 57/199 (28%), Positives = 95/199 (47%), Gaps = 20/199 (10%)
Query: 22  LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHE 81
           +G G+FG+V   +D  +G   AVK   K R+   ++      E+     L  P +V L+ 
Sbjct: 66  VGRGSFGEVHRMKDKQTGFQCAVK---KVRLEVFRV-----EELVACAGLSSPRIVPLYG 117
Query: 82  VLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLK 141
            +     + + +E + GG L   I   G L E        Q ++G+ Y H + + H D+K
Sbjct: 118 AVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVK 177
Query: 142 LENILLDSKGN-IKISDFGLSALPQHFRDDGLLHTTC------GSPNYVAPEVLANRGYD 194
            +N+LL S G+   + DFG +      + DGL  +        G+  ++APEV+  +  D
Sbjct: 178 ADNVLLSSDGSRAALCDFGHALC---LQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCD 234
Query: 195 GATSDIW-SCGVILYIFRG 212
            A  DIW SC ++L++  G
Sbjct: 235 -AKVDIWSSCCMMLHMLNG 252

>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352

Iteration: 1
 Score = 74.7 bits (182), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 57/199 (28%), Positives = 95/199 (47%), Gaps = 20/199 (10%)
Query: 22  LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHE 81
           +G G+FG+V   +D  +G   AVK   K R+   ++      E+     L  P +V L+ 
Sbjct: 82  VGRGSFGEVHRMKDKQTGFQCAVK---KVRLEVFRV-----EELVACAGLSSPRIVPLYG 133
Query: 82  VLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLK 141
            +     + + +E + GG L   I   G L E        Q ++G+ Y H + + H D+K
Sbjct: 134 AVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVK 193
Query: 142 LENILLDSKGN-IKISDFGLSALPQHFRDDGLLHTTC------GSPNYVAPEVLANRGYD 194
            +N+LL S G+   + DFG +      + DGL  +        G+  ++APEV+  +  D
Sbjct: 194 ADNVLLSSDGSRAALCDFGHALC---LQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCD 250
Query: 195 GATSDIW-SCGVILYIFRG 212
            A  DIW SC ++L++  G
Sbjct: 251 -AKVDIWSSCCMMLHMLNG 268

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 74.7 bits (182), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 64/214 (29%), Positives = 103/214 (48%), Gaps = 15/214 (7%)
Query: 22  LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHE 81
           LG G FG+V      +     AVK L++  +      D    E   +K L+H  +VRL+ 
Sbjct: 29  LGAGQFGEVWMGY-YNGHTKVAVKSLKQGSMS----PDAFLAEANLMKQLQHQRLVRLYA 83
Query: 82  VLASKSKIYMVLEYVTGGELFD--KIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRD 139
           V+ ++  IY++ EY+  G L D  K  S  +L   +   +  Q+ +G+++   +   HRD
Sbjct: 84  VV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRD 142
Query: 140 LKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP-NYVAPEVLANRGYDGATS 198
           L+  NIL+    + KI+DFGL+ L +   ++         P  + APE + N G     S
Sbjct: 143 LRAANILVSDTLSCKIADFGLARLIED--NEXTAREGAKFPIKWTAPEAI-NYGTFTIKS 199
Query: 199 DIWSCGVIL--YIFRGDFKLPKWLSPGA-QNLLR 229
           D+WS G++L   +  G    P   +P   QNL R
Sbjct: 200 DVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLER 233

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 74.7 bits (182), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 74/288 (25%), Positives = 124/288 (43%), Gaps = 49/288 (17%)
Query: 10  GMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVK-ILEKNRIIHLKITDQIKREIATL 68
           G  L  +E  + LG G FG V  A++      +A+K I   NR +     +++ RE+  L
Sbjct: 1   GRYLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNREL---AREKVMREVKAL 57
Query: 69  KLLKHPNVVRLHEVLASKSK------------IYMVLEYVTGGELFDKIASKGRLQEAEG 116
             L+HP +VR       K+             +Y+ ++      L D +  +  ++E E 
Sbjct: 58  AKLEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERER 117
Query: 117 R---KLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGL-SALPQHFRDDGL 172
                +F Q+ + V + H+KG+ HRDLK  NI       +K+ DFGL +A+ Q   +  +
Sbjct: 118 SVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTV 177
Query: 173 L--------HT-TCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIFRGDF--------- 214
           L        HT   G+  Y++PE +    Y     DI+S G+IL+     F         
Sbjct: 178 LTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKV-DIFSLGLILFELLYPFSTQMERVRT 236
Query: 215 -------KLPKWLS---PGAQNLLRKILEPNPVKRITIAGIKADEWFE 252
                  K P   +   P    +++ +L P+P++R     I  +  FE
Sbjct: 237 LTDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFE 284

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 58/192 (30%), Positives = 85/192 (44%), Gaps = 6/192 (3%)
Query: 19  GRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVR 78
           G   GEG FG V +   +++      K+     I   ++  Q  +EI      +H N+V 
Sbjct: 27  GNKXGEGGFGVV-YKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVXAKCQHENLVE 85
Query: 79  LHEVLASKSKIYMVLEYVTGGELFDKIAS---KGRLQEAEGRKLFQQLIDGVSYCHNKGV 135
           L    +    + +V  Y   G L D+++       L      K+ Q   +G+++ H    
Sbjct: 86  LLGFSSDGDDLCLVYVYXPNGSLLDRLSCLDGTPPLSWHXRCKIAQGAANGINFLHENHH 145
Query: 136 FHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDG 195
            HRD+K  NILLD     KISDFGL+   + F          G+  Y APE L  RG   
Sbjct: 146 IHRDIKSANILLDEAFTAKISDFGLARASEKFAQXVXXSRIVGTTAYXAPEAL--RGEIT 203
Query: 196 ATSDIWSCGVIL 207
             SDI+S GV+L
Sbjct: 204 PKSDIYSFGVVL 215

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 64/214 (29%), Positives = 103/214 (48%), Gaps = 15/214 (7%)
Query: 22  LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHE 81
           LG G FG+V      +     AVK L++  +      D    E   +K L+H  +VRL+ 
Sbjct: 27  LGAGQFGEVWMGY-YNGHTKVAVKSLKQGSMS----PDAFLAEANLMKQLQHQRLVRLYA 81
Query: 82  VLASKSKIYMVLEYVTGGELFD--KIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRD 139
           V+ ++  IY++ EY+  G L D  K  S  +L   +   +  Q+ +G+++   +   HRD
Sbjct: 82  VV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRD 140
Query: 140 LKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP-NYVAPEVLANRGYDGATS 198
           L+  NIL+    + KI+DFGL+ L +   ++         P  + APE + N G     S
Sbjct: 141 LRAANILVSDTLSCKIADFGLARLIED--NEXTAREGAKFPIKWTAPEAI-NYGTFTIKS 197
Query: 199 DIWSCGVIL--YIFRGDFKLPKWLSPGA-QNLLR 229
           D+WS G++L   +  G    P   +P   QNL R
Sbjct: 198 DVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLER 231

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 71/248 (28%), Positives = 108/248 (43%), Gaps = 28/248 (11%)
Query: 9   EGMRLG-RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIAT 67
            G  LG RY   + LG G  G V  A D D     A+K   K  +   +      REI  
Sbjct: 5   HGFDLGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIK---KIVLTDPQSVKHALREIKI 61
Query: 68  LKLLKHPNVVRLHEVLASK--------------SKIYMVLEYVTGGELFDKIASKGRLQE 113
           ++ L H N+V++ E+L                 + +Y+V EY+        +  +G L E
Sbjct: 62  IRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETD--LANVLEQGPLLE 119
Query: 114 AEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNI-KISDFGLS-ALPQHFRDDG 171
              R    QL+ G+ Y H+  V HRDLK  N+ ++++  + KI DFGL+  +  H+   G
Sbjct: 120 EHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKG 179
Query: 172 LLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIFRGDFKLPKWLSPGAQNL--LR 229
            L     +  Y +P +L +        D+W+ G I      +    K L  GA  L  ++
Sbjct: 180 HLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIF----AEMLTGKTLFAGAHELEQMQ 235
Query: 230 KILEPNPV 237
            ILE  PV
Sbjct: 236 LILESIPV 243

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 64/214 (29%), Positives = 103/214 (48%), Gaps = 15/214 (7%)
Query: 22  LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHE 81
           LG G FG+V      +     AVK L++  +      D    E   +K L+H  +VRL+ 
Sbjct: 30  LGAGQFGEVWMGY-YNGHTKVAVKSLKQGSMS----PDAFLAEANLMKQLQHQRLVRLYA 84
Query: 82  VLASKSKIYMVLEYVTGGELFD--KIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRD 139
           V+ ++  IY++ EY+  G L D  K  S  +L   +   +  Q+ +G+++   +   HRD
Sbjct: 85  VV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRD 143
Query: 140 LKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP-NYVAPEVLANRGYDGATS 198
           L+  NIL+    + KI+DFGL+ L +   ++         P  + APE + N G     S
Sbjct: 144 LRAANILVSDTLSCKIADFGLARLIED--NEXTAREGAKFPIKWTAPEAI-NYGTFTIKS 200
Query: 199 DIWSCGVIL--YIFRGDFKLPKWLSPGA-QNLLR 229
           D+WS G++L   +  G    P   +P   QNL R
Sbjct: 201 DVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLER 234

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 90/207 (43%), Gaps = 21/207 (10%)
Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEK--NRIIHLKITDQIKREIATLKLLKH 73
           ++L   LGEG +G V  A    +G   A+K +E     +  L+      REI  LK  KH
Sbjct: 13  FQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTL----REIKILKHFKH 68
Query: 74  PNVVRLHEVLASKS-----KIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVS 128
            N++ +  +    S     ++Y++ E +       ++ S   L +   +    Q +  V 
Sbjct: 69  ENIITIFNIQRPDSFENFNEVYIIQELMQTD--LHRVISTQMLSDDHIQYFIYQTLRAVK 126
Query: 129 YCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHT--------TCGSP 180
             H   V HRDLK  N+L++S  ++K+ DFGL+ +      D    T           + 
Sbjct: 127 VLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATR 186
Query: 181 NYVAPEVLANRGYDGATSDIWSCGVIL 207
            Y APEV+          D+WSCG IL
Sbjct: 187 WYRAPEVMLTSAKYSRAMDVWSCGCIL 213

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 63/221 (28%), Positives = 105/221 (47%), Gaps = 39/221 (17%)
Query: 18  LGRTLGEGNFGKVKFAQDL-------DSGLPFAVKILEKNRIIHLKITDQIKREIATLKL 70
           LG+ LGEG FG+V  A+ +          +  AVK+L K+      ++D +  E+  +K+
Sbjct: 39  LGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKML-KDDATEKDLSDLVS-EMEMMKM 96
Query: 71  L-KHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASK-----------GRLQEAEGR- 117
           + KH N++ L         +Y+++EY + G L + + ++            R+ E +   
Sbjct: 97  IGKHKNIIHLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTF 156
Query: 118 ----KLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD---- 169
                   QL  G+ Y  ++   HRDL   N+L+     +KI+DFGL+      RD    
Sbjct: 157 KDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLA------RDINNI 210
Query: 170 DGLLHTTCG--SPNYVAPEVLANRGYDGATSDIWSCGVILY 208
           D    TT G     ++APE L +R Y    SD+WS GV+++
Sbjct: 211 DYYKKTTNGRLPVKWMAPEALFDRVY-THQSDVWSFGVLMW 250

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 64/214 (29%), Positives = 103/214 (48%), Gaps = 15/214 (7%)
Query: 22  LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHE 81
           LG G FG+V      +     AVK L++  +      D    E   +K L+H  +VRL+ 
Sbjct: 21  LGAGQFGEVWMGY-YNGHTKVAVKSLKQGSMS----PDAFLAEANLMKQLQHQRLVRLYA 75
Query: 82  VLASKSKIYMVLEYVTGGELFD--KIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRD 139
           V+ ++  IY++ EY+  G L D  K  S  +L   +   +  Q+ +G+++   +   HRD
Sbjct: 76  VV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRD 134
Query: 140 LKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP-NYVAPEVLANRGYDGATS 198
           L+  NIL+    + KI+DFGL+ L +   ++         P  + APE + N G     S
Sbjct: 135 LRAANILVSDTLSCKIADFGLARLIED--NEXTAREGAKFPIKWTAPEAI-NYGTFTIKS 191
Query: 199 DIWSCGVIL--YIFRGDFKLPKWLSPGA-QNLLR 229
           D+WS G++L   +  G    P   +P   QNL R
Sbjct: 192 DVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLER 225

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 63/221 (28%), Positives = 105/221 (47%), Gaps = 39/221 (17%)
Query: 18  LGRTLGEGNFGKVKFAQDL-------DSGLPFAVKILEKNRIIHLKITDQIKREIATLKL 70
           LG+ LGEG FG+V  A+ +          +  AVK+L K+      ++D +  E+  +K+
Sbjct: 85  LGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKML-KDDATEKDLSDLVS-EMEMMKM 142
Query: 71  L-KHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASK-----------GRLQEAEGR- 117
           + KH N++ L         +Y+++EY + G L + + ++            R+ E +   
Sbjct: 143 IGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTF 202
Query: 118 ----KLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD---- 169
                   QL  G+ Y  ++   HRDL   N+L+     +KI+DFGL+      RD    
Sbjct: 203 KDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLA------RDINNI 256
Query: 170 DGLLHTTCG--SPNYVAPEVLANRGYDGATSDIWSCGVILY 208
           D    TT G     ++APE L +R Y    SD+WS GV+++
Sbjct: 257 DYYKKTTNGRLPVKWMAPEALFDRVYTHQ-SDVWSFGVLMW 296

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 64/214 (29%), Positives = 103/214 (48%), Gaps = 15/214 (7%)
Query: 22  LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHE 81
           LG G FG+V      +     AVK L++  +      D    E   +K L+H  +VRL+ 
Sbjct: 23  LGAGQFGEVWMGY-YNGHTKVAVKSLKQGSMS----PDAFLAEANLMKQLQHQRLVRLYA 77
Query: 82  VLASKSKIYMVLEYVTGGELFD--KIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRD 139
           V+ ++  IY++ EY+  G L D  K  S  +L   +   +  Q+ +G+++   +   HRD
Sbjct: 78  VV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRD 136
Query: 140 LKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP-NYVAPEVLANRGYDGATS 198
           L+  NIL+    + KI+DFGL+ L +   ++         P  + APE + N G     S
Sbjct: 137 LRAANILVSDTLSCKIADFGLARLIED--NEXTAREGAKFPIKWTAPEAI-NYGTFTIKS 193
Query: 199 DIWSCGVIL--YIFRGDFKLPKWLSPGA-QNLLR 229
           D+WS G++L   +  G    P   +P   QNL R
Sbjct: 194 DVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLER 227

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 61/217 (28%), Positives = 104/217 (47%), Gaps = 31/217 (14%)
Query: 18  LGRTLGEGNFGKVKFAQDL-------DSGLPFAVKILEKNRIIHLKITDQIKREIATLKL 70
           LG+ LGEG FG+V  A+ +          +  AVK+L K+      ++D +  E+  +K+
Sbjct: 39  LGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKML-KDDATEEDLSDLVS-EMEMMKM 96
Query: 71  L-KHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASK-----------GRLQEAEGR- 117
           + KH N++ L         +Y+++EY + G L + + ++            R+ E +   
Sbjct: 97  IGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTF 156
Query: 118 ----KLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLL 173
                   QL  G+ Y  ++   HRDL   N+L+     +KI+DFGL+    +   D   
Sbjct: 157 KDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNI--DYYK 214
Query: 174 HTTCG--SPNYVAPEVLANRGYDGATSDIWSCGVILY 208
            TT G     ++APE L +R Y    SD+WS GV+++
Sbjct: 215 KTTNGRLPVKWMAPEALFDRVY-THQSDVWSFGVLMW 250

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 64/214 (29%), Positives = 103/214 (48%), Gaps = 15/214 (7%)
Query: 22  LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHE 81
           LG G FG+V      +     AVK L++  +      D    E   +K L+H  +VRL+ 
Sbjct: 22  LGAGQFGEVWMGY-YNGHTKVAVKSLKQGSMS----PDAFLAEANLMKQLQHQRLVRLYA 76
Query: 82  VLASKSKIYMVLEYVTGGELFD--KIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRD 139
           V+ ++  IY++ EY+  G L D  K  S  +L   +   +  Q+ +G+++   +   HRD
Sbjct: 77  VV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRD 135
Query: 140 LKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP-NYVAPEVLANRGYDGATS 198
           L+  NIL+    + KI+DFGL+ L +   ++         P  + APE + N G     S
Sbjct: 136 LRAANILVSDTLSCKIADFGLARLIED--NEXTAREGAKFPIKWTAPEAI-NYGTFTIKS 192
Query: 199 DIWSCGVIL--YIFRGDFKLPKWLSPGA-QNLLR 229
           D+WS G++L   +  G    P   +P   QNL R
Sbjct: 193 DVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLER 226

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 61/217 (28%), Positives = 104/217 (47%), Gaps = 31/217 (14%)
Query: 18  LGRTLGEGNFGKVKFAQDL-------DSGLPFAVKILEKNRIIHLKITDQIKREIATLKL 70
           LG+ LGEG FG+V  A+ +          +  AVK+L K+      ++D +  E+  +K+
Sbjct: 26  LGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKML-KDDATEKDLSDLVS-EMEMMKM 83
Query: 71  L-KHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASK-----------GRLQEAEGR- 117
           + KH N++ L         +Y+++EY + G L + + ++            R+ E +   
Sbjct: 84  IGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTF 143
Query: 118 ----KLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLL 173
                   QL  G+ Y  ++   HRDL   N+L+     +KI+DFGL+    +   D   
Sbjct: 144 KDLVSCTYQLARGMEYLASQKCIHRDLTARNVLVTENNVMKIADFGLARDINNI--DYYK 201
Query: 174 HTTCG--SPNYVAPEVLANRGYDGATSDIWSCGVILY 208
            TT G     ++APE L +R Y    SD+WS GV+++
Sbjct: 202 KTTNGRLPVKWMAPEALFDRVY-THQSDVWSFGVLMW 237

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 65/216 (30%), Positives = 103/216 (47%), Gaps = 19/216 (8%)
Query: 22  LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHE 81
           LG G FG+V      +     AVK L++  +      D    E   +K L+H  +VRL+ 
Sbjct: 31  LGAGQFGEVWMGY-YNGHTKVAVKSLKQGSMS----PDAFLAEANLMKQLQHQRLVRLYA 85
Query: 82  VLASKSKIYMVLEYVTGGELFD--KIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRD 139
           V+ ++  IY++ EY+  G L D  K  S  +L   +   +  Q+ +G+++   +   HRD
Sbjct: 86  VV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRD 144
Query: 140 LKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP---NYVAPEVLANRGYDGA 196
           L+  NIL+    + KI+DFGL+ L     +D       G+     + APE + N G    
Sbjct: 145 LRAANILVSDTLSCKIADFGLARL----IEDNEYTAREGAKFPIKWTAPEAI-NYGTFTI 199
Query: 197 TSDIWSCGVIL--YIFRGDFKLPKWLSPGA-QNLLR 229
            SD+WS G++L   +  G    P   +P   QNL R
Sbjct: 200 KSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLER 235

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 67/218 (30%), Positives = 105/218 (48%), Gaps = 33/218 (15%)
Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVK-ILEKNRIIHLKITDQIKREIATLKLLKHP 74
           Y   + +G G+FG V  A+  DSG   A+K +L+  R  +        RE+  ++ L H 
Sbjct: 56  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN--------RELQIMRKLDHC 107
Query: 75  NVVRLHEVLAS----KSKIYM--VLEYVTGGELFDKIA-----SKGRLQEAEGRKLFQQL 123
           N+VRL     S    K ++Y+  VL+YV   E   ++A     +K  L     +    QL
Sbjct: 108 NIVRLRYFFYSSGEKKDEVYLNLVLDYVP--ETVYRVARHYSRAKQTLPVIYVKLYMYQL 165
Query: 124 IDGVSYCHNKGVFHRDLKLENILLDSKGNI-KISDFGLSALPQHFRDDGLLHTTCGSPNY 182
              ++Y H+ G+ HRD+K +N+LLD    + K+ DFG +   Q  R +  +   C S  Y
Sbjct: 166 FRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAK--QLVRGEPNVSXIC-SRYY 222
Query: 183 VAPEVLANRGYDGATSDIWSCGVILY-------IFRGD 213
            APE++       ++ D+WS G +L        IF GD
Sbjct: 223 RAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGD 260

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 61/217 (28%), Positives = 104/217 (47%), Gaps = 31/217 (14%)
Query: 18  LGRTLGEGNFGKVKFAQDL-------DSGLPFAVKILEKNRIIHLKITDQIKREIATLKL 70
           LG+ LGEG FG+V  A+ +          +  AVK+L K+      ++D +  E+  +K+
Sbjct: 39  LGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKML-KDDATEKDLSDLVS-EMEMMKM 96
Query: 71  L-KHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASK-----------GRLQEAEGR- 117
           + KH N++ L         +Y+++EY + G L + + ++            R+ E +   
Sbjct: 97  IGKHKNIITLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTF 156
Query: 118 ----KLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLL 173
                   QL  G+ Y  ++   HRDL   N+L+     +KI+DFGL+    +   D   
Sbjct: 157 KDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNI--DYYK 214
Query: 174 HTTCG--SPNYVAPEVLANRGYDGATSDIWSCGVILY 208
            TT G     ++APE L +R Y    SD+WS GV+++
Sbjct: 215 KTTNGRLPVKWMAPEALFDRVY-THQSDVWSFGVLMW 250

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 57/193 (29%), Positives = 94/193 (48%), Gaps = 20/193 (10%)
Query: 17  ELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNV 76
           +L + LG G FG+V  A   +     AVK ++   +      +    E   +K L+H  +
Sbjct: 185 KLEKKLGAGQFGEVWMAT-YNKHTKVAVKTMKPGSMS----VEAFLAEANVMKTLQHDKL 239
Query: 77  VRLHEVLASKSKIYMVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQ-QLIDGVSYCHNKG 134
           V+LH V+ +K  IY++ E++  G L D + S +G  Q       F  Q+ +G+++   + 
Sbjct: 240 VKLHAVV-TKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN 298
Query: 135 VFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYD 194
             HRDL+  NIL+ +    KI+DFGL+ +   F              + APE + N G  
Sbjct: 299 YIHRDLRAANILVSASLVCKIADFGLARVGAKF-----------PIKWTAPEAI-NFGSF 346
Query: 195 GATSDIWSCGVIL 207
              SD+WS G++L
Sbjct: 347 TIKSDVWSFGILL 359

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 61/217 (28%), Positives = 104/217 (47%), Gaps = 31/217 (14%)
Query: 18  LGRTLGEGNFGKVKFAQDL-------DSGLPFAVKILEKNRIIHLKITDQIKREIATLKL 70
           LG+ LGEG FG+V  A+ +          +  AVK+L K+      ++D +  E+  +K+
Sbjct: 31  LGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKML-KDDATEKDLSDLVS-EMEMMKM 88
Query: 71  L-KHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASK-----------GRLQEAEGR- 117
           + KH N++ L         +Y+++EY + G L + + ++            R+ E +   
Sbjct: 89  IGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTF 148
Query: 118 ----KLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLL 173
                   QL  G+ Y  ++   HRDL   N+L+     +KI+DFGL+    +   D   
Sbjct: 149 KDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNI--DYYK 206
Query: 174 HTTCG--SPNYVAPEVLANRGYDGATSDIWSCGVILY 208
            TT G     ++APE L +R Y    SD+WS GV+++
Sbjct: 207 KTTNGRLPVKWMAPEALFDRVY-THQSDVWSFGVLMW 242

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 61/217 (28%), Positives = 104/217 (47%), Gaps = 31/217 (14%)
Query: 18  LGRTLGEGNFGKVKFAQDL-------DSGLPFAVKILEKNRIIHLKITDQIKREIATLKL 70
           LG+ LGEG FG+V  A+ +          +  AVK+L K+      ++D +  E+  +K+
Sbjct: 28  LGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKML-KDDATEKDLSDLVS-EMEMMKM 85
Query: 71  L-KHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASK-----------GRLQEAEGR- 117
           + KH N++ L         +Y+++EY + G L + + ++            R+ E +   
Sbjct: 86  IGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTF 145
Query: 118 ----KLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLL 173
                   QL  G+ Y  ++   HRDL   N+L+     +KI+DFGL+    +   D   
Sbjct: 146 KDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNI--DYYK 203
Query: 174 HTTCG--SPNYVAPEVLANRGYDGATSDIWSCGVILY 208
            TT G     ++APE L +R Y    SD+WS GV+++
Sbjct: 204 KTTNGRLPVKWMAPEALFDRVYT-HQSDVWSFGVLMW 239

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 64/214 (29%), Positives = 103/214 (48%), Gaps = 15/214 (7%)
Query: 22  LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHE 81
           LG G FG+V      +     AVK L++  +      D    E   +K L+H  +VRL+ 
Sbjct: 27  LGAGQFGEVWMGY-YNGHTKVAVKSLKQGSMS----PDAFLAEANLMKQLQHQRLVRLYA 81
Query: 82  VLASKSKIYMVLEYVTGGELFD--KIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRD 139
           V+ ++  IY++ EY+  G L D  K  S  +L   +   +  Q+ +G+++   +   HRD
Sbjct: 82  VV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRD 140
Query: 140 LKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP-NYVAPEVLANRGYDGATS 198
           L+  NIL+    + KI+DFGL+ L +   ++         P  + APE + N G     S
Sbjct: 141 LRAANILVSDTLSCKIADFGLARLIED--NEYTAREGAKFPIKWTAPEAI-NYGTFTIKS 197
Query: 199 DIWSCGVIL--YIFRGDFKLPKWLSPGA-QNLLR 229
           D+WS G++L   +  G    P   +P   QNL R
Sbjct: 198 DVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLER 231

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 64/214 (29%), Positives = 103/214 (48%), Gaps = 15/214 (7%)
Query: 22  LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHE 81
           LG G FG+V      +     AVK L++  +      D    E   +K L+H  +VRL+ 
Sbjct: 26  LGAGQFGEVWMGY-YNGHTKVAVKSLKQGSMS----PDAFLAEANLMKQLQHQRLVRLYA 80
Query: 82  VLASKSKIYMVLEYVTGGELFD--KIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRD 139
           V+ ++  IY++ EY+  G L D  K  S  +L   +   +  Q+ +G+++   +   HRD
Sbjct: 81  VV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRD 139
Query: 140 LKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP-NYVAPEVLANRGYDGATS 198
           L+  NIL+    + KI+DFGL+ L +   ++         P  + APE + N G     S
Sbjct: 140 LRAANILVSDTLSCKIADFGLARLIED--NEYTAREGAKFPIKWTAPEAI-NYGTFTIKS 196
Query: 199 DIWSCGVIL--YIFRGDFKLPKWLSPGA-QNLLR 229
           D+WS G++L   +  G    P   +P   QNL R
Sbjct: 197 DVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLER 230

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 67/218 (30%), Positives = 105/218 (48%), Gaps = 33/218 (15%)
Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVK-ILEKNRIIHLKITDQIKREIATLKLLKHP 74
           Y   + +G G+FG V  A+  DSG   A+K +L+  R  +        RE+  ++ L H 
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN--------RELQIMRKLDHC 73
Query: 75  NVVRLHEVLAS----KSKIYM--VLEYVTGGELFDKIA-----SKGRLQEAEGRKLFQQL 123
           N+VRL     S    K ++Y+  VL+YV   E   ++A     +K  L     +    QL
Sbjct: 74  NIVRLRYFFYSSGEKKDEVYLNLVLDYVP--ETVYRVARHYSRAKQTLPVIYVKLYMYQL 131
Query: 124 IDGVSYCHNKGVFHRDLKLENILLDSKGNI-KISDFGLSALPQHFRDDGLLHTTCGSPNY 182
              ++Y H+ G+ HRD+K +N+LLD    + K+ DFG +   Q  R +  +   C S  Y
Sbjct: 132 FRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAK--QLVRGEPNVSXIC-SRYY 188
Query: 183 VAPEVLANRGYDGATSDIWSCGVILY-------IFRGD 213
            APE++       ++ D+WS G +L        IF GD
Sbjct: 189 RAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGD 226

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 65/216 (30%), Positives = 103/216 (47%), Gaps = 19/216 (8%)
Query: 22  LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHE 81
           LG G FG+V      +     AVK L++  +      D    E   +K L+H  +VRL+ 
Sbjct: 16  LGAGQFGEVWMGY-YNGHTKVAVKSLKQGSMS----PDAFLAEANLMKQLQHQRLVRLYA 70
Query: 82  VLASKSKIYMVLEYVTGGELFD--KIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRD 139
           V+ ++  IY++ EY+  G L D  K  S  +L   +   +  Q+ +G+++   +   HRD
Sbjct: 71  VV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRD 129
Query: 140 LKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP---NYVAPEVLANRGYDGA 196
           L+  NIL+    + KI+DFGL+ L +    D       G+     + APE + N G    
Sbjct: 130 LRAANILVSDTLSCKIADFGLARLIE----DNEYTAREGAKFPIKWTAPEAI-NYGTFTI 184
Query: 197 TSDIWSCGVIL--YIFRGDFKLPKWLSPGA-QNLLR 229
            SD+WS G++L   +  G    P   +P   QNL R
Sbjct: 185 KSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLER 220

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 64/214 (29%), Positives = 103/214 (48%), Gaps = 15/214 (7%)
Query: 22  LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHE 81
           LG G FG+V      +     AVK L++  +      D    E   +K L+H  +VRL+ 
Sbjct: 21  LGAGQFGEVWMGY-YNGHTKVAVKSLKQGSMS----PDAFLAEANLMKQLQHQRLVRLYA 75
Query: 82  VLASKSKIYMVLEYVTGGELFD--KIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRD 139
           V+ ++  IY++ EY+  G L D  K  S  +L   +   +  Q+ +G+++   +   HRD
Sbjct: 76  VV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRD 134
Query: 140 LKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP-NYVAPEVLANRGYDGATS 198
           L+  NIL+    + KI+DFGL+ L +   ++         P  + APE + N G     S
Sbjct: 135 LRAANILVSDTLSCKIADFGLARLIED--NEXTAREGAKFPIKWTAPEAI-NYGTFTIKS 191
Query: 199 DIWSCGVIL--YIFRGDFKLPKWLSPGA-QNLLR 229
           D+WS G++L   +  G    P   +P   QNL R
Sbjct: 192 DVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLER 225

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 67/218 (30%), Positives = 105/218 (48%), Gaps = 33/218 (15%)
Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVK-ILEKNRIIHLKITDQIKREIATLKLLKHP 74
           Y   + +G G+FG V  A+  DSG   A+K +L+  R  +        RE+  ++ L H 
Sbjct: 34  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN--------RELQIMRKLDHC 85
Query: 75  NVVRLHEVLAS----KSKIYM--VLEYVTGGELFDKIA-----SKGRLQEAEGRKLFQQL 123
           N+VRL     S    K ++Y+  VL+YV   E   ++A     +K  L     +    QL
Sbjct: 86  NIVRLRYFFYSSGEKKDEVYLNLVLDYVP--ETVYRVARHYSRAKQTLPVIYVKLYMYQL 143
Query: 124 IDGVSYCHNKGVFHRDLKLENILLDSKGNI-KISDFGLSALPQHFRDDGLLHTTCGSPNY 182
              ++Y H+ G+ HRD+K +N+LLD    + K+ DFG +   Q  R +  +   C S  Y
Sbjct: 144 FRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAK--QLVRGEPNVSXIC-SRYY 200
Query: 183 VAPEVLANRGYDGATSDIWSCGVILY-------IFRGD 213
            APE++       ++ D+WS G +L        IF GD
Sbjct: 201 RAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGD 238

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 67/218 (30%), Positives = 105/218 (48%), Gaps = 33/218 (15%)
Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVK-ILEKNRIIHLKITDQIKREIATLKLLKHP 74
           Y   + +G G+FG V  A+  DSG   A+K +L+  R  +        RE+  ++ L H 
Sbjct: 41  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN--------RELQIMRKLDHC 92
Query: 75  NVVRLHEVLAS----KSKIYM--VLEYVTGGELFDKIA-----SKGRLQEAEGRKLFQQL 123
           N+VRL     S    K ++Y+  VL+YV   E   ++A     +K  L     +    QL
Sbjct: 93  NIVRLRYFFYSSGEKKDEVYLNLVLDYVP--ETVYRVARHYSRAKQTLPVIYVKLYMYQL 150
Query: 124 IDGVSYCHNKGVFHRDLKLENILLDSKGNI-KISDFGLSALPQHFRDDGLLHTTCGSPNY 182
              ++Y H+ G+ HRD+K +N+LLD    + K+ DFG +   Q  R +  +   C S  Y
Sbjct: 151 FRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAK--QLVRGEPNVSXIC-SRYY 207
Query: 183 VAPEVLANRGYDGATSDIWSCGVILY-------IFRGD 213
            APE++       ++ D+WS G +L        IF GD
Sbjct: 208 RAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGD 245

>pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 67/213 (31%), Positives = 101/213 (47%), Gaps = 25/213 (11%)
Query: 13  LGRYELGRTLGEGNFGKV--KFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKL 70
           L  YE G  +G G +G V     +D      +A+K +E        I+    REIA L+ 
Sbjct: 21  LFEYE-GCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGT-----GISMSACREIALLRE 74
Query: 71  LKHPNVVRLHEVLASKS--KIYMVLEYVTGGELFDKI-------ASKGRLQEAEG--RKL 119
           LKHPNV+ L +V  S +  K++++ +Y    +L+  I       A+K  +Q   G  + L
Sbjct: 75  LKHPNVISLQKVFLSHADRKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSL 133
Query: 120 FQQLIDGVSYCHNKGVFHRDLKLENILL----DSKGNIKISDFGLSAL-PQHFRDDGLLH 174
             Q++DG+ Y H   V HRDLK  NIL+      +G +KI+D G + L     +    L 
Sbjct: 134 LYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLD 193
Query: 175 TTCGSPNYVAPEVLANRGYDGATSDIWSCGVIL 207
               +  Y APE+L    +     DIW+ G I 
Sbjct: 194 PVVVTFWYRAPELLLGARHYTKAIDIWAIGCIF 226

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 67/218 (30%), Positives = 105/218 (48%), Gaps = 33/218 (15%)
Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVK-ILEKNRIIHLKITDQIKREIATLKLLKHP 74
           Y   + +G G+FG V  A+  DSG   A+K +L+  R  +        RE+  ++ L H 
Sbjct: 34  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN--------RELQIMRKLDHC 85
Query: 75  NVVRLHEVLAS----KSKIYM--VLEYVTGGELFDKIA-----SKGRLQEAEGRKLFQQL 123
           N+VRL     S    K ++Y+  VL+YV   E   ++A     +K  L     +    QL
Sbjct: 86  NIVRLRYFFYSSGEKKDEVYLNLVLDYVP--ETVYRVARHYSRAKQTLPVIYVKLYMYQL 143
Query: 124 IDGVSYCHNKGVFHRDLKLENILLDSKGNI-KISDFGLSALPQHFRDDGLLHTTCGSPNY 182
              ++Y H+ G+ HRD+K +N+LLD    + K+ DFG +   Q  R +  +   C S  Y
Sbjct: 144 FRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAK--QLVRGEPNVSXIC-SRYY 200
Query: 183 VAPEVLANRGYDGATSDIWSCGVILY-------IFRGD 213
            APE++       ++ D+WS G +L        IF GD
Sbjct: 201 RAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGD 238

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 67/218 (30%), Positives = 105/218 (48%), Gaps = 33/218 (15%)
Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVK-ILEKNRIIHLKITDQIKREIATLKLLKHP 74
           Y   + +G G+FG V  A+  DSG   A+K +L+  R  +        RE+  ++ L H 
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN--------RELQIMRKLDHC 73
Query: 75  NVVRLHEVLAS----KSKIYM--VLEYVTGGELFDKIA-----SKGRLQEAEGRKLFQQL 123
           N+VRL     S    K ++Y+  VL+YV   E   ++A     +K  L     +    QL
Sbjct: 74  NIVRLRYFFYSSGEKKDEVYLNLVLDYVP--ETVYRVARHYSRAKQTLPVIYVKLYMYQL 131
Query: 124 IDGVSYCHNKGVFHRDLKLENILLDSKGNI-KISDFGLSALPQHFRDDGLLHTTCGSPNY 182
              ++Y H+ G+ HRD+K +N+LLD    + K+ DFG +   Q  R +  +   C S  Y
Sbjct: 132 FRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAK--QLVRGEPNVSXIC-SRYY 188
Query: 183 VAPEVLANRGYDGATSDIWSCGVILY-------IFRGD 213
            APE++       ++ D+WS G +L        IF GD
Sbjct: 189 RAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGD 226

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 71/286 (24%), Positives = 125/286 (43%), Gaps = 61/286 (21%)
Query: 7   KQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIA 66
           K+ GM     EL   +G G FG+V  A+    G  + ++ ++ N        ++ +RE+ 
Sbjct: 8   KRFGMDFKEIEL---IGSGGFGQVFKAKHRIDGKTYVIRRVKYN-------NEKAEREVK 57
Query: 67  TLKLLKHPNVVRLHEVL--------------------------ASKSK---IYMVLEYVT 97
            L  L H N+V  +                             +S+SK   +++ +E+  
Sbjct: 58  ALAKLDHVNIVHYNGCWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCD 117
Query: 98  GGELFDKIASKG--RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKI 155
            G L   I  +   +L +    +LF+Q+  GV Y H+K + HRDLK  NI L     +KI
Sbjct: 118 KGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLIHRDLKPSNIFLVDTKQVKI 177
Query: 156 SDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVI----LYIFR 211
            DFGL       ++DG    + G+  Y++PE ++++ Y G   D+++ G+I    L++  
Sbjct: 178 GDFGLVT---SLKNDGKRTRSKGTLRYMSPEQISSQDY-GKEVDLYALGLILAELLHVCD 233
Query: 212 GDFKLPKWLS------------PGAQNLLRKILEPNPVKRITIAGI 245
             F+  K+ +               + LL+K+L   P  R   + I
Sbjct: 234 TAFETSKFFTDLRDGIISDIFDKKEKTLLQKLLSKKPEDRPNTSEI 279

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 67/218 (30%), Positives = 105/218 (48%), Gaps = 33/218 (15%)
Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVK-ILEKNRIIHLKITDQIKREIATLKLLKHP 74
           Y   + +G G+FG V  A+  DSG   A+K +L+  R  +        RE+  ++ L H 
Sbjct: 30  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN--------RELQIMRKLDHC 81
Query: 75  NVVRLHEVLAS----KSKIYM--VLEYVTGGELFDKIA-----SKGRLQEAEGRKLFQQL 123
           N+VRL     S    K ++Y+  VL+YV   E   ++A     +K  L     +    QL
Sbjct: 82  NIVRLRYFFYSSGEKKDEVYLNLVLDYVP--ETVYRVARHYSRAKQTLPVIYVKLYMYQL 139
Query: 124 IDGVSYCHNKGVFHRDLKLENILLDSKGNI-KISDFGLSALPQHFRDDGLLHTTCGSPNY 182
              ++Y H+ G+ HRD+K +N+LLD    + K+ DFG +   Q  R +  +   C S  Y
Sbjct: 140 FRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAK--QLVRGEPNVSXIC-SRYY 196
Query: 183 VAPEVLANRGYDGATSDIWSCGVILY-------IFRGD 213
            APE++       ++ D+WS G +L        IF GD
Sbjct: 197 RAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGD 234

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 67/218 (30%), Positives = 105/218 (48%), Gaps = 33/218 (15%)
Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVK-ILEKNRIIHLKITDQIKREIATLKLLKHP 74
           Y   + +G G+FG V  A+  DSG   A+K +L+  R  +        RE+  ++ L H 
Sbjct: 23  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN--------RELQIMRKLDHC 74
Query: 75  NVVRLHEVLAS----KSKIYM--VLEYVTGGELFDKIA-----SKGRLQEAEGRKLFQQL 123
           N+VRL     S    K ++Y+  VL+YV   E   ++A     +K  L     +    QL
Sbjct: 75  NIVRLRYFFYSSGEKKDEVYLNLVLDYVP--ETVYRVARHYSRAKQTLPVIYVKLYMYQL 132
Query: 124 IDGVSYCHNKGVFHRDLKLENILLDSKGNI-KISDFGLSALPQHFRDDGLLHTTCGSPNY 182
              ++Y H+ G+ HRD+K +N+LLD    + K+ DFG +   Q  R +  +   C S  Y
Sbjct: 133 FRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAK--QLVRGEPNVSXIC-SRYY 189
Query: 183 VAPEVLANRGYDGATSDIWSCGVILY-------IFRGD 213
            APE++       ++ D+WS G +L        IF GD
Sbjct: 190 RAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGD 227

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 67/218 (30%), Positives = 105/218 (48%), Gaps = 33/218 (15%)
Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVK-ILEKNRIIHLKITDQIKREIATLKLLKHP 74
           Y   + +G G+FG V  A+  DSG   A+K +L+  R  +        RE+  ++ L H 
Sbjct: 26  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN--------RELQIMRKLDHC 77
Query: 75  NVVRLHEVLAS----KSKIYM--VLEYVTGGELFDKIA-----SKGRLQEAEGRKLFQQL 123
           N+VRL     S    K ++Y+  VL+YV   E   ++A     +K  L     +    QL
Sbjct: 78  NIVRLRYFFYSSGEKKDEVYLNLVLDYVP--ETVYRVARHYSRAKQTLPVIYVKLYMYQL 135
Query: 124 IDGVSYCHNKGVFHRDLKLENILLDSKGNI-KISDFGLSALPQHFRDDGLLHTTCGSPNY 182
              ++Y H+ G+ HRD+K +N+LLD    + K+ DFG +   Q  R +  +   C S  Y
Sbjct: 136 FRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAK--QLVRGEPNVSXIC-SRYY 192
Query: 183 VAPEVLANRGYDGATSDIWSCGVILY-------IFRGD 213
            APE++       ++ D+WS G +L        IF GD
Sbjct: 193 RAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGD 230

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 67/218 (30%), Positives = 105/218 (48%), Gaps = 33/218 (15%)
Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVK-ILEKNRIIHLKITDQIKREIATLKLLKHP 74
           Y   + +G G+FG V  A+  DSG   A+K +L+  R  +        RE+  ++ L H 
Sbjct: 56  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN--------RELQIMRKLDHC 107
Query: 75  NVVRLHEVLAS----KSKIYM--VLEYVTGGELFDKIA-----SKGRLQEAEGRKLFQQL 123
           N+VRL     S    K ++Y+  VL+YV   E   ++A     +K  L     +    QL
Sbjct: 108 NIVRLRYFFYSSGEKKDEVYLNLVLDYVP--ETVYRVARHYSRAKQTLPVIYVKLYMYQL 165
Query: 124 IDGVSYCHNKGVFHRDLKLENILLDSKGNI-KISDFGLSALPQHFRDDGLLHTTCGSPNY 182
              ++Y H+ G+ HRD+K +N+LLD    + K+ DFG +   Q  R +  +   C S  Y
Sbjct: 166 FRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAK--QLVRGEPNVSYIC-SRYY 222
Query: 183 VAPEVLANRGYDGATSDIWSCGVILY-------IFRGD 213
            APE++       ++ D+WS G +L        IF GD
Sbjct: 223 RAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGD 260

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 67/218 (30%), Positives = 105/218 (48%), Gaps = 33/218 (15%)
Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVK-ILEKNRIIHLKITDQIKREIATLKLLKHP 74
           Y   + +G G+FG V  A+  DSG   A+K +L+  R  +        RE+  ++ L H 
Sbjct: 50  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN--------RELQIMRKLDHC 101
Query: 75  NVVRLHEVLAS----KSKIYM--VLEYVTGGELFDKIA-----SKGRLQEAEGRKLFQQL 123
           N+VRL     S    K ++Y+  VL+YV   E   ++A     +K  L     +    QL
Sbjct: 102 NIVRLRYFFYSSGEKKDEVYLNLVLDYVP--ETVYRVARHYSRAKQTLPVIYVKLYMYQL 159
Query: 124 IDGVSYCHNKGVFHRDLKLENILLDSKGNI-KISDFGLSALPQHFRDDGLLHTTCGSPNY 182
              ++Y H+ G+ HRD+K +N+LLD    + K+ DFG +   Q  R +  +   C S  Y
Sbjct: 160 FRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAK--QLVRGEPNVSYIC-SRYY 216
Query: 183 VAPEVLANRGYDGATSDIWSCGVILY-------IFRGD 213
            APE++       ++ D+WS G +L        IF GD
Sbjct: 217 RAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGD 254

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 53/201 (26%), Positives = 99/201 (49%), Gaps = 14/201 (6%)
Query: 14  GRYELGRTLGEGNFGKV---KFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKL 70
           G+  +G+ +G G+FG V   K+  D+      AVK+L        ++    K E+  L+ 
Sbjct: 13  GQITVGQRIGSGSFGTVYKGKWHGDV------AVKMLNVTAPTPQQL-QAFKNEVGVLRK 65
Query: 71  LKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKI-ASKGRLQEAEGRKLFQQLIDGVSY 129
            +H N++ L    ++K ++ +V ++  G  L+  +   + + +  +   + +Q   G+ Y
Sbjct: 66  TRHVNIL-LFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDY 124
Query: 130 CHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEV-- 187
            H K + HRDLK  NI L     +KI DFGL+ +   +          GS  ++APEV  
Sbjct: 125 LHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIR 184
Query: 188 LANRGYDGATSDIWSCGVILY 208
           + ++      SD+++ G++LY
Sbjct: 185 MQDKNPYSFQSDVYAFGIVLY 205

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 67/218 (30%), Positives = 105/218 (48%), Gaps = 33/218 (15%)
Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVK-ILEKNRIIHLKITDQIKREIATLKLLKHP 74
           Y   + +G G+FG V  A+  DSG   A+K +L+  R  +        RE+  ++ L H 
Sbjct: 58  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN--------RELQIMRKLDHC 109
Query: 75  NVVRLHEVLAS----KSKIYM--VLEYVTGGELFDKIA-----SKGRLQEAEGRKLFQQL 123
           N+VRL     S    K ++Y+  VL+YV   E   ++A     +K  L     +    QL
Sbjct: 110 NIVRLRYFFYSSGEKKDEVYLNLVLDYVP--ETVYRVARHYSRAKQTLPVIYVKLYMYQL 167
Query: 124 IDGVSYCHNKGVFHRDLKLENILLDSKGNI-KISDFGLSALPQHFRDDGLLHTTCGSPNY 182
              ++Y H+ G+ HRD+K +N+LLD    + K+ DFG +   Q  R +  +   C S  Y
Sbjct: 168 FRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAK--QLVRGEPNVSYIC-SRYY 224
Query: 183 VAPEVLANRGYDGATSDIWSCGVILY-------IFRGD 213
            APE++       ++ D+WS G +L        IF GD
Sbjct: 225 RAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGD 262

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 67/218 (30%), Positives = 105/218 (48%), Gaps = 33/218 (15%)
Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVK-ILEKNRIIHLKITDQIKREIATLKLLKHP 74
           Y   + +G G+FG V  A+  DSG   A+K +L+  R  +        RE+  ++ L H 
Sbjct: 101 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN--------RELQIMRKLDHC 152
Query: 75  NVVRLHEVLAS----KSKIYM--VLEYVTGGELFDKIA-----SKGRLQEAEGRKLFQQL 123
           N+VRL     S    K ++Y+  VL+YV   E   ++A     +K  L     +    QL
Sbjct: 153 NIVRLRYFFYSSGEKKDEVYLNLVLDYVP--ETVYRVARHYSRAKQTLPVIYVKLYMYQL 210
Query: 124 IDGVSYCHNKGVFHRDLKLENILLDSKGNI-KISDFGLSALPQHFRDDGLLHTTCGSPNY 182
              ++Y H+ G+ HRD+K +N+LLD    + K+ DFG +   Q  R +  +   C S  Y
Sbjct: 211 FRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAK--QLVRGEPNVSYIC-SRYY 267
Query: 183 VAPEVLANRGYDGATSDIWSCGVILY-------IFRGD 213
            APE++       ++ D+WS G +L        IF GD
Sbjct: 268 RAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGD 305

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 53/201 (26%), Positives = 99/201 (49%), Gaps = 14/201 (6%)
Query: 14  GRYELGRTLGEGNFGKV---KFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKL 70
           G+  +G+ +G G+FG V   K+  D+      AVK+L        ++    K E+  L+ 
Sbjct: 13  GQITVGQRIGSGSFGTVYKGKWHGDV------AVKMLNVTAPTPQQL-QAFKNEVGVLRK 65
Query: 71  LKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKI-ASKGRLQEAEGRKLFQQLIDGVSY 129
            +H N++ L    ++K ++ +V ++  G  L+  +   + + +  +   + +Q   G+ Y
Sbjct: 66  TRHVNIL-LFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDY 124
Query: 130 CHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEV-- 187
            H K + HRDLK  NI L     +KI DFGL+ +   +          GS  ++APEV  
Sbjct: 125 LHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIR 184
Query: 188 LANRGYDGATSDIWSCGVILY 208
           + ++      SD+++ G++LY
Sbjct: 185 MQDKNPYSFQSDVYAFGIVLY 205

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 53/201 (26%), Positives = 99/201 (49%), Gaps = 14/201 (6%)
Query: 14  GRYELGRTLGEGNFGKV---KFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKL 70
           G+  +G+ +G G+FG V   K+  D+      AVK+L        ++    K E+  L+ 
Sbjct: 8   GQITVGQRIGSGSFGTVYKGKWHGDV------AVKMLNVTAPTPQQL-QAFKNEVGVLRK 60
Query: 71  LKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKI-ASKGRLQEAEGRKLFQQLIDGVSY 129
            +H N++ L    ++K ++ +V ++  G  L+  +   + + +  +   + +Q   G+ Y
Sbjct: 61  TRHVNIL-LFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDY 119
Query: 130 CHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEV-- 187
            H K + HRDLK  NI L     +KI DFGL+ +   +          GS  ++APEV  
Sbjct: 120 LHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIR 179
Query: 188 LANRGYDGATSDIWSCGVILY 208
           + ++      SD+++ G++LY
Sbjct: 180 MQDKNPYSFQSDVYAFGIVLY 200

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 96/204 (47%), Gaps = 28/204 (13%)
Query: 18  LGRTLGEGNFGKV---KFAQDLDSGLPFAVKILEKNRIIHLKITD-------QIKREIAT 67
           L   +G G+FG V   K+  D+      AVKIL        K+ D         + E+A 
Sbjct: 40  LSTRIGSGSFGTVYKGKWHGDV------AVKIL--------KVVDPTPEQFQAFRNEVAV 85
Query: 68  LKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKI-ASKGRLQEAEGRKLFQQLIDG 126
           L+  +H N++ L     +K  + +V ++  G  L+  +   + + Q  +   + +Q   G
Sbjct: 86  LRKTRHVNIL-LFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQG 144
Query: 127 VSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPE 186
           + Y H K + HRD+K  NI L     +KI DFGL+ +   +     +    GS  ++APE
Sbjct: 145 MDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPE 204
Query: 187 VLANRGYD--GATSDIWSCGVILY 208
           V+  +  +     SD++S G++LY
Sbjct: 205 VIRMQDNNPFSFQSDVYSYGIVLY 228

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 67/218 (30%), Positives = 105/218 (48%), Gaps = 33/218 (15%)
Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVK-ILEKNRIIHLKITDQIKREIATLKLLKHP 74
           Y   + +G G+FG V  A+  DSG   A+K +L+  R  +        RE+  ++ L H 
Sbjct: 35  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN--------RELQIMRKLDHC 86
Query: 75  NVVRLHEVLAS----KSKIYM--VLEYVTGGELFDKIA-----SKGRLQEAEGRKLFQQL 123
           N+VRL     S    K ++Y+  VL+YV   E   ++A     +K  L     +    QL
Sbjct: 87  NIVRLRYFFYSSGEKKDEVYLNLVLDYVP--ETVYRVARHYSRAKQTLPVIYVKLYMYQL 144
Query: 124 IDGVSYCHNKGVFHRDLKLENILLDSKGNI-KISDFGLSALPQHFRDDGLLHTTCGSPNY 182
              ++Y H+ G+ HRD+K +N+LLD    + K+ DFG +   Q  R +  +   C S  Y
Sbjct: 145 FRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAK--QLVRGEPNVSYIC-SRYY 201
Query: 183 VAPEVLANRGYDGATSDIWSCGVILY-------IFRGD 213
            APE++       ++ D+WS G +L        IF GD
Sbjct: 202 RAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGD 239

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 67/218 (30%), Positives = 105/218 (48%), Gaps = 33/218 (15%)
Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVK-ILEKNRIIHLKITDQIKREIATLKLLKHP 74
           Y   + +G G+FG V  A+  DSG   A+K +L+  R  +        RE+  ++ L H 
Sbjct: 60  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN--------RELQIMRKLDHC 111
Query: 75  NVVRLHEVLAS----KSKIYM--VLEYVTGGELFDKIA-----SKGRLQEAEGRKLFQQL 123
           N+VRL     S    K ++Y+  VL+YV   E   ++A     +K  L     +    QL
Sbjct: 112 NIVRLRYFFYSSGEKKDEVYLNLVLDYVP--ETVYRVARHYSRAKQTLPVIYVKLYMYQL 169
Query: 124 IDGVSYCHNKGVFHRDLKLENILLDSKGNI-KISDFGLSALPQHFRDDGLLHTTCGSPNY 182
              ++Y H+ G+ HRD+K +N+LLD    + K+ DFG +   Q  R +  +   C S  Y
Sbjct: 170 FRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAK--QLVRGEPNVSYIC-SRYY 226
Query: 183 VAPEVLANRGYDGATSDIWSCGVILY-------IFRGD 213
            APE++       ++ D+WS G +L        IF GD
Sbjct: 227 RAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGD 264

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 64/214 (29%), Positives = 103/214 (48%), Gaps = 15/214 (7%)
Query: 22  LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHE 81
           LG G FG+V      +     AVK L++  +      D    E   +K L+H  +VRL+ 
Sbjct: 21  LGAGQFGEVWMGY-YNGHTKVAVKSLKQGSMS----PDAFLAEANLMKQLQHQRLVRLYA 75
Query: 82  VLASKSKIYMVLEYVTGGELFD--KIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRD 139
           V+ ++  IY++ EY+  G L D  K  S  +L   +   +  Q+ +G+++   +   HRD
Sbjct: 76  VV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRD 134
Query: 140 LKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP-NYVAPEVLANRGYDGATS 198
           L+  NIL+    + KI+DFGL+ L +   ++         P  + APE + N G     S
Sbjct: 135 LRAANILVSDTLSCKIADFGLARLIED--NEYTAREGAKFPIKWTAPEAI-NYGTFTIKS 191
Query: 199 DIWSCGVIL--YIFRGDFKLPKWLSPGA-QNLLR 229
           D+WS G++L   +  G    P   +P   QNL R
Sbjct: 192 DVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLER 225

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 53/201 (26%), Positives = 99/201 (49%), Gaps = 14/201 (6%)
Query: 14  GRYELGRTLGEGNFGKV---KFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKL 70
           G+  +G+ +G G+FG V   K+  D+      AVK+L        ++    K E+  L+ 
Sbjct: 10  GQITVGQRIGSGSFGTVYKGKWHGDV------AVKMLNVTAPTPQQL-QAFKNEVGVLRK 62
Query: 71  LKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKI-ASKGRLQEAEGRKLFQQLIDGVSY 129
            +H N++ L    ++K ++ +V ++  G  L+  +   + + +  +   + +Q   G+ Y
Sbjct: 63  TRHVNIL-LFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDY 121
Query: 130 CHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEV-- 187
            H K + HRDLK  NI L     +KI DFGL+ +   +          GS  ++APEV  
Sbjct: 122 LHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIR 181
Query: 188 LANRGYDGATSDIWSCGVILY 208
           + ++      SD+++ G++LY
Sbjct: 182 MQDKNPYSFQSDVYAFGIVLY 202

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 67/218 (30%), Positives = 105/218 (48%), Gaps = 33/218 (15%)
Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVK-ILEKNRIIHLKITDQIKREIATLKLLKHP 74
           Y   + +G G+FG V  A+  DSG   A+K +L+  R  +        RE+  ++ L H 
Sbjct: 27  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN--------RELQIMRKLDHC 78
Query: 75  NVVRLHEVLAS----KSKIYM--VLEYVTGGELFDKIA-----SKGRLQEAEGRKLFQQL 123
           N+VRL     S    K ++Y+  VL+YV   E   ++A     +K  L     +    QL
Sbjct: 79  NIVRLRYFFYSSGEKKDEVYLNLVLDYVP--ETVYRVARHYSRAKQTLPVIYVKLYMYQL 136
Query: 124 IDGVSYCHNKGVFHRDLKLENILLDSKGNI-KISDFGLSALPQHFRDDGLLHTTCGSPNY 182
              ++Y H+ G+ HRD+K +N+LLD    + K+ DFG +   Q  R +  +   C S  Y
Sbjct: 137 FRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAK--QLVRGEPNVSYIC-SRYY 193
Query: 183 VAPEVLANRGYDGATSDIWSCGVILY-------IFRGD 213
            APE++       ++ D+WS G +L        IF GD
Sbjct: 194 RAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGD 231

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 60/217 (27%), Positives = 104/217 (47%), Gaps = 31/217 (14%)
Query: 18  LGRTLGEGNFGKVKFAQDL-------DSGLPFAVKILEKNRIIHLKITDQIKREIATLKL 70
           LG+ LGEG FG+V  A+ +          +  AVK+L K+      ++D +  E+  +K+
Sbjct: 39  LGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKML-KDDATEKDLSDLVS-EMEMMKM 96
Query: 71  L-KHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASK-----------GRLQEAEGR- 117
           + KH N++ L         +Y+++EY + G L + + ++            R+ E +   
Sbjct: 97  IGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTF 156
Query: 118 ----KLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLL 173
                   QL  G+ Y  ++   HRDL   N+L+     ++I+DFGL+    +   D   
Sbjct: 157 KDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMRIADFGLARDINNI--DYYK 214
Query: 174 HTTCG--SPNYVAPEVLANRGYDGATSDIWSCGVILY 208
            TT G     ++APE L +R Y    SD+WS GV+++
Sbjct: 215 KTTNGRLPVKWMAPEALFDRVY-THQSDVWSFGVLMW 250

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 53/201 (26%), Positives = 99/201 (49%), Gaps = 14/201 (6%)
Query: 14  GRYELGRTLGEGNFGKV---KFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKL 70
           G+  +G+ +G G+FG V   K+  D+      AVK+L        ++    K E+  L+ 
Sbjct: 35  GQITVGQRIGSGSFGTVYKGKWHGDV------AVKMLNVTAPTPQQL-QAFKNEVGVLRK 87
Query: 71  LKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKI-ASKGRLQEAEGRKLFQQLIDGVSY 129
            +H N++ L    ++K ++ +V ++  G  L+  +   + + +  +   + +Q   G+ Y
Sbjct: 88  TRHVNIL-LFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDY 146
Query: 130 CHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEV-- 187
            H K + HRDLK  NI L     +KI DFGL+ +   +          GS  ++APEV  
Sbjct: 147 LHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIR 206
Query: 188 LANRGYDGATSDIWSCGVILY 208
           + ++      SD+++ G++LY
Sbjct: 207 MQDKNPYSFQSDVYAFGIVLY 227

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 67/218 (30%), Positives = 105/218 (48%), Gaps = 33/218 (15%)
Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVK-ILEKNRIIHLKITDQIKREIATLKLLKHP 74
           Y   + +G G+FG V  A+  DSG   A+K +L+  R  +        RE+  ++ L H 
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN--------RELQIMRKLDHC 73
Query: 75  NVVRLHEVLAS----KSKIYM--VLEYVTGGELFDKIA-----SKGRLQEAEGRKLFQQL 123
           N+VRL     S    K ++Y+  VL+YV   E   ++A     +K  L     +    QL
Sbjct: 74  NIVRLRYFFYSSGEKKDEVYLNLVLDYVP--ETVYRVARHYSRAKQTLPVIYVKLYMYQL 131
Query: 124 IDGVSYCHNKGVFHRDLKLENILLDSKGNI-KISDFGLSALPQHFRDDGLLHTTCGSPNY 182
              ++Y H+ G+ HRD+K +N+LLD    + K+ DFG +   Q  R +  +   C S  Y
Sbjct: 132 FRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAK--QLVRGEPNVSYIC-SRYY 188
Query: 183 VAPEVLANRGYDGATSDIWSCGVILY-------IFRGD 213
            APE++       ++ D+WS G +L        IF GD
Sbjct: 189 RAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGD 226

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 53/201 (26%), Positives = 99/201 (49%), Gaps = 14/201 (6%)
Query: 14  GRYELGRTLGEGNFGKV---KFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKL 70
           G+  +G+ +G G+FG V   K+  D+      AVK+L        ++    K E+  L+ 
Sbjct: 36  GQITVGQRIGSGSFGTVYKGKWHGDV------AVKMLNVTAPTPQQL-QAFKNEVGVLRK 88
Query: 71  LKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKI-ASKGRLQEAEGRKLFQQLIDGVSY 129
            +H N++ L    ++K ++ +V ++  G  L+  +   + + +  +   + +Q   G+ Y
Sbjct: 89  TRHVNIL-LFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDY 147
Query: 130 CHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEV-- 187
            H K + HRDLK  NI L     +KI DFGL+ +   +          GS  ++APEV  
Sbjct: 148 LHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIR 207
Query: 188 LANRGYDGATSDIWSCGVILY 208
           + ++      SD+++ G++LY
Sbjct: 208 MQDKNPYSFQSDVYAFGIVLY 228

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 66/222 (29%), Positives = 99/222 (44%), Gaps = 28/222 (12%)
Query: 13  LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEK--NRIIHLKITDQIKREIATLKL 70
           L RY+  + +G G  G V  A D       A+K L +      H K   +  RE+  +K 
Sbjct: 23  LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAK---RAYRELVLMKC 79
Query: 71  LKHPNVVRLHEVLASKSK------IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLI 124
           + H N++ L  V   +        +Y+V+E +    L   I  +  L       L  Q++
Sbjct: 80  VNHKNIISLLNVFTPQKTLEEFQDVYLVME-LMDANLXQVI--QMELDHERMSYLLYQML 136
Query: 125 DGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDG---LLHTTCGSPN 181
            G+ + H+ G+ HRDLK  NI++ S   +KI DFGL+      R  G   ++     +  
Sbjct: 137 XGIKHLHSAGIIHRDLKPSNIVVKSDXTLKILDFGLA------RTAGTSFMMTPYVVTRY 190
Query: 182 YVAPEVLANRGYDGATSDIWSCGVILYIFRGDFKLPKWLSPG 223
           Y APEV+   GY     DIWS G I+    G+    K L PG
Sbjct: 191 YRAPEVILGMGY-KENVDIWSVGCIM----GEMVRHKILFPG 227

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 66/222 (29%), Positives = 99/222 (44%), Gaps = 28/222 (12%)
Query: 13  LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEK--NRIIHLKITDQIKREIATLKL 70
           L RY+  + +G G  G V  A D       A+K L +      H K   +  RE+  +K 
Sbjct: 16  LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAK---RAYRELVLMKC 72
Query: 71  LKHPNVVRLHEVLASKSK------IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLI 124
           + H N++ L  V   +        +Y+V+E +    L   I  +  L       L  Q++
Sbjct: 73  VNHKNIISLLNVFTPQKTLEEFQDVYLVME-LMDANLXQVI--QMELDHERMSYLLYQML 129
Query: 125 DGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDG---LLHTTCGSPN 181
            G+ + H+ G+ HRDLK  NI++ S   +KI DFGL+      R  G   ++     +  
Sbjct: 130 XGIKHLHSAGIIHRDLKPSNIVVKSDXTLKILDFGLA------RTAGTSFMMTPYVVTRY 183
Query: 182 YVAPEVLANRGYDGATSDIWSCGVILYIFRGDFKLPKWLSPG 223
           Y APEV+   GY     DIWS G I+    G+    K L PG
Sbjct: 184 YRAPEVILGMGYK-ENVDIWSVGCIM----GEMVRHKILFPG 220

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 66/222 (29%), Positives = 99/222 (44%), Gaps = 28/222 (12%)
Query: 13  LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEK--NRIIHLKITDQIKREIATLKL 70
           L RY+  + +G G  G V  A D       A+K L +      H K   +  RE+  +K 
Sbjct: 23  LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAK---RAYRELVLMKX 79
Query: 71  LKHPNVVRLHEVLASKSK------IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLI 124
           + H N++ L  V   +        +Y+V+E +    L   I  +  L       L  Q++
Sbjct: 80  VNHKNIISLLNVFTPQKTLEEFQDVYLVME-LMDANLXQVI--QMELDHERMSYLLYQML 136
Query: 125 DGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDG---LLHTTCGSPN 181
            G+ + H+ G+ HRDLK  NI++ S   +KI DFGL+      R  G   ++     +  
Sbjct: 137 XGIKHLHSAGIIHRDLKPSNIVVKSDXTLKILDFGLA------RTAGTSFMMTPYVVTRY 190
Query: 182 YVAPEVLANRGYDGATSDIWSCGVILYIFRGDFKLPKWLSPG 223
           Y APEV+   GY     DIWS G I+    G+    K L PG
Sbjct: 191 YRAPEVILGMGY-KENVDIWSVGCIM----GEMVRHKILFPG 227

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 55/200 (27%), Positives = 96/200 (48%), Gaps = 14/200 (7%)
Query: 22  LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHE 81
           +G G FG V     L+     A+K +++  +      D    E   +  L HP +V+L+ 
Sbjct: 35  IGSGQFGLVHLGYWLNKD-KVAIKTIKEGSMSE----DDFIEEAEVMMKLSHPKLVQLYG 89
Query: 82  VLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGR-KLFQQLIDGVSYCHNKGVFHRDL 140
           V   ++ I +V E++  G L D + ++  L  AE    +   + +G++Y     V HRDL
Sbjct: 90  VCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDL 149
Query: 141 KLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP---NYVAPEVLANRGYDGAT 197
              N L+     IK+SDFG++     F  D    ++ G+     + +PEV +   Y  + 
Sbjct: 150 AARNCLVGENQVIKVSDFGMT----RFVLDDQYTSSTGTKFPVKWASPEVFSFSRYS-SK 204
Query: 198 SDIWSCGVILYIFRGDFKLP 217
           SD+WS GV+++    + K+P
Sbjct: 205 SDVWSFGVLMWEVFSEGKIP 224

>pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 63/222 (28%), Positives = 97/222 (43%), Gaps = 34/222 (15%)
Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIH-LKITDQIKREIATLKLLKHP 74
           YE+   +G G++G V  A D ++    A+K  + NR+   L    +I REI  L  LK  
Sbjct: 30  YEIKHLIGRGSYGYVYLAYDKNANKNVAIK--KVNRMFEDLIDCKRILREITILNRLKSD 87
Query: 75  NVVRLHEVLASKS-----KIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSY 129
            ++RLH+++  +      ++Y+VLE +   +L     +   L E   + +   L+ G  +
Sbjct: 88  YIIRLHDLIIPEDLLKFDELYIVLE-IADSDLKKLFKTPIFLTEQHVKTILYNLLLGEKF 146
Query: 130 CHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQ-----HFRDDGLLHTTCGSPN--- 181
            H  G+ HRDLK  N LL+   ++KI DFGL+         H  +D         P    
Sbjct: 147 IHESGIIHRDLKPANCLLNQDCSVKICDFGLARTINSDKDIHIVNDLEEKEENEEPGPHN 206
Query: 182 ---------------YVAPE-VLANRGYDGATSDIWSCGVIL 207
                          Y APE +L    Y  +  DIWS G I 
Sbjct: 207 KNLKKQLTSHVVTRWYRAPELILLQENYTNSI-DIWSTGCIF 247

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 60/203 (29%), Positives = 93/203 (45%), Gaps = 18/203 (8%)
Query: 13  LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEK--NRIIHLKITDQIKREIATLKL 70
           L RY+  + +G G  G V  A D       A+K L +      H K   +  RE+  +K+
Sbjct: 23  LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAK---RAYRELVLMKV 79
Query: 71  LKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRK---LFQQLIDGV 127
           + H N++ L  V   +  +    +     EL D   S+    E +  +   L  Q++ G+
Sbjct: 80  VNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQMLVGI 139
Query: 128 SYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDG---LLHTTCGSPNYVA 184
            + H+ G+ HRDLK  NI++ S   +KI DFGL+      R  G   ++     +  Y A
Sbjct: 140 KHLHSAGIIHRDLKPSNIVVKSDATLKILDFGLA------RTAGTSFMMTPYVVTRYYRA 193
Query: 185 PEVLANRGYDGATSDIWSCGVIL 207
           PEV+   GY     DIWS G I+
Sbjct: 194 PEVILGMGYK-ENVDIWSVGCIM 215

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 57/194 (29%), Positives = 97/194 (50%), Gaps = 12/194 (6%)
Query: 17  ELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNV 76
           +L + LG G FG+V  A   +     AVK ++   +      +    E   +K L+H  +
Sbjct: 18  KLEKKLGAGQFGEVWMAT-YNKHTKVAVKTMKPGSMS----VEAFLAEANVMKTLQHDKL 72
Query: 77  VRLHEVLASKSKIYMVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQ-QLIDGVSYCHNKG 134
           V+LH V+ +K  IY++ E++  G L D + S +G  Q       F  Q+ +G+++   + 
Sbjct: 73  VKLHAVV-TKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN 131
Query: 135 VFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP-NYVAPEVLANRGY 193
             HRDL+  NIL+ +    KI+DFGL+ + +   ++         P  + APE + N G 
Sbjct: 132 YIHRDLRAANILVSASLVCKIADFGLARVIED--NEYTAREGAKFPIKWTAPEAI-NFGS 188
Query: 194 DGATSDIWSCGVIL 207
               SD+WS G++L
Sbjct: 189 FTIKSDVWSFGILL 202

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 67/218 (30%), Positives = 104/218 (47%), Gaps = 33/218 (15%)
Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVK-ILEKNRIIHLKITDQIKREIATLKLLKHP 74
           Y   + +G G+FG V  A+  DSG   A+K +L+  R  +        RE+  ++ L H 
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN--------RELQIMRKLDHC 73
Query: 75  NVVRLHEVLAS----KSKIYM--VLEYVTGGELFDKIA-----SKGRLQEAEGRKLFQQL 123
           N+VRL     S    K  +Y+  VL+YV   E   ++A     +K  L     +    QL
Sbjct: 74  NIVRLRYFFYSSGEKKDVVYLNLVLDYVP--ETVYRVARHYSRAKQTLPVIYVKLYMYQL 131
Query: 124 IDGVSYCHNKGVFHRDLKLENILLDSKGNI-KISDFGLSALPQHFRDDGLLHTTCGSPNY 182
              ++Y H+ G+ HRD+K +N+LLD    + K+ DFG +   Q  R +  +   C S  Y
Sbjct: 132 FRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAK--QLVRGEPNVSXIC-SRYY 188
Query: 183 VAPEVLANRGYDGATSDIWSCGVILY-------IFRGD 213
            APE++       ++ D+WS G +L        IF GD
Sbjct: 189 RAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGD 226

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 60/203 (29%), Positives = 93/203 (45%), Gaps = 18/203 (8%)
Query: 13  LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEK--NRIIHLKITDQIKREIATLKL 70
           L RY+  + +G G  G V  A D       A+K L +      H K   +  RE+  +K+
Sbjct: 23  LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAK---RAYRELVLMKV 79
Query: 71  LKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRK---LFQQLIDGV 127
           + H N++ L  V   +  +    +     EL D   S+    E +  +   L  Q++ G+
Sbjct: 80  VNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQMLCGI 139
Query: 128 SYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDG---LLHTTCGSPNYVA 184
            + H+ G+ HRDLK  NI++ S   +KI DFGL+      R  G   ++     +  Y A
Sbjct: 140 KHLHSAGIIHRDLKPSNIVVKSDATLKILDFGLA------RTAGTSFMMTPYVVTRYYRA 193
Query: 185 PEVLANRGYDGATSDIWSCGVIL 207
           PEV+   GY     DIWS G I+
Sbjct: 194 PEVILGMGYK-ENVDIWSVGCIM 215

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 66/222 (29%), Positives = 99/222 (44%), Gaps = 28/222 (12%)
Query: 13  LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEK--NRIIHLKITDQIKREIATLKL 70
           L RY+  + +G G  G V  A D       A+K L +      H K   +  RE+  +K 
Sbjct: 61  LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAK---RAYRELVLMKC 117
Query: 71  LKHPNVVRLHEVLASKSK------IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLI 124
           + H N++ L  V   +        +Y+V+E +    L   I  +  L       L  Q++
Sbjct: 118 VNHKNIISLLNVFTPQKTLEEFQDVYLVME-LMDANLCQVI--QMELDHERMSYLLYQML 174
Query: 125 DGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDG---LLHTTCGSPN 181
            G+ + H+ G+ HRDLK  NI++ S   +KI DFGL+      R  G   ++     +  
Sbjct: 175 CGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA------RTAGTSFMMTPYVVTRY 228
Query: 182 YVAPEVLANRGYDGATSDIWSCGVILYIFRGDFKLPKWLSPG 223
           Y APEV+   GY     DIWS G I+    G+    K L PG
Sbjct: 229 YRAPEVILGMGYK-ENVDIWSVGCIM----GEMVRHKILFPG 265

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 66/222 (29%), Positives = 99/222 (44%), Gaps = 28/222 (12%)
Query: 13  LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEK--NRIIHLKITDQIKREIATLKL 70
           L RY+  + +G G  G V  A D       A+K L +      H K   +  RE+  +K 
Sbjct: 16  LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAK---RAYRELVLMKC 72
Query: 71  LKHPNVVRLHEVLASKSK------IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLI 124
           + H N++ L  V   +        +Y+V+E +    L   I  +  L       L  Q++
Sbjct: 73  VNHKNIISLLNVFTPQKTLEEFQDVYLVME-LMDANLCQVI--QMELDHERMSYLLYQML 129
Query: 125 DGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDG---LLHTTCGSPN 181
            G+ + H+ G+ HRDLK  NI++ S   +KI DFGL+      R  G   ++     +  
Sbjct: 130 CGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA------RTAGTSFMMTPYVVTRY 183
Query: 182 YVAPEVLANRGYDGATSDIWSCGVILYIFRGDFKLPKWLSPG 223
           Y APEV+   GY     DIWS G I+    G+    K L PG
Sbjct: 184 YRAPEVILGMGYK-ENVDIWSVGCIM----GEMVRHKILFPG 220

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 66/222 (29%), Positives = 99/222 (44%), Gaps = 28/222 (12%)
Query: 13  LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEK--NRIIHLKITDQIKREIATLKL 70
           L RY+  + +G G  G V  A D       A+K L +      H K   +  RE+  +K 
Sbjct: 17  LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAK---RAYRELVLMKC 73
Query: 71  LKHPNVVRLHEVLASKSK------IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLI 124
           + H N++ L  V   +        +Y+V+E +    L   I  +  L       L  Q++
Sbjct: 74  VNHKNIISLLNVFTPQKTLEEFQDVYLVME-LMDANLCQVI--QMELDHERMSYLLYQML 130
Query: 125 DGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDG---LLHTTCGSPN 181
            G+ + H+ G+ HRDLK  NI++ S   +KI DFGL+      R  G   ++     +  
Sbjct: 131 CGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA------RTAGTSFMMTPYVVTRY 184
Query: 182 YVAPEVLANRGYDGATSDIWSCGVILYIFRGDFKLPKWLSPG 223
           Y APEV+   GY     DIWS G I+    G+    K L PG
Sbjct: 185 YRAPEVILGMGYK-ENVDIWSVGCIM----GEMVRHKILFPG 221

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 76/272 (27%), Positives = 123/272 (45%), Gaps = 40/272 (14%)
Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
           Y   + +G G+FG V  A+  DSG   A+K + + +           RE+  ++ L H N
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFK-------NRELQIMRKLDHCN 74
Query: 76  VVRLHEVLAS----KSKIYM--VLEYVTGGELFDKIA-----SKGRLQEAEGRKLFQQLI 124
           +VRL     S    K ++Y+  VL+YV   E   ++A     +K  L     +    QL 
Sbjct: 75  IVRLRYFFYSSGEKKDEVYLNLVLDYVP--ETVYRVARHYSRAKQTLPVIYVKLYMYQLF 132
Query: 125 DGVSYCHNKGVFHRDLKLENILLDSKGNI-KISDFGLSALPQHFRDDGLLHTTCGSPNYV 183
             ++Y H+ G+ HRD+K +N+LLD    + K+ DFG +   Q  R +  +   C S  Y 
Sbjct: 133 RSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAK--QLVRGEPNVSYIC-SRYYR 189
Query: 184 APEVLANRGYDGATSDIWSCGVILY-------IFRGD------FKLPKWLSPGAQNLLRK 230
           APE++       ++ D+WS G +L        IF GD       ++ K L    +  +R+
Sbjct: 190 APELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIRE 249
Query: 231 ILEPNPVKRITIAGIKADEWFEQDYTPANPDD 262
            + PN         IKA  W  + + P  P +
Sbjct: 250 -MNPN-YTEFAFPQIKAHPW-TKVFRPRTPPE 278

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 66/222 (29%), Positives = 99/222 (44%), Gaps = 28/222 (12%)
Query: 13  LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEK--NRIIHLKITDQIKREIATLKL 70
           L RY+  + +G G  G V  A D       A+K L +      H K   +  RE+  +K 
Sbjct: 24  LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAK---RAYRELVLMKC 80
Query: 71  LKHPNVVRLHEVLASKSK------IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLI 124
           + H N++ L  V   +        +Y+V+E +    L   I  +  L       L  Q++
Sbjct: 81  VNHKNIISLLNVFTPQKTLEEFQDVYLVME-LMDANLCQVI--QMELDHERMSYLLYQML 137
Query: 125 DGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDG---LLHTTCGSPN 181
            G+ + H+ G+ HRDLK  NI++ S   +KI DFGL+      R  G   ++     +  
Sbjct: 138 CGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA------RTAGTSFMMTPYVVTRY 191
Query: 182 YVAPEVLANRGYDGATSDIWSCGVILYIFRGDFKLPKWLSPG 223
           Y APEV+   GY     DIWS G I+    G+    K L PG
Sbjct: 192 YRAPEVILGMGY-KENVDIWSVGCIM----GEMVRHKILFPG 228

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 66/222 (29%), Positives = 99/222 (44%), Gaps = 28/222 (12%)
Query: 13  LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEK--NRIIHLKITDQIKREIATLKL 70
           L RY+  + +G G  G V  A D       A+K L +      H K   +  RE+  +K 
Sbjct: 17  LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAK---RAYRELVLMKC 73
Query: 71  LKHPNVVRLHEVLASKSK------IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLI 124
           + H N++ L  V   +        +Y+V+E +    L   I  +  L       L  Q++
Sbjct: 74  VNHKNIISLLNVFTPQKTLEEFQDVYLVME-LMDANLCQVI--QMELDHERMSYLLYQML 130
Query: 125 DGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDG---LLHTTCGSPN 181
            G+ + H+ G+ HRDLK  NI++ S   +KI DFGL+      R  G   ++     +  
Sbjct: 131 CGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA------RTAGTSFMMTPYVVTRY 184
Query: 182 YVAPEVLANRGYDGATSDIWSCGVILYIFRGDFKLPKWLSPG 223
           Y APEV+   GY     DIWS G I+    G+    K L PG
Sbjct: 185 YRAPEVILGMGY-KENVDIWSVGCIM----GEMVRHKILFPG 221

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 66/222 (29%), Positives = 99/222 (44%), Gaps = 28/222 (12%)
Query: 13  LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEK--NRIIHLKITDQIKREIATLKL 70
           L RY+  + +G G  G V  A D       A+K L +      H K   +  RE+  +K 
Sbjct: 61  LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAK---RAYRELVLMKC 117
Query: 71  LKHPNVVRLHEVLASKSK------IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLI 124
           + H N++ L  V   +        +Y+V+E +    L   I  +  L       L  Q++
Sbjct: 118 VNHKNIISLLNVFTPQKTLEEFQDVYLVME-LMDANLCQVI--QMELDHERMSYLLYQML 174
Query: 125 DGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDG---LLHTTCGSPN 181
            G+ + H+ G+ HRDLK  NI++ S   +KI DFGL+      R  G   ++     +  
Sbjct: 175 CGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA------RTAGTSFMMTPYVVTRY 228
Query: 182 YVAPEVLANRGYDGATSDIWSCGVILYIFRGDFKLPKWLSPG 223
           Y APEV+   GY     DIWS G I+    G+    K L PG
Sbjct: 229 YRAPEVILGMGYK-ENVDIWSVGCIM----GEMVRHKILFPG 265

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 66/222 (29%), Positives = 99/222 (44%), Gaps = 28/222 (12%)
Query: 13  LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEK--NRIIHLKITDQIKREIATLKL 70
           L RY+  + +G G  G V  A D       A+K L +      H K   +  RE+  +K 
Sbjct: 23  LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAK---RAYRELVLMKC 79
Query: 71  LKHPNVVRLHEVLASKSK------IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLI 124
           + H N++ L  V   +        +Y+V+E +    L   I  +  L       L  Q++
Sbjct: 80  VNHKNIISLLNVFTPQKTLEEFQDVYLVME-LMDANLCQVI--QMELDHERMSYLLYQML 136
Query: 125 DGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDG---LLHTTCGSPN 181
            G+ + H+ G+ HRDLK  NI++ S   +KI DFGL+      R  G   ++     +  
Sbjct: 137 CGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA------RTAGTSFMMTPYVVTRY 190
Query: 182 YVAPEVLANRGYDGATSDIWSCGVILYIFRGDFKLPKWLSPG 223
           Y APEV+   GY     DIWS G I+    G+    K L PG
Sbjct: 191 YRAPEVILGMGY-KENVDIWSVGCIM----GEMVRHKILFPG 227

>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 66/222 (29%), Positives = 99/222 (44%), Gaps = 28/222 (12%)
Query: 13  LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEK--NRIIHLKITDQIKREIATLKL 70
           L RY+  + +G G  G V  A D       A+K L +      H K   +  RE+  +K 
Sbjct: 23  LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAK---RAYRELVLMKC 79
Query: 71  LKHPNVVRLHEVLASKSK------IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLI 124
           + H N++ L  V   +        +Y+V+E +    L   I  +  L       L  Q++
Sbjct: 80  VNHKNIIGLLNVFTPQKSLEEFQDVYIVME-LMDANLCQVI--QMELDHERMSYLLYQML 136
Query: 125 DGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDG---LLHTTCGSPN 181
            G+ + H+ G+ HRDLK  NI++ S   +KI DFGL+      R  G   ++     +  
Sbjct: 137 CGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA------RTAGTSFMMEPEVVTRY 190
Query: 182 YVAPEVLANRGYDGATSDIWSCGVILYIFRGDFKLPKWLSPG 223
           Y APEV+   GY     DIWS G I+    G+    K L PG
Sbjct: 191 YRAPEVILGMGYK-ENVDIWSVGCIM----GEMVCHKILFPG 227

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 66/222 (29%), Positives = 99/222 (44%), Gaps = 28/222 (12%)
Query: 13  LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEK--NRIIHLKITDQIKREIATLKL 70
           L RY+  + +G G  G V  A D       A+K L +      H K   +  RE+  +K 
Sbjct: 23  LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAK---RAYRELVLMKC 79
Query: 71  LKHPNVVRLHEVLASKSK------IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLI 124
           + H N++ L  V   +        +Y+V+E +    L   I  +  L       L  Q++
Sbjct: 80  VNHKNIISLLNVFTPQKTLEEFQDVYLVME-LMDANLCQVI--QMELDHERMSYLLYQML 136
Query: 125 DGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDG---LLHTTCGSPN 181
            G+ + H+ G+ HRDLK  NI++ S   +KI DFGL+      R  G   ++     +  
Sbjct: 137 CGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA------RTAGTSFMMTPYVVTRY 190
Query: 182 YVAPEVLANRGYDGATSDIWSCGVILYIFRGDFKLPKWLSPG 223
           Y APEV+   GY     DIWS G I+    G+    K L PG
Sbjct: 191 YRAPEVILGMGY-KENVDIWSVGCIM----GEMVRHKILFPG 227

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 66/222 (29%), Positives = 99/222 (44%), Gaps = 28/222 (12%)
Query: 13  LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEK--NRIIHLKITDQIKREIATLKL 70
           L RY+  + +G G  G V  A D       A+K L +      H K   +  RE+  +K 
Sbjct: 24  LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAK---RAYRELVLMKC 80
Query: 71  LKHPNVVRLHEVLASKSK------IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLI 124
           + H N++ L  V   +        +Y+V+E +    L   I  +  L       L  Q++
Sbjct: 81  VNHKNIISLLNVFTPQKTLEEFQDVYLVME-LMDANLCQVI--QMELDHERMSYLLYQML 137
Query: 125 DGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDG---LLHTTCGSPN 181
            G+ + H+ G+ HRDLK  NI++ S   +KI DFGL+      R  G   ++     +  
Sbjct: 138 CGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA------RTAGTSFMMTPYVVTRY 191
Query: 182 YVAPEVLANRGYDGATSDIWSCGVILYIFRGDFKLPKWLSPG 223
           Y APEV+   GY     DIWS G I+    G+    K L PG
Sbjct: 192 YRAPEVILGMGYK-ENVDIWSVGCIM----GEMVRHKILFPG 228

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 66/222 (29%), Positives = 99/222 (44%), Gaps = 28/222 (12%)
Query: 13  LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEK--NRIIHLKITDQIKREIATLKL 70
           L RY+  + +G G  G V  A D       A+K L +      H K   +  RE+  +K 
Sbjct: 22  LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAK---RAYRELVLMKC 78
Query: 71  LKHPNVVRLHEVLASKSK------IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLI 124
           + H N++ L  V   +        +Y+V+E +    L   I  +  L       L  Q++
Sbjct: 79  VNHKNIISLLNVFTPQKTLEEFQDVYLVME-LMDANLCQVI--QMELDHERMSYLLYQML 135
Query: 125 DGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDG---LLHTTCGSPN 181
            G+ + H+ G+ HRDLK  NI++ S   +KI DFGL+      R  G   ++     +  
Sbjct: 136 CGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA------RTAGTSFMMTPYVVTRY 189
Query: 182 YVAPEVLANRGYDGATSDIWSCGVILYIFRGDFKLPKWLSPG 223
           Y APEV+   GY     DIWS G I+    G+    K L PG
Sbjct: 190 YRAPEVILGMGY-KENVDIWSVGCIM----GEMVRHKILFPG 226

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 66/222 (29%), Positives = 99/222 (44%), Gaps = 28/222 (12%)
Query: 13  LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEK--NRIIHLKITDQIKREIATLKL 70
           L RY+  + +G G  G V  A D       A+K L +      H K   +  RE+  +K 
Sbjct: 23  LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAK---RAYRELVLMKX 79
Query: 71  LKHPNVVRLHEVLASKSK------IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLI 124
           + H N++ L  V   +        +Y+V+E +    L   I  +  L       L  Q++
Sbjct: 80  VNHKNIISLLNVFTPQKTLEEFQDVYLVME-LMDANLXQVI--QMELDHERMSYLLYQML 136
Query: 125 DGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDG---LLHTTCGSPN 181
            G+ + H+ G+ HRDLK  NI++ S   +KI DFGL+      R  G   ++     +  
Sbjct: 137 CGIKHLHSAGIIHRDLKPSNIVVKSDXTLKILDFGLA------RTAGTSFMMTPYVVTRY 190
Query: 182 YVAPEVLANRGYDGATSDIWSCGVILYIFRGDFKLPKWLSPG 223
           Y APEV+   GY     DIWS G I+    G+    K L PG
Sbjct: 191 YRAPEVILGMGY-KENVDIWSVGCIM----GEMVRHKILFPG 227

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 65/217 (29%), Positives = 103/217 (47%), Gaps = 31/217 (14%)
Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
           Y   + +G G+FG V  A+  DSG   A+K + + +           RE+  ++ L H N
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFK-------NRELQIMRKLDHCN 74
Query: 76  VVRLHEVLAS----KSKIYM--VLEYVTGGELFDKIA-----SKGRLQEAEGRKLFQQLI 124
           +VRL     S    K ++Y+  VL+YV   E   ++A     +K  L     +    QL 
Sbjct: 75  IVRLRYFFYSSGEKKDEVYLNLVLDYVP--ETVYRVARHYSRAKQTLPVIYVKLYMYQLF 132
Query: 125 DGVSYCHNKGVFHRDLKLENILLDSKGNI-KISDFGLSALPQHFRDDGLLHTTCGSPNYV 183
             ++Y H+ G+ HRD+K +N+LLD    + K+ DFG +   Q  R +  +   C S  Y 
Sbjct: 133 RSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAK--QLVRGEPNVSYIC-SRYYR 189
Query: 184 APEVLANRGYDGATSDIWSCGVILY-------IFRGD 213
           APE++       ++ D+WS G +L        IF GD
Sbjct: 190 APELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGD 226

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 57/202 (28%), Positives = 99/202 (49%), Gaps = 18/202 (8%)
Query: 18  LGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVV 77
           L   +G G FGKV  A  +   +       + +  I   I + +++E     +LKHPN++
Sbjct: 11  LEEIIGIGGFGKVYRAFWIGDEVAVKAARHDPDEDISQTI-ENVRQEAKLFAMLKHPNII 69
Query: 78  RLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKG--- 134
            L  V   +  + +V+E+  GG L +++ S  R+          Q+  G++Y H++    
Sbjct: 70  ALRGVCLKEPNLCLVMEFARGGPL-NRVLSGKRIPPDILVNWAVQIARGMNYLHDEAIVP 128
Query: 135 VFHRDLKLENILLDSKGN--------IKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPE 186
           + HRDLK  NIL+  K          +KI+DFGL+   +  R   +  +  G+  ++APE
Sbjct: 129 IIHRDLKSSNILILQKVENGDLSNKILKITDFGLAR--EWHRTTKM--SAAGAYAWMAPE 184
Query: 187 VLANRGYDGATSDIWSCGVILY 208
           V+    +    SD+WS GV+L+
Sbjct: 185 VIRASMFSKG-SDVWSYGVLLW 205

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 66/222 (29%), Positives = 99/222 (44%), Gaps = 28/222 (12%)
Query: 13  LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEK--NRIIHLKITDQIKREIATLKL 70
           L RY+  + +G G  G V  A D       A+K L +      H K   +  RE+  +K 
Sbjct: 23  LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAK---RAYRELVLMKX 79
Query: 71  LKHPNVVRLHEVLASKSK------IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLI 124
           + H N++ L  V   +        +Y+V+E +    L   I  +  L       L  Q++
Sbjct: 80  VNHKNIISLLNVFTPQKTLEEFQDVYLVME-LMDANLCQVI--QMELDHERMSYLLYQML 136
Query: 125 DGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDG---LLHTTCGSPN 181
            G+ + H+ G+ HRDLK  NI++ S   +KI DFGL+      R  G   ++     +  
Sbjct: 137 CGIKHLHSAGIIHRDLKPSNIVVKSDXTLKILDFGLA------RTAGTSFMMTPYVVTRY 190
Query: 182 YVAPEVLANRGYDGATSDIWSCGVILYIFRGDFKLPKWLSPG 223
           Y APEV+   GY     DIWS G I+    G+    K L PG
Sbjct: 191 YRAPEVILGMGYK-ENVDIWSVGCIM----GEMVRHKILFPG 227

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 58/196 (29%), Positives = 97/196 (49%), Gaps = 16/196 (8%)
Query: 17  ELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNV 76
           +L + LG G FG+V  A   +     AVK ++   +      +    E   +K L+H  +
Sbjct: 191 KLEKKLGAGQFGEVWMAT-YNKHTKVAVKTMKPGSMS----VEAFLAEANVMKTLQHDKL 245
Query: 77  VRLHEVLASKSKIYMVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQ-QLIDGVSYCHNKG 134
           V+LH V+ +K  IY++ E++  G L D + S +G  Q       F  Q+ +G+++   + 
Sbjct: 246 VKLHAVV-TKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN 304
Query: 135 VFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP---NYVAPEVLANR 191
             HRDL+  NIL+ +    KI+DFGL+ + +    D       G+     + APE + N 
Sbjct: 305 YIHRDLRAANILVSASLVCKIADFGLARVIE----DNEYTAREGAKFPIKWTAPEAI-NF 359
Query: 192 GYDGATSDIWSCGVIL 207
           G     SD+WS G++L
Sbjct: 360 GSFTIKSDVWSFGILL 375

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 60/203 (29%), Positives = 92/203 (45%), Gaps = 18/203 (8%)
Query: 13  LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEK--NRIIHLKITDQIKREIATLKL 70
           L RY+  + +G G  G V  A D       A+K L +      H K   +  RE+  +K 
Sbjct: 23  LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAK---RAYRELVLMKC 79
Query: 71  LKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRK---LFQQLIDGV 127
           + H N++ L  V   +  +    +     EL D   S+    E +  +   L  Q++ G+
Sbjct: 80  VNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQMLCGI 139
Query: 128 SYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDG---LLHTTCGSPNYVA 184
            + H+ G+ HRDLK  NI++ S   +KI DFGL+      R  G   ++     +  Y A
Sbjct: 140 KHLHSAGIIHRDLKPSNIVVKSDATLKILDFGLA------RTAGTSFMMTPYVVTRYYRA 193
Query: 185 PEVLANRGYDGATSDIWSCGVIL 207
           PEV+   GY     DIWS G I+
Sbjct: 194 PEVILGMGYK-ENVDIWSVGCIM 215

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 60/217 (27%), Positives = 103/217 (47%), Gaps = 31/217 (14%)
Query: 18  LGRTLGEGNFGKVKFAQDL-------DSGLPFAVKILEKNRIIHLKITDQIKREIATLKL 70
           LG+ LGEG FG+V  A+ +          +  AVK+L K+      ++D +  E+  +K+
Sbjct: 39  LGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKML-KDDATEKDLSDLVS-EMEMMKM 96
Query: 71  L-KHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASK-----------GRLQEAEGR- 117
           + KH N++ L         +Y+++ Y + G L + + ++            R+ E +   
Sbjct: 97  IGKHKNIINLLGACTQDGPLYVIVAYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTF 156
Query: 118 ----KLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLL 173
                   QL  G+ Y  ++   HRDL   N+L+     +KI+DFGL+    +   D   
Sbjct: 157 KDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNI--DYYK 214
Query: 174 HTTCG--SPNYVAPEVLANRGYDGATSDIWSCGVILY 208
            TT G     ++APE L +R Y    SD+WS GV+++
Sbjct: 215 KTTNGRLPVKWMAPEALFDRVY-THQSDVWSFGVLMW 250

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 52/211 (24%), Positives = 96/211 (45%), Gaps = 12/211 (5%)
Query: 17  ELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKR----EIATLKLLK 72
           ++ + +G G FG+V         LP   +I    + +    T++ +R    E + +    
Sbjct: 36  KIEQVIGAGEFGEVCSGH---LKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFD 92
Query: 73  HPNVVRLHEVLASKSKIYMVLEYVTGGELFDKI-ASKGRLQEAEGRKLFQQLIDGVSYCH 131
           HPNV+ L  V+   + + ++ E++  G L   +  + G+    +   + + +  G+ Y  
Sbjct: 93  HPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLA 152
Query: 132 NKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP---NYVAPEVL 188
           +    HRDL   NIL++S    K+SDFGLS   +    D    +  G      + APE +
Sbjct: 153 DMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAI 212
Query: 189 ANRGYDGATSDIWSCGVILYIFRGDFKLPKW 219
             R +  A SD+WS G++++      + P W
Sbjct: 213 QYRKFTSA-SDVWSYGIVMWEVMSYGERPYW 242

>pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 55/204 (26%), Positives = 97/204 (47%), Gaps = 17/204 (8%)
Query: 17  ELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNV 76
           E+G  +G+G FG+V +       +   +  +E++    LK     KRE+   +  +H NV
Sbjct: 36  EIGELIGKGRFGQV-YHGRWHGEVAIRLIDIERDNEDQLK---AFKREVMAYRQTRHENV 91
Query: 77  VRLHEVLASKSKIYMVLEYVTGGELFDKIA-SKGRLQEAEGRKLFQQLIDGVSYCHNKGV 135
           V       S   + ++     G  L+  +  +K  L   + R++ Q+++ G+ Y H KG+
Sbjct: 92  VLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGI 151
Query: 136 FHRDLKLENILLDSKGNIKISDFGL---SALPQHFRDDGLLHTTCGSPNYVAPEVLANRG 192
            H+DLK +N+  D+ G + I+DFGL   S + Q  R +  L    G   ++APE++    
Sbjct: 152 LHKDLKSKNVFYDN-GKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLS 210
Query: 193 YD--------GATSDIWSCGVILY 208
            D           SD+++ G I Y
Sbjct: 211 PDTEEDKLPFSKHSDVFALGTIWY 234

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 44/161 (27%), Positives = 79/161 (49%), Gaps = 7/161 (4%)
Query: 64  EIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGEL--FDKIASKGRLQEAEGRKLFQ 121
           E + +   +HPN++RL  V+ +   + ++ E++  G L  F ++ + G+    +   + +
Sbjct: 65  EASIMGQFEHPNIIRLEGVVTNSMPVMILTEFMENGALDSFLRL-NDGQFTVIQLVGMLR 123
Query: 122 QLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP- 180
            +  G+ Y       HRDL   NIL++S    K+SDFGLS   +    D    ++ G   
Sbjct: 124 GIASGMRYLAEMSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTYTSSLGGKI 183
Query: 181 --NYVAPEVLANRGYDGATSDIWSCGVILYIFRGDFKLPKW 219
              + APE +A R +  A SD WS G++++      + P W
Sbjct: 184 PIRWTAPEAIAFRKFTSA-SDAWSYGIVMWEVMSFGERPYW 223

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 63/214 (29%), Positives = 103/214 (48%), Gaps = 15/214 (7%)
Query: 22  LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHE 81
           LG G FG+V      +     AVK L++  +      D    E   +K L+H  +VRL+ 
Sbjct: 17  LGAGQFGEVWMGY-YNGHTKVAVKSLKQGSMS----PDAFLAEANLMKQLQHQRLVRLYA 71
Query: 82  VLASKSKIYMVLEYVTGGELFD--KIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRD 139
           V+ ++  IY++ EY+  G L D  K  S  +L   +   +  Q+ +G+++   +   HR+
Sbjct: 72  VV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRN 130
Query: 140 LKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP-NYVAPEVLANRGYDGATS 198
           L+  NIL+    + KI+DFGL+ L +   ++         P  + APE + N G     S
Sbjct: 131 LRAANILVSDTLSCKIADFGLARLIED--NEYTAREGAKFPIKWTAPEAI-NYGTFTIKS 187
Query: 199 DIWSCGVIL--YIFRGDFKLPKWLSPGA-QNLLR 229
           D+WS G++L   +  G    P   +P   QNL R
Sbjct: 188 DVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLER 221

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 69/226 (30%), Positives = 107/226 (47%), Gaps = 29/226 (12%)
Query: 17  ELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNV 76
           +L + LG G FG+V +    +     A+K L+   +      +    E   +K LKH  +
Sbjct: 12  QLIKRLGNGQFGEV-WMGTWNGNTKVAIKTLKPGTMS----PESFLEEAQIMKKLKHDKL 66
Query: 77  VRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKL-FQQLID-------GVS 128
           V+L+ V+ S+  IY+V EY+  G L D       L++ EGR L    L+D       G++
Sbjct: 67  VQLYAVV-SEEPIYIVTEYMNKGSLLD------FLKDGEGRALKLPNLVDMAAQVAAGMA 119
Query: 129 YCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP-NYVAPEV 187
           Y       HRDL+  NIL+ +    KI+DFGL+ L +   ++         P  + APE 
Sbjct: 120 YIERMNYIHRDLRSANILVGNGLICKIADFGLARLIED--NEXTARQGAKFPIKWTAPEA 177
Query: 188 LANRGYDGATSDIWSCGVILYIFRGDFKLPKWLSPGAQNLLRKILE 233
            A  G     SD+WS G++L       ++P    PG  N  R++LE
Sbjct: 178 -ALYGRFTIKSDVWSFGILLTELVTKGRVP---YPGMNN--REVLE 217

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 53/201 (26%), Positives = 98/201 (48%), Gaps = 14/201 (6%)
Query: 14  GRYELGRTLGEGNFGKV---KFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKL 70
           G+  +G+ +G G+FG V   K+  D+      AVK+L        ++    K E+  L+ 
Sbjct: 8   GQITVGQRIGSGSFGTVYKGKWHGDV------AVKMLNVTAPTPQQL-QAFKNEVGVLRK 60
Query: 71  LKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKI-ASKGRLQEAEGRKLFQQLIDGVSY 129
            +H N++ L    ++K ++ +V ++  G  L+  +   + + +  +   + +Q   G+ Y
Sbjct: 61  TRHVNIL-LFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDY 119
Query: 130 CHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEV-- 187
            H K + HRDLK  NI L     +KI DFGL+     +          GS  ++APEV  
Sbjct: 120 LHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIR 179
Query: 188 LANRGYDGATSDIWSCGVILY 208
           + ++      SD+++ G++LY
Sbjct: 180 MQDKNPYSFQSDVYAFGIVLY 200

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 53/201 (26%), Positives = 98/201 (48%), Gaps = 14/201 (6%)
Query: 14  GRYELGRTLGEGNFGKV---KFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKL 70
           G+  +G+ +G G+FG V   K+  D+      AVK+L        ++    K E+  L+ 
Sbjct: 36  GQITVGQRIGSGSFGTVYKGKWHGDV------AVKMLNVTAPTPQQL-QAFKNEVGVLRK 88
Query: 71  LKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKI-ASKGRLQEAEGRKLFQQLIDGVSY 129
            +H N++ L    ++K ++ +V ++  G  L+  +   + + +  +   + +Q   G+ Y
Sbjct: 89  TRHVNIL-LFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDY 147
Query: 130 CHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEV-- 187
            H K + HRDLK  NI L     +KI DFGL+     +          GS  ++APEV  
Sbjct: 148 LHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIR 207
Query: 188 LANRGYDGATSDIWSCGVILY 208
           + ++      SD+++ G++LY
Sbjct: 208 MQDKNPYSFQSDVYAFGIVLY 228

>pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 70/281 (24%), Positives = 119/281 (42%), Gaps = 72/281 (25%)
Query: 19  GRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIAT-LKLLKHPNVV 77
            + LG G  GKV    +  +   FA+K+L+           + +RE+    +  + P++V
Sbjct: 23  SQVLGLGINGKVLQIFNKRTQEKFALKMLQD--------CPKARREVELHWRASQCPHIV 74
Query: 78  RLHEVL----ASKSKIYMVLEYVTGGELFDKIASKG--RLQEAEGRKLFQQLIDGVSYCH 131
           R+ +V     A +  + +V+E + GGELF +I  +G     E E  ++ + + + + Y H
Sbjct: 75  RIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH 134
Query: 132 NKGVFHRDLKLENILLDSK---GNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVL 188
           +  + HRD+K EN+L  SK     +K++DFG                        A E  
Sbjct: 135 SINIAHRDVKPENLLYTSKRPNAILKLTDFGF-----------------------AKETT 171
Query: 189 ANRGYDGATSDIWSCGVILYIF--------------------------RGDFKLPKW--L 220
             + YD  + D+WS GVI+YI                           + +F  P+W  +
Sbjct: 172 GEK-YD-KSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEV 229
Query: 221 SPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY-TPANP 260
           S   + L+R +L+  P +R+TI       W  Q    P  P
Sbjct: 230 SEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTP 270

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 53/201 (26%), Positives = 98/201 (48%), Gaps = 14/201 (6%)
Query: 14  GRYELGRTLGEGNFGKV---KFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKL 70
           G+  +G+ +G G+FG V   K+  D+      AVK+L        ++    K E+  L+ 
Sbjct: 28  GQITVGQRIGSGSFGTVYKGKWHGDV------AVKMLNVTAPTPQQL-QAFKNEVGVLRK 80
Query: 71  LKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKI-ASKGRLQEAEGRKLFQQLIDGVSY 129
            +H N++ L    ++K ++ +V ++  G  L+  +   + + +  +   + +Q   G+ Y
Sbjct: 81  TRHVNIL-LFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDY 139
Query: 130 CHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEV-- 187
            H K + HRDLK  NI L     +KI DFGL+     +          GS  ++APEV  
Sbjct: 140 LHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIR 199
Query: 188 LANRGYDGATSDIWSCGVILY 208
           + ++      SD+++ G++LY
Sbjct: 200 MQDKNPYSFQSDVYAFGIVLY 220

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 75/272 (27%), Positives = 122/272 (44%), Gaps = 40/272 (14%)
Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
           Y   + +G G+FG V  A+  DSG   A+K + + +           RE+  ++ L H N
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFK-------NRELQIMRKLDHCN 74
Query: 76  VVRLHEVLAS----KSKIYM--VLEYVTGGELFDKIA-----SKGRLQEAEGRKLFQQLI 124
           +VRL     S    K ++Y+  VL+YV       ++A     +K  L     +    QL 
Sbjct: 75  IVRLRYFFYSSGEKKDEVYLNLVLDYVPATVY--RVARHYSRAKQTLPVIYVKLYMYQLF 132
Query: 125 DGVSYCHNKGVFHRDLKLENILLDSKGNI-KISDFGLSALPQHFRDDGLLHTTCGSPNYV 183
             ++Y H+ G+ HRD+K +N+LLD    + K+ DFG +   Q  R +  +   C S  Y 
Sbjct: 133 RSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAK--QLVRGEPNVSXIC-SRYYR 189
Query: 184 APEVLANRGYDGATSDIWSCGVILY-------IFRGD------FKLPKWLSPGAQNLLRK 230
           APE++       ++ D+WS G +L        IF GD       ++ K L    +  +R+
Sbjct: 190 APELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIRE 249
Query: 231 ILEPNPVKRITIAGIKADEWFEQDYTPANPDD 262
            + PN         IKA  W  + + P  P +
Sbjct: 250 -MNPN-YTEFAFPQIKAHPW-TKVFRPRTPPE 278

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 71.2 bits (173), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 54/200 (27%), Positives = 95/200 (47%), Gaps = 14/200 (7%)
Query: 22  LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHE 81
           +G G FG V     L+     A+K + +  +      +    E   +  L HP +V+L+ 
Sbjct: 15  IGSGQFGLVHLGYWLNKD-KVAIKTIREGAMSE----EDFIEEAEVMMKLSHPKLVQLYG 69
Query: 82  VLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGR-KLFQQLIDGVSYCHNKGVFHRDL 140
           V   ++ I +V E++  G L D + ++  L  AE    +   + +G++Y     V HRDL
Sbjct: 70  VCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEASVIHRDL 129
Query: 141 KLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP---NYVAPEVLANRGYDGAT 197
              N L+     IK+SDFG++     F  D    ++ G+     + +PEV +   Y  + 
Sbjct: 130 AARNCLVGENQVIKVSDFGMT----RFVLDDQYTSSTGTKFPVKWASPEVFSFSRYS-SK 184
Query: 198 SDIWSCGVILYIFRGDFKLP 217
           SD+WS GV+++    + K+P
Sbjct: 185 SDVWSFGVLMWEVFSEGKIP 204

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 71.2 bits (173), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 52/201 (25%), Positives = 98/201 (48%), Gaps = 14/201 (6%)
Query: 14  GRYELGRTLGEGNFGKV---KFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKL 70
           G+  +G+ +G G+FG V   K+  D+      AVK+L        ++    K E+  L+ 
Sbjct: 8   GQITVGQRIGSGSFGTVYKGKWHGDV------AVKMLNVTAPTPQQL-QAFKNEVGVLRK 60
Query: 71  LKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKI-ASKGRLQEAEGRKLFQQLIDGVSY 129
            +H N++ L    ++  ++ +V ++  G  L+  +   + + +  +   + +Q   G+ Y
Sbjct: 61  TRHVNIL-LFMGYSTAPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDY 119
Query: 130 CHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEV-- 187
            H K + HRDLK  NI L     +KI DFGL+ +   +          GS  ++APEV  
Sbjct: 120 LHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIR 179
Query: 188 LANRGYDGATSDIWSCGVILY 208
           + ++      SD+++ G++LY
Sbjct: 180 MQDKNPYSFQSDVYAFGIVLY 200

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 71.2 bits (173), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 60/217 (27%), Positives = 103/217 (47%), Gaps = 31/217 (14%)
Query: 18  LGRTLGEGNFGKVKFAQDL-------DSGLPFAVKILEKNRIIHLKITDQIKREIATLKL 70
           LG+ LGEG FG+V  A+ +          +  AVK+L K+      ++D +  E+  +K+
Sbjct: 39  LGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKML-KDDATEKDLSDLVS-EMEMMKM 96
Query: 71  L-KHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASK-----------GRLQEAEGR- 117
           + KH N++ L         +Y+++ Y + G L + + ++            R+ E +   
Sbjct: 97  IGKHKNIINLLGACTQDGPLYVIVGYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTF 156
Query: 118 ----KLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLL 173
                   QL  G+ Y  ++   HRDL   N+L+     +KI+DFGL+    +   D   
Sbjct: 157 KDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNI--DYYK 214
Query: 174 HTTCG--SPNYVAPEVLANRGYDGATSDIWSCGVILY 208
            TT G     ++APE L +R Y    SD+WS GV+++
Sbjct: 215 KTTNGRLPVKWMAPEALFDRVYT-HQSDVWSFGVLMW 250

>pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370

Iteration: 1
 Score = 71.2 bits (173), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 65/222 (29%), Positives = 99/222 (44%), Gaps = 28/222 (12%)
Query: 13  LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEK--NRIIHLKITDQIKREIATLKL 70
           L RY+  + +G G  G V  A D       A+K L +      H K   +  RE+  +K 
Sbjct: 23  LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAK---RAYRELVLMKC 79
Query: 71  LKHPNVVRLHEVLASKSK------IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLI 124
           + H N++ L  V   +        +Y+V+E +    L   I  +  L       L  Q++
Sbjct: 80  VNHKNIIGLLNVFTPQKSLEEFQDVYIVME-LMDANLCQVI--QMELDHERMSYLLYQML 136
Query: 125 DGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDG---LLHTTCGSPN 181
            G+ + H+ G+ HRDLK  NI++ S   +KI DFGL+      R  G   ++     +  
Sbjct: 137 CGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA------RTAGTSFMMEPEVVTRY 190
Query: 182 YVAPEVLANRGYDGATSDIWSCGVILYIFRGDFKLPKWLSPG 223
           Y APEV+   GY     D+WS G I+    G+    K L PG
Sbjct: 191 YRAPEVILGMGYK-ENVDLWSVGCIM----GEMVCHKILFPG 227

>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313

Iteration: 1
 Score = 71.2 bits (173), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 65/227 (28%), Positives = 101/227 (44%), Gaps = 27/227 (11%)
Query: 18  LGRTLGEGNFGKV---KFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
           LG+ LGEG FG V      Q+  + L  AVK ++ +     +I ++   E A +K   HP
Sbjct: 38  LGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREI-EEFLSEAACMKDFSHP 96
Query: 75  NVVRLHEVLASKS-----KIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLID---- 125
           NV+RL  V    S     K  ++L ++  G+L   +    RL+        Q L+     
Sbjct: 97  NVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLY-SRLETGPKHIPLQTLLKFMVD 155
Query: 126 ---GVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSA---LPQHFRDDGLLHTTCGS 179
              G+ Y  N+   HRDL   N +L     + ++DFGLS       ++R   +       
Sbjct: 156 IALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPV-- 213
Query: 180 PNYVAPEVLANRGYDGATSDIWSCGVILYIFRGDFKLPKWLSPGAQN 226
             ++A E LA+R Y  + SD+W+ GV ++        P    PG QN
Sbjct: 214 -KWIAIESLADRVYT-SKSDVWAFGVTMWEIATRGMTP---YPGVQN 255

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 60/203 (29%), Positives = 92/203 (45%), Gaps = 18/203 (8%)
Query: 13  LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEK--NRIIHLKITDQIKREIATLKL 70
           L RY+  + +G G  G V  A D       A+K L +      H K   +  RE+  +K 
Sbjct: 23  LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAK---RAYRELVLMKC 79
Query: 71  LKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRK---LFQQLIDGV 127
           + H N++ L  V   +  +    +     EL D   S+    E +  +   L  Q++ G+
Sbjct: 80  VNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQMLCGI 139
Query: 128 SYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDG---LLHTTCGSPNYVA 184
            + H+ G+ HRDLK  NI++ S   +KI DFGL+      R  G   ++     +  Y A
Sbjct: 140 KHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA------RTAGTSFMMTPYVVTRYYRA 193
Query: 185 PEVLANRGYDGATSDIWSCGVIL 207
           PEV+   GY     DIWS G I+
Sbjct: 194 PEVILGMGYK-ENVDIWSVGCIM 215

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 44/161 (27%), Positives = 79/161 (49%), Gaps = 7/161 (4%)
Query: 64  EIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGEL--FDKIASKGRLQEAEGRKLFQ 121
           E + +   +HPN++RL  V+ +   + ++ E++  G L  F ++ + G+    +   + +
Sbjct: 67  EASIMGQFEHPNIIRLEGVVTNSMPVMILTEFMENGALDSFLRL-NDGQFTVIQLVGMLR 125
Query: 122 QLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP- 180
            +  G+ Y       HRDL   NIL++S    K+SDFGLS   +    D    ++ G   
Sbjct: 126 GIASGMRYLAEMSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTETSSLGGKI 185
Query: 181 --NYVAPEVLANRGYDGATSDIWSCGVILYIFRGDFKLPKW 219
              + APE +A R +  A SD WS G++++      + P W
Sbjct: 186 PIRWTAPEAIAFRKFTSA-SDAWSYGIVMWEVMSFGERPYW 225

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 54/200 (27%), Positives = 95/200 (47%), Gaps = 14/200 (7%)
Query: 22  LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHE 81
           +G G FG V     L+     A+K + +  +      +    E   +  L HP +V+L+ 
Sbjct: 18  IGSGQFGLVHLGYWLNKD-KVAIKTIREGAMSE----EDFIEEAEVMMKLSHPKLVQLYG 72
Query: 82  VLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGR-KLFQQLIDGVSYCHNKGVFHRDL 140
           V   ++ I +V E++  G L D + ++  L  AE    +   + +G++Y     V HRDL
Sbjct: 73  VCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDL 132
Query: 141 KLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP---NYVAPEVLANRGYDGAT 197
              N L+     IK+SDFG++     F  D    ++ G+     + +PEV +   Y  + 
Sbjct: 133 AARNCLVGENQVIKVSDFGMT----RFVLDDQYTSSTGTKFPVKWASPEVFSFSRYS-SK 187
Query: 198 SDIWSCGVILYIFRGDFKLP 217
           SD+WS GV+++    + K+P
Sbjct: 188 SDVWSFGVLMWEVFSEGKIP 207

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 54/200 (27%), Positives = 95/200 (47%), Gaps = 14/200 (7%)
Query: 22  LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHE 81
           +G G FG V     L+     A+K + +  +      +    E   +  L HP +V+L+ 
Sbjct: 15  IGSGQFGLVHLGYWLNKD-KVAIKTIREGAMSE----EDFIEEAEVMMKLSHPKLVQLYG 69
Query: 82  VLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGR-KLFQQLIDGVSYCHNKGVFHRDL 140
           V   ++ I +V E++  G L D + ++  L  AE    +   + +G++Y     V HRDL
Sbjct: 70  VCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDL 129
Query: 141 KLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP---NYVAPEVLANRGYDGAT 197
              N L+     IK+SDFG++     F  D    ++ G+     + +PEV +   Y  + 
Sbjct: 130 AARNCLVGENQVIKVSDFGMT----RFVLDDQYTSSTGTKFPVKWASPEVFSFSRYS-SK 184
Query: 198 SDIWSCGVILYIFRGDFKLP 217
           SD+WS GV+++    + K+P
Sbjct: 185 SDVWSFGVLMWEVFSEGKIP 204

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 54/200 (27%), Positives = 95/200 (47%), Gaps = 14/200 (7%)
Query: 22  LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHE 81
           +G G FG V     L+     A+K + +  +      +    E   +  L HP +V+L+ 
Sbjct: 13  IGSGQFGLVHLGYWLNKD-KVAIKTIREGAMSE----EDFIEEAEVMMKLSHPKLVQLYG 67
Query: 82  VLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGR-KLFQQLIDGVSYCHNKGVFHRDL 140
           V   ++ I +V E++  G L D + ++  L  AE    +   + +G++Y     V HRDL
Sbjct: 68  VCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDL 127
Query: 141 KLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP---NYVAPEVLANRGYDGAT 197
              N L+     IK+SDFG++     F  D    ++ G+     + +PEV +   Y  + 
Sbjct: 128 AARNCLVGENQVIKVSDFGMT----RFVLDDQYTSSTGTKFPVKWASPEVFSFSRY-SSK 182
Query: 198 SDIWSCGVILYIFRGDFKLP 217
           SD+WS GV+++    + K+P
Sbjct: 183 SDVWSFGVLMWEVFSEGKIP 202

>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 65/222 (29%), Positives = 99/222 (44%), Gaps = 28/222 (12%)
Query: 13  LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEK--NRIIHLKITDQIKREIATLKL 70
           L RY+  + +G G  G V  A D       A+K L +      H K   +  RE+  +K 
Sbjct: 17  LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAK---RAYRELVLMKC 73
Query: 71  LKHPNVVRLHEVLASKSK------IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLI 124
           + H N++ L  V   +        +Y+V+E +    L   I  +  L       L  Q++
Sbjct: 74  VNHKNIIGLLNVFTPQKSLEEFQDVYIVME-LMDANLCQVI--QMELDHERMSYLLYQML 130
Query: 125 DGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDG---LLHTTCGSPN 181
            G+ + H+ G+ HRDLK  NI++ S   +KI DFGL+      R  G   ++     +  
Sbjct: 131 CGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA------RTAGTSFMMTPYVVTRY 184
Query: 182 YVAPEVLANRGYDGATSDIWSCGVILYIFRGDFKLPKWLSPG 223
           Y APEV+   GY     D+WS G I+    G+    K L PG
Sbjct: 185 YRAPEVILGMGYK-ENVDLWSVGCIM----GEMVCHKILFPG 221

>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 65/222 (29%), Positives = 99/222 (44%), Gaps = 28/222 (12%)
Query: 13  LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEK--NRIIHLKITDQIKREIATLKL 70
           L RY+  + +G G  G V  A D       A+K L +      H K   +  RE+  +K 
Sbjct: 28  LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAK---RAYRELVLMKC 84
Query: 71  LKHPNVVRLHEVLASKSK------IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLI 124
           + H N++ L  V   +        +Y+V+E +    L   I  +  L       L  Q++
Sbjct: 85  VNHKNIIGLLNVFTPQKSLEEFQDVYIVME-LMDANLCQVI--QMELDHERMSYLLYQML 141
Query: 125 DGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDG---LLHTTCGSPN 181
            G+ + H+ G+ HRDLK  NI++ S   +KI DFGL+      R  G   ++     +  
Sbjct: 142 CGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA------RTAGTSFMMTPYVVTRY 195
Query: 182 YVAPEVLANRGYDGATSDIWSCGVILYIFRGDFKLPKWLSPG 223
           Y APEV+   GY     D+WS G I+    G+    K L PG
Sbjct: 196 YRAPEVILGMGYK-ENVDLWSVGCIM----GEMVCHKILFPG 232

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 64/216 (29%), Positives = 102/216 (47%), Gaps = 19/216 (8%)
Query: 22  LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHE 81
           LG G  G+V      +     AVK L++  +      D    E   +K L+H  +VRL+ 
Sbjct: 21  LGAGQAGEVWMGY-YNGHTKVAVKSLKQGSMS----PDAFLAEANLMKQLQHQRLVRLYA 75
Query: 82  VLASKSKIYMVLEYVTGGELFD--KIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRD 139
           V+ ++  IY++ EY+  G L D  K  S  +L   +   +  Q+ +G+++   +   HRD
Sbjct: 76  VV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRD 134
Query: 140 LKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP---NYVAPEVLANRGYDGA 196
           L+  NIL+    + KI+DFGL+ L     +D       G+     + APE + N G    
Sbjct: 135 LRAANILVSDTLSCKIADFGLARL----IEDAEXTAREGAKFPIKWTAPEAI-NYGTFTI 189
Query: 197 TSDIWSCGVIL--YIFRGDFKLPKWLSPGA-QNLLR 229
            SD+WS G++L   +  G    P   +P   QNL R
Sbjct: 190 KSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLER 225

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 54/200 (27%), Positives = 95/200 (47%), Gaps = 14/200 (7%)
Query: 22  LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHE 81
           +G G FG V     L+     A+K + +  +      +    E   +  L HP +V+L+ 
Sbjct: 16  IGSGQFGLVHLGYWLNKD-KVAIKTIREGAMSE----EDFIEEAEVMMKLSHPKLVQLYG 70
Query: 82  VLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGR-KLFQQLIDGVSYCHNKGVFHRDL 140
           V   ++ I +V E++  G L D + ++  L  AE    +   + +G++Y     V HRDL
Sbjct: 71  VCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDL 130
Query: 141 KLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP---NYVAPEVLANRGYDGAT 197
              N L+     IK+SDFG++     F  D    ++ G+     + +PEV +   Y  + 
Sbjct: 131 AARNCLVGENQVIKVSDFGMT----RFVLDDQYTSSTGTKFPVKWASPEVFSFSRYS-SK 185
Query: 198 SDIWSCGVILYIFRGDFKLP 217
           SD+WS GV+++    + K+P
Sbjct: 186 SDVWSFGVLMWEVFSEGKIP 205

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 99/211 (46%), Gaps = 39/211 (18%)
Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
           Y   + +G G+FG V  A+ ++S      K+L+  R  +        RE+  ++++KHPN
Sbjct: 42  YTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRFKN--------RELQIMRIVKHPN 93
Query: 76  VVRLHEVLAS----KSKIYM--VLEYVTGGELFDKIASKGRLQEAEGRKLFQ----QLID 125
           VV L     S    K ++++  VLEYV    ++       +L++     L +    QL+ 
Sbjct: 94  VVDLKAFFYSNGDKKDEVFLNLVLEYVPE-TVYRASRHYAKLKQTMPMLLIKLYMYQLLR 152
Query: 126 GVSYCHNKGVFHRDLKLENILLD-SKGNIKISDFGLSALPQHFRDDGLLHTTCGSPN--- 181
            ++Y H+ G+ HRD+K +N+LLD   G +K+ DFG + +              G PN   
Sbjct: 153 SLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKI-----------LIAGEPNVSX 201
Query: 182 -----YVAPEVLANRGYDGATSDIWSCGVIL 207
                Y APE++          DIWS G ++
Sbjct: 202 ICSRYYRAPELIFGATNYTTNIDIWSTGCVM 232

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 60/200 (30%), Positives = 94/200 (47%), Gaps = 24/200 (12%)
Query: 17  ELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNV 76
           E+   +G G FG V  A+     +  A+K +E        I      E+  L  + HPN+
Sbjct: 12  EVEEVVGRGAFGVVCKAKWRAKDV--AIKQIESESERKAFIV-----ELRQLSRVNHPNI 64
Query: 77  VRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRL---QEAEGRKLFQQLIDGVSYCHN- 132
           V+L+   A  + + +V+EY  GG L++ +     L     A       Q   GV+Y H+ 
Sbjct: 65  VKLYG--ACLNPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSM 122
Query: 133 --KGVFHRDLKLENILLDSKGNI-KISDFGLSA-LPQHFRDDGLLHTTCGSPNYVAPEVL 188
             K + HRDLK  N+LL + G + KI DFG +  +  H  ++       GS  ++APEV 
Sbjct: 123 QPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHMTNNK------GSAAWMAPEVF 176
Query: 189 ANRGYDGATSDIWSCGVILY 208
               Y     D++S G+IL+
Sbjct: 177 EGSNYS-EKCDVFSWGIILW 195

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 93/206 (45%), Gaps = 24/206 (11%)
Query: 13  LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEK--NRIIHLKITDQIKREIATLKL 70
           L RY+  + +G G  G V  A D       A+K L +      H K   +  RE+  +K 
Sbjct: 23  LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAK---RAYRELVLMKC 79
Query: 71  LKHPNVVRLHEVLASKSK------IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLI 124
           + H N++ L  V   +        +Y+V+E +    L   I  +  L       L  Q++
Sbjct: 80  VNHKNIIGLLNVFTPQKSLEEFQDVYIVME-LMDANLCQVI--QMELDHERMSYLLYQML 136
Query: 125 DGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDG---LLHTTCGSPN 181
            G+ + H+ G+ HRDLK  NI++ S   +KI DFGL+      R  G   ++     +  
Sbjct: 137 CGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA------RTAGTSFMMTPEVVTRY 190
Query: 182 YVAPEVLANRGYDGATSDIWSCGVIL 207
           Y APEV+   GY     DIWS G I+
Sbjct: 191 YRAPEVILGMGYK-ENVDIWSVGCIM 215

>pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 98/208 (47%), Gaps = 23/208 (11%)
Query: 18  LGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVV 77
           L   LG+G    V   +   +G  FA+K+   N I  L+  D   RE   LK L H N+V
Sbjct: 13  LSDILGQGATANVFRGRHKKTGDLFAIKVF--NNISFLRPVDVQMREFEVLKKLNHKNIV 70
Query: 78  RL---HEVLASKSKIYMVLEYVTGGELFDKIASKGR---LQEAEGRKLFQQLIDGVSYCH 131
           +L    E   ++ K+ +++E+   G L+  +        L E+E   + + ++ G+++  
Sbjct: 71  KLFAIEEETTTRHKV-LIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR 129
Query: 132 NKGVFHRDLKLENILL----DSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEV 187
             G+ HR++K  NI+     D +   K++DFG +   +   DD    +  G+  Y+ P++
Sbjct: 130 ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA---RELEDDEQFVSLYGTEEYLHPDM 186
Query: 188 LA-------NRGYDGATSDIWSCGVILY 208
                    ++   GAT D+WS GV  Y
Sbjct: 187 YERAVLRKDHQKKYGATVDLWSIGVTFY 214

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 93/206 (45%), Gaps = 24/206 (11%)
Query: 13  LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEK--NRIIHLKITDQIKREIATLKL 70
           L RY+  + +G G  G V  A D       A+K L +      H K   +  RE+  +K 
Sbjct: 23  LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAK---RAYRELVLMKC 79
Query: 71  LKHPNVVRLHEVLASKSK------IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLI 124
           + H N++ L  V   +        +Y+V+E +    L   I  +  L       L  Q++
Sbjct: 80  VNHKNIIGLLNVFTPQKSLEEFQDVYIVME-LMDANLCQVI--QMELDHERMSYLLYQML 136
Query: 125 DGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDG---LLHTTCGSPN 181
            G+ + H+ G+ HRDLK  NI++ S   +KI DFGL+      R  G   ++     +  
Sbjct: 137 CGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA------RTAGTSFMMTPYVVTRY 190
Query: 182 YVAPEVLANRGYDGATSDIWSCGVIL 207
           Y APEV+   GY     DIWS G I+
Sbjct: 191 YRAPEVILGMGYK-ENVDIWSVGCIM 215

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 93/206 (45%), Gaps = 24/206 (11%)
Query: 13  LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEK--NRIIHLKITDQIKREIATLKL 70
           L RY+  + +G G  G V  A D       A+K L +      H K   +  RE+  +K 
Sbjct: 23  LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAK---RAYRELVLMKC 79
Query: 71  LKHPNVVRLHEVLASKSK------IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLI 124
           + H N++ L  V   +        +Y+V+E +    L   I  +  L       L  Q++
Sbjct: 80  VNHKNIIGLLNVFTPQKSLEEFQDVYIVME-LMDANLCQVI--QMELDHERMSYLLYQML 136
Query: 125 DGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDG---LLHTTCGSPN 181
            G+ + H+ G+ HRDLK  NI++ S   +KI DFGL+      R  G   ++     +  
Sbjct: 137 CGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA------RTAGTSFMMTPYVVTRY 190
Query: 182 YVAPEVLANRGYDGATSDIWSCGVIL 207
           Y APEV+   GY     DIWS G I+
Sbjct: 191 YRAPEVILGMGYK-ENVDIWSVGCIM 215

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 60/200 (30%), Positives = 94/200 (47%), Gaps = 24/200 (12%)
Query: 17  ELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNV 76
           E+   +G G FG V  A+     +  A+K +E        I      E+  L  + HPN+
Sbjct: 11  EVEEVVGRGAFGVVCKAKWRAKDV--AIKQIESESERKAFIV-----ELRQLSRVNHPNI 63
Query: 77  VRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRL---QEAEGRKLFQQLIDGVSYCHN- 132
           V+L+   A  + + +V+EY  GG L++ +     L     A       Q   GV+Y H+ 
Sbjct: 64  VKLYG--ACLNPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSM 121
Query: 133 --KGVFHRDLKLENILLDSKGNI-KISDFGLSA-LPQHFRDDGLLHTTCGSPNYVAPEVL 188
             K + HRDLK  N+LL + G + KI DFG +  +  H  ++       GS  ++APEV 
Sbjct: 122 QPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHMTNNK------GSAAWMAPEVF 175
Query: 189 ANRGYDGATSDIWSCGVILY 208
               Y     D++S G+IL+
Sbjct: 176 EGSNYS-EKCDVFSWGIILW 194

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 93/206 (45%), Gaps = 24/206 (11%)
Query: 13  LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEK--NRIIHLKITDQIKREIATLKL 70
           L RY+  + +G G  G V  A D       A+K L +      H K   +  RE+  +K 
Sbjct: 24  LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAK---RAYRELVLMKC 80
Query: 71  LKHPNVVRLHEVLASKSK------IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLI 124
           + H N++ L  V   +        +Y+V+E +    L   I  +  L       L  Q++
Sbjct: 81  VNHKNIIGLLNVFTPQKSLEEFQDVYIVME-LMDANLCQVI--QMELDHERMSYLLYQML 137
Query: 125 DGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDG---LLHTTCGSPN 181
            G+ + H+ G+ HRDLK  NI++ S   +KI DFGL+      R  G   ++     +  
Sbjct: 138 CGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA------RTAGTSFMMTPYVVTRY 191
Query: 182 YVAPEVLANRGYDGATSDIWSCGVIL 207
           Y APEV+   GY     DIWS G I+
Sbjct: 192 YRAPEVILGMGYK-ENVDIWSVGCIM 216

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 64/230 (27%), Positives = 110/230 (47%), Gaps = 27/230 (11%)
Query: 22  LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIA----TLKLLKHPNVV 77
           LG G +G V+  + + SG   AVK     RI     + + KR +     +++ +  P  V
Sbjct: 15  LGRGAYGVVEKMRHVPSGQIMAVK-----RIRATVNSQEQKRLLMDLDISMRTVDCPFTV 69
Query: 78  RLHEVLASKSKIYMVLEYVTGG--ELFDKIASKGR-LQEAEGRKLFQQLIDGVSYCHNK- 133
             +  L  +  +++ +E +     + + ++  KG+ + E    K+   ++  + + H+K 
Sbjct: 70  TFYGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKL 129
Query: 134 GVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEV----LA 189
            V HRD+K  N+L+++ G +K+ DFG+S    +  DD       G   Y+APE     L 
Sbjct: 130 SVIHRDVKPSNVLINALGQVKMCDFGISG---YLVDDVAKDIDAGCKPYMAPERINPELN 186
Query: 190 NRGYDGATSDIWSCGVI---LYIFRGDFKLPKWLSPGAQNLLRKILEPNP 236
            +GY    SDIWS G+    L I R  F    W +P  Q L + + EP+P
Sbjct: 187 QKGY-SVKSDIWSLGITMIELAILR--FPYDSWGTP-FQQLKQVVEEPSP 232

>pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 65/250 (26%), Positives = 111/250 (44%), Gaps = 34/250 (13%)
Query: 22  LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATL----KLLKHPNVV 77
           LG G++G+V   +  + G  +AVK      +   +      R++A +    K+ +HP  V
Sbjct: 65  LGHGSYGEVFKVRSKEDGRLYAVK----RSMSPFRGPKDRARKLAEVGSHEKVGQHPCCV 120
Query: 78  RLHEVLASKSKIYMVLEYVTGGELFDKIASKG-RLQEAEGRKLFQQLIDGVSYCHNKGVF 136
           RL +       +Y+  E + G  L     + G  L EA+     +  +  +++ H++G+ 
Sbjct: 121 RLEQAWEEGGILYLQTE-LCGPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLV 179
Query: 137 HRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGA 196
           H D+K  NI L  +G  K+ DFGL          G      G P Y+APE+L  +G  G 
Sbjct: 180 HLDVKPANIFLGPRGRCKLGDFGLLV---ELGTAGAGEVQEGDPRYMAPELL--QGSYGT 234
Query: 197 TSDIWSCGVILYIFRGDFKLPK----W---------------LSPGAQNLLRKILEPNPV 237
            +D++S G+ +     + +LP     W               LS   +++L  +LEP+P 
Sbjct: 235 AADVFSLGLTILEVACNMELPHGGEGWQQLRQGYLPPEFTAGLSSELRSVLVMMLEPDPK 294
Query: 238 KRITIAGIKA 247
            R T   + A
Sbjct: 295 LRATAEALLA 304

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 59/194 (30%), Positives = 94/194 (48%), Gaps = 14/194 (7%)
Query: 22  LGEGNFGKVK--FAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRL 79
           LG GNFG V+    +     +  A+K+L++        T+++ RE   +  L +P +VRL
Sbjct: 18  LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG--TEKADTEEMMREAQIMHQLDNPYIVRL 75
Query: 80  HEVLASKSKIYMVLEYVTGGELFDKIASKGR-LQEAEGRKLFQQLIDGVSYCHNKGVFHR 138
             V  +++ + +V+E   GG L   +  K   +  +   +L  Q+  G+ Y   K   HR
Sbjct: 76  IGVCQAEA-LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHR 134
Query: 139 DLKLENILLDSKGNIKISDFGLS-ALPQHFRDDGLLHTTCGSP---NYVAPEVLANRGYD 194
           DL   N+LL ++   KISDFGLS AL     DD              + APE +  R + 
Sbjct: 135 DLAARNVLLVNRHYAKISDFGLSKALGA---DDSYYTARSAGKWPLKWYAPECINFRKFS 191
Query: 195 GATSDIWSCGVILY 208
            + SD+WS GV ++
Sbjct: 192 -SRSDVWSYGVTMW 204

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 59/200 (29%), Positives = 96/200 (48%), Gaps = 12/200 (6%)
Query: 17  ELGRTLGEGNFGKVKFAQDLDS-GLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
                +G G+FG V     LD+ G      +   NRI  +    Q   E   +K   HPN
Sbjct: 32  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 91
Query: 76  VVRLHEV-LASKSKIYMVLEYVTGGELFDKIASKGR---LQEAEGRKLFQQLIDGVSYCH 131
           V+ L  + L S+    +VL Y+  G+L + I ++     +++  G  L  Q+  G+ Y  
Sbjct: 92  VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGL--QVAKGMKYLA 149
Query: 132 NKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP---NYVAPEVL 188
           +K   HRDL   N +LD K  +K++DFGL A   + ++   +H   G+     ++A E L
Sbjct: 150 SKKFVHRDLAARNCMLDEKFTVKVADFGL-ARDMYDKEXXSVHNKTGAKLPVKWMALESL 208
Query: 189 ANRGYDGATSDIWSCGVILY 208
             + +    SD+WS GV+L+
Sbjct: 209 QTQKFT-TKSDVWSFGVLLW 227

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 60/215 (27%), Positives = 99/215 (46%), Gaps = 29/215 (13%)
Query: 17  ELGRTLGEGNFGKVKFAQDL-----DSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL 71
           + G+TLG G FGKV  A        D+ L  AVK+L+     H    + +  E+  +  L
Sbjct: 49  QFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKST--AHADEKEALMSELKIMSHL 106
Query: 72  -KHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQE-----------AEGRKL 119
            +H N+V L         + ++ EY   G+L + +  K R+ E           A  R L
Sbjct: 107 GQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDL 166
Query: 120 FQ---QLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDG--LLH 174
                Q+  G+++  +K   HRD+   N+LL +    KI DFGL+   +   +D   ++ 
Sbjct: 167 LHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLA---RDIMNDSNYIVK 223
Query: 175 TTCGSP-NYVAPEVLANRGYDGATSDIWSCGVILY 208
                P  ++APE + +  Y    SD+WS G++L+
Sbjct: 224 GNARLPVKWMAPESIFDCVYT-VQSDVWSYGILLW 257

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 96/215 (44%), Gaps = 31/215 (14%)
Query: 18  LGRTLGEGNFGKVKFAQDLD-----SGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK 72
           L R LGEG FGKV  A+  +       +  AVK L+      L      +RE   L  L+
Sbjct: 19  LKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPT---LAARKDFQREAELLTNLQ 75
Query: 73  HPNVVRLHEVLASKSKIYMVLEYVTGGELFDKI----------------ASKGRLQEAEG 116
           H ++V+ + V      + MV EY+  G+L   +                 +KG L  ++ 
Sbjct: 76  HEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQM 135
Query: 117 RKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLS---ALPQHFRDDGLL 173
             +  Q+  G+ Y  ++   HRDL   N L+ +   +KI DFG+S       ++R  G  
Sbjct: 136 LHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGG-- 193
Query: 174 HTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILY 208
           HT      ++ PE +  R +    SD+WS GVIL+
Sbjct: 194 HTML-PIRWMPPESIMYRKFT-TESDVWSFGVILW 226

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 64/225 (28%), Positives = 99/225 (44%), Gaps = 31/225 (13%)
Query: 13  LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEK--NRIIHLKITDQIKREIATLKL 70
           L RY+  + +G G  G V  A D       A+K L +      H K   +  RE+  +K 
Sbjct: 25  LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAK---RAYRELVLMKC 81
Query: 71  LKHPNVVRLHEVLASKSK------IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLI 124
           + H N++ L  V   +        +Y+V+E +    L   I  +  L       L  Q++
Sbjct: 82  VNHKNIIGLLNVFTPQKSLEEFQDVYIVME-LMDANLCQVI--QMELDHERMSYLLYQML 138
Query: 125 DGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDG---LLHTTCGSPN 181
            G+ + H+ G+ HRDLK  NI++ S   +KI DFGL+      R  G   ++     +  
Sbjct: 139 CGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA------RTAGTSFMMVPFVVTRY 192
Query: 182 YVAPEVLANRGYDGATSDIWSCGVIL-------YIFRGDFKLPKW 219
           Y APEV+   GY     DIWS G I+        +F G   + +W
Sbjct: 193 YRAPEVILGMGYK-ENVDIWSVGCIMGEMIKGGVLFPGTDHIDQW 236

>pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 98/210 (46%), Gaps = 23/210 (10%)
Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
           + L   LG+G    V   +   +G  FA+K+   N I  L+  D   RE   LK L H N
Sbjct: 11  WLLSDILGQGATANVFRGRHKKTGDLFAIKVF--NNISFLRPVDVQMREFEVLKKLNHKN 68
Query: 76  VVRL---HEVLASKSKIYMVLEYVTGGELFDKIASKGR---LQEAEGRKLFQQLIDGVSY 129
           +V+L    E   ++ K+ +++E+   G L+  +        L E+E   + + ++ G+++
Sbjct: 69  IVKLFAIEEETTTRHKV-LIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNH 127
Query: 130 CHNKGVFHRDLKLENILL----DSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAP 185
               G+ HR++K  NI+     D +   K++DFG +   +   DD       G+  Y+ P
Sbjct: 128 LRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA---RELEDDEQFVXLYGTEEYLHP 184
Query: 186 EVLA-------NRGYDGATSDIWSCGVILY 208
           ++         ++   GAT D+WS GV  Y
Sbjct: 185 DMYERAVLRKDHQKKYGATVDLWSIGVTFY 214

>pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 68/224 (30%), Positives = 111/224 (49%), Gaps = 33/224 (14%)
Query: 13  LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAV-KILEKNRIIHLKITDQIKREIATLKLL 71
           + R+++ R  G+G FG V+  ++  +G+  A+ K+++  R  + ++  QI +++A   +L
Sbjct: 22  MDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNREL--QIMQDLA---VL 76
Query: 72  KHPNVVRLHEVLAS-----KSKIYM--VLEYVTGGELFDKIASKGRLQEAEGRKLFQ--- 121
            HPN+V+L     +     +  IY+  V+EYV    L     +  R Q A    L +   
Sbjct: 77  HHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVP-DTLHRCCRNYYRRQVAPPPILIKVFL 135
Query: 122 -QLIDGVSYCH--NKGVFHRDLKLENILLD-SKGNIKISDFGLSALPQHFRDDGLLHTTC 177
            QLI  +   H  +  V HRD+K  N+L++ + G +K+ DFG SA      +  + +   
Sbjct: 136 FQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFG-SAKKLSPSEPNVAYIC- 193
Query: 178 GSPNYVAPE-VLANRGYDGATSDIWSCGVILY-------IFRGD 213
            S  Y APE +  N+ Y  A  DIWS G I         IFRGD
Sbjct: 194 -SRYYRAPELIFGNQHYTTAV-DIWSVGCIFAEMMLGEPIFRGD 235

>pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 64/203 (31%), Positives = 95/203 (46%), Gaps = 21/203 (10%)
Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
           RYE+ + +G+G+FG+V  A D       A+K++   +  H     Q   EI  L+ L+  
Sbjct: 98  RYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFH----RQAAEEIRILEHLRKQ 153
Query: 75  ------NVVRLHEVLASKSKIYMVLEYVTGG--ELFDKIASKGRLQEAEGRKLFQQLIDG 126
                 NV+ + E    ++ I M  E ++    EL  K   +G       RK    ++  
Sbjct: 154 DKDNTMNVIHMLENFTFRNHICMTFELLSMNLYELIKKNKFQG-FSLPLVRKFAHSILQC 212
Query: 127 VSYCHNKGVFHRDLKLENILLDSKGN--IKISDFGLSALPQHFRDDGLLHTTCGSPNYVA 184
           +   H   + H DLK ENILL  +G   IK+ DFG S+  +H R    ++T   S  Y A
Sbjct: 213 LDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFG-SSCYEHQR----VYTXIQSRFYRA 267
Query: 185 PEVLANRGYDGATSDIWSCGVIL 207
           PEV+    Y G   D+WS G IL
Sbjct: 268 PEVILGARY-GMPIDMWSLGCIL 289

>pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 64/203 (31%), Positives = 95/203 (46%), Gaps = 21/203 (10%)
Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
           RYE+ + +G+G+FG+V  A D       A+K++   +  H     Q   EI  L+ L+  
Sbjct: 98  RYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFH----RQAAEEIRILEHLRKQ 153
Query: 75  ------NVVRLHEVLASKSKIYMVLEYVTGG--ELFDKIASKGRLQEAEGRKLFQQLIDG 126
                 NV+ + E    ++ I M  E ++    EL  K   +G       RK    ++  
Sbjct: 154 DKDNTMNVIHMLENFTFRNHICMTFELLSMNLYELIKKNKFQG-FSLPLVRKFAHSILQC 212
Query: 127 VSYCHNKGVFHRDLKLENILLDSKGN--IKISDFGLSALPQHFRDDGLLHTTCGSPNYVA 184
           +   H   + H DLK ENILL  +G   IK+ DFG S+  +H R    ++T   S  Y A
Sbjct: 213 LDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFG-SSCYEHQR----VYTXIQSRFYRA 267
Query: 185 PEVLANRGYDGATSDIWSCGVIL 207
           PEV+    Y G   D+WS G IL
Sbjct: 268 PEVILGARY-GMPIDMWSLGCIL 289

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 51/211 (24%), Positives = 95/211 (45%), Gaps = 12/211 (5%)
Query: 17  ELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKR----EIATLKLLK 72
           ++ + +G G FG+V         LP   +I    + +    T++ +R    E + +    
Sbjct: 10  KIEQVIGAGEFGEVCSGH---LKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFD 66
Query: 73  HPNVVRLHEVLASKSKIYMVLEYVTGGELFDKI-ASKGRLQEAEGRKLFQQLIDGVSYCH 131
           HPNV+ L  V+   + + ++ E++  G L   +  + G+    +   + + +  G+ Y  
Sbjct: 67  HPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLA 126
Query: 132 NKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP---NYVAPEVL 188
           +    HR L   NIL++S    K+SDFGLS   +    D    +  G      + APE +
Sbjct: 127 DMNYVHRALAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAI 186
Query: 189 ANRGYDGATSDIWSCGVILYIFRGDFKLPKW 219
             R +  A SD+WS G++++      + P W
Sbjct: 187 QYRKFTSA-SDVWSYGIVMWEVMSYGERPYW 216

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 96/210 (45%), Gaps = 24/210 (11%)
Query: 18  LGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIK---REIATLKLLKHP 74
           L R LGEG FGKV F  +  +  P   KIL   + +     +  K   RE   L  L+H 
Sbjct: 17  LKRELGEGAFGKV-FLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHE 75
Query: 75  NVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKG-------------RLQEAEGRKLFQ 121
           ++V+ + V      + MV EY+  G+L   + + G              L +++   + Q
Sbjct: 76  HIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQ 135
Query: 122 QLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLS---ALPQHFRDDGLLHTTCG 178
           Q+  G+ Y  ++   HRDL   N L+     +KI DFG+S       ++R  G  HT   
Sbjct: 136 QIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGG--HTML- 192
Query: 179 SPNYVAPEVLANRGYDGATSDIWSCGVILY 208
              ++ PE +  R +    SD+WS GV+L+
Sbjct: 193 PIRWMPPESIMYRKFT-TESDVWSLGVVLW 221

>pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 58/218 (26%), Positives = 98/218 (44%), Gaps = 29/218 (13%)
Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIH-LKITDQIKREIATLKLLKHP 74
           Y +   +G G++G V  A D ++    A+K  + NR+   L    +I REI  L  LK  
Sbjct: 28  YIIKHLIGRGSYGYVYLAYDKNTEKNVAIK--KVNRMFEDLIDCKRILREITILNRLKSD 85
Query: 75  NVVRLHEV-----LASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSY 129
            ++RL+++     L    ++Y+VLE +   +L     +   L E   + +   L+ G ++
Sbjct: 86  YIIRLYDLIIPDDLLKFDELYIVLE-IADSDLKKLFKTPIFLTEEHIKTILYNLLLGENF 144
Query: 130 CHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGL----------------- 172
            H  G+ HRDLK  N LL+   ++K+ DFGL+      +D  +                 
Sbjct: 145 IHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNL 204
Query: 173 ---LHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVIL 207
              L +   +  Y APE++  +     + DIWS G I 
Sbjct: 205 KKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIF 242

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 57/196 (29%), Positives = 94/196 (47%), Gaps = 13/196 (6%)
Query: 20  RTLGEGNFGKVKFAQDLDSG----LPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
           + LG G FG V     +  G    +P A+K+L +N     K   +I  E   +  +  P 
Sbjct: 23  KVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLREN--TSPKANKEILDEAYVMAGVGSPY 80
Query: 76  VVRLHEVLASKSKIYMVLEYVTGGELFDKI-ASKGRLQEAEGRKLFQQLIDGVSYCHNKG 134
           V RL  +  + S + +V + +  G L D +  ++GRL   +      Q+  G+SY  +  
Sbjct: 81  VSRLLGICLT-STVQLVTQLMPYGCLLDHVRENRGRLGSQDLLNWCMQIAKGMSYLEDVR 139
Query: 135 VFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP--NYVAPEVLANRG 192
           + HRDL   N+L+ S  ++KI+DFGL+ L     D+   H   G     ++A E +  R 
Sbjct: 140 LVHRDLAARNVLVKSPNHVKITDFGLARLLDI--DETEYHADGGKVPIKWMALESILRRR 197
Query: 193 YDGATSDIWSCGVILY 208
           +    SD+WS GV ++
Sbjct: 198 FT-HQSDVWSYGVTVW 212

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 107/215 (49%), Gaps = 17/215 (7%)
Query: 22  LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHE 81
           LG+G FG+V +    +     A+K L+   +      +   +E   +K L+H  +V+L+ 
Sbjct: 26  LGQGCFGEV-WMGTWNGTTRVAIKTLKPGTMS----PEAFLQEAQVMKKLRHEKLVQLYA 80
Query: 82  VLASKSKIYMVLEYVTGGELFDKIASK-GR-LQEAEGRKLFQQLIDGVSYCHNKGVFHRD 139
           V+ S+  IY+V+EY++ G L D +  + G+ L+  +   +  Q+  G++Y       HRD
Sbjct: 81  VV-SEEPIYIVIEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRD 139
Query: 140 LKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP-NYVAPEVLANRGYDGATS 198
           L+  NIL+      K++DFGL+ L +   ++         P  + APE  A  G     S
Sbjct: 140 LRAANILVGENLVCKVADFGLARLIED--NEXTARQGAKFPIKWTAPEA-ALYGRFTIKS 196
Query: 199 DIWSCGVILYIFRGDFKLPKWLSPGAQNLLRKILE 233
           D+WS G++L       ++P    PG  N  R++L+
Sbjct: 197 DVWSFGILLTELTTKGRVP---YPGMVN--REVLD 226

>pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 54/203 (26%), Positives = 104/203 (51%), Gaps = 20/203 (9%)
Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKH-P 74
           Y+L R LG G + +V  A ++ +     VKIL+  +       ++IKREI  L+ L+  P
Sbjct: 39  YQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK------KNKIKREIKILENLRGGP 92
Query: 75  NVVRLHEVL---ASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCH 131
           N++ L +++    S++   +V E+V   + F ++     L + + R    +++  + YCH
Sbjct: 93  NIITLADIVKDPVSRTPA-LVFEHVNNTD-FKQLYQT--LTDYDIRFYMYEILKALDYCH 148
Query: 132 NKGVFHRDLKLENILLDSKGN-IKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLAN 190
           + G+ HRD+K  N+++D +   +++ D+GL+     +      +    S  +  PE+L +
Sbjct: 149 SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEF---YHPGQEYNVRVASRYFKGPELLVD 205
Query: 191 RGYDGATSDIWSCGVIL--YIFR 211
                 + D+WS G +L   IFR
Sbjct: 206 YQMYDYSLDMWSLGCMLASMIFR 228

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 107/217 (49%), Gaps = 21/217 (9%)
Query: 22  LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHE 81
           LG+G FG+V +    +     A+K L+   +      +   +E   +K L+H  +V+L+ 
Sbjct: 26  LGQGCFGEV-WMGTWNGTTRVAIKTLKPGTMS----PEAFLQEAQVMKKLRHEKLVQLYA 80
Query: 82  VLASKSKIYMVLEYVTGGELFDKIASK-GR-LQEAEGRKLFQQLIDGVSYCHNKGVFHRD 139
           V+ S+  IY+V+EY++ G L D +  + G+ L+  +   +  Q+  G++Y       HRD
Sbjct: 81  VV-SEEPIYIVIEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRD 139
Query: 140 LKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP---NYVAPEVLANRGYDGA 196
           L+  NIL+      K++DFGL+ L     +D       G+     + APE  A  G    
Sbjct: 140 LRAANILVGENLVCKVADFGLARL----IEDNEYTARQGAKFPIKWTAPEA-ALYGRFTI 194
Query: 197 TSDIWSCGVILYIFRGDFKLPKWLSPGAQNLLRKILE 233
            SD+WS G++L       ++P    PG  N  R++L+
Sbjct: 195 KSDVWSFGILLTELTTKGRVP---YPGMVN--REVLD 226

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 54/193 (27%), Positives = 96/193 (49%), Gaps = 12/193 (6%)
Query: 22  LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHE 81
           LG G FGKV +   L  G   AVK L++ R    ++  Q + E+  + +  H N++RL  
Sbjct: 46  LGRGGFGKV-YKGRLADGTLVAVKRLKEERXQGGEL--QFQTEVEMISMAVHRNLLRLRG 102
Query: 82  VLASKSKIYMVLEYVTGGE----LFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNK---G 134
              + ++  +V  Y+  G     L ++  S+  L   + +++      G++Y H+     
Sbjct: 103 FCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPK 162
Query: 135 VFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYD 194
           + HRD+K  NILLD +    + DFGL+ L   ++D  +     G+  ++APE L+  G  
Sbjct: 163 IIHRDVKAANILLDEEFEAVVGDFGLAKL-MDYKDXHVXXAVRGTIGHIAPEYLST-GKS 220
Query: 195 GATSDIWSCGVIL 207
              +D++  GV+L
Sbjct: 221 SEKTDVFGYGVML 233

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 59/200 (29%), Positives = 96/200 (48%), Gaps = 12/200 (6%)
Query: 17  ELGRTLGEGNFGKVKFAQDLDS-GLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
                +G G+FG V     LD+ G      +   NRI  +    Q   E   +K   HPN
Sbjct: 51  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 110
Query: 76  VVRLHEV-LASKSKIYMVLEYVTGGELFDKIASKGR---LQEAEGRKLFQQLIDGVSYCH 131
           V+ L  + L S+    +VL Y+  G+L + I ++     +++  G  L  Q+  G+ Y  
Sbjct: 111 VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGL--QVAKGMKYLA 168
Query: 132 NKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP---NYVAPEVL 188
           +K   HRDL   N +LD K  +K++DFGL A   + ++   +H   G+     ++A E L
Sbjct: 169 SKKFVHRDLAARNCMLDEKFTVKVADFGL-ARDMYDKEYYSVHNKTGAKLPVKWMALESL 227
Query: 189 ANRGYDGATSDIWSCGVILY 208
             + +    SD+WS GV+L+
Sbjct: 228 QTQKFT-TKSDVWSFGVLLW 246

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 59/200 (29%), Positives = 96/200 (48%), Gaps = 12/200 (6%)
Query: 17  ELGRTLGEGNFGKVKFAQDLDS-GLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
                +G G+FG V     LD+ G      +   NRI  +    Q   E   +K   HPN
Sbjct: 33  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 92
Query: 76  VVRLHEV-LASKSKIYMVLEYVTGGELFDKIASKGR---LQEAEGRKLFQQLIDGVSYCH 131
           V+ L  + L S+    +VL Y+  G+L + I ++     +++  G  L  Q+  G+ Y  
Sbjct: 93  VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGL--QVAKGMKYLA 150
Query: 132 NKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP---NYVAPEVL 188
           +K   HRDL   N +LD K  +K++DFGL A   + ++   +H   G+     ++A E L
Sbjct: 151 SKKFVHRDLAARNCMLDEKFTVKVADFGL-ARDMYDKEYYSVHNKTGAKLPVKWMALESL 209
Query: 189 ANRGYDGATSDIWSCGVILY 208
             + +    SD+WS GV+L+
Sbjct: 210 QTQKFT-TKSDVWSFGVLLW 228

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 99/211 (46%), Gaps = 25/211 (11%)
Query: 17  ELGRTLGEGNFGKVKFAQDL-----DSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL 71
           + G+TLG G FGKV  A        D+ L  AVK+L+     H    + +  E+  +  L
Sbjct: 41  QFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTA--HADEKEALMSELKIMSHL 98
Query: 72  -KHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGR--LQEAEGRKL--------F 120
            +H N+V L         + ++ EY   G+L + +  K    L + +GR L         
Sbjct: 99  GQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDLLHFS 158
Query: 121 QQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDG--LLHTTCG 178
            Q+  G+++  +K   HRD+   N+LL +    KI DFGL+   +   +D   ++     
Sbjct: 159 SQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLA---RDIMNDSNYIVKGNAR 215
Query: 179 SP-NYVAPEVLANRGYDGATSDIWSCGVILY 208
            P  ++APE + +  Y    SD+WS G++L+
Sbjct: 216 LPVKWMAPESIFDCVYT-VQSDVWSYGILLW 245

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 59/200 (29%), Positives = 96/200 (48%), Gaps = 12/200 (6%)
Query: 17  ELGRTLGEGNFGKVKFAQDLDS-GLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
                +G G+FG V     LD+ G      +   NRI  +    Q   E   +K   HPN
Sbjct: 31  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 90
Query: 76  VVRLHEV-LASKSKIYMVLEYVTGGELFDKIASKGR---LQEAEGRKLFQQLIDGVSYCH 131
           V+ L  + L S+    +VL Y+  G+L + I ++     +++  G  L  Q+  G+ Y  
Sbjct: 91  VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGL--QVAKGMKYLA 148
Query: 132 NKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP---NYVAPEVL 188
           +K   HRDL   N +LD K  +K++DFGL A   + ++   +H   G+     ++A E L
Sbjct: 149 SKKFVHRDLAARNCMLDEKFTVKVADFGL-ARDMYDKEYYSVHNKTGAKLPVKWMALESL 207
Query: 189 ANRGYDGATSDIWSCGVILY 208
             + +    SD+WS GV+L+
Sbjct: 208 QTQKFT-TKSDVWSFGVLLW 226

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 59/200 (29%), Positives = 96/200 (48%), Gaps = 12/200 (6%)
Query: 17  ELGRTLGEGNFGKVKFAQDLDS-GLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
                +G G+FG V     LD+ G      +   NRI  +    Q   E   +K   HPN
Sbjct: 30  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 89
Query: 76  VVRLHEV-LASKSKIYMVLEYVTGGELFDKIASKGR---LQEAEGRKLFQQLIDGVSYCH 131
           V+ L  + L S+    +VL Y+  G+L + I ++     +++  G  L  Q+  G+ Y  
Sbjct: 90  VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGL--QVAKGMKYLA 147
Query: 132 NKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP---NYVAPEVL 188
           +K   HRDL   N +LD K  +K++DFGL A   + ++   +H   G+     ++A E L
Sbjct: 148 SKKFVHRDLAARNCMLDEKFTVKVADFGL-ARDMYDKEYYSVHNKTGAKLPVKWMALESL 206
Query: 189 ANRGYDGATSDIWSCGVILY 208
             + +    SD+WS GV+L+
Sbjct: 207 QTQKFT-TKSDVWSFGVLLW 225

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 59/200 (29%), Positives = 96/200 (48%), Gaps = 12/200 (6%)
Query: 17  ELGRTLGEGNFGKVKFAQDLDS-GLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
                +G G+FG V     LD+ G      +   NRI  +    Q   E   +K   HPN
Sbjct: 28  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 87
Query: 76  VVRLHEV-LASKSKIYMVLEYVTGGELFDKIASKGR---LQEAEGRKLFQQLIDGVSYCH 131
           V+ L  + L S+    +VL Y+  G+L + I ++     +++  G  L  Q+  G+ Y  
Sbjct: 88  VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGL--QVAKGMKYLA 145
Query: 132 NKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP---NYVAPEVL 188
           +K   HRDL   N +LD K  +K++DFGL A   + ++   +H   G+     ++A E L
Sbjct: 146 SKKFVHRDLAARNCMLDEKFTVKVADFGL-ARDMYDKEYYSVHNKTGAKLPVKWMALESL 204
Query: 189 ANRGYDGATSDIWSCGVILY 208
             + +    SD+WS GV+L+
Sbjct: 205 QTQKFT-TKSDVWSFGVLLW 223

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 68.2 bits (165), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 59/200 (29%), Positives = 96/200 (48%), Gaps = 12/200 (6%)
Query: 17  ELGRTLGEGNFGKVKFAQDLDS-GLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
                +G G+FG V     LD+ G      +   NRI  +    Q   E   +K   HPN
Sbjct: 32  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 91
Query: 76  VVRLHEV-LASKSKIYMVLEYVTGGELFDKIASKGR---LQEAEGRKLFQQLIDGVSYCH 131
           V+ L  + L S+    +VL Y+  G+L + I ++     +++  G  L  Q+  G+ Y  
Sbjct: 92  VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGL--QVAKGMKYLA 149
Query: 132 NKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP---NYVAPEVL 188
           +K   HRDL   N +LD K  +K++DFGL A   + ++   +H   G+     ++A E L
Sbjct: 150 SKKFVHRDLAARNCMLDEKFTVKVADFGL-ARDMYDKEYYSVHNKTGAKLPVKWMALESL 208
Query: 189 ANRGYDGATSDIWSCGVILY 208
             + +    SD+WS GV+L+
Sbjct: 209 QTQKFT-TKSDVWSFGVLLW 227

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 68.2 bits (165), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 59/200 (29%), Positives = 96/200 (48%), Gaps = 12/200 (6%)
Query: 17  ELGRTLGEGNFGKVKFAQDLDS-GLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
                +G G+FG V     LD+ G      +   NRI  +    Q   E   +K   HPN
Sbjct: 33  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 92
Query: 76  VVRLHEV-LASKSKIYMVLEYVTGGELFDKIASKGR---LQEAEGRKLFQQLIDGVSYCH 131
           V+ L  + L S+    +VL Y+  G+L + I ++     +++  G  L  Q+  G+ Y  
Sbjct: 93  VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGL--QVAKGMKYLA 150
Query: 132 NKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP---NYVAPEVL 188
           +K   HRDL   N +LD K  +K++DFGL A   + ++   +H   G+     ++A E L
Sbjct: 151 SKKFVHRDLAARNCMLDEKFTVKVADFGL-ARDMYDKEYYSVHNKTGAKLPVKWMALESL 209
Query: 189 ANRGYDGATSDIWSCGVILY 208
             + +    SD+WS GV+L+
Sbjct: 210 QTQKFT-TKSDVWSFGVLLW 228

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 68.2 bits (165), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 99/211 (46%), Gaps = 25/211 (11%)
Query: 17  ELGRTLGEGNFGKVKFAQDL-----DSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL 71
           + G+TLG G FGKV  A        D+ L  AVK+L+     H    + +  E+  +  L
Sbjct: 49  QFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKST--AHADEKEALMSELKIMSHL 106
Query: 72  -KHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGR--LQEAEGRKL--------F 120
            +H N+V L         + ++ EY   G+L + +  K    L + +GR L         
Sbjct: 107 GQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDLLHFS 166
Query: 121 QQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDG--LLHTTCG 178
            Q+  G+++  +K   HRD+   N+LL +    KI DFGL+   +   +D   ++     
Sbjct: 167 SQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLA---RDIMNDSNYIVKGNAR 223
Query: 179 SP-NYVAPEVLANRGYDGATSDIWSCGVILY 208
            P  ++APE + +  Y    SD+WS G++L+
Sbjct: 224 LPVKWMAPESIFDCVYT-VQSDVWSYGILLW 253

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 68.2 bits (165), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 59/200 (29%), Positives = 96/200 (48%), Gaps = 12/200 (6%)
Query: 17  ELGRTLGEGNFGKVKFAQDLDS-GLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
                +G G+FG V     LD+ G      +   NRI  +    Q   E   +K   HPN
Sbjct: 25  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 84
Query: 76  VVRLHEV-LASKSKIYMVLEYVTGGELFDKIASKGR---LQEAEGRKLFQQLIDGVSYCH 131
           V+ L  + L S+    +VL Y+  G+L + I ++     +++  G  L  Q+  G+ Y  
Sbjct: 85  VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGL--QVAKGMKYLA 142
Query: 132 NKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP---NYVAPEVL 188
           +K   HRDL   N +LD K  +K++DFGL A   + ++   +H   G+     ++A E L
Sbjct: 143 SKKFVHRDLAARNCMLDEKFTVKVADFGL-ARDMYDKEYYSVHNKTGAKLPVKWMALESL 201
Query: 189 ANRGYDGATSDIWSCGVILY 208
             + +    SD+WS GV+L+
Sbjct: 202 QTQKFT-TKSDVWSFGVLLW 220

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 68.2 bits (165), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 104/217 (47%), Gaps = 21/217 (9%)
Query: 22  LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHE 81
           LG+G FG+V +    +     A+K L+   +      +   +E   +K L+H  +V+L+ 
Sbjct: 19  LGQGCFGEV-WMGTWNGTTRVAIKTLKPGTMS----PEAFLQEAQVMKKLRHEKLVQLYA 73
Query: 82  VLASKSKIYMVLEYVTGGELFD--KIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRD 139
           V+ S+  IY+V EY++ G L D  K  +   L+  +   +  Q+  G++Y       HRD
Sbjct: 74  VV-SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRD 132
Query: 140 LKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP---NYVAPEVLANRGYDGA 196
           L+  NIL+      K++DFGL+ L     +D       G+     + APE  A  G    
Sbjct: 133 LRAANILVGENLVCKVADFGLARL----IEDNEYTARQGAKFPIKWTAPEA-ALYGRFTI 187
Query: 197 TSDIWSCGVILYIFRGDFKLPKWLSPGAQNLLRKILE 233
            SD+WS G++L       ++P    PG  N  R++L+
Sbjct: 188 KSDVWSFGILLTELTTKGRVP---YPGMVN--REVLD 219

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 68.2 bits (165), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 59/200 (29%), Positives = 96/200 (48%), Gaps = 12/200 (6%)
Query: 17  ELGRTLGEGNFGKVKFAQDLDS-GLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
                +G G+FG V     LD+ G      +   NRI  +    Q   E   +K   HPN
Sbjct: 52  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 111
Query: 76  VVRLHEV-LASKSKIYMVLEYVTGGELFDKIASKGR---LQEAEGRKLFQQLIDGVSYCH 131
           V+ L  + L S+    +VL Y+  G+L + I ++     +++  G  L  Q+  G+ Y  
Sbjct: 112 VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGL--QVAKGMKYLA 169
Query: 132 NKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP---NYVAPEVL 188
           +K   HRDL   N +LD K  +K++DFGL A   + ++   +H   G+     ++A E L
Sbjct: 170 SKKFVHRDLAARNCMLDEKFTVKVADFGL-ARDMYDKEYYSVHNKTGAKLPVKWMALESL 228
Query: 189 ANRGYDGATSDIWSCGVILY 208
             + +    SD+WS GV+L+
Sbjct: 229 QTQKFT-TKSDVWSFGVLLW 247

>pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 78/270 (28%), Positives = 116/270 (42%), Gaps = 42/270 (15%)
Query: 14  GRYELGRTLGEGNFGKVKFAQDLDSG-LPFAVKILEKNRIIHLKITDQIKREIATLKLLK 72
            RYE+  TLGEG FGKV    D  +G    AVKI++       +  +  + EI  L+ L 
Sbjct: 14  ARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVD----RYCEAARSEIQVLEHLN 69
Query: 73  --HPN----VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRL--QEAEGRKLFQQLI 124
              PN     V++ E       I +V E + G   +D I   G L  +    RK+  Q+ 
Sbjct: 70  TTDPNSTFRCVQMLEWFEHHGHICIVFE-LLGLSTYDFIKENGFLPFRLDHIRKMAYQIC 128
Query: 125 DGVSYCHNKGVFHRDLKLENILL---------------DSKG----NIKISDFGLSALPQ 165
             V++ H+  + H DLK ENIL                D +     +IK+ DFG +    
Sbjct: 129 KSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATY-- 186
Query: 166 HFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIFRGDFKL-PKWLSPGA 224
              DD    T   + +Y APEV+   G+     D+WS G IL  +   F + P   S   
Sbjct: 187 ---DDEHHSTLVSTRHYRAPEVILALGW-SQPCDVWSIGCILIEYYLGFTVFPTHDSKEH 242
Query: 225 QNLLRKILEPNPVKRITIAGIKADEWFEQD 254
             ++ +IL P P  +  I   +  ++F  D
Sbjct: 243 LAMMERILGPLP--KHMIQKTRKRKYFHHD 270

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 56/194 (28%), Positives = 95/194 (48%), Gaps = 14/194 (7%)
Query: 22  LGEGNFGKVK--FAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRL 79
           LG GNFG V+    +     +  A+K+L++        T+++ RE   +  L +P +VRL
Sbjct: 344 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG--TEKADTEEMMREAQIMHQLDNPYIVRL 401
Query: 80  HEVLASKSKIYMVLEYVTGGELFDKIASKGR-LQEAEGRKLFQQLIDGVSYCHNKGVFHR 138
             V  +++ + +V+E   GG L   +  K   +  +   +L  Q+  G+ Y   K   HR
Sbjct: 402 IGVCQAEA-LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHR 460
Query: 139 DLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP----NYVAPEVLANRGYD 194
           +L   N+LL ++   KISDFGLS   +    D   +T   +      + APE +  R + 
Sbjct: 461 NLAARNVLLVNRHYAKISDFGLS---KALGADDSYYTARSAGKWPLKWYAPECINFRKFS 517
Query: 195 GATSDIWSCGVILY 208
            + SD+WS GV ++
Sbjct: 518 -SRSDVWSYGVTMW 530

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 63/230 (27%), Positives = 109/230 (47%), Gaps = 27/230 (11%)
Query: 22  LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIA----TLKLLKHPNVV 77
           LG G +G V+  + + SG   AVK     RI     + + KR +     +++ +  P  V
Sbjct: 59  LGRGAYGVVEKMRHVPSGQIMAVK-----RIRATVNSQEQKRLLMDLDISMRTVDCPFTV 113
Query: 78  RLHEVLASKSKIYMVLEYVTGG--ELFDKIASKGR-LQEAEGRKLFQQLIDGVSYCHNK- 133
             +  L  +  +++ +E +     + + ++  KG+ + E    K+   ++  + + H+K 
Sbjct: 114 TFYGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKL 173
Query: 134 GVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEV----LA 189
            V HRD+K  N+L+++ G +K+ DFG+S    +  D        G   Y+APE     L 
Sbjct: 174 SVIHRDVKPSNVLINALGQVKMCDFGISG---YLVDSVAKTIDAGCKPYMAPERINPELN 230
Query: 190 NRGYDGATSDIWSCGVI---LYIFRGDFKLPKWLSPGAQNLLRKILEPNP 236
            +GY    SDIWS G+    L I R  F    W +P  Q L + + EP+P
Sbjct: 231 QKGY-SVKSDIWSLGITMIELAILR--FPYDSWGTP-FQQLKQVVEEPSP 276

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 99/215 (46%), Gaps = 29/215 (13%)
Query: 17  ELGRTLGEGNFGKVKFAQDL-----DSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL 71
           + G+TLG G FGKV  A        D+ L  AVK+L+     H    + +  E+  +  L
Sbjct: 49  QFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKST--AHADEKEALMSELKIMSHL 106
Query: 72  -KHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAE-----------GRKL 119
            +H N+V L         + ++ EY   G+L + +  K R+ E +            R L
Sbjct: 107 GQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTLSTRDL 166
Query: 120 FQ---QLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDG--LLH 174
                Q+  G+++  +K   HRD+   N+LL +    KI DFGL+   +   +D   ++ 
Sbjct: 167 LHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLA---RDIMNDSNYIVK 223
Query: 175 TTCGSP-NYVAPEVLANRGYDGATSDIWSCGVILY 208
                P  ++APE + +  Y    SD+WS G++L+
Sbjct: 224 GNARLPVKWMAPESIFDCVYT-VQSDVWSYGILLW 257

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 103/215 (47%), Gaps = 17/215 (7%)
Query: 22  LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHE 81
           LG+G FG+V +    +     A+K L+   +      +   +E   +K L+H  +V+L+ 
Sbjct: 23  LGQGCFGEV-WMGTWNGTTRVAIKTLKPGTMS----PEAFLQEAQVMKKLRHEKLVQLYA 77
Query: 82  VLASKSKIYMVLEYVTGGELFD--KIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRD 139
           V+ S+  IY+V EY+  G L D  K  +   L+  +   +  Q+  G++Y       HRD
Sbjct: 78  VV-SEEPIYIVTEYMNKGSLLDFLKGETGKYLRLPQLVDMSAQIASGMAYVERMNYVHRD 136
Query: 140 LKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP-NYVAPEVLANRGYDGATS 198
           L+  NIL+      K++DFGL+ L +   ++         P  + APE  A  G     S
Sbjct: 137 LRAANILVGENLVCKVADFGLARLIED--NEWTARQGAKFPIKWTAPEA-ALYGRFTIKS 193
Query: 199 DIWSCGVILYIFRGDFKLPKWLSPGAQNLLRKILE 233
           D+WS G++L       ++P    PG  N  R++L+
Sbjct: 194 DVWSFGILLTELTTKGRVP---YPGMVN--REVLD 223

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 106/217 (48%), Gaps = 21/217 (9%)
Query: 22  LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHE 81
           LG+G FG+V +    +     A+K L+   +      +   +E   +K L+H  +V+L+ 
Sbjct: 26  LGQGCFGEV-WMGTWNGTTRVAIKTLKPGTMS----PEAFLQEAQVMKKLRHEKLVQLYA 80
Query: 82  VLASKSKIYMVLEYVTGGELFDKIASK-GR-LQEAEGRKLFQQLIDGVSYCHNKGVFHRD 139
           V+ S+  IY+V EY++ G L D +  + G+ L+  +   +  Q+  G++Y       HRD
Sbjct: 81  VV-SEEPIYIVCEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRD 139
Query: 140 LKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP---NYVAPEVLANRGYDGA 196
           L+  NIL+      K++DFGL+ L     +D       G+     + APE  A  G    
Sbjct: 140 LRAANILVGENLVCKVADFGLARL----IEDNEYTARQGAKFPIKWTAPEA-ALYGRFTI 194
Query: 197 TSDIWSCGVILYIFRGDFKLPKWLSPGAQNLLRKILE 233
            SD+WS G++L       ++P    PG  N  R++L+
Sbjct: 195 KSDVWSFGILLTELTTKGRVP---YPGMVN--REVLD 226

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 107/217 (49%), Gaps = 21/217 (9%)
Query: 22  LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHE 81
           LG+G FG+V +    +     A+K L+   +      +   +E   +K L+H  +V+L+ 
Sbjct: 26  LGQGCFGEV-WMGTWNGTTRVAIKTLKPGTMS----PEAFLQEAQVMKKLRHEKLVQLYA 80
Query: 82  VLASKSKIYMVLEYVTGGELFDKIASK-GR-LQEAEGRKLFQQLIDGVSYCHNKGVFHRD 139
           V+ S+  IY+V+EY++ G L D +  + G+ L+  +   +  Q+  G++Y       HRD
Sbjct: 81  VV-SEEPIYIVMEYMSKGCLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRD 139
Query: 140 LKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP---NYVAPEVLANRGYDGA 196
           L+  NIL+      K++DFGL+ L     +D       G+     + APE  A  G    
Sbjct: 140 LRAANILVGENLVCKVADFGLARL----IEDNEYTARQGAKFPIKWTAPEA-ALYGRFTI 194
Query: 197 TSDIWSCGVILYIFRGDFKLPKWLSPGAQNLLRKILE 233
            SD+WS G++L       ++P    PG  N  R++L+
Sbjct: 195 KSDVWSFGILLTELTTKGRVP---YPGMVN--REVLD 226

>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 66/213 (30%), Positives = 102/213 (47%), Gaps = 25/213 (11%)
Query: 15  RYELGRTLGEGNFGKVKFAQ---DLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL 71
           ++ LGR LG+G FG V+ AQ   +  S +  AVK+L K  II     ++  RE A +K  
Sbjct: 24  QFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKML-KADIIASSDIEEFLREAACMKEF 82
Query: 72  KHPNVVRLHEV-LASKSK----IYMV-LEYVTGGELFDKIASKGRLQEAEGRKLFQQLID 125
            HP+V +L  V L S++K    I MV L ++  G+L   + +  R+ E       Q L+ 
Sbjct: 83  DHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLA-SRIGENPFNLPLQTLVR 141
Query: 126 -------GVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCG 178
                  G+ Y  ++   HRDL   N +L     + ++DFGLS   +           C 
Sbjct: 142 FMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVADFGLS---RKIYSGDYYRQGCA 198
Query: 179 SP---NYVAPEVLANRGYDGATSDIWSCGVILY 208
           S     ++A E LA+  Y    SD+W+ GV ++
Sbjct: 199 SKLPVKWLALESLADNLYT-VHSDVWAFGVTMW 230

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 104/217 (47%), Gaps = 21/217 (9%)
Query: 22  LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHE 81
           LG+G FG+V +    +     A+K L+   +      +   +E   +K L+H  +V+L+ 
Sbjct: 192 LGQGCFGEV-WMGTWNGTTRVAIKTLKPGTMS----PEAFLQEAQVMKKLRHEKLVQLYA 246
Query: 82  VLASKSKIYMVLEYVTGGELFD--KIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRD 139
           V+ S+  IY+V EY++ G L D  K  +   L+  +   +  Q+  G++Y       HRD
Sbjct: 247 VV-SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRD 305
Query: 140 LKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP---NYVAPEVLANRGYDGA 196
           L+  NIL+      K++DFGL+ L     +D       G+     + APE  A  G    
Sbjct: 306 LRAANILVGENLVCKVADFGLARLI----EDNEYTARQGAKFPIKWTAPEA-ALYGRFTI 360
Query: 197 TSDIWSCGVILYIFRGDFKLPKWLSPGAQNLLRKILE 233
            SD+WS G++L       ++P    PG  N  R++L+
Sbjct: 361 KSDVWSFGILLTELTTKGRVP---YPGMVN--REVLD 392

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 104/217 (47%), Gaps = 21/217 (9%)
Query: 22  LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHE 81
           LG+G FG+V +    +     A+K L+   +      +   +E   +K L+H  +V+L+ 
Sbjct: 192 LGQGCFGEV-WMGTWNGTTRVAIKTLKPGTMS----PEAFLQEAQVMKKLRHEKLVQLYA 246
Query: 82  VLASKSKIYMVLEYVTGGELFD--KIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRD 139
           V+ S+  IY+V EY++ G L D  K  +   L+  +   +  Q+  G++Y       HRD
Sbjct: 247 VV-SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRD 305
Query: 140 LKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP---NYVAPEVLANRGYDGA 196
           L+  NIL+      K++DFGL+ L     +D       G+     + APE  A  G    
Sbjct: 306 LRAANILVGENLVCKVADFGLARLI----EDNEYTARQGAKFPIKWTAPEA-ALYGRFTI 360
Query: 197 TSDIWSCGVILYIFRGDFKLPKWLSPGAQNLLRKILE 233
            SD+WS G++L       ++P    PG  N  R++L+
Sbjct: 361 KSDVWSFGILLTELTTKGRVP---YPGMVN--REVLD 392

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 106/217 (48%), Gaps = 21/217 (9%)
Query: 22  LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHE 81
           LG+G FG+V +    +     A+K L+   +      +   +E   +K L+H  +V+L+ 
Sbjct: 26  LGQGCFGEV-WMGTWNGTTRVAIKTLKPGTMS----PEAFLQEAQVMKKLRHEKLVQLYA 80
Query: 82  VLASKSKIYMVLEYVTGGELFDKIASK-GR-LQEAEGRKLFQQLIDGVSYCHNKGVFHRD 139
           V+ S+  IY+V EY++ G L D +  + G+ L+  +   +  Q+  G++Y       HRD
Sbjct: 81  VV-SEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRD 139
Query: 140 LKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP---NYVAPEVLANRGYDGA 196
           L+  NIL+      K++DFGL+ L     +D       G+     + APE  A  G    
Sbjct: 140 LRAANILVGENLVCKVADFGLARL----IEDNEYTARQGAKFPIKWTAPEA-ALYGRFTI 194
Query: 197 TSDIWSCGVILYIFRGDFKLPKWLSPGAQNLLRKILE 233
            SD+WS G++L       ++P    PG  N  R++L+
Sbjct: 195 KSDVWSFGILLTELTTKGRVP---YPGMVN--REVLD 226

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 57/192 (29%), Positives = 93/192 (48%), Gaps = 6/192 (3%)
Query: 20  RTLGEGNFGKVK--FAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVV 77
           + LG GNFG VK  + Q        AVKIL KN      + D++  E   ++ L +P +V
Sbjct: 33  KELGSGNFGTVKKGYYQMKKVVKTVAVKIL-KNEANDPALKDELLAEANVMQQLDNPYIV 91
Query: 78  RLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFH 137
           R+  +  ++S + +V+E    G L   +     +++    +L  Q+  G+ Y       H
Sbjct: 92  RMIGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVH 150
Query: 138 RDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP-NYVAPEVLANRGYDGA 196
           RDL   N+LL ++   KISDFGLS   +   +     T    P  + APE +    +  +
Sbjct: 151 RDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKF-SS 209
Query: 197 TSDIWSCGVILY 208
            SD+WS GV+++
Sbjct: 210 KSDVWSFGVLMW 221

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 57/192 (29%), Positives = 93/192 (48%), Gaps = 6/192 (3%)
Query: 20  RTLGEGNFGKVK--FAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVV 77
           + LG GNFG VK  + Q        AVKIL KN      + D++  E   ++ L +P +V
Sbjct: 33  KELGSGNFGTVKKGYYQMKKVVKTVAVKIL-KNEANDPALKDELLAEANVMQQLDNPYIV 91
Query: 78  RLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFH 137
           R+  +  ++S + +V+E    G L   +     +++    +L  Q+  G+ Y       H
Sbjct: 92  RMIGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVH 150
Query: 138 RDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP-NYVAPEVLANRGYDGA 196
           RDL   N+LL ++   KISDFGLS   +   +     T    P  + APE +    +  +
Sbjct: 151 RDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKF-SS 209
Query: 197 TSDIWSCGVILY 208
            SD+WS GV+++
Sbjct: 210 KSDVWSFGVLMW 221

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 106/217 (48%), Gaps = 21/217 (9%)
Query: 22  LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHE 81
           LG+G FG+V +    +     A+K L+   +      +   +E   +K L+H  +V+L+ 
Sbjct: 17  LGQGCFGEV-WMGTWNGTTRVAIKTLKPGTMS----PEAFLQEAQVMKKLRHEKLVQLYA 71
Query: 82  VLASKSKIYMVLEYVTGGELFDKIASK-GR-LQEAEGRKLFQQLIDGVSYCHNKGVFHRD 139
           V+ S+  IY+V EY++ G L D +  + G+ L+  +   +  Q+  G++Y       HRD
Sbjct: 72  VV-SEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRD 130
Query: 140 LKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP---NYVAPEVLANRGYDGA 196
           L+  NIL+      K++DFGL+ L     +D       G+     + APE  A  G    
Sbjct: 131 LRAANILVGENLVCKVADFGLARL----IEDNEYTARQGAKFPIKWTAPEA-ALYGRFTI 185
Query: 197 TSDIWSCGVILYIFRGDFKLPKWLSPGAQNLLRKILE 233
            SD+WS G++L       ++P    PG  N  R++L+
Sbjct: 186 KSDVWSFGILLTELTTKGRVP---YPGMVN--REVLD 217

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 54/193 (27%), Positives = 95/193 (49%), Gaps = 12/193 (6%)
Query: 22  LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHE 81
           LG G FGKV +   L  G   AVK L++ R    ++  Q + E+  + +  H N++RL  
Sbjct: 38  LGRGGFGKV-YKGRLADGXLVAVKRLKEERTQGGEL--QFQTEVEMISMAVHRNLLRLRG 94
Query: 82  VLASKSKIYMVLEYVTGGE----LFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNK---G 134
              + ++  +V  Y+  G     L ++  S+  L   + +++      G++Y H+     
Sbjct: 95  FCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPK 154
Query: 135 VFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYD 194
           + HRD+K  NILLD +    + DFGL+ L   ++D  +     G   ++APE L+  G  
Sbjct: 155 IIHRDVKAANILLDEEFEAVVGDFGLAKL-MDYKDXHVXXAVRGXIGHIAPEYLST-GKS 212
Query: 195 GATSDIWSCGVIL 207
              +D++  GV+L
Sbjct: 213 SEKTDVFGYGVML 225

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 106/217 (48%), Gaps = 21/217 (9%)
Query: 22  LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHE 81
           LG+G FG+V +    +     A+K L+   +      +   +E   +K L+H  +V+L+ 
Sbjct: 15  LGQGCFGEV-WMGTWNGTTRVAIKTLKPGTMS----PEAFLQEAQVMKKLRHEKLVQLYA 69
Query: 82  VLASKSKIYMVLEYVTGGELFDKIASK-GR-LQEAEGRKLFQQLIDGVSYCHNKGVFHRD 139
           V+ S+  IY+V EY++ G L D +  + G+ L+  +   +  Q+  G++Y       HRD
Sbjct: 70  VV-SEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRD 128
Query: 140 LKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP---NYVAPEVLANRGYDGA 196
           L+  NIL+      K++DFGL+ L     +D       G+     + APE  A  G    
Sbjct: 129 LRAANILVGENLVCKVADFGLARL----IEDNEYTARQGAKFPIKWTAPEA-ALYGRFTI 183
Query: 197 TSDIWSCGVILYIFRGDFKLPKWLSPGAQNLLRKILE 233
            SD+WS G++L       ++P    PG  N  R++L+
Sbjct: 184 KSDVWSFGILLTELTTKGRVP---YPGMVN--REVLD 215

>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 62/221 (28%), Positives = 95/221 (42%), Gaps = 33/221 (14%)
Query: 15  RYELGRTLGEGNFGKVKFAQDL-----DSGLPFAVKILEKNRIIHLKITDQIKREIATLK 69
           R   G+TLG G FGKV  A        D+ +  AVK+L+ +   HL   + +  E+  L 
Sbjct: 47  RLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA--HLTEREALMSELKVLS 104
Query: 70  LL-KHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASK------------------GR 110
            L  H N+V L           ++ EY   G+L + +  K                    
Sbjct: 105 YLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELA 164
Query: 111 LQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD 170
           L   +      Q+  G+++  +K   HRDL   NILL      KI DFGL+   +H ++D
Sbjct: 165 LDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLA---RHIKND 221
Query: 171 G--LLHTTCGSP-NYVAPEVLANRGYDGATSDIWSCGVILY 208
              ++      P  ++APE + N  Y    SD+WS G+ L+
Sbjct: 222 SNYVVKGNARLPVKWMAPESIFNCVYT-FESDVWSYGIFLW 261

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 103/217 (47%), Gaps = 21/217 (9%)
Query: 22  LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHE 81
           LG+G FG+V +    +     A+K L+   +      +   +E   +K L+H  +V+L+ 
Sbjct: 23  LGQGCFGEV-WMGTWNGTTRVAIKTLKPGTMS----PEAFLQEAQVMKKLRHEKLVQLYA 77
Query: 82  VLASKSKIYMVLEYVTGGELFD--KIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRD 139
           V+ S+  IY+V EY+  G L D  K  +   L+  +   +  Q+  G++Y       HRD
Sbjct: 78  VV-SEEPIYIVTEYMNKGSLLDFLKGETGKYLRLPQLVDMSAQIASGMAYVERMNYVHRD 136
Query: 140 LKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP---NYVAPEVLANRGYDGA 196
           L+  NIL+      K++DFGL+ L     +D       G+     + APE  A  G    
Sbjct: 137 LRAANILVGENLVCKVADFGLARL----IEDNEYTARQGAKFPIKWTAPEA-ALYGRFTI 191
Query: 197 TSDIWSCGVILYIFRGDFKLPKWLSPGAQNLLRKILE 233
            SD+WS G++L       ++P    PG  N  R++L+
Sbjct: 192 KSDVWSFGILLTELTTKGRVP---YPGMVN--REVLD 223

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 57/192 (29%), Positives = 93/192 (48%), Gaps = 6/192 (3%)
Query: 20  RTLGEGNFGKVK--FAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVV 77
           + LG GNFG VK  + Q        AVKIL KN      + D++  E   ++ L +P +V
Sbjct: 17  KELGSGNFGTVKKGYYQMKKVVKTVAVKIL-KNEANDPALKDELLAEANVMQQLDNPYIV 75
Query: 78  RLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFH 137
           R+  +  ++S + +V+E    G L   +     +++    +L  Q+  G+ Y       H
Sbjct: 76  RMIGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVH 134
Query: 138 RDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP-NYVAPEVLANRGYDGA 196
           RDL   N+LL ++   KISDFGLS   +   +     T    P  + APE +    +  +
Sbjct: 135 RDLAARNVLLVTQHYAKISDFGLSKALRADENXYKAQTHGKWPVKWYAPECINYYKF-SS 193
Query: 197 TSDIWSCGVILY 208
            SD+WS GV+++
Sbjct: 194 KSDVWSFGVLMW 205

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/225 (27%), Positives = 101/225 (44%), Gaps = 40/225 (17%)
Query: 17  ELGRTLGEGNFGKVKFAQDLDSGLPF------AVKILEKNRIIHLKITDQIKREIATLKL 70
           E  R +GEG FG+V F       LP+      AVK+L++     ++   Q  RE A +  
Sbjct: 50  EYVRDIGEGAFGRV-FQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQ--REAALMAE 106
Query: 71  LKHPNVVRLHEVLASKSKIYMVLEYVTGGELFD----------------------KIASK 108
             +PN+V+L  V A    + ++ EY+  G+L +                      +++S 
Sbjct: 107 FDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSP 166
Query: 109 GR--LQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLS---AL 163
           G   L  AE   + +Q+  G++Y   +   HRDL   N L+     +KI+DFGLS     
Sbjct: 167 GPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYS 226
Query: 164 PQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILY 208
             +++ DG          ++ PE +    Y    SD+W+ GV+L+
Sbjct: 227 ADYYKADG---NDAIPIRWMPPESIFYNRYT-TESDVWAYGVVLW 267

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 104/217 (47%), Gaps = 21/217 (9%)
Query: 22  LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHE 81
           LG+G FG+V +    +     A+K L+   +      +   +E   +K L+H  +V+L+ 
Sbjct: 275 LGQGCFGEV-WMGTWNGTTRVAIKTLKPGTMS----PEAFLQEAQVMKKLRHEKLVQLYA 329
Query: 82  VLASKSKIYMVLEYVTGGELFD--KIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRD 139
           V+ S+  IY+V EY++ G L D  K  +   L+  +   +  Q+  G++Y       HRD
Sbjct: 330 VV-SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRD 388
Query: 140 LKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP---NYVAPEVLANRGYDGA 196
           L+  NIL+      K++DFGL+ L     +D       G+     + APE  A  G    
Sbjct: 389 LRAANILVGENLVCKVADFGLARL----IEDNEYTARQGAKFPIKWTAPEA-ALYGRFTI 443
Query: 197 TSDIWSCGVILYIFRGDFKLPKWLSPGAQNLLRKILE 233
            SD+WS G++L       ++P    PG  N  R++L+
Sbjct: 444 KSDVWSFGILLTELTTKGRVP---YPGMVN--REVLD 475

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 57/192 (29%), Positives = 93/192 (48%), Gaps = 6/192 (3%)
Query: 20  RTLGEGNFGKVK--FAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVV 77
           + LG GNFG VK  + Q        AVKIL KN      + D++  E   ++ L +P +V
Sbjct: 31  KELGSGNFGTVKKGYYQMKKVVKTVAVKIL-KNEANDPALKDELLAEANVMQQLDNPYIV 89
Query: 78  RLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFH 137
           R+  +  ++S + +V+E    G L   +     +++    +L  Q+  G+ Y       H
Sbjct: 90  RMIGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVH 148
Query: 138 RDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP-NYVAPEVLANRGYDGA 196
           RDL   N+LL ++   KISDFGLS   +   +     T    P  + APE +    +  +
Sbjct: 149 RDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKF-SS 207
Query: 197 TSDIWSCGVILY 208
            SD+WS GV+++
Sbjct: 208 KSDVWSFGVLMW 219

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/200 (29%), Positives = 96/200 (48%), Gaps = 12/200 (6%)
Query: 17  ELGRTLGEGNFGKVKFAQDLDS-GLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
                +G G+FG V     LD+ G      +   NRI  +    Q   E   +K   HPN
Sbjct: 31  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 90
Query: 76  VVRLHEV-LASKSKIYMVLEYVTGGELFDKIASKGR---LQEAEGRKLFQQLIDGVSYCH 131
           V+ L  + L S+    +VL Y+  G+L + I ++     +++  G  L  Q+  G+ +  
Sbjct: 91  VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGL--QVAKGMKFLA 148
Query: 132 NKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP---NYVAPEVL 188
           +K   HRDL   N +LD K  +K++DFGL A   + ++   +H   G+     ++A E L
Sbjct: 149 SKKFVHRDLAARNCMLDEKFTVKVADFGL-ARDMYDKEFDSVHNKTGAKLPVKWMALESL 207
Query: 189 ANRGYDGATSDIWSCGVILY 208
             + +    SD+WS GV+L+
Sbjct: 208 QTQKFT-TKSDVWSFGVLLW 226

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/200 (29%), Positives = 96/200 (48%), Gaps = 12/200 (6%)
Query: 17  ELGRTLGEGNFGKVKFAQDLDS-GLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
                +G G+FG V     LD+ G      +   NRI  +    Q   E   +K   HPN
Sbjct: 92  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 151
Query: 76  VVRLHEV-LASKSKIYMVLEYVTGGELFDKIASKGR---LQEAEGRKLFQQLIDGVSYCH 131
           V+ L  + L S+    +VL Y+  G+L + I ++     +++  G  L  Q+  G+ +  
Sbjct: 152 VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGL--QVAKGMKFLA 209
Query: 132 NKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP---NYVAPEVL 188
           +K   HRDL   N +LD K  +K++DFGL A   + ++   +H   G+     ++A E L
Sbjct: 210 SKKFVHRDLAARNCMLDEKFTVKVADFGL-ARDMYDKEFDSVHNKTGAKLPVKWMALESL 268
Query: 189 ANRGYDGATSDIWSCGVILY 208
             + +    SD+WS GV+L+
Sbjct: 269 QTQKFT-TKSDVWSFGVLLW 287

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/200 (29%), Positives = 96/200 (48%), Gaps = 12/200 (6%)
Query: 17  ELGRTLGEGNFGKVKFAQDLDS-GLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
                +G G+FG V     LD+ G      +   NRI  +    Q   E   +K   HPN
Sbjct: 33  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 92
Query: 76  VVRLHEV-LASKSKIYMVLEYVTGGELFDKIASKGR---LQEAEGRKLFQQLIDGVSYCH 131
           V+ L  + L S+    +VL Y+  G+L + I ++     +++  G  L  Q+  G+ +  
Sbjct: 93  VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGL--QVAKGMKFLA 150
Query: 132 NKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP---NYVAPEVL 188
           +K   HRDL   N +LD K  +K++DFGL A   + ++   +H   G+     ++A E L
Sbjct: 151 SKKFVHRDLAARNCMLDEKFTVKVADFGL-ARDMYDKEFDSVHNKTGAKLPVKWMALESL 209
Query: 189 ANRGYDGATSDIWSCGVILY 208
             + +    SD+WS GV+L+
Sbjct: 210 QTQKFT-TKSDVWSFGVLLW 228

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/200 (29%), Positives = 96/200 (48%), Gaps = 12/200 (6%)
Query: 17  ELGRTLGEGNFGKVKFAQDLDS-GLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
                +G G+FG V     LD+ G      +   NRI  +    Q   E   +K   HPN
Sbjct: 33  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 92
Query: 76  VVRLHEV-LASKSKIYMVLEYVTGGELFDKIASKGR---LQEAEGRKLFQQLIDGVSYCH 131
           V+ L  + L S+    +VL Y+  G+L + I ++     +++  G  L  Q+  G+ +  
Sbjct: 93  VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGL--QVAKGMKFLA 150
Query: 132 NKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP---NYVAPEVL 188
           +K   HRDL   N +LD K  +K++DFGL A   + ++   +H   G+     ++A E L
Sbjct: 151 SKKFVHRDLAARNCMLDEKFTVKVADFGL-ARDMYDKEFDSVHNKTGAKLPVKWMALESL 209
Query: 189 ANRGYDGATSDIWSCGVILY 208
             + +    SD+WS GV+L+
Sbjct: 210 QTQKFT-TKSDVWSFGVLLW 228

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 65/222 (29%), Positives = 100/222 (45%), Gaps = 36/222 (16%)
Query: 18  LGRTLGEGNFGKVKFAQDLD-----SGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK 72
           LG+TLGEG FGKV  A              AVK+L++N     ++ D +  E   LK + 
Sbjct: 27  LGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPS-ELRDLLS-EFNVLKQVN 84
Query: 73  HPNVVRLHEVLASKSKIYMVLEYVTGGEL--FDKIASK--------------GRLQEAEG 116
           HP+V++L+   +    + +++EY   G L  F + + K                L   + 
Sbjct: 85  HPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDE 144
Query: 117 RKLFQ--------QLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFR 168
           R L          Q+  G+ Y     + HRDL   NIL+     +KISDFGLS     + 
Sbjct: 145 RALTMGDLISFAWQISQGMQYLAEMSLVHRDLAARNILVAEGRKMKISDFGLSR--DVYE 202
Query: 169 DDGLLHTTCGS--PNYVAPEVLANRGYDGATSDIWSCGVILY 208
           +D  +  + G     ++A E L +  Y    SD+WS GV+L+
Sbjct: 203 EDSXVKRSQGRIPVKWMAIESLFDHIYT-TQSDVWSFGVLLW 243

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 57/192 (29%), Positives = 93/192 (48%), Gaps = 6/192 (3%)
Query: 20  RTLGEGNFGKVK--FAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVV 77
           + LG GNFG VK  + Q        AVKIL KN      + D++  E   ++ L +P +V
Sbjct: 23  KELGSGNFGTVKKGYYQMKKVVKTVAVKIL-KNEANDPALKDELLAEANVMQQLDNPYIV 81
Query: 78  RLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFH 137
           R+  +  ++S + +V+E    G L   +     +++    +L  Q+  G+ Y       H
Sbjct: 82  RMIGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVH 140
Query: 138 RDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP-NYVAPEVLANRGYDGA 196
           RDL   N+LL ++   KISDFGLS   +   +     T    P  + APE +    +  +
Sbjct: 141 RDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKF-SS 199
Query: 197 TSDIWSCGVILY 208
            SD+WS GV+++
Sbjct: 200 KSDVWSFGVLMW 211

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 57/192 (29%), Positives = 93/192 (48%), Gaps = 6/192 (3%)
Query: 20  RTLGEGNFGKVK--FAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVV 77
           + LG GNFG VK  + Q        AVKIL KN      + D++  E   ++ L +P +V
Sbjct: 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKIL-KNEANDPALKDELLAEANVMQQLDNPYIV 433
Query: 78  RLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFH 137
           R+  +  ++S + +V+E    G L   +     +++    +L  Q+  G+ Y       H
Sbjct: 434 RMIGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVH 492
Query: 138 RDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP-NYVAPEVLANRGYDGA 196
           RDL   N+LL ++   KISDFGLS   +   +     T    P  + APE +    +  +
Sbjct: 493 RDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFS-S 551
Query: 197 TSDIWSCGVILY 208
            SD+WS GV+++
Sbjct: 552 KSDVWSFGVLMW 563

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 58/200 (29%), Positives = 96/200 (48%), Gaps = 12/200 (6%)
Query: 17  ELGRTLGEGNFGKVKFAQDLDS-GLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
                +G G+FG V     LD+ G      +   NRI  +    Q   E   +K   HPN
Sbjct: 34  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 93
Query: 76  VVRLHEV-LASKSKIYMVLEYVTGGELFDKIASKGR---LQEAEGRKLFQQLIDGVSYCH 131
           V+ L  + L S+    +VL Y+  G+L + I ++     +++  G  L  Q+  G+ +  
Sbjct: 94  VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGL--QVAKGMKFLA 151
Query: 132 NKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP---NYVAPEVL 188
           +K   HRDL   N +LD K  +K++DFGL A   + ++   +H   G+     ++A E L
Sbjct: 152 SKKFVHRDLAARNCMLDEKFTVKVADFGL-ARDMYDKEFDSVHNKTGAKLPVKWMALESL 210
Query: 189 ANRGYDGATSDIWSCGVILY 208
             + +    SD+WS GV+L+
Sbjct: 211 QTQKFT-TKSDVWSFGVLLW 229

>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 63/235 (26%), Positives = 96/235 (40%), Gaps = 35/235 (14%)
Query: 2   VIAEKKQEGMR---LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLK-- 56
           +I + KQ  ++   L        LGE  FGKV        G  F     E+ + + +K  
Sbjct: 11  LINQHKQAKLKEISLSAVRFMEELGEDRFGKVY------KGHLFGPAPGEQTQAVAIKTL 64
Query: 57  -------ITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELF------- 102
                  + ++ + E      L+HPNVV L  V+     + M+  Y + G+L        
Sbjct: 65  KDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRS 124
Query: 103 ---------DKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNI 153
                    D    K  L+  +   L  Q+  G+ Y  +  V H+DL   N+L+  K N+
Sbjct: 125 PHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNV 184
Query: 154 KISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILY 208
           KISD GL           LL  +     ++APE +   G     SDIWS GV+L+
Sbjct: 185 KISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIM-YGKFSIDSDIWSYGVVLW 238

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 58/200 (29%), Positives = 96/200 (48%), Gaps = 12/200 (6%)
Query: 17  ELGRTLGEGNFGKVKFAQDLDS-GLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
                +G G+FG V     LD+ G      +   NRI  +    Q   E   +K   HPN
Sbjct: 38  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 97
Query: 76  VVRLHEV-LASKSKIYMVLEYVTGGELFDKIASKGR---LQEAEGRKLFQQLIDGVSYCH 131
           V+ L  + L S+    +VL Y+  G+L + I ++     +++  G  L  Q+  G+ +  
Sbjct: 98  VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGL--QVAKGMKFLA 155
Query: 132 NKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP---NYVAPEVL 188
           +K   HRDL   N +LD K  +K++DFGL A   + ++   +H   G+     ++A E L
Sbjct: 156 SKKFVHRDLAARNCMLDEKFTVKVADFGL-ARDMYDKEFDSVHNKTGAKLPVKWMALESL 214
Query: 189 ANRGYDGATSDIWSCGVILY 208
             + +    SD+WS GV+L+
Sbjct: 215 QTQKFT-TKSDVWSFGVLLW 233

>pdb|2VAG|A Chain A, Crystal Structure Of Di-Phosphorylated Human Clk1 In Complex With A Novel Substituted Indole Inhibitor Length = 339

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 78/270 (28%), Positives = 115/270 (42%), Gaps = 42/270 (15%)
Query: 14  GRYELGRTLGEGNFGKVKFAQDLDSG-LPFAVKILEKNRIIHLKITDQIKREIATLKLLK 72
            RYE+  TLGEG FGKV    D  +G    AVKI++       +  +  + EI  L+ L 
Sbjct: 14  ARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVD----RYCEAARSEIQVLEHLN 69
Query: 73  --HPN----VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRL--QEAEGRKLFQQLI 124
              PN     V++ E       I +V E + G   +D I   G L  +    RK+  Q+ 
Sbjct: 70  TTDPNSTFRCVQMLEWFEHHGHICIVFE-LLGLSTYDFIKENGFLPFRLDHIRKMAYQIC 128
Query: 125 DGVSYCHNKGVFHRDLKLENILL---------------DSKG----NIKISDFGLSALPQ 165
             V++ H+  + H DLK ENIL                D +     +IK+ DFG +    
Sbjct: 129 KSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATY-- 186
Query: 166 HFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIFRGDFKL-PKWLSPGA 224
              DD    T     +Y APEV+   G+     D+WS G IL  +   F + P   S   
Sbjct: 187 ---DDEHHSTLVXXRHYRAPEVILALGW-SQPCDVWSIGCILIEYYLGFTVFPTHDSKEH 242
Query: 225 QNLLRKILEPNPVKRITIAGIKADEWFEQD 254
             ++ +IL P P  +  I   +  ++F  D
Sbjct: 243 LAMMERILGPLP--KHMIQKTRKRKYFHHD 270

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 59/202 (29%), Positives = 96/202 (47%), Gaps = 16/202 (7%)
Query: 17  ELGRTLGEGNFGKVKFAQDLDS-GLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
                +G G+FG V     LD+ G      +   NRI  +    Q   E   +K   HPN
Sbjct: 34  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 93
Query: 76  VVRLHEV-LASKSKIYMVLEYVTGGELFDKIASKGR---LQEAEGRKLFQQLIDGVSYCH 131
           V+ L  + L S+    +VL Y+  G+L + I ++     +++  G  L  Q+  G+ +  
Sbjct: 94  VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGL--QVAKGMKFLA 151
Query: 132 NKGVFHRDLKLENILLDSKGNIKISDFGLS--ALPQHFRDDGLLHTTCGSP---NYVAPE 186
           +K   HRDL   N +LD K  +K++DFGL+   L + F     +H   G+     ++A E
Sbjct: 152 SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMLDKEFDS---VHNKTGAKLPVKWMALE 208
Query: 187 VLANRGYDGATSDIWSCGVILY 208
            L  + +    SD+WS GV+L+
Sbjct: 209 SLQTQKFT-TKSDVWSFGVLLW 229

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 57/192 (29%), Positives = 93/192 (48%), Gaps = 6/192 (3%)
Query: 20  RTLGEGNFGKVK--FAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVV 77
           + LG GNFG VK  + Q        AVKIL KN      + D++  E   ++ L +P +V
Sbjct: 376 KELGSGNFGTVKKGYYQMKKVVKTVAVKIL-KNEANDPALKDELLAEANVMQQLDNPYIV 434
Query: 78  RLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFH 137
           R+  +  ++S + +V+E    G L   +     +++    +L  Q+  G+ Y       H
Sbjct: 435 RMIGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVH 493
Query: 138 RDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP-NYVAPEVLANRGYDGA 196
           RDL   N+LL ++   KISDFGLS   +   +     T    P  + APE +    +  +
Sbjct: 494 RDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFS-S 552
Query: 197 TSDIWSCGVILY 208
            SD+WS GV+++
Sbjct: 553 KSDVWSFGVLMW 564

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 57/192 (29%), Positives = 93/192 (48%), Gaps = 6/192 (3%)
Query: 20  RTLGEGNFGKVK--FAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVV 77
           + LG GNFG VK  + Q        AVKIL KN      + D++  E   ++ L +P +V
Sbjct: 17  KELGSGNFGTVKKGYYQMKKVVKTVAVKIL-KNEANDPALKDELLAEANVMQQLDNPYIV 75
Query: 78  RLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFH 137
           R+  +  ++S + +V+E    G L   +     +++    +L  Q+  G+ Y       H
Sbjct: 76  RMIGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVH 134
Query: 138 RDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP-NYVAPEVLANRGYDGA 196
           RDL   N+LL ++   KISDFGLS   +   +     T    P  + APE +    +  +
Sbjct: 135 RDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKF-SS 193
Query: 197 TSDIWSCGVILY 208
            SD+WS GV+++
Sbjct: 194 KSDVWSFGVLMW 205

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 57/192 (29%), Positives = 93/192 (48%), Gaps = 6/192 (3%)
Query: 20  RTLGEGNFGKVK--FAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVV 77
           + LG GNFG VK  + Q        AVKIL KN      + D++  E   ++ L +P +V
Sbjct: 11  KELGSGNFGTVKKGYYQMKKVVKTVAVKIL-KNEANDPALKDELLAEANVMQQLDNPYIV 69
Query: 78  RLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFH 137
           R+  +  ++S + +V+E    G L   +     +++    +L  Q+  G+ Y       H
Sbjct: 70  RMIGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVH 128
Query: 138 RDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP-NYVAPEVLANRGYDGA 196
           RDL   N+LL ++   KISDFGLS   +   +     T    P  + APE +    +  +
Sbjct: 129 RDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKF-SS 187
Query: 197 TSDIWSCGVILY 208
            SD+WS GV+++
Sbjct: 188 KSDVWSFGVLMW 199

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 40/95 (42%), Positives = 51/95 (53%), Gaps = 9/95 (9%)
Query: 132 NKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVL--- 188
           N  + HRD+K  NILLD  GNIK+ DFG+S       D        G   Y+APE +   
Sbjct: 144 NLKIIHRDIKPSNILLDRSGNIKLCDFGISG---QLVDSIAKTRDAGCRPYMAPERIDPS 200
Query: 189 -ANRGYDGATSDIWSCGVILY-IFRGDFKLPKWLS 221
            + +GYD   SD+WS G+ LY +  G F  PKW S
Sbjct: 201 ASRQGYD-VRSDVWSLGITLYELATGRFPYPKWNS 234

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 106/217 (48%), Gaps = 21/217 (9%)
Query: 22  LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHE 81
           LG+G FG+V +    +     A+K L+   +      +   +E   +K L+H  +V+L+ 
Sbjct: 26  LGQGCFGEV-WMGTWNGTTRVAIKTLKPGTMS----PEAFLQEAQVMKKLRHEKLVQLYA 80
Query: 82  VLASKSKIYMVLEYVTGGELFDKIASK-GR-LQEAEGRKLFQQLIDGVSYCHNKGVFHRD 139
           V+ S+  IY+V EY++ G L D +  + G+ L+  +   +  Q+  G++Y       HRD
Sbjct: 81  VV-SEEPIYIVTEYMSKGCLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRD 139
Query: 140 LKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP---NYVAPEVLANRGYDGA 196
           L+  NIL+      K++DFGL+ L     +D       G+     + APE  A  G    
Sbjct: 140 LRAANILVGENLVCKVADFGLARL----IEDNEYTARQGAKFPIKWTAPEA-ALYGRFTI 194
Query: 197 TSDIWSCGVILYIFRGDFKLPKWLSPGAQNLLRKILE 233
            SD+WS G++L       ++P    PG  N  R++L+
Sbjct: 195 KSDVWSFGILLTELTTKGRVP---YPGMVN--REVLD 226

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 61/217 (28%), Positives = 106/217 (48%), Gaps = 21/217 (9%)
Query: 22  LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHE 81
           LG+G FG+V +    +     A+K L+   +      +   +E   +K ++H  +V+L+ 
Sbjct: 26  LGQGCFGEV-WMGTWNGTTRVAIKTLKPGTMS----PEAFLQEAQVMKKIRHEKLVQLYA 80
Query: 82  VLASKSKIYMVLEYVTGGELFDKIASK-GR-LQEAEGRKLFQQLIDGVSYCHNKGVFHRD 139
           V+ S+  IY+V EY++ G L D +  + G+ L+  +   +  Q+  G++Y       HRD
Sbjct: 81  VV-SEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRD 139
Query: 140 LKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP---NYVAPEVLANRGYDGA 196
           L+  NIL+      K++DFGL+ L     +D       G+     + APE  A  G    
Sbjct: 140 LRAANILVGENLVCKVADFGLARL----IEDNEYTARQGAKFPIKWTAPEA-ALYGRFTI 194
Query: 197 TSDIWSCGVILYIFRGDFKLPKWLSPGAQNLLRKILE 233
            SD+WS G++L       ++P    PG  N  R++L+
Sbjct: 195 KSDVWSFGILLTELTTKGRVP---YPGMVN--REVLD 226

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 104/217 (47%), Gaps = 21/217 (9%)
Query: 22  LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHE 81
           LG+G FG+V +    +     A+K L+   +      +   +E   +K L+H  +V+L+ 
Sbjct: 192 LGQGCFGEV-WMGTWNGTTRVAIKTLKPGTMS----PEAFLQEAQVMKKLRHEKLVQLYA 246
Query: 82  VLASKSKIYMVLEYVTGGELFD--KIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRD 139
           V+ S+  IY+V EY++ G L D  K  +   L+  +   +  Q+  G++Y       HRD
Sbjct: 247 VV-SEEPIYIVGEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRD 305
Query: 140 LKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP---NYVAPEVLANRGYDGA 196
           L+  NIL+      K++DFGL+ L     +D       G+     + APE  A  G    
Sbjct: 306 LRAANILVGENLVCKVADFGLARLI----EDNEYTARQGAKFPIKWTAPEA-ALYGRFTI 360
Query: 197 TSDIWSCGVILYIFRGDFKLPKWLSPGAQNLLRKILE 233
            SD+WS G++L       ++P    PG  N  R++L+
Sbjct: 361 KSDVWSFGILLTELTTKGRVP---YPGMVN--REVLD 392

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 105/217 (48%), Gaps = 21/217 (9%)
Query: 22  LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHE 81
           LG+G FG+V +    +     A+K L+   +      +   +E   +K L+H  +V+L+ 
Sbjct: 26  LGQGCFGEV-WMGTWNGTTRVAIKTLKPGTMS----PEAFLQEAQVMKKLRHEKLVQLYA 80
Query: 82  VLASKSKIYMVLEYVTGGELFDKIASK-GR-LQEAEGRKLFQQLIDGVSYCHNKGVFHRD 139
           V+ S+  IY+V EY++ G L D +  + G+ L+  +   +  Q+  G++Y       HRD
Sbjct: 81  VV-SEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRD 139
Query: 140 LKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP---NYVAPEVLANRGYDGA 196
           L   NIL+      K++DFGL+ L     +D       G+     + APE  A  G    
Sbjct: 140 LAAANILVGENLVCKVADFGLARL----IEDNEYTARQGAKFPIKWTAPEA-ALYGRFTI 194
Query: 197 TSDIWSCGVILYIFRGDFKLPKWLSPGAQNLLRKILE 233
            SD+WS G++L       ++P    PG  N  R++L+
Sbjct: 195 KSDVWSFGILLTELTTKGRVP---YPGMVN--REVLD 226

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 57/192 (29%), Positives = 93/192 (48%), Gaps = 6/192 (3%)
Query: 20  RTLGEGNFGKVK--FAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVV 77
           + LG GNFG VK  + Q        AVKIL KN      + D++  E   ++ L +P +V
Sbjct: 13  KELGSGNFGTVKKGYYQMKKVVKTVAVKIL-KNEANDPALKDELLAEANVMQQLDNPYIV 71
Query: 78  RLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFH 137
           R+  +  ++S + +V+E    G L   +     +++    +L  Q+  G+ Y       H
Sbjct: 72  RMIGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVH 130
Query: 138 RDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP-NYVAPEVLANRGYDGA 196
           RDL   N+LL ++   KISDFGLS   +   +     T    P  + APE +    +  +
Sbjct: 131 RDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKF-SS 189
Query: 197 TSDIWSCGVILY 208
            SD+WS GV+++
Sbjct: 190 KSDVWSFGVLMW 201

>pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 63/203 (31%), Positives = 93/203 (45%), Gaps = 21/203 (10%)
Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
           RYE+ + +G+G FG+V  A D       A+K++   +  H     Q   EI  L+ L+  
Sbjct: 98  RYEVLKVIGKGXFGQVVKAYDHKVHQHVALKMVRNEKRFH----RQAAEEIRILEHLRKQ 153
Query: 75  ------NVVRLHEVLASKSKIYMVLEYVTGG--ELFDKIASKGRLQEAEGRKLFQQLIDG 126
                 NV+ + E    ++ I M  E ++    EL  K   +G       RK    ++  
Sbjct: 154 DKDNTMNVIHMLENFTFRNHICMTFELLSMNLYELIKKNKFQG-FSLPLVRKFAHSILQC 212
Query: 127 VSYCHNKGVFHRDLKLENILLDSKGN--IKISDFGLSALPQHFRDDGLLHTTCGSPNYVA 184
           +   H   + H DLK ENILL  +G   IK+ DFG S+  +H R    ++    S  Y A
Sbjct: 213 LDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFG-SSCYEHQR----VYXXIQSRFYRA 267
Query: 185 PEVLANRGYDGATSDIWSCGVIL 207
           PEV+    Y G   D+WS G IL
Sbjct: 268 PEVILGARY-GMPIDMWSLGCIL 289

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 65/222 (29%), Positives = 100/222 (45%), Gaps = 36/222 (16%)
Query: 18  LGRTLGEGNFGKVKFAQDLD-----SGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK 72
           LG+TLGEG FGKV  A              AVK+L++N     ++ D +  E   LK + 
Sbjct: 27  LGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPS-ELRDLLS-EFNVLKQVN 84
Query: 73  HPNVVRLHEVLASKSKIYMVLEYVTGGEL--FDKIASK--------------GRLQEAEG 116
           HP+V++L+   +    + +++EY   G L  F + + K                L   + 
Sbjct: 85  HPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDE 144
Query: 117 RKLFQ--------QLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFR 168
           R L          Q+  G+ Y     + HRDL   NIL+     +KISDFGLS     + 
Sbjct: 145 RALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLSR--DVYE 202
Query: 169 DDGLLHTTCGS--PNYVAPEVLANRGYDGATSDIWSCGVILY 208
           +D  +  + G     ++A E L +  Y    SD+WS GV+L+
Sbjct: 203 EDSYVKRSQGRIPVKWMAIESLFDHIYT-TQSDVWSFGVLLW 243

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 65/222 (29%), Positives = 100/222 (45%), Gaps = 36/222 (16%)
Query: 18  LGRTLGEGNFGKVKFAQDLD-----SGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK 72
           LG+TLGEG FGKV  A              AVK+L++N     ++ D +  E   LK + 
Sbjct: 27  LGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPS-ELRDLLS-EFNVLKQVN 84
Query: 73  HPNVVRLHEVLASKSKIYMVLEYVTGGEL--FDKIASK--------------GRLQEAEG 116
           HP+V++L+   +    + +++EY   G L  F + + K                L   + 
Sbjct: 85  HPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDE 144
Query: 117 RKLFQ--------QLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFR 168
           R L          Q+  G+ Y     + HRDL   NIL+     +KISDFGLS     + 
Sbjct: 145 RALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLSR--DVYE 202
Query: 169 DDGLLHTTCGS--PNYVAPEVLANRGYDGATSDIWSCGVILY 208
           +D  +  + G     ++A E L +  Y    SD+WS GV+L+
Sbjct: 203 EDSXVKRSQGRIPVKWMAIESLFDHIYT-TQSDVWSFGVLLW 243

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 105/217 (48%), Gaps = 21/217 (9%)
Query: 22  LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHE 81
           LG+G FG+V +    +     A+K L+   +      +   +E   +K L+H  +V+L+ 
Sbjct: 193 LGQGCFGEV-WMGTWNGTTRVAIKTLKPGNMS----PEAFLQEAQVMKKLRHEKLVQLYA 247
Query: 82  VLASKSKIYMVLEYVTGGELFDKIASK-GR-LQEAEGRKLFQQLIDGVSYCHNKGVFHRD 139
           V+ S+  IY+V EY++ G L D +  + G+ L+  +   +  Q+  G++Y       HRD
Sbjct: 248 VV-SEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRD 306
Query: 140 LKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP---NYVAPEVLANRGYDGA 196
           L+  NIL+      K++DFGL  L     +D       G+     + APE  A  G    
Sbjct: 307 LRAANILVGENLVCKVADFGLGRLI----EDNEYTARQGAKFPIKWTAPEA-ALYGRFTI 361
Query: 197 TSDIWSCGVILYIFRGDFKLPKWLSPGAQNLLRKILE 233
            SD+WS G++L       ++P    PG  N  R++L+
Sbjct: 362 KSDVWSFGILLTELTTKGRVP---YPGMVN--REVLD 393

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 52/190 (27%), Positives = 89/190 (46%), Gaps = 14/190 (7%)
Query: 22  LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHE 81
           +G G+F  V    D ++ +  A   L+  ++   +   + K E   LK L+HPN+VR ++
Sbjct: 34  IGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSE-RQRFKEEAEXLKGLQHPNIVRFYD 92
Query: 82  VLASKSK----IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKG--V 135
              S  K    I +V E  T G L   +      +    R   +Q++ G+ + H +   +
Sbjct: 93  SWESTVKGKKCIVLVTELXTSGTLKTYLKRFKVXKIKVLRSWCRQILKGLQFLHTRTPPI 152
Query: 136 FHRDLKLENILLDS-KGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYD 194
            HRDLK +NI +    G++KI D GL+ L +            G+P + APE    + YD
Sbjct: 153 IHRDLKCDNIFITGPTGSVKIGDLGLATLKRA----SFAKAVIGTPEFXAPEXYEEK-YD 207
Query: 195 GATSDIWSCG 204
            +  D+++ G
Sbjct: 208 ESV-DVYAFG 216

>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 88/212 (41%), Gaps = 32/212 (15%)
Query: 22  LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLK---------ITDQIKREIATLKLLK 72
           LGE  FGKV        G  F     E+ + + +K         + ++ + E      L+
Sbjct: 17  LGEDRFGKVY------KGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQ 70
Query: 73  HPNVVRLHEVLASKSKIYMVLEYVTGGELF----------------DKIASKGRLQEAEG 116
           HPNVV L  V+     + M+  Y + G+L                 D    K  L+  + 
Sbjct: 71  HPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDF 130
Query: 117 RKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTT 176
             L  Q+  G+ Y  +  V H+DL   N+L+  K N+KISD GL           LL  +
Sbjct: 131 VHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNS 190
Query: 177 CGSPNYVAPEVLANRGYDGATSDIWSCGVILY 208
                ++APE +   G     SDIWS GV+L+
Sbjct: 191 LLPIRWMAPEAIMY-GKFSIDSDIWSYGVVLW 221

>pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 62/236 (26%), Positives = 105/236 (44%), Gaps = 54/236 (22%)
Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVK-ILEKNRIIHLKITDQIKREIATLKLLKH 73
           +Y LG+TLG G+FG V    D++SG  FA+K +L+  R  +        RE+  +K+L H
Sbjct: 8   KYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKN--------RELDIMKVLDH 59
Query: 74  PNVVRL--------------------HEVLASKSK------------------IYMVLEY 95
            N+++L                    H  L  K+                   + +++EY
Sbjct: 60  VNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEY 119
Query: 96  V--TGGELFDKIASKGRLQEAEGRKLF-QQLIDGVSYCHNKGVFHRDLKLENILLDSKGN 152
           V  T  ++       GR        ++  QL   V + H+ G+ HRD+K +N+L++SK N
Sbjct: 120 VPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNSKDN 179
Query: 153 -IKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVIL 207
            +K+ DFG +   +    +  +   C S  Y APE++        + D+WS G + 
Sbjct: 180 TLKLCDFGSAK--KLIPSEPSVAXIC-SRFYRAPELMLGATEYTPSIDLWSIGCVF 232

>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 65/230 (28%), Positives = 106/230 (46%), Gaps = 27/230 (11%)
Query: 22  LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATL----KLLKHPNVV 77
           LG G +G V+  + + SG   AVK     RI     + + KR +  L    + +  P  V
Sbjct: 42  LGRGAYGVVEKXRHVPSGQIXAVK-----RIRATVNSQEQKRLLXDLDISXRTVDCPFTV 96
Query: 78  RLHEVLASKSKIYMVLEY--VTGGELFDKIASKGR-LQEAEGRKLFQQLIDGVSYCHNK- 133
             +  L  +  +++  E    +  + + ++  KG+ + E    K+   ++  + + H+K 
Sbjct: 97  TFYGALFREGDVWICXELXDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKL 156
Query: 134 GVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEV----LA 189
            V HRD+K  N+L+++ G +K  DFG+S    +  DD       G   Y APE     L 
Sbjct: 157 SVIHRDVKPSNVLINALGQVKXCDFGISG---YLVDDVAKDIDAGCKPYXAPERINPELN 213
Query: 190 NRGYDGATSDIWSCGVI---LYIFRGDFKLPKWLSPGAQNLLRKILEPNP 236
            +GY    SDIWS G+    L I R  F    W +P  Q L + + EP+P
Sbjct: 214 QKGY-SVKSDIWSLGITXIELAILR--FPYDSWGTP-FQQLKQVVEEPSP 259

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 54/196 (27%), Positives = 92/196 (46%), Gaps = 10/196 (5%)
Query: 20  RTLGEGNFGKVKFAQDLDSG---LPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNV 76
           R +G+G+FG V   + +D     +  A+K L  +RI  ++  +   RE   ++ L HPNV
Sbjct: 27  RVIGKGHFGVVYHGEYIDQAQNRIQCAIKSL--SRITEMQQVEAFLREGLLMRGLNHPNV 84
Query: 77  VRLHEVLASKSKI-YMVLEYVTGGELFDKIASKGRLQEAEGRKLF-QQLIDGVSYCHNKG 134
           + L  ++     + +++L Y+  G+L   I S  R    +    F  Q+  G+ Y   + 
Sbjct: 85  LALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQK 144
Query: 135 VFHRDLKLENILLDSKGNIKISDFGLS--ALPQHFRDDGLLHTTCGSPNYVAPEVLANRG 192
             HRDL   N +LD    +K++DFGL+   L + +              + A E L    
Sbjct: 145 FVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALESLQTYR 204
Query: 193 YDGATSDIWSCGVILY 208
           +    SD+WS GV+L+
Sbjct: 205 FT-TKSDVWSFGVLLW 219

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 60/215 (27%), Positives = 103/215 (47%), Gaps = 17/215 (7%)
Query: 22  LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHE 81
           LG+G FG+V +    +     A+K L+   +      +   +E   +K L+H  +V+L+ 
Sbjct: 16  LGQGCFGEV-WMGTWNGTTRVAIKTLKPGTMS----PEAFLQEAQVMKKLRHEKLVQLYA 70
Query: 82  VLASKSKIYMVLEYVTGGELFD--KIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRD 139
           V+ S+  I +V EY++ G L D  K  +   L+  +   +  Q+  G++Y       HRD
Sbjct: 71  VV-SEEPIXIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRD 129
Query: 140 LKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP-NYVAPEVLANRGYDGATS 198
           L+  NIL+      K++DFGL+ L +   ++         P  + APE  A  G     S
Sbjct: 130 LRAANILVGENLVCKVADFGLARLIED--NEXTARQGAKFPIKWTAPEA-ALYGRFTIKS 186
Query: 199 DIWSCGVILYIFRGDFKLPKWLSPGAQNLLRKILE 233
           D+WS G++L       ++P    PG  N  R++L+
Sbjct: 187 DVWSFGILLTELTTKGRVP---YPGMVN--REVLD 216

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 100/205 (48%), Gaps = 20/205 (9%)
Query: 17  ELGRTLGEGNFGKVKFAQDLDSGLPFAVKIL----EKNRIIHLKITDQIKREIATLKLLK 72
           E  + +G+G FG V   + +      A+K L     +     ++   + +RE+  +  L 
Sbjct: 22  EYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLN 81
Query: 73  HPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGR-LQEAEGRKLFQQLIDGVSYCH 131
           HPN+V+L+ ++ +  +  MV+E+V  G+L+ ++  K   ++ +   +L   +  G+ Y  
Sbjct: 82  HPNIVKLYGLMHNPPR--MVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQ 139
Query: 132 NKG--VFHRDLKLENILLDSKGN-----IKISDFGLSALPQHFRDDGLLHTTCGSPNYVA 184
           N+   + HRDL+  NI L S         K++DFGLS    H    GLL    G+  ++A
Sbjct: 140 NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVH-SVSGLL----GNFQWMA 194
Query: 185 PEVL-ANRGYDGATSDIWSCGVILY 208
           PE + A        +D +S  +ILY
Sbjct: 195 PETIGAEEESYTEKADTYSFAMILY 219

>pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 60/236 (25%), Positives = 102/236 (43%), Gaps = 37/236 (15%)
Query: 59  DQIKREIATL-KLLKHPN-VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEG 116
           D  + EIA L KL +H + ++RL++   +   IYMV+E     +L   +  K  +   E 
Sbjct: 99  DSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWER 157
Query: 117 RKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTT 176
           +  ++ +++ V   H  G+ H DLK  N L+   G +K+ DFG++   Q      +  + 
Sbjct: 158 KSYWKNMLEAVHTIHQHGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQ 216
Query: 177 CGSPNYVAPEVLANRGYD----------GATSDIWSCGVILY-----------IFRGDFK 215
            G+ NY+ PE + +                 SD+WS G ILY           I     K
Sbjct: 217 VGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISK 276
Query: 216 LPKWLSPGA------------QNLLRKILEPNPVKRITIAGIKADEWFEQDYTPAN 259
           L   + P              Q++L+  L+ +P +RI+I  + A  + +    P N
Sbjct: 277 LHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVN 332

>pdb|2PZI|A Chain A, Crystal Structure Of Protein Kinase Pkng From Mycobacterium Tuberculosis In Complex With Tetrahydrobenzothiophene Ax20017 Length = 681

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 66/252 (26%), Positives = 115/252 (45%), Gaps = 37/252 (14%)
Query: 14  GRYELGRTLGEGNFGKVKFAQDLD-SGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK 72
           G+YE+   +  G  G +  A D + +G P  +K L  +     +     +R+   L  + 
Sbjct: 80  GQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQF--LAEVV 137
Query: 73  HPNVVRLHEVLASKSKI-----YMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGV 127
           HP++V++   +    +      Y+V+EYV G  L  K +   +L  AE      +++  +
Sbjct: 138 HPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSL--KRSKGQKLPVAEAIAYLLEILPAL 195
Query: 128 SYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEV 187
           SY H+ G+ + DLK ENI+L ++  +K+ D G  +    F   G L+   G+P + APE+
Sbjct: 196 SYLHSIGLVYNDLKPENIML-TEEQLKLIDLGAVSRINSF---GYLY---GTPGFQAPEI 248
Query: 188 LANRGYDGATSDIWSCGVILYIFRGDFK----------------LPKWLSPGAQNLLRKI 231
           +  R      +DI++ G  L     D                  L  + S G   LLR+ 
Sbjct: 249 V--RTGPTVATDIYTVGRTLAALTLDLPTRNGRYVDGLPEDDPVLKTYDSYG--RLLRRA 304
Query: 232 LEPNPVKRITIA 243
           ++P+P +R T A
Sbjct: 305 IDPDPRQRFTTA 316

>pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 60/236 (25%), Positives = 102/236 (43%), Gaps = 37/236 (15%)
Query: 59  DQIKREIATL-KLLKHPN-VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEG 116
           D  + EIA L KL +H + ++RL++   +   IYMV+E     +L   +  K  +   E 
Sbjct: 71  DSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWER 129
Query: 117 RKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTT 176
           +  ++ +++ V   H  G+ H DLK  N L+   G +K+ DFG++   Q      +  + 
Sbjct: 130 KSYWKNMLEAVHTIHQHGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQ 188
Query: 177 CGSPNYVAPEVLANRGYD----------GATSDIWSCGVILY-----------IFRGDFK 215
            G+ NY+ PE + +                 SD+WS G ILY           I     K
Sbjct: 189 VGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISK 248
Query: 216 LPKWLSPGA------------QNLLRKILEPNPVKRITIAGIKADEWFEQDYTPAN 259
           L   + P              Q++L+  L+ +P +RI+I  + A  + +    P N
Sbjct: 249 LHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVN 304

>pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 60/236 (25%), Positives = 102/236 (43%), Gaps = 37/236 (15%)
Query: 59  DQIKREIATL-KLLKHPN-VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEG 116
           D  + EIA L KL +H + ++RL++   +   IYMV+E     +L   +  K  +   E 
Sbjct: 99  DSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWER 157
Query: 117 RKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTT 176
           +  ++ +++ V   H  G+ H DLK  N L+   G +K+ DFG++   Q      +  + 
Sbjct: 158 KSYWKNMLEAVHTIHQHGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQ 216
Query: 177 CGSPNYVAPEVLANRGYD----------GATSDIWSCGVILY-----------IFRGDFK 215
            G+ NY+ PE + +                 SD+WS G ILY           I     K
Sbjct: 217 VGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISK 276
Query: 216 LPKWLSPGA------------QNLLRKILEPNPVKRITIAGIKADEWFEQDYTPAN 259
           L   + P              Q++L+  L+ +P +RI+I  + A  + +    P N
Sbjct: 277 LHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVN 332

>pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 60/236 (25%), Positives = 102/236 (43%), Gaps = 37/236 (15%)
Query: 59  DQIKREIATL-KLLKHPN-VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEG 116
           D  + EIA L KL +H + ++RL++   +   IYMV+E     +L   +  K  +   E 
Sbjct: 52  DSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWER 110
Query: 117 RKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTT 176
           +  ++ +++ V   H  G+ H DLK  N L+   G +K+ DFG++   Q      +  + 
Sbjct: 111 KSYWKNMLEAVHTIHQHGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQ 169
Query: 177 CGSPNYVAPEVLANRGYD----------GATSDIWSCGVILY-----------IFRGDFK 215
            G+ NY+ PE + +                 SD+WS G ILY           I     K
Sbjct: 170 VGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISK 229
Query: 216 LPKWLSPGA------------QNLLRKILEPNPVKRITIAGIKADEWFEQDYTPAN 259
           L   + P              Q++L+  L+ +P +RI+I  + A  + +    P N
Sbjct: 230 LHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVN 285

>pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 60/236 (25%), Positives = 102/236 (43%), Gaps = 37/236 (15%)
Query: 59  DQIKREIATL-KLLKHPN-VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEG 116
           D  + EIA L KL +H + ++RL++   +   IYMV+E     +L   +  K  +   E 
Sbjct: 99  DSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWER 157
Query: 117 RKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTT 176
           +  ++ +++ V   H  G+ H DLK  N L+   G +K+ DFG++   Q      +  + 
Sbjct: 158 KSYWKNMLEAVHTIHQHGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQ 216
Query: 177 CGSPNYVAPEVLANRGYD----------GATSDIWSCGVILY-----------IFRGDFK 215
            G+ NY+ PE + +                 SD+WS G ILY           I     K
Sbjct: 217 VGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISK 276
Query: 216 LPKWLSPGA------------QNLLRKILEPNPVKRITIAGIKADEWFEQDYTPAN 259
           L   + P              Q++L+  L+ +P +RI+I  + A  + +    P N
Sbjct: 277 LHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVN 332

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 56/198 (28%), Positives = 93/198 (46%), Gaps = 17/198 (8%)
Query: 20  RTLGEGNFGKVKFAQDLDSG----LPFAVKILE--KNRIIHLKITDQIKREIATLKLLKH 73
           + LG G FG V     +  G    +P  +K++E    R     +TD +      +  L H
Sbjct: 37  KVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHM----LAIGSLDH 92
Query: 74  PNVVRLHEVLASKSKIYMVLEYVTGGELFDKI-ASKGRLQEAEGRKLFQQLIDGVSYCHN 132
            ++VRL   L   S + +V +Y+  G L D +   +G L          Q+  G+ Y   
Sbjct: 93  AHIVRLLG-LCPGSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEE 151
Query: 133 KGVFHRDLKLENILLDSKGNIKISDFGLS-ALPQHFRDDGLLHTTCGSP-NYVAPEVLAN 190
            G+ HR+L   N+LL S   ++++DFG++  LP    D  LL++   +P  ++A E +  
Sbjct: 152 HGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPD--DKQLLYSEAKTPIKWMALESIHF 209
Query: 191 RGYDGATSDIWSCGVILY 208
             Y    SD+WS GV ++
Sbjct: 210 GKYT-HQSDVWSYGVTVW 226

>pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 60/236 (25%), Positives = 102/236 (43%), Gaps = 37/236 (15%)
Query: 59  DQIKREIATL-KLLKHPN-VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEG 116
           D  + EIA L KL +H + ++RL++   +   IYMV+E     +L   +  K  +   E 
Sbjct: 51  DSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWER 109
Query: 117 RKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTT 176
           +  ++ +++ V   H  G+ H DLK  N L+   G +K+ DFG++   Q      +  + 
Sbjct: 110 KSYWKNMLEAVHTIHQHGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQ 168
Query: 177 CGSPNYVAPEVLANRGYD----------GATSDIWSCGVILY-----------IFRGDFK 215
            G+ NY+ PE + +                 SD+WS G ILY           I     K
Sbjct: 169 VGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISK 228
Query: 216 LPKWLSPGA------------QNLLRKILEPNPVKRITIAGIKADEWFEQDYTPAN 259
           L   + P              Q++L+  L+ +P +RI+I  + A  + +    P N
Sbjct: 229 LHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVN 284

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 64/232 (27%), Positives = 98/232 (42%), Gaps = 54/232 (23%)
Query: 17  ELGRTLGEGNFGKVKFA-----QDLDSGLPFAVKILEKNRIIHLKITDQIKRE--IATLK 69
           E G+ LG G FGKV  A           +  AVK+L++         D  +RE  ++ LK
Sbjct: 48  EFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEK-------ADSSEREALMSELK 100
Query: 70  LL----KHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASK--------------GRL 111
           ++     H N+V L         IY++ EY   G+L + + SK               RL
Sbjct: 101 MMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRL 160
Query: 112 QEAEGRKLFQ---------QLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSA 162
           +E E   +           Q+  G+ +   K   HRDL   N+L+     +KI DFGL+ 
Sbjct: 161 EEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLA- 219
Query: 163 LPQHFRD-----DGLLHTTCGSP-NYVAPEVLANRGYDGATSDIWSCGVILY 208
                RD     + ++      P  ++APE L   G     SD+WS G++L+
Sbjct: 220 -----RDIMSDSNYVVRGNARLPVKWMAPESLF-EGIYTIKSDVWSYGILLW 265

>pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 60/236 (25%), Positives = 102/236 (43%), Gaps = 37/236 (15%)
Query: 59  DQIKREIATL-KLLKHPN-VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEG 116
           D  + EIA L KL +H + ++RL++   +   IYMV+E     +L   +  K  +   E 
Sbjct: 55  DSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWER 113
Query: 117 RKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTT 176
           +  ++ +++ V   H  G+ H DLK  N L+   G +K+ DFG++   Q      +  + 
Sbjct: 114 KSYWKNMLEAVHTIHQHGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQ 172
Query: 177 CGSPNYVAPEVLANRGYD----------GATSDIWSCGVILY-----------IFRGDFK 215
            G+ NY+ PE + +                 SD+WS G ILY           I     K
Sbjct: 173 VGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISK 232
Query: 216 LPKWLSPGA------------QNLLRKILEPNPVKRITIAGIKADEWFEQDYTPAN 259
           L   + P              Q++L+  L+ +P +RI+I  + A  + +    P N
Sbjct: 233 LHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVN 288

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 56/198 (28%), Positives = 93/198 (46%), Gaps = 17/198 (8%)
Query: 20  RTLGEGNFGKVKFAQDLDSG----LPFAVKILE--KNRIIHLKITDQIKREIATLKLLKH 73
           + LG G FG V     +  G    +P  +K++E    R     +TD +      +  L H
Sbjct: 19  KVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHM----LAIGSLDH 74
Query: 74  PNVVRLHEVLASKSKIYMVLEYVTGGELFDKI-ASKGRLQEAEGRKLFQQLIDGVSYCHN 132
            ++VRL   L   S + +V +Y+  G L D +   +G L          Q+  G+ Y   
Sbjct: 75  AHIVRLLG-LCPGSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEE 133
Query: 133 KGVFHRDLKLENILLDSKGNIKISDFGLS-ALPQHFRDDGLLHTTCGSP-NYVAPEVLAN 190
            G+ HR+L   N+LL S   ++++DFG++  LP    D  LL++   +P  ++A E +  
Sbjct: 134 HGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPD--DKQLLYSEAKTPIKWMALESIHF 191
Query: 191 RGYDGATSDIWSCGVILY 208
             Y    SD+WS GV ++
Sbjct: 192 GKYT-HQSDVWSYGVTVW 208

>pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 64/228 (28%), Positives = 100/228 (43%), Gaps = 33/228 (14%)
Query: 1   MVIAEKKQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITD- 59
           MVI + K        Y   + LGEG F  V   + L  G  +A+K     RI+  +  D 
Sbjct: 23  MVIIDNKH-------YLFIQKLGEGGFSYVDLVEGLHDGHFYALK-----RILCHEQQDR 70
Query: 60  -QIKREIATLKLLKHPNVVRLHEVL----ASKSKIYMVLEYVTGGELFDKI---ASKGR- 110
            + +RE    +L  HPN++RL         +K + +++L +   G L+++I     KG  
Sbjct: 71  EEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNF 130
Query: 111 LQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFG--------LSA 162
           L E +   L   +  G+   H KG  HRDLK  NILL  +G   + D G        +  
Sbjct: 131 LTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEG 190
Query: 163 LPQHFRDDGLLHTTCGSPNYVAPEVLANRGYD--GATSDIWSCGVILY 208
             Q           C + +Y APE+ + + +      +D+WS G +LY
Sbjct: 191 SRQALTLQDWAAQRC-TISYRAPELFSVQSHCVIDERTDVWSLGCVLY 237

>pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 60/236 (25%), Positives = 102/236 (43%), Gaps = 37/236 (15%)
Query: 59  DQIKREIATL-KLLKHPN-VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEG 116
           D  + EIA L KL +H + ++RL++   +   IYMV+E     +L   +  K  +   E 
Sbjct: 71  DSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWER 129
Query: 117 RKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTT 176
           +  ++ +++ V   H  G+ H DLK  N L+   G +K+ DFG++   Q      +  + 
Sbjct: 130 KSYWKNMLEAVHTIHQHGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDXXXVVKDSQ 188
Query: 177 CGSPNYVAPEVLANRGYD----------GATSDIWSCGVILY-----------IFRGDFK 215
            G+ NY+ PE + +                 SD+WS G ILY           I     K
Sbjct: 189 VGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISK 248
Query: 216 LPKWLSPGA------------QNLLRKILEPNPVKRITIAGIKADEWFEQDYTPAN 259
           L   + P              Q++L+  L+ +P +RI+I  + A  + +    P N
Sbjct: 249 LHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVN 304

>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 61/221 (27%), Positives = 94/221 (42%), Gaps = 33/221 (14%)
Query: 15  RYELGRTLGEGNFGKVKFAQDL-----DSGLPFAVKILEKNRIIHLKITDQIKREIATLK 69
           R   G+TLG G FGKV  A        D+ +  AVK+L+ +   HL   + +  E+  L 
Sbjct: 40  RLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA--HLTEREALMSELKVLS 97
Query: 70  LL-KHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASK------------------GR 110
            L  H N+V L           ++ EY   G+L + +  K                    
Sbjct: 98  YLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELA 157
Query: 111 LQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD 170
           L   +      Q+  G+++  +K   HRDL   NILL      KI DFGL+   +  ++D
Sbjct: 158 LDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLA---RDIKND 214
Query: 171 G--LLHTTCGSP-NYVAPEVLANRGYDGATSDIWSCGVILY 208
              ++      P  ++APE + N  Y    SD+WS G+ L+
Sbjct: 215 SNYVVKGNARLPVKWMAPESIFNCVYT-FESDVWSYGIFLW 254

>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 61/221 (27%), Positives = 94/221 (42%), Gaps = 33/221 (14%)
Query: 15  RYELGRTLGEGNFGKVKFAQDL-----DSGLPFAVKILEKNRIIHLKITDQIKREIATLK 69
           R   G+TLG G FGKV  A        D+ +  AVK+L+ +   HL   + +  E+  L 
Sbjct: 42  RLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA--HLTEREALMSELKVLS 99
Query: 70  LL-KHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASK------------------GR 110
            L  H N+V L           ++ EY   G+L + +  K                    
Sbjct: 100 YLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELA 159
Query: 111 LQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD 170
           L   +      Q+  G+++  +K   HRDL   NILL      KI DFGL+   +  ++D
Sbjct: 160 LDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLA---RDIKND 216
Query: 171 G--LLHTTCGSP-NYVAPEVLANRGYDGATSDIWSCGVILY 208
              ++      P  ++APE + N  Y    SD+WS G+ L+
Sbjct: 217 SNYVVKGNARLPVKWMAPESIFNCVYT-FESDVWSYGIFLW 256

>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 61/221 (27%), Positives = 94/221 (42%), Gaps = 33/221 (14%)
Query: 15  RYELGRTLGEGNFGKVKFAQDL-----DSGLPFAVKILEKNRIIHLKITDQIKREIATLK 69
           R   G+TLG G FGKV  A        D+ +  AVK+L+ +   HL   + +  E+  L 
Sbjct: 47  RLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA--HLTEREALMSELKVLS 104
Query: 70  LL-KHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASK------------------GR 110
            L  H N+V L           ++ EY   G+L + +  K                    
Sbjct: 105 YLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELA 164
Query: 111 LQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD 170
           L   +      Q+  G+++  +K   HRDL   NILL      KI DFGL+   +  ++D
Sbjct: 165 LDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLA---RDIKND 221
Query: 171 G--LLHTTCGSP-NYVAPEVLANRGYDGATSDIWSCGVILY 208
              ++      P  ++APE + N  Y    SD+WS G+ L+
Sbjct: 222 SNYVVKGNARLPVKWMAPESIFNCVYT-FESDVWSYGIFLW 261

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/224 (26%), Positives = 99/224 (44%), Gaps = 38/224 (16%)
Query: 17  ELGRTLGEGNFGKVKFAQDL-----DSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL 71
           + G+TLG G FGKV  A        D+ L  AVK+L+     H    + +  E+  +  L
Sbjct: 34  QFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTA--HADEKEALMSELKIMSHL 91
Query: 72  -KHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGR---------------LQEAE 115
            +H N+V L         + ++ EY   G+L + +  K                 L + +
Sbjct: 92  GQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEAMLGPSLAPGQDPEGLDKED 151
Query: 116 GRKL--------FQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHF 167
           GR L          Q+  G+++  +K   HRD+   N+LL +    KI DFGL+   +  
Sbjct: 152 GRPLELRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLA---RDI 208
Query: 168 RDDG--LLHTTCGSP-NYVAPEVLANRGYDGATSDIWSCGVILY 208
            +D   ++      P  ++APE + +  Y    SD+WS G++L+
Sbjct: 209 MNDSNYIVKGNARLPVKWMAPESIFDCVYT-VQSDVWSYGILLW 251

>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 61/221 (27%), Positives = 94/221 (42%), Gaps = 33/221 (14%)
Query: 15  RYELGRTLGEGNFGKVKFAQDL-----DSGLPFAVKILEKNRIIHLKITDQIKREIATLK 69
           R   G+TLG G FGKV  A        D+ +  AVK+L+ +   HL   + +  E+  L 
Sbjct: 24  RLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA--HLTEREALMSELKVLS 81
Query: 70  LL-KHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASK------------------GR 110
            L  H N+V L           ++ EY   G+L + +  K                    
Sbjct: 82  YLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELA 141
Query: 111 LQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD 170
           L   +      Q+  G+++  +K   HRDL   NILL      KI DFGL+   +  ++D
Sbjct: 142 LDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLA---RDIKND 198
Query: 171 G--LLHTTCGSP-NYVAPEVLANRGYDGATSDIWSCGVILY 208
              ++      P  ++APE + N  Y    SD+WS G+ L+
Sbjct: 199 SNYVVKGNARLPVKWMAPESIFNCVYT-FESDVWSYGIFLW 238

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 55/205 (26%), Positives = 99/205 (48%), Gaps = 20/205 (9%)
Query: 17  ELGRTLGEGNFGKVKFAQDLDSGLPFAVKIL----EKNRIIHLKITDQIKREIATLKLLK 72
           E  + +G+G FG V   + +      A+K L     +     ++   + +RE+  +  L 
Sbjct: 22  EYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLN 81
Query: 73  HPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGR-LQEAEGRKLFQQLIDGVSYCH 131
           HPN+V+L+ ++ +  +  MV+E+V  G+L+ ++  K   ++ +   +L   +  G+ Y  
Sbjct: 82  HPNIVKLYGLMHNPPR--MVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQ 139
Query: 132 NKG--VFHRDLKLENILLDSKGN-----IKISDFGLSALPQHFRDDGLLHTTCGSPNYVA 184
           N+   + HRDL+  NI L S         K++DFG S    H    GLL    G+  ++A
Sbjct: 140 NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGTSQQSVH-SVSGLL----GNFQWMA 194
Query: 185 PEVL-ANRGYDGATSDIWSCGVILY 208
           PE + A        +D +S  +ILY
Sbjct: 195 PETIGAEEESYTEKADTYSFAMILY 219

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 56/202 (27%), Positives = 94/202 (46%), Gaps = 25/202 (12%)
Query: 20  RTLGEGNFGKVKFAQDLDSG----LPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
           + LG G FG V     +  G    +P A+KIL  N     K   +   E   +  + HP+
Sbjct: 44  KVLGSGAFGTVYKGIWVPEGETVKIPVAIKIL--NETTGPKANVEFMDEALIMASMDHPH 101
Query: 76  VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLF----QQLIDGVSYCH 131
           +VRL  V  S + I +V + +  G L + +      ++  G +L      Q+  G+ Y  
Sbjct: 102 LVRLLGVCLSPT-IQLVTQLMPHGCLLEYVHEH---KDNIGSQLLLNWCVQIAKGMMYLE 157
Query: 132 NKGVFHRDLKLENILLDSKGNIKISDFGLSAL-----PQHFRDDGLLHTTCGSPNYVAPE 186
            + + HRDL   N+L+ S  ++KI+DFGL+ L      ++  D G +        ++A E
Sbjct: 158 ERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPI-----KWMALE 212
Query: 187 VLANRGYDGATSDIWSCGVILY 208
            +  R +    SD+WS GV ++
Sbjct: 213 CIHYRKFT-HQSDVWSYGVTIW 233

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 55/205 (26%), Positives = 99/205 (48%), Gaps = 20/205 (9%)
Query: 17  ELGRTLGEGNFGKVKFAQDLDSGLPFAVKIL----EKNRIIHLKITDQIKREIATLKLLK 72
           E  + +G+G FG V   + +      A+K L     +     ++   + +RE+  +  L 
Sbjct: 22  EYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLN 81
Query: 73  HPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGR-LQEAEGRKLFQQLIDGVSYCH 131
           HPN+V+L+ ++ +  +  MV+E+V  G+L+ ++  K   ++ +   +L   +  G+ Y  
Sbjct: 82  HPNIVKLYGLMHNPPR--MVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQ 139
Query: 132 NKG--VFHRDLKLENILLDSKGN-----IKISDFGLSALPQHFRDDGLLHTTCGSPNYVA 184
           N+   + HRDL+  NI L S         K++DF LS    H    GLL    G+  ++A
Sbjct: 140 NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFSLSQQSVH-SVSGLL----GNFQWMA 194
Query: 185 PEVL-ANRGYDGATSDIWSCGVILY 208
           PE + A        +D +S  +ILY
Sbjct: 195 PETIGAEEESYTEKADTYSFAMILY 219

>pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 67/237 (28%), Positives = 114/237 (48%), Gaps = 44/237 (18%)
Query: 7   KQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIK---- 62
           K E  +  RY L R LG G+F  V  A+D+ +    A+KI+  +++      D+IK    
Sbjct: 12  KGEPYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQR 71
Query: 63  -------REIAT-----LKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGE----LFDKIA 106
                  +E +      LKLL H N    H+     + +++V+ +   GE    L  K  
Sbjct: 72  VNDADNTKEDSMGANHILKLLDHFN----HK---GPNGVHVVMVFEVLGENLLALIKKYE 124
Query: 107 SKGRLQEAEGRKLFQQLIDGVSYCHNK-GVFHRDLKLENILL---DSKGN---IKISDFG 159
            +G +     +++ +QL+ G+ Y H + G+ H D+K EN+L+   DS  N   IKI+D G
Sbjct: 125 HRG-IPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLG 183
Query: 160 LSAL-PQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILY-IFRGDF 214
            +    +H+ +      +  +  Y +PEVL    + G  +DIWS   +++ +  GDF
Sbjct: 184 NACWYDEHYTN------SIQTREYRSPEVLLGAPW-GCGADIWSTACLIFELITGDF 233

>pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 67/237 (28%), Positives = 114/237 (48%), Gaps = 44/237 (18%)
Query: 7   KQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIK---- 62
           K E  +  RY L R LG G+F  V  A+D+ +    A+KI+  +++      D+IK    
Sbjct: 12  KGEPYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQR 71
Query: 63  -------REIAT-----LKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGE----LFDKIA 106
                  +E +      LKLL H N    H+     + +++V+ +   GE    L  K  
Sbjct: 72  VNDADNTKEDSMGANHILKLLDHFN----HK---GPNGVHVVMVFEVLGENLLALIKKYE 124
Query: 107 SKGRLQEAEGRKLFQQLIDGVSYCHNK-GVFHRDLKLENILL---DSKGN---IKISDFG 159
            +G +     +++ +QL+ G+ Y H + G+ H D+K EN+L+   DS  N   IKI+D G
Sbjct: 125 HRG-IPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLG 183
Query: 160 LSAL-PQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILY-IFRGDF 214
            +    +H+ +      +  +  Y +PEVL    + G  +DIWS   +++ +  GDF
Sbjct: 184 NACWYDEHYTN------SIQTREYRSPEVLLGAPW-GCGADIWSTACLIFELITGDF 233

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 56/202 (27%), Positives = 94/202 (46%), Gaps = 25/202 (12%)
Query: 20  RTLGEGNFGKVKFAQDLDSG----LPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
           + LG G FG V     +  G    +P A+KIL  N     K   +   E   +  + HP+
Sbjct: 21  KVLGSGAFGTVYKGIWVPEGETVKIPVAIKIL--NETTGPKANVEFMDEALIMASMDHPH 78
Query: 76  VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLF----QQLIDGVSYCH 131
           +VRL  V  S + I +V + +  G L + +      ++  G +L      Q+  G+ Y  
Sbjct: 79  LVRLLGVCLSPT-IQLVTQLMPHGCLLEYVHEH---KDNIGSQLLLNWCVQIAKGMMYLE 134
Query: 132 NKGVFHRDLKLENILLDSKGNIKISDFGLSAL-----PQHFRDDGLLHTTCGSPNYVAPE 186
            + + HRDL   N+L+ S  ++KI+DFGL+ L      ++  D G +        ++A E
Sbjct: 135 ERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPI-----KWMALE 189
Query: 187 VLANRGYDGATSDIWSCGVILY 208
            +  R +    SD+WS GV ++
Sbjct: 190 CIHYRKFT-HQSDVWSYGVTIW 210

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 102/211 (48%), Gaps = 28/211 (13%)
Query: 18  LGRTLGEGNFGKVK--FAQDLDSG---LPFAVKILEKNRIIHLKITDQIKREIATLKLLK 72
           L R LG+G+FG V    A+D+  G      AVK + ++  +  +I  +   E + +K   
Sbjct: 21  LLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERI--EFLNEASVMKGFT 78
Query: 73  HPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIAS-KGRLQEAEGR---------KLFQQ 122
             +VVRL  V++      +V+E +  G+L   + S +   +   GR         ++  +
Sbjct: 79  CHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAE 138
Query: 123 LIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLS---ALPQHFRD--DGLLHTTC 177
           + DG++Y + K   HRDL   N ++     +KI DFG++       ++R    GLL    
Sbjct: 139 IADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETAYYRKGGKGLLPV-- 196
Query: 178 GSPNYVAPEVLANRGYDGATSDIWSCGVILY 208
               ++APE L + G    +SD+WS GV+L+
Sbjct: 197 ---RWMAPESLKD-GVFTTSSDMWSFGVVLW 223

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 102/211 (48%), Gaps = 28/211 (13%)
Query: 18  LGRTLGEGNFGKVK--FAQDLDSG---LPFAVKILEKNRIIHLKITDQIKREIATLKLLK 72
           L R LG+G+FG V    A+D+  G      AVK + ++  +  +I  +   E + +K   
Sbjct: 21  LLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERI--EFLNEASVMKGFT 78
Query: 73  HPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIAS-KGRLQEAEGR---------KLFQQ 122
             +VVRL  V++      +V+E +  G+L   + S +   +   GR         ++  +
Sbjct: 79  CHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAE 138
Query: 123 LIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLS---ALPQHFRD--DGLLHTTC 177
           + DG++Y + K   HRDL   N ++     +KI DFG++       ++R    GLL    
Sbjct: 139 IADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPV-- 196
Query: 178 GSPNYVAPEVLANRGYDGATSDIWSCGVILY 208
               ++APE L + G    +SD+WS GV+L+
Sbjct: 197 ---RWMAPESLKD-GVFTTSSDMWSFGVVLW 223

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 57/217 (26%), Positives = 97/217 (44%), Gaps = 31/217 (14%)
Query: 17  ELGRTLGEGNFGKVKFAQDL-----DSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL 71
           + G+TLG G FGKV  A        D+ L  AVK+L+     H    + +  E+  +  L
Sbjct: 49  QFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKST--AHADEKEALMSELKIMSHL 106
Query: 72  -KHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKI-------------ASKGRLQEAEGR 117
            +H N+V L         + ++ EY   G+L + +              S    ++   R
Sbjct: 107 GQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKRPPGLEYSYNPSHNPEEQLSSR 166
Query: 118 KLFQ---QLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDG--L 172
            L     Q+  G+++  +K   HRD+   N+LL +    KI DFGL+   +   +D   +
Sbjct: 167 DLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLA---RDIMNDSNYI 223
Query: 173 LHTTCGSP-NYVAPEVLANRGYDGATSDIWSCGVILY 208
           +      P  ++APE + +  Y    SD+WS G++L+
Sbjct: 224 VKGNARLPVKWMAPESIFDCVYT-VQSDVWSYGILLW 259

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 86/208 (41%), Gaps = 27/208 (12%)
Query: 21  TLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATL-KLLKHPNVVRL 79
            +GEGNFG+V  A+    GL     I                 E+  L KL  HPN++ L
Sbjct: 22  VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINL 81
Query: 80  HEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLF----------QQLID---- 125
                 +  +Y+ +EY   G L D +  K R+ E +               QQL+     
Sbjct: 82  LGACEHRGYLYLAIEYAPHGNLLDFL-RKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 140
Query: 126 ---GVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGS--P 180
              G+ Y   K   HRDL   NIL+      KI+DFGLS   + +     +  T G    
Sbjct: 141 VARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVY-----VKKTMGRLPV 195
Query: 181 NYVAPEVLANRGYDGATSDIWSCGVILY 208
            ++A E L N       SD+WS GV+L+
Sbjct: 196 RWMAIESL-NYSVYTTNSDVWSYGVLLW 222

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 102/211 (48%), Gaps = 28/211 (13%)
Query: 18  LGRTLGEGNFGKV--KFAQDLDSG---LPFAVKILEKNRIIHLKITDQIKREIATLKLLK 72
           L R LG+G+FG V    A+D+  G      AVK + ++  +  +I  +   E + +K   
Sbjct: 20  LLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERI--EFLNEASVMKGFT 77
Query: 73  HPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIAS-KGRLQEAEGR---------KLFQQ 122
             +VVRL  V++      +V+E +  G+L   + S +   +   GR         ++  +
Sbjct: 78  CHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAE 137
Query: 123 LIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSA---LPQHFRD--DGLLHTTC 177
           + DG++Y + K   HRDL   N ++     +KI DFG++       ++R    GLL    
Sbjct: 138 IADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPV-- 195
Query: 178 GSPNYVAPEVLANRGYDGATSDIWSCGVILY 208
               ++APE L + G    +SD+WS GV+L+
Sbjct: 196 ---RWMAPESLKD-GVFTTSSDMWSFGVVLW 222

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 86/208 (41%), Gaps = 27/208 (12%)
Query: 21  TLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATL-KLLKHPNVVRL 79
            +GEGNFG+V  A+    GL     I                 E+  L KL  HPN++ L
Sbjct: 32  VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINL 91
Query: 80  HEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLF----------QQLID---- 125
                 +  +Y+ +EY   G L D +  K R+ E +               QQL+     
Sbjct: 92  LGACEHRGYLYLAIEYAPHGNLLDFL-RKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 150
Query: 126 ---GVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGS--P 180
              G+ Y   K   HRDL   NIL+      KI+DFGLS   + +     +  T G    
Sbjct: 151 VARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVY-----VKKTMGRLPV 205
Query: 181 NYVAPEVLANRGYDGATSDIWSCGVILY 208
            ++A E L N       SD+WS GV+L+
Sbjct: 206 RWMAIESL-NYSVYTTNSDVWSYGVLLW 232

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 88/208 (42%), Gaps = 26/208 (12%)
Query: 22  LGEGNFGKVKFAQDLDSGLPFAVKILEKNRII---HLKITDQIKREIATLKLLKHPNVVR 78
           LGEG FGKV F  +  + LP   K+L   + +           +RE   L +L+H ++VR
Sbjct: 20  LGEGAFGKV-FLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVR 78
Query: 79  LHEVLASKSKIYMVLEYVTGGELFDKIASK---------------GRLQEAEGRKLFQQL 123
              V      + MV EY+  G+L   + S                G L   +   +  Q+
Sbjct: 79  FFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQV 138
Query: 124 IDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLS---ALPQHFRDDGLLHTTCGSP 180
             G+ Y       HRDL   N L+     +KI DFG+S       ++R  G    T    
Sbjct: 139 AAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGG---RTMLPI 195
Query: 181 NYVAPEVLANRGYDGATSDIWSCGVILY 208
            ++ PE +  R +    SD+WS GV+L+
Sbjct: 196 RWMPPESILYRKFT-TESDVWSFGVVLW 222

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 88/208 (42%), Gaps = 26/208 (12%)
Query: 22  LGEGNFGKVKFAQDLDSGLPFAVKILEKNRII---HLKITDQIKREIATLKLLKHPNVVR 78
           LGEG FGKV F  +  + LP   K+L   + +           +RE   L +L+H ++VR
Sbjct: 49  LGEGAFGKV-FLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVR 107
Query: 79  LHEVLASKSKIYMVLEYVTGGELFDKIASK---------------GRLQEAEGRKLFQQL 123
              V      + MV EY+  G+L   + S                G L   +   +  Q+
Sbjct: 108 FFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQV 167
Query: 124 IDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLS---ALPQHFRDDGLLHTTCGSP 180
             G+ Y       HRDL   N L+     +KI DFG+S       ++R  G    T    
Sbjct: 168 AAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGG---RTMLPI 224
Query: 181 NYVAPEVLANRGYDGATSDIWSCGVILY 208
            ++ PE +  R +    SD+WS GV+L+
Sbjct: 225 RWMPPESILYRKFT-TESDVWSFGVVLW 251

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 88/208 (42%), Gaps = 26/208 (12%)
Query: 22  LGEGNFGKVKFAQDLDSGLPFAVKILEKNRII---HLKITDQIKREIATLKLLKHPNVVR 78
           LGEG FGKV F  +  + LP   K+L   + +           +RE   L +L+H ++VR
Sbjct: 26  LGEGAFGKV-FLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVR 84
Query: 79  LHEVLASKSKIYMVLEYVTGGELFDKIASK---------------GRLQEAEGRKLFQQL 123
              V      + MV EY+  G+L   + S                G L   +   +  Q+
Sbjct: 85  FFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQV 144
Query: 124 IDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLS---ALPQHFRDDGLLHTTCGSP 180
             G+ Y       HRDL   N L+     +KI DFG+S       ++R  G    T    
Sbjct: 145 AAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGG---RTMLPI 201
Query: 181 NYVAPEVLANRGYDGATSDIWSCGVILY 208
            ++ PE +  R +    SD+WS GV+L+
Sbjct: 202 RWMPPESILYRKFT-TESDVWSFGVVLW 228

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 50/197 (25%), Positives = 93/197 (47%), Gaps = 13/197 (6%)
Query: 18  LGRTLGEGNFGKVK---FAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
           L R LGEG FG+V    +       +  AVK  +K+  +  K  ++   E   +K L HP
Sbjct: 28  LNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNK--EKFMSEAVIMKNLDHP 85
Query: 75  NVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQ-QLIDGVSYCHNK 133
           ++V+L  ++  +   ++++E    GEL   +       +     L+  Q+   ++Y  + 
Sbjct: 86  HIVKLIGIIEEEPT-WIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESI 144
Query: 134 GVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGS--PNYVAPEVLANR 191
              HRD+ + NIL+ S   +K+ DFGLS   ++  D+     +       +++PE +  R
Sbjct: 145 NCVHRDIAVRNILVASPECVKLGDFGLS---RYIEDEDYYKASVTRLPIKWMSPESINFR 201
Query: 192 GYDGATSDIWSCGVILY 208
            +  A SD+W   V ++
Sbjct: 202 RFTTA-SDVWMFAVCMW 217

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 50/197 (25%), Positives = 93/197 (47%), Gaps = 13/197 (6%)
Query: 18  LGRTLGEGNFGKVK---FAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
           L R LGEG FG+V    +       +  AVK  +K+  +  K  ++   E   +K L HP
Sbjct: 12  LNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNK--EKFMSEAVIMKNLDHP 69
Query: 75  NVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQ-QLIDGVSYCHNK 133
           ++V+L  ++  +   ++++E    GEL   +       +     L+  Q+   ++Y  + 
Sbjct: 70  HIVKLIGIIEEEPT-WIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESI 128
Query: 134 GVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGS--PNYVAPEVLANR 191
              HRD+ + NIL+ S   +K+ DFGLS   ++  D+     +       +++PE +  R
Sbjct: 129 NCVHRDIAVRNILVASPECVKLGDFGLS---RYIEDEDYYKASVTRLPIKWMSPESINFR 185
Query: 192 GYDGATSDIWSCGVILY 208
            +  A SD+W   V ++
Sbjct: 186 RFTTA-SDVWMFAVCMW 201

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 50/197 (25%), Positives = 93/197 (47%), Gaps = 13/197 (6%)
Query: 18  LGRTLGEGNFGKVK---FAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
           L R LGEG FG+V    +       +  AVK  +K+  +  K  ++   E   +K L HP
Sbjct: 16  LNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNK--EKFMSEAVIMKNLDHP 73
Query: 75  NVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQ-QLIDGVSYCHNK 133
           ++V+L  ++  +   ++++E    GEL   +       +     L+  Q+   ++Y  + 
Sbjct: 74  HIVKLIGIIEEEPT-WIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESI 132
Query: 134 GVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGS--PNYVAPEVLANR 191
              HRD+ + NIL+ S   +K+ DFGLS   ++  D+     +       +++PE +  R
Sbjct: 133 NCVHRDIAVRNILVASPECVKLGDFGLS---RYIEDEDYYKASVTRLPIKWMSPESINFR 189
Query: 192 GYDGATSDIWSCGVILY 208
            +  A SD+W   V ++
Sbjct: 190 RFTTA-SDVWMFAVCMW 205

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 55/200 (27%), Positives = 91/200 (45%), Gaps = 27/200 (13%)
Query: 22  LGEGNFGKVKFAQDLDSGLPFAVKIL------EKNRIIHLKITDQIKREIATLKLLKHPN 75
           +G G  G+V   +   +G   AVK +      E+N+ I + +          LK    P 
Sbjct: 33  MGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLD-------VVLKSHDCPY 85
Query: 76  VVRLHEVLASKSKIYMVLEYVTGGELFDKIASK--GRLQEAEGRKLFQQLIDGVSYCHNK 133
           +V+      + + +++ +E +  G   +K+  +  G + E    K+   ++  + Y   K
Sbjct: 86  IVQCFGTFITNTDVFIAMELM--GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEK 143
Query: 134 -GVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVL---- 188
            GV HRD+K  NILLD +G IK+ DFG+S       DD     + G   Y+APE +    
Sbjct: 144 HGVIHRDVKPSNILLDERGQIKLCDFGISG---RLVDDKAKDRSAGCAAYMAPERIDPPD 200
Query: 189 -ANRGYDGATSDIWSCGVIL 207
                YD   +D+WS G+ L
Sbjct: 201 PTKPDYD-IRADVWSLGISL 219

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 60/217 (27%), Positives = 101/217 (46%), Gaps = 40/217 (18%)
Query: 18  LGRTLGEGNFGKVK--FAQDLDSG---LPFAVKILEKNRIIHLKITDQIKREIATLKLLK 72
           L R LG+G+FG V    A+D+  G      AVK + ++  +  +I  +   E + +K   
Sbjct: 21  LLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERI--EFLNEASVMKGFT 78
Query: 73  HPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIAS-KGRLQEAEGR---------KLFQQ 122
             +VVRL  V++      +V+E +  G+L   + S +   +   GR         ++  +
Sbjct: 79  CHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAE 138
Query: 123 LIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD-----------DG 171
           + DG++Y + K   HRDL   N ++     +KI DFG++      RD            G
Sbjct: 139 IADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMT------RDIXETDXXRKGGKG 192
Query: 172 LLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILY 208
           LL        ++APE L + G    +SD+WS GV+L+
Sbjct: 193 LLPV-----RWMAPESLKD-GVFTTSSDMWSFGVVLW 223

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 60/217 (27%), Positives = 101/217 (46%), Gaps = 40/217 (18%)
Query: 18  LGRTLGEGNFGKVK--FAQDLDSG---LPFAVKILEKNRIIHLKITDQIKREIATLKLLK 72
           L R LG+G+FG V    A+D+  G      AVK + ++  +  +I  +   E + +K   
Sbjct: 21  LLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERI--EFLNEASVMKGFT 78
Query: 73  HPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIAS-KGRLQEAEGR---------KLFQQ 122
             +VVRL  V++      +V+E +  G+L   + S +   +   GR         ++  +
Sbjct: 79  CHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAE 138
Query: 123 LIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD-----------DG 171
           + DG++Y + K   HRDL   N ++     +KI DFG++      RD            G
Sbjct: 139 IADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMT------RDIXETDXXRKGGKG 192
Query: 172 LLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILY 208
           LL        ++APE L + G    +SD+WS GV+L+
Sbjct: 193 LLPV-----RWMAPESLKD-GVFTTSSDMWSFGVVLW 223

>pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 71/279 (25%), Positives = 115/279 (41%), Gaps = 58/279 (20%)
Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVK----ILEKNRIIHLK----ITDQIKREIAT 67
           Y + R +  G++G V    D   G+P A+K     +   R +++     +  ++ REI  
Sbjct: 24  YTVQRFISSGSYGAVCAGVD-SEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRL 82
Query: 68  LKLLKHPNVVRLHEVLA-----SKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQ- 121
           L    HPN++ L ++       +  K+Y+V E +   +L   I  +  +   +  + F  
Sbjct: 83  LNHFHHPNILGLRDIFVHFEEPAMHKLYLVTE-LMRTDLAQVIHDQRIVISPQHIQYFMY 141
Query: 122 QLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPN 181
            ++ G+   H  GV HRDL   NILL    +I I DF L+      R+D          +
Sbjct: 142 HILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNLA------REDT---ADANKTH 192
Query: 182 YV------APE-VLANRGYDGATSDIWSCGVIL-------YIFRGD------------FK 215
           YV      APE V+  +G+     D+WS G ++        +FRG               
Sbjct: 193 YVTHRWYRAPELVMQFKGFTKLV-DMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVG 251
Query: 216 LPK------WLSPGAQNLLRKILEPNPVKRITIAGIKAD 248
            PK      + SP A++ LR  L   P +  T     AD
Sbjct: 252 TPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTAD 290

>pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 71/279 (25%), Positives = 115/279 (41%), Gaps = 58/279 (20%)
Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVK----ILEKNRIIHLK----ITDQIKREIAT 67
           Y + R +  G++G V    D   G+P A+K     +   R +++     +  ++ REI  
Sbjct: 24  YTVQRFISSGSYGAVCAGVD-SEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRL 82
Query: 68  LKLLKHPNVVRLHEVLA-----SKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQ- 121
           L    HPN++ L ++       +  K+Y+V E +   +L   I  +  +   +  + F  
Sbjct: 83  LNHFHHPNILGLRDIFVHFEEPAMHKLYLVTE-LMRTDLAQVIHDQRIVISPQHIQYFMY 141
Query: 122 QLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPN 181
            ++ G+   H  GV HRDL   NILL    +I I DF L+      R+D          +
Sbjct: 142 HILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNLA------REDT---ADANKTH 192
Query: 182 YV------APE-VLANRGYDGATSDIWSCGVIL-------YIFRGD------------FK 215
           YV      APE V+  +G+     D+WS G ++        +FRG               
Sbjct: 193 YVTHRWYRAPELVMQFKGFTKLV-DMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVG 251
Query: 216 LPK------WLSPGAQNLLRKILEPNPVKRITIAGIKAD 248
            PK      + SP A++ LR  L   P +  T     AD
Sbjct: 252 TPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTAD 290

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 60/217 (27%), Positives = 101/217 (46%), Gaps = 40/217 (18%)
Query: 18  LGRTLGEGNFGKV--KFAQDLDSG---LPFAVKILEKNRIIHLKITDQIKREIATLKLLK 72
           L R LG+G+FG V    A+D+  G      AVK + ++  +  +I  +   E + +K   
Sbjct: 18  LLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERI--EFLNEASVMKGFT 75
Query: 73  HPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIAS-KGRLQEAEGR---------KLFQQ 122
             +VVRL  V++      +V+E +  G+L   + S +   +   GR         ++  +
Sbjct: 76  CHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAE 135
Query: 123 LIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD-----------DG 171
           + DG++Y + K   HRDL   N ++     +KI DFG++      RD            G
Sbjct: 136 IADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMT------RDIXETDXXRKGGKG 189
Query: 172 LLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILY 208
           LL        ++APE L + G    +SD+WS GV+L+
Sbjct: 190 LLPV-----RWMAPESLKD-GVFTTSSDMWSFGVVLW 220

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 102/211 (48%), Gaps = 28/211 (13%)
Query: 18  LGRTLGEGNFGKVK--FAQDLDSG---LPFAVKILEKNRIIHLKITDQIKREIATLKLLK 72
           L R LG+G+FG V    A+D+  G      AVK + ++  +  +I  +   E + +K   
Sbjct: 22  LLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERI--EFLNEASVMKGFT 79
Query: 73  HPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIAS-KGRLQEAEGR---------KLFQQ 122
             +VVRL  V++      +V+E +  G+L   + S +   +   GR         ++  +
Sbjct: 80  CHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAE 139
Query: 123 LIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLS---ALPQHFRD--DGLLHTTC 177
           + DG++Y + K   HR+L   N ++     +KI DFG++       ++R    GLL    
Sbjct: 140 IADGMAYLNAKKFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPV-- 197
Query: 178 GSPNYVAPEVLANRGYDGATSDIWSCGVILY 208
               ++APE L + G    +SD+WS GV+L+
Sbjct: 198 ---RWMAPESLKD-GVFTTSSDMWSFGVVLW 224

>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 102/211 (48%), Gaps = 28/211 (13%)
Query: 18  LGRTLGEGNFGKVK--FAQDLDSG---LPFAVKILEKNRIIHLKITDQIKREIATLKLLK 72
           L R LG+G+FG V    A+D+  G      AVK + ++  +  +I  +   E + +K   
Sbjct: 21  LLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERI--EFLNEASVMKGFT 78
Query: 73  HPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIAS-KGRLQEAEGR---------KLFQQ 122
             +VVRL  V++      +V+E +  G+L   + S +   +   GR         ++  +
Sbjct: 79  CHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAE 138
Query: 123 LIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLS---ALPQHFRD--DGLLHTTC 177
           + DG++Y + K   HR+L   N ++     +KI DFG++       ++R    GLL    
Sbjct: 139 IADGMAYLNAKKFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPV-- 196
Query: 178 GSPNYVAPEVLANRGYDGATSDIWSCGVILY 208
               ++APE L + G    +SD+WS GV+L+
Sbjct: 197 ---RWMAPESLKD-GVFTTSSDMWSFGVVLW 223

>pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 76/282 (26%), Positives = 117/282 (41%), Gaps = 69/282 (24%)
Query: 20  RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK----HPN 75
           + LG G+ G V F      G P AVK +         + D     +  +KLL     HPN
Sbjct: 39  KILGYGSSGTVVFQGSF-QGRPVAVKRM---------LIDFCDIALMEIKLLTESDDHPN 88
Query: 76  VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKG------RLQ-EAEGRKLFQQLIDGVS 128
           V+R +    +   +Y+ LE +    L D + SK       +LQ E     L +Q+  GV+
Sbjct: 89  VIRYYCSETTDRFLYIALE-LCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVA 147
Query: 129 YCHNKGVFHRDLKLENILLDSKG-------------NIKISDFGLS----ALPQHFRDDG 171
           + H+  + HRDLK +NIL+ +                I ISDFGL     +    FR + 
Sbjct: 148 HLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXFRXN- 206
Query: 172 LLHTTCGSPNYVAPEVLANRGYDGATS--DIWSCGVILY-------------------IF 210
            L+   G+  + APE+L        T   DI+S G + Y                   I 
Sbjct: 207 -LNNPSGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRESNII 265
Query: 211 RGDFKL-------PKWLSPGAQNLLRKILEPNPVKRITIAGI 245
           RG F L        + L   A +L+ ++++ +P+KR T   +
Sbjct: 266 RGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKV 307

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 86/208 (41%), Gaps = 27/208 (12%)
Query: 21  TLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATL-KLLKHPNVVRL 79
            +GEGNFG+V  A+    GL     I                 E+  L KL  HPN++ L
Sbjct: 29  VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINL 88
Query: 80  HEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLF----------QQLID---- 125
                 +  +Y+ +EY   G L D +  K R+ E +               QQL+     
Sbjct: 89  LGACEHRGYLYLAIEYAPHGNLLDFL-RKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 147
Query: 126 ---GVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGS--P 180
              G+ Y   K   HR+L   NIL+      KI+DFGLS   + +     +  T G    
Sbjct: 148 VARGMDYLSQKQFIHRNLAARNILVGENYVAKIADFGLSRGQEVY-----VKKTMGRLPV 202
Query: 181 NYVAPEVLANRGYDGATSDIWSCGVILY 208
            ++A E L N       SD+WS GV+L+
Sbjct: 203 RWMAIESL-NYSVYTTNSDVWSYGVLLW 229

>pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 76/282 (26%), Positives = 117/282 (41%), Gaps = 69/282 (24%)
Query: 20  RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK----HPN 75
           + LG G+ G V F      G P AVK +         + D     +  +KLL     HPN
Sbjct: 39  KILGYGSSGTVVFQGSF-QGRPVAVKRM---------LIDFCDIALMEIKLLTESDDHPN 88
Query: 76  VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKG------RLQ-EAEGRKLFQQLIDGVS 128
           V+R +    +   +Y+ LE +    L D + SK       +LQ E     L +Q+  GV+
Sbjct: 89  VIRYYCSETTDRFLYIALE-LCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVA 147
Query: 129 YCHNKGVFHRDLKLENILLDSKG-------------NIKISDFGLS----ALPQHFRDDG 171
           + H+  + HRDLK +NIL+ +                I ISDFGL     +    FR + 
Sbjct: 148 HLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXFRXN- 206
Query: 172 LLHTTCGSPNYVAPEVLANRGYDGATS--DIWSCGVILY-------------------IF 210
            L+   G+  + APE+L        T   DI+S G + Y                   I 
Sbjct: 207 -LNNPSGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRESNII 265
Query: 211 RGDFKL-------PKWLSPGAQNLLRKILEPNPVKRITIAGI 245
           RG F L        + L   A +L+ ++++ +P+KR T   +
Sbjct: 266 RGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKV 307

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 47/190 (24%), Positives = 82/190 (43%), Gaps = 18/190 (9%)
Query: 68  LKLLKHPNVVRLHEVLASKSKIYMVLEYVTGG----ELFDKIASKGRLQEAEGRKLFQQL 123
           L   +HP++V L      ++++ ++ +Y+  G     L+        +   +  ++    
Sbjct: 89  LSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGA 148
Query: 124 IDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYV 183
             G+ Y H + + HRD+K  NILLD     KI+DFG+S          L     G+  Y+
Sbjct: 149 ARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLXXVVKGTLGYI 208
Query: 184 APEVLANRGYDGATSDIWSCGVILY------------IFRGDFKLPKWLSPGAQN-LLRK 230
            PE    +G     SD++S GV+L+            + R    L +W      N  L +
Sbjct: 209 DPEYFI-KGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQ 267
Query: 231 ILEPNPVKRI 240
           I++PN   +I
Sbjct: 268 IVDPNLADKI 277

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 51/196 (26%), Positives = 92/196 (46%), Gaps = 13/196 (6%)
Query: 20  RTLGEGNFGKVKFAQDLDSG----LPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
           + LG G FG V     +  G    +P A+K  E       K   +I  E   +  + +P+
Sbjct: 22  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIK--ELREATSPKANKEILDEAYVMASVDNPH 79
Query: 76  VVRLHEVLASKSKIYMVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKG 134
           V RL  +  + S + ++++ +  G L D +   K  +          Q+  G++Y  ++ 
Sbjct: 80  VCRLLGICLT-STVQLIMQLMPFGXLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR 138
Query: 135 VFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP--NYVAPEVLANRG 192
           + HRDL   N+L+ +  ++KI+DFGL+ L     ++   H   G     ++A E + +R 
Sbjct: 139 LVHRDLAARNVLVKTPQHVKITDFGLAKLLG--AEEKEYHAEGGKVPIKWMALESILHRI 196
Query: 193 YDGATSDIWSCGVILY 208
           Y    SD+WS GV ++
Sbjct: 197 YT-HQSDVWSYGVTVW 211

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 47/190 (24%), Positives = 82/190 (43%), Gaps = 18/190 (9%)
Query: 68  LKLLKHPNVVRLHEVLASKSKIYMVLEYVTGG----ELFDKIASKGRLQEAEGRKLFQQL 123
           L   +HP++V L      ++++ ++ +Y+  G     L+        +   +  ++    
Sbjct: 89  LSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGA 148
Query: 124 IDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYV 183
             G+ Y H + + HRD+K  NILLD     KI+DFG+S          L     G+  Y+
Sbjct: 149 ARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKKGTELGQTHLXXVVKGTLGYI 208
Query: 184 APEVLANRGYDGATSDIWSCGVILY------------IFRGDFKLPKWLSPGAQN-LLRK 230
            PE    +G     SD++S GV+L+            + R    L +W      N  L +
Sbjct: 209 DPEYFI-KGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQ 267
Query: 231 ILEPNPVKRI 240
           I++PN   +I
Sbjct: 268 IVDPNLADKI 277

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 51/196 (26%), Positives = 92/196 (46%), Gaps = 13/196 (6%)
Query: 20  RTLGEGNFGKVKFAQDLDSG----LPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
           + LG G FG V     +  G    +P A+K  E       K   +I  E   +  + +P+
Sbjct: 25  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIK--ELREATSPKANKEILDEAYVMASVDNPH 82
Query: 76  VVRLHEVLASKSKIYMVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKG 134
           V RL  +  + S + ++++ +  G L D +   K  +          Q+  G++Y  ++ 
Sbjct: 83  VCRLLGICLT-STVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR 141
Query: 135 VFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP--NYVAPEVLANRG 192
           + HRDL   N+L+ +  ++KI+DFGL+ L     ++   H   G     ++A E + +R 
Sbjct: 142 LVHRDLAARNVLVKTPQHVKITDFGLAKLLG--AEEKEYHAEGGKVPIKWMALESILHRI 199
Query: 193 YDGATSDIWSCGVILY 208
           Y    SD+WS GV ++
Sbjct: 200 YT-HQSDVWSYGVTVW 214

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 95/209 (45%), Gaps = 24/209 (11%)
Query: 18  LGRTLGEGNFGKVK--FAQDLDSGLPFA-VKILEKNRIIHLKITDQIKREIATLKLLKHP 74
           + R LG+G+FG V    A+ +    P   V I   N    ++   +   E + +K     
Sbjct: 29  MSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCH 88
Query: 75  NVVRLHEVLASKSKIYMVLEYVTGGELFD-------KIASKGRLQEAEGRKLFQ---QLI 124
           +VVRL  V++      +++E +T G+L          +A+   L      K+ Q   ++ 
Sbjct: 89  HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIA 148
Query: 125 DGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLS---ALPQHFRD--DGLLHTTCGS 179
           DG++Y +     HRDL   N ++     +KI DFG++       ++R    GLL      
Sbjct: 149 DGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPV---- 204
Query: 180 PNYVAPEVLANRGYDGATSDIWSCGVILY 208
             +++PE L + G     SD+WS GV+L+
Sbjct: 205 -RWMSPESLKD-GVFTTYSDVWSFGVVLW 231

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 51/196 (26%), Positives = 92/196 (46%), Gaps = 13/196 (6%)
Query: 20  RTLGEGNFGKVKFAQDLDSG----LPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
           + LG G FG V     +  G    +P A+K  E       K   +I  E   +  + +P+
Sbjct: 23  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIK--ELREATSPKANKEILDEAYVMASVDNPH 80
Query: 76  VVRLHEVLASKSKIYMVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKG 134
           V RL  +  + S + ++++ +  G L D +   K  +          Q+  G++Y  ++ 
Sbjct: 81  VCRLLGICLT-STVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR 139
Query: 135 VFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP--NYVAPEVLANRG 192
           + HRDL   N+L+ +  ++KI+DFGL+ L     ++   H   G     ++A E + +R 
Sbjct: 140 LVHRDLAARNVLVKTPQHVKITDFGLAKLLG--AEEKEYHAEGGKVPIKWMALESILHRI 197
Query: 193 YDGATSDIWSCGVILY 208
           Y    SD+WS GV ++
Sbjct: 198 YT-HQSDVWSYGVTVW 212

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 51/196 (26%), Positives = 92/196 (46%), Gaps = 13/196 (6%)
Query: 20  RTLGEGNFGKVKFAQDLDSG----LPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
           + LG G FG V     +  G    +P A+K  E       K   +I  E   +  + +P+
Sbjct: 21  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIK--ELREATSPKANKEILDEAYVMASVDNPH 78
Query: 76  VVRLHEVLASKSKIYMVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKG 134
           V RL  +  + S + ++++ +  G L D +   K  +          Q+  G++Y  ++ 
Sbjct: 79  VCRLLGICLT-STVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR 137
Query: 135 VFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP--NYVAPEVLANRG 192
           + HRDL   N+L+ +  ++KI+DFGL+ L     ++   H   G     ++A E + +R 
Sbjct: 138 LVHRDLAARNVLVKTPQHVKITDFGLAKLLG--AEEKEYHAEGGKVPIKWMALESILHRI 195
Query: 193 YDGATSDIWSCGVILY 208
           Y    SD+WS GV ++
Sbjct: 196 YT-HQSDVWSYGVTVW 210

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 50/194 (25%), Positives = 90/194 (46%), Gaps = 9/194 (4%)
Query: 20  RTLGEGNFGKVKFAQDLDSG--LPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVV 77
           + LG G FG V     +  G  +   V I+E       K   +I  E   +  + +P+V 
Sbjct: 55  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIMELREATSPKANKEILDEAYVMASVDNPHVC 114
Query: 78  RLHEVLASKSKIYMVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVF 136
           RL  +  + S + ++ + +  G L D +   K  +          Q+  G++Y  ++ + 
Sbjct: 115 RLLGICLT-STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLV 173
Query: 137 HRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP--NYVAPEVLANRGYD 194
           HRDL   N+L+ +  ++KI+DFGL+ L     ++   H   G     ++A E + +R Y 
Sbjct: 174 HRDLAARNVLVKTPQHVKITDFGLAKLLGA--EEKEYHAEGGKVPIKWMALESILHRIYT 231
Query: 195 GATSDIWSCGVILY 208
              SD+WS GV ++
Sbjct: 232 -HQSDVWSYGVTVW 244

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 51/196 (26%), Positives = 92/196 (46%), Gaps = 13/196 (6%)
Query: 20  RTLGEGNFGKVKFAQDLDSG----LPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
           + LG G FG V     +  G    +P A+K  E       K   +I  E   +  + +P+
Sbjct: 22  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIK--ELREATSPKANKEILDEAYVMASVDNPH 79
Query: 76  VVRLHEVLASKSKIYMVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKG 134
           V RL  +  + S + ++++ +  G L D +   K  +          Q+  G++Y  ++ 
Sbjct: 80  VCRLLGICLT-STVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR 138
Query: 135 VFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP--NYVAPEVLANRG 192
           + HRDL   N+L+ +  ++KI+DFGL+ L     ++   H   G     ++A E + +R 
Sbjct: 139 LVHRDLAARNVLVKTPQHVKITDFGLAKLLG--AEEKEYHAEGGKVPIKWMALESILHRI 196
Query: 193 YDGATSDIWSCGVILY 208
           Y    SD+WS GV ++
Sbjct: 197 YT-HQSDVWSYGVTVW 211

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 51/196 (26%), Positives = 92/196 (46%), Gaps = 13/196 (6%)
Query: 20  RTLGEGNFGKVKFAQDLDSG----LPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
           + LG G FG V     +  G    +P A+K  E       K   +I  E   +  + +P+
Sbjct: 24  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIK--ELREATSPKANKEILDEAYVMASVDNPH 81
Query: 76  VVRLHEVLASKSKIYMVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKG 134
           V RL  +  + S + ++++ +  G L D +   K  +          Q+  G++Y  ++ 
Sbjct: 82  VCRLLGICLT-STVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR 140
Query: 135 VFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP--NYVAPEVLANRG 192
           + HRDL   N+L+ +  ++KI+DFGL+ L     ++   H   G     ++A E + +R 
Sbjct: 141 LVHRDLAARNVLVKTPQHVKITDFGLAKLLG--AEEKEYHAEGGKVPIKWMALESILHRI 198
Query: 193 YDGATSDIWSCGVILY 208
           Y    SD+WS GV ++
Sbjct: 199 YT-HQSDVWSYGVTVW 213

>pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 75/286 (26%), Positives = 118/286 (41%), Gaps = 73/286 (25%)
Query: 20  RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK----HPN 75
           + LG G+ G V F      G P AVK +         + D     +  +KLL     HPN
Sbjct: 21  KILGYGSSGTVVFQGSF-QGRPVAVKRM---------LIDFCDIALMEIKLLTESDDHPN 70
Query: 76  VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKG------RLQ-EAEGRKLFQQLIDGVS 128
           V+R +    +   +Y+ LE +    L D + SK       +LQ E     L +Q+  GV+
Sbjct: 71  VIRYYCSETTDRFLYIALE-LCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVA 129
Query: 129 YCHNKGVFHRDLKLENILLDSKG-------------NIKISDFGLS----ALPQHFRDDG 171
           + H+  + HRDLK +NIL+ +                I ISDFGL     +    FR + 
Sbjct: 130 HLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTN- 188
Query: 172 LLHTTCGSPNYVAPEV------LANRGYDGATSDIWSCGVILY----------------- 208
            L+   G+  + APE+      L  +     + DI+S G + Y                 
Sbjct: 189 -LNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE 247
Query: 209 --IFRGDFKL-------PKWLSPGAQNLLRKILEPNPVKRITIAGI 245
             I RG F L        + L   A +L+ ++++ +P+KR T   +
Sbjct: 248 SNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKV 293

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 95/209 (45%), Gaps = 24/209 (11%)
Query: 18  LGRTLGEGNFGKVK--FAQDLDSGLPFA-VKILEKNRIIHLKITDQIKREIATLKLLKHP 74
           + R LG+G+FG V    A+ +    P   V I   N    ++   +   E + +K     
Sbjct: 19  MSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCH 78
Query: 75  NVVRLHEVLASKSKIYMVLEYVTGGELFD-------KIASKGRLQEAEGRKLFQ---QLI 124
           +VVRL  V++      +++E +T G+L          +A+   L      K+ Q   ++ 
Sbjct: 79  HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIA 138
Query: 125 DGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLS---ALPQHFRD--DGLLHTTCGS 179
           DG++Y +     HRDL   N ++     +KI DFG++       ++R    GLL      
Sbjct: 139 DGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPV---- 194
Query: 180 PNYVAPEVLANRGYDGATSDIWSCGVILY 208
             +++PE L + G     SD+WS GV+L+
Sbjct: 195 -RWMSPESLKD-GVFTTYSDVWSFGVVLW 221

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 51/196 (26%), Positives = 92/196 (46%), Gaps = 13/196 (6%)
Query: 20  RTLGEGNFGKVKFAQDLDSG----LPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
           + LG G FG V     +  G    +P A+K  E       K   +I  E   +  + +P+
Sbjct: 18  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIK--ELREATSPKANKEILDEAYVMASVDNPH 75
Query: 76  VVRLHEVLASKSKIYMVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKG 134
           V RL  +  + S + ++ + +  G L D +   K  +          Q+ +G++Y  ++ 
Sbjct: 76  VCRLLGICLT-STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAEGMNYLEDRR 134
Query: 135 VFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP--NYVAPEVLANRG 192
           + HRDL   N+L+ +  ++KI+DFGL+ L     ++   H   G     ++A E + +R 
Sbjct: 135 LVHRDLAARNVLVKTPQHVKITDFGLAKLLG--AEEKEYHAEGGKVPIKWMALESILHRI 192
Query: 193 YDGATSDIWSCGVILY 208
           Y    SD+WS GV ++
Sbjct: 193 YT-HQSDVWSYGVTVW 207

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 51/196 (26%), Positives = 91/196 (46%), Gaps = 13/196 (6%)
Query: 20  RTLGEGNFGKVKFAQDLDSG----LPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
           + LG G FG V     +  G    +P A+K  E       K   +I  E   +  + +P+
Sbjct: 21  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIK--ELREATSPKANKEILDEAYVMASVDNPH 78
Query: 76  VVRLHEVLASKSKIYMVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKG 134
           V RL  +  + S + ++ + +  G L D +   K  +          Q+  G++Y  ++ 
Sbjct: 79  VCRLLGICLT-STVQLITQLMPFGXLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR 137
Query: 135 VFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP--NYVAPEVLANRG 192
           + HRDL   N+L+ +  ++KI+DFGL+ L     ++   H   G     ++A E + +R 
Sbjct: 138 LVHRDLAARNVLVKTPQHVKITDFGLAKLLG--AEEKEYHAEGGKVPIKWMALESILHRI 195
Query: 193 YDGATSDIWSCGVILY 208
           Y    SD+WS GV ++
Sbjct: 196 YT-HQSDVWSYGVTVW 210

>pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 75/286 (26%), Positives = 118/286 (41%), Gaps = 73/286 (25%)
Query: 20  RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK----HPN 75
           + LG G+ G V F      G P AVK +         + D     +  +KLL     HPN
Sbjct: 21  KILGYGSSGTVVFQGSF-QGRPVAVKRM---------LIDFCDIALMEIKLLTESDDHPN 70
Query: 76  VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKG------RLQ-EAEGRKLFQQLIDGVS 128
           V+R +    +   +Y+ LE +    L D + SK       +LQ E     L +Q+  GV+
Sbjct: 71  VIRYYCSETTDRFLYIALE-LCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVA 129
Query: 129 YCHNKGVFHRDLKLENILLDSKG-------------NIKISDFGLS----ALPQHFRDDG 171
           + H+  + HRDLK +NIL+ +                I ISDFGL     +    FR + 
Sbjct: 130 HLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXFRXN- 188
Query: 172 LLHTTCGSPNYVAPEV------LANRGYDGATSDIWSCGVILY----------------- 208
            L+   G+  + APE+      L  +     + DI+S G + Y                 
Sbjct: 189 -LNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE 247
Query: 209 --IFRGDFKLPKW-------LSPGAQNLLRKILEPNPVKRITIAGI 245
             I RG F L +        L   A +L+ ++++ +P+KR T   +
Sbjct: 248 SNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKV 293

>pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 98/208 (47%), Gaps = 25/208 (12%)
Query: 13  LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL- 71
           + RYE+   +G+G+FG+V  A D       A+KI++  +       +Q + E+  L+L+ 
Sbjct: 53  MDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKK----AFLNQAQIEVRLLELMN 108
Query: 72  KHPN-----VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKG--RLQEAEGRKLFQQLI 124
           KH       +V L      ++ + +V E ++   L+D + +     +     RK  QQ+ 
Sbjct: 109 KHDTEMKYYIVHLKRHFMFRNHLCLVFEMLSYN-LYDLLRNTNFRGVSLNLTRKFAQQMC 167
Query: 125 DGVSYCHNK--GVFHRDLKLENILLDS--KGNIKISDFGLSA-LPQHFRDDGLLHTTCGS 179
             + +       + H DLK ENILL +  +  IKI DFG S  L Q       ++    S
Sbjct: 168 TALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQR------IYQXIQS 221
Query: 180 PNYVAPEVLANRGYDGATSDIWSCGVIL 207
             Y +PEVL    YD A  D+WS G IL
Sbjct: 222 RFYRSPEVLLGMPYDLAI-DMWSLGCIL 248

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 63/223 (28%), Positives = 96/223 (43%), Gaps = 42/223 (18%)
Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKIT------DQIKREIATL 68
           R  LG+ LG G FG+V  A        F +      R + +K+        + +  ++ L
Sbjct: 28  RLNLGKPLGRGAFGQVIEAD------AFGIDKTATXRTVAVKMLKEGATHSEHRALMSEL 81
Query: 69  KLL----KHPNVVRLHEVLASKSKIYMVL-EYVTGGELFDKIASKGRLQEAEGRKLFQ-- 121
           K+L     H NVV L           MV+ E+   G L   + SK R +    + L++  
Sbjct: 82  KILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSK-RNEFVPYKDLYKDF 140
Query: 122 -----------QLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLS----ALPQH 166
                      Q+  G+ +  ++   HRDL   NILL  K  +KI DFGL+      P +
Sbjct: 141 LTLEHLICYSFQVAKGMEFLASRKXIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY 200
Query: 167 FRD-DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILY 208
            R  D  L        ++APE + +R Y    SD+WS GV+L+
Sbjct: 201 VRKGDARLPL-----KWMAPETIFDRVYT-IQSDVWSFGVLLW 237

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 62/220 (28%), Positives = 97/220 (44%), Gaps = 36/220 (16%)
Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKIT------DQIKREIATL 68
           R  LG+ LG G FG+V  A        F +      R + +K+        + +  ++ L
Sbjct: 28  RLNLGKPLGRGAFGQVIEAD------AFGIDKTATXRTVAVKMLKEGATHSEHRALMSEL 81
Query: 69  KLL----KHPNVVRLHEVLASKSKIYMVL-EYVTGGELFDKIASKGRLQEAEGRKLFQ-- 121
           K+L     H NVV L           MV+ E+   G L   + SK R +    + L++  
Sbjct: 82  KILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSK-RNEFVPYKDLYKDF 140
Query: 122 -----------QLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD- 169
                      Q+  G+ +  ++   HRDL   NILL  K  +KI DFGL+     ++D 
Sbjct: 141 LTLEHLIXYSFQVAKGMEFLASRKXIHRDLAARNILLSEKNVVKIXDFGLAR--DIYKDP 198
Query: 170 DGLLHTTCGSP-NYVAPEVLANRGYDGATSDIWSCGVILY 208
           D +       P  ++APE + +R Y    SD+WS GV+L+
Sbjct: 199 DYVRKGDARLPLKWMAPETIFDRVYT-IQSDVWSFGVLLW 237

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 51/196 (26%), Positives = 91/196 (46%), Gaps = 13/196 (6%)
Query: 20  RTLGEGNFGKVKFAQDLDSG----LPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
           + LG G FG V     +  G    +P A+K  E       K   +I  E   +  + +P+
Sbjct: 24  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIK--ELREATSPKANKEILDEAYVMASVDNPH 81
Query: 76  VVRLHEVLASKSKIYMVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKG 134
           V RL  +  + S + ++ + +  G L D +   K  +          Q+  G++Y  ++ 
Sbjct: 82  VCRLLGICLT-STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR 140
Query: 135 VFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP--NYVAPEVLANRG 192
           + HRDL   N+L+ +  ++KI+DFGL+ L     ++   H   G     ++A E + +R 
Sbjct: 141 LVHRDLAARNVLVKTPQHVKITDFGLAKLLG--AEEKEYHAEGGKVPIKWMALESILHRI 198
Query: 193 YDGATSDIWSCGVILY 208
           Y    SD+WS GV ++
Sbjct: 199 YT-HQSDVWSYGVTVW 213

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 51/196 (26%), Positives = 91/196 (46%), Gaps = 13/196 (6%)
Query: 20  RTLGEGNFGKVKFAQDLDSG----LPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
           + LG G FG V     +  G    +P A+K  E       K   +I  E   +  + +P+
Sbjct: 24  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIK--ELREATSPKANKEILDEAYVMASVDNPH 81
Query: 76  VVRLHEVLASKSKIYMVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKG 134
           V RL  +  + S + ++ + +  G L D +   K  +          Q+  G++Y  ++ 
Sbjct: 82  VCRLLGICLT-STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR 140
Query: 135 VFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP--NYVAPEVLANRG 192
           + HRDL   N+L+ +  ++KI+DFGL+ L     ++   H   G     ++A E + +R 
Sbjct: 141 LVHRDLAARNVLVKTPQHVKITDFGLAKLLG--AEEKEYHAEGGKVPIKWMALESILHRI 198
Query: 193 YDGATSDIWSCGVILY 208
           Y    SD+WS GV ++
Sbjct: 199 YT-HQSDVWSYGVTVW 213

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 51/196 (26%), Positives = 91/196 (46%), Gaps = 13/196 (6%)
Query: 20  RTLGEGNFGKVKFAQDLDSG----LPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
           + LG G FG V     +  G    +P A+K  E       K   +I  E   +  + +P+
Sbjct: 23  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIK--ELREATSPKANKEILDEAYVMASVDNPH 80
Query: 76  VVRLHEVLASKSKIYMVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKG 134
           V RL  +  + S + ++ + +  G L D +   K  +          Q+  G++Y  ++ 
Sbjct: 81  VCRLLGICLT-STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR 139
Query: 135 VFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP--NYVAPEVLANRG 192
           + HRDL   N+L+ +  ++KI+DFGL+ L     ++   H   G     ++A E + +R 
Sbjct: 140 LVHRDLAARNVLVKTPQHVKITDFGLAKLLG--AEEKEYHAEGGKVPIKWMALESILHRI 197
Query: 193 YDGATSDIWSCGVILY 208
           Y    SD+WS GV ++
Sbjct: 198 YT-HQSDVWSYGVTVW 212

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 51/196 (26%), Positives = 91/196 (46%), Gaps = 13/196 (6%)
Query: 20  RTLGEGNFGKVKFAQDLDSG----LPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
           + LG G FG V     +  G    +P A+K  E       K   +I  E   +  + +P+
Sbjct: 31  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIK--ELREATSPKANKEILDEAYVMASVDNPH 88
Query: 76  VVRLHEVLASKSKIYMVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKG 134
           V RL  +  + S + ++ + +  G L D +   K  +          Q+  G++Y  ++ 
Sbjct: 89  VCRLLGICLT-STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR 147
Query: 135 VFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP--NYVAPEVLANRG 192
           + HRDL   N+L+ +  ++KI+DFGL+ L     ++   H   G     ++A E + +R 
Sbjct: 148 LVHRDLAARNVLVKTPQHVKITDFGLAKLLG--AEEKEYHAEGGKVPIKWMALESILHRI 205
Query: 193 YDGATSDIWSCGVILY 208
           Y    SD+WS GV ++
Sbjct: 206 YT-HQSDVWSYGVTVW 220

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 51/196 (26%), Positives = 91/196 (46%), Gaps = 13/196 (6%)
Query: 20  RTLGEGNFGKVKFAQDLDSG----LPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
           + LG G FG V     +  G    +P A+K  E       K   +I  E   +  + +P+
Sbjct: 46  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIK--ELREATSPKANKEILDEAYVMASVDNPH 103
Query: 76  VVRLHEVLASKSKIYMVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKG 134
           V RL  +  + S + ++ + +  G L D +   K  +          Q+  G++Y  ++ 
Sbjct: 104 VCRLLGICLT-STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR 162
Query: 135 VFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP--NYVAPEVLANRG 192
           + HRDL   N+L+ +  ++KI+DFGL+ L     ++   H   G     ++A E + +R 
Sbjct: 163 LVHRDLAARNVLVKTPQHVKITDFGLAKLLG--AEEKEYHAEGGKVPIKWMALESILHRI 220
Query: 193 YDGATSDIWSCGVILY 208
           Y    SD+WS GV ++
Sbjct: 221 YT-HQSDVWSYGVTVW 235

>pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 98/208 (47%), Gaps = 25/208 (12%)
Query: 13  LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL- 71
           + RYE+   +G+G+FG+V  A D       A+KI++  +       +Q + E+  L+L+ 
Sbjct: 34  MDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKK----AFLNQAQIEVRLLELMN 89
Query: 72  KHPN-----VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKG--RLQEAEGRKLFQQLI 124
           KH       +V L      ++ + +V E ++   L+D + +     +     RK  QQ+ 
Sbjct: 90  KHDTEMKYYIVHLKRHFMFRNHLCLVFEMLSYN-LYDLLRNTNFRGVSLNLTRKFAQQMC 148
Query: 125 DGVSYCHNK--GVFHRDLKLENILLDS--KGNIKISDFGLSA-LPQHFRDDGLLHTTCGS 179
             + +       + H DLK ENILL +  +  IKI DFG S  L Q       ++    S
Sbjct: 149 TALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQR------IYQXIQS 202
Query: 180 PNYVAPEVLANRGYDGATSDIWSCGVIL 207
             Y +PEVL    YD A  D+WS G IL
Sbjct: 203 RFYRSPEVLLGMPYDLAI-DMWSLGCIL 229

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 94/209 (44%), Gaps = 24/209 (11%)
Query: 18  LGRTLGEGNFGKVK--FAQDLDSGLPFA-VKILEKNRIIHLKITDQIKREIATLKLLKHP 74
           + R LG+G+FG V    A+ +    P   V I   N    ++   +   E + +K     
Sbjct: 29  MSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCH 88
Query: 75  NVVRLHEVLASKSKIYMVLEYVTGGELFDKIAS-------KGRLQEAEGRKLFQ---QLI 124
           +VVRL  V++      +++E +T G+L   + S          L      K+ Q   ++ 
Sbjct: 89  HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIA 148
Query: 125 DGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLS---ALPQHFRD--DGLLHTTCGS 179
           DG++Y +     HRDL   N ++     +KI DFG++       ++R    GLL      
Sbjct: 149 DGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPV---- 204
Query: 180 PNYVAPEVLANRGYDGATSDIWSCGVILY 208
             +++PE L + G     SD+WS GV+L+
Sbjct: 205 -RWMSPESLKD-GVFTTYSDVWSFGVVLW 231

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 51/196 (26%), Positives = 91/196 (46%), Gaps = 13/196 (6%)
Query: 20  RTLGEGNFGKVKFAQDLDSG----LPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
           + LG G FG V     +  G    +P A+K  E       K   +I  E   +  + +P+
Sbjct: 27  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIK--ELREATSPKANKEILDEAYVMASVDNPH 84
Query: 76  VVRLHEVLASKSKIYMVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKG 134
           V RL  +  + S + ++ + +  G L D +   K  +          Q+  G++Y  ++ 
Sbjct: 85  VCRLLGICLT-STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR 143
Query: 135 VFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP--NYVAPEVLANRG 192
           + HRDL   N+L+ +  ++KI+DFGL+ L     ++   H   G     ++A E + +R 
Sbjct: 144 LVHRDLAARNVLVKTPQHVKITDFGLAKLLG--AEEKEYHAEGGKVPIKWMALESILHRI 201
Query: 193 YDGATSDIWSCGVILY 208
           Y    SD+WS GV ++
Sbjct: 202 YT-HQSDVWSYGVTVW 216

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 51/196 (26%), Positives = 91/196 (46%), Gaps = 13/196 (6%)
Query: 20  RTLGEGNFGKVKFAQDLDSG----LPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
           + LG G FG V     +  G    +P A+K  E       K   +I  E   +  + +P+
Sbjct: 24  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIK--ELREATSPKANKEILDEAYVMASVDNPH 81
Query: 76  VVRLHEVLASKSKIYMVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKG 134
           V RL  +  + S + ++ + +  G L D +   K  +          Q+  G++Y  ++ 
Sbjct: 82  VCRLLGICLT-STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR 140
Query: 135 VFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP--NYVAPEVLANRG 192
           + HRDL   N+L+ +  ++KI+DFGL+ L     ++   H   G     ++A E + +R 
Sbjct: 141 LVHRDLAARNVLVKTPQHVKITDFGLAKLLG--AEEKEYHAEGGKVPIKWMALESILHRI 198
Query: 193 YDGATSDIWSCGVILY 208
           Y    SD+WS GV ++
Sbjct: 199 YT-HQSDVWSYGVTVW 213

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 51/196 (26%), Positives = 91/196 (46%), Gaps = 13/196 (6%)
Query: 20  RTLGEGNFGKVKFAQDLDSG----LPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
           + LG G FG V     +  G    +P A+K  E       K   +I  E   +  + +P+
Sbjct: 28  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIK--ELREATSPKANKEILDEAYVMASVDNPH 85
Query: 76  VVRLHEVLASKSKIYMVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKG 134
           V RL  +  + S + ++ + +  G L D +   K  +          Q+  G++Y  ++ 
Sbjct: 86  VCRLLGICLT-STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR 144
Query: 135 VFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP--NYVAPEVLANRG 192
           + HRDL   N+L+ +  ++KI+DFGL+ L     ++   H   G     ++A E + +R 
Sbjct: 145 LVHRDLAARNVLVKTPQHVKITDFGLAKLLG--AEEKEYHAEGGKVPIKWMALESILHRI 202
Query: 193 YDGATSDIWSCGVILY 208
           Y    SD+WS GV ++
Sbjct: 203 YT-HQSDVWSYGVTVW 217

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 94/209 (44%), Gaps = 24/209 (11%)
Query: 18  LGRTLGEGNFGKVK--FAQDLDSGLPFA-VKILEKNRIIHLKITDQIKREIATLKLLKHP 74
           + R LG+G+FG V    A+ +    P   V I   N    ++   +   E + +K     
Sbjct: 22  MSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCH 81
Query: 75  NVVRLHEVLASKSKIYMVLEYVTGGELFDKIAS-------KGRLQEAEGRKLFQ---QLI 124
           +VVRL  V++      +++E +T G+L   + S          L      K+ Q   ++ 
Sbjct: 82  HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIA 141
Query: 125 DGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLS---ALPQHFRD--DGLLHTTCGS 179
           DG++Y +     HRDL   N ++     +KI DFG++       ++R    GLL      
Sbjct: 142 DGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPV---- 197
Query: 180 PNYVAPEVLANRGYDGATSDIWSCGVILY 208
             +++PE L + G     SD+WS GV+L+
Sbjct: 198 -RWMSPESLKD-GVFTTYSDVWSFGVVLW 224

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 51/196 (26%), Positives = 91/196 (46%), Gaps = 13/196 (6%)
Query: 20  RTLGEGNFGKVKFAQDLDSG----LPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
           + LG G FG V     +  G    +P A+K  E       K   +I  E   +  + +P+
Sbjct: 21  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIK--ELREATSPKANKEILDEAYVMASVDNPH 78
Query: 76  VVRLHEVLASKSKIYMVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKG 134
           V RL  +  + S + ++ + +  G L D +   K  +          Q+  G++Y  ++ 
Sbjct: 79  VCRLLGICLT-STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR 137
Query: 135 VFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP--NYVAPEVLANRG 192
           + HRDL   N+L+ +  ++KI+DFGL+ L     ++   H   G     ++A E + +R 
Sbjct: 138 LVHRDLAARNVLVKTPQHVKITDFGLAKLLG--AEEKEYHAEGGKVPIKWMALESILHRI 195
Query: 193 YDGATSDIWSCGVILY 208
           Y    SD+WS GV ++
Sbjct: 196 YT-HQSDVWSYGVTVW 210

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 94/209 (44%), Gaps = 24/209 (11%)
Query: 18  LGRTLGEGNFGKVK--FAQDLDSGLPFA-VKILEKNRIIHLKITDQIKREIATLKLLKHP 74
           + R LG+G+FG V    A+ +    P   V I   N    ++   +   E + +K     
Sbjct: 20  MSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCH 79
Query: 75  NVVRLHEVLASKSKIYMVLEYVTGGELFDKIAS-------KGRLQEAEGRKLFQ---QLI 124
           +VVRL  V++      +++E +T G+L   + S          L      K+ Q   ++ 
Sbjct: 80  HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIA 139
Query: 125 DGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLS---ALPQHFRD--DGLLHTTCGS 179
           DG++Y +     HRDL   N ++     +KI DFG++       ++R    GLL      
Sbjct: 140 DGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPV---- 195
Query: 180 PNYVAPEVLANRGYDGATSDIWSCGVILY 208
             +++PE L + G     SD+WS GV+L+
Sbjct: 196 -RWMSPESLKD-GVFTTYSDVWSFGVVLW 222

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 51/196 (26%), Positives = 91/196 (46%), Gaps = 13/196 (6%)
Query: 20  RTLGEGNFGKVKFAQDLDSG----LPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
           + LG G FG V     +  G    +P A+K  E       K   +I  E   +  + +P+
Sbjct: 21  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIK--ELREATSPKANKEILDEAYVMASVDNPH 78
Query: 76  VVRLHEVLASKSKIYMVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKG 134
           V RL  +  + S + ++ + +  G L D +   K  +          Q+  G++Y  ++ 
Sbjct: 79  VCRLLGICLT-STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR 137
Query: 135 VFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP--NYVAPEVLANRG 192
           + HRDL   N+L+ +  ++KI+DFGL+ L     ++   H   G     ++A E + +R 
Sbjct: 138 LVHRDLAARNVLVKTPQHVKITDFGLAKLLG--AEEKEYHAEGGKVPIKWMALESILHRI 195
Query: 193 YDGATSDIWSCGVILY 208
           Y    SD+WS GV ++
Sbjct: 196 YT-HQSDVWSYGVTVW 210

>pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 98/208 (47%), Gaps = 25/208 (12%)
Query: 13  LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL- 71
           + RYE+   +G+G+FG+V  A D       A+KI++  +       +Q + E+  L+L+ 
Sbjct: 53  MDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKK----AFLNQAQIEVRLLELMN 108
Query: 72  KHPN-----VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKG--RLQEAEGRKLFQQLI 124
           KH       +V L      ++ + +V E ++   L+D + +     +     RK  QQ+ 
Sbjct: 109 KHDTEMKYYIVHLKRHFMFRNHLCLVFEMLSYN-LYDLLRNTNFRGVSLNLTRKFAQQMC 167
Query: 125 DGVSYCHNK--GVFHRDLKLENILLDS--KGNIKISDFGLSA-LPQHFRDDGLLHTTCGS 179
             + +       + H DLK ENILL +  +  IKI DFG S  L Q       ++    S
Sbjct: 168 TALLFLATPELSIIHCDLKPENILLCNPKRXAIKIVDFGSSCQLGQR------IYQXIQS 221
Query: 180 PNYVAPEVLANRGYDGATSDIWSCGVIL 207
             Y +PEVL    YD A  D+WS G IL
Sbjct: 222 RFYRSPEVLLGMPYDLAI-DMWSLGCIL 248

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 51/196 (26%), Positives = 91/196 (46%), Gaps = 13/196 (6%)
Query: 20  RTLGEGNFGKVKFAQDLDSG----LPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
           + LG G FG V     +  G    +P A+K  E       K   +I  E   +  + +P+
Sbjct: 15  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIK--ELREATSPKANKEILDEAYVMASVDNPH 72
Query: 76  VVRLHEVLASKSKIYMVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKG 134
           V RL  +  + S + ++ + +  G L D +   K  +          Q+  G++Y  ++ 
Sbjct: 73  VCRLLGICLT-STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR 131
Query: 135 VFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP--NYVAPEVLANRG 192
           + HRDL   N+L+ +  ++KI+DFGL+ L     ++   H   G     ++A E + +R 
Sbjct: 132 LVHRDLAARNVLVKTPQHVKITDFGLAKLLG--AEEKEYHAEGGKVPIKWMALESILHRI 189
Query: 193 YDGATSDIWSCGVILY 208
           Y    SD+WS GV ++
Sbjct: 190 YT-HQSDVWSYGVTVW 204

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 94/209 (44%), Gaps = 24/209 (11%)
Query: 18  LGRTLGEGNFGKVK--FAQDLDSGLPFA-VKILEKNRIIHLKITDQIKREIATLKLLKHP 74
           + R LG+G+FG V    A+ +    P   V I   N    ++   +   E + +K     
Sbjct: 16  MSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCH 75
Query: 75  NVVRLHEVLASKSKIYMVLEYVTGGELFDKIAS-------KGRLQEAEGRKLFQ---QLI 124
           +VVRL  V++      +++E +T G+L   + S          L      K+ Q   ++ 
Sbjct: 76  HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIA 135
Query: 125 DGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLS---ALPQHFRD--DGLLHTTCGS 179
           DG++Y +     HRDL   N ++     +KI DFG++       ++R    GLL      
Sbjct: 136 DGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPV---- 191
Query: 180 PNYVAPEVLANRGYDGATSDIWSCGVILY 208
             +++PE L + G     SD+WS GV+L+
Sbjct: 192 -RWMSPESLKD-GVFTTYSDVWSFGVVLW 218

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 94/209 (44%), Gaps = 24/209 (11%)
Query: 18  LGRTLGEGNFGKVK--FAQDLDSGLPFA-VKILEKNRIIHLKITDQIKREIATLKLLKHP 74
           + R LG+G+FG V    A+ +    P   V I   N    ++   +   E + +K     
Sbjct: 22  MSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCH 81
Query: 75  NVVRLHEVLASKSKIYMVLEYVTGGELFDKIAS-------KGRLQEAEGRKLFQ---QLI 124
           +VVRL  V++      +++E +T G+L   + S          L      K+ Q   ++ 
Sbjct: 82  HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIA 141
Query: 125 DGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLS---ALPQHFRD--DGLLHTTCGS 179
           DG++Y +     HRDL   N ++     +KI DFG++       ++R    GLL      
Sbjct: 142 DGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPV---- 197
Query: 180 PNYVAPEVLANRGYDGATSDIWSCGVILY 208
             +++PE L + G     SD+WS GV+L+
Sbjct: 198 -RWMSPESLKD-GVFTTYSDVWSFGVVLW 224

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 94/209 (44%), Gaps = 24/209 (11%)
Query: 18  LGRTLGEGNFGKVK--FAQDLDSGLPFA-VKILEKNRIIHLKITDQIKREIATLKLLKHP 74
           + R LG+G+FG V    A+ +    P   V I   N    ++   +   E + +K     
Sbjct: 23  MSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCH 82
Query: 75  NVVRLHEVLASKSKIYMVLEYVTGGELFDKIAS-------KGRLQEAEGRKLFQ---QLI 124
           +VVRL  V++      +++E +T G+L   + S          L      K+ Q   ++ 
Sbjct: 83  HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIA 142
Query: 125 DGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLS---ALPQHFRD--DGLLHTTCGS 179
           DG++Y +     HRDL   N ++     +KI DFG++       ++R    GLL      
Sbjct: 143 DGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPV---- 198
Query: 180 PNYVAPEVLANRGYDGATSDIWSCGVILY 208
             +++PE L + G     SD+WS GV+L+
Sbjct: 199 -RWMSPESLKD-GVFTTYSDVWSFGVVLW 225

>pdb|3LLT|A Chain A, Crystal Structure Of Pf14_0431, Kinase Domain Length = 360

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 59/232 (25%), Positives = 100/232 (43%), Gaps = 42/232 (18%)
Query: 8   QEGMRLGR-YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIA 66
           ++GM L   + + R +G+G FG+V   Q +D+   +AVK++   +    K T   K E  
Sbjct: 28  KKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIK----KYTRSAKIEAD 83
Query: 67  TLKLLKHPNVVRLHEVLASKSKIY---MVLEYVTGGELFDKIASKGRLQ--EAEGRKLFQ 121
            LK +++ ++   + V      +Y   M L +   G    +I ++        E  KL+ 
Sbjct: 84  ILKKIQNDDINNNNIVKYHGKFMYYDHMCLIFEPLGPSLYEIITRNNYNGFHIEDIKLYC 143
Query: 122 -QLIDGVSYCHNKGVFHRDLKLENILLD-------------------------SKGNIKI 155
            +++  ++Y     + H DLK ENILLD                             IK+
Sbjct: 144 IEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKL 203
Query: 156 SDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVIL 207
            DFG +     +       +   +  Y APEV+ N G+D  +SD+WS G +L
Sbjct: 204 IDFGCATFKSDYHG-----SIINTRQYRAPEVILNLGWD-VSSDMWSFGCVL 249

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 94/209 (44%), Gaps = 24/209 (11%)
Query: 18  LGRTLGEGNFGKVK--FAQDLDSGLPFA-VKILEKNRIIHLKITDQIKREIATLKLLKHP 74
           + R LG+G+FG V    A+ +    P   V I   N    ++   +   E + +K     
Sbjct: 51  MSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCH 110
Query: 75  NVVRLHEVLASKSKIYMVLEYVTGGELFDKIAS-------KGRLQEAEGRKLFQ---QLI 124
           +VVRL  V++      +++E +T G+L   + S          L      K+ Q   ++ 
Sbjct: 111 HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIA 170
Query: 125 DGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLS---ALPQHFRD--DGLLHTTCGS 179
           DG++Y +     HRDL   N ++     +KI DFG++       ++R    GLL      
Sbjct: 171 DGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPV---- 226
Query: 180 PNYVAPEVLANRGYDGATSDIWSCGVILY 208
             +++PE L + G     SD+WS GV+L+
Sbjct: 227 -RWMSPESLKD-GVFTTYSDVWSFGVVLW 253

>pdb|2WTK|B Chain B, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 373

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 59/233 (25%), Positives = 104/233 (44%), Gaps = 22/233 (9%)
Query: 14  GRYELGRTLGEG--NFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL 71
           G YEL   +G+G  +   V  A+   +G    V+ +      +  +T  ++ E+   KL 
Sbjct: 9   GCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVT-FLQGELHVSKLF 67
Query: 72  KHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGR--LQEAEGRKLFQQLIDGVSY 129
            HPN+V       + +++++V  ++  G   D I +     + E     + Q ++  + Y
Sbjct: 68  NHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDY 127
Query: 130 CHNKGVFHRDLKLENILLDSKGNIKISDF--GLSALPQHFRDDGLLHTTCGSPNY----- 182
            H+ G  HR +K  +IL+   G + +S     LS +  H +   ++H     P Y     
Sbjct: 128 IHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMI-SHGQRQRVVH---DFPKYSVKVL 183
Query: 183 --VAPEVLAN--RGYDGATSDIWSCGVILYIFRGDFKLPKWLSPGAQNLLRKI 231
             ++PEVL    +GYD A SDI+S G+       +  +P    P  Q LL K+
Sbjct: 184 PWLSPEVLQQNLQGYD-AKSDIYSVGITACEL-ANGHVPFKDMPATQMLLEKL 234

>pdb|3GNI|B Chain B, Structure Of Strad And Mo25 Length = 389

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 59/233 (25%), Positives = 104/233 (44%), Gaps = 22/233 (9%)
Query: 14  GRYELGRTLGEG--NFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL 71
           G YEL   +G+G  +   V  A+   +G    V+ +      +  +T  ++ E+   KL 
Sbjct: 25  GCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVT-FLQGELHVSKLF 83
Query: 72  KHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGR--LQEAEGRKLFQQLIDGVSY 129
            HPN+V       + +++++V  ++  G   D I +     + E     + Q ++  + Y
Sbjct: 84  NHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDY 143
Query: 130 CHNKGVFHRDLKLENILLDSKGNIKISDF--GLSALPQHFRDDGLLHTTCGSPNY----- 182
            H+ G  HR +K  +IL+   G + +S     LS +  H +   ++H     P Y     
Sbjct: 144 IHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMI-SHGQRQRVVHDF---PKYSVKVL 199
Query: 183 --VAPEVLAN--RGYDGATSDIWSCGVILYIFRGDFKLPKWLSPGAQNLLRKI 231
             ++PEVL    +GYD A SDI+S G+       +  +P    P  Q LL K+
Sbjct: 200 PWLSPEVLQQNLQGYD-AKSDIYSVGITACEL-ANGHVPFKDMPATQMLLEKL 250

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 50/196 (25%), Positives = 91/196 (46%), Gaps = 13/196 (6%)
Query: 20  RTLGEGNFGKVKFAQDLDSG----LPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
           + L  G FG V     +  G    +P A+K  E       K   +I  E   +  + +P+
Sbjct: 28  KVLSSGAFGTVYKGLWIPEGEKVKIPVAIK--ELREATSPKANKEILDEAYVMASVDNPH 85
Query: 76  VVRLHEVLASKSKIYMVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKG 134
           V RL  +  + S + ++++ +  G L D +   K  +          Q+  G++Y  ++ 
Sbjct: 86  VCRLLGICLT-STVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR 144
Query: 135 VFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP--NYVAPEVLANRG 192
           + HRDL   N+L+ +  ++KI+DFGL+ L     ++   H   G     ++A E + +R 
Sbjct: 145 LVHRDLAARNVLVKTPQHVKITDFGLAKLLG--AEEKEYHAEGGKVPIKWMALESILHRI 202
Query: 193 YDGATSDIWSCGVILY 208
           Y    SD+WS GV ++
Sbjct: 203 YT-HQSDVWSYGVTVW 217

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 50/196 (25%), Positives = 91/196 (46%), Gaps = 13/196 (6%)
Query: 20  RTLGEGNFGKVKFAQDLDSG----LPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
           + LG G FG V     +  G    +P A+K  E       K   +I  E   +  + +P+
Sbjct: 23  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIK--ELREATSPKANKEILDEAYVMASVDNPH 80
Query: 76  VVRLHEVLASKSKIYMVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKG 134
           V RL  +  + S + ++++ +  G L D +   K  +          Q+  G++Y  ++ 
Sbjct: 81  VCRLLGICLT-STVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR 139
Query: 135 VFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP--NYVAPEVLANRG 192
           + HRDL   N+L+ +  ++KI+DFG + L     ++   H   G     ++A E + +R 
Sbjct: 140 LVHRDLAARNVLVKTPQHVKITDFGRAKLLG--AEEKEYHAEGGKVPIKWMALESILHRI 197
Query: 193 YDGATSDIWSCGVILY 208
           Y    SD+WS GV ++
Sbjct: 198 YT-HQSDVWSYGVTVW 212

>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 49/201 (24%), Positives = 85/201 (42%), Gaps = 33/201 (16%)
Query: 84  ASKSKIYMVLEYVTGGELFDKIASKGRLQEAE---GRKLFQQLIDGVSYCHNKGVFHRDL 140
           + K  +Y+ ++      L D +  +  L++ E      +F Q+ + V + H+KG+ HRDL
Sbjct: 131 SPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKGLMHRDL 190
Query: 141 KLENILLDSKGNIKISDFGL-SALPQHFRDDGLLHTT---------CGSPNYVAPEVLAN 190
           K  NI       +K+ DFGL +A+ Q   +  +L             G+  Y++PE +  
Sbjct: 191 KPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHXGQVGTKLYMSPEQIHG 250
Query: 191 RGYDGATSDIWSCGVILYIFRGDF----------------KLPKWLS---PGAQNLLRKI 231
             Y     DI+S G+IL+     F                K P   +   P    +++ +
Sbjct: 251 NNYSHKV-DIFSLGLILFELLYSFSTQMERVRIITDVRNLKFPLLFTQKYPQEHMMVQDM 309
Query: 232 LEPNPVKRITIAGIKADEWFE 252
           L P+P +R     I  +  FE
Sbjct: 310 LSPSPTERPEATDIIENAIFE 330

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 50/196 (25%), Positives = 91/196 (46%), Gaps = 13/196 (6%)
Query: 20  RTLGEGNFGKVKFAQDLDSG----LPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
           + LG G FG V     +  G    +P A+K  E       K   +I  E   +  + +P+
Sbjct: 23  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIK--ELREATSPKANKEILDEAYVMASVDNPH 80
Query: 76  VVRLHEVLASKSKIYMVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKG 134
           V RL  +  + S + ++++ +  G L D +   K  +          Q+  G++Y  ++ 
Sbjct: 81  VCRLLGICLT-STVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR 139
Query: 135 VFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP--NYVAPEVLANRG 192
           + HRDL   N+L+ +  ++KI+DFG + L     ++   H   G     ++A E + +R 
Sbjct: 140 LVHRDLAARNVLVKTPQHVKITDFGRAKLLG--AEEKEYHAEGGKVPIKWMALESILHRI 197
Query: 193 YDGATSDIWSCGVILY 208
           Y    SD+WS GV ++
Sbjct: 198 YT-HQSDVWSYGVTVW 212

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 50/196 (25%), Positives = 91/196 (46%), Gaps = 13/196 (6%)
Query: 20  RTLGEGNFGKVKFAQDLDSG----LPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
           + LG G FG V     +  G    +P A+K  E       K   +I  E   +  + +P+
Sbjct: 25  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIK--ELREATSPKANKEILDEAYVMASVDNPH 82
Query: 76  VVRLHEVLASKSKIYMVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKG 134
           V RL  +  + S + ++++ +  G L D +   K  +          Q+  G++Y  ++ 
Sbjct: 83  VCRLLGICLT-STVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR 141
Query: 135 VFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP--NYVAPEVLANRG 192
           + HRDL   N+L+ +  ++KI+DFG + L     ++   H   G     ++A E + +R 
Sbjct: 142 LVHRDLAARNVLVKTPQHVKITDFGRAKLLG--AEEKEYHAEGGKVPIKWMALESILHRI 199
Query: 193 YDGATSDIWSCGVILY 208
           Y    SD+WS GV ++
Sbjct: 200 YT-HQSDVWSYGVTVW 214

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 62/225 (27%), Positives = 95/225 (42%), Gaps = 44/225 (19%)
Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKIT------DQIKREIATL 68
           R +LG+ LG G FG+V  A        F +      R + +K+        + +  ++ L
Sbjct: 30  RLKLGKPLGRGAFGQVIEAD------AFGIDKTATXRTVAVKMLKEGATHSEHRALMSEL 83
Query: 69  KLL----KHPNVVRLHEVLASKSKIYMVL-EYVTGGELFDKIASK-GRLQEAEGRKLFQ- 121
           K+L     H NVV L           MV+ E+   G L   + SK       +   L++ 
Sbjct: 84  KILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKPEDLYKD 143
Query: 122 ------------QLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD 169
                       Q+  G+ +  ++   HRDL   NILL  K  +KI DFGL+      RD
Sbjct: 144 FLTLEHLIXYSFQVAKGMEFLASRKXIHRDLAARNILLSEKNVVKICDFGLA------RD 197
Query: 170 -----DGLLHTTCGSP-NYVAPEVLANRGYDGATSDIWSCGVILY 208
                D +       P  ++APE + +R Y    SD+WS GV+L+
Sbjct: 198 IXKDPDXVRKGDARLPLKWMAPETIFDRVYT-IQSDVWSFGVLLW 241

>pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 64/260 (24%), Positives = 101/260 (38%), Gaps = 49/260 (18%)
Query: 22  LGEGNFGKV-KFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLH 80
           +G G FG V K  + LD G  +A+K  +K     +   + ++   A   L +H +VVR  
Sbjct: 17  IGSGEFGSVFKCVKRLD-GCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYF 75
Query: 81  EVLASKSKIYMVLEYVTGGELFDKIASKGRL----QEAEGRKLFQQLIDGVSYCHNKGVF 136
              A    + +  EY  GG L D I+   R+    +EAE + L  Q+  G+ Y H+  + 
Sbjct: 76  SAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLV 135
Query: 137 HRDLKLENILL-------------------DSKGNIKISDFGLSALPQHFRDDGLLHTTC 177
           H D+K  NI +                    +K   KI D G      H           
Sbjct: 136 HMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLG------HVTRISSPQVEE 189
Query: 178 GSPNYVAPEVLANRGYDGATSDIWSCGVILYIFRGDFKLPK----W-------------- 219
           G   ++A EVL         +DI++  + +    G   LP+    W              
Sbjct: 190 GDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQWHEIRQGRLPRIPQV 249
Query: 220 LSPGAQNLLRKILEPNPVKR 239
           LS     LL+ ++ P+P +R
Sbjct: 250 LSQEFTELLKVMIHPDPERR 269

>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 93/209 (44%), Gaps = 24/209 (11%)
Query: 18  LGRTLGEGNFGKVK--FAQDLDSGLPFA-VKILEKNRIIHLKITDQIKREIATLKLLKHP 74
           + R LG+G+FG V    A+ +    P   V I   N    ++   +   E + +K     
Sbjct: 16  MSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCH 75
Query: 75  NVVRLHEVLASKSKIYMVLEYVTGGELFDKIAS-------KGRLQEAEGRKLFQ---QLI 124
           +VVRL  V++      +++E +T G+L   + S          L      K+ Q   ++ 
Sbjct: 76  HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIA 135
Query: 125 DGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLS---ALPQHFRD--DGLLHTTCGS 179
           DG++Y +     HRDL   N  +     +KI DFG++       ++R    GLL      
Sbjct: 136 DGMAYLNANKFVHRDLAARNCXVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPV---- 191
Query: 180 PNYVAPEVLANRGYDGATSDIWSCGVILY 208
             +++PE L + G     SD+WS GV+L+
Sbjct: 192 -RWMSPESLKD-GVFTTYSDVWSFGVVLW 218

>pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 64/260 (24%), Positives = 101/260 (38%), Gaps = 49/260 (18%)
Query: 22  LGEGNFGKV-KFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLH 80
           +G G FG V K  + LD G  +A+K  +K     +   + ++   A   L +H +VVR  
Sbjct: 17  IGSGEFGSVFKCVKRLD-GCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYF 75
Query: 81  EVLASKSKIYMVLEYVTGGELFDKIASKGRL----QEAEGRKLFQQLIDGVSYCHNKGVF 136
              A    + +  EY  GG L D I+   R+    +EAE + L  Q+  G+ Y H+  + 
Sbjct: 76  SAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLV 135
Query: 137 HRDLKLENILL-------------------DSKGNIKISDFGLSALPQHFRDDGLLHTTC 177
           H D+K  NI +                    +K   KI D G      H           
Sbjct: 136 HMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLG------HVTRISSPQVEE 189
Query: 178 GSPNYVAPEVLANRGYDGATSDIWSCGVILYIFRGDFKLPK----W-------------- 219
           G   ++A EVL         +DI++  + +    G   LP+    W              
Sbjct: 190 GDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQWHEIRQGRLPRIPQV 249
Query: 220 LSPGAQNLLRKILEPNPVKR 239
           LS     LL+ ++ P+P +R
Sbjct: 250 LSQEFTELLKVMIHPDPERR 269

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 65/224 (29%), Positives = 98/224 (43%), Gaps = 40/224 (17%)
Query: 15  RYELGRTLGEGNFGKV----KFAQDLDSGL-PFAVKILEKNRII--HLKITDQIKREIAT 67
           R +LG+ LG G FG+V     F  D  +     AVK+L++      H  +  ++K     
Sbjct: 30  RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELK---IL 86
Query: 68  LKLLKHPNVVRLHEVLASKSKIYMVL-EYVTGGELFDKIASKGR----LQEAEGRKLFQ- 121
           + +  H NVV L           MV+ E+   G L   + SK       +EA    L++ 
Sbjct: 87  IHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKEAP-EDLYKD 145
Query: 122 ------------QLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLS----ALPQ 165
                       Q+  G+ +  ++   HRDL   NILL  K  +KI DFGL+      P 
Sbjct: 146 FLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 205
Query: 166 HFRD-DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILY 208
           + R  D  L        ++APE + +R Y    SD+WS GV+L+
Sbjct: 206 YVRKGDARLPL-----KWMAPETIFDRVYT-IQSDVWSFGVLLW 243

>pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 54/172 (31%), Positives = 81/172 (47%), Gaps = 20/172 (11%)
Query: 72  KHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEA-EGRKLFQQLIDGVSYC 130
           +HPNV+R       +   Y+ +E +    L + +  K       E   L QQ   G+++ 
Sbjct: 76  EHPNVIRYFCTEKDRQFQYIAIE-LCAATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHL 134
Query: 131 HNKGVFHRDLKLENILL---DSKGNIK--ISDFGLS---ALPQH--FRDDGLLHTTCGSP 180
           H+  + HRDLK  NIL+   ++ G IK  ISDFGL    A+ +H   R  G+     G+ 
Sbjct: 135 HSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVP----GTE 190
Query: 181 NYVAPEVLANRGYDGATS--DIWSCGVILY--IFRGDFKLPKWLSPGAQNLL 228
            ++APE+L+    +  T   DI+S G + Y  I  G     K L   A  LL
Sbjct: 191 GWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILL 242

>pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 64/260 (24%), Positives = 101/260 (38%), Gaps = 49/260 (18%)
Query: 22  LGEGNFGKV-KFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLH 80
           +G G FG V K  + LD G  +A+K  +K     +   + ++   A   L +H +VVR  
Sbjct: 19  IGSGEFGSVFKCVKRLD-GCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYF 77
Query: 81  EVLASKSKIYMVLEYVTGGELFDKIASKGRL----QEAEGRKLFQQLIDGVSYCHNKGVF 136
              A    + +  EY  GG L D I+   R+    +EAE + L  Q+  G+ Y H+  + 
Sbjct: 78  SAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLV 137
Query: 137 HRDLKLENILL-------------------DSKGNIKISDFGLSALPQHFRDDGLLHTTC 177
           H D+K  NI +                    +K   KI D G      H           
Sbjct: 138 HMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLG------HVTRISSPQVEE 191
Query: 178 GSPNYVAPEVLANRGYDGATSDIWSCGVILYIFRGDFKLPK----W-------------- 219
           G   ++A EVL         +DI++  + +    G   LP+    W              
Sbjct: 192 GDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQWHEIRQGRLPRIPQV 251
Query: 220 LSPGAQNLLRKILEPNPVKR 239
           LS     LL+ ++ P+P +R
Sbjct: 252 LSQEFTELLKVMIHPDPERR 271

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 56/215 (26%), Positives = 93/215 (43%), Gaps = 36/215 (16%)
Query: 18  LGRTLGEGNFGKVK--FAQDLDSGLPFA-VKILEKNRIIHLKITDQIKREIATLKLLKHP 74
           + R LG+G+FG V    A+ +    P   V I   N    ++   +   E + +K     
Sbjct: 23  MSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCH 82
Query: 75  NVVRLHEVLASKSKIYMVLEYVTGGELFDKIAS-------KGRLQEAEGRKLFQ---QLI 124
           +VVRL  V++      +++E +T G+L   + S          L      K+ Q   ++ 
Sbjct: 83  HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIA 142
Query: 125 DGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD-----------DGLL 173
           DG++Y +     HRDL   N ++     +KI DFG++      RD            GLL
Sbjct: 143 DGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMT------RDIXETDXXRKGGKGLL 196
Query: 174 HTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILY 208
                   +++PE L + G     SD+WS GV+L+
Sbjct: 197 PV-----RWMSPESLKD-GVFTTYSDVWSFGVVLW 225

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 63/220 (28%), Positives = 98/220 (44%), Gaps = 32/220 (14%)
Query: 15  RYELGRTLGEGNFGKV----KFAQDLDSGL-PFAVKILEKNRII--HLKITDQIKREIAT 67
           R +LG+ LG G FG+V     F  D  +     AVK+L++      H  +  ++K     
Sbjct: 28  RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELK---IL 84
Query: 68  LKLLKHPNVVRLHEVLASKSKIYMVL-EYVTGGELFDKIASKG------RLQEAEGRKLF 120
           + +  H NVV L           MV+ E+   G L   + SK       ++   +  K F
Sbjct: 85  IHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDF 144
Query: 121 Q----------QLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD- 169
                      Q+  G+ +  ++   HRDL   NILL  K  +KI DFGL+     ++D 
Sbjct: 145 LTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLAR--DIYKDP 202
Query: 170 DGLLHTTCGSP-NYVAPEVLANRGYDGATSDIWSCGVILY 208
           D +       P  ++APE + +R Y    SD+WS GV+L+
Sbjct: 203 DXVRKGDARLPLKWMAPETIFDRVYT-IQSDVWSFGVLLW 241

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 56/215 (26%), Positives = 93/215 (43%), Gaps = 36/215 (16%)
Query: 18  LGRTLGEGNFGKVK--FAQDLDSGLPFA-VKILEKNRIIHLKITDQIKREIATLKLLKHP 74
           + R LG+G+FG V    A+ +    P   V I   N    ++   +   E + +K     
Sbjct: 14  MSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCH 73
Query: 75  NVVRLHEVLASKSKIYMVLEYVTGGELFDKIAS-------KGRLQEAEGRKLFQ---QLI 124
           +VVRL  V++      +++E +T G+L   + S          L      K+ Q   ++ 
Sbjct: 74  HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIA 133
Query: 125 DGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD-----------DGLL 173
           DG++Y +     HRDL   N ++     +KI DFG++      RD            GLL
Sbjct: 134 DGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMT------RDIXETDXXRKGGKGLL 187
Query: 174 HTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILY 208
                   +++PE L + G     SD+WS GV+L+
Sbjct: 188 PV-----RWMSPESLKD-GVFTTYSDVWSFGVVLW 216
  Database: pdbaa

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	421
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	1e-153
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	1e-152
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	1e-150
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	1e-150
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	1e-150
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	1e-149
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	1e-147
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	1e-146
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	1e-142
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	1e-141
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	1e-138
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	1e-138
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	1e-135
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	1e-134
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	1e-134
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	1e-133
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	1e-132
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	1e-131
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	1e-119
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	1e-100
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	3e-98
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	4e-98
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	6e-97
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	2e-96
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	4e-96
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	1e-95
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	2e-95
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	3e-95
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	2e-93
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	9e-93
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	1e-92
3bhy_A	283	Death-associated protein kinase 3; death associate	9e-92
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	1e-91
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	2e-91
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	9e-91
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	1e-90
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	1e-90
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	1e-89
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	1e-89
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	3e-89
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	4e-89
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	5e-89
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	6e-89
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	7e-89
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	2e-88
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	2e-88
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	3e-88
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	2e-87
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	5e-87
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	6e-87
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	4e-86
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	3e-85
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	4e-84
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	4e-84
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	8e-84
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	3e-83
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	1e-82
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	2e-82
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	1e-75
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	3e-74
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	4e-74
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	4e-74
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	2e-73
2a19_B	284	Interferon-induced, double-stranded RNA-activated	2e-71
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	6e-71
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	8e-70
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	4e-69
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	9e-69
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	7e-68
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	4e-67
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	5e-67
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	9e-66
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	3e-65
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	5e-63
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	2e-61
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	2e-61
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	2e-60
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	6e-60
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	3e-59
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	7e-59
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	3e-58
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	5e-58
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	5e-58
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	8e-58
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	1e-57
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	3e-57
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	2e-56
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	3e-56
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	7e-56
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	1e-55
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	9e-55
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	1e-54
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	1e-54
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	2e-54
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	4e-54
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	2e-53
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	3e-51
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	7e-51
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	8e-49
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	2e-47
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	5e-47
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	3e-08
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	7e-47
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	1e-46
3o0g_A	292	Cell division protein kinase 5; kinase activator c	4e-46
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	8e-46
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	1e-45
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	2e-45
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	4e-45
3niz_A	311	Rhodanese family protein; structural genomics, str	8e-45
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	1e-44
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	1e-43
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	4e-43
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	2e-42
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	6e-42
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	2e-40
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	3e-40
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	2e-39
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	2e-39
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	7e-39
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	2e-38
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	3e-38
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	4e-38
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	4e-38
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	5e-38
2dyl_A	318	Dual specificity mitogen-activated protein kinase	8e-38
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	1e-37
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	2e-37
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	4e-37
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	5e-37
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	1e-36
2ehb_D	143	CBL-interacting serine/threonine-protein kinase 2;	3e-36
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	3e-36
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	4e-36
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	7e-36
3fme_A	290	Dual specificity mitogen-activated protein kinase;	9e-36
3aln_A	327	Dual specificity mitogen-activated protein kinase;	9e-36
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	1e-35
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	4e-35
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	5e-35
3ork_A	311	Serine/threonine protein kinase; structural genomi	7e-35
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	1e-34
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	1e-34
3an0_A	340	Dual specificity mitogen-activated protein kinase;	1e-34
2zfd_B	123	Putative uncharacterized protein T20L15_90; calciu	1e-33
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	6e-32
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	2e-31
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	3e-31
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	5e-31
3q4u_A	301	Activin receptor type-1; structural genomics conso	5e-31
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	8e-31
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	8e-31
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	2e-30
3rp9_A	458	Mitogen-activated protein kinase; structural genom	3e-30
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	5e-30
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	5e-30
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	7e-30
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	9e-30
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	9e-30
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	1e-29
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	3e-29
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	4e-29
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	4e-29
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	5e-29
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	6e-29
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	7e-29
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	8e-29
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	8e-29
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	9e-29
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	1e-28
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	1e-28
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	1e-28
3soc_A	322	Activin receptor type-2A; structural genomics cons	2e-28
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	4e-28
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	5e-28
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	5e-28
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	5e-28
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	6e-28
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	7e-28
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	8e-28
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	9e-28
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	1e-27
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	1e-27
3uqc_A	286	Probable conserved transmembrane protein; structur	2e-27
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	2e-27
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	2e-27
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	2e-27
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	3e-27
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	4e-27
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	4e-27
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	5e-27
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	5e-27
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	1e-26
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	1e-26
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	2e-26
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	4e-26
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	4e-26
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	4e-26
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	9e-26
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	3e-25
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	6e-25
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	1e-24
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	2e-24
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	3e-24
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	4e-24
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	6e-24
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	8e-24
3pls_A	298	Macrophage-stimulating protein receptor; protein k	8e-24
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	2e-23
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	2e-23
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	3e-23
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	3e-23
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	4e-23
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	8e-23
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	8e-23
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	9e-23
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	1e-22
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	1e-22
4aoj_A	329	High affinity nerve growth factor receptor; transf	2e-22
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	2e-22
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	3e-22
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	7e-22
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	1e-21
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	2e-21
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	2e-21
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	5e-21
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	2e-20
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	2e-20
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	2e-18
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	7e-17
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	1e-16
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	3e-16
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	2e-15
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	4e-15
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	2e-13
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	3e-13
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	7e-12
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	2e-11
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	2e-09
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	4e-07
3ose_A	120	Serine/threonine-protein kinase MARK1; kinase asso	5e-09
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	1e-06
1v5s_A	126	MAP/microtubule affinity-regulating kinase 3; Ka1	5e-04
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	6e-04

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score =  436 bits (1124), Expect = e-153
 Identities = 109/345 (31%), Positives = 163/345 (47%), Gaps = 38/345 (11%)

Query: 12  RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL 71
              RY+  + +G GNFG  +  +D  +    AVK +E+   I     + ++REI   + L
Sbjct: 18  DSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAI----DENVQREIINHRSL 73

Query: 72  KHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCH 131
           +HPN+VR  EV+ + + + +++EY +GGEL+++I + GR  E E R  FQQL+ GVSYCH
Sbjct: 74  RHPNIVRFKEVILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCH 133

Query: 132 NKGVFHRDLKLENILLDSK--GNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLA 189
           +  + HRDLKLEN LLD      +KI DFG S             +T G+P Y+APEVL 
Sbjct: 134 SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKS---SVLHSQPKSTVGTPAYIAPEVLL 190

Query: 190 NRGYDGATSDIWSCGVILY------------------------IFRGDFKLPK--WLSPG 223
            + YDG  +D+WSCGV LY                        I    + +P    +SP 
Sbjct: 191 RQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDDIRISPE 250

Query: 224 AQNLLRKILEPNPVKRITIAGIKADEWFEQDYTP--ANPDDDEEDIFVDNEAFSMHEVPS 281
             +L+ +I   +P  RI+I  IK   WF ++      N  +         +     +   
Sbjct: 251 CCHLISRIFVADPATRISIPEIKTHSWFLKNLPADLMNESNTGSQFQEPEQPMQSLDTIM 310

Query: 282 DGGRTPGSPPLINAFQLIGMSSCLDLSGFFEKEDVSERKIRFTSN 326
                   P + N      M+  LDL    +  D SE +I   S+
Sbjct: 311 QIISEATIPAVRNRCLDDFMTDNLDLDDDMDDFD-SESEIDIDSS 354

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score =  439 bits (1132), Expect = e-152
 Identities = 143/474 (30%), Positives = 220/474 (46%), Gaps = 86/474 (18%)

Query: 1   MVIAEKKQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQ 60
           M   +K    +++G Y LG TLG G FGKVK  +   +G   AVKIL + +I  L +  +
Sbjct: 3   MAEKQKHDGRVKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGK 62

Query: 61  IKREIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLF 120
           I+REI  LKL +HP++++L++V+++ S I+MV+EYV+GGELFD I   GRL E E R+LF
Sbjct: 63  IRREIQNLKLFRHPHIIKLYQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLF 122

Query: 121 QQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP 180
           QQ++ GV YCH   V HRDLK EN+LLD+  N KI+DFGLS +     D   L T+CGSP
Sbjct: 123 QQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNM---MSDGEFLRTSCGSP 179

Query: 181 NYVAPEVLANRGYDGATSDIWSCGVILY--------------------IFRGDFKLPKWL 220
           NY APEV++ R Y G   DIWS GVILY                    I  G F  P++L
Sbjct: 180 NYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIFYTPQYL 239

Query: 221 SPGAQNLLRKILEPNPVKRITIAGIKADEWF-----------EQDYTPANPDDD------ 263
           +P   +LL+ +L+ +P+KR TI  I+  EWF           +  Y+    DD+      
Sbjct: 240 NPSVISLLKHMLQVDPMKRATIKDIREHEWFKQDLPKYLFPEDPSYSSTMIDDEALKEVC 299

Query: 264 ------EEDI----------------------------------FVDNEAFSMHEVPSDG 283
                 EE++                                     +   S  +     
Sbjct: 300 EKFECSEEEVLSCLYNRNHQDPLAVAYHLIIDNRRIMNEAKDFYLATSPPDSFLDDHHLT 359

Query: 284 GRTPGSPPLINAFQLIGMSSCLDLSGFFEKEDVSERKIR---FTSNHSAKDLLERIEDIV 340
              P   P + A       +  +L+    K     +        S     D++  +   +
Sbjct: 360 RPHPERVPFLVAETPRARHTLDELNPQKSKHQGVRKAKWHLGIRSQSRPNDIMAEVCRAI 419

Query: 341 TEMGFRVQKKNG-KLKATQEHKPQKSLGSLSVAAEVFEISPSLYVVELRKSYGD 393
            ++ +  +  N   L+     K   +     ++ +++++    Y+++ R    +
Sbjct: 420 KQLDYEWKVVNPYYLRV--RRKNPVTSTFSKMSLQLYQVDSRTYLLDFRSIDDE 471

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score =  426 bits (1098), Expect = e-150
 Identities = 123/274 (44%), Positives = 168/274 (61%), Gaps = 23/274 (8%)

Query: 4   AEKKQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKR 63
             K    +++G Y LG TLG G FGKVK  +   +G   AVKIL + +I  L +  +IKR
Sbjct: 1   GSKHDGRVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKR 60

Query: 64  EIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQL 123
           EI  LKL +HP++++L++V+++ +  +MV+EYV+GGELFD I   GR++E E R+LFQQ+
Sbjct: 61  EIQNLKLFRHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQI 120

Query: 124 IDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYV 183
           +  V YCH   V HRDLK EN+LLD+  N KI+DFGLS +     D   L T+CGSPNY 
Sbjct: 121 LSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNM---MSDGEFLRTSCGSPNYA 177

Query: 184 APEVLANRGYDGATSDIWSCGVILY--------------------IFRGDFKLPKWLSPG 223
           APEV++ R Y G   DIWSCGVILY                    I  G F +P++L+  
Sbjct: 178 APEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFYIPEYLNRS 237

Query: 224 AQNLLRKILEPNPVKRITIAGIKADEWFEQDYTP 257
              LL  +L+ +P+KR TI  I+  EWF+QD   
Sbjct: 238 VATLLMHMLQVDPLKRATIKDIREHEWFKQDLPS 271

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score =  425 bits (1096), Expect = e-150
 Identities = 95/266 (35%), Positives = 141/266 (53%), Gaps = 25/266 (9%)

Query: 13  LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK 72
           +  ++L +TLGEG +G+V+ A +  +    AVKI++  R +     + IK+EI   K+L 
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKMLN 63

Query: 73  HPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHN 132
           H NVV+ +      +  Y+ LEY +GGELFD+I     + E + ++ F QL+ GV Y H 
Sbjct: 64  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 123

Query: 133 KGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRG 192
            G+ HRD+K EN+LLD + N+KISDFGL+ + ++   + LL+  CG+  YVAPE+L  R 
Sbjct: 124 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 183

Query: 193 YDGATSDIWSCGVILY---------------------IFRGDFKLPKW--LSPGAQNLLR 229
           +     D+WSCG++L                             L  W  +      LL 
Sbjct: 184 FHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLH 243

Query: 230 KILEPNPVKRITIAGIKADEWFEQDY 255
           KIL  NP  RITI  IK D W+ +  
Sbjct: 244 KILVENPSARITIPDIKKDRWYNKPL 269

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score =  427 bits (1100), Expect = e-150
 Identities = 102/309 (33%), Positives = 154/309 (49%), Gaps = 34/309 (11%)

Query: 13  LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK 72
           +  ++L +TLGEG +G+V+ A +  +    AVKI++  R +     + IK+EI   K+L 
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKMLN 63

Query: 73  HPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHN 132
           H NVV+ +      +  Y+ LEY +GGELFD+I     + E + ++ F QL+ GV Y H 
Sbjct: 64  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 123

Query: 133 KGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRG 192
            G+ HRD+K EN+LLD + N+KISDFGL+ + ++   + LL+  CG+  YVAPE+L  R 
Sbjct: 124 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 183

Query: 193 YDGATSDIWSCGVILY---------------------IFRGDFKLPKW--LSPGAQNLLR 229
           +     D+WSCG++L                             L  W  +      LL 
Sbjct: 184 FHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLH 243

Query: 230 KILEPNPVKRITIAGIKADEWFEQDYTP--------ANPDDDEEDIFVDNEAFSMHEVPS 281
           KIL  NP  RITI  IK D W+ +            +    +    F  +   ++   P 
Sbjct: 244 KILVENPSARITIPDIKKDRWYNKPLKKGAKRPRVTSGGVSESPSGFSKHIQSNLDFSPV 303

Query: 282 DGG-RTPGS 289
           +   RTPGS
Sbjct: 304 NSASRTPGS 312

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score =  421 bits (1084), Expect = e-147
 Identities = 112/290 (38%), Positives = 170/290 (58%), Gaps = 25/290 (8%)

Query: 7   KQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIA 66
                 +G Y +  TLGEG+FGKVK A    +    A+K + +  +    +  +++REI+
Sbjct: 2   AISKRHIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREIS 61

Query: 67  TLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDG 126
            LKLL+HP++++L++V+ + + I MV+EY  GGELFD I  K R+ E EGR+ FQQ+I  
Sbjct: 62  YLKLLRHPHIIKLYDVITTPTDIVMVIEYA-GGELFDYIVEKKRMTEDEGRRFFQQIICA 120

Query: 127 VSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPE 186
           + YCH   + HRDLK EN+LLD   N+KI+DFGLS +     D   L T+CGSPNY APE
Sbjct: 121 IEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNI---MTDGNFLKTSCGSPNYAAPE 177

Query: 187 VLANRGYDGATSDIWSCGVILY--------------------IFRGDFKLPKWLSPGAQN 226
           V+  + Y G   D+WSCG++LY                    +    + +P +LSPGAQ+
Sbjct: 178 VINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNSCVYVMPDFLSPGAQS 237

Query: 227 LLRKILEPNPVKRITIAGIKADEWFEQDYT-PANPDDDEEDIFVDNEAFS 275
           L+R+++  +P++RITI  I+ D WF  +      P ++ +  + D+   S
Sbjct: 238 LIRRMIVADPMQRITIQEIRRDPWFNVNLPDYLRPMEEVQGSYADSRIVS 287

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score =  416 bits (1072), Expect = e-146
 Identities = 97/289 (33%), Positives = 148/289 (51%), Gaps = 33/289 (11%)

Query: 12  RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLK-ITDQIKREIATLKL 70
            +G+Y +G  LGEG++GKVK   D ++    AVKIL+K ++  +      +K+EI  L+ 
Sbjct: 3   LIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRR 62

Query: 71  LKHPNVVRLHEVL--ASKSKIYMVLEYVTGG--ELFDKIASKGRLQEAEGRKLFQQLIDG 126
           L+H NV++L +VL    K K+YMV+EY   G  E+ D +  + R    +    F QLIDG
Sbjct: 63  LRHKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVP-EKRFPVCQAHGYFCQLIDG 121

Query: 127 VSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPE 186
           + Y H++G+ H+D+K  N+LL + G +KIS  G++     F  D    T+ GSP +  PE
Sbjct: 122 LEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPE 181

Query: 187 VLAN-RGYDGATSDIWSCGVILY--------------------IFRGDFKLPKWLSPGAQ 225
           +      + G   DIWS GV LY                    I +G + +P    P   
Sbjct: 182 IANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGSYAIPGDCGPPLS 241

Query: 226 NLLRKILEPNPVKRITIAGIKADEWFEQDYTPAN------PDDDEEDIF 268
           +LL+ +LE  P KR +I  I+   WF + + PA       P  D +D +
Sbjct: 242 DLLKGMLEYEPAKRFSIRQIRQHSWFRKKHPPAEAPVPIPPSPDTKDRW 290

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score =  407 bits (1048), Expect = e-142
 Identities = 88/276 (31%), Positives = 136/276 (49%), Gaps = 23/276 (8%)

Query: 3   IAEKKQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIK 62
           I E   +     RY  GR LG+G F K     D D+   FA KI+ K+ ++     +++ 
Sbjct: 4   IPEVLVDPRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMS 63

Query: 63  REIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQ 122
            EI+  + L H +VV  H        +++VLE      L +    +  L E E R   +Q
Sbjct: 64  MEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQ 123

Query: 123 LIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNY 182
           ++ G  Y H   V HRDLKL N+ L+    +KI DFGL+   ++  D       CG+PNY
Sbjct: 124 IVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY--DGERKKVLCGTPNY 181

Query: 183 VAPEVLANRGYDGATSDIWSCGVILY--------------------IFRGDFKLPKWLSP 222
           +APEVL+ +G+     D+WS G I+Y                    I + ++ +PK ++P
Sbjct: 182 IAPEVLSKKGHSFE-VDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINP 240

Query: 223 GAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPA 258
            A +L++K+L+ +P  R TI  +  DE+F   Y PA
Sbjct: 241 VAASLIQKMLQTDPTARPTINELLNDEFFTSGYIPA 276

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score =  404 bits (1041), Expect = e-141
 Identities = 88/276 (31%), Positives = 136/276 (49%), Gaps = 23/276 (8%)

Query: 3   IAEKKQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIK 62
           I E   +     RY  GR LG+G F K     D D+   FA KI+ K+ ++     +++ 
Sbjct: 30  IPEVLVDPRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMS 89

Query: 63  REIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQ 122
            EI+  + L H +VV  H        +++VLE      L +    +  L E E R   +Q
Sbjct: 90  MEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQ 149

Query: 123 LIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNY 182
           ++ G  Y H   V HRDLKL N+ L+    +KI DFGL+   ++  D       CG+PNY
Sbjct: 150 IVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY--DGERKKVLCGTPNY 207

Query: 183 VAPEVLANRGYDGATSDIWSCGVILY--------------------IFRGDFKLPKWLSP 222
           +APEVL+ +G+     D+WS G I+Y                    I + ++ +PK ++P
Sbjct: 208 IAPEVLSKKGHSFE-VDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINP 266

Query: 223 GAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPA 258
            A +L++K+L+ +P  R TI  +  DE+F   Y PA
Sbjct: 267 VAASLIQKMLQTDPTARPTINELLNDEFFTSGYIPA 302

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score =  398 bits (1025), Expect = e-138
 Identities = 107/283 (37%), Positives = 163/283 (57%), Gaps = 24/283 (8%)

Query: 3   IAEKKQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIK 62
           IA    E   +G Y L +T+G+GNF KVK A+ + +G   A+KI++K ++    +  ++ 
Sbjct: 4   IASCADEQPHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSL-QKLF 62

Query: 63  REIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQ 122
           RE+  +K+L HPN+V+L EV+ ++  +Y+++EY +GGE+FD + + GR++E E R  F+Q
Sbjct: 63  REVRIMKILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQ 122

Query: 123 LIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNY 182
           ++  V YCH K + HRDLK EN+LLD+  NIKI+DFG S     F   G L   CG+P Y
Sbjct: 123 IVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNE---FTVGGKLDAFCGAPPY 179

Query: 183 VAPEVLANRGYDGATSDIWSCGVILY--------------------IFRGDFKLPKWLSP 222
            APE+   + YDG   D+WS GVILY                    + RG +++P ++S 
Sbjct: 180 AAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMST 239

Query: 223 GAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPANPDDDEE 265
             +NLL++ L  NP+KR T+  I  D W    +         E
Sbjct: 240 DCENLLKRFLVLNPIKRGTLEQIMKDRWINAGHEEDELKPFVE 282

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score =  395 bits (1018), Expect = e-138
 Identities = 76/274 (27%), Positives = 144/274 (52%), Gaps = 24/274 (8%)

Query: 10  GMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLK 69
           G ++  +++G  LG+G+F  V  A+ + +GL  A+K+++K  +    +  +++ E+    
Sbjct: 7   GEKIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHC 66

Query: 70  LLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVS 128
            LKHP+++ L+      + +Y+VLE    GE+   + ++     E E R    Q+I G+ 
Sbjct: 67  QLKHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGML 126

Query: 129 YCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVL 188
           Y H+ G+ HRDL L N+LL    NIKI+DFGL+   +        +T CG+PNY++PE+ 
Sbjct: 127 YLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKM--PHEKHYTLCGTPNYISPEIA 184

Query: 189 ANRGYDGATSDIWSCGVILY--------------------IFRGDFKLPKWLSPGAQNLL 228
               + G  SD+WS G + Y                    +   D+++P +LS  A++L+
Sbjct: 185 TRSAH-GLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADYEMPSFLSIEAKDLI 243

Query: 229 RKILEPNPVKRITIAGIKADEWFEQDYTPANPDD 262
            ++L  NP  R++++ +    +  ++ +  + D+
Sbjct: 244 HQLLRRNPADRLSLSSVLDHPFMSRNSSTKSKDE 277

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score =  391 bits (1005), Expect = e-135
 Identities = 82/306 (26%), Positives = 133/306 (43%), Gaps = 23/306 (7%)

Query: 4   AEKKQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITD---- 59
                EG    +Y     LG G FG V  A D +      VK ++K +++     +    
Sbjct: 14  GLAACEGEYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKL 73

Query: 60  -QIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLE-YVTGGELFDKIASKGRLQEAEGR 117
            ++  EIA L  ++H N++++ ++  ++    +V+E + +G +LF  I    RL E    
Sbjct: 74  GKVTLEIAILSRVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLAS 133

Query: 118 KLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTC 177
            +F+QL+  V Y   K + HRD+K ENI++     IK+ DFG +A         L +T C
Sbjct: 134 YIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAY---LERGKLFYTFC 190

Query: 178 GSPNYVAPEVLANRGYDGATSDIWSCGVILY--------------IFRGDFKLPKWLSPG 223
           G+  Y APEVL    Y G   ++WS GV LY                      P  +S  
Sbjct: 191 GTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEETVEAAIHPPYLVSKE 250

Query: 224 AQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPANPDDDEEDIFVDNEAFSMHEVPSDG 283
             +L+  +L+P P +R T+  +  D W  Q    A+   +E       E+  +     + 
Sbjct: 251 LMSLVSGLLQPVPERRTTLEKLVTDPWVTQPVNLADYTWEEVFRVNKPESGVLSAASLEM 310

Query: 284 GRTPGS 289
           G    S
Sbjct: 311 GNRSLS 316

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score =  385 bits (992), Expect = e-134
 Identities = 83/278 (29%), Positives = 145/278 (52%), Gaps = 25/278 (8%)

Query: 3   IAEKKQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIK 62
           +AE  +    +  +++GR LG+G FG V  A++  +    A+K+L K+++    +  Q++
Sbjct: 3   LAEMPKRKFTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLR 62

Query: 63  REIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQ 122
           REI     L+HPN++R++     + +IY++LE+   GEL+ ++   GR  E       ++
Sbjct: 63  REIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEE 122

Query: 123 LIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNY 182
           L D + YCH + V HRD+K EN+L+  KG +KI+DFG S      R      T CG+ +Y
Sbjct: 123 LADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLR----RRTMCGTLDY 178

Query: 183 VAPEVLANRGYDGATSDIWSCGVILY--------------------IFRGDFKLPKWLSP 222
           + PE++  + +D    D+W  GV+ Y                    I   D K P +LS 
Sbjct: 179 LPPEMIEGKTHDEK-VDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKFPPFLSD 237

Query: 223 GAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPANP 260
           G+++L+ K+L  +P +R+ + G+    W + +     P
Sbjct: 238 GSKDLISKLLRYHPPQRLPLKGVMEHPWVKANSRRVLP 275

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score =  385 bits (990), Expect = e-134
 Identities = 88/298 (29%), Positives = 144/298 (48%), Gaps = 52/298 (17%)

Query: 5   EKKQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKIT------ 58
               + ++L +Y L   +G+G++G VK A + +    +A+K+L K ++I           
Sbjct: 4   GSSGDCVQLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPP 63

Query: 59  -----------------DQIKREIATLKLLKHPNVVRLHEVL--ASKSKIYMVLEYVTGG 99
                            +Q+ +EIA LK L HPNVV+L EVL   ++  +YMV E V  G
Sbjct: 64  RGTRPAPGGCIQPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQG 123

Query: 100 ELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFG 159
            + + + +   L E + R  FQ LI G+ Y H + + HRD+K  N+L+   G+IKI+DFG
Sbjct: 124 PVME-VPTLKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADFG 182

Query: 160 LSALPQHFRDDGLLHTTCGSPNYVAPEVLAN--RGYDGATSDIWSCGVILY--------- 208
           +S   +    D LL  T G+P ++APE L+   + + G   D+W+ GV LY         
Sbjct: 183 VSNEFK--GSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPF 240

Query: 209 -----------IFRGDFKLPKW--LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQ 253
                      I     + P    ++   ++L+ ++L+ NP  RI +  IK   W  +
Sbjct: 241 MDERIMCLHSKIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWVTR 298

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score =  384 bits (988), Expect = e-133
 Identities = 82/286 (28%), Positives = 124/286 (43%), Gaps = 27/286 (9%)

Query: 4   AEKKQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQ--- 60
              K        Y LG  LG+G FG V     L   L  A+K++ +NR++          
Sbjct: 21  PGGKDREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVT 80

Query: 61  IKREIATLKLL----KHPNVVRLHEVLASKSKIYMVLEY-VTGGELFDKIASKGRLQEAE 115
              E+A L  +     HP V+RL +   ++    +VLE  +   +LFD I  KG L E  
Sbjct: 81  CPLEVALLWKVGAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGP 140

Query: 116 GRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSK-GNIKISDFGLSALPQHFRDDGLLH 174
            R  F Q++  + +CH++GV HRD+K ENIL+D + G  K+ DFG  AL      D    
Sbjct: 141 SRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLH----DEPYT 196

Query: 175 TTCGSPNYVAPEVLANRGYDGATSDIWSCGVILY--------------IFRGDFKLPKWL 220
              G+  Y  PE ++   Y    + +WS G++LY              I   +   P  +
Sbjct: 197 DFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQEILEAELHFPAHV 256

Query: 221 SPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPANPDDDEED 266
           SP    L+R+ L P P  R ++  I  D W +        +  +  
Sbjct: 257 SPDCCALIRRCLAPKPSSRPSLEEILLDPWMQTPAEDVPLNPSKGG 302

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score =  382 bits (982), Expect = e-132
 Identities = 86/285 (30%), Positives = 131/285 (45%), Gaps = 25/285 (8%)

Query: 3   IAEKKQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRI---IHLKITD 59
           +A  K++     +Y++G  LG G FG V     +   LP A+K +EK+RI     L    
Sbjct: 32  LAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGT 91

Query: 60  QIKREIATLKLLKH--PNVVRLHEVLASKSKIYMVLEYVTG-GELFDKIASKGRLQEAEG 116
           ++  E+  LK +      V+RL +         ++LE      +LFD I  +G LQE   
Sbjct: 92  RVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELA 151

Query: 117 RKLFQQLIDGVSYCHNKGVFHRDLKLENILLDS-KGNIKISDFGLSALPQHFRDDGLLHT 175
           R  F Q+++ V +CHN GV HRD+K ENIL+D  +G +K+ DFG  AL +    D +   
Sbjct: 152 RSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK----DTVYTD 207

Query: 176 TCGSPNYVAPEVLANRGYDGATSDIWSCGVILY--------------IFRGDFKLPKWLS 221
             G+  Y  PE +    Y G ++ +WS G++LY              I RG     + +S
Sbjct: 208 FDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVS 267

Query: 222 PGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPANPDDDEED 266
              Q+L+R  L   P  R T   I+   W +    P    +    
Sbjct: 268 SECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAEIHLH 312

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score =  377 bits (970), Expect = e-131
 Identities = 82/281 (29%), Positives = 144/281 (51%), Gaps = 25/281 (8%)

Query: 7   KQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIA 66
           K+    L  +E+GR LG+G FG V  A++  S    A+K+L K ++    +  Q++RE+ 
Sbjct: 2   KKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVE 61

Query: 67  TLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDG 126
               L+HPN++RL+      +++Y++LEY   G ++ ++    +  E        +L + 
Sbjct: 62  IQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANA 121

Query: 127 VSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPE 186
           +SYCH+K V HRD+K EN+LL S G +KI+DFG S      R        CG+ +Y+ PE
Sbjct: 122 LSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR----RTDLCGTLDYLPPE 177

Query: 187 VLANRGYDGATSDIWSCGVILY--------------------IFRGDFKLPKWLSPGAQN 226
           ++  R +D    D+WS GV+ Y                    I R +F  P +++ GA++
Sbjct: 178 MIEGRMHD-EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARD 236

Query: 227 LLRKILEPNPVKRITIAGIKADEWFEQDYTPANPDDDEEDI 267
           L+ ++L+ NP +R  +  +    W   + +  +   ++E  
Sbjct: 237 LISRLLKHNPSQRPMLREVLEHPWITANSSKPSNCQNKESA 277

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score =  351 bits (902), Expect = e-119
 Identities = 69/324 (21%), Positives = 123/324 (37%), Gaps = 70/324 (21%)

Query: 6   KKQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLK--------- 56
            K++   +  Y + RTL +G F K+   +       +A+K  EK+ +   +         
Sbjct: 23  VKEKDKYINDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDK 80

Query: 57  -----ITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRL 111
                  D  K E+  +  +K+   +    ++ +  ++Y++ EY+    +         L
Sbjct: 81  ISIKSKYDDFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVL 140

Query: 112 Q--------EAEGRKLFQQLIDGVSYCHN-KGVFHRDLKLENILLDSKGNIKISDFGLSA 162
                        + + + +++  SY HN K + HRD+K  NIL+D  G +K+SDFG S 
Sbjct: 141 DKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNGRVKLSDFGESE 200

Query: 163 LPQHFRDDGLLHTTCGSPNYVAPEVLANRG-YDGATSDIWSCGVILY------------- 208
               +  D  +  + G+  ++ PE  +N   Y+GA  DIWS G+ LY             
Sbjct: 201 ----YMVDKKIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKI 256

Query: 209 --------IFRGDFKLP-------------------KWLSPGAQNLLRKILEPNPVKRIT 241
                   I   + + P                    +LS    + L+  L  NP +RIT
Sbjct: 257 SLVELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERIT 316

Query: 242 IAGIKADEWFEQDYTPANPDDDEE 265
                  EW          +  +E
Sbjct: 317 SEDALKHEWLADTNIEDLREFSKE 340

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score =  301 bits (772), Expect = e-100
 Identities = 92/283 (32%), Positives = 135/283 (47%), Gaps = 39/283 (13%)

Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRII-----HLKITDQIKREIATLK 69
            Y + +TLG G  G+VK A +  +    A+KI+ K +              ++ EI  LK
Sbjct: 11  EYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILK 70

Query: 70  LLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSY 129
            L HP ++++     ++   Y+VLE + GGELFDK+    RL+EA  +  F Q++  V Y
Sbjct: 71  KLNHPCIIKIKNFFDAED-YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQY 129

Query: 130 CHNKGVFHRDLKLENILLDSKG---NIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPE 186
            H  G+ HRDLK EN+LL S+     IKI+DFG S   +   +  L+ T CG+P Y+APE
Sbjct: 130 LHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHS---KILGETSLMRTLCGTPTYLAPE 186

Query: 187 VLANRGYDGATS--DIWSCGVILYI-------FRG----------------DFKLPKW-- 219
           VL + G  G     D WS GVIL+I       F                  +F    W  
Sbjct: 187 VLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAE 246

Query: 220 LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPANPDD 262
           +S  A +L++K+L  +P  R T        W + +       D
Sbjct: 247 VSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDEDMKRKFQD 289

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score =  294 bits (754), Expect = 3e-98
 Identities = 92/280 (32%), Positives = 144/280 (51%), Gaps = 32/280 (11%)

Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
            Y++   LG+G F  V+      +GL FA KI+   ++       +++RE    + L+HP
Sbjct: 7   NYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDF-QKLEREARICRKLQHP 65

Query: 75  NVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKG 134
           N+VRLH+ +  +S  Y+V + VTGGELF+ I ++    EA+     QQ+++ ++YCH+ G
Sbjct: 66  NIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNG 125

Query: 135 VFHRDLKLENILLDSKGN---IKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANR 191
           + HR+LK EN+LL SK     +K++DFGL+       D    H   G+P Y++PEVL   
Sbjct: 126 IVHRNLKPENLLLASKAKGAAVKLADFGLA---IEVNDSEAWHGFAGTPGYLSPEVLKKD 182

Query: 192 GYDGATSDIWSCGVILYI-------FRG---------------DFKLPKW--LSPGAQNL 227
            Y     DIW+CGVILYI       F                 D+  P+W  ++P A++L
Sbjct: 183 PY-SKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSL 241

Query: 228 LRKILEPNPVKRITIAGIKADEWFEQDYTPANPDDDEEDI 267
           +  +L  NP KRIT        W       A+    ++ +
Sbjct: 242 IDSMLTVNPKKRITADQALKVPWICNRERVASAIHRQDTV 281

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score =  293 bits (753), Expect = 4e-98
 Identities = 89/275 (32%), Positives = 144/275 (52%), Gaps = 36/275 (13%)

Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
            Y L  T+G G++G+VK A    + +  A K + K     ++  D+ K+EI  +K L HP
Sbjct: 10  YYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYF---VEDVDRFKQEIEIMKSLDHP 66

Query: 75  NVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKG 134
           N++RL+E     + IY+V+E  TGGELF+++  K   +E++  ++ + ++  V+YCH   
Sbjct: 67  NIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLN 126

Query: 135 VFHRDLKLENILLDSKG---NIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANR 191
           V HRDLK EN L  +      +K+ DFGL+A    F+   ++ T  G+P YV+P+VL   
Sbjct: 127 VAHRDLKPENFLFLTDSPDSPLKLIDFGLAA---RFKPGKMMRTKVGTPYYVSPQVL-EG 182

Query: 192 GYDGATSDIWSCGVILYI-------FRG---------------DFKLPKW--LSPGAQNL 227
            Y G   D WS GV++Y+       F                  F    W  +SP A++L
Sbjct: 183 LY-GPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEKDWLNVSPQAESL 241

Query: 228 LRKILEPNPVKRITIAGIKADEWFEQDYTPANPDD 262
           +R++L  +P +RIT       EWF +    ++P +
Sbjct: 242 IRRLLTKSPKQRITSLQALEHEWF-EKQLSSSPRN 275

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score =  295 bits (758), Expect = 6e-97
 Identities = 91/283 (32%), Positives = 135/283 (47%), Gaps = 39/283 (13%)

Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRII-----HLKITDQIKREIATLK 69
            Y + +TLG G  G+VK A +  +    A++I+ K +              ++ EI  LK
Sbjct: 136 EYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILK 195

Query: 70  LLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSY 129
            L HP ++++     ++   Y+VLE + GGELFDK+    RL+EA  +  F Q++  V Y
Sbjct: 196 KLNHPCIIKIKNFFDAED-YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQY 254

Query: 130 CHNKGVFHRDLKLENILLDSKG---NIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPE 186
            H  G+ HRDLK EN+LL S+     IKI+DFG S   +   +  L+ T CG+P Y+APE
Sbjct: 255 LHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHS---KILGETSLMRTLCGTPTYLAPE 311

Query: 187 VLANRGYDGATS--DIWSCGVILYI-------FRG----------------DFKLPKW-- 219
           VL + G  G     D WS GVIL+I       F                  +F    W  
Sbjct: 312 VLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAE 371

Query: 220 LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPANPDD 262
           +S  A +L++K+L  +P  R T        W + +       D
Sbjct: 372 VSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDEDMKRKFQD 414

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  290 bits (744), Expect = 2e-96
 Identities = 70/288 (24%), Positives = 118/288 (40%), Gaps = 52/288 (18%)

Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
           +E    LG+G FG+V  A++      +A+K +        +    I  E+  L  L H  
Sbjct: 8   FEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTE----EKLSTILSEVMLLASLNHQY 63

Query: 76  VVRLHEV-------------LASKSKIYMVLEYVTGGELFDKIASKGR-LQEAEGRKLFQ 121
           VVR +               +  KS +++ +EY   G L+D I S+    Q  E  +LF+
Sbjct: 64  VVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFR 123

Query: 122 QLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQH------------FRD 169
           Q+++ +SY H++G+ HRDLK  NI +D   N+KI DFGL+                    
Sbjct: 124 QILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGS 183

Query: 170 DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILY------------------IFR 211
              L +  G+  YVA EVL   G+     D++S G+I +                  +  
Sbjct: 184 SDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYPFSTGMERVNILKKLRS 243

Query: 212 GDFKLPKWL----SPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY 255
              + P           + ++R +++ +P KR     +    W    +
Sbjct: 244 VSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPVKH 291

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score =  291 bits (747), Expect = 4e-96
 Identities = 83/275 (30%), Positives = 131/275 (47%), Gaps = 40/275 (14%)

Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRI-----IHLKITDQIKREIATLK 69
           +Y+    +G G    V+      +G  FAVKI+E            ++ +  +RE   L+
Sbjct: 95  KYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILR 154

Query: 70  LLK-HPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVS 128
            +  HP+++ L +   S S +++V + +  GELFD +  K  L E E R + + L++ VS
Sbjct: 155 QVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVS 214

Query: 129 YCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVL 188
           + H   + HRDLK ENILLD    I++SDFG S    H      L   CG+P Y+APE+L
Sbjct: 215 FLHANNIVHRDLKPENILLDDNMQIRLSDFGFSC---HLEPGEKLRELCGTPGYLAPEIL 271

Query: 189 ------ANRGYDGATSDIWSCGVILYI-------FRG---------------DFKLPKW- 219
                  + GY G   D+W+CGVIL+        F                  F  P+W 
Sbjct: 272 KCSMDETHPGY-GKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQFSSPEWD 330

Query: 220 -LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQ 253
             S   ++L+ ++L+ +P  R+T        +FE+
Sbjct: 331 DRSSTVKDLISRLLQVDPEARLTAEQALQHPFFER 365

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score =  288 bits (738), Expect = 1e-95
 Identities = 80/283 (28%), Positives = 124/283 (43%), Gaps = 41/283 (14%)

Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITD------QIKREIATL 68
            YE    LG G    V+      +   +AVKI++          +         +E+  L
Sbjct: 18  NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 77

Query: 69  KLLK-HPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGV 127
           + +  HPN+++L +   + +  ++V + +  GELFD +  K  L E E RK+ + L++ +
Sbjct: 78  RKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVI 137

Query: 128 SYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEV 187
              H   + HRDLK ENILLD   NIK++DFG S           L   CG+P+Y+APE+
Sbjct: 138 CALHKLNIVHRDLKPENILLDDDMNIKLTDFGFS---CQLDPGEKLREVCGTPSYLAPEI 194

Query: 188 LA------NRGYDGATSDIWSCGVILYI-------FRG---------------DFKLPKW 219
           +       + GY G   D+WS GVI+Y        F                  F  P+W
Sbjct: 195 IECSMNDNHPGY-GKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEW 253

Query: 220 --LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPANP 260
              S   ++L+ + L   P KR T     A  +F+Q       
Sbjct: 254 DDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQYVVEEVR 296

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score =  287 bits (737), Expect = 2e-95
 Identities = 88/277 (31%), Positives = 134/277 (48%), Gaps = 35/277 (12%)

Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
            +     LG G F +V   +   +G  FA+K ++K+          ++ EIA LK +KH 
Sbjct: 10  TFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFR---DSSLENEIAVLKKIKHE 66

Query: 75  NVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKG 134
           N+V L ++  S +  Y+V++ V+GGELFD+I  +G   E +   + QQ++  V Y H  G
Sbjct: 67  NIVTLEDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENG 126

Query: 135 VFHRDLKLENILLDSKG---NIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANR 191
           + HRDLK EN+L  +      I I+DFGLS        +G++ T CG+P YVAPEVLA +
Sbjct: 127 IVHRDLKPENLLYLTPEENSKIMITDFGLS----KMEQNGIMSTACGTPGYVAPEVLAQK 182

Query: 192 GYDGATSDIWSCGVILYI-------FRG---------------DFKLPKW--LSPGAQNL 227
            Y     D WS GVI YI       F                 +F+ P W  +S  A++ 
Sbjct: 183 PY-SKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFESPFWDDISESAKDF 241

Query: 228 LRKILEPNPVKRITIAGIKADEWFEQDYTPANPDDDE 264
           +  +LE +P +R T     +  W + +          
Sbjct: 242 ICHLLEKDPNERYTCEKALSHPWIDGNTALHRDIYPS 278

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score =  289 bits (741), Expect = 3e-95
 Identities = 92/278 (33%), Positives = 142/278 (51%), Gaps = 32/278 (11%)

Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
            Y++   LG+G F  V+      +GL FA KI+   ++        ++RE    + L+HP
Sbjct: 30  NYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQK-LEREARICRKLQHP 88

Query: 75  NVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKG 134
           N+VRLH+ +  +S  Y+V + VTGGELF+ I ++    EA+     QQ+++ ++YCH+ G
Sbjct: 89  NIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNG 148

Query: 135 VFHRDLKLENILLDSKGN---IKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANR 191
           + HR+LK EN+LL SK     +K++DFGL+       D    H   G+P Y++PEVL   
Sbjct: 149 IVHRNLKPENLLLASKAKGAAVKLADFGLAI---EVNDSEAWHGFAGTPGYLSPEVLKKD 205

Query: 192 GYDGATSDIWSCGVILYI-------FRG---------------DFKLPKW--LSPGAQNL 227
            Y     DIW+CGVILYI       F                 D+  P+W  ++P A++L
Sbjct: 206 PY-SKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSL 264

Query: 228 LRKILEPNPVKRITIAGIKADEWFEQDYTPANPDDDEE 265
           +  +L  NP KRIT        W       A+    ++
Sbjct: 265 IDSMLTVNPKKRITADQALKVPWICNRERVASAIHRQD 302

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score =  282 bits (723), Expect = 2e-93
 Identities = 101/267 (37%), Positives = 144/267 (53%), Gaps = 33/267 (12%)

Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
           RY +   LG+G+FG+V   +D  +   +AVK++ K    + K T  I RE+  LK L HP
Sbjct: 23  RYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKN-KDTSTILREVELLKKLDHP 81

Query: 75  NVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKG 134
           N+++L E+L   S  Y+V E  TGGELFD+I  + R  E +  ++ +Q+  G++Y H   
Sbjct: 82  NIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHN 141

Query: 135 VFHRDLKLENILLDSKG---NIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANR 191
           + HRDLK ENILL+SK    +IKI DFGLS     F+ +  +    G+  Y+APEVL   
Sbjct: 142 IVHRDLKPENILLESKEKDCDIKIIDFGLST---CFQQNTKMKDRIGTAYYIAPEVL-RG 197

Query: 192 GYDGATSDIWSCGVILYI-------FRG---------------DFKLPKW--LSPGAQNL 227
            YD    D+WS GVILYI       F G                F LP+W  +S  A++L
Sbjct: 198 TYDEK-CDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDL 256

Query: 228 LRKILEPNPVKRITIAGIKADEWFEQD 254
           +RK+L  +P  RIT        W ++ 
Sbjct: 257 IRKMLTFHPSLRITATQCLEHPWIQKY 283

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score =  280 bits (718), Expect = 9e-93
 Identities = 86/269 (31%), Positives = 131/269 (48%), Gaps = 37/269 (13%)

Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
            +   R LG G FG V   ++  SGL   +K + K+R       +QI+ EI  LK L HP
Sbjct: 23  LFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPM--EQIEAEIEVLKSLDHP 80

Query: 75  NVVRLHEVLASKSKIYMVLEYVTGGELFDKIASK----GRLQEAEGRKLFQQLIDGVSYC 130
           N++++ EV      +Y+V+E   GGEL ++I S       L E    +L +Q+++ ++Y 
Sbjct: 81  NIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYF 140

Query: 131 HNKGVFHRDLKLENILLDSK---GNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEV 187
           H++ V H+DLK ENIL         IKI DFGL+     F+ D       G+  Y+APEV
Sbjct: 141 HSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAE---LFKSDEHSTNAAGTALYMAPEV 197

Query: 188 LANRGYDGATSDIWSCGVILYI-------F-------------RGDFKL---PKWLSPGA 224
              R       DIWS GV++Y        F               +       + L+P A
Sbjct: 198 F-KRDVTFKC-DIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYAVECRPLTPQA 255

Query: 225 QNLLRKILEPNPVKRITIAGIKADEWFEQ 253
            +LL+++L  +P +R + A +   EWF+Q
Sbjct: 256 VDLLKQMLTKDPERRPSAAQVLHHEWFKQ 284

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  280 bits (719), Expect = 1e-92
 Identities = 62/280 (22%), Positives = 115/280 (41%), Gaps = 39/280 (13%)

Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
            Y + + +G G   KV    +    + +A+K +      + +  D  + EIA L  L+  
Sbjct: 29  IYSILKQIGSGGSSKVFQVLNEKKQI-YAIKYVNLEEADN-QTLDSYRNEIAYLNKLQQH 86

Query: 75  N--VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHN 132
           +  ++RL++   +   IYMV+E     +L   +  K  +   E +  ++ +++ V   H 
Sbjct: 87  SDKIIRLYDYEITDQYIYMVMECG-NIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQ 145

Query: 133 KGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRG 192
            G+ H DLK  N L+   G +K+ DFG++   Q      +  +  G+ NY+ PE + +  
Sbjct: 146 HGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMS 204

Query: 193 YD----------GATSDIWSCGVILYIF-----------------------RGDFKLPKW 219
                          SD+WS G ILY                           + + P  
Sbjct: 205 SSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDI 264

Query: 220 LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPAN 259
                Q++L+  L+ +P +RI+I  + A  + +    P N
Sbjct: 265 PEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVN 304

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score =  277 bits (711), Expect = 9e-92
 Identities = 86/271 (31%), Positives = 137/271 (50%), Gaps = 35/271 (12%)

Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRII---HLKITDQIKREIATLKLL 71
            YE+G  LG G F  V+  +   +G  +A K ++K R+         ++I+RE+  L+ +
Sbjct: 6   HYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREI 65

Query: 72  KHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCH 131
           +HPN++ LH++  +K+ + ++LE V+GGELFD +A K  L E E  +  +Q++DGV Y H
Sbjct: 66  RHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLH 125

Query: 132 NKGVFHRDLKLENILLDSK----GNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEV 187
           +K + H DLK ENI+L  K      IK+ DFG++                G+P +VAPE+
Sbjct: 126 SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIA---HKIEAGNEFKNIFGTPEFVAPEI 182

Query: 188 LANRGYDGATSDIWSCGVILYI-------FRG---------------DFKLPKW--LSPG 223
           +          D+WS GVI YI       F G               DF    +   S  
Sbjct: 183 VNYEPLGLEA-DMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFSNTSEL 241

Query: 224 AQNLLRKILEPNPVKRITIAGIKADEWFEQD 254
           A++ +R++L  +P +R+TIA      W +  
Sbjct: 242 AKDFIRRLLVKDPKRRMTIAQSLEHSWIKAI 272

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score =  282 bits (724), Expect = 1e-91
 Identities = 94/279 (33%), Positives = 143/279 (51%), Gaps = 33/279 (11%)

Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
            Y+L   LG+G F  V+    + +G  +A  I+   ++        ++RE    +LLKHP
Sbjct: 12  EYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQK-LEREARICRLLKHP 70

Query: 75  NVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKG 134
           N+VRLH+ ++ +   Y++ + VTGGELF+ I ++    EA+     QQ+++ V +CH  G
Sbjct: 71  NIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMG 130

Query: 135 VFHRDLKLENILLDSKGN---IKISDFGLSALPQHFRDDG-LLHTTCGSPNYVAPEVLAN 190
           V HR+LK EN+LL SK     +K++DFGL+        +        G+P Y++PEVL  
Sbjct: 131 VVHRNLKPENLLLASKLKGAAVKLADFGLAI---EVEGEQQAWFGFAGTPGYLSPEVLRK 187

Query: 191 RGYDGATSDIWSCGVILYI-------FRG---------------DFKLPKW--LSPGAQN 226
             Y G   D+W+CGVILYI       F                 DF  P+W  ++P A++
Sbjct: 188 DPY-GKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPEAKD 246

Query: 227 LLRKILEPNPVKRITIAGIKADEWFEQDYTPANPDDDEE 265
           L+ K+L  NP KRIT A      W     T A+    +E
Sbjct: 247 LINKMLTINPSKRITAAEALKHPWISHRSTVASCMHRQE 285

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score =  277 bits (712), Expect = 2e-91
 Identities = 90/288 (31%), Positives = 140/288 (48%), Gaps = 35/288 (12%)

Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKIT---DQIKREIATLKLL 71
            Y++G  LG G F  VK  ++  +GL +A K ++K +    +     ++I+RE++ L+ +
Sbjct: 13  FYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQV 72

Query: 72  KHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCH 131
            H NV+ LH+V  +++ + ++LE V+GGELFD +A K  L E E     +Q++DGV+Y H
Sbjct: 73  LHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLH 132

Query: 132 NKGVFHRDLKLENILLDSK----GNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEV 187
            K + H DLK ENI+L  K     +IK+ DFGL+       D        G+P +VAPE+
Sbjct: 133 TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA---HEIEDGVEFKNIFGTPEFVAPEI 189

Query: 188 LANRGYDGATSDIWSCGVILYI-------FRG---------------DFKLPKW--LSPG 223
           +          D+WS GVI YI       F G               DF    +   S  
Sbjct: 190 VNYEPLGLEA-DMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFFSHTSEL 248

Query: 224 AQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPANPDDDEEDIFVDN 271
           A++ +RK+L     KR+TI       W             E  + ++N
Sbjct: 249 AKDFIRKLLVKETRKRLTIQEALRHPWITPVDNQQAMVRRESVVNLEN 296

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score =  277 bits (710), Expect = 9e-91
 Identities = 82/283 (28%), Positives = 135/283 (47%), Gaps = 36/283 (12%)

Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQ--IKREIATLKLLK 72
            YEL   +G+G F  V+   + ++G  FAVKI++  +           +KRE +   +LK
Sbjct: 25  VYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLK 84

Query: 73  HPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQ----EAEGRKLFQQLIDGVS 128
           HP++V L E  +S   +YMV E++ G +L  +I  +        EA      +Q+++ + 
Sbjct: 85  HPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALR 144

Query: 129 YCHNKGVFHRDLKLENILLDSKGN---IKISDFGLSALPQHFRDDGLLHTTCGSPNYVAP 185
           YCH+  + HRD+K   +LL SK N   +K+  FG++   Q      +     G+P+++AP
Sbjct: 145 YCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAI--QLGESGLVAGGRVGTPHFMAP 202

Query: 186 EVLANRGYDGATSDIWSCGVILYI-------FRG--------------DFKLPKW--LSP 222
           EV+    Y G   D+W CGVIL+I       F G                   +W  +S 
Sbjct: 203 EVVKREPY-GKPVDVWGCGVILFILLSGCLPFYGTKERLFEGIIKGKYKMNPRQWSHISE 261

Query: 223 GAQNLLRKILEPNPVKRITIAGIKADEWF-EQDYTPANPDDDE 264
            A++L+R++L  +P +RIT+       W  E+D         E
Sbjct: 262 SAKDLVRRMLMLDPAERITVYEALNHPWLKERDRYAYKIHLPE 304

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score =  277 bits (710), Expect = 1e-90
 Identities = 89/278 (32%), Positives = 133/278 (47%), Gaps = 38/278 (13%)

Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
            +E+   LG G    V   +   +  P+A+K+L+K           ++ EI  L  L HP
Sbjct: 54  FFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKT-----VDKKIVRTEIGVLLRLSHP 108

Query: 75  NVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKG 134
           N+++L E+  + ++I +VLE VTGGELFD+I  KG   E +     +Q+++ V+Y H  G
Sbjct: 109 NIIKLKEIFETPTEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENG 168

Query: 135 VFHRDLKLENILLDSKG---NIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANR 191
           + HRDLK EN+L  +      +KI+DFGLS   +      L+ T CG+P Y APE+L   
Sbjct: 169 IVHRDLKPENLLYATPAPDAPLKIADFGLS---KIVEHQVLMKTVCGTPGYCAPEILRGC 225

Query: 192 GYDGATSDIWSCGVILYI-------FRG----------------DFKLPKW--LSPGAQN 226
            Y G   D+WS G+I YI       F                   F  P W  +S  A++
Sbjct: 226 AY-GPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPWWDEVSLNAKD 284

Query: 227 LLRKILEPNPVKRITIAGIKADEWFEQDYTPANPDDDE 264
           L+RK++  +P KR+T        W            D 
Sbjct: 285 LVRKLIVLDPKKRLTTFQALQHPWV-TGKAANFVHMDT 321

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score =  277 bits (710), Expect = 1e-90
 Identities = 91/288 (31%), Positives = 141/288 (48%), Gaps = 35/288 (12%)

Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRII---HLKITDQIKREIATLKLL 71
            Y++G  LG G F  VK  ++  +GL +A K ++K +          ++I+RE++ L+ +
Sbjct: 13  FYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQV 72

Query: 72  KHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCH 131
            HPN++ LH+V  +++ + ++LE V+GGELFD +A K  L E E     +Q++DGV+Y H
Sbjct: 73  LHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLH 132

Query: 132 NKGVFHRDLKLENILLDSK----GNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEV 187
            K + H DLK ENI+L  K     +IK+ DFGL+       D        G+P +VAPE+
Sbjct: 133 TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA---HEIEDGVEFKNIFGTPEFVAPEI 189

Query: 188 LANRGYDGATSDIWSCGVILYI-------FRG---------------DFKLPKW--LSPG 223
           +          D+WS GVI YI       F G               DF    +   S  
Sbjct: 190 VNYEPLGLEA-DMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFFSQTSEL 248

Query: 224 AQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPANPDDDEEDIFVDN 271
           A++ +RK+L     KR+TI       W     T       E  + ++N
Sbjct: 249 AKDFIRKLLVKETRKRLTIQEALRHPWITPVDTQQAMVRRESVVNLEN 296

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score =  279 bits (715), Expect = 1e-89
 Identities = 101/276 (36%), Positives = 145/276 (52%), Gaps = 33/276 (11%)

Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
           RY +   LG+G+FG+V   +D  +   +AVK++ K    + K T  I RE+  LK L HP
Sbjct: 23  RYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKN-KDTSTILREVELLKKLDHP 81

Query: 75  NVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKG 134
           N+++L E+L   S  Y+V E  TGGELFD+I  + R  E +  ++ +Q+  G++Y H   
Sbjct: 82  NIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHN 141

Query: 135 VFHRDLKLENILLDSKG---NIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANR 191
           + HRDLK ENILL+SK    +IKI DFGLS     F+ +  +    G+  Y+APEVL   
Sbjct: 142 IVHRDLKPENILLESKEKDCDIKIIDFGLS---TCFQQNTKMKDRIGTAYYIAPEVL-RG 197

Query: 192 GYDGATSDIWSCGVILYI-------FRG---------------DFKLPKW--LSPGAQNL 227
            Y     D+WS GVILYI       F G                F LP+W  +S  A++L
Sbjct: 198 TY-DEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDL 256

Query: 228 LRKILEPNPVKRITIAGIKADEWFEQDYTPANPDDD 263
           +RK+L  +P  RIT        W ++  +      D
Sbjct: 257 IRKMLTFHPSLRITATQCLEHPWIQKYSSETPTISD 292

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score =  273 bits (701), Expect = 1e-89
 Identities = 90/288 (31%), Positives = 140/288 (48%), Gaps = 35/288 (12%)

Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKIT---DQIKREIATLKLL 71
            Y+ G  LG G F  VK  ++  +GL +A K ++K R    +     + I+RE++ LK +
Sbjct: 12  YYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEI 71

Query: 72  KHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCH 131
           +HPNV+ LHEV  +K+ + ++LE V GGELFD +A K  L E E  +  +Q+++GV Y H
Sbjct: 72  QHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLH 131

Query: 132 NKGVFHRDLKLENILLDSK----GNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEV 187
           +  + H DLK ENI+L  +      IKI DFGL+                G+P +VAPE+
Sbjct: 132 SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA---HKIDFGNEFKNIFGTPEFVAPEI 188

Query: 188 LANRGYDGATSDIWSCGVILYI-------FRG---------------DFKLPKW--LSPG 223
           +          D+WS GVI YI       F G               +F+   +   S  
Sbjct: 189 VNYEPLGLEA-DMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSAL 247

Query: 224 AQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPANPDDDEEDIFVDN 271
           A++ +R++L  +P KR+TI       W +   T          + ++ 
Sbjct: 248 AKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDTQQALSRKASAVNMEK 295

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score =  273 bits (700), Expect = 3e-89
 Identities = 87/284 (30%), Positives = 130/284 (45%), Gaps = 42/284 (14%)

Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATL-KLLKH 73
            YE+   +G G++   K      + + FAVKI++K++            EI  L +  +H
Sbjct: 23  GYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR-------DPTEEIEILLRYGQH 75

Query: 74  PNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNK 133
           PN++ L +V      +Y+V E + GGEL DKI  +    E E   +   +   V Y H +
Sbjct: 76  PNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQ 135

Query: 134 GVFHRDLKLENILLDSKG----NIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLA 189
           GV HRDLK  NIL   +     +I+I DFG +   Q   ++GLL T C + N+VAPEVL 
Sbjct: 136 GVVHRDLKPSNILYVDESGNPESIRICDFGFAK--QLRAENGLLMTPCYTANFVAPEVLE 193

Query: 190 NRGYDGATSDIWSCGVILYI-------FRG------------------DFKLPKW--LSP 222
            +GYD A  DIWS GV+LY        F                          W  +S 
Sbjct: 194 RQGYDAA-CDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGGYWNSVSD 252

Query: 223 GAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPANPDDDEED 266
            A++L+ K+L  +P +R+T A +    W            + +D
Sbjct: 253 TAKDLVSKMLHVDPHQRLTAALVLRHPWIVHWDQLPQYQLNRQD 296

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score =  278 bits (712), Expect = 4e-89
 Identities = 89/292 (30%), Positives = 140/292 (47%), Gaps = 42/292 (14%)

Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKIT----------DQIKRE 64
            Y   R LG G +G+V   ++ +     A+K+++K++    + +          ++I  E
Sbjct: 37  SYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNE 96

Query: 65  IATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLI 124
           I+ LK L HPN+++L +V   K   Y+V E+  GGELF++I ++ +  E +   + +Q++
Sbjct: 97  ISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQIL 156

Query: 125 DGVSYCHNKGVFHRDLKLENILLDSKG---NIKISDFGLSALPQHFRDDGLLHTTCGSPN 181
            G+ Y H   + HRD+K ENILL++K    NIKI DFGLS     F  D  L    G+  
Sbjct: 157 SGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLS---SFFSKDYKLRDRLGTAY 213

Query: 182 YVAPEVLANRGYDGATSDIWSCGVILYI-------FRG---------------DFKLPKW 219
           Y+APEVL  + Y     D+WSCGVI+YI       F G                F    W
Sbjct: 214 YIAPEVL-KKKY-NEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYFDFNDW 271

Query: 220 --LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPANPDDDEEDIFV 269
             +S  A+ L++ +L  +  KR T        W ++     N  D +     
Sbjct: 272 KNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKYANNINKSDQKTLCGA 323

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  272 bits (698), Expect = 5e-89
 Identities = 62/285 (21%), Positives = 115/285 (40%), Gaps = 39/285 (13%)

Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
            Y + + +G G   KV    + +    +A+K +      + +  D  + EIA L  L+  
Sbjct: 10  IYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADN-QTLDSYRNEIAYLNKLQQH 67

Query: 75  N--VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHN 132
           +  ++RL++   +   IYMV+E     +L   +  K  +   E +  ++ +++ V   H 
Sbjct: 68  SDKIIRLYDYEITDQYIYMVMECG-NIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQ 126

Query: 133 KGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRG 192
            G+ H DLK  N L+   G +K+ DFG++   Q      +  +  G+ NY+ PE + +  
Sbjct: 127 HGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMS 185

Query: 193 YD----------GATSDIWSCGVILYIF-----------------------RGDFKLPKW 219
                          SD+WS G ILY                           + + P  
Sbjct: 186 SSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDI 245

Query: 220 LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPANPDDDE 264
                Q++L+  L+ +P +RI+I  + A  + +    P N     
Sbjct: 246 PEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVNQMAKG 290

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score =  276 bits (709), Expect = 6e-89
 Identities = 100/282 (35%), Positives = 146/282 (51%), Gaps = 32/282 (11%)

Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
           RY+  R LG+G+FG+V   +D  +G   AVK++ K ++      + + RE+  LK L HP
Sbjct: 27  RYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHP 86

Query: 75  NVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKG 134
           N+++L+E    K   Y+V E  TGGELFD+I S+ R  E +  ++ +Q++ G++Y H   
Sbjct: 87  NIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNK 146

Query: 135 VFHRDLKLENILLDSKG---NIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANR 191
           + HRDLK EN+LL+SK    NI+I DFGLS    HF     +    G+  Y+APEVL + 
Sbjct: 147 IVHRDLKPENLLLESKSKDANIRIIDFGLS---THFEASKKMKDKIGTAYYIAPEVL-HG 202

Query: 192 GYDGATSDIWSCGVILYI-------FRG---------------DFKLPKW--LSPGAQNL 227
            Y     D+WS GVILYI       F G                F+LP+W  +S  A++L
Sbjct: 203 TY-DEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESAKDL 261

Query: 228 LRKILEPNPVKRITIAGIKADEWFEQDYTPANPDDDEEDIFV 269
           +RK+L   P  RI+       EW +         D       
Sbjct: 262 IRKMLTYVPSMRISARDALDHEWIQTYTKEQISVDVPSLDNA 303

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  271 bits (695), Expect = 7e-89
 Identities = 65/309 (21%), Positives = 108/309 (34%), Gaps = 70/309 (22%)

Query: 14  GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKH 73
             + L   LG+G    V   +   +G  FA+K+        L+  D   RE   LK L H
Sbjct: 9   HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISF--LRPVDVQMREFEVLKKLNH 66

Query: 74  PNVVRLHEVL--ASKSKIYMVLEYVTGGELFDKIASKGR---LQEAEGRKLFQQLIDGVS 128
            N+V+L  +    +     +++E+   G L+  +        L E+E   + + ++ G++
Sbjct: 67  KNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMN 126

Query: 129 YCHNKGVFHRDLKLENILL----DSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVA 184
           +    G+ HR++K  NI+     D +   K++DFG +       DD    +  G+  Y+ 
Sbjct: 127 HLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR---ELEDDEQFVSLYGTEEYLH 183

Query: 185 PEVLANRGYD-------GATSDIWSCGVILYI-------FRGD----------------- 213
           P++              GAT D+WS GV  Y        FR                   
Sbjct: 184 PDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGK 243

Query: 214 -------------------FKLPKW--LSPGAQN----LLRKILEPNPVKRITIAGIKAD 248
                                +P    LS G Q     +L  ILE +  K        A+
Sbjct: 244 PSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAE 303

Query: 249 EWFEQDYTP 257
                    
Sbjct: 304 TSDILHRGN 312

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score =  271 bits (694), Expect = 2e-88
 Identities = 86/312 (27%), Positives = 130/312 (41%), Gaps = 73/312 (23%)

Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQ--IKREIATLKLLK 72
           +Y L   +G+G++G V+ A +  +    A+KI+ KN+I  +   D   IK E+  +K L 
Sbjct: 27  KYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLH 86

Query: 73  HPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQ-------------------- 112
           HPN+ RL+EV   +  I +V+E   GG L DK+                           
Sbjct: 87  HPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECN 146

Query: 113 --------------------EAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGN 152
                               E     + +Q+   + Y HN+G+ HRD+K EN L  +  +
Sbjct: 147 EEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFSTNKS 206

Query: 153 --IKISDFGLSAL--PQHFRDDGLLHTTCGSPNYVAPEVL--ANRGYDGATSDIWSCGVI 206
             IK+ DFGLS      +  +   + T  G+P +VAPEVL   N  Y     D WS GV+
Sbjct: 207 FEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKC-DAWSAGVL 265

Query: 207 LYI-------FRG---------------DFKLPKW--LSPGAQNLLRKILEPNPVKRITI 242
           L++       F G                F+ P +  LSP A++LL  +L  N  +R   
Sbjct: 266 LHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFDA 325

Query: 243 AGIKADEWFEQD 254
                  W  Q 
Sbjct: 326 MRALQHPWISQF 337

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  281 bits (719), Expect = 2e-88
 Identities = 83/456 (18%), Positives = 138/456 (30%), Gaps = 81/456 (17%)

Query: 12  RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL 71
             G +E+   LG G FG V      D+G   A+K   +      K  ++   EI  +K L
Sbjct: 12  TCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSP--KNRERWCLEIQIMKKL 69

Query: 72  KHPNVVRLHEVLASKSKI------YMVLEYVTGGELFDKIASKGR---LQEAEGRKLFQQ 122
            HPNVV   EV     K+       + +EY  GG+L   +        L+E   R L   
Sbjct: 70  NHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSD 129

Query: 123 LIDGVSYCHNKGVFHRDLKLENILLDSKGN---IKISDFGLSALPQHFRDDGLLHTTCGS 179
           +   + Y H   + HRDLK ENI+L         KI D G +   +      L     G+
Sbjct: 130 ISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYA---KELDQGELCTEFVGT 186

Query: 180 PNYVAPEVLANRGYDGATSDIWSCGVILYI------------------------------ 209
             Y+APE+L  + Y   T D WS G + +                               
Sbjct: 187 LQYLAPELLEQKKYT-VTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIV 245

Query: 210 ----------FRGDFKLPKWLSPGAQNL----LRKILEPNPVKRITIAGIKADEWFEQDY 255
                     F      P  LS          L+ +L  +  +R T         F+   
Sbjct: 246 VYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQA-- 303

Query: 256 TPANPDDDEEDIFVDNEAFSMHEVPSDGGRTPGSPPLINAFQ-LIGMSSCLDLSG--FFE 312
             +        +        +H  P            +   +  +   + +        +
Sbjct: 304 LDSILSLKLLSVMNMVS-GRVHTYPVTENEN------LQNLKSWLQQDTGIPEEEQELLQ 356

Query: 313 KEDVSERKIRFTSNHSAKDLLERIEDIVTEMGFRVQKKNGKLKATQEHKPQKSLGSLSVA 372
              ++    +  + +     +        ++ F    +    +              SV+
Sbjct: 357 ASGLALNSAQPLTQYVIDCTVIDGRQGEGDLIFLFDNRKTVYEPQISLPAH----PESVS 412

Query: 373 AEVFEISPSLYVVELRKSYGDPTVYRQLCNKLSSDL 408
             + +    L    LR+ +G      Q    L  D 
Sbjct: 413 IVLQDPKRPLTYTHLRRVWGQIW---QTIRALKEDC 445

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  272 bits (697), Expect = 3e-88
 Identities = 62/286 (21%), Positives = 115/286 (40%), Gaps = 39/286 (13%)

Query: 14  GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKH 73
             Y + + +G G   KV    + +    +A+K +      + +  D  + EIA L  L+ 
Sbjct: 56  RIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADN-QTLDSYRNEIAYLNKLQQ 113

Query: 74  PN--VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCH 131
            +  ++RL++   +   IYMV+E     +L   +  K  +   E +  ++ +++ V   H
Sbjct: 114 HSDKIIRLYDYEITDQYIYMVMECG-NIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIH 172

Query: 132 NKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANR 191
             G+ H DLK  N L+   G +K+ DFG++   Q      +  +  G+ NY+ PE + + 
Sbjct: 173 QHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDM 231

Query: 192 GYD----------GATSDIWSCGVILYIF-----------------------RGDFKLPK 218
                           SD+WS G ILY                           + + P 
Sbjct: 232 SSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPD 291

Query: 219 WLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPANPDDDE 264
                 Q++L+  L+ +P +RI+I  + A  + +    P N     
Sbjct: 292 IPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVNQMAKG 337

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score =  273 bits (700), Expect = 2e-87
 Identities = 87/276 (31%), Positives = 142/276 (51%), Gaps = 33/276 (11%)

Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
            Y+  + LG G +G+V   +D  + +  A+KI+ K  +     +  +  E+A LKLL HP
Sbjct: 38  MYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSK-LLEEVAVLKLLDHP 96

Query: 75  NVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKG 134
           N+++L++    K   Y+V+E   GGELFD+I  + +  E +   + +Q++ GV+Y H   
Sbjct: 97  NIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHN 156

Query: 135 VFHRDLKLENILLDSKG---NIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANR 191
           + HRDLK EN+LL+SK     IKI DFGLS     F +   +    G+  Y+APEVL  +
Sbjct: 157 IVHRDLKPENLLLESKEKDALIKIVDFGLS---AVFENQKKMKERLGTAYYIAPEVL-RK 212

Query: 192 GYDGATSDIWSCGVILYI-------FRG---------------DFKLPKW--LSPGAQNL 227
            Y     D+WS GVIL+I       F G                F  P+W  +S GA++L
Sbjct: 213 KY-DEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKNVSEGAKDL 271

Query: 228 LRKILEPNPVKRITIAGIKADEWFEQDYTPANPDDD 263
           ++++L+ +  +RI+        W ++  +      +
Sbjct: 272 IKQMLQFDSQRRISAQQALEHPWIKEMCSKKESGIE 307

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score =  266 bits (683), Expect = 5e-87
 Identities = 95/298 (31%), Positives = 146/298 (48%), Gaps = 48/298 (16%)

Query: 15  RYELG---RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL 71
            Y+L    + LGEG+F   +      S   FAVKI+ K            ++EI  LKL 
Sbjct: 9   HYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRME------ANTQKEITALKLC 62

Query: 72  K-HPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYC 130
           + HPN+V+LHEV   +   ++V+E + GGELF++I  K    E E   + ++L+  VS+ 
Sbjct: 63  EGHPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHM 122

Query: 131 HNKGVFHRDLKLENILLDSKG---NIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEV 187
           H+ GV HRDLK EN+L   +     IKI DFG + L     D+  L T C + +Y APE+
Sbjct: 123 HDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPP--DNQPLKTPCFTLHYAAPEL 180

Query: 188 LANRGYDGATSDIWSCGVILYI-------FRG----------------------DFKLPK 218
           L   GYD +  D+WS GVILY        F+                        F+   
Sbjct: 181 LNQNGYDES-CDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEA 239

Query: 219 W--LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD-YTPANPDDDEEDIFVDNEA 273
           W  +S  A++L++ +L  +P KR+ ++G++ +EW +      +NP    + +     A
Sbjct: 240 WKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDGSQLSSNPLMTPDILGSSGAA 297

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score =  266 bits (682), Expect = 6e-87
 Identities = 61/274 (22%), Positives = 117/274 (42%), Gaps = 35/274 (12%)

Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
           +Y +   LG G FG V    +  S   +  K ++            +K+EI+ L + +H 
Sbjct: 6   KYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQ----VLVKKEISILNIARHR 61

Query: 75  NVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKG-RLQEAEGRKLFQQLIDGVSYCHNK 133
           N++ LHE   S  ++ M+ E+++G ++F++I +    L E E      Q+ + + + H+ 
Sbjct: 62  NILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSH 121

Query: 134 GVFHRDLKLENILLDSKGN--IKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANR 191
            + H D++ ENI+  ++ +  IKI +FG +   +  +          +P Y APEV  + 
Sbjct: 122 NIGHFDIRPENIIYQTRRSSTIKIIEFGQA---RQLKPGDNFRLLFTAPEYYAPEVHQHD 178

Query: 192 GYDGATSDIWSCGVILYI-------FRG---------------DFKLPKW--LSPGAQNL 227
               AT D+WS G ++Y+       F                  F    +  +S  A + 
Sbjct: 179 VVSTAT-DMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDF 237

Query: 228 LRKILEPNPVKRITIAGIKADEWFEQDYTPANPD 261
           + ++L      R+T +      W +Q     +  
Sbjct: 238 VDRLLVKERKSRMTASEALQHPWLKQKIERVSTK 271

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  267 bits (683), Expect = 4e-86
 Identities = 66/312 (21%), Positives = 112/312 (35%), Gaps = 75/312 (24%)

Query: 7   KQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIA 66
             +      + L   LG+G    V   +   +G  FA+K+        L+  D   RE  
Sbjct: 2   GSQSTSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISF--LRPVDVQMREFE 59

Query: 67  TLKLLKHPNVVRLHEVL--ASKSKIYMVLEYVTGGELFDKIASKGR---LQEAEGRKLFQ 121
            LK L H N+V+L  +    +     +++E+   G L+  +        L E+E   + +
Sbjct: 60  VLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLR 119

Query: 122 QLIDGVSYCHNKGVFHRDLKLENILL----DSKGNIKISDFGLSALPQHFRDDGLLHTTC 177
            ++ G+++    G+ HR++K  NI+     D +   K++DFG +       DD    +  
Sbjct: 120 DVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR---ELEDDEQFVSLY 176

Query: 178 GSPNYVAPEVLANRGYD-------GATSDIWSCGVILYI-------FRGD---------- 213
           G+  Y+ P++              GAT D+WS GV  Y        FR            
Sbjct: 177 GTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVM 236

Query: 214 --------------------------FKLPKW--LSPGAQ----NLLRKILEPNPVKRIT 241
                                       +P    LS G Q     +L  ILE +  K   
Sbjct: 237 YKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWG 296

Query: 242 IAGIKADEWFEQ 253
                 D++F +
Sbjct: 297 F-----DQFFAE 303

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score =  261 bits (670), Expect = 3e-85
 Identities = 86/300 (28%), Positives = 126/300 (42%), Gaps = 59/300 (19%)

Query: 15  RYELGR-TLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK- 72
            Y+L    LGEG   +V+   +L +   +AVKI+EK       I  ++ RE+  L   + 
Sbjct: 13  VYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQP---GHIRSRVFREVEMLYQCQG 69

Query: 73  HPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHN 132
           H NV+ L E    + + Y+V E + GG +   I  +    E E   + Q +   + + HN
Sbjct: 70  HRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHN 129

Query: 133 KGVFHRDLKLENILLDSKGN---IKISDFGLSAL-----PQHFRDDGLLHTTCGSPNYVA 184
           KG+ HRDLK ENIL +       +KI DF L +               L T CGS  Y+A
Sbjct: 130 KGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMA 189

Query: 185 PEVL-----ANRGYDGATSDIWSCGVILYI-------FRG-------------------- 212
           PEV+         YD    D+WS GVILYI       F G                    
Sbjct: 190 PEVVEAFSEEASIYDKR-CDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNM 248

Query: 213 ----------DFKLPKW--LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPANP 260
                     +F    W  +S  A++L+ K+L  +  +R++ A +    W  Q   P N 
Sbjct: 249 LFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWV-QGCAPENT 307

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score =  259 bits (664), Expect = 4e-84
 Identities = 90/282 (31%), Positives = 132/282 (46%), Gaps = 37/282 (13%)

Query: 15  RYEL-GRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKH 73
            Y L  + LG G F  V+      +G  +A K L+K R       + I  EIA L+L K 
Sbjct: 29  FYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAE-ILHEIAVLELAKS 87

Query: 74  -PNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASK--GRLQEAEGRKLFQQLIDGVSYC 130
            P V+ LHEV  + S+I ++LEY  GGE+F     +    + E +  +L +Q+++GV Y 
Sbjct: 88  CPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYL 147

Query: 131 HNKGVFHRDLKLENILLDSK---GNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEV 187
           H   + H DLK +NILL S    G+IKI DFG+S   +       L    G+P Y+APE+
Sbjct: 148 HQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMS---RKIGHACELREIMGTPEYLAPEI 204

Query: 188 LANRGYDGATSDIWSCGVILYI-------FRG---------------DFKLPKW--LSPG 223
           L       AT D+W+ G+I Y+       F G               D+    +  +S  
Sbjct: 205 LNYDPITTAT-DMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSEETFSSVSQL 263

Query: 224 AQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPANPDDDEE 265
           A + ++ +L  NP KR T     +  W  Q +   N    EE
Sbjct: 264 ATDFIQSLLVKNPEKRPTAEICLSHSWL-QQWDFENLFHPEE 304

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score =  261 bits (669), Expect = 4e-84
 Identities = 72/278 (25%), Positives = 130/278 (46%), Gaps = 34/278 (12%)

Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
            Y++   LG G FG V    +  +G  F  K +             +K EI+ +  L HP
Sbjct: 52  YYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY---PLDKYTVKNEISIMNQLHHP 108

Query: 75  NVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKG-RLQEAEGRKLFQQLIDGVSYCHNK 133
            ++ LH+    K ++ ++LE+++GGELFD+IA++  ++ EAE     +Q  +G+ + H  
Sbjct: 109 KLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEH 168

Query: 134 GVFHRDLKLENILLDSKGN--IKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANR 191
            + H D+K ENI+ ++K    +KI DFGL+        D ++  T  +  + APE++   
Sbjct: 169 SIVHLDIKPENIMCETKKASSVKIIDFGLA---TKLNPDEIVKVTTATAEFAAPEIVDRE 225

Query: 192 GYDGATSDIWSCGVILYI-------FRG---------------DFKLPKW--LSPGAQNL 227
                T D+W+ GV+ Y+       F G               +F    +  +SP A++ 
Sbjct: 226 PVGFYT-DMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDF 284

Query: 228 LRKILEPNPVKRITIAGIKADEWFEQDYTPANPDDDEE 265
           ++ +L+  P KR+T+       W + D++         
Sbjct: 285 IKNLLQKEPRKRLTVHDALEHPWLKGDHSNLTSRIPSS 322

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score =  259 bits (663), Expect = 8e-84
 Identities = 80/301 (26%), Positives = 132/301 (43%), Gaps = 53/301 (17%)

Query: 15  RYELGR-TLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATL-KLLK 72
            Y+L +  LG G  GKV       +G   A+K+L  +         + ++E+    +   
Sbjct: 29  DYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP--------KARQEVDHHWQASG 80

Query: 73  HPNVVRLHEV----LASKSKIYMVLEYVTGGELFDKIASKGRLQ--EAEGRKLFQQLIDG 126
            P++V + +V       K  + +++E + GGELF +I  +G     E E  ++ + +   
Sbjct: 81  GPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTA 140

Query: 127 VSYCHNKGVFHRDLKLENILLDSKG---NIKISDFGLSALPQHFRDDGLLHTTCGSPNYV 183
           + + H+  + HRD+K EN+L  SK     +K++DFG +           L T C +P YV
Sbjct: 141 IQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAK----ETTQNALQTPCYTPYYV 196

Query: 184 APEVLANRGYDGATSDIWSCGVILYI-------FRG-------------------DFKLP 217
           APEVL    YD +  D+WS GVI+YI       F                      F  P
Sbjct: 197 APEVLGPEKYDKS-CDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNP 255

Query: 218 KW--LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD-YTPANPDDDEEDIFVDNEAF 274
           +W  +S  A+ L+R +L+ +P +R+TI       W  Q    P  P      +  D + +
Sbjct: 256 EWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQSMVVPQTPLHTARVLQEDKDHW 315

Query: 275 S 275
            
Sbjct: 316 D 316

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score =  259 bits (664), Expect = 3e-83
 Identities = 78/300 (26%), Positives = 131/300 (43%), Gaps = 50/300 (16%)

Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLK-LLKHP 74
               + LG G  GKV    +  +   FA+K+L+           + +RE+       + P
Sbjct: 64  KVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD--------CPKARREVELHWRASQCP 115

Query: 75  NVVRLHEV----LASKSKIYMVLEYVTGGELFDKIASKGRLQ--EAEGRKLFQQLIDGVS 128
           ++VR+ +V     A +  + +V+E + GGELF +I  +G     E E  ++ + + + + 
Sbjct: 116 HIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQ 175

Query: 129 YCHNKGVFHRDLKLENILLDSKG---NIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAP 185
           Y H+  + HRD+K EN+L  SK     +K++DFG +   +       L T C +P YVAP
Sbjct: 176 YLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFA---KETTSHNSLTTPCYTPYYVAP 232

Query: 186 EVLANRGYDGATSDIWSCGVILYI-------FRG-------------------DFKLPKW 219
           EVL    YD +  D+WS GVI+YI       F                     +F  P+W
Sbjct: 233 EVLGPEKYDKS-CDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEW 291

Query: 220 --LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPANPDDDEEDIFVDNEAFSMH 277
             +S   + L+R +L+  P +R+TI       W  Q             +  +++     
Sbjct: 292 SEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWED 351

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score =  257 bits (658), Expect = 1e-82
 Identities = 80/269 (29%), Positives = 132/269 (49%), Gaps = 36/269 (13%)

Query: 15  RYELGRT--LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK 72
            Y + +T  LG G FG+V   ++  +GL  A KI++      +K  +++K EI+ +  L 
Sbjct: 88  FYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRG---MKDKEEVKNEISVMNQLD 144

Query: 73  HPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKG-RLQEAEGRKLFQQLIDGVSYCH 131
           H N+++L++   SK+ I +V+EYV GGELFD+I  +   L E +     +Q+ +G+ + H
Sbjct: 145 HANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMH 204

Query: 132 NKGVFHRDLKLENILLDSKGN--IKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLA 189
              + H DLK ENIL  ++    IKI DFGL+   + ++    L    G+P ++APEV+ 
Sbjct: 205 QMYILHLDLKPENILCVNRDAKQIKIIDFGLA---RRYKPREKLKVNFGTPEFLAPEVVN 261

Query: 190 NRGYDGATSDIWSCGVILYI-------FRG---------------DFKLPKW--LSPGAQ 225
                  T D+WS GVI Y+       F G               D +  ++  +S  A+
Sbjct: 262 YDFVSFPT-DMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEEFQDISEEAK 320

Query: 226 NLLRKILEPNPVKRITIAGIKADEWFEQD 254
             + K+L      RI+ +      W    
Sbjct: 321 EFISKLLIKEKSWRISASEALKHPWLSDH 349

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score =  262 bits (672), Expect = 2e-82
 Identities = 74/272 (27%), Positives = 125/272 (45%), Gaps = 34/272 (12%)

Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
            Y++   LG G FG V    +  +G  FA K +           + +++EI T+ +L+HP
Sbjct: 158 HYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH---ESDKETVRKEIQTMSVLRHP 214

Query: 75  NVVRLHEVLASKSKIYMVLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNK 133
            +V LH+     +++ M+ E+++GGELF+K+A +  ++ E E  +  +Q+  G+ + H  
Sbjct: 215 TLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHEN 274

Query: 134 GVFHRDLKLENILLDSKG--NIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANR 191
              H DLK ENI+  +K    +K+ DFGL+    H      +  T G+  + APEV   +
Sbjct: 275 NYVHLDLKPENIMFTTKRSNELKLIDFGLT---AHLDPKQSVKVTTGTAEFAAPEVAEGK 331

Query: 192 GYDGATSDIWSCGVILYI-------FRG---------------DFKLPKW--LSPGAQNL 227
                T D+WS GV+ YI       F G               +     +  +S   ++ 
Sbjct: 332 PVGYYT-DMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDF 390

Query: 228 LRKILEPNPVKRITIAGIKADEWFEQDYTPAN 259
           +RK+L  +P  R+TI       W      P  
Sbjct: 391 IRKLLLADPNTRMTIHQALEHPWLTPGNAPGR 422

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score =  237 bits (606), Expect = 1e-75
 Identities = 80/272 (29%), Positives = 128/272 (47%), Gaps = 27/272 (9%)

Query: 7   KQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIA 66
           +    R   ++ G+ LGEG+F  V  A++L +   +A+KILEK  II       + RE  
Sbjct: 23  QPRKKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERD 82

Query: 67  TLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDG 126
            +  L HP  V+L+       K+Y  L Y   GEL   I   G   E   R    +++  
Sbjct: 83  VMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSA 142

Query: 127 VSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPE 186
           + Y H KG+ HRDLK ENILL+   +I+I+DFG + +          ++  G+  YV+PE
Sbjct: 143 LEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPE 202

Query: 187 VLANRGYDGATSDIWSCGVILY--------------------IFRGDFKLPKWLSPGAQN 226
           +L  +     +SD+W+ G I+Y                    I + ++  P+   P A++
Sbjct: 203 LLTEKSA-CKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARD 261

Query: 227 LLRKILEPNPVKRITI------AGIKADEWFE 252
           L+ K+L  +  KR+          +KA  +FE
Sbjct: 262 LVEKLLVLDATKRLGCEEMEGYGPLKAHPFFE 293

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score =  236 bits (602), Expect = 3e-74
 Identities = 53/307 (17%), Positives = 96/307 (31%), Gaps = 65/307 (21%)

Query: 6   KKQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREI 65
           + + G R      G  LG+ +      A D ++G  F V +             Q+K E+
Sbjct: 65  ESELGERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEV 124

Query: 66  ATLKLLK-------------------------HPNVVRLHEVLASKSKIYMVLEY----- 95
             L+LL+                            ++R+         +     Y     
Sbjct: 125 LRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQS 184

Query: 96  ---VTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGN 152
                G  L    ++   L      +L  Q+I  ++  H+ G+ H  L+  +I+LD +G 
Sbjct: 185 NLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGG 244

Query: 153 IKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRG----------YDGATSDIWS 202
           + ++ F           DG    +  S  +  PE+ A R               + D W+
Sbjct: 245 VFLTGFEHL------VRDGARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWA 298

Query: 203 CGVILYI-------FRGD---------FKLPKWLSPGAQNLLRKILEPNPVKRITIAGIK 246
            G+++Y           D         F+  K +    + LL   L      R+      
Sbjct: 299 LGLVIYWIWCADLPITKDAALGGSEWIFRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAM 358

Query: 247 ADEWFEQ 253
               +EQ
Sbjct: 359 ETPEYEQ 365

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score =  237 bits (606), Expect = 4e-74
 Identities = 73/293 (24%), Positives = 111/293 (37%), Gaps = 65/293 (22%)

Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATL-KLLKH 73
                + LG G+ G V F      G P AVK +  +        D    EI  L +   H
Sbjct: 16  LVVSEKILGYGSSGTVVFQGSFQ-GRPVAVKRMLIDFC------DIALMEIKLLTESDDH 68

Query: 74  PNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKG-------RLQEAEGRKLFQQLIDG 126
           PNV+R +    +   +Y+ LE      L D + SK          +E     L +Q+  G
Sbjct: 69  PNVIRYYCSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASG 127

Query: 127 VSYCHNKGVFHRDLKLENILLDSKG-------------NIKISDFGLSAL--PQHFRDDG 171
           V++ H+  + HRDLK +NIL+ +                I ISDFGL             
Sbjct: 128 VAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRT 187

Query: 172 LLHTTCGSPNYVAPEVL-------ANRGYDGATSDIWSCGVILY---------------- 208
            L+   G+  + APE+L         R    +  DI+S G + Y                
Sbjct: 188 NLNNPSGTSGWRAPELLEESNNLQTKRRLTRS-IDIFSMGCVFYYILSKGKHPFGDKYSR 246

Query: 209 ---IFRGDFKLP-------KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWF 251
              I RG F L        + L   A +L+ ++++ +P+KR T   +     F
Sbjct: 247 ESNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLF 299

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score =  234 bits (598), Expect = 4e-74
 Identities = 81/304 (26%), Positives = 128/304 (42%), Gaps = 46/304 (15%)

Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK-H 73
           R  + R L EG F  V  AQD+ SG  +A+K L  N     +    I +E+  +K L  H
Sbjct: 29  RLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNR---AIIQEVCFMKKLSGH 85

Query: 74  PNVVRLH-------EVLASKSKIYMVLEYVTGGELFDKI---ASKGRLQEAEGRKLFQQL 123
           PN+V+         E   +    +++L  +  G+L + +    S+G L      K+F Q 
Sbjct: 86  PNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQT 145

Query: 124 IDGVSYCHNKG--VFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLH------- 174
              V + H +   + HRDLK+EN+LL ++G IK+ DFG +    H+ D            
Sbjct: 146 CRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVE 205

Query: 175 ---TTCGSPNYVAPEV--LANRGYDGATSDIWSCGVILY----------------IFRGD 213
              T   +P Y  PE+  L +    G   DIW+ G ILY                I  G 
Sbjct: 206 EEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLRIVNGK 265

Query: 214 FKLPKWL--SPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPANPDDDEEDIFVDN 271
           + +P          +L+R +L+ NP +R++IA +             NP     ++   N
Sbjct: 266 YSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAARNVNPKSPITELLEQN 325

Query: 272 EAFS 275
             + 
Sbjct: 326 GGYG 329

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  231 bits (591), Expect = 2e-73
 Identities = 62/286 (21%), Positives = 106/286 (37%), Gaps = 43/286 (15%)

Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
            Y   + LGEG F  V   + L  G  +A+K +  +     +   + +RE    +L  HP
Sbjct: 30  HYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDRE---EAQREADMHRLFNHP 86

Query: 75  NVVRLHEV----LASKSKIYMVLEYVTGGELFDKI----ASKGRLQEAEGRKLFQQLIDG 126
           N++RL         +K + +++L +   G L+++I         L E +   L   +  G
Sbjct: 87  NILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRG 146

Query: 127 VSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQH-------FRDDGLLHTTCGS 179
           +   H KG  HRDLK  NILL  +G   + D G                          +
Sbjct: 147 LEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCT 206

Query: 180 PNYVAPEVLANRGYDGAT--SDIWSCGVILY---------------------IFRGDFKL 216
            +Y APE+ + + +      +D+WS G +LY                       +    +
Sbjct: 207 ISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQNQLSI 266

Query: 217 PKW--LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPANP 260
           P+    S     LL  ++  +P +R  I  + +     Q   P   
Sbjct: 267 PQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPPAPGQH 312

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  225 bits (576), Expect = 2e-71
 Identities = 61/275 (22%), Positives = 112/275 (40%), Gaps = 49/275 (17%)

Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
            ++    +G G FG+V  A+    G  + +K ++ N        ++ +RE+  L  L H 
Sbjct: 12  DFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN-------EKAEREVKALAKLDHV 64

Query: 75  NVVRLHE----------------VLASKSKIYMVLEYVTGGELFDKI--ASKGRLQEAEG 116
           N+V  +                   +    +++ +E+   G L   I      +L +   
Sbjct: 65  NIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLA 124

Query: 117 RKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTT 176
            +LF+Q+  GV Y H+K + +RDLK  NI L     +KI DFGL       ++DG    +
Sbjct: 125 LELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVTS---LKNDGKRTRS 181

Query: 177 CGSPNYVAPEVLANRGYDGATSDIWSCGVILY------------------IFRGDFKLPK 218
            G+  Y++PE ++++ Y     D+++ G+IL                   +  G   +  
Sbjct: 182 KGTLRYMSPEQISSQDYG-KEVDLYALGLILAELLHVCDTAFETSKFFTDLRDG--IISD 238

Query: 219 WLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQ 253
                 + LL+K+L   P  R   + I       +
Sbjct: 239 IFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWK 273

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score =  224 bits (573), Expect = 6e-71
 Identities = 73/298 (24%), Positives = 122/298 (40%), Gaps = 72/298 (24%)

Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATL-KLLKHP 74
               + LG G  GKV    +  +   FA+K+L+           + +RE+    +  + P
Sbjct: 20  KVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD--------CPKARREVELHWRASQCP 71

Query: 75  NVVRLHEV----LASKSKIYMVLEYVTGGELFDKIASKGRLQ--EAEGRKLFQQLIDGVS 128
           ++VR+ +V     A +  + +V+E + GGELF +I  +G     E E  ++ + + + + 
Sbjct: 72  HIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQ 131

Query: 129 YCHNKGVFHRDLKLENILLDSKG---NIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAP 185
           Y H+  + HRD+K EN+L  SK     +K++DFG                        A 
Sbjct: 132 YLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGF-----------------------AK 168

Query: 186 EVLANRGYDGATSDIWSCGVILYI-------FRG-------------------DFKLPKW 219
           E      YD +  D+WS GVI+YI       F                     +F  P+W
Sbjct: 169 ETTG-EKYDKS-CDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEW 226

Query: 220 --LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD-YTPANPDDDEEDIFVDNEAF 274
             +S   + L+R +L+  P +R+TI       W  Q    P  P      +  D E +
Sbjct: 227 SEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERW 284

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  226 bits (577), Expect = 8e-70
 Identities = 58/272 (21%), Positives = 91/272 (33%), Gaps = 44/272 (16%)

Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLK-LLKH 73
            +     LG G  G + +    D     AVK +               RE+  L+   +H
Sbjct: 25  SFCPKDVLGHGAEGTIVYRGMFD-NRDVAVKRILPECF------SFADREVQLLRESDEH 77

Query: 74  PNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKG-RLQEAEGRKLFQQLIDGVSYCHN 132
           PNV+R       +   Y+ +E      L + +  K       E   L QQ   G+++ H+
Sbjct: 78  PNVIRYFCTEKDRQFQYIAIELC-AATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHS 136

Query: 133 KGVFHRDLKLENILLDSKGN-----IKISDFGLSA-LPQHFRDDGLLHTTCGSPNYVAPE 186
             + HRDLK  NIL+            ISDFGL   L              G+  ++APE
Sbjct: 137 LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPE 196

Query: 187 VL---ANRGYDGATSDIWSCGVILYIF---------------------RGDFKLPKW--- 219
           +L             DI+S G + Y                                   
Sbjct: 197 MLSEDCKENPTYT-VDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLDCLHPEKH 255

Query: 220 LSPGAQNLLRKILEPNPVKRITIAGIKADEWF 251
               A+ L+ K++  +P KR +   +    +F
Sbjct: 256 EDVIARELIEKMIAMDPQKRPSAKHVLKHPFF 287

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  219 bits (560), Expect = 4e-69
 Identities = 74/274 (27%), Positives = 122/274 (44%), Gaps = 36/274 (13%)

Query: 12  RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL 71
           R   YE+  T+G G++G+ +  +    G     K L+   +        +  E+  L+ L
Sbjct: 4   RAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTE-AEKQMLVSEVNLLREL 62

Query: 72  KHPNVVRLHE--VLASKSKIYMVLEYVTGGELFDKI----ASKGRLQEAEGRKLFQQLID 125
           KHPN+VR ++  +  + + +Y+V+EY  GG+L   I      +  L E    ++  QL  
Sbjct: 63  KHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTL 122

Query: 126 GVSYCHNKG-----VFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP 180
            +  CH +      V HRDLK  N+ LD K N+K+ DFGL+ +  H  D     T  G+P
Sbjct: 123 ALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNH--DTSFAKTFVGTP 180

Query: 181 NYVAPEVLANRGYDGATSDIWSCGVILY--------------------IFRGDF-KLPKW 219
            Y++PE +    Y+   SDIWS G +LY                    I  G F ++P  
Sbjct: 181 YYMSPEQMNRMSYN-EKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYR 239

Query: 220 LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQ 253
            S     ++ ++L      R ++  I  +    +
Sbjct: 240 YSDELNEIITRMLNLKDYHRPSVEEILENPLILE 273

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  220 bits (563), Expect = 9e-69
 Identities = 69/264 (26%), Positives = 128/264 (48%), Gaps = 27/264 (10%)

Query: 13  LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK 72
           + +Y   + +GEG+FGK    +  + G  + +K +  +R+   K  ++ +RE+A L  +K
Sbjct: 23  MEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSS-KEREESRREVAVLANMK 81

Query: 73  HPNVVRLHEVLASKSKIYMVLEYVTGGELFDKI--ASKGRLQEAEGRKLFQQLIDGVSYC 130
           HPN+V+  E       +Y+V++Y  GG+LF +I        QE +    F Q+   + + 
Sbjct: 82  HPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHV 141

Query: 131 HNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLAN 190
           H++ + HRD+K +NI L   G +++ DFG++ +        L     G+P Y++PE+  N
Sbjct: 142 HDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNS--TVELARACIGTPYYLSPEICEN 199

Query: 191 RGYDGATSDIWSCGVILY--------------------IFRGDFK-LPKWLSPGAQNLLR 229
           + Y+   SDIW+ G +LY                    I  G F  +    S   ++L+ 
Sbjct: 200 KPYN-NKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFPPVSLHYSYDLRSLVS 258

Query: 230 KILEPNPVKRITIAGIKADEWFEQ 253
           ++ + NP  R ++  I    +  +
Sbjct: 259 QLFKRNPRDRPSVNSILEKGFIAK 282

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  217 bits (554), Expect = 7e-68
 Identities = 62/259 (23%), Positives = 106/259 (40%), Gaps = 26/259 (10%)

Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
            ++    LG G++G+V   +  + G  +AVK              ++    +  K+ +HP
Sbjct: 58  SFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHP 117

Query: 75  NVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKG-RLQEAEGRKLFQQLIDGVSYCHNK 133
             VRL +       +Y+  E   G  L     + G  L EA+     +  +  +++ H++
Sbjct: 118 CCVRLEQAWEEGGILYLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQ 176

Query: 134 GVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGY 193
           G+ H D+K  NI L  +G  K+ DFGL          G      G P Y+APE+L    Y
Sbjct: 177 GLVHLDVKPANIFLGPRGRCKLGDFGLLV---ELGTAGAGEVQEGDPRYMAPELLQG-SY 232

Query: 194 DGATSDIWSCGVILY-----------------IFRGDFK--LPKWLSPGAQNLLRKILEP 234
             A +D++S G+ +                  + +G         LS   +++L  +LEP
Sbjct: 233 GTA-ADVFSLGLTILEVACNMELPHGGEGWQQLRQGYLPPEFTAGLSSELRSVLVMMLEP 291

Query: 235 NPVKRITIAGIKADEWFEQ 253
           +P  R T   + A     Q
Sbjct: 292 DPKLRATAEALLALPVLRQ 310

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  214 bits (548), Expect = 4e-67
 Identities = 65/290 (22%), Positives = 112/290 (38%), Gaps = 47/290 (16%)

Query: 13  LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK 72
           L  +E  + LG G FG V  A++      +A+K +        +  +++ RE+  L  L+
Sbjct: 4   LTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAR--EKVMREVKALAKLE 61

Query: 73  HPNVVRLHEV------------LASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGR--- 117
           HP +VR                 + K  +Y+ ++      L D +  +  ++E E     
Sbjct: 62  HPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCL 121

Query: 118 KLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSAL----------PQHF 167
            +F Q+ + V + H+KG+ HRDLK  NI       +K+ DFGL                 
Sbjct: 122 HIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPM 181

Query: 168 RDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILY------------------I 209
                     G+  Y++PE +    Y     DI+S G+IL+                  +
Sbjct: 182 PAYARHTGQVGTKLYMSPEQIHGNSYS-HKVDIFSLGLILFELLYPFSTQMERVRTLTDV 240

Query: 210 FRGDF-KLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPA 258
               F  L     P    +++ +L P+P++R     I  +  FE    P 
Sbjct: 241 RNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLDFPG 290

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score =  216 bits (552), Expect = 5e-67
 Identities = 85/272 (31%), Positives = 139/272 (51%), Gaps = 31/272 (11%)

Query: 5   EKKQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKRE 64
              Q   +L +++  +TLG G+FG+V   +  +SG  +A+KIL+K +++ LK  +    E
Sbjct: 32  TPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNE 91

Query: 65  IATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLI 124
              L+ +  P +V+L       S +YMV+EYV GGE+F  +   GR  E   R    Q++
Sbjct: 92  KRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIV 151

Query: 125 DGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVA 184
               Y H+  + +RDLK EN+L+D +G I+++DFG +      R  G   T CG+P  +A
Sbjct: 152 LTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWTLCGTPEALA 206

Query: 185 PEVLANRGYDGATSDIWSCGVILY--------------------IFRGDFKLPKWLSPGA 224
           PE++ ++GY+ A  D W+ GV++Y                    I  G  + P   S   
Sbjct: 207 PEIILSKGYNKAV-DWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDL 265

Query: 225 QNLLRKILEPNPVKRI-----TIAGIKADEWF 251
           ++LLR +L+ +  KR       +  IK  +WF
Sbjct: 266 KDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWF 297

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score =  212 bits (541), Expect = 9e-66
 Identities = 72/262 (27%), Positives = 134/262 (51%), Gaps = 31/262 (11%)

Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
           +++ RTLG G+FG+V   +   +G  +A+K+L+K  ++ LK  +    E   L ++ HP 
Sbjct: 8   FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPF 67

Query: 76  VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGV 135
           ++R+        +I+M+++Y+ GGELF  +    R      +    ++   + Y H+K +
Sbjct: 68  IIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDI 127

Query: 136 FHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDG 195
            +RDLK ENILLD  G+IKI+DFG +          + +T CG+P+Y+APEV++ + Y  
Sbjct: 128 IYRDLKPENILLDKNGHIKITDFGFAK-----YVPDVTYTLCGTPDYIAPEVVSTKPY-N 181

Query: 196 ATSDIWSCGVILY--------------------IFRGDFKLPKWLSPGAQNLLRKILEPN 235
            + D WS G+++Y                    I   + + P + +   ++LL +++  +
Sbjct: 182 KSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNEDVKDLLSRLITRD 241

Query: 236 PVKRI-----TIAGIKADEWFE 252
             +R+         +K   WF+
Sbjct: 242 LSQRLGNLQNGTEDVKNHPWFK 263

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  210 bits (536), Expect = 3e-65
 Identities = 71/262 (27%), Positives = 117/262 (44%), Gaps = 31/262 (11%)

Query: 12  RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL 71
            L  + + + +G G F +V  A  L  G+P A+K ++   ++  K      +EI  LK L
Sbjct: 30  TLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQL 89

Query: 72  KHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKI----ASKGRLQEAEGRKLFQQLIDGV 127
            HPNV++ +      +++ +VLE    G+L   I      K  + E    K F QL   +
Sbjct: 90  NHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSAL 149

Query: 128 SYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEV 187
            + H++ V HRD+K  N+ + + G +K+ D GL             H+  G+P Y++PE 
Sbjct: 150 EHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS--KTTAAHSLVGTPYYMSPER 207

Query: 188 LANRGYDGATSDIWSCGVILY----------------------IFRGDFK-LPKW-LSPG 223
           +   GY+   SDIWS G +LY                      I + D+  LP    S  
Sbjct: 208 IHENGYNFK-SDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEE 266

Query: 224 AQNLLRKILEPNPVKRITIAGI 245
            + L+   + P+P KR  +  +
Sbjct: 267 LRQLVNMCINPDPEKRPDVTYV 288

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score =  206 bits (525), Expect = 5e-63
 Identities = 34/301 (11%), Positives = 73/301 (24%), Gaps = 67/301 (22%)

Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
           + +L   L  G+   V   +D++    FA+K+            +++         L   
Sbjct: 63  KLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGE 122

Query: 75  NVVRLHEVL--------------------------ASKSKIYMVLEYVTG------GELF 102
           +     +                             + +   +++   +         L 
Sbjct: 123 SPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLD 182

Query: 103 DKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSA 162
                +G         L  QLI   +   +KG+ H     +N+ +   G + + D     
Sbjct: 183 FVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFIMPDGRLMLGDVSALW 242

Query: 163 LPQHFRDDGLLHTTCGSPNYVAPEVLANRGYD-GATSDIWSCGVILYIF----------- 210
                +       +     Y   E L           + W  G+ +Y             
Sbjct: 243 -----KVGTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVT 297

Query: 211 ------------------RGDFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFE 252
                                F     L    + L+ + L  +  +R+          F 
Sbjct: 298 PGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFL 357

Query: 253 Q 253
           Q
Sbjct: 358 Q 358

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score =  202 bits (515), Expect = 2e-61
 Identities = 49/298 (16%), Positives = 96/298 (32%), Gaps = 56/298 (18%)

Query: 6   KKQEGMRLG--RYELGRTLGEGNFGKVKFA-----QDLDSGLPFAVKILEKNRIIHLKIT 58
           K +   +LG     +   LGEG F +V  A      D  +   F +K+ +        I 
Sbjct: 55  KPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIG 114

Query: 59  DQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKI-----ASKGRLQE 113
            Q+      LK       ++ +     ++   +V E  + G L + I       +  + +
Sbjct: 115 TQLMER---LKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQ 171

Query: 114 AEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILL-----------DSKGNIKISDFGLSA 162
                   +++  +   H+  + H D+K +N +L           D    + + D G S 
Sbjct: 172 GLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSI 231

Query: 163 LPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYI------------- 209
             + F    +    C +  +   E+L+N+ ++    D +     +Y              
Sbjct: 232 DMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQI-DYFGVAATVYCMLFGTYMKVKNEG 290

Query: 210 --------FRGDFKLPKWLSPGAQNLLRKILEPNPVKRITIAGI---KADEWFEQDYT 256
                   FR    L  W           +L       +    +   K  + F+Q YT
Sbjct: 291 GECKPEGLFRRLPHLDMW-----NEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYT 343

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score =  202 bits (516), Expect = 2e-61
 Identities = 68/262 (25%), Positives = 123/262 (46%), Gaps = 31/262 (11%)

Query: 17  ELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNV 76
           E+ R +G+G+FGKV   Q  D+   +A+K + K + +       + +E+  ++ L+HP +
Sbjct: 18  EILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFL 77

Query: 77  VRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVF 136
           V L      +  ++MV++ + GG+L   +      +E   +    +L+  + Y  N+ + 
Sbjct: 78  VNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQRII 137

Query: 137 HRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANR---GY 193
           HRD+K +NILLD  G++ I+DF ++A       +  + T  G+  Y+APE+ ++R   GY
Sbjct: 138 HRDMKPDNILLDEHGHVHITDFNIAA---MLPRETQITTMAGTKPYMAPEMFSSRKGAGY 194

Query: 194 DGATSDIWSCGVILY-----------------------IFRGDFKLPKWLSPGAQNLLRK 230
                D WS GV  Y                               P   S    +LL+K
Sbjct: 195 -SFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVTYPSAWSQEMVSLLKK 253

Query: 231 ILEPNPVKRI-TIAGIKADEWF 251
           +LEPNP +R   ++ ++   + 
Sbjct: 254 LLEPNPDQRFSQLSDVQNFPYM 275

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score =  201 bits (512), Expect = 2e-60
 Identities = 56/342 (16%), Positives = 100/342 (29%), Gaps = 61/342 (17%)

Query: 10  GMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLK 69
           G R      G  LG+ +      A D ++G  F V +             Q+K E+  L+
Sbjct: 74  GERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLR 133

Query: 70  LL----------------------KHPNVVRLHEVLASKSKIYMVLEYVT---------- 97
           LL                      K P   ++  V   +  ++++  +            
Sbjct: 134 LLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQT 193

Query: 98  -GGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKIS 156
            G  L    ++   L      +L  Q+I  ++  H+ G+ H  L+  +I+LD +G + ++
Sbjct: 194 FGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLT 253

Query: 157 DFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGAT----SDIWSCGVILYI--- 209
            F              +      P   A  +L    +         D W+ G+ +Y    
Sbjct: 254 GFEHLVRDGASAVS-PIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWC 312

Query: 210 ----FRGD---------FKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQ--- 253
                  D         F+  K +    + LL   L      R+          +EQ   
Sbjct: 313 ADLPNTDDAALGGSEWIFRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQLRT 372

Query: 254 ---DYTPANPDDDEEDIFVDNEAFSMHEVPSDGGRTPGSPPL 292
                 P    D E          S    P + G       +
Sbjct: 373 ELSAALPLYQTDGEPTREGGAPP-SGTSQPDEAGAAEAVTAI 413

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score =  196 bits (502), Expect = 6e-60
 Identities = 84/259 (32%), Positives = 138/259 (53%), Gaps = 27/259 (10%)

Query: 5   EKKQEGMRLGRYELGRTLGEGNFGKV---KFAQDLDSGLPFAVKILEKNRII-HLKITDQ 60
            +  E +R   +EL R LG+G +GKV   +     ++G  FA+K+L+K  I+ + K T  
Sbjct: 8   NRGPEKIRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAH 67

Query: 61  IKREIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLF 120
            K E   L+ +KHP +V L     +  K+Y++LEY++GGELF ++  +G   E       
Sbjct: 68  TKAERNILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYL 127

Query: 121 QQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP 180
            ++   + + H KG+ +RDLK ENI+L+ +G++K++DFGL    +   D  + HT CG+ 
Sbjct: 128 AEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCK--ESIHDGTVTHTFCGTI 185

Query: 181 NYVAPEVLANRGYDGATSDIWSCGVILY--------------------IFRGDFKLPKWL 220
            Y+APE+L   G+     D WS G ++Y                    I +    LP +L
Sbjct: 186 EYMAPEILMRSGH-NRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLPPYL 244

Query: 221 SPGAQNLLRKILEPNPVKR 239
           +  A++LL+K+L+ N   R
Sbjct: 245 TQEARDLLKKLLKRNAASR 263

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score =  195 bits (499), Expect = 3e-59
 Identities = 83/268 (30%), Positives = 138/268 (51%), Gaps = 25/268 (9%)

Query: 6   KKQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREI 65
             Q  +++  + L + LG+G+FGKV  A+   +   FA+K L+K+ ++     +    E 
Sbjct: 9   SLQIKLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEK 68

Query: 66  ATLKL-LKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLI 124
             L L  +HP +  +     +K  ++ V+EY+ GG+L   I S  +   +       ++I
Sbjct: 69  RVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEII 128

Query: 125 DGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVA 184
            G+ + H+KG+ +RDLKL+NILLD  G+IKI+DFG+    ++   D   +T CG+P+Y+A
Sbjct: 129 LGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCK--ENMLGDAKTNTFCGTPDYIA 186

Query: 185 PEVLANRGYDGATSDIWSCGVILY--------------------IFRGDFKLPKWLSPGA 224
           PE+L  + Y   + D WS GV+LY                    I   +   P+WL   A
Sbjct: 187 PEILLGQKY-NHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKEA 245

Query: 225 QNLLRKILEPNPVKRITIAG-IKADEWF 251
           ++LL K+    P KR+ + G I+    F
Sbjct: 246 KDLLVKLFVREPEKRLGVRGDIRQHPLF 273

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score =  194 bits (495), Expect = 7e-59
 Identities = 78/244 (31%), Positives = 125/244 (51%), Gaps = 23/244 (9%)

Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
           ++  + LG+G FGKV   ++  +G  +A+KIL K  II          E   L+  +HP 
Sbjct: 7   FDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPF 66

Query: 76  VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGV 135
           +  L     +  ++  V+EY  GGELF  ++ +    E   R    +++  + Y H++ V
Sbjct: 67  LTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDV 126

Query: 136 FHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDG 195
            +RD+KLEN++LD  G+IKI+DFGL    +   D   + T CG+P Y+APEVL +  Y G
Sbjct: 127 VYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKTFCGTPEYLAPEVLEDNDY-G 183

Query: 196 ATSDIWSCGVILY--------------------IFRGDFKLPKWLSPGAQNLLRKILEPN 235
              D W  GV++Y                    I   + + P+ LSP A++LL  +L+ +
Sbjct: 184 RAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLLKKD 243

Query: 236 PVKR 239
           P +R
Sbjct: 244 PKQR 247

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score =  194 bits (494), Expect = 3e-58
 Identities = 83/274 (30%), Positives = 132/274 (48%), Gaps = 28/274 (10%)

Query: 3   IAEKKQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIK 62
           +        +   +   + +G+G+FGKV  A+     + +AVK+L+K  I+  K    I 
Sbjct: 27  LGPSSNPHAKPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIM 86

Query: 63  REIATL-KLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQ 121
            E   L K +KHP +V LH    +  K+Y VL+Y+ GGELF  +  +    E   R    
Sbjct: 87  SERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAA 146

Query: 122 QLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPN 181
           ++   + Y H+  + +RDLK ENILLDS+G+I ++DFGL    ++   +    T CG+P 
Sbjct: 147 EIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCK--ENIEHNSTTSTFCGTPE 204

Query: 182 YVAPEVLANRGYDGATSDIWSCGVILY--------------------IFRGDFKLPKWLS 221
           Y+APEVL  + Y   T D W  G +LY                    I     +L   ++
Sbjct: 205 YLAPEVLHKQPY-DRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPNIT 263

Query: 222 PGAQNLLRKILEPNPVKRITIAG----IKADEWF 251
             A++LL  +L+ +  KR+        IK+  +F
Sbjct: 264 NSARHLLEGLLQKDRTKRLGAKDDFMEIKSHVFF 297

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score =  192 bits (491), Expect = 5e-58
 Identities = 82/286 (28%), Positives = 133/286 (46%), Gaps = 40/286 (13%)

Query: 3   IAEKKQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIK 62
           I       + +  +E  R LG+G+FGKV  A+  ++G  +AVK+L+K+ I+     +   
Sbjct: 12  IGVNSSNRLGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTM 71

Query: 63  REIATLKL-LKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQ 121
            E   L L   HP + +L     +  +++ V+E+V GG+L   I    R  EA  R    
Sbjct: 72  TEKRILSLARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAA 131

Query: 122 QLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPN 181
           ++I  + + H+KG+ +RDLKL+N+LLD +G+ K++DFG+    +   +     T CG+P+
Sbjct: 132 EIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCK--EGICNGVTTATFCGTPD 189

Query: 182 YVAPEVLANRGYDGATSDIWSCGVILY--------------------IFRGDFKLPKWLS 221
           Y+APE+L    Y G   D W+ GV+LY                    I   +   P WL 
Sbjct: 190 YIAPEILQEMLY-GPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTWLH 248

Query: 222 PGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPANPDDDEEDI 267
             A  +L+  +  NP  R+   G             +     E  I
Sbjct: 249 EDATGILKSFMTKNPTMRL---G-------------SLTQGGEHAI 278

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score =  191 bits (489), Expect = 5e-58
 Identities = 80/259 (30%), Positives = 143/259 (55%), Gaps = 27/259 (10%)

Query: 4   AEKKQEGMRLGRYELGRTLGEGNFGKV---KFAQDLDSGLPFAVKILEKNRIIHLKITDQ 60
            ++  E     ++EL + LG+G+FGKV   K     D+   +A+K+L+K  +   +   +
Sbjct: 14  VKEGHEKADPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKV-RDRVR 72

Query: 61  IKREIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLF 120
            K E   L  + HP +V+LH    ++ K+Y++L+++ GG+LF +++ +    E + +   
Sbjct: 73  TKMERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYL 132

Query: 121 QQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP 180
            +L   + + H+ G+ +RDLK ENILLD +G+IK++DFGLS   +    +   ++ CG+ 
Sbjct: 133 AELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSK--ESIDHEKKAYSFCGTV 190

Query: 181 NYVAPEVLANRGYDGATSDIWSCGVILY--------------------IFRGDFKLPKWL 220
            Y+APEV+  RG+   ++D WS GV+++                    I +    +P++L
Sbjct: 191 EYMAPEVVNRRGH-TQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMPQFL 249

Query: 221 SPGAQNLLRKILEPNPVKR 239
           SP AQ+LLR + + NP  R
Sbjct: 250 SPEAQSLLRMLFKRNPANR 268

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score =  192 bits (489), Expect = 8e-58
 Identities = 76/290 (26%), Positives = 140/290 (48%), Gaps = 49/290 (16%)

Query: 8   QEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIAT 67
            + + L  ++L R +G G++ KV   +   +   +A+K+++K  +   +  D ++ E   
Sbjct: 3   MDPLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHV 62

Query: 68  LKL-LKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDG 126
            +    HP +V LH    ++S+++ V+EYV GG+L   +  + +L E   R    ++   
Sbjct: 63  FEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLA 122

Query: 127 VSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPE 186
           ++Y H +G+ +RDLKL+N+LLDS+G+IK++D+G+    +  R      T CG+PNY+APE
Sbjct: 123 LNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCK--EGLRPGDTTSTFCGTPNYIAPE 180

Query: 187 VLANRGYDGATSDIWSCGVILY-----------------------------IFRGDFKLP 217
           +L    Y G + D W+ GV+++                             I     ++P
Sbjct: 181 ILRGEDY-GFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIP 239

Query: 218 KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPANPDDDEEDI 267
           + LS  A ++L+  L  +P +R+   G              +P     DI
Sbjct: 240 RSLSVKAASVLKSFLNKDPKERL---G-------------CHPQTGFADI 273

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score =  192 bits (489), Expect = 1e-57
 Identities = 80/255 (31%), Positives = 134/255 (52%), Gaps = 24/255 (9%)

Query: 6   KKQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREI 65
             ++ M+L  +     LG+G+FGKV  ++   +   +AVKIL+K+ +I     +    E 
Sbjct: 12  GNRDRMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEK 71

Query: 66  ATLKL-LKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLI 124
             L L  K P + +LH    +  ++Y V+EYV GG+L   I   GR +E        ++ 
Sbjct: 72  RVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIA 131

Query: 125 DGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVA 184
            G+ +  +KG+ +RDLKL+N++LDS+G+IKI+DFG+    ++  D     T CG+P+Y+A
Sbjct: 132 IGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCK--ENIWDGVTTKTFCGTPDYIA 189

Query: 185 PEVLANRGYDGATSDIWSCGVILY--------------------IFRGDFKLPKWLSPGA 224
           PE++A + Y G + D W+ GV+LY                    I   +   PK +S  A
Sbjct: 190 PEIIAYQPY-GKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEA 248

Query: 225 QNLLRKILEPNPVKR 239
             + + ++  +P KR
Sbjct: 249 VAICKGLMTKHPGKR 263

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score =  192 bits (489), Expect = 3e-57
 Identities = 76/292 (26%), Positives = 140/292 (47%), Gaps = 49/292 (16%)

Query: 6   KKQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREI 65
           K    + L  ++L R +G G++ KV   +   +   +A+++++K  +   +  D ++ E 
Sbjct: 44  KASSSLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEK 103

Query: 66  ATLKL-LKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLI 124
              +    HP +V LH    ++S+++ V+EYV GG+L   +  + +L E   R    ++ 
Sbjct: 104 HVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEIS 163

Query: 125 DGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVA 184
             ++Y H +G+ +RDLKL+N+LLDS+G+IK++D+G+    +  R      T CG+PNY+A
Sbjct: 164 LALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCK--EGLRPGDTTSTFCGTPNYIA 221

Query: 185 PEVLANRGYDGATSDIWSCGVILY-----------------------------IFRGDFK 215
           PE+L    Y G + D W+ GV+++                             I     +
Sbjct: 222 PEILRGEDY-GFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIR 280

Query: 216 LPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPANPDDDEEDI 267
           +P+ LS  A ++L+  L  +P +R+   G              +P     DI
Sbjct: 281 IPRSLSVKAASVLKSFLNKDPKERL---G-------------CHPQTGFADI 316

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score =  194 bits (494), Expect = 2e-56
 Identities = 75/267 (28%), Positives = 118/267 (44%), Gaps = 35/267 (13%)

Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
           +   R LG+G FG+V   Q   +G  +A K LEK RI   K       E   L+ +    
Sbjct: 186 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRF 245

Query: 76  VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLF--QQLIDGVSYCHNK 133
           VV L     +K  + +VL  + GG+L   I   G+    E R +F   ++  G+   H +
Sbjct: 246 VVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRE 305

Query: 134 GVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGY 193
            + +RDLK ENILLD  G+I+ISD GL+    H  +   +    G+  Y+APEV+ N  Y
Sbjct: 306 RIVYRDLKPENILLDDHGHIRISDLGLA---VHVPEGQTIKGRVGTVGYMAPEVVKNERY 362

Query: 194 DGATSDIWSCGVILY------------------------IFRGDFKLPKWLSPGAQNLLR 229
             +  D W+ G +LY                        +     +  +  SP A++L  
Sbjct: 363 TFSP-DWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYSERFSPQARSLCS 421

Query: 230 KILEPNPVKRI-----TIAGIKADEWF 251
           ++L  +P +R+     +   +K    F
Sbjct: 422 QLLCKDPAERLGCRGGSAREVKEHPLF 448

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score =  190 bits (485), Expect = 3e-56
 Identities = 80/257 (31%), Positives = 130/257 (50%), Gaps = 24/257 (9%)

Query: 4   AEKKQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKR 63
             K +  + +  +E  + LG+G FGKV   ++  +G  +A+KIL+K  I+          
Sbjct: 138 LAKPKHRVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLT 197

Query: 64  EIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQL 123
           E   L+  +HP +  L     +  ++  V+EY  GGELF  ++ +    E   R    ++
Sbjct: 198 ENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEI 257

Query: 124 IDGVSYCHN-KGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNY 182
           +  + Y H+ K V +RDLKLEN++LD  G+IKI+DFGL    +  +D   + T CG+P Y
Sbjct: 258 VSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCK--EGIKDGATMKTFCGTPEY 315

Query: 183 VAPEVLANRGYDGATSDIWSCGVILY--------------------IFRGDFKLPKWLSP 222
           +APEVL +  Y G   D W  GV++Y                    I   + + P+ L P
Sbjct: 316 LAPEVLEDNDY-GRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGP 374

Query: 223 GAQNLLRKILEPNPVKR 239
            A++LL  +L+ +P +R
Sbjct: 375 EAKSLLSGLLKKDPKQR 391

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score =  194 bits (494), Expect = 7e-56
 Identities = 80/255 (31%), Positives = 134/255 (52%), Gaps = 24/255 (9%)

Query: 6   KKQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREI 65
             ++ M+L  +     LG+G+FGKV  ++   +   +AVKIL+K+ +I     +    E 
Sbjct: 333 GNRDRMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEK 392

Query: 66  ATLKL-LKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLI 124
             L L  K P + +LH    +  ++Y V+EYV GG+L   I   GR +E        ++ 
Sbjct: 393 RVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIA 452

Query: 125 DGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVA 184
            G+ +  +KG+ +RDLKL+N++LDS+G+IKI+DFG+    ++  D     T CG+P+Y+A
Sbjct: 453 IGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCK--ENIWDGVTTKTFCGTPDYIA 510

Query: 185 PEVLANRGYDGATSDIWSCGVILY--------------------IFRGDFKLPKWLSPGA 224
           PE++A + Y G + D W+ GV+LY                    I   +   PK +S  A
Sbjct: 511 PEIIAYQPY-GKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEA 569

Query: 225 QNLLRKILEPNPVKR 239
             + + ++  +P KR
Sbjct: 570 VAICKGLMTKHPGKR 584

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score =  191 bits (487), Expect = 1e-55
 Identities = 75/347 (21%), Positives = 131/347 (37%), Gaps = 62/347 (17%)

Query: 6   KKQEGMRLGR--YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKR 63
           K  E   +G   +   R LG G FG+V   Q   +G  +A K L K R+   K       
Sbjct: 175 KWLEAQPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMV 234

Query: 64  EIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQE--AEGRKLF- 120
           E   L  +    +V L     +K+ + +V+  + GG++   I +         E R +F 
Sbjct: 235 EKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFY 294

Query: 121 -QQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGS 179
             Q++ G+ + H + + +RDLK EN+LLD  GN++ISD GL+   +            G+
Sbjct: 295 TAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAV--ELKAGQTKTKGYAGT 352

Query: 180 PNYVAPEVLANRGYDGATSDIWSCGVILY------------------------IFRGDFK 215
           P ++APE+L    YD +  D ++ GV LY                        +      
Sbjct: 353 PGFMAPELLLGEEYDFSV-DYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVT 411

Query: 216 LPKWLSPGAQNLLRKILEPNPVKRITIAG-----IKADEWFEQDYTPANPDDDEEDIFVD 270
            P   SP +++    +L+ +P KR+         ++    F                 + 
Sbjct: 412 YPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRD---------------IS 456

Query: 271 NEAFSMHEVPSDGGRTPGSPPLINAFQLIGMSSCLDLSGFFEKEDVS 317
                   +          PP +   + +   +  D+  F   + V+
Sbjct: 457 WRQLEAGMLT---------PPFVPDSRTVYAKNIQDVGAFSTVKGVA 494

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  182 bits (464), Expect = 9e-55
 Identities = 71/258 (27%), Positives = 118/258 (45%), Gaps = 35/258 (13%)

Query: 13  LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK 72
                    LG+G +G V   +DL + +  A+K + +    + +    +  EIA  K LK
Sbjct: 21  YDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQ---PLHEEIALHKHLK 77

Query: 73  HPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASK-GRLQEAEG--RKLFQQLIDGVSY 129
           H N+V+     +    I + +E V GG L   + SK G L++ E       +Q+++G+ Y
Sbjct: 78  HKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKY 137

Query: 130 CHNKGVFHRDLKLENILLDSK-GNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVL 188
            H+  + HRD+K +N+L+++  G +KISDFG S             T  G+  Y+APE++
Sbjct: 138 LHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINP--CTETFTGTLQYMAPEII 195

Query: 189 --ANRGYDGATSDIWSCG---------------------VILYIFRGDF--KLPKWLSPG 223
               RGY  A +DIWS G                      +  +       ++P+ +S  
Sbjct: 196 DKGPRGYGKA-ADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEIPESMSAE 254

Query: 224 AQNLLRKILEPNPVKRIT 241
           A+  + K  EP+P KR  
Sbjct: 255 AKAFILKCFEPDPDKRAC 272

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  181 bits (462), Expect = 1e-54
 Identities = 58/271 (21%), Positives = 97/271 (35%), Gaps = 49/271 (18%)

Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
            +     +G G FG V        G  +A+K  +K     +   + ++   A   L +H 
Sbjct: 12  EFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHS 71

Query: 75  NVVRLHEVLASKSKIYMVLEYVTGGELFDKI----ASKGRLQEAEGRKLFQQLIDGVSYC 130
           +VVR     A    + +  EY  GG L D I          +EAE + L  Q+  G+ Y 
Sbjct: 72  HVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYI 131

Query: 131 HNKGVFHRDLKLENILLDSKGNI-------------------KISDFGLSALPQHFRDDG 171
           H+  + H D+K  NI +                         KI D G            
Sbjct: 132 HSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTR------IS 185

Query: 172 LLHTTCGSPNYVAPEVLA-NRGYDGATSDIWSCGVILY-----------------IFRGD 213
                 G   ++A EVL  N  +    +DI++  + +                  I +G 
Sbjct: 186 SPQVEEGDSRFLANEVLQENYTHLPK-ADIFALALTVVCAAGAEPLPRNGDQWHEIRQGR 244

Query: 214 F-KLPKWLSPGAQNLLRKILEPNPVKRITIA 243
             ++P+ LS     LL+ ++ P+P +R +  
Sbjct: 245 LPRIPQVLSQEFTELLKVMIHPDPERRPSAM 275

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score =  184 bits (468), Expect = 1e-54
 Identities = 77/266 (28%), Positives = 142/266 (53%), Gaps = 33/266 (12%)

Query: 5   EKKQEGMRLGRYELGRTLGEGNFGKV---KFAQDLDSGLPFAVKILEKNRII-HLKITDQ 60
               E + +  +EL + LG G +GKV   +     D+G  +A+K+L+K  I+   K T+ 
Sbjct: 45  TGHAEKVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEH 104

Query: 61  IKREIATLKLLKH-PNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKL 119
            + E   L+ ++  P +V LH    +++K++++L+Y+ GGELF  ++ + R  E E +  
Sbjct: 105 TRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIY 164

Query: 120 FQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGS 179
             +++  + + H  G+ +RD+KLENILLDS G++ ++DFGLS        +   +  CG+
Sbjct: 165 VGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETER-AYDFCGT 223

Query: 180 PNYVAPEVL--ANRGYDGATSDIWSCGVILY------------------------IFRGD 213
             Y+AP+++   + G+D A  D WS GV++Y                        I + +
Sbjct: 224 IEYMAPDIVRGGDSGHDKAV-DWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSE 282

Query: 214 FKLPKWLSPGAQNLLRKILEPNPVKR 239
              P+ +S  A++L++++L  +P KR
Sbjct: 283 PPYPQEMSALAKDLIQRLLMKDPKKR 308

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  183 bits (465), Expect = 2e-54
 Identities = 56/254 (22%), Positives = 96/254 (37%), Gaps = 36/254 (14%)

Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
                  +G G+FG+V   +D  +G   AVK +         +      E+     L  P
Sbjct: 59  WMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVR--------LEVFRVEELVACAGLSSP 110

Query: 75  NVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKG 134
            +V L+  +     + + +E + GG L   I   G L E        Q ++G+ Y H + 
Sbjct: 111 RIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRR 170

Query: 135 VFHRDLKLENILLDSKGN-IKISDFGLSA---LPQHFRDDGLLHTTCGSPNYVAPEVLAN 190
           + H D+K +N+LL S G+   + DFG +         +         G+  ++APEV+  
Sbjct: 171 ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMG 230

Query: 191 RGYDGATSDIWSCG--------------------VILYIFRGD---FKLPKWLSPGAQNL 227
           +  D    DIWS                      + L I        ++P   +P     
Sbjct: 231 KPCDAK-VDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPIREIPPSCAPLTAQA 289

Query: 228 LRKILEPNPVKRIT 241
           +++ L   PV R +
Sbjct: 290 IQEGLRKEPVHRAS 303

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score =  190 bits (483), Expect = 4e-54
 Identities = 86/395 (21%), Positives = 156/395 (39%), Gaps = 71/395 (17%)

Query: 6   KKQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKRE- 64
           +    + +  + + R +G G FG+V   +  D+G  +A+K L+K RI   +       E 
Sbjct: 181 ELNIHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNER 240

Query: 65  --IATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQ 122
             ++ +     P +V +     +  K+  +L+ + GG+L   ++  G   EA+ R    +
Sbjct: 241 IMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAE 300

Query: 123 LIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNY 182
           +I G+ + HN+ V +RDLK  NILLD  G+++ISD GL+            H + G+  Y
Sbjct: 301 IILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACD----FSKKKPHASVGTHGY 356

Query: 183 VAPEVLA-NRGYDGATSDIWSCGVILY-----------------------IFRGDFKLPK 218
           +APEVL     YD +  D +S G +L+                             +LP 
Sbjct: 357 MAPEVLQKGVAYDSSA-DWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPD 415

Query: 219 WLSPGAQNLLRKILEPNPVKRI-----TIAGIKADEWFEQDYTPANPDDDEEDIFVDNEA 273
             SP  ++LL  +L+ +  +R+         +K   +F                 +D + 
Sbjct: 416 SFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRS---------------LDWQM 460

Query: 274 FSMHEVPSDGGRTPGSPPLINAFQLIGMSSCLDLSGFFEKEDVSERKI---------RFT 324
             + + P         PPLI     +  +   D+   F++ED    K+          F 
Sbjct: 461 VFLQKYP---------PPLIPPRGEVNAADAFDIG-SFDEEDTKGIKLLDSDQELYRNFP 510

Query: 325 SNHSAKDLLERIEDIVTEMGFRVQKKNGKLKATQE 359
              S +   E  E +   +     +   + K   +
Sbjct: 511 LTISERWQQEVAETVFDTINAETDRLEARKKTKNK 545

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score =  182 bits (464), Expect = 2e-53
 Identities = 75/283 (26%), Positives = 127/283 (44%), Gaps = 37/283 (13%)

Query: 2   VIAEKKQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQI 61
            I + +   M+   YE+ + +G G FG+V+  +   +   +A+K+L K  +I    +   
Sbjct: 57  TINKIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFF 116

Query: 62  KREIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQ 121
             E   +     P VV+L         +YMV+EY+ GG+L   + S   + E   R    
Sbjct: 117 WEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLV-NLMSNYDVPEKWARFYTA 175

Query: 122 QLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLL--HTTCGS 179
           +++  +   H+ G  HRD+K +N+LLD  G++K++DFG          +G++   T  G+
Sbjct: 176 EVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCM---KMNKEGMVRCDTAVGT 232

Query: 180 PNYVAPEVLANRGYD---GATSDIWSCGVILY----------------------IFRGDF 214
           P+Y++PEVL ++G D   G   D WS GV LY                        +   
Sbjct: 233 PDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSL 292

Query: 215 KLPK--WLSPGAQNLLRKILEPNPVKRITIAG---IKADEWFE 252
             P    +S  A+NL+   L  +   R+   G   IK   +F+
Sbjct: 293 TFPDDNDISKEAKNLICAFLT-DREVRLGRNGVEEIKRHLFFK 334

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score =  177 bits (450), Expect = 3e-51
 Identities = 69/287 (24%), Positives = 124/287 (43%), Gaps = 41/287 (14%)

Query: 2   VIAEKKQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQI 61
             ++ KQ  +    +E+ + +G G FG+V   +  ++   FA+KIL K  ++    T   
Sbjct: 62  FTSKVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACF 121

Query: 62  KREIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIA-SKGRLQEAEGRKLF 120
           + E   L       +  LH      + +Y+V++Y  GG+L   ++  + RL E   R   
Sbjct: 122 REERDVLVNGDSKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYL 181

Query: 121 QQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLL--HTTCG 178
            +++  +   H     HRD+K +NIL+D  G+I+++DFG         +DG +      G
Sbjct: 182 AEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCL---KLMEDGTVQSSVAVG 238

Query: 179 SPNYVAPEVL-----ANRGYDGATSDIWSCGVILY----------------------IFR 211
           +P+Y++PE+L         Y G   D WS GV +Y                        +
Sbjct: 239 TPDYISPEILQAMEGGKGRY-GPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHK 297

Query: 212 GDFKLPKW---LSPGAQNLLRKILEPNPVKRITIAG---IKADEWFE 252
             F+ P     +S  A++L+R+++      R+   G    K   +F 
Sbjct: 298 ERFQFPTQVTDVSENAKDLIRRLICSRE-HRLGQNGIEDFKKHPFFS 343

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score =  175 bits (446), Expect = 7e-51
 Identities = 65/288 (22%), Positives = 122/288 (42%), Gaps = 41/288 (14%)

Query: 2   VIAEKKQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQI 61
           ++   K+  ++   +E+ + +G G F +V   +   +G  +A+KI+ K  ++        
Sbjct: 49  IVVRLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCF 108

Query: 62  KREIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKG-RLQEAEGRKLF 120
           + E   L       + +LH     ++ +Y+V+EY  GG+L   ++  G R+     R   
Sbjct: 109 REERDVLVNGDRRWITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYL 168

Query: 121 QQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLL--HTTCG 178
            +++  +   H  G  HRD+K +NILLD  G+I+++DFG        R DG +      G
Sbjct: 169 AEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCL---KLRADGTVRSLVAVG 225

Query: 179 SPNYVAPEVLANRGYD------GATSDIWSCGVILY--------------------IFRG 212
           +P+Y++PE+L   G        G   D W+ GV  Y                    I   
Sbjct: 226 TPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHY 285

Query: 213 DFKLP-----KWLSPGAQNLLRKILEPNPVKRITIAG---IKADEWFE 252
              L      + +   A++ ++++L   P  R+   G    +   +F 
Sbjct: 286 KEHLSLPLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTHPFFF 332

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score =  168 bits (428), Expect = 8e-49
 Identities = 77/321 (23%), Positives = 114/321 (35%), Gaps = 92/321 (28%)

Query: 12  RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIK--------R 63
           R  RYE    LGEG F  V  A+D ++    A+K   K   I L    + K        R
Sbjct: 8   RAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIK---K---IKLGHRSEAKDGINRTALR 61

Query: 64  EIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTG--GELFDKIASKGRLQEAEGRKLFQ 121
           EI  L+ L HPN++ L +    KS I +V +++      +     +   L  +  +    
Sbjct: 62  EIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKD--NSLVLTPSHIKAYML 119

Query: 122 QLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPN 181
             + G+ Y H   + HRDLK  N+LLD  G +K++DFGL+              + GSPN
Sbjct: 120 MTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLA-------------KSFGSPN 166

Query: 182 -----------YVAPEVL-ANRGYDGATSDIWSCGVILY-------IFRGD--------- 213
                      Y APE+L   R Y     D+W+ G IL           GD         
Sbjct: 167 RAYTHQVVTRWYRAPELLFGARMYGVGV-DMWAVGCILAELLLRVPFLPGDSDLDQLTRI 225

Query: 214 FKL---------------------PKW-----------LSPGAQNLLRKILEPNPVKRIT 241
           F+                        +                 +L++ +   NP  RIT
Sbjct: 226 FETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARIT 285

Query: 242 IAGIKADEWFEQDYTPANPDD 262
                  ++F     P     
Sbjct: 286 ATQALKMKYFSNRPGPTPGCQ 306

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score =  163 bits (415), Expect = 2e-47
 Identities = 74/312 (23%), Positives = 118/312 (37%), Gaps = 84/312 (26%)

Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVK-ILEKNRIIHLKITDQIKREIATLKLLKH 73
           +YE    +GEG++G V   ++ D+G   A+K  LE      +K      REI  LK LKH
Sbjct: 4   KYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIAL--REIRMLKQLKH 61

Query: 74  PNVVRLHEVLASKSKIYMVLEYVTG--GELFDKIASKGRLQEAEGRKLFQQLIDGVSYCH 131
           PN+V L EV   K ++++V EY         D+   +  + E   + +  Q +  V++CH
Sbjct: 62  PNLVNLLEVFRRKRRLHLVFEYCDHTVLHELDR--YQRGVPEHLVKSITWQTLQAVNFCH 119

Query: 132 NKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP-----NYV--- 183
                HRD+K ENIL+     IK+ DFG +      R           P     + V   
Sbjct: 120 KHNCIHRDVKPENILITKHSVIKLCDFGFA------R-------LLTGPSDYYDDEVATR 166

Query: 184 ---APEVL-ANRGYDGATSDIWSCGVILY-------IFRGD------------------- 213
              +PE+L  +  Y     D+W+ G +         ++ G                    
Sbjct: 167 WYRSPELLVGDTQYGPPV-DVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPR 225

Query: 214 -------------FKLPKW------------LSPGAQNLLRKILEPNPVKRITIAGIKAD 248
                         K+P              +S  A  LL+  L  +P +R+T   +   
Sbjct: 226 HQQVFSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHH 285

Query: 249 EWFEQDYTPANP 260
            +FE      + 
Sbjct: 286 PYFENIREIEDL 297

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score =  163 bits (414), Expect = 5e-47
 Identities = 49/244 (20%), Positives = 87/244 (35%), Gaps = 33/244 (13%)

Query: 41  PFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGE 100
            +         +      D    +I  +      N V   +  + K  +Y+ ++      
Sbjct: 88  IWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKEN 147

Query: 101 LFDKIASKGRLQEAEG---RKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISD 157
           L D +  +  L++ E      +F Q+ + V + H+KG+ HRDLK  NI       +K+ D
Sbjct: 148 LKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGD 207

Query: 158 FGLSA----------LPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVIL 207
           FGL            +              G+  Y++PE +    Y     DI+S G+IL
Sbjct: 208 FGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHK-VDIFSLGLIL 266

Query: 208 Y------------------IFRGDF-KLPKWLSPGAQNLLRKILEPNPVKRITIAGIKAD 248
           +                  +    F  L     P    +++ +L P+P +R     I  +
Sbjct: 267 FELLYSFSTQMERVRIITDVRNLKFPLLFTQKYPQEHMMVQDMLSPSPTERPEATDIIEN 326

Query: 249 EWFE 252
             FE
Sbjct: 327 AIFE 330

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score = 54.1 bits (130), Expect = 3e-08
 Identities = 17/66 (25%), Positives = 32/66 (48%), Gaps = 2/66 (3%)

Query: 16 YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
          +E  + +G G FG V  A++      +A+K +        +  +++ RE+  L  L+HP 
Sbjct: 8  FEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAR--EKVMREVKALAKLEHPG 65

Query: 76 VVRLHE 81
          +VR   
Sbjct: 66 IVRYFN 71

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score =  162 bits (413), Expect = 7e-47
 Identities = 78/310 (25%), Positives = 128/310 (41%), Gaps = 74/310 (23%)

Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVK-ILEKNRIIHLKITDQIKREIATLKLLKH 73
           +YE    +GEG++G V   ++ D+G   A+K  LE +    +K      REI  LK L+H
Sbjct: 26  KYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKI--AMREIKLLKQLRH 83

Query: 74  PNVVRLHEVLASKSKIYMVLEYVTG--GELFDKIASKGRLQEAEGRKLFQQLIDGVSYCH 131
            N+V L EV   K + Y+V E+V     +  +       L     +K   Q+I+G+ +CH
Sbjct: 84  ENLVNLLEVCKKKKRWYLVFEFVDHTILDDLELF--PNGLDYQVVQKYLFQIINGIGFCH 141

Query: 132 NKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYV------AP 185
           +  + HRD+K ENIL+   G +K+ DFG +   +     G ++      + V      AP
Sbjct: 142 SHNIIHRDIKPENILVSQSGVVKLCDFGFA---RTLAAPGEVYD-----DEVATRWYRAP 193

Query: 186 EVL-ANRGYDGATSDIWSCGVILY-------IFRGD------------------------ 213
           E+L  +  Y  A  D+W+ G ++        +F GD                        
Sbjct: 194 ELLVGDVKYGKAV-DVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELF 252

Query: 214 --------FKLPKW------------LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQ 253
                    +LP+             LS    +L +K L  +P KR   A +   ++F+ 
Sbjct: 253 NKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQM 312

Query: 254 DYTPANPDDD 263
           D        +
Sbjct: 313 DGFAERFSQE 322

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score =  159 bits (406), Expect = 4e-46
 Identities = 79/295 (26%), Positives = 127/295 (43%), Gaps = 89/295 (30%)

Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLK----ITDQIKREIATLKL 70
           +YE    +GEG +G V  A++ ++    A+K   + R+         +    REI  LK 
Sbjct: 3   KYEKLEKIGEGTYGTVFKAKNRETHEIVALK---RVRLDDDDEGVPSS--ALREICLLKE 57

Query: 71  LKHPNVVRLHEVLASKSKIYMVLEYVTG--GELFDKIASKGRLQEAEGRKLFQQLIDGVS 128
           LKH N+VRLH+VL S  K+ +V E+      + FD     G L     +    QL+ G+ 
Sbjct: 58  LKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSC--NGDLDPEIVKSFLFQLLKGLG 115

Query: 129 YCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPN------- 181
           +CH++ V HRDLK +N+L++  G +K+++FGL+      R         G P        
Sbjct: 116 FCHSRNVLHRDLKPQNLLINRNGELKLANFGLA------R-------AFGIPVRCYSAEV 162

Query: 182 ----YVAPEVL-ANRGYDGATSDIWSCGVILY--------IFRGD---------FKL--- 216
               Y  P+VL   + Y  +  D+WS G I          +F G+         F+L   
Sbjct: 163 VTLWYRPPDVLFGAKLYSTSI-DMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGT 221

Query: 217 ------------------PKW------------LSPGAQNLLRKILEPNPVKRIT 241
                             P +            L+   ++LL+ +L+ NPV+RI+
Sbjct: 222 PTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRIS 276

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  159 bits (403), Expect = 8e-46
 Identities = 61/272 (22%), Positives = 113/272 (41%), Gaps = 38/272 (13%)

Query: 14  GRYE-LGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK 72
           GR+      +G G+F  V    D ++ +  A   L+  ++   +   + K E   LK L+
Sbjct: 25  GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSER-QRFKEEAEMLKGLQ 83

Query: 73  HPNVVRLH----EVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVS 128
           HPN+VR +      +  K  I +V E +T G L   +     ++    R   +Q++ G+ 
Sbjct: 84  HPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQ 143

Query: 129 YCHNKG--VFHRDLKLENILLDSK-GNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAP 185
           + H +   + HRDLK +NI +    G++KI D GL+ L +            G+P ++AP
Sbjct: 144 FLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR----ASFAKAVIGTPEFMAP 199

Query: 186 EVLANRGYDGATSDIWSCG--------------------VILYIFRGDFK---LPKWLSP 222
           E+     YD +  D+++ G                     I        K     K   P
Sbjct: 200 EMY-EEKYDES-VDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIP 257

Query: 223 GAQNLLRKILEPNPVKRITIAGIKADEWFEQD 254
             + ++   +  N  +R +I  +    +F+++
Sbjct: 258 EVKEIIEGCIRQNKDERYSIKDLLNHAFFQEE 289

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score =  159 bits (404), Expect = 1e-45
 Identities = 71/322 (22%), Positives = 118/322 (36%), Gaps = 90/322 (27%)

Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIK----REIATLKL 70
            Y     LGEG +  V   +   +    A+K   +   I L+  +       RE++ LK 
Sbjct: 3   TYIKLDKLGEGTYATVYKGKSKLTDNLVALK---E---IRLEHEEGAPCTAIREVSLLKD 56

Query: 71  LKHPNVVRLHEVLASKSKIYMVLEYVTG--GELFDKIASKGRLQEAEGRKLFQQLIDGVS 128
           LKH N+V LH+++ ++  + +V EY+     +  D       +     +    QL+ G++
Sbjct: 57  LKHANIVTLHDIIHTEKSLTLVFEYLDKDLKQYLDD--CGNIINMHNVKLFLFQLLRGLA 114

Query: 129 YCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPN------- 181
           YCH + V HRDLK +N+L++ +G +K++DFGL+      R           P        
Sbjct: 115 YCHRQKVLHRDLKPQNLLINERGELKLADFGLA------R-------AKSIPTKTYDNEV 161

Query: 182 ----YVAPEVL-ANRGYDGATSDIWSCGVILY-------IFRGD---------------- 213
               Y  P++L  +  Y     D+W  G I Y       +F G                 
Sbjct: 162 VTLWYRPPDILLGSTDYSTQI-DMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTP 220

Query: 214 ----------------FKLPKW-----------LSPGAQNLLRKILEPNPVKRITIAGIK 246
                           +  PK+           L     +LL K+L+     RI+     
Sbjct: 221 TEETWPGILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAM 280

Query: 247 ADEWFEQDYTPANPDDDEEDIF 268
              +F       +   D   IF
Sbjct: 281 KHPFFLSLGERIHKLPDTTSIF 302

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score =  158 bits (403), Expect = 2e-45
 Identities = 73/321 (22%), Positives = 126/321 (39%), Gaps = 95/321 (29%)

Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIK----REIATLKL 70
           +++    LG G +  V    +  +G+  A+K       + L   +       REI+ +K 
Sbjct: 6   QFKQLEKLGNGTYATVYKGLNKTTGVYVALKE------VKLDSEEGTPSTAIREISLMKE 59

Query: 71  LKHPNVVRLHEVLASKSKIYMVLEYVTGG-----ELFDKIASKGRLQEAEGRKLFQQLID 125
           LKH N+VRL++V+ +++K+ +V E++        +      +   L+    +    QL+ 
Sbjct: 60  LKHENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQ 119

Query: 126 GVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPN---- 181
           G+++CH   + HRDLK +N+L++ +G +K+ DFGL+      R         G P     
Sbjct: 120 GLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLA------R-------AFGIPVNTFS 166

Query: 182 -------YVAPEVL-ANRGYDGATSDIWSCGVILY-------IFRGD---------FKL- 216
                  Y AP+VL  +R Y  +  DIWSCG IL        +F G          F + 
Sbjct: 167 SEVVTLWYRAPDVLMGSRTYSTSI-DIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIM 225

Query: 217 ---------------------PKW----------------LSPGAQNLLRKILEPNPVKR 239
                                 +                 L     + L  +L+ NP  R
Sbjct: 226 GTPNESLWPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMR 285

Query: 240 ITIAGIKADEWFEQDYTPANP 260
           ++        WF + Y  A+ 
Sbjct: 286 LSAKQALHHPWFAEYYHHASM 306

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score =  156 bits (398), Expect = 4e-45
 Identities = 79/316 (25%), Positives = 131/316 (41%), Gaps = 107/316 (33%)

Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIK------------ 62
           +Y     +GEG +G V  AQ+                   LK   +I+            
Sbjct: 3   KYHGLEKIGEGTYGVVYKAQN------------NYGETFALK---KIRLEKEDEGIPSTT 47

Query: 63  -REIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTG--GELFDKIASKGRLQEAEGRKL 119
            REI+ LK LKH N+V+L++V+ +K ++ +V E++     +L D    +G L+    +  
Sbjct: 48  IREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDV--CEGGLESVTAKSF 105

Query: 120 FQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGS 179
             QL++G++YCH++ V HRDLK +N+L++ +G +KI+DFGL+      R         G 
Sbjct: 106 LLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLA------R-------AFGI 152

Query: 180 PN-----------YVAPEVL-ANRGYDGATSDIWSCGVILY-------IFRGD------- 213
           P            Y AP+VL  ++ Y     DIWS G I         +F G        
Sbjct: 153 PVRKYTHEIVTLWYRAPDVLMGSKKYSTTI-DIWSVGCIFAEMVNGTPLFPGVSEADQLM 211

Query: 214 --FKL----------------------PKW-----------LSPGAQNLLRKILEPNPVK 238
             F++                        +           L     +LL K+L+ +P +
Sbjct: 212 RIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQ 271

Query: 239 RITIAGIKADEWFEQD 254
           RIT        +F+++
Sbjct: 272 RITAKQALEHAYFKEN 287

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score =  156 bits (398), Expect = 8e-45
 Identities = 76/304 (25%), Positives = 123/304 (40%), Gaps = 108/304 (35%)

Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIK------------ 62
           +Y+    +GEG +G V  A+D             + RI+ LK   +I+            
Sbjct: 22  KYQKLEKVGEGTYGVVYKAKD------------SQGRIVALK---RIRLDAEDEGIPSTA 66

Query: 63  -REIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTG--GELFDKIASKGRLQEAEGRKL 119
            REI+ LK L HPN+V L +V+ S+  + +V E++     ++ D+   K  LQ+++ +  
Sbjct: 67  IREISLLKELHHPNIVSLIDVIHSERCLTLVFEFMEKDLKKVLDEN--KTGLQDSQIKIY 124

Query: 120 FQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGS 179
             QL+ GV++CH   + HRDLK +N+L++S G +K++DFGL+      R         G 
Sbjct: 125 LYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLA------R-------AFGI 171

Query: 180 PN-----------YVAPEVL-ANRGYDGATSDIWSCGVILY-------IFRGD------- 213
           P            Y AP+VL  ++ Y  +  DIWS G I         +F G        
Sbjct: 172 PVRSYTHEVVTLWYRAPDVLMGSKKYSTSV-DIWSIGCIFAEMITGKPLFPGVTDDDQLP 230

Query: 214 -------------------------FKLPKW-----------LSPGAQNLLRKILEPNPV 237
                                         +                 +LL  +L  +P 
Sbjct: 231 KIFSILGTPNPREWPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPN 290

Query: 238 KRIT 241
           KRI+
Sbjct: 291 KRIS 294

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score =  156 bits (397), Expect = 1e-44
 Identities = 82/318 (25%), Positives = 127/318 (39%), Gaps = 92/318 (28%)

Query: 12  RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLK----ITDQIKREIAT 67
            + RY     LGEG +G+V  A D  +    A+K   + R+ H +     T  I RE++ 
Sbjct: 32  SIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIK---RIRLEHEEEGVPGT-AI-REVSL 86

Query: 68  LKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGV 127
           LK L+H N++ L  V+    +++++ EY    +L   +     +     +    QLI+GV
Sbjct: 87  LKELQHRNIIELKSVIHHNHRLHLIFEYAE-NDLKKYMDKNPDVSMRVIKSFLYQLINGV 145

Query: 128 SYCHNKGVFHRDLKLENILLDS-----KGNIKISDFGLSALPQHFRDDGLLHTTCGSPN- 181
           ++CH++   HRDLK +N+LL          +KI DFGL+      R         G P  
Sbjct: 146 NFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLA------R-------AFGIPIR 192

Query: 182 ----------YVAPEVL-ANRGYDGATSDIWSCGVILY-------IFRGD---------F 214
                     Y  PE+L  +R Y  +  DIWS   I         +F GD         F
Sbjct: 193 QFTHEIITLWYRPPEILLGSRHYSTSV-DIWSIACIWAEMLMKTPLFPGDSEIDQLFKIF 251

Query: 215 KL----------------------PKW------------LSPGAQNLLRKILEPNPVKRI 240
           ++                      PK+            L     +LL  +LE +PVKRI
Sbjct: 252 EVLGLPDDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRI 311

Query: 241 TIAGIKADEWF-EQDYTP 257
           +        +F   D+ P
Sbjct: 312 SAKNALEHPYFSHNDFDP 329

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score =  153 bits (390), Expect = 1e-43
 Identities = 82/311 (26%), Positives = 116/311 (37%), Gaps = 88/311 (28%)

Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKIL----EKNRIIHLKITDQIKREIATLKL 70
           RYE    +G G +G V  A+D  SG   A+K +           L I+    RE+A L+ 
Sbjct: 10  RYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPIS--TVREVALLRR 67

Query: 71  LK---HPNVVRLHEVLASKS-----KIYMVLEYVTG--GELFDKIASKGRLQEAEGRKLF 120
           L+   HPNVVRL +V A+       K+ +V E+V        DK    G L     + L 
Sbjct: 68  LEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPG-LPAETIKDLM 126

Query: 121 QQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP 180
           +Q + G+ + H   + HRDLK ENIL+ S G +K++DFGL+      R            
Sbjct: 127 RQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLA------R-------IYSYQ 173

Query: 181 N----------YVAPEVLANRGYDGATSDIWSCGVILY-------IFRGD---------- 213
                      Y APEVL    Y     D+WS G I         +F G+          
Sbjct: 174 MALTPVVVTLWYRAPEVLLQSTYATPV-DMWSVGCIFAEMFRRKPLFCGNSEADQLGKIF 232

Query: 214 -------------------FKLPKW-----------LSPGAQNLLRKILEPNPVKRITIA 243
                                 P             +      LL ++L  NP KRI+  
Sbjct: 233 DLIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAF 292

Query: 244 GIKADEWFEQD 254
                 +  +D
Sbjct: 293 RALQHSYLHKD 303

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score =  153 bits (389), Expect = 4e-43
 Identities = 80/327 (24%), Positives = 130/327 (39%), Gaps = 91/327 (27%)

Query: 12  RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLK----ITDQIKREIAT 67
            + +YE    +G+G FG+V  A+   +G   A+K   K  + + K    IT    REI  
Sbjct: 15  EVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALK---KVLMENEKEGFPITAL--REIKI 69

Query: 68  LKLLKHPNVVRLHEVLASKS--------KIYMVLEYV----TGGELFDKIASKGRLQEAE 115
           L+LLKH NVV L E+  +K+         IY+V ++      G  L   +    +   +E
Sbjct: 70  LQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAG--LLSNV--LVKFTLSE 125

Query: 116 GRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLS-ALPQHFRDDGLLH 174
            +++ Q L++G+ Y H   + HRD+K  N+L+   G +K++DFGL+ A           +
Sbjct: 126 IKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRY 185

Query: 175 TTCGSPN------YVAPEVL-ANRGYDGATSDIWSCGVILY-------IFRGD------- 213
           T     N      Y  PE+L   R Y     D+W  G I+        I +G+       
Sbjct: 186 T-----NRVVTLWYRPPELLLGERDYGPPI-DLWGAGCIMAEMWTRSPIMQGNTEQHQLA 239

Query: 214 -------------------------FKLPKW-------------LSPGAQNLLRKILEPN 235
                                     +L K                P A +L+ K+L  +
Sbjct: 240 LISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLD 299

Query: 236 PVKRITIAGIKADEWFEQDYTPANPDD 262
           P +RI        ++F  D  P++   
Sbjct: 300 PAQRIDSDDALNHDFFWSDPMPSDLKG 326

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score =  151 bits (384), Expect = 2e-42
 Identities = 71/252 (28%), Positives = 113/252 (44%), Gaps = 19/252 (7%)

Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITD----QIKREIATLKLL 71
           +E    LG GN G V       SGL  A K+      IHL+I      QI RE+  L   
Sbjct: 35  FEKISELGAGNGGVVFKVSHKPSGLVMARKL------IHLEIKPAIRNQIIRELQVLHEC 88

Query: 72  KHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCH 131
             P +V  +    S  +I + +E++ GG L   +   GR+ E    K+   +I G++Y  
Sbjct: 89  NSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLR 148

Query: 132 NKG-VFHRDLKLENILLDSKGNIKISDFGLSA-LPQHFRDDGLLHTTCGSPNYVAPEVLA 189
            K  + HRD+K  NIL++S+G IK+ DFG+S  L      D + ++  G+ +Y++PE L 
Sbjct: 149 EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL-----IDSMANSFVGTRSYMSPERLQ 203

Query: 190 NRGYDGATSDIWSCGVILY-IFRGDFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKAD 248
              Y    SDIWS G+ L  +  G + +P   +   + +    +E +  +          
Sbjct: 204 GTHYS-VQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGR 262

Query: 249 EWFEQDYTPANP 260
              +       P
Sbjct: 263 PLNKFGMDSRPP 274

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score =  149 bits (379), Expect = 6e-42
 Identities = 81/307 (26%), Positives = 119/307 (38%), Gaps = 108/307 (35%)

Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIK------------ 62
           +YE    +GEG +GKV  A+DL +G           R + LK   +++            
Sbjct: 12  QYECVAEIGEGAYGKVFKARDLKNG----------GRFVALK---RVRVQTGEEGMPLST 58

Query: 63  -REIATLKLLK---HPNVVRLHEVL-----ASKSKIYMVLEYVTG--GELFDKIASKGRL 111
            RE+A L+ L+   HPNVVRL +V        ++K+ +V E+V        DK+   G +
Sbjct: 59  IREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPG-V 117

Query: 112 QEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDG 171
                + +  QL+ G+ + H+  V HRDLK +NIL+ S G IK++DFGL+      R   
Sbjct: 118 PTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLA------R--- 168

Query: 172 LLHTTCGSPN----------YVAPEVLANRGYDGATSDIWSCGVILY-------IFRGD- 213
                               Y APEVL    Y     D+WS G I         +FRG  
Sbjct: 169 ----IYSFQMALTSVVVTLWYRAPEVLLQSSYATPV-DLWSVGCIFAEMFRRKPLFRGSS 223

Query: 214 --------FKL--------------------PKW-----------LSPGAQNLLRKILEP 234
                     +                                  +    ++LL K L  
Sbjct: 224 DVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTF 283

Query: 235 NPVKRIT 241
           NP KRI+
Sbjct: 284 NPAKRIS 290

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score =  145 bits (367), Expect = 2e-40
 Identities = 58/193 (30%), Positives = 102/193 (52%), Gaps = 10/193 (5%)

Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKI--LEKNRIIHLKITDQIKREIATLKLLK 72
            +     +G+G+FG+V    D  +    A+KI  LE+      +I D I++EI  L    
Sbjct: 23  LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA---EDEIED-IQQEITVLSQCD 78

Query: 73  HPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHN 132
            P V + +      +K+++++EY+ GG   D +   G L E +   + ++++ G+ Y H+
Sbjct: 79  SPYVTKYYGSYLKDTKLWIIMEYLGGGSALD-LLEPGPLDETQIATILREILKGLDYLHS 137

Query: 133 KGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRG 192
           +   HRD+K  N+LL   G +K++DFG++   Q        +T  G+P ++APEV+    
Sbjct: 138 EKKIHRDIKAANVLLSEHGEVKLADFGVAG--QLTDTQIKRNTFVGTPFWMAPEVIKQSA 195

Query: 193 YDGATSDIWSCGV 205
           YD   +DIWS G+
Sbjct: 196 YDSK-ADIWSLGI 207

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  144 bits (366), Expect = 3e-40
 Identities = 54/208 (25%), Positives = 92/208 (44%), Gaps = 23/208 (11%)

Query: 17  ELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNV 76
             G  LG+G FG+       ++G    +K L +      +      +E+  ++ L+HPNV
Sbjct: 13  IHGEVLGKGCFGQAIKVTHRETGEVMVMKELIR---FDEETQRTFLKEVKVMRCLEHPNV 69

Query: 77  VRLHEVLASKSKIYMVLEYVTGGELFDKIASKGR-LQEAEGRKLFQQLID---GVSYCHN 132
           ++   VL    ++  + EY+ GG L   I S           +      D   G++Y H+
Sbjct: 70  LKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPW---SQRVSFAKDIASGMAYLHS 126

Query: 133 KGVFHRDLKLENILLDSKGNIKISDFGLSALPQH------------FRDDGLLHTTCGSP 180
             + HRDL   N L+    N+ ++DFGL+ L                 D    +T  G+P
Sbjct: 127 MNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNP 186

Query: 181 NYVAPEVLANRGYDGATSDIWSCGVILY 208
            ++APE++  R YD    D++S G++L 
Sbjct: 187 YWMAPEMINGRSYDEK-VDVFSFGIVLC 213

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  142 bits (360), Expect = 2e-39
 Identities = 63/197 (31%), Positives = 104/197 (52%), Gaps = 11/197 (5%)

Query: 17  ELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNV 76
            +   +G G+FG V  A+    G   AVKIL +    H +  ++  RE+A +K L+HPN+
Sbjct: 40  NIKEKIGAGSFGTVHRAEW--HGSDVAVKILMEQDF-HAERVNEFLREVAIMKRLRHPNI 96

Query: 77  VRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLID---GVSYCHNK 133
           V     +     + +V EY++ G L+  +   G  ++ + R+      D   G++Y HN+
Sbjct: 97  VLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNR 156

Query: 134 G--VFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANR 191
              + HR+LK  N+L+D K  +K+ DFGLS L           +  G+P ++APEVL + 
Sbjct: 157 NPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKAS--TFLSSKSAAGTPEWMAPEVLRDE 214

Query: 192 GYDGATSDIWSCGVILY 208
             +   SD++S GVIL+
Sbjct: 215 PSNEK-SDVYSFGVILW 230

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  141 bits (358), Expect = 2e-39
 Identities = 52/198 (26%), Positives = 96/198 (48%), Gaps = 14/198 (7%)

Query: 17  ELGRTLGEGNFGKV---KFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKH 73
            +G+ +G G+FG V   K+  D+      AVK+L        +     K E+  L+  +H
Sbjct: 27  TVGQRIGSGSFGTVYKGKWHGDV------AVKMLNVTAP-TPQQLQAFKNEVGVLRKTRH 79

Query: 74  PNVVRLHEVLASKSKIYMVLEYVTGGELFDKI-ASKGRLQEAEGRKLFQQLIDGVSYCHN 132
            N++      ++  ++ +V ++  G  L+  + AS+ + +  +   + +Q   G+ Y H 
Sbjct: 80  VNILLFMGY-STAPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHA 138

Query: 133 KGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRG 192
           K + HRDLK  NI L     +KI DFGL+     +          GS  ++APEV+  + 
Sbjct: 139 KSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQD 198

Query: 193 YDGAT--SDIWSCGVILY 208
            +  +  SD+++ G++LY
Sbjct: 199 SNPYSFQSDVYAFGIVLY 216

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  140 bits (356), Expect = 7e-39
 Identities = 69/303 (22%), Positives = 113/303 (37%), Gaps = 61/303 (20%)

Query: 17  ELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNV 76
           E+   +G G FG V  A+        A+K +E               E+  L  + HPN+
Sbjct: 11  EVEEVVGRGAFGVVCKAKW--RAKDVAIKQIESE-----SERKAFIVELRQLSRVNHPNI 63

Query: 77  VRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLID---GVSYCHN- 132
           V+L    A  + + +V+EY  GG L++ +     L            +    GV+Y H+ 
Sbjct: 64  VKL--YGACLNPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSM 121

Query: 133 --KGVFHRDLKLENILLDSKGN-IKISDFGLSALPQHFRD-DGLLHTTCGSPNYVAPEVL 188
             K + HRDLK  N+LL + G  +KI DFG +       D    +    GS  ++APEV 
Sbjct: 122 QPKALIHRDLKPPNLLLVAGGTVLKICDFGTA------CDIQTHMTNNKGSAAWMAPEVF 175

Query: 189 ANRGYDGATSDIWSCGVILY----------------------IFRGD-FKLPKWLSPGAQ 225
               Y     D++S G+IL+                      +  G    L K L    +
Sbjct: 176 EGSNYSEK-CDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLIKNLPKPIE 234

Query: 226 NLLRKILEPNPVKR--------------ITIAGIKADEWFEQDYTPANPDDDEEDIFVDN 271
           +L+ +    +P +R                  G      +   ++    +D   + +VD 
Sbjct: 235 SLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPGADEPLQYPCQHSLPPGEDGRVEPYVDF 294

Query: 272 EAF 274
             F
Sbjct: 295 AEF 297

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score =  139 bits (353), Expect = 2e-38
 Identities = 68/254 (26%), Positives = 124/254 (48%), Gaps = 35/254 (13%)

Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
            +E+   LG+G FGKV  A++ ++G   A K++E       ++ D    EI  L    HP
Sbjct: 20  VWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKS--EEELED-YIVEIEILATCDHP 76

Query: 75  NVVRLHEVLASKSKIYMVLEYVTGGELFDKI-ASKGRLQEAEGRKLFQQLIDGVSYCHNK 133
            +V+L        K+++++E+  GG +   +      L E + + + +Q+++ +++ H+K
Sbjct: 77  YIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSK 136

Query: 134 GVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANR-- 191
            + HRDLK  N+L+  +G+I+++DFG+SA  ++ +      +  G+P ++APEV+     
Sbjct: 137 RIIHRDLKAGNVLMTLEGDIRLADFGVSA--KNLKTLQKRDSFIGTPYWMAPEVVMCETM 194

Query: 192 ---GYDGATSDIWSCG--------------------VILYIFRGD---FKLPKWLSPGAQ 225
               YD   +DIWS G                    V+L I + D      P   S   +
Sbjct: 195 KDTPYDYK-ADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTLLTPSKWSVEFR 253

Query: 226 NLLRKILEPNPVKR 239
           + L+  L+ NP  R
Sbjct: 254 DFLKIALDKNPETR 267

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score =  139 bits (352), Expect = 3e-38
 Identities = 56/193 (29%), Positives = 101/193 (52%), Gaps = 11/193 (5%)

Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKI--LEKNRIIHLKITDQIKREIATLKLLK 72
           +Y     +G+G  G V  A D+ +G   A++   L++     L     I  EI  ++  K
Sbjct: 21  KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKEL-----IINEILVMRENK 75

Query: 73  HPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHN 132
           +PN+V   +      ++++V+EY+ GG L D + ++  + E +   + ++ +  + + H+
Sbjct: 76  NPNIVNYLDSYLVGDELWVVMEYLAGGSLTD-VVTETCMDEGQIAAVCRECLQALEFLHS 134

Query: 133 KGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRG 192
             V HRD+K +NILL   G++K++DFG  A  Q   +     T  G+P ++APEV+  + 
Sbjct: 135 NQVIHRDIKSDNILLGMDGSVKLTDFGFCA--QITPEQSKRSTMVGTPYWMAPEVVTRKA 192

Query: 193 YDGATSDIWSCGV 205
           Y     DIWS G+
Sbjct: 193 YGPK-VDIWSLGI 204

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score =  139 bits (351), Expect = 4e-38
 Identities = 66/251 (26%), Positives = 117/251 (46%), Gaps = 32/251 (12%)

Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
            +++   LGEG++G V  A   ++G   A+K +     +      +I +EI+ ++    P
Sbjct: 30  VFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDL-----QEIIKEISIMQQCDSP 84

Query: 75  NVVRLHEVLASKSKIYMVLEYVTGGELFDKI-ASKGRLQEAEGRKLFQQLIDGVSYCHNK 133
           +VV+ +      + +++V+EY   G + D I      L E E   + Q  + G+ Y H  
Sbjct: 85  HVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFM 144

Query: 134 GVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGY 193
              HRD+K  NILL+++G+ K++DFG++   Q        +T  G+P ++APEV+   GY
Sbjct: 145 RKIHRDIKAGNILLNTEGHAKLADFGVAG--QLTDTMAKRNTVIGTPFWMAPEVIQEIGY 202

Query: 194 DGATSDIWSCG--------------------VILYIFRGD---FKLPKWLSPGAQNLLRK 230
           +   +DIWS G                     I  I       F+ P+  S    + +++
Sbjct: 203 NCV-ADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPPPTFRKPELWSDNFTDFVKQ 261

Query: 231 ILEPNPVKRIT 241
            L  +P +R T
Sbjct: 262 CLVKSPEQRAT 272

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score =  139 bits (351), Expect = 5e-38
 Identities = 61/193 (31%), Positives = 106/193 (54%), Gaps = 11/193 (5%)

Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKI--LEKNRIIHLKITDQIKREIATLKLLK 72
             +    +GEG+ G V  A++  SG   AVK+  L K +   L     +  E+  ++  +
Sbjct: 46  LLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRREL-----LFNEVVIMRDYQ 100

Query: 73  HPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHN 132
           H NVV +++      ++++++E++ GG L D I S+ RL E +   + + ++  ++Y H 
Sbjct: 101 HFNVVEMYKSYLVGEELWVLMEFLQGGALTD-IVSQVRLNEEQIATVCEAVLQALAYLHA 159

Query: 133 KGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRG 192
           +GV HRD+K ++ILL   G +K+SDFG  A  Q  +D     +  G+P ++APEV++   
Sbjct: 160 QGVIHRDIKSDSILLTLDGRVKLSDFGFCA--QISKDVPKRKSLVGTPYWMAPEVISRSL 217

Query: 193 YDGATSDIWSCGV 205
           Y     DIWS G+
Sbjct: 218 YA-TEVDIWSLGI 229

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score =  138 bits (349), Expect = 8e-38
 Identities = 56/228 (24%), Positives = 99/228 (43%), Gaps = 14/228 (6%)

Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATL-KLLKHP 74
            E    +G G  G+V   +   +G   AVK + ++   + +   +I  ++  + K    P
Sbjct: 27  LENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRS--GNKEENKRILMDLDVVLKSHDCP 84

Query: 75  NVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNK- 133
            +V+      + + +++ +E +       K   +G + E    K+   ++  + Y   K 
Sbjct: 85  YIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKH 144

Query: 134 GVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGY 193
           GV HRD+K  NILLD +G IK+ DFG+S       DD     + G   Y+APE +     
Sbjct: 145 GVIHRDVKPSNILLDERGQIKLCDFGISG---RLVDDKAKDRSAGCAAYMAPERIDPPDP 201

Query: 194 DGAT----SDIWSCGVILY-IFRGDFKLPKWLSPGAQNLLRKILEPNP 236
                   +D+WS G+ L  +  G F      +     +L K+L+  P
Sbjct: 202 TKPDYDIRADVWSLGISLVELATGQFPYKNCKTD--FEVLTKVLQEEP 247

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score =  137 bits (347), Expect = 1e-37
 Identities = 64/205 (31%), Positives = 99/205 (48%), Gaps = 19/205 (9%)

Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKI--LEKNRIIHLKITDQIKREIATLKLLK 72
            YEL   +G G    V+ A         A+K   LEK +       D++ +EI  +    
Sbjct: 16  DYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQ----TSMDELLKEIQAMSQCH 71

Query: 73  HPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLI-------- 124
           HPN+V  +     K ++++V++ ++GG + D I       E +   L +  I        
Sbjct: 72  HPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVL 131

Query: 125 DGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLL---HTTCGSPN 181
           +G+ Y H  G  HRD+K  NILL   G+++I+DFG+SA      D        T  G+P 
Sbjct: 132 EGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPC 191

Query: 182 YVAPEVLA-NRGYDGATSDIWSCGV 205
           ++APEV+   RGYD   +DIWS G+
Sbjct: 192 WMAPEVMEQVRGYD-FKADIWSFGI 215

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score =  136 bits (346), Expect = 2e-37
 Identities = 60/198 (30%), Positives = 96/198 (48%), Gaps = 8/198 (4%)

Query: 14  GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKH 73
            RY++   LG G    V  A+D    +  A+K +        +   + +RE+     L H
Sbjct: 11  ERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSH 70

Query: 74  PNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNK 133
            N+V + +V       Y+V+EY+ G  L + I S G L          Q++DG+ + H+ 
Sbjct: 71  QNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDM 130

Query: 134 GVFHRDLKLENILLDSKGNIKISDFGLS-ALPQHFRDDGLLHTTC--GSPNYVAPEVLAN 190
            + HRD+K +NIL+DS   +KI DFG++ AL     +  L  T    G+  Y +PE  A 
Sbjct: 131 RIVHRDIKPQNILIDSNKTLKIFDFGIAKAL----SETSLTQTNHVLGTVQYFSPE-QAK 185

Query: 191 RGYDGATSDIWSCGVILY 208
                  +DI+S G++LY
Sbjct: 186 GEATDECTDIYSIGIVLY 203

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  136 bits (345), Expect = 4e-37
 Identities = 53/207 (25%), Positives = 96/207 (46%), Gaps = 23/207 (11%)

Query: 17  ELGRTLGEGNFGKV---KFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKH 73
           E+G  +G+G FG+V   ++  ++      A+++++  R          KRE+   +  +H
Sbjct: 36  EIGELIGKGRFGQVYHGRWHGEV------AIRLIDIERDNE-DQLKAFKREVMAYRQTRH 88

Query: 74  PNVVRLHEVLASKSKIYMVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHN 132
            NVV       S   + ++     G  L+  +   K  L   + R++ Q+++ G+ Y H 
Sbjct: 89  ENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHA 148

Query: 133 KGVFHRDLKLENILLDSKGNIKISDFGLS---ALPQHFRDDGLLHTTCGSPNYVAPEVLA 189
           KG+ H+DLK +N+  D  G + I+DFGL     + Q  R +  L    G   ++APE++ 
Sbjct: 149 KGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIR 207

Query: 190 NRGYDGAT--------SDIWSCGVILY 208
               D           SD+++ G I Y
Sbjct: 208 QLSPDTEEDKLPFSKHSDVFALGTIWY 234

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score =  138 bits (348), Expect = 5e-37
 Identities = 48/205 (23%), Positives = 89/205 (43%), Gaps = 17/205 (8%)

Query: 14  GRYELGRTLGEG--NFGKVKFAQDLDSGLPFAVKI--LEKNRIIHLKITDQIKREIATLK 69
           G YEL   +G+G  +   V  A+   +G    V+   LE      +     ++ E+   K
Sbjct: 25  GCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMV---TFLQGELHVSK 81

Query: 70  LLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFD--KIASKGRLQEAEGRKLFQQLIDGV 127
           L  HPN+V       + +++++V  ++  G   D         + E     + Q ++  +
Sbjct: 82  LFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKAL 141

Query: 128 SYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSA-LPQHFRDDGLLHTTC----GSPNY 182
            Y H+ G  HR +K  +IL+   G + +S    +  +  H +   ++H           +
Sbjct: 142 DYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPW 201

Query: 183 VAPEVLA--NRGYDGATSDIWSCGV 205
           ++PEVL    +GYD   SDI+S G+
Sbjct: 202 LSPEVLQQNLQGYDAK-SDIYSVGI 225

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score =  137 bits (347), Expect = 1e-36
 Identities = 71/258 (27%), Positives = 103/258 (39%), Gaps = 58/258 (22%)

Query: 15  RYE-LGRTLGEGNFGKVKFAQDLD--SGLPFAVKILEKNRIIHLKITDQIKREIATLKLL 71
            +E  G  +G G +G V  A+  D      +A+K +E   I          REIA L+ L
Sbjct: 21  LFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSAC-----REIALLREL 75

Query: 72  KHPNVVRLHEVLASKS--KIYMVLEYV--------TGGELFDKIASKGRLQEAEGRKLFQ 121
           KHPNV+ L +V  S +  K++++ +Y                      +L     + L  
Sbjct: 76  KHPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLY 135

Query: 122 QLIDGVSYCHNKGVFHRDLKLENILLDS----KGNIKISDFGLSALPQHFRDDGLLHTTC 177
           Q++DG+ Y H   V HRDLK  NIL+      +G +KI+D G +      R         
Sbjct: 136 QILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFA------R-------LF 182

Query: 178 GSPN--------------YVAPEVL-ANRGYDGATSDIWSCGVILY-------IFRGDFK 215
            SP               Y APE+L   R Y  A  DIW+ G I         IF    +
Sbjct: 183 NSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAI-DIWAIGCIFAELLTSEPIFHCRQE 241

Query: 216 LPKWLSPGAQNLLRKILE 233
             K  +P   + L +I  
Sbjct: 242 DIKTSNPYHHDQLDRIFN 259

>2ehb_D CBL-interacting serine/threonine-protein kinase 2; protein complex, Ca(II) IONS bound to SOS3 (EF-hands 1 and 4 FISL motif; 2.10A {Arabidopsis thaliana} Length = 143

 Score =  128 bits (324), Expect = 3e-36
 Identities = 40/123 (32%), Positives = 69/123 (56%), Gaps = 3/123 (2%)

Query: 288 GSPPLINAFQLIGMSSCLDLSGFFEKE-DVSERKIRFTSNHSAKDLLERIEDIVTEMGFR 346
             P ++NAF++I +S  L+LS  F++  D  +R+ RF S     +++  IE +   MGF+
Sbjct: 2   EGPLMMNAFEMITLSQGLNLSALFDRRQDFVKRQTRFVSRREPSEIIANIEAVANSMGFK 61

Query: 347 VQKKNGKLKATQEHKPQKSLGSLSVAAEVFEISPSLYVVELRKSYGDPTVYRQLCNKLSS 406
              +N K +   E       G L+V  E++E++PSL++V++RK+ G+   Y +   KL S
Sbjct: 62  SHTRNFKTR--LEGLSSIKAGQLAVVIEIYEVAPSLFMVDVRKAAGETLEYHKFYKKLCS 119

Query: 407 DLG 409
            L 
Sbjct: 120 KLE 122

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  133 bits (336), Expect = 3e-36
 Identities = 52/208 (25%), Positives = 92/208 (44%), Gaps = 26/208 (12%)

Query: 17  ELGRTLGEGNFGKVKFAQDLDSGLPFAVKIL----EKNRIIHLKITDQIKREIATLKLLK 72
           E  + +G+G FG V   + +      A+K L     +     ++   + +RE+  +  L 
Sbjct: 22  EYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLN 81

Query: 73  HPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLID---GVSY 129
           HPN+V+L       +   MV+E+V  G+L+ ++  K      +     + ++D   G+ Y
Sbjct: 82  HPNIVKL--YGLMHNPPRMVMEFVPCGDLYHRLLDKAH--PIKWSVKLRLMLDIALGIEY 137

Query: 130 CHNKG--VFHRDLKLENILLDSKG-----NIKISDFGLSALPQHFRDDGLLHTTCGSPNY 182
             N+   + HRDL+  NI L S         K++DFGLS           +    G+  +
Sbjct: 138 MQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQ-----SVHSVSGLLGNFQW 192

Query: 183 VAPEVLANRG--YDGATSDIWSCGVILY 208
           +APE +      Y    +D +S  +ILY
Sbjct: 193 MAPETIGAEEESYTEK-ADTYSFAMILY 219

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score =  133 bits (337), Expect = 4e-36
 Identities = 55/208 (26%), Positives = 96/208 (46%), Gaps = 16/208 (7%)

Query: 8   QEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQI-----K 62
           +EG + G Y L R +G G  G V  A+D       A+K++ +     L  +D +     +
Sbjct: 28  REGTQFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSE----TLS-SDPVFRTRMQ 82

Query: 63  REIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQ 122
           RE  T   L+ P+VV +H+      ++Y+ +  + G +L   +  +G L       + +Q
Sbjct: 83  REARTAGRLQEPHVVPIHDFGEIDGQLYVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQ 142

Query: 123 LIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHT--TCGSP 180
           +   +   H  G  HRD+K ENIL+ +     + DFG++       D+ L     T G+ 
Sbjct: 143 IGSALDAAHAAGATHRDVKPENILVSADDFAYLVDFGIA---SATTDEKLTQLGNTVGTL 199

Query: 181 NYVAPEVLANRGYDGATSDIWSCGVILY 208
            Y+APE  +        +DI++   +LY
Sbjct: 200 YYMAPERFSESHATYR-ADIYALTCVLY 226

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score =  134 bits (338), Expect = 7e-36
 Identities = 56/195 (28%), Positives = 96/195 (49%), Gaps = 12/195 (6%)

Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
            +   R +G G+FG V FA+D+ +    A+K +  +     +    I +E+  L+ L+HP
Sbjct: 55  LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHP 114

Query: 75  NVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKG 134
           N ++       +   ++V+EY  G         K  LQE E   +    + G++Y H+  
Sbjct: 115 NTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHN 174

Query: 135 VFHRDLKLENILLDSKGNIKISDFGLSA-LPQHFRDDGLLHTTCGSPNYVAPEVLANR-- 191
           + HRD+K  NILL   G +K+ DFG ++ +          ++  G+P ++APEV+     
Sbjct: 175 MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA-------NSFVGTPYWMAPEVILAMDE 227

Query: 192 -GYDGATSDIWSCGV 205
             YDG   D+WS G+
Sbjct: 228 GQYDGK-VDVWSLGI 241

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score =  132 bits (334), Expect = 9e-36
 Identities = 55/237 (23%), Positives = 101/237 (42%), Gaps = 30/237 (12%)

Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITD----QIKREIA-TLKL 70
            E    LG G +G V+  + + SG   AVK       I   +      ++  ++  +++ 
Sbjct: 9   LEPIMELGRGAYGVVEKMRHVPSGQIMAVKR------IRATVNSQEQKRLLMDLDISMRT 62

Query: 71  LKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKI-----ASKGRLQEAEGRKLFQQLID 125
           +  P  V  +  L  +  +++ +E +      DK           + E    K+   ++ 
Sbjct: 63  VDCPFTVTFYGALFREGDVWICMELMDTS--LDKFYKQVIDKGQTIPEDILGKIAVSIVK 120

Query: 126 GVSYCHNKG-VFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVA 184
            + + H+K  V HRD+K  N+L+++ G +K+ DFG+S    +  DD       G   Y+A
Sbjct: 121 ALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISG---YLVDDVAKDIDAGCKPYMA 177

Query: 185 PEVLANR----GYDGATSDIWSCGVILY-IFRGDFKLPKWLSPGAQNLLRKILEPNP 236
           PE +       GY    SDIWS G+ +  +    F    W +P     L++++E   
Sbjct: 178 PERINPELNQKGYS-VKSDIWSLGITMIELAILRFPYDSWGTP--FQQLKQVVEEPS 231

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score =  133 bits (336), Expect = 9e-36
 Identities = 62/238 (26%), Positives = 102/238 (42%), Gaps = 31/238 (13%)

Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITD----QIKREIAT-LKL 70
            +    +G G +G V       SG   AVK       I   + +    Q+  ++   ++ 
Sbjct: 24  LKDLGEIGRGAYGSVNKMVHKPSGQIMAVKR------IRSTVDEKEQKQLLMDLDVVMRS 77

Query: 71  LKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKI------ASKGRLQEAEGRKLFQQLI 124
              P +V+ +  L  +   ++ +E ++    FDK            + E    K+    +
Sbjct: 78  SDCPYIVQFYGALFREGDCWICMELMSTS--FDKFYKYVYSVLDDVIPEEILGKITLATV 135

Query: 125 DGVSYCHNKG-VFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYV 183
             +++      + HRD+K  NILLD  GNIK+ DFG+S       D        G   Y+
Sbjct: 136 KALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISG---QLVDSIAKTRDAGCRPYM 192

Query: 184 APEVLA----NRGYDGATSDIWSCGVILY-IFRGDFKLPKWLSPGAQNLLRKILEPNP 236
           APE +      +GYD   SD+WS G+ LY +  G F  PKW S   Q  L ++++ +P
Sbjct: 193 APERIDPSASRQGYD-VRSDVWSLGITLYELATGRFPYPKWNSVFDQ--LTQVVKGDP 247

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score =  134 bits (340), Expect = 1e-35
 Identities = 81/340 (23%), Positives = 127/340 (37%), Gaps = 94/340 (27%)

Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVK-ILEKNRIIHLKITDQIKREIATLKLLKH 73
            Y   + +G G+FG V  A+  DSG   A+K +L+  R  +        RE+  ++ L H
Sbjct: 55  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN--------RELQIMRKLDH 106

Query: 74  PNVVRLHEVLASKS------KIYMVLEYVTG---GELFDKIASKGRLQEAEGRKLFQQLI 124
            N+VRL     S         + +VL+YV             +K  L     +    QL 
Sbjct: 107 CNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLF 166

Query: 125 DGVSYCHNKGVFHRDLKLENILLDSK-GNIKISDFGLSALPQHFRDDGLLHTTCGSPN-- 181
             ++Y H+ G+ HRD+K +N+LLD     +K+ DFG +                G PN  
Sbjct: 167 RSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSA-----------KQLVRGEPNVS 215

Query: 182 YV------APEVLAN-RGYDGATSDIWSCGVILY-------IFRGD-------------- 213
           Y+      APE++     Y  +  D+WS G +L        IF GD              
Sbjct: 216 YICSRYYRAPELIFGATDYTSSI-DVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLG 274

Query: 214 ----------------FKLPKW------------LSPGAQNLLRKILEPNPVKRITIAGI 245
                           FK P+               P A  L  ++LE  P  R+T    
Sbjct: 275 TPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEA 334

Query: 246 KADEWFEQDYTPAN--PDDDEEDIFVDNEAFSMHEVPSDG 283
            A  +F++   P    P+  +     +   F+  E+ S+ 
Sbjct: 335 CAHSFFDELRDPNVKLPNGRDTPALFN---FTTQELSSNP 371

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  130 bits (328), Expect = 4e-35
 Identities = 47/259 (18%), Positives = 90/259 (34%), Gaps = 52/259 (20%)

Query: 17  ELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNV 76
                L E + G++        G    VK+L K R    + +     E   L++  HPNV
Sbjct: 13  NFLTKLNENHSGELWKG--RWQGNDIVVKVL-KVRDWSTRKSRDFNEECPRLRIFSHPNV 69

Query: 77  VRLHEVLAS--KSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKL-FQQLID-------G 126
           + +     S       ++  ++  G L++       L E     +   Q +        G
Sbjct: 70  LPVLGACQSPPAPHPTLITHWMPYGSLYN------VLHEGTNFVVDQSQAVKFALDMARG 123

Query: 127 VSYCHNKG--VFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVA 184
           +++ H     +    L   ++++D     +IS   +                  +P +VA
Sbjct: 124 MAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVK----FSFQSP---GRMYAPAWVA 176

Query: 185 PEVLANRGYDGAT--SDIWSCGVILY-IFRGD--FK-------------------LPKWL 220
           PE L  +  D     +D+WS  V+L+ +   +  F                    +P  +
Sbjct: 177 PEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPTIPPGI 236

Query: 221 SPGAQNLLRKILEPNPVKR 239
           SP    L++  +  +P KR
Sbjct: 237 SPHVSKLMKICMNEDPAKR 255

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score =  131 bits (331), Expect = 5e-35
 Identities = 60/206 (29%), Positives = 105/206 (50%), Gaps = 21/206 (10%)

Query: 14  GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLK-LLK 72
           G +EL   +G G +G+V   + + +G   A+K+++   +   +  + IK+EI  LK    
Sbjct: 24  GIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMD---VTGDEEEE-IKQEINMLKKYSH 79

Query: 73  HPNVVRLHE------VLASKSKIYMVLEYVTGGELFD--KIASKGRLQEAEGRKLFQQLI 124
           H N+   +             ++++V+E+   G + D  K      L+E     + ++++
Sbjct: 80  HRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREIL 139

Query: 125 DGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVA 184
            G+S+ H   V HRD+K +N+LL     +K+ DFG+SA  Q  R  G  +T  G+P ++A
Sbjct: 140 RGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSA--QLDRTVGRRNTFIGTPYWMA 197

Query: 185 PEVLANR-----GYDGATSDIWSCGV 205
           PEV+A        YD   SD+WS G+
Sbjct: 198 PEVIACDENPDATYDFK-SDLWSLGI 222

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score =  130 bits (329), Expect = 7e-35
 Identities = 60/213 (28%), Positives = 96/213 (45%), Gaps = 19/213 (8%)

Query: 8   QEGMRL-GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQI----- 61
                L  RYELG  LG G   +V  A+DL      AVK+L       L   D       
Sbjct: 5   TTPSHLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRA----DLA-RDPSFYLRF 59

Query: 62  KREIATLKLLKHPNVVRLHEV----LASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGR 117
           +RE      L HP +V +++       +    Y+V+EYV G  L D + ++G +      
Sbjct: 60  RREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAI 119

Query: 118 KLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTC 177
           ++       +++ H  G+ HRD+K  NI++ +   +K+ DFG+ A       + +  T  
Sbjct: 120 EVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGI-ARAIADSGNSVTQTAA 178

Query: 178 --GSPNYVAPEVLANRGYDGATSDIWSCGVILY 208
             G+  Y++PE  A      A SD++S G +LY
Sbjct: 179 VIGTAQYLSPE-QARGDSVDARSDVYSLGCVLY 210

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score =  132 bits (333), Expect = 1e-34
 Identities = 72/310 (23%), Positives = 121/310 (39%), Gaps = 94/310 (30%)

Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVK--ILEKNRIIHLKITDQIKREIATLKLLK 72
            Y   + +G G+FG V  A+ ++S    A+K  + +K             RE+  ++++K
Sbjct: 41  AYTNCKVIGNGSFGVVFQAKLVESD-EVAIKKVLQDKRFKN---------RELQIMRIVK 90

Query: 73  HPNVVRLHEVLASKS------KIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQ----Q 122
           HPNVV L     S         + +VLEYV    ++       +L++     L +    Q
Sbjct: 91  HPNVVDLKAFFYSNGDKKDEVFLNLVLEYV-PETVYRASRHYAKLKQTMPMLLIKLYMYQ 149

Query: 123 LIDGVSYCHNKGVFHRDLKLENILLDS-KGNIKISDFGLSALPQHFRDDGLLHTTCGSPN 181
           L+  ++Y H+ G+ HRD+K +N+LLD   G +K+ DFG +                G PN
Sbjct: 150 LLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSA-----------KILIAGEPN 198

Query: 182 --YV------APEVLAN-RGYDGATSDIWSCGVILY-------IFRGD------------ 213
             Y+      APE++     Y     DIWS G ++        +F G+            
Sbjct: 199 VSYICSRYYRAPELIFGATNYTTNI-DIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKV 257

Query: 214 ------------------FKLPKW------------LSPGAQNLLRKILEPNPVKRITIA 243
                              K P+               P A +L+ ++LE  P  R+T  
Sbjct: 258 LGTPSREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAI 317

Query: 244 GIKADEWFEQ 253
                 +F++
Sbjct: 318 EALCHPFFDE 327

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  128 bits (324), Expect = 1e-34
 Identities = 58/204 (28%), Positives = 96/204 (47%), Gaps = 20/204 (9%)

Query: 17  ELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHL-KITDQIKREIATLKLLKHPN 75
            L   +G G FGKV  A     G   AVK    +    + +  + +++E     +LKHPN
Sbjct: 10  TLEEIIGIGGFGKVYRA--FWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPN 67

Query: 76  VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKG- 134
           ++ L  V   +  + +V+E+  GG L   ++ K R+          Q+  G++Y H++  
Sbjct: 68  IIALRGVCLKEPNLCLVMEFARGGPLNRVLSGK-RIPPDILVNWAVQIARGMNYLHDEAI 126

Query: 135 --VFHRDLKLENILLDSKG--------NIKISDFGLSALPQHFRDDGLLHTTCGSPNYVA 184
             + HRDLK  NIL+  K          +KI+DFGL+             +  G+  ++A
Sbjct: 127 VPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLA----REWHRTTKMSAAGAYAWMA 182

Query: 185 PEVLANRGYDGATSDIWSCGVILY 208
           PEV+    +    SD+WS GV+L+
Sbjct: 183 PEVIRASMFSKG-SDVWSYGVLLW 205

>2zfd_B Putative uncharacterized protein T20L15_90; calcium binding protein, protein-protein complex, ATP-bindin kinase, nucleotide-binding; 1.20A {Arabidopsis thaliana} Length = 123

 Score =  121 bits (305), Expect = 1e-33
 Identities = 31/115 (26%), Positives = 53/115 (46%), Gaps = 5/115 (4%)

Query: 289 SPPLINAFQLIGMSSCLDLSGFFEKEDVSERKIRFTSNHSAKDLLERIEDIVTEMGFRVQ 348
               +NAF +I  S   +LSG F      +R  RF S  +A+ ++ER+E+IV+     V 
Sbjct: 2   GARRMNAFDIISGSPGFNLSGLFGDARKYDRVERFVSAWTAERVVERLEEIVSAENLTVA 61

Query: 349 KKNGKLKATQEHKPQKSLGSLSVAAEVFEISPSLYVVELRKSYGDPTVYRQLCNK 403
           KK       +  K     G+ ++  E+ +++  L ++E+RK        R L   
Sbjct: 62  KKETWGMKIEGQK-----GNFAMVVEINQLTDELVMIEVRKRQRAAASGRDLWTD 111

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score =  121 bits (307), Expect = 6e-32
 Identities = 64/206 (31%), Positives = 91/206 (44%), Gaps = 25/206 (12%)

Query: 17  ELGRTLGEGNFGKV---KFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKH 73
            L   LG+G+FG V   ++       +  AVK L+ + +   +  D   RE+  +  L H
Sbjct: 21  RLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDH 80

Query: 74  PNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLID-------G 126
            N++RL+ V      + MV E    G L D      RL++ +G  L   L         G
Sbjct: 81  RNLIRLYGV-VLTPPMKMVTELAPLGSLLD------RLRKHQGHFLLGTLSRYAVQVAEG 133

Query: 127 VSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLS-ALPQHFRDDGLLHTTCGSPNYV-- 183
           + Y  +K   HRDL   N+LL ++  +KI DFGL  ALPQ   +D               
Sbjct: 134 MGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQ---NDDHYVMQEHRKVPFAW 190

Query: 184 -APEVLANRGYDGATSDIWSCGVILY 208
            APE L  R +  A SD W  GV L+
Sbjct: 191 CAPESLKTRTFSHA-SDTWMFGVTLW 215

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score =  121 bits (307), Expect = 2e-31
 Identities = 79/339 (23%), Positives = 123/339 (36%), Gaps = 81/339 (23%)

Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITD--QIKREIATLKLLK 72
            ++L   LGEG +G V  A    +G   A+K   K      K     +  REI  LK  K
Sbjct: 12  DFQLKSLLGEGAYGVVCSATHKPTGEIVAIK---KIEPFD-KPLFALRTLREIKILKHFK 67

Query: 73  HPNVVRLHEVLASKSK-----IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGV 127
           H N++ +  +    S      +Y++ E +   +L  ++ S   L +   +    Q +  V
Sbjct: 68  HENIITIFNIQRPDSFENFNEVYIIQELM-QTDL-HRVISTQMLSDDHIQYFIYQTLRAV 125

Query: 128 SYCHNKGVFHRDLKLENILLDSKGNIKISDFGL--SALPQHFRDDGLLHTTCGSPNYV-- 183
              H   V HRDLK  N+L++S  ++K+ DFGL          +        G   +V  
Sbjct: 126 KVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVAT 185

Query: 184 ----APEV-LANRGYDGATSDIWSCGVIL-------YIFRGD------------------ 213
               APEV L +  Y  A  D+WSCG IL        IF G                   
Sbjct: 186 RWYRAPEVMLTSAKYSRAM-DVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHS 244

Query: 214 ----------------FKLPKW-----------LSPGAQNLLRKILEPNPVKRITIAGIK 246
                             LP +           ++P   +LL+++L  +P KRIT     
Sbjct: 245 DNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEAL 304

Query: 247 ADEWFEQDYTP-----ANPDDDEEDIF-VDNEAFSMHEV 279
              + +  + P       P       F    EA +  ++
Sbjct: 305 EHPYLQTYHDPNDEPEGEPIPPSFFEFDHYKEALTTKDL 343

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score =  121 bits (305), Expect = 3e-31
 Identities = 61/229 (26%), Positives = 108/229 (47%), Gaps = 29/229 (12%)

Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK-H 73
            Y+L R LG G + +V  A ++ +     VKI      +      +IKREI  L+ L+  
Sbjct: 37  DYQLVRKLGRGKYSEVFEAINITNNEKVVVKI------LKPVKKKKIKREIKILENLRGG 90

Query: 74  PNVVRLHEVL--ASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCH 131
           PN++ L +++         +V E+V   +      +   L + + R    +++  + YCH
Sbjct: 91  PNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQT---LTDYDIRFYMYEILKALDYCH 147

Query: 132 NKGVFHRDLKLENILLDSK-GNIKISDFGLSALPQHFRDDGLLHTT-CGSPNYVAPEVLA 189
           + G+ HRD+K  N+++D +   +++ D+GL+     F   G  +     S  +  PE+L 
Sbjct: 148 SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLA----EFYHPGQEYNVRVASRYFKGPELLV 203

Query: 190 N-RGYDGATSDIWSCGVIL--YIFRGDFKLPKWLSPGAQNL--LRKILE 233
           + + YD +  D+WS G +L   IFR   K P     G  N   L +I +
Sbjct: 204 DYQMYDYSL-DMWSLGCMLASMIFR---KEP--FFHGHDNYDQLVRIAK 246

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score =  124 bits (313), Expect = 5e-31
 Identities = 64/259 (24%), Positives = 107/259 (41%), Gaps = 46/259 (17%)

Query: 8   QEGMRL-GRYELGRTLGEGNFGKVKFAQDLD-SGLPFAVKILEKNRIIHLKITDQI---- 61
             G  + G+YE+   +  G  G +  A D + +G P  +K L  +        D      
Sbjct: 73  NPGDIVAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSG-------DAEAQAM 125

Query: 62  -KREIATLKLLKHPNVVRLHEV-----LASKSKIYMVLEYVTGGELFDKIASKGRLQEAE 115
              E   L  + HP++V++               Y+V+EYV G  L        +L  AE
Sbjct: 126 AMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSK--GQKLPVAE 183

Query: 116 GRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGL-SALPQHFRDDGLLH 174
                 +++  +SY H+ G+ + DLK ENI+L  +  +K+ D G  S +       G L 
Sbjct: 184 AIAYLLEILPALSYLHSIGLVYNDLKPENIMLT-EEQLKLIDLGAVSRINS----FGYL- 237

Query: 175 TTCGSPNYVAPEVLANRGYDGATSDIWSCGVILY-------IFRGDFK--LPK-----WL 220
              G+P + APE++  R      +DI++ G  L           G +   LP+       
Sbjct: 238 --YGTPGFQAPEIV--RTGPTVATDIYTVGRTLAALTLDLPTRNGRYVDGLPEDDPVLKT 293

Query: 221 SPGAQNLLRKILEPNPVKR 239
                 LLR+ ++P+P +R
Sbjct: 294 YDSYGRLLRRAIDPDPRQR 312

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  119 bits (301), Expect = 5e-31
 Identities = 48/211 (22%), Positives = 89/211 (42%), Gaps = 26/211 (12%)

Query: 17  ELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNV 76
            L   +G+G +G+V        G   AVKI         + +   + E+    +L+H N+
Sbjct: 11  TLLECVGKGRYGEVWRGSW--QGENVAVKIFSS----RDEKSWFRETELYNTVMLRHENI 64

Query: 77  VRL----HEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHN 132
           +           S ++++++  Y   G L+D +     L      ++   +  G+++ H 
Sbjct: 65  LGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLT-TLDTVSCLRIVLSIASGLAHLHI 123

Query: 133 K--------GVFHRDLKLENILLDSKGNIKISDFGLSAL--PQHFRDDGLLHTTCGSPNY 182
           +         + HRDLK +NIL+   G   I+D GL+ +      + D   +   G+  Y
Sbjct: 124 EIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRY 183

Query: 183 VAPEVLANRGYDGAT-----SDIWSCGVILY 208
           +APEVL               DIW+ G++L+
Sbjct: 184 MAPEVLDETIQVDCFDSYKRVDIWAFGLVLW 214

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score =  120 bits (303), Expect = 8e-31
 Identities = 85/332 (25%), Positives = 131/332 (39%), Gaps = 84/332 (25%)

Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEK--NRIIHLKITDQIKREIATLKLLK 72
           RY+    +G G +G V  A D  +GL  AVK L +    IIH K   +  RE+  LK +K
Sbjct: 30  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK---RTYRELRLLKHMK 86

Query: 73  HPNVVRLHEVLASKSK------IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDG 126
           H NV+ L +V            +Y+V   + G +L + +  + +L +   + L  Q++ G
Sbjct: 87  HENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQ-KLTDDHVQFLIYQILRG 144

Query: 127 VSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYV--- 183
           + Y H+  + HRDLK  N+ ++    +KI DFGL+                    YV   
Sbjct: 145 LKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTG-----------YVATR 193

Query: 184 ---APEV-LANRGYDGATSDIWSCGVIL-------YIFRGD------------------- 213
              APE+ L    Y+    DIWS G I+        +F G                    
Sbjct: 194 WYRAPEIMLNWMHYNQTV-DIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAE 252

Query: 214 --------------FKLPKW-----------LSPGAQNLLRKILEPNPVKRITIAGIKAD 248
                           L +             +P A +LL K+L  +  KRIT A   A 
Sbjct: 253 LLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 312

Query: 249 EWFEQDYTPAN-PDDDEEDIFVDNEAFSMHEV 279
            +F Q + P + P  D  D  +++    + E 
Sbjct: 313 AYFAQYHDPDDEPVADPYDQSLESRDLLIDEW 344

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score =  120 bits (303), Expect = 8e-31
 Identities = 75/335 (22%), Positives = 131/335 (39%), Gaps = 84/335 (25%)

Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVK-ILE----KNRIIHLKITDQIKREIATLK 69
           R+++ R  G+G FG V+  ++  +G+  A+K +++    +NR +         + +  L 
Sbjct: 24  RFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNREL---------QIMQDLA 74

Query: 70  LLKHPNVVRLHEVLASKSK-------IYMVLEYV--TGGELFDKIASKGRLQEAEGRKLF 120
           +L HPN+V+L     +  +       + +V+EYV  T          +         K+F
Sbjct: 75  VLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVF 134

Query: 121 Q-QLIDGVSYCHNK--GVFHRDLKLENILLD-SKGNIKISDFGLSALPQHFRDDGLLHTT 176
             QLI  +   H     V HRD+K  N+L++ + G +K+ DFG +   +    +  +   
Sbjct: 135 LFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAK--KLSPSEPNVAYI 192

Query: 177 CGSPNYVAPEVLAN-RGYDGATSDIWSCGVILY-------IFRGD--------------- 213
           C S  Y APE++   + Y  A  DIWS G I         IFRGD               
Sbjct: 193 C-SRYYRAPELIFGNQHYTTAV-DIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGC 250

Query: 214 ---------------FKLPKW---------------LSPGAQNLLRKILEPNPVKRITIA 243
                            L                   +  A +LL  +L+  P +R+   
Sbjct: 251 PSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPY 310

Query: 244 GIKADEWFEQDYTPANPDDDEEDIFVDNEAFSMHE 278
                 +F++ + PA    + +D+  D   F  +E
Sbjct: 311 EALCHPYFDELHDPATKLPNNKDLPEDLFRFLPNE 345

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score =  119 bits (300), Expect = 2e-30
 Identities = 88/359 (24%), Positives = 131/359 (36%), Gaps = 98/359 (27%)

Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEK--NRIIHLKITDQIKREIATLKLLK 72
            Y   + +G G +G V  A D  +G   A+K L +     +  K   +  RE+  LK ++
Sbjct: 26  VYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAK---RAYRELRLLKHMR 82

Query: 73  HPNVVRLHEVLASKSK------IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDG 126
           H NV+ L +V             Y+V+ ++ G +L  K+    +L E   + L  Q++ G
Sbjct: 83  HENVIGLLDVFTPDETLDDFTDFYLVMPFM-GTDL-GKLMKHEKLGEDRIQFLVYQMLKG 140

Query: 127 VSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYV--- 183
           + Y H  G+ HRDLK  N+ ++    +KI DFGL+      R      T      YV   
Sbjct: 141 LRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLA------RQADSEMT-----GYVVTR 189

Query: 184 ---APEV-LANRGYDGATSDIWSCGVIL-------YIFRGD------------------- 213
              APEV L    Y     DIWS G I+        +F+G                    
Sbjct: 190 WYRAPEVILNWMRYTQTV-DIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAE 248

Query: 214 --------------FKLPKW-----------LSPGAQNLLRKILEPNPVKRITIAGIKAD 248
                           LP+             SP A NLL K+L  +  +R+T     A 
Sbjct: 249 FVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH 308

Query: 249 EWFEQDYTPA--------NPDDDEEDIFVD-------NEAFSMHEVPSDGGRTPGSPPL 292
            +FE  +           +   D+ D  +D        E  S       G R     PL
Sbjct: 309 PYFESLHDTEDEPQVQKYDDSFDDVDRTLDEWKRVTYKEVLSFKPPRQLGARVSKETPL 367

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score =  120 bits (302), Expect = 3e-30
 Identities = 66/233 (28%), Positives = 98/233 (42%), Gaps = 52/233 (22%)

Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITD---------QIKREI 65
           RYE+   +G G++G V  A D       A+K          KI           +I REI
Sbjct: 54  RYEIRHLIGTGSYGHVCEAYDKLEKRVVAIK----------KILRVFEDLIDCKRILREI 103

Query: 66  ATLKLLKHPNVVRLHEVLASKS-----KIYMVLEYVTGGELFDKIASKGRLQEAEGRKLF 120
           A L  L H +VV++ +++  K      ++Y+VLE     +      +   L E   + L 
Sbjct: 104 AILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIA-DSDFKKLFRTPVYLTELHIKTLL 162

Query: 121 QQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLS-----------ALPQHFRD 169
             L+ GV Y H+ G+ HRDLK  N L++   ++K+ DFGL+            LP   R+
Sbjct: 163 YNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPRE 222

Query: 170 DGLLHTTCGSPN--------YV------APEV-LANRGYDGATSDIWSCGVIL 207
           D +   T             +V      APE+ L    Y  A  D+WS G I 
Sbjct: 223 DDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAI-DVWSIGCIF 274

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score =  118 bits (298), Expect = 5e-30
 Identities = 79/331 (23%), Positives = 132/331 (39%), Gaps = 77/331 (23%)

Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVK-ILEKNRIIHLKITDQIKREIATLKLLKH 73
           RY     +GEG +G V  A D  + +  A+K I       + +   +  REI  L   +H
Sbjct: 28  RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQ---RTLREIKILLRFRH 84

Query: 74  PNVVRLHEVLASKSK-----IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVS 128
            N++ +++++ + +      +Y+V + +   +L+  + ++  L          Q++ G+ 
Sbjct: 85  ENIIGINDIIRAPTIEQMKDVYIVQDLM-ETDLYKLLKTQ-HLSNDHICYFLYQILRGLK 142

Query: 129 YCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYV----- 183
           Y H+  V HRDLK  N+LL++  ++KI DFGL+ +     D     T      YV     
Sbjct: 143 YIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLT-----EYVATRWY 197

Query: 184 -APEV-LANRGYDGATSDIWSCGVIL-------YIFRGD--------------------- 213
            APE+ L ++GY  +  DIWS G IL        IF G                      
Sbjct: 198 RAPEIMLNSKGYTKSI-DIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDL 256

Query: 214 ------------FKLPKW-----------LSPGAQNLLRKILEPNPVKRITIAGIKADEW 250
                         LP                 A +LL K+L  NP KRI +    A  +
Sbjct: 257 NCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPY 316

Query: 251 FEQDYTPANPDDDEE--DIFVDNEAFSMHEV 279
            EQ Y P++    E      ++ +     ++
Sbjct: 317 LEQYYDPSDEPIAEAPFKFDMELDDLPKEKL 347

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score =  118 bits (298), Expect = 5e-30
 Identities = 65/202 (32%), Positives = 91/202 (45%), Gaps = 17/202 (8%)

Query: 17  ELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNV 76
            LG  +G GNFG+V   +        AVK   +     LK   +  +E   LK   HPN+
Sbjct: 117 VLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKA--KFLQEARILKQYSHPNI 174

Query: 77  VRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLF-QQLIDGVSYCHNKGV 135
           VRL  V   K  IY+V+E V GG+    + ++G     +           G+ Y  +K  
Sbjct: 175 VRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCC 234

Query: 136 FHRDLKLENILLDSKGNIKISDFGLSALPQHFRD--DGLLHTTCGSPNY----VAPEVLA 189
            HRDL   N L+  K  +KISDFG+S      R+  DG+   + G         APE L 
Sbjct: 235 IHRDLAARNCLVTEKNVLKISDFGMS------REEADGVYAASGGLRQVPVKWTAPEALN 288

Query: 190 NRGYDGATSDIWSCGVILY-IF 210
              Y    SD+WS G++L+  F
Sbjct: 289 YGRYSSE-SDVWSFGILLWETF 309

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score =  117 bits (296), Expect = 7e-30
 Identities = 85/333 (25%), Positives = 132/333 (39%), Gaps = 86/333 (25%)

Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEK--NRIIHLKITDQIKREIATLKLLK 72
            Y     +G G +G V  A D  SG   A+K L +     I  K   +  RE+  LK ++
Sbjct: 25  TYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAK---RAYRELLLLKHMQ 81

Query: 73  HPNVVRLHEVLASKSK------IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDG 126
           H NV+ L +V    S        Y+V+ ++   +L   +    +  E + + L  Q++ G
Sbjct: 82  HENVIGLLDVFTPASSLRNFYDFYLVMPFM-QTDLQKIM--GLKFSEEKIQYLVYQMLKG 138

Query: 127 VSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYV--- 183
           + Y H+ GV HRDLK  N+ ++    +KI DFGL+      R      T      YV   
Sbjct: 139 LKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLA------RHADAEMT-----GYVVTR 187

Query: 184 ---APEV-LANRGYDGATSDIWSCGVIL-------YIFRGD------------------- 213
              APEV L+   Y+    DIWS G I+        +F+G                    
Sbjct: 188 WYRAPEVILSWMHYNQTV-DIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTE 246

Query: 214 --------------FKLPKW-----------LSPGAQNLLRKILEPNPVKRITIAGIKAD 248
                           LP+             SP A +LL K+LE +  KR+T A     
Sbjct: 247 FVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 306

Query: 249 EWFEQDYTPANPDDDEE--DIFVDNEAFSMHEV 279
            +FE    P    + ++  D  +++E  ++ E 
Sbjct: 307 PFFEPFRDPEEETEAQQPFDDSLEHEKLTVDEW 339

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score =  116 bits (293), Expect = 9e-30
 Identities = 73/325 (22%), Positives = 116/325 (35%), Gaps = 93/325 (28%)

Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITD--QIKREIATLKLLK 72
           RY   + LG G  G V  A D D     A+K     +I+           REI  ++ L 
Sbjct: 12  RYMDLKPLGCGGNGLVFSAVDNDCDKRVAIK-----KIVLTDPQSVKHALREIKIIRRLD 66

Query: 73  HPNVVRLHEVLASKSK--------------IYMVLEYVTGGELFDKIASKGRLQEAEGRK 118
           H N+V++ E+L                   +Y+V EY+   +L   +  +G L E   R 
Sbjct: 67  HDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYM-ETDL-ANVLEQGPLLEEHARL 124

Query: 119 LFQQLIDGVSYCHNKGVFHRDLKLENILLDSKG-NIKISDFGLS-ALPQHFRDDGLLHTT 176
              QL+ G+ Y H+  V HRDLK  N+ ++++   +KI DFGL+  +  H+   G L   
Sbjct: 125 FMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHL--- 181

Query: 177 CGSPNYV------APEV-LANRGYDGATSDIWSCGVIL-------YIFRGD--------- 213
                 +      +P + L+   Y  A  D+W+ G I         +F G          
Sbjct: 182 ---SEGLVTKWYRSPRLLLSPNNYTKAI-DMWAAGCIFAEMLTGKTLFAGAHELEQMQLI 237

Query: 214 -----------------------FKLPKW-----------LSPGAQNLLRKILEPNPVKR 239
                                                   +S  A + L +IL  +P+ R
Sbjct: 238 LESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDR 297

Query: 240 ITIAGIKADEWFEQDYTPANPDDDE 264
           +T     +  +      P     DE
Sbjct: 298 LTAEEALSHPYMSIYSFP----MDE 318

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score =  119 bits (300), Expect = 1e-29
 Identities = 54/202 (26%), Positives = 90/202 (44%), Gaps = 24/202 (11%)

Query: 17  ELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNV 76
            +   LG G +G+V         L  AVK L+++ +      ++  +E A +K +KHPN+
Sbjct: 223 TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV----EEFLKEAAVMKEIKHPNL 278

Query: 77  VRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKL-FQQLID-------GVS 128
           V+L  V   +   Y++ E++T G L D       L+E   +++    L+         + 
Sbjct: 279 VQLLGVCTREPPFYIITEFMTYGNLLD------YLRECNRQEVSAVVLLYMATQISSAME 332

Query: 129 YCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNY--VAPE 186
           Y   K   HR+L   N L+     +K++DFGLS   +    D               APE
Sbjct: 333 YLEKKNFIHRNLAARNCLVGENHLVKVADFGLS---RLMTGDTYTAHAGAKFPIKWTAPE 389

Query: 187 VLANRGYDGATSDIWSCGVILY 208
            LA   +    SD+W+ GV+L+
Sbjct: 390 SLAYNKFSIK-SDVWAFGVLLW 410

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score =  116 bits (292), Expect = 3e-29
 Identities = 70/339 (20%), Positives = 119/339 (35%), Gaps = 86/339 (25%)

Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHL------KITD--QIKREIA 66
            Y + R +  G++G V    D   G+P A+K +                    ++ REI 
Sbjct: 23  PYTVQRFISSGSYGAVCAGVD-SEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIR 81

Query: 67  TLKLLKHPNVVRLHEVLASKSK-----IYMVLEYVTGGELFDKIAS-KGRLQEAEGRKLF 120
            L    HPN++ L ++     +     +Y+V E +   +L   I   +  +     +   
Sbjct: 82  LLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELM-RTDLAQVIHDQRIVISPQHIQYFM 140

Query: 121 QQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP 180
             ++ G+   H  GV HRDL   NILL    +I I DF L+   +    D          
Sbjct: 141 YHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNLA---REDTADANK------T 191

Query: 181 NYV------APEV-LANRGYDGATSDIWSCGVIL-------YIFRGD------------- 213
           +YV      APE+ +  +G+     D+WS G ++        +FRG              
Sbjct: 192 HYVTHRWYRAPELVMQFKGFTKLV-DMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVV 250

Query: 214 ---------------------FKLPKW-----------LSPGAQNLLRKILEPNPVKRIT 241
                                  L                P A +L+ K+LE NP +RI+
Sbjct: 251 GTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRIS 310

Query: 242 IAGIKADEWFEQDYTPAN-PDDDEEDIFVDNEAFSMHEV 279
                   +FE  + P +  +   E    D     ++++
Sbjct: 311 TEQALRHPYFESLFDPLDLTEGLSERFHFDESVTDVYDM 349

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score =  114 bits (287), Expect = 4e-29
 Identities = 63/206 (30%), Positives = 101/206 (49%), Gaps = 24/206 (11%)

Query: 17  ELGRTLGEGNFGKVKFA----QDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK 72
           +  + LG+GNFG V+         ++G   AVK L+ +     +     +REI  LK L+
Sbjct: 13  KFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS---TEEHLRDFEREIEILKSLQ 69

Query: 73  HPNVVRLHEVLASKSK--IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLID----- 125
           H N+V+   V  S  +  + +++EY+  G L D       LQ+ + R    +L+      
Sbjct: 70  HDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRD------YLQKHKERIDHIKLLQYTSQI 123

Query: 126 --GVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP-NY 182
             G+ Y   K   HRDL   NIL++++  +KI DFGL+ +    ++   +     SP  +
Sbjct: 124 CKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFW 183

Query: 183 VAPEVLANRGYDGATSDIWSCGVILY 208
            APE L    +  A SD+WS GV+LY
Sbjct: 184 YAPESLTESKFSVA-SDVWSFGVVLY 208

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score =  113 bits (286), Expect = 4e-29
 Identities = 58/197 (29%), Positives = 88/197 (44%), Gaps = 12/197 (6%)

Query: 18  LGRTLGEGNFGKVKFA--QDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
             + LG GNFG VK    Q        AVKIL KN      + D++  E   ++ L +P 
Sbjct: 21  EDKELGSGNFGTVKKGYYQMKKVVKTVAVKIL-KNEANDPALKDELLAEANVMQQLDNPY 79

Query: 76  VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGV 135
           +VR+  +        +V+E    G L   +     +++    +L  Q+  G+ Y      
Sbjct: 80  IVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNF 138

Query: 136 FHRDLKLENILLDSKGNIKISDFGLS-ALPQHFRDDGLLHTTCGS--P-NYVAPEVLANR 191
            HRDL   N+LL ++   KISDFGLS AL     D+           P  + APE +   
Sbjct: 139 VHRDLAARNVLLVTQHYAKISDFGLSKALRA---DENYYKAQTHGKWPVKWYAPECINYY 195

Query: 192 GYDGATSDIWSCGVILY 208
            +    SD+WS GV+++
Sbjct: 196 KFSSK-SDVWSFGVLMW 211

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score =  114 bits (288), Expect = 5e-29
 Identities = 58/205 (28%), Positives = 94/205 (45%), Gaps = 24/205 (11%)

Query: 17  ELGRTLGEGNFGKV---KFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKH 73
            + + +G G+ G+V   +        +P A+K L+       +       E + +    H
Sbjct: 52  HIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQR--RDFLSEASIMGQFDH 109

Query: 74  PNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLID-------G 126
           PN++RL  V+       +V EY+  G L         L+  +G+    QL+        G
Sbjct: 110 PNIIRLEGVVTRGRLAMIVTEYMENGSLDT------FLRTHDGQFTIMQLVGMLRGVGAG 163

Query: 127 VSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYV--- 183
           + Y  + G  HRDL   N+L+DS    K+SDFGLS + +   D    +TT G    +   
Sbjct: 164 MRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLE--DDPDAAYTTTGGKIPIRWT 221

Query: 184 APEVLANRGYDGATSDIWSCGVILY 208
           APE +A R +  A SD+WS GV+++
Sbjct: 222 APEAIAFRTFSSA-SDVWSFGVVMW 245

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score =  114 bits (287), Expect = 6e-29
 Identities = 66/211 (31%), Positives = 100/211 (47%), Gaps = 34/211 (16%)

Query: 17  ELGRTLGEGNFGKVKFA----QDLDSGLPFAVKILEKNRIIHLKITDQIK---REIATLK 69
           +    LG+GNFG V+         ++G   AVK L+ +        DQ +   REI  LK
Sbjct: 26  KYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSG------PDQQRDFQREIQILK 79

Query: 70  LLKHPNVVRLHEVLASKSK--IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLID-- 125
            L    +V+   V     +  + +V+EY+  G L D       LQ    R    +L+   
Sbjct: 80  ALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRD------FLQRHRARLDASRLLLYS 133

Query: 126 -----GVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLS-ALPQHFRDDGLLHTTCG- 178
                G+ Y  ++   HRDL   NIL++S+ ++KI+DFGL+  LP     D  +    G 
Sbjct: 134 SQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLD--KDYYVVREPGQ 191

Query: 179 SP-NYVAPEVLANRGYDGATSDIWSCGVILY 208
           SP  + APE L++  +    SD+WS GV+LY
Sbjct: 192 SPIFWYAPESLSDNIFSRQ-SDVWSFGVVLY 221

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score =  113 bits (285), Expect = 7e-29
 Identities = 57/204 (27%), Positives = 91/204 (44%), Gaps = 28/204 (13%)

Query: 17  ELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIK--REIATLKLLKHP 74
            +   LG G +G+V         L  AVK L+++        +  +  +E A +K +KHP
Sbjct: 16  TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT------MEVEEFLKEAAVMKEIKHP 69

Query: 75  NVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKL-FQQLID-------G 126
           N+V+L  V   +   Y++ E++T G L D       L+E   +++    L+         
Sbjct: 70  NLVQLLGVCTREPPFYIITEFMTYGNLLD------YLRECNRQEVSAVVLLYMATQISSA 123

Query: 127 VSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGS-P-NYVA 184
           + Y   K   HRDL   N L+     +K++DFGLS L      D          P  + A
Sbjct: 124 MEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRL---MTGDTYTAHAGAKFPIKWTA 180

Query: 185 PEVLANRGYDGATSDIWSCGVILY 208
           PE LA   +    SD+W+ GV+L+
Sbjct: 181 PESLAYNKFSIK-SDVWAFGVLLW 203

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score =  114 bits (287), Expect = 8e-29
 Identities = 51/206 (24%), Positives = 94/206 (45%), Gaps = 27/206 (13%)

Query: 17  ELGRTLGEGNFGKVK----FAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK 72
           +  + LG G FG V       +     +P A+K L +          +I  E   +  + 
Sbjct: 18  KKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN--KEILDEAYVMASVD 75

Query: 73  HPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLID------- 125
           +P+V RL  +    S + ++ + +  G L D       ++E +     Q L++       
Sbjct: 76  NPHVCRLLGIC-LTSTVQLITQLMPFGCLLD------YVREHKDNIGSQYLLNWCVQIAK 128

Query: 126 GVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLS-ALPQHFRDDGLLHTTCGS-P-NY 182
           G++Y  ++ + HRDL   N+L+ +  ++KI+DFGL+  L     ++   H   G  P  +
Sbjct: 129 GMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA---EEKEYHAEGGKVPIKW 185

Query: 183 VAPEVLANRGYDGATSDIWSCGVILY 208
           +A E + +R Y    SD+WS GV ++
Sbjct: 186 MALESILHRIYTHQ-SDVWSYGVTVW 210

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score =  116 bits (291), Expect = 8e-29
 Identities = 57/221 (25%), Positives = 95/221 (42%), Gaps = 33/221 (14%)

Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEK--NRIIHLKITDQIKREIATLKLLK 72
            Y +   +G G++G V  A D ++    A+K + +    +I  K   +I REI  L  LK
Sbjct: 27  NYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCK---RILREITILNRLK 83

Query: 73  HPNVVRLHEVLASKSK-----IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGV 127
              ++RL++++          +Y+VLE     +L     +   L E   + +   L+ G 
Sbjct: 84  SDYIIRLYDLIIPDDLLKFDELYIVLEIA-DSDLKKLFKTPIFLTEEHIKTILYNLLLGE 142

Query: 128 SYCHNKGVFHRDLKLENILLDSKGNIKISDFGLS-----------ALPQHFRDDGLLHTT 176
           ++ H  G+ HRDLK  N LL+   ++K+ DFGL+                  ++   H  
Sbjct: 143 NFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNK 202

Query: 177 CGSP---NYV------APEV-LANRGYDGATSDIWSCGVIL 207
                  ++V      APE+ L    Y  +  DIWS G I 
Sbjct: 203 NLKKQLTSHVVTRWYRAPELILLQENYTKSI-DIWSTGCIF 242

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score =  116 bits (292), Expect = 9e-29
 Identities = 57/202 (28%), Positives = 91/202 (45%), Gaps = 26/202 (12%)

Query: 17  ELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNV 76
            L   LG+G FG+V       +    A+K L+   +      +   +E   +K L+H  +
Sbjct: 187 RLEVKLGQGCFGEVWMGTWNGTT-RVAIKTLKPGTMSP----EAFLQEAQVMKKLRHEKL 241

Query: 77  VRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKL-FQQLID-------GVS 128
           V+L+ V  S+  IY+V EY++ G L D       L+   G+ L   QL+D       G++
Sbjct: 242 VQLYAV-VSEEPIYIVTEYMSKGSLLD------FLKGETGKYLRLPQLVDMAAQIASGMA 294

Query: 129 YCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGS-P-NYVAPE 186
           Y       HRDL+  NIL+      K++DFGL+   +   D+          P  + APE
Sbjct: 295 YVERMNYVHRDLRAANILVGENLVCKVADFGLA---RLIEDNEYTARQGAKFPIKWTAPE 351

Query: 187 VLANRGYDGATSDIWSCGVILY 208
                 +    SD+WS G++L 
Sbjct: 352 AALYGRFTIK-SDVWSFGILLT 372

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score =  116 bits (293), Expect = 1e-28
 Identities = 57/202 (28%), Positives = 91/202 (45%), Gaps = 26/202 (12%)

Query: 17  ELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNV 76
            L   LG+G FG+V       +    A+K L+   +      +   +E   +K L+H  +
Sbjct: 270 RLEVKLGQGCFGEVWMGTWNGTT-RVAIKTLKPGTMSP----EAFLQEAQVMKKLRHEKL 324

Query: 77  VRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKL-FQQLID-------GVS 128
           V+L+ V  S+  IY+V EY++ G L D       L+   G+ L   QL+D       G++
Sbjct: 325 VQLYAV-VSEEPIYIVTEYMSKGSLLD------FLKGETGKYLRLPQLVDMAAQIASGMA 377

Query: 129 YCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGS-P-NYVAPE 186
           Y       HRDL+  NIL+      K++DFGL+   +   D+          P  + APE
Sbjct: 378 YVERMNYVHRDLRAANILVGENLVCKVADFGLA---RLIEDNEYTARQGAKFPIKWTAPE 434

Query: 187 VLANRGYDGATSDIWSCGVILY 208
                 +    SD+WS G++L 
Sbjct: 435 AALYGRFTIK-SDVWSFGILLT 455

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  114 bits (286), Expect = 1e-28
 Identities = 51/211 (24%), Positives = 92/211 (43%), Gaps = 26/211 (12%)

Query: 17  ELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNV 76
            L  ++G+G FG+V   +    G   AVKI         + +   + EI    +L+H N+
Sbjct: 45  VLQESIGKGRFGEVWRGKW--RGEEVAVKIFSS----REERSWFREAEIYQTVMLRHENI 98

Query: 77  VRL----HEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCH- 131
           +      ++   + +++++V +Y   G LFD +     +      KL      G+++ H 
Sbjct: 99  LGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHM 157

Query: 132 -------NKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD--DGLLHTTCGSPNY 182
                     + HRDLK +NIL+   G   I+D GL+       D  D   +   G+  Y
Sbjct: 158 EIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRY 217

Query: 183 VAPEVLANRGYDGAT-----SDIWSCGVILY 208
           +APEVL +            +DI++ G++ +
Sbjct: 218 MAPEVLDDSINMKHFESFKRADIYAMGLVFW 248

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score =  113 bits (285), Expect = 1e-28
 Identities = 63/206 (30%), Positives = 101/206 (49%), Gaps = 24/206 (11%)

Query: 17  ELGRTLGEGNFGKVKFA----QDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK 72
           +  + LG+GNFG V+         ++G   AVK L+ +     +     +REI  LK L+
Sbjct: 44  KFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS---TEEHLRDFEREIEILKSLQ 100

Query: 73  HPNVVRLHEVLASKSK--IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLID----- 125
           H N+V+   V  S  +  + +++EY+  G L D       LQ+ + R    +L+      
Sbjct: 101 HDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRD------YLQKHKERIDHIKLLQYTSQI 154

Query: 126 --GVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP-NY 182
             G+ Y   K   HRDL   NIL++++  +KI DFGL+ +    ++   +     SP  +
Sbjct: 155 CKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFW 214

Query: 183 VAPEVLANRGYDGATSDIWSCGVILY 208
            APE L    +  A SD+WS GV+LY
Sbjct: 215 YAPESLTESKFSVA-SDVWSFGVVLY 239

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  113 bits (284), Expect = 2e-28
 Identities = 49/215 (22%), Positives = 89/215 (41%), Gaps = 25/215 (11%)

Query: 12  RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL 71
           +    +L      G FG V  AQ        AVKI         K + Q + E+ +L  +
Sbjct: 22  QSMPLQLLEVKARGRFGCVWKAQL--LNEYVAVKIFPIQD----KQSWQNEYEVYSLPGM 75

Query: 72  KHPNVVRL----HEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGV 127
           KH N+++         +    ++++  +   G L D +     +   E   + + +  G+
Sbjct: 76  KHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFL-KANVVSWNELCHIAETMARGL 134

Query: 128 SYCHNK----------GVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTC 177
           +Y H             + HRD+K +N+LL +     I+DFGL+   +  +  G  H   
Sbjct: 135 AYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQV 194

Query: 178 GSPNYVAPEVLANRGYDGAT----SDIWSCGVILY 208
           G+  Y+APEVL              D+++ G++L+
Sbjct: 195 GTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLW 229

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score =  112 bits (282), Expect = 4e-28
 Identities = 56/205 (27%), Positives = 91/205 (44%), Gaps = 25/205 (12%)

Query: 18  LGRTLGEGNFGKVKFA----QDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKH 73
             + +G G FG+V             +P A+K L+       +       E   +    H
Sbjct: 48  RQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQR--VDFLGEAGIMGQFSH 105

Query: 74  PNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLID-------G 126
            N++RL  V++    + ++ EY+  G L         L+E +G     QL+        G
Sbjct: 106 HNIIRLEGVISKYKPMMIITEYMENGALDK------FLREKDGEFSVLQLVGMLRGIAAG 159

Query: 127 VSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYV--- 183
           + Y  N    HRDL   NIL++S    K+SDFGLS + +   D    +TT G    +   
Sbjct: 160 MKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLE--DDPEATYTTSGGKIPIRWT 217

Query: 184 APEVLANRGYDGATSDIWSCGVILY 208
           APE ++ R +  A SD+WS G++++
Sbjct: 218 APEAISYRKFTSA-SDVWSFGIVMW 241

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score =  111 bits (280), Expect = 5e-28
 Identities = 60/206 (29%), Positives = 100/206 (48%), Gaps = 23/206 (11%)

Query: 17  ELGRTLGEGNFGKVKFA----QDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK 72
           +  R LGEG+FGKV+      +  ++G   AVK L K       I D +K+EI  L+ L 
Sbjct: 24  KRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSL-KPESGGNHIAD-LKKEIEILRNLY 81

Query: 73  HPNVVRLHEVLASKSK--IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLID----- 125
           H N+V+   +        I +++E++  G L +       L + + +   +Q +      
Sbjct: 82  HENIVKYKGICTEDGGNGIKLIMEFLPSGSLKE------YLPKNKNKINLKQQLKYAVQI 135

Query: 126 --GVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP-NY 182
             G+ Y  ++   HRDL   N+L++S+  +KI DFGL+   +  ++   +     SP  +
Sbjct: 136 CKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFW 195

Query: 183 VAPEVLANRGYDGATSDIWSCGVILY 208
            APE L    +  A SD+WS GV L+
Sbjct: 196 YAPECLMQSKFYIA-SDVWSFGVTLH 220

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score =  110 bits (278), Expect = 5e-28
 Identities = 56/207 (27%), Positives = 97/207 (46%), Gaps = 31/207 (14%)

Query: 17  ELGRTLGEGNFGKV---KFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKH 73
           ELGR +GEG FG V    +    +  L  A+K  +      ++  ++  +E  T++   H
Sbjct: 18  ELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVR--EKFLQEALTMRQFDH 75

Query: 74  PNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLID-------G 126
           P++V+L  V+ +++ +++++E  T GEL         LQ  +       LI         
Sbjct: 76  PHIVKLIGVI-TENPVWIIMELCTLGELRS------FLQVRKYSLDLASLILYAYQLSTA 128

Query: 127 VSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD--DGLLHTTCGS--P-N 181
           ++Y  +K   HRD+   N+L+ S   +K+ DFGLS      R   D   +       P  
Sbjct: 129 LAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLS------RYMEDSTYYKASKGKLPIK 182

Query: 182 YVAPEVLANRGYDGATSDIWSCGVILY 208
           ++APE +  R +  A SD+W  GV ++
Sbjct: 183 WMAPESINFRRFTSA-SDVWMFGVCMW 208

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score =  114 bits (286), Expect = 5e-28
 Identities = 69/235 (29%), Positives = 103/235 (43%), Gaps = 36/235 (15%)

Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEK--NRIIHLKITDQIKREIATLKLLK 72
           RY+  + +G G  G V  A D       A+K L +      H K   +  RE+  +K + 
Sbjct: 63  RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAK---RAYRELVLMKCVN 119

Query: 73  HPNVVRLHEVLASKSK------IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDG 126
           H N++ L  V   +        +Y+V+E +    L   I  +  L       L  Q++ G
Sbjct: 120 HKNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLCQVI--QMELDHERMSYLLYQMLCG 176

Query: 127 VSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYV--- 183
           + + H+ G+ HRDLK  NI++ S   +KI DFGL+      R  G   T+     YV   
Sbjct: 177 IKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA------RTAG---TSFMMTPYVVTR 227

Query: 184 ---APEVLANRGYDGATSDIWSCGVILYIFRGDFKLPKWLSPGA--QNLLRKILE 233
              APEV+   GY     DIWS G I+    G+    K L PG    +   K++E
Sbjct: 228 YYRAPEVILGMGYKENV-DIWSVGCIM----GEMVRHKILFPGRDYIDQWNKVIE 277

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score =  112 bits (283), Expect = 6e-28
 Identities = 67/235 (28%), Positives = 100/235 (42%), Gaps = 36/235 (15%)

Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEK--NRIIHLKITDQIKREIATLKLLK 72
           RY+  + +G G  G V  A D       A+K L +      H K   +  RE+  +K + 
Sbjct: 26  RYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAK---RAYRELVLMKCVN 82

Query: 73  HPNVVRLHEVLASKSK------IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDG 126
           H N++ L  V   +        +Y+V+E +    L   I  +  L       L  Q++ G
Sbjct: 83  HKNIIGLLNVFTPQKSLEEFQDVYIVMELM-DANLCQVI--QMELDHERMSYLLYQMLCG 139

Query: 127 VSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYV--- 183
           + + H+ G+ HRDLK  NI++ S   +KI DFGL+      R  G          YV   
Sbjct: 140 IKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA------RTAGTSFMMTP---YVVTR 190

Query: 184 ---APEVLANRGYDGATSDIWSCGVILYIFRGDFKLPKWLSPGA--QNLLRKILE 233
              APEV+   GY     DIWS G I+    G+      L PG    +   K++E
Sbjct: 191 YYRAPEVILGMGYKENV-DIWSVGCIM----GEMIKGGVLFPGTDHIDQWNKVIE 240

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score =  112 bits (282), Expect = 7e-28
 Identities = 59/209 (28%), Positives = 95/209 (45%), Gaps = 34/209 (16%)

Query: 18  LGRTLGEGNFGKV---KFAQDLDSGLPFAVKIL-----EKNRIIHLKITDQIKREIATLK 69
           + + +G G FG+V   +        +  A+K L     EK R   L        E + + 
Sbjct: 49  IDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFL-------GEASIMG 101

Query: 70  LLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLID---- 125
              HPN++RL  V+     + +V EY+  G L         L++ + +    QL+     
Sbjct: 102 QFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSF------LRKHDAQFTVIQLVGMLRG 155

Query: 126 ---GVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNY 182
              G+ Y  + G  HRDL   NIL++S    K+SDFGL  + +   D    +TT G    
Sbjct: 156 IASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLE--DDPEAAYTTRGGKIP 213

Query: 183 V---APEVLANRGYDGATSDIWSCGVILY 208
           +   +PE +A R +  A SD+WS G++L+
Sbjct: 214 IRWTSPEAIAYRKFTSA-SDVWSYGIVLW 241

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  111 bits (280), Expect = 8e-28
 Identities = 51/211 (24%), Positives = 93/211 (44%), Gaps = 26/211 (12%)

Query: 17  ELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNV 76
           ++ + +G+G +G+V   +    G   AVK+         + +   + EI    L++H N+
Sbjct: 40  QMVKQIGKGRYGEVWMGKW--RGEKVAVKVFFT----TEEASWFRETEIYQTVLMRHENI 93

Query: 77  VRL----HEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHN 132
           +       +   S +++Y++ +Y   G L+D + S   L      KL    + G+ + H 
Sbjct: 94  LGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKST-TLDAKSMLKLAYSSVSGLCHLHT 152

Query: 133 K--------GVFHRDLKLENILLDSKGNIKISDFGLSAL--PQHFRDDGLLHTTCGSPNY 182
           +         + HRDLK +NIL+   G   I+D GL+          D   +T  G+  Y
Sbjct: 153 EIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRY 212

Query: 183 VAPEVLANRGYDGAT-----SDIWSCGVILY 208
           + PEVL              +D++S G+IL+
Sbjct: 213 MPPEVLDESLNRNHFQSYIMADMYSFGLILW 243

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score =  110 bits (277), Expect = 9e-28
 Identities = 59/217 (27%), Positives = 90/217 (41%), Gaps = 30/217 (13%)

Query: 5   EKKQEGMRLGRYELGRTLGEGNFGKVKFAQ--DLDSGLPFAVKILEKNRIIHLKITDQIK 62
             K++ + +   ELG     GNFG V+          +  A+K+L++         +++ 
Sbjct: 5   FLKRDNLLIADIELG----CGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADT--EEMM 58

Query: 63  REIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQ 122
           RE   +  L +P +VRL  V      + +V+E   GG L         L           
Sbjct: 59  REAQIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHK------FLVGKREEIPVSN 111

Query: 123 LID-------GVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLS-ALPQHFRDDGLLH 174
           + +       G+ Y   K   HRDL   N+LL ++   KISDFGLS AL     DD    
Sbjct: 112 VAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGA---DDSYYT 168

Query: 175 TTCGS--P-NYVAPEVLANRGYDGATSDIWSCGVILY 208
                  P  + APE +  R +    SD+WS GV ++
Sbjct: 169 ARSAGKWPLKWYAPECINFRKFSSR-SDVWSYGVTMW 204

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score =  109 bits (276), Expect = 1e-27
 Identities = 52/209 (24%), Positives = 91/209 (43%), Gaps = 35/209 (16%)

Query: 17  ELGRTLGEGNFGKV---KFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKH 73
            L R LGEG FG+V    +       +  AVK  +K+  +  K  ++   E   +K L H
Sbjct: 15  VLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNK--EKFMSEAVIMKNLDH 72

Query: 74  PNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLID-------G 126
           P++V+L  ++  +   ++++E    GEL         L+  +       L+         
Sbjct: 73  PHIVKLIGII-EEEPTWIIMELYPYGELGH------YLERNKNSLKVLTLVLYSLQICKA 125

Query: 127 VSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD--DGLLHTTCGS--PNY 182
           ++Y  +    HRD+ + NIL+ S   +K+ DFGLS      R   D   +    +  P  
Sbjct: 126 MAYLESINCVHRDIAVRNILVASPECVKLGDFGLS------RYIEDEDYYKASVTRLP-- 177

Query: 183 V---APEVLANRGYDGATSDIWSCGVILY 208
           +   +PE +  R +  A SD+W   V ++
Sbjct: 178 IKWMSPESINFRRFTTA-SDVWMFAVCMW 205

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score =  110 bits (277), Expect = 1e-27
 Identities = 67/207 (32%), Positives = 101/207 (48%), Gaps = 27/207 (13%)

Query: 17  ELGRTLGEGNFGKVKFAQ----DLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK 72
           +  R LGEG+FGKV        +  +G   AVK L+ +     +     K+EI  L+ L 
Sbjct: 34  KKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADA--GPQHRSGWKQEIDILRTLY 91

Query: 73  HPNVVRLHEVLASKSK--IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYC 130
           H ++++            + +V+EYV  G L D +  +  +  A+     QQ+ +G++Y 
Sbjct: 92  HEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYL-PRHSIGLAQLLLFAQQICEGMAYL 150

Query: 131 HNKGVFHRDLKLENILLDSKGNIKISDFGLS-ALPQ-----HFRDDGLLHTTCGSPNYV- 183
           H +   HRDL   N+LLD+   +KI DFGL+ A+P+       R+DG        P  V 
Sbjct: 151 HAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDS------P--VF 202

Query: 184 --APEVLANRGYDGATSDIWSCGVILY 208
             APE L    +  A SD+WS GV LY
Sbjct: 203 WYAPECLKEYKFYYA-SDVWSFGVTLY 228

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score =  109 bits (275), Expect = 2e-27
 Identities = 31/201 (15%), Positives = 59/201 (29%), Gaps = 34/201 (16%)

Query: 10  GMRL--GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIAT 67
           G R+  GRY L    G     +   A D       A+  ++   ++   +  +       
Sbjct: 25  GARIANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLR 84

Query: 68  LKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGV 127
           L  +  P V R+ +V+ +++   +V E++ GG L +              +  Q L    
Sbjct: 85  LSRIDKPGVARVLDVVHTRAGGLVVAEWIRGGSLQEVAD--TSPSPVGAIRAMQSLAAAA 142

Query: 128 SYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEV 187
              H  GV         + +   G++ ++                          +    
Sbjct: 143 DAAHRAGVALSIDHPSRVRVSIDGDVVLAYPA----------------------TMPDA- 179

Query: 188 LANRGYDGATSDIWSCGVILY 208
                      DI   G  LY
Sbjct: 180 -------NPQDDIRGIGASLY 193

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  110 bits (277), Expect = 2e-27
 Identities = 53/220 (24%), Positives = 85/220 (38%), Gaps = 37/220 (16%)

Query: 17  ELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKRE--IATLKLLKHP 74
           +L   +G G +G V     LD   P AVK+                 E  I  + L++H 
Sbjct: 16  KLLELIGRGRYGAVYKGS-LD-ERPVAVKVFSFAN------RQNFINEKNIYRVPLMEHD 67

Query: 75  NVVRL-----HEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSY 129
           N+ R            + +  +V+EY   G L   + S          +L   +  G++Y
Sbjct: 68  NIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYL-SLHTSDWVSSCRLAHSVTRGLAY 126

Query: 130 CH---------NKGVFHRDLKLENILLDSKGNIKISDFGLS------ALPQHFRDDGLLH 174
            H            + HRDL   N+L+ + G   ISDFGLS       L +   +D    
Sbjct: 127 LHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAI 186

Query: 175 TTCGSPNYVAPEVL------ANRGYDGATSDIWSCGVILY 208
           +  G+  Y+APEVL       +        D+++ G+I +
Sbjct: 187 SEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYW 226

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score =  111 bits (279), Expect = 2e-27
 Identities = 69/343 (20%), Positives = 117/343 (34%), Gaps = 127/343 (37%)

Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIK---REIATLKLL 71
           +Y LG+TLG G+FG V    D++SG  FA+K          K+    +   RE+  +K+L
Sbjct: 8   KYSLGKTLGTGSFGIVCEVFDIESGKRFALK----------KVLQDPRYKNRELDIMKVL 57

Query: 72  KHPNVVRLHEVLASKSK--------------------------------------IYMVL 93
            H N+++L +   +                                         + +++
Sbjct: 58  DHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIM 117

Query: 94  EYVTGGELFDKI----ASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDS 149
           EYV    L   +     S   +          QL   V + H+ G+ HRD+K +N+L++S
Sbjct: 118 EYV-PDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNS 176

Query: 150 K-GNIKISDFGLSALPQHFRDDGLLHTTCGSPN--YV------APEVLAN-RGYDGATSD 199
           K   +K+ DFG +      +           P+  Y+      APE++     Y  +  D
Sbjct: 177 KDNTLKLCDFGSA------K-----KLIPSEPSVAYICSRFYRAPELMLGATEYTPSI-D 224

Query: 200 IWSCGVILY-------IFRGD------------------------------FKLPKW--- 219
           +WS G +         +F G+                               + P     
Sbjct: 225 LWSIGCVFGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAK 284

Query: 220 ---------LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQ 253
                        A +LL +IL   P  RI      A  +F+ 
Sbjct: 285 DWRKILPEGTPSLAIDLLEQILRYEPDLRINPYEAMAHPFFDH 327

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score =  110 bits (276), Expect = 2e-27
 Identities = 51/206 (24%), Positives = 91/206 (44%), Gaps = 27/206 (13%)

Query: 17  ELGRTLGEGNFGKVKFA----QDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK 72
              + LG G FG V       +     +P  +K++E       +    +   +  +  L 
Sbjct: 16  RKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSG--RQSFQAVTDHMLAIGSLD 73

Query: 73  HPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLID------- 125
           H ++VRL  +    S + +V +Y+  G L D       +++  G    Q L++       
Sbjct: 74  HAHIVRLLGLC-PGSSLQLVTQYLPLGSLLD------HVRQHRGALGPQLLLNWGVQIAK 126

Query: 126 GVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLS-ALPQHFRDDGLLHTTCG-SP-NY 182
           G+ Y    G+ HR+L   N+LL S   ++++DFG++  LP    DD  L  +   +P  +
Sbjct: 127 GMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPP---DDKQLLYSEAKTPIKW 183

Query: 183 VAPEVLANRGYDGATSDIWSCGVILY 208
           +A E +    Y    SD+WS GV ++
Sbjct: 184 MALESIHFGKYTHQ-SDVWSYGVTVW 208

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score =  108 bits (272), Expect = 3e-27
 Identities = 58/212 (27%), Positives = 92/212 (43%), Gaps = 46/212 (21%)

Query: 17  ELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNV 76
           +L   LG G FG+V      +     AVK L++  +      D    E   +K L+H  +
Sbjct: 16  KLVERLGAGQFGEVWMGY-YNGHTKVAVKSLKQGSMSP----DAFLAEANLMKQLQHQRL 70

Query: 77  VRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKL-FQQLID-------GVS 128
           VRL+ V  ++  IY++ EY+  G L D       L+   G KL   +L+D       G++
Sbjct: 71  VRLYAV-VTQEPIYIITEYMENGSLVD------FLKTPSGIKLTINKLLDMAAQIAEGMA 123

Query: 129 YCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYV----- 183
           +   +   HRDL+  NIL+    + KI+DFGL+   +   D+           Y      
Sbjct: 124 FIEERNYIHRDLRAANILVSDTLSCKIADFGLA---RLIEDN----------EYTAREGA 170

Query: 184 -------APEVLANRGYDGATSDIWSCGVILY 208
                  APE +    +    SD+WS G++L 
Sbjct: 171 KFPIKWTAPEAINYGTFTIK-SDVWSFGILLT 201

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score =  109 bits (275), Expect = 4e-27
 Identities = 51/206 (24%), Positives = 94/206 (45%), Gaps = 27/206 (13%)

Query: 17  ELGRTLGEGNFGKVK----FAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK 72
           +  + LG G FG V       +     +P A+K L +          +I  E   +  + 
Sbjct: 18  KKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN--KEILDEAYVMASVD 75

Query: 73  HPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLID------- 125
           +P+V RL  +    S + ++ + +  G L D       ++E +     Q L++       
Sbjct: 76  NPHVCRLLGIC-LTSTVQLITQLMPFGCLLD------YVREHKDNIGSQYLLNWCVQIAK 128

Query: 126 GVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLS-ALPQHFRDDGLLHTTCGS-P-NY 182
           G++Y  ++ + HRDL   N+L+ +  ++KI+DFGL+  L     ++   H   G  P  +
Sbjct: 129 GMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA---EEKEYHAEGGKVPIKW 185

Query: 183 VAPEVLANRGYDGATSDIWSCGVILY 208
           +A E + +R Y    SD+WS GV ++
Sbjct: 186 MALESILHRIYTHQ-SDVWSYGVTVW 210

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score =  108 bits (271), Expect = 4e-27
 Identities = 52/206 (25%), Positives = 87/206 (42%), Gaps = 34/206 (16%)

Query: 17  ELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIK--REIATLKLLKHP 74
              + +G G FG V       +    A+K + +          +     E   +  L HP
Sbjct: 11  TFVQEIGSGQFGLVHLGY-WLNKDKVAIKTIREGA------MSEEDFIEEAEVMMKLSHP 63

Query: 75  NVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLID-------GV 127
            +V+L+ V   ++ I +V E++  G L D       L+   G    + L+        G+
Sbjct: 64  KLVQLYGVCLEQAPICLVTEFMEHGCLSD------YLRTQRGLFAAETLLGMCLDVCEGM 117

Query: 128 SYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD--DGLLHTTCGS--P-NY 182
           +Y     V HRDL   N L+     IK+SDFG++      R   D    ++ G+  P  +
Sbjct: 118 AYLEEACVIHRDLAARNCLVGENQVIKVSDFGMT------RFVLDDQYTSSTGTKFPVKW 171

Query: 183 VAPEVLANRGYDGATSDIWSCGVILY 208
            +PEV +   Y    SD+WS GV+++
Sbjct: 172 ASPEVFSFSRYSSK-SDVWSFGVLMW 196

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score =  111 bits (279), Expect = 5e-27
 Identities = 58/202 (28%), Positives = 93/202 (46%), Gaps = 26/202 (12%)

Query: 17  ELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNV 76
           +L + LG G FG+V  A         AVK ++   +      +    E   +K L+H  +
Sbjct: 191 KLEKKLGAGQFGEVWMATYNKHT-KVAVKTMKPGSMSV----EAFLAEANVMKTLQHDKL 245

Query: 77  VRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKL-FQQLID-------GVS 128
           V+LH V  +K  IY++ E++  G L D       L+  EG K    +LID       G++
Sbjct: 246 VKLHAV-VTKEPIYIITEFMAKGSLLD------FLKSDEGSKQPLPKLIDFSAQIAEGMA 298

Query: 129 YCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGS-P-NYVAPE 186
           +   +   HRDL+  NIL+ +    KI+DFGL+   +   D+          P  + APE
Sbjct: 299 FIEQRNYIHRDLRAANILVSASLVCKIADFGLA---RVIEDNEYTAREGAKFPIKWTAPE 355

Query: 187 VLANRGYDGATSDIWSCGVILY 208
            +    +    SD+WS G++L 
Sbjct: 356 AINFGSFTIK-SDVWSFGILLM 376

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score =  108 bits (271), Expect = 5e-27
 Identities = 57/206 (27%), Positives = 95/206 (46%), Gaps = 34/206 (16%)

Query: 17  ELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIK--REIATLKLLKHP 74
              + LG G FG VK+ +        A+K++++          + +   E   +  L H 
Sbjct: 27  TFLKELGTGQFGVVKYGK-WRGQYDVAIKMIKEG------SMSEDEFIEEAKVMMNLSHE 79

Query: 75  NVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLID-------GV 127
            +V+L+ V   +  I+++ EY+  G L +       L+E   R   QQL++        +
Sbjct: 80  KLVQLYGVCTKQRPIFIITEYMANGCLLN------YLREMRHRFQTQQLLEMCKDVCEAM 133

Query: 128 SYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD--DGLLHTTCGS--P-NY 182
            Y  +K   HRDL   N L++ +G +K+SDFGLS      R   D    ++ GS  P  +
Sbjct: 134 EYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLS------RYVLDDEYTSSVGSKFPVRW 187

Query: 183 VAPEVLANRGYDGATSDIWSCGVILY 208
             PEVL    +    SDIW+ GV+++
Sbjct: 188 SPPEVLMYSKFSSK-SDIWAFGVLMW 212

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score =  111 bits (279), Expect = 1e-26
 Identities = 55/204 (26%), Positives = 97/204 (47%), Gaps = 25/204 (12%)

Query: 17  ELGRTLGEGNFGKV---KFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKH 73
           ELGR +GEG FG V    +    +  +  A+K  +      ++  ++  +E  T++   H
Sbjct: 393 ELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVR--EKFLQEALTMRQFDH 450

Query: 74  PNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLID-------G 126
           P++V+L  V+ +++ +++++E  T GEL         LQ  +       LI         
Sbjct: 451 PHIVKLIGVI-TENPVWIIMELCTLGELRS------FLQVRKFSLDLASLILYAYQLSTA 503

Query: 127 VSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCG-SP-NYVA 184
           ++Y  +K   HRD+   N+L+ S   +K+ DFGLS       D      + G  P  ++A
Sbjct: 504 LAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRY---MEDSTYYKASKGKLPIKWMA 560

Query: 185 PEVLANRGYDGATSDIWSCGVILY 208
           PE +  R +  A SD+W  GV ++
Sbjct: 561 PESINFRRFTSA-SDVWMFGVCMW 583

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score =  106 bits (267), Expect = 1e-26
 Identities = 54/205 (26%), Positives = 95/205 (46%), Gaps = 34/205 (16%)

Query: 18  LGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIK--REIATLKLLKHPN 75
           L + LG G FG VK  +        AVK++++          + +  +E  T+  L HP 
Sbjct: 12  LLKELGSGQFGVVKLGK-WKGQYDVAVKMIKEG------SMSEDEFFQEAQTMMKLSHPK 64

Query: 76  VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLID-------GVS 128
           +V+ + V + +  IY+V EY++ G L +       L+         QL++       G++
Sbjct: 65  LVKFYGVCSKEYPIYIVTEYISNGCLLN------YLRSHGKGLEPSQLLEMCYDVCEGMA 118

Query: 129 YCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD--DGLLHTTCGS--P-NYV 183
           +  +    HRDL   N L+D    +K+SDFG++      R   D    ++ G+  P  + 
Sbjct: 119 FLESHQFIHRDLAARNCLVDRDLCVKVSDFGMT------RYVLDDQYVSSVGTKFPVKWS 172

Query: 184 APEVLANRGYDGATSDIWSCGVILY 208
           APEV     Y    SD+W+ G++++
Sbjct: 173 APEVFHYFKYSSK-SDVWAFGILMW 196

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score =  106 bits (267), Expect = 2e-26
 Identities = 53/205 (25%), Positives = 86/205 (41%), Gaps = 36/205 (17%)

Query: 17  ELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNV 76
           +L +T+G+G FG V        G   AVK ++ +             E + +  L+H N+
Sbjct: 24  KLLQTIGKGEFGDVMLG--DYRGNKVAVKCIKND-----ATAQAFLAEASVMTQLRHSNL 76

Query: 77  VRLHEV-LASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKL-FQQLID-------GV 127
           V+L  V +  K  +Y+V EY+  G L D       L+      L    L+         +
Sbjct: 77  VQLLGVIVEEKGGLYIVTEYMAKGSLVD------YLRSRGRSVLGGDCLLKFSLDVCEAM 130

Query: 128 SYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNY----V 183
            Y       HRDL   N+L+      K+SDFGL+      ++     +T  +        
Sbjct: 131 EYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLT------KEA---SSTQDTGKLPVKWT 181

Query: 184 APEVLANRGYDGATSDIWSCGVILY 208
           APE L  + +    SD+WS G++L+
Sbjct: 182 APEALREKKFSTK-SDVWSFGILLW 205

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score =  108 bits (272), Expect = 4e-26
 Identities = 56/203 (27%), Positives = 88/203 (43%), Gaps = 32/203 (15%)

Query: 17  ELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQ-IKREIATLKLLKHPN 75
           +L +T+G+G FG V        G   AVK ++ +       T Q    E + +  L+H N
Sbjct: 196 KLLQTIGKGEFGDVMLG--DYRGNKVAVKCIKND------ATAQAFLAEASVMTQLRHSN 247

Query: 76  VVRLHEV-LASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKL-FQQLID-------G 126
           +V+L  V +  K  +Y+V EY+  G L D       L+      L    L+         
Sbjct: 248 LVQLLGVIVEEKGGLYIVTEYMAKGSLVD------YLRSRGRSVLGGDCLLKFSLDVCEA 301

Query: 127 VSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP-NYVAP 185
           + Y       HRDL   N+L+      K+SDFGL+      ++      T   P  + AP
Sbjct: 302 MEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLT------KEASSTQDTGKLPVKWTAP 355

Query: 186 EVLANRGYDGATSDIWSCGVILY 208
           E L  + +    SD+WS G++L+
Sbjct: 356 EALREKKFSTK-SDVWSFGILLW 377

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score =  109 bits (274), Expect = 4e-26
 Identities = 60/220 (27%), Positives = 90/220 (40%), Gaps = 29/220 (13%)

Query: 5   EKKQEGMRLGRYEL---GRTLGEGNFGKVKFAQ--DLDSGLPFAVKILEKNRIIHLKITD 59
           E K + + L R  L      LG GNFG V+          +  A+K+L++         +
Sbjct: 324 ELKDKKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADT--E 381

Query: 60  QIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKL 119
           ++ RE   +  L +P +VRL  V      + +V+E   GG L         L        
Sbjct: 382 EMMREAQIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHK------FLVGKREEIP 434

Query: 120 FQQLID-------GVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLS-ALPQHFRDDG 171
              + +       G+ Y   K   HR+L   N+LL ++   KISDFGLS AL     DD 
Sbjct: 435 VSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGA---DDS 491

Query: 172 LLHTTCGSPNYV---APEVLANRGYDGATSDIWSCGVILY 208
                      +   APE +  R +    SD+WS GV ++
Sbjct: 492 YYTARSAGKWPLKWYAPECINFRKFSSR-SDVWSYGVTMW 530

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score =  108 bits (271), Expect = 4e-26
 Identities = 71/273 (26%), Positives = 110/273 (40%), Gaps = 41/273 (15%)

Query: 14  GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKH 73
            RYE+ + +G+G+FG+V  A D       A+K++ +N     +   Q   EI  L+ L+ 
Sbjct: 97  YRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMV-RN---EKRFHRQAAEEIRILEHLRK 152

Query: 74  ------PNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEG------RKLFQ 121
                  NV+ + E    ++ I M  E +    L++ I  K + Q   G      RK   
Sbjct: 153 QDKDNTMNVIHMLENFTFRNHICMTFELL-SMNLYELI-KKNKFQ---GFSLPLVRKFAH 207

Query: 122 QLIDGVSYCHNKGVFHRDLKLENILL--DSKGNIKISDFGLSALPQHFRDDGLLHTTCGS 179
            ++  +   H   + H DLK ENILL    +  IK+ DFG S       +   ++T   S
Sbjct: 208 SILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSS-----CYEHQRVYTYIQS 262

Query: 180 PNYVAPEVLANRGYDGATSDIWSCGVILY-IFRGDFKLPKWLSPGA--QNLLRKILE--- 233
             Y APEV+    Y     D+WS G IL  +  G       L PG    + L  ++E   
Sbjct: 263 RFYRAPEVILGARYGMP-IDMWSLGCILAELLTG-----YPLLPGEDEGDQLACMIELLG 316

Query: 234 PNPVKRITIAGIKADEWFEQDYTPANPDDDEED 266
               K +  A  +A  +      P         
Sbjct: 317 MPSQKLLD-ASKRAKNFVSSKGYPRYCTVTTLS 348

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score =  106 bits (267), Expect = 9e-26
 Identities = 64/218 (29%), Positives = 102/218 (46%), Gaps = 31/218 (14%)

Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEK--NRIIHLKITDQIKREIATLKLLK 72
           +YEL + LG+G +G V  + D  +G   AVK +          +   +  REI  L  L 
Sbjct: 10  KYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQ---RTFREIMILTELS 66

Query: 73  -HPNVVRLHEVLASKSK--IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSY 129
            H N+V L  VL + +   +Y+V +Y+   +L   I +   L+    + +  QLI  + Y
Sbjct: 67  GHENIVNLLNVLRADNDRDVYLVFDYM-ETDLHAVIRAN-ILEPVHKQYVVYQLIKVIKY 124

Query: 130 CHNKGVFHRDLKLENILLDSKGNIKISDFGLS-ALPQHFRDDGLLHTTCGSPN------- 181
            H+ G+ HRD+K  NILL+++ ++K++DFGLS +     R    +  +            
Sbjct: 125 LHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQ 184

Query: 182 -----YV------APEV-LANRGYDGATSDIWSCGVIL 207
                YV      APE+ L +  Y     D+WS G IL
Sbjct: 185 PILTDYVATRWYRAPEILLGSTKYTKGI-DMWSLGCIL 221

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score =  103 bits (259), Expect = 3e-25
 Identities = 39/221 (17%), Positives = 74/221 (33%), Gaps = 51/221 (23%)

Query: 17  ELGRTLGEGNFGKV-------KFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLK 69
               +LG+G F K+                    +K+L+K    H   ++      + + 
Sbjct: 11  IFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKA---HRNYSESFFEAASMMS 67

Query: 70  LLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLID---- 125
            L H ++V  + V     +  +V E+V  G L         L++ +        ++    
Sbjct: 68  KLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTY------LKKNKNCINILWKLEVAKQ 121

Query: 126 ---GVSYCHNKGVFHRDLKLENILLDSKGN--------IKISDFGLSALPQHFRDDGLLH 174
               + +     + H ++  +NILL  + +        IK+SD G+S             
Sbjct: 122 LAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGIS------IT----- 170

Query: 175 TTCGSPNY-------VAPEVLANRGYDGATSDIWSCGVILY 208
                 +        V PE + N       +D WS G  L+
Sbjct: 171 --VLPKDILQERIPWVPPECIENPKNLNLATDKWSFGTTLW 209

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score =  102 bits (257), Expect = 6e-25
 Identities = 56/215 (26%), Positives = 87/215 (40%), Gaps = 42/215 (19%)

Query: 17  ELGRTLGEGNFGKV---KFAQDLDSGLPFAVKILEKNRIIHLKITDQIK--REIATLKLL 71
                +G G+FG V       +    +  AVK L +       I +  +   E   +K  
Sbjct: 28  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI----TDIGEVSQFLTEGIIMKDF 83

Query: 72  KHPNVVRLHEV-LASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLI------ 124
            HPNV+ L  + L S+    +VL Y+  G+L      +  ++        + LI      
Sbjct: 84  SHPNVLSLLGICLRSEGSPLVVLPYMKHGDL------RNFIRNETHNPTVKDLIGFGLQV 137

Query: 125 -DGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSAL-------PQHFRDDGLLHTT 176
             G+ Y  +K   HRDL   N +LD K  +K++DFGL+           H +    L   
Sbjct: 138 AKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKL--- 194

Query: 177 CGSPNYV---APEVLANRGYDGATSDIWSCGVILY 208
              P  V   A E L  + +    SD+WS GV+L+
Sbjct: 195 ---P--VKWMALESLQTQKFTTK-SDVWSFGVLLW 223

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score =  102 bits (256), Expect = 1e-24
 Identities = 57/221 (25%), Positives = 94/221 (42%), Gaps = 45/221 (20%)

Query: 17  ELGRTLGEGNFGKV---KFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKH 73
            LGR LG+G FG V   +  Q+  S +  AVK+L+ + I    I +   RE A +K   H
Sbjct: 26  TLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEE-FLREAACMKEFDH 84

Query: 74  PNVVRL------HEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLI--- 124
           P+V +L                 ++L ++  G+L   + +  R+ E       Q L+   
Sbjct: 85  PHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLAS-RIGENPFNLPLQTLVRFM 143

Query: 125 ----DGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP 180
                G+ Y  ++   HRDL   N +L     + ++DFGLS      R    +++     
Sbjct: 144 VDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVADFGLS------RK---IYSG---- 190

Query: 181 NY-------------VAPEVLANRGYDGATSDIWSCGVILY 208
           +Y             +A E LA+  Y    SD+W+ GV ++
Sbjct: 191 DYYRQGCASKLPVKWLALESLADNLYTVH-SDVWAFGVTMW 230

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score =  103 bits (258), Expect = 2e-24
 Identities = 74/271 (27%), Positives = 115/271 (42%), Gaps = 35/271 (12%)

Query: 14  GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKH 73
            RYE+   +G+G+FG+V  A D       A+KI+ KN        +Q + E+  L+L+  
Sbjct: 54  DRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKII-KN---KKAFLNQAQIEVRLLELMNK 109

Query: 74  P------NVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGR--LQEAEGRKLFQQLID 125
                   +V L      ++ + +V E +    L+D + +     +     RK  QQ+  
Sbjct: 110 HDTEMKYYIVHLKRHFMFRNHLCLVFEML-SYNLYDLLRNTNFRGVSLNLTRKFAQQMCT 168

Query: 126 GVSYCHNK--GVFHRDLKLENILL--DSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPN 181
            + +       + H DLK ENILL    +  IKI DFG S+     R    ++    S  
Sbjct: 169 ALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFG-SSCQLGQR----IYQYIQSRF 223

Query: 182 YVAPEVLANRGYDGATSDIWSCGVILY-IFRGDFKLPKWLSPGAQN--LLRKILE---PN 235
           Y +PEVL    YD A  D+WS G IL  +  G+      L  GA     + KI+E     
Sbjct: 224 YRSPEVLLGMPYDLA-IDMWSLGCILVEMHTGEP-----LFSGANEVDQMNKIVEVLGIP 277

Query: 236 PVKRITIAGIKADEWFEQDYTPANPDDDEED 266
           P   +     KA ++FE+           +D
Sbjct: 278 PAHILD-QAPKARKFFEKLPDGTWNLKKTKD 307

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score =  102 bits (255), Expect = 3e-24
 Identities = 56/218 (25%), Positives = 88/218 (40%), Gaps = 48/218 (22%)

Query: 17  ELGRTLGEGNFGKV---KFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKH 73
                +G G+FG V       +    +  AVK L  NRI  +    Q   E   +K   H
Sbjct: 92  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL--NRITDIGEVSQFLTEGIIMKDFSH 149

Query: 74  PNVVRLHEV-LASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLI-------D 125
           PNV+ L  + L S+    +VL Y+  G+L      +  ++        + LI        
Sbjct: 150 PNVLSLLGICLRSEGSPLVVLPYMKHGDL------RNFIRNETHNPTVKDLIGFGLQVAK 203

Query: 126 GVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYV-- 183
           G+ +  +K   HRDL   N +LD K  +K++DFGL+      RD   ++       +   
Sbjct: 204 GMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLA------RD---MYDK----EFDSV 250

Query: 184 -------------APEVLANRGYDGATSDIWSCGVILY 208
                        A E L  + +    SD+WS GV+L+
Sbjct: 251 HNKTGAKLPVKWMALESLQTQKFTTK-SDVWSFGVLLW 287

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score =  100 bits (252), Expect = 4e-24
 Identities = 54/221 (24%), Positives = 93/221 (42%), Gaps = 46/221 (20%)

Query: 17  ELGRTLGEGNFGKV--KFAQDLDSGLPF---AVKILEKNRIIHLKITDQIKREIATLKLL 71
            + R LG+G+FG V    A+ +    P    A+K + +   +  +I  +   E + +K  
Sbjct: 28  TMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERI--EFLNEASVMKEF 85

Query: 72  KHPNVVRLHEVLASKSKIYMVLEYVTGGEL--FDKIASKGRLQEAEGRKL-FQQLI---- 124
              +VVRL  V++      +++E +T G+L  + +                  ++I    
Sbjct: 86  NCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAG 145

Query: 125 ---DGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD-----------D 170
              DG++Y +     HRDL   N ++     +KI DFG++      RD            
Sbjct: 146 EIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMT------RDIYETDYYRKGGK 199

Query: 171 GLLHTTCGSPNYV---APEVLANRGYDGATSDIWSCGVILY 208
           GLL      P  V   +PE L +  +    SD+WS GV+L+
Sbjct: 200 GLL------P--VRWMSPESLKDGVFTTY-SDVWSFGVVLW 231

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score =  100 bits (251), Expect = 6e-24
 Identities = 59/222 (26%), Positives = 86/222 (38%), Gaps = 44/222 (19%)

Query: 18  LGRTLGEGNFGKVKFAQ--DLDSGLPFAVKILEKNRIIHLKITDQIK----REIATLK-L 70
               +GEGNFG+V  A+       +  A+K +++        +         E+  L  L
Sbjct: 29  FQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY------ASKDDHRDFAGELEVLCKL 82

Query: 71  LKHPNVVRLHEVLASKSKIYMVLEYVTGGELFD--------KIASKGRLQEAEGRKL-FQ 121
             HPN++ L      +  +Y+ +EY   G L D        +      +  +    L  Q
Sbjct: 83  GHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQ 142

Query: 122 QLID-------GVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLH 174
           QL+        G+ Y   K   HRDL   NIL+      KI+DFGLS      R   +  
Sbjct: 143 QLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLS------RGQEVYV 196

Query: 175 TTCGS--PNYV---APEVLANRGYDGATSDIWSCGVILY-IF 210
                  P  V   A E L    Y    SD+WS GV+L+ I 
Sbjct: 197 KKTMGRLP--VRWMAIESLNYSVYTTN-SDVWSYGVLLWEIV 235

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score = 99.6 bits (249), Expect = 8e-24
 Identities = 56/234 (23%), Positives = 86/234 (36%), Gaps = 61/234 (26%)

Query: 17  ELGRTLGEGNFGKV-----KFAQDLDSGLPFAVKILEKNRIIHLKITDQIK----REIAT 67
                LGE  FGKV           +     A+K L+            ++     E   
Sbjct: 12  RFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDK------AEGPLREEFRHEAML 65

Query: 68  LKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFD---------KIASKGRLQEAEGRK 118
              L+HPNVV L  V+     + M+  Y + G+L +          + S    +  +   
Sbjct: 66  RARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSAL 125

Query: 119 LFQQLI-------DGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD-- 169
                +        G+ Y  +  V H+DL   N+L+  K N+KISD GL       R+  
Sbjct: 126 EPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLF------REVY 179

Query: 170 ---------DGLLHTTCGSPNYV---APEVLANRGYDGATSDIWSCGVILY-IF 210
                    + LL      P  +   APE +    +    SDIWS GV+L+ +F
Sbjct: 180 AADYYKLLGNSLL------P--IRWMAPEAIMYGKFSID-SDIWSYGVVLWEVF 224

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score = 99.7 bits (249), Expect = 8e-24
 Identities = 53/213 (24%), Positives = 90/213 (42%), Gaps = 38/213 (17%)

Query: 17  ELGRTLGEGNFGKV---KFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKH 73
              R +G+G+FG V   ++     + +  A+K L  +RI  ++  +   RE   ++ L H
Sbjct: 24  HSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSL--SRITEMQQVEAFLREGLLMRGLNH 81

Query: 74  PNVVRLHEV-LASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLID------- 125
           PNV+ L  + L  +   +++L Y+  G+L         ++  +     + LI        
Sbjct: 82  PNVLALIGIMLPPEGLPHVLLPYMCHGDL------LQFIRSPQRNPTVKDLISFGLQVAR 135

Query: 126 GVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSAL-------PQHFRDDGLLHTTCG 178
           G+ Y   +   HRDL   N +LD    +K++DFGL+                  L     
Sbjct: 136 GMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARL----- 190

Query: 179 SPNYV---APEVLANRGYDGATSDIWSCGVILY 208
            P  V   A E L    +    SD+WS GV+L+
Sbjct: 191 -P--VKWTALESLQTYRFTTK-SDVWSFGVLLW 219

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score = 98.9 bits (247), Expect = 2e-23
 Identities = 59/221 (26%), Positives = 89/221 (40%), Gaps = 46/221 (20%)

Query: 17  ELGRTLGEGNFGKV---KFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKH 73
            LG+ LGEG FG V      Q+  + L  AVK + K      +  ++   E A +K   H
Sbjct: 37  ILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTM-KLDNSSQREIEEFLSEAACMKDFSH 95

Query: 74  PNVVRL-----HEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLI---- 124
           PNV+RL             K  ++L ++  G+L   +    RL+        Q L+    
Sbjct: 96  PNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYS-RLETGPKHIPLQTLLKFMV 154

Query: 125 ---DGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD-----------D 170
               G+ Y  N+   HRDL   N +L     + ++DFGLS      +             
Sbjct: 155 DIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVADFGLS------KKIYSGDYYRQGRI 208

Query: 171 GLLHTTCGSPNYV---APEVLANRGYDGATSDIWSCGVILY 208
             +      P  V   A E LA+R Y    SD+W+ GV ++
Sbjct: 209 AKM------P--VKWIAIESLADRVYTSK-SDVWAFGVTMW 240

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score = 98.9 bits (247), Expect = 2e-23
 Identities = 58/227 (25%), Positives = 94/227 (41%), Gaps = 48/227 (21%)

Query: 17  ELGRTLGEGNFGKVKFAQ-----DLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL 71
           + G+TLG G FGKV  A        D+ L  AVK+L+     H    + +  E+  +  L
Sbjct: 49  QFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKST--AHADEKEALMSELKIMSHL 106

Query: 72  -KHPNVVRLHEVLASKSKIYMVLEYVTGGELFD------KIASKGRLQEAEGRKL-FQQL 123
            +H N+V L         + ++ EY   G+L +      ++                + L
Sbjct: 107 GQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDL 166

Query: 124 ID-------GVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTT 176
           +        G+++  +K   HRD+   N+LL +    KI DFGL+      RD   +   
Sbjct: 167 LHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLA------RD---IMND 217

Query: 177 CGSPNYV------------APEVLANRGYDGATSDIWSCGVILY-IF 210
               NY+            APE + +  Y    SD+WS G++L+ IF
Sbjct: 218 ---SNYIVKGNARLPVKWMAPESIFDCVYT-VQSDVWSYGILLWEIF 260

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score = 98.9 bits (247), Expect = 3e-23
 Identities = 56/225 (24%), Positives = 82/225 (36%), Gaps = 49/225 (21%)

Query: 17  ELGRTLGEGNFGKV-----KFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL 71
            L R LG G FG+V         +  S L  AVK L +      ++      E   +   
Sbjct: 33  TLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDEL--DFLMEALIISKF 90

Query: 72  KHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKL-FQQLI------ 124
            H N+VR   V       ++++E + GG+L   +    R + ++   L    L+      
Sbjct: 91  NHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRET-RPRPSQPSSLAMLDLLHVARDI 149

Query: 125 -DGVSYCHNKGVFHRDLKLENILLDSKGN---IKISDFGLSALPQHFRD----------- 169
             G  Y       HRD+   N LL   G     KI DFG++      RD           
Sbjct: 150 ACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMA------RDIYRASYYRKGG 203

Query: 170 DGLLHTTCGSPNYV---APEVLANRGYDGATSDIWSCGVILY-IF 210
             +L      P  V    PE      +    +D WS GV+L+ IF
Sbjct: 204 CAML------P--VKWMPPEAFMEGIFTSK-TDTWSFGVLLWEIF 239

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score = 98.5 bits (246), Expect = 3e-23
 Identities = 64/231 (27%), Positives = 93/231 (40%), Gaps = 52/231 (22%)

Query: 17  ELGRTLGEGNFGKVKFA-----QDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL 71
             G+TLG G FGKV  A        D+ +  AVK+L+ +   HL   + +  E+  L  L
Sbjct: 26  SFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPS--AHLTEREALMSELKVLSYL 83

Query: 72  -KHPNVVRLHEVLASKSKIYMVLEYVTGGEL-----------FDKIASKGRLQEAEGRKL 119
             H N+V L           ++ EY   G+L                S   +++ E    
Sbjct: 84  GNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALD 143

Query: 120 FQQLID-------GVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGL 172
            + L+        G+++  +K   HRDL   NILL      KI DFGL+      RD   
Sbjct: 144 LEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLA------RD--- 194

Query: 173 LHTTCGSPNYV------------APEVLANRGYDGATSDIWSCGVILY-IF 210
           +       NYV            APE + N  Y    SD+WS G+ L+ +F
Sbjct: 195 IKND---SNYVVKGNARLPVKWMAPESIFNCVYT-FESDVWSYGIFLWELF 241

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score = 98.6 bits (246), Expect = 4e-23
 Identities = 58/229 (25%), Positives = 84/229 (36%), Gaps = 57/229 (24%)

Query: 17  ELGRTLGEGNFGKV-----KFAQDLDSGLPFAVKILEKNRIIHLKITDQIK----REIAT 67
            L R LG G FG+V         +  S L  AVK L +        ++Q +     E   
Sbjct: 74  TLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV------CSEQDELDFLMEALI 127

Query: 68  LKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKL-FQQLI-- 124
           +    H N+VR   V       +++LE + GG+L   +    R + ++   L    L+  
Sbjct: 128 ISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRET-RPRPSQPSSLAMLDLLHV 186

Query: 125 -----DGVSYCHNKGVFHRDLKLENILLDSKGN---IKISDFGLSALPQHFRD------- 169
                 G  Y       HRD+   N LL   G     KI DFG++      RD       
Sbjct: 187 ARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMA------RDIYRAGYY 240

Query: 170 ----DGLLHTTCGSPNYV---APEVLANRGYDGATSDIWSCGVILY-IF 210
                 +L      P  V    PE      +    +D WS GV+L+ IF
Sbjct: 241 RKGGCAML------P--VKWMPPEAFMEGIFTSK-TDTWSFGVLLWEIF 280

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score = 96.9 bits (242), Expect = 8e-23
 Identities = 64/234 (27%), Positives = 94/234 (40%), Gaps = 62/234 (26%)

Query: 17  ELGRTLGEGNFGKV-----KFAQDLDSGLPFAVKILEKNRIIHLKITDQIK----REIAT 67
            L R LGEG FGKV              +  AVK L+         T   +    RE   
Sbjct: 18  VLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDP-------TLAARKDFQREAEL 70

Query: 68  LKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFD---------KIASKGRLQEAEGRK 118
           L  L+H ++V+ + V      + MV EY+  G+L            I   G+ ++A+G  
Sbjct: 71  LTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGEL 130

Query: 119 LFQQLI-------DGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD-- 169
              Q++        G+ Y  ++   HRDL   N L+ +   +KI DFG+S      RD  
Sbjct: 131 GLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMS------RDVY 184

Query: 170 ---------DGLLHTTCGSPNYV---APEVLANRGYDGATSDIWSCGVILY-IF 210
                      +L      P  +    PE +  R +    SD+WS GVIL+ IF
Sbjct: 185 STDYYRVGGHTML------P--IRWMPPESIMYRKFTTE-SDVWSFGVILWEIF 229

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score = 97.8 bits (244), Expect = 8e-23
 Identities = 59/242 (24%), Positives = 98/242 (40%), Gaps = 69/242 (28%)

Query: 17  ELGRTLGEGNFGKV--KFAQDLDSGLPF---AVKILEKNRIIHLKITDQIK----REIAT 67
           E  R +GEG FG+V    A  L    PF   AVK+L++        +  ++    RE A 
Sbjct: 50  EYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEE------ASADMQADFQREAAL 103

Query: 68  LKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGEL----------------FDKIASKGRL 111
           +    +PN+V+L  V A    + ++ EY+  G+L                   ++++ R+
Sbjct: 104 MAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARV 163

Query: 112 QEAEGRKL-FQQLI-------DGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSAL 163
                  L   + +        G++Y   +   HRDL   N L+     +KI+DFGLS  
Sbjct: 164 SSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLS-- 221

Query: 164 PQHFRD-----------DGLLHTTCGSPNYV---APEVLANRGYDGATSDIWSCGVILY- 208
               R+           +  +      P  +    PE +    Y    SD+W+ GV+L+ 
Sbjct: 222 ----RNIYSADYYKADGNDAI------P--IRWMPPESIFYNRYTTE-SDVWAYGVVLWE 268

Query: 209 IF 210
           IF
Sbjct: 269 IF 270

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score = 96.9 bits (242), Expect = 9e-23
 Identities = 67/240 (27%), Positives = 96/240 (40%), Gaps = 65/240 (27%)

Query: 17  ELGRTLGEGNFGKVK--FAQDLDSGLPF---AVKILEKNRIIHLKITDQIK----REIAT 67
            LG+TLGEG FGKV    A  L     +   AVK+L++N       +         E   
Sbjct: 26  VLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKEN------ASPSELRDLLSEFNV 79

Query: 68  LKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGEL----------------FDKIASKGRL 111
           LK + HP+V++L+   +    + +++EY   G L                     +   L
Sbjct: 80  LKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSL 139

Query: 112 QEAEGRKL-FQQLI-------DGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSAL 163
              + R L    LI        G+ Y     + HRDL   NIL+     +KISDFGLS  
Sbjct: 140 DHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLS-- 197

Query: 164 PQHFRDDGLLHTTCGSPNYV------------APEVLANRGYDGATSDIWSCGVILY-IF 210
               RD   ++      +YV            A E L +  Y    SD+WS GV+L+ I 
Sbjct: 198 ----RD---VYEE---DSYVKRSQGRIPVKWMAIESLFDHIYTTQ-SDVWSFGVLLWEIV 246

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score = 97.9 bits (244), Expect = 1e-22
 Identities = 61/276 (22%), Positives = 109/276 (39%), Gaps = 49/276 (17%)

Query: 14  GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK- 72
            RY L R LG G+F  V  A+D+ +    A+KI+  ++      T+  + EI  L+ +  
Sbjct: 19  ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK----VYTEAAEDEIKLLQRVND 74

Query: 73  ----------HPNVVRLHEVLASKSKIY----MVLEYVTGGELFD--KIASKGRLQEAEG 116
                       ++++L +    K        MV E V G  L    K      +     
Sbjct: 75  ADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFE-VLGENLLALIKKYEHRGIPLIYV 133

Query: 117 RKLFQQLIDGVSYCHNK-GVFHRDLKLENILLD------SKGNIKISDFGLSALPQHFRD 169
           +++ +QL+ G+ Y H + G+ H D+K EN+L++      +   IKI+D G +        
Sbjct: 134 KQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACW-----Y 188

Query: 170 DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILY-------IFRGDFKLPKWLSP 222
           D     +  +  Y +PEVL    +     DIWS   +++       +F  D +   +   
Sbjct: 189 DEHYTNSIQTREYRSPEVLLGAPWGCGA-DIWSTACLIFELITGDFLFEPD-EGHSYTKD 246

Query: 223 GAQNLLRKILE---PNPVKRITIAGIKADEWFEQDY 255
                + +I+E     P   +   G     +F    
Sbjct: 247 DDH--IAQIIELLGELP-SYLLRNGKYTRTFFNSRG 279

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score = 96.6 bits (241), Expect = 1e-22
 Identities = 62/237 (26%), Positives = 102/237 (43%), Gaps = 64/237 (27%)

Query: 17  ELGRTLGEGNFGKVKFA-------QDLDSGLPFAVKILEKNRIIHLKITDQIK----REI 65
            LG+ LGEG FG+V  A             +  AVK+L+ +       T++       E+
Sbjct: 38  TLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDD------ATEKDLSDLVSEM 91

Query: 66  ATLKLL-KHPNVVRLHEVLASKSKIYMVLEYVTGGELFD--------KIASKGRLQEAEG 116
             +K++ KH N++ L         +Y+++EY + G L +         +     +     
Sbjct: 92  EMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPE 151

Query: 117 RKL-FQQLI-------DGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFR 168
            ++ F+ L+        G+ Y  ++   HRDL   N+L+     +KI+DFGL+      R
Sbjct: 152 EQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLA------R 205

Query: 169 D-----------DGLLHTTCGSPNYV---APEVLANRGYDGATSDIWSCGVILY-IF 210
           D           +G L      P  V   APE L +R Y    SD+WS GV+++ IF
Sbjct: 206 DINNIDYYKKTTNGRL------P--VKWMAPEALFDRVYTHQ-SDVWSFGVLMWEIF 253

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score = 96.2 bits (240), Expect = 2e-22
 Identities = 63/233 (27%), Positives = 88/233 (37%), Gaps = 61/233 (26%)

Query: 17  ELGRTLGEGNFGKV-----KFAQDLDSGLPFAVKILEKNRIIHLKITDQIK----REIAT 67
            L   LGEG FGKV              +  AVK L++        ++  +    RE   
Sbjct: 44  VLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA-------SESARQDFQREAEL 96

Query: 68  LKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGEL--------FDKIASKGRLQEAEGRKL 119
           L +L+H ++VR   V      + MV EY+  G+L         D     G    A G   
Sbjct: 97  LTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLG 156

Query: 120 FQQLI-------DGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD--- 169
             QL+        G+ Y       HRDL   N L+     +KI DFG+S      RD   
Sbjct: 157 LGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMS------RDIYS 210

Query: 170 --------DGLLHTTCGSPNYV---APEVLANRGYDGATSDIWSCGVILY-IF 210
                     +L      P  +    PE +  R +    SD+WS GV+L+ IF
Sbjct: 211 TDYYRVGGRTML------P--IRWMPPESILYRKFTTE-SDVWSFGVVLWEIF 254

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score = 96.6 bits (241), Expect = 2e-22
 Identities = 56/227 (24%), Positives = 94/227 (41%), Gaps = 43/227 (18%)

Query: 14  GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKH 73
             + + R +G+G FG+V   Q +D+   +AVK++ +N     K T   K E   LK +++
Sbjct: 35  NAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVV-RN---IKKYTRSAKIEADILKKIQN 90

Query: 74  -----PNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGR--LQEAEGRKLFQQLIDG 126
                 N+V+ H        + ++ E   G  L++ I           + +    +++  
Sbjct: 91  DDINNNNIVKYHGKFMYYDHMCLIFE-PLGPSLYEIITRNNYNGFHIEDIKLYCIEILKA 149

Query: 127 VSYCHNKGVFHRDLKLENILLDS-------------------------KGNIKISDFGLS 161
           ++Y     + H DLK ENILLD                             IK+ DFG  
Sbjct: 150 LNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFG-C 208

Query: 162 ALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILY 208
           A  +         +   +  Y APEV+ N G+D + SD+WS G +L 
Sbjct: 209 ATFKSDY----HGSIINTRQYRAPEVILNLGWDVS-SDMWSFGCVLA 250

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score = 96.7 bits (241), Expect = 3e-22
 Identities = 62/237 (26%), Positives = 102/237 (43%), Gaps = 64/237 (27%)

Query: 17  ELGRTLGEGNFGKVKFA-------QDLDSGLPFAVKILEKNRIIHLKITDQIK----REI 65
            LG+ LGEG FG+V  A             +  AVK+L+ +       T++       E+
Sbjct: 84  TLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDD------ATEKDLSDLVSEM 137

Query: 66  ATLKLL-KHPNVVRLHEVLASKSKIYMVLEYVTGGELFD--------KIASKGRLQEAEG 116
             +K++ KH N++ L         +Y+++EY + G L +         +     +     
Sbjct: 138 EMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPE 197

Query: 117 RKL-FQQLID-------GVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFR 168
            ++ F+ L+        G+ Y  ++   HRDL   N+L+     +KI+DFGL+      R
Sbjct: 198 EQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLA------R 251

Query: 169 D-----------DGLLHTTCGSPNYV---APEVLANRGYDGATSDIWSCGVILY-IF 210
           D           +G L      P  V   APE L +R Y    SD+WS GV+++ IF
Sbjct: 252 DINNIDYYKKTTNGRL------P--VKWMAPEALFDRVYTHQ-SDVWSFGVLMWEIF 299

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score = 94.3 bits (235), Expect = 7e-22
 Identities = 64/234 (27%), Positives = 96/234 (41%), Gaps = 59/234 (25%)

Query: 17  ELGRTLGEGNFGKVK--FAQDLDSGLPF---AVKILEKNRIIHLKITDQIK----REIAT 67
           +LG+ LG G FG+V    A  +D        AVK+L++        T         E+  
Sbjct: 30  KLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEG------ATHSEHRALMSELKI 83

Query: 68  LKLL-KHPNVVRLHEV-LASKSKIYMVLEYVTGGELFD--------KIASKGRLQEAEGR 117
           L  +  H NVV L          + +++E+   G L           +  K   ++    
Sbjct: 84  LIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKD 143

Query: 118 KL-FQQLID-------GVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD 169
            L  + LI        G+ +  ++   HRDL   NILL  K  +KI DFGL+      RD
Sbjct: 144 FLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLA------RD 197

Query: 170 DGLLHTTCGSPNYV------------APEVLANRGYDGATSDIWSCGVILY-IF 210
              ++     P+YV            APE + +R Y    SD+WS GV+L+ IF
Sbjct: 198 ---IYKD---PDYVRKGDARLPLKWMAPETIFDRVYT-IQSDVWSFGVLLWEIF 244

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score = 94.7 bits (236), Expect = 1e-21
 Identities = 63/236 (26%), Positives = 93/236 (39%), Gaps = 57/236 (24%)

Query: 17  ELGRTLGEGNFGKVKFAQ-----DLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL 71
           E G+ LG G FGKV  A           +  AVK+L++         + +  E+  +  L
Sbjct: 48  EFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEK--ADSSEREALMSELKMMTQL 105

Query: 72  -KHPNVVRLHEVLASKSKIYMVLEYVTGGEL---------------FDKIASKGRLQEAE 115
             H N+V L         IY++ EY   G+L                +    K   +E +
Sbjct: 106 GSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEED 165

Query: 116 GRKL-FQQLI-------DGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHF 167
              L F+ L+        G+ +   K   HRDL   N+L+     +KI DFGL+      
Sbjct: 166 LNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLA------ 219

Query: 168 RDDGLLHTTCGSPNYV------------APEVLANRGYDGATSDIWSCGVILY-IF 210
           RD   + +     NYV            APE L    Y    SD+WS G++L+ IF
Sbjct: 220 RD---IMSD---SNYVVRGNARLPVKWMAPESLFEGIYT-IKSDVWSYGILLWEIF 268

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score = 93.5 bits (233), Expect = 2e-21
 Identities = 67/229 (29%), Positives = 91/229 (39%), Gaps = 51/229 (22%)

Query: 14  GRYELGRTLGEGNFGKVKFAQDLDSGLPF-AVKILEKNRIIHLKITDQIKREIATLKLLK 72
            RYE+  TLGEG FGKV    D  +G    AVKI+ KN     +  +  + EI  L+ L 
Sbjct: 14  ARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIV-KN---VDRYCEAARSEIQVLEHLN 69

Query: 73  HP------NVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGR--LQEAEGRKLFQQLI 124
                     V++ E       I +V E + G   +D I   G    +    RK+  Q+ 
Sbjct: 70  TTDPNSTFRCVQMLEWFEHHGHICIVFE-LLGLSTYDFIKENGFLPFRLDHIRKMAYQIC 128

Query: 125 DGVSYCHNKGVFHRDLKLENILLDSKGN-------------------IKISDFGLSALPQ 165
             V++ H+  + H DLK ENIL                         IK+ DFG SA   
Sbjct: 129 KSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFG-SATYD 187

Query: 166 HFRDDGLLHTTCGSPNYV------APEVLANRGYDGATSDIWSCGVILY 208
                   H+T      V      APEV+   G+     D+WS G IL 
Sbjct: 188 DEH-----HST-----LVSTRHYRAPEVILALGWSQP-CDVWSIGCILI 225

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score = 94.0 bits (234), Expect = 2e-21
 Identities = 64/237 (27%), Positives = 100/237 (42%), Gaps = 64/237 (27%)

Query: 17  ELGRTLGEGNFGKVKFA-------QDLDSGLPFAVKILEKNRIIHLKITDQIK----REI 65
            LG+ LGEG FG+V  A          +     AVK+L+ +       T++       E+
Sbjct: 72  VLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSD------ATEKDLSDLISEM 125

Query: 66  ATLKLL-KHPNVVRLHEVLASKSKIYMVLEYVTGGELFD--------KIASKGRLQEAEG 116
             +K++ KH N++ L         +Y+++EY + G L +         +           
Sbjct: 126 EMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPE 185

Query: 117 RKL-FQQLID-------GVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFR 168
            +L  + L+        G+ Y  +K   HRDL   N+L+     +KI+DFGL+      R
Sbjct: 186 EQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLA------R 239

Query: 169 D-----------DGLLHTTCGSPNYV---APEVLANRGYDGATSDIWSCGVILY-IF 210
           D           +G L      P  V   APE L +R Y    SD+WS GV+L+ IF
Sbjct: 240 DIHHIDYYKKTTNGRL------P--VKWMAPEALFDRIYT-HQSDVWSFGVLLWEIF 287

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score = 91.9 bits (229), Expect = 5e-21
 Identities = 55/201 (27%), Positives = 89/201 (44%), Gaps = 31/201 (15%)

Query: 22  LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHE 81
           +G G FGKV +   L  G   A+K         ++   + + EI TL   +HP++V L  
Sbjct: 47  IGHGVFGKV-YKGVLRDGAKVALKRRTPESSQGIE---EFETEIETLSFCRHPHLVSLIG 102

Query: 82  VLASKSKIYMVLEYVTGGE----LFDKIASKG------RLQEAEG--RKLFQQLIDGVSY 129
               ++++ ++ +Y+  G     L+             RL+   G  R        G+ Y
Sbjct: 103 FCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAAR--------GLHY 154

Query: 130 CHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTT---CGSPNYVAPE 186
            H + + HRD+K  NILLD     KI+DFG+S       +    H +    G+  Y+ PE
Sbjct: 155 LHTRAIIHRDVKSINILLDENFVPKITDFGISKK---GTELDQTHLSTVVKGTLGYIDPE 211

Query: 187 VLANRGYDGATSDIWSCGVIL 207
               +G     SD++S GV+L
Sbjct: 212 -YFIKGRLTEKSDVYSFGVVL 231

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score = 89.9 bits (224), Expect = 2e-20
 Identities = 60/213 (28%), Positives = 85/213 (39%), Gaps = 52/213 (24%)

Query: 22  LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKR----EIATLKLLKHPNVV 77
           +GEG FG V +   ++     AVK L     I  +   ++K+    EI  +   +H N+V
Sbjct: 39  MGEGGFGVV-YKGYVN-NTTVAVKKLAAMVDITTE---ELKQQFDQEIKVMAKCQHENLV 93

Query: 78  RL--------HEVLASKSKIYMVLEYVTGG----ELFDKIASKG-----RLQEAEG--RK 118
            L           L     +Y    Y+  G     L     +       R + A+G    
Sbjct: 94  ELLGFSSDGDDLCL-----VY---VYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAAN- 144

Query: 119 LFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTT-- 176
                  G+++ H     HRD+K  NILLD     KISDFGL+              T  
Sbjct: 145 -------GINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARA---SEKFAQTVMTSR 194

Query: 177 -CGSPNYVAPEVLANRGYDGATSDIWSCGVILY 208
             G+  Y+APE L  RG     SDI+S GV+L 
Sbjct: 195 IVGTTAYMAPEAL--RGEITPKSDIYSFGVVLL 225

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score = 90.8 bits (226), Expect = 2e-20
 Identities = 66/257 (25%), Positives = 97/257 (37%), Gaps = 59/257 (22%)

Query: 14  GRYELGRTLGEGNFGKVKFAQDLDSG-LPFAVKILEKNRIIHLKITDQIKREIATLKLLK 72
            RYE+   LGEG FGKV    D   G    A+KI+ +N     K  +  + EI  LK +K
Sbjct: 19  ERYEIVGNLGEGTFGKVVECLDHARGKSQVALKII-RN---VGKYREAARLEINVLKKIK 74

Query: 73  HP------NVVRLHEVLASKSKIYMVLEYVTGGELFD--KIASKGRLQEAEGRKLFQQLI 124
                     V + +       + +  E + G   F+  K  +         R +  QL 
Sbjct: 75  EKDKENKFLCVLMSDWFNFHGHMCIAFE-LLGKNTFEFLKENNFQPYPLPHVRHMAYQLC 133

Query: 125 DGVSYCHNKGVFHRDLKLENILLDS-------------------KGNIKISDFGLSALPQ 165
             + + H   + H DLK ENIL  +                     +I+++DFG SA   
Sbjct: 134 HALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFG-SATFD 192

Query: 166 HFRDDGLLHTTCGSPNYV------APEVLANRGYDGATSDIWSCGVILY-IFRGDFKLPK 218
           H       HTT      V       PEV+   G+     D+WS G IL+  +RG      
Sbjct: 193 HEH-----HTT-----IVATRHYRPPEVILELGWAQP-CDVWSIGCILFEYYRGFT---- 237

Query: 219 WLSPGAQNL--LRKILE 233
            L    +N   L  + +
Sbjct: 238 -LFQTHENREHLVMMEK 253

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score = 84.9 bits (211), Expect = 2e-18
 Identities = 58/204 (28%), Positives = 92/204 (45%), Gaps = 34/204 (16%)

Query: 22  LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHE 81
           LG G FGKV   + L  G   AVK L++ R        Q + E+  + +  H N++RL  
Sbjct: 38  LGRGGFGKVYKGR-LADGTLVAVKRLKEER--TQGGELQFQTEVEMISMAVHRNLLRLRG 94

Query: 82  VLASKSKIYMVLEYVTGG----ELFDKIASKG------RLQEAEG--RKLFQQLIDGVSY 129
              + ++  +V  Y+  G     L ++  S+       R + A G  R        G++Y
Sbjct: 95  FCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSAR--------GLAY 146

Query: 130 CH---NKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTT---CGSPNYV 183
            H   +  + HRD+K  NILLD +    + DFGL+ L     D    H T    G+  ++
Sbjct: 147 LHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL----MDYKDTHVTTAVRGTIGHI 202

Query: 184 APEVLANRGYDGATSDIWSCGVIL 207
           APE   + G     +D++  GV+L
Sbjct: 203 APE-YLSTGKSSEKTDVFGYGVML 225

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 81.6 bits (201), Expect = 7e-17
 Identities = 56/238 (23%), Positives = 99/238 (41%), Gaps = 41/238 (17%)

Query: 14  GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK- 72
            ++ LGR +G G+FG++    ++ +    A+K+ E  +  H     Q+  E    ++L+ 
Sbjct: 7   NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKL-ENVKTKH----PQLLYESKIYRILQG 61

Query: 73  HPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGR-------LQEAEGRKLFQQLID 125
              +  +           +V++ + G  L D      R       L  A+      Q+I+
Sbjct: 62  GTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLAD------QMIN 114

Query: 126 GVSYCHNKGVFHRDLKLENILLDSKGN---IKISDFGLSAL------PQH--FRDDGLLH 174
            V + H+K   HRD+K +N L+        + I DFGL+         QH  +R++    
Sbjct: 115 RVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYREN---K 171

Query: 175 TTCGSPNYVAPEVLANRGYD-GATSDIWSCG-VILYIFRGDFKLPKWLSPGAQNLLRK 230
              G+  Y +  V  + G +     D+ S G V++Y  RG   LP W    A    +K
Sbjct: 172 NLTGTARYAS--VNTHLGIEQSRRDDLESLGYVLMYFLRG--SLP-WQGLKAGTKKQK 224

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 79.3 bits (196), Expect = 1e-16
 Identities = 59/241 (24%), Positives = 99/241 (41%), Gaps = 45/241 (18%)

Query: 14  GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKH 73
             + +G+ +G GNFG+++  ++L +    A+K LE  +        Q+  E    K L  
Sbjct: 9   PNFRVGKKIGCGNFGELRLGKNLYTNEYVAIK-LEPMKSRA----PQLHLEYRFYKQLGS 63

Query: 74  -PNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRK--------LFQQLI 124
              + +++          MVLE   G  L D       L +   R         +  QLI
Sbjct: 64  GDGIPQVYYFGPCGKYNAMVLEL-LGPSLED-------LFDLCDRTFSLKTVLMIAIQLI 115

Query: 125 DGVSYCHNKGVFHRDLKLENILLDSKGN-----IKISDFGLS------ALPQH--FRDDG 171
             + Y H+K + +RD+K EN L+   GN     I I DF L+         +H  +R+  
Sbjct: 116 SRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHK 175

Query: 172 LLHTTCGSPNYVAPEVLANRGYD-GATSDIWSCG-VILYIFRGDFKLPKWLSPGAQNLLR 229
            L    G+  Y++  +  + G +     D+ + G + +Y  RG   LP W    A  L  
Sbjct: 176 SL---TGTARYMS--INTHLGKEQSRRDDLEALGHMFMYFLRG--SLP-WQGLKADTLKE 227

Query: 230 K 230
           +
Sbjct: 228 R 228

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 77.8 bits (192), Expect = 3e-16
 Identities = 62/244 (25%), Positives = 98/244 (40%), Gaps = 44/244 (18%)

Query: 14  GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKH 73
            RY LGR +G G+FG +    D+ +G   A+K+ E  +  H     Q+  E    K+++ 
Sbjct: 9   NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKL-ECVKTKH----PQLHIESKIYKMMQG 63

Query: 74  -PNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGR-------LQEAEGRKLFQQLID 125
              +  +    A      MV+E + G  L D      R       L  A+      Q+I 
Sbjct: 64  GVGIPTIRWCGAEGDYNVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLAD------QMIS 116

Query: 126 GVSYCHNKGVFHRDLKLENILLDSKGN---IKISDFGLSALPQHFRDD-GLLHTT----- 176
            + Y H+K   HRD+K +N L+        + I DFGL+   + +RD     H       
Sbjct: 117 RIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLA---KKYRDARTHQHIPYRENK 173

Query: 177 --CGSPNYVAPEVLANRGYD-GATSDIWSCG-VILYIFRGDFKLPKWLSPGAQNL---LR 229
              G+  Y +  +  + G +     D+ S G V++Y   G   LP W    A        
Sbjct: 174 NLTGTARYAS--INTHLGIEQSRRDDLESLGYVLMYFNLG--SLP-WQGLKAATKRQKYE 228

Query: 230 KILE 233
           +I E
Sbjct: 229 RISE 232

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 75.5 bits (186), Expect = 2e-15
 Identities = 58/241 (24%), Positives = 97/241 (40%), Gaps = 45/241 (18%)

Query: 14  GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKH 73
             Y++GR +GEG+FG +    +L +    A+K  E  R        Q++ E  T KLL  
Sbjct: 10  VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKF-EPRRSDA----PQLRDEYRTYKLLAG 64

Query: 74  -PNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRK--------LFQQLI 124
              +  ++          +V++   G  L D       L +  GRK          +Q++
Sbjct: 65  CTGIPNVYYFGQEGLHNVLVIDL-LGPSLED-------LLDLCGRKFSVKTVAMAAKQML 116

Query: 125 DGVSYCHNKGVFHRDLKLENILL----DSKGN-IKISDFGLS------ALPQH--FRDDG 171
             V   H K + +RD+K +N L+        N I + DFG+          QH  +R+  
Sbjct: 117 ARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREK- 175

Query: 172 LLHTTCGSPNYVAPEVLANRGYD-GATSDIWSCG-VILYIFRGDFKLPKWLSPGAQNLLR 229
                 G+  Y++  +  + G +     D+ + G V +Y  RG   LP W    A    +
Sbjct: 176 --KNLSGTARYMS--INTHLGREQSRRDDLEALGHVFMYFLRG--SLP-WQGLKAATNKQ 228

Query: 230 K 230
           K
Sbjct: 229 K 229

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 75.3 bits (185), Expect = 4e-15
 Identities = 64/267 (23%), Positives = 94/267 (35%), Gaps = 78/267 (29%)

Query: 14  GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK- 72
           GRY + R LG G+F  V  + D+      A+K+++         T+    EI  LK ++ 
Sbjct: 37  GRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAE----HYTETALDEIRLLKSVRN 92

Query: 73  ----HPN---VVRLHEVLASKSK----IYMVLEYVTGGELFDKIAS--KGRLQEAEGRKL 119
                PN   VV+L +           I MV E V G  L   I       L     +K+
Sbjct: 93  SDPNDPNREMVVQLLDDFKISGVNGTHICMVFE-VLGHHLLKWIIKSNYQGLPLPCVKKI 151

Query: 120 FQQLIDGVSYCHNK-GVFHRDLKLENILL------------------------------- 147
            QQ++ G+ Y H K  + H D+K ENILL                               
Sbjct: 152 IQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVS 211

Query: 148 ------------------DSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPN-YVAPEVL 188
                               K  +KI+D G +             T       Y + EVL
Sbjct: 212 TAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH------FTEDIQTRQYRSLEVL 265

Query: 189 ANRGYDGATSDIWSCGVILY-IFRGDF 214
              GY+   +DIWS   + + +  GD+
Sbjct: 266 IGSGYN-TPADIWSTACMAFELATGDY 291

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 70.3 bits (171), Expect = 2e-13
 Identities = 38/192 (19%), Positives = 66/192 (34%), Gaps = 48/192 (25%)

Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKIL-----EKNRIIHLKITDQIKREIATLK 69
           + +    +GEG FG+V F Q +    P A+KI+     +     H K  ++I  EI   K
Sbjct: 21  KLQRCEKIGEGVFGEV-F-QTIADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISK 78

Query: 70  LL---------KHPNVVRLHEV------------------------------LASKSKIY 90
            L         +    + L+ V                                   +++
Sbjct: 79  ELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLF 138

Query: 91  MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNK-GVFHRDLKLENILLDS 149
           +VLE+  GG   +++ +K     A  + +  QL   ++         HRDL   N+LL  
Sbjct: 139 IVLEFEFGGIDLEQMRTK-LSSLATAKSILHQLTASLAVAEASLRFEHRDLHWGNVLLKK 197

Query: 150 KGNIKISDFGLS 161
               K+      
Sbjct: 198 TSLKKLHYTLNG 209

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 69.8 bits (171), Expect = 3e-13
 Identities = 31/179 (17%), Positives = 69/179 (38%), Gaps = 29/179 (16%)

Query: 14  GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKH 73
            ++ LG+ +G G FG +  A   +     A  +++     +      +  E+   + +  
Sbjct: 37  NQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQEN----GPLFSELKFYQRVAK 92

Query: 74  PNVVRLHEVLASKSKI-------------------YMVLEYVTGGELFDKIASKGRLQEA 114
            + ++          +                   +MV+E + G +L       G  +++
Sbjct: 93  KDCIKKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERL-GIDLQKISGQNGTFKKS 151

Query: 115 EGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSK--GNIKISDFGLSALPQHFRDDG 171
              +L  +++D + Y H     H D+K  N+LL  K    + ++D+GLS     +  +G
Sbjct: 152 TVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYLADYGLS---YRYCPNG 207

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 65.6 bits (160), Expect = 7e-12
 Identities = 34/207 (16%), Positives = 74/207 (35%), Gaps = 55/207 (26%)

Query: 3   IAEKKQEGMRL-----GRYELGRTLGEGNFGKVKFA-----QDLDSGLPFAVKILEKNRI 52
           +AE+   G  +       +++G  +G+G FG +  A     + + S  P  VK+   +  
Sbjct: 19  LAEQFAVGEIITDMAAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSD-- 76

Query: 53  IHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKI-------------------YMVL 93
                   +  E+   +    P  ++          +                   +M++
Sbjct: 77  -----NGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIM 131

Query: 94  EYVTGGELFDKIASKGR-------LQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENIL 146
           +   G +L     +  +       LQ +       +++D + Y H     H D+K  N+L
Sbjct: 132 DRF-GSDLQKIYEANAKRFSRKTVLQLSL------RILDILEYIHEHEYVHGDIKASNLL 184

Query: 147 LDSK--GNIKISDFGLSALPQHFRDDG 171
           L+ K    + + D+GL+     +  +G
Sbjct: 185 LNYKNPDQVYLVDYGLA---YRYCPEG 208

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 64.0 bits (156), Expect = 2e-11
 Identities = 23/186 (12%), Positives = 59/186 (31%), Gaps = 40/186 (21%)

Query: 14  GRYELGRTLGEGNFGKVKFAQDLDSGL--------PFAVKILEKNRIIHLKI-------- 57
            +++L       N G +  A    +           F++K+  K+  +  +         
Sbjct: 42  RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAK 101

Query: 58  TDQIKREIATLKLLKHPNVVRLHEVLASKSKI-YMVLEYVTGGELFDKIASKGRLQEAEG 116
             Q+ +    L       +         + K  ++VL  + G  L           +   
Sbjct: 102 PLQVNKWK-KLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQS-------ALDVSP 152

Query: 117 RKLF---------QQLIDGVSYCHNKGVFHRDLKLENILL--DSKGNIKISDFGLSALPQ 165
           + +           +L+D + + H     H ++  ENI +  + +  + ++ +G +    
Sbjct: 153 KHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIFVDPEDQSQVTLAGYGFA---F 209

Query: 166 HFRDDG 171
            +   G
Sbjct: 210 RYCPSG 215

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 57.6 bits (139), Expect = 2e-09
 Identities = 34/99 (34%), Positives = 47/99 (47%), Gaps = 25/99 (25%)

Query: 122 QLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPN 181
           Q+  G+ +  ++   HRDL   NILL  K  +KI DFGL+      RD          P+
Sbjct: 201 QVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLA------RD------IYKDPD 248

Query: 182 YV------------APEVLANRGYDGATSDIWSCGVILY 208
           YV            APE + +R Y    SD+WS GV+L+
Sbjct: 249 YVRKGDARLPLKWMAPETIFDRVYT-IQSDVWSFGVLLW 286

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 50.7 bits (121), Expect = 4e-07
 Identities = 32/171 (18%), Positives = 52/171 (30%), Gaps = 13/171 (7%)

Query: 17  ELGRTLGEGNFGKVKFAQ-----DLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL 71
           +LG+ LG G FG+V  A         +    AVK+L             +  E+  L  +
Sbjct: 25  KLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKML--KEGATHSEHRALMSELKILIHI 82

Query: 72  -KHPNVVRLH-EVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSY 129
             H NVV L          + +++E+   G L   +    R +  E      +       
Sbjct: 83  GHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYL----RSKRNEFVPYKTKGARFRQG 138

Query: 130 CHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP 180
               G    DLK     + S  +   S F          ++          
Sbjct: 139 KDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDF 189

>3ose_A Serine/threonine-protein kinase MARK1; kinase associated-1(Ka1) domain, transferase, lipid binding membrane association; 1.70A {Homo sapiens} PDB: 1ul7_A Length = 120

 Score = 53.1 bits (127), Expect = 5e-09
 Identities = 20/106 (18%), Positives = 44/106 (41%), Gaps = 8/106 (7%)

Query: 312 EKEDVSERKIRF------TSNHSAKDLLERIEDIVTEMGFRVQKKNGKLKATQEHKPQKS 365
           E +D   R +RF      TS+    D++  I  ++       ++K   L        ++ 
Sbjct: 16  EGKDSKPRSLRFTWSMKTTSSMDPNDMMREIRKVLDANNCDYEQKERFLLFCVHGDARQD 75

Query: 366 LGSLSVAAEVFEIS-PSLYVVELRKSYGDPTVYRQLCNKLSSDLGL 410
              +    EV ++   SL  V  ++  G    ++ + +K++++L L
Sbjct: 76  -SLVQWEMEVCKLPRLSLNGVRFKRISGTSIAFKNIASKIANELKL 120

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 49.9 bits (118), Expect = 1e-06
 Identities = 63/402 (15%), Positives = 112/402 (27%), Gaps = 131/402 (32%)

Query: 2   VIAEKKQEGMRLGRYELGRTLGEGN--FGKV--KFAQDL----DSGLPFAVKILEKNRII 53
            ++      + L  + +  T  E      K      QDL     +  P  + I       
Sbjct: 280 FLSAATTTHISLDHHSMTLTPDEVKSLLLKYLDCRPQDLPREVLTTNPRRLSI------- 332

Query: 54  HLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQE 113
              I + I+  +AT    KH N  +L  ++ S       L                 L+ 
Sbjct: 333 ---IAESIRDGLATWDNWKHVNCDKLTTIIESS------LNV---------------LEP 368

Query: 114 AEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSK-GNIKISDFGLSALPQHFRDDGL 172
           AE RK+F +L           VF     +  ILL     ++  SD           +   
Sbjct: 369 AEYRKMFDRL----------SVFPPSAHIPTILLSLIWFDVIKSD------VMVVVNK-- 410

Query: 173 LHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIFRGDFKLPKWLSPGAQNLLRKIL 232
           LH             L  +    +T  I S    +Y+   + K+          L R I+
Sbjct: 411 LHKYS----------LVEKQPKESTISIPS----IYL---ELKVK---LENEYALHRSIV 450

Query: 233 EP-NPVKRITIAGIKADEWFEQDYTPANPDD----------------DEED-----IFVD 270
           +  N  K            F+ D       D                 E       +F+D
Sbjct: 451 DHYNIPKT-----------FDSDDLIPPYLDQYFYSHIGHHLKNIEHPERMTLFRMVFLD 499

Query: 271 NEAFSMHEVPSDGGRTPGSPPLINAFQLIGMSSCLDLSGF----FEKEDVSERKIR---- 322
              F   ++  D      S  ++N  Q         L  +     + +   ER +     
Sbjct: 500 FR-FLEQKIRHDSTAWNASGSILNTLQ--------QLKFYKPYICDNDPKYERLVNAILD 550

Query: 323 FTSNHSAKDLLERIEDIVTEMGFRVQKKNGKLKATQEHKPQK 364
           F        +  +  D++      +  ++  +      + Q+
Sbjct: 551 FLPKIEENLICSKYTDLLR---IALMAEDEAIFEEAHKQVQR 589

>1v5s_A MAP/microtubule affinity-regulating kinase 3; Ka1 domain, ELKL motif, MARK3, phosphorylation, structural genomics, NPPSFA; NMR {Mus musculus} SCOP: d.129.6.1 Length = 126

 Score = 38.9 bits (90), Expect = 5e-04
 Identities = 14/102 (13%), Positives = 37/102 (36%), Gaps = 7/102 (6%)

Query: 319 RKIRFTSNHSAK---DLLERIEDIVTEMGFRVQKKNG-KLKATQEHKPQKSLGSLSVAAE 374
                    S+    D++  I  ++       +++    L         ++L  +    E
Sbjct: 26  TTENLYFQGSSGSSGDMMREIRKVLGANNCDYEQRERFLLFCVHGDGHAENL--VQWEME 83

Query: 375 VFEIS-PSLYVVELRKSYGDPTVYRQLCNKLSSDLGLPPSQE 415
           V ++   SL  V  ++  G    ++ + +K++++L L     
Sbjct: 84  VCKLPRLSLNGVRFKRISGTSIAFKNIASKIANELKLSGPSS 125

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* Length = 282

 Score = 40.3 bits (94), Expect = 6e-04
 Identities = 28/166 (16%), Positives = 63/166 (37%), Gaps = 28/166 (16%)

Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQI-------------- 61
             +G+ +GEG    V      +      VK  +       K+ ++               
Sbjct: 92  DAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRS 150

Query: 62  -KREIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLF 120
            + E   L+ L+   V +++          +++E +   EL+       R++  +  ++ 
Sbjct: 151 ARNEFRALQKLQGLAVPKVYAW----EGNAVLMELIDAKELYRV-----RVENPD--EVL 199

Query: 121 QQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQH 166
             +++ V+  +++G+ H DL   N+L+  +  I I DF  S     
Sbjct: 200 DMILEEVAKFYHRGIVHGDLSQYNVLVS-EEGIWIIDFPQSVEVGE 244

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	421
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	100.0
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	100.0
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
3aln_A	327	Dual specificity mitogen-activated protein kinase;	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
2dyl_A	318	Dual specificity mitogen-activated protein kinase	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	100.0
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
3uqc_A	286	Probable conserved transmembrane protein; structur	100.0
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	100.0
2ehb_D	143	CBL-interacting serine/threonine-protein kinase 2;	99.97
2zfd_B	123	Putative uncharacterized protein T20L15_90; calciu	99.96
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.95
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.94
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.88
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.8
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.5
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	99.36
3ose_A	120	Serine/threonine-protein kinase MARK1; kinase asso	99.32
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	99.26
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	99.03
1v5s_A	126	MAP/microtubule affinity-regulating kinase 3; Ka1	98.98
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.95
4eai_A	106	5'-AMP-activated protein kinase catalytic subunit	98.86
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.79
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.78
2v8q_A	157	5'-AMP-activated protein kinase catalytic subunit;	98.7
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	98.61
2y8l_A	173	5'-AMP-activated protein kinase catalytic subunit;	98.53
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.48
4eag_A	130	EG:132E8.2 protein; AMPK, transferase; HET: ATP TA	98.47
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	98.46
2qrd_A	137	SNF1-like protein kinase SSP2; AMPK, ADP, ATP-bind	98.35
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	98.32
3ats_A	357	Putative uncharacterized protein; hypothetical pro	98.32
3t4n_A	179	Carbon catabolite-derepressing protein kinase; CBS	98.17
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	97.99
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	97.91
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	97.76
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	97.7
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	97.58
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	97.54
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	97.51
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	97.47
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	97.41
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	97.32
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	97.25
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	97.18
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	96.99
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	96.68
3mes_A	424	Choline kinase; malaria, structural genomics, stru	96.16
3g15_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	93.6
4ano_A	219	ESSB; membrane protein, membrane secretion, ESS ty	86.96
4ann_A	215	ESSB; membrane protein, membrane secretion, ESS ty	84.06
3cxl_A	463	N-chimerin; SH2, RHO-GAP, structural genomics cons	83.18

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=3.8e-64  Score=477.09  Aligned_cols=246  Identities=47%  Similarity=0.906  Sum_probs=201.1

Q ss_pred             cccCCeeecceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEe
Q 014609            6 KKQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLAS   85 (421)
Q Consensus         6 ~~~~~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~   85 (421)
                      ....|.++|+|++++.||+|+||+||+|++..+|+.||||++++...........+.+|+++|++++|||||++++++++
T Consensus         5 ~l~~G~~ig~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~   84 (275)
T 3hyh_A            5 SLADGAHIGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKS   84 (275)
T ss_dssp             ---------CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred             CCCCCCEeeCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEE
Confidence            34567889999999999999999999999999999999999987766555556789999999999999999999999999


Q ss_pred             CCEEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCc
Q 014609           86 KSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQ  165 (421)
Q Consensus        86 ~~~~~lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~  165 (421)
                      ++.+|+||||+ +|+|.+++...+++++..++.+++||+.||+|||++||+||||||+|||++.+|++||+|||+|+...
T Consensus        85 ~~~~~ivmEy~-~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~  163 (275)
T 3hyh_A           85 KDEIIMVIEYA-GNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMT  163 (275)
T ss_dssp             SSEEEEEEECC-CEEHHHHHHHSCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTCCEEECCSSCC----
T ss_pred             CCEEEEEEeCC-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEECCCCCEEEeecCCCeecC
Confidence            99999999999 78999999998999999999999999999999999999999999999999999999999999998543


Q ss_pred             cccCCCccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhh--------------------cCCcCCCCCCCHHHH
Q 014609          166 HFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIF--------------------RGDFKLPKWLSPGAQ  225 (421)
Q Consensus       166 ~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~--------------------~~~~~~p~~~s~~~~  225 (421)
                      .   .....+.+|||.|+|||++.+..|++.++||||+||++|++                    .+.+++|.++|++++
T Consensus       164 ~---~~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~  240 (275)
T 3hyh_A          164 D---GNFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYTLPKFLSPGAA  240 (275)
T ss_dssp             --------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTSCHHHH
T ss_pred             C---CCccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHH
Confidence            2   33456789999999999999988888899999999999933                    334556778999999


Q ss_pred             HHHHHhcCCCCCCCCCHHhhhcCccccccc
Q 014609          226 NLLRKILEPNPVKRITIAGIKADEWFEQDY  255 (421)
Q Consensus       226 ~li~~~L~~dP~~R~t~~eil~~~w~~~~~  255 (421)
                      +||.+||++||++|||++|+++||||+...
T Consensus       241 ~li~~~L~~dP~~R~s~~eil~hpw~k~~~  270 (275)
T 3hyh_A          241 GLIKRMLIVNPLNRISIHEIMQDDWFKVDL  270 (275)
T ss_dssp             HHHHHHSCSSGGGSCCHHHHHHCHHHHTTC
T ss_pred             HHHHHHccCChhHCcCHHHHHcCcccccCC
Confidence            999999999999999999999999998643

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=5.4e-64  Score=482.82  Aligned_cols=242  Identities=33%  Similarity=0.588  Sum_probs=220.3

Q ss_pred             eeecceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEE
Q 014609           11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIY   90 (421)
Q Consensus        11 ~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~   90 (421)
                      ...++|++++.||+|+||+||+|++..+|+.||||++++.........+.+.+|+++|++|+|||||++++++++++.+|
T Consensus        29 ~~~~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~y  108 (311)
T 4aw0_A           29 KRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLY  108 (311)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred             CCccccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEE
Confidence            45578999999999999999999999999999999998766555555678999999999999999999999999999999


Q ss_pred             EEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCccccCC
Q 014609           91 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD  170 (421)
Q Consensus        91 lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~  170 (421)
                      +|||||+||+|++++...+.+++..++.|+.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+........
T Consensus       109 ivmEy~~gG~L~~~i~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~~~  188 (311)
T 4aw0_A          109 FGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQ  188 (311)
T ss_dssp             EEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECCTTTTC
T ss_pred             EEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCCCc
Confidence            99999999999999999899999999999999999999999999999999999999999999999999999876544444


Q ss_pred             CccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhh--------------------cCCcCCCCCCCHHHHHHHHH
Q 014609          171 GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIF--------------------RGDFKLPKWLSPGAQNLLRK  230 (421)
Q Consensus       171 ~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~--------------------~~~~~~p~~~s~~~~~li~~  230 (421)
                      ....+.||||.|+|||++.+.+| +.++|||||||++|++                    .+.+.+|..+|+++++||++
T Consensus       189 ~~~~~~~GTp~YmAPEvl~~~~y-~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~dli~~  267 (311)
T 4aw0_A          189 ARANSFVGTAQYVSPELLTEKSA-CKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLEYDFPEKFFPKARDLVEK  267 (311)
T ss_dssp             CCBCCCCSCGGGCCHHHHHHSCB-CHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTCCHHHHHHHHH
T ss_pred             ccccCcccCcccCCHHHHcCCCC-CcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCcccCHHHHHHHHH
Confidence            56678899999999999999888 5899999999999932                    34556778899999999999


Q ss_pred             hcCCCCCCCCCHHh------hhcCccccc
Q 014609          231 ILEPNPVKRITIAG------IKADEWFEQ  253 (421)
Q Consensus       231 ~L~~dP~~R~t~~e------il~~~w~~~  253 (421)
                      ||++||.+|||++|      |++||||+.
T Consensus       268 lL~~dp~~R~t~~e~~~~~~i~~Hp~F~~  296 (311)
T 4aw0_A          268 LLVLDATKRLGCEEMEGYGPLKAHPFFES  296 (311)
T ss_dssp             HSCSSGGGSTTSGGGTCHHHHHTSGGGTT
T ss_pred             HccCCHhHCcChHHHcCCHHHHCCCCcCC
Confidence            99999999999988      588999874

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=1.1e-61  Score=474.08  Aligned_cols=241  Identities=27%  Similarity=0.559  Sum_probs=207.9

Q ss_pred             eeecceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEE
Q 014609           11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIY   90 (421)
Q Consensus        11 ~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~   90 (421)
                      ..+++|++++.||+|+||+||+|++..+|+.||||++++.... ....+.+.+|+.+|++|+|||||++++++++++.+|
T Consensus        21 ~sme~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~-~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~y   99 (350)
T 4b9d_A           21 QSMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMS-SKEREESRREVAVLANMKHPNIVQYRESFEENGSLY   99 (350)
T ss_dssp             SCCCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred             CcccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCC-HHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEE
Confidence            3568999999999999999999999999999999999876543 334678999999999999999999999999999999


Q ss_pred             EEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCcccc
Q 014609           91 MVLEYVTGGELFDKIASK--GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFR  168 (421)
Q Consensus        91 lv~E~~~gg~L~~~i~~~--~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~~  168 (421)
                      ||||||+||+|++++...  ..+++..++.|+.||+.||+|||++||+||||||+||||+.+|.+||+|||+|+..... 
T Consensus       100 iVmEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~-  178 (350)
T 4b9d_A          100 IVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNST-  178 (350)
T ss_dssp             EEEECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEECTTCCEEECSTTEESCCCHH-
T ss_pred             EEEeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCCEEEcccccceeecCC-
Confidence            999999999999999754  35799999999999999999999999999999999999999999999999999865431 


Q ss_pred             CCCccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhh-cCCc--------------------CCCCCCCHHHHHH
Q 014609          169 DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIF-RGDF--------------------KLPKWLSPGAQNL  227 (421)
Q Consensus       169 ~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~-~~~~--------------------~~p~~~s~~~~~l  227 (421)
                       .....+.|||+.|+|||++.+.+|+ .++|||||||+||++ .|..                    +.|..+|+++.+|
T Consensus       179 -~~~~~~~~GT~~YmAPE~l~~~~y~-~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~l  256 (350)
T 4b9d_A          179 -VELARACIGTPYYLSPEICENKPYN-NKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFPPVSLHYSYDLRSL  256 (350)
T ss_dssp             -HHHHHHHHSCCTTCCHHHHTTCCCC-HHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCCTTSCHHHHHH
T ss_pred             -cccccccCCCccccCHHHHCCCCCC-cHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCCccCCHHHHHH
Confidence             1234567899999999999998884 899999999999943 3332                    2345689999999


Q ss_pred             HHHhcCCCCCCCCCHHhhhcCccccccc
Q 014609          228 LRKILEPNPVKRITIAGIKADEWFEQDY  255 (421)
Q Consensus       228 i~~~L~~dP~~R~t~~eil~~~w~~~~~  255 (421)
                      |.+||++||.+|||++|+++||||++..
T Consensus       257 i~~~L~~dP~~R~s~~e~l~hp~~~~~~  284 (350)
T 4b9d_A          257 VSQLFKRNPRDRPSVNSILEKGFIAKRI  284 (350)
T ss_dssp             HHHHTCSSGGGSCCHHHHHTSHHHHTTG
T ss_pred             HHHHccCChhHCcCHHHHhcCHHhhcCC
Confidence            9999999999999999999999998654

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=3.9e-61  Score=469.50  Aligned_cols=238  Identities=27%  Similarity=0.471  Sum_probs=211.6

Q ss_pred             ecceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEE
Q 014609           13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMV   92 (421)
Q Consensus        13 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv   92 (421)
                      ...|++++.||+|+||+||+|+++.+|+.||||++++.....   .+.+.+|+.+|+.++|||||++++++.+++.+|||
T Consensus        73 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~---~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iv  149 (346)
T 4fih_A           73 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQR---RELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVV  149 (346)
T ss_dssp             GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSS---GGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred             hHhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhH---HHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence            467999999999999999999999999999999998654332   35688999999999999999999999999999999


Q ss_pred             EeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCccccCCCc
Q 014609           93 LEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGL  172 (421)
Q Consensus        93 ~E~~~gg~L~~~i~~~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~  172 (421)
                      ||||+||+|++++.. +++++..++.|+.||+.||+|||++||+||||||+||||+.+|.+||+|||+|+....  ....
T Consensus       150 mEy~~gg~L~~~l~~-~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~--~~~~  226 (346)
T 4fih_A          150 MEFLEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSK--EVPR  226 (346)
T ss_dssp             ECCCTTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCS--SSCC
T ss_pred             EeCCCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEECCCCCEEEecCcCceecCC--CCCc
Confidence            999999999998875 6799999999999999999999999999999999999999999999999999985533  2344


Q ss_pred             cccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhh-cCCcCC----------------------CCCCCHHHHHHHH
Q 014609          173 LHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIF-RGDFKL----------------------PKWLSPGAQNLLR  229 (421)
Q Consensus       173 ~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~-~~~~~~----------------------p~~~s~~~~~li~  229 (421)
                      ..+.||||.|+|||++.+.+| +.++|||||||++|++ .|..|+                      +..+|+++.+||.
T Consensus       227 ~~~~~GTp~YmAPEvl~~~~y-~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~dli~  305 (346)
T 4fih_A          227 RKSLVGTPYWMAPELISRLPY-GPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLD  305 (346)
T ss_dssp             BCCCCSCGGGCCHHHHTTCCB-CTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCCSCGGGSCHHHHHHHH
T ss_pred             ccccccCcCcCCHHHHCCCCC-CcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCCccccCCHHHHHHHH
Confidence            567899999999999998888 5999999999999954 343332                      2237899999999


Q ss_pred             HhcCCCCCCCCCHHhhhcCccccccccC
Q 014609          230 KILEPNPVKRITIAGIKADEWFEQDYTP  257 (421)
Q Consensus       230 ~~L~~dP~~R~t~~eil~~~w~~~~~~~  257 (421)
                      +||++||.+|||++|+++||||++...+
T Consensus       306 ~~L~~dP~~R~ta~e~l~Hp~~~~~~~p  333 (346)
T 4fih_A          306 RLLVRDPAQRATAAELLKHPFLAKAGPP  333 (346)
T ss_dssp             HHSCSSTTTSCCHHHHTTCGGGGGCCCG
T ss_pred             HHcCCChhHCcCHHHHhcCHhhcCCCCC
Confidence            9999999999999999999999975543

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=6.2e-61  Score=461.09  Aligned_cols=237  Identities=34%  Similarity=0.644  Sum_probs=204.8

Q ss_pred             ecceEEeceEeecCcEEEEEEEEC---CCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEE
Q 014609           13 LGRYELGRTLGEGNFGKVKFAQDL---DSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKI   89 (421)
Q Consensus        13 ~~~y~i~~~LG~G~~g~V~~a~~~---~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~   89 (421)
                      -++|++++.||+|+||+||+|++.   .+++.||||++++....... ...+.+|+.+|++++|||||++++++++++.+
T Consensus        23 p~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~-~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~  101 (304)
T 3ubd_A           23 PSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRD-RVRTKMERDILVEVNHPFIVKLHYAFQTEGKL  101 (304)
T ss_dssp             GGGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEE-CC------CCCCCCCCTTEECEEEEEEETTEE
T ss_pred             ccccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHH-HHHHHHHHHHHHHCCCCCCCeEEEEEEECCEE
Confidence            368999999999999999999984   46889999999875543222 34688999999999999999999999999999


Q ss_pred             EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCccccC
Q 014609           90 YMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD  169 (421)
Q Consensus        90 ~lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~  169 (421)
                      |+|||||+||+|++++...+.+++..++.|+.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+....  .
T Consensus       102 ~ivmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~--~  179 (304)
T 3ubd_A          102 YLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESID--H  179 (304)
T ss_dssp             EEEECCCTTCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTSCEEEESSEEEEC------
T ss_pred             EEEEEcCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEEcCCCCEEecccccceeccC--C
Confidence            99999999999999999989999999999999999999999999999999999999999999999999999985432  2


Q ss_pred             CCccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhh--------------------cCCcCCCCCCCHHHHHHHH
Q 014609          170 DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIF--------------------RGDFKLPKWLSPGAQNLLR  229 (421)
Q Consensus       170 ~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~--------------------~~~~~~p~~~s~~~~~li~  229 (421)
                      .....+.|||+.|+|||++.+.+|+ .++|||||||++|++                    .+.+++|..+|+++.+||+
T Consensus       180 ~~~~~~~~GT~~YmAPE~~~~~~y~-~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~  258 (304)
T 3ubd_A          180 EKKAYSFCGTVEYMAPEVVNRRGHT-QSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMPQFLSPEAQSLLR  258 (304)
T ss_dssp             -CCCCSCCCCGGGCCHHHHHTSCCC-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHH
T ss_pred             CccccccccCcccCCHHHhccCCCC-CCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCCCCCCcCCHHHHHHHH
Confidence            3445678999999999999988885 899999999999933                    3445667889999999999


Q ss_pred             HhcCCCCCCCCC-----HHhhhcCccccc
Q 014609          230 KILEPNPVKRIT-----IAGIKADEWFEQ  253 (421)
Q Consensus       230 ~~L~~dP~~R~t-----~~eil~~~w~~~  253 (421)
                      +||++||++|||     ++|+++||||+.
T Consensus       259 ~~L~~dP~~R~ta~~~~~~eil~Hp~f~~  287 (304)
T 3ubd_A          259 MLFKRNPANRLGAGPDGVEEIKRHSFFST  287 (304)
T ss_dssp             HHTCSSGGGSTTCSTTTHHHHHTSGGGTT
T ss_pred             HHcccCHHHCCCCCcCCHHHHHcCccccC
Confidence            999999999998     579999999975

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=9.1e-60  Score=470.84  Aligned_cols=238  Identities=26%  Similarity=0.459  Sum_probs=211.9

Q ss_pred             eecceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEE
Q 014609           12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYM   91 (421)
Q Consensus        12 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l   91 (421)
                      ..++|++++.||+|+||+||+|++..+|+.||||+++......   .+.+.+|+.+|+.++|||||++++++.+++.+||
T Consensus       149 p~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~---~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~i  225 (423)
T 4fie_A          149 PRSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQR---RELLFNEVVIMRDYQHENVVEMYNSYLVGDELWV  225 (423)
T ss_dssp             GGGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSS---GGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred             hhHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhH---HHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEE
Confidence            3467999999999999999999999999999999998654332   3568899999999999999999999999999999


Q ss_pred             EEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCccccCCC
Q 014609           92 VLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDG  171 (421)
Q Consensus        92 v~E~~~gg~L~~~i~~~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~  171 (421)
                      |||||+||+|++++.. +++++..++.|+.||+.||+|||++||+||||||+||||+.+|.+||+|||+|+....  ...
T Consensus       226 VmEy~~gG~L~~~i~~-~~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~--~~~  302 (423)
T 4fie_A          226 VMEFLEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSK--EVP  302 (423)
T ss_dssp             EEECCTTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEECTTCCEEECCCTTCEECCS--SCC
T ss_pred             EEeCCCCCcHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEecCccceECCC--CCc
Confidence            9999999999998865 6799999999999999999999999999999999999999999999999999985533  234


Q ss_pred             ccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhh-cCCcCC----------------------CCCCCHHHHHHH
Q 014609          172 LLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIF-RGDFKL----------------------PKWLSPGAQNLL  228 (421)
Q Consensus       172 ~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~-~~~~~~----------------------p~~~s~~~~~li  228 (421)
                      ...+.|||+.|||||++.+..| +.++|||||||++|++ .|..++                      +..+|+++++||
T Consensus       303 ~~~~~~GTp~YmAPEvl~~~~y-~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~dli  381 (423)
T 4fie_A          303 RRKSLVGTPYWMAPELISRLPY-GPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFL  381 (423)
T ss_dssp             CBCCCEECTTTCCHHHHTTCCB-CTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCTTSSCHHHHHHH
T ss_pred             cccccccCcCcCCHHHHCCCCC-CcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCcccccCCHHHHHHH
Confidence            5567899999999999998888 5999999999999944 333332                      234799999999


Q ss_pred             HHhcCCCCCCCCCHHhhhcCcccccccc
Q 014609          229 RKILEPNPVKRITIAGIKADEWFEQDYT  256 (421)
Q Consensus       229 ~~~L~~dP~~R~t~~eil~~~w~~~~~~  256 (421)
                      .+||++||.+|||+.|+++||||++...
T Consensus       382 ~~~L~~dP~~R~ta~ell~Hp~~~~~~~  409 (423)
T 4fie_A          382 DRLLVRDPAQRATAAELLKHPFLAKAGP  409 (423)
T ss_dssp             HHHSCSSTTTSCCHHHHTTCGGGGGCCC
T ss_pred             HHHcCCChhHCcCHHHHhcCHHhcCCCC
Confidence            9999999999999999999999997543

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=1.4e-59  Score=449.34  Aligned_cols=233  Identities=25%  Similarity=0.483  Sum_probs=204.7

Q ss_pred             cce-EEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEe----CCE
Q 014609           14 GRY-ELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLAS----KSK   88 (421)
Q Consensus        14 ~~y-~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~----~~~   88 (421)
                      |+| ++.+.||+|+||+||+|.+..+++.||+|++...... ....+.+.+|+++|++|+|||||++++++++    +..
T Consensus        25 gr~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~-~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~  103 (290)
T 3fpq_A           25 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLT-KSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKC  103 (290)
T ss_dssp             SSEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSC-HHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEE
T ss_pred             CceEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCC-HHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcE
Confidence            566 7888999999999999999999999999999865543 3346789999999999999999999999875    356


Q ss_pred             EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--ceeccCCCCCEEecc-CCCEEEEeccCCCCCc
Q 014609           89 IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKG--VFHRDLKLENILLDS-KGNIKISDFGLSALPQ  165 (421)
Q Consensus        89 ~~lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~ql~~aL~~LH~~g--i~HrDlkp~NILl~~-~~~~kL~DFGla~~~~  165 (421)
                      +|+|||||+||+|.+++...+.+++..++.|+.||+.||+|||++|  |+||||||+||||+. +|.+||+|||+|+.. 
T Consensus       104 ~~lvmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~-  182 (290)
T 3fpq_A          104 IVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK-  182 (290)
T ss_dssp             EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGC-
T ss_pred             EEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCCEEEEeCcCCEeC-
Confidence            8999999999999999999899999999999999999999999998  999999999999984 799999999999753 


Q ss_pred             cccCCCccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhh-cCCcCC----------------------CCCCCH
Q 014609          166 HFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIF-RGDFKL----------------------PKWLSP  222 (421)
Q Consensus       166 ~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~-~~~~~~----------------------p~~~s~  222 (421)
                         ......+.+|||.|||||++.+ +| +.++|||||||+||++ .|..|+                      |...++
T Consensus       183 ---~~~~~~~~~GTp~YmAPE~~~~-~y-~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~  257 (290)
T 3fpq_A          183 ---RASFAKAVIGTPEFMAPEMYEE-KY-DESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIP  257 (290)
T ss_dssp             ---CTTSBEESCSSCCCCCGGGGGT-CC-CTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCH
T ss_pred             ---CCCccCCcccCccccCHHHcCC-CC-CcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHcCCCCCCCCccCCH
Confidence               2345667899999999999865 57 5899999999999943 444443                      234678


Q ss_pred             HHHHHHHHhcCCCCCCCCCHHhhhcCccccc
Q 014609          223 GAQNLLRKILEPNPVKRITIAGIKADEWFEQ  253 (421)
Q Consensus       223 ~~~~li~~~L~~dP~~R~t~~eil~~~w~~~  253 (421)
                      ++.+||.+||++||++|||++|+++||||++
T Consensus       258 ~~~~li~~~L~~dP~~R~s~~e~l~Hp~~~~  288 (290)
T 3fpq_A          258 EVKEIIEGCIRQNKDERYSIKDLLNHAFFQE  288 (290)
T ss_dssp             HHHHHHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred             HHHHHHHHHccCChhHCcCHHHHhcCccccC
Confidence            9999999999999999999999999999986

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=1.8e-58  Score=471.80  Aligned_cols=389  Identities=35%  Similarity=0.612  Sum_probs=290.7

Q ss_pred             cccccCCeeecceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEE
Q 014609            4 AEKKQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVL   83 (421)
Q Consensus         4 ~~~~~~~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~   83 (421)
                      .....+...+++|++++.||+|+||+||+|++..+|+.||||++.+...........+.+|+.+++.++||||+++++++
T Consensus         6 ~~~~~~~~~~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~   85 (476)
T 2y94_A            6 KQKHDGRVKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVI   85 (476)
T ss_dssp             ---CCSCCEETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred             hhccCCCceecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEE
Confidence            34455667889999999999999999999999999999999999865443334467899999999999999999999999


Q ss_pred             EeCCEEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCC
Q 014609           84 ASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSAL  163 (421)
Q Consensus        84 ~~~~~~~lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~  163 (421)
                      .+.+.+|+||||++|++|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++++||+|||++..
T Consensus        86 ~~~~~~~lv~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll~~~~~vkL~DFG~a~~  165 (476)
T 2y94_A           86 STPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNM  165 (476)
T ss_dssp             ECSSEEEEEEECCSSEEHHHHTTSSSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEECTTCCEEECCCSSCEE
T ss_pred             EECCEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEEecCCCeEEEeccchhh
Confidence            99999999999999999999998888899999999999999999999999999999999999999999999999999985


Q ss_pred             CccccCCCccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhh-c-------------------CCcCCCCCCCHH
Q 014609          164 PQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIF-R-------------------GDFKLPKWLSPG  223 (421)
Q Consensus       164 ~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~-~-------------------~~~~~p~~~s~~  223 (421)
                      ...   .....+.+||+.|+|||++.+..+.+.++|||||||++|.+ .                   +.+..|..++++
T Consensus       166 ~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~  242 (476)
T 2y94_A          166 MSD---GEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIFYTPQYLNPS  242 (476)
T ss_dssp             CCT---TCCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHHTTCCCCCTTCCHH
T ss_pred             ccc---cccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCcCCCccCCHH
Confidence            432   33456779999999999999887777899999999999943 2                   234456678999


Q ss_pred             HHHHHHHhcCCCCCCCCCHHhhhcCccccccccCCCC----CCCcc--c-c----ccCcccccccC--------CCCC--
Q 014609          224 AQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPANP----DDDEE--D-I----FVDNEAFSMHE--------VPSD--  282 (421)
Q Consensus       224 ~~~li~~~L~~dP~~R~t~~eil~~~w~~~~~~~~~~----~~~~~--~-~----~~~~~~~~~~~--------~~~~--  282 (421)
                      +.+||++||+.||.+|||+.++++||||.+.......    .....  + .    ..........+        .+.+  
T Consensus       243 ~~~Li~~~L~~dP~~Rpt~~eil~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~  322 (476)
T 2y94_A          243 VISLLKHMLQVDPMKRATIKDIREHEWFKQDLPKYLFPEDPSYSSTMIDDEALKEVCEKFECSEEEVLSCLYNRNHQDPL  322 (476)
T ss_dssp             HHHHHHHHTCSSTTTSCCHHHHHTCHHHHTTCCTTTTTSSSCSSCSHHHHHHHHSCCCC---------------------
T ss_pred             HHHHHHHHcCCCchhCcCHHHHHhCHHhhhcCccccCCCCcccccccCCHHHHHHHHHHcCCCHHHHHHHHhCCCCCCHH
Confidence            9999999999999999999999999999875432111    00000  0 0    00000000000        0000  


Q ss_pred             ---------CCCC------------------------CCCCCccchhhhhccccccccCCCc--c----ccccccceeeE
Q 014609          283 ---------GGRT------------------------PGSPPLINAFQLIGMSSCLDLSGFF--E----KEDVSERKIRF  323 (421)
Q Consensus       283 ---------~~~~------------------------~~~~~~~~~~~~~~~~~~~~~~~~~--~----~~~~~~~~~~f  323 (421)
                               ..+.                        ...|.........+.+....+....  .    .....++.+++
T Consensus       323 ~~~y~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~lgi  402 (476)
T 2y94_A          323 AVAYHLIIDNRRIMNEAKDFYLATSPPDSFLDDHHLTRPHPERVPFLVAETPRARHTLDELNPQKSKHQGVRKAKWHLGI  402 (476)
T ss_dssp             ----------CCTTCCSSHHHHHHHHHHSCGGGTSCCCCSSCTTTTCSCCCCCCSTTCTTTSSSTTTCSCCCCCCEEESE
T ss_pred             HHHHHHHHhchhhhhhhhccccccCCccccccccccccCCcccCCcccccCCcccccccccccccccccccccceeeecC
Confidence                     0000                        0000000000000000000000000  0    01234678899


Q ss_pred             EecCCHHHHHHHHHHHHHhcCcEEEE-eCCeeEEEeecCCCCccCceEEEEEEEEecCceEEEEEEccCCChhhH
Q 014609          324 TSNHSAKDLLERIEDIVTEMGFRVQK-KNGKLKATQEHKPQKSLGSLSVAAEVFEISPSLYVVELRKSYGDPTVY  397 (421)
Q Consensus       324 ~s~~~~~~i~~~l~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~l~~~~~i~~~~~~~~~v~~~k~~Gd~le~  397 (421)
                      .|+..|.+|+.+|..+++.+|+.|++ +.+.|+++...+...  ..+.|.+++|++.++.+||||++..|+.++|
T Consensus       403 ~s~~~p~~im~ev~~al~~lg~~Wk~~~~~~i~~r~~~~~~~--~~~k~~lqly~~~~~~~llDf~~~~~~~~~~  475 (476)
T 2y94_A          403 RSQSRPNDIMAEVCRAIKQLDYEWKVVNPYYLRVRRKNPVTS--TFSKMSLQLYQVDSRTYLLDFRSIDDEILEV  475 (476)
T ss_dssp             EECSCHHHHHHHHHHHHHTTTCBCCEEETTEEEEEEECTTTC--CEEEEEEEEEECSSSCEEEEEEEECCC----
T ss_pred             ccCCCHHHHHHHHHHHHHHcCCeeccCCCEEEEEEECCCCCC--ceEEEEEEEEEecCCcEEEEeeecCCCcccc
Confidence            99999999999999999999999987 568899987543333  6788999999999999999999999999987

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=1.5e-58  Score=449.95  Aligned_cols=235  Identities=25%  Similarity=0.374  Sum_probs=204.1

Q ss_pred             eecceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEE
Q 014609           12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYM   91 (421)
Q Consensus        12 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l   91 (421)
                      .++.|++.++||+|+||+||+|+++.+|+.||||+++++..        ..+|+.+|++++|||||++++++.+++.+||
T Consensus        56 ~~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~--------~~~E~~il~~l~HpnIV~l~~~~~~~~~~~i  127 (336)
T 4g3f_A           56 EVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF--------RVEELVACAGLSSPRIVPLYGAVREGPWVNI  127 (336)
T ss_dssp             TTTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC--------CTHHHHTTTTCCCTTBCCEEEEEEETTEEEE
T ss_pred             chhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh--------HHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence            35679999999999999999999999999999999986532        2469999999999999999999999999999


Q ss_pred             EEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCC-CEEEEeccCCCCCccccCC
Q 014609           92 VLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKG-NIKISDFGLSALPQHFRDD  170 (421)
Q Consensus        92 v~E~~~gg~L~~~i~~~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~-~~kL~DFGla~~~~~~~~~  170 (421)
                      |||||+||+|++++...+++++..++.|+.||+.||+|||++||+||||||+||||+.+| .+||+|||+|+........
T Consensus       128 vmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~  207 (336)
T 4g3f_A          128 FMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLG  207 (336)
T ss_dssp             EECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC------
T ss_pred             EEeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCcc
Confidence            999999999999999889999999999999999999999999999999999999999988 5999999999865432111


Q ss_pred             ---CccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhh-cCCcC----------------------CCCCCCHHH
Q 014609          171 ---GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIF-RGDFK----------------------LPKWLSPGA  224 (421)
Q Consensus       171 ---~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~-~~~~~----------------------~p~~~s~~~  224 (421)
                         ......||||.|||||++.+.+|+ .++|||||||++|++ .|..|                      +|+.+|+.+
T Consensus       208 ~~~~~~~~~~GT~~YmAPE~~~~~~y~-~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~  286 (336)
T 4g3f_A          208 KSLLTGDYIPGTETHMAPEVVMGKPCD-AKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPIREIPPSCAPLT  286 (336)
T ss_dssp             ------CCCCCCGGGCCHHHHTTCCCC-THHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHSCCGGGGSCTTSCHHH
T ss_pred             cceecCCccccCccccCHHHHCCCCCC-cHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcCCCCchhcCccCCHHH
Confidence               122346899999999999998884 899999999999944 33332                      356689999


Q ss_pred             HHHHHHhcCCCCCCCCCHHhh-------------hcCccccccc
Q 014609          225 QNLLRKILEPNPVKRITIAGI-------------KADEWFEQDY  255 (421)
Q Consensus       225 ~~li~~~L~~dP~~R~t~~ei-------------l~~~w~~~~~  255 (421)
                      .++|.+||++||.+|||+.|+             ++|||+.+..
T Consensus       287 ~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~~l~hPw~~~~~  330 (336)
T 4g3f_A          287 AQAIQEGLRKEPVHRASAMELRRKVGKALQEVGGLKSPWKGEYK  330 (336)
T ss_dssp             HHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTTSSCSCSSSSCC
T ss_pred             HHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhhhccCCCcCCCC
Confidence            999999999999999999997             5789987543

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=4.7e-58  Score=441.60  Aligned_cols=240  Identities=26%  Similarity=0.443  Sum_probs=195.0

Q ss_pred             eecceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCC----
Q 014609           12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKS----   87 (421)
Q Consensus        12 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~----   87 (421)
                      .+++|++++.||+|+||+||+|+++.+|+.||||+++...  .....+.+.+|+.+|++|+|||||++++++.+.+    
T Consensus         3 ~l~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~--~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~   80 (299)
T 4g31_A            3 YLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPN--RELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEK   80 (299)
T ss_dssp             HHHHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECS--SHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC----
T ss_pred             cchhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccc
Confidence            4578999999999999999999999999999999997653  2334578999999999999999999999987544    


Q ss_pred             --------EEEEEEeccCCCChHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEE
Q 014609           88 --------KIYMVLEYVTGGELFDKIASKGR---LQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKIS  156 (421)
Q Consensus        88 --------~~~lv~E~~~gg~L~~~i~~~~~---~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~  156 (421)
                              .+|+|||||+||+|.+++.....   .++..++.++.||++||+|||++||+||||||+|||++.+|.+||+
T Consensus        81 ~~~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~~~~~vKl~  160 (299)
T 4g31_A           81 LQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVG  160 (299)
T ss_dssp             ------CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEEC
T ss_pred             ccccCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEECCCCcEEEc
Confidence                    37999999999999999987654   4556789999999999999999999999999999999999999999


Q ss_pred             eccCCCCCccccCC----------CccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhhcCCc------------
Q 014609          157 DFGLSALPQHFRDD----------GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIFRGDF------------  214 (421)
Q Consensus       157 DFGla~~~~~~~~~----------~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~~~~~------------  214 (421)
                      |||+|+........          ....+.||||.|||||++.+.+| +.++|||||||++|++...+            
T Consensus       161 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y-~~~~DiwSlGvilyell~Pf~~~~~~~~~~~~  239 (299)
T 4g31_A          161 DFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSY-SHKVDIFSLGLILFELLYPFSTQMERVRTLTD  239 (299)
T ss_dssp             CCCCC--------------------------CCCTTSCHHHHTTCCC-CTHHHHHHHHHHHHHHHSCCSSHHHHHHHHHH
T ss_pred             cCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCC-CCHHHHHHHHHHHHHHccCCCCccHHHHHHHH
Confidence            99999865432111          12345689999999999998888 58999999999999765321            


Q ss_pred             ----CCCC---CCCHHHHHHHHHhcCCCCCCCCCHHhhhcCcccccc
Q 014609          215 ----KLPK---WLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD  254 (421)
Q Consensus       215 ----~~p~---~~s~~~~~li~~~L~~dP~~R~t~~eil~~~w~~~~  254 (421)
                          .+|+   ..++.+.+||.+||++||.+|||+.|+++||||+..
T Consensus       240 ~~~~~~p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h~~~~~~  286 (299)
T 4g31_A          240 VRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDL  286 (299)
T ss_dssp             HHTTCCCHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGCCC
T ss_pred             HhcCCCCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCCC
Confidence                1121   135677899999999999999999999999999853

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=2.8e-57  Score=452.33  Aligned_cols=240  Identities=26%  Similarity=0.396  Sum_probs=207.9

Q ss_pred             cceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEe------CC
Q 014609           14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLAS------KS   87 (421)
Q Consensus        14 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~------~~   87 (421)
                      ++|++++.||+|+||+||+|++..+|+.||||++++... .......+.+|+++|+.|+|||||++++++..      .+
T Consensus        54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~  132 (398)
T 4b99_A           54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFD-VVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFK  132 (398)
T ss_dssp             SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTS-SHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCC
T ss_pred             CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECcccc-chHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCC
Confidence            479999999999999999999999999999999976433 33345778899999999999999999999864      36


Q ss_pred             EEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCccc
Q 014609           88 KIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHF  167 (421)
Q Consensus        88 ~~~lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~  167 (421)
                      .+|+|||||. |+|++.+...+++++..++.|++||+.||+|||++||+||||||+|||++.+|.+||+|||+|+.....
T Consensus       133 ~~~ivmE~~~-g~L~~~i~~~~~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~~~~  211 (398)
T 4b99_A          133 SVYVVLDLME-SDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTS  211 (398)
T ss_dssp             CEEEEEECCS-EEHHHHHTSSSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCC---
T ss_pred             EEEEEEeCCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccCCCCCEEEeecceeeecccC
Confidence            7999999995 689999998899999999999999999999999999999999999999999999999999999865332


Q ss_pred             --cCCCccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhh-cCCcCCC---------------------------
Q 014609          168 --RDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIF-RGDFKLP---------------------------  217 (421)
Q Consensus       168 --~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~-~~~~~~p---------------------------  217 (421)
                        .......+.|||+.|+|||++.+..+.+.++||||+||++|++ .|..+++                           
T Consensus       212 ~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~~~~~~  291 (398)
T 4b99_A          212 PAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQAVG  291 (398)
T ss_dssp             ----CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGGTC---
T ss_pred             ccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhhh
Confidence              1233456789999999999998877767999999999999954 3444332                           


Q ss_pred             -----------------------CCCCHHHHHHHHHhcCCCCCCCCCHHhhhcCccccccc
Q 014609          218 -----------------------KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY  255 (421)
Q Consensus       218 -----------------------~~~s~~~~~li~~~L~~dP~~R~t~~eil~~~w~~~~~  255 (421)
                                             +.+|+++.+||.+||+.||.+|||+.|+++||||++..
T Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~  352 (398)
T 4b99_A          292 AERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFLAKYH  352 (398)
T ss_dssp             --CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGTTTC
T ss_pred             hhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHhhCcCC
Confidence                                   13588999999999999999999999999999998643

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=2.3e-56  Score=465.91  Aligned_cols=240  Identities=29%  Similarity=0.494  Sum_probs=210.8

Q ss_pred             CCeeecceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHH---HHHHHHhcCCCCCcceEEEEEEe
Q 014609            9 EGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIK---REIATLKLLKHPNVVRLHEVLAS   85 (421)
Q Consensus         9 ~~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~---~Ei~il~~l~hpnIv~l~~~~~~   85 (421)
                      ....+++|++++.||+|+||+||+|++..+|+.||||++++...........+.   +++.+++.++|||||++++++++
T Consensus       184 ~~~slddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~  263 (689)
T 3v5w_A          184 IHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHT  263 (689)
T ss_dssp             CCCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEEC
T ss_pred             CCCchHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEE
Confidence            456789999999999999999999999999999999999876543322233333   44667778899999999999999


Q ss_pred             CCEEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCc
Q 014609           86 KSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQ  165 (421)
Q Consensus        86 ~~~~~lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~  165 (421)
                      ++.+|+|||||+||+|++++...+.+++..++.|+.||+.||+|||++||+||||||+||||+.+|++||+|||+|....
T Consensus       264 ~~~lylVmEy~~GGdL~~~l~~~~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILld~~G~vKL~DFGlA~~~~  343 (689)
T 3v5w_A          264 PDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFS  343 (689)
T ss_dssp             SSEEEEEECCCCSCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred             CCEEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEEeCCCCEEecccceeeecC
Confidence            99999999999999999999998999999999999999999999999999999999999999999999999999998543


Q ss_pred             cccCCCccccccCCCCccChhhhcc-cCCCCCcchHHHHHHHHhhh-cC----------------------CcCCCCCCC
Q 014609          166 HFRDDGLLHTTCGSPNYVAPEVLAN-RGYDGATSDIWSCGVILYIF-RG----------------------DFKLPKWLS  221 (421)
Q Consensus       166 ~~~~~~~~~~~~gt~~y~APEvl~~-~~~~~~~~DiwSlGvil~~~-~~----------------------~~~~p~~~s  221 (421)
                          .....+.||||.|+|||++.+ .+| +.++|||||||++|++ .|                      ...+|..+|
T Consensus       344 ----~~~~~t~~GTp~YmAPEvl~~~~~y-~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~~~~~~p~~~S  418 (689)
T 3v5w_A          344 ----KKKPHASVGTHGYMAPEVLQKGVAY-DSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFS  418 (689)
T ss_dssp             ----SCCCCSCCSCGGGCCHHHHSTTCCC-CTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHHCCCCCCTTSC
T ss_pred             ----CCCCCCccCCcCccCHHHHhCCCCC-CcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCCCCCccCC
Confidence                234567899999999999975 456 6899999999999943 23                      334567799


Q ss_pred             HHHHHHHHHhcCCCCCCCCC-----HHhhhcCccccc
Q 014609          222 PGAQNLLRKILEPNPVKRIT-----IAGIKADEWFEQ  253 (421)
Q Consensus       222 ~~~~~li~~~L~~dP~~R~t-----~~eil~~~w~~~  253 (421)
                      +++++||.+||++||.+|++     ++||++||||+.
T Consensus       419 ~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~HpfF~~  455 (689)
T 3v5w_A          419 PELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRS  455 (689)
T ss_dssp             HHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTSGGGTT
T ss_pred             HHHHHHHHHHccCCHhHCCCCCCCCHHHHhcCccccC
Confidence            99999999999999999998     799999999985

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=8.9e-56  Score=436.63  Aligned_cols=232  Identities=25%  Similarity=0.423  Sum_probs=197.9

Q ss_pred             cceEEeceEeecCcEEEEEEEEC---CCCceEEEEEeecccccchhHHHHHHHHHHHHhcC-CCCCcceEEEEEEeCCEE
Q 014609           14 GRYELGRTLGEGNFGKVKFAQDL---DSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEVLASKSKI   89 (421)
Q Consensus        14 ~~y~i~~~LG~G~~g~V~~a~~~---~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~   89 (421)
                      ++|++++.||+|+||+||+|++.   .+++.||||.+.+..     ...++.+|+++|+.+ +||||+++++++.+++.+
T Consensus        21 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~-----~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~   95 (361)
T 4f9c_A           21 NVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS-----HPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHV   95 (361)
T ss_dssp             GTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS-----CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEE
T ss_pred             CcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc-----CHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEE
Confidence            68999999999999999999874   468899999986542     245688999999998 699999999999999999


Q ss_pred             EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccC-CCEEEEeccCCCCCcccc
Q 014609           90 YMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSK-GNIKISDFGLSALPQHFR  168 (421)
Q Consensus        90 ~lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~-~~~kL~DFGla~~~~~~~  168 (421)
                      |+||||++||+|.+.+.   .+++.+++.|++||+.||+|||++||+||||||+|||++.+ +.+||+|||+|+......
T Consensus        96 ~lvmE~~~g~~L~~~~~---~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~~~  172 (361)
T 4f9c_A           96 VIAMPYLEHESFLDILN---SLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDTK  172 (361)
T ss_dssp             EEEEECCCCCCHHHHHT---TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECTTCS
T ss_pred             EEEEeCCCcccHHHHHc---CCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeCCCCeEEECcCCCCcccCCcc
Confidence            99999999999999884   59999999999999999999999999999999999999877 799999999997432210


Q ss_pred             --------------------------CCCccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhh-cCCcCCC----
Q 014609          169 --------------------------DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIF-RGDFKLP----  217 (421)
Q Consensus       169 --------------------------~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~-~~~~~~p----  217 (421)
                                                ......+.|||+.|+|||++.+.++++.++||||+||++|++ .|..|+.    
T Consensus       173 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~~~~  252 (361)
T 4f9c_A          173 IELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYKASD  252 (361)
T ss_dssp             CGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSCCSS
T ss_pred             ccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCCCCC
Confidence                                      112244568999999999998876557999999999999954 4554441    


Q ss_pred             ----------------------------------------------------------------------CCCCHHHHHH
Q 014609          218 ----------------------------------------------------------------------KWLSPGAQNL  227 (421)
Q Consensus       218 ----------------------------------------------------------------------~~~s~~~~~l  227 (421)
                                                                                            ..+|+++.+|
T Consensus       253 ~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is~~a~DL  332 (361)
T 4f9c_A          253 DLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVPDEAYDL  332 (361)
T ss_dssp             HHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTCCHHHHHH
T ss_pred             HHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccCCHHHHHH
Confidence                                                                                  1267899999


Q ss_pred             HHHhcCCCCCCCCCHHhhhcCccccc
Q 014609          228 LRKILEPNPVKRITIAGIKADEWFEQ  253 (421)
Q Consensus       228 i~~~L~~dP~~R~t~~eil~~~w~~~  253 (421)
                      |++||+.||.+|+|++|+++||||+.
T Consensus       333 l~~lL~~dP~~R~ta~eaL~Hp~f~~  358 (361)
T 4f9c_A          333 LDKLLDLNPASRITAEEALLHPFFKD  358 (361)
T ss_dssp             HHHHTCSCTTTSCCHHHHHTSGGGTT
T ss_pred             HHHHCcCChhHCcCHHHHhcCcccCC
Confidence            99999999999999999999999985

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=2.2e-55  Score=422.61  Aligned_cols=237  Identities=27%  Similarity=0.391  Sum_probs=201.8

Q ss_pred             eeecceEEeceEeecCcEEEEEEEEC-----CCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEe
Q 014609           11 MRLGRYELGRTLGEGNFGKVKFAQDL-----DSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLAS   85 (421)
Q Consensus        11 ~~~~~y~i~~~LG~G~~g~V~~a~~~-----~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~   85 (421)
                      ...++|.+.+.||+|+||+||+|++.     .+++.||||+++..   .....+.+.+|+++|++++|||||++++++.+
T Consensus        10 I~r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~---~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~   86 (299)
T 4asz_A           10 IKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA---SDNARKDFHREAELLTNLQHEHIVKFYGVCVE   86 (299)
T ss_dssp             CCGGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSC---CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS
T ss_pred             cCHHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCC---ChHHHHHHHHHHHHHHhCCCCCCccEEEEEee
Confidence            34468999999999999999999874     36889999999754   23346789999999999999999999999999


Q ss_pred             CCEEEEEEeccCCCChHHHHHhc-------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCC
Q 014609           86 KSKIYMVLEYVTGGELFDKIASK-------------GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGN  152 (421)
Q Consensus        86 ~~~~~lv~E~~~gg~L~~~i~~~-------------~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~  152 (421)
                      ++.+|+|||||+||+|.+++...             ..+++..+..++.|+++||+|||+++|+||||||+||||+.++.
T Consensus        87 ~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl~~~~~  166 (299)
T 4asz_A           87 GDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLL  166 (299)
T ss_dssp             SSSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGC
T ss_pred             CCEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEECCCCc
Confidence            99999999999999999999753             36999999999999999999999999999999999999999999


Q ss_pred             EEEEeccCCCCCccccCCCccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhhc--CCcC---------------
Q 014609          153 IKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIFR--GDFK---------------  215 (421)
Q Consensus       153 ~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~~--~~~~---------------  215 (421)
                      +||+|||+|+..............+||+.|+|||++.+..| +.++|||||||+||++.  |..|               
T Consensus       167 ~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~-~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~  245 (299)
T 4asz_A          167 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKF-TTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQ  245 (299)
T ss_dssp             EEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHH
T ss_pred             EEECCcccceecCCCCceeecCceecChhhcCHHHHcCCCC-CchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHc
Confidence            99999999975433222223334579999999999998888 59999999999999553  4433               


Q ss_pred             -----CCCCCCHHHHHHHHHhcCCCCCCCCCHHhhhcCccccc
Q 014609          216 -----LPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQ  253 (421)
Q Consensus       216 -----~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~~~w~~~  253 (421)
                           .|+.+|+++.+||.+||+.||++|||+.+|  ++|+++
T Consensus       246 ~~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i--~~~L~~  286 (299)
T 4asz_A          246 GRVLQRPRTCPQEVYELMLGCWQREPHMRKNIKGI--HTLLQN  286 (299)
T ss_dssp             TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH--HHHHHH
T ss_pred             CCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHH--HHHHHH
Confidence                 456689999999999999999999999999  568765

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=9.5e-54  Score=446.20  Aligned_cols=241  Identities=31%  Similarity=0.594  Sum_probs=213.1

Q ss_pred             eeecceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEE
Q 014609           11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIY   90 (421)
Q Consensus        11 ~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~   90 (421)
                      ..+++|++++.||+|+||+||+|+++.+|+.||+|++.+..   ....+.+.+|+.+|+.|+|||||++++++++++.+|
T Consensus       154 ~il~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~---~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~  230 (573)
T 3uto_A          154 HVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH---ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMV  230 (573)
T ss_dssp             CGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS---HHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEE
T ss_pred             cCccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccc---hhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEE
Confidence            45689999999999999999999999999999999997653   233577899999999999999999999999999999


Q ss_pred             EEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccC--CCEEEEeccCCCCCccc
Q 014609           91 MVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSK--GNIKISDFGLSALPQHF  167 (421)
Q Consensus        91 lv~E~~~gg~L~~~i~~-~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~--~~~kL~DFGla~~~~~~  167 (421)
                      +|||||+||+|++++.. .+.+++..++.|++||+.||+|||++||+||||||+|||++.+  +.+||+|||+|+...  
T Consensus       231 iv~E~~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~--  308 (573)
T 3uto_A          231 MIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLD--  308 (573)
T ss_dssp             EEEECCCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCSSCEECC--
T ss_pred             EEEeecCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccCCCCCCEEEeeccceeEcc--
Confidence            99999999999999964 4679999999999999999999999999999999999999854  899999999998543  


Q ss_pred             cCCCccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhh-cCCcCC-------------------C----CCCCHH
Q 014609          168 RDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIF-RGDFKL-------------------P----KWLSPG  223 (421)
Q Consensus       168 ~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~-~~~~~~-------------------p----~~~s~~  223 (421)
                       ......+.|||+.|+|||++.+.+| +.++|||||||++|++ .|..|+                   |    ..+|++
T Consensus       309 -~~~~~~~~~GT~~y~APEv~~~~~y-~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~  386 (573)
T 3uto_A          309 -PKQSVKVTTGTAEFAAPEVAEGKPV-GYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISED  386 (573)
T ss_dssp             -TTSEEEEECSSGGGCCHHHHTTCCB-CHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCSGGGTTSCHH
T ss_pred             -CCCceeeeEECccccCHHHhCCCCC-CcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCCCCCCcccccCCCHH
Confidence             2345667899999999999999888 5899999999999944 333222                   2    347999


Q ss_pred             HHHHHHHhcCCCCCCCCCHHhhhcCccccccccCC
Q 014609          224 AQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPA  258 (421)
Q Consensus       224 ~~~li~~~L~~dP~~R~t~~eil~~~w~~~~~~~~  258 (421)
                      +++||++||++||.+|||+.|+++||||+....+.
T Consensus       387 ~~dli~~~L~~dp~~R~t~~e~l~Hpw~~~~~~~~  421 (573)
T 3uto_A          387 GKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPG  421 (573)
T ss_dssp             HHHHHHTTSCSSGGGSCCHHHHHHSTTTSCCCCTT
T ss_pred             HHHHHHHHccCChhHCcCHHHHhcCcCcCCCCCCC
Confidence            99999999999999999999999999999765543

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=1.1e-53  Score=416.09  Aligned_cols=233  Identities=28%  Similarity=0.399  Sum_probs=193.8

Q ss_pred             eecceEEeceEeecCcEEEEEEEEC-----CCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeC
Q 014609           12 RLGRYELGRTLGEGNFGKVKFAQDL-----DSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASK   86 (421)
Q Consensus        12 ~~~~y~i~~~LG~G~~g~V~~a~~~-----~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~   86 (421)
                      ...+|.+.+.||+|+||+||+|++.     .+++.||||+++..   .....+.+.+|+++|++++|||||++++++.+.
T Consensus        39 ~~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~---~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~  115 (329)
T 4aoj_A           39 KRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA---SESARQDFQREAELLTMLQHQHIVRFFGVCTEG  115 (329)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCC---SHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS
T ss_pred             CHHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcC---CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEEC
Confidence            3467999999999999999999864     36889999999753   334467899999999999999999999999999


Q ss_pred             CEEEEEEeccCCCChHHHHHhc---------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCC
Q 014609           87 SKIYMVLEYVTGGELFDKIASK---------------GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKG  151 (421)
Q Consensus        87 ~~~~lv~E~~~gg~L~~~i~~~---------------~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~  151 (421)
                      +.+|+|||||++|+|.+++...               +++++.++..++.|++.||+|||+++|+||||||+||||+.++
T Consensus       116 ~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NILl~~~~  195 (329)
T 4aoj_A          116 RPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGL  195 (329)
T ss_dssp             SSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTT
T ss_pred             CEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhEEECCCC
Confidence            9999999999999999998653               3589999999999999999999999999999999999999999


Q ss_pred             CEEEEeccCCCCCccccCCCccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhh-c-CCcC--------------
Q 014609          152 NIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIF-R-GDFK--------------  215 (421)
Q Consensus       152 ~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~-~-~~~~--------------  215 (421)
                      .+||+|||+|+..............+||+.|||||++.+..| +.++|||||||+||++ . |..|              
T Consensus       196 ~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~-~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~  274 (329)
T 4aoj_A          196 VVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKF-TTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCIT  274 (329)
T ss_dssp             EEEECCCC----------------CCCCGGGCCHHHHTTCCC-CHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHHHHHH
T ss_pred             cEEEcccccceeccCCCcceecCcccccccccChhhhcCCCC-CccccccchHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence            999999999986543323334456789999999999998888 5999999999999954 3 4433              


Q ss_pred             ------CCCCCCHHHHHHHHHhcCCCCCCCCCHHhhhcC
Q 014609          216 ------LPKWLSPGAQNLLRKILEPNPVKRITIAGIKAD  248 (421)
Q Consensus       216 ------~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~~  248 (421)
                            .|..+|+++.+||.+||+.||++|||+.||+++
T Consensus       275 ~g~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~  313 (329)
T 4aoj_A          275 QGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHAR  313 (329)
T ss_dssp             HTCCCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHH
T ss_pred             cCCCCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence                  456689999999999999999999999999764

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=4.9e-54  Score=413.93  Aligned_cols=233  Identities=24%  Similarity=0.385  Sum_probs=191.1

Q ss_pred             ecceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEE
Q 014609           13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMV   92 (421)
Q Consensus        13 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv   92 (421)
                      .+++++++.||+|+||+||+|++.   ..||||+++.... .....+.+.+|+.+|++++|||||++++++.. +.+|+|
T Consensus        35 ~~~l~l~~~iG~G~fG~Vy~~~~~---~~vAvK~~~~~~~-~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iV  109 (307)
T 3omv_A           35 ASEVMLSTRIGSGSFGTVYKGKWH---GDVAVKILKVVDP-TPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIV  109 (307)
T ss_dssp             TTSCCEEEECCCCSSSEEEEEESS---SEEEEEECCCSSC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEE
T ss_pred             HHHeEEeeEEeeCCCcEEEEEEEC---CcEEEEEEEecCC-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEE
Confidence            467889999999999999999853   3599999875432 33446789999999999999999999998864 568999


Q ss_pred             EeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCccccCCC
Q 014609           93 LEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDG  171 (421)
Q Consensus        93 ~E~~~gg~L~~~i~~-~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~  171 (421)
                      ||||+||+|.+++.. ..++++..+..++.|++.||+|||+++|+||||||+||||+.++.+||+|||+|+.........
T Consensus       110 mEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~  189 (307)
T 3omv_A          110 TQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQ  189 (307)
T ss_dssp             EECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEETTEEEEECCCSSCBC--------
T ss_pred             EEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEECCCCcEEEeeccCceecccCCcce
Confidence            999999999999975 4579999999999999999999999999999999999999999999999999998765433344


Q ss_pred             ccccccCCCCccChhhhccc---CCCCCcchHHHHHHHHhhh-cCCcCC-------------------------CCCCCH
Q 014609          172 LLHTTCGSPNYVAPEVLANR---GYDGATSDIWSCGVILYIF-RGDFKL-------------------------PKWLSP  222 (421)
Q Consensus       172 ~~~~~~gt~~y~APEvl~~~---~~~~~~~DiwSlGvil~~~-~~~~~~-------------------------p~~~s~  222 (421)
                      .....+||+.|||||++.+.   +| +.++|||||||+||++ .|..|+                         |+.+|+
T Consensus       190 ~~~~~~GT~~ymAPE~l~~~~~~~y-~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~  268 (307)
T 3omv_A          190 QVEQPTGSVLWMAPEVIRMQDNNPF-SFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPK  268 (307)
T ss_dssp             ----CCCCTTSCCHHHHHCCSSCCC-CHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTTCCCCCSTTSCTTSCH
T ss_pred             eecccccCCCccCHHHhhccCCCCC-CcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCCcccccccchH
Confidence            55677999999999998643   35 5899999999999943 333222                         345789


Q ss_pred             HHHHHHHHhcCCCCCCCCCHHhhhcCccc
Q 014609          223 GAQNLLRKILEPNPVKRITIAGIKADEWF  251 (421)
Q Consensus       223 ~~~~li~~~L~~dP~~R~t~~eil~~~w~  251 (421)
                      .+.+||.+||+.||++|||+.|++++-+.
T Consensus       269 ~l~~li~~cl~~dP~~RPs~~ei~~~Le~  297 (307)
T 3omv_A          269 AMKRLVADCVKKVKEERPLFPQILSSIEL  297 (307)
T ss_dssp             HHHHHHHHHTCSSSTTSCCHHHHHHHHHH
T ss_pred             HHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence            99999999999999999999998766543

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=9e-54  Score=413.12  Aligned_cols=235  Identities=26%  Similarity=0.378  Sum_probs=202.8

Q ss_pred             eeecceEEeceEeecCcEEEEEEEEC-----CCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEe
Q 014609           11 MRLGRYELGRTLGEGNFGKVKFAQDL-----DSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLAS   85 (421)
Q Consensus        11 ~~~~~y~i~~~LG~G~~g~V~~a~~~-----~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~   85 (421)
                      ..++.+++++.||+|+||+||+|...     .+++.||||+++...  .....+.+.+|+.+|++++|||||++++++.+
T Consensus        23 i~~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~--~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~  100 (308)
T 4gt4_A           23 ISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKA--EGPLREEFRHEAMLRARLQHPNVVCLLGVVTK  100 (308)
T ss_dssp             CCGGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-C--CC-CHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             CCHHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECccc--ChHHHHHHHHHHHHHHhCCCCCCCCcceEEEE
Confidence            55678999999999999999999853     467899999997543  22335789999999999999999999999999


Q ss_pred             CCEEEEEEeccCCCChHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecc
Q 014609           86 KSKIYMVLEYVTGGELFDKIASK----------------GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDS  149 (421)
Q Consensus        86 ~~~~~lv~E~~~gg~L~~~i~~~----------------~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~  149 (421)
                      ++.+|+|||||++|+|.+++...                ..+++..+..++.|++.||+|||+++|+||||||+||||++
T Consensus       101 ~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~NILl~~  180 (308)
T 4gt4_A          101 DQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYD  180 (308)
T ss_dssp             SSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECG
T ss_pred             CCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccceEECC
Confidence            99999999999999999999642                35899999999999999999999999999999999999999


Q ss_pred             CCCEEEEeccCCCCCccccCCCccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhhc--CCc-------------
Q 014609          150 KGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIFR--GDF-------------  214 (421)
Q Consensus       150 ~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~~--~~~-------------  214 (421)
                      ++.+||+|||+|+..............+||+.|+|||++.+..| +.++|||||||+||++.  |..             
T Consensus       181 ~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~-s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~~~~  259 (308)
T 4gt4_A          181 KLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKF-SIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEM  259 (308)
T ss_dssp             GGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTTCCTTTTCCHHHHHHH
T ss_pred             CCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCC-CccchhhhHHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence            99999999999986544333344556789999999999998888 59999999999999543  333             


Q ss_pred             -------CCCCCCCHHHHHHHHHhcCCCCCCCCCHHhhhcC
Q 014609          215 -------KLPKWLSPGAQNLLRKILEPNPVKRITIAGIKAD  248 (421)
Q Consensus       215 -------~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~~  248 (421)
                             +.|+.+|+.+.+|+.+||+.||.+|||+.||+++
T Consensus       260 i~~~~~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~  300 (308)
T 4gt4_A          260 IRNRQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSR  300 (308)
T ss_dssp             HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHcCCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence                   3456689999999999999999999999999765

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=2e-52  Score=408.02  Aligned_cols=244  Identities=42%  Similarity=0.824  Sum_probs=218.7

Q ss_pred             cCCeeecceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCC
Q 014609            8 QEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKS   87 (421)
Q Consensus         8 ~~~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~   87 (421)
                      .....+++|++++.||+|+||+||+|.+..+|+.||||++.+... .....+.+.+|+.+|+.++||||+++++++.+.+
T Consensus         9 ~~~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~   87 (328)
T 3fe3_A            9 DEQPHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQL-NPTSLQKLFREVRIMKILNHPNIVKLFEVIETEK   87 (328)
T ss_dssp             --CCEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred             ccCCccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcC-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECC
Confidence            345678999999999999999999999999999999999987543 3334677899999999999999999999999999


Q ss_pred             EEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCccc
Q 014609           88 KIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHF  167 (421)
Q Consensus        88 ~~~lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~  167 (421)
                      ..|+||||++|++|.+++...+++++..++.++.|++.||+|||++||+||||||+|||++.++++||+|||++..... 
T Consensus        88 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~-  166 (328)
T 3fe3_A           88 TLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTV-  166 (328)
T ss_dssp             EEEEEECCCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTCCGGGSS-
T ss_pred             EEEEEEECCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEcCCCCEEEeeccCceecCC-
Confidence            9999999999999999999888999999999999999999999999999999999999999999999999999975432 


Q ss_pred             cCCCccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhh-c-------------------CCcCCCCCCCHHHHHH
Q 014609          168 RDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIF-R-------------------GDFKLPKWLSPGAQNL  227 (421)
Q Consensus       168 ~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~-~-------------------~~~~~p~~~s~~~~~l  227 (421)
                        .......+||+.|+|||++.+..+.+.++||||+||++|.+ .                   +.+..|..+++++.+|
T Consensus       167 --~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~l  244 (328)
T 3fe3_A          167 --GGKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMSTDCENL  244 (328)
T ss_dssp             --SCGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHH
T ss_pred             --CCccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence              34456779999999999999888877899999999999943 2                   3345567789999999


Q ss_pred             HHHhcCCCCCCCCCHHhhhcCccccccc
Q 014609          228 LRKILEPNPVKRITIAGIKADEWFEQDY  255 (421)
Q Consensus       228 i~~~L~~dP~~R~t~~eil~~~w~~~~~  255 (421)
                      |++||+.||.+|||++|+++||||+...
T Consensus       245 i~~~L~~dP~~R~t~~eil~h~~~~~~~  272 (328)
T 3fe3_A          245 LKRFLVLNPIKRGTLEQIMKDRWINAGH  272 (328)
T ss_dssp             HHHHCCSSTTTSCCHHHHTTCTTTTTTC
T ss_pred             HHHHCCCChhHCcCHHHHhcCHhhcCCC
Confidence            9999999999999999999999998643

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=2.6e-52  Score=409.91  Aligned_cols=234  Identities=27%  Similarity=0.364  Sum_probs=200.0

Q ss_pred             eecceEEeceEeecCcEEEEEEEECCC-----CceEEEEEeecccccchhHHHHHHHHHHHHhcCCC-CCcceEEEEEEe
Q 014609           12 RLGRYELGRTLGEGNFGKVKFAQDLDS-----GLPFAVKILEKNRIIHLKITDQIKREIATLKLLKH-PNVVRLHEVLAS   85 (421)
Q Consensus        12 ~~~~y~i~~~LG~G~~g~V~~a~~~~~-----~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~h-pnIv~l~~~~~~   85 (421)
                      ..++|++++.||+|+||+||+|.+..+     ++.||||.+.....  ....+.+.+|+++|++++| ||||+++++|..
T Consensus        62 ~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~--~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~  139 (353)
T 4ase_A           62 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT--HSEHRALMSELKILIHIGHHLNVVNLLGACTK  139 (353)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCC--HHHHHHHHHHHHHHHHHCCCTTBCCEEEEECC
T ss_pred             cHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccC--hHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEe
Confidence            347899999999999999999987653     46899999975432  2335679999999999975 999999999866


Q ss_pred             C-CEEEEEEeccCCCChHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEec
Q 014609           86 K-SKIYMVLEYVTGGELFDKIASK----------------GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLD  148 (421)
Q Consensus        86 ~-~~~~lv~E~~~gg~L~~~i~~~----------------~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~  148 (421)
                      + +.+|+|||||++|+|.+++...                ..+++..+..++.||+.||+|||+++|+||||||+|||++
T Consensus       140 ~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK~~NILl~  219 (353)
T 4ase_A          140 PGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLS  219 (353)
T ss_dssp             TTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC
T ss_pred             cCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccCccceeeC
Confidence            4 5789999999999999999752                3489999999999999999999999999999999999999


Q ss_pred             cCCCEEEEeccCCCCCccccCCCccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhhc--CCcC-----------
Q 014609          149 SKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIFR--GDFK-----------  215 (421)
Q Consensus       149 ~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~~--~~~~-----------  215 (421)
                      .++.+||+|||+|+..............+||+.|||||++.+..| +.++|||||||+||++.  |..|           
T Consensus       220 ~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y-~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~~~~  298 (353)
T 4ase_A          220 EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVY-TIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFC  298 (353)
T ss_dssp             GGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHH
T ss_pred             CCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCC-CCcccEeehHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence            999999999999986543222223445689999999999998888 59999999999999653  4443           


Q ss_pred             ----------CCCCCCHHHHHHHHHhcCCCCCCCCCHHhhhcC
Q 014609          216 ----------LPKWLSPGAQNLLRKILEPNPVKRITIAGIKAD  248 (421)
Q Consensus       216 ----------~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~~  248 (421)
                                .|+.+++++.++|.+||+.||.+|||+.||++|
T Consensus       299 ~~i~~g~~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~  341 (353)
T 4ase_A          299 RRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH  341 (353)
T ss_dssp             HHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHcCCCCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence                      355688999999999999999999999999987

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=7.3e-52  Score=405.36  Aligned_cols=242  Identities=45%  Similarity=0.886  Sum_probs=215.8

Q ss_pred             CeeecceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEE
Q 014609           10 GMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKI   89 (421)
Q Consensus        10 ~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~   89 (421)
                      +..+++|++++.||+|+||+||+|.+..+|+.||+|++.+...........+.+|+.+++.++||||+++++++.+.+..
T Consensus         5 ~~~i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~   84 (336)
T 3h4j_B            5 KRHIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDI   84 (336)
T ss_dssp             CSEETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred             ccccCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEE
Confidence            45789999999999999999999999999999999999865433333346789999999999999999999999999999


Q ss_pred             EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCccccC
Q 014609           90 YMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD  169 (421)
Q Consensus        90 ~lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~  169 (421)
                      |+||||+ +|+|.+++...+++++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||++.....   
T Consensus        85 ~lv~E~~-~g~l~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~---  160 (336)
T 3h4j_B           85 VMVIEYA-GGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTD---  160 (336)
T ss_dssp             EEEECCC-CEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEECTTCCEEECCSSCTBTTTT---
T ss_pred             EEEEECC-CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEcCCCCEEEEEeccceeccC---
Confidence            9999999 789999998888999999999999999999999999999999999999999999999999999986543   


Q ss_pred             CCccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhh-cCC-------------------cCCCCCCCHHHHHHHH
Q 014609          170 DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIF-RGD-------------------FKLPKWLSPGAQNLLR  229 (421)
Q Consensus       170 ~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~-~~~-------------------~~~p~~~s~~~~~li~  229 (421)
                      .......+||+.|+|||++.+..+.+.++|||||||++|.+ .|.                   +.+|..+|+.+.+||+
T Consensus       161 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~  240 (336)
T 3h4j_B          161 GNFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNSCVYVMPDFLSPGAQSLIR  240 (336)
T ss_dssp             SBTTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCCCCSSCCCCCTTSCHHHHHHHH
T ss_pred             CcccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHHHHcCCCCCcccCCHHHHHHHH
Confidence            23456678999999999998887767899999999999943 333                   2346668999999999


Q ss_pred             HhcCCCCCCCCCHHhhhcCccccccc
Q 014609          230 KILEPNPVKRITIAGIKADEWFEQDY  255 (421)
Q Consensus       230 ~~L~~dP~~R~t~~eil~~~w~~~~~  255 (421)
                      +||+.||.+|||++|+++||||+...
T Consensus       241 ~~L~~dP~~Rpt~~eil~hp~~~~~~  266 (336)
T 3h4j_B          241 RMIVADPMQRITIQEIRRDPWFNVNL  266 (336)
T ss_dssp             TTSCSSGGGSCCHHHHTTCHHHHTTC
T ss_pred             HHcCCChhHCcCHHHHHhChhhccCC
Confidence            99999999999999999999998643

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=5.2e-51  Score=399.53  Aligned_cols=240  Identities=33%  Similarity=0.634  Sum_probs=215.0

Q ss_pred             eeecceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEE
Q 014609           11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIY   90 (421)
Q Consensus        11 ~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~   90 (421)
                      ..+++|++++.||+|+||+||+|++..+|+.||||++++...........+.+|+.+++.++||||+++++++.+.+.+|
T Consensus         2 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~   81 (337)
T 1o6l_A            2 VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLC   81 (337)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEE
T ss_pred             CChHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEE
Confidence            35789999999999999999999999999999999998754433344678899999999999999999999999999999


Q ss_pred             EEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCccccCC
Q 014609           91 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD  170 (421)
Q Consensus        91 lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~  170 (421)
                      +||||++||+|.+.+...+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||++.....  ..
T Consensus        82 lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~--~~  159 (337)
T 1o6l_A           82 FVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS--DG  159 (337)
T ss_dssp             EEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC--TT
T ss_pred             EEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEECCCCCEEEeeccchhhccc--CC
Confidence            9999999999999999888999999999999999999999999999999999999999999999999999975322  23


Q ss_pred             CccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhh-cC-------------------CcCCCCCCCHHHHHHHHH
Q 014609          171 GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIF-RG-------------------DFKLPKWLSPGAQNLLRK  230 (421)
Q Consensus       171 ~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~-~~-------------------~~~~p~~~s~~~~~li~~  230 (421)
                      ....+.+||+.|+|||++.+..| +.++|||||||++|.+ .|                   ...+|..+++++.++|.+
T Consensus       160 ~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~  238 (337)
T 1o6l_A          160 ATMKTFCGTPEYLAPEVLEDNDY-GRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAG  238 (337)
T ss_dssp             CCBCCCEECGGGCCGGGGSSSCB-CTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHH
T ss_pred             CcccccccChhhCChhhhcCCCC-CchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence            34567799999999999988877 5899999999999943 23                   344567789999999999


Q ss_pred             hcCCCCCCCC-----CHHhhhcCccccc
Q 014609          231 ILEPNPVKRI-----TIAGIKADEWFEQ  253 (421)
Q Consensus       231 ~L~~dP~~R~-----t~~eil~~~w~~~  253 (421)
                      ||++||.+||     ++.++++||||..
T Consensus       239 lL~~dP~~R~g~~~~~~~ei~~h~~f~~  266 (337)
T 1o6l_A          239 LLKKDPKQRLGGGPSDAKEVMEHRFFLS  266 (337)
T ss_dssp             HTCSSTTTSTTCSTTTHHHHHTSGGGTT
T ss_pred             HhhcCHHHhcCCCCCCHHHHHcCCCcCC
Confidence            9999999999     8999999999975

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=2.2e-51  Score=404.71  Aligned_cols=241  Identities=33%  Similarity=0.631  Sum_probs=209.1

Q ss_pred             CeeecceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcC-CCCCcceEEEEEEeCCE
Q 014609           10 GMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEVLASKSK   88 (421)
Q Consensus        10 ~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~   88 (421)
                      ...+++|++++.||+|+||+||+|++..+|+.||||++.+.........+.+.+|..+++.+ +||||+++++++.+.+.
T Consensus        19 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~   98 (353)
T 3txo_A           19 RLGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDR   98 (353)
T ss_dssp             ----CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred             CCchhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCE
Confidence            35678999999999999999999999999999999999876544444567788999999988 69999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCcccc
Q 014609           89 IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFR  168 (421)
Q Consensus        89 ~~lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~~  168 (421)
                      +|+||||++||+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|.....  
T Consensus        99 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~g~ikL~DFG~a~~~~~--  176 (353)
T 3txo_A           99 LFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIC--  176 (353)
T ss_dssp             EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC--
T ss_pred             EEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEECCCCCEEEccccceeeccc--
Confidence            999999999999999999888999999999999999999999999999999999999999999999999999975322  


Q ss_pred             CCCccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhh--------------------cCCcCCCCCCCHHHHHHH
Q 014609          169 DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIF--------------------RGDFKLPKWLSPGAQNLL  228 (421)
Q Consensus       169 ~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~--------------------~~~~~~p~~~s~~~~~li  228 (421)
                      ......+.|||+.|+|||++.+..| +.++|||||||++|.+                    .+...+|.++++.+.++|
T Consensus       177 ~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li  255 (353)
T 3txo_A          177 NGVTTATFCGTPDYIAPEILQEMLY-GPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTWLHEDATGIL  255 (353)
T ss_dssp             ---------CCGGGCCHHHHHHHHC-TTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHH
T ss_pred             CCccccccCCCcCeEChhhcCCCCc-CCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHH
Confidence            2334567799999999999988877 5899999999999943                    234456788999999999


Q ss_pred             HHhcCCCCCCCCCH------HhhhcCccccc
Q 014609          229 RKILEPNPVKRITI------AGIKADEWFEQ  253 (421)
Q Consensus       229 ~~~L~~dP~~R~t~------~eil~~~w~~~  253 (421)
                      ++||++||.+||++      +++++||||+.
T Consensus       256 ~~lL~~dP~~R~~~~~~~~~~~il~hp~f~~  286 (353)
T 3txo_A          256 KSFMTKNPTMRLGSLTQGGEHAILRHPFFKE  286 (353)
T ss_dssp             HHHTCSSGGGSTTSGGGTCTHHHHTSGGGTT
T ss_pred             HHHhhhCHHHccCCcccCCHHHHhhCCcccC
Confidence            99999999999998      89999999985

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=1e-50  Score=405.43  Aligned_cols=242  Identities=30%  Similarity=0.612  Sum_probs=212.4

Q ss_pred             CCeeecceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcC-CCCCcceEEEEEEeCC
Q 014609            9 EGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEVLASKS   87 (421)
Q Consensus         9 ~~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~   87 (421)
                      ....+++|++++.||+|+||+||+|++..+++.||||++++.........+.+.+|..+++++ +||||+++++++.+.+
T Consensus        47 ~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~  126 (396)
T 4dc2_A           47 SSLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTES  126 (396)
T ss_dssp             --CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSS
T ss_pred             cCCChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECC
Confidence            345678999999999999999999999999999999999876655444456788999999887 8999999999999999


Q ss_pred             EEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCccc
Q 014609           88 KIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHF  167 (421)
Q Consensus        88 ~~~lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~  167 (421)
                      .+|+||||++||+|.+.+...+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|..... 
T Consensus       127 ~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFGla~~~~~-  205 (396)
T 4dc2_A          127 RLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR-  205 (396)
T ss_dssp             EEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC-
T ss_pred             EEEEEEEcCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEECCCCCEEEeecceeeeccc-
Confidence            9999999999999999999888999999999999999999999999999999999999999999999999999974322 


Q ss_pred             cCCCccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhh-cCC----------------------------cCCCC
Q 014609          168 RDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIF-RGD----------------------------FKLPK  218 (421)
Q Consensus       168 ~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~-~~~----------------------------~~~p~  218 (421)
                       ......+.|||+.|+|||++.+..| +.++|||||||++|.+ .|.                            ..+|.
T Consensus       206 -~~~~~~~~~gt~~Y~aPE~l~~~~~-~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~  283 (396)
T 4dc2_A          206 -PGDTTSTFCGTPNYIAPEILRGEDY-GFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPR  283 (396)
T ss_dssp             -TTCCBCCCCBCGGGCCHHHHTTCCB-CTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCCCCCT
T ss_pred             -CCCccccccCCcccCCchhhcCCCC-ChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhccccCCCC
Confidence             2344567899999999999998887 5899999999999943 333                            23466


Q ss_pred             CCCHHHHHHHHHhcCCCCCCCCCH------HhhhcCccccc
Q 014609          219 WLSPGAQNLLRKILEPNPVKRITI------AGIKADEWFEQ  253 (421)
Q Consensus       219 ~~s~~~~~li~~~L~~dP~~R~t~------~eil~~~w~~~  253 (421)
                      .+++++.+||++||++||.+||++      ++|++||||+.
T Consensus       284 ~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hpff~~  324 (396)
T 4dc2_A          284 SLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRN  324 (396)
T ss_dssp             TSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHSTTTTT
T ss_pred             cCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCccccC
Confidence            789999999999999999999985      79999999975

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=1e-50  Score=398.65  Aligned_cols=242  Identities=33%  Similarity=0.611  Sum_probs=213.0

Q ss_pred             CCeeecceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcC-CCCCcceEEEEEEeCC
Q 014609            9 EGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEVLASKS   87 (421)
Q Consensus         9 ~~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~   87 (421)
                      ....+++|++++.||+|+||+||+|++..+|+.||||++++.........+.+.+|..+++.+ +||||+++++++.+.+
T Consensus        12 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~   91 (345)
T 1xjd_A           12 IKLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKE   91 (345)
T ss_dssp             ----CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSS
T ss_pred             CCCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCC
Confidence            356789999999999999999999999999999999999875443333456788999999876 8999999999999999


Q ss_pred             EEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCccc
Q 014609           88 KIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHF  167 (421)
Q Consensus        88 ~~~lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~  167 (421)
                      .+|+||||++||+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||++..... 
T Consensus        92 ~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~-  170 (345)
T 1xjd_A           92 NLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENML-  170 (345)
T ss_dssp             EEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC-
T ss_pred             EEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEECCCCCEEEeEChhhhhccc-
Confidence            9999999999999999999888999999999999999999999999999999999999999999999999999975322 


Q ss_pred             cCCCccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhh-cC-------------------CcCCCCCCCHHHHHH
Q 014609          168 RDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIF-RG-------------------DFKLPKWLSPGAQNL  227 (421)
Q Consensus       168 ~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~-~~-------------------~~~~p~~~s~~~~~l  227 (421)
                       ........+||+.|+|||++.+..| +.++|||||||++|.+ .|                   ...+|.++++++.+|
T Consensus       171 -~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~l  248 (345)
T 1xjd_A          171 -GDAKTNTFCGTPDYIAPEILLGQKY-NHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKEAKDL  248 (345)
T ss_dssp             -TTCCBCCCCSCGGGCCHHHHTTCCB-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHH
T ss_pred             -CCCcccCCCCCcccCChhhhcCCCC-CChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhCCCCCCcccCHHHHHH
Confidence             2234567799999999999988877 5899999999999943 22                   344577899999999


Q ss_pred             HHHhcCCCCCCCCCHH-hhhcCccccc
Q 014609          228 LRKILEPNPVKRITIA-GIKADEWFEQ  253 (421)
Q Consensus       228 i~~~L~~dP~~R~t~~-eil~~~w~~~  253 (421)
                      |.+||+.||.+||++. ++++||||+.
T Consensus       249 i~~lL~~dp~~R~~~~~~i~~hp~f~~  275 (345)
T 1xjd_A          249 LVKLFVREPEKRLGVRGDIRQHPLFRE  275 (345)
T ss_dssp             HHHHSCSSGGGSBTTBSCGGGSGGGTT
T ss_pred             HHHHhcCCHhHcCCChHHHHcCccccC
Confidence            9999999999999998 9999999975

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=2.3e-50  Score=391.86  Aligned_cols=237  Identities=30%  Similarity=0.672  Sum_probs=213.9

Q ss_pred             eeecceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEE
Q 014609           11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIY   90 (421)
Q Consensus        11 ~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~   90 (421)
                      ..+++|++++.||+|+||+||+|++..+|+.||+|++.+.........+.+.+|+.+++.++||||+++++++.+...+|
T Consensus         3 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~   82 (318)
T 1fot_A            3 YSLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIF   82 (318)
T ss_dssp             CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEE
T ss_pred             CChHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEE
Confidence            46789999999999999999999999999999999998764433344677889999999999999999999999999999


Q ss_pred             EEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCccccCC
Q 014609           91 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD  170 (421)
Q Consensus        91 lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~  170 (421)
                      +||||++||+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||++....     
T Consensus        83 lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~-----  157 (318)
T 1fot_A           83 MIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVP-----  157 (318)
T ss_dssp             EEECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECS-----
T ss_pred             EEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEEcCCCCEEEeecCcceecC-----
Confidence            999999999999999988899999999999999999999999999999999999999999999999999997532     


Q ss_pred             CccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhh-c-------------------CCcCCCCCCCHHHHHHHHH
Q 014609          171 GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIF-R-------------------GDFKLPKWLSPGAQNLLRK  230 (421)
Q Consensus       171 ~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~-~-------------------~~~~~p~~~s~~~~~li~~  230 (421)
                      ....+.+||+.|+|||++.+..| +.++|||||||++|.+ .                   +...+|+.+++++.++|++
T Consensus       158 ~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~  236 (318)
T 1fot_A          158 DVTYTLCGTPDYIAPEVVSTKPY-NKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNEDVKDLLSR  236 (318)
T ss_dssp             SCBCCCCSCTTTCCHHHHTTCCB-CTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHH
T ss_pred             CccccccCCccccCHhHhcCCCC-CcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence            23456789999999999988877 5899999999999943 2                   3345677789999999999


Q ss_pred             hcCCCCCCCC-----CHHhhhcCccccc
Q 014609          231 ILEPNPVKRI-----TIAGIKADEWFEQ  253 (421)
Q Consensus       231 ~L~~dP~~R~-----t~~eil~~~w~~~  253 (421)
                      ||..||.+|+     +++++++||||+.
T Consensus       237 lL~~dp~~R~~~~~~~~~~i~~hp~f~~  264 (318)
T 1fot_A          237 LITRDLSQRLGNLQNGTEDVKNHPWFKE  264 (318)
T ss_dssp             HTCSCTTTCTTSSTTTTHHHHTSGGGSS
T ss_pred             HhccCHHHcCCCcCCCHHHHhcCccccC
Confidence            9999999999     8999999999975

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=5e-50  Score=383.62  Aligned_cols=239  Identities=29%  Similarity=0.478  Sum_probs=206.1

Q ss_pred             ecceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEE
Q 014609           13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMV   92 (421)
Q Consensus        13 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv   92 (421)
                      +++|++++.||+|+||+||+|.+..+|+.||+|++..... .......+.+|+.++++++||||+++++++.+++..|+|
T Consensus         1 l~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv   79 (292)
T 3o0g_A            1 MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD-DEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLV   79 (292)
T ss_dssp             CCSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCS-STTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             CCCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCC-cCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEE
Confidence            5789999999999999999999999999999999986543 333457788999999999999999999999999999999


Q ss_pred             EeccCCCChHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCccccCCC
Q 014609           93 LEYVTGGELFDKIA-SKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDG  171 (421)
Q Consensus        93 ~E~~~gg~L~~~i~-~~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~  171 (421)
                      |||+++ +|.+.+. ..+.+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||++.....  ...
T Consensus        80 ~e~~~~-~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~--~~~  156 (292)
T 3o0g_A           80 FEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGI--PVR  156 (292)
T ss_dssp             EECCSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCS--CCS
T ss_pred             EecCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecCC--ccc
Confidence            999976 5555554 467899999999999999999999999999999999999999999999999999975432  223


Q ss_pred             ccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhhc-CCcCC----------------------------------
Q 014609          172 LLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIFR-GDFKL----------------------------------  216 (421)
Q Consensus       172 ~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~~-~~~~~----------------------------------  216 (421)
                      .....+||+.|+|||++.+....+.++||||+||++|.+. +..++                                  
T Consensus       157 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  236 (292)
T 3o0g_A          157 CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDY  236 (292)
T ss_dssp             CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTC
T ss_pred             cccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhcccccc
Confidence            3455689999999999987764579999999999999665 44331                                  


Q ss_pred             ---------------CCCCCHHHHHHHHHhcCCCCCCCCCHHhhhcCccccccc
Q 014609          217 ---------------PKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY  255 (421)
Q Consensus       217 ---------------p~~~s~~~~~li~~~L~~dP~~R~t~~eil~~~w~~~~~  255 (421)
                                     ++.+++.+.+||.+||+.||.+|||++|+++||||+...
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~  290 (292)
T 3o0g_A          237 KPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFC  290 (292)
T ss_dssp             CCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTC-
T ss_pred             cccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcCcccccCC
Confidence                           123678899999999999999999999999999998643

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=7.8e-50  Score=392.43  Aligned_cols=241  Identities=31%  Similarity=0.607  Sum_probs=215.4

Q ss_pred             CeeecceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcC-CCCCcceEEEEEEeCCE
Q 014609           10 GMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEVLASKSK   88 (421)
Q Consensus        10 ~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~   88 (421)
                      ...+++|++++.||+|+||+||+|++..+++.||||++.+.........+.+.+|..+++++ +||||+++++++.+.+.
T Consensus         5 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~   84 (345)
T 3a8x_A            5 PLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESR   84 (345)
T ss_dssp             CCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred             CCchhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCE
Confidence            35678999999999999999999999999999999999887665656677899999999988 89999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCcccc
Q 014609           89 IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFR  168 (421)
Q Consensus        89 ~~lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~~  168 (421)
                      +|+||||++||+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||++.....  
T Consensus        85 ~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~--  162 (345)
T 3a8x_A           85 LFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR--  162 (345)
T ss_dssp             EEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCGGGCBCSCC--
T ss_pred             EEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEEeccccccccC--
Confidence            999999999999999999888999999999999999999999999999999999999999999999999999975322  


Q ss_pred             CCCccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhh-cCCc----------------------------CCCCC
Q 014609          169 DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIF-RGDF----------------------------KLPKW  219 (421)
Q Consensus       169 ~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~-~~~~----------------------------~~p~~  219 (421)
                      ........+||+.|+|||++.+..| +.++|||||||++|.+ .|..                            .+|..
T Consensus       163 ~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~~  241 (345)
T 3a8x_A          163 PGDTTSTFCGTPNYIAPEILRGEDY-GFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRS  241 (345)
T ss_dssp             TTCCBCCCCSCGGGCCHHHHTTCCB-CTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCCCCCTT
T ss_pred             CCCcccccCCCccccCccccCCCCC-ChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCCCCCCC
Confidence            2234567799999999999988877 5899999999999943 3332                            34566


Q ss_pred             CCHHHHHHHHHhcCCCCCCCCCH------HhhhcCccccc
Q 014609          220 LSPGAQNLLRKILEPNPVKRITI------AGIKADEWFEQ  253 (421)
Q Consensus       220 ~s~~~~~li~~~L~~dP~~R~t~------~eil~~~w~~~  253 (421)
                      +++.+.++|++||++||.+||++      +++++||||..
T Consensus       242 ~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp~f~~  281 (345)
T 3a8x_A          242 LSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRN  281 (345)
T ss_dssp             SCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTSGGGTT
T ss_pred             CCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcCCccCC
Confidence            89999999999999999999995      89999999975

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=4.7e-50  Score=395.13  Aligned_cols=242  Identities=34%  Similarity=0.606  Sum_probs=212.9

Q ss_pred             CCeeecceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcC-CCCCcceEEEEEEeCC
Q 014609            9 EGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEVLASKS   87 (421)
Q Consensus         9 ~~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~   87 (421)
                      ....+++|++++.||+|+||+||+|++..+|+.||||++++.........+.+.+|..++..+ +||||+++++++.+.+
T Consensus        15 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~   94 (353)
T 2i0e_A           15 DRMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMD   94 (353)
T ss_dssp             ----CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSS
T ss_pred             CCCchHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCC
Confidence            356789999999999999999999999999999999999876543334467788999999988 7999999999999999


Q ss_pred             EEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCccc
Q 014609           88 KIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHF  167 (421)
Q Consensus        88 ~~~lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~  167 (421)
                      .+|+||||++||+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||++..... 
T Consensus        95 ~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~-  173 (353)
T 2i0e_A           95 RLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIW-  173 (353)
T ss_dssp             EEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC-
T ss_pred             EEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEcCCCcEEEEeCCccccccc-
Confidence            9999999999999999999888999999999999999999999999999999999999999999999999999975322 


Q ss_pred             cCCCccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhh-c-------------------CCcCCCCCCCHHHHHH
Q 014609          168 RDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIF-R-------------------GDFKLPKWLSPGAQNL  227 (421)
Q Consensus       168 ~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~-~-------------------~~~~~p~~~s~~~~~l  227 (421)
                       ........+||+.|+|||++.+.+| +.++|||||||++|.+ .                   +...+|..+++++.+|
T Consensus       174 -~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~l  251 (353)
T 2i0e_A          174 -DGVTTKTFCGTPDYIAPEIIAYQPY-GKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAVAI  251 (353)
T ss_dssp             -TTCCBCCCCSCGGGCCHHHHTTCCB-STHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHH
T ss_pred             -CCcccccccCCccccChhhhcCCCc-CCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence             2234567799999999999988887 5899999999999943 2                   3345577799999999


Q ss_pred             HHHhcCCCCCCCCC-----HHhhhcCccccc
Q 014609          228 LRKILEPNPVKRIT-----IAGIKADEWFEQ  253 (421)
Q Consensus       228 i~~~L~~dP~~R~t-----~~eil~~~w~~~  253 (421)
                      |++||++||.+||+     +.++++||||+.
T Consensus       252 i~~lL~~dP~~R~~~~~~~~~~i~~h~~f~~  282 (353)
T 2i0e_A          252 CKGLMTKHPGKRLGCGPEGERDIKEHAFFRY  282 (353)
T ss_dssp             HHHHTCSCTTSCTTCSTTHHHHHHTSGGGTT
T ss_pred             HHHHhhcCHHHcCCCCCCCHHHHhcCccccC
Confidence            99999999999995     699999999974

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=6.9e-50  Score=393.56  Aligned_cols=239  Identities=33%  Similarity=0.667  Sum_probs=215.7

Q ss_pred             CCeeecceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCE
Q 014609            9 EGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSK   88 (421)
Q Consensus         9 ~~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~   88 (421)
                      ....+++|++++.||+|+||+||+|++..+|+.||||++.+.........+.+.+|+.+++.++||||+++++++.+...
T Consensus        36 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~  115 (350)
T 1rdq_E           36 NTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSN  115 (350)
T ss_dssp             CCCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred             cCCCHHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCE
Confidence            34678999999999999999999999999999999999987654444446788999999999999999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCcccc
Q 014609           89 IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFR  168 (421)
Q Consensus        89 ~~lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~~  168 (421)
                      +|+||||++||+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||++.....  
T Consensus       116 ~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~--  193 (350)
T 1rdq_E          116 LYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG--  193 (350)
T ss_dssp             EEEEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSS--
T ss_pred             EEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEECCCCCEEEcccccceeccC--
Confidence            999999999999999999888999999999999999999999999999999999999999999999999999975432  


Q ss_pred             CCCccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhh--------------------cCCcCCCCCCCHHHHHHH
Q 014609          169 DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIF--------------------RGDFKLPKWLSPGAQNLL  228 (421)
Q Consensus       169 ~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~--------------------~~~~~~p~~~s~~~~~li  228 (421)
                         .....+||+.|+|||++.+..| +.++|||||||++|.+                    .+...+|..+++.+.++|
T Consensus       194 ---~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li  269 (350)
T 1rdq_E          194 ---RTWTLCGTPEALAPEIILSKGY-NKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLL  269 (350)
T ss_dssp             ---CBCCCEECGGGCCHHHHTTCCB-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTCCHHHHHHH
T ss_pred             ---CcccccCCccccCHHHhcCCCC-CCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHH
Confidence               2346789999999999988877 5899999999999943                    234456778999999999


Q ss_pred             HHhcCCCCCCCCC-----HHhhhcCccccc
Q 014609          229 RKILEPNPVKRIT-----IAGIKADEWFEQ  253 (421)
Q Consensus       229 ~~~L~~dP~~R~t-----~~eil~~~w~~~  253 (421)
                      .+||+.||.+||+     ++++++||||..
T Consensus       270 ~~lL~~dp~~R~~~~~~~~~ei~~h~~f~~  299 (350)
T 1rdq_E          270 RNLLQVDLTKRFGNLKNGVNDIKNHKWFAT  299 (350)
T ss_dssp             HHHSCSCTTTCTTSSTTTTHHHHTSGGGTT
T ss_pred             HHHhhcCHHhccCCccCCHHHHHhCcCcCC
Confidence            9999999999998     999999999975

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=2.7e-50  Score=391.92  Aligned_cols=242  Identities=39%  Similarity=0.706  Sum_probs=210.8

Q ss_pred             eecceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEE
Q 014609           12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYM   91 (421)
Q Consensus        12 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l   91 (421)
                      .+++|++++.||+|+||+||+|++..+++.||||++.......  ..+.+.+|+.+++.++||||+++++++.+.+..|+
T Consensus         5 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l   82 (323)
T 3tki_A            5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVD--CPENIKKEICINKMLNHENVVKFYGHRREGNIQYL   82 (323)
T ss_dssp             TTTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC---------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred             HhhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccc--hHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEE
Confidence            4589999999999999999999999999999999997554322  23668899999999999999999999999999999


Q ss_pred             EEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCccccCCC
Q 014609           92 VLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDG  171 (421)
Q Consensus        92 v~E~~~gg~L~~~i~~~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~  171 (421)
                      ||||++|++|.+++.....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++..........
T Consensus        83 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~  162 (323)
T 3tki_A           83 FLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRER  162 (323)
T ss_dssp             EEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEEC
T ss_pred             EEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEeCCCCEEEEEeeccceeccCCccc
Confidence            99999999999999888889999999999999999999999999999999999999999999999999998654333334


Q ss_pred             ccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhh-cCCcCCC----------------------CCCCHHHHHHH
Q 014609          172 LLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIF-RGDFKLP----------------------KWLSPGAQNLL  228 (421)
Q Consensus       172 ~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~-~~~~~~p----------------------~~~s~~~~~li  228 (421)
                      .....+||+.|+|||++.+..+.+.++|||||||++|.+ .|..++.                      ..+++.+.+||
T Consensus       163 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  242 (323)
T 3tki_A          163 LLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALL  242 (323)
T ss_dssp             CBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTCTTSTTGGGSCHHHHHHH
T ss_pred             ccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcccccCCccccCCHHHHHHH
Confidence            455678999999999998877766889999999999944 4444332                      23788999999


Q ss_pred             HHhcCCCCCCCCCHHhhhcCccccccc
Q 014609          229 RKILEPNPVKRITIAGIKADEWFEQDY  255 (421)
Q Consensus       229 ~~~L~~dP~~R~t~~eil~~~w~~~~~  255 (421)
                      .+||+.||.+|||+.|+++||||++..
T Consensus       243 ~~~L~~dP~~R~t~~eil~h~~~~~~~  269 (323)
T 3tki_A          243 HKILVENPSARITIPDIKKDRWYNKPL  269 (323)
T ss_dssp             HHHSCSSTTTSCCHHHHTTCTTTTCCC
T ss_pred             HHHccCChhhCcCHHHHhhChhhcccc
Confidence            999999999999999999999998654

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=1.5e-49  Score=381.97  Aligned_cols=239  Identities=27%  Similarity=0.483  Sum_probs=210.7

Q ss_pred             CCeeecceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCE
Q 014609            9 EGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSK   88 (421)
Q Consensus         9 ~~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~   88 (421)
                      .+...++|++++.||+|+||+||+|.+..+|+.||||++.......   .+.+.+|+.+++.++||||+++++++...+.
T Consensus        15 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~---~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~   91 (297)
T 3fxz_A           15 VGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK---KELIINEILVMRENKNPNIVNYLDSYLVGDE   91 (297)
T ss_dssp             SSCGGGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSC---HHHHHHHHHHHHHCCCTTBCCEEEEEEETTE
T ss_pred             cCChhhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccH---HHHHHHHHHHHhcCCCCCCCeEeEEEEECCE
Confidence            3456689999999999999999999999999999999997654322   4678999999999999999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCcccc
Q 014609           89 IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFR  168 (421)
Q Consensus        89 ~~lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~~  168 (421)
                      .|+||||++|++|.+++.. ..+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||++.....  
T Consensus        92 ~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~--  168 (297)
T 3fxz_A           92 LWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP--  168 (297)
T ss_dssp             EEEEEECCTTCBHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCS--
T ss_pred             EEEEEECCCCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEECCCCCEEEeeCCCceecCC--
Confidence            9999999999999998876 4699999999999999999999999999999999999999999999999999875433  


Q ss_pred             CCCccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhh-cCCcCC----------------------CCCCCHHHH
Q 014609          169 DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIF-RGDFKL----------------------PKWLSPGAQ  225 (421)
Q Consensus       169 ~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~-~~~~~~----------------------p~~~s~~~~  225 (421)
                      ........+||+.|+|||++.+..| +.++||||+||++|.+ .|..++                      |..+++.+.
T Consensus       169 ~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (297)
T 3fxz_A          169 EQSKRSTMVGTPYWMAPEVVTRKAY-GPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFR  247 (297)
T ss_dssp             TTCCBCCCCSCGGGCCHHHHHCSCB-CTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSCGGGSCHHHH
T ss_pred             cccccCCccCCcCccChhhhcCCCC-CcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCccccCHHHH
Confidence            2233456689999999999988877 5899999999999944 343332                      445788999


Q ss_pred             HHHHHhcCCCCCCCCCHHhhhcCcccccc
Q 014609          226 NLLRKILEPNPVKRITIAGIKADEWFEQD  254 (421)
Q Consensus       226 ~li~~~L~~dP~~R~t~~eil~~~w~~~~  254 (421)
                      ++|.+||+.||.+|||+.|+++||||+..
T Consensus       248 ~li~~~l~~dp~~Rps~~ell~h~~~~~~  276 (297)
T 3fxz_A          248 DFLNRCLEMDVEKRGSAKELLQHQFLKIA  276 (297)
T ss_dssp             HHHHHHSCSSTTTSCCHHHHTTCGGGGGC
T ss_pred             HHHHHHccCChhHCcCHHHHhhChhhccc
Confidence            99999999999999999999999999854

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=3.5e-49  Score=390.10  Aligned_cols=240  Identities=35%  Similarity=0.618  Sum_probs=210.7

Q ss_pred             CeeecceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccch---hHHHHHHHHHHHHhcCCCCCcceEEEEEEeC
Q 014609           10 GMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHL---KITDQIKREIATLKLLKHPNVVRLHEVLASK   86 (421)
Q Consensus        10 ~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~---~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~   86 (421)
                      ...-++|++++.||+|+||+||+|++..+|+.||+|++.+......   ...+.+.+|+.+|+.++||||+++++++.+.
T Consensus         8 ~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~   87 (361)
T 2yab_A            8 QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENR   87 (361)
T ss_dssp             SCGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred             CChhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeC
Confidence            3345789999999999999999999999999999999987543221   1246799999999999999999999999999


Q ss_pred             CEEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCC----CEEEEeccCCC
Q 014609           87 SKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKG----NIKISDFGLSA  162 (421)
Q Consensus        87 ~~~~lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~----~~kL~DFGla~  162 (421)
                      +.+|+||||++||+|++++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++    .+||+|||++.
T Consensus        88 ~~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~~~vkl~DFG~a~  167 (361)
T 2yab_A           88 TDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH  167 (361)
T ss_dssp             SEEEEEEECCCSCBHHHHHTTCSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCSSCE
T ss_pred             CEEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCccCEEEEecCCce
Confidence            99999999999999999998888999999999999999999999999999999999999998877    79999999997


Q ss_pred             CCccccCCCccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhh-cCCcCC-------------------C----C
Q 014609          163 LPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIF-RGDFKL-------------------P----K  218 (421)
Q Consensus       163 ~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~-~~~~~~-------------------p----~  218 (421)
                      ....   .......+||+.|+|||++.+..| +.++|||||||++|++ .|..|+                   +    .
T Consensus       168 ~~~~---~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~  243 (361)
T 2yab_A          168 EIED---GVEFKNIFGTPEFVAPEIVNYEPL-GLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFFS  243 (361)
T ss_dssp             ECCT---TCCCCCCCSCGGGCCHHHHTTCCC-CTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHHHT
T ss_pred             EcCC---CCccccCCCCccEECchHHcCCCC-CccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCchhcc
Confidence            5432   233456789999999999988777 5899999999999944 343333                   2    3


Q ss_pred             CCCHHHHHHHHHhcCCCCCCCCCHHhhhcCccccc
Q 014609          219 WLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQ  253 (421)
Q Consensus       219 ~~s~~~~~li~~~L~~dP~~R~t~~eil~~~w~~~  253 (421)
                      .+|+.+.+||.+||.+||.+|||+.|+++||||..
T Consensus       244 ~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~  278 (361)
T 2yab_A          244 QTSELAKDFIRKLLVKETRKRLTIQEALRHPWITP  278 (361)
T ss_dssp             TSCHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTSC
T ss_pred             CCCHHHHHHHHHHCCCChhHCcCHHHHhcCcCcCC
Confidence            47889999999999999999999999999999974

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=1.3e-49  Score=395.91  Aligned_cols=242  Identities=29%  Similarity=0.568  Sum_probs=215.6

Q ss_pred             cCCeeecceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCC
Q 014609            8 QEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKS   87 (421)
Q Consensus         8 ~~~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~   87 (421)
                      .....+++|++++.||+|+||+||+|++..+++.||+|++.+...........+.+|+.+|+.++||||+++++++.+.+
T Consensus         9 ~~~v~~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~   88 (384)
T 4fr4_A            9 NEDVNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEE   88 (384)
T ss_dssp             CCCCCGGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSS
T ss_pred             CCCCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCC
Confidence            34567899999999999999999999999999999999998765444444678999999999999999999999999999


Q ss_pred             EEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCccc
Q 014609           88 KIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHF  167 (421)
Q Consensus        88 ~~~lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~  167 (421)
                      .+|+||||+.||+|.+++.....+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||++....  
T Consensus        89 ~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~--  166 (384)
T 4fr4_A           89 DMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLP--  166 (384)
T ss_dssp             EEEEEECCCTTEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC--
T ss_pred             EEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEECCCCCEEEeccceeeecc--
Confidence            999999999999999999988899999999999999999999999999999999999999999999999999998543  


Q ss_pred             cCCCccccccCCCCccChhhhcc---cCCCCCcchHHHHHHHHhhh-cCCc----------------------CCCCCCC
Q 014609          168 RDDGLLHTTCGSPNYVAPEVLAN---RGYDGATSDIWSCGVILYIF-RGDF----------------------KLPKWLS  221 (421)
Q Consensus       168 ~~~~~~~~~~gt~~y~APEvl~~---~~~~~~~~DiwSlGvil~~~-~~~~----------------------~~p~~~s  221 (421)
                       ........+||+.|+|||++..   .+| +.++|||||||++|.+ .|..                      .+|..++
T Consensus       167 -~~~~~~~~~gt~~Y~aPE~~~~~~~~~~-~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~p~~~s  244 (384)
T 4fr4_A          167 -RETQITTMAGTKPYMAPEMFSSRKGAGY-SFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVTYPSAWS  244 (384)
T ss_dssp             -TTCCBCCCCSCGGGCCGGGTCCCSSCCB-CTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHHCCCCCCTTSC
T ss_pred             -CCCceeccCCCccccCCeeeccCCCCCC-CccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhhcccCCCCcCC
Confidence             2344567899999999999864   335 5889999999999944 3333                      3456689


Q ss_pred             HHHHHHHHHhcCCCCCCCCC-HHhhhcCccccc
Q 014609          222 PGAQNLLRKILEPNPVKRIT-IAGIKADEWFEQ  253 (421)
Q Consensus       222 ~~~~~li~~~L~~dP~~R~t-~~eil~~~w~~~  253 (421)
                      +.+.+||.+||++||.+||+ ++++++||||..
T Consensus       245 ~~~~~li~~lL~~dP~~R~s~~~~l~~hp~f~~  277 (384)
T 4fr4_A          245 QEMVSLLKKLLEPNPDQRFSQLSDVQNFPYMND  277 (384)
T ss_dssp             HHHHHHHHHHSCSSGGGSCCSHHHHHTSGGGTT
T ss_pred             HHHHHHHHHHhcCCHhHhcccHHHHHcChhhhc
Confidence            99999999999999999998 899999999985

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=2.4e-50  Score=388.98  Aligned_cols=228  Identities=25%  Similarity=0.360  Sum_probs=180.7

Q ss_pred             cceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCC----EE
Q 014609           14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKS----KI   89 (421)
Q Consensus        14 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~----~~   89 (421)
                      .+|.+.+.||+|+||+||+|++  +|+.||||+++...    ........|+..+.+++|||||++++++..++    .+
T Consensus         3 r~i~L~~~iG~G~fG~Vy~~~~--~g~~VAvK~l~~~~----~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~   76 (303)
T 3hmm_A            3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSRE----ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQL   76 (303)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEE--TTEEEEEEEECGGG----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccc----hhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEE
Confidence            4689999999999999999986  68999999996542    11223345666677899999999999997654    68


Q ss_pred             EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC--------CceeccCCCCCEEeccCCCEEEEeccCC
Q 014609           90 YMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNK--------GVFHRDLKLENILLDSKGNIKISDFGLS  161 (421)
Q Consensus        90 ~lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~ql~~aL~~LH~~--------gi~HrDlkp~NILl~~~~~~kL~DFGla  161 (421)
                      |+||||++||+|.+++.. .+++++.+.+++.|++.||+|||++        +|+||||||+||||+.++++||+|||+|
T Consensus        77 ~lV~Ey~~~gsL~~~l~~-~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla  155 (303)
T 3hmm_A           77 WLVSDYHEHGSLFDYLNR-YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA  155 (303)
T ss_dssp             EEEEECCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred             EEEecCCCCCcHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCC
Confidence            999999999999999976 5699999999999999999999987        9999999999999999999999999999


Q ss_pred             CCCccccC--CCccccccCCCCccChhhhcccCC-----CCCcchHHHHHHHHhhhcCCc-----------C--------
Q 014609          162 ALPQHFRD--DGLLHTTCGSPNYVAPEVLANRGY-----DGATSDIWSCGVILYIFRGDF-----------K--------  215 (421)
Q Consensus       162 ~~~~~~~~--~~~~~~~~gt~~y~APEvl~~~~~-----~~~~~DiwSlGvil~~~~~~~-----------~--------  215 (421)
                      +.......  .......+||+.|+|||++.+...     .+.++|||||||+||++.++.           +        
T Consensus       156 ~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~  235 (303)
T 3hmm_A          156 VRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSD  235 (303)
T ss_dssp             EEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSS
T ss_pred             ccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhccccc
Confidence            75433211  122345689999999999875421     146899999999999653221           1        


Q ss_pred             ------------------CCCC-----CCHHHHHHHHHhcCCCCCCCCCHHhhhcC
Q 014609          216 ------------------LPKW-----LSPGAQNLLRKILEPNPVKRITIAGIKAD  248 (421)
Q Consensus       216 ------------------~p~~-----~s~~~~~li~~~L~~dP~~R~t~~eil~~  248 (421)
                                        +|..     .+..+.+|+.+||+.||++|||+.|+++.
T Consensus       236 ~~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~  291 (303)
T 3hmm_A          236 PSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT  291 (303)
T ss_dssp             CCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHH
T ss_pred             chHHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence                              1110     11357789999999999999999998764

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=3.5e-49  Score=390.07  Aligned_cols=237  Identities=41%  Similarity=0.802  Sum_probs=200.8

Q ss_pred             eecceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEE
Q 014609           12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYM   91 (421)
Q Consensus        12 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l   91 (421)
                      ..++|++++.||+|+||+||+|++..+++.||||++......    .+.+.+|+.+++.++||||+++++++.+.+..|+
T Consensus        18 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l   93 (361)
T 3uc3_A           18 DSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAI----DENVQREIINHRSLRHPNIVRFKEVILTPTHLAI   93 (361)
T ss_dssp             CTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTS----CHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred             CCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccc----cHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEE
Confidence            457999999999999999999999999999999999765432    3568899999999999999999999999999999


Q ss_pred             EEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCC--EEEEeccCCCCCccccC
Q 014609           92 VLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGN--IKISDFGLSALPQHFRD  169 (421)
Q Consensus        92 v~E~~~gg~L~~~i~~~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~--~kL~DFGla~~~~~~~~  169 (421)
                      ||||++|++|.+++...+++++..++.++.||+.||+|||++||+||||||+|||++.++.  +||+|||++.....   
T Consensus        94 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~---  170 (361)
T 3uc3_A           94 IMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL---  170 (361)
T ss_dssp             EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSSSSCCEEECCCCCC--------
T ss_pred             EEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCceEEEeecCccccccc---
Confidence            9999999999999988889999999999999999999999999999999999999987765  99999999874322   


Q ss_pred             CCccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhh-cCCcCC-----------------------CC--CCCHH
Q 014609          170 DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIF-RGDFKL-----------------------PK--WLSPG  223 (421)
Q Consensus       170 ~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~-~~~~~~-----------------------p~--~~s~~  223 (421)
                      .......+||+.|+|||++.+..+.+.++|||||||++|.+ .|..++                       |.  .+++.
T Consensus       171 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~  250 (361)
T 3uc3_A          171 HSQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDDIRISPE  250 (361)
T ss_dssp             ----------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTTCCCCCTTSCCCHH
T ss_pred             cCCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcCCCCCCCcCCCCHH
Confidence            22345568999999999998888876669999999999943 343332                       22  36899


Q ss_pred             HHHHHHHhcCCCCCCCCCHHhhhcCccccccc
Q 014609          224 AQNLLRKILEPNPVKRITIAGIKADEWFEQDY  255 (421)
Q Consensus       224 ~~~li~~~L~~dP~~R~t~~eil~~~w~~~~~  255 (421)
                      +.+||.+||++||.+|||+.|+++||||.+..
T Consensus       251 ~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~  282 (361)
T 3uc3_A          251 CCHLISRIFVADPATRISIPEIKTHSWFLKNL  282 (361)
T ss_dssp             HHHHHHHHSCSCTTTSCCHHHHHTSHHHHTTC
T ss_pred             HHHHHHHHccCChhHCcCHHHHHhCcchhcCC
Confidence            99999999999999999999999999998754

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=7.4e-49  Score=397.86  Aligned_cols=240  Identities=36%  Similarity=0.672  Sum_probs=209.2

Q ss_pred             eecceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEE
Q 014609           12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYM   91 (421)
Q Consensus        12 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l   91 (421)
                      ..++|++++.||+|+||+||+|.+..+|+.||+|++...... ....+.+.+|+.++++++||||+++++++.+++..|+
T Consensus         9 ~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~-~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l   87 (444)
T 3soa_A            9 FTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLS-ARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYL   87 (444)
T ss_dssp             HHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCH-HHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEE
T ss_pred             ccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCC-HHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEE
Confidence            347899999999999999999999999999999999876543 2335678999999999999999999999999999999


Q ss_pred             EEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEec---cCCCEEEEeccCCCCCcccc
Q 014609           92 VLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLD---SKGNIKISDFGLSALPQHFR  168 (421)
Q Consensus        92 v~E~~~gg~L~~~i~~~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~---~~~~~kL~DFGla~~~~~~~  168 (421)
                      ||||++||+|++.+...+.+++..+..++.||+.||+|||++||+||||||+|||++   .++.+||+|||++.....  
T Consensus        88 v~E~~~gg~L~~~i~~~~~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~--  165 (444)
T 3soa_A           88 IFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEG--  165 (444)
T ss_dssp             EECCCBCCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCT--
T ss_pred             EEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEccCceeEEecC--
Confidence            999999999999999988999999999999999999999999999999999999998   457899999999976543  


Q ss_pred             CCCccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhhc-CCcCC-------------------C----CCCCHHH
Q 014609          169 DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIFR-GDFKL-------------------P----KWLSPGA  224 (421)
Q Consensus       169 ~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~~-~~~~~-------------------p----~~~s~~~  224 (421)
                      ........+||+.|+|||++.+..| +.++|||||||++|++. |..++                   |    +.+++++
T Consensus       166 ~~~~~~~~~gt~~Y~APE~l~~~~~-~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~  244 (444)
T 3soa_A          166 EQQAWFGFAGTPGYLSPEVLRKDPY-GKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPEA  244 (444)
T ss_dssp             TCCBCCCSCSCGGGCCHHHHTTCCB-CTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCTTTTTTSCHHH
T ss_pred             CCceeecccCCcccCCHHHhcCCCC-CCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCccccccCCHHH
Confidence            2233456789999999999988777 58999999999999543 33222                   2    2478999


Q ss_pred             HHHHHHhcCCCCCCCCCHHhhhcCccccccc
Q 014609          225 QNLLRKILEPNPVKRITIAGIKADEWFEQDY  255 (421)
Q Consensus       225 ~~li~~~L~~dP~~R~t~~eil~~~w~~~~~  255 (421)
                      .+||.+||++||.+|||+.|+++||||....
T Consensus       245 ~~li~~~L~~dP~~Rpta~e~L~hp~~~~~~  275 (444)
T 3soa_A          245 KDLINKMLTINPSKRITAAEALKHPWISHRS  275 (444)
T ss_dssp             HHHHHHHSCSSTTTSCCHHHHHHSCTTHHHH
T ss_pred             HHHHHHHcCCChhHCCCHHHHhcCccccCCc
Confidence            9999999999999999999999999998643

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=4.4e-49  Score=391.01  Aligned_cols=241  Identities=34%  Similarity=0.596  Sum_probs=205.0

Q ss_pred             CeeecceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHH-HhcCCCCCcceEEEEEEeCCE
Q 014609           10 GMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIAT-LKLLKHPNVVRLHEVLASKSK   88 (421)
Q Consensus        10 ~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~i-l~~l~hpnIv~l~~~~~~~~~   88 (421)
                      ....++|++++.||+|+||+||+|++..+++.||||++.+...........+.+|..+ ++.++||||+++++++.+.+.
T Consensus        34 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~  113 (373)
T 2r5t_A           34 HAKPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADK  113 (373)
T ss_dssp             TCCGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSE
T ss_pred             CCChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCE
Confidence            4667899999999999999999999999999999999988765544445667778777 577899999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCcccc
Q 014609           89 IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFR  168 (421)
Q Consensus        89 ~~lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~~  168 (421)
                      +|+||||++||+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||++.....  
T Consensus       114 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~--  191 (373)
T 2r5t_A          114 LYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIE--  191 (373)
T ss_dssp             EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCBCGGGBC--
T ss_pred             EEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEeeCcccccccc--
Confidence            999999999999999999888999999999999999999999999999999999999999999999999999974322  


Q ss_pred             CCCccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhh-cC-------------------CcCCCCCCCHHHHHHH
Q 014609          169 DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIF-RG-------------------DFKLPKWLSPGAQNLL  228 (421)
Q Consensus       169 ~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~-~~-------------------~~~~p~~~s~~~~~li  228 (421)
                      ........+||+.|+|||++.+..| +.++|||||||++|++ .|                   ...+|+.+++.+.+||
T Consensus       192 ~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li  270 (373)
T 2r5t_A          192 HNSTTSTFCGTPEYLAPEVLHKQPY-DRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPNITNSARHLL  270 (373)
T ss_dssp             CCCCCCSBSCCCCCCCHHHHTTCCC-CTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHHHSCCCCCSSSCHHHHHHH
T ss_pred             CCCccccccCCccccCHHHhCCCCC-CchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Confidence            2334567799999999999988887 5899999999999943 23                   3345677899999999


Q ss_pred             HHhcCCCCCCCCCH----HhhhcCccccc
Q 014609          229 RKILEPNPVKRITI----AGIKADEWFEQ  253 (421)
Q Consensus       229 ~~~L~~dP~~R~t~----~eil~~~w~~~  253 (421)
                      .+||++||.+||++    .++++||||..
T Consensus       271 ~~lL~~dp~~R~~~~~~~~~i~~h~~f~~  299 (373)
T 2r5t_A          271 EGLLQKDRTKRLGAKDDFMEIKSHVFFSL  299 (373)
T ss_dssp             HHHTCSSGGGSTTTTTTHHHHHTSGGGTT
T ss_pred             HHHcccCHHhCCCCCCCHHHHhCCccccC
Confidence            99999999999997    69999999975

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=3.9e-49  Score=400.35  Aligned_cols=240  Identities=34%  Similarity=0.633  Sum_probs=203.6

Q ss_pred             eeecceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEE
Q 014609           11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIY   90 (421)
Q Consensus        11 ~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~   90 (421)
                      ..+++|++++.||+|+||.||+|++..+|+.||||++.+...........+.+|+.+++.++||||+++++++.+.+.+|
T Consensus       145 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~  224 (446)
T 4ejn_A          145 VTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLC  224 (446)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEE
T ss_pred             CChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEE
Confidence            45689999999999999999999999999999999998654444444567889999999999999999999999999999


Q ss_pred             EEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCceeccCCCCCEEeccCCCEEEEeccCCCCCccccC
Q 014609           91 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHN-KGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD  169 (421)
Q Consensus        91 lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~ql~~aL~~LH~-~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~  169 (421)
                      +||||++|++|.+.+...+.+++..++.++.||+.||+|||+ +||+||||||+|||++.++.+||+|||+|.....  .
T Consensus       225 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~--~  302 (446)
T 4ejn_A          225 FVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIK--D  302 (446)
T ss_dssp             EEECCCSSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC---
T ss_pred             EEEeeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECCCCCEEEccCCCceeccC--C
Confidence            999999999999999988899999999999999999999998 9999999999999999999999999999975322  2


Q ss_pred             CCccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhh-cCC-------------------cCCCCCCCHHHHHHHH
Q 014609          170 DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIF-RGD-------------------FKLPKWLSPGAQNLLR  229 (421)
Q Consensus       170 ~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~-~~~-------------------~~~p~~~s~~~~~li~  229 (421)
                      .......+||+.|+|||++.+..| +.++|||||||++|.+ .|.                   ..+|..+++.+.+||.
T Consensus       303 ~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~  381 (446)
T 4ejn_A          303 GATMKTFCGTPEYLAPEVLEDNDY-GRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPEAKSLLS  381 (446)
T ss_dssp             ----CCSSSCGGGCCHHHHHTSCC-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHH
T ss_pred             CcccccccCCccccCHhhcCCCCC-CCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHHHHH
Confidence            234556799999999999988877 5899999999999943 333                   3456778999999999


Q ss_pred             HhcCCCCCCCC-----CHHhhhcCccccc
Q 014609          230 KILEPNPVKRI-----TIAGIKADEWFEQ  253 (421)
Q Consensus       230 ~~L~~dP~~R~-----t~~eil~~~w~~~  253 (421)
                      +||++||.+||     |++++++||||..
T Consensus       382 ~~L~~dP~~R~~~~~~t~~ell~hp~f~~  410 (446)
T 4ejn_A          382 GLLKKDPKQRLGGGSEDAKEIMQHRFFAG  410 (446)
T ss_dssp             HHTCSSTTTSTTCSTTTHHHHHTSGGGTT
T ss_pred             HHcccCHHHhCCCCCCCHHHHHhCccccC
Confidence            99999999999     9999999999985

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=9.2e-49  Score=372.16  Aligned_cols=243  Identities=32%  Similarity=0.667  Sum_probs=212.1

Q ss_pred             cCCeeecceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCC
Q 014609            8 QEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKS   87 (421)
Q Consensus         8 ~~~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~   87 (421)
                      .....+++|++++.||+|+||.||+|.+..+++.||+|++.............+.+|+.++++++||||+++++++.+.+
T Consensus         3 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   82 (279)
T 3fdn_A            3 KRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDAT   82 (279)
T ss_dssp             -CCCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred             cceeecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCC
Confidence            34567899999999999999999999999999999999997655444444577999999999999999999999999999


Q ss_pred             EEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCccc
Q 014609           88 KIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHF  167 (421)
Q Consensus        88 ~~~lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~  167 (421)
                      ..|+||||+++++|.+.+.....+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||++..... 
T Consensus        83 ~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~-  161 (279)
T 3fdn_A           83 RVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS-  161 (279)
T ss_dssp             EEEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEECTTSCEEECSCCEESCC---
T ss_pred             EEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEEcCCCCEEEEeccccccCCc-
Confidence            9999999999999999999888999999999999999999999999999999999999999999999999999864322 


Q ss_pred             cCCCccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhh-cCC-------------------cCCCCCCCHHHHHH
Q 014609          168 RDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIF-RGD-------------------FKLPKWLSPGAQNL  227 (421)
Q Consensus       168 ~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~-~~~-------------------~~~p~~~s~~~~~l  227 (421)
                         ......+||+.|+|||++.+..+ +.++||||+|+++|.+ .|.                   ..+|..+++.+.+|
T Consensus       162 ---~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  237 (279)
T 3fdn_A          162 ---SRRTDLCGTLDYLPPEMIEGRMH-DEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDL  237 (279)
T ss_dssp             ---------CCCCTTCCHHHHTTCCC-CTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCTTSCHHHHHH
T ss_pred             ---ccccccCCCCCccCHhHhccCCC-CccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHHhCCCCCCCcCCHHHHHH
Confidence               23345689999999999987766 5899999999999943 333                   34566789999999


Q ss_pred             HHHhcCCCCCCCCCHHhhhcCccccccc
Q 014609          228 LRKILEPNPVKRITIAGIKADEWFEQDY  255 (421)
Q Consensus       228 i~~~L~~dP~~R~t~~eil~~~w~~~~~  255 (421)
                      |.+||+.||.+|||+.|+++||||+...
T Consensus       238 i~~~l~~~p~~Rps~~e~l~h~~~~~~~  265 (279)
T 3fdn_A          238 ISRLLKHNPSQRPMLREVLEHPWITANS  265 (279)
T ss_dssp             HHHHCCSSGGGSCCHHHHHHCHHHHHHC
T ss_pred             HHHHhccChhhCCCHHHHhhCccccCCc
Confidence            9999999999999999999999998754

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=1.5e-48  Score=380.14  Aligned_cols=243  Identities=36%  Similarity=0.648  Sum_probs=201.8

Q ss_pred             cCCeeecceEEeceEeecCcEEEEEEEEC---CCCceEEEEEeeccccc-chhHHHHHHHHHHHHhcCCCCCcceEEEEE
Q 014609            8 QEGMRLGRYELGRTLGEGNFGKVKFAQDL---DSGLPFAVKILEKNRII-HLKITDQIKREIATLKLLKHPNVVRLHEVL   83 (421)
Q Consensus         8 ~~~~~~~~y~i~~~LG~G~~g~V~~a~~~---~~~~~vAvK~i~~~~~~-~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~   83 (421)
                      ......++|++++.||+|+||+||+|++.   .+|+.||+|++.+.... .......+.+|+.+|+.++||||+++++++
T Consensus        11 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~   90 (327)
T 3a62_A           11 PEKIRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAF   90 (327)
T ss_dssp             --CCCGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEE
T ss_pred             CCCCCHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEE
Confidence            34566789999999999999999999985   68999999999865432 122345688999999999999999999999


Q ss_pred             EeCCEEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCC
Q 014609           84 ASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSAL  163 (421)
Q Consensus        84 ~~~~~~~lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~  163 (421)
                      ...+.+|+||||++|++|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||++..
T Consensus        91 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~  170 (327)
T 3a62_A           91 QTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKE  170 (327)
T ss_dssp             ECSSCEEEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTSCEEECCCSCC--
T ss_pred             EcCCEEEEEEeCCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEECCCCcEEEEeCCcccc
Confidence            99999999999999999999999888999999999999999999999999999999999999999999999999999874


Q ss_pred             CccccCCCccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhh-cC-------------------CcCCCCCCCHH
Q 014609          164 PQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIF-RG-------------------DFKLPKWLSPG  223 (421)
Q Consensus       164 ~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~-~~-------------------~~~~p~~~s~~  223 (421)
                      ...  ........+||+.|+|||++.+..+ +.++|||||||++|.+ .|                   ...+|+.+++.
T Consensus       171 ~~~--~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~  247 (327)
T 3a62_A          171 SIH--DGTVTHTFCGTIEYMAPEILMRSGH-NRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLPPYLTQE  247 (327)
T ss_dssp             ----------CTTSSCCTTSCHHHHTTSCC-CTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCTTSCHH
T ss_pred             ccc--CCccccccCCCcCccCHhhCcCCCC-CCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHH
Confidence            322  2233456789999999999988777 5899999999999943 23                   34456778999


Q ss_pred             HHHHHHHhcCCCCCCCC-----CHHhhhcCccccc
Q 014609          224 AQNLLRKILEPNPVKRI-----TIAGIKADEWFEQ  253 (421)
Q Consensus       224 ~~~li~~~L~~dP~~R~-----t~~eil~~~w~~~  253 (421)
                      +.++|.+||+.||.+||     ++.++++||||+.
T Consensus       248 ~~~li~~~L~~dp~~R~~~~~~~~~e~l~hp~f~~  282 (327)
T 3a62_A          248 ARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRH  282 (327)
T ss_dssp             HHHHHHHHSCSCGGGSTTSSTTTHHHHHHSGGGSS
T ss_pred             HHHHHHHHHhcCHhhccCCCCCCHHHHHcCCcccC
Confidence            99999999999999999     8899999999975

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=7.1e-49  Score=399.63  Aligned_cols=241  Identities=30%  Similarity=0.412  Sum_probs=192.5

Q ss_pred             ecceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEe-----CC
Q 014609           13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLAS-----KS   87 (421)
Q Consensus        13 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~-----~~   87 (421)
                      -++|++++.||+|+||+||+|++..+|+.||||++.+.. ........+.+|+.+|+.++||||+++++++..     ..
T Consensus        52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~  130 (458)
T 3rp9_A           52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVF-EDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFD  130 (458)
T ss_dssp             CTTEEECCC-------CEEEEEECC--CEEEEEEECSTT-SSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCC
T ss_pred             CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhh-cCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCc
Confidence            378999999999999999999999999999999996542 333446789999999999999999999999943     35


Q ss_pred             EEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCccc
Q 014609           88 KIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHF  167 (421)
Q Consensus        88 ~~~lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~  167 (421)
                      .+|+||||+ +++|.+.+.....+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||+|......
T Consensus       131 ~~~lv~e~~-~~~L~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~  209 (458)
T 3rp9_A          131 ELYVVLEIA-DSDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYP  209 (458)
T ss_dssp             CEEEEECCC-SEEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCTTSC
T ss_pred             eEEEEEecc-ccchhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEECCCCCEeecccccchhccCc
Confidence            799999998 6799999988888999999999999999999999999999999999999999999999999999865321


Q ss_pred             cC-------------------------CCccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhhcC----------
Q 014609          168 RD-------------------------DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIFRG----------  212 (421)
Q Consensus       168 ~~-------------------------~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~~~----------  212 (421)
                      ..                         .......+||+.|+|||++......+.++|||||||++|++..          
T Consensus       210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~~~~~~  289 (458)
T 3rp9_A          210 ENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYHA  289 (458)
T ss_dssp             TTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTTCSSGG
T ss_pred             cccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhccccccccc
Confidence            11                         0234556899999999987544434699999999999997652          


Q ss_pred             --CcCCC----------------------------------------------------------------------CCC
Q 014609          213 --DFKLP----------------------------------------------------------------------KWL  220 (421)
Q Consensus       213 --~~~~p----------------------------------------------------------------------~~~  220 (421)
                        ...+|                                                                      +..
T Consensus       290 ~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  369 (458)
T 3rp9_A          290 DRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAERFPAS  369 (458)
T ss_dssp             GCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGGGGSTTS
T ss_pred             cccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHHHHCCCC
Confidence              22221                                                                      224


Q ss_pred             CHHHHHHHHHhcCCCCCCCCCHHhhhcCccccccc
Q 014609          221 SPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY  255 (421)
Q Consensus       221 s~~~~~li~~~L~~dP~~R~t~~eil~~~w~~~~~  255 (421)
                      ++++.+||++||..||.+|||++|+++||||+...
T Consensus       370 s~~~~dLl~~mL~~dP~~R~t~~e~L~Hp~f~~~~  404 (458)
T 3rp9_A          370 SADAIHLLKRMLVFNPNKRITINECLAHPFFKEVR  404 (458)
T ss_dssp             CHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred             CHHHHHHHHHHhccCccccCCHHHHhcCHhhhhcC
Confidence            88999999999999999999999999999998654

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=1.2e-48  Score=378.14  Aligned_cols=240  Identities=30%  Similarity=0.445  Sum_probs=200.8

Q ss_pred             CeeecceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEE
Q 014609           10 GMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKI   89 (421)
Q Consensus        10 ~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~   89 (421)
                      ....++|++++.||+|+||+||+|++. +|+.||+|++..... .......+.+|+.++++++||||+++++++.+++..
T Consensus        17 q~l~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~   94 (311)
T 3niz_A           17 QGLMEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDAE-DEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCL   94 (311)
T ss_dssp             ECSSCEEEEEEEEEECSSCEEEEEEET-TSCEEEEEEEC-------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCE
T ss_pred             cchHhhhHhhhhccCCCCeEEEEEEEC-CCCEEEEEEEecccc-cchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEE
Confidence            445689999999999999999999984 699999999975432 223356788999999999999999999999999999


Q ss_pred             EEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCcccc
Q 014609           90 YMVLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFR  168 (421)
Q Consensus        90 ~lv~E~~~gg~L~~~i~~~-~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~~  168 (421)
                      |+||||+++ +|.+.+... ..+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||++.....  
T Consensus        95 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~--  171 (311)
T 3niz_A           95 TLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGI--  171 (311)
T ss_dssp             EEEEECCSE-EHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEETTS--
T ss_pred             EEEEcCCCC-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEECCCCCEEEccCcCceecCC--
Confidence            999999975 787877654 4599999999999999999999999999999999999999999999999999975432  


Q ss_pred             CCCccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhh-cCCcCCC------------------------------
Q 014609          169 DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIF-RGDFKLP------------------------------  217 (421)
Q Consensus       169 ~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~-~~~~~~p------------------------------  217 (421)
                      ........+||+.|+|||++.+....+.++||||+||++|.+ .|..+++                              
T Consensus       172 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  251 (311)
T 3niz_A          172 PVRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELP  251 (311)
T ss_dssp             CCC---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTTSH
T ss_pred             CcccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhccc
Confidence            223344568999999999987755446899999999999944 4443332                              


Q ss_pred             -------------------CCCCHHHHHHHHHhcCCCCCCCCCHHhhhcCcccccc
Q 014609          218 -------------------KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD  254 (421)
Q Consensus       218 -------------------~~~s~~~~~li~~~L~~dP~~R~t~~eil~~~w~~~~  254 (421)
                                         +.+++++.+||++||++||.+|||+.|+++||||+..
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~  307 (311)
T 3niz_A          252 LWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDL  307 (311)
T ss_dssp             HHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTS
T ss_pred             hhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcCcccccC
Confidence                               1256789999999999999999999999999999863

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=2.4e-48  Score=378.61  Aligned_cols=238  Identities=37%  Similarity=0.639  Sum_probs=209.3

Q ss_pred             eecceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccch---hHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCE
Q 014609           12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHL---KITDQIKREIATLKLLKHPNVVRLHEVLASKSK   88 (421)
Q Consensus        12 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~---~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~   88 (421)
                      .-++|++++.||+|+||.||+|.+..+|+.||+|++........   ...+.+.+|+.+|++++||||+++++++.+...
T Consensus         9 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~   88 (326)
T 2y0a_A            9 VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTD   88 (326)
T ss_dssp             HHHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred             cccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCE
Confidence            34689999999999999999999999999999999986543221   125779999999999999999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCC----CEEEEeccCCCCC
Q 014609           89 IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKG----NIKISDFGLSALP  164 (421)
Q Consensus        89 ~~lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~----~~kL~DFGla~~~  164 (421)
                      .|+||||++|++|.+++.....+++..++.++.||+.||+|||++||+||||||+|||++.++    .+||+|||++...
T Consensus        89 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~  168 (326)
T 2y0a_A           89 VILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI  168 (326)
T ss_dssp             EEEEEECCCSCBHHHHHTTSSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSSCCEEECCCTTCEEC
T ss_pred             EEEEEEcCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCCCCEEEEECCCCeEC
Confidence            999999999999999998888899999999999999999999999999999999999999887    7999999999754


Q ss_pred             ccccCCCccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhh-cCCcCCC-----------------------CCC
Q 014609          165 QHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIF-RGDFKLP-----------------------KWL  220 (421)
Q Consensus       165 ~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~-~~~~~~p-----------------------~~~  220 (421)
                      ..   .......+||+.|+|||++.+..+ +.++|||||||++|.+ .|..++.                       ..+
T Consensus       169 ~~---~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (326)
T 2y0a_A          169 DF---GNEFKNIFGTPEFVAPEIVNYEPL-GLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNT  244 (326)
T ss_dssp             CT---TSCCCCCCSCTTTCCHHHHTTCCC-CTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHTCCCCCHHHHTTS
T ss_pred             CC---CCccccccCCcCcCCceeecCCCC-CcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhcCCCcCccccccC
Confidence            32   223455689999999999987777 5899999999999944 3444331                       346


Q ss_pred             CHHHHHHHHHhcCCCCCCCCCHHhhhcCccccc
Q 014609          221 SPGAQNLLRKILEPNPVKRITIAGIKADEWFEQ  253 (421)
Q Consensus       221 s~~~~~li~~~L~~dP~~R~t~~eil~~~w~~~  253 (421)
                      ++.+.+||.+||++||.+|||+.++++||||..
T Consensus       245 ~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~  277 (326)
T 2y0a_A          245 SALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKP  277 (326)
T ss_dssp             CHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTSC
T ss_pred             CHHHHHHHHHHccCChhhCCCHHHHhcCCCccC
Confidence            888999999999999999999999999999975

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=1.3e-48  Score=373.28  Aligned_cols=236  Identities=33%  Similarity=0.527  Sum_probs=198.2

Q ss_pred             ecceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEE
Q 014609           13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMV   92 (421)
Q Consensus        13 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv   92 (421)
                      +++|++++.||+|+||+||+|++ .+|+.||+|++...... ......+.+|+.++++++||||+++++++.+.+..|+|
T Consensus         1 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv   78 (288)
T 1ob3_A            1 MEKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKED-EGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLV   78 (288)
T ss_dssp             CCSEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSGG-GCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEE
T ss_pred             CccchhhhhcccCCCEEEEEEEc-CCCCEEEEEEEeccccc-cccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEE
Confidence            47899999999999999999998 78999999999754322 22246788999999999999999999999999999999


Q ss_pred             EeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCccccCCC
Q 014609           93 LEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDG  171 (421)
Q Consensus        93 ~E~~~gg~L~~~i~~~-~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~  171 (421)
                      |||+++ +|.+.+... +.+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||++.....  ...
T Consensus        79 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~--~~~  155 (288)
T 1ob3_A           79 FEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGI--PVR  155 (288)
T ss_dssp             EECCSE-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-----
T ss_pred             EEecCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEeECccccccCc--ccc
Confidence            999975 898888753 6799999999999999999999999999999999999999999999999999874332  122


Q ss_pred             ccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhh-cCCcCCC---------------------------------
Q 014609          172 LLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIF-RGDFKLP---------------------------------  217 (421)
Q Consensus       172 ~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~-~~~~~~p---------------------------------  217 (421)
                      .....+||+.|+|||++.+....+.++|||||||++|.+ .|..+++                                 
T Consensus       156 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (288)
T 1ob3_A          156 KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYD  235 (288)
T ss_dssp             ------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCC
T ss_pred             ccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhcccccc
Confidence            334567899999999987655446899999999999944 3332221                                 


Q ss_pred             ---------------CCCCHHHHHHHHHhcCCCCCCCCCHHhhhcCccccc
Q 014609          218 ---------------KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQ  253 (421)
Q Consensus       218 ---------------~~~s~~~~~li~~~L~~dP~~R~t~~eil~~~w~~~  253 (421)
                                     ..+++.+.+||.+||+.||.+|||+.|+++||||++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~  286 (288)
T 1ob3_A          236 PNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE  286 (288)
T ss_dssp             TTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred             cccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhh
Confidence                           236788999999999999999999999999999985

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=2.7e-48  Score=383.91  Aligned_cols=237  Identities=37%  Similarity=0.697  Sum_probs=208.6

Q ss_pred             ecceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEE
Q 014609           13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMV   92 (421)
Q Consensus        13 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv   92 (421)
                      .++|++++.||+|+||.||+|.+..+|+.||+|++...... ....+.+.+|+.+++.++||||+++++++.+.+..|+|
T Consensus        28 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv  106 (362)
T 2bdw_A           28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLS-ARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV  106 (362)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCC-HHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence            36899999999999999999999999999999999865443 33457799999999999999999999999999999999


Q ss_pred             EeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCC---CEEEEeccCCCCCccccC
Q 014609           93 LEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKG---NIKISDFGLSALPQHFRD  169 (421)
Q Consensus        93 ~E~~~gg~L~~~i~~~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~---~~kL~DFGla~~~~~~~~  169 (421)
                      |||++|++|.+.+.....+++..++.++.||+.||+|||++||+||||||+|||++.++   .+||+|||++.....   
T Consensus       107 ~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~---  183 (362)
T 2bdw_A          107 FDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND---  183 (362)
T ss_dssp             ECCCCSCBHHHHHTTCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTT---
T ss_pred             EecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeecCcceEecC---
Confidence            99999999999998888899999999999999999999999999999999999998654   599999999985542   


Q ss_pred             CCccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhh-cCCcCC-------------------C----CCCCHHHH
Q 014609          170 DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIF-RGDFKL-------------------P----KWLSPGAQ  225 (421)
Q Consensus       170 ~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~-~~~~~~-------------------p----~~~s~~~~  225 (421)
                      .......+||+.|+|||++.+..| +.++|||||||++|++ .|..++                   |    ..+++++.
T Consensus       184 ~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  262 (362)
T 2bdw_A          184 SEAWHGFAGTPGYLSPEVLKKDPY-SKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAK  262 (362)
T ss_dssp             CCSCCCSCSCTTTCCHHHHTTCCC-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTGGGGSCHHHH
T ss_pred             CcccccCCCCccccCHHHHccCCC-CchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHH
Confidence            233456789999999999988777 5899999999999954 333222                   2    13689999


Q ss_pred             HHHHHhcCCCCCCCCCHHhhhcCcccccc
Q 014609          226 NLLRKILEPNPVKRITIAGIKADEWFEQD  254 (421)
Q Consensus       226 ~li~~~L~~dP~~R~t~~eil~~~w~~~~  254 (421)
                      +||.+||++||.+|||+.++++||||...
T Consensus       263 ~li~~~L~~dP~~R~t~~e~l~hp~~~~~  291 (362)
T 2bdw_A          263 SLIDSMLTVNPKKRITADQALKVPWICNR  291 (362)
T ss_dssp             HHHHHHSCSSGGGSCCHHHHTTSHHHHTH
T ss_pred             HHHHHHcCCChhhCcCHHHHhcCcccCCC
Confidence            99999999999999999999999999753

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=1.8e-48  Score=377.86  Aligned_cols=241  Identities=28%  Similarity=0.477  Sum_probs=191.4

Q ss_pred             eecceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEE
Q 014609           12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYM   91 (421)
Q Consensus        12 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l   91 (421)
                      ..++|++++.||+|+||+||+|.+..+|+.||+|++......  ...+.+.+|+.++++++||||+++++++.+++..|+
T Consensus         3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l   80 (317)
T 2pmi_A            3 SSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEE--GTPSTAIREISLMKELKHENIVRLYDVIHTENKLTL   80 (317)
T ss_dssp             ----------------CEEEEEECSSSCCEEEEEEEECCSTT--CSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEE
T ss_pred             cccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeeccccc--ccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEE
Confidence            357899999999999999999999999999999999765422  224678899999999999999999999999999999


Q ss_pred             EEeccCCCChHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCc
Q 014609           92 VLEYVTGGELFDKIASK------GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQ  165 (421)
Q Consensus        92 v~E~~~gg~L~~~i~~~------~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~  165 (421)
                      ||||++ ++|.+++...      ..+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||++....
T Consensus        81 v~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~  159 (317)
T 2pmi_A           81 VFEFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFG  159 (317)
T ss_dssp             EEECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCSSCEETT
T ss_pred             EEEecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEEcCCCCEEECcCccceecC
Confidence            999997 5999988653      358999999999999999999999999999999999999999999999999997543


Q ss_pred             cccCCCccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhh-cCCcCCC---------------------------
Q 014609          166 HFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIF-RGDFKLP---------------------------  217 (421)
Q Consensus       166 ~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~-~~~~~~p---------------------------  217 (421)
                      .  ........+||+.|+|||++.+....+.++|||||||++|.+ .|..+++                           
T Consensus       160 ~--~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  237 (317)
T 2pmi_A          160 I--PVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVT  237 (317)
T ss_dssp             S--CCCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGG
T ss_pred             C--CcccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhh
Confidence            2  122344568999999999997654446899999999999944 3433321                           


Q ss_pred             --------------------------CCCCHHHHHHHHHhcCCCCCCCCCHHhhhcCccccccccC
Q 014609          218 --------------------------KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTP  257 (421)
Q Consensus       218 --------------------------~~~s~~~~~li~~~L~~dP~~R~t~~eil~~~w~~~~~~~  257 (421)
                                                ..+++++.+||.+||++||.+|||+.|+++||||.+.+..
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~  303 (317)
T 2pmi_A          238 KLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFAEYYHH  303 (317)
T ss_dssp             GCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCC-
T ss_pred             hhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCChhhhcccch
Confidence                                      1367889999999999999999999999999999986644

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=2.6e-48  Score=369.98  Aligned_cols=247  Identities=33%  Similarity=0.709  Sum_probs=214.5

Q ss_pred             cccccCCeeecceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEE
Q 014609            4 AEKKQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVL   83 (421)
Q Consensus         4 ~~~~~~~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~   83 (421)
                      ++-......+++|++++.||+|+||.||+|.+..+++.||+|++.............+.+|+.++++++||||+++++++
T Consensus         4 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~   83 (284)
T 2vgo_A            4 AEMPKRKFTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYF   83 (284)
T ss_dssp             ------CCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred             hhCCccchhhhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEE
Confidence            44455667889999999999999999999999999999999999765433333356789999999999999999999999


Q ss_pred             EeCCEEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCC
Q 014609           84 ASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSAL  163 (421)
Q Consensus        84 ~~~~~~~lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~  163 (421)
                      .+.+..|+||||+++++|.+.+...+.+++..++.++.|++.||+|||++||+||||||+||+++.++.+||+|||++..
T Consensus        84 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~  163 (284)
T 2vgo_A           84 HDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVH  163 (284)
T ss_dssp             ECSSEEEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred             EcCCEEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEcCCCCEEEeccccccc
Confidence            99999999999999999999999888899999999999999999999999999999999999999999999999999864


Q ss_pred             CccccCCCccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhh-cC-------------------CcCCCCCCCHH
Q 014609          164 PQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIF-RG-------------------DFKLPKWLSPG  223 (421)
Q Consensus       164 ~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~-~~-------------------~~~~p~~~s~~  223 (421)
                      ...    ......+||+.|+|||++.+..+ +.++||||||+++|.+ .|                   ...+|+.+++.
T Consensus       164 ~~~----~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (284)
T 2vgo_A          164 APS----LRRRTMCGTLDYLPPEMIEGKTH-DEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKFPPFLSDG  238 (284)
T ss_dssp             CSS----SCBCCCCSCGGGCCHHHHTTCCB-CTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCTTSCHH
T ss_pred             Ccc----cccccccCCCCcCCHHHhccCCC-CcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHhccccCCCCcCCHH
Confidence            332    22345689999999999988777 5899999999999943 23                   33456778999


Q ss_pred             HHHHHHHhcCCCCCCCCCHHhhhcCccccccc
Q 014609          224 AQNLLRKILEPNPVKRITIAGIKADEWFEQDY  255 (421)
Q Consensus       224 ~~~li~~~L~~dP~~R~t~~eil~~~w~~~~~  255 (421)
                      +.++|.+||+.||.+|||+.++++||||+...
T Consensus       239 ~~~li~~~l~~~p~~Rps~~~ll~h~~~~~~~  270 (284)
T 2vgo_A          239 SKDLISKLLRYHPPQRLPLKGVMEHPWVKANS  270 (284)
T ss_dssp             HHHHHHHHSCSSGGGSCCHHHHHTCHHHHHHC
T ss_pred             HHHHHHHHhhcCHhhCCCHHHHhhCHHHHhhc
Confidence            99999999999999999999999999998654

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=1.9e-48  Score=383.28  Aligned_cols=238  Identities=32%  Similarity=0.637  Sum_probs=205.2

Q ss_pred             cceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccch--hHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEE
Q 014609           14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHL--KITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYM   91 (421)
Q Consensus        14 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~--~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l   91 (421)
                      ++|++.+.||+|+||+||+|.+..+|+.||||++........  ...+.+.+|+.+++.++||||+++++++.+.+.+|+
T Consensus        24 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l  103 (351)
T 3c0i_A           24 DVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYM  103 (351)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred             cceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence            689999999999999999999999999999999975432211  125779999999999999999999999999999999


Q ss_pred             EEeccCCCChHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCC---EEEEeccCCCCC
Q 014609           92 VLEYVTGGELFDKIASK----GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGN---IKISDFGLSALP  164 (421)
Q Consensus        92 v~E~~~gg~L~~~i~~~----~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~---~kL~DFGla~~~  164 (421)
                      ||||++|++|.+.+...    ..+++..++.++.||+.||+|||++||+||||||+|||++.++.   +||+|||++...
T Consensus       104 v~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a~~~  183 (351)
T 3c0i_A          104 VFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQL  183 (351)
T ss_dssp             EEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTCCEEECCCTTCEEC
T ss_pred             EEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCCcEEEecCcceeEe
Confidence            99999999998887542    35899999999999999999999999999999999999987665   999999999754


Q ss_pred             ccccCCCccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhh-cCCcCC------------------C----CCCC
Q 014609          165 QHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIF-RGDFKL------------------P----KWLS  221 (421)
Q Consensus       165 ~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~-~~~~~~------------------p----~~~s  221 (421)
                      ..  ........+||+.|+|||++.+..| +.++|||||||++|++ .|..++                  +    ..++
T Consensus       184 ~~--~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~i~~~~~~~~~~~~~~~s  260 (351)
T 3c0i_A          184 GE--SGLVAGGRVGTPHFMAPEVVKREPY-GKPVDVWGCGVILFILLSGCLPFYGTKERLFEGIIKGKYKMNPRQWSHIS  260 (351)
T ss_dssp             CT--TSCBCCCCCSCGGGCCHHHHTTCCB-CTHHHHHHHHHHHHHHHHSSCSSCSSHHHHHHHHHHTCCCCCHHHHTTSC
T ss_pred             cC--CCeeecCCcCCcCccCHHHHcCCCC-CchHhhHHHHHHHHHHHHCCCCCCCcHHHHHHHHHcCCCCCCccccccCC
Confidence            33  2223456689999999999988777 5899999999999954 333332                  1    3478


Q ss_pred             HHHHHHHHHhcCCCCCCCCCHHhhhcCcccccc
Q 014609          222 PGAQNLLRKILEPNPVKRITIAGIKADEWFEQD  254 (421)
Q Consensus       222 ~~~~~li~~~L~~dP~~R~t~~eil~~~w~~~~  254 (421)
                      +.+.+||.+||+.||.+|||+.++++||||+..
T Consensus       261 ~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~~  293 (351)
T 3c0i_A          261 ESAKDLVRRMLMLDPAERITVYEALNHPWLKER  293 (351)
T ss_dssp             HHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTH
T ss_pred             HHHHHHHHHHCCCChhHCcCHHHHhcChhhcCC
Confidence            999999999999999999999999999999853

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=3.9e-48  Score=373.38  Aligned_cols=239  Identities=29%  Similarity=0.447  Sum_probs=201.7

Q ss_pred             ecceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEE
Q 014609           13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMV   92 (421)
Q Consensus        13 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv   92 (421)
                      +++|++++.||+|+||+||+|.+..+|+.||+|++..... .....+.+.+|+.++++++||||+++++++...+..|+|
T Consensus         2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv   80 (311)
T 4agu_A            2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESED-DPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLV   80 (311)
T ss_dssp             -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC--HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred             cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeecccc-chHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEE
Confidence            5899999999999999999999999999999999865432 333456788999999999999999999999999999999


Q ss_pred             EeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCccccCCCc
Q 014609           93 LEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGL  172 (421)
Q Consensus        93 ~E~~~gg~L~~~i~~~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~  172 (421)
                      |||+++++|.+.+...+.+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||++.....  ....
T Consensus        81 ~e~~~~~~l~~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~--~~~~  158 (311)
T 4agu_A           81 FEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTG--PSDY  158 (311)
T ss_dssp             EECCSEEHHHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC-------
T ss_pred             EEeCCCchHHHHHhhhcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEcCCCCEEEeeCCCchhccC--cccc
Confidence            99999999999888888899999999999999999999999999999999999999999999999999975432  2223


Q ss_pred             cccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhh-cCCcCCC----------------------------------
Q 014609          173 LHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIF-RGDFKLP----------------------------------  217 (421)
Q Consensus       173 ~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~-~~~~~~p----------------------------------  217 (421)
                      ....+||+.|+|||++.+....+.++||||+||++|.+ .|..+++                                  
T Consensus       159 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (311)
T 4agu_A          159 YDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSG  238 (311)
T ss_dssp             -------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGGTT
T ss_pred             cCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhccccccccccccccccccc
Confidence            44568999999999997744446899999999999944 3433321                                  


Q ss_pred             ----------------CCCCHHHHHHHHHhcCCCCCCCCCHHhhhcCcccccc
Q 014609          218 ----------------KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD  254 (421)
Q Consensus       218 ----------------~~~s~~~~~li~~~L~~dP~~R~t~~eil~~~w~~~~  254 (421)
                                      +.+++.+.+||.+||+.||.+|||++|+++||||++.
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~  291 (311)
T 4agu_A          239 VKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENI  291 (311)
T ss_dssp             CCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTSGGGTTC
T ss_pred             CcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcChHHHhc
Confidence                            2367889999999999999999999999999999863

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2e-48  Score=378.59  Aligned_cols=237  Identities=25%  Similarity=0.464  Sum_probs=208.0

Q ss_pred             eecceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEE
Q 014609           12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYM   91 (421)
Q Consensus        12 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l   91 (421)
                      ..++|++++.||+|+||+||+|.+..+++.||+|++....    .....+.+|+.+++.++||||+++++++.+.+.+|+
T Consensus         3 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~----~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l   78 (321)
T 1tki_A            3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG----TDQVLVKKEISILNIARHRNILHLHESFESMEELVM   78 (321)
T ss_dssp             CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT----HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEE
T ss_pred             hhhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc----ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEE
Confidence            3579999999999999999999999999999999986432    234678999999999999999999999999999999


Q ss_pred             EEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecc--CCCEEEEeccCCCCCcccc
Q 014609           92 VLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDS--KGNIKISDFGLSALPQHFR  168 (421)
Q Consensus        92 v~E~~~gg~L~~~i~~~-~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~--~~~~kL~DFGla~~~~~~~  168 (421)
                      ||||++|++|.+++... ..+++..++.++.|++.||+|||++||+||||||+|||++.  ++.+||+|||++.....  
T Consensus        79 v~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~--  156 (321)
T 1tki_A           79 IFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP--  156 (321)
T ss_dssp             EECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCT--
T ss_pred             EEEeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCC--
Confidence            99999999999999765 47999999999999999999999999999999999999987  78999999999985432  


Q ss_pred             CCCccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhh-cCCcCC-------------------C----CCCCHHH
Q 014609          169 DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIF-RGDFKL-------------------P----KWLSPGA  224 (421)
Q Consensus       169 ~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~-~~~~~~-------------------p----~~~s~~~  224 (421)
                       .......+||+.|+|||++.+..+ +.++|||||||++|++ .|..|+                   +    +.+|+++
T Consensus       157 -~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~  234 (321)
T 1tki_A          157 -GDNFRLLFTAPEYYAPEVHQHDVV-STATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEA  234 (321)
T ss_dssp             -TCEEEEEESCGGGSCHHHHTTCEE-CHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHH
T ss_pred             -CCccccccCChhhcCcHHhcCCCC-CchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCCCCCChhhhccCCHHH
Confidence             234456789999999999987766 5899999999999954 333332                   1    2478999


Q ss_pred             HHHHHHhcCCCCCCCCCHHhhhcCcccccccc
Q 014609          225 QNLLRKILEPNPVKRITIAGIKADEWFEQDYT  256 (421)
Q Consensus       225 ~~li~~~L~~dP~~R~t~~eil~~~w~~~~~~  256 (421)
                      .++|.+||.+||.+|||+.|+++||||++...
T Consensus       235 ~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~~  266 (321)
T 1tki_A          235 MDFVDRLLVKERKSRMTASEALQHPWLKQKIE  266 (321)
T ss_dssp             HHHHHTTSCSSGGGSCCHHHHHHSHHHHSCGG
T ss_pred             HHHHHHHcCCChhHCcCHHHHhcChhhccCcc
Confidence            99999999999999999999999999986543

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=3.9e-48  Score=391.58  Aligned_cols=241  Identities=29%  Similarity=0.430  Sum_probs=203.4

Q ss_pred             ecceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeC-----C
Q 014609           13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASK-----S   87 (421)
Q Consensus        13 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~-----~   87 (421)
                      -++|++++.||+|+||.||+|++..+|+.||||++.... ........+.+|+.+|+.++||||+++++++...     .
T Consensus        25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~  103 (432)
T 3n9x_A           25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMF-EDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFD  103 (432)
T ss_dssp             CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTT-TSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCC
T ss_pred             cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchh-cChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCC
Confidence            479999999999999999999999999999999997542 3334467899999999999999999999999776     5


Q ss_pred             EEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCccc
Q 014609           88 KIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHF  167 (421)
Q Consensus        88 ~~~lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~  167 (421)
                      ..|+||||+. ++|.+.+.....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|......
T Consensus       104 ~~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~~kL~DFGla~~~~~~  182 (432)
T 3n9x_A          104 ELYIVLEIAD-SDLKKLFKTPIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSE  182 (432)
T ss_dssp             CEEEEEECCS-EEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEEC---
T ss_pred             eEEEEEecCC-cCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEECCCCCEEEccCCCccccccc
Confidence            7999999995 599999998888999999999999999999999999999999999999999999999999999865332


Q ss_pred             cCC--------------------CccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhhcC-----------CcC-
Q 014609          168 RDD--------------------GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIFRG-----------DFK-  215 (421)
Q Consensus       168 ~~~--------------------~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~~~-----------~~~-  215 (421)
                      ...                    ......+||+.|+|||++......+.++||||+||++|++..           +.+ 
T Consensus       183 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~p~  262 (432)
T 3n9x_A          183 KDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNRFPL  262 (432)
T ss_dssp             ----------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCSSGGGCCCS
T ss_pred             ccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccccccccccccc
Confidence            111                    234677899999999997544444699999999999997652           111 


Q ss_pred             CC-------------------------------------------------------------------CCCCHHHHHHH
Q 014609          216 LP-------------------------------------------------------------------KWLSPGAQNLL  228 (421)
Q Consensus       216 ~p-------------------------------------------------------------------~~~s~~~~~li  228 (421)
                      +|                                                                   +.+++.+.+||
T Consensus       263 f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl  342 (432)
T 3n9x_A          263 FPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSISDDGINLL  342 (432)
T ss_dssp             CCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHH
T ss_pred             CCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHH
Confidence            11                                                                   23689999999


Q ss_pred             HHhcCCCCCCCCCHHhhhcCccccccc
Q 014609          229 RKILEPNPVKRITIAGIKADEWFEQDY  255 (421)
Q Consensus       229 ~~~L~~dP~~R~t~~eil~~~w~~~~~  255 (421)
                      ++||+.||.+|||++|+++||||+...
T Consensus       343 ~~mL~~dP~~R~ta~e~L~Hp~f~~~~  369 (432)
T 3n9x_A          343 ESMLKFNPNKRITIDQALDHPYLKDVR  369 (432)
T ss_dssp             HHHSCSSTTTSCCHHHHHTCGGGTTTC
T ss_pred             HHHhcCCcccCCCHHHHhcChhhhhcc
Confidence            999999999999999999999998643

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=8e-48  Score=383.57  Aligned_cols=243  Identities=22%  Similarity=0.382  Sum_probs=207.7

Q ss_pred             eeecceEEeceEeec--CcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCE
Q 014609           11 MRLGRYELGRTLGEG--NFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSK   88 (421)
Q Consensus        11 ~~~~~y~i~~~LG~G--~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~   88 (421)
                      ...++|++++.||+|  +||+||+|++..+|+.||||++..... .....+.+.+|+.+++.++||||+++++++.+++.
T Consensus        22 ~~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~  100 (389)
T 3gni_B           22 PEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEAC-SNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNE  100 (389)
T ss_dssp             CCGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTE
T ss_pred             CCCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEeccccc-ChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCE
Confidence            345899999999999  999999999999999999999987543 33456788999999999999999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCcc
Q 014609           89 IYMVLEYVTGGELFDKIASK--GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQH  166 (421)
Q Consensus        89 ~~lv~E~~~gg~L~~~i~~~--~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~  166 (421)
                      +|+||||+++++|.+++...  ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||.+.....
T Consensus       101 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~~  180 (389)
T 3gni_B          101 LWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMIS  180 (389)
T ss_dssp             EEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCGGGCEECEE
T ss_pred             EEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccccceeecc
Confidence            99999999999999999875  6799999999999999999999999999999999999999999999999998864321


Q ss_pred             cc-----CCCccccccCCCCccChhhhcc--cCCCCCcchHHHHHHHHhhh-cCCcCC----------------------
Q 014609          167 FR-----DDGLLHTTCGSPNYVAPEVLAN--RGYDGATSDIWSCGVILYIF-RGDFKL----------------------  216 (421)
Q Consensus       167 ~~-----~~~~~~~~~gt~~y~APEvl~~--~~~~~~~~DiwSlGvil~~~-~~~~~~----------------------  216 (421)
                      ..     ........+||+.|+|||++.+  ..| +.++|||||||++|.+ .|..++                      
T Consensus       181 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~-~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  259 (389)
T 3gni_B          181 HGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGY-DAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLD  259 (389)
T ss_dssp             TTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCB-CTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC----------
T ss_pred             ccccccccccccccccccccccCHHHHhccCCCC-CcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCcccc
Confidence            11     1122334589999999999987  455 5899999999999944 333332                      


Q ss_pred             -------------------------------------------CCCCCHHHHHHHHHhcCCCCCCCCCHHhhhcCccccc
Q 014609          217 -------------------------------------------PKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQ  253 (421)
Q Consensus       217 -------------------------------------------p~~~s~~~~~li~~~L~~dP~~R~t~~eil~~~w~~~  253 (421)
                                                                 +..+++.+.+||++||+.||.+|||+.|+++||||+.
T Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~hp~f~~  339 (389)
T 3gni_B          260 TSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQ  339 (389)
T ss_dssp             ----------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTSGGGGG
T ss_pred             ccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcCHHHHH
Confidence                                                       2336788999999999999999999999999999986


Q ss_pred             cc
Q 014609          254 DY  255 (421)
Q Consensus       254 ~~  255 (421)
                      ..
T Consensus       340 ~~  341 (389)
T 3gni_B          340 IK  341 (389)
T ss_dssp             C-
T ss_pred             Hh
Confidence            43

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=1.5e-48  Score=380.32  Aligned_cols=243  Identities=27%  Similarity=0.424  Sum_probs=196.9

Q ss_pred             cCCeeecceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCC
Q 014609            8 QEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKS   87 (421)
Q Consensus         8 ~~~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~   87 (421)
                      ..+..+++|++++.||+|+||+||+|++..+|+.||||++..... .......+.+|+.++++++||||+++++++.+++
T Consensus        28 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~  106 (329)
T 3gbz_A           28 PSATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHE-EEGVPGTAIREVSLLKELQHRNIIELKSVIHHNH  106 (329)
T ss_dssp             ----CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC---------CHHHHHHGGGCCCTTBCCEEEEEEETT
T ss_pred             CcccchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEccccc-ccccchhHHHHHHHHHHcCCCCcceEEEEEecCC
Confidence            345678999999999999999999999999999999999975532 2223456789999999999999999999999999


Q ss_pred             EEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEec-----cCCCEEEEeccCCC
Q 014609           88 KIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLD-----SKGNIKISDFGLSA  162 (421)
Q Consensus        88 ~~~lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~-----~~~~~kL~DFGla~  162 (421)
                      .+|+||||++| +|.+++.....+++..++.++.||+.||+|||++||+||||||+|||++     .++.+||+|||++.
T Consensus       107 ~~~lv~e~~~~-~L~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~  185 (329)
T 3gbz_A          107 RLHLIFEYAEN-DLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLAR  185 (329)
T ss_dssp             EEEEEEECCSE-EHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEECCTTHHH
T ss_pred             EEEEEEecCCC-CHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEECcCCCcc
Confidence            99999999974 9999999888999999999999999999999999999999999999995     44459999999997


Q ss_pred             CCccccCCCccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhh-cCCcCCCC-----------------------
Q 014609          163 LPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIF-RGDFKLPK-----------------------  218 (421)
Q Consensus       163 ~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~-~~~~~~p~-----------------------  218 (421)
                      ....  ........+||+.|+|||++.+....+.++|||||||++|.+ .|..+++.                       
T Consensus       186 ~~~~--~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  263 (329)
T 3gbz_A          186 AFGI--PIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWP  263 (329)
T ss_dssp             HHC-------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTST
T ss_pred             ccCC--cccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhhhh
Confidence            5432  223345567899999999998765447999999999999944 33333211                       


Q ss_pred             --------------------------CCCHHHHHHHHHhcCCCCCCCCCHHhhhcCcccccc
Q 014609          219 --------------------------WLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD  254 (421)
Q Consensus       219 --------------------------~~s~~~~~li~~~L~~dP~~R~t~~eil~~~w~~~~  254 (421)
                                                .+++++.+||.+||+.||.+|||+.|+++||||+..
T Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~  325 (329)
T 3gbz_A          264 GVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFSHN  325 (329)
T ss_dssp             TGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSS
T ss_pred             hhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCCcccCCC
Confidence                                      167899999999999999999999999999999864

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=1.5e-48  Score=374.51  Aligned_cols=243  Identities=36%  Similarity=0.659  Sum_probs=200.8

Q ss_pred             cCCeeecceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccch-----------------------hHHHHHHHH
Q 014609            8 QEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHL-----------------------KITDQIKRE   64 (421)
Q Consensus         8 ~~~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~-----------------------~~~~~~~~E   64 (421)
                      .....+++|++.+.||+|+||.||+|++..+|+.||||++........                       ...+.+.+|
T Consensus         7 ~~~~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E   86 (298)
T 2zv2_A            7 GDCVQLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQE   86 (298)
T ss_dssp             ---CEETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHH
T ss_pred             CCceeecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHH
Confidence            344678999999999999999999999999999999999976543211                       123568899


Q ss_pred             HHHHhcCCCCCcceEEEEEEe--CCEEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCC
Q 014609           65 IATLKLLKHPNVVRLHEVLAS--KSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKL  142 (421)
Q Consensus        65 i~il~~l~hpnIv~l~~~~~~--~~~~~lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp  142 (421)
                      +.++++++||||+++++++.+  ....|+||||+++++|.+.+. ..++++..++.++.||+.||+|||++||+||||||
T Consensus        87 ~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp  165 (298)
T 2zv2_A           87 IAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT-LKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKP  165 (298)
T ss_dssp             HHHHHTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC-SSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCG
T ss_pred             HHHHHhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCH
Confidence            999999999999999999987  578999999999999987543 46799999999999999999999999999999999


Q ss_pred             CCEEeccCCCEEEEeccCCCCCccccCCCccccccCCCCccChhhhcccCC--CCCcchHHHHHHHHhhh-cCCcCC---
Q 014609          143 ENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGY--DGATSDIWSCGVILYIF-RGDFKL---  216 (421)
Q Consensus       143 ~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~--~~~~~DiwSlGvil~~~-~~~~~~---  216 (421)
                      +|||++.++.+||+|||++.....  ........+||+.|+|||++.+...  .+.++|||||||++|.+ .|..++   
T Consensus       166 ~Nil~~~~~~~kl~Dfg~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~  243 (298)
T 2zv2_A          166 SNLLVGEDGHIKIADFGVSNEFKG--SDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDE  243 (298)
T ss_dssp             GGEEECTTSCEEECCCTTCEECSS--SSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             HHEEECCCCCEEEecCCCcccccc--ccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCc
Confidence            999999999999999999975432  2233455689999999999876542  35789999999999943 333222   


Q ss_pred             ------------------CCCCCHHHHHHHHHhcCCCCCCCCCHHhhhcCccccc
Q 014609          217 ------------------PKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQ  253 (421)
Q Consensus       217 ------------------p~~~s~~~~~li~~~L~~dP~~R~t~~eil~~~w~~~  253 (421)
                                        ++.+++.+.++|.+||++||.+|||+.|+++||||.+
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~hp~~~~  298 (298)
T 2zv2_A          244 RIMCLHSKIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWVTR  298 (298)
T ss_dssp             SHHHHHHHHHHCCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTCHHHHC
T ss_pred             cHHHHHHHHhcccCCCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhcCccccC
Confidence                              2357899999999999999999999999999999963

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=3.1e-48  Score=368.15  Aligned_cols=243  Identities=31%  Similarity=0.648  Sum_probs=191.5

Q ss_pred             CeeecceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEE
Q 014609           10 GMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKI   89 (421)
Q Consensus        10 ~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~   89 (421)
                      +..+++|++++.||+|+||.||+|.+..+|+.||||++...........+.+.+|+.++++++||||+++++++.+.+..
T Consensus         7 g~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   86 (278)
T 3cok_A            7 GEKIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYV   86 (278)
T ss_dssp             CSSGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEE
T ss_pred             ccccccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeE
Confidence            56788999999999999999999999999999999999765433333457899999999999999999999999999999


Q ss_pred             EEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCcccc
Q 014609           90 YMVLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFR  168 (421)
Q Consensus        90 ~lv~E~~~gg~L~~~i~~~-~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~~  168 (421)
                      |+||||+++++|.+++... ..+++..++.++.|++.||+|||++||+||||||+||+++.++.+||+|||++...... 
T Consensus        87 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~-  165 (278)
T 3cok_A           87 YLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMP-  165 (278)
T ss_dssp             EEEEECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEECTTCCEEECCCTTCEECC---
T ss_pred             EEEEecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEEeecceeeccCC-
Confidence            9999999999999998865 57999999999999999999999999999999999999999999999999999754321 


Q ss_pred             CCCccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhh-cCC-------------------cCCCCCCCHHHHHHH
Q 014609          169 DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIF-RGD-------------------FKLPKWLSPGAQNLL  228 (421)
Q Consensus       169 ~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~-~~~-------------------~~~p~~~s~~~~~li  228 (421)
                       .......+||+.|+|||++.+..+ +.++||||+|+++|.+ .|.                   ...|..+++++.++|
T Consensus       166 -~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  243 (278)
T 3cok_A          166 -HEKHYTLCGTPNYISPEIATRSAH-GLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADYEMPSFLSIEAKDLI  243 (278)
T ss_dssp             ----------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----CCSSCCCCCTTSCHHHHHHH
T ss_pred             -CCcceeccCCCCcCCcchhcCCCC-CchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHHHhhcccCCccccCHHHHHHH
Confidence             122345679999999999887766 5899999999999943 232                   234556899999999


Q ss_pred             HHhcCCCCCCCCCHHhhhcCccccccc
Q 014609          229 RKILEPNPVKRITIAGIKADEWFEQDY  255 (421)
Q Consensus       229 ~~~L~~dP~~R~t~~eil~~~w~~~~~  255 (421)
                      .+||+.||.+|||+.++++||||....
T Consensus       244 ~~~l~~dp~~Rps~~~~l~h~~~~~~~  270 (278)
T 3cok_A          244 HQLLRRNPADRLSLSSVLDHPFMSRNS  270 (278)
T ss_dssp             HHHSCSSGGGSCCHHHHTTSTTTC---
T ss_pred             HHHcccCHhhCCCHHHHhcCccccCCC
Confidence            999999999999999999999998643

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=3.1e-48  Score=367.49  Aligned_cols=245  Identities=49%  Similarity=0.909  Sum_probs=207.0

Q ss_pred             cCCeeecceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCC
Q 014609            8 QEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKS   87 (421)
Q Consensus         8 ~~~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~   87 (421)
                      .+...+++|++++.||+|+||.||+|.+..+|+.||||++...........+.+.+|+.+++.++||||+++++++.+.+
T Consensus         5 ~g~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   84 (276)
T 2h6d_A            5 DGRVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPT   84 (276)
T ss_dssp             --CCEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSS
T ss_pred             cCcceeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCC
Confidence            34567899999999999999999999999999999999997654333344578999999999999999999999999999


Q ss_pred             EEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCccc
Q 014609           88 KIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHF  167 (421)
Q Consensus        88 ~~~lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~  167 (421)
                      ..|+||||+++++|.+++...+.+++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||++..... 
T Consensus        85 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~-  163 (276)
T 2h6d_A           85 DFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSD-  163 (276)
T ss_dssp             EEEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC-
T ss_pred             eEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEECCCCCEEEeecccccccCC-
Confidence            9999999999999999998888899999999999999999999999999999999999999999999999999985432 


Q ss_pred             cCCCccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhh-cCC-------------------cCCCCCCCHHHHHH
Q 014609          168 RDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIF-RGD-------------------FKLPKWLSPGAQNL  227 (421)
Q Consensus       168 ~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~-~~~-------------------~~~p~~~s~~~~~l  227 (421)
                        .......+||+.|+|||++.+..+.+.++||||||+++|.+ .|.                   ...|..+++.+.++
T Consensus       164 --~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  241 (276)
T 2h6d_A          164 --GEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFYIPEYLNRSVATL  241 (276)
T ss_dssp             ---------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHH
T ss_pred             --CcceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCcccCchhcCHHHHHH
Confidence              22334568999999999998877666889999999999943 333                   23456689999999


Q ss_pred             HHHhcCCCCCCCCCHHhhhcCccccccc
Q 014609          228 LRKILEPNPVKRITIAGIKADEWFEQDY  255 (421)
Q Consensus       228 i~~~L~~dP~~R~t~~eil~~~w~~~~~  255 (421)
                      |.+||+.||.+|||+.++++||||++..
T Consensus       242 i~~~l~~~p~~Rps~~~~l~h~~~~~~~  269 (276)
T 2h6d_A          242 LMHMLQVDPLKRATIKDIREHEWFKQDL  269 (276)
T ss_dssp             HHHHTCSSGGGSCCHHHHHHSHHHHTTC
T ss_pred             HHHHccCChhhCCCHHHHHhChhhccCc
Confidence            9999999999999999999999998654

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=1.2e-48  Score=392.33  Aligned_cols=243  Identities=30%  Similarity=0.518  Sum_probs=208.4

Q ss_pred             CeeecceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEE
Q 014609           10 GMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKI   89 (421)
Q Consensus        10 ~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~   89 (421)
                      ....++|++++.||+|+||+||+|++..+++.||+|++.+...........+.+|+.+++.++||||+++++++.+...+
T Consensus        65 ~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~  144 (410)
T 3v8s_A           65 RMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYL  144 (410)
T ss_dssp             SCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             ccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEE
Confidence            34568999999999999999999999999999999999764433222234588999999999999999999999999999


Q ss_pred             EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCccccC
Q 014609           90 YMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD  169 (421)
Q Consensus        90 ~lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~  169 (421)
                      |+||||++||+|.+++.. ..+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|...... .
T Consensus       145 ~lV~E~~~gg~L~~~l~~-~~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFG~a~~~~~~-~  222 (410)
T 3v8s_A          145 YMVMEYMPGGDLVNLMSN-YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKE-G  222 (410)
T ss_dssp             EEEECCCTTEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTT-S
T ss_pred             EEEEeCCCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeECCCCCEEEeccceeEeeccC-C
Confidence            999999999999998875 57999999999999999999999999999999999999999999999999999754321 1


Q ss_pred             CCccccccCCCCccChhhhcccCC---CCCcchHHHHHHHHhhh-cCCc---------------------CCC--CCCCH
Q 014609          170 DGLLHTTCGSPNYVAPEVLANRGY---DGATSDIWSCGVILYIF-RGDF---------------------KLP--KWLSP  222 (421)
Q Consensus       170 ~~~~~~~~gt~~y~APEvl~~~~~---~~~~~DiwSlGvil~~~-~~~~---------------------~~p--~~~s~  222 (421)
                      .....+.+||+.|+|||++.+.+.   .+.++|||||||++|.+ .|..                     .+|  ..+|+
T Consensus       223 ~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~  302 (410)
T 3v8s_A          223 MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISK  302 (410)
T ss_dssp             EEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCCTTCCCCH
T ss_pred             cccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhccccccCCCcccccH
Confidence            112346799999999999986551   25899999999999943 2322                     233  35899


Q ss_pred             HHHHHHHHhcCCCCCC--CCCHHhhhcCcccccc
Q 014609          223 GAQNLLRKILEPNPVK--RITIAGIKADEWFEQD  254 (421)
Q Consensus       223 ~~~~li~~~L~~dP~~--R~t~~eil~~~w~~~~  254 (421)
                      ++.+||++||..+|.+  |++++||++||||+..
T Consensus       303 ~~~~li~~lL~~~~~rlgR~~~~ei~~Hp~f~~~  336 (410)
T 3v8s_A          303 EAKNLICAFLTDREVRLGRNGVEEIKRHLFFKND  336 (410)
T ss_dssp             HHHHHHHHHSSCGGGCTTSSCHHHHHTSGGGCCS
T ss_pred             HHHHHHHHHccChhhhCCCCCHHHHhcCccccCC
Confidence            9999999999999988  9999999999999863

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=2.4e-47  Score=365.10  Aligned_cols=244  Identities=35%  Similarity=0.618  Sum_probs=216.8

Q ss_pred             eeecceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEE
Q 014609           11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIY   90 (421)
Q Consensus        11 ~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~   90 (421)
                      ...++|++++.||+|+||.||+|.+..+++.||+|++...........+.+.+|+.+++.++||||+++++++.+.+..|
T Consensus        12 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~   91 (294)
T 2rku_A           12 RSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVF   91 (294)
T ss_dssp             TTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred             CcccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEE
Confidence            44579999999999999999999999999999999998766555556678999999999999999999999999999999


Q ss_pred             EEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCccccCC
Q 014609           91 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD  170 (421)
Q Consensus        91 lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~  170 (421)
                      +||||++|++|.+.+.....+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||++.....  ..
T Consensus        92 lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~--~~  169 (294)
T 2rku_A           92 VVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY--DG  169 (294)
T ss_dssp             EEEECCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCS--TT
T ss_pred             EEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEcCCCCEEEEeccCceeccc--Cc
Confidence            9999999999999998888999999999999999999999999999999999999999999999999999975432  12


Q ss_pred             CccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhh-cC-------------------CcCCCCCCCHHHHHHHHH
Q 014609          171 GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIF-RG-------------------DFKLPKWLSPGAQNLLRK  230 (421)
Q Consensus       171 ~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~-~~-------------------~~~~p~~~s~~~~~li~~  230 (421)
                      ......+||+.|+|||++.+..+ +.++||||+|+++|.+ .|                   ....|..+++.+.++|.+
T Consensus       170 ~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  248 (294)
T 2rku_A          170 ERKKVLCGTPNYIAPEVLSKKGH-SFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQK  248 (294)
T ss_dssp             CCBCCCCSCCSSCCHHHHTTSCB-CTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCTTSCHHHHHHHHH
T ss_pred             cccccccCCCCcCCcchhccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhccCCCccccCHHHHHHHHH
Confidence            23445679999999999987766 5899999999999943 22                   234567789999999999


Q ss_pred             hcCCCCCCCCCHHhhhcCccccccccC
Q 014609          231 ILEPNPVKRITIAGIKADEWFEQDYTP  257 (421)
Q Consensus       231 ~L~~dP~~R~t~~eil~~~w~~~~~~~  257 (421)
                      ||+.||.+|||+.++++||||.....+
T Consensus       249 ~l~~~p~~Rps~~~ll~~~~~~~~~~~  275 (294)
T 2rku_A          249 MLQTDPTARPTINELLNDEFFTSGYIP  275 (294)
T ss_dssp             HTCSSGGGSCCGGGGGGSHHHHTSCCC
T ss_pred             HcccChhhCcCHHHHhhChheecCCcC
Confidence            999999999999999999999876544

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=5.5e-48  Score=376.00  Aligned_cols=233  Identities=39%  Similarity=0.731  Sum_probs=187.3

Q ss_pred             ecceEEe---ceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCC-CCCcceEEEEEEeCCE
Q 014609           13 LGRYELG---RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK-HPNVVRLHEVLASKSK   88 (421)
Q Consensus        13 ~~~y~i~---~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~   88 (421)
                      ..+|++.   +.||+|+||+||+|.+..+|+.||||++.+.      ....+.+|+.+++.+. ||||+++++++.+...
T Consensus         7 ~~~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~   80 (325)
T 3kn6_A            7 YQHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKR------MEANTQKEITALKLCEGHPNIVKLHEVFHDQLH   80 (325)
T ss_dssp             HHHEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGG------GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred             hhccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChh------hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCE
Confidence            4678885   7899999999999999999999999999753      2467889999999997 9999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCC---CEEEEeccCCCCCc
Q 014609           89 IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKG---NIKISDFGLSALPQ  165 (421)
Q Consensus        89 ~~lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~---~~kL~DFGla~~~~  165 (421)
                      .|+||||++|++|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++   .+||+|||++....
T Consensus        81 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~  160 (325)
T 3kn6_A           81 TFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKP  160 (325)
T ss_dssp             EEEEECCCCSCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEECCCTTCEECC
T ss_pred             EEEEEEccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEEeccccceecC
Confidence            999999999999999999988999999999999999999999999999999999999998766   79999999997543


Q ss_pred             cccCCCccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhh-cCCcCCC---------------------------
Q 014609          166 HFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIF-RGDFKLP---------------------------  217 (421)
Q Consensus       166 ~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~-~~~~~~p---------------------------  217 (421)
                      .  ........+||+.|+|||++.+..| +.++|||||||++|.+ .|..++.                           
T Consensus       161 ~--~~~~~~~~~~t~~y~aPE~~~~~~~-~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~~~~  237 (325)
T 3kn6_A          161 P--DNQPLKTPCFTLHYAAPELLNQNGY-DESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEG  237 (325)
T ss_dssp             C------------------------CCC-CHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCCCCS
T ss_pred             C--CCCcccccCCCcCccCHHHhcCCCC-CCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCCCCc
Confidence            3  2334556789999999999988877 5899999999999944 3444432                           


Q ss_pred             ---CCCCHHHHHHHHHhcCCCCCCCCCHHhhhcCcccccc
Q 014609          218 ---KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD  254 (421)
Q Consensus       218 ---~~~s~~~~~li~~~L~~dP~~R~t~~eil~~~w~~~~  254 (421)
                         ..+++++.+||.+||++||.+|||+.++++||||+..
T Consensus       238 ~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h~w~~~~  277 (325)
T 3kn6_A          238 EAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDG  277 (325)
T ss_dssp             HHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTCGGGCTT
T ss_pred             ccccCCCHHHHHHHHHHCCCChhHCCCHHHHhcChhhccC
Confidence               1368999999999999999999999999999999853

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=5.1e-48  Score=384.97  Aligned_cols=240  Identities=32%  Similarity=0.444  Sum_probs=194.0

Q ss_pred             eecceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCC-CCCcceEEEEEEeCC--E
Q 014609           12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK-HPNVVRLHEVLASKS--K   88 (421)
Q Consensus        12 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~--~   88 (421)
                      .+++|++++.||+|+||.||+|.+..+|+.||||++.+.. ........+.+|+.+++.+. ||||+++++++...+  .
T Consensus         7 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~-~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~   85 (388)
T 3oz6_A            7 VLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAF-QNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRD   85 (388)
T ss_dssp             HHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC---CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSC
T ss_pred             ccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccc-cChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCE
Confidence            4589999999999999999999999999999999986542 23344677889999999997 999999999997654  7


Q ss_pred             EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCccc-
Q 014609           89 IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHF-  167 (421)
Q Consensus        89 ~~lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~-  167 (421)
                      +|+||||+. ++|.+.+.. ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|...... 
T Consensus        86 ~~lv~e~~~-~~L~~~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~  163 (388)
T 3oz6_A           86 VYLVFDYME-TDLHAVIRA-NILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIR  163 (388)
T ss_dssp             EEEEEECCS-EEHHHHHHH-TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEESSSCC
T ss_pred             EEEEecccC-cCHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEcCCCCEEecCCcccccccccc
Confidence            999999996 589888876 67999999999999999999999999999999999999999999999999999754221 


Q ss_pred             ------------------cCCCccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhh-cCCcCCC-----------
Q 014609          168 ------------------RDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIF-RGDFKLP-----------  217 (421)
Q Consensus       168 ------------------~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~-~~~~~~p-----------  217 (421)
                                        .........+||+.|+|||++.+....+.++||||+||++|.+ .|..+++           
T Consensus       164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i  243 (388)
T 3oz6_A          164 RVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLERI  243 (388)
T ss_dssp             CCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH
T ss_pred             cccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence                              1122345568999999999998744446899999999999954 4444432           


Q ss_pred             -------------------------------------------------------CCCCHHHHHHHHHhcCCCCCCCCCH
Q 014609          218 -------------------------------------------------------KWLSPGAQNLLRKILEPNPVKRITI  242 (421)
Q Consensus       218 -------------------------------------------------------~~~s~~~~~li~~~L~~dP~~R~t~  242 (421)
                                                                             ..+++++.+||.+||+.||.+|||+
T Consensus       244 ~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~R~t~  323 (388)
T 3oz6_A          244 IGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKRISA  323 (388)
T ss_dssp             HHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGGSCCH
T ss_pred             HHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcccCCCH
Confidence                                                                   1467899999999999999999999


Q ss_pred             HhhhcCcccccc
Q 014609          243 AGIKADEWFEQD  254 (421)
Q Consensus       243 ~eil~~~w~~~~  254 (421)
                      +|+++||||...
T Consensus       324 ~e~l~Hp~~~~~  335 (388)
T 3oz6_A          324 NDALKHPFVSIF  335 (388)
T ss_dssp             HHHTTSTTTTTT
T ss_pred             HHHhCCHHHHHh
Confidence            999999999854

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=1.8e-47  Score=363.16  Aligned_cols=236  Identities=24%  Similarity=0.344  Sum_probs=203.0

Q ss_pred             eecceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcC-CCCCcceEEEEEEeCCEEE
Q 014609           12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEVLASKSKIY   90 (421)
Q Consensus        12 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~   90 (421)
                      ..++|++++.||+|+||+||+|.+..+++.||+|++....... .....+.+|+..+..+ +||||+++++++.+++..|
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~   87 (289)
T 1x8b_A            9 YTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGS-VDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHML   87 (289)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTS-HHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEE
T ss_pred             ccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEeccccccc-HHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEE
Confidence            3478999999999999999999999999999999998654333 2356788999999999 8999999999999999999


Q ss_pred             EEEeccCCCChHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCC---------------
Q 014609           91 MVLEYVTGGELFDKIASK----GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKG---------------  151 (421)
Q Consensus        91 lv~E~~~gg~L~~~i~~~----~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~---------------  151 (421)
                      +||||++|++|.+++...    ..+++..++.++.||+.||+|||++||+||||||+|||++.++               
T Consensus        88 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~  167 (289)
T 1x8b_A           88 IQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWA  167 (289)
T ss_dssp             EEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC------------------
T ss_pred             EEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCccccccccccccc
Confidence            999999999999999764    6799999999999999999999999999999999999998544               


Q ss_pred             ----CEEEEeccCCCCCccccCCCccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhhcCCcC------------
Q 014609          152 ----NIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIFRGDFK------------  215 (421)
Q Consensus       152 ----~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~~~~~~------------  215 (421)
                          .+||+|||++.....      .....||+.|+|||++.+....+.++|||||||++|.+.+..+            
T Consensus       168 ~~~~~~kl~Dfg~~~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~  241 (289)
T 1x8b_A          168 SNKVMFKIGDLGHVTRISS------PQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQWHEIR  241 (289)
T ss_dssp             --CCCEEECCCTTCEETTC------SCCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHHHHHHH
T ss_pred             CCceEEEEcccccccccCC------ccccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhHHHHHH
Confidence                799999999875432      2234699999999999876454578999999999997665433            


Q ss_pred             ------CCCCCCHHHHHHHHHhcCCCCCCCCCHHhhhcCcccccc
Q 014609          216 ------LPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD  254 (421)
Q Consensus       216 ------~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~~~w~~~~  254 (421)
                            +|..+++.+.++|.+||++||.+|||+.++++||||...
T Consensus       242 ~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~  286 (289)
T 1x8b_A          242 QGRLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLSA  286 (289)
T ss_dssp             TTCCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTCTTC---
T ss_pred             cCCCCCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhChHhhhh
Confidence                  345689999999999999999999999999999999863

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=6.5e-48  Score=365.03  Aligned_cols=242  Identities=39%  Similarity=0.706  Sum_probs=211.9

Q ss_pred             eecceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEE
Q 014609           12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYM   91 (421)
Q Consensus        12 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l   91 (421)
                      .+++|++++.||+|+||.||+|.+..+++.||+|++......  ...+.+.+|+.+++.++||||+++++++.+.+..|+
T Consensus         5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   82 (276)
T 2yex_A            5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKMLNHENVVKFYGHRREGNIQYL   82 (276)
T ss_dssp             HHHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCT--THHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred             eecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccch--hhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEE
Confidence            357999999999999999999999999999999999765432  335789999999999999999999999999999999


Q ss_pred             EEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCccccCCC
Q 014609           92 VLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDG  171 (421)
Q Consensus        92 v~E~~~gg~L~~~i~~~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~  171 (421)
                      ||||+++++|.+++.....+++..++.++.|++.||+|||++||+||||||+||+++.++.+||+|||++..........
T Consensus        83 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~  162 (276)
T 2yex_A           83 FLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRER  162 (276)
T ss_dssp             EEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEEC
T ss_pred             EEEecCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEccCCCEEEeeCCCccccCCCcchh
Confidence            99999999999999877789999999999999999999999999999999999999999999999999997654322223


Q ss_pred             ccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhh-cCCcCCC----------------------CCCCHHHHHHH
Q 014609          172 LLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIF-RGDFKLP----------------------KWLSPGAQNLL  228 (421)
Q Consensus       172 ~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~-~~~~~~p----------------------~~~s~~~~~li  228 (421)
                      .....+||+.|+|||++.+..+.+.++||||||+++|.+ .|..++.                      ..+++.+.++|
T Consensus       163 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  242 (276)
T 2yex_A          163 LLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALL  242 (276)
T ss_dssp             CBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTCTTSTTGGGSCHHHHHHH
T ss_pred             cccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhcccccCchhhcCHHHHHHH
Confidence            345678999999999998777656789999999999944 3433321                      23688999999


Q ss_pred             HHhcCCCCCCCCCHHhhhcCccccccc
Q 014609          229 RKILEPNPVKRITIAGIKADEWFEQDY  255 (421)
Q Consensus       229 ~~~L~~dP~~R~t~~eil~~~w~~~~~  255 (421)
                      .+||+.||.+|||+.++++||||++..
T Consensus       243 ~~~l~~~p~~Rps~~~il~~~~~~~~~  269 (276)
T 2yex_A          243 HKILVENPSARITIPDIKKDRWYNKPL  269 (276)
T ss_dssp             HHHSCSSTTTSCCHHHHTTCTTTTCCC
T ss_pred             HHHCCCCchhCCCHHHHhcCccccChh
Confidence            999999999999999999999998754

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=2.9e-47  Score=372.11  Aligned_cols=243  Identities=35%  Similarity=0.623  Sum_probs=216.9

Q ss_pred             eecceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEE
Q 014609           12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYM   91 (421)
Q Consensus        12 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l   91 (421)
                      ..++|++++.||+|+||.||+|.+..+++.||+|++...........+.+.+|+.+++.++||||+++++++.+.+..|+
T Consensus        39 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  118 (335)
T 2owb_A           39 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFV  118 (335)
T ss_dssp             TTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred             cCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEE
Confidence            34689999999999999999999999999999999987665555567889999999999999999999999999999999


Q ss_pred             EEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCccccCCC
Q 014609           92 VLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDG  171 (421)
Q Consensus        92 v~E~~~gg~L~~~i~~~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~  171 (421)
                      ||||+.+++|.+++.....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.....  ...
T Consensus       119 v~e~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~--~~~  196 (335)
T 2owb_A          119 VLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY--DGE  196 (335)
T ss_dssp             EECCCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCS--TTC
T ss_pred             EEecCCCCCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEEcCCCCEEEeeccCceeccc--Ccc
Confidence            999999999999998888899999999999999999999999999999999999999999999999999975432  122


Q ss_pred             ccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhh-cC-------------------CcCCCCCCCHHHHHHHHHh
Q 014609          172 LLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIF-RG-------------------DFKLPKWLSPGAQNLLRKI  231 (421)
Q Consensus       172 ~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~-~~-------------------~~~~p~~~s~~~~~li~~~  231 (421)
                      .....+||+.|+|||++.+..+ +.++|||||||++|.+ .|                   ...+|..+++.+.++|.+|
T Consensus       197 ~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~  275 (335)
T 2owb_A          197 RKKVLCGTPNYIAPEVLSKKGH-SFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQKM  275 (335)
T ss_dssp             CBCCCCSCCSSCCHHHHHTSCB-CTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCTTSCHHHHHHHHHH
T ss_pred             cccccCCCccccCHHHhccCCC-CchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHhcCCCCCCccCCHHHHHHHHHH
Confidence            3445689999999999988776 5899999999999943 22                   2345667899999999999


Q ss_pred             cCCCCCCCCCHHhhhcCccccccccC
Q 014609          232 LEPNPVKRITIAGIKADEWFEQDYTP  257 (421)
Q Consensus       232 L~~dP~~R~t~~eil~~~w~~~~~~~  257 (421)
                      |+.||.+|||+.++++||||...+.+
T Consensus       276 l~~dp~~Rps~~ell~~~~~~~~~~~  301 (335)
T 2owb_A          276 LQTDPTARPTINELLNDEFFTSGYIP  301 (335)
T ss_dssp             TCSSGGGSCCGGGGGGSHHHHTSCCC
T ss_pred             ccCChhHCcCHHHHhcCccccCCCcc
Confidence            99999999999999999999976654

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=2.2e-48  Score=381.63  Aligned_cols=231  Identities=36%  Similarity=0.636  Sum_probs=202.1

Q ss_pred             ecceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcC-CCCCcceEEEEEEeCCEEEE
Q 014609           13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEVLASKSKIYM   91 (421)
Q Consensus        13 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~l   91 (421)
                      .++|++++.||+|+||+||+|.+..+|+.||||++.+...       ...+|++++.++ +||||+++++++.+.+..|+
T Consensus        21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~-------~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~l   93 (342)
T 2qr7_A           21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR-------DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYV   93 (342)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC-------CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEE
T ss_pred             cccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC-------ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEE
Confidence            4789999999999999999999999999999999976532       235688888887 79999999999999999999


Q ss_pred             EEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccC-C---CEEEEeccCCCCCccc
Q 014609           92 VLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSK-G---NIKISDFGLSALPQHF  167 (421)
Q Consensus        92 v~E~~~gg~L~~~i~~~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~-~---~~kL~DFGla~~~~~~  167 (421)
                      ||||++||+|.+.+...+.+++..++.++.||+.||+|||++||+||||||+|||+..+ +   .+||+|||++..... 
T Consensus        94 v~E~~~gg~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~-  172 (342)
T 2qr7_A           94 VTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRA-  172 (342)
T ss_dssp             EECCCCSCBHHHHHHTCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBC-
T ss_pred             EEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcC-
Confidence            99999999999999988899999999999999999999999999999999999998543 3   499999999985433 


Q ss_pred             cCCCccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhh-cCCcCCC--------------------------CCC
Q 014609          168 RDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIF-RGDFKLP--------------------------KWL  220 (421)
Q Consensus       168 ~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~-~~~~~~p--------------------------~~~  220 (421)
                       ......+.+||+.|+|||++.+..| +.++|||||||++|++ .|..++.                          ..+
T Consensus       173 -~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~  250 (342)
T 2qr7_A          173 -ENGLLMTPCYTANFVAPEVLERQGY-DAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGGYWNSV  250 (342)
T ss_dssp             -TTCCBCCSSCCSSCCCHHHHHHHHH-HHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCCCCCCSTTTTTS
T ss_pred             -CCCceeccCCCccccCHHHhcCCCC-CCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCCcccCccccccC
Confidence             2334567799999999999988777 4899999999999954 3333321                          347


Q ss_pred             CHHHHHHHHHhcCCCCCCCCCHHhhhcCccccc
Q 014609          221 SPGAQNLLRKILEPNPVKRITIAGIKADEWFEQ  253 (421)
Q Consensus       221 s~~~~~li~~~L~~dP~~R~t~~eil~~~w~~~  253 (421)
                      |+.+.+||++||.+||.+|||+.++++||||..
T Consensus       251 s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~  283 (342)
T 2qr7_A          251 SDTAKDLVSKMLHVDPHQRLTAALVLRHPWIVH  283 (342)
T ss_dssp             CHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHT
T ss_pred             CHHHHHHHHHHCCCChhHCcCHHHHhcCCeecC
Confidence            899999999999999999999999999999975

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=2.2e-48  Score=380.47  Aligned_cols=241  Identities=31%  Similarity=0.522  Sum_probs=211.7

Q ss_pred             eeecceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccch-----hHHHHHHHHHHHHhcCCCCCcceEEEEEEe
Q 014609           11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHL-----KITDQIKREIATLKLLKHPNVVRLHEVLAS   85 (421)
Q Consensus        11 ~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~-----~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~   85 (421)
                      ...++|++++.||+|+||+||+|++..+++.||||++........     .....+.+|+.++++++||||+++++++.+
T Consensus        21 ~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~  100 (335)
T 3dls_A           21 EYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFEN  100 (335)
T ss_dssp             HHHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEEC
T ss_pred             ccccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEee
Confidence            445799999999999999999999999999999999987543221     123457789999999999999999999999


Q ss_pred             CCEEEEEEeccCCC-ChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCC
Q 014609           86 KSKIYMVLEYVTGG-ELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALP  164 (421)
Q Consensus        86 ~~~~~lv~E~~~gg-~L~~~i~~~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~  164 (421)
                      .+..|+||||+.+| +|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++...
T Consensus       101 ~~~~~lv~e~~~~g~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~  180 (335)
T 3dls_A          101 QGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYL  180 (335)
T ss_dssp             SSEEEEEEECCTTSCBHHHHHHTCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred             CCEEEEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEcCCCcEEEeecccceEC
Confidence            99999999999766 99999998889999999999999999999999999999999999999999999999999999754


Q ss_pred             ccccCCCccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhh-cCCcC-------------CCCCCCHHHHHHHHH
Q 014609          165 QHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIF-RGDFK-------------LPKWLSPGAQNLLRK  230 (421)
Q Consensus       165 ~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~-~~~~~-------------~p~~~s~~~~~li~~  230 (421)
                      ..   .......+||+.|+|||++.+..+.+.++|||||||++|.+ .|..+             .|..+++++.+||.+
T Consensus       181 ~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~l~~li~~  257 (335)
T 3dls_A          181 ER---GKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEETVEAAIHPPYLVSKELMSLVSG  257 (335)
T ss_dssp             CT---TCCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGGTTTCCCCSSCCCHHHHHHHHH
T ss_pred             CC---CCceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHHHhhccCCCcccCHHHHHHHHH
Confidence            32   33445678999999999998888767889999999999954 33333             345589999999999


Q ss_pred             hcCCCCCCCCCHHhhhcCcccccc
Q 014609          231 ILEPNPVKRITIAGIKADEWFEQD  254 (421)
Q Consensus       231 ~L~~dP~~R~t~~eil~~~w~~~~  254 (421)
                      ||++||.+|||+.++++||||.+.
T Consensus       258 ~L~~dP~~Rps~~ell~hp~~~~~  281 (335)
T 3dls_A          258 LLQPVPERRTTLEKLVTDPWVTQP  281 (335)
T ss_dssp             HTCSSGGGSCCHHHHHHCTTTTCC
T ss_pred             HccCChhhCcCHHHHhcCccccCC
Confidence            999999999999999999999864

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=5.9e-48  Score=390.26  Aligned_cols=241  Identities=27%  Similarity=0.501  Sum_probs=207.0

Q ss_pred             eeecceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEE
Q 014609           11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIY   90 (421)
Q Consensus        11 ~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~   90 (421)
                      ...++|++++.||+|+||+||+|++..+++.||+|++.+...........+.+|+.++..++||||+++++++.+.+.+|
T Consensus        71 ~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~  150 (437)
T 4aw2_A           71 LHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLY  150 (437)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEE
T ss_pred             CChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCEEE
Confidence            44579999999999999999999999999999999998644332222345889999999999999999999999999999


Q ss_pred             EEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCccccC
Q 014609           91 MVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD  169 (421)
Q Consensus        91 lv~E~~~gg~L~~~i~~-~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~  169 (421)
                      +||||++||+|.+++.. .+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|...... .
T Consensus       151 lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~-~  229 (437)
T 4aw2_A          151 LVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMED-G  229 (437)
T ss_dssp             EEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTT-S
T ss_pred             EEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeEcCCCCEEEcchhhhhhcccC-C
Confidence            99999999999999987 578999999999999999999999999999999999999999999999999999744321 1


Q ss_pred             CCccccccCCCCccChhhhc-----ccCCCCCcchHHHHHHHHhhh-cCCc---------------------CCCCC---
Q 014609          170 DGLLHTTCGSPNYVAPEVLA-----NRGYDGATSDIWSCGVILYIF-RGDF---------------------KLPKW---  219 (421)
Q Consensus       170 ~~~~~~~~gt~~y~APEvl~-----~~~~~~~~~DiwSlGvil~~~-~~~~---------------------~~p~~---  219 (421)
                      .......+||+.|+|||++.     ...| +.++|||||||++|++ .|..                     .+|..   
T Consensus       230 ~~~~~~~~GT~~Y~APE~l~~~~~~~~~~-~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~  308 (437)
T 4aw2_A          230 TVQSSVAVGTPDYISPEILQAMEGGKGRY-GPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPTQVTD  308 (437)
T ss_dssp             CEECCSCCSCGGGCCHHHHHHHHTSCCEE-CTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCCSSCCC
T ss_pred             CcccccccCCcCeeChHHHhhcccCCCCC-CCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhccccccCCccccc
Confidence            12234468999999999987     3344 6899999999999943 3332                     33433   


Q ss_pred             CCHHHHHHHHHhcCCCCCC--CCCHHhhhcCccccc
Q 014609          220 LSPGAQNLLRKILEPNPVK--RITIAGIKADEWFEQ  253 (421)
Q Consensus       220 ~s~~~~~li~~~L~~dP~~--R~t~~eil~~~w~~~  253 (421)
                      +|+++.+||++||..+|++  |++++|+++||||+.
T Consensus       309 ~s~~~~dLi~~lL~~~~~r~~r~~~~eil~Hpff~~  344 (437)
T 4aw2_A          309 VSENAKDLIRRLICSREHRLGQNGIEDFKKHPFFSG  344 (437)
T ss_dssp             SCHHHHHHHHTTSSCGGGCTTTTTTHHHHTSGGGTT
T ss_pred             CCHHHHHHHHHHhcccccccCCCCHHHHhCCCccCC
Confidence            8999999999999998888  999999999999975

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=8.9e-48  Score=392.29  Aligned_cols=236  Identities=29%  Similarity=0.451  Sum_probs=197.2

Q ss_pred             eecceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeC-----
Q 014609           12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASK-----   86 (421)
Q Consensus        12 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~-----   86 (421)
                      ..++|++++.||+|+||+||+|.+..+|+.||||++.+.. ........+.+|+.+|+.++||||+++++++...     
T Consensus        60 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~  138 (464)
T 3ttj_A           60 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPF-QNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEE  138 (464)
T ss_dssp             EETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGG-GSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTT
T ss_pred             ecCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccc-cChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCcccc
Confidence            4589999999999999999999999999999999997653 2334467889999999999999999999999654     


Q ss_pred             -CEEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCc
Q 014609           87 -SKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQ  165 (421)
Q Consensus        87 -~~~~lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~  165 (421)
                       ..+|+||||+.+ +|.+.+.  ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++....
T Consensus       139 ~~~~~lv~E~~~~-~l~~~~~--~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~  215 (464)
T 3ttj_A          139 FQDVYLVMELMDA-NLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG  215 (464)
T ss_dssp             CCEEEEEEECCSE-EHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCCC----
T ss_pred             CCeEEEEEeCCCC-CHHHHHh--hcCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEEeCCCCEEEEEEEeeeecC
Confidence             468999999965 5666664  359999999999999999999999999999999999999999999999999998543


Q ss_pred             cccCCCccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhh-cCCcCCCCC-------------------------
Q 014609          166 HFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIF-RGDFKLPKW-------------------------  219 (421)
Q Consensus       166 ~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~-~~~~~~p~~-------------------------  219 (421)
                      .   .......+||+.|+|||++.+..|+ .++|||||||++|.+ .|..+++..                         
T Consensus       216 ~---~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~~  291 (464)
T 3ttj_A          216 T---SFMMTPYVVTRYYRAPEVILGMGYK-ENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ  291 (464)
T ss_dssp             ----CCCC----CCCTTCCHHHHTTCCCC-TTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTSC
T ss_pred             C---CcccCCCcccccccCHHHHcCCCCC-HHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHcc
Confidence            2   3345667999999999999988884 899999999999954 444443311                         


Q ss_pred             ------------------------------------CCHHHHHHHHHhcCCCCCCCCCHHhhhcCccccccc
Q 014609          220 ------------------------------------LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY  255 (421)
Q Consensus       220 ------------------------------------~s~~~~~li~~~L~~dP~~R~t~~eil~~~w~~~~~  255 (421)
                                                          .++++.+||.+||+.||.+|||++|+++||||+...
T Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~~~~~~  363 (464)
T 3ttj_A          292 PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWY  363 (464)
T ss_dssp             HHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGGC
T ss_pred             hhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcChhhhhcc
Confidence                                                045789999999999999999999999999998654

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=6.4e-48  Score=374.18  Aligned_cols=239  Identities=25%  Similarity=0.442  Sum_probs=200.5

Q ss_pred             eecceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCC----
Q 014609           12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKS----   87 (421)
Q Consensus        12 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~----   87 (421)
                      .+++|++++.||+|+||.||+|++..+|+.||||++....  .....+.+.+|+.+|++++||||+++++++.+..    
T Consensus         4 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~   81 (332)
T 3qd2_B            4 YLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPN--RELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKW   81 (332)
T ss_dssp             HHHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCS--TTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHH
T ss_pred             hhhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCC--chhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchh
Confidence            4689999999999999999999999999999999997644  2234578999999999999999999999986543    


Q ss_pred             -----------------------------------------------------EEEEEEeccCCCChHHHHHhcCC---C
Q 014609           88 -----------------------------------------------------KIYMVLEYVTGGELFDKIASKGR---L  111 (421)
Q Consensus        88 -----------------------------------------------------~~~lv~E~~~gg~L~~~i~~~~~---~  111 (421)
                                                                           ..|+||||++|++|.+++.....   .
T Consensus        82 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~  161 (332)
T 3qd2_B           82 QEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDR  161 (332)
T ss_dssp             HHHHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGS
T ss_pred             hhhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccch
Confidence                                                                 38999999999999999987543   5


Q ss_pred             CHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCccccCC----------CccccccCCCC
Q 014609          112 QEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD----------GLLHTTCGSPN  181 (421)
Q Consensus       112 ~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~----------~~~~~~~gt~~  181 (421)
                      ++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.........          ......+||+.
T Consensus       162 ~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~  241 (332)
T 3qd2_B          162 EHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKL  241 (332)
T ss_dssp             CHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGG
T ss_pred             hhHHHHHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcC
Confidence            66678999999999999999999999999999999999999999999999865432111          12344579999


Q ss_pred             ccChhhhcccCCCCCcchHHHHHHHHhhhcCCcCC----------------C---CCCCHHHHHHHHHhcCCCCCCCCCH
Q 014609          182 YVAPEVLANRGYDGATSDIWSCGVILYIFRGDFKL----------------P---KWLSPGAQNLLRKILEPNPVKRITI  242 (421)
Q Consensus       182 y~APEvl~~~~~~~~~~DiwSlGvil~~~~~~~~~----------------p---~~~s~~~~~li~~~L~~dP~~R~t~  242 (421)
                      |+|||++.+..+ +.++||||+||++|.+...+..                |   ...++.+.++|.+||++||.+|||+
T Consensus       242 y~aPE~~~~~~~-~~~~Di~slG~il~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~  320 (332)
T 3qd2_B          242 YMSPEQIHGNNY-SHKVDIFSLGLILFELLYSFSTQMERVRIITDVRNLKFPLLFTQKYPQEHMMVQDMLSPSPTERPEA  320 (332)
T ss_dssp             GSCHHHHHCCCC-CTHHHHHHHHHHHHHHHSCCCCHHHHHHHHHHHHTTCCCHHHHHHCHHHHHHHHHHHCSSGGGSCCH
T ss_pred             ccChHHhcCCCC-cchhhHHHHHHHHHHHHHcCCChhHHHHHHHHhhccCCCcccccCChhHHHHHHHHccCCCCcCCCH
Confidence            999999988877 5899999999999966543321                1   1246788999999999999999999


Q ss_pred             HhhhcCccccc
Q 014609          243 AGIKADEWFEQ  253 (421)
Q Consensus       243 ~eil~~~w~~~  253 (421)
                      .|+++||||++
T Consensus       321 ~~~l~~~~f~~  331 (332)
T 3qd2_B          321 TDIIENAIFEN  331 (332)
T ss_dssp             HHHHHSTTCCC
T ss_pred             HHHhhchhhhc
Confidence            99999999974

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=8.7e-48  Score=399.28  Aligned_cols=240  Identities=31%  Similarity=0.463  Sum_probs=212.0

Q ss_pred             CeeecceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEE
Q 014609           10 GMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKI   89 (421)
Q Consensus        10 ~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~   89 (421)
                      ....++|++++.||+|+||+||+|++..+|+.||||++.+...........+.+|+.+|+.++||||+++++++.+.+.+
T Consensus       180 ~~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l  259 (576)
T 2acx_A          180 PVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDAL  259 (576)
T ss_dssp             CCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             CccccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEE
Confidence            35668999999999999999999999999999999999876544334456789999999999999999999999999999


Q ss_pred             EEEEeccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCccc
Q 014609           90 YMVLEYVTGGELFDKIASKG--RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHF  167 (421)
Q Consensus        90 ~lv~E~~~gg~L~~~i~~~~--~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~  167 (421)
                      |+||||++||+|.+++...+  .+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||++..... 
T Consensus       260 ~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~-  338 (576)
T 2acx_A          260 CLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPE-  338 (576)
T ss_dssp             EEEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECCT-
T ss_pred             EEEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEEeCCCCeEEEecccceeccc-
Confidence            99999999999999997654  499999999999999999999999999999999999999999999999999975432 


Q ss_pred             cCCCccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhh-cCCc-----------------------CCCCCCCHH
Q 014609          168 RDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIF-RGDF-----------------------KLPKWLSPG  223 (421)
Q Consensus       168 ~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~-~~~~-----------------------~~p~~~s~~  223 (421)
                        .......+||+.|+|||++.+..| +.++|||||||++|++ .|..                       .+|..+|++
T Consensus       339 --~~~~~~~~GT~~Y~APEvl~~~~~-~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~~~~~p~~~s~~  415 (576)
T 2acx_A          339 --GQTIKGRVGTVGYMAPEVVKNERY-TFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYSERFSPQ  415 (576)
T ss_dssp             --TCCEECCCSCGGGCCHHHHTTCEE-SSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHCCCCCCTTSCHH
T ss_pred             --CccccccCCCccccCHHHHcCCCC-CccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhcccccCCccCCHH
Confidence              233456799999999999988777 5899999999999944 3322                       345568999


Q ss_pred             HHHHHHHhcCCCCCCCC-----CHHhhhcCccccc
Q 014609          224 AQNLLRKILEPNPVKRI-----TIAGIKADEWFEQ  253 (421)
Q Consensus       224 ~~~li~~~L~~dP~~R~-----t~~eil~~~w~~~  253 (421)
                      +.+||++||++||.+||     +++|+++||||+.
T Consensus       416 ~~dLI~~lL~~dP~~R~g~~~~sa~eil~HpfF~~  450 (576)
T 2acx_A          416 ARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKK  450 (576)
T ss_dssp             HHHHHHHHTCSSGGGSTTCSSSHHHHHHTSGGGTT
T ss_pred             HHHHHHHhccCCHHHcCCCCCCCHHHHHhChhhcc
Confidence            99999999999999999     7899999999986

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=2.5e-47  Score=367.58  Aligned_cols=239  Identities=32%  Similarity=0.436  Sum_probs=198.2

Q ss_pred             eeecceEEeceEeecCcEEEEEEEECCCCceEEEEEeeccccc--chhHHHHHHHHHHHHhcCC---CCCcceEEEEEEe
Q 014609           11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRII--HLKITDQIKREIATLKLLK---HPNVVRLHEVLAS   85 (421)
Q Consensus        11 ~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~--~~~~~~~~~~Ei~il~~l~---hpnIv~l~~~~~~   85 (421)
                      ...++|++++.||+|+||+||+|++..+|+.||||++......  .......+.+|+.++++++   ||||+++++++..
T Consensus         6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~   85 (308)
T 3g33_A            6 MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCAT   85 (308)
T ss_dssp             ----CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEE
T ss_pred             ccccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeec
Confidence            3458999999999999999999999999999999999754321  1112245677888877765   9999999999987


Q ss_pred             CC-----EEEEEEeccCCCChHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEec
Q 014609           86 KS-----KIYMVLEYVTGGELFDKIASKGR--LQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDF  158 (421)
Q Consensus        86 ~~-----~~~lv~E~~~gg~L~~~i~~~~~--~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DF  158 (421)
                      ..     ..++||||+. ++|.+++.....  +++..++.++.||+.||+|||++||+||||||+|||++.++.+||+||
T Consensus        86 ~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Df  164 (308)
T 3g33_A           86 SRTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADF  164 (308)
T ss_dssp             CCSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEECTTSCEEECSC
T ss_pred             cCCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEEeeC
Confidence            65     5899999996 599999987554  999999999999999999999999999999999999999999999999


Q ss_pred             cCCCCCccccCCCccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhhcC-CcCC---------------------
Q 014609          159 GLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIFRG-DFKL---------------------  216 (421)
Q Consensus       159 Gla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~~~-~~~~---------------------  216 (421)
                      |++.....   .......+||+.|+|||++.+..+ +.++|||||||++|.+.. ..++                     
T Consensus       165 g~a~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~  240 (308)
T 3g33_A          165 GLARIYSY---QMALTPVVVTLWYRAPEVLLQSTY-ATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPE  240 (308)
T ss_dssp             SCTTTSTT---CCCSGGGGCCCSSCCHHHHHTSCC-CSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCCCT
T ss_pred             ccccccCC---CcccCCccccccccCchHHcCCCC-CchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCh
Confidence            99986532   334456789999999999988877 589999999999995543 2222                     


Q ss_pred             -------------------------CCCCCHHHHHHHHHhcCCCCCCCCCHHhhhcCcccccc
Q 014609          217 -------------------------PKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD  254 (421)
Q Consensus       217 -------------------------p~~~s~~~~~li~~~L~~dP~~R~t~~eil~~~w~~~~  254 (421)
                                               .+.+++.+.+||.+||+.||.+|||+.|+++||||++.
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h~~~~~~  303 (308)
T 3g33_A          241 DDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHKD  303 (308)
T ss_dssp             TTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTC---
T ss_pred             hhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcCccccCC
Confidence                                     12367889999999999999999999999999999864

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=8e-48  Score=409.21  Aligned_cols=241  Identities=34%  Similarity=0.608  Sum_probs=214.0

Q ss_pred             CeeecceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcC-CCCCcceEEEEEEeCCE
Q 014609           10 GMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEVLASKSK   88 (421)
Q Consensus        10 ~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~   88 (421)
                      ...+++|++++.||+|+||+||+|++..+++.||||++.+.........+.+.+|..++..+ +||||+++++++.+.+.
T Consensus       337 ~~~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~  416 (674)
T 3pfq_A          337 RMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDR  416 (674)
T ss_dssp             ---CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSE
T ss_pred             cccccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCE
Confidence            35678999999999999999999999999999999999875443334457788999999988 69999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCcccc
Q 014609           89 IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFR  168 (421)
Q Consensus        89 ~~lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~~  168 (421)
                      +|+||||++||+|.+++...+.+++..++.|+.||+.||+|||++||+||||||+||||+.+|.+||+|||+|.....  
T Consensus       417 ~~lV~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~~--  494 (674)
T 3pfq_A          417 LYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIW--  494 (674)
T ss_dssp             EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEECSSSCEEECCCTTCEECCC--
T ss_pred             EEEEEeCcCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEEcCCCcEEEeecceeecccc--
Confidence            999999999999999999888999999999999999999999999999999999999999999999999999974322  


Q ss_pred             CCCccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhh--------------------cCCcCCCCCCCHHHHHHH
Q 014609          169 DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIF--------------------RGDFKLPKWLSPGAQNLL  228 (421)
Q Consensus       169 ~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~--------------------~~~~~~p~~~s~~~~~li  228 (421)
                      ......+.+||+.|+|||++.+..| +.++|||||||++|++                    .+...+|..+++++.+||
T Consensus       495 ~~~~~~~~~GT~~Y~APE~l~~~~~-~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li  573 (674)
T 3pfq_A          495 DGVTTKTFCGTPDYIAPEIIAYQPY-GKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAVAIC  573 (674)
T ss_dssp             TTCCBCCCCSCSSSCCHHHHTCCCB-STHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHSSCCCCCTTSCHHHHHHH
T ss_pred             CCcccccccCCCcccCHhhhcCCCC-CccceEechHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHHHH
Confidence            2334567899999999999988888 5899999999999933                    334556778999999999


Q ss_pred             HHhcCCCCCCCCCH-----HhhhcCccccc
Q 014609          229 RKILEPNPVKRITI-----AGIKADEWFEQ  253 (421)
Q Consensus       229 ~~~L~~dP~~R~t~-----~eil~~~w~~~  253 (421)
                      ++||++||.+|+++     ++|++||||+.
T Consensus       574 ~~lL~~dP~~R~~~~~~~~~ei~~h~ff~~  603 (674)
T 3pfq_A          574 KGLMTKHPGKRLGCGPEGERDIKEHAFFRY  603 (674)
T ss_dssp             HHHSCSSSTTCTTCSTTHHHHHHSSGGGSS
T ss_pred             HHHccCCHHHCCCCCCCcHHHHhcCccccC
Confidence            99999999999998     99999999975

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=1.4e-47  Score=396.27  Aligned_cols=242  Identities=28%  Similarity=0.435  Sum_probs=212.6

Q ss_pred             CCeeecceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCE
Q 014609            9 EGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSK   88 (421)
Q Consensus         9 ~~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~   88 (421)
                      .+...++|++++.||+|+||+||+|++..+|+.||||++.+...........+.+|+.++++++||||+++++++.+.+.
T Consensus       180 ~~~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~  259 (543)
T 3c4z_A          180 QPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTD  259 (543)
T ss_dssp             SCCCGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred             ccCChhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCE
Confidence            35667899999999999999999999999999999999987654443445778999999999999999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCC
Q 014609           89 IYMVLEYVTGGELFDKIASK----GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALP  164 (421)
Q Consensus        89 ~~lv~E~~~gg~L~~~i~~~----~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~  164 (421)
                      +|+||||++||+|.+++...    ..+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||++...
T Consensus       260 l~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~  339 (543)
T 3c4z_A          260 LCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVEL  339 (543)
T ss_dssp             EEEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred             EEEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEEeCCCCEEEeecceeeec
Confidence            99999999999999998763    36999999999999999999999999999999999999999999999999999754


Q ss_pred             ccccCCCccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhh-cCCc-----------------------CCCCCC
Q 014609          165 QHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIF-RGDF-----------------------KLPKWL  220 (421)
Q Consensus       165 ~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~-~~~~-----------------------~~p~~~  220 (421)
                      ..  ........+||+.|+|||++.+..| +.++|||||||++|++ .|..                       .+|..+
T Consensus       340 ~~--~~~~~~~~~GT~~Y~APE~l~~~~~-~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~~~~~~p~~~  416 (543)
T 3c4z_A          340 KA--GQTKTKGYAGTPGFMAPELLLGEEY-DFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPDKF  416 (543)
T ss_dssp             CT--TCCCBCCCCSCTTTSCHHHHTTCCB-CTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHCCCCCCTTS
T ss_pred             cC--CCcccccccCCccccChhhhcCCCC-ChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhhcccCCCccc
Confidence            32  2223445699999999999988877 5899999999999943 3332                       345668


Q ss_pred             CHHHHHHHHHhcCCCCCCCCC-----HHhhhcCccccc
Q 014609          221 SPGAQNLLRKILEPNPVKRIT-----IAGIKADEWFEQ  253 (421)
Q Consensus       221 s~~~~~li~~~L~~dP~~R~t-----~~eil~~~w~~~  253 (421)
                      |+.+.+||++||++||.+||+     ++++++||||+.
T Consensus       417 s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~Hpff~~  454 (543)
T 3c4z_A          417 SPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRD  454 (543)
T ss_dssp             CHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTSGGGTT
T ss_pred             CHHHHHHHHHhccCCHhHCCCCcccCHHHHHcCccccC
Confidence            999999999999999999996     489999999985

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=6.3e-48  Score=375.11  Aligned_cols=238  Identities=26%  Similarity=0.423  Sum_probs=195.5

Q ss_pred             ecceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEE
Q 014609           13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMV   92 (421)
Q Consensus        13 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv   92 (421)
                      +++|++++.||+|+||+||+|.+..+++.||+|++.......  ....+.+|+.++++++||||+++++++.+.+..|+|
T Consensus         1 l~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv   78 (324)
T 3mtl_A            1 METYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEG--APCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLV   78 (324)
T ss_dssp             CCSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC--------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEE
T ss_pred             CCceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccc--cchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEE
Confidence            578999999999999999999999999999999996543211  112455799999999999999999999999999999


Q ss_pred             EeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCccccCCC
Q 014609           93 LEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDG  171 (421)
Q Consensus        93 ~E~~~gg~L~~~i~~~-~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~  171 (421)
                      |||+. ++|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.....  ...
T Consensus        79 ~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~--~~~  155 (324)
T 3mtl_A           79 FEYLD-KDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARAKSI--PTK  155 (324)
T ss_dssp             EECCS-EEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEECTTCCEEECSSSEEECC-------
T ss_pred             ecccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEECCCCCEEEccCcccccccC--Ccc
Confidence            99997 5888888764 4599999999999999999999999999999999999999999999999999975432  223


Q ss_pred             ccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhh-cCCcCCC---------------------------------
Q 014609          172 LLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIF-RGDFKLP---------------------------------  217 (421)
Q Consensus       172 ~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~-~~~~~~p---------------------------------  217 (421)
                      .....+||+.|+|||++.+....+.++||||+||++|.+ .|..+++                                 
T Consensus       156 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  235 (324)
T 3mtl_A          156 TYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFK  235 (324)
T ss_dssp             -------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHHHH
T ss_pred             ccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcchhhc
Confidence            344567899999999987755446899999999999943 4443332                                 


Q ss_pred             ----------------CCCCHHHHHHHHHhcCCCCCCCCCHHhhhcCccccccc
Q 014609          218 ----------------KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY  255 (421)
Q Consensus       218 ----------------~~~s~~~~~li~~~L~~dP~~R~t~~eil~~~w~~~~~  255 (421)
                                      +.+++++.+||.+||+.||.+|||++|+++||||....
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~  289 (324)
T 3mtl_A          236 TYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLG  289 (324)
T ss_dssp             HTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGC
T ss_pred             ccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhcc
Confidence                            13578899999999999999999999999999998654

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=3.3e-47  Score=367.96  Aligned_cols=233  Identities=26%  Similarity=0.386  Sum_probs=195.4

Q ss_pred             cceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcC-CCCCcceEEEEEEeCCEEEEE
Q 014609           14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEVLASKSKIYMV   92 (421)
Q Consensus        14 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~lv   92 (421)
                      ++|++++.||+|+||+||+|++..+|+.||||++........ ......+|+..+.++ +||||+++++++.+.+..|+|
T Consensus        57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~-~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv  135 (311)
T 3p1a_A           57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPK-DRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQ  135 (311)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHH-HHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred             hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChH-HHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEE
Confidence            689999999999999999999999999999999865433222 234445555555544 899999999999999999999


Q ss_pred             EeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCccccCCC
Q 014609           93 LEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDG  171 (421)
Q Consensus        93 ~E~~~gg~L~~~i~~~-~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~  171 (421)
                      |||+ +++|.+.+... ..+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||++.....   ..
T Consensus       136 ~e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~---~~  211 (311)
T 3p1a_A          136 TELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGT---AG  211 (311)
T ss_dssp             EECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECGGGCEEECCCTTCEECC------
T ss_pred             Eecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEccceeeeeccc---CC
Confidence            9999 67898887754 4699999999999999999999999999999999999999999999999999875432   23


Q ss_pred             ccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhhcCCcCC-------------------CCCCCHHHHHHHHHhc
Q 014609          172 LLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIFRGDFKL-------------------PKWLSPGAQNLLRKIL  232 (421)
Q Consensus       172 ~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~~~~~~~-------------------p~~~s~~~~~li~~~L  232 (421)
                      .....+||+.|+|||++.+ .+ +.++||||+||++|.+.....+                   +..+++.+.++|.+||
T Consensus       212 ~~~~~~gt~~y~aPE~~~~-~~-~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L  289 (311)
T 3p1a_A          212 AGEVQEGDPRYMAPELLQG-SY-GTAADVFSLGLTILEVACNMELPHGGEGWQQLRQGYLPPEFTAGLSSELRSVLVMML  289 (311)
T ss_dssp             ---CCCCCGGGCCGGGGGT-CC-STHHHHHHHHHHHHHHHHTCCCCSSHHHHHHHTTTCCCHHHHTTSCHHHHHHHHHHS
T ss_pred             CCcccCCCccccCHhHhcC-CC-CchhhHHHHHHHHHHHHhCCCCCCCccHHHHHhccCCCcccccCCCHHHHHHHHHHc
Confidence            3445679999999999876 55 5899999999999965433222                   2347899999999999


Q ss_pred             CCCCCCCCCHHhhhcCccccc
Q 014609          233 EPNPVKRITIAGIKADEWFEQ  253 (421)
Q Consensus       233 ~~dP~~R~t~~eil~~~w~~~  253 (421)
                      ++||.+|||+.++++||||++
T Consensus       290 ~~dP~~Rpt~~ell~hp~~~~  310 (311)
T 3p1a_A          290 EPDPKLRATAEALLALPVLRQ  310 (311)
T ss_dssp             CSSTTTSCCHHHHHTSGGGSC
T ss_pred             CCChhhCcCHHHHHhCccccC
Confidence            999999999999999999985

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=6.9e-48  Score=387.02  Aligned_cols=242  Identities=25%  Similarity=0.460  Sum_probs=206.5

Q ss_pred             CeeecceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEE
Q 014609           10 GMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKI   89 (421)
Q Consensus        10 ~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~   89 (421)
                      ....++|++++.||+|+||+||+|++..+|+.||||++++.........+.+.+|..++..++||||+++++++.+.+.+
T Consensus        57 ~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~  136 (412)
T 2vd5_A           57 RLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYL  136 (412)
T ss_dssp             SCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSSEE
T ss_pred             cCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEE
Confidence            34568999999999999999999999999999999999865433333345688999999999999999999999999999


Q ss_pred             EEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCcccc
Q 014609           90 YMVLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFR  168 (421)
Q Consensus        90 ~lv~E~~~gg~L~~~i~~~-~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~~  168 (421)
                      |+||||++||+|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||++...... 
T Consensus       137 ~lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILld~~g~vkL~DFGla~~~~~~-  215 (412)
T 2vd5_A          137 YLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRAD-  215 (412)
T ss_dssp             EEEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTT-
T ss_pred             EEEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeeecCCCCEEEeechhheeccCC-
Confidence            9999999999999999875 47999999999999999999999999999999999999999999999999999754321 


Q ss_pred             CCCccccccCCCCccChhhhcc-------cCCCCCcchHHHHHHHHhhh-cCCcC---------------------CC--
Q 014609          169 DDGLLHTTCGSPNYVAPEVLAN-------RGYDGATSDIWSCGVILYIF-RGDFK---------------------LP--  217 (421)
Q Consensus       169 ~~~~~~~~~gt~~y~APEvl~~-------~~~~~~~~DiwSlGvil~~~-~~~~~---------------------~p--  217 (421)
                      ........+||+.|+|||++..       ..| +.++|||||||++|++ .|..+                     +|  
T Consensus       216 ~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~-~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~  294 (412)
T 2vd5_A          216 GTVRSLVAVGTPDYLSPEILQAVGGGPGTGSY-GPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLSLPLV  294 (412)
T ss_dssp             SCEECSSCCSCGGGCCHHHHHHHHTCTTCSEE-CTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCC--
T ss_pred             CccccceeccccCcCCHHHHhhcccCcCCCCC-ChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCcCCCcc
Confidence            1112335689999999999873       345 5899999999999943 23222                     23  


Q ss_pred             -CCCCHHHHHHHHHhcCCCCCCC---CCHHhhhcCcccccc
Q 014609          218 -KWLSPGAQNLLRKILEPNPVKR---ITIAGIKADEWFEQD  254 (421)
Q Consensus       218 -~~~s~~~~~li~~~L~~dP~~R---~t~~eil~~~w~~~~  254 (421)
                       ..+|+++++||++||. +|.+|   ++++++++||||...
T Consensus       295 ~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hpff~~i  334 (412)
T 2vd5_A          295 DEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTHPFFFGL  334 (412)
T ss_dssp             --CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTSGGGTTC
T ss_pred             ccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcCCCcCCC
Confidence             4689999999999999 99998   599999999999753

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=5.7e-47  Score=359.21  Aligned_cols=238  Identities=37%  Similarity=0.691  Sum_probs=208.9

Q ss_pred             CeeecceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEE
Q 014609           10 GMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKI   89 (421)
Q Consensus        10 ~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~   89 (421)
                      +...++|++.+.||+|+||.||+|.+..++..||+|++.......   .+.+.+|+.++++++||||+++++++.+....
T Consensus         5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~---~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~   81 (277)
T 3f3z_A            5 GDINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVED---VDRFKQEIEIMKSLDHPNIIRLYETFEDNTDI   81 (277)
T ss_dssp             -CHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSC---HHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred             hhhhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccch---HHHHHHHHHHHHhCCCCCEeeEEEEEecCCeE
Confidence            344578999999999999999999999999999999997654322   56789999999999999999999999999999


Q ss_pred             EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEe---ccCCCEEEEeccCCCCCcc
Q 014609           90 YMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILL---DSKGNIKISDFGLSALPQH  166 (421)
Q Consensus        90 ~lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl---~~~~~~kL~DFGla~~~~~  166 (421)
                      |+||||++|++|.+.+.....+++..++.++.|++.||+|||++||+||||||+|||+   +.++.+||+|||++.....
T Consensus        82 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~  161 (277)
T 3f3z_A           82 YLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKP  161 (277)
T ss_dssp             EEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCT
T ss_pred             EEEEeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCCCcEEEEecccceeccC
Confidence            9999999999999999988899999999999999999999999999999999999999   7888999999999975432


Q ss_pred             ccCCCccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhh-cCCcCC-------------------CC----CCCH
Q 014609          167 FRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIF-RGDFKL-------------------PK----WLSP  222 (421)
Q Consensus       167 ~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~-~~~~~~-------------------p~----~~s~  222 (421)
                         .......+||+.|+|||++.+. + +.++||||||+++|.+ .|..++                   |.    .+++
T Consensus       162 ---~~~~~~~~~t~~y~aPE~~~~~-~-~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (277)
T 3f3z_A          162 ---GKMMRTKVGTPYYVSPQVLEGL-Y-GPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEKDWLNVSP  236 (277)
T ss_dssp             ---TSCBCCCCSCTTTCCHHHHTTC-B-CTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHHHHTTSCH
T ss_pred             ---ccchhccCCCCCccChHHhccc-C-CchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCchhhhcCCH
Confidence               2344566899999999998654 4 6899999999999944 344333                   21    4788


Q ss_pred             HHHHHHHHhcCCCCCCCCCHHhhhcCccccccc
Q 014609          223 GAQNLLRKILEPNPVKRITIAGIKADEWFEQDY  255 (421)
Q Consensus       223 ~~~~li~~~L~~dP~~R~t~~eil~~~w~~~~~  255 (421)
                      .+.++|.+||++||.+|||+.++++||||++..
T Consensus       237 ~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~~  269 (277)
T 3f3z_A          237 QAESLIRRLLTKSPKQRITSLQALEHEWFEKQL  269 (277)
T ss_dssp             HHHHHHHHHTCSSTTTSCCHHHHTTSHHHHHHH
T ss_pred             HHHHHHHHHccCChhhCcCHHHHhcCHHHhccc
Confidence            999999999999999999999999999998754

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=7.6e-47  Score=359.42  Aligned_cols=238  Identities=37%  Similarity=0.692  Sum_probs=209.0

Q ss_pred             ecceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEE
Q 014609           13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMV   92 (421)
Q Consensus        13 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv   92 (421)
                      -++|++.+.||+|+||.||+|.+..+|+.||+|++...... ....+.+.+|+.++++++||||+++++++...+..|+|
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v   83 (284)
T 3kk8_A            5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLS-ARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV   83 (284)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCC-HHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEE
Confidence            47899999999999999999999999999999999865442 33457789999999999999999999999999999999


Q ss_pred             EeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCC---EEEEeccCCCCCccccC
Q 014609           93 LEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGN---IKISDFGLSALPQHFRD  169 (421)
Q Consensus        93 ~E~~~gg~L~~~i~~~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~---~kL~DFGla~~~~~~~~  169 (421)
                      |||++|++|.+.+.....+++..+..++.|++.||+|||++||+||||||+||+++.++.   +||+|||++.....   
T Consensus        84 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~---  160 (284)
T 3kk8_A           84 FDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND---  160 (284)
T ss_dssp             ECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCS---
T ss_pred             EecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEccc---
Confidence            999999999999988889999999999999999999999999999999999999987665   99999999975432   


Q ss_pred             CCccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhh-cCCcCC-------------------C----CCCCHHHH
Q 014609          170 DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIF-RGDFKL-------------------P----KWLSPGAQ  225 (421)
Q Consensus       170 ~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~-~~~~~~-------------------p----~~~s~~~~  225 (421)
                      ........||+.|+|||++.+..+ +.++||||+|+++|.+ .|..++                   |    ..+++.+.
T Consensus       161 ~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (284)
T 3kk8_A          161 SEAWHGFAGTPGYLSPEVLKKDPY-SKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAK  239 (284)
T ss_dssp             SCBCCCSCSCGGGCCHHHHTTCCB-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTTTTSCHHHH
T ss_pred             CccccCCCCCcCCcCchhhcCCCC-CcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhccccCCchhhcccCHHHH
Confidence            233345689999999999988777 5899999999999943 333222                   2    24789999


Q ss_pred             HHHHHhcCCCCCCCCCHHhhhcCccccccc
Q 014609          226 NLLRKILEPNPVKRITIAGIKADEWFEQDY  255 (421)
Q Consensus       226 ~li~~~L~~dP~~R~t~~eil~~~w~~~~~  255 (421)
                      ++|.+||++||.+|||+.|+++||||.+..
T Consensus       240 ~li~~~l~~dp~~Rps~~~~l~h~~~~~~~  269 (284)
T 3kk8_A          240 SLIDSMLTVNPKKRITADQALKVPWICNRE  269 (284)
T ss_dssp             HHHHHHSCSSTTTSCCHHHHTTSHHHHSCC
T ss_pred             HHHHHHcccChhhCCCHHHHhcCccccCCh
Confidence            999999999999999999999999998643

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=4e-47  Score=378.72  Aligned_cols=240  Identities=29%  Similarity=0.566  Sum_probs=208.8

Q ss_pred             CCeeecceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCE
Q 014609            9 EGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSK   88 (421)
Q Consensus         9 ~~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~   88 (421)
                      .+...++|++++.||+|+||+||+|.+..+|+.||+|++....   ......+.+|+.+|+.++||||+++++++.+...
T Consensus        46 ~~~~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~---~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~  122 (387)
T 1kob_A           46 QGSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY---PLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYE  122 (387)
T ss_dssp             CSCGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS---HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSE
T ss_pred             CCccccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccc---hhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCE
Confidence            3456689999999999999999999999999999999997543   2224578999999999999999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecc--CCCEEEEeccCCCCCc
Q 014609           89 IYMVLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDS--KGNIKISDFGLSALPQ  165 (421)
Q Consensus        89 ~~lv~E~~~gg~L~~~i~~~-~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~--~~~~kL~DFGla~~~~  165 (421)
                      .|+||||++|++|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.  ++.+||+|||++....
T Consensus       123 ~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~  202 (387)
T 1kob_A          123 MVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLN  202 (387)
T ss_dssp             EEEEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECC
T ss_pred             EEEEEEcCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEecCCCCceEEEecccceecC
Confidence            99999999999999998764 37999999999999999999999999999999999999974  4679999999998543


Q ss_pred             cccCCCccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhh-cCCcCC-----------------------CCCCC
Q 014609          166 HFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIF-RGDFKL-----------------------PKWLS  221 (421)
Q Consensus       166 ~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~-~~~~~~-----------------------p~~~s  221 (421)
                      .   .......+||+.|+|||++.+..+ +.++|||||||++|.+ .|..++                       +..++
T Consensus       203 ~---~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s  278 (387)
T 1kob_A          203 P---DEIVKVTTATAEFAAPEIVDREPV-GFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVS  278 (387)
T ss_dssp             T---TSCEEEECSSGGGCCHHHHTTCCB-CHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSC
T ss_pred             C---CcceeeeccCCCccCchhccCCCC-CCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccccccCC
Confidence            2   234456689999999999988777 5899999999999944 333222                       13478


Q ss_pred             HHHHHHHHHhcCCCCCCCCCHHhhhcCccccccc
Q 014609          222 PGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY  255 (421)
Q Consensus       222 ~~~~~li~~~L~~dP~~R~t~~eil~~~w~~~~~  255 (421)
                      +++.+||.+||+.||.+|||+.++++||||....
T Consensus       279 ~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~  312 (387)
T 1kob_A          279 PEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDH  312 (387)
T ss_dssp             HHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSCC
T ss_pred             HHHHHHHHHHcCCChhHCcCHHHHhhCccccCCc
Confidence            9999999999999999999999999999998654

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=1.2e-47  Score=393.35  Aligned_cols=239  Identities=38%  Similarity=0.659  Sum_probs=211.1

Q ss_pred             eecceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEE
Q 014609           12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYM   91 (421)
Q Consensus        12 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l   91 (421)
                      .-++|++.+.||+|+||.||+|++..+|+.||||++.+.........+.+.+|+.++++++||||+++++++.+.+.+|+
T Consensus        24 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l  103 (484)
T 3nyv_A           24 FSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYL  103 (484)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred             ccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence            34789999999999999999999999999999999987655444456789999999999999999999999999999999


Q ss_pred             EEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEe---ccCCCEEEEeccCCCCCcccc
Q 014609           92 VLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILL---DSKGNIKISDFGLSALPQHFR  168 (421)
Q Consensus        92 v~E~~~gg~L~~~i~~~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl---~~~~~~kL~DFGla~~~~~~~  168 (421)
                      ||||+.|++|.+.+...+.+++..++.++.||+.||+|||++||+||||||+|||+   +.++.+||+|||++.....  
T Consensus       104 v~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~--  181 (484)
T 3nyv_A          104 VGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEA--  181 (484)
T ss_dssp             EECCCCSCBHHHHHHTCSCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBCC--
T ss_pred             EEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEccc--
Confidence            99999999999999988899999999999999999999999999999999999999   4678999999999975432  


Q ss_pred             CCCccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhh-cCCcCC---------------------C--CCCCHHH
Q 014609          169 DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIF-RGDFKL---------------------P--KWLSPGA  224 (421)
Q Consensus       169 ~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~-~~~~~~---------------------p--~~~s~~~  224 (421)
                       .......+||+.|+|||++.+ .| +.++|||||||++|.+ .|..|+                     |  ..+|+.+
T Consensus       182 -~~~~~~~~gt~~y~aPE~~~~-~~-~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~  258 (484)
T 3nyv_A          182 -SKKMKDKIGTAYYIAPEVLHG-TY-DEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESA  258 (484)
T ss_dssp             -CCSHHHHTTGGGTCCHHHHHT-CC-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGGGSCHHH
T ss_pred             -ccccccCCCCccccCceeecC-CC-CCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCCcccccCCHHH
Confidence             334566789999999999876 46 5899999999999944 333332                     2  2378999


Q ss_pred             HHHHHHhcCCCCCCCCCHHhhhcCccccccc
Q 014609          225 QNLLRKILEPNPVKRITIAGIKADEWFEQDY  255 (421)
Q Consensus       225 ~~li~~~L~~dP~~R~t~~eil~~~w~~~~~  255 (421)
                      .+||++||++||.+|||+.++++||||+...
T Consensus       259 ~~li~~~L~~dp~~R~s~~e~l~h~~~~~~~  289 (484)
T 3nyv_A          259 KDLIRKMLTYVPSMRISARDALDHEWIQTYT  289 (484)
T ss_dssp             HHHHHHHTCSSGGGSCCHHHHHTSHHHHHHT
T ss_pred             HHHHHHHCCCChhHCcCHHHHhhChhhcccc
Confidence            9999999999999999999999999998654

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=2.5e-47  Score=371.71  Aligned_cols=242  Identities=30%  Similarity=0.447  Sum_probs=205.5

Q ss_pred             CeeecceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEE
Q 014609           10 GMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKI   89 (421)
Q Consensus        10 ~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~   89 (421)
                      ...+++|++++.||+|+||.||+|++..+|+.||+|++..... .....+.+.+|+.++++++||||+++++++.+.+..
T Consensus        21 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   99 (331)
T 4aaa_A           21 FQSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDD-DKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRW   99 (331)
T ss_dssp             CBCGGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSS-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred             hhhhhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCC-chHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEE
Confidence            3567899999999999999999999999999999999875532 333456788999999999999999999999999999


Q ss_pred             EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCccccC
Q 014609           90 YMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD  169 (421)
Q Consensus        90 ~lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~  169 (421)
                      |+||||+++++|.+.+.....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.....  .
T Consensus       100 ~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~--~  177 (331)
T 4aaa_A          100 YLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAA--P  177 (331)
T ss_dssp             EEEEECCSEEHHHHHHHSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCTTC--------
T ss_pred             EEEEecCCcchHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEEcCCCcEEEEeCCCceeecC--C
Confidence            99999999999988887778899999999999999999999999999999999999999999999999999975433  2


Q ss_pred             CCccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhh-cCCcCCC-------------------------------
Q 014609          170 DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIF-RGDFKLP-------------------------------  217 (421)
Q Consensus       170 ~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~-~~~~~~p-------------------------------  217 (421)
                      .......+||+.|+|||++.+....+.++|||||||++|.+ .|..+++                               
T Consensus       178 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  257 (331)
T 4aaa_A          178 GEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPV  257 (331)
T ss_dssp             ------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCGG
T ss_pred             ccccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhccc
Confidence            23345568999999999998764446899999999999944 4443332                               


Q ss_pred             -------------------CCCCHHHHHHHHHhcCCCCCCCCCHHhhhcCcccccc
Q 014609          218 -------------------KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD  254 (421)
Q Consensus       218 -------------------~~~s~~~~~li~~~L~~dP~~R~t~~eil~~~w~~~~  254 (421)
                                         +.+++.+.+||.+||+.||.+|||+.|+++||||+..
T Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~~~  313 (331)
T 4aaa_A          258 FAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQMD  313 (331)
T ss_dssp             GTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHGG
T ss_pred             cccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcCchhccC
Confidence                               1368889999999999999999999999999999863

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=8.4e-47  Score=360.31  Aligned_cols=237  Identities=36%  Similarity=0.646  Sum_probs=201.4

Q ss_pred             CeeecceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEE
Q 014609           10 GMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKI   89 (421)
Q Consensus        10 ~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~   89 (421)
                      |...++|++.+.||+|+||+||+|.+..+++.||+|++......  ...+.+.+|++++++++||||+++++++.+....
T Consensus        18 g~i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~   95 (285)
T 3is5_A           18 GTIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQ--VPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNM   95 (285)
T ss_dssp             SCHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCC--SCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred             CChhhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccc--hhHHHHHHHHHHHHhCCCchHHhHHHheecCCeE
Confidence            55668999999999999999999999999999999999865432  2257899999999999999999999999999999


Q ss_pred             EEEEeccCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEe---ccCCCEEEEeccCCC
Q 014609           90 YMVLEYVTGGELFDKIAS----KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILL---DSKGNIKISDFGLSA  162 (421)
Q Consensus        90 ~lv~E~~~gg~L~~~i~~----~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl---~~~~~~kL~DFGla~  162 (421)
                      |+||||++|++|.+.+..    ...+++..++.++.|++.||+|||++||+||||||+|||+   +.++.+||+|||++.
T Consensus        96 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~  175 (285)
T 3is5_A           96 YIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAE  175 (285)
T ss_dssp             EEEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEEECCCCCCC
T ss_pred             EEEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEEEEeeecce
Confidence            999999999999998854    3679999999999999999999999999999999999999   455789999999998


Q ss_pred             CCccccCCCccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhh-cCCcCCC----------------------CC
Q 014609          163 LPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIF-RGDFKLP----------------------KW  219 (421)
Q Consensus       163 ~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~-~~~~~~p----------------------~~  219 (421)
                      ....   .......+||+.|+|||++.+ .+ +.++|||||||++|.+ .|..++.                      ..
T Consensus       176 ~~~~---~~~~~~~~~t~~y~aPE~~~~-~~-~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  250 (285)
T 3is5_A          176 LFKS---DEHSTNAAGTALYMAPEVFKR-DV-TFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYAVECRP  250 (285)
T ss_dssp             C-------------CTTGGGCCHHHHTT-CC-CHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCC--CC
T ss_pred             ecCC---cccCcCcccccCcCChHHhcc-CC-CcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccCCcccccccCc
Confidence            6543   223456689999999999864 45 5899999999999954 3444332                      12


Q ss_pred             CCHHHHHHHHHhcCCCCCCCCCHHhhhcCccccc
Q 014609          220 LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQ  253 (421)
Q Consensus       220 ~s~~~~~li~~~L~~dP~~R~t~~eil~~~w~~~  253 (421)
                      +++.+.++|.+||++||.+|||+.|+++||||++
T Consensus       251 ~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~f~~  284 (285)
T 3is5_A          251 LTPQAVDLLKQMLTKDPERRPSAAQVLHHEWFKQ  284 (285)
T ss_dssp             CCHHHHHHHHHHTCSCTTTSCCHHHHHTSGGGGC
T ss_pred             CCHHHHHHHHHHccCChhhCcCHHHHhcCHHhhc
Confidence            6899999999999999999999999999999985

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=7.1e-47  Score=366.95  Aligned_cols=240  Identities=35%  Similarity=0.606  Sum_probs=209.7

Q ss_pred             CeeecceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccch---hHHHHHHHHHHHHhcCCCCCcceEEEEEEeC
Q 014609           10 GMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHL---KITDQIKREIATLKLLKHPNVVRLHEVLASK   86 (421)
Q Consensus        10 ~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~---~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~   86 (421)
                      ....++|++++.||+|+||.||+|.+..+|+.||+|++........   ...+.+.+|+.+++.++||||+++++++.+.
T Consensus         8 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~   87 (321)
T 2a2a_A            8 QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENR   87 (321)
T ss_dssp             SCHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred             hhhhccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecC
Confidence            3445789999999999999999999999999999999986543221   1256799999999999999999999999999


Q ss_pred             CEEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCC----CEEEEeccCCC
Q 014609           87 SKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKG----NIKISDFGLSA  162 (421)
Q Consensus        87 ~~~~lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~----~~kL~DFGla~  162 (421)
                      +..|+||||++|++|.+++.....+++..++.++.|++.||+|||++||+||||||+|||++.++    .+||+|||++.
T Consensus        88 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~  167 (321)
T 2a2a_A           88 TDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH  167 (321)
T ss_dssp             SEEEEEECCCCSCBHHHHHHTCSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCTTCE
T ss_pred             CEEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCCCcCCEEEccCccce
Confidence            99999999999999999999888899999999999999999999999999999999999999888    79999999997


Q ss_pred             CCccccCCCccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhh-cCCcCCC-----------------------C
Q 014609          163 LPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIF-RGDFKLP-----------------------K  218 (421)
Q Consensus       163 ~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~-~~~~~~p-----------------------~  218 (421)
                      ....   .......+||+.|+|||++.+..+ +.++|||||||++|.+ .|..++.                       .
T Consensus       168 ~~~~---~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  243 (321)
T 2a2a_A          168 EIED---GVEFKNIFGTPEFVAPEIVNYEPL-GLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFFS  243 (321)
T ss_dssp             ECCT---TCCCCCCCSCGGGCCHHHHTTCCC-CTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHHHT
T ss_pred             ecCc---cccccccCCCCCccCcccccCCCC-CCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccccChhhhc
Confidence            5432   223345679999999999987777 5899999999999944 3443331                       3


Q ss_pred             CCCHHHHHHHHHhcCCCCCCCCCHHhhhcCccccc
Q 014609          219 WLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQ  253 (421)
Q Consensus       219 ~~s~~~~~li~~~L~~dP~~R~t~~eil~~~w~~~  253 (421)
                      .+++.+.++|.+||++||.+|||+.++++||||..
T Consensus       244 ~~~~~~~~li~~~l~~dp~~Rps~~e~l~hp~~~~  278 (321)
T 2a2a_A          244 HTSELAKDFIRKLLVKETRKRLTIQEALRHPWITP  278 (321)
T ss_dssp             TCCHHHHHHHHTTSCSSTTTSCCHHHHHHSTTTSC
T ss_pred             ccCHHHHHHHHHHcCCChhhCcCHHHHhcCccccC
Confidence            47888999999999999999999999999999974

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=2.5e-47  Score=391.24  Aligned_cols=241  Identities=39%  Similarity=0.672  Sum_probs=208.2

Q ss_pred             CCeeecceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCE
Q 014609            9 EGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSK   88 (421)
Q Consensus         9 ~~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~   88 (421)
                      .|...++|++++.||+|+||+||+|.+..+|+.||||++.+..... .....+.+|+.++++++||||+++++++.+...
T Consensus        17 ~g~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~   95 (486)
T 3mwu_A           17 QGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKN-KDTSTILREVELLKKLDHPNIMKLFEILEDSSS   95 (486)
T ss_dssp             CCHHHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBC-SCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred             cCChhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccc-hHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCE
Confidence            3556689999999999999999999999999999999997644322 225778999999999999999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEec---cCCCEEEEeccCCCCCc
Q 014609           89 IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLD---SKGNIKISDFGLSALPQ  165 (421)
Q Consensus        89 ~~lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~---~~~~~kL~DFGla~~~~  165 (421)
                      +|+||||++|++|.+.+...+.+++..++.++.||+.||.|||++||+||||||+|||++   .++.+||+|||++....
T Consensus        96 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~  175 (486)
T 3mwu_A           96 FYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ  175 (486)
T ss_dssp             EEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBC
T ss_pred             EEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEEECCcCeECC
Confidence            999999999999999998888999999999999999999999999999999999999995   45679999999998653


Q ss_pred             cccCCCccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhh-cCCcCC---------------------C--CCCC
Q 014609          166 HFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIF-RGDFKL---------------------P--KWLS  221 (421)
Q Consensus       166 ~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~-~~~~~~---------------------p--~~~s  221 (421)
                      .   .......+||+.|+|||++.+ .| +.++||||+||++|.+ .|..|+                     |  ..+|
T Consensus       176 ~---~~~~~~~~gt~~y~aPE~~~~-~~-~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s  250 (486)
T 3mwu_A          176 Q---NTKMKDRIGTAYYIAPEVLRG-TY-DEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTIS  250 (486)
T ss_dssp             C---C----CCTTGGGGCCGGGGGS-CC-CHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCSGGGGGSC
T ss_pred             C---CCccCCCcCCCCCCCHHHhCC-CC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCcccCCCC
Confidence            3   233456789999999999875 45 5899999999999944 333332                     2  2378


Q ss_pred             HHHHHHHHHhcCCCCCCCCCHHhhhcCccccccc
Q 014609          222 PGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY  255 (421)
Q Consensus       222 ~~~~~li~~~L~~dP~~R~t~~eil~~~w~~~~~  255 (421)
                      +.+.+||++||++||.+|||+.++++||||++..
T Consensus       251 ~~~~~li~~~L~~dp~~R~t~~~~l~hp~~~~~~  284 (486)
T 3mwu_A          251 DDAKDLIRKMLTFHPSLRITATQCLEHPWIQKYS  284 (486)
T ss_dssp             HHHHHHHHHHTCSSTTTSCCHHHHHHCHHHHHTC
T ss_pred             HHHHHHHHHHcCCChhhCcCHHHHhcCHhhccCc
Confidence            9999999999999999999999999999998754

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=7.8e-47  Score=389.28  Aligned_cols=241  Identities=36%  Similarity=0.634  Sum_probs=207.0

Q ss_pred             CeeecceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccch----------hHHHHHHHHHHHHhcCCCCCcceE
Q 014609           10 GMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHL----------KITDQIKREIATLKLLKHPNVVRL   79 (421)
Q Consensus        10 ~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~----------~~~~~~~~Ei~il~~l~hpnIv~l   79 (421)
                      +...++|++++.||+|+||+||+|.+..+++.||+|++.+......          ...+.+.+|+.++++++||||+++
T Consensus        32 ~~i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~  111 (504)
T 3q5i_A           32 GKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKL  111 (504)
T ss_dssp             SCGGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCE
T ss_pred             CCcccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeE
Confidence            4456799999999999999999999999999999999986543221          235678999999999999999999


Q ss_pred             EEEEEeCCEEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCC---CEEEE
Q 014609           80 HEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKG---NIKIS  156 (421)
Q Consensus        80 ~~~~~~~~~~~lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~---~~kL~  156 (421)
                      ++++.+...+|+||||++||+|.+.+.....+++..++.++.||+.||+|||++||+||||||+|||++.++   .+||+
T Consensus       112 ~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~  191 (504)
T 3q5i_A          112 FDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIV  191 (504)
T ss_dssp             EEEEECSSEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTTCCSSEEEC
T ss_pred             EEEEEcCCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCCCCccEEEE
Confidence            999999999999999999999999999888999999999999999999999999999999999999998876   69999


Q ss_pred             eccCCCCCccccCCCccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhh-cCCcCCC------------------
Q 014609          157 DFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIF-RGDFKLP------------------  217 (421)
Q Consensus       157 DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~-~~~~~~p------------------  217 (421)
                      |||++.....   .......+||+.|+|||++.+ .| +.++||||+||++|.+ .|..|++                  
T Consensus       192 Dfg~a~~~~~---~~~~~~~~gt~~y~aPE~~~~-~~-~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~  266 (504)
T 3q5i_A          192 DFGLSSFFSK---DYKLRDRLGTAYYIAPEVLKK-KY-NEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYF  266 (504)
T ss_dssp             CCTTCEECCT---TSCBCCCCSCTTTCCHHHHTT-CB-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCC
T ss_pred             ECCCCEEcCC---CCccccccCCcCCCCHHHhcc-CC-CchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCC
Confidence            9999985533   234556789999999999864 45 5899999999999954 3443332                  


Q ss_pred             -----CCCCHHHHHHHHHhcCCCCCCCCCHHhhhcCccccccc
Q 014609          218 -----KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY  255 (421)
Q Consensus       218 -----~~~s~~~~~li~~~L~~dP~~R~t~~eil~~~w~~~~~  255 (421)
                           ..+|+.+.+||++||++||.+|||+.|+++||||++..
T Consensus       267 ~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~  309 (504)
T 3q5i_A          267 DFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKYA  309 (504)
T ss_dssp             CHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHTC
T ss_pred             CccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcCHhhhhch
Confidence                 34789999999999999999999999999999998754

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=2e-46  Score=364.28  Aligned_cols=234  Identities=27%  Similarity=0.490  Sum_probs=204.5

Q ss_pred             ceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEEe
Q 014609           15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLE   94 (421)
Q Consensus        15 ~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E   94 (421)
                      .|+..+.||+|+||.||+|++..+|+.||||++.....   ...+.+.+|+.++++++||||+++++++...+..|+|||
T Consensus        46 ~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  122 (321)
T 2c30_A           46 LLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQ---QRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLME  122 (321)
T ss_dssp             HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC---CSHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred             hhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccch---hHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEe
Confidence            58888999999999999999999999999999975532   225678899999999999999999999999999999999


Q ss_pred             ccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCccccCCCccc
Q 014609           95 YVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLH  174 (421)
Q Consensus        95 ~~~gg~L~~~i~~~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~  174 (421)
                      |++|++|.+++.. ..+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||++.....  ......
T Consensus       123 ~~~~~~L~~~l~~-~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~--~~~~~~  199 (321)
T 2c30_A          123 FLQGGALTDIVSQ-VRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISK--DVPKRK  199 (321)
T ss_dssp             CCCSCBHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCS--SSCCBC
T ss_pred             cCCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCcEEEeeeeeeeeccc--Cccccc
Confidence            9999999998764 5799999999999999999999999999999999999999999999999999875433  122334


Q ss_pred             cccCCCCccChhhhcccCCCCCcchHHHHHHHHhhh-cCCcCC----------------------CCCCCHHHHHHHHHh
Q 014609          175 TTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIF-RGDFKL----------------------PKWLSPGAQNLLRKI  231 (421)
Q Consensus       175 ~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~-~~~~~~----------------------p~~~s~~~~~li~~~  231 (421)
                      ..+||+.|+|||++.+..+ +.++|||||||++|.+ .|..++                      +..+++.+.++|.+|
T Consensus       200 ~~~gt~~y~aPE~~~~~~~-~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~  278 (321)
T 2c30_A          200 SLVGTPYWMAPEVISRSLY-ATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNSHKVSPVLRDFLERM  278 (321)
T ss_dssp             CCCSCGGGCCHHHHTTCCB-CTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCCTTGGGSCHHHHHHHHHH
T ss_pred             cccCCccccCHhhhcCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCcCccccCCHHHHHHHHHH
Confidence            5689999999999987776 5899999999999954 343332                      123688999999999


Q ss_pred             cCCCCCCCCCHHhhhcCccccccc
Q 014609          232 LEPNPVKRITIAGIKADEWFEQDY  255 (421)
Q Consensus       232 L~~dP~~R~t~~eil~~~w~~~~~  255 (421)
                      |+.||.+|||+.++++||||.+..
T Consensus       279 l~~dp~~Rps~~ell~hp~~~~~~  302 (321)
T 2c30_A          279 LVRDPQERATAQELLDHPFLLQTG  302 (321)
T ss_dssp             SCSSTTTSCCHHHHHTSGGGGGCC
T ss_pred             ccCChhhCcCHHHHhcChhhccCC
Confidence            999999999999999999998643

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=5e-47  Score=372.38  Aligned_cols=246  Identities=27%  Similarity=0.431  Sum_probs=204.2

Q ss_pred             CeeecceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEe----
Q 014609           10 GMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLAS----   85 (421)
Q Consensus        10 ~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~----   85 (421)
                      ...+++|++++.||+|+||+||+|++..+|+.||||++....... .....+.+|+.+++.++||||+++++++..    
T Consensus        13 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   91 (351)
T 3mi9_A           13 CDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKE-GFPITALREIKILQLLKHENVVNLIEICRTKASP   91 (351)
T ss_dssp             SCBGGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSS-SSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC---
T ss_pred             cccccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccc-cchHHHHHHHHHHHhccCCCcccHhheeeccccc
Confidence            456799999999999999999999999999999999987654322 224567899999999999999999999987    


Q ss_pred             ----CCEEEEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccC
Q 014609           86 ----KSKIYMVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGL  160 (421)
Q Consensus        86 ----~~~~~lv~E~~~gg~L~~~i~~-~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGl  160 (421)
                          .+.+|+||||+.+ +|.+.+.. ...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+
T Consensus        92 ~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~  170 (351)
T 3mi9_A           92 YNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGL  170 (351)
T ss_dssp             -----CEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTT
T ss_pred             cccCCceEEEEEeccCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCCEEEccchh
Confidence                4578999999975 77777664 35799999999999999999999999999999999999999999999999999


Q ss_pred             CCCCcccc--CCCccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhh-cCCcCCCCC------------------
Q 014609          161 SALPQHFR--DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIF-RGDFKLPKW------------------  219 (421)
Q Consensus       161 a~~~~~~~--~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~-~~~~~~p~~------------------  219 (421)
                      +.......  ........+||+.|+|||++.+....+.++|||||||++|.+ .|..++...                  
T Consensus       171 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~  250 (351)
T 3mi9_A          171 ARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITP  250 (351)
T ss_dssp             CEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCT
T ss_pred             cccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCh
Confidence            97543211  122345568999999999987755446899999999999954 333322110                  


Q ss_pred             ---------------------------------CCHHHHHHHHHhcCCCCCCCCCHHhhhcCccccccccC
Q 014609          220 ---------------------------------LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTP  257 (421)
Q Consensus       220 ---------------------------------~s~~~~~li~~~L~~dP~~R~t~~eil~~~w~~~~~~~  257 (421)
                                                       .++.+.+||.+||+.||.+|||++|+++||||.....+
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~  321 (351)
T 3mi9_A          251 EVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSDPMP  321 (351)
T ss_dssp             TTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGSSSCC
T ss_pred             hhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCCCCcCCCCCc
Confidence                                             26779999999999999999999999999999865443

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=5.8e-47  Score=389.32  Aligned_cols=237  Identities=36%  Similarity=0.652  Sum_probs=202.0

Q ss_pred             eecceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEE
Q 014609           12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYM   91 (421)
Q Consensus        12 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l   91 (421)
                      ..++|++++.||+|+||+||+|++..+++.||+|++.+...... ....+.+|+.+++.++||||+++++++.+...+|+
T Consensus        35 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l  113 (494)
T 3lij_A           35 LSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTS-SNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYL  113 (494)
T ss_dssp             HHHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----C-TTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred             hhcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCch-HHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEE
Confidence            34689999999999999999999999999999999986543222 24678999999999999999999999999999999


Q ss_pred             EEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccC---CCEEEEeccCCCCCcccc
Q 014609           92 VLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSK---GNIKISDFGLSALPQHFR  168 (421)
Q Consensus        92 v~E~~~gg~L~~~i~~~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~---~~~kL~DFGla~~~~~~~  168 (421)
                      ||||++||+|.+.+....++++..++.++.||+.||+|||++||+||||||+|||++.+   +.+||+|||++.....  
T Consensus       114 v~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~--  191 (494)
T 3lij_A          114 VMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFEN--  191 (494)
T ss_dssp             EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBT--
T ss_pred             EEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEEECCCCeECCC--
Confidence            99999999999999888899999999999999999999999999999999999999764   4599999999986543  


Q ss_pred             CCCccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhh-cCCcCC---------------------C--CCCCHHH
Q 014609          169 DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIF-RGDFKL---------------------P--KWLSPGA  224 (421)
Q Consensus       169 ~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~-~~~~~~---------------------p--~~~s~~~  224 (421)
                       .......+||+.|+|||++.+ .| +.++||||+||++|.+ .|..|+                     |  ..+|+.+
T Consensus       192 -~~~~~~~~gt~~y~aPE~l~~-~~-~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~  268 (494)
T 3lij_A          192 -QKKMKERLGTAYYIAPEVLRK-KY-DEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKNVSEGA  268 (494)
T ss_dssp             -TBCBCCCCSCTTTCCHHHHTT-CB-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCSGGGTTSCHHH
T ss_pred             -CccccccCCCcCeeCHHHHcc-cC-CCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCchhcccCCHHH
Confidence             233456789999999999864 45 5899999999999944 333332                     1  2378999


Q ss_pred             HHHHHHhcCCCCCCCCCHHhhhcCcccccc
Q 014609          225 QNLLRKILEPNPVKRITIAGIKADEWFEQD  254 (421)
Q Consensus       225 ~~li~~~L~~dP~~R~t~~eil~~~w~~~~  254 (421)
                      .+||++||++||.+|||+.++++||||++.
T Consensus       269 ~~li~~~L~~dp~~R~s~~e~l~hp~~~~~  298 (494)
T 3lij_A          269 KDLIKQMLQFDSQRRISAQQALEHPWIKEM  298 (494)
T ss_dssp             HHHHHHHTCSSTTTSCCHHHHHTCHHHHHH
T ss_pred             HHHHHHHCCCChhhCccHHHHhcCcccccC
Confidence            999999999999999999999999999864

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=7.6e-47  Score=365.14  Aligned_cols=241  Identities=34%  Similarity=0.549  Sum_probs=199.8

Q ss_pred             CeeecceEEe-ceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcC-CCCCcceEEEEEEeCC
Q 014609           10 GMRLGRYELG-RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEVLASKS   87 (421)
Q Consensus        10 ~~~~~~y~i~-~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~   87 (421)
                      +..-++|++. +.||+|+||+||+|.+..+++.||||++.....   .....+.+|+.+++++ +||||+++++++.+.+
T Consensus         8 ~~~~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~   84 (316)
T 2ac3_A            8 GRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPG---HIRSRVFREVEMLYQCQGHRNVLELIEFFEEED   84 (316)
T ss_dssp             CCTTTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSS---CCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETT
T ss_pred             cccceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcc---hhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCC
Confidence            3445789995 789999999999999999999999999976532   2356789999999885 7999999999999999


Q ss_pred             EEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCC---EEEEeccCCCCC
Q 014609           88 KIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGN---IKISDFGLSALP  164 (421)
Q Consensus        88 ~~~lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~---~kL~DFGla~~~  164 (421)
                      .+|+||||++|++|.+++.....+++..++.++.||+.||+|||++||+||||||+|||++.++.   +||+|||++...
T Consensus        85 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~  164 (316)
T 2ac3_A           85 RFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGI  164 (316)
T ss_dssp             EEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC--
T ss_pred             EEEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEEEccCcccc
Confidence            99999999999999999998889999999999999999999999999999999999999998776   999999998754


Q ss_pred             ccccC-----CCccccccCCCCccChhhhcc-----cCCCCCcchHHHHHHHHhhh-cCCcCCC----------------
Q 014609          165 QHFRD-----DGLLHTTCGSPNYVAPEVLAN-----RGYDGATSDIWSCGVILYIF-RGDFKLP----------------  217 (421)
Q Consensus       165 ~~~~~-----~~~~~~~~gt~~y~APEvl~~-----~~~~~~~~DiwSlGvil~~~-~~~~~~p----------------  217 (421)
                      .....     .......+||+.|+|||++..     ..+ +.++|||||||++|.+ .|..++.                
T Consensus       165 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~-~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~  243 (316)
T 2ac3_A          165 KLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIY-DKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACP  243 (316)
T ss_dssp             -----------------CCSGGGCCHHHHHHTSHHHHHH-TTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCH
T ss_pred             ccCCccccccccccccccCCcCccChHHhhcccccccCC-CcccccHhHHHHHHHHHHCCCCCcccccccccccccccch
Confidence            32111     112335579999999999865     334 5889999999999954 3443331                


Q ss_pred             ----------------------CCCCHHHHHHHHHhcCCCCCCCCCHHhhhcCcccccc
Q 014609          218 ----------------------KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD  254 (421)
Q Consensus       218 ----------------------~~~s~~~~~li~~~L~~dP~~R~t~~eil~~~w~~~~  254 (421)
                                            ..+++.+.+||.+||+.||.+|||+.|+++||||+..
T Consensus       244 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~  302 (316)
T 2ac3_A          244 ACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGC  302 (316)
T ss_dssp             HHHHHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSTTCC--
T ss_pred             hHHHHHHHHHhccCcccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcChhhcCC
Confidence                                  2367889999999999999999999999999999863

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=7.3e-47  Score=371.73  Aligned_cols=234  Identities=37%  Similarity=0.654  Sum_probs=191.1

Q ss_pred             ecceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEE
Q 014609           13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMV   92 (421)
Q Consensus        13 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv   92 (421)
                      -++|++.+.||+|+||+||+|++..+++.||||++....     ..+.+.+|+.++++++||||+++++++.+.+..|+|
T Consensus        52 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  126 (349)
T 2w4o_A           52 SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV-----DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLV  126 (349)
T ss_dssp             GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC---------------CHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             cCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch-----hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEE
Confidence            467999999999999999999999999999999997542     235688999999999999999999999999999999


Q ss_pred             EeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecc---CCCEEEEeccCCCCCccccC
Q 014609           93 LEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDS---KGNIKISDFGLSALPQHFRD  169 (421)
Q Consensus        93 ~E~~~gg~L~~~i~~~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~---~~~~kL~DFGla~~~~~~~~  169 (421)
                      |||++|++|.+++...+.+++..++.++.|++.||+|||++||+||||||+|||++.   ++.+||+|||++.....   
T Consensus       127 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~---  203 (349)
T 2w4o_A          127 LELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEH---  203 (349)
T ss_dssp             ECCCCSCBHHHHHTTCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCEEECCCC----------
T ss_pred             EEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCCEEEccCccccccCc---
Confidence            999999999999998888999999999999999999999999999999999999975   78999999999985432   


Q ss_pred             CCccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhh-cCCcCC------------------------CCCCCHHH
Q 014609          170 DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIF-RGDFKL------------------------PKWLSPGA  224 (421)
Q Consensus       170 ~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~-~~~~~~------------------------p~~~s~~~  224 (421)
                      .......+||+.|+|||++.+..+ +.++|||||||++|++ .|..++                        ...+++.+
T Consensus       204 ~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  282 (349)
T 2w4o_A          204 QVLMKTVCGTPGYCAPEILRGCAY-GPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPWWDEVSLNA  282 (349)
T ss_dssp             ---------CGGGSCHHHHTTCCC-CTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCCCCCTTTTTTSCHHH
T ss_pred             ccccccccCCCCccCHHHhcCCCC-CcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCCCccCCchhhhCCHHH
Confidence            233456789999999999988777 5899999999999944 332222                        13478899


Q ss_pred             HHHHHHhcCCCCCCCCCHHhhhcCccccccc
Q 014609          225 QNLLRKILEPNPVKRITIAGIKADEWFEQDY  255 (421)
Q Consensus       225 ~~li~~~L~~dP~~R~t~~eil~~~w~~~~~  255 (421)
                      .+||++||+.||.+|||+.++++||||....
T Consensus       283 ~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~  313 (349)
T 2w4o_A          283 KDLVRKLIVLDPKKRLTTFQALQHPWVTGKA  313 (349)
T ss_dssp             HHHHHTTSCSSGGGSCCHHHHHHSTTTTSTT
T ss_pred             HHHHHHHccCChhhCcCHHHHhcCcccCCCc
Confidence            9999999999999999999999999998643

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=8.2e-47  Score=378.19  Aligned_cols=235  Identities=31%  Similarity=0.586  Sum_probs=194.9

Q ss_pred             CCeeecceEEe-ceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHH-hcCCCCCcceEEEEEEe-
Q 014609            9 EGMRLGRYELG-RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATL-KLLKHPNVVRLHEVLAS-   85 (421)
Q Consensus         9 ~~~~~~~y~i~-~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il-~~l~hpnIv~l~~~~~~-   85 (421)
                      .+..+++|.+. +.||+|+||+||+|.+..+|+.||||++...        ..+.+|+.++ +..+||||+++++++.. 
T Consensus        56 ~~~~~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~--------~~~~~E~~~~~~~~~hp~iv~l~~~~~~~  127 (400)
T 1nxk_A           56 KNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYENL  127 (400)
T ss_dssp             CSCGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEEE
T ss_pred             CCcccccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc--------hhHHHHHHHHHHhcCCCCcceEeEEEeec
Confidence            35567899987 7899999999999999999999999998632        3567888887 45589999999999876 


Q ss_pred             ---CCEEEEEEeccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecc---CCCEEEEe
Q 014609           86 ---KSKIYMVLEYVTGGELFDKIASKG--RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDS---KGNIKISD  157 (421)
Q Consensus        86 ---~~~~~lv~E~~~gg~L~~~i~~~~--~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~---~~~~kL~D  157 (421)
                         ...+|+||||++||+|.+++...+  .+++..++.++.||+.||+|||++||+||||||+|||++.   ++.+||+|
T Consensus       128 ~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~~kl~D  207 (400)
T 1nxk_A          128 YAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTD  207 (400)
T ss_dssp             ETTEEEEEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTCCEEECC
T ss_pred             ccCCcEEEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCccEEEEe
Confidence               567999999999999999998643  5999999999999999999999999999999999999998   78899999


Q ss_pred             ccCCCCCccccCCCccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhh-cCCcCC--------------------
Q 014609          158 FGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIF-RGDFKL--------------------  216 (421)
Q Consensus       158 FGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~-~~~~~~--------------------  216 (421)
                      ||++.....   .......+||+.|+|||++.+..| +.++|||||||++|.+ .|..++                    
T Consensus       208 FG~a~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~  283 (400)
T 1nxk_A          208 FGFAKETTS---HNSLTTPCYTPYYVAPEVLGPEKY-DKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQ  283 (400)
T ss_dssp             CTTCEECC--------------CTTCCGGGSCCCCS-SSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTC
T ss_pred             cccccccCC---CCccccCCCCCCccCHhhcCCCCC-CCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCc
Confidence            999975432   233457799999999999988777 5899999999999944 232221                    


Q ss_pred             ---C----CCCCHHHHHHHHHhcCCCCCCCCCHHhhhcCccccccc
Q 014609          217 ---P----KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY  255 (421)
Q Consensus       217 ---p----~~~s~~~~~li~~~L~~dP~~R~t~~eil~~~w~~~~~  255 (421)
                         |    ..+++++.+||++||+.||.+|||+.++++||||.+..
T Consensus       284 ~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~  329 (400)
T 1nxk_A          284 YEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQST  329 (400)
T ss_dssp             CCCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHTTT
T ss_pred             ccCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccCCC
Confidence               2    24789999999999999999999999999999998643

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=2.6e-46  Score=358.79  Aligned_cols=240  Identities=25%  Similarity=0.394  Sum_probs=204.1

Q ss_pred             eeecceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEE
Q 014609           11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIY   90 (421)
Q Consensus        11 ~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~   90 (421)
                      ..-++|++++.||+|+||.||+|++..+++.||+|++...........+.+.+|+.++++++||||+++++++.+.+..|
T Consensus         8 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~   87 (294)
T 4eqm_A            8 IINERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYY   87 (294)
T ss_dssp             CEETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEE
T ss_pred             HhhccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEE
Confidence            34478999999999999999999999999999999997665555556688999999999999999999999999999999


Q ss_pred             EEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCccccCC
Q 014609           91 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD  170 (421)
Q Consensus        91 lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~  170 (421)
                      +||||++|++|.+++...+++++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||++...... ..
T Consensus        88 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-~~  166 (294)
T 4eqm_A           88 LVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSET-SL  166 (294)
T ss_dssp             EEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCSSSTTC------
T ss_pred             EEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEEeCCCccccccc-cc
Confidence            99999999999999998889999999999999999999999999999999999999999999999999999865332 11


Q ss_pred             CccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhh-cCCcCC------------------------CCCCCHHHH
Q 014609          171 GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIF-RGDFKL------------------------PKWLSPGAQ  225 (421)
Q Consensus       171 ~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~-~~~~~~------------------------p~~~s~~~~  225 (421)
                      ......+||+.|+|||++.+..+ +.++||||+||++|.+ .|..++                        ++.+++.+.
T Consensus       167 ~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  245 (294)
T 4eqm_A          167 TQTNHVLGTVQYFSPEQAKGEAT-DECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTTDVRKDIPQSLS  245 (294)
T ss_dssp             --------CCSSCCHHHHHTCCC-CTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHSSCCCCHHHHSCTTSCHHHH
T ss_pred             cccCccccCccccCHhHhcCCCC-CchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhccCCCcchhcccCCCHHHH
Confidence            22345679999999999988777 5889999999999944 444443                        234789999


Q ss_pred             HHHHHhcCCCCCCCCCHHhhhcCcccc
Q 014609          226 NLLRKILEPNPVKRITIAGIKADEWFE  252 (421)
Q Consensus       226 ~li~~~L~~dP~~R~t~~eil~~~w~~  252 (421)
                      ++|.+||++||.+||+..+.+.+.|..
T Consensus       246 ~li~~~l~~dp~~R~~~~~~l~~~l~~  272 (294)
T 4eqm_A          246 NVILRATEKDKANRYKTIQEMKDDLSS  272 (294)
T ss_dssp             HHHHHHSCSSGGGSCSSHHHHHHHHHT
T ss_pred             HHHHHHhcCCHhHccccHHHHHHHHHH
Confidence            999999999999999766667777654

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4.4e-47  Score=372.49  Aligned_cols=245  Identities=28%  Similarity=0.385  Sum_probs=197.6

Q ss_pred             CCeeecceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccch--hHHHHHHHHHHHHhcCCCCCcceEEEEEEeC
Q 014609            9 EGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHL--KITDQIKREIATLKLLKHPNVVRLHEVLASK   86 (421)
Q Consensus         9 ~~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~--~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~   86 (421)
                      .+...++|++++.||+|+||.||+|.+..+|+.||||++........  .....+.+|+.+++.++||||+++++++.+.
T Consensus         5 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~   84 (346)
T 1ua2_A            5 VKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHK   84 (346)
T ss_dssp             --------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCT
T ss_pred             hHHHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeC
Confidence            34567899999999999999999999999999999999975432211  1124678999999999999999999999999


Q ss_pred             CEEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCc
Q 014609           87 SKIYMVLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQ  165 (421)
Q Consensus        87 ~~~~lv~E~~~gg~L~~~i~~~-~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~  165 (421)
                      +..|+||||+++ +|.+.+... ..+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||++....
T Consensus        85 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~  163 (346)
T 1ua2_A           85 SNISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFG  163 (346)
T ss_dssp             TCCEEEEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTT
T ss_pred             CceEEEEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEcCCCCEEEEecccceecc
Confidence            999999999976 888887654 468999999999999999999999999999999999999999999999999998653


Q ss_pred             cccCCCccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhhc-CCcCCC---------------------------
Q 014609          166 HFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIFR-GDFKLP---------------------------  217 (421)
Q Consensus       166 ~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~~-~~~~~p---------------------------  217 (421)
                      .  ........+||+.|+|||++.+....+.++|||||||++|.+. |..+++                           
T Consensus       164 ~--~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~  241 (346)
T 1ua2_A          164 S--PNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMC  241 (346)
T ss_dssp             S--CCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTT
T ss_pred             C--CcccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhhhhc
Confidence            3  2234456789999999999876554468999999999999543 221110                           


Q ss_pred             --------------------CCCCHHHHHHHHHhcCCCCCCCCCHHhhhcCcccccccc
Q 014609          218 --------------------KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYT  256 (421)
Q Consensus       218 --------------------~~~s~~~~~li~~~L~~dP~~R~t~~eil~~~w~~~~~~  256 (421)
                                          ..+++.+.+||.+||+.||.+|||+.|+++||||.+...
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~f~~~~~  300 (346)
T 1ua2_A          242 SLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPG  300 (346)
T ss_dssp             SSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSSC
T ss_pred             cCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcChhhhcCCC
Confidence                                234688999999999999999999999999999986543

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=2.4e-46  Score=369.82  Aligned_cols=238  Identities=30%  Similarity=0.475  Sum_probs=204.2

Q ss_pred             cceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeC-----CE
Q 014609           14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASK-----SK   88 (421)
Q Consensus        14 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~-----~~   88 (421)
                      ++|++++.||+|+||.||+|.+..+++.||||++....  .......+.+|+.++++++||||+++++++...     ..
T Consensus        27 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  104 (364)
T 3qyz_A           27 PRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFE--HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD  104 (364)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTT--CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred             ccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEecccc--CcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccce
Confidence            58999999999999999999999999999999997432  333457889999999999999999999999765     46


Q ss_pred             EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCcccc
Q 014609           89 IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFR  168 (421)
Q Consensus        89 ~~lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~~  168 (421)
                      .|+||||+. ++|.+.+.. ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.......
T Consensus       105 ~~iv~e~~~-~~L~~~l~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~  182 (364)
T 3qyz_A          105 VYIVQDLME-TDLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDH  182 (364)
T ss_dssp             EEEEEECCS-EEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCGGG
T ss_pred             EEEEEcccC-cCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEECCCCCEEEEeCcceEecCCCC
Confidence            899999996 589888875 579999999999999999999999999999999999999999999999999998654322


Q ss_pred             C-CCccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhh-cCCcCCC-----------------------------
Q 014609          169 D-DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIF-RGDFKLP-----------------------------  217 (421)
Q Consensus       169 ~-~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~-~~~~~~p-----------------------------  217 (421)
                      . .......+||+.|+|||++.+....+.++|||||||++|.+ .|..+++                             
T Consensus       183 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  262 (364)
T 3qyz_A          183 DHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINL  262 (364)
T ss_dssp             CBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHHTCCCH
T ss_pred             CccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhh
Confidence            2 22345668999999999976655446899999999999944 4444432                             


Q ss_pred             ---------------------CCCCHHHHHHHHHhcCCCCCCCCCHHhhhcCccccccc
Q 014609          218 ---------------------KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY  255 (421)
Q Consensus       218 ---------------------~~~s~~~~~li~~~L~~dP~~R~t~~eil~~~w~~~~~  255 (421)
                                           +.+++++.+||.+||++||.+|||+.|+++||||++..
T Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~~  321 (364)
T 3qyz_A          263 KARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYY  321 (364)
T ss_dssp             HHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTTC
T ss_pred             hHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhhcc
Confidence                                 23578999999999999999999999999999998754

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=2e-46  Score=364.34  Aligned_cols=231  Identities=25%  Similarity=0.440  Sum_probs=201.6

Q ss_pred             eecceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCC-CCCcceEEEEEEe--CCE
Q 014609           12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK-HPNVVRLHEVLAS--KSK   88 (421)
Q Consensus        12 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~--~~~   88 (421)
                      ..++|++++.||+|+||+||+|++..+++.||||++....      .+.+.+|+.++++++ ||||+++++++.+  ...
T Consensus        34 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~  107 (330)
T 3nsz_A           34 NQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK------KKKIKREIKILENLRGGPNIITLADIVKDPVSRT  107 (330)
T ss_dssp             EGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC------HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCC
T ss_pred             CCCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc------hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCc
Confidence            4579999999999999999999999999999999986432      467899999999997 9999999999988  678


Q ss_pred             EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCC-CEEEEeccCCCCCccc
Q 014609           89 IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKG-NIKISDFGLSALPQHF  167 (421)
Q Consensus        89 ~~lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~-~~kL~DFGla~~~~~~  167 (421)
                      .++||||+.+++|.+.+..   +++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||++..... 
T Consensus       108 ~~lv~e~~~~~~l~~~~~~---~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~-  183 (330)
T 3nsz_A          108 PALVFEHVNNTDFKQLYQT---LTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP-  183 (330)
T ss_dssp             EEEEEECCCCCCHHHHGGG---CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCEECCT-
T ss_pred             eEEEEeccCchhHHHHHHh---CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCC-
Confidence            9999999999999888753   89999999999999999999999999999999999999777 899999999975432 


Q ss_pred             cCCCccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhh-cCCcCCCC----------------------------
Q 014609          168 RDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIF-RGDFKLPK----------------------------  218 (421)
Q Consensus       168 ~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~-~~~~~~p~----------------------------  218 (421)
                        .......+||+.|+|||++.+....+.++|||||||++|.+ .|..++..                            
T Consensus       184 --~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~  261 (330)
T 3nsz_A          184 --GQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYN  261 (330)
T ss_dssp             --TCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTT
T ss_pred             --CCccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhc
Confidence              23345568999999999988744446899999999999954 45544411                            


Q ss_pred             -----------------------------CCCHHHHHHHHHhcCCCCCCCCCHHhhhcCcccccc
Q 014609          219 -----------------------------WLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD  254 (421)
Q Consensus       219 -----------------------------~~s~~~~~li~~~L~~dP~~R~t~~eil~~~w~~~~  254 (421)
                                                   .+++.+.+||.+||++||.+|||++|+++||||+..
T Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~  326 (330)
T 3nsz_A          262 IELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTV  326 (330)
T ss_dssp             CCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTSGGGTTC
T ss_pred             cccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcCccHhhh
Confidence                                         168999999999999999999999999999999864

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=3.9e-47  Score=367.17  Aligned_cols=244  Identities=26%  Similarity=0.427  Sum_probs=204.3

Q ss_pred             CeeecceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCC--
Q 014609           10 GMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKS--   87 (421)
Q Consensus        10 ~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~--   87 (421)
                      ....++|++++.||+|+||.||+|++..+++.||||++.............+.+|+.++++++||||+++++++....  
T Consensus         8 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~   87 (311)
T 3ork_A            8 SHLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPA   87 (311)
T ss_dssp             SEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETT
T ss_pred             ceecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCC
Confidence            445689999999999999999999999999999999998765555555678999999999999999999999987654  


Q ss_pred             --EEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCc
Q 014609           88 --KIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQ  165 (421)
Q Consensus        88 --~~~lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~  165 (421)
                        ..|+||||++|++|.+++...+++++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||++....
T Consensus        88 ~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~  167 (311)
T 3ork_A           88 GPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIA  167 (311)
T ss_dssp             EEEEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTSCEEECCCSCC----
T ss_pred             CcccEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcCCCCEEEeeccCccccc
Confidence              359999999999999999988899999999999999999999999999999999999999999999999999998653


Q ss_pred             cccC-CCccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhh-cCCcCCC-----------------------CCC
Q 014609          166 HFRD-DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIF-RGDFKLP-----------------------KWL  220 (421)
Q Consensus       166 ~~~~-~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~-~~~~~~p-----------------------~~~  220 (421)
                      .... .......+||+.|+|||++.+..+ +.++|||||||++|.+ .|..++.                       ..+
T Consensus       168 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (311)
T 3ork_A          168 DSGNSVTQTAAVIGTAQYLSPEQARGDSV-DARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGL  246 (311)
T ss_dssp             --------------CCTTCCHHHHHTCCC-CHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCHHHHSTTC
T ss_pred             ccccccccccccCcCcccCCHHHhcCCCC-CchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCcccccCCC
Confidence            3211 122344679999999999988777 5899999999999944 4444432                       237


Q ss_pred             CHHHHHHHHHhcCCCCCCCCCHHhhhcCcccccc
Q 014609          221 SPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD  254 (421)
Q Consensus       221 s~~~~~li~~~L~~dP~~R~t~~eil~~~w~~~~  254 (421)
                      ++++.++|.+||++||.+||+..+++.|+|+...
T Consensus       247 ~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~  280 (311)
T 3ork_A          247 SADLDAVVLKALAKNPENRYQTAAEMRADLVRVH  280 (311)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred             CHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHh
Confidence            8899999999999999999999999999999753

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=5.9e-46  Score=354.77  Aligned_cols=233  Identities=24%  Similarity=0.458  Sum_probs=202.8

Q ss_pred             cceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEe----CCEE
Q 014609           14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLAS----KSKI   89 (421)
Q Consensus        14 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~----~~~~   89 (421)
                      ..|++.+.||+|+||.||+|.+..++..||+|++...... ....+.+.+|+.++++++||||+++++++..    ...+
T Consensus        26 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  104 (290)
T 1t4h_A           26 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLT-KSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCI  104 (290)
T ss_dssp             CEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSC-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEE
T ss_pred             eeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhC-HHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceE
Confidence            3589999999999999999999999999999999865443 3346789999999999999999999999875    4668


Q ss_pred             EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--ceeccCCCCCEEec-cCCCEEEEeccCCCCCcc
Q 014609           90 YMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKG--VFHRDLKLENILLD-SKGNIKISDFGLSALPQH  166 (421)
Q Consensus        90 ~lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~ql~~aL~~LH~~g--i~HrDlkp~NILl~-~~~~~kL~DFGla~~~~~  166 (421)
                      |+||||+++++|.+++.....+++..++.++.||+.||+|||++|  |+||||||+|||++ .++.+||+|||++.... 
T Consensus       105 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~~-  183 (290)
T 1t4h_A          105 VLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR-  183 (290)
T ss_dssp             EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCC-
T ss_pred             EEEEEecCCCCHHHHHHHccCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCCEEEeeCCCccccc-
Confidence            999999999999999998889999999999999999999999999  99999999999998 78999999999997432 


Q ss_pred             ccCCCccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhh-cCCcCCC----------------------CCCCHH
Q 014609          167 FRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIF-RGDFKLP----------------------KWLSPG  223 (421)
Q Consensus       167 ~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~-~~~~~~p----------------------~~~s~~  223 (421)
                         .......+||+.|+|||++.+ .+ +.++|||||||++|.+ .|..+++                      ...++.
T Consensus       184 ---~~~~~~~~~t~~y~aPE~~~~-~~-~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  258 (290)
T 1t4h_A          184 ---ASFAKAVIGTPEFMAPEMYEE-KY-DESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPE  258 (290)
T ss_dssp             ---TTSBEESCSSCCCCCGGGGGT-CC-CTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCHH
T ss_pred             ---ccccccccCCcCcCCHHHHhc-cC-CCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhccCCccccCCCCCHH
Confidence               234456689999999998864 35 5899999999999944 4444432                      235688


Q ss_pred             HHHHHHHhcCCCCCCCCCHHhhhcCccccc
Q 014609          224 AQNLLRKILEPNPVKRITIAGIKADEWFEQ  253 (421)
Q Consensus       224 ~~~li~~~L~~dP~~R~t~~eil~~~w~~~  253 (421)
                      +.++|.+||+.||.+|||+.++++||||+.
T Consensus       259 l~~li~~~l~~dp~~Rps~~ell~h~~f~~  288 (290)
T 1t4h_A          259 VKEIIEGCIRQNKDERYSIKDLLNHAFFQE  288 (290)
T ss_dssp             HHHHHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred             HHHHHHHHccCChhhCCCHHHHhhCccccc
Confidence            999999999999999999999999999985

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=2.2e-46  Score=368.26  Aligned_cols=234  Identities=26%  Similarity=0.431  Sum_probs=203.8

Q ss_pred             cceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEE
Q 014609           14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVL   93 (421)
Q Consensus        14 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~   93 (421)
                      .+|++++.||+|+||+||+|++..+|+.||||++...........+.+.+|+.++++++||||+++++++..++..|+||
T Consensus        54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  133 (348)
T 1u5q_A           54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM  133 (348)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence            56999999999999999999999999999999998655444445578999999999999999999999999999999999


Q ss_pred             eccCCCChHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCccccCCCc
Q 014609           94 EYVTGGELFDKIA-SKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGL  172 (421)
Q Consensus        94 E~~~gg~L~~~i~-~~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~  172 (421)
                      ||+. |+|.+.+. ...++++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||++.....      
T Consensus       134 e~~~-g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~------  206 (348)
T 1u5q_A          134 EYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP------  206 (348)
T ss_dssp             ECCS-EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS------
T ss_pred             ecCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEeeccCceecCC------
Confidence            9997 57878775 456799999999999999999999999999999999999999999999999999985432      


Q ss_pred             cccccCCCCccChhhhc---ccCCCCCcchHHHHHHHHhhh-cCCcCC---------------------CCCCCHHHHHH
Q 014609          173 LHTTCGSPNYVAPEVLA---NRGYDGATSDIWSCGVILYIF-RGDFKL---------------------PKWLSPGAQNL  227 (421)
Q Consensus       173 ~~~~~gt~~y~APEvl~---~~~~~~~~~DiwSlGvil~~~-~~~~~~---------------------p~~~s~~~~~l  227 (421)
                      ....+||+.|+|||++.   ...+ +.++|||||||++|.+ .|..++                     +..+++.+.++
T Consensus       207 ~~~~~gt~~y~aPE~~~~~~~~~~-~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  285 (348)
T 1u5q_A          207 ANSFVGTPYWMAPEVILAMDEGQY-DGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNF  285 (348)
T ss_dssp             BCCCCSCGGGCCHHHHHTTSSCCB-CTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCCCTTSCHHHHHH
T ss_pred             CCcccCCcceeCHhhhccccCCCC-CcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCHHHHHH
Confidence            23568999999999985   3445 5899999999999954 333322                     23478999999


Q ss_pred             HHHhcCCCCCCCCCHHhhhcCccccccc
Q 014609          228 LRKILEPNPVKRITIAGIKADEWFEQDY  255 (421)
Q Consensus       228 i~~~L~~dP~~R~t~~eil~~~w~~~~~  255 (421)
                      |.+||+.||.+|||+.++++||||....
T Consensus       286 i~~~l~~dP~~Rps~~~ll~h~~~~~~~  313 (348)
T 1u5q_A          286 VDSCLQKIPQDRPTSEVLLKHRFVLRER  313 (348)
T ss_dssp             HHHHTCSSGGGSCCHHHHTTCHHHHSCC
T ss_pred             HHHHcccChhhCcCHHHHhhChhhhccC
Confidence            9999999999999999999999998643

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=1.3e-46  Score=368.59  Aligned_cols=240  Identities=26%  Similarity=0.436  Sum_probs=199.0

Q ss_pred             ecceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCC--CCcceEEEEEEeCCEEE
Q 014609           13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKH--PNVVRLHEVLASKSKIY   90 (421)
Q Consensus        13 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~h--pnIv~l~~~~~~~~~~~   90 (421)
                      -++|++++.||+|+||.||+|.+ .+++.||||++..... .....+.+.+|+.+|++++|  |||+++++++.++..+|
T Consensus         8 ~~~y~i~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~   85 (343)
T 3dbq_A            8 GRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEA-DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIY   85 (343)
T ss_dssp             SCEEEEEEEESCCSSEEEEEEEC-TTSCEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred             cCEEEEEEEEecCCCeEEEEEEe-CCCCEEEEEEeecccc-chHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEE
Confidence            35799999999999999999987 5789999999976543 33345789999999999986  99999999999999999


Q ss_pred             EEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCccccCC
Q 014609           91 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD  170 (421)
Q Consensus        91 lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~  170 (421)
                      +|||+ .+++|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++ ++.+||+|||++.........
T Consensus        86 lv~e~-~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~~~~  163 (343)
T 3dbq_A           86 MVMEC-GNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTS  163 (343)
T ss_dssp             EEECC-CSEEHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC------
T ss_pred             EEEeC-CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEE-CCcEEEeecccccccCccccc
Confidence            99995 5889999999988999999999999999999999999999999999999996 688999999999865443223


Q ss_pred             CccccccCCCCccChhhhcc-----------cCCCCCcchHHHHHHHHhhh-cCCcC----------------------C
Q 014609          171 GLLHTTCGSPNYVAPEVLAN-----------RGYDGATSDIWSCGVILYIF-RGDFK----------------------L  216 (421)
Q Consensus       171 ~~~~~~~gt~~y~APEvl~~-----------~~~~~~~~DiwSlGvil~~~-~~~~~----------------------~  216 (421)
                      ......+||+.|+|||++.+           ..+ +.++|||||||++|.+ .|..+                      +
T Consensus       164 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~-~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~  242 (343)
T 3dbq_A          164 VVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKI-SPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEF  242 (343)
T ss_dssp             ------CCCCSSCCHHHHHHCC-----------C-CHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTSCCCC
T ss_pred             ccCCCCcCCcCcCCHHHHhhccccccccccccCC-CchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHHHHhcCCcccCC
Confidence            33456789999999999864           334 5889999999999943 33333                      3


Q ss_pred             CCCCCHHHHHHHHHhcCCCCCCCCCHHhhhcCccccccccC
Q 014609          217 PKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTP  257 (421)
Q Consensus       217 p~~~s~~~~~li~~~L~~dP~~R~t~~eil~~~w~~~~~~~  257 (421)
                      |...++.+.++|.+||+.||.+|||+.++++||||+....+
T Consensus       243 ~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~~~  283 (343)
T 3dbq_A          243 PDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHP  283 (343)
T ss_dssp             CCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSCCC-
T ss_pred             cccCCHHHHHHHHHHcCCChhHCCCHHHHHhCccccccCCc
Confidence            44567899999999999999999999999999999865433

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.1e-46  Score=372.97  Aligned_cols=235  Identities=30%  Similarity=0.425  Sum_probs=196.8

Q ss_pred             ecceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeC------
Q 014609           13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASK------   86 (421)
Q Consensus        13 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~------   86 (421)
                      .++|++++.||+|+||.||+|.+..+|+.||||++.... ........+.+|+.+++.++||||+++++++...      
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~  102 (367)
T 1cm8_A           24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPF-QSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF  102 (367)
T ss_dssp             BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTT-SSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred             cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccc-cCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccC
Confidence            368999999999999999999999999999999986543 2334467889999999999999999999999766      


Q ss_pred             CEEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCcc
Q 014609           87 SKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQH  166 (421)
Q Consensus        87 ~~~~lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~  166 (421)
                      ..+|+||||+ |++|.+.+.. ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.....
T Consensus       103 ~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~  180 (367)
T 1cm8_A          103 TDFYLVMPFM-GTDLGKLMKH-EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADS  180 (367)
T ss_dssp             CCCEEEEECC-SEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred             ceEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEcCCCCEEEEeeeccccccc
Confidence            3469999999 8899988876 6799999999999999999999999999999999999999999999999999985432


Q ss_pred             ccCCCccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhh-cCCcCCC----------------------------
Q 014609          167 FRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIF-RGDFKLP----------------------------  217 (421)
Q Consensus       167 ~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~-~~~~~~p----------------------------  217 (421)
                           .....+||+.|+|||++.+....+.++||||+||++|.+ .|..+++                            
T Consensus       181 -----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~  255 (367)
T 1cm8_A          181 -----EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQS  255 (367)
T ss_dssp             -----SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSC
T ss_pred             -----ccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhh
Confidence                 244568999999999988733346899999999999944 3333321                            


Q ss_pred             ----------------------CCCCHHHHHHHHHhcCCCCCCCCCHHhhhcCccccccc
Q 014609          218 ----------------------KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY  255 (421)
Q Consensus       218 ----------------------~~~s~~~~~li~~~L~~dP~~R~t~~eil~~~w~~~~~  255 (421)
                                            +..++.+.+||.+||+.||.+|||+.++++||||....
T Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~~  315 (367)
T 1cm8_A          256 DEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLH  315 (367)
T ss_dssp             HHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred             HHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhhc
Confidence                                  23588999999999999999999999999999998643

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=1.1e-46  Score=371.30  Aligned_cols=239  Identities=30%  Similarity=0.471  Sum_probs=208.8

Q ss_pred             CeeecceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEE
Q 014609           10 GMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKI   89 (421)
Q Consensus        10 ~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~   89 (421)
                      ....++|++++.||+|+||+||+|.+..+++.||+|++....  .....+.+.+|+.+++.++||||+++++++..++..
T Consensus        29 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  106 (360)
T 3eqc_A           29 ELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEI  106 (360)
T ss_dssp             CCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCC--CHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEE
T ss_pred             ccccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEecccc--CHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEE
Confidence            345689999999999999999999999999999999997653  334457899999999999999999999999999999


Q ss_pred             EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC-CceeccCCCCCEEeccCCCEEEEeccCCCCCcccc
Q 014609           90 YMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNK-GVFHRDLKLENILLDSKGNIKISDFGLSALPQHFR  168 (421)
Q Consensus        90 ~lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~ql~~aL~~LH~~-gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~~  168 (421)
                      |+||||++|++|.+++...+.+++..+..++.|++.||+|||+. ||+||||||+|||++.++.+||+|||++.....  
T Consensus       107 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~--  184 (360)
T 3eqc_A          107 SICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID--  184 (360)
T ss_dssp             EEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHH--
T ss_pred             EEEEECCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEECCCCCEEEEECCCCccccc--
Confidence            99999999999999999888999999999999999999999996 999999999999999999999999999864322  


Q ss_pred             CCCccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhh-cCCcCCC------------------------------
Q 014609          169 DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIF-RGDFKLP------------------------------  217 (421)
Q Consensus       169 ~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~-~~~~~~p------------------------------  217 (421)
                        ......+||+.|+|||++.+..+ +.++|||||||++|.+ .|..+++                              
T Consensus       185 --~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  261 (360)
T 3eqc_A          185 --SMANSFVGTRSYMSPERLQGTHY-SVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPG  261 (360)
T ss_dssp             --HC----CCCCTTCCHHHHTTCCC-SHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC------------------
T ss_pred             --ccccCCCCCCCeECHHHHcCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCC
Confidence              12345689999999999988777 5899999999999944 4544432                              


Q ss_pred             ---------------------------------CCCCHHHHHHHHHhcCCCCCCCCCHHhhhcCccccccc
Q 014609          218 ---------------------------------KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY  255 (421)
Q Consensus       218 ---------------------------------~~~s~~~~~li~~~L~~dP~~R~t~~eil~~~w~~~~~  255 (421)
                                                       ..+++++.+||.+||+.||.+|||+.++++||||+...
T Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~  332 (360)
T 3eqc_A          262 RPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSD  332 (360)
T ss_dssp             ------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHHHH
T ss_pred             CcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhChHhhcch
Confidence                                             12578899999999999999999999999999998644

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=1.1e-46  Score=379.55  Aligned_cols=236  Identities=37%  Similarity=0.654  Sum_probs=194.3

Q ss_pred             ecceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccc-----hhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCC
Q 014609           13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIH-----LKITDQIKREIATLKLLKHPNVVRLHEVLASKS   87 (421)
Q Consensus        13 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~-----~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~   87 (421)
                      .++|++.+.||+|+||+||+|.+..+++.||||++.+.....     ......+.+|+.+|++++||||+++++++.. .
T Consensus       134 ~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-~  212 (419)
T 3i6u_A          134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA-E  212 (419)
T ss_dssp             HTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES-S
T ss_pred             hccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec-C
Confidence            478999999999999999999999999999999998654321     1112358899999999999999999999854 5


Q ss_pred             EEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCC---CEEEEeccCCCCC
Q 014609           88 KIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKG---NIKISDFGLSALP  164 (421)
Q Consensus        88 ~~~lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~---~~kL~DFGla~~~  164 (421)
                      ..|+||||+++++|.+.+...+.+++..++.++.|++.||+|||++||+||||||+|||++.++   .+||+|||++...
T Consensus       213 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~  292 (419)
T 3i6u_A          213 DYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL  292 (419)
T ss_dssp             EEEEEEECCTTCBGGGGTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCEEECCSSTTTSC
T ss_pred             ceEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcceEEEeecccceec
Confidence            6899999999999999998888999999999999999999999999999999999999997654   5999999999865


Q ss_pred             ccccCCCccccccCCCCccChhhhcc---cCCCCCcchHHHHHHHHhhh-cCCcCCC-----------------------
Q 014609          165 QHFRDDGLLHTTCGSPNYVAPEVLAN---RGYDGATSDIWSCGVILYIF-RGDFKLP-----------------------  217 (421)
Q Consensus       165 ~~~~~~~~~~~~~gt~~y~APEvl~~---~~~~~~~~DiwSlGvil~~~-~~~~~~p-----------------------  217 (421)
                      ..   .......+||+.|+|||++.+   ..| +.++|||||||++|.+ .|..+++                       
T Consensus       293 ~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~-~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~~~~~~~~~~  368 (419)
T 3i6u_A          293 GE---TSLMRTLCGTPTYLAPEVLVSVGTAGY-NRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEV  368 (419)
T ss_dssp             C--------------CTTCCTTTTC----CTT-HHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHTTCCCCCHHH
T ss_pred             CC---CccccccCCCCCccCceeeecCCCCCC-CchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhcCCCCCCchh
Confidence            42   334556789999999999853   334 5789999999999954 4444332                       


Q ss_pred             -CCCCHHHHHHHHHhcCCCCCCCCCHHhhhcCccccc
Q 014609          218 -KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQ  253 (421)
Q Consensus       218 -~~~s~~~~~li~~~L~~dP~~R~t~~eil~~~w~~~  253 (421)
                       ..+++.+.+||.+||+.||.+|||++|+++||||+.
T Consensus       369 ~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~  405 (419)
T 3i6u_A          369 WAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQD  405 (419)
T ss_dssp             HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCC
T ss_pred             hcccCHHHHHHHHHHccCChhHCcCHHHHhCCcccCC
Confidence             236889999999999999999999999999999975

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=4.3e-46  Score=366.75  Aligned_cols=229  Identities=27%  Similarity=0.450  Sum_probs=199.4

Q ss_pred             ecceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCC-----CCCcceEEEEEEeCC
Q 014609           13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK-----HPNVVRLHEVLASKS   87 (421)
Q Consensus        13 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~-----hpnIv~l~~~~~~~~   87 (421)
                      -++|++++.||+|+||+||+|++..+++.||||++...    ......+.+|+.+++.++     ||||+++++++...+
T Consensus        34 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~~~  109 (360)
T 3llt_A           34 NNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI----KKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYYD  109 (360)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC----HHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEETT
T ss_pred             cCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc----hhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeECC
Confidence            37999999999999999999999999999999998642    233567788999999997     999999999999999


Q ss_pred             EEEEEEeccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecc----------------
Q 014609           88 KIYMVLEYVTGGELFDKIASKG--RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDS----------------  149 (421)
Q Consensus        88 ~~~lv~E~~~gg~L~~~i~~~~--~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~----------------  149 (421)
                      ..|+||||+ +++|.+++....  .+++..++.++.||+.||+|||++||+||||||+|||++.                
T Consensus       110 ~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~~~~~~~~~~  188 (360)
T 3llt_A          110 HMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDG  188 (360)
T ss_dssp             EEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCCEEEEEEECTTTC
T ss_pred             eeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEccccccccccchhccccc
Confidence            999999999 999999998654  5999999999999999999999999999999999999975                


Q ss_pred             ---------CCCEEEEeccCCCCCccccCCCccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhh-cCCcCCCCC
Q 014609          150 ---------KGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIF-RGDFKLPKW  219 (421)
Q Consensus       150 ---------~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~-~~~~~~p~~  219 (421)
                               ++.+||+|||++.....     .....+||+.|+|||++.+..+ +.++|||||||++|.+ .|..++...
T Consensus       189 ~~~~~~~~~~~~~kl~DFG~a~~~~~-----~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~g~~pf~~~  262 (360)
T 3llt_A          189 KKIQIYRTKSTGIKLIDFGCATFKSD-----YHGSIINTRQYRAPEVILNLGW-DVSSDMWSFGCVLAELYTGSLLFRTH  262 (360)
T ss_dssp             CEEEEEEESCCCEEECCCTTCEETTS-----CCCSCCSCGGGCCHHHHTTCCC-CTTHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred             ccccccccCCCCEEEEeccCceecCC-----CCcCccCcccccCcHHHcCCCC-CCccchHHHHHHHHHHHHCCCCCCCC
Confidence                     78999999999975322     2345689999999999988887 5899999999999954 454443210


Q ss_pred             -----------------------------------------------------------------CCHHHHHHHHHhcCC
Q 014609          220 -----------------------------------------------------------------LSPGAQNLLRKILEP  234 (421)
Q Consensus       220 -----------------------------------------------------------------~s~~~~~li~~~L~~  234 (421)
                                                                                       .++.+.+||.+||+.
T Consensus       263 ~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~  342 (360)
T 3llt_A          263 EHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSILQI  342 (360)
T ss_dssp             SHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHHHHHCCS
T ss_pred             cHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHHHHHhcC
Confidence                                                                             126677999999999


Q ss_pred             CCCCCCCHHhhhcCcccc
Q 014609          235 NPVKRITIAGIKADEWFE  252 (421)
Q Consensus       235 dP~~R~t~~eil~~~w~~  252 (421)
                      ||.+|||+.|+++||||+
T Consensus       343 dP~~Rpta~elL~hp~f~  360 (360)
T 3llt_A          343 DPTLRPSPAELLKHKFLE  360 (360)
T ss_dssp             SGGGSCCHHHHTTSGGGC
T ss_pred             ChhhCCCHHHHhcCcccC
Confidence            999999999999999995

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=3.8e-46  Score=354.44  Aligned_cols=238  Identities=35%  Similarity=0.654  Sum_probs=205.1

Q ss_pred             ecceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccch---hHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEE
Q 014609           13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHL---KITDQIKREIATLKLLKHPNVVRLHEVLASKSKI   89 (421)
Q Consensus        13 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~---~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~   89 (421)
                      -++|++++.||+|+||.||+|.+..+|+.||+|++........   ...+.+.+|+.++++++||||+++++++.+.+..
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~   83 (283)
T 3bhy_A            4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDV   83 (283)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             hhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeE
Confidence            3689999999999999999999999999999999986543221   1257899999999999999999999999999999


Q ss_pred             EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCC----CEEEEeccCCCCCc
Q 014609           90 YMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKG----NIKISDFGLSALPQ  165 (421)
Q Consensus        90 ~lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~----~~kL~DFGla~~~~  165 (421)
                      |+||||+++++|.+++.....+++..+..++.|++.||+|||++||+||||||+||+++.++    .+||+|||++....
T Consensus        84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~~~  163 (283)
T 3bhy_A           84 VLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIE  163 (283)
T ss_dssp             EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCEEECCCTTCEECC
T ss_pred             EEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCceEEEecccceecc
Confidence            99999999999999998888899999999999999999999999999999999999998877    89999999997543


Q ss_pred             cccCCCccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhh-cCCcCCC-----------------------CCCC
Q 014609          166 HFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIF-RGDFKLP-----------------------KWLS  221 (421)
Q Consensus       166 ~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~-~~~~~~p-----------------------~~~s  221 (421)
                      .   ........||+.|+|||++.+..+ +.++||||||+++|.+ .|..++.                       ..++
T Consensus       164 ~---~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (283)
T 3bhy_A          164 A---GNEFKNIFGTPEFVAPEIVNYEPL-GLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFSNTS  239 (283)
T ss_dssp             -----------CCCGGGCCHHHHTTCCC-CTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCHHHHTTCC
T ss_pred             C---CCcccccCCCcCccCcceecCCCC-CcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHhcccCCcchhcccCC
Confidence            2   223345679999999999987776 5899999999999944 3333321                       3468


Q ss_pred             HHHHHHHHHhcCCCCCCCCCHHhhhcCcccccc
Q 014609          222 PGAQNLLRKILEPNPVKRITIAGIKADEWFEQD  254 (421)
Q Consensus       222 ~~~~~li~~~L~~dP~~R~t~~eil~~~w~~~~  254 (421)
                      +.+.++|.+||..||.+|||+.++++||||+..
T Consensus       240 ~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~  272 (283)
T 3bhy_A          240 ELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAI  272 (283)
T ss_dssp             HHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHH
T ss_pred             HHHHHHHHHHccCCHhHCcCHHHHHhCHHHHHH
Confidence            889999999999999999999999999999864

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=8.1e-47  Score=369.41  Aligned_cols=241  Identities=35%  Similarity=0.579  Sum_probs=200.1

Q ss_pred             cceEEeceEeecCcEEEEEEEECCCCceEEEEEeeccccc--chhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEE
Q 014609           14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRII--HLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYM   91 (421)
Q Consensus        14 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~--~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l   91 (421)
                      ++|++++.||+|+||.||+|.+..+++.||+|++.+....  .....+.+.+|+.++++++||||+++++++.+.+..|+
T Consensus        26 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l  105 (345)
T 3hko_A           26 KKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICL  105 (345)
T ss_dssp             HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred             hheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCCeEEE
Confidence            6899999999999999999999999999999999765322  22345789999999999999999999999999999999


Q ss_pred             EEeccCCCChHHHHHh----------------------------------------cCCCCHHHHHHHHHHHHHHHHHHH
Q 014609           92 VLEYVTGGELFDKIAS----------------------------------------KGRLQEAEGRKLFQQLIDGVSYCH  131 (421)
Q Consensus        92 v~E~~~gg~L~~~i~~----------------------------------------~~~~~~~~~~~~~~ql~~aL~~LH  131 (421)
                      ||||++|++|.+++..                                        ...+++..++.++.||+.||+|||
T Consensus       106 v~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH  185 (345)
T 3hko_A          106 VMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLH  185 (345)
T ss_dssp             EEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred             EEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHH
Confidence            9999999999998742                                        112467888999999999999999


Q ss_pred             hCCceeccCCCCCEEeccCC--CEEEEeccCCCCCccccCC--CccccccCCCCccChhhhcc--cCCCCCcchHHHHHH
Q 014609          132 NKGVFHRDLKLENILLDSKG--NIKISDFGLSALPQHFRDD--GLLHTTCGSPNYVAPEVLAN--RGYDGATSDIWSCGV  205 (421)
Q Consensus       132 ~~gi~HrDlkp~NILl~~~~--~~kL~DFGla~~~~~~~~~--~~~~~~~gt~~y~APEvl~~--~~~~~~~~DiwSlGv  205 (421)
                      ++||+||||||+|||++.++  .+||+|||++.........  ......+||+.|+|||++.+  ..+ +.++|||||||
T Consensus       186 ~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~-~~~~DiwslG~  264 (345)
T 3hko_A          186 NQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESY-GPKCDAWSAGV  264 (345)
T ss_dssp             HTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCC-CTHHHHHHHHH
T ss_pred             HCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCC-CcHHHHHHHHH
Confidence            99999999999999998777  8999999999754332111  12456689999999999865  344 68999999999


Q ss_pred             HHhhh-cCCcCCCC-----------------------CCCHHHHHHHHHhcCCCCCCCCCHHhhhcCccccccc
Q 014609          206 ILYIF-RGDFKLPK-----------------------WLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY  255 (421)
Q Consensus       206 il~~~-~~~~~~p~-----------------------~~s~~~~~li~~~L~~dP~~R~t~~eil~~~w~~~~~  255 (421)
                      ++|.+ .|..+++.                       .+++.+.++|.+||++||.+|||+.++++||||+...
T Consensus       265 il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~hp~~~~~~  338 (345)
T 3hko_A          265 LLHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFDAMRALQHPWISQFS  338 (345)
T ss_dssp             HHHHHHHSSCSSCCSSHHHHHHHHHHCCCCTTSGGGGGSCHHHHHHHHHHSCSCTTTSCCHHHHHHSHHHHTTS
T ss_pred             HHHHHHHCCCCCCCCChHHHHHHHHhcccccCCcccccCCHHHHHHHHHHcCCChhHCCCHHHHhcChhhccCh
Confidence            99944 44444321                       2689999999999999999999999999999998643

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=6.4e-46  Score=367.20  Aligned_cols=236  Identities=33%  Similarity=0.609  Sum_probs=205.0

Q ss_pred             cceEEeceEeecCcEEEEEEEECCCCceEEEEEeeccccc-----chhHHHHHHHHHHHHhcC-CCCCcceEEEEEEeCC
Q 014609           14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRII-----HLKITDQIKREIATLKLL-KHPNVVRLHEVLASKS   87 (421)
Q Consensus        14 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~-----~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~   87 (421)
                      ++|++.+.||+|+||.||+|.+..+|+.||||+++.....     .....+.+.+|+.+++++ +||||+++++++...+
T Consensus        94 ~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~  173 (365)
T 2y7j_A           94 QKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSS  173 (365)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBSS
T ss_pred             hhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeCC
Confidence            6899999999999999999999999999999999764321     112246788999999999 7999999999999999


Q ss_pred             EEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCccc
Q 014609           88 KIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHF  167 (421)
Q Consensus        88 ~~~lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~  167 (421)
                      ..|+||||++|++|.+++.....+++..++.++.||+.||.|||+.||+||||||+|||++.+|.+||+|||++..... 
T Consensus       174 ~~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~~~~~ikl~DfG~~~~~~~-  252 (365)
T 2y7j_A          174 FMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEP-  252 (365)
T ss_dssp             EEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECCT-
T ss_pred             EEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEEecCcccccCC-
Confidence            9999999999999999998888899999999999999999999999999999999999999999999999999875432 


Q ss_pred             cCCCccccccCCCCccChhhhccc------CCCCCcchHHHHHHHHhhh-cCCcCCC-----------------------
Q 014609          168 RDDGLLHTTCGSPNYVAPEVLANR------GYDGATSDIWSCGVILYIF-RGDFKLP-----------------------  217 (421)
Q Consensus       168 ~~~~~~~~~~gt~~y~APEvl~~~------~~~~~~~DiwSlGvil~~~-~~~~~~p-----------------------  217 (421)
                        .......+||+.|+|||++.+.      .+ +.++|||||||++|.+ .|..++.                       
T Consensus       253 --~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~-~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  329 (365)
T 2y7j_A          253 --GEKLRELCGTPGYLAPEILKCSMDETHPGY-GKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQFSSPEW  329 (365)
T ss_dssp             --TCCBCCCCSCGGGCCHHHHHHTTCTTSCCB-CTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCHHHH
T ss_pred             --CcccccCCCCCCccChhhccccccccCcCC-CchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCccc
Confidence              2334567899999999998642      34 5889999999999944 4443331                       


Q ss_pred             CCCCHHHHHHHHHhcCCCCCCCCCHHhhhcCccccc
Q 014609          218 KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQ  253 (421)
Q Consensus       218 ~~~s~~~~~li~~~L~~dP~~R~t~~eil~~~w~~~  253 (421)
                      ..+++.+.++|.+||+.||.+|||+.++++||||++
T Consensus       330 ~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~f~r  365 (365)
T 2y7j_A          330 DDRSSTVKDLISRLLQVDPEARLTAEQALQHPFFER  365 (365)
T ss_dssp             SSSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCC
T ss_pred             ccCCHHHHHHHHHHcCCChhHCcCHHHHhcCcccCC
Confidence            236788999999999999999999999999999973

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=3.4e-46  Score=372.47  Aligned_cols=239  Identities=26%  Similarity=0.420  Sum_probs=199.9

Q ss_pred             cceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCC--CCCcceEEEEEEeCCEEEE
Q 014609           14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK--HPNVVRLHEVLASKSKIYM   91 (421)
Q Consensus        14 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~--hpnIv~l~~~~~~~~~~~l   91 (421)
                      .+|++++.||+|+||+||+|.+.. ++.||||++..... .....+.+.+|+.+|++++  ||||+++++++...+.+|+
T Consensus        56 ~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vaiK~~~~~~~-~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~l  133 (390)
T 2zmd_A           56 RIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEA-DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYM  133 (390)
T ss_dssp             EEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred             CceEEEEEEccCCCeEEEEEEcCC-CCEEEEEEEecccc-cHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEE
Confidence            469999999999999999999754 99999999976543 3344678999999999997  5999999999999999999


Q ss_pred             EEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCccccCCC
Q 014609           92 VLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDG  171 (421)
Q Consensus        92 v~E~~~gg~L~~~i~~~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~  171 (421)
                      ||| +.+++|.+++.....+++..++.++.||+.||+|||++||+||||||+|||++ ++.+||+|||++..........
T Consensus       134 v~E-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~~~~  211 (390)
T 2zmd_A          134 VME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSV  211 (390)
T ss_dssp             EEE-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEES-SSCEEECCCSSSCCC-------
T ss_pred             EEe-cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEE-CCeEEEEecCccccccCCCccc
Confidence            999 55889999999888999999999999999999999999999999999999995 6899999999998654322222


Q ss_pred             ccccccCCCCccChhhhccc----------CCCCCcchHHHHHHHHhhh-cCCc----------------------CCCC
Q 014609          172 LLHTTCGSPNYVAPEVLANR----------GYDGATSDIWSCGVILYIF-RGDF----------------------KLPK  218 (421)
Q Consensus       172 ~~~~~~gt~~y~APEvl~~~----------~~~~~~~DiwSlGvil~~~-~~~~----------------------~~p~  218 (421)
                      .....+||+.|+|||++.+.          ...+.++|||||||++|++ .|..                      ++|.
T Consensus       212 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~  291 (390)
T 2zmd_A          212 VKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPD  291 (390)
T ss_dssp             --CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHCTTSCCCCCC
T ss_pred             cCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHHHhCccccCCCCc
Confidence            34567899999999998652          2235889999999999943 2322                      3455


Q ss_pred             CCCHHHHHHHHHhcCCCCCCCCCHHhhhcCcccccccc
Q 014609          219 WLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYT  256 (421)
Q Consensus       219 ~~s~~~~~li~~~L~~dP~~R~t~~eil~~~w~~~~~~  256 (421)
                      +.++.+.+||.+||+.||.+|||+.|+++||||+....
T Consensus       292 ~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~~~~  329 (390)
T 2zmd_A          292 IPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTH  329 (390)
T ss_dssp             CSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSCC-
T ss_pred             cchHHHHHHHHHHcccChhhCCCHHHHhhCcCccccCc
Confidence            67889999999999999999999999999999986543

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=4.1e-46  Score=369.22  Aligned_cols=236  Identities=29%  Similarity=0.435  Sum_probs=193.2

Q ss_pred             eecceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCC----
Q 014609           12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKS----   87 (421)
Q Consensus        12 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~----   87 (421)
                      .+++|++++.||+|+||.||+|.+..+++.||||++..... .......+.+|+.+++.++||||+++++++...+    
T Consensus        23 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~  101 (371)
T 2xrw_A           23 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQ-NQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEE  101 (371)
T ss_dssp             EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTS-SHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTT
T ss_pred             hhhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccC-ChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccc
Confidence            46899999999999999999999999999999999976432 3344577899999999999999999999997665    


Q ss_pred             --EEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCc
Q 014609           88 --KIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQ  165 (421)
Q Consensus        88 --~~~lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~  165 (421)
                        ..|+||||+.+ +|.+.+.  ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++....
T Consensus       102 ~~~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~  178 (371)
T 2xrw_A          102 FQDVYIVMELMDA-NLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG  178 (371)
T ss_dssp             CCEEEEEEECCSE-EHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCCC-----
T ss_pred             ccceEEEEEcCCC-CHHHHHh--hccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEEEeecccccc
Confidence              78999999965 7888875  469999999999999999999999999999999999999999999999999998543


Q ss_pred             cccCCCccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhh-cCCcCCCCC-------------------------
Q 014609          166 HFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIF-RGDFKLPKW-------------------------  219 (421)
Q Consensus       166 ~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~-~~~~~~p~~-------------------------  219 (421)
                      .   .......+||+.|+|||++.+..+ +.++|||||||++|.+ .|..+++..                         
T Consensus       179 ~---~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  254 (371)
T 2xrw_A          179 T---SFMMTPYVVTRYYRAPEVILGMGY-KENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQ  254 (371)
T ss_dssp             --------------CTTCCHHHHTTCCC-CTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTSC
T ss_pred             c---ccccCCceecCCccCHHHhcCCCC-CchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhh
Confidence            2   223455689999999999988877 5899999999999944 444433210                         


Q ss_pred             ------------------------------------CCHHHHHHHHHhcCCCCCCCCCHHhhhcCccccccc
Q 014609          220 ------------------------------------LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY  255 (421)
Q Consensus       220 ------------------------------------~s~~~~~li~~~L~~dP~~R~t~~eil~~~w~~~~~  255 (421)
                                                          .++.+.+||++||+.||.+|||++|+++||||+...
T Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~  326 (371)
T 2xrw_A          255 PTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWY  326 (371)
T ss_dssp             HHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTTC
T ss_pred             hHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCcchhhhc
Confidence                                                145789999999999999999999999999998543

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=2.2e-47  Score=379.06  Aligned_cols=233  Identities=19%  Similarity=0.238  Sum_probs=198.1

Q ss_pred             ecceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHH---HHhcCCCCCcceEE-------EE
Q 014609           13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIA---TLKLLKHPNVVRLH-------EV   82 (421)
Q Consensus        13 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~---il~~l~hpnIv~l~-------~~   82 (421)
                      .++|++.+.||+|+||+||+|++..+|+.||||++...........+.+.+|+.   +++.++||||++++       ++
T Consensus        72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~  151 (377)
T 3byv_A           72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL  151 (377)
T ss_dssp             CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred             CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence            478999999999999999999998999999999998665545555688999995   55556799999998       77


Q ss_pred             EEeCCE-----------------EEEEEeccCCCChHHHHHhcCCCCH-------HHHHHHHHHHHHHHHHHHhCCceec
Q 014609           83 LASKSK-----------------IYMVLEYVTGGELFDKIASKGRLQE-------AEGRKLFQQLIDGVSYCHNKGVFHR  138 (421)
Q Consensus        83 ~~~~~~-----------------~~lv~E~~~gg~L~~~i~~~~~~~~-------~~~~~~~~ql~~aL~~LH~~gi~Hr  138 (421)
                      ++..+.                 .|+||||+ +|+|.+++...+.+++       ..+..++.||+.||+|||++||+||
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHr  230 (377)
T 3byv_A          152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHT  230 (377)
T ss_dssp             EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred             hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCCeecC
Confidence            776643                 89999999 6799999987555555       7888899999999999999999999


Q ss_pred             cCCCCCEEeccCCCEEEEeccCCCCCccccCCCccccccCCCCccChhhhccc-----------CCCCCcchHHHHHHHH
Q 014609          139 DLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANR-----------GYDGATSDIWSCGVIL  207 (421)
Q Consensus       139 Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~-----------~~~~~~~DiwSlGvil  207 (421)
                      ||||+|||++.++.+||+|||++...     .......+| +.|+|||++.+.           .| +.++|||||||++
T Consensus       231 Dikp~NIll~~~~~~kL~DFG~a~~~-----~~~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~-~~~~DvwSlG~il  303 (377)
T 3byv_A          231 YLRPVDIVLDQRGGVFLTGFEHLVRD-----GARVVSSVS-RGFEPPELEARRATISYHRDRRTLM-TFSFDAWALGLVI  303 (377)
T ss_dssp             CCCGGGEEECTTCCEEECCGGGCEET-----TCEEECCCC-TTCCCHHHHHHHTSTHHHHCCEEEC-CHHHHHHHHHHHH
T ss_pred             CCCHHHEEEcCCCCEEEEechhheec-----CCcccCCCC-cCccChhhhcccccccccccccccC-ChhhhHHHHHHHH
Confidence            99999999999999999999999742     224456678 999999999877           66 5899999999999


Q ss_pred             hhh-cCCcCCC---------------CCCCHHHHHHHHHhcCCCCCCCCCHHhhhcCccccc
Q 014609          208 YIF-RGDFKLP---------------KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQ  253 (421)
Q Consensus       208 ~~~-~~~~~~p---------------~~~s~~~~~li~~~L~~dP~~R~t~~eil~~~w~~~  253 (421)
                      |.+ .|..++.               ..+++.+.++|.+||+.||.+|||+.++++||||+.
T Consensus       304 ~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~  365 (377)
T 3byv_A          304 YWIWCADLPITKDAALGGSEWIFRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQ  365 (377)
T ss_dssp             HHHHHSSCCC------CCSGGGGSSCCCCCHHHHHHHHHHTCSSGGGCCCHHHHHTSHHHHH
T ss_pred             HHHHHCCCCCcccccccchhhhhhhccCCCHHHHHHHHHHcCCCchhCCCHHHHhhChHHHH
Confidence            954 4444432               457899999999999999999999999999999985

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=5.2e-46  Score=357.76  Aligned_cols=236  Identities=36%  Similarity=0.654  Sum_probs=205.8

Q ss_pred             eeecceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEE
Q 014609           11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIY   90 (421)
Q Consensus        11 ~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~   90 (421)
                      ...++|++.+.||+|+||.||+|++..+|+.||+|++......   ..+.+.+|+.++++++||||+++++++.+.+..|
T Consensus         6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   82 (304)
T 2jam_A            6 NIRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAF---RDSSLENEIAVLKKIKHENIVTLEDIYESTTHYY   82 (304)
T ss_dssp             CHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC---------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             chhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEeccccc---chHHHHHHHHHHHhCCCCCeeehhhhcccCCEEE
Confidence            3457999999999999999999999999999999999764322   2356889999999999999999999999999999


Q ss_pred             EEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEe---ccCCCEEEEeccCCCCCccc
Q 014609           91 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILL---DSKGNIKISDFGLSALPQHF  167 (421)
Q Consensus        91 lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl---~~~~~~kL~DFGla~~~~~~  167 (421)
                      +||||++|++|.+.+...+.+++..++.++.|++.||+|||++||+||||||+||++   +.++.+||+|||++..... 
T Consensus        83 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~-  161 (304)
T 2jam_A           83 LVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQN-  161 (304)
T ss_dssp             EEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCC-
T ss_pred             EEEEcCCCccHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCCCCEEEccCCcceecCC-
Confidence            999999999999999888899999999999999999999999999999999999999   7788999999999975432 


Q ss_pred             cCCCccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhh-cCCcCC-----------------------CCCCCHH
Q 014609          168 RDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIF-RGDFKL-----------------------PKWLSPG  223 (421)
Q Consensus       168 ~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~-~~~~~~-----------------------p~~~s~~  223 (421)
                         ......+||+.|+|||++.+..+ +.++||||+||++|.+ .|..++                       +..+++.
T Consensus       162 ---~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  237 (304)
T 2jam_A          162 ---GIMSTACGTPGYVAPEVLAQKPY-SKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFESPFWDDISES  237 (304)
T ss_dssp             ---BTTHHHHSCCCBCCTTTBSSCSC-CHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHCCCCCCTTTTTTSCHH
T ss_pred             ---CccccccCCCCccChHHhccCCC-CchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCccccccCCHH
Confidence               23455689999999999987777 5899999999999944 332221                       2347899


Q ss_pred             HHHHHHHhcCCCCCCCCCHHhhhcCcccccc
Q 014609          224 AQNLLRKILEPNPVKRITIAGIKADEWFEQD  254 (421)
Q Consensus       224 ~~~li~~~L~~dP~~R~t~~eil~~~w~~~~  254 (421)
                      +.++|.+||..||.+|||+.++++||||...
T Consensus       238 ~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~  268 (304)
T 2jam_A          238 AKDFICHLLEKDPNERYTCEKALSHPWIDGN  268 (304)
T ss_dssp             HHHHHHHHHCSSTTTSCCHHHHHTSHHHHSS
T ss_pred             HHHHHHHHcCCChhHCcCHHHHhcCccccCC
Confidence            9999999999999999999999999999864

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=2.4e-46  Score=359.61  Aligned_cols=244  Identities=37%  Similarity=0.660  Sum_probs=203.9

Q ss_pred             eecceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccc-hhHHHHHHHHHHHHhcCCCCCcceEEEEEE--eCCE
Q 014609           12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIH-LKITDQIKREIATLKLLKHPNVVRLHEVLA--SKSK   88 (421)
Q Consensus        12 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~-~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~--~~~~   88 (421)
                      .+++|++++.||+|+||.||+|.+..+++.||+|++....... ......+.+|+.++++++||||+++++++.  +...
T Consensus         3 l~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   82 (305)
T 2wtk_C            3 LIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQK   82 (305)
T ss_dssp             --CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---C
T ss_pred             cccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCe
Confidence            4689999999999999999999999999999999997653221 233577999999999999999999999984  4567


Q ss_pred             EEEEEeccCCCChHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCcc
Q 014609           89 IYMVLEYVTGGELFDKIAS--KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQH  166 (421)
Q Consensus        89 ~~lv~E~~~gg~L~~~i~~--~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~  166 (421)
                      .|+||||+.++ |.+.+..  ...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.....
T Consensus        83 ~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~~  161 (305)
T 2wtk_C           83 MYMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHP  161 (305)
T ss_dssp             EEEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECCT
T ss_pred             EEEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEcCCCcEEeeccccccccCc
Confidence            99999999876 7777664  45799999999999999999999999999999999999999999999999999986543


Q ss_pred             ccCCCccccccCCCCccChhhhcccC-CCCCcchHHHHHHHHhhh-cC-------------------CcCCCCCCCHHHH
Q 014609          167 FRDDGLLHTTCGSPNYVAPEVLANRG-YDGATSDIWSCGVILYIF-RG-------------------DFKLPKWLSPGAQ  225 (421)
Q Consensus       167 ~~~~~~~~~~~gt~~y~APEvl~~~~-~~~~~~DiwSlGvil~~~-~~-------------------~~~~p~~~s~~~~  225 (421)
                      ...........||+.|+|||++.+.. +.+.++||||||+++|.+ .|                   ...+|..+++.+.
T Consensus       162 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l~  241 (305)
T 2wtk_C          162 FAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGSYAIPGDCGPPLS  241 (305)
T ss_dssp             TCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCCSSSCHHHH
T ss_pred             cccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHHhcCCCCCCCccCHHHH
Confidence            33333445667999999999987643 235789999999999943 23                   2345666899999


Q ss_pred             HHHHHhcCCCCCCCCCHHhhhcCcccccccc
Q 014609          226 NLLRKILEPNPVKRITIAGIKADEWFEQDYT  256 (421)
Q Consensus       226 ~li~~~L~~dP~~R~t~~eil~~~w~~~~~~  256 (421)
                      ++|.+||+.||.+|||+.++++||||++...
T Consensus       242 ~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~  272 (305)
T 2wtk_C          242 DLLKGMLEYEPAKRFSIRQIRQHSWFRKKHP  272 (305)
T ss_dssp             HHHHHHTCSSTTTSCCHHHHHHSHHHHSCCC
T ss_pred             HHHHHHccCChhhCCCHHHHhcCcccccCCC
Confidence            9999999999999999999999999987544

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=2.5e-46  Score=372.30  Aligned_cols=232  Identities=28%  Similarity=0.413  Sum_probs=194.7

Q ss_pred             eecceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEe------
Q 014609           12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLAS------   85 (421)
Q Consensus        12 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~------   85 (421)
                      ..++|++++.||+|+||+||+|.+..+|+.||||++.....       ...+|+.+|+.++||||+++++++..      
T Consensus         5 ~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~-------~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~   77 (383)
T 3eb0_A            5 SSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR-------YKNRELDIMKVLDHVNIIKLVDYFYTTGDEEP   77 (383)
T ss_dssp             -CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT-------SCCHHHHHHTTCCCTTBCCEEEEEEEC-----
T ss_pred             ccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc-------hHHHHHHHHHHcCCCCccchhheeeecCcccc
Confidence            34789999999999999999999999999999999875421       23479999999999999999999844      


Q ss_pred             --------------------------------CCEEEEEEeccCCCChHHHHH----hcCCCCHHHHHHHHHHHHHHHHH
Q 014609           86 --------------------------------KSKIYMVLEYVTGGELFDKIA----SKGRLQEAEGRKLFQQLIDGVSY  129 (421)
Q Consensus        86 --------------------------------~~~~~lv~E~~~gg~L~~~i~----~~~~~~~~~~~~~~~ql~~aL~~  129 (421)
                                                      ...+++||||++| +|.+.+.    ....+++..++.++.||+.||+|
T Consensus        78 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~  156 (383)
T 3eb0_A           78 KPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGF  156 (383)
T ss_dssp             --------------------------------CCEEEEEECCCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHH
T ss_pred             cccccccccccccccccccccccccccccCCCceEEEEEEecCCc-cHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHH
Confidence                                            3458999999975 7666554    45789999999999999999999


Q ss_pred             HHhCCceeccCCCCCEEec-cCCCEEEEeccCCCCCccccCCCccccccCCCCccChhhhcccCCCCCcchHHHHHHHHh
Q 014609          130 CHNKGVFHRDLKLENILLD-SKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILY  208 (421)
Q Consensus       130 LH~~gi~HrDlkp~NILl~-~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~  208 (421)
                      ||++||+||||||+|||++ .++.+||+|||++.....   .......+||+.|+|||++.+....+.++||||+||++|
T Consensus       157 LH~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~  233 (383)
T 3eb0_A          157 IHSLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIP---SEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFG  233 (383)
T ss_dssp             HHTTTEECSCCCGGGEEEETTTTEEEECCCTTCEECCT---TSCCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHH
T ss_pred             HHHCcCccCccCHHHEEEcCCCCcEEEEECCCCcccCC---CCCCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHH
Confidence            9999999999999999998 678999999999985432   233445688999999999887654468999999999999


Q ss_pred             hh-cCCcCC------------------------------------------------CCCCCHHHHHHHHHhcCCCCCCC
Q 014609          209 IF-RGDFKL------------------------------------------------PKWLSPGAQNLLRKILEPNPVKR  239 (421)
Q Consensus       209 ~~-~~~~~~------------------------------------------------p~~~s~~~~~li~~~L~~dP~~R  239 (421)
                      .+ .|..++                                                |..+++.+.+||.+||+.||.+|
T Consensus       234 ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R  313 (383)
T 3eb0_A          234 ELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLR  313 (383)
T ss_dssp             HHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGS
T ss_pred             HHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhhC
Confidence            43 333322                                                33478889999999999999999


Q ss_pred             CCHHhhhcCcccccc
Q 014609          240 ITIAGIKADEWFEQD  254 (421)
Q Consensus       240 ~t~~eil~~~w~~~~  254 (421)
                      ||+.|+++||||+..
T Consensus       314 ~t~~e~l~hp~f~~~  328 (383)
T 3eb0_A          314 INPYEAMAHPFFDHL  328 (383)
T ss_dssp             CCHHHHHTSGGGHHH
T ss_pred             CCHHHHhcCHHHHHH
Confidence            999999999999864

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=1.2e-45  Score=356.08  Aligned_cols=237  Identities=25%  Similarity=0.457  Sum_probs=203.5

Q ss_pred             eeecceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEE
Q 014609           11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIY   90 (421)
Q Consensus        11 ~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~   90 (421)
                      ...++|++++.||+|+||+||+|.+..+++.||+|++...   .....+.+.+|+.++++++||||+++++++.+++..|
T Consensus         7 ~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~---~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~   83 (310)
T 3s95_A            7 FRPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRF---DEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLN   83 (310)
T ss_dssp             ECGGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCC---CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEE
T ss_pred             eChhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccC---CHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeE
Confidence            3468999999999999999999999999999999988543   3344678999999999999999999999999999999


Q ss_pred             EEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCccccC
Q 014609           91 MVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD  169 (421)
Q Consensus        91 lv~E~~~gg~L~~~i~~-~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~  169 (421)
                      +||||++|++|.+++.. ...+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||++........
T Consensus        84 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  163 (310)
T 3s95_A           84 FITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKT  163 (310)
T ss_dssp             EEEECCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEECTTSCEEECCCTTCEECC----
T ss_pred             EEEEecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEECCCCCEEEeecccceecccccc
Confidence            99999999999999987 56799999999999999999999999999999999999999999999999999975433211


Q ss_pred             C------------CccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhhcC-CcC---------------------
Q 014609          170 D------------GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIFRG-DFK---------------------  215 (421)
Q Consensus       170 ~------------~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~~~-~~~---------------------  215 (421)
                      .            ......+||+.|+|||++.+..+ +.++||||+||++|.+.+ ..+                     
T Consensus       164 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~  242 (310)
T 3s95_A          164 QPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSY-DEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDR  242 (310)
T ss_dssp             ----------------CCCCSCGGGCCHHHHTTCCC-CTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHHHHH
T ss_pred             cccccccccccccccccccCCCcceeCHHHhcCCCC-CcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhccccc
Confidence            1            11125689999999999988777 589999999999996542 222                     


Q ss_pred             -CCCCCCHHHHHHHHHhcCCCCCCCCCHHhhhcCccccc
Q 014609          216 -LPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQ  253 (421)
Q Consensus       216 -~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~~~w~~~  253 (421)
                       .|+.+++.+.++|.+||+.||.+|||+.++++  |+..
T Consensus       243 ~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~--~L~~  279 (310)
T 3s95_A          243 YCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEH--WLET  279 (310)
T ss_dssp             TCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHH--HHHH
T ss_pred             cCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH--HHHH
Confidence             24557889999999999999999999999986  5543

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=9.9e-46  Score=353.90  Aligned_cols=237  Identities=30%  Similarity=0.479  Sum_probs=196.1

Q ss_pred             ecceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEe-------
Q 014609           13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLAS-------   85 (421)
Q Consensus        13 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~-------   85 (421)
                      .++|++++.||+|+||.||+|++..+|+.||||++...    ....+.+.+|+.++++++||||+++++++.+       
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~   80 (303)
T 1zy4_A            5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT----EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKP   80 (303)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE----HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC-
T ss_pred             cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc----HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhh
Confidence            47899999999999999999999999999999999643    2335778999999999999999999998865       


Q ss_pred             ------CCEEEEEEeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEec
Q 014609           86 ------KSKIYMVLEYVTGGELFDKIASKG-RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDF  158 (421)
Q Consensus        86 ------~~~~~lv~E~~~gg~L~~~i~~~~-~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DF  158 (421)
                            .+..|+||||++|++|.+++.... .+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+||
T Consensus        81 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~~~~~~kl~df  160 (303)
T 1zy4_A           81 MTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDF  160 (303)
T ss_dssp             -----CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCC
T ss_pred             hcccccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEcCCCCEEEeeC
Confidence                  457899999999999999998543 5788999999999999999999999999999999999999999999999


Q ss_pred             cCCCCCcccc------------CCCccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhhcCC-------------
Q 014609          159 GLSALPQHFR------------DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIFRGD-------------  213 (421)
Q Consensus       159 Gla~~~~~~~------------~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~~~~-------------  213 (421)
                      |++.......            ........+||+.|+|||++.+.+..+.++||||+||++|.+...             
T Consensus       161 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~p~~~~~~~~~~~~~  240 (303)
T 1zy4_A          161 GLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYPFSTGMERVNILKK  240 (303)
T ss_dssp             CCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHSCCSSHHHHHHHHHH
T ss_pred             cchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHhccCCchhHHHHHHh
Confidence            9998653211            012234567999999999998664446899999999999955422             


Q ss_pred             -----cCCC----CCCCHHHHHHHHHhcCCCCCCCCCHHhhhcCccccc
Q 014609          214 -----FKLP----KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQ  253 (421)
Q Consensus       214 -----~~~p----~~~s~~~~~li~~~L~~dP~~R~t~~eil~~~w~~~  253 (421)
                           ..+|    ...++.+.++|.+||++||.+|||+.++++||||..
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~  289 (303)
T 1zy4_A          241 LRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPV  289 (303)
T ss_dssp             HHSTTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHSSCSCC
T ss_pred             ccccccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCCCCcCC
Confidence                 1222    335677999999999999999999999999999975

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.4e-46  Score=368.82  Aligned_cols=242  Identities=31%  Similarity=0.592  Sum_probs=205.7

Q ss_pred             eeecceEEeceEeecCcEEEEEEEEC---CCCceEEEEEeeccccc-chhHHHHHHHHHHHHhcC-CCCCcceEEEEEEe
Q 014609           11 MRLGRYELGRTLGEGNFGKVKFAQDL---DSGLPFAVKILEKNRII-HLKITDQIKREIATLKLL-KHPNVVRLHEVLAS   85 (421)
Q Consensus        11 ~~~~~y~i~~~LG~G~~g~V~~a~~~---~~~~~vAvK~i~~~~~~-~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~   85 (421)
                      ..+++|++++.||+|+||+||+|++.   .+|+.||||++++.... .....+.+.+|+.+++.+ +||||+++++++..
T Consensus        51 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~  130 (355)
T 1vzo_A           51 VGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQT  130 (355)
T ss_dssp             CCGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEE
T ss_pred             ccccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEee
Confidence            44589999999999999999999984   58999999999754321 112235677899999999 69999999999999


Q ss_pred             CCEEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCc
Q 014609           86 KSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQ  165 (421)
Q Consensus        86 ~~~~~lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~  165 (421)
                      .+..|+||||+++++|.+++.....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++....
T Consensus       131 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~  210 (355)
T 1vzo_A          131 ETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFV  210 (355)
T ss_dssp             TTEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEECC
T ss_pred             CceEEEEeecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCcEEEeeCCCCeecc
Confidence            99999999999999999999988899999999999999999999999999999999999999999999999999997543


Q ss_pred             cccCCCccccccCCCCccChhhhccc-CCCCCcchHHHHHHHHhhh-cCCc-----------------------CCCCCC
Q 014609          166 HFRDDGLLHTTCGSPNYVAPEVLANR-GYDGATSDIWSCGVILYIF-RGDF-----------------------KLPKWL  220 (421)
Q Consensus       166 ~~~~~~~~~~~~gt~~y~APEvl~~~-~~~~~~~DiwSlGvil~~~-~~~~-----------------------~~p~~~  220 (421)
                      .. ........+||+.|+|||++.+. ...+.++|||||||++|.+ .|..                       ++|..+
T Consensus       211 ~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  289 (355)
T 1vzo_A          211 AD-ETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEM  289 (355)
T ss_dssp             GG-GGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCCCCTTS
T ss_pred             cC-CCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHhccCCCCCccc
Confidence            21 12233456899999999998753 2235889999999999943 3332                       345567


Q ss_pred             CHHHHHHHHHhcCCCCCCCC-----CHHhhhcCccccc
Q 014609          221 SPGAQNLLRKILEPNPVKRI-----TIAGIKADEWFEQ  253 (421)
Q Consensus       221 s~~~~~li~~~L~~dP~~R~-----t~~eil~~~w~~~  253 (421)
                      ++.+.+||.+||.+||.+||     |+.++++||||.+
T Consensus       290 ~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f~~  327 (355)
T 1vzo_A          290 SALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQK  327 (355)
T ss_dssp             CHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTT
T ss_pred             CHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcchhc
Confidence            89999999999999999999     9999999999985

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=1.3e-45  Score=372.84  Aligned_cols=233  Identities=30%  Similarity=0.445  Sum_probs=198.7

Q ss_pred             eecceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcC------CCCCcceEEEEEEe
Q 014609           12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL------KHPNVVRLHEVLAS   85 (421)
Q Consensus        12 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l------~hpnIv~l~~~~~~   85 (421)
                      ..++|++++.||+|+||+||+|.+..+++.||||++....    .....+.+|+.+++.+      +|+||+++++++..
T Consensus        95 ~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~----~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~  170 (429)
T 3kvw_A           95 VAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEK----RFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTF  170 (429)
T ss_dssp             ETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCH----HHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEE
T ss_pred             ccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCcc----chHHHHHHHHHHHHHHhhccccCCcCEEEEEeeccc
Confidence            3468999999999999999999999999999999997532    2346778888888877      57799999999999


Q ss_pred             CCEEEEEEeccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCC--EEEEeccCC
Q 014609           86 KSKIYMVLEYVTGGELFDKIASKG--RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGN--IKISDFGLS  161 (421)
Q Consensus        86 ~~~~~lv~E~~~gg~L~~~i~~~~--~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~--~kL~DFGla  161 (421)
                      .+.+|+||||+. ++|.+.+....  .+++..++.++.||+.||+|||++||+||||||+|||++.++.  +||+|||++
T Consensus       171 ~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~~~~~~vkL~DFG~a  249 (429)
T 3kvw_A          171 RNHICMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSS  249 (429)
T ss_dssp             TTEEEEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEESSTTSCCEEECCCTTC
T ss_pred             CCeEEEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEccCCCcceEEeecccc
Confidence            999999999995 69999887643  5999999999999999999999999999999999999999987  999999999


Q ss_pred             CCCccccCCCccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhh-cCCcCCCC----------------------
Q 014609          162 ALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIF-RGDFKLPK----------------------  218 (421)
Q Consensus       162 ~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~-~~~~~~p~----------------------  218 (421)
                      ....     ....+.+||+.|+|||++.+..| +.++|||||||++|.+ .|..+++.                      
T Consensus       250 ~~~~-----~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p~~~~~  323 (429)
T 3kvw_A          250 CYEH-----QRVYTYIQSRFYRAPEVILGARY-GMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLL  323 (429)
T ss_dssp             EETT-----CCCCSSCSCGGGCCHHHHHTBCC-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred             eecC-----CcccccCCCCCccChHHHhCCCC-CchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHH
Confidence            6432     23456789999999999998887 5899999999999954 33332211                      


Q ss_pred             --------------------------------------------------------CCCHHHHHHHHHhcCCCCCCCCCH
Q 014609          219 --------------------------------------------------------WLSPGAQNLLRKILEPNPVKRITI  242 (421)
Q Consensus       219 --------------------------------------------------------~~s~~~~~li~~~L~~dP~~R~t~  242 (421)
                                                                              ..++.+.+||++||+.||.+|||+
T Consensus       324 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~Rpta  403 (429)
T 3kvw_A          324 DASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTP  403 (429)
T ss_dssp             HTBTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTSCCH
T ss_pred             HhhhhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhhCCCH
Confidence                                                                    126778999999999999999999


Q ss_pred             HhhhcCccccccc
Q 014609          243 AGIKADEWFEQDY  255 (421)
Q Consensus       243 ~eil~~~w~~~~~  255 (421)
                      .|+++||||++..
T Consensus       404 ~e~L~Hpw~~~~~  416 (429)
T 3kvw_A          404 GQALRHPWLRRRL  416 (429)
T ss_dssp             HHHHTSTTTC---
T ss_pred             HHHhCChhhccCC
Confidence            9999999999754

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=1.7e-45  Score=352.51  Aligned_cols=242  Identities=32%  Similarity=0.546  Sum_probs=207.3

Q ss_pred             CeeecceEEeceEeecCcEEEEEEEECCCCceEEEEEeeccccc------chhHHHHHHHHHHHHhcCC-CCCcceEEEE
Q 014609           10 GMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRII------HLKITDQIKREIATLKLLK-HPNVVRLHEV   82 (421)
Q Consensus        10 ~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~------~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~   82 (421)
                      ....++|++.+.||+|+||.||+|.+..+|+.||||+++.....      .....+.+.+|+.+++++. ||||++++++
T Consensus        13 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~   92 (298)
T 1phk_A           13 HGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDT   92 (298)
T ss_dssp             --CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEE
T ss_pred             cchhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeee
Confidence            34568999999999999999999999999999999999764311      1223467889999999996 9999999999


Q ss_pred             EEeCCEEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCC
Q 014609           83 LASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSA  162 (421)
Q Consensus        83 ~~~~~~~~lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~  162 (421)
                      +...+..|+||||+++++|.+++.....+++..++.++.||+.||+|||++||+||||||+||+++.++.+||+|||++.
T Consensus        93 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~  172 (298)
T 1phk_A           93 YETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSC  172 (298)
T ss_dssp             EECSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred             eccCCeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEcCCCcEEEecccchh
Confidence            99999999999999999999999988899999999999999999999999999999999999999999999999999997


Q ss_pred             CCccccCCCccccccCCCCccChhhhcc------cCCCCCcchHHHHHHHHhhh-cCCcCC-------------------
Q 014609          163 LPQHFRDDGLLHTTCGSPNYVAPEVLAN------RGYDGATSDIWSCGVILYIF-RGDFKL-------------------  216 (421)
Q Consensus       163 ~~~~~~~~~~~~~~~gt~~y~APEvl~~------~~~~~~~~DiwSlGvil~~~-~~~~~~-------------------  216 (421)
                      ....   .......+||+.|+|||++.+      ..+ +.++||||||+++|.+ .|..++                   
T Consensus       173 ~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~-~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~  248 (298)
T 1phk_A          173 QLDP---GEKLREVCGTPSYLAPEIIECSMNDNHPGY-GKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQF  248 (298)
T ss_dssp             ECCT---TCCBCCCCSCGGGCCHHHHHHHHCTTSCCB-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCC
T ss_pred             hcCC---CcccccccCCccccCHHHhccccccccccC-CcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHhcCCccc
Confidence            5432   233455689999999999852      334 5899999999999944 332221                   


Q ss_pred             --C--CCCCHHHHHHHHHhcCCCCCCCCCHHhhhcCccccccc
Q 014609          217 --P--KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY  255 (421)
Q Consensus       217 --p--~~~s~~~~~li~~~L~~dP~~R~t~~eil~~~w~~~~~  255 (421)
                        |  ..+++.+.++|.+||+.||.+|||+.++++||||++..
T Consensus       249 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~  291 (298)
T 1phk_A          249 GSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQYV  291 (298)
T ss_dssp             CTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTTC
T ss_pred             CcccccccCHHHHHHHHHHccCCcccCCCHHHHHhChHhhhcc
Confidence              1  23788999999999999999999999999999998643

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=5.3e-46  Score=354.39  Aligned_cols=239  Identities=23%  Similarity=0.345  Sum_probs=190.5

Q ss_pred             eeecceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEE
Q 014609           11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIY   90 (421)
Q Consensus        11 ~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~   90 (421)
                      ...++|++++.||+|+||+||+|++..+|+.||+|++..... .......+.++...++.++||||+++++++.+++..|
T Consensus         4 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~   82 (290)
T 3fme_A            4 VKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVN-SQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVW   82 (290)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---C-HHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEE
T ss_pred             ccHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccC-cHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEE
Confidence            456899999999999999999999999999999999975432 2222344555666688899999999999999999999


Q ss_pred             EEEeccCCCChHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhC-CceeccCCCCCEEeccCCCEEEEeccCCCCCc
Q 014609           91 MVLEYVTGGELFDKIA----SKGRLQEAEGRKLFQQLIDGVSYCHNK-GVFHRDLKLENILLDSKGNIKISDFGLSALPQ  165 (421)
Q Consensus        91 lv~E~~~gg~L~~~i~----~~~~~~~~~~~~~~~ql~~aL~~LH~~-gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~  165 (421)
                      +||||++| +|.+.+.    ....+++..++.++.|++.||+|||++ ||+||||||+|||++.++.+||+|||++....
T Consensus        83 lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  161 (290)
T 3fme_A           83 ICMELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLV  161 (290)
T ss_dssp             EEEECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEECTTCCEEBCCC-------
T ss_pred             EEEehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecCCccccc
Confidence            99999975 8776654    356799999999999999999999998 99999999999999999999999999997543


Q ss_pred             cccCCCccccccCCCCccChhhh----cccCCCCCcchHHHHHHHHhhh-cCCcCCC----------------------C
Q 014609          166 HFRDDGLLHTTCGSPNYVAPEVL----ANRGYDGATSDIWSCGVILYIF-RGDFKLP----------------------K  218 (421)
Q Consensus       166 ~~~~~~~~~~~~gt~~y~APEvl----~~~~~~~~~~DiwSlGvil~~~-~~~~~~p----------------------~  218 (421)
                      .   .......+||+.|+|||++    .+..+ +.++||||+||++|.+ .|..++.                      .
T Consensus       162 ~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  237 (290)
T 3fme_A          162 D---DVAKDIDAGCKPYMAPERINPELNQKGY-SVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQLPAD  237 (290)
T ss_dssp             -----------CCCCCCSCHHHHSCCTTC--C-CHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHSCCCCCCTT
T ss_pred             c---cccccccCCCccccChhhcChhhcCcCC-CcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhccCCCCcccc
Confidence            3   2233445799999999996    33444 5899999999999954 4544432                      2


Q ss_pred             CCCHHHHHHHHHhcCCCCCCCCCHHhhhcCccccccc
Q 014609          219 WLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY  255 (421)
Q Consensus       219 ~~s~~~~~li~~~L~~dP~~R~t~~eil~~~w~~~~~  255 (421)
                      .+++.+.++|.+||+.||.+|||+.++++||||+...
T Consensus       238 ~~~~~~~~li~~~l~~~p~~Rpt~~e~l~hp~f~~~~  274 (290)
T 3fme_A          238 KFSAEFVDFTSQCLKKNSKERPTYPELMQHPFFTLHE  274 (290)
T ss_dssp             TSCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHHH
T ss_pred             cCCHHHHHHHHHHhhcChhhCcCHHHHHhCcccccCc
Confidence            4789999999999999999999999999999998643

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=2.4e-46  Score=375.09  Aligned_cols=239  Identities=32%  Similarity=0.473  Sum_probs=185.8

Q ss_pred             ecceEE-eceEeecCcEEEEEEEEC--CCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEe--CC
Q 014609           13 LGRYEL-GRTLGEGNFGKVKFAQDL--DSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLAS--KS   87 (421)
Q Consensus        13 ~~~y~i-~~~LG~G~~g~V~~a~~~--~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~--~~   87 (421)
                      -+.|++ +++||+|+||+||+|++.  .+++.||||++.....     ...+.+|+.+|++++||||+++++++..  ..
T Consensus        19 ~~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~-----~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~   93 (405)
T 3rgf_A           19 EDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI-----SMSACREIALLRELKHPNVISLQKVFLSHADR   93 (405)
T ss_dssp             HHHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSC-----CHHHHHHHHHHHHCCCTTBCCCCEEEEETTTT
T ss_pred             hhhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCC-----CHHHHHHHHHHHhcCCCCeeeEeeEEecCCCC
Confidence            357887 668999999999999965  5789999999975432     2468899999999999999999999954  67


Q ss_pred             EEEEEEeccCCCChHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEe----ccCCCEE
Q 014609           88 KIYMVLEYVTGGELFDKIASK---------GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILL----DSKGNIK  154 (421)
Q Consensus        88 ~~~lv~E~~~gg~L~~~i~~~---------~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl----~~~~~~k  154 (421)
                      .+|+||||+. ++|.+.+...         ..+++..++.++.||+.||+|||++||+||||||+|||+    +.++.+|
T Consensus        94 ~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~k  172 (405)
T 3rgf_A           94 KVWLLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVK  172 (405)
T ss_dssp             EEEEEEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTTTTCEE
T ss_pred             eEEEEEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCCCCcEE
Confidence            8999999996 5888877532         249999999999999999999999999999999999999    6778999


Q ss_pred             EEeccCCCCCcccc-CCCccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhh-cCCcCCCC--------------
Q 014609          155 ISDFGLSALPQHFR-DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIF-RGDFKLPK--------------  218 (421)
Q Consensus       155 L~DFGla~~~~~~~-~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~-~~~~~~p~--------------  218 (421)
                      |+|||++....... ........+||+.|+|||++.+..+.+.++|||||||++|.+ .|..++..              
T Consensus       173 l~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~  252 (405)
T 3rgf_A          173 IADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHD  252 (405)
T ss_dssp             ECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHH
T ss_pred             EEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHH
Confidence            99999998654321 113345678999999999998765457899999999999954 44443310              


Q ss_pred             ----------------------------------------------------CCCHHHHHHHHHhcCCCCCCCCCHHhhh
Q 014609          219 ----------------------------------------------------WLSPGAQNLLRKILEPNPVKRITIAGIK  246 (421)
Q Consensus       219 ----------------------------------------------------~~s~~~~~li~~~L~~dP~~R~t~~eil  246 (421)
                                                                          ..++.+.+||.+||+.||.+|||++|++
T Consensus       253 ~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L  332 (405)
T 3rgf_A          253 QLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAM  332 (405)
T ss_dssp             HHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHH
T ss_pred             HHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHh
Confidence                                                                0167889999999999999999999999


Q ss_pred             cCccccccccC
Q 014609          247 ADEWFEQDYTP  257 (421)
Q Consensus       247 ~~~w~~~~~~~  257 (421)
                      +||||.....+
T Consensus       333 ~hp~f~~~~~~  343 (405)
T 3rgf_A          333 QDPYFLEDPLP  343 (405)
T ss_dssp             TSGGGTSSSCC
T ss_pred             cChhhccCCCC
Confidence            99999876544

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=7.6e-46  Score=359.68  Aligned_cols=238  Identities=37%  Similarity=0.659  Sum_probs=199.4

Q ss_pred             eecceEEeceEeecCcEEEEEEEECCCCceEEEEEeeccccc-----chhHHHHHHHHHHHHhcCCCCCcceEEEEEEeC
Q 014609           12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRII-----HLKITDQIKREIATLKLLKHPNVVRLHEVLASK   86 (421)
Q Consensus        12 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~-----~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~   86 (421)
                      ..++|++.+.||+|+||.||+|.+..+++.||||++......     .......+.+|+.++++++||||+++++++..+
T Consensus         8 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~   87 (322)
T 2ycf_A            8 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE   87 (322)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESS
T ss_pred             hhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCC
Confidence            347899999999999999999999999999999999764321     112234588999999999999999999999776


Q ss_pred             CEEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCC---EEEEeccCCCC
Q 014609           87 SKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGN---IKISDFGLSAL  163 (421)
Q Consensus        87 ~~~~lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~---~kL~DFGla~~  163 (421)
                      . .|+||||+++++|.+.+.....+++..++.++.||+.||+|||++||+||||||+|||++.++.   +||+|||++..
T Consensus        88 ~-~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~  166 (322)
T 2ycf_A           88 D-YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI  166 (322)
T ss_dssp             S-EEEEEECCTTEETHHHHSTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCEEECCCTTCEE
T ss_pred             c-eEEEEecCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeEEEccCcccee
Confidence            5 8999999999999999988889999999999999999999999999999999999999987665   99999999975


Q ss_pred             CccccCCCccccccCCCCccChhhhc---ccCCCCCcchHHHHHHHHhhh-cCCcCCC----------------------
Q 014609          164 PQHFRDDGLLHTTCGSPNYVAPEVLA---NRGYDGATSDIWSCGVILYIF-RGDFKLP----------------------  217 (421)
Q Consensus       164 ~~~~~~~~~~~~~~gt~~y~APEvl~---~~~~~~~~~DiwSlGvil~~~-~~~~~~p----------------------  217 (421)
                      ...   .......+||+.|+|||++.   ...+ +.++|||||||++|.+ .|..++.                      
T Consensus       167 ~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~-~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  242 (322)
T 2ycf_A          167 LGE---TSLMRTLCGTPTYLAPEVLVSVGTAGY-NRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPE  242 (322)
T ss_dssp             CCC---CHHHHHHHSCCTTCCHHHHHHTTTTTC-TTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHHTCCCCCHH
T ss_pred             ccc---ccccccccCCcCccCchhhccCCCCCC-CchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHhCccccCch
Confidence            432   22334568999999999974   3344 5899999999999944 3433321                      


Q ss_pred             --CCCCHHHHHHHHHhcCCCCCCCCCHHhhhcCcccccc
Q 014609          218 --KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD  254 (421)
Q Consensus       218 --~~~s~~~~~li~~~L~~dP~~R~t~~eil~~~w~~~~  254 (421)
                        ..+++.+.++|.+||+.||.+|||+.++++||||...
T Consensus       243 ~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h~~~~~~  281 (322)
T 2ycf_A          243 VWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDE  281 (322)
T ss_dssp             HHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGCCH
T ss_pred             hhhhcCHHHHHHHHHHcccCHhhCCCHHHHhhCcCcCCH
Confidence              2368889999999999999999999999999999853

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=3.3e-46  Score=369.58  Aligned_cols=235  Identities=31%  Similarity=0.463  Sum_probs=185.3

Q ss_pred             ecceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeC------
Q 014609           13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASK------   86 (421)
Q Consensus        13 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~------   86 (421)
                      -++|++++.||+|+||.||+|.+..+|+.||||++.... ........+.+|+.+++.++||||+++++++...      
T Consensus        28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~  106 (367)
T 2fst_X           28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF  106 (367)
T ss_dssp             ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTT-SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGC
T ss_pred             CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccc-cCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccC
Confidence            379999999999999999999999999999999986543 2334457788999999999999999999999654      


Q ss_pred             CEEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCcc
Q 014609           87 SKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQH  166 (421)
Q Consensus        87 ~~~~lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~  166 (421)
                      ...|+|+||+ +++|.+.+.. ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.....
T Consensus       107 ~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~  184 (367)
T 2fst_X          107 NDVYLVTHLM-GADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTAD  184 (367)
T ss_dssp             CCCEEEEECC-CEECC------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECC---------
T ss_pred             CeEEEEeccc-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEECCCCCEEEeeccccccccc
Confidence            5689999999 7899888765 6799999999999999999999999999999999999999999999999999975432


Q ss_pred             ccCCCccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhh-cCCcCCC----------------------------
Q 014609          167 FRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIF-RGDFKLP----------------------------  217 (421)
Q Consensus       167 ~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~-~~~~~~p----------------------------  217 (421)
                           .....+||+.|+|||++.+....+.++||||+||++|.+ .|..+++                            
T Consensus       185 -----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~  259 (367)
T 2fst_X          185 -----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS  259 (367)
T ss_dssp             -----------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHTTCCC
T ss_pred             -----cCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhh
Confidence                 234568999999999988744446899999999999944 4444332                            


Q ss_pred             ----------------------CCCCHHHHHHHHHhcCCCCCCCCCHHhhhcCccccccc
Q 014609          218 ----------------------KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY  255 (421)
Q Consensus       218 ----------------------~~~s~~~~~li~~~L~~dP~~R~t~~eil~~~w~~~~~  255 (421)
                                            +..++.+.+||.+||+.||.+|||+.++++||||....
T Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp~~~~~~  319 (367)
T 2fst_X          260 ESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH  319 (367)
T ss_dssp             HHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTC
T ss_pred             HHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcChhhhhcc
Confidence                                  12467899999999999999999999999999998644

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=7.5e-46  Score=367.85  Aligned_cols=234  Identities=32%  Similarity=0.558  Sum_probs=197.2

Q ss_pred             cceEE--eceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEE
Q 014609           14 GRYEL--GRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYM   91 (421)
Q Consensus        14 ~~y~i--~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l   91 (421)
                      +.|++  .+.||+|+||.||+|.+..+|+.||+|++.....   ...+.+.+|+.++++++||||+++++++.+.+..|+
T Consensus        87 ~~~~~~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l  163 (373)
T 2x4f_A           87 SFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGM---KDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVL  163 (373)
T ss_dssp             GTEEEEEEEECC-----CEEEEEETTTCCEEEEEEEECCSH---HHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred             cceeeecceEEecCcCEEEEEEEEcCCCcEEEEEEEccccc---ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEE
Confidence            44555  6789999999999999999999999999976432   335789999999999999999999999999999999


Q ss_pred             EEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEe--ccCCCEEEEeccCCCCCcccc
Q 014609           92 VLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILL--DSKGNIKISDFGLSALPQHFR  168 (421)
Q Consensus        92 v~E~~~gg~L~~~i~~~-~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl--~~~~~~kL~DFGla~~~~~~~  168 (421)
                      ||||++|++|.+.+... ..+++..++.++.||+.||+|||++||+||||||+|||+  +.++.+||+|||++.....  
T Consensus       164 v~E~~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~--  241 (373)
T 2x4f_A          164 VMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKP--  241 (373)
T ss_dssp             EEECCTTCEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCT--
T ss_pred             EEeCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCC--
Confidence            99999999999988653 469999999999999999999999999999999999999  5667899999999985433  


Q ss_pred             CCCccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhh-cCCcCC-------------------C----CCCCHHH
Q 014609          169 DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIF-RGDFKL-------------------P----KWLSPGA  224 (421)
Q Consensus       169 ~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~-~~~~~~-------------------p----~~~s~~~  224 (421)
                       .......+||+.|+|||++....+ +.++|||||||++|.+ .|..++                   +    ..+++++
T Consensus       242 -~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  319 (373)
T 2x4f_A          242 -REKLKVNFGTPEFLAPEVVNYDFV-SFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEEFQDISEEA  319 (373)
T ss_dssp             -TCBCCCCCSSCTTCCHHHHTTCBC-CHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCSCSGGGTTSCHHH
T ss_pred             -ccccccccCCCcEeChhhccCCCC-CcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCChhhhccCCHHH
Confidence             233445689999999999987666 5899999999999944 333322                   1    3478999


Q ss_pred             HHHHHHhcCCCCCCCCCHHhhhcCcccccc
Q 014609          225 QNLLRKILEPNPVKRITIAGIKADEWFEQD  254 (421)
Q Consensus       225 ~~li~~~L~~dP~~R~t~~eil~~~w~~~~  254 (421)
                      .+||.+||++||.+|||+.|+++||||...
T Consensus       320 ~~li~~~L~~dp~~Rps~~e~l~hp~~~~~  349 (373)
T 2x4f_A          320 KEFISKLLIKEKSWRISASEALKHPWLSDH  349 (373)
T ss_dssp             HHHHHTTSCSSGGGSCCHHHHHHSHHHHCH
T ss_pred             HHHHHHHcCCChhhCCCHHHHhcCcCcCCC
Confidence            999999999999999999999999999864

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=1.3e-45  Score=359.34  Aligned_cols=236  Identities=35%  Similarity=0.570  Sum_probs=200.8

Q ss_pred             cceEEe-ceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCC-CCCcceEEEEEEeCCEEEE
Q 014609           14 GRYELG-RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK-HPNVVRLHEVLASKSKIYM   91 (421)
Q Consensus        14 ~~y~i~-~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~l   91 (421)
                      ++|.+. +.||+|+||.||+|.+..+|+.||+|++....... .....+.+|+.+++.+. ||||+++++++......|+
T Consensus        28 ~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~~~l  106 (327)
T 3lm5_A           28 NFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQ-DCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIIL  106 (327)
T ss_dssp             HHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTE-ECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred             hEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcch-HHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCeEEE
Confidence            578887 89999999999999999999999999998654322 23567899999999995 6999999999999999999


Q ss_pred             EEeccCCCChHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecc---CCCEEEEeccCCCCCcc
Q 014609           92 VLEYVTGGELFDKIAS--KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDS---KGNIKISDFGLSALPQH  166 (421)
Q Consensus        92 v~E~~~gg~L~~~i~~--~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~---~~~~kL~DFGla~~~~~  166 (421)
                      ||||++|++|.+++..  ...+++..++.++.||+.||+|||++||+||||||+|||++.   ++.+||+|||++.....
T Consensus       107 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~~~~  186 (327)
T 3lm5_A          107 ILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGH  186 (327)
T ss_dssp             EEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTBCCEEECCGGGCEEC--
T ss_pred             EEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCCCcEEEeeCccccccCC
Confidence            9999999999998854  367999999999999999999999999999999999999988   78999999999985432


Q ss_pred             ccCCCccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhh-cCCcCC-----------------------CCCCCH
Q 014609          167 FRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIF-RGDFKL-----------------------PKWLSP  222 (421)
Q Consensus       167 ~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~-~~~~~~-----------------------p~~~s~  222 (421)
                         .......+||+.|+|||++.+..+ +.++|||||||++|.+ .|..++                       +..+++
T Consensus       187 ---~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  262 (327)
T 3lm5_A          187 ---ACELREIMGTPEYLAPEILNYDPI-TTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSEETFSSVSQ  262 (327)
T ss_dssp             ----------CCCGGGCCHHHHTTCCC-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTTTTSCH
T ss_pred             ---ccccccccCCcCccCCeeecCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhcccccCchhhcccCH
Confidence               223345689999999999988777 5899999999999944 333332                       124788


Q ss_pred             HHHHHHHHhcCCCCCCCCCHHhhhcCcccccc
Q 014609          223 GAQNLLRKILEPNPVKRITIAGIKADEWFEQD  254 (421)
Q Consensus       223 ~~~~li~~~L~~dP~~R~t~~eil~~~w~~~~  254 (421)
                      .+.++|.+||+.||.+|||++++++||||+..
T Consensus       263 ~~~~li~~~L~~dP~~Rpt~~~ll~h~~~~~~  294 (327)
T 3lm5_A          263 LATDFIQSLLVKNPEKRPTAEICLSHSWLQQW  294 (327)
T ss_dssp             HHHHHHHHHSCSSGGGSCCHHHHTTCGGGCCC
T ss_pred             HHHHHHHHHcCCChhhCcCHHHHhCCHhhccc
Confidence            99999999999999999999999999999864

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=2.9e-45  Score=359.52  Aligned_cols=241  Identities=27%  Similarity=0.419  Sum_probs=201.3

Q ss_pred             eeecceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeC----
Q 014609           11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASK----   86 (421)
Q Consensus        11 ~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~----   86 (421)
                      ...++|++.+.||+|+||.||+|.+..+|+.||||++....  .......+.+|+.++++++||||+++++++...    
T Consensus         8 ~i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   85 (353)
T 2b9h_A            8 NISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFD--KPLFALRTLREIKILKHFKHENIITIFNIQRPDSFEN   85 (353)
T ss_dssp             CSCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCS--SHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTT
T ss_pred             ccccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccc--cchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCc
Confidence            34579999999999999999999999999999999996432  333456788999999999999999999998764    


Q ss_pred             -CEEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCc
Q 014609           87 -SKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQ  165 (421)
Q Consensus        87 -~~~~lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~  165 (421)
                       ...|+||||+. ++|.+.+.. ..+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||++....
T Consensus        86 ~~~~~lv~e~~~-~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~  163 (353)
T 2b9h_A           86 FNEVYIIQELMQ-TDLHRVIST-QMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIID  163 (353)
T ss_dssp             CCCEEEEECCCS-EEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred             cceEEEEEeccC-ccHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEcCCCcEEEEecccccccc
Confidence             67999999996 589888876 679999999999999999999999999999999999999999999999999997543


Q ss_pred             cccCC--------CccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhh-cCCcCCC-------------------
Q 014609          166 HFRDD--------GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIF-RGDFKLP-------------------  217 (421)
Q Consensus       166 ~~~~~--------~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~-~~~~~~p-------------------  217 (421)
                      .....        ......+||+.|+|||++.+....+.++|||||||++|.+ .|..+++                   
T Consensus       164 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~  243 (353)
T 2b9h_A          164 ESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPH  243 (353)
T ss_dssp             ----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred             cccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCc
Confidence            21111        1123457899999999987644446899999999999944 3332221                   


Q ss_pred             --------------------------------CCCCHHHHHHHHHhcCCCCCCCCCHHhhhcCccccccc
Q 014609          218 --------------------------------KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY  255 (421)
Q Consensus       218 --------------------------------~~~s~~~~~li~~~L~~dP~~R~t~~eil~~~w~~~~~  255 (421)
                                                      +.+++.+.+||.+||+.||.+|||+.++++||||+...
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~  313 (353)
T 2b9h_A          244 SDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQTYH  313 (353)
T ss_dssp             STTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTC
T ss_pred             hhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCccccccC
Confidence                                            24788999999999999999999999999999998643

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=1.4e-45  Score=356.50  Aligned_cols=237  Identities=30%  Similarity=0.518  Sum_probs=195.6

Q ss_pred             eeecceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEE
Q 014609           11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIY   90 (421)
Q Consensus        11 ~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~   90 (421)
                      ...++|++.+.||+|+||+||+|++  +|+.||||++..... .....+.+.+|+.++++++||||+++++++.+....|
T Consensus        34 i~~~~y~i~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~  110 (309)
T 3p86_A           34 IPWCDLNIKEKIGAGSFGTVHRAEW--HGSDVAVKILMEQDF-HAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLS  110 (309)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEECCCCC-SHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCE
T ss_pred             CChhHceeeeEeecCCCeEEEEEEE--CCCcEEEEEecCCCC-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceE
Confidence            4568999999999999999999986  688999999976543 3334578899999999999999999999999999999


Q ss_pred             EEEeccCCCChHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHhCC--ceeccCCCCCEEeccCCCEEEEeccCCCCCc
Q 014609           91 MVLEYVTGGELFDKIASKGR---LQEAEGRKLFQQLIDGVSYCHNKG--VFHRDLKLENILLDSKGNIKISDFGLSALPQ  165 (421)
Q Consensus        91 lv~E~~~gg~L~~~i~~~~~---~~~~~~~~~~~ql~~aL~~LH~~g--i~HrDlkp~NILl~~~~~~kL~DFGla~~~~  165 (421)
                      +||||++|++|.+++...+.   +++..+..++.|++.||+|||++|  |+||||||+|||++.++.+||+|||++....
T Consensus       111 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~  190 (309)
T 3p86_A          111 IVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKA  190 (309)
T ss_dssp             EEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTCCEEECCCC------
T ss_pred             EEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCCcEEECCCCCCcccc
Confidence            99999999999999986543   999999999999999999999999  9999999999999999999999999997543


Q ss_pred             cccCCCccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhh-cCC---------------------cCCCCCCCHH
Q 014609          166 HFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIF-RGD---------------------FKLPKWLSPG  223 (421)
Q Consensus       166 ~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~-~~~---------------------~~~p~~~s~~  223 (421)
                      .  ........+||+.|+|||++.+..+ +.++|||||||++|.+ .|.                     ...|..+++.
T Consensus       191 ~--~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  267 (309)
T 3p86_A          191 S--TFLSSKSAAGTPEWMAPEVLRDEPS-NEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIPRNLNPQ  267 (309)
T ss_dssp             -------------CCTTSCHHHHTTCCC-CTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHHSCCCCCCCTTSCHH
T ss_pred             c--cccccccCCCCccccChhhhcCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCccCCHH
Confidence            2  1223445689999999999988777 5899999999999943 222                     3445678999


Q ss_pred             HHHHHHHhcCCCCCCCCCHHhhhc--Cccccc
Q 014609          224 AQNLLRKILEPNPVKRITIAGIKA--DEWFEQ  253 (421)
Q Consensus       224 ~~~li~~~L~~dP~~R~t~~eil~--~~w~~~  253 (421)
                      +.++|.+||+.||.+|||+.++++  ++|+..
T Consensus       268 l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~  299 (309)
T 3p86_A          268 VAAIIEGCWTNEPWKRPSFATIMDLLRPLIKS  299 (309)
T ss_dssp             HHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC-
T ss_pred             HHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence            999999999999999999999987  456554

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=2.2e-45  Score=354.58  Aligned_cols=235  Identities=27%  Similarity=0.461  Sum_probs=200.5

Q ss_pred             eecceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEE
Q 014609           12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYM   91 (421)
Q Consensus        12 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l   91 (421)
                      .-++|++++.||+|+||.||+|.+..+|+.||+|++.....     .+.+.+|+.+++.++||||+++++++...+..|+
T Consensus        27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l  101 (314)
T 3com_A           27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESD-----LQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWI  101 (314)
T ss_dssp             ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTSC-----CHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred             chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchHH-----HHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEE
Confidence            34689999999999999999999999999999999975431     3678899999999999999999999999999999


Q ss_pred             EEeccCCCChHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCccccCC
Q 014609           92 VLEYVTGGELFDKIA-SKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD  170 (421)
Q Consensus        92 v~E~~~gg~L~~~i~-~~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~  170 (421)
                      ||||+++++|.+++. ....+++..++.++.|++.||.|||+.||+||||||+||+++.++.+||+|||++......  .
T Consensus       102 v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~--~  179 (314)
T 3com_A          102 VMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDT--M  179 (314)
T ss_dssp             EEECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECBTT--B
T ss_pred             EeecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEECCCCCEEEeecccchhhhhh--c
Confidence            999999999999987 4567999999999999999999999999999999999999999999999999999754321  1


Q ss_pred             CccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhh-cCCcCC----------------------CCCCCHHHHHH
Q 014609          171 GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIF-RGDFKL----------------------PKWLSPGAQNL  227 (421)
Q Consensus       171 ~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~-~~~~~~----------------------p~~~s~~~~~l  227 (421)
                      .......||+.|+|||++.+..+ +.++||||||+++|.+ .|..++                      |..+++.+.++
T Consensus       180 ~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  258 (314)
T 3com_A          180 AKRNTVIGTPFWMAPEVIQEIGY-NCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPPPTFRKPELWSDNFTDF  258 (314)
T ss_dssp             SCBCCCCSCGGGCCHHHHSSSCB-CTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSSGGGSCHHHHHH
T ss_pred             cccCccCCCCCccChhhcCCCCC-CccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCcccCCcccCCHHHHHH
Confidence            22345679999999999988777 5889999999999944 333332                      23468899999


Q ss_pred             HHHhcCCCCCCCCCHHhhhcCcccccc
Q 014609          228 LRKILEPNPVKRITIAGIKADEWFEQD  254 (421)
Q Consensus       228 i~~~L~~dP~~R~t~~eil~~~w~~~~  254 (421)
                      |.+||..||.+|||+.++++||||...
T Consensus       259 i~~~l~~dp~~Rpt~~~ll~~~~~~~~  285 (314)
T 3com_A          259 VKQCLVKSPEQRATATQLLQHPFVRSA  285 (314)
T ss_dssp             HHHHTCSCTTTSCCHHHHTTSHHHHTC
T ss_pred             HHHHccCChhhCcCHHHHHhCHHHhcC
Confidence            999999999999999999999999864

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=1e-45  Score=358.35  Aligned_cols=233  Identities=25%  Similarity=0.429  Sum_probs=197.5

Q ss_pred             eecceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCC--EE
Q 014609           12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKS--KI   89 (421)
Q Consensus        12 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~--~~   89 (421)
                      .-++|++.+.||+|+||+||+|.+..+|+.||||++.......  ..+.+.+|+.++++++||||+++++++....  ..
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   84 (319)
T 4euu_A            7 SNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLR--PVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHK   84 (319)
T ss_dssp             SSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGS--CHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCE
T ss_pred             CCCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccc--hHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceE
Confidence            3478999999999999999999999999999999997544322  2567889999999999999999999998765  78


Q ss_pred             EEEEeccCCCChHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEe----ccCCCEEEEeccCCC
Q 014609           90 YMVLEYVTGGELFDKIASKG---RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILL----DSKGNIKISDFGLSA  162 (421)
Q Consensus        90 ~lv~E~~~gg~L~~~i~~~~---~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl----~~~~~~kL~DFGla~  162 (421)
                      |+||||++|++|.+++....   .+++..++.++.||+.||+|||++||+||||||+|||+    +.++.+||+|||++.
T Consensus        85 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~  164 (319)
T 4euu_A           85 VLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR  164 (319)
T ss_dssp             EEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCEEEEECCCTTCE
T ss_pred             EEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCceEEEccCCCce
Confidence            99999999999999997643   39999999999999999999999999999999999999    777889999999997


Q ss_pred             CCccccCCCccccccCCCCccChhhhc--------ccCCCCCcchHHHHHHHHhhh-cCCcCCC----------------
Q 014609          163 LPQHFRDDGLLHTTCGSPNYVAPEVLA--------NRGYDGATSDIWSCGVILYIF-RGDFKLP----------------  217 (421)
Q Consensus       163 ~~~~~~~~~~~~~~~gt~~y~APEvl~--------~~~~~~~~~DiwSlGvil~~~-~~~~~~p----------------  217 (421)
                      ....   .......+||+.|+|||++.        +..+ +.++|||||||++|.+ .|..++.                
T Consensus       165 ~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~-~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~  240 (319)
T 4euu_A          165 ELED---DEQFVSLYGTEEYLHPDMYERAVLRKDHQKKY-GATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKII  240 (319)
T ss_dssp             ECCT---TCCBCCCCSCGGGCCHHHHHHHTSCCCCCCCB-CTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHH
T ss_pred             ecCC---CCceeecccCCCccCHHHhhhccccccccCCC-CcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHh
Confidence            5433   23344567999999999986        3444 6899999999999944 3433331                


Q ss_pred             --------------------------------CCCCHHHHHHHHHhcCCCCCCCCCHHhhhcCcc
Q 014609          218 --------------------------------KWLSPGAQNLLRKILEPNPVKRITIAGIKADEW  250 (421)
Q Consensus       218 --------------------------------~~~s~~~~~li~~~L~~dP~~R~t~~eil~~~w  250 (421)
                                                      ..+++.+.++|++||+.||.+|||++|+++||-
T Consensus       241 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~  305 (319)
T 4euu_A          241 TGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETS  305 (319)
T ss_dssp             HHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHH
T ss_pred             cCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccH
Confidence                                            012457889999999999999999999999984

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=3.9e-45  Score=365.27  Aligned_cols=234  Identities=28%  Similarity=0.435  Sum_probs=192.6

Q ss_pred             CeeecceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCC--
Q 014609           10 GMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKS--   87 (421)
Q Consensus        10 ~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~--   87 (421)
                      ...-++|++++.||+|+||+||+|++..+++ ||+|.+.....       ...+|+.+++.++||||+++++++....  
T Consensus        36 ~~~~~~Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~~~-------~~~~E~~il~~l~h~niv~l~~~~~~~~~~  107 (394)
T 4e7w_A           36 EQREIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKR-------FKNRELQIMRIVKHPNVVDLKAFFYSNGDK  107 (394)
T ss_dssp             CEEEEEEEEEEEEEEETTEEEEEEEETTTEE-EEEEEEECCTT-------SCCHHHHHHHTCCCTTBCCEEEEEEEESSS
T ss_pred             CcccceEEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEecCcc-------hHHHHHHHHHhCCCCCcceEEEEEEecCCC
Confidence            3445789999999999999999999977766 88888764321       2236999999999999999999996543  


Q ss_pred             ----EEEEEEeccCCCChHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEec-cCCCEEEEec
Q 014609           88 ----KIYMVLEYVTGGELFDKIA----SKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLD-SKGNIKISDF  158 (421)
Q Consensus        88 ----~~~lv~E~~~gg~L~~~i~----~~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~-~~~~~kL~DF  158 (421)
                          .+|+||||++++ +.+.+.    ....+++..++.++.||+.||+|||++||+||||||+|||++ .++.+||+||
T Consensus       108 ~~~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~kL~DF  186 (394)
T 4e7w_A          108 KDEVFLNLVLEYVPET-VYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDF  186 (394)
T ss_dssp             SSCEEEEEEEECCSEE-HHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCC
T ss_pred             CCceEEEEEeeccCcc-HHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEcCCCCcEEEeeC
Confidence                388999999764 433332    356799999999999999999999999999999999999999 7899999999


Q ss_pred             cCCCCCccccCCCccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhh-cCCcCCC--------------------
Q 014609          159 GLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIF-RGDFKLP--------------------  217 (421)
Q Consensus       159 Gla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~-~~~~~~p--------------------  217 (421)
                      |++.....   .......+||+.|+|||++.+....+.++||||+||++|.+ .|..+++                    
T Consensus       187 G~a~~~~~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~  263 (394)
T 4e7w_A          187 GSAKILIA---GEPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSR  263 (394)
T ss_dssp             TTCEECCT---TCCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCH
T ss_pred             CCcccccC---CCCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCH
Confidence            99975432   22334568899999999987765446899999999999943 3433332                    


Q ss_pred             ----------------------------CCCCHHHHHHHHHhcCCCCCCCCCHHhhhcCccccccc
Q 014609          218 ----------------------------KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY  255 (421)
Q Consensus       218 ----------------------------~~~s~~~~~li~~~L~~dP~~R~t~~eil~~~w~~~~~  255 (421)
                                                  +.+++++.+||.+||+.||.+|||+.++++||||+...
T Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~  329 (394)
T 4e7w_A          264 EQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDELR  329 (394)
T ss_dssp             HHHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGSTTT
T ss_pred             HHHHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhhhc
Confidence                                        23788999999999999999999999999999998643

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=2.2e-45  Score=361.28  Aligned_cols=240  Identities=24%  Similarity=0.385  Sum_probs=188.5

Q ss_pred             CeeecceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCE-
Q 014609           10 GMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSK-   88 (421)
Q Consensus        10 ~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~-   88 (421)
                      ...+++|++.+.||+|+||+||+|++..+|+.||||++......    .....+++..++.++||||+++++++..... 
T Consensus        19 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~   94 (360)
T 3e3p_A           19 RKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRF----RNRELQIMQDLAVLHHPNIVQLQSYFYTLGER   94 (360)
T ss_dssp             HHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTTC----CCHHHHHHHHHHHHCCTTBCCEEEEEEEECSS
T ss_pred             hhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccc----cHHHHHHHHHHHhcCCCCcccHHHhhhccccc
Confidence            35678999999999999999999999999999999998654322    2356678888899999999999999966433 


Q ss_pred             ------EEEEEeccCCCChHHHH----HhcCCCCHHHHHHHHHHHHHHHHHHH--hCCceeccCCCCCEEecc-CCCEEE
Q 014609           89 ------IYMVLEYVTGGELFDKI----ASKGRLQEAEGRKLFQQLIDGVSYCH--NKGVFHRDLKLENILLDS-KGNIKI  155 (421)
Q Consensus        89 ------~~lv~E~~~gg~L~~~i----~~~~~~~~~~~~~~~~ql~~aL~~LH--~~gi~HrDlkp~NILl~~-~~~~kL  155 (421)
                            .|+||||+++ +|.+.+    .....+++..++.++.|++.||.|||  ++||+||||||+|||++. ++.+||
T Consensus        95 ~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~~kl  173 (360)
T 3e3p_A           95 DRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKL  173 (360)
T ss_dssp             CTTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEETTTTEEEE
T ss_pred             cccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeCCCCcEEE
Confidence                  8999999976 444433    34567999999999999999999999  999999999999999997 899999


Q ss_pred             EeccCCCCCccccCCCccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhh-cCCcCCCC----------------
Q 014609          156 SDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIF-RGDFKLPK----------------  218 (421)
Q Consensus       156 ~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~-~~~~~~p~----------------  218 (421)
                      +|||++.....   .......+||+.|+|||++.+....+.++|||||||++|.+ .|..++..                
T Consensus       174 ~Dfg~a~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~  250 (360)
T 3e3p_A          174 CDFGSAKKLSP---SEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGC  250 (360)
T ss_dssp             CCCTTCBCCCT---TSCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCC
T ss_pred             eeCCCceecCC---CCCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCC
Confidence            99999986543   22334567899999999987666457999999999999944 44433321                


Q ss_pred             -----------------------------------CCCHHHHHHHHHhcCCCCCCCCCHHhhhcCccccccccC
Q 014609          219 -----------------------------------WLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTP  257 (421)
Q Consensus       219 -----------------------------------~~s~~~~~li~~~L~~dP~~R~t~~eil~~~w~~~~~~~  257 (421)
                                                         ..++.+.+||.+||+.||.+|||+.|+++||||+....+
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~  324 (360)
T 3e3p_A          251 PSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDELHDP  324 (360)
T ss_dssp             CCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGGGGGCT
T ss_pred             CCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCccccccCCc
Confidence                                               135789999999999999999999999999999975543

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=5.6e-45  Score=350.18  Aligned_cols=236  Identities=25%  Similarity=0.470  Sum_probs=207.3

Q ss_pred             cceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEE
Q 014609           14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVL   93 (421)
Q Consensus        14 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~   93 (421)
                      ++|++++.||+|+||.||+|.+..+++.||||++......  ...+.+.+|+.+++.++||||+++++++......|+||
T Consensus        22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   99 (303)
T 3a7i_A           22 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAE--DEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIM   99 (303)
T ss_dssp             GTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCS--TTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             HHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccH--HHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEE
Confidence            5799999999999999999999999999999999765432  23578999999999999999999999999999999999


Q ss_pred             eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCccccCCCcc
Q 014609           94 EYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLL  173 (421)
Q Consensus        94 E~~~gg~L~~~i~~~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~  173 (421)
                      ||++|++|.+++.. +++++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++......  ....
T Consensus       100 e~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~--~~~~  176 (303)
T 3a7i_A          100 EYLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDT--QIKR  176 (303)
T ss_dssp             ECCTTEEHHHHHTT-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECBTT--BCCB
T ss_pred             EeCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEECCCCCEEEeecccceecCcc--cccc
Confidence            99999999998865 67999999999999999999999999999999999999999999999999999754331  1223


Q ss_pred             ccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhh-cCCcC--------------------CCCCCCHHHHHHHHHhc
Q 014609          174 HTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIF-RGDFK--------------------LPKWLSPGAQNLLRKIL  232 (421)
Q Consensus       174 ~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~-~~~~~--------------------~p~~~s~~~~~li~~~L  232 (421)
                      ....||+.|+|||++.+..+ +.++||||||+++|.+ .|..+                    ++..+++.+.++|.+||
T Consensus       177 ~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l  255 (303)
T 3a7i_A          177 NTFVGTPFWMAPEVIKQSAY-DSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVEACL  255 (303)
T ss_dssp             CCCCSCGGGCCHHHHTTCCB-CTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCCSSCCHHHHHHHHHHC
T ss_pred             CccCCCcCccCHHHHhcCCC-CchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHhhcCCCCCCccccCHHHHHHHHHHc
Confidence            45679999999999988777 4899999999999944 33322                    23457899999999999


Q ss_pred             CCCCCCCCCHHhhhcCccccccc
Q 014609          233 EPNPVKRITIAGIKADEWFEQDY  255 (421)
Q Consensus       233 ~~dP~~R~t~~eil~~~w~~~~~  255 (421)
                      ++||.+|||+.++++||||....
T Consensus       256 ~~dp~~Rps~~~ll~~~~~~~~~  278 (303)
T 3a7i_A          256 NKEPSFRPTAKELLKHKFILRNA  278 (303)
T ss_dssp             CSSGGGSCCHHHHTTCHHHHHHC
T ss_pred             CCChhhCcCHHHHhhChhhhcCC
Confidence            99999999999999999998654

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=2.9e-45  Score=353.68  Aligned_cols=241  Identities=28%  Similarity=0.420  Sum_probs=195.9

Q ss_pred             eecceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEE-------
Q 014609           12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLA-------   84 (421)
Q Consensus        12 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~-------   84 (421)
                      .-++|++++.||+|+||.||+|.+..+|+.||+|++...   .....+.+.+|+.++++++||||+++++++.       
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   85 (320)
T 2i6l_A            9 LGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLT---DPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLT   85 (320)
T ss_dssp             ETTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECC---SHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCC
T ss_pred             cCCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecC---ChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccc
Confidence            347999999999999999999999999999999998754   2344678899999999999999999999873       


Q ss_pred             -------eCCEEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEec-cCCCEEEE
Q 014609           85 -------SKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLD-SKGNIKIS  156 (421)
Q Consensus        85 -------~~~~~~lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~-~~~~~kL~  156 (421)
                             .....|+||||+. ++|.+.+.. +++++..++.++.|++.||+|||++||+||||||+|||++ .++.+||+
T Consensus        86 ~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~  163 (320)
T 2i6l_A           86 DDVGSLTELNSVYIVQEYME-TDLANVLEQ-GPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIG  163 (320)
T ss_dssp             C----CCSCSEEEEEEECCS-EEHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTTEEEEC
T ss_pred             cccccccccCceeEEeeccC-CCHHHHhhc-CCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCeEEEc
Confidence                   4478999999997 599888864 6799999999999999999999999999999999999997 56789999


Q ss_pred             eccCCCCCcccc-CCCccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhh-cCCcCCC-----------------
Q 014609          157 DFGLSALPQHFR-DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIF-RGDFKLP-----------------  217 (421)
Q Consensus       157 DFGla~~~~~~~-~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~-~~~~~~p-----------------  217 (421)
                      |||++....... .........+|+.|+|||++.+....+.++|||||||++|.+ .|..++.                 
T Consensus       164 Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~  243 (320)
T 2i6l_A          164 DFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPV  243 (320)
T ss_dssp             CCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHSCC
T ss_pred             cCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCC
Confidence            999998653321 122344567899999999987644446899999999999944 3433331                 


Q ss_pred             --------------------------------CCCCHHHHHHHHHhcCCCCCCCCCHHhhhcCccccccccC
Q 014609          218 --------------------------------KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTP  257 (421)
Q Consensus       218 --------------------------------~~~s~~~~~li~~~L~~dP~~R~t~~eil~~~w~~~~~~~  257 (421)
                                                      +.+++.+.++|++||+.||.+|||+.++++||||+....|
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~p  315 (320)
T 2i6l_A          244 VHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYMSIYSFP  315 (320)
T ss_dssp             CCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHHHHTTCC-
T ss_pred             CchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCcccccccCc
Confidence                                            3478999999999999999999999999999999865433

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=2.6e-45  Score=369.52  Aligned_cols=232  Identities=28%  Similarity=0.394  Sum_probs=192.5

Q ss_pred             ecceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeC------
Q 014609           13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASK------   86 (421)
Q Consensus        13 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~------   86 (421)
                      ..+|++++.||+|+||+||+|++..+|+.||||++....       ....+|+++|+.++||||+++++++...      
T Consensus        53 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~  125 (420)
T 1j1b_A           53 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK-------RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDE  125 (420)
T ss_dssp             EEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCT-------TSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTE
T ss_pred             cceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccc-------hhHHHHHHHHHHcCCCCccceeeEEeccCCCCcc
Confidence            457999999999999999999999999999999987542       1234799999999999999999998542      


Q ss_pred             CEEEEEEeccCCCChHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccC-CCEEEEeccCC
Q 014609           87 SKIYMVLEYVTGGELFDKIA----SKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSK-GNIKISDFGLS  161 (421)
Q Consensus        87 ~~~~lv~E~~~gg~L~~~i~----~~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~-~~~kL~DFGla  161 (421)
                      ..+++||||+++ +|.+.+.    ....+++..++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||++
T Consensus       126 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~~kl~DFG~a  204 (420)
T 1j1b_A          126 VYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSA  204 (420)
T ss_dssp             EEEEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred             eeEEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeCCCCeEEeccchhh
Confidence            246799999975 6655543    35679999999999999999999999999999999999999965 56899999999


Q ss_pred             CCCccccCCCccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhh-cCCcCC------------------------
Q 014609          162 ALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIF-RGDFKL------------------------  216 (421)
Q Consensus       162 ~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~-~~~~~~------------------------  216 (421)
                      .....   .......+||+.|+|||++.+....+.++|||||||++|++ .|..++                        
T Consensus       205 ~~~~~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~  281 (420)
T 1j1b_A          205 KQLVR---GEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQI  281 (420)
T ss_dssp             EECCT---TCCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHH
T ss_pred             hhccc---CCCceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence            85432   22334568999999999987654346899999999999943 333322                        


Q ss_pred             ------------------------CCCCCHHHHHHHHHhcCCCCCCCCCHHhhhcCccccccc
Q 014609          217 ------------------------PKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY  255 (421)
Q Consensus       217 ------------------------p~~~s~~~~~li~~~L~~dP~~R~t~~eil~~~w~~~~~  255 (421)
                                              ++.+++++.+||.+||+.||.+|||+.|+++||||....
T Consensus       282 ~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f~~~~  344 (420)
T 1j1b_A          282 REMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELR  344 (420)
T ss_dssp             HHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGG
T ss_pred             HhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhhcccc
Confidence                                    223578999999999999999999999999999998644

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=3.4e-46  Score=357.74  Aligned_cols=242  Identities=28%  Similarity=0.510  Sum_probs=182.3

Q ss_pred             CeeecceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEE
Q 014609           10 GMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKI   89 (421)
Q Consensus        10 ~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~   89 (421)
                      ....++|++++.||+|+||.||+|.+..+++.||||++......  ...+.+.+|+.++++++||||+++++++...+..
T Consensus        11 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   88 (303)
T 2vwi_A           11 SINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQ--TSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDEL   88 (303)
T ss_dssp             --CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC------------------CCCCCCCTTBCCEEEEEESSSCE
T ss_pred             ccchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcc--hhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCc
Confidence            45568999999999999999999999889999999998654322  2346788999999999999999999999999999


Q ss_pred             EEEEeccCCCChHHHHHh--------cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCC
Q 014609           90 YMVLEYVTGGELFDKIAS--------KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLS  161 (421)
Q Consensus        90 ~lv~E~~~gg~L~~~i~~--------~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla  161 (421)
                      |+||||++|++|.+++..        ...+++..++.++.|++.||+|||++||+||||||+||+++.++.+||+|||++
T Consensus        89 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~  168 (303)
T 2vwi_A           89 WLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVS  168 (303)
T ss_dssp             EEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCHHH
T ss_pred             EEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEEcCCCCEEEEeccch
Confidence            999999999999998863        456999999999999999999999999999999999999999999999999998


Q ss_pred             CCCcccc---CCCccccccCCCCccChhhhcc-cCCCCCcchHHHHHHHHhhh-cCCcCC--------------------
Q 014609          162 ALPQHFR---DDGLLHTTCGSPNYVAPEVLAN-RGYDGATSDIWSCGVILYIF-RGDFKL--------------------  216 (421)
Q Consensus       162 ~~~~~~~---~~~~~~~~~gt~~y~APEvl~~-~~~~~~~~DiwSlGvil~~~-~~~~~~--------------------  216 (421)
                      .......   ........+||+.|+|||++.+ ..+ +.++|||||||++|.+ .|..++                    
T Consensus       169 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~  247 (303)
T 2vwi_A          169 AFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGY-DFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSL  247 (303)
T ss_dssp             HHCC---------------CCCTTCCHHHHHHHHCC-CTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHTSSCCCT
T ss_pred             heeccCCCccchhhhcccCCCccccCHHHhccccCC-CchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhccCCCcc
Confidence            7543211   1122345679999999999876 344 6899999999999944 333222                    


Q ss_pred             ---------CCCCCHHHHHHHHHhcCCCCCCCCCHHhhhcCcccccc
Q 014609          217 ---------PKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD  254 (421)
Q Consensus       217 ---------p~~~s~~~~~li~~~L~~dP~~R~t~~eil~~~w~~~~  254 (421)
                               +..+++.+.++|.+||+.||.+|||+.++++||||++.
T Consensus       248 ~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~  294 (303)
T 2vwi_A          248 ETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKA  294 (303)
T ss_dssp             TC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTSTTC---
T ss_pred             ccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhChhhhcC
Confidence                     12367889999999999999999999999999999864

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=5.7e-45  Score=353.51  Aligned_cols=237  Identities=27%  Similarity=0.454  Sum_probs=197.2

Q ss_pred             eeecceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcC-CCCCcceEEEEEEe----
Q 014609           11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEVLAS----   85 (421)
Q Consensus        11 ~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~----   85 (421)
                      ...++|++++.||+|+||.||+|.+..+|+.||||++.....    ..+.+.+|+.+++++ +||||+++++++..    
T Consensus        21 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~----~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~   96 (326)
T 2x7f_A           21 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD----EEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPP   96 (326)
T ss_dssp             CCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS----TTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--
T ss_pred             CCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcc----cHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCc
Confidence            345799999999999999999999999999999999975432    236788999999999 79999999999987    


Q ss_pred             --CCEEEEEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCC
Q 014609           86 --KSKIYMVLEYVTGGELFDKIASK--GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLS  161 (421)
Q Consensus        86 --~~~~~lv~E~~~gg~L~~~i~~~--~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla  161 (421)
                        ....|+||||+++++|.+++...  ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++
T Consensus        97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~  176 (326)
T 2x7f_A           97 GMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVS  176 (326)
T ss_dssp             CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCTTT
T ss_pred             cccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEEcCCCCEEEeeCcCc
Confidence              56899999999999999999764  57999999999999999999999999999999999999999999999999999


Q ss_pred             CCCccccCCCccccccCCCCccChhhhc-----ccCCCCCcchHHHHHHHHhhh-cCCcCC-------------------
Q 014609          162 ALPQHFRDDGLLHTTCGSPNYVAPEVLA-----NRGYDGATSDIWSCGVILYIF-RGDFKL-------------------  216 (421)
Q Consensus       162 ~~~~~~~~~~~~~~~~gt~~y~APEvl~-----~~~~~~~~~DiwSlGvil~~~-~~~~~~-------------------  216 (421)
                      .....  ........+||+.|+|||++.     ...+ +.++|||||||++|.+ .|..++                   
T Consensus       177 ~~~~~--~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~  253 (326)
T 2x7f_A          177 AQLDR--TVGRRNTFIGTPYWMAPEVIACDENPDATY-DFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPR  253 (326)
T ss_dssp             C---------------CCGGGCCHHHHC--------C-CTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCC
T ss_pred             eecCc--CccccccccCCccccChhhhccccccCcCC-CccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCcccc
Confidence            85432  122334567999999999986     3344 5889999999999944 333332                   


Q ss_pred             --CCCCCHHHHHHHHHhcCCCCCCCCCHHhhhcCcccccc
Q 014609          217 --PKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD  254 (421)
Q Consensus       217 --p~~~s~~~~~li~~~L~~dP~~R~t~~eil~~~w~~~~  254 (421)
                        +..+++.+.++|.+||..||.+|||+.++++||||...
T Consensus       254 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~hp~~~~~  293 (326)
T 2x7f_A          254 LKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKHPFIRDQ  293 (326)
T ss_dssp             CSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTSHHHHCC
T ss_pred             CCccccCHHHHHHHHHHhccChhhCCCHHHHhhChHHhhC
Confidence              23478999999999999999999999999999999864

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=1.1e-45  Score=365.90  Aligned_cols=235  Identities=15%  Similarity=0.142  Sum_probs=183.8

Q ss_pred             ecceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcC--CCCCcceEE-------EEE
Q 014609           13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL--KHPNVVRLH-------EVL   83 (421)
Q Consensus        13 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l--~hpnIv~l~-------~~~   83 (421)
                      ...|++++.||+|+||.||+|.+..+|+.||||++...........+.+.+|+.+++.|  +||||++++       +++
T Consensus        61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~  140 (371)
T 3q60_A           61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAV  140 (371)
T ss_dssp             EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEE
T ss_pred             ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhe
Confidence            34599999999999999999999999999999999876554445567788885544444  699988755       555


Q ss_pred             EeC-----------------CEEEEEEeccCCCChHHHHHhc-CCCCHHHH------HHHHHHHHHHHHHHHhCCceecc
Q 014609           84 ASK-----------------SKIYMVLEYVTGGELFDKIASK-GRLQEAEG------RKLFQQLIDGVSYCHNKGVFHRD  139 (421)
Q Consensus        84 ~~~-----------------~~~~lv~E~~~gg~L~~~i~~~-~~~~~~~~------~~~~~ql~~aL~~LH~~gi~HrD  139 (421)
                      ...                 ..+|+||||++ ++|.+++... ..+++...      ..++.||+.||+|||++||+|||
T Consensus       141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~ivHrD  219 (371)
T 3q60_A          141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGH  219 (371)
T ss_dssp             EETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTTEEETT
T ss_pred             ecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHCCCccCc
Confidence            543                 34899999998 8999999863 33444444      56679999999999999999999


Q ss_pred             CCCCCEEeccCCCEEEEeccCCCCCccccCCCccccccCCCCccChhhhcc--cCCCCCcchHHHHHHHHhhh-cCCcCC
Q 014609          140 LKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLAN--RGYDGATSDIWSCGVILYIF-RGDFKL  216 (421)
Q Consensus       140 lkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~--~~~~~~~~DiwSlGvil~~~-~~~~~~  216 (421)
                      |||+|||++.+|.+||+|||++.....     ......+|+.|+|||++.+  ..| +.++|||||||++|.+ .|..|+
T Consensus       220 ikp~NIll~~~~~~kL~DFG~a~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~-~~~~DiwSlG~il~elltg~~Pf  293 (371)
T 3q60_A          220 FTPDNLFIMPDGRLMLGDVSALWKVGT-----RGPASSVPVTYAPREFLNASTATF-THALNAWQLGLSIYRVWCLFLPF  293 (371)
T ss_dssp             CSGGGEEECTTSCEEECCGGGEEETTC-----EEEGGGSCGGGCCHHHHTCSEEEC-CHHHHHHHHHHHHHHHHHSSCST
T ss_pred             CCHHHEEECCCCCEEEEecceeeecCC-----CccCccCCcCCcChhhccCCCCCc-CccccHHHHHHHHHHHHhCCCCC
Confidence            999999999999999999999984422     2224567799999999976  556 5899999999999944 333322


Q ss_pred             --------------------------C--CCCCHHHHHHHHHhcCCCCCCCCCHHhhhcCcccccc
Q 014609          217 --------------------------P--KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD  254 (421)
Q Consensus       217 --------------------------p--~~~s~~~~~li~~~L~~dP~~R~t~~eil~~~w~~~~  254 (421)
                                                |  +.+++.+.+||.+||+.||.+|||+.++++||||++.
T Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~  359 (371)
T 3q60_A          294 GLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFLQL  359 (371)
T ss_dssp             TBCCTTCTTCCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTSHHHHHH
T ss_pred             CCcCcccccchhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCHHHHHH
Confidence                                      1  3468999999999999999999999999999999863

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=5.3e-46  Score=364.05  Aligned_cols=240  Identities=27%  Similarity=0.519  Sum_probs=206.0

Q ss_pred             CCeeecceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchh--------------HHHHHHHHHHHHhcCCCC
Q 014609            9 EGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLK--------------ITDQIKREIATLKLLKHP   74 (421)
Q Consensus         9 ~~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~--------------~~~~~~~Ei~il~~l~hp   74 (421)
                      ....+++|++++.||+|+||.||+|.+  +|+.||||++.........              ..+.+.+|+.++++++||
T Consensus        26 ~~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~  103 (348)
T 2pml_X           26 KDKYINDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNE  103 (348)
T ss_dssp             SCEEETTEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCT
T ss_pred             cccccCceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCC
Confidence            345669999999999999999999998  8999999999765432211              127899999999999999


Q ss_pred             CcceEEEEEEeCCEEEEEEeccCCCChHHH------HHh--cCCCCHHHHHHHHHHHHHHHHHHHh-CCceeccCCCCCE
Q 014609           75 NVVRLHEVLASKSKIYMVLEYVTGGELFDK------IAS--KGRLQEAEGRKLFQQLIDGVSYCHN-KGVFHRDLKLENI  145 (421)
Q Consensus        75 nIv~l~~~~~~~~~~~lv~E~~~gg~L~~~------i~~--~~~~~~~~~~~~~~ql~~aL~~LH~-~gi~HrDlkp~NI  145 (421)
                      ||+++++++.+.+..|+||||++|++|.++      +..  ...+++..++.++.|++.||+|||+ +||+||||||+||
T Consensus       104 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p~Ni  183 (348)
T 2pml_X          104 YCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNI  183 (348)
T ss_dssp             TBCCCSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCGGGE
T ss_pred             CcceEEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCChHhE
Confidence            999999999999999999999999999988      655  5679999999999999999999999 9999999999999


Q ss_pred             EeccCCCEEEEeccCCCCCccccCCCccccccCCCCccChhhhccc-CCCCCcchHHHHHHHHhhh-cCC----------
Q 014609          146 LLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANR-GYDGATSDIWSCGVILYIF-RGD----------  213 (421)
Q Consensus       146 Ll~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~-~~~~~~~DiwSlGvil~~~-~~~----------  213 (421)
                      |++.++.+||+|||++.....    .......||+.|+|||++.+. .+.+.++||||+||++|.+ .|.          
T Consensus       184 l~~~~~~~kl~dfg~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~  259 (348)
T 2pml_X          184 LMDKNGRVKLSDFGESEYMVD----KKIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLV  259 (348)
T ss_dssp             EECTTSCEEECCCTTCEECBT----TEECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSH
T ss_pred             EEcCCCcEEEecccccccccc----ccccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHH
Confidence            999999999999999975432    234556899999999999876 4543389999999999943 222          


Q ss_pred             ----------cCCC-------------------CCCCHHHHHHHHHhcCCCCCCCCCHHhhhcCcccccc
Q 014609          214 ----------FKLP-------------------KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD  254 (421)
Q Consensus       214 ----------~~~p-------------------~~~s~~~~~li~~~L~~dP~~R~t~~eil~~~w~~~~  254 (421)
                                ..+|                   ..+++.+.++|.+||+.||.+|||+.++++||||...
T Consensus       260 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~hp~f~~~  329 (348)
T 2pml_X          260 ELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWLADT  329 (348)
T ss_dssp             HHHHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGTTC
T ss_pred             HHHHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcCccccCC
Confidence                      2233                   4578999999999999999999999999999999853

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=3e-45  Score=363.08  Aligned_cols=236  Identities=26%  Similarity=0.432  Sum_probs=200.8

Q ss_pred             CeeecceEEeceEeecCcEEEEEEEEC-------CCCceEEEEEeecccccchhHHHHHHHHHHHHhcC-CCCCcceEEE
Q 014609           10 GMRLGRYELGRTLGEGNFGKVKFAQDL-------DSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHE   81 (421)
Q Consensus        10 ~~~~~~y~i~~~LG~G~~g~V~~a~~~-------~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~   81 (421)
                      ....++|++++.||+|+||+||+|++.       .++..||||+++...  .....+.+.+|+.+++++ +||||+++++
T Consensus        77 ~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hpnIv~~~~  154 (370)
T 2psq_A           77 EFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINLLG  154 (370)
T ss_dssp             BCCGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTC--BHHHHHHHHHHHHHHHHSCCCTTBCCEEE
T ss_pred             cccHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCc--CHHHHHHHHHHHHHHHHhcCCCCEeeEEE
Confidence            345589999999999999999999874       355689999997543  333467899999999999 8999999999


Q ss_pred             EEEeCCEEEEEEeccCCCChHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCE
Q 014609           82 VLASKSKIYMVLEYVTGGELFDKIASKG----------------RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENI  145 (421)
Q Consensus        82 ~~~~~~~~~lv~E~~~gg~L~~~i~~~~----------------~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NI  145 (421)
                      ++...+.+|+||||++||+|.+++....                .+++..+..++.||+.||+|||++||+||||||+||
T Consensus       155 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NI  234 (370)
T 2psq_A          155 ACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNV  234 (370)
T ss_dssp             EECSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGE
T ss_pred             EEccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchhhE
Confidence            9999999999999999999999997643                478999999999999999999999999999999999


Q ss_pred             EeccCCCEEEEeccCCCCCccccCCCccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhhc--CCcC--------
Q 014609          146 LLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIFR--GDFK--------  215 (421)
Q Consensus       146 Ll~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~~--~~~~--------  215 (421)
                      |++.++.+||+|||++................+|+.|+|||++.+..| +.++|||||||++|.+.  |..+        
T Consensus       235 ll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~-~~~~DvwslG~il~ellt~g~~p~~~~~~~~  313 (370)
T 2psq_A          235 LVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVY-THQSDVWSFGVLMWEIFTLGGSPYPGIPVEE  313 (370)
T ss_dssp             EECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCC-CHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG
T ss_pred             EECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCC-CcHHHHHHHHHHHHHHHcCCCCCCCCCCHHH
Confidence            999999999999999985443222223344567889999999988777 58999999999999643  4333        


Q ss_pred             ------------CCCCCCHHHHHHHHHhcCCCCCCCCCHHhhhcC
Q 014609          216 ------------LPKWLSPGAQNLLRKILEPNPVKRITIAGIKAD  248 (421)
Q Consensus       216 ------------~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~~  248 (421)
                                  .|..+++.+.++|.+||+.||.+|||+.|++++
T Consensus       314 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~  358 (370)
T 2psq_A          314 LFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED  358 (370)
T ss_dssp             HHHHHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence                        344578899999999999999999999998864

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=100.00  E-value=5.1e-45  Score=361.39  Aligned_cols=232  Identities=31%  Similarity=0.441  Sum_probs=197.1

Q ss_pred             cceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEE----
Q 014609           14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKI----   89 (421)
Q Consensus        14 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~----   89 (421)
                      ++|++.+.||+|+||+||+|.+..+|+.||||++.... ........+.+|+.+++.++||||+++++++...+..    
T Consensus        42 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  120 (371)
T 4exu_A           42 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPF-QSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY  120 (371)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTT-SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred             ccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccc-cchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence            69999999999999999999999999999999997643 2334467889999999999999999999999877654    


Q ss_pred             --EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCccc
Q 014609           90 --YMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHF  167 (421)
Q Consensus        90 --~lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~  167 (421)
                        |+||||+. ++|.+.+.  ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++..... 
T Consensus       121 ~~~lv~e~~~-~~l~~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~-  196 (371)
T 4exu_A          121 DFYLVMPFMQ-TDLQKIMG--MEFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADA-  196 (371)
T ss_dssp             CCEEEEECCC-EEHHHHTT--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECSTTCC------
T ss_pred             eEEEEEcccc-ccHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEECCCCCEEEEecCccccccc-
Confidence              99999996 58877764  4599999999999999999999999999999999999999999999999999975432 


Q ss_pred             cCCCccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhh-cCCcCCC-----------------------------
Q 014609          168 RDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIF-RGDFKLP-----------------------------  217 (421)
Q Consensus       168 ~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~-~~~~~~p-----------------------------  217 (421)
                          .....+||+.|+|||++.+....+.++|||||||++|.+ .|..++.                             
T Consensus       197 ----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  272 (371)
T 4exu_A          197 ----EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDK  272 (371)
T ss_dssp             -------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCSCH
T ss_pred             ----CcCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHHHhhhh
Confidence                234568999999999988744446899999999999944 4444432                             


Q ss_pred             ---------------------CCCCHHHHHHHHHhcCCCCCCCCCHHhhhcCcccccc
Q 014609          218 ---------------------KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD  254 (421)
Q Consensus       218 ---------------------~~~s~~~~~li~~~L~~dP~~R~t~~eil~~~w~~~~  254 (421)
                                           +.+++.+.+||.+||+.||.+|||+.|+++||||+..
T Consensus       273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~  330 (371)
T 4exu_A          273 AAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPF  330 (371)
T ss_dssp             HHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTT
T ss_pred             hhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcCcccccC
Confidence                                 2358899999999999999999999999999999853

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=1.3e-45  Score=349.93  Aligned_cols=241  Identities=29%  Similarity=0.515  Sum_probs=205.3

Q ss_pred             eeecceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEe--CCE
Q 014609           11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLAS--KSK   88 (421)
Q Consensus        11 ~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~--~~~   88 (421)
                      ...++|++++.||+|+||.||+|.+..+|+.||+|++...... ....+.+.+|+.++++++||||+++++++..  ...
T Consensus         3 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   81 (279)
T 2w5a_A            3 SRAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMT-EAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTT   81 (279)
T ss_dssp             CCGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTE
T ss_pred             CchhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCC-HHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCce
Confidence            4578999999999999999999999999999999999865432 3346789999999999999999999998854  678


Q ss_pred             EEEEEeccCCCChHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC-----ceeccCCCCCEEeccCCCEEEEecc
Q 014609           89 IYMVLEYVTGGELFDKIASK----GRLQEAEGRKLFQQLIDGVSYCHNKG-----VFHRDLKLENILLDSKGNIKISDFG  159 (421)
Q Consensus        89 ~~lv~E~~~gg~L~~~i~~~----~~~~~~~~~~~~~ql~~aL~~LH~~g-----i~HrDlkp~NILl~~~~~~kL~DFG  159 (421)
                      .|+||||++|++|.+++...    ..+++..++.++.|++.||+|||+.|     |+||||||+|||++.++.+||+|||
T Consensus        82 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg  161 (279)
T 2w5a_A           82 LYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFG  161 (279)
T ss_dssp             EEEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCC
T ss_pred             EEEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCc
Confidence            99999999999999998753    34999999999999999999999999     9999999999999999999999999


Q ss_pred             CCCCCccccCCCccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhh-cCCc--------------------CCCC
Q 014609          160 LSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIF-RGDF--------------------KLPK  218 (421)
Q Consensus       160 la~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~-~~~~--------------------~~p~  218 (421)
                      ++.....  ........+||+.|+|||++.+..+ +.++||||||+++|.+ .|..                    .+|.
T Consensus       162 ~~~~~~~--~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~  238 (279)
T 2w5a_A          162 LARILNH--DTSFAKTFVGTPYYMSPEQMNRMSY-NEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPY  238 (279)
T ss_dssp             HHHHC-----CHHHHHHHSCCTTCCHHHHHCC-C-CHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCCT
T ss_pred             hheeecc--ccccccccCCCccccChHHhccCCC-CchhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHHhhcccccCCc
Confidence            9875432  1122345679999999999988777 5899999999999943 3322                    3445


Q ss_pred             CCCHHHHHHHHHhcCCCCCCCCCHHhhhcCccccccc
Q 014609          219 WLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY  255 (421)
Q Consensus       219 ~~s~~~~~li~~~L~~dP~~R~t~~eil~~~w~~~~~  255 (421)
                      .+++.+.++|.+||+.||.+|||+.++++|+|+....
T Consensus       239 ~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~~~~  275 (279)
T 2w5a_A          239 RYSDELNEIITRMLNLKDYHRPSVEEILENPLILEHH  275 (279)
T ss_dssp             TSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCCGGG
T ss_pred             ccCHHHHHHHHHHcCCCcccCCCHHHHHhChhhhhhc
Confidence            6789999999999999999999999999999998643

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=3e-45  Score=364.38  Aligned_cols=229  Identities=30%  Similarity=0.477  Sum_probs=195.7

Q ss_pred             ecceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCC--------CCCcceEEEEEE
Q 014609           13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK--------HPNVVRLHEVLA   84 (421)
Q Consensus        13 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~--------hpnIv~l~~~~~   84 (421)
                      .++|++++.||+|+||+||+|++..+++.||||++...    ....+.+.+|+.+++.++        ||||+++++++.
T Consensus        36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~  111 (397)
T 1wak_A           36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA----EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFK  111 (397)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC----HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEE
T ss_pred             CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC----CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeeccee
Confidence            37899999999999999999999999999999999743    233577899999999986        788999999997


Q ss_pred             ----eCCEEEEEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC-CceeccCCCCCEEeccCC------
Q 014609           85 ----SKSKIYMVLEYVTGGELFDKIASK--GRLQEAEGRKLFQQLIDGVSYCHNK-GVFHRDLKLENILLDSKG------  151 (421)
Q Consensus        85 ----~~~~~~lv~E~~~gg~L~~~i~~~--~~~~~~~~~~~~~ql~~aL~~LH~~-gi~HrDlkp~NILl~~~~------  151 (421)
                          ....+|+||||+ +++|.+.+...  ..+++..++.++.||+.||+|||++ ||+||||||+|||++.++      
T Consensus       112 ~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~~~~~~~~~~  190 (397)
T 1wak_A          112 ISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRL  190 (397)
T ss_dssp             EEETTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEECCCHHHHHHH
T ss_pred             ecCCCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEeccchhhhhh
Confidence                556899999999 66777777654  4699999999999999999999998 999999999999999775      


Q ss_pred             -------------------------------------------CEEEEeccCCCCCccccCCCccccccCCCCccChhhh
Q 014609          152 -------------------------------------------NIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVL  188 (421)
Q Consensus       152 -------------------------------------------~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl  188 (421)
                                                                 .+||+|||++.....     .....+||+.|+|||++
T Consensus       191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~-----~~~~~~gt~~y~aPE~~  265 (397)
T 1wak_A          191 AAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHK-----HFTEDIQTRQYRSLEVL  265 (397)
T ss_dssp             HHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTB-----CSCSCCSCGGGCCHHHH
T ss_pred             hhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEeccccccccccc-----cCccCCCCCcccCChhh
Confidence                                                       799999999975432     23455899999999999


Q ss_pred             cccCCCCCcchHHHHHHHHhhh-cCCcCCCCC------------------------------------------------
Q 014609          189 ANRGYDGATSDIWSCGVILYIF-RGDFKLPKW------------------------------------------------  219 (421)
Q Consensus       189 ~~~~~~~~~~DiwSlGvil~~~-~~~~~~p~~------------------------------------------------  219 (421)
                      .+..+ +.++|||||||++|.+ .|..++...                                                
T Consensus       266 ~~~~~-~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~  344 (397)
T 1wak_A          266 IGSGY-NTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITK  344 (397)
T ss_dssp             HTSCC-CTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCC
T ss_pred             cCCCC-CcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccc
Confidence            88877 5899999999999954 455444311                                                


Q ss_pred             -------------------CCHHHHHHHHHhcCCCCCCCCCHHhhhcCcccc
Q 014609          220 -------------------LSPGAQNLLRKILEPNPVKRITIAGIKADEWFE  252 (421)
Q Consensus       220 -------------------~s~~~~~li~~~L~~dP~~R~t~~eil~~~w~~  252 (421)
                                         .++.+.+||.+||+.||.+|||+.|+++||||+
T Consensus       345 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~  396 (397)
T 1wak_A          345 LKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPWLN  396 (397)
T ss_dssp             CCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTSGGGG
T ss_pred             cCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhCcccc
Confidence                               124578999999999999999999999999996

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=2.4e-45  Score=355.90  Aligned_cols=243  Identities=24%  Similarity=0.334  Sum_probs=182.5

Q ss_pred             eeecceEEeceEeecCcEEEEEEEECCCCc---eEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCC
Q 014609           11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGL---PFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKS   87 (421)
Q Consensus        11 ~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~---~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~   87 (421)
                      ..-++|++++.||+|+||+||+|.+..++.   .||||++....... ...+.+.+|+.++++++||||+++++++....
T Consensus        20 i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   98 (323)
T 3qup_A           20 IPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIAS-SDIEEFLREAACMKEFDHPHVAKLVGVSLRSR   98 (323)
T ss_dssp             CC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------C-HHHHHHHHHHHHHTTCCCTTBCCCCEEEECC-
T ss_pred             cChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCH-HHHHHHHHHHHHHHHCCCCceehhhceeeccc
Confidence            344789999999999999999999877665   89999997654332 33678999999999999999999999998876


Q ss_pred             EE------EEEEeccCCCChHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEE
Q 014609           88 KI------YMVLEYVTGGELFDKIASKG------RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKI  155 (421)
Q Consensus        88 ~~------~lv~E~~~gg~L~~~i~~~~------~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL  155 (421)
                      ..      |+||||+++++|.+++....      .+++..++.++.|++.||+|||++||+||||||+|||++.++.+||
T Consensus        99 ~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli~~~~~~kl  178 (323)
T 3qup_A           99 AKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCV  178 (323)
T ss_dssp             ------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEE
T ss_pred             cccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEEcCCCCEEE
Confidence            65      99999999999999986532      5999999999999999999999999999999999999999999999


Q ss_pred             EeccCCCCCccccCCCccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhh-c-CCcC------------------
Q 014609          156 SDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIF-R-GDFK------------------  215 (421)
Q Consensus       156 ~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~-~-~~~~------------------  215 (421)
                      +|||++................+|+.|+|||++.+..+ +.++|||||||++|.+ . |..+                  
T Consensus       179 ~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~  257 (323)
T 3qup_A          179 ADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLY-TVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIGGNR  257 (323)
T ss_dssp             CCCCC-----------------CCGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCC
T ss_pred             eeccccccccccccccccccccCcccccCchhhcCCCC-CCccchhhHHHHHHHHHhCCCCCccccChHHHHHHHhcCCC
Confidence            99999986543222222334456788999999988777 5899999999999954 4 3333                  


Q ss_pred             --CCCCCCHHHHHHHHHhcCCCCCCCCC-------HHhhhcCccccccc
Q 014609          216 --LPKWLSPGAQNLLRKILEPNPVKRIT-------IAGIKADEWFEQDY  255 (421)
Q Consensus       216 --~p~~~s~~~~~li~~~L~~dP~~R~t-------~~eil~~~w~~~~~  255 (421)
                        .|+.+++.+.++|.+||+.||.+|||       +++++.|||+....
T Consensus       258 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~~~~~  306 (323)
T 3qup_A          258 LKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLSTS  306 (323)
T ss_dssp             CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC-------
T ss_pred             CCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhhcCCC
Confidence              34557899999999999999999999       88899999998643

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=1.3e-45  Score=354.02  Aligned_cols=238  Identities=27%  Similarity=0.444  Sum_probs=198.4

Q ss_pred             eeecceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEE
Q 014609           11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIY   90 (421)
Q Consensus        11 ~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~   90 (421)
                      ...++|++++.||+|+||.||+|.+..+++.||+|++.....   ...+.+.+|+.+++.++||||+++++++...+..|
T Consensus        16 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   92 (302)
T 2j7t_A           16 DPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSE---EELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLW   92 (302)
T ss_dssp             CGGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEE
T ss_pred             CCccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCH---HHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEE
Confidence            344799999999999999999999999999999999875432   23578899999999999999999999999999999


Q ss_pred             EEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCccccC
Q 014609           91 MVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD  169 (421)
Q Consensus        91 lv~E~~~gg~L~~~i~~-~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~  169 (421)
                      +||||+++++|.+++.. ...+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||++......  
T Consensus        93 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--  170 (302)
T 2j7t_A           93 IMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKT--  170 (302)
T ss_dssp             EEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHH--
T ss_pred             EEEEeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEECCCCCEEEEECCCCcccccc--
Confidence            99999999999998865 567999999999999999999999999999999999999999999999999987532111  


Q ss_pred             CCccccccCCCCccChhhhc-----ccCCCCCcchHHHHHHHHhhh-cCCcCC----------------------CCCCC
Q 014609          170 DGLLHTTCGSPNYVAPEVLA-----NRGYDGATSDIWSCGVILYIF-RGDFKL----------------------PKWLS  221 (421)
Q Consensus       170 ~~~~~~~~gt~~y~APEvl~-----~~~~~~~~~DiwSlGvil~~~-~~~~~~----------------------p~~~s  221 (421)
                      .......+||+.|+|||++.     ...+ +.++|||||||++|.+ .|..++                      |..++
T Consensus       171 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  249 (302)
T 2j7t_A          171 LQKRDSFIGTPYWMAPEVVMCETMKDTPY-DYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTLLTPSKWS  249 (302)
T ss_dssp             HHC-----CCGGGCCHHHHHHHHTTSTTT-TTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSSGGGSC
T ss_pred             ccccccccCChhhcCCeeeccccCCCCCC-chhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhccCCcccCCccccC
Confidence            11223457999999999984     3444 5899999999999944 333221                      33468


Q ss_pred             HHHHHHHHHhcCCCCCCCCCHHhhhcCcccccc
Q 014609          222 PGAQNLLRKILEPNPVKRITIAGIKADEWFEQD  254 (421)
Q Consensus       222 ~~~~~li~~~L~~dP~~R~t~~eil~~~w~~~~  254 (421)
                      ..+.++|.+||+.||.+|||+.++++||||...
T Consensus       250 ~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~  282 (302)
T 2j7t_A          250 VEFRDFLKIALDKNPETRPSAAQLLEHPFVSSI  282 (302)
T ss_dssp             HHHHHHHHHHSCSCTTTSCCHHHHTTSTTTTTC
T ss_pred             HHHHHHHHHHcccChhhCCCHHHHhcChHHhhh
Confidence            899999999999999999999999999999853

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=100.00  E-value=8e-46  Score=359.66  Aligned_cols=241  Identities=33%  Similarity=0.573  Sum_probs=209.1

Q ss_pred             eeecceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccch---hHHHHHHHHHHHHhcCC--CCCcceEEEEEEe
Q 014609           11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHL---KITDQIKREIATLKLLK--HPNVVRLHEVLAS   85 (421)
Q Consensus        11 ~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~---~~~~~~~~Ei~il~~l~--hpnIv~l~~~~~~   85 (421)
                      ...++|++++.||+|+||.||+|.+..+++.||||++........   .....+.+|+.++++++  ||||+++++++..
T Consensus        40 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~  119 (320)
T 3a99_A           40 PLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFER  119 (320)
T ss_dssp             CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEEC
T ss_pred             CccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEec
Confidence            345789999999999999999999999999999999986543321   11245678999999996  5999999999999


Q ss_pred             CCEEEEEEeccCC-CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEec-cCCCEEEEeccCCCC
Q 014609           86 KSKIYMVLEYVTG-GELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLD-SKGNIKISDFGLSAL  163 (421)
Q Consensus        86 ~~~~~lv~E~~~g-g~L~~~i~~~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~-~~~~~kL~DFGla~~  163 (421)
                      .+..++|||++.+ ++|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++ .++.+||+|||++..
T Consensus       120 ~~~~~lv~e~~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~kL~Dfg~~~~  199 (320)
T 3a99_A          120 PDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGAL  199 (320)
T ss_dssp             SSEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred             CCcEEEEEEcCCCCccHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeCCCCCEEEeeCccccc
Confidence            9999999999976 89999999888999999999999999999999999999999999999999 778999999999975


Q ss_pred             CccccCCCccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhh-cCCcC-------------CCCCCCHHHHHHHH
Q 014609          164 PQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIF-RGDFK-------------LPKWLSPGAQNLLR  229 (421)
Q Consensus       164 ~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~-~~~~~-------------~p~~~s~~~~~li~  229 (421)
                      ...    .......||+.|+|||++.+..+.+.++|||||||++|.+ .|..+             ++..+++.+.++|.
T Consensus       200 ~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~li~  275 (320)
T 3a99_A          200 LKD----TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQHLIR  275 (320)
T ss_dssp             CCS----SCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHHHHCCCCCSSCCCHHHHHHHH
T ss_pred             ccc----ccccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhhhhcccccccccCCHHHHHHHH
Confidence            432    2334567999999999998877766889999999999944 34333             34568999999999


Q ss_pred             HhcCCCCCCCCCHHhhhcCccccccc
Q 014609          230 KILEPNPVKRITIAGIKADEWFEQDY  255 (421)
Q Consensus       230 ~~L~~dP~~R~t~~eil~~~w~~~~~  255 (421)
                      +||+.||.+|||+.++++||||+...
T Consensus       276 ~~l~~dp~~Rps~~~ll~hp~~~~~~  301 (320)
T 3a99_A          276 WCLALRPSDRPTFEEIQNHPWMQDVL  301 (320)
T ss_dssp             HHTCSSGGGSCCHHHHHTSGGGSSCC
T ss_pred             HHccCChhhCcCHHHHhcCHhhcCcc
Confidence            99999999999999999999998644

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=1e-44  Score=352.37  Aligned_cols=231  Identities=32%  Similarity=0.485  Sum_probs=198.5

Q ss_pred             eecceEEeceEeecCcEEEEEEEE-CCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCC------CcceEEEEEE
Q 014609           12 RLGRYELGRTLGEGNFGKVKFAQD-LDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP------NVVRLHEVLA   84 (421)
Q Consensus        12 ~~~~y~i~~~LG~G~~g~V~~a~~-~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hp------nIv~l~~~~~   84 (421)
                      ..++|++++.||+|+||+||+|.+ ..+++.||||++...    ....+.+.+|+.+++.++|+      +|+++++++.
T Consensus        12 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~   87 (339)
T 1z57_A           12 LSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV----DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFE   87 (339)
T ss_dssp             ETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS----HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEE
T ss_pred             ccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC----CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccc
Confidence            347999999999999999999998 568999999998643    23356788999999988765      4999999999


Q ss_pred             eCCEEEEEEeccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecc-------------
Q 014609           85 SKSKIYMVLEYVTGGELFDKIASKG--RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDS-------------  149 (421)
Q Consensus        85 ~~~~~~lv~E~~~gg~L~~~i~~~~--~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~-------------  149 (421)
                      ..+..|+||||+ +++|.+++...+  ++++..++.++.||+.||+|||++||+||||||+|||++.             
T Consensus        88 ~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~  166 (339)
T 1z57_A           88 HHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKR  166 (339)
T ss_dssp             ETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEEEC----C
T ss_pred             cCCcEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeccccccccCCcccc
Confidence            999999999999 889999998755  6899999999999999999999999999999999999987             


Q ss_pred             ------CCCEEEEeccCCCCCccccCCCccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhh-hcCCcCCCCC---
Q 014609          150 ------KGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYI-FRGDFKLPKW---  219 (421)
Q Consensus       150 ------~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~-~~~~~~~p~~---  219 (421)
                            ++.+||+|||++.....     .....+||+.|+|||++.+..+ +.++|||||||++|. +.|..+++..   
T Consensus       167 ~~~~~~~~~~kl~Dfg~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~el~~g~~pf~~~~~~  240 (339)
T 1z57_A          167 DERTLINPDIKVVDFGSATYDDE-----HHSTLVSTRHYRAPEVILALGW-SQPCDVWSIGCILIEYYLGFTVFPTHDSK  240 (339)
T ss_dssp             EEEEESCCCEEECCCSSCEETTS-----CCCSSCSCGGGCCHHHHTTSCC-CTHHHHHHHHHHHHHHHHSSCSCCCSCHH
T ss_pred             ccccccCCCceEeeCcccccCcc-----ccccccCCccccChHHhhCCCC-CcchhhHHHHHHHHHHHhCCCCCCCCChH
Confidence                  66899999999975322     2345689999999999988777 589999999999994 4454444321   


Q ss_pred             ------------------------------------------------------------CCHHHHHHHHHhcCCCCCCC
Q 014609          220 ------------------------------------------------------------LSPGAQNLLRKILEPNPVKR  239 (421)
Q Consensus       220 ------------------------------------------------------------~s~~~~~li~~~L~~dP~~R  239 (421)
                                                                                  .++.+.+||.+||+.||.+|
T Consensus       241 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R  320 (339)
T 1z57_A          241 EHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKR  320 (339)
T ss_dssp             HHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTS
T ss_pred             HHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccc
Confidence                                                                        13567899999999999999


Q ss_pred             CCHHhhhcCccccc
Q 014609          240 ITIAGIKADEWFEQ  253 (421)
Q Consensus       240 ~t~~eil~~~w~~~  253 (421)
                      ||+.|+++||||+.
T Consensus       321 pt~~ell~hp~f~~  334 (339)
T 1z57_A          321 ITLREALKHPFFDL  334 (339)
T ss_dssp             CCHHHHTTSGGGGG
T ss_pred             cCHHHHhcCHHHHH
Confidence            99999999999985

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=4.9e-45  Score=348.10  Aligned_cols=239  Identities=41%  Similarity=0.687  Sum_probs=206.9

Q ss_pred             CeeecceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEE
Q 014609           10 GMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKI   89 (421)
Q Consensus        10 ~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~   89 (421)
                      +...++|++++.||+|+||.||+|.+..+++.||+|++....... ...+.+.+|+.++++++||||+++++++...+..
T Consensus        18 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   96 (287)
T 2wei_A           18 GTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKN-KDTSTILREVELLKKLDHPNIMKLFEILEDSSSF   96 (287)
T ss_dssp             HHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSS-SCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred             HHHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccch-HHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeE
Confidence            455689999999999999999999999999999999997654322 2357899999999999999999999999999999


Q ss_pred             EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCC---CEEEEeccCCCCCcc
Q 014609           90 YMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKG---NIKISDFGLSALPQH  166 (421)
Q Consensus        90 ~lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~---~~kL~DFGla~~~~~  166 (421)
                      |+||||+++++|.+.+.....+++..++.++.||+.||+|||++||+||||||+||+++.++   .+||+|||++.....
T Consensus        97 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~  176 (287)
T 2wei_A           97 YIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ  176 (287)
T ss_dssp             EEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCC
T ss_pred             EEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEeccCcceeecC
Confidence            99999999999999998888899999999999999999999999999999999999997654   699999999985433


Q ss_pred             ccCCCccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhh-cCCcCC---------------------C--CCCCH
Q 014609          167 FRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIF-RGDFKL---------------------P--KWLSP  222 (421)
Q Consensus       167 ~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~-~~~~~~---------------------p--~~~s~  222 (421)
                         ........||+.|+|||++.+. + +.++||||||+++|.+ .|..++                     |  ..+++
T Consensus       177 ---~~~~~~~~~~~~y~aPE~~~~~-~-~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  251 (287)
T 2wei_A          177 ---NTKMKDRIGTAYYIAPEVLRGT-Y-DEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISD  251 (287)
T ss_dssp             ---CSSCSCHHHHHTTCCHHHHTTC-C-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGTTSCH
T ss_pred             ---CCccccccCcccccChHHhcCC-C-CCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCchhhhhcCH
Confidence               2233445689999999998754 5 5899999999999943 333221                     1  34789


Q ss_pred             HHHHHHHHhcCCCCCCCCCHHhhhcCcccccc
Q 014609          223 GAQNLLRKILEPNPVKRITIAGIKADEWFEQD  254 (421)
Q Consensus       223 ~~~~li~~~L~~dP~~R~t~~eil~~~w~~~~  254 (421)
                      .+.++|.+||++||.+|||+.++++||||++.
T Consensus       252 ~~~~li~~~l~~dp~~Rps~~ell~hp~~~~~  283 (287)
T 2wei_A          252 DAKDLIRKMLTFHPSLRITATQCLEHPWIQKY  283 (287)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHHHSHHHHHH
T ss_pred             HHHHHHHHHcccChhhCcCHHHHhcCHHHhcc
Confidence            99999999999999999999999999999864

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=4.3e-45  Score=359.90  Aligned_cols=240  Identities=26%  Similarity=0.401  Sum_probs=192.7

Q ss_pred             ecceEEeceEeecCcEEEEEEEECCCCceEEEEEeeccccc--------chhHHHHHHHHHHHHhcCCCCCcceEEEEEE
Q 014609           13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRII--------HLKITDQIKREIATLKLLKHPNVVRLHEVLA   84 (421)
Q Consensus        13 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~--------~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~   84 (421)
                      .++|++++.||+|+||.||+|.+. +|+.||||++......        .....+.+.+|+.++++++||||+++++++.
T Consensus        21 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~   99 (362)
T 3pg1_A           21 QSPYTVQRFISSGSYGAVCAGVDS-EGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFV   99 (362)
T ss_dssp             TCSCEEEEEEEEETTEEEEEEECT-TSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEE
T ss_pred             ccceEEeEEeccCCCEEEEEEECC-CCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeeeEE
Confidence            479999999999999999999975 4999999998653321        2223478999999999999999999999985


Q ss_pred             e-----CCEEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEec
Q 014609           85 S-----KSKIYMVLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDF  158 (421)
Q Consensus        85 ~-----~~~~~lv~E~~~gg~L~~~i~~~-~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DF  158 (421)
                      .     ...+|+||||+. ++|.+.+... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+||
T Consensus       100 ~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Df  178 (362)
T 3pg1_A          100 HFEEPAMHKLYLVTELMR-TDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDF  178 (362)
T ss_dssp             ECCTTTCCEEEEEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCT
T ss_pred             eccCCCcceEEEEEccCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEEcCCCCEEEEec
Confidence            4     347899999997 5888877654 47999999999999999999999999999999999999999999999999


Q ss_pred             cCCCCCccccCCCccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhh-cCCcCCC--------------------
Q 014609          159 GLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIF-RGDFKLP--------------------  217 (421)
Q Consensus       159 Gla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~-~~~~~~p--------------------  217 (421)
                      |++.....   .......+||+.|+|||++.+....+.++|||||||++|.+ .|..++.                    
T Consensus       179 g~~~~~~~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~  255 (362)
T 3pg1_A          179 NLAREDTA---DANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKI  255 (362)
T ss_dssp             TC------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCH
T ss_pred             Cccccccc---ccccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCh
Confidence            99974332   23344568999999999988744446899999999999944 3443332                    


Q ss_pred             -------------------------------CCCCHHHHHHHHHhcCCCCCCCCCHHhhhcCccccccccC
Q 014609          218 -------------------------------KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTP  257 (421)
Q Consensus       218 -------------------------------~~~s~~~~~li~~~L~~dP~~R~t~~eil~~~w~~~~~~~  257 (421)
                                                     +..++.+.+||.+||+.||.+|||+.++++||||+..+.+
T Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~  326 (362)
T 3pg1_A          256 EDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYFESLFDP  326 (362)
T ss_dssp             HHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGTTTCCG
T ss_pred             HHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcCchhhhccCc
Confidence                                           2357889999999999999999999999999999975533

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=9.7e-45  Score=350.17  Aligned_cols=245  Identities=24%  Similarity=0.371  Sum_probs=194.0

Q ss_pred             CcccccccCCeeecceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEE
Q 014609            1 MVIAEKKQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLH   80 (421)
Q Consensus         1 m~~~~~~~~~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~   80 (421)
                      |.-......+..+++|++.+.||+|+||.||+|.+..+++.||+|++...........+.+.+|+.++++++||||++++
T Consensus        21 ~~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~  100 (309)
T 2h34_A           21 MDGTAESREGTQFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIH  100 (309)
T ss_dssp             -------------CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEE
T ss_pred             cccccccCCCcEeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEE
Confidence            33444556788899999999999999999999999999999999999766554555567899999999999999999999


Q ss_pred             EEEEeCCEEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccC
Q 014609           81 EVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGL  160 (421)
Q Consensus        81 ~~~~~~~~~~lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGl  160 (421)
                      +++..++..|+||||++|++|.+++...+.+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||+
T Consensus       101 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~  180 (309)
T 2h34_A          101 DFGEIDGQLYVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADDFAYLVDFGI  180 (309)
T ss_dssp             EEEEETTEEEEEEECCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSCCC
T ss_pred             EEEeeCCeEEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEcCCCCEEEecCcc
Confidence            99999999999999999999999999888899999999999999999999999999999999999999999999999999


Q ss_pred             CCCCccccCCCccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhh-cCCcC----------------------CC
Q 014609          161 SALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIF-RGDFK----------------------LP  217 (421)
Q Consensus       161 a~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~-~~~~~----------------------~p  217 (421)
                      +...... .........||+.|+|||++.+..+ +.++||||||+++|.+ .|..+                      .+
T Consensus       181 ~~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  258 (309)
T 2h34_A          181 ASATTDE-KLTQLGNTVGTLYYMAPERFSESHA-TYRADIYALTCVLYECLTGSPPYQGDQLSVMGAHINQAIPRPSTVR  258 (309)
T ss_dssp             -----------------CCGGGCCGGGTCC-----CCCHHHHHHHHHHHHHHSSCSSCSCHHHHHHHHHHSCCCCGGGTS
T ss_pred             Ccccccc-ccccccccCCCcCccCHHHHcCCCC-CchHhHHHHHHHHHHHHHCCCCCCCchHHHHHHHhccCCCCccccC
Confidence            8754331 1122345679999999999987766 5899999999999944 33333                      23


Q ss_pred             CCCCHHHHHHHHHhcCCCCCCCC-CHHhhhc
Q 014609          218 KWLSPGAQNLLRKILEPNPVKRI-TIAGIKA  247 (421)
Q Consensus       218 ~~~s~~~~~li~~~L~~dP~~R~-t~~eil~  247 (421)
                      +.+|+.+.++|.+||++||.+|| |++++++
T Consensus       259 ~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~  289 (309)
T 2h34_A          259 PGIPVAFDAVIARGMAKNPEDRYVTCGDLSA  289 (309)
T ss_dssp             TTCCTHHHHHHHHHTCSSGGGSCSSHHHHHH
T ss_pred             CCCCHHHHHHHHHhccCCHHHHHHhHHHHHH
Confidence            45789999999999999999999 7777654

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=2.7e-45  Score=360.59  Aligned_cols=235  Identities=27%  Similarity=0.372  Sum_probs=200.0

Q ss_pred             eeecceEEeceEeecCcEEEEEEE-----ECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcC-CCCCcceEEEEEE
Q 014609           11 MRLGRYELGRTLGEGNFGKVKFAQ-----DLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEVLA   84 (421)
Q Consensus        11 ~~~~~y~i~~~LG~G~~g~V~~a~-----~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~   84 (421)
                      ...++|++++.||+|+||.||+|+     +..+++.||||++....  .....+.+.+|+.+++++ +||||+++++++.
T Consensus        19 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~   96 (359)
T 3vhe_A           19 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLGACT   96 (359)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             ccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcC--CHHHHHHHHHHHHHHHhhcCCcceeeeeeeee
Confidence            345899999999999999999998     55678999999997543  233356799999999999 7899999999998


Q ss_pred             eCCE-EEEEEeccCCCChHHHHHhcCC-----------------------------------------------------
Q 014609           85 SKSK-IYMVLEYVTGGELFDKIASKGR-----------------------------------------------------  110 (421)
Q Consensus        85 ~~~~-~~lv~E~~~gg~L~~~i~~~~~-----------------------------------------------------  110 (421)
                      ..+. .|+||||++||+|.+++.....                                                     
T Consensus        97 ~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  176 (359)
T 3vhe_A           97 KPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDV  176 (359)
T ss_dssp             STTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-----------------------------------------------
T ss_pred             cCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccchh
Confidence            7654 8999999999999999976433                                                     


Q ss_pred             -------------CCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCccccCCCcccccc
Q 014609          111 -------------LQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTC  177 (421)
Q Consensus       111 -------------~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~  177 (421)
                                   +++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++................
T Consensus       177 ~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~  256 (359)
T 3vhe_A          177 EEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDAR  256 (359)
T ss_dssp             -------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEEC--CE
T ss_pred             hhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCcEEEEeccceeeecccccchhccccC
Confidence                         8999999999999999999999999999999999999999999999999998654322222344567


Q ss_pred             CCCCccChhhhcccCCCCCcchHHHHHHHHhhhc--CCcCC---------------------CCCCCHHHHHHHHHhcCC
Q 014609          178 GSPNYVAPEVLANRGYDGATSDIWSCGVILYIFR--GDFKL---------------------PKWLSPGAQNLLRKILEP  234 (421)
Q Consensus       178 gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~~--~~~~~---------------------p~~~s~~~~~li~~~L~~  234 (421)
                      ||+.|+|||++.+..+ +.++|||||||++|.+.  |..++                     |..+++++.++|.+||+.
T Consensus       257 ~t~~y~aPE~~~~~~~-~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~  335 (359)
T 3vhe_A          257 LPLKWMAPETIFDRVY-TIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHG  335 (359)
T ss_dssp             ECGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCS
T ss_pred             CCceeEChhhhcCCCC-CchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHccC
Confidence            8999999999988777 58999999999999664  44433                     445789999999999999


Q ss_pred             CCCCCCCHHhhhcC
Q 014609          235 NPVKRITIAGIKAD  248 (421)
Q Consensus       235 dP~~R~t~~eil~~  248 (421)
                      ||.+|||+.++++|
T Consensus       336 dP~~Rps~~ell~~  349 (359)
T 3vhe_A          336 EPSQRPTFSELVEH  349 (359)
T ss_dssp             SGGGSCCHHHHHHH
T ss_pred             ChhhCCCHHHHHHH
Confidence            99999999999876

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.9e-45  Score=354.94  Aligned_cols=242  Identities=33%  Similarity=0.596  Sum_probs=199.4

Q ss_pred             CeeecceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccch---hHHHHHHHHHHHHhcC----CCCCcceEEEE
Q 014609           10 GMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHL---KITDQIKREIATLKLL----KHPNVVRLHEV   82 (421)
Q Consensus        10 ~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~---~~~~~~~~Ei~il~~l----~hpnIv~l~~~   82 (421)
                      ....++|++++.||+|+||.||+|.+..+++.||||++........   .....+.+|+.+++++    +||||++++++
T Consensus        27 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~  106 (312)
T 2iwi_A           27 EAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDW  106 (312)
T ss_dssp             ------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEE
T ss_pred             hhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEE
Confidence            3445789999999999999999999999999999999976543221   1123466799999988    89999999999


Q ss_pred             EEeCCEEEEEEec-cCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEec-cCCCEEEEeccC
Q 014609           83 LASKSKIYMVLEY-VTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLD-SKGNIKISDFGL  160 (421)
Q Consensus        83 ~~~~~~~~lv~E~-~~gg~L~~~i~~~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~-~~~~~kL~DFGl  160 (421)
                      +...+..++|||| +.+++|.+++...+.+++..++.++.||+.||+|||++||+||||||+||+++ .++.+||+|||+
T Consensus       107 ~~~~~~~~~v~e~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~dfg~  186 (312)
T 2iwi_A          107 FETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGS  186 (312)
T ss_dssp             C-----CEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEETTTTEEEECCCSS
T ss_pred             EecCCeEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEeCCCCeEEEEEcch
Confidence            9999999999999 78999999999888899999999999999999999999999999999999999 789999999999


Q ss_pred             CCCCccccCCCccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhh-cCCc-------------CCCCCCCHHHHH
Q 014609          161 SALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIF-RGDF-------------KLPKWLSPGAQN  226 (421)
Q Consensus       161 a~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~-~~~~-------------~~p~~~s~~~~~  226 (421)
                      +.....    .......||+.|+|||++.+..+.+.++|||||||++|.+ .|..             .+|..+++.+.+
T Consensus       187 ~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  262 (312)
T 2iwi_A          187 GALLHD----EPYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQEILEAELHFPAHVSPDCCA  262 (312)
T ss_dssp             CEECCS----SCBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHHHHTCCCCCTTSCHHHHH
T ss_pred             hhhccc----CcccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChHHHhhhccCCcccCCHHHHH
Confidence            875432    2344567999999999998877765689999999999944 3333             345678999999


Q ss_pred             HHHHhcCCCCCCCCCHHhhhcCccccccc
Q 014609          227 LLRKILEPNPVKRITIAGIKADEWFEQDY  255 (421)
Q Consensus       227 li~~~L~~dP~~R~t~~eil~~~w~~~~~  255 (421)
                      +|.+||+.||.+|||+.++++||||+...
T Consensus       263 li~~~l~~~p~~Rps~~e~l~~~~~~~~~  291 (312)
T 2iwi_A          263 LIRRCLAPKPSSRPSLEEILLDPWMQTPA  291 (312)
T ss_dssp             HHHHHTCSSTTTSCCHHHHHHSTTTCC--
T ss_pred             HHHHHccCChhhCcCHHHHhcChhhcCch
Confidence            99999999999999999999999998643

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=1.9e-45  Score=364.13  Aligned_cols=241  Identities=23%  Similarity=0.273  Sum_probs=203.8

Q ss_pred             eeecceEEeceEeecCcEEEEEEE-----ECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEe
Q 014609           11 MRLGRYELGRTLGEGNFGKVKFAQ-----DLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLAS   85 (421)
Q Consensus        11 ~~~~~y~i~~~LG~G~~g~V~~a~-----~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~   85 (421)
                      ...++|++++.||+|+||+||+|.     +..+++.||||+++...  .......+.+|+.++++++||||+++++++..
T Consensus        68 ~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~  145 (367)
T 3l9p_A           68 VPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC--SEQDELDFLMEALIISKFNHQNIVRCIGVSLQ  145 (367)
T ss_dssp             CCGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             cCHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEeccccc--ChhhHHHHHHHHHHHHhCCCCCCCeEEEEEec
Confidence            445789999999999999999999     45678899999986432  23335678899999999999999999999999


Q ss_pred             CCEEEEEEeccCCCChHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCC---CEEE
Q 014609           86 KSKIYMVLEYVTGGELFDKIASKG-------RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKG---NIKI  155 (421)
Q Consensus        86 ~~~~~lv~E~~~gg~L~~~i~~~~-------~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~---~~kL  155 (421)
                      ....|+||||++||+|.+++....       .+++..++.++.||+.||+|||++||+||||||+|||++.+|   .+||
T Consensus       146 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~kL  225 (367)
T 3l9p_A          146 SLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKI  225 (367)
T ss_dssp             SSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEE
T ss_pred             CCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCCCCceEEE
Confidence            999999999999999999997643       589999999999999999999999999999999999999655   4999


Q ss_pred             EeccCCCCCccccCCCccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhhc--CCcC------------------
Q 014609          156 SDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIFR--GDFK------------------  215 (421)
Q Consensus       156 ~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~~--~~~~------------------  215 (421)
                      +|||++................||+.|+|||++.+..+ +.++|||||||++|.+.  |..+                  
T Consensus       226 ~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~-~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~i~~~~~  304 (367)
T 3l9p_A          226 GDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIF-TSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGR  304 (367)
T ss_dssp             CCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCC
T ss_pred             CCCccccccccccccccCCCcCCcccEECHHHhcCCCC-CcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC
Confidence            99999974433222333445678999999999988877 58999999999999654  4333                  


Q ss_pred             --CCCCCCHHHHHHHHHhcCCCCCCCCCHHhhhcCcccccc
Q 014609          216 --LPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD  254 (421)
Q Consensus       216 --~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~~~w~~~~  254 (421)
                        .|..+++.+.++|.+||+.||.+|||+.+++++.|+...
T Consensus       305 ~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~  345 (367)
T 3l9p_A          305 MDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQ  345 (367)
T ss_dssp             CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhh
Confidence              345688999999999999999999999999999987653

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=5.5e-45  Score=348.92  Aligned_cols=235  Identities=26%  Similarity=0.416  Sum_probs=195.8

Q ss_pred             CCeeecceEEeceEeecCcEEEEEEE----ECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEE
Q 014609            9 EGMRLGRYELGRTLGEGNFGKVKFAQ----DLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLA   84 (421)
Q Consensus         9 ~~~~~~~y~i~~~LG~G~~g~V~~a~----~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~   84 (421)
                      .....++|++++.||+|+||+||+|+    +..+++.||||++...   .....+.+.+|+.++++++||||+++++++.
T Consensus         5 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~   81 (295)
T 3ugc_A            5 TQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS---TEEHLRDFEREIEILKSLQHDNIVKYKGVCY   81 (295)
T ss_dssp             -CCCGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCC---CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred             CcCCHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccC---CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe
Confidence            44556899999999999999999998    5678999999998654   2334578999999999999999999999985


Q ss_pred             e--CCEEEEEEeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCC
Q 014609           85 S--KSKIYMVLEYVTGGELFDKIASKG-RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLS  161 (421)
Q Consensus        85 ~--~~~~~lv~E~~~gg~L~~~i~~~~-~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla  161 (421)
                      .  ...+|+||||+++++|.+++.... .+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||++
T Consensus        82 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~  161 (295)
T 3ugc_A           82 SAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLT  161 (295)
T ss_dssp             HHHHTSCEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCSC
T ss_pred             cCCCCceEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEcCCCeEEEccCccc
Confidence            4  356899999999999999997644 5999999999999999999999999999999999999999999999999999


Q ss_pred             CCCccccCC-CccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhhcC----------------------------
Q 014609          162 ALPQHFRDD-GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIFRG----------------------------  212 (421)
Q Consensus       162 ~~~~~~~~~-~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~~~----------------------------  212 (421)
                      ......... .......+++.|+|||++.+..+ +.++||||+|+++|.+..                            
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (295)
T 3ugc_A          162 KVLPQDKEFFKVKEPGESPIFWYAPESLTESKF-SVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFH  240 (295)
T ss_dssp             C-------------CTTCGGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHH
T ss_pred             ccccCCcceeeeccCCCCccceeCcHHhcCCCC-ChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHH
Confidence            865432111 22233457778999999988877 589999999999995432                            


Q ss_pred             ---------CcCCCCCCCHHHHHHHHHhcCCCCCCCCCHHhhhc
Q 014609          213 ---------DFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKA  247 (421)
Q Consensus       213 ---------~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~  247 (421)
                               ..+.|..+++.+.++|.+||+.||.+|||+.++++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~  284 (295)
T 3ugc_A          241 LIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL  284 (295)
T ss_dssp             HHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             HHHHHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence                     23446678999999999999999999999999875

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=1.2e-44  Score=352.28  Aligned_cols=234  Identities=25%  Similarity=0.401  Sum_probs=197.6

Q ss_pred             eeecceEEeceEeecCcEEEEEEEECCCCc---eEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCC
Q 014609           11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGL---PFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKS   87 (421)
Q Consensus        11 ~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~---~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~   87 (421)
                      ...++|++.+.||+|+||+||+|.+..+++   .||||++....  .....+.+.+|+.++++++||||+++++++.+.+
T Consensus        46 ~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~  123 (325)
T 3kul_A           46 IEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGY--TERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGR  123 (325)
T ss_dssp             CCGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGG
T ss_pred             cChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCC--CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCC
Confidence            445799999999999999999999986655   49999997543  2334577999999999999999999999999999


Q ss_pred             EEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCcc
Q 014609           88 KIYMVLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQH  166 (421)
Q Consensus        88 ~~~lv~E~~~gg~L~~~i~~~-~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~  166 (421)
                      ..|+||||++|++|.+++... ..+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||++.....
T Consensus       124 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~  203 (325)
T 3kul_A          124 LAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLED  203 (325)
T ss_dssp             CCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCSSCEECC-
T ss_pred             ccEEEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEECCCCCEEECCCCccccccc
Confidence            999999999999999999754 5799999999999999999999999999999999999999999999999999986543


Q ss_pred             ccCCC-ccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhhc--CCcC--------------------CCCCCCHH
Q 014609          167 FRDDG-LLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIFR--GDFK--------------------LPKWLSPG  223 (421)
Q Consensus       167 ~~~~~-~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~~--~~~~--------------------~p~~~s~~  223 (421)
                      ..... ......+|+.|+|||++.+..+ +.++|||||||++|.+.  |..+                    .|..+++.
T Consensus       204 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~-~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  282 (325)
T 3kul_A          204 DPDAAYTTTGGKIPIRWTAPEAIAFRTF-SSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGYRLPAPMGCPHA  282 (325)
T ss_dssp             ---CCEECC---CCGGGSCHHHHHHCEE-CHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCCCCTTCCHH
T ss_pred             CccceeeccCCCCcccccCHhHhcCCCC-CcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCCCCCCCCcCHH
Confidence            21111 1223356778999999987777 58999999999999543  4433                    34558899


Q ss_pred             HHHHHHHhcCCCCCCCCCHHhhhc
Q 014609          224 AQNLLRKILEPNPVKRITIAGIKA  247 (421)
Q Consensus       224 ~~~li~~~L~~dP~~R~t~~eil~  247 (421)
                      +.++|.+||+.||.+|||+.++++
T Consensus       283 l~~li~~~l~~dp~~Rps~~eil~  306 (325)
T 3kul_A          283 LHQLMLDCWHKDRAQRPRFSQIVS  306 (325)
T ss_dssp             HHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHHccCChhhCcCHHHHHH
Confidence            999999999999999999999876

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=2.9e-44  Score=348.32  Aligned_cols=236  Identities=32%  Similarity=0.455  Sum_probs=198.1

Q ss_pred             ecceEEeceEeecCcEEEEEEEEC-CCCceEEEEEeecccccchhHHHHHHHHHHHHhcC---CCCCcceEEEEEE----
Q 014609           13 LGRYELGRTLGEGNFGKVKFAQDL-DSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL---KHPNVVRLHEVLA----   84 (421)
Q Consensus        13 ~~~y~i~~~LG~G~~g~V~~a~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l---~hpnIv~l~~~~~----   84 (421)
                      .++|++++.||+|+||.||+|++. .+|+.||+|++....... .....+.+|+.+++.+   +||||+++++++.    
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~   88 (326)
T 1blx_A           10 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEE-GMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT   88 (326)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTT-SCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred             hhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccc-cCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence            379999999999999999999996 678999999997543221 1123466777777766   8999999999987    


Q ss_pred             -eCCEEEEEEeccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCC
Q 014609           85 -SKSKIYMVLEYVTGGELFDKIASKG--RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLS  161 (421)
Q Consensus        85 -~~~~~~lv~E~~~gg~L~~~i~~~~--~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla  161 (421)
                       .....|+||||+. ++|.+++....  .+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||++
T Consensus        89 ~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~~~~~~kl~Dfg~~  167 (326)
T 1blx_A           89 DRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLA  167 (326)
T ss_dssp             SSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCSC
T ss_pred             CCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEEcCCCCEEEecCccc
Confidence             5577999999997 59999987643  4999999999999999999999999999999999999999999999999999


Q ss_pred             CCCccccCCCccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhhc-CCcCC------------------------
Q 014609          162 ALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIFR-GDFKL------------------------  216 (421)
Q Consensus       162 ~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~~-~~~~~------------------------  216 (421)
                      ......   ......+||+.|+|||++.+..+ +.++|||||||++|.+. |..++                        
T Consensus       168 ~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  243 (326)
T 1blx_A          168 RIYSFQ---MALTSVVVTLWYRAPEVLLQSSY-ATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDW  243 (326)
T ss_dssp             CCCCGG---GGGCCCCCCCTTCCHHHHTTCCC-CTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGS
T ss_pred             ccccCC---CCccccccccceeCHHHHhcCCC-CcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCcccC
Confidence            865432   23345689999999999988777 58999999999999442 32221                        


Q ss_pred             ----------------------CCCCCHHHHHHHHHhcCCCCCCCCCHHhhhcCcccccc
Q 014609          217 ----------------------PKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD  254 (421)
Q Consensus       217 ----------------------p~~~s~~~~~li~~~L~~dP~~R~t~~eil~~~w~~~~  254 (421)
                                            +..+++.+.+||.+||+.||.+|||+.++++||||+..
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~  303 (326)
T 1blx_A          244 PRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDL  303 (326)
T ss_dssp             CTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTC
T ss_pred             ccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcCcccccc
Confidence                                  23478889999999999999999999999999999753

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=100.00  E-value=1.6e-44  Score=354.98  Aligned_cols=233  Identities=31%  Similarity=0.431  Sum_probs=196.5

Q ss_pred             ecceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCE----
Q 014609           13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSK----   88 (421)
Q Consensus        13 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~----   88 (421)
                      -++|.+.+.||+|+||.||+|.+..+|+.||||++.... ........+.+|+.+++.++||||+++++++.....    
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  101 (353)
T 3coi_A           23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPF-QSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNF  101 (353)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTT-SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGC
T ss_pred             CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccc-cchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccc
Confidence            378999999999999999999999999999999997643 233445788999999999999999999999987654    


Q ss_pred             --EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCcc
Q 014609           89 --IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQH  166 (421)
Q Consensus        89 --~~lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~  166 (421)
                        +|+||||+. ++|.+.+.  ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.....
T Consensus       102 ~~~~lv~e~~~-~~l~~~~~--~~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~  178 (353)
T 3coi_A          102 YDFYLVMPFMQ-TDLQKIMG--LKFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADA  178 (353)
T ss_dssp             CCCEEEEECCS-EEGGGTTT--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTCCEEECSTTCTTC---
T ss_pred             eeEEEEecccc-CCHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeECCCCcEEEeecccccCCCC
Confidence              599999996 58877764  3599999999999999999999999999999999999999999999999999985432


Q ss_pred             ccCCCccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhh-cCCcCC-----------------------------
Q 014609          167 FRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIF-RGDFKL-----------------------------  216 (421)
Q Consensus       167 ~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~-~~~~~~-----------------------------  216 (421)
                           .....+||+.|+|||++.+....+.++|||||||++|.+ .|..++                             
T Consensus       179 -----~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  253 (353)
T 3coi_A          179 -----EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLND  253 (353)
T ss_dssp             ----------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTTCSC
T ss_pred             -----CccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHHhh
Confidence                 234567899999999987744446899999999999944 333222                             


Q ss_pred             ---------------------CCCCCHHHHHHHHHhcCCCCCCCCCHHhhhcCcccccc
Q 014609          217 ---------------------PKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD  254 (421)
Q Consensus       217 ---------------------p~~~s~~~~~li~~~L~~dP~~R~t~~eil~~~w~~~~  254 (421)
                                           ++.+++.+.+||.+||+.||.+|||+.++++||||+..
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~  312 (353)
T 3coi_A          254 KAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPF  312 (353)
T ss_dssp             HHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTT
T ss_pred             HHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhc
Confidence                                 13468999999999999999999999999999999853

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=2.5e-44  Score=343.64  Aligned_cols=235  Identities=30%  Similarity=0.492  Sum_probs=197.7

Q ss_pred             cceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEE
Q 014609           14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVL   93 (421)
Q Consensus        14 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~   93 (421)
                      ++|.....||+|+||.||+|.+..+++.||||++....   ....+.+.+|+.+++.++||||+++++++...+..++||
T Consensus        22 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   98 (295)
T 2clq_A           22 DENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERD---SRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFM   98 (295)
T ss_dssp             CTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCC---C---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             cCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCc---hHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEE
Confidence            33444459999999999999999999999999997643   233577899999999999999999999999999999999


Q ss_pred             eccCCCChHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecc-CCCEEEEeccCCCCCccccC
Q 014609           94 EYVTGGELFDKIASK---GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDS-KGNIKISDFGLSALPQHFRD  169 (421)
Q Consensus        94 E~~~gg~L~~~i~~~---~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~-~~~~kL~DFGla~~~~~~~~  169 (421)
                      ||+++++|.+++...   ..+++..++.++.|++.||+|||++||+||||||+||+++. ++.+||+|||++......  
T Consensus        99 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~--  176 (295)
T 2clq_A           99 EQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGI--  176 (295)
T ss_dssp             ECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC---
T ss_pred             EeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEECCCCCEEEeecccccccCCC--
Confidence            999999999998764   24678999999999999999999999999999999999987 899999999999754321  


Q ss_pred             CCccccccCCCCccChhhhcccC--CCCCcchHHHHHHHHhhh-cCCc----------------------CCCCCCCHHH
Q 014609          170 DGLLHTTCGSPNYVAPEVLANRG--YDGATSDIWSCGVILYIF-RGDF----------------------KLPKWLSPGA  224 (421)
Q Consensus       170 ~~~~~~~~gt~~y~APEvl~~~~--~~~~~~DiwSlGvil~~~-~~~~----------------------~~p~~~s~~~  224 (421)
                      ........||+.|+|||++.+..  + +.++||||||+++|.+ .|..                      .+|..+++.+
T Consensus       177 ~~~~~~~~~~~~y~aPE~~~~~~~~~-~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  255 (295)
T 2clq_A          177 NPCTETFTGTLQYMAPEIIDKGPRGY-GKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEIPESMSAEA  255 (295)
T ss_dssp             ----CCCCCCGGGCCHHHHHHGGGGC-SHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHHHCCCCCCCTTSCHHH
T ss_pred             CCcccccCCCccccChhhhcCCCCCC-CcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhccccccccccccCCHHH
Confidence            22234567999999999987643  4 5889999999999943 2322                      3355689999


Q ss_pred             HHHHHHhcCCCCCCCCCHHhhhcCcccccc
Q 014609          225 QNLLRKILEPNPVKRITIAGIKADEWFEQD  254 (421)
Q Consensus       225 ~~li~~~L~~dP~~R~t~~eil~~~w~~~~  254 (421)
                      .++|.+||+.||.+|||+.++++||||+..
T Consensus       256 ~~li~~~l~~dp~~Rps~~~ll~~~~~~~~  285 (295)
T 2clq_A          256 KAFILKCFEPDPDKRACANDLLVDEFLKVS  285 (295)
T ss_dssp             HHHHHHTTCSSTTTSCCHHHHHTSGGGCC-
T ss_pred             HHHHHHHccCChhhCCCHHHHhcChhhhhc
Confidence            999999999999999999999999999854

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=1e-44  Score=349.46  Aligned_cols=236  Identities=29%  Similarity=0.378  Sum_probs=200.8

Q ss_pred             CeeecceEEeceEeecCcEEEEEEEEC-----CCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEE
Q 014609           10 GMRLGRYELGRTLGEGNFGKVKFAQDL-----DSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLA   84 (421)
Q Consensus        10 ~~~~~~y~i~~~LG~G~~g~V~~a~~~-----~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~   84 (421)
                      ....++|++++.||+|+||.||+|.+.     .+++.||+|++....  .....+.+.+|+.++++++||||+++++++.
T Consensus        19 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~   96 (314)
T 2ivs_A           19 EFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENA--SPSELRDLLSEFNVLKQVNHPHVIKLYGACS   96 (314)
T ss_dssp             BCCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC
T ss_pred             ccchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCC--CHHHHHHHHHHHHHHhhCCCCceeeEEEEEe
Confidence            345579999999999999999999883     456899999997543  3344678999999999999999999999999


Q ss_pred             eCCEEEEEEeccCCCChHHHHHhcCC------------------------CCHHHHHHHHHHHHHHHHHHHhCCceeccC
Q 014609           85 SKSKIYMVLEYVTGGELFDKIASKGR------------------------LQEAEGRKLFQQLIDGVSYCHNKGVFHRDL  140 (421)
Q Consensus        85 ~~~~~~lv~E~~~gg~L~~~i~~~~~------------------------~~~~~~~~~~~ql~~aL~~LH~~gi~HrDl  140 (421)
                      +.+..|+||||++|++|.+++.....                        +++..++.++.||+.||+|||++||+||||
T Consensus        97 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~di  176 (314)
T 2ivs_A           97 QDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDL  176 (314)
T ss_dssp             SSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTTEECCCC
T ss_pred             cCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCCCccccc
Confidence            99999999999999999999986443                        899999999999999999999999999999


Q ss_pred             CCCCEEeccCCCEEEEeccCCCCCccccCCCccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhhc--CCcC---
Q 014609          141 KLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIFR--GDFK---  215 (421)
Q Consensus       141 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~~--~~~~---  215 (421)
                      ||+|||++.++.+||+|||++................+|+.|+|||++.+..+ +.++|||||||++|.+.  |..+   
T Consensus       177 kp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~el~t~g~~p~~~  255 (314)
T 2ivs_A          177 AARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIY-TTQSDVWSFGVLLWEIVTLGGNPYPG  255 (314)
T ss_dssp             SGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEE-CHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred             chheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCc-CchhhHHHHHHHHHHHHhCCCCCCCC
Confidence            99999999999999999999975433211112334467889999999987776 58999999999999554  4333   


Q ss_pred             -----------------CCCCCCHHHHHHHHHhcCCCCCCCCCHHhhhcC
Q 014609          216 -----------------LPKWLSPGAQNLLRKILEPNPVKRITIAGIKAD  248 (421)
Q Consensus       216 -----------------~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~~  248 (421)
                                       .|..+++.+.++|.+||+.||.+|||+.+++++
T Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~  305 (314)
T 2ivs_A          256 IPPERLFNLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKD  305 (314)
T ss_dssp             CCGGGHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCHHHHHHHhhcCCcCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence                             344578999999999999999999999999865

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=3.4e-44  Score=356.86  Aligned_cols=237  Identities=27%  Similarity=0.437  Sum_probs=203.1

Q ss_pred             CeeecceEEeceEeecCcEEEEEEEECC-------CCceEEEEEeecccccchhHHHHHHHHHHHHhcC-CCCCcceEEE
Q 014609           10 GMRLGRYELGRTLGEGNFGKVKFAQDLD-------SGLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHE   81 (421)
Q Consensus        10 ~~~~~~y~i~~~LG~G~~g~V~~a~~~~-------~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~   81 (421)
                      ....++|++++.||+|+||+||+|++..       .+..||||++....  .......+.+|+++++++ +||||+++++
T Consensus        65 ~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hpnIv~~~~  142 (382)
T 3tt0_A           65 ELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA--TEKDLSDLISEMEMMKMIGKHKNIINLLG  142 (382)
T ss_dssp             BCCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred             ccchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeecccc--CHHHHHHHHHHHHHHHHhcCCchhhhhee
Confidence            3455899999999999999999999754       33579999997543  333457899999999999 8999999999


Q ss_pred             EEEeCCEEEEEEeccCCCChHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCE
Q 014609           82 VLASKSKIYMVLEYVTGGELFDKIASKG----------------RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENI  145 (421)
Q Consensus        82 ~~~~~~~~~lv~E~~~gg~L~~~i~~~~----------------~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NI  145 (421)
                      ++...+..|+||||+++++|.+++....                .+++..++.++.||+.||+|||++||+||||||+||
T Consensus       143 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NI  222 (382)
T 3tt0_A          143 ACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNV  222 (382)
T ss_dssp             EECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGE
T ss_pred             eeccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecCCCCcceE
Confidence            9999999999999999999999998643                499999999999999999999999999999999999


Q ss_pred             EeccCCCEEEEeccCCCCCccccCCCccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhhc--CCcCC-------
Q 014609          146 LLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIFR--GDFKL-------  216 (421)
Q Consensus       146 Ll~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~~--~~~~~-------  216 (421)
                      |++.++.+||+|||++................+|+.|+|||++.+..+ +.++|||||||++|.+.  |..++       
T Consensus       223 ll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~-~~~~DiwslG~il~ellt~g~~p~~~~~~~~  301 (382)
T 3tt0_A          223 LVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIY-THQSDVWSFGVLLWEIFTLGGSPYPGVPVEE  301 (382)
T ss_dssp             EECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCC-CHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH
T ss_pred             EEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCC-CchhHHHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence            999999999999999986544332233445567889999999988777 58999999999999553  44333       


Q ss_pred             -------------CCCCCHHHHHHHHHhcCCCCCCCCCHHhhhcCc
Q 014609          217 -------------PKWLSPGAQNLLRKILEPNPVKRITIAGIKADE  249 (421)
Q Consensus       217 -------------p~~~s~~~~~li~~~L~~dP~~R~t~~eil~~~  249 (421)
                                   |..+++.+.++|.+||+.||.+|||+.+++++-
T Consensus       302 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L  347 (382)
T 3tt0_A          302 LFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDL  347 (382)
T ss_dssp             HHHHHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             HHHHHHcCCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence                         445789999999999999999999999998863

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=9e-45  Score=345.96  Aligned_cols=229  Identities=21%  Similarity=0.287  Sum_probs=198.3

Q ss_pred             eeecceEEeceEeecCcEEEEEEEECCCC-------ceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEE
Q 014609           11 MRLGRYELGRTLGEGNFGKVKFAQDLDSG-------LPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVL   83 (421)
Q Consensus        11 ~~~~~y~i~~~LG~G~~g~V~~a~~~~~~-------~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~   83 (421)
                      ...++|++.+.||+|+||+||+|.+..++       ..||+|++....   ....+.+.+|+.++++++||||+++++++
T Consensus         5 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~   81 (289)
T 4fvq_A            5 IRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAH---RNYSESFFEAASMMSKLSHKHLVLNYGVC   81 (289)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGG---GGGHHHHHHHHHHHHTSCCTTBCCEEEEE
T ss_pred             echhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhccccc---HHHHHHHHHHHHHHHhCCCCCEeEEEEEE
Confidence            45689999999999999999999988777       469999986543   23457899999999999999999999999


Q ss_pred             EeCCEEEEEEeccCCCChHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCC--------EE
Q 014609           84 ASKSKIYMVLEYVTGGELFDKIASKGR-LQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGN--------IK  154 (421)
Q Consensus        84 ~~~~~~~lv~E~~~gg~L~~~i~~~~~-~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~--------~k  154 (421)
                      .+++..|+||||++|++|.+++..... +++..++.++.||+.||+|||++||+||||||+|||++.++.        +|
T Consensus        82 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~k  161 (289)
T 4fvq_A           82 VCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIK  161 (289)
T ss_dssp             CCTTCCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECCBGGGTBCCEEE
T ss_pred             EeCCCCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecCCcccccccceee
Confidence            999999999999999999999987554 999999999999999999999999999999999999999887        99


Q ss_pred             EEeccCCCCCccccCCCccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhhcC-C-------------------c
Q 014609          155 ISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIFRG-D-------------------F  214 (421)
Q Consensus       155 L~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~~~-~-------------------~  214 (421)
                      |+|||++.....      .....||+.|+|||++.+....+.++|||||||++|.+.. .                   .
T Consensus       162 l~Dfg~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~~~~~~  235 (289)
T 4fvq_A          162 LSDPGISITVLP------KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYEDRH  235 (289)
T ss_dssp             ECCCCSCTTTSC------HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTC
T ss_pred             eccCcccccccC------ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHHHhhccC
Confidence            999999874322      2345689999999999873434689999999999996543 2                   2


Q ss_pred             CCCCCCCHHHHHHHHHhcCCCCCCCCCHHhhhcC
Q 014609          215 KLPKWLSPGAQNLLRKILEPNPVKRITIAGIKAD  248 (421)
Q Consensus       215 ~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~~  248 (421)
                      ..|...++.+.++|.+||+.||.+|||+.+++++
T Consensus       236 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  269 (289)
T 4fvq_A          236 QLPAPKAAELANLINNCMDYEPDHRPSFRAIIRD  269 (289)
T ss_dssp             CCCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred             CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            2345568889999999999999999999999875

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=100.00  E-value=3.5e-44  Score=346.43  Aligned_cols=240  Identities=26%  Similarity=0.428  Sum_probs=196.1

Q ss_pred             cceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCC--CCCcceEEEEEEeCCEEEE
Q 014609           14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK--HPNVVRLHEVLASKSKIYM   91 (421)
Q Consensus        14 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~--hpnIv~l~~~~~~~~~~~l   91 (421)
                      ++|++++.||+|+||.||+|.+. +++.||||++..... .....+.+.+|+.++++++  ||||+++++++......|+
T Consensus        28 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~l  105 (313)
T 3cek_A           28 RIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEA-DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYM  105 (313)
T ss_dssp             EEEEEEEEEECCSSEEEEEEECT-TCCEEEEEEEECSSC-CHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEEE
T ss_pred             ceEEEEEEecCCCCEEEEEEEcC-CCcEEEEEEeccccc-cccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEEEE
Confidence            57999999999999999999974 589999999976543 2334678999999999997  5999999999999999999


Q ss_pred             EEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCccccCCC
Q 014609           92 VLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDG  171 (421)
Q Consensus        92 v~E~~~gg~L~~~i~~~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~  171 (421)
                      ||| +.+++|.+++.....+++..++.++.|++.||+|||++||+||||||+|||++ ++.+||+|||++..........
T Consensus       106 v~e-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~-~~~~kL~Dfg~~~~~~~~~~~~  183 (313)
T 3cek_A          106 VME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSV  183 (313)
T ss_dssp             EEC-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSCC--------
T ss_pred             EEe-cCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEE-CCeEEEeeccccccccCccccc
Confidence            999 55889999999888999999999999999999999999999999999999996 5899999999998654332222


Q ss_pred             ccccccCCCCccChhhhccc----------CCCCCcchHHHHHHHHhhh-cCCc----------------------CCCC
Q 014609          172 LLHTTCGSPNYVAPEVLANR----------GYDGATSDIWSCGVILYIF-RGDF----------------------KLPK  218 (421)
Q Consensus       172 ~~~~~~gt~~y~APEvl~~~----------~~~~~~~DiwSlGvil~~~-~~~~----------------------~~p~  218 (421)
                      .....+||+.|+|||++.+.          ...+.++|||||||++|.+ .|..                      .+|.
T Consensus       184 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  263 (313)
T 3cek_A          184 VKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPD  263 (313)
T ss_dssp             ------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTSCCCCCC
T ss_pred             cccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHHHHHHhcccccCCcc
Confidence            33456899999999998651          2235789999999999943 3332                      2345


Q ss_pred             CCCHHHHHHHHHhcCCCCCCCCCHHhhhcCccccccccC
Q 014609          219 WLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTP  257 (421)
Q Consensus       219 ~~s~~~~~li~~~L~~dP~~R~t~~eil~~~w~~~~~~~  257 (421)
                      ..++.+.++|.+||+.||.+|||+.++++||||+....+
T Consensus       264 ~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~~~~~~~~  302 (313)
T 3cek_A          264 IPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHP  302 (313)
T ss_dssp             CSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHCC---
T ss_pred             cchHHHHHHHHHHccCCcccCcCHHHHhcCccccCCCCc
Confidence            568899999999999999999999999999999875544

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=100.00  E-value=2.1e-44  Score=352.25  Aligned_cols=234  Identities=31%  Similarity=0.552  Sum_probs=178.0

Q ss_pred             CeeecceEEec-eEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEe---
Q 014609           10 GMRLGRYELGR-TLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLAS---   85 (421)
Q Consensus        10 ~~~~~~y~i~~-~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~---   85 (421)
                      ....++|++.+ .||+|+||+||+|.+..+|+.||||++....       ....+....++.++||||+++++++..   
T Consensus        24 ~~~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~   96 (336)
T 3fhr_A           24 YAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP-------KARQEVDHHWQASGGPHIVCILDVYENMHH   96 (336)
T ss_dssp             SCGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSH-------HHHHHHHHHHHHTTSTTBCCEEEEEEEEET
T ss_pred             ccccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcH-------HHHHHHHHHHHhcCCCChHHHHHHHhhccC
Confidence            34558999965 6999999999999999999999999986531       122223344677799999999999976   


Q ss_pred             -CCEEEEEEeccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccC---CCEEEEecc
Q 014609           86 -KSKIYMVLEYVTGGELFDKIASKG--RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSK---GNIKISDFG  159 (421)
Q Consensus        86 -~~~~~lv~E~~~gg~L~~~i~~~~--~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~---~~~kL~DFG  159 (421)
                       ....|+||||++||+|.+++....  .+++..++.++.||+.||+|||++||+||||||+|||++.+   +.+||+|||
T Consensus        97 ~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg  176 (336)
T 3fhr_A           97 GKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFG  176 (336)
T ss_dssp             TEEEEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCT
T ss_pred             CCceEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCceEEEeccc
Confidence             456899999999999999998653  69999999999999999999999999999999999999864   459999999


Q ss_pred             CCCCCccccCCCccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhh-cCCcCC----------------------
Q 014609          160 LSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIF-RGDFKL----------------------  216 (421)
Q Consensus       160 la~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~-~~~~~~----------------------  216 (421)
                      ++....    .......+||+.|+|||++.+..+ +.++|||||||++|.+ .|..++                      
T Consensus       177 ~~~~~~----~~~~~~~~~t~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  251 (336)
T 3fhr_A          177 FAKETT----QNALQTPCYTPYYVAPEVLGPEKY-DKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYG  251 (336)
T ss_dssp             TCEEC--------------------------CHH-HHHHHHHHHHHHHHHHHHSSCCC---------------------C
T ss_pred             cceecc----ccccccCCCCcCccChhhhCCCCC-CchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhccccc
Confidence            997433    223456689999999999877766 4889999999999944 333222                      


Q ss_pred             -C----CCCCHHHHHHHHHhcCCCCCCCCCHHhhhcCccccccc
Q 014609          217 -P----KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY  255 (421)
Q Consensus       217 -p----~~~s~~~~~li~~~L~~dP~~R~t~~eil~~~w~~~~~  255 (421)
                       |    ..+++.+.+||.+||+.||.+|||+.++++||||+...
T Consensus       252 ~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~  295 (336)
T 3fhr_A          252 FPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQSM  295 (336)
T ss_dssp             CCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTGG
T ss_pred             cCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccccc
Confidence             1    24789999999999999999999999999999998643

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=100.00  E-value=2e-44  Score=355.90  Aligned_cols=233  Identities=27%  Similarity=0.486  Sum_probs=197.7

Q ss_pred             eecceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCC-----------CCCcceEE
Q 014609           12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK-----------HPNVVRLH   80 (421)
Q Consensus        12 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~-----------hpnIv~l~   80 (421)
                      ..++|++++.||+|+||+||+|.+..+++.||||++....    ...+.+.+|+.++++++           ||||++++
T Consensus        17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~   92 (373)
T 1q8y_A           17 KDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK----VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLL   92 (373)
T ss_dssp             TTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH----HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCC
T ss_pred             cCCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCc----cchhhhhHHHHHHHHhhcccccchhccccchHHHHH
Confidence            3479999999999999999999999999999999997532    23467889999999886           89999999


Q ss_pred             EEEEeCC----EEEEEEeccCCCChHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhC-CceeccCCCCCEEecc----
Q 014609           81 EVLASKS----KIYMVLEYVTGGELFDKIAS--KGRLQEAEGRKLFQQLIDGVSYCHNK-GVFHRDLKLENILLDS----  149 (421)
Q Consensus        81 ~~~~~~~----~~~lv~E~~~gg~L~~~i~~--~~~~~~~~~~~~~~ql~~aL~~LH~~-gi~HrDlkp~NILl~~----  149 (421)
                      +++...+    .+++||||+ +++|.+++..  ...+++..++.++.||+.||+|||++ ||+||||||+|||++.    
T Consensus        93 ~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~~~~~~  171 (373)
T 1q8y_A           93 DHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSP  171 (373)
T ss_dssp             EEEEEEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETT
T ss_pred             HHhhccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEeccCCC
Confidence            9998654    789999999 8999999876  34599999999999999999999998 9999999999999954    


Q ss_pred             --CCCEEEEeccCCCCCccccCCCccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhh-cCCcCCCC--------
Q 014609          150 --KGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIF-RGDFKLPK--------  218 (421)
Q Consensus       150 --~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~-~~~~~~p~--------  218 (421)
                        .+.+||+|||++.....     .....+||+.|+|||++.+..+ +.++|||||||++|.+ .|..++..        
T Consensus       172 ~~~~~~kl~Dfg~a~~~~~-----~~~~~~~t~~y~aPE~~~~~~~-~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~  245 (373)
T 1q8y_A          172 ENLIQIKIADLGNACWYDE-----HYTNSIQTREYRSPEVLLGAPW-GCGADIWSTACLIFELITGDFLFEPDEGHSYTK  245 (373)
T ss_dssp             TTEEEEEECCCTTCEETTB-----CCCSCCSCGGGCCHHHHHTCCC-CTHHHHHHHHHHHHHHHHSSCCC---------C
T ss_pred             cCcceEEEcccccccccCC-----CCCCCCCCccccCcHHHhCCCC-CchHhHHHHHHHHHHHHhCCCCCCCCcccccCC
Confidence              34799999999975432     2344589999999999988877 5899999999999944 45444321        


Q ss_pred             -----------------------------------------------------------CCCHHHHHHHHHhcCCCCCCC
Q 014609          219 -----------------------------------------------------------WLSPGAQNLLRKILEPNPVKR  239 (421)
Q Consensus       219 -----------------------------------------------------------~~s~~~~~li~~~L~~dP~~R  239 (421)
                                                                                 ..++.+.+||.+||+.||.+|
T Consensus       246 ~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R  325 (373)
T 1q8y_A          246 DDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKR  325 (373)
T ss_dssp             HHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTC
T ss_pred             hHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCcccc
Confidence                                                                       124577899999999999999


Q ss_pred             CCHHhhhcCccccccc
Q 014609          240 ITIAGIKADEWFEQDY  255 (421)
Q Consensus       240 ~t~~eil~~~w~~~~~  255 (421)
                      ||+.|+++||||++..
T Consensus       326 pt~~ell~hp~f~~~~  341 (373)
T 1q8y_A          326 ADAGGLVNHPWLKDTL  341 (373)
T ss_dssp             BCHHHHHTCGGGTTCT
T ss_pred             CCHHHHhhChhhhccc
Confidence            9999999999998644

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=2.9e-44  Score=339.37  Aligned_cols=231  Identities=23%  Similarity=0.391  Sum_probs=198.4

Q ss_pred             eeecceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEE
Q 014609           11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIY   90 (421)
Q Consensus        11 ~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~   90 (421)
                      ...++|++.+.||+|+||.||+|.+. +++.||+|++......    .+.+.+|+.++++++||||+++++++.+.+..|
T Consensus         7 i~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   81 (269)
T 4hcu_A            7 IDPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMS----EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPIC   81 (269)
T ss_dssp             CCGGGEEEEEEEEECSSCEEEEEEET-TTEEEEEEEECTTSBC----HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred             eChhhceeeheecCCCccEEEEEEec-CCCeEEEEEecccccC----HHHHHHHHHHHHhCCCCCEeeEEEEEecCCceE
Confidence            34579999999999999999999986 5778999999765432    367899999999999999999999999999999


Q ss_pred             EEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCccccC
Q 014609           91 MVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD  169 (421)
Q Consensus        91 lv~E~~~gg~L~~~i~~-~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~  169 (421)
                      +||||+++++|.+++.. ...+++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||++....... 
T Consensus        82 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~-  160 (269)
T 4hcu_A           82 LVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ-  160 (269)
T ss_dssp             EEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHH-
T ss_pred             EEEEeCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEEcCCCCEEeccccccccccccc-
Confidence            99999999999999975 3468999999999999999999999999999999999999999999999999997543211 


Q ss_pred             CCccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhhc--CCcCC--------------------CCCCCHHHHHH
Q 014609          170 DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIFR--GDFKL--------------------PKWLSPGAQNL  227 (421)
Q Consensus       170 ~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~~--~~~~~--------------------p~~~s~~~~~l  227 (421)
                      ........+|+.|+|||++.+..+ +.++||||+|+++|.+.  |..++                    |...++.+.++
T Consensus       161 ~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  239 (269)
T 4hcu_A          161 YTSSTGTKFPVKWASPEVFSFSRY-SSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQI  239 (269)
T ss_dssp             HHSTTSTTCCGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTSCHHHHHH
T ss_pred             cccccCcccccccCCHHHhcCCCC-CchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcCccCCCCCcCCHHHHHH
Confidence            112233456778999999988777 58999999999999653  44332                    44578999999


Q ss_pred             HHHhcCCCCCCCCCHHhhhcC
Q 014609          228 LRKILEPNPVKRITIAGIKAD  248 (421)
Q Consensus       228 i~~~L~~dP~~R~t~~eil~~  248 (421)
                      +.+||+.||.+|||+.+++++
T Consensus       240 i~~~l~~~p~~Rps~~~ll~~  260 (269)
T 4hcu_A          240 MNHCWRERPEDRPAFSRLLRQ  260 (269)
T ss_dssp             HHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHccCCcccCcCHHHHHHH
Confidence            999999999999999999875

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=100.00  E-value=9.3e-44  Score=348.09  Aligned_cols=232  Identities=28%  Similarity=0.456  Sum_probs=196.9

Q ss_pred             eecceEEeceEeecCcEEEEEEEECCCC-ceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCC------cceEEEEEE
Q 014609           12 RLGRYELGRTLGEGNFGKVKFAQDLDSG-LPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN------VVRLHEVLA   84 (421)
Q Consensus        12 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~-~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpn------Iv~l~~~~~   84 (421)
                      .-++|++++.||+|+||+||+|.+..++ +.||+|+++..    ....+.+.+|+.+++.++|++      ++.+++++.
T Consensus        17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~   92 (355)
T 2eu9_A           17 LQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV----GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFN   92 (355)
T ss_dssp             ETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC----HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEE
T ss_pred             ecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc----ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeee
Confidence            3479999999999999999999998776 79999999643    233567889999999997665      999999999


Q ss_pred             eCCEEEEEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEe---------------
Q 014609           85 SKSKIYMVLEYVTGGELFDKIASK--GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILL---------------  147 (421)
Q Consensus        85 ~~~~~~lv~E~~~gg~L~~~i~~~--~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl---------------  147 (421)
                      ..+..|+||||+ +++|.+.+...  .++++..++.++.||+.||+|||++||+||||||+|||+               
T Consensus        93 ~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~~  171 (355)
T 2eu9_A           93 FHGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSC  171 (355)
T ss_dssp             ETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEEEEECCC-CC
T ss_pred             eCCeEEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecccccccccccccc
Confidence            999999999999 67787877654  369999999999999999999999999999999999999               


Q ss_pred             ----ccCCCEEEEeccCCCCCccccCCCccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhh-cCCcCCCCC---
Q 014609          148 ----DSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIF-RGDFKLPKW---  219 (421)
Q Consensus       148 ----~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~-~~~~~~p~~---  219 (421)
                          +.++.+||+|||++.....     .....+||+.|+|||++.+..+ +.++|||||||++|.+ .|..++...   
T Consensus       172 ~~~~~~~~~~kl~Dfg~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~el~~g~~pf~~~~~~  245 (355)
T 2eu9_A          172 EEKSVKNTSIRVADFGSATFDHE-----HHTTIVATRHYRPPEVILELGW-AQPCDVWSIGCILFEYYRGFTLFQTHENR  245 (355)
T ss_dssp             CEEEESCCCEEECCCTTCEETTS-----CCCSSCSCGGGCCHHHHTTCCC-CTHHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred             cccccCCCcEEEeecCccccccc-----cccCCcCCCcccCCeeeecCCC-CCccchHHHHHHHHHHHhCCCCCCCCCHH
Confidence                6678999999999975322     2345689999999999988777 5899999999999944 444443221   


Q ss_pred             ------------------------------------------------------------CCHHHHHHHHHhcCCCCCCC
Q 014609          220 ------------------------------------------------------------LSPGAQNLLRKILEPNPVKR  239 (421)
Q Consensus       220 ------------------------------------------------------------~s~~~~~li~~~L~~dP~~R  239 (421)
                                                                                  .++.+.+||.+||+.||.+|
T Consensus       246 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R  325 (355)
T 2eu9_A          246 EHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQR  325 (355)
T ss_dssp             HHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTS
T ss_pred             HHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhC
Confidence                                                                        12367899999999999999


Q ss_pred             CCHHhhhcCcccccc
Q 014609          240 ITIAGIKADEWFEQD  254 (421)
Q Consensus       240 ~t~~eil~~~w~~~~  254 (421)
                      ||+.|+++||||...
T Consensus       326 pt~~e~l~hp~f~~~  340 (355)
T 2eu9_A          326 ITLAEALLHPFFAGL  340 (355)
T ss_dssp             CCHHHHTTSGGGGGC
T ss_pred             cCHHHHhcChhhcCC
Confidence            999999999999863

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=1.6e-43  Score=341.11  Aligned_cols=236  Identities=28%  Similarity=0.482  Sum_probs=193.7

Q ss_pred             CeeecceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEE
Q 014609           10 GMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKI   89 (421)
Q Consensus        10 ~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~   89 (421)
                      ...+++|++.+.||+|+||.||+|.+..+|+.||||++.............+.+|+.++++++||||+++++++...+..
T Consensus        28 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~  107 (310)
T 2wqm_A           28 YNTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNEL  107 (310)
T ss_dssp             TSSGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEE
T ss_pred             cccccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcE
Confidence            45678999999999999999999999999999999999865555555567899999999999999999999999999999


Q ss_pred             EEEEeccCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCc
Q 014609           90 YMVLEYVTGGELFDKIAS----KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQ  165 (421)
Q Consensus        90 ~lv~E~~~gg~L~~~i~~----~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~  165 (421)
                      |+||||+++++|.+++..    ...+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||++....
T Consensus       108 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~  187 (310)
T 2wqm_A          108 NIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFS  187 (310)
T ss_dssp             EEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCC-------
T ss_pred             EEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEEcCCCCEEEEeccceeeec
Confidence            999999999999998864    4569999999999999999999999999999999999999999999999999987543


Q ss_pred             cccCCCccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhh-cCCcCC-----------------------CCCCC
Q 014609          166 HFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIF-RGDFKL-----------------------PKWLS  221 (421)
Q Consensus       166 ~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~-~~~~~~-----------------------p~~~s  221 (421)
                      .  .........||+.|+|||++.+..+ +.++||||||+++|.+ .|..++                       +..++
T Consensus       188 ~--~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  264 (310)
T 2wqm_A          188 S--KTTAAHSLVGTPYYMSPERIHENGY-NFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYS  264 (310)
T ss_dssp             -------------CCSSCCHHHHTTCCC-CHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHTTCSCCCCTTTSC
T ss_pred             C--CCccccccCCCeeEeChHHhCCCCC-CchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhcccCCCCcccccC
Confidence            3  1223345679999999999988777 5899999999999944 332222                       13478


Q ss_pred             HHHHHHHHHhcCCCCCCCCCHHhhhcC
Q 014609          222 PGAQNLLRKILEPNPVKRITIAGIKAD  248 (421)
Q Consensus       222 ~~~~~li~~~L~~dP~~R~t~~eil~~  248 (421)
                      +.+.++|.+||+.||.+|||+.+++++
T Consensus       265 ~~l~~li~~~l~~dp~~Rps~~~il~~  291 (310)
T 2wqm_A          265 EELRQLVNMCINPDPEKRPDVTYVYDV  291 (310)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence            999999999999999999999999864

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=4.6e-44  Score=343.19  Aligned_cols=233  Identities=27%  Similarity=0.408  Sum_probs=196.6

Q ss_pred             eecceEEeceEeecCcEEEEEEE----ECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeC-
Q 014609           12 RLGRYELGRTLGEGNFGKVKFAQ----DLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASK-   86 (421)
Q Consensus        12 ~~~~y~i~~~LG~G~~g~V~~a~----~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~-   86 (421)
                      .-.+|++++.||+|+||.||+|+    +..+++.||+|++.....  ....+.+.+|+.+++.++||||+++++++... 
T Consensus        19 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~   96 (302)
T 4e5w_A           19 EKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESG--GNHIADLKKEIEILRNLYHENIVKYKGICTEDG   96 (302)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-------CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC--
T ss_pred             hhhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEeccccc--chhHHHHHHHHHHHHhCCCCCeeeeeeEEecCC
Confidence            34679999999999999999998    567899999999975432  22357899999999999999999999999877 


Q ss_pred             -CEEEEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCC
Q 014609           87 -SKIYMVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALP  164 (421)
Q Consensus        87 -~~~~lv~E~~~gg~L~~~i~~-~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~  164 (421)
                       ..+|+||||+++++|.+++.. ...+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||++...
T Consensus        97 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~  176 (302)
T 4e5w_A           97 GNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAI  176 (302)
T ss_dssp             -CCEEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred             CceEEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEcCCCCEEECcccccccc
Confidence             678999999999999999954 457999999999999999999999999999999999999999999999999999755


Q ss_pred             ccccCC-CccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhhcC-------------------------------
Q 014609          165 QHFRDD-GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIFRG-------------------------------  212 (421)
Q Consensus       165 ~~~~~~-~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~~~-------------------------------  212 (421)
                      ...... .......||+.|+|||++.+..+ +.++||||+||++|.+..                               
T Consensus       177 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  255 (302)
T 4e5w_A          177 ETDKEYYTVKDDRDSPVFWYAPECLMQSKF-YIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNT  255 (302)
T ss_dssp             CTTCCEEECCCCTTCCGGGCCHHHHHHCEE-EHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHHHH
T ss_pred             cCCCcceeccCCCCCCccccCCeeecCCCC-CcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHHHH
Confidence            432110 22344568888999999988777 488999999999995533                               


Q ss_pred             -----CcCCCCCCCHHHHHHHHHhcCCCCCCCCCHHhhhc
Q 014609          213 -----DFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKA  247 (421)
Q Consensus       213 -----~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~  247 (421)
                           ..+.|..+++.+.++|.+||+.||.+|||+.++++
T Consensus       256 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  295 (302)
T 4e5w_A          256 LKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIE  295 (302)
T ss_dssp             HHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHH
T ss_pred             HhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHH
Confidence                 12345678999999999999999999999999875

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.5e-44  Score=351.75  Aligned_cols=238  Identities=25%  Similarity=0.350  Sum_probs=200.5

Q ss_pred             eeecceEEeceEeecCcEEEEEEEE-----CCCCceEEEEEeecccccchhHHHHHHHHHHHHhcC-CCCCcceEEEEEE
Q 014609           11 MRLGRYELGRTLGEGNFGKVKFAQD-----LDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEVLA   84 (421)
Q Consensus        11 ~~~~~y~i~~~LG~G~~g~V~~a~~-----~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~   84 (421)
                      ...++|++++.||+|+||.||+|.+     ..+++.||+|++....  .....+.+.+|+.+++++ +||||+++++++.
T Consensus        42 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~  119 (344)
T 1rjb_A           42 FPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA--DSSEREALMSELKMMTQLGSHENIVNLLGACT  119 (344)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC--------CHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             cCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEeccccc--CHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEe
Confidence            3457999999999999999999997     3467789999997543  222346799999999999 8999999999999


Q ss_pred             eCCEEEEEEeccCCCChHHHHHhcC-----------------------CCCHHHHHHHHHHHHHHHHHHHhCCceeccCC
Q 014609           85 SKSKIYMVLEYVTGGELFDKIASKG-----------------------RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLK  141 (421)
Q Consensus        85 ~~~~~~lv~E~~~gg~L~~~i~~~~-----------------------~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlk  141 (421)
                      ..+..|+||||++||+|.+++....                       .+++..++.++.||+.||+|||++||+|||||
T Consensus       120 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dik  199 (344)
T 1rjb_A          120 LSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLA  199 (344)
T ss_dssp             SSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCS
T ss_pred             eCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCC
Confidence            9999999999999999999997643                       37999999999999999999999999999999


Q ss_pred             CCCEEeccCCCEEEEeccCCCCCccccCCCccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhhc--CCcCC---
Q 014609          142 LENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIFR--GDFKL---  216 (421)
Q Consensus       142 p~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~~--~~~~~---  216 (421)
                      |+|||++.++.+||+|||++................||+.|+|||++.+..+ +.++|||||||++|.+.  |..++   
T Consensus       200 p~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~-~~~~Di~slG~il~el~t~g~~p~~~~  278 (344)
T 1rjb_A          200 ARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIY-TIKSDVWSYGILLWEIFSLGVNPYPGI  278 (344)
T ss_dssp             GGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHTTTSCCSSTTC
T ss_pred             hhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCC-ChhHhHHHHHHHHHHHHcCCCCCcccC
Confidence            9999999999999999999986543222223344567889999999988777 58999999999999664  43332   


Q ss_pred             ------------------CCCCCHHHHHHHHHhcCCCCCCCCCHHhhhcCccc
Q 014609          217 ------------------PKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWF  251 (421)
Q Consensus       217 ------------------p~~~s~~~~~li~~~L~~dP~~R~t~~eil~~~w~  251 (421)
                                        |..+++.+.++|.+||+.||.+|||+.+++++..-
T Consensus       279 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~  331 (344)
T 1rjb_A          279 PVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGC  331 (344)
T ss_dssp             CCSHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             CcHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHH
Confidence                              44578999999999999999999999999987653

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=100.00  E-value=1.3e-43  Score=352.60  Aligned_cols=233  Identities=28%  Similarity=0.411  Sum_probs=196.4

Q ss_pred             eeecceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCC-CC-----CcceEEEEEE
Q 014609           11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK-HP-----NVVRLHEVLA   84 (421)
Q Consensus        11 ~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hp-----nIv~l~~~~~   84 (421)
                      ...++|++.+.||+|+||+||+|.+..+++.||||++....    .....+.+|+.+++.++ |+     +|+++++++.
T Consensus        51 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~  126 (382)
T 2vx3_A           51 KWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKK----AFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFM  126 (382)
T ss_dssp             EETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSH----HHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEE
T ss_pred             EeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccH----HHHHHHHHHHHHHHHHHhcccccceeEEEeeeeec
Confidence            44589999999999999999999999999999999997432    33567888999998885 55     4999999999


Q ss_pred             eCCEEEEEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH--hCCceeccCCCCCEEec--cCCCEEEEec
Q 014609           85 SKSKIYMVLEYVTGGELFDKIASK--GRLQEAEGRKLFQQLIDGVSYCH--NKGVFHRDLKLENILLD--SKGNIKISDF  158 (421)
Q Consensus        85 ~~~~~~lv~E~~~gg~L~~~i~~~--~~~~~~~~~~~~~ql~~aL~~LH--~~gi~HrDlkp~NILl~--~~~~~kL~DF  158 (421)
                      ..+..|+||||+. ++|.+.+...  ..+++..++.++.|++.||.|||  +.||+||||||+|||++  .++.+||+||
T Consensus       127 ~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~kL~DF  205 (382)
T 2vx3_A          127 FRNHLCLVFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDF  205 (382)
T ss_dssp             ETTEEEEEEECCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEEECCC
T ss_pred             cCCceEEEEecCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEEEEec
Confidence            9999999999995 5999998764  46999999999999999999999  46999999999999995  4678999999


Q ss_pred             cCCCCCccccCCCccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhh-cCCcCCCCC------------------
Q 014609          159 GLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIF-RGDFKLPKW------------------  219 (421)
Q Consensus       159 Gla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~-~~~~~~p~~------------------  219 (421)
                      |++.....     .....+||+.|+|||++.+..+ +.++|||||||++|.+ .|..++...                  
T Consensus       206 G~a~~~~~-----~~~~~~~t~~y~aPE~~~~~~~-~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~  279 (382)
T 2vx3_A          206 GSSCQLGQ-----RIYQYIQSRFYRSPEVLLGMPY-DLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPA  279 (382)
T ss_dssp             TTCEETTC-----CCCSSCSCGGGCCHHHHTTCCC-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCH
T ss_pred             cCceeccc-----ccccccCCccccChHHHcCCCC-CcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCH
Confidence            99975422     2345689999999999988877 5899999999999943 343333210                  


Q ss_pred             ---------------C--------------------------------------------------CHHHHHHHHHhcCC
Q 014609          220 ---------------L--------------------------------------------------SPGAQNLLRKILEP  234 (421)
Q Consensus       220 ---------------~--------------------------------------------------s~~~~~li~~~L~~  234 (421)
                                     +                                                  ++.+.+||.+||+.
T Consensus       280 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~  359 (382)
T 2vx3_A          280 HILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDY  359 (382)
T ss_dssp             HHHTTCTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHHHTCS
T ss_pred             HHHHhhHHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHHHhcCC
Confidence                           0                                                  03678999999999


Q ss_pred             CCCCCCCHHhhhcCcccccc
Q 014609          235 NPVKRITIAGIKADEWFEQD  254 (421)
Q Consensus       235 dP~~R~t~~eil~~~w~~~~  254 (421)
                      ||.+|||+.|+++||||++.
T Consensus       360 dP~~Rpta~e~L~hp~f~~~  379 (382)
T 2vx3_A          360 DPKTRIQPYYALQHSFFKKT  379 (382)
T ss_dssp             CTTTSCCHHHHTTSGGGCC-
T ss_pred             ChhhCCCHHHHhcCcccccC
Confidence            99999999999999999864

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=2.1e-44  Score=351.71  Aligned_cols=235  Identities=27%  Similarity=0.362  Sum_probs=200.6

Q ss_pred             CeeecceEEeceEeecCcEEEEEEEEC-----CCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEE
Q 014609           10 GMRLGRYELGRTLGEGNFGKVKFAQDL-----DSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLA   84 (421)
Q Consensus        10 ~~~~~~y~i~~~LG~G~~g~V~~a~~~-----~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~   84 (421)
                      ....++|++++.||+|+||.||+|++.     .+++.||||++....  .....+.+.+|+.++++++||||+++++++.
T Consensus        43 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~  120 (343)
T 1luf_A           43 EYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALMAEFDNPNIVKLLGVCA  120 (343)
T ss_dssp             BCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred             EecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEecccc--CHHHHHHHHHHHHHHHhCCCCCEEEEEEEEc
Confidence            345589999999999999999999986     456899999997543  2334678999999999999999999999999


Q ss_pred             eCCEEEEEEeccCCCChHHHHHhc------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccC
Q 014609           85 SKSKIYMVLEYVTGGELFDKIASK------------------------GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDL  140 (421)
Q Consensus        85 ~~~~~~lv~E~~~gg~L~~~i~~~------------------------~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDl  140 (421)
                      +.+..|+||||+++++|.+++...                        ..+++..++.++.||+.||+|||++||+||||
T Consensus       121 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dl  200 (343)
T 1luf_A          121 VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDL  200 (343)
T ss_dssp             SSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCC
T ss_pred             cCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCC
Confidence            999999999999999999999763                        56899999999999999999999999999999


Q ss_pred             CCCCEEeccCCCEEEEeccCCCCCccccCCCccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhhc--CCc----
Q 014609          141 KLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIFR--GDF----  214 (421)
Q Consensus       141 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~~--~~~----  214 (421)
                      ||+|||++.++.+||+|||++................+|+.|+|||++.+..+ +.++|||||||++|.+.  |..    
T Consensus       201 kp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~-~~~~Di~slG~il~el~t~g~~p~~~  279 (343)
T 1luf_A          201 ATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRY-TTESDVWAYGVVLWEIFSYGLQPYYG  279 (343)
T ss_dssp             SGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTTCCTTTT
T ss_pred             CcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCc-CcccccHHHHHHHHHHHhcCCCcCCC
Confidence            99999999999999999999875433222223345578899999999988777 58999999999999554  332    


Q ss_pred             ----------------CCCCCCCHHHHHHHHHhcCCCCCCCCCHHhhhc
Q 014609          215 ----------------KLPKWLSPGAQNLLRKILEPNPVKRITIAGIKA  247 (421)
Q Consensus       215 ----------------~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~  247 (421)
                                      ..|..+++.+.++|.+||+.||.+|||+.++++
T Consensus       280 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~  328 (343)
T 1luf_A          280 MAHEEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHR  328 (343)
T ss_dssp             SCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CChHHHHHHHhCCCcCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence                            235568899999999999999999999999875

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=1.1e-44  Score=359.72  Aligned_cols=233  Identities=28%  Similarity=0.394  Sum_probs=197.5

Q ss_pred             eecceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEE
Q 014609           12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYM   91 (421)
Q Consensus        12 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l   91 (421)
                      ..++|++++.||+|+||.||+|.+..+++.||||+++...  .....+.+.+|+.+|++++||||+++++++...+..|+
T Consensus       112 ~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l  189 (377)
T 3cbl_A          112 NHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETL--PPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYI  189 (377)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTS--CHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred             chHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccC--CHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEE
Confidence            3478999999999999999999999899999999987542  23334678899999999999999999999999999999


Q ss_pred             EEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCccccCC
Q 014609           92 VLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD  170 (421)
Q Consensus        92 v~E~~~gg~L~~~i~~~-~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~  170 (421)
                      ||||++||+|.+++... ..+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||++.........
T Consensus       190 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~~~  269 (377)
T 3cbl_A          190 VMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYA  269 (377)
T ss_dssp             EEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEECTTSEEE
T ss_pred             EEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEEcCCCcEEECcCCCceecCCCcee
Confidence            99999999999999764 36999999999999999999999999999999999999999999999999998743221101


Q ss_pred             CccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhhc--CCc--------------------CCCCCCCHHHHHHH
Q 014609          171 GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIFR--GDF--------------------KLPKWLSPGAQNLL  228 (421)
Q Consensus       171 ~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~~--~~~--------------------~~p~~~s~~~~~li  228 (421)
                      .......+++.|+|||++....+ +.++|||||||++|++.  |..                    +.|..+++.+.++|
T Consensus       270 ~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li  348 (377)
T 3cbl_A          270 ASGGLRQVPVKWTAPEALNYGRY-SSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGGRLPCPELCPDAVFRLM  348 (377)
T ss_dssp             CCSSCCEEEGGGSCHHHHHHCEE-EHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHHHTTCCCCCCTTCCHHHHHHH
T ss_pred             ecCCCCCCCcCcCCHhHhccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHH
Confidence            11112234678999999987776 58999999999999543  333                    33556889999999


Q ss_pred             HHhcCCCCCCCCCHHhhhc
Q 014609          229 RKILEPNPVKRITIAGIKA  247 (421)
Q Consensus       229 ~~~L~~dP~~R~t~~eil~  247 (421)
                      .+||+.||.+|||+.++++
T Consensus       349 ~~cl~~dP~~Rps~~~i~~  367 (377)
T 3cbl_A          349 EQCWAYEPGQRPSFSTIYQ  367 (377)
T ss_dssp             HHHTCSSGGGSCCHHHHHH
T ss_pred             HHHcCCCchhCcCHHHHHH
Confidence            9999999999999999875

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=1.8e-43  Score=338.22  Aligned_cols=232  Identities=19%  Similarity=0.237  Sum_probs=199.3

Q ss_pred             CeeecceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcC-CCCCcceEEEEEEeCCE
Q 014609           10 GMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEVLASKSK   88 (421)
Q Consensus        10 ~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~   88 (421)
                      ...-++|++++.||+|+||.||+|.+..+|+.||||++.....     .+.+.+|+.+++.+ +|||++++++++.....
T Consensus         6 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~   80 (298)
T 1csn_A            6 NVVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD-----APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLH   80 (298)
T ss_dssp             CEETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT-----SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTE
T ss_pred             cccccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCc-----cHHHHHHHHHHHHHhcCCCCCeEEeecCCCce
Confidence            3445789999999999999999999999999999999875432     24578899999999 79999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCC-----EEEEeccCCC
Q 014609           89 IYMVLEYVTGGELFDKIASKG-RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGN-----IKISDFGLSA  162 (421)
Q Consensus        89 ~~lv~E~~~gg~L~~~i~~~~-~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~-----~kL~DFGla~  162 (421)
                      .|+||||+ |++|.+++...+ ++++..++.++.|++.||+|||++||+||||||+|||++.++.     +||+|||++.
T Consensus        81 ~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~  159 (298)
T 1csn_A           81 NVLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK  159 (298)
T ss_dssp             EEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCE
T ss_pred             eEEEEEec-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEEEEECcccc
Confidence            99999999 999999998644 5999999999999999999999999999999999999988776     9999999998


Q ss_pred             CCccccCC-----CccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhh-cCCcCCCC------------------
Q 014609          163 LPQHFRDD-----GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIF-RGDFKLPK------------------  218 (421)
Q Consensus       163 ~~~~~~~~-----~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~-~~~~~~p~------------------  218 (421)
                      ........     ......+||+.|+|||++.+..+ +.++|||||||++|.+ .|..++..                  
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~  238 (298)
T 1csn_A          160 FYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQ-SRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQ  238 (298)
T ss_dssp             ESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCC-CHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHH
T ss_pred             ccccccccccccccCccCCCCCcccCCchhhcCCCC-ChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhcc
Confidence            65432211     12355689999999999988777 5899999999999944 45544432                  


Q ss_pred             ---------CCCHHHHHHHHHhcCCCCCCCCCHHhhhcC
Q 014609          219 ---------WLSPGAQNLLRKILEPNPVKRITIAGIKAD  248 (421)
Q Consensus       219 ---------~~s~~~~~li~~~L~~dP~~R~t~~eil~~  248 (421)
                               .+++.+.++|.+||+.||.+|||+.++++.
T Consensus       239 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~  277 (298)
T 1csn_A          239 STPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGL  277 (298)
T ss_dssp             HSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHH
T ss_pred             CccHHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence                     468899999999999999999999998763

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=4.6e-44  Score=339.68  Aligned_cols=230  Identities=27%  Similarity=0.439  Sum_probs=201.5

Q ss_pred             cceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEe--------
Q 014609           14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLAS--------   85 (421)
Q Consensus        14 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~--------   85 (421)
                      ++|++++.||+|+||.||+|.+..+|+.||+|++....       +.+.+|+.++++++||||+++++++..        
T Consensus        11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   83 (284)
T 2a19_B           11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN-------EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETS   83 (284)
T ss_dssp             HHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS-------GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC----
T ss_pred             cccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc-------HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccc
Confidence            68999999999999999999999999999999997542       356789999999999999999999864        


Q ss_pred             --------CCEEEEEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEE
Q 014609           86 --------KSKIYMVLEYVTGGELFDKIASK--GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKI  155 (421)
Q Consensus        86 --------~~~~~lv~E~~~gg~L~~~i~~~--~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL  155 (421)
                              ...+|+||||+++++|.+++...  ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||
T Consensus        84 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl  163 (284)
T 2a19_B           84 SKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKI  163 (284)
T ss_dssp             -----CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEE
T ss_pred             cccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEEcCCCCEEE
Confidence                    45689999999999999999753  57999999999999999999999999999999999999999999999


Q ss_pred             EeccCCCCCccccCCCccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhhcCC----------------cCCCCC
Q 014609          156 SDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIFRGD----------------FKLPKW  219 (421)
Q Consensus       156 ~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~~~~----------------~~~p~~  219 (421)
                      +|||++.....   ........||+.|+|||++.+..+ +.++||||||+++|.+...                ..++..
T Consensus       164 ~Dfg~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~~~~  239 (284)
T 2a19_B          164 GDFGLVTSLKN---DGKRTRSKGTLRYMSPEQISSQDY-GKEVDLYALGLILAELLHVCDTAFETSKFFTDLRDGIISDI  239 (284)
T ss_dssp             CCCTTCEESSC---CSCCCCCCSCCTTSCHHHHHCSCC-CTHHHHHHHHHHHHHHHSCCSSHHHHHHHHHHHHTTCCCTT
T ss_pred             Ccchhheeccc---cccccccCCcccccChhhhccCCC-cchhhhHHHHHHHHHHHhcCCcchhHHHHHHHhhccccccc
Confidence            99999875433   223345679999999999988777 5899999999999955422                124566


Q ss_pred             CCHHHHHHHHHhcCCCCCCCCCHHhhhcCcccccc
Q 014609          220 LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD  254 (421)
Q Consensus       220 ~s~~~~~li~~~L~~dP~~R~t~~eil~~~w~~~~  254 (421)
                      +++.+.++|.+||+.||.+|||+.+++++.|..+.
T Consensus       240 ~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~  274 (284)
T 2a19_B          240 FDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKK  274 (284)
T ss_dssp             SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC
T ss_pred             CCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhh
Confidence            89999999999999999999999999999987653

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=7e-44  Score=336.30  Aligned_cols=232  Identities=25%  Similarity=0.415  Sum_probs=198.3

Q ss_pred             eeecceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEE
Q 014609           11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIY   90 (421)
Q Consensus        11 ~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~   90 (421)
                      ...++|++++.||+|+||.||+|.+. ++..||+|++......    .+.+.+|+.++++++||||+++++++.+....|
T Consensus         5 l~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   79 (268)
T 3sxs_A            5 LKREEITLLKELGSGQFGVVKLGKWK-GQYDVAVKMIKEGSMS----EDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIY   79 (268)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECBTTBC----HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEE
T ss_pred             echhheeeeeeeccCCCceEEEEEec-CceeEEEEEeccCCCc----HHHHHHHHHHHHhCCCCCEeeEEEEEccCCceE
Confidence            45689999999999999999999875 6778999999765432    367899999999999999999999999999999


Q ss_pred             EEEeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCccccC
Q 014609           91 MVLEYVTGGELFDKIASKG-RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD  169 (421)
Q Consensus        91 lv~E~~~gg~L~~~i~~~~-~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~  169 (421)
                      +||||+++++|.+++...+ .+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||++....... 
T Consensus        80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~-  158 (268)
T 3sxs_A           80 IVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQ-  158 (268)
T ss_dssp             EEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEECTTCCEEECCTTCEEECCTTC-
T ss_pred             EEEEccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEECCCCCEEEccCccceecchhh-
Confidence            9999999999999997654 59999999999999999999999999999999999999999999999999997543211 


Q ss_pred             CCccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhhc--CCcCC--------------------CCCCCHHHHHH
Q 014609          170 DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIFR--GDFKL--------------------PKWLSPGAQNL  227 (421)
Q Consensus       170 ~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~~--~~~~~--------------------p~~~s~~~~~l  227 (421)
                      ........+|+.|+|||++.+..+ +.++||||+|+++|.+.  |..++                    |...++.+.++
T Consensus       159 ~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  237 (268)
T 3sxs_A          159 YVSSVGTKFPVKWSAPEVFHYFKY-SSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHRLYRPHLASDTIYQI  237 (268)
T ss_dssp             EEECCSCCCCGGGCCHHHHHHSEE-ETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCCCTTSCHHHHHH
T ss_pred             hhcccCCCcCcccCCHHHHhccCC-chhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHHcCCCCCCCCcChHHHHHH
Confidence            111223446678999999988777 58999999999999653  44433                    34478999999


Q ss_pred             HHHhcCCCCCCCCCHHhhhcCc
Q 014609          228 LRKILEPNPVKRITIAGIKADE  249 (421)
Q Consensus       228 i~~~L~~dP~~R~t~~eil~~~  249 (421)
                      |.+||+.||.+|||+.+++++-
T Consensus       238 i~~~l~~~p~~Rps~~~ll~~L  259 (268)
T 3sxs_A          238 MYSCWHELPEKRPTFQQLLSSI  259 (268)
T ss_dssp             HHHTTCSSGGGSCCHHHHHHHH
T ss_pred             HHHHcCCChhhCcCHHHHHHHH
Confidence            9999999999999999998763

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=3.9e-44  Score=345.19  Aligned_cols=235  Identities=28%  Similarity=0.419  Sum_probs=201.7

Q ss_pred             eeecceEEeceEeecCcEEEEEEEE-----CCCCceEEEEEeecccccchhHHHHHHHHHHHHhcC-CCCCcceEEEEEE
Q 014609           11 MRLGRYELGRTLGEGNFGKVKFAQD-----LDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEVLA   84 (421)
Q Consensus        11 ~~~~~y~i~~~LG~G~~g~V~~a~~-----~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~   84 (421)
                      ...++|++++.||+|+||.||+|.+     ..+++.||+|++....  .....+.+.+|+.+++++ +||||+++++++.
T Consensus        20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~   97 (313)
T 1t46_A           20 FPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA--HLTEREALMSELKVLSYLGNHMNIVNLLGACT   97 (313)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             cChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcch--hHHHHHHHHHHHHHHhhcccCCCeeeEEEEEe
Confidence            3457999999999999999999985     4578899999997543  223457899999999999 8999999999999


Q ss_pred             eCCEEEEEEeccCCCChHHHHHhcC------------------CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEE
Q 014609           85 SKSKIYMVLEYVTGGELFDKIASKG------------------RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENIL  146 (421)
Q Consensus        85 ~~~~~~lv~E~~~gg~L~~~i~~~~------------------~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NIL  146 (421)
                      ..+..|+||||+++++|.+++....                  .+++..++.++.||+.||+|||++||+||||||+|||
T Consensus        98 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil  177 (313)
T 1t46_A           98 IGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNIL  177 (313)
T ss_dssp             SSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEE
T ss_pred             cCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEE
Confidence            9999999999999999999997643                  4899999999999999999999999999999999999


Q ss_pred             eccCCCEEEEeccCCCCCccccCCCccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhhc--CCcCC--------
Q 014609          147 LDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIFR--GDFKL--------  216 (421)
Q Consensus       147 l~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~~--~~~~~--------  216 (421)
                      ++.++.+||+|||++................||+.|+|||++.+..+ +.++|||||||++|.+.  |..++        
T Consensus       178 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~ellt~g~~p~~~~~~~~~  256 (313)
T 1t46_A          178 LTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVY-TFESDVWSYGIFLWELFSLGSSPYPGMPVDSK  256 (313)
T ss_dssp             EETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHH
T ss_pred             EcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCC-ChHHHHHHHHHHHHHHHhCCCCCCCcccchhH
Confidence            99999999999999986544322222334567889999999988777 58999999999999654  44333        


Q ss_pred             -------------CCCCCHHHHHHHHHhcCCCCCCCCCHHhhhcC
Q 014609          217 -------------PKWLSPGAQNLLRKILEPNPVKRITIAGIKAD  248 (421)
Q Consensus       217 -------------p~~~s~~~~~li~~~L~~dP~~R~t~~eil~~  248 (421)
                                   |..+++.+.++|.+||++||.+|||+.+++++
T Consensus       257 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  301 (313)
T 1t46_A          257 FYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQL  301 (313)
T ss_dssp             HHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHhccCCCCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHH
Confidence                         34578999999999999999999999999874

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=100.00  E-value=9e-44  Score=345.64  Aligned_cols=239  Identities=24%  Similarity=0.358  Sum_probs=182.7

Q ss_pred             CeeecceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHH-HHhcCCCCCcceEEEEEEeCCE
Q 014609           10 GMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIA-TLKLLKHPNVVRLHEVLASKSK   88 (421)
Q Consensus        10 ~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~-il~~l~hpnIv~l~~~~~~~~~   88 (421)
                      ....++|++++.||+|+||.||+|.+..+|+.||||++.....  ......+.+|+. +++.++||||+++++++...+.
T Consensus        18 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~   95 (327)
T 3aln_A           18 DFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVD--EKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGD   95 (327)
T ss_dssp             CCCSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCC--HHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSE
T ss_pred             ccCHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccC--chHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCc
Confidence            4556899999999999999999999999999999999976432  222345556665 7788899999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhC-CceeccCCCCCEEeccCCCEEEEeccCCC
Q 014609           89 IYMVLEYVTGGELFDKIAS-----KGRLQEAEGRKLFQQLIDGVSYCHNK-GVFHRDLKLENILLDSKGNIKISDFGLSA  162 (421)
Q Consensus        89 ~~lv~E~~~gg~L~~~i~~-----~~~~~~~~~~~~~~ql~~aL~~LH~~-gi~HrDlkp~NILl~~~~~~kL~DFGla~  162 (421)
                      .|+||||+.| +|.+.+..     ...+++..+..++.|++.||.|||+. ||+||||||+|||++.++.+||+|||++.
T Consensus        96 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~  174 (327)
T 3aln_A           96 CWICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISG  174 (327)
T ss_dssp             EEEEECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEETTTEEEECCCSSSC
T ss_pred             eEEEEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEcCCCCEEEccCCCce
Confidence            9999999975 78777653     56799999999999999999999999 99999999999999999999999999997


Q ss_pred             CCccccCCCccccccCCCCccChhhhc----ccCCCCCcchHHHHHHHHhhh-cCCcCCC--------------------
Q 014609          163 LPQHFRDDGLLHTTCGSPNYVAPEVLA----NRGYDGATSDIWSCGVILYIF-RGDFKLP--------------------  217 (421)
Q Consensus       163 ~~~~~~~~~~~~~~~gt~~y~APEvl~----~~~~~~~~~DiwSlGvil~~~-~~~~~~p--------------------  217 (421)
                      ....   ........||+.|+|||++.    +..+ +.++|||||||++|.+ .|..+++                    
T Consensus       175 ~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~-~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~  250 (327)
T 3aln_A          175 QLVD---SIAKTRDAGCRPYMAPERIDPSASRQGY-DVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDPPQL  250 (327)
T ss_dssp             C---------------------------------C-CSHHHHHHHHHHHHHHHHSCCCSSCC-------CCCCCSCCCCC
T ss_pred             eccc---ccccccCCCCccccCceeeccccCcCCC-CchhhHHHHHHHHHHHHHCCCCCCCcchHHHHHHHHhcCCCCCC
Confidence            5432   12233447999999999983    4445 5899999999999944 3333321                    


Q ss_pred             -----CCCCHHHHHHHHHhcCCCCCCCCCHHhhhcCccccccc
Q 014609          218 -----KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY  255 (421)
Q Consensus       218 -----~~~s~~~~~li~~~L~~dP~~R~t~~eil~~~w~~~~~  255 (421)
                           ..+++.+.++|.+||+.||.+|||+.++++||||....
T Consensus       251 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~~  293 (327)
T 3aln_A          251 SNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFILMYE  293 (327)
T ss_dssp             CCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHHH
T ss_pred             CCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhChHHHHhH
Confidence                 23688999999999999999999999999999998643

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=4e-44  Score=348.74  Aligned_cols=234  Identities=22%  Similarity=0.325  Sum_probs=189.6

Q ss_pred             eeecceEEeceEeecCcEEEEEEEECCCCceE----EEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeC
Q 014609           11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPF----AVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASK   86 (421)
Q Consensus        11 ~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~v----AvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~   86 (421)
                      ...++|++++.||+|+||+||+|++..+++.+    |+|.+....  .......+.+|+.++++++||||+++++++.+.
T Consensus        12 l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~   89 (327)
T 3poz_A           12 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT--SPKANKEILDEAYVMASVDNPHVCRLLGICLTS   89 (327)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC---------CHHHHHHHHHHHHHCCBTTBCCEEEEEESS
T ss_pred             cCHHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeeccccc--CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecC
Confidence            34478999999999999999999998887765    677665332  223357799999999999999999999999876


Q ss_pred             CEEEEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCc
Q 014609           87 SKIYMVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQ  165 (421)
Q Consensus        87 ~~~~lv~E~~~gg~L~~~i~~-~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~  165 (421)
                      . .++|+||+.+|+|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++....
T Consensus        90 ~-~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~  168 (327)
T 3poz_A           90 T-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG  168 (327)
T ss_dssp             S-EEEEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTHHHHHT
T ss_pred             C-eEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEECCCCCEEEccCcceeEcc
Confidence            5 7889999999999999876 4579999999999999999999999999999999999999999999999999997554


Q ss_pred             cccCCCccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhh-c-CCcC--------------------CCCCCCHH
Q 014609          166 HFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIF-R-GDFK--------------------LPKWLSPG  223 (421)
Q Consensus       166 ~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~-~-~~~~--------------------~p~~~s~~  223 (421)
                      ............+|+.|+|||++.+..+ +.++|||||||++|.+ . |..+                    .|..++..
T Consensus       169 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~-~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (327)
T 3poz_A          169 AEEKEYHAEGGKVPIKWMALESILHRIY-THQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTID  247 (327)
T ss_dssp             TTCC-------CCCGGGSCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCTTBCHH
T ss_pred             CCcccccccCCCccccccChHHhccCCC-CchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHHcCCCCCCCccCCHH
Confidence            3222223334567889999999988877 5899999999999964 3 4433                    34457899


Q ss_pred             HHHHHHHhcCCCCCCCCCHHhhhcC
Q 014609          224 AQNLLRKILEPNPVKRITIAGIKAD  248 (421)
Q Consensus       224 ~~~li~~~L~~dP~~R~t~~eil~~  248 (421)
                      +.+++.+||+.||.+|||+.+++++
T Consensus       248 ~~~li~~~l~~~p~~Rps~~ell~~  272 (327)
T 3poz_A          248 VYMIMVKCWMIDADSRPKFRELIIE  272 (327)
T ss_dssp             HHHHHHHHTCSCGGGSCCHHHHHHH
T ss_pred             HHHHHHHHcCCChhhCCCHHHHHHH
Confidence            9999999999999999999999876

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=2e-44  Score=350.49  Aligned_cols=234  Identities=22%  Similarity=0.342  Sum_probs=194.7

Q ss_pred             eeecceEEeceEeecCcEEEEEEEECCCCce----EEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeC
Q 014609           11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLP----FAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASK   86 (421)
Q Consensus        11 ~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~----vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~   86 (421)
                      ...++|++++.||+|+||+||+|.+..+++.    ||+|.+.....  ......+.+|+.++++++||||+++++++.. 
T Consensus        10 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-   86 (325)
T 3kex_A           10 FKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSG--RQSFQAVTDHMLAIGSLDHAHIVRLLGLCPG-   86 (325)
T ss_dssp             CCTTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTS--CSCBCSCCHHHHHHHTCCCTTBCCEEEEECB-
T ss_pred             cCHhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEecccccc--HHHHHHHHHHHHHHhcCCCCCcCeEEEEEcC-
Confidence            3457999999999999999999999888887    66676643321  1123457789999999999999999999864 


Q ss_pred             CEEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCc
Q 014609           87 SKIYMVLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQ  165 (421)
Q Consensus        87 ~~~~lv~E~~~gg~L~~~i~~~-~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~  165 (421)
                      ...++||||+.+|+|.+++... +.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++....
T Consensus        87 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~  166 (325)
T 3kex_A           87 SSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLP  166 (325)
T ss_dssp             SSEEEEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEESSSSCEEECSCSGGGGSC
T ss_pred             CccEEEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEECCCCeEEECCCCcccccC
Confidence            5689999999999999998764 579999999999999999999999999999999999999999999999999998665


Q ss_pred             cccCCCccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhh-c-CCcCC--------------------CCCCCHH
Q 014609          166 HFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIF-R-GDFKL--------------------PKWLSPG  223 (421)
Q Consensus       166 ~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~-~-~~~~~--------------------p~~~s~~  223 (421)
                      ............||+.|+|||++.+..+ +.++|||||||++|.+ . |..++                    |..+++.
T Consensus       167 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (325)
T 3kex_A          167 PDDKQLLYSEAKTPIKWMALESIHFGKY-THQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGERLAQPQICTID  245 (325)
T ss_dssp             CCTTCCC-----CCTTTSCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHHTTCBCCCCTTBCTT
T ss_pred             cccccccccCCCCcccccChHHhccCCC-ChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCCCCCCcCcHH
Confidence            4333334456678889999999988777 5899999999999964 3 44433                    3446788


Q ss_pred             HHHHHHHhcCCCCCCCCCHHhhhcC
Q 014609          224 AQNLLRKILEPNPVKRITIAGIKAD  248 (421)
Q Consensus       224 ~~~li~~~L~~dP~~R~t~~eil~~  248 (421)
                      +.++|.+||+.||.+|||+.+++++
T Consensus       246 ~~~li~~~l~~dp~~Rps~~el~~~  270 (325)
T 3kex_A          246 VYMVMVKCWMIDENIRPTFKELANE  270 (325)
T ss_dssp             TTHHHHHHTCSCTTTSCCHHHHHHH
T ss_pred             HHHHHHHHcCCChhhCcCHHHHHHH
Confidence            9999999999999999999999887

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=7e-44  Score=338.98  Aligned_cols=232  Identities=23%  Similarity=0.394  Sum_probs=196.9

Q ss_pred             eeecceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEE
Q 014609           11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIY   90 (421)
Q Consensus        11 ~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~   90 (421)
                      ...++|++++.||+|+||.||+|.+. ++..||+|++......    .+.+.+|+.++++++||||+++++++.+.+..|
T Consensus        21 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   95 (283)
T 3gen_A           21 IDPKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMS----EDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIF   95 (283)
T ss_dssp             CCGGGEEEEEECC---CEEEEEEEET-TTEEEEEEEECTTSBC----HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred             CCHHHHHhHhhcCCCCCceEEEEEEc-CCCeEEEEEecCCCCC----HHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeE
Confidence            44579999999999999999999875 6788999999765432    367899999999999999999999999999999


Q ss_pred             EEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCccccC
Q 014609           91 MVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD  169 (421)
Q Consensus        91 lv~E~~~gg~L~~~i~~-~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~  169 (421)
                      +||||+++++|.+++.. ...+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||++....... 
T Consensus        96 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~-  174 (283)
T 3gen_A           96 IITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE-  174 (283)
T ss_dssp             EEECCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHH-
T ss_pred             EEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEEcCCCCEEEccccccccccccc-
Confidence            99999999999999976 5679999999999999999999999999999999999999999999999999997543211 


Q ss_pred             CCccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhhc--CCcC--------------------CCCCCCHHHHHH
Q 014609          170 DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIFR--GDFK--------------------LPKWLSPGAQNL  227 (421)
Q Consensus       170 ~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~~--~~~~--------------------~p~~~s~~~~~l  227 (421)
                      ........+|+.|+|||++.+..+ +.++||||+|+++|.+.  |..+                    .|...++.+.++
T Consensus       175 ~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  253 (283)
T 3gen_A          175 YTSSVGSKFPVRWSPPEVLMYSKF-SSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYTI  253 (283)
T ss_dssp             HHSTTSTTSCGGGCCHHHHHHCCC-SHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCCCTTCCHHHHHH
T ss_pred             cccccCCccCcccCCHHHhccCCC-CchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHhcccCCCCCCcCCHHHHHH
Confidence            111233456788999999988777 58999999999999663  4443                    344578999999


Q ss_pred             HHHhcCCCCCCCCCHHhhhcCc
Q 014609          228 LRKILEPNPVKRITIAGIKADE  249 (421)
Q Consensus       228 i~~~L~~dP~~R~t~~eil~~~  249 (421)
                      |.+||+.||.+|||+.++++|-
T Consensus       254 i~~~l~~~p~~Rps~~~ll~~L  275 (283)
T 3gen_A          254 MYSCWHEKADERPTFKILLSNI  275 (283)
T ss_dssp             HHHTTCSSGGGSCCHHHHHHHH
T ss_pred             HHHHccCChhHCcCHHHHHHHH
Confidence            9999999999999999998764

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=100.00  E-value=2.2e-43  Score=340.71  Aligned_cols=239  Identities=24%  Similarity=0.365  Sum_probs=184.2

Q ss_pred             CeeecceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEE
Q 014609           10 GMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKI   89 (421)
Q Consensus        10 ~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~   89 (421)
                      ...+++|++++.||+|+||.||+|.+..+|+.||||++...... ....+.+.++..+++.++||||+++++++...+..
T Consensus        21 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~   99 (318)
T 2dyl_A           21 QAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNK-EENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDV   99 (318)
T ss_dssp             ECCGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCH-HHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred             hhhhccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccc-hHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcE
Confidence            34578999999999999999999999999999999999765422 22234455556678889999999999999999999


Q ss_pred             EEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhC-CceeccCCCCCEEeccCCCEEEEeccCCCCCccc
Q 014609           90 YMVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNK-GVFHRDLKLENILLDSKGNIKISDFGLSALPQHF  167 (421)
Q Consensus        90 ~lv~E~~~gg~L~~~i~~-~~~~~~~~~~~~~~ql~~aL~~LH~~-gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~  167 (421)
                      |+||||+ ++.+...... ...+++..++.++.|++.||+|||++ ||+||||||+|||++.++.+||+|||++..... 
T Consensus       100 ~lv~e~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~-  177 (318)
T 2dyl_A          100 FIAMELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVD-  177 (318)
T ss_dssp             EEEECCC-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEECTTSCEEECCCTTC------
T ss_pred             EEEEecc-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEECCCCCEEEEECCCchhccC-
Confidence            9999999 5555555443 56799999999999999999999995 999999999999999999999999999975432 


Q ss_pred             cCCCccccccCCCCccChhhhc-----ccCCCCCcchHHHHHHHHhhh-cCCcCCC-----------------------C
Q 014609          168 RDDGLLHTTCGSPNYVAPEVLA-----NRGYDGATSDIWSCGVILYIF-RGDFKLP-----------------------K  218 (421)
Q Consensus       168 ~~~~~~~~~~gt~~y~APEvl~-----~~~~~~~~~DiwSlGvil~~~-~~~~~~p-----------------------~  218 (421)
                        .......+||+.|+|||++.     ...+ +.++|||||||++|.+ .|..++.                       .
T Consensus       178 --~~~~~~~~~~~~y~aPE~~~~~~~~~~~~-~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  254 (318)
T 2dyl_A          178 --DKAKDRSAGCAAYMAPERIDPPDPTKPDY-DIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLLPGHM  254 (318)
T ss_dssp             -----------CCTTCCHHHHC--------C-CTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHHSCCCCCCSSS
T ss_pred             --CccccccCCCccccChhhcccccccccCC-ccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhccCCCCCCccC
Confidence              22334567999999999985     3344 5899999999999944 3333321                       2


Q ss_pred             CCCHHHHHHHHHhcCCCCCCCCCHHhhhcCcccccc
Q 014609          219 WLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD  254 (421)
Q Consensus       219 ~~s~~~~~li~~~L~~dP~~R~t~~eil~~~w~~~~  254 (421)
                      .+++.+.++|.+||+.||.+|||+.++++||||+..
T Consensus       255 ~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~  290 (318)
T 2dyl_A          255 GFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKRY  290 (318)
T ss_dssp             CCCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHHH
T ss_pred             CCCHHHHHHHHHHccCChhHCcCHHHHhhCHHHHhc
Confidence            368999999999999999999999999999999864

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=1.6e-43  Score=344.77  Aligned_cols=234  Identities=22%  Similarity=0.332  Sum_probs=190.0

Q ss_pred             eeecceEEeceEeecCcEEEEEEEECCCCceE----EEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeC
Q 014609           11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPF----AVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASK   86 (421)
Q Consensus        11 ~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~v----AvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~   86 (421)
                      ...++|++++.||+|+||+||+|.+..+++.+    |+|.+....  .......+.+|+.++++++||||+++++++...
T Consensus        12 l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~   89 (327)
T 3lzb_A           12 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT--SPKANKEILDEAYVMASVDNPHVCRLLGICLTS   89 (327)
T ss_dssp             CCTTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCS--SCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESS
T ss_pred             cCHhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeecccc--CHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecC
Confidence            34479999999999999999999998888876    555554322  223357899999999999999999999999876


Q ss_pred             CEEEEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCc
Q 014609           87 SKIYMVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQ  165 (421)
Q Consensus        87 ~~~~lv~E~~~gg~L~~~i~~-~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~  165 (421)
                      . .++|+||+.+++|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++....
T Consensus        90 ~-~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~  168 (327)
T 3lzb_A           90 T-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG  168 (327)
T ss_dssp             S-EEEEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTC-----
T ss_pred             C-ceEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEcCCCCEEEccCcceeEcc
Confidence            5 7889999999999999876 4579999999999999999999999999999999999999999999999999998654


Q ss_pred             cccCCCccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhhc--CCcC--------------------CCCCCCHH
Q 014609          166 HFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIFR--GDFK--------------------LPKWLSPG  223 (421)
Q Consensus       166 ~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~~--~~~~--------------------~p~~~s~~  223 (421)
                      ............+|+.|+|||++.+..+ +.++|||||||++|.+.  |..+                    .|..+++.
T Consensus       169 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~-~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (327)
T 3lzb_A          169 AEEKEYHAEGGKVPIKWMALESILHRIY-THQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTID  247 (327)
T ss_dssp             -----------CCCGGGSCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCTTBCHH
T ss_pred             CccccccccCCCccccccCHHHHcCCCC-ChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCccCCHH
Confidence            4333333344567889999999988877 58999999999999643  4333                    34557899


Q ss_pred             HHHHHHHhcCCCCCCCCCHHhhhcC
Q 014609          224 AQNLLRKILEPNPVKRITIAGIKAD  248 (421)
Q Consensus       224 ~~~li~~~L~~dP~~R~t~~eil~~  248 (421)
                      +.++|.+||+.||.+|||+.++++.
T Consensus       248 l~~li~~~l~~dp~~Rps~~ell~~  272 (327)
T 3lzb_A          248 VYMIMRKCWMIDADSRPKFRELIIE  272 (327)
T ss_dssp             HHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHcCCChhHCcCHHHHHHH
Confidence            9999999999999999999999873

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=6e-44  Score=344.36  Aligned_cols=235  Identities=27%  Similarity=0.364  Sum_probs=199.9

Q ss_pred             eecceEEeceEeecCcEEEEEEEE-----CCCCceEEEEEeecccccchhHHHHHHHHHHHHhcC-CCCCcceEEEEEEe
Q 014609           12 RLGRYELGRTLGEGNFGKVKFAQD-----LDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEVLAS   85 (421)
Q Consensus        12 ~~~~y~i~~~LG~G~~g~V~~a~~-----~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~   85 (421)
                      ..++|++++.||+|+||+||+|.+     ..+++.||||++....  .......+.+|+.+++++ +||||+++++++..
T Consensus        25 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~  102 (316)
T 2xir_A           25 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLGACTK  102 (316)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECC
T ss_pred             chhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCC--CcHHHHHHHHHHHHHHhcccCCCeeeEEEEEec
Confidence            457999999999999999999985     4578899999997543  233356789999999999 69999999999877


Q ss_pred             CC-EEEEEEeccCCCChHHHHHhcCC----------------CCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEec
Q 014609           86 KS-KIYMVLEYVTGGELFDKIASKGR----------------LQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLD  148 (421)
Q Consensus        86 ~~-~~~lv~E~~~gg~L~~~i~~~~~----------------~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~  148 (421)
                      .+ .+|+||||++|++|.+++.....                +++..++.++.|++.||+|||++||+||||||+||+++
T Consensus       103 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~  182 (316)
T 2xir_A          103 PGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLS  182 (316)
T ss_dssp             TTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC
T ss_pred             CCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEEC
Confidence            55 58999999999999999987543                89999999999999999999999999999999999999


Q ss_pred             cCCCEEEEeccCCCCCccccCCCccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhhc--CCcC-----------
Q 014609          149 SKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIFR--GDFK-----------  215 (421)
Q Consensus       149 ~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~~--~~~~-----------  215 (421)
                      .++.+||+|||++................||+.|+|||++.+..+ +.++|||||||++|.+.  |..+           
T Consensus       183 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~  261 (316)
T 2xir_A          183 EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVY-TIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFC  261 (316)
T ss_dssp             GGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHH
T ss_pred             CCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccc-cchhHHHHHHHHHHHHHhCCCCCCcccchhHHHH
Confidence            999999999999986543222223345578899999999988777 58999999999999653  4433           


Q ss_pred             ----------CCCCCCHHHHHHHHHhcCCCCCCCCCHHhhhcCc
Q 014609          216 ----------LPKWLSPGAQNLLRKILEPNPVKRITIAGIKADE  249 (421)
Q Consensus       216 ----------~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~~~  249 (421)
                                .|..+++.+.++|.+||+.||.+|||+.++++|-
T Consensus       262 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L  305 (316)
T 2xir_A          262 RRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHL  305 (316)
T ss_dssp             HHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             HHhccCccCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence                      3455789999999999999999999999998863

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=1.3e-43  Score=337.29  Aligned_cols=234  Identities=26%  Similarity=0.422  Sum_probs=187.7

Q ss_pred             CeeecceEEeceEeecCcEEEEEEEECCC---CceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeC
Q 014609           10 GMRLGRYELGRTLGEGNFGKVKFAQDLDS---GLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASK   86 (421)
Q Consensus        10 ~~~~~~y~i~~~LG~G~~g~V~~a~~~~~---~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~   86 (421)
                      ....++|++++.||+|+||.||+|.+..+   +..||+|++....  .....+.+.+|+.++++++||||+++++++. +
T Consensus        11 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~   87 (281)
T 1mp8_A           11 EIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT--SDSVREKFLQEALTMRQFDHPHIVKLIGVIT-E   87 (281)
T ss_dssp             BCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTT--SHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-S
T ss_pred             EEehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCccceEEEEEc-c
Confidence            34568999999999999999999998654   4579999986432  3344578999999999999999999999984 5


Q ss_pred             CEEEEEEeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCc
Q 014609           87 SKIYMVLEYVTGGELFDKIASKG-RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQ  165 (421)
Q Consensus        87 ~~~~lv~E~~~gg~L~~~i~~~~-~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~  165 (421)
                      +..|+||||+++++|.+++.... .+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||++....
T Consensus        88 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  167 (281)
T 1mp8_A           88 NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYME  167 (281)
T ss_dssp             SSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC--------
T ss_pred             CccEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEECCCCCEEECccccccccC
Confidence            67899999999999999997644 69999999999999999999999999999999999999999999999999998653


Q ss_pred             cccCCCccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhhc--CCcC--------------------CCCCCCHH
Q 014609          166 HFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIFR--GDFK--------------------LPKWLSPG  223 (421)
Q Consensus       166 ~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~~--~~~~--------------------~p~~~s~~  223 (421)
                      ... ........+|+.|+|||++....+ +.++|||||||++|.+.  |..+                    .|+.+++.
T Consensus       168 ~~~-~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  245 (281)
T 1mp8_A          168 DST-YYKASKGKLPIKWMAPESINFRRF-TSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPT  245 (281)
T ss_dssp             ------------CCGGGCCHHHHHHCCC-SHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCTTCCHH
T ss_pred             ccc-ccccccCCCcccccChhhcccCCC-CCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHHcCCCCCCCCCCCHH
Confidence            311 112234456789999999987777 58999999999999543  4333                    34567899


Q ss_pred             HHHHHHHhcCCCCCCCCCHHhhhcC
Q 014609          224 AQNLLRKILEPNPVKRITIAGIKAD  248 (421)
Q Consensus       224 ~~~li~~~L~~dP~~R~t~~eil~~  248 (421)
                      +.++|.+||+.||.+|||+.+++++
T Consensus       246 l~~li~~~l~~~p~~Rps~~~l~~~  270 (281)
T 1mp8_A          246 LYSLMTKCWAYDPSRRPRFTELKAQ  270 (281)
T ss_dssp             HHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHccCChhhCcCHHHHHHH
Confidence            9999999999999999999998764

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=1.4e-43  Score=345.59  Aligned_cols=236  Identities=26%  Similarity=0.434  Sum_probs=198.7

Q ss_pred             CeeecceEEeceEeecCcEEEEEEEEC-------CCCceEEEEEeecccccchhHHHHHHHHHHHHhcC-CCCCcceEEE
Q 014609           10 GMRLGRYELGRTLGEGNFGKVKFAQDL-------DSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHE   81 (421)
Q Consensus        10 ~~~~~~y~i~~~LG~G~~g~V~~a~~~-------~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~   81 (421)
                      ....++|++++.||+|+||+||+|.+.       .+++.||+|++....  .......+.+|+.+++++ +||||+++++
T Consensus        31 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~  108 (334)
T 2pvf_A           31 EFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINLLG  108 (334)
T ss_dssp             BCCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred             cCCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCC--cHHHHHHHHHHHHHHHHhhcCCCEeeEEE
Confidence            345589999999999999999999986       467789999997543  233457799999999999 8999999999


Q ss_pred             EEEeCCEEEEEEeccCCCChHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCE
Q 014609           82 VLASKSKIYMVLEYVTGGELFDKIASKG----------------RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENI  145 (421)
Q Consensus        82 ~~~~~~~~~lv~E~~~gg~L~~~i~~~~----------------~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NI  145 (421)
                      ++...+..|+||||+++++|.+++....                .+++..++.++.||+.||+|||++||+||||||+||
T Consensus       109 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NI  188 (334)
T 2pvf_A          109 ACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNV  188 (334)
T ss_dssp             EECSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGE
T ss_pred             EEccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCccceE
Confidence            9999999999999999999999998643                389999999999999999999999999999999999


Q ss_pred             EeccCCCEEEEeccCCCCCccccCCCccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhhc--CCcC--------
Q 014609          146 LLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIFR--GDFK--------  215 (421)
Q Consensus       146 Ll~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~~--~~~~--------  215 (421)
                      |++.++.+||+|||++................+|+.|+|||++.+..+ +.++|||||||++|.+.  |..+        
T Consensus       189 ll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~ellt~g~~p~~~~~~~~  267 (334)
T 2pvf_A          189 LVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVY-THQSDVWSFGVLMWEIFTLGGSPYPGIPVEE  267 (334)
T ss_dssp             EECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEE-CHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH
T ss_pred             EEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCc-ChHHHHHHHHHHHHHHHhCCCCCcCcCCHHH
Confidence            999999999999999975433211112233457889999999987766 58999999999999553  4333        


Q ss_pred             ------------CCCCCCHHHHHHHHHhcCCCCCCCCCHHhhhcC
Q 014609          216 ------------LPKWLSPGAQNLLRKILEPNPVKRITIAGIKAD  248 (421)
Q Consensus       216 ------------~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~~  248 (421)
                                  .|..+++.+.++|.+||+.||.+|||+.+++++
T Consensus       268 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  312 (334)
T 2pvf_A          268 LFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED  312 (334)
T ss_dssp             HHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHhcCCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence                        344578999999999999999999999999875

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=1.3e-43  Score=345.32  Aligned_cols=228  Identities=21%  Similarity=0.280  Sum_probs=196.3

Q ss_pred             ecceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcC-CCCCcceEEEEEEeCCEEEE
Q 014609           13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEVLASKSKIYM   91 (421)
Q Consensus        13 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~l   91 (421)
                      -++|++++.||+|+||+||+|.+..+|+.||||++.....     .+.+.+|+.+++++ +||||+++++++...+..|+
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~l   82 (330)
T 2izr_A            8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR-----APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAM   82 (330)
T ss_dssp             TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS-----SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEE
T ss_pred             cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc-----hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEE
Confidence            3689999999999999999999999999999999875432     23578999999999 89999999999999999999


Q ss_pred             EEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCC-----EEEEeccCCCCCc
Q 014609           92 VLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGN-----IKISDFGLSALPQ  165 (421)
Q Consensus        92 v~E~~~gg~L~~~i~~-~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~-----~kL~DFGla~~~~  165 (421)
                      ||||+ |++|.+++.. ...+++..++.++.|++.||+|||++||+||||||+|||++.++.     +||+|||++....
T Consensus        83 v~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~  161 (330)
T 2izr_A           83 VLELL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYI  161 (330)
T ss_dssp             EEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESB
T ss_pred             EEEeC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeeccCCCCCCceEEEEEcccceeee
Confidence            99999 9999999986 468999999999999999999999999999999999999998887     9999999998543


Q ss_pred             cccCC-----CccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhh-cCCcCCCCC--------------------
Q 014609          166 HFRDD-----GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIF-RGDFKLPKW--------------------  219 (421)
Q Consensus       166 ~~~~~-----~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~-~~~~~~p~~--------------------  219 (421)
                      .....     ......+||+.|+|||++.+..+ +.++|||||||++|.+ .|..++...                    
T Consensus       162 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~  240 (330)
T 2izr_A          162 DPETKKHIPYREHKSLTGTARYMSINTHLGKEQ-SRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRATP  240 (330)
T ss_dssp             CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCC-CHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHHSC
T ss_pred             cCCCCccccccccCCcCCCccccChHHHcCCCC-CchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhccCC
Confidence            32111     12346789999999999988877 5899999999999954 555555321                    


Q ss_pred             ------CCHHHHHHHHHhcCCCCCCCCCHHhhhc
Q 014609          220 ------LSPGAQNLLRKILEPNPVKRITIAGIKA  247 (421)
Q Consensus       220 ------~s~~~~~li~~~L~~dP~~R~t~~eil~  247 (421)
                            ..+++.++|.+||+.||.+||+++++.+
T Consensus       241 ~~~~~~~~p~~~~li~~~l~~~p~~RP~~~~l~~  274 (330)
T 2izr_A          241 IEVLCENFPEMATYLRYVRRLDFFEKPDYDYLRK  274 (330)
T ss_dssp             HHHHTTTCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred             HHHHhccChHHHHHHHHHHhCCCCCCCCHHHHHH
Confidence                  1248999999999999999999998876

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=2.2e-43  Score=332.45  Aligned_cols=230  Identities=20%  Similarity=0.349  Sum_probs=198.1

Q ss_pred             cCCeeecceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeC-
Q 014609            8 QEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASK-   86 (421)
Q Consensus         8 ~~~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~-   86 (421)
                      ..+..+++|++.+.||+|+||.||+|++  +++.||+|++..... .....+.+.+|+.++++++||||+++++++.+. 
T Consensus         4 ~~~i~~~~y~~~~~lg~G~~g~V~~~~~--~~~~~avK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   80 (271)
T 3kmu_A            4 HSGIDFKQLNFLTKLNENHSGELWKGRW--QGNDIVVKVLKVRDW-STRKSRDFNEECPRLRIFSHPNVLPVLGACQSPP   80 (271)
T ss_dssp             CCCCCGGGCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECCTTC-CHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTT
T ss_pred             cCCCCHHHhHHHHHhcCCCcceEEEEEE--CCeeEEEEEeccccc-CHHHHHHHHHHHHHHHhcCCCchhheEEEEccCC
Confidence            3467789999999999999999999997  488999999976543 233457799999999999999999999999887 


Q ss_pred             -CEEEEEEeccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC--ceeccCCCCCEEeccCCCEEEEeccCC
Q 014609           87 -SKIYMVLEYVTGGELFDKIASKG--RLQEAEGRKLFQQLIDGVSYCHNKG--VFHRDLKLENILLDSKGNIKISDFGLS  161 (421)
Q Consensus        87 -~~~~lv~E~~~gg~L~~~i~~~~--~~~~~~~~~~~~ql~~aL~~LH~~g--i~HrDlkp~NILl~~~~~~kL~DFGla  161 (421)
                       ...|+||||++|++|.+++....  .+++..+..++.|++.||+|||++|  |+||||||+|||++.++.++|+|||++
T Consensus        81 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~  160 (271)
T 3kmu_A           81 APHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVK  160 (271)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTSCEEEEGGGSC
T ss_pred             CCCeEeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCcceeEEeccce
Confidence             78899999999999999998755  4899999999999999999999999  999999999999999999999999987


Q ss_pred             CCCccccCCCccccccCCCCccChhhhcccCCCC--CcchHHHHHHHHhhh-cCCc---------------------CCC
Q 014609          162 ALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDG--ATSDIWSCGVILYIF-RGDF---------------------KLP  217 (421)
Q Consensus       162 ~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~--~~~DiwSlGvil~~~-~~~~---------------------~~p  217 (421)
                      ....       .....||+.|+|||++.+..+..  .++|||||||++|.+ .|..                     ..|
T Consensus       161 ~~~~-------~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~  233 (271)
T 3kmu_A          161 FSFQ-------SPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPTIP  233 (271)
T ss_dssp             CTTS-------CTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHHHSCCCCCCC
T ss_pred             eeec-------ccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHHHhcCCCCCCC
Confidence            6422       23457899999999998765532  279999999999943 3332                     335


Q ss_pred             CCCCHHHHHHHHHhcCCCCCCCCCHHhhhc
Q 014609          218 KWLSPGAQNLLRKILEPNPVKRITIAGIKA  247 (421)
Q Consensus       218 ~~~s~~~~~li~~~L~~dP~~R~t~~eil~  247 (421)
                      ..+++.+.++|.+||+.||.+|||+.++++
T Consensus       234 ~~~~~~~~~li~~~l~~~p~~Rps~~~il~  263 (271)
T 3kmu_A          234 PGISPHVSKLMKICMNEDPAKRPKFDMIVP  263 (271)
T ss_dssp             TTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            568999999999999999999999999875

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=7.6e-44  Score=346.03  Aligned_cols=229  Identities=22%  Similarity=0.271  Sum_probs=189.4

Q ss_pred             ecceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCC----E
Q 014609           13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKS----K   88 (421)
Q Consensus        13 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~----~   88 (421)
                      .++|++++.||+|+||+||+|++.  ++.||||++....    .......+|+.++++++||||+++++++....    .
T Consensus        23 ~~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~   96 (322)
T 3soc_A           23 SMPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQD----KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVD   96 (322)
T ss_dssp             TEEEEEEEEEECSTTCEEEEEEET--TEEEEEEEECGGG----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEE
T ss_pred             hhhchhhheecccCceEEEEEEEC--CCEEEEEEeecCc----hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCce
Confidence            479999999999999999999874  7999999996542    22355677999999999999999999998743    4


Q ss_pred             EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC----------CceeccCCCCCEEeccCCCEEEEec
Q 014609           89 IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNK----------GVFHRDLKLENILLDSKGNIKISDF  158 (421)
Q Consensus        89 ~~lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~ql~~aL~~LH~~----------gi~HrDlkp~NILl~~~~~~kL~DF  158 (421)
                      +|+||||+++|+|.+++.. ..+++..++.++.|++.||+|||+.          ||+||||||+|||++.++.+||+||
T Consensus        97 ~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DF  175 (322)
T 3soc_A           97 LWLITAFHEKGSLSDFLKA-NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADF  175 (322)
T ss_dssp             EEEEEECCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEECCC
T ss_pred             EEEEEecCCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEccC
Confidence            7999999999999999976 5699999999999999999999999          9999999999999999999999999


Q ss_pred             cCCCCCccccCCCccccccCCCCccChhhhcccCC----CCCcchHHHHHHHHhhhc-CCcCCCC---------------
Q 014609          159 GLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGY----DGATSDIWSCGVILYIFR-GDFKLPK---------------  218 (421)
Q Consensus       159 Gla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~----~~~~~DiwSlGvil~~~~-~~~~~p~---------------  218 (421)
                      |++...............+||+.|+|||++.+...    .+.++|||||||++|.+. |..++..               
T Consensus       176 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~  255 (322)
T 3soc_A          176 GLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQ  255 (322)
T ss_dssp             TTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCS
T ss_pred             CcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhcc
Confidence            99976544333333445689999999999876322    135789999999999654 3332211               


Q ss_pred             ------------------C---------CCHHHHHHHHHhcCCCCCCCCCHHhhhcC
Q 014609          219 ------------------W---------LSPGAQNLLRKILEPNPVKRITIAGIKAD  248 (421)
Q Consensus       219 ------------------~---------~s~~~~~li~~~L~~dP~~R~t~~eil~~  248 (421)
                                        .         .++.+.++|.+||+.||.+|||+.++++.
T Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~  312 (322)
T 3soc_A          256 HPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGER  312 (322)
T ss_dssp             SCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence                              0         12348899999999999999999998763

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=2.4e-43  Score=333.01  Aligned_cols=230  Identities=27%  Similarity=0.460  Sum_probs=185.9

Q ss_pred             eeecceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccc-hhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEE
Q 014609           11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIH-LKITDQIKREIATLKLLKHPNVVRLHEVLASKSKI   89 (421)
Q Consensus        11 ~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~-~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~   89 (421)
                      ...++|++.+.||+|+||.||+|.+  +|+.||||++....... ....+.+.+|+.+++.++||||+++++++.+.+..
T Consensus         4 ~~~~~~~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   81 (271)
T 3dtc_A            4 IDFAELTLEEIIGIGGFGKVYRAFW--IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNL   81 (271)
T ss_dssp             CCTTSEEEEEEEEEETTEEEEEEEE--TTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--C
T ss_pred             cchhheeeeeeeccCCCeEEEEEEE--cCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCce
Confidence            3568999999999999999999997  48899999987543322 22346789999999999999999999999999999


Q ss_pred             EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---ceeccCCCCCEEecc--------CCCEEEEec
Q 014609           90 YMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKG---VFHRDLKLENILLDS--------KGNIKISDF  158 (421)
Q Consensus        90 ~lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~ql~~aL~~LH~~g---i~HrDlkp~NILl~~--------~~~~kL~DF  158 (421)
                      |+||||++|++|.+++. ..++++..++.++.|++.||+|||++|   |+||||||+|||++.        ++.+||+||
T Consensus        82 ~lv~e~~~~~~L~~~~~-~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Df  160 (271)
T 3dtc_A           82 CLVMEFARGGPLNRVLS-GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDF  160 (271)
T ss_dssp             EEEEECCTTEEHHHHHT-SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCC
T ss_pred             EEEEEcCCCCCHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccC
Confidence            99999999999988875 468999999999999999999999999   999999999999986        678999999


Q ss_pred             cCCCCCccccCCCccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhh-cCCc---------------------CC
Q 014609          159 GLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIF-RGDF---------------------KL  216 (421)
Q Consensus       159 Gla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~-~~~~---------------------~~  216 (421)
                      |++.....    .......||+.|+|||++.+..+ +.++||||+|+++|.+ .|..                     +.
T Consensus       161 g~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~  235 (271)
T 3dtc_A          161 GLAREWHR----TTKMSAAGAYAWMAPEVIRASMF-SKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLALPI  235 (271)
T ss_dssp             CC-----------------CCGGGSCHHHHHHCCC-SHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHTSCCCCCC
T ss_pred             Cccccccc----ccccCCCCccceeCHHHhccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhhcCCCCCCC
Confidence            99975432    22335579999999999988777 5899999999999943 3332                     33


Q ss_pred             CCCCCHHHHHHHHHhcCCCCCCCCCHHhhhcC
Q 014609          217 PKWLSPGAQNLLRKILEPNPVKRITIAGIKAD  248 (421)
Q Consensus       217 p~~~s~~~~~li~~~L~~dP~~R~t~~eil~~  248 (421)
                      |..+++.+.++|.+||+.||.+|||+.+++++
T Consensus       236 ~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~  267 (271)
T 3dtc_A          236 PSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQ  267 (271)
T ss_dssp             CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CcccCHHHHHHHHHHhcCCcccCcCHHHHHHH
Confidence            45678999999999999999999999999864

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=1.6e-43  Score=344.62  Aligned_cols=233  Identities=25%  Similarity=0.391  Sum_probs=199.2

Q ss_pred             eecceEEeceEeecCcEEEEEEEECCCCc-----eEEEEEeecccccchhHHHHHHHHHHHHhcC-CCCCcceEEEEEEe
Q 014609           12 RLGRYELGRTLGEGNFGKVKFAQDLDSGL-----PFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEVLAS   85 (421)
Q Consensus        12 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~-----~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~   85 (421)
                      ..++|++++.||+|+||+||+|.+..+++     .||+|++....  .....+.+.+|+.+++++ +||||+++++++.+
T Consensus        44 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~  121 (333)
T 2i1m_A           44 PRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTA--HADEKEALMSELKIMSHLGQHENIVNLLGACTH  121 (333)
T ss_dssp             CTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             CHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhccccc--ChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEec
Confidence            34789999999999999999999977665     79999997543  233457799999999999 89999999999999


Q ss_pred             CCEEEEEEeccCCCChHHHHHhc--------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCC
Q 014609           86 KSKIYMVLEYVTGGELFDKIASK--------------GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKG  151 (421)
Q Consensus        86 ~~~~~lv~E~~~gg~L~~~i~~~--------------~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~  151 (421)
                      .+..|+||||+++|+|.+++...              ..+++..+..++.|++.||+|||++||+||||||+|||++.++
T Consensus       122 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~  201 (333)
T 2i1m_A          122 GGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGH  201 (333)
T ss_dssp             SSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGCEEEGGG
T ss_pred             CCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccceEEECCCC
Confidence            99999999999999999998642              3589999999999999999999999999999999999999999


Q ss_pred             CEEEEeccCCCCCccccCCCccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhhc--CCcCC-------------
Q 014609          152 NIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIFR--GDFKL-------------  216 (421)
Q Consensus       152 ~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~~--~~~~~-------------  216 (421)
                      .+||+|||++................||+.|+|||++.+..+ +.++|||||||++|.+.  |..++             
T Consensus       202 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~  280 (333)
T 2i1m_A          202 VAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVY-TVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLV  280 (333)
T ss_dssp             EEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCC-CHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHHHHHH
T ss_pred             eEEECccccccccccccceeecCCCCCCccccCHHHhccCCC-ChHHHHHHHHHHHHHHHcCCCCCCcccchhHHHHHHH
Confidence            999999999986543222222334567889999999988777 58999999999999664  43332             


Q ss_pred             --------CCCCCHHHHHHHHHhcCCCCCCCCCHHhhhc
Q 014609          217 --------PKWLSPGAQNLLRKILEPNPVKRITIAGIKA  247 (421)
Q Consensus       217 --------p~~~s~~~~~li~~~L~~dP~~R~t~~eil~  247 (421)
                              |...++.+.++|.+||+.||.+|||+.++++
T Consensus       281 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~  319 (333)
T 2i1m_A          281 KDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICS  319 (333)
T ss_dssp             HHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             hcCCCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence                    3447899999999999999999999999986

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=2.7e-43  Score=342.39  Aligned_cols=233  Identities=27%  Similarity=0.432  Sum_probs=198.8

Q ss_pred             eecceEEeceEeecCcEEEEEEE----ECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEE--e
Q 014609           12 RLGRYELGRTLGEGNFGKVKFAQ----DLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLA--S   85 (421)
Q Consensus        12 ~~~~y~i~~~LG~G~~g~V~~a~----~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~--~   85 (421)
                      .-++|++++.||+|+||.||+|+    +..+++.||||++...   .....+.+.+|+.++++++||||+++++++.  .
T Consensus        21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~   97 (327)
T 3lxl_A           21 EERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHS---GPDQQRDFQREIQILKALHSDFIVKYRGVSYGPG   97 (327)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSC---CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSS
T ss_pred             chhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccC---CHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCC
Confidence            34799999999999999999998    5678999999999754   2334567999999999999999999999986  5


Q ss_pred             CCEEEEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCC
Q 014609           86 KSKIYMVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALP  164 (421)
Q Consensus        86 ~~~~~lv~E~~~gg~L~~~i~~-~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~  164 (421)
                      ....|+||||++|++|.+++.. ...+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||++...
T Consensus        98 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~  177 (327)
T 3lxl_A           98 RQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLL  177 (327)
T ss_dssp             SCEEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCGGGCEEC
T ss_pred             CceEEEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEECCCCCEEEcccccceec
Confidence            5679999999999999999976 456999999999999999999999999999999999999999999999999999855


Q ss_pred             ccccCC-CccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhhcCC------------------------------
Q 014609          165 QHFRDD-GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIFRGD------------------------------  213 (421)
Q Consensus       165 ~~~~~~-~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~~~~------------------------------  213 (421)
                      ...... .......||+.|+|||++.+..+ +.++|||||||++|.+...                              
T Consensus       178 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  256 (327)
T 3lxl_A          178 PLDKDYYVVREPGQSPIFWYAPESLSDNIF-SRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLEL  256 (327)
T ss_dssp             CTTCSEEECSSCCCSCGGGSCHHHHHHCEE-EHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHHH
T ss_pred             ccCCccceeeccCCccccccCHHHhccCCC-ChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHHHH
Confidence            332111 12234568888999999988776 5899999999999954331                              


Q ss_pred             ------cCCCCCCCHHHHHHHHHhcCCCCCCCCCHHhhhcC
Q 014609          214 ------FKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKAD  248 (421)
Q Consensus       214 ------~~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~~  248 (421)
                            .+.|..+++.+.++|.+||++||.+|||+.+++++
T Consensus       257 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~  297 (327)
T 3lxl_A          257 LEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQ  297 (327)
T ss_dssp             HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             hhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence                  23456689999999999999999999999999654

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=2.9e-43  Score=347.67  Aligned_cols=229  Identities=15%  Similarity=0.219  Sum_probs=192.8

Q ss_pred             cceEEeceEeecCcEEEEEE-----EECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCC---CCCcceEEEEEEe
Q 014609           14 GRYELGRTLGEGNFGKVKFA-----QDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK---HPNVVRLHEVLAS   85 (421)
Q Consensus        14 ~~y~i~~~LG~G~~g~V~~a-----~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~---hpnIv~l~~~~~~   85 (421)
                      ++|++.+.||+|+||+||+|     .+..+++.||||++....      ...+.+|+.++++++   |+||+++++++..
T Consensus        65 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~------~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~  138 (365)
T 3e7e_A           65 KLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN------PWEFYIGTQLMERLKPSMQHMFMKFYSAHLF  138 (365)
T ss_dssp             SEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC------HHHHHHHHHHHHHSCGGGGGGBCCEEEEEEC
T ss_pred             EEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC------hhHHHHHHHHHHHhhhhhhhhhhhhheeeec
Confidence            67999999999999999999     467789999999986542      456788888888887   8999999999999


Q ss_pred             CCEEEEEEeccCCCChHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecc-----------
Q 014609           86 KSKIYMVLEYVTGGELFDKIAS-----KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDS-----------  149 (421)
Q Consensus        86 ~~~~~lv~E~~~gg~L~~~i~~-----~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~-----------  149 (421)
                      .+..|+||||++||+|.+++..     ...+++..++.++.||+.||+|||++||+||||||+|||++.           
T Consensus       139 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~~~~~~~~~~~  218 (365)
T 3e7e_A          139 QNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDL  218 (365)
T ss_dssp             SSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECGGGTCC------
T ss_pred             CCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEecccccCccccccc
Confidence            9999999999999999999973     467999999999999999999999999999999999999998           


Q ss_pred             CCCEEEEeccCCCCCccccCCCccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhh-cCCcCCC-----------
Q 014609          150 KGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIF-RGDFKLP-----------  217 (421)
Q Consensus       150 ~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~-~~~~~~p-----------  217 (421)
                      ++.+||+|||+|...............+||+.|+|||++.+..| +.++|||||||++|++ .|..++.           
T Consensus       219 ~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~  297 (365)
T 3e7e_A          219 SAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPW-NYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEG  297 (365)
T ss_dssp             CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCB-STHHHHHHHHHHHHHHHHSSCCCEEEETTEEEECS
T ss_pred             cCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCC-CccccHHHHHHHHHHHHhCCCccccCCCCceeech
Confidence            89999999999975443333445566789999999999988887 5899999999999954 4443321           


Q ss_pred             ----CCCCHHHHHHHHHhcCCCCCCCCCHHhhhcCc
Q 014609          218 ----KWLSPGAQNLLRKILEPNPVKRITIAGIKADE  249 (421)
Q Consensus       218 ----~~~s~~~~~li~~~L~~dP~~R~t~~eil~~~  249 (421)
                          .+.++.+.+++.+||+.+|.+|++..+.+.+.
T Consensus       298 ~~~~~~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~  333 (365)
T 3e7e_A          298 LFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQK  333 (365)
T ss_dssp             CCTTCSSHHHHHHHHHHHHCCCCTTCCCCHHHHHHH
T ss_pred             hccccCcHHHHHHHHHHHcCCCCCCcchHHHHHHHH
Confidence                23567889999999999999997665555443

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=1.2e-43  Score=338.07  Aligned_cols=232  Identities=27%  Similarity=0.382  Sum_probs=201.5

Q ss_pred             CeeecceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEE
Q 014609           10 GMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKI   89 (421)
Q Consensus        10 ~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~   89 (421)
                      .+..++|++.+.||+|+||.||+|.+..+++.||+|++....    ...+.+.+|+.++++++||||+++++++.+.+..
T Consensus         9 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~   84 (288)
T 3kfa_A            9 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT----MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPF   84 (288)
T ss_dssp             BCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCS----THHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSE
T ss_pred             cccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCH----HHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCE
Confidence            355689999999999999999999999999999999997542    2357789999999999999999999999999999


Q ss_pred             EEEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCccc
Q 014609           90 YMVLEYVTGGELFDKIASK--GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHF  167 (421)
Q Consensus        90 ~lv~E~~~gg~L~~~i~~~--~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~  167 (421)
                      |+||||++|++|.+++...  ..+++..++.++.|++.||+|||++||+||||||+||+++.++.+||+|||++......
T Consensus        85 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~  164 (288)
T 3kfa_A           85 YIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD  164 (288)
T ss_dssp             EEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEECGGGCEEECCCCGGGTSCSS
T ss_pred             EEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEEcCCCCEEEccCccceeccCC
Confidence            9999999999999999863  45999999999999999999999999999999999999999999999999999865432


Q ss_pred             cCCCccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhhc--CCcC--------------------CCCCCCHHHH
Q 014609          168 RDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIFR--GDFK--------------------LPKWLSPGAQ  225 (421)
Q Consensus       168 ~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~~--~~~~--------------------~p~~~s~~~~  225 (421)
                      . ........+|+.|+|||++.+..+ +.++||||||+++|.+.  |..+                    .|..+++.+.
T Consensus       165 ~-~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  242 (288)
T 3kfa_A          165 T-YTAHAGAKFPIKWTAPESLAYNKF-SIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVY  242 (288)
T ss_dssp             S-SEEETTEEECGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCCCCTTCCHHHH
T ss_pred             c-cccccCCccccCcCChhhhccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhccCCCCCCCCCCHHHH
Confidence            1 122334457889999999988777 58999999999999654  3333                    2445789999


Q ss_pred             HHHHHhcCCCCCCCCCHHhhhc
Q 014609          226 NLLRKILEPNPVKRITIAGIKA  247 (421)
Q Consensus       226 ~li~~~L~~dP~~R~t~~eil~  247 (421)
                      ++|.+||..||.+|||+.++++
T Consensus       243 ~li~~~l~~dp~~Rps~~~~~~  264 (288)
T 3kfa_A          243 ELMRACWQWNPSDRPSFAEIHQ  264 (288)
T ss_dssp             HHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHhCCChhhCcCHHHHHH
Confidence            9999999999999999999876

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=2.4e-43  Score=342.82  Aligned_cols=234  Identities=26%  Similarity=0.391  Sum_probs=197.4

Q ss_pred             CeeecceEEeceEeecCcEEEEEEEECCCCceE--EEEEeecccccchhHHHHHHHHHHHHhcC-CCCCcceEEEEEEeC
Q 014609           10 GMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPF--AVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEVLASK   86 (421)
Q Consensus        10 ~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~v--AvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~   86 (421)
                      ...+++|++.+.||+|+||.||+|++..+|..+  |+|.+....  .....+.+.+|+.+++++ +||||+++++++.+.
T Consensus        21 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~   98 (327)
T 1fvr_A           21 VLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA--SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHR   98 (327)
T ss_dssp             BCCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC--------CHHHHHHHHHTTCCCCTTBCCEEEEEEET
T ss_pred             cccHHHccceeeeecCCCceEEEEEEccCCcccceeeeeecccc--chHHHHHHHHHHHHHHhccCCCchhhhceeeeeC
Confidence            456789999999999999999999998888865  999887432  222356789999999999 899999999999999


Q ss_pred             CEEEEEEeccCCCChHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccC
Q 014609           87 SKIYMVLEYVTGGELFDKIASKG----------------RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSK  150 (421)
Q Consensus        87 ~~~~lv~E~~~gg~L~~~i~~~~----------------~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~  150 (421)
                      +..|+||||+++++|.+++....                .+++..++.++.||+.||+|||++||+||||||+|||++.+
T Consensus        99 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~  178 (327)
T 1fvr_A           99 GYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGEN  178 (327)
T ss_dssp             TEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGG
T ss_pred             CceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccceEEEcCC
Confidence            99999999999999999997653                69999999999999999999999999999999999999999


Q ss_pred             CCEEEEeccCCCCCccccCCCccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhhc--CCcC-------------
Q 014609          151 GNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIFR--GDFK-------------  215 (421)
Q Consensus       151 ~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~~--~~~~-------------  215 (421)
                      +.+||+|||++......   .......+++.|+|||++.+..+ +.++|||||||++|.+.  |..+             
T Consensus       179 ~~~kL~Dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~  254 (327)
T 1fvr_A          179 YVAKIADFGLSRGQEVY---VKKTMGRLPVRWMAIESLNYSVY-TTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKL  254 (327)
T ss_dssp             GCEEECCTTCEESSCEE---CCC----CCTTTCCHHHHHHCEE-CHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHG
T ss_pred             CeEEEcccCcCcccccc---ccccCCCCCccccChhhhccccC-CchhcchHHHHHHHHHHcCCCCCCCCCcHHHHHHHh
Confidence            99999999998743221   12234467889999999987766 58999999999999654  4433             


Q ss_pred             -------CCCCCCHHHHHHHHHhcCCCCCCCCCHHhhhcCc
Q 014609          216 -------LPKWLSPGAQNLLRKILEPNPVKRITIAGIKADE  249 (421)
Q Consensus       216 -------~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~~~  249 (421)
                             .|..+++.+.++|.+||..||.+|||+.+++++-
T Consensus       255 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L  295 (327)
T 1fvr_A          255 PQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSL  295 (327)
T ss_dssp             GGTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             hcCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHH
Confidence                   2345789999999999999999999999998864

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=9.5e-44  Score=345.64  Aligned_cols=241  Identities=22%  Similarity=0.260  Sum_probs=198.3

Q ss_pred             CeeecceEEeceEeecCcEEEEEEE-----ECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEE
Q 014609           10 GMRLGRYELGRTLGEGNFGKVKFAQ-----DLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLA   84 (421)
Q Consensus        10 ~~~~~~y~i~~~LG~G~~g~V~~a~-----~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~   84 (421)
                      ....++|++++.||+|+||.||+|.     +..+++.||||++....  .......+.+|+.++++++||||+++++++.
T Consensus        26 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~  103 (327)
T 2yfx_A           26 EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC--SEQDELDFLMEALIISKFNHQNIVRCIGVSL  103 (327)
T ss_dssp             BCCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             cCChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEecccc--chhhHHHHHHHHHHHhhCCCCCCCeEEEEEc
Confidence            3456899999999999999999998     55688999999996432  2334567899999999999999999999999


Q ss_pred             eCCEEEEEEeccCCCChHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccC---CCEE
Q 014609           85 SKSKIYMVLEYVTGGELFDKIASKG-------RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSK---GNIK  154 (421)
Q Consensus        85 ~~~~~~lv~E~~~gg~L~~~i~~~~-------~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~---~~~k  154 (421)
                      .....|+||||++|++|.+++....       .+++..++.++.|++.||.|||++||+||||||+|||++.+   +.+|
T Consensus       104 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~~~~~~k  183 (327)
T 2yfx_A          104 QSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAK  183 (327)
T ss_dssp             SSSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEE
T ss_pred             CCCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCCCcceEE
Confidence            9999999999999999999998653       48999999999999999999999999999999999999854   4699


Q ss_pred             EEeccCCCCCccccCCCccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhhc--CCcC-----------------
Q 014609          155 ISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIFR--GDFK-----------------  215 (421)
Q Consensus       155 L~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~~--~~~~-----------------  215 (421)
                      |+|||++................||+.|+|||++.+..+ +.++|||||||++|.+.  |..+                 
T Consensus       184 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~  262 (327)
T 2yfx_A          184 IGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIF-TSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGG  262 (327)
T ss_dssp             ECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTC
T ss_pred             ECccccccccccccccccCCCcCCCcceeCHhHhcCCCC-CchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHHHHhcCC
Confidence            999999874322222223345578999999999988777 58999999999999654  4333                 


Q ss_pred             ---CCCCCCHHHHHHHHHhcCCCCCCCCCHHhhhcCccccc
Q 014609          216 ---LPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQ  253 (421)
Q Consensus       216 ---~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~~~w~~~  253 (421)
                         .|..+++.+.++|.+||+.||.+|||+.+++++.|+..
T Consensus       263 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~  303 (327)
T 2yfx_A          263 RMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCT  303 (327)
T ss_dssp             CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             CCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHh
Confidence               23457899999999999999999999999999999764

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=3.5e-44  Score=347.81  Aligned_cols=234  Identities=22%  Similarity=0.317  Sum_probs=198.3

Q ss_pred             eecceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEE
Q 014609           12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYM   91 (421)
Q Consensus        12 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l   91 (421)
                      ..++|++.+.||+|+||+||+|.+ .+|+.||||++....   ....+.+.+|+.+++.++||||+++++++...+..|+
T Consensus        37 ~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  112 (321)
T 2qkw_B           37 ATNNFDHKFLIGHGVFGKVYKGVL-RDGAKVALKRRTPES---SQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMIL  112 (321)
T ss_dssp             CCCCCSCCCCSCBCSSSEEEEEEC-TTCCEEEEEECCSCC---SSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCEE
T ss_pred             HHhccCccceeecCCCeeEEEEEE-CCCCEEEEEEecccC---hHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEE
Confidence            457999999999999999999996 578999999886543   2335789999999999999999999999999999999


Q ss_pred             EEeccCCCChHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCccc
Q 014609           92 VLEYVTGGELFDKIASKG----RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHF  167 (421)
Q Consensus        92 v~E~~~gg~L~~~i~~~~----~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~  167 (421)
                      ||||++|++|.+++....    .+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||++......
T Consensus       113 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  192 (321)
T 2qkw_B          113 IYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKKGTEL  192 (321)
T ss_dssp             EEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEECTTCCEEECCCTTCEECSSS
T ss_pred             EEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEECCCCCEEEeecccccccccc
Confidence            999999999999886533    5899999999999999999999999999999999999999999999999999754332


Q ss_pred             cCCCccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhh-cCCcCCC-----------------------------
Q 014609          168 RDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIF-RGDFKLP-----------------------------  217 (421)
Q Consensus       168 ~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~-~~~~~~p-----------------------------  217 (421)
                      .........+||+.|+|||++.+..+ +.++|||||||++|.+ .|..++.                             
T Consensus       193 ~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  271 (321)
T 2qkw_B          193 DQTHLSTVVKGTLGYIDPEYFIKGRL-TEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDP  271 (321)
T ss_dssp             SCCCCBCCCEEETTTCCHHHHHHCBC-CTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCCSSSSS
T ss_pred             cccccccccCCCccccCHHHhcCCCC-CcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHHHhcCh
Confidence            22333445679999999999987777 5899999999999954 3332221                             


Q ss_pred             -------CCCCHHHHHHHHHhcCCCCCCCCCHHhhhcCcc
Q 014609          218 -------KWLSPGAQNLLRKILEPNPVKRITIAGIKADEW  250 (421)
Q Consensus       218 -------~~~s~~~~~li~~~L~~dP~~R~t~~eil~~~w  250 (421)
                             +..+..+.+++.+||+.||.+|||+.+++++..
T Consensus       272 ~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~  311 (321)
T 2qkw_B          272 NLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLE  311 (321)
T ss_dssp             SCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             hhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHH
Confidence                   112356789999999999999999999998754

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=2.4e-43  Score=341.50  Aligned_cols=235  Identities=22%  Similarity=0.306  Sum_probs=199.9

Q ss_pred             eeecceEEeceEeecCcEEEEEEEEC-----CCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEe
Q 014609           11 MRLGRYELGRTLGEGNFGKVKFAQDL-----DSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLAS   85 (421)
Q Consensus        11 ~~~~~y~i~~~LG~G~~g~V~~a~~~-----~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~   85 (421)
                      ...++|++.+.||+|+||.||+|.+.     .+++.||+|++....  .......+.+|+.+++.++||||+++++++.+
T Consensus        22 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~   99 (322)
T 1p4o_A           22 VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA--SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQ   99 (322)
T ss_dssp             CCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS--CHHHHHHHHHHHHHGGGCCCTTBCCEEEEECS
T ss_pred             chhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEeccccc--CHHHHHHHHHHHHHHHhcCCCCEeeeEEEEcc
Confidence            34479999999999999999999876     467899999997543  22335678999999999999999999999999


Q ss_pred             CCEEEEEEeccCCCChHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEE
Q 014609           86 KSKIYMVLEYVTGGELFDKIASK----------GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKI  155 (421)
Q Consensus        86 ~~~~~lv~E~~~gg~L~~~i~~~----------~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL  155 (421)
                      .+..|+||||++|++|.+++...          ..+++..+..++.|++.||+|||++||+||||||+|||++.++.+||
T Consensus       100 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~kl  179 (322)
T 1p4o_A          100 GQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKI  179 (322)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCCEEE
T ss_pred             CCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEEcCCCeEEE
Confidence            99999999999999999988652          45799999999999999999999999999999999999999999999


Q ss_pred             EeccCCCCCccccCCCccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhhc--CCcC------------------
Q 014609          156 SDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIFR--GDFK------------------  215 (421)
Q Consensus       156 ~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~~--~~~~------------------  215 (421)
                      +|||++................+|+.|+|||++.+..+ +.++|||||||++|.+.  |..+                  
T Consensus       180 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~  258 (322)
T 1p4o_A          180 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVF-TTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGL  258 (322)
T ss_dssp             CCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTTCC
T ss_pred             CcCccccccccccccccccCCCCCCCccChhhhccCCC-CchhhHHHHHHHHHHHHhcCCCccccCCHHHHHHHHHcCCc
Confidence            99999985433222222334467889999999988777 58999999999999543  3322                  


Q ss_pred             --CCCCCCHHHHHHHHHhcCCCCCCCCCHHhhhcC
Q 014609          216 --LPKWLSPGAQNLLRKILEPNPVKRITIAGIKAD  248 (421)
Q Consensus       216 --~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~~  248 (421)
                        .|..+++.+.++|.+||+.||.+|||+.+++++
T Consensus       259 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~  293 (322)
T 1p4o_A          259 LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS  293 (322)
T ss_dssp             CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence              345688999999999999999999999999886

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=7.5e-43  Score=332.56  Aligned_cols=229  Identities=26%  Similarity=0.435  Sum_probs=194.2

Q ss_pred             eeecceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhH----HHHHHHHHHHHhcCCCCCcceEEEEEEeC
Q 014609           11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKI----TDQIKREIATLKLLKHPNVVRLHEVLASK   86 (421)
Q Consensus        11 ~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~----~~~~~~Ei~il~~l~hpnIv~l~~~~~~~   86 (421)
                      ..-++|++.+.||+|+||+||+|++..+++.||+|++..........    .+.+.+|+.++++++||||+++++++.+.
T Consensus        16 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~   95 (287)
T 4f0f_A           16 LADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNP   95 (287)
T ss_dssp             CCSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTT
T ss_pred             hhhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCC
Confidence            44579999999999999999999999999999999997654332221    16789999999999999999999999776


Q ss_pred             CEEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC--ceeccCCCCCEEeccCCC-----EEEEec
Q 014609           87 SKIYMVLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNKG--VFHRDLKLENILLDSKGN-----IKISDF  158 (421)
Q Consensus        87 ~~~~lv~E~~~gg~L~~~i~~~-~~~~~~~~~~~~~ql~~aL~~LH~~g--i~HrDlkp~NILl~~~~~-----~kL~DF  158 (421)
                      .  ++||||+++++|.+.+... ..+++..+..++.|++.||+|||++|  |+||||||+|||++.++.     +||+||
T Consensus        96 ~--~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~Df  173 (287)
T 4f0f_A           96 P--RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADF  173 (287)
T ss_dssp             T--EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCCEEECCC
T ss_pred             C--eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCceeEEeCCC
Confidence            6  6999999999999888654 47999999999999999999999999  999999999999988876     999999


Q ss_pred             cCCCCCccccCCCccccccCCCCccChhhhcc--cCCCCCcchHHHHHHHHhhh-cCCc---------------------
Q 014609          159 GLSALPQHFRDDGLLHTTCGSPNYVAPEVLAN--RGYDGATSDIWSCGVILYIF-RGDF---------------------  214 (421)
Q Consensus       159 Gla~~~~~~~~~~~~~~~~gt~~y~APEvl~~--~~~~~~~~DiwSlGvil~~~-~~~~---------------------  214 (421)
                      |++....     .......||+.|+|||++..  ..+ +.++||||+||++|.+ .|..                     
T Consensus       174 g~~~~~~-----~~~~~~~g~~~y~aPE~~~~~~~~~-~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~  247 (287)
T 4f0f_A          174 GLSQQSV-----HSVSGLLGNFQWMAPETIGAEEESY-TEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGL  247 (287)
T ss_dssp             TTCBCCS-----SCEECCCCCCTTSCGGGSSCSSCEE-CHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHHHSCC
T ss_pred             Ccccccc-----ccccccCCCccccCchhhccCCCCc-CchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHhccCC
Confidence            9997432     23445689999999999843  333 5789999999999943 3332                     


Q ss_pred             --CCCCCCCHHHHHHHHHhcCCCCCCCCCHHhhhc
Q 014609          215 --KLPKWLSPGAQNLLRKILEPNPVKRITIAGIKA  247 (421)
Q Consensus       215 --~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~  247 (421)
                        ..|..+++.+.++|.+||+.||.+|||+.++++
T Consensus       248 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  282 (287)
T 4f0f_A          248 RPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVK  282 (287)
T ss_dssp             CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence              234567899999999999999999999999875

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=4e-43  Score=335.48  Aligned_cols=233  Identities=24%  Similarity=0.323  Sum_probs=194.2

Q ss_pred             eecceEEec-eEeecCcEEEEEEEE--CCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCE
Q 014609           12 RLGRYELGR-TLGEGNFGKVKFAQD--LDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSK   88 (421)
Q Consensus        12 ~~~~y~i~~-~LG~G~~g~V~~a~~--~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~   88 (421)
                      ..++|++.+ .||+|+||+||+|.+  ..+++.||||++..... .....+.+.+|+.+++.++||||+++++++ ..+.
T Consensus        14 ~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~   91 (291)
T 1xbb_A           14 DRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAN-DPALKDELLAEANVMQQLDNPYIVRMIGIC-EAES   91 (291)
T ss_dssp             CGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC------CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSS
T ss_pred             cchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeeccccc-CHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCC
Confidence            346899998 999999999999954  56789999999976532 233457899999999999999999999999 5667


Q ss_pred             EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCcccc
Q 014609           89 IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFR  168 (421)
Q Consensus        89 ~~lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~~  168 (421)
                      .|+||||+++++|.+++...+.+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||++.......
T Consensus        92 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~  171 (291)
T 1xbb_A           92 WMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADE  171 (291)
T ss_dssp             EEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTC
T ss_pred             cEEEEEeCCCCCHHHHHHhCcCCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEeCCCcEEEccCCcceeeccCC
Confidence            89999999999999999988889999999999999999999999999999999999999999999999999997543311


Q ss_pred             CC-CccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhhc--CCcC--------------------CCCCCCHHHH
Q 014609          169 DD-GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIFR--GDFK--------------------LPKWLSPGAQ  225 (421)
Q Consensus       169 ~~-~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~~--~~~~--------------------~p~~~s~~~~  225 (421)
                      .. .......+|+.|+|||++.+..+ +.++||||||+++|.+.  |..+                    .|..+++.+.
T Consensus       172 ~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  250 (291)
T 1xbb_A          172 NYYKAQTHGKWPVKWYAPECINYYKF-SSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMY  250 (291)
T ss_dssp             SEEEC----CCCGGGCCHHHHHHCEE-EHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHH
T ss_pred             CcccccccCCCCceeeChHHhccCCC-ChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHH
Confidence            10 11223356788999999987776 48999999999999653  4433                    3455789999


Q ss_pred             HHHHHhcCCCCCCCCCHHhhhc
Q 014609          226 NLLRKILEPNPVKRITIAGIKA  247 (421)
Q Consensus       226 ~li~~~L~~dP~~R~t~~eil~  247 (421)
                      ++|.+||+.||.+|||+.++++
T Consensus       251 ~li~~~l~~dp~~Rps~~~l~~  272 (291)
T 1xbb_A          251 DLMNLCWTYDVENRPGFAAVEL  272 (291)
T ss_dssp             HHHHHHTCSSTTTSCCHHHHHH
T ss_pred             HHHHHHcCCChhhCcCHHHHHH
Confidence            9999999999999999999875

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=4.1e-43  Score=338.72  Aligned_cols=236  Identities=25%  Similarity=0.347  Sum_probs=187.0

Q ss_pred             eeecceEEeceEeecCcEEEEEEEECC---CCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCC
Q 014609           11 MRLGRYELGRTLGEGNFGKVKFAQDLD---SGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKS   87 (421)
Q Consensus        11 ~~~~~y~i~~~LG~G~~g~V~~a~~~~---~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~   87 (421)
                      ...++|++++.||+|+||.||+|.+..   +++.||+|++..... .....+.+.+|+.++++++||||+++++++....
T Consensus        31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~  109 (313)
T 3brb_A           31 IDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNS-SQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMS  109 (313)
T ss_dssp             CCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CC-CHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC--
T ss_pred             cCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEecccc-chhHHHHHHHHHHHHhcCCCCCeeeeeEEEeecc
Confidence            344799999999999999999998765   566899999975533 2334577999999999999999999999998765


Q ss_pred             E-----EEEEEeccCCCChHHHHH------hcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEE
Q 014609           88 K-----IYMVLEYVTGGELFDKIA------SKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKIS  156 (421)
Q Consensus        88 ~-----~~lv~E~~~gg~L~~~i~------~~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~  156 (421)
                      .     .|+||||+++++|.+++.      ....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+
T Consensus       110 ~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kl~  189 (313)
T 3brb_A          110 SQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVA  189 (313)
T ss_dssp             -----CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEECTTSCEEEC
T ss_pred             ccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEEe
Confidence            3     599999999999999984      23569999999999999999999999999999999999999999999999


Q ss_pred             eccCCCCCccccCCCccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhhc--CCcC-------------------
Q 014609          157 DFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIFR--GDFK-------------------  215 (421)
Q Consensus       157 DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~~--~~~~-------------------  215 (421)
                      |||++................+++.|+|||++.+..+ +.++|||||||++|.+.  |..+                   
T Consensus       190 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~  268 (313)
T 3brb_A          190 DFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVY-TSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHGHRL  268 (313)
T ss_dssp             SCSCC----------------CCGGGSCHHHHHSSCC-CHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCC
T ss_pred             ecCcceecccccccCcccccCCCccccCchhhcCCCc-cchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHHcCCCC
Confidence            9999986543222222334567889999999988777 58999999999999553  3322                   


Q ss_pred             -CCCCCCHHHHHHHHHhcCCCCCCCCCHHhhhcC
Q 014609          216 -LPKWLSPGAQNLLRKILEPNPVKRITIAGIKAD  248 (421)
Q Consensus       216 -~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~~  248 (421)
                       .|..+++.+.++|.+||..||.+|||+.+++++
T Consensus       269 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~  302 (313)
T 3brb_A          269 KQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQ  302 (313)
T ss_dssp             CCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred             CCCccccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence             334578999999999999999999999999864

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=3.7e-43  Score=335.57  Aligned_cols=231  Identities=24%  Similarity=0.426  Sum_probs=181.4

Q ss_pred             eeecceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEE
Q 014609           11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIY   90 (421)
Q Consensus        11 ~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~   90 (421)
                      ..-++|++++.||+|+||+||+|++.   ..||+|++..... .....+.+.+|+.++++++||||++++++. .....+
T Consensus        21 i~~~~y~~~~~lG~G~~g~Vy~~~~~---~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~   95 (289)
T 3og7_A           21 IPDGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAP-TPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLA   95 (289)
T ss_dssp             CCTTSCEEEEEEEECSSEEEEEEESS---SEEEEEEESCSSC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCE
T ss_pred             cCccceeeeeEecCCCCeEEEEEEEc---CceEEEEEeccCC-CHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccE
Confidence            44579999999999999999999853   3599999975433 334467899999999999999999999965 556689


Q ss_pred             EEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCccccC
Q 014609           91 MVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD  169 (421)
Q Consensus        91 lv~E~~~gg~L~~~i~~-~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~  169 (421)
                      +||||++|++|.+.+.. ...+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||++........
T Consensus        96 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  175 (289)
T 3og7_A           96 IVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSG  175 (289)
T ss_dssp             EEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTEEEECCCC----------
T ss_pred             EEEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCCCEEEccceeccccccccc
Confidence            99999999999999864 45699999999999999999999999999999999999999999999999999986544333


Q ss_pred             CCccccccCCCCccChhhhc---ccCCCCCcchHHHHHHHHhhh-cCCcCC-------------------------CCCC
Q 014609          170 DGLLHTTCGSPNYVAPEVLA---NRGYDGATSDIWSCGVILYIF-RGDFKL-------------------------PKWL  220 (421)
Q Consensus       170 ~~~~~~~~gt~~y~APEvl~---~~~~~~~~~DiwSlGvil~~~-~~~~~~-------------------------p~~~  220 (421)
                      ........||+.|+|||++.   ...+ +.++|||||||++|.+ .|..++                         +..+
T Consensus       176 ~~~~~~~~gt~~y~aPE~~~~~~~~~~-~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  254 (289)
T 3og7_A          176 SHQFEQLSGSILWMAPEVIRMQDSNPY-SFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRSNC  254 (289)
T ss_dssp             --------CCCTTCCHHHHC----CCS-CHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTSCCCCTTSSCTTS
T ss_pred             cccccccCCCccccCchhhcccCCCCC-CcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcccccCcchhhccccC
Confidence            34445668999999999986   3444 5789999999999943 343332                         1246


Q ss_pred             CHHHHHHHHHhcCCCCCCCCCHHhhhc
Q 014609          221 SPGAQNLLRKILEPNPVKRITIAGIKA  247 (421)
Q Consensus       221 s~~~~~li~~~L~~dP~~R~t~~eil~  247 (421)
                      ++.+.++|.+||+.||.+|||+.++++
T Consensus       255 ~~~l~~li~~~l~~~p~~Rps~~ell~  281 (289)
T 3og7_A          255 PKRMKRLMAECLKKKRDERPSFPRILA  281 (289)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CHHHHHHHHHHccCChhhCCCHHHHHH
Confidence            789999999999999999999999875

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=6.7e-43  Score=345.07  Aligned_cols=238  Identities=15%  Similarity=0.198  Sum_probs=193.8

Q ss_pred             cCCeeec-----ceEEeceEeecCcEEEEEEEECCC-----CceEEEEEeecccccchhH--------HHHHHHHHHHHh
Q 014609            8 QEGMRLG-----RYELGRTLGEGNFGKVKFAQDLDS-----GLPFAVKILEKNRIIHLKI--------TDQIKREIATLK   69 (421)
Q Consensus         8 ~~~~~~~-----~y~i~~~LG~G~~g~V~~a~~~~~-----~~~vAvK~i~~~~~~~~~~--------~~~~~~Ei~il~   69 (421)
                      ..|..+.     +|++++.||+|+||.||+|.+..+     ++.||||++..........        .....+|+..++
T Consensus        24 ~~g~~i~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~  103 (364)
T 3op5_A           24 AVGEIITDMAAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTR  103 (364)
T ss_dssp             CTTCEEECTTCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHT
T ss_pred             CCCcEeeccCCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHh
Confidence            3455554     899999999999999999998764     6899999987653111000        123445667788


Q ss_pred             cCCCCCcceEEEEEEeC----CEEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCC
Q 014609           70 LLKHPNVVRLHEVLASK----SKIYMVLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLEN  144 (421)
Q Consensus        70 ~l~hpnIv~l~~~~~~~----~~~~lv~E~~~gg~L~~~i~~~-~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~N  144 (421)
                      .++||||+++++++...    ...|+||||+ |++|.+++... +.+++..++.++.||+.||+|||++||+||||||+|
T Consensus       104 ~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~N  182 (364)
T 3op5_A          104 KLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASN  182 (364)
T ss_dssp             TCSCCCSCCEEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGG
T ss_pred             hccCCCCCeEEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHH
Confidence            88999999999998764    5689999999 99999999865 679999999999999999999999999999999999


Q ss_pred             EEec--cCCCEEEEeccCCCCCccccCC-----CccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhh-hcCCcCC
Q 014609          145 ILLD--SKGNIKISDFGLSALPQHFRDD-----GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYI-FRGDFKL  216 (421)
Q Consensus       145 ILl~--~~~~~kL~DFGla~~~~~~~~~-----~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~-~~~~~~~  216 (421)
                      ||++  .++.+||+|||++.........     ......+||+.|+|||++.+..+ +.++|||||||++|. +.|..++
T Consensus       183 ill~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~~l~el~~g~~Pf  261 (364)
T 3op5_A          183 LLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAP-SRRGDLEILGYCMIQWLTGHLPW  261 (364)
T ss_dssp             EEEESSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCC-CHHHHHHHHHHHHHHHHHSCCTT
T ss_pred             EEEecCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCC-CchhhHHHHHHHHHHHHhCCCCc
Confidence            9999  8899999999999765432211     12244569999999999988877 589999999999994 4555554


Q ss_pred             C------------------------------CCCCHHHHHHHHHhcCCCCCCCCCHHhhhc
Q 014609          217 P------------------------------KWLSPGAQNLLRKILEPNPVKRITIAGIKA  247 (421)
Q Consensus       217 p------------------------------~~~s~~~~~li~~~L~~dP~~R~t~~eil~  247 (421)
                      .                              ..+++++.+++.+||..||.+||++.++++
T Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~  322 (364)
T 3op5_A          262 EDNLKDPKYVRDSKIRYRENIASLMDKCFPAANAPGEIAKYMETVKLLDYTEKPLYENLRD  322 (364)
T ss_dssp             GGGTTCHHHHHHHHHHHHHCHHHHHHHHSCTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred             cccccCHHHHHHHHHHhhhhHHHHHHHhcccccCHHHHHHHHHHHhcCCCCCCCCHHHHHH
Confidence            3                              345889999999999999999999999876

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=6e-43  Score=329.26  Aligned_cols=230  Identities=23%  Similarity=0.383  Sum_probs=197.6

Q ss_pred             eecceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEE
Q 014609           12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYM   91 (421)
Q Consensus        12 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l   91 (421)
                      ..++|++.+.||+|+||.||+|.+. +++.||+|++......    .+.+.+|+.++++++||||+++++++.+.+..|+
T Consensus         6 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   80 (267)
T 3t9t_A            6 DPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMS----EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICL   80 (267)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTTBC----HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEE
T ss_pred             chhheeeeeEecCCCceeEEEEEec-CCCeEEEEEccccCCC----HHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEE
Confidence            3478999999999999999999985 6789999999765432    3678999999999999999999999999999999


Q ss_pred             EEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCccccCC
Q 014609           92 VLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD  170 (421)
Q Consensus        92 v~E~~~gg~L~~~i~~~-~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~  170 (421)
                      ||||+++++|.+++... ..+++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||++....... .
T Consensus        81 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~-~  159 (267)
T 3t9t_A           81 VTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ-Y  159 (267)
T ss_dssp             EECCCTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHH-H
T ss_pred             EEeCCCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEECCCCCEEEccccccccccccc-c
Confidence            99999999999999764 568999999999999999999999999999999999999999999999999987543211 1


Q ss_pred             CccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhhc--CCcCC--------------------CCCCCHHHHHHH
Q 014609          171 GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIFR--GDFKL--------------------PKWLSPGAQNLL  228 (421)
Q Consensus       171 ~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~~--~~~~~--------------------p~~~s~~~~~li  228 (421)
                      .......+|+.|+|||++.+..+ +.++||||+|+++|.+.  |..++                    |...++.+.+++
T Consensus       160 ~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li  238 (267)
T 3t9t_A          160 TSSTGTKFPVKWASPEVFSFSRY-SSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIM  238 (267)
T ss_dssp             HSTTSTTCCGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTSCHHHHHHH
T ss_pred             cccccccccccccChhhhcCCCc-cchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHHhcCCcCCCCccCcHHHHHHH
Confidence            11233457788999999987777 58999999999999653  34332                    345789999999


Q ss_pred             HHhcCCCCCCCCCHHhhhcC
Q 014609          229 RKILEPNPVKRITIAGIKAD  248 (421)
Q Consensus       229 ~~~L~~dP~~R~t~~eil~~  248 (421)
                      .+||+.||.+|||+.+++++
T Consensus       239 ~~~l~~~p~~Rps~~~ll~~  258 (267)
T 3t9t_A          239 NHCWRERPEDRPAFSRLLRQ  258 (267)
T ss_dssp             HHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHccCChhhCcCHHHHHHH
Confidence            99999999999999999864

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=2.9e-43  Score=349.22  Aligned_cols=234  Identities=23%  Similarity=0.377  Sum_probs=188.5

Q ss_pred             eeecceEEeceEeecCcEEEEEEEEC---CCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCC
Q 014609           11 MRLGRYELGRTLGEGNFGKVKFAQDL---DSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKS   87 (421)
Q Consensus        11 ~~~~~y~i~~~LG~G~~g~V~~a~~~---~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~   87 (421)
                      ...++|++.+.||+|+||.||+|++.   .++..||||+++...  .....+.+.+|+.++++++||||+++++++...+
T Consensus        42 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~  119 (373)
T 2qol_A           42 LDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGY--TEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSK  119 (373)
T ss_dssp             CCGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS
T ss_pred             cCHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCcc--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCC
Confidence            44568999999999999999999876   467789999997542  2334578999999999999999999999999999


Q ss_pred             EEEEEEeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCcc
Q 014609           88 KIYMVLEYVTGGELFDKIASKG-RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQH  166 (421)
Q Consensus        88 ~~~lv~E~~~gg~L~~~i~~~~-~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~  166 (421)
                      ..|+||||++|++|.+++...+ .+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||++.....
T Consensus       120 ~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~  199 (373)
T 2qol_A          120 PVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLED  199 (373)
T ss_dssp             SCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred             ceEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEcCCCCEEECcCcccccccc
Confidence            9999999999999999997643 699999999999999999999999999999999999999999999999999986543


Q ss_pred             ccCC-CccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhh-c-CCcCC--------------------CCCCCHH
Q 014609          167 FRDD-GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIF-R-GDFKL--------------------PKWLSPG  223 (421)
Q Consensus       167 ~~~~-~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~-~-~~~~~--------------------p~~~s~~  223 (421)
                      .... .......+|+.|+|||++.+..+ +.++|||||||++|.+ . |..++                    |..+++.
T Consensus       200 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~  278 (373)
T 2qol_A          200 DPEAAYTTRGGKIPIRWTSPEAIAYRKF-TSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPMDCPAA  278 (373)
T ss_dssp             --------------CTTSCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHHHTTEECCCCTTCBHH
T ss_pred             CCccceeccCCCcCCCccChhhhccCCc-CchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCccccHH
Confidence            2111 11122345778999999988777 5899999999999964 3 55443                    3457889


Q ss_pred             HHHHHHHhcCCCCCCCCCHHhhhc
Q 014609          224 AQNLLRKILEPNPVKRITIAGIKA  247 (421)
Q Consensus       224 ~~~li~~~L~~dP~~R~t~~eil~  247 (421)
                      +.++|.+||+.||.+||++.++++
T Consensus       279 l~~li~~cl~~dp~~RPs~~~i~~  302 (373)
T 2qol_A          279 LYQLMLDCWQKDRNNRPKFEQIVS  302 (373)
T ss_dssp             HHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHHhCcChhhCcCHHHHHH
Confidence            999999999999999999999876

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=9.8e-44  Score=355.26  Aligned_cols=231  Identities=26%  Similarity=0.437  Sum_probs=193.3

Q ss_pred             eecceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCC--EE
Q 014609           12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKS--KI   89 (421)
Q Consensus        12 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~--~~   89 (421)
                      .-++|++.+.||+|+||+||+|++..+|+.||||++.......  ..+.+.+|+.++++++||||+++++++...+  ..
T Consensus         7 ~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~   84 (396)
T 4eut_A            7 SNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLR--PVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHK   84 (396)
T ss_dssp             SSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGS--CHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCE
T ss_pred             CCCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccc--hHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCee
Confidence            3478999999999999999999999999999999997544322  2567889999999999999999999998765  78


Q ss_pred             EEEEeccCCCChHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEe----ccCCCEEEEeccCCC
Q 014609           90 YMVLEYVTGGELFDKIASKG---RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILL----DSKGNIKISDFGLSA  162 (421)
Q Consensus        90 ~lv~E~~~gg~L~~~i~~~~---~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl----~~~~~~kL~DFGla~  162 (421)
                      |+||||++|++|.+++....   .+++..++.++.||+.||+|||++||+||||||+|||+    +.++.+||+|||++.
T Consensus        85 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~  164 (396)
T 4eut_A           85 VLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR  164 (396)
T ss_dssp             EEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCEEEEECCGGGCE
T ss_pred             EEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCceeEEEecCCCce
Confidence            99999999999999987543   39999999999999999999999999999999999999    777789999999997


Q ss_pred             CCccccCCCccccccCCCCccChhhhcc--------cCCCCCcchHHHHHHHHhhh-cCCcCCC----------------
Q 014609          163 LPQHFRDDGLLHTTCGSPNYVAPEVLAN--------RGYDGATSDIWSCGVILYIF-RGDFKLP----------------  217 (421)
Q Consensus       163 ~~~~~~~~~~~~~~~gt~~y~APEvl~~--------~~~~~~~~DiwSlGvil~~~-~~~~~~p----------------  217 (421)
                      ....   .......+||+.|+|||++.+        ..+ +.++|||||||++|.+ .|..++.                
T Consensus       165 ~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~-~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~  240 (396)
T 4eut_A          165 ELED---DEQFVSLYGTEEYLHPDMYERAVLRKDHQKKY-GATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKII  240 (396)
T ss_dssp             ECCC---GGGSSCSSSCCTTCCHHHHHHHCC--CHHHHH-HHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHH
T ss_pred             EccC---CCccccccCCccccCHHHhhccccccccccCC-CcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHh
Confidence            5433   223345679999999999865        334 5789999999999944 3433321                


Q ss_pred             --------------------------------CCCCHHHHHHHHHhcCCCCCCCCCHHhhhcC
Q 014609          218 --------------------------------KWLSPGAQNLLRKILEPNPVKRITIAGIKAD  248 (421)
Q Consensus       218 --------------------------------~~~s~~~~~li~~~L~~dP~~R~t~~eil~~  248 (421)
                                                      ..+++.+.++|++||+.||.+|||+.+++++
T Consensus       241 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~  303 (396)
T 4eut_A          241 TGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAE  303 (396)
T ss_dssp             HSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHH
T ss_pred             cCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHH
Confidence                                            0123567899999999999999999997554

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=3.5e-42  Score=328.95  Aligned_cols=228  Identities=22%  Similarity=0.275  Sum_probs=193.1

Q ss_pred             ecceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEE-EEeCCEEEE
Q 014609           13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEV-LASKSKIYM   91 (421)
Q Consensus        13 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~-~~~~~~~~l   91 (421)
                      -++|++++.||+|+||.||+|++..+|+.||||++.....     .+.+.+|+.+++.++|++++..+.. .......|+
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~l   82 (296)
T 3uzp_A            8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK-----HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVM   82 (296)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS-----CCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEE
T ss_pred             ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc-----hhHHHHHHHHHHHhhcCCCCCccccccCCCCceEE
Confidence            4789999999999999999999999999999999875432     2458899999999998876655554 467788999


Q ss_pred             EEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEe---ccCCCEEEEeccCCCCCccc
Q 014609           92 VLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILL---DSKGNIKISDFGLSALPQHF  167 (421)
Q Consensus        92 v~E~~~gg~L~~~i~~-~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl---~~~~~~kL~DFGla~~~~~~  167 (421)
                      ||||+ +++|.+++.. ...+++..++.++.|++.||+|||++||+||||||+|||+   +.++.+||+|||++......
T Consensus        83 v~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~  161 (296)
T 3uzp_A           83 VMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA  161 (296)
T ss_dssp             EEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCT
T ss_pred             EEEec-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCccccccc
Confidence            99999 9999999974 5679999999999999999999999999999999999999   48889999999999865432


Q ss_pred             cCC-----CccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhh-cCCcCCC------------------------
Q 014609          168 RDD-----GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIF-RGDFKLP------------------------  217 (421)
Q Consensus       168 ~~~-----~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~-~~~~~~p------------------------  217 (421)
                      ...     ......+||+.|+|||++.+..+ +.++|||||||++|.+ .|..++.                        
T Consensus       162 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  240 (296)
T 3uzp_A          162 RTHQHIPYRENKNLTGTARYASINTHLGIEQ-SRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIE  240 (296)
T ss_dssp             TTCCBCCCCCSCCCCSCTTTCCHHHHTTCCC-CHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCHH
T ss_pred             ccccccccccccccccccccCChhhhcCCCC-CcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCchH
Confidence            211     12345689999999999988776 5899999999999954 4444432                        


Q ss_pred             ---CCCCHHHHHHHHHhcCCCCCCCCCHHhhhc
Q 014609          218 ---KWLSPGAQNLLRKILEPNPVKRITIAGIKA  247 (421)
Q Consensus       218 ---~~~s~~~~~li~~~L~~dP~~R~t~~eil~  247 (421)
                         ..+|+.+.++|.+||+.||.+|||+.++++
T Consensus       241 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~  273 (296)
T 3uzp_A          241 VLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ  273 (296)
T ss_dssp             HHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred             HHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHH
Confidence               346889999999999999999999999876

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=7.1e-43  Score=342.40  Aligned_cols=232  Identities=17%  Similarity=0.210  Sum_probs=190.5

Q ss_pred             cceEEeceEeecCcEEEEEEEECC---CCceEEEEEeecccccchh--------HHHHHHHHHHHHhcCCCCCcceEEEE
Q 014609           14 GRYELGRTLGEGNFGKVKFAQDLD---SGLPFAVKILEKNRIIHLK--------ITDQIKREIATLKLLKHPNVVRLHEV   82 (421)
Q Consensus        14 ~~y~i~~~LG~G~~g~V~~a~~~~---~~~~vAvK~i~~~~~~~~~--------~~~~~~~Ei~il~~l~hpnIv~l~~~   82 (421)
                      ++|++++.||+|+||+||+|.+..   ++..||+|++.........        ....+.+|+.+++.++||||++++++
T Consensus        37 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~~  116 (345)
T 2v62_A           37 NQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGS  116 (345)
T ss_dssp             CEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEEE
T ss_pred             ceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeecc
Confidence            479999999999999999999987   8899999998765321100        11346788899999999999999999


Q ss_pred             EEe----CCEEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCC--CEEEE
Q 014609           83 LAS----KSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKG--NIKIS  156 (421)
Q Consensus        83 ~~~----~~~~~lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~--~~kL~  156 (421)
                      +..    ....|+||||+ |++|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++  .+||+
T Consensus       117 ~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kL~  195 (345)
T 2v62_A          117 GLTEFKGRSYRFMVMERL-GIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYLA  195 (345)
T ss_dssp             EEEESSSCEEEEEEEECE-EEEHHHHCBGGGBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEESSSTTSEEEC
T ss_pred             cccccCCCcEEEEEEecc-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEccCCCCcEEEE
Confidence            988    78899999999 999999998777899999999999999999999999999999999999999887  99999


Q ss_pred             eccCCCCCccccC-----CCccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhh-hcCCcCCCC------------
Q 014609          157 DFGLSALPQHFRD-----DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYI-FRGDFKLPK------------  218 (421)
Q Consensus       157 DFGla~~~~~~~~-----~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~-~~~~~~~p~------------  218 (421)
                      |||++........     .......+||+.|+|||++.+..+ +.++|||||||++|. +.|..++..            
T Consensus       196 Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~  274 (345)
T 2v62_A          196 DYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVAL-SRRSDVEILGYCMLRWLCGKLPWEQNLKDPVAVQTAK  274 (345)
T ss_dssp             CCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCC-CHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHHHHHHH
T ss_pred             eCCCceecccccccccchhccccccCCCccccCHHHhcCCCC-CchhhHHHHHHHHHHHHhCCCCccccccccHHHHHHH
Confidence            9999975533211     122245689999999999988776 589999999999994 445554421            


Q ss_pred             ------------------CCCHHHHHHHHHhcCCCCCCCCCHHhhhc
Q 014609          219 ------------------WLSPGAQNLLRKILEPNPVKRITIAGIKA  247 (421)
Q Consensus       219 ------------------~~s~~~~~li~~~L~~dP~~R~t~~eil~  247 (421)
                                        .+++.+.++|.+||..||.+|||+.++++
T Consensus       275 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~  321 (345)
T 2v62_A          275 TNLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKK  321 (345)
T ss_dssp             HHHHHTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred             HhhcccccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHH
Confidence                              56779999999999999999999999876

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=1.2e-42  Score=330.29  Aligned_cols=236  Identities=24%  Similarity=0.362  Sum_probs=196.5

Q ss_pred             cCCeeecceEEeceEeecCcEEEEEEEECC---CCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEE
Q 014609            8 QEGMRLGRYELGRTLGEGNFGKVKFAQDLD---SGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLA   84 (421)
Q Consensus         8 ~~~~~~~~y~i~~~LG~G~~g~V~~a~~~~---~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~   84 (421)
                      ..+...++|++.+.||+|+||+||+|.+..   ++..||+|++....  .....+.+.+|+.++++++||||+++++++.
T Consensus         6 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~   83 (281)
T 3cc6_A            6 QYGIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDC--TLDNKEKFMSEAVIMKNLDHPHIVKLIGIIE   83 (281)
T ss_dssp             CCSCCGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTS--CHHHHHHHHHHHHHHHHHCCTTBCCEEEEEC
T ss_pred             cceecccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEeccccc--CchHHHHHHHHHHHHHhCCCCCcceEEEEEc
Confidence            446677899999999999999999998654   34569999987643  2334578999999999999999999999987


Q ss_pred             eCCEEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCC
Q 014609           85 SKSKIYMVLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSAL  163 (421)
Q Consensus        85 ~~~~~~lv~E~~~gg~L~~~i~~~-~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~  163 (421)
                      ++ ..|+||||+++++|.+++... ..+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||++..
T Consensus        84 ~~-~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~  162 (281)
T 3cc6_A           84 EE-PTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRY  162 (281)
T ss_dssp             SS-SCEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEEETTEEEECCCCGGGC
T ss_pred             CC-CCEEEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEECCCCcEEeCccCCCcc
Confidence            54 568999999999999999764 4599999999999999999999999999999999999999999999999999986


Q ss_pred             CccccCCCccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhhc--CCcCC--------------------CCCCC
Q 014609          164 PQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIFR--GDFKL--------------------PKWLS  221 (421)
Q Consensus       164 ~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~~--~~~~~--------------------p~~~s  221 (421)
                      ..... ........+|+.|+|||++.+..+ +.++||||||+++|.+.  |..++                    |..++
T Consensus       163 ~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (281)
T 3cc6_A          163 IEDED-YYKASVTRLPIKWMSPESINFRRF-TTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDRLPKPDLCP  240 (281)
T ss_dssp             C----------CCCCCGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHHHTCCCCCCTTCC
T ss_pred             ccccc-ccccccCCCCcceeCchhhccCCC-CchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHhcCCCCCCCCCCC
Confidence            53321 112234457889999999987777 58999999999999653  44433                    44578


Q ss_pred             HHHHHHHHHhcCCCCCCCCCHHhhhcC
Q 014609          222 PGAQNLLRKILEPNPVKRITIAGIKAD  248 (421)
Q Consensus       222 ~~~~~li~~~L~~dP~~R~t~~eil~~  248 (421)
                      +.+.++|.+||+.||.+|||+.+++++
T Consensus       241 ~~l~~li~~~l~~~p~~Rps~~ell~~  267 (281)
T 3cc6_A          241 PVLYTLMTRCWDYDPSDRPRFTELVCS  267 (281)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHHHccCCchhCcCHHHHHHH
Confidence            999999999999999999999999875

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=2e-42  Score=351.50  Aligned_cols=224  Identities=26%  Similarity=0.475  Sum_probs=192.9

Q ss_pred             eeecceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCC-EE
Q 014609           11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKS-KI   89 (421)
Q Consensus        11 ~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~-~~   89 (421)
                      ...++|++++.||+|+||+||+|.+.  |+.||||+++...     ..+.+.+|+.+|++++||||+++++++.... .+
T Consensus       190 i~~~~~~~~~~lG~G~fg~V~~~~~~--~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  262 (450)
T 1k9a_A          190 LNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGL  262 (450)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEET--TEEEEEEEESSCT-----TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCE
T ss_pred             cChHHeEEEeeecCcCCeeEEEEEec--CCeEEEEEeCCch-----HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCce
Confidence            45679999999999999999999874  7899999997543     2467899999999999999999999987665 79


Q ss_pred             EEEEeccCCCChHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCccc
Q 014609           90 YMVLEYVTGGELFDKIASKGR--LQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHF  167 (421)
Q Consensus        90 ~lv~E~~~gg~L~~~i~~~~~--~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~  167 (421)
                      |+||||+++|+|.+++...+.  +++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||++..... 
T Consensus       263 ~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~-  341 (450)
T 1k9a_A          263 YIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS-  341 (450)
T ss_dssp             EEEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTSCEEECCCTTCEECC--
T ss_pred             EEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEECCCCCEEEeeCCCcccccc-
Confidence            999999999999999987543  79999999999999999999999999999999999999999999999999974322 


Q ss_pred             cCCCccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhhc--CCcC--------------------CCCCCCHHHH
Q 014609          168 RDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIFR--GDFK--------------------LPKWLSPGAQ  225 (421)
Q Consensus       168 ~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~~--~~~~--------------------~p~~~s~~~~  225 (421)
                          ......+++.|+|||++.+..+ +.++|||||||++|.+.  |..+                    .|..+++.+.
T Consensus       342 ----~~~~~~~~~~y~aPE~~~~~~~-~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~  416 (450)
T 1k9a_A          342 ----TQDTGKLPVKWTAPEALREKKF-STKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVY  416 (450)
T ss_dssp             ---------CCCTTTSCHHHHHSSCC-CHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHHTTCCCCCCTTCCHHHH
T ss_pred             ----cccCCCCCcceeCHHHhcCCCC-CcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHHH
Confidence                1233467889999999988877 58999999999999653  4433                    3456789999


Q ss_pred             HHHHHhcCCCCCCCCCHHhhhc
Q 014609          226 NLLRKILEPNPVKRITIAGIKA  247 (421)
Q Consensus       226 ~li~~~L~~dP~~R~t~~eil~  247 (421)
                      ++|.+||+.||.+|||+.++++
T Consensus       417 ~li~~cl~~dp~~Rpt~~~l~~  438 (450)
T 1k9a_A          417 DVMKNCWHLDAATRPTFLQLRE  438 (450)
T ss_dssp             HHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHcCCChhHCcCHHHHHH
Confidence            9999999999999999999875

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=1.9e-42  Score=330.53  Aligned_cols=227  Identities=22%  Similarity=0.283  Sum_probs=190.5

Q ss_pred             cceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEE-EEeCCEEEEE
Q 014609           14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEV-LASKSKIYMV   92 (421)
Q Consensus        14 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~-~~~~~~~~lv   92 (421)
                      ++|++++.||+|+||+||+|++..+++.||||++.....     ...+.+|+.+++.++|++++..+.. +...+..++|
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv   83 (296)
T 4hgt_A            9 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK-----HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMV   83 (296)
T ss_dssp             --CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC--------CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEE
T ss_pred             CceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccccc-----chHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEE
Confidence            689999999999999999999999999999998765432     2357889999999998776666555 4778889999


Q ss_pred             EeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEe---ccCCCEEEEeccCCCCCcccc
Q 014609           93 LEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILL---DSKGNIKISDFGLSALPQHFR  168 (421)
Q Consensus        93 ~E~~~gg~L~~~i~~-~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl---~~~~~~kL~DFGla~~~~~~~  168 (421)
                      |||+ +++|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||+   +.++.+||+|||++.......
T Consensus        84 ~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~  162 (296)
T 4hgt_A           84 MELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDAR  162 (296)
T ss_dssp             EECC-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTTCEEECCCTTCEECBCTT
T ss_pred             EEcc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCCeEEEecCccceeccCcc
Confidence            9999 9999999874 4679999999999999999999999999999999999999   788999999999998654322


Q ss_pred             CC-----CccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhh-cCCcCCC-------------------------
Q 014609          169 DD-----GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIF-RGDFKLP-------------------------  217 (421)
Q Consensus       169 ~~-----~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~-~~~~~~p-------------------------  217 (421)
                      ..     ......+||+.|+|||++.+..+ +.++||||+||++|.+ .|..+++                         
T Consensus       163 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (296)
T 4hgt_A          163 THQHIPYRENKNLTGTARYASINTHLGIEQ-SRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEV  241 (296)
T ss_dssp             TCCBCCCCCSCCCCSCGGGCCHHHHTTCCC-CHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCHHH
T ss_pred             cCccCCCCcccccCCCccccchHHhcCCCC-CchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccchhhh
Confidence            11     12345689999999999988777 5899999999999954 4554443                         


Q ss_pred             --CCCCHHHHHHHHHhcCCCCCCCCCHHhhhc
Q 014609          218 --KWLSPGAQNLLRKILEPNPVKRITIAGIKA  247 (421)
Q Consensus       218 --~~~s~~~~~li~~~L~~dP~~R~t~~eil~  247 (421)
                        ..+|+.+.++|.+||+.||.+|||+.++++
T Consensus       242 ~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~  273 (296)
T 4hgt_A          242 LCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ  273 (296)
T ss_dssp             HTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred             hhccCCHHHHHHHHHHHhcCCCCCCCHHHHHH
Confidence              335889999999999999999999999876

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.6e-42  Score=330.18  Aligned_cols=231  Identities=23%  Similarity=0.354  Sum_probs=195.0

Q ss_pred             cceEEeceEeecCcEEEEEEEECCCCc---eEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEE-
Q 014609           14 GRYELGRTLGEGNFGKVKFAQDLDSGL---PFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKI-   89 (421)
Q Consensus        14 ~~y~i~~~LG~G~~g~V~~a~~~~~~~---~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~-   89 (421)
                      -.|++.+.||+|+||+||+|.+..+++   .||+|++....  .....+.+.+|+.++++++||||+++++++.+.+.. 
T Consensus        21 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   98 (298)
T 3pls_A           21 VVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRIT--EMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLP   98 (298)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCC--SHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCC
T ss_pred             eEEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccc--cHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCc
Confidence            367888999999999999999765544   79999986432  334467889999999999999999999999876655 


Q ss_pred             EEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCcccc
Q 014609           90 YMVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFR  168 (421)
Q Consensus        90 ~lv~E~~~gg~L~~~i~~-~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~~  168 (421)
                      ++||||+.+++|.+++.. ...+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||++.......
T Consensus        99 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~  178 (298)
T 3pls_A           99 HVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDRE  178 (298)
T ss_dssp             EEEECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTGG
T ss_pred             EEEEecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEeCcCCCcccccCCc
Confidence            999999999999999976 4568999999999999999999999999999999999999999999999999997543321


Q ss_pred             --CCCccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhhcC-C---------------------cCCCCCCCHHH
Q 014609          169 --DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIFRG-D---------------------FKLPKWLSPGA  224 (421)
Q Consensus       169 --~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~~~-~---------------------~~~p~~~s~~~  224 (421)
                        .........+|+.|+|||++.+..+ +.++|||||||++|.+.. .                     .+.|..+++.+
T Consensus       179 ~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  257 (298)
T 3pls_A          179 YYSVQQHRHARLPVKWTALESLQTYRF-TTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGRRLPQPEYCPDSL  257 (298)
T ss_dssp             GGCSCCSSCTTCGGGGSCHHHHTTCCC-CHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHTTCCCCCCTTCCHHH
T ss_pred             ccccccCcCCCCCccccChhhhccCCC-ChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhcCCCCCCCccchHHH
Confidence              1223345578889999999988777 589999999999995432 2                     23345688999


Q ss_pred             HHHHHHhcCCCCCCCCCHHhhhc
Q 014609          225 QNLLRKILEPNPVKRITIAGIKA  247 (421)
Q Consensus       225 ~~li~~~L~~dP~~R~t~~eil~  247 (421)
                      .++|.+||+.||.+|||+.++++
T Consensus       258 ~~li~~~l~~~p~~Rps~~~ll~  280 (298)
T 3pls_A          258 YQVMQQCWEADPAVRPTFRVLVG  280 (298)
T ss_dssp             HHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHccCChhhCcCHHHHHH
Confidence            99999999999999999999876

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=9.1e-43  Score=337.69  Aligned_cols=233  Identities=28%  Similarity=0.398  Sum_probs=194.8

Q ss_pred             eeecce-EEeceEeecCcEEEEEEE----ECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEe
Q 014609           11 MRLGRY-ELGRTLGEGNFGKVKFAQ----DLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLAS   85 (421)
Q Consensus        11 ~~~~~y-~i~~~LG~G~~g~V~~a~----~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~   85 (421)
                      ..-++| ++++.||+|+||+||++.    +..+++.||||++....  .....+.+.+|+.++++++||||+++++++.+
T Consensus        27 ~~~~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~  104 (318)
T 3lxp_A           27 VFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADA--GPQHRSGWKQEIDILRTLYHEHIIKYKGCCED  104 (318)
T ss_dssp             BCCGGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE
T ss_pred             eecHHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEecccc--ChHHHHHHHHHHHHHHhCCCcchhhEEEEEec
Confidence            344566 999999999999998875    34589999999997653  23345779999999999999999999999988


Q ss_pred             --CCEEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCC
Q 014609           86 --KSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSAL  163 (421)
Q Consensus        86 --~~~~~lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~  163 (421)
                        ...+|+||||+++++|.+++.. ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++..
T Consensus       105 ~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~  183 (318)
T 3lxp_A          105 AGAASLQLVMEYVPLGSLRDYLPR-HSIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKA  183 (318)
T ss_dssp             TTTTEEEEEECCCTTCBHHHHGGG-SCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEE
T ss_pred             CCCceEEEEEecccCCcHHHHHhh-CCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEcCCCCEEECCcccccc
Confidence              4689999999999999998876 4599999999999999999999999999999999999999999999999999986


Q ss_pred             CccccCC-CccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhhcC------------------------------
Q 014609          164 PQHFRDD-GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIFRG------------------------------  212 (421)
Q Consensus       164 ~~~~~~~-~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~~~------------------------------  212 (421)
                      ....... .......||+.|+|||++.+..+ +.++|||||||++|.+..                              
T Consensus       184 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  262 (318)
T 3lxp_A          184 VPEGHEYYRVREDGDSPVFWYAPECLKEYKF-YYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTE  262 (318)
T ss_dssp             CCTTCSEEEC---CCCCGGGCCHHHHHHCEE-EHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHH
T ss_pred             ccccccccccccCCCCCceeeChHHhcCCCC-CcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHH
Confidence            5332110 12334568888999999988777 489999999999995533                              


Q ss_pred             ------CcCCCCCCCHHHHHHHHHhcCCCCCCCCCHHhhhc
Q 014609          213 ------DFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKA  247 (421)
Q Consensus       213 ------~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~  247 (421)
                            ..+.|..+++.+.++|++||+.||.+|||+.++++
T Consensus       263 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~  303 (318)
T 3lxp_A          263 LLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIP  303 (318)
T ss_dssp             HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHhcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence                  12345668999999999999999999999999984

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.3e-42  Score=331.21  Aligned_cols=236  Identities=25%  Similarity=0.357  Sum_probs=198.6

Q ss_pred             eeecceEEec-eEeecCcEEEEEEEEC--CCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCC
Q 014609           11 MRLGRYELGR-TLGEGNFGKVKFAQDL--DSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKS   87 (421)
Q Consensus        11 ~~~~~y~i~~-~LG~G~~g~V~~a~~~--~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~   87 (421)
                      ...++|.+.+ .||+|+||.||+|.+.  .+++.||+|++....  .....+.+.+|+.++++++||||+++++++ ..+
T Consensus         6 ~~~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~   82 (287)
T 1u59_A            6 LKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT--EKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAE   82 (287)
T ss_dssp             CCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESS
T ss_pred             ccHHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCcc--chhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCC
Confidence            4457898887 9999999999999864  478899999997642  334467899999999999999999999999 456


Q ss_pred             EEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCcc
Q 014609           88 KIYMVLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQH  166 (421)
Q Consensus        88 ~~~lv~E~~~gg~L~~~i~~~-~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~  166 (421)
                      ..|+||||+++++|.+++... ..+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||++.....
T Consensus        83 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~  162 (287)
T 1u59_A           83 ALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGA  162 (287)
T ss_dssp             SEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECTT
T ss_pred             CcEEEEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEcCCCCEEECcccceeeecc
Confidence            689999999999999998653 5699999999999999999999999999999999999999999999999999975432


Q ss_pred             ccC-CCccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhhc--CCcC--------------------CCCCCCHH
Q 014609          167 FRD-DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIFR--GDFK--------------------LPKWLSPG  223 (421)
Q Consensus       167 ~~~-~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~~--~~~~--------------------~p~~~s~~  223 (421)
                      ... ........+|+.|+|||++.+..+ +.++|||||||++|.+.  |..+                    .|+.+++.
T Consensus       163 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~  241 (287)
T 1u59_A          163 DDSYYTARSAGKWPLKWYAPECINFRKF-SSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPPE  241 (287)
T ss_dssp             CSCEECCCCSSCCCGGGCCHHHHHHCEE-CHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCCCCCCTTCCHH
T ss_pred             CcceeeccccccccccccCHHHhccCCC-CchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHhcCCcCCCCCCcCHH
Confidence            111 112233456889999999987776 58999999999999544  4433                    34568899


Q ss_pred             HHHHHHHhcCCCCCCCCCHHhhhcCcc
Q 014609          224 AQNLLRKILEPNPVKRITIAGIKADEW  250 (421)
Q Consensus       224 ~~~li~~~L~~dP~~R~t~~eil~~~w  250 (421)
                      +.++|.+||+.||.+|||+.+++++.|
T Consensus       242 l~~li~~~l~~~p~~Rps~~~l~~~l~  268 (287)
T 1u59_A          242 LYALMSDCWIYKWEDRPDFLTVEQRMR  268 (287)
T ss_dssp             HHHHHHHTTCSSGGGSCCHHHHHHHHH
T ss_pred             HHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence            999999999999999999999998876

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=1.1e-42  Score=336.17  Aligned_cols=234  Identities=26%  Similarity=0.381  Sum_probs=194.7

Q ss_pred             cceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEe----CCEE
Q 014609           14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLAS----KSKI   89 (421)
Q Consensus        14 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~----~~~~   89 (421)
                      ++|++++.||+|+||.||+|.+..+|+.||||++...   .....+.+.+|+.+++.++||||+++++++..    ....
T Consensus        29 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  105 (317)
T 2buj_A           29 KHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCH---EQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEA  105 (317)
T ss_dssp             EEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEES---SHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEE
T ss_pred             eEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecC---CHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCcee
Confidence            6899999999999999999999999999999998653   23346788999999999999999999999863    3578


Q ss_pred             EEEEeccCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCc
Q 014609           90 YMVLEYVTGGELFDKIAS----KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQ  165 (421)
Q Consensus        90 ~lv~E~~~gg~L~~~i~~----~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~  165 (421)
                      |+||||+++++|.+++..    ...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++....
T Consensus       106 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~~  185 (317)
T 2buj_A          106 WLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQAC  185 (317)
T ss_dssp             EEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCSSCEESC
T ss_pred             EEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCCEEEEecCcchhcc
Confidence            999999999999998875    4679999999999999999999999999999999999999999999999999987543


Q ss_pred             cccCCC-------ccccccCCCCccChhhhcccCC--CCCcchHHHHHHHHhhh-cCCcC--------------------
Q 014609          166 HFRDDG-------LLHTTCGSPNYVAPEVLANRGY--DGATSDIWSCGVILYIF-RGDFK--------------------  215 (421)
Q Consensus       166 ~~~~~~-------~~~~~~gt~~y~APEvl~~~~~--~~~~~DiwSlGvil~~~-~~~~~--------------------  215 (421)
                      ......       ......||+.|+|||++.....  .+.++|||||||++|.+ .|..+                    
T Consensus       186 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~  265 (317)
T 2buj_A          186 IHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQNQLS  265 (317)
T ss_dssp             EEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHHHHCC--
T ss_pred             cccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHHhhccCC
Confidence            211110       1123467999999999875431  25899999999999944 33322                    


Q ss_pred             --CCCCCCHHHHHHHHHhcCCCCCCCCCHHhhhcCcc
Q 014609          216 --LPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEW  250 (421)
Q Consensus       216 --~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~~~w  250 (421)
                        .+..+++.+.++|.+||+.||.+|||+.+++++-.
T Consensus       266 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~  302 (317)
T 2buj_A          266 IPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLE  302 (317)
T ss_dssp             CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             CCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhh
Confidence              23457899999999999999999999999998643

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=1.9e-42  Score=331.56  Aligned_cols=234  Identities=24%  Similarity=0.307  Sum_probs=192.8

Q ss_pred             eeecceEEeceEeecCcEEEEEEEECCC---CceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEE-EeC
Q 014609           11 MRLGRYELGRTLGEGNFGKVKFAQDLDS---GLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVL-ASK   86 (421)
Q Consensus        11 ~~~~~y~i~~~LG~G~~g~V~~a~~~~~---~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~-~~~   86 (421)
                      ....+|++.+.||+|+||+||+|.+..+   +..||+|.+....  .....+.+.+|+.++++++||||+++++++ ..+
T Consensus        22 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   99 (298)
T 3f66_A           22 PSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT--DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSE   99 (298)
T ss_dssp             GGGEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCC--SHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSS
T ss_pred             ccceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCC--CHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCC
Confidence            3446899999999999999999997543   3468999886532  334467899999999999999999999985 456


Q ss_pred             CEEEEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCc
Q 014609           87 SKIYMVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQ  165 (421)
Q Consensus        87 ~~~~lv~E~~~gg~L~~~i~~-~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~  165 (421)
                      +..|+||||+++++|.+++.. ...+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||++....
T Consensus       100 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~  179 (298)
T 3f66_A          100 GSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMY  179 (298)
T ss_dssp             SCCEEEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSCGGGCCCS
T ss_pred             CceEEEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEECCCCCEEECccccccccc
Confidence            688999999999999999975 4568999999999999999999999999999999999999999999999999998653


Q ss_pred             cccC--CCccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhhcC-Cc---------------------CCCCCCC
Q 014609          166 HFRD--DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIFRG-DF---------------------KLPKWLS  221 (421)
Q Consensus       166 ~~~~--~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~~~-~~---------------------~~p~~~s  221 (421)
                      ....  ........||+.|+|||++.+..+ +.++||||||+++|.+.. ..                     ..|..++
T Consensus       180 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  258 (298)
T 3f66_A          180 DKEYYSVHNKTGAKLPVKWMALESLQTQKF-TTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCP  258 (298)
T ss_dssp             CGGGCBC-----CCBCGGGSCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHHTTCCCCCCTTCC
T ss_pred             ccchhccccccCCCCCccccChHHhcCCCC-ChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhcCCCCCCCccCC
Confidence            3221  122334567889999999988777 589999999999996432 22                     1245578


Q ss_pred             HHHHHHHHHhcCCCCCCCCCHHhhhc
Q 014609          222 PGAQNLLRKILEPNPVKRITIAGIKA  247 (421)
Q Consensus       222 ~~~~~li~~~L~~dP~~R~t~~eil~  247 (421)
                      +.+.++|.+||++||.+|||+.++++
T Consensus       259 ~~l~~li~~~l~~~p~~Rps~~ell~  284 (298)
T 3f66_A          259 DPLYEVMLKCWHPKAEMRPSFSELVS  284 (298)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            99999999999999999999999876

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=1.9e-42  Score=331.54  Aligned_cols=228  Identities=24%  Similarity=0.357  Sum_probs=185.2

Q ss_pred             eeecceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhc--CCCCCcceEEEEEEe---
Q 014609           11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKL--LKHPNVVRLHEVLAS---   85 (421)
Q Consensus        11 ~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~--l~hpnIv~l~~~~~~---   85 (421)
                      ...++|++++.||+|+||+||+|++  +|+.||||++....      ...+.+|.+++..  ++||||+++++++..   
T Consensus         5 ~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~------~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~   76 (301)
T 3q4u_A            5 TVARDITLLECVGKGRYGEVWRGSW--QGENVAVKIFSSRD------EKSWFRETELYNTVMLRHENILGFIASDMTSRH   76 (301)
T ss_dssp             CCGGGCEEEEEEEECSSEEEEEEEE--TTEEEEEEEECGGG------HHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEET
T ss_pred             cccCcEEEEEeeccCCCcEEEEEEE--CCEEEEEEEecccc------chhhHHHHHHHHHhhccCcCeeeEEEeeccccC
Confidence            3457999999999999999999987  68999999986532      3455667777666  799999999998654   


Q ss_pred             -CCEEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH--------hCCceeccCCCCCEEeccCCCEEEE
Q 014609           86 -KSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCH--------NKGVFHRDLKLENILLDSKGNIKIS  156 (421)
Q Consensus        86 -~~~~~lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~ql~~aL~~LH--------~~gi~HrDlkp~NILl~~~~~~kL~  156 (421)
                       ....|+||||+++|+|.+++.. ..+++..+..++.|++.||+|||        +.||+||||||+|||++.++.+||+
T Consensus        77 ~~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl~  155 (301)
T 3q4u_A           77 SSTQLWLITHYHEMGSLYDYLQL-TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIA  155 (301)
T ss_dssp             TEEEEEEEECCCTTCBHHHHHTT-CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEEEC
T ss_pred             CCceeEEehhhccCCCHHHHHhh-cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEEEe
Confidence             3568999999999999999964 67999999999999999999999        9999999999999999999999999


Q ss_pred             eccCCCCCccccCC--CccccccCCCCccChhhhcccCCC-----CCcchHHHHHHHHhhhcCC-----------cCCCC
Q 014609          157 DFGLSALPQHFRDD--GLLHTTCGSPNYVAPEVLANRGYD-----GATSDIWSCGVILYIFRGD-----------FKLPK  218 (421)
Q Consensus       157 DFGla~~~~~~~~~--~~~~~~~gt~~y~APEvl~~~~~~-----~~~~DiwSlGvil~~~~~~-----------~~~p~  218 (421)
                      |||++.........  ......+||+.|+|||++.+....     +.++|||||||++|.+..+           .++..
T Consensus       156 Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~  235 (301)
T 3q4u_A          156 DLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYD  235 (301)
T ss_dssp             CCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTT
T ss_pred             eCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccc
Confidence            99999754321111  112345899999999998765322     2589999999999965432           22211


Q ss_pred             ----------------------C---------CCHHHHHHHHHhcCCCCCCCCCHHhhhc
Q 014609          219 ----------------------W---------LSPGAQNLLRKILEPNPVKRITIAGIKA  247 (421)
Q Consensus       219 ----------------------~---------~s~~~~~li~~~L~~dP~~R~t~~eil~  247 (421)
                                            .         .++.+.++|.+||+.||.+|||+.++++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~  295 (301)
T 3q4u_A          236 VVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKK  295 (301)
T ss_dssp             TSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred             cCCCCcchhhhhHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHH
Confidence                                  0         2256899999999999999999999875

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=1.4e-42  Score=341.10  Aligned_cols=225  Identities=16%  Similarity=0.212  Sum_probs=191.4

Q ss_pred             cceEEeceEeecCcEEEEEEEECC--------CCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcce-------
Q 014609           14 GRYELGRTLGEGNFGKVKFAQDLD--------SGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVR-------   78 (421)
Q Consensus        14 ~~y~i~~~LG~G~~g~V~~a~~~~--------~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~-------   78 (421)
                      ++|++.+.||+|+||.||+|++..        .++.||+|++...        +.+.+|+.++++++||||++       
T Consensus        42 ~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~--------~~~~~E~~~l~~l~h~niv~~~~~~~~  113 (352)
T 2jii_A           42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD--------GRLFNEQNFFQRAAKPLQVNKWKKLYS  113 (352)
T ss_dssp             CEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT--------STHHHHHHHHHHHCCHHHHHHHHHHTT
T ss_pred             CeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc--------chHHHHHHHHHHhcccchhhhhhhhcc
Confidence            799999999999999999999987        4899999998754        35788999999999999887       


Q ss_pred             --------EEEEEEe-CCEEEEEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEe
Q 014609           79 --------LHEVLAS-KSKIYMVLEYVTGGELFDKIASK--GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILL  147 (421)
Q Consensus        79 --------l~~~~~~-~~~~~lv~E~~~gg~L~~~i~~~--~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl  147 (421)
                              +++++.. +...|+||||+ |++|.+++...  ..+++..++.++.||+.||+|||++||+||||||+|||+
T Consensus       114 ~~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIl~  192 (352)
T 2jii_A          114 TPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIFV  192 (352)
T ss_dssp             CTTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGGGEEE
T ss_pred             CCccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEE
Confidence                    6777776 78899999999 99999999875  789999999999999999999999999999999999999


Q ss_pred             ccCC--CEEEEeccCCCCCccccCC-----CccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhh-hcCCcCCCC-
Q 014609          148 DSKG--NIKISDFGLSALPQHFRDD-----GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYI-FRGDFKLPK-  218 (421)
Q Consensus       148 ~~~~--~~kL~DFGla~~~~~~~~~-----~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~-~~~~~~~p~-  218 (421)
                      +.++  .+||+|||++.........     .......||+.|+|||++.+..+ +.++|||||||++|. +.|..++.. 
T Consensus       193 ~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~el~~g~~pf~~~  271 (352)
T 2jii_A          193 DPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGP-SRRSDLQSLGYCMLKWLYGFLPWTNC  271 (352)
T ss_dssp             ETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCC-CHHHHHHHHHHHHHHHHHSCCTTGGG
T ss_pred             cCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCC-CchhhHHHHHHHHHHHHhCCCCcccC
Confidence            9998  8999999999865432211     12244589999999999988777 589999999999994 344433321 


Q ss_pred             -----------------------------CCCHHHHHHHHHhcCCCCCCCCCHHhhhcC
Q 014609          219 -----------------------------WLSPGAQNLLRKILEPNPVKRITIAGIKAD  248 (421)
Q Consensus       219 -----------------------------~~s~~~~~li~~~L~~dP~~R~t~~eil~~  248 (421)
                                                   .+++.+.++|.+||+.||.+|||+.++++.
T Consensus       272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~  330 (352)
T 2jii_A          272 LPNTEDIMKQKQKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRNN  330 (352)
T ss_dssp             TTCHHHHHHHHHHHHHSCCCEECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHH
T ss_pred             CcCHHHHHHHHHhccCChhhhhhhccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHH
Confidence                                         258999999999999999999999998763

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=1e-43  Score=344.87  Aligned_cols=234  Identities=23%  Similarity=0.322  Sum_probs=196.5

Q ss_pred             ecceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEE
Q 014609           13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMV   92 (421)
Q Consensus        13 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv   92 (421)
                      .++|++.+.||+|+||.||+|.+ .+|+.||||++........  ...+.+|+.+++.++||||+++++++.+.+..++|
T Consensus        29 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~--~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv  105 (326)
T 3uim_A           29 SDNFSNKNILGRGGFGKVYKGRL-ADGTLVAVKRLKEERTQGG--ELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLV  105 (326)
T ss_dssp             TTSSCSTTEEECCSSSEEEEECC-SSSCCEEEEECCC-----C--CCHHHHHHHGGGTCCCTTBCCCCEEECCSSCCEEE
T ss_pred             hhccccceeEecCCCcEEEEEEe-cCCCEEEEEEeccccCchH--HHHHHHHHHHHHhccCCCccceEEEEecCCceEEE
Confidence            46899999999999999999984 5799999999976542221  23689999999999999999999999999999999


Q ss_pred             EeccCCCChHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CceeccCCCCCEEeccCCCEEEEeccCCCCCc
Q 014609           93 LEYVTGGELFDKIASKG----RLQEAEGRKLFQQLIDGVSYCHNK---GVFHRDLKLENILLDSKGNIKISDFGLSALPQ  165 (421)
Q Consensus        93 ~E~~~gg~L~~~i~~~~----~~~~~~~~~~~~ql~~aL~~LH~~---gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~  165 (421)
                      |||+++++|.+.+....    .+++..+..++.|++.||+|||++   ||+||||||+|||++.++.+||+|||++....
T Consensus       106 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~  185 (326)
T 3uim_A          106 YPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD  185 (326)
T ss_dssp             EECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEECCCSSCEECC
T ss_pred             EEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEeccCccccccC
Confidence            99999999999997543    499999999999999999999999   99999999999999999999999999998553


Q ss_pred             cccCCCccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhh-cCCcCCC---------------------------
Q 014609          166 HFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIF-RGDFKLP---------------------------  217 (421)
Q Consensus       166 ~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~-~~~~~~p---------------------------  217 (421)
                      .. ........+||+.|+|||++.+..+ +.++|||||||++|.+ .|..++.                           
T Consensus       186 ~~-~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  263 (326)
T 3uim_A          186 YK-DTHVTTAVRGTIGHIAPEYLSTGKS-SEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEA  263 (326)
T ss_dssp             SS-SSCEECCCCSCGGGCCHHHHHHSEE-CHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTTTSSCCSTT
T ss_pred             cc-cccccccccCCcCccCHHHhccCCC-CccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHHhhchhhhh
Confidence            32 2233445569999999999987776 5899999999999944 4444431                           


Q ss_pred             -----------CCCCHHHHHHHHHhcCCCCCCCCCHHhhhcCccc
Q 014609          218 -----------KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWF  251 (421)
Q Consensus       218 -----------~~~s~~~~~li~~~L~~dP~~R~t~~eil~~~w~  251 (421)
                                 ...++.+.+++.+||+.||.+|||+.++++|-+-
T Consensus       264 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~  308 (326)
T 3uim_A          264 LVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEG  308 (326)
T ss_dssp             SSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHT
T ss_pred             hcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcC
Confidence                       0012678999999999999999999999988764

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3e-42  Score=336.40  Aligned_cols=234  Identities=24%  Similarity=0.360  Sum_probs=191.1

Q ss_pred             eecceEEeceEeecCcEEEEEEEECCCC----ceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCC
Q 014609           12 RLGRYELGRTLGEGNFGKVKFAQDLDSG----LPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKS   87 (421)
Q Consensus        12 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~----~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~   87 (421)
                      .-++|++.+.||+|+||+||+|.+..++    ..||||++....  .......+.+|+.++++++||||+++++++...+
T Consensus        42 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~  119 (333)
T 1mqb_A           42 HPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY--TEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYK  119 (333)
T ss_dssp             CTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSS
T ss_pred             ChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCC--CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCC
Confidence            3468999999999999999999876543    459999997543  2333567899999999999999999999999999


Q ss_pred             EEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCcc
Q 014609           88 KIYMVLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQH  166 (421)
Q Consensus        88 ~~~lv~E~~~gg~L~~~i~~~-~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~  166 (421)
                      ..|+||||+++++|.+++... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++.....
T Consensus       120 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~  199 (333)
T 1mqb_A          120 PMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLED  199 (333)
T ss_dssp             SEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC------
T ss_pred             CcEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEECCCCcEEECCCCcchhhcc
Confidence            999999999999999998764 5799999999999999999999999999999999999999999999999999986543


Q ss_pred             ccCC-CccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhh-c-CCcC--------------------CCCCCCHH
Q 014609          167 FRDD-GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIF-R-GDFK--------------------LPKWLSPG  223 (421)
Q Consensus       167 ~~~~-~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~-~-~~~~--------------------~p~~~s~~  223 (421)
                      .... .......+|+.|+|||++.+..+ +.++|||||||++|.+ . |..+                    .|..+++.
T Consensus       200 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  278 (333)
T 1mqb_A          200 DPEATYTTSGGKIPIRWTAPEAISYRKF-TSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMDCPSA  278 (333)
T ss_dssp             -----------CCCGGGSCHHHHHSCCC-CHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTCBHH
T ss_pred             ccccccccCCCCccccccCchhcccCCC-CchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHCCCcCCCcccCCHH
Confidence            2111 11223346788999999987777 5899999999999964 3 4433                    23457899


Q ss_pred             HHHHHHHhcCCCCCCCCCHHhhhcC
Q 014609          224 AQNLLRKILEPNPVKRITIAGIKAD  248 (421)
Q Consensus       224 ~~~li~~~L~~dP~~R~t~~eil~~  248 (421)
                      +.++|.+||+.||.+||++.+++++
T Consensus       279 l~~li~~~l~~~p~~Rps~~~l~~~  303 (333)
T 1mqb_A          279 IYQLMMQCWQQERARRPKFADIVSI  303 (333)
T ss_dssp             HHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred             HHHHHHHHcCCChhhCcCHHHHHHH
Confidence            9999999999999999999998875

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=100.00  E-value=8.2e-42  Score=327.98  Aligned_cols=217  Identities=29%  Similarity=0.557  Sum_probs=187.0

Q ss_pred             cccCCeeecceEEe-ceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHH-hcCCCCCcceEEEEE
Q 014609            6 KKQEGMRLGRYELG-RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATL-KLLKHPNVVRLHEVL   83 (421)
Q Consensus         6 ~~~~~~~~~~y~i~-~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il-~~l~hpnIv~l~~~~   83 (421)
                      ....+..+++|.+. +.||+|+||.||+|.+..+++.||+|++...        ..+.+|+.++ +.++||||+++++++
T Consensus         9 ~~~~~~~~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--------~~~~~e~~~~~~~~~h~~i~~~~~~~   80 (299)
T 3m2w_A            9 QIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVY   80 (299)
T ss_dssp             CCBCSCGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEE
T ss_pred             cCcccccccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc--------HHHHHHHHHHHHhccCCCchhHHhhh
Confidence            34557788999998 7899999999999999999999999998642        4567888888 666899999999999


Q ss_pred             Ee----CCEEEEEEeccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecc---CCCEE
Q 014609           84 AS----KSKIYMVLEYVTGGELFDKIASKG--RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDS---KGNIK  154 (421)
Q Consensus        84 ~~----~~~~~lv~E~~~gg~L~~~i~~~~--~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~---~~~~k  154 (421)
                      ..    ...+|+||||++|++|.+++....  .+++..++.++.|++.||+|||++||+||||||+|||++.   ++.+|
T Consensus        81 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~k  160 (299)
T 3m2w_A           81 ENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILK  160 (299)
T ss_dssp             EEEETTEEEEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEE
T ss_pred             hhhcCCCceEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCCcEE
Confidence            87    678999999999999999998754  6999999999999999999999999999999999999998   78899


Q ss_pred             EEeccCCCCCccccCCCccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhh-cCCcCC-----------------
Q 014609          155 ISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIF-RGDFKL-----------------  216 (421)
Q Consensus       155 L~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~-~~~~~~-----------------  216 (421)
                      |+|||++....                        +..+ +.++||||+||++|.+ .|..++                 
T Consensus       161 l~Dfg~a~~~~------------------------~~~~-~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~  215 (299)
T 3m2w_A          161 LTDFGFAKETT------------------------GEKY-DKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIR  215 (299)
T ss_dssp             ECCCTTCEECT------------------------TCGG-GGHHHHHHHHHHHHHHHHSSCSCCC-------CCSCCSSC
T ss_pred             Eeccccccccc------------------------cccC-CchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHHHHHh
Confidence            99999986321                        1224 4789999999999954 343333                 


Q ss_pred             ------C----CCCCHHHHHHHHHhcCCCCCCCCCHHhhhcCccccccc
Q 014609          217 ------P----KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY  255 (421)
Q Consensus       217 ------p----~~~s~~~~~li~~~L~~dP~~R~t~~eil~~~w~~~~~  255 (421)
                            |    ..+++++.++|.+||+.||.+|||+.++++||||.+..
T Consensus       216 ~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~~~~~  264 (299)
T 3m2w_A          216 MGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQST  264 (299)
T ss_dssp             TTCCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTGG
T ss_pred             hccccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcChhhcccc
Confidence                  1    34689999999999999999999999999999998644

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.2e-42  Score=335.21  Aligned_cols=228  Identities=24%  Similarity=0.367  Sum_probs=185.5

Q ss_pred             eecceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcC--CCCCcceEEEEEEeC---
Q 014609           12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL--KHPNVVRLHEVLASK---   86 (421)
Q Consensus        12 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l--~hpnIv~l~~~~~~~---   86 (421)
                      ..++|++++.||+|+||.||+|++.  |+.||||++....      .....+|.+++..+  +||||+++++++...   
T Consensus        35 ~~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~------~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~  106 (337)
T 3mdy_A           35 IAKQIQMVKQIGKGRYGEVWMGKWR--GEKVAVKVFFTTE------EASWFRETEIYQTVLMRHENILGFIAADIKGTGS  106 (337)
T ss_dssp             HHHHCEEEEEEEEETTEEEEEEEET--TEEEEEEEEEGGG------HHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGG
T ss_pred             cccceEEEeEeecCCCeEEEEEEEC--CceEEEEEEeccc------cchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCC
Confidence            3479999999999999999999974  8999999986432      24455566666554  899999999999887   


Q ss_pred             -CEEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC--------CceeccCCCCCEEeccCCCEEEEe
Q 014609           87 -SKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNK--------GVFHRDLKLENILLDSKGNIKISD  157 (421)
Q Consensus        87 -~~~~lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~ql~~aL~~LH~~--------gi~HrDlkp~NILl~~~~~~kL~D  157 (421)
                       ...|+||||+++++|.+++.. ..+++..+..++.|++.||+|||++        ||+||||||+|||++.++.+||+|
T Consensus       107 ~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~D  185 (337)
T 3mdy_A          107 WTQLYLITDYHENGSLYDYLKS-TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIAD  185 (337)
T ss_dssp             GCEEEEEECCCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEECC
T ss_pred             CCceEEEEeccCCCcHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEEEe
Confidence             789999999999999999976 5799999999999999999999999        999999999999999999999999


Q ss_pred             ccCCCCCccccCC--CccccccCCCCccChhhhcccCCCCC-----cchHHHHHHHHhhhcCC-----------cCCCC-
Q 014609          158 FGLSALPQHFRDD--GLLHTTCGSPNYVAPEVLANRGYDGA-----TSDIWSCGVILYIFRGD-----------FKLPK-  218 (421)
Q Consensus       158 FGla~~~~~~~~~--~~~~~~~gt~~y~APEvl~~~~~~~~-----~~DiwSlGvil~~~~~~-----------~~~p~-  218 (421)
                      ||++.........  ......+||+.|+|||++.+..+...     ++|||||||++|.+..+           .++.. 
T Consensus       186 fg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~  265 (337)
T 3mdy_A          186 LGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDL  265 (337)
T ss_dssp             CTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTT
T ss_pred             CCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhhh
Confidence            9999754332111  11235689999999999987665422     38999999999965332           22211 


Q ss_pred             ------------------------------CCCHHHHHHHHHhcCCCCCCCCCHHhhhcC
Q 014609          219 ------------------------------WLSPGAQNLLRKILEPNPVKRITIAGIKAD  248 (421)
Q Consensus       219 ------------------------------~~s~~~~~li~~~L~~dP~~R~t~~eil~~  248 (421)
                                                    .+++.+.++|.+||+.||.+|||+.+++++
T Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~  325 (337)
T 3mdy_A          266 VPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKT  325 (337)
T ss_dssp             SCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred             cCCCCchhhhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHH
Confidence                                          123558899999999999999999999875

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=1.8e-42  Score=328.60  Aligned_cols=225  Identities=26%  Similarity=0.471  Sum_probs=187.6

Q ss_pred             CeeecceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeC-CE
Q 014609           10 GMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASK-SK   88 (421)
Q Consensus        10 ~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~-~~   88 (421)
                      ....++|++.+.||+|+||+||+|.+  +|+.||||++....     ..+.+.+|+.++++++||||+++++++... +.
T Consensus        17 ~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   89 (278)
T 1byg_A           17 ALNMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGG   89 (278)
T ss_dssp             BCCGGGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCCC-------HHHHHTHHHHTTCCCTTBCCEEEEECCC--C
T ss_pred             cCChhhceEEeEEecCCCceEEEEEE--cCCEEEEEEecchh-----HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCc
Confidence            35568999999999999999999987  48899999987542     256789999999999999999999997554 47


Q ss_pred             EEEEEeccCCCChHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCcc
Q 014609           89 IYMVLEYVTGGELFDKIASKGR--LQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQH  166 (421)
Q Consensus        89 ~~lv~E~~~gg~L~~~i~~~~~--~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~  166 (421)
                      .|+||||+++++|.+++.....  +++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||++.....
T Consensus        90 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~  169 (278)
T 1byg_A           90 LYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS  169 (278)
T ss_dssp             CEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC------
T ss_pred             eEEEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEEeCCCcEEEeeccccccccc
Confidence            8999999999999999976543  89999999999999999999999999999999999999999999999999874332


Q ss_pred             ccCCCccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhhc--CCcC--------------------CCCCCCHHH
Q 014609          167 FRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIFR--GDFK--------------------LPKWLSPGA  224 (421)
Q Consensus       167 ~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~~--~~~~--------------------~p~~~s~~~  224 (421)
                           ......+++.|+|||++.+..+ +.++||||||+++|.+.  |..+                    .|..+++.+
T Consensus       170 -----~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  243 (278)
T 1byg_A          170 -----TQDTGKLPVKWTAPEALREKKF-STKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAV  243 (278)
T ss_dssp             -----------CCTTTSCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCCCCCCTTCCHHH
T ss_pred             -----cccCCCccccccCHHHhCCCCC-CchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCcccCCHHH
Confidence                 1234467899999999988777 58999999999999654  4433                    234578999


Q ss_pred             HHHHHHhcCCCCCCCCCHHhhhc
Q 014609          225 QNLLRKILEPNPVKRITIAGIKA  247 (421)
Q Consensus       225 ~~li~~~L~~dP~~R~t~~eil~  247 (421)
                      .++|.+||+.||.+|||+.++++
T Consensus       244 ~~li~~~l~~~p~~Rps~~~l~~  266 (278)
T 1byg_A          244 YEVMKNCWHLDAAMRPSFLQLRE  266 (278)
T ss_dssp             HHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHhcCChhhCCCHHHHHH
Confidence            99999999999999999999875

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=1.2e-42  Score=338.58  Aligned_cols=237  Identities=23%  Similarity=0.360  Sum_probs=184.5

Q ss_pred             cCCeeecceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHH--HhcCCCCCcceEEEEEEe
Q 014609            8 QEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIAT--LKLLKHPNVVRLHEVLAS   85 (421)
Q Consensus         8 ~~~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~i--l~~l~hpnIv~l~~~~~~   85 (421)
                      .....+++|++++.||+|+||.||+|++  +++.||||++....      ...+..|.++  +..++||||+++++.+..
T Consensus         7 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~------~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~   78 (336)
T 3g2f_A            7 EPSLDLDNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFAN------RQNFINEKNIYRVPLMEHDNIARFIVGDER   78 (336)
T ss_dssp             --CCCTTSEEEEEEEEECSSEEEEEEEE--TTEEEEEEEEEGGG------HHHHHHHHHHHTSTTCCCTTBCCEEEEEEE
T ss_pred             CCCcChHHhheeeecccCCCeEEEEEEE--CCeEEEEEEeeccc------hhhHHHHHHHHHHHhccCcchhhheecccc
Confidence            4567789999999999999999999976  78999999997542      2334444444  455899999999986542


Q ss_pred             -----CCEEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---------CceeccCCCCCEEeccCC
Q 014609           86 -----KSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNK---------GVFHRDLKLENILLDSKG  151 (421)
Q Consensus        86 -----~~~~~lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~ql~~aL~~LH~~---------gi~HrDlkp~NILl~~~~  151 (421)
                           ...+|+||||+++|+|.+++.. ...++..+..++.||+.||+|||+.         ||+||||||+|||++.++
T Consensus        79 ~~~~~~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~  157 (336)
T 3g2f_A           79 VTADGRMEYLLVMEYYPNGSLXKYLSL-HTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDG  157 (336)
T ss_dssp             ECTTSCEEEEEEECCCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTS
T ss_pred             cccCCCceEEEEEecCCCCcHHHHHhh-cccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCC
Confidence                 3368999999999999999976 4568999999999999999999999         999999999999999999


Q ss_pred             CEEEEeccCCCCCcccc------CCCccccccCCCCccChhhhccc-------CCCCCcchHHHHHHHHhhhc-CCcCC-
Q 014609          152 NIKISDFGLSALPQHFR------DDGLLHTTCGSPNYVAPEVLANR-------GYDGATSDIWSCGVILYIFR-GDFKL-  216 (421)
Q Consensus       152 ~~kL~DFGla~~~~~~~------~~~~~~~~~gt~~y~APEvl~~~-------~~~~~~~DiwSlGvil~~~~-~~~~~-  216 (421)
                      .+||+|||++.......      ........+||+.|+|||++.+.       .+ +.++|||||||++|.+. |..++ 
T Consensus       158 ~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~-~~~~DiwslG~il~ell~g~~p~~  236 (336)
T 3g2f_A          158 TCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESA-LKQVDMYALGLIYWEIFMRCTDLF  236 (336)
T ss_dssp             CEEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHH-HHHHHHHHHHHHHHHHHTTBGGGS
T ss_pred             cEEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCccccccccc-ccccchHHHHHHHHHHHhcCCcCC
Confidence            99999999997543211      11223355799999999998762       23 46799999999999553 32211 


Q ss_pred             --------------------------------------CCC------CCHHHHHHHHHhcCCCCCCCCCHHhh------h
Q 014609          217 --------------------------------------PKW------LSPGAQNLLRKILEPNPVKRITIAGI------K  246 (421)
Q Consensus       217 --------------------------------------p~~------~s~~~~~li~~~L~~dP~~R~t~~ei------l  246 (421)
                                                            |..      .++.+.++|.+||+.||.+|||+.|+      +
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~l  316 (336)
T 3g2f_A          237 PGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAEL  316 (336)
T ss_dssp             TTSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred             CccchhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHH
Confidence                                                  111      22469999999999999999999999      4


Q ss_pred             cCcccccc
Q 014609          247 ADEWFEQD  254 (421)
Q Consensus       247 ~~~w~~~~  254 (421)
                      -++|-++.
T Consensus       317 l~~~~~~~  324 (336)
T 3g2f_A          317 MMIWERNK  324 (336)
T ss_dssp             HHCCCC--
T ss_pred             HHHHHhcc
Confidence            45666543

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=1e-42  Score=357.86  Aligned_cols=230  Identities=27%  Similarity=0.382  Sum_probs=198.6

Q ss_pred             eecceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEE
Q 014609           12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYM   91 (421)
Q Consensus        12 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l   91 (421)
                      ...+|++.+.||+|+||.||+|.+..++..||||++.....    ..+.+.+|+.+|++++||||+++++++.....+|+
T Consensus       218 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l  293 (495)
T 1opk_A          218 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYI  293 (495)
T ss_dssp             CGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSS----CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred             CHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCccc----chHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEE
Confidence            34689999999999999999999998999999999975432    25679999999999999999999999999999999


Q ss_pred             EEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCccccC
Q 014609           92 VLEYVTGGELFDKIASK--GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD  169 (421)
Q Consensus        92 v~E~~~gg~L~~~i~~~--~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~  169 (421)
                      ||||+++|+|.+++...  ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++....... 
T Consensus       294 v~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~-  372 (495)
T 1opk_A          294 ITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDT-  372 (495)
T ss_dssp             EEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEECCTTCEECCTTCC-
T ss_pred             EEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEECCCCcEEEeecccceeccCCc-
Confidence            99999999999999763  458999999999999999999999999999999999999999999999999998643211 


Q ss_pred             CCccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhhc--CCcC--------------------CCCCCCHHHHHH
Q 014609          170 DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIFR--GDFK--------------------LPKWLSPGAQNL  227 (421)
Q Consensus       170 ~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~~--~~~~--------------------~p~~~s~~~~~l  227 (421)
                      ........+++.|+|||++....+ +.++|||||||++|.+.  |..+                    .|..+++.+.+|
T Consensus       373 ~~~~~~~~~~~~y~aPE~~~~~~~-~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  451 (495)
T 1opk_A          373 YTAHAGAKFPIKWTAPESLAYNKF-SIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYEL  451 (495)
T ss_dssp             EECCTTCCCCGGGCCHHHHHHCEE-CHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCCCCTTCCHHHHHH
T ss_pred             eeecCCCcCCcceeCHhHHhcCCC-CcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHH
Confidence            111223346778999999987777 58999999999999653  3333                    345688999999


Q ss_pred             HHHhcCCCCCCCCCHHhhhc
Q 014609          228 LRKILEPNPVKRITIAGIKA  247 (421)
Q Consensus       228 i~~~L~~dP~~R~t~~eil~  247 (421)
                      |.+||+.||.+|||+.++++
T Consensus       452 i~~cl~~dP~~RPs~~el~~  471 (495)
T 1opk_A          452 MRACWQWNPSDRPSFAEIHQ  471 (495)
T ss_dssp             HHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHcCcChhHCcCHHHHHH
Confidence            99999999999999999875

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=2.4e-42  Score=335.77  Aligned_cols=235  Identities=26%  Similarity=0.416  Sum_probs=197.0

Q ss_pred             CCeeecceEEeceEeecCcEEEEEEE----ECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEE
Q 014609            9 EGMRLGRYELGRTLGEGNFGKVKFAQ----DLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLA   84 (421)
Q Consensus         9 ~~~~~~~y~i~~~LG~G~~g~V~~a~----~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~   84 (421)
                      .....++|++++.||+|+||.||+|+    +..+|+.||||++...   .....+.+.+|+.++++++||||+++++++.
T Consensus        36 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~  112 (326)
T 2w1i_A           36 TQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS---TEEHLRDFEREIEILKSLQHDNIVKYKGVCY  112 (326)
T ss_dssp             -CCCGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSC---CSHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred             cccCHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccC---CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEE
Confidence            34456789999999999999999998    4568999999998753   2334578999999999999999999999986


Q ss_pred             eCC--EEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCC
Q 014609           85 SKS--KIYMVLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLS  161 (421)
Q Consensus        85 ~~~--~~~lv~E~~~gg~L~~~i~~~-~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla  161 (421)
                      ..+  ..++||||+++++|.+++... ..+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||++
T Consensus       113 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kL~Dfg~~  192 (326)
T 2w1i_A          113 SAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLT  192 (326)
T ss_dssp             C----CCEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTC
T ss_pred             ecCCCceEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEcCCCcEEEecCcch
Confidence            654  689999999999999999875 46999999999999999999999999999999999999999999999999999


Q ss_pred             CCCccccCC-CccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhhcC----------------------------
Q 014609          162 ALPQHFRDD-GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIFRG----------------------------  212 (421)
Q Consensus       162 ~~~~~~~~~-~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~~~----------------------------  212 (421)
                      ......... .......+++.|+|||++.+..+ +.++|||||||++|.+..                            
T Consensus       193 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~  271 (326)
T 2w1i_A          193 KVLPQDKEYYKVKEPGESPIFWYAPESLTESKF-SVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFH  271 (326)
T ss_dssp             EECCSSCSEEECSSCCSCCGGGCCHHHHHHCEE-EHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHH
T ss_pred             hhccccccccccccCCCCceeEECchhhcCCCC-CchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHH
Confidence            865432111 11223457778999999987776 589999999999994422                            


Q ss_pred             ---------CcCCCCCCCHHHHHHHHHhcCCCCCCCCCHHhhhc
Q 014609          213 ---------DFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKA  247 (421)
Q Consensus       213 ---------~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~  247 (421)
                               ..+.|..+++.+.++|.+||+.||.+|||+.++++
T Consensus       272 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~  315 (326)
T 2w1i_A          272 LIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL  315 (326)
T ss_dssp             HHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             HHHHhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence                     13345678999999999999999999999999875

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=100.00  E-value=2.9e-42  Score=348.80  Aligned_cols=232  Identities=29%  Similarity=0.384  Sum_probs=181.6

Q ss_pred             cceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcC-CCCCcceEEEEEEeCCEEEEE
Q 014609           14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEVLASKSKIYMV   92 (421)
Q Consensus        14 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~lv   92 (421)
                      +.|.+.+.||+|+||+||.+. ..+|+.||||++....      .+.+.+|+.+++++ +||||+++++++.+.+..|+|
T Consensus        15 ~~~~~~~~LG~G~~g~V~~~~-~~~g~~vAvK~~~~~~------~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv   87 (434)
T 2rio_A           15 NLVVSEKILGYGSSGTVVFQG-SFQGRPVAVKRMLIDF------CDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIA   87 (434)
T ss_dssp             SCEEEEEEEEECSTTCEEEEE-ESSSSEEEEEEEEGGG------HHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEE
T ss_pred             heeeccCeEeeCCCeEEEEEE-EECCeEEEEEEEcHHH------HHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEE
Confidence            456678999999999998764 4689999999986532      35678999999876 899999999999999999999


Q ss_pred             EeccCCCChHHHHHhcCCC-------CHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccC-------------CC
Q 014609           93 LEYVTGGELFDKIASKGRL-------QEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSK-------------GN  152 (421)
Q Consensus        93 ~E~~~gg~L~~~i~~~~~~-------~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~-------------~~  152 (421)
                      |||+. |+|.+++......       ++..+..++.||+.||+|||++||+||||||+|||++.+             +.
T Consensus        88 ~E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~  166 (434)
T 2rio_A           88 LELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLR  166 (434)
T ss_dssp             ECCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCTTCCCSCE
T ss_pred             EecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCcccccccccCCCceE
Confidence            99995 6999999865433       223456799999999999999999999999999999754             47


Q ss_pred             EEEEeccCCCCCccccCC--CccccccCCCCccChhhhcc------cCCCCCcchHHHHHHHHhhhc--CCcCCCCC---
Q 014609          153 IKISDFGLSALPQHFRDD--GLLHTTCGSPNYVAPEVLAN------RGYDGATSDIWSCGVILYIFR--GDFKLPKW---  219 (421)
Q Consensus       153 ~kL~DFGla~~~~~~~~~--~~~~~~~gt~~y~APEvl~~------~~~~~~~~DiwSlGvil~~~~--~~~~~p~~---  219 (421)
                      +||+|||++.........  ......+||+.|+|||++.+      ....+.++|||||||++|.+.  |..++...   
T Consensus       167 ~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~  246 (434)
T 2rio_A          167 ILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSR  246 (434)
T ss_dssp             EEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTH
T ss_pred             EEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhh
Confidence            999999999865432111  12345689999999999865      123368999999999999653  44443211   


Q ss_pred             ---------------------CCHHHHHHHHHhcCCCCCCCCCHHhhhcCccccc
Q 014609          220 ---------------------LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQ  253 (421)
Q Consensus       220 ---------------------~s~~~~~li~~~L~~dP~~R~t~~eil~~~w~~~  253 (421)
                                           +++++.++|.+||+.||.+|||+.++++||||..
T Consensus       247 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~hp~f~~  301 (434)
T 2rio_A          247 ESNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLFWP  301 (434)
T ss_dssp             HHHHHHTCCCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSC
T ss_pred             HHHHhcCCCCcccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHhCCccCC
Confidence                                 2477899999999999999999999999999964

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=3.1e-42  Score=334.90  Aligned_cols=235  Identities=31%  Similarity=0.474  Sum_probs=182.2

Q ss_pred             cceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCC-CCCcceEEEEEE--------
Q 014609           14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK-HPNVVRLHEVLA--------   84 (421)
Q Consensus        14 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~--------   84 (421)
                      .+|++.+.||+|+||.||+|++..+|+.||||++....   ......+.+|+.+++++. ||||+++++++.        
T Consensus        28 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~  104 (337)
T 3ll6_A           28 LRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNE---EEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDT  104 (337)
T ss_dssp             EEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESS---HHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTT
T ss_pred             ceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCc---hHHHHHHHHHHHHHHHhccCCChhhcccccccccccccc
Confidence            38999999999999999999999999999999986542   333567899999999996 999999999994        


Q ss_pred             eCCEEEEEEeccCCCChHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC--ceeccCCCCCEEeccCCCEEEEecc
Q 014609           85 SKSKIYMVLEYVTGGELFDKIAS---KGRLQEAEGRKLFQQLIDGVSYCHNKG--VFHRDLKLENILLDSKGNIKISDFG  159 (421)
Q Consensus        85 ~~~~~~lv~E~~~gg~L~~~i~~---~~~~~~~~~~~~~~ql~~aL~~LH~~g--i~HrDlkp~NILl~~~~~~kL~DFG  159 (421)
                      ....+|+||||+. |+|.+++..   .+.+++..++.++.||+.||+|||++|  |+||||||+|||++.++.+||+|||
T Consensus       105 ~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~~~~kl~Dfg  183 (337)
T 3ll6_A          105 GQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFG  183 (337)
T ss_dssp             SSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTTSCEEBCCCT
T ss_pred             CCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCCCCEEEecCc
Confidence            3456899999995 688888764   567999999999999999999999999  9999999999999999999999999


Q ss_pred             CCCCCccccCC----------CccccccCCCCccChhhh---cccCCCCCcchHHHHHHHHhhh-cCCcCC---------
Q 014609          160 LSALPQHFRDD----------GLLHTTCGSPNYVAPEVL---ANRGYDGATSDIWSCGVILYIF-RGDFKL---------  216 (421)
Q Consensus       160 la~~~~~~~~~----------~~~~~~~gt~~y~APEvl---~~~~~~~~~~DiwSlGvil~~~-~~~~~~---------  216 (421)
                      ++.........          ......+||+.|+|||++   .+..+ +.++|||||||++|.+ .|..++         
T Consensus       184 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~-~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~  262 (337)
T 3ll6_A          184 SATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPI-GEKQDIWALGCILYLLCFRQHPFEDGAKLRIV  262 (337)
T ss_dssp             TCBCCSSCC-------------------------------CCTTSCS-SHHHHHHHHHHHHHHHHHSSCCC---------
T ss_pred             cceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCC-ChHHhHHHHHHHHHHHHhCCCCCcchhHHHhh
Confidence            99865432111          111255799999999998   34444 5899999999999954 343332         


Q ss_pred             --------CCCCCHHHHHHHHHhcCCCCCCCCCHHhhhcCccccc
Q 014609          217 --------PKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQ  253 (421)
Q Consensus       217 --------p~~~s~~~~~li~~~L~~dP~~R~t~~eil~~~w~~~  253 (421)
                              +...++.+.++|.+||+.||.+|||+.+++++.+-..
T Consensus       263 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~  307 (337)
T 3ll6_A          263 NGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIA  307 (337)
T ss_dssp             ---CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred             cCcccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence                    2346788999999999999999999999999876443

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=5.7e-42  Score=325.11  Aligned_cols=229  Identities=26%  Similarity=0.405  Sum_probs=193.6

Q ss_pred             eeecceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEE
Q 014609           11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIY   90 (421)
Q Consensus        11 ~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~   90 (421)
                      ...++|++++.||+|+||.||+|.+. ++..||+|++.....    ..+.+.+|++++++++||||+++++++.. +..|
T Consensus        10 v~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~   83 (279)
T 1qpc_A           10 VPRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSM----SPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIY   83 (279)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSS----CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred             cCHHhhhheeeecCCCCeEEEEEEEc-CCcEEEEEEecCCcc----cHHHHHHHHHHHHhCCCcCcceEEEEEcC-CCcE
Confidence            34579999999999999999999974 677899999975432    24678999999999999999999999864 4589


Q ss_pred             EEEeccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCcccc
Q 014609           91 MVLEYVTGGELFDKIASKG--RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFR  168 (421)
Q Consensus        91 lv~E~~~gg~L~~~i~~~~--~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~~  168 (421)
                      +||||++|++|.+++....  .+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||++.......
T Consensus        84 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~  163 (279)
T 1qpc_A           84 IITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNE  163 (279)
T ss_dssp             EEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSC
T ss_pred             EEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEEcCCCCEEECCCcccccccCcc
Confidence            9999999999999987543  69999999999999999999999999999999999999999999999999997543211


Q ss_pred             CCCccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhhc--CCcCC--------------------CCCCCHHHHH
Q 014609          169 DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIFR--GDFKL--------------------PKWLSPGAQN  226 (421)
Q Consensus       169 ~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~~--~~~~~--------------------p~~~s~~~~~  226 (421)
                       ........+++.|+|||++.+..+ +.++||||||+++|.+.  |..++                    |..+++.+.+
T Consensus       164 -~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  241 (279)
T 1qpc_A          164 -YTAREGAKFPIKWTAPEAINYGTF-TIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQ  241 (279)
T ss_dssp             -EECCTTCCCCTTTSCHHHHHHCEE-CHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHH
T ss_pred             -cccccCCCCccCccChhhhccCCC-CchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHHhcccCCCCcccccHHHHH
Confidence             111233456889999999987766 58999999999999554  44333                    3457899999


Q ss_pred             HHHHhcCCCCCCCCCHHhhhc
Q 014609          227 LLRKILEPNPVKRITIAGIKA  247 (421)
Q Consensus       227 li~~~L~~dP~~R~t~~eil~  247 (421)
                      +|.+||..||.+|||+.++++
T Consensus       242 li~~~l~~~p~~Rps~~~l~~  262 (279)
T 1qpc_A          242 LMRLCWKERPEDRPTFDYLRS  262 (279)
T ss_dssp             HHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHhccChhhCCCHHHHHH
Confidence            999999999999999999876

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=100.00  E-value=2.5e-43  Score=369.85  Aligned_cols=240  Identities=28%  Similarity=0.380  Sum_probs=197.0

Q ss_pred             cCCeeecceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEe--
Q 014609            8 QEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLAS--   85 (421)
Q Consensus         8 ~~~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~--   85 (421)
                      ..+..+++|++.+.||+|+||.||+|.+..+|+.||||++....  .....+.+.+|+.++++++||||+++++++..  
T Consensus         8 ~pg~~~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~--~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~   85 (676)
T 3qa8_A            8 LPTQTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQEL--SPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQ   85 (676)
T ss_dssp             ---------CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCC--CHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTC
T ss_pred             CCCCCCCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccC--CHHHHHHHHHHHHHHHhCCCCCCCceeeeecccc
Confidence            44667899999999999999999999999999999999987542  33446789999999999999999999999765  


Q ss_pred             ----CCEEEEEEeccCCCChHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCC---EEE
Q 014609           86 ----KSKIYMVLEYVTGGELFDKIASKG---RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGN---IKI  155 (421)
Q Consensus        86 ----~~~~~lv~E~~~gg~L~~~i~~~~---~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~---~kL  155 (421)
                          .+..|+||||++|++|.+++....   .+++..++.++.|++.||+|||++||+||||||+|||++.++.   +||
T Consensus        86 ~~~~~~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~~~~vKL  165 (676)
T 3qa8_A           86 KLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKI  165 (676)
T ss_dssp             CCCTTSSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSSSCEEEE
T ss_pred             cccCCCeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCCceeEEE
Confidence                677899999999999999998644   6999999999999999999999999999999999999998775   999


Q ss_pred             EeccCCCCCccccCCCccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhh-cCCcCCCC----------------
Q 014609          156 SDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIF-RGDFKLPK----------------  218 (421)
Q Consensus       156 ~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~-~~~~~~p~----------------  218 (421)
                      +|||++.....   .......+||+.|+|||++.+..+ +.++||||+||++|.+ .|..++..                
T Consensus       166 ~DFG~a~~~~~---~~~~~~~~gt~~Y~APE~l~~~~~-s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~  241 (676)
T 3qa8_A          166 IDLGYAKELDQ---GELCTEFVGTLQYLAPELLEQKKY-TVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSN  241 (676)
T ss_dssp             CSCCCCCBTTS---CCCCCCCCSCCTTCSSCSSCCSCC-STTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC----
T ss_pred             ccccccccccc---ccccccccCCcccCChHHhccCCC-CchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccc
Confidence            99999986533   233455689999999999988777 5899999999999954 34333311                


Q ss_pred             ---------------------------CCCHHHHHHHHHhcCCCCCCCCCHHhhhcCccccc
Q 014609          219 ---------------------------WLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQ  253 (421)
Q Consensus       219 ---------------------------~~s~~~~~li~~~L~~dP~~R~t~~eil~~~w~~~  253 (421)
                                                 .+++.+.++|.+||..||.+|||+.++++||||..
T Consensus       242 ~~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~  303 (676)
T 3qa8_A          242 EHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQA  303 (676)
T ss_dssp             --CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHH
T ss_pred             hhhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHH
Confidence                                       14578999999999999999999999999999964

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=3.9e-42  Score=349.73  Aligned_cols=229  Identities=25%  Similarity=0.416  Sum_probs=194.1

Q ss_pred             eeecceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEE
Q 014609           11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIY   90 (421)
Q Consensus        11 ~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~   90 (421)
                      ...++|++.+.||+|+||+||+|.+. ++..||||+++....    ..+.+.+|+.+|++++||||+++++++. ....|
T Consensus       185 i~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~  258 (454)
T 1qcf_A          185 IPRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGSM----SVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIY  258 (454)
T ss_dssp             CCGGGEEEEEEEECCSSEEEEEEEET-TTEEEEEEEECTTSB----CHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCE
T ss_pred             echHHeEEEEEcccCCceEEEEEEEC-CccEEEEEEecCCCc----cHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccE
Confidence            34478999999999999999999984 577899999975432    2578999999999999999999999986 56789


Q ss_pred             EEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCcccc
Q 014609           91 MVLEYVTGGELFDKIASK--GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFR  168 (421)
Q Consensus        91 lv~E~~~gg~L~~~i~~~--~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~~  168 (421)
                      +||||+++|+|.+++...  ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++.......
T Consensus       259 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~  338 (454)
T 1qcf_A          259 IITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNE  338 (454)
T ss_dssp             EEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHH
T ss_pred             EEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCc
Confidence            999999999999999753  368999999999999999999999999999999999999999999999999998543211


Q ss_pred             CCCccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhhc--CCcCC--------------------CCCCCHHHHH
Q 014609          169 DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIFR--GDFKL--------------------PKWLSPGAQN  226 (421)
Q Consensus       169 ~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~~--~~~~~--------------------p~~~s~~~~~  226 (421)
                      . .......+|+.|+|||++....+ +.++|||||||++|.+.  |..++                    |..+++.+.+
T Consensus       339 ~-~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~  416 (454)
T 1qcf_A          339 Y-TAREGAKFPIKWTAPEAINFGSF-TIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENCPEELYN  416 (454)
T ss_dssp             H-HTTCSSSSCGGGSCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHTCCCCCCTTSCHHHHH
T ss_pred             e-eccCCCcccccccCHHHhccCCC-CcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHH
Confidence            0 11123346778999999987777 58999999999999543  44433                    4557899999


Q ss_pred             HHHHhcCCCCCCCCCHHhhhc
Q 014609          227 LLRKILEPNPVKRITIAGIKA  247 (421)
Q Consensus       227 li~~~L~~dP~~R~t~~eil~  247 (421)
                      +|.+||+.||.+|||+.++++
T Consensus       417 li~~cl~~dp~~RPt~~~i~~  437 (454)
T 1qcf_A          417 IMMRCWKNRPEERPTFEYIQS  437 (454)
T ss_dssp             HHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHccCChhHCcCHHHHHH
Confidence            999999999999999999875

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=1.4e-42  Score=330.82  Aligned_cols=233  Identities=27%  Similarity=0.408  Sum_probs=185.8

Q ss_pred             ecceEEeceEeecCcEEEEEEEECC-CCc--eEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEE
Q 014609           13 LGRYELGRTLGEGNFGKVKFAQDLD-SGL--PFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKI   89 (421)
Q Consensus        13 ~~~y~i~~~LG~G~~g~V~~a~~~~-~~~--~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~   89 (421)
                      .++|++++.||+|+||+||+|.+.. +++  .||+|+++..........+.+.+|+.++++++||||+++++++.+.. .
T Consensus        17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~   95 (291)
T 1u46_A           17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-M   95 (291)
T ss_dssp             GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-C
T ss_pred             hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-c
Confidence            4689999999999999999998643 333  69999997655444455678999999999999999999999998765 8


Q ss_pred             EEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCcccc
Q 014609           90 YMVLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFR  168 (421)
Q Consensus        90 ~lv~E~~~gg~L~~~i~~~-~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~~  168 (421)
                      ++||||+++++|.+++... ..+++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||++.......
T Consensus        96 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~  175 (291)
T 1u46_A           96 KMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQND  175 (291)
T ss_dssp             EEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECCC-C
T ss_pred             eeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEcCCCCEEEccccccccccccc
Confidence            8999999999999998764 569999999999999999999999999999999999999999999999999987543321


Q ss_pred             CC-CccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhhc--CCcCC---------------------CCCCCHHH
Q 014609          169 DD-GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIFR--GDFKL---------------------PKWLSPGA  224 (421)
Q Consensus       169 ~~-~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~~--~~~~~---------------------p~~~s~~~  224 (421)
                      .. .......+|+.|+|||++.+..+ +.++||||||+++|.+.  |..++                     +..+++.+
T Consensus       176 ~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  254 (291)
T 1u46_A          176 DHYVMQEHRKVPFAWCAPESLKTRTF-SHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQDI  254 (291)
T ss_dssp             CEEEC-----CCGGGCCHHHHHHCEE-EHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCCCCTTCCHHH
T ss_pred             cchhhhccCCCCceeeCchhhcCCCC-CchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHHccCCCCCCCcCcCHHH
Confidence            11 12234467889999999987766 58999999999999654  33332                     34578999


Q ss_pred             HHHHHHhcCCCCCCCCCHHhhhc
Q 014609          225 QNLLRKILEPNPVKRITIAGIKA  247 (421)
Q Consensus       225 ~~li~~~L~~dP~~R~t~~eil~  247 (421)
                      .++|.+||+.||.+|||+.++++
T Consensus       255 ~~li~~~l~~~p~~Rps~~~l~~  277 (291)
T 1u46_A          255 YNVMVQCWAHKPEDRPTFVALRD  277 (291)
T ss_dssp             HHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHccCCcccCcCHHHHHH
Confidence            99999999999999999999987

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=100.00  E-value=2.4e-42  Score=349.12  Aligned_cols=234  Identities=26%  Similarity=0.351  Sum_probs=184.6

Q ss_pred             eeec--ceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcC-CCCCcceEEEEEEeCC
Q 014609           11 MRLG--RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEVLASKS   87 (421)
Q Consensus        11 ~~~~--~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~   87 (421)
                      ..++  +|++.+.||+|+||+|+.. ...+|+.||||++.....      ..+.+|+.+|+.+ +||||+++++++.+..
T Consensus        19 ~~i~~~~y~~~~~LG~G~~G~V~~~-~~~~~~~vAvK~~~~~~~------~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~   91 (432)
T 3p23_A           19 VIVGKISFCPKDVLGHGAEGTIVYR-GMFDNRDVAVKRILPECF------SFADREVQLLRESDEHPNVIRYFCTEKDRQ   91 (432)
T ss_dssp             EEETTEEEEEEEEEEECGGGCEEEE-EESSSSEEEEEEECTTTE------EECHHHHHHHHHSCCCTTBCCEEEEEEETT
T ss_pred             EEEccEEEecCCeeecCcCEEEEEE-EEeCCeEEEEEEECHHHH------HHHHHHHHHHHhccCCCCcCeEEEEEecCC
Confidence            4444  5999999999999997643 347899999999965432      2356799999999 7999999999999999


Q ss_pred             EEEEEEeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccC-----CCEEEEeccCC
Q 014609           88 KIYMVLEYVTGGELFDKIASKG-RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSK-----GNIKISDFGLS  161 (421)
Q Consensus        88 ~~~lv~E~~~gg~L~~~i~~~~-~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~-----~~~kL~DFGla  161 (421)
                      ..|+||||+. |+|.+++.... ..++..+..++.||+.||+|||++||+||||||+|||++.+     ..+||+|||++
T Consensus        92 ~~~lv~E~~~-g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a  170 (432)
T 3p23_A           92 FQYIAIELCA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLC  170 (432)
T ss_dssp             EEEEEEECCS-EEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEE
T ss_pred             EEEEEEECCC-CCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEecccce
Confidence            9999999995 59999987643 45666778999999999999999999999999999999532     35889999999


Q ss_pred             CCCccccC-CCccccccCCCCccChhhhcc---cCCCCCcchHHHHHHHHhhhc--CCcCCCCC----------------
Q 014609          162 ALPQHFRD-DGLLHTTCGSPNYVAPEVLAN---RGYDGATSDIWSCGVILYIFR--GDFKLPKW----------------  219 (421)
Q Consensus       162 ~~~~~~~~-~~~~~~~~gt~~y~APEvl~~---~~~~~~~~DiwSlGvil~~~~--~~~~~p~~----------------  219 (421)
                      ........ .......+||+.|+|||++.+   ..+ +.++|||||||++|++.  |..++...                
T Consensus       171 ~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~-t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~~  249 (432)
T 3p23_A          171 KKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENP-TYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLDC  249 (432)
T ss_dssp             ECC------------CCSCTTSCCGGGTSCC---CC-CTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHHHHTTCCCCTT
T ss_pred             eeccCCCcceeeccccCCCcCccChhhhhcccccCC-CcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHHHHhccCCccc
Confidence            86543211 123445689999999999874   333 57899999999999654  34333211                


Q ss_pred             ------CCHHHHHHHHHhcCCCCCCCCCHHhhhcCccccc
Q 014609          220 ------LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQ  253 (421)
Q Consensus       220 ------~s~~~~~li~~~L~~dP~~R~t~~eil~~~w~~~  253 (421)
                            .+..+.+||.+||+.||.+|||+.++++||||..
T Consensus       250 ~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~hp~f~~  289 (432)
T 3p23_A          250 LHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFFWS  289 (432)
T ss_dssp             SCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTSTTTCC
T ss_pred             cCccccccHHHHHHHHHHHhCCHhhCCCHHHHHhCccccC
Confidence                  2355789999999999999999999999999974

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=8.1e-42  Score=328.55  Aligned_cols=229  Identities=28%  Similarity=0.374  Sum_probs=190.7

Q ss_pred             eEEeceEeecCcEEEEEEEECCCCceEEEEEeecccc-cchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEEe
Q 014609           16 YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRI-IHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLE   94 (421)
Q Consensus        16 y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E   94 (421)
                      |..++.||+|+||.||+|.+  +++.||+|++..... ......+.+.+|+.++++++||||+++++++.+.+..|+|||
T Consensus        33 ~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e  110 (307)
T 2nru_A           33 SVGGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYV  110 (307)
T ss_dssp             TTTCCEEEECSSEEEEEEES--SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred             cccCCccccCCCeEEEEEEE--CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEecCCceEEEEE
Confidence            44568999999999999985  688999999875432 233446789999999999999999999999999999999999


Q ss_pred             ccCCCChHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCccccCCC
Q 014609           95 YVTGGELFDKIAS---KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDG  171 (421)
Q Consensus        95 ~~~gg~L~~~i~~---~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~  171 (421)
                      |+++++|.+++..   ..++++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||++..........
T Consensus       111 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~  190 (307)
T 2nru_A          111 YMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTV  190 (307)
T ss_dssp             CCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSCSSCE
T ss_pred             ecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEcCCCcEEEeecccccccccccccc
Confidence            9999999999873   3469999999999999999999999999999999999999999999999999987554322222


Q ss_pred             ccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhh-cCCcCCCC--------------------------------
Q 014609          172 LLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIF-RGDFKLPK--------------------------------  218 (421)
Q Consensus       172 ~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~-~~~~~~p~--------------------------------  218 (421)
                      .....+||+.|+|||++.+. + +.++||||||+++|.+ .|..++..                                
T Consensus       191 ~~~~~~g~~~y~aPE~~~~~-~-~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  268 (307)
T 2nru_A          191 MTSRIVGTTAYMAPEALRGE-I-TPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMNDA  268 (307)
T ss_dssp             ECSSCCSCGGGCCHHHHTTE-E-CTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHHTTSCCHHHHSCSSCSCC
T ss_pred             cccccCCCcCcCChHHhcCC-C-CccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhhhhhhhhhhhcccccccc
Confidence            33456799999999998654 4 5899999999999954 33333211                                


Q ss_pred             --CCCHHHHHHHHHhcCCCCCCCCCHHhhhcC
Q 014609          219 --WLSPGAQNLLRKILEPNPVKRITIAGIKAD  248 (421)
Q Consensus       219 --~~s~~~~~li~~~L~~dP~~R~t~~eil~~  248 (421)
                        ..++.+.+++.+||+.||.+|||+.+++++
T Consensus       269 ~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~  300 (307)
T 2nru_A          269 DSTSVEAMYSVASQCLHEKKNKRPDIKKVQQL  300 (307)
T ss_dssp             CHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred             chHHHHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence              123567899999999999999999998864

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=100.00  E-value=4.9e-44  Score=349.11  Aligned_cols=224  Identities=21%  Similarity=0.271  Sum_probs=184.2

Q ss_pred             eecceEEeceEeecCcEEEEEEEECCCCceEEEEEeeccccc-----chhHHHHHHHHHHHHhcCC---------CCCcc
Q 014609           12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRII-----HLKITDQIKREIATLKLLK---------HPNVV   77 (421)
Q Consensus        12 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~-----~~~~~~~~~~Ei~il~~l~---------hpnIv   77 (421)
                      ..++|++++.||+|+||+||+|++  +|+.||||++......     .....+.+.+|+.+++.++         ||||+
T Consensus        18 ~~~~y~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv   95 (336)
T 2vuw_A           18 PTEKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFI   95 (336)
T ss_dssp             CHHHHHTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBC
T ss_pred             ccccchheeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchh
Confidence            357899999999999999999997  7899999999865421     2223477889999998886         88888


Q ss_pred             eEEEEEE------------------------------eCCEEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHH
Q 014609           78 RLHEVLA------------------------------SKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGV  127 (421)
Q Consensus        78 ~l~~~~~------------------------------~~~~~~lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~ql~~aL  127 (421)
                      ++.+++.                              ..+..|+||||+++|++.+.+.. ..+++..++.++.||+.||
T Consensus        96 ~l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~-~~~~~~~~~~i~~qi~~aL  174 (336)
T 2vuw_A           96 GLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT-KLSSLATAKSILHQLTASL  174 (336)
T ss_dssp             CEEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT-TCCCHHHHHHHHHHHHHHH
T ss_pred             hhcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh-cCCCHHHHHHHHHHHHHHH
Confidence            8877653                              26789999999999987777754 6789999999999999999


Q ss_pred             HHHH-hCCceeccCCCCCEEeccCC--------------------CEEEEeccCCCCCccccCCCccccccCCCCccChh
Q 014609          128 SYCH-NKGVFHRDLKLENILLDSKG--------------------NIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPE  186 (421)
Q Consensus       128 ~~LH-~~gi~HrDlkp~NILl~~~~--------------------~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE  186 (421)
                      +||| ++||+||||||+|||++.++                    .+||+|||+|+....       ...+||+.|+|||
T Consensus       175 ~~lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~-------~~~~gt~~y~aPE  247 (336)
T 2vuw_A          175 AVAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERD-------GIVVFCDVSMDED  247 (336)
T ss_dssp             HHHHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEET-------TEEECCCCTTCSG
T ss_pred             HHHHHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCC-------CcEEEeecccChh
Confidence            9999 99999999999999999987                    899999999985432       2458999999999


Q ss_pred             hhcccCCCCCcchHHHHHHHH-hhhc-CCcCC---------------------------CCCCCHHHHHHHHHhcCCCCC
Q 014609          187 VLANRGYDGATSDIWSCGVIL-YIFR-GDFKL---------------------------PKWLSPGAQNLLRKILEPNPV  237 (421)
Q Consensus       187 vl~~~~~~~~~~DiwSlGvil-~~~~-~~~~~---------------------------p~~~s~~~~~li~~~L~~dP~  237 (421)
                      ++.+..  +.++||||+|++. +.+. +..++                           ++.+|+++.+||++||+.|  
T Consensus       248 ~~~g~~--~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~d--  323 (336)
T 2vuw_A          248 LFTGDG--DYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTKCNTPAMKQIKRKIQEFHRTMLNFS--  323 (336)
T ss_dssp             GGCCCS--SHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHTCCCSSCCCSHHHHHHHHHHHHHHHHGGGSS--
T ss_pred             hhcCCC--ccceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhhhhccCcccchhhhhhcCHHHHHHHHHHhccC--
Confidence            998665  5899999998773 3111 11111                           1126788999999999977  


Q ss_pred             CCCCHHhhh-cCcccc
Q 014609          238 KRITIAGIK-ADEWFE  252 (421)
Q Consensus       238 ~R~t~~eil-~~~w~~  252 (421)
                         |+.|++ +||||+
T Consensus       324 ---sa~e~l~~Hp~f~  336 (336)
T 2vuw_A          324 ---SATDLLCQHSLFK  336 (336)
T ss_dssp             ---SHHHHHHHCGGGC
T ss_pred             ---CHHHHHhcCCCcC
Confidence               999999 999995

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=1.1e-41  Score=346.21  Aligned_cols=228  Identities=25%  Similarity=0.381  Sum_probs=189.7

Q ss_pred             eecceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEE
Q 014609           12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYM   91 (421)
Q Consensus        12 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l   91 (421)
                      ..++|++.+.||+|+||.||+|.+.. +..||||+++....    ..+.+.+|+.+|++++||||+++++++.. ...|+
T Consensus       182 ~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~i  255 (452)
T 1fmk_A          182 PRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTM----SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYI  255 (452)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTTSS----CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEE
T ss_pred             ChhHceeeeeecCCCCeEEEEEEECC-CceEEEEEeccCCC----CHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEE
Confidence            34789999999999999999999864 56799999975432    14678999999999999999999999876 67899


Q ss_pred             EEeccCCCChHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCccccC
Q 014609           92 VLEYVTGGELFDKIAS--KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD  169 (421)
Q Consensus        92 v~E~~~gg~L~~~i~~--~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~  169 (421)
                      ||||+++|+|.+++..  ...+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||++....... 
T Consensus       256 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~-  334 (452)
T 1fmk_A          256 VTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE-  334 (452)
T ss_dssp             EECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC-------
T ss_pred             EehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEECCCCCEEECCCccceecCCCc-
Confidence            9999999999999974  3569999999999999999999999999999999999999999999999999998643211 


Q ss_pred             CCccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhhc--CCcC--------------------CCCCCCHHHHHH
Q 014609          170 DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIFR--GDFK--------------------LPKWLSPGAQNL  227 (421)
Q Consensus       170 ~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~~--~~~~--------------------~p~~~s~~~~~l  227 (421)
                      ........+++.|+|||++....+ +.++|||||||++|.+.  |..+                    .|..+++.+.++
T Consensus       335 ~~~~~~~~~~~~y~aPE~~~~~~~-~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~l  413 (452)
T 1fmk_A          335 YTARQGAKFPIKWTAPEAALYGRF-TIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDL  413 (452)
T ss_dssp             --------CCGGGSCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTSCHHHHHH
T ss_pred             eecccCCcccccccCHhHHhcCCC-CccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHH
Confidence            112223456788999999988777 58999999999999553  3333                    345678999999


Q ss_pred             HHHhcCCCCCCCCCHHhhhc
Q 014609          228 LRKILEPNPVKRITIAGIKA  247 (421)
Q Consensus       228 i~~~L~~dP~~R~t~~eil~  247 (421)
                      |.+||+.||.+|||++++++
T Consensus       414 i~~cl~~dP~~Rpt~~~l~~  433 (452)
T 1fmk_A          414 MCQCWRKEPEERPTFEYLQA  433 (452)
T ss_dssp             HHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHccCChhhCcCHHHHHH
Confidence            99999999999999999876

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=1.8e-41  Score=327.04  Aligned_cols=223  Identities=29%  Similarity=0.453  Sum_probs=185.6

Q ss_pred             eeecceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEE
Q 014609           11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIY   90 (421)
Q Consensus        11 ~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~   90 (421)
                      ...++|++.+.||+|+||+||+|.+  .++.||+|++...     ...+.+.+|+.++++++||||+++++++.+  ..|
T Consensus         5 i~~~~~~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~-----~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~   75 (307)
T 2eva_A            5 IDYKEIEVEEVVGRGAFGVVCKAKW--RAKDVAIKQIESE-----SERKAFIVELRQLSRVNHPNIVKLYGACLN--PVC   75 (307)
T ss_dssp             CCGGGEEEEEEEECCSSSEEEEEEE--TTEEEEEEECSST-----THHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTE
T ss_pred             CCHhHeeeeeEeecCCCceEEEEEE--CCeeEEEEEecCh-----hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcE
Confidence            3467999999999999999999987  4789999998643     235678999999999999999999998874  478


Q ss_pred             EEEeccCCCChHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHh---CCceeccCCCCCEEeccCCC-EEEEeccCCCC
Q 014609           91 MVLEYVTGGELFDKIASKG---RLQEAEGRKLFQQLIDGVSYCHN---KGVFHRDLKLENILLDSKGN-IKISDFGLSAL  163 (421)
Q Consensus        91 lv~E~~~gg~L~~~i~~~~---~~~~~~~~~~~~ql~~aL~~LH~---~gi~HrDlkp~NILl~~~~~-~kL~DFGla~~  163 (421)
                      +||||++|++|.+++....   .+++..+..++.|++.||+|||+   +||+||||||+|||++.++. +||+|||++..
T Consensus        76 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~  155 (307)
T 2eva_A           76 LVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACD  155 (307)
T ss_dssp             EEEECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC---
T ss_pred             EEEEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccc
Confidence            9999999999999998654   47899999999999999999999   89999999999999998887 79999999974


Q ss_pred             CccccCCCccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhh-cCCcC----------------------CCCCC
Q 014609          164 PQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIF-RGDFK----------------------LPKWL  220 (421)
Q Consensus       164 ~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~-~~~~~----------------------~p~~~  220 (421)
                      ...     ......||+.|+|||++.+..+ +.++|||||||++|.+ .|..+                      .+..+
T Consensus       156 ~~~-----~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (307)
T 2eva_A          156 IQT-----HMTNNKGSAAWMAPEVFEGSNY-SEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLIKNL  229 (307)
T ss_dssp             --------------CCTTSSCHHHHTCCCC-CTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHTTCCCCCBTTC
T ss_pred             ccc-----ccccCCCCCceEChhhhCCCCC-CcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhcCCCCCccccc
Confidence            332     2234579999999999988777 5899999999999943 33332                      23457


Q ss_pred             CHHHHHHHHHhcCCCCCCCCCHHhhhcC
Q 014609          221 SPGAQNLLRKILEPNPVKRITIAGIKAD  248 (421)
Q Consensus       221 s~~~~~li~~~L~~dP~~R~t~~eil~~  248 (421)
                      ++.+.++|.+||+.||.+|||+.+++++
T Consensus       230 ~~~l~~li~~~l~~dp~~Rps~~ell~~  257 (307)
T 2eva_A          230 PKPIESLMTRCWSKDPSQRPSMEEIVKI  257 (307)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CHHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence            8999999999999999999999999874

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=6.3e-42  Score=339.65  Aligned_cols=232  Identities=24%  Similarity=0.310  Sum_probs=184.8

Q ss_pred             cceEEeceEeecCcEEEEEEEECCC---CceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEE-eCCEE
Q 014609           14 GRYELGRTLGEGNFGKVKFAQDLDS---GLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLA-SKSKI   89 (421)
Q Consensus        14 ~~y~i~~~LG~G~~g~V~~a~~~~~---~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~-~~~~~   89 (421)
                      ..|++.+.||+|+||+||+|.+..+   +..||+|.++...  .....+.+.+|+.++++++||||+++++++. .++..
T Consensus        89 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~  166 (373)
T 3c1x_A           89 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT--DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSP  166 (373)
T ss_dssp             EEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCS--CSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCC
T ss_pred             ceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCC--CHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCe
Confidence            3689999999999999999987543   3468999886432  3344678999999999999999999999865 45688


Q ss_pred             EEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCcccc
Q 014609           90 YMVLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFR  168 (421)
Q Consensus        90 ~lv~E~~~gg~L~~~i~~~-~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~~  168 (421)
                      |+||||+++++|.+++... ..+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||++.......
T Consensus       167 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~  246 (373)
T 3c1x_A          167 LVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE  246 (373)
T ss_dssp             EEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC----------
T ss_pred             EEEEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEECCCCCEEEeeccccccccccc
Confidence            9999999999999999764 458999999999999999999999999999999999999999999999999997543211


Q ss_pred             C--CCccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhhcC--CcC--------------------CCCCCCHHH
Q 014609          169 D--DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIFRG--DFK--------------------LPKWLSPGA  224 (421)
Q Consensus       169 ~--~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~~~--~~~--------------------~p~~~s~~~  224 (421)
                      .  ........+|+.|+|||++.+..+ +.++|||||||++|.+..  ..+                    .|..+++.+
T Consensus       247 ~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~~~~~~~~p~~~~~~l  325 (373)
T 3c1x_A          247 FDSVHNKTGAKLPVKWMALESLQTQKF-TTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPL  325 (373)
T ss_dssp             -----------CCGGGSCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHHTTCCCCCCTTCCHHH
T ss_pred             cccccccCCCCCcccccChHHhcCCCC-CcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHH
Confidence            1  112233467789999999988777 589999999999996432  222                    245578999


Q ss_pred             HHHHHHhcCCCCCCCCCHHhhhcC
Q 014609          225 QNLLRKILEPNPVKRITIAGIKAD  248 (421)
Q Consensus       225 ~~li~~~L~~dP~~R~t~~eil~~  248 (421)
                      .++|.+||+.||.+|||+.+++++
T Consensus       326 ~~li~~cl~~dp~~RPs~~ell~~  349 (373)
T 3c1x_A          326 YEVMLKCWHPKAEMRPSFSELVSR  349 (373)
T ss_dssp             HHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHcCCChhhCcCHHHHHHH
Confidence            999999999999999999999875

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=3.6e-41  Score=355.77  Aligned_cols=230  Identities=25%  Similarity=0.339  Sum_probs=190.2

Q ss_pred             ceEE-eceEeecCcEEEEEEEE--CCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEE
Q 014609           15 RYEL-GRTLGEGNFGKVKFAQD--LDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYM   91 (421)
Q Consensus        15 ~y~i-~~~LG~G~~g~V~~a~~--~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l   91 (421)
                      .+.+ .+.||+|+||+||+|.+  ..+++.||||+++.... .....+.+.+|+.+|++++||||+++++++.. ...++
T Consensus       369 ~~~l~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~l  446 (635)
T 4fl3_A          369 LLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAN-DPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWML  446 (635)
T ss_dssp             GEEEEEEEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGG-CGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEE
T ss_pred             hccccCCEeccCCCEEEEEEEEcCCCcceEEEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEE
Confidence            3444 34899999999999954  45778999999976432 33346789999999999999999999999975 45889


Q ss_pred             EEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCccccC-C
Q 014609           92 VLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD-D  170 (421)
Q Consensus        92 v~E~~~gg~L~~~i~~~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~-~  170 (421)
                      ||||+++|+|.+++...+.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++........ .
T Consensus       447 v~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~  526 (635)
T 4fl3_A          447 VMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY  526 (635)
T ss_dssp             EEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC-----
T ss_pred             EEEccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCcccc
Confidence            999999999999999888899999999999999999999999999999999999999999999999999975433211 1


Q ss_pred             CccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhhc--CCcC--------------------CCCCCCHHHHHHH
Q 014609          171 GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIFR--GDFK--------------------LPKWLSPGAQNLL  228 (421)
Q Consensus       171 ~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~~--~~~~--------------------~p~~~s~~~~~li  228 (421)
                      .......+|+.|+|||++.+..+ +.++|||||||++|++.  |..+                    .|..+++++.++|
T Consensus       527 ~~~~~~~~t~~y~APE~~~~~~~-~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li  605 (635)
T 4fl3_A          527 KAQTHGKWPVKWYAPECINYYKF-SSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLM  605 (635)
T ss_dssp             --------CGGGSCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHH
T ss_pred             ccccCCCCceeeeChhhhcCCCC-CcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHH
Confidence            12233456788999999988777 58999999999999653  4443                    3556889999999


Q ss_pred             HHhcCCCCCCCCCHHhhhc
Q 014609          229 RKILEPNPVKRITIAGIKA  247 (421)
Q Consensus       229 ~~~L~~dP~~R~t~~eil~  247 (421)
                      .+||+.||.+|||+.++++
T Consensus       606 ~~cl~~dP~~RPs~~~l~~  624 (635)
T 4fl3_A          606 NLCWTYDVENRPGFAAVEL  624 (635)
T ss_dssp             HHHTCSSTTTSCCHHHHHH
T ss_pred             HHHcCCCHhHCcCHHHHHH
Confidence            9999999999999999865

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=1.6e-40  Score=339.72  Aligned_cols=229  Identities=19%  Similarity=0.276  Sum_probs=195.1

Q ss_pred             eecceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCC-CCcceEEEEEEeCCEEE
Q 014609           12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKH-PNVVRLHEVLASKSKIY   90 (421)
Q Consensus        12 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~h-pnIv~l~~~~~~~~~~~   90 (421)
                      ..++|++++.||+|+||.||+|.+..+++.||||++.....     ...+.+|+.+++.++| ++|..+..++......|
T Consensus         5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~-----~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~   79 (483)
T 3sv0_A            5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-----HPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNV   79 (483)
T ss_dssp             ETTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS-----SCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEE
T ss_pred             cCCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc-----cHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEE
Confidence            44799999999999999999999999999999999875432     2357889999999987 56667777778889999


Q ss_pred             EEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEe---ccCCCEEEEeccCCCCCcc
Q 014609           91 MVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILL---DSKGNIKISDFGLSALPQH  166 (421)
Q Consensus        91 lv~E~~~gg~L~~~i~~-~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl---~~~~~~kL~DFGla~~~~~  166 (421)
                      +||||+ +++|.+++.. ...+++..++.++.||+.||+|||++||+||||||+||||   +.++.+||+|||++.....
T Consensus        80 lvme~~-g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~  158 (483)
T 3sv0_A           80 LVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRD  158 (483)
T ss_dssp             EEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBC
T ss_pred             EEEECC-CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCCeEEEEeCCcceeccC
Confidence            999999 9999999975 5679999999999999999999999999999999999999   6889999999999986543


Q ss_pred             ccCC-----CccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhh-hcCCcCCC-----------------------
Q 014609          167 FRDD-----GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYI-FRGDFKLP-----------------------  217 (421)
Q Consensus       167 ~~~~-----~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~-~~~~~~~p-----------------------  217 (421)
                      ....     ......+||+.|+|||++.+..+ +.++|||||||+||+ +.|..++.                       
T Consensus       159 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~-s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~  237 (483)
T 3sv0_A          159 TSTHQHIPYRENKNLTGTARYASVNTHLGIEQ-SRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATSI  237 (483)
T ss_dssp             TTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCC-CHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSCH
T ss_pred             CccccccccccccccCCCccccCHHHhcCCCC-ChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccccccH
Confidence            2211     12236689999999999988877 589999999999994 45555543                       


Q ss_pred             ----CCCCHHHHHHHHHhcCCCCCCCCCHHhhhc
Q 014609          218 ----KWLSPGAQNLLRKILEPNPVKRITIAGIKA  247 (421)
Q Consensus       218 ----~~~s~~~~~li~~~L~~dP~~R~t~~eil~  247 (421)
                          ..+++++.++|.+||+.||.+||++.++++
T Consensus       238 ~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~  271 (483)
T 3sv0_A          238 EALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKR  271 (483)
T ss_dssp             HHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred             HHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence                346889999999999999999999987664

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=1e-40  Score=325.58  Aligned_cols=226  Identities=25%  Similarity=0.352  Sum_probs=188.1

Q ss_pred             cceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhc--CCCCCcceEEEEEEeCC----
Q 014609           14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKL--LKHPNVVRLHEVLASKS----   87 (421)
Q Consensus        14 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~--l~hpnIv~l~~~~~~~~----   87 (421)
                      ++|++.+.||+|+||.||+|.+  +|+.||||++....      ...+.+|.++++.  ++||||+++++++....    
T Consensus        42 ~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~------~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~  113 (342)
T 1b6c_B           42 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSRE------ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWT  113 (342)
T ss_dssp             HHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECGGG------HHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCC
T ss_pred             ccEEEEeeecCCCCcEEEEEEE--cCccEEEEEeCchh------HHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccc
Confidence            6899999999999999999997  58999999986432      4567889999887  78999999999998876    


Q ss_pred             EEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH--------hCCceeccCCCCCEEeccCCCEEEEecc
Q 014609           88 KIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCH--------NKGVFHRDLKLENILLDSKGNIKISDFG  159 (421)
Q Consensus        88 ~~~lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~ql~~aL~~LH--------~~gi~HrDlkp~NILl~~~~~~kL~DFG  159 (421)
                      ..|+||||+++++|.+++.. .++++..++.++.|++.||+|||        +.||+||||||+|||++.++.+||+|||
T Consensus       114 ~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg  192 (342)
T 1b6c_B          114 QLWLVSDYHEHGSLFDYLNR-YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLG  192 (342)
T ss_dssp             CEEEEECCCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSCEEECCCT
T ss_pred             eeEEEEeecCCCcHHHHHhc-cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCCEEEEECC
Confidence            89999999999999999976 57999999999999999999999        8999999999999999999999999999


Q ss_pred             CCCCCccccCC--CccccccCCCCccChhhhcccCCC-----CCcchHHHHHHHHhhhcCC-----------cCCCC---
Q 014609          160 LSALPQHFRDD--GLLHTTCGSPNYVAPEVLANRGYD-----GATSDIWSCGVILYIFRGD-----------FKLPK---  218 (421)
Q Consensus       160 la~~~~~~~~~--~~~~~~~gt~~y~APEvl~~~~~~-----~~~~DiwSlGvil~~~~~~-----------~~~p~---  218 (421)
                      ++.........  ......+||+.|+|||++.+....     +.++|||||||++|.+..+           .++..   
T Consensus       193 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~~~  272 (342)
T 1b6c_B          193 LAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVP  272 (342)
T ss_dssp             TCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSC
T ss_pred             CceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCccccCc
Confidence            99754321110  023455799999999998765322     1579999999999966432           22211   


Q ss_pred             -------------------CCC---------HHHHHHHHHhcCCCCCCCCCHHhhhcC
Q 014609          219 -------------------WLS---------PGAQNLLRKILEPNPVKRITIAGIKAD  248 (421)
Q Consensus       219 -------------------~~s---------~~~~~li~~~L~~dP~~R~t~~eil~~  248 (421)
                                         .++         +.+.++|.+||+.||.+|||+.+++++
T Consensus       273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~  330 (342)
T 1b6c_B          273 SDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT  330 (342)
T ss_dssp             SSCCHHHHHHHHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHH
T ss_pred             CcccHHHHHHHHHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHH
Confidence                               111         367899999999999999999999875

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.1e-40  Score=350.90  Aligned_cols=230  Identities=26%  Similarity=0.365  Sum_probs=188.6

Q ss_pred             cceEEec-eEeecCcEEEEEEEEC--CCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEE
Q 014609           14 GRYELGR-TLGEGNFGKVKFAQDL--DSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIY   90 (421)
Q Consensus        14 ~~y~i~~-~LG~G~~g~V~~a~~~--~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~   90 (421)
                      +++.+.+ .||+|+||+||+|.+.  .++..||||+++...  .....+.+.+|+.+|++++||||+++++++.. +.+|
T Consensus       335 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~  411 (613)
T 2ozo_A          335 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT--EKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALM  411 (613)
T ss_dssp             TSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCC--SSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEE
T ss_pred             cceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCC--ChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeE
Confidence            4566666 8999999999999875  356789999997643  22336789999999999999999999999976 5689


Q ss_pred             EEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCccccC
Q 014609           91 MVLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD  169 (421)
Q Consensus        91 lv~E~~~gg~L~~~i~~~-~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~  169 (421)
                      +||||+++|+|.+++... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++........
T Consensus       412 lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~  491 (613)
T 2ozo_A          412 LVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDS  491 (613)
T ss_dssp             EEEECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCSTTTTCC----
T ss_pred             EEEEeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCc
Confidence            999999999999998753 4699999999999999999999999999999999999999999999999999986533211


Q ss_pred             C-CccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhhc--CCcC--------------------CCCCCCHHHHH
Q 014609          170 D-GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIFR--GDFK--------------------LPKWLSPGAQN  226 (421)
Q Consensus       170 ~-~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~~--~~~~--------------------~p~~~s~~~~~  226 (421)
                      . .......+|+.|+|||++....+ +.++|||||||++|++.  |..+                    .|..+++.+.+
T Consensus       492 ~~~~~~~~~~~~~y~APE~~~~~~~-~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~  570 (613)
T 2ozo_A          492 YYTARSAGKWPLKWYAPECINFRKF-SSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPPELYA  570 (613)
T ss_dssp             ----------CCTTSCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHHTTCCCCCCTTCCHHHHH
T ss_pred             eeeeccCCCCccceeCHhhhcCCCC-CcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHHHH
Confidence            1 11223346689999999988777 58999999999999643  4433                    34568899999


Q ss_pred             HHHHhcCCCCCCCCCHHhhhc
Q 014609          227 LLRKILEPNPVKRITIAGIKA  247 (421)
Q Consensus       227 li~~~L~~dP~~R~t~~eil~  247 (421)
                      +|.+||+.||.+|||+.++++
T Consensus       571 li~~cl~~dP~~RPs~~~l~~  591 (613)
T 2ozo_A          571 LMSDCWIYKWEDRPDFLTVEQ  591 (613)
T ss_dssp             HHHHTTCSSTTTSCCHHHHHH
T ss_pred             HHHHHcCCChhHCcCHHHHHH
Confidence            999999999999999998743

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=100.00  E-value=1.6e-41  Score=341.10  Aligned_cols=233  Identities=19%  Similarity=0.208  Sum_probs=183.1

Q ss_pred             cceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCC-CCc----------------
Q 014609           14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKH-PNV----------------   76 (421)
Q Consensus        14 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~h-pnI----------------   76 (421)
                      ..|.+.+.||+|+||+||+|.+..+|+.||||++...........+.+.+|+.+++.++| +|.                
T Consensus        78 ~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~  157 (413)
T 3dzo_A           78 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLV  157 (413)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEE
T ss_pred             eeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhc
Confidence            458999999999999999999999999999999874443333335779999999999987 221                


Q ss_pred             -----ceEEEEEEe-----CCEEEEEEeccCCCChHHHHHh-------cCCCCHHHHHHHHHHHHHHHHHHHhCCceecc
Q 014609           77 -----VRLHEVLAS-----KSKIYMVLEYVTGGELFDKIAS-------KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRD  139 (421)
Q Consensus        77 -----v~l~~~~~~-----~~~~~lv~E~~~gg~L~~~i~~-------~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrD  139 (421)
                           ..+..++..     ...++++|+++ +++|.+++..       ...+++..+..++.||+.||+|||++||+|||
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iiHrD  236 (413)
T 3dzo_A          158 KDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTY  236 (413)
T ss_dssp             ECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEECSC
T ss_pred             ccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCC
Confidence                 111111221     22467788876 6799888841       23477888899999999999999999999999


Q ss_pred             CCCCCEEeccCCCEEEEeccCCCCCccccCCCccccccCCCCccChhhh----------cccCCCCCcchHHHHHHHHhh
Q 014609          140 LKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVL----------ANRGYDGATSDIWSCGVILYI  209 (421)
Q Consensus       140 lkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl----------~~~~~~~~~~DiwSlGvil~~  209 (421)
                      |||+|||++.++.+||+|||++.....     .....+| +.|+|||++          ....| +.++|||||||++|.
T Consensus       237 iKp~NILl~~~~~~kL~DFG~a~~~~~-----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~-~~~~DvwSlGvil~e  309 (413)
T 3dzo_A          237 LRPVDIVLDQRGGVFLTGFEHLVRDGA-----SAVSPIG-RGFAPPETTAERMLPFGQHHPTLM-TFAFDTWTLGLAIYW  309 (413)
T ss_dssp             CCGGGEEECTTCCEEECCGGGCEETTE-----EECCCCC-TTTCCHHHHHHHTSTTGGGCCEEE-CHHHHHHHHHHHHHH
T ss_pred             cccceEEEecCCeEEEEeccceeecCC-----ccccCCC-CceeCchhhhccccccccccCcCC-CchhhHHHHHHHHHH
Confidence            999999999999999999999875432     2456688 999999998          33334 479999999999995


Q ss_pred             h-cCCcCCC---------------CCCCHHHHHHHHHhcCCCCCCCCCHHhhhcCcccccc
Q 014609          210 F-RGDFKLP---------------KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD  254 (421)
Q Consensus       210 ~-~~~~~~p---------------~~~s~~~~~li~~~L~~dP~~R~t~~eil~~~w~~~~  254 (421)
                      + .|..++.               ..+|+.+.+||.+||+.||.+|||+.++++||||+.-
T Consensus       310 lltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~~~~~~~~  370 (413)
T 3dzo_A          310 IWCADLPNTDDAALGGSEWIFRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQL  370 (413)
T ss_dssp             HHHSSCCCCTTGGGSCSGGGGSSCCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHH
T ss_pred             HHHCCCCCCCcchhhhHHHHHhhcccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHHHH
Confidence            4 4544442               3478999999999999999999999999999999853

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=7.2e-41  Score=347.18  Aligned_cols=229  Identities=25%  Similarity=0.383  Sum_probs=194.0

Q ss_pred             eeecceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEE
Q 014609           11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIY   90 (421)
Q Consensus        11 ~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~   90 (421)
                      ...++|++.+.||+|+||.||+|.+.. +..||||+++....    ..+.+.+|+.+|++++||||+++++++.. ...|
T Consensus       264 i~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~  337 (535)
T 2h8h_A          264 IPRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTM----SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIY  337 (535)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEETT-TEEEEEEEECTTSS----CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred             cchhhhhhheecccCCCeEEEEEEECC-CceEEEEEeCCCCC----CHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccce
Confidence            344789999999999999999999854 56799999976432    14678999999999999999999999876 6789


Q ss_pred             EEEeccCCCChHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCcccc
Q 014609           91 MVLEYVTGGELFDKIAS--KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFR  168 (421)
Q Consensus        91 lv~E~~~gg~L~~~i~~--~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~~  168 (421)
                      +||||+++|+|.+++..  ...+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++.......
T Consensus       338 lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~  417 (535)
T 2h8h_A          338 IVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE  417 (535)
T ss_dssp             EEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHH
T ss_pred             EeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEcCCCcEEEcccccceecCCCc
Confidence            99999999999999974  3569999999999999999999999999999999999999999999999999998643211


Q ss_pred             CCCccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhhc--CCcC--------------------CCCCCCHHHHH
Q 014609          169 DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIFR--GDFK--------------------LPKWLSPGAQN  226 (421)
Q Consensus       169 ~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~~--~~~~--------------------~p~~~s~~~~~  226 (421)
                      . .......++..|+|||++....+ +.++|||||||++|++.  |..+                    .|..+++.+.+
T Consensus       418 ~-~~~~~~~~~~~y~aPE~~~~~~~-~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~  495 (535)
T 2h8h_A          418 Y-TARQGAKFPIKWTAPEAALYGRF-TIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHD  495 (535)
T ss_dssp             H-HTTCSTTSCGGGSCHHHHHHCCC-CHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHH
T ss_pred             e-ecccCCcCcccccCHHHhccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHH
Confidence            0 11123356778999999988777 58999999999999654  3333                    34567899999


Q ss_pred             HHHHhcCCCCCCCCCHHhhhc
Q 014609          227 LLRKILEPNPVKRITIAGIKA  247 (421)
Q Consensus       227 li~~~L~~dP~~R~t~~eil~  247 (421)
                      ||.+||+.||++|||+.++++
T Consensus       496 li~~cl~~dP~~RPt~~~l~~  516 (535)
T 2h8h_A          496 LMCQCWRKEPEERPTFEYLQA  516 (535)
T ss_dssp             HHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHcCCChhHCcCHHHHHH
Confidence            999999999999999999876

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=100.00  E-value=5.7e-41  Score=357.59  Aligned_cols=226  Identities=26%  Similarity=0.429  Sum_probs=191.9

Q ss_pred             cceEEeceEeecCcEEEEEEEECC-CCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCE----
Q 014609           14 GRYELGRTLGEGNFGKVKFAQDLD-SGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSK----   88 (421)
Q Consensus        14 ~~y~i~~~LG~G~~g~V~~a~~~~-~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~----   88 (421)
                      ++|++.+.||+|+||+||+|.+.. +|+.||||++....  .......+.+|+.++++++||||+++++++...+.    
T Consensus        80 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~  157 (681)
T 2pzi_A           80 GQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSG--DAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDP  157 (681)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSC--CHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCE
T ss_pred             CceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccC--CHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCc
Confidence            899999999999999999999976 79999999986432  23345678999999999999999999999987665    


Q ss_pred             -EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCccc
Q 014609           89 -IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHF  167 (421)
Q Consensus        89 -~~lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~  167 (421)
                       .|+||||++|++|.+.+..  .+++..++.++.||+.||+|||++||+||||||+|||++.+ .+||+|||++..... 
T Consensus       158 ~~~lv~E~~~g~~L~~~~~~--~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~~~-~~kl~DFG~a~~~~~-  233 (681)
T 2pzi_A          158 VGYIVMEYVGGQSLKRSKGQ--KLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEE-QLKLIDLGAVSRINS-  233 (681)
T ss_dssp             EEEEEEECCCCEECC----C--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSS-CEEECCCTTCEETTC-
T ss_pred             eeEEEEEeCCCCcHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEeCC-cEEEEecccchhccc-
Confidence             7999999999999887754  79999999999999999999999999999999999999875 999999999975432 


Q ss_pred             cCCCccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhhcCCcCC---------CCC-----CCHHHHHHHHHhcC
Q 014609          168 RDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIFRGDFKL---------PKW-----LSPGAQNLLRKILE  233 (421)
Q Consensus       168 ~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~~~~~~~---------p~~-----~s~~~~~li~~~L~  233 (421)
                           ....+||+.|+|||++.+. + +.++|||||||++|.+....+.         |..     .++.+.++|.+||+
T Consensus       234 -----~~~~~gt~~y~aPE~~~~~-~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~  306 (681)
T 2pzi_A          234 -----FGYLYGTPGFQAPEIVRTG-P-TVATDIYTVGRTLAALTLDLPTRNGRYVDGLPEDDPVLKTYDSYGRLLRRAID  306 (681)
T ss_dssp             -----CSCCCCCTTTSCTTHHHHC-S-CHHHHHHHHHHHHHHHHSCCCEETTEECSSCCTTCHHHHHCHHHHHHHHHHTC
T ss_pred             -----CCccCCCccccCHHHHcCC-C-CCceehhhhHHHHHHHHhCCCCCcccccccccccccccccCHHHHHHHhhhcc
Confidence                 2456899999999998764 4 5899999999999976544321         111     35788999999999


Q ss_pred             CCCCCCCCHHhhhcCcccc
Q 014609          234 PNPVKRITIAGIKADEWFE  252 (421)
Q Consensus       234 ~dP~~R~t~~eil~~~w~~  252 (421)
                      +||.+||+..+.+.|+|+.
T Consensus       307 ~dP~~R~~~~~~l~~~l~~  325 (681)
T 2pzi_A          307 PDPRQRFTTAEEMSAQLTG  325 (681)
T ss_dssp             SSGGGSCSSHHHHHHHHHH
T ss_pred             CChhhCCCHHHHHHHHHHH
Confidence            9999999999999999975

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=100.00  E-value=4.9e-40  Score=348.36  Aligned_cols=233  Identities=26%  Similarity=0.424  Sum_probs=193.5

Q ss_pred             eeecceEEeceEeecCcEEEEEEEECCC---CceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCC
Q 014609           11 MRLGRYELGRTLGEGNFGKVKFAQDLDS---GLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKS   87 (421)
Q Consensus        11 ~~~~~y~i~~~LG~G~~g~V~~a~~~~~---~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~   87 (421)
                      ...++|++++.||+|+||+||+|.+..+   +..||+|.+....  .....+.+.+|+.++++++||||+++++++. ++
T Consensus       387 i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~  463 (656)
T 2j0j_A          387 IQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCT--SDSVREKFLQEALTMRQFDHPHIVKLIGVIT-EN  463 (656)
T ss_dssp             CCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTT--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SS
T ss_pred             cccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccC--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cC
Confidence            3457899999999999999999998653   4679999886432  3344578999999999999999999999985 45


Q ss_pred             EEEEEEeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCcc
Q 014609           88 KIYMVLEYVTGGELFDKIASKG-RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQH  166 (421)
Q Consensus        88 ~~~lv~E~~~gg~L~~~i~~~~-~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~  166 (421)
                      ..|+||||+++|+|.+++...+ .+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||++.....
T Consensus       464 ~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~~~~~vkL~DFG~a~~~~~  543 (656)
T 2j0j_A          464 PVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED  543 (656)
T ss_dssp             SCEEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCCCCSCCC
T ss_pred             ceEEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEeCCCCEEEEecCCCeecCC
Confidence            6899999999999999998644 689999999999999999999999999999999999999999999999999986533


Q ss_pred             ccCCCccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhhc--CCc--------------------CCCCCCCHHH
Q 014609          167 FRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIFR--GDF--------------------KLPKWLSPGA  224 (421)
Q Consensus       167 ~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~~--~~~--------------------~~p~~~s~~~  224 (421)
                      .. ........+|+.|+|||++.+..+ +.++|||||||++|.+.  |..                    +.|+.+++.+
T Consensus       544 ~~-~~~~~~~~~t~~y~aPE~~~~~~~-~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~l  621 (656)
T 2j0j_A          544 ST-YYKASKGKLPIKWMAPESINFRRF-TSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTL  621 (656)
T ss_dssp             -----------CCGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHHTCCCCCCTTCCHHH
T ss_pred             Cc-ceeccCCCCCcceeCHHHhcCCCC-CchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCccccHHH
Confidence            21 112234467789999999988777 58999999999999643  433                    3456688999


Q ss_pred             HHHHHHhcCCCCCCCCCHHhhhcC
Q 014609          225 QNLLRKILEPNPVKRITIAGIKAD  248 (421)
Q Consensus       225 ~~li~~~L~~dP~~R~t~~eil~~  248 (421)
                      .++|.+||+.||.+|||+.++++.
T Consensus       622 ~~li~~~l~~dP~~RPs~~el~~~  645 (656)
T 2j0j_A          622 YSLMTKCWAYDPSRRPRFTELKAQ  645 (656)
T ss_dssp             HHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHcCCChhHCcCHHHHHHH
Confidence            999999999999999999998753

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=3.2e-41  Score=325.94  Aligned_cols=233  Identities=23%  Similarity=0.397  Sum_probs=189.5

Q ss_pred             CeeecceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEE
Q 014609           10 GMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKI   89 (421)
Q Consensus        10 ~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~   89 (421)
                      ....++|++++.||+|+||.||+|.+..   .+|+|++...... ....+.+.+|+.++++++||||+++++++.+....
T Consensus        29 ~i~~~~~~~~~~lg~G~~g~V~~~~~~~---~~avk~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~  104 (319)
T 2y4i_B           29 DIPFEQLEIGELIGKGRFGQVYHGRWHG---EVAIRLIDIERDN-EDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHL  104 (319)
T ss_dssp             SSCCSCEECCCBCCCSSSSEEEEEEESS---SEEEEECCCCSCC-CCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCE
T ss_pred             cCCHHHeEEeeEeccCCceEEEEEEEcC---eEEEEEeecCCCC-HHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCce
Confidence            4566899999999999999999999753   5999998754322 12235678899999999999999999999999999


Q ss_pred             EEEEeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCccc-
Q 014609           90 YMVLEYVTGGELFDKIASKG-RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHF-  167 (421)
Q Consensus        90 ~lv~E~~~gg~L~~~i~~~~-~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~-  167 (421)
                      |+||||++|++|.+++...+ .+++..++.++.|++.||+|||++||+||||||+|||++ ++.+||+|||++...... 
T Consensus       105 ~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~~  183 (319)
T 2y4i_B          105 AIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQ  183 (319)
T ss_dssp             EEECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC---CCEECCCSCCC------
T ss_pred             EEEeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEe-CCCEEEeecCCcccccccc
Confidence            99999999999999987644 699999999999999999999999999999999999998 789999999998754321 


Q ss_pred             --cCCCccccccCCCCccChhhhccc--------CCCCCcchHHHHHHHHhhh-cCCcCC--------------------
Q 014609          168 --RDDGLLHTTCGSPNYVAPEVLANR--------GYDGATSDIWSCGVILYIF-RGDFKL--------------------  216 (421)
Q Consensus       168 --~~~~~~~~~~gt~~y~APEvl~~~--------~~~~~~~DiwSlGvil~~~-~~~~~~--------------------  216 (421)
                        ..........||+.|+|||++...        ...+.++|||||||++|.+ .|..++                    
T Consensus       184 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~  263 (319)
T 2y4i_B          184 AGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGMKPNL  263 (319)
T ss_dssp             ----CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHHHHTTCCCCC
T ss_pred             ccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhccCCCCCC
Confidence              112233455789999999998742        2235789999999999954 333322                    


Q ss_pred             -CCCCCHHHHHHHHHhcCCCCCCCCCHHhhhc
Q 014609          217 -PKWLSPGAQNLLRKILEPNPVKRITIAGIKA  247 (421)
Q Consensus       217 -p~~~s~~~~~li~~~L~~dP~~R~t~~eil~  247 (421)
                       +..+++.+.++|.+||..||.+|||+.++++
T Consensus       264 ~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~  295 (319)
T 2y4i_B          264 SQIGMGKEISDILLFCWAFEQEERPTFTKLMD  295 (319)
T ss_dssp             CCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHH
T ss_pred             CcCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence             1236789999999999999999999999886

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=100.00  E-value=1.7e-39  Score=310.54  Aligned_cols=202  Identities=15%  Similarity=0.181  Sum_probs=176.5

Q ss_pred             cceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEE
Q 014609           14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVL   93 (421)
Q Consensus        14 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~   93 (421)
                      ++|++.+.||+|+||.||+|.+..+|+.||||++...........+.+.+|+.++++++||||+++++++...+..|+||
T Consensus        31 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~  110 (286)
T 3uqc_A           31 GRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVA  110 (286)
T ss_dssp             TTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             CcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEEE
Confidence            78999999999999999999999999999999998765555555678999999999999999999999999999999999


Q ss_pred             eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCccccCCCcc
Q 014609           94 EYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLL  173 (421)
Q Consensus        94 E~~~gg~L~~~i~~~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~  173 (421)
                      ||++|++|.+++.. + ..+..+..++.|++.||+|||++||+||||||+|||++.+|.+||+++|              
T Consensus       111 e~~~g~~L~~~l~~-~-~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~~~g~~kl~~~~--------------  174 (286)
T 3uqc_A          111 EWIRGGSLQEVADT-S-PSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSIDGDVVLAYPA--------------  174 (286)
T ss_dssp             ECCCEEEHHHHHTT-C-CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEETTSCEEECSCC--------------
T ss_pred             EecCCCCHHHHHhc-C-CChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEcCCCCEEEEecc--------------
Confidence            99999999999854 3 4667889999999999999999999999999999999999999998544              


Q ss_pred             ccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhh-cCCcCC--------------------------CCCCCHHHHH
Q 014609          174 HTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIF-RGDFKL--------------------------PKWLSPGAQN  226 (421)
Q Consensus       174 ~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~-~~~~~~--------------------------p~~~s~~~~~  226 (421)
                              |++|       + +.++|||||||++|.+ .|..++                          ++.+++.+.+
T Consensus       175 --------~~~~-------~-~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  238 (286)
T 3uqc_A          175 --------TMPD-------A-NPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDIPFQISA  238 (286)
T ss_dssp             --------CCTT-------C-CHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCBCTTSCBCCHHHHCTTSCHHHHH
T ss_pred             --------ccCC-------C-CchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHHHhccCCCChhhcccCCCHHHHH
Confidence                    3332       3 5889999999999943 333222                          1347899999


Q ss_pred             HHHHhcCCCCCCCCCHHhhhcC
Q 014609          227 LLRKILEPNPVKRITIAGIKAD  248 (421)
Q Consensus       227 li~~~L~~dP~~R~t~~eil~~  248 (421)
                      +|.+||++||.+| |+.++++.
T Consensus       239 li~~~l~~dP~~R-s~~el~~~  259 (286)
T 3uqc_A          239 VAARSVQGDGGIR-SASTLLNL  259 (286)
T ss_dssp             HHHHHHCTTSSCC-CHHHHHHH
T ss_pred             HHHHHcccCCccC-CHHHHHHH
Confidence            9999999999999 99998873

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=100.00  E-value=3e-36  Score=314.13  Aligned_cols=226  Identities=15%  Similarity=0.120  Sum_probs=161.3

Q ss_pred             ceEeecCcEEEEEEEECCCCceEEEEEeeccccc-------chhHHHHHHHHHHHHhcC-CCCCcceEEEEEEeCCEEEE
Q 014609           20 RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRII-------HLKITDQIKREIATLKLL-KHPNVVRLHEVLASKSKIYM   91 (421)
Q Consensus        20 ~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~-------~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~l   91 (421)
                      ...+.|+.|.+..++....|+.+|+|++.+....       .....+.+.+|+++|+++ .|+||+++++++++++..||
T Consensus       240 ~~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yL  319 (569)
T 4azs_A          240 NQPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWL  319 (569)
T ss_dssp             CC-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEE
T ss_pred             hccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEE
Confidence            3467788888888887789999999999865322       112245699999999999 69999999999999999999


Q ss_pred             EEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCccccCCC
Q 014609           92 VLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDG  171 (421)
Q Consensus        92 v~E~~~gg~L~~~i~~~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~  171 (421)
                      ||||++|++|.++|...+++++.   .++.||++||+|||++||+||||||+||||+.+|.+||+|||+|+....  ...
T Consensus       320 VMEyv~G~~L~d~i~~~~~l~~~---~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~--~~~  394 (569)
T 4azs_A          320 VMEKLPGRLLSDMLAAGEEIDRE---KILGSLLRSLAALEKQGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQ--DCS  394 (569)
T ss_dssp             EEECCCSEEHHHHHHTTCCCCHH---HHHHHHHHHHHHHHHTTCEESCCCGGGEEECTTSCEEECCCTTEESCC-----C
T ss_pred             EEecCCCCcHHHHHHhCCCCCHH---HHHHHHHHHHHHHHHCCceeccCchHhEEECCCCCEEEeecccCeeCCC--CCc
Confidence            99999999999999998888765   5889999999999999999999999999999999999999999986543  234


Q ss_pred             ccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhhcCCc--------CCCCCCCHHHHHHHHHhcCCCCCCCCCHH
Q 014609          172 LLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIFRGDF--------KLPKWLSPGAQNLLRKILEPNPVKRITIA  243 (421)
Q Consensus       172 ~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~~~~~--------~~p~~~s~~~~~li~~~L~~dP~~R~t~~  243 (421)
                      ...+.+||+.|+|||++.+..  ..++|+||+|+++|.+....        ..|.. ...+..+...++..+|..|+...
T Consensus       395 ~~~t~vGTp~YmAPE~l~g~~--~~~~d~~s~g~~~~~l~~~~~~~~~~l~~~~~~-~~~~~~l~~~l~~~~~~~~~~~~  471 (569)
T 4azs_A          395 WPTNLVQSFFVFVNELFAENK--SWNGFWRSAPVHPFNLPQPWSNWLYAVWQEPVE-RWNFVLLLALFEKKAKLPSAEQQ  471 (569)
T ss_dssp             CSHHHHHHHHHHHHHHC-------------------CCCCTTHHHHHHHHHTSCGG-GCSHHHHHHHHHTGGGSCCGGGS
T ss_pred             cccCceechhhccHHHhCCCC--CCcccccccccchhhhccccchhHHHhhcCCCC-CCcHHHHHHHHhCCCCCCCCChh
Confidence            456789999999999987653  36799999999988543221        11111 12345677778888898888888


Q ss_pred             hhhcCccccc
Q 014609          244 GIKADEWFEQ  253 (421)
Q Consensus       244 eil~~~w~~~  253 (421)
                      ....++|...
T Consensus       472 ~~~~~~~~~~  481 (569)
T 4azs_A          472 RGATEQWIIA  481 (569)
T ss_dssp             SCCHHHHHHH
T ss_pred             hhccchhHHH
Confidence            8778887653

>2ehb_D CBL-interacting serine/threonine-protein kinase 2; protein complex, Ca(II) IONS bound to SOS3 (EF-hands 1 and 4 FISL motif; 2.10A {Arabidopsis thaliana}

Probab=99.97  E-value=8.2e-31  Score=220.78  Aligned_cols=124  Identities=31%  Similarity=0.572  Sum_probs=116.3

Q ss_pred             CCCccchhhhhccccccccCCCcccccc-ccceeeEEecCCHHHHHHHHHHHHHhcCcEEEEeCCeeEEEeecCCCCccC
Q 014609          289 SPPLINAFQLIGMSSCLDLSGFFEKEDV-SERKIRFTSNHSAKDLLERIEDIVTEMGFRVQKKNGKLKATQEHKPQKSLG  367 (421)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~f~s~~~~~~i~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  367 (421)
                      .|..+|||++|++|+|+|||++|+.... ++++|||+|+.++++|+++||++++.+||+|+++++++++++..+|++  |
T Consensus         3 ~p~~lNAFdiIs~S~g~dLSgLFe~~~~~~~r~tRF~s~~~a~~ii~klEe~a~~lg~~V~kk~~~vkl~~~~~grk--G   80 (143)
T 2ehb_D            3 GPLMMNAFEMITLSQGLNLSALFDRRQDFVKRQTRFVSRREPSEIIANIEAVANSMGFKSHTRNFKTRLEGLSSIKA--G   80 (143)
T ss_dssp             CCEECCHHHHHTTCTTTCGGGGGCSCCCSCCCCCEEEECSCHHHHHHHHHHHHHHTTEEEEESSSEEEEEECCSSGG--G
T ss_pred             CccccCHHHHHHHCcCCCchhhhccccccccccceEEeCCCHHHHHHHHHHHHHhcCcEEEEcCcEEEEEEecCCCc--c
Confidence            4667999999999999999999976432 578999999999999999999999999999999989999999999999  9


Q ss_pred             ceEEEEEEEEecCceEEEEEEccCCChhhHHHHHHHHHhhcCCCCcc
Q 014609          368 SLSVAAEVFEISPSLYVVELRKSYGDPTVYRQLCNKLSSDLGLPPSQ  414 (421)
Q Consensus       368 ~l~~~~~i~~~~~~~~~v~~~k~~Gd~le~~~~~~~l~~~l~~~~~~  414 (421)
                      .|++.+|||+++|+++||||||++||++||++||++|+++|+|++.+
T Consensus        81 ~l~v~~EVfevapsl~vVEvrks~GD~lEy~k~~~~Lr~~L~diV~~  127 (143)
T 2ehb_D           81 QLAVVIEIYEVAPSLFMVDVRKAAGETLEYHKFYKKLCSKLENIIWR  127 (143)
T ss_dssp             CCEEEEEEEEEETTEEEEEEEEEESCHHHHHHHHHHHHHHSTTTBCC
T ss_pred             eEEEEEEEEEecCCEEEEEEEecCCChHHHHHHHHHHHHHhhcceec
Confidence            99999999999999999999999999999999999999999999865

>2zfd_B Putative uncharacterized protein T20L15_90; calcium binding protein, protein-protein complex, ATP-bindin kinase, nucleotide-binding; 1.20A {Arabidopsis thaliana}

Probab=99.96  E-value=4.4e-30  Score=211.17  Aligned_cols=119  Identities=28%  Similarity=0.378  Sum_probs=104.3

Q ss_pred             CCccchhhhhccccccccCCCccccccccceeeEEecCCHHHHHHHHHHHHHhcCcEEEEeCCeeEEEeecCCCCccCce
Q 014609          290 PPLINAFQLIGMSSCLDLSGFFEKEDVSERKIRFTSNHSAKDLLERIEDIVTEMGFRVQKKNGKLKATQEHKPQKSLGSL  369 (421)
Q Consensus       290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~f~s~~~~~~i~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  369 (421)
                      |..+|||++|++|+++|||++|+.+...+++|||+|+.+|++|+++||++++++||+|++++++   .+..++++  |.|
T Consensus         3 ~~~lNAFdiIs~S~g~dLSgLFe~~~~~~r~tRF~S~~~a~~ii~klEe~a~~lg~~v~kk~~~---~~~~~g~k--G~l   77 (123)
T 2zfd_B            3 ARRMNAFDIISGSPGFNLSGLFGDARKYDRVERFVSAWTAERVVERLEEIVSAENLTVAKKETW---GMKIEGQK--GNF   77 (123)
T ss_dssp             -CCCCHHHHHHTSTTSSSGGGGGGGCSSCCCEEEEESSCHHHHHHHHHHHHHHTTCEEEEEETT---EEEEEEGG--GTE
T ss_pred             cccccHHHHHHHCcCCCchHhcCcccccccceEEEeCCCHHHHHHHHHHHHHHCCCEEEEcCCc---cccccCCC--ccE
Confidence            4569999999999999999999764334678999999999999999999999999999988775   55567888  999


Q ss_pred             EEEEEEEEecCceEEEEEEccCCChhhHHHHHH-HHHhhcCCCCc
Q 014609          370 SVAAEVFEISPSLYVVELRKSYGDPTVYRQLCN-KLSSDLGLPPS  413 (421)
Q Consensus       370 ~~~~~i~~~~~~~~~v~~~k~~Gd~le~~~~~~-~l~~~l~~~~~  413 (421)
                      ++.+|||+++|+++||||||++||++||++||. +|+++|+|++-
T Consensus        78 ~v~~EVfev~p~l~vVEvrks~GD~lEy~~~~~~~L~~~L~diV~  122 (123)
T 2zfd_B           78 AMVVEINQLTDELVMIEVRKRQRAAASGRDLWTDTLRPFFVELVH  122 (123)
T ss_dssp             EEEEEEEECSSSCEEEEEEEEESCC---CCHHHHTHHHHHHHTBC
T ss_pred             EEEEEEEEecCCEEEEEEEecCCChHHHHHHHHHHHHHHHhhhhc
Confidence            999999999999999999999999999999776 89999999873

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.95  E-value=6e-30  Score=265.08  Aligned_cols=179  Identities=19%  Similarity=0.235  Sum_probs=136.9

Q ss_pred             EEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchh-----HHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEE
Q 014609           17 ELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLK-----ITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYM   91 (421)
Q Consensus        17 ~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~-----~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l   91 (421)
                      ...+.||+|+||+||+|.  ..++.+|+|...........     ..+++.+|++++++++||||+++..++...+..|+
T Consensus       339 ~~~~~LG~G~fg~Vy~~~--~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~l  416 (540)
T 3en9_A          339 IPEHLIGKGAEADIKRDS--YLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRI  416 (540)
T ss_dssp             ---------CCEEEEEEE--CSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEE
T ss_pred             CCCCEEeeCCCEEEEEEE--ECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEE
Confidence            346789999999999994  57889999987654332221     23558999999999999999955555556777899


Q ss_pred             EEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCccccCCC
Q 014609           92 VLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDG  171 (421)
Q Consensus        92 v~E~~~gg~L~~~i~~~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~  171 (421)
                      ||||++|++|.+++..        +..++.|+++||+|||++||+||||||+|||++.  ++||+|||+++.........
T Consensus       417 VmE~~~ggsL~~~l~~--------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~~~~  486 (540)
T 3en9_A          417 MMSYINGKLAKDVIED--------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDEDKA  486 (540)
T ss_dssp             EEECCCSEEHHHHSTT--------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEESS--SEEECCCTTCEECCCHHHHH
T ss_pred             EEECCCCCCHHHHHHH--------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEECC--eEEEEECccCEECCCccccc
Confidence            9999999999998875        6789999999999999999999999999999998  99999999998654321111


Q ss_pred             -----ccccccCCCCccChhhhcc--cCCCCCcchHHHHHHHHh
Q 014609          172 -----LLHTTCGSPNYVAPEVLAN--RGYDGATSDIWSCGVILY  208 (421)
Q Consensus       172 -----~~~~~~gt~~y~APEvl~~--~~~~~~~~DiwSlGvil~  208 (421)
                           .....+||+.|+|||++..  .+|. ...|+||...-..
T Consensus       487 ~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~-~~~d~ws~vl~~l  529 (540)
T 3en9_A          487 VDLIVFKKAVLSTHHEKFDEIWERFLEGYK-SVYDRWEIILELM  529 (540)
T ss_dssp             HHHHHHHHHHHHHCGGGHHHHHHHHHHHHH-HHCTTHHHHHHHH
T ss_pred             cchhhhhhhhcCCCCcCCHHHHHHHHHHHH-HHHhHHHHHHHHH
Confidence                 1246789999999999976  5663 6789999765443

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.94  E-value=1.9e-27  Score=226.50  Aligned_cols=155  Identities=21%  Similarity=0.264  Sum_probs=121.9

Q ss_pred             ceEeecCcEEEEEEEECCCCceEEEEEeecccccch---------------hHHHHHHHHHHHHhcCCCCCcceEEEEEE
Q 014609           20 RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHL---------------KITDQIKREIATLKLLKHPNVVRLHEVLA   84 (421)
Q Consensus        20 ~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~---------------~~~~~~~~Ei~il~~l~hpnIv~l~~~~~   84 (421)
                      +.||+|+||.||+|.+ .+|+.||||+++.......               .....+.+|+.+|++++|   +++.+++.
T Consensus        96 ~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~~---~~v~~~~~  171 (282)
T 1zar_A           96 KLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQG---LAVPKVYA  171 (282)
T ss_dssp             EEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTT---SSSCCEEE
T ss_pred             CEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhccC---CCcCeEEe
Confidence            9999999999999999 8899999999965322110               124678999999999994   55555444


Q ss_pred             eCCEEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCC
Q 014609           85 SKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALP  164 (421)
Q Consensus        85 ~~~~~~lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~  164 (421)
                      . +..|+||||++|++|.+ +.      ...+..++.|++.||+|||++||+||||||+|||++ +|.+||+|||+|.  
T Consensus       172 ~-~~~~lvmE~~~g~~L~~-l~------~~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl~-~~~vkl~DFG~a~--  240 (282)
T 1zar_A          172 W-EGNAVLMELIDAKELYR-VR------VENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS-EEGIWIIDFPQSV--  240 (282)
T ss_dssp             E-ETTEEEEECCCCEEGGG-CC------CSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE-TTEEEECCCTTCE--
T ss_pred             c-cceEEEEEecCCCcHHH-cc------hhhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEEE-CCcEEEEECCCCe--
Confidence            3 45699999999999987 42      134567999999999999999999999999999999 9999999999986  


Q ss_pred             ccccCCCccccccCCCCccChhhhcc----------cCCCCCcchHHHH
Q 014609          165 QHFRDDGLLHTTCGSPNYVAPEVLAN----------RGYDGATSDIWSC  203 (421)
Q Consensus       165 ~~~~~~~~~~~~~gt~~y~APEvl~~----------~~~~~~~~DiwSl  203 (421)
                                   .+..|.|||++.+          ..| +..+|+|.+
T Consensus       241 -------------~~~~~~a~e~l~rdv~~i~~~f~~~~-~~~~~~~~~  275 (282)
T 1zar_A          241 -------------EVGEEGWREILERDVRNIITYFSRTY-RTEKDINSA  275 (282)
T ss_dssp             -------------ETTSTTHHHHHHHHHHHHHHHHHHHH-CCCCCHHHH
T ss_pred             -------------ECCCCCHHHHHHHHHHHHHHHHHHhc-CCCCChHHH
Confidence                         3456789998753          333 355677653

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.88  E-value=7.9e-23  Score=192.01  Aligned_cols=139  Identities=21%  Similarity=0.280  Sum_probs=109.3

Q ss_pred             eEEeceEeecCcEEEEEEEECCCCce--EEEEEeecccccc---------------------hhHHHHHHHHHHHHhcCC
Q 014609           16 YELGRTLGEGNFGKVKFAQDLDSGLP--FAVKILEKNRIIH---------------------LKITDQIKREIATLKLLK   72 (421)
Q Consensus        16 y~i~~~LG~G~~g~V~~a~~~~~~~~--vAvK~i~~~~~~~---------------------~~~~~~~~~Ei~il~~l~   72 (421)
                      |++.+.||+|+||.||+|.+..+|+.  ||||+++......                     ......+.+|+.+|+++.
T Consensus        49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~  128 (258)
T 1zth_A           49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK  128 (258)
T ss_dssp             EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred             hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence            78999999999999999998778999  9999976432110                     011236889999999998


Q ss_pred             CCCc--ceEEEEEEeCCEEEEEEeccCC-C----ChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH-hCCceeccCCCCC
Q 014609           73 HPNV--VRLHEVLASKSKIYMVLEYVTG-G----ELFDKIASKGRLQEAEGRKLFQQLIDGVSYCH-NKGVFHRDLKLEN  144 (421)
Q Consensus        73 hpnI--v~l~~~~~~~~~~~lv~E~~~g-g----~L~~~i~~~~~~~~~~~~~~~~ql~~aL~~LH-~~gi~HrDlkp~N  144 (421)
                      |+++  ..+++.    +..++||||+.+ |    +|.+....   .++..+..++.|++.||.||| +.||+||||||+|
T Consensus       129 ~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~---~~~~~~~~i~~qi~~~l~~lH~~~givHrDlkp~N  201 (258)
T 1zth_A          129 EAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE---LKELDVEGIFNDVVENVKRLYQEAELVHADLSEYN  201 (258)
T ss_dssp             HTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG---GGGSCHHHHHHHHHHHHHHHHHTSCEECSSCSTTS
T ss_pred             hCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc---cChHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHH
Confidence            8764  444443    246899999942 3    66655432   335678899999999999999 9999999999999


Q ss_pred             EEeccCCCEEEEeccCCCC
Q 014609          145 ILLDSKGNIKISDFGLSAL  163 (421)
Q Consensus       145 ILl~~~~~~kL~DFGla~~  163 (421)
                      ||++.  .++|+|||+|..
T Consensus       202 ILl~~--~~~liDFG~a~~  218 (258)
T 1zth_A          202 IMYID--KVYFIDMGQAVT  218 (258)
T ss_dssp             EEESS--SEEECCCTTCEE
T ss_pred             EEEcC--cEEEEECccccc
Confidence            99988  999999999973

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.80  E-value=9.2e-20  Score=179.31  Aligned_cols=138  Identities=20%  Similarity=0.236  Sum_probs=103.0

Q ss_pred             eEEeceEeecCcEEEEEEEECCCCceEEEEEeeccccc---------------chhH----HHHHHHHHHHHhcCCCCCc
Q 014609           16 YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRII---------------HLKI----TDQIKREIATLKLLKHPNV   76 (421)
Q Consensus        16 y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~---------------~~~~----~~~~~~Ei~il~~l~hpnI   76 (421)
                      |++++.||.|+||.||+|.+ .+|+.||||+++.....               ....    .-...+|...|.++.++++
T Consensus        97 Y~I~~~IG~Gk~a~VY~a~d-~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv  175 (397)
T 4gyi_A           97 YSVGSRIGVGKESDIMIVAD-EKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGF  175 (397)
T ss_dssp             SEEEEEEEECSSEEEEEEEC-TTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred             EEecCEeeeCCceEEEEEEC-CCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCC
Confidence            89999999999999999997 57999999998643211               0000    0123568888888866554


Q ss_pred             ceEEEEEEeCCEEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCC----
Q 014609           77 VRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGN----  152 (421)
Q Consensus        77 v~l~~~~~~~~~~~lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~----  152 (421)
                      ....-+....  .++||||++|++|.+..      ..+.+..++.||+.+|.|||++||+||||||.|||++++|.    
T Consensus       176 ~vp~p~~~~~--~~LVME~i~G~~L~~l~------~~~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl~~dgd~~d~  247 (397)
T 4gyi_A          176 PVPEPIAQSR--HTIVMSLVDALPMRQVS------SVPDPASLYADLIALILRLAKHGLIHGDFNEFNILIREEKDAEDP  247 (397)
T ss_dssp             SCCCEEEEET--TEEEEECCSCEEGGGCC------CCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEEEEECSSCT
T ss_pred             CCCeeeeccC--ceEEEEecCCccHhhhc------ccHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeCCCCcccc
Confidence            3222222222  37999999998885532      22345778999999999999999999999999999988773    


Q ss_pred             ------EEEEeccCCC
Q 014609          153 ------IKISDFGLSA  162 (421)
Q Consensus       153 ------~kL~DFGla~  162 (421)
                            +.|+||+.+.
T Consensus       248 ~~~~~~~~iID~~Q~V  263 (397)
T 4gyi_A          248 SSITLTPIIIXFPQMV  263 (397)
T ss_dssp             TSEEEEEEECCCTTCE
T ss_pred             cccccceEEEEeCCcc
Confidence                  8999999775

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.50  E-value=7.6e-14  Score=130.37  Aligned_cols=142  Identities=15%  Similarity=0.108  Sum_probs=115.2

Q ss_pred             eeecceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCC-CCCcceEEEEEEeCCEE
Q 014609           11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK-HPNVVRLHEVLASKSKI   89 (421)
Q Consensus        11 ~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~~   89 (421)
                      ..++.|++...+|.|+.+.||++..  .++.+++|+........   ...+.+|+.+++.+. +..+.+++++....+..
T Consensus        11 ~~l~~~~~~~~~~g~s~~~v~~~~~--~~~~~vlK~~~~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~   85 (263)
T 3tm0_A           11 KLIEKYRCVKDTEGMSPAKVYKLVG--ENENLYLKMTDSRYKGT---TYDVEREKDMMLWLEGKLPVPKVLHFERHDGWS   85 (263)
T ss_dssp             HHHTTSEEEECCSCCSSSEEEEEEC--SSCEEEEEEECGGGTTS---TTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEE
T ss_pred             HHhccceeEeeccCCCCCeEEEEEC--CCCcEEEEeCCcccCCC---HHHHHHHHHHHHHHhcCCCCCeEEEEEecCCce
Confidence            4568899999999999999999974  47899999986532111   245889999999885 67788999999999999


Q ss_pred             EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-------------------------------------
Q 014609           90 YMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHN-------------------------------------  132 (421)
Q Consensus        90 ~lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~ql~~aL~~LH~-------------------------------------  132 (421)
                      |+||||++|.+|.+.+.     +......++.+++.+|+.||+                                     
T Consensus        86 ~lv~e~i~G~~l~~~~~-----~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (263)
T 3tm0_A           86 NLLMSEADGVLCSEEYE-----DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEE  160 (263)
T ss_dssp             EEEEECCSSEEHHHHCC-----TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGST
T ss_pred             EEEEEecCCeehhhccC-----CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccc
Confidence            99999999999876521     223345788999999999998                                     


Q ss_pred             ----------------------CCceeccCCCCCEEeccCCCEEEEeccCCC
Q 014609          133 ----------------------KGVFHRDLKLENILLDSKGNIKISDFGLSA  162 (421)
Q Consensus       133 ----------------------~gi~HrDlkp~NILl~~~~~~kL~DFGla~  162 (421)
                                            ..++|+|++|.|||++.++.+.|+||+.+.
T Consensus       161 ~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~  212 (263)
T 3tm0_A          161 DTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG  212 (263)
T ss_dssp             TCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred             cccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence                                  458999999999999876556799999875

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=99.36  E-value=9e-13  Score=122.26  Aligned_cols=136  Identities=19%  Similarity=0.192  Sum_probs=103.0

Q ss_pred             eecceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCC--cceEEEEEEeCCEE
Q 014609           12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN--VVRLHEVLASKSKI   89 (421)
Q Consensus        12 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpn--Iv~l~~~~~~~~~~   89 (421)
                      .+..|.+....+.|..+.||++. ..+|+.+++|+.....      ...+.+|+.+++.+.+.+  +.+++.+....+..
T Consensus        18 ~~~~~~~~~~~~gg~~~~v~~~~-~~~g~~~vlK~~~~~~------~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~   90 (264)
T 1nd4_A           18 RLFGYDWAQQTIGCSDAAVFRLS-AQGRPVLFVKTDLSGA------LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRD   90 (264)
T ss_dssp             TTTTCEEEECSCTTSSCEEEEEE-CTTSCCEEEEEECSCT------TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCE
T ss_pred             hcCCCceEecccCCCCceEEEEe-cCCCCeEEEEeCCccc------chhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCC
Confidence            45667775555566779999996 4567889999975431      245788999999886544  56689988888889


Q ss_pred             EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC-----------------------------------
Q 014609           90 YMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKG-----------------------------------  134 (421)
Q Consensus        90 ~lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~ql~~aL~~LH~~g-----------------------------------  134 (421)
                      |+||||++|.+|.  ..   ..+   ...++.+++..|+.||+..                                   
T Consensus        91 ~~v~e~i~G~~l~--~~---~~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  162 (264)
T 1nd4_A           91 WLLLGEVPGQDLL--SS---HLA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEH  162 (264)
T ss_dssp             EEEEECCSSEETT--TS---CCC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGG
T ss_pred             EEEEEecCCcccC--cC---cCC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhc
Confidence            9999999998883  11   122   2356778888888888643                                   


Q ss_pred             -----------------------ceeccCCCCCEEeccCCCEEEEeccCCC
Q 014609          135 -----------------------VFHRDLKLENILLDSKGNIKISDFGLSA  162 (421)
Q Consensus       135 -----------------------i~HrDlkp~NILl~~~~~~kL~DFGla~  162 (421)
                                             ++|+|++|.|||++.++.+.|+|||.+.
T Consensus       163 ~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~  213 (264)
T 1nd4_A          163 QGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG  213 (264)
T ss_dssp             TTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred             cCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence                                   9999999999999877667799999876

>3ose_A Serine/threonine-protein kinase MARK1; kinase associated-1(Ka1) domain, transferase, lipid binding membrane association; 1.70A {Homo sapiens} SCOP: d.129.6.1 PDB: 1ul7_A

Probab=99.32  E-value=1.5e-11  Score=100.39  Aligned_cols=86  Identities=17%  Similarity=0.290  Sum_probs=76.7

Q ss_pred             eEEecCCHHHHHHHHHHHHHhcCcEEEEeC-CeeEEEeecCCCCccCceEEEEEEEEec-CceEEEEEEccCCChhhHHH
Q 014609          322 RFTSNHSAKDLLERIEDIVTEMGFRVQKKN-GKLKATQEHKPQKSLGSLSVAAEVFEIS-PSLYVVELRKSYGDPTVYRQ  399 (421)
Q Consensus       322 ~f~s~~~~~~i~~~l~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~l~~~~~i~~~~-~~~~~v~~~k~~Gd~le~~~  399 (421)
                      ..+|..+|.+|+.+|+++++.+|+.|++++ |.+++........  +.+.|.+||+++. +++++|+|+|.+||.+.|++
T Consensus        32 ~tTS~~~P~eIm~eI~rvL~~~gi~~~~~g~y~l~C~~~~~~~~--~~v~fElEVckl~~~~l~gV~~kRi~Gd~~~yk~  109 (120)
T 3ose_A           32 KTTSSMDPNDMMREIRKVLDANNCDYEQKERFLLFCVHGDARQD--SLVQWEMEVCKLPRLSLNGVRFKRISGTSIAFKN  109 (120)
T ss_dssp             CCEECSCHHHHHHHHHHHHHHTTCEEEEEETTEEEEEESCTTTT--CCEEEEEEEEEEGGGTEEEEEEEEEESCHHHHHH
T ss_pred             cCcccCCHHHHHHHHHHHHHHCCCEEEEcCCEEEEEEecCCCCC--ccEEEEEEEEEecCCCceeEEEEecCCCHHHHHH
Confidence            346889999999999999999999998765 7889987644444  7899999999996 89999999999999999999


Q ss_pred             HHHHHHhhcC
Q 014609          400 LCNKLSSDLG  409 (421)
Q Consensus       400 ~~~~l~~~l~  409 (421)
                      +|.+|.+.|+
T Consensus       110 lc~~il~~L~  119 (120)
T 3ose_A          110 IASKIANELK  119 (120)
T ss_dssp             HHHHHHHHCC
T ss_pred             HHHHHHHHhc
Confidence            9999999886

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=99.26  E-value=1.1e-11  Score=121.29  Aligned_cols=140  Identities=17%  Similarity=0.361  Sum_probs=106.7

Q ss_pred             EeceEeecCcEEEEEEEECCCCceEEEEEee--cccccchhHHHHHHHHHHHHhcCC--CCCcceEEEEEEeC---CEEE
Q 014609           18 LGRTLGEGNFGKVKFAQDLDSGLPFAVKILE--KNRIIHLKITDQIKREIATLKLLK--HPNVVRLHEVLASK---SKIY   90 (421)
Q Consensus        18 i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~--~~~~~~~~~~~~~~~Ei~il~~l~--hpnIv~l~~~~~~~---~~~~   90 (421)
                      -++.|+.|.++.||++..  .+..+++|+..  .....  .....+.+|..+++.|.  +..+.+++.++.+.   +..|
T Consensus        42 ~~~~l~~G~sn~~y~v~~--~~~~~vlr~~~~p~~~~~--~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~  117 (359)
T 3dxp_A           42 SVEQFKGGQSNPTFKLVT--PGQTYVMRAKPGPKSKLL--PSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAF  117 (359)
T ss_dssp             EEEECCC-CCSCEEEEEC--SSCEEEEECCCC------------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCE
T ss_pred             eEEEcCCcccceEEEEEE--CCceEEEEeCCCCCCCCC--CcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeE
Confidence            467889999999999874  34678899875  32211  11356889999999997  45688899988776   4589


Q ss_pred             EEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh--------------------------------------
Q 014609           91 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHN--------------------------------------  132 (421)
Q Consensus        91 lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~ql~~aL~~LH~--------------------------------------  132 (421)
                      +||||++|..+.+..  ...+++.....++.+++.+|+.||+                                      
T Consensus       118 ~vme~v~G~~l~~~~--~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  195 (359)
T 3dxp_A          118 YIMEFVSGRVLWDQS--LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIP  195 (359)
T ss_dssp             EEEECCCCBCCCCTT--CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCH
T ss_pred             EEEEecCCeecCCCc--cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCCh
Confidence            999999998775421  2347788889999999999999997                                      


Q ss_pred             --------------------CCceeccCCCCCEEeccCCC--EEEEeccCCCC
Q 014609          133 --------------------KGVFHRDLKLENILLDSKGN--IKISDFGLSAL  163 (421)
Q Consensus       133 --------------------~gi~HrDlkp~NILl~~~~~--~kL~DFGla~~  163 (421)
                                          .+++|||++|.|||++.++.  +.|+||+.+..
T Consensus       196 ~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~  248 (359)
T 3dxp_A          196 AMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL  248 (359)
T ss_dssp             HHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred             HHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence                                36899999999999997763  68999998863

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=99.03  E-value=5.7e-10  Score=106.46  Aligned_cols=133  Identities=19%  Similarity=0.190  Sum_probs=100.2

Q ss_pred             eceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCC-CCC--cceEEEEEEeCC---EEEEE
Q 014609           19 GRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK-HPN--VVRLHEVLASKS---KIYMV   92 (421)
Q Consensus        19 ~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpn--Iv~l~~~~~~~~---~~~lv   92 (421)
                      ++.++.|....||++.     ..+++|+....     .....+.+|..+|+.+. +..  +.+++.......   ..|+|
T Consensus        25 i~~~~~G~~n~v~~v~-----~~~vlR~~~~~-----~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~v   94 (304)
T 3sg8_A           25 IEISGEGNDCIAYEIN-----RDFIFKFPKHS-----RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAG   94 (304)
T ss_dssp             CCEEEECSSEEEEEST-----TSEEEEEESSH-----HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEE
T ss_pred             eEecCCCCcceEEEEC-----CEEEEEecCCc-----chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEE
Confidence            4569999999999863     56899986432     23567899999998884 333  445555443333   35899


Q ss_pred             EeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh----------------------------------------
Q 014609           93 LEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHN----------------------------------------  132 (421)
Q Consensus        93 ~E~~~gg~L~~~i~~~~~~~~~~~~~~~~ql~~aL~~LH~----------------------------------------  132 (421)
                      |++++|..|.+...  ..++..+...++.|++..++.||+                                        
T Consensus        95 m~~i~G~~l~~~~~--~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  172 (304)
T 3sg8_A           95 FTKIKGVPLTPLLL--NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKK  172 (304)
T ss_dssp             EECCCCEECCHHHH--HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHH
T ss_pred             EcccCCeECCcccc--ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHH
Confidence            99999988865433  347788888889999999988886                                        


Q ss_pred             ------------------CCceeccCCCCCEEecc--CCCEEEEeccCCCC
Q 014609          133 ------------------KGVFHRDLKLENILLDS--KGNIKISDFGLSAL  163 (421)
Q Consensus       133 ------------------~gi~HrDlkp~NILl~~--~~~~kL~DFGla~~  163 (421)
                                        ..++|+|++|.||+++.  ++.+.|+||+.+..
T Consensus       173 l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~  223 (304)
T 3sg8_A          173 VDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAI  223 (304)
T ss_dssp             HHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEE
T ss_pred             HHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCcc
Confidence                              13799999999999998  45678999999864

>1v5s_A MAP/microtubule affinity-regulating kinase 3; Ka1 domain, ELKL motif, MARK3, phosphorylation, structural genomics, NPPSFA; NMR {Mus musculus} SCOP: d.129.6.1

Probab=98.98  E-value=1.1e-09  Score=89.22  Aligned_cols=86  Identities=16%  Similarity=0.255  Sum_probs=74.9

Q ss_pred             EEecCCHHHHHHHHHHHHHhcCcEEEE-eCCeeEEEeecCCCCccCceEEEEEEEEec-CceEEEEEEccCCChhhHHHH
Q 014609          323 FTSNHSAKDLLERIEDIVTEMGFRVQK-KNGKLKATQEHKPQKSLGSLSVAAEVFEIS-PSLYVVELRKSYGDPTVYRQL  400 (421)
Q Consensus       323 f~s~~~~~~i~~~l~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~l~~~~~i~~~~-~~~~~v~~~k~~Gd~le~~~~  400 (421)
                      .+|..+|.+|+.+|..+++.+|+.|+. +.+.+++........  ..+.|.+||+++. .+++.|+|+|.+||.+.|+++
T Consensus        33 tTSsk~P~eIm~EI~rvL~~~~i~~k~~~~y~L~C~~~~~~~~--~~vkfEiEVcKvp~l~l~GI~fKRisGd~w~YK~l  110 (126)
T 1v5s_A           33 QGSSGSSGDMMREIRKVLGANNCDYEQRERFLLFCVHGDGHAE--NLVQWEMEVCKLPRLSLNGVRFKRISGTSIAFKNI  110 (126)
T ss_dssp             CCCCSSHHHHHHHHHHHHHHTTEEEEEEETTEEEEEECSSSTT--TCEEEEEECCCCTTTCSCCCEEEEEESCHHHHHHH
T ss_pred             eecCCCHHHHHHHHHHHHHHcCCcEEEECCEEEEEEECCCCCC--ceEEEEEEEEEecCCCceeEEEeeccCchhHHHHH
Confidence            356789999999999999999999986 567888876543334  7899999999995 789999999999999999999


Q ss_pred             HHHHHhhcCC
Q 014609          401 CNKLSSDLGL  410 (421)
Q Consensus       401 ~~~l~~~l~~  410 (421)
                      |.+|...|+-
T Consensus       111 c~~IL~eLkL  120 (126)
T 1v5s_A          111 ASKIANELKL  120 (126)
T ss_dssp             HHHHHHHTTC
T ss_pred             HHHHHHHHhc
Confidence            9999998873

>4eai_A 5'-AMP-activated protein kinase catalytic subunit linker, 5'-AMP-activated protein...; AMPK, transferase; HET: AMP; 2.29A {Rattus norvegicus} PDB: 4eaj_A* 4eak_A* 4eal_A*

Probab=98.86  E-value=4.3e-08  Score=77.10  Aligned_cols=89  Identities=9%  Similarity=0.269  Sum_probs=76.6

Q ss_pred             ceeeEEecCCHHHHHHHHHHHHHhcCcEEEE-eCCeeEEEeecCCCCccCceEEEEEEEEecCceEEEEEEccCCC----
Q 014609          319 RKIRFTSNHSAKDLLERIEDIVTEMGFRVQK-KNGKLKATQEHKPQKSLGSLSVAAEVFEISPSLYVVELRKSYGD----  393 (421)
Q Consensus       319 ~~~~f~s~~~~~~i~~~l~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~l~~~~~i~~~~~~~~~v~~~k~~Gd----  393 (421)
                      ......|...|.+|+.+|..+++.+|+.|+. +.+.+++....+...  ..+.|.+++|++.++.+|+||++..||    
T Consensus         8 W~LGIrS~~~P~eiM~eIyraLk~lg~~Wk~~~~Y~lkcR~~~~~~~--~~vK~~lQLYkv~~~~YLLDfq~i~g~~~~~   85 (106)
T 4eai_A            8 WHLGIRSQSRPNDIMAEVCRAIKQLDYEWKVVNPYYLRVRRKNPVTS--TFSKMSLQLYQVDSRTYLLDFRSIDDGGGGG   85 (106)
T ss_dssp             EEESEEECSCHHHHHHHHHHHHHHHTCEEEEEETTEEEEEEECTTTC--CEEEEEEEEEECSSSCEEEEEEECCSSCCCS
T ss_pred             ceEcceeCCCHHHHHHHHHHHHHHcCCEEeeCCceEEEEEEcCCCCC--ceeEEEEEEEEecCCcEEEEEEeccCCCCCC
Confidence            4455678899999999999999999999987 568999987643333  679999999999989999999999994    


Q ss_pred             ----hhhHHHHHHHHHhhcC
Q 014609          394 ----PTVYRQLCNKLSSDLG  409 (421)
Q Consensus       394 ----~le~~~~~~~l~~~l~  409 (421)
                          .++|-++|.++...|.
T Consensus        86 ~~~~~~~F~d~ca~li~~la  105 (106)
T 4eai_A           86 GGSHTIEFFEMCANLIKILA  105 (106)
T ss_dssp             SSCHHHHHHHHHHHHHHHCC
T ss_pred             CCcCcEeHHHHHHHHHHHHh
Confidence                9999999999988775

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.79  E-value=7.5e-08  Score=91.95  Aligned_cols=133  Identities=21%  Similarity=0.224  Sum_probs=95.9

Q ss_pred             eceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCC---CcceEEEEEE-eCCEEEEEEe
Q 014609           19 GRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP---NVVRLHEVLA-SKSKIYMVLE   94 (421)
Q Consensus        19 ~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hp---nIv~l~~~~~-~~~~~~lv~E   94 (421)
                      ++.++.|....||+.     |..+++|+-..     ......+.+|..+|+.|.+.   .+.+.+.+.. ..+..|+|||
T Consensus        24 v~~l~~G~~n~v~~v-----g~~~VlR~~~~-----~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e   93 (306)
T 3tdw_A           24 VESLGEGFRNYAILV-----NGDWVFRFPKS-----QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYR   93 (306)
T ss_dssp             EEEEEECSSEEEEEE-----TTTEEEEEESS-----HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEE
T ss_pred             eeecCCCcceeEEEE-----CCEEEEEecCC-----chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEe
Confidence            356788999999988     57789998432     22356899999999999752   3566676664 4556789999


Q ss_pred             ccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC-----------------------------------------
Q 014609           95 YVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNK-----------------------------------------  133 (421)
Q Consensus        95 ~~~gg~L~~~i~~~~~~~~~~~~~~~~ql~~aL~~LH~~-----------------------------------------  133 (421)
                      |++|..+.+...  ..++......+..|+...|+.||+.                                         
T Consensus        94 ~i~G~~l~~~~~--~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~  171 (306)
T 3tdw_A           94 KVQGQILGEDGM--AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDY  171 (306)
T ss_dssp             CCCSEECHHHHH--TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHH
T ss_pred             ccCCeECchhhh--hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHH
Confidence            999988865322  2345555555666666666655542                                         


Q ss_pred             -------------------CceeccCCCCCEEecc---CCCE-EEEeccCCCC
Q 014609          134 -------------------GVFHRDLKLENILLDS---KGNI-KISDFGLSAL  163 (421)
Q Consensus       134 -------------------gi~HrDlkp~NILl~~---~~~~-kL~DFGla~~  163 (421)
                                         .++|+|++|.|||++.   ++.+ .|+||+.+..
T Consensus       172 l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~  224 (306)
T 3tdw_A          172 LTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI  224 (306)
T ss_dssp             HHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred             HHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence                               3599999999999987   4564 8999998874

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.78  E-value=6.5e-08  Score=90.17  Aligned_cols=138  Identities=15%  Similarity=0.221  Sum_probs=100.7

Q ss_pred             cceEEeceEeecCcE-EEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCC-CCCcceEEEEEEeCCEEEE
Q 014609           14 GRYELGRTLGEGNFG-KVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK-HPNVVRLHEVLASKSKIYM   91 (421)
Q Consensus        14 ~~y~i~~~LG~G~~g-~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~l   91 (421)
                      ..|+.. .+..|..+ .||.......+..+.+|+-...      ....+.+|..+|+.+. +--+.+++.++.+.+..|+
T Consensus        25 ~g~~~~-~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~------~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~l   97 (272)
T 4gkh_A           25 YGYRWA-RDNVGQSGATIYRLYGKPNAPELFLKHGKGS------VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWL   97 (272)
T ss_dssp             TTCEEE-EEECSSSSCEEEEEECCTTCCCEEEEEEETH------HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEE
T ss_pred             cCCeEE-EccCCCcCCeEEEEEecCCCeEEEEEECCCC------CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEE
Confidence            345443 34445444 6898877667888999986533      2467889999998885 3347788999999999999


Q ss_pred             EEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC--------------------------------------
Q 014609           92 VLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNK--------------------------------------  133 (421)
Q Consensus        92 v~E~~~gg~L~~~i~~~~~~~~~~~~~~~~ql~~aL~~LH~~--------------------------------------  133 (421)
                      |||+++|.++.+.....    ......+..++...|+-||+.                                      
T Consensus        98 vme~l~G~~~~~~~~~~----~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  173 (272)
T 4gkh_A           98 LTTAIPGKTAFQVLEEY----PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNG  173 (272)
T ss_dssp             EEECCCSEEHHHHHHHC----GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTT
T ss_pred             EEEeeCCccccccccCC----HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccc
Confidence            99999998887655431    223344556666666666630                                      


Q ss_pred             --------------------CceeccCCCCCEEeccCCCEEEEeccCCC
Q 014609          134 --------------------GVFHRDLKLENILLDSKGNIKISDFGLSA  162 (421)
Q Consensus       134 --------------------gi~HrDlkp~NILl~~~~~~kL~DFGla~  162 (421)
                                          .++|+|++|.|||++.++.+-|+||+.+.
T Consensus       174 ~~~~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~  222 (272)
T 4gkh_A          174 WPVEQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVG  222 (272)
T ss_dssp             CCHHHHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred             hHHHHHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccc
Confidence                                27899999999999887777799999886

>2v8q_A 5'-AMP-activated protein kinase catalytic subunit; phosphorylation, nucleotide-binding, serine/threonine-protei kinase, magnesium, CBS domain; HET: AMP; 2.10A {Rattus norvegicus} SCOP: d.129.6.2 PDB: 2v92_A* 2v9j_A* 2y94_C*

Probab=98.70  E-value=3e-07  Score=76.62  Aligned_cols=75  Identities=7%  Similarity=0.234  Sum_probs=63.2

Q ss_pred             cceeeEEecCCHHHHHHHHHHHHHhcCcEEEE-eCCeeEEEeecCCCCccCceEEEEEEEEecCceEEEEEEccCCCh
Q 014609          318 ERKIRFTSNHSAKDLLERIEDIVTEMGFRVQK-KNGKLKATQEHKPQKSLGSLSVAAEVFEISPSLYVVELRKSYGDP  394 (421)
Q Consensus       318 ~~~~~f~s~~~~~~i~~~l~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~l~~~~~i~~~~~~~~~v~~~k~~Gd~  394 (421)
                      +.....-|..+|.+|+.+|..+++.+|+.|++ +.+.|++....+...  ..+.|.+++|++.++.|||||++..||+
T Consensus         4 kWhLGIrSrs~P~eIM~EVyRALk~Lg~eWK~~~pY~IkcRw~~~~~~--~~vKm~LQLYkv~~~~YLLDFk~l~g~~   79 (157)
T 2v8q_A            4 AWHLGIRSQSRPNDIMAEVCRAIKQLDYEWKVVNPYYLRVRRKNPVTS--TFSKMSLQLYQVDSRTYLLDFRSIDDEI   79 (157)
T ss_dssp             EEEESEEECSCHHHHHHHHHHHHHHTTCEEEEEETTEEEEEEECTTTC--CEEEEEEEEEECSSSCEEEEEEEECCC-
T ss_pred             cceeecccCCCHHHHHHHHHHHHHHcCCEEeeCCCeEEEEEEcCCCCC--ceEEEEEEEEEecCCCEEEEEEecCCCc
Confidence            44556678889999999999999999999997 568899987643322  4689999999999999999999999986

>2y8l_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, serine/threonine-protein KI; HET: ADP AMP; 2.50A {Rattus norvegicus} PDB: 2y8q_A* 2ya3_A*

Probab=98.53  E-value=1.3e-06  Score=73.68  Aligned_cols=78  Identities=8%  Similarity=0.222  Sum_probs=64.3

Q ss_pred             ccceeeEEecCCHHHHHHHHHHHHHhcCcEEEE-eCCeeEEEeecCCCCccCceEEEEEEEEecCceEEEEEEccCCChh
Q 014609          317 SERKIRFTSNHSAKDLLERIEDIVTEMGFRVQK-KNGKLKATQEHKPQKSLGSLSVAAEVFEISPSLYVVELRKSYGDPT  395 (421)
Q Consensus       317 ~~~~~~f~s~~~~~~i~~~l~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~l~~~~~i~~~~~~~~~v~~~k~~Gd~l  395 (421)
                      .+.....-|+..|.+|+..|..|++.+|+.|++ ..+.|++....+...  ..+.|.+++|++.++.|||||++..||+.
T Consensus        17 ~kWhLGIrSrs~P~eIM~EVyRALk~Lg~eWK~i~pY~IkcRw~~~~~~--~~vKmeLQLYKv~~~~YLLDFk~l~Gd~~   94 (173)
T 2y8l_A           17 MAWHLGIRSQSRPNDIMAEVCRAIKQLDYEWKVVNPYYLRVRRKNPVTS--TFSKMSLQLYQVDSRTYLLDFRSIDDEIT   94 (173)
T ss_dssp             CEEEESEEECSCHHHHHHHHHHHHHHTTCEEEEEETTEEEEEEECTTTC--CEEEEEEEEEECSSSCEEEEEEEECCC--
T ss_pred             ceeeeecccCCCHHHHHHHHHHHHHHcCCEEeeCCCeEEEEEEcCCCCC--eeEEEEEEEEEEcCCCEEEEEEecCCCcc
Confidence            356677789999999999999999999999987 568899987633222  46899999999999999999999999874


Q ss_pred             h
Q 014609          396 V  396 (421)
Q Consensus       396 e  396 (421)
                      |
T Consensus        95 e   95 (173)
T 2y8l_A           95 E   95 (173)
T ss_dssp             -
T ss_pred             c
Confidence            4

>4eag_A EG:132E8.2 protein; AMPK, transferase; HET: ATP TAM; 2.70A {Drosophila melanogaster}

Probab=98.47  E-value=1.9e-06  Score=69.54  Aligned_cols=73  Identities=5%  Similarity=0.233  Sum_probs=59.7

Q ss_pred             eeeEEecCCHHHHHHHHHHHHHhcCcEEEE-eCCeeEEEeecCCCCccCceEEEEEEEEecCceEEEEEEccCCCh
Q 014609          320 KIRFTSNHSAKDLLERIEDIVTEMGFRVQK-KNGKLKATQEHKPQKSLGSLSVAAEVFEISPSLYVVELRKSYGDP  394 (421)
Q Consensus       320 ~~~f~s~~~~~~i~~~l~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~l~~~~~i~~~~~~~~~v~~~k~~Gd~  394 (421)
                      ....-|...|.+|+..|..+++.+|+.|+. +.+.+++........  ..+.+.+++|++.++.||+||++..||.
T Consensus         9 ~LGIrS~~~P~eIM~EVyrALk~Lg~eWK~~~pY~vkcR~~n~~~~--~~vKm~LQLYqv~~~~YLLDfk~~~~~~   82 (130)
T 4eag_A            9 HLGIRSQSKPNDIMLEVYRAMKALSYEWKIINPYHVRVRRQNVKTG--KFSKMSLQLYQVDAKSYLLDFKSLTNDE   82 (130)
T ss_dssp             EESBCCCSCHHHHHHHHHHHHHHTTCEEEEEETTEEEEEEECTTTC--CEEEEEEEEEESSSSCEEEEEEECC---
T ss_pred             eeeeecCCCHHHHHHHHHHHHHHCCCEEeeCCCEEEEEEecCCCCC--ceeEEEEEEEEecCCcEEEEeccCCcch
Confidence            344457788999999999999999999987 468899987644444  6788999999999999999999999994

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=98.46  E-value=3.1e-07  Score=90.74  Aligned_cols=79  Identities=18%  Similarity=0.162  Sum_probs=50.4

Q ss_pred             eceEeecCcEEEEEEEECCCCceEEEEEeecccc-cch---hHHHHHHHHHHHHhcCCC--CC-cceEEEEEEeCCEEEE
Q 014609           19 GRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRI-IHL---KITDQIKREIATLKLLKH--PN-VVRLHEVLASKSKIYM   91 (421)
Q Consensus        19 ~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~-~~~---~~~~~~~~Ei~il~~l~h--pn-Iv~l~~~~~~~~~~~l   91 (421)
                      .+.||.|..+.||++.+..+++.++||....... ...   ...+.+..|.++++.+..  |. +.+++.+  +....++
T Consensus        35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l  112 (397)
T 2olc_A           35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT  112 (397)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred             EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence            5689999999999997655678999998653211 000   113456789999887742  33 4456544  3445689


Q ss_pred             EEeccCCC
Q 014609           92 VLEYVTGG   99 (421)
Q Consensus        92 v~E~~~gg   99 (421)
                      |||+++|.
T Consensus       113 vmE~l~g~  120 (397)
T 2olc_A          113 VMEDLSHL  120 (397)
T ss_dssp             EECCCTTS
T ss_pred             EEEeCCCc
Confidence            99999874

>2qrd_A SNF1-like protein kinase SSP2; AMPK, ADP, ATP-binding, kinase, nucleotide-binding, serine/T protein kinase, transferase, CBS domain; HET: ADP ATP; 2.41A {Schizosaccharomyces pombe} SCOP: d.129.6.2 PDB: 2ooy_A* 2qr1_A* 2qrc_A* 2oox_A* 2qre_A*

Probab=98.35  E-value=1.2e-06  Score=72.36  Aligned_cols=92  Identities=12%  Similarity=0.177  Sum_probs=74.3

Q ss_pred             cceeeEEecCCHHHHHHHHHHHHHhcCcEEEEe---------C-CeeEEEeecCCC---CccCceEEEEEEEEecCceEE
Q 014609          318 ERKIRFTSNHSAKDLLERIEDIVTEMGFRVQKK---------N-GKLKATQEHKPQ---KSLGSLSVAAEVFEISPSLYV  384 (421)
Q Consensus       318 ~~~~~f~s~~~~~~i~~~l~~~~~~~~~~~~~~---------~-~~~~~~~~~~~~---~~~~~l~~~~~i~~~~~~~~~  384 (421)
                      +.....-|+..|.+|+.+|..|++.+|+.|++.         + +.|++....+..   .....+.|.+++|++.++.+|
T Consensus        12 kWhlGIRSrs~P~eIM~EVyrALk~Lg~eWk~~~~~~~~~~~~~y~Ik~R~~~~~~~~~~~~~~vkm~iQLYqv~~~~YL   91 (137)
T 2qrd_A           12 KWHFGVRCRGDAPEILLAVYRALQRAGAQFTVPKPVNGKYRSDMYTIKSRWEIPHCKREGKNTYAYIELQLYEVMPGCFM   91 (137)
T ss_dssp             CCEESEEEESCHHHHHHHHHHHHHHHTCEECCCCCBTTBCCGGGGEEEEEEECHHHHHTTCCEEEEEEEEEEEEETTEEE
T ss_pred             ccccccccCCCHHHHHHHHHHHHHHCCCEEEeccccccccCCCceEEEEEEecCCCccccCCceEEEEEEEEEecCCcEE
Confidence            455666788999999999999999999999865         3 678887753221   001468999999999999999


Q ss_pred             EEEEccCCC---------------h----hhHHHHHHHHHhhcC
Q 014609          385 VELRKSYGD---------------P----TVYRQLCNKLSSDLG  409 (421)
Q Consensus       385 v~~~k~~Gd---------------~----le~~~~~~~l~~~l~  409 (421)
                      |||++..|+               .    ++|-.+|.+|.-.|.
T Consensus        92 lDFk~~~~~~~~~~~~~~~~~~~~~~~s~~~Fldlca~Li~eLa  135 (137)
T 2qrd_A           92 LDVKSNGYKDIYSHPERTADHGMDDLKSSFPFLDLCAMLVCKLF  135 (137)
T ss_dssp             EEEEEEEEEESCC-------------CCCTTHHHHHHHHHHHHH
T ss_pred             EEEEecCCccccccCccccccCCccccccccHHHHHHHHHHHHh
Confidence            999999999               6    999999998877664

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=98.32  E-value=3.3e-06  Score=80.99  Aligned_cols=134  Identities=13%  Similarity=0.130  Sum_probs=78.3

Q ss_pred             ceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCC-----CCCcceEE-E--EEEeCCEEEE
Q 014609           20 RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK-----HPNVVRLH-E--VLASKSKIYM   91 (421)
Q Consensus        20 ~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~-----hpnIv~l~-~--~~~~~~~~~l   91 (421)
                      +.|+.|..+.||++.. .+ ..+++|+....       ...+..|..+++.|.     .|.++... +  +....+..|+
T Consensus        38 ~~l~gG~~n~~~~v~~-~~-~~~vlk~~~~~-------~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~  108 (346)
T 2q83_A           38 DVIQGNQMALVWKVHT-DS-GAVCLKRIHRP-------EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFV  108 (346)
T ss_dssp             EECC----CEEEEEEE-TT-EEEEEEEECSC-------HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEE
T ss_pred             eeccccccCcEEEEEe-CC-CCEEEEecCCC-------HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEE
Confidence            4566678889999875 33 35899998642       133445555555443     34444310 0  1234678899


Q ss_pred             EEeccCCCChH--------------HHHHh-cCCC-------------CHHH----------------------------
Q 014609           92 VLEYVTGGELF--------------DKIAS-KGRL-------------QEAE----------------------------  115 (421)
Q Consensus        92 v~E~~~gg~L~--------------~~i~~-~~~~-------------~~~~----------------------------  115 (421)
                      +|+|++|..+.              ..++. ...+             .+..                            
T Consensus       109 l~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~  188 (346)
T 2q83_A          109 VYDWIEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLY  188 (346)
T ss_dssp             EEECCCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHH
T ss_pred             EEEeecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHH
Confidence            99999986531              11221 1111             1100                            


Q ss_pred             ---HHHHHHHHHHHHHHHHh-------------CCceeccCCCCCEEeccCCCEEEEeccCCC
Q 014609          116 ---GRKLFQQLIDGVSYCHN-------------KGVFHRDLKLENILLDSKGNIKISDFGLSA  162 (421)
Q Consensus       116 ---~~~~~~ql~~aL~~LH~-------------~gi~HrDlkp~NILl~~~~~~kL~DFGla~  162 (421)
                         ...+..++..++++|++             .+++|+|++|.|||++.++.+.|+||+.+.
T Consensus       189 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~  251 (346)
T 2q83_A          189 LQEIDGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVS  251 (346)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred             HHHHHHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence               11122234445666652             579999999999999888899999999875

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=98.32  E-value=3e-07  Score=89.34  Aligned_cols=85  Identities=9%  Similarity=0.148  Sum_probs=56.4

Q ss_pred             EEeceE-eecCcEEEEEEEEC--C----CCceEEEEEeecccccchhHHHHHHHHHHHHhcCC-C--CCcceEEEEEEeC
Q 014609           17 ELGRTL-GEGNFGKVKFAQDL--D----SGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK-H--PNVVRLHEVLASK   86 (421)
Q Consensus        17 ~i~~~L-G~G~~g~V~~a~~~--~----~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~-h--pnIv~l~~~~~~~   86 (421)
                      ...+.| +.|....+|+....  .    +++.+++|+..............+.+|..+++.|. +  -.+.+++.+..+.
T Consensus        23 ~~~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~  102 (357)
T 3ats_A           23 TVESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTG  102 (357)
T ss_dssp             EEEEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSS
T ss_pred             EEEEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCC
Confidence            345678 88889999988642  0    26789999865432000000145778889888885 3  3567788877655


Q ss_pred             ---CEEEEEEeccCCCCh
Q 014609           87 ---SKIYMVLEYVTGGEL  101 (421)
Q Consensus        87 ---~~~~lv~E~~~gg~L  101 (421)
                         +..|+||||++|..+
T Consensus       103 ~~~g~~~~v~e~l~G~~l  120 (357)
T 3ats_A          103 DVLGTPFFLMDYVEGVVP  120 (357)
T ss_dssp             TTTSSCEEEEECCCCBCC
T ss_pred             CccCCceEEEEecCCCCh
Confidence               357899999998654

>3t4n_A Carbon catabolite-derepressing protein kinase; CBS domain, nucleotide binding, cytosol, protein binding; HET: ADP; 2.30A {Saccharomyces cerevisiae} SCOP: d.129.6.2 PDB: 3tdh_A* 3te5_A* 2qlv_A

Probab=98.17  E-value=2.2e-05  Score=66.90  Aligned_cols=91  Identities=18%  Similarity=0.216  Sum_probs=73.4

Q ss_pred             cceeeEEecCCHHHHHHHHHHHHHhcCcEEEEe----CCeeEEEeecCCC-------CccCceEEEEEEEEecCceEEEE
Q 014609          318 ERKIRFTSNHSAKDLLERIEDIVTEMGFRVQKK----NGKLKATQEHKPQ-------KSLGSLSVAAEVFEISPSLYVVE  386 (421)
Q Consensus       318 ~~~~~f~s~~~~~~i~~~l~~~~~~~~~~~~~~----~~~~~~~~~~~~~-------~~~~~l~~~~~i~~~~~~~~~v~  386 (421)
                      +......|...|.+|+.+|..|++.+|+.|++.    .|.|++....+..       +....+.|.+++|++.++.||||
T Consensus        50 kW~LGIrS~~~P~eIM~EVyrALk~Lg~~WKk~~~~~pY~IkcRw~~~~~~~~~~~~~~p~~vKmeLQLYkv~~~~YLLD  129 (179)
T 3t4n_A           50 RWHFGIRSRSYPLDVMGEIYIALKNLGAEWAKPSEEDLWTIKLRWKYDIGNKTNTNEKIPDLMKMVIQLFQIETNNYLVD  129 (179)
T ss_dssp             CCEESEEECSCHHHHHHHHHHHHHHHTCEEECCCGGGTTEEEEEECC-----------CCCEEEEEEEEEEEETTEEEEE
T ss_pred             eeeeccccCCCHHHHHHHHHHHHHHcCCEEeeCCCCCceEEEEEEeCCCCcccccccCCCceeEEEEEEEEecCCceEEE
Confidence            455567789999999999999999999999874    5778888642211       11245899999999999999999


Q ss_pred             EEccCC----------------------ChhhHHHHHHHHHhhcC
Q 014609          387 LRKSYG----------------------DPTVYRQLCNKLSSDLG  409 (421)
Q Consensus       387 ~~k~~G----------------------d~le~~~~~~~l~~~l~  409 (421)
                      |+ ..|                      ..+.|-.+|.+|.-.|.
T Consensus       130 fk-~~G~e~~~~~~~~~~~~~~~e~~~~s~~pFLdlca~LI~eLa  173 (179)
T 3t4n_A          130 FK-FDGWESSYGDDTTVSNISEDEMSTFSAYPFLHLTTKLIMELA  173 (179)
T ss_dssp             EE-EEEEECC----------------CCCCHHHHHHHHHHHHHHH
T ss_pred             EE-eccccccccccccccccccccccccCCccHHHHHHHHHHHHH
Confidence            99 888                      77999999998877764

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=97.99  E-value=4.6e-05  Score=72.77  Aligned_cols=75  Identities=21%  Similarity=0.247  Sum_probs=60.4

Q ss_pred             eceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCC---CCCcceEEEEEEeCCEEEEEEec
Q 014609           19 GRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK---HPNVVRLHEVLASKSKIYMVLEY   95 (421)
Q Consensus        19 ~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~---hpnIv~l~~~~~~~~~~~lv~E~   95 (421)
                      .+.|+.|....+|+...  ++..+++|+....      ....+.+|...|+.|.   ...+.+++.+....+..|+||||
T Consensus        41 ~~~l~gG~~n~~y~v~~--~~~~~vlK~~~~~------~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~  112 (312)
T 3jr1_A           41 KEKLYSGEMNEIWLIND--EVQTVFVKINERS------YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEA  112 (312)
T ss_dssp             EEEECCSSSSEEEEEES--SSCEEEEEEEEGG------GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEEC
T ss_pred             eEEeCCccceeeeEEEE--CCCeEEEEeCCcc------cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEe
Confidence            56789999999999873  5678899987643      1467889999998884   35688889888888899999999


Q ss_pred             cCCCCh
Q 014609           96 VTGGEL  101 (421)
Q Consensus        96 ~~gg~L  101 (421)
                      ++|..+
T Consensus       113 l~G~~~  118 (312)
T 3jr1_A          113 LNKSKN  118 (312)
T ss_dssp             CCCCCC
T ss_pred             ccCCCC
Confidence            998754

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=97.91  E-value=3.5e-05  Score=76.59  Aligned_cols=32  Identities=16%  Similarity=0.326  Sum_probs=28.1

Q ss_pred             HhCCceeccCCCCCEEeccCCCEEEEeccCCCC
Q 014609          131 HNKGVFHRDLKLENILLDSKGNIKISDFGLSAL  163 (421)
Q Consensus       131 H~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~  163 (421)
                      +...++|+|++|.|||++.++ +.|+||+.+..
T Consensus       230 ~~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~  261 (420)
T 2pyw_A          230 RAQALIHGDLHTGSVMVTQDS-TQVIDPEFSFY  261 (420)
T ss_dssp             BCCEEECSCCSGGGEEECSSC-EEECCCTTCEE
T ss_pred             CCCeEEecCCCCCcEEEeCCC-CEEEeCccccc
Confidence            456899999999999998776 99999998874

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=97.76  E-value=8e-05  Score=70.37  Aligned_cols=132  Identities=17%  Similarity=0.090  Sum_probs=75.9

Q ss_pred             eceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCc-ceEEEEEEeCCEEEEEEecc-
Q 014609           19 GRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNV-VRLHEVLASKSKIYMVLEYV-   96 (421)
Q Consensus        19 ~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnI-v~l~~~~~~~~~~~lv~E~~-   96 (421)
                      ++.|+.|....+|++      ..+++|+.......    .....+|..+++.+...++ .+++.+.  ...-++++||+ 
T Consensus        23 i~~l~gG~tN~~~~~------~~~vlR~~~~~~~~----~~~r~~E~~~l~~l~~~g~~P~~~~~~--~~~~~~v~e~i~   90 (301)
T 3dxq_A           23 PLERLGGLTNLVFRA------GDLCLRIPGKGTEE----YINRANEAVAAREAAKAGVSPEVLHVD--PATGVMVTRYIA   90 (301)
T ss_dssp             CEEEESCSSEEEEEE------TTEEEEEECC--------CCCHHHHHHHHHHHHHTTSSCCEEEEC--TTTCCEEEECCT
T ss_pred             eeEcCCcccccccee------eeEEEECCCCCccc----eeCHHHHHHHHHHHHHcCCCCceEEEE--CCCCEEEEeecC
Confidence            788999999999998      56899987643111    1123568888877753233 4555543  33347899999 


Q ss_pred             CCCChHH------------------HHHhcC-CC----C-HHHHHHHHHH--------------HHHHHHHH----Hh--
Q 014609           97 TGGELFD------------------KIASKG-RL----Q-EAEGRKLFQQ--------------LIDGVSYC----HN--  132 (421)
Q Consensus        97 ~gg~L~~------------------~i~~~~-~~----~-~~~~~~~~~q--------------l~~aL~~L----H~--  132 (421)
                      +|.++..                  .++... .+    . ......+..+              +...+..+    ..  
T Consensus        91 ~g~~l~~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~l~~~~  170 (301)
T 3dxq_A           91 GAQTMSPEKFKTRPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGVRSALAAHP  170 (301)
T ss_dssp             TCEECCHHHHHHSTTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHHHHHHHSSC
T ss_pred             CCccCCHhhHhhhHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHHHHHHhcC
Confidence            6654421                  011111 01    1 1111112111              11111111    11  


Q ss_pred             --CCceeccCCCCCEEeccCCCEEEEeccCCCC
Q 014609          133 --KGVFHRDLKLENILLDSKGNIKISDFGLSAL  163 (421)
Q Consensus       133 --~gi~HrDlkp~NILl~~~~~~kL~DFGla~~  163 (421)
                        ..++|+|+.|.||+ ..++.+.|+||..+..
T Consensus       171 ~~~~l~HgDl~~~Nil-~~~~~~~lID~e~a~~  202 (301)
T 3dxq_A          171 LPLAACHCDPLCENFL-DTGERMWIVDWEYSGM  202 (301)
T ss_dssp             CCCEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred             CCceeeccCCCcCCEE-ECCCCEEEEecccccC
Confidence              24899999999999 6677899999998863

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=97.70  E-value=0.00024  Score=63.55  Aligned_cols=119  Identities=18%  Similarity=0.144  Sum_probs=78.3

Q ss_pred             ChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHH-HhCCceeccCCCCCEEeccCCCEEEEeccCCCCCccccCCCcccccc
Q 014609          100 ELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYC-HNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTC  177 (421)
Q Consensus       100 ~L~~~i~~-~~~~~~~~~~~~~~ql~~aL~~L-H~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~  177 (421)
                      +|.+.+.. +.+++++++|.++.|.+.+|.-+ +...-..+=+.|..|++..+|++...+ +.+.              .
T Consensus        34 SL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~dG~V~f~~-~~s~--------------~   98 (229)
T 2yle_A           34 SLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRDGAVTLAP-AADD--------------A   98 (229)
T ss_dssp             EHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEETTSCEEECC-C------------------
T ss_pred             cHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEecCCceeccc-cccc--------------c
Confidence            68888764 57899999999999999998776 212212334567999999999988763 2111              1


Q ss_pred             CCCCccChhhhcccCCCCCcchHHHHHHHHhhhc-CC--cCCCCCCCHHHHHHHHHhcCCC
Q 014609          178 GSPNYVAPEVLANRGYDGATSDIWSCGVILYIFR-GD--FKLPKWLSPGAQNLLRKILEPN  235 (421)
Q Consensus       178 gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~~-~~--~~~p~~~s~~~~~li~~~L~~d  235 (421)
                      ....+.|||...  ...+.+.=|||||+++|.-. -+  ..-+..+|+.+.+||..|..-.
T Consensus        99 ~~~~~~~pe~~~--~~~te~~~IysLG~tLY~ALDygL~e~eE~eLS~~LE~LL~~Mt~~~  157 (229)
T 2yle_A           99 GEPPPVAGKLGY--SQCMETEVIESLGIIIYKALDYGLKENEERELSPPLEQLIDHMANTV  157 (229)
T ss_dssp             --------CCSS--SSSCHHHHHHHHHHHHHHHHTTTCCTTEEECCCHHHHHHHHHHTTCC
T ss_pred             cccCCCChhhcc--ccchHHHHHHHHHHHHHHHhhcCCCcccchhhCHHHHHHHHHHHhcc
Confidence            233567888753  22347789999999999432 11  1234559999999999998663

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=97.58  E-value=0.00013  Score=69.96  Aligned_cols=136  Identities=11%  Similarity=0.144  Sum_probs=72.2

Q ss_pred             eceEeecCcEE-EEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCC--CCcceEEEEEEeCCEEEEEEec
Q 014609           19 GRTLGEGNFGK-VKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKH--PNVVRLHEVLASKSKIYMVLEY   95 (421)
Q Consensus        19 ~~~LG~G~~g~-V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~h--pnIv~l~~~~~~~~~~~lv~E~   95 (421)
                      .+.|+.|+... +|+.. ..+|..+++|......      .+.+..|+.+++.+..  -.+.+++.+....+  +++||+
T Consensus        23 ~~~l~gg~s~~~~~r~~-~~~~~~~vlk~~~~~~------~~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~g--~ll~e~   93 (333)
T 3csv_A           23 RTPLAGDASSRRYQRLR-SPTGAKAVLMDWSPEE------GGDTQPFVDLAQYLRNLDISAPEIYAEEHARG--LLLIED   93 (333)
T ss_dssp             ECC--------CCEEEE-CTTCCEEEEEECCTTT------TCCSHHHHHHHHHHHHTTCBCCCEEEEETTTT--EEEECC
T ss_pred             eeECCCCCCCceEEEEE-cCCCCeEEEEECCCCC------CccccHHHHHHHHHHhCCCCCCceeeecCCCC--EEEEee
Confidence            35566665554 55664 2336778888654321      0234557777776642  23556666543333  789999


Q ss_pred             cCCCChHHHHHhc--------------------------CCCCHHHHH-------HHH-------------HHHHHHHHH
Q 014609           96 VTGGELFDKIASK--------------------------GRLQEAEGR-------KLF-------------QQLIDGVSY  129 (421)
Q Consensus        96 ~~gg~L~~~i~~~--------------------------~~~~~~~~~-------~~~-------------~ql~~aL~~  129 (421)
                      +.+..+.+.+...                          ..++.....       .++             ..+...++.
T Consensus        94 l~~~~l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~  173 (333)
T 3csv_A           94 LGDALFTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQ  173 (333)
T ss_dssp             CCSCBHHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHH
T ss_pred             CCCcchHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHH
Confidence            9776665433211                          012221111       000             011122223


Q ss_pred             H------HhCCceeccCCCCCEEeccC----CCEEEEeccCCCC
Q 014609          130 C------HNKGVFHRDLKLENILLDSK----GNIKISDFGLSAL  163 (421)
Q Consensus       130 L------H~~gi~HrDlkp~NILl~~~----~~~kL~DFGla~~  163 (421)
                      +      +...++|||+.|.|||++.+    +.+.|+||+.+..
T Consensus       174 l~~~~~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~  217 (333)
T 3csv_A          174 ILSAQLEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL  217 (333)
T ss_dssp             HHHHHCCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred             HHHhcccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence            3      23479999999999999874    6799999998874

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=97.54  E-value=0.00012  Score=69.60  Aligned_cols=139  Identities=14%  Similarity=0.191  Sum_probs=78.7

Q ss_pred             EEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCC-----CCCcceEE-E--EEEeCCE
Q 014609           17 ELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK-----HPNVVRLH-E--VLASKSK   88 (421)
Q Consensus        17 ~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~-----hpnIv~l~-~--~~~~~~~   88 (421)
                      .-.+.|+.|....+|+... .+| .+++|+.....  .   .+.+..|..+++.|.     -|.++... +  +....+.
T Consensus        25 ~~~~~i~~G~~n~~~~v~~-~~g-~~vlk~~~~~~--~---~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~   97 (322)
T 2ppq_A           25 TSYKGIAEGVENSNFLLHT-TKD-PLILTLYEKRV--E---KNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGR   97 (322)
T ss_dssp             EEEEEECC---EEEEEEEE-SSC-CEEEEEECC--------CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTE
T ss_pred             eEeeccCCCcccceEEEEe-CCc-cEEEEEeCCCC--C---HHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCE
Confidence            3456788888899999875 334 68899886521  1   234566777777664     23333210 0  1223467


Q ss_pred             EEEEEeccCCCChH--------------HHHHhc-CC--------CCHHHHHHHH---------------HHHHHHHHHH
Q 014609           89 IYMVLEYVTGGELF--------------DKIASK-GR--------LQEAEGRKLF---------------QQLIDGVSYC  130 (421)
Q Consensus        89 ~~lv~E~~~gg~L~--------------~~i~~~-~~--------~~~~~~~~~~---------------~ql~~aL~~L  130 (421)
                      .+++++|++|..+.              ..++.. ..        .........+               ..+...++++
T Consensus        98 ~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l  177 (322)
T 2ppq_A           98 PAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYL  177 (322)
T ss_dssp             EEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHH
T ss_pred             EEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHH
Confidence            89999999986431              112211 01        1111111110               1133445555


Q ss_pred             Hh-------CCceeccCCCCCEEeccCCCEEEEeccCCC
Q 014609          131 HN-------KGVFHRDLKLENILLDSKGNIKISDFGLSA  162 (421)
Q Consensus       131 H~-------~gi~HrDlkp~NILl~~~~~~kL~DFGla~  162 (421)
                      ++       .+++|+|++|.|||++.++.+.|+||+.+.
T Consensus       178 ~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~  216 (322)
T 2ppq_A          178 AAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC  216 (322)
T ss_dssp             HHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             HhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence            42       369999999999999877656899999875

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=97.51  E-value=0.0003  Score=67.00  Aligned_cols=135  Identities=23%  Similarity=0.188  Sum_probs=78.6

Q ss_pred             ceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCC--cceEEEE-----EEeCCEEEEE
Q 014609           20 RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN--VVRLHEV-----LASKSKIYMV   92 (421)
Q Consensus        20 ~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpn--Iv~l~~~-----~~~~~~~~lv   92 (421)
                      ..|+ |....||++.. .+|+.+++|+.+.... .   .+.+..|..+++.|...+  +++++..     ....+..+++
T Consensus        32 ~~l~-g~~n~~y~v~~-~~g~~~vlK~~~~~~~-~---~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l  105 (328)
T 1zyl_A           32 TPLN-SYENRVYQFQD-EDRRRFVVKFYRPERW-T---ADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAV  105 (328)
T ss_dssp             EEEC-CSSSEEEEECC-TTCCCEEEEEECTTTS-C---HHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEE
T ss_pred             Eeec-CcccceEEEEc-CCCCEEEEEEcCCCCC-C---HHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEE
Confidence            3466 88889998753 4577899999863321 1   346677888887764212  3333332     2335677899


Q ss_pred             EeccCCCChH-----------HH---HHh---cC------CCCHHHH----H------------------HHHHHHHHHH
Q 014609           93 LEYVTGGELF-----------DK---IAS---KG------RLQEAEG----R------------------KLFQQLIDGV  127 (421)
Q Consensus        93 ~E~~~gg~L~-----------~~---i~~---~~------~~~~~~~----~------------------~~~~ql~~aL  127 (421)
                      |++++|..+.           ..   ++.   ..      ..+....    .                  ..+.+++..+
T Consensus       106 ~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l  185 (328)
T 1zyl_A          106 FPSVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAV  185 (328)
T ss_dssp             EECCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHH
T ss_pred             EEecCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHH
Confidence            9999885431           01   111   00      1111111    1                  1112222222


Q ss_pred             HHH----HhCCceeccCCCCCEEeccCCCEEEEeccCCC
Q 014609          128 SYC----HNKGVFHRDLKLENILLDSKGNIKISDFGLSA  162 (421)
Q Consensus       128 ~~L----H~~gi~HrDlkp~NILl~~~~~~kL~DFGla~  162 (421)
                      +-+    +...++|+|++|.|||++ + .+.|+||+.+.
T Consensus       186 ~~~~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~  222 (328)
T 1zyl_A          186 TAHWREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDAR  222 (328)
T ss_dssp             HHHCCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCC
T ss_pred             HHHhhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCC
Confidence            222    234689999999999998 4 89999999876

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=97.47  E-value=0.00016  Score=72.16  Aligned_cols=73  Identities=10%  Similarity=0.115  Sum_probs=49.8

Q ss_pred             eceEeecCcEEEEEEEECC-------CCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCc-ceEEEEEEeCCEEE
Q 014609           19 GRTLGEGNFGKVKFAQDLD-------SGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNV-VRLHEVLASKSKIY   90 (421)
Q Consensus        19 ~~~LG~G~~g~V~~a~~~~-------~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnI-v~l~~~~~~~~~~~   90 (421)
                      ++.|+.|....||++....       .++.+++|+.....  .   .+.+.+|..+++.|...++ .++++.+.  +  .
T Consensus        78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~--~---~~~li~E~~~l~~L~~~g~~P~l~~~~~--~--g  148 (429)
T 1nw1_A           78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE--T---ESHLVAESVIFTLLSERHLGPKLYGIFS--G--G  148 (429)
T ss_dssp             EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC--C---HHHHHHHHHHHHHHHHTTSSSCEEEEET--T--E
T ss_pred             EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCC--c---HHHHHHHHHHHHHHHhCCCCCcEEEEeC--C--C
Confidence            4678889999999998643       25789999874321  1   1445579999988853333 56776554  2  3


Q ss_pred             EEEeccCCCC
Q 014609           91 MVLEYVTGGE  100 (421)
Q Consensus        91 lv~E~~~gg~  100 (421)
                      +|+||++|..
T Consensus       149 ~v~e~l~G~~  158 (429)
T 1nw1_A          149 RLEEYIPSRP  158 (429)
T ss_dssp             EEECCCCEEE
T ss_pred             EEEEEeCCcc
Confidence            8999998743

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=97.41  E-value=0.00025  Score=69.48  Aligned_cols=135  Identities=16%  Similarity=0.148  Sum_probs=82.6

Q ss_pred             ceEeecCcEEEEEEEECC-------CCceEEEEEeecccccchhHHHHHHHHHHHHhcCC-CCCcceEEEEEEeCCEEEE
Q 014609           20 RTLGEGNFGKVKFAQDLD-------SGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK-HPNVVRLHEVLASKSKIYM   91 (421)
Q Consensus        20 ~~LG~G~~g~V~~a~~~~-------~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~l   91 (421)
                      +.|..|-...+|++....       +++.+++|+.... .   .....+.+|..+++.|. +.-..++++++.+    .+
T Consensus        56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~-~---~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~  127 (379)
T 3feg_A           56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI-L---QGVDSLVLESVMFAILAERSLGPQLYGVFPE----GR  127 (379)
T ss_dssp             EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC-------CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EE
T ss_pred             EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc-c---chHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----cc
Confidence            567668888899987532       3578999985321 1   12456778999998885 3333566666543    28


Q ss_pred             EEeccCCCChHH--------------H---HHhc-----CCCC--HHHHHHHHHHHHH-------------------HHH
Q 014609           92 VLEYVTGGELFD--------------K---IASK-----GRLQ--EAEGRKLFQQLID-------------------GVS  128 (421)
Q Consensus        92 v~E~~~gg~L~~--------------~---i~~~-----~~~~--~~~~~~~~~ql~~-------------------aL~  128 (421)
                      ||||++|..|..              .   ++..     +...  ..++.+|..|+..                   .++
T Consensus       128 v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~  207 (379)
T 3feg_A          128 LEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMG  207 (379)
T ss_dssp             EEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHH
T ss_pred             EEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHH
Confidence            999999855421              1   1111     1111  3556666655532                   233


Q ss_pred             HHH----h----CCceeccCCCCCEEeccC----CCEEEEeccCCC
Q 014609          129 YCH----N----KGVFHRDLKLENILLDSK----GNIKISDFGLSA  162 (421)
Q Consensus       129 ~LH----~----~gi~HrDlkp~NILl~~~----~~~kL~DFGla~  162 (421)
                      .|.    .    ..++|+|+.+.|||++.+    +.+.|+||..+.
T Consensus       208 ~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~  253 (379)
T 3feg_A          208 NLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS  253 (379)
T ss_dssp             HHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred             HHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence            332    2    259999999999999876    789999999886

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=97.32  E-value=0.0043  Score=57.90  Aligned_cols=79  Identities=15%  Similarity=0.110  Sum_probs=55.5

Q ss_pred             ceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCC---CCcceEEEEEEeCCEEEE
Q 014609           15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKH---PNVVRLHEVLASKSKIYM   91 (421)
Q Consensus        15 ~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~h---pnIv~l~~~~~~~~~~~l   91 (421)
                      +..-++.+|.|..+.||+... .+|+.|.+|+-.......   ...+.+|...|+.|.-   --+.+++.+  +.  -++
T Consensus        16 ~v~~v~~~g~G~~~~vyrv~l-~DG~~~~vK~~~~~~~~~---~~~~~~Ea~~L~~L~~~~~vpvP~v~~~--~~--~~l   87 (288)
T 3f7w_A           16 EVAAVAERGHSHRWHLYRVEL-ADGTPLFVKALPDDAPAL---DGLFRAEALGLDWLGRSFGSPVPQVAGW--DD--RTL   87 (288)
T ss_dssp             CEEEEEEEEEETTEEEEEEEE-TTSCEEEEEECCTTCCCC---TTHHHHHHHHHHHHTCSTTCCSCCEEEE--ET--TEE
T ss_pred             CeEEEEecCCCCCeEEEEEEE-CCCCEEEEEEeCCCCcch---hhHHHHHHHHHHHHHhhCCCCcceEEec--cC--ceE
Confidence            445678899999999999974 678999999865433211   2457889999988842   234555554  22  378


Q ss_pred             EEeccCCCCh
Q 014609           92 VLEYVTGGEL  101 (421)
Q Consensus        92 v~E~~~gg~L  101 (421)
                      ||||+.++..
T Consensus        88 v~e~l~~~~~   97 (288)
T 3f7w_A           88 AMEWVDERPP   97 (288)
T ss_dssp             EEECCCCCCC
T ss_pred             EEEeecccCC
Confidence            9999987643

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=97.25  E-value=0.00036  Score=67.84  Aligned_cols=74  Identities=11%  Similarity=0.034  Sum_probs=44.5

Q ss_pred             eceEeecCcEEEEEEEECC--------CCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCC-cceEEEEEEeCCEE
Q 014609           19 GRTLGEGNFGKVKFAQDLD--------SGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN-VVRLHEVLASKSKI   89 (421)
Q Consensus        19 ~~~LG~G~~g~V~~a~~~~--------~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpn-Iv~l~~~~~~~~~~   89 (421)
                      .+.|+.|....+|++....        .+..+++|+......   . ......|..+++.+...+ +.++++..  .+  
T Consensus        38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~---~-~~~~~~E~~~l~~L~~~g~~P~~~~~~--~~--  109 (369)
T 3c5i_A           38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVD---E-LYNTISEFEVYKTMSKYKIAPQLLNTF--NG--  109 (369)
T ss_dssp             EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGG---G-TSCHHHHHHHHHHHHHTTSSCCEEEEE--TT--
T ss_pred             EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCcc---c-eecHHHHHHHHHHHHhcCCCCceEEec--CC--
Confidence            4567888888999987543        136889998754211   1 112467888888775333 44666544  22  


Q ss_pred             EEEEeccCCCC
Q 014609           90 YMVLEYVTGGE  100 (421)
Q Consensus        90 ~lv~E~~~gg~  100 (421)
                      ++||||++|..
T Consensus       110 ~~v~e~i~G~~  120 (369)
T 3c5i_A          110 GRIEEWLYGDP  120 (369)
T ss_dssp             EEEEECCCSEE
T ss_pred             cEEEEEecCCc
Confidence            68999998854

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=97.18  E-value=0.0014  Score=63.03  Aligned_cols=31  Identities=26%  Similarity=0.387  Sum_probs=27.7

Q ss_pred             CCceeccCCCCCEEeccCCCEEEEeccCCCC
Q 014609          133 KGVFHRDLKLENILLDSKGNIKISDFGLSAL  163 (421)
Q Consensus       133 ~gi~HrDlkp~NILl~~~~~~kL~DFGla~~  163 (421)
                      ..++|+|+.|.||+++.++.+.|+||+.+..
T Consensus       206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~  236 (339)
T 3i1a_A          206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPML  236 (339)
T ss_dssp             CEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred             ceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence            3699999999999999888999999988764

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=96.99  E-value=0.006  Score=61.18  Aligned_cols=75  Identities=12%  Similarity=0.157  Sum_probs=48.7

Q ss_pred             eceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCc-ceEEEEEEeCCEEEEEEeccC
Q 014609           19 GRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNV-VRLHEVLASKSKIYMVLEYVT   97 (421)
Q Consensus        19 ~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnI-v~l~~~~~~~~~~~lv~E~~~   97 (421)
                      ++.|+.|-...+|++.....+..+++|+..... ..   .-...+|..+++.|...++ .++++++.  +.  .||||++
T Consensus       113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~-~~---~idR~~E~~vl~~L~~~gl~P~ll~~~~--~G--~v~e~I~  184 (458)
T 2qg7_A          113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKT-DE---IINREREKKISCILYNKNIAKKIYVFFT--NG--RIEEFMD  184 (458)
T ss_dssp             EEEECC--CEEEEEEEETTTTEEEEEEEECC-C-CS---CSCHHHHHHHHHHHTTSSSBCCEEEEET--TE--EEEECCC
T ss_pred             EEEcCCCeEeEEEEEEECCCCceEEEEECCCCh-hh---hcCHHHHHHHHHHHHhcCCCCCEEEEeC--Ce--EEEEeeC
Confidence            467888999999999865445789999874321 11   1112579999998875444 56777663  32  5999998


Q ss_pred             CCCh
Q 014609           98 GGEL  101 (421)
Q Consensus        98 gg~L  101 (421)
                      |..|
T Consensus       185 G~~l  188 (458)
T 2qg7_A          185 GYAL  188 (458)
T ss_dssp             SEEC
T ss_pred             CccC
Confidence            7443

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=96.16  E-value=0.0068  Score=60.09  Aligned_cols=136  Identities=15%  Similarity=0.150  Sum_probs=82.5

Q ss_pred             eceEeecCcEEEEEEEECCC-------CceEEEEEeecccccchhHHHHHHHHHHHHhcCC-CCCcceEEEEEEeCCEEE
Q 014609           19 GRTLGEGNFGKVKFAQDLDS-------GLPFAVKILEKNRIIHLKITDQIKREIATLKLLK-HPNVVRLHEVLASKSKIY   90 (421)
Q Consensus        19 ~~~LG~G~~g~V~~a~~~~~-------~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~   90 (421)
                      ++.|..|-...+|+......       ++.+++|+.....   .. .-...+|..+++.+. +.-..++++.+  .+  +
T Consensus        75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t---~~-~idR~~E~~~l~~L~~~gi~P~l~~~~--~~--~  146 (424)
T 3mes_A           75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHV---GK-FYDSKVELDVFRYLSNINIAPNIIADF--PE--G  146 (424)
T ss_dssp             EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC----C-CCCHHHHHHHHHHHHHTTSSCCEEEEE--TT--E
T ss_pred             EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCc---ch-hcCHHHHHHHHHHHHhcCCCCCEEEEc--CC--C
Confidence            45677788889999876421       6789999864321   11 123467888888875 33345566533  22  6


Q ss_pred             EEEeccCCCChH----------HH-------HH---h-c-------C--CCCHHHHHHHHHHHH----------------
Q 014609           91 MVLEYVTGGELF----------DK-------IA---S-K-------G--RLQEAEGRKLFQQLI----------------  124 (421)
Q Consensus        91 lv~E~~~gg~L~----------~~-------i~---~-~-------~--~~~~~~~~~~~~ql~----------------  124 (421)
                      .||||++|..|.          ..       ++   . .       .  +.-...+.+|..++-                
T Consensus       147 ~I~efI~G~~l~~~~l~~~~~~~~ia~~La~LH~~~~~~~~L~~~~~~~p~~~~~i~~w~~~~~~~~~~~~~~~~~~~~~  226 (424)
T 3mes_A          147 RIEEFIDGEPLTTKQLQLTHICVEVAKNMGSLHIINSKRADFPSRFDKEPILFKRIYLWREEAKIQVSKNNFQIDKELYS  226 (424)
T ss_dssp             EEEECCCSEECCTGGGGSHHHHHHHHHHHHHHHTHHHHCTTSCTTSCCSCCHHHHHHHHHHHHHHHHHTCC--CCHHHHH
T ss_pred             EEEEEeCCccCChhhcCCHHHHHHHHHHHHHHhcCchhhccCccccCCCCcHHHHHHHHHHHHHHhhcccchhhccccHH
Confidence            899999986531          11       11   1 0       0  111344444443322                


Q ss_pred             ---HHHHHHH--------------------h----CCceeccCCCCCEEeccCCCEEEEeccCCCC
Q 014609          125 ---DGVSYCH--------------------N----KGVFHRDLKLENILLDSKGNIKISDFGLSAL  163 (421)
Q Consensus       125 ---~aL~~LH--------------------~----~gi~HrDlkp~NILl~~~~~~kL~DFGla~~  163 (421)
                         ..+++|.                    .    ..++|+|+.+.||+ +.++.+.|+||..|..
T Consensus       227 ~l~~e~~~L~~~l~~~~~~~~~r~~~~~~~~~~~~~~~~H~D~~~~N~l-~~~~~~~~IDwe~a~~  291 (424)
T 3mes_A          227 KILEEIDQLEELIMGGEKFSMERALELKLYSPAFSLVFAHNDLQENNLL-QTQNNIRMIDYEYSAI  291 (424)
T ss_dssp             HHHHHHHHHHHHHHTSSCCCHHHHHHHHTTCGGGCEEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred             HHHHHHHHHHHHHhhhcccccccccccccccCCCCceEECCCCCcccee-cCCCcEEEEecccCCc
Confidence               1223322                    1    25899999999999 7888999999998873

>3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A*

Probab=93.60  E-value=0.17  Score=49.40  Aligned_cols=30  Identities=33%  Similarity=0.440  Sum_probs=25.4

Q ss_pred             CceeccCCCCCEEe------ccCCCEEEEeccCCCC
Q 014609          134 GVFHRDLKLENILL------DSKGNIKISDFGLSAL  163 (421)
Q Consensus       134 gi~HrDlkp~NILl------~~~~~~kL~DFGla~~  163 (421)
                      .++|+|+.+.|||+      ++++.+.++||.+|..
T Consensus       245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~  280 (401)
T 3g15_A          245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY  280 (401)
T ss_dssp             EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred             eeEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence            36899999999999      3456799999999873

>4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid}

Probab=86.96  E-value=2.5  Score=37.52  Aligned_cols=83  Identities=12%  Similarity=0.107  Sum_probs=63.2

Q ss_pred             CCCCcceEEEEEEeCCEEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHH-HHHhCCceeccCCCCCEEeccC
Q 014609           72 KHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVS-YCHNKGVFHRDLKLENILLDSK  150 (421)
Q Consensus        72 ~hpnIv~l~~~~~~~~~~~lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~ql~~aL~-~LH~~gi~HrDlkp~NILl~~~  150 (421)
                      .||+.  -..+-++++.+.+.++.-+++.-+..+.   .++....++++.+|+.... ++  ..-+|--|+|+||+++.+
T Consensus        48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i~---~~~~~eKlrll~nl~~L~~~~~--~~r~tf~l~P~NL~f~~~  120 (219)
T 4ano_A           48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAIR---KTTLLSRIRAAIHLVSKVKHHS--ARRLIFIVCPENLMFNRA  120 (219)
T ss_dssp             SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHHH---TSCHHHHHHHHHHHHHHHSSCC--SSSEECCCCGGGEEECTT
T ss_pred             cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHHH---hcCHHHHHHHHHHHHHHHHHhh--hCceeEEEeCceEEEeCC
Confidence            57888  5556688888888888776665566664   3788899999888887666 44  445666799999999999


Q ss_pred             CCEEEEeccCC
Q 014609          151 GNIKISDFGLS  161 (421)
Q Consensus       151 ~~~kL~DFGla  161 (421)
                      +.+++.=.|+-
T Consensus       121 ~~p~i~hRGi~  131 (219)
T 4ano_A          121 LEPFFLHVGVK  131 (219)
T ss_dssp             CCEEESCCEET
T ss_pred             CcEEEEEcCCc
Confidence            99999877754

>4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp}

Probab=84.06  E-value=2.1  Score=37.89  Aligned_cols=84  Identities=12%  Similarity=0.171  Sum_probs=62.8

Q ss_pred             CCCCcceEEEEEEeCCEEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCC
Q 014609           72 KHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKG  151 (421)
Q Consensus        72 ~hpnIv~l~~~~~~~~~~~lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~  151 (421)
                      .||+.+.. .+-++.+.+.+.++.-+.+.=+..+.   ..+....++++.+|+....++  ..-+|--|+|+||+++.++
T Consensus        43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~ik---~~~~~eKlr~l~ni~~l~~~~--~~r~tf~L~P~NL~f~~~~  116 (215)
T 4ann_A           43 HSPYFIDA-ELTELRDSFQIHYDINDNHTPFDNIK---SFTKNEKLRYLLNIKNLEEVN--RTRYTFVLAPDELFFTRDG  116 (215)
T ss_dssp             CCTTBCCE-EEEECSSEEEEEECCCTTSEEGGGGG---GSCHHHHHHHHHHGGGGGGGG--GSSEECCCSGGGEEECTTS
T ss_pred             cCCcccce-EEEEcccEEEEEEEcCcccCCHHHHH---hcCHHHHHHHHHHHHHHHHHh--cCceEEEEecceEEEcCCC
Confidence            58888877 67777888777777665443344443   378889999999998877444  4456777999999999999


Q ss_pred             CEEEEeccCC
Q 014609          152 NIKISDFGLS  161 (421)
Q Consensus       152 ~~kL~DFGla  161 (421)
                      .+++.=-|+-
T Consensus       117 ~p~i~~RGik  126 (215)
T 4ann_A          117 LPIAKTRGLQ  126 (215)
T ss_dssp             CEEESCCEET
T ss_pred             CEEEEEccCc
Confidence            9999866654

>3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A

Probab=83.18  E-value=0.082  Score=52.93  Aligned_cols=65  Identities=9%  Similarity=0.149  Sum_probs=18.9

Q ss_pred             EEeceEeecCcEEEEEEEECCCCceEEE------EEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEe
Q 014609           17 ELGRTLGEGNFGKVKFAQDLDSGLPFAV------KILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLAS   85 (421)
Q Consensus        17 ~i~~~LG~G~~g~V~~a~~~~~~~~vAv------K~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~   85 (421)
                      .+.+.||   ||.||.|.......+||+      |....... .......+.+|..+++.++|||+++.+.+...
T Consensus       145 ~l~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~-~~e~~~~~~rea~l~~~~~H~niv~~h~f~~~  215 (463)
T 3cxl_A          145 PIYEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGV-SEKRLTSLVRRATLKENEQIPKYEKIHNFKVH  215 (463)
T ss_dssp             CSTTTSS---BCCC---------CCBGGGC------------------------------------CBCCCEEEE
T ss_pred             cccccCC---chhhhcccccccCCchhhhhccCccccccccc-cccccccccccccccccccccccCCCcceEEe
Confidence            3456676   999999987655568888      65543222 22223467889999999999999999887643

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	421
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	9e-79
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	1e-78
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	8e-74
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	3e-72
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	8e-72
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	4e-70
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	6e-70
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	4e-69
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	5e-69
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	2e-68
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	5e-68
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	2e-66
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	6e-66
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	6e-66
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	8e-66
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	1e-64
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	1e-64
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	9e-64
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	3e-63
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	6e-04
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	2e-60
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	2e-60
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	3e-60
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	6e-60
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	7e-59
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	2e-56
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	8e-56
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	1e-55
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	3e-55
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	3e-54
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	5e-54
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	8e-54
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	1e-53
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	3e-53
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	3e-53
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	4e-53
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	6e-53
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	1e-52
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	1e-52
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	2e-52
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	2e-52
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	2e-52
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	3e-52
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	8e-52
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	1e-51
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	3e-51
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	2e-50
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	7e-50
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	2e-49
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	3e-49
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	4e-49
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	7e-49
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	7e-49
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	5e-47
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	3e-46
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	1e-45
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	2e-45
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	4e-45
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	7e-44
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	5e-43
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	2e-41
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	7e-39
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	4e-31
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	8e-06
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	4e-23
d1ul7a_	102	d.129.6.1 (A:) Map/microtubule affinity-regulating	1e-15

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  242 bits (619), Expect = 9e-79
 Identities = 80/262 (30%), Positives = 137/262 (52%), Gaps = 25/262 (9%)

Query: 13  LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK 72
           L  +E+GR LG+G FG V  A++  S    A+K+L K ++    +  Q++RE+     L+
Sbjct: 5   LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR 64

Query: 73  HPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHN 132
           HPN++RL+      +++Y++LEY   G ++ ++    +  E        +L + +SYCH+
Sbjct: 65  HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHS 124

Query: 133 KGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRG 192
           K V HRD+K EN+LL S G +KI+DFG S             T CG+ +Y+ PE++  R 
Sbjct: 125 KRVIHRDIKPENLLLGSAGELKIADFGWSV----HAPSSRRTTLCGTLDYLPPEMIEGRM 180

Query: 193 YDGATSDIWSCGVILY--------------------IFRGDFKLPKWLSPGAQNLLRKIL 232
           +D    D+WS GV+ Y                    I R +F  P +++ GA++L+ ++L
Sbjct: 181 HDEK-VDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLL 239

Query: 233 EPNPVKRITIAGIKADEWFEQD 254
           + NP +R  +  +    W   +
Sbjct: 240 KHNPSQRPMLREVLEHPWITAN 261

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  242 bits (619), Expect = 1e-78
 Identities = 95/266 (35%), Positives = 141/266 (53%), Gaps = 25/266 (9%)

Query: 13  LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK 72
           +  ++L +TLGEG +G+V+ A +  +    AVKI++  R +     + IK+EI   K+L 
Sbjct: 4   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKMLN 61

Query: 73  HPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHN 132
           H NVV+ +      +  Y+ LEY +GGELFD+I     + E + ++ F QL+ GV Y H 
Sbjct: 62  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 121

Query: 133 KGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRG 192
            G+ HRD+K EN+LLD + N+KISDFGL+ + ++   + LL+  CG+  YVAPE+L  R 
Sbjct: 122 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 181

Query: 193 YDGATSDIWSCGVILY---------------------IFRGDFKLPKW--LSPGAQNLLR 229
           +     D+WSCG++L                             L  W  +      LL 
Sbjct: 182 FHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLH 241

Query: 230 KILEPNPVKRITIAGIKADEWFEQDY 255
           KIL  NP  RITI  IK D W+ +  
Sbjct: 242 KILVENPSARITIPDIKKDRWYNKPL 267

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  230 bits (588), Expect = 8e-74
 Identities = 76/263 (28%), Positives = 124/263 (47%), Gaps = 21/263 (7%)

Query: 11  MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKL 70
            R   ++ G+ LGEG+F  V  A++L +   +A+KILEK  II       + RE   +  
Sbjct: 5   KRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSR 64

Query: 71  LKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYC 130
           L HP  V+L+       K+Y  L Y   GEL   I   G   E   R    +++  + Y 
Sbjct: 65  LDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYL 124

Query: 131 HNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLAN 190
           H KG+ HRDLK ENILL+   +I+I+DFG + +          ++  G+  YV+PE+L  
Sbjct: 125 HGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTE 184

Query: 191 RGYDGATSDIWSCGVILY--------------------IFRGDFKLPKWLSPGAQNLLRK 230
           +    + SD+W+ G I+Y                    I + ++  P+   P A++L+ K
Sbjct: 185 KSACKS-SDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEK 243

Query: 231 ILEPNPVKRITIAGIKADEWFEQ 253
           +L  +  KR+    ++     + 
Sbjct: 244 LLVLDATKRLGCEEMEGYGPLKA 266

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  228 bits (583), Expect = 3e-72
 Identities = 71/275 (25%), Positives = 134/275 (48%), Gaps = 34/275 (12%)

Query: 8   QEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIAT 67
           ++G     Y++   LG G FG V    +  +G  F  K +     +       +K EI+ 
Sbjct: 23  KQGSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKY---TVKNEISI 79

Query: 68  LKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKG-RLQEAEGRKLFQQLIDG 126
           +  L HP ++ LH+    K ++ ++LE+++GGELFD+IA++  ++ EAE     +Q  +G
Sbjct: 80  MNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEG 139

Query: 127 VSYCHNKGVFHRDLKLENILLDSK--GNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVA 184
           + + H   + H D+K ENI+ ++K   ++KI DFGL+        D ++  T  +  + A
Sbjct: 140 LKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLA---TKLNPDEIVKVTTATAEFAA 196

Query: 185 PEVLANRGYDGATSDIWSCGVILY--------------------IFRGDFKLPK----WL 220
           PE++         +D+W+ GV+ Y                    + R D++  +     +
Sbjct: 197 PEIVDREPVG-FYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSV 255

Query: 221 SPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY 255
           SP A++ ++ +L+  P KR+T+       W + D+
Sbjct: 256 SPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDH 290

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  227 bits (580), Expect = 8e-72
 Identities = 74/280 (26%), Positives = 128/280 (45%), Gaps = 34/280 (12%)

Query: 8   QEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIAT 67
           +    L  Y++   LG G FG V    +  +G  FA K +      H    + +++EI T
Sbjct: 20  KHDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTP---HESDKETVRKEIQT 76

Query: 68  LKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDG 126
           + +L+HP +V LH+     +++ M+ E+++GGELF+K+A +  ++ E E  +  +Q+  G
Sbjct: 77  MSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKG 136

Query: 127 VSYCHNKGVFHRDLKLENILLDSK--GNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVA 184
           + + H     H DLK ENI+  +K    +K+ DFGL+A   H      +  T G+  + A
Sbjct: 137 LCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTA---HLDPKQSVKVTTGTAEFAA 193

Query: 185 PEVLANRGYDGATSDIWSCGVILY--------------------IFRGDFKLP----KWL 220
           PEV   +      +D+WS GV+ Y                    +   D+ +       +
Sbjct: 194 PEVAEGKPVGYY-TDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGI 252

Query: 221 SPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPANP 260
           S   ++ +RK+L  +P  R+TI       W      P   
Sbjct: 253 SEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPGRD 292

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  221 bits (565), Expect = 4e-70
 Identities = 62/272 (22%), Positives = 110/272 (40%), Gaps = 30/272 (11%)

Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
            +   R +G G+FG V FA+D+ +    A+K +  +     +    I +E+  L+ L+HP
Sbjct: 16  LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHP 75

Query: 75  NVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKG 134
           N ++       +   ++V+EY  G         K  LQE E   +    + G++Y H+  
Sbjct: 76  NTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHN 135

Query: 135 VFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYD 194
           + HRD+K  NILL   G +K+ DFG +            ++  G+P ++APEV+      
Sbjct: 136 MIHRDVKAGNILLSEPGLVKLGDFGSA------SIMAPANSFVGTPYWMAPEVILAMDEG 189

Query: 195 GAT--SDIWSCGVILY--------------------IFRGDFKLPKW--LSPGAQNLLRK 230
                 D+WS G+                       I + +    +    S   +N +  
Sbjct: 190 QYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDS 249

Query: 231 ILEPNPVKRITIAGIKADEWFEQDYTPANPDD 262
            L+  P  R T   +    +  ++  P    D
Sbjct: 250 CLQKIPQDRPTSEVLLKHRFVLRERPPTVIMD 281

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  220 bits (562), Expect = 6e-70
 Identities = 70/269 (26%), Positives = 126/269 (46%), Gaps = 33/269 (12%)

Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
            +E+   LG+G FGKV  AQ+ ++ +  A K+++      L+       EI  L    HP
Sbjct: 13  FWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELE---DYMVEIDILASCDHP 69

Query: 75  NVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGR-LQEAEGRKLFQQLIDGVSYCHNK 133
           N+V+L +    ++ +++++E+  GG +   +    R L E++ + + +Q +D ++Y H+ 
Sbjct: 70  NIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDN 129

Query: 134 GVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGY 193
            + HRDLK  NIL    G+IK++DFG+SA  ++ R      +  G+P ++APEV+     
Sbjct: 130 KIIHRDLKAGNILFTLDGDIKLADFGVSA--KNTRTIQRRDSFIGTPYWMAPEVVMCETS 187

Query: 194 D----GATSDIWSCGVILY--------------------IFRGD---FKLPKWLSPGAQN 226
                   +D+WS G+ L                     I + +      P   S   ++
Sbjct: 188 KDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSNFKD 247

Query: 227 LLRKILEPNPVKRITIAGIKADEWFEQDY 255
            L+K LE N   R T + +    +   D 
Sbjct: 248 FLKKCLEKNVDARWTTSQLLQHPFVTVDS 276

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  218 bits (555), Expect = 4e-69
 Identities = 82/268 (30%), Positives = 123/268 (45%), Gaps = 25/268 (9%)

Query: 14  GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRII---HLKITDQIKREIATLKL 70
            +Y++G  LG G FG V     +   LP A+K +EK+RI     L    ++  E+  LK 
Sbjct: 4   SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 63

Query: 71  LK--HPNVVRLHEVLASKSKIYMVLEYVTGG-ELFDKIASKGRLQEAEGRKLFQQLIDGV 127
           +      V+RL +         ++LE      +LFD I  +G LQE   R  F Q+++ V
Sbjct: 64  VSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAV 123

Query: 128 SYCHNKGVFHRDLKLENILLD-SKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPE 186
            +CHN GV HRD+K ENIL+D ++G +K+ DFG          D +     G+  Y  PE
Sbjct: 124 RHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSG----ALLKDTVYTDFDGTRVYSPPE 179

Query: 187 VLANRGYDGATSDIWSCGVILY--------------IFRGDFKLPKWLSPGAQNLLRKIL 232
            +    Y G ++ +WS G++LY              I RG     + +S   Q+L+R  L
Sbjct: 180 WIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQHLIRWCL 239

Query: 233 EPNPVKRITIAGIKADEWFEQDYTPANP 260
              P  R T   I+   W +    P   
Sbjct: 240 ALRPSDRPTFEEIQNHPWMQDVLLPQET 267

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  218 bits (556), Expect = 5e-69
 Identities = 60/261 (22%), Positives = 120/261 (45%), Gaps = 30/261 (11%)

Query: 14  GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKH 73
            +Y     +G+G  G V  A D+ +G   A++ +   +    +    I  EI  ++  K+
Sbjct: 20  KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKE---LIINEILVMRENKN 76

Query: 74  PNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNK 133
           PN+V   +      ++++V+EY+ GG L D + ++  + E +   + ++ +  + + H+ 
Sbjct: 77  PNIVNYLDSYLVGDELWVVMEYLAGGSLTDVV-TETCMDEGQIAAVCRECLQALEFLHSN 135

Query: 134 GVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGY 193
            V HRD+K +NILL   G++K++DFG  A      +     T  G+P ++APEV+  + Y
Sbjct: 136 QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP--EQSKRSTMVGTPYWMAPEVVTRKAY 193

Query: 194 DGATSDIWSCGVILYI-------FRGD----------------FKLPKWLSPGAQNLLRK 230
                DIWS G++          +  +                 + P+ LS   ++ L +
Sbjct: 194 GPK-VDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNR 252

Query: 231 ILEPNPVKRITIAGIKADEWF 251
            L+ +  KR +   +   ++ 
Sbjct: 253 CLDMDVEKRGSAKELLQHQFL 273

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  216 bits (550), Expect = 2e-68
 Identities = 79/275 (28%), Positives = 127/275 (46%), Gaps = 39/275 (14%)

Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHL------KITDQIKREIATL 68
            YE    LG G    V+      +   +AVKI++             ++ +   +E+  L
Sbjct: 4   NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 63

Query: 69  KLLK-HPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGV 127
           + +  HPN+++L +   + +  ++V + +  GELFD +  K  L E E RK+ + L++ +
Sbjct: 64  RKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVI 123

Query: 128 SYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEV 187
              H   + HRDLK ENILLD   NIK++DFG S           L   CG+P+Y+APE+
Sbjct: 124 CALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSC---QLDPGEKLREVCGTPSYLAPEI 180

Query: 188 LA-----NRGYDGATSDIWSCGVILY--------------------IFRGDFKL--PKW- 219
           +      N    G   D+WS GVI+Y                    I  G+++   P+W 
Sbjct: 181 IECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWD 240

Query: 220 -LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQ 253
             S   ++L+ + L   P KR T     A  +F+Q
Sbjct: 241 DYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQ 275

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  216 bits (551), Expect = 5e-68
 Identities = 91/273 (33%), Positives = 134/273 (49%), Gaps = 33/273 (12%)

Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
            Y+    LG G F +V  A+D  +    A+K + K  +   +    ++ EIA L  +KHP
Sbjct: 10  IYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKE--GSMENEIAVLHKIKHP 67

Query: 75  NVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKG 134
           N+V L ++  S   +Y++++ V+GGELFD+I  KG   E +  +L  Q++D V Y H+ G
Sbjct: 68  NIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLG 127

Query: 135 VFHRDLKLENILL---DSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANR 191
           + HRDLK EN+L    D    I ISDFGLS +        +L T CG+P YVAPEVLA +
Sbjct: 128 IVHRDLKPENLLYYSLDEDSKIMISDFGLSKM---EDPGSVLSTACGTPGYVAPEVLAQK 184

Query: 192 GYDGATSDIWSCGVILY--------------------IFRGDFKLP----KWLSPGAQNL 227
            Y  A  D WS GVI Y                    I + +++        +S  A++ 
Sbjct: 185 PYSKA-VDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAKDF 243

Query: 228 LRKILEPNPVKRITIAGIKADEWFEQDYTPANP 260
           +R ++E +P KR T        W   D      
Sbjct: 244 IRHLMEKDPEKRFTCEQALQHPWIAGDTALDKN 276

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  211 bits (538), Expect = 2e-66
 Identities = 73/271 (26%), Positives = 121/271 (44%), Gaps = 36/271 (13%)

Query: 12  RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL 71
           R   YE+  T+G G++G+ +  +    G     K L+   +   +    +  E+  L+ L
Sbjct: 2   RAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEK-QMLVSEVNLLREL 60

Query: 72  KHPNVVRLHEVLASKS--KIYMVLEYVTGGELFDKIA----SKGRLQEAEGRKLFQQLID 125
           KHPN+VR ++ +  ++   +Y+V+EY  GG+L   I      +  L E    ++  QL  
Sbjct: 61  KHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTL 120

Query: 126 GVSYCHNKG-----VFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP 180
            +  CH +      V HRDLK  N+ LD K N+K+ DFGL+ +  H  D        G+P
Sbjct: 121 ALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNH--DTSFAKAFVGTP 178

Query: 181 NYVAPEVLANRGYDGATSDIWSCGVILY--------------------IFRGDF-KLPKW 219
            Y++PE +    Y+   SDIWS G +LY                    I  G F ++P  
Sbjct: 179 YYMSPEQMNRMSYNEK-SDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYR 237

Query: 220 LSPGAQNLLRKILEPNPVKRITIAGIKADEW 250
            S     ++ ++L      R ++  I  +  
Sbjct: 238 YSDELNEIITRMLNLKDYHRPSVEEILENPL 268

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  211 bits (538), Expect = 6e-66
 Identities = 60/274 (21%), Positives = 117/274 (42%), Gaps = 35/274 (12%)

Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
           +Y +   LG G FG V    +  S   +  K ++            +K+EI+ L + +H 
Sbjct: 6   KYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQ----VLVKKEISILNIARHR 61

Query: 75  NVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKG-RLQEAEGRKLFQQLIDGVSYCHNK 133
           N++ LHE   S  ++ M+ E+++G ++F++I +    L E E      Q+ + + + H+ 
Sbjct: 62  NILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSH 121

Query: 134 GVFHRDLKLENILLDSKGN--IKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANR 191
            + H D++ ENI+  ++ +  IKI +FG +   +  +          +P Y APEV  + 
Sbjct: 122 NIGHFDIRPENIIYQTRRSSTIKIIEFGQA---RQLKPGDNFRLLFTAPEYYAPEVHQHD 178

Query: 192 GYDGATSDIWSCGVILY--------------------IFRGDFKLP----KWLSPGAQNL 227
               A +D+WS G ++Y                    I   ++       K +S  A + 
Sbjct: 179 VVSTA-TDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDF 237

Query: 228 LRKILEPNPVKRITIAGIKADEWFEQDYTPANPD 261
           + ++L      R+T +      W +Q     +  
Sbjct: 238 VDRLLVKERKSRMTASEALQHPWLKQKIERVSTK 271

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  212 bits (541), Expect = 6e-66
 Identities = 91/392 (23%), Positives = 160/392 (40%), Gaps = 64/392 (16%)

Query: 11  MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKL 70
           + +  + + R +G G FG+V   +  D+G  +A+K L+K RI   +       E   L L
Sbjct: 1   LTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSL 60

Query: 71  LK---HPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGV 127
           +     P +V +     +  K+  +L+ + GG+L   ++  G   EA+ R    ++I G+
Sbjct: 61  VSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGL 120

Query: 128 SYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEV 187
            + HN+ V +RDLK  NILLD  G+++ISD GL+            H + G+  Y+APEV
Sbjct: 121 EHMHNRFVVYRDLKPANILLDEHGHVRISDLGLAC----DFSKKKPHASVGTHGYMAPEV 176

Query: 188 LANRGYDGATSDIWSCGVILYIF-----------------------RGDFKLPKWLSPGA 224
           L       +++D +S G +L+                             +LP   SP  
Sbjct: 177 LQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPEL 236

Query: 225 QNLLRKILEPNPVKRITIAGIKADE-----WFEQDYTPANPDDDEEDIFVDNEAFSMHEV 279
           ++LL  +L+ +  +R+   G  A E     +F                 +D +   + + 
Sbjct: 237 RSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRS---------------LDWQMVFLQKY 281

Query: 280 PSDGGRTPGSPPLINAFQLIGMSSCLDLSGFFEKEDVSERKIRFTSNHSAKD----LLER 335
           P         PPLI     +  +   D+   F++ED    K+  +     ++    + ER
Sbjct: 282 P---------PPLIPPRGEVNAADAFDIG-SFDEEDTKGIKLLDSDQELYRNFPLTISER 331

Query: 336 IEDIVTEMGFRVQKKNGKLKATQEHKPQKSLG 367
            +  V E  F            ++    K LG
Sbjct: 332 WQQEVAETVFDTINAETDRLEARKKTKNKQLG 363

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  211 bits (537), Expect = 8e-66
 Identities = 82/261 (31%), Positives = 136/261 (52%), Gaps = 25/261 (9%)

Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKL-LKH 73
            + L + LG+G+FGKV  A+   +   FA+K L+K+ ++     +    E   L L  +H
Sbjct: 3   DFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEH 62

Query: 74  PNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNK 133
           P +  +     +K  ++ V+EY+ GG+L   I S  +   +       ++I G+ + H+K
Sbjct: 63  PFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSK 122

Query: 134 GVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGY 193
           G+ +RDLKL+NILLD  G+IKI+DFG+    ++   D   +T CG+P+Y+APE+L  + Y
Sbjct: 123 GIVYRDLKLDNILLDKDGHIKIADFGMCK--ENMLGDAKTNTFCGTPDYIAPEILLGQKY 180

Query: 194 DGATSDIWSCGVILY--------------------IFRGDFKLPKWLSPGAQNLLRKILE 233
           + +  D WS GV+LY                    I   +   P+WL   A++LL K+  
Sbjct: 181 NHS-VDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKEAKDLLVKLFV 239

Query: 234 PNPVKRITIAG-IKADEWFEQ 253
             P KR+ + G I+    F +
Sbjct: 240 REPEKRLGVRGDIRQHPLFRE 260

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  207 bits (527), Expect = 1e-64
 Identities = 85/270 (31%), Positives = 134/270 (49%), Gaps = 35/270 (12%)

Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLK---ITDQIKREIATLKLL 71
            Y+ G  LG G F  VK  ++  +GL +A K ++K R    +     + I+RE++ LK +
Sbjct: 11  YYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEI 70

Query: 72  KHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCH 131
           +HPNV+ LHEV  +K+ + ++LE V GGELFD +A K  L E E  +  +Q+++GV Y H
Sbjct: 71  QHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLH 130

Query: 132 NKGVFHRDLKLENILLDSKG----NIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEV 187
           +  + H DLK ENI+L  +      IKI DFGL+                G+P +VAPE+
Sbjct: 131 SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA---HKIDFGNEFKNIFGTPEFVAPEI 187

Query: 188 LANRGYDGATSDIWSCGVILY--------------------IFRGDFKLP----KWLSPG 223
           +         +D+WS GVI Y                    +   +++         S  
Sbjct: 188 VNYEPLG-LEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSAL 246

Query: 224 AQNLLRKILEPNPVKRITIAGIKADEWFEQ 253
           A++ +R++L  +P KR+TI       W + 
Sbjct: 247 AKDFIRRLLVKDPKKRMTIQDSLQHPWIKP 276

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  206 bits (525), Expect = 1e-64
 Identities = 59/270 (21%), Positives = 112/270 (41%), Gaps = 38/270 (14%)

Query: 14  GRY-ELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK 72
           GR+ +    +G G+F  V    D ++ +  A   L+  ++       + K E   LK L+
Sbjct: 8   GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTK-SERQRFKEEAEMLKGLQ 66

Query: 73  HPNVVRLHEVLASKSK----IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVS 128
           HPN+VR ++   S  K    I +V E +T G L   +     ++    R   +Q++ G+ 
Sbjct: 67  HPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQ 126

Query: 129 YCHNKG--VFHRDLKLENILLDSK-GNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAP 185
           + H +   + HRDLK +NI +    G++KI D GL+      +         G+P ++AP
Sbjct: 127 FLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT----LKRASFAKAVIGTPEFMAP 182

Query: 186 EVLANRGYDGATSDIWSCGVILYI-------FRGDF----------------KLPKWLSP 222
           E+     YD +  D+++ G+ +         +                       K   P
Sbjct: 183 EMY-EEKYDES-VDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIP 240

Query: 223 GAQNLLRKILEPNPVKRITIAGIKADEWFE 252
             + ++   +  N  +R +I  +    +F+
Sbjct: 241 EVKEIIEGCIRQNKDERYSIKDLLNHAFFQ 270

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  205 bits (523), Expect = 9e-64
 Identities = 72/263 (27%), Positives = 136/263 (51%), Gaps = 31/263 (11%)

Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
           +++ RTLG G+FG+V   +   +G  +A+K+L+K  ++ LK  +    E   L ++ HP 
Sbjct: 6   FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPF 65

Query: 76  VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGV 135
           ++R+        +I+M+++Y+ GGELF  +    R      +    ++   + Y H+K +
Sbjct: 66  IIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDI 125

Query: 136 FHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDG 195
            +RDLK ENILLD  G+IKI+DFG +          + +T CG+P+Y+APEV++ + Y+ 
Sbjct: 126 IYRDLKPENILLDKNGHIKITDFGFAK-----YVPDVTYTLCGTPDYIAPEVVSTKPYNK 180

Query: 196 ATSDIWSCGVILY--------------------IFRGDFKLPKWLSPGAQNLLRKILEPN 235
           +  D WS G+++Y                    I   + + P + +   ++LL +++  +
Sbjct: 181 S-IDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNEDVKDLLSRLITRD 239

Query: 236 PVKRI-----TIAGIKADEWFEQ 253
             +R+         +K   WF++
Sbjct: 240 LSQRLGNLQNGTEDVKNHPWFKE 262

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  204 bits (520), Expect = 3e-63
 Identities = 64/199 (32%), Positives = 99/199 (49%), Gaps = 8/199 (4%)

Query: 11  MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKL 70
           ++   +E    LG GN G V       SGL  A K++     I   I +QI RE+  L  
Sbjct: 3   LKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLE--IKPAIRNQIIRELQVLHE 60

Query: 71  LKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYC 130
              P +V  +    S  +I + +E++ GG L   +   GR+ E    K+   +I G++Y 
Sbjct: 61  CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYL 120

Query: 131 HNK-GVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLA 189
             K  + HRD+K  NIL++S+G IK+ DFG+S        D + ++  G+ +Y++PE L 
Sbjct: 121 REKHKIMHRDVKPSNILVNSRGEIKLCDFGVSG----QLIDSMANSFVGTRSYMSPERLQ 176

Query: 190 NRGYDGATSDIWSCGVILY 208
              Y    SDIWS G+ L 
Sbjct: 177 GTHYSVQ-SDIWSMGLSLV 194

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 39.3 bits (91), Expect = 6e-04
 Identities = 7/37 (18%), Positives = 15/37 (40%)

Query: 217 PKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQ 253
               S   Q+ + K L  NP +R  +  +    + ++
Sbjct: 267 SGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKR 303

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  195 bits (498), Expect = 2e-60
 Identities = 54/261 (20%), Positives = 106/261 (40%), Gaps = 34/261 (13%)

Query: 14  GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKH 73
           G+  +G+ +G G+FG V   +        AVK+L        +     K E+  L+  +H
Sbjct: 8   GQITVGQRIGSGSFGTVYKGKWHGD---VAVKMLNVTAPTP-QQLQAFKNEVGVLRKTRH 63

Query: 74  PNVVRLHEVLASKSKIYMVLEYVTGGELFDKI-ASKGRLQEAEGRKLFQQLIDGVSYCHN 132
            N++      ++  ++ +V ++  G  L+  +   + + +  +   + +Q   G+ Y H 
Sbjct: 64  VNILLFMGY-STAPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHA 122

Query: 133 KGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRG 192
           K + HRDLK  NI L     +KI DFGL+ +   +          GS  ++APEV+  + 
Sbjct: 123 KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQD 182

Query: 193 YDGAT--SDIWSCGVILYI-------FRGD-------------------FKLPKWLSPGA 224
            +  +  SD+++ G++LY        +                       K+        
Sbjct: 183 KNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAM 242

Query: 225 QNLLRKILEPNPVKRITIAGI 245
           + L+ + L+    +R     I
Sbjct: 243 KRLMAECLKKKRDERPLFPQI 263

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  197 bits (502), Expect = 2e-60
 Identities = 81/264 (30%), Positives = 130/264 (49%), Gaps = 28/264 (10%)

Query: 13  LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK 72
           +  ++  + LG+G FGKV   ++  +G  +A+KIL K  II          E   L+  +
Sbjct: 4   MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTR 63

Query: 73  HPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHN 132
           HP +  L     +  ++  V+EY  GGELF  ++ +    E   R    +++  + Y H+
Sbjct: 64  HPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHS 123

Query: 133 KGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRG 192
           + V +RD+KLEN++LD  G+IKI+DFGL        D   + T CG+P Y+APEVL +  
Sbjct: 124 RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS--DGATMKTFCGTPEYLAPEVLEDND 181

Query: 193 YDGATSDIWSCGVILY--------------------IFRGDFKLPKWLSPGAQNLLRKIL 232
           Y  A  D W  GV++Y                    I   + + P+ LSP A++LL  +L
Sbjct: 182 YGRA-VDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLL 240

Query: 233 EPNPVKRITIAGIKADE-----WF 251
           + +P +R+      A E     +F
Sbjct: 241 KKDPKQRLGGGPSDAKEVMEHRFF 264

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  196 bits (500), Expect = 3e-60
 Identities = 76/301 (25%), Positives = 130/301 (43%), Gaps = 45/301 (14%)

Query: 8   QEGMRLGRYE-LGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIA 66
           ++   +  Y+   + LG G  GKV    +  +   FA+K+L+           + +RE+ 
Sbjct: 5   KKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------PKARREVE 56

Query: 67  TL-KLLKHPNVVRLHEVL----ASKSKIYMVLEYVTGGELFDKIASKG--RLQEAEGRKL 119
              +  + P++VR+ +V     A +  + +V+E + GGELF +I  +G     E E  ++
Sbjct: 57  LHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEI 116

Query: 120 FQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGS 179
            + + + + Y H+  + HRD+K EN+L  SK    I         +       L T C +
Sbjct: 117 MKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYT 176

Query: 180 PNYVAPEVLANRGYDGATSDIWSCGVILYI-------FRGD------------------- 213
           P YVAPEVL    YD +  D+WS GVI+YI       F  +                   
Sbjct: 177 PYYVAPEVLGPEKYDKS-CDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYE 235

Query: 214 FKLPKW--LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPANPDDDEEDIFVDN 271
           F  P+W  +S   + L+R +L+  P +R+TI       W  Q             +  ++
Sbjct: 236 FPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKED 295

Query: 272 E 272
           +
Sbjct: 296 K 296

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  194 bits (493), Expect = 6e-60
 Identities = 65/266 (24%), Positives = 109/266 (40%), Gaps = 30/266 (11%)

Query: 14  GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKH 73
            RYELG  LG G   +V  A+DL      AVK+L  +         + +RE      L H
Sbjct: 7   DRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNH 66

Query: 74  PNVVRLHEVLASKSK----IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSY 129
           P +V +++   +++      Y+V+EYV G  L D + ++G +      ++       +++
Sbjct: 67  PAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNF 126

Query: 130 CHNKGVFHRDLKLENILLDSKGNIKISDFGLSA-LPQHFRDDGLLHTTCGSPNYVAPEVL 188
            H  G+ HRD+K  NI++ +   +K+ DFG++  +              G+  Y++PE  
Sbjct: 127 SHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQA 186

Query: 189 ANRGYDGATSDIWSCGVILY--------------------IFRGDFKLP----KWLSPGA 224
                D   SD++S G +LY                      R D   P    + LS   
Sbjct: 187 RGDSVDAR-SDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSADL 245

Query: 225 QNLLRKILEPNPVKRITIAGIKADEW 250
             ++ K L  NP  R   A     + 
Sbjct: 246 DAVVLKALAKNPENRYQTAAEMRADL 271

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  193 bits (492), Expect = 7e-59
 Identities = 83/272 (30%), Positives = 138/272 (50%), Gaps = 31/272 (11%)

Query: 6   KKQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREI 65
             Q   +L +++  +TLG G+FG+V   +  +SG  +A+KIL+K +++ LK  +    E 
Sbjct: 33  PSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEK 92

Query: 66  ATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLID 125
             L+ +  P +V+L       S +YMV+EYV GGE+F  +   GR  E   R    Q++ 
Sbjct: 93  RILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVL 152

Query: 126 GVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAP 185
              Y H+  + +RDLK EN+L+D +G I+++DFG +   +         T CG+P  +AP
Sbjct: 153 TFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT-----WTLCGTPEALAP 207

Query: 186 EVLANRGYDGATSDIWSCGVILY--------------------IFRGDFKLPKWLSPGAQ 225
           E++ ++GY+ A  D W+ GV++Y                    I  G  + P   S   +
Sbjct: 208 EIILSKGYNKA-VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLK 266

Query: 226 NLLRKILEPNPVKRI-----TIAGIKADEWFE 252
           +LLR +L+ +  KR       +  IK  +WF 
Sbjct: 267 DLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFA 298

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  187 bits (474), Expect = 2e-56
 Identities = 67/311 (21%), Positives = 113/311 (36%), Gaps = 63/311 (20%)

Query: 12  RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL 71
            + +YE    +G+G FG+V  A+   +G   A+K +               REI  L+LL
Sbjct: 8   EVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKE-GFPITALREIKILQLL 66

Query: 72  KHPNVVRLHEVLAS--------KSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQL 123
           KH NVV L E+  +        K  IY+V ++              +   +E +++ Q L
Sbjct: 67  KHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQML 126

Query: 124 IDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSAL--PQHFRDDGLLHTTCGSPN 181
           ++G+ Y H   + HRD+K  N+L+   G +K++DFGL+                   +  
Sbjct: 127 LNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLW 186

Query: 182 YVAPEVLANRGYDGATSDIWSCGVILY--------------------IFRGDFKLPK--- 218
           Y  PE+L      G   D+W  G I+                     I +    +     
Sbjct: 187 YRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVW 246

Query: 219 -----------------------------WLSPGAQNLLRKILEPNPVKRITIAGIKADE 249
                                           P A +L+ K+L  +P +RI        +
Sbjct: 247 PNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHD 306

Query: 250 WFEQDYTPANP 260
           +F  D  P++ 
Sbjct: 307 FFWSDPMPSDL 317

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  185 bits (471), Expect = 8e-56
 Identities = 75/315 (23%), Positives = 120/315 (38%), Gaps = 59/315 (18%)

Query: 14  GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKH 73
            RY     +GEG +G V  A D  + +  A+K +      H     +  REI  L   +H
Sbjct: 8   PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE--HQTYCQRTLREIKILLRFRH 65

Query: 74  PNVVRLHEVLASKS----KIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSY 129
            N++ +++++ + +    K   ++ ++ G +L+  +     L          Q++ G+ Y
Sbjct: 66  ENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLL-KTQHLSNDHICYFLYQILRGLKY 124

Query: 130 CHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTT-CGSPNYVAPEVL 188
            H+  V HRDLK  N+LL++  ++KI DFGL+ +     D     T    +  Y APE++
Sbjct: 125 IHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIM 184

Query: 189 ANRGYDGATSDIWSCGVILY---------------------------------------- 208
            N      + DIWS G IL                                         
Sbjct: 185 LNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLK 244

Query: 209 IFRGDFKLPKW-----------LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTP 257
                  LP                 A +LL K+L  NP KRI +    A  + EQ Y P
Sbjct: 245 ARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDP 304

Query: 258 ANPDDDEEDIFVDNE 272
           ++    E     D E
Sbjct: 305 SDEPIAEAPFKFDME 319

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  182 bits (463), Expect = 1e-55
 Identities = 60/257 (23%), Positives = 102/257 (39%), Gaps = 38/257 (14%)

Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
             +L +T+G+G FG V        G   AVK ++ +             E + +  L+H 
Sbjct: 8   ELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKND-----ATAQAFLAEASVMTQLRHS 60

Query: 75  NVVRLHEVLA-SKSKIYMVLEYVTGGELFDKIASKGR--LQEAEGRKLFQQLIDGVSYCH 131
           N+V+L  V+   K  +Y+V EY+  G L D + S+GR  L      K    + + + Y  
Sbjct: 61  NLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE 120

Query: 132 NKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANR 191
                HRDL   N+L+      K+SDFGL+      +D     T      + APE L  +
Sbjct: 121 GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQD-----TGKLPVKWTAPEALREK 175

Query: 192 GYDGATSDIWSCGVILY---------------------IFRG-DFKLPKWLSPGAQNLLR 229
            +    SD+WS G++L+                     + +G     P    P    +++
Sbjct: 176 KFSTK-SDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYEVMK 234

Query: 230 KILEPNPVKRITIAGIK 246
                +   R +   ++
Sbjct: 235 NCWHLDAAMRPSFLQLR 251

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  182 bits (463), Expect = 3e-55
 Identities = 66/294 (22%), Positives = 103/294 (35%), Gaps = 52/294 (17%)

Query: 17  ELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLK--ITDQIKREIATLKLLKHP 74
           E    LGEG F  V  A+D ++    A+K ++       K  I     REI  L+ L HP
Sbjct: 1   EKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHP 60

Query: 75  NVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKG 134
           N++ L +    KS I +V +++          +   L  +  +      + G+ Y H   
Sbjct: 61  NIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW 120

Query: 135 VFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYD 194
           + HRDLK  N+LLD  G +K++DFGL+        +        +  Y APE+L      
Sbjct: 121 ILHRDLKPNNLLLDENGVLKLADFGLAK--SFGSPNRAYTHQVVTRWYRAPELLFGARMY 178

Query: 195 GATSDIWSCGVILY-------IFRGD---------------------------------- 213
           G   D+W+ G IL           GD                                  
Sbjct: 179 GVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFK 238

Query: 214 -------FKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPANP 260
                    +         +L++ +   NP  RIT       ++F     P   
Sbjct: 239 SFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGPTPG 292

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  179 bits (455), Expect = 3e-54
 Identities = 59/259 (22%), Positives = 98/259 (37%), Gaps = 28/259 (10%)

Query: 15  RYELGRTLGEGNFGKVKFAQ---DLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL 71
              L   LG+G+FG V+  +        +  AVK L+ + +   +  D   RE+  +  L
Sbjct: 9   DLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSL 68

Query: 72  KHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYC 130
            H N++RL+ V+ +   + MV E    G L D++    G        +   Q+ +G+ Y 
Sbjct: 69  DHRNLIRLYGVVLTP-PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYL 127

Query: 131 HNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLAN 190
            +K   HRDL   N+LL ++  +KI DFGL        D  ++      P          
Sbjct: 128 ESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLK 187

Query: 191 RGYDGATSDIWSCGVILY---------------------IFRGDFKLPKW--LSPGAQNL 227
                  SD W  GV L+                     I +   +LP+         N+
Sbjct: 188 TRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQDIYNV 247

Query: 228 LRKILEPNPVKRITIAGIK 246
           + +     P  R T   ++
Sbjct: 248 MVQCWAHKPEDRPTFVALR 266

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  178 bits (453), Expect = 5e-54
 Identities = 62/261 (23%), Positives = 99/261 (37%), Gaps = 30/261 (11%)

Query: 20  RTLGEGNFGKVKFA--QDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVV 77
           + LG GNFG VK    Q        AVKIL KN      + D++  E   ++ L +P +V
Sbjct: 13  KELGSGNFGTVKKGYYQMKKVVKTVAVKIL-KNEANDPALKDELLAEANVMQQLDNPYIV 71

Query: 78  RLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFH 137
           R+  +        +V+E    G L   +     +++    +L  Q+  G+ Y       H
Sbjct: 72  RMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVH 130

Query: 138 RDLKLENILLDSKGNIKISDFGLS-ALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGA 196
           RDL   N+LL ++   KISDFGLS AL                  + APE +    +   
Sbjct: 131 RDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSK 190

Query: 197 TSDIWSCGVILYI--------FRGD--------------FKLPKWLSPGAQNLLRKILEP 234
            SD+WS GV+++         +RG                  P        +L+      
Sbjct: 191 -SDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTY 249

Query: 235 NPVKRITIAGIKA--DEWFEQ 253
           +   R   A ++     ++  
Sbjct: 250 DVENRPGFAAVELRLRNYYYD 270

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  177 bits (451), Expect = 8e-54
 Identities = 57/253 (22%), Positives = 105/253 (41%), Gaps = 34/253 (13%)

Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
               + LG G FG VK+ +        A+K++++  +      D+   E   +  L H  
Sbjct: 6   LTFLKELGTGQFGVVKYGK-WRGQYDVAIKMIKEGSMSE----DEFIEEAKVMMNLSHEK 60

Query: 76  VVRLHEVLASKSKIYMVLEYVTGGELFDKIA-SKGRLQEAEGRKLFQQLIDGVSYCHNKG 134
           +V+L+ V   +  I+++ EY+  G L + +   + R Q  +  ++ + + + + Y  +K 
Sbjct: 61  LVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ 120

Query: 135 VFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTT--CGSPNYVAPEVLANRG 192
             HRDL   N L++ +G +K+SDFGLS   ++  DD    +        +  PEVL    
Sbjct: 121 FLHRDLAARNCLVNDQGVVKVSDFGLS---RYVLDDEYTSSVGSKFPVRWSPPEVLMYSK 177

Query: 193 YDGATSDIWSCGVILY---------------------IFRG-DFKLPKWLSPGAQNLLRK 230
           +    SDIW+ GV+++                     I +G     P   S     ++  
Sbjct: 178 FSSK-SDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYTIMYS 236

Query: 231 ILEPNPVKRITIA 243
                  +R T  
Sbjct: 237 CWHEKADERPTFK 249

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  178 bits (452), Expect = 1e-53
 Identities = 76/288 (26%), Positives = 123/288 (42%), Gaps = 53/288 (18%)

Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
           +Y     +GEG +G V  AQ+ + G  FA+K +   +     I     REI+ LK LKH 
Sbjct: 3   KYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDE-GIPSTTIREISILKELKHS 60

Query: 75  NVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKG 134
           N+V+L++V+ +K ++ +V E++           +G L+    +    QL++G++YCH++ 
Sbjct: 61  NIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRR 120

Query: 135 VFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYD 194
           V HRDLK +N+L++ +G +KI+DFGL+                 +  Y AP+VL      
Sbjct: 121 VLHRDLKPQNLLINREGELKIADFGLARAFGI--PVRKYTHEIVTLWYRAPDVLMGSKKY 178

Query: 195 GATSDIWSCGVILYI-------FRGD---------------------------------- 213
             T DIWS G I          F G                                   
Sbjct: 179 STTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNF 238

Query: 214 --------FKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQ 253
                       K L     +LL K+L+ +P +RIT        +F++
Sbjct: 239 TVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  177 bits (450), Expect = 3e-53
 Identities = 67/275 (24%), Positives = 114/275 (41%), Gaps = 32/275 (11%)

Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
              +   LG G +G+V         L  AVK L+++ +      ++  +E A +K +KHP
Sbjct: 18  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME----VEEFLKEAAVMKEIKHP 73

Query: 75  NVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGR--LQEAEGRKLFQQLIDGVSYCHN 132
           N+V+L  V   +   Y++ E++T G L D +    R  +       +  Q+   + Y   
Sbjct: 74  NLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK 133

Query: 133 KGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRG 192
           K   HRDL   N L+     +K++DFGLS L                  + APE LA   
Sbjct: 134 KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG-DTYTAHAGAKFPIKWTAPESLAYNK 192

Query: 193 YDGATSDIWSCGVILY--------------------IFRGDFKL--PKWLSPGAQNLLRK 230
           +    SD+W+ GV+L+                    +   D+++  P+        L+R 
Sbjct: 193 FSIK-SDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRA 251

Query: 231 ILEPNPVKRITIAGIKADEWFEQDYTPANPDDDEE 265
             + NP  R + A I   + FE  +  ++  D+ E
Sbjct: 252 CWQWNPSDRPSFAEIH--QAFETMFQESSISDEVE 284

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  177 bits (449), Expect = 3e-53
 Identities = 75/293 (25%), Positives = 127/293 (43%), Gaps = 53/293 (18%)

Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
            ++    +GEG +G V  A++  +G   A+K +  +      +     REI+ LK L HP
Sbjct: 3   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETE-GVPSTAIREISLLKELNHP 61

Query: 75  NVVRLHEVLASKSKIYMVLEYV-TGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNK 133
           N+V+L +V+ +++K+Y+V E++    + F   ++   +     +    QL+ G+++CH+ 
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 121

Query: 134 GVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGY 193
            V HRDLK +N+L++++G IK++DFGL+                 +  Y APE+L    Y
Sbjct: 122 RVLHRDLKPQNLLINTEGAIKLADFGLA--RAFGVPVRTYTHEVVTLWYRAPEILLGCKY 179

Query: 194 DGATSDIWSCGVILYI-------FRGD-------------------------------FK 215
                DIWS G I          F GD                                 
Sbjct: 180 YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPS 239

Query: 216 LPKW-----------LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTP 257
            PKW           L    ++LL ++L  +P KRI+     A  +F+    P
Sbjct: 240 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 292

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  178 bits (451), Expect = 4e-53
 Identities = 60/283 (21%), Positives = 103/283 (36%), Gaps = 55/283 (19%)

Query: 15  RYELGRTLGEGNFGKVKFAQDLDSG-----LPFAVKILEKNRIIHLKITDQIKREIATL- 68
             E G+ LG G FGKV  A           +  AVK+L++         + +  E+  + 
Sbjct: 38  NLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA--DSSEREALMSELKMMT 95

Query: 69  KLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASK-------------------- 108
           +L  H N+V L         IY++ EY   G+L + + SK                    
Sbjct: 96  QLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEE 155

Query: 109 ---GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQ 165
                L   +      Q+  G+ +   K   HRDL   N+L+     +KI DFGL+    
Sbjct: 156 EDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIM 215

Query: 166 HFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILY----------------- 208
              +  +         ++APE L    Y    SD+WS G++L+                 
Sbjct: 216 SDSNYVVRGNARLPVKWMAPESLFEGIYTIK-SDVWSYGILLWEIFSLGVNPYPGIPVDA 274

Query: 209 ----IFRGDFKL--PKWLSPGAQNLLRKILEPNPVKRITIAGI 245
               + +  FK+  P + +     +++     +  KR +   +
Sbjct: 275 NFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNL 317

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  177 bits (450), Expect = 6e-53
 Identities = 74/282 (26%), Positives = 136/282 (48%), Gaps = 34/282 (12%)

Query: 6   KKQEGMRLGRYELGRTLGEGNFGKVKFAQDL---DSGLPFAVKILEKNRIIH-LKITDQI 61
              E + +  +EL + LG G +GKV   + +   D+G  +A+K+L+K  I+   K T+  
Sbjct: 16  GHAEKVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHT 75

Query: 62  KREIATLKLLKH-PNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLF 120
           + E   L+ ++  P +V LH    +++K++++L+Y+ GGELF  ++ + R  E E +   
Sbjct: 76  RTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYV 135

Query: 121 QQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP 180
            +++  + + H  G+ +RD+KLENILLDS G++ ++DFGLS        +          
Sbjct: 136 GEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIE 195

Query: 181 NYVAPEVLANRGYDGATSDIWSCGVILY------------------------IFRGDFKL 216
                 V           D WS GV++Y                        I + +   
Sbjct: 196 YMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPY 255

Query: 217 PKWLSPGAQNLLRKILEPNPVKRITIAGIKADE-----WFEQ 253
           P+ +S  A++L++++L  +P KR+      ADE     +F++
Sbjct: 256 PQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQK 297

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  175 bits (445), Expect = 1e-52
 Identities = 72/295 (24%), Positives = 122/295 (41%), Gaps = 54/295 (18%)

Query: 13  LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK 72
           + +YE    +GEG +G V  A++ ++    A+K +  +      +     REI  LK LK
Sbjct: 1   MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDE-GVPSSALREICLLKELK 59

Query: 73  HPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHN 132
           H N+VRLH+VL S  K+ +V E+          +  G L     +    QL+ G+ +CH+
Sbjct: 60  HKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHS 119

Query: 133 KGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRG 192
           + V HRDLK +N+L++  G +K+++FGL+                 +  Y  P+VL    
Sbjct: 120 RNVLHRDLKPQNLLINRNGELKLANFGLARAFGI--PVRCYSAEVVTLWYRPPDVLFGAK 177

Query: 193 YDGATSDIWSCGVILY--------IFRGD------------------------------- 213
               + D+WS G I          +F G+                               
Sbjct: 178 LYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYK 237

Query: 214 -----------FKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTP 257
                        +   L+   ++LL+ +L+ NPV+RI+        +F  D+ P
Sbjct: 238 PYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYF-SDFCP 291

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  176 bits (446), Expect = 1e-52
 Identities = 66/296 (22%), Positives = 102/296 (34%), Gaps = 45/296 (15%)

Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATL-KLLKH 73
             +    +GEGNFG+V  A+    GL     I                 E+  L KL  H
Sbjct: 11  DIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHH 70

Query: 74  PNVVRLHEVLASKSKIYMVLEYVTGGELFDKI----------------ASKGRLQEAEGR 117
           PN++ L      +  +Y+ +EY   G L D +                ++   L   +  
Sbjct: 71  PNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLL 130

Query: 118 KLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTC 177
                +  G+ Y   K   HRDL   NIL+      KI+DFGLS   +            
Sbjct: 131 HFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLS---RGQEVYVKKTMGR 187

Query: 178 GSPNYVAPEVLANRGYDGATSDIWSCGVILYI--------FRGD--------------FK 215
               ++A E L N       SD+WS GV+L+         + G                +
Sbjct: 188 LPVRWMAIESL-NYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLE 246

Query: 216 LPKWLSPGAQNLLRKILEPNPVKRITIAGIKA--DEWFEQDYTPANPDDDEEDIFV 269
            P        +L+R+     P +R + A I    +   E+  T  N    E+  + 
Sbjct: 247 KPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKTYVNTTLYEKFTYA 302

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  177 bits (449), Expect = 2e-52
 Identities = 72/302 (23%), Positives = 116/302 (38%), Gaps = 69/302 (22%)

Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
            Y   + +G G+FG V  A+  DSG   A+K + +++           RE+  ++ L H 
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-------FKNRELQIMRKLDHC 73

Query: 75  NVVRLHEVLASKSK------IYMVLEYVTGG---ELFDKIASKGRLQEAEGRKLFQQLID 125
           N+VRL     S  +      + +VL+YV             +K  L     +    QL  
Sbjct: 74  NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFR 133

Query: 126 GVSYCHNKGVFHRDLKLENILLDSKGN-IKISDFGLSALPQHFRDDGLLHTTCGSPNYVA 184
            ++Y H+ G+ HRD+K +N+LLD     +K+ DFG +   +         +   S  Y A
Sbjct: 134 SLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSA---KQLVRGEPNVSYICSRYYRA 190

Query: 185 PEVLANRGYDGATSDIWSCGVILY-------IFRGD------------------------ 213
           PE++       ++ D+WS G +L        IF GD                        
Sbjct: 191 PELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREM 250

Query: 214 ------FKLPKW------------LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY 255
                 FK P+               P A  L  ++LE  P  R+T     A  +F++  
Sbjct: 251 NPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELR 310

Query: 256 TP 257
            P
Sbjct: 311 DP 312

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  174 bits (443), Expect = 2e-52
 Identities = 62/275 (22%), Positives = 112/275 (40%), Gaps = 34/275 (12%)

Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
              L   LG+G FG+V       +    A+K L+   +      +   +E   +K L+H 
Sbjct: 18  SLRLEVKLGQGCFGEVWMGTWNGTT-RVAIKTLKPGTMSP----EAFLQEAQVMKKLRHE 72

Query: 75  NVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGR--LQEAEGRKLFQQLIDGVSYCHN 132
            +V+L+ V+ S+  IY+V EY++ G L D +  +    L+  +   +  Q+  G++Y   
Sbjct: 73  KLVQLYAVV-SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER 131

Query: 133 KGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRG 192
               HRDL+  NIL+      K++DFGL+ L +   +            + APE      
Sbjct: 132 MNYVHRDLRAANILVGENLVCKVADFGLARLIED-NEYTARQGAKFPIKWTAPEAALYGR 190

Query: 193 YDGATSDIWSCGVILY---------------------IFRG-DFKLPKWLSPGAQNLLRK 230
           +    SD+WS G++L                      + RG     P        +L+ +
Sbjct: 191 FTIK-SDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQ 249

Query: 231 ILEPNPVKRITIAGIKA--DEWFEQDYTPANPDDD 263
                P +R T   ++A  +++F        P ++
Sbjct: 250 CWRKEPEERPTFEYLQAFLEDYFTSTEPQYQPGEN 284

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  174 bits (442), Expect = 2e-52
 Identities = 64/263 (24%), Positives = 111/263 (42%), Gaps = 34/263 (12%)

Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
             +L   LG G FG+V      +     AVK L++  +      D    E   +K L+H 
Sbjct: 14  TLKLVERLGAGQFGEVWMGY-YNGHTKVAVKSLKQGSMSP----DAFLAEANLMKQLQHQ 68

Query: 75  NVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKG--RLQEAEGRKLFQQLIDGVSYCHN 132
            +VRL+ V+ ++  IY++ EY+  G L D + +    +L   +   +  Q+ +G+++   
Sbjct: 69  RLVRLYAVV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE 127

Query: 133 KGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRG 192
           +   HRDL+  NIL+    + KI+DFGL+ L     +            + APE + N G
Sbjct: 128 RNYIHRDLRAANILVSDTLSCKIADFGLARL-IEDNEYTAREGAKFPIKWTAPEAI-NYG 185

Query: 193 YDGATSDIWSCGVILY---------------------IFRG-DFKLPKWLSPGAQNLLRK 230
                SD+WS G++L                      + RG     P         L+R 
Sbjct: 186 TFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQLMRL 245

Query: 231 ILEPNPVKRITIAGIKA--DEWF 251
             +  P  R T   +++  +++F
Sbjct: 246 CWKERPEDRPTFDYLRSVLEDFF 268

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  174 bits (441), Expect = 3e-52
 Identities = 66/260 (25%), Positives = 113/260 (43%), Gaps = 31/260 (11%)

Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLP-FAVKILEKNRIIHLKITDQIKREIATLKLLKH 73
           R ELGR +GEG FG V     +    P  AV I          + ++  +E  T++   H
Sbjct: 8   RIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDH 67

Query: 74  PNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHN 132
           P++V+L  V+ +++ +++++E  T GEL   +  +   L  A       QL   ++Y  +
Sbjct: 68  PHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLES 126

Query: 133 KGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTC--GSPNYVAPEVLAN 190
           K   HRD+   N+L+ S   +K+ DFGLS   ++  D      +       ++APE +  
Sbjct: 127 KRFVHRDIAARNVLVSSNDCVKLGDFGLS---RYMEDSTYYKASKGKLPIKWMAPESINF 183

Query: 191 RGYDGATSDIWSCGVILY---------------------IFRGD-FKLPKWLSPGAQNLL 228
           R +  A SD+W  GV ++                     I  G+   +P    P   +L+
Sbjct: 184 RRFTSA-SDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYSLM 242

Query: 229 RKILEPNPVKRITIAGIKAD 248
            K    +P +R     +KA 
Sbjct: 243 TKCWAYDPSRRPRFTELKAQ 262

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  172 bits (437), Expect = 8e-52
 Identities = 54/252 (21%), Positives = 95/252 (37%), Gaps = 30/252 (11%)

Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
                + +G G FG V     L+     A+K + +  +      +    E   +  L HP
Sbjct: 6   ELTFVQEIGSGQFGLVHLGYWLN-KDKVAIKTIREGAMSE----EDFIEEAEVMMKLSHP 60

Query: 75  NVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQ-EAEGRKLFQQLIDGVSYCHNK 133
            +V+L+ V   ++ I +V E++  G L D + ++  L        +   + +G++Y    
Sbjct: 61  KLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEA 120

Query: 134 GVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGY 193
            V HRDL   N L+     IK+SDFG++              T     + +PEV +   Y
Sbjct: 121 CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLD-DQYTSSTGTKFPVKWASPEVFSFSRY 179

Query: 194 DGATSDIWSCGVILY---------------------IFRG-DFKLPKWLSPGAQNLLRKI 231
               SD+WS GV+++                     I  G     P+  S     ++   
Sbjct: 180 SSK-SDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNHC 238

Query: 232 LEPNPVKRITIA 243
            +  P  R   +
Sbjct: 239 WKERPEDRPAFS 250

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  175 bits (443), Expect = 1e-51
 Identities = 74/303 (24%), Positives = 115/303 (37%), Gaps = 65/303 (21%)

Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
            Y   + +G G +G V  A D  +G   A+K L +          +  RE+  LK ++H 
Sbjct: 19  VYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSE-LFAKRAYRELRLLKHMRHE 77

Query: 75  NVVRLHEV------LASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVS 128
           NV+ L +V      L   +  Y+V+ ++  G    K+    +L E   + L  Q++ G+ 
Sbjct: 78  NVIGLLDVFTPDETLDDFTDFYLVMPFM--GTDLGKLMKHEKLGEDRIQFLVYQMLKGLR 135

Query: 129 YCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVL 188
           Y H  G+ HRDLK  N+ ++    +KI DFGL+        D  +     +  Y APEV+
Sbjct: 136 YIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQA-----DSEMTGYVVTRWYRAPEVI 190

Query: 189 ANRGYDGATSDIWSCGVILY--------------------IFRGDFKLPKW--------- 219
            N      T DIWS G I+                     I +     P           
Sbjct: 191 LNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDE 250

Query: 220 ----------------------LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTP 257
                                  SP A NLL K+L  +  +R+T     A  +FE  +  
Sbjct: 251 AKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDT 310

Query: 258 ANP 260
            + 
Sbjct: 311 EDE 313

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  172 bits (436), Expect = 3e-51
 Identities = 63/250 (25%), Positives = 97/250 (38%), Gaps = 30/250 (12%)

Query: 22  LGEGNFGKVKFAQD--LDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRL 79
           LG GNFG V+          +  A+K+L++        T+++ RE   +  L +P +VRL
Sbjct: 17  LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG--TEKADTEEMMREAQIMHQLDNPYIVRL 74

Query: 80  HEVLASKSKIYMVLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNKGVFHR 138
             V      + +V+E   GG L   +  K   +  +   +L  Q+  G+ Y   K   HR
Sbjct: 75  IGVC-QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHR 133

Query: 139 DLKLENILLDSKGNIKISDFGLS-ALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGAT 197
           DL   N+LL ++   KISDFGLS AL                  + APE +  R +    
Sbjct: 134 DLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSR- 192

Query: 198 SDIWSCGVILY---------------------IFRGD-FKLPKWLSPGAQNLLRKILEPN 235
           SD+WS GV ++                     I +G   + P    P    L+       
Sbjct: 193 SDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPPELYALMSDCWIYK 252

Query: 236 PVKRITIAGI 245
              R     +
Sbjct: 253 WEDRPDFLTV 262

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  170 bits (432), Expect = 2e-50
 Identities = 78/295 (26%), Positives = 123/295 (41%), Gaps = 62/295 (21%)

Query: 15  RYELGRTLGEGNFGKVKFAQDL-DSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK- 72
           +YE    +GEG +GKV  A+DL + G   A+K + + +     +     RE+A L+ L+ 
Sbjct: 8   QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRV-RVQTGEEGMPLSTIREVAVLRHLET 66

Query: 73  --HPNVVRLHEVLAS-----KSKIYMVLEYVTGGEL-FDKIASKGRLQEAEGRKLFQQLI 124
             HPNVVRL +V        ++K+ +V E+V      +     +  +     + +  QL+
Sbjct: 67  FEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLL 126

Query: 125 DGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVA 184
            G+ + H+  V HRDLK +NIL+ S G IK++DFGL+ +           +   +  Y A
Sbjct: 127 RGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMAL---TSVVVTLWYRA 183

Query: 185 PEVLANRGYDGATSDIWSCGVILY-------IFRGD------------------------ 213
           PEVL    Y     D+WS G I         +FRG                         
Sbjct: 184 PEVLLQSSYATP-VDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRD 242

Query: 214 ----------------FKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFE 252
                            K    +    ++LL K L  NP KRI+     +  +F+
Sbjct: 243 VALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQ 297

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  168 bits (427), Expect = 7e-50
 Identities = 55/262 (20%), Positives = 100/262 (38%), Gaps = 32/262 (12%)

Query: 13  LGRYELGRTLGEGNFGKVKFAQDLDSG---LPFAVKILEKNRIIHLKITDQIKREIATLK 69
           +   ++ + +G G FG+V        G   +  A+K L+       K       E + + 
Sbjct: 25  ISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYT--EKQRRDFLSEASIMG 82

Query: 70  LLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVS 128
              HPNV+ L  V+   + + ++ E++  G L   +    G+    +   + + +  G+ 
Sbjct: 83  QFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMK 142

Query: 129 YCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTT---CGSPNYVAP 185
           Y  +    HRDL   NIL++S    K+SDFGLS   +    D    +         + AP
Sbjct: 143 YLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAP 202

Query: 186 EVLANRGYDGATSDIWSCGVILY--------------------IFRGDFKLPKW--LSPG 223
           E +  R +  A SD+WS G++++                        D++LP        
Sbjct: 203 EAIQYRKFTSA-SDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLPPPMDCPSA 261

Query: 224 AQNLLRKILEPNPVKRITIAGI 245
              L+    + +   R     I
Sbjct: 262 LHQLMLDCWQKDRNHRPKFGQI 283

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  167 bits (424), Expect = 2e-49
 Identities = 52/293 (17%), Positives = 92/293 (31%), Gaps = 47/293 (16%)

Query: 11  MRLG-RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLK 69
           +R+G RY LGR +G G+FG +    D+ +G   A+K+             Q+  E    K
Sbjct: 3   LRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVK-----TKHPQLHIESKIYK 57

Query: 70  LLKHPN-VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVS 128
           +++    +  +    A      MV+E +             +        L  Q+I  + 
Sbjct: 58  MMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIE 117

Query: 129 YCHNKGVFHRDLKLENILLDSKG---NIKISDFGLSALPQHFRDDGLLH-----TTCGSP 180
           Y H+K   HRD+K +N L+        + I DFGL+   +  R    +         G+ 
Sbjct: 118 YIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTA 177

Query: 181 NYVAPEVLANRGYDGATSDIWSCGVILYIF----------------------------RG 212
            Y +              D+ S G +L  F                              
Sbjct: 178 RYASINTHLGIEQSRR-DDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP 236

Query: 213 DFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKA---DEWFEQDYTPANPDD 262
              L K         L          +   + ++    + +  Q ++     D
Sbjct: 237 IEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFD 289

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  167 bits (423), Expect = 3e-49
 Identities = 62/282 (21%), Positives = 103/282 (36%), Gaps = 54/282 (19%)

Query: 15  RYELGRTLGEGNFGKV-----KFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLK 69
             E  R +GEG FG+V           +     AVK+L++     ++     +RE A + 
Sbjct: 14  NIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQ--ADFQREAALMA 71

Query: 70  LLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGR------------------- 110
              +PN+V+L  V A    + ++ EY+  G+L + + S                      
Sbjct: 72  EFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSS 131

Query: 111 -----LQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQ 165
                L  AE   + +Q+  G++Y   +   HRDL   N L+     +KI+DFGLS    
Sbjct: 132 PGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIY 191

Query: 166 HFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILY----------------- 208
                           ++ PE +    Y    SD+W+ GV+L+                 
Sbjct: 192 SADYYKADGNDAIPIRWMPPESIFYNRYTTE-SDVWAYGVVLWEIFSYGLQPYYGMAHEE 250

Query: 209 ----IFRGDF-KLPKWLSPGAQNLLRKILEPNPVKRITIAGI 245
               +  G+    P+       NL+R      P  R +   I
Sbjct: 251 VIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSI 292

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  168 bits (425), Expect = 4e-49
 Identities = 76/321 (23%), Positives = 121/321 (37%), Gaps = 71/321 (22%)

Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
           RY+    +G G +G V  A D  +GL  AVK L +     +    +  RE+  LK +KH 
Sbjct: 19  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ-SIIHAKRTYRELRLLKHMKHE 77

Query: 75  NVVRLHEVLASKSKI-----YMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSY 129
           NV+ L +V      +       ++ ++ G    + I    +L +   + L  Q++ G+ Y
Sbjct: 78  NVIGLLDVFTPARSLEEFNDVYLVTHLMGA-DLNNIVKCQKLTDDHVQFLIYQILRGLKY 136

Query: 130 CHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLA 189
            H+  + HRDLK  N+ ++    +KI DFGL+                 +  Y APE++ 
Sbjct: 137 IHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM-----TGYVATRWYRAPEIML 191

Query: 190 NRGYDGATSDIWSCGVILY--------------------IFRGDFKLPKWL--------- 220
           N  +   T DIWS G I+                     I R        L         
Sbjct: 192 NWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESA 251

Query: 221 ----------------------SPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPA 258
                                 +P A +LL K+L  +  KRIT A   A  +F Q + P 
Sbjct: 252 RNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 311

Query: 259 --------NPDDDEEDIFVDN 271
                   +   +  D+ +D 
Sbjct: 312 DEPVADPYDQSFESRDLLIDE 332

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  166 bits (421), Expect = 7e-49
 Identities = 65/278 (23%), Positives = 109/278 (39%), Gaps = 50/278 (17%)

Query: 15  RYELGRTLGEGNFGKVKFAQDL-----DSGLPFAVKILEKNRIIHLKITDQIKREIATLK 69
           R   G+TLG G FGKV  A        D+ +  AVK+L+ +   HL   + +  E+  L 
Sbjct: 24  RLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA--HLTEREALMSELKVLS 81

Query: 70  LLK-HPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKG------------------R 110
            L  H N+V L           ++ EY   G+L + +  K                    
Sbjct: 82  YLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELA 141

Query: 111 LQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD 170
           L   +      Q+  G+++  +K   HRDL   NILL      KI DFGL+   ++  + 
Sbjct: 142 LDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNY 201

Query: 171 GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILY---------------------I 209
            +         ++APE + N       SD+WS G+ L+                     +
Sbjct: 202 VVKGNARLPVKWMAPESIFN-CVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKM 260

Query: 210 FRGDFKL--PKWLSPGAQNLLRKILEPNPVKRITIAGI 245
            +  F++  P+       ++++   + +P+KR T   I
Sbjct: 261 IKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQI 298

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  166 bits (422), Expect = 7e-49
 Identities = 51/285 (17%), Positives = 102/285 (35%), Gaps = 26/285 (9%)

Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEK--NRIIHLKITDQIKREIATLKLLKH 73
           ++  + LG G FG V     +  G    + +  K        K   +I  E   +  + +
Sbjct: 11  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 70

Query: 74  PNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNK 133
           P+V RL  +  + +   +      G  L      K  +          Q+  G++Y  ++
Sbjct: 71  PHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR 130

Query: 134 GVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGY 193
            + HRDL   N+L+ +  ++KI+DFGL+ L      +           ++A E + +R Y
Sbjct: 131 RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIY 190

Query: 194 DGATSDIWSCGVILY---------------------IFRGD-FKLPKWLSPGAQNLLRKI 231
               SD+WS GV ++                     + +G+    P   +     ++ K 
Sbjct: 191 THQ-SDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKC 249

Query: 232 LEPNPVKRITIAGIKAD-EWFEQDYTPANPDDDEEDIFVDNEAFS 275
              +   R     +  +     +D         +E + + +   S
Sbjct: 250 WMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDS 294

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  161 bits (407), Expect = 5e-47
 Identities = 40/235 (17%), Positives = 80/235 (34%), Gaps = 18/235 (7%)

Query: 14  GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKH 73
             Y++GR +GEG+FG +    +L +    A+K   +          Q++ E  T KLL  
Sbjct: 5   VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRR-----SDAPQLRDEYRTYKLLAG 59

Query: 74  -PNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHN 132
              +  ++          +V++ +             +          +Q++  V   H 
Sbjct: 60  CTGIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHE 119

Query: 133 KGVFHRDLKLENILLDSK-----GNIKISDFGLSALPQHFRDDGLLH-----TTCGSPNY 182
           K + +RD+K +N L+          I + DFG+    +       +         G+  Y
Sbjct: 120 KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARY 179

Query: 183 VAPEVLANRGYDGATSDIWSCGVILY-IFRGDFKLPKWLSPGAQNLLRKILEPNP 236
           ++      R       D+ + G +     RG        +   +    +I E   
Sbjct: 180 MSINTHLGREQSRR-DDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQ 233

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  158 bits (401), Expect = 3e-46
 Identities = 58/259 (22%), Positives = 97/259 (37%), Gaps = 31/259 (11%)

Query: 15  RYELGRTLGEGNFGKVKFAQDLDSG----LPFAVKILEKNRIIHLKITDQIKREIATLKL 70
                + +G G FG+V       S     +P A+K L+       ++      E   +  
Sbjct: 8   CVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRV--DFLGEAGIMGQ 65

Query: 71  LKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSY 129
             H N++RL  V++    + ++ EY+  G L   +  K G     +   + + +  G+ Y
Sbjct: 66  FSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKY 125

Query: 130 CHNKGVFHRDLKLENILLDSKGNIKISDFGLSA-LPQHFRDDGLLHTTCGSPNYVAPEVL 188
             N    HRDL   NIL++S    K+SDFGLS  L                  + APE +
Sbjct: 126 LANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAI 185

Query: 189 ANRGYDGATSDIWSCGVILY---------------------IFRG-DFKLPKWLSPGAQN 226
           + R +  A SD+WS G++++                     I  G     P         
Sbjct: 186 SYRKFTSA-SDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMDCPSAIYQ 244

Query: 227 LLRKILEPNPVKRITIAGI 245
           L+ +  +    +R   A I
Sbjct: 245 LMMQCWQQERARRPKFADI 263

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  158 bits (401), Expect = 1e-45
 Identities = 57/299 (19%), Positives = 111/299 (37%), Gaps = 74/299 (24%)

Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK-H 73
            Y+L R LG G + +V  A ++ +     VKIL+  +        +IKREI  L+ L+  
Sbjct: 36  DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKK------KKIKREIKILENLRGG 89

Query: 74  PNVVRLHEVLASKSK--IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCH 131
           PN++ L +++         +V E+V   +          L + + R    +++  + YCH
Sbjct: 90  PNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYCH 146

Query: 132 NKGVFHRDLKLENILLDSKGN-IKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLAN 190
           + G+ HRD+K  N+++D +   +++ D+GL+   + +      +    S  +  PE+L +
Sbjct: 147 SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLA---EFYHPGQEYNVRVASRYFKGPELLVD 203

Query: 191 RGYDGATSDIWSCGVILY----------------------------------IFRGDFKL 216
                 + D+WS G +L                                   I + + +L
Sbjct: 204 YQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIEL 263

Query: 217 PKWLSPGAQNLLRK------------------------ILEPNPVKRITIAGIKADEWF 251
               +       RK                        +L  +   R+T        +F
Sbjct: 264 DPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYF 322

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  156 bits (396), Expect = 2e-45
 Identities = 65/280 (23%), Positives = 109/280 (38%), Gaps = 49/280 (17%)

Query: 15  RYELGRTLGEGNFGKVKFAQDL-------DSGLPFAVKILEKNRIIHLKITDQIKREIAT 67
           R  LG+ LGEG FG+V  A+ +       +     AVK+L+ +     K    +  E+  
Sbjct: 14  RLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDAT--EKDLSDLISEMEM 71

Query: 68  LK-LLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKI----------------ASKGR 110
           +K + KH N++ L         +Y+++EY + G L + +                  + +
Sbjct: 72  MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQ 131

Query: 111 LQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD 170
           L   +      Q+  G+ Y  +K   HRDL   N+L+     +KI+DFGL+    H    
Sbjct: 132 LSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYY 191

Query: 171 GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYI--------FRGD--------- 213
                      ++APE L +R Y    SD+WS GV+L+         + G          
Sbjct: 192 KKTTNGRLPVKWMAPEALFDRIYTHQ-SDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLL 250

Query: 214 -----FKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKAD 248
                   P   +     ++R      P +R T   +  D
Sbjct: 251 KEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 290

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  156 bits (395), Expect = 4e-45
 Identities = 64/281 (22%), Positives = 108/281 (38%), Gaps = 38/281 (13%)

Query: 15  RYELGRTLGEGNFGKVKFAQDLDS---GLPFAVKILEKNRIIHLKITDQIKREIATLKLL 71
                  +G G+FG V     LD+    +  AVK L  NRI  +    Q   E   +K  
Sbjct: 28  IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL--NRITDIGEVSQFLTEGIIMKDF 85

Query: 72  KHPNVVRLHEV-LASKSKIYMVLEYVTGGELFD-KIASKGRLQEAEGRKLFQQLIDGVSY 129
            HPNV+ L  + L S+    +VL Y+  G+L +            +      Q+  G+ +
Sbjct: 86  SHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKF 145

Query: 130 CHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTT--CGSPNYVAPEV 187
             +K   HRDL   N +LD K  +K++DFGL+        D + + T       ++A E 
Sbjct: 146 LASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALES 205

Query: 188 LANRGYDGATSDIWSCGVILY---------------------IFRGD-FKLPKWLSPGAQ 225
           L  + +    SD+WS GV+L+                     + +G     P++      
Sbjct: 206 LQTQKFTTK-SDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLY 264

Query: 226 NLLRKILEPNPVKRITIAGIKA------DEWFEQDYTPANP 260
            ++ K   P    R + + + +        +  + Y   N 
Sbjct: 265 EVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGEHYVHVNA 305

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  153 bits (386), Expect = 7e-44
 Identities = 51/214 (23%), Positives = 89/214 (41%), Gaps = 26/214 (12%)

Query: 14  GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKH 73
               L  ++G+G FG+V   +    G   AVKI               + EI    +L+H
Sbjct: 3   RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREERSW----FREAEIYQTVMLRH 56

Query: 74  PNVVRLHEVL----ASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSY 129
            N++           + +++++V +Y   G LFD + ++  +      KL      G+++
Sbjct: 57  ENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYL-NRYTVTVEGMIKLALSTASGLAH 115

Query: 130 CH--------NKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD--DGLLHTTCGS 179
            H           + HRDLK +NIL+   G   I+D GL+       D  D   +   G+
Sbjct: 116 LHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGT 175

Query: 180 PNYVAPEVL-----ANRGYDGATSDIWSCGVILY 208
             Y+APEVL              +DI++ G++ +
Sbjct: 176 KRYMAPEVLDDSINMKHFESFKRADIYAMGLVFW 209

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  151 bits (381), Expect = 5e-43
 Identities = 56/291 (19%), Positives = 109/291 (37%), Gaps = 42/291 (14%)

Query: 15  RYELGRTLGEGNFGKV-----KFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLK 69
           +  + R LG+G+FG V     K     +     A+K + +     ++   +   E + +K
Sbjct: 21  KITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA--SMRERIEFLNEASVMK 78

Query: 70  LLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGR----------LQEAEGRKL 119
                +VVRL  V++      +++E +T G+L   + S                ++  ++
Sbjct: 79  EFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQM 138

Query: 120 FQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGS 179
             ++ DG++Y +     HRDL   N ++     +KI DFG++                  
Sbjct: 139 AGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLP 198

Query: 180 PNYVAPEVLANRGYDGATSDIWSCGVILY---------------------IFRGD-FKLP 217
             +++PE L +  +   + D+WS GV+L+                     +  G     P
Sbjct: 199 VRWMSPESLKDGVFTTYS-DVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDKP 257

Query: 218 KWLSPGAQNLLRKILEPNPVKRITIAGIKA--DEWFEQDYTPANPDDDEED 266
                    L+R   + NP  R +   I +   E  E  +   +    EE+
Sbjct: 258 DNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFREVSFYYSEEN 308

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  146 bits (370), Expect = 2e-41
 Identities = 62/276 (22%), Positives = 101/276 (36%), Gaps = 47/276 (17%)

Query: 15  RYELGRTLGEGNFGKVKFAQD-----LDSGLPFAVKILEKNRIIHLKITDQIKREIATLK 69
           R +LG+ LG G FG+V  A         +    AVK+L++    H +    +      + 
Sbjct: 14  RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT-HSEHRALMSELKILIH 72

Query: 70  LLKHPNVVRLHEVLASK-SKIYMVLEYVTGGELFDKIASKGR----------------LQ 112
           +  H NVV L          + +++E+   G L   + SK                  L 
Sbjct: 73  IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 132

Query: 113 EAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGL 172
                    Q+  G+ +  ++   HRDL   NILL  K  +KI DFGL+       D   
Sbjct: 133 LEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVR 192

Query: 173 LHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILY--------IFRGD----------- 213
                    ++APE + +R Y    SD+WS GV+L+         + G            
Sbjct: 193 KGDARLPLKWMAPETIFDRVYT-IQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLK 251

Query: 214 ----FKLPKWLSPGAQNLLRKILEPNPVKRITIAGI 245
                + P + +P     +       P +R T + +
Sbjct: 252 EGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSEL 287

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  141 bits (355), Expect = 7e-39
 Identities = 68/338 (20%), Positives = 114/338 (33%), Gaps = 79/338 (23%)

Query: 13  LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK 72
           L RY+  + +G G  G V  A D       A+K L +    +     +  RE+  +K + 
Sbjct: 16  LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSR-PFQNQTHAKRAYRELVLMKCVN 74

Query: 73  HPNVVRLHEVLASKSK------IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDG 126
           H N++ L  V   +        +Y+V+E +           +  L       L  Q++ G
Sbjct: 75  HKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVI---QMELDHERMSYLLYQMLCG 131

Query: 127 VSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPE 186
           + + H+ G+ HRDLK  NI++ S   +KI DFGL+   +      ++     +  Y APE
Sbjct: 132 IKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA---RTAGTSFMMTPYVVTRYYRAPE 188

Query: 187 VLANRGYDGATSDIWSCGVILY--------------------IFRGDFKLPKWLSPGAQN 226
           V+   GY     DIWS G I+                     +               Q 
Sbjct: 189 VILGMGYKEN-VDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQP 247

Query: 227 LLRKILE------------------------------------------PNPVKRITIAG 244
            +R  +E                                           +P KRI++  
Sbjct: 248 TVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDD 307

Query: 245 IKADEWFEQDYTPANPDDDEEDIF---VDNEAFSMHEV 279
                +    Y PA  +     I+   +D    ++ E 
Sbjct: 308 ALQHPYINVWYDPAEVEAPPPQIYDKQLDEREHTIEEW 345

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  120 bits (300), Expect = 4e-31
 Identities = 49/252 (19%), Positives = 100/252 (39%), Gaps = 30/252 (11%)

Query: 14  GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKH 73
            RY L R LG G+F  V  A+D+ +    A+KI+  +++     T+  + EI  L+ +  
Sbjct: 13  ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKV----YTEAAEDEIKLLQRVND 68

Query: 74  PNVVRL-------------HEVLASKSKIYMVLEYVTGG---ELFDKIASKGRLQEAEGR 117
            +  +              H      + +++V+ +   G       K      +     +
Sbjct: 69  ADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVK 128

Query: 118 KLFQQLIDGVSYCHNK-GVFHRDLKLENILLDSKGNI-KISDFGLSALPQHFRDDGLLHT 175
           ++ +QL+ G+ Y H + G+ H D+K EN+L++   +   +    ++ L      D     
Sbjct: 129 QISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTN 188

Query: 176 TCGSPNYVAPEVLANRGYDGATSDIWSCGVILY-------IFRGDFKLPKWLSPGAQNLL 228
           +  +  Y +PEVL    +    +DIWS   +++       +F  D              +
Sbjct: 189 SIQTREYRSPEVLLGAPWGCG-ADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQI 247

Query: 229 RKILEPNPVKRI 240
            ++L   P   +
Sbjct: 248 IELLGELPSYLL 259

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score = 45.0 bits (105), Expect = 8e-06
 Identities = 10/52 (19%), Positives = 19/52 (36%), Gaps = 1/52 (1%)

Query: 209 IFRGDFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPANP 260
           +    +K  K  +    + L  +L+ +P KR    G+    W  +D      
Sbjct: 289 VLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNHPWL-KDTLGMEE 339

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 93.7 bits (232), Expect = 4e-23
 Identities = 36/209 (17%), Positives = 70/209 (33%), Gaps = 36/209 (17%)

Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITD---------------Q 60
             +G+ +GEG    V             VK  +       K+ +                
Sbjct: 2   DAIGKLMGEGKESAVFNCYSEK-FGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRS 60

Query: 61  IKREIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLF 120
            + E   L+ L+   V +++          +++E +   EL+         +     ++ 
Sbjct: 61  ARNEFRALQKLQGLAVPKVYAW----EGNAVLMELIDAKELYRV-------RVENPDEVL 109

Query: 121 QQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP 180
             +++ V+  +++G+ H DL   N+L+  +G I I DF  S          +L     + 
Sbjct: 110 DMILEEVAKFYHRGIVHGDLSQYNVLVSEEG-IWIIDFPQSVEVGEEGWREILERDVRNI 168

Query: 181 NYVAPEVLANRGYDGATSDIWSCGVILYI 209
                    +R Y     DI S   I  I
Sbjct: 169 IT-----YFSRTY-RTEKDINS--AIDRI 189

>d1ul7a_ d.129.6.1 (A:) Map/microtubule affinity-regulating kinase 3 {Mouse (Mus musculus) [TaxId: 10090]} Length = 102

class: Alpha and beta proteins (a+b)
fold: TBP-like
superfamily: KA1-like
family: Kinase associated domain 1, KA1
domain: Map/microtubule affinity-regulating kinase 3
species: Mouse (Mus musculus) [TaxId: 10090]

 Score = 69.8 bits (171), Expect = 1e-15
 Identities = 16/99 (16%), Positives = 38/99 (38%), Gaps = 8/99 (8%)

Query: 319 RKIRF------TSNHSAKDLLERIEDIVTEMGFRVQKKNGKLKATQEHKPQKSLGSLSVA 372
              RF      TS+    D++  I  ++        ++  +      H    +   +   
Sbjct: 5   SSGRFTWSMKTTSSMDPSDMMREIRKVLGANNCDY-EQRERFLLFCVHGDGHAENLVQWE 63

Query: 373 AEVFEI-SPSLYVVELRKSYGDPTVYRQLCNKLSSDLGL 410
            EV ++   SL  V  ++  G    ++ + +K++++L L
Sbjct: 64  MEVCKLPRLSLNGVRFKRISGTSIAFKNIASKIANELKL 102

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	421
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	100.0
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.94
d1ul7a_	102	Map/microtubule affinity-regulating kinase 3 {Mous	99.49
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.73
d2v8qa1	153	5'-AMP-activated protein kinase catalytic subunit	98.48
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	98.24
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	98.23
d2qrda1	127	Snf1-like protein kinase ssp2 {Schizosaccharomyces	97.97
d2qlva1	171	Carbon catabolite-derepressing protein kinase SNF1	97.62
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	97.36
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	97.22
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	96.5

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-61  Score=458.20  Aligned_cols=241  Identities=39%  Similarity=0.714  Sum_probs=212.3

Q ss_pred             ecceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEE
Q 014609           13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMV   92 (421)
Q Consensus        13 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv   92 (421)
                      +++|++++.||+|+||+||+|+++.+|+.||||++++.....  ..+.+.+|+++|++++||||+++++++.+++.+|+|
T Consensus         4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~--~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~iv   81 (271)
T d1nvra_           4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVD--CPENIKKEICINKMLNHENVVKFYGHRREGNIQYLF   81 (271)
T ss_dssp             TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC---------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcch--HHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEE
Confidence            578999999999999999999999999999999998654322  246789999999999999999999999999999999


Q ss_pred             EeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCccccCCCc
Q 014609           93 LEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGL  172 (421)
Q Consensus        93 ~E~~~gg~L~~~i~~~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~  172 (421)
                      |||++||+|++++...+.+++..++.++.||++||+|||++||+||||||+|||++.++++||+|||+|...........
T Consensus        82 mEy~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~~~  161 (271)
T d1nvra_          82 LEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERL  161 (271)
T ss_dssp             EECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECEETTEECC
T ss_pred             EeccCCCcHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEECCCCCEEEccchhheeeccCCcccc
Confidence            99999999999998888999999999999999999999999999999999999999999999999999986644333344


Q ss_pred             cccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhh-cCCcCCC----------------------CCCCHHHHHHHH
Q 014609          173 LHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIF-RGDFKLP----------------------KWLSPGAQNLLR  229 (421)
Q Consensus       173 ~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~-~~~~~~p----------------------~~~s~~~~~li~  229 (421)
                      ....+||+.|+|||++.+..+++.++|||||||++|++ .|..++.                      ..+|+++.+||.
T Consensus       162 ~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~  241 (271)
T d1nvra_         162 LNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLH  241 (271)
T ss_dssp             BCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCTTSTTGGGSCHHHHHHHH
T ss_pred             ccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccCCHHHHHHHH
Confidence            56779999999999999888877889999999999954 4444432                      236899999999


Q ss_pred             HhcCCCCCCCCCHHhhhcCccccccc
Q 014609          230 KILEPNPVKRITIAGIKADEWFEQDY  255 (421)
Q Consensus       230 ~~L~~dP~~R~t~~eil~~~w~~~~~  255 (421)
                      +||++||.+|||++|+++||||++..
T Consensus       242 ~~L~~dP~~R~t~~eil~hpwf~~~l  267 (271)
T d1nvra_         242 KILVENPSARITIPDIKKDRWYNKPL  267 (271)
T ss_dssp             HHSCSSTTTSCCHHHHTTCTTTTCCC
T ss_pred             HHcCCChhHCcCHHHHhcCHhhCcCC
Confidence            99999999999999999999998644

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-60  Score=449.45  Aligned_cols=238  Identities=33%  Similarity=0.687  Sum_probs=216.3

Q ss_pred             eecceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEE
Q 014609           12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYM   91 (421)
Q Consensus        12 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l   91 (421)
                      .+++|++++.||+|+||+||+|++..+|+.||+|++.+.........+.+.+|+++|++++||||+++++++.+++.+|+
T Consensus         4 ~l~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i   83 (263)
T d2j4za1           4 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYL   83 (263)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred             chhHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEE
Confidence            47899999999999999999999999999999999987655444556789999999999999999999999999999999


Q ss_pred             EEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCccccCCC
Q 014609           92 VLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDG  171 (421)
Q Consensus        92 v~E~~~gg~L~~~i~~~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~  171 (421)
                      ||||++||+|.+++...+.+++..++.++.||++||+|||++||+||||||+|||++.+|.+||+|||+|....    ..
T Consensus        84 vmEy~~~g~L~~~l~~~~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~----~~  159 (263)
T d2j4za1          84 ILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP----SS  159 (263)
T ss_dssp             EEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCSCSCCC----CC
T ss_pred             EEeecCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccceecCCCCEeecccceeeecC----CC
Confidence            99999999999999988899999999999999999999999999999999999999999999999999997543    23


Q ss_pred             ccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhh--------------------cCCcCCCCCCCHHHHHHHHHh
Q 014609          172 LLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIF--------------------RGDFKLPKWLSPGAQNLLRKI  231 (421)
Q Consensus       172 ~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~--------------------~~~~~~p~~~s~~~~~li~~~  231 (421)
                      .....+||+.|+|||++.+.+| +.++|||||||++|++                    .+.+.+|+.+|+++.+||.+|
T Consensus       160 ~~~~~~Gt~~Y~APE~~~~~~~-~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~  238 (263)
T d2j4za1         160 RRTTLCGTLDYLPPEMIEGRMH-DEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRL  238 (263)
T ss_dssp             CCEETTEEGGGCCHHHHTTCCC-CTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCTTSCHHHHHHHHHH
T ss_pred             cccccCCCCcccCHHHHcCCCC-CchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCccCCHHHHHHHHHH
Confidence            4456789999999999998888 5899999999999932                    334456777999999999999


Q ss_pred             cCCCCCCCCCHHhhhcCcccccc
Q 014609          232 LEPNPVKRITIAGIKADEWFEQD  254 (421)
Q Consensus       232 L~~dP~~R~t~~eil~~~w~~~~  254 (421)
                      |++||.+|||++|+++||||...
T Consensus       239 L~~dp~~R~t~~eil~hp~~~~~  261 (263)
T d2j4za1         239 LKHNPSQRPMLREVLEHPWITAN  261 (263)
T ss_dssp             TCSSGGGSCCHHHHHTCHHHHHH
T ss_pred             ccCCHhHCcCHHHHHcCcCcCCc
Confidence            99999999999999999999754

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-59  Score=448.66  Aligned_cols=242  Identities=33%  Similarity=0.588  Sum_probs=212.0

Q ss_pred             eeecceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEE
Q 014609           11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIY   90 (421)
Q Consensus        11 ~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~   90 (421)
                      .+-++|++++.||+|+||+||+|++..+|+.||||++++.........+.+.+|+++|++++||||+++++++.+++.+|
T Consensus         5 ~~p~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~   84 (288)
T d1uu3a_           5 KRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLY   84 (288)
T ss_dssp             CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEE
T ss_pred             CCCCCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEE
Confidence            34578999999999999999999999999999999998765544445678999999999999999999999999999999


Q ss_pred             EEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCccccCC
Q 014609           91 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD  170 (421)
Q Consensus        91 lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~  170 (421)
                      +||||++||+|.+++...+.+++..++.++.|++.||+|||++||+||||||+|||++.+|.+||+|||+|.........
T Consensus        85 ivmEy~~gg~L~~~~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~~  164 (288)
T d1uu3a_          85 FGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQ  164 (288)
T ss_dssp             EEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECC-----
T ss_pred             EEEEccCCCCHHHhhhccCCCCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccCCCceEEecccccceecccCCcc
Confidence            99999999999999999899999999999999999999999999999999999999999999999999999876544444


Q ss_pred             CccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhh--------------------cCCcCCCCCCCHHHHHHHHH
Q 014609          171 GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIF--------------------RGDFKLPKWLSPGAQNLLRK  230 (421)
Q Consensus       171 ~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~--------------------~~~~~~p~~~s~~~~~li~~  230 (421)
                      ....+.+||+.|+|||++.+..| +.++|||||||++|.+                    .+.+.+|..+|+++++||++
T Consensus       165 ~~~~~~~GT~~Y~APE~~~~~~~-~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~  243 (288)
T d1uu3a_         165 ARANSFVGTAQYVSPELLTEKSA-CKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEK  243 (288)
T ss_dssp             -----CCCCGGGCCHHHHHTCCC-CHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCCTTCCHHHHHHHHT
T ss_pred             cccccccCCccccCceeeccCCC-CcccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHHcCCCCCCccCCHHHHHHHHH
Confidence            45567799999999999998888 5899999999999932                    34456677899999999999


Q ss_pred             hcCCCCCCCCCHHh------hhcCccccc
Q 014609          231 ILEPNPVKRITIAG------IKADEWFEQ  253 (421)
Q Consensus       231 ~L~~dP~~R~t~~e------il~~~w~~~  253 (421)
                      ||++||.+|||++|      +++||||+.
T Consensus       244 ~L~~dP~~R~t~~e~~~~~~i~~Hpff~~  272 (288)
T d1uu3a_         244 LLVLDATKRLGCEEMEGYGPLKAHPFFES  272 (288)
T ss_dssp             TSCSSGGGSTTSGGGTCHHHHHTSGGGTT
T ss_pred             HccCCHhHCcCHHHHcCCHHHHcCCccCC
Confidence            99999999999998      477888864

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.1e-59  Score=451.37  Aligned_cols=240  Identities=33%  Similarity=0.623  Sum_probs=218.3

Q ss_pred             eeecceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEE
Q 014609           11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIY   90 (421)
Q Consensus        11 ~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~   90 (421)
                      ..+++|++++.||+|+||+||+|++..+|+.||||++++.........+.+.+|+.+|++++||||+++++++.+++.+|
T Consensus         2 i~l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~   81 (337)
T d1o6la_           2 VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLC   81 (337)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEE
T ss_pred             CchHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccc
Confidence            46889999999999999999999999999999999998765544445678999999999999999999999999999999


Q ss_pred             EEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCccccCC
Q 014609           91 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD  170 (421)
Q Consensus        91 lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~  170 (421)
                      +||||++||+|++++...+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+....  ..
T Consensus        82 iv~ey~~gg~L~~~~~~~~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~--~~  159 (337)
T d1o6la_          82 FVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS--DG  159 (337)
T ss_dssp             EEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC--TT
T ss_pred             cceeccCCCchhhhhhcccCCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEecCCCCEEEeeccccccccc--CC
Confidence            9999999999999999999999999999999999999999999999999999999999999999999999985432  23


Q ss_pred             CccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhh--------------------cCCcCCCCCCCHHHHHHHHH
Q 014609          171 GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIF--------------------RGDFKLPKWLSPGAQNLLRK  230 (421)
Q Consensus       171 ~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~--------------------~~~~~~p~~~s~~~~~li~~  230 (421)
                      ....+.|||+.|+|||++.+.+| +.++|||||||++|++                    .+.+++|..+|+++.+||++
T Consensus       160 ~~~~~~~GT~~Y~aPE~~~~~~y-~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~dli~~  238 (337)
T d1o6la_         160 ATMKTFCGTPEYLAPEVLEDNDY-GRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAG  238 (337)
T ss_dssp             CCBCCCEECGGGCCGGGGSSSCB-CTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHH
T ss_pred             cccccceeCHHHhhhhhccCCCC-ChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHhcCCCCCCccCCHHHHHHHHh
Confidence            45567899999999999999988 5899999999999943                    23456677899999999999


Q ss_pred             hcCCCCCCCCC-----HHhhhcCccccc
Q 014609          231 ILEPNPVKRIT-----IAGIKADEWFEQ  253 (421)
Q Consensus       231 ~L~~dP~~R~t-----~~eil~~~w~~~  253 (421)
                      ||++||.+|++     ++|+++||||..
T Consensus       239 ~L~~dP~~R~~~~~~~~~eil~Hp~f~~  266 (337)
T d1o6la_         239 LLKKDPKQRLGGGPSDAKEVMEHRFFLS  266 (337)
T ss_dssp             HTCSSTTTSTTCSTTTHHHHHTSGGGTT
T ss_pred             hccCCchhhcccccccHHHHHcCccccc
Confidence            99999999994     899999999975

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.9e-58  Score=439.49  Aligned_cols=233  Identities=27%  Similarity=0.492  Sum_probs=208.1

Q ss_pred             cceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEE
Q 014609           14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVL   93 (421)
Q Consensus        14 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~   93 (421)
                      ++|++++.||+|+||+||+|++..+|+.||||+++......   .+.+.+|+.+|++++||||+++++++.+++.+|+||
T Consensus        20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~---~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm   96 (293)
T d1yhwa1          20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK---KELIINEILVMRENKNPNIVNYLDSYLVGDELWVVM   96 (293)
T ss_dssp             TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSC---HHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChH---HHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEE
Confidence            57999999999999999999999999999999998654322   467999999999999999999999999999999999


Q ss_pred             eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCccccCCCcc
Q 014609           94 EYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLL  173 (421)
Q Consensus        94 E~~~gg~L~~~i~~~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~  173 (421)
                      ||++||+|.+++.. +++++..++.+++||+.||+|||++||+||||||+|||++.+|++||+|||+|.....  .....
T Consensus        97 Ey~~gg~L~~~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~--~~~~~  173 (293)
T d1yhwa1          97 EYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP--EQSKR  173 (293)
T ss_dssp             ECCTTCBHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCS--TTCCB
T ss_pred             EecCCCcHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEECCCCcEeeccchhheeecc--ccccc
Confidence            99999999987765 6799999999999999999999999999999999999999999999999999985433  23345


Q ss_pred             ccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhh-cCCcC----------------------CCCCCCHHHHHHHHH
Q 014609          174 HTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIF-RGDFK----------------------LPKWLSPGAQNLLRK  230 (421)
Q Consensus       174 ~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~-~~~~~----------------------~p~~~s~~~~~li~~  230 (421)
                      ...+||+.|+|||++.+..| +.++||||+||++|.+ .|..|                      .|+.+|+.+++||.+
T Consensus       174 ~~~~gt~~Y~aPE~~~~~~~-~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~  252 (293)
T d1yhwa1         174 STMVGTPYWMAPEVVTRKAY-GPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNR  252 (293)
T ss_dssp             CCCCSCGGGCCHHHHSSSCB-CTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSSGGGSCHHHHHHHHH
T ss_pred             cccccCCCccChhhhcCCCC-CchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCcccCCHHHHHHHHH
Confidence            66789999999999998888 5899999999999943 33333                      234588999999999


Q ss_pred             hcCCCCCCCCCHHhhhcCccccc
Q 014609          231 ILEPNPVKRITIAGIKADEWFEQ  253 (421)
Q Consensus       231 ~L~~dP~~R~t~~eil~~~w~~~  253 (421)
                      ||++||.+|||++|+++||||+.
T Consensus       253 ~L~~dP~~R~s~~eil~Hp~~~~  275 (293)
T d1yhwa1         253 CLDMDVEKRGSAKELLQHQFLKI  275 (293)
T ss_dssp             HTCSSTTTSCCHHHHTTCGGGGG
T ss_pred             HccCChhHCcCHHHHhcCHhhCC
Confidence            99999999999999999999974

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.8e-58  Score=445.97  Aligned_cols=235  Identities=30%  Similarity=0.477  Sum_probs=207.8

Q ss_pred             ecceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEE
Q 014609           13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMV   92 (421)
Q Consensus        13 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv   92 (421)
                      -++|++++.||+|+||+||+|++..+|+.||+|++++..  .....+.+.+|+.+|++++|||||++++++.+++.+|+|
T Consensus         5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~--~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iV   82 (322)
T d1s9ja_           5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISIC   82 (322)
T ss_dssp             GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCC--CTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhh--CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence            468999999999999999999999999999999997653  233457899999999999999999999999999999999


Q ss_pred             EeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC-CceeccCCCCCEEeccCCCEEEEeccCCCCCccccCCC
Q 014609           93 LEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNK-GVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDG  171 (421)
Q Consensus        93 ~E~~~gg~L~~~i~~~~~~~~~~~~~~~~ql~~aL~~LH~~-gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~  171 (421)
                      |||++||+|.+++.+.+.+++..++.++.||+.||.|||++ ||+||||||+|||++.+|.+||+|||+|.....    .
T Consensus        83 mEy~~gg~L~~~l~~~~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~----~  158 (322)
T d1s9ja_          83 MEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID----S  158 (322)
T ss_dssp             EECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHH----H
T ss_pred             EEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECCCCCEEEeeCCCccccCC----C
Confidence            99999999999999888999999999999999999999974 999999999999999999999999999985432    2


Q ss_pred             ccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhh-cCCcCCCC--------------------------------
Q 014609          172 LLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIF-RGDFKLPK--------------------------------  218 (421)
Q Consensus       172 ~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~-~~~~~~p~--------------------------------  218 (421)
                      ...+.+||+.|+|||++.+..| +.++||||+||++|++ .|..|++.                                
T Consensus       159 ~~~~~~GT~~Y~APEvl~~~~y-~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (322)
T d1s9ja_         159 MANSFVGTRSYMSPERLQGTHY-SVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPL  237 (322)
T ss_dssp             TC---CCSSCCCCHHHHHCSCC-CTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC----------------------
T ss_pred             ccccccCCccccCchHHcCCCC-CcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCcccccccccc
Confidence            3456799999999999999888 5899999999999954 45444321                                


Q ss_pred             -------------------------------CCCHHHHHHHHHhcCCCCCCCCCHHhhhcCcccccc
Q 014609          219 -------------------------------WLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD  254 (421)
Q Consensus       219 -------------------------------~~s~~~~~li~~~L~~dP~~R~t~~eil~~~w~~~~  254 (421)
                                                     .+|+++.+||.+||+.||.+|||++|+++||||++.
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~~  304 (322)
T d1s9ja_         238 SSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS  304 (322)
T ss_dssp             --------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHH
T ss_pred             cccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhhCcC
Confidence                                           146889999999999999999999999999999864

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=1.8e-57  Score=438.90  Aligned_cols=236  Identities=31%  Similarity=0.680  Sum_probs=214.8

Q ss_pred             eecceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEE
Q 014609           12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYM   91 (421)
Q Consensus        12 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l   91 (421)
                      .+.+|++++.||+|+||+||+|+++.+|+.||||++++.........+.+.+|+.+|++++||||+++++++.+++.+|+
T Consensus         2 sl~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~i   81 (316)
T d1fota_           2 SLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFM   81 (316)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEE
T ss_pred             chhHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeee
Confidence            36789999999999999999999999999999999987654444456789999999999999999999999999999999


Q ss_pred             EEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCccccCCC
Q 014609           92 VLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDG  171 (421)
Q Consensus        92 v~E~~~gg~L~~~i~~~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~  171 (421)
                      ||||++||+|...+.....+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|.....     
T Consensus        82 vmE~~~gg~l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~-----  156 (316)
T d1fota_          82 IMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD-----  156 (316)
T ss_dssp             EECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSS-----
T ss_pred             EeeecCCccccccccccccccccHHHHHHHHHHHhhhhhccCcEEccccCchheeEcCCCCEEEecCccceEecc-----
Confidence            999999999999999989999999999999999999999999999999999999999999999999999985432     


Q ss_pred             ccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhh--------------------cCCcCCCCCCCHHHHHHHHHh
Q 014609          172 LLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIF--------------------RGDFKLPKWLSPGAQNLLRKI  231 (421)
Q Consensus       172 ~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~--------------------~~~~~~p~~~s~~~~~li~~~  231 (421)
                      ...+.+||+.|+|||++.+.+|+ .++|||||||++|.+                    .+...+|+.+|+++.++|.+|
T Consensus       157 ~~~~~~Gt~~Y~APE~l~~~~y~-~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~  235 (316)
T d1fota_         157 VTYTLCGTPDYIAPEVVSTKPYN-KSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNEDVKDLLSRL  235 (316)
T ss_dssp             CBCCCCSCTTTCCHHHHTTCCBC-TTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHH
T ss_pred             ccccccCcccccCHHHHcCCCCC-chhhccccchhHHHHHhCCCCCCCcCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHH
Confidence            34567999999999999988885 899999999999932                    344556778999999999999


Q ss_pred             cCCCCCCCC-----CHHhhhcCccccc
Q 014609          232 LEPNPVKRI-----TIAGIKADEWFEQ  253 (421)
Q Consensus       232 L~~dP~~R~-----t~~eil~~~w~~~  253 (421)
                      |++||.+|+     |++++++||||+.
T Consensus       236 L~~dp~~R~~~~r~t~~~il~Hp~f~~  262 (316)
T d1fota_         236 ITRDLSQRLGNLQNGTEDVKNHPWFKE  262 (316)
T ss_dssp             TCSCTTTCTTSSTTTTHHHHTSGGGSS
T ss_pred             hhhCHHhccccchhhHHHHHcCccccc
Confidence            999999996     8999999999976

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.3e-57  Score=438.25  Aligned_cols=235  Identities=26%  Similarity=0.404  Sum_probs=208.6

Q ss_pred             cceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEE
Q 014609           14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVL   93 (421)
Q Consensus        14 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~   93 (421)
                      .+|++++.||+|+||+||+|++..+|+.||||++++.........+.+.+|+.+|++++|||||++++++.+++.+|+||
T Consensus        15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~   94 (309)
T d1u5ra_          15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM   94 (309)
T ss_dssp             HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEE
Confidence            35999999999999999999999999999999998766555555678999999999999999999999999999999999


Q ss_pred             eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCccccCCCcc
Q 014609           94 EYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLL  173 (421)
Q Consensus        94 E~~~gg~L~~~i~~~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~  173 (421)
                      |||.||+|...+...+++++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|.....      .
T Consensus        95 E~~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~------~  168 (309)
T d1u5ra_          95 EYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP------A  168 (309)
T ss_dssp             ECCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS------B
T ss_pred             EecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEECCCCCEEEeecccccccCC------C
Confidence            9999999987777788999999999999999999999999999999999999999999999999999985432      3


Q ss_pred             ccccCCCCccChhhhcc---cCCCCCcchHHHHHHHHhhh-cCCcCC---------------------CCCCCHHHHHHH
Q 014609          174 HTTCGSPNYVAPEVLAN---RGYDGATSDIWSCGVILYIF-RGDFKL---------------------PKWLSPGAQNLL  228 (421)
Q Consensus       174 ~~~~gt~~y~APEvl~~---~~~~~~~~DiwSlGvil~~~-~~~~~~---------------------p~~~s~~~~~li  228 (421)
                      ...+||+.|+|||++.+   ..| +.++|||||||++|++ .|..|+                     +..+|+.+.+||
T Consensus       169 ~~~~GT~~Y~APE~~~~~~~~~y-~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li  247 (309)
T d1u5ra_         169 NSFVGTPYWMAPEVILAMDEGQY-DGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFV  247 (309)
T ss_dssp             CCCCSCGGGCCHHHHTTTTSCCB-CTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCTTSCHHHHHHH
T ss_pred             CccccCccccCHHHHhccCCCCc-CchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCCCCCCHHHHHHH
Confidence            45689999999999864   235 5899999999999943 233322                     234789999999


Q ss_pred             HHhcCCCCCCCCCHHhhhcCccccccc
Q 014609          229 RKILEPNPVKRITIAGIKADEWFEQDY  255 (421)
Q Consensus       229 ~~~L~~dP~~R~t~~eil~~~w~~~~~  255 (421)
                      .+||++||.+|||++|+++||||.+..
T Consensus       248 ~~~L~~dP~~Rpt~~ell~Hp~~~~~~  274 (309)
T d1u5ra_         248 DSCLQKIPQDRPTSEVLLKHRFVLRER  274 (309)
T ss_dssp             HHHTCSSGGGSCCHHHHTTCHHHHSCC
T ss_pred             HHHCcCChhHCcCHHHHHhCHHhcCCC
Confidence            999999999999999999999998643

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.6e-57  Score=425.40  Aligned_cols=232  Identities=25%  Similarity=0.487  Sum_probs=203.0

Q ss_pred             cce-EEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEe----CCE
Q 014609           14 GRY-ELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLAS----KSK   88 (421)
Q Consensus        14 ~~y-~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~----~~~   88 (421)
                      ||| ++.+.||+|+||+||+|++..+++.||+|++...... ....+.+.+|+++|++++||||+++++++++    +..
T Consensus         8 gry~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~-~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~   86 (270)
T d1t4ha_           8 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLT-KSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKC   86 (270)
T ss_dssp             SCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSC-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEE
T ss_pred             CCEEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCC-HHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCE
Confidence            456 7888999999999999999999999999999865443 3346789999999999999999999999875    456


Q ss_pred             EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--ceeccCCCCCEEec-cCCCEEEEeccCCCCCc
Q 014609           89 IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKG--VFHRDLKLENILLD-SKGNIKISDFGLSALPQ  165 (421)
Q Consensus        89 ~~lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~ql~~aL~~LH~~g--i~HrDlkp~NILl~-~~~~~kL~DFGla~~~~  165 (421)
                      +|+||||++||+|.+++.....+++..++.++.||+.||+|||++|  |+||||||+|||++ .++.+||+|||+|+...
T Consensus        87 ~~ivmE~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~  166 (270)
T d1t4ha_          87 IVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR  166 (270)
T ss_dssp             EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred             EEEEEeCCCCCcHHHHHhccccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEEeecCcceecc
Confidence            8999999999999999998889999999999999999999999998  99999999999996 57899999999997532


Q ss_pred             cccCCCccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhh-cCCcCCC----------------------CCCCH
Q 014609          166 HFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIF-RGDFKLP----------------------KWLSP  222 (421)
Q Consensus       166 ~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~-~~~~~~p----------------------~~~s~  222 (421)
                          .......+|||.|+|||++.+ +| +.++|||||||++|.+ .|..|++                      ...++
T Consensus       167 ----~~~~~~~~GT~~Y~aPE~~~~-~~-~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~  240 (270)
T d1t4ha_         167 ----ASFAKAVIGTPEFMAPEMYEE-KY-DESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIP  240 (270)
T ss_dssp             ----TTSBEESCSSCCCCCGGGGGT-CC-CTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCH
T ss_pred             ----CCccCCcccCccccCHHHhCC-CC-CCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHcCCCCcccCccCCH
Confidence                234567799999999999865 46 5899999999999944 4444432                      23688


Q ss_pred             HHHHHHHHhcCCCCCCCCCHHhhhcCcccc
Q 014609          223 GAQNLLRKILEPNPVKRITIAGIKADEWFE  252 (421)
Q Consensus       223 ~~~~li~~~L~~dP~~R~t~~eil~~~w~~  252 (421)
                      ++.+||.+||++||++|||++|+++||||+
T Consensus       241 ~~~~li~~~l~~dp~~R~s~~ell~Hp~fk  270 (270)
T d1t4ha_         241 EVKEIIEGCIRQNKDERYSIKDLLNHAFFQ  270 (270)
T ss_dssp             HHHHHHHHHSCSSGGGSCCHHHHHTSGGGC
T ss_pred             HHHHHHHHHccCCHhHCcCHHHHhCCcccC
Confidence            999999999999999999999999999995

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.6e-57  Score=437.42  Aligned_cols=236  Identities=38%  Similarity=0.671  Sum_probs=192.8

Q ss_pred             ecceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEE
Q 014609           13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMV   92 (421)
Q Consensus        13 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv   92 (421)
                      -++|++++.||+|+||+||+|++..+|+.||||++.+......  ...+.+|+.+|++++||||+++++++.+++.+|+|
T Consensus         8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~--~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv   85 (307)
T d1a06a_           8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGK--EGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLI   85 (307)
T ss_dssp             GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC------------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhH--HHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence            3679999999999999999999999999999999987654322  35688999999999999999999999999999999


Q ss_pred             EeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEec---cCCCEEEEeccCCCCCccccC
Q 014609           93 LEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLD---SKGNIKISDFGLSALPQHFRD  169 (421)
Q Consensus        93 ~E~~~gg~L~~~i~~~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~---~~~~~kL~DFGla~~~~~~~~  169 (421)
                      ||||+||+|.+++...+++++..++.++.||+.||+|||++||+||||||+|||+.   .++.+||+|||+|.....   
T Consensus        86 mE~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~---  162 (307)
T d1a06a_          86 MQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDP---  162 (307)
T ss_dssp             ECCCCSCBHHHHHHTCSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC-----------
T ss_pred             EeccCCCcHHHhhhcccCCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEeccceeEEccC---
Confidence            99999999999999888999999999999999999999999999999999999995   578999999999985432   


Q ss_pred             CCccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhh-cCCcCC-----------------------CCCCCHHHH
Q 014609          170 DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIF-RGDFKL-----------------------PKWLSPGAQ  225 (421)
Q Consensus       170 ~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~-~~~~~~-----------------------p~~~s~~~~  225 (421)
                      .....+.+||+.|+|||++.+..| +.++|||||||++|.+ .|..|+                       ++.+|+++.
T Consensus       163 ~~~~~~~~GT~~y~APE~~~~~~~-~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~  241 (307)
T d1a06a_         163 GSVLSTACGTPGYVAPEVLAQKPY-SKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAK  241 (307)
T ss_dssp             ----------CTTSCHHHHTTCCC-CTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTCCCCCTTTTTTSCHHHH
T ss_pred             CCeeeeeeeCccccCcHHHcCCCC-CcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCCCccccCCCHHHH
Confidence            334567789999999999998888 5899999999999943 333332                       235789999


Q ss_pred             HHHHHhcCCCCCCCCCHHhhhcCcccccc
Q 014609          226 NLLRKILEPNPVKRITIAGIKADEWFEQD  254 (421)
Q Consensus       226 ~li~~~L~~dP~~R~t~~eil~~~w~~~~  254 (421)
                      +||.+||++||.+|||++|+++||||+..
T Consensus       242 ~li~~~L~~dP~~R~s~~eil~hp~~~~~  270 (307)
T d1a06a_         242 DFIRHLMEKDPEKRFTCEQALQHPWIAGD  270 (307)
T ss_dssp             HHHHHHSCSSGGGSCCHHHHHHSTTTTSS
T ss_pred             HHHHHHccCCHhHCcCHHHHhcCHhhCCC
Confidence            99999999999999999999999999753

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-57  Score=432.99  Aligned_cols=234  Identities=29%  Similarity=0.479  Sum_probs=204.2

Q ss_pred             cceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEE
Q 014609           14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVL   93 (421)
Q Consensus        14 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~   93 (421)
                      +.|++++.||+|+||+||+|++..+|+.||||++++...   ...+.+.+|+++|++++|||||++++++.+++.+|+||
T Consensus        12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~---~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvm   88 (288)
T d2jfla1          12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSE---EELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILI   88 (288)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSS---GGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCH---HHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEE
Confidence            479999999999999999999999999999999976532   23467899999999999999999999999999999999


Q ss_pred             eccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCccccCCCc
Q 014609           94 EYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGL  172 (421)
Q Consensus        94 E~~~gg~L~~~i~~-~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~  172 (421)
                      ||++||+|.+++.. .+++++..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||+|......  ...
T Consensus        89 Ey~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~--~~~  166 (288)
T d2jfla1          89 EFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT--IQR  166 (288)
T ss_dssp             ECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECHHH--HHH
T ss_pred             ecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeECCCCCEEEEechhhhccCCC--ccc
Confidence            99999999998765 467999999999999999999999999999999999999999999999999999754321  123


Q ss_pred             cccccCCCCccChhhhc-----ccCCCCCcchHHHHHHHHhhh-cCCcCC----------------------CCCCCHHH
Q 014609          173 LHTTCGSPNYVAPEVLA-----NRGYDGATSDIWSCGVILYIF-RGDFKL----------------------PKWLSPGA  224 (421)
Q Consensus       173 ~~~~~gt~~y~APEvl~-----~~~~~~~~~DiwSlGvil~~~-~~~~~~----------------------p~~~s~~~  224 (421)
                      ..+.+||+.|+|||++.     +.+| +.++|||||||++|.+ .|..|+                      |..+|+++
T Consensus       167 ~~~~~Gt~~y~APE~l~~~~~~~~~y-~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~  245 (288)
T d2jfla1         167 RDSFIGTPYWMAPEVVMCETSKDRPY-DYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSNF  245 (288)
T ss_dssp             HTCCCSCCTTCCHHHHTTCSTTTSST-TTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHSCCCCCSSGGGSCHHH
T ss_pred             ccccccccccCCHHHHhhcccCCCCC-ChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCccccCCHHH
Confidence            44678999999999984     3445 5899999999999943 333322                      33478999


Q ss_pred             HHHHHHhcCCCCCCCCCHHhhhcCccccc
Q 014609          225 QNLLRKILEPNPVKRITIAGIKADEWFEQ  253 (421)
Q Consensus       225 ~~li~~~L~~dP~~R~t~~eil~~~w~~~  253 (421)
                      .+||++||++||.+|||++|+++||||+.
T Consensus       246 ~~li~~~L~~dp~~R~t~~ell~hp~~~~  274 (288)
T d2jfla1         246 KDFLKKCLEKNVDARWTTSQLLQHPFVTV  274 (288)
T ss_dssp             HHHHHHHSCSSTTTSCCHHHHTTSGGGCC
T ss_pred             HHHHHHHccCChhHCcCHHHHhcCcccCC
Confidence            99999999999999999999999999974

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-57  Score=429.75  Aligned_cols=236  Identities=30%  Similarity=0.534  Sum_probs=195.5

Q ss_pred             eecceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEe--CCEE
Q 014609           12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLAS--KSKI   89 (421)
Q Consensus        12 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~--~~~~   89 (421)
                      +.++|++++.||+|+||+||+|+++.+|+.||||+++..... ....+.+.+|+++|++++||||+++++++.+  ++.+
T Consensus         2 r~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~-~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~   80 (269)
T d2java1           2 RAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMT-EAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTL   80 (269)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSC-HHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CE
T ss_pred             CchhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCC-HHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEE
Confidence            467899999999999999999999999999999999876543 3346779999999999999999999999864  4568


Q ss_pred             EEEEeccCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC-----ceeccCCCCCEEeccCCCEEEEeccC
Q 014609           90 YMVLEYVTGGELFDKIAS----KGRLQEAEGRKLFQQLIDGVSYCHNKG-----VFHRDLKLENILLDSKGNIKISDFGL  160 (421)
Q Consensus        90 ~lv~E~~~gg~L~~~i~~----~~~~~~~~~~~~~~ql~~aL~~LH~~g-----i~HrDlkp~NILl~~~~~~kL~DFGl  160 (421)
                      |+||||++||+|.+++..    ...+++..++.++.||+.||+|||++|     |+||||||+|||++.+|.+||+|||+
T Consensus        81 ~ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~  160 (269)
T d2java1          81 YIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGL  160 (269)
T ss_dssp             EEEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHH
T ss_pred             EEEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccc
Confidence            999999999999998853    457999999999999999999999976     99999999999999999999999999


Q ss_pred             CCCCccccCCCccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhh-cCCc--------------------CCCCC
Q 014609          161 SALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIF-RGDF--------------------KLPKW  219 (421)
Q Consensus       161 a~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~-~~~~--------------------~~p~~  219 (421)
                      |.....  ........+||+.|+|||++.+..| +.++|||||||++|++ .|..                    ++|..
T Consensus       161 a~~~~~--~~~~~~~~~gt~~Y~APE~l~~~~~-~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~~~~~~~~~~  237 (269)
T d2java1         161 ARILNH--DTSFAKAFVGTPYYMSPEQMNRMSY-NEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYR  237 (269)
T ss_dssp             HHHC-------------CCCSCCCHHHHTTCCC-CHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCCTT
T ss_pred             eeeccc--CCCccccCCCCcccCCHHHHcCCCC-ChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCcc
Confidence            986543  2334556799999999999988888 5899999999999943 2322                    24556


Q ss_pred             CCHHHHHHHHHhcCCCCCCCCCHHhhhcCccc
Q 014609          220 LSPGAQNLLRKILEPNPVKRITIAGIKADEWF  251 (421)
Q Consensus       220 ~s~~~~~li~~~L~~dP~~R~t~~eil~~~w~  251 (421)
                      +|+++.+||.+||++||.+|||++|+++|||+
T Consensus       238 ~s~~l~~li~~~L~~dp~~Rps~~ell~hp~i  269 (269)
T d2java1         238 YSDELNEIITRMLNLKDYHRPSVEEILENPLI  269 (269)
T ss_dssp             SCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred             cCHHHHHHHHHHcCCChhHCcCHHHHHhCCcC
Confidence            89999999999999999999999999999995

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=2.3e-56  Score=436.67  Aligned_cols=241  Identities=30%  Similarity=0.587  Sum_probs=211.8

Q ss_pred             CeeecceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEE
Q 014609           10 GMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKI   89 (421)
Q Consensus        10 ~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~   89 (421)
                      +..+++|++++.||+|+||+||+|++..+|+.||||++.+..   ....+.+.+|+.+|++++||||+++++++.+++.+
T Consensus        22 ~~il~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~---~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~   98 (350)
T d1koaa2          22 DHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH---ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEM   98 (350)
T ss_dssp             SCGGGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCS---HHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEE
T ss_pred             CCCccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccc---hhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence            456789999999999999999999999999999999997653   23357789999999999999999999999999999


Q ss_pred             EEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecc--CCCEEEEeccCCCCCcc
Q 014609           90 YMVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDS--KGNIKISDFGLSALPQH  166 (421)
Q Consensus        90 ~lv~E~~~gg~L~~~i~~-~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~--~~~~kL~DFGla~~~~~  166 (421)
                      |+||||++||+|.+++.. .+++++..++.++.||+.||+|||++||+||||||+|||++.  ++.+||+|||+|.....
T Consensus        99 ~ivmE~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~  178 (350)
T d1koaa2          99 VMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDP  178 (350)
T ss_dssp             EEEECCCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCT
T ss_pred             EEEEEcCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeeccCCCCeEEEeecchheeccc
Confidence            999999999999999854 467999999999999999999999999999999999999964  57899999999985432


Q ss_pred             ccCCCccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhh-cCCcCCC-----------------------CCCCH
Q 014609          167 FRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIF-RGDFKLP-----------------------KWLSP  222 (421)
Q Consensus       167 ~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~-~~~~~~p-----------------------~~~s~  222 (421)
                         .....+.+||+.|+|||++.+.+| +.++|||||||++|++ .|..|+.                       +.+|+
T Consensus       179 ---~~~~~~~~gT~~Y~aPEv~~~~~~-~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~  254 (350)
T d1koaa2         179 ---KQSVKVTTGTAEFAAPEVAEGKPV-GYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISE  254 (350)
T ss_dssp             ---TSCEEEECSCTTTCCHHHHHTCCB-CHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCCGGGGGCCH
T ss_pred             ---ccccceecCcccccCHHHHcCCCC-ChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCH
Confidence               344567899999999999998888 5899999999999944 3444331                       23789


Q ss_pred             HHHHHHHHhcCCCCCCCCCHHhhhcCccccccccC
Q 014609          223 GAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTP  257 (421)
Q Consensus       223 ~~~~li~~~L~~dP~~R~t~~eil~~~w~~~~~~~  257 (421)
                      ++++||++||++||.+|||++|+++||||+....+
T Consensus       255 ~~~~li~~~L~~dP~~R~t~~eil~hp~~~~~~~~  289 (350)
T d1koaa2         255 DGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAP  289 (350)
T ss_dssp             HHHHHHHHHCCSSGGGSCCHHHHHHSTTTSCTTCC
T ss_pred             HHHHHHHHHccCChhHCcCHHHHhcCcccCCCCCC
Confidence            99999999999999999999999999999875543

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=1.3e-56  Score=438.58  Aligned_cols=237  Identities=34%  Similarity=0.673  Sum_probs=215.2

Q ss_pred             eeecceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEE
Q 014609           11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIY   90 (421)
Q Consensus        11 ~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~   90 (421)
                      ..+++|++++.||+|+||+||+|+++.+|+.||||++++.........+.+.+|+.+|+.++||||+++++++.+...+|
T Consensus        38 ~~ld~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~  117 (350)
T d1rdqe_          38 AQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLY  117 (350)
T ss_dssp             CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred             CCccCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeecccccccccccc
Confidence            45799999999999999999999999999999999998765544455678999999999999999999999999999999


Q ss_pred             EEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCccccCC
Q 014609           91 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD  170 (421)
Q Consensus        91 lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~  170 (421)
                      +||||+.||+|.+.+...+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+|+....    
T Consensus       118 ~v~e~~~~g~l~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~----  193 (350)
T d1rdqe_         118 MVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG----  193 (350)
T ss_dssp             EEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSS----
T ss_pred             cccccccccchhhhHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcccCCCCCEEeeeceeeeeccc----
Confidence            9999999999999999889999999999999999999999999999999999999999999999999999985432    


Q ss_pred             CccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhh-c-------------------CCcCCCCCCCHHHHHHHHH
Q 014609          171 GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIF-R-------------------GDFKLPKWLSPGAQNLLRK  230 (421)
Q Consensus       171 ~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~-~-------------------~~~~~p~~~s~~~~~li~~  230 (421)
                       ...+.+||+.|+|||++.+.+| +.++|||||||++|.+ .                   +.+.+|..+|+++.+||++
T Consensus       194 -~~~~~~Gt~~Y~APE~~~~~~~-~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~  271 (350)
T d1rdqe_         194 -RTWTLCGTPEALAPEIILSKGY-NKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRN  271 (350)
T ss_dssp             -CBCCCEECGGGCCHHHHTTCCB-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTCCHHHHHHHHH
T ss_pred             -ccccccCccccCCHHHHcCCCC-CccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHhcCCCCCCccCCHHHHHHHHH
Confidence             3456789999999999998888 5899999999999943 2                   3345567799999999999


Q ss_pred             hcCCCCCCCC-----CHHhhhcCccccc
Q 014609          231 ILEPNPVKRI-----TIAGIKADEWFEQ  253 (421)
Q Consensus       231 ~L~~dP~~R~-----t~~eil~~~w~~~  253 (421)
                      ||++||.+|+     |++++++||||+.
T Consensus       272 ~L~~dP~kR~~~~r~t~~ell~Hp~f~~  299 (350)
T d1rdqe_         272 LLQVDLTKRFGNLKNGVNDIKNHKWFAT  299 (350)
T ss_dssp             HSCSCTTTCTTSSTTTTHHHHTSGGGTT
T ss_pred             HhhhCHHhccccccccHHHHHcCccccC
Confidence            9999999995     9999999999975

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.2e-56  Score=425.08  Aligned_cols=236  Identities=37%  Similarity=0.655  Sum_probs=209.4

Q ss_pred             cceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccch---hHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEE
Q 014609           14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHL---KITDQIKREIATLKLLKHPNVVRLHEVLASKSKIY   90 (421)
Q Consensus        14 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~---~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~   90 (421)
                      ++|++++.||+|+||+||+|+++.+|+.||||++++......   ...+.+.+|+.+|++++|||||++++++.+++.+|
T Consensus        10 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~   89 (293)
T d1jksa_          10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI   89 (293)
T ss_dssp             GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             cCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence            579999999999999999999999999999999986544322   23578999999999999999999999999999999


Q ss_pred             EEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCC----CEEEEeccCCCCCcc
Q 014609           91 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKG----NIKISDFGLSALPQH  166 (421)
Q Consensus        91 lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~----~~kL~DFGla~~~~~  166 (421)
                      +|||||+||+|.+++...+.+++..++.++.|++.||+|||++||+||||||+|||++.++    .+||+|||+|.....
T Consensus        90 iv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~~~~  169 (293)
T d1jksa_          90 LILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDF  169 (293)
T ss_dssp             EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCCTTCEECTT
T ss_pred             EEEEcCCCccccchhccccccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccceEecchhhhhhcCC
Confidence            9999999999999999888999999999999999999999999999999999999998876    499999999975432


Q ss_pred             ccCCCccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhh-cCCcCC-------------------C----CCCCH
Q 014609          167 FRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIF-RGDFKL-------------------P----KWLSP  222 (421)
Q Consensus       167 ~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~-~~~~~~-------------------p----~~~s~  222 (421)
                         .....+.+||+.|+|||++.+..| +.++|||||||++|.+ .|..|+                   +    +.+|+
T Consensus       170 ---~~~~~~~~~t~~y~APE~~~~~~~-~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~  245 (293)
T d1jksa_         170 ---GNEFKNIFGTPEFVAPEIVNYEPL-GLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSA  245 (293)
T ss_dssp             ---SCBCSCCCCCGGGCCHHHHTTCCB-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCCHHHHTTSCH
T ss_pred             ---CccccccCCCCcccCHHHHcCCCC-CCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCchhcCCCCH
Confidence               234556789999999999988777 5999999999999943 333332                   1    34789


Q ss_pred             HHHHHHHHhcCCCCCCCCCHHhhhcCccccc
Q 014609          223 GAQNLLRKILEPNPVKRITIAGIKADEWFEQ  253 (421)
Q Consensus       223 ~~~~li~~~L~~dP~~R~t~~eil~~~w~~~  253 (421)
                      .+++||++||++||.+|||++|+++||||+.
T Consensus       246 ~~~~li~~~L~~dP~~R~s~~eil~hp~~~~  276 (293)
T d1jksa_         246 LAKDFIRRLLVKDPKKRMTIQDSLQHPWIKP  276 (293)
T ss_dssp             HHHHHHHTTSCSSGGGSCCHHHHHHSTTTCC
T ss_pred             HHHHHHHHHccCChhHCcCHHHHhcCcccCC
Confidence            9999999999999999999999999999975

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=2.8e-56  Score=438.52  Aligned_cols=238  Identities=29%  Similarity=0.475  Sum_probs=207.3

Q ss_pred             eecceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHH---HHHHHHhcCCCCCcceEEEEEEeCCE
Q 014609           12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIK---REIATLKLLKHPNVVRLHEVLASKSK   88 (421)
Q Consensus        12 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~---~Ei~il~~l~hpnIv~l~~~~~~~~~   88 (421)
                      .+++|++++.||+|+||+||+|++..+|+.||||++.+...........+.   +|+++++.++||||+++++++.+++.
T Consensus         2 slddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~   81 (364)
T d1omwa3           2 TMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDK   81 (364)
T ss_dssp             CSTTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSE
T ss_pred             CHHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCE
Confidence            578999999999999999999999999999999999865443322223333   45777888899999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCcccc
Q 014609           89 IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFR  168 (421)
Q Consensus        89 ~~lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~~  168 (421)
                      +|+||||++||+|.+++.....+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+....  
T Consensus        82 ~~ivmE~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~--  159 (364)
T d1omwa3          82 LSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSK--  159 (364)
T ss_dssp             EEEEECCCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSSSCEEECCCTTCEECSS--
T ss_pred             EEEEEEecCCCcHHHHHHhcccccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEEcCCCcEEEeeeceeeecCC--
Confidence            999999999999999999889999999999999999999999999999999999999999999999999999985432  


Q ss_pred             CCCccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhh-cCCc----------------------CCCCCCCHHHH
Q 014609          169 DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIF-RGDF----------------------KLPKWLSPGAQ  225 (421)
Q Consensus       169 ~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~-~~~~----------------------~~p~~~s~~~~  225 (421)
                        ......+||+.|+|||++....+.+.++|||||||++|++ .|..                      .+|..+|+++.
T Consensus       160 --~~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~  237 (364)
T d1omwa3         160 --KKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELR  237 (364)
T ss_dssp             --SCCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHSSSCCCCCCSSSCHHHH
T ss_pred             --CcccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCHHHH
Confidence              3345678999999999997554446899999999999943 3333                      33456899999


Q ss_pred             HHHHHhcCCCCCCCCC-----HHhhhcCccccc
Q 014609          226 NLLRKILEPNPVKRIT-----IAGIKADEWFEQ  253 (421)
Q Consensus       226 ~li~~~L~~dP~~R~t-----~~eil~~~w~~~  253 (421)
                      +||.+||++||.+|||     ++++++||||+.
T Consensus       238 ~li~~~L~~dP~~R~t~~~~~a~eil~Hp~f~~  270 (364)
T d1omwa3         238 SLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRS  270 (364)
T ss_dssp             HHHHHHTCSSTTTSTTTSSSTHHHHHTSGGGTT
T ss_pred             HHHHHHcccCHHHhCCCcccCHHHHHcCccccC
Confidence            9999999999999999     799999999985

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=6.8e-56  Score=433.70  Aligned_cols=240  Identities=29%  Similarity=0.568  Sum_probs=211.4

Q ss_pred             CCeeecceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCE
Q 014609            9 EGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSK   88 (421)
Q Consensus         9 ~~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~   88 (421)
                      .+..+++|++++.||+|+||+||+|++..+|+.||||++++...   .....+.+|+.+|++++||||+++++++.+++.
T Consensus        24 ~~~~~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~---~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~  100 (352)
T d1koba_          24 QGSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYP---LDKYTVKNEISIMNQLHHPKLINLHDAFEDKYE  100 (352)
T ss_dssp             CSCGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSH---HHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSE
T ss_pred             CCCcccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcch---hHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCE
Confidence            35567899999999999999999999999999999999976532   224678899999999999999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEec--cCCCEEEEeccCCCCCc
Q 014609           89 IYMVLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLD--SKGNIKISDFGLSALPQ  165 (421)
Q Consensus        89 ~~lv~E~~~gg~L~~~i~~~-~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~--~~~~~kL~DFGla~~~~  165 (421)
                      +|+|||||+||+|++.+... .++++..++.++.||+.||+|||++||+||||||+||||+  .++.+||+|||+|....
T Consensus       101 ~~ivmE~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~  180 (352)
T d1koba_         101 MVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLN  180 (352)
T ss_dssp             EEEEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECC
T ss_pred             EEEEEEcCCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccccCCCeEEEeecccceecC
Confidence            99999999999999987654 4699999999999999999999999999999999999998  56899999999998653


Q ss_pred             cccCCCccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhh-cCCcC-------------------CC----CCCC
Q 014609          166 HFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIF-RGDFK-------------------LP----KWLS  221 (421)
Q Consensus       166 ~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~-~~~~~-------------------~p----~~~s  221 (421)
                      .   .....+.+||+.|+|||++.+..| +.++|||||||++|.+ .|..|                   +|    +.+|
T Consensus       181 ~---~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s  256 (352)
T d1koba_         181 P---DEIVKVTTATAEFAAPEIVDREPV-GFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVS  256 (352)
T ss_dssp             T---TSCEEEECSSGGGCCHHHHTTCCB-CHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSC
T ss_pred             C---CCceeeccCcccccCHHHHcCCCC-CCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCC
Confidence            2   345667899999999999998888 5899999999999943 33332                   22    3489


Q ss_pred             HHHHHHHHHhcCCCCCCCCCHHhhhcCccccccc
Q 014609          222 PGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY  255 (421)
Q Consensus       222 ~~~~~li~~~L~~dP~~R~t~~eil~~~w~~~~~  255 (421)
                      +++.+||.+||++||.+|||+.|+++||||+...
T Consensus       257 ~~~~~li~~~L~~dp~~R~s~~eil~Hp~~~~~~  290 (352)
T d1koba_         257 PEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDH  290 (352)
T ss_dssp             HHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSCC
T ss_pred             HHHHHHHHHHccCChhHCcCHHHHhcCHhhCCCc
Confidence            9999999999999999999999999999998654

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4e-56  Score=430.07  Aligned_cols=238  Identities=33%  Similarity=0.607  Sum_probs=211.6

Q ss_pred             ecceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHh-cCCCCCcceEEEEEEeCCEEEE
Q 014609           13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLK-LLKHPNVVRLHEVLASKSKIYM   91 (421)
Q Consensus        13 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~-~l~hpnIv~l~~~~~~~~~~~l   91 (421)
                      +++|++++.||+|+||+||+|++..+|+.||||++++.........+.+.+|..++. .++||||+++++++.+++.+|+
T Consensus         1 iddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yi   80 (320)
T d1xjda_           1 IEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFF   80 (320)
T ss_dssp             CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred             CCCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeE
Confidence            478999999999999999999999999999999998755433334566777777765 6899999999999999999999


Q ss_pred             EEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCccccCCC
Q 014609           92 VLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDG  171 (421)
Q Consensus        92 v~E~~~gg~L~~~i~~~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~  171 (421)
                      ||||++||+|.+++....++++..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||++.....  ...
T Consensus        81 vmEy~~~g~L~~~i~~~~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~--~~~  158 (320)
T d1xjda_          81 VMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENML--GDA  158 (320)
T ss_dssp             EEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC--TTC
T ss_pred             EEeecCCCcHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceeecCCCceeccccchhhhccc--ccc
Confidence            999999999999999989999999999999999999999999999999999999999999999999999985433  233


Q ss_pred             ccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhh--------------------cCCcCCCCCCCHHHHHHHHHh
Q 014609          172 LLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIF--------------------RGDFKLPKWLSPGAQNLLRKI  231 (421)
Q Consensus       172 ~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~--------------------~~~~~~p~~~s~~~~~li~~~  231 (421)
                      .....+||+.|+|||++.+.+|+ .++|||||||++|.+                    .+.+.+|+.+|+++.+||++|
T Consensus       159 ~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~dli~~~  237 (320)
T d1xjda_         159 KTNTFCGTPDYIAPEILLGQKYN-HSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKEAKDLLVKL  237 (320)
T ss_dssp             CBCCCCSCGGGCCHHHHTTCCBC-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHH
T ss_pred             cccccCCCCCcCCHHHHcCCCCC-chhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCccCCHHHHHHHHHh
Confidence            45567899999999999998885 899999999999933                    334556778999999999999


Q ss_pred             cCCCCCCCCCHH-hhhcCccccc
Q 014609          232 LEPNPVKRITIA-GIKADEWFEQ  253 (421)
Q Consensus       232 L~~dP~~R~t~~-eil~~~w~~~  253 (421)
                      |++||.+|||+. ++++||||++
T Consensus       238 L~~dP~~R~s~~~~l~~hpff~~  260 (320)
T d1xjda_         238 FVREPEKRLGVRGDIRQHPLFRE  260 (320)
T ss_dssp             SCSSGGGSBTTBSCGGGSGGGTT
T ss_pred             cccCCCCCcCHHHHHHhCchhcc
Confidence            999999999995 8999999975

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.2e-56  Score=421.63  Aligned_cols=238  Identities=34%  Similarity=0.584  Sum_probs=208.4

Q ss_pred             cceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchh---HHHHHHHHHHHHhcCC--CCCcceEEEEEEeCCE
Q 014609           14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLK---ITDQIKREIATLKLLK--HPNVVRLHEVLASKSK   88 (421)
Q Consensus        14 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~---~~~~~~~Ei~il~~l~--hpnIv~l~~~~~~~~~   88 (421)
                      ++|++++.||+|+||+||+|++..+|+.||||++++.......   ...++.+|+.+|++++  ||||+++++++.+++.
T Consensus         4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~   83 (273)
T d1xwsa_           4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS   83 (273)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred             CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCe
Confidence            6899999999999999999999999999999999865433221   1234678999999997  8999999999999999


Q ss_pred             EEEEEeccCC-CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccC-CCEEEEeccCCCCCcc
Q 014609           89 IYMVLEYVTG-GELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSK-GNIKISDFGLSALPQH  166 (421)
Q Consensus        89 ~~lv~E~~~g-g~L~~~i~~~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~-~~~kL~DFGla~~~~~  166 (421)
                      .|+||||+.+ +++.+.+.....+++..++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+|.... 
T Consensus        84 ~~lv~e~~~~~~~l~~~~~~~~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~~~~vkl~DFG~a~~~~-  162 (273)
T d1xwsa_          84 FVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK-  162 (273)
T ss_dssp             EEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECC-
T ss_pred             EEEEEEeccCcchHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEecCCCeEEECccccceecc-
Confidence            9999999976 6888888888899999999999999999999999999999999999999855 789999999997543 


Q ss_pred             ccCCCccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhh-cCC-------------cCCCCCCCHHHHHHHHHhc
Q 014609          167 FRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIF-RGD-------------FKLPKWLSPGAQNLLRKIL  232 (421)
Q Consensus       167 ~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~-~~~-------------~~~p~~~s~~~~~li~~~L  232 (421)
                         .....+.+||+.|+|||++.+..+++.++||||+||++|.+ .|.             ..+|+.+|+++.+||++||
T Consensus       163 ---~~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~i~~~~~~~~~~~s~~~~~li~~~L  239 (273)
T d1xwsa_         163 ---DTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQHLIRWCL  239 (273)
T ss_dssp             ---SSCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHHHHCCCCCSSCCCHHHHHHHHHHT
T ss_pred             ---cccccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCchHHhhcccCCCCCCCHHHHHHHHHHc
Confidence               23455678999999999998888777889999999999943 343             3456679999999999999


Q ss_pred             CCCCCCCCCHHhhhcCccccccc
Q 014609          233 EPNPVKRITIAGIKADEWFEQDY  255 (421)
Q Consensus       233 ~~dP~~R~t~~eil~~~w~~~~~  255 (421)
                      ++||.+|||++|+++||||++..
T Consensus       240 ~~dp~~R~s~~eil~hp~~~~~~  262 (273)
T d1xwsa_         240 ALRPSDRPTFEEIQNHPWMQDVL  262 (273)
T ss_dssp             CSSGGGSCCHHHHHTSGGGSSCC
T ss_pred             cCCHhHCcCHHHHhcCHhhCCCC
Confidence            99999999999999999998643

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=5.7e-55  Score=413.59  Aligned_cols=238  Identities=32%  Similarity=0.531  Sum_probs=208.0

Q ss_pred             ecceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccc------hhHHHHHHHHHHHHhcCC-CCCcceEEEEEEe
Q 014609           13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIH------LKITDQIKREIATLKLLK-HPNVVRLHEVLAS   85 (421)
Q Consensus        13 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~------~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~   85 (421)
                      .++|++++.||+|+||+||+|++..+|+.||||++++.....      ....+.+.+|+.+|++++ ||||+++++++.+
T Consensus         2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~   81 (277)
T d1phka_           2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET   81 (277)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred             cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc
Confidence            368999999999999999999999999999999998764332      123456889999999997 9999999999999


Q ss_pred             CCEEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCc
Q 014609           86 KSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQ  165 (421)
Q Consensus        86 ~~~~~lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~  165 (421)
                      ++..|+||||++||+|.+++...+++++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++....
T Consensus        82 ~~~~~ivmE~~~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~  161 (277)
T d1phka_          82 NTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLD  161 (277)
T ss_dssp             SSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred             CcceEEEEEcCCCchHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcCCCCeEEccchheeEcc
Confidence            99999999999999999999988999999999999999999999999999999999999999999999999999998543


Q ss_pred             cccCCCccccccCCCCccChhhhccc-----CCCCCcchHHHHHHHHhhh-cCCcCC-------------------C---
Q 014609          166 HFRDDGLLHTTCGSPNYVAPEVLANR-----GYDGATSDIWSCGVILYIF-RGDFKL-------------------P---  217 (421)
Q Consensus       166 ~~~~~~~~~~~~gt~~y~APEvl~~~-----~~~~~~~DiwSlGvil~~~-~~~~~~-------------------p---  217 (421)
                      .   .......+||+.|+|||++.+.     ...+.++||||+||++|.+ .|..|+                   +   
T Consensus       162 ~---~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~  238 (277)
T d1phka_         162 P---GEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPE  238 (277)
T ss_dssp             T---TCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTT
T ss_pred             C---CCceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHhCCCCCCCcc
Confidence            3   2334567899999999998642     2236789999999999933 333222                   2   


Q ss_pred             -CCCCHHHHHHHHHhcCCCCCCCCCHHhhhcCccccc
Q 014609          218 -KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQ  253 (421)
Q Consensus       218 -~~~s~~~~~li~~~L~~dP~~R~t~~eil~~~w~~~  253 (421)
                       +.+|+++++||.+||++||.+|||++|+++||||++
T Consensus       239 ~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h~~~~~  275 (277)
T d1phka_         239 WDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQ  275 (277)
T ss_dssp             GGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCT
T ss_pred             cccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHHHH
Confidence             248999999999999999999999999999999985

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-55  Score=422.98  Aligned_cols=238  Identities=27%  Similarity=0.366  Sum_probs=199.8

Q ss_pred             EeceEeecCcEEEEEEEECCCCceEEEEEeecccccch--hHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEEec
Q 014609           18 LGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHL--KITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLEY   95 (421)
Q Consensus        18 i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~--~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E~   95 (421)
                      .++.||+|+||+||+|++..+|+.||||+++.......  .....+.+|+.+|++++|||||++++++.+++.+|+||||
T Consensus         2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~   81 (299)
T d1ua2a_           2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF   81 (299)
T ss_dssp             EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred             cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence            46889999999999999999999999999976543221  1235688999999999999999999999999999999999


Q ss_pred             cCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCccccCCCcccc
Q 014609           96 VTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHT  175 (421)
Q Consensus        96 ~~gg~L~~~i~~~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~  175 (421)
                      +.|+++.........+++..++.+++||+.||+|||++||+||||||+|||++.++.+||+|||+|.....  .......
T Consensus        82 ~~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~--~~~~~~~  159 (299)
T d1ua2a_          82 METDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGS--PNRAYTH  159 (299)
T ss_dssp             CSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTS--CCCCCCC
T ss_pred             hcchHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEecCCCccccccCccccccCC--Ccccccc
Confidence            99888877776677899999999999999999999999999999999999999999999999999985443  2334456


Q ss_pred             ccCCCCccChhhhcccCCCCCcchHHHHHHHHhhh-cCCcCCC-------------------------------------
Q 014609          176 TCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIF-RGDFKLP-------------------------------------  217 (421)
Q Consensus       176 ~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~-~~~~~~p-------------------------------------  217 (421)
                      .+||+.|+|||++....+.+.++||||+||++|++ .|..+++                                     
T Consensus       160 ~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (299)
T d1ua2a_         160 QVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKS  239 (299)
T ss_dssp             SCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCCCC
T ss_pred             eecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccchhhhhcc
Confidence            78999999999987665557899999999999954 3332221                                     


Q ss_pred             ----------CCCCHHHHHHHHHhcCCCCCCCCCHHhhhcCccccccccC
Q 014609          218 ----------KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTP  257 (421)
Q Consensus       218 ----------~~~s~~~~~li~~~L~~dP~~R~t~~eil~~~w~~~~~~~  257 (421)
                                +.+++++.+||++||+.||++|||++|+++||||+....|
T Consensus       240 ~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~p~p  289 (299)
T d1ua2a_         240 FPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGP  289 (299)
T ss_dssp             CCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSSCC
T ss_pred             CCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhhCCCCCC
Confidence                      1357899999999999999999999999999999865433

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.2e-55  Score=423.99  Aligned_cols=236  Identities=25%  Similarity=0.475  Sum_probs=208.2

Q ss_pred             eecceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEE
Q 014609           12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYM   91 (421)
Q Consensus        12 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l   91 (421)
                      .+++|++++.||+|+||+||+|.+..+|+.||||++++...    ....+.+|+++|++++||||+++++++++++.+|+
T Consensus         3 ~~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~----~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~l   78 (321)
T d1tkia_           3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGT----DQVLVKKEISILNIARHRNILHLHESFESMEELVM   78 (321)
T ss_dssp             CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTH----HHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEE
T ss_pred             CccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcc----cHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEE
Confidence            46899999999999999999999999999999999976532    23568899999999999999999999999999999


Q ss_pred             EEeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccC--CCEEEEeccCCCCCcccc
Q 014609           92 VLEYVTGGELFDKIASKG-RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSK--GNIKISDFGLSALPQHFR  168 (421)
Q Consensus        92 v~E~~~gg~L~~~i~~~~-~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~--~~~kL~DFGla~~~~~~~  168 (421)
                      |||||+||+|++++...+ .+++.+++.++.||+.||+|||++||+||||||+|||++.+  +.+||+|||++....   
T Consensus        79 vmE~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~---  155 (321)
T d1tkia_          79 IFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLK---  155 (321)
T ss_dssp             EECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECC---
T ss_pred             EEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecCCCceEEEEcccchhhccc---
Confidence            999999999999998655 79999999999999999999999999999999999999854  489999999998543   


Q ss_pred             CCCccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhh-cCCcCCC-----------------------CCCCHHH
Q 014609          169 DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIF-RGDFKLP-----------------------KWLSPGA  224 (421)
Q Consensus       169 ~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~-~~~~~~p-----------------------~~~s~~~  224 (421)
                      ......+.+||+.|+|||++.+..| +.++|||||||++|.+ .|..|++                       +.+|+++
T Consensus       156 ~~~~~~~~~~t~~y~ape~~~~~~~-~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~  234 (321)
T d1tkia_         156 PGDNFRLLFTAPEYYAPEVHQHDVV-STATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEA  234 (321)
T ss_dssp             TTCEEEEEESCGGGSCHHHHTTCEE-CHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHH
T ss_pred             cCCcccccccccccccchhccCCCC-CchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCChhhccCCCHHH
Confidence            2344567789999999999988877 5899999999999943 4444332                       2478999


Q ss_pred             HHHHHHhcCCCCCCCCCHHhhhcCccccccc
Q 014609          225 QNLLRKILEPNPVKRITIAGIKADEWFEQDY  255 (421)
Q Consensus       225 ~~li~~~L~~dP~~R~t~~eil~~~w~~~~~  255 (421)
                      .+||++||++||.+|||++|+++||||++..
T Consensus       235 ~~li~~~L~~dp~~R~s~~eil~hp~~~~~~  265 (321)
T d1tkia_         235 MDFVDRLLVKERKSRMTASEALQHPWLKQKI  265 (321)
T ss_dssp             HHHHHTTSCSSGGGSCCHHHHHHSHHHHSCG
T ss_pred             HHHHHHHccCChhHCcCHHHHhcCHhhccCc
Confidence            9999999999999999999999999998643

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.9e-55  Score=416.50  Aligned_cols=241  Identities=29%  Similarity=0.476  Sum_probs=204.4

Q ss_pred             ecceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEE
Q 014609           13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMV   92 (421)
Q Consensus        13 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv   92 (421)
                      +++|++++.||+|+||+||+|++..+|+.||||+++.... .....+++.+|+++|++++||||+++++++.+++.+|+|
T Consensus         1 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv   79 (298)
T d1gz8a_           1 MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE-TEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLV   79 (298)
T ss_dssp             CTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC--------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             CCCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhc-ChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEE
Confidence            5789999999999999999999999999999999975432 223356889999999999999999999999999999999


Q ss_pred             EeccCCCChHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCccccCC
Q 014609           93 LEYVTGGELFDKIA--SKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD  170 (421)
Q Consensus        93 ~E~~~gg~L~~~i~--~~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~  170 (421)
                      |||+.++ +.+.+.  ...++++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|.....  ..
T Consensus        80 ~e~~~~~-~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~--~~  156 (298)
T d1gz8a_          80 FEFLHQD-LKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGV--PV  156 (298)
T ss_dssp             EECCSEE-HHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCC--CS
T ss_pred             EeecCCc-hhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheeecccCcceeccCCcceeccC--Cc
Confidence            9999664 444443  345799999999999999999999999999999999999999999999999999975432  23


Q ss_pred             CccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhh-hcCCcCCC--------------------------------
Q 014609          171 GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYI-FRGDFKLP--------------------------------  217 (421)
Q Consensus       171 ~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~-~~~~~~~p--------------------------------  217 (421)
                      ......+||+.|+|||++....+.+.++||||+||++|. +.|..|++                                
T Consensus       157 ~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  236 (298)
T d1gz8a_         157 RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY  236 (298)
T ss_dssp             BCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTC
T ss_pred             ccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhcccccccccc
Confidence            345566899999999999888887899999999999994 34554432                                


Q ss_pred             ----------------CCCCHHHHHHHHHhcCCCCCCCCCHHhhhcCccccccccC
Q 014609          218 ----------------KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTP  257 (421)
Q Consensus       218 ----------------~~~s~~~~~li~~~L~~dP~~R~t~~eil~~~w~~~~~~~  257 (421)
                                      +.+|+++.+||++||++||.+|||++|+++||||++-..|
T Consensus       237 ~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~~~p  292 (298)
T d1gz8a_         237 KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP  292 (298)
T ss_dssp             CTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTCCCC
T ss_pred             ccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccCCCC
Confidence                            1357889999999999999999999999999999865444

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.6e-54  Score=418.90  Aligned_cols=234  Identities=32%  Similarity=0.575  Sum_probs=201.5

Q ss_pred             CCeeecceEEec-eEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhc-CCCCCcceEEEEEEe-
Q 014609            9 EGMRLGRYELGR-TLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKL-LKHPNVVRLHEVLAS-   85 (421)
Q Consensus         9 ~~~~~~~y~i~~-~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~-l~hpnIv~l~~~~~~-   85 (421)
                      ....+++|++++ .||+|+||+||+|++..+|+.||||+++..        ..+.+|+.++.+ ++||||+++++++++ 
T Consensus         6 ~~~i~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~--------~~~~~E~~~~~~~~~hpnIv~l~~~~~~~   77 (335)
T d2ozaa1           6 KNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYENL   77 (335)
T ss_dssp             CSCGGGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEEE
T ss_pred             CCCcccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc--------HHHHHHHHHHHHhcCCCCCCeEEEEEeec
Confidence            345679999875 699999999999999999999999999643        457889998755 589999999999976 


Q ss_pred             ---CCEEEEEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecc---CCCEEEEe
Q 014609           86 ---KSKIYMVLEYVTGGELFDKIASK--GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDS---KGNIKISD  157 (421)
Q Consensus        86 ---~~~~~lv~E~~~gg~L~~~i~~~--~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~---~~~~kL~D  157 (421)
                         +..+|+|||||+||+|++++...  .++++.+++.++.||+.||+|||++||+||||||+|||++.   ++.+||+|
T Consensus        78 ~~~~~~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~D  157 (335)
T d2ozaa1          78 YAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTD  157 (335)
T ss_dssp             ETTEEEEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEECC
T ss_pred             ccCCCEEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCccccccccccccccccccccccccc
Confidence               46799999999999999999864  46999999999999999999999999999999999999986   45799999


Q ss_pred             ccCCCCCccccCCCccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhh-cCCcCC--------------------
Q 014609          158 FGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIF-RGDFKL--------------------  216 (421)
Q Consensus       158 FGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~-~~~~~~--------------------  216 (421)
                      ||+|+....   .......+||+.|+|||++.+..|+ .++|||||||++|.+ .|..|+                    
T Consensus       158 FG~a~~~~~---~~~~~~~~gt~~y~aPE~~~~~~y~-~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~~~  233 (335)
T d2ozaa1         158 FGFAKETTS---HNSLTTPCYTPYYVAPEVLGPEKYD-KSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQ  233 (335)
T ss_dssp             CTTCEECCC---CCCCCCCSCCCSSCCCCCCCGGGGS-HHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCCSCS
T ss_pred             cceeeeccC---CCccccccCCcccCCcHHHcCCCCC-HHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHhcCC
Confidence            999985433   3345677899999999999988884 899999999999954 343332                    


Q ss_pred             ---CC----CCCHHHHHHHHHhcCCCCCCCCCHHhhhcCcccccc
Q 014609          217 ---PK----WLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD  254 (421)
Q Consensus       217 ---p~----~~s~~~~~li~~~L~~dP~~R~t~~eil~~~w~~~~  254 (421)
                         |.    .+|+++.+||++||++||++|||+.|+++||||.+.
T Consensus       234 ~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~  278 (335)
T d2ozaa1         234 YEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS  278 (335)
T ss_dssp             SSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHSHHHHTT
T ss_pred             CCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHhhCC
Confidence               21    268899999999999999999999999999999754

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=6.2e-54  Score=408.44  Aligned_cols=237  Identities=32%  Similarity=0.486  Sum_probs=202.8

Q ss_pred             ecceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEE
Q 014609           13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMV   92 (421)
Q Consensus        13 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv   92 (421)
                      +++|++++.||+|+||+||+|++. +|+.||||+++.... .....+.+.+|+.+|++++||||+++++++.+++..|++
T Consensus         1 ~~~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~   78 (286)
T d1ob3a_           1 MEKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKE-DEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLV   78 (286)
T ss_dssp             CCSEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSG-GGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEE
T ss_pred             CCCceeccEEecCCCcEEEEEEeC-CCCEEEEEEEehhhc-ChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEE
Confidence            579999999999999999999985 889999999976543 223357899999999999999999999999999999999


Q ss_pred             EeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCccccCCCc
Q 014609           93 LEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGL  172 (421)
Q Consensus        93 ~E~~~gg~L~~~i~~~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~  172 (421)
                      |||+.++.+.......+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|.....  ....
T Consensus        79 ~e~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~--~~~~  156 (286)
T d1ob3a_          79 FEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGI--PVRK  156 (286)
T ss_dssp             EECCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC------
T ss_pred             EEeehhhhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEcCCCCEEecccccceeccc--Cccc
Confidence            99998887777777778899999999999999999999999999999999999999999999999999975432  2223


Q ss_pred             cccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhh-cCCcCC-----------------------------------
Q 014609          173 LHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIF-RGDFKL-----------------------------------  216 (421)
Q Consensus       173 ~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~-~~~~~~-----------------------------------  216 (421)
                      .....|++.|+|||++.+..+.+.++||||+||++|++ .|..|+                                   
T Consensus       157 ~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~  236 (286)
T d1ob3a_         157 YTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDP  236 (286)
T ss_dssp             -----CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCT
T ss_pred             cceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhhccc
Confidence            44557999999999998777778999999999999943 343332                                   


Q ss_pred             -------------CCCCCHHHHHHHHHhcCCCCCCCCCHHhhhcCccccc
Q 014609          217 -------------PKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQ  253 (421)
Q Consensus       217 -------------p~~~s~~~~~li~~~L~~dP~~R~t~~eil~~~w~~~  253 (421)
                                   ++.+++.+.+||++||++||++|||++|+++||||++
T Consensus       237 ~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~Hp~f~~  286 (286)
T d1ob3a_         237 NFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE  286 (286)
T ss_dssp             TCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred             ccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCc
Confidence                         2336789999999999999999999999999999974

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-52  Score=399.47  Aligned_cols=240  Identities=29%  Similarity=0.449  Sum_probs=211.2

Q ss_pred             ecceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEE
Q 014609           13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMV   92 (421)
Q Consensus        13 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv   92 (421)
                      +++|++++.||+|+||+||+|++..+|+.||||+++.... ......++.+|+.+|+.++||||+++++++.+....++|
T Consensus         1 ~~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv   79 (292)
T d1unla_           1 MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD-DEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLV   79 (292)
T ss_dssp             CCSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCS-STTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             CCCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhC-ChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEE
Confidence            5799999999999999999999999999999999976543 334568899999999999999999999999999999999


Q ss_pred             EeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCccccCCCc
Q 014609           93 LEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGL  172 (421)
Q Consensus        93 ~E~~~gg~L~~~i~~~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~  172 (421)
                      ++++.|++|...+...+.+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||.|.....  ....
T Consensus        80 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~--~~~~  157 (292)
T d1unla_          80 FEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGI--PVRC  157 (292)
T ss_dssp             EECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCS--CCSC
T ss_pred             eeeccccccccccccccccchhHHHHHHHHHHHHHHHhhcCCEeeecccCcccccccCCceeeeecchhhcccC--CCcc
Confidence            99999999999888888999999999999999999999999999999999999999999999999999986543  2223


Q ss_pred             cccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhhc-CCcCC-----------------------------------
Q 014609          173 LHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIFR-GDFKL-----------------------------------  216 (421)
Q Consensus       173 ~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~~-~~~~~-----------------------------------  216 (421)
                      .....+++.|+|||++....+.+.++||||+||++|.+. |..++                                   
T Consensus       158 ~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (292)
T d1unla_         158 YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYK  237 (292)
T ss_dssp             CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCC
T ss_pred             ceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhccccc
Confidence            344567889999999987776679999999999999553 33331                                   


Q ss_pred             --------------CCCCCHHHHHHHHHhcCCCCCCCCCHHhhhcCccccccc
Q 014609          217 --------------PKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY  255 (421)
Q Consensus       217 --------------p~~~s~~~~~li~~~L~~dP~~R~t~~eil~~~w~~~~~  255 (421)
                                    ++.+++.+.+||++||++||.+|||++|+++||||++..
T Consensus       238 ~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp~f~~~~  290 (292)
T d1unla_         238 PYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFC  290 (292)
T ss_dssp             CCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGSSCS
T ss_pred             ccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcChhhcCCC
Confidence                          123578999999999999999999999999999998643

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=7.4e-53  Score=399.21  Aligned_cols=238  Identities=26%  Similarity=0.443  Sum_probs=198.5

Q ss_pred             cceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCC----EE
Q 014609           14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKS----KI   89 (421)
Q Consensus        14 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~----~~   89 (421)
                      ++|++++.||+|+||+||+|++..+|+.||||++++....+......+.+|+.+|+.++||||+++++++...+    .+
T Consensus         7 drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~~   86 (277)
T d1o6ya_           7 DRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLP   86 (277)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred             ceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCceE
Confidence            67999999999999999999999999999999998776666666778999999999999999999999997654    48


Q ss_pred             EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCcccc-
Q 014609           90 YMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFR-  168 (421)
Q Consensus        90 ~lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~~-  168 (421)
                      |+||||++|++|.+.+...+++++.+++.++.||+.||+|||++||+||||||+|||++.++..+|+|||.+....... 
T Consensus        87 ~lvmE~~~g~~L~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~~~~~  166 (277)
T d1o6ya_          87 YIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGN  166 (277)
T ss_dssp             EEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTSCEEECCCTTCEECC----
T ss_pred             EEEEECCCCCEehhhhcccCCCCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccCccccceeehhhhhhhhccccc
Confidence            9999999999999999988999999999999999999999999999999999999999999999999999987443221 


Q ss_pred             CCCccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhh-hcCCcCCC-----------------------CCCCHHH
Q 014609          169 DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYI-FRGDFKLP-----------------------KWLSPGA  224 (421)
Q Consensus       169 ~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~-~~~~~~~p-----------------------~~~s~~~  224 (421)
                      ........+||+.|+|||++.+..| +.++||||+||++|. +.|..|++                       +.+|+++
T Consensus       167 ~~~~~~~~~Gt~~Y~aPE~~~~~~~-~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l  245 (277)
T d1o6ya_         167 SVTQTAAVIGTAQYLSPEQARGDSV-DARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSADL  245 (277)
T ss_dssp             ------------TTCCHHHHTTCCC-CHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCGGGTSSSCCHHH
T ss_pred             cccccccccCcccccCHHHHcCCCC-CcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhcCCCCCchhccCCCHHH
Confidence            2234556789999999999988877 489999999999994 34444432                       3478999


Q ss_pred             HHHHHHhcCCCCCCCCCHHhhhcCcccc
Q 014609          225 QNLLRKILEPNPVKRITIAGIKADEWFE  252 (421)
Q Consensus       225 ~~li~~~L~~dP~~R~t~~eil~~~w~~  252 (421)
                      .++|.+||++||.+||+..+.+.|+|.+
T Consensus       246 ~~li~~~L~~dp~~R~~sa~~l~~~l~r  273 (277)
T d1o6ya_         246 DAVVLKALAKNPENRYQTAAEMRADLVR  273 (277)
T ss_dssp             HHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred             HHHHHHHccCCHhHCHhHHHHHHHHHHH
Confidence            9999999999999999544455677764

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-52  Score=404.85  Aligned_cols=246  Identities=27%  Similarity=0.396  Sum_probs=201.8

Q ss_pred             eeecceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEe-----
Q 014609           11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLAS-----   85 (421)
Q Consensus        11 ~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~-----   85 (421)
                      ..+++|+++++||+|+||+||+|++..+|+.||||++.+.... .....++.+|+.+|++++||||+++++++..     
T Consensus         7 ~~~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~-~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~   85 (318)
T d3blha1           7 DEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEK-EGFPITALREIKILQLLKHENVVNLIEICRTKASPY   85 (318)
T ss_dssp             CBGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CT-TSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC-----
T ss_pred             CccCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcc-hHHHHHHHHHHHHHHHhcCCCccceEeeeecccccc
Confidence            3579999999999999999999999999999999998765433 2335678899999999999999999999855     


Q ss_pred             ---CCEEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCC
Q 014609           86 ---KSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSA  162 (421)
Q Consensus        86 ---~~~~~lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~  162 (421)
                         ++..|+||||+.++.+.........+++..++.+++|++.||.|||++||+||||||+|||++.++.+||+|||++.
T Consensus        86 ~~~~~~~~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~~~~~kl~dfg~~~  165 (318)
T d3blha1          86 NRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLAR  165 (318)
T ss_dssp             -----CEEEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCE
T ss_pred             cccCceEEEEEeccCCCccchhhhcccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheeecCCCcEEeeecceee
Confidence               34689999999877766555666789999999999999999999999999999999999999999999999999997


Q ss_pred             CCcccc--CCCccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhh-cCCcCCCC---------------------
Q 014609          163 LPQHFR--DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIF-RGDFKLPK---------------------  218 (421)
Q Consensus       163 ~~~~~~--~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~-~~~~~~p~---------------------  218 (421)
                      ......  ........+||+.|+|||++.+....+.++||||+||++|++ .|..++..                     
T Consensus       166 ~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~  245 (318)
T d3blha1         166 AFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEV  245 (318)
T ss_dssp             ECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTT
T ss_pred             ecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCChhh
Confidence            543211  223345568999999999987765446899999999999954 34333210                     


Q ss_pred             ------------------------------CCCHHHHHHHHHhcCCCCCCCCCHHhhhcCccccccccC
Q 014609          219 ------------------------------WLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTP  257 (421)
Q Consensus       219 ------------------------------~~s~~~~~li~~~L~~dP~~R~t~~eil~~~w~~~~~~~  257 (421)
                                                    ..++.+.+||.+||++||++|||++|+++||||+..+.|
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hpff~~~p~p  314 (318)
T d3blha1         246 WPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSDPMP  314 (318)
T ss_dssp             STTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGSSSSCC
T ss_pred             ccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcChhhccCCCC
Confidence                                          026778899999999999999999999999999965443

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-52  Score=401.52  Aligned_cols=236  Identities=32%  Similarity=0.450  Sum_probs=196.8

Q ss_pred             ecceEEeceEeecCcEEEEEEEECCC-CceEEEEEeecccccchhHHHHHHHHHHHHhcC---CCCCcceEEEEEEe---
Q 014609           13 LGRYELGRTLGEGNFGKVKFAQDLDS-GLPFAVKILEKNRIIHLKITDQIKREIATLKLL---KHPNVVRLHEVLAS---   85 (421)
Q Consensus        13 ~~~y~i~~~LG~G~~g~V~~a~~~~~-~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l---~hpnIv~l~~~~~~---   85 (421)
                      -++|++++.||+|+||+||+|++..+ ++.||||+++...... .....+.+|+.+|+.|   +||||+++++++..   
T Consensus         6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~-~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~   84 (305)
T d1blxa_           6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEE-GMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT   84 (305)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTT-SCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred             cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccc-hHHHHHHHHHHHHHHHhhcCCCCcceeeeeeccccc
Confidence            36899999999999999999999765 6789999997643322 1223466788877766   79999999999853   


Q ss_pred             --CCEEEEEEeccCCCChHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCC
Q 014609           86 --KSKIYMVLEYVTGGELFDKIA-SKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSA  162 (421)
Q Consensus        86 --~~~~~lv~E~~~gg~L~~~i~-~~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~  162 (421)
                        ...+|++|||+.++.+..... ....+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||++.
T Consensus        85 ~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~~~~~kl~dfg~~~  164 (305)
T d1blxa_          85 DRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLAR  164 (305)
T ss_dssp             SSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCSCC
T ss_pred             ccCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEEcCCCCeeecchhhhh
Confidence              357899999998877654443 34579999999999999999999999999999999999999999999999999998


Q ss_pred             CCccccCCCccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhh-cCCcCC-------------------------
Q 014609          163 LPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIF-RGDFKL-------------------------  216 (421)
Q Consensus       163 ~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~-~~~~~~-------------------------  216 (421)
                      ....   .......+||+.|+|||++.+.+| +.++||||+||++|++ .|..++                         
T Consensus       165 ~~~~---~~~~~~~~gT~~Y~APE~~~~~~y-~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  240 (305)
T d1blxa_         165 IYSF---QMALTSVVVTLWYRAPEVLLQSSY-ATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWP  240 (305)
T ss_dssp             CCCG---GGGGCCCCCCCTTCCHHHHTTCCC-CTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSC
T ss_pred             hhcc---cccCCCcccChhhcCcchhcCCCC-ChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhccc
Confidence            6543   234567789999999999998888 5899999999999944 333332                         


Q ss_pred             ---------------------CCCCCHHHHHHHHHhcCCCCCCCCCHHhhhcCccccc
Q 014609          217 ---------------------PKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQ  253 (421)
Q Consensus       217 ---------------------p~~~s~~~~~li~~~L~~dP~~R~t~~eil~~~w~~~  253 (421)
                                           +..+++.+.+||++||++||.+|||++|+++||||+.
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff~~  298 (305)
T d1blxa_         241 RDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQD  298 (305)
T ss_dssp             TTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTT
T ss_pred             ccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhcC
Confidence                                 2336889999999999999999999999999999975

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=1.3e-52  Score=399.59  Aligned_cols=230  Identities=27%  Similarity=0.384  Sum_probs=201.0

Q ss_pred             eecceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEE
Q 014609           12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYM   91 (421)
Q Consensus        12 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l   91 (421)
                      ..++|++++.||+|+||+||+|++..+|+.||||+++.+..    ..+++.+|+.+|++++||||+++++++.+++.+|+
T Consensus        15 ~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~----~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~i   90 (287)
T d1opja_          15 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYI   90 (287)
T ss_dssp             CGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCS----CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred             cHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccc----hHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEE
Confidence            44689999999999999999999999999999999975432    24679999999999999999999999999999999


Q ss_pred             EEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCccccC
Q 014609           92 VLEYVTGGELFDKIASK--GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD  169 (421)
Q Consensus        92 v~E~~~gg~L~~~i~~~--~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~  169 (421)
                      ||||+++|+|.+++...  ..+++..++.++.|++.||+|||++||+||||||+||||+.++.+||+|||+|+...... 
T Consensus        91 v~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~-  169 (287)
T d1opja_          91 ITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT-  169 (287)
T ss_dssp             EEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSS-
T ss_pred             EeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEECCCCcEEEccccceeecCCCC-
Confidence            99999999999998753  568999999999999999999999999999999999999999999999999998654311 


Q ss_pred             CCccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhhc-CC---------------------cCCCCCCCHHHHHH
Q 014609          170 DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIFR-GD---------------------FKLPKWLSPGAQNL  227 (421)
Q Consensus       170 ~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~~-~~---------------------~~~p~~~s~~~~~l  227 (421)
                      ........||+.|+|||++.+..| +.++||||+||++|++. +.                     .+.|..+|+.+.+|
T Consensus       170 ~~~~~~~~g~~~y~aPE~~~~~~~-~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~l  248 (287)
T d1opja_         170 YTAHAGAKFPIKWTAPESLAYNKF-SIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYEL  248 (287)
T ss_dssp             SEEETTEEECGGGCCHHHHHHCCC-SHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHH
T ss_pred             ceeeccccccccccChHHHcCCCC-CchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHHhcCCCCCCCccchHHHHHH
Confidence            112233458899999999998888 58999999999999542 22                     23456689999999


Q ss_pred             HHHhcCCCCCCCCCHHhhhc
Q 014609          228 LRKILEPNPVKRITIAGIKA  247 (421)
Q Consensus       228 i~~~L~~dP~~R~t~~eil~  247 (421)
                      |.+||+.||.+|||++++++
T Consensus       249 i~~cl~~dP~~Rps~~ei~~  268 (287)
T d1opja_         249 MRACWQWNPSDRPSFAEIHQ  268 (287)
T ss_dssp             HHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHcCCCHhHCcCHHHHHH
Confidence            99999999999999999965

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.7e-52  Score=406.70  Aligned_cols=234  Identities=30%  Similarity=0.430  Sum_probs=197.6

Q ss_pred             ecceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCC-----
Q 014609           13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKS-----   87 (421)
Q Consensus        13 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~-----   87 (421)
                      -++|++++.||+|+||+||+|.+..+|+.||||++++... .....+.+.+|+.+|+.++|||||++++++...+     
T Consensus        17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~   95 (346)
T d1cm8a_          17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQ-SELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF   95 (346)
T ss_dssp             BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTS-SHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred             CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhc-ChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCcccccc
Confidence            3699999999999999999999999999999999976433 4445678999999999999999999999997654     


Q ss_pred             -EEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCcc
Q 014609           88 -KIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQH  166 (421)
Q Consensus        88 -~~~lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~  166 (421)
                       .+|+||||+ |.+|...+. .+++++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|.... 
T Consensus        96 ~~~~lv~e~~-~~~l~~~~~-~~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~~-  172 (346)
T d1cm8a_          96 TDFYLVMPFM-GTDLGKLMK-HEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQAD-  172 (346)
T ss_dssp             CCCEEEEECC-SEEHHHHHH-HCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECC-
T ss_pred             ceEEEEEecc-cccHHHHHH-hccccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhcccccccccccccceeccC-
Confidence             579999999 667766654 4789999999999999999999999999999999999999999999999999998543 


Q ss_pred             ccCCCccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhh-cCCcCCC----------------------------
Q 014609          167 FRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIF-RGDFKLP----------------------------  217 (421)
Q Consensus       167 ~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~-~~~~~~p----------------------------  217 (421)
                          ......+||+.|+|||++.+..+.+.++||||+||++|.+ .|..+++                            
T Consensus       173 ----~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  248 (346)
T d1cm8a_         173 ----SEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQS  248 (346)
T ss_dssp             ----SSCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSC
T ss_pred             ----CccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhhhcc
Confidence                2345678999999999998776767999999999999944 3433321                            


Q ss_pred             ----------------------CCCCHHHHHHHHHhcCCCCCCCCCHHhhhcCcccccc
Q 014609          218 ----------------------KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD  254 (421)
Q Consensus       218 ----------------------~~~s~~~~~li~~~L~~dP~~R~t~~eil~~~w~~~~  254 (421)
                                            ..+++.+.+||++||+.||.+|||+.|+++||||+.-
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~  307 (346)
T d1cm8a_         249 DEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESL  307 (346)
T ss_dssp             HHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTT
T ss_pred             hhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcC
Confidence                                  2368899999999999999999999999999999863

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-52  Score=395.59  Aligned_cols=233  Identities=24%  Similarity=0.398  Sum_probs=191.7

Q ss_pred             eecceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEE
Q 014609           12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYM   91 (421)
Q Consensus        12 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l   91 (421)
                      ..++|++++.||+|+||+||+|+.   +..||||+++..... ....+.+.+|+.+|++++||||+++++++.+ ..+|+
T Consensus         6 ~~~~~~~~~~lG~G~fg~Vy~~~~---~~~vAvK~~~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~l   80 (276)
T d1uwha_           6 PDGQITVGQRIGSGSFGTVYKGKW---HGDVAVKMLNVTAPT-PQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAI   80 (276)
T ss_dssp             CTTCCCCCSEEEECSSCEEEEEES---SSEEEEEECCCSSCC-TTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEE
T ss_pred             ccccEEEEEEEeeCCCcEEEEEEE---CCEEEEEEEEcccCC-HHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEE
Confidence            357899999999999999999974   336999999765433 3346789999999999999999999998754 56899


Q ss_pred             EEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCccccCC
Q 014609           92 VLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD  170 (421)
Q Consensus        92 v~E~~~gg~L~~~i~~~-~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~  170 (421)
                      ||||++||+|.+++... .++++..+..++.||+.||+|||++||+||||||+||||+.++.+||+|||+|.........
T Consensus        81 v~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~~  160 (276)
T d1uwha_          81 VTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGS  160 (276)
T ss_dssp             EEECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTSSEEECCCCCSCC-------
T ss_pred             EEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEcCCCCEEEccccceeeccccCCc
Confidence            99999999999999754 56999999999999999999999999999999999999999999999999999876543334


Q ss_pred             CccccccCCCCccChhhhccc---CCCCCcchHHHHHHHHhhh-cCCcCC-------------------------CCCCC
Q 014609          171 GLLHTTCGSPNYVAPEVLANR---GYDGATSDIWSCGVILYIF-RGDFKL-------------------------PKWLS  221 (421)
Q Consensus       171 ~~~~~~~gt~~y~APEvl~~~---~~~~~~~DiwSlGvil~~~-~~~~~~-------------------------p~~~s  221 (421)
                      ......+||+.|+|||++...   .| +.++|||||||++|++ .|..|+                         +..+|
T Consensus       161 ~~~~~~~gt~~y~APE~l~~~~~~~~-~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~  239 (276)
T d1uwha_         161 HQFEQLSGSILWMAPEVIRMQDKNPY-SFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCP  239 (276)
T ss_dssp             -----CCCCGGGCCHHHHTTCSSCCC-CHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCCCCGGGSCTTCC
T ss_pred             ccccccccCcccCCHHHHhcccCCCC-CchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCcchhccccch
Confidence            455667899999999998643   34 5889999999999943 343332                         33478


Q ss_pred             HHHHHHHHHhcCCCCCCCCCHHhhhcCcc
Q 014609          222 PGAQNLLRKILEPNPVKRITIAGIKADEW  250 (421)
Q Consensus       222 ~~~~~li~~~L~~dP~~R~t~~eil~~~w  250 (421)
                      +.+.+||.+||+.||.+|||+.+|+++-.
T Consensus       240 ~~l~~li~~cl~~dp~~RPt~~~il~~Le  268 (276)
T d1uwha_         240 KAMKRLMAECLKKKRDERPLFPQILASIE  268 (276)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             HHHHHHHHHHcCCCHhHCcCHHHHHHHHH
Confidence            89999999999999999999999998743

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.4e-52  Score=403.55  Aligned_cols=233  Identities=25%  Similarity=0.355  Sum_probs=198.2

Q ss_pred             ecceEEeceEeecCcEEEEEEEECCCCc-----eEEEEEeecccccchhHHHHHHHHHHHHhcC-CCCCcceEEEEEEeC
Q 014609           13 LGRYELGRTLGEGNFGKVKFAQDLDSGL-----PFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEVLASK   86 (421)
Q Consensus        13 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~-----~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~   86 (421)
                      .++|++++.||+|+||+||+|++..+++     .||+|.+.....  ......+.+|+.+|+++ +|||||++++++.+.
T Consensus        36 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~  113 (325)
T d1rjba_          36 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKAD--SSEREALMSELKMMTQLGSHENIVNLLGACTLS  113 (325)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC--------CHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             HHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccC--HHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeC
Confidence            3689999999999999999999876544     699999865432  22346789999999998 899999999999999


Q ss_pred             CEEEEEEeccCCCChHHHHHhc-----------------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCC
Q 014609           87 SKIYMVLEYVTGGELFDKIASK-----------------------GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLE  143 (421)
Q Consensus        87 ~~~~lv~E~~~gg~L~~~i~~~-----------------------~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~  143 (421)
                      +.+|+||||++||+|.+++...                       ..+++..++.++.|++.||+|||++||+||||||+
T Consensus       114 ~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiHRDlKp~  193 (325)
T d1rjba_         114 GPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAAR  193 (325)
T ss_dssp             SSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSGG
T ss_pred             CeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCchh
Confidence            9999999999999999999754                       24899999999999999999999999999999999


Q ss_pred             CEEeccCCCEEEEeccCCCCCccccCCCccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhhc--CCcC------
Q 014609          144 NILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIFR--GDFK------  215 (421)
Q Consensus       144 NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~~--~~~~------  215 (421)
                      |||++.++.+||+|||+|+............+.+||+.|+|||++.+..| +.++|||||||++|++.  |..|      
T Consensus       194 Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~-~~~~DiwS~Gvil~emlt~g~~Pf~~~~~  272 (325)
T d1rjba_         194 NVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIY-TIKSDVWSYGILLWEIFSLGVNPYPGIPV  272 (325)
T ss_dssp             GEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHTTTSCCSSTTCCC
T ss_pred             ccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCC-CcceeccchhHHHHHHHhCCCCCCCCCCH
Confidence            99999999999999999986554333333446678999999999988887 58999999999999643  4433      


Q ss_pred             ---------------CCCCCCHHHHHHHHHhcCCCCCCCCCHHhhhcC
Q 014609          216 ---------------LPKWLSPGAQNLLRKILEPNPVKRITIAGIKAD  248 (421)
Q Consensus       216 ---------------~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~~  248 (421)
                                     .|..+|+++.+||.+||+.||++|||++||++|
T Consensus       273 ~~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~  320 (325)
T d1rjba_         273 DANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF  320 (325)
T ss_dssp             SHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHhcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence                           345689999999999999999999999999875

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=1.4e-51  Score=399.55  Aligned_cols=230  Identities=25%  Similarity=0.441  Sum_probs=197.9

Q ss_pred             eecceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCC-CCCcceEEEEEEeC--CE
Q 014609           12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK-HPNVVRLHEVLASK--SK   88 (421)
Q Consensus        12 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~--~~   88 (421)
                      ..++|++++.||+|+||+||+|++..+|+.||||++++..      .+++.+|+.+|+.++ ||||+++++++...  ..
T Consensus        33 ~~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~------~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~  106 (328)
T d3bqca1          33 NQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK------KKKIKREIKILENLRGGPNIITLADIVKDPVSRT  106 (328)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC------HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCS
T ss_pred             CCcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH------HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCc
Confidence            3478999999999999999999999999999999997542      467899999999996 99999999999754  56


Q ss_pred             EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCC-CEEEEeccCCCCCccc
Q 014609           89 IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKG-NIKISDFGLSALPQHF  167 (421)
Q Consensus        89 ~~lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~-~~kL~DFGla~~~~~~  167 (421)
                      +|+||||+.+++|....   +.+++..++.+++||+.||+|||++||+||||||+|||++.++ .+||+|||+|..... 
T Consensus       107 ~~~v~e~~~~~~L~~~~---~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~-  182 (328)
T d3bqca1         107 PALVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP-  182 (328)
T ss_dssp             EEEEEECCCSCBGGGTT---TSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCGGGCEECCT-
T ss_pred             eeEEEeecCCCcHHHHh---cCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEcCCCCeeeecccccceeccC-
Confidence            99999999999997653   5699999999999999999999999999999999999999765 599999999985433 


Q ss_pred             cCCCccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhh-cCCcCCC-----------------------------
Q 014609          168 RDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIF-RGDFKLP-----------------------------  217 (421)
Q Consensus       168 ~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~-~~~~~~p-----------------------------  217 (421)
                        .......+||+.|+|||++.+....+.++||||+||++|.+ .|..++.                             
T Consensus       183 --~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~  260 (328)
T d3bqca1         183 --GQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYN  260 (328)
T ss_dssp             --TCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTT
T ss_pred             --CCcccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhcc
Confidence              23455678999999999988766557999999999999943 2322211                             


Q ss_pred             ----------------------------CCCCHHHHHHHHHhcCCCCCCCCCHHhhhcCccccc
Q 014609          218 ----------------------------KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQ  253 (421)
Q Consensus       218 ----------------------------~~~s~~~~~li~~~L~~dP~~R~t~~eil~~~w~~~  253 (421)
                                                  ..+|+++.+||++||++||.+|||++|+++||||+.
T Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~Hp~F~~  324 (328)
T d3bqca1         261 IELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYT  324 (328)
T ss_dssp             CCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTT
T ss_pred             cccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCC
Confidence                                        126789999999999999999999999999999985

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-51  Score=402.64  Aligned_cols=241  Identities=29%  Similarity=0.461  Sum_probs=200.5

Q ss_pred             cceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCC----EE
Q 014609           14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKS----KI   89 (421)
Q Consensus        14 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~----~~   89 (421)
                      .+|++++.||+|+||+||+|++..+|+.||||++++..  .....+.+.+|+.+|++++||||+++++++....    ..
T Consensus         8 ~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~   85 (345)
T d1pmea_           8 PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE--HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD   85 (345)
T ss_dssp             TTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTT--CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred             CCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhc--ChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccce
Confidence            57999999999999999999999999999999997543  3344678899999999999999999999997653    23


Q ss_pred             EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCcccc-
Q 014609           90 YMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFR-  168 (421)
Q Consensus        90 ~lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~~-  168 (421)
                      +++++|+.||+|++++.. .++++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|....... 
T Consensus        86 ~~l~~~~~~g~L~~~l~~-~~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~~~~  164 (345)
T d1pmea_          86 VYLVTHLMGADLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHD  164 (345)
T ss_dssp             EEEEEECCCEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCGGGC
T ss_pred             EEEEEeecCCchhhhhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEECCCCCEEEcccCceeeccCCCc
Confidence            444556669999999875 579999999999999999999999999999999999999999999999999998553322 


Q ss_pred             CCCccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhh-cCCcCCC------------------------------
Q 014609          169 DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIF-RGDFKLP------------------------------  217 (421)
Q Consensus       169 ~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~-~~~~~~p------------------------------  217 (421)
                      ........+||+.|+|||++....+++.++||||+||++|.+ .|..+++                              
T Consensus       165 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (345)
T d1pmea_         165 HTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLK  244 (345)
T ss_dssp             BCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTCCCHH
T ss_pred             cceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhhhhhhh
Confidence            223456678999999999986666667899999999999954 3443331                              


Q ss_pred             --------------------CCCCHHHHHHHHHhcCCCCCCCCCHHhhhcCccccccccC
Q 014609          218 --------------------KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTP  257 (421)
Q Consensus       218 --------------------~~~s~~~~~li~~~L~~dP~~R~t~~eil~~~w~~~~~~~  257 (421)
                                          +.+|+++.+||.+||+.||.+|||++|+++||||+....+
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~~~~~  304 (345)
T d1pmea_         245 ARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDP  304 (345)
T ss_dssp             HHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTTCCG
T ss_pred             hhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccCCCC
Confidence                                2367889999999999999999999999999999865443

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-51  Score=402.89  Aligned_cols=232  Identities=28%  Similarity=0.383  Sum_probs=194.8

Q ss_pred             cceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeC------C
Q 014609           14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASK------S   87 (421)
Q Consensus        14 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~------~   87 (421)
                      -+|+.++.||+|+||+||+|++..+|+.||||++.+...       ...+|+++|++++||||+++++++...      .
T Consensus        20 ~~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~-------~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~   92 (350)
T d1q5ka_          20 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-------FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEV   92 (350)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS-------SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCC
T ss_pred             CCcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch-------HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCce
Confidence            379999999999999999999999999999999976532       234799999999999999999998543      3


Q ss_pred             EEEEEEeccCCCChHHH---HHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCC-CEEEEeccCCCC
Q 014609           88 KIYMVLEYVTGGELFDK---IASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKG-NIKISDFGLSAL  163 (421)
Q Consensus        88 ~~~lv~E~~~gg~L~~~---i~~~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~-~~kL~DFGla~~  163 (421)
                      ++|+||||++++.+...   ......+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||++..
T Consensus        93 ~~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~  172 (350)
T d1q5ka_          93 YLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ  172 (350)
T ss_dssp             EEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTTCCEEECCCTTCEE
T ss_pred             EEEEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEecCCCceeEecccchhh
Confidence            58999999976543322   23456799999999999999999999999999999999999999775 899999999975


Q ss_pred             CccccCCCccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhh-cCCcCCC-------------------------
Q 014609          164 PQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIF-RGDFKLP-------------------------  217 (421)
Q Consensus       164 ~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~-~~~~~~p-------------------------  217 (421)
                      ...   .....+.+||+.|+|||++.+..+.+.++||||+||++|++ .|..+++                         
T Consensus       173 ~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~  249 (350)
T d1q5ka_         173 LVR---GEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIRE  249 (350)
T ss_dssp             CCT---TSCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHH
T ss_pred             ccC---CcccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhh
Confidence            432   33455678999999999987665557999999999999943 3333321                         


Q ss_pred             -----------------------CCCCHHHHHHHHHhcCCCCCCCCCHHhhhcCccccccc
Q 014609          218 -----------------------KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY  255 (421)
Q Consensus       218 -----------------------~~~s~~~~~li~~~L~~dP~~R~t~~eil~~~w~~~~~  255 (421)
                                             +.+++++.+||++||++||.+|||+.|+++||||+...
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~  310 (350)
T d1q5ka_         250 MNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELR  310 (350)
T ss_dssp             HCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGG
T ss_pred             hccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhcccc
Confidence                                   23688999999999999999999999999999998644

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.8e-52  Score=388.93  Aligned_cols=228  Identities=23%  Similarity=0.373  Sum_probs=189.2

Q ss_pred             cceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEE
Q 014609           14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVL   93 (421)
Q Consensus        14 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~   93 (421)
                      .+|++++.||+|+||+||+|++. +++.||||+++.....    .+.+.+|++++++++||||+++++++..++..|+||
T Consensus         5 ~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~----~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~   79 (263)
T d1sm2a_           5 SELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMS----EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVF   79 (263)
T ss_dssp             SCEEEEEEEECCSSCCEEEEEET-TTEEEEEEECCSSSSC----HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEE
T ss_pred             HHcEEEEEEeeCCCeEEEEEEEC-CCCEEEEEEECCCcCc----HHHHHHHHHHHHhcCCCCcccccceeccCCceEEEE
Confidence            47999999999999999999975 6778999999764322    467899999999999999999999999999999999


Q ss_pred             eccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCccccCCCc
Q 014609           94 EYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGL  172 (421)
Q Consensus        94 E~~~gg~L~~~i~~~-~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~  172 (421)
                      ||+++|+|.+++... ..+++..+..++.|++.||+|||+++|+||||||+|||++.++++||+|||+|+...... ...
T Consensus        80 E~~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~-~~~  158 (263)
T d1sm2a_          80 EFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ-YTS  158 (263)
T ss_dssp             ECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECGGGCEEECSCC-------------
T ss_pred             EecCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheeecCCCCeEecccchheeccCCC-cee
Confidence            999999999988754 568999999999999999999999999999999999999999999999999998654321 222


Q ss_pred             cccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhhc-CCc---------------------CCCCCCCHHHHHHHHH
Q 014609          173 LHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIFR-GDF---------------------KLPKWLSPGAQNLLRK  230 (421)
Q Consensus       173 ~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~~-~~~---------------------~~p~~~s~~~~~li~~  230 (421)
                      .....||+.|+|||++.+..|+ .++||||+||++|++. +..                     ..|..+++++.++|.+
T Consensus       159 ~~~~~gt~~y~aPE~l~~~~~~-~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~  237 (263)
T d1sm2a_         159 STGTKFPVKWASPEVFSFSRYS-SKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNH  237 (263)
T ss_dssp             ------CTTSCCHHHHTTCCCC-HHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHHTCCCCCCTTSCHHHHHHHHH
T ss_pred             ecceecCcccCChHHhcCCCCC-chhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHhcCCCCCccccCHHHHHHHHH
Confidence            3446799999999999988884 8999999999999543 221                     2345578999999999


Q ss_pred             hcCCCCCCCCCHHhhhcC
Q 014609          231 ILEPNPVKRITIAGIKAD  248 (421)
Q Consensus       231 ~L~~dP~~R~t~~eil~~  248 (421)
                      ||++||.+|||+++|++|
T Consensus       238 cl~~~p~~Rps~~~il~~  255 (263)
T d1sm2a_         238 CWKERPEDRPAFSRLLRQ  255 (263)
T ss_dssp             HTCSSGGGSCCHHHHHHH
T ss_pred             HccCCHhHCcCHHHHHHH
Confidence            999999999999999876

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.7e-52  Score=391.20  Aligned_cols=233  Identities=26%  Similarity=0.400  Sum_probs=199.2

Q ss_pred             eecceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEE
Q 014609           12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYM   91 (421)
Q Consensus        12 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l   91 (421)
                      ..++|++++.||+|+||+||+|++. +++.||||+++....    ..+.+.+|+.+|++++|||||++++++.+ +..|+
T Consensus        11 ~~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~----~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~i   84 (272)
T d1qpca_          11 PRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSM----SPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYI   84 (272)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSS----CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEE
T ss_pred             CHHHeEEeEEEecCCCcEEEEEEEC-CCCEEEEEEEccCcC----CHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEE
Confidence            4479999999999999999999974 678899999975432    24679999999999999999999998754 56799


Q ss_pred             EEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCccccC
Q 014609           92 VLEYVTGGELFDKIASK--GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD  169 (421)
Q Consensus        92 v~E~~~gg~L~~~i~~~--~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~  169 (421)
                      ||||+++|+|.+.+...  .++++..+..++.||+.||+|||++||+||||||+||||+.++.+||+|||+|+..... .
T Consensus        85 v~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~-~  163 (272)
T d1qpca_          85 ITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDN-E  163 (272)
T ss_dssp             EEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSS-C
T ss_pred             EEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheeeecccceeeccccceEEccCC-c
Confidence            99999999999877543  36999999999999999999999999999999999999999999999999999865431 1


Q ss_pred             CCccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhhc-CC---------------------cCCCCCCCHHHHHH
Q 014609          170 DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIFR-GD---------------------FKLPKWLSPGAQNL  227 (421)
Q Consensus       170 ~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~~-~~---------------------~~~p~~~s~~~~~l  227 (421)
                      ........||+.|+|||++.+..| +.++||||+||++|++. +.                     .+.|..+++++.+|
T Consensus       164 ~~~~~~~~gt~~y~APE~~~~~~~-~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~l  242 (272)
T d1qpca_         164 YTAREGAKFPIKWTAPEAINYGTF-TIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQL  242 (272)
T ss_dssp             EECCTTCCCCTTTSCHHHHHHCEE-CHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHH
T ss_pred             cccccccCCcccccChHHHhCCCC-CchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCcccChHHHHHH
Confidence            122344578999999999988777 58999999999999543 22                     23456689999999


Q ss_pred             HHHhcCCCCCCCCCHHhhhc--Ccccc
Q 014609          228 LRKILEPNPVKRITIAGIKA--DEWFE  252 (421)
Q Consensus       228 i~~~L~~dP~~R~t~~eil~--~~w~~  252 (421)
                      |.+||+.||++|||++++++  |+||.
T Consensus       243 i~~cl~~~P~~Rpt~~ei~~~L~~~ft  269 (272)
T d1qpca_         243 MRLCWKERPEDRPTFDYLRSVLEDFFT  269 (272)
T ss_dssp             HHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHHHcCCCHhHCcCHHHHHHHhhhhhh
Confidence            99999999999999999988  78875

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-51  Score=398.86  Aligned_cols=243  Identities=31%  Similarity=0.590  Sum_probs=208.8

Q ss_pred             CeeecceEEeceEeecCcEEEEEEEEC---CCCceEEEEEeeccccc-chhHHHHHHHHHHHHhcCCC-CCcceEEEEEE
Q 014609           10 GMRLGRYELGRTLGEGNFGKVKFAQDL---DSGLPFAVKILEKNRII-HLKITDQIKREIATLKLLKH-PNVVRLHEVLA   84 (421)
Q Consensus        10 ~~~~~~y~i~~~LG~G~~g~V~~a~~~---~~~~~vAvK~i~~~~~~-~~~~~~~~~~Ei~il~~l~h-pnIv~l~~~~~   84 (421)
                      ...+++|++++.||+|+||+||+|++.   .+|+.||||++++.... +....+.+.+|+++|++++| |||+++++++.
T Consensus        20 ~~~l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~   99 (322)
T d1vzoa_          20 KVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQ   99 (322)
T ss_dssp             CCCGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEE
T ss_pred             ccchhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeec
Confidence            356789999999999999999999874   47899999999765432 22234678899999999977 89999999999


Q ss_pred             eCCEEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCC
Q 014609           85 SKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALP  164 (421)
Q Consensus        85 ~~~~~~lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~  164 (421)
                      +...+|++|||+.||+|.+.+...+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|...
T Consensus       100 ~~~~~~~v~e~~~~~~L~~~i~~~~~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~~~vkL~DFG~a~~~  179 (322)
T d1vzoa_         100 TETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEF  179 (322)
T ss_dssp             ETTEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEEC
T ss_pred             cCCceeeeeecccccHHHHHHHhcccccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceeecCCCCEEEeeccchhhh
Confidence            99999999999999999999999899999999999999999999999999999999999999999999999999999755


Q ss_pred             ccccCCCccccccCCCCccChhhhcccC-CCCCcchHHHHHHHHhhh-cCC-----------------------cCCCCC
Q 014609          165 QHFRDDGLLHTTCGSPNYVAPEVLANRG-YDGATSDIWSCGVILYIF-RGD-----------------------FKLPKW  219 (421)
Q Consensus       165 ~~~~~~~~~~~~~gt~~y~APEvl~~~~-~~~~~~DiwSlGvil~~~-~~~-----------------------~~~p~~  219 (421)
                      ... ......+.+|++.|+|||.+.... +.+.++|||||||+||.+ .|.                       .++|..
T Consensus       180 ~~~-~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~  258 (322)
T d1vzoa_         180 VAD-ETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQE  258 (322)
T ss_dssp             CGG-GGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCCCCTT
T ss_pred             ccc-ccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccCCCCCccc
Confidence            332 223345678999999999987643 346789999999999943 333                       234556


Q ss_pred             CCHHHHHHHHHhcCCCCCCCC-----CHHhhhcCccccc
Q 014609          220 LSPGAQNLLRKILEPNPVKRI-----TIAGIKADEWFEQ  253 (421)
Q Consensus       220 ~s~~~~~li~~~L~~dP~~R~-----t~~eil~~~w~~~  253 (421)
                      +|+++.+||++||++||.+||     |++|+++||||+.
T Consensus       259 ~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff~~  297 (322)
T d1vzoa_         259 MSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQK  297 (322)
T ss_dssp             SCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTT
T ss_pred             CCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcCHhhcC
Confidence            899999999999999999999     5899999999975

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=5e-51  Score=390.72  Aligned_cols=235  Identities=23%  Similarity=0.366  Sum_probs=188.9

Q ss_pred             eeecceEEeceEeecCcEEEEEEEECCCCc---eEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCC
Q 014609           11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGL---PFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKS   87 (421)
Q Consensus        11 ~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~---~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~   87 (421)
                      ...++|++.+.||+|+||+||+|++..+|+   .||||.+....  .....+.+.+|+.+|++++|||||++++++.+++
T Consensus        23 i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~  100 (299)
T d1jpaa_          23 IDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY--TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKST  100 (299)
T ss_dssp             CCGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS
T ss_pred             hChhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECccc--CHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCC
Confidence            345789999999999999999999887665   58888876543  2334577999999999999999999999999999


Q ss_pred             EEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCcc
Q 014609           88 KIYMVLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQH  166 (421)
Q Consensus        88 ~~~lv~E~~~gg~L~~~i~~~-~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~  166 (421)
                      .+|+||||++||+|.+++... +.+++..+..++.||+.||+|||++||+||||||+||||+.++.+||+|||+|+....
T Consensus       101 ~~~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~  180 (299)
T d1jpaa_         101 PVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLED  180 (299)
T ss_dssp             SCEEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred             EEEEEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEECCCCcEEECCcccceEccC
Confidence            999999999999999988764 5699999999999999999999999999999999999999999999999999986543


Q ss_pred             ccCCC---ccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhh-c-CCcC--------------------CCCCCC
Q 014609          167 FRDDG---LLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIF-R-GDFK--------------------LPKWLS  221 (421)
Q Consensus       167 ~~~~~---~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~-~-~~~~--------------------~p~~~s  221 (421)
                      .....   ......||+.|+|||++.+..| +.++|||||||++|++ . |..|                    .|..++
T Consensus       181 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~-~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~  259 (299)
T d1jpaa_         181 DTSDPTYTSALGGKIPIRWTAPEAIQYRKF-TSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLPPPMDCP  259 (299)
T ss_dssp             ---------------CGGGSCHHHHHSCCC-CHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTCC
T ss_pred             CCCcceeeecccccCCccccCHHHHhcCCC-CcccccccchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCccch
Confidence            22111   1122457899999999988877 4899999999999954 3 4433                    344578


Q ss_pred             HHHHHHHHHhcCCCCCCCCCHHhhhcC
Q 014609          222 PGAQNLLRKILEPNPVKRITIAGIKAD  248 (421)
Q Consensus       222 ~~~~~li~~~L~~dP~~R~t~~eil~~  248 (421)
                      +.+.+||.+||+.||.+|||+.|++++
T Consensus       260 ~~l~~li~~cl~~~P~~RPs~~ei~~~  286 (299)
T d1jpaa_         260 SALHQLMLDCWQKDRNHRPKFGQIVNT  286 (299)
T ss_dssp             HHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred             HHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence            999999999999999999999998865

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.5e-51  Score=388.59  Aligned_cols=230  Identities=24%  Similarity=0.356  Sum_probs=191.2

Q ss_pred             ceEeecCcEEEEEEEEC--CCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEEeccC
Q 014609           20 RTLGEGNFGKVKFAQDL--DSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVT   97 (421)
Q Consensus        20 ~~LG~G~~g~V~~a~~~--~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~~   97 (421)
                      +.||+|+||+||+|.+.  .+++.||||+++.... +....+.+.+|+.+|++++||||+++++++.++ ..|+||||++
T Consensus        13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~-~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~~-~~~lvmE~~~   90 (277)
T d1xbba_          13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAN-DPALKDELLAEANVMQQLDNPYIVRMIGICEAE-SWMLVMEMAE   90 (277)
T ss_dssp             EEEEECSSEEEEEEEEECSSSEEEEEEEEEC------CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESS-SEEEEEECCT
T ss_pred             CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhC-CHHHHHHHHHHHHHHHhCCCCCCceEEEEeccC-CEEEEEEcCC
Confidence            57999999999999764  4568899999975432 334457899999999999999999999999755 5789999999


Q ss_pred             CCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCccccC-CCccccc
Q 014609           98 GGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD-DGLLHTT  176 (421)
Q Consensus        98 gg~L~~~i~~~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~-~~~~~~~  176 (421)
                      +|+|.+++....++++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+....... .......
T Consensus        91 ~g~L~~~l~~~~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~~~  170 (277)
T d1xbba_          91 LGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHG  170 (277)
T ss_dssp             TEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC----
T ss_pred             CCcHHHHHhhccCCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhcccccCcccccchhhhhhcccccccccccccc
Confidence            999999999888999999999999999999999999999999999999999999999999999985433211 1122345


Q ss_pred             cCCCCccChhhhcccCCCCCcchHHHHHHHHhhh-c-CCcC--------------------CCCCCCHHHHHHHHHhcCC
Q 014609          177 CGSPNYVAPEVLANRGYDGATSDIWSCGVILYIF-R-GDFK--------------------LPKWLSPGAQNLLRKILEP  234 (421)
Q Consensus       177 ~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~-~-~~~~--------------------~p~~~s~~~~~li~~~L~~  234 (421)
                      .||+.|+|||++.+..| +.++|||||||++|++ . |..|                    .|..+|+++.+||.+||+.
T Consensus       171 ~gt~~y~APE~l~~~~~-~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~~~~li~~cl~~  249 (277)
T d1xbba_         171 KWPVKWYAPECINYYKF-SSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTY  249 (277)
T ss_dssp             CCCGGGCCHHHHHHCEE-EHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCS
T ss_pred             CCCceecCchhhcCCCC-CchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHHcCCCCCCCcccCHHHHHHHHHHcCC
Confidence            78999999999988777 5899999999999953 3 4443                    3556899999999999999


Q ss_pred             CCCCCCCHHhh---hcCcccc
Q 014609          235 NPVKRITIAGI---KADEWFE  252 (421)
Q Consensus       235 dP~~R~t~~ei---l~~~w~~  252 (421)
                      ||.+|||+++|   ++|+|+.
T Consensus       250 dp~~RPs~~~i~~~L~~~~~~  270 (277)
T d1xbba_         250 DVENRPGFAAVELRLRNYYYD  270 (277)
T ss_dssp             STTTSCCHHHHHHHHHHHHHH
T ss_pred             CHhHCcCHHHHHHHhhCHHhh
Confidence            99999999998   4566543

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.7e-51  Score=387.56  Aligned_cols=235  Identities=25%  Similarity=0.371  Sum_probs=198.5

Q ss_pred             cceEEece-EeecCcEEEEEEEECC--CCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEE
Q 014609           14 GRYELGRT-LGEGNFGKVKFAQDLD--SGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIY   90 (421)
Q Consensus        14 ~~y~i~~~-LG~G~~g~V~~a~~~~--~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~   90 (421)
                      ++|.+.+. ||+|+||+||+|.+..  ++..||||+++...  .....+.+.+|+++|++++|||||++++++.++ .+|
T Consensus         8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~-~~~   84 (285)
T d1u59a_           8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT--EKADTEEMMREAQIMHQLDNPYIVRLIGVCQAE-ALM   84 (285)
T ss_dssp             GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEE
T ss_pred             cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhc--CHHHHHHHHHHHHHHHhCCCCCEeeEeeeeccC-eEE
Confidence            57888884 9999999999998754  45589999997543  334467899999999999999999999999754 589


Q ss_pred             EEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCccccC
Q 014609           91 MVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD  169 (421)
Q Consensus        91 lv~E~~~gg~L~~~i~~-~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~  169 (421)
                      +||||++||+|.+++.. +..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+.......
T Consensus        85 lvmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~  164 (285)
T d1u59a_          85 LVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDS  164 (285)
T ss_dssp             EEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSC
T ss_pred             EEEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeeccCCceeeccchhhhccccccc
Confidence            99999999999998765 45799999999999999999999999999999999999999999999999999986543211


Q ss_pred             -CCccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhh-hc-CCc--------------------CCCCCCCHHHHH
Q 014609          170 -DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYI-FR-GDF--------------------KLPKWLSPGAQN  226 (421)
Q Consensus       170 -~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~-~~-~~~--------------------~~p~~~s~~~~~  226 (421)
                       .......+||+.|+|||++....| +.++|||||||++|+ +. |..                    +.|+.+|+++.+
T Consensus       165 ~~~~~~~~~gt~~y~aPE~~~~~~~-~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~  243 (285)
T d1u59a_         165 YYTARSAGKWPLKWYAPECINFRKF-SSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPPELYA  243 (285)
T ss_dssp             EECCCCSSCCCGGGCCHHHHHHCEE-CHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCCCCCCTTCCHHHHH
T ss_pred             ccccccccccCccccChHHHhCCCC-CccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHHHH
Confidence             122335578999999999988877 589999999999995 33 443                    345668999999


Q ss_pred             HHHHhcCCCCCCCCCHHhh---hcCcccc
Q 014609          227 LLRKILEPNPVKRITIAGI---KADEWFE  252 (421)
Q Consensus       227 li~~~L~~dP~~R~t~~ei---l~~~w~~  252 (421)
                      ||.+||+.||++|||+.+|   ++|+|+.
T Consensus       244 li~~cl~~~p~~RPs~~~i~~~L~~~~~~  272 (285)
T d1u59a_         244 LMSDCWIYKWEDRPDFLTVEQRMRACYYS  272 (285)
T ss_dssp             HHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence            9999999999999999887   6678765

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.8e-51  Score=400.60  Aligned_cols=235  Identities=31%  Similarity=0.434  Sum_probs=199.9

Q ss_pred             cceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeC-----CE
Q 014609           14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASK-----SK   88 (421)
Q Consensus        14 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~-----~~   88 (421)
                      +||++++.||+|+||+||+|++..+|+.||||++++... +....+++.+|+.+|++++||||+++++++...     ..
T Consensus        18 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~   96 (348)
T d2gfsa1          18 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ-SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN   96 (348)
T ss_dssp             TTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTS-SHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred             CCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhc-ChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence            689999999999999999999999999999999986543 333456789999999999999999999998643     33


Q ss_pred             EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCcccc
Q 014609           89 IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFR  168 (421)
Q Consensus        89 ~~lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~~  168 (421)
                      .+++++|+.||+|.+++.. +++++..++.++.||+.||+|||++||+||||||+|||++.+|.+|++|||++.....  
T Consensus        97 ~~~i~~~~~gg~L~~~~~~-~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~~~~~kl~dfg~a~~~~~--  173 (348)
T d2gfsa1          97 DVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD--  173 (348)
T ss_dssp             CCEEEEECCSEEHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCC----CCTG--
T ss_pred             eEEEEEeecCCchhhhccc-ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCCccccccccccccccccchhcccCc--
Confidence            4666777889999998864 6799999999999999999999999999999999999999999999999999975432  


Q ss_pred             CCCccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhh-cCCcCCC------------------------------
Q 014609          169 DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIF-RGDFKLP------------------------------  217 (421)
Q Consensus       169 ~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~-~~~~~~p------------------------------  217 (421)
                         ...+.+||+.|+|||++.+..+.+.++||||+||++|.+ .|..+++                              
T Consensus       174 ---~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  250 (348)
T d2gfsa1         174 ---EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES  250 (348)
T ss_dssp             ---GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCCCHH
T ss_pred             ---ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhccchh
Confidence               345668999999999988877778999999999999944 4544432                              


Q ss_pred             --------------------CCCCHHHHHHHHHhcCCCCCCCCCHHhhhcCccccccc
Q 014609          218 --------------------KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY  255 (421)
Q Consensus       218 --------------------~~~s~~~~~li~~~L~~dP~~R~t~~eil~~~w~~~~~  255 (421)
                                          ..+++.+.+||++||+.||.+|||+.|+++||||++..
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~~  308 (348)
T d2gfsa1         251 ARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH  308 (348)
T ss_dssp             HHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTC
T ss_pred             hhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCCC
Confidence                                23688999999999999999999999999999998654

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-50  Score=379.07  Aligned_cols=228  Identities=24%  Similarity=0.412  Sum_probs=200.0

Q ss_pred             cceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEEEEE
Q 014609           14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVL   93 (421)
Q Consensus        14 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~   93 (421)
                      ++|+++++||+|+||+||+|++ .+++.||||++++....    .+.+.+|+.++++++||||+++++++.+++.+|+||
T Consensus         4 ~~~~~~~~iG~G~fg~Vy~~~~-~~~~~vAvK~l~~~~~~----~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~   78 (258)
T d1k2pa_           4 KDLTFLKELGTGQFGVVKYGKW-RGQYDVAIKMIKEGSMS----EDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIIT   78 (258)
T ss_dssp             CCCCCCCCCCEETTEEEEEEEE-TTTEEEEEEEEESSSSC----HHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEE
T ss_pred             HHCEEeEEEecCCCeEEEEEEE-CCCCEEEEEEECcCcCC----HHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEE
Confidence            5789999999999999999998 47889999999865432    467999999999999999999999999999999999


Q ss_pred             eccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCccccCCCc
Q 014609           94 EYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGL  172 (421)
Q Consensus        94 E~~~gg~L~~~i~~-~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~  172 (421)
                      ||+++|+|.+++.. ...+++..+.+++.|+++||+|||++||+||||||+|||++.++.+||+|||++...... ....
T Consensus        79 Ey~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~-~~~~  157 (258)
T d1k2pa_          79 EYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDD-EYTS  157 (258)
T ss_dssp             ECCTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSS-SCCC
T ss_pred             EccCCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEcCCCcEEECcchhheeccCC-Ccee
Confidence            99999999988654 467999999999999999999999999999999999999999999999999999865432 2223


Q ss_pred             cccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhhc--CCcC--------------------CCCCCCHHHHHHHHH
Q 014609          173 LHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIFR--GDFK--------------------LPKWLSPGAQNLLRK  230 (421)
Q Consensus       173 ~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~~--~~~~--------------------~p~~~s~~~~~li~~  230 (421)
                      .....||+.|+|||++.+..|+ .++|||||||++|++.  |..|                    .|...++.+.+||++
T Consensus       158 ~~~~~~t~~y~aPE~~~~~~~~-~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~  236 (258)
T d1k2pa_         158 SVGSKFPVRWSPPEVLMYSKFS-SKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYTIMYS  236 (258)
T ss_dssp             CCCSCCCGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHH
T ss_pred             ecccCCCCCcCCcHHhcCCCCC-cceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHHhCCCCCCcccccHHHHHHHHH
Confidence            3346789999999999988885 8999999999999543  3433                    345578999999999


Q ss_pred             hcCCCCCCCCCHHhhhcC
Q 014609          231 ILEPNPVKRITIAGIKAD  248 (421)
Q Consensus       231 ~L~~dP~~R~t~~eil~~  248 (421)
                      ||+.||++|||+++|++|
T Consensus       237 cl~~dP~~RPt~~eil~~  254 (258)
T d1k2pa_         237 CWHEKADERPTFKILLSN  254 (258)
T ss_dssp             TTCSSGGGSCCHHHHHHH
T ss_pred             HccCCHhHCcCHHHHHHH
Confidence            999999999999999986

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-50  Score=383.68  Aligned_cols=236  Identities=25%  Similarity=0.393  Sum_probs=196.4

Q ss_pred             eeecceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEEE
Q 014609           11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIY   90 (421)
Q Consensus        11 ~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~   90 (421)
                      ...++|++++.||+|+||+||+|++..+ +.||||+++.....    .+.+.+|+.+|++++|||||++++++.+ +.+|
T Consensus        14 i~~~~~~i~~~iG~G~fg~Vy~~~~~~~-~~vAiK~l~~~~~~----~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~   87 (285)
T d1fmka3          14 IPRESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMS----PEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIY   87 (285)
T ss_dssp             CCGGGEEEEEEEEECSSCEEEEEEETTT-EEEEEEECCTTSSC----HHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred             cCHHHEEEeeEEeeCCCeEEEEEEECCC-CEEEEEEECcccCC----HHHHHHHHHHHHhcccCCEeEEEEEEec-CCeE
Confidence            4568999999999999999999998654 57999999754321    4679999999999999999999999854 5689


Q ss_pred             EEEeccCCCChHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCcccc
Q 014609           91 MVLEYVTGGELFDKIAS--KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFR  168 (421)
Q Consensus        91 lv~E~~~gg~L~~~i~~--~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~~  168 (421)
                      +||||+++|+|.+.+..  ...+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||+|...... 
T Consensus        88 lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~-  166 (285)
T d1fmka3          88 IVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDN-  166 (285)
T ss_dssp             EEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC------
T ss_pred             EEEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEECCCCcEEEcccchhhhccCC-
Confidence            99999999999888754  457999999999999999999999999999999999999999999999999999865332 


Q ss_pred             CCCccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhhc-C---------------------CcCCCCCCCHHHHH
Q 014609          169 DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIFR-G---------------------DFKLPKWLSPGAQN  226 (421)
Q Consensus       169 ~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~~-~---------------------~~~~p~~~s~~~~~  226 (421)
                      ........+||+.|+|||++.+..+ +.++||||+||++|++. +                     ..+.|+.+|+++.+
T Consensus       167 ~~~~~~~~~gt~~y~aPE~~~~~~~-~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~  245 (285)
T d1fmka3         167 EYTARQGAKFPIKWTAPEAALYGRF-TIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHD  245 (285)
T ss_dssp             ---------CCGGGSCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTSCHHHHH
T ss_pred             CceeeccccccccccChHHHhCCCC-CcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCCcccCHHHHH
Confidence            1223344679999999999988887 58999999999999542 2                     13456678999999


Q ss_pred             HHHHhcCCCCCCCCCHHhhhc--Ccccccc
Q 014609          227 LLRKILEPNPVKRITIAGIKA--DEWFEQD  254 (421)
Q Consensus       227 li~~~L~~dP~~R~t~~eil~--~~w~~~~  254 (421)
                      +|.+||+.||++|||+++|++  ++||...
T Consensus       246 li~~cl~~dP~~Rps~~~i~~~L~~~~~~~  275 (285)
T d1fmka3         246 LMCQCWRKEPEERPTFEYLQAFLEDYFTST  275 (285)
T ss_dssp             HHHHHTCSSGGGSCCHHHHHHHHHTTTSCS
T ss_pred             HHHHHcccCHhHCcCHHHHHHHHhhhhcCC
Confidence            999999999999999999987  7888653

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4e-50  Score=393.64  Aligned_cols=236  Identities=29%  Similarity=0.442  Sum_probs=191.4

Q ss_pred             eecceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEe------
Q 014609           12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLAS------   85 (421)
Q Consensus        12 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~------   85 (421)
                      .+++|++++.||+|+||+||+|+++.+|+.||||++++... +.....++.+|+.+|++++||||+++++++..      
T Consensus        15 i~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~   93 (355)
T d2b1pa1          15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQ-NQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEE   93 (355)
T ss_dssp             EETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTS-SHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTT
T ss_pred             ecCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhc-CHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeccccccc
Confidence            45799999999999999999999999999999999986543 34446789999999999999999999999953      


Q ss_pred             CCEEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCc
Q 014609           86 KSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQ  165 (421)
Q Consensus        86 ~~~~~lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~  165 (421)
                      .+.+|+||||+.|+ +.+.+.  ..+++..++.+++||+.||+|||++||+||||||+|||++.++.+|++|||++....
T Consensus        94 ~~~~~iv~Ey~~~~-l~~~~~--~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~~~~~~kl~df~~~~~~~  170 (355)
T d2b1pa1          94 FQDVYLVMELMDAN-LCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG  170 (355)
T ss_dssp             CCEEEEEEECCSEE-HHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred             CceeEEEEeccchH-HHHhhh--cCCCHHHHHHHHHHHHHHHHHhhhcccccccCCccccccccccceeeechhhhhccc
Confidence            47899999999665 445543  569999999999999999999999999999999999999999999999999988544


Q ss_pred             cccCCCccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhh-cCCcCCCC--------------------------
Q 014609          166 HFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIF-RGDFKLPK--------------------------  218 (421)
Q Consensus       166 ~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~-~~~~~~p~--------------------------  218 (421)
                      .   .......+||+.|+|||++.+..+ +.++||||+||++|.+ .|..+++.                          
T Consensus       171 ~---~~~~~~~~~t~~y~aPE~l~~~~~-~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~  246 (355)
T d2b1pa1         171 T---SFMMTPYVVTRYYRAPEVILGMGY-KENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ  246 (355)
T ss_dssp             -------------CCTTCCHHHHTTCCC-CTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSC
T ss_pred             c---ccccccccccccccChhhhcCCCC-CCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhh
Confidence            3   334456689999999999988877 5899999999999943 45444321                          


Q ss_pred             -----------------------------------CCCHHHHHHHHHhcCCCCCCCCCHHhhhcCccccccc
Q 014609          219 -----------------------------------WLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY  255 (421)
Q Consensus       219 -----------------------------------~~s~~~~~li~~~L~~dP~~R~t~~eil~~~w~~~~~  255 (421)
                                                         ..|+++.+||++||.+||++|||++|+|+||||+...
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~Hpw~~~~~  318 (355)
T d2b1pa1         247 PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWY  318 (355)
T ss_dssp             HHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGGC
T ss_pred             hhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCCCC
Confidence                                               0256789999999999999999999999999998643

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.7e-50  Score=379.21  Aligned_cols=231  Identities=24%  Similarity=0.359  Sum_probs=190.2

Q ss_pred             cceEEeceEeecCcEEEEEEEECCCC----ceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEE
Q 014609           14 GRYELGRTLGEGNFGKVKFAQDLDSG----LPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKI   89 (421)
Q Consensus        14 ~~y~i~~~LG~G~~g~V~~a~~~~~~----~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~   89 (421)
                      ..|++.+.||+|+||+||+|.+..++    ..||||+++...  .......+.+|+.+|++++|||||++++++.+....
T Consensus         7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~   84 (283)
T d1mqba_           7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY--TEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPM   84 (283)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSE
T ss_pred             HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECccc--ChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCce
Confidence            57999999999999999999876554    479999997543  233356789999999999999999999999999999


Q ss_pred             EEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCcccc
Q 014609           90 YMVLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFR  168 (421)
Q Consensus        90 ~lv~E~~~gg~L~~~i~~~-~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~~  168 (421)
                      ++||||+.++++.+.+... ..+++..+..++.|++.||+|||+++|+||||||+||||+.++.+||+|||+|+......
T Consensus        85 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~  164 (283)
T d1mqba_          85 MIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP  164 (283)
T ss_dssp             EEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC--------
T ss_pred             EEEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccccccCccccceEEECCCCeEEEcccchhhcccCCC
Confidence            9999999999999877654 579999999999999999999999999999999999999999999999999998654322


Q ss_pred             CC-CccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhhc-CC---------------------cCCCCCCCHHHH
Q 014609          169 DD-GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIFR-GD---------------------FKLPKWLSPGAQ  225 (421)
Q Consensus       169 ~~-~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~~-~~---------------------~~~p~~~s~~~~  225 (421)
                      .. .......||+.|+|||++.+..| +.++|||||||++|++. +.                     .+.|..+++.+.
T Consensus       165 ~~~~~~~~~~gt~~Y~APE~l~~~~~-~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~  243 (283)
T d1mqba_         165 EATYTTSGGKIPIRWTAPEAISYRKF-TSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMDCPSAIY  243 (283)
T ss_dssp             ---------CCCGGGSCHHHHHSCCC-CHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTCBHHHH
T ss_pred             ccceEeccCCCCccccCHHHHccCCC-CCcccccccHHHHHHHHhCCCCccccCCHHHHHHHHhccCCCCCchhhHHHHH
Confidence            21 12334568999999999988877 48999999999999543 22                     234556889999


Q ss_pred             HHHHHhcCCCCCCCCCHHhhhc
Q 014609          226 NLLRKILEPNPVKRITIAGIKA  247 (421)
Q Consensus       226 ~li~~~L~~dP~~R~t~~eil~  247 (421)
                      +||.+||+.||++|||+.+|++
T Consensus       244 ~li~~cl~~~p~~RPt~~eil~  265 (283)
T d1mqba_         244 QLMMQCWQQERARRPKFADIVS  265 (283)
T ss_dssp             HHHHHHTCSSTTTSCCHHHHHH
T ss_pred             HHHHHHCcCCHhHCcCHHHHHH
Confidence            9999999999999999999976

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-49  Score=383.98  Aligned_cols=233  Identities=22%  Similarity=0.327  Sum_probs=191.5

Q ss_pred             cceEEeceEeecCcEEEEEEEECCCCc----eEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEE
Q 014609           14 GRYELGRTLGEGNFGKVKFAQDLDSGL----PFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKI   89 (421)
Q Consensus        14 ~~y~i~~~LG~G~~g~V~~a~~~~~~~----~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~   89 (421)
                      .+|++++.||+|+||+||+|.+..+|+    .||+|.++...  .....+.+.+|+.+|++++|||||++++++.++ ..
T Consensus         9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~   85 (317)
T d1xkka_           9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT--SPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TV   85 (317)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC------CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SE
T ss_pred             HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEecccc--CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-Ce
Confidence            579999999999999999999988876    57888775432  223357899999999999999999999999875 46


Q ss_pred             EEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCcccc
Q 014609           90 YMVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFR  168 (421)
Q Consensus        90 ~lv~E~~~gg~L~~~i~~-~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~~  168 (421)
                      ++++||+.+++|.+.+.. ...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|.......
T Consensus        86 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~~~  165 (317)
T d1xkka_          86 QLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE  165 (317)
T ss_dssp             EEEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCCSHHHHTTTTC
T ss_pred             eEEEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeCCCCCeEeeccccceeccccc
Confidence            788899999999988765 4579999999999999999999999999999999999999999999999999998654433


Q ss_pred             CCCccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhhc--CC--------------------cCCCCCCCHHHHH
Q 014609          169 DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIFR--GD--------------------FKLPKWLSPGAQN  226 (421)
Q Consensus       169 ~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~~--~~--------------------~~~p~~~s~~~~~  226 (421)
                      .........||+.|+|||++.+..| +.++|||||||++|++.  |.                    .+.|+.+++.+.+
T Consensus       166 ~~~~~~~~~gt~~y~APE~l~~~~~-~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~p~~~~~~~~~  244 (317)
T d1xkka_         166 KEYHAEGGKVPIKWMALESILHRIY-THQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYM  244 (317)
T ss_dssp             C--------CCTTTSCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHHHTCCCCCCTTBCHHHHH
T ss_pred             ccccccccccCccccChHHHhcCCC-ChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCcccCHHHHH
Confidence            3333445578999999999988887 58999999999999553  22                    2345568899999


Q ss_pred             HHHHhcCCCCCCCCCHHhhhcCcc
Q 014609          227 LLRKILEPNPVKRITIAGIKADEW  250 (421)
Q Consensus       227 li~~~L~~dP~~R~t~~eil~~~w  250 (421)
                      ||.+||+.||.+|||+.||++|.+
T Consensus       245 li~~cl~~dP~~RPs~~eil~~l~  268 (317)
T d1xkka_         245 IMVKCWMIDADSRPKFRELIIEFS  268 (317)
T ss_dssp             HHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             HHHHhCCCChhhCcCHHHHHHHHH
Confidence            999999999999999999998843

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.4e-50  Score=381.87  Aligned_cols=234  Identities=26%  Similarity=0.367  Sum_probs=189.3

Q ss_pred             eecceEEeceEeecCcEEEEEEEECC-----CCceEEEEEeecccccchhHHHHHHHHHHHHhcC-CCCCcceEEEEEEe
Q 014609           12 RLGRYELGRTLGEGNFGKVKFAQDLD-----SGLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEVLAS   85 (421)
Q Consensus        12 ~~~~y~i~~~LG~G~~g~V~~a~~~~-----~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~   85 (421)
                      ..++|++++.||+|+||+||+|.+..     +++.||||+++...  .....+.+.+|..++.++ +||||+.+++++..
T Consensus        11 ~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~--~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~   88 (299)
T d1ywna1          11 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLGACTK   88 (299)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC------CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             cHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEcccc--CcHHHHHHHHHHHHHHhhcCCCeEEEeeeeecc
Confidence            34789999999999999999998753     45789999987543  223356677888888776 68999999999865


Q ss_pred             C-CEEEEEEeccCCCChHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEec
Q 014609           86 K-SKIYMVLEYVTGGELFDKIASK----------------GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLD  148 (421)
Q Consensus        86 ~-~~~~lv~E~~~gg~L~~~i~~~----------------~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~  148 (421)
                      . ..+|+||||+++|+|.+++...                ..+++..+..++.||++||+|||++||+||||||+||||+
T Consensus        89 ~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~NILl~  168 (299)
T d1ywna1          89 PGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLS  168 (299)
T ss_dssp             TTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC
T ss_pred             CCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCccceeEC
Confidence            4 5689999999999999998643                2489999999999999999999999999999999999999


Q ss_pred             cCCCEEEEeccCCCCCccccCCCccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhhc-CC--------------
Q 014609          149 SKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIFR-GD--------------  213 (421)
Q Consensus       149 ~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~~-~~--------------  213 (421)
                      .++.+||+|||+|+..............+||+.|+|||++.+..| +.++||||+||++|++. +.              
T Consensus       169 ~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~-~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~~~~  247 (299)
T d1ywna1         169 EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVY-TIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFC  247 (299)
T ss_dssp             GGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHH
T ss_pred             CCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCC-CcccceeehHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence            999999999999986554333344556789999999999988877 58999999999999643 22              


Q ss_pred             --------cCCCCCCCHHHHHHHHHhcCCCCCCCCCHHhhhcC
Q 014609          214 --------FKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKAD  248 (421)
Q Consensus       214 --------~~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~~  248 (421)
                              ++.|..+++++.++|.+||+.||.+|||++|+++|
T Consensus       248 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~  290 (299)
T d1ywna1         248 RRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH  290 (299)
T ss_dssp             HHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHhcCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence                    22345588999999999999999999999999987

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.7e-49  Score=373.92  Aligned_cols=231  Identities=27%  Similarity=0.421  Sum_probs=186.5

Q ss_pred             ecceEEeceEeecCcEEEEEEEECCC---CceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEE
Q 014609           13 LGRYELGRTLGEGNFGKVKFAQDLDS---GLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKI   89 (421)
Q Consensus        13 ~~~y~i~~~LG~G~~g~V~~a~~~~~---~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~   89 (421)
                      -++|++++.||+|+||+||+|++..+   +..||||.++...  .....+.+.+|+.+|++++||||+++++++. ++.+
T Consensus         6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~   82 (273)
T d1mp8a_           6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT--SDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPV   82 (273)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTT--SHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSC
T ss_pred             HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEecccc--CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeE
Confidence            36899999999999999999998754   3468888875432  3344578999999999999999999999985 4678


Q ss_pred             EEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCcccc
Q 014609           90 YMVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFR  168 (421)
Q Consensus        90 ~lv~E~~~gg~L~~~i~~-~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~~  168 (421)
                      |+||||+++|+|.+++.. ...+++..++.++.||++||+|||++||+||||||+||+++.++.+||+|||+|+..... 
T Consensus        83 ~iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~~-  161 (273)
T d1mp8a_          83 WIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS-  161 (273)
T ss_dssp             EEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC-----------
T ss_pred             EEEEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeecCCCcEEEccchhheeccCC-
Confidence            999999999999988765 457999999999999999999999999999999999999999999999999999865432 


Q ss_pred             CCCccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhh-c-CCc--------------------CCCCCCCHHHHH
Q 014609          169 DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIF-R-GDF--------------------KLPKWLSPGAQN  226 (421)
Q Consensus       169 ~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~-~-~~~--------------------~~p~~~s~~~~~  226 (421)
                      ........+||+.|+|||++.+..| +.++|||||||++|.+ . |..                    +.|+.+|+++.+
T Consensus       162 ~~~~~~~~~gt~~y~apE~l~~~~~-~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  240 (273)
T d1mp8a_         162 TYYKASKGKLPIKWMAPESINFRRF-TSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYS  240 (273)
T ss_dssp             ---------CCGGGCCHHHHHHCCC-SHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCTTCCHHHHH
T ss_pred             cceeccceecCcccchhhHhccCCC-CCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHH
Confidence            1223345678999999999988887 4899999999999953 3 332                    345668999999


Q ss_pred             HHHHhcCCCCCCCCCHHhhhcC
Q 014609          227 LLRKILEPNPVKRITIAGIKAD  248 (421)
Q Consensus       227 li~~~L~~dP~~R~t~~eil~~  248 (421)
                      ||.+||+.||.+|||+.||+++
T Consensus       241 li~~cl~~dp~~Rps~~ei~~~  262 (273)
T d1mp8a_         241 LMTKCWAYDPSRRPRFTELKAQ  262 (273)
T ss_dssp             HHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHcCCCHhHCcCHHHHHHH
Confidence            9999999999999999999876

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=2.6e-49  Score=379.22  Aligned_cols=232  Identities=27%  Similarity=0.375  Sum_probs=198.6

Q ss_pred             ecceEEeceEeecCcEEEEEEEEC-----CCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCC
Q 014609           13 LGRYELGRTLGEGNFGKVKFAQDL-----DSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKS   87 (421)
Q Consensus        13 ~~~y~i~~~LG~G~~g~V~~a~~~-----~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~   87 (421)
                      .++|++++.||+|+||+||+|++.     .+++.||||+++...  .....+++.+|+.+|++++||||+++++++...+
T Consensus        12 ~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~   89 (301)
T d1lufa_          12 RNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALMAEFDNPNIVKLLGVCAVGK   89 (301)
T ss_dssp             GGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSS
T ss_pred             HHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhc--ChHHHHHHHHHHHHHHhcCCCCcccceeeeccCC
Confidence            468999999999999999999874     356889999987543  2334578999999999999999999999999999


Q ss_pred             EEEEEEeccCCCChHHHHHhcC------------------------CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCC
Q 014609           88 KIYMVLEYVTGGELFDKIASKG------------------------RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLE  143 (421)
Q Consensus        88 ~~~lv~E~~~gg~L~~~i~~~~------------------------~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~  143 (421)
                      ..+++|||+++|+|.+++....                        .+++..+..++.|++.||+|||++||+||||||+
T Consensus        90 ~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivHrDlKp~  169 (301)
T d1lufa_          90 PMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATR  169 (301)
T ss_dssp             SCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGG
T ss_pred             ceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeEeeEEccc
Confidence            9999999999999999886422                        4889999999999999999999999999999999


Q ss_pred             CEEeccCCCEEEEeccCCCCCccccCCCccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhh-cCCc--------
Q 014609          144 NILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIF-RGDF--------  214 (421)
Q Consensus       144 NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~-~~~~--------  214 (421)
                      |||++.++++||+|||+|.............+.+||+.|+|||++.+..|+ .++|||||||++|++ .+..        
T Consensus       170 NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t-~ksDVwS~Gvvl~ell~~~~~p~~~~~~  248 (301)
T d1lufa_         170 NCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYT-TESDVWAYGVVLWEIFSYGLQPYYGMAH  248 (301)
T ss_dssp             GEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTTCCTTTTSCH
T ss_pred             ceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCC-hhhhhccchhhHHHHHccCCCCCCCCCH
Confidence            999999999999999999755443333444567899999999999988885 899999999999954 3321        


Q ss_pred             -------------CCCCCCCHHHHHHHHHhcCCCCCCCCCHHhhhc
Q 014609          215 -------------KLPKWLSPGAQNLLRKILEPNPVKRITIAGIKA  247 (421)
Q Consensus       215 -------------~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~  247 (421)
                                   +.|..+++++.+||.+||+.||++|||+.||++
T Consensus       249 ~e~~~~v~~~~~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~  294 (301)
T d1lufa_         249 EEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHR  294 (301)
T ss_dssp             HHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHHcCCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence                         235568999999999999999999999999854

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.3e-49  Score=378.45  Aligned_cols=233  Identities=26%  Similarity=0.388  Sum_probs=196.5

Q ss_pred             CeeecceEEeceEeecCcEEEEEEEECCCCce--EEEEEeecccccchhHHHHHHHHHHHHhcC-CCCCcceEEEEEEeC
Q 014609           10 GMRLGRYELGRTLGEGNFGKVKFAQDLDSGLP--FAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEVLASK   86 (421)
Q Consensus        10 ~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~--vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~   86 (421)
                      -..+++|++.+.||+|+||+||+|.+..+|..  ||||.++...  .....+.+.+|+++|+++ +||||+++++++.++
T Consensus         6 ~i~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~   83 (309)
T d1fvra_           6 VLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA--SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHR   83 (309)
T ss_dssp             BCCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC--------CHHHHHHHHHTTCCCCTTBCCEEEEEEET
T ss_pred             ccCHHHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECccc--ChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecC
Confidence            34568999999999999999999999888875  6677765332  223356799999999998 799999999999999


Q ss_pred             CEEEEEEeccCCCChHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccC
Q 014609           87 SKIYMVLEYVTGGELFDKIASK----------------GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSK  150 (421)
Q Consensus        87 ~~~~lv~E~~~gg~L~~~i~~~----------------~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~  150 (421)
                      +.+|+||||++||+|.+++...                ..+++..+..++.||+.||.|||++||+||||||+|||++.+
T Consensus        84 ~~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~~~~  163 (309)
T d1fvra_          84 GYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGEN  163 (309)
T ss_dssp             TEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGG
T ss_pred             CeeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEEcCC
Confidence            9999999999999999998643                568999999999999999999999999999999999999999


Q ss_pred             CCEEEEeccCCCCCccccCCCccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhh-cCC----------------
Q 014609          151 GNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIF-RGD----------------  213 (421)
Q Consensus       151 ~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~-~~~----------------  213 (421)
                      +.+||+|||+|......   ......+||+.|+|||.+.+..| +.++|||||||++|++ .+.                
T Consensus       164 ~~~kl~DfG~a~~~~~~---~~~~~~~gt~~y~aPE~l~~~~~-~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~i  239 (309)
T d1fvra_         164 YVAKIADFGLSRGQEVY---VKKTMGRLPVRWMAIESLNYSVY-TTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKL  239 (309)
T ss_dssp             GCEEECCTTCEESSCEE---CCC----CCTTTCCHHHHHHCEE-CHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHG
T ss_pred             CceEEcccccccccccc---ccccceecCCcccchHHhccCCC-CccceeehhHHHHHHHHhcCCCCCCCCCHHHHHHHH
Confidence            99999999999865432   22345579999999999988887 5899999999999954 222                


Q ss_pred             -----cCCCCCCCHHHHHHHHHhcCCCCCCCCCHHhhhcC
Q 014609          214 -----FKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKAD  248 (421)
Q Consensus       214 -----~~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~~  248 (421)
                           ++.|..+++++.+||.+||+.||++|||+.+++++
T Consensus       240 ~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~  279 (309)
T d1fvra_         240 PQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS  279 (309)
T ss_dssp             GGTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HhcCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence                 23355689999999999999999999999999987

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-48  Score=374.19  Aligned_cols=234  Identities=27%  Similarity=0.442  Sum_probs=197.7

Q ss_pred             eeecceEEeceEeecCcEEEEEEEECCCC-------ceEEEEEeecccccchhHHHHHHHHHHHHhcC-CCCCcceEEEE
Q 014609           11 MRLGRYELGRTLGEGNFGKVKFAQDLDSG-------LPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEV   82 (421)
Q Consensus        11 ~~~~~y~i~~~LG~G~~g~V~~a~~~~~~-------~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~   82 (421)
                      ...++|++++.||+|+||.||+|++..++       ..||||++++...  ......+.+|...+.++ +||||++++++
T Consensus        10 i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~--~~~~~~~~~e~~~l~~~~~HpnIv~~~~~   87 (299)
T d1fgka_          10 LPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDAT--EKDLSDLISEMEMMKMIGKHKNIINLLGA   87 (299)
T ss_dssp             CCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCC--HHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             ccHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccC--hHHHHHHHHHHHHHHHhcCCCeEEecccc
Confidence            34589999999999999999999876544       4799999976542  23356788899988888 79999999999


Q ss_pred             EEeCCEEEEEEeccCCCChHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEE
Q 014609           83 LASKSKIYMVLEYVTGGELFDKIASK----------------GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENIL  146 (421)
Q Consensus        83 ~~~~~~~~lv~E~~~gg~L~~~i~~~----------------~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NIL  146 (421)
                      +.+++..|+||||+++|+|.+++...                ..+++..+..++.||+.||+|||++||+||||||+|||
T Consensus        88 ~~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiKp~NiL  167 (299)
T d1fgka_          88 CTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVL  167 (299)
T ss_dssp             ECSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEE
T ss_pred             cccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeeeeccccee
Confidence            99999999999999999999999754                34899999999999999999999999999999999999


Q ss_pred             eccCCCEEEEeccCCCCCccccCCCccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhhc--CCc----------
Q 014609          147 LDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIFR--GDF----------  214 (421)
Q Consensus       147 l~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~~--~~~----------  214 (421)
                      ++.++.+||+|||++...............+||+.|+|||++.+..| +.++|||||||++|.+.  |..          
T Consensus       168 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y-~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~~  246 (299)
T d1fgka_         168 VTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIY-THQSDVWSFGVLLWEIFTLGGSPYPGVPVEEL  246 (299)
T ss_dssp             ECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHH
T ss_pred             ecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCC-CchhhhHHhHHHHHHhccCCCCCCCCCCHHHH
Confidence            99999999999999997665444445566789999999999988888 59999999999999542  332          


Q ss_pred             ----------CCCCCCCHHHHHHHHHhcCCCCCCCCCHHhhhc
Q 014609          215 ----------KLPKWLSPGAQNLLRKILEPNPVKRITIAGIKA  247 (421)
Q Consensus       215 ----------~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~  247 (421)
                                +.|.++|+.+.+||.+||++||++|||+.|+++
T Consensus       247 ~~~i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~  289 (299)
T d1fgka_         247 FKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE  289 (299)
T ss_dssp             HHHHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHcCCCCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHH
Confidence                      345678999999999999999999999999986

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.1e-49  Score=368.17  Aligned_cols=225  Identities=25%  Similarity=0.460  Sum_probs=187.9

Q ss_pred             eeecceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEe-CCEE
Q 014609           11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLAS-KSKI   89 (421)
Q Consensus        11 ~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~-~~~~   89 (421)
                      ..+++|++++.||+|+||.||+|++  +|+.||||+++++.     ..+.+.+|++++++++||||+++++++.+ ++.+
T Consensus         4 i~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~i~~~~-----~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~   76 (262)
T d1byga_           4 LNMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGL   76 (262)
T ss_dssp             CCGGGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCCC-------HHHHHTHHHHTTCCCTTBCCEEEEECCC--CC
T ss_pred             cCHHHeEEeEEEecCCCeEEEEEEE--CCeEEEEEEECcHH-----HHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcE
Confidence            3467899999999999999999997  57899999997543     24678999999999999999999998854 5678


Q ss_pred             EEEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCccc
Q 014609           90 YMVLEYVTGGELFDKIASK--GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHF  167 (421)
Q Consensus        90 ~lv~E~~~gg~L~~~i~~~--~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~  167 (421)
                      |+||||+++|+|.+++...  ..+++..++.++.||+.||.|||+.+|+||||||+|||++.+|.+||+|||++..... 
T Consensus        77 ~lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~-  155 (262)
T d1byga_          77 YIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS-  155 (262)
T ss_dssp             EEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC-------
T ss_pred             EEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccchHhheecCCCCEeecccccceecCC-
Confidence            9999999999999998654  3589999999999999999999999999999999999999999999999999985432 


Q ss_pred             cCCCccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhhc--CC--------------------cCCCCCCCHHHH
Q 014609          168 RDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIFR--GD--------------------FKLPKWLSPGAQ  225 (421)
Q Consensus       168 ~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~~--~~--------------------~~~p~~~s~~~~  225 (421)
                          .....++|+.|+|||++.+..+ +.++|||||||++|++.  +.                    .++|+.+++.+.
T Consensus       156 ----~~~~~~~~~~y~aPE~l~~~~~-t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  230 (262)
T d1byga_         156 ----TQDTGKLPVKWTAPEALREKKF-STKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVY  230 (262)
T ss_dssp             ----------CCTTTSCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCCCCCCTTCCHHHH
T ss_pred             ----CCccccccccCCChHHHhCCCC-ChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCccCCHHHH
Confidence                3345678999999999988877 58999999999999653  22                    234566889999


Q ss_pred             HHHHHhcCCCCCCCCCHHhhhcC
Q 014609          226 NLLRKILEPNPVKRITIAGIKAD  248 (421)
Q Consensus       226 ~li~~~L~~dP~~R~t~~eil~~  248 (421)
                      +||.+||+.||.+|||+.+++++
T Consensus       231 ~li~~cl~~dP~~Rps~~~l~~~  253 (262)
T d1byga_         231 EVMKNCWHLDAAMRPSFLQLREQ  253 (262)
T ss_dssp             HHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHcccCHhHCcCHHHHHHH
Confidence            99999999999999999999773

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.5e-48  Score=372.49  Aligned_cols=239  Identities=22%  Similarity=0.301  Sum_probs=203.7

Q ss_pred             eecceEEeceEeecCcEEEEEEEEC-----CCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeC
Q 014609           12 RLGRYELGRTLGEGNFGKVKFAQDL-----DSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASK   86 (421)
Q Consensus        12 ~~~~y~i~~~LG~G~~g~V~~a~~~-----~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~   86 (421)
                      ..++|++++.||+|+||+||+|.+.     .+++.||||+++...  .......+.+|+.++++++||||+++++++..+
T Consensus        18 ~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~--~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~   95 (308)
T d1p4oa_          18 AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA--SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQG   95 (308)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS--CHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSS
T ss_pred             cHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECccc--ChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecC
Confidence            3489999999999999999999874     246789999997543  233356789999999999999999999999999


Q ss_pred             CEEEEEEeccCCCChHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEE
Q 014609           87 SKIYMVLEYVTGGELFDKIASK----------GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKIS  156 (421)
Q Consensus        87 ~~~~lv~E~~~gg~L~~~i~~~----------~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~  156 (421)
                      ...++||||+++|+|.+++...          ..+++..+..++.|+++||.|||+++|+||||||+|||++.++++||+
T Consensus        96 ~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLld~~~~~Kl~  175 (308)
T d1p4oa_          96 QPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIG  175 (308)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCCEEEC
T ss_pred             CceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceeecCCceEEEe
Confidence            9999999999999999987642          247889999999999999999999999999999999999999999999


Q ss_pred             eccCCCCCccccCCCccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhhc-C---------------------Cc
Q 014609          157 DFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIFR-G---------------------DF  214 (421)
Q Consensus       157 DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~~-~---------------------~~  214 (421)
                      |||+|...............+||+.|+|||.+.+..++ .++|||||||++|++. +                     ..
T Consensus       176 DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~-~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~i~~~~~~  254 (308)
T d1p4oa_         176 DFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFT-TYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLL  254 (308)
T ss_dssp             CTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTTCCC
T ss_pred             ecccceeccCCcceeeccceecccccCCHHHHccCCCC-cccccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCCCC
Confidence            99999866543333344555789999999999988874 8999999999999432 2                     12


Q ss_pred             CCCCCCCHHHHHHHHHhcCCCCCCCCCHHhhhc------Cccccc
Q 014609          215 KLPKWLSPGAQNLLRKILEPNPVKRITIAGIKA------DEWFEQ  253 (421)
Q Consensus       215 ~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~------~~w~~~  253 (421)
                      +.|+.+|+.+.++|.+||+.||++|||+.++++      +|+|++
T Consensus       255 ~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~~~~~~  299 (308)
T d1p4oa_         255 DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFRE  299 (308)
T ss_dssp             CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCTTHHH
T ss_pred             CCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCCCcC
Confidence            345678999999999999999999999999987      566653

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.6e-48  Score=372.17  Aligned_cols=233  Identities=28%  Similarity=0.404  Sum_probs=201.1

Q ss_pred             eecceEEeceEeecCcEEEEEEEE-----CCCCceEEEEEeecccccchhHHHHHHHHHHHHhcC-CCCCcceEEEEEEe
Q 014609           12 RLGRYELGRTLGEGNFGKVKFAQD-----LDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEVLAS   85 (421)
Q Consensus        12 ~~~~y~i~~~LG~G~~g~V~~a~~-----~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~   85 (421)
                      .-++|++++.||+|+||+||+|++     ..+++.||||+++...  .......+.+|+.+++++ +|||||++++++.+
T Consensus        21 ~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~   98 (311)
T d1t46a_          21 PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA--HLTEREALMSELKVLSYLGNHMNIVNLLGACTI   98 (311)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             CHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECccc--CHHHHHHHHHHHHHHHhccCCCCEEEEEEEEee
Confidence            347999999999999999999985     3567899999997654  233456789999999999 69999999999999


Q ss_pred             CCEEEEEEeccCCCChHHHHHhcC------------------CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEe
Q 014609           86 KSKIYMVLEYVTGGELFDKIASKG------------------RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILL  147 (421)
Q Consensus        86 ~~~~~lv~E~~~gg~L~~~i~~~~------------------~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl  147 (421)
                      +...|+||||+++|+|.+++....                  .+++..++.++.||+.||+|||++||+||||||+|||+
T Consensus        99 ~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLKp~NIl~  178 (311)
T d1t46a_          99 GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILL  178 (311)
T ss_dssp             SSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE
T ss_pred             CCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeecccccccccc
Confidence            999999999999999999987533                  58999999999999999999999999999999999999


Q ss_pred             ccCCCEEEEeccCCCCCccccCCCccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhhc-CCc------------
Q 014609          148 DSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIFR-GDF------------  214 (421)
Q Consensus       148 ~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~~-~~~------------  214 (421)
                      +.++.+||+|||++...............+||+.|+|||++.+..+ +.++|||||||++|++. ++.            
T Consensus       179 ~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~~  257 (311)
T d1t46a_         179 THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVY-TFESDVWSYGIFLWELFSLGSSPYPGMPVDSKF  257 (311)
T ss_dssp             ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHH
T ss_pred             cccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCC-CCcccccchHHHHHHHHhCCCCCCCCCCHHHHH
Confidence            9999999999999987654333334455689999999999988777 58999999999999653 221            


Q ss_pred             ----------CCCCCCCHHHHHHHHHhcCCCCCCCCCHHhhhc
Q 014609          215 ----------KLPKWLSPGAQNLLRKILEPNPVKRITIAGIKA  247 (421)
Q Consensus       215 ----------~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~  247 (421)
                                ..|..+|+.+.+||.+||++||.+|||+++|++
T Consensus       258 ~~~i~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~  300 (311)
T d1t46a_         258 YKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ  300 (311)
T ss_dssp             HHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHhcCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence                      224557899999999999999999999999986

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-48  Score=367.47  Aligned_cols=233  Identities=27%  Similarity=0.416  Sum_probs=185.0

Q ss_pred             ecceEEeceEeecCcEEEEEEEEC-CCC--ceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCCEE
Q 014609           13 LGRYELGRTLGEGNFGKVKFAQDL-DSG--LPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKI   89 (421)
Q Consensus        13 ~~~y~i~~~LG~G~~g~V~~a~~~-~~~--~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~   89 (421)
                      -++|++++.||+|+||+||+|+.. .++  ..||||++.+.........+.+.+|+.+|++++||||+++++++.+ ...
T Consensus         7 ~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~   85 (273)
T d1u46a_           7 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPM   85 (273)
T ss_dssp             GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSC
T ss_pred             hHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cch
Confidence            368999999999999999999864 333  4789999987665555556789999999999999999999999976 467


Q ss_pred             EEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCcccc
Q 014609           90 YMVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFR  168 (421)
Q Consensus        90 ~lv~E~~~gg~L~~~i~~-~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~~  168 (421)
                      ++||||+++|+|.+.+.. .+.+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++......
T Consensus        86 ~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~~~  165 (273)
T d1u46a_          86 KMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQND  165 (273)
T ss_dssp             EEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECCC-C
T ss_pred             heeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhccccccceeeccchhhhhcccCC
Confidence            899999999999987765 4579999999999999999999999999999999999999999999999999998654322


Q ss_pred             CCC-ccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhh-c-CCcC---------------------CCCCCCHHH
Q 014609          169 DDG-LLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIF-R-GDFK---------------------LPKWLSPGA  224 (421)
Q Consensus       169 ~~~-~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~-~-~~~~---------------------~p~~~s~~~  224 (421)
                      ... ......||+.|+|||++.+..+ +.++|||||||++|++ . |..|                     .|+.+|+.+
T Consensus       166 ~~~~~~~~~~~~~~~~aPE~~~~~~~-~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~l  244 (273)
T d1u46a_         166 DHYVMQEHRKVPFAWCAPESLKTRTF-SHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQDI  244 (273)
T ss_dssp             CEEEC-----CCGGGCCHHHHHHCEE-EHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCCCCTTCCHHH
T ss_pred             CcceecCccccCcccCCHHHHhCCCC-CcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHHhCCCCCCCcccccHHH
Confidence            211 2334467889999999988776 5889999999999954 3 4433                     234588999


Q ss_pred             HHHHHHhcCCCCCCCCCHHhhhc
Q 014609          225 QNLLRKILEPNPVKRITIAGIKA  247 (421)
Q Consensus       225 ~~li~~~L~~dP~~R~t~~eil~  247 (421)
                      .+||.+||++||++|||+.+|++
T Consensus       245 ~~li~~cl~~dp~~RPt~~ei~~  267 (273)
T d1u46a_         245 YNVMVQCWAHKPEDRPTFVALRD  267 (273)
T ss_dssp             HHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHcCCChhHCcCHHHHHH
Confidence            99999999999999999999863

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.4e-46  Score=359.97  Aligned_cols=229  Identities=24%  Similarity=0.324  Sum_probs=192.2

Q ss_pred             EEeceEeecCcEEEEEEEECCCC---ceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEe-CCEEEEE
Q 014609           17 ELGRTLGEGNFGKVKFAQDLDSG---LPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLAS-KSKIYMV   92 (421)
Q Consensus        17 ~i~~~LG~G~~g~V~~a~~~~~~---~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~-~~~~~lv   92 (421)
                      .+.+.||+|+||+||+|.+..++   ..||||.+++.  .+....+++.+|+++|++++||||+++++++.. ++..++|
T Consensus        30 ~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~--~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv  107 (311)
T d1r0pa_          30 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI--TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV  107 (311)
T ss_dssp             EEEEEEEEETTEEEEEEEECC----CEEEEEEEECCC--CCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEE
T ss_pred             ccceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcc--cCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEE
Confidence            34678999999999999986543   36899998643  244456889999999999999999999999865 5689999


Q ss_pred             EeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccCCCCCccccC--
Q 014609           93 LEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD--  169 (421)
Q Consensus        93 ~E~~~gg~L~~~i~~~-~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~--  169 (421)
                      |||+++|+|.+++... ..+++..+..++.|++.||.|||+.+|+||||||+|||+++++.+||+|||+++.......  
T Consensus       108 ~E~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~~  187 (311)
T d1r0pa_         108 LPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDS  187 (311)
T ss_dssp             EECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCCC
T ss_pred             EEEeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeECCCCCEEEecccchhhcccccccc
Confidence            9999999999988754 4577889999999999999999999999999999999999999999999999986543211  


Q ss_pred             CCccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhhc-CCc---------------------CCCCCCCHHHHHH
Q 014609          170 DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIFR-GDF---------------------KLPKWLSPGAQNL  227 (421)
Q Consensus       170 ~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~~-~~~---------------------~~p~~~s~~~~~l  227 (421)
                      ........||+.|+|||++....+ +.++||||||+++|++. +..                     ..|+.+++.+.+|
T Consensus       188 ~~~~~~~~gt~~y~aPE~~~~~~~-~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~g~~~~~p~~~~~~l~~l  266 (311)
T d1r0pa_         188 VHNKTGAKLPVKWMALESLQTQKF-TTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYEV  266 (311)
T ss_dssp             TTCTTCSSCCGGGSCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHHTTCCCCCCTTCCHHHHHH
T ss_pred             ceecccccccccccChHHHhcCCC-CChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCcccCcHHHHHH
Confidence            122334568999999999988777 58999999999999542 222                     2356688999999


Q ss_pred             HHHhcCCCCCCCCCHHhhhcC
Q 014609          228 LRKILEPNPVKRITIAGIKAD  248 (421)
Q Consensus       228 i~~~L~~dP~~R~t~~eil~~  248 (421)
                      |.+||+.||++|||+.||++|
T Consensus       267 i~~cl~~dP~~RPs~~ei~~~  287 (311)
T d1r0pa_         267 MLKCWHPKAEMRPSFSELVSR  287 (311)
T ss_dssp             HHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHcCCCHhHCcCHHHHHHH
Confidence            999999999999999999987

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=2.5e-46  Score=357.85  Aligned_cols=239  Identities=23%  Similarity=0.309  Sum_probs=195.3

Q ss_pred             eeec-ceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCC-cceEEEEEEeCCE
Q 014609           11 MRLG-RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN-VVRLHEVLASKSK   88 (421)
Q Consensus        11 ~~~~-~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpn-Iv~l~~~~~~~~~   88 (421)
                      +++| +|++++.||+|+||+||+|++..+|+.||||++.....     ...+.+|+++++.++|+| |+.+.+++.+.+.
T Consensus         3 ~~vg~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~-----~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~   77 (299)
T d1ckia_           3 LRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK-----HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDY   77 (299)
T ss_dssp             CEETTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT-----SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTE
T ss_pred             CeECCEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc-----CHHHHHHHHHHHHccCCCcccEEEEEEecCCE
Confidence            4564 79999999999999999999999999999999876432     235788999999998766 5556677788899


Q ss_pred             EEEEEeccCCCChHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecc---CCCEEEEeccCCCCC
Q 014609           89 IYMVLEYVTGGELFDKIA-SKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDS---KGNIKISDFGLSALP  164 (421)
Q Consensus        89 ~~lv~E~~~gg~L~~~i~-~~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~---~~~~kL~DFGla~~~  164 (421)
                      .++||||+ +++|.+.+. ..+.+++..+..++.|++.||+|||++||+||||||+|||++.   +..+||+|||+|...
T Consensus        78 ~~ivme~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~  156 (299)
T d1ckia_          78 NVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY  156 (299)
T ss_dssp             EEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEEC
T ss_pred             EEEEEEEc-CCchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCcceec
Confidence            99999999 556666554 4568999999999999999999999999999999999999864   457999999999865


Q ss_pred             ccccC-----CCccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhh-cCCcCCC---------------------
Q 014609          165 QHFRD-----DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIF-RGDFKLP---------------------  217 (421)
Q Consensus       165 ~~~~~-----~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~-~~~~~~p---------------------  217 (421)
                      .....     .......+||+.|+|||++.+.+| +.++|||||||++|++ .|..|++                     
T Consensus       157 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~  235 (299)
T d1ckia_         157 RDARTHQHIPYRENKNLTGTARYASINTHLGIEQ-SRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMST  235 (299)
T ss_dssp             BCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCC-CHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHS
T ss_pred             cccccccceeccccCCcCCCccccCHHHHhCCCC-CChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCC
Confidence            43221     123345689999999999998887 5899999999999944 4544442                     


Q ss_pred             ------CCCCHHHHHHHHHhcCCCCCCCCCHH---hhhcCcccccccc
Q 014609          218 ------KWLSPGAQNLLRKILEPNPVKRITIA---GIKADEWFEQDYT  256 (421)
Q Consensus       218 ------~~~s~~~~~li~~~L~~dP~~R~t~~---eil~~~w~~~~~~  256 (421)
                            +.+|+++.++|.+||+.||.+||+++   ++++|+|.+..+.
T Consensus       236 ~~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~~~~~  283 (299)
T d1ckia_         236 PIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFS  283 (299)
T ss_dssp             CHHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHHHTCC
T ss_pred             ChhHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHHcCCC
Confidence                  23678899999999999999999987   4577887765443

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=3.4e-45  Score=349.13  Aligned_cols=227  Identities=18%  Similarity=0.228  Sum_probs=194.1

Q ss_pred             cceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCC-CCcceEEEEEEeCCEEEEE
Q 014609           14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKH-PNVVRLHEVLASKSKIYMV   92 (421)
Q Consensus        14 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~h-pnIv~l~~~~~~~~~~~lv   92 (421)
                      ++|++++.||+|+||+||+|++..+|+.||||+++....     ...+.+|+++++.++| +||+.+++++......|+|
T Consensus         5 ~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~-----~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~v   79 (293)
T d1csna_           5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD-----APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLV   79 (293)
T ss_dssp             TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT-----SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEE
T ss_pred             CceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccC-----cHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEE
Confidence            689999999999999999999999999999999865432     2357789999999975 8999999999999999999


Q ss_pred             EeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecc-----CCCEEEEeccCCCCCcc
Q 014609           93 LEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDS-----KGNIKISDFGLSALPQH  166 (421)
Q Consensus        93 ~E~~~gg~L~~~i~~~-~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~-----~~~~kL~DFGla~~~~~  166 (421)
                      |||+ |++|.+.+... ..+++..+..++.|++.||+|||++||+||||||+|||++.     ++.+||+|||+|+....
T Consensus        80 me~~-~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~  158 (293)
T d1csna_          80 IDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRD  158 (293)
T ss_dssp             EECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBC
T ss_pred             EEec-CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEcccceeEEccc
Confidence            9999 78999988764 47999999999999999999999999999999999999974     57899999999986543


Q ss_pred             ccC-----CCccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhh-hcCCcCCC-----------------------
Q 014609          167 FRD-----DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYI-FRGDFKLP-----------------------  217 (421)
Q Consensus       167 ~~~-----~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~-~~~~~~~p-----------------------  217 (421)
                      ...     .......+||+.|+|||++.+..+ +.++|||||||++|+ +.|..|++                       
T Consensus       159 ~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~-~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~~~  237 (293)
T d1csna_         159 PVTKQHIPYREKKNLSGTARYMSINTHLGREQ-SRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPL  237 (293)
T ss_dssp             TTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCC-CHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCH
T ss_pred             CccccceeecccCceEEchhhcCHHHhcCCCC-ChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCCCh
Confidence            211     123445689999999999998877 589999999999995 44555442                       


Q ss_pred             ----CCCCHHHHHHHHHhcCCCCCCCCCHHhhhc
Q 014609          218 ----KWLSPGAQNLLRKILEPNPVKRITIAGIKA  247 (421)
Q Consensus       218 ----~~~s~~~~~li~~~L~~dP~~R~t~~eil~  247 (421)
                          +.+|+++.+++..|+..+|++||+.+.+.+
T Consensus       238 ~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~  271 (293)
T d1csna_         238 RELCAGFPEEFYKYMHYARNLAFDATPDYDYLQG  271 (293)
T ss_dssp             HHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred             HHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence                237789999999999999999999877654

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-45  Score=353.81  Aligned_cols=228  Identities=25%  Similarity=0.340  Sum_probs=180.0

Q ss_pred             cceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCcceEEEEEEeCC----EE
Q 014609           14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKS----KI   89 (421)
Q Consensus        14 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~----~~   89 (421)
                      .+|.+.+.||+|+||.||+|++  +|+.||||+++....    ......+|+..+..++||||+++++++.+.+    .+
T Consensus         3 ~~~~l~~~iG~G~fg~Vy~~~~--~g~~vAvK~~~~~~~----~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~   76 (303)
T d1vjya_           3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREE----RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQL   76 (303)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEE--TTEEEEEEEECGGGH----HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccch----hHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEE
Confidence            5799999999999999999985  689999999864321    1122334555556789999999999997654    68


Q ss_pred             EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh--------CCceeccCCCCCEEeccCCCEEEEeccCC
Q 014609           90 YMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHN--------KGVFHRDLKLENILLDSKGNIKISDFGLS  161 (421)
Q Consensus        90 ~lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~ql~~aL~~LH~--------~gi~HrDlkp~NILl~~~~~~kL~DFGla  161 (421)
                      |+||||+++|+|.+++.+ .++++.....++.|++.||+|||+        +||+||||||+||||+.++.+||+|||++
T Consensus        77 ~lv~Ey~~~g~L~~~l~~-~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~  155 (303)
T d1vjya_          77 WLVSDYHEHGSLFDYLNR-YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA  155 (303)
T ss_dssp             EEEEECCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred             EEEEecccCCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCcc
Confidence            999999999999999976 469999999999999999999996        59999999999999999999999999999


Q ss_pred             CCCccccC--CCccccccCCCCccChhhhcccCC-----CCCcchHHHHHHHHhhhcCCcCCC-----------------
Q 014609          162 ALPQHFRD--DGLLHTTCGSPNYVAPEVLANRGY-----DGATSDIWSCGVILYIFRGDFKLP-----------------  217 (421)
Q Consensus       162 ~~~~~~~~--~~~~~~~~gt~~y~APEvl~~~~~-----~~~~~DiwSlGvil~~~~~~~~~p-----------------  217 (421)
                      ........  .......+||+.|+|||++.+...     .+.++|||||||+||++.++.+++                 
T Consensus       156 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~  235 (303)
T d1vjya_         156 VRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSD  235 (303)
T ss_dssp             EEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSS
T ss_pred             ccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhccccc
Confidence            86533211  123445789999999999875431     146799999999999654321110                 


Q ss_pred             ----------------CCC---------CHHHHHHHHHhcCCCCCCCCCHHhhhcC
Q 014609          218 ----------------KWL---------SPGAQNLLRKILEPNPVKRITIAGIKAD  248 (421)
Q Consensus       218 ----------------~~~---------s~~~~~li~~~L~~dP~~R~t~~eil~~  248 (421)
                                      +.+         +..+.+|+.+||+.||.+|||+.|++++
T Consensus       236 ~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~  291 (303)
T d1vjya_         236 PSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT  291 (303)
T ss_dssp             CCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHH
T ss_pred             chHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence                            011         1247899999999999999999998763

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=4.6e-44  Score=350.66  Aligned_cols=235  Identities=26%  Similarity=0.451  Sum_probs=190.0

Q ss_pred             Ceee--cceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCC-----------CCCc
Q 014609           10 GMRL--GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK-----------HPNV   76 (421)
Q Consensus        10 ~~~~--~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~-----------hpnI   76 (421)
                      |..+  +||++++.||+|+||+||+|++..+|+.||||++++..    ...+.+.+|+.+++.++           ||||
T Consensus         7 g~~~~~~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~----~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~i   82 (362)
T d1q8ya_           7 GEPYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK----VYTEAAEDEIKLLQRVNDADNTKEDSMGANHI   82 (362)
T ss_dssp             TCEETTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH----HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTB
T ss_pred             CCCccCCcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc----cchHHHHHHHHHHHHhcchhhhhhhhcCcCce
Confidence            4444  57999999999999999999999999999999997643    22467788999988775           5789


Q ss_pred             ceEEEEEEe--CCEEEEEEeccCCCChHHHH---HhcCCCCHHHHHHHHHHHHHHHHHHHh-CCceeccCCCCCEEeccC
Q 014609           77 VRLHEVLAS--KSKIYMVLEYVTGGELFDKI---ASKGRLQEAEGRKLFQQLIDGVSYCHN-KGVFHRDLKLENILLDSK  150 (421)
Q Consensus        77 v~l~~~~~~--~~~~~lv~E~~~gg~L~~~i---~~~~~~~~~~~~~~~~ql~~aL~~LH~-~gi~HrDlkp~NILl~~~  150 (421)
                      +++++++..  ....+++|+++..+......   .....+++..++.++.|++.||+|||+ .||+||||||+|||++.+
T Consensus        83 v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~  162 (362)
T d1q8ya_          83 LKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIV  162 (362)
T ss_dssp             CCCCEEEEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEE
T ss_pred             EEEEEEeeeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeecc
Confidence            999988754  45677777777655433322   234578999999999999999999998 899999999999999876


Q ss_pred             CC------EEEEeccCCCCCccccCCCccccccCCCCccChhhhcccCCCCCcchHHHHHHHHhhh-cCCcCCC------
Q 014609          151 GN------IKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYIF-RGDFKLP------  217 (421)
Q Consensus       151 ~~------~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~~~-~~~~~~p------  217 (421)
                      +.      ++++|||.|.....     .....+||+.|+|||++...+|+ .++||||+||+++.+ .|..++.      
T Consensus       163 ~~~~~~~~~kl~dfg~s~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlG~il~el~~g~~pF~~~~~~~  236 (362)
T d1q8ya_         163 DSPENLIQIKIADLGNACWYDE-----HYTNSIQTREYRSPEVLLGAPWG-CGADIWSTACLIFELITGDFLFEPDEGHS  236 (362)
T ss_dssp             ETTTTEEEEEECCCTTCEETTB-----CCCSCCSCGGGCCHHHHHTCCCC-THHHHHHHHHHHHHHHHSSCCC-------
T ss_pred             CcccccceeeEeeccccccccc-----ccccccccccccChhhccccCCC-ccccccchHHHHHHHHHCCCCCCCCcccc
Confidence            64      99999999874332     23566899999999999988884 899999999999843 2332211      


Q ss_pred             -------------------------------------------------------------CCCCHHHHHHHHHhcCCCC
Q 014609          218 -------------------------------------------------------------KWLSPGAQNLLRKILEPNP  236 (421)
Q Consensus       218 -------------------------------------------------------------~~~s~~~~~li~~~L~~dP  236 (421)
                                                                                   ...++.+.+||.+||+.||
T Consensus       237 ~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP  316 (362)
T d1q8ya_         237 YTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDP  316 (362)
T ss_dssp             --CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSST
T ss_pred             ccchhHHHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCCh
Confidence                                                                         0124678999999999999


Q ss_pred             CCCCCHHhhhcCcccccc
Q 014609          237 VKRITIAGIKADEWFEQD  254 (421)
Q Consensus       237 ~~R~t~~eil~~~w~~~~  254 (421)
                      .+|||++|+|+||||+..
T Consensus       317 ~~Rpta~e~L~Hp~f~~~  334 (362)
T d1q8ya_         317 RKRADAGGLVNHPWLKDT  334 (362)
T ss_dssp             TTCBCHHHHHTCGGGTTC
T ss_pred             hHCcCHHHHhcCcccCCC
Confidence            999999999999999843

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.94  E-value=6.1e-27  Score=207.98  Aligned_cols=135  Identities=20%  Similarity=0.276  Sum_probs=108.2

Q ss_pred             eEEeceEeecCcEEEEEEEECCCCceEEEEEeeccccc---------------chhHHHHHHHHHHHHhcCCCCCcceEE
Q 014609           16 YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRII---------------HLKITDQIKREIATLKLLKHPNVVRLH   80 (421)
Q Consensus        16 y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~---------------~~~~~~~~~~Ei~il~~l~hpnIv~l~   80 (421)
                      |.++++||+|+||+||+|++ .+|+.||||+++.....               .........+|...+.++.|++++..+
T Consensus         2 ~~vg~~IG~G~~g~Vy~a~~-~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~   80 (191)
T d1zara2           2 DAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVY   80 (191)
T ss_dssp             SEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEE
T ss_pred             chhCCEeeeCcceEEEEEEC-CCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEE
Confidence            56899999999999999998 57999999987642110               011123456789999999999999988


Q ss_pred             EEEEeCCEEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEeccCCCEEEEeccC
Q 014609           81 EVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGL  160 (421)
Q Consensus        81 ~~~~~~~~~~lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~ql~~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGl  160 (421)
                      ++..    .+++|||+++..+.       .++...+..++.|++.+|+|||++||+||||||+|||++++ .++|+|||+
T Consensus        81 ~~~~----~~lvme~~~~~~~~-------~l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~~-~~~liDFG~  148 (191)
T d1zara2          81 AWEG----NAVLMELIDAKELY-------RVRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEE-GIWIIDFPQ  148 (191)
T ss_dssp             EEET----TEEEEECCCCEEGG-------GCCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEETT-EEEECCCTT
T ss_pred             EecC----CEEEEEeecccccc-------chhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeeeCC-CEEEEECCC
Confidence            7632    27999999886553       25566678899999999999999999999999999999865 599999999


Q ss_pred             CCC
Q 014609          161 SAL  163 (421)
Q Consensus       161 a~~  163 (421)
                      |..
T Consensus       149 a~~  151 (191)
T d1zara2         149 SVE  151 (191)
T ss_dssp             CEE
T ss_pred             ccc
Confidence            864

>d1ul7a_ d.129.6.1 (A:) Map/microtubule affinity-regulating kinase 3 {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: TBP-like
superfamily: KA1-like
family: Kinase associated domain 1, KA1
domain: Map/microtubule affinity-regulating kinase 3
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=99.49  E-value=8.5e-14  Score=108.18  Aligned_cols=87  Identities=15%  Similarity=0.273  Sum_probs=79.6

Q ss_pred             eeEEecCCHHHHHHHHHHHHHhcCcEEEEe-CCeeEEEeecCCCCccCceEEEEEEEEec-CceEEEEEEccCCChhhHH
Q 014609          321 IRFTSNHSAKDLLERIEDIVTEMGFRVQKK-NGKLKATQEHKPQKSLGSLSVAAEVFEIS-PSLYVVELRKSYGDPTVYR  398 (421)
Q Consensus       321 ~~f~s~~~~~~i~~~l~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~~~~i~~~~-~~~~~v~~~k~~Gd~le~~  398 (421)
                      ...+|..+|++|+.+|+++++.+|+.|+++ ++.+++...+++++  +.++|.+||+++. +++++|+|+|..||+++|+
T Consensus        13 v~tTS~~~P~eIm~eI~rvL~~lgv~~~~~g~y~l~c~~~~~~~~--~~v~fEieV~kv~~~~l~gv~~kR~~Gd~~~yk   90 (102)
T d1ul7a_          13 MKTTSSMDPSDMMREIRKVLGANNCDYEQRERFLLFCVHGDGHAE--NLVQWEMEVCKLPRLSLNGVRFKRISGTSIAFK   90 (102)
T ss_dssp             CCCCBCSCHHHHHHHHHHHHHHTTCEEEECSTTCEEEEECSSCGG--GCEEEEEEEEECSSSSSEEEEEEEEESCHHHHH
T ss_pred             eecCcCCCHHHHHHHHHHHHHHcCcEEEEcCCEEEEEEecCCCCC--ceEEEEEEEEEcCCCceEEEEEEEccCCHHHHH
Confidence            345689999999999999999999999775 58999999888888  9999999999996 7999999999999999999


Q ss_pred             HHHHHHHhhcC
Q 014609          399 QLCNKLSSDLG  409 (421)
Q Consensus       399 ~~~~~l~~~l~  409 (421)
                      ++|.+|...|+
T Consensus        91 ~l~~~il~~l~  101 (102)
T d1ul7a_          91 NIASKIANELK  101 (102)
T ss_dssp             HHHHHHHHHCC
T ss_pred             HHHHHHHHhcc
Confidence            99999998875

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.73  E-value=1.8e-08  Score=91.31  Aligned_cols=142  Identities=14%  Similarity=0.102  Sum_probs=98.5

Q ss_pred             eeecceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCC-CCCcceEEEEEEeCCEE
Q 014609           11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK-HPNVVRLHEVLASKSKI   89 (421)
Q Consensus        11 ~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~~   89 (421)
                      ..++.|++.+..+.++.+.||+..  ..++.+.+|+........   ...+.+|...++.+. +--+.+++.+...++..
T Consensus        11 ~~~~~~~~~~~~~G~s~~~v~rv~--~~~~~~vlk~~~~~~~~~---~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~   85 (263)
T d1j7la_          11 KLIEKYRCVKDTEGMSPAKVYKLV--GENENLYLKMTDSRYKGT---TYDVEREKDMMLWLEGKLPVPKVLHFERHDGWS   85 (263)
T ss_dssp             HHHTTSEEEECSCCCSSSEEEEEE--CSSCEEEEEEECGGGTTS---TTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEE
T ss_pred             HhhhceEEEEcCCCCCCCcEEEEE--eCCCeEEEEEcCCCcccc---hhhHHHHHHHHHHHhccCCCCcEEEEEecCCce
Confidence            346788888876666678999885  566778889876443222   345778888887774 43467888888899999


Q ss_pred             EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-------------------------------------
Q 014609           90 YMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHN-------------------------------------  132 (421)
Q Consensus        90 ~lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~ql~~aL~~LH~-------------------------------------  132 (421)
                      |+||++++|..+.+.....     .....++.++...++.||+                                     
T Consensus        86 ~lv~~~l~G~~~~~~~~~~-----~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (263)
T d1j7la_          86 NLLMSEADGVLCSEEYEDE-----QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEE  160 (263)
T ss_dssp             EEEEECCSSEEHHHHTTTC-----SCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGST
T ss_pred             EEEEEeccccccccccccc-----ccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccc
Confidence            9999999998775543211     1122233444444444442                                     


Q ss_pred             ----------------------CCceeccCCCCCEEeccCCCEEEEeccCCC
Q 014609          133 ----------------------KGVFHRDLKLENILLDSKGNIKISDFGLSA  162 (421)
Q Consensus       133 ----------------------~gi~HrDlkp~NILl~~~~~~kL~DFGla~  162 (421)
                                            ..++|+|+.|.|||+++++..-|.||+.+.
T Consensus       161 ~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~  212 (263)
T d1j7la_         161 DTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG  212 (263)
T ss_dssp             TCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred             cccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence                                  137999999999999877666799999876

>d2v8qa1 d.129.6.2 (A:396-548) 5'-AMP-activated protein kinase catalytic subunit alpha-1, AMPK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: TBP-like
superfamily: KA1-like
family: Ssp2 C-terminal domain-like
domain: 5'-AMP-activated protein kinase catalytic subunit alpha-1, AMPK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=98.48  E-value=1.3e-06  Score=70.25  Aligned_cols=73  Identities=8%  Similarity=0.235  Sum_probs=62.0

Q ss_pred             eEEecCCHHHHHHHHHHHHHhcCcEEEE-eCCeeEEEeecCCCCccCceEEEEEEEEecCceEEEEEEccCCChhh
Q 014609          322 RFTSNHSAKDLLERIEDIVTEMGFRVQK-KNGKLKATQEHKPQKSLGSLSVAAEVFEISPSLYVVELRKSYGDPTV  396 (421)
Q Consensus       322 ~f~s~~~~~~i~~~l~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~l~~~~~i~~~~~~~~~v~~~k~~Gd~le  396 (421)
                      .+-|+..|.+|+..|..+++.+|+.|++ +.|.|++........  ..+.|.+++|++.++.|||||++..|+-.|
T Consensus         4 GIrS~s~P~dIM~eVyrALk~L~~eWk~~~~y~ir~R~~~~~~~--~~~Km~lQLYqv~~~~YLLDfk~i~~~~~e   77 (153)
T d2v8qa1           4 GIRSQSRPNDIMAEVCRAIKQLDYEWKVVNPYYLRVRRKNPVTS--TFSKMSLQLYQVDSRTYLLDFRSIDDEITE   77 (153)
T ss_dssp             SEEECSCHHHHHHHHHHHHHHTTCEEEEEETTEEEEEEECTTTC--CEEEEEEEEEECSSSCEEEEEEEECCC---
T ss_pred             ccccCCCHHHHHHHHHHHHHHcCCeEEecCceEEEEEEECCCCC--ceeEEEEEEEEEcCCceEEEeeecCcchhc
Confidence            3567889999999999999999999987 568899988755544  789999999999999999999999888544

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=98.24  E-value=7.4e-07  Score=79.82  Aligned_cols=81  Identities=19%  Similarity=0.172  Sum_probs=56.0

Q ss_pred             ecceEEeceEeecC-cEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCC--CCcceEEEEEEeCCEE
Q 014609           13 LGRYELGRTLGEGN-FGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKH--PNVVRLHEVLASKSKI   89 (421)
Q Consensus        13 ~~~y~i~~~LG~G~-~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~h--pnIv~l~~~~~~~~~~   89 (421)
                      +..++.. .+..|. -+.||+... ..+..+.+|.-....      ...+.+|...++.+..  -.+.+++.+..+++..
T Consensus        10 l~g~~~~-~~~~G~s~~~v~r~~~-~~~~~~vlK~~~~~~------~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~   81 (255)
T d1nd4a_          10 LFGYDWA-QQTIGCSDAAVFRLSA-QGRPVLFVKTDLSGA------LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRD   81 (255)
T ss_dssp             TTTCEEE-ECSCTTSSCEEEEEEC-TTSCCEEEEEECSCT------TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCE
T ss_pred             ccCCceE-EcCCcccCCeEEEEEe-CCCCEEEEEeCCccC------HhHHHHHHHHHHHHHhcCCCCCceeeecccccce
Confidence            3345553 344454 468898874 567778999865432      2346778888877743  3367788888888899


Q ss_pred             EEEEeccCCCCh
Q 014609           90 YMVLEYVTGGEL  101 (421)
Q Consensus        90 ~lv~E~~~gg~L  101 (421)
                      ++||++++|.++
T Consensus        82 ~~v~~~i~G~~~   93 (255)
T d1nd4a_          82 WLLLGEVPGQDL   93 (255)
T ss_dssp             EEEEECCSSEET
T ss_pred             EEEEEeeecccc
Confidence            999999988665

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=98.23  E-value=1.4e-06  Score=83.76  Aligned_cols=81  Identities=17%  Similarity=0.182  Sum_probs=50.4

Q ss_pred             eceEeecCcEEEEEEEECCCCceEEEEEeecc-cccc---hhHHHHHHHHHHHHhcCC-C--CCcceEEEEEEeCCEEEE
Q 014609           19 GRTLGEGNFGKVKFAQDLDSGLPFAVKILEKN-RIIH---LKITDQIKREIATLKLLK-H--PNVVRLHEVLASKSKIYM   91 (421)
Q Consensus        19 ~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~-~~~~---~~~~~~~~~Ei~il~~l~-h--pnIv~l~~~~~~~~~~~l   91 (421)
                      .+.||.|....||++.+..+++.++||.-... ....   ....++...|.+.|+.+. +  ..+.+++.+  ++...++
T Consensus        31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l  108 (392)
T d2pula1          31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT  108 (392)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred             EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEE
Confidence            45789999999999988778889999965321 1000   011345667888887663 2  345566654  4445678


Q ss_pred             EEeccCCCCh
Q 014609           92 VLEYVTGGEL  101 (421)
Q Consensus        92 v~E~~~gg~L  101 (421)
                      |||++.+..+
T Consensus       109 vmE~L~~~~~  118 (392)
T d2pula1         109 VMEDLSHLKI  118 (392)
T ss_dssp             EECCCTTSEE
T ss_pred             EEeccCCccc
Confidence            9999987554

>d2qrda1 d.129.6.2 (A:450-576) Snf1-like protein kinase ssp2 {Schizosaccharomyces pombe [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: TBP-like
superfamily: KA1-like
family: Ssp2 C-terminal domain-like
domain: Snf1-like protein kinase ssp2
species: Schizosaccharomyces pombe [TaxId: 4896]

Probab=97.97  E-value=2.3e-05  Score=61.50  Aligned_cols=92  Identities=12%  Similarity=0.175  Sum_probs=68.0

Q ss_pred             cceeeEEecCCHHHHHHHHHHHHHhcCcEEEEeC----------CeeEEEeecCCC---CccCceEEEEEEEEecCceEE
Q 014609          318 ERKIRFTSNHSAKDLLERIEDIVTEMGFRVQKKN----------GKLKATQEHKPQ---KSLGSLSVAAEVFEISPSLYV  384 (421)
Q Consensus       318 ~~~~~f~s~~~~~~i~~~l~~~~~~~~~~~~~~~----------~~~~~~~~~~~~---~~~~~l~~~~~i~~~~~~~~~  384 (421)
                      +.....-|+..|-+|+-.|..|++.+|+.|++-+          +.|+++...+..   .....+.|.+++|++.++.+|
T Consensus         2 KWhfGIRSrs~P~eiM~eVYrALk~Lg~eWk~~~~~~~~~~~d~y~Ir~R~~~~~~~~~~~~~~vkm~iQLYqve~~~YL   81 (127)
T d2qrda1           2 KWHFGVRCRGDAPEILLAVYRALQRAGAQFTVPKPVNGKYRSDMYTIKSRWEIPHCKREGKNTYAYIELQLYEVMPGCFM   81 (127)
T ss_dssp             CCEESEEEESCHHHHHHHHHHHHHHHTCEECCCCCBTTBCCGGGGEEEEEEECHHHHHTTCCEEEEEEEEEEEEETTEEE
T ss_pred             CceeccccCCChHHHHHHHHHHHHHcCCEEeecCcccccccCCceEEEEEeecCCccccCCCceEEEEEEEEEEcCCcEE
Confidence            3445566889999999999999999999998643          558887432211   111457889999999999999


Q ss_pred             EEEE------ccCC-------------ChhhHHHHHHHHHhhcC
Q 014609          385 VELR------KSYG-------------DPTVYRQLCNKLSSDLG  409 (421)
Q Consensus       385 v~~~------k~~G-------------d~le~~~~~~~l~~~l~  409 (421)
                      |||+      ...+             .+++|-.+|.+|.-.|.
T Consensus        82 lDFK~dg~e~~~~~~~~~~~~~~~~~~s~~pFldl~a~LI~qL~  125 (127)
T d2qrda1          82 LDVKSNGYKDIYSHPERTADHGMDDLKSSFPFLDLCAMLVCKLF  125 (127)
T ss_dssp             EEEEEEEEEESCC-------------CCCTTHHHHHHHHHHHHH
T ss_pred             EEEccCCcccccCCccccccCccccccCCccHHHHHHHHHHHHh
Confidence            9998      2222             25779999998776653

>d2qlva1 d.129.6.2 (A:460-630) Carbon catabolite-derepressing protein kinase SNF1 {Saccharomyces cerevisiae [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: TBP-like
superfamily: KA1-like
family: Ssp2 C-terminal domain-like
domain: Carbon catabolite-derepressing protein kinase SNF1
species: Saccharomyces cerevisiae [TaxId: 4932]

Probab=97.62  E-value=0.00012  Score=60.30  Aligned_cols=91  Identities=19%  Similarity=0.277  Sum_probs=63.8

Q ss_pred             cceeeEEecCCHHHHHHHHHHHHHhcCcEEEEeC----CeeEEEeecCC-------CCccCceEEEEEEEEecCceEEEE
Q 014609          318 ERKIRFTSNHSAKDLLERIEDIVTEMGFRVQKKN----GKLKATQEHKP-------QKSLGSLSVAAEVFEISPSLYVVE  386 (421)
Q Consensus       318 ~~~~~f~s~~~~~~i~~~l~~~~~~~~~~~~~~~----~~~~~~~~~~~-------~~~~~~l~~~~~i~~~~~~~~~v~  386 (421)
                      ++....-|+..|-+|+..|..|++.+|+.|++.+    +.|++....+.       ......+.|.+++|++.++.||||
T Consensus        45 kWhfGIRSrs~P~eiM~evykALk~Lg~eWk~~~~~~~~~ir~Rwk~~~~~~~~~~~~~~~~vk~~iQLYqv~~~~YLlD  124 (171)
T d2qlva1          45 RWHFGIRSRSYPLDVMGEIYIALKNLGAEWAKPSEEDLWTIKLRWKYDIGNKTNTNEKIPDLMKMVIQLFQIETNNYLVD  124 (171)
T ss_dssp             CCEESEEECSCHHHHHHHHHHHHHHHTCEECCCC---CCEEEEEEC--------------CEEEEEEEEEC---CCEEEE
T ss_pred             eeeeecccCCCHHHHHHHHHHHHHHcCCEEeecCCCCceEEEEEeecCCCcccccCCCCCceEEEEEEEEEEcCCceEEE
Confidence            4556677999999999999999999999997643    66888753211       111245789999999999999999


Q ss_pred             EEcc-----CC----------------ChhhHHHHHHHHHhhc
Q 014609          387 LRKS-----YG----------------DPTVYRQLCNKLSSDL  408 (421)
Q Consensus       387 ~~k~-----~G----------------d~le~~~~~~~l~~~l  408 (421)
                      |+-.     .|                .+++|-.+|.+|.-.|
T Consensus       125 FK~~g~e~~~~~~~~~~~~~~~e~~~~Sp~pFldlca~LI~qL  167 (171)
T d2qlva1         125 FKFDGWESSYGDDTTVSNISEDEMSTFSAYPFLHLTTKLIMEL  167 (171)
T ss_dssp             EEEEEEEC--------------CHHHHTSHHHHHHHHHHHHHH
T ss_pred             EecCCccccccccccccccCCCcccCcCCccHHHHHHHHHHHH
Confidence            9731     12                2367888888776655

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=97.36  E-value=0.00034  Score=64.61  Aligned_cols=69  Identities=26%  Similarity=0.280  Sum_probs=45.7

Q ss_pred             cEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCCCCc-----ceE--EEEEEeCCEEEEEEeccCCC
Q 014609           27 FGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNV-----VRL--HEVLASKSKIYMVLEYVTGG   99 (421)
Q Consensus        27 ~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnI-----v~l--~~~~~~~~~~~lv~E~~~gg   99 (421)
                      --.||++.. .+|+.|++|+.+.... +   .+++..|...+..|...++     +..  -..+...+..+.++++++|.
T Consensus        35 EN~vy~v~~-~dg~~~VlK~~rp~~~-s---~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~  109 (325)
T d1zyla1          35 ENRVYQFQD-EDRRRFVVKFYRPERW-T---ADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGR  109 (325)
T ss_dssp             SSEEEEECC-TTCCCEEEEEECTTTS-C---HHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCE
T ss_pred             cceeEEEEc-CCCCEEEEEEeCCCCC-C---HHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCc
Confidence            357999974 6889999999865432 1   4667888888877752221     111  11234567889999999874


Q ss_pred             C
Q 014609          100 E  100 (421)
Q Consensus       100 ~  100 (421)
                      .
T Consensus       110 ~  110 (325)
T d1zyla1         110 Q  110 (325)
T ss_dssp             E
T ss_pred             C
Confidence            3

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=97.22  E-value=0.00059  Score=64.73  Aligned_cols=77  Identities=10%  Similarity=0.124  Sum_probs=52.1

Q ss_pred             ceEEeceEeecCcEEEEEEEECC-------CCceEEEEEeecccccchhHHHHHHHHHHHHhcCC-CCCcceEEEEEEeC
Q 014609           15 RYELGRTLGEGNFGKVKFAQDLD-------SGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK-HPNVVRLHEVLASK   86 (421)
Q Consensus        15 ~y~i~~~LG~G~~g~V~~a~~~~-------~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~   86 (421)
                      ..++ +.|+.|-.-.+|++....       .++.|.+++.-...    . .....+|..+++.+. +.-..++++++.+ 
T Consensus        44 ~l~v-~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~~----~-~idr~~E~~i~~~ls~~gl~Pkll~~~~~-  116 (395)
T d1nw1a_          44 HLRI-SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE----T-ESHLVAESVIFTLLSERHLGPKLYGIFSG-  116 (395)
T ss_dssp             GEEE-EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC----C-HHHHHHHHHHHHHHHHTTSSSCEEEEETT-
T ss_pred             ceEE-EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCcc----h-hhHHHHHHHHHHHHHhCCCCCeEEEEcCC-
Confidence            3444 678889999999998643       34568888764221    1 235668999999885 4334577777643 


Q ss_pred             CEEEEEEeccCCCCh
Q 014609           87 SKIYMVLEYVTGGEL  101 (421)
Q Consensus        87 ~~~~lv~E~~~gg~L  101 (421)
                         ++|+||++|..|
T Consensus       117 ---g~I~efi~g~~l  128 (395)
T d1nw1a_         117 ---GRLEEYIPSRPL  128 (395)
T ss_dssp             ---EEEECCCCEEEC
T ss_pred             ---ceEEEEeccccC
Confidence               588999987543

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=96.50  E-value=0.0052  Score=55.74  Aligned_cols=142  Identities=15%  Similarity=0.165  Sum_probs=75.2

Q ss_pred             cceEEeceEeecCcEEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHhcCCC-----CCcceEE---EEEEe
Q 014609           14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKH-----PNVVRLH---EVLAS   85 (421)
Q Consensus        14 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~h-----pnIv~l~---~~~~~   85 (421)
                      |+..-.+.|..|---+.|+... .+| .+++|+.....  .   .+.+..|++++..|..     |..+...   .+..-
T Consensus        18 g~~~~~~~i~~G~~N~ny~v~t-~~g-~yVLri~~~~~--~---~~~l~~~~~~l~~L~~~g~pvp~pi~~~~g~~~~~~   90 (316)
T d2ppqa1          18 GSLTSYKGIAEGVENSNFLLHT-TKD-PLILTLYEKRV--E---KNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGEL   90 (316)
T ss_dssp             CCEEEEEEECC---EEEEEEEE-SSC-CEEEEEECC--------CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEE
T ss_pred             CCceEeecCCCCcccCeEEEEE-CCC-cEEEEEcCCCC--C---HHHHHHHHHHHHhhhhccccccccceecCCCcceee
Confidence            3334445566777788999874 344 58999986432  1   2345667777766642     2222110   01233


Q ss_pred             CCEEEEEEeccCCCChH--------------HHHHh---c------CCCCH------------------HHHHHHHHHHH
Q 014609           86 KSKIYMVLEYVTGGELF--------------DKIAS---K------GRLQE------------------AEGRKLFQQLI  124 (421)
Q Consensus        86 ~~~~~lv~E~~~gg~L~--------------~~i~~---~------~~~~~------------------~~~~~~~~ql~  124 (421)
                      ....+.++.++.|....              ..+..   .      .....                  ......+..+.
T Consensus        91 ~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~  170 (316)
T d2ppqa1          91 SGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEI  170 (316)
T ss_dssp             TTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHH
T ss_pred             ecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcchhHHHHHHHHH
Confidence            45677777777664321              00100   0      00011                  11112222222


Q ss_pred             HHHHHHHh----CCceeccCCCCCEEeccCCCEEEEeccCCC
Q 014609          125 DGVSYCHN----KGVFHRDLKLENILLDSKGNIKISDFGLSA  162 (421)
Q Consensus       125 ~aL~~LH~----~gi~HrDlkp~NILl~~~~~~kL~DFGla~  162 (421)
                      ..+.-.+.    .|+||+|+.++|++++.++..-|.||+.+.
T Consensus       171 ~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~  212 (316)
T d2ppqa1         171 DYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC  212 (316)
T ss_dssp             HHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             HhhhccCccccccccccCCcchhhhhcccccceeEecccccc
Confidence            33333222    479999999999999988777899999886